{"meta":{"query_hash":"b7c0148e4fc6","filters":{"venue":"Cancer Research"},"cohort_total":7379,"direct_labels_cover":8,"predictions_cover":7379,"exported":7379,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b7c0148e4fc6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Research"},"results":[{"id":"W1017173493","doi":"10.1158/1538-7445.sabcs14-p4-11-04","title":"Abstract P4-11-04: Intrinsic subtypes and BCL2 as predictive and prognostic biomarkers in the TACT2 trial (CRUK/05/019)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Capecitabine; Medicine; Internal medicine; Oncology; Tissue microarray; Predictive marker; Immunohistochemistry; Breast cancer; Cancer; Pathology; Colorectal cancer","score_opus":0.14191170795308158,"score_gpt":0.46231688462889625,"score_spread":0.3204051766758147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1017173493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97316897,0.0012198486,0.000020913176,0.02169884,0.0000469283,0.001977744,0.000011757429,0.000042623204,0.0018123521],"genre_scores_gemma":[0.99755156,0.00074671174,0.00017361718,0.00027399888,0.0002600226,0.0008454922,0.000011430751,0.0000139560225,0.00012322066],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99851537,0.00012429747,0.00018349812,0.0002923913,0.00057503907,0.0003094238],"domain_scores_gemma":[0.998769,0.00047438356,0.000033181943,0.00026563698,0.00018157635,0.0002762315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018060275,0.00009379078,0.00017229575,0.00015547764,0.00008471337,0.000057903293,0.00014791341,0.00008316343,0.000053376363],"category_scores_gemma":[0.0013716407,0.00006046972,0.00001973173,0.0004119738,0.00053014525,0.00006547197,0.00009401704,0.000514103,0.00000951611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04334395,0.0018749959,0.16622666,0.0010085962,0.00041214537,0.00073622,0.008192884,0.0000014226874,0.01475056,0.005950705,0.58958185,0.16792],"study_design_scores_gemma":[0.08496277,0.007554554,0.52636814,0.0025328598,0.00033232986,0.00041846253,0.0072934274,0.0012871813,0.009725657,0.023057947,0.3355878,0.0008788721],"about_ca_topic_score_codex":0.0020737522,"about_ca_topic_score_gemma":0.00011613115,"teacher_disagreement_score":0.3601415,"about_ca_system_score_codex":0.000084867075,"about_ca_system_score_gemma":0.0004697849,"threshold_uncertainty_score":0.3134907},"labels":[],"label_agreement":null},{"id":"W1028621643","doi":"10.1158/1538-7445.sabcs14-p2-07-03","title":"Abstract P2-07-03: Pax-5 regulates EMT and MET in breast cancer through FAK1 regulation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Metastasis; Malignancy; Medicine; Oncology; Biology; Internal medicine","score_opus":0.15565740993192523,"score_gpt":0.43974590841737077,"score_spread":0.28408849848544554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1028621643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97336346,0.009558826,0.0000026690288,0.012621548,0.00016994071,0.000604207,0.00005800945,0.000041787862,0.0035795309],"genre_scores_gemma":[0.99308306,0.0042709806,0.00013271593,0.0002629807,0.00051089836,0.0004952761,0.000019230358,0.000044949058,0.0011799163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751306,0.00011651939,0.00031973113,0.0005301389,0.00091266655,0.00060786546],"domain_scores_gemma":[0.99860734,0.0000781929,0.00006458373,0.000379859,0.00056897686,0.0003010603],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010874104,0.00018227132,0.00036981617,0.00020918314,0.00010503659,0.00007703894,0.0001466197,0.00016512557,0.0014069388],"category_scores_gemma":[0.0000713267,0.00015099673,0.000053557436,0.0006647792,0.00027795671,0.00031783822,0.00011162439,0.00052714377,0.000058270278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004089723,0.00058787625,0.5548284,0.0013052225,0.00032186843,0.00010357261,0.0075829583,0.00033288836,0.081362255,0.0014708554,0.16343933,0.18457507],"study_design_scores_gemma":[0.0033646503,0.00025747102,0.93943995,0.0011204035,0.000047201494,0.000030627412,0.0015091947,0.00017951269,0.02559875,0.0017425389,0.026408954,0.00030076946],"about_ca_topic_score_codex":0.011222868,"about_ca_topic_score_gemma":0.0010299564,"teacher_disagreement_score":0.38461155,"about_ca_system_score_codex":0.0007438861,"about_ca_system_score_gemma":0.0006187132,"threshold_uncertainty_score":0.99950594},"labels":[],"label_agreement":null},{"id":"W1032191575","doi":"","title":"A role of Wnt signalling pathway in the hematopoietic differentiation of murine embryonic stem cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Wnt signaling pathway; Embryonic stem cell; Stem cell; Cell biology; Embryoid body; Cellular differentiation; Haematopoiesis; Cancer stem cell; Molecular biology; Adult stem cell; Immunology; Cancer research; Signal transduction; Genetics","score_opus":0.06541200029445488,"score_gpt":0.3572740243322902,"score_spread":0.29186202403783534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1032191575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596524,0.0028332358,0.000028594723,0.00051957363,0.000026836235,0.0004469217,0.0000040395694,0.0000037500083,0.00017178265],"genre_scores_gemma":[0.99964523,0.0001303546,0.000009682295,0.000010489582,0.00005059071,0.00006132198,0.0000021642163,0.0000050126464,0.00008515853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894255,0.00019133344,0.00019399665,0.00019313015,0.00029858778,0.0001803793],"domain_scores_gemma":[0.9993567,0.00009471441,0.000048192578,0.00027192544,0.0002014567,0.00002705178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011501869,0.00005350165,0.0001849826,0.00009132015,0.00003083343,0.0000023243192,0.00012346519,0.000057054764,0.000049103564],"category_scores_gemma":[0.000044310033,0.00003332815,0.000044843648,0.000283601,0.00018529092,0.000021533728,0.000035282217,0.00028847947,0.000003903734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007719422,0.00025457528,0.0075886413,0.00026030216,0.000020852367,0.0000029868472,0.0021221458,0.00006859044,0.9871403,0.00044245922,0.000004649927,0.0013225573],"study_design_scores_gemma":[0.00056384905,0.00020823849,0.1404701,0.00015042996,0.0000054294433,0.0000017463134,0.00086908846,0.00001152572,0.8558589,0.0018018442,0.00003369463,0.000025120795],"about_ca_topic_score_codex":0.00026485493,"about_ca_topic_score_gemma":0.0000561684,"teacher_disagreement_score":0.13288146,"about_ca_system_score_codex":0.000100266916,"about_ca_system_score_gemma":0.00022446281,"threshold_uncertainty_score":0.13590825},"labels":[],"label_agreement":null},{"id":"W1136136811","doi":"10.1158/1538-7445.am2015-256","title":"Abstract 256: Identification of additional cancers likely to respond to anti-PD-1 therapy (pembrolizumab): Evaluation of PD-L1 expression in a large molecular tumor profiling gene expression database","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Melanoma; Cancer; PD-L1; Oncology; Internal medicine; Database; Cancer research; Immunotherapy","score_opus":0.1575729984442325,"score_gpt":0.463054980766536,"score_spread":0.3054819823223035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1136136811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921824,0.0029600263,0.0002353076,0.00040769437,0.00015714532,0.0023063899,0.0015965399,0.000014779381,0.00013972541],"genre_scores_gemma":[0.99643445,0.00031470874,0.001010469,0.0001536553,0.00013188619,0.001258837,0.0005792189,0.00003941385,0.0000773373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953846,0.00044151006,0.00069958856,0.0005546497,0.0024657678,0.00045389638],"domain_scores_gemma":[0.9969915,0.00012974584,0.00021858122,0.0006688293,0.0017161096,0.00027520204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005428395,0.00017389824,0.00034721696,0.0008403823,0.0000755012,0.000024387424,0.0002863276,0.000096234326,0.001269867],"category_scores_gemma":[0.0007701871,0.00015487091,0.0000832829,0.0012104425,0.00009987742,0.00021316946,0.00010668843,0.00029996858,0.000012555838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017538833,0.00023829885,0.0009524902,0.00015747585,0.000032803462,0.000015050828,0.0009530114,0.00071752054,0.9682708,0.000005888004,0.006952104,0.004165744],"study_design_scores_gemma":[0.005449822,0.00033819757,0.03826834,0.0014328768,0.000012899621,0.0000035168632,0.00056522025,0.00028488,0.9519706,0.000039073537,0.0014905764,0.00014401646],"about_ca_topic_score_codex":0.00081463356,"about_ca_topic_score_gemma":0.00010704512,"teacher_disagreement_score":0.03731585,"about_ca_system_score_codex":0.0012528626,"about_ca_system_score_gemma":0.0029324892,"threshold_uncertainty_score":0.9996431},"labels":[],"label_agreement":null},{"id":"W1136861330","doi":"","title":"Regression of primary breast tumor and blockage of osteolytic skeletal metastasis by a non-RGD based integrin binding peptide (ATN-161) targeting α5β1 and αvβ3 in a xenograft model of breast cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Metastasis; Breast cancer; Cancer; Primary tumor; Cancer research; Malignancy; Internal medicine; Pathology; Oncology","score_opus":0.04095124760478549,"score_gpt":0.36835342815493677,"score_spread":0.3274021805501513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1136861330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420613,0.0032959722,0.000024244478,0.00087660016,0.000019939867,0.000756699,0.00072173675,0.000007923864,0.00009076202],"genre_scores_gemma":[0.99805486,0.0005830145,0.00092430314,0.000041942796,0.000019640176,0.00020006916,0.000035526893,0.000034746903,0.000105895655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99773556,0.00010801188,0.00053897133,0.00040036681,0.00067402044,0.0005430559],"domain_scores_gemma":[0.99880826,0.00012793117,0.00020637277,0.00024088363,0.00030822674,0.0003083084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083480787,0.00020650281,0.0007088168,0.00051458244,0.00007725909,0.000008079358,0.00009826563,0.00008920249,0.000057118363],"category_scores_gemma":[0.00006521598,0.00015590113,0.00006820343,0.000630329,0.00038351348,0.00010670929,0.00011766106,0.00048147482,5.629083e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038099943,0.00096275384,0.28094733,0.007041052,0.00020220049,0.00009522629,0.0014169246,0.0002691158,0.6852087,0.000014936056,0.00046808677,0.019563716],"study_design_scores_gemma":[0.050376948,0.002470298,0.46847925,0.030413372,0.0005864859,0.0003099774,0.002606902,0.01103324,0.43261325,0.00018628356,0.00007196767,0.00085201836],"about_ca_topic_score_codex":0.0139251845,"about_ca_topic_score_gemma":0.00076891383,"teacher_disagreement_score":0.25259542,"about_ca_system_score_codex":0.0004838079,"about_ca_system_score_gemma":0.0014334783,"threshold_uncertainty_score":0.99264115},"labels":[],"label_agreement":null},{"id":"W1138223905","doi":"10.1158/1538-7445.sabcs14-p3-07-25","title":"Abstract P3-07-25: 2 year survival analysis of triple negative breast cancer from SEER data","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Oncology; Internal medicine; Population; Surveillance, Epidemiology, and End Results; Epidemiology; Cohort; Stage (stratigraphy); Cancer; Incidence (geometry); Disease; Ethnic group; Multivariate analysis; Cancer registry","score_opus":0.15301081720977786,"score_gpt":0.4337342604534813,"score_spread":0.28072344324370346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1138223905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773613,0.004358995,0.00003339985,0.0012019237,0.00036066814,0.00025243097,0.014759746,0.00001208311,0.001659419],"genre_scores_gemma":[0.99608123,0.0014418209,0.00009643777,0.00003791445,0.0005725237,0.00011225247,0.001045321,0.000028522063,0.00058398617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789023,0.00015073459,0.00023166642,0.00067065796,0.00064757006,0.00040915865],"domain_scores_gemma":[0.9978838,0.00007037279,0.00009581546,0.0010373032,0.0007298479,0.00018289317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005633601,0.00017255258,0.00037317144,0.00015394487,0.00008431246,0.000028904731,0.0006695757,0.00011710256,0.00068605423],"category_scores_gemma":[0.0001388415,0.00015028311,0.00009738907,0.0007210558,0.00030131903,0.000015468731,0.00066448265,0.00018931346,0.00002975661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005389853,0.0007498063,0.68369055,0.00009340168,0.02445776,0.00003112941,0.0020849332,0.0008514201,0.09775285,0.00008739891,0.1600254,0.024785511],"study_design_scores_gemma":[0.0029911858,0.00010594262,0.94744694,0.0000627228,0.0008300667,8.9094766e-7,0.0020540694,0.00010800376,0.029376065,0.00013970223,0.016492032,0.00039235214],"about_ca_topic_score_codex":0.04657764,"about_ca_topic_score_gemma":0.015203961,"teacher_disagreement_score":0.26375642,"about_ca_system_score_codex":0.00018040773,"about_ca_system_score_gemma":0.00069245696,"threshold_uncertainty_score":0.9597713},"labels":[],"label_agreement":null},{"id":"W1161004126","doi":"10.1158/0008-5472.can-15-0908","title":"Cell Death Identification in Anticancer Therapy—Letter","year":2015,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Clonogenic assay; Programmed cell death; Cancer; Identification (biology); Cell; Cancer cell; Medicine; Biology; Cancer research; Apoptosis; Genetics; Internal medicine","score_opus":0.09143240220311963,"score_gpt":0.38733877597874444,"score_spread":0.2959063737756248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1161004126","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38707188,0.048890665,0.00068169105,0.55120444,0.0030646375,0.003337054,0.000246233,0.000053326843,0.005450044],"genre_scores_gemma":[0.34367448,0.04441156,0.00029894375,0.39357457,0.041987285,0.0023104218,0.005130299,0.0005232795,0.16808918],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975929,0.00026627228,0.0002595583,0.000664347,0.0006763166,0.0005405602],"domain_scores_gemma":[0.998829,0.000016791755,0.00008260738,0.0006251737,0.00038683502,0.0000595816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000840826,0.0002038859,0.00019471138,0.0002379912,0.00007309744,0.00007972371,0.0003862222,0.0008040725,0.00015061417],"category_scores_gemma":[0.000022005566,0.00018247323,0.00007906832,0.00022757903,0.00009134211,0.0000048894276,0.00012502228,0.0010106538,0.000055939694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035218218,0.00001777134,0.000105990934,0.000044708548,0.000012624524,0.000020577261,0.000028645412,0.000023588571,0.295859,0.0000032284029,0.7020667,0.0017818847],"study_design_scores_gemma":[0.00043616843,0.00007673785,0.00025873556,0.000033794055,0.0000044072785,0.000001628904,0.00000737006,0.00002190031,0.11655418,0.00025823756,0.88214123,0.00020560926],"about_ca_topic_score_codex":0.00035796335,"about_ca_topic_score_gemma":0.00006441504,"teacher_disagreement_score":0.1800745,"about_ca_system_score_codex":0.00017507856,"about_ca_system_score_gemma":0.00042772514,"threshold_uncertainty_score":0.7441042},"labels":[],"label_agreement":null},{"id":"W1175362930","doi":"","title":"Radiation and Cisplatin activation of EBV in nasopharyngeal cancer: Understanding the oncolytic potential of EBV","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"BZLF1; Lytic cycle; Transactivation; Nasopharyngeal carcinoma; Cancer research; Cisplatin; Epstein–Barr virus; Biology; Chromatin immunoprecipitation; Oncolytic virus; Gene expression; Molecular biology; Gene; Virus; Immunology; Medicine; Radiation therapy; Genetics; Herpesviridae; Chemotherapy; Internal medicine","score_opus":0.06231959474109398,"score_gpt":0.3848915594018078,"score_spread":0.3225719646607138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1175362930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255013,0.002639545,0.00011641063,0.002423443,0.00006685622,0.00047698512,0.000017994906,0.000006285131,0.0017023744],"genre_scores_gemma":[0.9981853,0.0013350813,0.000007622502,0.000042716943,0.00012487457,0.00006232236,0.000011899998,0.000012857941,0.00021736897],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873435,0.00009589186,0.00024117793,0.00016314664,0.0005192953,0.00024615382],"domain_scores_gemma":[0.9994903,0.000119512144,0.00011000198,0.00011502541,0.00012683064,0.000038283742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055955217,0.00007173154,0.0002037819,0.000213056,0.00008906808,0.0000118885,0.00006635788,0.0000814182,0.00009785388],"category_scores_gemma":[0.00006619201,0.000056948757,0.000036150366,0.00059144886,0.00018372602,0.00008669848,0.00002673947,0.00026901506,4.185245e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005300292,0.0004917624,0.3471051,0.0013191733,0.0002963283,0.000022680224,0.0046003517,0.011186169,0.5360587,0.0077321795,0.014559034,0.07132825],"study_design_scores_gemma":[0.023214914,0.0013456969,0.81921625,0.0018744582,0.00020051372,0.000004906995,0.01203221,0.014664099,0.110964045,0.015145443,0.00091503025,0.00042241722],"about_ca_topic_score_codex":0.016557233,"about_ca_topic_score_gemma":0.001533267,"teacher_disagreement_score":0.4721112,"about_ca_system_score_codex":0.0010416465,"about_ca_system_score_gemma":0.0005493988,"threshold_uncertainty_score":0.9899916},"labels":[],"label_agreement":null},{"id":"W1184463969","doi":"10.1158/1538-7445.am2015-lb-185","title":"Abstract LB-185: The effects of plasma folate and other B vitamins on breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Cancer; Population; Oncology; Cancer prevention; Internal medicine; BRCA mutation; Vitamin B12; Diet and cancer; Biomarker; Gynecology; Genetics; Biology; Environmental health","score_opus":0.04711938928321144,"score_gpt":0.39257323724404114,"score_spread":0.3454538479608297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1184463969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940145,0.0030793424,6.276149e-7,0.001113508,0.00009226301,0.00081067573,0.00009133928,0.000010160202,0.00078759715],"genre_scores_gemma":[0.9968041,0.0022293336,0.0000056869567,0.00008009906,0.00016079581,0.0001662096,0.0000027975523,0.00003209401,0.000518892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979549,0.00022539632,0.00019746032,0.00033858803,0.0008124826,0.00047119445],"domain_scores_gemma":[0.998523,0.0005709678,0.00005369708,0.00028208617,0.0002835587,0.00028668228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013522996,0.0001364851,0.00025618976,0.0003282242,0.00010897332,0.000041345073,0.00012446185,0.00012033907,0.000054174998],"category_scores_gemma":[0.0004173991,0.00008969401,0.00003153061,0.00050089986,0.0004569297,0.00009301097,0.00008030138,0.00076387264,0.000010477845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006193439,0.00039483243,0.5080472,0.0021612924,0.00055392575,0.00043257253,0.015616469,0.00011696549,0.10233528,0.0001757865,0.006781162,0.35719106],"study_design_scores_gemma":[0.006916801,0.0013257626,0.95343727,0.0010158245,0.00005125246,0.000049856695,0.0017303249,0.0007672884,0.031757634,0.000220145,0.0025428692,0.00018500148],"about_ca_topic_score_codex":0.019983556,"about_ca_topic_score_gemma":0.003490384,"teacher_disagreement_score":0.44539002,"about_ca_system_score_codex":0.00031819916,"about_ca_system_score_gemma":0.0005049686,"threshold_uncertainty_score":0.98654246},"labels":[],"label_agreement":null},{"id":"W1185137088","doi":"10.1158/1538-7445.sabcs14-p6-10-15","title":"Abstract P6-10-15: Association between vitamin D supplementation and mammographic density change over time in women at high risk for breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Vitamin D and neurology; Confounding; Logistic regression; Prospective cohort study; Cancer; Internal medicine; Gynecology; Oncology; Breast biopsy; Mammography; Obstetrics","score_opus":0.08381447351200427,"score_gpt":0.4045966829330621,"score_spread":0.32078220942105784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1185137088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993633,0.00042012162,0.0000016065655,0.0020349098,0.00010215222,0.0011548034,0.0025989895,0.000020291922,0.000034139284],"genre_scores_gemma":[0.9948437,0.0013138202,0.000013453272,0.000095509095,0.0007578127,0.0010726347,0.00017432748,0.000032453103,0.001696268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795204,0.00009302923,0.0002367395,0.00037255517,0.00071812334,0.00062749017],"domain_scores_gemma":[0.9987911,0.00020657809,0.00012414581,0.00017235924,0.0003877575,0.0003180768],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016567257,0.00013898886,0.00031818677,0.00033078942,0.00012634067,0.00004161283,0.00007392142,0.0001476379,0.0019060186],"category_scores_gemma":[0.00008484478,0.00012927772,0.000045181627,0.000441265,0.000071153765,0.00018470336,0.000079657206,0.00031826925,0.000020966649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012216084,0.000041321964,0.9418701,0.00010645259,0.00011170273,0.000003803854,0.0016697826,0.0000014986223,0.001418145,0.0000017598071,0.025430998,0.028122814],"study_design_scores_gemma":[0.0043289615,0.00019555526,0.9883375,0.00010172352,0.000049249073,8.366688e-7,0.00017618567,0.000028324523,0.0008934062,0.000109962464,0.005645423,0.00013284881],"about_ca_topic_score_codex":0.050034568,"about_ca_topic_score_gemma":0.019889776,"teacher_disagreement_score":0.04646741,"about_ca_system_score_codex":0.004419127,"about_ca_system_score_gemma":0.00026407442,"threshold_uncertainty_score":0.9994027},"labels":[],"label_agreement":null},{"id":"W1185608525","doi":"","title":"Molecular RB1 gene detection of minimal residual disease in metastatic retinoblastoma","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Retinoblastoma; Bone marrow; Pathology; Neuroblastoma; Enucleation; Allele; Cancer research; Minimal residual disease; Medicine; Primary tumor; Biology; Cancer; Gene; Metastasis; Internal medicine; Genetics; Cell culture","score_opus":0.041826177962937014,"score_gpt":0.4018419785198209,"score_spread":0.36001580055688387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1185608525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962877,0.0023445901,0.000027512719,0.00051621406,0.000032449945,0.0003884711,0.000015633092,0.000009935355,0.000377512],"genre_scores_gemma":[0.99918765,0.00004554024,0.00019367172,0.00002081198,0.000056584726,0.00013961455,0.000015940475,0.00001442876,0.0003257534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872077,0.00021324474,0.00017788916,0.00021453405,0.00039892065,0.000274675],"domain_scores_gemma":[0.999464,0.00006467533,0.00003038911,0.00020122087,0.00014244436,0.0000973162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003615986,0.0000723075,0.00017518386,0.00025437263,0.00004073526,0.000004882069,0.000054578606,0.000046000147,0.00007457805],"category_scores_gemma":[0.000112945585,0.00006443972,0.00004595135,0.0003883671,0.0001699908,0.00003024846,0.00003410803,0.0002116912,0.00001867086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003597593,0.00071948086,0.19916634,0.00022588656,0.000117485426,0.0028182222,0.00007611477,0.00016475654,0.7893469,0.00015816248,0.00017418989,0.0034349207],"study_design_scores_gemma":[0.002477404,0.000539425,0.3481085,0.00008761482,0.000078580124,0.000009471854,0.000029945628,0.00012894372,0.64772457,0.00047420044,0.00028278932,0.000058544432],"about_ca_topic_score_codex":0.0013118838,"about_ca_topic_score_gemma":0.00039570933,"teacher_disagreement_score":0.14894217,"about_ca_system_score_codex":0.00021840258,"about_ca_system_score_gemma":0.0003413366,"threshold_uncertainty_score":0.26277757},"labels":[],"label_agreement":null},{"id":"W1210100457","doi":"10.1158/1538-7445.am2015-966","title":"Abstract 966: LSD1 functions as a global androgen receptor coactivator and is a therapeutic target in prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Coactivator; FOXA1; Androgen receptor; Prostate cancer; Enzalutamide; Transactivation; Cancer research; Enhancer; Histone; Transcription factor; Demethylase; Biology; Chemistry; Medicine; Cancer; Gene; Genetics","score_opus":0.1201457261693139,"score_gpt":0.4461896029677064,"score_spread":0.3260438767983925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1210100457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95029825,0.032888312,0.000001359375,0.011015997,0.00020004631,0.001515081,0.00038576452,0.000044423694,0.0036507682],"genre_scores_gemma":[0.9832576,0.005762705,0.000036875717,0.00039856718,0.00027089255,0.0014297335,0.000049486476,0.000041676714,0.008752461],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715745,0.00013018235,0.00024336614,0.00057693425,0.0010038648,0.0008881899],"domain_scores_gemma":[0.9983061,0.000076014614,0.000043268086,0.0003239816,0.0005696734,0.00068094063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007889308,0.00021103387,0.0003414146,0.00023825876,0.0001707588,0.00009123224,0.00014180031,0.00012554695,0.0016774706],"category_scores_gemma":[0.000091087655,0.00016204674,0.000057133453,0.0010672889,0.00038790458,0.00020608278,0.00011950227,0.00066168734,0.00018479874],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011595255,0.00073437823,0.8027272,0.00050760503,0.00065495603,0.00037200612,0.004751343,0.000016370052,0.02619972,0.00013284734,0.09310594,0.059202358],"study_design_scores_gemma":[0.031237368,0.0035338856,0.1972829,0.0017078654,0.00015054777,0.00012650013,0.009954482,0.00020484833,0.07523584,0.005396232,0.67407584,0.0010937126],"about_ca_topic_score_codex":0.0077473545,"about_ca_topic_score_gemma":0.00056804734,"teacher_disagreement_score":0.6054443,"about_ca_system_score_codex":0.0018710645,"about_ca_system_score_gemma":0.0033539736,"threshold_uncertainty_score":0.99923515},"labels":[],"label_agreement":null},{"id":"W1212960208","doi":"","title":"The β-catenin target gene bFGF is expressed in a small fraction of tumor cells with characteristics of cancer stem cells in human colorectal cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Wnt signaling pathway; Cancer stem cell; Adherens junction; Biology; Cancer research; Catenin; Stem cell; Basic fibroblast growth factor; Epithelial–mesenchymal transition; Beta-catenin; Cancer; Tumor progression; Colorectal cancer; Cancer cell; Cell biology; Cell; Cadherin; Metastasis; Growth factor; Signal transduction; Genetics","score_opus":0.0313536059985938,"score_gpt":0.31519414312402017,"score_spread":0.28384053712542634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1212960208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959812,0.0028225917,0.000029667608,0.000107693515,0.00012141686,0.00059156824,0.00031053202,0.0000040116465,0.000031278236],"genre_scores_gemma":[0.9940088,0.004788123,0.00005251939,0.00001708056,0.00017653598,0.0005141956,0.000030593288,0.0000393241,0.00037282755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981838,0.00018104393,0.00042507285,0.00041878334,0.00035504706,0.00043626557],"domain_scores_gemma":[0.99890333,0.000040489493,0.00024506997,0.00030717324,0.00043519298,0.00006871688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038885695,0.00016520075,0.00029319664,0.00015475634,0.000121085825,0.0000120241,0.00028037195,0.00015895808,0.00006482413],"category_scores_gemma":[0.000009390404,0.00013688751,0.000054676777,0.00046960168,0.00041483206,0.000008638619,0.000094366354,0.0003242287,9.72854e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009807623,0.00007711823,0.02632447,0.00007914232,0.000055346314,0.0000065082922,0.0003509287,0.0022671137,0.96779734,0.000001969563,0.00057788286,0.0014814262],"study_design_scores_gemma":[0.0009088406,0.00022536176,0.036681574,0.0001298083,0.000008840152,0.000001561311,0.000121285004,0.00026778536,0.95988625,0.000008509296,0.0016147755,0.00014541345],"about_ca_topic_score_codex":0.009348645,"about_ca_topic_score_gemma":0.009430305,"teacher_disagreement_score":0.010357103,"about_ca_system_score_codex":0.00032466569,"about_ca_system_score_gemma":0.0008268124,"threshold_uncertainty_score":0.9972482},"labels":[],"label_agreement":null},{"id":"W1251260552","doi":"","title":"Ewing tumor cells grown as anchorage independent multicellular spheroids suppress anoikis through an E-cadherin dependent cell survival pathway.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Anoikis; Spheroid; Cell biology; CDC42; Cancer research; Cadherin; Biology; Cell culture; RAC1; Cell; Chemistry; Cancer cell; Kinase; Cancer; Signal transduction","score_opus":0.06755385063142968,"score_gpt":0.3683571558698068,"score_spread":0.30080330523837706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1251260552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717604,0.0055360165,0.00027377674,0.00024442462,0.0009983805,0.0013849969,0.0002250054,0.00012350899,0.019453513],"genre_scores_gemma":[0.98342043,0.0010438554,0.00088939635,0.00019936281,0.0016203072,0.00033567607,0.000114555645,0.00017043552,0.01220599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934466,0.0005355215,0.000659689,0.0012563386,0.0024761877,0.001625649],"domain_scores_gemma":[0.997316,0.00016548274,0.00014309939,0.0011924335,0.00058160216,0.0006013798],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016572536,0.00047137582,0.00074326084,0.00022742304,0.00039140997,0.00023598933,0.0005883238,0.00022961336,0.0044856737],"category_scores_gemma":[0.000044236138,0.00044159123,0.00024943036,0.0007651316,0.00029694257,0.00051212235,0.00034695887,0.0013960942,0.0003281036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007865306,0.0009431763,0.0025164054,0.00053891685,0.00007461015,0.0015592424,0.0008633049,0.00039405178,0.9866836,0.0001489012,0.0024094167,0.003081852],"study_design_scores_gemma":[0.0038180363,0.00058734656,0.001121632,0.00015350174,0.00009164684,0.000034587585,0.0018605615,0.00009954709,0.9046659,0.0001574917,0.086932234,0.0004775034],"about_ca_topic_score_codex":0.039768234,"about_ca_topic_score_gemma":0.0030047602,"teacher_disagreement_score":0.08452282,"about_ca_system_score_codex":0.0009075372,"about_ca_system_score_gemma":0.00100606,"threshold_uncertainty_score":0.9998036},"labels":[],"label_agreement":null},{"id":"W1259037943","doi":"","title":"Multiplexed in situ analysis of protein expression to predict response to trastuzumab","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Institute","funders":"","keywords":"Trastuzumab; Oncology; Breast cancer; Internal medicine; Multivariate analysis; Cohort; Estrogen receptor; Survival analysis; Cancer; Hierarchical clustering; Medicine; Tissue microarray; Biology; Cancer research; Cluster analysis; Artificial intelligence; Computer science","score_opus":0.12425819423436822,"score_gpt":0.5046287916801975,"score_spread":0.38037059744582924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1259037943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914266,0.00033502156,0.0003154752,0.0028525803,0.000049425285,0.0033717453,0.000059513597,0.000038366616,0.0015512555],"genre_scores_gemma":[0.9939872,0.000029636965,0.001363848,0.00012974901,0.0001415256,0.0010332959,0.000011228007,0.000051534396,0.003251962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99385333,0.0007051755,0.00067448337,0.00076608366,0.002712828,0.0012881105],"domain_scores_gemma":[0.9962597,0.0008006612,0.000050360908,0.0010065789,0.0009121967,0.0009705159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010842149,0.00019053386,0.0006707835,0.004879929,0.000092187,0.000028033328,0.000517999,0.00018184319,0.0008395516],"category_scores_gemma":[0.0037811345,0.00017003619,0.00015043617,0.009786966,0.00018465084,0.00007093064,0.00034680206,0.0009141322,0.00006962639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026126262,0.00026593608,0.016724518,0.00016868948,0.00013943412,0.0001792788,0.002875613,0.00032911962,0.9371452,0.000007331463,0.002546156,0.0134925],"study_design_scores_gemma":[0.0015145679,0.0011894939,0.25039464,0.0008365612,0.000036939666,0.0000013322945,0.000802856,0.00007944987,0.7351279,0.000007509375,0.009869105,0.00013960002],"about_ca_topic_score_codex":0.0025195268,"about_ca_topic_score_gemma":0.0049925516,"teacher_disagreement_score":0.23367012,"about_ca_system_score_codex":0.0021490648,"about_ca_system_score_gemma":0.0013813549,"threshold_uncertainty_score":0.91925013},"labels":[],"label_agreement":null},{"id":"W1439800910","doi":"10.1158/1538-7445.sabcs14-p3-05-04","title":"Abstract P3-05-04: AKT antagonist AZD5363 targets estrogen receptor (ER) function in endocrine resistant breast cancer (BC) and synergises with fulvestrant in vivo","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; Fulvestrant; Protein kinase B; Cancer research; Estrogen receptor; Medicine; Pharmacology; Signal transduction; Biology; Internal medicine; Cancer; Cell biology; Breast cancer","score_opus":0.022297874755570494,"score_gpt":0.31705262722853883,"score_spread":0.29475475247296834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1439800910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627776,0.01158813,0.0000035676221,0.0008043605,0.00015046388,0.00045934782,0.00012368239,0.000013903968,0.00057880505],"genre_scores_gemma":[0.99407476,0.0046957918,0.000051850933,0.00004607763,0.00024800008,0.00026462012,0.000058070305,0.00004575415,0.00051508495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978372,0.00016375344,0.0002658024,0.0006190854,0.0004164562,0.0006977042],"domain_scores_gemma":[0.99909323,0.000028663047,0.000062083614,0.0003035255,0.00021038234,0.00030212788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005553156,0.00023642331,0.000249548,0.00019010171,0.000105648156,0.00006354256,0.00018651738,0.0001714861,0.00008287853],"category_scores_gemma":[0.000033057247,0.00018989149,0.000039968138,0.00039234528,0.00030115474,0.000020583413,0.00010639513,0.00051180506,0.0000072140224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006676349,0.0001733093,0.023882208,0.0001259179,0.000103252976,0.00022282534,0.00012441186,0.00039031426,0.9589508,0.00005254301,0.006244706,0.0030533173],"study_design_scores_gemma":[0.0072955396,0.002620584,0.040467758,0.0006949171,0.000044813012,0.00016646976,0.0011666049,0.00007556972,0.89964503,0.000089850124,0.046875652,0.00085721345],"about_ca_topic_score_codex":0.0104492195,"about_ca_topic_score_gemma":0.003809245,"teacher_disagreement_score":0.059305817,"about_ca_system_score_codex":0.00021686424,"about_ca_system_score_gemma":0.0007440951,"threshold_uncertainty_score":0.9961403},"labels":[],"label_agreement":null},{"id":"W1440249570","doi":"10.1158/1538-7445.am2015-4674","title":"Abstract 4674: Localization of estrogen receptor α(ERα) at the centrosome and its regulation by protein kinases in breast cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Centrosome; PLK1; Biology; Cancer research; Cell biology; Kinase; Centrosome cycle; Mitosis; Chromosome instability; Estrogen receptor; Aurora inhibitor; Cell cycle; Breast cancer; Cancer; Genetics; Chromosome; Gene","score_opus":0.027012151624629395,"score_gpt":0.3234117341411583,"score_spread":0.2963995825165289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1440249570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918379,0.0066750334,0.000023491622,0.0005864001,0.000050352948,0.0004665527,0.00030919438,0.0000024621752,0.00004862033],"genre_scores_gemma":[0.99626166,0.0023958664,0.000006895549,0.000033348202,0.00012047788,0.00014169584,0.00013580218,0.000016107933,0.0008881736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907637,0.00009397281,0.00014995299,0.00023278847,0.00021858366,0.00022834819],"domain_scores_gemma":[0.99943674,0.0000091206875,0.00005812556,0.00017060751,0.00024992722,0.00007548061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003339947,0.00008100825,0.00008895597,0.00003724338,0.000057048837,0.000016726312,0.00012372303,0.00010241412,0.00009196257],"category_scores_gemma":[0.000026936044,0.000064237334,0.000019767673,0.00014336711,0.00010947413,0.0000072579137,0.00011207194,0.00009490903,0.000004272723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020352218,0.000033074433,0.0038790694,0.000050112132,0.000012028313,2.6683895e-7,0.00006138722,0.00046277817,0.9815605,0.000017161601,0.012697187,0.0010229006],"study_design_scores_gemma":[0.0004296606,0.000044845256,0.0012683289,0.000060038434,0.000003027214,0.0000010255535,0.0000638115,0.00020417759,0.98193985,0.000016117949,0.015894145,0.000074980526],"about_ca_topic_score_codex":0.0009914314,"about_ca_topic_score_gemma":0.00045016813,"teacher_disagreement_score":0.0044237403,"about_ca_system_score_codex":0.00012461755,"about_ca_system_score_gemma":0.00019938478,"threshold_uncertainty_score":0.26195225},"labels":[],"label_agreement":null},{"id":"W1443384835","doi":"","title":"Replication of mutant strains of oncolytic reovirus in different cell lines","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Oncolytic virus; Biology; Interferon; Mutant; Virology; Virus; Protein kinase R; Cell culture; Viral replication; 3T3 cells; Proteases; Cell; Molecular biology; Transfection; Gene; Cell cycle; Genetics; Enzyme; Biochemistry","score_opus":0.09846802512613592,"score_gpt":0.42068021358125035,"score_spread":0.32221218845511446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1443384835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725443,0.0014803587,0.000014110075,0.00017957673,0.000022163687,0.00037734993,0.00004290428,0.000002983869,0.00062610913],"genre_scores_gemma":[0.99506164,0.0037603255,0.000023248327,0.000015414984,0.000114625225,0.000114146496,0.0000254892,0.000020435842,0.0008647044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983399,0.00021275604,0.00028643178,0.00038000502,0.00045906904,0.00032184768],"domain_scores_gemma":[0.99866396,0.000035736495,0.00006746946,0.0008215141,0.00033445974,0.00007684386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007018867,0.00009293395,0.00018414251,0.00018090183,0.00004584939,0.0000034605207,0.0003614068,0.00010449355,0.00006866734],"category_scores_gemma":[0.00014837504,0.00008078519,0.000059605693,0.00034852335,0.0003155153,0.0000025735646,0.000120967845,0.00020727795,0.0000032936691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010215496,0.0002013022,0.0035773483,0.00008080066,0.0000151121,0.000004538946,0.0001494028,0.000099561854,0.99097836,0.000008434661,0.0002948105,0.0035687902],"study_design_scores_gemma":[0.00069067074,0.0015092809,0.0067498307,0.000031023596,0.0000017002864,0.0000017709531,0.00005853208,0.000049686954,0.99009895,0.00003686587,0.0006995527,0.00007211766],"about_ca_topic_score_codex":0.00033366162,"about_ca_topic_score_gemma":0.0007405031,"teacher_disagreement_score":0.0034966725,"about_ca_system_score_codex":0.0000825823,"about_ca_system_score_gemma":0.0005382604,"threshold_uncertainty_score":0.32943243},"labels":[],"label_agreement":null},{"id":"W1451217554","doi":"","title":"Role of mitochondrial glycerophosphate dehydrogenase (mGPDH) in prostate cancer cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"LNCaP; Biology; Reactive oxygen species; Mitochondrion; Mitochondrial ROS; DU145; Cancer cell; Respiratory chain; Prostate cancer; Biochemistry; Cancer research; Cancer; Genetics","score_opus":0.021798416174915198,"score_gpt":0.3338811453970824,"score_spread":0.31208272922216723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1451217554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285525,0.005110676,0.00003362967,0.00023882769,0.0006446205,0.0004984493,0.00009245801,0.000006981594,0.0005191101],"genre_scores_gemma":[0.99318707,0.0037236002,0.00034741568,0.00011969028,0.0006337413,0.00042907766,0.00003978087,0.000036494734,0.0014831176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839735,0.00014276769,0.00025992087,0.00044382908,0.00027624046,0.0004799078],"domain_scores_gemma":[0.9992351,0.000014221079,0.000059204234,0.00034267563,0.00022084531,0.00012793894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023946447,0.00013151293,0.00018559316,0.00013391592,0.00006548318,0.000014897766,0.00024052388,0.00015502056,0.00027036833],"category_scores_gemma":[0.000060476978,0.00012570614,0.00007370808,0.0003482697,0.00020061177,0.0000052588184,0.00012679014,0.00026382692,0.00003352342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010800959,0.00007832184,0.0008447375,0.000029190762,0.000020724185,0.000012402003,0.00021243466,0.0019110384,0.99358124,0.00009896177,0.0008704901,0.0012603619],"study_design_scores_gemma":[0.0018311476,0.00027983636,0.00014495678,0.000042105556,0.0000044402514,0.000003272879,0.000102200276,0.000005956791,0.96555346,0.0003672974,0.03153825,0.00012708682],"about_ca_topic_score_codex":0.0025679884,"about_ca_topic_score_gemma":0.0019396683,"teacher_disagreement_score":0.030667761,"about_ca_system_score_codex":0.00009574721,"about_ca_system_score_gemma":0.000627103,"threshold_uncertainty_score":0.5126148},"labels":[],"label_agreement":null},{"id":"W1451799208","doi":"10.1158/1538-7445.am2015-lb-274","title":"Abstract LB-274: Transcriptional factor Snail and MMP-9 signaling axis amplifies Neu1-MMP-9 crosstalk on EGF receptor to regulate tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Biology; Snail; Tumor progression; Epidermal growth factor; Cell culture; Cancer","score_opus":0.10177360391345615,"score_gpt":0.3653188909963857,"score_spread":0.26354528708292957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1451799208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700385,0.001291565,0.00013490974,0.0002884575,0.00002384145,0.0005222001,0.0006412574,0.000006938104,0.000087003675],"genre_scores_gemma":[0.99869204,0.00024159203,0.00026122513,0.00004712371,0.00007654646,0.00018238739,0.00013440887,0.000036564874,0.00032811373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979365,0.00013030427,0.00027416748,0.00057999446,0.0005986516,0.000480374],"domain_scores_gemma":[0.9988683,0.00002528968,0.000046585417,0.00029919768,0.0003838894,0.0003767402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048346957,0.00019364401,0.00025213082,0.00026903715,0.0001626137,0.000100734746,0.00019070772,0.000097507735,0.000044155975],"category_scores_gemma":[0.00012404463,0.00018144817,0.000064591775,0.00024393489,0.0002522134,0.000025338799,0.0001228729,0.00021670431,0.0000022221766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087410153,0.00011963885,0.008933579,0.000113603135,0.00011603411,0.0000064027367,0.00057303585,0.00069749745,0.9874128,0.00021655197,0.00024490352,0.0006918406],"study_design_scores_gemma":[0.0025652682,0.0008018121,0.01814731,0.000061050916,0.00001297406,0.0000024733367,0.00021847797,0.00011157914,0.97699434,0.00048890995,0.00034855944,0.00024723032],"about_ca_topic_score_codex":0.0046243076,"about_ca_topic_score_gemma":0.0013334409,"teacher_disagreement_score":0.010418457,"about_ca_system_score_codex":0.00012667634,"about_ca_system_score_gemma":0.0004077061,"threshold_uncertainty_score":0.73992413},"labels":[],"label_agreement":null},{"id":"W1455409207","doi":"10.1158/1538-7445.am2015-4664","title":"Abstract 4664: Impact of TP53 mutations, single nucleotide variants and global methylation patterns on pre-menopausal breast cancer risk","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Breast cancer; Sanger sequencing; Cancer; Single-nucleotide polymorphism; Cancer research; Germline mutation; Germline; Exon; Methylation; DNA methylation; Biology; Genetics; Oncology; Internal medicine; Medicine; Molecular biology; Mutation; Gene; Genotype; Gene expression","score_opus":0.07041222605663565,"score_gpt":0.42160961673309333,"score_spread":0.35119739067645767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1455409207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993764,0.0016504311,0.00010774312,0.00048604296,0.00021964552,0.00071670895,0.002002852,0.000038102655,0.0010144714],"genre_scores_gemma":[0.99877113,0.0005884421,0.00004965673,0.000030005704,0.00029890903,0.00009247743,0.000061455474,0.000042315252,0.0000656143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997557,0.0002005123,0.0003242519,0.00043847715,0.0009874039,0.0004923802],"domain_scores_gemma":[0.99813366,0.00010795053,0.00015920612,0.00039431802,0.0007489655,0.00045591747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083885255,0.00019113341,0.0003187504,0.00021382305,0.000097674136,0.00004644987,0.00012519429,0.00014718274,0.00037815605],"category_scores_gemma":[0.00024910452,0.00016652449,0.00006718565,0.000554505,0.00017854852,0.0001438457,0.00007407266,0.00054965756,0.000022050932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007108072,0.0011143609,0.33323592,0.00046654535,0.0012671878,0.00021536069,0.0022988613,0.0076742345,0.48525694,0.000095378375,0.0072964765,0.15397064],"study_design_scores_gemma":[0.0032114005,0.0014340895,0.97867286,0.00060177647,0.00013921024,0.00004733679,0.00017265276,0.00046556073,0.014580217,0.00030379483,0.00017957449,0.00019155146],"about_ca_topic_score_codex":0.034077536,"about_ca_topic_score_gemma":0.0012546513,"teacher_disagreement_score":0.6454369,"about_ca_system_score_codex":0.0022219936,"about_ca_system_score_gemma":0.001462705,"threshold_uncertainty_score":0.97235465},"labels":[],"label_agreement":null},{"id":"W1455755008","doi":"","title":"AEG35156, a XIAP antisense oligonucleotide, suppresses XIAP levels in targeted tissues isolated from pre-clinical models and from patients","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Cancer research; Docetaxel; Inhibitor of apoptosis; Apoptosis; Cancer; In vivo; Medicine; Chemistry; Pharmacology; Biology; Caspase; Internal medicine; Programmed cell death; Biochemistry","score_opus":0.05452248551189761,"score_gpt":0.3748736452327271,"score_spread":0.3203511597208295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1455755008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323446,0.005134023,0.0004975995,0.00007678151,0.00016412509,0.00038563157,0.00036368635,0.0000133263675,0.00013039603],"genre_scores_gemma":[0.99564266,0.0019731063,0.00043656706,0.000031603788,0.0003653001,0.000037034006,0.0007286531,0.000034099678,0.0007509632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810094,0.0002528812,0.00036109597,0.00061352045,0.00028871838,0.00038285696],"domain_scores_gemma":[0.99921477,0.00007218966,0.000062875726,0.00032641273,0.00021724314,0.000106495165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027501432,0.00015742792,0.00022987367,0.00008436731,0.00009429559,0.00006348447,0.00016835255,0.00028957907,0.0001504498],"category_scores_gemma":[0.00006009077,0.00014606044,0.000049995335,0.00015101783,0.00014276462,0.00001614114,0.00020973897,0.00022913181,0.00000719374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004363074,0.00020681719,0.01747283,0.000017338025,0.000052306095,0.0000081909,0.00011352799,0.0006973655,0.97055423,0.000036651705,0.0032230727,0.0071813376],"study_design_scores_gemma":[0.00291231,0.0003849254,0.23137847,0.00011822313,0.000020811489,6.9981775e-7,0.000041260006,0.008478982,0.74300635,0.0060811453,0.007188989,0.00038782455],"about_ca_topic_score_codex":0.010405872,"about_ca_topic_score_gemma":0.0015017375,"teacher_disagreement_score":0.22754788,"about_ca_system_score_codex":0.00002861416,"about_ca_system_score_gemma":0.00008893685,"threshold_uncertainty_score":0.99618393},"labels":[],"label_agreement":null},{"id":"W1460035918","doi":"","title":"Exosomes and microvesicles derived from activated platelets increase the metastatic potential of lung cancer cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Microvesicles; Metastasis; Cancer research; Platelet activation; Biology; Lung cancer; Tumor microenvironment; Cancer cell; Angiogenesis; Platelet; Immunology; Cell biology; Cancer; Medicine; Pathology; microRNA","score_opus":0.020754695287916916,"score_gpt":0.338790955418234,"score_spread":0.3180362601303171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1460035918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978898,0.01990068,0.00012080664,0.0003873435,0.000066684166,0.00034827922,0.00024651494,0.0000063009684,0.000025427256],"genre_scores_gemma":[0.9963026,0.0029383355,0.00024565338,0.00008688158,0.00014467715,0.00009971392,0.000044655808,0.000029745832,0.00010770311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863935,0.00020713334,0.00017776525,0.00035774065,0.00028545066,0.0003325755],"domain_scores_gemma":[0.9991942,0.00005337674,0.000069360365,0.00037484584,0.00016741645,0.00014081779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025490826,0.00013376589,0.000150186,0.00005032755,0.00014435341,0.000038925962,0.0003216556,0.000073675554,0.000095322146],"category_scores_gemma":[0.00007172071,0.00010346163,0.000059865957,0.00014654451,0.00047001362,0.000008461899,0.00025646028,0.00019399662,0.000002271365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029813917,0.000066852284,0.0004073821,0.00005679654,0.00019694908,0.000024574822,0.00013148077,0.0003271369,0.99659854,0.000012753991,0.0004510344,0.001428351],"study_design_scores_gemma":[0.0010019155,0.00004611498,0.0033270216,0.000056166315,0.000050462422,0.0000025073186,0.00016604233,0.000032211105,0.9945721,0.00028435167,0.0003426357,0.000118475444],"about_ca_topic_score_codex":0.003824994,"about_ca_topic_score_gemma":0.00023404676,"teacher_disagreement_score":0.01740467,"about_ca_system_score_codex":0.00005451898,"about_ca_system_score_gemma":0.00040910847,"threshold_uncertainty_score":0.5782272},"labels":[],"label_agreement":null},{"id":"W1464852285","doi":"10.1158/1538-7445.sabcs14-p3-09-02","title":"Abstract P3-09-02: Association between definitive surgery and times to administration of adjuvant chemotherapy and outcomes in early breast cancer: Analysis of adjuvant studies conducted by NCIC Clinical Trials Group (NCIC CTG)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Adjuvant; Internal medicine; Chemotherapy; Cancer; Oncology; Clinical trial; Univariate analysis; Adjuvant therapy; Multivariate analysis; Stage (stratigraphy); Surgery","score_opus":0.23942579303129502,"score_gpt":0.50950987412441,"score_spread":0.27008408109311494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1464852285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848555,0.011050543,0.0000039340603,0.0016470482,0.00007001993,0.00043896446,0.0019134155,0.0000051548786,0.000015465337],"genre_scores_gemma":[0.98942405,0.00997395,0.00002591948,0.00004854652,0.00010637509,0.00019562613,0.00015601798,0.00001772117,0.000051767103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970975,0.0007117007,0.0008939183,0.0004915134,0.00048039405,0.00032497328],"domain_scores_gemma":[0.9968667,0.0014727253,0.00045009505,0.00020606977,0.00084643735,0.00015796447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045561437,0.00019785464,0.0013832641,0.00028276624,0.000054767002,0.000020501571,0.00010136215,0.0001826147,0.000013268998],"category_scores_gemma":[0.0017016677,0.00016310374,0.00015621806,0.0005503512,0.0002649798,0.000017898388,0.0001033429,0.000163639,6.182282e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001351691,0.00014529072,0.96763307,0.000049857084,0.0045929938,0.0000017709316,0.00054392964,0.0000030353328,0.0077611096,0.0000027571562,0.0015682665,0.016346252],"study_design_scores_gemma":[0.0016152841,0.00033133535,0.9824409,0.00008509851,0.00043989634,4.091021e-7,0.00075763924,0.000002193171,0.014059502,0.00003175213,0.000089492154,0.00014652986],"about_ca_topic_score_codex":0.0032489395,"about_ca_topic_score_gemma":0.0028640197,"teacher_disagreement_score":0.016199721,"about_ca_system_score_codex":0.00024104126,"about_ca_system_score_gemma":0.00043286616,"threshold_uncertainty_score":0.6651178},"labels":[],"label_agreement":null},{"id":"W1479873883","doi":"10.1158/1538-7445.am2014-3710","title":"Abstract 3710: The role of eIF4E in promoting melanoma cell proliferation and maintaining acquired resistance to Vemurafenib in melanoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital; McGill University","funders":"","keywords":"Vemurafenib; Melanoma; Cancer research; EIF4E; Medicine; Cell culture; Cell growth; Translation (biology); Biology; Messenger RNA; Genetics; Gene; Metastatic melanoma","score_opus":0.021449525651567762,"score_gpt":0.32669726307322233,"score_spread":0.30524773742165456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1479873883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947042,0.0022284565,0.000020754773,0.00049107923,0.000036012338,0.0004855253,0.0000086100945,0.000004179309,0.0020211798],"genre_scores_gemma":[0.99902487,0.000086732696,0.00013966979,0.00005968811,0.0001882736,0.0002647525,0.000008181986,0.000023572687,0.00020427156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983989,0.00023414157,0.00027530047,0.00039119378,0.00029646573,0.00040397287],"domain_scores_gemma":[0.99930054,0.0000925935,0.00007080784,0.0003212866,0.00014317632,0.0000716057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001884277,0.000111824316,0.00015288107,0.00012604267,0.00007992668,0.000038007474,0.00029204422,0.00011286049,0.000017366],"category_scores_gemma":[0.00025143253,0.0000957762,0.000023500996,0.00029842198,0.000112880436,0.000008315736,0.00014528853,0.00019602255,0.0000024498627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031094518,0.00002789347,0.03496493,0.000071133305,0.000007129773,0.000002414231,0.0011064264,0.00022403171,0.9573969,0.00008459774,0.00011313506,0.0056904606],"study_design_scores_gemma":[0.0005928294,0.00022925583,0.03252814,0.00019094536,0.0000021682097,0.0000010281796,0.0004063972,0.0002775307,0.9597159,0.00039988468,0.005519844,0.00013608612],"about_ca_topic_score_codex":0.00030831326,"about_ca_topic_score_gemma":0.0023160777,"teacher_disagreement_score":0.005554375,"about_ca_system_score_codex":0.00010391669,"about_ca_system_score_gemma":0.00020503983,"threshold_uncertainty_score":0.39056402},"labels":[],"label_agreement":null},{"id":"W1480361366","doi":"10.1158/1538-7445.am2014-1665","title":"Abstract 1665: Biopsy induced metastasis: Role of SOX4/TGF-β driven EMT and immunosuppressive microenvironment","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Tumor microenvironment; Metastasis; Biopsy; Metastatic breast cancer; Cancer research; Cancer; Pathology; Breast cancer; CD8; Oncology; Internal medicine; Immune system; Immunology","score_opus":0.049875782657332786,"score_gpt":0.3651630622615324,"score_spread":0.3152872796041996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480361366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874056,0.008678021,0.0000086381515,0.0009077278,0.00009040561,0.0005201576,0.000075800075,0.000014570404,0.00229906],"genre_scores_gemma":[0.99591804,0.002824967,0.00036620413,0.00006601765,0.00018450792,0.00014931418,0.000015379374,0.000035861634,0.00043971097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979527,0.00012234489,0.000319784,0.00043138932,0.00065929216,0.00051446166],"domain_scores_gemma":[0.99880975,0.00012480309,0.000108216365,0.0005246841,0.00016501838,0.00026750966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006974869,0.0001745425,0.00044983477,0.00023199868,0.000115800416,0.00002873814,0.00018092108,0.0000977808,0.00080163195],"category_scores_gemma":[0.00008136842,0.00014647635,0.00010722031,0.00024050081,0.0002684069,0.00007571488,0.00019424014,0.00047963287,0.00003450837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031114588,0.0001305435,0.0023151657,0.00023802521,0.00020064914,0.000011153466,0.0005040334,0.000006185171,0.93109137,0.000073994204,0.0009238225,0.06419393],"study_design_scores_gemma":[0.0020505749,0.0004002262,0.049489304,0.00034027864,0.00013646913,0.000022533906,0.0010021299,0.000019234923,0.8881585,0.00014485714,0.0580563,0.00017959748],"about_ca_topic_score_codex":0.0016149877,"about_ca_topic_score_gemma":0.00006311456,"teacher_disagreement_score":0.06401433,"about_ca_system_score_codex":0.00017647281,"about_ca_system_score_gemma":0.00020177999,"threshold_uncertainty_score":0.8777308},"labels":[],"label_agreement":null},{"id":"W1480370941","doi":"10.1158/1538-7445.am2014-163","title":"Abstract 163: Identification of a bone marrow-derived MDSC subset that promotes the growth of colon carcinoma liver metastases","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Chemokine; CXCL1; Tumor microenvironment; Medicine; Cancer research; Downregulation and upregulation; Cytokine; Tumor necrosis factor alpha; Chemokine receptor; Pathology; Bone marrow; Hepatocellular carcinoma; Receptor; Immunology; Inflammation; Biology; Cancer; Immune system; Internal medicine","score_opus":0.04929770731485575,"score_gpt":0.33067147754043824,"score_spread":0.2813737702255825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480370941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890103,0.009746067,0.000083684085,0.00021324052,0.00021128303,0.00041150727,0.00017050578,0.0000041627063,0.00014929223],"genre_scores_gemma":[0.9963788,0.0026219327,0.000043601172,0.000027715223,0.00041979473,0.00013913625,0.00007551114,0.000019998497,0.0002735138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984978,0.0002389346,0.00026422154,0.0003026609,0.0004102113,0.00028619324],"domain_scores_gemma":[0.9986914,0.00006968789,0.00017262866,0.0004897888,0.0005092749,0.00006721985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013144044,0.000112322996,0.00021491028,0.000086228225,0.00009767688,0.000023045654,0.00031808633,0.000093490096,0.000074361065],"category_scores_gemma":[0.0002490897,0.00008495388,0.00010825801,0.00019082036,0.0004054776,0.000008298294,0.00012408015,0.00015015966,0.00000417242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019340416,0.00005889794,0.0018452386,0.00018379676,0.000051675248,4.7763336e-7,0.00017127978,0.0000038373473,0.99041307,0.00013871382,0.0039810203,0.0029585937],"study_design_scores_gemma":[0.00039804555,0.00011286546,0.06785082,0.00002302513,0.000030306854,0.0000026362027,0.00010514973,0.000014806021,0.92215264,0.00008667813,0.009139264,0.000083776045],"about_ca_topic_score_codex":0.001395913,"about_ca_topic_score_gemma":0.0004503964,"teacher_disagreement_score":0.06826044,"about_ca_system_score_codex":0.00002132236,"about_ca_system_score_gemma":0.00021464,"threshold_uncertainty_score":0.34643185},"labels":[],"label_agreement":null},{"id":"W1480824400","doi":"10.1158/1538-7445.am2014-4141","title":"Abstract 4141: Access to medical or radiation oncology consultation in patients who died from cancer in the Sudbury-Manitoulin District of Northeastern Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Medicine; Cancer; Referral; Family medicine; Cancer registry; Radiation oncologist; Population; Radiation therapy; Emergency medicine; Internal medicine; Environmental health","score_opus":0.13652092718358505,"score_gpt":0.4559282600882067,"score_spread":0.31940733290462164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480824400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936042,0.00018034989,0.000010558238,0.004156225,0.00018986539,0.00074575894,0.00008944036,0.0000033757442,0.0010202188],"genre_scores_gemma":[0.9980426,0.00010138484,0.000006704389,0.0012536839,0.00018845426,0.00025521914,0.00006877604,0.000010067089,0.000073129784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701536,0.00025193646,0.0004483387,0.00029802404,0.0015798571,0.00040647425],"domain_scores_gemma":[0.9982139,0.00083255506,0.00009955147,0.00023057686,0.0003855433,0.0002378996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010878249,0.00011027603,0.00033125107,0.00016602222,0.00005844945,0.000028212336,0.00042966157,0.000119312994,0.0014827324],"category_scores_gemma":[0.0016107097,0.00007646747,0.000023370045,0.0006952704,0.000081211394,0.00012217273,0.00006564846,0.000647579,0.0000035363419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019988636,0.00008075842,0.86851007,0.000040242594,0.000017467482,0.000045079065,0.002243792,0.0002863469,0.00003946797,0.0000063976377,0.0042839837,0.122447535],"study_design_scores_gemma":[0.0024966265,0.00027411839,0.9859351,0.00045234687,0.000009752373,4.933969e-7,0.0006286262,0.00019924306,0.00020305159,0.000014111299,0.009707967,0.00007857245],"about_ca_topic_score_codex":0.9959942,"about_ca_topic_score_gemma":0.99955004,"teacher_disagreement_score":0.12236896,"about_ca_system_score_codex":0.0028702565,"about_ca_system_score_gemma":0.007160716,"threshold_uncertainty_score":0.99943006},"labels":[],"label_agreement":null},{"id":"W1482014066","doi":"10.1158/1538-7445.am2015-ct113","title":"Abstract CT113: A phase III, multicenter, randomized study evaluating the efficacy and safety and efficacy of erythrocyte encapsulated l-asparaginase (Ery001) versus native l-asparaginase (L-asp) in combination with COOPRALL regimen in patients with first relapse of acut","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect; Gastroenterology; Cmax; Regimen; Pharmacology; Pharmacokinetics","score_opus":0.0631438127890481,"score_gpt":0.40859306961626624,"score_spread":0.34544925682721817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482014066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899266,0.0006405219,0.000017977021,0.00042551672,0.00003978148,0.008741032,0.000023609928,0.000015149696,0.00016986155],"genre_scores_gemma":[0.9990459,0.00024244083,0.00011196475,0.000010560661,0.0000184499,0.0004131159,0.00004210838,0.000045377707,0.000070090355],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946071,0.0011209466,0.0008503056,0.0006662249,0.002123389,0.00063201634],"domain_scores_gemma":[0.9914295,0.005521958,0.00038273793,0.0005764884,0.0017696586,0.00031964754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005791775,0.00031548992,0.001110385,0.0006648991,0.00013580416,0.000038739236,0.0002765785,0.00011346948,0.00002434243],"category_scores_gemma":[0.004640069,0.0001968939,0.000036063142,0.0013875084,0.0014289973,0.00026023935,0.00025826835,0.00089874555,0.0000011969059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95438164,0.005410298,0.020175027,0.00028140142,0.0005201211,0.00016147592,0.015883528,0.0007863737,0.00042016865,0.000025044239,0.00007783646,0.0018770595],"study_design_scores_gemma":[0.8762068,0.0127603095,0.09784138,0.0014532332,0.00020081445,0.0000051376537,0.0029821447,0.007474093,0.00086414895,0.0000074185505,0.000009363745,0.00019515624],"about_ca_topic_score_codex":0.005568635,"about_ca_topic_score_gemma":0.0013051243,"teacher_disagreement_score":0.07817487,"about_ca_system_score_codex":0.0012651861,"about_ca_system_score_gemma":0.002269949,"threshold_uncertainty_score":0.8418148},"labels":[],"label_agreement":null},{"id":"W1482247829","doi":"10.1158/1538-7445.sabcs14-p4-11-10","title":"Abstract P4-11-10: Time dependence of biomarkers: Non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Proportional hazards model; Oncology; Internal medicine; Breast cancer; Confounding; Tamoxifen; Cancer; Immunohistochemistry; Exemestane; Demography","score_opus":0.023892343650877248,"score_gpt":0.34296692652569094,"score_spread":0.3190745828748137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482247829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459153,0.0041961935,0.000008578352,0.00010634749,0.00010659454,0.00039247214,0.00031918552,0.000007048366,0.00027207297],"genre_scores_gemma":[0.99857926,0.0006013299,0.0000837891,0.0000054106777,0.00017312868,0.00033457603,0.00003733909,0.000028915556,0.00015622174],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793494,0.00012343083,0.00038712448,0.0004640498,0.0006468409,0.0004436168],"domain_scores_gemma":[0.9985625,0.00011630405,0.00021133774,0.00037910434,0.00059224165,0.00013848663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007137388,0.00018191579,0.00029997723,0.00013406694,0.00006290871,0.000009812789,0.00031648958,0.00017968906,0.000096986485],"category_scores_gemma":[0.00031766482,0.00016754454,0.00008997432,0.00033236653,0.00045334184,0.00001370227,0.0002629114,0.0002532519,0.000010016909],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012733835,0.00018333626,0.2874057,0.0001788924,0.0002514054,0.0000139729755,0.0003023443,0.000055998473,0.70658207,0.0000018636837,0.0014755335,0.0022755137],"study_design_scores_gemma":[0.0016829647,0.00015259437,0.52697855,0.0003676361,0.00003004738,0.0000079420215,0.00007797945,0.00002178195,0.47042987,0.000035052213,0.00007633155,0.0001392299],"about_ca_topic_score_codex":0.0147015015,"about_ca_topic_score_gemma":0.00032523886,"teacher_disagreement_score":0.23957288,"about_ca_system_score_codex":0.00030731474,"about_ca_system_score_gemma":0.00078408857,"threshold_uncertainty_score":0.9918597},"labels":[],"label_agreement":null},{"id":"W1482253718","doi":"10.1158/1538-7445.am2015-117","title":"Abstract 117: DOT1L is a human chromosome stability gene","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Biology; Mitosis; Histone; Cell biology; Histone H2B; Epigenetics; Genetics; Histone methyltransferase; Ubiquitin; Ubiquitin ligase; Histone H3; Gene","score_opus":0.1969304908049955,"score_gpt":0.45240998559652557,"score_spread":0.2554794947915301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482253718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026746,0.005141988,0.000050269184,0.00031103482,0.0001067805,0.00021882009,0.000050414594,0.000008813483,0.0038444423],"genre_scores_gemma":[0.9979267,0.0005117378,0.00010668788,0.000054948323,0.0005540393,0.000078315854,0.00007518642,0.00002261784,0.0006697372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850184,0.00010488575,0.00017510187,0.00040477555,0.00043928664,0.00037410928],"domain_scores_gemma":[0.9987008,0.000013395488,0.000036604706,0.0005108443,0.00050365704,0.00023472162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011609502,0.00010231029,0.00010683952,0.000053687058,0.00013097157,0.00004814605,0.0002437227,0.00014036197,0.00029742665],"category_scores_gemma":[0.000119532495,0.0000974552,0.000052423944,0.0001561051,0.00015787466,0.000004183182,0.00016376286,0.00019627128,0.00004540009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038415506,0.0000493574,0.0043825293,0.00001715231,0.000020388106,0.000002399327,0.00014537925,0.000015016927,0.9911659,0.000022608912,0.0026731864,0.0014677013],"study_design_scores_gemma":[0.0003807337,0.00019110207,0.0072027016,0.0000062592085,0.0000029296043,3.9770856e-7,0.00006355313,0.000005141391,0.9419748,0.00082417,0.049230542,0.00011766274],"about_ca_topic_score_codex":0.00052696385,"about_ca_topic_score_gemma":0.00020073012,"teacher_disagreement_score":0.049191058,"about_ca_system_score_codex":0.00009834761,"about_ca_system_score_gemma":0.00035822892,"threshold_uncertainty_score":0.39741078},"labels":[],"label_agreement":null},{"id":"W1487473883","doi":"10.1158/1538-7445.am2014-4007","title":"Abstract 4007: The identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nasopharyngeal carcinoma; microRNA; Medicine; Oncology; Proportional hazards model; Cancer; Metastasis; Internal medicine; Cohort; Hazard ratio; Radiation therapy; Bioinformatics; Biology; Gene; Genetics; Confidence interval","score_opus":0.020620217728157364,"score_gpt":0.3227490354201371,"score_spread":0.30212881769197975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487473883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539495,0.0028053613,0.0006859072,0.00018351116,0.000047965303,0.00051239756,0.00018603072,0.000003362531,0.00018053457],"genre_scores_gemma":[0.99904454,0.0005079266,0.00002505584,0.000012731328,0.000053568598,0.00012345106,0.00007632106,0.000030558258,0.00012582191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997582,0.0005728951,0.00037007744,0.0003864578,0.00069601485,0.00039256405],"domain_scores_gemma":[0.99836665,0.00012573545,0.00023290586,0.00058766553,0.0006177033,0.00006935594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028563156,0.00012629204,0.00021460836,0.00016392078,0.00009000739,0.000021971164,0.0004919146,0.00017460245,0.000040428356],"category_scores_gemma":[0.0007158221,0.00009111722,0.000087812514,0.00064468425,0.00032585993,0.0000054706957,0.00013968346,0.0005900451,0.00000167534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052933616,0.000084700885,0.0008478137,0.00006062022,0.00014812668,0.0000033537165,0.00013435104,0.0005544254,0.99490994,0.000071009505,0.0004097893,0.0022465503],"study_design_scores_gemma":[0.00092131307,0.0002946152,0.02216646,0.000070751914,0.000026959018,0.0000010906684,0.00014339689,0.00018516654,0.9752723,0.00012973894,0.00069038675,0.00009779795],"about_ca_topic_score_codex":0.0010889926,"about_ca_topic_score_gemma":0.0016192014,"teacher_disagreement_score":0.021318648,"about_ca_system_score_codex":0.00011539282,"about_ca_system_score_gemma":0.00038688423,"threshold_uncertainty_score":0.37156522},"labels":[],"label_agreement":null},{"id":"W1488885619","doi":"","title":"Prostate-specific expression of ICP4 complements ICP4(−) HSV-1 virus for oncolysis of prostate cancer cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; LNCaP; Virology; Amplicon; Virus; Biology; Viral replication; Herpes simplex virus; Virotherapy; Prostate cancer; Cancer research; Cancer; Gene","score_opus":0.06455437393185925,"score_gpt":0.4121057282187696,"score_spread":0.34755135428691036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488885619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891119,0.0068492633,0.00008874049,0.00017065492,0.00010552522,0.0018246592,0.001543475,0.000008173181,0.00029759682],"genre_scores_gemma":[0.9895477,0.005195068,0.0003417513,0.000024444378,0.00032007138,0.0015371542,0.00026252778,0.00007279261,0.002698439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695593,0.00027111385,0.0005130471,0.0006114305,0.00085964485,0.00078882143],"domain_scores_gemma":[0.9978216,0.0000735536,0.00018584265,0.00066394324,0.001126639,0.00012840338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010720071,0.00020669967,0.0003449712,0.00022724745,0.00017697747,0.000029880472,0.0005519014,0.0001396829,0.00034504666],"category_scores_gemma":[0.000027444528,0.00018886923,0.00015437468,0.00046438677,0.00040538554,0.000009752457,0.00026039418,0.00021733575,0.0000064820965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006494136,0.00025922834,0.0014479592,0.000259305,0.000063205145,0.0000016741959,0.00012702249,0.00075989956,0.9600595,0.000012048221,0.023364158,0.007151852],"study_design_scores_gemma":[0.0018701673,0.0017629442,0.00025220614,0.00010153368,0.000008509039,2.2743936e-7,0.00010845485,0.000030419027,0.93463075,0.0001166206,0.06094286,0.00017531753],"about_ca_topic_score_codex":0.0014119736,"about_ca_topic_score_gemma":0.0015850991,"teacher_disagreement_score":0.037578702,"about_ca_system_score_codex":0.00015733615,"about_ca_system_score_gemma":0.00063510326,"threshold_uncertainty_score":0.7701864},"labels":[],"label_agreement":null},{"id":"W1490058918","doi":"10.1158/1538-7445.am2014-2914","title":"Abstract 2914: Phosphoproteomic and transcriptional biomarkers predict response to SAR302503, a JAK2 inhibitor, in human acute myeloid leukemia preclinical models","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Biomarker; Cancer research; NPM1; Leukemia; Medicine; Cancer; Myeloid; Biomarker discovery; Oncology; Biology; Immunology; Internal medicine; Gene; Proteomics","score_opus":0.07934854208616081,"score_gpt":0.4099494661520082,"score_spread":0.3306009240658474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490058918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906663,0.0007237473,0.00004495785,0.0055405055,0.00009649471,0.0019195459,0.00012288243,0.000038648068,0.00084695674],"genre_scores_gemma":[0.9960823,0.00068050524,0.000414205,0.00035446024,0.00024009102,0.0015529168,0.00004005344,0.000046099234,0.0005893886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966883,0.0004020133,0.0005261411,0.00079816254,0.00090787513,0.0006775081],"domain_scores_gemma":[0.9981664,0.0005678231,0.00004843714,0.00040012004,0.00024388898,0.00057335966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002790818,0.00025905168,0.00049775623,0.0004664211,0.00021931209,0.00007305161,0.00016298088,0.00021805534,0.00035755365],"category_scores_gemma":[0.0002893583,0.00021816071,0.00010630237,0.0004274544,0.00029359572,0.00015698298,0.000092262206,0.0007230838,0.000034753204],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044962313,0.001130669,0.06625617,0.00033551242,0.00082406885,0.0002623546,0.0035862925,0.00041708988,0.83864754,0.001575159,0.011254836,0.030748012],"study_design_scores_gemma":[0.014399332,0.0045139,0.8503993,0.0015119447,0.00010376523,0.00004024451,0.00019070138,0.0013830365,0.11855677,0.0015631088,0.006870124,0.00046775636],"about_ca_topic_score_codex":0.0014641772,"about_ca_topic_score_gemma":0.00065149006,"teacher_disagreement_score":0.78414315,"about_ca_system_score_codex":0.0011754856,"about_ca_system_score_gemma":0.0010050911,"threshold_uncertainty_score":0.88963354},"labels":[],"label_agreement":null},{"id":"W1491955991","doi":"10.1158/1538-7445.am2014-2476","title":"Abstract 2476: A novel NUT translocation partner binds to BRD4 and is necessary for the blockade of differentiation in NUT midline carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Variation Biotechnologies (Canada)","funders":"","keywords":"BRD4; Gene knockdown; Fusion protein; Biology; Gene; Fusion gene; Bromodomain; Nut; Cell biology; Genetics; Histone; Cancer research","score_opus":0.056833504920675106,"score_gpt":0.3712492209399482,"score_spread":0.3144157160192731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491955991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158436,0.0008471493,0.0032897517,0.003616895,0.00004841222,0.0005077203,0.000036101592,0.0000020786454,0.00006750507],"genre_scores_gemma":[0.99872845,0.00022785053,0.0000900684,0.00013229751,0.00020783435,0.00028100517,0.00004470965,0.000010625691,0.00027712702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992587,0.00003718188,0.00016271012,0.00020780247,0.00016358109,0.000170003],"domain_scores_gemma":[0.9995276,0.00004778231,0.000034776567,0.0001895909,0.00015070423,0.000049585156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049748266,0.00006599838,0.00008471108,0.00007586151,0.00006351969,0.000018099083,0.00012787929,0.00007776768,0.00001977241],"category_scores_gemma":[0.0001048531,0.000050338207,0.000028828621,0.00013845011,0.00006531356,0.000004856489,0.00003295585,0.000088643945,7.797525e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013679096,0.000045474233,0.0029357392,0.000059439113,0.000010557376,3.359652e-8,0.00018358721,0.000030796895,0.9825259,0.00006580499,0.0016112339,0.0123946555],"study_design_scores_gemma":[0.0008308761,0.0001356483,0.053149108,0.00003352191,0.0000039098986,2.9715096e-7,0.00007522506,0.0009808621,0.93138015,0.00004962818,0.013291594,0.00006916355],"about_ca_topic_score_codex":0.00030976636,"about_ca_topic_score_gemma":0.00033914842,"teacher_disagreement_score":0.05114572,"about_ca_system_score_codex":0.000017239314,"about_ca_system_score_gemma":0.00007415459,"threshold_uncertainty_score":0.20527324},"labels":[],"label_agreement":null},{"id":"W1492024125","doi":"10.1158/1538-7445.sabcs14-p2-13-07","title":"Abstract P2-13-07: Prophylactic mastectomy in young women with breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lumpectomy; Mastectomy; Breast cancer; Prospective cohort study; Psychosocial; Hospital Anxiety and Depression Scale; Depression (economics); Cohort; Cancer; Anxiety; Surgery; Gynecology; Internal medicine","score_opus":0.04676663178974358,"score_gpt":0.37140049471664105,"score_spread":0.32463386292689744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492024125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926726,0.0016508114,0.000018018136,0.0008175962,0.00019905451,0.00044973087,0.000073103874,0.000011299204,0.004107774],"genre_scores_gemma":[0.9953479,0.00020528637,0.00008163767,0.00006984599,0.0005361503,0.0016939786,0.000012043974,0.000053525564,0.0019996036],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978824,0.00010595503,0.00018572187,0.00053546444,0.00057449087,0.00071592507],"domain_scores_gemma":[0.99861646,0.000014471209,0.000054163884,0.00046566047,0.0006088531,0.00024041529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007117004,0.00016632561,0.00015862314,0.00016025823,0.00008320375,0.000069369584,0.0003549037,0.00013703841,0.00057452964],"category_scores_gemma":[0.000053584565,0.00014062918,0.000022232718,0.0005232469,0.00025345566,0.000016005342,0.00014597079,0.0004070009,0.000069779366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069081034,0.00043836943,0.24113034,0.00048143612,0.00034294414,0.00013300433,0.0050923196,0.0085822875,0.6696808,0.000037161695,0.023267474,0.043905813],"study_design_scores_gemma":[0.010552599,0.0016319533,0.68150836,0.0004162076,0.000032189033,0.00023082648,0.009060484,0.00013428193,0.23441993,0.0005036619,0.0598445,0.001665028],"about_ca_topic_score_codex":0.002937762,"about_ca_topic_score_gemma":0.0072776354,"teacher_disagreement_score":0.440378,"about_ca_system_score_codex":0.001470258,"about_ca_system_score_gemma":0.0029618556,"threshold_uncertainty_score":0.6290697},"labels":[],"label_agreement":null},{"id":"W1494107087","doi":"10.1158/1538-7445.am2014-821","title":"Abstract 821: Fusogenic liposomes: A novel therapeutic strategy to efficiently target and destroy prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"LNCaP; Prostate cancer; Liposome; Bombesin; Cancer research; Cancer; Prostate; Cancer cell; Medicine; Biology; Internal medicine; Receptor; Biochemistry","score_opus":0.05342700384451804,"score_gpt":0.37678616495912,"score_spread":0.32335916111460195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494107087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313074,0.0051503703,0.00018130305,0.000451739,0.000116775795,0.00038315885,0.00007578757,0.000009973975,0.0005001636],"genre_scores_gemma":[0.9963576,0.0012894927,0.000073665695,0.00038250635,0.0003244677,0.00028288108,0.000022935114,0.000030026498,0.0012363769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983905,0.00006063492,0.00016987973,0.000523653,0.000280555,0.00057475356],"domain_scores_gemma":[0.9992038,0.000024898376,0.00003475785,0.0003301434,0.00019475984,0.00021166798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044473363,0.00016278781,0.00014984644,0.00009811033,0.00014360971,0.000097730226,0.00029062227,0.00011299992,0.00013083358],"category_scores_gemma":[0.00003940034,0.00014047514,0.00004970333,0.00019027431,0.00013868167,0.00000676615,0.00014961835,0.00022012845,0.000030341218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023217777,0.00005250053,0.0017732027,0.000044964676,0.00006064494,0.0000014471889,0.0001324606,0.0009772021,0.9737813,0.000040254716,0.0017853169,0.021118538],"study_design_scores_gemma":[0.0010859946,0.0017733994,0.025586942,0.00013396672,0.000017055221,0.0000071196105,0.00032528472,0.00023804986,0.91034156,0.00013314189,0.05990262,0.000454848],"about_ca_topic_score_codex":0.0005818525,"about_ca_topic_score_gemma":0.00043376093,"teacher_disagreement_score":0.06343971,"about_ca_system_score_codex":0.00004674107,"about_ca_system_score_gemma":0.0003060138,"threshold_uncertainty_score":0.572841},"labels":[],"label_agreement":null},{"id":"W1494718766","doi":"10.1158/1538-7445.am2014-3604","title":"Abstract 3604: Investigation of the role of CSF-1 and its receptor in the bone marrow stroma microenvironment in acute myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bone marrow; Stromal cell; Macrophage colony-stimulating factor; Myeloid leukemia; Myeloid; Cytokine; Biology; Cancer research; Leukemia; Immunology; Cell biology; Chemistry; Macrophage; In vitro; Biochemistry","score_opus":0.028607013694659525,"score_gpt":0.3174480148794716,"score_spread":0.2888410011848121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494718766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914799,0.0017486303,4.4982775e-7,0.0048669754,0.000024943127,0.0009936332,0.00002865992,0.000003841347,0.00085299887],"genre_scores_gemma":[0.99771345,0.0014932858,0.000064864274,0.00013082552,0.00007756269,0.0001714538,0.000010644441,0.000023028108,0.0003149019],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99724716,0.00050849846,0.0004040046,0.00031275375,0.0010544278,0.00047317334],"domain_scores_gemma":[0.99876136,0.00037345508,0.000104037805,0.00051882264,0.00013047786,0.00011182905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029143055,0.00012881873,0.00030215824,0.00027887002,0.00006738134,0.000016026595,0.00041495127,0.0001291116,0.00016853926],"category_scores_gemma":[0.00035416795,0.00008125075,0.000049769747,0.00068536866,0.00055213104,0.00009526787,0.00023766265,0.0010687642,0.000013539826],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032685118,0.000037177477,0.057905607,0.00019252118,0.000025970412,0.000005601729,0.0017244891,0.000019795696,0.93323874,0.00016112257,0.0009369405,0.005425193],"study_design_scores_gemma":[0.0015744976,0.00019702749,0.5723606,0.00037883478,0.00001222296,0.000008877603,0.00095199386,0.0003919441,0.42156154,0.0003203532,0.0021698044,0.00007235076],"about_ca_topic_score_codex":0.001433245,"about_ca_topic_score_gemma":0.000309527,"teacher_disagreement_score":0.51445496,"about_ca_system_score_codex":0.0010423604,"about_ca_system_score_gemma":0.00070262427,"threshold_uncertainty_score":0.46433085},"labels":[],"label_agreement":null},{"id":"W1495635576","doi":"10.1158/1538-7445.am2014-3905","title":"Abstract 3905: Stem like cells in human breast cancer: EP4 as a therapeutic target","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Mediprobe Research (Canada); Western University","funders":"","keywords":"Cancer research; Angiogenesis; Cancer; Breast cancer; Cancer cell; Metastasis; Clonogenic assay; Medicine; Tumor progression; Biology; Internal medicine; Cell culture","score_opus":0.045284962898615215,"score_gpt":0.38970253551841877,"score_spread":0.34441757261980355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1495635576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205613,0.0015968804,0.0000033204635,0.0011420508,0.0004457403,0.0007714393,0.000026561705,0.000049456787,0.003908449],"genre_scores_gemma":[0.9950609,0.00039974521,0.000007635256,0.00049469067,0.001017017,0.0004253153,0.000005857469,0.00006067824,0.0025281324],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972709,0.0002551221,0.00029616448,0.00044408697,0.0008705233,0.00086320855],"domain_scores_gemma":[0.9986608,0.00020066528,0.000058789796,0.0004755373,0.00024276425,0.00036141582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018232107,0.00019930369,0.00039786403,0.000339771,0.00017380618,0.000042981756,0.0002468377,0.00017309327,0.0020540778],"category_scores_gemma":[0.00001872776,0.00016428817,0.000084795705,0.00045277347,0.00019241696,0.00009091174,0.00006795468,0.0009687302,0.0003222997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010347165,0.0003292907,0.07707499,0.001444181,0.00013097466,0.00033283068,0.0015977207,0.000094388,0.85466385,0.0005922221,0.013186099,0.049518764],"study_design_scores_gemma":[0.007930756,0.0010553309,0.43898505,0.0023078816,0.00006280885,0.000055559605,0.000527646,0.0005963801,0.3850238,0.0007751923,0.16185065,0.00082892337],"about_ca_topic_score_codex":0.0035610902,"about_ca_topic_score_gemma":0.0005450488,"teacher_disagreement_score":0.46964002,"about_ca_system_score_codex":0.00056624314,"about_ca_system_score_gemma":0.00064763235,"threshold_uncertainty_score":0.99885815},"labels":[],"label_agreement":null},{"id":"W1496662536","doi":"10.1158/1538-7445.am2014-375","title":"Abstract 375: A novel diagnostic assay for detection of primate-specific RNA editing events in leukemia stem cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"RNA editing; ADAR; RNA; Biology; Myeloid leukemia; Leukemia; K562 cells; Molecular biology; Context (archaeology); Computational biology; Gene; Cancer research; Genetics","score_opus":0.04525555945828635,"score_gpt":0.34948454552708114,"score_spread":0.3042289860687948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496662536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944876,0.00036105403,0.0043215742,0.000043873042,0.00016758297,0.00036786296,0.000033685945,0.0000044804347,0.00021232848],"genre_scores_gemma":[0.9990529,0.00012349362,0.000053999087,0.00001579732,0.00033511376,0.00017574454,0.000019760273,0.000017031281,0.0002061824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990319,0.000063848696,0.00019011249,0.00024151402,0.00022130899,0.0002513039],"domain_scores_gemma":[0.99930066,0.00016475722,0.000064312684,0.00019315176,0.00019450647,0.00008259549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008081096,0.00007274953,0.00009702033,0.00008567184,0.000056750792,0.000011057542,0.00012758948,0.00009277632,0.0000162815],"category_scores_gemma":[0.00021979463,0.00007225816,0.000052267616,0.00011703862,0.000048149348,0.0000051200905,0.000045882323,0.00009486172,0.0000046127216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013610386,0.000041430834,0.0014917557,0.00010277213,0.0000068352606,2.4711733e-7,0.000016841395,0.0007725159,0.97990525,0.00002692284,0.00038978754,0.017109519],"study_design_scores_gemma":[0.0009419365,0.000079052596,0.02823343,0.00006396372,0.0000023756693,2.365777e-7,0.000049664683,0.00051222515,0.96323735,0.00004428728,0.0067573176,0.00007818915],"about_ca_topic_score_codex":0.00006773943,"about_ca_topic_score_gemma":0.000076319426,"teacher_disagreement_score":0.026741674,"about_ca_system_score_codex":0.00012234128,"about_ca_system_score_gemma":0.00014779992,"threshold_uncertainty_score":0.29466024},"labels":[],"label_agreement":null},{"id":"W1496976756","doi":"10.1158/1538-7445.am2014-4372","title":"Abstract 4372: MiR-449a promotes breast cancer progression by activating the NF-κB pathway","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Gene knockdown; Cancer research; microRNA; Biology; Viability assay; Breast cancer; Cell culture; Gene expression profiling; Clonogenic assay; Cell growth; Microarray analysis techniques; Cancer; Gene expression; Gene; Genetics","score_opus":0.02853262374219626,"score_gpt":0.37375934252906734,"score_spread":0.34522671878687106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496976756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934258,0.0030918964,0.000053923835,0.0020926013,0.000093641596,0.00053280464,0.00013010972,0.000018065677,0.00056115625],"genre_scores_gemma":[0.9979199,0.00020521601,0.000041244486,0.000074047755,0.00067894807,0.00046024163,0.00008968533,0.000040266605,0.00049042545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823797,0.00020724721,0.00017309657,0.00043780927,0.0004618211,0.00048204573],"domain_scores_gemma":[0.99895865,0.000049698876,0.00009187337,0.00045862308,0.00031269804,0.00012845498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077165285,0.00014805474,0.00010759682,0.00003860952,0.00033411328,0.000087004104,0.00036939097,0.00014545117,0.0002477527],"category_scores_gemma":[0.00013901481,0.00010250097,0.000059807266,0.00018486548,0.00021442276,0.000010137904,0.00018913683,0.00028596778,0.000014761365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009483717,0.00004815218,0.0016865034,0.00006727089,0.000029072491,5.277306e-7,0.00004824798,0.000016296492,0.90479267,0.00001345062,0.013172116,0.08003086],"study_design_scores_gemma":[0.00029332336,0.00005228586,0.015145584,0.00014832334,0.0000038538324,0.000003233162,0.00004022014,0.000084451116,0.9194437,0.000052341773,0.06458449,0.00014815317],"about_ca_topic_score_codex":0.0002902859,"about_ca_topic_score_gemma":0.00007746866,"teacher_disagreement_score":0.07988271,"about_ca_system_score_codex":0.000101064004,"about_ca_system_score_gemma":0.00031053842,"threshold_uncertainty_score":0.41798684},"labels":[],"label_agreement":null},{"id":"W1497938321","doi":"10.1158/1538-7445.sabcs14-p1-09-02","title":"Abstract P1-09-02: BMI and metabolic factors in long-term breast cancer survivors: Changes from diagnosis and comparison to non-breast cancer controls","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Waist; Breast cancer; Cancer; Internal medicine; Metabolic syndrome; Circumference; Body mass index; Gynecology; Obesity","score_opus":0.12841516848777249,"score_gpt":0.4367070151365179,"score_spread":0.3082918466487454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1497938321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535258,0.03391156,0.000003307027,0.007351075,0.00048956595,0.0014945549,0.003119914,0.000037911494,0.00006634038],"genre_scores_gemma":[0.9779095,0.0189528,0.0000057058437,0.00024228128,0.00085014995,0.0017202683,0.000051761504,0.000080875725,0.00018665617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655503,0.00013358709,0.00043464615,0.0008976447,0.00093612284,0.0010429807],"domain_scores_gemma":[0.99752253,0.00034220007,0.00011780413,0.00045752715,0.00047091141,0.0010890405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066093955,0.0004216026,0.0011102849,0.00055245595,0.00014377902,0.00017916107,0.00025610623,0.0002263878,0.001263675],"category_scores_gemma":[0.00006835693,0.00034134428,0.00007108955,0.0007276002,0.00033207732,0.00022726666,0.0002330428,0.0008442014,0.000015254657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010647204,0.00018637333,0.92340565,0.00016004195,0.00020021002,0.000031777377,0.0029738944,0.00002662074,0.003845518,0.0000023511775,0.0024401012,0.06566273],"study_design_scores_gemma":[0.0036177551,0.00013319361,0.985189,0.00097264844,0.00010354377,0.0000065412382,0.0010508318,0.000037821224,0.0050345757,0.000007616161,0.0034814249,0.00036505357],"about_ca_topic_score_codex":0.5234762,"about_ca_topic_score_gemma":0.41740716,"teacher_disagreement_score":0.106069036,"about_ca_system_score_codex":0.0007782427,"about_ca_system_score_gemma":0.00071891467,"threshold_uncertainty_score":0.99990386},"labels":[],"label_agreement":null},{"id":"W1498162435","doi":"10.1158/1538-7445.sabcs14-p4-11-06","title":"Abstract P4-11-06: TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; McMaster University; Queen's University; University of British Columbia; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Taxane; Epirubicin; Internal medicine; Biomarker; Oncology; Breast cancer; Cyclophosphamide; Clinical trial; Cancer; Chemotherapy","score_opus":0.2881856690080417,"score_gpt":0.5048653406492384,"score_spread":0.21667967164119667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498162435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991219,0.00094512146,0.000079973644,0.0051346603,0.00032760156,0.0013726437,0.0004837319,0.000008739361,0.0004285452],"genre_scores_gemma":[0.9963529,0.00035179695,0.00006566029,0.00047483275,0.0012811066,0.001029766,0.00010060101,0.000025819896,0.00031753123],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99760824,0.0004340538,0.0003101262,0.0005962602,0.0005089406,0.00054234965],"domain_scores_gemma":[0.998484,0.0003792685,0.00008043382,0.0004944193,0.0004283389,0.00013354258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003694904,0.00017516062,0.0002664011,0.00006787264,0.0001347774,0.00003628144,0.0002350684,0.0002130021,0.00001736025],"category_scores_gemma":[0.0008000568,0.00012516626,0.00015696163,0.0002156727,0.0004110902,0.000007434639,0.000197297,0.00028219476,0.000023128758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2452637,0.0024325422,0.10976705,0.00018242633,0.001400398,0.00016702779,0.0027094102,0.000043408465,0.049494293,0.00011757389,0.5511339,0.037288327],"study_design_scores_gemma":[0.08427665,0.0028274728,0.59854084,0.00013430332,0.0001274211,0.00002859612,0.0022594265,0.00013485747,0.051239606,0.00035412307,0.25940767,0.0006690711],"about_ca_topic_score_codex":0.0012318641,"about_ca_topic_score_gemma":0.0021781193,"teacher_disagreement_score":0.48877376,"about_ca_system_score_codex":0.00016696403,"about_ca_system_score_gemma":0.0006547564,"threshold_uncertainty_score":0.5104132},"labels":[],"label_agreement":null},{"id":"W1498789110","doi":"10.1158/1538-7445.am2014-4369","title":"Abstract 4369: The microRNA-218-survivin axis regulates cervical cancer cell migration and invasion","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Survivin; Clonogenic assay; Transfection; Gene knockdown; microRNA; Cancer research; Biology; Cervical cancer; Molecular biology; Cell; Cancer; Cell culture; Gene; Genetics","score_opus":0.030141223925882574,"score_gpt":0.3295198340203751,"score_spread":0.2993786100944925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498789110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899941,0.0073018456,0.00003910972,0.0017310746,0.00009485603,0.00031760006,0.000026513737,0.000009508885,0.000485405],"genre_scores_gemma":[0.9958623,0.0025726024,0.000051204348,0.00012424147,0.00048170035,0.00012938354,0.00005952813,0.00002766677,0.00069137744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854386,0.00022907891,0.00017093658,0.00041438168,0.00030670315,0.00033502976],"domain_scores_gemma":[0.9990848,0.00006613279,0.000058320948,0.00042943057,0.00023967425,0.000121663914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080525805,0.00012879781,0.000104250794,0.00003725985,0.00024384068,0.00008396573,0.0002437013,0.0001589671,0.00023519687],"category_scores_gemma":[0.00008735228,0.00009682206,0.000042961376,0.00012788878,0.00022137008,0.000010255282,0.00018127107,0.00018256121,0.000015921856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089466295,0.00003202931,0.0040042643,0.000077526114,0.000017530354,3.2738882e-7,0.00007739202,0.000045804554,0.9808053,0.000026536907,0.007349103,0.0074747424],"study_design_scores_gemma":[0.00040394766,0.00007347925,0.0937328,0.00005006214,0.000010616392,0.0000018048373,0.0000675394,0.00027224113,0.8581637,0.00015267832,0.046924923,0.00014619848],"about_ca_topic_score_codex":0.0030872773,"about_ca_topic_score_gemma":0.0067970436,"teacher_disagreement_score":0.12264156,"about_ca_system_score_codex":0.00008228763,"about_ca_system_score_gemma":0.00016249696,"threshold_uncertainty_score":0.46670604},"labels":[],"label_agreement":null},{"id":"W1498810926","doi":"10.1158/1538-7445.sabcs14-p1-07-24","title":"Abstract P1-07-24: Modeling breast cancer metastasis in the mouse via measurement of circulating tumor cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Circulating tumor cell; Breast cancer; Metastasis; Metastatic breast cancer; Intravasation; Cancer; Cancer cell; Mammary tumor; Cancer research; Medicine; CA15-3; Pathology; Primary tumor; Internal medicine","score_opus":0.2886679308405861,"score_gpt":0.4188207245197693,"score_spread":0.1301527936791832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498810926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862122,0.008521259,0.00021800329,0.0022395179,0.00022746608,0.0010404711,0.0002115437,0.000021532816,0.0013079904],"genre_scores_gemma":[0.9980918,0.0007040421,0.00017868666,0.00019264365,0.0003411334,0.00035189456,0.0000066865477,0.0000470799,0.00008600439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99548745,0.00024136525,0.0005443278,0.00044251126,0.0025683327,0.00071600365],"domain_scores_gemma":[0.9977058,0.00007603544,0.000117656185,0.00059475,0.0012069296,0.00029882748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052447035,0.0002044374,0.00048713782,0.0003079712,0.00009943603,0.000045176577,0.0003456828,0.00006188768,0.0005663883],"category_scores_gemma":[0.00010842384,0.00014566992,0.00015063422,0.0007876341,0.00014304278,0.00012505695,0.000099809884,0.0007453816,0.000025048354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013631213,0.0007289383,0.003780434,0.0014229898,0.00041660527,0.00018991205,0.0052513042,0.03826267,0.8736013,0.00004275791,0.009154061,0.06578586],"study_design_scores_gemma":[0.016722947,0.0007447261,0.009043942,0.003832382,0.0009485814,0.00024906232,0.024512038,0.027777772,0.8939186,0.0006003211,0.020069228,0.0015804499],"about_ca_topic_score_codex":0.035773095,"about_ca_topic_score_gemma":0.0027864107,"teacher_disagreement_score":0.064205416,"about_ca_system_score_codex":0.0011715153,"about_ca_system_score_gemma":0.001550794,"threshold_uncertainty_score":0.97064775},"labels":[],"label_agreement":null},{"id":"W1498860864","doi":"10.1158/1538-7445.sabcs14-p2-01-01","title":"Abstract P2-01-01: Sentinel node surgery after neoadjuvant chemotherapy in patient with axillary node involvement: The French GANEA 2 prospective multi-institutional trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Sentinel lymph node; Breast cancer; Axillary Lymph Node Dissection; Axilla; Lymph node; Surgery; Sentinel node; Axillary lymph nodes; Neoadjuvant therapy; Radiology; Cancer; Internal medicine","score_opus":0.05927418140317342,"score_gpt":0.3360423694170694,"score_spread":0.27676818801389597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498860864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203247,0.0044360613,0.00002814031,0.0018531961,0.00022514685,0.0009645345,0.00008942664,0.000012082731,0.00035895873],"genre_scores_gemma":[0.99631,0.0006799884,0.000088410736,0.00041773787,0.00047675762,0.0017959786,0.00009548547,0.00003322242,0.000102449834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978137,0.00012124431,0.0002694032,0.0005654273,0.0006668295,0.000563396],"domain_scores_gemma":[0.99897397,0.000056463923,0.000077727775,0.00041616682,0.00034781036,0.00012788697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055399875,0.00025022036,0.0002561962,0.00010151491,0.00017876978,0.000050749917,0.00019673341,0.00011097306,0.000059658578],"category_scores_gemma":[0.00007943012,0.000156244,0.00008988382,0.00028859128,0.00044829003,0.000013976271,0.00016709667,0.00029587926,0.0000143009975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0961034,0.0035306553,0.82016575,0.00020223923,0.0015277213,0.0007239201,0.0059058075,0.0014034595,0.019470818,0.000028821412,0.038149916,0.0127874715],"study_design_scores_gemma":[0.057723075,0.0006055479,0.837483,0.00036779558,0.000044192875,0.000045217002,0.0014272785,0.000069168986,0.06764513,0.000081801125,0.03366107,0.0008467262],"about_ca_topic_score_codex":0.0027598352,"about_ca_topic_score_gemma":0.0026088897,"teacher_disagreement_score":0.048174314,"about_ca_system_score_codex":0.0004104253,"about_ca_system_score_gemma":0.001004099,"threshold_uncertainty_score":0.63714457},"labels":[],"label_agreement":null},{"id":"W1498943852","doi":"10.1158/1538-7445.am2014-767","title":"Abstract 767: Cyclosporin-modulated intensified-dosage chemotherapy for saving eyes with Group D intraocular retinoblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Carboplatin; Medicine; Etoposide; Vincristine; Enucleation; Chemotherapy; Regimen; Surgery; Urology; Chemotherapy regimen; Retinoblastoma; Cisplatin; Cyclophosphamide","score_opus":0.039658789401982864,"score_gpt":0.3837587097080501,"score_spread":0.34409992030606723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498943852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385685,0.00050993805,0.0003946079,0.002428616,0.00011786105,0.0010986525,0.000008419748,0.000079804806,0.0015052536],"genre_scores_gemma":[0.9968241,0.00022443055,0.001071896,0.00037107692,0.00035566516,0.00030786695,0.00004076102,0.00006552189,0.00073870877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817485,0.0000788148,0.00020685645,0.00048081222,0.0004379724,0.00062070065],"domain_scores_gemma":[0.9986159,0.00022275842,0.00006111308,0.00044655582,0.000440238,0.00021342625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008543498,0.00019031261,0.0003704154,0.00016863304,0.00022302734,0.000028259361,0.00014691427,0.0001876369,0.00024620196],"category_scores_gemma":[0.00017014057,0.00014120832,0.000092103684,0.00029912216,0.00029751819,0.00007508485,0.000035296405,0.0004980313,0.000042018422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016367305,0.0014632277,0.1703858,0.0011170512,0.002145227,0.00078761857,0.0011679332,0.000044946788,0.58870274,0.0015953389,0.005026924,0.21119592],"study_design_scores_gemma":[0.020120975,0.0063818074,0.71862215,0.001432627,0.00022782065,0.00011939983,0.00041254857,0.0005318622,0.18582909,0.0013313028,0.064414635,0.00057580206],"about_ca_topic_score_codex":0.00028788784,"about_ca_topic_score_gemma":0.00015305336,"teacher_disagreement_score":0.54823637,"about_ca_system_score_codex":0.00028922636,"about_ca_system_score_gemma":0.00017055593,"threshold_uncertainty_score":0.5758308},"labels":[],"label_agreement":null},{"id":"W1499729288","doi":"10.1158/1538-7445.am2014-942","title":"Abstract 942: Imputation from The 1000 Genomes Project identifies rare large effect variants of BRCA2-K3326X and CHEK2-I157T as risk factors for lung cancer; a study from the TRICL consortium","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"1000 Genomes Project; Odds ratio; Imputation (statistics); Genome-wide association study; Statistics; Single-nucleotide polymorphism; Lung cancer; Logistic regression; Medicine; Biology; Oncology; Genetics; Missing data; Mathematics; Genotype","score_opus":0.03245820380299861,"score_gpt":0.39866224176875464,"score_spread":0.366204037965756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499729288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331505,0.01136606,0.00040432223,0.00024383696,0.00030206083,0.0024040886,0.0019023577,0.0000104376695,0.000051801177],"genre_scores_gemma":[0.99607986,0.0016286072,0.000023657001,0.000055195836,0.0005275471,0.0012682098,0.00022146975,0.000042588337,0.00015286903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761105,0.00066948385,0.0003137491,0.00059578667,0.00041032396,0.00039960633],"domain_scores_gemma":[0.99726546,0.00144835,0.00020638884,0.0005875584,0.00043528635,0.00005694962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016805071,0.0002033441,0.00026043522,0.00006137756,0.00049273745,0.00013618104,0.00049708324,0.00014051342,0.0000950745],"category_scores_gemma":[0.0008734915,0.0001276355,0.00009112312,0.000292107,0.00023620838,0.000015219925,0.00021924876,0.00029155443,0.0000014237619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015322469,0.00023248885,0.7615991,0.00015794068,0.002093139,0.0000024193441,0.01300796,0.0011235896,0.1843376,0.000023224433,0.015239363,0.020650934],"study_design_scores_gemma":[0.0038742174,0.000703243,0.7971553,0.00008704876,0.00032783084,7.808723e-7,0.0066403258,0.0014738564,0.18275207,0.00018877063,0.006449627,0.00034693474],"about_ca_topic_score_codex":0.022894628,"about_ca_topic_score_gemma":0.005385525,"teacher_disagreement_score":0.0355562,"about_ca_system_score_codex":0.0001506059,"about_ca_system_score_gemma":0.0006926466,"threshold_uncertainty_score":0.983612},"labels":[],"label_agreement":null},{"id":"W1499934474","doi":"","title":"Novel anti-CD33 immunoconjugate demonstrating in vitro and in vivo activity against human acute myeloid leukemia (AML) cells.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunoconjugate; Myeloid leukemia; Cytotoxic T cell; CD33; Clonogenic assay; Cancer research; Cytotoxicity; Leukemia; Chemistry; In vivo; Antigen; Haematopoiesis; Stem cell; Monoclonal antibody; Antibody; Immunology; In vitro; Biology; CD34; Cell biology; Biochemistry","score_opus":0.0378726971746742,"score_gpt":0.3588795019694974,"score_spread":0.32100680479482324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499934474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910781,0.0006830393,0.000028961424,0.0009347435,0.0000641312,0.0013433043,0.00007968593,0.000056015302,0.005732013],"genre_scores_gemma":[0.9956947,0.0011230814,0.00049812713,0.00011156149,0.00029653808,0.00032649795,0.000027719,0.00008710642,0.0018346625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544495,0.00031632232,0.00056649104,0.00092275004,0.0011124078,0.0016371016],"domain_scores_gemma":[0.9983643,0.0003241823,0.00009488875,0.0006362097,0.0002944208,0.00028596853],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023280678,0.00034388996,0.00070226385,0.0011077096,0.00033701028,0.0001475699,0.00040765706,0.00032245903,0.0000945344],"category_scores_gemma":[0.00012008859,0.00033575372,0.00008937937,0.0016155216,0.00075195247,0.00035039114,0.0004645464,0.002798995,0.00002199267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008600825,0.00018334325,0.008545635,0.00018552264,0.00004977984,0.00056201214,0.0002275502,0.00009474318,0.9827546,0.00003448873,0.0007214639,0.0057808137],"study_design_scores_gemma":[0.005824455,0.00012518665,0.046037327,0.00035838626,0.000012502801,0.000044136777,0.0002562632,0.0020123215,0.94399744,0.000056711357,0.000958495,0.0003167462],"about_ca_topic_score_codex":0.022170907,"about_ca_topic_score_gemma":0.0030183634,"teacher_disagreement_score":0.038757097,"about_ca_system_score_codex":0.004280345,"about_ca_system_score_gemma":0.0021504103,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W1499937040","doi":"10.1158/1538-7445.sabcs14-p5-10-16","title":"Abstract P5-10-16: Evaluation of RT-qPCR and luminex-based methodolgies in HER2 breast cancer testing","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Cancer; Breast carcinoma; Pathology","score_opus":0.35186833761467967,"score_gpt":0.543468939257221,"score_spread":0.19160060164254128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499937040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652387,0.003503283,0.0000690463,0.006136679,0.00009595826,0.00041082676,0.000011735185,0.000019630861,0.0032289897],"genre_scores_gemma":[0.99767596,0.00009841607,0.001517326,0.00012701572,0.00020015826,0.00013346715,0.0000076682045,0.000025718417,0.00021430082],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974207,0.00038763243,0.0002750013,0.00028481608,0.0012806207,0.00035122497],"domain_scores_gemma":[0.99772257,0.00053269265,0.00007786012,0.00020768141,0.0012181896,0.00024098453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009458936,0.000103984166,0.00028454934,0.0003105412,0.000051771796,0.00002681098,0.00010937724,0.00007040318,0.0004297366],"category_scores_gemma":[0.0051038745,0.00008720446,0.000027037433,0.0005822422,0.0002874873,0.00007946173,0.000053681586,0.000624289,0.0000035030366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056571775,0.00015056449,0.352029,0.00074810704,0.000060348073,0.000030658663,0.00087613385,0.0052124797,0.060905483,0.000026605037,0.0067993407,0.5725956],"study_design_scores_gemma":[0.006999843,0.00020765408,0.85249484,0.0023675323,0.0001084946,0.000031080115,0.0009910956,0.12754533,0.0060591456,0.00067268236,0.0022906752,0.00023165932],"about_ca_topic_score_codex":0.014178388,"about_ca_topic_score_gemma":0.0003205902,"teacher_disagreement_score":0.5723639,"about_ca_system_score_codex":0.0005744976,"about_ca_system_score_gemma":0.0017656434,"threshold_uncertainty_score":0.9923863},"labels":[],"label_agreement":null},{"id":"W1500798294","doi":"10.1158/1538-7445.sabcs14-p6-01-10","title":"Abstract P6-01-10: Prognostic significance of breast cancer index (BCI) in node-positive hormone receptor positive early breast cancer: NCIC CTG MA.14","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Tamoxifen; Cancer","score_opus":0.03335125958251184,"score_gpt":0.3427225291239435,"score_spread":0.3093712695414317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1500798294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749012,0.012633343,0.000017856406,0.0030661637,0.00028929228,0.0013238143,0.006830215,0.00002774456,0.00091037387],"genre_scores_gemma":[0.9924996,0.0034748632,0.000046254772,0.0001145041,0.00075580605,0.0021014863,0.00017548572,0.000103036284,0.0007289631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956252,0.00031813732,0.0005552621,0.0011754018,0.0010902717,0.0012357122],"domain_scores_gemma":[0.9966598,0.000131507,0.00025723758,0.0006110884,0.0019107454,0.0004295995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006772492,0.00051257975,0.0006370223,0.00028312273,0.00019146308,0.00006600832,0.0006257252,0.00034552242,0.00035079784],"category_scores_gemma":[0.00010429298,0.0004854666,0.00015038437,0.0009718613,0.0008545045,0.00004865761,0.0004113613,0.0006384545,0.00004574491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019126397,0.0012467919,0.5283501,0.00030988993,0.0014446536,0.00010233044,0.002830526,0.00094481907,0.39239123,0.000032096315,0.031276047,0.021945095],"study_design_scores_gemma":[0.0031367028,0.00034303698,0.93657637,0.00056044036,0.000059972663,0.000021763237,0.0005687887,0.000014654539,0.057526615,0.000037924732,0.0006220363,0.0005316983],"about_ca_topic_score_codex":0.05120347,"about_ca_topic_score_gemma":0.0064604185,"teacher_disagreement_score":0.40822625,"about_ca_system_score_codex":0.0013757679,"about_ca_system_score_gemma":0.0022179408,"threshold_uncertainty_score":0.9997597},"labels":[],"label_agreement":null},{"id":"W1503840835","doi":"10.1158/1538-7445.am2014-865","title":"Abstract 865: Evolving biological and clinical concepts of radiation delivery in NSCLC: response to ablative versus fractionated radiotherapy","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Clonogenic assay; Radiation therapy; Medicine; Cancer research; Lung cancer; Cell growth; Oncology; Cancer; A549 cell; Cell; Internal medicine; Biology","score_opus":0.25264662083640127,"score_gpt":0.47719178247318106,"score_spread":0.2245451616367798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503840835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955808,0.002273569,0.0000246031,0.0011754711,0.0000914855,0.0005465685,0.000007843121,0.000010041114,0.00028962968],"genre_scores_gemma":[0.9980265,0.0014416678,0.00019877999,0.000059893224,0.00013701618,0.00005962418,0.000011387959,0.000010644113,0.000054467066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826777,0.0006634347,0.0002761741,0.0002771533,0.00027973912,0.00023573179],"domain_scores_gemma":[0.9967333,0.0026870759,0.000047295667,0.00014445862,0.00021954128,0.00016832275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023692078,0.00008480793,0.0002625994,0.00024571767,0.000053294916,0.000012255058,0.00005641372,0.00014634707,0.0004884682],"category_scores_gemma":[0.0014313691,0.000069039605,0.00005478048,0.0003554445,0.00018066695,0.000065522465,0.000025007086,0.00031992813,0.000015223589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018104434,0.00011958187,0.8372006,0.000015622882,0.00008618063,0.000022615804,0.00040129563,0.000003089084,0.03670149,0.000011396972,0.0003054442,0.107028276],"study_design_scores_gemma":[0.004874906,0.001823594,0.98232555,0.00009598727,0.000011522731,0.0000010379093,0.00012787568,0.0009932646,0.006995915,0.000013509229,0.002665557,0.0000712616],"about_ca_topic_score_codex":0.0003841034,"about_ca_topic_score_gemma":0.000041478128,"teacher_disagreement_score":0.14512499,"about_ca_system_score_codex":0.00028577406,"about_ca_system_score_gemma":0.00022068681,"threshold_uncertainty_score":0.53483844},"labels":[],"label_agreement":null},{"id":"W1503912124","doi":"","title":"Drug-specific pattern of P53 phosphorylation in endometrial cancer cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Transactivation; Mdm2; Endometrial cancer; Cancer research; Phosphorylation; Cancer cell; DNA damage; Biology; Cancer; Cell cycle; Cisplatin; DNA repair; Apoptosis; Gene; Cell biology; DNA; Gene expression; Genetics; Chemotherapy","score_opus":0.10382070291419425,"score_gpt":0.38137093649939163,"score_spread":0.27755023358519737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503912124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809561,0.0152507955,0.00011530092,0.0005007399,0.00065498706,0.000967086,0.00006113192,0.00002600146,0.0014678735],"genre_scores_gemma":[0.9823592,0.015627138,0.000047197547,0.0000528884,0.00046784134,0.00029416013,0.00001567747,0.00004982766,0.0010860998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725515,0.00016790688,0.00042421662,0.0004381348,0.0011567391,0.00055787864],"domain_scores_gemma":[0.9986497,0.00017988344,0.00008715821,0.0004547855,0.00045167137,0.00017679449],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070463575,0.00014804244,0.00039628797,0.0008174298,0.00008158831,0.000009169193,0.00018613721,0.00013971719,0.0015986343],"category_scores_gemma":[0.00008948814,0.00014609372,0.00011247766,0.0018790727,0.00029119238,0.00006566415,0.00008401868,0.0007969887,0.00006860455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014236022,0.0002544085,0.020192795,0.000192364,0.00007750805,0.0002555606,0.0023993265,0.0004919786,0.90073204,0.000021251853,0.02385899,0.050100178],"study_design_scores_gemma":[0.005945995,0.00019212616,0.015068452,0.00044865673,0.000014725012,0.000012320866,0.00015084518,0.00012480786,0.9470707,0.000020004054,0.030782811,0.00016854507],"about_ca_topic_score_codex":0.008303529,"about_ca_topic_score_gemma":0.0009146061,"teacher_disagreement_score":0.049931634,"about_ca_system_score_codex":0.0011047943,"about_ca_system_score_gemma":0.00097496144,"threshold_uncertainty_score":0.999314},"labels":[],"label_agreement":null},{"id":"W1503938240","doi":"10.1158/1538-7445.am2014-620","title":"Abstract 620: Evidence for combination tamoxifen and betulinic acid to treat hormone responsive- and unresponsive breast cancer by attenuation of Pygopus expression","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Fulvestrant; Betulinic acid; Tamoxifen; Estrogen receptor; Breast cancer; Cancer research; Sp1 transcription factor; Estrogen; Estrogen receptor alpha; Hormone response element; Chromatin immunoprecipitation; Biology; Promoter; Cancer; Internal medicine; Endocrinology; Medicine; Gene expression; Biochemistry; Gene","score_opus":0.060193334304737584,"score_gpt":0.4012679750194463,"score_spread":0.3410746407147087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503938240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853872,0.008894012,0.000108056054,0.004825081,0.000045148656,0.00051366765,0.00020295434,0.0000038803882,0.000020021085],"genre_scores_gemma":[0.9950089,0.003935635,0.00010298546,0.00008028977,0.00015680944,0.00019543919,0.000028360064,0.000016763202,0.00047484873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987741,0.00018680203,0.00015945571,0.00041201978,0.0002341365,0.00023344498],"domain_scores_gemma":[0.99878263,0.00033596097,0.00007429551,0.00022182296,0.000479964,0.000105333005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088778586,0.000110099005,0.00016000365,0.0000882271,0.00012173885,0.000030724175,0.000114398266,0.0001222852,0.000020892187],"category_scores_gemma":[0.00094919896,0.00009362697,0.000029922125,0.000113707145,0.00015998,0.000020438161,0.00010384285,0.000104407256,5.93588e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031889249,0.000022092627,0.00048255906,0.00007514082,0.000013150893,1.4999995e-7,0.00010341739,0.0000024430594,0.94264823,0.000006977898,0.0077939285,0.04566299],"study_design_scores_gemma":[0.00055549433,0.0004835462,0.025663884,0.00014512164,0.00001173354,0.0000017768891,0.00008348356,0.000015951471,0.97096175,0.00009853196,0.0018625546,0.000116194155],"about_ca_topic_score_codex":0.00034474538,"about_ca_topic_score_gemma":0.000032978798,"teacher_disagreement_score":0.0455468,"about_ca_system_score_codex":0.000047223642,"about_ca_system_score_gemma":0.0000987216,"threshold_uncertainty_score":0.3817997},"labels":[],"label_agreement":null},{"id":"W1504632404","doi":"10.1158/1538-7445.sabcs14-s2-01","title":"Abstract S2-01: Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Gene signature; Breast cancer; Oncology; Exemestane; Medicine; Internal medicine; Cohort; Gene expression; Gene expression profiling; Cancer research; Cancer; Bioinformatics; Biology; Gene; Tamoxifen; Genetics","score_opus":0.056571101111083676,"score_gpt":0.4127610542971349,"score_spread":0.35618995318605123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1504632404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122083,0.005550774,0.000007894785,0.0010116019,0.00037938866,0.0005569731,0.00055769406,0.000017012091,0.00069782033],"genre_scores_gemma":[0.9956565,0.0017761575,0.00012473122,0.000057349593,0.0010441534,0.00092828966,0.000034896577,0.000052124135,0.00032582544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971143,0.00024820765,0.00029419336,0.00075506995,0.00075283507,0.00083536725],"domain_scores_gemma":[0.9983967,0.00014042137,0.000105433166,0.0005193613,0.0005730301,0.00026504992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009359214,0.0002694289,0.0002797684,0.00026209946,0.00016463455,0.00008170904,0.00038400013,0.00018463942,0.000076973396],"category_scores_gemma":[0.00027877843,0.00023452584,0.00007068166,0.00064467033,0.0003122028,0.000017756938,0.00028304348,0.0006424648,0.000030915202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012811793,0.00042957245,0.89184815,0.000057866288,0.00029636075,0.000054560896,0.00053228845,0.00034081138,0.06645741,0.0000094703655,0.0076092863,0.031083027],"study_design_scores_gemma":[0.002706459,0.00026262144,0.9817894,0.00007628611,0.000028371562,0.000007200132,0.00033989584,0.00001806481,0.013066234,0.000081150705,0.0013524484,0.0002718876],"about_ca_topic_score_codex":0.031337958,"about_ca_topic_score_gemma":0.008112174,"teacher_disagreement_score":0.08994122,"about_ca_system_score_codex":0.00074283517,"about_ca_system_score_gemma":0.0013483955,"threshold_uncertainty_score":0.97511244},"labels":[],"label_agreement":null},{"id":"W1505536437","doi":"10.1158/1538-7445.am2014-2716","title":"Abstract 2716: Discovery of novel TAM family kinase inhibitors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"Receptor tyrosine kinase; Cancer research; Kinase; Cancer; Tyrosine kinase; Pharmacology; Biology; Medicine; Signal transduction; Biochemistry; Internal medicine","score_opus":0.07002308327446585,"score_gpt":0.36401845298936203,"score_spread":0.29399536971489615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505536437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991751,0.0047623324,0.00013946703,0.00020876671,0.000504336,0.00017677873,0.00003903046,0.000016549042,0.0024017063],"genre_scores_gemma":[0.99762577,0.0002446796,0.000012443819,0.000030174397,0.000096416734,0.00004330993,0.000039966104,0.000015692647,0.0018915347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889106,0.00012772049,0.0002596724,0.00023719955,0.00010653862,0.00037779988],"domain_scores_gemma":[0.9992088,0.00018924949,0.00007804733,0.00032169462,0.00018247968,0.000019715932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081134494,0.00009992698,0.00020950874,0.00016937018,0.00014352094,0.000021796579,0.00023584215,0.00015721664,0.00015563417],"category_scores_gemma":[0.00012980103,0.0000838481,0.000078623925,0.00023247884,0.00037021266,0.00019857328,0.000113763585,0.00036124632,0.00009228719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010630701,0.00013873092,0.0007340248,0.000041001636,0.00004021925,2.46983e-7,0.00009774689,0.000025443705,0.9766795,0.0011034502,0.005308048,0.015725298],"study_design_scores_gemma":[0.0010490459,0.00011600914,0.080544256,0.000119018485,0.0000063357525,0.0000012658554,0.00011497945,0.000008996912,0.8793156,0.000093780436,0.038527716,0.00010298491],"about_ca_topic_score_codex":0.0010563771,"about_ca_topic_score_gemma":0.000030474614,"teacher_disagreement_score":0.09736387,"about_ca_system_score_codex":0.000084918116,"about_ca_system_score_gemma":0.00014318008,"threshold_uncertainty_score":0.34192264},"labels":[],"label_agreement":null},{"id":"W1506161303","doi":"10.1158/1538-7445.sabcs14-p4-01-12","title":"Abstract P4-01-12: Circulating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Circulating tumor cell; Metastatic breast cancer; Oncology; Cancer; Prospective cohort study; Cohort; Breast cancer; Gastroenterology; Chemotherapy; Metastasis","score_opus":0.04347094340345074,"score_gpt":0.32966811734128276,"score_spread":0.286197173937832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506161303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766154,0.0028525828,0.000005323433,0.002510928,0.00010754163,0.0032791623,0.014449224,0.00004019457,0.00013959063],"genre_scores_gemma":[0.9960077,0.0012571798,0.00020632266,0.00010171302,0.0003809777,0.0016631756,0.00007143079,0.0001133172,0.00019823108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958078,0.0002929138,0.00063137774,0.0010771616,0.001296182,0.0008945508],"domain_scores_gemma":[0.9964235,0.00086254545,0.0004363396,0.00056356826,0.0012787061,0.00043533408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074824126,0.00052057486,0.0009335074,0.0002713002,0.00023502066,0.000067968955,0.0002694904,0.000114440154,0.00018722127],"category_scores_gemma":[0.00015256749,0.00035319882,0.000057798017,0.00081017637,0.0010990249,0.00030916673,0.00020250815,0.0008760336,0.000002971088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043964107,0.0010603823,0.8752999,0.0008683296,0.0013858055,0.00023925104,0.02098086,0.00086976093,0.025993615,0.000004044938,0.00066381786,0.028670156],"study_design_scores_gemma":[0.016240964,0.0014559777,0.950964,0.0030325123,0.00023725344,0.000049355727,0.0024271978,0.00022407576,0.02471776,0.00012535475,0.00013171599,0.00039384209],"about_ca_topic_score_codex":0.20295706,"about_ca_topic_score_gemma":0.08670198,"teacher_disagreement_score":0.11625508,"about_ca_system_score_codex":0.001418132,"about_ca_system_score_gemma":0.0011002442,"threshold_uncertainty_score":0.999892},"labels":[],"label_agreement":null},{"id":"W1506859052","doi":"10.1158/1538-7445.am2014-807","title":"Abstract 807: Selamectin and ivermectin are small molecule inhibitors that interfere with Sin3A-PAH2 function and exert anti-tumor activity in triple-negative breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Chemistry; Epigenetics; In vivo; Cell biology; Cancer research; Biology; Biochemistry; Genetics","score_opus":0.03266877192381467,"score_gpt":0.31727507112665476,"score_spread":0.2846062992028401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506859052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774444,0.0011859706,0.00013336253,0.00023418665,0.00009245611,0.0003785754,0.000043906282,0.000007992253,0.00017913323],"genre_scores_gemma":[0.998544,0.000963279,0.000020941246,0.000031953736,0.00018779784,0.00011929636,0.000009702031,0.000029416862,0.00009365418],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985695,0.0002129086,0.00012592309,0.0005359843,0.00021299082,0.00034272534],"domain_scores_gemma":[0.99934024,0.00005438426,0.00009536839,0.00019551578,0.00019358167,0.000120919074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056374754,0.00017270359,0.00019164546,0.00012912757,0.00013467428,0.00007276479,0.00008636493,0.0001316139,0.000032022315],"category_scores_gemma":[0.000057911264,0.00014938271,0.000025011268,0.00019562947,0.00017660961,0.00001510386,0.00012098974,0.00035310557,9.492648e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008956009,0.000057405385,0.24267809,0.000079364494,0.000041550473,0.0000040851883,0.000116270974,0.00005461899,0.736897,0.00000453983,0.00008196371,0.019089503],"study_design_scores_gemma":[0.0009586502,0.00029280357,0.5302189,0.00009571485,0.0000083247705,0.0000028504096,0.00025199563,0.000059233767,0.4677559,0.000051567047,0.00015618582,0.00014786232],"about_ca_topic_score_codex":0.002799026,"about_ca_topic_score_gemma":0.014100052,"teacher_disagreement_score":0.28754082,"about_ca_system_score_codex":0.00007698653,"about_ca_system_score_gemma":0.00013511647,"threshold_uncertainty_score":0.786816},"labels":[],"label_agreement":null},{"id":"W1507398635","doi":"10.1158/1538-7445.am2014-610","title":"Abstract 610: Preclinical evaluation of novel androgen receptor N-terminal domain inhibitor EPI-002 for the treatment of castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Enzalutamide; Androgen receptor; Prostate cancer; LNCaP; Cancer research; Reporter gene; Transfection; Tramp; Transcription factor; Chemistry; Luciferase; Androgen; Biology; Cancer; Medicine; Gene expression; Internal medicine; Endocrinology; Gene; Biochemistry; Hormone","score_opus":0.24168133760158508,"score_gpt":0.5061190440993341,"score_spread":0.264437706497749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507398635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836967,0.00765305,0.00002877377,0.0027355044,0.00022695298,0.0047745467,0.00060599885,0.0000114262475,0.00026702942],"genre_scores_gemma":[0.9896592,0.0036210285,0.00036797475,0.000014137581,0.00065561535,0.0043794434,0.00009560939,0.000037815575,0.0011692101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99660647,0.00021579514,0.0005902864,0.00044109422,0.001609724,0.000536656],"domain_scores_gemma":[0.99616116,0.0009834875,0.00019501364,0.0004822152,0.0019867113,0.0001913994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033526164,0.00018949836,0.00044507126,0.00017276384,0.00021952704,0.00002915954,0.0001739752,0.000107526066,0.0005695868],"category_scores_gemma":[0.00029176185,0.00011321124,0.00019245116,0.0003678632,0.0005574698,0.00008274321,0.0000313118,0.00021446496,0.0000051976326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016860945,0.0028068025,0.008333867,0.0011100592,0.00092947035,0.000006441832,0.003016111,0.00033718473,0.7107041,0.00018633626,0.0037549143,0.25195378],"study_design_scores_gemma":[0.039273746,0.011042729,0.04309273,0.0014553983,0.00077245466,0.0000094441575,0.0013621068,0.004304725,0.8477157,0.00047317697,0.05012779,0.00037003023],"about_ca_topic_score_codex":0.0012693863,"about_ca_topic_score_gemma":0.00071994844,"teacher_disagreement_score":0.25158376,"about_ca_system_score_codex":0.0009181382,"about_ca_system_score_gemma":0.0022256477,"threshold_uncertainty_score":0.62365764},"labels":[],"label_agreement":null},{"id":"W1508051168","doi":"","title":"Complete regression of ovarian cancer xenografts following treatment with the recombinant immunocytotoxic protein, VB6-845.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"In vivo; Ovarian cancer; Immunohistochemistry; Medicine; Epithelial cell adhesion molecule; Cancer; Internal medicine; Pathology; Oncology; Biology","score_opus":0.049744870263220296,"score_gpt":0.3370717015101619,"score_spread":0.28732683124694164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508051168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701895,0.02503919,0.00008823323,0.0015070285,0.00070989714,0.0016469961,0.00008827491,0.000044403678,0.000686477],"genre_scores_gemma":[0.9806455,0.000362535,0.00008075537,0.000019125582,0.00007718396,0.0014994221,0.00005162997,0.000045696816,0.017218199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977062,0.0005332955,0.00032864243,0.00043904933,0.00017619904,0.0008166405],"domain_scores_gemma":[0.998797,0.000128742,0.00015881633,0.00068797707,0.00019860663,0.000028865163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064387155,0.00027388122,0.00043242722,0.00016294666,0.00096805155,0.00005135614,0.0005165156,0.0001931467,0.00073286984],"category_scores_gemma":[0.000014474879,0.00014283144,0.0001703762,0.00048753203,0.0005716299,0.0000991027,0.00012045664,0.00052767975,0.00006499372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005022956,0.0001620196,0.00058916985,0.000029330578,0.00026522065,0.000015670445,0.00048127075,0.0000102859585,0.9874634,0.0014445501,0.0016198115,0.007416987],"study_design_scores_gemma":[0.003156631,0.0012848764,0.0029073895,0.0005890893,0.000048314952,0.0000102591375,0.00043995286,0.0000031667228,0.85702974,0.0003469746,0.13395369,0.0002299141],"about_ca_topic_score_codex":0.01266607,"about_ca_topic_score_gemma":0.0016340056,"teacher_disagreement_score":0.13233387,"about_ca_system_score_codex":0.00031025137,"about_ca_system_score_gemma":0.00051977584,"threshold_uncertainty_score":0.99390864},"labels":[],"label_agreement":null},{"id":"W1508147782","doi":"10.1158/1538-7445.am2014-156","title":"Abstract 156: Autophagic degradation of granzyme B impairs NK-mediated killing of hypoxic tumor cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Autophagy; Granzyme; Biology; Immune system; Granzyme B; Cytotoxic T cell; Cancer research; Tumor microenvironment; Cell biology; Innate immune system; Cancer cell; Interleukin 12; NK-92; Natural killer cell; Interleukin 21; Immunology; T cell; Cancer; CD8; In vitro; Perforin; Apoptosis","score_opus":0.04849117876618802,"score_gpt":0.3699638995978879,"score_spread":0.32147272083169987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508147782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956499,0.002410331,0.000057608733,0.0001675983,0.00013048436,0.00041261697,0.000046913603,0.000034458182,0.0010901091],"genre_scores_gemma":[0.99827987,0.0007743273,0.00008985355,0.00007886184,0.00017221394,0.00004890172,0.00004078315,0.000030893087,0.00048427604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800885,0.00011750711,0.00038379015,0.00025284456,0.0008527942,0.0003842383],"domain_scores_gemma":[0.99843657,0.0003279215,0.00013880034,0.00039305814,0.0004947536,0.00020886988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010473792,0.00012404757,0.00035544264,0.00029245508,0.000064971966,0.000008591882,0.00018871247,0.00008779338,0.0010260091],"category_scores_gemma":[0.00016784601,0.00010327435,0.00011966231,0.0005104086,0.00025326124,0.000074856216,0.000032358414,0.0003502351,0.00005354821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000458993,0.0002535043,0.0024054837,0.0006699032,0.00009518803,0.00002177592,0.00023404647,0.00005553291,0.9886079,0.00018982252,0.001049709,0.00595817],"study_design_scores_gemma":[0.0018132786,0.00036408816,0.036906306,0.00037488388,0.000033854143,0.0000026284195,0.00013134713,0.0008898066,0.95765156,0.0004278995,0.0012988765,0.00010548555],"about_ca_topic_score_codex":0.0005311584,"about_ca_topic_score_gemma":0.00001232427,"teacher_disagreement_score":0.034500822,"about_ca_system_score_codex":0.00010923384,"about_ca_system_score_gemma":0.00043650204,"threshold_uncertainty_score":0.99988717},"labels":[],"label_agreement":null},{"id":"W1510819614","doi":"10.1158/0008-5472.can-05-1513","title":"Multiple Microalterations Detected at High Frequency in Oral Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Dental and Craniofacial Research","keywords":"Tiling array; Comparative genomic hybridization; Genome; Gene; Biology; Computational biology; Cancer; Genetics; DNA microarray; Gene expression","score_opus":0.03600891827636665,"score_gpt":0.3405096641148513,"score_spread":0.30450074583848463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510819614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652475,0.0019014071,0.000036696776,0.00080161414,0.0000839117,0.00019704175,0.00013996883,0.0000073835267,0.00030725263],"genre_scores_gemma":[0.9936197,0.0005553117,0.00049817906,0.00009265447,0.00039220933,0.00040462724,0.00009331579,0.000016401584,0.0043276385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989816,0.000097310585,0.00016128262,0.0002627964,0.0001371702,0.0003598308],"domain_scores_gemma":[0.99950355,0.000018052202,0.000023184613,0.0002224856,0.00016654767,0.00006618717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017948764,0.00008627197,0.00008410399,0.00008248847,0.0001782806,0.000030332922,0.00017185327,0.00009178648,0.0007898919],"category_scores_gemma":[0.00004646994,0.00008466049,0.000031073472,0.00016693473,0.000077399905,0.000006798873,0.00012450872,0.00014359206,0.00003849742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004428012,0.00003775881,0.058495123,0.000010815428,0.000018858489,0.0000017356996,0.00017799046,0.0009922342,0.9364792,0.000085891996,0.0021156862,0.0015403838],"study_design_scores_gemma":[0.0009853267,0.00007285406,0.058867145,0.000021325703,0.0000045659713,0.0000043257605,0.00009604874,0.0001299253,0.9007924,0.00007753502,0.038755644,0.00019287996],"about_ca_topic_score_codex":0.0049000583,"about_ca_topic_score_gemma":0.06850349,"teacher_disagreement_score":0.06360343,"about_ca_system_score_codex":0.00029558293,"about_ca_system_score_gemma":0.00028303452,"threshold_uncertainty_score":0.9484939},"labels":[],"label_agreement":null},{"id":"W1512205759","doi":"10.1158/1538-7445.am2014-2740","title":"Abstract 2740: Identification of new binding partners of the DNA repair protein MGMT using a proteomic discovery-based approach in glioblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Angiogenesis; Proteome; Proteomics; Tandem mass spectrometry; Biology; Cancer research; Molecular biology; Chemistry; Biochemistry; Gene; Mass spectrometry","score_opus":0.10213207501210286,"score_gpt":0.4029769163912655,"score_spread":0.3008448413791626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512205759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969114,0.00012647078,0.00025702463,0.000450227,0.000043411004,0.002007689,0.000010751352,0.000016483664,0.00017656136],"genre_scores_gemma":[0.9988122,0.000010479899,0.0003173504,0.000014293797,0.00009886844,0.00045339725,0.0000027105364,0.000027975813,0.0002627079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977795,0.00019404448,0.0004993119,0.0003546368,0.00082101644,0.00035151833],"domain_scores_gemma":[0.99888176,0.000045143443,0.00022573995,0.00055854046,0.00020178244,0.00008701257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017922833,0.00011702206,0.00029821158,0.00030588958,0.00007706237,0.000028513416,0.00024273817,0.00009274491,0.000032404027],"category_scores_gemma":[0.00025509004,0.00008415353,0.00014783244,0.0010809399,0.0002514923,0.00013045824,0.00006975731,0.0003780749,0.000001965916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006330269,0.00018985027,0.036482044,0.0011447832,0.000030342659,6.071817e-7,0.0002946925,0.00078760093,0.95848167,0.00012999732,0.00019892793,0.0016264315],"study_design_scores_gemma":[0.0012032356,0.00018330319,0.053791244,0.0013758453,0.00002269758,8.620873e-7,0.00022447275,0.0049566836,0.937983,0.0000466189,0.00012238175,0.00008967258],"about_ca_topic_score_codex":0.0017398701,"about_ca_topic_score_gemma":0.00011536956,"teacher_disagreement_score":0.020498712,"about_ca_system_score_codex":0.00039873234,"about_ca_system_score_gemma":0.0011571703,"threshold_uncertainty_score":0.34316814},"labels":[],"label_agreement":null},{"id":"W1513478713","doi":"10.1158/1538-7445.am2014-2521","title":"Abstract 2521: Small molecule inhibitors targeting the activation function-2 site of estrogen receptor-α","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transactivation; Tamoxifen; Estrogen receptor; Estrogen receptor alpha; Reporter gene; Cancer research; Estrogen; Transfection; Breast cancer; Small molecule; Coactivator; Biology; Chemistry; Medicine; Computational biology; Cancer; Internal medicine; Transcription factor; Gene; Biochemistry; Gene expression","score_opus":0.02028978018287853,"score_gpt":0.30616455871698145,"score_spread":0.2858747785341029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1513478713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965337,0.0015902454,0.00010940662,0.00031205607,0.00016734561,0.00023926215,0.0000051608845,0.00000924929,0.0010335658],"genre_scores_gemma":[0.99862736,0.00028073363,0.000038037088,0.000048231523,0.000612618,0.00006536159,0.000072725736,0.000024150564,0.00023077009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884266,0.00018694204,0.00016736786,0.00025465986,0.0002514834,0.0002969118],"domain_scores_gemma":[0.9992947,0.000060072947,0.000075902535,0.0002709997,0.00022690238,0.00007143618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085019384,0.00010050557,0.00009268482,0.000054065662,0.00017967343,0.000022952589,0.000168554,0.00016489284,0.000055349483],"category_scores_gemma":[0.00015644854,0.00007281935,0.00007760734,0.00020747309,0.00014330834,0.0000045832103,0.00009904862,0.0003329868,0.000027786127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011304401,0.000022650425,0.0015217048,0.000025964006,0.000050634466,2.0798502e-7,0.00005142171,0.00013550032,0.9853438,0.00008246101,0.007691906,0.004960703],"study_design_scores_gemma":[0.00026046444,0.00021740871,0.000976679,0.000029837029,0.0000068756776,4.6674486e-7,0.00009536155,0.0000247121,0.9736721,0.000026667803,0.024606312,0.00008315055],"about_ca_topic_score_codex":0.00025527386,"about_ca_topic_score_gemma":0.0000108320955,"teacher_disagreement_score":0.016914405,"about_ca_system_score_codex":0.00002914691,"about_ca_system_score_gemma":0.00012688406,"threshold_uncertainty_score":0.29694867},"labels":[],"label_agreement":null},{"id":"W1514964176","doi":"10.1158/1538-7445.sabcs14-p1-01-11","title":"Abstract P1-01-11: The impact of a critical look at the consequences of preoperative MRI in breast cancer patients","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Breast MRI; Axilla; Radiology; Cancer; Guideline; Magnetic resonance imaging; Mammography; Internal medicine; Pathology","score_opus":0.13695540524481523,"score_gpt":0.4948930032264357,"score_spread":0.3579375979816205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514964176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96642923,0.002379891,4.5362268e-7,0.027823722,0.00011796035,0.0010061272,0.0005893116,0.0000059854365,0.0016473295],"genre_scores_gemma":[0.99715,0.0016979552,0.0000072867324,0.00012900174,0.00014757099,0.000651678,0.0000064835626,0.000021706976,0.00018829056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972193,0.0003529327,0.0003938443,0.0003073391,0.0012117011,0.00051484484],"domain_scores_gemma":[0.9966238,0.0012009665,0.00008880603,0.00048735997,0.0013783645,0.00022070184],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014231843,0.00015199237,0.00036384127,0.00013471175,0.00009264843,0.000020781397,0.00038137336,0.000091365575,0.002837805],"category_scores_gemma":[0.0004641614,0.000075996424,0.00010603944,0.00064051937,0.0027408479,0.00011087565,0.00018448426,0.000532038,0.000015597847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091213954,0.00038937383,0.89723134,0.0001938651,0.00009742636,0.000010349395,0.0037958298,0.00034762977,0.0034865225,0.00007507871,0.09290024,0.0005601968],"study_design_scores_gemma":[0.0018931656,0.00052264513,0.96283424,0.00091250625,0.00003986259,0.000008552431,0.0017366769,0.00006147101,0.031094048,0.00022390041,0.0005542654,0.00011868962],"about_ca_topic_score_codex":0.06270797,"about_ca_topic_score_gemma":0.00665974,"teacher_disagreement_score":0.092345975,"about_ca_system_score_codex":0.0015991258,"about_ca_system_score_gemma":0.0031716507,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W1516639348","doi":"10.1158/1538-7445.sabcs14-s6-04","title":"Abstract S6-04: Fulvestrant 500 mg versus anastrozole as first-line treatment for advanced breast cancer: Overall survival from the Phase II ‘FIRST’ study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Fulvestrant; Anastrozole; Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Metastatic breast cancer; Oncology; Breast cancer; Phases of clinical research; Cancer; Confidence interval; Tamoxifen; Randomized controlled trial; Clinical trial","score_opus":0.19792366326965274,"score_gpt":0.4825408365740193,"score_spread":0.28461717330436653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516639348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669524,0.00575466,0.00008393194,0.018990139,0.0011907225,0.004205298,0.002449838,0.00012796043,0.0002450562],"genre_scores_gemma":[0.99054044,0.001483498,0.00016632256,0.00020362154,0.002480222,0.0037633658,0.00018344028,0.00014201886,0.0010370534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537706,0.00014557596,0.00055726035,0.0010447609,0.0015512054,0.001324122],"domain_scores_gemma":[0.9960897,0.00083226396,0.0001779851,0.0011865714,0.00094528665,0.000768225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078860525,0.0005482918,0.0008196499,0.00015757066,0.0008155288,0.00008781837,0.0005850175,0.00013435118,0.00093482697],"category_scores_gemma":[0.00016670652,0.00038294692,0.0002341526,0.0005106236,0.000408856,0.00047365765,0.00018189961,0.0006485844,0.000047681366],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29995108,0.013885095,0.014606713,0.00027113297,0.004843694,0.0004956904,0.015615872,0.0095262015,0.017667612,0.0002446168,0.0053586396,0.6175336],"study_design_scores_gemma":[0.32766333,0.045826964,0.07309281,0.0012804263,0.0009770858,0.00005562262,0.02059683,0.00054513646,0.011352847,0.0011132292,0.51586205,0.0016336472],"about_ca_topic_score_codex":0.025401779,"about_ca_topic_score_gemma":0.018889831,"teacher_disagreement_score":0.6159,"about_ca_system_score_codex":0.003031794,"about_ca_system_score_gemma":0.0019874019,"threshold_uncertainty_score":0.9999785},"labels":[],"label_agreement":null},{"id":"W1517489529","doi":"10.1158/1538-7445.am2014-3453","title":"Abstract 3453: Autophagic regulation of the Met receptor tyrosine kinase in breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endocytic cycle; Autophagy; Cell biology; Receptor tyrosine kinase; Hepatocyte growth factor; Biology; Protein kinase B; PI3K/AKT/mTOR pathway; Signal transduction; Cancer research; Tyrosine kinase; Endocytosis; Receptor; Apoptosis; Biochemistry","score_opus":0.05877307065088418,"score_gpt":0.38383533724082325,"score_spread":0.3250622665899391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517489529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98564667,0.0016697507,0.0000024398826,0.010310104,0.0002534811,0.0005236326,0.000060324823,0.000017142967,0.0015164639],"genre_scores_gemma":[0.9972545,0.0007163202,0.000041177915,0.00021009926,0.00038202648,0.00033515625,0.000007113325,0.00002836099,0.0010252509],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99803865,0.00016365087,0.00030278662,0.00031300896,0.000787885,0.0003940269],"domain_scores_gemma":[0.9988141,0.00008634828,0.00008741298,0.00047176043,0.00042492527,0.00011542194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010794562,0.00011883776,0.00027969052,0.00018341409,0.0000897228,0.000019861365,0.00022462769,0.00010201097,0.0039190482],"category_scores_gemma":[0.00009767509,0.00007984543,0.00009114902,0.0009358165,0.0002350825,0.00008243966,0.00008675814,0.00046118587,0.000020570991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078476255,0.00029157542,0.21367791,0.0005971456,0.000058334663,0.00000152371,0.0003853969,0.00019201917,0.6447458,0.0007943105,0.022110054,0.116361156],"study_design_scores_gemma":[0.0011573475,0.00008262617,0.8492689,0.00081454136,0.000017996217,0.000001907697,0.000060191753,0.00017870509,0.13815272,0.000098426666,0.010081213,0.00008538237],"about_ca_topic_score_codex":0.004331221,"about_ca_topic_score_gemma":0.0005430097,"teacher_disagreement_score":0.63559103,"about_ca_system_score_codex":0.00048227038,"about_ca_system_score_gemma":0.00043769286,"threshold_uncertainty_score":0.9969915},"labels":[],"label_agreement":null},{"id":"W1518327794","doi":"","title":"Proteolytic cascades of human tissue kallikreins","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Proteases; Kallikrein; Proteolytic enzymes; Proteolysis; Biology; Cell biology; Trypsin; Protease; Biochemistry; Chemistry; Enzyme","score_opus":0.08958310660247847,"score_gpt":0.44346495509227185,"score_spread":0.35388184848979337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518327794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848793,0.0043194913,0.000019319861,0.001314479,0.000055242803,0.00070680067,0.000010806327,0.00004213426,0.00865239],"genre_scores_gemma":[0.97368735,0.000079648504,0.000077923476,0.00003413416,0.0005970601,0.00011849556,0.000021105307,0.000027539065,0.025356729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984004,0.000056280278,0.00026552143,0.00024399854,0.00063449214,0.00039933014],"domain_scores_gemma":[0.99908876,0.00006701659,0.00004971519,0.00030538632,0.00037864226,0.00011045672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040968665,0.00009977558,0.00024553132,0.0002099697,0.00015355868,0.000018954845,0.00012886543,0.00008582815,0.0009582879],"category_scores_gemma":[0.000062506755,0.00008696041,0.00006126628,0.00043340767,0.00028276368,0.000060033133,0.00005170742,0.0002281941,0.000035087105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016127779,0.00029940615,0.07817448,0.0006879034,0.00006440592,0.00007161873,0.0006432299,0.000029869901,0.8767101,0.009254464,0.022409063,0.011494183],"study_design_scores_gemma":[0.0015055987,0.00059473625,0.20055304,0.00046088727,0.00003924648,0.00001778882,0.0001266749,0.00006533508,0.7570752,0.0034925982,0.035895407,0.00017347845],"about_ca_topic_score_codex":0.008786868,"about_ca_topic_score_gemma":0.0007065033,"teacher_disagreement_score":0.122378565,"about_ca_system_score_codex":0.00014095032,"about_ca_system_score_gemma":0.00028931285,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W1519253444","doi":"10.1158/1538-7445.am2014-5538","title":"Abstract 5538: Development of HDACi resistance in DLBCL leads to a switch in subtype towards a more differentiated B-cell and is associated with increased sensitivity to proteasome inhibition","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Germinal center; Cancer research; Epigenetics; Diffuse large B-cell lymphoma; Histone deacetylase inhibitor; clone (Java method); Histone deacetylase; B cell; Immunology; Histone; Lymphoma; Gene; Genetics","score_opus":0.032056474950070545,"score_gpt":0.31515241791080517,"score_spread":0.28309594296073465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519253444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998199,0.00014217116,0.00007555229,0.0003159209,0.000008827218,0.00088702794,0.000048582904,0.0000067982733,0.0003161481],"genre_scores_gemma":[0.99889356,0.00001894899,0.0003922737,0.0001293134,0.000024161229,0.0003292972,0.00005606826,0.000022489756,0.00013386586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982811,0.00023372944,0.00024090632,0.00044830856,0.00037611357,0.00041980046],"domain_scores_gemma":[0.99924487,0.00003547886,0.00005999986,0.00021803186,0.00027881115,0.00016280625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012648192,0.0001485508,0.0002337051,0.00021075037,0.00005903657,0.00002390886,0.000090359055,0.00014442742,0.000015386333],"category_scores_gemma":[0.00031737535,0.00013704362,0.000019134484,0.0005155204,0.00006916075,0.000006477185,0.00013706612,0.00024028904,0.0000034486632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008879761,0.00019123613,0.03004461,0.00017594712,0.000012115848,0.0000104213605,0.0010226637,0.0000055798255,0.9662276,0.0000042990114,0.00010669214,0.0013108968],"study_design_scores_gemma":[0.0010617254,0.00014307958,0.29783967,0.00040209488,0.0000015932582,4.389381e-7,0.000064582404,0.000008998147,0.70008856,0.0000140540615,0.00024031477,0.0001348628],"about_ca_topic_score_codex":0.0007268756,"about_ca_topic_score_gemma":0.015466829,"teacher_disagreement_score":0.26779506,"about_ca_system_score_codex":0.00014729156,"about_ca_system_score_gemma":0.0004286922,"threshold_uncertainty_score":0.8630853},"labels":[],"label_agreement":null},{"id":"W1519693764","doi":"","title":"Oncogenic pathways in breast cancer downstream of Pten","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; Cancer research; Cancer; Biology; Breast cancer; Population; PI3K/AKT/mTOR pathway; Medicine; Signal transduction; Cell biology; Genetics","score_opus":0.039800957378586695,"score_gpt":0.3644501426309271,"score_spread":0.32464918525234043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519693764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889913,0.0073000602,0.000015906426,0.00047540528,0.00016465384,0.00023213302,0.00035900308,0.000009253069,0.0024522662],"genre_scores_gemma":[0.9962581,0.0014058097,0.000042603584,0.000057804365,0.0008253132,0.00029347592,0.000045378147,0.000035982357,0.0010355362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810284,0.00013116293,0.00028725807,0.00046119624,0.00045287667,0.00056468276],"domain_scores_gemma":[0.99902475,0.000028601675,0.00006972655,0.00044919687,0.00034625916,0.00008148573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053100206,0.00014698057,0.00020216563,0.00015364647,0.000058269794,0.000018105831,0.00041183914,0.0001845332,0.0004169706],"category_scores_gemma":[0.000026064286,0.00014115774,0.00008014199,0.00042389135,0.00026795268,0.000005431393,0.00016837004,0.00027566764,0.000016058058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021009576,0.00008718772,0.036874868,0.000053363983,0.00003063295,0.000008296814,0.000027063885,0.0006340466,0.9429609,0.00007320752,0.012690005,0.0063503147],"study_design_scores_gemma":[0.0010317111,0.00011816592,0.026139107,0.0001400156,0.000008761593,0.000009131436,0.000055818655,0.0000377643,0.9537196,0.00025574266,0.018252617,0.0002315795],"about_ca_topic_score_codex":0.00873144,"about_ca_topic_score_gemma":0.0018448308,"teacher_disagreement_score":0.01075867,"about_ca_system_score_codex":0.00024021136,"about_ca_system_score_gemma":0.00083660433,"threshold_uncertainty_score":0.9978695},"labels":[],"label_agreement":null},{"id":"W1521656434","doi":"","title":"Inhibition of Wnt-1 in human prostate cancer cells blocks prostate cancer cell proliferation, invasion, growth and skeletal metastasis in vitro and in vivo","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Wnt signaling pathway; Prostate cancer; Cancer research; Metastasis; Biology; Cancer; Cancer cell; Prostate; Transfection; Cell growth; Cell culture; Pathology; Medicine; Internal medicine; Cell biology; Signal transduction","score_opus":0.01760187214700776,"score_gpt":0.3014180376509078,"score_spread":0.28381616550390004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521656434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886766,0.0099135395,0.0000017784581,0.0002616656,0.000045997956,0.0008170896,0.000105434985,0.0000046401788,0.00017323412],"genre_scores_gemma":[0.9892249,0.008591966,0.00006493172,0.000046329893,0.000098987504,0.0011410409,0.000060993072,0.00002995757,0.000740898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979945,0.00017426586,0.0004537819,0.0005588949,0.00033209566,0.00048647507],"domain_scores_gemma":[0.9994358,0.00001998935,0.000101288984,0.00013323403,0.00024116099,0.00006851562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070948765,0.00019273556,0.00026035588,0.00027136086,0.00008539563,0.000044498945,0.00010860279,0.00014419894,0.000068175505],"category_scores_gemma":[0.000017338067,0.0001871586,0.00002629078,0.0004783733,0.0002380518,0.000028947285,0.00014824679,0.0002563961,2.391283e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036683827,0.000087395856,0.07556382,0.0002624073,0.000011787978,0.000007660757,0.0005869166,0.00022721743,0.92153436,0.0000060718025,0.00074617186,0.0005993587],"study_design_scores_gemma":[0.001777564,0.000081650964,0.0067597046,0.00018876225,0.0000066427606,7.8146115e-7,0.00017995916,0.000020771507,0.9901797,0.00020766763,0.0003817015,0.00021507956],"about_ca_topic_score_codex":0.014064222,"about_ca_topic_score_gemma":0.02124605,"teacher_disagreement_score":0.06880411,"about_ca_system_score_codex":0.00017151781,"about_ca_system_score_gemma":0.00045433512,"threshold_uncertainty_score":0.9966137},"labels":[],"label_agreement":null},{"id":"W1522872244","doi":"10.1158/1538-7445.am2015-60","title":"Abstract 60: Genotranscriptomic meta-analysis of centromere protein A (CENPA): An essential role in human cancer progression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Cancer; Biology; Chromosome instability; Metastasis; Locus (genetics); Cancer research; Copy-number variation; Oncology; Genetics; Gene; Bioinformatics; Chromosome; Medicine; Genome","score_opus":0.15545231646587213,"score_gpt":0.45982628977116613,"score_spread":0.30437397330529403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522872244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829521,0.01569446,0.00007569101,0.00030839365,0.000028237919,0.0005395079,0.00011769905,0.0000067092064,0.00027719422],"genre_scores_gemma":[0.99770415,0.00034864317,0.00011936868,0.000016321348,0.00010373922,0.0010982199,0.000128303,0.000022286118,0.0004589499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980704,0.00020779163,0.00031281702,0.0005045868,0.00051043666,0.00039393292],"domain_scores_gemma":[0.9986708,0.000004200722,0.000099799756,0.00062005327,0.00042476886,0.0001803358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007655277,0.00013828352,0.0003823943,0.00029284036,0.00008341474,0.00004629442,0.00046833826,0.00014041048,0.0003694875],"category_scores_gemma":[0.000016512533,0.000116224735,0.0002482246,0.0007209706,0.00014692663,0.000017993016,0.00007910021,0.0002144261,0.0000018301707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012254949,0.00019057277,0.000675962,0.000027868087,0.004208568,0.00000265998,0.00021270603,0.0012162941,0.99108934,0.00009461085,0.00026197726,0.0018968714],"study_design_scores_gemma":[0.0008217228,0.00021545745,0.007875526,0.000016390659,0.0027345256,3.3465736e-7,0.00030286436,0.00024049281,0.98069,0.00014707464,0.0067069386,0.00024866074],"about_ca_topic_score_codex":0.005383975,"about_ca_topic_score_gemma":0.004551766,"teacher_disagreement_score":0.015345816,"about_ca_system_score_codex":0.00011865779,"about_ca_system_score_gemma":0.00052014244,"threshold_uncertainty_score":0.8138995},"labels":[],"label_agreement":null},{"id":"W1523307507","doi":"","title":"Questioning the concept of stem cell plasticity: Tissue-committed early muscle, liver and neural cells reside in the bone marrow and can be isolated by chemotactic gradients to SDF-1, HGF or LIF and mobilized into peripheral blood during tissue/organ injury","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stem cell; Bone marrow; Progenitor cell; Population; Haematopoiesis; Biology; CD34; Pathology; Cell biology; Immunology; Chemistry; Medicine","score_opus":0.028113736375848027,"score_gpt":0.3318099618592566,"score_spread":0.3036962254834086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523307507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916702,0.0031622022,0.000004755575,0.0030673405,0.000034916193,0.0019671158,0.000029535235,0.000019676352,0.000044250533],"genre_scores_gemma":[0.99717295,0.000803424,0.00006616831,0.00014220073,0.000065965665,0.00015232286,0.000005138617,0.000048913484,0.0015429212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966361,0.0006154912,0.00041588323,0.0005815469,0.0009955287,0.00075545185],"domain_scores_gemma":[0.99812037,0.0007194558,0.00008245378,0.0003857481,0.00027740584,0.0004145542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010409768,0.0002485444,0.00045428218,0.0002545199,0.0003911328,0.00015356606,0.0002810919,0.00014232629,0.00008671762],"category_scores_gemma":[0.00026545036,0.00016231321,0.000022831437,0.00094555307,0.0006749265,0.00012895897,0.00034059616,0.0010553648,0.0000020123398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020338919,0.00017597876,0.0067402213,0.0006610726,0.00004789531,0.00033141614,0.02484409,0.000019365989,0.96086687,0.000009276,0.00027521115,0.00399474],"study_design_scores_gemma":[0.008807927,0.0040445128,0.080941655,0.0010115185,0.00010962286,0.00013400931,0.005943205,0.0002850265,0.89745814,0.000028526723,0.00083718036,0.00039866046],"about_ca_topic_score_codex":0.017709339,"about_ca_topic_score_gemma":0.002048643,"teacher_disagreement_score":0.074201435,"about_ca_system_score_codex":0.00026889885,"about_ca_system_score_gemma":0.00027658942,"threshold_uncertainty_score":0.9888318},"labels":[],"label_agreement":null},{"id":"W1523445811","doi":"","title":"AEG33783, a potent JNK pathway inhibitor with neuroprotective properties, selectively induces apoptosis in tumor cell lines","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Pharmacology; DU145; Vinblastine; Cisplatin; Medicine; Chemosensitizer; Cancer research; Neuroprotection; Clonogenic assay; Paclitaxel; Chemotherapy; Apoptosis; Cytotoxicity; Cancer; Biology; Cancer cell; Internal medicine; LNCaP; In vitro","score_opus":0.06511056408115463,"score_gpt":0.3362190570709432,"score_spread":0.27110849298978856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523445811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924487,0.0007408562,0.0000030590832,0.0027366786,0.000033855147,0.0022579797,0.000019675535,0.000060761995,0.0016984241],"genre_scores_gemma":[0.9951541,0.00017835063,0.0001719535,0.00018754521,0.00039157877,0.0017445337,0.0000038748212,0.000073616255,0.0020944707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963923,0.00034690258,0.0002504551,0.00070847664,0.0012680419,0.0010338273],"domain_scores_gemma":[0.99841136,0.000083190476,0.000050579885,0.0003365491,0.00070557714,0.00041272547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004109815,0.00025545157,0.00034894602,0.0006252241,0.00020394125,0.00007361099,0.0001984107,0.00007241321,0.000107],"category_scores_gemma":[0.00019291363,0.00017015306,0.000058067966,0.0014204346,0.0002705416,0.00021746146,0.00015058566,0.0012680393,0.00012366785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051918607,0.0014732064,0.0027609963,0.00026884893,0.000078453435,0.0005299293,0.00076188875,0.00005477918,0.9642019,0.0000052687024,0.00056475925,0.024108093],"study_design_scores_gemma":[0.0037792928,0.0031847428,0.011876315,0.00044481212,0.000011382365,0.000044175795,0.00025320193,0.000097548305,0.9785235,0.000008987192,0.0016012226,0.00017480766],"about_ca_topic_score_codex":0.0013237825,"about_ca_topic_score_gemma":0.0005169053,"teacher_disagreement_score":0.023933286,"about_ca_system_score_codex":0.0009176141,"about_ca_system_score_gemma":0.0016464412,"threshold_uncertainty_score":0.69386405},"labels":[],"label_agreement":null},{"id":"W1525973260","doi":"","title":"Differential proteomics of metastatic and non-metastatic lung carcinoma cell lines","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Alexa Fluor; Chemistry; Molecular biology; Fluorescence; Cell culture; Cytosol; Trypan blue; Polyacrylamide gel electrophoresis; Biochemistry; Cell; Biology","score_opus":0.035232080261312394,"score_gpt":0.3700365351189957,"score_spread":0.3348044548576833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525973260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833616,0.00055734353,0.014017736,0.000117102376,0.000009652844,0.00049095246,0.00013342145,0.00002763521,0.0012845575],"genre_scores_gemma":[0.97657907,0.00019996655,0.020590477,0.000004072176,0.000099873025,0.000996992,0.000028946872,0.000031392367,0.0014692263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998833,0.000022684639,0.00026712468,0.0002861892,0.00027031254,0.00032071062],"domain_scores_gemma":[0.9992186,0.00009805669,0.00009259858,0.0003227872,0.00019889063,0.000069084104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013174274,0.00012384394,0.00020998594,0.000089694215,0.00012903713,0.00003204526,0.00021882274,0.00004204639,0.00026783947],"category_scores_gemma":[0.00001684035,0.00011400536,0.00004428256,0.00020443773,0.00021224089,0.000055960005,0.00013929763,0.0003098653,0.0000022600132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035304452,0.00008659914,0.0024862199,0.00072168896,0.000010174382,0.0000030131428,0.000047270223,0.00003625594,0.99505454,0.00053192745,0.0004328378,0.0005541521],"study_design_scores_gemma":[0.00042827908,0.000021932794,0.000388383,0.000054178065,0.00002211577,0.0000020050172,0.000059753882,0.0018086177,0.9920715,0.0047440315,0.00028161998,0.00011754478],"about_ca_topic_score_codex":0.0009687858,"about_ca_topic_score_gemma":0.000038103793,"teacher_disagreement_score":0.0067825443,"about_ca_system_score_codex":0.00008220347,"about_ca_system_score_gemma":0.00011778488,"threshold_uncertainty_score":0.46490034},"labels":[],"label_agreement":null},{"id":"W1526193998","doi":"10.1158/1538-7445.am2014-642","title":"Abstract 642: Transcend, a protein vector for brain delivery, allows trastuzumab to reach the brain at effective concentration after incorporation to form BT2111","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trastuzumab; SKBR3; Medicine; Doxorubicin; Blood–brain barrier; Monoclonal antibody; Cancer research; Pathology; Brain tumor; Distribution (mathematics); Cancer cell; Breast cancer; Cancer; Antibody; Immunology; Internal medicine; Chemotherapy; Central nervous system","score_opus":0.0431286911016632,"score_gpt":0.38614166274529,"score_spread":0.34301297164362676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526193998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91535664,0.00018720311,0.00086540566,0.07379079,0.00008608274,0.008719884,0.00015053259,0.00003105903,0.0008123786],"genre_scores_gemma":[0.98190176,0.000018003206,0.00025970332,0.0022272079,0.0008292246,0.008626011,0.00009556295,0.000049417704,0.005993095],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667215,0.00033533212,0.00033988632,0.0005926204,0.0011837917,0.000876224],"domain_scores_gemma":[0.99724346,0.0011259761,0.000047511017,0.00038101495,0.0007001099,0.00050190865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002582932,0.00023099655,0.000332381,0.00017994027,0.0004377595,0.000094098075,0.000282684,0.00013305403,0.00037245633],"category_scores_gemma":[0.00075470825,0.00015778835,0.00016131364,0.0005197797,0.00018673367,0.00013194785,0.00009699927,0.0005276871,0.00019639054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018005665,0.00016283014,0.0011782841,0.000530037,0.00011178412,0.000018608383,0.0036250828,0.000029238046,0.8514859,0.0007419722,0.03176331,0.09234728],"study_design_scores_gemma":[0.004883701,0.0070933965,0.16807881,0.00091398886,0.000043370343,0.000021264917,0.00031812262,0.0011939765,0.36812028,0.00092206465,0.4478392,0.00057183625],"about_ca_topic_score_codex":0.0016682653,"about_ca_topic_score_gemma":0.004522412,"teacher_disagreement_score":0.48336563,"about_ca_system_score_codex":0.00093817915,"about_ca_system_score_gemma":0.0004070136,"threshold_uncertainty_score":0.6434423},"labels":[],"label_agreement":null},{"id":"W1526387215","doi":"10.1158/1538-7445.am2014-4349","title":"Abstract 4349: Regulation of proliferation and platelet-derived growth factor expression in desmoid tumors by microRNA-29","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Platelet-derived growth factor receptor; Wnt signaling pathway; Growth factor; Cancer research; Biology; CTGF; microRNA; Platelet-derived growth factor; WNT3A; Signal transduction; Molecular biology; Receptor; Cell biology; Gene; Genetics","score_opus":0.05193019080070366,"score_gpt":0.3669404148567952,"score_spread":0.3150102240560915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526387215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972186,0.0011933431,0.0000234813,0.0006150157,0.000033840206,0.0006036429,0.000015288853,0.000020990898,0.00027581153],"genre_scores_gemma":[0.9991779,0.00026013734,0.00013106463,0.000024602046,0.000108406326,0.00010463229,0.000021388772,0.000022120323,0.00014978866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986327,0.000107630054,0.00026385413,0.00027290575,0.0004436487,0.00027920684],"domain_scores_gemma":[0.9991816,0.00020184951,0.00007129819,0.00016961555,0.00027592934,0.0000996625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000499555,0.000109165456,0.0002664135,0.00020880674,0.00008483829,0.000015095352,0.000058298356,0.000071604205,0.000110581575],"category_scores_gemma":[0.00053665094,0.000093248156,0.000021551221,0.00023154532,0.0001935739,0.00010770834,0.00005562114,0.00030029277,0.0000062472645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039359022,0.0000427004,0.055168618,0.00031613224,0.000009886689,0.000008123109,0.00095053285,0.0000017959378,0.9387119,0.000013862253,0.0016031,0.0027797853],"study_design_scores_gemma":[0.0009895768,0.00012490271,0.38612098,0.0003333958,0.000002577164,0.000006121741,0.000115006886,0.000030476545,0.6118597,0.00008878862,0.00027131653,0.00005719873],"about_ca_topic_score_codex":0.00033243367,"about_ca_topic_score_gemma":0.00006920369,"teacher_disagreement_score":0.33095235,"about_ca_system_score_codex":0.0001554355,"about_ca_system_score_gemma":0.00010167673,"threshold_uncertainty_score":0.38025495},"labels":[],"label_agreement":null},{"id":"W1526435020","doi":"10.1158/1538-7445.am2014-4256","title":"Abstract 4256: Characterization of the cellular inhibitor of apoptosis 1 (cIAP1) IRES trans-acting factors and their contribution to apoptotic resistance in rhabdomyosarcomas","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Internal ribosome entry site; Apoptosis; Biology; Inhibitor of apoptosis; Programmed cell death; Cell biology; Translation (biology); Context (archaeology); XIAP; Cancer research; Caspase; Genetics; Messenger RNA; Gene","score_opus":0.027831938300068245,"score_gpt":0.302094093718963,"score_spread":0.27426215541889476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526435020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979777,0.000343739,0.000724798,0.0004120351,0.00006166581,0.00032220944,0.00006588115,0.0000022258175,0.00008976635],"genre_scores_gemma":[0.9995159,0.00020693305,0.000016179623,0.000014984151,0.00007409882,0.00006502745,0.00002887474,0.000011755228,0.000066245855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990427,0.0001330222,0.0002292502,0.00022335074,0.0001720619,0.00019959963],"domain_scores_gemma":[0.9993297,0.00004177416,0.0000896805,0.0002716433,0.00022004775,0.000047154444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050208403,0.000087903536,0.0001446818,0.000073512834,0.000086745546,0.000014471342,0.00017364525,0.00008325226,0.000009864222],"category_scores_gemma":[0.00014964704,0.00006306457,0.000043754397,0.00026945033,0.00013109813,0.000007800646,0.000047752033,0.000117409334,2.0764237e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000936406,0.000027171023,0.0073950877,0.00006909367,0.000010259614,1.7641254e-8,0.00027132456,0.000013105141,0.9904363,0.00013505801,0.000022310975,0.0015266422],"study_design_scores_gemma":[0.00021323383,0.00004241897,0.09823846,0.000104082574,0.000002453445,3.011282e-8,0.00010340043,0.000008224773,0.89675397,0.000036053527,0.004437489,0.00006018932],"about_ca_topic_score_codex":0.00014739466,"about_ca_topic_score_gemma":0.0002478092,"teacher_disagreement_score":0.09368233,"about_ca_system_score_codex":0.00004261611,"about_ca_system_score_gemma":0.000084891006,"threshold_uncertainty_score":0.25716987},"labels":[],"label_agreement":null},{"id":"W1526500741","doi":"","title":"Elucidation of the mechanisms underlying the potentiation of cell killing by ionizing radiation in MCF-7 breast tumor cells by the vitamin D3 analog EB 1089","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"DNA damage; Programmed cell death; Molecular biology; Reactive oxygen species; MCF-7; Radiation sensitivity; Chemistry; Senescence; DNA repair; Ionizing radiation; Cell culture; Radiosensitivity; Cancer research; Apoptosis; Biology; Cell biology; Biochemistry; Cancer cell; DNA; Irradiation; Cancer; Radiation therapy; Internal medicine; Medicine; Genetics","score_opus":0.012190619827360452,"score_gpt":0.2843564797015129,"score_spread":0.2721658598741524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526500741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499655,0.0025748296,0.0013427412,0.0004491106,0.00007924917,0.00036924155,0.00004119619,0.0000023452894,0.00014474645],"genre_scores_gemma":[0.9992016,0.00036687258,0.000019489229,0.000023169101,0.00003219108,0.000034164073,0.00008186697,0.000013201273,0.00022746807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987682,0.00033547732,0.0002018844,0.00017857965,0.0003039104,0.000211967],"domain_scores_gemma":[0.9994454,0.00005754588,0.00013298803,0.00023355457,0.00011224806,0.000018258468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008459218,0.000077937984,0.000079825266,0.00004400223,0.00017919156,0.00002176608,0.0002490365,0.00009649281,0.0000068010977],"category_scores_gemma":[0.000017644752,0.00004530649,0.00005554926,0.0003281961,0.00010709687,0.0000070577607,0.000066610395,0.00023078224,0.0000010949756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028387965,0.000034760895,0.00027332403,0.00002154353,0.000012060402,1.9629995e-7,0.000054867938,0.0012844139,0.99516565,0.00006230653,0.0014820617,0.0015804599],"study_design_scores_gemma":[0.0002942618,0.00005328801,0.0018720392,0.00003122392,0.000010783454,0.0000017466607,0.0002156806,0.0010667543,0.99607205,0.00015112184,0.00017914125,0.00005193081],"about_ca_topic_score_codex":0.000993874,"about_ca_topic_score_gemma":0.00006347848,"teacher_disagreement_score":0.004205038,"about_ca_system_score_codex":0.000060527964,"about_ca_system_score_gemma":0.00009800801,"threshold_uncertainty_score":0.1847545},"labels":[],"label_agreement":null},{"id":"W1527731547","doi":"","title":"Inhibition of angiogenesis and MMP-9 expression by PCK3145 is mediated through targeting of the Akt signaling pathway","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université du Québec à Montréal","funders":"","keywords":"Prostate cancer; Medicine; Angiogenesis; Cancer; Protein kinase B; Prostate; Cancer research; Internal medicine; Endocrinology; In vivo; Metastasis; Biology; Signal transduction","score_opus":0.05163472821041296,"score_gpt":0.3615203585525663,"score_spread":0.30988563034215333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527731547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978741,0.018393723,0.00001910169,0.0013735737,0.000036725472,0.00055245124,0.00016913228,0.000012195648,0.0007020994],"genre_scores_gemma":[0.9976449,0.0010233315,0.00010200953,0.00004352584,0.00011223071,0.00009393192,0.0000626399,0.000023260036,0.0008941857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980102,0.00018364665,0.0002871197,0.00026814695,0.0008819008,0.0003689796],"domain_scores_gemma":[0.99892545,0.00020509564,0.000093716066,0.00022331148,0.00048214637,0.00007027569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006163229,0.00010881428,0.00024359068,0.00010672114,0.00017378242,0.000012475523,0.000096488,0.00009995447,0.00022660357],"category_scores_gemma":[0.00009834864,0.00006711788,0.00007943653,0.00063199585,0.00041069312,0.000088615736,0.00013117654,0.0002286478,0.0000021518563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028036284,0.00009410134,0.021096874,0.0003321094,0.000030940195,0.0000054095585,0.000696595,0.00000432631,0.9638762,0.00001667836,0.012991928,0.0005744833],"study_design_scores_gemma":[0.0013113461,0.00013867924,0.001276408,0.00064212544,0.000016661359,0.0000012040566,0.00042531526,0.000017249056,0.9938932,0.0002602687,0.0019557981,0.000061744184],"about_ca_topic_score_codex":0.0019598566,"about_ca_topic_score_gemma":0.000015586555,"teacher_disagreement_score":0.030017009,"about_ca_system_score_codex":0.00013782646,"about_ca_system_score_gemma":0.0003008423,"threshold_uncertainty_score":0.296273},"labels":[],"label_agreement":null},{"id":"W1528195165","doi":"10.1158/1538-7445.am2014-1687","title":"Abstract 1687: A BRCA2-targeting antisense oligodeoxynucleotide enhances cisplatin effectiveness by decreasing human tumor cell proliferation, metastatic frequency, and metabolic response","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Cisplatin; RAD51; Cancer research; Cancer cell; DNA repair; Cancer; A549 cell; Homologous recombination; Biology; Population; Molecular biology; Cell; Medicine; Internal medicine; Chemotherapy; DNA; Biochemistry","score_opus":0.02055860724898617,"score_gpt":0.3446540109912709,"score_spread":0.32409540374228474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1528195165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534816,0.0029199577,0.0006078752,0.00007445671,0.000068804635,0.0006259907,0.000057006724,0.000029397572,0.0002683398],"genre_scores_gemma":[0.9974697,0.00021063621,0.0015453913,0.00008156424,0.0001471606,0.00025184228,0.000060233353,0.00006333094,0.00017010552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99631715,0.0015984505,0.0003214001,0.0007093468,0.00045083696,0.00060281897],"domain_scores_gemma":[0.99862623,0.00030717027,0.00012209038,0.0003970659,0.0003270581,0.0002203713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004758476,0.0002375668,0.00030467907,0.00014603416,0.0004423432,0.00015401104,0.00024891522,0.00008949623,0.000051150146],"category_scores_gemma":[0.0010426891,0.00022832234,0.00006799278,0.00023233258,0.00021525894,0.000022736574,0.00014991786,0.00025885238,0.000010702575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036863427,0.000059668146,0.0013495409,0.0001635078,0.000047286663,0.000011427376,0.00009181228,0.000011798614,0.99651843,0.0001242424,0.000483494,0.0007701623],"study_design_scores_gemma":[0.00074720103,0.00028883255,0.0052823164,0.00007869941,0.000023005687,0.000011834987,0.00008109109,0.000074492746,0.9903443,0.0005850531,0.0022306724,0.00025248525],"about_ca_topic_score_codex":0.00033913908,"about_ca_topic_score_gemma":0.000098679724,"teacher_disagreement_score":0.00617411,"about_ca_system_score_codex":0.000050048533,"about_ca_system_score_gemma":0.00024099673,"threshold_uncertainty_score":0.9310715},"labels":[],"label_agreement":null},{"id":"W1530286875","doi":"10.1158/1538-7445.mel2014-a33","title":"Abstract A33: Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor survival","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Cohort; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Survival analysis; Cancer; Primary tumor; Metastasis; Cancer research","score_opus":0.04099922852141936,"score_gpt":0.31047052523955737,"score_spread":0.269471296718138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530286875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970061,0.0006748483,0.000011842058,0.000037007132,0.000085815795,0.00027374033,0.00017616915,0.000003791853,0.0017306651],"genre_scores_gemma":[0.9992844,0.00010671131,0.00005744882,0.000012907123,0.00006749253,0.000040391802,0.00010496507,0.000020192132,0.00030552477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866706,0.000115941286,0.00020479932,0.00028120435,0.00045458614,0.00027642548],"domain_scores_gemma":[0.9988364,0.000034773762,0.00009046275,0.00029460303,0.00059702335,0.00014672753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057195744,0.00011223417,0.00021925053,0.00008016371,0.000037997957,0.000015613125,0.00022236485,0.00008301196,0.000021007669],"category_scores_gemma":[0.00009727099,0.00009027763,0.00003288294,0.000117517266,0.0003570626,0.000009502643,0.00019817446,0.00013118178,0.0000015956954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039723,0.00020126696,0.32542947,0.00048202448,0.000110744,0.000019835761,0.00028058834,0.000009780827,0.66872114,0.00015141696,0.0023953542,0.0005944363],"study_design_scores_gemma":[0.0014483068,0.0007862215,0.23995656,0.0000745333,0.000010595981,0.0000028633874,0.00014841507,0.0000011367956,0.75526994,0.00009675389,0.0020689648,0.00013570112],"about_ca_topic_score_codex":0.00066043757,"about_ca_topic_score_gemma":0.0002916593,"teacher_disagreement_score":0.086548835,"about_ca_system_score_codex":0.0000278008,"about_ca_system_score_gemma":0.00036451055,"threshold_uncertainty_score":0.3681415},"labels":[],"label_agreement":null},{"id":"W1530976754","doi":"10.1158/1538-7445.am2014-2905","title":"Abstract 2905: The activity of a new class of biologics: trastuzumab conjugates designed to treat brain metastases of HER2+ breast cancers","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Trastuzumab; SKBR3; Antibody-dependent cell-mediated cytotoxicity; Monoclonal antibody; Cytotoxicity; Medicine; Breast cancer; Conjugate; Cancer research; In vivo; Antibody; Cancer; Pharmacology; In vitro; Immunology; Chemistry; Internal medicine; Biology; Biochemistry; Human breast","score_opus":0.1024113189590185,"score_gpt":0.4239348184027095,"score_spread":0.321523499443691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530976754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98618793,0.0010375523,0.000056030793,0.009687408,0.000037167738,0.00074362574,0.00041545302,0.0000095484975,0.0018252997],"genre_scores_gemma":[0.99703366,0.00056228484,0.00013228289,0.00012870242,0.00017633881,0.00006586102,0.000011929382,0.000019942776,0.0018689863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733436,0.00042995161,0.00037849613,0.0003322151,0.0009660277,0.00055892905],"domain_scores_gemma":[0.9966417,0.0018408293,0.00013122994,0.0004457721,0.000618859,0.0003216133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018127557,0.00017836098,0.00064448256,0.00025069088,0.000097805125,0.000011881724,0.00041442606,0.00009304186,0.00081533846],"category_scores_gemma":[0.0005959373,0.00010437211,0.00018074688,0.0006897384,0.00088603154,0.00005555177,0.00014499664,0.0004102062,0.000011425672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059091677,0.00019321134,0.004190627,0.00070777506,0.00022462256,0.0000071273826,0.0005869689,0.00009501636,0.87595224,0.00044129754,0.013821076,0.097870864],"study_design_scores_gemma":[0.0015675292,0.0024709746,0.06492576,0.00046608972,0.000052456173,0.000017975266,0.00052512245,0.00009211687,0.91987354,0.0002790139,0.009582514,0.00014691768],"about_ca_topic_score_codex":0.04747216,"about_ca_topic_score_gemma":0.0015763934,"teacher_disagreement_score":0.097723946,"about_ca_system_score_codex":0.00021442398,"about_ca_system_score_gemma":0.0014193108,"threshold_uncertainty_score":0.9588708},"labels":[],"label_agreement":null},{"id":"W1531621676","doi":"10.1158/1538-7445.am2014-5610","title":"Abstract 5610: Circulating tumor DNA: FOXL2 402C-G mutation can be identified in plasma from adult granulosa cell tumor patients with recurrent disease","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Digital polymerase chain reaction; Mutation; TaqMan; Primer (cosmetics); Biology; Molecular biology; Genotyping; Somatic cell; Cancer research; Polymerase chain reaction; Medicine; Genetics; Genotype; Gene; Chemistry","score_opus":0.01892054091500921,"score_gpt":0.29671739388369267,"score_spread":0.27779685296868345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531621676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791557,0.00026590485,0.000033224525,0.00022252835,0.00023109688,0.00050810125,0.00063607516,0.000007865044,0.00017963095],"genre_scores_gemma":[0.99810433,0.0000838187,0.00006711955,0.00018092821,0.0003118535,0.00023159807,0.00095259614,0.00004476671,0.000022998398],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980783,0.00009090677,0.00027926223,0.000599736,0.0004682009,0.00048363037],"domain_scores_gemma":[0.9987233,0.0000977115,0.00011819679,0.0003967689,0.00040118696,0.00026279653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025479053,0.0001834906,0.0001705471,0.00010676084,0.00013762481,0.00009351199,0.00024627184,0.000058813435,0.000037126483],"category_scores_gemma":[0.0004065799,0.00017908773,0.000054790395,0.000183727,0.000114465736,0.000008802708,0.000121909776,0.0002623317,0.000008500033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056600515,0.0016020536,0.44289878,0.000968839,0.00016824312,0.00030523792,0.00155922,0.009468238,0.5081108,0.00033936353,0.0047427136,0.024176449],"study_design_scores_gemma":[0.009709706,0.00065230153,0.79028153,0.0005525082,0.00005045728,0.000001448536,0.0003318596,0.0007700567,0.19346358,0.001078132,0.0022750753,0.0008333602],"about_ca_topic_score_codex":0.0043736324,"about_ca_topic_score_gemma":0.009078013,"teacher_disagreement_score":0.34738272,"about_ca_system_score_codex":0.00023436197,"about_ca_system_score_gemma":0.0005950331,"threshold_uncertainty_score":0.7302986},"labels":[],"label_agreement":null},{"id":"W1534178831","doi":"10.1158/1538-7445.sabcs14-p4-04-01","title":"Abstract P4-04-01: A new breast cancer classification scheme based on novel classes of tumor stroma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Stromal cell; Stroma; Cancer; Population; Tumor microenvironment; Oncology; Medicine; Biology; Cancer research; Internal medicine; Immunohistochemistry","score_opus":0.1580689722974703,"score_gpt":0.4195330586618271,"score_spread":0.2614640863643568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534178831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835695,0.0011232329,0.0011968712,0.0043641403,0.0003359283,0.00049438304,0.0002529232,0.000025118852,0.0038504614],"genre_scores_gemma":[0.9969967,0.0001569815,0.000361333,0.00023124169,0.0005957056,0.0002569802,0.000080301776,0.000037887352,0.0012828805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979521,0.00008225947,0.00028546306,0.0005479649,0.0007427719,0.0003894639],"domain_scores_gemma":[0.9981567,0.000026952512,0.00015752862,0.0006530356,0.00066535216,0.0003403978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004967996,0.00017008267,0.00017385614,0.00018009121,0.00008344147,0.000044022905,0.00041191076,0.0001522079,0.00031800964],"category_scores_gemma":[0.00013058804,0.0001539649,0.00007851942,0.00041009838,0.00016509763,0.000011355514,0.00007523496,0.00027310933,0.00002112681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006912356,0.00016554503,0.0047509945,0.000045790668,0.00002228574,7.271336e-7,0.00002636003,0.0003131689,0.94178003,0.00014159533,0.047608227,0.004454044],"study_design_scores_gemma":[0.0022651362,0.000309136,0.1507669,0.0002180697,0.000011587279,0.000003188844,0.00033554964,0.0011277288,0.76484317,0.00005261688,0.07977791,0.00028902295],"about_ca_topic_score_codex":0.000778953,"about_ca_topic_score_gemma":0.000130731,"teacher_disagreement_score":0.17693686,"about_ca_system_score_codex":0.00020868161,"about_ca_system_score_gemma":0.0025955292,"threshold_uncertainty_score":0.62785065},"labels":[],"label_agreement":null},{"id":"W1535244400","doi":"10.1158/1538-7445.sabcs14-s6-05","title":"Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Anthracycline; Log-rank test; Breast cancer; Cancer; Male breast cancer; Gastroenterology; Gynecology; Oncology; Survival analysis","score_opus":0.12980466209154085,"score_gpt":0.4410469845529094,"score_spread":0.31124232246136857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535244400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95732325,0.0005327599,0.0000017311776,0.032794528,0.0008242805,0.0014800472,0.00086982286,0.000030050944,0.0061434987],"genre_scores_gemma":[0.99018085,0.0014395392,0.000047482652,0.00010498927,0.000885673,0.0005421567,0.00007003665,0.000029825344,0.0066994578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969937,0.00009345153,0.0006072378,0.00035686186,0.0014678058,0.0004809146],"domain_scores_gemma":[0.9966287,0.00009374661,0.00031039814,0.00051243964,0.0022211876,0.00023351728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011585162,0.00015307388,0.00035421498,0.00020151304,0.00012764131,0.0000182557,0.0004167855,0.000108260356,0.0006015597],"category_scores_gemma":[0.0003306972,0.000110952766,0.000087012224,0.00062791904,0.0004025066,0.0001283577,0.00027887642,0.00045222978,0.000020024188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010245893,0.0016691906,0.6839605,0.003966803,0.0004596555,0.00006947723,0.003471207,0.00006858157,0.054511882,0.0003102965,0.051826414,0.1894401],"study_design_scores_gemma":[0.0025263082,0.00019953691,0.9209928,0.0010804314,0.000025946803,0.00008316787,0.00027497683,0.00012108409,0.005022214,0.000011587727,0.069559276,0.00010268411],"about_ca_topic_score_codex":0.0077576465,"about_ca_topic_score_gemma":0.0013940415,"teacher_disagreement_score":0.23703228,"about_ca_system_score_codex":0.00055309787,"about_ca_system_score_gemma":0.0014531658,"threshold_uncertainty_score":0.9988498},"labels":[],"label_agreement":null},{"id":"W1535686168","doi":"10.1158/1538-7445.am2014-4172","title":"Abstract 4172: Noncoding mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phytronix (Canada); Western University","funders":"","keywords":"RNA splicing; Biology; Genetics; Exon; Intron; Breast cancer; Germline mutation; Exon skipping; Gene; Mutation; Alternative splicing; Cancer; RNA","score_opus":0.05423323638951847,"score_gpt":0.3696447946056773,"score_spread":0.3154115582161588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535686168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539614,0.0018771628,0.00044323964,0.00050933583,0.00009375807,0.0003267968,0.00015456996,0.000012164223,0.0011868284],"genre_scores_gemma":[0.9945014,0.0034765967,0.000115694354,0.00014928958,0.00039661216,0.0007631148,0.00015048306,0.00003112688,0.00041567298],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99786854,0.00024069894,0.00033981935,0.00062092964,0.00038264607,0.00054735126],"domain_scores_gemma":[0.99861795,0.00008207193,0.00011877007,0.000504681,0.0005288434,0.00014766106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012534204,0.00016360861,0.00026682686,0.0003216374,0.00016913044,0.00007822188,0.00032861865,0.00016555373,0.00043324663],"category_scores_gemma":[0.0001755862,0.00015671778,0.00013791348,0.0009875345,0.00009799998,0.000014587986,0.00008657337,0.00020839644,0.000024045426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022071677,0.00009319943,0.053267717,0.000127514,0.00031080033,0.000006788448,0.00026886418,0.0046580513,0.8826489,0.000060537735,0.0011073698,0.05722958],"study_design_scores_gemma":[0.003192813,0.000109606655,0.7874053,0.0004320258,0.00022429255,0.0000106730395,0.00056331937,0.0018318675,0.20130688,0.00049809506,0.0035904136,0.000834704],"about_ca_topic_score_codex":0.0026403824,"about_ca_topic_score_gemma":0.0037485717,"teacher_disagreement_score":0.7341376,"about_ca_system_score_codex":0.00029657074,"about_ca_system_score_gemma":0.0005454368,"threshold_uncertainty_score":0.63907653},"labels":[],"label_agreement":null},{"id":"W1536849030","doi":"10.1158/1538-7445.sabcs14-p1-07-29","title":"Abstract P1-07-29: The role of cytoplasmic polyadenylation element binding protein-2 in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Breast cancer; Gene silencing; Cancer; Metastasis; Biology; microRNA; Clonogenic assay; Cancer cell; Transfection; Cell culture; Gene; Genetics","score_opus":0.05012927549638,"score_gpt":0.3788708354732545,"score_spread":0.3287415599768745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536849030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458265,0.0012765572,6.1342007e-7,0.0016578449,0.00012801998,0.0011319949,0.000028063905,0.000013649878,0.0011806188],"genre_scores_gemma":[0.9984025,0.000120234356,0.00000913364,0.000025279369,0.00044710274,0.0005704942,0.0000061400265,0.000023169214,0.00039597772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803215,0.00013093234,0.00026556614,0.00021012928,0.0009068745,0.00045436472],"domain_scores_gemma":[0.9991251,0.000078948484,0.00007622869,0.00026144253,0.00027797837,0.00018026932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018813047,0.00010678121,0.00020632832,0.00024654128,0.00007619526,0.000019032583,0.00015029742,0.00008461572,0.00051178987],"category_scores_gemma":[0.000091474445,0.00007282906,0.00004104788,0.0004283125,0.0001283735,0.00009369109,0.00006244843,0.00053855934,0.00007175566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011114503,0.00011903678,0.26913714,0.00034610127,0.000055131743,0.0000337582,0.0017827268,0.000089018824,0.69948536,0.00023398883,0.0023127352,0.025293563],"study_design_scores_gemma":[0.0036089832,0.00025289148,0.22465417,0.0015831252,0.000027071572,0.000018384857,0.0024490051,0.0006361389,0.7564656,0.00024778937,0.009831516,0.00022532365],"about_ca_topic_score_codex":0.0032211384,"about_ca_topic_score_gemma":0.0006620407,"teacher_disagreement_score":0.056980252,"about_ca_system_score_codex":0.0007246643,"about_ca_system_score_gemma":0.0010909617,"threshold_uncertainty_score":0.560374},"labels":[],"label_agreement":null},{"id":"W1538330154","doi":"10.1158/1538-7445.sabcs14-ot3-1-06","title":"Abstract OT3-1-06: A phase 2 single-arm study to evaluate the clinical activity, safety and tolerability of enzalutamide (ENZA) with trastuzumab in patients with advanced human growth factor receptor 2 (HER2)-positive breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Tolerability; Medicine; Enzalutamide; Oncology; Internal medicine; Clinical endpoint; Metastatic breast cancer; Cancer; Breast cancer; Clinical trial; Androgen receptor; Adverse effect; Prostate cancer","score_opus":0.11846389618430828,"score_gpt":0.46990363913841154,"score_spread":0.3514397429541033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1538330154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928631,0.0002896975,0.000038684226,0.0011925345,0.00007620041,0.004762527,0.0006457721,0.00003485335,0.000096594624],"genre_scores_gemma":[0.9988544,0.00004375173,0.00012310848,0.00010133918,0.00016314475,0.00056510203,0.000018395012,0.000084276835,0.000046500365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476796,0.00078644574,0.0007085804,0.0010115699,0.0019303022,0.00079511123],"domain_scores_gemma":[0.99569976,0.00051982293,0.00022399152,0.00072404975,0.0022378522,0.0005945475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020606187,0.0004077154,0.0010141168,0.00024354736,0.00020563442,0.00004394233,0.00034224856,0.00009705918,0.00023373569],"category_scores_gemma":[0.00025499417,0.00025284674,0.0000665676,0.0009807236,0.00095173466,0.00038053512,0.00019791501,0.0011476915,0.000004263567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103802085,0.012971005,0.72764856,0.00015724186,0.0004834588,0.000018851235,0.008669234,0.00014106423,0.006717322,0.000006033107,0.000051278803,0.13933389],"study_design_scores_gemma":[0.027866965,0.016043477,0.94856507,0.0007108848,0.00007597226,0.000004544898,0.0024875687,0.000005580057,0.0037648685,0.00003135161,0.00014259992,0.00030113687],"about_ca_topic_score_codex":0.0028441611,"about_ca_topic_score_gemma":0.0049385987,"teacher_disagreement_score":0.22091652,"about_ca_system_score_codex":0.0021567165,"about_ca_system_score_gemma":0.0013279646,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W1538972651","doi":"10.1158/0008-5472.can-03-3013","title":"Suppression of Ovarian Cancer Cell Tumorigenicity and Evasion of Cisplatin Resistance Using a Truncated Epidermal Growth Factor Receptor in a Rat Model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Epidermal growth factor receptor; Cisplatin; Epidermal growth factor; Ovarian cancer; Cancer research; Biology; MAPK/ERK pathway; Signal transduction; Tyrosine kinase; Cancer; Cell growth; Internal medicine; Endocrinology; Medicine; Receptor; Cell biology; Chemotherapy","score_opus":0.1587982255810195,"score_gpt":0.44702963869025175,"score_spread":0.2882314131092323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1538972651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026406,0.006316344,0.00010170105,0.0012157237,0.00008501262,0.0011858993,0.00020978654,0.00001737438,0.0006041029],"genre_scores_gemma":[0.9916649,0.003926316,0.002789798,0.000038874125,0.00017746624,0.00017652432,0.000011201863,0.00006207503,0.0011528676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995645,0.00049132,0.0007598136,0.0006539365,0.0015838883,0.00086608354],"domain_scores_gemma":[0.99759054,0.0003179894,0.0001810212,0.0005278662,0.0010302222,0.00035236974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016582905,0.0002343082,0.0006887956,0.0004646354,0.00012235827,0.000019899639,0.00031003074,0.00022682073,0.0010586365],"category_scores_gemma":[0.00045365188,0.00020679382,0.00008625683,0.001077737,0.00043911854,0.00025570692,0.00025208964,0.0009270177,0.0000031203408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031867959,0.0002224975,0.021012792,0.0017203159,0.00002284599,0.00001301405,0.0016862972,0.00086115894,0.9668662,0.000051494855,0.0020579845,0.0022986208],"study_design_scores_gemma":[0.0034745114,0.00017924816,0.0072418405,0.0021943443,0.000021337839,0.000003050127,0.00020676726,0.024209332,0.961562,0.00009390689,0.00060875545,0.00020494475],"about_ca_topic_score_codex":0.009921338,"about_ca_topic_score_gemma":0.004303938,"teacher_disagreement_score":0.023348171,"about_ca_system_score_codex":0.0016717901,"about_ca_system_score_gemma":0.0024748535,"threshold_uncertainty_score":0.9998545},"labels":[],"label_agreement":null},{"id":"W1539332217","doi":"10.1158/1538-7445.am2014-8","title":"Abstract 8: The protein tyrosine phosphatase DEP-1/PTPRJ is an essential promoter of vascular permeability, angiogenesis and tumor progression","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Angiogenesis; Protein tyrosine phosphatase; Proto-oncogene tyrosine-protein kinase Src; Phosphorylation; Tyrosine phosphorylation; Cell biology; Vascular permeability; Biology; Gene knockdown; Phosphatase; Cancer research; Endothelial stem cell; Tyrosine; In vitro; Biochemistry; Endocrinology; Apoptosis","score_opus":0.027060836015010106,"score_gpt":0.3536643455959292,"score_spread":0.3266035095809191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539332217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257733,0.02525293,0.000084977335,0.00050718186,0.000036097845,0.001318565,0.00019104782,0.000011061044,0.000020809088],"genre_scores_gemma":[0.9982272,0.0002494096,0.0003920686,0.0000746081,0.00026763146,0.00059237174,0.00011809742,0.00003817341,0.000040474966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997857,0.0002759699,0.00025283347,0.00060380425,0.0005601929,0.00045021586],"domain_scores_gemma":[0.99843895,0.00002455124,0.00009352168,0.00091443287,0.00036523902,0.00016331667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014703152,0.00018425309,0.00019150338,0.00005531783,0.00023167259,0.00007242025,0.00047319298,0.00010699293,0.00012685053],"category_scores_gemma":[0.00027301227,0.00012917664,0.000088179695,0.00020430954,0.0006393711,0.000017820686,0.00041778368,0.00018020504,0.000004714996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032656416,0.00018973956,0.0029820476,0.00028558003,0.00005106518,0.0000033866625,0.00007188634,0.0000046912864,0.9724783,0.00023048076,0.0009192951,0.022456983],"study_design_scores_gemma":[0.0005294743,0.00045766064,0.011753283,0.00010644708,0.000016840244,0.000003862303,0.000026805981,0.00004763893,0.980563,0.00019991997,0.0061378214,0.00015727417],"about_ca_topic_score_codex":0.000560501,"about_ca_topic_score_gemma":0.00010192634,"teacher_disagreement_score":0.025649836,"about_ca_system_score_codex":0.00002430075,"about_ca_system_score_gemma":0.0002000398,"threshold_uncertainty_score":0.5267671},"labels":[],"label_agreement":null},{"id":"W1539777734","doi":"10.1158/1538-7445.sabcs14-p2-14-09","title":"Abstract P2-14-09: Variation in UK reconstructive practice in the face of post-mastectomy radiotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Cosmesis; Medicine; Mastectomy; Reconstructive surgery; Quality of life (healthcare); Population; General surgery; Radiation therapy; Breast reconstruction; Surgery; Patient satisfaction; Randomized controlled trial; Breast cancer; Cancer; Nursing; Internal medicine","score_opus":0.07964877796287342,"score_gpt":0.41660725032165374,"score_spread":0.3369584723587803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539777734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886309,0.0011594665,0.000023919856,0.0050310185,0.00025946568,0.0006949458,0.000014418007,0.000007463113,0.0041783857],"genre_scores_gemma":[0.9989857,0.00021555505,0.00033536667,0.000060434857,0.00020671655,0.000068244415,0.0000065015847,0.000010906458,0.00011054887],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998381,0.00033751436,0.00026027634,0.0001964922,0.0005582215,0.00026648527],"domain_scores_gemma":[0.99862266,0.00053355424,0.00009647655,0.00020897454,0.00046356738,0.0000747439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024754247,0.00008235671,0.00019803774,0.00035582442,0.000032545224,0.000019887415,0.00012766069,0.000117473006,0.00012775259],"category_scores_gemma":[0.00045338832,0.000056370565,0.000030200505,0.0006692187,0.00016701726,0.00021273842,0.000015400754,0.000693944,0.000011529217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008136003,0.00043385,0.040141597,0.0002007358,0.00018298051,0.0001578494,0.042271182,0.00014635373,0.052147955,0.0005073306,0.0015327603,0.8541414],"study_design_scores_gemma":[0.017504562,0.0012439254,0.8736118,0.0011253842,0.00006017242,0.017202694,0.06897739,0.0003392394,0.012289553,0.0014357256,0.0057809856,0.00042854613],"about_ca_topic_score_codex":0.004286201,"about_ca_topic_score_gemma":0.0005901777,"teacher_disagreement_score":0.85371286,"about_ca_system_score_codex":0.00037624498,"about_ca_system_score_gemma":0.000823453,"threshold_uncertainty_score":0.64794827},"labels":[],"label_agreement":null},{"id":"W1540431185","doi":"10.1158/1538-7445.am2014-3507","title":"Abstract 3507: STAT3beta suppresses tumorigenesis via modulating the phosphorylation dynamics and transcription activity of STAT3alpha in esophageal squamous cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"STAT3; Cancer research; Carcinogenesis; Biology; Phosphorylation; Cancer; Cell biology; Genetics","score_opus":0.04426863527456,"score_gpt":0.3444778191474218,"score_spread":0.30020918387286183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540431185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721944,0.00040084217,0.0010386996,0.00034155554,0.00009917178,0.00040546784,0.000043593423,0.000012223186,0.00043898105],"genre_scores_gemma":[0.9995719,0.00006384772,0.000047666963,0.000012744996,0.000100563775,0.000056109853,0.000018074694,0.000022659762,0.00010642241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986516,0.00014468186,0.00024791525,0.00025223652,0.00041452257,0.0002890223],"domain_scores_gemma":[0.99896914,0.0003973217,0.000077846555,0.0002365909,0.00023909965,0.00008003055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008106233,0.00010865916,0.00021122098,0.00017888498,0.0001456025,0.000028227918,0.00008333819,0.00005860148,0.00012916492],"category_scores_gemma":[0.00010020003,0.00008507789,0.00004950141,0.00029911517,0.00013202419,0.00013725799,0.000027029711,0.00045749254,0.0000015279566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042770716,0.00017209617,0.047979746,0.0003902351,0.0000085652,0.0000072805174,0.0009814608,0.0010870356,0.9266528,0.000088959496,0.000052631916,0.022151511],"study_design_scores_gemma":[0.0007052441,0.00022193084,0.4716318,0.00005129517,0.000016827957,0.0000038088258,0.00020602602,0.03902695,0.48794883,0.000083517065,0.000041188534,0.00006257044],"about_ca_topic_score_codex":0.010462329,"about_ca_topic_score_gemma":0.0017016011,"teacher_disagreement_score":0.43870392,"about_ca_system_score_codex":0.00023177324,"about_ca_system_score_gemma":0.00014950358,"threshold_uncertainty_score":0.99612707},"labels":[],"label_agreement":null},{"id":"W1542863370","doi":"10.1158/1538-7445.sabcs14-p4-15-08","title":"Abstract P4-15-08: A phase 1b study of ONT-380, an oral HER2-specific inhibitor, combined with ado-trastuzumab emtansine (T-DM1), in HER2+ metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; La Cité Médicale","funders":"","keywords":"Lapatinib; Medicine; Taxane; Trastuzumab; Metastatic breast cancer; Internal medicine; Neratinib; Oncology; Trastuzumab emtansine; Progressive disease; Anthracycline; Cancer; Breast cancer; Pharmacology; Chemotherapy","score_opus":0.19817550286950686,"score_gpt":0.4931715194821537,"score_spread":0.29499601661264685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542863370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214184,0.0026184402,0.0000033139581,0.0015140333,0.00030434306,0.0027683403,0.00024362783,0.00005448202,0.00035158073],"genre_scores_gemma":[0.9970205,0.0005403601,0.00006369328,0.00010152257,0.00037930076,0.0010968467,0.000079796104,0.00009688484,0.0006210879],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99571145,0.00045088958,0.0006445188,0.0007874619,0.0014381283,0.0009675484],"domain_scores_gemma":[0.9973985,0.00014014576,0.00016108068,0.00059449516,0.000991901,0.0007138611],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011027207,0.00040244087,0.0010085827,0.00061423326,0.00011464446,0.000049966664,0.00030503486,0.00010363966,0.0019798945],"category_scores_gemma":[0.000026723244,0.00031312744,0.00007584343,0.0014825758,0.0004106844,0.00029336917,0.000093760274,0.0009217956,0.000029893796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22961389,0.1797667,0.2605771,0.0017583703,0.0039513456,0.010073119,0.042603455,0.00087741157,0.11489595,0.00009073723,0.06282467,0.092967264],"study_design_scores_gemma":[0.41565338,0.101898864,0.40221563,0.002451054,0.0012893243,0.0003363813,0.034026213,0.00043122613,0.026166309,0.00016950656,0.01362379,0.0017383227],"about_ca_topic_score_codex":0.04247638,"about_ca_topic_score_gemma":0.08159491,"teacher_disagreement_score":0.1860395,"about_ca_system_score_codex":0.0019684958,"about_ca_system_score_gemma":0.0026671672,"threshold_uncertainty_score":0.9999321},"labels":[],"label_agreement":null},{"id":"W1543311118","doi":"","title":"Comparative pharmacokinetics, tissue distribution and excretion of free versus liposomal vincristine in rats.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); Cantox Health Sciences International","funders":"","keywords":"Vincristine; Pharmacokinetics; Pharmacology; Liposome; Distribution (mathematics); Chemistry; Medicine; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.13425563897400392,"score_gpt":0.49710398120301547,"score_spread":0.3628483422290115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543311118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924752,0.0034872147,0.000024191359,0.0023461161,0.00018398417,0.00050353404,0.00015084143,0.000010824604,0.00081806665],"genre_scores_gemma":[0.99776185,0.0015379431,0.000048000966,0.000017886694,0.00021631147,0.00008977838,0.00013509285,0.000007254171,0.00018586748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990723,0.00007615529,0.0001598713,0.00019615715,0.00025721578,0.00023830126],"domain_scores_gemma":[0.9994484,0.00009930121,0.000031816606,0.00012176464,0.00019782355,0.000100877674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020495156,0.00008259466,0.00022938967,0.00011064906,0.000044833065,0.0000060996585,0.00006617344,0.000051933508,0.0003146844],"category_scores_gemma":[0.000042672476,0.00007635783,0.000018248802,0.00033166446,0.0002809582,0.00004346008,0.000064434724,0.0002678111,0.0000069247667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01459022,0.00072852866,0.007845682,0.00027849147,0.00017079696,0.00012203468,0.0016412956,0.00013991269,0.9564036,0.0010563455,0.009860483,0.007162599],"study_design_scores_gemma":[0.021230975,0.002250261,0.046124157,0.00017610184,0.000089344176,0.000008857371,0.00017261834,0.00006520769,0.91825044,0.0003456355,0.011176648,0.00010977209],"about_ca_topic_score_codex":0.0024790107,"about_ca_topic_score_gemma":0.0007228225,"teacher_disagreement_score":0.03827847,"about_ca_system_score_codex":0.0004972862,"about_ca_system_score_gemma":0.00024056464,"threshold_uncertainty_score":0.37475392},"labels":[],"label_agreement":null},{"id":"W1543724683","doi":"10.1158/1538-7445.sabcs14-pd6-7","title":"Abstract PD6-7: In-silico discovery of novel estrogen receptor-α inhibitors as potential therapeutics for tamoxifen resistant breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Coactivator; Tamoxifen; Estrogen receptor; Cancer research; Pharmacophore; Pharmacology; Breast cancer; In silico; Cancer; Biology; Bioinformatics; Transcription factor; Biochemistry; Genetics; Gene","score_opus":0.04704874270534042,"score_gpt":0.37409260209820755,"score_spread":0.3270438593928671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543724683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989138,0.008661714,0.000034337583,0.00064512336,0.00031096156,0.0005934877,0.000357028,0.000006971746,0.00025237957],"genre_scores_gemma":[0.996657,0.0016168711,0.00008453377,0.000048154074,0.00055016525,0.00024266797,0.000084212144,0.00004841044,0.00066799787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822354,0.00008011213,0.000294145,0.00041817865,0.000450871,0.00053316605],"domain_scores_gemma":[0.9989672,0.000034038778,0.00009243341,0.0003281269,0.00041614482,0.00016211453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007157539,0.00017363363,0.00021423407,0.00012170755,0.00007379298,0.000042847038,0.0003079854,0.0002996307,0.000015554466],"category_scores_gemma":[0.000057311277,0.00014862658,0.00012684843,0.00026285896,0.00024847288,0.000016165615,0.00013784543,0.00032278834,0.000004593639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024804974,0.00020882729,0.0017450156,0.00006966075,0.00014110036,0.0000041288704,0.000107878994,0.00037643508,0.9888901,0.000098167744,0.0033543326,0.0025238444],"study_design_scores_gemma":[0.00266814,0.0005525797,0.002154935,0.00015093143,0.00002637021,0.0000085338215,0.0003111513,0.0000481034,0.9847979,0.00009776712,0.008936542,0.00024702604],"about_ca_topic_score_codex":0.0013335939,"about_ca_topic_score_gemma":0.00014752548,"teacher_disagreement_score":0.0075189914,"about_ca_system_score_codex":0.0001626607,"about_ca_system_score_gemma":0.0011616031,"threshold_uncertainty_score":0.60608166},"labels":[],"label_agreement":null},{"id":"W1544584205","doi":"10.1158/1538-7445.am2014-2510","title":"Abstract 2510: A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Chemistry; Viability assay; Stereochemistry; Cancer cell; Cisplatin; Biochemistry; Cancer; Cancer research; Apoptosis; Biology","score_opus":0.02936354385417252,"score_gpt":0.3577156348008459,"score_spread":0.3283520909466734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1544584205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921896,0.0025797947,0.00010681254,0.00014137889,0.00011442319,0.0001648581,0.00003217114,0.000009345934,0.0046616565],"genre_scores_gemma":[0.9981994,0.0004795702,0.0002961702,0.00009099832,0.0005105925,0.00006320405,0.0000440954,0.000029510202,0.00028644712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984054,0.00011950523,0.00023380338,0.00039191724,0.00041302026,0.00043638662],"domain_scores_gemma":[0.9989598,0.00003947652,0.000064360895,0.00050323806,0.0002527798,0.00018038263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008459195,0.00013356903,0.00019070825,0.000096278614,0.00005697557,0.0000158751,0.00036528692,0.0001505754,0.0001891812],"category_scores_gemma":[0.000348117,0.00012282933,0.00010526741,0.00021339933,0.0003117979,0.0000042065253,0.00020755717,0.0002042453,0.000029655112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016550669,0.00008503002,0.0010803142,0.000046862457,0.00002801525,0.0000018403651,0.000027366397,0.00001368043,0.98520267,0.00022114544,0.0053086528,0.007818927],"study_design_scores_gemma":[0.00065921707,0.00008469737,0.0026585492,0.000016666687,0.0000072716152,0.0000021326628,0.00003825089,0.0000073910983,0.9512398,0.00034809115,0.04479951,0.00013838935],"about_ca_topic_score_codex":0.0002746817,"about_ca_topic_score_gemma":0.000018508708,"teacher_disagreement_score":0.039490856,"about_ca_system_score_codex":0.000015203045,"about_ca_system_score_gemma":0.0002143068,"threshold_uncertainty_score":0.5008834},"labels":[],"label_agreement":null},{"id":"W1545204232","doi":"10.1158/1538-7445.sabcs14-p5-07-05","title":"Abstract P5-07-05: Regulation of system Xc- by signal transducer and activator of transcription 3 and 5 in human breast cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"STAT5; STAT protein; Cancer cell; STAT3; Transcription factor; Glutathione; Cell biology; Activator (genetics); GCLC; Biology; GCLM; Chemistry; Signal transduction; Biochemistry; Cancer; Gene; Genetics","score_opus":0.036423976066879964,"score_gpt":0.333566030387516,"score_spread":0.297142054320636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1545204232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939227,0.0053958907,0.000038428298,0.00007806893,0.0000475809,0.00019354615,0.00019137193,0.000002267226,0.0001301544],"genre_scores_gemma":[0.9988463,0.0007820463,0.000013240936,0.000005976576,0.00010247416,0.000036224894,0.000024114957,0.000013365613,0.00017626543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991289,0.00007022198,0.00018580879,0.00021784149,0.00021850702,0.00017872301],"domain_scores_gemma":[0.9995628,0.000006573567,0.000052210955,0.00011519287,0.00016845806,0.00009474099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004007346,0.00008200216,0.00016044141,0.000062863415,0.000028802397,0.000008640895,0.00007142478,0.000118388874,0.000032920627],"category_scores_gemma":[0.00000265965,0.00007515516,0.00002368573,0.000085209664,0.00015670656,0.000011398098,0.000018944162,0.00010638433,2.040595e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002599137,0.000029669967,0.0008622426,0.00026865586,0.00001862674,3.9251697e-7,0.0002635745,0.000042586147,0.99432796,0.000033107313,0.00091565144,0.0029776257],"study_design_scores_gemma":[0.00087350927,0.000069349844,0.027566502,0.00011210701,0.000008775834,0.0000022792706,0.00034201605,0.000022151306,0.9693081,0.0000109625435,0.0016088134,0.0000754453],"about_ca_topic_score_codex":0.0017466901,"about_ca_topic_score_gemma":0.00017217375,"teacher_disagreement_score":0.02670426,"about_ca_system_score_codex":0.000039336606,"about_ca_system_score_gemma":0.0001213317,"threshold_uncertainty_score":0.30647385},"labels":[],"label_agreement":null},{"id":"W1546804450","doi":"10.1158/1538-7445.am2014-2864","title":"Abstract 2864: RPS4X, a new prognostic and predictive biomarker of ovarian and breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec; Université de Montréal; Université Laval","funders":"","keywords":"Ovarian cancer; Cisplatin; Breast cancer; Cancer research; Cancer; Medicine; Oncology; Internal medicine; Chemotherapy","score_opus":0.031778587918899065,"score_gpt":0.3624613174403453,"score_spread":0.3306827295214463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546804450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950397,0.0029724597,0.00017513422,0.00078374957,0.00002982045,0.00029300546,0.000089647714,0.0000042575693,0.0006122094],"genre_scores_gemma":[0.99686486,0.0016585821,0.00006272854,0.00003287266,0.00022825229,0.000077399156,0.000012687902,0.000018192131,0.0010444154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987373,0.0000943166,0.0001298505,0.00034832733,0.0002961924,0.00039403167],"domain_scores_gemma":[0.9991918,0.000060996368,0.00003416109,0.00021093673,0.00022686424,0.00027521167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005956508,0.000099200755,0.00013302758,0.00009053979,0.00009920729,0.000040182458,0.00014192943,0.00010100371,0.000095943506],"category_scores_gemma":[0.00019113501,0.0000836382,0.000025026797,0.00014797474,0.00030489848,0.0000075301505,0.00018504223,0.00018119096,0.0000015113162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046386206,0.000022726528,0.04576821,0.000115200324,0.00007224462,0.0000018043377,0.000055194112,0.0000058517376,0.90395683,0.000040436153,0.003019294,0.046478353],"study_design_scores_gemma":[0.0011974656,0.00037166913,0.9303624,0.00019854205,0.00001372153,0.000017576103,0.00009742222,0.00041331013,0.060609803,0.00018164901,0.006370985,0.0001654679],"about_ca_topic_score_codex":0.0025707316,"about_ca_topic_score_gemma":0.00045830928,"teacher_disagreement_score":0.8845942,"about_ca_system_score_codex":0.000023821225,"about_ca_system_score_gemma":0.00033932284,"threshold_uncertainty_score":0.38861942},"labels":[],"label_agreement":null},{"id":"W1549754984","doi":"10.1158/1538-7445.am2014-3994","title":"Abstract 3994: Identifying molecular networks linked to colorectal liver metastasis progression during liver regeneration by RNA-seq","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transcriptome; Medicine; RNA; Metastasis; Colorectal cancer; Liver regeneration; Tumor progression; Cancer; Cancer research; Internal medicine; Gastroenterology; Pathology; Regeneration (biology); Oncology; Gene; Biology; Gene expression; Genetics","score_opus":0.04499993849203945,"score_gpt":0.3740753678770606,"score_spread":0.32907542938502116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549754984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198473,0.0076720603,0.0089745,0.00031197185,0.00014173158,0.0004988671,0.000021129754,0.000018686931,0.00037633604],"genre_scores_gemma":[0.99506456,0.00237773,0.0004718023,0.000090905385,0.00049522007,0.0005704048,0.00012694005,0.000043452546,0.00075901736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980698,0.00019628552,0.00022048262,0.0005797026,0.00043923242,0.0004944939],"domain_scores_gemma":[0.99892616,0.000017474273,0.00006765384,0.00042382762,0.00035999354,0.00020488942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006983078,0.00015900601,0.00014164438,0.00010273171,0.00035084548,0.00014753336,0.00031649554,0.0001785555,0.00015840301],"category_scores_gemma":[0.00009059978,0.00015249346,0.000081112565,0.00028930098,0.0000935064,0.000015273841,0.00018987061,0.00027793826,0.000034248435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013867611,0.00004140005,0.000098761244,0.0000401808,0.000043939028,0.00000535723,0.00005031008,0.0020157103,0.95626783,0.00005184423,0.0058225677,0.035423443],"study_design_scores_gemma":[0.00037870626,0.00014451072,0.0033778895,0.00007224466,0.0000141057735,0.000003034029,0.000029815777,0.0012347571,0.98046774,0.000015170279,0.014036023,0.00022601662],"about_ca_topic_score_codex":0.00023398332,"about_ca_topic_score_gemma":0.00011793162,"teacher_disagreement_score":0.03519743,"about_ca_system_score_codex":0.00012336556,"about_ca_system_score_gemma":0.000103714854,"threshold_uncertainty_score":0.6218503},"labels":[],"label_agreement":null},{"id":"W1550585504","doi":"10.1158/1538-7445.sabcs14-p3-07-01","title":"Abstract P3-07-01: Circulating vitamin D concentrations and breast cancer risk: A pooled analysis of 17 cohorts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Breast cancer; Vitamin D and neurology; Internal medicine; Cancer; Odds ratio; Oncology; Prospective cohort study; Incidence (geometry); Logistic regression; Physiology; Mathematics","score_opus":0.08283911352085353,"score_gpt":0.429569092419306,"score_spread":0.3467299788984525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550585504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98896456,0.005872347,0.000030469404,0.0021493272,0.00005694239,0.0006737632,0.00046961976,0.0000281031,0.0017548674],"genre_scores_gemma":[0.99596804,0.0026159135,0.000083427134,0.000034612152,0.00019577242,0.00028804265,0.00003130273,0.000024575993,0.0007583299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967167,0.00021697488,0.00039717724,0.0004721885,0.0015059827,0.00069102296],"domain_scores_gemma":[0.9968402,0.00042917402,0.00013315743,0.00044146448,0.0016231736,0.0005328522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019465802,0.00016686831,0.0006456894,0.0006280209,0.00027199206,0.000053847678,0.00015848904,0.000099982506,0.0008319024],"category_scores_gemma":[0.00096618774,0.00013744253,0.00012195702,0.0018774922,0.0007407385,0.00013582649,0.00019531183,0.0006615232,0.00001050708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025661988,0.00017564335,0.9426466,0.0002767947,0.0046552545,0.00009873147,0.0024300204,0.0009682135,0.026781593,0.000035881243,0.011560321,0.010114297],"study_design_scores_gemma":[0.0014013713,0.00010983675,0.9909699,0.00027607087,0.0010418203,0.000010005824,0.0019652045,0.0025872118,0.001168262,0.00003109606,0.00030739186,0.00013183554],"about_ca_topic_score_codex":0.011901477,"about_ca_topic_score_gemma":0.0029542544,"teacher_disagreement_score":0.048323262,"about_ca_system_score_codex":0.0006056751,"about_ca_system_score_gemma":0.001125798,"threshold_uncertainty_score":0.9946784},"labels":[],"label_agreement":null},{"id":"W1551649529","doi":"10.1158/1538-7445.sabcs14-p5-11-04","title":"Abstract P5-11-04: Inhibition of alternative NF-κB activity prevents the expansion of genetically unstable progenitor cells in BRCA1-deficient mammary glands","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cancer research; Biology; Progenitor cell; RELB; Carcinogenesis; DNA damage; Cancer; Stem cell; Cell biology; Genetics; NFKB1; Gene; Transcription factor; DNA","score_opus":0.0773186762839013,"score_gpt":0.3752282708040286,"score_spread":0.29790959452012733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551649529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562556,0.0010616858,0.00028163462,0.00041963105,0.00017797961,0.0012915919,0.00006547855,0.000011133023,0.0010652872],"genre_scores_gemma":[0.99898064,0.00036988204,0.00013501235,0.00001849294,0.000100165475,0.00018122625,0.000013250366,0.00002634175,0.00017497649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732405,0.0002481253,0.00034182877,0.00034960484,0.0013222789,0.0004141],"domain_scores_gemma":[0.9984317,0.00010497945,0.00013130292,0.00049932796,0.000652101,0.00018059523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014547519,0.00013195115,0.00028975587,0.0002528679,0.0000413856,0.000013775442,0.0001995461,0.00013003842,0.00005594856],"category_scores_gemma":[0.0001637661,0.00010039339,0.000077661774,0.00063930434,0.00024083101,0.00008656237,0.00018992113,0.00053608255,0.000007875263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086158625,0.00040627542,0.0012724095,0.00025206208,0.000043884316,0.000055749984,0.0009391343,0.00067407626,0.9858286,0.00004396121,0.0009077123,0.008714561],"study_design_scores_gemma":[0.0022828272,0.00046319497,0.0068737264,0.0006001083,0.00001846936,0.000006026282,0.00018437387,0.00043069915,0.9882745,0.00015511362,0.0006241947,0.00008674353],"about_ca_topic_score_codex":0.0026170642,"about_ca_topic_score_gemma":0.00026007212,"teacher_disagreement_score":0.008627818,"about_ca_system_score_codex":0.0006442075,"about_ca_system_score_gemma":0.0015320773,"threshold_uncertainty_score":0.40939236},"labels":[],"label_agreement":null},{"id":"W1551938148","doi":"10.1158/1538-7445.sabcs14-p5-19-09","title":"Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Enzalutamide; Medicine; Triple-negative breast cancer; Clinical endpoint; Tolerability; Androgen receptor; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Population; Breast cancer; Bicalutamide; Progesterone receptor; Progressive disease; Cancer; Estrogen receptor; Prostate cancer; Clinical trial; Adverse effect; Disease","score_opus":0.16474672359369158,"score_gpt":0.4742801947823902,"score_spread":0.3095334711886986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551938148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901594,0.0007230119,0.000023412791,0.0041795806,0.00012244779,0.0027819332,0.0014155312,0.000105112675,0.00048956723],"genre_scores_gemma":[0.9952504,0.0003857543,0.0015841606,0.00011946959,0.00045323523,0.001640117,0.0001883049,0.00005518389,0.00032339286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962451,0.0002900801,0.0007903434,0.0008193472,0.0012667273,0.00058841496],"domain_scores_gemma":[0.99678904,0.00042310468,0.00021678432,0.0008537084,0.0008845802,0.0008327802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015796378,0.00024185517,0.0005628278,0.00036392733,0.00010360372,0.000032442957,0.0003977828,0.00015706487,0.0004022603],"category_scores_gemma":[0.001081448,0.00020983476,0.00006057507,0.0010835681,0.00038175232,0.00024696524,0.00018001429,0.0009841092,0.00001372887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07492277,0.046572454,0.011435695,0.00038647215,0.00034766176,0.00048604765,0.030320056,0.00013386433,0.4664206,0.000043078657,0.08964193,0.27928936],"study_design_scores_gemma":[0.18403128,0.043022644,0.06535919,0.008239385,0.00041097536,0.000066189365,0.051219027,0.0032933257,0.590943,0.0030269907,0.04825581,0.002132176],"about_ca_topic_score_codex":0.026392587,"about_ca_topic_score_gemma":0.001321579,"teacher_disagreement_score":0.2771572,"about_ca_system_score_codex":0.0008799709,"about_ca_system_score_gemma":0.0013430429,"threshold_uncertainty_score":0.98009074},"labels":[],"label_agreement":null},{"id":"W1553737124","doi":"","title":"The effect of hypoxia on the natural killer activity of human peripheral blood lymphocytes against cancer cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lymphokine-activated killer cell; Immunology; Natural killer cell; Cytotoxicity; Cancer research; Immune system; Biology; NK-92; DU145; Cancer cell; K562 cells; Lymphocyte; Immunotherapy; Innate immune system; Cancer; Natural killer T cell; Interleukin 21; Leukemia; T cell; In vitro","score_opus":0.0161457675092684,"score_gpt":0.3257048728896148,"score_spread":0.3095591053803464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553737124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978748,0.018394986,7.9524125e-7,0.00020916606,0.00090689835,0.0004355282,0.00004133718,0.000004892596,0.0012583565],"genre_scores_gemma":[0.990533,0.0040146955,0.0000024498274,0.000043197786,0.0014331532,0.0002492765,0.000009368576,0.000027569013,0.0036872884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981535,0.00040596904,0.00018828033,0.00031807207,0.00047874264,0.00045543635],"domain_scores_gemma":[0.99889624,0.00017772029,0.00010486736,0.00054721086,0.00022381065,0.00005015586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076760905,0.00017151616,0.00023272837,0.00004383002,0.00034013155,0.000031424668,0.0004733983,0.000112687034,0.000043415977],"category_scores_gemma":[0.000066536864,0.00009620651,0.00017126669,0.00020530219,0.00060060166,0.000004456232,0.00014955681,0.00028451474,0.0000014367902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044006124,0.000041229818,0.00041608838,0.00004620883,0.00009870277,4.579432e-7,0.00003398187,0.00012563867,0.97863704,0.000086817825,0.0119315265,0.008142231],"study_design_scores_gemma":[0.00095046696,0.00032603263,0.0036631546,0.000039600945,0.000023222035,5.479514e-7,0.000022801958,0.0000129594,0.9501382,0.000016076823,0.04470087,0.00010604738],"about_ca_topic_score_codex":0.0029075767,"about_ca_topic_score_gemma":0.0015181325,"teacher_disagreement_score":0.03276934,"about_ca_system_score_codex":0.00007571174,"about_ca_system_score_gemma":0.00029851042,"threshold_uncertainty_score":0.43954054},"labels":[],"label_agreement":null},{"id":"W1554484942","doi":"10.1158/1538-7445.am2015-ct136","title":"Abstract CT136: Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF-mutant colorectal cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; KRAS; Cetuximab; Internal medicine; Tolerability; Colorectal cancer; Oncology; Adverse effect; Cancer; Hypophosphatemia; Pharmacology","score_opus":0.07167755327505136,"score_gpt":0.3857461648551156,"score_spread":0.3140686115800642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554484942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292326,0.00070579525,0.0000014226758,0.00046847152,0.00016119961,0.0052184076,0.00023195682,0.000018397554,0.0002711106],"genre_scores_gemma":[0.998091,0.000082096754,0.00001601763,0.000042981228,0.00007288677,0.0014046835,0.000013057602,0.00005960799,0.0002176615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512076,0.0004042997,0.0006063051,0.0007539015,0.0024138405,0.00070089486],"domain_scores_gemma":[0.99616766,0.0002828801,0.00044221763,0.00078285864,0.0021378805,0.00018652469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000659563,0.0004492689,0.0011286031,0.00040593487,0.00040471496,0.000046097146,0.0004997293,0.00008946231,0.0001056028],"category_scores_gemma":[0.00011531863,0.00016920283,0.00014076967,0.0058549284,0.0012146151,0.00017311492,0.0002505765,0.0007683223,8.600181e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121758945,0.005890147,0.8471544,0.00007403113,0.0035913766,0.00003507174,0.012608102,0.0004028285,0.0025486418,0.0000025653221,0.00047654126,0.0054573794],"study_design_scores_gemma":[0.043541424,0.019979104,0.9124207,0.00061134744,0.0010325554,0.0000043724503,0.010029704,0.000083075174,0.011859131,0.000003202856,0.00016987728,0.00026551393],"about_ca_topic_score_codex":0.004513652,"about_ca_topic_score_gemma":0.059883453,"teacher_disagreement_score":0.07821752,"about_ca_system_score_codex":0.0013280828,"about_ca_system_score_gemma":0.002138583,"threshold_uncertainty_score":0.9572712},"labels":[],"label_agreement":null},{"id":"W1554495658","doi":"","title":"AR47A6.4.2, a naked monoclonal antibody targeting Trop-2, exhibits anti-tumor efficacy in multiple human cancer models as a monotherapeutic agent and demonstrates efficacy in combination therapy","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arius3D (Canada)","funders":"","keywords":"Pancreatic cancer; Cancer; Gemcitabine; In vivo; Colorectal cancer; Medicine; Monoclonal antibody; Cancer research; Antibody; Metastasis; Prostate cancer; Breast cancer; Growth inhibition; Combination therapy; Internal medicine; Oncology; Immunology; Apoptosis; Biology","score_opus":0.07728802983399234,"score_gpt":0.3903754138534551,"score_spread":0.31308738401946273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554495658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97799665,0.020667743,0.000020392752,0.000186653,0.00005123102,0.0009671128,0.000008850081,0.000016714852,0.00008464964],"genre_scores_gemma":[0.98460317,0.014722402,0.00004729875,0.00006514114,0.00009193425,0.00024473105,0.00006974861,0.000049965154,0.00010560898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768656,0.00038097802,0.00033272145,0.0006182665,0.00033382745,0.0006476337],"domain_scores_gemma":[0.9993407,0.000090759735,0.00007531203,0.00022118953,0.00013157653,0.00014046996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052958913,0.0002423593,0.00029136834,0.0002601154,0.00029060847,0.000041872125,0.00021839107,0.00021382724,0.00001817033],"category_scores_gemma":[0.000057572255,0.00022064599,0.0000732336,0.00042912285,0.00029972216,0.00002002109,0.000090570335,0.0005509385,0.0000042015768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004415052,0.00067526486,0.030765308,0.000026245489,0.000066594985,0.00007911342,0.00053111877,0.0025260712,0.9610429,0.00004977322,0.00005965268,0.0037364918],"study_design_scores_gemma":[0.013676991,0.0011595365,0.118763395,0.00026957266,0.000010183695,0.00003600237,0.0001635776,0.008999496,0.85564613,0.00015297458,0.000555793,0.00056635],"about_ca_topic_score_codex":0.0015485969,"about_ca_topic_score_gemma":0.00014208101,"teacher_disagreement_score":0.10539673,"about_ca_system_score_codex":0.0001162258,"about_ca_system_score_gemma":0.00032236165,"threshold_uncertainty_score":0.89976823},"labels":[],"label_agreement":null},{"id":"W1555525114","doi":"10.1158/1538-7445.am2014-1746","title":"Abstract 1746: Novel and selective Axl inhibitors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"GAS6; Cancer research; AXL receptor tyrosine kinase; Cancer; Downregulation and upregulation; Cell growth; Receptor tyrosine kinase; Tyrosine kinase; Kinase; Pharmacology; In vivo; Chemistry; Biology; Medicine; Internal medicine; Biochemistry; Signal transduction","score_opus":0.05371618654534896,"score_gpt":0.3641061309413925,"score_spread":0.3103899443960435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1555525114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915887,0.0037982806,0.000045636585,0.00048239433,0.00025626682,0.00017040789,0.000009055884,0.000025188949,0.0036240614],"genre_scores_gemma":[0.99808717,0.00020722325,0.000010317579,0.00003617318,0.00009603478,0.000050668583,0.000014517605,0.000012131384,0.0014857467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991146,0.00011045548,0.00012996978,0.00023781769,0.000059477625,0.00034772244],"domain_scores_gemma":[0.9994538,0.00017553521,0.0000335899,0.00015256518,0.00016034408,0.000024182791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006830867,0.00008156236,0.00013412019,0.00012411382,0.00026030547,0.00002420739,0.000106676576,0.00014044491,0.00024450166],"category_scores_gemma":[0.00011264282,0.000069672,0.000027524757,0.00017986051,0.00026592467,0.00009824307,0.00007878522,0.0003970769,0.00013715246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006405627,0.00003826834,0.0013868252,0.000015093596,0.000037404203,1.3327163e-7,0.00021476006,0.0000033948386,0.96337986,0.00082829536,0.005981743,0.02805016],"study_design_scores_gemma":[0.0009911401,0.00012483304,0.15636636,0.000055271255,0.0000056922386,0.000006659761,0.00009012401,0.000010698485,0.7458078,0.00033146664,0.09609189,0.000118035925],"about_ca_topic_score_codex":0.0005295463,"about_ca_topic_score_gemma":0.000052060772,"teacher_disagreement_score":0.21757203,"about_ca_system_score_codex":0.00008574806,"about_ca_system_score_gemma":0.00007918998,"threshold_uncertainty_score":0.28411418},"labels":[],"label_agreement":null},{"id":"W1558255535","doi":"10.1158/1538-7445.am2014-3958","title":"Abstract 3958: Investigation of HMGB1 as a potential marker for radiation response in muscle invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Comet assay; Clonogenic assay; Gene knockdown; DNA damage; Cancer research; DNA repair; Bladder cancer; HMGB1; Small hairpin RNA; Cell culture; Medicine; Biology; Cancer; Pathology; Immunology; Internal medicine; DNA; Genetics","score_opus":0.0627725174592787,"score_gpt":0.400404244669854,"score_spread":0.3376317272105753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558255535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935853,0.001124133,0.000042656236,0.0030118013,0.00018203088,0.0013285005,0.00008122352,0.000016239766,0.000628116],"genre_scores_gemma":[0.9964991,0.00054839085,0.00008955815,0.0003490124,0.00035240263,0.0011645219,0.000036145553,0.00003876429,0.00092210644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980804,0.00025823878,0.0003100487,0.00035838102,0.00058342464,0.00040954226],"domain_scores_gemma":[0.9985472,0.0004494444,0.00008920493,0.00028030257,0.00045344763,0.00018038026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013705126,0.00013396137,0.00026960394,0.00036849207,0.00008593486,0.000021406226,0.000115446885,0.00013494627,0.000861922],"category_scores_gemma":[0.0006725472,0.00012104183,0.00008388064,0.0004369072,0.00017728654,0.00013207144,0.000033020606,0.00026613788,0.000021390346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024325814,0.00024937507,0.0653147,0.00076080597,0.00028432766,0.000028099133,0.0027583495,0.00029941034,0.8027664,0.0001409685,0.009766908,0.093304835],"study_design_scores_gemma":[0.005554013,0.0008752021,0.84987336,0.00039081567,0.000058590653,0.0000026123544,0.00022697139,0.0002101698,0.13750683,0.0011611086,0.004001523,0.00013879614],"about_ca_topic_score_codex":0.005571242,"about_ca_topic_score_gemma":0.0008621341,"teacher_disagreement_score":0.78455865,"about_ca_system_score_codex":0.00051859376,"about_ca_system_score_gemma":0.0017195668,"threshold_uncertainty_score":0.9437441},"labels":[],"label_agreement":null},{"id":"W1560006484","doi":"10.1158/1538-7445.am2014-3773","title":"Abstract 3773: Identification of ALDH1A3 as a driver of resistance to both low-dose metronomic and conventional cyclophosphamide chemotherapy in prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Docetaxel; Cancer research; Cancer; LNCaP; Biology; Cabazitaxel; Medicine; Pharmacology; Oncology; Internal medicine; Androgen deprivation therapy","score_opus":0.013976363487309774,"score_gpt":0.33982999741299286,"score_spread":0.32585363392568306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1560006484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928238,0.0056029903,0.00003671417,0.00033795368,0.0004946987,0.00042272752,0.000070412294,0.000002612962,0.00020813152],"genre_scores_gemma":[0.9907373,0.005885595,0.00006858042,0.00008185649,0.0007152859,0.00022813717,0.000017434713,0.000020997612,0.0022448073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986891,0.00007205832,0.00033487822,0.00037316108,0.00026347645,0.00026728646],"domain_scores_gemma":[0.99923295,0.000027888434,0.00012408994,0.00028554606,0.00023702749,0.0000925099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007969396,0.000103824685,0.00020850604,0.00013838729,0.000038561546,0.00001518009,0.0001824152,0.00006766809,0.00008513136],"category_scores_gemma":[0.000086544605,0.00010723209,0.000050722112,0.00021068045,0.00021344256,0.000009698806,0.00006122648,0.00011361272,0.000002790909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090692716,0.000060113707,0.010245973,0.00017149729,0.000038172093,6.25573e-8,0.00023543103,0.00012303022,0.97630876,0.0002451207,0.0059733097,0.0056915744],"study_design_scores_gemma":[0.001470301,0.00006635038,0.33368802,0.00012391037,0.000005940661,2.9601242e-7,0.00008965845,0.000008793679,0.55042565,0.00022974903,0.11376634,0.00012500248],"about_ca_topic_score_codex":0.0015010533,"about_ca_topic_score_gemma":0.0018342836,"teacher_disagreement_score":0.42588314,"about_ca_system_score_codex":0.000076061835,"about_ca_system_score_gemma":0.00035746544,"threshold_uncertainty_score":0.43727976},"labels":[],"label_agreement":null},{"id":"W1562027300","doi":"10.1158/1538-7445.am2014-4149","title":"Abstract 4149: Genetic variation in CYP2A6, a nicotine/nitrosamine metabolism enzyme, influences lung cancer risk in two independent case-control studies of African American smokers","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lung cancer; CYP2A6; Medicine; Odds ratio; Internal medicine; Case-control study; Oncology; Population; Nested case-control study; Cancer; Genotype; Lung cancer susceptibility; Nicotine; Confidence interval; Physiology; Single-nucleotide polymorphism; Genetics; Biology; Environmental health; Metabolism; Cytochrome P450; Gene","score_opus":0.025820277810524508,"score_gpt":0.3766961093374619,"score_spread":0.3508758315269374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562027300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812643,0.017502882,0.00017791195,0.00025701636,0.00012094376,0.00045500664,0.00016518975,0.000005599243,0.000051168703],"genre_scores_gemma":[0.9924737,0.006636325,0.00010492738,0.000072027025,0.00022976633,0.00042458158,0.0000069613784,0.000027225582,0.000024447783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975001,0.0005134945,0.00049585756,0.00049580925,0.00042688384,0.0005678334],"domain_scores_gemma":[0.99891305,0.00019404365,0.000169471,0.0003288869,0.00027907142,0.000115477436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012085416,0.00020611573,0.00042570944,0.0003270952,0.00009296454,0.000024442805,0.00026131875,0.00007787298,0.000043299733],"category_scores_gemma":[0.00026820146,0.00018524917,0.00008351048,0.0006238004,0.0003379472,0.000011883837,0.00007184212,0.00042314213,0.000001187072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073106773,0.00019778693,0.23559448,0.00013973871,0.0003892393,0.00006497526,0.0019601088,0.026039971,0.72211045,0.00005876761,0.00010017789,0.012613218],"study_design_scores_gemma":[0.004422873,0.00037407674,0.92328084,0.00012468365,0.00011533883,0.00001828987,0.0011658481,0.0015675764,0.06793159,0.00012320412,0.00047666646,0.00039904317],"about_ca_topic_score_codex":0.07413603,"about_ca_topic_score_gemma":0.048921015,"teacher_disagreement_score":0.6876863,"about_ca_system_score_codex":0.00012433511,"about_ca_system_score_gemma":0.00028621868,"threshold_uncertainty_score":0.9684337},"labels":[],"label_agreement":null},{"id":"W1562786172","doi":"10.1158/1538-7445.sabcs14-p1-12-12","title":"Abstract P1-12-12: The insulin like growth factor axis and development of tamoxifen resistance in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Tamoxifen; Antiestrogen; Cancer research; Growth factor; Insulin-like growth factor-binding protein; Cell growth; Transfection; Endocrinology; Biology; Insulin-like growth factor; MCF-7; Internal medicine; Western blot; Breast cancer; Blot; Cell culture; Cancer; Medicine; Receptor; Gene; Genetics; Human breast","score_opus":0.10733419787674246,"score_gpt":0.3648837643479004,"score_spread":0.2575495664711579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562786172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98571295,0.007861844,0.0000061867536,0.0031337608,0.00016709662,0.0006988932,0.000111783345,0.000024778685,0.0022827217],"genre_scores_gemma":[0.9962469,0.002160181,0.00018448605,0.00020129072,0.00019024305,0.0002523686,0.000011666851,0.00004298178,0.0007098981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968985,0.00013601063,0.0005794838,0.0004759401,0.0012069448,0.00070312363],"domain_scores_gemma":[0.9982287,0.00017322476,0.00011593941,0.00041531867,0.00063381996,0.000432941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012723675,0.00023648088,0.00044502254,0.00034676795,0.00015162966,0.000039191567,0.00033757335,0.00017153466,0.00026293946],"category_scores_gemma":[0.00021172556,0.00016357371,0.000048285343,0.00063031615,0.00043100695,0.00019127651,0.00019081665,0.00085315946,0.000021564547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005654614,0.0006531244,0.83501905,0.0014841451,0.00033664875,0.00012760443,0.035722815,0.000005346527,0.035719078,0.00021387888,0.04681354,0.038250133],"study_design_scores_gemma":[0.0023027528,0.00008033174,0.96293235,0.00045226206,0.000011329869,0.000005676036,0.001003795,0.000005966134,0.0110429255,0.00016594262,0.021793526,0.00020312854],"about_ca_topic_score_codex":0.0036854444,"about_ca_topic_score_gemma":0.005400786,"teacher_disagreement_score":0.1279133,"about_ca_system_score_codex":0.00070522766,"about_ca_system_score_gemma":0.0023518407,"threshold_uncertainty_score":0.66703427},"labels":[],"label_agreement":null},{"id":"W1563433484","doi":"10.1158/1538-7445.sabcs14-s2-03","title":"Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Anastrozole; Medicine; Clinical endpoint; Breast cancer; Internal medicine; Oncology; Aromatase inhibitor; Population; PTEN; Cancer; PI3K/AKT/mTOR pathway; Aromatase; Clinical trial; Apoptosis; Biology","score_opus":0.08048488932397262,"score_gpt":0.3796009434621001,"score_spread":0.2991160541381275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563433484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212843,0.00020367371,0.0000041955263,0.00085950067,0.00018722977,0.005789906,0.0004655711,0.00002765304,0.00033381267],"genre_scores_gemma":[0.9978823,0.000029248638,0.000058729016,0.000093592644,0.0001917158,0.0010464278,0.00001791401,0.00009167683,0.0005883751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940134,0.0006916618,0.00090550934,0.0008339037,0.002631456,0.00092406373],"domain_scores_gemma":[0.9943984,0.0001534338,0.00043131088,0.0011369488,0.0032693467,0.0006105192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013833287,0.00046956033,0.0011714606,0.00041985864,0.0002166694,0.000036680365,0.00063288445,0.00011679732,0.0004882816],"category_scores_gemma":[0.0002125373,0.00031757876,0.000087185945,0.001777373,0.0008107105,0.0005680986,0.0004146736,0.0013399877,0.000004357222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018134661,0.0062054847,0.946979,0.00017295305,0.0005854211,0.000048003145,0.018804185,0.003543704,0.0008668035,0.0000024275223,0.0004187262,0.004238634],"study_design_scores_gemma":[0.023602864,0.005019256,0.91818357,0.0007648626,0.000089438705,0.000004280038,0.046020497,0.000031086558,0.0059251823,0.000009555364,0.00009057825,0.00025885238],"about_ca_topic_score_codex":0.03396218,"about_ca_topic_score_gemma":0.016997142,"teacher_disagreement_score":0.028795449,"about_ca_system_score_codex":0.0017890893,"about_ca_system_score_gemma":0.0043101846,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W1563983159","doi":"10.1158/1538-7445.sabcs14-p6-09-03","title":"Abstract P6-09-03: Development of a cardiac toxicity prediction tool for HER2 (+) breast cancer patients receiving trastuzumab","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Trastuzumab; Ejection fraction; Internal medicine; Breast cancer; Discontinuation; Oncology; Cancer; Cardiotoxicity; Cardiology; Metastatic breast cancer; Concomitant; Heart failure; Toxicity","score_opus":0.1123989428833025,"score_gpt":0.4361029065365645,"score_spread":0.32370396365326204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563983159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941824,0.0010455599,0.000011482031,0.0005883883,0.0007524372,0.0016295662,0.0006276111,0.000034207616,0.001128341],"genre_scores_gemma":[0.9956769,0.00040984788,0.00020435598,0.0000435874,0.00062604336,0.0017723321,0.00011594016,0.00003541988,0.0011156184],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979162,0.000073504714,0.0003779889,0.00036689162,0.00073917833,0.00052622485],"domain_scores_gemma":[0.998202,0.00012586227,0.00009207894,0.0001834857,0.0011277348,0.00026881223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082360744,0.00016136664,0.00037825282,0.00018010539,0.00014229736,0.000016216105,0.00011809921,0.0001190515,0.00042865446],"category_scores_gemma":[0.000071504175,0.00014076587,0.00010134535,0.0003266111,0.00011082885,0.00011847661,0.000059090184,0.00028408176,0.000017074193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077425134,0.0019074177,0.3860387,0.001103282,0.0011064704,0.000005392447,0.007909674,0.000058330214,0.07709157,0.000009088244,0.10958682,0.40744075],"study_design_scores_gemma":[0.0054516764,0.0007442112,0.8739556,0.00040176293,0.00012817045,0.0000022618333,0.00027185664,0.00003681558,0.08068672,0.000026260288,0.038110394,0.0001842514],"about_ca_topic_score_codex":0.0010947771,"about_ca_topic_score_gemma":0.00041872315,"teacher_disagreement_score":0.48791692,"about_ca_system_score_codex":0.0023616161,"about_ca_system_score_gemma":0.0024672176,"threshold_uncertainty_score":0.6175544},"labels":[],"label_agreement":null},{"id":"W1564241760","doi":"10.1158/1538-7445.am2014-80","title":"Abstract 80: Activated SHP2 collaborates with MYCN in neuroblastoma tumorigenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neuroblastoma; Zebrafish; Cancer research; Carcinogenesis; Transgene; Biology; Genetically modified mouse; Pediatric cancer; N-Myc; Oncogene; Cancer; Ganglioneuroma; Gene; Genetics; Cell culture","score_opus":0.048216664386402645,"score_gpt":0.3887054510267201,"score_spread":0.34048878664031745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564241760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932484,0.00013193196,0.0000020162458,0.0016529576,0.000045272398,0.00080442836,0.000017722017,0.00006469229,0.0040325993],"genre_scores_gemma":[0.9976027,0.00020515184,0.000054087042,0.000118621414,0.00013803616,0.00038445718,0.000012004163,0.00006569354,0.001419252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969262,0.00022929536,0.00021392453,0.0005579031,0.0011065796,0.00096611696],"domain_scores_gemma":[0.9980864,0.0003640851,0.0000400875,0.00047753728,0.0005601694,0.00047172804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005311556,0.00020265939,0.00033765897,0.00058412674,0.00015378144,0.00007383814,0.0002093591,0.00007541845,0.00055690855],"category_scores_gemma":[0.00029503956,0.00014888281,0.000038675636,0.001971003,0.0002566702,0.00014418684,0.000083753715,0.0006987824,0.00022983515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059508025,0.0007952049,0.06425295,0.00032745604,0.00012410215,0.0017157746,0.00014085695,0.00008302767,0.90752465,0.00007869799,0.0032859428,0.015720509],"study_design_scores_gemma":[0.0039402614,0.0018782978,0.47147447,0.0003680523,0.000011033569,0.000034654062,0.00007908082,0.00006288388,0.51701087,0.000044798155,0.0049364287,0.00015915537],"about_ca_topic_score_codex":0.0009962104,"about_ca_topic_score_gemma":0.0008848078,"teacher_disagreement_score":0.40722153,"about_ca_system_score_codex":0.0003806125,"about_ca_system_score_gemma":0.0008747703,"threshold_uncertainty_score":0.60977584},"labels":[],"label_agreement":null},{"id":"W1565323904","doi":"10.1158/1538-7445.sabcs14-s1-04","title":"Abstract S1-04: Exome sequencing of post-menopausal ER+ breast cancer (BC) treated pre-surgically with aromatase inhibitors (AIs) in the POETIC trial (CRUK/07/015)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Exome sequencing; Medicine; Exome; Internal medicine; Cancer; Breast cancer; Oncology; Bioinformatics; Gene; Phenotype; Genetics; Biology","score_opus":0.054193883444537905,"score_gpt":0.35604741191851763,"score_spread":0.3018535284739797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565323904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948688,0.0015905366,0.0000037086922,0.00085537124,0.0001649877,0.00095835776,0.0008953958,0.000008291226,0.0006545251],"genre_scores_gemma":[0.99737984,0.00089203386,0.000024370367,0.00012901529,0.00070658664,0.00044185104,0.00023384491,0.00004432683,0.00014813352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974967,0.00020697448,0.0004239342,0.0005308908,0.00070814905,0.00063331355],"domain_scores_gemma":[0.99827224,0.00013683396,0.00013696354,0.00059847656,0.00061145285,0.00024401963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010712172,0.00023765126,0.00030511632,0.0001473948,0.00009477191,0.00008321209,0.00044624184,0.00018871589,0.00014876644],"category_scores_gemma":[0.00019488361,0.00016836986,0.00006048537,0.00043620248,0.0003537457,0.00001424832,0.00013391099,0.00040478638,0.000015581292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06303032,0.0006664884,0.008497472,0.00021369763,0.0002529737,0.000360747,0.0017614048,0.0039891195,0.9015928,0.00009864887,0.015670065,0.0038662935],"study_design_scores_gemma":[0.114126824,0.018432563,0.09985756,0.0015887601,0.0003116046,0.00041340626,0.0062477337,0.00020190673,0.7060172,0.00046288216,0.049667783,0.0026717507],"about_ca_topic_score_codex":0.021269258,"about_ca_topic_score_gemma":0.00722219,"teacher_disagreement_score":0.19557555,"about_ca_system_score_codex":0.00037078702,"about_ca_system_score_gemma":0.0022905252,"threshold_uncertainty_score":0.9852482},"labels":[],"label_agreement":null},{"id":"W1565820605","doi":"10.1158/1538-7445.sabcs14-s3-01","title":"Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or <i>BRCA1/2</i> breast cancer (CRUK/07/012)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Oncology; Internal medicine; Docetaxel; Carboplatin; Metastatic breast cancer; Breast cancer; Taxane; Clinical endpoint; Triple-negative breast cancer; Progression-free survival; Chemotherapy; Anthracycline; Chemotherapy regimen; Randomized controlled trial; Cancer; Cisplatin","score_opus":0.07511545520705774,"score_gpt":0.3992765637296873,"score_spread":0.3241611085226295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565820605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018587,0.0006887914,0.001026265,0.0003774349,0.0005065543,0.015876338,0.001175958,0.000022644303,0.0001401543],"genre_scores_gemma":[0.98727334,0.00030834464,0.0012368992,0.00007606682,0.0003053093,0.009788471,0.00018632719,0.0000895938,0.00073567394],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959367,0.0007171729,0.0007687675,0.00072490855,0.0011399308,0.0007125162],"domain_scores_gemma":[0.9961279,0.00057688734,0.0005480748,0.00068228674,0.0017480012,0.0003168499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023166167,0.00038493637,0.0010605991,0.00011100691,0.00017396173,0.00006417813,0.0005482383,0.00011207522,0.00012461483],"category_scores_gemma":[0.0009808709,0.00019221353,0.00020083909,0.0004698853,0.0005767138,0.000025739626,0.00013404692,0.0003307706,0.0000018991334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9792563,0.0012028014,0.0000031386674,0.00011270245,0.0007822715,0.000006016353,0.00044091095,0.00030066053,0.008097945,0.000013839916,0.0023135925,0.0074698427],"study_design_scores_gemma":[0.94354117,0.010800976,0.00000629783,0.00024060611,0.00023162109,0.0000033684532,0.0006181625,0.00029996183,0.042096406,0.00008382317,0.0017600221,0.00031759814],"about_ca_topic_score_codex":0.00090083224,"about_ca_topic_score_gemma":0.0024599,"teacher_disagreement_score":0.03571512,"about_ca_system_score_codex":0.0002172076,"about_ca_system_score_gemma":0.0032914318,"threshold_uncertainty_score":0.783824},"labels":[],"label_agreement":null},{"id":"W1566186431","doi":"10.1158/1538-7445.sabcs14-p4-04-14","title":"Abstract P4-04-14: High mammographic density is associated with deposition of organised fibrillar collagen and increased stiffness in periductal breast stroma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Collagen fibril; Stroma; Breast tissue; Trichrome; Stromal cell; Breast cancer; Connective tissue; Pathology; Materials science; Hard tissue; Medicine; Anatomy; Chemistry; Staining; Cancer; H&E stain; Immunohistochemistry; Internal medicine; Dentistry","score_opus":0.03129289899717937,"score_gpt":0.3101914529460003,"score_spread":0.27889855394882096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566186431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981397,0.00032748596,0.0000020372263,0.00042642033,0.000025851106,0.0004229835,0.00019150545,0.00002947044,0.000434541],"genre_scores_gemma":[0.99968034,0.00003821363,0.0000392806,0.000034985813,0.00005603855,0.000021116042,0.00007099971,0.000028350543,0.000030648454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811506,0.00009892576,0.00021526896,0.00032730488,0.0008303328,0.0004130766],"domain_scores_gemma":[0.9985022,0.00008052847,0.00007266002,0.00021434319,0.0007924446,0.00033780368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005849423,0.00015024703,0.0003548305,0.0004902763,0.00007584077,0.00006905099,0.00009249739,0.00009233253,0.00004552759],"category_scores_gemma":[0.00010648987,0.00012853171,0.00004561061,0.0014896076,0.00041861087,0.00022135187,0.00005613577,0.00021678778,0.0000017638719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035844357,0.00037872492,0.7946807,0.0002699418,0.00028847702,0.0005726104,0.00067838083,0.0000030705005,0.19128338,0.000031578926,0.00045610883,0.00777255],"study_design_scores_gemma":[0.0038296299,0.00026488167,0.9699854,0.0005928785,0.00004439688,0.00029048315,0.0004266647,0.000020723322,0.024314044,0.00008834713,0.0000086988275,0.00013383408],"about_ca_topic_score_codex":0.0058017205,"about_ca_topic_score_gemma":0.00050553755,"teacher_disagreement_score":0.17530468,"about_ca_system_score_codex":0.00020064945,"about_ca_system_score_gemma":0.00055522245,"threshold_uncertainty_score":0.87705046},"labels":[],"label_agreement":null},{"id":"W1568937786","doi":"10.1158/1538-7445.am2014-830","title":"Abstract 830: Disulfiram is a potent inhibitor of topoisomerase II","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Disulfiram; Topoisomerase; Cytotoxicity; Chemistry; Pharmacology; Etoposide; K562 cells; Buthionine sulfoximine; Biochemistry; Glutathione; In vitro; Biology; Enzyme; Medicine; Chemotherapy; Internal medicine","score_opus":0.21170719502235508,"score_gpt":0.5057847738331176,"score_spread":0.2940775788107625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568937786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98195124,0.002205544,0.000012416693,0.01238274,0.00019589585,0.0005505481,0.0000135585115,0.00002666753,0.0026614082],"genre_scores_gemma":[0.9935658,0.0006483372,0.00003824932,0.0020116891,0.00041139283,0.00010346725,0.0000057900884,0.000018101122,0.0031971703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983623,0.00007972983,0.00024086825,0.00023811178,0.0006750812,0.00040392912],"domain_scores_gemma":[0.9987664,0.00014493274,0.00004884332,0.00034481837,0.00036068616,0.00033431797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009494703,0.00008627829,0.0002410745,0.00018769002,0.0001801573,0.000010482008,0.00009509849,0.00008866224,0.002320529],"category_scores_gemma":[0.0002763858,0.000069655995,0.00006912019,0.0002581665,0.00018330473,0.00004402149,0.000080795995,0.00047367613,0.00019306636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021144818,0.00097203226,0.030695833,0.004783159,0.00013036226,0.000055912216,0.0030701202,0.0000045170937,0.29227698,0.0011746959,0.42655224,0.23816966],"study_design_scores_gemma":[0.005024068,0.0016428301,0.3282564,0.0013640354,0.000035389046,0.000013620445,0.00018604398,0.00021276649,0.13378696,0.00022641121,0.52901036,0.00024113567],"about_ca_topic_score_codex":0.0005038792,"about_ca_topic_score_gemma":0.000031211068,"teacher_disagreement_score":0.29756057,"about_ca_system_score_codex":0.00016865991,"about_ca_system_score_gemma":0.0003651955,"threshold_uncertainty_score":0.9985915},"labels":[],"label_agreement":null},{"id":"W1569821970","doi":"10.1158/1538-7445.am2014-3687","title":"Abstract 3687: Analgesic effects of capsazepine on a mouse model of bone cancer pain","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bone pain; Breast cancer; Bone cancer; Cancer; Nociception; Capsazepine; Nociceptor; Pharmacology; Internal medicine; Cancer research; Receptor; TRPV1; Transient receptor potential channel","score_opus":0.05050804939070736,"score_gpt":0.3748203810502452,"score_spread":0.3243123316595378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1569821970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899962,0.007290635,0.00008843444,0.0010902277,0.000085386804,0.0007015082,0.000040692237,0.000027556458,0.0006793662],"genre_scores_gemma":[0.98977643,0.0055882703,0.000049272814,0.0002052048,0.0003870651,0.0002202143,0.000009476437,0.000057937847,0.0037061088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971833,0.00036495074,0.00044658594,0.00038957509,0.0010270042,0.0005885624],"domain_scores_gemma":[0.997482,0.0008964605,0.00016154758,0.000730981,0.0005044061,0.00022460303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059819,0.00020837823,0.00071824016,0.0004979403,0.00007968206,0.000011370331,0.0002151961,0.00014546557,0.00022927528],"category_scores_gemma":[0.0009933538,0.00017642039,0.00018677636,0.0004777415,0.00040146327,0.00005679346,0.000051483446,0.00054417277,0.00001179218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053287065,0.00048296808,0.0012475771,0.004165641,0.00015774669,0.000020046187,0.00069073954,0.0020134188,0.89136803,0.00016401702,0.009576642,0.08478444],"study_design_scores_gemma":[0.004388925,0.00195652,0.019801548,0.0032707967,0.000089677305,0.000003494639,0.00014452166,0.0073278667,0.9565158,0.00011761977,0.006088327,0.00029490594],"about_ca_topic_score_codex":0.0054288483,"about_ca_topic_score_gemma":0.0003281142,"teacher_disagreement_score":0.08448954,"about_ca_system_score_codex":0.00032612428,"about_ca_system_score_gemma":0.00088329945,"threshold_uncertainty_score":0.82068306},"labels":[],"label_agreement":null},{"id":"W1570480111","doi":"","title":"A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada); BC Cancer Agency","funders":"","keywords":"Liposome; Chemistry; Irinotecan; SN-38; Topoisomerase; Camptothecin; In vivo; Combinatorial chemistry; Hydrolysis; Drug delivery; Stereochemistry; Biophysics; Chromatography; Enzyme; Organic chemistry; Biochemistry; Colorectal cancer; Cancer","score_opus":0.11135848333179693,"score_gpt":0.37976760789241953,"score_spread":0.2684091245606226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1570480111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97388774,0.00042101758,0.021544255,0.0007376969,0.000089751615,0.0009699719,0.00007833199,0.000016202692,0.002255003],"genre_scores_gemma":[0.9972632,0.00017502597,0.00066073186,0.0002658091,0.0001834565,0.00077212247,0.000012248439,0.000040483046,0.00062691333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982347,0.00005556845,0.00013512999,0.00058409147,0.0003890338,0.000601506],"domain_scores_gemma":[0.9991424,0.00001402868,0.000032281638,0.0005016182,0.0001334822,0.00017617855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039839765,0.0001631819,0.00015869741,0.00017046847,0.00014508424,0.000058423346,0.00032606762,0.00014687038,0.0000321579],"category_scores_gemma":[0.000016467024,0.0001569223,0.00007613488,0.0004074455,0.00007547284,0.000008533808,0.00018500362,0.00022402602,0.000003979203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029914445,0.0003401809,0.000096822005,0.00002426613,0.00003710942,0.0000013512246,0.0005787633,0.002150055,0.9884855,0.0015933713,0.000044144006,0.0063493005],"study_design_scores_gemma":[0.001170294,0.00042998942,0.0007659978,0.00003801672,0.0000072076723,0.0000045542783,0.00018839144,0.00012536283,0.9727673,0.00043674777,0.02383568,0.00023044297],"about_ca_topic_score_codex":0.001830219,"about_ca_topic_score_gemma":0.0027219953,"teacher_disagreement_score":0.023791537,"about_ca_system_score_codex":0.00029858414,"about_ca_system_score_gemma":0.0005726197,"threshold_uncertainty_score":0.6399106},"labels":[],"label_agreement":null},{"id":"W1572226695","doi":"10.1158/1538-7445.am2014-4317","title":"Abstract 4317: Inhibiting the mitochondrial DNA polymerase gamma (POLG) with 2′,3′-dideoxycytidine reduces oxidative phosphorylation and increases apoptosis in acute myeloid leukemia (AML) cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitochondrial DNA; Mitochondrion; Biology; Oxidative phosphorylation; Molecular biology; Mitochondrial ribosome; Polymerase; TFAM; Myeloid leukemia; DNA; Cell biology; Biochemistry; Gene; Cancer research; Ribosome; RNA","score_opus":0.01598757515935424,"score_gpt":0.31509890671755875,"score_spread":0.2991113315582045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572226695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826515,0.0005178347,0.00010929856,0.000452124,0.00002930188,0.000296834,0.00003760241,0.000020392887,0.0002714421],"genre_scores_gemma":[0.99691576,0.0013088199,0.0008632325,0.00010048455,0.00039350995,0.0000768684,0.00007457229,0.000026826072,0.00023991175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982656,0.00021265172,0.00024014077,0.0005283664,0.000338086,0.00041510156],"domain_scores_gemma":[0.9991547,0.00011947741,0.00011726034,0.00029891968,0.00020824019,0.000101419966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060735736,0.0001949174,0.00020510032,0.00013255392,0.0002599819,0.00008469995,0.00018902955,0.00014420282,0.0000069583857],"category_scores_gemma":[0.00015784877,0.00013117243,0.000050165792,0.00037241384,0.0004470202,0.000017458095,0.00014395449,0.00032942026,0.0000017309582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005222329,0.000025983067,0.00028566242,0.000012605223,0.000059382503,0.0000025390977,0.000061168226,0.000016407977,0.98856777,0.000009473027,0.0005450389,0.009891747],"study_design_scores_gemma":[0.0005118424,0.00023215458,0.00079132203,0.00011387426,0.000025403555,0.000004350208,0.00026779622,0.000036557896,0.996626,0.00006269578,0.0011387354,0.00018923702],"about_ca_topic_score_codex":0.0014060999,"about_ca_topic_score_gemma":0.000615451,"teacher_disagreement_score":0.00970251,"about_ca_system_score_codex":0.00011515347,"about_ca_system_score_gemma":0.00020346996,"threshold_uncertainty_score":0.5349056},"labels":[],"label_agreement":null},{"id":"W1572282953","doi":"10.1158/1538-7445.am2014-837","title":"Abstract 837: The unique profile of microtubule stability initiated by the taccalonolides leads to potent antitumor activities","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microtubule; Potency; Chemistry; In vivo; Tubulin; Biophysics; Depolymerization; Covalent bond; Biochemistry; Stereochemistry; In vitro; Biology; Cell biology","score_opus":0.06842271074085562,"score_gpt":0.39321277203144595,"score_spread":0.3247900612905903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572282953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449235,0.00037194174,0.000100639496,0.0023666825,0.00007837249,0.0007439741,0.00016135626,0.000008169759,0.0016765264],"genre_scores_gemma":[0.99826115,0.000100088466,0.000040051258,0.00016686661,0.00013072084,0.00059120916,0.000029410774,0.000019199648,0.0006612765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986312,0.00034658614,0.00017820313,0.00027252856,0.00024530714,0.00032616686],"domain_scores_gemma":[0.99879736,0.00015158895,0.00005644104,0.00060424674,0.0003263413,0.00006402021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010451284,0.00010265191,0.00011256154,0.000039161398,0.0002313765,0.000050221784,0.0004720832,0.00007666195,0.00021577305],"category_scores_gemma":[0.00045241218,0.00006376482,0.000059920218,0.00017724167,0.00038424865,0.000007789095,0.00022726832,0.00035109266,0.000017497658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013142427,0.000057365898,0.0008867891,0.00003746774,0.000026616111,2.7974525e-7,0.00013826083,0.0000148948475,0.98067063,0.000033677632,0.016706744,0.0012958304],"study_design_scores_gemma":[0.00013528386,0.0001693193,0.0040803943,0.000031804182,0.0000032207206,0.0000022253525,0.0003404989,0.00000556939,0.9602944,0.000043393637,0.034819458,0.0000744333],"about_ca_topic_score_codex":0.0013763683,"about_ca_topic_score_gemma":0.00048571505,"teacher_disagreement_score":0.02037625,"about_ca_system_score_codex":0.00006454066,"about_ca_system_score_gemma":0.0002317008,"threshold_uncertainty_score":0.26002538},"labels":[],"label_agreement":null},{"id":"W1572312535","doi":"","title":"The RET signaling pathway: Linking developmental and neoplastic roles","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Carcinogenesis; Neural crest; Neoplastic transformation; Cancer research; Receptor tyrosine kinase; Multiple endocrine neoplasia type 2; Mutation; Endocrinology; Cancer; Internal medicine; Genetics; Germline mutation; Signal transduction; Gene; Medicine","score_opus":0.06434419350081462,"score_gpt":0.39927939248376054,"score_spread":0.33493519898294594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572312535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98407036,0.006362347,0.000011302825,0.0072981436,0.000051003455,0.00045970757,0.0000051831903,0.00004751693,0.0016944552],"genre_scores_gemma":[0.9936946,0.0018836219,0.00062208355,0.00016787897,0.00049409823,0.00017244222,0.0000031977154,0.000033025914,0.002929073],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975478,0.00014937873,0.00019703516,0.00033078843,0.0009782339,0.0007967444],"domain_scores_gemma":[0.99844736,0.0008240112,0.000025977637,0.00018895042,0.00024014154,0.00027357627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007545855,0.00011618146,0.00015588618,0.00015081164,0.00064819615,0.00013185671,0.00019992008,0.000011681302,0.00011249206],"category_scores_gemma":[0.00064116,0.00007813771,0.000029174293,0.00035629878,0.00040237897,0.00012811413,0.00026023225,0.0008000378,0.00006721652],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013645089,0.00011767893,0.026892513,0.00036639723,0.00012589704,0.0019176028,0.0010118684,0.00010351388,0.5074388,0.001224112,0.0043812306,0.4550559],"study_design_scores_gemma":[0.0022088292,0.0005133481,0.0034338466,0.0007389128,0.00001380918,0.0012299063,0.0020772845,0.0005437422,0.489382,0.0008768124,0.49870563,0.00027588604],"about_ca_topic_score_codex":0.000047700072,"about_ca_topic_score_gemma":0.00037981017,"teacher_disagreement_score":0.4943244,"about_ca_system_score_codex":0.00028373476,"about_ca_system_score_gemma":0.00063352764,"threshold_uncertainty_score":0.49854663},"labels":[],"label_agreement":null},{"id":"W1572793643","doi":"10.1158/1538-7445.am2014-824","title":"Abstract 824: In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Delmar (Canada)","funders":"","keywords":"Medicine; Lung cancer; Gefitinib; Cisplatin; Oncology; Internal medicine; Brain metastasis; Clinical trial; Chemotherapy; Cancer; Metastasis; Cancer research; Epidermal growth factor receptor","score_opus":0.05436315843481817,"score_gpt":0.4469286762644234,"score_spread":0.39256551782960525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572793643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986008,0.0032208061,0.0000053916547,0.0008139385,0.00007631927,0.0012132433,0.000042988515,0.000004537243,0.008614765],"genre_scores_gemma":[0.99540865,0.0024637969,0.000054420587,0.000040233623,0.00012578056,0.00064589287,0.0000074779177,0.000018653964,0.0012351156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861157,0.00009577277,0.00029597257,0.00024061928,0.00040686983,0.00034921517],"domain_scores_gemma":[0.99894696,0.0003789477,0.000068711124,0.00037518083,0.00015733384,0.00007288005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004273466,0.00011783228,0.00031003516,0.0002569182,0.00004074978,0.000008744186,0.00014813055,0.000062384985,0.00039192464],"category_scores_gemma":[0.000029070514,0.00007345858,0.00007998851,0.000514643,0.00011035927,0.00003163446,0.000016020675,0.00017614417,0.0000041711255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016418187,0.008494153,0.6873254,0.0021683231,0.0004774091,0.0001194418,0.050397534,0.0021004686,0.14559259,0.00025357283,0.006232019,0.09519729],"study_design_scores_gemma":[0.013705908,0.0013798884,0.8207611,0.0009801352,0.00018448268,0.0000015998731,0.0012389895,0.00041558422,0.1478082,0.00005583106,0.013311768,0.00015653014],"about_ca_topic_score_codex":0.022972062,"about_ca_topic_score_gemma":0.005342102,"teacher_disagreement_score":0.1334357,"about_ca_system_score_codex":0.000693972,"about_ca_system_score_gemma":0.00068255886,"threshold_uncertainty_score":0.98353404},"labels":[],"label_agreement":null},{"id":"W1574266964","doi":"10.1158/1538-7445.sabcs14-p4-11-09","title":"Abstract P4-11-09: Comparison of immunohistochemical residual risk panels to predict risk in early breast cancers treated with endocrine therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Proportional hazards model; Immunohistochemistry; Estrogen receptor; Residual risk; Cohort; Tamoxifen; Gynecology; Cancer","score_opus":0.056758672570007544,"score_gpt":0.3847369789097579,"score_spread":0.32797830633975034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574266964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993409,0.00469865,0.000007987948,0.00023437147,0.000049400307,0.00063181017,0.00059271115,0.00001677937,0.00035929366],"genre_scores_gemma":[0.9973103,0.0016127656,0.000091173635,0.000012974647,0.00022695771,0.00051735394,0.00007496595,0.000047784953,0.00010575004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975013,0.00022308285,0.00035568804,0.00061223406,0.0006490411,0.0006586522],"domain_scores_gemma":[0.9984614,0.00006890072,0.00014625366,0.0005680798,0.0004992768,0.00025607186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004656705,0.00026587164,0.00042102355,0.00017251066,0.000107014275,0.000023376442,0.00037456388,0.00012059278,0.00003038417],"category_scores_gemma":[0.00010184616,0.00021280536,0.000060472034,0.00048211415,0.00039362532,0.000009102051,0.00016399012,0.00040287402,0.000008017813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068861567,0.0002406715,0.86866236,0.00001705254,0.00030657192,0.0000134811135,0.0010832417,0.00072170375,0.111809544,0.000002305474,0.0032202045,0.0070367274],"study_design_scores_gemma":[0.0041269273,0.000998743,0.66883373,0.000103251434,0.000026852664,0.000008473379,0.000577818,0.0000062356567,0.32289457,0.000010999259,0.0021796154,0.00023278657],"about_ca_topic_score_codex":0.08510554,"about_ca_topic_score_gemma":0.0065738386,"teacher_disagreement_score":0.21108504,"about_ca_system_score_codex":0.0005835885,"about_ca_system_score_gemma":0.00071911194,"threshold_uncertainty_score":0.92098683},"labels":[],"label_agreement":null},{"id":"W1577931245","doi":"10.1158/1538-7445.am2014-578","title":"Abstract 578: RARRES1 is a tumor suppressor in triple-negative breast cancer cell lines","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cancer research; Breast cancer; Retinoic acid; Triple-negative breast cancer; Cell growth; Oncogene; Cancer; Gene knockdown; Metastasis; Biology; Medicine; Cell culture; Internal medicine; Cell cycle; Biochemistry","score_opus":0.025728701837933982,"score_gpt":0.35213376998403156,"score_spread":0.3264050681460976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1577931245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890929,0.004312917,0.000024090054,0.0006938968,0.00021200617,0.00034552143,0.00015517585,0.000011112365,0.0051523917],"genre_scores_gemma":[0.99336034,0.001840653,0.000050258554,0.00028877915,0.0008989173,0.00044531506,0.000026719781,0.00004286794,0.0030461485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979272,0.00017448916,0.0002651053,0.0006006558,0.00041080028,0.0006217571],"domain_scores_gemma":[0.99889106,0.000072608615,0.00007524657,0.00042717,0.00038033395,0.0001535606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006543652,0.00019545948,0.00021751256,0.00008154388,0.00012520455,0.00006528814,0.0005057474,0.00017146174,0.0008964331],"category_scores_gemma":[0.00016557587,0.00017237004,0.000080357175,0.00027194017,0.00023878034,0.000013373182,0.0001817162,0.0003990669,0.000032002554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037148595,0.00008603355,0.0025340782,0.0002659634,0.00002438049,0.000009353174,0.0002352123,0.00004772359,0.9746996,0.000015636753,0.019579604,0.002130897],"study_design_scores_gemma":[0.001217992,0.00008606756,0.0056839166,0.00010736293,0.000005619126,0.0000049903115,0.00021593641,0.00006813023,0.9718082,0.00016914832,0.020401279,0.00023138431],"about_ca_topic_score_codex":0.0030593327,"about_ca_topic_score_gemma":0.00091903214,"teacher_disagreement_score":0.0042674523,"about_ca_system_score_codex":0.00013353824,"about_ca_system_score_gemma":0.0006037856,"threshold_uncertainty_score":0.9815313},"labels":[],"label_agreement":null},{"id":"W1579807830","doi":"10.1158/1538-7445.sabcs14-p3-13-08","title":"Abstract P3-13-08: Modification of the response to chemotherapy of HER2 negative metastatic breast cancer by lipids of marine origin: A controlled, randomized, double blind dietary supplementation trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Digital Humanities","funders":"","keywords":"Docosahexaenoic acid; Eicosapentaenoic acid; Metastatic breast cancer; Fish oil; Polyunsaturated fatty acid; Medicine; Breast cancer; Chemotherapy; Internal medicine; Cancer; Metastasis; Gastroenterology; Clinical endpoint; Oncology; Fatty acid; Randomized controlled trial; Biology; Biochemistry","score_opus":0.0794228045661967,"score_gpt":0.41717487334851366,"score_spread":0.33775206878231695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579807830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104595,0.0012235157,0.00007841764,0.0020039063,0.0012483092,0.003515838,0.00070095103,0.0000029344503,0.00018020233],"genre_scores_gemma":[0.99311763,0.0020176359,0.000120402314,0.00007911535,0.0016198364,0.0015709226,0.000077619494,0.000027580836,0.0013692532],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99749,0.00063821074,0.0006217118,0.00031756624,0.00065408024,0.0002784142],"domain_scores_gemma":[0.9978392,0.00019925914,0.00034445428,0.00044485249,0.0010432947,0.00012890044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031271828,0.00015999483,0.0006468911,0.00012534966,0.000050468607,0.000014982656,0.00033312882,0.000080786835,0.0002491948],"category_scores_gemma":[0.0002881706,0.00011302688,0.00021826505,0.00037685857,0.00037219704,0.000013403204,0.000097967604,0.00014875179,0.0000011747497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6298643,0.00014662885,0.00007719083,0.000046751542,0.0002581641,1.6618186e-8,0.00041912505,0.00023603991,0.35305288,0.0000131222605,0.013685441,0.0022003578],"study_design_scores_gemma":[0.64186764,0.00042536957,0.0005952956,0.000047403,0.00009658338,7.534666e-7,0.0004690262,0.000046026333,0.34306258,0.000098282755,0.013164781,0.00012626723],"about_ca_topic_score_codex":0.013322863,"about_ca_topic_score_gemma":0.0013486495,"teacher_disagreement_score":0.012003344,"about_ca_system_score_codex":0.00010197496,"about_ca_system_score_gemma":0.0012268102,"threshold_uncertainty_score":0.9932475},"labels":[],"label_agreement":null},{"id":"W1580102644","doi":"10.1158/1538-7445.am2014-797","title":"Abstract 797: Interaction of multitargeted tyrosine kinase inhibitors with human nucleoside transporters","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Pharmacology; Uridine; Cytidine; Medicine; Cancer research; Chemistry; Biochemistry; Cancer; Internal medicine; Enzyme","score_opus":0.03478543745202216,"score_gpt":0.35518919287577383,"score_spread":0.32040375542375166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580102644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807596,0.00068380684,0.00016606304,0.00010669312,0.000057378133,0.00012552978,0.000010563101,0.000007759215,0.0007662262],"genre_scores_gemma":[0.99910206,0.000070488735,0.00008889075,0.000032812306,0.00033058127,0.00002764689,0.00006896189,0.00002396176,0.0002545998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990448,0.000055426754,0.00017378277,0.00025001235,0.00024508446,0.00023090988],"domain_scores_gemma":[0.9994182,0.000027640954,0.00005744296,0.0002178506,0.0002013416,0.000077513454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038578108,0.0000952225,0.00011167291,0.00008413347,0.00010418101,0.000013000531,0.00013491031,0.000085913845,0.00011702181],"category_scores_gemma":[0.000027002472,0.00007995595,0.00004515671,0.00013043357,0.00013039308,0.000005940639,0.000024910776,0.00024144189,0.0000032777743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002197446,0.000052639647,0.0032360966,0.00006478188,0.000040677973,0.0000036918789,0.00011270022,0.0004025489,0.99266386,0.000035531084,0.0024555274,0.00071222574],"study_design_scores_gemma":[0.0006420771,0.00037877078,0.007247301,0.00012232925,0.00001069485,0.0000015795928,0.0001739905,0.000022394632,0.9823049,0.000016230257,0.008963281,0.00011647879],"about_ca_topic_score_codex":0.0007287697,"about_ca_topic_score_gemma":0.0001783355,"teacher_disagreement_score":0.010358962,"about_ca_system_score_codex":0.000021804924,"about_ca_system_score_gemma":0.00006212353,"threshold_uncertainty_score":0.3260509},"labels":[],"label_agreement":null},{"id":"W1580153842","doi":"10.1158/1538-7445.am2014-666","title":"Abstract 666: AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alethia Biotherapeutics (Canada)","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer; LNCaP; Prostate cancer; Antibody; Monoclonal antibody; Medicine; Serous fluid; Antigen; Triple-negative breast cancer; Cytotoxic T cell; Breast cancer; Internal medicine; Chemistry; Immunology; In vitro","score_opus":0.05511131120432988,"score_gpt":0.390798829242364,"score_spread":0.3356875180380341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580153842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98951864,0.0018163419,0.00003620593,0.0037345847,0.00009409747,0.0021643117,0.0012571082,0.000023843293,0.0013548471],"genre_scores_gemma":[0.99475384,0.0024974255,0.00026485746,0.0001514122,0.00022306443,0.0006980378,0.000038089387,0.0000911464,0.0012821238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950196,0.00027850852,0.000768236,0.0010227292,0.0016995799,0.0012113162],"domain_scores_gemma":[0.99646765,0.0004682093,0.00024888242,0.0005165812,0.0017666548,0.0005320197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018195935,0.00037483062,0.0007851915,0.00058432884,0.00026291586,0.00009410697,0.00031825897,0.00018247656,0.00093377783],"category_scores_gemma":[0.00028800365,0.00033191984,0.000114107104,0.0012199103,0.0007130563,0.00037411953,0.00024496848,0.001403635,0.000009097424],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00653033,0.00032680295,0.029403174,0.0013502683,0.00018622195,0.00008992404,0.0070294794,0.00057607266,0.9414138,0.00022657221,0.0013603348,0.011507003],"study_design_scores_gemma":[0.011447708,0.0003474262,0.60515285,0.0021658055,0.00007183804,0.000022007422,0.0030298543,0.018092684,0.35806438,0.00043988068,0.0005604743,0.00060510496],"about_ca_topic_score_codex":0.11624084,"about_ca_topic_score_gemma":0.009593304,"teacher_disagreement_score":0.5833494,"about_ca_system_score_codex":0.0009945127,"about_ca_system_score_gemma":0.0022468094,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W1580620611","doi":"10.1158/1538-7445.sabcs14-p3-12-11","title":"Abstract P3-12-11: Cardiac toxicity in breast cancer patients: A single centre, retrospective review","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Cancer; Trastuzumab; Referral","score_opus":0.07872107739560182,"score_gpt":0.3838695735052642,"score_spread":0.3051484961096624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580620611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97533864,0.010044281,0.0000013569585,0.0069796457,0.00029832183,0.001451365,0.00021833336,0.00004185778,0.0056262286],"genre_scores_gemma":[0.9872169,0.010388314,0.000014888509,0.0008923372,0.000566556,0.00023042886,0.00004873075,0.00004003109,0.0006018314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720895,0.00019468233,0.00032031478,0.0004821272,0.0011920471,0.0006018792],"domain_scores_gemma":[0.99796647,0.000057494883,0.00007756751,0.0003829731,0.0011354474,0.00038004108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204472,0.00018035877,0.00054265704,0.00017759684,0.00007124515,0.000031599186,0.00014281283,0.00014919584,0.00046221248],"category_scores_gemma":[0.00028531745,0.00016415268,0.0001477661,0.0007875159,0.0001487606,0.00018937082,0.0000639525,0.00067300076,0.00003856623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010490132,0.0013987366,0.58204347,0.002482608,0.00026247677,0.00005942911,0.0020074667,0.00001115541,0.21778278,0.000080738064,0.14191768,0.05090443],"study_design_scores_gemma":[0.0056316103,0.00035811827,0.75633717,0.011454843,0.00009112607,0.000007996902,0.0005527309,0.000010257025,0.18909013,0.00023724756,0.035706185,0.0005225906],"about_ca_topic_score_codex":0.003345685,"about_ca_topic_score_gemma":0.0011561094,"teacher_disagreement_score":0.17429367,"about_ca_system_score_codex":0.0037444627,"about_ca_system_score_gemma":0.0008062605,"threshold_uncertainty_score":0.97916394},"labels":[],"label_agreement":null},{"id":"W1581409743","doi":"10.1158/1538-7445.sabcs14-p2-05-12","title":"Abstract P2-05-12: Signatures of endocrine resistance in the tamoxifen and exemestane adjuvant multinational trial (TEAM)-UK cohort","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Gene signature; Exemestane; Medicine; Cohort; Oncology; Breast cancer; Internal medicine; Cancer; Tamoxifen; Bioinformatics; Gene; Biology; Gene expression; Genetics","score_opus":0.04996638289820254,"score_gpt":0.38043571360041445,"score_spread":0.3304693307022119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581409743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813948,0.014526687,0.0000071967493,0.0005269223,0.0000993584,0.00065654784,0.00011715064,0.0000028906095,0.0026684268],"genre_scores_gemma":[0.99685216,0.0016825233,0.00013840251,0.00008521217,0.0004014837,0.00019233962,0.00011467565,0.00001153484,0.00052167394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985118,0.00016882228,0.00021601701,0.0002967217,0.0005416761,0.00026495862],"domain_scores_gemma":[0.9990873,0.00007192048,0.00005122176,0.00028420408,0.0003832584,0.00012209953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092558,0.00009667186,0.00013024692,0.00007627467,0.000061657935,0.000025862835,0.00025035656,0.00007679008,0.00003410823],"category_scores_gemma":[0.0004883492,0.00007679877,0.000038652324,0.000117496034,0.00027118032,0.0000045602974,0.00008041438,0.00017373367,9.924361e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055408753,0.0011654313,0.04243965,0.00039408967,0.00013222403,0.00009678095,0.0010530819,0.00013160838,0.6961856,0.000960704,0.19909944,0.002932642],"study_design_scores_gemma":[0.08620535,0.001968396,0.39300552,0.00029427704,0.00006213955,0.0000143519455,0.001418706,0.000047708792,0.3504972,0.012269897,0.15338662,0.0008298197],"about_ca_topic_score_codex":0.0001907063,"about_ca_topic_score_gemma":0.000665368,"teacher_disagreement_score":0.35056588,"about_ca_system_score_codex":0.000035405956,"about_ca_system_score_gemma":0.00038382615,"threshold_uncertainty_score":0.3131763},"labels":[],"label_agreement":null},{"id":"W1581566476","doi":"10.1158/1538-7445.am2014-4053","title":"Abstract 4053: Formin-binding protein-17 (FBP17) is a target of p53 and promotes invadopodia formation in breast cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen's University","funders":"","keywords":"Invadopodia; Cortactin; Cancer research; Downregulation and upregulation; Gene silencing; CDC42; Cancer; Biology; Cell biology; Cancer cell; Chemistry; Cell; Actin; Cytoskeleton","score_opus":0.029762606210927436,"score_gpt":0.33345461535724585,"score_spread":0.30369200914631844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581566476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978043,0.000392201,0.00009790294,0.00052961614,0.000055744575,0.00042671207,0.00012465408,0.0000031383695,0.00056574657],"genre_scores_gemma":[0.998345,0.0005065853,0.00010849358,0.000037616603,0.00010949792,0.0002084335,0.00003027967,0.000016518336,0.0006375635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990076,0.000048266684,0.00021037277,0.00024257807,0.00019980424,0.00029142338],"domain_scores_gemma":[0.99943936,0.0000142926765,0.000077284676,0.00019861342,0.00019647401,0.00007398385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004771939,0.00009641037,0.00012679794,0.00013131874,0.00008324535,0.000034669043,0.00013710864,0.00010495376,0.0002656002],"category_scores_gemma":[0.0000321435,0.00009018776,0.000038886188,0.00014636657,0.000055623248,0.000020582635,0.00010893992,0.00020695296,0.0000051554866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006388135,0.00004096419,0.0003263404,0.00013741774,0.000013195289,7.542636e-7,0.00014900362,0.000009000748,0.9946879,0.000052978638,0.001344753,0.0031737986],"study_design_scores_gemma":[0.00033214694,0.000095615906,0.0004847068,0.00014916697,0.0000027451301,0.000004502759,0.000114758026,0.0006029311,0.98929316,0.00016574563,0.008651834,0.000102671685],"about_ca_topic_score_codex":0.00081689353,"about_ca_topic_score_gemma":0.0004390383,"teacher_disagreement_score":0.007307081,"about_ca_system_score_codex":0.000060757993,"about_ca_system_score_gemma":0.000113921975,"threshold_uncertainty_score":0.367775},"labels":[],"label_agreement":null},{"id":"W1584772315","doi":"10.1158/1538-7445.sabcs14-p2-09-02","title":"Abstract P2-09-02: ICRP analysis: Environmental influences in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; General partnership; Cancer; Medicine; Environmental health; Family medicine; Business; Internal medicine; Finance","score_opus":0.08471283870620154,"score_gpt":0.40809361434047375,"score_spread":0.3233807756342722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584772315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919016,0.00077787304,0.000011876388,0.0017963116,0.00008497758,0.0005285199,0.0001582641,0.000026339192,0.0047142496],"genre_scores_gemma":[0.99711,0.0012750058,0.000045854526,0.00040570623,0.00012895941,0.00047425844,0.000014890717,0.000034465844,0.00051082845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513763,0.00039539277,0.0004330633,0.001048115,0.0017815033,0.0012043223],"domain_scores_gemma":[0.99852455,0.00014871797,0.000103971885,0.0005606556,0.000015066806,0.0006470641],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002812206,0.00024978997,0.00033106355,0.00036637785,0.00022325864,0.00007785423,0.000636124,0.00014118032,0.015689204],"category_scores_gemma":[0.000059493286,0.00023872458,0.00008924982,0.0015431565,0.000859771,0.0006048316,0.00050705246,0.00089480577,0.0019608084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007137889,0.00016096952,0.94776064,0.000012804552,0.00007382071,0.000057221107,0.0012175371,0.008821893,0.015082823,0.000003308987,0.0012260447,0.025511581],"study_design_scores_gemma":[0.00057997025,0.00003197062,0.99021864,0.000044196844,0.000033658947,0.0000033032447,0.0012494548,0.0003885696,0.0015526653,0.00014201342,0.005473489,0.0002820611],"about_ca_topic_score_codex":0.03237554,"about_ca_topic_score_gemma":0.008765183,"teacher_disagreement_score":0.042458028,"about_ca_system_score_codex":0.0035434808,"about_ca_system_score_gemma":0.00019348632,"threshold_uncertainty_score":0.99881625},"labels":[],"label_agreement":null},{"id":"W1585588547","doi":"10.1158/1538-7445.am2014-4283","title":"Abstract 4283: Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre on Substance Use; BC Cancer Agency","funders":"","keywords":"Medicine; Cancer; Ion semiconductor sequencing; KRAS; Oncology; Colorectal cancer; DNA sequencing; Internal medicine; Bioinformatics; Biology; Gene; Genetics","score_opus":0.025497692908672136,"score_gpt":0.34455785818240253,"score_spread":0.3190601652737304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1585588547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975321,0.0007503639,0.00020043114,0.00037339117,0.00011648102,0.0006659507,0.00020929564,0.0000048769202,0.00014706248],"genre_scores_gemma":[0.9971158,0.00031222767,0.00077860255,0.0010279634,0.00017247065,0.00044711906,0.000020483187,0.000047171678,0.00007816836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99790674,0.000042638985,0.00028414637,0.00064196554,0.00041055857,0.0007139493],"domain_scores_gemma":[0.9988954,0.00009417613,0.000038555474,0.0004543501,0.00031669965,0.00020078535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045230813,0.00018363482,0.0002368994,0.00026612586,0.0000900921,0.00007366299,0.00037189538,0.000104823645,0.0000933872],"category_scores_gemma":[0.0003284273,0.0001738959,0.00003481708,0.00052059203,0.00005742475,0.000011909992,0.00027623057,0.00021842557,0.000027295659],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001353027,0.00007925603,0.14308353,0.000070329406,0.000021112804,0.000013690954,0.0014245332,0.030612528,0.7634316,0.000015304415,0.0006503352,0.05924477],"study_design_scores_gemma":[0.00271518,0.0011044337,0.82257617,0.001180402,0.0000061309497,8.6424683e-7,0.00051644753,0.000044583492,0.08273703,0.00013814493,0.08824739,0.0007332623],"about_ca_topic_score_codex":0.0012498652,"about_ca_topic_score_gemma":0.0068358453,"teacher_disagreement_score":0.6806946,"about_ca_system_score_codex":0.00057101226,"about_ca_system_score_gemma":0.00052725343,"threshold_uncertainty_score":0.7091269},"labels":[],"label_agreement":null},{"id":"W1586602460","doi":"10.1158/1538-7445.am2014-2657","title":"Abstract 2657: Utilization of the Angiopep platform to enable brain penetration of therapeutic mAbs or Antibody-Drug Conjugates for treatment of brain tumors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Angiochem (Canada)","funders":"","keywords":"Transcytosis; LRP1; Monoclonal antibody; Blood–brain barrier; In vitro; Cancer research; Antibody; Pharmacology; Receptor; Tumor microenvironment; Biology; Chemistry; Immunology; Biochemistry; Endocrinology; Central nervous system; Lipoprotein; LDL receptor; Endocytosis","score_opus":0.11484004875053222,"score_gpt":0.4085034241297273,"score_spread":0.29366337537919507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586602460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967184,0.00024157176,0.0002440729,0.0012752892,0.00009938477,0.0011965177,0.000109436674,0.000011145109,0.00010415131],"genre_scores_gemma":[0.99909055,0.000029511157,0.00012521047,0.00007740106,0.000054322103,0.00014708086,0.000010466362,0.000018302795,0.0004471339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983766,0.00014840289,0.00039224952,0.00024481604,0.00051715673,0.0003207477],"domain_scores_gemma":[0.9979544,0.0009641157,0.00016654184,0.00039165735,0.00045656168,0.0000666966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015464801,0.000106259606,0.00025351287,0.00013189699,0.00011165839,0.000029526249,0.00030461815,0.00004113512,0.00028308018],"category_scores_gemma":[0.00033172205,0.00006727596,0.00006948534,0.00045077596,0.00021007795,0.00016240566,0.00004649518,0.000034488923,0.00000932882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067263766,0.00015142585,0.00089301815,0.000195655,0.000012172533,2.861443e-7,0.0007675757,0.0011275791,0.9914199,0.0010201144,0.0004748129,0.003264835],"study_design_scores_gemma":[0.00084895955,0.0006474766,0.0048584766,0.00014568205,0.000009590915,4.4734662e-7,0.000259341,0.00075082754,0.99099845,0.00061561196,0.0007945821,0.00007052974],"about_ca_topic_score_codex":0.0013372648,"about_ca_topic_score_gemma":0.0006242825,"teacher_disagreement_score":0.0039654584,"about_ca_system_score_codex":0.00015788131,"about_ca_system_score_gemma":0.00042245086,"threshold_uncertainty_score":0.30995294},"labels":[],"label_agreement":null},{"id":"W1586805947","doi":"10.1158/0008-5472.can-13-0080","title":"Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute on Aging; National Institute of General Medical Sciences; Wellcome Trust","keywords":"Metformin; Glutamine; Prostate cancer; Cancer cell; Cancer; Internal medicine; Endocrinology; Metabolism; Carbohydrate metabolism; Medicine; Cancer research; Biology; Chemistry; Biochemistry; Diabetes mellitus; Amino acid","score_opus":0.025133187334624475,"score_gpt":0.3329481174391847,"score_spread":0.3078149301045602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586805947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7284647,0.2705501,0.0000037186944,0.00008932989,0.000101055855,0.00056990597,0.00008395331,0.0000045097263,0.00013270257],"genre_scores_gemma":[0.77737486,0.22064818,0.000048802776,0.00012401765,0.00035817074,0.00094146875,0.000029417877,0.000023809398,0.0004512618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822295,0.00027840122,0.00022638185,0.0004169081,0.00043673042,0.00041863837],"domain_scores_gemma":[0.99867123,0.00008130539,0.00010387145,0.0004140033,0.0005779431,0.00015162458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054961216,0.00017071054,0.00022449184,0.00010154677,0.00015892612,0.000050539595,0.00027566613,0.00009772955,0.00034970875],"category_scores_gemma":[0.00021956902,0.00011585383,0.000060299826,0.00025472796,0.00038239665,0.000022702843,0.0001573522,0.00019237417,0.000010125059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001861416,0.00007947872,0.00039809165,0.000051783398,0.000097980585,6.145028e-7,0.00015708829,0.000020706291,0.7879448,0.00015517577,0.0033992738,0.20750889],"study_design_scores_gemma":[0.00052004226,0.00013126424,0.003294137,0.000046002508,0.00003722398,0.0000013742982,0.00036078715,0.000010953162,0.95171356,0.0005003581,0.04324762,0.00013665075],"about_ca_topic_score_codex":0.0069257338,"about_ca_topic_score_gemma":0.00035696276,"teacher_disagreement_score":0.20737225,"about_ca_system_score_codex":0.0000391471,"about_ca_system_score_gemma":0.0003610832,"threshold_uncertainty_score":0.99968725},"labels":[],"label_agreement":null},{"id":"W1586861096","doi":"10.1158/1538-7445.sabcs14-p1-10-01","title":"Abstract P1-10-01: Are physicians \"choosing wisely\" when imaging for distant metastases in women with early stage (1 or 2) breast cancer? A population study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Breast imaging; Asymptomatic; Malignancy; Cancer; Population; Radiology; Mammography; Internal medicine","score_opus":0.07266942242713635,"score_gpt":0.39509913239974076,"score_spread":0.3224297099726044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586861096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995468,0.0012018321,0.00003773631,0.00079797173,0.000075161406,0.0010954958,0.0012652571,0.000018364839,0.000040162417],"genre_scores_gemma":[0.9964692,0.00009397408,0.0000765678,0.00005634233,0.00032195498,0.0025238898,0.00007408359,0.000060356822,0.00032364952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978078,0.00012368512,0.00022816859,0.0006339541,0.00048917235,0.0007172075],"domain_scores_gemma":[0.99890673,0.000042994256,0.00012174216,0.00036787454,0.0004132534,0.0001473921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005175797,0.00024127412,0.00031928916,0.00012841113,0.00019869664,0.00010172475,0.00022300334,0.000042034346,0.000050582476],"category_scores_gemma":[0.000053066124,0.00018605217,0.000036721045,0.00029983284,0.00013017614,0.000033726246,0.0001334808,0.00015774324,0.0000018986902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02888044,0.0015770843,0.8923506,0.0002832774,0.0009003314,0.00012480699,0.007948987,0.0011834886,0.016537005,0.000008637793,0.005625479,0.04457986],"study_design_scores_gemma":[0.0062888884,0.00071143854,0.96387035,0.00036360987,0.000058856698,0.0000047728563,0.020960482,0.000025726924,0.0033348007,0.00007603477,0.0038481238,0.0004568998],"about_ca_topic_score_codex":0.016104927,"about_ca_topic_score_gemma":0.020605002,"teacher_disagreement_score":0.07151976,"about_ca_system_score_codex":0.0008808079,"about_ca_system_score_gemma":0.00041190535,"threshold_uncertainty_score":0.9972664},"labels":[],"label_agreement":null},{"id":"W1587087382","doi":"","title":"Abstract #5543: Lovastatin induces apoptosis of ovarian cancer cells and modulates the efficacy of chemotherapeutics: Implications for patient treatment","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Lovastatin; Doxorubicin; Apoptosis; Statin; Ovarian cancer; Cancer research; HMG-CoA reductase; Pharmacology; Cancer; Cancer cell; Medicine; Chemotherapy; Biology; Cholesterol; Reductase; Internal medicine; Biochemistry; Enzyme","score_opus":0.05403544030168635,"score_gpt":0.38117151457366183,"score_spread":0.3271360742719755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1587087382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913761,0.0060273246,0.000051252406,0.0012291602,0.00025859752,0.00064070977,0.00031133823,0.0000026575342,0.000102875885],"genre_scores_gemma":[0.98978335,0.0087205125,0.00015684216,0.00008758478,0.000915143,0.00020761034,0.000019844392,0.000013316284,0.00009581998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991645,0.000034399567,0.00020320335,0.00024290032,0.0001205629,0.00023442827],"domain_scores_gemma":[0.99923146,0.00007008547,0.00008952976,0.00029974853,0.00025115904,0.000058028232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017185217,0.00010292659,0.00016428407,0.00004816844,0.00009133351,0.000014139887,0.00014343248,0.00007083299,0.000020340294],"category_scores_gemma":[0.00002191647,0.00007292701,0.00007428787,0.00011789764,0.00016260962,0.000003481596,0.000026666887,0.000061317514,2.1753738e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015949756,0.00011023605,0.0001479065,0.000026506072,0.0000793668,2.2260285e-9,0.00046575477,0.00010370461,0.84240884,0.000098434204,0.0014210015,0.15497874],"study_design_scores_gemma":[0.0007938032,0.00035004897,0.028742565,0.000023478755,0.00002732742,1.8596407e-7,0.00015383525,0.0000057749603,0.9217457,0.00018017071,0.047901355,0.00007573654],"about_ca_topic_score_codex":0.000806051,"about_ca_topic_score_gemma":0.00008523006,"teacher_disagreement_score":0.15490301,"about_ca_system_score_codex":0.000038020786,"about_ca_system_score_gemma":0.00024993566,"threshold_uncertainty_score":0.29738772},"labels":[],"label_agreement":null},{"id":"W1587415694","doi":"10.1158/1538-7445.am2014-1535","title":"Abstract 1535: Immunohistochemistry predicts presence and type of TP53 mutation in high-grade serous carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Missense mutation; Frameshift mutation; Immunohistochemistry; Sanger sequencing; Biology; Serous fluid; Molecular biology; Tissue microarray; Ovarian carcinoma; Mutation; Exon; Pathology; Cancer research; Genetics; Medicine; Ovarian cancer; Cancer; Gene","score_opus":0.031213650873473525,"score_gpt":0.3786251126751206,"score_spread":0.34741146180164706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1587415694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975396,0.0012964352,0.00019001754,0.00017491958,0.000021726159,0.00022013915,0.000016066968,0.0000066075145,0.0005345026],"genre_scores_gemma":[0.9987679,0.00044380943,0.000315172,0.000023893817,0.000059857462,0.00013519014,0.00007778442,0.000011759969,0.0001645956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991855,0.00006117454,0.00014854384,0.00027997952,0.00012574009,0.00019908385],"domain_scores_gemma":[0.9994259,0.00002540607,0.000045391953,0.0003142234,0.00013920695,0.000049862916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003425485,0.00007507858,0.00009762498,0.000049326645,0.000048168567,0.000008088266,0.00018477293,0.00015090856,0.000014694524],"category_scores_gemma":[0.000114702074,0.000074565636,0.000018135359,0.00014687883,0.00022104978,0.0000022995982,0.00010945886,0.00016923914,0.0000011921367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004682446,0.000030351714,0.005861911,0.000054620985,0.000006872128,0.0000015553562,0.000025164807,0.000019155823,0.9910587,0.000219875,0.0006162864,0.0020587037],"study_design_scores_gemma":[0.0003236634,0.00018623444,0.06379121,0.00003467147,0.0000034541258,0.0000061336737,0.000026391204,0.00005838841,0.93226737,0.00042977737,0.0027801236,0.000092614326],"about_ca_topic_score_codex":0.0006769339,"about_ca_topic_score_gemma":0.00004556649,"teacher_disagreement_score":0.05879134,"about_ca_system_score_codex":0.00002345959,"about_ca_system_score_gemma":0.000097957185,"threshold_uncertainty_score":0.30406985},"labels":[],"label_agreement":null},{"id":"W1588091866","doi":"10.1158/1538-7445.am2014-1881","title":"Abstract 1881: New therapeutic options for CLL treatment: Src/c-abl-directed molecular re-engineering of chlorambucil and bendamustine","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Concordia University; Royal Victoria Regional Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Chlorambucil; Chronic lymphocytic leukemia; Fludarabine; Cancer research; Dasatinib; Nitrogen mustard; Bendamustine; Medicine; Pharmacology; Imatinib; Leukemia; Chemistry; Immunology; Chemotherapy; Cyclophosphamide; Internal medicine; Myeloid leukemia","score_opus":0.09612360987829247,"score_gpt":0.41265592706558135,"score_spread":0.3165323171872889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1588091866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847417,0.0088904,0.0011010646,0.0019645856,0.000094684736,0.0017635411,0.0000507236,0.00012150694,0.0012718351],"genre_scores_gemma":[0.9939852,0.0014394799,0.0013588854,0.00004095228,0.00031843208,0.00030100453,0.000037497288,0.000069211725,0.0024493427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790215,0.00005447162,0.0002925043,0.0004256594,0.00063643145,0.00068878836],"domain_scores_gemma":[0.99794775,0.0006238848,0.00004682904,0.00052573386,0.0004627024,0.00039312404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007340708,0.00018530722,0.0003977205,0.0003177795,0.0001034715,0.000040408504,0.00016173613,0.00013534074,0.00024147677],"category_scores_gemma":[0.0005732666,0.00015482574,0.00010254812,0.0005201206,0.00017940674,0.00006587366,0.00006843995,0.0003007187,0.000010820529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022307194,0.0004215775,0.00031672086,0.0023982099,0.00087419676,0.000074969816,0.0011185823,0.0023790172,0.84783244,0.0035000506,0.0042625056,0.13459098],"study_design_scores_gemma":[0.0676507,0.004419051,0.009217077,0.0019070214,0.00042460978,0.00011254227,0.00036367038,0.17018,0.5814462,0.0012276645,0.16225189,0.00079961395],"about_ca_topic_score_codex":0.0030384788,"about_ca_topic_score_gemma":0.0001180935,"teacher_disagreement_score":0.2663863,"about_ca_system_score_codex":0.0042623905,"about_ca_system_score_gemma":0.0042033973,"threshold_uncertainty_score":0.99956006},"labels":[],"label_agreement":null},{"id":"W1588538733","doi":"","title":"Preferential potentiation of paclitaxel and doxorubicin cytotoxicity in drug-resistant breast tumor cells by tesmilifene.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Clonogenic assay; Cytotoxicity; Anthracycline; Medicine; Chemotherapy; Breast cancer; Pharmacology; Cancer research; Internal medicine; Cancer; Oncology; In vitro; Chemistry; Biochemistry","score_opus":0.027685970481697564,"score_gpt":0.36610498746509595,"score_spread":0.3384190169833984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1588538733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460185,0.0024489888,0.0000037554091,0.0009210791,0.00006980445,0.00061840797,0.00032745424,0.000012547321,0.0009960923],"genre_scores_gemma":[0.99684536,0.00038348007,0.000023250312,0.000047490215,0.00016781161,0.00013328904,0.000065994915,0.000016568994,0.0023167732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851596,0.00015347268,0.0002676248,0.00029684367,0.0003956393,0.00037045285],"domain_scores_gemma":[0.99942946,0.000097420925,0.000057486446,0.00015032997,0.00016309581,0.000102200735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039844305,0.00011354333,0.00026994385,0.00022052276,0.000059993337,0.000012702861,0.0000709602,0.000055516226,0.0005226766],"category_scores_gemma":[0.000009719878,0.00009922056,0.000041262083,0.0003413237,0.00019578877,0.00005765936,0.000054050633,0.00026020338,0.0000053768977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015046297,0.00047187853,0.043263346,0.00019102318,0.000033258995,0.00001777651,0.000092894625,0.0000074599257,0.9318046,0.000049973343,0.021891627,0.0006715202],"study_design_scores_gemma":[0.0042568506,0.0002778011,0.15480207,0.00013910394,0.000050953586,0.000008298709,0.000093999864,0.000057534064,0.8378002,0.00017926937,0.0022307772,0.00010311841],"about_ca_topic_score_codex":0.020707848,"about_ca_topic_score_gemma":0.0032237105,"teacher_disagreement_score":0.111538716,"about_ca_system_score_codex":0.00031501814,"about_ca_system_score_gemma":0.00023809761,"threshold_uncertainty_score":0.9858133},"labels":[],"label_agreement":null},{"id":"W1590421787","doi":"10.1158/1538-7445.am2014-4329","title":"Abstract 4329: Lipid droplets and associated proteins in hepatocellular carcinoma tumour cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lipid metabolism and biosynthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Lipid droplet; Hepatocellular carcinoma; Lipid metabolism; Perilipin; Small hairpin RNA; Cancer research; Fatty liver; Cancer; RNA interference; Biology; Medicine; Cell biology; Apoptosis; Biochemistry; Disease; Gene knockdown; Internal medicine; Adipose tissue; RNA; Gene","score_opus":0.02843782020930665,"score_gpt":0.29793394159072323,"score_spread":0.2694961213814166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590421787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769294,0.0009815297,0.000008692633,0.00018896555,0.00010712193,0.00034893898,0.000021866954,0.000008301679,0.0006416299],"genre_scores_gemma":[0.99815017,0.00034667502,0.00004487272,0.000060202652,0.00056451454,0.000115016584,0.00002051842,0.000027197984,0.00067085563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834496,0.00021949928,0.00019008228,0.0004344415,0.00030318787,0.0005078533],"domain_scores_gemma":[0.9993538,0.000036474186,0.00004505367,0.00028456497,0.00013261632,0.00014748386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012125457,0.00013669417,0.00018520662,0.00010902209,0.000111313355,0.000047930578,0.00023279824,0.00018513738,0.00005307594],"category_scores_gemma":[0.00023995557,0.000121762954,0.000041812855,0.00017925822,0.00012878596,0.00000552274,0.00016571998,0.00025504333,0.000021039894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047329548,0.00006707298,0.031236703,0.00005045874,0.000011967203,0.000004826406,0.00006444821,0.0000015357172,0.96413976,0.00001173878,0.0007993193,0.0035648197],"study_design_scores_gemma":[0.00045293523,0.00006954413,0.089031026,0.000033750366,0.000003669607,7.470941e-7,0.00003071506,0.00005704049,0.8745443,0.0000147462215,0.035615314,0.00014621115],"about_ca_topic_score_codex":0.00071209937,"about_ca_topic_score_gemma":0.0004039715,"teacher_disagreement_score":0.08959548,"about_ca_system_score_codex":0.000038285532,"about_ca_system_score_gemma":0.00017874672,"threshold_uncertainty_score":0.4965349},"labels":[],"label_agreement":null},{"id":"W1590504688","doi":"10.1158/1538-7445.am2014-3804","title":"Abstract 3804: CPA-7, an inhibitor of STAT3, is a potent tumoricidal agent in peripheral tumor models and is impermeable to the CNS","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Survivin; Glioma; Cancer research; STAT3; Cisplatin; Apoptosis; Medicine; Biology; Chemistry; Molecular biology; Chemotherapy; Internal medicine; Biochemistry","score_opus":0.2743382566298365,"score_gpt":0.5091478968132257,"score_spread":0.23480964018338918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590504688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298227,0.00073411135,0.000040520434,0.0037544135,0.00033389343,0.0005754238,0.00017660987,0.000012413467,0.0013903697],"genre_scores_gemma":[0.99607646,0.00043315097,0.000042689517,0.0024393976,0.0003073435,0.00013697734,0.000004337902,0.000024684849,0.00053494435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772996,0.00043222378,0.00030131658,0.0004409003,0.00040923132,0.0006863755],"domain_scores_gemma":[0.998959,0.00013894176,0.00006351792,0.0002745297,0.00023333514,0.00033066445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015918047,0.00017735931,0.00027080072,0.0001669771,0.00029754904,0.000055031196,0.00039767323,0.00009997453,0.0012883778],"category_scores_gemma":[0.000031937496,0.00013375422,0.00005783584,0.00035731954,0.00031356548,0.00016651549,0.00022357488,0.00085509,0.000024537463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033903173,0.0021152091,0.04872003,0.0006049748,0.00029961593,0.00016900204,0.031431347,0.0069483696,0.7209887,0.0018207023,0.09964417,0.08386756],"study_design_scores_gemma":[0.0071389494,0.0025336354,0.16806388,0.00036195214,0.00008869034,0.000038325637,0.005771003,0.08324131,0.45128837,0.0038429594,0.27639982,0.0012310991],"about_ca_topic_score_codex":0.0015126562,"about_ca_topic_score_gemma":0.00041754617,"teacher_disagreement_score":0.26970035,"about_ca_system_score_codex":0.00020031592,"about_ca_system_score_gemma":0.00019596846,"threshold_uncertainty_score":0.99962455},"labels":[],"label_agreement":null},{"id":"W1591498347","doi":"10.1158/1538-7445.am2014-2987","title":"Abstract 2987: Evaluation of CTLA-4 blockage with sequential metronomic chemotherapy for the treatment of preclinical breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Ipilimumab; Cyclophosphamide; Breast cancer; Chemotherapy; Paclitaxel; Internal medicine; Bolus (digestion); Oncology; Combination therapy; Cancer; Immunotherapy","score_opus":0.16587068743173164,"score_gpt":0.4865170146534458,"score_spread":0.32064632722171416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591498347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906222,0.0042012683,0.00008377348,0.0026599944,0.0001279832,0.00189712,0.00012538927,0.0000074322625,0.0002748126],"genre_scores_gemma":[0.99478686,0.00335153,0.00005999153,0.000050088096,0.0004591116,0.00090657757,0.00001058782,0.000028040924,0.00034719278],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982996,0.00012920448,0.0003165828,0.00025823968,0.00072276656,0.00027359521],"domain_scores_gemma":[0.9981848,0.0004482958,0.00014250456,0.00040675767,0.00075517135,0.00006249591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022133065,0.00012031511,0.00033261825,0.000100191566,0.00008263721,0.0000116146275,0.00014118371,0.000074036776,0.0014729311],"category_scores_gemma":[0.000030088037,0.00006765348,0.00016269089,0.0002275216,0.00040073352,0.000034488563,0.000008332798,0.00011021227,0.0000011117617],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02823901,0.000726701,0.01279332,0.0002494143,0.00178785,3.258563e-7,0.0007582289,0.00033296362,0.16376983,0.0000273332,0.0015391804,0.78977585],"study_design_scores_gemma":[0.033332933,0.0048852405,0.45557886,0.00063883944,0.0007989718,0.0000075836865,0.00027665892,0.004292717,0.47524694,0.000075199096,0.024645729,0.00022033132],"about_ca_topic_score_codex":0.0038532694,"about_ca_topic_score_gemma":0.0008741137,"teacher_disagreement_score":0.7895555,"about_ca_system_score_codex":0.0006592546,"about_ca_system_score_gemma":0.0010959663,"threshold_uncertainty_score":0.99943984},"labels":[],"label_agreement":null},{"id":"W1593299612","doi":"10.1158/1538-7445.am2014-753","title":"Abstract 753: Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Erlotinib; T790M; Cancer research; Tyrosine kinase; Epidermal growth factor receptor; Medicine; Erlotinib Hydrochloride; EGFR inhibitors; Proto-oncogene tyrosine-protein kinase Src; Tyrosine-kinase inhibitor; Gefitinib; Cancer; Internal medicine; Receptor","score_opus":0.04532424740537488,"score_gpt":0.3983098243007043,"score_spread":0.3529855768953294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593299612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241436,0.0008024056,0.000075175245,0.0011023902,0.00016132223,0.0024271219,0.000032684376,0.000028368999,0.002956152],"genre_scores_gemma":[0.99740773,0.0005081669,0.00010451317,0.000056320034,0.00023100643,0.0011298385,0.000012215592,0.0000903637,0.0004598596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955183,0.00035546866,0.000549015,0.0007838134,0.0016234115,0.0011699448],"domain_scores_gemma":[0.9975359,0.000445915,0.00017649445,0.00067269197,0.00083441276,0.00033459644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028573638,0.00028950113,0.0007245173,0.001096036,0.00009154364,0.000046262998,0.0003935961,0.00018882118,0.00048090133],"category_scores_gemma":[0.00034686932,0.00025736084,0.00007221389,0.0022314156,0.00041714616,0.00020751513,0.00017053928,0.001800369,0.000016667109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014446412,0.0010075131,0.2128247,0.0028808285,0.00002567378,0.00009373419,0.0008966609,0.00064733543,0.7617131,0.000021744174,0.0011794146,0.017264664],"study_design_scores_gemma":[0.0053903884,0.00057136157,0.3310405,0.0024898988,0.000010828354,0.0000017537723,0.00016452845,0.0013543906,0.65836775,0.000015195876,0.0003827951,0.00021057972],"about_ca_topic_score_codex":0.020162795,"about_ca_topic_score_gemma":0.017837051,"teacher_disagreement_score":0.1182158,"about_ca_system_score_codex":0.001700926,"about_ca_system_score_gemma":0.0020640537,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W1593340928","doi":"","title":"Molecular mechanisms of the growth inhibitory effects of the bacterial metabolites, kinamycin A and C.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Waterloo","funders":"","keywords":"K562 cells; Glutathione; Chronic myelogenous leukemia; Chemistry; Biochemistry; Dithiothreitol; Cytotoxic T cell; Cell culture; Cancer cell; Benzidine; Leukemia; Molecular biology; Biology; Cell; Immunology; Cancer; In vitro; Enzyme","score_opus":0.006369013475117227,"score_gpt":0.26220983524297076,"score_spread":0.25584082176785355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593340928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663335,0.0022947537,0.000028178018,0.00014814509,0.00014290611,0.00018663371,0.000017978551,0.0000017769378,0.00054628827],"genre_scores_gemma":[0.99931914,0.00010275612,0.00003109056,0.000029774983,0.0001453173,0.00003221541,0.0000040120985,0.000013269041,0.00032242187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991157,0.00012942823,0.00012119702,0.00018349696,0.00026455402,0.00018563539],"domain_scores_gemma":[0.99941725,0.000020486581,0.000055616096,0.00034022573,0.00013699164,0.000029447765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020504574,0.00007889917,0.00010764929,0.000016308115,0.00006254754,0.000008409227,0.00029808166,0.00009885032,0.00000900821],"category_scores_gemma":[0.000102892096,0.000048456724,0.00007295168,0.00013661987,0.0003221499,0.0000018505323,0.000339952,0.00012478732,2.1110118e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035836252,0.000030220317,0.0004609109,0.00014577557,0.00002059079,7.1769256e-7,0.000011898556,0.0000013257542,0.9973915,0.0009951511,0.000775782,0.0001302564],"study_design_scores_gemma":[0.0003624597,0.00003886195,0.0031159918,0.000047893802,0.000014341312,0.0000018530267,0.000011443683,0.0000012035717,0.9933203,0.0013798948,0.0016541844,0.00005160329],"about_ca_topic_score_codex":0.00021589054,"about_ca_topic_score_gemma":0.0000146080665,"teacher_disagreement_score":0.004071266,"about_ca_system_score_codex":0.000012744805,"about_ca_system_score_gemma":0.00012423705,"threshold_uncertainty_score":0.19760078},"labels":[],"label_agreement":null},{"id":"W1594175490","doi":"10.1158/1538-7445.sabcs14-pd2-1","title":"Abstract PD2-1: The effect on overall and disease-free survival (OS &amp; DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Bevacizumab; Internal medicine; Capecitabine; Chemotherapy; Breast cancer; Gemcitabine; Neoadjuvant therapy; Oncology; Taxane; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.09054911960160768,"score_gpt":0.46391539685108785,"score_spread":0.3733662772494802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594175490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367036,0.0018193761,0.0000045908264,0.013746265,0.00016684175,0.04526555,0.00049650023,0.000060879043,0.0017363935],"genre_scores_gemma":[0.89548206,0.0006509157,0.000105385625,0.0018771613,0.0013743822,0.09239396,0.00005794738,0.00013523934,0.007922934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974744,0.00026101194,0.00020854316,0.0005185677,0.0009123007,0.00062522816],"domain_scores_gemma":[0.9977696,0.00059810595,0.000047610483,0.00049423386,0.0002007407,0.0008897052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001298285,0.00025734137,0.00044151343,0.00014438927,0.00022150106,0.000111487425,0.00022098531,0.00007718654,0.00090980844],"category_scores_gemma":[0.00044358068,0.00014895071,0.00006055167,0.00027102974,0.00024138369,0.000087631175,0.00016106546,0.00047808696,0.00003366902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16493657,0.00042142862,0.039404698,0.00081521727,0.0005521013,0.00015547164,0.0014527487,0.000011482469,0.04393295,0.000119675366,0.6098318,0.13836583],"study_design_scores_gemma":[0.028102703,0.0053291395,0.04056122,0.00043633033,0.00012312617,0.000013166234,0.00009428567,0.000020916505,0.016018767,0.00024618002,0.90872496,0.0003292103],"about_ca_topic_score_codex":0.00053228805,"about_ca_topic_score_gemma":0.00017254516,"teacher_disagreement_score":0.29889312,"about_ca_system_score_codex":0.00040935655,"about_ca_system_score_gemma":0.0006441412,"threshold_uncertainty_score":0.9961764},"labels":[],"label_agreement":null},{"id":"W1595061092","doi":"10.1158/1538-7445.am2014-2093","title":"Abstract 2093: LPP promotes ErbB2 overexpressing breast cancer cell migration, invasion and metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre; McGill University Health Centre","funders":"","keywords":"Metastasis; Cancer research; Breast cancer; Cell migration; Carcinogenesis; Biology; Cancer; Mediator; Focal adhesion; Signal transduction; Medicine; Cell; Internal medicine; Cell biology","score_opus":0.0363658713395475,"score_gpt":0.3427078200605678,"score_spread":0.30634194872102033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595061092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97060597,0.026358474,0.00006953961,0.00079463376,0.00038253897,0.00030882415,0.00016804512,0.000013734117,0.0012982457],"genre_scores_gemma":[0.97757095,0.018398514,0.0001626573,0.00015449068,0.0022412976,0.0001892909,0.000048070804,0.00003951256,0.0011952403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982681,0.0001431681,0.00019607203,0.00054099975,0.00037561366,0.00047601602],"domain_scores_gemma":[0.99896926,0.000034328572,0.00007205828,0.00038450348,0.00033790403,0.00020193825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006630166,0.0001750952,0.00019500469,0.000066926084,0.00025402952,0.000120092605,0.00021193524,0.00014724396,0.00029450824],"category_scores_gemma":[0.0000678948,0.00015526109,0.00006494875,0.00014533957,0.00018584072,0.00002282148,0.00017437151,0.00022434561,0.000007473712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010350822,0.000043649557,0.001039446,0.000118706856,0.000031667954,3.6951633e-7,0.00012536641,0.000019910116,0.93512803,0.000022743694,0.019306071,0.04406054],"study_design_scores_gemma":[0.00071374397,0.000068727284,0.018609026,0.000098306926,0.000025534326,0.000007438301,0.00011097463,0.000037513415,0.6578898,0.00009511641,0.32210085,0.00024298544],"about_ca_topic_score_codex":0.0044245133,"about_ca_topic_score_gemma":0.0035570043,"teacher_disagreement_score":0.30279478,"about_ca_system_score_codex":0.00005855486,"about_ca_system_score_gemma":0.000317437,"threshold_uncertainty_score":0.66885704},"labels":[],"label_agreement":null},{"id":"W1595122151","doi":"","title":"Folate and cancer prevention","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer; Medicine; Oncology; Internal medicine","score_opus":0.19545656733097444,"score_gpt":0.49681786198321876,"score_spread":0.3013612946522443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595122151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98213255,0.011444853,0.0000071500776,0.0020882708,0.000058747508,0.00043530727,0.000006600975,0.000027661514,0.0037988704],"genre_scores_gemma":[0.9262936,0.030342376,0.00004830401,0.00007700501,0.00027970504,0.00022707153,0.000004985119,0.000021372018,0.042705562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833417,0.00009073569,0.00012307876,0.00028522543,0.0006882334,0.00047856857],"domain_scores_gemma":[0.9991253,0.000055397057,0.000013944091,0.00022046106,0.00034852544,0.00023637262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048827298,0.00007928026,0.00016424352,0.00023339438,0.00026543712,0.00001918284,0.00008469322,0.00008101067,0.0010945118],"category_scores_gemma":[0.00007427091,0.0000638296,0.000041413336,0.00047941844,0.000294795,0.00010063425,0.00010325382,0.0004989383,0.00008380734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014142912,0.00037446374,0.19703805,0.00068454526,0.0003472582,0.0007260732,0.0017667993,0.0000042103884,0.35475373,0.00043055677,0.07479936,0.36766064],"study_design_scores_gemma":[0.007032947,0.002887821,0.52318823,0.0009908637,0.00007665712,0.0004371825,0.00038727632,0.0005749611,0.12515236,0.001224688,0.33755493,0.0004920939],"about_ca_topic_score_codex":0.0016257004,"about_ca_topic_score_gemma":0.00016119145,"teacher_disagreement_score":0.36716855,"about_ca_system_score_codex":0.00018116986,"about_ca_system_score_gemma":0.0005958705,"threshold_uncertainty_score":0.9998186},"labels":[],"label_agreement":null},{"id":"W1596415786","doi":"10.1158/1538-7445.am2014-390","title":"Abstract 390: Impact of loss of <i>IGF2</i> genomic imprinting on IGF1R signaling and cancer stem cell-associated biomarkers in gastric cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Cancer; Immunohistochemistry; Pathological; Insulin-like growth factor 1 receptor; Pathology; Insulin-like growth factor; Internal medicine; Growth factor; Oncology; Gastroenterology; Receptor","score_opus":0.026362192937132378,"score_gpt":0.35173012743312065,"score_spread":0.3253679344959883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596415786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273187,0.0059552374,0.00014453243,0.000068164605,0.00008820975,0.0005332331,0.00016718567,0.0000073655783,0.00030419382],"genre_scores_gemma":[0.99489564,0.0045636445,0.000030703595,0.000022757973,0.000117086456,0.00018350597,0.000019948544,0.00007123942,0.00009548123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996939,0.00034188485,0.0004968963,0.00067358697,0.00066169206,0.0008869246],"domain_scores_gemma":[0.99847674,0.00012246835,0.00025172034,0.0004520472,0.00048503693,0.00021195943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017430718,0.0002585252,0.00041116553,0.0004676679,0.00009843841,0.000033234788,0.00043161618,0.00030341078,0.00014025495],"category_scores_gemma":[0.0001159314,0.00025059402,0.00017102009,0.00077345833,0.0003201409,0.000009501411,0.0002957116,0.0005963042,0.000001559301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057435693,0.000098782446,0.006020368,0.00021705603,0.0002695035,0.000005572526,0.00010288901,0.0122994445,0.96702266,0.0000061846663,0.0002306428,0.013152571],"study_design_scores_gemma":[0.0017887299,0.0006054101,0.013342702,0.00041551064,0.000019991852,0.0000016905282,0.00011208407,0.00080593344,0.9824541,0.000021051457,0.00018084384,0.00025190448],"about_ca_topic_score_codex":0.012786118,"about_ca_topic_score_gemma":0.0010413165,"teacher_disagreement_score":0.0154315205,"about_ca_system_score_codex":0.00063090766,"about_ca_system_score_gemma":0.0011187545,"threshold_uncertainty_score":0.99999464},"labels":[],"label_agreement":null},{"id":"W1596497920","doi":"","title":"Polymorphisms in cell cycle pathway genes and risk of non-Hodgkin’s lymphoma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"BCL6; CDKN2A; Lymphoma; Cell cycle; Biology; Cancer research; Population; Chronic lymphocytic leukemia; Single-nucleotide polymorphism; Genotype; Mantle cell lymphoma; Carcinogenesis; Cancer; Oncology; Immunology; Leukemia; Genetics; Medicine; Gene; B cell","score_opus":0.027786280541727618,"score_gpt":0.3363369260730757,"score_spread":0.3085506455313481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596497920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762698,0.018947385,0.000043699438,0.00050240546,0.00007766987,0.0005072932,0.000048188784,0.000018972669,0.0035846038],"genre_scores_gemma":[0.98953813,0.008732862,0.00043594724,0.00006014525,0.00021693538,0.00012035475,0.000005645239,0.0000456701,0.0008443316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980601,0.00013672512,0.00028987543,0.00039101145,0.00060145685,0.0005208442],"domain_scores_gemma":[0.99899375,0.00009212256,0.00006817679,0.00044222557,0.00018464398,0.00021907588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007378839,0.00013871709,0.00030928245,0.00041580346,0.0000694901,0.000013957277,0.00014422415,0.00015381578,0.00024130133],"category_scores_gemma":[0.00007132466,0.00013046013,0.00006624548,0.00059398694,0.00025330528,0.000063320775,0.0001319623,0.00037938327,0.000040502895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045369606,0.00023423295,0.024330309,0.00012730519,0.00005050631,0.00009038652,0.000920293,0.00024166753,0.71480834,0.0000270281,0.0008029185,0.25791332],"study_design_scores_gemma":[0.0048490805,0.00039228058,0.063064225,0.00028174685,0.000033397762,0.000025498437,0.00016306865,0.0013848218,0.91522926,0.000062870895,0.01433866,0.0001750976],"about_ca_topic_score_codex":0.005003582,"about_ca_topic_score_gemma":0.0012408992,"teacher_disagreement_score":0.25773823,"about_ca_system_score_codex":0.00047521052,"about_ca_system_score_gemma":0.00072515843,"threshold_uncertainty_score":0.75639534},"labels":[],"label_agreement":null},{"id":"W1596733644","doi":"10.1158/1538-7445.am2014-3436","title":"Abstract 3436: Ameloblastoma driver mutations revealed by next-generation sequencing of formalin-fixed paraffin-embedded specimens","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral and Maxillofacial Pathology","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sanger sequencing; Ameloblastoma; Hedgehog; PDGFRA; Cancer; Cancer research; Mutation; Biology; Medicine; Pathology; Genetics; Gene; Anatomy","score_opus":0.1543362556390473,"score_gpt":0.3918818468548309,"score_spread":0.2375455912157836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596733644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957448,0.00016948259,0.00047193887,0.00028455997,0.00040733168,0.00034056214,0.00011800306,0.000049506238,0.0024137895],"genre_scores_gemma":[0.9958703,0.000054550244,0.00035350453,0.0000799659,0.00035714864,0.00009604027,0.00008901862,0.00002717639,0.003072289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789345,0.00022463001,0.0004140211,0.0003657942,0.0005778249,0.00052429026],"domain_scores_gemma":[0.99878454,0.0001187819,0.00014139272,0.00034936998,0.0004599658,0.00014593951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083068653,0.00014578951,0.00027310566,0.00017631962,0.00025271688,0.00007171084,0.00026862556,0.00016249932,0.0011388133],"category_scores_gemma":[0.00024538508,0.00013928457,0.000086446635,0.0003843833,0.00027149625,0.00030525387,0.000095776246,0.0004034277,0.00044542964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005622995,0.000041652384,0.0012335702,0.000059722854,0.000023954724,0.000023019353,0.00038326517,0.00019211446,0.9818564,0.0016056743,0.0087174745,0.005806891],"study_design_scores_gemma":[0.0019048296,0.0003544851,0.041757323,0.00010765812,0.000037882724,0.000029824309,0.00066731725,0.002043947,0.9347509,0.0020227311,0.015842393,0.0004806663],"about_ca_topic_score_codex":0.00086964405,"about_ca_topic_score_gemma":0.0010306388,"teacher_disagreement_score":0.047105487,"about_ca_system_score_codex":0.00025140445,"about_ca_system_score_gemma":0.00020627561,"threshold_uncertainty_score":0.9997743},"labels":[],"label_agreement":null},{"id":"W1597122917","doi":"10.1158/1538-7445.am2014-909","title":"Abstract 909: Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cisplatin; Oncology; Internal medicine; Chemotherapy; Cancer; Cohort; Gemcitabine","score_opus":0.02193102164403776,"score_gpt":0.34740595409681296,"score_spread":0.3254749324527752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597122917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654306,0.004341207,0.000015871365,0.006361986,0.00009704111,0.0011056521,0.000965102,0.00002548634,0.0005445732],"genre_scores_gemma":[0.99712133,0.0011699292,0.0002626844,0.00072992756,0.00015843989,0.00041866032,0.000026360736,0.00005908358,0.000053602867],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974828,0.00032767205,0.00037304428,0.00065559556,0.00063810666,0.00052279665],"domain_scores_gemma":[0.9980714,0.000706096,0.00009619273,0.0004067094,0.0003616942,0.0003579243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012250141,0.00025383887,0.00043354885,0.0004774318,0.00010240684,0.000025082967,0.00012695511,0.00019552463,0.00007611252],"category_scores_gemma":[0.00033557726,0.00022156119,0.000046236495,0.0006460226,0.00028684048,0.00007762344,0.000058749843,0.0004340016,0.0000028174545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22488417,0.0005859529,0.06776802,0.0011476794,0.00087320054,0.0005402325,0.012255947,0.00050941313,0.57537633,0.000042344516,0.004901915,0.11111481],"study_design_scores_gemma":[0.014980411,0.004686786,0.83460456,0.0016835269,0.000092479146,0.0000061135943,0.0013913907,0.00021782197,0.13642144,0.000042585747,0.0055535296,0.00031933832],"about_ca_topic_score_codex":0.0018594546,"about_ca_topic_score_gemma":0.00050216133,"teacher_disagreement_score":0.7668366,"about_ca_system_score_codex":0.00030918952,"about_ca_system_score_gemma":0.0013047145,"threshold_uncertainty_score":0.90350026},"labels":[],"label_agreement":null},{"id":"W1598432591","doi":"10.1158/1538-7445.am2014-959","title":"Abstract 959: FAS mutations induce therapeutic resistance in non-Hodgkin lymphomas","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Simon Fraser University; BC Cancer Agency; West Fraser (Canada); Fraser Institute; McGill University","funders":"","keywords":"Fas ligand; Immune system; Cancer research; Lymphoma; Fas receptor; Apoptosis; Biology; Immunology; Programmed cell death; Genetics","score_opus":0.05678424617299321,"score_gpt":0.37736271122829546,"score_spread":0.32057846505530224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598432591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736506,0.001929878,0.0001269537,0.00058312115,0.00008677806,0.0003098073,0.000021964814,0.000009495673,0.023281403],"genre_scores_gemma":[0.996894,0.00027211368,0.00013467338,0.00018832841,0.0002802843,0.000315262,0.000034243618,0.000026891297,0.0018542226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985574,0.00017636566,0.00017120446,0.00037116182,0.00027848443,0.00044538456],"domain_scores_gemma":[0.9992667,0.00006482372,0.00003655901,0.00038306776,0.00015181302,0.000097048505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009611286,0.00011074263,0.000115088566,0.00011157076,0.00013375556,0.0000446189,0.00030503699,0.00014850027,0.0001391175],"category_scores_gemma":[0.0001429244,0.00010805785,0.000043453172,0.0002879536,0.00015338993,0.0000054538614,0.00008205863,0.00026335023,0.000059059425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116666204,0.000053324664,0.0018450951,0.000058823873,0.000016984319,0.0000047015806,0.0002462177,0.000025703954,0.98174727,0.000776679,0.0012415673,0.013866947],"study_design_scores_gemma":[0.0008742038,0.00012235681,0.048698373,0.00009559063,0.000002943938,0.0000016231165,0.00013653503,0.000025275835,0.855187,0.0028595575,0.09176665,0.00022986578],"about_ca_topic_score_codex":0.00022756252,"about_ca_topic_score_gemma":0.0012833007,"teacher_disagreement_score":0.12656026,"about_ca_system_score_codex":0.00007500994,"about_ca_system_score_gemma":0.00027871068,"threshold_uncertainty_score":0.44064713},"labels":[],"label_agreement":null},{"id":"W1598759982","doi":"10.1158/1538-7445.sabcs14-p4-05-17","title":"Abstract P4-05-17: Mammaglobin is a potent regulator of breast cancer processes leading to disease progression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Breast cancer; Cancer; Medicine; Malignancy; Cancer research; Metastasis; Regulator; Tumor progression; Mammaglobin; Focal adhesion; Internal medicine; Oncology; Signal transduction; Biology; Gene; Cell biology","score_opus":0.16264150047594692,"score_gpt":0.45962515725675845,"score_spread":0.2969836567808115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598759982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723945,0.0136687495,0.0000030365447,0.0109388195,0.00013175637,0.0009818629,0.00034747546,0.000028954359,0.0015048418],"genre_scores_gemma":[0.9945932,0.00065595855,0.00007303285,0.00027817555,0.00046998044,0.0006219702,0.000008720793,0.000036400157,0.0032625669],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970294,0.00006066232,0.00031650523,0.00047647,0.0015262954,0.00059062784],"domain_scores_gemma":[0.9964897,0.000044616896,0.0000818552,0.00042870574,0.0020216336,0.00093347585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082186115,0.00018381097,0.00042215417,0.00024919573,0.00013226843,0.000027940081,0.00017637631,0.000051820407,0.00051164825],"category_scores_gemma":[0.00030594575,0.00013228931,0.00008692304,0.0008539133,0.00021267691,0.000102397906,0.00020520498,0.0002680603,0.00004329919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009068603,0.00093558274,0.199842,0.007638577,0.00044579798,0.0005603544,0.004147643,0.00006177997,0.11494361,0.00012483151,0.5290439,0.13318728],"study_design_scores_gemma":[0.0032923198,0.00074550457,0.7534569,0.0067707147,0.00023578573,0.00005298706,0.002258919,0.000019594692,0.16446541,0.00012420995,0.06807138,0.0005062693],"about_ca_topic_score_codex":0.0007071059,"about_ca_topic_score_gemma":0.0000978348,"teacher_disagreement_score":0.5536149,"about_ca_system_score_codex":0.00043435616,"about_ca_system_score_gemma":0.0020865018,"threshold_uncertainty_score":0.560219},"labels":[],"label_agreement":null},{"id":"W1599658625","doi":"10.1158/1538-7445.sabcs14-p2-05-01","title":"Abstract P2-05-01: The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Biology; H3K4me3; Long non-coding RNA; Transcriptome; Cancer research; Epigenetics; RNA; Breast cancer; Hypoxia (environmental); Downregulation and upregulation; microRNA; Gene; Cell biology; Gene expression; Cancer; Genetics; Promoter; Chemistry","score_opus":0.10465819298479966,"score_gpt":0.40674585824479,"score_spread":0.3020876652599903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599658625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98387927,0.0044595925,0.008393234,0.0006771243,0.0005466529,0.0010460903,0.00013727063,0.000010300183,0.00085048226],"genre_scores_gemma":[0.99312645,0.005582248,0.00015537141,0.00006451123,0.0005516548,0.00020648215,0.000024604982,0.00008703478,0.00020165542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951964,0.00032335578,0.0011643509,0.0008591288,0.0014660341,0.0009907328],"domain_scores_gemma":[0.99724865,0.00021787899,0.0002972766,0.0008121011,0.0010406988,0.00038339137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004104249,0.00031149935,0.0006557802,0.00041269508,0.00014875628,0.00005307811,0.0011527567,0.0004791527,0.00007299296],"category_scores_gemma":[0.0004120416,0.0002573226,0.00029360695,0.0010475446,0.00059775764,0.000028036686,0.00038268944,0.0014361837,0.000006769499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011673233,0.00021635565,0.0002554261,0.00024181115,0.00017774157,0.00003573738,0.00045435224,0.0026376976,0.9870996,0.000053261887,0.00061236613,0.0070483596],"study_design_scores_gemma":[0.0033695323,0.00042906104,0.00921128,0.00082409783,0.00003181803,0.000018746969,0.00055911933,0.0021507584,0.98199254,0.00009020777,0.0009820717,0.0003407387],"about_ca_topic_score_codex":0.0034061754,"about_ca_topic_score_gemma":0.0017639585,"teacher_disagreement_score":0.009247184,"about_ca_system_score_codex":0.00030163515,"about_ca_system_score_gemma":0.0024975436,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W1600622480","doi":"10.1158/1538-7445.am2014-3575","title":"Abstract 3575: The OncoNetwork Consortium: A global collaborative research study on the development and verification of an Ion AmpliSeq RNA gene lung fusion panel","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"ROS1; Fusion gene; Carcinogenesis; RNA; RNA extraction; Cancer research; Lung cancer; Biology; Cancer; Gene; Molecular biology; Computational biology; Oncology; Adenocarcinoma; Medicine; Genetics","score_opus":0.13171677221677097,"score_gpt":0.4320652854630428,"score_spread":0.3003485132462718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600622480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960264,0.00091437914,0.00010497726,0.00077668217,0.000060772647,0.00096268667,0.000023291628,0.000004041828,0.0011267564],"genre_scores_gemma":[0.9984435,0.00047497923,0.000050232306,0.00004516022,0.00022025833,0.0006054602,0.000029274934,0.000011886168,0.00011928806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99767125,0.00078457064,0.00022868635,0.00040429702,0.0006081022,0.00030306962],"domain_scores_gemma":[0.9982406,0.00013340043,0.00007783288,0.00064138556,0.0008249158,0.00008189959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037048713,0.00010145864,0.00010629746,0.00004305958,0.00065671204,0.00007886693,0.00038708805,0.00008300366,0.00002380766],"category_scores_gemma":[0.0001648938,0.0000624976,0.000018263258,0.00047787384,0.00039434436,0.0000064818496,0.00014270465,0.00025806704,0.0000047180565],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081216183,0.0004059845,0.005054554,0.000029450148,0.00010818343,0.0000010215896,0.002239306,0.00027462697,0.94369835,0.001397365,0.0041076834,0.041871317],"study_design_scores_gemma":[0.0010689237,0.0011390365,0.4860716,0.00007917091,0.000015532707,0.000001520657,0.009763881,0.000259089,0.46593907,0.00032552407,0.0350933,0.00024336568],"about_ca_topic_score_codex":0.00022607659,"about_ca_topic_score_gemma":0.00040437176,"teacher_disagreement_score":0.48101702,"about_ca_system_score_codex":0.0001301009,"about_ca_system_score_gemma":0.0005459345,"threshold_uncertainty_score":0.50509644},"labels":[],"label_agreement":null},{"id":"W1602439496","doi":"","title":"NSC101612 potently inhibits tumor cell growth and is a topoisomerase IIα catalytic inhibitor.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Topoisomerase; Chinese hamster ovary cell; Molecular biology; DNA; Dithiothreitol; Biochemistry; Growth inhibition; Glutathione; K562 cells; DNA damage; Chemistry; Cell culture; PBR322; Cell growth; Biology; Apoptosis; Enzyme; Plasmid","score_opus":0.021412915548453912,"score_gpt":0.31208485571311095,"score_spread":0.29067194016465703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602439496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634726,0.0098945405,0.00006610073,0.0008477155,0.00014679848,0.00031625235,0.0000900649,0.000012222165,0.00227906],"genre_scores_gemma":[0.9932837,0.001449663,0.00006145083,0.00064469274,0.00068341306,0.00012079323,0.000047085196,0.00004261844,0.0036666116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983387,0.000056675504,0.00018417547,0.00053329737,0.00034674106,0.0005404243],"domain_scores_gemma":[0.9992615,0.000013627105,0.000043094686,0.00032343884,0.00020005165,0.00015829178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026699778,0.00016945522,0.00014957221,0.00010895094,0.00019125882,0.000080268284,0.00018759858,0.00010924875,0.00005770198],"category_scores_gemma":[0.000013188759,0.00016253702,0.00006313093,0.00022448732,0.00016171075,0.000007002915,0.00022064616,0.00022610693,0.000018978175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010237906,0.00006554495,0.00028735976,0.00007311916,0.000016564523,0.000012142295,0.00006581368,0.0000022419927,0.99165267,0.00025691505,0.0060250037,0.0014402326],"study_design_scores_gemma":[0.0008343421,0.00023991177,0.00018495508,0.000026845004,0.000011107668,0.000012217267,0.00008292588,0.000009812047,0.9517577,0.0008228176,0.045817584,0.00019977846],"about_ca_topic_score_codex":0.0011871442,"about_ca_topic_score_gemma":0.00022978437,"teacher_disagreement_score":0.03989498,"about_ca_system_score_codex":0.00005885844,"about_ca_system_score_gemma":0.0002565393,"threshold_uncertainty_score":0.66280675},"labels":[],"label_agreement":null},{"id":"W1602810241","doi":"","title":"Colon cancer chemopreventive properties of β-Escin, a triterpene saponin constituent of Aesculus hippocastanum","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Azoxymethane; Aberrant crypt foci; Medicine; Traditional medicine; Aesculus hippocastanum; Apoptosis; Limonin; Colorectal cancer; Perilla; Cancer; Pharmacology; Internal medicine; Chemistry; Food science; Botany; Biology; Biochemistry","score_opus":0.06193321961214754,"score_gpt":0.3662948354223552,"score_spread":0.30436161581020765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602810241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701616,0.027604105,0.000007257542,0.0012116742,0.00009374922,0.00039398848,0.000087216875,0.0000035809817,0.0004367927],"genre_scores_gemma":[0.9935054,0.0032366158,0.000088152156,0.000040538907,0.00026793277,0.00012985163,0.0000063539114,0.000015480222,0.0027096656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985942,0.0001501356,0.0002485976,0.00032330074,0.0003559969,0.00032774155],"domain_scores_gemma":[0.9990413,0.0000182659,0.00009482721,0.0003010013,0.0004781832,0.00006638257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005232455,0.00011963768,0.00024554282,0.00008280084,0.000073800926,0.000011268547,0.0002482275,0.00010901704,0.00016215382],"category_scores_gemma":[0.00013491642,0.00009526696,0.00009603618,0.00019667878,0.00053705304,0.000008752276,0.0001732203,0.0001719181,0.0000021493663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000678727,0.000103985316,0.0002300763,0.00015021644,0.000106233536,9.795549e-7,0.00018682607,0.000032916712,0.9722984,0.000031126354,0.0023148996,0.023865635],"study_design_scores_gemma":[0.0004369276,0.0001785201,0.00010685106,0.00016181408,0.000014414778,0.0000024004862,0.00028587948,0.000020221674,0.97897893,0.000013647188,0.019690963,0.00010944315],"about_ca_topic_score_codex":0.0009125651,"about_ca_topic_score_gemma":0.00048259826,"teacher_disagreement_score":0.024367489,"about_ca_system_score_codex":0.00009821392,"about_ca_system_score_gemma":0.00044117295,"threshold_uncertainty_score":0.3884874},"labels":[],"label_agreement":null},{"id":"W1602852817","doi":"10.1158/1538-7445.am2014-3895","title":"Abstract 3895: Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Cell biology; Biology; PI3K/AKT/mTOR pathway; Senescence; Cancer cell; Cancer research; Cell cycle; Signal transduction; Cell; Cancer; Genetics","score_opus":0.04364875536596474,"score_gpt":0.31197097774244864,"score_spread":0.2683222223764839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602852817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807453,0.0003126387,0.00036059262,0.00004588996,0.000045341094,0.0004265001,0.00006996942,0.0000026788175,0.00066186173],"genre_scores_gemma":[0.99940866,0.000042042728,0.00014171636,0.0000035451346,0.000084915555,0.00006632615,0.000031813375,0.00001287926,0.00020808811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988632,0.00015929135,0.00020797664,0.00024044809,0.0003340411,0.00019502421],"domain_scores_gemma":[0.99906874,0.00002955561,0.00018989788,0.0004052647,0.0002654069,0.000041133055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007466494,0.000076285774,0.00013813883,0.000041083742,0.000056305435,0.000008029396,0.00018103216,0.00007924462,0.000034298315],"category_scores_gemma":[0.000108612985,0.00005972952,0.00007409302,0.00014260109,0.00018302273,0.000005523876,0.000097129065,0.00014987797,8.6811605e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010642197,0.00011549257,0.00035044993,0.00021005337,0.000008981979,2.3247364e-7,0.000045836598,0.00001162397,0.99547976,0.000035924855,0.0007196013,0.0029156224],"study_design_scores_gemma":[0.00030515663,0.00023092172,0.0017100828,0.000066480214,0.000003852468,4.1932392e-7,0.000046209967,0.000007267803,0.9940598,0.000039255345,0.0034732693,0.000057283894],"about_ca_topic_score_codex":0.0002872117,"about_ca_topic_score_gemma":0.000031024225,"teacher_disagreement_score":0.0028583384,"about_ca_system_score_codex":0.000019886553,"about_ca_system_score_gemma":0.00012309398,"threshold_uncertainty_score":0.24356991},"labels":[],"label_agreement":null},{"id":"W1603897512","doi":"","title":"Verification of high-risk patterns of allelic loss in prediction of cancer progression of primary oral premalignant lesions (OPLs) in a longitudinal study","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biopsy; Loss of heterozygosity; Dysplasia; Cancer; Medicine; OPLS; Prospective cohort study; Pathology; Internal medicine; Allele; Biology; Genetics","score_opus":0.13151942543155093,"score_gpt":0.4659005214784222,"score_spread":0.3343810960468713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603897512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965681,0.0015089291,0.000022168855,0.00004014426,0.000099546334,0.001227308,0.0005053355,0.000005892565,0.000022563108],"genre_scores_gemma":[0.99864346,0.00062020123,0.000054545475,8.043306e-7,0.00002678265,0.0005297505,0.00004287829,0.000011736828,0.00006982757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975014,0.000609671,0.00072702125,0.00030608167,0.0005820099,0.00027382086],"domain_scores_gemma":[0.9988853,0.00010718565,0.00033607407,0.00032917035,0.0003069921,0.000035286903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010673918,0.00009866551,0.0003941804,0.00034970636,0.000042669817,0.0000021174997,0.0001575052,0.00012388782,0.00007387992],"category_scores_gemma":[0.000031873435,0.00008304813,0.00004050213,0.00051488227,0.00016861153,0.00007869516,0.000086895954,0.00028538602,0.0000014109855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000835359,0.002487678,0.9829985,0.00076406717,0.000030143903,0.000045703862,0.0005001195,0.00026762826,0.004919413,0.000098078104,0.000027368853,0.007025955],"study_design_scores_gemma":[0.002202241,0.00078738306,0.9705813,0.0006786803,0.000025982943,0.0000013765875,0.00020029282,0.000026588015,0.025300642,0.00014817028,0.000004182825,0.000043181546],"about_ca_topic_score_codex":0.09920206,"about_ca_topic_score_gemma":0.05333259,"teacher_disagreement_score":0.04586947,"about_ca_system_score_codex":0.00035517736,"about_ca_system_score_gemma":0.00036293096,"threshold_uncertainty_score":0.96394163},"labels":[],"label_agreement":null},{"id":"W1606039500","doi":"10.1158/1538-7445.am2015-ct104","title":"Abstract CT104: Efficacy of pembrolizumab (MK-3475) and relationship with PD-L1 expression in patients with non-small cell lung cancer: Findings from KEYNOTE-001)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Lung cancer; Oncology; Cancer; Response Evaluation Criteria in Solid Tumors; Clinical trial; Disease; Progressive disease; Immunotherapy","score_opus":0.04928253500601571,"score_gpt":0.3471469764546767,"score_spread":0.297864441448661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606039500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460644,0.0031526282,0.00000854816,0.00032551732,0.000067883615,0.0010769974,0.00007951768,0.000016376809,0.0006660758],"genre_scores_gemma":[0.9985575,0.00038582322,0.00017828445,0.000054097563,0.00008111875,0.00016427625,0.000073302486,0.000046208337,0.00045940012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782026,0.00008507463,0.00031967775,0.00045657405,0.00085975364,0.00045868207],"domain_scores_gemma":[0.9985372,0.0002924233,0.00011686132,0.0003876539,0.00041512915,0.00025077807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049793505,0.00019760503,0.000355702,0.00031000556,0.000101869875,0.00003557483,0.00017255041,0.00015044278,0.00021475542],"category_scores_gemma":[0.00006496844,0.00014068186,0.00003392468,0.00057162845,0.0002675716,0.00015208218,0.000066424174,0.00062485907,0.0000038154235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040184468,0.00036829183,0.93858826,0.00028167482,0.00006849843,0.000016556662,0.0021462082,0.000058578065,0.013321681,0.0000010890795,0.0030737887,0.0018909018],"study_design_scores_gemma":[0.027315494,0.00073730975,0.9494702,0.0019000282,0.0000393411,8.2825665e-7,0.0003710213,0.000034198965,0.019317755,0.000007924701,0.00062692125,0.00017892524],"about_ca_topic_score_codex":0.0113692675,"about_ca_topic_score_gemma":0.0010590628,"teacher_disagreement_score":0.012868975,"about_ca_system_score_codex":0.0006071133,"about_ca_system_score_gemma":0.000966627,"threshold_uncertainty_score":0.9952141},"labels":[],"label_agreement":null},{"id":"W1606649881","doi":"10.1158/1538-7445.sabcs14-p5-21-09","title":"Abstract P5-21-09: Oncologist treatment choices in patients with early stage invasive lobular breast carcinoma - a survey","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiation oncologist; Breast cancer; Invasive lobular carcinoma; Radiation therapy; Specialty; Mastectomy; Stage (stratigraphy); Systemic therapy; Oncology; Cancer; Radiology; Internal medicine; Invasive ductal carcinoma; Family medicine","score_opus":0.08785284789739845,"score_gpt":0.3667952214305912,"score_spread":0.27894237353319273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606649881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634093,0.0011358031,0.0000011473765,0.00017608424,0.00008030695,0.0006738175,0.00083053345,0.000010403587,0.0007509731],"genre_scores_gemma":[0.9979279,0.00023372006,0.000022503362,0.000032885328,0.00015464851,0.0004905905,0.00037302927,0.000039588667,0.0007251503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976764,0.00026729712,0.00020694346,0.0006497184,0.00054168084,0.0006580149],"domain_scores_gemma":[0.9984373,0.000081156395,0.0000815599,0.0004840203,0.00067166256,0.00024429095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047404532,0.00026677473,0.00029289533,0.00012793385,0.00012195134,0.00005874101,0.0002843936,0.00013549227,0.00003992421],"category_scores_gemma":[0.00010607087,0.0002003186,0.000045901314,0.00032520053,0.0003499303,0.000015749769,0.00018586522,0.00018376984,0.000029314544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024766466,0.0005041186,0.9932301,0.000021735417,0.00016678727,0.000038819195,0.0002875748,0.00006376091,0.00055956177,0.00000246338,0.000792537,0.001855863],"study_design_scores_gemma":[0.004987609,0.0014668016,0.9854949,0.000037816822,0.00001184874,0.000001623861,0.00020199896,4.2973156e-7,0.005208774,0.000004292557,0.0023694425,0.00021443034],"about_ca_topic_score_codex":0.069569275,"about_ca_topic_score_gemma":0.07386672,"teacher_disagreement_score":0.0077352007,"about_ca_system_score_codex":0.00097157224,"about_ca_system_score_gemma":0.0011840205,"threshold_uncertainty_score":0.9430328},"labels":[],"label_agreement":null},{"id":"W1607477907","doi":"10.1158/1538-7445.sabcs14-p1-11-10","title":"Abstract P1-11-10: Young women with breast cancer: Needs and experiences","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Psychosocial; Breast cancer; Focus group; Medicine; Family medicine; Mastectomy; Information needs; Qualitative research; Fertility preservation; Cancer; Gynecology; Human sexuality; Fertility; Gerontology; Population; Psychiatry; Internal medicine","score_opus":0.09799947839965391,"score_gpt":0.41487484271466535,"score_spread":0.31687536431501145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607477907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676257,0.00093486055,0.0000010847341,0.0026527045,0.00038469158,0.00030417586,0.00003611509,0.000057473135,0.028003244],"genre_scores_gemma":[0.9913245,0.00042525836,0.000013938837,0.00007365259,0.0005477397,0.0011342668,0.0000013376576,0.000022268201,0.0064570457],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99670315,0.00018524776,0.00015515999,0.00034580316,0.0015919582,0.0010186573],"domain_scores_gemma":[0.9983209,0.00013867742,0.000050776627,0.00023765142,0.0005692277,0.00068278355],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002243894,0.00013094874,0.00019224308,0.00020475236,0.00069366506,0.000301651,0.00051654427,0.000104154504,0.0031649529],"category_scores_gemma":[0.00011376694,0.00010513243,0.000014368603,0.0011515629,0.0017986493,0.0005506516,0.00012583853,0.00028388153,0.00003554132],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005129713,0.00007633719,0.17746553,0.00006011156,0.000046230787,0.00006181351,0.7361193,0.000019926618,0.00030202218,0.0011658556,0.05586026,0.028309664],"study_design_scores_gemma":[0.0005318528,0.000087420194,0.03865054,0.00009240749,0.000003780409,0.000006577735,0.8350009,0.0000051418115,0.00022656584,0.00022102895,0.12488729,0.00028649694],"about_ca_topic_score_codex":0.09874843,"about_ca_topic_score_gemma":0.028753266,"teacher_disagreement_score":0.13881499,"about_ca_system_score_codex":0.000972392,"about_ca_system_score_gemma":0.0025631962,"threshold_uncertainty_score":0.9977463},"labels":[],"label_agreement":null},{"id":"W1607488740","doi":"10.1158/1538-7445.am2014-4102","title":"Abstract 4102: p27 as a biomarker and determinant of risk for endometrial carcinoma arising in the setting of obesity","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Endometrial cancer; Medicine; Endometrial hyperplasia; Leptin; Internal medicine; Endocrinology; Adiponectin; Obesity; Carcinoma; Adipokine; Hyperplasia; Weight loss; Cancer; Oncology; Insulin resistance","score_opus":0.11781204302561513,"score_gpt":0.4242108390494647,"score_spread":0.30639879602384956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607488740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954599,0.002928068,0.000024293924,0.00020831554,0.000055671113,0.00063751364,0.000051311465,0.0000021670428,0.00063274463],"genre_scores_gemma":[0.99929386,0.00031853846,0.00014038973,0.00001608282,0.00013220342,0.00007503266,0.0000025291636,0.0000098344535,0.000011541942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984189,0.00027106967,0.0003193867,0.00021438282,0.00047944815,0.00029676704],"domain_scores_gemma":[0.9971626,0.0021373723,0.00012086547,0.00025334518,0.00027104563,0.000054778113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00555804,0.00008688308,0.00038157322,0.00029131008,0.00012259437,0.000013249572,0.00010208986,0.00004700661,0.000032930107],"category_scores_gemma":[0.00297375,0.00005476963,0.00009006824,0.0004159358,0.00021333943,0.000030201289,0.000081396145,0.00023242952,6.3453894e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017134788,0.00016379413,0.7628456,0.001151603,0.000085267224,0.000023145492,0.003185546,6.609243e-7,0.050812934,0.00017639289,0.00060887827,0.17923272],"study_design_scores_gemma":[0.0025863664,0.00034022878,0.9662173,0.00019125626,0.000059941347,0.0000116281435,0.0015794885,0.000121435885,0.028018871,0.00023323105,0.0005851353,0.000055141103],"about_ca_topic_score_codex":0.0033798027,"about_ca_topic_score_gemma":0.00040478178,"teacher_disagreement_score":0.20337169,"about_ca_system_score_codex":0.000043027914,"about_ca_system_score_gemma":0.00012443264,"threshold_uncertainty_score":0.5109273},"labels":[],"label_agreement":null},{"id":"W1607532916","doi":"10.1158/1538-7445.sabcs14-ot1-4-01","title":"Abstract OT1-4-01: HIOB trial - Hypofractionated whole-breast irradiation preceded by intraoperative radiotherapy with electrons as anticipated boost","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cosmesis; Breast cancer; Radiation therapy; Nuclear medicine; Cancer; Breast-conserving surgery; Dose fractionation; Oncology; Internal medicine; Mastectomy; Surgery","score_opus":0.05273043285248219,"score_gpt":0.39399491967224803,"score_spread":0.34126448681976584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607532916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896737,0.003288616,0.000040741663,0.0045910953,0.00017646077,0.0009741615,0.00024741917,0.000036984726,0.0009708556],"genre_scores_gemma":[0.99584746,0.0007999591,0.00004463708,0.00018159844,0.0006308233,0.0007815516,0.0006051095,0.000056187673,0.0010526611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978475,0.0002276879,0.00020785979,0.00057316624,0.00054013776,0.00060365675],"domain_scores_gemma":[0.9987391,0.000047975496,0.000086280364,0.0003164922,0.0005822299,0.0002278744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003949466,0.00024474793,0.00024223576,0.000103360915,0.00022099062,0.00008631837,0.00020196615,0.00016828168,0.00015238642],"category_scores_gemma":[0.00008499701,0.00019942583,0.000048081158,0.00035541644,0.000256129,0.000031150743,0.00004487573,0.00033680495,0.00003612329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07122795,0.00060503924,0.0015565897,0.000016893817,0.0010704302,0.0000122570045,0.00069796114,0.00020886827,0.83452356,0.000035625857,0.08301909,0.007025718],"study_design_scores_gemma":[0.097211085,0.00638242,0.02501739,0.00011432364,0.00011251354,0.00010582457,0.0011114407,0.000071683906,0.6680791,0.0000976951,0.20063905,0.0010574668],"about_ca_topic_score_codex":0.0024116405,"about_ca_topic_score_gemma":0.0006001838,"teacher_disagreement_score":0.16644448,"about_ca_system_score_codex":0.0005751286,"about_ca_system_score_gemma":0.0011238625,"threshold_uncertainty_score":0.813235},"labels":[],"label_agreement":null},{"id":"W1608094756","doi":"10.1158/1538-7445.am2014-4422","title":"Abstract 4422: A Hippo-independent pathway modulates YAP-induced resistance of cancer cells to antitubulin drugs","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hippo signaling pathway; Cancer; Carcinogenesis; Biology; Cancer research; Drug resistance; Cancer cell; Transactivation; Signal transduction; Cell biology; Transcription factor; Gene; Genetics","score_opus":0.03592158821545235,"score_gpt":0.3518294396311489,"score_spread":0.31590785141569655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608094756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995504,0.0016746493,0.000082569444,0.00041674092,0.00027127351,0.00038723456,0.00013258435,0.000018604847,0.0015123211],"genre_scores_gemma":[0.99571466,0.0004220604,0.00014295372,0.00013611812,0.00052393816,0.00019673703,0.000022331586,0.00005351393,0.0027876724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973479,0.00015701342,0.00036513107,0.0007103166,0.00071413873,0.00070553104],"domain_scores_gemma":[0.99825203,0.00006650057,0.000103152815,0.00071457657,0.0005656139,0.0002981203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013780132,0.00022028609,0.0002989252,0.0001605717,0.00016926712,0.00004814581,0.00056567375,0.00024046264,0.00019068172],"category_scores_gemma":[0.00014746713,0.00020796222,0.000121325254,0.0003355508,0.00012169396,0.0000066047264,0.00019163942,0.00036407504,0.0000637646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024113285,0.00006809956,0.0003665965,0.00013237666,0.000048399455,0.0000042701204,0.00028449358,0.0005212007,0.9914555,0.000058281883,0.0010495882,0.005770088],"study_design_scores_gemma":[0.00046102537,0.00018203299,0.0011215602,0.00019126594,0.000006541555,3.3550674e-7,0.000092017835,0.000025635918,0.9658937,0.00011274203,0.031668764,0.0002443704],"about_ca_topic_score_codex":0.001483659,"about_ca_topic_score_gemma":0.0012641727,"teacher_disagreement_score":0.030619176,"about_ca_system_score_codex":0.00009351183,"about_ca_system_score_gemma":0.00053094194,"threshold_uncertainty_score":0.84804535},"labels":[],"label_agreement":null},{"id":"W1608335223","doi":"","title":"Tat-immunoconjugates specifically inhibit the function of nuclear p21WAF-1/CIP-1 and differentially sensitize human breast cancer cells to antiproliferative agents","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Camptothecin; Cell cycle; Cell growth; Biology; Flow cytometry; Growth inhibition; Cancer cell; Cancer research; Epidermal growth factor; Molecular biology; Cell biology; Cell; Chemistry; Cancer; Receptor; Biochemistry","score_opus":0.03885515179803165,"score_gpt":0.337588676832293,"score_spread":0.2987335250342613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608335223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924431,0.0010375667,0.00005498074,0.0031733012,0.00024117496,0.0014102872,0.00020466936,0.000043626576,0.0013912981],"genre_scores_gemma":[0.99717706,0.0004490631,0.000033946664,0.00034954867,0.0005581683,0.00012715811,0.000025268891,0.00007645295,0.0012033138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973043,0.0002503295,0.00041192985,0.0005408346,0.0009055932,0.00058698835],"domain_scores_gemma":[0.9983373,0.000074537165,0.00010229921,0.00050632184,0.00077586214,0.00020365149],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005053018,0.00023294809,0.00039962548,0.00024761326,0.00037445498,0.00009803094,0.00017663732,0.00014681878,0.0009514655],"category_scores_gemma":[0.00002605356,0.00017669253,0.0001051216,0.000585031,0.000507705,0.00007267486,0.0002087703,0.0007090555,0.00004790831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00126651,0.00013799669,0.0011680551,0.0001178056,0.00016004899,0.000037980935,0.00057421834,0.00008659086,0.97678894,0.0005911288,0.016350213,0.002720518],"study_design_scores_gemma":[0.0044955756,0.0010749442,0.2982038,0.0011355005,0.00024156737,0.00005793972,0.0006820235,0.00018500008,0.675833,0.00035050913,0.017270014,0.00047012966],"about_ca_topic_score_codex":0.0038885525,"about_ca_topic_score_gemma":0.0008416198,"teacher_disagreement_score":0.30095595,"about_ca_system_score_codex":0.0003729421,"about_ca_system_score_gemma":0.00029449575,"threshold_uncertainty_score":0.9999618},"labels":[],"label_agreement":null},{"id":"W1610547722","doi":"","title":"Relationship of intracellular glutathione concentrations with the cytotoxicity of cisplatin, acetaminophen and arsenic in tumor cell lines","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cisplatin; Cytotoxicity; Clonogenic assay; Glutathione; Cytotoxic T cell; Cell culture; Acetaminophen; Chemistry; Pharmacology; Intracellular; A549 cell; Toxicology; Cell; Biochemistry; In vitro; Biology; Chemotherapy; Enzyme; Genetics","score_opus":0.031450414619498046,"score_gpt":0.31480668790284444,"score_spread":0.2833562732833464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1610547722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942861,0.004058436,0.00024410934,0.000953187,0.000009012485,0.0002751421,0.000036338202,0.000001799406,0.00013586372],"genre_scores_gemma":[0.9990251,0.0003682479,0.0002226528,0.000033175605,0.00006434048,0.000043173648,0.000013916648,0.000009805507,0.00021956705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915797,0.00012797999,0.00018289645,0.00016647507,0.000183222,0.0001814648],"domain_scores_gemma":[0.9994849,0.000090184694,0.0000463497,0.0001937953,0.00014023333,0.000044519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038169656,0.00007306248,0.00011033511,0.00004912856,0.00007320847,0.00000806458,0.00011601684,0.000055235956,0.00002539086],"category_scores_gemma":[0.00003733005,0.000051814448,0.000024725014,0.00020148206,0.0003294984,0.0000058593673,0.000031606636,0.00019191456,0.0000010237325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016849762,0.000058827136,0.017776135,0.000045266454,0.000010147726,0.0000017137992,0.0004147379,0.0009609045,0.9798142,0.00039937824,0.00010565521,0.00024454028],"study_design_scores_gemma":[0.0007723128,0.00023884478,0.028717995,0.000031764106,0.000011445173,0.0000050422964,0.00027324967,0.0002181879,0.96905816,0.00003610384,0.0005626308,0.000074285614],"about_ca_topic_score_codex":0.000147956,"about_ca_topic_score_gemma":0.0007460377,"teacher_disagreement_score":0.010941859,"about_ca_system_score_codex":0.000014052627,"about_ca_system_score_gemma":0.00018019897,"threshold_uncertainty_score":0.21129319},"labels":[],"label_agreement":null},{"id":"W1618401680","doi":"10.1158/1538-7445.sabcs14-p3-08-04","title":"Abstract P3-08-04: Aspirin and breast cancer risk for <i>BRCA1</i> and <i>BRCA2</i> mutation carriers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aspirin; Medicine; Odds ratio; Breast cancer; Internal medicine; Confidence interval; Cancer; Oncology","score_opus":0.029256137918354467,"score_gpt":0.3572949319640684,"score_spread":0.32803879404571396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1618401680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772174,0.020897316,0.00004213735,0.0005600636,0.00014951105,0.00049744785,0.00028220046,0.000011500913,0.000342462],"genre_scores_gemma":[0.99335116,0.0053594625,0.000086930064,0.00009345827,0.00037289946,0.0003008246,0.00006274589,0.0000340121,0.00033853095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987205,0.00009012388,0.00013312392,0.00042156992,0.00022897215,0.00040567716],"domain_scores_gemma":[0.99909425,0.00004156976,0.000052694282,0.00019067815,0.0002978358,0.00032294763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069709163,0.00013953146,0.00013637834,0.000060901522,0.00019049173,0.000061043946,0.00010997427,0.0002131175,0.00000927649],"category_scores_gemma":[0.000078261415,0.000121343866,0.000040307787,0.000119413475,0.00025282727,0.000010705002,0.0000923007,0.00027720348,0.0000041371877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021979157,0.00007870349,0.01960162,0.00030521848,0.00045910038,0.000026534502,0.00073040416,0.00037029866,0.8191525,0.000079879916,0.037119742,0.119878076],"study_design_scores_gemma":[0.0134612825,0.0026034801,0.03573118,0.00033952686,0.00023199605,0.00023037299,0.0018186151,0.0008450737,0.80811083,0.001409633,0.13387533,0.0013426541],"about_ca_topic_score_codex":0.00093318487,"about_ca_topic_score_gemma":0.00019159752,"teacher_disagreement_score":0.11853542,"about_ca_system_score_codex":0.000067585424,"about_ca_system_score_gemma":0.00035531863,"threshold_uncertainty_score":0.4948259},"labels":[],"label_agreement":null},{"id":"W1623428497","doi":"10.1158/1538-7445.am2015-3684","title":"Abstract 3684: Nanoparticle-encapsulated piperine and piperlongumine inhibit breast cancer cell growth and metastatic activity","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Piperaceae Chemical and Biological Studies","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Piperine; Breast cancer; Cancer research; In vivo; Chemistry; Cancer cell; Metastasis; Pharmacology; Cancer; Bioavailability; Metastatic breast cancer; In vitro; Medicine; Triple-negative breast cancer; Nanotechnology; Materials science; Internal medicine; Biochemistry; Biology; Biotechnology","score_opus":0.32214649469068185,"score_gpt":0.5052561345454498,"score_spread":0.18310963985476797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1623428497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812728,0.011635311,6.471336e-7,0.0052921884,0.000147422,0.0003372492,0.00021176715,0.000049309656,0.0010533142],"genre_scores_gemma":[0.98995864,0.008755177,0.000014011378,0.00036957726,0.00018933126,0.00020172061,0.0000054539987,0.000015474252,0.0004905879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980243,0.00029793262,0.0002121566,0.00047531913,0.00028190468,0.00070837716],"domain_scores_gemma":[0.99851173,0.00039678268,0.00005375954,0.00010797221,0.000303098,0.0006266461],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008937103,0.00022291265,0.00033415094,0.000046142402,0.0003102145,0.00004230377,0.00016339368,0.00017202612,0.0010139495],"category_scores_gemma":[0.00014848854,0.00015542982,0.00003471378,0.00030433648,0.00087133824,0.00017480638,0.00035392595,0.0008887524,0.000022015121],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009109441,0.00030518734,0.021990044,0.00016093763,0.00009562881,0.00004250465,0.00041796488,0.0000052961086,0.96093655,0.00003270229,0.0023612354,0.012741015],"study_design_scores_gemma":[0.0025889175,0.00020512882,0.047188748,0.000035849618,0.000067866444,0.000027225251,0.00034472553,0.00023918622,0.94278437,0.0004008666,0.0057988227,0.00031829148],"about_ca_topic_score_codex":0.0021801156,"about_ca_topic_score_gemma":0.00024175322,"teacher_disagreement_score":0.025198702,"about_ca_system_score_codex":0.00015347135,"about_ca_system_score_gemma":0.000115134026,"threshold_uncertainty_score":0.99989927},"labels":[],"label_agreement":null},{"id":"W1624802556","doi":"10.1158/1538-7445.sabcs14-p3-07-28","title":"Abstract P3-07-28: Population-based rates of in-situ breast cancer [DCIS] invasive breast cancer [BrINV], and breast cancer [BrCa] mortality [BrMOR] over time. A case for screening mammography? [ScreenMam]","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Cohort; Cancer registry; Breast cancer; Cancer; Population; Demography; Incidence (geometry); Gynecology; Oncology; Internal medicine; Environmental health","score_opus":0.12212850669700545,"score_gpt":0.43434476451333215,"score_spread":0.31221625781632667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1624802556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761783,0.0053637857,0.000025534264,0.0037219261,0.0002955275,0.0023457776,0.011875573,0.000062907835,0.00013067269],"genre_scores_gemma":[0.99432933,0.001788646,0.00009392875,0.00034608334,0.0009991112,0.0018484009,0.00018774465,0.00015432737,0.00025243143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945581,0.00020643583,0.0010009994,0.0012452065,0.0015626227,0.0014266176],"domain_scores_gemma":[0.9952459,0.0004481915,0.00043018739,0.0007930043,0.0019978283,0.0010849093],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014749519,0.00063034106,0.0012315124,0.00093450124,0.0003112945,0.00013735193,0.00035352778,0.000377062,0.002601493],"category_scores_gemma":[0.00010199798,0.0005693563,0.00033058028,0.0016027807,0.00063763966,0.00053316,0.0001880913,0.001021775,0.000006922302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004434349,0.0002758631,0.9449677,0.0011606332,0.00051944447,0.00032257583,0.00045263165,0.0008810913,0.007051423,0.000018375016,0.0051906845,0.03472522],"study_design_scores_gemma":[0.0068085054,0.00015747566,0.9851392,0.0021997627,0.00026641696,0.00030934322,0.0005522604,0.0012229213,0.0023498067,0.00005779693,0.00032393434,0.0006126075],"about_ca_topic_score_codex":0.5312986,"about_ca_topic_score_gemma":0.1976785,"teacher_disagreement_score":0.33362004,"about_ca_system_score_codex":0.0016371233,"about_ca_system_score_gemma":0.0035206648,"threshold_uncertainty_score":0.9996758},"labels":[],"label_agreement":null},{"id":"W1631305180","doi":"10.1158/1538-7445.sabcs14-p6-05-02","title":"Abstract P6-05-02: Expression of ING1b-derived peptide inhibits viability of breast cancer cells and promotes apoptosis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Cancer research; NLS; Nuclear localization sequence; Biology; Molecular biology; Cancer cell; Chromatin; Cell biology; Cancer; Gene; Biochemistry; Genetics","score_opus":0.048738929109735575,"score_gpt":0.3510219115377742,"score_spread":0.3022829824280386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1631305180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979327,0.0009218004,0.000014552319,0.00029418655,0.00007548835,0.00036645183,0.0001455806,0.000005375208,0.00024391542],"genre_scores_gemma":[0.99894464,0.0004536014,0.0001656035,0.00001762314,0.00012765516,0.00009337072,0.000018180644,0.00001573447,0.0001635721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987019,0.00012188657,0.00024888653,0.000319698,0.0003683822,0.00023925134],"domain_scores_gemma":[0.9987781,0.000022524559,0.00010812591,0.00029382377,0.0006359676,0.00016146248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006528496,0.00010812216,0.00017059098,0.00007155543,0.00005070946,0.000014787088,0.00016578246,0.00013113717,0.00007691475],"category_scores_gemma":[0.00015424134,0.00009220072,0.000042595297,0.00015607823,0.00032737662,0.000013030011,0.00021329838,0.00016148314,0.0000015385282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020976948,0.00007441031,0.0024806135,0.00017352583,0.000013141494,1.961755e-7,0.00019366996,0.000012994471,0.9910818,0.000002668906,0.0032500033,0.0025072421],"study_design_scores_gemma":[0.00047265852,0.00013621664,0.004832865,0.00015687743,0.0000035679573,8.425643e-7,0.00017856309,0.0000061557753,0.99319357,0.00004281443,0.0008813849,0.00009451507],"about_ca_topic_score_codex":0.00096474943,"about_ca_topic_score_gemma":0.00007225333,"teacher_disagreement_score":0.0024127269,"about_ca_system_score_codex":0.000047075227,"about_ca_system_score_gemma":0.00036775589,"threshold_uncertainty_score":0.37598363},"labels":[],"label_agreement":null},{"id":"W1631901224","doi":"10.1158/1538-7445.am2015-538","title":"Abstract 538: Identification and validation of novel prostate cancer biomarkers using the Berg Interrogative Biology™ platform","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; FLNA; DU145; Filamin; LNCaP; Cancer; Prostate; Cancer research; PCA3; Prostatectomy; Medicine; Biology; Oncology; Pathology; Internal medicine; Cell; Genetics","score_opus":0.2082572915303301,"score_gpt":0.4786776471918304,"score_spread":0.27042035566150036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1631901224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948228,0.0005005544,0.003166865,0.00049435045,0.000024411771,0.00034867434,0.00019604582,0.000022671074,0.00042361152],"genre_scores_gemma":[0.99721676,0.00039416063,0.0015973176,0.000006347046,0.00005174189,0.00053477567,0.0000331715,0.000014443822,0.0001512891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918354,0.000012359801,0.00021056285,0.00021915502,0.00017210015,0.000202266],"domain_scores_gemma":[0.9990626,0.00007367393,0.00015017042,0.00024180599,0.00041362434,0.000058121397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006228894,0.0000755227,0.00008887438,0.00006111072,0.0001520225,0.000031912154,0.00019564663,0.00007059217,0.00004877727],"category_scores_gemma":[0.0000706219,0.000057798734,0.00001993411,0.00022789,0.00036249444,0.000139675,0.00012198888,0.00022599028,8.670069e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000630002,0.000024990117,0.0015672552,0.00005194951,0.000029327612,8.902466e-8,0.00084008434,0.00012480949,0.99058896,0.0007022849,0.000096534,0.0059107076],"study_design_scores_gemma":[0.0002674061,0.000009699807,0.0001685416,0.00009004754,0.000007758561,9.582315e-7,0.0012887893,0.0009506151,0.9919566,0.004074325,0.0011139307,0.00007132661],"about_ca_topic_score_codex":0.0016459324,"about_ca_topic_score_gemma":0.00008075651,"teacher_disagreement_score":0.005839381,"about_ca_system_score_codex":0.00025911556,"about_ca_system_score_gemma":0.0001814564,"threshold_uncertainty_score":0.24881686},"labels":[],"label_agreement":null},{"id":"W1632475638","doi":"10.1158/1538-7445.am2014-941","title":"Abstract 941: Exome sequencing identified <i>POT1</i>, a telomere shelterin gene, as a major susceptibility gene for familial cutaneous malignant melanoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Exome sequencing; CDKN2A; Exome; Genetics; Biology; Penetrance; Telomere; Shelterin; Telomere-binding protein; Germline mutation; Melanoma; Missense mutation; Mutation; Gene; Cancer research; Phenotype","score_opus":0.0820255016447718,"score_gpt":0.3806213988431563,"score_spread":0.29859589719838453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1632475638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331766,0.0010988239,0.000223198,0.0008489922,0.00063453143,0.0022294966,0.00024258738,0.00017315219,0.0012315781],"genre_scores_gemma":[0.9913432,0.0005164477,0.0011639951,0.00045797904,0.0014461357,0.0006627023,0.000098723656,0.00012766696,0.004183148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943343,0.0002498753,0.0008195065,0.0013998434,0.00149798,0.0016985283],"domain_scores_gemma":[0.9962432,0.00056532334,0.00015344638,0.0013358406,0.00092927366,0.00077295577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021774897,0.00045581974,0.000839349,0.00046743476,0.0005342228,0.00017365465,0.0006368431,0.00032100617,0.0009704782],"category_scores_gemma":[0.00096524623,0.0004055683,0.0003119975,0.0006860102,0.00052015414,0.00019493345,0.00022728703,0.0008301474,0.00032295648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019503752,0.00015560878,0.0054493695,0.0010072823,0.0001292693,0.0005811849,0.00070455443,0.00001648045,0.97145176,0.00014125735,0.0020141308,0.01639874],"study_design_scores_gemma":[0.0041271397,0.0012338178,0.025337886,0.00058552396,0.00012823561,0.000820424,0.00096884475,0.00043439466,0.95128906,0.0013333757,0.0128989285,0.0008423553],"about_ca_topic_score_codex":0.005859538,"about_ca_topic_score_gemma":0.0016408478,"teacher_disagreement_score":0.020162674,"about_ca_system_score_codex":0.0011730585,"about_ca_system_score_gemma":0.0015028676,"threshold_uncertainty_score":0.9999428},"labels":[],"label_agreement":null},{"id":"W1633890482","doi":"10.1158/1538-7445.am2015-2488","title":"Abstract 2488: FGFR4 as a potential therapeutic target for monoclonal antibody based intervention in rhabdomyosarcoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Monoclonal antibody; Alveolar rhabdomyosarcoma; Cancer research; Antibody; Fibroblast growth factor receptor 4; Immunohistochemistry; Embryonal rhabdomyosarcoma; Immunogen; Biology; Cancer; Molecular biology; Medicine; Pathology; Immunology; Rhabdomyosarcoma; Sarcoma; Receptor; Internal medicine; Fibroblast growth factor; Fibroblast growth factor receptor","score_opus":0.07861003281696348,"score_gpt":0.4443510188095365,"score_spread":0.365740985992573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633890482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257743,0.0025010323,0.0025636007,0.0007893859,0.00016587158,0.00091564766,0.0000768326,0.000013106451,0.00039706682],"genre_scores_gemma":[0.99761546,0.000048647762,0.00040372246,0.000055870765,0.0003254276,0.00047552664,0.00031480755,0.00005017662,0.00071036885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997523,0.0002597591,0.00026783854,0.00053071114,0.0006632421,0.00075546],"domain_scores_gemma":[0.99876726,0.000056279638,0.000047743837,0.00037270456,0.0005167975,0.00023919767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017330181,0.00016450451,0.00017440195,0.0002759939,0.00009011692,0.00008568768,0.00047490862,0.0001989068,0.0001958429],"category_scores_gemma":[0.00027878932,0.00015993837,0.00014896582,0.00029056577,0.00019746507,0.000013996523,0.00018348111,0.0003955833,0.00004664966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023283167,0.00022505152,0.00523098,0.00012876239,0.000048243735,0.000016466904,0.000033850418,0.00042539873,0.9836815,0.0000632122,0.0022337087,0.0055845156],"study_design_scores_gemma":[0.0066999164,0.0024465872,0.0231684,0.00015291761,0.000007554997,0.000009819869,0.000258621,0.0025228895,0.92767936,0.002075378,0.034562472,0.0004160558],"about_ca_topic_score_codex":0.0007189298,"about_ca_topic_score_gemma":0.00014153119,"teacher_disagreement_score":0.056002107,"about_ca_system_score_codex":0.00018146819,"about_ca_system_score_gemma":0.0008512963,"threshold_uncertainty_score":0.65220976},"labels":[],"label_agreement":null},{"id":"W1638065039","doi":"10.1158/1538-7445.sabcs14-s5-04","title":"Abstract S5-04: A large prospectively-designed study of the DCIS score: Predicting recurrence risk after local excision for ductal carcinoma in situ patients with and without irradiation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"NOSM University; Kingston General Hospital; Thunder Bay Regional Health Sciences Centre; Health Sciences Centre; London Health Sciences Centre; Health Sciences North; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Hazard ratio; Breast-conserving surgery; Internal medicine; Cohort; Population; Oncology; Breast cancer; Proportional hazards model; Radiation therapy; Urology; Mastectomy; Gynecology; Cancer; Confidence interval","score_opus":0.03527532864524957,"score_gpt":0.33785603890822113,"score_spread":0.30258071026297156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1638065039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735403,0.0008272576,0.000063080326,0.000034452394,0.000052961193,0.0015205012,0.00012492356,0.0000028999807,0.000019867335],"genre_scores_gemma":[0.99900967,0.000033595166,0.000035243447,0.0000045194406,0.000066375964,0.0008127359,0.0000115702705,0.000015861748,0.000010451638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987356,0.00012079366,0.00014802106,0.0003739901,0.00036062056,0.00026093924],"domain_scores_gemma":[0.9991704,0.000030443136,0.000088450455,0.00021761132,0.00043512226,0.000057964735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046379952,0.00011274427,0.00014045661,0.00005317501,0.000114659735,0.000014867672,0.000097301236,0.00005251974,0.0000013451785],"category_scores_gemma":[0.0001628332,0.00007463887,0.000019414903,0.00018603203,0.00014712065,0.000012022314,0.00014710931,0.00013530016,2.2432e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028971524,0.00035093425,0.9917183,0.000028199727,0.000046868736,9.230029e-7,0.002239897,0.000022537639,0.00089131744,8.571574e-7,0.000054506847,0.0017485083],"study_design_scores_gemma":[0.004696418,0.0010727689,0.9884963,0.00006648444,0.000018997333,6.7275386e-7,0.0012762125,0.000021308422,0.0042276024,0.000027611099,0.000015333922,0.000080303],"about_ca_topic_score_codex":0.0010384811,"about_ca_topic_score_gemma":0.0055755493,"teacher_disagreement_score":0.0045370683,"about_ca_system_score_codex":0.00015879479,"about_ca_system_score_gemma":0.00019763701,"threshold_uncertainty_score":0.31112874},"labels":[],"label_agreement":null},{"id":"W1642111304","doi":"10.1158/1538-7445.sabcs14-p3-12-01","title":"Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre hospitalier universitaire de Québec; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Clinical endpoint; Randomized controlled trial; Surgery; Gynecology","score_opus":0.21759885467456136,"score_gpt":0.44223123032071143,"score_spread":0.22463237564615007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1642111304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838251,0.011888993,0.000005281584,0.0002544549,0.00010817521,0.0028278835,0.00015752215,0.000009159021,0.00092341757],"genre_scores_gemma":[0.9953619,0.0040401025,0.00012644049,0.0000677149,0.000109410816,0.00019547963,0.00001824267,0.000029668152,0.000050992054],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995703,0.0008750366,0.0014591919,0.0005144202,0.00096601737,0.00048233249],"domain_scores_gemma":[0.9955835,0.002501334,0.0005599827,0.00054834224,0.00032707772,0.00047981116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005140961,0.00034054273,0.0022879227,0.00040871682,0.000059755737,0.000013342345,0.00020805313,0.00014806293,0.00011089147],"category_scores_gemma":[0.0014050633,0.00022996141,0.00024865067,0.00025799556,0.0010190469,0.00013901407,0.00011238887,0.00040825777,5.1396484e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9018516,0.0008961405,0.022767354,0.00079923525,0.00065647846,0.000027474664,0.011132858,0.00028592383,0.036428835,0.00009501222,0.0008765624,0.024182541],"study_design_scores_gemma":[0.79808104,0.007289468,0.17421716,0.00072130695,0.000218541,0.000011894536,0.002942705,0.00046102286,0.015238483,0.00012876028,0.00036059303,0.00032902395],"about_ca_topic_score_codex":0.046835046,"about_ca_topic_score_gemma":0.002301869,"teacher_disagreement_score":0.15144981,"about_ca_system_score_codex":0.0011909732,"about_ca_system_score_gemma":0.0020570243,"threshold_uncertainty_score":0.9595122},"labels":[],"label_agreement":null},{"id":"W1647140950","doi":"","title":"Metformin mediated AMPK activation inhibits translation initiation in breast cancer cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metformin; AMPK; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1; Protein kinase A; AMP-activated protein kinase; mTORC1; Endocrinology; Cell growth; Cancer research; Internal medicine; Chemistry; Kinase; Signal transduction; Biology; Cell biology; Medicine; Biochemistry; Insulin","score_opus":0.057594142443361036,"score_gpt":0.38332078919944484,"score_spread":0.3257266467560838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1647140950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644841,0.03373979,0.00032329973,0.00018321085,0.0002081715,0.00037521563,0.00008995903,0.0000108964905,0.00058537815],"genre_scores_gemma":[0.955947,0.04262121,0.000051628638,0.00024779004,0.0006388048,0.00019549226,0.00017617435,0.000029002918,0.00009288663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827105,0.00013417358,0.000275839,0.0003610259,0.00044599487,0.00051189197],"domain_scores_gemma":[0.9992396,0.000055817953,0.00006708356,0.00019791382,0.00032719848,0.00011234304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013866189,0.00012888707,0.00014467651,0.00025693848,0.00008368577,0.000028429877,0.00015166934,0.00021212944,0.0002628025],"category_scores_gemma":[0.000046780657,0.0001274411,0.00004389931,0.0006430609,0.00008233307,0.000026109949,0.000034311448,0.0002681936,0.000012379705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002410356,0.00003843817,0.001309394,0.000034440665,0.000016202444,9.3224907e-7,0.0002068813,0.00008069502,0.7977865,0.000019617582,0.0008860379,0.19937985],"study_design_scores_gemma":[0.0008878027,0.00003343942,0.0077347388,0.00005675884,0.000005433729,6.715829e-7,0.00012121388,0.000046235087,0.9316183,0.00006228286,0.059279546,0.00015359891],"about_ca_topic_score_codex":0.00081543304,"about_ca_topic_score_gemma":0.00208409,"teacher_disagreement_score":0.19922625,"about_ca_system_score_codex":0.00017428762,"about_ca_system_score_gemma":0.00035305336,"threshold_uncertainty_score":0.51968974},"labels":[],"label_agreement":null},{"id":"W1647473915","doi":"10.1158/1538-7445.sabcs14-p2-09-01","title":"Abstract P2-09-01: MBC alliance: Coordinating metastatic research from lab bench to clinical trials","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alliance; Clinical trial; Metastatic breast cancer; Medicine; General partnership; Translational research; Breast cancer; Family medicine; Cancer; Political science; Business; Internal medicine; Pathology; Finance","score_opus":0.7263462525258191,"score_gpt":0.6603201260117515,"score_spread":0.06602612651406758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1647473915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94537646,0.01671634,0.0006522832,0.026668271,0.001396635,0.003995407,0.00036263504,0.00017860637,0.004653382],"genre_scores_gemma":[0.977847,0.0010192228,0.008155072,0.00088277005,0.004752304,0.0015863235,0.00007365438,0.00017612854,0.0055075306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.987753,0.0036838353,0.0015917155,0.0012765698,0.0039132135,0.0017816955],"domain_scores_gemma":[0.98482746,0.00826671,0.00023386131,0.0013290159,0.0034938352,0.0018491152],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.047249004,0.0003371663,0.0014970797,0.00051307137,0.00035436387,0.00018394303,0.0008402082,0.00023658789,0.0026171925],"category_scores_gemma":[0.02619841,0.0002802993,0.00025620582,0.0021087932,0.00081483327,0.00031689843,0.00050565676,0.0030343153,0.0013325568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012009952,0.00095328887,0.016626203,0.00042347584,0.001214318,0.0007272527,0.0043383488,0.00027150696,0.06518497,0.0005192628,0.14148292,0.7562485],"study_design_scores_gemma":[0.02424858,0.003628984,0.061276384,0.0033878998,0.00023235021,0.00004176137,0.015758092,0.0002897585,0.04785792,0.020042414,0.8220126,0.0012232317],"about_ca_topic_score_codex":0.0046668835,"about_ca_topic_score_gemma":0.00055789837,"teacher_disagreement_score":0.75502527,"about_ca_system_score_codex":0.0016720549,"about_ca_system_score_gemma":0.003485088,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W1651501803","doi":"","title":"Sulfasalazine: Potential use of an old drug for treatment of pancreatic cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Medicine; In vivo; Sulfasalazine; Pharmacology; Cancer; Cancer research; Internal medicine; Biology","score_opus":0.0700495575133309,"score_gpt":0.3881878349745938,"score_spread":0.3181382774612629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1651501803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538374,0.0022861403,0.00015725264,0.0005019892,0.00015151699,0.0010938421,0.0002981131,0.000018921784,0.00010846968],"genre_scores_gemma":[0.9744079,0.001342336,0.0010435294,0.000014692757,0.00035286386,0.00050000387,0.00010649123,0.000039102724,0.022193093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983993,0.000046613302,0.0003188285,0.00028187252,0.0005431098,0.00041025085],"domain_scores_gemma":[0.99886745,0.000073100404,0.000074505995,0.0003536447,0.0005247292,0.000106581305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022944435,0.00012969875,0.00045128306,0.00019039091,0.000070600225,0.000010583478,0.00009519449,0.000070601425,0.0002771321],"category_scores_gemma":[0.000011540031,0.000097798125,0.00014880816,0.0002930788,0.00019035247,0.0000803152,0.000008475655,0.00006822416,0.0000012142428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047411895,0.0016447341,0.022797855,0.0013898932,0.0003021458,0.00007390752,0.00065067003,0.0005664039,0.94752413,0.0012487037,0.0033482804,0.015712094],"study_design_scores_gemma":[0.0055452427,0.0012434305,0.048352864,0.00052728306,0.0003410965,0.0000031626735,0.0002450504,0.00042142416,0.9285538,0.00042407773,0.014170425,0.00017212862],"about_ca_topic_score_codex":0.013001767,"about_ca_topic_score_gemma":0.00425316,"teacher_disagreement_score":0.02555501,"about_ca_system_score_codex":0.00022076227,"about_ca_system_score_gemma":0.0003836207,"threshold_uncertainty_score":0.99357074},"labels":[],"label_agreement":null},{"id":"W1652309814","doi":"10.1158/1538-7445.am2015-846","title":"Abstract 846: Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in a pooled analysis of three prospective cohorts of Chinese men and women in Shanghai and Singapore","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Quartile; Odds ratio; Internal medicine; Lymphoma; Prospective cohort study; Population; Logistic regression; Incidence (geometry); Immunology; Confidence interval; Demography; Environmental health","score_opus":0.044997440399100634,"score_gpt":0.3566884812036524,"score_spread":0.31169104080455173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1652309814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691546,0.001792039,4.6765408e-7,0.000061718994,0.0000048376037,0.0006891802,0.00023239899,0.000002557641,0.0003013558],"genre_scores_gemma":[0.9994205,0.00035840634,0.00002562637,0.0000026925889,0.0000059258473,0.00013537708,0.000010382872,0.000012585392,0.0000284555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.000085378764,0.00036332413,0.00029015288,0.00053842,0.0002897773],"domain_scores_gemma":[0.9985981,0.0002722191,0.00028283402,0.00020248044,0.00048930093,0.00015505737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432852,0.00013155189,0.0009510478,0.00061663234,0.000020799776,0.000007748853,0.000054727137,0.00008538258,0.00002034669],"category_scores_gemma":[0.00036624123,0.000091618356,0.000034700075,0.0013018466,0.00032489863,0.00007230554,0.0000841837,0.00009678339,5.063192e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011977272,0.00074012385,0.9844702,0.00020327192,0.001829517,0.000044028093,0.006916291,0.00004436202,0.0017705373,0.0000029061248,0.000014211602,0.0027668546],"study_design_scores_gemma":[0.008715824,0.00079057436,0.98287356,0.00059145596,0.00029798647,0.0000014268909,0.0018091392,0.0005419169,0.004060432,0.00024663363,3.9983163e-7,0.0000706462],"about_ca_topic_score_codex":0.015295181,"about_ca_topic_score_gemma":0.01696087,"teacher_disagreement_score":0.0075180973,"about_ca_system_score_codex":0.00059619313,"about_ca_system_score_gemma":0.0004415041,"threshold_uncertainty_score":0.9912621},"labels":[],"label_agreement":null},{"id":"W1653949476","doi":"","title":"Comparison of lung adenocarcinoma and squamous cell carcinoma genomes reveals distinct regions of amplification on chromosome 3q","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Lung cancer; Adenocarcinoma; Genome; Comparative genomic hybridization; Chromosome; Genetics; Cancer; Copy-number variation; Computational biology; Gene; Pathology; Medicine","score_opus":0.11061310750524814,"score_gpt":0.41482289750814483,"score_spread":0.3042097900028967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1653949476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95140696,0.040263362,0.000015029534,0.0020673545,0.00005256584,0.0006641054,0.00006355078,0.000017117956,0.0054499866],"genre_scores_gemma":[0.99788404,0.00034823522,0.00010618918,0.000043064385,0.00035656453,0.00013870675,0.000024531537,0.000032103442,0.0010665699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997872,0.00011773396,0.0004823091,0.00043723,0.00066863484,0.00042212175],"domain_scores_gemma":[0.9983104,0.00030697344,0.00016817347,0.0005608144,0.00046541242,0.00018823169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038603006,0.00018004335,0.00058760744,0.00033528573,0.00016661272,0.000013804564,0.000184043,0.00008487048,0.00017985096],"category_scores_gemma":[0.00007795444,0.00015898925,0.00009927674,0.00047012637,0.00045930233,0.000062179635,0.00012339526,0.00038984488,0.0000057807374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035221473,0.00029699007,0.9456237,0.0008283396,0.000044388456,0.000006222245,0.003045473,0.0000073585798,0.032470137,0.0004149114,0.013507681,0.00340261],"study_design_scores_gemma":[0.0015753165,0.0007343753,0.9368982,0.0001581858,0.00010464952,0.000008856675,0.000949034,0.00011558611,0.057477113,0.00006688943,0.0017605207,0.00015127457],"about_ca_topic_score_codex":0.00063309865,"about_ca_topic_score_gemma":0.00010889596,"teacher_disagreement_score":0.046477105,"about_ca_system_score_codex":0.0002744513,"about_ca_system_score_gemma":0.00021566408,"threshold_uncertainty_score":0.64833933},"labels":[],"label_agreement":null},{"id":"W1655918213","doi":"10.1158/1538-7445.sabcs14-p2-09-05","title":"Abstract P2-09-05: ICRP analysis: Obesity research in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Obesity; Medicine; Cancer; Incidence (geometry); General partnership; Environmental health; Internal medicine; Business; Finance","score_opus":0.27411900863647115,"score_gpt":0.5224737260891539,"score_spread":0.24835471745268273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1655918213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776893,0.005462955,0.0000038344647,0.008882551,0.00027640947,0.0007606874,0.00020724231,0.000048683825,0.0066683358],"genre_scores_gemma":[0.99257666,0.0027889959,0.000016223454,0.00013371586,0.0009021614,0.00045800736,0.000029729135,0.0000492526,0.003045245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99414915,0.0003615709,0.0004466584,0.00082704937,0.0027452316,0.0014703188],"domain_scores_gemma":[0.99610066,0.00022619174,0.000059006336,0.0008738803,0.0017732048,0.00096705067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052114604,0.0002227403,0.00064438226,0.0020010874,0.00020894765,0.00011733166,0.0004645341,0.00023916339,0.0027197683],"category_scores_gemma":[0.00014154619,0.00018877505,0.00018996713,0.006159599,0.0005343738,0.00021195237,0.00027140477,0.0022803836,0.00028787585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016413666,0.00048489793,0.86939955,0.00023588908,0.0005003164,0.00041291388,0.0014123293,0.00029626995,0.0043175053,0.00009497453,0.099409856,0.021794159],"study_design_scores_gemma":[0.0021849037,0.00014786945,0.95791125,0.00037938592,0.00010417163,0.000013929702,0.0013608714,0.00016776563,0.0015766171,0.0002784962,0.035631374,0.00024338855],"about_ca_topic_score_codex":0.13833086,"about_ca_topic_score_gemma":0.0332812,"teacher_disagreement_score":0.10504967,"about_ca_system_score_codex":0.0032572944,"about_ca_system_score_gemma":0.003392593,"threshold_uncertainty_score":0.9981919},"labels":[],"label_agreement":null},{"id":"W1665915602","doi":"10.1158/1538-7445.sabcs14-p6-08-11","title":"Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Economic evaluation; Context (archaeology); Breast cancer; Nice; Quality-adjusted life year; Oncology; Cohort; Internal medicine; Cancer; Cost effectiveness; Computer science; Risk analysis (engineering)","score_opus":0.3097562947804768,"score_gpt":0.46784292085788837,"score_spread":0.15808662607741159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1665915602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111354,0.0042493474,0.000008037858,0.0005163119,0.0005922434,0.0019164536,0.00043492543,0.000014379551,0.0011547715],"genre_scores_gemma":[0.9979957,0.000544478,0.00014211981,0.00004530598,0.0002543014,0.0008720913,0.000008705172,0.0000538623,0.000083469684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594617,0.00021860478,0.0018162883,0.0009314275,0.00023849314,0.0008490297],"domain_scores_gemma":[0.9977373,0.00047317185,0.0005064657,0.0005757415,0.00039802672,0.00030932183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009779877,0.00027955367,0.00092914206,0.0008015991,0.000060143993,0.00012537237,0.0006128776,0.0002806789,0.00048352903],"category_scores_gemma":[0.0011924931,0.0003165744,0.00013286283,0.000506885,0.00038078698,0.00060642144,0.00016900714,0.0007733366,0.0002196689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022740918,0.000606919,0.97148484,0.000031586576,0.000060000923,0.000008396631,0.0013540263,0.017668337,0.000010932498,0.00029648503,0.0005244005,0.007726642],"study_design_scores_gemma":[0.004773436,0.00024527902,0.97238517,0.00014844659,0.000015550133,0.0000016521705,0.00055634696,0.018504273,0.00003066037,0.0029458217,0.00006937586,0.00032401184],"about_ca_topic_score_codex":0.07097816,"about_ca_topic_score_gemma":0.028814824,"teacher_disagreement_score":0.042163335,"about_ca_system_score_codex":0.0021061583,"about_ca_system_score_gemma":0.0015197708,"threshold_uncertainty_score":0.99992865},"labels":[],"label_agreement":null},{"id":"W1668195681","doi":"10.1158/1538-7445.am2014-4006","title":"Abstract 4006: MicroRNA footprints of circulating tumor cells in patients with non-small cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Epithelial cell adhesion molecule; Circulating tumor cell; Interquartile range; Lung cancer; microRNA; Medicine; Cancer; Oncology; Adenocarcinoma; Internal medicine; TaqMan; Pathology; Metastasis; Biology; Real-time polymerase chain reaction; Gene","score_opus":0.015252222477355679,"score_gpt":0.3005403210874778,"score_spread":0.2852880986101221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1668195681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833286,0.00041283653,0.000056040757,0.000016352336,0.000061502986,0.00050364644,0.000046185116,0.0000036109504,0.00056696497],"genre_scores_gemma":[0.9994145,0.00003301384,0.00015587184,0.000021194295,0.00011536179,0.000100719095,0.000046964935,0.000036454287,0.00007591291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985719,0.000083087245,0.00023980123,0.00039869125,0.00030186915,0.00040470072],"domain_scores_gemma":[0.9989513,0.00002371002,0.00012145418,0.00037019138,0.00043041856,0.00010289168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038844434,0.00013253228,0.0001586392,0.00010985429,0.000053143183,0.000018875087,0.00025146353,0.00008701947,0.00007836201],"category_scores_gemma":[0.000036347257,0.00012426107,0.00004067085,0.00023750382,0.00009761729,0.0000048371194,0.0001255022,0.00018714607,0.0000040051186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012949001,0.00008128519,0.2386861,0.00027122363,0.000017767474,0.0000010435954,0.000047596845,0.0010486417,0.75854427,0.0000011645287,0.0003015147,0.0008699381],"study_design_scores_gemma":[0.00091809296,0.00005563241,0.42493936,0.00014200441,0.000005838363,9.161063e-8,0.00001082158,0.00009524432,0.5733627,0.0000034684372,0.00035841344,0.00010830301],"about_ca_topic_score_codex":0.00074454595,"about_ca_topic_score_gemma":0.00032177847,"teacher_disagreement_score":0.18625328,"about_ca_system_score_codex":0.00012480759,"about_ca_system_score_gemma":0.00029892445,"threshold_uncertainty_score":0.506722},"labels":[],"label_agreement":null},{"id":"W1669742922","doi":"10.1158/1538-7445.sabcs14-es4-2","title":"Abstract ES4-2: What have we learned from the randomized trials of partial breast RT?","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cosmesis; Medicine; Brachytherapy; Randomized controlled trial; Nuclear medicine; Breast-conserving surgery; Urology; Oncology; Breast cancer; Internal medicine; Surgery; Radiation therapy; Mastectomy; Cancer","score_opus":0.26175812869838455,"score_gpt":0.45639091088924194,"score_spread":0.1946327821908574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1669742922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88263077,0.08550487,0.00006619383,0.02827077,0.0007089987,0.0013638497,0.00054976484,0.000016190728,0.0008886081],"genre_scores_gemma":[0.98140687,0.016345356,0.000034763816,0.00009660742,0.0012110271,0.00048420863,0.000090099114,0.000025311907,0.00030577852],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969829,0.0012177321,0.00046337905,0.00039572423,0.00055940304,0.00038087062],"domain_scores_gemma":[0.9977552,0.0009184295,0.00018092644,0.00052354997,0.0004891933,0.00013270063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047253454,0.0001672362,0.00067464256,0.000038612292,0.00011808536,0.00008605375,0.00036129678,0.00012512924,0.00022234603],"category_scores_gemma":[0.0015955348,0.00010051763,0.00026763452,0.00011178614,0.0006668469,0.000012803476,0.00024153065,0.00020508254,0.000024372775],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35477543,0.00056271994,0.00563052,0.000089345995,0.0051559415,0.000024802383,0.0055079986,0.00027812854,0.23740792,0.0002517344,0.10703706,0.28327838],"study_design_scores_gemma":[0.23739897,0.0002837684,0.006457319,0.00061215594,0.00043345775,0.000013771612,0.010560484,0.000034166733,0.6469733,0.004314307,0.092307106,0.0006111923],"about_ca_topic_score_codex":0.004476541,"about_ca_topic_score_gemma":0.0005033037,"teacher_disagreement_score":0.4095654,"about_ca_system_score_codex":0.0000753592,"about_ca_system_score_gemma":0.00051193376,"threshold_uncertainty_score":0.6767221},"labels":[],"label_agreement":null},{"id":"W1672542447","doi":"10.1158/1538-7445.am2015-4963","title":"Abstract 4963: Prognostic significance of the expression of nuclear EIF5A2 in human melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Melanoma; Medicine; Nodular melanoma; Tissue microarray; Cancer research; Cancer; Pathology; Immunohistochemistry; Oncogene; Oncology; Internal medicine; Cell cycle","score_opus":0.15731109701879503,"score_gpt":0.4376265455884473,"score_spread":0.2803154485696523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1672542447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987902,0.00097047194,3.4611554e-7,0.0014488751,0.00005220754,0.00066613744,0.000023388313,0.000006671075,0.008929897],"genre_scores_gemma":[0.99807817,0.00010587416,0.000047077512,0.000028078657,0.00011387774,0.00006158517,0.000003885364,0.000019393654,0.0015420319],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757934,0.0001838781,0.00032480125,0.00022906113,0.001283711,0.00039918322],"domain_scores_gemma":[0.99864066,0.00021105105,0.00007474152,0.0003724286,0.00051167567,0.00018941764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011043618,0.000094056246,0.00027547934,0.0001806919,0.0000745695,0.000008907312,0.00038341936,0.00008186729,0.00042767526],"category_scores_gemma":[0.0004066624,0.00005837565,0.0000775375,0.0005548439,0.0005723926,0.00005134399,0.00023571003,0.00061092153,0.0000178939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007448217,0.0002531422,0.15734479,0.0005359742,0.00001651707,0.000031454114,0.0008091141,0.000019012126,0.83303666,0.00047522053,0.0054211696,0.0013121588],"study_design_scores_gemma":[0.0012887585,0.0005429198,0.505283,0.0013362943,0.000007950689,0.0000059380127,0.00067337963,0.000027807135,0.480762,0.00070683146,0.00926552,0.000099626006],"about_ca_topic_score_codex":0.0031534566,"about_ca_topic_score_gemma":0.00015313902,"teacher_disagreement_score":0.35227463,"about_ca_system_score_codex":0.00013442255,"about_ca_system_score_gemma":0.0005649818,"threshold_uncertainty_score":0.4767104},"labels":[],"label_agreement":null},{"id":"W1679330090","doi":"10.1158/1538-7445.sabcs14-p6-09-07","title":"Abstract P6-09-07: The development of a prediction tool for moderate to severe diarrhea in HER-2/hormone positive metastatic breast cancer (MBC) patients receiving lapatinib in combination with letrozole (L-L)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Lapatinib; Letrozole; Diarrhea; Discontinuation; Internal medicine; Gee; Metastatic breast cancer; Receiver operating characteristic; Cancer; Oncology; Breast cancer; Generalized estimating equation; Statistics; Mathematics","score_opus":0.09324568005919245,"score_gpt":0.40662034562188604,"score_spread":0.31337466556269356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1679330090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138874,0.0003042108,0.0002767717,0.0029481864,0.00008628836,0.0042098295,0.00038262235,0.000016524307,0.00038683295],"genre_scores_gemma":[0.9938859,0.00008740326,0.00093512423,0.00007942787,0.00007066018,0.004554294,0.00008165292,0.000055881985,0.00024965557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610776,0.0003053126,0.00061059184,0.00048443236,0.0017274617,0.00076441694],"domain_scores_gemma":[0.99697846,0.000385594,0.000110647015,0.0003206832,0.001945564,0.0002590624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033377216,0.00019979794,0.00041276478,0.0005164532,0.00013892206,0.000053329768,0.00025250032,0.000083183426,0.00006501181],"category_scores_gemma":[0.00045798125,0.00014751765,0.00003606559,0.0012435948,0.00013796735,0.00023430653,0.00012077822,0.0006870794,0.000012933979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03602075,0.00349725,0.5509249,0.0021556646,0.0005172001,0.000050944942,0.060791656,0.009217195,0.014830334,0.00008501991,0.010279905,0.3116292],"study_design_scores_gemma":[0.010243357,0.0012300842,0.97127616,0.0021474976,0.000021552441,0.0000051873017,0.0016369586,0.0019303429,0.010683111,0.00011245702,0.00048020724,0.00023306491],"about_ca_topic_score_codex":0.0048370576,"about_ca_topic_score_gemma":0.009719116,"teacher_disagreement_score":0.4203513,"about_ca_system_score_codex":0.0035275177,"about_ca_system_score_gemma":0.003365191,"threshold_uncertainty_score":0.92243356},"labels":[],"label_agreement":null},{"id":"W1679717407","doi":"10.1158/1538-7445.am2015-lb-273","title":"Abstract LB-273: Molecular targeting Neu1 with oseltamivir phosphate abrogates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Medicine; Tamoxifen; Metastasis; Viability assay; Breast cancer; Cancer; Pathology; Internal medicine; Biology; Cell culture","score_opus":0.0372052696630489,"score_gpt":0.3503113883762815,"score_spread":0.31310611871323263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1679717407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940681,0.004395865,0.00010973503,0.00017317547,0.00001587815,0.00063454,0.0004346761,0.000009364282,0.00015870405],"genre_scores_gemma":[0.9970764,0.0017624076,0.00026677738,0.000038784216,0.000051738072,0.00047380928,0.000094494484,0.00005319999,0.00018239854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976677,0.0001687997,0.00028177083,0.00058812037,0.00067755696,0.00061606173],"domain_scores_gemma":[0.99850965,0.00002333679,0.00010043265,0.0003071573,0.0007546292,0.00030479766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061906077,0.0002264532,0.0003016266,0.00020668228,0.00012702512,0.000061440005,0.0002644202,0.00008446,0.00003279904],"category_scores_gemma":[0.000108169756,0.0001929306,0.00006415747,0.00045703107,0.00037044942,0.000033466236,0.00015911588,0.00028247357,0.000001377487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010889468,0.00020544812,0.022413796,0.00017812506,0.00038579907,0.000037216294,0.00044285847,0.0046422035,0.9692023,0.00008427423,0.00034426505,0.0009747735],"study_design_scores_gemma":[0.0036458978,0.00030074315,0.0023974811,0.00009469092,0.000025595205,0.0000039376932,0.0003112858,0.00042471092,0.9922125,0.00031767564,0.00003631231,0.00022921029],"about_ca_topic_score_codex":0.016514273,"about_ca_topic_score_gemma":0.0040084873,"teacher_disagreement_score":0.023010164,"about_ca_system_score_codex":0.00015502652,"about_ca_system_score_gemma":0.0007280659,"threshold_uncertainty_score":0.9900348},"labels":[],"label_agreement":null},{"id":"W1712386042","doi":"10.1158/1538-7445.sabcs14-s3-02","title":"Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Epirubicin; Medicine; Internal medicine; Breast cancer; Clinical endpoint; Cyclophosphamide; Placebo; Fluorouracil; Oncology; Adverse effect; Randomized controlled trial; Cancer; Chemotherapy; Gastroenterology; Surgery; Pathology","score_opus":0.032470689897146944,"score_gpt":0.3438482803364555,"score_spread":0.3113775904393085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1712386042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919981,0.005117704,0.000024352108,0.00016743703,0.000117346586,0.002177061,0.00014574801,0.000009749279,0.00024254364],"genre_scores_gemma":[0.9965916,0.002513403,0.00020436129,0.000037491718,0.00012549669,0.0003915649,0.000031639498,0.000049404705,0.000055029668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969942,0.00042181354,0.0006795823,0.00065235526,0.0006460776,0.0006060032],"domain_scores_gemma":[0.99802446,0.00028645698,0.0002904071,0.000351553,0.0006300289,0.0004170981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015654238,0.00033979237,0.0009979336,0.00022861414,0.000099506855,0.000037413567,0.0002617425,0.00025289573,0.000019447954],"category_scores_gemma":[0.00040949124,0.00026483028,0.00010295354,0.0004021303,0.00063956925,0.000030487545,0.00027134322,0.00044326694,0.000001724236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8369943,0.00074003206,0.041252226,0.00027687414,0.00056818046,0.00003268742,0.0012922412,0.0010383009,0.10199411,0.000024555635,0.0006381652,0.015148361],"study_design_scores_gemma":[0.63617486,0.001916571,0.05693482,0.00085603044,0.00012277893,0.000012270131,0.0004511693,0.00024326824,0.30258864,0.00008191813,0.000094246316,0.00052340736],"about_ca_topic_score_codex":0.009403389,"about_ca_topic_score_gemma":0.0012680473,"teacher_disagreement_score":0.20081939,"about_ca_system_score_codex":0.00013445965,"about_ca_system_score_gemma":0.0004912957,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W1734173180","doi":"10.1158/1538-7445.am2014-1553","title":"Abstract 1553: Rho guanine nucleotide exchange factor (ARHGEF) 10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; Biology; Cancer; Cell culture; Tumor suppressor gene; Pancreatic cancer; Guanine nucleotide exchange factor; Cell growth; Tumor progression; Adenocarcinoma; Signal transduction; Carcinogenesis; Genetics","score_opus":0.10151692443293182,"score_gpt":0.42277960702996387,"score_spread":0.32126268259703206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1734173180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97721463,0.002157118,0.000012341846,0.004245479,0.000105744504,0.0015496819,0.00014841672,0.000059641712,0.014506939],"genre_scores_gemma":[0.98624265,0.00041149443,0.00027462046,0.0004267383,0.00065151695,0.0007854389,0.000042822296,0.0000873678,0.011077348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949269,0.000538587,0.00060601457,0.0008665938,0.0014965838,0.0015652692],"domain_scores_gemma":[0.9965406,0.0012645973,0.00011604791,0.0007516757,0.00066913594,0.00065791537],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019127234,0.00034333745,0.0010642372,0.00075227185,0.00022532068,0.0000687545,0.00046071925,0.00021761093,0.023798343],"category_scores_gemma":[0.0017753814,0.00028784378,0.00014602364,0.0009144516,0.0007499439,0.00019985336,0.0002706039,0.0014608529,0.0011520565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033866423,0.0008050052,0.8652083,0.0017081292,0.00042474616,0.0018262608,0.007875295,0.000003181331,0.07967872,0.00021321395,0.036186807,0.0026836428],"study_design_scores_gemma":[0.0046490673,0.0012448374,0.97501504,0.00053579384,0.00007803847,0.000080907084,0.0009791967,0.00092895783,0.0094964355,0.00042132757,0.006249969,0.00032043288],"about_ca_topic_score_codex":0.0037650303,"about_ca_topic_score_gemma":0.00040665703,"teacher_disagreement_score":0.10980668,"about_ca_system_score_codex":0.0008550231,"about_ca_system_score_gemma":0.0010798022,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W1765232554","doi":"10.1158/1538-7445.am2014-2012","title":"Abstract 2012: GPNMB cooperates with Neuropilin-1 and Integrin a5b1 to promote breast cancer tumorigenesis and metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Neuropilin 1; Cancer research; Breast cancer; Metastasis; Metastatic breast cancer; Medicine; Intravasation; Cancer; Biology; Internal medicine; Vascular endothelial growth factor","score_opus":0.03295704308470934,"score_gpt":0.35230574161450695,"score_spread":0.31934869852979764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1765232554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906287,0.0068819383,0.00011307298,0.0016448379,0.00007217488,0.00032731143,0.00012967868,0.000010085185,0.00019215583],"genre_scores_gemma":[0.99199665,0.005475706,0.00022806611,0.00033755333,0.00047785116,0.00030782665,0.00001057461,0.000049459635,0.0011163426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983942,0.000096902004,0.00015411338,0.0006206542,0.0002668297,0.00046731674],"domain_scores_gemma":[0.9989374,0.000026325442,0.000035290974,0.00031333396,0.00040214797,0.0002854985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004937089,0.00019746464,0.0002106856,0.00008862571,0.00019735626,0.00009838039,0.0001925763,0.00008444655,0.00016920773],"category_scores_gemma":[0.000037362075,0.00014532942,0.00003327308,0.00023002287,0.00022473352,0.00001208333,0.00019791225,0.0001632613,0.0000075716152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172227,0.000050259972,0.018150795,0.00013307318,0.00014465298,0.0000071018303,0.00009633919,0.00013751745,0.8532399,0.000068215566,0.005888763,0.12146616],"study_design_scores_gemma":[0.0010558342,0.00087180827,0.1562668,0.0002265975,0.000058805294,0.000057852267,0.00015037404,0.00006344229,0.5764182,0.00002173094,0.26418436,0.0006242165],"about_ca_topic_score_codex":0.0012263511,"about_ca_topic_score_gemma":0.0012043708,"teacher_disagreement_score":0.2768217,"about_ca_system_score_codex":0.000036209094,"about_ca_system_score_gemma":0.00021004553,"threshold_uncertainty_score":0.5926362},"labels":[],"label_agreement":null},{"id":"W1766927364","doi":"10.1158/1538-7445.am2014-841","title":"Abstract 841: Therapeutic targeting of cancer cells in the hypoxic microenvironment using an orally bioavailable small molecule inhibitor of carbonic anhydrase IX","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"In vivo; Pharmacology; Carbonic anhydrase; Bioavailability; Chemistry; Carbonic anhydrase inhibitor; ADME; Cancer; Cancer cell; Carbonic anhydrase II; Oral administration; Extracellular; Cancer research; Pharmacokinetics; Enzyme; Biochemistry; Biology; Medicine; Internal medicine","score_opus":0.05317285775975756,"score_gpt":0.3333135282114789,"score_spread":0.28014067045172136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1766927364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961716,0.003108935,0.00007190615,0.000097851036,0.0000776342,0.00019481438,0.00002388601,0.0000025463164,0.00025081713],"genre_scores_gemma":[0.99861276,0.000783079,0.000085510415,0.00015871093,0.00017393967,0.000045925968,0.00002124697,0.000021106323,0.000097703756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864304,0.00024942582,0.00025420485,0.00028519082,0.0002576038,0.00031051607],"domain_scores_gemma":[0.99940544,0.000024319164,0.0000988535,0.00031575531,0.00010304197,0.00005259556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009430666,0.00010778397,0.00013190649,0.00008312981,0.00006629031,0.000016369824,0.00021023201,0.00010266854,0.00012247666],"category_scores_gemma":[0.000024483277,0.000086624925,0.000052565083,0.00018417908,0.00018586338,0.0000073690208,0.00006233439,0.00019586759,0.0000023762589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008378647,0.00013484103,0.0012385297,0.00006327438,0.000014197082,7.913385e-7,0.00010190488,0.0010986949,0.9964038,0.000008784658,0.0003137869,0.00053757284],"study_design_scores_gemma":[0.00039761464,0.0002517732,0.0011016668,0.0000628246,0.000007827259,3.9813435e-7,0.00020700129,0.00028505226,0.99521405,0.000011109511,0.0023674024,0.00009329253],"about_ca_topic_score_codex":0.0019416481,"about_ca_topic_score_gemma":0.0006377871,"teacher_disagreement_score":0.0024411671,"about_ca_system_score_codex":0.00007165898,"about_ca_system_score_gemma":0.0001653908,"threshold_uncertainty_score":0.35324618},"labels":[],"label_agreement":null},{"id":"W1773200659","doi":"10.1158/1538-7445.am2014-3955","title":"Abstract 3955: 53BP1 facilitates the ATM-dependent phosphorylation of APLF in the DNA damage response","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"DNA damage; Phosphorylation; DNA repair; DNA repair protein XRCC4; DNA; Molecular biology; Biology; Cell biology; Chemistry; Biochemistry; Nucleotide excision repair","score_opus":0.0653809883637213,"score_gpt":0.3850120324174756,"score_spread":0.3196310440537543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773200659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877175,0.0016497705,0.000045088684,0.00648917,0.00010615195,0.0009418651,0.000031312735,0.00001769712,0.0030014424],"genre_scores_gemma":[0.99850833,0.00024367379,0.000015960497,0.00017942833,0.000100795565,0.00021174518,0.000010818209,0.000024384195,0.00070485065],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969317,0.0008284973,0.000318979,0.0003040853,0.0011864632,0.00043029408],"domain_scores_gemma":[0.9973803,0.0013418798,0.00006975928,0.0008342723,0.00029227108,0.00008151155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067962552,0.00012517135,0.00020908721,0.00019094195,0.00013673316,0.00003210136,0.00039548366,0.00011371613,0.00036521323],"category_scores_gemma":[0.0015217557,0.00007482179,0.000085794316,0.00064739725,0.0003572543,0.00005894034,0.000086990396,0.00093012705,0.000079261146],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054727728,0.00019419564,0.002183749,0.00020810767,0.00007223567,0.00007102789,0.008436371,0.0005473268,0.9592879,0.0005188905,0.0058203684,0.017187094],"study_design_scores_gemma":[0.004326038,0.0010453773,0.48183697,0.0006774498,0.00005413315,0.000027095513,0.0046846005,0.00083129347,0.4393346,0.0010788402,0.0658277,0.00027589954],"about_ca_topic_score_codex":0.0018030171,"about_ca_topic_score_gemma":0.0005911427,"teacher_disagreement_score":0.51995325,"about_ca_system_score_codex":0.00038761093,"about_ca_system_score_gemma":0.0005019218,"threshold_uncertainty_score":0.40409908},"labels":[],"label_agreement":null},{"id":"W1788100462","doi":"10.1158/1538-7445.am2015-lb-129","title":"Abstract LB-129: Identifying tumor subpopulations and the functional consequences of intratumor heterogeneity using single-cell profiling of breast cancer patient-derived xenografts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Breast cancer; Exome; Cancer research; Exome sequencing; Population; Cancer; Gene; Genetics; Phenotype; Medicine","score_opus":0.1364423829722075,"score_gpt":0.36901146400010976,"score_spread":0.23256908102790225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1788100462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287266,0.0059251282,0.00012155132,0.00014831155,0.00024304123,0.0003278189,0.00031071334,0.0000028024986,0.000047969086],"genre_scores_gemma":[0.9991032,0.0003411161,0.00019857481,0.0000335071,0.00020783654,0.000064174514,0.00002978101,0.000016123766,0.000005698513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877447,0.00010173153,0.00029667874,0.0002588656,0.00031864957,0.00024963423],"domain_scores_gemma":[0.9987297,0.00007426438,0.00017844785,0.00021078202,0.0006992627,0.00010750799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047715887,0.00010679855,0.0001751883,0.000069345195,0.00013544256,0.000042476382,0.000137562,0.000056067413,0.000017095974],"category_scores_gemma":[0.00013577678,0.000086120024,0.000058793656,0.00016927112,0.0008100136,0.0000101907235,0.00015966094,0.00014011507,3.4937008e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004834263,0.000054179236,0.015854737,0.00007744051,0.000042987824,0.0000014497434,0.00013710583,0.002983051,0.9797754,0.000040794428,0.00012843993,0.00042097285],"study_design_scores_gemma":[0.0010940528,0.000081619626,0.009057049,0.00007759706,0.00002540006,0.000015951859,0.0006062832,0.00015152087,0.9885442,0.00016422383,0.00007037767,0.00011172275],"about_ca_topic_score_codex":0.0023843143,"about_ca_topic_score_gemma":0.0006739354,"teacher_disagreement_score":0.008768785,"about_ca_system_score_codex":0.00007975041,"about_ca_system_score_gemma":0.0007634471,"threshold_uncertainty_score":0.3604386},"labels":[],"label_agreement":null},{"id":"W1789190912","doi":"10.1158/1538-7445.am2015-2940","title":"Abstract 2940: Identifying the minimal region of the ING1 tumor suppressor capable of efficiently killing cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Cancer research; Biology; Cell culture; Cancer cell; Molecular biology; Cancer; Annexin; Histone H3; Programmed cell death; Tumor suppressor gene; Histone; Carcinogenesis; Genetics; Gene","score_opus":0.10065221931854287,"score_gpt":0.37637355518482973,"score_spread":0.2757213358662869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1789190912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950253,0.0032461185,0.00003638182,0.00044722416,0.00033419102,0.00031737544,0.000024885221,0.000002874126,0.00056566775],"genre_scores_gemma":[0.998547,0.00022015002,0.000022100518,0.00004538249,0.0002055447,0.00007457153,0.0000041806547,0.000014158309,0.0008669054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870884,0.0001299162,0.00021987555,0.00021080372,0.00047076528,0.000259808],"domain_scores_gemma":[0.99891204,0.000039035473,0.00013252132,0.00040179308,0.00045089013,0.00006374836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619683,0.00007961127,0.00010761183,0.000044959572,0.00011883009,0.000024638848,0.00046453928,0.000062442465,0.00003323979],"category_scores_gemma":[0.00020493557,0.00004939158,0.000072938885,0.00023943537,0.000309771,0.0000068001445,0.00021028455,0.00020223783,0.0000025060729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092443865,0.000028276561,0.00066180335,0.00006305669,0.000018878281,9.155338e-7,0.00024858664,0.00066121656,0.98640734,0.000023258328,0.011472179,0.00032202576],"study_design_scores_gemma":[0.0002761168,0.00004682886,0.00060590723,0.00011177436,0.0000057326383,0.0000011075749,0.00048322245,0.000075184376,0.9869018,0.00002427051,0.011410117,0.00005790176],"about_ca_topic_score_codex":0.0013268905,"about_ca_topic_score_gemma":0.00013909194,"teacher_disagreement_score":0.0035217246,"about_ca_system_score_codex":0.00004944076,"about_ca_system_score_gemma":0.00043924912,"threshold_uncertainty_score":0.20141302},"labels":[],"label_agreement":null},{"id":"W1790156287","doi":"10.1158/1538-7445.am2014-2559","title":"Abstract 2559: Molecular and immunological correlates of latent versus productive reoviral infection in cancers","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Biology; Antibody; Immune system; Cell sorting; Virology; Cancer; Immunology; CD8; CD19; Cell; Cancer research; Plasma cell; Flow cytometry","score_opus":0.04438525121303377,"score_gpt":0.37818637654089376,"score_spread":0.33380112532786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1790156287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573606,0.0031658767,0.00000955947,0.0001646334,0.00011103557,0.0003182608,0.00000695061,0.0000057527604,0.0004818797],"genre_scores_gemma":[0.99657637,0.0030705982,0.000015336356,0.000011753225,0.00008792598,0.00012145885,0.000015247608,0.000018138293,0.0000831437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847126,0.00026616527,0.00016878675,0.00040508548,0.0002991824,0.0003894907],"domain_scores_gemma":[0.99931246,0.000048118025,0.000042080028,0.00029907428,0.00022979539,0.00006848645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010138518,0.00010812779,0.0001497151,0.00014464969,0.00006203902,0.000016113974,0.0001566365,0.00014956255,0.0000422495],"category_scores_gemma":[0.0003025639,0.00009944053,0.000040336552,0.0002711068,0.00041078415,0.0000063292005,0.00014808119,0.00038357713,0.000005116522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061369617,0.000045925502,0.017294198,0.000037211375,0.000059513062,0.0000034503241,0.000065755106,0.0009070218,0.95584613,0.000056816592,0.00006345462,0.019483533],"study_design_scores_gemma":[0.0016480794,0.0037686205,0.05132764,0.000045790825,0.0000042744055,0.0000014887955,0.000034452587,0.00007230664,0.9419112,0.00017257438,0.00086829165,0.00014528296],"about_ca_topic_score_codex":0.0016269011,"about_ca_topic_score_gemma":0.001351925,"teacher_disagreement_score":0.03403344,"about_ca_system_score_codex":0.00015786277,"about_ca_system_score_gemma":0.00026835708,"threshold_uncertainty_score":0.4055067},"labels":[],"label_agreement":null},{"id":"W1813342387","doi":"","title":"Comprehensive therapy for trilateral retinoblastoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Vincristine; Chemotherapy; Surgery; Cisplatin; Cyclophosphamide","score_opus":0.20862391280658532,"score_gpt":0.482170068429745,"score_spread":0.2735461556231597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1813342387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932741,0.0023588687,0.00001073159,0.0021175416,0.000108890934,0.00089069805,0.000011912639,0.000026035548,0.0012012369],"genre_scores_gemma":[0.9902359,0.0016317802,0.00025279674,0.0004155151,0.00025146554,0.00042359266,0.000017619199,0.000017710327,0.0067536174],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910307,0.00006952056,0.00008860281,0.00019759095,0.00022452718,0.00031666105],"domain_scores_gemma":[0.99922794,0.00013467629,0.000014154713,0.00017601585,0.00034517495,0.0001020366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115678195,0.000069877016,0.00017384882,0.00009213346,0.0002349826,0.0000039132765,0.000059163718,0.000082203806,0.0002701809],"category_scores_gemma":[0.000025690424,0.000052540763,0.00007130434,0.00015362987,0.00022878798,0.000026671287,0.00001904848,0.0001983972,0.000074988326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03869142,0.0022190933,0.45040455,0.00038799396,0.0018797478,0.0027965426,0.004183382,0.000011378362,0.18407252,0.00061802706,0.20790161,0.106833726],"study_design_scores_gemma":[0.018194074,0.004925828,0.2840713,0.00008568748,0.000025813293,0.00024401602,0.00010249153,0.000046142486,0.11601844,0.00041272925,0.57571775,0.00015576246],"about_ca_topic_score_codex":0.00006104103,"about_ca_topic_score_gemma":0.000004712675,"teacher_disagreement_score":0.36781612,"about_ca_system_score_codex":0.00013411015,"about_ca_system_score_gemma":0.00029765337,"threshold_uncertainty_score":0.29582912},"labels":[],"label_agreement":null},{"id":"W1838530782","doi":"10.1158/1538-7445.am2014-3765","title":"Abstract 3765: Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, γ radiation, and cisplatin","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Olaparib; Indoleamine 2,3-dioxygenase; Cancer research; Immune system; Cisplatin; Cancer; Cancer cell; Immunosurveillance; PARP inhibitor; DNA repair; Medicine; Biology; Immunology; Poly ADP ribose polymerase; Internal medicine; Chemotherapy; DNA; Biochemistry","score_opus":0.04319448803183638,"score_gpt":0.35010785905885977,"score_spread":0.3069133710270234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1838530782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900934,0.0008022375,0.00001574281,0.0011492383,0.00012853822,0.00052226585,0.000060554365,0.000060472048,0.0071675396],"genre_scores_gemma":[0.9961069,0.00017603512,0.000037157195,0.0004603282,0.00021356944,0.00015715936,0.0000069959615,0.00003805602,0.002803754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704134,0.00027068728,0.00036682218,0.0007317799,0.0008905207,0.0006988632],"domain_scores_gemma":[0.99826825,0.000692346,0.00009725275,0.00048272606,0.00012160867,0.0003378118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012495633,0.00018749549,0.00022787903,0.0003056457,0.000501403,0.00018584145,0.000535618,0.00007226069,0.00026223424],"category_scores_gemma":[0.001389284,0.00017722319,0.0000433035,0.0006151718,0.00023454172,0.00017467655,0.00019128926,0.00051237346,0.00017700168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014077665,0.00008088769,0.0002704386,0.000096428244,0.0000029821683,0.000018860816,0.000586579,0.00003724984,0.9886392,0.0006911392,0.0068800612,0.0025554346],"study_design_scores_gemma":[0.0014283913,0.000096330725,0.052204207,0.0000572567,0.0000011444339,0.0000013089273,0.00015166006,0.000026906193,0.92564595,0.0006295263,0.019531086,0.00022624152],"about_ca_topic_score_codex":0.00025348377,"about_ca_topic_score_gemma":0.00050410477,"teacher_disagreement_score":0.06299322,"about_ca_system_score_codex":0.00013382276,"about_ca_system_score_gemma":0.00013446235,"threshold_uncertainty_score":0.7226952},"labels":[],"label_agreement":null},{"id":"W1839791560","doi":"10.1158/0008-5472.can-14-2676","title":"Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research; University of Waterloo","funders":"","keywords":"Myeloid leukemia; Mitochondrion; Stem cell; Leukemia; Progenitor cell; Haematopoiesis; Apoptosis; Biology; Programmed cell death; Cell; Viability assay; Cancer research; Cytotoxicity; Hematopoietic stem cell; Cell biology; Cytotoxic T cell; Myeloid; Biochemistry; Chemistry; Immunology; In vitro","score_opus":0.053372265259228516,"score_gpt":0.35332562395454015,"score_spread":0.29995335869531164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1839791560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133737,0.010952999,0.00020695069,0.0001273748,0.0005374351,0.0003690385,0.000019718003,0.00001627874,0.0064328164],"genre_scores_gemma":[0.9881115,0.0012849169,0.00087619387,0.00011441413,0.0035049838,0.00029931287,0.000049116956,0.00004822296,0.005711339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981237,0.00018146963,0.00014363042,0.00050419744,0.00046544636,0.0005815296],"domain_scores_gemma":[0.9986134,0.000021603082,0.00005414543,0.00031791485,0.0007190786,0.0002738513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057290855,0.00015895128,0.0001678717,0.00008669435,0.00015389865,0.000056181423,0.00030888457,0.00014922876,0.000026516653],"category_scores_gemma":[0.00015137394,0.00013281702,0.00003906261,0.0003237416,0.0001417239,0.000008640289,0.00014477459,0.00039119238,0.00002786494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033042827,0.000029291365,0.0007349651,0.000023340692,0.00003800169,0.0000021701298,0.00045143752,0.00026160164,0.91600287,0.000027969729,0.08056176,0.001536147],"study_design_scores_gemma":[0.0011278037,0.00033796148,0.00041644322,0.000022742934,0.000012764337,0.000005200998,0.0007289191,0.000019279398,0.73373586,0.000068361485,0.26330444,0.00022021627],"about_ca_topic_score_codex":0.0011341027,"about_ca_topic_score_gemma":0.0002562935,"teacher_disagreement_score":0.18274269,"about_ca_system_score_codex":0.00021309873,"about_ca_system_score_gemma":0.0023643756,"threshold_uncertainty_score":0.5416121},"labels":[],"label_agreement":null},{"id":"W1845339086","doi":"10.1158/1538-7445.sabcs14-p2-12-11","title":"Abstract P2-12-11: Socioeconomic factors and the use of complimentary and alternative therapies in patients with early stage breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Socioeconomic status; Cancer; Family medicine; Psychological intervention; Stage (stratigraphy); Internal medicine; Population; Environmental health","score_opus":0.1590712801927092,"score_gpt":0.3969689068927285,"score_spread":0.23789762670001932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845339086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449587,0.0009414463,9.568614e-7,0.0031597426,0.0000650628,0.00086280826,0.00043074435,0.000008589778,0.000034793695],"genre_scores_gemma":[0.9989914,0.0004307148,0.00002076853,0.0002734711,0.00007746136,0.00007187587,0.000012651119,0.00002727491,0.000094386574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828637,0.00021942264,0.00027137576,0.00030584386,0.00060514006,0.00031187214],"domain_scores_gemma":[0.99873155,0.0004501904,0.000119193595,0.00025427892,0.0002545768,0.00019017929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007557574,0.00015754899,0.00040467083,0.00014253405,0.000075205004,0.000053141473,0.00012739502,0.000047962974,0.0001581519],"category_scores_gemma":[0.000029840743,0.00009649911,0.000029526016,0.00009738928,0.0010483882,0.0002599014,0.00011326102,0.0003854776,0.0000014499384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029594894,0.00009804023,0.97715056,0.00009858773,0.00021017712,0.0000021275266,0.018144641,0.000020079064,0.000030653933,0.00005007416,0.00043009222,0.000805473],"study_design_scores_gemma":[0.008224798,0.0002017141,0.98759985,0.00024574294,0.00001794978,6.1599707e-7,0.0029123288,0.000014415549,0.00019986818,0.000061383136,0.00041693033,0.00010439285],"about_ca_topic_score_codex":0.17068833,"about_ca_topic_score_gemma":0.023280958,"teacher_disagreement_score":0.14740737,"about_ca_system_score_codex":0.0003558783,"about_ca_system_score_gemma":0.00034788714,"threshold_uncertainty_score":0.99454165},"labels":[],"label_agreement":null},{"id":"W1862608543","doi":"10.1158/1538-7445.am2014-1886","title":"Abstract 1886: Highly sensitive detection of circulating tumor DNA in plasma as a biomarker of colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colorectal cancer; Medicine; Concordance; Biomarker; Oncology; Cancer; Liquid biopsy; Internal medicine; Population; KRAS; COLD-PCR; Genotyping; Mutation; Cancer research; Genotype; Biology; Gene; Genetics; Point mutation","score_opus":0.026441567061414026,"score_gpt":0.3375254906358463,"score_spread":0.31108392357443226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1862608543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782515,0.00041180186,0.000031588526,0.0000569585,0.00014876368,0.00023824244,0.0000773999,0.0000029998855,0.0012071254],"genre_scores_gemma":[0.9993507,0.00030091824,0.000033161105,0.000026078018,0.00013904442,0.00008710189,0.000014058416,0.000022340846,0.000026569876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879414,0.00008915678,0.00026574076,0.00030285373,0.0002458997,0.00030218548],"domain_scores_gemma":[0.99914354,0.00013975773,0.0001161254,0.00018254238,0.00034716603,0.00007087068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055648654,0.000103654034,0.00018994264,0.00014286167,0.000047468006,0.000011611253,0.00012525848,0.00010437531,0.00002660887],"category_scores_gemma":[0.000414856,0.000108338274,0.000062976535,0.0002588724,0.00018703651,0.0000038814605,0.00010677789,0.00015656161,0.000002771193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045197073,0.00004089705,0.0031992933,0.000080114245,0.000038121445,0.0000050135213,0.000110853725,0.00042225624,0.9857241,0.000037953956,0.000109287124,0.0097801555],"study_design_scores_gemma":[0.00064530416,0.00021424516,0.05421715,0.00009400148,0.000006173896,0.00000356727,0.00011158948,0.00074073824,0.9429212,0.00006206117,0.00087583903,0.000108098604],"about_ca_topic_score_codex":0.006645937,"about_ca_topic_score_gemma":0.0066023753,"teacher_disagreement_score":0.051017854,"about_ca_system_score_codex":0.00012346821,"about_ca_system_score_gemma":0.00047114975,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W1863671141","doi":"10.1158/1538-7445.am2014-2563","title":"Abstract 2563: Development of clinical assay to mitigate daratumumab, an IgG1κ monoclonal antibody, interference with serum immunofixation (IFE) and clinical assessment of M-protein response in multiple myeloma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Daratumumab; Serum protein electrophoresis; Monoclonal antibody; Immunofixation; Medicine; Multiple myeloma; Antibody; Monoclonal; Immunology; Internal medicine","score_opus":0.17600398529680306,"score_gpt":0.5321469711729264,"score_spread":0.35614298587612336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1863671141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970475,0.00008920594,0.0005616061,0.0005492645,0.000047232126,0.001435251,0.000040965944,0.00001370642,0.00021526353],"genre_scores_gemma":[0.9873878,0.00008776611,0.012048723,0.000025763859,0.00006561623,0.0001972955,0.000051960724,0.000030793344,0.000104303304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994445,0.0017242515,0.001329316,0.0006967918,0.001198472,0.0006061228],"domain_scores_gemma":[0.99616724,0.0015679919,0.0002317568,0.0006236137,0.0007998969,0.0006094893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012285193,0.00021074552,0.00075614237,0.00047638908,0.00012125131,0.00003330842,0.00029373675,0.00018239307,0.00009686318],"category_scores_gemma":[0.0024427513,0.00016105907,0.00007646056,0.00049265404,0.00054384733,0.00015923535,0.00025373432,0.0008994859,0.000009758823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021121616,0.0009034238,0.75967973,0.00020197067,0.0001656387,0.000045330347,0.000251178,0.000011372536,0.08260898,0.000020725547,0.0000116633155,0.13497837],"study_design_scores_gemma":[0.006767088,0.00414615,0.9639808,0.0011775891,0.000011483683,0.000003703992,0.00014330419,0.002598767,0.020779615,0.000017009119,0.00023250993,0.00014196477],"about_ca_topic_score_codex":0.00073839154,"about_ca_topic_score_gemma":0.0017473528,"teacher_disagreement_score":0.20430109,"about_ca_system_score_codex":0.0002372501,"about_ca_system_score_gemma":0.0022291539,"threshold_uncertainty_score":0.6567798},"labels":[],"label_agreement":null},{"id":"W1871478153","doi":"10.1158/1538-7445.sabcs14-p1-07-16","title":"Abstract P1-07-16: Galectin-7 increases resistance of breast cancer cells to drug-induced apoptosis and promotes tumor escape by killing T cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Armand Frappier Museum","funders":"","keywords":"Breast cancer; Cancer cell; Cancer research; Cancer; Apoptosis; Galectin-3; Metastatic breast cancer; Biology; Medicine; Immunology; Internal medicine","score_opus":0.040333395247935167,"score_gpt":0.33037105467939676,"score_spread":0.2900376594314616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1871478153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98315513,0.013203304,0.0000036629851,0.0010630483,0.0005985498,0.00062944664,0.0005919179,0.000043715187,0.0007112229],"genre_scores_gemma":[0.9951502,0.0012290904,0.000036739388,0.0001448185,0.00014430335,0.00036517528,0.000022018105,0.000046437042,0.0028612074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972252,0.00041284147,0.00043408005,0.00075797614,0.00019291099,0.0009769415],"domain_scores_gemma":[0.9981989,0.00031428403,0.00016972487,0.00041918372,0.00067949976,0.00021837334],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010992105,0.00028843476,0.00053605175,0.00025234005,0.0002815499,0.0000424913,0.0004627471,0.00022061625,0.0010448378],"category_scores_gemma":[0.000095371564,0.00025727498,0.00007366494,0.0005615968,0.00044103936,0.00010446842,0.00022941631,0.00069143774,0.00011076095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007854757,0.00014692274,0.002020442,0.00014266734,0.00011071952,0.0000023236248,0.00050189294,0.0000040450395,0.91543347,0.000012110422,0.077742755,0.0030971945],"study_design_scores_gemma":[0.000980963,0.00018936004,0.0018876551,0.00026639455,0.000025143847,0.00000904833,0.00082441873,5.41491e-7,0.9742814,0.00005742062,0.021190785,0.0002869034],"about_ca_topic_score_codex":0.02174644,"about_ca_topic_score_gemma":0.0034306382,"teacher_disagreement_score":0.05884791,"about_ca_system_score_codex":0.00039635604,"about_ca_system_score_gemma":0.0007358773,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W1872623955","doi":"10.1158/1538-7445.am2014-1855","title":"Abstract 1855: SCT methylation is a potential cancer biomarker for lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Methylation; Bisulfite sequencing; DNA methylation; Cancer; Cancer research; Biomarker; CpG site; Bisulfite; Pathology; Biology; Medicine; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.06060386183324847,"score_gpt":0.4370706517509806,"score_spread":0.37646678991773214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1872623955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965956,0.020352254,0.010114197,0.0013842824,0.0005569633,0.0007059454,0.00022106788,0.000013519595,0.0006958122],"genre_scores_gemma":[0.99066466,0.0048874966,0.0002952107,0.00015990717,0.00124211,0.0009459864,0.000108860644,0.000051970957,0.0016437797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813455,0.00012329346,0.00024362531,0.00055311335,0.00041425478,0.00053113734],"domain_scores_gemma":[0.9987113,0.00005397613,0.000089423906,0.00035792912,0.00064136,0.0001460345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011162915,0.00016256457,0.00016244967,0.0001266213,0.00027216502,0.00008054659,0.00024234438,0.00022687209,0.0005007191],"category_scores_gemma":[0.00013426782,0.00015508509,0.00012445914,0.00021543006,0.00011391816,0.000009347682,0.000097642565,0.0001689411,0.000005012166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019586846,0.000025991645,0.0027122798,0.000097538235,0.0001124858,3.1303253e-7,0.000057305235,0.0007475177,0.92468023,0.000033325523,0.009882787,0.06145438],"study_design_scores_gemma":[0.00087323936,0.000104440245,0.017275574,0.000053472362,0.000037054844,1.9048561e-7,0.000018637156,0.0053024176,0.8501141,0.00033348816,0.12562971,0.00025764137],"about_ca_topic_score_codex":0.0016291356,"about_ca_topic_score_gemma":0.0007365751,"teacher_disagreement_score":0.11574692,"about_ca_system_score_codex":0.00011407023,"about_ca_system_score_gemma":0.00035830395,"threshold_uncertainty_score":0.63241863},"labels":[],"label_agreement":null},{"id":"W1874198797","doi":"10.1158/0008-5472.493.65.2","title":"Calcium Sensing Receptor in Human Colon Carcinoma: Interaction with Ca2+ and 1,25-Dihydroxyvitamin D3","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"National Cancer Institute","keywords":"Calcium-sensing receptor; Crypt; Receptor; Internal medicine; Endocrinology; Extracellular; Cancer research; Cellular differentiation; Colorectal cancer; Biology; Calcium; Cell biology; Calcium metabolism; Medicine; Cancer; Gene; Biochemistry","score_opus":0.08640854961261511,"score_gpt":0.4335106941643868,"score_spread":0.3471021445517717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874198797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922595,0.0025135095,0.000006042364,0.0014276827,0.000026158406,0.0004513193,0.0000056409735,0.000013174408,0.0032969895],"genre_scores_gemma":[0.9982125,0.00011132928,0.00012446911,0.00010319883,0.00015176048,0.00005502198,0.000025191754,0.000017828026,0.0011986975],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988177,0.0001029109,0.00012423359,0.00028330128,0.00033201033,0.00033987992],"domain_scores_gemma":[0.99955195,0.00005057892,0.000023413655,0.00016379445,0.00009798818,0.00011224923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026033245,0.00010326359,0.00017741727,0.00023847277,0.00012186058,0.000032237316,0.00004012297,0.0000618685,0.00003253578],"category_scores_gemma":[0.00002040086,0.000082977815,0.000017491142,0.00029110032,0.00009908521,0.00011065238,0.00002426755,0.00034890103,0.000025282949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019739445,0.0012593432,0.42443424,0.00012878703,0.00012787637,0.00089166546,0.010018099,0.000039454575,0.496734,0.00016114484,0.04677037,0.01746105],"study_design_scores_gemma":[0.037979715,0.0065704337,0.6288154,0.00065321097,0.00016631583,0.00047304062,0.010609657,0.0019256762,0.20824568,0.00012438654,0.10351844,0.00091802154],"about_ca_topic_score_codex":0.0034225846,"about_ca_topic_score_gemma":0.0033157582,"teacher_disagreement_score":0.28848833,"about_ca_system_score_codex":0.00045329347,"about_ca_system_score_gemma":0.00012572996,"threshold_uncertainty_score":0.51739466},"labels":[],"label_agreement":null},{"id":"W1874333151","doi":"10.1158/1538-7445.am2014-4136","title":"Abstract 4136: Comparison of overall survival of Chronic Lymphocytic Leukemia (CLL) patients referred or not referred to a specialized CLL clinic: A Canadian population-based study","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Hazard ratio; Internal medicine; Proportional hazards model; Referral; Population; Cohort; Cancer registry; Cancer; Medical diagnosis; Pediatrics; Leukemia; Confidence interval; Pathology; Family medicine","score_opus":0.17535362228692705,"score_gpt":0.46852088222767524,"score_spread":0.2931672599407482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874333151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937402,0.00012027732,0.000008457217,0.00017261587,0.0005204078,0.0035141225,0.00017396496,0.00004501941,0.0017049066],"genre_scores_gemma":[0.9971469,0.000029865076,0.000077301214,0.00010787093,0.00051988807,0.0003274376,0.00019371728,0.00011939226,0.0014775997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915579,0.0007879011,0.0016603963,0.0009913899,0.003465744,0.0015366785],"domain_scores_gemma":[0.993053,0.0018154014,0.00034960956,0.0016422301,0.0018460336,0.0012936854],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033002559,0.00039932915,0.0015429471,0.0012960209,0.00023046412,0.00005804984,0.0007925883,0.0003291111,0.0024387126],"category_scores_gemma":[0.0042142496,0.00034291652,0.00021944514,0.0015275037,0.00024445416,0.00011306241,0.00023542836,0.0008406814,0.0001745442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12760998,0.005718767,0.71853334,0.009599064,0.0020861262,0.00038702818,0.0076794326,0.017028011,0.0124828955,0.00022982291,0.04177368,0.05687183],"study_design_scores_gemma":[0.09100585,0.008060436,0.86091346,0.0015060215,0.00016468242,0.0000026070106,0.00061488565,0.022624038,0.005370418,0.000027965918,0.009041833,0.0006678212],"about_ca_topic_score_codex":0.7088345,"about_ca_topic_score_gemma":0.53682387,"teacher_disagreement_score":0.17201066,"about_ca_system_score_codex":0.16312371,"about_ca_system_score_gemma":0.11031305,"threshold_uncertainty_score":0.9999023},"labels":[],"label_agreement":null},{"id":"W1882056938","doi":"10.1158/1538-7445.sabcs14-p5-10-02","title":"Abstract P5-10-02: A copy number aberration driven endocrine response gene signature stratifies risk in estrogen receptor positive breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Gene signature; Comparative genomic hybridization; Oncology; Tamoxifen; Internal medicine; Gene expression profiling; Estrogen receptor; Medicine; Microarray; Cancer; Aromatase; Cancer research; Copy-number variation; Biology; Gene expression; Gene; Genetics","score_opus":0.027368783532176127,"score_gpt":0.34394426826121355,"score_spread":0.3165754847290374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882056938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995241,0.001192991,0.000012970855,0.0009369068,0.0001384742,0.00035224887,0.0015095887,0.000010613013,0.00060524116],"genre_scores_gemma":[0.9945509,0.0007505543,0.0002004425,0.000045253215,0.0005017526,0.00033142115,0.00030508236,0.000029473482,0.0032851484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981008,0.0004031428,0.00025286616,0.0004219196,0.0003539763,0.00046726337],"domain_scores_gemma":[0.9987648,0.000049895407,0.00008726572,0.0002995562,0.00062324264,0.00017520496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006807464,0.0001739431,0.00016606519,0.00008530624,0.00014975702,0.00008179602,0.00024014649,0.0001772442,0.0011399132],"category_scores_gemma":[0.000115045914,0.00016508448,0.000058760776,0.00023292037,0.00013988237,0.000021680453,0.00012071491,0.00037352927,0.0000642528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004367687,0.00013449408,0.04640305,0.000025409103,0.00013950991,0.000022624998,0.0011687634,0.0017500188,0.920792,0.000100822865,0.023933804,0.0011618043],"study_design_scores_gemma":[0.002180081,0.00037080515,0.108454145,0.00009354008,0.000023481642,0.000042318396,0.0020836212,0.000060495528,0.8695667,0.00021890772,0.01643633,0.000469572],"about_ca_topic_score_codex":0.0035193956,"about_ca_topic_score_gemma":0.0016728514,"teacher_disagreement_score":0.0620511,"about_ca_system_score_codex":0.00029768152,"about_ca_system_score_gemma":0.0011363912,"threshold_uncertainty_score":0.9997732},"labels":[],"label_agreement":null},{"id":"W1886604250","doi":"10.1158/1538-7445.sabcs14-p6-12-02","title":"Abstract P6-12-02: Phase Ib dose-escalation study of an Akt inhibitor ipatasertib (Ipat) in combination with docetaxel (Doc) or paclitaxel (Pac) in patients (pts) with metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Protein kinase B; Paclitaxel; Internal medicine; Cancer; Breast cancer; PTEN; Pharmacology; Oncology; PI3K/AKT/mTOR pathway; Chemistry; Apoptosis","score_opus":0.09496959590241856,"score_gpt":0.42083388458046533,"score_spread":0.3258642886780468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886604250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973233,0.0002882962,0.00002211805,0.00009787631,0.00010926111,0.0016502435,0.00044574964,0.0000119185825,0.00005125469],"genre_scores_gemma":[0.99844897,0.000046736106,0.00009699124,0.000033497297,0.00012587951,0.00079430046,0.00030356788,0.00006692211,0.000083137405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644756,0.00042992277,0.0005473196,0.0007601243,0.0011926315,0.00062245695],"domain_scores_gemma":[0.99789107,0.00005470667,0.00024083006,0.00060275104,0.00093931286,0.00027135768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012255482,0.00029859398,0.00041339314,0.00037594693,0.00007768667,0.00006212892,0.000380417,0.00013214618,0.000086092325],"category_scores_gemma":[0.00011744921,0.00022797602,0.00003153439,0.00081009045,0.00021916105,0.0000812982,0.000110794215,0.00043596252,0.000003279607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062985346,0.028021108,0.6800048,0.00069536135,0.0005768043,0.0001907694,0.0067353803,0.011260145,0.15972477,0.000011318988,0.0021943843,0.04759987],"study_design_scores_gemma":[0.08823711,0.03148228,0.7612308,0.0010658186,0.000121589976,0.000011802717,0.005267881,0.0007534056,0.110103995,0.0000747611,0.000498979,0.0011515558],"about_ca_topic_score_codex":0.010459288,"about_ca_topic_score_gemma":0.031198164,"teacher_disagreement_score":0.08122608,"about_ca_system_score_codex":0.0006583536,"about_ca_system_score_gemma":0.0012164643,"threshold_uncertainty_score":0.99613017},"labels":[],"label_agreement":null},{"id":"W1904154547","doi":"10.1158/0008-5472.can-15-0988","title":"Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Senescence; Integrin; Cancer research; Cancer; Downregulation and upregulation; Kinase; Biology; Phenotype; Signal transduction; Cell biology; Effector; Oncogene; Glioblastoma; Cell; Cell cycle; Genetics; Gene","score_opus":0.19313030840691373,"score_gpt":0.4712506937706263,"score_spread":0.27812038536371253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904154547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97726184,0.001283807,0.00051697105,0.010250784,0.00021730845,0.0012010398,0.000010690694,0.00012056074,0.009136992],"genre_scores_gemma":[0.97318,0.00012535806,0.0008329482,0.0004970856,0.00063973025,0.00032282827,0.0000075490702,0.000080467034,0.02431401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945997,0.00037249582,0.00033998926,0.0007368501,0.0027487301,0.0012022626],"domain_scores_gemma":[0.99527365,0.00020482752,0.000033053944,0.000830199,0.001962921,0.0016953417],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00267229,0.00020916048,0.00036194915,0.000553534,0.00016708877,0.000110969246,0.0005623067,0.00015686847,0.0014042156],"category_scores_gemma":[0.00198822,0.0001803693,0.00009493415,0.0021745467,0.00028398188,0.00015795082,0.0006484876,0.0012606912,0.0022310321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015468509,0.00013234613,0.0029885678,0.00020254176,0.000036898076,0.00061690784,0.00109308,0.00008996974,0.914007,0.00017471015,0.051984802,0.02712633],"study_design_scores_gemma":[0.0019567325,0.0017059406,0.0010519759,0.00086312357,0.000015346675,0.00008699818,0.0021523044,0.00049616356,0.7492544,0.00023099083,0.24182701,0.00035902025],"about_ca_topic_score_codex":0.0013957684,"about_ca_topic_score_gemma":0.00028678693,"teacher_disagreement_score":0.18984221,"about_ca_system_score_codex":0.001220314,"about_ca_system_score_gemma":0.0017253121,"threshold_uncertainty_score":0.9995086},"labels":[],"label_agreement":null},{"id":"W1908220583","doi":"10.1158/0008-5472.can-14-2992","title":"Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Signal transduction; Biology; Estrogen receptor; PI3K/AKT/mTOR pathway; Metastasis; Internal medicine; Medicine; Genetics","score_opus":0.1351957236679593,"score_gpt":0.4598918872068976,"score_spread":0.3246961635389383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1908220583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677444,0.00049960887,0.00014368066,0.001164576,0.00023000989,0.000571878,0.0005126985,0.000008408523,0.00009470049],"genre_scores_gemma":[0.9985391,0.00009504852,0.00016686766,0.000039385955,0.00022767673,0.00027557346,0.000030487661,0.000022918699,0.00060293946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986406,0.00006399565,0.00024790608,0.00023246027,0.0005387784,0.00027624637],"domain_scores_gemma":[0.99783224,0.00022772432,0.0000795662,0.00011865289,0.0015429078,0.0001989097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063327805,0.00009701312,0.00024912023,0.0001943753,0.00009071086,0.000025049789,0.00006761424,0.0000343403,0.00017528393],"category_scores_gemma":[0.0002743178,0.00007839171,0.000059470647,0.00023390667,0.000115697105,0.000100778925,0.000043554784,0.00017042147,0.00000238215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040976503,0.00091863546,0.09060025,0.0018501924,0.00034757622,0.000017756098,0.008167355,0.000022686654,0.813301,0.0001307546,0.02282564,0.057720497],"study_design_scores_gemma":[0.007933283,0.0027697252,0.06162146,0.0037031265,0.00044733827,0.00004725042,0.003960752,0.003437738,0.9031184,0.00027492095,0.012255676,0.00043033718],"about_ca_topic_score_codex":0.0011552732,"about_ca_topic_score_gemma":0.00012706287,"teacher_disagreement_score":0.08981739,"about_ca_system_score_codex":0.00020139295,"about_ca_system_score_gemma":0.0003769491,"threshold_uncertainty_score":0.31967214},"labels":[],"label_agreement":null},{"id":"W1910594103","doi":"10.1158/1538-7445.am2014-2693","title":"Abstract 2693: Harnessing MALT1 inhibition for rational combinatorial therapy of ABC-DLBCL","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Cancer research; Chemistry; breakpoint cluster region; Diffuse large B-cell lymphoma; Cell growth; Biology; Molecular biology; Cell biology; Lymphoma; Receptor; Biochemistry; Immunology","score_opus":0.0779610751238212,"score_gpt":0.4040757505143962,"score_spread":0.32611467539057504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910594103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933702,0.0010133125,0.0033272118,0.00049769337,0.0005830079,0.00040473766,0.000056552115,0.0000059286153,0.00074139604],"genre_scores_gemma":[0.9976851,0.00054105103,0.00015964688,0.000121094025,0.000991009,0.0001946183,0.00010151947,0.000022796605,0.00018321774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990664,0.000051782252,0.0001527791,0.00023346272,0.00025418063,0.00024137738],"domain_scores_gemma":[0.99927324,0.000032982123,0.00005848493,0.00018968353,0.00038991348,0.000055683548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000721299,0.00008005333,0.00010727397,0.000054175278,0.0001366579,0.00003016437,0.00011301286,0.000108781955,0.000061833416],"category_scores_gemma":[0.00003910292,0.00007643913,0.00006847177,0.00007972091,0.00009757142,0.0000046934256,0.00003536339,0.00009953093,0.0000018441849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045114072,0.00007425103,0.000036752117,0.000032043157,0.000025750356,1.2429159e-7,0.000037128655,0.000018502484,0.96470535,0.008412479,0.0010530107,0.025153479],"study_design_scores_gemma":[0.0019824093,0.0003498727,0.00032680613,0.000027688999,0.0000021943713,5.2942795e-7,0.000020788639,0.000052782547,0.8836698,0.0068260217,0.106653914,0.00008717334],"about_ca_topic_score_codex":0.000058904247,"about_ca_topic_score_gemma":0.000028267956,"teacher_disagreement_score":0.1056009,"about_ca_system_score_codex":0.00003695618,"about_ca_system_score_gemma":0.00025564613,"threshold_uncertainty_score":0.31170973},"labels":[],"label_agreement":null},{"id":"W1911886261","doi":"10.1158/1538-7445.sabcs14-p4-11-07","title":"Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Population; Chemotherapy; Cancer","score_opus":0.2141857310701174,"score_gpt":0.4862654370182897,"score_spread":0.2720797059481723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1911886261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945068,0.0028178522,0.0000053567283,0.00081978086,0.00015218148,0.000520434,0.0000351591,0.0000037697012,0.0011387162],"genre_scores_gemma":[0.99885356,0.0001501531,0.00012895458,0.000063186984,0.0002995084,0.00039224885,0.000027517088,0.000014661719,0.00007022338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846166,0.00017091392,0.0002416618,0.00029979393,0.0004658605,0.00036008828],"domain_scores_gemma":[0.9990473,0.00013768901,0.00006154241,0.00043276532,0.00024998115,0.00007071373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080717553,0.00012240397,0.00021689058,0.00006729246,0.000059849506,0.000023025412,0.000385505,0.0001034276,0.000030310635],"category_scores_gemma":[0.00031311688,0.00008523535,0.00006312607,0.00019032956,0.00026031205,0.0000036467754,0.00016502565,0.00021525347,0.000018148225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05563652,0.002893198,0.5123592,0.00018692204,0.0005357136,0.00004446,0.008661631,0.002676113,0.12465965,0.000121934274,0.27301583,0.019208828],"study_design_scores_gemma":[0.10108874,0.0039008907,0.5601632,0.0002774306,0.000090874666,0.00001332042,0.007974622,0.000120469114,0.27075404,0.0005247448,0.054180603,0.0009110748],"about_ca_topic_score_codex":0.0029603427,"about_ca_topic_score_gemma":0.0028208017,"teacher_disagreement_score":0.21883523,"about_ca_system_score_codex":0.00008910965,"about_ca_system_score_gemma":0.00023730886,"threshold_uncertainty_score":0.44751722},"labels":[],"label_agreement":null},{"id":"W1926009117","doi":"10.1158/1538-7445.am2014-1632","title":"Abstract 1632: Discovery of a novel series of androgen receptor antagonists with potential therapeutic applications in castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Bicalutamide; Enzalutamide; Antiandrogens; Androgen receptor; LNCaP; Androgen; Medicine; Cancer research; Androgen Receptor Antagonists; Cancer; Pharmacology; Chemistry; Internal medicine; Hormone","score_opus":0.052938950992479736,"score_gpt":0.38397622675363685,"score_spread":0.3310372757611571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926009117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303794,0.0031030965,0.00006490226,0.0013510325,0.000033095497,0.0016091423,0.00039753882,0.000011721476,0.00039155135],"genre_scores_gemma":[0.99496263,0.0020737858,0.00016173377,0.000011199396,0.00009216255,0.0010928911,0.000086806656,0.000031565898,0.0014872282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805945,0.00006218892,0.00033750074,0.00034193508,0.0007552542,0.0004436541],"domain_scores_gemma":[0.9987976,0.00008542483,0.00011121461,0.0003426646,0.0005505267,0.00011258558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004757652,0.00014900249,0.0003485512,0.00026378763,0.00010629052,0.000036252157,0.0001552612,0.00007149633,0.00011380827],"category_scores_gemma":[0.000018016486,0.00010206891,0.000056197416,0.00071255787,0.0006060397,0.0002144154,0.000044239187,0.00031295422,0.0000018087609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005888163,0.0005771062,0.038556848,0.001006313,0.00018780393,0.000008287101,0.0007381366,0.00014224974,0.94713277,0.0004832065,0.000118650256,0.0051604677],"study_design_scores_gemma":[0.007541734,0.0015566462,0.14609082,0.0011268604,0.00007774166,0.000008749592,0.0015983641,0.0000722445,0.8373369,0.00017963508,0.0041537257,0.00025656962],"about_ca_topic_score_codex":0.003067035,"about_ca_topic_score_gemma":0.0014457101,"teacher_disagreement_score":0.10979587,"about_ca_system_score_codex":0.00028379625,"about_ca_system_score_gemma":0.001632329,"threshold_uncertainty_score":0.463646},"labels":[],"label_agreement":null},{"id":"W1926179112","doi":"10.1158/0008-5472.can-14-3587","title":"Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":522,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Medical Research Council; Cancer Research UK; Wellcome Trust; Breast Cancer Research Foundation","keywords":"Chemotherapy; Cancer research; Tumor hypoxia; Metastasis; Tumor microenvironment; Neovascularization; Cancer; Pathology; Medicine; Angiogenesis; Biology; Internal medicine","score_opus":0.056770650728667583,"score_gpt":0.37319198259941216,"score_spread":0.31642133187074456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926179112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92625755,0.06902168,0.000030661613,0.0008119561,0.0015893695,0.00044478005,0.000018861452,0.000082096005,0.0017430658],"genre_scores_gemma":[0.9677499,0.00086150324,0.00006883933,0.00046977753,0.00017855255,0.00071167294,0.000014919987,0.00007025311,0.029874606],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976354,0.00050472294,0.0002480162,0.00050619734,0.00020267685,0.000902983],"domain_scores_gemma":[0.99855024,0.00010575123,0.00004502872,0.0007672144,0.00045078786,0.00008097072],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012522979,0.00020852324,0.00030166798,0.000183693,0.00018761457,0.000046500234,0.0005636236,0.00021305612,0.008488373],"category_scores_gemma":[0.00012648069,0.00018216683,0.000112407404,0.00037150335,0.0007589561,0.00011195177,0.00026324572,0.00096538954,0.0034399377],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043861615,0.00028671266,0.003947384,0.00014858521,0.00070006785,0.0003390924,0.013507929,0.00013859743,0.7245392,0.00011690616,0.23380528,0.01808404],"study_design_scores_gemma":[0.0037701335,0.00024628654,0.0015986627,0.00008813554,0.000018201345,0.00004437475,0.0010717467,0.000007318635,0.4159986,0.00026307275,0.57657516,0.0003183346],"about_ca_topic_score_codex":0.00045378006,"about_ca_topic_score_gemma":0.000018855502,"teacher_disagreement_score":0.34276986,"about_ca_system_score_codex":0.00045831717,"about_ca_system_score_gemma":0.0005066962,"threshold_uncertainty_score":0.997336},"labels":[],"label_agreement":null},{"id":"W1926597952","doi":"10.1158/0008-5472.can-15-0054","title":"IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; U.S. Public Health Service","keywords":"CXCL1; Biology; Tumor progression; Cancer research; CCL20; Interleukin 17; Mammary tumor; Breast cancer; Immunology; Cancer; Chemokine; Cytokine; Inflammation; Chemokine receptor","score_opus":0.11275075693953343,"score_gpt":0.3966626480439419,"score_spread":0.2839118911044085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926597952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95247996,0.043518122,0.0000099499775,0.00054240035,0.00068505405,0.0023687747,0.00006720052,0.000041972773,0.00028655157],"genre_scores_gemma":[0.9939783,0.0005758372,0.000091640795,0.00009106935,0.00010912116,0.0032972053,0.000031273892,0.00004469098,0.0017808529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975092,0.0006030306,0.0003526687,0.00043877185,0.00022007056,0.00087624765],"domain_scores_gemma":[0.99868226,0.00020467318,0.00017214975,0.0005176416,0.00035930471,0.000063969055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001960847,0.00019977048,0.00030549528,0.00019568612,0.00038420028,0.000043773067,0.0005816418,0.00009944291,0.00015228597],"category_scores_gemma":[0.00009040084,0.00014032733,0.00005765092,0.00042744924,0.00070255087,0.00011677637,0.0006209388,0.00075094495,0.000045412467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014559506,0.000102432416,0.000547383,0.00008655269,0.000047222587,0.000023152757,0.0013710497,0.000001457822,0.9689696,0.00007761153,0.0062752995,0.022352641],"study_design_scores_gemma":[0.00092388416,0.00037250042,0.00017623296,0.0002469899,0.000027055647,0.000058615587,0.0012113821,0.0000070954834,0.9592428,0.00009144571,0.037477925,0.00016403497],"about_ca_topic_score_codex":0.00023463309,"about_ca_topic_score_gemma":0.000008943519,"teacher_disagreement_score":0.042942286,"about_ca_system_score_codex":0.0002600771,"about_ca_system_score_gemma":0.00041524746,"threshold_uncertainty_score":0.57223827},"labels":[],"label_agreement":null},{"id":"W1927374894","doi":"10.1158/1538-7445.am2015-4038","title":"Abstract 4038: Role of the Rho-GTPase CDC42 in glioma migration","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CDC42; Cancer research; Lamellipodium; Cell migration; Glioma; Temozolomide; Biology; Cell polarity; RHOA; Cell; Medicine; GTPase; Cell biology; Signal transduction; Genetics","score_opus":0.04127005548709465,"score_gpt":0.36141053956952696,"score_spread":0.3201404840824323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1927374894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639285,0.0020165553,0.000004757271,0.0003038191,0.00006151841,0.000177564,0.000027259262,0.000001760552,0.0010139471],"genre_scores_gemma":[0.99926335,0.00024938132,0.000017326134,0.00003047924,0.00009820666,0.000048970294,0.00002201576,0.000007698125,0.00026259653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992367,0.000072631345,0.00012413184,0.00016352566,0.00020527825,0.00019774496],"domain_scores_gemma":[0.99942404,0.000008726603,0.00003141017,0.0002925834,0.00018724542,0.00005599615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043574724,0.000055946257,0.00006611393,0.000053980282,0.0000309103,0.000011605579,0.00023605,0.000091663744,0.000018723862],"category_scores_gemma":[0.00009960964,0.000042537256,0.00003745614,0.00019968797,0.00009194644,0.0000030230597,0.0001185092,0.00014330957,0.0000076501165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007364391,0.00004090952,0.00772497,0.000012776556,0.0000074077348,0.000001115266,0.00013632046,0.00010723543,0.98591,0.000035510428,0.004364685,0.0015854414],"study_design_scores_gemma":[0.00035376693,0.000060466267,0.007887927,0.00002398767,0.0000018232056,0.0000017872986,0.0003048912,0.00005613517,0.9647328,0.0001592165,0.026357735,0.00005943355],"about_ca_topic_score_codex":0.0013884613,"about_ca_topic_score_gemma":0.0040667523,"teacher_disagreement_score":0.021993048,"about_ca_system_score_codex":0.000048123708,"about_ca_system_score_gemma":0.00032725147,"threshold_uncertainty_score":0.22693431},"labels":[],"label_agreement":null},{"id":"W1928986782","doi":"10.1158/0008-5472.can-04-3977","title":"Restoration of the Expression of Transporters Associated with Antigen Processing in Lung Carcinoma Increases Tumor-Specific Immune Responses and Survival","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Boehringer Ingelheim Stiftung","keywords":"Antigen; Antigen presentation; MHC class I; Biology; Immune system; Cancer research; Immunology; Major histocompatibility complex; Immunotherapy; CD8; Antigen processing; Cytotoxic T cell; T cell; In vitro","score_opus":0.036900735867443316,"score_gpt":0.3173508040818644,"score_spread":0.2804500682144211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1928986782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408255,0.058593724,0.000006531662,0.00012009649,0.00004473183,0.00031204853,0.000028737886,0.000008828278,0.000059761176],"genre_scores_gemma":[0.9985457,0.0010222079,0.000009835128,0.000006648858,0.000010046799,0.000039047234,0.000012649526,0.000016660011,0.0003372071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977651,0.0012383218,0.00035390205,0.00020211832,0.00014050974,0.00030000563],"domain_scores_gemma":[0.9990213,0.0003285306,0.00016870562,0.00025442697,0.00021601876,0.000011033584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012760748,0.00011514628,0.0002795989,0.00023696956,0.00021332785,0.00001109748,0.00023701253,0.00010663056,0.00007820038],"category_scores_gemma":[0.00012969096,0.00007791947,0.00003958159,0.00048565544,0.0007500775,0.00015918919,0.000044188444,0.00035864525,6.499107e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053160014,0.00011574456,0.14556694,0.000038253533,0.000020136207,0.0000020639288,0.0016046896,0.000010785255,0.8446817,0.000020548045,0.000028171813,0.002594963],"study_design_scores_gemma":[0.0010116034,0.00009862618,0.46514332,0.0004468231,0.000004095361,0.0000033055653,0.0005431859,0.000002449978,0.532147,0.0000036648496,0.0005398624,0.000056066645],"about_ca_topic_score_codex":0.0010337116,"about_ca_topic_score_gemma":0.00028485392,"teacher_disagreement_score":0.31957638,"about_ca_system_score_codex":0.00011040183,"about_ca_system_score_gemma":0.00039486875,"threshold_uncertainty_score":0.31774637},"labels":[],"label_agreement":null},{"id":"W1933865299","doi":"10.1158/1538-7445.sabcs14-s6-03","title":"Abstract S6-03: Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York cancer consortium trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Metastatic breast cancer; Cancer; Breast cancer; Oncology; Estrogen receptor; Bortezomib; Clinical endpoint; Progression-free survival; Randomized controlled trial; Chemotherapy; Multiple myeloma","score_opus":0.09604018843932562,"score_gpt":0.4197523491040481,"score_spread":0.32371216066472247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933865299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97140336,0.0067227497,0.000059244336,0.0088808825,0.00043517607,0.011121683,0.0012631393,0.000044333236,0.00006943496],"genre_scores_gemma":[0.9906082,0.00092268974,0.00063812104,0.00019034978,0.0008158382,0.006028437,0.00013867144,0.00010815645,0.0005495473],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99361235,0.0008460599,0.0015984898,0.00088808074,0.0020208578,0.0010341712],"domain_scores_gemma":[0.99630916,0.0007930686,0.00051208277,0.0005897427,0.0009532419,0.00084272487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038940918,0.0004849357,0.0021523186,0.0010599953,0.000109716304,0.00005170021,0.00031157956,0.0001659784,0.0004862427],"category_scores_gemma":[0.0007857559,0.000355501,0.00015919327,0.0024169413,0.00070898735,0.00044334398,0.00009657615,0.00094762247,0.000009501242],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93694395,0.0030239287,0.000037062673,0.00016919163,0.0004610344,0.00021232365,0.0035208643,0.000261794,0.036851108,0.000039662606,0.004089758,0.014389328],"study_design_scores_gemma":[0.9690336,0.00926738,0.0005276885,0.0027459306,0.00020375047,0.00001925436,0.0017366438,0.000038294696,0.014559901,0.0001460813,0.0013075332,0.00041396663],"about_ca_topic_score_codex":0.0494237,"about_ca_topic_score_gemma":0.012798494,"teacher_disagreement_score":0.036625206,"about_ca_system_score_codex":0.0027059028,"about_ca_system_score_gemma":0.008336491,"threshold_uncertainty_score":0.9998897},"labels":[],"label_agreement":null},{"id":"W1935026499","doi":"10.1158/1538-7445.sabcs14-pd2-2","title":"Abstract PD2-2: Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Internal medicine; Hazard ratio; Oncology; Taxane; Triple-negative breast cancer; Population; Anthracycline; Randomized controlled trial; Adjuvant therapy; Cancer; Chemotherapy; Confidence interval","score_opus":0.28649548767260063,"score_gpt":0.5366607232827357,"score_spread":0.2501652356101351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1935026499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844504,0.0042758724,0.000001210834,0.0028641669,0.00071159133,0.006008062,0.00023285451,0.000021153428,0.0014346682],"genre_scores_gemma":[0.99476784,0.001112117,0.000024465566,0.00009832242,0.0010032866,0.0016742185,0.00001921399,0.000035075995,0.0012654607],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952352,0.0013040358,0.0009185875,0.00052236044,0.0013338223,0.00068597856],"domain_scores_gemma":[0.9955649,0.0023914794,0.000367836,0.00040247312,0.0010087377,0.00026462015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062440103,0.00025812056,0.0010963073,0.0003612494,0.00016338634,0.000032183685,0.00033210622,0.00014667789,0.0005959863],"category_scores_gemma":[0.0013996941,0.00016352984,0.0002833083,0.0011448992,0.00049571245,0.00013248829,0.00009776766,0.0010149527,0.000007523936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9209607,0.00096164533,0.0004984296,0.000029584106,0.00037554238,0.000034225024,0.007459265,0.00009718053,0.008768996,0.000008390914,0.0018384028,0.058967624],"study_design_scores_gemma":[0.9772135,0.0036791938,0.008496089,0.00039588704,0.00017748089,0.000008048656,0.0005105808,0.0003175718,0.0086958185,0.000090624104,0.00026095784,0.00015421888],"about_ca_topic_score_codex":0.031007571,"about_ca_topic_score_gemma":0.0011959765,"teacher_disagreement_score":0.058813404,"about_ca_system_score_codex":0.0012248325,"about_ca_system_score_gemma":0.0041371123,"threshold_uncertainty_score":0.97544503},"labels":[],"label_agreement":null},{"id":"W1937278795","doi":"10.1158/1538-7445.sabcs14-p1-07-32","title":"Abstract P1-07-32: Activated thrombin activatable fibrinolysis inhibitor is a novel anti-metastatic factor in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Plasmin; Zymogen; Thrombomodulin; Thrombin; Cancer research; Cancer cell; Fibrinolysis; Plasminogen activator; Chemistry; Carboxypeptidase; Cell migration; Tissue factor; Cancer; Cell biology; Cell; Biochemistry; Biology; Immunology; Medicine; Endocrinology; Internal medicine; Coagulation; Enzyme; Platelet","score_opus":0.08877747040555836,"score_gpt":0.3785636772988412,"score_spread":0.2897862068932828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937278795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961282,0.0010992084,0.000033341952,0.0007925035,0.00021394323,0.0005323464,0.00092323584,0.00001936886,0.0002578493],"genre_scores_gemma":[0.99782395,0.0003932194,0.00007966559,0.00018712963,0.0004771349,0.0003525159,0.00006819483,0.000059204438,0.0005589921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997347,0.000110782334,0.0003070318,0.0007115937,0.000676724,0.0008468992],"domain_scores_gemma":[0.99860466,0.000026684786,0.00009440915,0.0005379309,0.00040384431,0.0003324548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049279287,0.00026116343,0.00032579727,0.00021626081,0.00012005039,0.00009105553,0.00038044676,0.00020780743,0.00077508437],"category_scores_gemma":[0.00009536799,0.00024101815,0.000098206074,0.0005671755,0.00013028928,0.000036210266,0.00030663854,0.0004939032,0.0000630229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028871075,0.00022040919,0.0020219518,0.00006445083,0.00009871976,0.000009606069,0.00016011762,0.00005715297,0.9831831,0.0000072971516,0.012781697,0.0011067749],"study_design_scores_gemma":[0.001523352,0.00012069347,0.0049733957,0.00017290987,0.000008813286,0.0000089348205,0.00024854546,0.000039976592,0.9886902,0.000056999954,0.0038606094,0.00029558007],"about_ca_topic_score_codex":0.0058055855,"about_ca_topic_score_gemma":0.000276616,"teacher_disagreement_score":0.008921088,"about_ca_system_score_codex":0.00031620022,"about_ca_system_score_gemma":0.001176667,"threshold_uncertainty_score":0.98284346},"labels":[],"label_agreement":null},{"id":"W1937690720","doi":"","title":"Computational modeling and biological evaluation of methylated (-)-EGCG analogs","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Proteasome; Methylation; Chemistry; Biochemistry; In vitro; In silico; Jurkat cells; Polyphenol; Apoptosis; Stereochemistry; Pharmacology; Biology; Antioxidant; T cell; Gene; Immunology","score_opus":0.28626141930398347,"score_gpt":0.5011596679880385,"score_spread":0.214898248684055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937690720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946175,0.0032113802,0.0005945481,0.00043120643,0.00002062299,0.0002841601,0.000006163358,0.000011333454,0.0008230621],"genre_scores_gemma":[0.9992926,0.000049766448,0.0004459456,0.000017713743,0.00009226309,0.000035538407,0.00003106876,0.0000052985183,0.000029820483],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988324,0.00017957717,0.00012284574,0.00014588446,0.0005614826,0.00015780715],"domain_scores_gemma":[0.9991733,0.00011302043,0.000017219636,0.00007120885,0.0005770423,0.00004821815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015600225,0.00004393417,0.00012365414,0.00011218508,0.00005132072,0.000007196014,0.000029833507,0.000055510383,0.00012322463],"category_scores_gemma":[0.00012768595,0.000032844167,0.000019895482,0.00023154657,0.00010084961,0.000022694441,0.000026483605,0.00014477782,0.0000033923718],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010457853,0.0004742108,0.114801064,0.0004291951,0.00022624462,0.000022511502,0.0006433085,0.2900762,0.47678307,0.009224304,0.0027691894,0.10350495],"study_design_scores_gemma":[0.0020207283,0.00028704712,0.12167054,0.0001072841,0.000042506123,0.000006501193,0.000073383235,0.8507794,0.004317252,0.02057275,0.000052240495,0.00007038334],"about_ca_topic_score_codex":0.0012464905,"about_ca_topic_score_gemma":0.000022414068,"teacher_disagreement_score":0.5607032,"about_ca_system_score_codex":0.000081672355,"about_ca_system_score_gemma":0.0001874912,"threshold_uncertainty_score":0.18843292},"labels":[],"label_agreement":null},{"id":"W1941925635","doi":"10.1158/1538-7445.sabcs14-ot3-1-10","title":"Abstract OT3-1-10: HERmione: A Phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with physician's choice of chemotherapy plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer, previously treated with pe","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Vinorelbine; Capecitabine; Internal medicine; Anthracycline; Oncology; Metastatic breast cancer; Taxane; Trastuzumab emtansine; Chemotherapy; Breast cancer; Lapatinib; Cancer; Colorectal cancer","score_opus":0.14428242805559724,"score_gpt":0.4836444026667105,"score_spread":0.3393619746111133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1941925635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97238463,0.005107907,0.00021607064,0.0018560811,0.00011101258,0.016742548,0.0003881923,0.000087712004,0.0031058486],"genre_scores_gemma":[0.9867595,0.0032675602,0.00067267026,0.0002021313,0.00051999,0.006225764,0.0001571364,0.0002904925,0.001904744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9902269,0.0012923154,0.00149602,0.0015844058,0.003383456,0.0020168899],"domain_scores_gemma":[0.9930672,0.0013617577,0.0006193042,0.0011343342,0.0027186144,0.0010987571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042215404,0.00085038424,0.0036512539,0.0007835397,0.00025592724,0.00023368423,0.0010474344,0.00021184445,0.00075257756],"category_scores_gemma":[0.00041276487,0.0006287985,0.00019172211,0.0030387242,0.0020471811,0.0007536518,0.00027803646,0.002074497,0.000027748825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9183907,0.0050821295,0.0007647016,0.001098661,0.0011529482,0.0008211931,0.0027915116,0.002673449,0.0033057118,0.000014431058,0.0015852028,0.062319398],"study_design_scores_gemma":[0.96442604,0.009596747,0.0018018545,0.008061421,0.00029768344,0.00012324272,0.0018081772,0.0046906034,0.007616558,0.000038020735,0.00077152305,0.0007681173],"about_ca_topic_score_codex":0.036009096,"about_ca_topic_score_gemma":0.008459313,"teacher_disagreement_score":0.06155128,"about_ca_system_score_codex":0.0059206346,"about_ca_system_score_gemma":0.01272497,"threshold_uncertainty_score":0.9996163},"labels":[],"label_agreement":null},{"id":"W1943685717","doi":"10.1158/1538-7445.am2014-2490","title":"Abstract 2490: Integrative systems analysis of HPV+ and HPV- oropharyngeal carcinomas","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Concordance; Immunohistochemistry; Biology; Oncology; Cancer research; Computational biology; Medicine; Internal medicine; Bioinformatics; Immunology","score_opus":0.045149015511977614,"score_gpt":0.4098302940119935,"score_spread":0.36468127850001586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943685717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829923,0.0030394811,0.0003866829,0.0012257764,0.00012075039,0.00023975929,0.000012780903,0.000018075645,0.011964387],"genre_scores_gemma":[0.99813527,0.000494976,0.00009877656,0.00007500385,0.000230312,0.000036589565,0.000017762994,0.00001773826,0.0008935698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983305,0.00017616057,0.00026061814,0.00030244474,0.0006080712,0.00032224087],"domain_scores_gemma":[0.9986303,0.00040440177,0.000068742804,0.00027917174,0.00035653246,0.0002608861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016142643,0.00010711562,0.0005339596,0.0005582197,0.00009226141,0.000037529975,0.00013260351,0.000067085784,0.00048139945],"category_scores_gemma":[0.00065113563,0.000076228935,0.00008768326,0.00081537786,0.00037991718,0.00004841146,0.000067428446,0.0007385031,0.0000054799884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008003976,0.00029818746,0.46783713,0.002314156,0.0043473323,0.00017705876,0.005577482,0.001545616,0.09721369,0.0060781674,0.012680899,0.4011299],"study_design_scores_gemma":[0.0014324988,0.0003681601,0.88762337,0.00024901755,0.0006567172,0.000012820232,0.0010182053,0.09465653,0.0020381794,0.00007596677,0.011692489,0.00017601982],"about_ca_topic_score_codex":0.005894459,"about_ca_topic_score_gemma":0.00007982559,"teacher_disagreement_score":0.41978627,"about_ca_system_score_codex":0.0001229793,"about_ca_system_score_gemma":0.00016913668,"threshold_uncertainty_score":0.89106977},"labels":[],"label_agreement":null},{"id":"W1947060780","doi":"10.1158/0008-5472.can-14-3569","title":"CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ovarian cancer; Cancer research; Stromal cell; Metastasis; Serous fluid; Biology; Cancer; Tumor progression; Medicine; Internal medicine","score_opus":0.07876753002403131,"score_gpt":0.37291640083901195,"score_spread":0.29414887081498065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947060780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170876,0.005019614,0.000021549344,0.002428856,0.00007501392,0.00028628623,0.00004778513,0.000012284799,0.00039983063],"genre_scores_gemma":[0.99572194,0.00032017595,0.00006381978,0.00031998786,0.00038572162,0.00038792315,0.000056595625,0.000035222227,0.0027085948],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983386,0.00016414387,0.00014718222,0.00039649688,0.00043464705,0.0005189509],"domain_scores_gemma":[0.99921113,0.000021418711,0.00004319483,0.00018314045,0.00036740815,0.00017371574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054789067,0.00013134416,0.00016180634,0.00009769935,0.00007264491,0.00004067039,0.00025005182,0.00016234674,0.00012333434],"category_scores_gemma":[0.00008113038,0.000109422785,0.000028370318,0.0005012663,0.0001030016,0.000006368341,0.00011645134,0.0002822331,0.000008053883],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001247728,0.00054192165,0.307618,0.00008370016,0.0006544616,0.00026819814,0.0013650471,0.0016455386,0.25720727,0.00014923037,0.42639503,0.0028238927],"study_design_scores_gemma":[0.0070097544,0.0014724919,0.022306237,0.0004330905,0.00006121962,0.00001949847,0.0007117771,0.0002082251,0.9124506,0.00032709687,0.054181475,0.0008185414],"about_ca_topic_score_codex":0.00662441,"about_ca_topic_score_gemma":0.0017355714,"teacher_disagreement_score":0.65524334,"about_ca_system_score_codex":0.00016111934,"about_ca_system_score_gemma":0.00071995886,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W1950624415","doi":"10.1158/1538-7445.am2014-2488","title":"Abstract 2488: Analysis of the salivary proteome of the prolactin-inducible-protein knockout mouse","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Saliva; Proteome; Biology; Knockout mouse; Immune system; Transcriptome; S100A9; Proteomics; Immunology; Salivary gland; Receptor; Molecular biology; Gene; Inflammation; Gene expression; Genetics; Biochemistry","score_opus":0.07803003212262405,"score_gpt":0.37840700943228733,"score_spread":0.3003769773096633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950624415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889705,0.0002602762,0.00001979388,0.0026461515,0.0000762631,0.0011446902,0.000034131317,0.000012876551,0.006835317],"genre_scores_gemma":[0.99522054,0.00002734645,0.000024179086,0.00008389038,0.00011357201,0.00024661332,0.00000487326,0.000017390841,0.0042616082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816185,0.0002002457,0.0002846333,0.00024750823,0.00081373926,0.00029203383],"domain_scores_gemma":[0.998276,0.00013501267,0.00012352775,0.0009980116,0.00038360353,0.00008387529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010482916,0.00009932216,0.0003096541,0.00026189917,0.00018795916,0.00001249611,0.00033902662,0.00008918784,0.0006734469],"category_scores_gemma":[0.00051611493,0.00005040384,0.00026995354,0.0020808307,0.00029202647,0.00004275547,0.0001370858,0.00051260676,0.000007802114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001332957,0.00062339124,0.2740923,0.00065516256,0.0014766112,0.0000014938772,0.00093222264,0.00040747365,0.7101091,0.00089106284,0.0047254506,0.0047527817],"study_design_scores_gemma":[0.0010953472,0.00018474863,0.7672098,0.0002179827,0.00041567077,0.0000013260986,0.00040534418,0.00028602048,0.2250937,0.00031452277,0.004672103,0.0001033895],"about_ca_topic_score_codex":0.0023095817,"about_ca_topic_score_gemma":0.000338202,"teacher_disagreement_score":0.49311754,"about_ca_system_score_codex":0.00006921006,"about_ca_system_score_gemma":0.00041314284,"threshold_uncertainty_score":0.73737717},"labels":[],"label_agreement":null},{"id":"W1961223560","doi":"10.1158/1538-7445.am2014-3682","title":"Abstract 3682: Contribution of hepatic uptake transporters OATP1B1/OATP1B3 to the disposition of docetaxel","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Docetaxel; Pharmacology; Chemistry; P-glycoprotein; Transporter; Intracellular; Efflux; Organic anion-transporting polypeptide; Organic anion transporter 1; Abcg2; ATP-binding cassette transporter; Internal medicine; Medicine; Biochemistry; Cancer; Multiple drug resistance","score_opus":0.035456004139332496,"score_gpt":0.3583789266577451,"score_spread":0.32292292251841265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1961223560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107486,0.00040339917,0.0028292267,0.003940496,0.00015181044,0.00080952904,0.00008596804,0.000017916169,0.0006867999],"genre_scores_gemma":[0.99904436,0.00021126418,0.00008549992,0.000088588764,0.00014254458,0.00010438175,0.000062433486,0.00001969717,0.00024123187],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980993,0.00006082723,0.00039842728,0.00023056712,0.0008434507,0.00036738729],"domain_scores_gemma":[0.9987404,0.00009557153,0.000081966304,0.00038815488,0.0005355054,0.00015840905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00144741,0.000109915745,0.00033658915,0.00015969451,0.00009637174,0.000007793321,0.00019021455,0.000081680366,0.00024825725],"category_scores_gemma":[0.00006685938,0.000072007206,0.00013138629,0.0004631061,0.00018014766,0.00005048436,0.000009409789,0.00028277986,0.000015918426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002361381,0.00034399086,0.015623422,0.0010779692,0.00015424544,0.000017364791,0.0015487869,0.00017253189,0.95290416,0.004020227,0.0010371576,0.02073876],"study_design_scores_gemma":[0.0019565625,0.00053124723,0.5716557,0.001106165,0.00012495359,0.0000025115405,0.000290761,0.000112690206,0.41153905,0.0006409387,0.011902422,0.00013699503],"about_ca_topic_score_codex":0.0004683425,"about_ca_topic_score_gemma":0.00063129805,"teacher_disagreement_score":0.5560323,"about_ca_system_score_codex":0.00009598472,"about_ca_system_score_gemma":0.00016341536,"threshold_uncertainty_score":0.29363686},"labels":[],"label_agreement":null},{"id":"W1963753563","doi":"10.1158/1538-7445.am2014-lb-282","title":"Abstract LB-282: Transethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Cancer Care Ontario; University of Ottawa","funders":"","keywords":"Colorectal cancer; Locus (genetics); Genome-wide association study; Cancer; Medicine; Genetics; Genealogy; Demography; Gerontology; Biology; Single-nucleotide polymorphism; History; Gene; Genotype; Sociology","score_opus":0.048113740071798576,"score_gpt":0.3853945103318683,"score_spread":0.3372807702600697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963753563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966267,0.0017640077,0.000043841723,0.0005080979,0.000109838016,0.0005834745,0.00003680166,0.0000063618336,0.0003209108],"genre_scores_gemma":[0.99662435,0.0009325099,0.0000071405534,0.000032518714,0.00019761345,0.00031933477,0.000022781502,0.000020019836,0.0018437041],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980858,0.00025868468,0.00033569525,0.00046412004,0.00046566446,0.0003900615],"domain_scores_gemma":[0.998966,0.000099806566,0.00010934894,0.00037166468,0.00035546056,0.00009774322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014399822,0.00011934337,0.00020683155,0.00011798823,0.000089320376,0.000032740085,0.0003187068,0.0001519825,0.00025853692],"category_scores_gemma":[0.00025934554,0.000117764386,0.000065985194,0.0003700818,0.000084441876,0.000010186159,0.00006394251,0.0002784725,0.000007480332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024329471,0.00027358186,0.20248768,0.000055345645,0.00006775715,6.7574507e-7,0.000924244,0.0006033301,0.78909403,0.0000038522735,0.001512308,0.0047339164],"study_design_scores_gemma":[0.0014516104,0.00039520214,0.86334693,0.00003008363,0.000015241329,1.16354954e-7,0.0008045084,0.000017612367,0.12885663,0.00013821834,0.00476635,0.00017750822],"about_ca_topic_score_codex":0.01825169,"about_ca_topic_score_gemma":0.07484333,"teacher_disagreement_score":0.6608592,"about_ca_system_score_codex":0.0003497294,"about_ca_system_score_gemma":0.0005098712,"threshold_uncertainty_score":0.98828584},"labels":[],"label_agreement":null},{"id":"W1963830683","doi":"10.1158/0008-5472.can-05-2570","title":"Growth-Regulated Oncogene Is Pivotal in Thrombin-Induced Angiogenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Angiogenesis; Thrombin; Matrigel; Biology; Thrombin receptor; Molecular biology; Cell biology; Endothelial stem cell; Cancer research; Chemistry; Immunology; In vitro; Biochemistry; Platelet","score_opus":0.048405811932166254,"score_gpt":0.3668347059447938,"score_spread":0.31842889401262753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963830683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919964,0.0075940806,0.000021354586,0.00064410915,0.00015318212,0.00027418692,0.000047507485,0.0000140022585,0.002051938],"genre_scores_gemma":[0.99520046,0.0009895972,0.000052065614,0.00020115449,0.0007304609,0.00020015889,0.00006740786,0.000053052496,0.0025056377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978625,0.00014197934,0.00026799674,0.0006128782,0.00042962987,0.00068500394],"domain_scores_gemma":[0.999075,0.000018647575,0.000045056397,0.00042370165,0.0003355092,0.000102075996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047745436,0.00018846242,0.00020481355,0.00018681839,0.00014251668,0.0000406195,0.00034707267,0.00025629916,0.00032119013],"category_scores_gemma":[0.000026890888,0.00018287818,0.00015555516,0.0006493558,0.00014360336,0.000006518817,0.0001826337,0.00014356615,0.000044550783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010477603,0.0000932811,0.019063057,0.000018972325,0.000040378578,0.000011486819,0.000026110858,0.00002480224,0.95333,0.00011803154,0.02549368,0.0016754222],"study_design_scores_gemma":[0.00068317814,0.00015502592,0.029826446,0.00002916123,0.000007844817,0.000006111529,0.000038488324,0.000016472128,0.95607936,0.00020931533,0.012712152,0.00023645075],"about_ca_topic_score_codex":0.0049413587,"about_ca_topic_score_gemma":0.0013387769,"teacher_disagreement_score":0.012781527,"about_ca_system_score_codex":0.00015520907,"about_ca_system_score_gemma":0.00034275264,"threshold_uncertainty_score":0.74698895},"labels":[],"label_agreement":null},{"id":"W1963919576","doi":"10.1158/1538-7445.am2013-932","title":"Abstract 932: Predictive markers of the <i>in vitro</i> anticancer effect of the pan class I PI3K inhibitor BKM120 in primary B-CLL lymphocytes.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"PI3K/AKT/mTOR pathway; Chronic lymphocytic leukemia; CD38; CD5; Protein kinase B; Apoptosis; Cancer research; Biology; Leukemia; PTEN; CD8; Immunology; Immune system; Flow cytometry; Cell biology; Genetics; Stem cell","score_opus":0.017487766335753534,"score_gpt":0.32732695568785114,"score_spread":0.3098391893520976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963919576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264325,0.001829393,5.3171965e-7,0.0012123358,0.00024553988,0.0037528644,0.00005526048,0.000013238486,0.010247595],"genre_scores_gemma":[0.99716896,0.0005703441,0.000009907378,0.00014643394,0.00018979723,0.0008547936,0.000005082955,0.000056401885,0.000998291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944857,0.0008136465,0.0006893844,0.0005582318,0.0023945745,0.0010584596],"domain_scores_gemma":[0.99618226,0.0017696943,0.00016868759,0.0012214477,0.00047233087,0.00018557446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002837127,0.00025721913,0.0007018313,0.00034373565,0.00008919042,0.000026282783,0.0009085794,0.00024556197,0.00032576444],"category_scores_gemma":[0.0010892405,0.00014474287,0.00023810039,0.0019400275,0.0016381334,0.00016162267,0.0006939297,0.0013042121,0.00002817119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012831334,0.00042259484,0.07738022,0.0037595737,0.00021130362,0.000054438282,0.0007835852,0.00016149766,0.8744173,0.000021974132,0.011365602,0.01859055],"study_design_scores_gemma":[0.017273087,0.000503577,0.34405026,0.0019837855,0.00002839499,0.000013099592,0.00018724258,0.0012021295,0.6340321,0.000046471352,0.0005403767,0.00013953332],"about_ca_topic_score_codex":0.02128194,"about_ca_topic_score_gemma":0.00043554328,"teacher_disagreement_score":0.26667005,"about_ca_system_score_codex":0.025475211,"about_ca_system_score_gemma":0.015964352,"threshold_uncertainty_score":0.9896142},"labels":[],"label_agreement":null},{"id":"W1963995522","doi":"10.1158/1538-7445.am2013-4206","title":"Abstract 4206: Impact of nuclear telomere architecture in the transition of myelodysplastic syndromes to acute myeloid leukemias.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Myelodysplastic syndromes; Telomere; Myeloid leukemia; Disease; Genome instability; Epigenetics; Oncology; Biology; Medicine; Internal medicine; Bioinformatics; Cancer research; Genetics; Bone marrow; Gene","score_opus":0.043737082976709384,"score_gpt":0.3773805224404439,"score_spread":0.33364343946373454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963995522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950128,0.0004791587,0.000010943392,0.0025289543,0.00004791287,0.0011222484,0.00007558193,0.000019249219,0.00070315925],"genre_scores_gemma":[0.9988801,0.00047185764,0.00011817382,0.00017388069,0.00010273578,0.000113033886,0.000012398526,0.000037166934,0.00009067519],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99746925,0.0001536015,0.0004344062,0.00034354354,0.0009758919,0.0006233122],"domain_scores_gemma":[0.9984418,0.00035012857,0.000074770185,0.0005330291,0.00036536934,0.00023491259],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006243079,0.0001991287,0.00048918044,0.0006255401,0.00008017147,0.00002937239,0.00042296262,0.00013599682,0.001400593],"category_scores_gemma":[0.00017140084,0.00012726572,0.00017713354,0.0012724354,0.00033169103,0.00012197671,0.00004826976,0.0008303664,0.00008893004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013706055,0.0003565787,0.0046221074,0.00096087466,0.00027716995,0.00016411819,0.014434123,0.0008048396,0.92660344,0.00006858427,0.008392141,0.041945435],"study_design_scores_gemma":[0.001581819,0.0014750515,0.97641873,0.0010753479,0.00005496238,0.00013276684,0.0018987295,0.00008251251,0.016214598,0.0002698608,0.00056754577,0.00022807182],"about_ca_topic_score_codex":0.0069575,"about_ca_topic_score_gemma":0.00021863179,"teacher_disagreement_score":0.97179663,"about_ca_system_score_codex":0.00032339626,"about_ca_system_score_gemma":0.00057820434,"threshold_uncertainty_score":0.99965525},"labels":[],"label_agreement":null},{"id":"W1964272930","doi":"10.1158/1538-7445.am2014-152","title":"Abstract 152: Galectin-7 increases the invasive behavior of ovarian cancer cells and promotes tumor escape","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Cancer research; Ovarian cancer; Metastasis; Galectin; Cancer; Tumor microenvironment; Matrigel; Cancer cell; Biology; Medicine; Immunology; Internal medicine; Angiogenesis","score_opus":0.0412511218573742,"score_gpt":0.34061029261982056,"score_spread":0.29935917076244634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964272930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900053,0.007645867,0.0000014306353,0.00047148333,0.00031283763,0.00056305766,0.00010670447,0.00002096885,0.0008723267],"genre_scores_gemma":[0.99722147,0.0011190725,0.000009603739,0.00012229616,0.00013757704,0.0006308332,0.000011400956,0.000021825008,0.00072592066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819446,0.00048566124,0.00025653956,0.00040132797,0.00009083782,0.0005711878],"domain_scores_gemma":[0.998473,0.0006929189,0.00012279628,0.00035131865,0.00031198876,0.00004799212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009199107,0.00016387651,0.0002978369,0.00012571929,0.0003694912,0.000025944735,0.0003798363,0.00016398437,0.002055652],"category_scores_gemma":[0.00022068662,0.000110403555,0.000059950908,0.00026858225,0.0009945728,0.00005018498,0.00018560876,0.0006479155,0.00004377487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017116542,0.00010391621,0.038791876,0.000079439225,0.0000855385,0.000003167772,0.00026531468,0.0000011383294,0.9453821,0.000202603,0.0036564416,0.011257306],"study_design_scores_gemma":[0.00074600417,0.00031266885,0.15678276,0.00009574925,0.000041217063,0.000024259862,0.0002725316,6.2236376e-7,0.82515895,0.00014047713,0.01628129,0.00014348624],"about_ca_topic_score_codex":0.019704651,"about_ca_topic_score_gemma":0.005220261,"teacher_disagreement_score":0.120223165,"about_ca_system_score_codex":0.000072802024,"about_ca_system_score_gemma":0.000400223,"threshold_uncertainty_score":0.9988566},"labels":[],"label_agreement":null},{"id":"W1964373111","doi":"10.1158/1538-7445.am2012-994","title":"Abstract 994: Colorectal cancer, adenoma and normal whole genome methylation sequencing in Africa Americans","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"CpG site; DNA methylation; Epigenetics; Biology; Colorectal cancer; Bisulfite sequencing; Methylation; Cancer; Cancer research; Cancer epigenetics; Gene; Genetics; Gene expression","score_opus":0.062280409061599824,"score_gpt":0.37005718734397375,"score_spread":0.30777677828237393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964373111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740792,0.022646843,0.00065057393,0.00024988168,0.00013881821,0.0005312144,0.000099775054,0.000013501037,0.001590175],"genre_scores_gemma":[0.99490774,0.0033329043,0.00017591935,0.000041690106,0.000496308,0.0005067424,0.00006323693,0.000052141604,0.00042334068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973119,0.0002280017,0.00024137688,0.0004937333,0.0005713291,0.0011536685],"domain_scores_gemma":[0.9990804,0.000044376302,0.00005927974,0.00028143826,0.00021937041,0.00031510508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012641789,0.0001818276,0.00019879136,0.00028943914,0.00017813465,0.000058106165,0.0002774484,0.00022633118,0.00019815867],"category_scores_gemma":[0.00013991262,0.0001920005,0.000054750108,0.00062014186,0.00024860326,0.000026071015,0.00030217122,0.000640042,0.000021539412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018880676,0.000030082627,0.00049619,0.00004517383,0.000046545065,0.000009129478,0.0005736663,0.0006563226,0.98662364,0.000024418714,0.00031303466,0.010992979],"study_design_scores_gemma":[0.0009013472,0.00030358532,0.014089068,0.000059338272,0.000012211111,0.000014523163,0.00069943484,0.00019985379,0.9317535,0.000050136783,0.051536854,0.00038014917],"about_ca_topic_score_codex":0.002994427,"about_ca_topic_score_gemma":0.0010758728,"teacher_disagreement_score":0.054870155,"about_ca_system_score_codex":0.00080056436,"about_ca_system_score_gemma":0.00085252256,"threshold_uncertainty_score":0.78295535},"labels":[],"label_agreement":null},{"id":"W1964702643","doi":"10.1158/1538-7445.am2011-3940","title":"Abstract 3940: Identifying novel susceptibility genes in genomic aberrant regions in early-onset breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Breast cancer; Cancer; Single-nucleotide polymorphism; SNP array; Germline mutation; Biology; Germline; SNP; Genetics; Cancer research; Gene; Mutation; Genotype","score_opus":0.117903169228264,"score_gpt":0.40379499337743496,"score_spread":0.28589182414917097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964702643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966974,0.0015034582,0.0003278693,0.00028825385,0.00004459774,0.00050807523,0.00014796588,0.000013559341,0.00046877284],"genre_scores_gemma":[0.99594766,0.0023989154,0.00038685984,0.00006761731,0.00008403727,0.00087506714,0.000044970304,0.000027648784,0.00016721505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833214,0.00009261421,0.0002847665,0.0006099095,0.00014777057,0.00053276797],"domain_scores_gemma":[0.99911803,0.000013409261,0.000054029282,0.00057995686,0.00013484282,0.00009972769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006985107,0.00014503479,0.00016018377,0.00016935346,0.00010251168,0.000020435953,0.00043641188,0.00023034099,0.00019795245],"category_scores_gemma":[0.000020266147,0.00014368209,0.00007060986,0.0003228994,0.00028170613,0.0000065619697,0.0002390756,0.00038493876,0.00001125864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011046193,0.00014220785,0.17786361,0.000024114292,0.000016249658,0.0000069516523,0.00014116912,0.000009151074,0.8197442,0.00012732584,0.00041120828,0.0014033011],"study_design_scores_gemma":[0.00039364284,0.000040227114,0.8364357,0.000056884182,0.0000036834267,0.000011213132,0.00007765913,0.000012054354,0.16060631,0.00036025018,0.0018163815,0.0001860175],"about_ca_topic_score_codex":0.0147084305,"about_ca_topic_score_gemma":0.020543676,"teacher_disagreement_score":0.65913796,"about_ca_system_score_codex":0.00014316259,"about_ca_system_score_gemma":0.00028181582,"threshold_uncertainty_score":0.9973289},"labels":[],"label_agreement":null},{"id":"W1964891103","doi":"10.1158/0008-5472.sabcs13-p1-13-14","title":"Abstract P1-13-14: Discordance of ER and PR status between primary and recurrent breast cancer in association with endocrine therapy","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Statistics Canada","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Internal medicine; Oncology; Lymph node; Cancer; Tamoxifen; Primary tumor; Mastectomy; Metastasis","score_opus":0.025570668405971695,"score_gpt":0.3482595005825155,"score_spread":0.32268883217654376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964891103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844083,0.013333619,0.0000021224096,0.0013215975,0.000031549742,0.0004253649,0.00032597964,0.000003609014,0.00014782196],"genre_scores_gemma":[0.9703093,0.028830506,0.000031918138,0.000026945147,0.00014314974,0.000474228,0.00003341597,0.000017998298,0.00013254507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987557,0.00006534036,0.00015309587,0.00033658522,0.00028894364,0.00040035695],"domain_scores_gemma":[0.9993926,0.0000547945,0.00008253272,0.0001557127,0.00023296103,0.00008134546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017198693,0.00013165512,0.00020466124,0.00006154875,0.000062322724,0.000025220088,0.0000749366,0.00005315963,0.00005290114],"category_scores_gemma":[0.000016021086,0.0000992423,0.000016993596,0.00013933284,0.00017416758,0.000016346752,0.000101889695,0.00017236907,8.1832536e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002853433,0.00005273963,0.8621371,0.00006957631,0.00013470156,0.0000010235336,0.000149243,0.000003242616,0.039028194,0.0000021398614,0.0004591381,0.09767755],"study_design_scores_gemma":[0.0013841062,0.00013424824,0.97588176,0.000106865606,0.000007881296,0.000001409332,0.00007785236,6.7415516e-7,0.021332106,0.000029721445,0.0009370021,0.00010639889],"about_ca_topic_score_codex":0.007311817,"about_ca_topic_score_gemma":0.0021652584,"teacher_disagreement_score":0.11374463,"about_ca_system_score_codex":0.00022535968,"about_ca_system_score_gemma":0.00020005321,"threshold_uncertainty_score":0.9992986},"labels":[],"label_agreement":null},{"id":"W1965131689","doi":"10.1158/1538-7445.am10-3535","title":"Abstract 3535: Retinoblastoma cerebrospinal fluid metastases treatable by intensive intraventricular and multidrug resistance-reversal systemic chemotherapy without radiation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Vincristine; Etoposide; Radiation therapy; Chemotherapy; Carboplatin; Oncology; Internal medicine; Cyclophosphamide","score_opus":0.020909934386143376,"score_gpt":0.36098403419045744,"score_spread":0.3400740998043141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965131689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088335,0.005812022,0.000024408342,0.0016531188,0.00017593346,0.0009465891,0.00011434501,0.000042009135,0.00034825367],"genre_scores_gemma":[0.99481684,0.0018089422,0.00026909442,0.00016200785,0.00020379097,0.00018105026,0.000105049345,0.000036948015,0.0024162594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817926,0.00012772215,0.0002458876,0.0004799923,0.00047732185,0.0004898051],"domain_scores_gemma":[0.99862975,0.00013359415,0.00008627945,0.0003543675,0.00053538743,0.0002605931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005975666,0.00019771788,0.00039452992,0.00017306628,0.000243702,0.000042185886,0.000106141684,0.00019271288,0.00045277816],"category_scores_gemma":[0.00024804304,0.00015936249,0.000068044574,0.0002448256,0.00034820227,0.00013702975,0.000028709534,0.00069106417,0.000056689358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038778975,0.00036852702,0.07724465,0.00042634414,0.0007548586,0.00042597845,0.000665134,0.0000014724562,0.8669633,0.00009798665,0.033769958,0.015403878],"study_design_scores_gemma":[0.016881017,0.0010659182,0.11980614,0.00079258764,0.00038415255,0.00042516435,0.0012055895,0.00011262164,0.816383,0.00009612915,0.042379923,0.00046774786],"about_ca_topic_score_codex":0.00064352504,"about_ca_topic_score_gemma":0.0002207652,"teacher_disagreement_score":0.05058032,"about_ca_system_score_codex":0.00031400623,"about_ca_system_score_gemma":0.00031486666,"threshold_uncertainty_score":0.6498614},"labels":[],"label_agreement":null},{"id":"W1965207153","doi":"10.1158/1538-7445.am2012-3718","title":"Abstract 3718: Oncolytic reovirus synergizes with bortezomib and dexamethasone in overcoming therapy resistance of multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"Bortezomib; Oncolytic virus; Cell culture; Cancer research; Combination therapy; Multiple myeloma; Cytotoxicity; Biology; Dexamethasone; Virology; Pharmacology; In vitro; Immunology; Tumor cells; Biochemistry","score_opus":0.059570581265218484,"score_gpt":0.38207333956500417,"score_spread":0.3225027582997857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965207153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731622,0.02548209,0.000009292928,0.00014809072,0.00002963897,0.00045642568,0.000023183082,0.000006257696,0.0006828495],"genre_scores_gemma":[0.9918248,0.0069807977,0.0002493562,0.000046392233,0.00017353399,0.00018691758,0.000008959785,0.000047559926,0.00048168653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784154,0.0002577646,0.0002382016,0.00038966417,0.00053367676,0.0007391642],"domain_scores_gemma":[0.99882823,0.00020773792,0.00006876435,0.00050296687,0.0002069063,0.0001853962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018077563,0.0001650803,0.00024300413,0.00018975815,0.00010055481,0.000026605807,0.00028597898,0.00014141049,0.00007031069],"category_scores_gemma":[0.000182004,0.00013978351,0.000039081482,0.0003974097,0.00041175133,0.00001836485,0.00011220627,0.00036559466,0.0000035750468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009509302,0.00013207039,0.04830539,0.000076400385,0.00006310689,0.000006990666,0.00023239506,0.000028354001,0.9289029,0.000013526412,0.00028136512,0.012448191],"study_design_scores_gemma":[0.0022786607,0.00087365607,0.06467577,0.00012304322,0.000002812715,0.0000025243353,0.00019977614,0.000009048449,0.9240036,0.000023236564,0.007616009,0.00019188109],"about_ca_topic_score_codex":0.0005249335,"about_ca_topic_score_gemma":0.0046546925,"teacher_disagreement_score":0.018662624,"about_ca_system_score_codex":0.00011242656,"about_ca_system_score_gemma":0.00038284008,"threshold_uncertainty_score":0.5700206},"labels":[],"label_agreement":null},{"id":"W1965274991","doi":"10.1158/1538-7445.am2014-5319","title":"Abstract 5319: The role of ISBER (The International Society for Biological and Environmental Repositories) in cancer research","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Society for Cellular Therapy","funders":"","keywords":"Biorepository; Standardization; Medicine; Citation; Library science; Biobank; Political science; Computer science; Bioinformatics; Biology","score_opus":0.5000255663928951,"score_gpt":0.6204276813080263,"score_spread":0.1204021149151312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965274991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96577966,0.002311224,0.000004754336,0.027739227,0.00014486877,0.0009340335,0.000045393474,0.0000046090136,0.0030362082],"genre_scores_gemma":[0.9891228,0.0070222886,0.00007513084,0.00019459611,0.000885037,0.0007499914,0.000009939077,0.000017095683,0.0019230852],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996365,0.00027902448,0.00037084552,0.00043889444,0.0019787909,0.0005674479],"domain_scores_gemma":[0.9820721,0.016747598,0.00005207787,0.0004812663,0.000511899,0.0001350369],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019696737,0.0000893751,0.00020182444,0.00008334905,0.0003293878,0.00005511571,0.0006532759,0.00028257904,0.00040367784],"category_scores_gemma":[0.006519202,0.000048773625,0.00012235538,0.0002966188,0.0026030643,0.00004681565,0.0005944592,0.0032298851,0.000008776677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023359363,0.0005667483,0.3298147,0.0003105262,0.0003156221,0.0000069690245,0.0036603075,0.00002400429,0.5858665,0.015107381,0.0144292265,0.047562066],"study_design_scores_gemma":[0.003950993,0.0014404585,0.38021928,0.0008674187,0.00002725405,0.000011201705,0.013169392,0.00237741,0.13424319,0.096273035,0.3671274,0.00029296172],"about_ca_topic_score_codex":0.0016075654,"about_ca_topic_score_gemma":0.00061927503,"teacher_disagreement_score":0.45162332,"about_ca_system_score_codex":0.0004940537,"about_ca_system_score_gemma":0.00061753823,"threshold_uncertainty_score":0.9990697},"labels":[],"label_agreement":null},{"id":"W1965468254","doi":"10.1158/0008-5472.sabcs13-p6-07-01","title":"Abstract P6-07-01: Are patient perceptions and expectations about peri-operative imaging for metastatic breast cancer in keeping with current guidelines?","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Concordance; Stage (stratigraphy); Abdomen; Breast cancer; Asymptomatic; Radiology; Cancer; Disease; Surgery; Internal medicine","score_opus":0.06354478689642754,"score_gpt":0.4312049140350922,"score_spread":0.3676601271386647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965468254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760873,0.017639894,0.00021714087,0.0042686965,0.00008700243,0.0010917699,0.00053818227,0.00001047363,0.00005958603],"genre_scores_gemma":[0.9902437,0.002621078,0.00043125288,0.000112914946,0.00019080027,0.0062624947,0.00006045848,0.000034275858,0.00004305589],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984889,0.000066216875,0.00024855015,0.00049981696,0.00023903622,0.00045746448],"domain_scores_gemma":[0.998609,0.00004667879,0.000072393945,0.0002060513,0.00095595693,0.00010989186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121958685,0.0001913607,0.00020068047,0.00011787683,0.00032873257,0.00008903729,0.00010859598,0.000029432422,0.00022490407],"category_scores_gemma":[0.000057429173,0.00015321522,0.000044848694,0.00017133498,0.0002382388,0.000028768502,0.000101719794,0.00016642892,0.000009239021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009763972,0.000913583,0.3577651,0.0007842504,0.00096015475,0.000019988165,0.020747673,0.003098137,0.14747761,0.00007935108,0.025134468,0.44204327],"study_design_scores_gemma":[0.002595975,0.0001434679,0.9629319,0.00088223134,0.000060312082,0.000021960559,0.026239058,0.0005003855,0.0039374004,0.000074221745,0.0021094226,0.0005037031],"about_ca_topic_score_codex":0.00294065,"about_ca_topic_score_gemma":0.0045152386,"teacher_disagreement_score":0.60516673,"about_ca_system_score_codex":0.00023881475,"about_ca_system_score_gemma":0.00028503445,"threshold_uncertainty_score":0.6247936},"labels":[],"label_agreement":null},{"id":"W1965469776","doi":"10.1158/1538-7445.am2013-1494","title":"Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Notch signaling pathway; Notch 1; Epithelial–mesenchymal transition; Biology; Cancer research; Carcinogenesis; Small hairpin RNA; Pathology; Bladder cancer; Cancer; Cell biology; Gene knockdown; Metastasis; Cell culture; Signal transduction; Medicine","score_opus":0.018291871538272792,"score_gpt":0.3341918152519449,"score_spread":0.31589994371367214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965469776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460435,0.0018429484,0.00034889093,0.0014458048,0.000105556195,0.0013472759,0.000061377075,0.000023787723,0.00021999842],"genre_scores_gemma":[0.9961576,0.001771968,0.0002116282,0.00014141067,0.00047425265,0.0008363852,0.000037014903,0.00006764811,0.00030211205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696374,0.00020047878,0.00031894154,0.00090357225,0.00065916206,0.00095408136],"domain_scores_gemma":[0.9987601,0.000029729234,0.000047607515,0.00037531965,0.00039764057,0.00038959028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070874614,0.00026487352,0.00025563833,0.00034183252,0.00029777188,0.00018562323,0.000285409,0.0003328394,0.00042410623],"category_scores_gemma":[0.00007343151,0.00027017857,0.00006215613,0.00038995256,0.0002155592,0.000027933183,0.00029182184,0.00063176575,0.000017921622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010441164,0.0000892163,0.000062123676,0.000120846256,0.000074277035,0.000025105503,0.0006154623,0.00038839536,0.99068296,0.000020673695,0.00053417135,0.007282352],"study_design_scores_gemma":[0.0013653138,0.000490095,0.0043971324,0.00015859614,0.00001686644,0.000014953378,0.00031156268,0.0004980911,0.9914361,0.00029095655,0.0006433993,0.00037691044],"about_ca_topic_score_codex":0.0139332535,"about_ca_topic_score_gemma":0.0038313475,"teacher_disagreement_score":0.010101906,"about_ca_system_score_codex":0.00019532385,"about_ca_system_score_gemma":0.00047019296,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W1965945689","doi":"10.1158/1538-7445.am2012-1232","title":"Abstract 1232: Overcoming resistance to EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Lung cancer; Cancer research; Cancer; Medicine; Targeted therapy; Epidermal growth factor receptor; Receptor tyrosine kinase; Small hairpin RNA; Tyrosine kinase; EGFR inhibitors; Bioinformatics; Gene; Biology; Oncology; Internal medicine; Receptor; Genetics","score_opus":0.053612020385462054,"score_gpt":0.42470477319784306,"score_spread":0.371092752812381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965945689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96187276,0.025569772,0.000015448539,0.0035113106,0.000431742,0.0017029935,0.00007567928,0.00003210732,0.006788194],"genre_scores_gemma":[0.9830837,0.0024430847,0.00031572315,0.0006087619,0.001054928,0.001647557,0.000018494862,0.00006745154,0.01076029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975787,0.00006187947,0.00030650926,0.0004290286,0.000603696,0.001020234],"domain_scores_gemma":[0.99855727,0.00013612912,0.000053895492,0.00044420682,0.00030124246,0.0005072643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060423225,0.00021619612,0.00032023015,0.00037346545,0.00019213415,0.000053474014,0.00017049858,0.000111845155,0.00086542265],"category_scores_gemma":[0.000049587477,0.00018226376,0.000076190925,0.0008619561,0.00007284169,0.00020474753,0.000070072485,0.0005331295,0.000057955243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015561214,0.001331136,0.5314401,0.0009553083,0.00019080631,0.00012282001,0.009317547,0.000101464146,0.3391293,0.00012093143,0.094219714,0.02151479],"study_design_scores_gemma":[0.006961449,0.0002316215,0.6716078,0.001902773,0.000065758744,0.0000019642134,0.0006842263,0.000021410428,0.2007999,0.000025991303,0.11727338,0.00042376138],"about_ca_topic_score_codex":0.005347375,"about_ca_topic_score_gemma":0.003155945,"teacher_disagreement_score":0.1401677,"about_ca_system_score_codex":0.0021604092,"about_ca_system_score_gemma":0.00083084975,"threshold_uncertainty_score":0.9475771},"labels":[],"label_agreement":null},{"id":"W1966036358","doi":"10.1158/1538-7445.am2013-895","title":"Abstract 895: Activating transcription factor 3 (ATF3) down-regulation correlates with platinum resistance in non-small cell lung cancer (NSCLC).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Cisplatin; Vorinostat; Cancer research; Cytotoxicity; Lung cancer; Cell culture; Biology; Molecular biology; Medicine; Oncology; Histone deacetylase; Chemotherapy; Histone; Genetics; Gene; In vitro","score_opus":0.02913054420328339,"score_gpt":0.31736934080235474,"score_spread":0.28823879659907137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966036358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913959,0.003725134,0.00059992296,0.00038929423,0.000099356104,0.00088497327,0.000047468362,0.000013009736,0.00284498],"genre_scores_gemma":[0.9937729,0.0009442967,0.0002574383,0.000038401842,0.00021333419,0.0012928987,0.00006390497,0.000044361575,0.003372432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982619,0.00007236775,0.0002732206,0.0005356198,0.00033936973,0.00051750365],"domain_scores_gemma":[0.9989812,0.000035722063,0.00010739859,0.00037583927,0.00039021377,0.00010964365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024289345,0.0001878585,0.00016050554,0.00013100597,0.00019673524,0.00010160027,0.00024912457,0.00019134449,0.00050806935],"category_scores_gemma":[0.000020082918,0.00016414338,0.0000478442,0.0003598837,0.00011229427,0.00003781365,0.000034506054,0.0003988477,0.000014156235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017625953,0.000049747625,0.016818348,0.00013385911,0.000024389585,9.808241e-7,0.00048079234,0.0009415443,0.97371167,0.000017087737,0.0023406069,0.005304699],"study_design_scores_gemma":[0.0015888417,0.00010217102,0.46149823,0.00046196047,0.000009689566,6.298831e-7,0.00048202966,0.0006071324,0.53112084,0.00008774723,0.0036104044,0.00043033555],"about_ca_topic_score_codex":0.0023081761,"about_ca_topic_score_gemma":0.0036638966,"teacher_disagreement_score":0.4446799,"about_ca_system_score_codex":0.00024281935,"about_ca_system_score_gemma":0.00038288458,"threshold_uncertainty_score":0.66935724},"labels":[],"label_agreement":null},{"id":"W1966211525","doi":"10.1158/0008-5472.sabcs10-pd10-08","title":"Abstract PD10-08: Quantitative and Standardized Measurement of Estrogen Receptor Predicts Response to Radiation Therapy in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tamoxifen; Breast cancer; Estrogen receptor; Medicine; Oncology; Radiation therapy; Internal medicine; Cancer; Immunohistochemistry; Estrogen; Nuclear medicine; Pathology","score_opus":0.03387257482425272,"score_gpt":0.37622856647480957,"score_spread":0.34235599165055686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966211525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924912,0.0055314456,0.000008062681,0.0010180849,0.00015384883,0.00057391456,0.00016607546,0.000006310648,0.000051060608],"genre_scores_gemma":[0.99527866,0.004181653,0.00012260929,0.000026617037,0.00011076568,0.00021470529,0.000011061828,0.000020329364,0.00003358644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850875,0.00025126626,0.0001776182,0.00030279282,0.0004658861,0.0002936662],"domain_scores_gemma":[0.9991059,0.000051928855,0.00004914137,0.0002077036,0.0004367179,0.00014864786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020887328,0.000108600885,0.00014975893,0.00014248441,0.000063782485,0.000019722118,0.0001349037,0.00016492466,0.00006293218],"category_scores_gemma":[0.00021877613,0.000092148635,0.000036932375,0.00023528133,0.00013853559,0.0000068815343,0.000052261734,0.00032256788,0.0000037456025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00914588,0.000053665986,0.007349926,0.00002012227,0.000074466545,0.0000019312047,0.00026384342,0.000043500317,0.9678799,0.000016392023,0.0021160142,0.013034356],"study_design_scores_gemma":[0.001952313,0.0006131796,0.08854421,0.00007908578,0.000004191784,0.000002100164,0.00008414509,0.000014480788,0.9013278,0.000010083603,0.0072489437,0.0001195009],"about_ca_topic_score_codex":0.00046602782,"about_ca_topic_score_gemma":0.0001810168,"teacher_disagreement_score":0.08119429,"about_ca_system_score_codex":0.000088748726,"about_ca_system_score_gemma":0.0006401386,"threshold_uncertainty_score":0.37577122},"labels":[],"label_agreement":null},{"id":"W1966323955","doi":"10.1158/1538-7445.am10-70","title":"Abstract 70: Mitochondrial localization of adiponectin receptor 1 (AdipoR1) induces apoptosis in cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Adiponectin receptor 1; Biology; Population; Apoptosis; Transfection; Cell biology; Receptor; Molecular biology; Cell culture; Adiponectin; Endocrinology; Biochemistry; Medicine; Insulin","score_opus":0.03487396822553417,"score_gpt":0.3587094624400414,"score_spread":0.32383549421450725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966323955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985504,0.0022261075,0.000037827616,0.00020630096,0.010902012,0.0003935624,0.000111317386,0.000007677946,0.0006112002],"genre_scores_gemma":[0.97911096,0.004747372,0.000120452314,0.00006826602,0.014562717,0.0003620183,0.000058999274,0.000042401753,0.00092681794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982595,0.00009767652,0.00031745346,0.00046375027,0.0003967929,0.0004648587],"domain_scores_gemma":[0.9989472,0.00003628733,0.00010043626,0.00038906286,0.00038544973,0.00014153602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984258,0.0001502827,0.00022953555,0.00019908113,0.00008295922,0.00002912686,0.00032912332,0.00030975151,0.000795836],"category_scores_gemma":[0.00017589342,0.0001480962,0.00007955333,0.00041726575,0.0002366826,0.000011586853,0.00010168562,0.00050805055,0.000013110995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027039627,0.00008091492,0.0008172718,0.000065311455,0.000030764666,4.3812843e-8,0.00017302844,0.00017525353,0.9430648,0.000025275152,0.04740109,0.007895834],"study_design_scores_gemma":[0.00054062845,0.000049696977,0.0008907529,0.00003740719,0.000006120928,2.2650612e-7,0.00006991731,0.000006445502,0.69805,0.000016723305,0.30021322,0.00011884337],"about_ca_topic_score_codex":0.0068904883,"about_ca_topic_score_gemma":0.00690919,"teacher_disagreement_score":0.25281215,"about_ca_system_score_codex":0.000061835344,"about_ca_system_score_gemma":0.0007222597,"threshold_uncertainty_score":0.9997227},"labels":[],"label_agreement":null},{"id":"W1966438134","doi":"10.1158/0008-5472.sabcs11-p2-14-02","title":"P2-14-02: NCIC CTG MA.27: Clinical Tolerability and Overall Survival of Racial and Ethnic Minority Women on Aromatase Inhibitor Therapy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Aromatase inhibitor; Breast cancer; Pacific islanders; Anastrozole; Proportional hazards model; Exemestane; Cancer; Tamoxifen; Oncology; Demography; Population","score_opus":0.34842295435104587,"score_gpt":0.5226997295747786,"score_spread":0.17427677522373275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966438134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928019,0.0038532629,2.8374262e-7,0.0004948306,0.00045529453,0.00072603906,0.00010635221,0.000017392542,0.0015446334],"genre_scores_gemma":[0.99262065,0.005363172,0.000020146997,0.00021087108,0.0006321676,0.00014870394,0.000012852431,0.000015658414,0.00097577326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977636,0.00050968886,0.00036735943,0.0004746049,0.00042187911,0.00046292174],"domain_scores_gemma":[0.9985797,0.00047933112,0.00006812024,0.00032190917,0.00018951752,0.00036141396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019280238,0.00015572763,0.0005197914,0.000117602816,0.00008001341,0.000009508528,0.00009884638,0.00017063614,0.0016074522],"category_scores_gemma":[0.0001356769,0.00012361226,0.00006768377,0.0001801661,0.0007205756,0.00006282321,0.00010874173,0.00062621885,0.000012030786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047009453,0.0033148234,0.79296225,0.0005767858,0.0005087136,0.00013644934,0.0076230876,1.9242252e-7,0.022494743,0.00020265789,0.011165476,0.11400536],"study_design_scores_gemma":[0.010317796,0.0055605727,0.9607205,0.00006841008,0.000043291166,0.0000064568017,0.00018016828,0.000008256363,0.011986302,0.00069590355,0.010240055,0.0001723317],"about_ca_topic_score_codex":0.001185202,"about_ca_topic_score_gemma":0.0003458524,"teacher_disagreement_score":0.1677582,"about_ca_system_score_codex":0.00023346,"about_ca_system_score_gemma":0.00039738844,"threshold_uncertainty_score":0.9993052},"labels":[],"label_agreement":null},{"id":"W1966683891","doi":"10.1158/1538-7445.am2013-2262","title":"Abstract 2262: Anti-proliferative and cytotoxic activities of the anti-malarial compound artesunate for breast and ovarian cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Malaria Research and Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Artemisinin; Artesunate; Ovarian cancer; Cancer; Cytotoxic T cell; Breast cancer; Cancer research; Medicine; Cancer cell; Propidium iodide; Cell growth; Pharmacology; Immunology; Traditional medicine; Biology; Internal medicine; Programmed cell death; Apoptosis; Plasmodium falciparum; Malaria; In vitro; Biochemistry","score_opus":0.04231693275822886,"score_gpt":0.3593669690831962,"score_spread":0.31705003632496737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966683891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98267263,0.0020608057,0.00001959002,0.011108811,0.00012462978,0.0027225313,0.00039315212,0.000013007137,0.0008848234],"genre_scores_gemma":[0.9960054,0.0012437475,0.00004082552,0.000113559254,0.00056259,0.0008835028,0.0000062438066,0.000030182735,0.0011139583],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797744,0.0001461354,0.00025042408,0.0003742318,0.00062030426,0.00063148834],"domain_scores_gemma":[0.9982493,0.00041080697,0.00008223645,0.0003188738,0.00066504354,0.0002737452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069303374,0.00017471764,0.00042647056,0.000113875736,0.0003162307,0.00014180093,0.00018802387,0.00012687007,0.0007987649],"category_scores_gemma":[0.00012684226,0.00011413907,0.00007544116,0.00020376625,0.00065206963,0.00023928992,0.00015621618,0.0005517327,0.0000028452985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011632212,0.00017520374,0.012801973,0.00094318145,0.00021740016,0.000008587795,0.000565127,0.0000074983595,0.9723018,0.0007235163,0.002524222,0.008568304],"study_design_scores_gemma":[0.007637034,0.00035008165,0.83197695,0.00041465592,0.00006371507,0.000032840268,0.0008642656,0.0013628041,0.15581752,0.0005470457,0.00071799726,0.00021511957],"about_ca_topic_score_codex":0.0072576543,"about_ca_topic_score_gemma":0.000788966,"teacher_disagreement_score":0.81917495,"about_ca_system_score_codex":0.00012344423,"about_ca_system_score_gemma":0.0008387118,"threshold_uncertainty_score":0.9993531},"labels":[],"label_agreement":null},{"id":"W1966812518","doi":"10.1158/0008-5472.can-14-3124","title":"Novel Insights into Head and Neck Cancer using Next-Generation “Omic” Technologies","year":2015,"lang":"en","type":"review","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Head and neck squamous-cell carcinoma; Carcinogenesis; Omics; Medicine; Head and neck cancer; Cancer; Bioinformatics; Disease; Personalized medicine; Computational biology; Oncology; Cancer research; Internal medicine; Biology","score_opus":0.5895551673651261,"score_gpt":0.5475243533439392,"score_spread":0.04203081402118691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966812518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005642464,0.99090624,0.000011264653,0.00091320364,0.0004687308,0.0015348746,0.000035827667,0.00011792459,0.00036945465],"genre_scores_gemma":[0.00030408776,0.9959793,0.00040575548,0.00006484064,0.0011758729,0.0011703034,0.000036099784,0.000092482034,0.0007712352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706084,0.00012556919,0.0005106673,0.00082689716,0.0008098536,0.0006661511],"domain_scores_gemma":[0.99822253,0.00009735756,0.00013481257,0.0005572655,0.00076723413,0.00022081508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056403835,0.0004351369,0.0019722981,0.0006944593,0.00039232025,0.0001063576,0.0002580823,0.0005441721,0.000035917194],"category_scores_gemma":[0.00024521592,0.00031457556,0.00014312974,0.0011284976,0.00054658396,0.00016818159,0.00047458502,0.0013000749,0.000017787148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033169235,0.000046851575,0.000025160762,0.011995396,0.00023847037,0.000022247747,0.00046193597,0.0000012358162,0.001687797,0.00006336282,0.008206285,0.9772181],"study_design_scores_gemma":[0.0006791719,0.0002122667,0.00000466117,0.0219321,0.00028798674,0.000029403935,0.00020440404,0.00010341763,0.0001965077,0.000044399,0.9759978,0.00030786273],"about_ca_topic_score_codex":0.003986496,"about_ca_topic_score_gemma":0.0021605713,"teacher_disagreement_score":0.97691023,"about_ca_system_score_codex":0.0023293344,"about_ca_system_score_gemma":0.0042296983,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W1967038424","doi":"10.1158/1538-7445.am2013-4850","title":"Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Biology; Circadian rhythm; CLOCK; Single-nucleotide polymorphism; Ovarian cancer; Serous fluid; Circadian clock; Internal medicine; Carcinogenesis; Population; Genetics; Timeless; Oncology; Cancer; Cancer research; Endocrinology; Gene; Genotype; Medicine","score_opus":0.025182243515339424,"score_gpt":0.3255118183809382,"score_spread":0.30032957486559875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967038424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898428,0.008886144,0.000049884562,0.0003867267,0.000108884786,0.00046199668,0.00014424075,0.0000066908055,0.000112644775],"genre_scores_gemma":[0.977739,0.020764425,0.00006217184,0.0001408904,0.0005345276,0.00060180656,0.00003242606,0.000022557404,0.00010224742],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985515,0.00014833534,0.00019787904,0.00045178435,0.00023649368,0.00041400408],"domain_scores_gemma":[0.9990316,0.000032563417,0.000054569402,0.0002913964,0.00036547476,0.00022438323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036937912,0.00012752377,0.000121685465,0.00013647128,0.0001575214,0.0000910356,0.00016527862,0.00015989927,0.0002429041],"category_scores_gemma":[0.00016644891,0.00013167568,0.000033940563,0.00018899536,0.00018676282,0.000018856304,0.000096923206,0.00019489131,0.000023810877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012049368,0.00006629225,0.11925874,0.00011168376,0.000029319493,0.000007358386,0.00021513319,0.0004509556,0.86068237,0.00005476941,0.0005842408,0.018418666],"study_design_scores_gemma":[0.001018855,0.00006509713,0.91526103,0.000060505885,0.000007911316,0.0000023912412,0.00007751139,0.000031073872,0.07645527,0.0018033223,0.005021908,0.00019512637],"about_ca_topic_score_codex":0.017853128,"about_ca_topic_score_gemma":0.0033339674,"teacher_disagreement_score":0.79600227,"about_ca_system_score_codex":0.00007269026,"about_ca_system_score_gemma":0.00048953807,"threshold_uncertainty_score":0.9886871},"labels":[],"label_agreement":null},{"id":"W1967238137","doi":"10.1158/0008-5472.sabcs11-pd06-01","title":"PD06-01: Molecular Classification with 21 Gene Assay (Oncotype DX®) Shows in 196,967 ER Positive Patients High Frequency of Low Recurrence Score [LRS] in Both Node Positive (N+) and Negative (N-) Breast Cancer (BrCa) Cohorts. Definition of Chemoresistance Based on LRS with Cost and Guideline Implications.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Oncology; Gynecology","score_opus":0.036737005205539554,"score_gpt":0.3121608027012461,"score_spread":0.2754237974957065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967238137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948044,0.0008467168,0.00038437368,0.00051782525,0.000015674439,0.0010147678,0.001916963,0.0000039771835,0.00049533],"genre_scores_gemma":[0.99606526,0.00071955635,0.0018812877,0.00011186378,0.00001796759,0.0007874177,0.00038145029,0.000030443045,0.0000047564936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981287,0.00020968604,0.00033375097,0.0006457369,0.0003550514,0.0003270865],"domain_scores_gemma":[0.9982346,0.00007086116,0.00022684094,0.000334586,0.0010443081,0.00008875198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002832284,0.00023146278,0.00031782218,0.00018106376,0.00007542693,0.000011017836,0.0001393092,0.000114424925,0.000018947734],"category_scores_gemma":[0.000059134654,0.00019472795,0.00002284316,0.0004800822,0.0006389601,0.000023401508,0.000061863844,0.00019954899,2.5208044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004214668,0.0005180392,0.89671457,0.00011390908,0.00013625546,0.000008068924,0.00039610028,0.000095068244,0.09386239,0.00031750338,0.00007731312,0.0035461246],"study_design_scores_gemma":[0.0022080147,0.00038476984,0.84936655,0.0006307927,0.00003062656,0.0000024907463,0.00009987372,0.000041944986,0.14690407,0.00015135415,0.0000014461395,0.00017806794],"about_ca_topic_score_codex":0.0075621577,"about_ca_topic_score_gemma":0.008243097,"teacher_disagreement_score":0.053041674,"about_ca_system_score_codex":0.0003297179,"about_ca_system_score_gemma":0.00049189857,"threshold_uncertainty_score":0.99904656},"labels":[],"label_agreement":null},{"id":"W1967553819","doi":"10.1158/1538-7445.am2012-464","title":"Abstract 464: CXCR7 protein is strongly expressed in B-acute lymphoblastic leukemia (ALL) but not in T-ALL or acute myelogenous leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Medicine; Bone marrow; Leukemia; Peripheral blood mononuclear cell; Cancer research; CXCR4; Flow cytometry; Myeloid; Immunology; Chemokine; Pathology; Biology; In vitro; Inflammation","score_opus":0.09803249925159335,"score_gpt":0.3906966365395528,"score_spread":0.2926641372879594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967553819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956776,0.0009530041,0.000017206237,0.0006585716,0.00015458185,0.0014725436,0.00010921759,0.000050567705,0.00090671465],"genre_scores_gemma":[0.99313253,0.00074453297,0.00025347556,0.00027259407,0.00067884795,0.0007577621,0.000045938228,0.000100064,0.0040142513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955504,0.00013316305,0.000643897,0.0006390794,0.0011967845,0.0018366578],"domain_scores_gemma":[0.99827087,0.00024394593,0.000104674604,0.0005881969,0.00022656025,0.000565743],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013306512,0.0003551704,0.00067795033,0.0005645662,0.000097721015,0.000069402064,0.00041018103,0.00034181433,0.0022729565],"category_scores_gemma":[0.00020345906,0.00029176736,0.00012709986,0.00077338895,0.00019359183,0.00027434938,0.000219676,0.0013503297,0.00016936418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030674327,0.00019086903,0.0043689213,0.00037463347,0.00021070997,0.00052262016,0.0021986964,0.000091680755,0.98056024,0.000016503396,0.002519015,0.005878665],"study_design_scores_gemma":[0.006707695,0.0004147691,0.01822102,0.0011535891,0.000085515145,0.00006266697,0.00060451624,0.00057541527,0.95905226,0.000027354385,0.012592505,0.00050267036],"about_ca_topic_score_codex":0.0067274654,"about_ca_topic_score_gemma":0.00044191326,"teacher_disagreement_score":0.021507971,"about_ca_system_score_codex":0.0066393837,"about_ca_system_score_gemma":0.0031929011,"threshold_uncertainty_score":0.99995345},"labels":[],"label_agreement":null},{"id":"W1967576466","doi":"10.1158/1538-7445.am10-5463","title":"Abstract 5463: YK5, a novel dual Hsc70 and Hsp70 inhibitor, is selective for tumor Hsp70 and has potent but selective activity in cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Carcinogenesis; Heat shock protein; Biology; Hsp70; Chaperone (clinical); Cancer research; Cancer cell; Hsp90; Metastasis; Cell biology; Cancer; Genetics; Medicine; Pathology; Gene","score_opus":0.057637327544725135,"score_gpt":0.38603366644904447,"score_spread":0.32839633890431935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967576466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946222,0.0010395845,0.00007146856,0.0014399186,0.00013212673,0.0018905519,0.0005816887,0.000009817933,0.00021266249],"genre_scores_gemma":[0.9959699,0.0006372157,0.00021895439,0.00010340221,0.00058705977,0.001670751,0.0000146004495,0.00006497758,0.0007331759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969459,0.00012835793,0.00023625368,0.001043568,0.0005572849,0.0010886388],"domain_scores_gemma":[0.9982988,0.00014928132,0.000058859092,0.0003651682,0.0007704518,0.00035738948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012247311,0.00027622588,0.0003142167,0.000262552,0.00038427277,0.00015878244,0.00023652661,0.00034320436,0.000051432096],"category_scores_gemma":[0.0003655296,0.00026719834,0.00006546329,0.00041500083,0.0006030163,0.000027804073,0.00039731676,0.0012560054,0.000004316812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097848,0.00020466602,0.0016772411,0.00014862765,0.000072465904,0.000010645428,0.00036331426,0.000007935934,0.9860812,0.00000797882,0.004149478,0.00629797],"study_design_scores_gemma":[0.0017080953,0.0005244582,0.017366748,0.00005324153,0.0000067544847,0.000013088537,0.00011858952,0.00011122688,0.9723384,0.0000710451,0.007395821,0.00029253738],"about_ca_topic_score_codex":0.009941755,"about_ca_topic_score_gemma":0.009292125,"teacher_disagreement_score":0.015689507,"about_ca_system_score_codex":0.0002665642,"about_ca_system_score_gemma":0.0018597262,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W1967588226","doi":"10.1158/1538-7445.am2014-2303","title":"Abstract 2303: Decitabine impact on immunohistochemistry scores for tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in human tumor samples","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Decitabine; FHIT; PTEN; WWOX; Immunohistochemistry; Azacitidine; Medicine; Cancer research; Methylation; Tumor suppressor gene; Pathology; DNA methylation; Cancer; Internal medicine; Biology; Gene expression; Suppressor; Gene; Apoptosis; Carcinogenesis","score_opus":0.03839755056041863,"score_gpt":0.3870296578829128,"score_spread":0.34863210732249417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967588226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933712,0.0049093757,0.000031208798,0.0001635264,0.00008691394,0.0004799012,0.0004180636,0.0000077769355,0.00053207326],"genre_scores_gemma":[0.9976863,0.0005658943,0.000120808305,0.00012331404,0.00064868387,0.0004410417,0.00020085285,0.000053044558,0.00016004332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982499,0.0000472814,0.00027547294,0.00057857507,0.00023290014,0.0006158587],"domain_scores_gemma":[0.99879694,0.00023796062,0.00007442707,0.0005078026,0.00020190554,0.00018097222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006189416,0.00022619712,0.0002659694,0.00012165505,0.00020049713,0.00009598937,0.00034982173,0.00010434507,0.00007662627],"category_scores_gemma":[0.000458368,0.00020515578,0.0001033869,0.00010442033,0.00024809683,0.000005730523,0.00018555006,0.00023375786,0.0000032542275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059416634,0.0000781773,0.0054928064,0.00012846601,0.000035083343,0.000005187948,0.00003605873,0.00021733927,0.9857145,0.00012201583,0.0051269988,0.0024492126],"study_design_scores_gemma":[0.0020324793,0.0007072926,0.051447272,0.00013682836,0.000011936681,0.000008476931,0.000076631026,0.000082051614,0.92535394,0.0007495742,0.019010622,0.00038288784],"about_ca_topic_score_codex":0.0013496269,"about_ca_topic_score_gemma":0.00039364374,"teacher_disagreement_score":0.06036054,"about_ca_system_score_codex":0.00015334322,"about_ca_system_score_gemma":0.00027630007,"threshold_uncertainty_score":0.836601},"labels":[],"label_agreement":null},{"id":"W1967656855","doi":"10.1158/0008-5472.can-09-3252","title":"Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Hsp27; Phosphorylation; Protein kinase B; MAPK/ERK pathway; Cancer research; Biology; PI3K/AKT/mTOR pathway; Autocrine signalling; Signal transduction; Paracrine signalling; Cell biology; Kinase; Heat shock protein; Biochemistry; Receptor; Hsp70","score_opus":0.032435563730235754,"score_gpt":0.3588094555276846,"score_spread":0.32637389179744886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967656855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718595,0.0011686134,0.000112636604,0.00028954024,0.00012086003,0.00096579717,0.00005129283,0.0000065092922,0.000098790544],"genre_scores_gemma":[0.9978862,0.001097854,0.000117510055,0.000010562804,0.00015388038,0.00042534622,0.000034299213,0.000034381985,0.0002400125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779284,0.00027503446,0.0002859998,0.00048333174,0.0006722139,0.0004905643],"domain_scores_gemma":[0.9987342,0.00007256846,0.000065810134,0.0002809164,0.00071055937,0.00013598353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013424708,0.00014395734,0.00018656357,0.00022822291,0.00011539507,0.000042223382,0.00023076673,0.00019413806,0.000107155494],"category_scores_gemma":[0.0004433262,0.00013723712,0.000029850728,0.00040697714,0.00021344883,0.000022264876,0.00024807517,0.00068637263,0.0000025356153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031870825,0.00006583501,0.05917076,0.00013941884,0.000026228208,0.00000307446,0.00028724116,0.000024445708,0.93002665,0.000026790609,0.000017059212,0.00989378],"study_design_scores_gemma":[0.0006978763,0.00020059964,0.030889336,0.000057669116,0.0000022728955,0.0000013138041,0.00007127223,0.00012713253,0.96727747,0.00018742787,0.00034674996,0.00014089378],"about_ca_topic_score_codex":0.0063615963,"about_ca_topic_score_gemma":0.0033325357,"teacher_disagreement_score":0.0372508,"about_ca_system_score_codex":0.00012947351,"about_ca_system_score_gemma":0.0005980526,"threshold_uncertainty_score":0.96168727},"labels":[],"label_agreement":null},{"id":"W1967658153","doi":"10.1158/1538-7445.am2013-5436","title":"Abstract 5436: Oct4 interaction with Hmgb2 regulates Akt signaling and the pluripotent gene expression signature.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Protein kinase B; Biology; Homeobox protein NANOG; SOX2; Cell biology; Chromatin; Induced pluripotent stem cell; Cancer research; Signal transduction; Genetics; Embryonic stem cell; Gene","score_opus":0.02991102410088043,"score_gpt":0.3309758268020578,"score_spread":0.30106480270117736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967658153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917995,0.0056930073,0.00029152405,0.0013166165,0.00005990758,0.0004257508,0.0000055435758,0.0000071678282,0.00040100992],"genre_scores_gemma":[0.9966906,0.001183069,0.00019401444,0.00009070243,0.00029048542,0.00047820437,0.000022858783,0.00001873089,0.0010313622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897647,0.00009270147,0.00012485532,0.00031438278,0.00024687112,0.0002447009],"domain_scores_gemma":[0.99921495,0.000040466395,0.000052485953,0.00032406842,0.00029323704,0.00007479876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036709142,0.00009951043,0.000090909794,0.00004268182,0.0002516425,0.00011756219,0.00017319615,0.000089917296,0.00018752943],"category_scores_gemma":[0.00003113781,0.000057727888,0.000032211134,0.00010140088,0.00026219687,0.000013985703,0.00008620773,0.0002572724,0.000010649544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028537,0.00001636672,0.00010049183,0.000015687016,0.000029128887,7.282115e-7,0.00009351302,0.0004468077,0.9878318,0.000038321432,0.003450016,0.007691793],"study_design_scores_gemma":[0.0007151458,0.00007094459,0.002181322,0.00006628249,0.0000060134544,0.000005649612,0.00030689462,0.00007659688,0.987507,0.00020316838,0.00875981,0.00010120837],"about_ca_topic_score_codex":0.0005367338,"about_ca_topic_score_gemma":0.00004109819,"teacher_disagreement_score":0.007590585,"about_ca_system_score_codex":0.000036566908,"about_ca_system_score_gemma":0.00009200625,"threshold_uncertainty_score":0.2354075},"labels":[],"label_agreement":null},{"id":"W1967716186","doi":"10.1158/1538-7445.am2011-999","title":"Abstract 999: PTEN/PI-3 kinase pathway's regulation of β-catenin in epithelial to mesenchymal transition (EMT)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Epithelial–mesenchymal transition; PTEN; Biology; Cancer research; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Cell migration; Actin cytoskeleton; Cell biology; Cancer cell; Metastasis; Signal transduction; Cancer; Cell; Cytoskeleton; Genetics","score_opus":0.1386978741300782,"score_gpt":0.3942976096437046,"score_spread":0.25559973551362636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967716186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943768,0.00054976344,0.000021950942,0.0017013637,0.000094368246,0.0008325561,0.00007100936,0.000015758016,0.0023364366],"genre_scores_gemma":[0.998477,0.00042454572,0.00014719687,0.00006878176,0.00016914701,0.00044822178,0.000024853205,0.000022169856,0.000218107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838454,0.0000649305,0.0002969791,0.00032159945,0.0005625243,0.0003694275],"domain_scores_gemma":[0.9991522,0.00006122978,0.000040903313,0.0002685301,0.00028170526,0.00019543472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005702378,0.00011385363,0.00026204428,0.00037370142,0.000046113153,0.0000088783845,0.00008553737,0.0000872503,0.0015438051],"category_scores_gemma":[0.000040107534,0.00009817929,0.00008033883,0.000509985,0.00009506543,0.00008361628,0.00001999686,0.00023126366,0.000058632144],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051635546,0.0019898845,0.018412244,0.00053019484,0.00013513232,0.00032513682,0.0132457,0.0001479347,0.77480245,0.0014776913,0.0023226433,0.18144745],"study_design_scores_gemma":[0.0018228444,0.00052606553,0.4979773,0.00044159353,0.000017969958,0.0000035074047,0.0002110524,0.00003170631,0.49746907,0.0003882098,0.001020213,0.00009048171],"about_ca_topic_score_codex":0.01020124,"about_ca_topic_score_gemma":0.0018886176,"teacher_disagreement_score":0.47956505,"about_ca_system_score_codex":0.0004415045,"about_ca_system_score_gemma":0.00033697757,"threshold_uncertainty_score":0.9993689},"labels":[],"label_agreement":null},{"id":"W1967725065","doi":"10.1158/0008-5472.sabcs-09-303","title":"Can We Predict Which Women with a Negative Sentinel Lymph Node Biopsy Are at High Risk of a False Negative Result?","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Sentinel lymph node; Axillary Lymph Node Dissection; Breast cancer; Biopsy; Sentinel node; Logistic regression; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.020745539843848235,"score_gpt":0.31417168642178395,"score_spread":0.2934261465779357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967725065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928095,0.0010555009,0.0000098204155,0.003971969,0.00003817818,0.00037343128,0.0010589187,0.000017949616,0.0006647643],"genre_scores_gemma":[0.99582696,0.002348353,0.00016522311,0.000087876215,0.00023492283,0.00044840353,0.00004493256,0.0000330234,0.0008103246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975171,0.0002763599,0.00023770868,0.0006826072,0.0005616978,0.00072450837],"domain_scores_gemma":[0.9979821,0.000090039146,0.00020417666,0.0005626111,0.00097060186,0.00019046156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032020008,0.00026596358,0.00035337874,0.000121935016,0.00028758455,0.000023130186,0.00029001528,0.00013209031,0.000043652817],"category_scores_gemma":[0.00028465746,0.00020451896,0.000050568095,0.00068969413,0.00044148712,0.000007192948,0.0002393752,0.00021746826,0.0000059556505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025267538,0.0009230563,0.7097998,0.00030301439,0.0036327627,0.00010476518,0.0104332995,0.0008430227,0.23141934,0.00007973375,0.0061937324,0.010999918],"study_design_scores_gemma":[0.0045426525,0.00041700734,0.8239835,0.0002517258,0.000059969334,0.000012849583,0.002290089,0.000012457995,0.16727322,0.0005853888,0.00027814685,0.00029299824],"about_ca_topic_score_codex":0.0035545274,"about_ca_topic_score_gemma":0.0012762855,"teacher_disagreement_score":0.11418368,"about_ca_system_score_codex":0.00055587577,"about_ca_system_score_gemma":0.00048277687,"threshold_uncertainty_score":0.8340041},"labels":[],"label_agreement":null},{"id":"W1967801015","doi":"10.1158/1538-7445.am2012-4103","title":"Abstract 4103: Hepatocellular carcinoma-specific isoforms of methylated DNA-binding protein 2 and their therapeutic and diagnostic potential","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; Hepatocellular carcinoma; Cancer research; Gene knockdown; Metastasis; Biology; Cancer; Liver cancer; Cancer cell; Liver cell; Gene isoform; Somatic cell; Cell culture; Gene; Medicine; Internal medicine; Gene expression; Genetics","score_opus":0.054810775275307276,"score_gpt":0.3275848451606018,"score_spread":0.27277406988529457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967801015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504924,0.048636094,0.00019133718,0.000051365903,0.000056742887,0.00041789966,0.000023412464,0.0000042332595,0.00012652164],"genre_scores_gemma":[0.9949751,0.0045488845,0.000052456588,0.00000427349,0.00018115324,0.00007599682,0.000031776683,0.000025583471,0.000104813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886346,0.00010770333,0.00018482884,0.00025482362,0.00019161685,0.00039759272],"domain_scores_gemma":[0.99936926,0.000066543704,0.000060267193,0.00022608295,0.00014089576,0.00013693685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000862022,0.00012745056,0.00014362638,0.00009317008,0.00013368335,0.000031839158,0.00010773288,0.00014581354,0.00003771468],"category_scores_gemma":[0.000070212605,0.00010085324,0.000037981863,0.00012720241,0.0002038887,0.000009771314,0.00012115907,0.00017420365,0.0000021408541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005108389,0.000035821748,0.030699072,0.00005202597,0.00003696114,0.0000010824193,0.00016346131,0.0000024520339,0.9586022,0.00007722054,0.000012149532,0.010266508],"study_design_scores_gemma":[0.0003188907,0.00013901496,0.04869961,0.00002572006,0.0000062769755,0.0000014423124,0.0001490888,0.000027897126,0.94865835,0.00034104937,0.0015141503,0.00011853848],"about_ca_topic_score_codex":0.00009371331,"about_ca_topic_score_gemma":0.0000066469647,"teacher_disagreement_score":0.04448267,"about_ca_system_score_codex":0.000021834585,"about_ca_system_score_gemma":0.000058977297,"threshold_uncertainty_score":0.4112676},"labels":[],"label_agreement":null},{"id":"W1967958271","doi":"10.1158/1538-7445.am2012-4983","title":"Abstract 4983: Correlation telomere shortening in chronic lymphocytic leukemia cells with oxidative stress and dysregulation of shelterin proteins","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Shelterin; Telomere; Chronic lymphocytic leukemia; Molecular biology; Oxidative stress; Biology; DNA damage; Telomere-binding protein; DNA; Leukemia; Cancer research; Immunology; Genetics; Endocrinology; Gene; DNA-binding protein","score_opus":0.02125922879989887,"score_gpt":0.31121125399981886,"score_spread":0.28995202519991997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967958271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982141,0.0008267503,0.00023409483,0.0000055341693,0.000045601573,0.0002889585,0.000009933255,0.0000034122288,0.0003716069],"genre_scores_gemma":[0.9993382,0.0001422422,0.00015710284,0.0000036981135,0.00017351296,0.00003933724,0.00003179598,0.000014756712,0.000099372635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992782,0.00004457705,0.000111391746,0.00017203366,0.00016856247,0.00022527216],"domain_scores_gemma":[0.99967563,0.000011392551,0.000047166577,0.00013156269,0.00008451506,0.00004971582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019913889,0.00007496086,0.00008459017,0.0000795791,0.0000482071,0.000012201765,0.000052772,0.000094481264,0.0000417291],"category_scores_gemma":[0.000009047458,0.000063868574,0.000012277587,0.00013835152,0.000106872634,0.000017502138,0.00004308494,0.00012749532,0.0000017172554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023048154,0.0000059945974,0.012865152,0.00009882958,0.000018051272,7.03533e-7,0.00018568277,0.0038290552,0.97477275,0.00003501147,0.0000355643,0.007922725],"study_design_scores_gemma":[0.00057952676,0.00026593733,0.17253321,0.00013066185,0.000006142593,0.0000026477271,0.00020860897,0.00072197185,0.8250671,0.000012157943,0.00037184122,0.00010021268],"about_ca_topic_score_codex":0.0004972147,"about_ca_topic_score_gemma":0.0003603674,"teacher_disagreement_score":0.15966806,"about_ca_system_score_codex":0.0006312895,"about_ca_system_score_gemma":0.00043802208,"threshold_uncertainty_score":0.2604485},"labels":[],"label_agreement":null},{"id":"W1968258914","doi":"10.1158/1538-7445.am2011-3041","title":"Abstract 3041: Focal amplification of chromosome 9p13 is associated with progression risk and activation of multiple oncogenes in oral precancers","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"OPLS; Carcinogenesis; Biology; Gene duplication; Tumor progression; Gene; Cancer research; Cancer; KRAS; Gene dosage; Disease; Pathology; Gene expression; Genetics; Medicine; Mutation","score_opus":0.09189509022879588,"score_gpt":0.3824694419785054,"score_spread":0.2905743517497095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968258914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851507,0.0007372977,0.00015572071,0.000031789576,0.000014056669,0.00031923727,0.000060612005,0.00000285623,0.00016335951],"genre_scores_gemma":[0.99822617,0.0012481047,0.00021227241,0.0000055674627,0.000022671873,0.00018842418,0.000039388407,0.000012721516,0.000044690976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911225,0.00008166232,0.000179799,0.00024582187,0.0002148763,0.0001655664],"domain_scores_gemma":[0.99924743,0.000025447493,0.00015460681,0.00020949106,0.000321466,0.00004156236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039313553,0.000072430594,0.00011830945,0.00008246831,0.00004923117,0.000006129472,0.000110468776,0.00010514224,0.000038047005],"category_scores_gemma":[0.00009774778,0.00006004014,0.000020405389,0.00024315533,0.00021364416,0.000011365138,0.000034397304,0.00011528895,3.462055e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004655347,0.00013135494,0.13087511,0.000042657528,0.000038151422,2.1979723e-7,0.0004397131,0.00003370327,0.8364193,0.000010963863,0.00009116406,0.031452145],"study_design_scores_gemma":[0.00050461816,0.00021716875,0.33580923,0.00010585661,0.000004607106,1.77504e-7,0.00012598746,0.000055569064,0.6628992,0.000034541663,0.00018779637,0.00005527154],"about_ca_topic_score_codex":0.00170266,"about_ca_topic_score_gemma":0.0007542018,"teacher_disagreement_score":0.20493412,"about_ca_system_score_codex":0.0000687855,"about_ca_system_score_gemma":0.00022562932,"threshold_uncertainty_score":0.25739238},"labels":[],"label_agreement":null},{"id":"W1968694761","doi":"10.1158/0008-5472.sabcs13-pd2-6","title":"Abstract PD2-6: Exercise dose and type effects in breast cancer patients receiving chemotherapy: A randomized trial","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Ottawa; Ottawa Hospital; University of British Columbia; Alberta Health Services","funders":"","keywords":"Medicine; Aerobic exercise; Breast cancer; Clinical endpoint; Randomized controlled trial; Internal medicine; Physical therapy; Chemotherapy; Cancer","score_opus":0.027943775181983307,"score_gpt":0.3663591546197945,"score_spread":0.3384153794378112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968694761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840976,0.0039610146,4.233806e-7,0.0019245384,0.0006782776,0.0040451623,0.000011347498,0.000028870081,0.0009406358],"genre_scores_gemma":[0.98914367,0.0068975557,0.0000071863437,0.00025130255,0.0004060433,0.0024965452,0.0000092861,0.000045921493,0.0007425093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99787974,0.00020994752,0.0002999782,0.00041732917,0.00064064236,0.0005523518],"domain_scores_gemma":[0.9984592,0.00044895848,0.000059697646,0.00027349874,0.00049466884,0.0002639423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010277472,0.0001809158,0.00066377845,0.00027085483,0.00007823996,0.000079672216,0.0001237248,0.00014408701,0.0016875356],"category_scores_gemma":[0.0001948772,0.00014017899,0.00008934584,0.0005963046,0.00020912613,0.00015218776,0.00006430166,0.00056960655,0.000041418974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74610746,0.0003140377,0.038733184,0.0008016073,0.000095160285,0.000014951992,0.0027946786,0.0000015111408,0.003599571,0.000008536483,0.005413257,0.20211604],"study_design_scores_gemma":[0.6673339,0.00018658556,0.32909194,0.001595126,0.000035557452,0.0000014537151,0.00014770105,0.000041712305,0.00069777266,0.00015171722,0.00052144343,0.00019509847],"about_ca_topic_score_codex":0.032152925,"about_ca_topic_score_gemma":0.0018899019,"teacher_disagreement_score":0.29035878,"about_ca_system_score_codex":0.00039502684,"about_ca_system_score_gemma":0.0004059854,"threshold_uncertainty_score":0.9992251},"labels":[],"label_agreement":null},{"id":"W1968700451","doi":"10.1158/0008-5472.sabcs-09-23","title":"First Results from FACT – An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Anastrozole; Medicine; Tolerability; Tamoxifen; Breast cancer; Internal medicine; Clinical endpoint; Oncology; Estrogen; Aromatase inhibitor; Cancer; Estrogen receptor; Endocrinology; Clinical trial; Adverse effect","score_opus":0.04106490875859826,"score_gpt":0.365630971919384,"score_spread":0.32456606316078573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968700451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406487,0.0013524318,0.0000073733263,0.0007778419,0.00009394695,0.0026755952,0.0008518811,0.000017775603,0.00015831253],"genre_scores_gemma":[0.99753773,0.00093105313,0.00025345673,0.000032806773,0.00013601437,0.00031490435,0.00064556306,0.000047075344,0.00010141178],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99626964,0.0007760339,0.00067373365,0.0009517711,0.00057036994,0.0007584429],"domain_scores_gemma":[0.99806476,0.00025995355,0.0002961841,0.00064441736,0.00032187675,0.0004128079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014276905,0.0003718248,0.0007904274,0.0001819949,0.00043871906,0.00010093952,0.00070239237,0.0002352987,0.00003506855],"category_scores_gemma":[0.00018630002,0.0003056713,0.00006349575,0.00066093344,0.0004934515,0.000056060297,0.00031557688,0.0006472437,0.0000036037545],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46887696,0.0015909056,0.00058024464,0.000012598024,0.00037654565,0.000052190684,0.0013679446,0.0007240448,0.524679,0.0000068462855,0.0007601177,0.00097256055],"study_design_scores_gemma":[0.7201788,0.02030945,0.0053928397,0.00062443496,0.00013945044,0.000007092819,0.0014504857,0.0010437052,0.25020343,0.000012377942,0.00007234027,0.00056560873],"about_ca_topic_score_codex":0.011691867,"about_ca_topic_score_gemma":0.005881368,"teacher_disagreement_score":0.2744756,"about_ca_system_score_codex":0.00032142497,"about_ca_system_score_gemma":0.00046192663,"threshold_uncertainty_score":0.99993956},"labels":[],"label_agreement":null},{"id":"W1968802517","doi":"10.1158/0008-5472.can-08-0645","title":"Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"University of Cincinnati; Ohio Cancer Research Associates; College of Medicine, University of Cincinnati; National Cancer Institute; National Institutes of Health; Ohio Cancer Research","keywords":"Prostate cancer; Prostatitis; Prostate; Cancer research; Cancer; Oncogene; Intraepithelial neoplasia; Tramp; PCA3; Medicine; Biology; Internal medicine; Cell cycle","score_opus":0.07736956106048473,"score_gpt":0.4065717295991332,"score_spread":0.3292021685386485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968802517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871985,0.008112387,7.2333955e-7,0.0014111731,0.00012773722,0.0024666763,0.00032426536,0.00002639882,0.00033216606],"genre_scores_gemma":[0.97519577,0.019626746,0.00017407039,0.00004166343,0.00019133273,0.0014937617,0.00007239232,0.00005425506,0.0031499849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678653,0.00025855392,0.00046078712,0.00057912304,0.0010664846,0.00084851333],"domain_scores_gemma":[0.99846715,0.00016098302,0.000108308064,0.00032222443,0.00062726834,0.00031407023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006190681,0.00023264851,0.00053603656,0.00055576186,0.00020914571,0.000027860728,0.00015133792,0.00014607783,0.0005197882],"category_scores_gemma":[0.00015759486,0.00017585179,0.000054865115,0.0009579743,0.0008012261,0.0002273745,0.00018669767,0.000631753,0.000008787713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036199975,0.00030358325,0.12541617,0.0008701765,0.000081949474,0.00020668675,0.005179564,0.0000065258378,0.8525254,0.000012945642,0.001433939,0.010343038],"study_design_scores_gemma":[0.0074198553,0.0010818895,0.20666002,0.0019167914,0.000020931759,0.000031946085,0.00040941223,0.000044087898,0.7804717,0.00014932807,0.0015685116,0.00022555553],"about_ca_topic_score_codex":0.00485803,"about_ca_topic_score_gemma":0.00031389465,"teacher_disagreement_score":0.08124385,"about_ca_system_score_codex":0.0005044311,"about_ca_system_score_gemma":0.0020849449,"threshold_uncertainty_score":0.73439205},"labels":[],"label_agreement":null},{"id":"W1968874773","doi":"10.1158/1538-7445.am10-3417","title":"Abstract 3417: Ezh2 is up-regulated and correlates with Ki67 and CD31 expression in human pediatric rhabdomyosarcoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Rhabdomyosarcoma; EZH2; Biology; Immunohistochemistry; CD31; Cancer research; Myogenesis; Pathology; Angiogenesis; Gene expression; Skeletal muscle; Medicine; Endocrinology; Sarcoma; Immunology; Gene; Genetics","score_opus":0.04399584112906887,"score_gpt":0.3835422866956413,"score_spread":0.33954644556657243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968874773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919655,0.0057164575,2.1435547e-7,0.0012610495,0.00006234782,0.0005501633,0.000010561643,0.0000222445,0.00041147432],"genre_scores_gemma":[0.99744207,0.0016994465,0.00006559172,0.000058771286,0.00014699664,0.00018863594,0.000011701556,0.000029120425,0.0003576671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985332,0.000039389473,0.00018063773,0.00040905105,0.00043556292,0.00040214794],"domain_scores_gemma":[0.9990836,0.0002037609,0.00003967865,0.000290178,0.00013540835,0.0002473993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033170034,0.0001515008,0.0002493701,0.00031841008,0.00017539754,0.000053724303,0.00007471369,0.00013548553,0.000530519],"category_scores_gemma":[0.000039886607,0.00010452296,0.000023331386,0.00034134128,0.00021526101,0.000089477784,0.00008657281,0.000712938,0.000009686601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024123846,0.00023632907,0.9134384,0.00011606803,0.000024614095,0.00018001476,0.00049193477,4.57207e-7,0.07470532,0.00003794107,0.0026106113,0.007917085],"study_design_scores_gemma":[0.0035309843,0.0002654881,0.95338243,0.00021912146,0.00003317043,0.000039894396,0.00013026502,0.000018724131,0.041209415,0.00015308375,0.00089535856,0.000122032616],"about_ca_topic_score_codex":0.000887079,"about_ca_topic_score_gemma":0.0004166183,"teacher_disagreement_score":0.03994407,"about_ca_system_score_codex":0.00006886391,"about_ca_system_score_gemma":0.00012963986,"threshold_uncertainty_score":0.5808811},"labels":[],"label_agreement":null},{"id":"W1968946820","doi":"10.1158/1538-7445.am2014-2249","title":"Abstract 2249: N- and C-terminal peptides of the tumor suppressor protein IGFBP7 differentially induce growth arrest or senescence in breast cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Cancer research; Protein kinase B; Growth factor; PI3K/AKT/mTOR pathway; Cell growth; Senescence; Breast cancer; Growth inhibition; Biology; Cancer; Insulin-like growth factor 1 receptor; Signal transduction; Cell biology; Receptor; Biochemistry","score_opus":0.024370419079039966,"score_gpt":0.3173410566888646,"score_spread":0.2929706376098246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968946820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972645,0.0010099348,0.0000068828604,0.00048390834,0.00044646088,0.0005179997,0.00015016738,0.0000042707115,0.00011585806],"genre_scores_gemma":[0.99677277,0.0011103579,0.000023753202,0.00006867614,0.0011194648,0.00028427076,0.0000049982573,0.000028154036,0.0005875835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982222,0.00019190315,0.00024800794,0.00046058337,0.0003949842,0.00048237067],"domain_scores_gemma":[0.99907076,0.000035942347,0.00009841982,0.0003996677,0.00026827346,0.00012694095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004799625,0.00017444565,0.00023550537,0.000079469304,0.00011044198,0.000050426548,0.00048409012,0.00011486204,0.00008817051],"category_scores_gemma":[0.00010315066,0.000119642435,0.00006122407,0.00021890418,0.00043026582,0.000012350843,0.0003200387,0.0003504133,0.000001666961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045563086,0.00006638007,0.004859624,0.0002621816,0.000017554084,0.0000022528657,0.000087973356,0.000007356892,0.99003947,0.000027873797,0.0009230049,0.0032507223],"study_design_scores_gemma":[0.00069386035,0.000054420205,0.1809361,0.00027264265,0.000008870537,0.000008690541,0.000056170833,0.000010761332,0.8139295,0.00003692203,0.0038404462,0.00015164414],"about_ca_topic_score_codex":0.0031719774,"about_ca_topic_score_gemma":0.0033530507,"teacher_disagreement_score":0.17610997,"about_ca_system_score_codex":0.00003916546,"about_ca_system_score_gemma":0.0005594969,"threshold_uncertainty_score":0.48788768},"labels":[],"label_agreement":null},{"id":"W1969036848","doi":"10.1158/1538-7445.am2013-958","title":"Abstract 958: Improving survival of extraocular, metastatic and trilateral retinoblastoma patients with combined intensive therapy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Medicine; Topotecan; Etoposide; Vincristine; Surgery; Carboplatin; Radiation therapy; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.05102639420220159,"score_gpt":0.36524833848185534,"score_spread":0.3142219442796538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969036848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976139,0.00057187746,0.0000045638435,0.0004169452,0.000055285742,0.0010616014,0.000010489463,0.000011531059,0.0002538197],"genre_scores_gemma":[0.9991894,0.00011051277,0.00016214499,0.00006765504,0.000019314692,0.00013496178,0.000019006604,0.000021476872,0.00027557524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987408,0.000110909816,0.00018010651,0.00024312365,0.00040937783,0.00031566346],"domain_scores_gemma":[0.99834996,0.00014679845,0.00006669049,0.00020781066,0.0010905365,0.00013819833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026898002,0.00011840158,0.0003128692,0.0001317498,0.000079221245,0.000016812433,0.00006439108,0.000057290214,0.000395097],"category_scores_gemma":[0.000095887226,0.00007691317,0.00003766475,0.00017308844,0.00031327514,0.00010321225,0.00004221165,0.0002883976,0.000016996828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004859284,0.0007319355,0.9053608,0.00030331776,0.00092980644,0.0001474578,0.0009907117,9.548548e-7,0.022772744,0.000038785853,0.00031252857,0.06355163],"study_design_scores_gemma":[0.009714654,0.0028423208,0.97646767,0.0001418167,0.000049218146,0.00000485629,0.00031254432,0.000024529521,0.010173014,0.00009377027,0.0000898037,0.00008578125],"about_ca_topic_score_codex":0.00094853126,"about_ca_topic_score_gemma":0.000041662017,"teacher_disagreement_score":0.07110684,"about_ca_system_score_codex":0.000079553116,"about_ca_system_score_gemma":0.0001769673,"threshold_uncertainty_score":0.43260354},"labels":[],"label_agreement":null},{"id":"W1969063831","doi":"10.1158/1538-7445.am10-1588","title":"Abstract 1588: NR2F6, a novel regulator of stem cell maintenance, is necessary and sufficient for initiation of acute leukemia","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; Sunnybrook Hospital","funders":"","keywords":"Stem cell; Haematopoiesis; Chronic myelomonocytic leukemia; Progenitor cell; Biology; Clonogenic assay; Cancer research; Myeloid leukemia; Leukemia; CD34; Myeloid; Bone marrow; Population; Immunology; Medicine; Cell; Cell biology; Myelodysplastic syndromes; Genetics","score_opus":0.038976220381328974,"score_gpt":0.3484672154305348,"score_spread":0.30949099504920585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969063831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981788,0.00035968533,0.00020435228,0.00009309948,0.0000978087,0.00024799834,0.00031312075,0.0000018608291,0.00050332106],"genre_scores_gemma":[0.9983242,0.0005068252,0.00014788844,0.000050116887,0.00009272285,0.00005664261,0.00003076438,0.00001242805,0.000778368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999149,0.000011724948,0.00019383748,0.00024703503,0.00017814284,0.00022021442],"domain_scores_gemma":[0.99905217,0.000025623982,0.00009005661,0.00025406384,0.00052086345,0.00005723934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003418007,0.000078019424,0.00012632545,0.00007030908,0.000044058612,0.000011902702,0.00018081207,0.00013088336,0.000030117291],"category_scores_gemma":[0.000012581408,0.00006932334,0.000054976328,0.00009063562,0.0001724678,0.0000061686846,0.00009042339,0.0001428762,0.0000011291005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026306725,0.000041505642,0.0006499593,0.00013140576,0.000037111226,4.1046437e-7,0.00013040112,0.0000094527995,0.9916513,0.00006405951,0.0054357466,0.0015855561],"study_design_scores_gemma":[0.0005550602,0.000284591,0.0062066503,0.000039037972,0.00001102337,0.0000015173766,0.00018970732,0.00010056085,0.989194,0.0000290052,0.0033142637,0.00007460611],"about_ca_topic_score_codex":0.00011700935,"about_ca_topic_score_gemma":0.00005544462,"teacher_disagreement_score":0.005556691,"about_ca_system_score_codex":0.000020765514,"about_ca_system_score_gemma":0.00033019396,"threshold_uncertainty_score":0.28269237},"labels":[],"label_agreement":null},{"id":"W1969090863","doi":"10.1158/0008-5472.can-11-2104","title":"Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Innate immune system; Nitric oxide; Cancer cell; Biology; Hypoxia (environmental); Cell biology; Tumor microenvironment; Cancer research; Effector; Immunology; Cancer; Chemistry; Endocrinology","score_opus":0.04513560555080264,"score_gpt":0.3244720840715944,"score_spread":0.27933647852079174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969090863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97328264,0.02539454,0.00001122765,0.000009120412,0.00019159922,0.0002941654,0.00019923644,0.0000052538066,0.00061224436],"genre_scores_gemma":[0.9899864,0.009101593,0.0002014345,0.000025806685,0.00033003715,0.00017596608,0.00003926325,0.000031338273,0.00010814346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801517,0.0003738574,0.0003825458,0.0003914124,0.00040253284,0.00043447613],"domain_scores_gemma":[0.99872464,0.000047628768,0.00016300437,0.00057941023,0.0003477826,0.00013751155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060792995,0.00017026949,0.00034028845,0.00025906236,0.000059549773,0.000007720767,0.0005434971,0.00024089008,0.00035142238],"category_scores_gemma":[0.000087487424,0.0001597512,0.000090724054,0.00049957656,0.00021857087,0.000013361194,0.0003401383,0.0003825038,0.000003515583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006666234,0.00018133984,0.0045425273,0.000048407735,0.000038599635,8.848807e-7,0.00038707157,0.000010352923,0.9858157,0.0000042213605,0.0005766509,0.0077276044],"study_design_scores_gemma":[0.0008498567,0.000073805444,0.067230105,0.000109278306,0.000014063745,3.1926643e-7,0.00033484987,0.000008241811,0.9266383,0.0002392886,0.0043508895,0.00015100563],"about_ca_topic_score_codex":0.107065074,"about_ca_topic_score_gemma":0.0023027316,"teacher_disagreement_score":0.10476234,"about_ca_system_score_codex":0.000056630455,"about_ca_system_score_gemma":0.0005490097,"threshold_uncertainty_score":0.8988811},"labels":[],"label_agreement":null},{"id":"W1969109991","doi":"10.1158/1538-7445.am10-238","title":"Abstract 238: NPAS3 is a novel late-stage acting progression factor in gliomas with tumor-suppressive functions","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Loss of heterozygosity; Glioma; Astrocytoma; Anaplastic astrocytoma; Cancer research; Tumor progression; Biology; Cancer; Frameshift mutation; Medicine; Genetics; Mutation; Gene; Allele","score_opus":0.045462304926839746,"score_gpt":0.38106637777573377,"score_spread":0.33560407284889404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969109991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958698,0.0010831286,0.00004667476,0.00028079952,0.0006382871,0.0004675176,0.00020835879,0.000016315085,0.0013890963],"genre_scores_gemma":[0.9950359,0.00018755453,0.00017875854,0.000079026024,0.0011929108,0.0003432621,0.000041635278,0.000046109224,0.0028948707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813604,0.000038621893,0.00019134382,0.00056360045,0.0004433294,0.00062708266],"domain_scores_gemma":[0.99891794,0.00002729463,0.00008626792,0.0004727708,0.0003007116,0.00019499188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000317039,0.0001829617,0.00017772736,0.0001741045,0.00021189233,0.0000817713,0.00028051846,0.00018337856,0.00049129187],"category_scores_gemma":[0.00010900217,0.00014833511,0.000063360894,0.00037066906,0.00021098174,0.000018638071,0.00016118876,0.0008419017,0.000016860518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036326953,0.000103489314,0.002526488,0.000048047797,0.000025898262,0.000010094736,0.0003034816,0.000038388596,0.98447055,0.000009668531,0.0020995291,0.010001114],"study_design_scores_gemma":[0.0013871952,0.00013389719,0.016600836,0.000091529735,0.000006739818,0.000010226031,0.00032399,0.000030026174,0.62987417,0.0000057717325,0.35128987,0.00024575103],"about_ca_topic_score_codex":0.0006731212,"about_ca_topic_score_gemma":0.002653604,"teacher_disagreement_score":0.35459638,"about_ca_system_score_codex":0.000045463996,"about_ca_system_score_gemma":0.00060372544,"threshold_uncertainty_score":0.604893},"labels":[],"label_agreement":null},{"id":"W1969135551","doi":"10.1158/1538-7445.am10-5376","title":"Abstract 5376: Antisense oligonucleotide targeting insulin-like growth factor-1 receptor (IGF-1R) enhances paclitaxel sensitivity in a castrate-resistant and paclitaxel-resistant prostate cancer model","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Docetaxel; Paclitaxel; Prostate cancer; Cancer research; In vivo; Androgen deprivation therapy; Pharmacology; Flow cytometry; Growth factor; Apoptosis; Medicine; Cancer; Biology; Receptor; Internal medicine; Immunology; Biochemistry","score_opus":0.05089294191755297,"score_gpt":0.3744116511016078,"score_spread":0.32351870918405484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969135551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846124,0.0077295583,0.000004893345,0.003352092,0.00037488027,0.0021672514,0.0009999176,0.00010730256,0.0006517245],"genre_scores_gemma":[0.9801587,0.01645815,0.00054348237,0.00011579438,0.00039466104,0.00065484404,0.00008074159,0.00013600566,0.0014576528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99354315,0.00037104567,0.0008355385,0.0014453154,0.0016607532,0.0021442],"domain_scores_gemma":[0.99637103,0.0005826058,0.00020406785,0.0006455675,0.0012316379,0.0009651199],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00275366,0.0006100093,0.0009378222,0.00070026703,0.0005891553,0.00028044762,0.00025455162,0.00036538587,0.00040506112],"category_scores_gemma":[0.00063050183,0.0004953492,0.0001657175,0.0011247983,0.0011902994,0.00051588716,0.000293468,0.0028161926,0.00004280597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005582336,0.00037249253,0.024053382,0.0009597641,0.00016416147,0.00087516103,0.0022231294,0.000032073942,0.95952034,0.000107794796,0.0017751793,0.004334211],"study_design_scores_gemma":[0.010355452,0.0010815943,0.26661438,0.002379293,0.000095005424,0.000037365666,0.0029999015,0.0020931503,0.70886314,0.0008743305,0.0031596287,0.0014467676],"about_ca_topic_score_codex":0.015596299,"about_ca_topic_score_gemma":0.017144315,"teacher_disagreement_score":0.25065717,"about_ca_system_score_codex":0.001006787,"about_ca_system_score_gemma":0.0027093373,"threshold_uncertainty_score":0.99974984},"labels":[],"label_agreement":null},{"id":"W1969169415","doi":"10.1158/1538-7445.am2012-4916","title":"Abstract 4916: Molecular basis for the concentration-dependent tumor suppressing effects of KLK6 in breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Cancer research; Transcriptome; Chemistry; Cancer; Biology; Gene expression; Biochemistry; Genetics; Gene","score_opus":0.044565928292306684,"score_gpt":0.391513931402781,"score_spread":0.34694800311047436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969169415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97265935,0.023033068,0.000091143535,0.002382611,0.00033238894,0.0012060482,0.00006193225,0.000013720288,0.00021973433],"genre_scores_gemma":[0.99787354,0.0006366227,0.000035247413,0.00019046183,0.00046397626,0.00057518465,0.000008446939,0.000029370423,0.00018716206],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982942,0.00007478806,0.00026292732,0.0002060521,0.0005797599,0.0005822807],"domain_scores_gemma":[0.9984471,0.00076514453,0.00007498823,0.0002657596,0.00028943128,0.00015755811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077690865,0.00011803612,0.0002398714,0.00009326238,0.00012928293,0.000028961507,0.00014370453,0.000060515034,0.0004719223],"category_scores_gemma":[0.00019195444,0.00008586362,0.000092652765,0.0002856745,0.00017150913,0.00014538436,0.000040936327,0.00023352112,0.000004472597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083669956,0.0003593514,0.47764018,0.0016263607,0.000201107,0.000026853815,0.0025644142,0.00023901321,0.47906438,0.0007507254,0.003293532,0.03339737],"study_design_scores_gemma":[0.0014244218,0.00003834125,0.61298543,0.0007243513,0.000052302177,0.00000792015,0.00021750688,0.00029482992,0.38330877,0.00005296286,0.00079744455,0.00009571035],"about_ca_topic_score_codex":0.0029980314,"about_ca_topic_score_gemma":0.00020097996,"teacher_disagreement_score":0.13534525,"about_ca_system_score_codex":0.00026936343,"about_ca_system_score_gemma":0.0004788583,"threshold_uncertainty_score":0.51672184},"labels":[],"label_agreement":null},{"id":"W1969173539","doi":"10.1158/0008-5472.can-08-2854","title":"Telomere Dysfunction and DNA-PKcs Deficiency: Characterization and Consequence","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; National Aeronautics and Space Administration; U.S. Department of Energy","keywords":"Telomere; Genome instability; DNA repair; Biology; DNA damage; Non-homologous end joining; DNA; Homologous recombination; Cancer research; Cell biology; Molecular biology; Genetics","score_opus":0.0661494307676194,"score_gpt":0.375928711851129,"score_spread":0.3097792810835096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969173539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253905,0.0021253494,0.00013170805,0.0040749814,0.0000841915,0.0003772254,0.000013008265,0.000052172545,0.0006023422],"genre_scores_gemma":[0.9938957,0.0040180576,0.00006833525,0.0005666303,0.00015091374,0.000028225273,0.000020294912,0.000011789632,0.0012400666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985588,0.000073948424,0.00016518054,0.0003795328,0.0004394445,0.00038308004],"domain_scores_gemma":[0.99920434,0.00006630365,0.00003480691,0.00021031794,0.0002608102,0.00022341667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042329682,0.000114586794,0.00018826468,0.00022258246,0.00023489594,0.000064959924,0.00006392863,0.00009012533,0.00010529364],"category_scores_gemma":[0.0001704607,0.00009947676,0.00001697535,0.000487553,0.0003502838,0.0001716713,0.000031793006,0.00030734472,0.000015480795],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020710375,0.000046478868,0.010681831,0.000113706374,0.0000061094324,0.000065446526,0.00046440234,2.4645766e-7,0.84453183,0.00063787063,0.00023520806,0.14300975],"study_design_scores_gemma":[0.0015194777,0.0009179213,0.8984372,0.00038727437,0.000032352717,0.0003908256,0.0004224164,0.0001836573,0.08596252,0.0006937337,0.0107720215,0.00028061107],"about_ca_topic_score_codex":0.00013320176,"about_ca_topic_score_gemma":0.000017422028,"teacher_disagreement_score":0.88775533,"about_ca_system_score_codex":0.00010935148,"about_ca_system_score_gemma":0.00026423967,"threshold_uncertainty_score":0.40565446},"labels":[],"label_agreement":null},{"id":"W1969400850","doi":"10.1158/0008-5472.can-09-2090","title":"ETS-1 Oncogenic Activity Mediated by Transforming Growth Factor α","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Cell growth; Downregulation and upregulation; TGF alpha; Transforming growth factor; Biology; Cell culture; Cancer research; Cell biology; Cancer; Growth factor; Growth inhibition; In vivo; Cancer cell; Epidermal growth factor; Genetics; Gene; Receptor","score_opus":0.03458634874814739,"score_gpt":0.36399839471183193,"score_spread":0.32941204596368456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969400850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342746,0.0031287621,0.00010911908,0.00053909124,0.0011036987,0.00030738465,0.0002904306,0.00001879662,0.0010752472],"genre_scores_gemma":[0.9905572,0.005083795,0.000027967184,0.00010943017,0.0019053075,0.00016882113,0.000069633905,0.000039504273,0.0020383357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982981,0.000096262454,0.00013136778,0.00044631417,0.00042638302,0.0006015902],"domain_scores_gemma":[0.99905926,0.000039229722,0.000032157735,0.00035001314,0.00026524186,0.00025407007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043719995,0.00015220471,0.00017067725,0.00007712418,0.00017830975,0.000040482384,0.00034809182,0.00026449282,0.00034283698],"category_scores_gemma":[0.00019460743,0.00014129568,0.000102879145,0.00023177538,0.00021782759,0.000010343117,0.000084169274,0.0006685674,0.000027453578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012957827,0.00004444532,0.00025604744,0.000021903963,0.000039362767,6.5764215e-7,0.000085939566,2.0384161e-7,0.95978373,0.00001922748,0.015472795,0.02414613],"study_design_scores_gemma":[0.00041545735,0.000054086693,0.00055910053,0.0000037541581,0.000004654477,0.0000022438246,0.000014278751,0.0000026275611,0.5957596,0.000016796384,0.40305454,0.00011289509],"about_ca_topic_score_codex":0.0008758135,"about_ca_topic_score_gemma":0.0013183863,"teacher_disagreement_score":0.38758174,"about_ca_system_score_codex":0.00004007791,"about_ca_system_score_gemma":0.000550078,"threshold_uncertainty_score":0.576187},"labels":[],"label_agreement":null},{"id":"W1969402650","doi":"10.1158/0008-5472.can-06-2117","title":"Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Neuroblastoma; Doxorubicin; Cancer research; Medicine; Angiogenesis; Cancer; Pharmacology; Chemotherapy; Biology; Internal medicine; Cell culture","score_opus":0.027724562108697847,"score_gpt":0.3278074989992909,"score_spread":0.30008293689059307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969402650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621384,0.03432686,0.000045787765,0.0010005034,0.00012523489,0.0011842496,0.000016411333,0.000110316396,0.0010522323],"genre_scores_gemma":[0.9931586,0.0033793848,0.00021190503,0.00018628374,0.0008729892,0.00017336973,0.000037167112,0.0001239351,0.0018563949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960337,0.0001610118,0.00034989993,0.0008545627,0.0013115874,0.0012891819],"domain_scores_gemma":[0.9983861,0.00023838777,0.00007016373,0.0005416934,0.00033098293,0.0004326882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005456131,0.00034192388,0.00045693887,0.0004110176,0.00048582075,0.00022437655,0.00025386232,0.000091961185,0.0006640517],"category_scores_gemma":[0.000020170324,0.00027111595,0.00016509523,0.00078581634,0.00044189952,0.00014580047,0.00012253341,0.0009492608,0.00013343296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021813733,0.001101999,0.011921829,0.0002183085,0.00017941203,0.0011155972,0.00014739617,0.000015636066,0.9601753,0.00010815266,0.013048071,0.009786926],"study_design_scores_gemma":[0.015440117,0.0022013907,0.19390297,0.0003625148,0.00006311996,0.000274206,0.00015976583,0.0002977606,0.73024076,0.00072061457,0.055707,0.0006297709],"about_ca_topic_score_codex":0.0002493451,"about_ca_topic_score_gemma":0.000007927312,"teacher_disagreement_score":0.22993453,"about_ca_system_score_codex":0.00027602774,"about_ca_system_score_gemma":0.00023531824,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W1969512609","doi":"10.1158/0008-5472.can-04-4281","title":"Identification of a Genetic Signature of Activated Signal Transducer and Activator of Transcription 3 in Human Tumors","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; Dana-Farber Cancer Institute; Albert J. Ryan Foundation","keywords":"STAT3; STAT protein; Carcinogenesis; Biology; Cancer research; Transcription factor; Tissue microarray; Transcription (linguistics); Immunohistochemistry; Gene; Genetics; Immunology","score_opus":0.059987850907455925,"score_gpt":0.39628371566876436,"score_spread":0.33629586476130846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969512609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861425,0.0004968488,0.00007238895,0.00033521626,0.00001516263,0.00033612887,0.00003436536,0.000004902608,0.00009071005],"genre_scores_gemma":[0.99963176,0.00010181055,0.000044728047,0.0000063985235,0.00005721935,0.00003729371,0.0000075314197,0.000012456326,0.0001008195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988865,0.00007733664,0.00039848554,0.00016252825,0.00033647454,0.000138642],"domain_scores_gemma":[0.9993585,0.00005057866,0.00009457875,0.00013275673,0.00031369829,0.000049885293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032020593,0.00006495323,0.00022085918,0.00038047283,0.000028285482,0.0000038903327,0.00006141471,0.00007037563,0.00038475665],"category_scores_gemma":[0.000029917433,0.000059311104,0.00005100156,0.00042623593,0.00015053796,0.00008522344,0.0000069923503,0.00031951512,3.744422e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039479046,0.00022675408,0.0012868971,0.00032517937,0.000029305967,0.000001144049,0.0016205066,0.00013558313,0.9915264,0.000062315965,0.00005253824,0.0043385853],"study_design_scores_gemma":[0.0008556836,0.00025573617,0.045317087,0.00044299275,0.000017557364,0.0000027963144,0.0002946939,0.00017758034,0.9524211,0.000041288484,0.00013293141,0.00004054246],"about_ca_topic_score_codex":0.000451208,"about_ca_topic_score_gemma":0.00007131724,"teacher_disagreement_score":0.04403019,"about_ca_system_score_codex":0.00008749472,"about_ca_system_score_gemma":0.00014506979,"threshold_uncertainty_score":0.42128158},"labels":[],"label_agreement":null},{"id":"W1969517177","doi":"10.1158/0008-5472.sabcs-09-3022","title":"Examination of TIMP-1 Levels and Relapse-Free Survival for Patients in NCIC CTG MA.14 Who Received Adjuvant Tamoxifen +/- Octreotide LAR.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; McGill University; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Oncology; Chemotherapy; Octreotide; Breast cancer; Antiestrogen; Randomized controlled trial; Gastroenterology; Cancer; Endocrinology; Somatostatin","score_opus":0.04517435616402815,"score_gpt":0.3455094730164229,"score_spread":0.3003351168523947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969517177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974161,0.0008134684,0.00012212823,0.00021674228,0.000086130836,0.0006556946,0.00014049713,0.000004136798,0.0005451039],"genre_scores_gemma":[0.99811554,0.00046356546,0.00017351331,0.00005378212,0.00012305677,0.00010570695,0.00007748282,0.000015282707,0.00087208045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866503,0.00017787599,0.0002059099,0.00032731533,0.0002996899,0.00032419714],"domain_scores_gemma":[0.99917996,0.000035039786,0.000056742632,0.000305909,0.00034389668,0.00007847816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093613705,0.00010204072,0.00016567191,0.00010762115,0.000060998354,0.000014750437,0.00021220777,0.00013434328,0.000015253308],"category_scores_gemma":[0.000528079,0.000098676304,0.00003648668,0.00014485748,0.00006283165,0.000010953375,0.00010703742,0.00013933243,0.0000011314843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003793868,0.00014277024,0.0016178589,0.00006930906,0.000015269794,0.0000018558563,0.00014068364,0.000005872249,0.9728116,0.00019368193,0.0031695447,0.021452175],"study_design_scores_gemma":[0.0021327897,0.0012857938,0.055359636,0.000105745065,0.000005308533,4.628297e-7,0.000043224773,0.00005679448,0.9369059,0.0019077873,0.0020554569,0.00014105982],"about_ca_topic_score_codex":0.00009562354,"about_ca_topic_score_gemma":0.00016791045,"teacher_disagreement_score":0.053741775,"about_ca_system_score_codex":0.00005652416,"about_ca_system_score_gemma":0.00011806834,"threshold_uncertainty_score":0.4023903},"labels":[],"label_agreement":null},{"id":"W1969572743","doi":"10.1158/0008-5472.can-08-2649","title":"Transforming Growth Factor β Induces Clustering of HER2 and Integrins by Activating Src-Focal Adhesion Kinase and Receptor Association to the Cytoskeleton","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Cancer research; Proto-oncogene tyrosine-protein kinase Src; Focal adhesion; Epidermal growth factor receptor; Growth factor receptor; Cell biology; Integrin; Transforming growth factor; Signal transduction; Biology; Chemistry; Receptor; Biochemistry","score_opus":0.05257237440280305,"score_gpt":0.38424180219819487,"score_spread":0.3316694277953918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969572743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778445,0.0005936872,0.00017703419,0.010319947,0.000031289535,0.00078092184,0.000020529964,0.000016664873,0.00027545387],"genre_scores_gemma":[0.9977333,0.0011902818,0.00018816224,0.00015877413,0.00012147612,0.000049309343,0.0000065313916,0.000019959878,0.0005322386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977665,0.000219961,0.0002402594,0.00032386376,0.0009856754,0.000463741],"domain_scores_gemma":[0.9987288,0.00044566087,0.00005339132,0.0001643136,0.00035471885,0.0002530892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011229789,0.00012399927,0.00023812518,0.00017394545,0.00021433544,0.00006020519,0.00014030004,0.00012991225,0.00009002461],"category_scores_gemma":[0.0010776797,0.00008820056,0.000036859452,0.00052533735,0.000071058115,0.0001233162,0.00010854267,0.00079015444,0.000004457465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028650308,0.000038075308,0.002037168,0.00012217321,0.00001584286,0.0000025199943,0.0013810731,8.681979e-7,0.816478,0.000009159708,0.0009336886,0.17869492],"study_design_scores_gemma":[0.00082374923,0.0010315726,0.017674472,0.00046368266,0.0000075597673,0.0000031320294,0.001260227,0.00017506875,0.97247595,0.000021042973,0.005948987,0.00011453211],"about_ca_topic_score_codex":0.0009876619,"about_ca_topic_score_gemma":0.00013414488,"teacher_disagreement_score":0.17858039,"about_ca_system_score_codex":0.00052164216,"about_ca_system_score_gemma":0.0001458891,"threshold_uncertainty_score":0.35967144},"labels":[],"label_agreement":null},{"id":"W1969593381","doi":"10.1158/0008-5472.sabcs-705","title":"A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Breast cancer; Internal medicine; Oncology; Medicine; Anthracycline; Interim analysis; Cancer; Estrogen receptor; Clinical trial","score_opus":0.23614154314008903,"score_gpt":0.5082386485427101,"score_spread":0.272097105402621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969593381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98348993,0.010726906,0.00006307365,0.002176883,0.00002121969,0.0025033012,0.0009800646,0.000018372193,0.000020236195],"genre_scores_gemma":[0.9975132,0.0008588859,0.00012873442,0.00024419712,0.00006943756,0.0008610078,0.00003620618,0.0000358885,0.0002524945],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950574,0.0012443408,0.0010450968,0.0005968033,0.0015294459,0.0005269211],"domain_scores_gemma":[0.9960226,0.0011086488,0.0005848133,0.00060425024,0.0015044103,0.0001752664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032076666,0.00032143036,0.002367101,0.0007716664,0.00015501777,0.000019306874,0.000241891,0.00009604525,0.00070273277],"category_scores_gemma":[0.00027276317,0.00015980103,0.0003985969,0.0029794823,0.000614729,0.00018448949,0.00004405151,0.00044500045,2.0411231e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32044944,0.006253886,0.08359875,0.00020283219,0.12580927,0.00005528335,0.013216435,0.008139691,0.103550166,0.000022059688,0.000052212552,0.33865],"study_design_scores_gemma":[0.138456,0.038710102,0.5918273,0.0009861408,0.10765092,0.000011286033,0.0017467764,0.017349664,0.10221215,0.00014536004,0.00012355612,0.0007807556],"about_ca_topic_score_codex":0.008197206,"about_ca_topic_score_gemma":0.0006944039,"teacher_disagreement_score":0.50822854,"about_ca_system_score_codex":0.0003888959,"about_ca_system_score_gemma":0.0011948685,"threshold_uncertainty_score":0.9984073},"labels":[],"label_agreement":null},{"id":"W1969619516","doi":"10.1158/0008-5472.can-06-3117","title":"The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Prostate cancer; Prostate; Cancer research; Biology; Cancer; Internal medicine; Tumor progression; Endocrinology; Medicine","score_opus":0.041019041452049786,"score_gpt":0.3809138062298688,"score_spread":0.33989476477781905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969619516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096406,0.0075530973,0.000042067764,0.00027829455,0.00022554124,0.0005397736,0.00009155885,0.000012526965,0.0002930625],"genre_scores_gemma":[0.9964038,0.0010788846,0.00005632062,0.00010325054,0.00037120946,0.00026656152,0.000032772845,0.000042709667,0.0016444533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808943,0.00006875626,0.00024613488,0.00040279262,0.00042873426,0.0007641515],"domain_scores_gemma":[0.99902636,0.00008594213,0.000041614556,0.0002976931,0.00038228813,0.00016613015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076363154,0.00014631297,0.00012402024,0.00008705802,0.00025164764,0.000058780224,0.00043122447,0.000080138,0.00015837142],"category_scores_gemma":[0.0002481618,0.00011282629,0.000052451214,0.00035184866,0.00022539678,0.000007898242,0.000108284505,0.0003058291,0.000015572003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011868108,0.0000560938,0.0035780931,0.000040351915,0.000038520484,0.0000095485575,0.00034277316,0.000028583607,0.99094653,0.000029834779,0.0013011709,0.0024416754],"study_design_scores_gemma":[0.00074533763,0.00012171983,0.0027015875,0.00005662013,0.0000037785192,0.0000025320446,0.00018165745,0.000005422376,0.9375721,0.000024438154,0.058431048,0.00015375085],"about_ca_topic_score_codex":0.001478051,"about_ca_topic_score_gemma":0.0021664805,"teacher_disagreement_score":0.057129875,"about_ca_system_score_codex":0.00014959852,"about_ca_system_score_gemma":0.0008368086,"threshold_uncertainty_score":0.46009225},"labels":[],"label_agreement":null},{"id":"W1969666177","doi":"10.1158/1538-7445.am10-2602","title":"Abstract 2602: The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sunitinib; Tyrosine kinase; Lapatinib; Cardiotoxicity; Dasatinib; Medicine; Imatinib; Tyrosine-kinase inhibitor; Pharmacology; Nilotinib; Kinase; Gefitinib; Erlotinib; Sorafenib; Cancer; Internal medicine; Chemistry; Biochemistry; Receptor; Toxicity; Breast cancer; Epidermal growth factor receptor; Trastuzumab","score_opus":0.05392565443431722,"score_gpt":0.35480449594693425,"score_spread":0.300878841512617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969666177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940184,0.0015315574,0.000008145573,0.0012016889,0.00012131264,0.0012688878,0.00023951534,0.000030706815,0.0015798049],"genre_scores_gemma":[0.99753416,0.00062541774,0.00008510408,0.00014339387,0.00018913732,0.00013171088,0.00003755128,0.000054294873,0.0011992264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766,0.00009353472,0.0002959394,0.0005155981,0.00084568124,0.0005892395],"domain_scores_gemma":[0.9981747,0.00020300859,0.00010595351,0.000766364,0.00045766195,0.00029227778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066915445,0.0002377331,0.00044046083,0.00011613193,0.00018629352,0.000041392315,0.00021095015,0.00017956637,0.0008268526],"category_scores_gemma":[0.00013394088,0.00015291676,0.00006932049,0.0005613582,0.0010502372,0.000068858186,0.0001278457,0.0013757938,0.000018060215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000784042,0.00020535594,0.04899987,0.00023757375,0.00031543136,0.00015336042,0.00057139806,0.00002158487,0.9297511,0.000026086505,0.018088916,0.0008452738],"study_design_scores_gemma":[0.0046459152,0.000364351,0.10083046,0.0002631926,0.00009160411,0.000015143781,0.0001571859,0.00032580213,0.8859608,0.00001446996,0.0071349316,0.00019611091],"about_ca_topic_score_codex":0.0065122363,"about_ca_topic_score_gemma":0.00062138285,"teacher_disagreement_score":0.05183059,"about_ca_system_score_codex":0.0007035263,"about_ca_system_score_gemma":0.0011645163,"threshold_uncertainty_score":0.9844597},"labels":[],"label_agreement":null},{"id":"W1969766327","doi":"10.1158/1538-7445.am2013-3253","title":"Abstract 3253: A novel small-molecule inhibitor of Stat3 induces antitumor cell effects in human glioma and breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amorfix (Canada)","funders":"","keywords":"STAT3; Cancer research; Glioma; Breast cancer; Carcinogenesis; Cancer cell; STAT protein; Cancer; Tumor progression; Biology; Chemistry; Signal transduction; Medicine; Internal medicine; Cell biology","score_opus":0.023915949482227052,"score_gpt":0.3258590014972657,"score_spread":0.3019430520150387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969766327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161506,0.0062001524,0.0000076220435,0.00012498058,0.00090747577,0.00061821373,0.000138862,0.0000063173534,0.00038129295],"genre_scores_gemma":[0.99506223,0.0014920477,0.000049443737,0.00005317442,0.0025617713,0.00038708153,0.000016881593,0.000038959166,0.0003383797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829066,0.00007442025,0.00027040121,0.00050297886,0.00029989643,0.0005616386],"domain_scores_gemma":[0.99907625,0.000030614727,0.0000869207,0.00031779363,0.00030059286,0.0001878333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033468124,0.00019005963,0.00027551083,0.00021370636,0.00009238858,0.000057849513,0.00025936408,0.00016593136,0.00011542502],"category_scores_gemma":[0.000022666805,0.00017842189,0.00005925803,0.00029969655,0.0002886127,0.000014606229,0.000211957,0.00030793733,0.000005167268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008245922,0.00015855294,0.0013941849,0.00041222677,0.000024409193,0.0000010371073,0.00014259711,0.00001229455,0.989678,0.000017818445,0.006223004,0.0018533893],"study_design_scores_gemma":[0.0014694137,0.00012050434,0.048333026,0.0001375275,0.000008090276,0.0000035733603,0.000121238416,0.0000046330183,0.9456787,0.000017150327,0.00390674,0.00019938948],"about_ca_topic_score_codex":0.014185363,"about_ca_topic_score_gemma":0.0018361844,"teacher_disagreement_score":0.04693884,"about_ca_system_score_codex":0.00005884937,"about_ca_system_score_gemma":0.0003917025,"threshold_uncertainty_score":0.99237925},"labels":[],"label_agreement":null},{"id":"W1969934582","doi":"10.1158/0008-5472.can-11-1701","title":"CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog–Driven Medulloblastoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Sonic hedgehog; Medulloblastoma; CXCR4; Cancer research; Cyclin D1; Biology; Hedgehog signaling pathway; Cyclopamine; Pathology; Internal medicine; Medicine; Cancer; Signal transduction; Cell biology; Cell cycle; Receptor","score_opus":0.163249444574977,"score_gpt":0.3846133358547783,"score_spread":0.2213638912798013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969934582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572694,0.0013636462,0.0004740608,0.00016166571,0.00009257934,0.0002165154,0.000011224203,0.000012883503,0.0019404542],"genre_scores_gemma":[0.9972379,0.0004596905,0.00044614184,0.00004205976,0.00030202168,0.00007509358,0.000013093034,0.000027977429,0.0013960104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868107,0.00011043707,0.00018868847,0.00033498486,0.000301841,0.0003829732],"domain_scores_gemma":[0.9990918,0.00003130817,0.00006152655,0.00034928584,0.000354094,0.00011197164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033692375,0.00012006528,0.00016136104,0.00011105468,0.00009931489,0.000009312545,0.0003043924,0.00012059487,0.00012979501],"category_scores_gemma":[0.0002592227,0.00011107787,0.0000710613,0.00027628592,0.00022005072,0.0000051842417,0.00021576248,0.00015888388,0.000023069462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017928796,0.000049556915,0.0060802577,0.000051703457,0.00008362895,0.00000174428,0.00064947864,0.000012955295,0.98344827,0.00020380104,0.0050737862,0.004165516],"study_design_scores_gemma":[0.0003921345,0.0003631386,0.008247936,0.00006720071,0.0000075562807,0.0000016142277,0.0002011674,0.000007863987,0.98062366,0.00022257965,0.00974306,0.00012207027],"about_ca_topic_score_codex":0.0007922683,"about_ca_topic_score_gemma":0.00036138823,"teacher_disagreement_score":0.004669274,"about_ca_system_score_codex":0.000046069148,"about_ca_system_score_gemma":0.00045451522,"threshold_uncertainty_score":0.4529624},"labels":[],"label_agreement":null},{"id":"W1969983816","doi":"10.1158/1538-7445.am10-4007","title":"Abstract 4007: Cooperative regulation of Stat3 signaling by TC-PTP, SHP1, and SHP2 in keratinocytes following UVB irradiation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Dephosphorylation; Gene knockdown; Phosphorylation; Protein tyrosine phosphatase; Phosphatase; Transfection; Keratinocyte; STAT3; Biology; Molecular biology; Cell biology; Cancer research; Chemistry; Apoptosis; Biochemistry; In vitro; Gene","score_opus":0.05777992245257056,"score_gpt":0.41085478257641994,"score_spread":0.35307486012384937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969983816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732536,0.001206561,0.000008728094,0.0005294124,0.000058282203,0.00050162565,0.000008628988,0.000008328738,0.0003530543],"genre_scores_gemma":[0.99945223,0.00013851661,0.000071334325,0.000057830588,0.000069100315,0.00006714302,0.000024809371,0.000009021578,0.00010999949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889433,0.00012822915,0.00022375114,0.00022708529,0.00027219168,0.00025441544],"domain_scores_gemma":[0.9992916,0.00039417023,0.000034567463,0.00010238095,0.000096641044,0.00008061605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011614104,0.00008235906,0.00021822522,0.00013573925,0.000053658234,0.000017609096,0.00004991966,0.00011933384,0.00021527978],"category_scores_gemma":[0.0002307017,0.00006211089,0.000027418295,0.00031222534,0.000107935324,0.000079262754,0.000021068294,0.00049329427,0.000003812347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019740956,0.00005944783,0.043770988,0.000056810237,0.000018378276,0.0000100154075,0.0005003442,0.000060877574,0.94712496,0.00016764991,0.00003442489,0.007998724],"study_design_scores_gemma":[0.0024899794,0.00040792505,0.29705992,0.00030676075,0.000009512272,0.0000018674261,0.0002191403,0.0019492273,0.6960902,0.0007015513,0.0006328045,0.0001311231],"about_ca_topic_score_codex":0.0006077796,"about_ca_topic_score_gemma":0.0003013228,"teacher_disagreement_score":0.25328892,"about_ca_system_score_codex":0.00007547439,"about_ca_system_score_gemma":0.00012581244,"threshold_uncertainty_score":0.25328085},"labels":[],"label_agreement":null},{"id":"W1970069874","doi":"10.1158/0008-5472.sabcs-09-4056","title":"Prognostic and Predictive Impact of Intrinsic Biological Classification by Immunohistochemistry (IHC) and QPCR for Adjuvant Tamoxifen in Pre-Menopausal Breast Cancer: Results from the NCIC CTG MA.12 Trial.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Tamoxifen; Oncology; Immunohistochemistry; Internal medicine; Subtyping; Population; Estrogen receptor; Biomarker; Tissue microarray; Cancer; Pathology; Biology","score_opus":0.04702133200026477,"score_gpt":0.3863652711130364,"score_spread":0.33934393911277166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970069874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771977,0.015055721,0.000017812694,0.0014672162,0.000040241364,0.0013374918,0.004841389,0.0000066204598,0.000035773206],"genre_scores_gemma":[0.99183035,0.0063453987,0.000023477609,0.000029112767,0.000260632,0.00095307507,0.000500079,0.000013427272,0.000044421697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99840057,0.00015444844,0.0003053292,0.00057362224,0.00019820868,0.000367851],"domain_scores_gemma":[0.99900115,0.00026164486,0.00013093207,0.0003133928,0.00021051546,0.00008238008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044433854,0.00018857603,0.0002708289,0.000037156307,0.00013531504,0.0000259672,0.00020481327,0.00016984224,0.0000072326097],"category_scores_gemma":[0.00032350988,0.00012617675,0.00004416592,0.00014344533,0.00046388555,0.000008972234,0.00012107816,0.00020653395,1.8832313e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085682705,0.00028849175,0.037298918,0.000029448362,0.00029017948,0.0000015205183,0.0006255988,0.000012805872,0.8419383,0.000007936103,0.005050937,0.028773174],"study_design_scores_gemma":[0.014906929,0.0020940404,0.96091145,0.00013575057,0.00005209091,0.0000053027807,0.0001772833,0.000041011263,0.021047438,0.00022828602,0.00022973657,0.0001707024],"about_ca_topic_score_codex":0.0026130313,"about_ca_topic_score_gemma":0.00015118548,"teacher_disagreement_score":0.92361253,"about_ca_system_score_codex":0.00026139017,"about_ca_system_score_gemma":0.00033140974,"threshold_uncertainty_score":0.5145339},"labels":[],"label_agreement":null},{"id":"W1970168404","doi":"10.1158/1538-7445.am2014-lb-67","title":"Abstract LB-67: Breast cancer-associated lymphangiogenesis: roles of PGE2 and EP4 receptor on lymphatic endothelial cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lymphangiogenesis; Matrigel; Cancer research; Angiogenesis; Vascular endothelial growth factor C; Lymphatic system; Metastasis; Medicine; Cancer; Internal medicine; Biology; Vascular endothelial growth factor; Immunology; Vascular endothelial growth factor A","score_opus":0.027237858693325574,"score_gpt":0.33641459556650144,"score_spread":0.3091767368731759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970168404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599314,0.0013867853,0.0000013359232,0.00062229787,0.0003954882,0.00055135606,0.00025658138,0.000038858878,0.00075417635],"genre_scores_gemma":[0.9964341,0.0016088327,0.000011046088,0.00015159372,0.0008865804,0.00022055126,0.000012969286,0.00005573649,0.0006186071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975243,0.00025929022,0.00031162053,0.00038505462,0.00088687264,0.0006328409],"domain_scores_gemma":[0.9983492,0.00047844363,0.00012436725,0.00032792627,0.0003763894,0.0003436644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014693093,0.00020586798,0.00048557037,0.000294623,0.00014630072,0.000025081628,0.00016257174,0.00017630227,0.00066345715],"category_scores_gemma":[0.00022242057,0.00016827373,0.00010377309,0.00032482564,0.0002537973,0.00006324182,0.0000559956,0.00014172478,0.0000843741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001404419,0.00026728035,0.026494203,0.00091144146,0.00021879292,0.000022631539,0.0006185594,0.000025339425,0.9029062,0.00010541879,0.005596827,0.061428897],"study_design_scores_gemma":[0.0048131146,0.00056676683,0.10362572,0.0018753151,0.00009021637,0.000007948941,0.00016583773,0.00019341032,0.88375264,0.000048137073,0.0045832824,0.00027760712],"about_ca_topic_score_codex":0.0012968897,"about_ca_topic_score_gemma":0.00019637428,"teacher_disagreement_score":0.077131525,"about_ca_system_score_codex":0.0004653522,"about_ca_system_score_gemma":0.00057589536,"threshold_uncertainty_score":0.72643906},"labels":[],"label_agreement":null},{"id":"W1970369889","doi":"10.1158/1538-7445.am2014-5125","title":"Abstract 5125: Defining the minimal ING1b-derived peptide that is pro-apoptotic","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Cancer research; Biology; Cancer cell; Cancer; Carcinogenesis; Cell biology; Molecular biology; Genetics","score_opus":0.0603972348306339,"score_gpt":0.36294588929466326,"score_spread":0.30254865446402934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970369889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827475,0.0012959006,0.000070666276,0.0025915038,0.0001268487,0.0002839843,0.000010252406,0.000013060631,0.0073330193],"genre_scores_gemma":[0.99648374,0.00024952012,0.00011582473,0.00060928153,0.00039039517,0.00015973934,0.000023632007,0.000023964387,0.0019439127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986289,0.00013511292,0.00013672623,0.00033008365,0.0003714379,0.0003977482],"domain_scores_gemma":[0.9992495,0.000049746108,0.000049641698,0.0004022862,0.00015550804,0.0000933087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008384235,0.00011036105,0.00009310014,0.000049619975,0.00027228805,0.0000863347,0.00035752828,0.000106492225,0.00024047605],"category_scores_gemma":[0.0003014032,0.000079999285,0.00006354825,0.00012764576,0.00022152666,0.0000067609803,0.00017692837,0.00030131187,0.00010488257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008292517,0.000023258659,0.001642749,0.000036190824,0.00003279282,9.7305e-7,0.00018619289,0.000008715197,0.94193834,0.00025955346,0.042941935,0.012846389],"study_design_scores_gemma":[0.00026216748,0.00011412134,0.005363937,0.0000387036,0.0000036882586,0.0000020322257,0.0001984976,0.00003217402,0.8395506,0.00009000366,0.15423068,0.000113363596],"about_ca_topic_score_codex":0.00014163642,"about_ca_topic_score_gemma":0.00006061739,"teacher_disagreement_score":0.11128875,"about_ca_system_score_codex":0.000033995882,"about_ca_system_score_gemma":0.0001743675,"threshold_uncertainty_score":0.32622764},"labels":[],"label_agreement":null},{"id":"W1970475960","doi":"10.1158/1538-7445.am2013-4594","title":"Abstract 4594: Recurrent FGFR1 hotspot mutations represent a novel therapeutic target in childhood astrocytoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medulloblastoma; Cancer research; Germline; Germline mutation; PTPN11; Biology; Noonan syndrome; Pilocytic astrocytoma; Mutation; Genetics; Medicine; Glioma; Astrocytoma; Gene","score_opus":0.062455724580565246,"score_gpt":0.38645896517727496,"score_spread":0.3240032405967097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970475960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912949,0.004181729,0.00031035312,0.0014468182,0.000119488584,0.000698437,0.00005043372,0.000011603917,0.0018861878],"genre_scores_gemma":[0.99611187,0.0008155322,0.00022944514,0.0000941931,0.00025771064,0.0015031899,0.000092919894,0.000027684011,0.00086742605],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983603,0.00007210162,0.00024299027,0.00049916666,0.00033355865,0.0004918928],"domain_scores_gemma":[0.9989494,0.000025968799,0.000051593757,0.0005463571,0.00029764493,0.0001290005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036239985,0.00013145764,0.00012371312,0.00014704329,0.00014229248,0.00008009158,0.00033652416,0.00011051766,0.0007417317],"category_scores_gemma":[0.00006560039,0.00012084289,0.00006741061,0.00034313282,0.0001392869,0.000012644712,0.000100324905,0.00034463182,0.00009227992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078943536,0.00042916203,0.0033548537,0.000024659426,0.000060850787,0.000001961257,0.00025703807,0.0006503238,0.9605847,0.00017212315,0.0055463538,0.028839035],"study_design_scores_gemma":[0.0018843783,0.00038378657,0.7528467,0.00009971649,0.000009121021,0.000008268717,0.0008164598,0.0002784754,0.1836392,0.00088708923,0.058702465,0.00044430202],"about_ca_topic_score_codex":0.0007212342,"about_ca_topic_score_gemma":0.00024340821,"teacher_disagreement_score":0.7769455,"about_ca_system_score_codex":0.00011828646,"about_ca_system_score_gemma":0.00040132317,"threshold_uncertainty_score":0.8121442},"labels":[],"label_agreement":null},{"id":"W1970479272","doi":"10.1158/1538-7445.am2013-4491","title":"Abstract 4491: Discovery of potent small molecular tubulin inhibitors for the treatment of cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Cancer; Paclitaxel; Medicine; Docetaxel; In vivo; Pharmacology; Cancer cell; Chemotherapy; Breast cancer; Drug; Cancer research; Internal medicine; Biology; Genetics","score_opus":0.035204644689862404,"score_gpt":0.3479985209698545,"score_spread":0.3127938762799921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970479272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98214585,0.015698452,0.0003657601,0.0004151704,0.00012661835,0.0010052468,0.00015295311,0.0000020727873,0.000087884284],"genre_scores_gemma":[0.985833,0.01205111,0.00009057627,0.000032542524,0.00021686452,0.0009926596,0.000038541402,0.000023878334,0.00072086224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900836,0.000035795805,0.00022480794,0.0002521162,0.00017382362,0.00030511967],"domain_scores_gemma":[0.9991052,0.000051744682,0.000076737146,0.00038971362,0.00032476973,0.00005181894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001641629,0.00011602639,0.00015977214,0.000044483608,0.000064856824,0.000022545997,0.00024426883,0.00010312641,0.000032921856],"category_scores_gemma":[0.000027639218,0.00007757347,0.00016762529,0.00009509902,0.00018441053,0.0000041941994,0.000060672275,0.00007203868,0.0000018803584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011832062,0.0001531581,0.0009128407,0.000078774894,0.00016997692,5.42497e-7,0.00006508812,0.0003570868,0.9693753,0.000042401185,0.0013874648,0.027339019],"study_design_scores_gemma":[0.00056819106,0.00049507833,0.0022526528,0.00003885733,0.000023818697,3.310759e-7,0.00012923936,0.000052709107,0.9833156,0.000055444598,0.012983934,0.00008412878],"about_ca_topic_score_codex":0.005314147,"about_ca_topic_score_gemma":0.00097528246,"teacher_disagreement_score":0.02725489,"about_ca_system_score_codex":0.00006935568,"about_ca_system_score_gemma":0.00026858939,"threshold_uncertainty_score":0.8033436},"labels":[],"label_agreement":null},{"id":"W1970525670","doi":"10.1158/1538-7445.am2013-1719","title":"Abstract 1719: Differential Mcl-1 processing in evasion of DCA-induced apoptosis of colorectal cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Apoptosis; Cytochrome c; Cancer cell; Biology; Cell culture; Cancer research; Molecular biology; Cytotoxic T cell; Programmed cell death; Cancer; Cell biology; Chemistry; Biochemistry; Genetics; In vitro","score_opus":0.06993099613310845,"score_gpt":0.3994666719725544,"score_spread":0.329535675839446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970525670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971712,0.0007686026,0.0000034063307,0.00026674927,0.00014330722,0.0008160871,0.000011729397,0.000012920096,0.0008059786],"genre_scores_gemma":[0.99875677,0.00047032564,0.00004548549,0.000015942283,0.00015589177,0.0003432628,0.0000039384504,0.00002838596,0.00017998749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981126,0.0000842651,0.00034782302,0.00026771342,0.0007267302,0.00046082257],"domain_scores_gemma":[0.9989244,0.00015647722,0.00009641813,0.00018685423,0.00048968074,0.00014618761],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003980868,0.00012509723,0.0003999334,0.00037695532,0.000045359808,0.000014032665,0.00014305091,0.00013488547,0.0013380708],"category_scores_gemma":[0.00012236278,0.00009889005,0.00007360514,0.0006255698,0.00013689556,0.000105184765,0.00007155474,0.0004973077,0.000022650027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003987228,0.00020783689,0.011256135,0.0011319153,0.000021555672,0.0000027749593,0.00041218393,0.000010945374,0.9460304,0.000002172783,0.00048674006,0.040038668],"study_design_scores_gemma":[0.0015024306,0.00021705889,0.113908336,0.00093228265,0.00001788938,6.766788e-7,0.00018999535,0.00021510923,0.8828834,0.00003189559,0.000023268127,0.00007763143],"about_ca_topic_score_codex":0.012583413,"about_ca_topic_score_gemma":0.00022208695,"teacher_disagreement_score":0.1026522,"about_ca_system_score_codex":0.0002488103,"about_ca_system_score_gemma":0.0005937545,"threshold_uncertainty_score":0.99957484},"labels":[],"label_agreement":null},{"id":"W1970623261","doi":"10.1158/1538-7445.am2011-2540","title":"Abstract 2540: Evaluation of novel <i>bis</i>-amidine osmium complex as anti-proliferative agents","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"HeLa; Apoptosis; Carboplatin; MTT assay; Cell cycle; Cell growth; Annexin; Flow cytometry; Chemistry; Cancer research; Molecular biology; Cisplatin; Cell; Biology; Medicine; Biochemistry; Internal medicine; Chemotherapy","score_opus":0.7230565261489744,"score_gpt":0.5139988728551047,"score_spread":0.20905765329386972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970623261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292847,0.0010348302,0.000015260444,0.0003872745,0.000109866996,0.00087021885,0.000036371803,0.000017582039,0.06824393],"genre_scores_gemma":[0.99810815,0.00021763842,0.00024548985,0.0001128507,0.00017192616,0.00016465473,0.000020686693,0.000027450093,0.00093113293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970666,0.00023153625,0.0003526735,0.00031711836,0.0016565307,0.00037552457],"domain_scores_gemma":[0.9975514,0.00008587335,0.00009417016,0.0004138079,0.0017014692,0.00015331004],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028756612,0.00013965911,0.00037141956,0.00021164547,0.00013433582,0.000018813056,0.00020792203,0.00007174871,0.010473679],"category_scores_gemma":[0.0005328287,0.00010304177,0.00009008627,0.00032851717,0.00028989502,0.00010613024,0.000099481746,0.0003139377,0.00009898918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006068764,0.00043321663,0.0036070244,0.00025325257,0.00015163874,0.000004030082,0.0012468429,0.000013848004,0.98523617,0.0003999198,0.0031385787,0.004908622],"study_design_scores_gemma":[0.0019317674,0.0004613007,0.28572488,0.00032673302,0.00010569686,0.00000933157,0.0005254486,0.0011675918,0.70388305,0.00024960973,0.0054613133,0.00015323807],"about_ca_topic_score_codex":0.0019573586,"about_ca_topic_score_gemma":0.000058632453,"teacher_disagreement_score":0.28211787,"about_ca_system_score_codex":0.00015068831,"about_ca_system_score_gemma":0.00065009046,"threshold_uncertainty_score":0.9904309},"labels":[],"label_agreement":null},{"id":"W1970635098","doi":"10.1158/1538-7445.am2011-2516","title":"Abstract 2516: ERa-targeted therapy in ovarian cancer cells by 17b-estradiol-linked chemotherapeutic hybrid; VP-128 (E2-Pt(II))","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Ovarian cancer; Cisplatin; Cancer research; Cancer cell; Cancer; Estrogen receptor; In vivo; Apoptosis; Breast cancer; MTT assay; Viability assay; Biology; Chemistry; Internal medicine; Medicine; Chemotherapy; Genetics","score_opus":0.22888700220874147,"score_gpt":0.3824722785745125,"score_spread":0.15358527636577102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970635098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663015,0.02167022,0.0000075932453,0.0019442427,0.00026736225,0.0011371472,0.00008912622,0.000060483722,0.008522338],"genre_scores_gemma":[0.9818008,0.010471284,0.00019803288,0.0006989063,0.0003040117,0.0004978754,0.000021247815,0.000107431064,0.0059004272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964679,0.00029284973,0.00054830953,0.000704978,0.00090536894,0.001080586],"domain_scores_gemma":[0.9983861,0.00014485988,0.00010140449,0.0007191083,0.0003058344,0.00034269853],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013966444,0.00035253257,0.00066265004,0.00034347223,0.0002664942,0.000060168935,0.0005059528,0.00017094178,0.013533017],"category_scores_gemma":[0.000054449392,0.0002685826,0.00016591675,0.00057202636,0.00037341288,0.00015992281,0.000080215636,0.0011693033,0.00011518586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016349234,0.00040058466,0.003456433,0.00017238595,0.00020886601,0.000043282427,0.0015661373,0.0000021745,0.9488088,0.000040376242,0.0092700515,0.03439599],"study_design_scores_gemma":[0.0022345693,0.0005303514,0.050970197,0.0003292852,0.000022757173,0.000009204559,0.00015062396,0.000072688694,0.9104548,0.00031421025,0.034560796,0.00035051611],"about_ca_topic_score_codex":0.013278069,"about_ca_topic_score_gemma":0.0003195308,"teacher_disagreement_score":0.047513764,"about_ca_system_score_codex":0.00040832054,"about_ca_system_score_gemma":0.00079643616,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W1970936041","doi":"10.1158/0008-5472.sabcs-09-2078","title":"Evaluation of Cardiac Comorbidities in Patients with Metastatic Breast Cancer Receiving Doxorubicin-Based and Non-Doxorubicin-Based Chemotherapy.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Chemotherapy; Internal medicine; Heart failure; Doxorubicin; Cancer; Cardiotoxicity; Myocardial infarction; Coronary artery disease; Comorbidity; Oncology; Cardiology","score_opus":0.052079876476413316,"score_gpt":0.37850419549969416,"score_spread":0.32642431902328084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970936041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470437,0.00085381116,0.000034027682,0.0021954223,0.00005682038,0.001716688,0.00008964934,0.000017706416,0.00033149184],"genre_scores_gemma":[0.99872446,0.00022823477,0.00014151887,0.0004799001,0.00009916651,0.00021109919,0.00004556769,0.000035029156,0.000035048386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965377,0.000397055,0.0003053735,0.00039072149,0.0019461368,0.00042302004],"domain_scores_gemma":[0.99770135,0.0001712011,0.0001120856,0.00034625095,0.0015297326,0.00013935308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024975028,0.0001997048,0.00052518805,0.00043375368,0.000096710806,0.000027999395,0.000093964496,0.00008942152,0.00018997739],"category_scores_gemma":[0.00008148991,0.00016818637,0.00007605595,0.0007699351,0.00022908345,0.000111664776,0.0000091858465,0.0003938349,0.0000011085864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039029606,0.0007672148,0.24959257,0.0006351226,0.00036225354,0.0000046483483,0.0016060212,0.002700734,0.4677608,0.00001310786,0.00053672015,0.27211785],"study_design_scores_gemma":[0.007931656,0.0004970595,0.6256903,0.0010707541,0.00014770393,6.392613e-7,0.00019075711,0.0019074461,0.36231667,0.00005500901,0.00004040704,0.0001516289],"about_ca_topic_score_codex":0.0015747302,"about_ca_topic_score_gemma":0.00025326712,"teacher_disagreement_score":0.3760977,"about_ca_system_score_codex":0.00092815555,"about_ca_system_score_gemma":0.0015043657,"threshold_uncertainty_score":0.6858441},"labels":[],"label_agreement":null},{"id":"W1971207361","doi":"10.1158/1538-7445.am10-2627","title":"Abstract 2627: Mechanisms of bortezomib resistance in human NSCLC cell lines; potential role of proteasome beta5-subunits and autophagy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bortezomib; Proteasome; Proteasome inhibitor; Autophagy; Lung cancer; Cancer research; IC50; Protein subunit; Chemistry; Pharmacology; Medicine; Biology; Multiple myeloma; Internal medicine; In vitro; Biochemistry; Apoptosis","score_opus":0.021284001816719057,"score_gpt":0.3211634092168735,"score_spread":0.2998794074001544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971207361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445546,0.0019626452,0.000025684729,0.000066879715,0.00005507755,0.0005305264,0.00012906348,0.000005203601,0.0027694725],"genre_scores_gemma":[0.99845284,0.00015553208,0.00045025945,0.00001168919,0.00014487225,0.00013900455,0.000034937195,0.000025278512,0.0005855831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985778,0.0000917858,0.00029236355,0.00035435345,0.00032670883,0.0003570277],"domain_scores_gemma":[0.9990863,0.00001693226,0.000109213426,0.00038075208,0.00029930234,0.00010745728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082322455,0.0001262321,0.00020336462,0.00013660509,0.00007896973,0.000016586482,0.0003079742,0.0002244858,0.00011097915],"category_scores_gemma":[0.00007454596,0.00012517085,0.000050444643,0.00018594437,0.0002383034,0.000007339552,0.00017329871,0.00044253137,0.000001661073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017744677,0.000092379174,0.00025932593,0.00020340018,0.000011849626,0.0000050050985,0.000093334515,0.0000032128582,0.9966223,0.0012993873,0.000049934228,0.0011823856],"study_design_scores_gemma":[0.0006796626,0.00016516296,0.006336014,0.000062035084,0.0000040279892,0.0000012400376,0.00007558004,0.000007121088,0.9865021,0.0048259534,0.0012220797,0.00011903937],"about_ca_topic_score_codex":0.000308761,"about_ca_topic_score_gemma":0.0008324346,"teacher_disagreement_score":0.010120255,"about_ca_system_score_codex":0.00001284602,"about_ca_system_score_gemma":0.00026327232,"threshold_uncertainty_score":0.5104319},"labels":[],"label_agreement":null},{"id":"W1971412329","doi":"10.1158/0008-5472.sabcs13-p3-05-06","title":"Abstract P3-05-06: A better clinical cutpoint for progesterone receptor expression in tamoxifen treated breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Tamoxifen; Immunohistochemistry; Breast cancer; Medicine; Progesterone receptor; Estrogen receptor; Tissue microarray; Internal medicine; Oncology; Gynecology; Estrogen; Cancer; Pathology","score_opus":0.047253436256512106,"score_gpt":0.4070305179820251,"score_spread":0.359777081725513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971412329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405664,0.002017393,0.000012080039,0.00200684,0.0001606841,0.0015029875,0.00010573927,0.00001586373,0.00012179187],"genre_scores_gemma":[0.9925914,0.0016516868,0.00022645875,0.00020237565,0.0007848337,0.0028282267,0.00017301897,0.00005857551,0.0014834336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978953,0.00021294245,0.0003696278,0.0005958295,0.00025804315,0.00066825084],"domain_scores_gemma":[0.99896455,0.000071712864,0.00007376067,0.00036688132,0.0002909151,0.00023218863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006760744,0.00018802068,0.0002443559,0.00009737728,0.0001051353,0.00005755709,0.00027978237,0.00044506742,0.0003628423],"category_scores_gemma":[0.000066185865,0.0001448343,0.00012277045,0.00018025098,0.00019115214,0.000014984161,0.00014713433,0.0005328455,0.00009662039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055279356,0.00017766033,0.024036204,0.00006792875,0.00005819512,0.0000045848165,0.00003843476,0.000008391017,0.863843,0.0000011588855,0.088186674,0.02302494],"study_design_scores_gemma":[0.0035820298,0.00077922107,0.07615281,0.00045899887,0.000015491763,0.000010167231,0.00006421988,0.00008076936,0.8928186,0.000057129688,0.02557438,0.00040614902],"about_ca_topic_score_codex":0.00071857654,"about_ca_topic_score_gemma":0.0000976866,"teacher_disagreement_score":0.062612295,"about_ca_system_score_codex":0.00010229767,"about_ca_system_score_gemma":0.0002467693,"threshold_uncertainty_score":0.59061706},"labels":[],"label_agreement":null},{"id":"W1971461431","doi":"10.1158/1538-7445.am10-5741","title":"Abstract 5741: Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women's Health Initiative","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Logistic regression; Gynecology; Cancer; Oncology; Confounding; Obstetrics; Internal medicine; Mammography","score_opus":0.11474860291334356,"score_gpt":0.4152043347323056,"score_spread":0.30045573181896207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971461431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899785,0.0033084613,2.639839e-7,0.004950701,0.000032730633,0.0015143842,0.00014852168,0.000009079631,0.000057360816],"genre_scores_gemma":[0.9918225,0.0064579835,0.000012708577,0.00030322926,0.00014082788,0.0012332996,0.0000035271967,0.000022500823,0.0000034267691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980353,0.00021322143,0.0002141028,0.00031871162,0.00065898214,0.00055968796],"domain_scores_gemma":[0.9990221,0.00013647538,0.000112994916,0.00029119023,0.00025963873,0.0001775804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020842974,0.00014485784,0.00035438087,0.000337395,0.000093253475,0.000021890564,0.00014353647,0.00008759916,0.00010533208],"category_scores_gemma":[0.00004146838,0.00008717161,0.000030300584,0.001050657,0.000559271,0.000088304914,0.000032635242,0.0014504421,5.817349e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014855465,0.00016730979,0.91680497,0.00013315905,0.00004206845,0.000022319446,0.013079066,6.899369e-7,0.0012016537,0.000030836523,0.00004475107,0.06698764],"study_design_scores_gemma":[0.0020207628,0.0003839625,0.9941084,0.00035377592,0.0000051877273,0.00002199949,0.0022254856,0.0000066723846,0.0004289779,0.000056919762,0.00030252652,0.00008534112],"about_ca_topic_score_codex":0.11651077,"about_ca_topic_score_gemma":0.13061517,"teacher_disagreement_score":0.07730343,"about_ca_system_score_codex":0.00024646486,"about_ca_system_score_gemma":0.0010998676,"threshold_uncertainty_score":0.88937247},"labels":[],"label_agreement":null},{"id":"W1971482312","doi":"10.1158/1538-7445.am2012-lb-333","title":"Abstract LB-333: A case-parent-triad approach in assessing risk of osteosarcoma associated with genetic variation in insulin-like growth factor 1/growth hormone axis genes: a Children's Oncology Group (COG) study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"IGFBP3; Insulin-like growth factor; Single-nucleotide polymorphism; Medicine; Internal medicine; Oncology; Incidence (geometry); Endocrinology; Biology; Genetics; Gene; Growth factor; Genotype; Receptor","score_opus":0.07134595197091378,"score_gpt":0.3635658173094825,"score_spread":0.2922198653385687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971482312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987937,0.0055304794,0.000092361086,0.00006652048,0.00013883079,0.0037613416,0.00013404043,0.00006661461,0.0003304692],"genre_scores_gemma":[0.9971354,0.0010194113,0.0005033966,0.000031679447,0.00028180386,0.0007713268,0.000119606564,0.00012332959,0.000014031725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99276155,0.0017344198,0.0013307014,0.0009492833,0.0015891304,0.001634905],"domain_scores_gemma":[0.99662,0.00080905587,0.0005757342,0.0006474581,0.00080798595,0.0005397456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035950844,0.00053729065,0.0012727581,0.00175335,0.00024577125,0.000080088445,0.00040503926,0.00054656673,0.000052030977],"category_scores_gemma":[0.0010502323,0.00045251774,0.00014769782,0.0032683562,0.00030940474,0.0006477451,0.00022017084,0.0021807565,0.000010632089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013992623,0.006462803,0.9692187,0.00015293038,0.0006091527,0.000536815,0.0079786815,0.000018844332,0.0086374115,0.0000127726125,0.00005582832,0.0049168435],"study_design_scores_gemma":[0.0112366015,0.0027724402,0.9811196,0.00018961735,0.00026301673,0.00015727022,0.0031943829,0.00018845247,0.000417211,0.000030768242,0.000009015916,0.00042167335],"about_ca_topic_score_codex":0.029042514,"about_ca_topic_score_gemma":0.0022592547,"teacher_disagreement_score":0.02678326,"about_ca_system_score_codex":0.001717993,"about_ca_system_score_gemma":0.0010794634,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W1971594271","doi":"10.1158/1538-7445.am2012-3663","title":"Abstract 3663: A gene signature for predicting outcome in patients with basal-like breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Gene signature; Oncology; Basal (medicine); Medicine; Internal medicine; Gene expression profiling; Cancer; Disease; Gene expression; Gene; Bioinformatics; Biology","score_opus":0.06748966516925203,"score_gpt":0.40318814520118224,"score_spread":0.3356984800319302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971594271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026066,0.0047713746,0.000011251853,0.0015318595,0.00047392107,0.0017781386,0.00054035534,0.000031179923,0.00060127245],"genre_scores_gemma":[0.99560285,0.00015131156,0.00022110737,0.00031556876,0.0010768836,0.0017064132,0.00003684675,0.00008232043,0.000806716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970393,0.00004786946,0.00032259306,0.00043994607,0.0009637187,0.001186541],"domain_scores_gemma":[0.99843115,0.00022311846,0.00008586413,0.0003716137,0.0005937618,0.00029450233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007902817,0.0002279052,0.00043230876,0.00026690762,0.0001811622,0.000024845318,0.00017388214,0.00014675558,0.00062185246],"category_scores_gemma":[0.00009323751,0.00017009831,0.00006994987,0.0005511869,0.000182759,0.00022017994,0.00012440843,0.0008142561,0.0000144203295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001921199,0.00023710607,0.98358876,0.0004193144,0.00015109501,0.000007472388,0.0005143388,0.000017806891,0.00055548165,0.0000055329674,0.006617609,0.005964289],"study_design_scores_gemma":[0.004232043,0.00018066242,0.9907896,0.00044038406,0.00003831668,0.0000026442192,0.00015903517,0.0000067097276,0.0011021453,0.000008608841,0.002854089,0.00018576828],"about_ca_topic_score_codex":0.0016114237,"about_ca_topic_score_gemma":0.0010697555,"teacher_disagreement_score":0.0072008385,"about_ca_system_score_codex":0.0012366738,"about_ca_system_score_gemma":0.00042548994,"threshold_uncertainty_score":0.69364077},"labels":[],"label_agreement":null},{"id":"W1971715644","doi":"10.1158/0008-5472.can-06-2616","title":"Androgen-Independent Growth and Tumorigenesis of Prostate Cancer Cells Are Enhanced by the Presence of PKA-Differentiated Neuroendocrine Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"U.S. Public Health Service; McKnight Foundation; National Cancer Institute; Sanofi; U.S. Department of Health and Human Services","keywords":"LNCaP; Prostate cancer; Neuroendocrine differentiation; Paracrine signalling; Cancer research; Androgen; Prostate; Biology; Internal medicine; Endocrinology; Tumor progression; Carcinogenesis; Cancer; Medicine; Receptor; Hormone","score_opus":0.03592840544183467,"score_gpt":0.35957330584924974,"score_spread":0.32364490040741506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971715644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841622,0.012152881,0.000021059153,0.0011172632,0.00019248897,0.001775065,0.00031414928,0.000021911628,0.0002429998],"genre_scores_gemma":[0.9696839,0.026543379,0.000015908663,0.000037438276,0.00009161856,0.00028602406,0.000017236913,0.000048092792,0.00327642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962446,0.00022129546,0.0005018414,0.00057378097,0.0014793732,0.0009791265],"domain_scores_gemma":[0.99764985,0.0003966946,0.00020277147,0.0004964385,0.00090983475,0.00034442535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073540414,0.00024979803,0.0005268224,0.00029089465,0.00019599909,0.00003088453,0.00035406052,0.000063131694,0.00025487752],"category_scores_gemma":[0.00008062225,0.00016047055,0.000098196884,0.00097142434,0.00084826007,0.000093775336,0.0002669867,0.0005729895,0.0000039667057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002334846,0.00028110974,0.030365402,0.000992994,0.00019789583,0.00008424285,0.0006085762,0.0000064490378,0.95881784,0.00001235376,0.0024569144,0.0038413878],"study_design_scores_gemma":[0.002594705,0.00047584093,0.017392041,0.00036193285,0.00006716338,0.0000074611694,0.0006013246,0.000020771466,0.97789884,0.000035486442,0.00041328478,0.00013117652],"about_ca_topic_score_codex":0.002836023,"about_ca_topic_score_gemma":0.00032145853,"teacher_disagreement_score":0.019080983,"about_ca_system_score_codex":0.0001926124,"about_ca_system_score_gemma":0.0004887727,"threshold_uncertainty_score":0.6543799},"labels":[],"label_agreement":null},{"id":"W1971718189","doi":"10.1158/1538-7445.am2012-4060","title":"Abstract 4060: Use of small animal MRI and cone-beam CT for image-guided radiotherapy of orthotopic tumors in mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nuclear medicine; Radiation therapy; Image-guided radiation therapy; Contouring; Cone beam ct; Cone beam computed tomography; Soft tissue; Radiology; Computer science; Computed tomography","score_opus":0.08113521525970581,"score_gpt":0.38611583795368803,"score_spread":0.30498062269398224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971718189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832111,0.01581457,0.00006621785,0.00007927033,0.00015048061,0.0004935074,0.00009529885,0.0000023832245,0.0000871514],"genre_scores_gemma":[0.99048156,0.0073654,0.0010109543,0.000046657657,0.00057867606,0.00012374233,0.00001919755,0.000024580195,0.00034925324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891794,0.000056592657,0.0002516348,0.00023134261,0.000145767,0.00039670992],"domain_scores_gemma":[0.9993294,0.00006179461,0.00007617269,0.00021745679,0.0002109924,0.000104183724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061450055,0.00010312059,0.00023524274,0.00010273832,0.000031018863,0.00001299008,0.00013652902,0.000069139554,0.000035391407],"category_scores_gemma":[0.000110791596,0.000098401004,0.00006524037,0.00012188936,0.00022974084,0.000012388563,0.000054358094,0.00012337805,3.1564596e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040269017,0.00006779095,0.009344358,0.00019885281,0.000036061327,6.93918e-7,0.00012890929,0.000009037625,0.98517424,0.00005366476,0.0021377369,0.0024459672],"study_design_scores_gemma":[0.0013240969,0.00015572355,0.0557839,0.00004190949,0.000007540936,0.0000072343237,0.00006687468,0.000010008716,0.86199486,0.000011108296,0.08048487,0.00011184854],"about_ca_topic_score_codex":0.0013990017,"about_ca_topic_score_gemma":0.0003260571,"teacher_disagreement_score":0.12317935,"about_ca_system_score_codex":0.00002791178,"about_ca_system_score_gemma":0.00023019832,"threshold_uncertainty_score":0.40126765},"labels":[],"label_agreement":null},{"id":"W1971722268","doi":"10.1158/1538-7445.am2014-1106","title":"Abstract 1106: The tumor immune microenvironment modulates response to chemotherapy in high-grade serous epithelial ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Tumor microenvironment; Ovarian cancer; Serous fluid; Cancer research; Tumor progression; Medicine; Gene expression profiling; Chemotherapy; Cancer; Gene signature; Oncology; Biology; Gene expression; Internal medicine; Gene","score_opus":0.03640738135706841,"score_gpt":0.35030569499182673,"score_spread":0.31389831363475834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971722268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93629205,0.0018912137,0.000011098748,0.060208246,0.00021102163,0.0012135949,0.000041651772,0.000029065919,0.00010208033],"genre_scores_gemma":[0.99275744,0.0014869077,0.00012347786,0.0023729673,0.0005739081,0.0015539196,0.0000051058505,0.000078016696,0.0010482299],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99690783,0.0003789126,0.000396771,0.00058770657,0.0008498589,0.000878927],"domain_scores_gemma":[0.9985318,0.0002559487,0.000066010085,0.0007741018,0.00010992419,0.00026220235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025116093,0.00023938729,0.0004241157,0.00024901237,0.00021624139,0.00007181001,0.00044622004,0.00009714567,0.0016930696],"category_scores_gemma":[0.000119550925,0.00016687684,0.000105544896,0.0006102507,0.00024303139,0.000062415755,0.00013475952,0.0007626463,0.00011774625],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007011726,0.0003201777,0.012669711,0.00010040608,0.00009233661,0.000026942662,0.0013293667,0.0004970485,0.9358408,0.000046863403,0.0034609556,0.03860367],"study_design_scores_gemma":[0.0029168436,0.0004039432,0.6625923,0.0003535281,0.000015384336,0.000005128255,0.00018948095,0.000084083906,0.27932808,0.000075064396,0.053850178,0.00018598475],"about_ca_topic_score_codex":0.014652567,"about_ca_topic_score_gemma":0.00086017465,"teacher_disagreement_score":0.6565127,"about_ca_system_score_codex":0.0010442946,"about_ca_system_score_gemma":0.00036108223,"threshold_uncertainty_score":0.99921954},"labels":[],"label_agreement":null},{"id":"W1971744627","doi":"10.1158/1538-7445.am10-2054","title":"Abstract 2054: A microRNA hypothesis for the precursor lesions of ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Fallopian tube; Serous fluid; Stromal cell; Laser capture microdissection; Biology; Cancer research; Pathology; Ovary; Epithelium; Cancer; Medicine; Internal medicine; Gene; Gene expression; Endocrinology","score_opus":0.14515863496322948,"score_gpt":0.43244220748167295,"score_spread":0.2872835725184435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971744627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319744,0.007452092,0.000028218123,0.05207663,0.0008895441,0.003370267,0.0007177919,0.000033569333,0.003457449],"genre_scores_gemma":[0.9900328,0.0027507094,0.00066359993,0.0002057173,0.0007589292,0.0034839858,0.000005781671,0.000043671393,0.0020548068],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984469,0.000031847136,0.00024189477,0.00034106942,0.00046042,0.0004778852],"domain_scores_gemma":[0.9974668,0.001162484,0.00007705497,0.0006023724,0.0005083026,0.00018300593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000679433,0.00013699092,0.00027762554,0.00012704932,0.0002509315,0.00003371658,0.00026254077,0.00011411577,0.0033302573],"category_scores_gemma":[0.00027043954,0.00008460605,0.00017048785,0.00032547038,0.0002941559,0.000046566172,0.000054348304,0.00050237647,0.000028707056],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013490935,0.0009345819,0.019159378,0.0005915593,0.0010023954,0.000020516525,0.0008942753,0.000017151771,0.32475317,0.0018463032,0.15116291,0.49826866],"study_design_scores_gemma":[0.003552085,0.0003151637,0.3994889,0.00045875818,0.00029035073,0.000007521623,0.00019405053,0.000035706886,0.296201,0.0005733037,0.29871,0.00017316855],"about_ca_topic_score_codex":0.004182289,"about_ca_topic_score_gemma":0.0034702544,"teacher_disagreement_score":0.49809548,"about_ca_system_score_codex":0.00018592102,"about_ca_system_score_gemma":0.0010808668,"threshold_uncertainty_score":0.9975808},"labels":[],"label_agreement":null},{"id":"W1971805819","doi":"10.1158/1538-7445.am2013-5160","title":"Abstract 5160: Claudin1 induces cell motility and invasion through PI3K/Akt/NFkB signaling in keratin-depleted carcinoma cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Keratin 8; Epithelial–mesenchymal transition; Keratin; Biology; Cell biology; Keratin 5; Cancer cell; Cancer research; Intermediate filament; Cell migration; PI3K/AKT/mTOR pathway; Cell; Signal transduction; Cytoskeleton; Cancer; Metastasis","score_opus":0.07787007899624733,"score_gpt":0.3614652111401359,"score_spread":0.2835951321438886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971805819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928955,0.0031945906,0.00000920379,0.0004282032,0.00008752168,0.0009042592,0.00003924277,0.000014786221,0.0024267],"genre_scores_gemma":[0.9977879,0.00069090177,0.00014370552,0.000089831155,0.00030593367,0.0002555722,0.00007491495,0.00005671949,0.0005945017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966177,0.00036357396,0.00041021424,0.00091416563,0.00070836383,0.0009859834],"domain_scores_gemma":[0.9982736,0.00015059515,0.00007639345,0.00062425726,0.00060467,0.00027044566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010102099,0.0002695027,0.00028437137,0.00018984242,0.00020631493,0.00018305384,0.0005168445,0.00039543974,0.00048808608],"category_scores_gemma":[0.00027523495,0.0002466003,0.00007049267,0.0004643821,0.0003445225,0.00003126439,0.0005717825,0.0010008943,0.00007795717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007555439,0.000120742865,0.05408506,0.00021048341,0.00000971639,0.0000126172135,0.00024920356,0.000027587423,0.94072455,0.0000018865147,0.0030600852,0.0014225069],"study_design_scores_gemma":[0.00083517807,0.00023238013,0.0917682,0.000045860063,0.0000025881018,0.0000016623891,0.00044107495,0.000056544144,0.9054162,0.00015936494,0.00082440313,0.0002165381],"about_ca_topic_score_codex":0.008326638,"about_ca_topic_score_gemma":0.00067807396,"teacher_disagreement_score":0.037683137,"about_ca_system_score_codex":0.00017706006,"about_ca_system_score_gemma":0.0006577394,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W1972000776","doi":"10.1158/0008-5472.can-10-2484","title":"Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PLK1; Cancer research; Neuroblastoma; Cytotoxic T cell; Kinase; Polo-like kinase; Biology; PI3K/AKT/mTOR pathway; Protein kinase B; Aurora kinase; Stem cell; Cancer; Medicine; Internal medicine; Cell cycle; Signal transduction; Cell biology; Cell culture; In vitro; Biochemistry","score_opus":0.12197838533226471,"score_gpt":0.3743966627450988,"score_spread":0.25241827741283407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972000776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991756,0.00044932403,0.000065717024,0.00045747787,0.00027008698,0.002296261,0.0002265953,0.00012778089,0.004350706],"genre_scores_gemma":[0.9910331,0.00008960194,0.001195925,0.000522884,0.00041932781,0.0012815043,0.00004872849,0.00014294362,0.0052660233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957882,0.0003188532,0.00040439432,0.0008749377,0.0010576596,0.0015559301],"domain_scores_gemma":[0.997119,0.00033903745,0.000093073955,0.0006917738,0.00086209475,0.0008950148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007047799,0.0003296671,0.00043012944,0.0006205416,0.00047246332,0.00011894349,0.00040709853,0.00010530012,0.0010211791],"category_scores_gemma":[0.00060491177,0.0002969421,0.00022657818,0.0007057887,0.00041183943,0.000188889,0.00037884928,0.0007671809,0.0004842701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055857017,0.001420872,0.0012896303,0.00077058526,0.00028641854,0.00635239,0.0007897045,0.0000040946343,0.96164036,0.00020550822,0.019114835,0.0025398864],"study_design_scores_gemma":[0.003773551,0.004056324,0.0016853142,0.0003339504,0.000049175123,0.00006672716,0.0003102994,0.00015231065,0.9857228,0.0004067244,0.0031892227,0.00025361823],"about_ca_topic_score_codex":0.0022462567,"about_ca_topic_score_gemma":0.00025688403,"teacher_disagreement_score":0.024082411,"about_ca_system_score_codex":0.00027422066,"about_ca_system_score_gemma":0.00092752144,"threshold_uncertainty_score":0.99994826},"labels":[],"label_agreement":null},{"id":"W1972164821","doi":"10.1158/0008-5472.sabcs11-p2-12-23","title":"P2-12-23: How Should We Assess Tumour Size (T Stage) in Patients with Multicentric/Multifocal Breast Cancer? Results from the NCIC CTG MA.5 Randomized Trial of CEF vs. CMF in Pre-Menopausal Women with Node Positive Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Baker Hughes (Canada); Juravinski Cancer Centre; Vancouver Hospital and Health Sciences Centre; Queen's University; Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Calgary; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Oncology; Lymph node; Internal medicine","score_opus":0.03698919270106996,"score_gpt":0.3232380076111097,"score_spread":0.28624881491003973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972164821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838575,0.00081615103,0.000016078055,0.0025737977,0.00018831724,0.0033866812,0.009054458,0.00001476417,0.00009224518],"genre_scores_gemma":[0.9937163,0.0016713111,0.00011599079,0.00010795464,0.00035317938,0.0035225928,0.00016328825,0.00008677476,0.00026261088],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9947275,0.0011638486,0.0006154337,0.0011445074,0.0011416236,0.0012070864],"domain_scores_gemma":[0.9971977,0.00066214724,0.00039307872,0.00070344476,0.000811201,0.00023241415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001114839,0.0005378285,0.0010403926,0.00015382265,0.00018879602,0.00006626207,0.0006808315,0.0002366972,0.00011811039],"category_scores_gemma":[0.00021694913,0.00033685693,0.00007335917,0.00064931746,0.00092469633,0.000044111835,0.00038055572,0.00068139203,0.0000016853625],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87688893,0.0010501889,0.10993984,0.0000566911,0.00088997325,0.00002973375,0.0045291604,0.00020625732,0.003925696,0.0000035871633,0.0002407603,0.0022391912],"study_design_scores_gemma":[0.41131067,0.000863778,0.57974786,0.00045833248,0.00009328899,0.000002074416,0.00080630026,0.000031555595,0.00629899,0.0000065850004,0.000040878145,0.00033966952],"about_ca_topic_score_codex":0.085162915,"about_ca_topic_score_gemma":0.037166007,"teacher_disagreement_score":0.46980804,"about_ca_system_score_codex":0.0011872115,"about_ca_system_score_gemma":0.001356744,"threshold_uncertainty_score":0.9999083},"labels":[],"label_agreement":null},{"id":"W1972241306","doi":"10.1158/1538-7445.am2014-996","title":"Abstract 996: Metastasis and tumor recurrence from rare SOX9-positive cells in Group 4 medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; SOX9; Cancer research; Population; Metastasis; Wnt signaling pathway; Biology; Pathology; Cancer; Medicine; Internal medicine; Transcription factor; Gene; Genetics","score_opus":0.024122643032740247,"score_gpt":0.33150122378118924,"score_spread":0.307378580748449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972241306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963278,0.0026285695,0.00010244719,0.00012556229,0.00007071613,0.00024780884,0.00022081594,0.0000053061876,0.0002709663],"genre_scores_gemma":[0.9989538,0.0003195527,0.00021408888,0.00005340266,0.00019052371,0.00008926703,0.00011883795,0.000018704375,0.00004182597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986093,0.0002127707,0.00015383086,0.00045828806,0.00024671448,0.0003190708],"domain_scores_gemma":[0.99934655,0.00007190769,0.00004428588,0.00027859025,0.00012541472,0.00013324188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004911564,0.00011450711,0.00012961948,0.00008605098,0.00007219114,0.000043512217,0.00018641245,0.000080145735,0.000118384705],"category_scores_gemma":[0.00011701544,0.00011305971,0.000035875673,0.00015194928,0.00017209772,0.000008177458,0.00015698814,0.00018711352,0.000016984379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016298667,0.000037675618,0.0017848213,0.000034848166,0.000025182482,0.0000067606165,0.000057805843,0.000019578818,0.9850554,0.000027505266,0.0014845977,0.0113028735],"study_design_scores_gemma":[0.00056283,0.000111812034,0.08752352,0.00012395388,0.0000083765435,0.0000015991442,0.00007989298,0.00010547605,0.9029952,0.000279994,0.008035031,0.00017228197],"about_ca_topic_score_codex":0.0006781468,"about_ca_topic_score_gemma":0.00056312367,"teacher_disagreement_score":0.085738696,"about_ca_system_score_codex":0.000062790656,"about_ca_system_score_gemma":0.00011408532,"threshold_uncertainty_score":0.4610441},"labels":[],"label_agreement":null},{"id":"W1972569514","doi":"10.1158/1538-7445.am2013-518","title":"Abstract 518: Kisspeptin stimulates invasiveness of ERα -negative human mammary epithelial and breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Epithelial–mesenchymal transition; Cancer research; Transactivation; Biology; Vimentin; Cancer cell; Estrogen receptor; SKBR3; Cell biology; Cancer; Breast cancer; Metastasis; Immunology; Transcription factor","score_opus":0.022852850442898975,"score_gpt":0.3421682074829256,"score_spread":0.3193153570400266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972569514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551535,0.003113254,0.0000037846305,0.00028863287,0.00006960314,0.00041808386,0.00009340762,0.0000073664883,0.00049049774],"genre_scores_gemma":[0.9961054,0.002665046,0.00004076391,0.000030941486,0.00018979139,0.0001570244,0.000019664882,0.000026631591,0.00076475064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874777,0.00011479233,0.00017620789,0.00035471964,0.00023230242,0.00037421347],"domain_scores_gemma":[0.99911386,0.000054753564,0.000064085165,0.00025662483,0.000355823,0.00015488375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023889478,0.00014578809,0.0001766495,0.000082279636,0.00013984276,0.00004103882,0.00024244082,0.00020501937,0.00026136244],"category_scores_gemma":[0.000022704537,0.00012149016,0.000056110646,0.00014277823,0.0003501064,0.000013042161,0.00021440636,0.00030616557,0.000017357817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009073719,0.00005038381,0.0026381344,0.00011519822,0.00010435157,0.000006367404,0.0000846112,0.0000715625,0.9900439,0.000029556883,0.0014617055,0.005303518],"study_design_scores_gemma":[0.00062993926,0.00015788103,0.043380603,0.000103316816,0.000008957225,0.0000043996215,0.000065521745,0.000019421785,0.9551408,0.00016561657,0.00017938743,0.00014410756],"about_ca_topic_score_codex":0.0032929243,"about_ca_topic_score_gemma":0.00007223939,"teacher_disagreement_score":0.040742468,"about_ca_system_score_codex":0.000036362922,"about_ca_system_score_gemma":0.00020615717,"threshold_uncertainty_score":0.49779382},"labels":[],"label_agreement":null},{"id":"W1972629209","doi":"10.1158/1538-7445.am10-2384","title":"Abstract 2384: Role of bone marrow derived progenitor cells in intracranial tumor neovascularization","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre for Social Innovation; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Bone marrow; mCherry; Glioma; U87; Pathology; Cancer research; Neovascularization; Green fluorescent protein; In vivo; Medicine; Brain tumor; Progenitor cell; Angiogenesis; Stem cell; Biology; Cell biology","score_opus":0.013898820607376463,"score_gpt":0.30519284458236867,"score_spread":0.2912940239749922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972629209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551606,0.002884149,0.000019303823,0.00006398432,0.0007618276,0.00042042427,0.000041874566,0.0000061459914,0.00028622197],"genre_scores_gemma":[0.99640334,0.00083958317,0.0003188157,0.000025604795,0.002036248,0.00015647523,0.000036928934,0.000029473336,0.00015355113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986082,0.00006972984,0.0002459292,0.00034178712,0.00034181715,0.0003925787],"domain_scores_gemma":[0.9991607,0.000014159904,0.00006411657,0.00035963,0.00028976274,0.00011161558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006074637,0.000114676004,0.00018636794,0.00012922785,0.00005785298,0.000025376716,0.0002195234,0.0001613849,0.00017572429],"category_scores_gemma":[0.00011741086,0.000115413575,0.000086003376,0.00023923861,0.0001763781,0.000007831295,0.00009671431,0.00039468525,0.0000100359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000201616,0.00008281098,0.000962374,0.000049100083,0.000021233334,0.000003196975,0.00008223032,0.000023466324,0.9827434,0.000024025334,0.0004212888,0.015385259],"study_design_scores_gemma":[0.0007361423,0.00005092186,0.012578053,0.000016788383,0.000006529497,0.0000049252712,0.00007476074,0.00002497451,0.9361243,0.00006972247,0.050192796,0.000120067765],"about_ca_topic_score_codex":0.0007971312,"about_ca_topic_score_gemma":0.001784741,"teacher_disagreement_score":0.049771506,"about_ca_system_score_codex":0.00002358357,"about_ca_system_score_gemma":0.00047892102,"threshold_uncertainty_score":0.4706429},"labels":[],"label_agreement":null},{"id":"W1972696984","doi":"10.1158/0008-5472.can-10-1012","title":"PALB2/FANCN: Recombining Cancer and Fanconi Anemia","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; Ministero dello Sviluppo Economico; Jewish General Hospital; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Rutgers Cancer Institute of New Jersey; Susan G. Komen for the Cure","keywords":"PALB2; Fanconi anemia; Breast cancer; BRCA2 Protein; Cancer; Genetics; Biology; Mutation; DNA repair; Cancer research; Gene; Medicine; Germline mutation","score_opus":0.10519663336883868,"score_gpt":0.4582809718195272,"score_spread":0.35308433845068854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972696984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021517398,0.9947965,0.0000058214905,0.00007422201,0.000776792,0.00081156334,0.00013068249,0.000024665687,0.0012280224],"genre_scores_gemma":[0.000088913366,0.9898345,0.00017585958,0.000046956004,0.001149112,0.0015603314,0.00012330817,0.00013725205,0.0068837567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971467,0.00026630095,0.00036691065,0.0010307273,0.000407608,0.0007817127],"domain_scores_gemma":[0.9984133,0.00006892303,0.00014815443,0.00085126195,0.000248904,0.00026942464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010026884,0.00039243753,0.0008149622,0.0001838656,0.00020530478,0.0000998807,0.00060951797,0.00097288215,0.000258694],"category_scores_gemma":[0.0001770969,0.00034434727,0.00021180471,0.0003078464,0.0002603389,0.000004511872,0.0006301717,0.0015014578,0.000038266655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013612725,0.000013313042,0.000011801514,0.0039296234,0.0000792933,0.0000127962285,0.000018737013,1.4228546e-7,0.009235927,0.0000560748,0.0051964563,0.9814322],"study_design_scores_gemma":[0.0002073614,0.00011625929,0.0000018513957,0.002947942,0.000075293516,0.000027735014,0.000013713582,8.117834e-7,0.005944831,0.000061846484,0.9902233,0.00037908496],"about_ca_topic_score_codex":0.00023638934,"about_ca_topic_score_gemma":0.00043682125,"teacher_disagreement_score":0.98502684,"about_ca_system_score_codex":0.00012842665,"about_ca_system_score_gemma":0.0014553146,"threshold_uncertainty_score":0.9999009},"labels":[],"label_agreement":null},{"id":"W1972770053","doi":"10.1158/1538-7445.am2014-1274","title":"Abstract 1274: Alcohol and lung cancer risk: a pooled analysis using International Lung Cancer Consortium studies","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Confounding; Logistic regression; Cancer; Internal medicine; Cohort; Risk factor; Environmental health; Alcohol consumption; Demography; Alcohol; Oncology; Biology","score_opus":0.2259403094040936,"score_gpt":0.5571192557237882,"score_spread":0.3311789463196946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972770053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223679,0.07124886,0.00011139269,0.004518055,0.00050035736,0.00075576984,0.000083367944,0.000036289082,0.0003780569],"genre_scores_gemma":[0.95791394,0.038582407,0.0000841534,0.00092429353,0.00087517756,0.00051467645,0.000012534629,0.00003208347,0.0010607279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971965,0.00027436548,0.00040082735,0.0005818222,0.0008995678,0.0006469244],"domain_scores_gemma":[0.9975142,0.0005320938,0.00017989441,0.0003258059,0.0010647075,0.00038331217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017789189,0.00020536526,0.00058910914,0.0007369796,0.00044537033,0.000072324045,0.000157291,0.00012744356,0.0031933566],"category_scores_gemma":[0.00059720204,0.00017457655,0.00012695504,0.00079051615,0.00037283445,0.00013560416,0.00015143327,0.00080122455,0.0000109439825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005909824,0.000068327485,0.950541,0.0011131294,0.006883649,0.000029336896,0.0014176307,0.00078354543,0.009592898,0.00005922583,0.013444827,0.015475425],"study_design_scores_gemma":[0.004283838,0.00007242373,0.89043236,0.0013937424,0.0038737827,0.0000073433853,0.000459087,0.0874689,0.0018728733,0.000024668218,0.009718812,0.00039215933],"about_ca_topic_score_codex":0.00878064,"about_ca_topic_score_gemma":0.0027362567,"teacher_disagreement_score":0.08668535,"about_ca_system_score_codex":0.0011780051,"about_ca_system_score_gemma":0.0007403906,"threshold_uncertainty_score":0.99781996},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W1972850311","doi":"10.1158/0008-5472.sabcs10-p2-06-11","title":"Abstract P2-06-11: Ramifications of HER2/ER/PR Guidelines from ASCO/CAP for Translational Cancer Research Using a Cohort from a Tertiary Care Centre in Ontario","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Tissue microarray; Cohort; Breast cancer; Internal medicine; Oncology; Human Epidermal Growth Factor Receptor 2; Immunohistochemistry; Cancer; Cohort study; Pathology; Gynecology","score_opus":0.12468849251408298,"score_gpt":0.44756102768467504,"score_spread":0.32287253517059206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972850311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910755,0.0053028236,0.000054968208,0.0019192606,0.00020263763,0.000968944,0.0023387661,0.0000074514824,0.00009759624],"genre_scores_gemma":[0.99466765,0.00041606702,0.0017962004,0.000042598687,0.00062917854,0.0008192346,0.0012948428,0.000044463464,0.00028978114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748045,0.00011773061,0.00044082906,0.00072702684,0.00064518687,0.0005887569],"domain_scores_gemma":[0.9972816,0.0002130195,0.00007873409,0.0005472683,0.0017590239,0.00012036913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055090146,0.00019791476,0.00027469549,0.00017333336,0.0002606848,0.000037103928,0.00039356464,0.00024807005,0.00047264592],"category_scores_gemma":[0.00016479564,0.00019050988,0.00011901659,0.00024071465,0.00042537425,0.000015705684,0.00013083297,0.000538288,0.000003940921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024514485,0.000106196785,0.5992847,0.000037632533,0.00019919658,0.0000022956444,0.0014565131,0.00022889864,0.3945555,0.000016344491,0.0021655308,0.0017020565],"study_design_scores_gemma":[0.0016525257,0.000024160303,0.8786873,0.00021406422,0.000043960525,5.1448615e-7,0.0012399495,0.00009378514,0.09853215,0.00036776852,0.01891956,0.00022426352],"about_ca_topic_score_codex":0.6322668,"about_ca_topic_score_gemma":0.89065737,"teacher_disagreement_score":0.29602337,"about_ca_system_score_codex":0.00038712766,"about_ca_system_score_gemma":0.0024153818,"threshold_uncertainty_score":0.7768767},"labels":[],"label_agreement":null},{"id":"W1972878824","doi":"10.1158/1538-7445.am2014-4716","title":"Abstract 4716: Discovery of biomarkers from highly enriched prostate cancer microparticles for prognostication of prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Prostate; Biopsy; Cancer; Urology; PCA3; Flow cytometry; Lymph node; Pathology; Internal medicine; Immunology","score_opus":0.03933019718290282,"score_gpt":0.3864289645103644,"score_spread":0.3470987673274616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972878824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922196,0.0018678923,0.0012687596,0.0010161942,0.000033862252,0.0012218494,0.0021218718,0.00004966479,0.00020030816],"genre_scores_gemma":[0.9847652,0.002279137,0.004443449,0.000015824775,0.000138899,0.0077564903,0.000111411,0.000051989995,0.00043763526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982267,0.000029388872,0.0004747034,0.00046795857,0.00034764226,0.00045359612],"domain_scores_gemma":[0.99808586,0.0003781026,0.00031232173,0.00048859476,0.0006429066,0.000092201946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038957354,0.00016526133,0.00028056937,0.00008414767,0.00012452787,0.00004054612,0.00036618352,0.00010559903,0.00014288045],"category_scores_gemma":[0.00015223492,0.00015086636,0.00008343082,0.00031579894,0.00039070722,0.0001853381,0.0001011498,0.00022442602,0.0000018297864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046663883,0.000108279295,0.013651301,0.0006033193,0.000081488324,1.769505e-7,0.0002818703,0.000099582256,0.95619935,0.00066765497,0.0006921972,0.027148165],"study_design_scores_gemma":[0.0006301125,0.000038738763,0.003449673,0.00033392393,0.00003068565,9.220931e-8,0.00011587743,0.00029959902,0.98424643,0.006133986,0.004551456,0.0001694451],"about_ca_topic_score_codex":0.0054752724,"about_ca_topic_score_gemma":0.00037616852,"teacher_disagreement_score":0.028047083,"about_ca_system_score_codex":0.00022228864,"about_ca_system_score_gemma":0.00035962646,"threshold_uncertainty_score":0.82770103},"labels":[],"label_agreement":null},{"id":"W1972926597","doi":"10.1158/0008-5472.can-06-1576","title":"Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"FOXM1; Survivin; Transcription factor; Thiostrepton; Cancer research; Biology; Forkhead Transcription Factors; Transcription (linguistics); Apoptosis; Gene; RNA; Biochemistry","score_opus":0.03809713116405349,"score_gpt":0.34414110340458315,"score_spread":0.30604397224052965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972926597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981488,0.00060038676,0.00038441876,0.00023777333,0.00014571751,0.00031594012,0.00010370654,0.0000047165754,0.000058517337],"genre_scores_gemma":[0.99924785,0.00003929551,0.0000174805,0.0000060794355,0.00016948357,0.000050130373,0.000051423158,0.000013752834,0.00040448623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881136,0.00010091412,0.0003029179,0.00020868723,0.00040502206,0.00017109732],"domain_scores_gemma":[0.999241,0.00000969852,0.00008767663,0.0003108878,0.00032329196,0.000027475786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002473381,0.00007208604,0.000094220086,0.00005720503,0.000042769687,0.0000098713035,0.00020937769,0.00012625595,0.000035287656],"category_scores_gemma":[0.00003588689,0.00005903512,0.0001180586,0.00023416578,0.00023727895,0.00000712115,0.000025979285,0.00011354174,0.0000022139836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098744196,0.000058590584,0.0016425152,0.000059219055,0.000013631595,3.8867693e-8,0.000053344687,0.000035838188,0.9965197,0.00013824631,0.00058904866,0.000791088],"study_design_scores_gemma":[0.0003564095,0.00004494836,0.013010574,0.000023303148,0.0000072157245,6.221221e-7,0.000019748397,0.000024312047,0.9837973,0.00014540867,0.0025155277,0.00005461576],"about_ca_topic_score_codex":0.00019570184,"about_ca_topic_score_gemma":0.000078048695,"teacher_disagreement_score":0.01272238,"about_ca_system_score_codex":0.00006031247,"about_ca_system_score_gemma":0.00013211781,"threshold_uncertainty_score":0.24073823},"labels":[],"label_agreement":null},{"id":"W1972933671","doi":"10.1158/0008-5472.can-10-2717","title":"The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Biology; Gene knockdown; Breast cancer; Transcription factor; Cancer research; Downregulation and upregulation; Progenitor cell; Genome instability; Gene isoform; Tumor suppressor gene; Enhancer; Stem cell; Cell biology; Cancer; Carcinogenesis; Gene; Genetics; DNA damage; DNA","score_opus":0.10623054645667628,"score_gpt":0.3853397230396365,"score_spread":0.2791091765829602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972933671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97999346,0.009897091,0.000045461078,0.003425781,0.00018502664,0.002423088,0.000102271995,0.000014760491,0.0039130743],"genre_scores_gemma":[0.9948957,0.002842227,0.000042854113,0.000072397444,0.000110030145,0.0010131466,0.0000041890694,0.000030151863,0.0009893079],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99764836,0.00037182658,0.000345788,0.00025778514,0.00095384376,0.00042239035],"domain_scores_gemma":[0.9984198,0.00010608875,0.00015483634,0.00065774884,0.0005919947,0.000069489935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015713795,0.00011824282,0.00025112968,0.00016340587,0.000108966844,0.0000122465335,0.00041425045,0.00010623018,0.00044652828],"category_scores_gemma":[0.00012968098,0.00007081368,0.00010820805,0.00077971356,0.0005076507,0.00005710401,0.000106260384,0.00063204754,0.000007835435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012525241,0.0028490555,0.11881135,0.00417047,0.001434002,0.00026128915,0.04654272,0.00019831183,0.6255263,0.0073920395,0.044688117,0.13560112],"study_design_scores_gemma":[0.004671494,0.0011250494,0.6550328,0.004739887,0.00014999634,0.00004956181,0.0064942576,0.00014113617,0.30719462,0.002336837,0.017744128,0.0003202384],"about_ca_topic_score_codex":0.008837653,"about_ca_topic_score_gemma":0.011988419,"teacher_disagreement_score":0.53622144,"about_ca_system_score_codex":0.00028515278,"about_ca_system_score_gemma":0.00091555447,"threshold_uncertainty_score":0.99776256},"labels":[],"label_agreement":null},{"id":"W1972987163","doi":"10.1158/1538-7445.fbcr13-ia7","title":"Abstract IA7: Translational control of cancer via eIF4E/4E-BPs","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"EIF4E; mTORC1; PI3K/AKT/mTOR pathway; Cancer research; Biology; PTEN; Cancer; Phosphorylation; Translation (biology); P70-S6 Kinase 1; Mechanistic target of rapamycin; Cell growth; Initiation factor; Cell biology; Signal transduction; Genetics; Messenger RNA; Gene","score_opus":0.04372067828464899,"score_gpt":0.3939833166977745,"score_spread":0.3502626384131255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972987163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98199975,0.012453816,0.0011527126,0.0015542434,0.00029938912,0.0006033405,0.00020556292,0.000013113494,0.001718089],"genre_scores_gemma":[0.9966385,0.0006488731,0.00009917871,0.00020250033,0.00077943626,0.000685785,0.000035823403,0.000038979975,0.0008709409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998062,0.00009765952,0.0002984628,0.0004217064,0.00060037884,0.0005197866],"domain_scores_gemma":[0.9985765,0.00007634331,0.00008005207,0.00037489404,0.0007294066,0.00016279545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046065226,0.00015450623,0.00020386599,0.00008965679,0.00010177902,0.000031560867,0.00039992627,0.0002024945,0.0035351976],"category_scores_gemma":[0.0000609747,0.00014411088,0.00011410087,0.00019732215,0.00031883942,0.000010971484,0.000050248054,0.00031718687,0.00005808832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016176137,0.000047827172,0.008676488,0.00006925101,0.00013189482,0.0000017339776,0.000050799405,0.0007274704,0.96792305,0.00004467497,0.00888235,0.013282712],"study_design_scores_gemma":[0.0018090481,0.00022063611,0.04382125,0.00010136918,0.000020857835,0.000002593379,0.00003347706,0.00030134336,0.9175765,0.00058985513,0.035214886,0.0003081776],"about_ca_topic_score_codex":0.0029044398,"about_ca_topic_score_gemma":0.000393681,"teacher_disagreement_score":0.05034653,"about_ca_system_score_codex":0.000078326346,"about_ca_system_score_gemma":0.00064702687,"threshold_uncertainty_score":0.9973757},"labels":[],"label_agreement":null},{"id":"W1973125664","doi":"10.1158/0008-5472.sabcs-09-36","title":"Adherence of Adjuvant Hormonal Therapies in Post-Menopausal Hormone Receptor Positive (HR+) Early Stage Breast Cancer: A Population Based Study from British Columbia.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Oncology; Internal medicine; Hormonal therapy; Cancer; Population; Aromatase; Gynecology; Stage (stratigraphy); Adjuvant; Aromatase inhibitor; Cohort","score_opus":0.053213495247285365,"score_gpt":0.38080797417523793,"score_spread":0.32759447892795257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973125664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921082,0.00325734,0.000011590924,0.0017589687,0.00006393459,0.0015447028,0.0010529914,0.00003078648,0.00017148179],"genre_scores_gemma":[0.9958653,0.00059636444,0.000104589395,0.0003750297,0.00015821923,0.0004452609,0.00015651477,0.00002062248,0.0022780977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969904,0.0002977914,0.00046469443,0.0005277938,0.0012568566,0.00046249776],"domain_scores_gemma":[0.99825335,0.00012395349,0.00014908504,0.0003720819,0.0008773658,0.0002241889],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005832533,0.000137972,0.00044931448,0.00014474906,0.00012687671,0.0001011189,0.00028281452,0.00010039754,0.0059970026],"category_scores_gemma":[0.00008191909,0.00017073097,0.00004090845,0.00078922213,0.00012740846,0.00018453348,0.000039252358,0.0005703259,0.00005700896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019380937,0.0012968226,0.79493386,0.00003601621,0.00010264781,0.0000782947,0.0010926642,0.000006865748,0.120436914,0.000006402318,0.004683092,0.075388335],"study_design_scores_gemma":[0.0030023302,0.0029637206,0.99156815,0.00059819943,0.000022790098,0.0000024128187,0.0010701895,0.000058215675,0.0003873685,0.00007201797,0.00009662372,0.00015800442],"about_ca_topic_score_codex":0.42144096,"about_ca_topic_score_gemma":0.038969196,"teacher_disagreement_score":0.38247177,"about_ca_system_score_codex":0.00047365428,"about_ca_system_score_gemma":0.0009818035,"threshold_uncertainty_score":0.9949117},"labels":[],"label_agreement":null},{"id":"W1973331825","doi":"10.1158/1538-7445.am2013-2851","title":"Abstract 2851: Development of an alkalizing antibody-enzyme conjugate for NSCLC treatment that is in Phase I clinical testing.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Immunoconjugate; Tumor microenvironment; Chemistry; In vivo; Antibody; Cancer cell; Extracellular; Cancer research; Conjugate; Cancer; In vitro; Pancreatic cancer; Pharmacology; Monoclonal antibody; Biochemistry; Biology; Immunology; Medicine; Internal medicine","score_opus":0.21233923693065299,"score_gpt":0.4933378677471322,"score_spread":0.2809986308164792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973331825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407774,0.0041113687,0.00009577456,0.00014904983,0.00030301214,0.0008812973,0.000069768794,0.0000069020793,0.0003050853],"genre_scores_gemma":[0.9939891,0.0017308936,0.0021520888,0.0001269277,0.00083522836,0.000570593,0.000117672855,0.000032744683,0.00044476395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982333,0.00008966089,0.00042936686,0.00049066386,0.00024362939,0.0005133498],"domain_scores_gemma":[0.99891084,0.0000902847,0.00010007825,0.00036086552,0.00034620526,0.00019169845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000944424,0.00015513459,0.00029671783,0.000099446755,0.00010851038,0.0000386803,0.00023528005,0.00015533422,0.00010396184],"category_scores_gemma":[0.00014777847,0.00013563517,0.00008797036,0.00014574885,0.00016632689,0.000013749216,0.000078018966,0.00014536991,0.000009128826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002232253,0.00034632784,0.001311474,0.000046806388,0.00006003176,0.0000010040851,0.00024020497,0.000005078849,0.7538801,0.000004356381,0.0016763932,0.24220504],"study_design_scores_gemma":[0.004120222,0.00069351733,0.012452094,0.00007966157,0.000012575704,0.0000016504596,0.00022981505,0.000091026224,0.7968433,0.00004991924,0.1852278,0.00019840618],"about_ca_topic_score_codex":0.0011359062,"about_ca_topic_score_gemma":0.0004891466,"teacher_disagreement_score":0.24200663,"about_ca_system_score_codex":0.0000734424,"about_ca_system_score_gemma":0.00095091684,"threshold_uncertainty_score":0.5531042},"labels":[],"label_agreement":null},{"id":"W1973345929","doi":"10.1158/1538-7445.am2012-281","title":"Abstract 281: Novel nucleic acid constructs and formulations for treatment of bladder cancer and malignant ascites","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nucleic acid; Oligonucleotide; Small interfering RNA; microRNA; Gene silencing; Molecular biology; Locked nucleic acid; Chemistry; Cancer research; Druggability; RNA; Biology; Biochemistry; Gene","score_opus":0.10156479825782266,"score_gpt":0.40779629792362626,"score_spread":0.3062314996658036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973345929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911084,0.019482156,0.00017009427,0.00026913843,0.000058858826,0.0003757966,0.00031753955,0.0000027055323,0.00021286002],"genre_scores_gemma":[0.9918988,0.006456202,0.00047722002,0.00001908233,0.0002093274,0.0004562736,0.000029116256,0.000014871843,0.00043910986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992886,0.000010453501,0.00012270627,0.00019745271,0.00010321674,0.00027755834],"domain_scores_gemma":[0.99945945,0.000027164217,0.000041897856,0.00017703585,0.00018963293,0.00010484584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001436614,0.00008481472,0.00010934682,0.000051387982,0.00013632575,0.000020200268,0.00005519094,0.000071559174,0.000064493805],"category_scores_gemma":[0.000020429421,0.000068794514,0.000030748022,0.00007184658,0.00020722275,0.000010399184,0.000032073538,0.000027986312,6.883881e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061003964,0.00006850645,0.00903889,0.00004272611,0.00007617459,5.4884183e-8,0.00013912843,0.000006856557,0.96500134,0.0008066919,0.00041675856,0.024341855],"study_design_scores_gemma":[0.0013536416,0.00024503475,0.08528767,0.000034152476,0.000033149478,0.0000040830473,0.00023762711,0.000056675268,0.853446,0.00011029516,0.05903589,0.0001557664],"about_ca_topic_score_codex":0.00026905962,"about_ca_topic_score_gemma":0.00013120924,"teacher_disagreement_score":0.11155534,"about_ca_system_score_codex":0.00004231291,"about_ca_system_score_gemma":0.00014951546,"threshold_uncertainty_score":0.2805359},"labels":[],"label_agreement":null},{"id":"W1973401983","doi":"10.1158/1538-7445.cansusc14-ia10","title":"Abstract IA10: Li-Fraumeni syndrome: p53 and beyond","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Cancer; Germline; Context (archaeology); Medicine; Cancer syndrome; Cancer research; Germline mutation; Genetics; Biology; Internal medicine; Mutation; Gene","score_opus":0.04811493997834517,"score_gpt":0.3825296962434486,"score_spread":0.3344147562651035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973401983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96215475,0.004572146,0.000072777766,0.0038438775,0.00024568223,0.000571095,0.000017620521,0.000072411734,0.02844967],"genre_scores_gemma":[0.9956684,0.0008701076,0.0001391075,0.0003814333,0.0002509026,0.00014382276,0.000013356746,0.000057129764,0.002475739],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978166,0.000085037704,0.00020820097,0.00046949007,0.00080111454,0.0006195339],"domain_scores_gemma":[0.9986227,0.00013759092,0.00003670893,0.0005382807,0.000255109,0.00040957372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000966272,0.00015040534,0.00028461046,0.0002721636,0.00016196813,0.00005484481,0.00015428933,0.00017357653,0.0010028883],"category_scores_gemma":[0.00026839555,0.00013815223,0.00006262251,0.00043796765,0.0003052374,0.00007336856,0.00013589137,0.0009151127,0.00024816763],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008843821,0.00032608875,0.0047620735,0.0013277545,0.00041369454,0.0011562157,0.0012354326,0.000059142392,0.6723452,0.0028017357,0.091455385,0.22323288],"study_design_scores_gemma":[0.010834541,0.0028024619,0.17807621,0.0016920568,0.00019523311,0.0013373528,0.00055413204,0.00076120376,0.1360627,0.0033162963,0.6633216,0.0010462091],"about_ca_topic_score_codex":0.00045863786,"about_ca_topic_score_gemma":0.00008978591,"teacher_disagreement_score":0.5718662,"about_ca_system_score_codex":0.0003062466,"about_ca_system_score_gemma":0.00037868274,"threshold_uncertainty_score":0.99991035},"labels":[],"label_agreement":null},{"id":"W1973471572","doi":"10.1158/0008-5472.can-12-4183","title":"A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Pazopanib; Sunitinib; Metastatic breast cancer; Bevacizumab; Oncology; Breast cancer; Internal medicine; Cancer; Clinical trial; Chemotherapy; Phases of clinical research","score_opus":0.26187886519085657,"score_gpt":0.5499455557350358,"score_spread":0.2880666905441792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973471572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767812,0.0053855795,0.000005780944,0.0155991865,0.000101328704,0.0015131346,0.00019543419,0.000020133592,0.00039825187],"genre_scores_gemma":[0.99172235,0.0054436345,0.00013751438,0.00028575028,0.00016473608,0.0006553891,0.000016856298,0.000033663433,0.0015400908],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99753016,0.0002679305,0.0006279722,0.00043354067,0.00062785536,0.0005125289],"domain_scores_gemma":[0.997117,0.00095203205,0.00018177033,0.0005915887,0.00092354737,0.00023408934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007926741,0.00017282677,0.00062433054,0.00014711602,0.000088743094,0.000012102143,0.00034235878,0.0000872291,0.002032229],"category_scores_gemma":[0.00010354931,0.00010518103,0.00031524358,0.000654664,0.00091691944,0.000095339456,0.00015127534,0.0004957896,0.000030031446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016305843,0.0044314987,0.07653998,0.0011267024,0.0042978274,0.00004858722,0.0039405664,0.0024410456,0.5532556,0.0005443777,0.07111399,0.26595396],"study_design_scores_gemma":[0.052790254,0.003842357,0.6589547,0.0017759431,0.003234655,0.00019576409,0.0026791731,0.034722943,0.23199666,0.0020715902,0.0065994477,0.0011365435],"about_ca_topic_score_codex":0.002060148,"about_ca_topic_score_gemma":0.00004195293,"teacher_disagreement_score":0.5824147,"about_ca_system_score_codex":0.00015302305,"about_ca_system_score_gemma":0.0010528251,"threshold_uncertainty_score":0.99888},"labels":[],"label_agreement":null},{"id":"W1973538336","doi":"10.1158/1538-7445.am2011-968","title":"Abstract 968: Invadopodia formation and microparticle release are required for cancer cell extravasation in vivo","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Extravasation; Invadopodia; Cancer cell; Cancer; In vivo; Medicine; Bosutinib; Intravasation; Proto-oncogene tyrosine-protein kinase Src; Endothelium; Cancer research; Pathology; Internal medicine; Biology; Dasatinib; Receptor","score_opus":0.10457599069321903,"score_gpt":0.3606325785235451,"score_spread":0.25605658783032603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973538336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632657,0.0021236155,0.0002900283,0.00011855262,0.00008447281,0.00034700523,0.000054488693,0.0000039445617,0.0006513299],"genre_scores_gemma":[0.99648726,0.0024320583,0.00011183933,0.000051781222,0.00009189383,0.00033016005,0.00002128292,0.000014729503,0.0004590203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992818,0.00003438823,0.00014696563,0.00021142048,0.00009166102,0.00023372796],"domain_scores_gemma":[0.9995469,0.000012255615,0.00005054778,0.0001546252,0.00016661212,0.000069092224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000290492,0.00006648432,0.00006679084,0.00004954316,0.0000886912,0.000025122414,0.00008117663,0.00007498961,0.00023678927],"category_scores_gemma":[0.000041862142,0.00006763243,0.000027742726,0.00007289194,0.00003306217,0.000021973075,0.000044360822,0.00008944998,0.000003520259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016740547,0.000053097727,0.00039952056,0.000058986676,0.0000055524542,0.0000011067968,0.00030563652,0.000005360685,0.99441195,0.00005875483,0.0021082421,0.0024243668],"study_design_scores_gemma":[0.00045172634,0.00009269633,0.0018043898,0.000035603553,0.0000038138191,9.986089e-7,0.00057360413,0.00034088534,0.9847101,0.00016860553,0.011733102,0.00008449978],"about_ca_topic_score_codex":0.0018277662,"about_ca_topic_score_gemma":0.005140016,"teacher_disagreement_score":0.009701895,"about_ca_system_score_codex":0.00007848734,"about_ca_system_score_gemma":0.00008139499,"threshold_uncertainty_score":0.28682494},"labels":[],"label_agreement":null},{"id":"W1973665054","doi":"10.1158/1538-7445.am2012-1018","title":"Abstract 1018: Epithelial-to-mesenchymal transition (EMT) alters vesiculation of cancer cells expressing oncogenic epidermal growth factor receptor (EGFR): Implications for the aggressive, procoagulant and proangiogenic properties","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Montreal Children's Hospital","funders":"","keywords":"A431 cells; Epidermal growth factor receptor; Cancer cell; Epithelial–mesenchymal transition; Angiogenesis; Cell biology; Epidermal growth factor; Biology; Cancer research; Cancer; Cell; Chemistry; Cell culture; Metastasis; Cell cycle; Oncogene; Biochemistry","score_opus":0.06720609946534638,"score_gpt":0.3662079903148307,"score_spread":0.2990018908494843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973665054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97774553,0.017599432,0.00091115653,0.0012080354,0.000119771925,0.0018953845,0.00050101796,0.000010126329,0.000009523933],"genre_scores_gemma":[0.99553347,0.001260597,0.00044020623,0.00006969279,0.00058764877,0.0019307616,0.00004586247,0.000043402928,0.000088335684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843365,0.00012851157,0.00028487193,0.00036858974,0.00025588533,0.0005284987],"domain_scores_gemma":[0.9987986,0.00009626051,0.00015529133,0.00033814224,0.00040619183,0.00020548933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004656551,0.00016594179,0.00015828355,0.00008228357,0.00030342583,0.00004267963,0.0002564895,0.000115083785,0.000033532564],"category_scores_gemma":[0.00020406132,0.00012335158,0.00011820272,0.00016339692,0.0002656186,0.000031558437,0.00009175133,0.00013339466,0.0000031297834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033619592,0.0000808721,0.0016471338,0.00023743439,0.000096046446,2.1452868e-7,0.0007274565,0.00022100496,0.9859426,0.000020378766,0.00059154845,0.010099085],"study_design_scores_gemma":[0.0003396465,0.00008438522,0.022081682,0.00014716838,0.000042733416,0.000002135428,0.00012417484,0.00006781633,0.9756336,0.000026441245,0.0012849652,0.00016525172],"about_ca_topic_score_codex":0.00019613981,"about_ca_topic_score_gemma":0.000028674755,"teacher_disagreement_score":0.02043455,"about_ca_system_score_codex":0.00008965968,"about_ca_system_score_gemma":0.00029515527,"threshold_uncertainty_score":0.50301313},"labels":[],"label_agreement":null},{"id":"W1973680761","doi":"10.1158/1538-7445.am10-3486","title":"Abstract 3486: Interaction of flaxseed oil with trastuzumab in HER2 overexpressing human breast tumors (BT-474)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Estrogen receptor; Internal medicine; Immunohistochemistry; Cancer; Oncology; Endocrinology","score_opus":0.06242576303604715,"score_gpt":0.4324249008362107,"score_spread":0.3699991378001636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973680761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354935,0.00010022192,0.000003142273,0.0016016243,0.00023282517,0.0002712312,0.000047089983,0.000036564616,0.004157935],"genre_scores_gemma":[0.99903,0.00003204193,0.00013950317,0.000033165034,0.0003452517,0.00009912294,0.00002166219,0.00005359994,0.0002456566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669564,0.00023433569,0.00041866963,0.00046320984,0.0011534309,0.0010347352],"domain_scores_gemma":[0.9984911,0.00021225603,0.000120404766,0.0004596973,0.00040269885,0.0003138618],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015121072,0.00017820776,0.00032512823,0.00063837506,0.00036761622,0.00012661028,0.00041432586,0.00014527906,0.00090272917],"category_scores_gemma":[0.00012881018,0.00015231587,0.000056691355,0.00066754513,0.0004250841,0.00045514724,0.00008350085,0.002755115,0.000031702726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022414653,0.00030497622,0.015309857,0.0006310666,0.000015792653,0.000038550123,0.0013485254,0.00005533687,0.9414644,0.000087722634,0.0010986314,0.037403647],"study_design_scores_gemma":[0.0036002782,0.0007979823,0.44957694,0.002846648,0.0000065740296,0.00007449891,0.002628379,0.00019193073,0.53722703,0.0002547272,0.0024096002,0.0003853735],"about_ca_topic_score_codex":0.024945682,"about_ca_topic_score_gemma":0.025627732,"teacher_disagreement_score":0.4342671,"about_ca_system_score_codex":0.0006311464,"about_ca_system_score_gemma":0.0005244512,"threshold_uncertainty_score":0.9995456},"labels":[],"label_agreement":null},{"id":"W1973823302","doi":"10.1158/0008-5472.sabcs12-s6-6","title":"Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Capecitabine; Medicine; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Clinical endpoint; Anthracycline; Breast cancer; Phases of clinical research; Cancer; Randomized controlled trial; Clinical trial; Colorectal cancer","score_opus":0.09217394740378554,"score_gpt":0.4726768322864767,"score_spread":0.3805028848826912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973823302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874912,0.0028909796,0.0000018765007,0.00029722095,0.000101758014,0.008966781,0.00016615969,0.000017377954,0.000066658395],"genre_scores_gemma":[0.9944089,0.0016347775,0.00013023232,0.00004644276,0.00008274465,0.0031838305,0.00005465365,0.000055904737,0.0004024911],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99724615,0.0003262968,0.00056196185,0.0004896807,0.0006197933,0.00075610756],"domain_scores_gemma":[0.9979093,0.00054306776,0.00024660752,0.00030166877,0.0006574379,0.00034189367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075631123,0.0003369136,0.0012717383,0.00028459632,0.00010652886,0.00003414611,0.00018970009,0.00005319732,0.0010999871],"category_scores_gemma":[0.000070761205,0.00018986569,0.000028548711,0.00067679764,0.0004497684,0.00049399823,0.000114964154,0.000368637,0.0000026609634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7920519,0.014505205,0.17390226,0.0002751424,0.0013511373,0.00010191687,0.0016302036,0.000034946173,0.0008509607,0.0000011632505,0.00009880265,0.015196347],"study_design_scores_gemma":[0.9054677,0.0088457195,0.08174569,0.00073976367,0.0009135953,0.0000063306397,0.0009118393,0.00008604249,0.0008807562,4.0631818e-7,0.00016012885,0.00024203752],"about_ca_topic_score_codex":0.011471941,"about_ca_topic_score_gemma":0.009888553,"teacher_disagreement_score":0.11341577,"about_ca_system_score_codex":0.00033642165,"about_ca_system_score_gemma":0.00044680806,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W1973836742","doi":"10.1158/1538-7445.am10-lb-296","title":"Abstract LB-296: Synergistic anticancer action of inhibitor of DNA methylation 5-aza-2-deocycytidine and EZH2 histone methylase inhibitor 3-deazaneplanocin A","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"EZH2; Biology; Epigenetics; DNA methylation; Methyltransferase; Cancer research; Carcinogenesis; Methylation; Epigenetic therapy; Molecular biology; Histone methyltransferase; PRC2; DNA; Gene; Genetics; Gene expression","score_opus":0.05095738796661584,"score_gpt":0.4057045201538518,"score_spread":0.3547471321872359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973836742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948861,0.0035769716,0.00026830687,0.00016749867,0.00037919634,0.0003216325,0.00008601695,0.00000771791,0.00030658048],"genre_scores_gemma":[0.9965424,0.0020344115,0.00045529188,0.000007859387,0.0005876845,0.000056717327,0.00007405892,0.00003379213,0.0002077944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981934,0.00013439973,0.00043268787,0.0004359083,0.0004902956,0.00031334648],"domain_scores_gemma":[0.9985191,0.00013933498,0.00021865842,0.00040537617,0.00057331927,0.00014417365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012198869,0.0001649397,0.00027017348,0.00022628378,0.0001013032,0.000019448,0.00015199908,0.00027201802,0.000103488885],"category_scores_gemma":[0.00055094,0.00015989524,0.00007337256,0.00028251857,0.0004006172,0.000014369682,0.0001140762,0.00037235906,0.0000026973248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029353012,0.00008424218,0.0008861318,0.00019487391,0.000048567472,0.0000014630442,0.00009114038,0.000042578406,0.983612,0.00009596868,0.00028320076,0.014366324],"study_design_scores_gemma":[0.0006585427,0.00029911465,0.009642175,0.000047707086,0.000025716285,8.9189865e-7,0.000064540545,0.00004956752,0.9846379,0.00025328062,0.004167156,0.0001533838],"about_ca_topic_score_codex":0.000644944,"about_ca_topic_score_gemma":0.00065927167,"teacher_disagreement_score":0.014212941,"about_ca_system_score_codex":0.00004872705,"about_ca_system_score_gemma":0.00028693688,"threshold_uncertainty_score":0.65203387},"labels":[],"label_agreement":null},{"id":"W1973887305","doi":"10.1158/1538-7445.am2014-2338","title":"Abstract 2338: Functional investigation of the CRD-BP hnRNP-K-Homology domains for C-myc messenger RNA interaction","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"","keywords":"RNA-binding protein; Ribonucleoprotein; Messenger RNA; Biology; RNA; RNA recognition motif; Molecular biology; Alternative splicing; Gene; Heterogeneous nuclear ribonucleoprotein; Genetics","score_opus":0.06574736034825482,"score_gpt":0.3838569103655847,"score_spread":0.3181095500173299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973887305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635595,0.00021641821,0.0005997414,0.0014188067,0.00025925206,0.0003388805,0.00001694187,0.0000045920096,0.00078941946],"genre_scores_gemma":[0.99689734,0.00010797893,0.00007139423,0.00014983454,0.00054792344,0.00020352998,0.000044128148,0.00001777487,0.0019600748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986767,0.00019477805,0.00017844905,0.00027265347,0.00034022788,0.00033718982],"domain_scores_gemma":[0.99890906,0.00015229464,0.00006854953,0.00032066778,0.00045803055,0.00009138293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011245525,0.00008307302,0.000103319406,0.00008099342,0.00020626358,0.000023435901,0.0002420416,0.00012435754,0.00009207723],"category_scores_gemma":[0.00048418742,0.00006204484,0.00008813744,0.00015293747,0.00028767486,0.000008851008,0.00011509546,0.00026550094,0.000007636455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025257602,0.000015705293,0.0020337214,0.000057325688,0.00003418947,1.886683e-7,0.000028843415,0.000111192974,0.9757736,0.0004008479,0.018854182,0.0024376751],"study_design_scores_gemma":[0.0005844081,0.00021699368,0.041133463,0.000041049454,0.000005145122,0.0000031864859,0.000087106026,0.0002165211,0.9233756,0.0006974004,0.033553977,0.00008514269],"about_ca_topic_score_codex":0.00024288073,"about_ca_topic_score_gemma":0.00028955523,"teacher_disagreement_score":0.052397944,"about_ca_system_score_codex":0.00006454125,"about_ca_system_score_gemma":0.00028609028,"threshold_uncertainty_score":0.25301152},"labels":[],"label_agreement":null},{"id":"W1974137744","doi":"10.1158/1538-7445.am2011-3935","title":"Abstract 3935: International Cancer Genome Consortium (ICGC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Political science; Biology; Genetics","score_opus":0.10322129887233138,"score_gpt":0.38914689420514914,"score_spread":0.28592559533281775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974137744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96781963,0.0054710065,0.000049475948,0.00044873205,0.00082466955,0.00023096107,0.00029818324,0.00001136337,0.024845976],"genre_scores_gemma":[0.98469216,0.011445123,0.00010833154,0.00033078057,0.0011279925,0.00025768284,0.000069806985,0.000033622542,0.0019344981],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998658,0.000028282155,0.00018722258,0.00041023846,0.0002867621,0.00042952175],"domain_scores_gemma":[0.99902177,0.000018600704,0.000050804865,0.00035655237,0.0003920797,0.00016018945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032648968,0.00012083602,0.00010875315,0.00009051727,0.000107852895,0.00004437499,0.00048515803,0.00011939921,0.0025710904],"category_scores_gemma":[0.000097135504,0.000121836434,0.00006828283,0.000113332375,0.00020723545,0.0000051968245,0.0002637553,0.00022354108,0.00007781325],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003267576,0.00011135862,0.011173335,0.000029407327,0.00016283002,0.000022535532,0.00029162114,0.00007059539,0.95856446,0.0004961238,0.021337166,0.0074138185],"study_design_scores_gemma":[0.00074701436,0.00014156349,0.07150895,0.00003095772,0.000012108683,0.0000050912527,0.00014997798,0.000010615688,0.29325524,0.000331236,0.63349223,0.00031498115],"about_ca_topic_score_codex":0.0021074517,"about_ca_topic_score_gemma":0.0009924758,"teacher_disagreement_score":0.6653092,"about_ca_system_score_codex":0.00012721133,"about_ca_system_score_gemma":0.00051707024,"threshold_uncertainty_score":0.99834067},"labels":[],"label_agreement":null},{"id":"W1974331314","doi":"10.1158/1538-7445.am2014-1296","title":"Abstract 1296: Family history of cancer and rhabdomyosarcoma in children: a report from the Children's Oncology Group","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Rhabdomyosarcoma; Family history; Odds ratio; Cancer; Cancer registry; Sarcoma; Population; Confidence interval; Pediatrics; Internal medicine; Oncology; Pathology","score_opus":0.056160192555549465,"score_gpt":0.3819335793845328,"score_spread":0.3257733868289834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974331314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94014716,0.053960837,7.982322e-7,0.0032404328,0.00014474003,0.00072558277,0.000039427603,0.000013104291,0.0017279353],"genre_scores_gemma":[0.9934182,0.004910164,0.00006093971,0.00047138767,0.00037359414,0.00052820635,0.000044155542,0.000026414524,0.00016691671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811614,0.00016549308,0.00035708147,0.00044819864,0.0005240806,0.00038901163],"domain_scores_gemma":[0.99848765,0.0005934544,0.00011574178,0.0005308869,0.00012799996,0.00014424605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009276472,0.00014699344,0.00042186357,0.00014779772,0.000058961497,0.000009375074,0.00017453675,0.00012387383,0.00026383658],"category_scores_gemma":[0.00016687217,0.00009885028,0.00007559545,0.00018591857,0.00045138082,0.00004325008,0.00011169427,0.0005348639,0.000007778444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018003909,0.00037773975,0.8750048,0.000015040078,0.00016976848,0.00009324198,0.0003108743,0.0000015031161,0.0022926559,0.00006864737,0.010669237,0.11081644],"study_design_scores_gemma":[0.0023802011,0.00019529139,0.9702746,0.00020005807,0.00005269904,0.00004096092,0.000061825405,0.000007127802,0.00041252945,0.000103869796,0.02618569,0.00008510974],"about_ca_topic_score_codex":0.08500085,"about_ca_topic_score_gemma":0.0045123673,"teacher_disagreement_score":0.11073133,"about_ca_system_score_codex":0.001248759,"about_ca_system_score_gemma":0.0007050084,"threshold_uncertainty_score":0.9210922},"labels":[],"label_agreement":null},{"id":"W1974350437","doi":"10.1158/0008-5472.can-06-0037","title":"The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":457,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Gene knockdown; Genomic imprinting; Chromatin immunoprecipitation; Cancer research; Carcinogenesis; Long non-coding RNA; Oncogene; Transcription factor; Gene; Gene expression; Molecular biology; RNA; Genetics; Promoter; DNA methylation; Cell cycle","score_opus":0.039916658065585,"score_gpt":0.336401392140191,"score_spread":0.29648473407460596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974350437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836903,0.011548966,0.00014184583,0.0019488283,0.0003028748,0.0003651761,0.000021348991,0.0000113004735,0.0019693498],"genre_scores_gemma":[0.98847675,0.0038917721,0.000098285804,0.000079132085,0.0007532465,0.0001933757,0.000024855433,0.00004263782,0.006439935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775857,0.00020342699,0.00025719794,0.0004881234,0.00049617526,0.00079651724],"domain_scores_gemma":[0.9989998,0.00007719899,0.000063208754,0.0005344382,0.00021065543,0.00011474437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012717313,0.00016563966,0.0001320813,0.000063858955,0.0010547332,0.0002533161,0.0007471304,0.000092375514,0.00004572659],"category_scores_gemma":[0.00007125505,0.00010607151,0.00009232616,0.0004165074,0.00015066628,0.000004212656,0.00041926856,0.00023053602,0.000053305885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015431811,0.00001558181,0.0005382147,0.000005730317,0.000031123862,0.0000017489788,0.000038761467,0.00008229085,0.94234943,0.000026755257,0.03275912,0.024135796],"study_design_scores_gemma":[0.00014450555,0.000074178584,0.0019409228,0.000015501766,0.000004230154,0.0000058224123,0.00024317863,0.0000066363673,0.65459985,0.000024587755,0.34281316,0.00012744578],"about_ca_topic_score_codex":0.0008483597,"about_ca_topic_score_gemma":0.00022797794,"teacher_disagreement_score":0.31005406,"about_ca_system_score_codex":0.00008402618,"about_ca_system_score_gemma":0.00013802425,"threshold_uncertainty_score":0.8112261},"labels":[],"label_agreement":null},{"id":"W1974409590","doi":"10.1158/1538-7445.am2013-3545","title":"Abstract 3545: ATM, TS and RRM1 protein expression in nasopharyngeal carcinomas (NPC) treated with curative intent.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada); BC Cancer Agency; Alberta Health Services; University of British Columbia","funders":"","keywords":"Immunohistochemistry; Gemcitabine; Medicine; Oncology; Nasopharyngeal carcinoma; Radiation therapy; Tissue microarray; Chemotherapy; Internal medicine; Thymidylate synthase; Pathology; Cancer research","score_opus":0.08750636261906847,"score_gpt":0.3942539337474491,"score_spread":0.30674757112838064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974409590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987419,0.0040459875,5.7521106e-7,0.0027982416,0.000021713524,0.0017415034,0.000010560064,0.000029023839,0.003933411],"genre_scores_gemma":[0.9952065,0.0006367001,0.00006748255,0.000071694536,0.00010758857,0.0016561211,0.000008864622,0.000028057255,0.0022170367],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982178,0.00009426292,0.00020265504,0.00042367814,0.00050762686,0.0005539475],"domain_scores_gemma":[0.9989797,0.00008985347,0.000035913246,0.00022313744,0.0004251974,0.00024623488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021674203,0.0001716952,0.00037433137,0.00020227418,0.00014328679,0.000037568298,0.00008733654,0.00008361442,0.00055078795],"category_scores_gemma":[0.00007767891,0.00011114324,0.000022729782,0.00038899016,0.00031253553,0.0002066609,0.000100300145,0.0006195801,0.00004480532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021822003,0.00023869114,0.33691916,0.0005605477,0.000088482644,0.0003565299,0.0043341815,0.00000134121,0.6233001,0.00002862946,0.010930717,0.021059407],"study_design_scores_gemma":[0.003514515,0.0010950172,0.841842,0.002027145,0.0000075688254,0.000010942049,0.0018324683,0.000029921765,0.14721222,0.000040511262,0.0022098657,0.0001778564],"about_ca_topic_score_codex":0.007217655,"about_ca_topic_score_gemma":0.0009736117,"teacher_disagreement_score":0.5049228,"about_ca_system_score_codex":0.00032533455,"about_ca_system_score_gemma":0.0003070879,"threshold_uncertainty_score":0.99939334},"labels":[],"label_agreement":null},{"id":"W1974478675","doi":"10.1158/1538-7445.am2012-lb-404","title":"Abstract LB-404: Genomic analysis reveals roles for chromatin modification and axon guidance in pancreatic cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Exome sequencing; Pancreatic cancer; Cancer; Cancer research; Chromatin; PTEN; Genetics; Bioinformatics; Gene; Mutation; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.15001946162883345,"score_gpt":0.480617636682275,"score_spread":0.3305981750534415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974478675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97521794,0.020354936,0.00013703671,0.0016089694,0.0000386952,0.0015047641,0.000066045875,0.000019931033,0.001051702],"genre_scores_gemma":[0.98981756,0.0040517435,0.00088512345,0.00010190925,0.00039667301,0.0028421655,0.000036875994,0.000029544484,0.0018383805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974729,0.00020817577,0.00045513513,0.0004102617,0.0005268379,0.0009266816],"domain_scores_gemma":[0.9980807,0.0007111692,0.00010004088,0.0004291455,0.0003415829,0.0003373878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003204108,0.0001600261,0.0007002318,0.00066513725,0.00017740358,0.00003268532,0.00016963873,0.00017146759,0.00061445945],"category_scores_gemma":[0.00052276044,0.00013689202,0.000091501264,0.000858174,0.00027250237,0.00014816657,0.000068749636,0.0004090685,0.000027758102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004497817,0.00015458376,0.88107294,0.0005595142,0.00041795205,0.0000040714044,0.0008985248,0.000035902805,0.10759563,0.00018494342,0.0018019387,0.0068242257],"study_design_scores_gemma":[0.0013151909,0.0001069017,0.99216855,0.0002532612,0.00034792034,0.0000029239195,0.0002847039,0.001676877,0.0022616847,0.00028816971,0.0011625473,0.00013126743],"about_ca_topic_score_codex":0.0032803442,"about_ca_topic_score_gemma":0.0011212917,"teacher_disagreement_score":0.11109562,"about_ca_system_score_codex":0.0008503756,"about_ca_system_score_gemma":0.00051767397,"threshold_uncertainty_score":0.67279005},"labels":[],"label_agreement":null},{"id":"W1974484226","doi":"10.1158/1538-7445.am2014-lb-302","title":"Abstract LB-302: eIF4E phosphorylation is Mnk-dependent but does not require assembly of the eIF4F translation initiation complex","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"EIF4E; EIF4G; Biology; Cancer research; Eukaryotic translation; Kinase; Cell biology; Initiation factor; Phosphorylation; Translation (biology); Genetics; Messenger RNA","score_opus":0.10644704070520095,"score_gpt":0.39403881974788585,"score_spread":0.2875917790426849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974484226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398035,0.00062214665,0.0009493509,0.0014008742,0.0003459308,0.0004123743,0.00017926499,0.000012937188,0.0020967566],"genre_scores_gemma":[0.9980085,0.0002906526,0.00009757737,0.00027233738,0.0005050337,0.000092147544,0.00006561737,0.000032821426,0.00063530385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979178,0.00022404929,0.0003309939,0.00041368915,0.0007726598,0.00034082323],"domain_scores_gemma":[0.9986408,0.00009218203,0.00016378766,0.000540397,0.00049254735,0.00007030596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011319716,0.00014408746,0.00015660924,0.00007053582,0.00020337901,0.00004583863,0.00041662616,0.00020839444,0.00028789387],"category_scores_gemma":[0.00015693063,0.00010758635,0.000105670006,0.00018838451,0.00019473663,0.000020919459,0.00008828037,0.0002748464,0.000012961131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018377585,0.000031326777,0.0013742556,0.000081429076,0.0000360131,2.8535644e-7,0.00018626044,0.0002942873,0.9844103,0.00009261633,0.0009983748,0.012311111],"study_design_scores_gemma":[0.00053906353,0.000113038564,0.015389712,0.00006313916,0.000011757232,8.1467516e-7,0.00006379934,0.00038428383,0.97175366,0.00025840176,0.011281151,0.00014117635],"about_ca_topic_score_codex":0.00054296164,"about_ca_topic_score_gemma":0.00032246145,"teacher_disagreement_score":0.014015456,"about_ca_system_score_codex":0.000121089084,"about_ca_system_score_gemma":0.0002850666,"threshold_uncertainty_score":0.4387244},"labels":[],"label_agreement":null},{"id":"W1974505004","doi":"10.1158/1538-7445.am2014-1140","title":"Abstract 1140: Par-4 mediates EMT in response to TGF-β stimulation","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Epithelial–mesenchymal transition; Endometrial cancer; Metastasis; Cancer research; Cancer; Cell culture; Transforming growth factor; HeLa; Cancer cell; Cell; Biology; Medicine; Internal medicine; Oncology; Genetics","score_opus":0.06309722340685384,"score_gpt":0.4295122864532608,"score_spread":0.3664150630464069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974505004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661696,0.00035070244,0.00008169917,0.0016228185,0.00007987858,0.0004861082,0.000018486739,0.000011041498,0.00073227676],"genre_scores_gemma":[0.99850845,0.00006789599,0.000049750626,0.00007401575,0.0003147122,0.00026122786,0.000025651485,0.000031987467,0.0006663263],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975349,0.0005717374,0.00019154687,0.0005157258,0.00055534346,0.0006308007],"domain_scores_gemma":[0.9985536,0.00036880956,0.000023006767,0.00046595727,0.0003488589,0.00023980325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031125855,0.00012279376,0.0001411588,0.00033565838,0.000104049526,0.000052881012,0.00037142224,0.00013608957,0.00030805488],"category_scores_gemma":[0.0032032225,0.00012237349,0.00003917214,0.0004809578,0.00011793008,0.00000695002,0.00026694144,0.00033995078,0.00018045529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016633365,0.00003809697,0.032395802,0.000023570941,0.000010468164,0.0000060116245,0.00015090914,0.0002991299,0.95355946,0.000021498763,0.0023439506,0.00948774],"study_design_scores_gemma":[0.0007009614,0.00039214743,0.5624121,0.00003843158,0.0000011483492,7.9903947e-7,0.00006308501,0.00006654808,0.38957185,0.00017216448,0.04641145,0.00016935285],"about_ca_topic_score_codex":0.0006200895,"about_ca_topic_score_gemma":0.0011852799,"teacher_disagreement_score":0.5639877,"about_ca_system_score_codex":0.00015911949,"about_ca_system_score_gemma":0.00028085857,"threshold_uncertainty_score":0.49902463},"labels":[],"label_agreement":null},{"id":"W1974760106","doi":"10.1158/1538-7445.am2013-1674","title":"Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Autophagy; Programmed cell death; Apoptosis; Cancer research; Pancreatic cancer; Cell culture; GSK-3; Small hairpin RNA; Cancer cell; Growth inhibition; Cell biology; Chemistry; Cell growth; Signal transduction; Biology; Cancer; Medicine; Internal medicine; Biochemistry; Gene knockdown","score_opus":0.05522335914205901,"score_gpt":0.3775434836466359,"score_spread":0.3223201245045769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974760106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948375,0.0015272617,0.0000010950853,0.001063885,0.00006348612,0.00083430106,0.000029565033,0.00001440252,0.0016285093],"genre_scores_gemma":[0.9986584,0.00037850076,0.000010871102,0.000036801604,0.00010410251,0.00012953934,0.0000028759641,0.00001672002,0.00066214835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985432,0.00010871085,0.00019844896,0.00022283451,0.0006661693,0.00026064357],"domain_scores_gemma":[0.9989865,0.00010783248,0.00010807309,0.0003265054,0.00035217323,0.00011893795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043798488,0.000099473036,0.000226187,0.00011456827,0.00009424144,0.000017994145,0.00012191597,0.00010306502,0.0011117965],"category_scores_gemma":[0.000113128495,0.00006557541,0.000071019276,0.00024666634,0.00043300007,0.00015885498,0.0000967242,0.00038615233,0.00001067441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015918,0.00022479682,0.0023223863,0.0002859463,0.0000624766,0.000006375452,0.00047170793,7.9952326e-7,0.9609623,0.00013856884,0.00040797616,0.034957502],"study_design_scores_gemma":[0.0005235734,0.0001165086,0.3323699,0.0002236028,0.000008410099,0.000002585831,0.00009559581,0.000013304791,0.66551155,0.0010336434,0.00006229173,0.000039065133],"about_ca_topic_score_codex":0.001470643,"about_ca_topic_score_gemma":0.000029792354,"teacher_disagreement_score":0.33004752,"about_ca_system_score_codex":0.00007116749,"about_ca_system_score_gemma":0.00047340736,"threshold_uncertainty_score":0.99980134},"labels":[],"label_agreement":null},{"id":"W1974829941","doi":"10.1158/0008-5472.sabcs-09-6096","title":"A Phase (Ph) I/II Study of CR011-VcMMAE, an Antibody-Drug Conjugate, in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (MBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Taxane; Internal medicine; Gastroenterology; Breast cancer; Anthracycline; Phases of clinical research; Clinical endpoint; Capecitabine; Chemotherapy; Progressive disease; Cancer; Surgery; Urology; Clinical trial","score_opus":0.0804814699381781,"score_gpt":0.5015973090577689,"score_spread":0.4211158391195908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974829941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959715,0.00021902562,0.00001531921,0.0012138148,0.000017346576,0.0020638502,0.00016337991,0.000028648687,0.0003071184],"genre_scores_gemma":[0.9982348,0.00016914794,0.00010224148,0.00018870743,0.00006928395,0.00052287144,0.000047596302,0.000027443717,0.0006378983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975655,0.00013121842,0.00040984296,0.00051777624,0.00083340623,0.00054226513],"domain_scores_gemma":[0.99825615,0.0000824856,0.0000846248,0.000506457,0.00066415797,0.0004061016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003868344,0.0001981487,0.00046102784,0.0001570588,0.0001581818,0.000019106095,0.00026863633,0.000042446325,0.00055910624],"category_scores_gemma":[0.000050498642,0.00014117036,0.00003237577,0.0011829683,0.0002352584,0.0001827086,0.00004668369,0.0006021803,0.000004500501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061022516,0.090672106,0.06468117,0.0011812494,0.00050398835,0.00042862946,0.0046197358,0.001032876,0.5988319,0.00010739363,0.0014864688,0.175432],"study_design_scores_gemma":[0.25356385,0.058915,0.2939955,0.0037270358,0.00083562173,0.00009583672,0.008530864,0.0031344846,0.37047112,0.00025946784,0.004753757,0.001717477],"about_ca_topic_score_codex":0.00064810266,"about_ca_topic_score_gemma":0.00040197468,"teacher_disagreement_score":0.22931434,"about_ca_system_score_codex":0.0002897424,"about_ca_system_score_gemma":0.00064498687,"threshold_uncertainty_score":0.61218214},"labels":[],"label_agreement":null},{"id":"W1974867720","doi":"10.1158/0008-5472.sabcs13-p3-15-09","title":"Abstract P3-15-09: Impact of granulocyte colony-stimulating factors on febrile neutropenia risk during early-stage breast cancer treatment","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Febrile neutropenia; Filgrastim; Docetaxel; Internal medicine; Breast cancer; Cyclophosphamide; Chemotherapy; Neutropenia; Incidence (geometry); Epirubicin; Oncology; Surgery; Cancer","score_opus":0.06883934832537066,"score_gpt":0.4156470856874734,"score_spread":0.34680773736210274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974867720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455965,0.00032414048,9.710676e-7,0.00025928975,0.00019654319,0.0018292251,0.00073863455,0.00007424442,0.0020173197],"genre_scores_gemma":[0.99415076,0.0012127801,0.000008773909,0.000014323314,0.00043801678,0.00090657006,0.000019624656,0.00008815026,0.0031610273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970414,0.00015201286,0.00044905732,0.00060445763,0.0007923047,0.0009607651],"domain_scores_gemma":[0.99779534,0.00023441242,0.00019993477,0.0006560538,0.00059343275,0.0005207951],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023756608,0.0003615639,0.00063728564,0.00039717817,0.00051117217,0.000105022555,0.00021079785,0.00014133415,0.010088163],"category_scores_gemma":[0.000041262407,0.0002588781,0.00036462475,0.0006855969,0.00024524156,0.0002650706,0.000084553576,0.0008095761,0.00021039305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011718966,0.00028670247,0.8224979,0.00013319436,0.0004149977,0.000027723227,0.00048096394,0.0038373994,0.1664659,0.0000069793628,0.0005904522,0.0040859035],"study_design_scores_gemma":[0.0028355091,0.0013386334,0.9523048,0.0003177256,0.00008084131,0.000008759463,0.0001221999,0.00007301388,0.04240822,0.000007977524,0.00028661394,0.00021573607],"about_ca_topic_score_codex":0.25519314,"about_ca_topic_score_gemma":0.0023383219,"teacher_disagreement_score":0.25285482,"about_ca_system_score_codex":0.0027250932,"about_ca_system_score_gemma":0.00084964396,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W1974920096","doi":"10.1158/1538-7445.am2013-lb-295","title":"Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenib <i>vs</i> placebo in TKI-refractory metastatic GIST.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Regorafenib; PDGFRA; GiST; Sunitinib; Cancer research; CD117; Sanger sequencing; Exon; Mutation; Stromal tumor; Medicine; Cancer; Internal medicine; Oncology; Biology; Pathology; Stromal cell; Colorectal cancer; CD34; Gene; Genetics","score_opus":0.10870604600429198,"score_gpt":0.43906326333323686,"score_spread":0.33035721732894485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974920096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966603,0.00016225946,0.00001078023,0.00019080608,0.000020056503,0.0028460869,0.000013114341,0.0000054056504,0.00009118391],"genre_scores_gemma":[0.9992377,0.00004827054,0.000084922416,0.0000066050957,0.000029243682,0.0005365963,0.000020279096,0.000016474802,0.000019921248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997402,0.00042980714,0.00070297153,0.0003228098,0.0007796832,0.00036270608],"domain_scores_gemma":[0.9977573,0.0013514257,0.00017535154,0.0002725496,0.00031234397,0.0001309907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021552092,0.00012836314,0.00038781232,0.0005199177,0.000063564534,0.000020371219,0.00010595213,0.000036558344,0.00004478565],"category_scores_gemma":[0.0007276448,0.000089154295,0.000037956193,0.00086411455,0.00024144594,0.00015650413,0.000039119874,0.0008428016,0.000003518863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014623927,0.012680184,0.83021796,0.00060886756,0.00019823975,0.00143613,0.0076689785,0.002976992,0.07476206,0.000028396988,0.000027473989,0.05477082],"study_design_scores_gemma":[0.03385141,0.008548611,0.9365086,0.00069991907,0.00006131429,0.00008651891,0.01092923,0.0049313996,0.0041608396,0.00011060851,0.000007970198,0.000103566825],"about_ca_topic_score_codex":0.013329782,"about_ca_topic_score_gemma":0.013668615,"teacher_disagreement_score":0.10629068,"about_ca_system_score_codex":0.00029400503,"about_ca_system_score_gemma":0.0003454637,"threshold_uncertainty_score":0.99324054},"labels":[],"label_agreement":null},{"id":"W1974956114","doi":"10.1158/0008-5472.sabcs13-p2-01-05","title":"Abstract P2-01-05: Mammographic microcalcifications and breast cancer tumorigenesis: A radiologic-pathologic analysis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Malignancy; Cancer; Oncology; Lymphovascular invasion; Ductal carcinoma; Radiology; Internal medicine; Pathology; Metastasis","score_opus":0.07230949596602132,"score_gpt":0.37940964869363203,"score_spread":0.3071001527276107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974956114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794469,0.010590184,0.000027059717,0.008490866,0.000057362486,0.0006450584,0.00013064392,0.00006310537,0.00054884737],"genre_scores_gemma":[0.99173486,0.005391944,0.00014007534,0.00027687644,0.00024001939,0.0012987665,0.000032226464,0.000024466604,0.00086073467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978326,0.0001408664,0.00029547067,0.00061954436,0.00043449967,0.000677036],"domain_scores_gemma":[0.99826044,0.00010966329,0.000065866116,0.00057530735,0.0005743844,0.00041434425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062786567,0.00019297992,0.00043305813,0.0007978908,0.00035221607,0.000087893815,0.00022518788,0.00016484142,0.003634972],"category_scores_gemma":[0.00003210564,0.00013975725,0.00018842507,0.0022560146,0.00053690636,0.000106315114,0.00009937299,0.00054492283,0.00009389117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019063674,0.00029376533,0.7057944,0.00019219308,0.00074795925,0.00017545056,0.00025162144,0.000019165318,0.24048439,0.00026383475,0.0102860015,0.041300617],"study_design_scores_gemma":[0.00046087377,0.000064368025,0.996293,0.00006350681,0.0002729872,0.00017754201,0.00052897306,0.0000649102,0.00073147606,0.00016740593,0.0010189154,0.00015603856],"about_ca_topic_score_codex":0.006449329,"about_ca_topic_score_gemma":0.00031662927,"teacher_disagreement_score":0.2904986,"about_ca_system_score_codex":0.00017992477,"about_ca_system_score_gemma":0.0002905298,"threshold_uncertainty_score":0.9972758},"labels":[],"label_agreement":null},{"id":"W1975101441","doi":"10.1158/1538-7445.am10-lb-346","title":"Abstract LB-346: A novel lung tumor suppressor implicated in somatic and familial cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University of British Columbia","funders":"","keywords":"DNA methylation; Biology; Epigenetics; Lung cancer; Cancer research; Methylation; Gene; Tumor suppressor gene; Gene silencing; Molecular biology; Genetics; Gene expression; Medicine; Oncology; Carcinogenesis","score_opus":0.025589003161048444,"score_gpt":0.3621478640169164,"score_spread":0.33655886085586795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975101441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973603,0.0009843328,0.000024867391,0.0004379242,0.00023305761,0.0005111658,0.00006614288,0.000012199598,0.00037002625],"genre_scores_gemma":[0.9986616,0.00021727801,0.000084971245,0.000040122937,0.00038620512,0.0002968075,0.00004940002,0.000034306526,0.00022935202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848795,0.00003716542,0.00022336995,0.0004789861,0.00027968307,0.00049285335],"domain_scores_gemma":[0.99922484,0.00003249555,0.000052875137,0.0003856787,0.00016342092,0.00014069192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004319614,0.00013939582,0.00014917752,0.00014359491,0.000101961705,0.000046571477,0.00022289285,0.00019046306,0.00010579229],"category_scores_gemma":[0.00012190965,0.00014097184,0.00003836887,0.00027713718,0.00022726732,0.000009357525,0.00014047921,0.00050341076,0.0000055257224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015716533,0.000026521784,0.0030511136,0.000067124,0.000024696341,0.0000025547092,0.00007635675,0.0002606607,0.99258757,0.00002096904,0.0016917373,0.002033548],"study_design_scores_gemma":[0.0018683234,0.00009041992,0.1691851,0.00008007607,0.000010321868,0.000019281762,0.00008722051,0.0016685836,0.81875217,0.00007863431,0.007868353,0.00029154003],"about_ca_topic_score_codex":0.0031690677,"about_ca_topic_score_gemma":0.0074326866,"teacher_disagreement_score":0.17383541,"about_ca_system_score_codex":0.00017240214,"about_ca_system_score_gemma":0.0006213498,"threshold_uncertainty_score":0.5748665},"labels":[],"label_agreement":null},{"id":"W1975302839","doi":"10.1158/1538-7445.am2012-693","title":"Abstract 693: Development of a protein-based functional assay for the determination of BRCA1 carrier status","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Gene; In silico; Mutation; Cancer research; Transcriptome; Suppressor; Genetics; Gene expression","score_opus":0.10070545792073021,"score_gpt":0.39622556569121603,"score_spread":0.2955201077704858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975302839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96694654,0.0023099266,0.02917838,0.00021157345,0.00015947068,0.00076819444,0.00005801544,0.00000306222,0.0003648186],"genre_scores_gemma":[0.9975785,0.000027189088,0.00086174667,0.000016418144,0.00013734709,0.00085137837,0.00004931139,0.000009847512,0.00046828706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912626,0.000053994685,0.00016497613,0.00012958709,0.00030090383,0.00022425961],"domain_scores_gemma":[0.9991827,0.000041374416,0.00008347814,0.00019518299,0.00043811277,0.00005912976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089046336,0.000054679,0.00006050108,0.000053249914,0.000101485624,0.0000062675444,0.00010962188,0.000066124696,0.00009682677],"category_scores_gemma":[0.0001381119,0.000039734285,0.00003978397,0.000101934645,0.000089297675,0.000003826725,0.000029195773,0.00006855704,9.1307606e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018752241,0.000044976696,0.00091712706,0.00007391852,0.000013976718,1.0837319e-8,0.00010439161,0.00002344387,0.9462178,0.00004601791,0.00077592215,0.051594913],"study_design_scores_gemma":[0.00030991845,0.000036878082,0.030939499,0.000023048126,0.0000032633513,7.0336455e-8,0.00013709914,0.000053996228,0.8815689,0.000010549311,0.08687338,0.00004339308],"about_ca_topic_score_codex":0.000022695476,"about_ca_topic_score_gemma":0.000028504466,"teacher_disagreement_score":0.08609746,"about_ca_system_score_codex":0.000055226737,"about_ca_system_score_gemma":0.0007561061,"threshold_uncertainty_score":0.16203171},"labels":[],"label_agreement":null},{"id":"W1975382383","doi":"10.1158/1538-7445.am10-1576","title":"Abstract 1576: Molecular targeting of histone deacetylase 2 for treatment of human hepatocellular carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Histone deacetylase 2; Gene silencing; Cancer research; Biology; Histone deacetylase; Cell growth; Molecular biology; Cell culture; Gene expression; Small interfering RNA; Chemistry; Histone; Transfection; Gene; Biochemistry; Genetics","score_opus":0.04699315977972056,"score_gpt":0.4171567364785402,"score_spread":0.3701635766988196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975382383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953304,0.002806739,0.000059708076,0.00009309082,0.00011945132,0.0009056778,0.00014570342,0.0000071275085,0.00053212675],"genre_scores_gemma":[0.9975141,0.00012832775,0.00040553286,0.0000051858756,0.0003037832,0.0004453767,0.00017155807,0.000062498635,0.00096363435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781936,0.00010007453,0.00042419528,0.00051133946,0.0005458927,0.00059914344],"domain_scores_gemma":[0.99804723,0.0000697604,0.00012882287,0.00068715675,0.0008650577,0.00020198998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082006876,0.00018974337,0.00033101306,0.00021339061,0.00017333768,0.000012764312,0.00037453847,0.00023709399,0.00013705253],"category_scores_gemma":[0.0002878265,0.0001850272,0.00023154571,0.00021637883,0.0005611383,0.000005167821,0.0001094314,0.00021017462,0.0000051253533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024750686,0.00030902727,0.0014281902,0.000212933,0.000060301376,0.00001663034,0.00017969614,0.000012858628,0.99424654,0.000133055,0.0017940569,0.0013591945],"study_design_scores_gemma":[0.0013260832,0.0010334332,0.00033247314,0.000021424352,0.000012071057,0.000002334442,0.000085924614,0.00004183285,0.9832749,0.00004026425,0.013672073,0.00015719114],"about_ca_topic_score_codex":0.0015042509,"about_ca_topic_score_gemma":0.00021595838,"teacher_disagreement_score":0.011878016,"about_ca_system_score_codex":0.00014456893,"about_ca_system_score_gemma":0.000565368,"threshold_uncertainty_score":0.754519},"labels":[],"label_agreement":null},{"id":"W1975597047","doi":"10.1158/1538-7445.am2013-327","title":"Abstract 327: Establishment of patient primary ovarian cancer xenograft models for test of anticancer agents.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Ovarian cancer; Medicine; Carboplatin; Primary tumor; Docetaxel; Cisplatin; Ovarian tumor; Cancer; Transplantation; Cancer research; Paclitaxel; Pathology; Oncology; Chemotherapy; Internal medicine; Metastasis","score_opus":0.054630233029706134,"score_gpt":0.37930770234223415,"score_spread":0.324677469312528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975597047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900574,0.005745025,0.00011292783,0.00045456557,0.000107512446,0.0018931334,0.0009098294,0.000006745435,0.001764531],"genre_scores_gemma":[0.991884,0.0043513803,0.0003143451,0.00007684184,0.00014481819,0.002566509,0.00013969395,0.00004109926,0.0004812968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976846,0.000051640116,0.0003744096,0.00047509975,0.00072688743,0.0006873725],"domain_scores_gemma":[0.99801916,0.000087219414,0.00013174002,0.0005177007,0.0010181178,0.00022606814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032210015,0.0001765256,0.00028416724,0.0001515119,0.00010129153,0.000037168644,0.0003625549,0.000119475415,0.00049543736],"category_scores_gemma":[0.00009418025,0.0001537974,0.00014366145,0.0002759626,0.00030430223,0.000025107605,0.00023193647,0.0001630792,0.0000044722997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006626506,0.0008319238,0.014390972,0.00071489706,0.00043221854,0.0000033101433,0.00022707178,0.00068843813,0.87974846,0.000076826575,0.034015875,0.06820736],"study_design_scores_gemma":[0.0025972172,0.0013557468,0.02032021,0.00023557582,0.000031058127,0.0000010461921,0.00017024331,0.00025033325,0.95473737,0.0008029098,0.019216886,0.00028143195],"about_ca_topic_score_codex":0.013268523,"about_ca_topic_score_gemma":0.00069081713,"teacher_disagreement_score":0.07498889,"about_ca_system_score_codex":0.00021536819,"about_ca_system_score_gemma":0.00092424423,"threshold_uncertainty_score":0.9933022},"labels":[],"label_agreement":null},{"id":"W1975600980","doi":"10.1158/0008-5472.can-04-2111","title":"Conditional Overexpression of Active Transforming Growth Factor β1 <b> <i>In vivo</i> </b> Accelerates Metastases of Transgenic Mammary Tumors","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"Transforming growth factor; Cancer research; Biology; Autocrine signalling; Tumor progression; In vivo; Mammary tumor; TGF alpha; Genetically modified mouse; Cancer; Transgene; Cell culture; Endocrinology; Epidermal growth factor receptor; Breast cancer","score_opus":0.04388398175578465,"score_gpt":0.36195453907055886,"score_spread":0.3180705573147742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975600980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674016,0.001454944,0.00034440926,0.000056708122,0.000018348357,0.00026826773,0.00096162636,0.000005230024,0.000150298],"genre_scores_gemma":[0.9992468,0.00029428522,0.00013029747,0.000018883842,0.000051299794,0.00009846317,0.00010470843,0.00001950932,0.000035761845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864763,0.00010735569,0.00026474087,0.00028896163,0.0003993176,0.00029197737],"domain_scores_gemma":[0.9993628,0.00005788152,0.000061843064,0.00018402153,0.00024627466,0.00008713438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016549404,0.00012212797,0.00019557415,0.00014276845,0.000054153843,0.000009328304,0.00029152256,0.00008710773,0.00017264912],"category_scores_gemma":[0.000071163086,0.00011388082,0.000104189974,0.00021668081,0.00021626687,0.000019602001,0.000050172297,0.00015308267,7.4719446e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046784536,0.00016982328,0.00052231975,0.00019555747,0.00005055877,0.0000034567784,0.00022137431,0.00037902233,0.9973326,0.00018285388,0.0000823,0.0003923266],"study_design_scores_gemma":[0.0010698887,0.00017891188,0.0022163626,0.00023490883,0.0000065789973,0.0000013630344,0.00014643937,0.000001501518,0.9952736,0.00056060235,0.00019994819,0.00010992949],"about_ca_topic_score_codex":0.00026698338,"about_ca_topic_score_gemma":0.00006902003,"teacher_disagreement_score":0.0025066228,"about_ca_system_score_codex":0.000057334924,"about_ca_system_score_gemma":0.0007308871,"threshold_uncertainty_score":0.4643925},"labels":[],"label_agreement":null},{"id":"W1975658556","doi":"10.1158/1538-7445.am2014-2190","title":"Abstract 2190: Fine-mapping of common genetic variants associated with colorectal tumor risk identified potential functional variants","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Genetics; SNP; Biology; Minor allele frequency; Colorectal cancer; Odds ratio; Genetic association; Allele; Genotype; Cancer; Medicine; Internal medicine; Gene","score_opus":0.051778379778683443,"score_gpt":0.3334752412851715,"score_spread":0.28169686150648804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975658556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537635,0.00025723423,0.00046033872,0.00015344883,0.0006536501,0.00080267614,0.00012087959,0.00005137747,0.0021240418],"genre_scores_gemma":[0.99847025,0.000047462967,0.00029372764,0.0000421153,0.0004154988,0.0001886109,0.000050985975,0.00006521273,0.00042614475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960071,0.00039365445,0.0005305626,0.0006035138,0.0017084228,0.00075673877],"domain_scores_gemma":[0.99739695,0.00054395245,0.00028712218,0.0004742275,0.0010111725,0.00028658833],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016483869,0.00024655013,0.0005441793,0.00036427908,0.00027541185,0.00005517443,0.00029371472,0.00017923245,0.0022159321],"category_scores_gemma":[0.0011551142,0.00021192546,0.00011425851,0.0008614887,0.000389332,0.000075320175,0.00015187246,0.0009773733,0.000051636012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046578688,0.00089596445,0.26362604,0.00044198596,0.0011483951,0.0002316955,0.0005920584,0.0056376117,0.70757926,0.000048878366,0.0049195783,0.010220679],"study_design_scores_gemma":[0.0029979437,0.0008355511,0.970443,0.00044512024,0.00010693351,0.000038763563,0.000065932465,0.002510896,0.021895377,0.00030935358,0.00014044254,0.00021067983],"about_ca_topic_score_codex":0.0015434098,"about_ca_topic_score_gemma":0.0012507804,"teacher_disagreement_score":0.706817,"about_ca_system_score_codex":0.00051694544,"about_ca_system_score_gemma":0.0009441443,"threshold_uncertainty_score":0.99869615},"labels":[],"label_agreement":null},{"id":"W1975766525","doi":"10.1158/1538-7445.cansusc14-29","title":"Abstract 29: Design of a phase I chemoprevention study of metformin and Li-Fraumeni syndrome (LFS)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metformin; Medicine; Internal medicine; Endocrinology; Cancer; Tolerability; Type 2 diabetes; Insulin; Diabetes mellitus; Adverse effect","score_opus":0.11505599146862368,"score_gpt":0.4405553914390811,"score_spread":0.32549939997045746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975766525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542063,0.0014404962,0.0011229938,0.00007225473,0.000053603253,0.0014412393,0.000009105034,0.000015144426,0.00042452643],"genre_scores_gemma":[0.9989622,0.00026528802,0.00024618092,0.000008049744,0.000040869505,0.00017476137,0.00000506083,0.000029777908,0.00026781484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981111,0.00016643472,0.0003599137,0.0003037362,0.00075925543,0.0002995402],"domain_scores_gemma":[0.9988098,0.00014791315,0.000115163464,0.00043317903,0.00033634048,0.00015758871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019284254,0.00011543415,0.00039686757,0.00032859412,0.00005181982,0.000009385476,0.00012721239,0.00009660982,0.00027035037],"category_scores_gemma":[0.00027081792,0.00010490551,0.000055151755,0.00047859107,0.0001569162,0.000068798996,0.00008057308,0.00039347057,0.0000069581315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013385819,0.0018661956,0.00041756302,0.0007122244,0.0002881672,0.0000861361,0.001285865,0.000099087796,0.93160003,0.0000449119,0.00056285807,0.06169837],"study_design_scores_gemma":[0.034122955,0.019995794,0.019827286,0.0019120066,0.00044949912,0.00021631457,0.0022852123,0.002114161,0.916111,0.000670241,0.0018822605,0.00041326167],"about_ca_topic_score_codex":0.0006687142,"about_ca_topic_score_gemma":0.000043102304,"teacher_disagreement_score":0.06128511,"about_ca_system_score_codex":0.00014954824,"about_ca_system_score_gemma":0.00027345328,"threshold_uncertainty_score":0.42779225},"labels":[],"label_agreement":null},{"id":"W1975826911","doi":"10.1158/1538-7445.am2012-2468","title":"Abstract 2468: Inhibition of autophagy as a potential mechanism by which pantoprazole, a proton pump inhibitor (PPI), enhances the therapeutic effect of docetaxel chemotherapy for solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Autophagy; Docetaxel; Cytotoxicity; Pharmacology; Lysosome; Programmed cell death; In vivo; Chemistry; Autophagosome; Apoptosis; Cell biology; In vitro; Cancer research; Biology; Cancer; Biochemistry; Medicine; Internal medicine; Enzyme","score_opus":0.027123534589916762,"score_gpt":0.39297428496530257,"score_spread":0.3658507503753858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975826911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815167,0.005297131,0.00015950696,0.00089325116,0.00019836318,0.004955271,0.00008323032,0.000037443537,0.00022415073],"genre_scores_gemma":[0.9946352,0.0011905236,0.000017151,0.00020508748,0.00063281565,0.002913854,0.00003630383,0.00006518573,0.00030383992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711525,0.00024233363,0.00049991405,0.00033906236,0.0010434343,0.0007599975],"domain_scores_gemma":[0.9982492,0.00030888905,0.00025809565,0.00045973965,0.000513458,0.00021065994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021656777,0.00026143657,0.00058162666,0.00017794916,0.00019388266,0.0000272057,0.00023894705,0.00018453554,0.0006412317],"category_scores_gemma":[0.00011149484,0.00016715229,0.00023651832,0.00047838868,0.0003016124,0.00020313614,0.0000463704,0.00045273482,0.000016954322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004132425,0.0004967184,0.00016301817,0.0011590042,0.00031089163,0.0000034225334,0.0007967537,0.0000022573565,0.9840604,0.0003327653,0.00043508745,0.0081072245],"study_design_scores_gemma":[0.0040612994,0.0018247957,0.002129548,0.00043572907,0.00008982357,0.000010326571,0.00018072163,0.00007233807,0.9890454,0.0012382535,0.0007648483,0.00014691033],"about_ca_topic_score_codex":0.0002469498,"about_ca_topic_score_gemma":0.000005477013,"teacher_disagreement_score":0.007960314,"about_ca_system_score_codex":0.00013180386,"about_ca_system_score_gemma":0.00046987605,"threshold_uncertainty_score":0.70210373},"labels":[],"label_agreement":null},{"id":"W1975927343","doi":"10.1158/1538-7445.am2012-3354","title":"Abstract 3354: Investigating the role of Nodal in the regulation of integrin α6β4high trophoblast progenitor cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytotrophoblast; Biology; Trophoblast; Progenitor cell; Cell biology; Stem cell; Population; Clonogenic assay; Embryonic stem cell; Immunology; Cell culture; Placenta; Genetics; Fetus; Medicine","score_opus":0.08590368082613281,"score_gpt":0.38063097255090333,"score_spread":0.2947272917247705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975927343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738956,0.006902761,0.0000011320806,0.00082391605,0.000062948195,0.0005538015,0.000008441811,0.0000049037635,0.004252519],"genre_scores_gemma":[0.9992141,0.00017588698,0.00007423256,0.000025546791,0.00026681682,0.00015501487,0.0000020250593,0.000008920697,0.00007741995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986323,0.00020657542,0.00024018402,0.00010194647,0.0005261987,0.0002927751],"domain_scores_gemma":[0.9990189,0.00042796976,0.00007734116,0.0002749474,0.00015755405,0.000043296674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015470128,0.000070934,0.00016183175,0.00007676213,0.00008639893,0.0000064113688,0.00019184157,0.00005269827,0.00006669302],"category_scores_gemma":[0.0002189324,0.000037357782,0.00004686814,0.00037640418,0.0003887462,0.00007108923,0.0000708045,0.00048258988,0.0000059911963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001639958,0.00011759169,0.150144,0.0003035826,0.00004501029,7.5492875e-7,0.01612025,0.000015992617,0.8211029,0.0008784548,0.00055586116,0.010551565],"study_design_scores_gemma":[0.0003166937,0.000074438285,0.46208143,0.000539904,0.000012587575,0.0000019603851,0.0036749917,0.000030341926,0.53110725,0.0005514923,0.0015709222,0.00003795392],"about_ca_topic_score_codex":0.00082559284,"about_ca_topic_score_gemma":0.000115849565,"teacher_disagreement_score":0.31193745,"about_ca_system_score_codex":0.00006117255,"about_ca_system_score_gemma":0.00014974813,"threshold_uncertainty_score":0.20966397},"labels":[],"label_agreement":null},{"id":"W1975987260","doi":"10.1158/1538-7445.am2011-1690","title":"Abstract 1690: Definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Toxicity; Medicine; Clinical trial; Internal medicine; Oncology; Limiting; Cancer; Grading (engineering); Phases of clinical research","score_opus":0.9503854268774826,"score_gpt":0.7368618717235832,"score_spread":0.21352355515389942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975987260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877166,0.00033791777,0.0061992933,0.00009177527,0.00047037416,0.0012514743,0.00069110247,0.000022815118,0.0032186443],"genre_scores_gemma":[0.847461,0.00069761835,0.1512609,0.000041055497,0.00022125286,0.00025911254,0.0000032429023,0.000039877796,0.000015961377],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.985724,0.007695999,0.004312008,0.00053259754,0.0011381984,0.00059723237],"domain_scores_gemma":[0.93014675,0.06705253,0.0011884087,0.0005725817,0.0008023589,0.00023738111],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.059077784,0.0001816097,0.001654689,0.0002880364,0.0000495716,0.000015107476,0.0005021081,0.00034893717,0.0041578277],"category_scores_gemma":[0.3005419,0.00015713915,0.0003583439,0.00069268735,0.0006035412,0.000089259476,0.00016981797,0.0010187279,0.000009660306],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017564828,0.013278183,0.027288092,0.004857581,0.0014051995,0.0002838505,0.0031536166,0.000009511958,0.4266304,0.17423084,0.005025924,0.32627195],"study_design_scores_gemma":[0.006513728,0.00054932234,0.015778653,0.0009862195,0.000090023794,3.9382192e-7,0.00016447724,0.00008268501,0.20708752,0.76851785,0.000027661019,0.00020144218],"about_ca_topic_score_codex":0.0010990573,"about_ca_topic_score_gemma":0.0001268381,"teacher_disagreement_score":0.59428704,"about_ca_system_score_codex":0.0001537332,"about_ca_system_score_gemma":0.0005480435,"threshold_uncertainty_score":0.9967525},"labels":[],"label_agreement":null},{"id":"W1976033816","doi":"10.1158/0008-5472.can-06-2071","title":"HER2/Neu (ErbB2) Signaling to Rac1-Pak1 Is Temporally and Spatially Modulated by Transforming Growth Factor β","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"PAK1; RAC1; Lamellipodium; Cell biology; Rac GTP-Binding Proteins; Pseudopodia; Actin cytoskeleton; Biology; Filopodia; Signal transduction; Actin; Cell migration; Cancer research; Cytoskeleton; Cell; Biochemistry","score_opus":0.02679419137179795,"score_gpt":0.33902574605520114,"score_spread":0.3122315546834032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976033816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944373,0.0031711566,0.00090304826,0.0005491345,0.00005180722,0.00043957244,0.00020565465,0.000027965294,0.00021437186],"genre_scores_gemma":[0.99744874,0.00013843637,0.00025265737,0.00023600005,0.00031070842,0.00010935162,0.0001210004,0.000056477234,0.0013266011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800193,0.00010723359,0.00026288116,0.00058897346,0.00046478925,0.0005741756],"domain_scores_gemma":[0.99908274,0.00004169057,0.00003925719,0.00026935272,0.00032514075,0.00024179048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028388127,0.00019767147,0.00017739582,0.000110199886,0.000223017,0.00010644102,0.0002999858,0.00016333412,0.00014340949],"category_scores_gemma":[0.00008678777,0.00019582032,0.000063099564,0.00023793505,0.00012470077,0.000010901137,0.00010969661,0.00018840686,0.000011991049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017185883,0.000055663233,0.00561973,0.00008381921,0.00003889715,0.000007768235,0.00013805983,0.00014579543,0.98412067,0.000006852201,0.007912218,0.0016986752],"study_design_scores_gemma":[0.0004961654,0.00019435011,0.0014890366,0.00007225375,0.000008099557,0.0000018283523,0.00003098343,0.000038529957,0.9799328,0.00008348743,0.017394299,0.00025820988],"about_ca_topic_score_codex":0.0020262029,"about_ca_topic_score_gemma":0.0003573792,"teacher_disagreement_score":0.009482081,"about_ca_system_score_codex":0.00006123739,"about_ca_system_score_gemma":0.00035876464,"threshold_uncertainty_score":0.79853207},"labels":[],"label_agreement":null},{"id":"W1976113809","doi":"10.1158/1538-7445.tumimm2012-b51","title":"Abstract B51: Synergistic effects of αCTLA-4 and radiotherapy in the treatment of prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Blockade; Radiation therapy; Oncology; Prostate; Internal medicine; Cancer; Androgen deprivation therapy; Tramp; Castration; Urology; External beam radiotherapy; Receptor; Hormone","score_opus":0.0402545338470468,"score_gpt":0.39681315848190984,"score_spread":0.35655862463486304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976113809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9458134,0.050906587,8.156416e-7,0.0014406004,0.00006909952,0.0015460956,0.000011996395,0.000004607297,0.00020677599],"genre_scores_gemma":[0.9394278,0.059069905,0.000016472955,0.00006869037,0.00008004353,0.00089987746,0.000002375124,0.000014501996,0.00042033478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988569,0.000099298195,0.00022337776,0.00018121477,0.0003612444,0.00027796032],"domain_scores_gemma":[0.9991093,0.00038419163,0.000059388203,0.000260933,0.00013212822,0.000054035085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032631762,0.00010398995,0.00027904124,0.00014893012,0.000040417137,0.000014508819,0.00009929821,0.000051300733,0.0003440145],"category_scores_gemma":[0.000024072195,0.000060153277,0.000054932996,0.00037693605,0.00037322802,0.000041841016,0.000007127707,0.00012709797,0.0000013350842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018644836,0.00045111903,0.034016915,0.0010315799,0.000224836,0.00002385518,0.005221536,0.000006016154,0.6824631,0.000022788317,0.0015848851,0.27308884],"study_design_scores_gemma":[0.0074536605,0.0028176035,0.7365269,0.0009817582,0.000034918467,0.000003474359,0.00059005566,0.000046514804,0.24315456,0.000086971195,0.0081841275,0.00011946027],"about_ca_topic_score_codex":0.025004731,"about_ca_topic_score_gemma":0.00047941972,"teacher_disagreement_score":0.70251,"about_ca_system_score_codex":0.00029219294,"about_ca_system_score_gemma":0.00027234844,"threshold_uncertainty_score":0.9814879},"labels":[],"label_agreement":null},{"id":"W1976120640","doi":"10.1158/1538-7445.fbcr13-a45","title":"Abstract A45: Investigating the role of ASCL1 in regulating differentiation of gliobastoma precursor cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Neurogenesis; Phenotype; Cellular differentiation; Lineage markers; Wnt signaling pathway; Cancer research; Precursor cell; DKK1; Cell biology; Pathology; Cell; Genetics; Signal transduction; Gene; Medicine","score_opus":0.022468503767172743,"score_gpt":0.3142680889758184,"score_spread":0.2917995852086457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976120640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810994,0.00091339764,0.000015910711,0.000067968045,0.00002792659,0.00030387592,0.000010612598,0.0000017326413,0.0005486106],"genre_scores_gemma":[0.99940586,0.00015748628,0.0001342957,0.0000105771205,0.00006502332,0.000081688544,0.000012872298,0.000011503162,0.000120670695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991348,0.00009115609,0.00022060177,0.00016143103,0.00018625928,0.00020579915],"domain_scores_gemma":[0.9993935,0.00003954229,0.000097038515,0.00023812168,0.00019851494,0.000033263153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035501848,0.000063693704,0.00009538107,0.00005784282,0.000040949693,0.000013084811,0.00020626387,0.00008249152,0.000052826465],"category_scores_gemma":[0.000091389185,0.00004948063,0.000037662343,0.00015682053,0.00013424204,0.0000053851227,0.0001101994,0.00015159849,0.0000028198824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011477767,0.000024796298,0.010824399,0.00005413698,0.000012209999,4.053868e-8,0.00019983109,0.00014502757,0.9800299,0.000048674345,0.0002098902,0.008439625],"study_design_scores_gemma":[0.00015589493,0.00004964557,0.0451145,0.00007674329,0.00000215701,1.9552104e-7,0.00029454898,0.00070792914,0.9529702,0.00034453667,0.00023596857,0.00004769997],"about_ca_topic_score_codex":0.0011909544,"about_ca_topic_score_gemma":0.0004166967,"teacher_disagreement_score":0.0342901,"about_ca_system_score_codex":0.000021409005,"about_ca_system_score_gemma":0.00009936336,"threshold_uncertainty_score":0.20177615},"labels":[],"label_agreement":null},{"id":"W1976205021","doi":"10.1158/1538-7445.am10-lb-290","title":"Abstract LB-290: Tranilast inhibits breast cancer stem cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tranilast; Cancer stem cell; Cancer research; Cancer; Cancer cell; Pharmacology; CD44; Breast cancer; Chemistry; Medicine; Internal medicine; Cell; Biochemistry","score_opus":0.051209388710906065,"score_gpt":0.37702112826601836,"score_spread":0.3258117395551123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976205021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853186,0.0035414367,0.0000017687162,0.0059719617,0.0009792809,0.00081922114,0.00019774892,0.00009593845,0.00307407],"genre_scores_gemma":[0.98085874,0.0040849685,0.000016557997,0.00027812048,0.0027412074,0.00038965512,0.000008550006,0.00010134467,0.011520831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99651796,0.0001176159,0.00041546926,0.0006482228,0.0011960982,0.0011046571],"domain_scores_gemma":[0.99769527,0.00021690832,0.00008688837,0.00077842735,0.0006789433,0.0005435675],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008109284,0.00029983107,0.00050838344,0.0003745639,0.00031316804,0.00011466399,0.00038542174,0.00028164618,0.005675878],"category_scores_gemma":[0.000030052859,0.0002574084,0.00020210267,0.0006974889,0.0007126738,0.00019760556,0.0000808317,0.0019341912,0.00036881698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028102521,0.00023568353,0.0025072482,0.00044017594,0.00008845428,0.000119420314,0.000712487,0.000009964639,0.8571436,0.000047470665,0.023466729,0.11241854],"study_design_scores_gemma":[0.0035080917,0.00025721462,0.14636494,0.0009400856,0.00006774196,0.00030579785,0.0007259572,0.00003590112,0.56109613,0.000022665605,0.28618485,0.0004905998],"about_ca_topic_score_codex":0.004229796,"about_ca_topic_score_gemma":0.0019693468,"teacher_disagreement_score":0.29604742,"about_ca_system_score_codex":0.0004116998,"about_ca_system_score_gemma":0.0020845667,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W1976227494","doi":"10.1158/0008-5472.can-06-1931","title":"Blastemal Expression of Type I Insulin-Like Growth Factor Receptor in Wilms' Tumors Is Driven by Increased Copy Number and Correlates with Relapse","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Wilms' tumor; Biology; Cancer research; Copy-number variation; Insulin-like growth factor; Growth factor; Pathology; Receptor; Oncology; Internal medicine; Medicine; Gene; Genetics","score_opus":0.010318402920865687,"score_gpt":0.2855792374267753,"score_spread":0.27526083450590966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976227494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960219,0.00297341,0.0000055136848,0.000094719515,0.000058734866,0.00022177496,0.00007685035,0.000005199331,0.00054187735],"genre_scores_gemma":[0.9958629,0.0022302372,0.000057038375,0.000035499248,0.00006568048,0.000038681217,0.00007262918,0.000024964427,0.0016123466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876267,0.00012566181,0.0001956209,0.0003446008,0.00028157327,0.0002899034],"domain_scores_gemma":[0.99941915,0.000031334304,0.00006709071,0.0001669619,0.00022030895,0.000095152915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014060845,0.00012993488,0.0001761713,0.00006111974,0.000060131642,0.000015077041,0.00013966783,0.00019532786,0.000120458986],"category_scores_gemma":[0.00002970231,0.00009532158,0.00002651014,0.00027692437,0.0002749628,0.000008251788,0.00008470715,0.0002975082,0.000008610024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010082425,0.000051966457,0.1435942,0.000073191506,0.00002184978,0.00000498892,0.00009476661,0.000031125048,0.8379473,0.000007710762,0.017032968,0.00013167025],"study_design_scores_gemma":[0.0013778236,0.000413843,0.004223397,0.00035486167,0.000005720511,0.000005534092,0.00008802761,0.000022097263,0.9898232,0.000029949093,0.0034899355,0.00016557398],"about_ca_topic_score_codex":0.0015351125,"about_ca_topic_score_gemma":0.000082532926,"teacher_disagreement_score":0.15187591,"about_ca_system_score_codex":0.00005445922,"about_ca_system_score_gemma":0.00021529013,"threshold_uncertainty_score":0.3887101},"labels":[],"label_agreement":null},{"id":"W1976322590","doi":"10.1158/1538-7445.am2012-lb-230","title":"Abstract LB-230: A prospective clinical trial to evaluate DNA sequencing as a diagnostic tool to guide cancer therapy: results from the initial 50 patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; London Health Sciences Centre; Western University; Ottawa Hospital; Princess Margaret Cancer Centre; Hamilton Health Sciences; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; KRAS; Concordance; Internal medicine; Oncology; Liquid biopsy; Clinical trial; Genotyping; Cancer; Lung cancer; Colorectal cancer; Genotype; Gene","score_opus":0.17858246769119968,"score_gpt":0.49403305352611354,"score_spread":0.31545058583491387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976322590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897548,0.0016993589,0.000019907999,0.0016591498,0.0017039139,0.0028580949,0.001264085,0.000012024573,0.001028675],"genre_scores_gemma":[0.9840294,0.0027186288,0.000104863466,0.003271339,0.0073725036,0.0020381561,0.00013112891,0.000060507118,0.00027346387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651253,0.00033693347,0.0006829708,0.00078724686,0.00076292205,0.0009173761],"domain_scores_gemma":[0.9963837,0.0014345885,0.00012372185,0.0008167747,0.00078577414,0.00045544186],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002691349,0.00025228894,0.00029908342,0.0000651216,0.00029636326,0.00014516058,0.0006250036,0.00021423315,0.00018434231],"category_scores_gemma":[0.011803405,0.00019350191,0.00015583732,0.0002854726,0.00015950717,0.000014178388,0.0005008681,0.00046822926,0.00017151982],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16975296,0.0013787693,0.07934018,0.000028509794,0.0010129578,0.00002531688,0.006319269,0.0010007719,0.1587584,0.000115038965,0.38062155,0.20164628],"study_design_scores_gemma":[0.044314437,0.004094424,0.22423208,0.0002366237,0.00007131946,0.0000012297746,0.00041791948,0.00000864163,0.12787127,0.00030457386,0.59757787,0.00086956937],"about_ca_topic_score_codex":0.011525505,"about_ca_topic_score_gemma":0.0021768287,"teacher_disagreement_score":0.21695635,"about_ca_system_score_codex":0.0005891197,"about_ca_system_score_gemma":0.0020346201,"threshold_uncertainty_score":0.9965206},"labels":[],"label_agreement":null},{"id":"W1976337331","doi":"10.1158/1538-7445.tim2013-b10","title":"Abstract B10: Soluble lung-derived factors mediate breast cancer cell migration and growth via CD44 receptor-ligand interactions","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Breast cancer; CD44; Cancer research; Cancer stem cell; Tumor microenvironment; Cancer; Cancer cell; Lymph node; Lung cancer; Metastasis; Metastatic breast cancer; Biology; Medicine; Pathology; Immunology; Internal medicine; Cell","score_opus":0.02381618676659308,"score_gpt":0.3232679944497882,"score_spread":0.2994518076831951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976337331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863683,0.010065312,0.000046937774,0.0008124928,0.0014618672,0.00045295508,0.00014558871,0.000017245982,0.0006292991],"genre_scores_gemma":[0.9697104,0.025303284,0.000032025026,0.000088937624,0.001831235,0.00044936594,0.00012918847,0.00004158935,0.002413978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983722,0.00008174897,0.00021942233,0.0004937453,0.00030759475,0.0005253086],"domain_scores_gemma":[0.9988005,0.00003650939,0.000080049445,0.0002780638,0.00053095474,0.00027388925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022019348,0.0001951919,0.00018957876,0.00008539279,0.00025121376,0.00012294498,0.00020395567,0.00015815176,0.001259964],"category_scores_gemma":[0.00003351241,0.00017745882,0.000073561125,0.00015766444,0.00018437387,0.000049151768,0.00013404642,0.00031147533,0.000030984684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006755675,0.000045377266,0.006840601,0.00006668343,0.000053639666,2.1999988e-7,0.00029166412,0.000007079693,0.94592357,0.0000047813783,0.0434099,0.0032889543],"study_design_scores_gemma":[0.00071390957,0.000055465745,0.10089574,0.00004870597,0.000023452254,0.0000040546897,0.0003728261,0.000041344527,0.8356415,0.000051517796,0.061842773,0.0003086977],"about_ca_topic_score_codex":0.030195843,"about_ca_topic_score_gemma":0.0090884175,"teacher_disagreement_score":0.11028203,"about_ca_system_score_codex":0.00012562254,"about_ca_system_score_gemma":0.0002861872,"threshold_uncertainty_score":0.99965304},"labels":[],"label_agreement":null},{"id":"W1976435116","doi":"10.1158/1538-7445.am2014-lb-312","title":"Abstract LB-312: The somatic mutational landscape of ovarian clear cell carcinoma and its precursor lesions","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"","keywords":"ARID1A; KRAS; Biology; Serous fluid; Cancer research; Endometriosis; Clear cell carcinoma; Mutation; Somatic cell; Gene; Genetics; Oncology; Carcinoma; Internal medicine; Medicine","score_opus":0.0689584520663348,"score_gpt":0.3711548639577383,"score_spread":0.30219641189140345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976435116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196644,0.002894391,0.000004409142,0.0061508166,0.000067338624,0.0005613904,0.00004055252,0.000009885342,0.008304806],"genre_scores_gemma":[0.99842,0.00033215637,0.00006688219,0.00008812535,0.0002080761,0.0002075988,0.000012204472,0.000019423998,0.0006455054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987157,0.000100180725,0.00018496974,0.00023316979,0.000496838,0.0002691556],"domain_scores_gemma":[0.9988267,0.00048281832,0.000053707325,0.00026043426,0.00022863023,0.00014774346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055429176,0.000094688476,0.0001907399,0.000102273836,0.00016467241,0.000026815667,0.00010665007,0.000056366527,0.00091747585],"category_scores_gemma":[0.00010091625,0.000060411603,0.000049945873,0.00020464764,0.00010499303,0.000045520243,0.000052118827,0.00024211734,0.0000529266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038140947,0.0047795223,0.6132833,0.008845052,0.001209509,0.00031703652,0.01681646,0.00047410806,0.06628714,0.03550431,0.098692834,0.14997667],"study_design_scores_gemma":[0.0026055353,0.0005255676,0.9684369,0.00023325207,0.00008072743,0.000012691136,0.00034820652,0.0006621707,0.022158518,0.00045445078,0.004390336,0.00009165046],"about_ca_topic_score_codex":0.0002813107,"about_ca_topic_score_gemma":0.00006419621,"teacher_disagreement_score":0.35515362,"about_ca_system_score_codex":0.000076223885,"about_ca_system_score_gemma":0.0003372446,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W1976457595","doi":"10.1158/0008-5472.can-04-1918","title":"Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice","year":2004,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":510,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Survivin; Caspase; Malignancy; Apoptosis; Cancer research; Inhibitor of apoptosis; Cell cycle; Cancer; Signal transduction; Biology; Medicine; Programmed cell death; Pathology; Cell biology; Internal medicine; Biochemistry","score_opus":0.15816113535687343,"score_gpt":0.5181853095956691,"score_spread":0.3600241742387957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976457595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025456664,0.9968639,0.00033288612,0.000057281944,0.00034793874,0.0014080612,0.000018757422,0.000007844856,0.0007087872],"genre_scores_gemma":[0.0006206212,0.9947205,0.0018573131,0.000006459653,0.0014773213,0.0004971563,0.0001285621,0.00007225232,0.0006197684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699473,0.0007680549,0.00081118284,0.0006569802,0.00040521284,0.0003638137],"domain_scores_gemma":[0.998319,0.00013280382,0.00029606288,0.0005343677,0.00058453035,0.00013328067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023597046,0.00025064792,0.00075494696,0.00016016114,0.00012950358,0.000029297162,0.00035344076,0.00073796127,0.000038753748],"category_scores_gemma":[0.0005996439,0.00020432568,0.00046039405,0.00042584547,0.00021386443,0.000006448334,0.00019926559,0.0006901984,0.000020694293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004164079,0.00015453213,5.16587e-7,0.014953733,0.00015955235,0.0000014386447,0.00009680719,0.00000247901,0.006402275,0.000115622424,0.0002705914,0.9778008],"study_design_scores_gemma":[0.00033778686,0.00039453647,3.5471425e-7,0.008863238,0.00015940642,0.0000048903107,0.000056113444,0.0000013993341,0.008237991,0.00007966109,0.98165053,0.00021409318],"about_ca_topic_score_codex":0.00014827808,"about_ca_topic_score_gemma":0.00005559057,"teacher_disagreement_score":0.9813799,"about_ca_system_score_codex":0.00013177084,"about_ca_system_score_gemma":0.0024311764,"threshold_uncertainty_score":0.83321595},"labels":[],"label_agreement":null},{"id":"W1976605228","doi":"10.1158/0008-5472.can-04-4575","title":"A Hypoxia-Driven Vascular Endothelial Growth Factor/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1α through Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 Pathway in Neuroblastoma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Autocrine signalling; Vascular endothelial growth factor; Angiogenesis; MAPK/ERK pathway; Cancer research; Signal transduction; Paracrine signalling; Biology; Vascular endothelial growth factor A; Kinase; Cell biology; Receptor; Biochemistry","score_opus":0.03493867526904716,"score_gpt":0.3024512578544751,"score_spread":0.2675125825854279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976605228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023455,0.0058313855,0.00028296007,0.00043622317,0.00045703878,0.0021597447,0.0003059607,0.00008724903,0.00020487559],"genre_scores_gemma":[0.992349,0.00084271835,0.00034774,0.00013507191,0.0019468985,0.0008608524,0.00014925178,0.00021062502,0.003157788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941674,0.000662852,0.0006690828,0.0016445356,0.0011593485,0.001696803],"domain_scores_gemma":[0.99734557,0.0000748986,0.00021613036,0.0011483846,0.0007466501,0.00046835432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039698396,0.00071248144,0.0007010405,0.0004250537,0.00028078223,0.0001727982,0.0008625776,0.0004361429,0.00053606834],"category_scores_gemma":[0.0002549402,0.0006428844,0.0002708425,0.0011028511,0.000419419,0.00009834548,0.0004072855,0.001176996,0.000053491927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014281818,0.00041821555,0.0001407043,0.00012659849,0.00021907945,0.00008178142,0.0005088733,0.0006316515,0.9863115,0.000055076667,0.0006141938,0.009464155],"study_design_scores_gemma":[0.0036455733,0.0007291595,0.0012401699,0.00021231973,0.0000186326,0.000021254837,0.00008658186,0.00013025744,0.84383774,0.000028070981,0.14940207,0.0006481787],"about_ca_topic_score_codex":0.002073623,"about_ca_topic_score_gemma":0.0013390069,"teacher_disagreement_score":0.14878787,"about_ca_system_score_codex":0.0003659406,"about_ca_system_score_gemma":0.0012695048,"threshold_uncertainty_score":0.99960226},"labels":[],"label_agreement":null},{"id":"W1976684063","doi":"10.1158/1538-7445.am10-2240","title":"Abstract 2240: Clinical significance of <i>CEA, PRL3</i> and <i>EZH2</i> transcripts expressed in lymph nodes of colorectal cancer patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Toronto General Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Lymph; Lymph node; Stage (stratigraphy); Oncology; Internal medicine; T-stage; Gastroenterology; Cancer; Overall survival; Pathology; Biology","score_opus":0.03567579261915652,"score_gpt":0.3818570597787248,"score_spread":0.34618126715956826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976684063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617094,0.0016574524,0.00006611114,0.00012786975,0.00030715682,0.00076513336,0.00032841126,0.000006239981,0.00057067635],"genre_scores_gemma":[0.9950767,0.0040584854,0.000120128614,0.000044777727,0.00013731571,0.0003684953,0.00003733195,0.00005045993,0.00010628932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970192,0.00025213306,0.000639144,0.0007025357,0.00076216465,0.0006248758],"domain_scores_gemma":[0.99829596,0.00014654869,0.00015396305,0.0004448347,0.0007359918,0.00022271204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013533715,0.00020319773,0.00039840993,0.00019067805,0.0000685686,0.000023232848,0.00051558117,0.00041765347,0.00012206449],"category_scores_gemma":[0.00045104342,0.00020256417,0.00012590866,0.00041661796,0.00084443414,0.0000140056045,0.00020539464,0.0008030131,0.0000017821243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011469134,0.00038495957,0.020596612,0.00021302784,0.00006121229,0.0000045040415,0.000107565436,0.000050149123,0.9661343,0.000033396533,0.00049002585,0.010777347],"study_design_scores_gemma":[0.0024197917,0.00033419527,0.06107984,0.00012579784,0.000009975268,7.711525e-7,0.000052107505,0.000039341856,0.9327389,0.000058694524,0.0029505931,0.00019000533],"about_ca_topic_score_codex":0.0020395757,"about_ca_topic_score_gemma":0.0015463686,"teacher_disagreement_score":0.04048323,"about_ca_system_score_codex":0.000057007386,"about_ca_system_score_gemma":0.0009916858,"threshold_uncertainty_score":0.8260327},"labels":[],"label_agreement":null},{"id":"W1976702855","doi":"10.1158/1538-7445.am2011-5097","title":"Abstract 5097: Proteomic characterization of non-small cell lung cancer (NSCLC): Discovery and validation of NSCLC protein signatures and signaling networks","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Lung cancer; Immunohistochemistry; Adenocarcinoma; Proteomics; Cancer research; Proteome; Cancer; Epidermal growth factor receptor; Pathology; Medicine; Biology; Internal medicine; Bioinformatics; Gene","score_opus":0.031201783263340575,"score_gpt":0.3276986443240366,"score_spread":0.29649686106069606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976702855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835355,0.0005983426,0.014200839,0.000028625916,0.000010495481,0.0011234618,0.000106742315,0.000022798891,0.00037314053],"genre_scores_gemma":[0.9943758,0.0010347383,0.002629583,0.000004655646,0.00009625077,0.0015755636,0.00003751195,0.000035524463,0.0002103706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884564,0.000025271613,0.0003151808,0.00034063487,0.0002052526,0.00026803004],"domain_scores_gemma":[0.99914515,0.00003789475,0.000258362,0.0002538286,0.00023496359,0.000069825735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031078685,0.00014099867,0.00020490473,0.00009039556,0.00011381603,0.00003490199,0.00018599186,0.00016928202,0.00012703137],"category_scores_gemma":[0.000012968265,0.00013581588,0.000032971766,0.00018422729,0.00017560303,0.0002241344,0.00011874699,0.00042156735,1.6340503e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000141778,0.000049041773,0.0026184293,0.00085848995,0.000017473116,6.912691e-7,0.00027531845,0.00009654697,0.99327934,0.000109397406,0.000006100452,0.0025474108],"study_design_scores_gemma":[0.00027619617,0.000025938361,0.0024908734,0.00071837817,0.000014135851,3.22344e-7,0.000044714645,0.00097137416,0.99501765,0.00028980125,0.000014486239,0.00013615424],"about_ca_topic_score_codex":0.00061084575,"about_ca_topic_score_gemma":0.000008315598,"teacher_disagreement_score":0.011571256,"about_ca_system_score_codex":0.00007299665,"about_ca_system_score_gemma":0.0001503635,"threshold_uncertainty_score":0.55384105},"labels":[],"label_agreement":null},{"id":"W1976748828","doi":"10.1158/1538-7445.am2011-3193","title":"Abstract 3193: Valosin containing protein (VCP) is a potential novel serum marker for ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe","funders":"","keywords":"Ovarian cancer; Medicine; Biology; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.17529859857631414,"score_gpt":0.4159299085706017,"score_spread":0.24063130999428756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976748828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96261305,0.003357997,0.00051446474,0.014003744,0.00071038137,0.0063239564,0.0010739447,0.00011100229,0.011291488],"genre_scores_gemma":[0.9865731,0.0003109781,0.00167653,0.00065277907,0.0008545915,0.006174038,0.00002188291,0.000095471754,0.0036406305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705094,0.000049811108,0.00037492497,0.00074218825,0.00076198805,0.0010201288],"domain_scores_gemma":[0.9981951,0.00007899266,0.00010198884,0.0005431852,0.0006801313,0.00040060788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008590456,0.0002714247,0.00044493066,0.00023947062,0.00030402598,0.00007507724,0.00023062748,0.00019394093,0.009426037],"category_scores_gemma":[0.00006890873,0.00022954603,0.00021315311,0.0003707898,0.00017599482,0.00014907373,0.00010009284,0.00050788664,0.00006326075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032823104,0.007453977,0.20253669,0.004597547,0.007267438,0.0012408617,0.0121626,0.000029312097,0.3039379,0.008667399,0.113765955,0.3055172],"study_design_scores_gemma":[0.017441273,0.0018146471,0.76243764,0.0023329118,0.00037202632,0.000028088825,0.0006495458,0.00025716302,0.14757904,0.0009098187,0.0655158,0.00066200725],"about_ca_topic_score_codex":0.009565785,"about_ca_topic_score_gemma":0.0006675128,"teacher_disagreement_score":0.559901,"about_ca_system_score_codex":0.0008741118,"about_ca_system_score_gemma":0.0014363476,"threshold_uncertainty_score":0.9970296},"labels":[],"label_agreement":null},{"id":"W1977014227","doi":"10.1158/0008-5472.sabcs11-s2-2","title":"S2-2: Luminal A Subtype Predicts Radiation Response in Patients with T1N0 Breast Cancer Enrolled in a Randomized Trial of Tamoxifen with or without Breast Radiation.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Biomarker; Cancer; Immunohistochemistry; Gynecology","score_opus":0.02341877420849849,"score_gpt":0.3204212930066587,"score_spread":0.29700251879816025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977014227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996111,0.00061006594,0.000010866367,0.00026348775,0.00009008425,0.0025268213,0.00027259835,0.000008432448,0.00010668862],"genre_scores_gemma":[0.99632245,0.00055764243,0.00006378698,0.000027401304,0.00019422274,0.0025362014,0.00006057939,0.000043130225,0.00019460596],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99698234,0.0009408415,0.00042171704,0.0005399325,0.00061349984,0.0005016966],"domain_scores_gemma":[0.9986701,0.00014493702,0.00021418293,0.00037199934,0.00048346448,0.000115285475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013254563,0.0002474496,0.0006675409,0.00035181575,0.000074988835,0.000016071344,0.00022434264,0.00014018721,0.00012294692],"category_scores_gemma":[0.00019209522,0.0001641676,0.00006473244,0.0006854748,0.00045391626,0.000024143354,0.00008452443,0.00021710654,0.0000018586102],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6807748,0.00042696678,0.3151323,0.000029707202,0.00021259916,0.0000059681333,0.0009137488,0.000030371195,0.00032085847,0.0000019460388,0.00008635478,0.0020643768],"study_design_scores_gemma":[0.4859182,0.0013030311,0.5104841,0.00016470786,0.000046099343,0.0000054251836,0.00009137664,0.000016874636,0.0017688762,0.0000052402393,0.000039908013,0.00015617294],"about_ca_topic_score_codex":0.006338731,"about_ca_topic_score_gemma":0.0047031473,"teacher_disagreement_score":0.19535178,"about_ca_system_score_codex":0.00035210096,"about_ca_system_score_gemma":0.001537059,"threshold_uncertainty_score":0.95823073},"labels":[],"label_agreement":null},{"id":"W1977396699","doi":"10.1158/0008-5472.can-06-1954","title":"Alteration of the Methylation Status of Tumor-Promoting Genes Decreases Prostate Cancer Cell Invasiveness and Tumorigenesis <i>In vitro</i> and <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Immunovaccine (Canada)","funders":"","keywords":"Biology; Carcinogenesis; Cancer research; DNA methylation; DU145; Angiogenesis; Prostate cancer; Methylation; Cancer; Tumor progression; Methyltransferase; Molecular biology; Gene expression; Gene; LNCaP","score_opus":0.021010574043247104,"score_gpt":0.31894088553189975,"score_spread":0.2979303114886527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977396699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608287,0.038571063,0.00001888887,0.000041931944,0.00003419333,0.00036409157,0.00005883191,0.0000011805519,0.00008112468],"genre_scores_gemma":[0.9871667,0.012491013,0.00010250729,0.000008158493,0.00005273813,0.00010009536,0.00001550298,0.000013764926,0.000049527505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876165,0.00024164587,0.0002695223,0.00026020437,0.00020977475,0.00025719134],"domain_scores_gemma":[0.9994343,0.000058093643,0.0001145455,0.0001540213,0.00019800203,0.000041058232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005311432,0.00008886128,0.00014013737,0.00007086272,0.00005823452,0.000016580696,0.000075773634,0.000051872383,0.000004935917],"category_scores_gemma":[0.000058230744,0.00007448947,0.000022737306,0.0002286588,0.00013241649,0.00001048188,0.0000931192,0.000067990346,3.1105117e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001182643,0.00003100045,0.14853829,0.00013294672,0.0000037647244,5.193153e-7,0.000107840795,0.00090018875,0.84747016,0.000007382773,0.0000037322877,0.0026858917],"study_design_scores_gemma":[0.0004469497,0.000048124053,0.049949307,0.000057871428,0.0000057320335,2.5920582e-7,0.00008894474,0.00020887953,0.9486504,0.00017401476,0.0002983171,0.00007120127],"about_ca_topic_score_codex":0.0130678015,"about_ca_topic_score_gemma":0.007087539,"teacher_disagreement_score":0.10118022,"about_ca_system_score_codex":0.000050364353,"about_ca_system_score_gemma":0.00024497818,"threshold_uncertainty_score":0.9935043},"labels":[],"label_agreement":null},{"id":"W1977416266","doi":"10.1158/1538-7445.am2012-4805","title":"Abstract 4805: Distinctive phospho-proteome signatures in non-small cell lung carcinoma tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Receptor tyrosine kinase; Cancer research; Biology; ErbB; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Epidermal growth factor receptor; Kinase; Focal adhesion; Protein kinase domain; LYN; Adherens junction; Cell biology; Signal transduction; Cancer; Cell; Cadherin; Biochemistry; Genetics","score_opus":0.028290090150960363,"score_gpt":0.349363443421051,"score_spread":0.3210733532700907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977416266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867038,0.0045337505,0.000065884706,0.00011994493,0.00023795576,0.0007734725,0.000052520863,0.000009132057,0.007503508],"genre_scores_gemma":[0.9955837,0.00009946852,0.00012750595,0.000048455044,0.00061897066,0.0008987579,0.000034123586,0.000044922584,0.0025440922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814457,0.000110508365,0.00020835729,0.00042091697,0.00029627435,0.00081938226],"domain_scores_gemma":[0.9990237,0.000055360968,0.00006075468,0.0004268253,0.00022607362,0.00020729126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005955428,0.00017561231,0.00015455254,0.0001435612,0.00014641443,0.00004314964,0.00036898884,0.00019615128,0.00046551778],"category_scores_gemma":[0.00015960334,0.0001708879,0.000079309495,0.000269128,0.00014050535,0.000014587102,0.00024891717,0.0007738704,0.000057872767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018991217,0.00014908607,0.051980384,0.00009508628,0.000019717918,0.000015148236,0.0003276977,0.0000869004,0.9411907,0.000013968846,0.005460319,0.00047106663],"study_design_scores_gemma":[0.0004007158,0.00008383998,0.20741525,0.000054124597,0.000003889988,0.0000021228232,0.0002768716,0.000019197914,0.78663874,0.000019479685,0.004898833,0.00018693607],"about_ca_topic_score_codex":0.0026887893,"about_ca_topic_score_gemma":0.00049961335,"teacher_disagreement_score":0.15543488,"about_ca_system_score_codex":0.00026773533,"about_ca_system_score_gemma":0.00027606293,"threshold_uncertainty_score":0.6968606},"labels":[],"label_agreement":null},{"id":"W1977423773","doi":"10.1158/1538-7445.am2014-1352","title":"Abstract 1352: Cytoplasmic galectin-7 has an antiapoptotic function by decreasing p53 nuclear translocation in breast cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Galectin; Cancer research; Cancer cell; Cancer; Apoptosis; Breast cancer; Biology; Cell biology; Galectin-3; Mitochondrion; Immunology; Biochemistry; Genetics","score_opus":0.038568952620019956,"score_gpt":0.3241390639682203,"score_spread":0.2855701113482003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977423773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354297,0.003365888,0.00006587891,0.0011448566,0.00086736743,0.0003234752,0.00007498744,0.000067358356,0.00054720056],"genre_scores_gemma":[0.99731845,0.0017352104,0.000010583434,0.00021529675,0.00016829916,0.0001205189,0.00007480024,0.000048492293,0.00030836926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744993,0.00059610774,0.0003305795,0.000648194,0.00011325127,0.00086194556],"domain_scores_gemma":[0.9991348,0.00013528627,0.00008714988,0.00033954333,0.00022319735,0.000080032354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009761623,0.00021465385,0.0003105582,0.00028913817,0.00048661476,0.000073749026,0.00032048125,0.00038895576,0.0028056945],"category_scores_gemma":[0.00002112716,0.00020698711,0.00006236042,0.00049992464,0.00043904383,0.00019874382,0.000037694066,0.0009586141,0.00023475016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007538012,0.00015608934,0.004188259,0.000043516415,0.000048908205,0.0000011173001,0.00037663063,0.000063816966,0.9292782,0.000096619515,0.00408683,0.060906187],"study_design_scores_gemma":[0.00564829,0.0009800117,0.20599703,0.00045454048,0.00006325907,0.00009921989,0.0011024994,0.00020722313,0.67192155,0.0004649869,0.112109706,0.0009517012],"about_ca_topic_score_codex":0.013283371,"about_ca_topic_score_gemma":0.0044090142,"teacher_disagreement_score":0.2573567,"about_ca_system_score_codex":0.0003780087,"about_ca_system_score_gemma":0.00034243,"threshold_uncertainty_score":0.9981059},"labels":[],"label_agreement":null},{"id":"W1977628220","doi":"10.1158/0008-5472.sabcs12-es2-3","title":"Abstract ES2-3: The Clonal and Mutational Composition of Triple Negative Breast Cancers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; Somatic evolution in cancer; Biology; Breast cancer; Disease; Cancer; Copy-number variation; Transcriptome; Genetics; Computational biology; Genome; Gene; Medicine; Pathology; Gene expression","score_opus":0.03639238739646247,"score_gpt":0.36656934967459154,"score_spread":0.3301769622781291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977628220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944675,0.0035916632,0.000039043913,0.0005215531,0.00015740684,0.0001806573,0.00033091503,0.0000014874134,0.0007097714],"genre_scores_gemma":[0.99806035,0.0010586915,0.00006135157,0.000093490075,0.0005123159,0.000067821755,0.00005725593,0.000009335318,0.00007936324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929965,0.000043885942,0.000105984145,0.00012771557,0.00019770811,0.00022507254],"domain_scores_gemma":[0.99947226,0.00008506041,0.000042022042,0.00012105255,0.00019923954,0.00008034289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035196295,0.00006064147,0.000068150235,0.000030806863,0.000122154,0.000016904776,0.00009989199,0.00004882034,0.000079624],"category_scores_gemma":[0.000041662817,0.00004812546,0.000028961747,0.00008826454,0.0002809242,0.000005093684,0.00007491243,0.00011740003,0.000002462002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074239896,0.00010485572,0.016437555,0.00007311478,0.0001496368,0.000001449805,0.00074846187,0.00044695914,0.9439796,0.0022646391,0.020708418,0.014342913],"study_design_scores_gemma":[0.0015375434,0.00021028363,0.47861746,0.000059153677,0.000025176896,0.00004186221,0.0007998202,0.00008540582,0.4992998,0.00063214946,0.018445525,0.00024584535],"about_ca_topic_score_codex":0.0011640477,"about_ca_topic_score_gemma":0.00023422512,"teacher_disagreement_score":0.4621799,"about_ca_system_score_codex":0.0000730896,"about_ca_system_score_gemma":0.00030200026,"threshold_uncertainty_score":0.19624993},"labels":[],"label_agreement":null},{"id":"W1977665910","doi":"10.1158/1538-7445.am10-3508","title":"Abstract 3508: A diazirine-based photoaffinity etoposide probe for labeling topoisomerase II","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Diazirine; Etoposide; Topoisomerase; Chemistry; Covalent bond; Photoaffinity labeling; Adduct; Stereochemistry; Biochemistry; DNA; Biophysics; Binding site; Biology; Organic chemistry; Genetics","score_opus":0.06618147967887554,"score_gpt":0.4056547534831715,"score_spread":0.3394732738042959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977665910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952602,0.0006216467,0.0011053192,0.0011696942,0.00047161043,0.00082258147,0.00013978222,0.000019627345,0.00038954546],"genre_scores_gemma":[0.9949849,0.00019899235,0.0014218966,0.0005640236,0.0007565325,0.0010039379,0.000081888466,0.00004786284,0.00093995646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985338,0.000029881443,0.00017651568,0.0004437811,0.0002649355,0.00055109174],"domain_scores_gemma":[0.9988579,0.000049613936,0.000047430058,0.00046731794,0.00040454167,0.00017320483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007600754,0.00014811673,0.00013950626,0.000081095954,0.0003674275,0.000057565514,0.00032117596,0.00018340173,0.00020422802],"category_scores_gemma":[0.000121816294,0.00014072764,0.00010822675,0.00014221943,0.000115106835,0.000004407897,0.0001258775,0.0004175995,0.000006687783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031165092,0.00010391718,0.0000926834,0.000065027205,0.000032206084,0.0000019157087,0.00003908209,0.000023847204,0.98884887,0.00041904175,0.001199179,0.0088626],"study_design_scores_gemma":[0.00092143606,0.00029244588,0.000116241805,0.000019230072,0.0000073285514,0.000001099707,0.000021936694,0.00006779825,0.8240002,0.00057381723,0.1738204,0.00015809597],"about_ca_topic_score_codex":0.00029554975,"about_ca_topic_score_gemma":0.0019252234,"teacher_disagreement_score":0.17262122,"about_ca_system_score_codex":0.00004158991,"about_ca_system_score_gemma":0.0006375806,"threshold_uncertainty_score":0.57387066},"labels":[],"label_agreement":null},{"id":"W1977885634","doi":"10.1158/0008-5472.can-03-2219","title":"Oncogenic Ras Sensitizes Normal Human Cells to Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand-Induced Apoptosis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; U.S. Department of Defense","keywords":"Apoptosis; Biology; Cell biology; Kinase; Cancer research; Tumor necrosis factor alpha; Protein kinase A; Fas ligand; Caspase 8; Molecular biology; Programmed cell death; Caspase; Immunology; Biochemistry","score_opus":0.04100054697270824,"score_gpt":0.34676731995651794,"score_spread":0.3057667729838097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977885634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997842,0.0001729113,0.00014615535,0.00043981386,0.0003878998,0.00056982215,0.000027632994,0.000034725563,0.00037899677],"genre_scores_gemma":[0.9972491,0.00015744478,0.00018531468,0.00017109145,0.00044921276,0.00010884469,0.000060851515,0.00006371315,0.0015544225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757254,0.00011677756,0.00032897733,0.0007016099,0.0005093445,0.00077074184],"domain_scores_gemma":[0.9987405,0.000018482102,0.000072292394,0.00051155547,0.00033122324,0.0003259644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045637888,0.00024627143,0.0002470187,0.00021260002,0.000515633,0.000110604706,0.00029777753,0.0002735802,0.00011943408],"category_scores_gemma":[0.00004295709,0.00023590813,0.00016265556,0.0004609371,0.00007297885,0.000011758981,0.00027247923,0.00036105452,0.000109563465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072420415,0.000057506346,0.00004837537,0.000028489478,0.00006895309,0.0000032401435,0.00028151795,0.00067486434,0.9960966,0.00007652595,0.00052145496,0.0020700525],"study_design_scores_gemma":[0.000938278,0.0004570342,0.00049893896,0.00007992099,0.000017326422,0.000004443521,0.00014570852,0.0000085325555,0.9959145,0.0001250992,0.001499592,0.00031063196],"about_ca_topic_score_codex":0.0014498573,"about_ca_topic_score_gemma":0.00016488617,"teacher_disagreement_score":0.0017594206,"about_ca_system_score_codex":0.00023368478,"about_ca_system_score_gemma":0.00031754115,"threshold_uncertainty_score":0.96200544},"labels":[],"label_agreement":null},{"id":"W1977981331","doi":"10.1158/0008-5472.can-05-3296","title":"BRCA1 DNA-Binding Activity Is Stimulated by BARD1","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"DNA repair; DNA; Ubiquitin; DNA damage; Biology; Cell biology; DNA-binding domain; DNA-binding protein; Transcription factor; Molecular biology; Genetics; Gene","score_opus":0.035764991600143285,"score_gpt":0.3725587902727699,"score_spread":0.3367937986726266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977981331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585104,0.00057661097,0.00016797835,0.0003594865,0.000103786224,0.00023262521,0.00009727761,0.000025587087,0.0025855869],"genre_scores_gemma":[0.9846317,0.000113420414,0.000065919136,0.00007303736,0.00024586552,0.00007561516,0.000069251255,0.00003541779,0.014689768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983813,0.00012408695,0.00010788277,0.00046550846,0.00039455615,0.0005266705],"domain_scores_gemma":[0.9992837,0.000018735793,0.000029231216,0.00040326273,0.00016549589,0.000099624165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044775227,0.00012068523,0.000114113325,0.00006480075,0.00016012734,0.000050270664,0.0002684874,0.00017893406,0.00029386414],"category_scores_gemma":[0.000044757442,0.000121722216,0.000063508065,0.00022219711,0.000098161254,0.0000050764065,0.00019761937,0.00022471725,0.00007526386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068295005,0.0000436572,0.00048738113,0.000013164435,0.000023521106,0.000004219687,0.0000094152165,0.000014604599,0.91312444,0.000024117817,0.08440971,0.0017774644],"study_design_scores_gemma":[0.00037307045,0.00011103018,0.00033150837,0.000011995246,0.0000037632701,0.0000018788589,0.000011416338,0.00008840636,0.9238674,0.000109016175,0.07495825,0.000132262],"about_ca_topic_score_codex":0.00063144584,"about_ca_topic_score_gemma":0.00009390575,"teacher_disagreement_score":0.012104182,"about_ca_system_score_codex":0.000107748165,"about_ca_system_score_gemma":0.00016624559,"threshold_uncertainty_score":0.4963688},"labels":[],"label_agreement":null},{"id":"W1978000105","doi":"10.1158/1538-7445.am2011-200","title":"Abstract 200: Identification of proteins involved in c-Myc induced mammary epithelia apoptosis in 3D culture system","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Apoptosis; Mammary tumor; Carcinogenesis; Cell biology; Cell culture; Biology; Morphogenesis; Cancer research; Small hairpin RNA; Cell growth; Cancer; Gene knockdown; Gene; Breast cancer; Genetics","score_opus":0.07815766228748416,"score_gpt":0.3669627970075208,"score_spread":0.28880513472003666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978000105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963653,0.0014408826,0.000016993099,0.000043584736,0.000048170445,0.0008664585,0.000054864053,0.000006529593,0.0011572205],"genre_scores_gemma":[0.99769425,0.000902613,0.00008659474,0.0000061105598,0.000054403656,0.0009189603,0.000055004395,0.000018454804,0.00026357715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982958,0.0001625725,0.0003255985,0.00040382665,0.00037888633,0.0004333293],"domain_scores_gemma":[0.99910784,0.000008460019,0.00007698688,0.00046032347,0.00024351005,0.00010287812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073848106,0.000117660624,0.00016730293,0.00025431582,0.00004502944,0.000021933303,0.00037303523,0.00017538726,0.000033438624],"category_scores_gemma":[0.000077672215,0.00010642063,0.000048464888,0.00047812497,0.000083455416,0.000015904772,0.00014151806,0.00029031088,0.000015900785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036937214,0.00021014316,0.028058015,0.0002637168,0.00004365734,0.0000133350595,0.0004092577,0.0000026185705,0.967235,0.000069248585,0.00025452505,0.0030711072],"study_design_scores_gemma":[0.0009196619,0.00018958705,0.07622966,0.00017634481,0.0000024714132,7.9203556e-7,0.00037825812,0.000009810708,0.9216938,0.00005788292,0.00023937614,0.00010235421],"about_ca_topic_score_codex":0.013157275,"about_ca_topic_score_gemma":0.005558649,"teacher_disagreement_score":0.048171643,"about_ca_system_score_codex":0.00026057655,"about_ca_system_score_gemma":0.00041326345,"threshold_uncertainty_score":0.9934142},"labels":[],"label_agreement":null},{"id":"W1978004227","doi":"10.1158/1538-7445.am10-216","title":"Abstract 216: Role of Akt isoforms in chemoresistance of human endometrial carcinoma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Protein kinase B; AKT2; Cancer research; Gene isoform; Cisplatin; Transfection; Cell culture; XIAP; Biology; Cell growth; Apoptosis; Chemistry; AKT1; Cell biology; Signal transduction; Internal medicine; Medicine; Programmed cell death; Caspase; Gene; Biochemistry","score_opus":0.03351290177873132,"score_gpt":0.37899462418511193,"score_spread":0.3454817224063806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978004227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568367,0.00072400784,0.0000012946371,0.00003816637,0.0001166126,0.00037378023,0.00009970117,0.000003226712,0.0029595126],"genre_scores_gemma":[0.9988771,0.00014338846,0.00004876508,0.0000040817713,0.0002743112,0.000070208196,0.000032151012,0.00003105163,0.0005189282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977827,0.00007978104,0.00038840904,0.0004049714,0.0007298792,0.00061425637],"domain_scores_gemma":[0.9985187,0.00008323482,0.00010035032,0.00066343584,0.0004921743,0.00014208876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012124948,0.0001362714,0.00027545344,0.00039735646,0.00005578836,0.00001814646,0.00070532475,0.0002483704,0.0003149759],"category_scores_gemma":[0.00037551564,0.00012601804,0.000105308354,0.0005912557,0.00050534576,0.000008296851,0.00028501905,0.00060324394,0.000007793405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036584554,0.00027566485,0.035268523,0.000117428965,0.000018440893,0.0000037594968,0.00008291023,0.0000021829521,0.9614802,0.000066198256,0.00068327977,0.0016355768],"study_design_scores_gemma":[0.0019662231,0.00024023339,0.036029093,0.000023120034,0.000001750012,5.6404735e-7,0.00014673868,0.00000288444,0.95901155,0.00013470049,0.002331063,0.00011205719],"about_ca_topic_score_codex":0.0025786546,"about_ca_topic_score_gemma":0.003047373,"teacher_disagreement_score":0.0031934166,"about_ca_system_score_codex":0.000063280575,"about_ca_system_score_gemma":0.0005193149,"threshold_uncertainty_score":0.51388663},"labels":[],"label_agreement":null},{"id":"W1978091144","doi":"10.1158/0008-5472.can-09-1299","title":"Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27Kip1 Localization","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medulloblastoma; PI3K/AKT/mTOR pathway; TSC1; GSK-3; TSC2; Biology; Cancer research; Protein kinase B; Cell biology; Kinase; Signal transduction","score_opus":0.11600120435637795,"score_gpt":0.3808243957661371,"score_spread":0.26482319140975913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978091144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970263,0.0007844219,0.00025762626,0.00087339757,0.000018244677,0.0008215847,0.000014653645,0.000015596173,0.00018813935],"genre_scores_gemma":[0.9982751,0.00024643738,0.0012030381,0.000026166023,0.000028434699,0.000040837218,0.000023486891,0.000021165599,0.00013534974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972253,0.00039594897,0.00043161982,0.00043870785,0.0010289373,0.00047950493],"domain_scores_gemma":[0.9987585,0.0001384364,0.00009102174,0.0003140911,0.0004881048,0.00020985669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013398556,0.00016082516,0.00045899063,0.0005744739,0.00013778957,0.000023824241,0.00012494814,0.00013706792,0.00015763343],"category_scores_gemma":[0.0001392266,0.0001490238,0.00002855401,0.000881653,0.0003844492,0.00014478227,0.00015087378,0.00033486504,0.000002210532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011414348,0.00025181202,0.07733296,0.00043892875,0.000022644062,0.0000037853583,0.0010911891,0.00033847193,0.8889571,0.00007841349,0.0005134649,0.029829802],"study_design_scores_gemma":[0.0013749235,0.00029633337,0.6046258,0.00048849056,0.0000056510544,0.0000052075807,0.000078040604,0.0034075452,0.38938096,0.00010064395,0.0001578808,0.000078500794],"about_ca_topic_score_codex":0.00080173597,"about_ca_topic_score_gemma":0.00045119788,"teacher_disagreement_score":0.52729285,"about_ca_system_score_codex":0.00029455044,"about_ca_system_score_gemma":0.0003224843,"threshold_uncertainty_score":0.6077015},"labels":[],"label_agreement":null},{"id":"W1978309989","doi":"10.1158/1538-7445.am2013-lb-214","title":"Abstract LB-214: Common genomic alterations in malignant peripheral nerve sheath tumors augment Aurora A activity and sensitize tumors to aurora kinase inhibitors.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer research; Aurora kinase; Aurora inhibitor; Cancer; Oncogene; Biology; Medicine; Kinase; Cell cycle; Internal medicine; Genetics","score_opus":0.047444526089392335,"score_gpt":0.36893268877215507,"score_spread":0.32148816268276276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978309989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924315,0.00022294695,0.0000024202793,0.00411187,0.00006570412,0.0025045276,0.000051199007,0.00004255089,0.00056727254],"genre_scores_gemma":[0.99739754,0.00007402081,0.00012391116,0.00020188156,0.00018025491,0.0009906046,0.000019878758,0.000058088543,0.000953844],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967057,0.00028312064,0.00034503257,0.00070175785,0.0008493184,0.0011150442],"domain_scores_gemma":[0.9980572,0.00015466698,0.000046013894,0.00050127355,0.00025784754,0.0009830056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054689613,0.0002779472,0.0004524977,0.0005274249,0.000281797,0.00021426672,0.00014832268,0.000076700286,0.00055706396],"category_scores_gemma":[0.00010224517,0.00023660577,0.000077070494,0.0005780817,0.00022561423,0.0002576644,0.00028187328,0.0008261508,0.00019126754],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012558585,0.0007714666,0.019310176,0.00021446304,0.00007080299,0.0038572263,0.0011089401,0.00010432451,0.9507008,0.00003701096,0.002747458,0.01982145],"study_design_scores_gemma":[0.003620549,0.0018067836,0.8275412,0.00078102853,0.000016664633,0.00014029235,0.0005507282,0.00068418944,0.16393232,0.00010039727,0.00048145273,0.00034442992],"about_ca_topic_score_codex":0.021404715,"about_ca_topic_score_gemma":0.002413636,"teacher_disagreement_score":0.808231,"about_ca_system_score_codex":0.0012619162,"about_ca_system_score_gemma":0.0006973706,"threshold_uncertainty_score":0.98511183},"labels":[],"label_agreement":null},{"id":"W1978599343","doi":"10.1158/1538-7445.am2014-lb-77","title":"Abstract LB-77: The Met receptor tyrosine kinase drives signaling through EGFR and ErbB3 in Met-amplified non-small-cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"ERBB3; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; ErbB; Epidermal growth factor receptor; Cyclin-dependent kinase 8; Proto-oncogene tyrosine-protein kinase Src; Signal transduction; Biology; ERBB4; ROR1; Autophosphorylation; Kinase; Cancer; Cell biology; Platelet-derived growth factor receptor; Receptor; Protein kinase A; Biochemistry; Notch signaling pathway; Growth factor","score_opus":0.06111581085428957,"score_gpt":0.42670170940010793,"score_spread":0.36558589854581836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978599343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764011,0.012596134,0.00013823618,0.0043252837,0.0002502751,0.0013579519,0.00006560184,0.00003187861,0.0048335707],"genre_scores_gemma":[0.9915979,0.002982995,0.0008329742,0.000457617,0.0005038523,0.0010558624,0.00003667018,0.000053575106,0.002478581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978739,0.00015001102,0.0003074132,0.0005200248,0.00051549764,0.0006331778],"domain_scores_gemma":[0.99857813,0.00042894558,0.000079777215,0.00042913947,0.00029071627,0.00019331634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080826256,0.00021765898,0.00035840363,0.00016662688,0.00033276135,0.00009945824,0.0002049255,0.000109606335,0.0009005141],"category_scores_gemma":[0.000107014064,0.00014494984,0.00007065668,0.0005732593,0.00028860432,0.00014692964,0.00009977022,0.000612102,0.000022447626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00138677,0.001001738,0.12209412,0.0024024884,0.0010898911,0.00010419591,0.025589503,0.0010182057,0.7478201,0.0028531267,0.033574387,0.061065525],"study_design_scores_gemma":[0.02801998,0.0019171714,0.18678865,0.0056887,0.001324771,0.0000172934,0.011396109,0.0015334254,0.5687167,0.002213276,0.19080359,0.0015802953],"about_ca_topic_score_codex":0.01012727,"about_ca_topic_score_gemma":0.0014720071,"teacher_disagreement_score":0.17910331,"about_ca_system_score_codex":0.0006099069,"about_ca_system_score_gemma":0.00064596394,"threshold_uncertainty_score":0.9964644},"labels":[],"label_agreement":null},{"id":"W1978871709","doi":"10.1158/0008-5472.sabcs12-p3-06-34","title":"Abstract P3-06-34: Plasma (p) VEGF-A and VEGFR-2 biomarker (BM) results from the BEATRICE phase III trial of bevacizumab (BEV) in triple-negative early breast cancer (BC)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Population; Oncology; Breast cancer; Anthracycline; Cancer; Clinical endpoint; Triple-negative breast cancer; Chemotherapy; Metastatic breast cancer; Randomized controlled trial; Epirubicin","score_opus":0.12452955586661835,"score_gpt":0.45668403905827626,"score_spread":0.3321544831916579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978871709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843738,0.004949208,5.5886835e-7,0.0039831363,0.0006386462,0.002163456,0.0021981362,0.000020777752,0.0016722503],"genre_scores_gemma":[0.99267566,0.0036114142,0.000017525563,0.000094279356,0.0015377996,0.0007048867,0.0000961702,0.0000407991,0.0012214741],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967733,0.0003745989,0.0006389659,0.0005310375,0.0008062879,0.0008758052],"domain_scores_gemma":[0.9968086,0.0018640882,0.00020709963,0.00043341203,0.0003242101,0.00036260826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014647074,0.00027781478,0.00061653263,0.0003281051,0.00018606496,0.000035674682,0.0002590982,0.00021869052,0.0010680602],"category_scores_gemma":[0.00021330091,0.00019592704,0.00012217197,0.00095311244,0.00054887566,0.000247655,0.00013454647,0.0008571647,0.00003169361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7937441,0.0030067856,0.02135821,0.00016639309,0.0011709204,0.00011198604,0.011393395,0.000003910174,0.049534965,0.00002933365,0.032564998,0.086915],"study_design_scores_gemma":[0.53998923,0.0017789471,0.41872722,0.0005662935,0.0004467716,0.000021084916,0.0012108105,0.000098875804,0.024376899,0.00008082409,0.012310509,0.00039254798],"about_ca_topic_score_codex":0.096995935,"about_ca_topic_score_gemma":0.004560823,"teacher_disagreement_score":0.397369,"about_ca_system_score_codex":0.00089028256,"about_ca_system_score_gemma":0.0009109044,"threshold_uncertainty_score":0.9998451},"labels":[],"label_agreement":null},{"id":"W1978882188","doi":"10.1158/0008-5472.sabcs-09-47","title":"CIRG/TORI 010: 10-Month Analysis of a Randomized Phase II Trial of Motesanib Plus Weekly Paclitaxel as First Line Therapy in HER2-Negative Metastatic Breast Cancer (MBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Placebo; Breast cancer; Gastroenterology; Surgery; Urology; Cancer; Pathology","score_opus":0.07820365543155519,"score_gpt":0.4614026070120939,"score_spread":0.38319895158053874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978882188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97333235,0.010296633,0.00036939656,0.009751879,0.00016448187,0.0048087775,0.0007460802,0.000043639953,0.00048678034],"genre_scores_gemma":[0.98848754,0.00746448,0.00037418632,0.00020925957,0.00041147904,0.001281475,0.00005156684,0.00005975406,0.0016602734],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942613,0.00090820604,0.001393618,0.0007611898,0.0018070036,0.0008686429],"domain_scores_gemma":[0.99532944,0.0012671117,0.0005776515,0.00086714095,0.0016372512,0.00032142582],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029758636,0.00043376046,0.0032353417,0.0016298734,0.00015970255,0.00002323349,0.00043133958,0.00015353071,0.003783912],"category_scores_gemma":[0.0010193518,0.00033778948,0.0007442036,0.004686898,0.000948242,0.00023090067,0.000080435886,0.00072697573,0.000004903433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.880442,0.002992902,0.00009156089,0.00014429943,0.0050259577,0.00004993098,0.0049411664,0.0016391453,0.010820803,0.00012773216,0.0001624072,0.09356206],"study_design_scores_gemma":[0.9641602,0.00877448,0.0017088932,0.00084433594,0.0015282051,0.000007885701,0.00108313,0.0024378889,0.01613283,0.0019494515,0.0009785609,0.00039415987],"about_ca_topic_score_codex":0.017513787,"about_ca_topic_score_gemma":0.002475323,"teacher_disagreement_score":0.0931679,"about_ca_system_score_codex":0.0012760779,"about_ca_system_score_gemma":0.0017311949,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W1979042664","doi":"10.1158/0008-5472.sabcs-6068","title":"Reductions in tumor RNA integrity associated with clinical response to epirubicin/docetaxel chemotherapy in breast cancer patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Ontario Institute for Cancer Research; Sunnybrook Health Science Centre; Sudbury Regional Hospital","funders":"","keywords":"Medicine; Epirubicin; Docetaxel; Taxane; Internal medicine; Breast cancer; Anthracycline; Oncology; Chemotherapy; Regimen; Cancer; Pathology","score_opus":0.04741261998502231,"score_gpt":0.41572546855696685,"score_spread":0.3683128485719445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979042664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881583,0.00039623512,0.000007199651,0.010407243,0.00014233339,0.00051251036,0.00022148345,0.000006929289,0.000147788],"genre_scores_gemma":[0.9962065,0.0013363068,0.00005278206,0.0016196171,0.00026734077,0.0001862854,0.000033420223,0.00002666505,0.00027103978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978736,0.00035683074,0.00036216926,0.00055464695,0.0002965629,0.00055619783],"domain_scores_gemma":[0.99881214,0.00012475811,0.00006445006,0.0003506374,0.00044363766,0.00020435647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015049698,0.00015575251,0.00025474743,0.00021801284,0.00007472173,0.000038125472,0.0002863211,0.00015490496,0.000064895554],"category_scores_gemma":[0.00072519213,0.00014346513,0.00005658635,0.00074853346,0.00014895988,0.000006699661,0.000074597,0.00063469406,0.000005354071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02450216,0.0027354048,0.6491683,0.000018242425,0.00011018079,0.00004790583,0.00054699794,0.00095524796,0.24758719,0.000059876125,0.039856955,0.03441152],"study_design_scores_gemma":[0.002978097,0.0009774443,0.97351414,0.00016747831,0.0000050400236,0.00000189427,0.0000880434,0.00002112215,0.0147838425,0.00007404389,0.0071549662,0.00023387738],"about_ca_topic_score_codex":0.0018785768,"about_ca_topic_score_gemma":0.005938698,"teacher_disagreement_score":0.32434583,"about_ca_system_score_codex":0.0005283897,"about_ca_system_score_gemma":0.0010956299,"threshold_uncertainty_score":0.58503383},"labels":[],"label_agreement":null},{"id":"W1979045512","doi":"10.1158/0008-5472.can-09-2669","title":"Adult-Type Granulosa Cell Tumors and FOXL2 Mutation","year":2009,"lang":"en","type":"review","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Somatic cell; Granulosa cell; Pathogenesis; Stromal cell; Biology; Germline mutation; Mutation; Cancer research; Cell type; Cell; Ovary; Genetics; Gene; Immunology","score_opus":0.1457025029729518,"score_gpt":0.48234876590819875,"score_spread":0.33664626293524696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979045512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003048556,0.9938241,7.5747613e-7,0.0006195743,0.00015237581,0.0017233544,0.000053642605,0.000031827916,0.0032894963],"genre_scores_gemma":[0.0006714487,0.9958034,0.00008440405,0.00010312396,0.0005300373,0.0006288747,0.00017124183,0.00006513193,0.001942318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760544,0.0002019393,0.00037791254,0.00065043615,0.00064841565,0.0005158601],"domain_scores_gemma":[0.998448,0.0002147845,0.00010883147,0.00046010825,0.0004570086,0.00031122888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837536,0.00031350972,0.0011737406,0.00037696847,0.00013963607,0.00006666405,0.00012989047,0.00023097175,0.00030106714],"category_scores_gemma":[0.00007878077,0.00023134254,0.00018931384,0.0007467856,0.00012882547,0.00004877521,0.00005790284,0.0007531887,0.00016679426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041563708,0.0001450245,0.00005387222,0.013914563,0.00011741646,0.000377021,0.000067112625,1.15816924e-7,0.0000012539285,0.000112602094,0.010146695,0.97502273],"study_design_scores_gemma":[0.0009811952,0.0007349939,0.00020722474,0.019872013,0.0006746185,0.00008570886,0.000024879386,0.0000014065806,0.000046494344,0.000106334315,0.97704995,0.00021521217],"about_ca_topic_score_codex":0.00043497645,"about_ca_topic_score_gemma":0.000047501275,"teacher_disagreement_score":0.97480756,"about_ca_system_score_codex":0.0007600302,"about_ca_system_score_gemma":0.0014794494,"threshold_uncertainty_score":0.9433875},"labels":[],"label_agreement":null},{"id":"W1979137486","doi":"10.1158/1538-7445.am2013-4469","title":"Abstract 4469: Combating lapatinib resistance of HER2 positive breast cancer cells by combined inhibition of mTOR and autophagy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Lapatinib; mTORC1; Autophagy; PI3K/AKT/mTOR pathway; Cancer research; Trastuzumab; Pharmacology; Protein kinase B; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Chemistry; Medicine; Signal transduction; Cancer; Biology; Cell biology; Breast cancer; Internal medicine; Biochemistry; Apoptosis","score_opus":0.018003642872603445,"score_gpt":0.3277632599152287,"score_spread":0.3097596170426253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979137486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412245,0.0033651947,0.000017218768,0.00042191288,0.00009791852,0.0004432797,0.00091114413,0.0000075123676,0.0006133821],"genre_scores_gemma":[0.9978817,0.00079875265,0.000114875395,0.00008964331,0.00012992382,0.00022563648,0.000062244544,0.000033602977,0.0006636327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835116,0.00012851038,0.00033879583,0.00039596023,0.0004153719,0.0003701939],"domain_scores_gemma":[0.9984889,0.00008745956,0.00019931309,0.00028566443,0.0008279221,0.00011072332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004122113,0.00015334564,0.0002410369,0.00006622902,0.00009509915,0.000028237237,0.00018658329,0.000160249,0.0003183683],"category_scores_gemma":[0.00004129984,0.00015114018,0.000052493135,0.00020279379,0.0004298784,0.000015914498,0.00012593827,0.00023772202,0.0000035954577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023637315,0.00007393861,0.0013230433,0.0002317133,0.000065952256,0.0000010837613,0.00013036843,0.000024283336,0.9822888,0.000021898093,0.014248092,0.0013544818],"study_design_scores_gemma":[0.00078094413,0.00016476733,0.013324842,0.00035740135,0.0000096776375,8.283134e-7,0.000105941,0.000024540133,0.98446447,0.00006193572,0.0005550363,0.00014963852],"about_ca_topic_score_codex":0.002995299,"about_ca_topic_score_gemma":0.00023662669,"teacher_disagreement_score":0.013693056,"about_ca_system_score_codex":0.000096690266,"about_ca_system_score_gemma":0.00027880885,"threshold_uncertainty_score":0.61633176},"labels":[],"label_agreement":null},{"id":"W1979378213","doi":"10.1158/0008-5472.sabcs13-pd5-7","title":"Abstract PD5-7: Phase Ib study of LCL161, an oral antagonist of inhibitor of apoptosis proteins, in combination with weekly paclitaxel in patients with advanced solid tumors: Safety and efficacy results, including breast cancer cohort","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Pharmacokinetics; Paclitaxel; Ovarian cancer; Pharmacology; Pharmacodynamics; Cancer; Internal medicine; Adverse effect; Chemotherapy; Breast cancer; Combination therapy; Tolerability; Oncology; Inhibitor of apoptosis; Gastroenterology; Apoptosis","score_opus":0.02146484204743586,"score_gpt":0.34809153100826146,"score_spread":0.3266266889608256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979378213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975501,0.00009443827,0.000011621014,0.00005248055,0.00001570074,0.0021159088,0.00013962571,0.0000023498426,0.000017790619],"genre_scores_gemma":[0.99935967,0.00015848422,0.00009270454,0.0000020987547,0.000020416028,0.00019561338,0.00013507472,0.000019683688,0.00001627088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983966,0.00012210509,0.00045526834,0.000363668,0.0004270706,0.00023531994],"domain_scores_gemma":[0.9988582,0.000017583761,0.00022927499,0.00025381093,0.00057248975,0.000068632784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005205937,0.00012979555,0.00029560216,0.00017141904,0.000057635716,0.0000132559735,0.000113042275,0.000078592384,0.000009753193],"category_scores_gemma":[0.000029334866,0.00009991058,0.000015141341,0.0003212014,0.00015866464,0.000033229513,0.0000807116,0.0001464335,7.8059784e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011056096,0.0037681372,0.21938907,0.000213025,0.000061579485,0.0000010123588,0.00063950237,0.0007613439,0.73996377,0.000008922296,0.000009169504,0.024128392],"study_design_scores_gemma":[0.01367783,0.0042955047,0.76788944,0.00037102372,0.000008455606,2.84049e-7,0.00067574886,0.000078262325,0.21287271,0.0000061360906,0.000007359172,0.00011725207],"about_ca_topic_score_codex":0.005896802,"about_ca_topic_score_gemma":0.0020174829,"teacher_disagreement_score":0.54850036,"about_ca_system_score_codex":0.00008312077,"about_ca_system_score_gemma":0.00017221157,"threshold_uncertainty_score":0.891424},"labels":[],"label_agreement":null},{"id":"W1979444473","doi":"10.1158/1538-7445.am2012-3687","title":"Abstract 3687: An integrative genomics approach identifies distinct molecular and epigenetic subgroups of pediatric glioblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenetics; Biology; Transcriptome; Methylation; DNA methylation; Genomics; Genetics; Gene; Genome; Computational biology; Cancer research; Gene expression","score_opus":0.05168068183011822,"score_gpt":0.37422014286644567,"score_spread":0.32253946103632747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979444473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98382795,0.014871157,0.00003370023,0.00007395726,0.00005288775,0.00051216193,0.000032477146,0.000012181135,0.0005835493],"genre_scores_gemma":[0.9979854,0.0012531013,0.00020023473,0.000008990172,0.0002484942,0.00021303869,0.000023228373,0.00002740384,0.000040068207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853706,0.00009241713,0.00021182012,0.00027050587,0.00043839717,0.00044978238],"domain_scores_gemma":[0.99898624,0.000106946776,0.000058419126,0.0003027024,0.00022253122,0.00032317537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005299603,0.0001410692,0.00026679874,0.00027087095,0.000086978274,0.00003149364,0.00010372104,0.0000731345,0.00009671154],"category_scores_gemma":[0.000087789056,0.0001055914,0.00005965459,0.0003603509,0.00020801683,0.00010435026,0.0000834468,0.0002411049,0.000010652146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067667227,0.0028498431,0.6477791,0.0009379967,0.00038140875,0.00012641311,0.005249121,0.00002311683,0.32445112,0.0008272807,0.00095129356,0.015746629],"study_design_scores_gemma":[0.0011170559,0.00055574544,0.6543741,0.00004977543,0.00015179043,0.000020172987,0.0013106538,0.000042234842,0.34189644,0.00015222255,0.00018247428,0.00014730169],"about_ca_topic_score_codex":0.000504552,"about_ca_topic_score_gemma":0.000068522415,"teacher_disagreement_score":0.017445333,"about_ca_system_score_codex":0.00017209863,"about_ca_system_score_gemma":0.00013197873,"threshold_uncertainty_score":0.43058926},"labels":[],"label_agreement":null},{"id":"W1979650794","doi":"10.1158/1538-7445.am2012-4169","title":"Abstract 4169: The Wnt/β-catenin pathway is involved in KRAS-induced intestinal epithelial cell transformation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Wnt signaling pathway; AXIN2; KRAS; Catenin; Cancer research; TCF4; Beta-catenin; Signal transduction; MAPK/ERK pathway; Biology; Carcinogenesis; Cell biology; Colorectal cancer; Cancer; Genetics; Gene expression; Gene; Promoter","score_opus":0.08378714088668651,"score_gpt":0.3836189901578749,"score_spread":0.29983184927118833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979650794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409866,0.0019879956,0.000017279162,0.00080100965,0.00010248378,0.0005328961,0.000063259446,0.0000073425576,0.0023890983],"genre_scores_gemma":[0.9979336,0.00072945695,0.000012286877,0.00010064182,0.00040022194,0.00042805873,0.000067528854,0.000024454686,0.0003036955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806386,0.00016212549,0.0002076707,0.0002675852,0.00048779076,0.0008109369],"domain_scores_gemma":[0.99928683,0.000045933724,0.00003727408,0.00026549175,0.00016325069,0.00020121656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009744515,0.00014488855,0.00011702079,0.00011358281,0.00017095004,0.000055083026,0.0003394613,0.00011778166,0.00020777543],"category_scores_gemma":[0.00006233427,0.0001044412,0.000075025404,0.00029757145,0.00013837796,0.000023140125,0.000098449265,0.0004530838,0.00011095166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025760187,0.00016995259,0.005074675,0.0000456714,0.000025730998,0.000004368642,0.0008332465,0.0000044925173,0.9778551,0.000030325693,0.0010413696,0.014657456],"study_design_scores_gemma":[0.001064899,0.00019602128,0.010645131,0.00003275538,0.000003457935,0.000002568958,0.0003492108,0.000009926707,0.97770566,0.00007859535,0.009789125,0.00012263664],"about_ca_topic_score_codex":0.0037402455,"about_ca_topic_score_gemma":0.0020650541,"teacher_disagreement_score":0.01453482,"about_ca_system_score_codex":0.00017819316,"about_ca_system_score_gemma":0.00043126184,"threshold_uncertainty_score":0.56541574},"labels":[],"label_agreement":null},{"id":"W1979822673","doi":"10.1158/1538-7445.am10-3171","title":"Abstract 3171: Expression of PKC iota in breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Breast cancer; Carcinogenesis; Cancer research; Immunohistochemistry; Breast carcinoma; Myoepithelial cell; Protein kinase C; Tissue microarray; PKC alpha; Cancer; Pathology; Biology; Medicine; Signal transduction; Molecular biology; Internal medicine; Cell biology","score_opus":0.053687829767682854,"score_gpt":0.4131921709810286,"score_spread":0.35950434121334574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979822673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116886,0.001606615,0.0000032155444,0.0020825397,0.00042310212,0.0005419857,0.00010335149,0.000020405965,0.004049904],"genre_scores_gemma":[0.99777853,0.00089275953,0.00007506397,0.00007131342,0.00037431653,0.0002498295,0.0000074671466,0.000048139376,0.0005025998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775916,0.000057121313,0.00031594106,0.0004051496,0.0008954355,0.00056717976],"domain_scores_gemma":[0.99853605,0.00008522739,0.00006984856,0.0006149203,0.00044374683,0.00025022734],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070834236,0.00014010494,0.00030492048,0.00040874365,0.000059112044,0.000015338046,0.00024502512,0.00023970888,0.0046165204],"category_scores_gemma":[0.0001196844,0.00012266485,0.000082289866,0.00072026154,0.00028096134,0.000055423294,0.00012495395,0.0017346326,0.00004294402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005157433,0.0001438527,0.0138001265,0.00022121271,0.000017898145,0.000074782256,0.00026306964,0.000033561817,0.9660766,0.00004682662,0.0064411247,0.012365203],"study_design_scores_gemma":[0.0021656756,0.0000665356,0.26013023,0.0012662911,0.000012875141,0.000031790853,0.00011513679,0.000043668566,0.72573805,0.00007264442,0.010205284,0.0001518016],"about_ca_topic_score_codex":0.0063256607,"about_ca_topic_score_gemma":0.0028660595,"teacher_disagreement_score":0.24633011,"about_ca_system_score_codex":0.00034356923,"about_ca_system_score_gemma":0.0012924529,"threshold_uncertainty_score":0.99629337},"labels":[],"label_agreement":null},{"id":"W1979836319","doi":"10.1158/0008-5472.sabcs-09-5111","title":"A Phase 1 Study To Assess the Safety, Tolerability and Pharmacokinetics of ARRY-380 – An Oral Inhibitor of HER2.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Dosing; Nausea; Rash; Adverse effect; Pharmacology; Internal medicine; Cancer; Toxicity; Pharmacodynamics; Breast cancer; Oncology; Gastroenterology","score_opus":0.2830463335743338,"score_gpt":0.5830860017591729,"score_spread":0.3000396681848391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979836319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013567,0.00064897106,0.000031696538,0.0054391907,0.000102301274,0.0028568306,0.000082366685,0.000019222403,0.00068375573],"genre_scores_gemma":[0.99854684,0.00027774496,0.00015720644,0.00020854775,0.00031203145,0.00014538187,0.000004661842,0.00002764085,0.00031995383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99548656,0.00090225774,0.00057013956,0.0005227299,0.0018901413,0.0006281445],"domain_scores_gemma":[0.9968158,0.00035436882,0.00006816433,0.00092599535,0.0013341759,0.0005014706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051289783,0.00017037507,0.0005543246,0.00027597402,0.00013985868,0.000039359726,0.000477148,0.00006503572,0.00047740914],"category_scores_gemma":[0.00058954145,0.00012059997,0.00005892571,0.0012436629,0.0005182666,0.000094540716,0.00024066263,0.00085008185,0.0000047553826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01231369,0.014240807,0.06580758,0.00082244567,0.00021487786,0.000108910055,0.011625861,0.00008075566,0.54097825,0.00014258055,0.010320551,0.34334368],"study_design_scores_gemma":[0.028335424,0.06630943,0.21099976,0.0009897781,0.00022487191,0.000034426605,0.011994822,0.0011254146,0.64078605,0.0006222609,0.037950505,0.0006272446],"about_ca_topic_score_codex":0.0012960857,"about_ca_topic_score_gemma":0.00031668862,"teacher_disagreement_score":0.34271643,"about_ca_system_score_codex":0.0003155133,"about_ca_system_score_gemma":0.0010421129,"threshold_uncertainty_score":0.5227295},"labels":[],"label_agreement":null},{"id":"W1979976889","doi":"10.1158/0008-5472.can-12-4063","title":"MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; University of Pennsylvania","keywords":"Mutant; Biology; Carcinogenesis; Gene; Regulator; Cancer research; Allele; Cancer; Suppressor; Mutation; Phosphorylation; Genetics","score_opus":0.06663645336999723,"score_gpt":0.34853727609687896,"score_spread":0.2819008227268817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979976889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933382,0.0011992209,0.0005061867,0.00069123093,0.00008198661,0.00052699615,0.000034313915,0.000016318185,0.003605502],"genre_scores_gemma":[0.99272555,0.0004780985,0.000096622614,0.000059234968,0.0002593434,0.00050396955,0.000035471443,0.000025307405,0.0058163735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879766,0.00007650832,0.0001013219,0.0003341792,0.00028821104,0.00040212277],"domain_scores_gemma":[0.99923444,0.00002967452,0.000028144654,0.0003560172,0.00022210032,0.00012959709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032520844,0.00010392726,0.000093283066,0.000054336,0.00028602692,0.00003820965,0.00019542698,0.00014845414,0.00050008955],"category_scores_gemma":[0.000062303356,0.000098658966,0.000059647104,0.00013677884,0.0001679675,0.000013240814,0.00012146478,0.00019567079,0.000063208274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070053284,0.00003387237,0.00041262564,0.000035644483,0.000018274219,4.929984e-7,0.00009824048,0.000013741894,0.98478734,0.00015842878,0.008068509,0.0063028],"study_design_scores_gemma":[0.00029351376,0.0000820329,0.0031857297,0.0000235503,0.0000029837718,0.0000037401946,0.000042201053,0.00003112584,0.9287785,0.00013167552,0.067306414,0.000118486554],"about_ca_topic_score_codex":0.00047089907,"about_ca_topic_score_gemma":0.00018444807,"teacher_disagreement_score":0.059237905,"about_ca_system_score_codex":0.000090397116,"about_ca_system_score_gemma":0.00017322335,"threshold_uncertainty_score":0.54756296},"labels":[],"label_agreement":null},{"id":"W1980010790","doi":"10.1158/1538-7445.am2011-2045","title":"Abstract 2045: Intriguing role of estrogen-related receptor alpha (ERRα) in colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer research; Gene silencing; Colorectal cancer; Small hairpin RNA; Carcinogenesis; Gene knockdown; Estrogen receptor; Cancer; Prostate cancer; Estrogen-related receptor alpha; Nuclear receptor; Chemistry; Biology; Breast cancer; Internal medicine; Medicine; Apoptosis; Transcription factor; Genetics; Gene","score_opus":0.029378957325630565,"score_gpt":0.3396917609887076,"score_spread":0.31031280366307706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980010790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709204,0.02481951,7.581172e-7,0.000038496077,0.00020449149,0.000349339,0.000028616378,0.000010878705,0.0036275454],"genre_scores_gemma":[0.99550617,0.003818255,0.00006194853,0.00000959164,0.00013867643,0.00018391809,0.000031041385,0.00003615869,0.00021426374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983499,0.00014107203,0.00029924215,0.0003905163,0.00027452505,0.00054471655],"domain_scores_gemma":[0.99932367,0.000027620024,0.00008238758,0.00022387481,0.00019966289,0.000142779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000593228,0.00015244362,0.00020224624,0.00016592826,0.00007028787,0.00001047777,0.0003221409,0.00035832272,0.0006127336],"category_scores_gemma":[0.00008413374,0.00013958712,0.000089836816,0.00040445602,0.00024675566,0.000008021314,0.00014709552,0.00054465525,0.00003553584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050535076,0.00011691883,0.01516782,0.00003153058,0.00011600711,0.000010146729,0.00042639446,0.000032863514,0.9746601,0.00021549326,0.0009158003,0.007801562],"study_design_scores_gemma":[0.00072594977,0.00029985115,0.009703718,0.0001015758,0.000008530293,0.000003263128,0.00020303892,0.000023770495,0.98565614,0.00009220986,0.0030254624,0.00015650754],"about_ca_topic_score_codex":0.002577137,"about_ca_topic_score_gemma":0.0002337861,"teacher_disagreement_score":0.024585782,"about_ca_system_score_codex":0.00009789482,"about_ca_system_score_gemma":0.00040673677,"threshold_uncertainty_score":0.6709003},"labels":[],"label_agreement":null},{"id":"W1980044847","doi":"10.1158/1538-7445.am2014-3432","title":"Abstract 3432: A genome-wide shRNA screen for suppressors of prostate cancer cell invasion","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Matrigel; Intravasation; Biology; Small hairpin RNA; Cancer research; Prostate cancer; RNA interference; Transcriptome; Metastasis; Cell biology; Cell culture; Cancer; Gene; Genetics; Gene expression; Angiogenesis; Gene knockdown; RNA","score_opus":0.039442328314146013,"score_gpt":0.37491382387091343,"score_spread":0.3354714955567674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980044847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917474,0.0022205724,0.0023283842,0.0005588295,0.00003130743,0.0009990117,0.00032886612,0.000013224845,0.0017723974],"genre_scores_gemma":[0.99317974,0.0030547644,0.00092593423,0.000156781,0.00014815244,0.001348724,0.00023818116,0.000031450243,0.0009162456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880946,0.00006595041,0.00019916537,0.0003946467,0.00016231084,0.0003684601],"domain_scores_gemma":[0.99899644,0.000043496664,0.00007930067,0.0004487348,0.00033809678,0.00009393053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005855028,0.000112263064,0.00014391908,0.000046224475,0.00012397069,0.000014342169,0.00036478814,0.00016228092,0.00010083596],"category_scores_gemma":[0.00007396661,0.00010086188,0.00008504394,0.0001006907,0.00018031396,0.000003412078,0.00017238545,0.0001337009,0.0000028513914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012177541,0.000045919078,0.0024783271,0.00008916368,0.000022008819,1.9480395e-7,0.000026180624,0.00004580294,0.9868421,0.000117013115,0.0071570063,0.0030544964],"study_design_scores_gemma":[0.00034059593,0.00021128879,0.003927199,0.000022747075,0.000006918045,2.9515618e-7,0.00001934528,0.00001959658,0.81595314,0.00025423212,0.17913663,0.000108034765],"about_ca_topic_score_codex":0.00093846547,"about_ca_topic_score_gemma":0.0003901965,"teacher_disagreement_score":0.17197962,"about_ca_system_score_codex":0.00003528432,"about_ca_system_score_gemma":0.0001617122,"threshold_uncertainty_score":0.4113028},"labels":[],"label_agreement":null},{"id":"W1980242979","doi":"10.1158/1538-7445.prca2012-c25","title":"Abstract C25: The 16p13.3 genomic gain in prostate cancer: A role for PDK1 in disease progression","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostate cancer; Prostate; Cancer; Cancer research; Fluorescence in situ hybridization; Metastasis; Lymph node; Primary tumor; Tumor progression; Medicine; Oncology; Biology; Internal medicine; Chromosome; Gene; Genetics","score_opus":0.0866243045279558,"score_gpt":0.4705110445223528,"score_spread":0.38388673999439704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980242979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311689,0.053069085,8.249869e-7,0.010433462,0.0001446098,0.004577846,0.00012458839,0.00002461791,0.00045603554],"genre_scores_gemma":[0.97812885,0.00849486,0.00003058343,0.00011335531,0.0005535129,0.010519909,0.00005383317,0.000058488196,0.0020466063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677116,0.00018062186,0.00031766013,0.00042843842,0.00076900475,0.0015331269],"domain_scores_gemma":[0.99852836,0.00027892904,0.00005288275,0.00042883906,0.00021389278,0.00049711374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022696417,0.00019656756,0.00029331452,0.00039860333,0.00021376417,0.00005759829,0.00026966725,0.00007929815,0.0002600929],"category_scores_gemma":[0.00017059728,0.00012146741,0.000090568035,0.0007519569,0.00031733594,0.0001995059,0.00015277886,0.0007975353,0.00003792264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007904763,0.0007623035,0.861132,0.0008315146,0.000062198655,0.00009871799,0.004929942,0.00007054713,0.032747302,0.00009407294,0.0024702847,0.08889636],"study_design_scores_gemma":[0.007374311,0.0002889558,0.92815715,0.0014071475,0.000030425877,0.0000034705274,0.0015288985,0.00043626345,0.013483152,0.0005287535,0.04649088,0.00027057214],"about_ca_topic_score_codex":0.0018764316,"about_ca_topic_score_gemma":0.0008525127,"teacher_disagreement_score":0.08862578,"about_ca_system_score_codex":0.0016908617,"about_ca_system_score_gemma":0.0015693499,"threshold_uncertainty_score":0.49532974},"labels":[],"label_agreement":null},{"id":"W1980291124","doi":"10.1158/0008-5472.sabcs13-p1-09-06","title":"Abstract P1-09-06: Breast cancer in the Pan-American region: Inequities in incidence and mortality rates according to the human development index","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human Development Index; Demography; Geography; Latin Americans; Incidence (geometry); Mortality rate; Life expectancy; Ecological study; Population; Medicine; Socioeconomics; Human development (humanity); Economic growth; Mathematics","score_opus":0.15909826396542168,"score_gpt":0.45314354411149754,"score_spread":0.2940452801460759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980291124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052779,0.00021070371,0.000002198136,0.09237917,0.00006420513,0.0006394563,0.0000024716817,0.000013645502,0.0014102572],"genre_scores_gemma":[0.98610574,0.00022031138,0.0000024952396,0.011876576,0.00066639355,0.001058953,0.0000030128692,0.0000116146275,0.000054884393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978274,0.00013753625,0.00042935484,0.00032142378,0.00039572222,0.0008885517],"domain_scores_gemma":[0.999049,0.00027845308,0.00012641923,0.00028263684,0.00022384603,0.00003966628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035643782,0.00014497172,0.00026545417,0.00027874645,0.00045292277,0.00036684846,0.0006374379,0.00005297897,0.000121883466],"category_scores_gemma":[0.0002761509,0.000087488464,0.000019628234,0.0012298318,0.00032201366,0.0005554093,0.0004956697,0.0005381095,0.000046941997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010389102,0.000018410674,0.9283186,0.00012522354,0.000008179704,0.0000053718654,0.0006596159,0.00022213008,0.000032987642,0.0015443173,0.050068785,0.018985942],"study_design_scores_gemma":[0.00014272418,0.0000052108658,0.94521827,0.00012143251,0.0000013230754,0.0000014062116,0.0068353526,0.00018591335,0.0000017895646,0.00055706524,0.046823014,0.000106487],"about_ca_topic_score_codex":0.6250469,"about_ca_topic_score_gemma":0.10446669,"teacher_disagreement_score":0.52058023,"about_ca_system_score_codex":0.0002827139,"about_ca_system_score_gemma":0.00022712561,"threshold_uncertainty_score":0.9118745},"labels":[],"label_agreement":null},{"id":"W1980420968","doi":"10.1158/1538-7445.am2011-4703","title":"Abstract 4703: Mitochondrial DNA mutations affect respiratory complex-I in never-smoker lung cancer patients and contribute to lung cancer cell growth","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mitochondrial DNA; Lung cancer; Cancer; Medicine; Lung; Internal medicine; Oncology; Somatic cell; Genotype; Mitochondrion; Pathology; Gastroenterology; Biology; Genetics; Gene","score_opus":0.057558360061321125,"score_gpt":0.3775026423836137,"score_spread":0.31994428232229255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980420968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989166,0.0074557653,0.00005891596,0.0002820776,0.0003637849,0.0011587641,0.00055163907,0.000011622872,0.00095141673],"genre_scores_gemma":[0.9944949,0.0018183591,0.00007080483,0.00047138322,0.00040310156,0.0021291699,0.00008495216,0.000047049292,0.00048025534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778914,0.00016736808,0.0003192141,0.0006764459,0.00039040713,0.00065742974],"domain_scores_gemma":[0.9986038,0.000039987633,0.00008628445,0.00036111023,0.0006331256,0.0002756444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033481652,0.00021635165,0.00022747759,0.00015327935,0.0002420283,0.00005940756,0.00033687727,0.00018454916,0.00058933545],"category_scores_gemma":[0.000079663085,0.00021284235,0.00006503819,0.00035682964,0.00017402497,0.000034797926,0.00017649886,0.0002874342,0.000006166752],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006015717,0.00023459822,0.15888436,0.0001853381,0.000104315746,0.000006209339,0.00068649,0.0000849607,0.78694457,0.00007712806,0.05035162,0.0018388538],"study_design_scores_gemma":[0.0034138039,0.00027132774,0.67287207,0.0001635364,0.000045718843,4.1825757e-7,0.00015478663,0.00009220786,0.2992561,0.000037145506,0.023134826,0.00055807515],"about_ca_topic_score_codex":0.010721131,"about_ca_topic_score_gemma":0.007240519,"teacher_disagreement_score":0.5139877,"about_ca_system_score_codex":0.0004264306,"about_ca_system_score_gemma":0.00059933384,"threshold_uncertainty_score":0.99586654},"labels":[],"label_agreement":null},{"id":"W1980445246","doi":"10.1158/0008-5472.can-05-0654","title":"Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell–Mediated Apoptosis, Uptake, and Cross-Presentation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Fas ligand; Dendritic cell; Cell biology; Antigen presentation; Apoptosis; Follicular dendritic cells; Cytotoxic T cell; Antigen-presenting cell; Chemistry; Biology; Cancer research; Programmed cell death; Antigen; Immunology; In vitro; Biochemistry","score_opus":0.03318863151359928,"score_gpt":0.3541431202604213,"score_spread":0.320954488746822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980445246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804277,0.017629173,0.000021403515,0.0006410732,0.00024158729,0.00050548883,0.00007445216,0.000061601495,0.00039755806],"genre_scores_gemma":[0.9837249,0.0020324702,0.0001042145,0.00051768974,0.00008293261,0.00016851982,0.000041869025,0.000037029815,0.013290386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977464,0.00058404275,0.00032068355,0.0004156235,0.00013399559,0.00079924386],"domain_scores_gemma":[0.9985718,0.0006733792,0.000049633974,0.0003328554,0.0003033773,0.00006892368],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007575708,0.00018671901,0.0002541521,0.0004455439,0.0005082128,0.00010827951,0.0002705734,0.00016345132,0.0009348403],"category_scores_gemma":[0.00020235647,0.00017646463,0.000058598453,0.0005535211,0.00041964778,0.00018346755,0.00014959094,0.0005530228,0.0016555678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009442635,0.00007742308,0.0003755292,0.000030129342,0.00006349417,0.000005334821,0.00048192963,0.000027578239,0.9829039,0.000020533911,0.0096305795,0.0054393043],"study_design_scores_gemma":[0.0013740688,0.000109808316,0.010386653,0.00003665262,0.000009949851,0.000019327537,0.000425563,0.000004956719,0.88156337,0.000012711149,0.10587684,0.00018011755],"about_ca_topic_score_codex":0.00058602274,"about_ca_topic_score_gemma":0.000042006675,"teacher_disagreement_score":0.10134055,"about_ca_system_score_codex":0.00015796954,"about_ca_system_score_gemma":0.00021091607,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W1980484972","doi":"10.1158/0008-5472.can-08-0174","title":"αvβ6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"New York Institute of Technology","funders":"Cancer Research UK","keywords":"Stromal cell; Myofibroblast; Cancer research; Biology; Transdifferentiation; GLI1; Paracrine signalling; Pathology; Stroma; Fibrosis; Hedgehog signaling pathway; Cell biology; Medicine; Immunology; Signal transduction; Stem cell; Immunohistochemistry; Receptor","score_opus":0.126895365547648,"score_gpt":0.36218116492221897,"score_spread":0.23528579937457098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980484972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963913,0.0020346958,0.00021767194,0.00028424512,0.00007455467,0.00030749053,0.000021895516,0.000005309485,0.0006628164],"genre_scores_gemma":[0.9985361,0.00034433327,0.00016836818,0.000033018063,0.0002460354,0.00008686584,0.000022258326,0.000019878256,0.0005431119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986709,0.0001979371,0.00017324639,0.00029073254,0.00036261088,0.00030462493],"domain_scores_gemma":[0.99915814,0.0000477782,0.000050151633,0.00036267168,0.00034198607,0.00003925045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041335615,0.00010526249,0.00012344022,0.000041580493,0.00024350107,0.000008760602,0.0002833076,0.00009344685,0.000030737705],"category_scores_gemma":[0.00014453405,0.000074576616,0.000060711576,0.00020246636,0.00039280637,0.0000051141096,0.00024373097,0.00023092778,0.000007755738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007609531,0.00004430446,0.01505735,0.000042868855,0.000016413493,0.000005258027,0.00087716914,0.00014295639,0.98064405,0.000020904808,0.002765971,0.0003066801],"study_design_scores_gemma":[0.0003034505,0.00027999785,0.022897953,0.0000188292,0.0000037365653,0.0000035170813,0.00033853162,0.000084603496,0.97450614,0.000076760225,0.0014041922,0.00008225879],"about_ca_topic_score_codex":0.00056191947,"about_ca_topic_score_gemma":0.000071328686,"teacher_disagreement_score":0.0078406045,"about_ca_system_score_codex":0.000043861248,"about_ca_system_score_gemma":0.00029654164,"threshold_uncertainty_score":0.3041146},"labels":[],"label_agreement":null},{"id":"W1980611460","doi":"10.1158/0008-5472.can-06-3892","title":"Characterization of Viral Particles Isolated from Primary Cultures of Human Breast Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"University of Oklahoma","keywords":"Retrovirus; Mouse mammary tumor virus; Provirus; Biology; Virus; Virology; Tumor Virus; Breast cancer; Cancer; Complementary DNA; RNA; Gene; Molecular biology; Genome; Genetics","score_opus":0.030065372932372245,"score_gpt":0.33871646154719665,"score_spread":0.3086510886148244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980611460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950094,0.0036178497,0.00001491144,0.00017356643,0.00024956904,0.00016599588,0.00049706374,0.000016156158,0.00025546967],"genre_scores_gemma":[0.99738747,0.0010812436,0.00000406194,0.000034526183,0.000084507614,0.000020306496,0.00008597828,0.0000109663415,0.0012909523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989626,0.00012542949,0.0002754685,0.00019434452,0.000087796034,0.00035440567],"domain_scores_gemma":[0.9993632,0.000065647764,0.00010898273,0.0001538662,0.00028728414,0.000021030786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029559204,0.00009310735,0.00024578423,0.00009765241,0.00017706431,0.000005164618,0.00017556205,0.0001463538,0.00077456003],"category_scores_gemma":[0.0000065950203,0.000070122835,0.00005088852,0.00019837501,0.0005393603,0.000055683602,0.00011285359,0.00025923568,0.000023622319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045882488,0.00010947258,0.01423632,0.00005386527,0.00017537491,0.0000014104905,0.0012530553,8.2293525e-7,0.9782066,0.00006461229,0.0009345166,0.0045051235],"study_design_scores_gemma":[0.00047223744,0.000082267805,0.15665449,0.00006624217,0.000016290482,5.420509e-7,0.0001951943,3.0544282e-7,0.84111893,0.000039982962,0.0012885024,0.0000649874],"about_ca_topic_score_codex":0.0059130527,"about_ca_topic_score_gemma":0.0005893273,"teacher_disagreement_score":0.14241818,"about_ca_system_score_codex":0.00007359862,"about_ca_system_score_gemma":0.000076224394,"threshold_uncertainty_score":0.89388067},"labels":[],"label_agreement":null},{"id":"W1980766188","doi":"10.1158/0008-5472.sabcs-09-6093","title":"First-Line Bevacizumab (Bev) Combination Therapy in Triple-Negative (TN) Locally Recurrent/Metastatic Breast Cancer (LR/MBC): Subpopulation Analysis of Study MO19391 in &amp;gt;2000 Patients (Pts).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Capecitabine; Population; Oncology; Regimen; Combination therapy; Clinical endpoint; Metastatic breast cancer; Anthracycline; Cancer; Gastroenterology; Breast cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","score_opus":0.11227216648163586,"score_gpt":0.47499098614583407,"score_spread":0.3627188196641982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980766188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343675,0.0013787234,0.00001215987,0.0016216945,0.00016029601,0.0030510311,0.00022021351,0.000017406248,0.00010174643],"genre_scores_gemma":[0.9956977,0.0026170237,0.000019840607,0.00009363786,0.000064675754,0.00070510345,0.0003198021,0.000023290233,0.00045893856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652666,0.00060402986,0.0007424219,0.00056520535,0.0010187286,0.0005429838],"domain_scores_gemma":[0.99818945,0.00026489823,0.00021036394,0.00033354393,0.0008530089,0.00014874812],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086870184,0.00025324922,0.0008122452,0.0019836684,0.00009746225,0.000021441594,0.0001874524,0.00009473456,0.0014514183],"category_scores_gemma":[0.000097073156,0.0002238037,0.00013511426,0.004946858,0.0001186298,0.00018376714,0.000035220586,0.0005180632,0.0000073594415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011515395,0.01047522,0.80678827,0.000073255855,0.00086845807,0.000025281077,0.0068564313,0.002674716,0.00069728,0.000013532094,0.00031626585,0.1596959],"study_design_scores_gemma":[0.025692737,0.0034017107,0.9666016,0.00020257325,0.00039190263,7.147371e-7,0.00020871563,0.0025115001,0.00050693506,0.00018631054,0.00011549342,0.00017982561],"about_ca_topic_score_codex":0.016403617,"about_ca_topic_score_gemma":0.077940956,"teacher_disagreement_score":0.1598133,"about_ca_system_score_codex":0.0025414843,"about_ca_system_score_gemma":0.00055764295,"threshold_uncertainty_score":0.9994614},"labels":[],"label_agreement":null},{"id":"W1980935574","doi":"10.1158/1538-7445.am10-lb-147","title":"Abstract LB-147: Characterization of a Kaiso overexpressing transgenic mouse model","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University","funders":"","keywords":"Wnt signaling pathway; Cell biology; Transcription factor; Biology; Carcinogenesis; Cancer research; Signal transduction; Cancer; Genetics; Gene","score_opus":0.0393748461935639,"score_gpt":0.3621684647604401,"score_spread":0.3227936185668762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980935574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997838,0.00013396298,0.0010674456,0.00014476874,0.00011917094,0.00024318832,0.00009571542,0.000010372265,0.00034736027],"genre_scores_gemma":[0.99775517,0.0003462497,0.0001382925,0.0000148818535,0.0003181893,0.0000632813,0.00015767447,0.00003373867,0.0011725411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886185,0.000035734112,0.0002020897,0.00030344655,0.00031629571,0.00028061334],"domain_scores_gemma":[0.9991726,0.0000089043615,0.000071986855,0.0003830458,0.00028267936,0.00008077221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031840694,0.00009955876,0.00010998393,0.00009646529,0.00009005734,0.000026617947,0.00019603517,0.00022577205,0.00012043596],"category_scores_gemma":[0.000037849237,0.00010370271,0.00006768324,0.00015464524,0.0001449633,0.0000116106385,0.000051837524,0.0003088373,0.0000045690545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014310102,0.000033815028,0.00013204307,0.000047668953,0.000023473694,9.76407e-8,0.00008833837,0.0015148866,0.992512,0.000033986184,0.00018237086,0.005288259],"study_design_scores_gemma":[0.00036938023,0.000040146202,0.002949262,0.000026552361,0.0000055405512,5.768823e-7,0.00000824861,0.0015995513,0.9926323,0.000045609115,0.0022156597,0.0001071216],"about_ca_topic_score_codex":0.000088310175,"about_ca_topic_score_gemma":0.00016232983,"teacher_disagreement_score":0.0051811375,"about_ca_system_score_codex":0.00003548329,"about_ca_system_score_gemma":0.00037283587,"threshold_uncertainty_score":0.42288738},"labels":[],"label_agreement":null},{"id":"W1980950441","doi":"10.1158/1538-7445.am2012-1686","title":"Abstract 1686: Identification of potential prostate cancer biomarkers associated with TMPRSS2-ERG fusion and PTEN deletions","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"TMPRSS2; PTEN; DU145; Fusion gene; Biology; Prostate cancer; Erg; Cancer research; Gene knockdown; Molecular biology; Gene; LNCaP; Cancer; Genetics; Medicine; Pathology; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.05890981685796283,"score_gpt":0.4041013279733595,"score_spread":0.3451915111153967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980950441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865362,0.009115632,0.000012059157,0.002416358,0.0001240144,0.0010994293,0.00018683035,0.000033319673,0.0004761584],"genre_scores_gemma":[0.9891265,0.0070906715,0.000021894875,0.000017032286,0.00015666166,0.0004995821,0.00013809103,0.00003726994,0.002912302],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975196,0.00011968431,0.00030227916,0.00032443047,0.0010045846,0.0007293883],"domain_scores_gemma":[0.99828833,0.00009573489,0.0001228677,0.00027319725,0.00088063104,0.0003392411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012174328,0.00015121172,0.00025659363,0.00036090193,0.00028439352,0.00004326638,0.00010829665,0.000117700445,0.00038610504],"category_scores_gemma":[0.00011235568,0.000108474866,0.000052481693,0.0007751917,0.0005307703,0.0002468704,0.0000851663,0.00038826477,0.000012090303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028980214,0.0006342559,0.23673199,0.0005073224,0.00080609834,0.00003562014,0.0013939578,0.000024305753,0.7188305,0.00005040515,0.0040995027,0.03398799],"study_design_scores_gemma":[0.003686764,0.00030113617,0.8994919,0.0006911061,0.00015318964,0.0000096502745,0.00071317435,0.00018224907,0.09323352,0.000042885476,0.0013037636,0.0001906728],"about_ca_topic_score_codex":0.0016092976,"about_ca_topic_score_gemma":0.00020148471,"teacher_disagreement_score":0.6627599,"about_ca_system_score_codex":0.0005239821,"about_ca_system_score_gemma":0.0006732877,"threshold_uncertainty_score":0.44234765},"labels":[],"label_agreement":null},{"id":"W1980958122","doi":"10.1158/1538-7445.am2012-2628","title":"Abstract 2628: Genome-wide sequencing identifies <i>ATM</i> as a pancreatic cancer susceptibility gene","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"PALB2; Pancreatic cancer; STK11; CDKN2A; CHEK2; Genetics; Cancer; Exome; Exome sequencing; Germline mutation; Breast cancer; Mutation; Biology; Medicine; Cancer research; Gene; KRAS","score_opus":0.05747547485180766,"score_gpt":0.37094790569368824,"score_spread":0.3134724308418806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980958122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692485,0.026813595,0.00005166822,0.00032199378,0.0004918577,0.00047050708,0.0001929598,0.000018212977,0.0023907209],"genre_scores_gemma":[0.98236847,0.013038389,0.00009233457,0.00044155485,0.0017595307,0.00043662646,0.00010835667,0.00006127325,0.0016934585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973935,0.00011333956,0.0003296722,0.00058416993,0.00048198705,0.0010973385],"domain_scores_gemma":[0.9982119,0.0001408887,0.00008827725,0.00075752556,0.00040526217,0.0003960995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011975586,0.00023591382,0.00025404073,0.000098043245,0.00030151903,0.00011637409,0.0004270697,0.0001942867,0.0007603365],"category_scores_gemma":[0.00049815216,0.0002348666,0.00013231927,0.00026293646,0.00029200324,0.00001919468,0.00035459036,0.00035831024,0.00013353303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000127845,0.00006098962,0.049780916,0.00011247941,0.00010132963,0.000007567528,0.0003091695,0.00018214865,0.94245094,0.00003721598,0.005610231,0.0012191961],"study_design_scores_gemma":[0.0005806343,0.00013180966,0.05337344,0.000065715416,0.000043163152,0.0000075453368,0.000457832,0.0000062778863,0.85969275,0.00028763534,0.08489682,0.00045635906],"about_ca_topic_score_codex":0.0061903507,"about_ca_topic_score_gemma":0.0025311352,"teacher_disagreement_score":0.08275814,"about_ca_system_score_codex":0.00059592916,"about_ca_system_score_gemma":0.0011128795,"threshold_uncertainty_score":0.95775825},"labels":[],"label_agreement":null},{"id":"W1981113808","doi":"10.1158/1538-7445.am2012-5648","title":"Abstract 5648: Low MEOX2 expression is a feature of stem-like Rat BTUC glioma cell line and contributes to its profound resistance to oncolytic herpes virus infection","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Glioma; Biology; Cancer research; Cell culture; Lytic cycle; Stem cell; Neurosphere; U87; Cancer stem cell; BMI1; Neural stem cell; Nestin; Virology; Virus; Cellular differentiation; Adult stem cell; Cell biology; Gene; Tumor cells; Genetics","score_opus":0.0436538154239017,"score_gpt":0.36914373557191715,"score_spread":0.3254899201480155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981113808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95833856,0.03854998,0.000027252348,0.001039829,0.00067676575,0.0009015251,0.00008709044,0.000025772193,0.00035325086],"genre_scores_gemma":[0.9687826,0.0008138129,0.000014249252,0.00019932368,0.00007037332,0.00022267386,0.000009353313,0.000024347668,0.029863257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982124,0.0003822267,0.0002727292,0.00032614227,0.00012684213,0.00067964307],"domain_scores_gemma":[0.9986867,0.00034596684,0.00008114642,0.00031336062,0.00047726423,0.00009557165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008675384,0.00018601044,0.00034216145,0.0003650436,0.00025426527,0.000040551382,0.00020480585,0.00029916593,0.0004530421],"category_scores_gemma":[0.00014811038,0.00015187575,0.000057904635,0.00045626523,0.00015666161,0.00018056644,0.00021275974,0.0004590956,0.00028259118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004707622,0.00018880209,0.0004110201,0.00025878852,0.00005248031,0.0000029672483,0.0011105648,0.0000016865208,0.9239428,0.000019515393,0.0669807,0.0023230694],"study_design_scores_gemma":[0.00085439335,0.00030727583,0.0056989314,0.00052821974,0.0000104176315,0.0000044736016,0.00022522193,2.3969403e-7,0.82128507,0.0000048780785,0.17095439,0.00012651063],"about_ca_topic_score_codex":0.00030457048,"about_ca_topic_score_gemma":0.00031052608,"teacher_disagreement_score":0.103973694,"about_ca_system_score_codex":0.00023759155,"about_ca_system_score_gemma":0.00018947053,"threshold_uncertainty_score":0.6193313},"labels":[],"label_agreement":null},{"id":"W1981146909","doi":"10.1158/1538-7445.cansusc14-ia12","title":"Abstract IA12: Regulation of the RNF168-dependent response to DNA double-strand breaks","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"DNA damage; Chromatin; Ubiquitin; DNA repair; DNA; Ataxia-telangiectasia; Cancer; Cell biology; Biology; Cancer research; Genetics; Gene","score_opus":0.036410821587293515,"score_gpt":0.35739816099129246,"score_spread":0.32098733940399893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981146909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996228,0.000099515055,0.00017055924,0.001040058,0.00015188947,0.00040385558,0.000016785045,0.0000076189685,0.001881751],"genre_scores_gemma":[0.9961136,0.00001897432,0.00006714788,0.00007094403,0.00017725413,0.00008156907,0.0000062153244,0.000021350737,0.003442929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847263,0.0002382228,0.00017129426,0.00031460883,0.0005080623,0.0002951613],"domain_scores_gemma":[0.99886936,0.00004643394,0.00004678874,0.00067990826,0.0002530739,0.000104452905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019332547,0.00008914687,0.00010012739,0.00006534363,0.00010204499,0.000029633693,0.00040154072,0.0001232912,0.00013732056],"category_scores_gemma":[0.00019202985,0.000068599715,0.00006822468,0.00017308937,0.00009495675,0.0000042841157,0.00020431538,0.00015407607,0.000019741856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021631075,0.000023744213,0.00014092233,0.000021911765,0.000016225982,4.1216873e-7,0.0000674223,0.0002141395,0.9926932,0.00015147973,0.0016322106,0.0028752424],"study_design_scores_gemma":[0.00068390823,0.00017131018,0.018706098,0.00003598329,0.0000036959113,0.000002179695,0.000039699597,0.000011472981,0.96150094,0.00018707344,0.018578952,0.00007869214],"about_ca_topic_score_codex":0.00019723168,"about_ca_topic_score_gemma":0.00022296654,"teacher_disagreement_score":0.031192249,"about_ca_system_score_codex":0.000054065033,"about_ca_system_score_gemma":0.00020403735,"threshold_uncertainty_score":0.2797415},"labels":[],"label_agreement":null},{"id":"W1981336987","doi":"10.1158/0008-5472.sabcs-09-3083","title":"Wait Times and Diagnostic Pathways among Women with Invasive Breast Cancer in a Population-Based Publicly Funded Cancer Centre, British Columbia, Canada.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cancer; Mammography; Population; Medical record; Oncology; Internal medicine","score_opus":0.04425919618940727,"score_gpt":0.3183247069974123,"score_spread":0.274065510808005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981336987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909225,0.002866778,9.623697e-7,0.0042065075,0.00006727645,0.00094578264,0.00057075446,0.000036069276,0.0003833351],"genre_scores_gemma":[0.99543256,0.0010142606,0.000014820255,0.0015112893,0.00021721551,0.0006713364,0.0000402863,0.000033751567,0.0010644974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642366,0.00013263058,0.0003240559,0.0006688377,0.0012649718,0.0011858683],"domain_scores_gemma":[0.9979013,0.00034475606,0.00009177138,0.0002976522,0.000719097,0.00064541993],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044363335,0.00018899076,0.00045918,0.00015801427,0.00027648374,0.00035626575,0.00021152206,0.000117551885,0.0025068382],"category_scores_gemma":[0.00034306123,0.00022625066,0.000027153907,0.0011677864,0.00018323465,0.0002934135,0.000051868683,0.0006050634,0.0000014155394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033884248,0.000054253087,0.96437436,0.00012167055,0.000045042863,0.00053851993,0.00023493431,0.00023655532,0.00009663866,0.000009712249,0.0106759295,0.023273556],"study_design_scores_gemma":[0.0021661357,0.00018988083,0.993571,0.002199634,0.000023878736,0.000028722374,0.0007846509,0.00017743613,0.00007059208,0.00009686023,0.0004257658,0.0002654455],"about_ca_topic_score_codex":0.9963458,"about_ca_topic_score_gemma":0.9994742,"teacher_disagreement_score":0.029196654,"about_ca_system_score_codex":0.004079417,"about_ca_system_score_gemma":0.006329049,"threshold_uncertainty_score":0.99974376},"labels":[],"label_agreement":null},{"id":"W1981429430","doi":"10.1158/1538-7445.tim2013-b12","title":"Abstract B12: The role of stromal cells in supporting tumor-initiating cells in serous ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"CD90; Stromal cell; Vimentin; Tumor microenvironment; Mesenchymal stem cell; Cancer research; Serous fluid; Immunostaining; Biology; Population; Pathology; CD44; Cell; Medicine; Immunohistochemistry","score_opus":0.054761627964146194,"score_gpt":0.36564278832427644,"score_spread":0.31088116036013025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981429430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990715,0.0009711286,0.0000011781333,0.0004986456,0.000106202366,0.0009393563,0.000039752576,0.000009977386,0.0075265863],"genre_scores_gemma":[0.9989269,0.00010822452,0.00015311434,0.000098164666,0.00021549454,0.00022642998,0.000005557045,0.00003652358,0.00022962519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738353,0.00015823751,0.000581883,0.00035487761,0.00066983356,0.0008516501],"domain_scores_gemma":[0.99874306,0.00028318423,0.00014165137,0.00041468817,0.00024578674,0.00017164068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016486458,0.00014969232,0.00037852788,0.0003056019,0.00007720966,0.000045303357,0.0002607258,0.00007051195,0.001956187],"category_scores_gemma":[0.000094870775,0.000115049086,0.000084358304,0.00068722863,0.00015261874,0.00012193898,0.00013530029,0.0009074196,0.000055483335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013566368,0.00013870174,0.09441078,0.0003109315,0.000021280583,0.00014124929,0.0020363664,0.00010601134,0.8728533,0.000041778738,0.00053388264,0.029270079],"study_design_scores_gemma":[0.001645394,0.00018163808,0.25628033,0.00035647576,0.000015623807,0.0000103005195,0.0076932083,0.00032087095,0.7312942,0.00017899228,0.0018660221,0.00015691452],"about_ca_topic_score_codex":0.061055254,"about_ca_topic_score_gemma":0.002722988,"teacher_disagreement_score":0.16186957,"about_ca_system_score_codex":0.00034797977,"about_ca_system_score_gemma":0.00075546105,"threshold_uncertainty_score":0.99895614},"labels":[],"label_agreement":null},{"id":"W1981623348","doi":"10.1158/1538-7445.am2011-4217","title":"Abstract 4217: The anti-malarial compound artesunate induces reactive oxygen species-dependent killing of breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Malaria Research and Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Artesunate; Artemisinin; Propidium iodide; Pharmacology; Cytotoxic T cell; Cancer cell; Apoptosis; Biology; Programmed cell death; Immunology; Cancer; Biochemistry; Plasmodium falciparum; In vitro","score_opus":0.11288074150771643,"score_gpt":0.371021819993445,"score_spread":0.2581410784857286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981623348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403634,0.0013229122,0.000015634094,0.0052353158,0.00042598747,0.0013128417,0.00030628502,0.000026802982,0.017317897],"genre_scores_gemma":[0.9950699,0.0017952023,0.00002082721,0.00009235534,0.0010503837,0.00024416673,0.000009998527,0.00004035295,0.0016767682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996208,0.00026865525,0.00040514415,0.00047973223,0.0016904089,0.00094804866],"domain_scores_gemma":[0.9973589,0.00034940487,0.0001431332,0.0006247855,0.0011650318,0.00035870343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019975696,0.00021031877,0.00047094372,0.00027109968,0.00030808116,0.00006875727,0.0005904986,0.00015512411,0.006161733],"category_scores_gemma":[0.00010923376,0.00013807684,0.00014980124,0.0004959715,0.00060340407,0.00016827996,0.00020095479,0.001457824,0.00006990836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032785663,0.00035909918,0.0027752495,0.00019120262,0.00051739754,0.0001773066,0.0014329072,0.000013696974,0.98332053,0.0009383466,0.0020920085,0.004903691],"study_design_scores_gemma":[0.0036385441,0.00031014986,0.50923747,0.0004678535,0.000092767026,0.000034963676,0.0018330776,0.000100954596,0.48021054,0.0004308256,0.0033871888,0.00025566982],"about_ca_topic_score_codex":0.015861794,"about_ca_topic_score_gemma":0.00058372144,"teacher_disagreement_score":0.5064622,"about_ca_system_score_codex":0.00036264962,"about_ca_system_score_gemma":0.00136052,"threshold_uncertainty_score":0.99474674},"labels":[],"label_agreement":null},{"id":"W1981681061","doi":"10.1158/1538-7445.chtme14-a12","title":"Abstract A12: Heterogeneous accumulation of trastuzumab in Her2+ve tumor and metastases models","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Studies","funders":"","keywords":"Trastuzumab; Immunohistochemistry; Medicine; Pathology; Breast cancer; Tissue microarray; CD31; Context (archaeology); Cancer; Cancer research; Biology; Internal medicine","score_opus":0.23531661260084896,"score_gpt":0.48797679525375476,"score_spread":0.2526601826529058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981681061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955202,0.0025310847,0.00018393119,0.0007993588,0.00004379932,0.00024998176,0.000007632661,0.000011249272,0.0006527813],"genre_scores_gemma":[0.99911076,0.00020130929,0.00040539136,0.00008002211,0.000080992126,0.00002960085,0.000008612233,0.000017484821,0.0000658584],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99871576,0.00008945827,0.0002134701,0.00020103986,0.0005204154,0.00025988158],"domain_scores_gemma":[0.9993103,0.000106433385,0.000039204562,0.0001504981,0.00017437973,0.00021916509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00124114,0.00007409573,0.00023139681,0.00022180355,0.000029536428,0.00001817249,0.00007513389,0.000033436358,0.000053611064],"category_scores_gemma":[0.00038997538,0.00006159407,0.000027418031,0.00022026307,0.00015750663,0.00008947972,0.000047884318,0.00043095436,0.000002606778],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004295713,0.0015175169,0.11587982,0.002631664,0.00048119426,0.001998995,0.013765339,0.1883441,0.1429159,0.001466405,0.009047121,0.5176562],"study_design_scores_gemma":[0.021091593,0.0022533054,0.11969852,0.0029429784,0.00017321804,0.0005518268,0.0038722425,0.7653349,0.05671852,0.016129205,0.010337417,0.00089627784],"about_ca_topic_score_codex":0.0018634776,"about_ca_topic_score_gemma":0.00007709022,"teacher_disagreement_score":0.5769908,"about_ca_system_score_codex":0.00015916734,"about_ca_system_score_gemma":0.00031502935,"threshold_uncertainty_score":0.28170332},"labels":[],"label_agreement":null},{"id":"W1981777112","doi":"10.1158/1538-7445.chtme14-a43","title":"Abstract A43: Systemic tumor-stroma interactions are prognostic indicators of breast tumor invasiveness","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stroma; Stromal cell; Metastasis; Biology; Primary tumor; Cancer research; Tumor progression; Tumor microenvironment; Breast cancer; Crosstalk; Cancer; Gene expression profiling; Pathology; Gene; Gene expression; Immunohistochemistry; Medicine; Immunology; Tumor cells; Genetics","score_opus":0.048384394250874665,"score_gpt":0.3845658394660352,"score_spread":0.3361814452151605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981777112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973584,0.000774968,0.0002875998,0.00023327747,0.00006614659,0.0005210796,0.00014825206,0.000020472466,0.00058981864],"genre_scores_gemma":[0.9986031,0.00007210519,0.00012291153,0.000052742278,0.00015481949,0.0007585113,0.00007973747,0.000025799502,0.00013024618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986956,0.00012559204,0.00024865198,0.0003708144,0.00024406779,0.00031526538],"domain_scores_gemma":[0.9987055,0.000028852955,0.0001563362,0.00046963603,0.0004562378,0.00018343769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045512858,0.00012454641,0.00017124545,0.00016635822,0.00009174459,0.000019633822,0.00040569974,0.00008690434,0.000034113094],"category_scores_gemma":[0.00015923988,0.000114794675,0.00007034108,0.0003434783,0.00026962263,0.000005122235,0.00020746961,0.00026790623,0.00001480928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000822107,0.000113916394,0.06519432,0.00010153901,0.000051796793,0.000016017908,0.000028724558,0.000018297467,0.9292818,0.00020315383,0.0043005943,0.0006076416],"study_design_scores_gemma":[0.00061217754,0.00030589872,0.078981966,0.00043641738,0.00002565263,0.0003643174,0.00079148816,0.00000813819,0.9006659,0.00021624162,0.01727422,0.00031759363],"about_ca_topic_score_codex":0.0001922085,"about_ca_topic_score_gemma":0.000066364926,"teacher_disagreement_score":0.028615896,"about_ca_system_score_codex":0.000075313335,"about_ca_system_score_gemma":0.0005039097,"threshold_uncertainty_score":0.4681191},"labels":[],"label_agreement":null},{"id":"W1981783268","doi":"10.1158/1538-7445.am2013-5276","title":"Abstract 5276: Normalization of miRNA-sequencing data.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Normalization (sociology); Biology; Computational biology; microRNA; DNA microarray; Database normalization; Deep sequencing; Gene; Genetics; Gene expression; Computer science; Genome; Artificial intelligence; Pattern recognition (psychology)","score_opus":0.1030384582743519,"score_gpt":0.4103650843595181,"score_spread":0.30732662608516614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981783268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98227996,0.003962221,0.0068967124,0.0004831557,0.00021740743,0.0010351831,0.00012785589,0.000019552042,0.004977935],"genre_scores_gemma":[0.9963097,0.0015747476,0.00032892847,0.000059478967,0.00026841916,0.00017299886,0.00030885087,0.000042640666,0.00093424344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978557,0.0001291107,0.00025947933,0.00051029207,0.00070894696,0.0005364498],"domain_scores_gemma":[0.99781084,0.000027039241,0.000067073735,0.0011251746,0.0008147515,0.00015509293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089748285,0.00011899524,0.00013760371,0.00017068796,0.00011378189,0.000057259924,0.0008692483,0.00018513441,0.0010328322],"category_scores_gemma":[0.00032536284,0.00011803133,0.00004614262,0.00040615743,0.00019189541,0.000021824875,0.00065580825,0.00033512057,0.00009297911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042425218,0.00002356372,0.00006325919,0.00008248006,0.00004692978,0.0000030070767,0.0000343055,0.00033977025,0.9814414,0.000106731,0.010330628,0.0074855424],"study_design_scores_gemma":[0.00037944806,0.0001233993,0.0006242103,0.000065318076,0.0000049883265,0.0000043675277,0.00013520836,0.0004785958,0.9802618,0.00018440987,0.017596116,0.00014213086],"about_ca_topic_score_codex":0.0031354153,"about_ca_topic_score_gemma":0.00030103052,"teacher_disagreement_score":0.014029714,"about_ca_system_score_codex":0.00012811553,"about_ca_system_score_gemma":0.00080987683,"threshold_uncertainty_score":0.9998804},"labels":[],"label_agreement":null},{"id":"W1981786398","doi":"10.1158/1538-7445.am2013-2836","title":"Abstract 2836: Metronomic cyclophosphamide enhances antitumor immune response induced by a DepoVaxTM-based peptide vaccine.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Sunnybrook Hospital; Immunovaccine (Canada)","funders":"","keywords":"Immune system; ELISPOT; Adjuvant; Medicine; In vivo; Immunology; Cancer vaccine; Cytotoxic T cell; Antigen; Vaccination; Pharmacology; Peptide vaccine; Cyclophosphamide; Ex vivo; T cell; Immunotherapy; Internal medicine; Biology; In vitro; Chemotherapy; Epitope; Biotechnology","score_opus":0.02998856971749576,"score_gpt":0.3344485031515284,"score_spread":0.30445993343403266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981786398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94168895,0.05430516,0.000022553671,0.0018287812,0.0006641446,0.0009707471,0.000052518604,0.000121088095,0.00034606346],"genre_scores_gemma":[0.98847455,0.0014514367,0.00004031147,0.00023458147,0.000050969913,0.00096074754,0.000069830545,0.000080619684,0.008636927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995538,0.0014370912,0.0007119313,0.0006927044,0.00019311614,0.0014271362],"domain_scores_gemma":[0.9967207,0.0016819541,0.0002070808,0.00092165277,0.00039180083,0.000076829994],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024330951,0.0003995617,0.00059787347,0.0005500008,0.0007288287,0.00015188592,0.0009980014,0.00038162118,0.011176015],"category_scores_gemma":[0.00058576325,0.00035281235,0.00022256674,0.00067118835,0.00039502507,0.0004006836,0.00016095063,0.0013573685,0.0042012823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007817741,0.00022098263,0.00044644656,0.000035638222,0.00026181067,0.0000071374016,0.00017990996,0.000005963409,0.9630648,0.000014680532,0.019080928,0.008863961],"study_design_scores_gemma":[0.0025326384,0.0004383855,0.0954691,0.00013164524,0.000011606476,0.000007740266,0.00031989056,0.0000022825209,0.84120226,0.000031985503,0.05949649,0.00035595187],"about_ca_topic_score_codex":0.008515718,"about_ca_topic_score_gemma":0.000062848034,"teacher_disagreement_score":0.121862516,"about_ca_system_score_codex":0.0004257454,"about_ca_system_score_gemma":0.0009817597,"threshold_uncertainty_score":0.9998924},"labels":[],"label_agreement":null},{"id":"W1981887684","doi":"10.1158/1538-7445.am2013-4810","title":"Abstract 4810: Family history of cancers, medical history, and pancreatic cancer risk in the Ontario Pancreatic Cancer Case-Control Study.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Pancreatic cancer; Family history; Medicine; Cancer; Odds ratio; Internal medicine; Medical history; Pancreatitis; Oncology; Disease; Case-control study","score_opus":0.08534078825496395,"score_gpt":0.39019640697848756,"score_spread":0.3048556187235236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981887684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928182,0.060234882,0.0000039819474,0.0015729264,0.0003885626,0.0038938343,0.000060760904,0.000024469904,0.005638567],"genre_scores_gemma":[0.97006714,0.012862476,0.00003536357,0.00063819025,0.00040034647,0.006572465,0.000004063077,0.00005854192,0.0093613975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931851,0.0013162206,0.00093248754,0.0008177837,0.0024921738,0.0012562065],"domain_scores_gemma":[0.99518555,0.0022474194,0.00026045652,0.0009137173,0.00074976956,0.00064309407],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049342285,0.0003908013,0.0014243841,0.00054184743,0.00019688584,0.00002640519,0.00059207587,0.00035525294,0.0203491],"category_scores_gemma":[0.0009037278,0.00026970758,0.00013461345,0.0004352746,0.0016083735,0.00018810402,0.0001430604,0.0027033922,0.000041862782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008292071,0.000515895,0.91756094,0.00046165293,0.0006876289,0.0016746526,0.018779226,0.000010390163,0.0008076721,0.000016663114,0.04470692,0.013949137],"study_design_scores_gemma":[0.006270544,0.00081779424,0.97430503,0.0007184578,0.00058566895,0.0001430345,0.004798585,0.0005939119,0.000010011232,0.000058994112,0.011437123,0.00026085324],"about_ca_topic_score_codex":0.9361671,"about_ca_topic_score_gemma":0.64390814,"teacher_disagreement_score":0.29225898,"about_ca_system_score_codex":0.018730538,"about_ca_system_score_gemma":0.019032294,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W1981890973","doi":"10.1158/1538-7445.am2013-863","title":"Abstract 863: Inhibition of breast cancer metastaticprogression by a novel uPAR targeted monoclonal antibody, ATN-658, correlateswith the uPAR expression.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Concordia University; McGill University","funders":"","keywords":"Urokinase receptor; Medicine; Cancer research; Metastasis; Breast cancer; Cancer; Metastatic breast cancer; Pathology; Trastuzumab; Monoclonal antibody; Sunitinib; Triple-negative breast cancer; Antibody; Plasminogen activator; Internal medicine; Immunology","score_opus":0.029376156211489885,"score_gpt":0.38233683359656806,"score_spread":0.3529606773850782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981890973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98639035,0.009970792,0.00011523,0.0011078692,0.000099705685,0.000994159,0.0011226516,0.000012237984,0.00018701587],"genre_scores_gemma":[0.9938292,0.0033378997,0.00013294972,0.00006237225,0.00018880292,0.0011752871,0.00052941777,0.00004625984,0.00069783645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973539,0.00014882871,0.00032559564,0.00055169314,0.0008780862,0.00074186985],"domain_scores_gemma":[0.9983099,0.00006084494,0.00014669825,0.0005007441,0.0007116488,0.0002701408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044786028,0.00023566105,0.00023981149,0.000103485836,0.0003092558,0.00008363628,0.00036933488,0.00015408697,0.0015472493],"category_scores_gemma":[0.000056893696,0.0001518485,0.000120210774,0.00036746514,0.00047637615,0.000033065542,0.00029056953,0.00042547972,0.000039374856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000506606,0.00028065962,0.008084171,0.000057769375,0.00016815301,0.000004506427,0.00006902955,0.00005396755,0.9316037,0.0000072491475,0.05461326,0.0045508947],"study_design_scores_gemma":[0.0018620045,0.00024678028,0.030249774,0.00028596172,0.000021477006,0.000011640243,0.00017295465,0.0001248686,0.960439,0.00007309481,0.0062899105,0.00022252605],"about_ca_topic_score_codex":0.011241928,"about_ca_topic_score_gemma":0.00036792402,"teacher_disagreement_score":0.04832335,"about_ca_system_score_codex":0.00012690695,"about_ca_system_score_gemma":0.0005425591,"threshold_uncertainty_score":0.99936545},"labels":[],"label_agreement":null},{"id":"W1981955743","doi":"10.1158/1538-7445.am2013-3972","title":"Abstract 3972: Carpet bombing with CARs: Influence of dose, timing, lymphodepletion and costimulatory domain on efficacy of mRNA engineered anti-CD19 Chimeric Antigen Receptor T cells in preclinical xenograft models.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chimeric antigen receptor; CD28; Electroporation; Cancer research; Ex vivo; Transduction (biophysics); Genetic enhancement; CD19; Viral vector; T cell; Antigen; Medicine; Immunology; Biology; In vivo; Immune system; Gene; Recombinant DNA","score_opus":0.07944169261502196,"score_gpt":0.39057946450735204,"score_spread":0.31113777189233005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981955743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652606,0.0009145767,0.00001014289,0.00015996322,0.000040710132,0.0018916781,0.000034969216,0.000024761663,0.00039715573],"genre_scores_gemma":[0.99687904,0.0022447107,0.00040573798,0.000026065276,0.000073063144,0.00013131127,0.000017329103,0.00006727456,0.00015546911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965522,0.00024861874,0.00060839264,0.00058154046,0.0013114858,0.00069771055],"domain_scores_gemma":[0.9974772,0.00083696534,0.00013579239,0.00063711125,0.0006005011,0.0003124532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015783298,0.00023443348,0.0006692668,0.0006675523,0.000063120606,0.000032278425,0.00027754763,0.00020165542,0.0005330408],"category_scores_gemma":[0.00019277149,0.00019843857,0.00008395993,0.0009142254,0.00061806093,0.00019573799,0.0001123189,0.00083618454,0.000018188139],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017287371,0.00041167432,0.018611545,0.00039473656,0.00011546831,0.000016462503,0.0011854157,0.018218625,0.949854,0.000011992898,0.000223441,0.009227878],"study_design_scores_gemma":[0.011314939,0.0020317389,0.6269922,0.002663447,0.00002666739,0.000009353072,0.00034947883,0.0040359013,0.35162857,0.00006786329,0.00051933515,0.0003604778],"about_ca_topic_score_codex":0.0057443217,"about_ca_topic_score_gemma":0.00006292364,"teacher_disagreement_score":0.6083807,"about_ca_system_score_codex":0.00035922814,"about_ca_system_score_gemma":0.00068657007,"threshold_uncertainty_score":0.8683734},"labels":[],"label_agreement":null},{"id":"W1982024468","doi":"10.1158/0008-5472.can-12-3682","title":"Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated Protein","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Aptamer; Systematic evolution of ligands by exponential enrichment; Cancer research; Biology; Cancer; Carcinogenesis; Gene knockdown; Molecular biology; Malignancy; Cell; Cancer cell; RNA; Cell culture; Gene; Biochemistry; Genetics","score_opus":0.03973760385896362,"score_gpt":0.3611200122493492,"score_spread":0.32138240839038557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982024468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962883,0.0012505583,0.00025823872,0.0010267543,0.000021012891,0.0006623027,0.00014648416,0.00003931854,0.00030701797],"genre_scores_gemma":[0.99118394,0.00025747836,0.0011270152,0.00039805606,0.00017417813,0.00040852616,0.00021521926,0.000032731903,0.0062028505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982416,0.000099654,0.00021641524,0.0005055843,0.00038321817,0.000553513],"domain_scores_gemma":[0.9986314,0.000016676728,0.00007012677,0.00051873614,0.0006081544,0.00015491495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043322687,0.0001708714,0.0002013194,0.00009623633,0.00018052176,0.00006298057,0.0002787838,0.0001853068,0.0001286533],"category_scores_gemma":[0.00021082477,0.00014273493,0.00009962079,0.00041475153,0.00022204791,0.000007678494,0.0001868923,0.0002453107,0.000046161313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038418337,0.00009796861,0.00080340466,0.00001740731,0.00007358583,0.0000024924332,0.000019188541,7.360803e-7,0.97375685,0.000023741846,0.023210613,0.0019556005],"study_design_scores_gemma":[0.00042137367,0.00020125254,0.0008569549,0.00005004293,0.000016996262,0.0000021397443,0.000057746813,0.00011014141,0.9793712,0.00015715988,0.01855631,0.00019869552],"about_ca_topic_score_codex":0.0020140337,"about_ca_topic_score_gemma":0.00014983663,"teacher_disagreement_score":0.0058958326,"about_ca_system_score_codex":0.00009239348,"about_ca_system_score_gemma":0.00016706245,"threshold_uncertainty_score":0.5820562},"labels":[],"label_agreement":null},{"id":"W1982101816","doi":"10.1158/1538-7445.am2012-1397","title":"Abstract 1397: A novel ligand-independent Flt3 allele drives RANKL expression in a murine model of B-precursor acute lymphoblastic leukemia with CNS dissemination","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Progenitor cell; Cancer research; Haematopoiesis; Receptor tyrosine kinase; Tyrosine kinase; Precursor cell; Molecular biology; Signal transduction; Stem cell; Cell biology; Genetics; In vitro","score_opus":0.04111707338153089,"score_gpt":0.3694985977590538,"score_spread":0.32838152437752294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982101816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920119,0.0006584918,0.0037411097,0.00040401702,0.00006548802,0.0013413302,0.00011263798,0.000045991714,0.00161901],"genre_scores_gemma":[0.994332,0.0006492551,0.0016163938,0.000026757241,0.00024836673,0.0006479888,0.00007227415,0.000098624456,0.0023083445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947197,0.00010011543,0.0005807777,0.0006224936,0.002559836,0.0014170638],"domain_scores_gemma":[0.99716777,0.0006367687,0.00015564206,0.0006988737,0.00071706076,0.0006238719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014789585,0.00033462798,0.0006276732,0.00085302384,0.0001366107,0.00004181284,0.0004694399,0.0002839141,0.00024016773],"category_scores_gemma":[0.00046218763,0.00025222136,0.00010649912,0.0009655769,0.00043526606,0.000474934,0.00036164882,0.0009337865,0.000044776105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004466264,0.000827003,0.007103844,0.0006247596,0.00016674337,0.00007125639,0.0031048662,0.0023590964,0.9772434,0.00008712289,0.0021106272,0.0018349814],"study_design_scores_gemma":[0.016001435,0.0007898117,0.06118506,0.0037232551,0.00013817564,0.00012995358,0.0011367997,0.054603703,0.8613972,0.000080072554,0.00027582975,0.00053870725],"about_ca_topic_score_codex":0.000534164,"about_ca_topic_score_gemma":0.0001567987,"teacher_disagreement_score":0.11584624,"about_ca_system_score_codex":0.004235459,"about_ca_system_score_gemma":0.0032933361,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W1982152759","doi":"10.1158/1538-7445.am2014-2436","title":"Abstract 2436: Regulation of breast cancer cell metabolism by the AMPK/ERR/PGC pathway","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"AMPK; Coactivator; Cell biology; Chromatin immunoprecipitation; Biology; Cancer research; Signal transduction; Transcription factor; Kinase; Chemistry; Protein kinase A; Gene expression; Gene; Biochemistry","score_opus":0.023581606739152564,"score_gpt":0.3229623785185668,"score_spread":0.29938077177941425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982152759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419101,0.04774647,0.00013727984,0.0011980643,0.0015272173,0.00054142455,0.0006138457,0.00001553173,0.006310103],"genre_scores_gemma":[0.9818739,0.009150328,0.000024700203,0.0001789016,0.0030482942,0.000230165,0.0000701253,0.00004304513,0.0053805313],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800664,0.00020488289,0.0002729692,0.00044600814,0.0005570939,0.00051240425],"domain_scores_gemma":[0.99854374,0.00004052351,0.00012799766,0.0006686635,0.00047710398,0.00014196456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000990725,0.00017619415,0.00023512241,0.00004891966,0.00019034852,0.000041205985,0.00047679897,0.00017987045,0.00053030334],"category_scores_gemma":[0.00004993879,0.000131711,0.00012714745,0.00022334816,0.0003103029,0.000012740199,0.00014939612,0.0002729204,0.0000116199035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013254271,0.000046413556,0.00010205533,0.000050277427,0.00003749402,6.9972e-8,0.00009662534,0.00006257953,0.89531744,0.00016356641,0.063667655,0.0403233],"study_design_scores_gemma":[0.00049412507,0.00002496495,0.019695846,0.000018722174,0.000014737669,0.0000018548286,0.00006883978,0.000016554262,0.46743113,0.00008805842,0.51202154,0.00012365068],"about_ca_topic_score_codex":0.0051677055,"about_ca_topic_score_gemma":0.0013922664,"teacher_disagreement_score":0.44835386,"about_ca_system_score_codex":0.000057295998,"about_ca_system_score_gemma":0.00038500942,"threshold_uncertainty_score":0.7812059},"labels":[],"label_agreement":null},{"id":"W1982173961","doi":"10.1158/1538-7445.am2011-3224","title":"Abstract 3224: Targeted non-invasive therapy of prostate cancer using fusogenic liposomes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Liposome; Cancer cell; HT1080; Fusion protein; Endocytosis; Cancer research; Biology; Cell; Cancer; Chemistry; Molecular biology; Biochemistry","score_opus":0.10420851285155924,"score_gpt":0.3706981034063516,"score_spread":0.2664895905547924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982173961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846603,0.0140167065,0.000026183016,0.000046949604,0.00014458923,0.00053951296,0.00006323086,0.000006229876,0.0004962751],"genre_scores_gemma":[0.9771768,0.021471323,0.0003558022,0.00004228747,0.00021621386,0.00026553308,0.000010132099,0.000039880582,0.00042204987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998565,0.000102817794,0.00020977699,0.00036471942,0.00030767024,0.00044999734],"domain_scores_gemma":[0.9990196,0.000018584558,0.00009601684,0.00038087866,0.00037848458,0.00010643857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046259322,0.0001452646,0.00017937688,0.00009614779,0.00011517919,0.000015009024,0.00033473648,0.00015130533,0.0007153598],"category_scores_gemma":[0.00005100749,0.00012408185,0.00009714268,0.0001945086,0.00017273097,0.000007430609,0.0000986036,0.0001489516,0.000009053304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035502494,0.000052811985,0.0020709937,0.00005369875,0.00012478227,0.0000049344358,0.00042775128,0.000013486827,0.9846276,0.000012015992,0.00023073053,0.012026182],"study_design_scores_gemma":[0.00039728906,0.00022355601,0.00436495,0.00007885748,0.000005004298,0.0000013386666,0.00012610511,0.000003139795,0.9929278,0.00018993484,0.0015327047,0.00014934607],"about_ca_topic_score_codex":0.0016544525,"about_ca_topic_score_gemma":0.0001788568,"teacher_disagreement_score":0.011876836,"about_ca_system_score_codex":0.00004170602,"about_ca_system_score_gemma":0.00068022945,"threshold_uncertainty_score":0.78326887},"labels":[],"label_agreement":null},{"id":"W1982193331","doi":"10.1158/1538-7445.am2011-2015","title":"Abstract 2015: Effect of valproic acid on fludarabine activity in chronic lymphocytic leukemia patients","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Manitoba; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Pharmacology; Apoptosis; Immunology; Leukemia; Cancer research; Internal medicine; Chemotherapy; Chemistry; Cyclophosphamide; Biochemistry","score_opus":0.07036853108156604,"score_gpt":0.40470299198644333,"score_spread":0.3343344609048773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982193331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896652,0.0009974843,0.0000016111445,0.000039546623,0.00016226362,0.0019028764,0.000025143929,0.000044689972,0.007161145],"genre_scores_gemma":[0.9979502,0.0005250536,0.0000127907215,0.000020912561,0.00020272139,0.00048552995,0.000015763351,0.00007893881,0.0007080795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949633,0.00041633242,0.00047185353,0.0007553923,0.0020690567,0.0013240862],"domain_scores_gemma":[0.9973414,0.0005914851,0.00011386676,0.0010866388,0.0004536099,0.0004130049],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002422419,0.00032023856,0.00074652047,0.0008517283,0.00009554072,0.000017865894,0.0005163736,0.0002827008,0.0013626181],"category_scores_gemma":[0.0008307893,0.0002543938,0.00016953396,0.001224675,0.0005668109,0.00017498601,0.00027151013,0.001212762,0.00042359642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0608832,0.0013622738,0.046038654,0.0142584,0.0007166539,0.0015482116,0.002526474,0.0007052271,0.681545,0.00016600406,0.013439012,0.17681089],"study_design_scores_gemma":[0.038734898,0.0053741434,0.11672565,0.0014692696,0.000032063166,0.000010826584,0.0000180281,0.0019935179,0.8350202,0.00004611822,0.0003201413,0.0002551802],"about_ca_topic_score_codex":0.017040737,"about_ca_topic_score_gemma":0.0004611711,"teacher_disagreement_score":0.18158238,"about_ca_system_score_codex":0.22832945,"about_ca_system_score_gemma":0.046747085,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W1982209500","doi":"10.1158/1538-7445.am10-455","title":"Abstract 455: Hypoxia induced carbonic anhydrase IX is essential for the growth and metastasis of breast tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Child and Family Research Institute; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Metastasis; Breast cancer; Metastatic breast cancer; Tumor hypoxia; Pathology; Cancer; Medicine; Primary tumor; Anoikis; Biology; Internal medicine; Radiation therapy","score_opus":0.03456146393820839,"score_gpt":0.3519949284551389,"score_spread":0.31743346451693055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982209500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976798,0.0004085446,0.000036646983,0.001020268,0.00013603938,0.00024538263,0.00013966378,0.0000034485927,0.00033016934],"genre_scores_gemma":[0.9990232,0.00023573289,0.000026069316,0.000098310265,0.00034085932,0.000102516235,0.00002670136,0.000013847675,0.00013275114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924445,0.000030041248,0.000118754986,0.00021997142,0.00018007457,0.00020673257],"domain_scores_gemma":[0.9993951,0.000042510535,0.00004054711,0.0002159104,0.0002369981,0.00006893562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040672586,0.00007329362,0.00008236943,0.000050584084,0.00012882432,0.000025622854,0.00011893553,0.00008883304,0.00014190949],"category_scores_gemma":[0.00009895368,0.0000541628,0.000055885834,0.0001086986,0.00018263342,0.000005440374,0.000065970016,0.00021994939,0.0000013818542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001426594,0.000025465082,0.00019747327,0.000033046406,0.00003604332,3.90702e-7,0.000034250505,5.8068065e-7,0.99372536,0.00013359846,0.0035859905,0.0020851162],"study_design_scores_gemma":[0.0004235205,0.00010517552,0.005722677,0.000010151261,0.0000127786325,0.000007215912,0.00009062297,0.00001483074,0.9913154,0.00007222814,0.002160318,0.00006503951],"about_ca_topic_score_codex":0.0005435298,"about_ca_topic_score_gemma":0.00028197718,"teacher_disagreement_score":0.005525204,"about_ca_system_score_codex":0.0000071680765,"about_ca_system_score_gemma":0.00016277884,"threshold_uncertainty_score":0.2208695},"labels":[],"label_agreement":null},{"id":"W1982272716","doi":"10.1158/0008-5472.can-07-1486","title":"Identification of Tumorsphere- and Tumor-Initiating Cells in HER2/Neu-Induced Mammary Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Cancer research; Cancer; Oncogene; Mammary tumor; Breast cancer; Biology; Genetically modified mouse; HER2/neu; Mouse mammary tumor virus; Mammary gland; Transgene; Immunology; Cell cycle; Genetics; Gene; Virus","score_opus":0.07686259250650566,"score_gpt":0.40724004185153895,"score_spread":0.33037744934503327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982272716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953322,0.0013569499,0.00008799052,0.00031782524,0.00011733762,0.00049404666,0.00001187059,0.000016052545,0.0022657248],"genre_scores_gemma":[0.99853396,0.00041371194,0.00020451429,0.00008827789,0.00014501617,0.00005123707,0.0000037167522,0.000025533547,0.00053405593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979882,0.00009645264,0.0004988649,0.00034851424,0.0005871851,0.00048074132],"domain_scores_gemma":[0.9989443,0.00014953293,0.00011179785,0.0003240494,0.0002834986,0.00018682529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026543944,0.00010972338,0.0002993296,0.00035061367,0.00006342335,0.00002588996,0.0001289167,0.000050894563,0.00012705683],"category_scores_gemma":[0.00015233255,0.00010643903,0.000047018762,0.00082895334,0.000121387886,0.00010972386,0.00009416591,0.00044484533,0.000009000546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000208258,0.00009002585,0.009066484,0.0004890768,0.000016901766,0.00018199965,0.0005719669,0.0000035618457,0.95649,0.00017592128,0.00025320184,0.032452643],"study_design_scores_gemma":[0.0010610416,0.0001549337,0.057757035,0.0003682046,0.000013513868,0.000024064078,0.001237203,0.000046935234,0.9384474,0.00013529773,0.0006456857,0.000108694956],"about_ca_topic_score_codex":0.0023225937,"about_ca_topic_score_gemma":0.0006400358,"teacher_disagreement_score":0.04869055,"about_ca_system_score_codex":0.00026141698,"about_ca_system_score_gemma":0.0004112127,"threshold_uncertainty_score":0.43404576},"labels":[],"label_agreement":null},{"id":"W1982282601","doi":"10.1158/1538-7445.am2012-1649","title":"Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Copy-number variation; Genome-wide association study; Biology; Ovarian cancer; Copy number analysis; Comparative genomic hybridization; Genetics; Serous fluid; Cancer; Single-nucleotide polymorphism; SNP array; Breast cancer; Chromosome; Genome; Genotype; Gene","score_opus":0.03988532673580449,"score_gpt":0.3609951564067025,"score_spread":0.321109829670898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982282601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770015,0.00025211414,0.000022499587,0.00024482157,0.00021611253,0.00049694924,0.00019133076,0.00000591222,0.0008701019],"genre_scores_gemma":[0.997867,0.0002116928,0.000051515402,0.000038903116,0.0004804164,0.0003059106,0.000046423746,0.000019443889,0.000978696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822277,0.00027669588,0.0003466451,0.00027362743,0.00036924076,0.0005110254],"domain_scores_gemma":[0.99895644,0.000096875905,0.00012553525,0.0003335914,0.00039005151,0.000097476506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015237797,0.00011583935,0.00017833381,0.000075124866,0.00014002266,0.000027809125,0.00021275644,0.00015538432,0.0008732204],"category_scores_gemma":[0.00024096559,0.000116769006,0.000049406248,0.00027395604,0.00004352627,0.000018309654,0.00013029404,0.0002429067,0.00002504168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008275659,0.00055781147,0.9273376,0.000030363653,0.00008907212,5.737731e-7,0.0018834485,0.0002670757,0.06919858,0.00005419781,0.00035360095,0.00014495793],"study_design_scores_gemma":[0.0009039036,0.000101811886,0.97689825,0.000010241324,0.000014958436,3.4290306e-7,0.0013951669,0.000003210271,0.017787158,0.00006758336,0.0026837927,0.00013356553],"about_ca_topic_score_codex":0.0108427545,"about_ca_topic_score_gemma":0.008421654,"teacher_disagreement_score":0.051411416,"about_ca_system_score_codex":0.00044807288,"about_ca_system_score_gemma":0.00037206232,"threshold_uncertainty_score":0.9957441},"labels":[],"label_agreement":null},{"id":"W1982374310","doi":"10.1158/0008-5472.sabcs13-p5-08-14","title":"Abstract P5-08-14: Deregulated histone and cell cycle pathways are associated with anthracycline resistance in breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cell cycle; Biology; Cancer research; Histone deacetylase; Vorinostat; SKBR3; Cancer; Cell cycle checkpoint; Epirubicin; Histone; Epigenetics; Histone deacetylase inhibitor; Breast cancer; Genetics; Gene","score_opus":0.014965557851361456,"score_gpt":0.3049890692366231,"score_spread":0.29002351138526167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982374310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824482,0.015133533,0.0000017537632,0.0009808545,0.000049195354,0.0004575769,0.00008657747,0.000017800463,0.0008245073],"genre_scores_gemma":[0.9945588,0.0034950834,0.00002289436,0.000078797726,0.0000807275,0.00024600403,0.00005932328,0.0000462331,0.001412127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.00013631795,0.00020656438,0.0005086928,0.0003178715,0.00060657266],"domain_scores_gemma":[0.99901134,0.000055022054,0.0001004855,0.0002946403,0.00034653148,0.00019197591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034237152,0.00019093238,0.00022112668,0.000102995655,0.0001629146,0.00005025647,0.0001871725,0.0002951942,0.00018179289],"category_scores_gemma":[0.000051405215,0.0001565039,0.000035467678,0.00034206922,0.0003061745,0.000015201436,0.00009582681,0.0005113971,0.00001641987],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004370334,0.00022278885,0.03681522,0.00011078815,0.00008217133,0.000059564096,0.0001277911,0.000116442425,0.9507114,0.00000597486,0.010180993,0.0011298031],"study_design_scores_gemma":[0.00295098,0.00016101735,0.7434911,0.0006035533,0.0000179245,0.000007049424,0.00018613177,0.000084937084,0.25109443,0.00010213668,0.00086044555,0.00044026013],"about_ca_topic_score_codex":0.0012028132,"about_ca_topic_score_gemma":0.0023643225,"teacher_disagreement_score":0.7066759,"about_ca_system_score_codex":0.0001678004,"about_ca_system_score_gemma":0.0002474638,"threshold_uncertainty_score":0.6382044},"labels":[],"label_agreement":null},{"id":"W1982447894","doi":"10.1158/1538-7445.am2013-4615","title":"Abstract 4615: The hyperinsulinemia caused by PI3K inhibitors attenuates their antineoplastic efficacy, but can be minimized by co-administration of metformin.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Hyperinsulinemia; PI3K/AKT/mTOR pathway; Insulin; Insulin resistance; Endocrinology; Metformin; Internal medicine; Medicine; Insulin receptor; Pharmacology; Glucose uptake; Glucose homeostasis; Signal transduction; Chemistry; Biochemistry","score_opus":0.033426274629419134,"score_gpt":0.3346101422401994,"score_spread":0.3011838676107803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982447894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95089626,0.046973556,0.0000058834858,0.00048748407,0.00016455041,0.00058551494,0.0006400711,0.000010272534,0.00023639681],"genre_scores_gemma":[0.9799194,0.017977385,0.0000113673605,0.00018224897,0.0003763976,0.00035103713,0.0004298682,0.00003935034,0.0007129427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980391,0.00014030175,0.00038567747,0.00042119113,0.00046296028,0.0005507291],"domain_scores_gemma":[0.99863404,0.00017373088,0.00014289275,0.00047679013,0.0004052942,0.00016725581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000539581,0.00022288808,0.0002903934,0.0000562034,0.00017453973,0.00007374409,0.00043172864,0.00018871072,0.0003648002],"category_scores_gemma":[0.00025179563,0.0001533452,0.00010551478,0.00020645962,0.000434378,0.000011463513,0.0000857959,0.00029755596,0.000014657044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013471843,0.000078362216,0.00027672338,0.000050732673,0.00007738803,6.780698e-7,0.000110905356,0.000005390066,0.87002134,0.000002749853,0.11133782,0.017903168],"study_design_scores_gemma":[0.0009887924,0.00016126932,0.00094287406,0.000023780249,0.000014495173,0.0000011535482,0.00039487373,0.000014654173,0.8405088,0.0000075541125,0.15678298,0.0001587608],"about_ca_topic_score_codex":0.0010249336,"about_ca_topic_score_gemma":0.00018379526,"teacher_disagreement_score":0.045445167,"about_ca_system_score_codex":0.000039157323,"about_ca_system_score_gemma":0.00050292903,"threshold_uncertainty_score":0.6253236},"labels":[],"label_agreement":null},{"id":"W1982540564","doi":"10.1158/0008-5472.sabcs-09-2108","title":"A Population Based Patterns of Care Study for Male Breast Cancer in Ontario.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Cancer; Cohort; Cancer registry; Population; Oncology; Male breast cancer; Internal medicine; Gynecology; Environmental health","score_opus":0.04638363791068619,"score_gpt":0.4076093900636465,"score_spread":0.3612257521529603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982540564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977164,0.0005769906,0.0000965997,0.00032662807,0.00008888112,0.0008423682,0.0002700593,0.000002895092,0.00007915527],"genre_scores_gemma":[0.9984725,0.000030429492,0.00009010005,0.000057830042,0.00012631677,0.0006569702,0.000100208366,0.000014443272,0.00045118635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989408,0.00007606804,0.00017414668,0.00031434838,0.00023850468,0.00025611705],"domain_scores_gemma":[0.9992376,0.000013957926,0.00004022737,0.00028153462,0.00038594223,0.000040760566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000246597,0.00008425499,0.00012630432,0.00012263299,0.000056599918,0.000013079973,0.0001786648,0.000076213284,0.0002373187],"category_scores_gemma":[0.000018048479,0.00008613625,0.000044801305,0.00015757831,0.0000197123,0.000004067854,0.000031916505,0.00012996528,4.9913467e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044774383,0.00013932862,0.9344515,0.000053964657,0.000016582566,0.000001386849,0.0007587981,0.0029522665,0.050461777,0.0000060705584,0.00029237728,0.010418173],"study_design_scores_gemma":[0.0012532765,0.0004638201,0.97115535,0.000057396464,0.000008300562,8.211984e-7,0.0007664599,0.000038812723,0.025166761,0.000019427698,0.0009667313,0.00010283265],"about_ca_topic_score_codex":0.088995874,"about_ca_topic_score_gemma":0.5892327,"teacher_disagreement_score":0.5002368,"about_ca_system_score_codex":0.0007762867,"about_ca_system_score_gemma":0.001078482,"threshold_uncertainty_score":0.91707057},"labels":[],"label_agreement":null},{"id":"W1982852502","doi":"10.1158/0008-5472.can-12-1629","title":"Functional Genomics Identifies Drivers of Medulloblastoma Dissemination","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medulloblastoma; Genomics; Functional genomics; Computational biology; Biology; Genetics; Genome; Gene","score_opus":0.07430983453756487,"score_gpt":0.4119191200929435,"score_spread":0.3376092855553786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982852502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964406,0.0013246121,0.000009971816,0.0007643028,0.00019372354,0.00019633226,0.000015803507,0.000008486673,0.001046163],"genre_scores_gemma":[0.99809206,0.00034395684,0.0000402713,0.00001138247,0.00019545862,0.00010916023,0.000015979755,0.000009275623,0.0011824536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990952,0.000029438723,0.00009989223,0.00009876866,0.00044945272,0.00022721966],"domain_scores_gemma":[0.9993542,0.00011289593,0.000025360332,0.0001315309,0.00025754527,0.000118460375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030110023,0.00004899654,0.00010113692,0.00016490166,0.0000652883,0.000007949499,0.000038182057,0.00003608388,0.0011310957],"category_scores_gemma":[0.00007175238,0.00004023482,0.00004601444,0.00020545293,0.000109144064,0.000077816345,0.000035793273,0.00009119584,0.00006295614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016411269,0.0004889007,0.20751382,0.00010841717,0.00015696062,0.000008980069,0.0010195056,0.0000096464555,0.7297517,0.0009808351,0.053000614,0.006796476],"study_design_scores_gemma":[0.00046305658,0.00007318915,0.35797966,0.00007853391,0.000032272914,0.0000069355924,0.0005129909,0.000009666746,0.63521206,0.00004345261,0.005552055,0.00003609955],"about_ca_topic_score_codex":0.000091240385,"about_ca_topic_score_gemma":0.000019905789,"teacher_disagreement_score":0.15046583,"about_ca_system_score_codex":0.00028781572,"about_ca_system_score_gemma":0.00009149934,"threshold_uncertainty_score":0.999782},"labels":[],"label_agreement":null},{"id":"W1982862878","doi":"10.1158/0008-5472.can-07-0807","title":"Opposing Function of the Proprotein Convertases Furin and PACE4 on Breast Cancer Cells' Malignant Phenotypes: Role of Tissue Inhibitors of Metalloproteinase-1","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Furin; Proprotein Convertases; Metalloproteinase; Matrix metalloproteinase; Cancer research; Motility; Secretion; Cancer; Cancer cell; Zymogen; Phenotype; Biology; Tissue inhibitor of metalloproteinase; Cell migration; Cell; Cell biology; Chemistry; Endocrinology; Internal medicine; Enzyme; Biochemistry; Medicine; Gene","score_opus":0.017588117709571655,"score_gpt":0.3018663130848813,"score_spread":0.2842781953753097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982862878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949828,0.0036548865,0.00006931537,0.00010311001,0.00009469991,0.00080571556,0.00013401938,0.0000029639864,0.00015252091],"genre_scores_gemma":[0.99920976,0.00022122024,0.000048202248,0.000023571054,0.00015142799,0.00007795883,0.0000052631676,0.000019454792,0.00024314492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987109,0.00011524979,0.00024826755,0.00026715235,0.0003950951,0.0002633703],"domain_scores_gemma":[0.99915725,0.000015188664,0.00014042144,0.00030882153,0.00030880052,0.00006949779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006337652,0.00011588305,0.00017765583,0.000076671764,0.00007528528,0.0000066568336,0.00015481339,0.00012020681,0.00006079572],"category_scores_gemma":[0.000030728002,0.000081844075,0.00005417732,0.00019463898,0.000223067,0.000006673062,0.00014507589,0.00014548648,7.2014615e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008280357,0.00008266421,0.00017418116,0.00019978594,0.000053710235,8.5416855e-7,0.000064567124,0.000009154028,0.9901634,0.00037230723,0.00010987992,0.007941465],"study_design_scores_gemma":[0.00034864742,0.0006276332,0.00034948852,0.00019506871,0.000027876284,0.0000016587711,0.00022106216,0.000003625278,0.99684495,0.00018720655,0.0011058208,0.00008697354],"about_ca_topic_score_codex":0.0017333247,"about_ca_topic_score_gemma":0.00022130573,"teacher_disagreement_score":0.0078544915,"about_ca_system_score_codex":0.000033503442,"about_ca_system_score_gemma":0.00026002206,"threshold_uncertainty_score":0.33375046},"labels":[],"label_agreement":null},{"id":"W1982903140","doi":"10.1158/1538-7445.am10-1601","title":"Abstract 1601: COX-2 and EP4 receptor as targets to ameliorate tumor growth, lymphangiogenesis, and metastasis in a murine breast cancer model","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Lymphangiogenesis; Angiogenesis; Metastasis; Cancer research; Medicine; Cancer; Breast cancer; Primary tumor; Matrigel; Vascular endothelial growth factor C; Vascular endothelial growth factor; Internal medicine; Vascular endothelial growth factor A","score_opus":0.030864091119379822,"score_gpt":0.3708237616831478,"score_spread":0.33995967056376797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982903140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926432,0.0027306394,0.0000032767712,0.003071042,0.00022453173,0.0009288265,0.00018921548,0.000030415964,0.00017887099],"genre_scores_gemma":[0.9957777,0.0018861019,0.00025319745,0.00046083398,0.00049087446,0.0007680824,0.000009878634,0.000060710903,0.00029259737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977004,0.00008697766,0.00027449854,0.0005633567,0.00061413366,0.0007606558],"domain_scores_gemma":[0.9983726,0.00012499288,0.0000495315,0.00029959515,0.00040480887,0.0007484661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013489877,0.00023695326,0.00044477545,0.00054570776,0.000145224,0.000054975928,0.00013770841,0.000118791955,0.0007666095],"category_scores_gemma":[0.00021302544,0.00019889306,0.000049679013,0.00057019293,0.0002251264,0.00014639259,0.00015487616,0.00039091994,0.00006320061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001757897,0.00016534192,0.048633862,0.0008065868,0.00010202358,0.00031247162,0.0008544647,0.000031772095,0.9193326,0.00016055565,0.0066488637,0.021193536],"study_design_scores_gemma":[0.0075391955,0.00048759882,0.3796389,0.0011108315,0.00012866016,0.0002512944,0.0003822727,0.0014805838,0.5985595,0.0003971085,0.009070556,0.0009534769],"about_ca_topic_score_codex":0.0053886133,"about_ca_topic_score_gemma":0.0022249022,"teacher_disagreement_score":0.33100504,"about_ca_system_score_codex":0.00021089129,"about_ca_system_score_gemma":0.0007477417,"threshold_uncertainty_score":0.8393836},"labels":[],"label_agreement":null},{"id":"W1983040426","doi":"10.1158/1538-7445.chtme14-a51","title":"Abstract A51: Chemotherapy rescues hypoxic tumor cells and induces reoxygenation and repopulation - an effect that is inhibited by the hypoxia-activated pro-drug TH-302","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hypoxia (environmental); Tumor hypoxia; Doxorubicin; Chemotherapy; Repopulation; Cancer research; Biology; Medicine; Pathology; Immunology; Radiation therapy; Internal medicine; Stem cell; Haematopoiesis; Chemistry; Cell biology; Oxygen","score_opus":0.059053214024637785,"score_gpt":0.3591296841178375,"score_spread":0.3000764700931997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983040426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862429,0.011493558,0.0000042860747,0.0009582125,0.0002704826,0.00078166823,0.00005472444,0.000020401665,0.00017374792],"genre_scores_gemma":[0.99414176,0.0036970377,0.000026489679,0.00028866864,0.0007228874,0.00017576801,0.00011008443,0.000042619693,0.00079471595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803823,0.00031484882,0.00020111694,0.00057871925,0.0004829113,0.0003841903],"domain_scores_gemma":[0.9989548,0.000045054174,0.000112893475,0.00041747806,0.00025748025,0.00021229885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015047502,0.00020049915,0.00019970548,0.00009554477,0.00023359356,0.00016263913,0.00018628928,0.00014791012,0.000018129092],"category_scores_gemma":[0.00012842465,0.00014585331,0.000037357902,0.00023591075,0.0002468875,0.000042467684,0.00009669511,0.00029471604,0.0000021406152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041085944,0.000033124048,0.00036022798,0.000036368852,0.000039513703,8.1661744e-7,0.0006428249,0.0000034220548,0.955718,0.0000031363172,0.020832669,0.021919029],"study_design_scores_gemma":[0.0010350008,0.00021435098,0.007219906,0.00002609013,0.000013938832,0.000008601192,0.00030724588,0.00002336845,0.91555494,0.00008349017,0.07533599,0.00017709259],"about_ca_topic_score_codex":0.0012633172,"about_ca_topic_score_gemma":0.00017455153,"teacher_disagreement_score":0.054503318,"about_ca_system_score_codex":0.00006464721,"about_ca_system_score_gemma":0.0001917459,"threshold_uncertainty_score":0.5947725},"labels":[],"label_agreement":null},{"id":"W1983134388","doi":"10.1158/1538-7445.am2014-ct105","title":"Abstract CT105: MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Monoclonal antibody; Immunohistochemistry; Cohort; Cancer; Antibody; Immunology","score_opus":0.032183674932666294,"score_gpt":0.3776240989429154,"score_spread":0.3454404240102491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983134388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993221,0.0019381364,0.00038195643,0.0014699189,0.00028804917,0.0016275739,0.00018827278,0.00004734045,0.0008377597],"genre_scores_gemma":[0.99446434,0.0017746157,0.00033290673,0.0002296682,0.00070654467,0.0006068879,0.00004136734,0.00007316898,0.0017704766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997215,0.00011489343,0.00028405644,0.00067619915,0.0008592024,0.0008506846],"domain_scores_gemma":[0.9981958,0.0004128199,0.00023296973,0.00037741175,0.0005285017,0.00025246645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001512047,0.0002789525,0.00049552403,0.00023320908,0.00040860366,0.00012405956,0.00019902704,0.00017726338,0.0002719637],"category_scores_gemma":[0.000092711685,0.00021794363,0.00012336165,0.000384215,0.00017450389,0.00022758849,0.0000637761,0.00064726116,0.000005626783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005661466,0.00017279455,0.132278,0.0010005477,0.00014029053,0.00001447888,0.00022162874,0.000011957176,0.8458335,0.000003985138,0.0089632375,0.005698122],"study_design_scores_gemma":[0.005602102,0.00044823007,0.47004154,0.0011961107,0.00007400462,0.0000047301996,0.00008459217,0.00068307103,0.5115155,0.000008293524,0.01005639,0.00028547356],"about_ca_topic_score_codex":0.0033698285,"about_ca_topic_score_gemma":0.0005161909,"teacher_disagreement_score":0.33776355,"about_ca_system_score_codex":0.0008273321,"about_ca_system_score_gemma":0.00091891026,"threshold_uncertainty_score":0.88874835},"labels":[],"label_agreement":null},{"id":"W1983308453","doi":"10.1158/1538-7445.am2013-169","title":"Abstract 169: Temporal trends, predictors, and outcome of chemotherapy in elderly women with advanced stage endometrial cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Chemotherapy; Radiation therapy; Proportional hazards model; Brachytherapy; Gynecology; Serous fluid; Hysterectomy; Population; Surgery","score_opus":0.06634039957560396,"score_gpt":0.4088209263197235,"score_spread":0.34248052674411955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983308453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935389,0.0028940327,0.0000013649923,0.0010844178,0.00010671373,0.0010239732,0.00011277353,0.000027286109,0.0012105417],"genre_scores_gemma":[0.9930185,0.0025164704,0.00010668771,0.00008285135,0.0002204072,0.0013200556,0.000015029161,0.000041970798,0.002677998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973469,0.000074125455,0.0004698884,0.0004598998,0.00092742447,0.0007218098],"domain_scores_gemma":[0.99863267,0.00027327013,0.00012124417,0.00031570878,0.0002635573,0.00039354322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005281398,0.00021940251,0.00068490324,0.0008434448,0.000058057507,0.000033943215,0.00016439387,0.000115386036,0.0066271205],"category_scores_gemma":[0.000100508165,0.00015072242,0.000052080217,0.0019595,0.00027277746,0.00020396976,0.00004000418,0.0004986418,0.0000068049612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008263346,0.00036489617,0.72843224,0.00038116323,0.00022850241,0.00003416497,0.0006793605,0.000009764626,0.011656952,0.000012057389,0.00030608088,0.2496315],"study_design_scores_gemma":[0.030801002,0.004094901,0.948894,0.00030042714,0.000020700385,0.0000024215096,0.0006136279,0.00000574729,0.008724148,0.000057784,0.006272808,0.00021241522],"about_ca_topic_score_codex":0.015126225,"about_ca_topic_score_gemma":0.0012785482,"teacher_disagreement_score":0.24941908,"about_ca_system_score_codex":0.0007399075,"about_ca_system_score_gemma":0.00030869787,"threshold_uncertainty_score":0.99428093},"labels":[],"label_agreement":null},{"id":"W1983357205","doi":"10.1158/0008-5472.can-06-3557","title":"Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":947,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Side population; Cancer stem cell; Biology; Population; Matrigel; Stem cell; Cancer research; Cancer; Cancer cell; Flow cytometry; Cell culture; Lung cancer; Molecular biology; Immunology; Pathology; Cell biology; Angiogenesis; Medicine; Genetics","score_opus":0.06261129612072285,"score_gpt":0.42390579244373716,"score_spread":0.3612944963230143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983357205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675023,0.029045314,0.000024089246,0.0006888425,0.0001931043,0.0009773418,0.0000512485,0.000029346287,0.0014883884],"genre_scores_gemma":[0.9811258,0.0072066598,0.000098907374,0.00044553104,0.00052095595,0.0003235937,0.000014578025,0.00006906132,0.010194938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971924,0.000080324564,0.00040199378,0.000622633,0.00085204915,0.00085064315],"domain_scores_gemma":[0.99872553,0.00009729418,0.00010330956,0.00035655787,0.00036425208,0.0003530803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009684204,0.00024009356,0.00046401273,0.00035909077,0.00018330239,0.000049599403,0.00013324586,0.00012081199,0.0010509922],"category_scores_gemma":[0.000007015376,0.00019551741,0.000054976837,0.0008644172,0.00015938646,0.00015206485,0.00008486427,0.0005699745,0.0000030655794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012805206,0.00019823143,0.34557524,0.0016917576,0.0001165646,0.00018618695,0.0030265222,0.0002224617,0.6101859,0.000034690715,0.0074458634,0.030036036],"study_design_scores_gemma":[0.00715163,0.0005060544,0.24787322,0.0017263966,0.00023418048,0.0000120857285,0.0020870054,0.00023318584,0.7180908,0.00003078201,0.021329617,0.00072505866],"about_ca_topic_score_codex":0.14431219,"about_ca_topic_score_gemma":0.09163229,"teacher_disagreement_score":0.107904874,"about_ca_system_score_codex":0.001309344,"about_ca_system_score_gemma":0.00052902556,"threshold_uncertainty_score":0.9998622},"labels":[],"label_agreement":null},{"id":"W1983464947","doi":"10.1158/1538-7445.am2013-5116","title":"Abstract 5116: The calcium channel subunit CACNG4 plays a role in breast cancer metastasis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Gene knockdown; Metastasis; Cancer research; Calcium channel; Cell migration; Breast cancer; Biology; Cell culture; Voltage-dependent calcium channel; Cancer; Medicine; Calcium; Internal medicine; Genetics","score_opus":0.06467236476981769,"score_gpt":0.3638856583602717,"score_spread":0.299213293590454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983464947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793805,0.0020240515,0.00004629346,0.0075552906,0.00033713746,0.00052537443,0.00009484872,0.000010883635,0.0014680887],"genre_scores_gemma":[0.9950338,0.0006637134,0.0000035022852,0.00031681324,0.00085416035,0.0008156021,0.00005122773,0.000024932568,0.002236221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985676,0.0001279627,0.00017467594,0.00032224928,0.00033565078,0.00047186267],"domain_scores_gemma":[0.9991523,0.000025763591,0.000040340026,0.00030559237,0.00036318766,0.00011281453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055134925,0.00012475777,0.00011397062,0.00011835435,0.0001797343,0.000067260175,0.0002572585,0.00013345497,0.0013596679],"category_scores_gemma":[0.00003201122,0.00008981692,0.000060249386,0.00033348237,0.00014254174,0.000013223215,0.000114722585,0.0003138356,0.0000991197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000374514,0.00014682792,0.004474067,0.000063621694,0.00011484326,0.0000044898497,0.0005662739,0.0039893026,0.8839299,0.00012536364,0.08562209,0.020588724],"study_design_scores_gemma":[0.0026527904,0.00021009069,0.3856981,0.00014601683,0.000025371133,0.000035647197,0.004075903,0.0039643473,0.43787736,0.00071118487,0.1637908,0.00081239553],"about_ca_topic_score_codex":0.008821637,"about_ca_topic_score_gemma":0.0012994126,"teacher_disagreement_score":0.44605252,"about_ca_system_score_codex":0.00010246937,"about_ca_system_score_gemma":0.00023094562,"threshold_uncertainty_score":0.9995532},"labels":[],"label_agreement":null},{"id":"W1983471716","doi":"10.1158/1538-7445.am2014-4948","title":"Abstract 4948: PET/CT clinical protocol design for the novel, first in class 68Ga labeled guanylyl cyclase C targeted peptide MLN6907 ([68Ga]MLN6907)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nickel Institute","funders":"","keywords":"In vivo; Medicine; Ex vivo; Vascularity; Biomarker; Positron emission tomography; Preclinical imaging; Molecular imaging; Cancer research; Nuclear medicine; Pathology; Chemistry; Biology","score_opus":0.2604551980831771,"score_gpt":0.5338957675463034,"score_spread":0.27344056946312634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983471716","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24015723,0.00031342602,0.061675,0.23797056,0.00046274666,0.45238328,0.00023545887,0.0009540501,0.005848247],"genre_scores_gemma":[0.5846539,0.00013931876,0.017100865,0.0015032256,0.0008934537,0.39330468,0.00003369557,0.00010003761,0.0022708476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996613,0.00021452938,0.0007769498,0.00066740904,0.0008429178,0.000885166],"domain_scores_gemma":[0.9945195,0.0033772646,0.00013850849,0.0010262901,0.0004988099,0.00043963885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068045934,0.00022699915,0.00047151322,0.00017797048,0.00037254326,0.00007790009,0.00066156714,0.000048971808,0.0006675743],"category_scores_gemma":[0.0031568094,0.00015339129,0.00016887356,0.0006466765,0.0006261753,0.00007882955,0.00016810368,0.0015504083,0.00008522625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022726073,0.002348082,0.0061885836,0.0012611125,0.00016379244,0.00023282279,0.00010729618,0.00013289714,0.03997033,0.0033247734,0.9295261,0.0144716175],"study_design_scores_gemma":[0.006286391,0.00065832725,0.007400283,0.0007032729,0.000045354634,0.0000697175,0.00007819761,0.029526265,0.014081866,0.0011007398,0.9397504,0.00029921392],"about_ca_topic_score_codex":0.00084655784,"about_ca_topic_score_gemma":0.00029228756,"teacher_disagreement_score":0.34449664,"about_ca_system_score_codex":0.00029417026,"about_ca_system_score_gemma":0.00084197486,"threshold_uncertainty_score":0.730947},"labels":[],"label_agreement":null},{"id":"W1983660720","doi":"10.1158/0008-5472.can-08-1127","title":"Erlotinib Attenuates Homologous Recombinational Repair of Chromosomal Breaks in Human Breast Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Erlotinib; RAD51; Cancer research; DNA repair; DNA damage; Epidermal growth factor receptor; Cancer; Homologous recombination; Biology; Breast cancer; Medicine; DNA; Genetics","score_opus":0.04013506881330303,"score_gpt":0.3536191425484176,"score_spread":0.31348407373511455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983660720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750423,0.00087001146,0.0000038278486,0.00022563712,0.00014601082,0.00031519352,0.00016451119,0.000021114012,0.00074945],"genre_scores_gemma":[0.9958681,0.0006601683,0.00011300218,0.00004615819,0.00022161532,0.0002723857,0.000053818472,0.000034219705,0.0027305752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813974,0.00020231634,0.00028071206,0.00048221115,0.0004265936,0.00046842164],"domain_scores_gemma":[0.9989965,0.000029315675,0.00007043752,0.00038934423,0.0004176001,0.00009680577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052376493,0.00013664809,0.00019972744,0.00016135901,0.00013852211,0.0000072275375,0.0003355906,0.00018251824,0.0004359199],"category_scores_gemma":[0.000036532096,0.00013958565,0.00010228233,0.00030684678,0.0003507696,0.000006911834,0.00021632652,0.00026956358,0.000010151881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010259445,0.00018213256,0.015315307,0.000046573667,0.00004195154,0.000038013815,0.000092574555,0.000064832704,0.978425,0.000120311655,0.0050369543,0.00053371146],"study_design_scores_gemma":[0.0007965422,0.0002628249,0.033815153,0.0000597709,0.0000040993723,0.000060016013,0.000045950204,0.00003369903,0.96345013,0.00016396701,0.0011459452,0.00016186839],"about_ca_topic_score_codex":0.0018298927,"about_ca_topic_score_gemma":0.0006706154,"teacher_disagreement_score":0.018499846,"about_ca_system_score_codex":0.00013257792,"about_ca_system_score_gemma":0.0004971004,"threshold_uncertainty_score":0.56921375},"labels":[],"label_agreement":null},{"id":"W1983811366","doi":"10.1158/0008-5472.can-14-2718","title":"Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Cancer research; Breast cancer; Cancer; Biology; Protein tyrosine phosphatase; Cancer cell; Apoptosis; Gene isoform; Receptor tyrosine kinase; Kinase; Cell biology; Gene; Genetics","score_opus":0.08759103560490007,"score_gpt":0.4006309142778754,"score_spread":0.31303987867297534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983811366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781781,0.019047573,0.00008729447,0.00095949817,0.00013387487,0.0007785716,0.00022265357,0.000006742885,0.00058572245],"genre_scores_gemma":[0.9962688,0.00079038215,0.00048799464,0.00008392561,0.000116242634,0.0007503167,0.000019470848,0.000023721766,0.0014591104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842113,0.00014010214,0.00020234585,0.00038883582,0.00044401057,0.000403594],"domain_scores_gemma":[0.99887776,0.000015768117,0.000046091365,0.0004231857,0.00043792752,0.00019929062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062019797,0.0001085716,0.00016206807,0.00010873133,0.000035995487,0.00001567104,0.00036078546,0.00009434954,0.000048447386],"category_scores_gemma":[0.00021980578,0.000097587785,0.000029958212,0.00034386973,0.00014494755,0.000005293467,0.00025100238,0.00015562156,0.000010812393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006341524,0.000045577297,0.00089705,0.000072166156,0.000006574713,0.000001628131,0.00011284165,0.00019441993,0.9413984,0.000052044554,0.05586681,0.0007183476],"study_design_scores_gemma":[0.0005352477,0.00014379206,0.00017773878,0.0002186234,0.0000019436116,1.1646415e-7,0.00010684603,0.0000016242101,0.9482171,0.000053296055,0.050430313,0.00011338963],"about_ca_topic_score_codex":0.001558129,"about_ca_topic_score_gemma":0.0010066701,"teacher_disagreement_score":0.018257191,"about_ca_system_score_codex":0.00013381286,"about_ca_system_score_gemma":0.0006707596,"threshold_uncertainty_score":0.39795145},"labels":[],"label_agreement":null},{"id":"W1983840193","doi":"10.1158/1538-7445.am2014-4800","title":"Abstract 4800: Heterogeneity of cancer associated fibroblasts in non-small cell lung cancer is defined by the level of collagen gel contraction activity","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Desmoplasia; Lung cancer; Stroma; Pathology; Biology; Cancer-Associated Fibroblasts; Procollagen peptidase; Parenchyma; Gene signature; Metastasis; Cancer research; Gene expression; Cancer; Medicine; Molecular biology; Gene; Immunohistochemistry; Genetics","score_opus":0.08862967476822459,"score_gpt":0.4098339586953429,"score_spread":0.3212042839271183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983840193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080056,0.004080982,0.000013766032,0.0022175007,0.0001685177,0.0012872787,0.0008425168,0.000009561847,0.0005793027],"genre_scores_gemma":[0.9941792,0.003762778,0.000011837032,0.00013812567,0.00010921111,0.001080772,0.000017481916,0.000039449413,0.0006611849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975523,0.00021097364,0.00040678142,0.000457325,0.0007908896,0.0005817492],"domain_scores_gemma":[0.9978656,0.0006017975,0.00030298348,0.00045499176,0.0006180709,0.00015653756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00099905,0.00021953858,0.00058903475,0.00014847328,0.00011709536,0.000020289031,0.00021872547,0.00019484966,0.00038335228],"category_scores_gemma":[0.00011709995,0.00016131149,0.00014966624,0.00056941266,0.00017897783,0.00008402754,0.00007904637,0.0003932427,0.000003469222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008595725,0.0011604773,0.5809907,0.0010146459,0.0005296253,0.000005075085,0.0006925919,0.00030492924,0.38351807,0.0000039685633,0.022804681,0.008115684],"study_design_scores_gemma":[0.0025418298,0.00016054804,0.5087882,0.00061408913,0.00009343023,2.8356143e-7,0.000035297908,0.0004061784,0.48678097,0.000005571215,0.000482527,0.00009106551],"about_ca_topic_score_codex":0.1402848,"about_ca_topic_score_gemma":0.06201187,"teacher_disagreement_score":0.103262916,"about_ca_system_score_codex":0.002111529,"about_ca_system_score_gemma":0.0009493018,"threshold_uncertainty_score":0.955104},"labels":[],"label_agreement":null},{"id":"W1983872188","doi":"10.1158/0008-5472.sabcs10-p1-03-08","title":"Abstract P1-03-08: Targeting Neurotensinergic Receptors for Bone Cancer Pain Relief","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Breast cancer; Agonist; Bone pain; Cancer; Cancer pain; Anesthesia; Internal medicine; Receptor","score_opus":0.10044112252815236,"score_gpt":0.3942550148682382,"score_spread":0.29381389234008587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983872188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385345,0.00019771235,0.000003869349,0.0027378523,0.0013644944,0.0006281892,0.000056362227,0.00009733904,0.0010607202],"genre_scores_gemma":[0.9931404,0.0007956397,0.00010313327,0.001747985,0.0015605837,0.00039747343,0.0000042772,0.00008610808,0.002164417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697375,0.00027223903,0.00031468607,0.00088538486,0.000489717,0.0010642499],"domain_scores_gemma":[0.9978285,0.0011817841,0.00010064457,0.00037874572,0.00026797256,0.00024236577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012489499,0.00020540257,0.00026191672,0.00015870693,0.0005677866,0.00011047423,0.00052596396,0.000117131734,0.0010935435],"category_scores_gemma":[0.0029272,0.00017553785,0.00011811595,0.0005290505,0.0004464261,0.0001643239,0.00019802581,0.0013204208,0.00015500846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018117504,0.000048982685,0.00008059993,0.00006346437,0.0000025491324,0.000027489776,0.00004362972,0.000079227444,0.9220472,0.0005165186,0.065709755,0.011199438],"study_design_scores_gemma":[0.00037209917,0.0002468202,0.00097080116,0.00004419884,0.0000030078506,0.0000027391563,0.000028212069,0.00027479287,0.58885014,0.00066442124,0.4083177,0.00022506641],"about_ca_topic_score_codex":0.0006816848,"about_ca_topic_score_gemma":0.0001556148,"teacher_disagreement_score":0.34260795,"about_ca_system_score_codex":0.00006019487,"about_ca_system_score_gemma":0.00024450236,"threshold_uncertainty_score":0.9998196},"labels":[],"label_agreement":null},{"id":"W1983909661","doi":"10.1158/1538-7445.am2011-1779","title":"Abstract 1779: Selective oncolysis of multiple myeloma cells by reovirus is mediated through apoptosis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"Apoptosis; Multiplicity of infection; Oncolytic virus; DNA fragmentation; Annexin; Cell culture; Multiple myeloma; Biology; Programmed cell death; Flow cytometry; Cancer research; Annexin A5; Fragmentation (computing); Molecular biology; Immunology; Tumor cells; Genetics","score_opus":0.07193887691151313,"score_gpt":0.37938008702465736,"score_spread":0.30744121011314424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983909661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171776,0.0023532999,0.000031007847,0.00014742685,0.00007225346,0.00055006996,0.00043231438,0.00001609928,0.0046797567],"genre_scores_gemma":[0.99375045,0.004103573,0.00017520977,0.00017478279,0.00014159818,0.0002978186,0.00008375957,0.000068165384,0.0012046613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701273,0.00030595582,0.0003444269,0.00068753207,0.00082946935,0.0008198686],"domain_scores_gemma":[0.99798787,0.00012789818,0.000110878864,0.0007371391,0.00082922087,0.00020700035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091172184,0.00022234353,0.0002966465,0.00015121489,0.00017734022,0.00002202246,0.00071816624,0.00029661306,0.0012768059],"category_scores_gemma":[0.00019425286,0.00021256744,0.00015380909,0.0007527956,0.00047704508,0.000013577055,0.00023024472,0.0004754469,0.000111873356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032849023,0.00023399269,0.0008883309,0.000049706814,0.00028023444,0.0000023519767,0.0008491465,0.00000474037,0.9520078,0.0000020081227,0.037957903,0.004438901],"study_design_scores_gemma":[0.0009141165,0.001618431,0.0004588835,0.000023930736,0.000011190236,4.499222e-7,0.00022058391,0.000009695883,0.98236644,0.000053177755,0.014106364,0.000216714],"about_ca_topic_score_codex":0.0032486196,"about_ca_topic_score_gemma":0.0007674285,"teacher_disagreement_score":0.03035868,"about_ca_system_score_codex":0.00015227274,"about_ca_system_score_gemma":0.00064041064,"threshold_uncertainty_score":0.9996362},"labels":[],"label_agreement":null},{"id":"W1983910372","doi":"10.1158/1538-7445.am2013-623","title":"Abstract 623: The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Phosphorylation; DNA damage; Serine; DNA repair; DNA; Poly ADP ribose polymerase; Cancer cell; Cell biology; Chemistry; Molecular biology; Cancer; Biology; Cancer research; Biochemistry; Genetics; Polymerase","score_opus":0.09970882893528606,"score_gpt":0.4057869596043363,"score_spread":0.30607813066905026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983910372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981721,0.008265202,0.000012975266,0.004136922,0.0001043072,0.0012769725,0.000049736725,0.000051168274,0.0043817493],"genre_scores_gemma":[0.99371886,0.0031367894,0.000045683835,0.00011882836,0.00016791506,0.00055368576,0.000012713776,0.000023010907,0.0022224823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797827,0.00008722074,0.00034507102,0.00034013987,0.0008576379,0.00039168663],"domain_scores_gemma":[0.99840695,0.00031654403,0.00007618787,0.00046307294,0.000567409,0.00016985254],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010897329,0.0001348679,0.000243394,0.00008709957,0.00017486616,0.000043512955,0.00013470423,0.00010119944,0.003064025],"category_scores_gemma":[0.000052862106,0.00009238355,0.00008267395,0.00027336617,0.00054062845,0.0001633387,0.00004890351,0.00045864485,0.000085562395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049841106,0.0003829249,0.048771027,0.0017331734,0.00060330535,0.000032937263,0.0068664765,0.00013010894,0.8238504,0.0009680425,0.05515496,0.05652256],"study_design_scores_gemma":[0.010972854,0.0006716983,0.32106328,0.00090671325,0.00006380145,0.000046876918,0.0027023721,0.00022180569,0.6225834,0.0029310426,0.037466668,0.000369515],"about_ca_topic_score_codex":0.0040721293,"about_ca_topic_score_gemma":0.00013539096,"teacher_disagreement_score":0.27229226,"about_ca_system_score_codex":0.00021856275,"about_ca_system_score_gemma":0.00026707587,"threshold_uncertainty_score":0.9978473},"labels":[],"label_agreement":null},{"id":"W1983969086","doi":"10.1158/1538-7445.am2011-1450","title":"Abstract 1450: Loss of the UPR member CREB3L1 is vital for the survival of breast cancer cells in the tumor microenvironment and development of the metastatic phenotype","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Cancer research; Metastasis; Cancer; Breast cancer; Unfolded protein response; Transfection; Angiogenesis; Cancer cell; Biology; Microarray analysis techniques; Tumor microenvironment; Medicine; Cell culture; Internal medicine; Endoplasmic reticulum; Gene expression; Gene; Cell biology","score_opus":0.056916170916543295,"score_gpt":0.33239134011741406,"score_spread":0.2754751692008708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983969086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674374,0.0017818302,0.000012344081,0.00033186263,0.00006942818,0.00052001793,0.00039835568,3.719238e-7,0.0001420746],"genre_scores_gemma":[0.9991472,0.0004686822,0.00004722285,0.00006337926,0.000025460846,0.00015876642,0.000002424039,0.000010372183,0.000076523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897367,0.0001047843,0.0002215058,0.00017661993,0.00030901,0.00021441166],"domain_scores_gemma":[0.99932015,0.00007819692,0.00010568533,0.00037547838,0.000087961824,0.00003250079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049276714,0.00009271944,0.00012258365,0.00001476342,0.00009547519,0.000006890323,0.00044728737,0.00002691957,0.00012437697],"category_scores_gemma":[0.000023310778,0.000040778945,0.0000717458,0.00008302536,0.0005044542,0.000002972059,0.00020364465,0.00010747528,4.296372e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068446033,0.00030612905,0.0402005,0.00046879478,0.00024583837,0.0000014466734,0.0035721834,0.000114391834,0.9502834,0.000075446194,0.0013263519,0.0027210736],"study_design_scores_gemma":[0.00046972954,0.000027636717,0.21912308,0.00005679517,0.000028107004,0.0000012837538,0.0011063823,0.000007988701,0.7778912,0.000041005627,0.0011887052,0.000058082944],"about_ca_topic_score_codex":0.0008845356,"about_ca_topic_score_gemma":0.00064095116,"teacher_disagreement_score":0.17892258,"about_ca_system_score_codex":0.000022891147,"about_ca_system_score_gemma":0.00028549018,"threshold_uncertainty_score":0.18586825},"labels":[],"label_agreement":null},{"id":"W1984084081","doi":"10.1158/1538-7445.am2014-5540","title":"Abstract 5540: Preclinical investigation of the novel histone deacetylase (HDAC) inhibitor AR-42 in the treatment of cancer-induced cachexia","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cachexia; Medicine; Skeletal muscle; Vorinostat; Cancer; Internal medicine; Histone deacetylase inhibitor; Lewis lung carcinoma; Weight loss; Histone deacetylase; Cancer research; Endocrinology; Oncology; Biology; Histone; Obesity","score_opus":0.11614954142874488,"score_gpt":0.443476966070967,"score_spread":0.3273274246422221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984084081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953076,0.0013611753,0.000006354838,0.0019258672,0.00018266618,0.0008338769,0.000072202434,0.0000043102464,0.00030592032],"genre_scores_gemma":[0.99797064,0.0004923885,0.000032721073,0.00006905863,0.0004914142,0.00051051273,0.00002678778,0.000030107347,0.0003763575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970213,0.00060271384,0.00053082034,0.0004813823,0.00087921007,0.00048453637],"domain_scores_gemma":[0.99809647,0.000281057,0.00017789456,0.0009122363,0.00038630285,0.00014605315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019068541,0.00018172867,0.00028164004,0.00013546571,0.000153024,0.000017938526,0.000643058,0.00024558677,0.000044032546],"category_scores_gemma":[0.0007126855,0.000117255986,0.0001650268,0.0005465704,0.00078544294,0.000007743641,0.00012410583,0.0004401587,0.00000515014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024873664,0.00033842854,0.0033339171,0.000105097686,0.00003793481,0.0000011660749,0.0007915023,0.00009855025,0.98927176,0.000047540965,0.0017891855,0.003936178],"study_design_scores_gemma":[0.0013613725,0.0006463742,0.023201117,0.0001063305,0.000012386348,0.0000017165366,0.0001269294,0.0000522914,0.9644304,0.000030171226,0.009914902,0.000116045914],"about_ca_topic_score_codex":0.008839739,"about_ca_topic_score_gemma":0.0087556625,"teacher_disagreement_score":0.0248414,"about_ca_system_score_codex":0.00044728612,"about_ca_system_score_gemma":0.0012628174,"threshold_uncertainty_score":0.9977605},"labels":[],"label_agreement":null},{"id":"W1984161746","doi":"10.1158/1538-7445.am2011-1703","title":"Abstract 1703: Importance of pregnane X receptor (PXR) and P-glycoprotein (MDR1) to tamoxifen response and endoxifen disposition","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pregnane X receptor; Tamoxifen; Pharmacology; Estrogen receptor; CYP3A4; Abcg2; P-glycoprotein; Breast cancer; Biology; Internal medicine; Endocrinology; Chemistry; Cytochrome P450; Nuclear receptor; Cancer; Multiple drug resistance; Transporter; Medicine; Drug resistance; Biochemistry; ATP-binding cassette transporter; Metabolism","score_opus":0.03575237916178119,"score_gpt":0.33882326332878565,"score_spread":0.30307088416700445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984161746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925394,0.0062950063,0.000009811434,0.00019186155,0.000037471447,0.00054406794,0.000038404385,0.000007120687,0.00033684098],"genre_scores_gemma":[0.9972771,0.0016151852,0.00027159392,0.00003219769,0.000070535054,0.00015522038,0.00001790049,0.000022450515,0.00053784903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882823,0.00015421041,0.00016575746,0.00035878285,0.00019434249,0.00029870356],"domain_scores_gemma":[0.99932665,0.000035713307,0.000048908456,0.00027213545,0.0001248711,0.00019170142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007256459,0.00011260569,0.00013336018,0.00008339453,0.00008480138,0.000014575168,0.00013020569,0.0001651279,0.00005769603],"category_scores_gemma":[0.00014682395,0.00009844338,0.000029447436,0.00014138063,0.00020449574,0.000007700729,0.00014932193,0.00019583691,0.000007399433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031663566,0.000041773885,0.00539744,0.000065942746,0.000038761074,0.000011427421,0.0003208901,7.0908203e-7,0.9868268,0.000035056986,0.0007213308,0.0033735123],"study_design_scores_gemma":[0.00045334297,0.0008616532,0.048596982,0.00011485967,0.000006472314,0.000009548927,0.000063374435,0.0000013404012,0.94840705,0.000056458153,0.0013114474,0.00011744225],"about_ca_topic_score_codex":0.00016677615,"about_ca_topic_score_gemma":0.000025850464,"teacher_disagreement_score":0.043199543,"about_ca_system_score_codex":0.00002509003,"about_ca_system_score_gemma":0.00010843272,"threshold_uncertainty_score":0.40144044},"labels":[],"label_agreement":null},{"id":"W1984236918","doi":"10.1158/1538-7445.am2014-2433","title":"Abstract 2433: Metabolic reprogramming by an epigenetic mechanism in endocrine therapy resistance of breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational and Environmental Medical Association of Canada","funders":"","keywords":"Reprogramming; Epigenetics; Tamoxifen; Cancer research; Biology; Histone methyltransferase; Breast cancer; Cancer; Cell; Gene; Genetics","score_opus":0.03284683424659222,"score_gpt":0.36424231291724585,"score_spread":0.3313954786706536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984236918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323521,0.0658024,0.00011227414,0.00031132682,0.00041370146,0.00044583224,0.00017140024,0.000012970812,0.00037799223],"genre_scores_gemma":[0.94542027,0.0513851,0.00016513697,0.00010686194,0.0012362323,0.0004899443,0.000044658416,0.000056622404,0.001095162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997396,0.00027061885,0.0003691995,0.0007267259,0.0004969922,0.00074044673],"domain_scores_gemma":[0.9985161,0.000030173045,0.000114377384,0.00078653224,0.0003515573,0.00020129996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011823314,0.00021362359,0.00037173805,0.00015832482,0.000101628786,0.000038355036,0.000505738,0.00012335081,0.00022051403],"category_scores_gemma":[0.00006660112,0.00020329774,0.00009657951,0.00041024294,0.00021528381,0.000013690745,0.0001066717,0.00031239234,0.0000030455974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037126936,0.00012343614,0.00082480017,0.000049727118,0.000042791497,0.0000010528224,0.00009204233,0.000029758829,0.9077798,0.00030544883,0.0016811204,0.08869872],"study_design_scores_gemma":[0.0011389583,0.00008765228,0.013986965,0.000050295308,0.000007371023,0.0000029712035,0.00006511226,0.000008536561,0.6566272,0.00036265128,0.32745546,0.00020686834],"about_ca_topic_score_codex":0.004598038,"about_ca_topic_score_gemma":0.0064768037,"teacher_disagreement_score":0.32577434,"about_ca_system_score_codex":0.00005087663,"about_ca_system_score_gemma":0.00034302735,"threshold_uncertainty_score":0.82902414},"labels":[],"label_agreement":null},{"id":"W1984252859","doi":"10.1158/0008-5472.sabcs13-p6-10-03","title":"Abstract P6-10-03: Comparative efficacy of everolimus in combination with exemestane and chemotherapy for advanced breast cancer in terms of progression-free survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Progression-free survival; Hazard ratio; Cancer; Meta-analysis; Chemotherapy; Tamoxifen; Confidence interval","score_opus":0.05116332335270693,"score_gpt":0.4282500882082477,"score_spread":0.3770867648555408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984252859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376774,0.0010412065,0.00002957952,0.0020716,0.00003718182,0.002734405,0.00009498917,0.000012696334,0.0002105792],"genre_scores_gemma":[0.9973083,0.00040986604,0.0006614352,0.000026169708,0.000043903197,0.001355826,0.0000124641365,0.000036675618,0.00014535812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812776,0.000069191934,0.0003886645,0.00036467172,0.00061635056,0.00043336596],"domain_scores_gemma":[0.99840057,0.0003625103,0.00017530634,0.00034332252,0.00061003916,0.000108238826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041892135,0.00018144851,0.0005878524,0.00031799026,0.00003646637,0.000011313275,0.00019213412,0.00007823402,0.0003403419],"category_scores_gemma":[0.000046439498,0.0001373683,0.000034441182,0.00056112575,0.00050435157,0.0002474471,0.000049178427,0.00029266722,9.354739e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036769457,0.0016211127,0.2395188,0.0017515251,0.00020182751,0.00001219621,0.0058205584,0.00044734537,0.23519146,0.00019114956,0.00017006985,0.47830448],"study_design_scores_gemma":[0.022462567,0.00078064075,0.94156325,0.002100148,0.000008291883,0.0000058247583,0.0005788158,0.00017022592,0.03137996,0.0006695316,0.00013256194,0.00014816076],"about_ca_topic_score_codex":0.0012175618,"about_ca_topic_score_gemma":0.0010473174,"teacher_disagreement_score":0.7020444,"about_ca_system_score_codex":0.000348469,"about_ca_system_score_gemma":0.00027390532,"threshold_uncertainty_score":0.5601717},"labels":[],"label_agreement":null},{"id":"W1984383126","doi":"10.1158/1538-7445.am2013-1977","title":"Abstract 1977: The protein phosphatase 2 subunit PR48 is a novel melanoma tumor suppressor gene.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Jewish General Hospital","funders":"","keywords":"Melanoma; Cell cycle; Biology; Cancer research; Ectopic expression; Small hairpin RNA; Tumor progression; Cell growth; Protein subunit; Cancer; Tumor suppressor gene; Metastasis; Cell culture; Molecular biology; Carcinogenesis; Gene; Genetics; Gene knockdown","score_opus":0.05754206354359743,"score_gpt":0.3367499962151376,"score_spread":0.2792079326715402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984383126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892798,0.0041220402,0.00002199138,0.0024041927,0.00007059193,0.0016782064,0.00042830463,0.000014859213,0.001980019],"genre_scores_gemma":[0.99212015,0.00013126856,0.00016708902,0.0005738606,0.00049931026,0.0026294985,0.00009998045,0.00004276209,0.0037360596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981153,0.00010499332,0.00019835457,0.00046313505,0.00044741787,0.00067080697],"domain_scores_gemma":[0.9986371,0.000033141918,0.000058983973,0.0007287508,0.00034985712,0.00019220733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064350484,0.00017591944,0.00013149927,0.000050366005,0.0003035598,0.00014513997,0.00068989943,0.00012086624,0.0025904153],"category_scores_gemma":[0.00013631291,0.00012497853,0.00008394238,0.00019050347,0.0002781738,0.000010730807,0.00031713836,0.00041247238,0.0004089377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088906345,0.00006809653,0.00020242458,0.000055084864,0.00004040598,0.0000054071215,0.000100491845,0.000002258947,0.96243286,0.00010029793,0.0352745,0.0016292669],"study_design_scores_gemma":[0.00043167334,0.00013544521,0.0018157786,0.00003174325,0.0000034064874,0.0000074267555,0.000079020254,0.000016847256,0.8531584,0.0001234286,0.1440436,0.00015319843],"about_ca_topic_score_codex":0.0021037213,"about_ca_topic_score_gemma":0.00010003577,"teacher_disagreement_score":0.109274425,"about_ca_system_score_codex":0.000039787337,"about_ca_system_score_gemma":0.000355416,"threshold_uncertainty_score":0.99832135},"labels":[],"label_agreement":null},{"id":"W1984555565","doi":"10.1158/1538-7445.am2014-lb-165","title":"Abstract LB-165: Early detection of the therapeutic effect in tumors treated with a thermosensitive liposome (TSL) using noninvasive ultrasound and photoacoustic imaging","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; Ontario Institute for Cancer Research","funders":"","keywords":"Photoacoustic imaging in biomedicine; Medicine; Liposome; Drug delivery; Therapeutic effect; Ultrasound; Drug; Ultrasound imaging; Cancer research; Pharmacology; Biomedical engineering; Nuclear medicine; Radiology; Materials science; Nanotechnology","score_opus":0.015369050011033855,"score_gpt":0.27212343849437487,"score_spread":0.25675438848334103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984555565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980353,0.00070797675,0.00029321216,0.000006476167,0.00007703843,0.0006435849,0.000014525113,0.000043967815,0.00017790179],"genre_scores_gemma":[0.9996908,0.00009006713,0.000011141627,0.000011304163,0.0000557531,0.00006173285,7.683596e-7,0.00007068465,0.00000779738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986379,0.000110087436,0.00018977496,0.00023027512,0.000379678,0.00045224788],"domain_scores_gemma":[0.9987577,0.00073611527,0.00004967086,0.00025981365,0.00013342897,0.000063241896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005021663,0.0001935361,0.00025314643,0.00021511751,0.00012150329,0.00005503302,0.00015057021,0.00008211201,0.0000095260775],"category_scores_gemma":[0.00006595965,0.00013208982,0.000040348288,0.00067744835,0.00027814278,0.00017749719,0.00002651231,0.0006675948,0.0000016581555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018027912,0.000008752023,0.018039562,0.00016877224,0.000057602727,0.000009958391,0.00079364487,0.006307734,0.9686345,0.000003361163,4.2017297e-7,0.0057954397],"study_design_scores_gemma":[0.0009800781,0.0001594408,0.13111752,0.0005801956,0.00003418617,0.000026215548,0.00017184827,0.009208754,0.85742134,0.000120716555,0.000004970554,0.00017474388],"about_ca_topic_score_codex":0.0021089076,"about_ca_topic_score_gemma":0.0006009328,"teacher_disagreement_score":0.11307797,"about_ca_system_score_codex":0.0004553537,"about_ca_system_score_gemma":0.00008372666,"threshold_uncertainty_score":0.53864664},"labels":[],"label_agreement":null},{"id":"W1984619149","doi":"10.1158/1538-7445.am10-3449","title":"Abstract 3449: Tungsten induces DNA damage and alters growth of developing B lymphocytes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stromal cell; Tungsten; Apoptosis; Leukemia; Lymphoblast; Peripheral blood mononuclear cell; Biology; Cell growth; Cell culture; Cancer research; Chemistry; Cell biology; Molecular biology; Immunology; Biochemistry; Genetics; In vitro","score_opus":0.10721963329830105,"score_gpt":0.44038256787540236,"score_spread":0.33316293457710133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984619149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904735,0.0006738113,0.000003707212,0.0041055623,0.00019481557,0.00036733338,0.00000640766,0.000019874875,0.004154978],"genre_scores_gemma":[0.99730986,0.001161335,0.000281507,0.0002535614,0.0003398709,0.000049160364,0.000004749548,0.000018063,0.0005818694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975593,0.000046775025,0.00023365927,0.00035802776,0.0011893077,0.00061292615],"domain_scores_gemma":[0.99819416,0.00033493998,0.000046623147,0.00030226455,0.00069449755,0.00042750742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021053683,0.00011352506,0.00027533554,0.0005010776,0.00016103552,0.000034140292,0.00028768467,0.00010250326,0.00031372948],"category_scores_gemma":[0.0010664534,0.00008322845,0.000033350305,0.00075994275,0.0011784468,0.00015615487,0.0001563049,0.00068166706,0.000014216181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015378396,0.000035004185,0.030869855,0.00044327002,0.000029693085,0.000058162583,0.0009887137,7.853444e-8,0.95224255,0.00057348964,0.0013866283,0.013218748],"study_design_scores_gemma":[0.0014658964,0.00018443477,0.4369632,0.00043613464,0.000010650569,0.000027872884,0.0010421646,0.000017980856,0.5574785,0.00023711972,0.0020303917,0.000105650615],"about_ca_topic_score_codex":0.0020532922,"about_ca_topic_score_gemma":0.00023837308,"teacher_disagreement_score":0.40609336,"about_ca_system_score_codex":0.00013418413,"about_ca_system_score_gemma":0.001739012,"threshold_uncertainty_score":0.43420365},"labels":[],"label_agreement":null},{"id":"W1984699932","doi":"10.1158/0008-5472.can-04-2102","title":"Regulation of Protein Catabolism by Muscle-Specific and Cytokine-Inducible Ubiquitin Ligase E3α-II during Cancer Cachexia","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ubiquitin ligase; Cachexia; Myogenesis; Ubiquitin; Wasting; Skeletal muscle; Protein degradation; Proteasome; Biology; Catabolism; Endocrinology; Proinflammatory cytokine; Cancer; Internal medicine; Cancer research; Cell biology; Biochemistry; Immunology; Inflammation; Medicine; Metabolism","score_opus":0.04121954133012316,"score_gpt":0.3310382325214565,"score_spread":0.2898186911913333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984699932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854157,0.012596567,0.00003338975,0.0006825754,0.000056139255,0.00066721626,0.00023378212,0.00001324965,0.00030140145],"genre_scores_gemma":[0.994793,0.0026815915,0.00013479954,0.000025747288,0.00044285628,0.000536087,0.00007554474,0.000038646187,0.0012717156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998309,0.00009799056,0.0002341028,0.0005229303,0.00036100176,0.00047494896],"domain_scores_gemma":[0.99906987,0.00000745624,0.000079492915,0.0004107556,0.0002725942,0.00015984027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047586663,0.00015745884,0.00017486689,0.00010483835,0.00027761352,0.000031196894,0.00021814779,0.00018273774,0.00010748173],"category_scores_gemma":[0.000051231298,0.00015724052,0.00004476414,0.00025735292,0.0002332849,0.000012179337,0.00026011074,0.00026690698,0.0000037267512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014800238,0.000052093837,0.00016208517,0.00014170232,0.000018056813,0.0000025561644,0.00030184456,0.000056216923,0.99464446,0.00028058773,0.0005539904,0.003638382],"study_design_scores_gemma":[0.0010497198,0.00015522553,0.0024613289,0.00016948904,0.000004054369,0.0000037561226,0.000086365704,0.0000022961874,0.9669005,0.00029946957,0.028697573,0.00017020128],"about_ca_topic_score_codex":0.0015302066,"about_ca_topic_score_gemma":0.000262565,"teacher_disagreement_score":0.028143583,"about_ca_system_score_codex":0.00011421703,"about_ca_system_score_gemma":0.00034524366,"threshold_uncertainty_score":0.64120823},"labels":[],"label_agreement":null},{"id":"W1984741870","doi":"10.1158/0008-5472.sabcs-09-2063","title":"Comparative Analysis of Breast Cancer (BrCa) Mortality Reduction among Regions of Canada between 1950 – 2004: Impact of Systemic and Diagnostic Guidelines after 1977, with Model Definition of Number of Potentially Avoided Annual Deaths (N-PAAD).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Demography; Medicine; Cancer; Breast cancer; Mortality rate; Guideline; Internal medicine; Pathology","score_opus":0.16496336487364913,"score_gpt":0.4612321730859561,"score_spread":0.29626880821230694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984741870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453616,0.0016963744,0.0003433059,0.0001968424,0.00001487984,0.00044909862,0.0026135533,0.0000041341614,0.00014564893],"genre_scores_gemma":[0.9989644,0.00054220937,0.00029081095,0.000007687173,0.00005412684,0.00004757446,0.00005596335,0.000009177435,0.000028017957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971549,0.00016261893,0.00086356857,0.00030530023,0.0011913155,0.00032228473],"domain_scores_gemma":[0.994708,0.00015494434,0.0005377543,0.00036844923,0.004050885,0.00017995592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063246605,0.00017289016,0.0010768286,0.00034069378,0.00004790134,0.0000045334164,0.00013396356,0.00009286211,0.00006263151],"category_scores_gemma":[0.00014814366,0.00013677253,0.00016770988,0.0013682899,0.000462417,0.00017099343,0.000035197456,0.00022024338,5.1872913e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016308763,0.00007774066,0.9472401,0.00041062044,0.0019757147,0.000010436287,0.0010747002,0.036064398,0.010096708,0.00004994542,0.0010853651,0.00028335472],"study_design_scores_gemma":[0.00078038446,0.00032247187,0.98658437,0.0023567474,0.0017233726,0.000018706503,0.0013584719,0.0014437387,0.005157065,0.00013928564,3.286401e-7,0.00011508037],"about_ca_topic_score_codex":0.7390603,"about_ca_topic_score_gemma":0.23802395,"teacher_disagreement_score":0.50103635,"about_ca_system_score_codex":0.00047523744,"about_ca_system_score_gemma":0.002979705,"threshold_uncertainty_score":0.7758801},"labels":[],"label_agreement":null},{"id":"W1984774118","doi":"10.1158/1538-7445.am2014-1963","title":"Abstract 1963: Toll-like receptor activation in bacterial pneumonia increases lung cancer cell adhesion and metastasis formation","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"TLR2; TLR4; Metastasis; Pneumonia; Lung cancer; Immunology; Lipopolysaccharide; Medicine; Biology; Cancer research; Pathology; Cancer; Microbiology; Inflammation; Internal medicine","score_opus":0.029087493196512694,"score_gpt":0.3323720746071759,"score_spread":0.30328458141066317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984774118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641734,0.0020627805,0.000020179441,0.00040374085,0.00029815064,0.00040038035,0.000016304604,0.000023948027,0.00035717044],"genre_scores_gemma":[0.9962988,0.0026517096,0.0000141763285,0.000034540426,0.000094413685,0.00025849385,0.00017682849,0.000015784331,0.00045528766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983434,0.00062702567,0.00029951168,0.00024475486,0.00010219172,0.00038312687],"domain_scores_gemma":[0.9992113,0.00032140384,0.00010450699,0.00018556752,0.00014919425,0.00002801893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010898216,0.00012876367,0.00020003747,0.00023618511,0.00023960734,0.000050056933,0.00013376793,0.00019561774,0.0015802599],"category_scores_gemma":[0.00014437763,0.0001160226,0.00003426899,0.00019084282,0.00009307723,0.0006480184,0.00007971685,0.0003327902,0.000075178585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905968,0.000044468903,0.00064098596,0.000117383235,0.000021999123,2.30775e-7,0.00043292702,0.000006214412,0.9681406,0.00004040659,0.0027568517,0.02680731],"study_design_scores_gemma":[0.0012149716,0.00008913126,0.02288672,0.0001788733,0.000010729693,0.000001250703,0.00021883847,0.000033320506,0.94183123,0.000019344445,0.03338179,0.00013379913],"about_ca_topic_score_codex":0.0070479107,"about_ca_topic_score_gemma":0.00088479585,"teacher_disagreement_score":0.030624937,"about_ca_system_score_codex":0.00035767708,"about_ca_system_score_gemma":0.00013340074,"threshold_uncertainty_score":0.99956423},"labels":[],"label_agreement":null},{"id":"W1984901059","doi":"10.1158/1538-7445.am2011-4917","title":"Abstract 4917: PRKCE and other genetic networks in osteosarcoma metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Osteosarcoma; Metastasis; Gene; Medicine; Cancer; Interactome; Oncology; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.087256895886929,"score_gpt":0.3908844360310217,"score_spread":0.30362754014409266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984901059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901676,0.0047257473,0.001304711,0.000113101894,0.00001786329,0.00036112813,0.000017417238,0.000010783613,0.003281605],"genre_scores_gemma":[0.9963039,0.0012790111,0.0015565351,0.00019645391,0.00007282403,0.00040085925,0.000010368144,0.000021416574,0.00015863113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999033,0.00008479882,0.00013441076,0.0003418312,0.000086485874,0.0003194917],"domain_scores_gemma":[0.9995012,0.0000098954815,0.000025868676,0.0003264985,0.000059080565,0.00007744383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035751567,0.00009158033,0.00009199358,0.00006777396,0.000064969005,0.000012781823,0.00020863666,0.00014511042,0.00012804675],"category_scores_gemma":[0.00001804321,0.000083772866,0.000030448808,0.00015044904,0.00020221906,0.0000016148991,0.00015370686,0.00019563019,0.000004887639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001715735,0.00016217418,0.054906998,0.000037816037,0.000076756005,0.000022740314,0.00013537497,0.00002498787,0.88171357,0.0012763018,0.003635008,0.0578367],"study_design_scores_gemma":[0.0008642317,0.0004904799,0.19771034,0.00006255007,0.000018046048,0.000033485874,0.0001346079,0.0001131633,0.62824047,0.001497907,0.17032607,0.000508619],"about_ca_topic_score_codex":0.00066041684,"about_ca_topic_score_gemma":0.00045997658,"teacher_disagreement_score":0.25347307,"about_ca_system_score_codex":0.0000143385405,"about_ca_system_score_gemma":0.000051896015,"threshold_uncertainty_score":0.34161583},"labels":[],"label_agreement":null},{"id":"W1985144105","doi":"10.1158/1538-7445.fbcr13-a09","title":"Abstract A09: Downregulation of PI3K signaling by high ERK activity prevents transformation by oncogenic RAS","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Protein kinase B; Cell biology; Biology; Signal transduction; PTEN; Cancer research; Senescence","score_opus":0.025523660509246805,"score_gpt":0.3437683311013616,"score_spread":0.3182446705921148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985144105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591583,0.0023960834,0.00026257,0.0001872224,0.00038118838,0.00050149026,0.00009241814,0.0000046579366,0.00025854955],"genre_scores_gemma":[0.99666953,0.0014749857,0.000022329381,0.000019657044,0.00090804644,0.00020446563,0.00014165646,0.00001591117,0.000543439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987821,0.00010398384,0.0002211074,0.00025283202,0.00032792354,0.00031208005],"domain_scores_gemma":[0.99946874,0.000021135684,0.00006860644,0.0002055861,0.00015623233,0.00007972425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048586616,0.00009976147,0.00015124872,0.0000715213,0.0000574826,0.000022429094,0.00015870623,0.00014306493,0.00025377708],"category_scores_gemma":[0.00002760929,0.00009821195,0.000059616985,0.000162559,0.000080086975,0.000026378164,0.000028687746,0.00017388599,0.0000086025475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010666162,0.00006751245,0.00017444775,0.00006258959,0.000021645184,1.05792095e-8,0.00009443468,0.000109168555,0.9477456,0.0000074400496,0.024018103,0.027592365],"study_design_scores_gemma":[0.00081727456,0.00007368137,0.012437125,0.000035996225,0.0000055646774,3.0437084e-7,0.000048275055,0.000029061839,0.9430161,0.00008842112,0.04333661,0.00011158672],"about_ca_topic_score_codex":0.00392368,"about_ca_topic_score_gemma":0.00016433821,"teacher_disagreement_score":0.02748078,"about_ca_system_score_codex":0.00008002468,"about_ca_system_score_gemma":0.00017446453,"threshold_uncertainty_score":0.5931457},"labels":[],"label_agreement":null},{"id":"W1985269876","doi":"10.1158/1538-7445.am2013-2474","title":"Abstract 2474: Synthesis and antiproliferative activity of novel 17β-acetyl-testosterone-7α-platinum(II) hybrids designed for the treatment of human prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Prostate cancer; LNCaP; DU145; Medicine; Cancer; Cancer research; Testosterone (patch); Internal medicine; Prostate; Androgen receptor; Bicalutamide; Oncology; Androgen; Endocrinology; Hormone","score_opus":0.23805814350619472,"score_gpt":0.4214775671484535,"score_spread":0.1834194236422588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985269876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916471,0.0037870067,0.000023319337,0.0011732747,0.00003445841,0.0028605203,0.0001851511,0.00001105318,0.00027807083],"genre_scores_gemma":[0.9937732,0.0018045957,0.00023911842,0.000013548744,0.00010600367,0.0027831863,0.0000031440914,0.00003330269,0.0012438837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984323,0.0001081962,0.00031458345,0.00032286363,0.0004318413,0.0003902442],"domain_scores_gemma":[0.9977625,0.00105287,0.0001495447,0.00037779025,0.0005484185,0.00010890354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005906003,0.00019158032,0.000566729,0.000107097105,0.00038345714,0.000036665137,0.00013793085,0.00005732846,0.00045895673],"category_scores_gemma":[0.00018302744,0.00010853064,0.00010307885,0.00015682925,0.0005413925,0.00012535248,0.000056778656,0.00013393647,0.0000017103704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000977219,0.00042275107,0.0034851325,0.00048366206,0.00027005104,5.515458e-7,0.0016469291,0.0000074260765,0.92989975,0.000032959393,0.00032234745,0.06245124],"study_design_scores_gemma":[0.0012156292,0.002432693,0.052708693,0.0003510572,0.000093740855,0.000002178105,0.000347086,0.00027076303,0.9418264,0.000027259646,0.00061754097,0.00010692993],"about_ca_topic_score_codex":0.0075053554,"about_ca_topic_score_gemma":0.00037955205,"teacher_disagreement_score":0.06234431,"about_ca_system_score_codex":0.00014938702,"about_ca_system_score_gemma":0.00026929422,"threshold_uncertainty_score":0.9991037},"labels":[],"label_agreement":null},{"id":"W1985492248","doi":"10.1158/1538-7445.am2011-1000","title":"Abstract 1000: Inactivation of notch1 signaling suppresses FGFR1 knockdown-dependent growth inhibition of MDA-MB-231 breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Cancer research; Notch signaling pathway; Cancer; Biology; Gene knockdown; Phenotype; Carcinogenesis; Signal transduction; Gene; Genetics","score_opus":0.053360435838245394,"score_gpt":0.33909491690774063,"score_spread":0.2857344810694952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985492248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969332,0.00052651856,0.00009452678,0.00011194026,0.00010313601,0.0004602386,0.00045454805,0.000010594432,0.0013052574],"genre_scores_gemma":[0.9983194,0.0008394146,0.00008018895,0.000012534771,0.00023177497,0.00016020623,0.00006236135,0.000052212516,0.00024192654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973037,0.00020525527,0.00043909214,0.0005242121,0.00092820637,0.00059949857],"domain_scores_gemma":[0.99761665,0.0000776774,0.00019020961,0.00044183695,0.001511027,0.00016260508],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075901265,0.00019999001,0.00026536742,0.0003002952,0.00010574622,0.000023922657,0.00040509782,0.00024629346,0.0013142559],"category_scores_gemma":[0.000092653994,0.00019153485,0.000108007334,0.0004203006,0.00037874124,0.000034890705,0.0003090096,0.0004322085,0.000013790777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008799792,0.0002028132,0.0055409167,0.00057597633,0.00009127714,0.0000045457073,0.0002877735,0.00006389715,0.9902871,0.000067348315,0.0010646188,0.0009337406],"study_design_scores_gemma":[0.000559637,0.0002498764,0.026213609,0.00026410996,0.000009824772,0.0000027721578,0.00021096111,0.000006103754,0.9720934,0.00010132197,0.00011219675,0.00017615664],"about_ca_topic_score_codex":0.0068030274,"about_ca_topic_score_gemma":0.0002519443,"teacher_disagreement_score":0.020672692,"about_ca_system_score_codex":0.00015697582,"about_ca_system_score_gemma":0.0006331799,"threshold_uncertainty_score":0.99981076},"labels":[],"label_agreement":null},{"id":"W1985497084","doi":"10.1158/1538-7445.am2014-2248","title":"Abstract 2248: The implication of STAT3 degradation and its mitochondrial functions in cellular senescence","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Senescence; STAT3; Cell biology; Phosphorylation; DNA damage; Biology; Mitochondrion; Transcription factor; STAT protein; Biochemistry; Gene; DNA","score_opus":0.0504418124512604,"score_gpt":0.3540022770453503,"score_spread":0.3035604645940899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985497084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953273,0.0028743069,0.00016528019,0.0007235855,0.00024715994,0.00023612351,0.0000130927965,0.000006757227,0.0004063855],"genre_scores_gemma":[0.9975652,0.00027553234,0.000002739743,0.000013396738,0.000029820754,0.0000667135,0.000018809998,0.00000550892,0.0020222948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911016,0.00033777492,0.00015802098,0.00014707587,0.000048318532,0.00019863009],"domain_scores_gemma":[0.99929553,0.00033144437,0.000040511328,0.00017364154,0.00014910313,0.000009758384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005579244,0.000053441654,0.00008655615,0.00011671259,0.00013315289,0.000011179401,0.00013692005,0.000079810416,0.0002636158],"category_scores_gemma":[0.00020564614,0.00003839667,0.000018773515,0.00016235597,0.00017471197,0.000061428254,0.00004786437,0.00029205412,0.00008065555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030813695,0.000024637553,0.00045410218,0.000017930446,0.000010575832,1.1521141e-7,0.00022365802,0.0000028859445,0.9922264,0.00085384905,0.000931063,0.004946596],"study_design_scores_gemma":[0.00047723055,0.000099777695,0.033662822,0.00004223947,0.0000035075655,0.000002303933,0.00029352997,0.000013815785,0.94565123,0.00006994765,0.0196364,0.000047212405],"about_ca_topic_score_codex":0.0005996196,"about_ca_topic_score_gemma":0.00015701393,"teacher_disagreement_score":0.046575237,"about_ca_system_score_codex":0.000042111827,"about_ca_system_score_gemma":0.00008938743,"threshold_uncertainty_score":0.28864083},"labels":[],"label_agreement":null},{"id":"W1985500090","doi":"10.1158/1538-7445.am2011-1680","title":"Abstract 1680: Effect of folate and γ-glutamyl hydrolase modulation on in vitro chemosensitivity of colon and breast cancer cells to antifolates and 5-fluorouracil","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Social Innovation; University of Toronto","funders":"","keywords":"Antifolate; Thymidylate synthase; Antimetabolite; Cancer research; Chemistry; Methotrexate; In vitro; Transfection; Pharmacology; Intracellular; Colorectal cancer; Fluorouracil; Cancer; Internal medicine; Biology; Biochemistry; Medicine","score_opus":0.02699316955990902,"score_gpt":0.3422572867156643,"score_spread":0.3152641171557553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985500090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979351,0.0011428763,0.0000017777768,0.00007177397,0.000017360682,0.00048031972,0.00026278888,0.000002191908,0.00008582015],"genre_scores_gemma":[0.99816483,0.0016486351,0.000020613339,0.000009130681,0.000026086645,0.00007332203,0.000012838597,0.000014626531,0.000029897996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988981,0.00011310831,0.00014003844,0.00035048075,0.00020890735,0.0002893952],"domain_scores_gemma":[0.9994666,0.00006114331,0.000044640892,0.00017062495,0.00010838077,0.00014859461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048814138,0.00012249025,0.0002174651,0.00012950141,0.000047773014,0.000012848415,0.00005894817,0.0000878474,0.000013890414],"category_scores_gemma":[0.000031614658,0.000105478095,0.0000242864,0.00014411076,0.0001698406,0.000010911748,0.000121634504,0.00013405611,6.16124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067529916,0.00006518135,0.020599015,0.00017168069,0.0000503343,0.000010654088,0.0001330314,0.000014652356,0.9246612,0.0000015653749,0.000024914367,0.047514748],"study_design_scores_gemma":[0.0015339375,0.0007146695,0.1702295,0.000082776794,0.000006626857,0.0000037368136,0.000010171747,0.00010101175,0.8272094,0.000018500905,0.000017216471,0.00007242073],"about_ca_topic_score_codex":0.007196658,"about_ca_topic_score_gemma":0.0011326736,"teacher_disagreement_score":0.14963049,"about_ca_system_score_codex":0.00004924655,"about_ca_system_score_gemma":0.00007914182,"threshold_uncertainty_score":0.9994145},"labels":[],"label_agreement":null},{"id":"W1985912955","doi":"10.1158/1538-7445.am2011-694","title":"Abstract 694: Cyclosporin-modulated intensified dosage chemotherapy well-tolerated for saving eyes with intraocular retinoblastoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Vincristine; Enucleation; Surgery; Chemotherapy; Retinoblastoma; Cyclophosphamide; Cisplatin","score_opus":0.08520861054754228,"score_gpt":0.3872017106744469,"score_spread":0.3019931001269046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985912955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925321,0.0005653024,0.000082249586,0.0008477512,0.0001121281,0.001402641,0.000011481211,0.00009896191,0.004347422],"genre_scores_gemma":[0.9964761,0.0002986415,0.0010688109,0.00024029106,0.00015822929,0.0003213384,0.000044977693,0.00007193322,0.0013196387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981194,0.0000680309,0.00024806254,0.0005043354,0.00039328408,0.0006668949],"domain_scores_gemma":[0.9984251,0.000097153425,0.000072593924,0.00044459512,0.00072609226,0.00023441917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005515093,0.00021804444,0.000394802,0.00020288916,0.000221842,0.000021365633,0.00015865838,0.00022939811,0.0011542655],"category_scores_gemma":[0.00007382585,0.00016238913,0.00009036294,0.00042663873,0.00033228242,0.000087740955,0.000034017587,0.00053967856,0.00008268273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05405597,0.0032083842,0.24946555,0.0011004864,0.0050650695,0.004832721,0.0062799263,0.000026195417,0.6025967,0.0006033453,0.00735693,0.06540873],"study_design_scores_gemma":[0.01242199,0.0031762742,0.409715,0.00082124496,0.00018066345,0.00009067416,0.0006324019,0.00015060144,0.5638713,0.00037741117,0.008173613,0.00038880753],"about_ca_topic_score_codex":0.0006862783,"about_ca_topic_score_gemma":0.00017305427,"teacher_disagreement_score":0.16024944,"about_ca_system_score_codex":0.00028487336,"about_ca_system_score_gemma":0.00037314484,"threshold_uncertainty_score":0.99975884},"labels":[],"label_agreement":null},{"id":"W1985941952","doi":"10.1158/1538-7445.am2011-1224","title":"Abstract 1224: Repression of cancer cell senescence by PKCι","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Senescence; Cancer; Cancer research; Protein kinase C; Cancer cell; Biology; Breast cancer; Cell culture; Cell growth; Cell biology; Kinase; Medicine; Genetics","score_opus":0.11788669343941295,"score_gpt":0.41613614240424607,"score_spread":0.29824944896483313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985941952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.918617,0.033421304,0.00008076985,0.0003119079,0.00033876044,0.0008171353,0.00010871181,0.00006314158,0.04624126],"genre_scores_gemma":[0.9875011,0.00856326,0.00013150548,0.00007844142,0.00014322043,0.00021386964,0.000012831872,0.000056099125,0.0032996708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997537,0.00008144768,0.00033335763,0.00051840843,0.0009455887,0.00058419263],"domain_scores_gemma":[0.9982286,0.000057678648,0.00011471105,0.0007440861,0.0005561578,0.00029875318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056278514,0.00016066819,0.00030660286,0.0001273515,0.00009231464,0.000009712921,0.00027727758,0.00019688428,0.0051285545],"category_scores_gemma":[0.00008857406,0.00014143174,0.00010253121,0.000449422,0.00028610384,0.000095503194,0.00013863816,0.00069718465,0.00006237602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005385468,0.00020794444,0.0037688483,0.0003665353,0.000044539418,0.00005511178,0.0007212401,0.000005486383,0.94672304,0.000016183665,0.033689287,0.013863259],"study_design_scores_gemma":[0.0011279196,0.00022714608,0.009703011,0.0007924129,0.00003375364,0.0000045744755,0.00019368996,0.000029893166,0.97561574,0.00003477733,0.0120945675,0.00014250359],"about_ca_topic_score_codex":0.026048582,"about_ca_topic_score_gemma":0.0004966841,"teacher_disagreement_score":0.0688841,"about_ca_system_score_codex":0.00051181135,"about_ca_system_score_gemma":0.00085112534,"threshold_uncertainty_score":0.9957809},"labels":[],"label_agreement":null},{"id":"W1986004507","doi":"10.1158/0008-5472.sabcs-4115","title":"Activity and safety of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: initial results from a phase II study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Tolerability; Medicine; Metastatic breast cancer; Trastuzumab; Taxane; Internal medicine; Sunitinib; Dosing; Breast cancer; Clinical endpoint; Lapatinib; Placebo; Oncology; Pharmacology; Adverse effect; Cancer; Clinical trial; Pathology","score_opus":0.1784208525827542,"score_gpt":0.5111586758417982,"score_spread":0.332737823259044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986004507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864847,0.0009497005,0.00004309775,0.0053049647,0.00003120829,0.0043615834,0.0026934652,0.000008457414,0.0001227993],"genre_scores_gemma":[0.9964685,0.0022619436,0.00006170927,0.000016232045,0.0000931956,0.0009208565,0.00004237977,0.000020930644,0.00011425315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99743265,0.00037324315,0.00039945144,0.00039670357,0.00097291515,0.000425061],"domain_scores_gemma":[0.99733424,0.0013211836,0.0001171408,0.00042396394,0.0006688668,0.00013457866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013398152,0.00015871688,0.00053318683,0.0002899771,0.00017629916,0.000016627979,0.00015962296,0.000046843837,0.000101696365],"category_scores_gemma":[0.00015073687,0.00010061841,0.000050602874,0.0007500339,0.00038847464,0.00008800435,0.00003310695,0.00030459434,2.5076818e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10631632,0.013145925,0.003241605,0.00018119944,0.00047600738,0.000054576623,0.013802581,0.000057622856,0.015687523,0.00005147593,0.0001958999,0.84678924],"study_design_scores_gemma":[0.2288283,0.14225863,0.49478382,0.0017396867,0.000588543,0.00002580448,0.011194964,0.0028676926,0.11406375,0.00041561568,0.002818165,0.00041502793],"about_ca_topic_score_codex":0.029989218,"about_ca_topic_score_gemma":0.009240391,"teacher_disagreement_score":0.8463742,"about_ca_system_score_codex":0.00087681436,"about_ca_system_score_gemma":0.0014231614,"threshold_uncertainty_score":0.9764702},"labels":[],"label_agreement":null},{"id":"W1986007087","doi":"10.1158/0008-5472.can-08-0749","title":"Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced NMR Techniques and Applications","field":"Chemistry","cited_by":520,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Prostate cancer; Alanine; Tramp; Prostate; Medicine; Cancer; Grading (engineering); Glycolysis; Adenocarcinoma; Pathology; Nuclear medicine; Internal medicine; Chemistry; Metabolism; Amino acid; Biology; Biochemistry","score_opus":0.05819907956121243,"score_gpt":0.38249835021839196,"score_spread":0.3242992706571795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986007087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557936,0.0021284807,0.0005421144,0.00042346393,0.000014329954,0.00054320355,0.00015989973,0.00010501856,0.0005041446],"genre_scores_gemma":[0.9830919,0.01065592,0.0011130285,0.00002880077,0.00011441858,0.002935088,0.000015095837,0.000042269698,0.0020035165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888813,0.000015342855,0.00014529923,0.00038762848,0.00017409568,0.00038952767],"domain_scores_gemma":[0.99926215,0.00016084423,0.000052619573,0.00017445398,0.00022048902,0.00012944255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016131248,0.00012527575,0.00015137375,0.00009993956,0.0005824096,0.000035921003,0.00009962343,0.000091143156,0.00005561258],"category_scores_gemma":[0.000058796024,0.00011869506,0.000028225526,0.0002810125,0.00028465598,0.00012523572,0.00007315104,0.00025732865,9.804191e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017924118,0.00001522499,0.0034825234,0.00016927418,0.00003757419,0.000005060897,0.00030361346,0.0000047222593,0.977374,0.000056798628,0.000623107,0.017748816],"study_design_scores_gemma":[0.0012625102,0.00006143587,0.00092261774,0.0001270858,0.000017155035,0.0000354109,0.0003542822,0.00086786627,0.96019524,0.0013326309,0.03456561,0.00025815627],"about_ca_topic_score_codex":0.00096241373,"about_ca_topic_score_gemma":0.00024734315,"teacher_disagreement_score":0.033942502,"about_ca_system_score_codex":0.00017005892,"about_ca_system_score_gemma":0.00010932791,"threshold_uncertainty_score":0.4840244},"labels":[],"label_agreement":null},{"id":"W1986120117","doi":"10.1158/0008-5472.can-06-4217","title":"Sodium Selenite Induces Superoxide-Mediated Mitochondrial Damage and Subsequent Autophagic Cell Death in Malignant Glioma Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Programmed cell death; Superoxide; Autophagy; Glioma; Mitochondrion; Mitophagy; Chemistry; Superoxide dismutase; Apoptosis; Cancer research; Cancer cell; Cell biology; Biology; Biochemistry; Cancer; Oxidative stress","score_opus":0.0713233436205746,"score_gpt":0.36071103449230185,"score_spread":0.2893876908717272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986120117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994199,0.00194122,0.0000065977397,0.00047511442,0.0015356521,0.0010741439,0.000032080956,0.00009371611,0.0006424907],"genre_scores_gemma":[0.99837655,0.00011712061,0.0001659416,0.00010999085,0.00077885896,0.00012719547,0.000020216807,0.000047854443,0.00025624732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954883,0.0007367353,0.0005905479,0.0008144696,0.00087039836,0.0014995737],"domain_scores_gemma":[0.9978608,0.001007138,0.000085025196,0.0004011266,0.00025463794,0.0003912971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024641403,0.00027961942,0.0004072482,0.00060034695,0.00021441419,0.0001532743,0.0005175682,0.00042249917,0.0001989052],"category_scores_gemma":[0.00018974935,0.00022762663,0.00006194741,0.0012418899,0.00032262545,0.00016991167,0.00020581494,0.0009814223,0.00012929985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068921637,0.00011814297,0.019324107,0.000096329364,0.000009138114,0.00017585378,0.00083915476,0.000004751312,0.9777426,0.00003209579,0.0006472152,0.0003213962],"study_design_scores_gemma":[0.0016483904,0.00031849422,0.038532495,0.000118096184,0.0000068618187,0.000012443486,0.0005646107,0.000069502974,0.9556593,0.00013095337,0.0026431915,0.00029568496],"about_ca_topic_score_codex":0.005381594,"about_ca_topic_score_gemma":0.00095851376,"teacher_disagreement_score":0.022083323,"about_ca_system_score_codex":0.0007921824,"about_ca_system_score_gemma":0.00012543269,"threshold_uncertainty_score":0.92823446},"labels":[],"label_agreement":null},{"id":"W1986124313","doi":"10.1158/1538-7445.am2013-1841","title":"Abstract 1841: Characterizing long non-coding RNAs located within a replication origin at the human DBF4 locus.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Biology; Replication timing; Origin recognition complex; Origin of replication; DNA replication factor CDT1; Licensing factor; Pre-replication complex; Genetics; DNA replication; Control of chromosome duplication; Chromatin; Transcription (linguistics); Eukaryotic DNA replication; Cell biology; Gene","score_opus":0.05725948492479384,"score_gpt":0.38704653081847745,"score_spread":0.32978704589368363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986124313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176687,0.0009904569,0.0020414745,0.001893282,0.00017785908,0.0014852769,0.000018597539,0.000033045373,0.0015931525],"genre_scores_gemma":[0.9910536,0.00057572126,0.000028470555,0.00025093113,0.0005087293,0.0012075907,0.00021498585,0.00008957363,0.006070412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967164,0.00020678769,0.00038174668,0.00095689425,0.0008320333,0.00090612937],"domain_scores_gemma":[0.9973107,0.00004023919,0.0001388537,0.0015464731,0.0007208324,0.00024290552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016943923,0.00023869274,0.00019538277,0.00017127866,0.0007744217,0.00024944468,0.0008221663,0.00028054923,0.00094753207],"category_scores_gemma":[0.00021025968,0.00019513455,0.000107658525,0.0005643807,0.00034247473,0.00002276311,0.00062029687,0.0008610596,0.00041221586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006801633,0.00003381864,0.00011530454,0.000060722585,0.00007769124,0.000010028022,0.00012430128,0.00009439083,0.98567533,0.00006437004,0.0084357485,0.0052402886],"study_design_scores_gemma":[0.00048700222,0.000113788214,0.0032469076,0.0001053115,0.000008039156,0.000014796617,0.00008795033,0.00016360614,0.98173964,0.00006611254,0.013729204,0.00023764053],"about_ca_topic_score_codex":0.0025818418,"about_ca_topic_score_gemma":0.0007322881,"teacher_disagreement_score":0.005293456,"about_ca_system_score_codex":0.00049971195,"about_ca_system_score_gemma":0.0004593509,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W1986242878","doi":"10.1158/1538-7445.am2011-1763","title":"Abstract 1763: The discovery of novel non-RGD-containing αvβ3 ligands for molecular imaging","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Integrin; Peptide; Extracellular matrix; Tripeptide; Metastasis; Cancer research; Molecular imaging; RGD motif; Chemistry; Cancer; Cell; Medicine; Molecular biology; Biochemistry; Biology; In vivo; Internal medicine","score_opus":0.137020546918634,"score_gpt":0.43255861705070203,"score_spread":0.295538070132068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986242878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676705,0.0011945533,0.002461783,0.0015078656,0.00010405572,0.0013262902,0.000037863756,0.000018244742,0.0065822895],"genre_scores_gemma":[0.9974539,0.00017038253,0.0004478642,0.00020011976,0.00018573599,0.00042319414,0.0000120638015,0.00006425599,0.0010424366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973506,0.000028358596,0.00033841503,0.00041528264,0.0010913564,0.0007760141],"domain_scores_gemma":[0.9978487,0.00041881192,0.00007651989,0.0006979361,0.0007692621,0.0001887817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015393978,0.00015463533,0.00030015764,0.00022497779,0.00018367244,0.000055495522,0.00049283914,0.00007373268,0.00024536054],"category_scores_gemma":[0.00052411604,0.000107564774,0.00019081277,0.00050870015,0.00045404604,0.00014225663,0.00026881517,0.0006932427,0.00001630115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011213132,0.00019545335,0.004070271,0.00032744042,0.00008582651,0.000070825234,0.00085479615,0.0000071119075,0.98350173,0.0003977085,0.0016996847,0.0076678395],"study_design_scores_gemma":[0.0023084497,0.00035295272,0.025870137,0.0003884778,0.000031007665,0.000012843069,0.0012464427,0.0006701775,0.9669564,0.00018520826,0.0018380457,0.00013985718],"about_ca_topic_score_codex":0.0014549476,"about_ca_topic_score_gemma":0.000038383256,"teacher_disagreement_score":0.021799866,"about_ca_system_score_codex":0.00019596043,"about_ca_system_score_gemma":0.0007043366,"threshold_uncertainty_score":0.43863642},"labels":[],"label_agreement":null},{"id":"W1986353792","doi":"10.1158/0008-5472.sabcs12-pd04-02","title":"Abstract PD04-02: Accelerated hypofractionated versus conventional whole breast radiotherapy for localised left-sided breast cancer: the effect on long-term cardiac morbidity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Population; Diabetes mellitus; Cumulative incidence; Cancer; Internal medicine; Stage (stratigraphy); Incidence (geometry); Oncology; Cohort","score_opus":0.06829026407298927,"score_gpt":0.4061751028954868,"score_spread":0.33788483882249754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986353792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835356,0.0065879636,0.000037811616,0.0039311056,0.0015646594,0.0013660728,0.0027552661,0.00003632246,0.00018519875],"genre_scores_gemma":[0.9928737,0.001501327,0.000008102334,0.0001443424,0.0025818967,0.0016723259,0.0007147052,0.00007217029,0.00043137668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974066,0.0003044052,0.00023693558,0.00057012856,0.0005900505,0.0008918877],"domain_scores_gemma":[0.9982489,0.00040793844,0.00010823813,0.0005082596,0.00051312393,0.00021359301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007666307,0.00033584484,0.00032981008,0.00008883881,0.00062183256,0.00008385733,0.000354638,0.00020651099,0.0005237166],"category_scores_gemma":[0.00006489841,0.00024768943,0.0002599762,0.0002332609,0.00039098924,0.000035087403,0.00009902243,0.00036295253,0.00003414347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030778278,0.000719863,0.27739814,0.00025194418,0.0050476324,0.000008054036,0.00015047209,0.00052232796,0.5485942,0.000081955506,0.07460946,0.061837703],"study_design_scores_gemma":[0.0053682914,0.00034726833,0.867655,0.000090480775,0.00008615602,0.000018241832,0.00003857967,0.000012153245,0.11326088,0.0000036762774,0.012813017,0.00030624654],"about_ca_topic_score_codex":0.0012905127,"about_ca_topic_score_gemma":0.00025075558,"teacher_disagreement_score":0.59025687,"about_ca_system_score_codex":0.0006776841,"about_ca_system_score_gemma":0.0003680538,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W1986429657","doi":"10.1158/0008-5472.sabcs10-p5-10-09","title":"Abstract P5-10-09: Comparison of the (Non-)Hematological Toxicity and Compliance of Different Anthracycline Containing Regimen with the Standard AC/EC in Elderly Patients with Primary Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epirubicin; Anthracycline; Medicine; Docetaxel; Regimen; Taxane; Cyclophosphamide; Doxorubicin; Internal medicine; Breast cancer; Chemotherapy; Paclitaxel; Gastroenterology; Pharmacology; Cancer","score_opus":0.07047424158493303,"score_gpt":0.43264467587703886,"score_spread":0.3621704342921058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986429657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942609,0.0004415261,0.0000027229487,0.003561059,0.00005957155,0.0010939117,0.000147297,0.0000066051016,0.00042642106],"genre_scores_gemma":[0.9994046,0.00012100591,0.000023560655,0.00006708417,0.000056165703,0.00018449922,0.000010388774,0.000016186274,0.00011651912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983375,0.0000969597,0.0002841921,0.00028835153,0.00063539075,0.0003575846],"domain_scores_gemma":[0.9986492,0.00033404565,0.00019386863,0.00030794303,0.00041130476,0.0001036292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031215223,0.00016502329,0.000580464,0.00006590213,0.00013009366,0.000012584357,0.00021513193,0.00008448626,0.00043798986],"category_scores_gemma":[0.00001772508,0.00007388957,0.000036968075,0.00027864048,0.0010696074,0.000052438634,0.0001066366,0.0008340934,4.301005e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011964525,0.0008056983,0.95418483,0.00030525576,0.00013239603,0.000007080852,0.0008078752,0.000008516852,0.022612186,0.000024291227,0.00095173495,0.008195605],"study_design_scores_gemma":[0.006843692,0.0015054002,0.9685569,0.0006067599,0.00005861585,0.000006101201,0.000289391,0.000028744813,0.021714298,0.0000128992915,0.00029009258,0.00008710066],"about_ca_topic_score_codex":0.0009469172,"about_ca_topic_score_gemma":0.0055015855,"teacher_disagreement_score":0.01437207,"about_ca_system_score_codex":0.00019228586,"about_ca_system_score_gemma":0.00045461705,"threshold_uncertainty_score":0.47956818},"labels":[],"label_agreement":null},{"id":"W1986471949","doi":"10.1158/1538-7445.am2012-3184","title":"Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Prostate; Genotyping; DNA sequencing; Cancer; Whole genome sequencing; Prostate biopsy; Population; Biopsy; Malignancy; Medicine; Oncology; Genome; Computational biology; Biology; Internal medicine; Gene; Genetics; Genotype","score_opus":0.10786961761115928,"score_gpt":0.42035672455036627,"score_spread":0.312487106939207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986471949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521159,0.039444406,0.000002087175,0.0023596415,0.00027525675,0.0013023237,0.0004914585,0.000058972848,0.003949986],"genre_scores_gemma":[0.9798289,0.008154377,0.00008776371,0.00009056232,0.00092305144,0.000760957,0.00010663459,0.00007916769,0.009968565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959538,0.00012039204,0.00043309803,0.00046427106,0.0014212218,0.0016072372],"domain_scores_gemma":[0.9976193,0.00016132325,0.00010846332,0.00059605675,0.00088693696,0.0006279578],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013780927,0.0002609905,0.00051561784,0.00050990307,0.00026229833,0.000053624994,0.00031294292,0.00016884074,0.0023954895],"category_scores_gemma":[0.00012322876,0.00019909992,0.00014365223,0.00093281234,0.00066753675,0.00035698115,0.00022721816,0.00088252546,0.00021093957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009782957,0.00023729287,0.10215848,0.0015251824,0.00031655005,0.00007392624,0.003938323,0.00004385967,0.8789531,0.000035693585,0.005378963,0.0063603353],"study_design_scores_gemma":[0.0048370445,0.00050024834,0.23838256,0.0019081542,0.0001000496,0.000020079058,0.0033943846,0.000041073086,0.7016606,0.00015428968,0.048481323,0.0005202279],"about_ca_topic_score_codex":0.0040945183,"about_ca_topic_score_gemma":0.00019882624,"teacher_disagreement_score":0.17729253,"about_ca_system_score_codex":0.0016814508,"about_ca_system_score_gemma":0.0019896976,"threshold_uncertainty_score":0.99851644},"labels":[],"label_agreement":null},{"id":"W1986497569","doi":"10.1158/0008-5472.can-05-3951","title":"Differentially Active Origins of DNA Replication in Tumor versus Normal Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; DNA replication; Replication timing; Eukaryotic DNA replication; Control of chromosome duplication; Molecular biology; Origin recognition complex; Origin of replication; Genetics; Consensus sequence; DNA; Plasmid; Replication factor C; Autonomously replicating sequence","score_opus":0.03285787097454156,"score_gpt":0.3567271416710614,"score_spread":0.32386927069651983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986497569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976274,0.00010599865,0.00006451388,0.00004841251,0.00012075446,0.00022147385,0.00003205675,0.0000052704927,0.0017741371],"genre_scores_gemma":[0.998879,0.00005645736,0.00009116668,0.0000072919524,0.00016218578,0.00010613245,0.00004681978,0.000014165096,0.0006367917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989671,0.0000849122,0.0001371071,0.00031784907,0.00023669019,0.00025632052],"domain_scores_gemma":[0.99931765,0.000018294599,0.000042495176,0.00042833254,0.00015694728,0.000036270485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025864976,0.000067227964,0.000087563225,0.000079953315,0.000030472262,0.0000088753595,0.00020369863,0.00006580619,0.000057750818],"category_scores_gemma":[0.000041944422,0.00006764348,0.000037405236,0.00017146982,0.00007598973,0.000003519649,0.00010864798,0.0001203979,0.000007700382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053672143,0.000066132685,0.00028106524,0.000017457987,0.00001019434,0.0000023354883,0.000016856828,0.000034233202,0.9967283,0.0006640251,0.00042011248,0.0012225467],"study_design_scores_gemma":[0.0007113777,0.00019974883,0.0029392727,0.000011250435,0.0000026809753,4.1758904e-7,0.000033375552,0.000028831972,0.99041545,0.00010198563,0.0054891845,0.00006643102],"about_ca_topic_score_codex":0.0013331862,"about_ca_topic_score_gemma":0.0010815421,"teacher_disagreement_score":0.0063128755,"about_ca_system_score_codex":0.00015640567,"about_ca_system_score_gemma":0.00020946574,"threshold_uncertainty_score":0.2758421},"labels":[],"label_agreement":null},{"id":"W1986504786","doi":"10.1158/1538-7445.am2012-3389","title":"Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Jewish General Hospital; Hôtel-Dieu de Québec; Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Medicine; Biopsy; Pathology; Biomarker; Colorectal cancer; Rectum; Cancer; Biology; Internal medicine; Genetics","score_opus":0.12368655406764423,"score_gpt":0.5140245364904902,"score_spread":0.39033798242284595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986504786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989224,0.0010795807,0.003580967,0.00009856823,0.00003349532,0.0049578203,0.00034470213,0.000005680975,0.000006958049],"genre_scores_gemma":[0.9825456,0.00032763803,0.008768384,0.000022971784,0.000036572772,0.0081935795,0.00003425137,0.00002066432,0.000050337047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866235,0.00012224575,0.00044273012,0.00034988447,0.00012664418,0.00029616398],"domain_scores_gemma":[0.9988284,0.00020081423,0.00014647972,0.0001352954,0.0005921662,0.00009684848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011070236,0.000114238355,0.00028576027,0.00018839308,0.00015768938,0.00001509862,0.00012905226,0.000054801338,0.000007784424],"category_scores_gemma":[0.00045084118,0.00010559737,0.00006348952,0.0004812848,0.0001701747,0.00001008751,0.00006718756,0.000084401676,1.1243169e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004314683,0.001056355,0.05253558,0.00024663296,0.0003085738,7.538279e-7,0.0013283856,0.000062877705,0.9369014,0.000010513981,0.0006747777,0.0025594856],"study_design_scores_gemma":[0.0030666303,0.002610339,0.37516305,0.00016994403,0.00006321712,0.000001150155,0.0011094984,0.00041638612,0.6166029,0.000029818819,0.0005789949,0.00018810583],"about_ca_topic_score_codex":0.00023879751,"about_ca_topic_score_gemma":0.003003451,"teacher_disagreement_score":0.32262745,"about_ca_system_score_codex":0.000054484753,"about_ca_system_score_gemma":0.00021533087,"threshold_uncertainty_score":0.43061358},"labels":[],"label_agreement":null},{"id":"W1986558997","doi":"10.1158/0008-5472.can-04-1005","title":"Celastraceae Sesquiterpenes as a New Class of Modulators That Bind Specifically to Human P-Glycoprotein and Reverse Cellular Multidrug Resistance","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Institutes of Health","keywords":"P-glycoprotein; ABCC1; Multiple drug resistance; Efflux; Multidrug resistance-associated protein 2; Abcg2; Biochemistry; ATP-binding cassette transporter; Biology; Chemistry; Transporter; Gene","score_opus":0.06302614274224803,"score_gpt":0.3615455965704268,"score_spread":0.29851945382817874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986558997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071443,0.001419201,0.00042301163,0.0044322503,0.000112897214,0.0012879822,0.00002853349,0.000041067866,0.0015405958],"genre_scores_gemma":[0.9729034,0.0003020843,0.0027374919,0.00012995958,0.00023105045,0.00007314719,0.000011297877,0.00005911504,0.023552481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713576,0.0000581166,0.00036854082,0.00063908927,0.0011537512,0.00064476236],"domain_scores_gemma":[0.99822515,0.00003602616,0.00007461424,0.0005937393,0.00026162548,0.00080887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006240146,0.00023237239,0.0004691142,0.00035231153,0.00019794107,0.000040238712,0.00025719305,0.00016581544,0.00038518215],"category_scores_gemma":[0.000063532454,0.00020083369,0.000106938896,0.0006196478,0.0002956222,0.00010980215,0.00007361918,0.0005180751,0.000045829827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037725,0.0001484034,0.0014647528,0.0005399308,0.000057262365,0.0003408945,0.001647429,0.000066882894,0.9885488,0.0036703127,0.001376622,0.0011009482],"study_design_scores_gemma":[0.003435235,0.0003843964,0.0066311695,0.0018042497,0.000042420732,0.000006883754,0.0010413581,0.0000019339955,0.9380094,0.0025463759,0.04581416,0.0002824576],"about_ca_topic_score_codex":0.0015099302,"about_ca_topic_score_gemma":0.0013581974,"teacher_disagreement_score":0.05053948,"about_ca_system_score_codex":0.0002962196,"about_ca_system_score_gemma":0.000757754,"threshold_uncertainty_score":0.81897604},"labels":[],"label_agreement":null},{"id":"W1986594613","doi":"10.1158/1538-7445.am2012-2251","title":"Abstract 2251: Loss of epithelial PTEN affects gastric homeostasis and leads to spasmolytic polypeptide-expressing metaplasia in the mouse","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"PTEN; Biology; Tensin; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; Cell biology; Pathology; Signal transduction; Medicine","score_opus":0.0514612777714931,"score_gpt":0.3717913036536596,"score_spread":0.32033002588216647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986594613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064666,0.008183482,0.000049072623,0.00034541305,0.000087041524,0.00034988066,0.00006541162,0.000005133451,0.00026793414],"genre_scores_gemma":[0.99838316,0.0006282709,0.00015115994,0.00012402316,0.00041028034,0.00012763383,0.000010804591,0.00003251203,0.0001321502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980927,0.00022631556,0.00019137759,0.00032476397,0.0004817584,0.0006830835],"domain_scores_gemma":[0.9990869,0.00013318649,0.000059889004,0.0004455627,0.00010971814,0.00016470902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015354919,0.0001545156,0.00019988786,0.00019246391,0.00009280222,0.00004611433,0.00040967658,0.0001260443,0.000049525464],"category_scores_gemma":[0.00025158966,0.00012034174,0.00005793819,0.00040744268,0.0002395266,0.000014597427,0.00019161022,0.00031594423,0.000010311838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021487863,0.00006455291,0.02270874,0.00007400509,0.00003284086,0.000005596198,0.00039776784,0.00011473692,0.96845275,0.000016002938,0.0018405407,0.0060775857],"study_design_scores_gemma":[0.00051705324,0.00021057464,0.040683478,0.000081906815,0.00001491478,0.00001285021,0.00020350522,0.000005422107,0.9538011,0.000014168557,0.004288686,0.00016636577],"about_ca_topic_score_codex":0.00042408498,"about_ca_topic_score_gemma":0.0001298249,"teacher_disagreement_score":0.017974738,"about_ca_system_score_codex":0.00008516127,"about_ca_system_score_gemma":0.00018152258,"threshold_uncertainty_score":0.49073938},"labels":[],"label_agreement":null},{"id":"W1986877085","doi":"10.1158/1538-7445.am2014-5011","title":"Abstract 5011: Cancer immunotherapy targeting CD47: Wild type SIRPαFc is the ideal CD47-blocking agent to minimize unwanted erythrocyte binding","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Monoclonal antibody; Antibody; Flow cytometry; Biology; Cancer research; Fusion protein; Cancer immunotherapy; Wild type; Blocking antibody; Cell biology; Immunotherapy; Immunology; Chemistry; Immune system; Mutant; Biochemistry; Recombinant DNA","score_opus":0.06941449683637128,"score_gpt":0.3791838079166253,"score_spread":0.309769311080254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986877085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97258455,0.020553123,0.00009136252,0.0041522537,0.0014127028,0.00061530364,0.000035813016,0.00009656188,0.00045832616],"genre_scores_gemma":[0.9936169,0.0027620115,0.000053416108,0.00070808636,0.00033696886,0.00021595672,0.000040704126,0.00008129549,0.002184665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971748,0.0004719307,0.00048780063,0.0005642874,0.00025153754,0.0010496518],"domain_scores_gemma":[0.99831796,0.00046360324,0.00017045533,0.0005636146,0.00042138604,0.00006299259],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019458473,0.0002717128,0.00039022716,0.00026301813,0.00097486743,0.00011879067,0.0006825773,0.00025309128,0.0018947176],"category_scores_gemma":[0.00021682272,0.00020106656,0.0001399014,0.00071988977,0.00028371045,0.00015026111,0.00023729326,0.0008803728,0.0004388074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053634966,0.000041966352,0.0013908657,0.000031105195,0.00025580925,0.0000020250986,0.0018977387,0.00014303543,0.93322897,0.00006121577,0.026642622,0.03576831],"study_design_scores_gemma":[0.0013060329,0.00013953146,0.027274655,0.0003292974,0.00002141748,0.000007525927,0.0006076707,0.00004870969,0.5766983,0.00007237911,0.39317375,0.00032069295],"about_ca_topic_score_codex":0.0028583757,"about_ca_topic_score_gemma":0.00014293562,"teacher_disagreement_score":0.36653113,"about_ca_system_score_codex":0.00046691563,"about_ca_system_score_gemma":0.00031412367,"threshold_uncertainty_score":0.9990177},"labels":[],"label_agreement":null},{"id":"W1987054725","doi":"10.1158/1538-7445.am2014-1282","title":"Abstract 1282: Genetic basis of hereditary gastric cancer: Beyond the CDH1 locus","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Mount Sinai Hospital; Vancouver General Hospital; BC Cancer Agency; McGill University; University of British Columbia","funders":"","keywords":"Germline mutation; Genetics; CDH1; Germline; Sanger sequencing; Cancer; Biology; Proband; Cancer syndrome; Loss of heterozygosity; Missense mutation; Genetic testing; Mutation; Gene; Allele; Cadherin","score_opus":0.05758938808084085,"score_gpt":0.37996748715261214,"score_spread":0.3223780990717713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987054725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97493446,0.011401424,0.00003407169,0.003995644,0.00074995897,0.0007861955,0.00007515319,0.00003045038,0.007992672],"genre_scores_gemma":[0.993924,0.002740371,0.00023218908,0.0003523353,0.0012250642,0.00044977866,0.0000065376335,0.000058278765,0.0010114013],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99674463,0.00019438744,0.00039264382,0.00046955873,0.0014404136,0.0007583746],"domain_scores_gemma":[0.99756914,0.00056298746,0.000099775796,0.0008302547,0.000661557,0.00027630554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010351551,0.00020479636,0.00038536973,0.0002480092,0.00017582109,0.000025553903,0.0005287602,0.00014799659,0.003965645],"category_scores_gemma":[0.0003505999,0.00014245999,0.00013224699,0.0009321354,0.0006527529,0.000039816863,0.0001829056,0.00084567076,0.000073606876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00108825,0.00024918452,0.079082705,0.0011608751,0.0003749125,0.00006412737,0.00080664223,0.0011122782,0.24649833,0.00007524064,0.16282374,0.50666374],"study_design_scores_gemma":[0.003024871,0.0017140626,0.6953397,0.0007586325,0.00020548677,0.00007676427,0.0005134254,0.00045618476,0.22983365,0.0012890043,0.066303164,0.00048507305],"about_ca_topic_score_codex":0.00403757,"about_ca_topic_score_gemma":0.000655771,"teacher_disagreement_score":0.616257,"about_ca_system_score_codex":0.0005134407,"about_ca_system_score_gemma":0.0009400124,"threshold_uncertainty_score":0.99694484},"labels":[],"label_agreement":null},{"id":"W1987122320","doi":"10.1158/0008-5472.sabcs-4118","title":"Primary analysis of study MO19391, an open-label safety study of bevacizumab (B) plus taxane-based therapy as 1st-line treatment of patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Bevacizumab; Internal medicine; Population; Regimen; Clinical endpoint; Metastatic breast cancer; Phases of clinical research; Gastroenterology; Surgery; Oncology; Chemotherapy; Cancer; Breast cancer; Clinical trial","score_opus":0.1958622123719409,"score_gpt":0.5105737341160985,"score_spread":0.3147115217441576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987122320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988962,0.0015143579,0.000009852307,0.00046335798,0.00006471138,0.00792694,0.0009476682,0.000015573401,0.000095538446],"genre_scores_gemma":[0.99591124,0.001823245,0.00009147996,0.000118605145,0.000054467462,0.0012592775,0.0002767203,0.000041263705,0.0004236864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954569,0.0007976563,0.0009036894,0.00076293555,0.0015411987,0.00053765974],"domain_scores_gemma":[0.99645734,0.00023150959,0.00046046978,0.0008621329,0.00168141,0.00030711156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064738386,0.0003921098,0.0018163892,0.0008531954,0.00013224859,0.000020619762,0.0004689244,0.00006201364,0.0015588471],"category_scores_gemma":[0.000017333203,0.00024470984,0.00010647528,0.0027847968,0.00026259682,0.00013817832,0.00007576624,0.00023602492,0.0000013291622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2982393,0.1953661,0.15344377,0.00021742676,0.016418539,0.00018043509,0.008258299,0.002901595,0.0042031975,0.0000040804257,0.00017821352,0.32058907],"study_design_scores_gemma":[0.19954127,0.32476282,0.4559399,0.00024848472,0.008724748,0.0000035890764,0.0031569104,0.00093318213,0.0060454393,0.000005921283,0.00026021857,0.00037752202],"about_ca_topic_score_codex":0.021476226,"about_ca_topic_score_gemma":0.015802266,"teacher_disagreement_score":0.32021153,"about_ca_system_score_codex":0.0021805156,"about_ca_system_score_gemma":0.0032701246,"threshold_uncertainty_score":0.9993539},"labels":[],"label_agreement":null},{"id":"W1987130968","doi":"10.1158/1538-7445.am2011-5561","title":"Abstract 5561: 20(S)-Protopanaxadiol-aglycone downregulates full-length and ligand-independent splice variants of androgen receptor","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"","keywords":"Androgen receptor; Prostate cancer; Dihydrotestosterone; Androgen; Cancer research; Dutasteride; LNCaP; Endocrinology; Prostate; Finasteride; Internal medicine; Cancer; Protopanaxadiol; splice; Medicine; Biology; Pharmacology; Ginseng; Hormone; Biochemistry; Ginsenoside","score_opus":0.05867166598619896,"score_gpt":0.3439887689697813,"score_spread":0.28531710298358237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987130968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953458,0.0019244674,0.000027386292,0.00012748168,0.00003532376,0.0006143503,0.00008152627,0.000009600929,0.0018340904],"genre_scores_gemma":[0.9969329,0.0020290415,0.00021213862,0.000031704298,0.00011909064,0.0003047482,0.000038412432,0.000015568297,0.00031634618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988056,0.000073798976,0.00018869089,0.00041896652,0.00017578596,0.00033717236],"domain_scores_gemma":[0.9992041,0.000037926053,0.00006312828,0.00035398055,0.00018522888,0.00015563292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005565261,0.00012492908,0.00016823901,0.000050186864,0.00011876863,0.000014307511,0.00025337256,0.00018209142,0.0002135502],"category_scores_gemma":[0.0000710722,0.00009691072,0.000048343078,0.00013458912,0.00027065814,0.0000049324995,0.000176978,0.00018900249,0.000019057841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021333287,0.00008919344,0.0013430925,0.000049307135,0.00005503469,0.0000019462618,0.00006746723,0.0000022482952,0.99102914,0.00022315224,0.0011442841,0.0057818047],"study_design_scores_gemma":[0.00051214435,0.0005036405,0.03309204,0.000040515166,0.00000973163,0.000007895475,0.000102295315,0.000008905448,0.9530137,0.0002645077,0.012277769,0.00016685306],"about_ca_topic_score_codex":0.0003814298,"about_ca_topic_score_gemma":0.000076334545,"teacher_disagreement_score":0.038015436,"about_ca_system_score_codex":0.00001662375,"about_ca_system_score_gemma":0.00010906995,"threshold_uncertainty_score":0.39519045},"labels":[],"label_agreement":null},{"id":"W1987269574","doi":"10.1158/0008-5472.can-08-0343","title":"Phosphorylated Caveolin-1 Regulates Rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":259,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Cancer Research Society","keywords":"Focal adhesion; Cell migration; Tyrosine phosphorylation; Phosphorylation; RHOA; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Metastasis; Cell biology; Biology; Caveolin 1; Signal transduction; Cell; Cancer; Biochemistry","score_opus":0.02413126912354954,"score_gpt":0.2932387752233475,"score_spread":0.269107506099798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987269574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857497,0.013435482,0.00011646944,0.000194911,0.000055458564,0.00023269687,0.000020647829,0.000011981645,0.0001826201],"genre_scores_gemma":[0.9813582,0.014582155,0.000046815123,0.000057874004,0.00013281716,0.00004383205,0.000109860455,0.00002632003,0.0036421681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866545,0.00007420986,0.00016884334,0.0004688476,0.00029515786,0.00032751795],"domain_scores_gemma":[0.99930656,0.000024471963,0.000044415625,0.00022391541,0.00024592955,0.00015472689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028987756,0.0001427365,0.00013592141,0.000077218196,0.0003077472,0.000038650276,0.00012017417,0.0001543923,0.000027683465],"category_scores_gemma":[0.00005766589,0.00013173647,0.000030645948,0.00014114591,0.00017228814,0.000009304284,0.00021097282,0.00021648832,0.000006794048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002577448,0.000050357256,0.0070080985,0.00011049793,0.000012938938,0.000029882858,0.00015577883,0.000059438193,0.9896706,0.000014629554,0.0009940384,0.0016359966],"study_design_scores_gemma":[0.00062967633,0.00029916994,0.0020069801,0.000036451995,0.000008654727,0.00007508892,0.00020115703,0.0019261008,0.9925428,0.00007922447,0.0020184224,0.00017625505],"about_ca_topic_score_codex":0.000624457,"about_ca_topic_score_gemma":0.0010553411,"teacher_disagreement_score":0.0050011184,"about_ca_system_score_codex":0.000055226745,"about_ca_system_score_gemma":0.0002125827,"threshold_uncertainty_score":0.53720576},"labels":[],"label_agreement":null},{"id":"W1987314487","doi":"10.1158/0008-5472.sabcs12-p6-07-17","title":"Abstract P6-07-17: Proteomic screening of FFPE tissue identifies FKBP4 as an independent prognostic factor in hormone receptor positive breast cancers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Breast cancer; Tamoxifen; Tissue microarray; Medicine; Oncology; Estrogen receptor; Internal medicine; Cancer; Lymph node; Immunohistochemistry; Cancer research; Pathology","score_opus":0.027850995456299817,"score_gpt":0.360853545234407,"score_spread":0.33300254977810717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987314487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189675,0.006301239,0.000017988506,0.00008574985,0.00012813932,0.00105863,0.00014799046,0.000011549293,0.0003519498],"genre_scores_gemma":[0.99776596,0.0008208133,0.000082397266,0.000015055734,0.00034645072,0.00029259257,0.00014224974,0.000045103032,0.0004893611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997775,0.0002340997,0.000286088,0.00042837922,0.0005144572,0.00076198485],"domain_scores_gemma":[0.9989799,0.000040805033,0.00010470422,0.0003214822,0.0002624943,0.00029056138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007046098,0.00020211333,0.00022989382,0.0001790108,0.00012210444,0.000045566336,0.00031851197,0.00032306608,0.00019459915],"category_scores_gemma":[0.000112679096,0.00018591,0.000062702406,0.000270934,0.00023992045,0.000041224677,0.00017324704,0.0005934303,0.000046696205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067992305,0.00013461275,0.01876754,0.000056531062,0.00010272281,0.000010398983,0.00063744833,0.00004813389,0.97388417,0.000010169195,0.0005943988,0.0050739786],"study_design_scores_gemma":[0.0006605532,0.0005279732,0.19619963,0.00015812994,0.0000108407485,0.000019725609,0.00034391982,0.0000058031073,0.801565,0.000010518267,0.00028889286,0.00020900618],"about_ca_topic_score_codex":0.0039930246,"about_ca_topic_score_gemma":0.00021088262,"teacher_disagreement_score":0.17743208,"about_ca_system_score_codex":0.00019931191,"about_ca_system_score_gemma":0.00046579566,"threshold_uncertainty_score":0.758119},"labels":[],"label_agreement":null},{"id":"W1987536571","doi":"10.1158/1538-7445.am10-2120","title":"Abstract 2120: Single cell whole genome amplification for high density SNP analysis of circulating tumor cells in early breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Circulating tumor cell; Laser capture microdissection; Metastasis; Biology; Breast cancer; Cancer research; Cancer; Cancer cell; Pathology; Primary tumor; Medicine; Gene; Gene expression; Genetics","score_opus":0.03709309886640754,"score_gpt":0.33303737564158975,"score_spread":0.2959442767751822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987536571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702805,0.0003301916,0.00017428033,0.0001367321,0.00014924962,0.000364301,0.0017251142,0.0000036861422,0.00008837865],"genre_scores_gemma":[0.9987703,0.00013579824,0.00022190112,0.00004262165,0.00030291948,0.00017154017,0.00024100782,0.000027252929,0.00008666271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862987,0.000029769617,0.00028842763,0.00044089992,0.00021941766,0.00039158916],"domain_scores_gemma":[0.9987228,0.00008637973,0.00013135043,0.00043176697,0.00052247196,0.0001052534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050491863,0.00011808217,0.00022981208,0.00023632255,0.00009090702,0.000049229417,0.00025719075,0.00012319561,0.00008671904],"category_scores_gemma":[0.00006272947,0.0001283622,0.00010897611,0.0005127776,0.00012077666,0.0000062725753,0.00009623849,0.00023101163,0.0000031736124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010723266,0.00010755444,0.016848518,0.00006164808,0.000082287836,0.0000015978331,0.00009921048,0.0023653524,0.9789831,0.000030089852,0.00015929918,0.0011541045],"study_design_scores_gemma":[0.0004153319,0.000059301976,0.359586,0.000012142269,0.000060743012,4.763183e-7,0.000051301668,0.00014679082,0.6378802,0.000063037696,0.0015766543,0.00014801646],"about_ca_topic_score_codex":0.0095507195,"about_ca_topic_score_gemma":0.012490974,"teacher_disagreement_score":0.34273747,"about_ca_system_score_codex":0.00011993843,"about_ca_system_score_gemma":0.0003388234,"threshold_uncertainty_score":0.99704474},"labels":[],"label_agreement":null},{"id":"W1987567323","doi":"10.1158/1538-7445.am2012-lb-182","title":"Abstract LB-182: Effects of methyl donor status on intestinal tumorigenesis in ApcMin/+ mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Colorectal cancer; Choline; Carcinogenesis; Medicine; Familial adenomatous polyposis; Cancer; Internal medicine; Immune system; Methionine; Vitamin B12; Endocrinology; Immunology; Biology; Genetics","score_opus":0.09174752563398593,"score_gpt":0.45016919370088526,"score_spread":0.35842166806689935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987567323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963255,0.004673173,0.0000023018813,0.00040429327,0.0001663143,0.00075190095,0.000011655946,0.000017717903,0.0043401057],"genre_scores_gemma":[0.9965359,0.0011212945,0.000116279516,0.00005614997,0.00035824822,0.00022547104,0.000010463829,0.00003916001,0.0015370536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99667585,0.00023192438,0.00030656598,0.0003198855,0.0011726565,0.0012930987],"domain_scores_gemma":[0.99721754,0.001378128,0.000046455283,0.0004071613,0.00045925536,0.00049145165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018256916,0.00016105537,0.00037885614,0.0007768202,0.00006854587,0.000018132281,0.00022293896,0.00011320286,0.0005044106],"category_scores_gemma":[0.001599877,0.00012843615,0.00007149885,0.00122656,0.00024336246,0.0001300669,0.00012248414,0.0010101465,0.00022053403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001475715,0.0008525654,0.12853466,0.0018006703,0.00007317132,0.00014474498,0.0007570434,0.00000455816,0.8147989,0.00010729762,0.0030479173,0.04840273],"study_design_scores_gemma":[0.0012533604,0.00069094414,0.4493721,0.0006533246,0.000012906961,0.0000067082906,0.00019047082,0.000011524988,0.5433883,0.00001854832,0.0043018335,0.00009996166],"about_ca_topic_score_codex":0.0054485532,"about_ca_topic_score_gemma":0.00020907584,"teacher_disagreement_score":0.32083747,"about_ca_system_score_codex":0.0006002328,"about_ca_system_score_gemma":0.0007030739,"threshold_uncertainty_score":0.8236619},"labels":[],"label_agreement":null},{"id":"W1987574013","doi":"10.1158/1538-7445.am2013-4082","title":"Abstract 4082: Mechanisms of androgen receptor splicing in prostate cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"RNA splicing; Androgen receptor; Minigene; Biology; Splicing factor; Cancer research; Intron; Molecular biology; Alternative splicing; LNCaP; Trichostatin A; RNA polymerase II; Prostate cancer; Messenger RNA; Gene; RNA; Gene expression; Cancer; Promoter; Genetics; Histone; Histone deacetylase","score_opus":0.06564885891987825,"score_gpt":0.4002745788000257,"score_spread":0.33462571988014744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987574013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878327,0.0044958224,0.0000035894045,0.0030312997,0.00015992536,0.002250526,0.00007392238,0.00002920275,0.00212298],"genre_scores_gemma":[0.983705,0.007855349,0.00017517652,0.00007043079,0.00013413806,0.001734471,0.00002422426,0.000055071072,0.006246173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971204,0.00009257924,0.0003867769,0.0004771725,0.0009721636,0.00095094275],"domain_scores_gemma":[0.998426,0.00012022522,0.000071408016,0.0003950296,0.0006675357,0.0003198036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007834468,0.0001870303,0.0004161782,0.0005091293,0.000103704166,0.000044036846,0.00022823396,0.000114540984,0.004842218],"category_scores_gemma":[0.000045992867,0.00014336807,0.00008475889,0.00095913745,0.00025159962,0.00018989167,0.00013516514,0.0007139189,0.0002134733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061252556,0.00021572661,0.012613191,0.0007005482,0.00009788107,0.000051942283,0.00081973354,0.000028687906,0.95143926,0.00009976759,0.007095478,0.026225278],"study_design_scores_gemma":[0.0027884312,0.00032198834,0.014958254,0.0009338138,0.000013361593,0.000002335835,0.0007472861,0.0000692719,0.9767812,0.00088608527,0.002332614,0.0001653686],"about_ca_topic_score_codex":0.017385902,"about_ca_topic_score_gemma":0.00036778845,"teacher_disagreement_score":0.02605991,"about_ca_system_score_codex":0.0007883933,"about_ca_system_score_gemma":0.0012010512,"threshold_uncertainty_score":0.99606746},"labels":[],"label_agreement":null},{"id":"W1987729106","doi":"10.1158/1538-7445.am2012-1302","title":"Abstract 1302: Effect of intestinal-specific Kaiso overexpression on the APC MIN/+ mouse colon cancer model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Biology; Cell biology; Carcinogenesis; Cancer research; Catenin; Signal transduction; Cancer; Genetics","score_opus":0.059962570454558,"score_gpt":0.38584811264121444,"score_spread":0.32588554218665644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987729106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305356,0.0045917328,0.000051412746,0.00036046933,0.00014219765,0.00056773284,0.00015795248,0.000010373444,0.0010645832],"genre_scores_gemma":[0.9958911,0.001445295,0.000028532319,0.000032847904,0.0005752787,0.00048079793,0.00007451803,0.00004230128,0.0014293105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998241,0.00020783588,0.00020790054,0.00032948403,0.00051025394,0.0005035002],"domain_scores_gemma":[0.9987813,0.000206095,0.00010579814,0.0005564589,0.00022456957,0.00012573555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085523544,0.00017197752,0.00016650517,0.00008509288,0.00015729341,0.000022061047,0.00031105464,0.00020139205,0.00060936215],"category_scores_gemma":[0.00018202014,0.000120020304,0.00009450467,0.00021744196,0.00021799844,0.000009889296,0.00015437449,0.00039154562,0.000023612847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007742809,0.00004914815,0.00041004608,0.000058768677,0.000032499334,2.2682896e-7,0.00007010813,0.0054066684,0.9070848,0.000046090954,0.0807108,0.0053565297],"study_design_scores_gemma":[0.00041054338,0.00026214033,0.0013938022,0.00023338995,0.00000766292,0.0000011712477,0.000018720075,0.0004858516,0.9826085,0.000021031936,0.0144260265,0.0001311776],"about_ca_topic_score_codex":0.00027686075,"about_ca_topic_score_gemma":0.00005418084,"teacher_disagreement_score":0.075523645,"about_ca_system_score_codex":0.0002154455,"about_ca_system_score_gemma":0.00019298568,"threshold_uncertainty_score":0.66720885},"labels":[],"label_agreement":null},{"id":"W1987962292","doi":"10.1158/0008-5472.sabcs12-ms2-2","title":"Abstract MS2-2: Breast Density: Clinical Implications","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Mammography; Cancer; Disease; Oncology; Breast cancer screening; Atypia; Breast disease; Gynecology; Internal medicine; Radiology; Pathology","score_opus":0.5264727378423883,"score_gpt":0.5938261682780586,"score_spread":0.06735343043567021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987962292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97388065,0.0018717435,0.000043269614,0.0103429025,0.00023060617,0.00030817313,0.000024871219,0.00004964453,0.013248169],"genre_scores_gemma":[0.9958275,0.00051084824,0.00017608945,0.0007086409,0.0019038996,0.000089577414,0.000011810572,0.000017592512,0.0007540465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810207,0.00007571669,0.00027128647,0.0002501215,0.0005879812,0.0007128093],"domain_scores_gemma":[0.9981982,0.0001845227,0.000038877202,0.00046062862,0.00052663,0.00059111253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019092656,0.00008747258,0.00020986721,0.000100267884,0.00019811878,0.00003040255,0.00017177153,0.00011656939,0.00088370783],"category_scores_gemma":[0.00024009476,0.00007434622,0.00010344089,0.00042534946,0.00023334884,0.00018479876,0.000105917825,0.00073335605,0.00060403976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019825668,0.0001511199,0.8759695,0.000036220066,0.000048144928,0.000012008447,0.0000819171,6.1960276e-7,0.006215713,0.0014487313,0.053016294,0.06282146],"study_design_scores_gemma":[0.0003848525,0.000065929846,0.9630328,0.00010547932,0.000021905813,0.000120236065,0.00013018682,0.0000024092994,0.0008817428,0.00020772133,0.034967147,0.00007960206],"about_ca_topic_score_codex":0.0009886945,"about_ca_topic_score_gemma":0.00010131231,"teacher_disagreement_score":0.087063275,"about_ca_system_score_codex":0.0002800944,"about_ca_system_score_gemma":0.0004910985,"threshold_uncertainty_score":0.9675981},"labels":[],"label_agreement":null},{"id":"W1988049837","doi":"10.1158/0008-5472.can-04-2837","title":"p300 Regulates Androgen Receptor–Independent Expression of Prostate-Specific Antigen in Prostate Cancer Cells Treated Chronically with Interleukin-6","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Prostate Cancer Foundation; National Cancer Institute; National Institutes of Health; Terry Fox Foundation; Oesterreichische Nationalbank","keywords":"Androgen receptor; Prostate cancer; Coactivator; Androgen; Internal medicine; Endocrinology; Prostate; Cancer research; CREB; Cancer; Medicine; Biology; Transcription factor; Hormone","score_opus":0.04580033513448021,"score_gpt":0.36727588928392657,"score_spread":0.32147555414944634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988049837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763079,0.017481606,0.0000013120913,0.0023998215,0.000072087656,0.0028251489,0.0001442691,0.000054447664,0.0007133824],"genre_scores_gemma":[0.9600164,0.030961957,0.00023323357,0.000029674096,0.00022662523,0.0011629794,0.000081742335,0.00009565874,0.0071916925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954057,0.0002766463,0.00062445004,0.0009030897,0.0015374686,0.0012526694],"domain_scores_gemma":[0.99778026,0.00011662769,0.00014575468,0.0006736491,0.0008702892,0.00041340216],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092866184,0.00035111108,0.0006726003,0.00068807864,0.00015933014,0.00006847515,0.00036049966,0.00017783273,0.0016923641],"category_scores_gemma":[0.000021390117,0.00023752713,0.00010406612,0.0013405863,0.00066144654,0.00026886418,0.00020526291,0.00092120585,0.00006010764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01354884,0.0006399375,0.079700164,0.00043961103,0.00013884352,0.00018204341,0.0023749862,0.00029707485,0.8710902,0.00000916373,0.0051271524,0.026452001],"study_design_scores_gemma":[0.00747654,0.0014713455,0.014847322,0.0024354695,0.000018198198,0.000008896906,0.0004591551,0.000060907016,0.94768584,0.0000150723345,0.025261285,0.0002599731],"about_ca_topic_score_codex":0.0015476187,"about_ca_topic_score_gemma":0.00098243,"teacher_disagreement_score":0.07659566,"about_ca_system_score_codex":0.0020256122,"about_ca_system_score_gemma":0.0015863337,"threshold_uncertainty_score":0.99922025},"labels":[],"label_agreement":null},{"id":"W1988107995","doi":"10.1158/0008-5472.sabcs-09-5122","title":"Evaluation of Factors Associated with Recruitment in Breast Cancer Clinical Trials in a Specialized Breast Cancer Centre.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Quebec Population Health Research Network; Cégep Garneau; Université Laval","funders":"","keywords":"Medicine; Breast cancer; Protocol (science); Cancer; Clinical trial; Population; Cohort; Inclusion and exclusion criteria; Cancer registry; Internal medicine; Oncology; Gynecology; Alternative medicine; Pathology","score_opus":0.9197288068225137,"score_gpt":0.7412198721928895,"score_spread":0.17850893462962414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988107995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95680124,0.0014856035,0.000001346737,0.035533078,0.00026820495,0.0044739493,0.0004790145,0.000020960828,0.00093660434],"genre_scores_gemma":[0.98695296,0.01067655,0.00001580874,0.00026442824,0.00058865536,0.00078257825,0.000033328128,0.000043149645,0.00064252014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9745916,0.012525644,0.0025679432,0.0010194571,0.00807339,0.0012219679],"domain_scores_gemma":[0.9752758,0.017059661,0.0005103326,0.00068398466,0.0059559913,0.00051420584],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.14534451,0.00026852218,0.0017529046,0.000764322,0.000081097074,0.000045256824,0.00045130143,0.00071877026,0.0054440275],"category_scores_gemma":[0.04914883,0.0001950298,0.00025684634,0.00247103,0.00071510795,0.00013214102,0.00012303394,0.004177242,0.000007858515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00805396,0.0021489437,0.8744437,0.00014136678,0.00041994682,0.000041322823,0.0009673317,0.00020462077,0.0026965246,0.0002781806,0.0017344053,0.10886966],"study_design_scores_gemma":[0.015877975,0.0003889679,0.9736402,0.0049071256,0.00019073817,0.0000014775794,0.00047708798,0.0005053061,0.0010143215,0.0026557518,0.0001454557,0.00019557108],"about_ca_topic_score_codex":0.01138114,"about_ca_topic_score_gemma":0.06649798,"teacher_disagreement_score":0.10867409,"about_ca_system_score_codex":0.0055929534,"about_ca_system_score_gemma":0.012945457,"threshold_uncertainty_score":0.9982244},"labels":[],"label_agreement":null},{"id":"W1988249742","doi":"10.1158/1538-7445.am10-2129","title":"Abstract 2129: Pediatric diffuse intrinsic pontine gliomas are genetically distinct from high and low grade astrocytomas","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Pons; Brainstem; Pathology; SNP array; Medicine; Cancer; Biology; Oncology; Cancer research; Internal medicine; Single-nucleotide polymorphism; Genetics; Genotype; Gene","score_opus":0.03341220666078044,"score_gpt":0.3426178020250434,"score_spread":0.30920559536426295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988249742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932932,0.0022542512,0.0000017453117,0.0032985222,0.00025258402,0.0005643875,0.00015338742,0.00005383352,0.00012808818],"genre_scores_gemma":[0.99687535,0.0008198944,0.00027620274,0.000055022592,0.0015228039,0.0002542687,0.00005851028,0.000047975373,0.00009000286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976566,0.00005102754,0.00027616302,0.00058721507,0.00078589603,0.0006431012],"domain_scores_gemma":[0.99814016,0.00036915136,0.0000722075,0.00053727673,0.00028146358,0.00059977226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025509423,0.00022635322,0.00037595842,0.00032116126,0.0001822926,0.00010836338,0.00017415764,0.00015778985,0.00083396817],"category_scores_gemma":[0.00030186475,0.00017479419,0.00007736791,0.0004826699,0.00023632661,0.00006071487,0.0001760018,0.0008140947,0.00010578815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040065142,0.0013069417,0.86154383,0.0001492808,0.00013192263,0.0015598694,0.000082336126,5.927857e-7,0.11177538,0.000120939076,0.0030005157,0.01992773],"study_design_scores_gemma":[0.004140167,0.00025440482,0.9679736,0.00007122519,0.00010082551,0.00002347824,0.000029593493,0.000010452518,0.025697242,0.00017115063,0.0013760518,0.00015178986],"about_ca_topic_score_codex":0.0020893463,"about_ca_topic_score_gemma":0.0013885453,"teacher_disagreement_score":0.10642978,"about_ca_system_score_codex":0.0001157735,"about_ca_system_score_gemma":0.00020858721,"threshold_uncertainty_score":0.91313666},"labels":[],"label_agreement":null},{"id":"W1988368041","doi":"10.1158/1538-7445.am2014-3283","title":"Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Biology; SNP; Locus (genetics); Genotype; Genetic association; Minor allele frequency; 1000 Genomes Project; Imputation (statistics); Genetics; Allele; Ovarian cancer; Oncology; Gene; Cancer; Medicine","score_opus":0.09044935625200771,"score_gpt":0.41160121404870936,"score_spread":0.32115185779670163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988368041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795922,0.0018924504,0.00033950995,0.0051150536,0.00080100854,0.0018943963,0.00023547732,0.00008147007,0.0100484025],"genre_scores_gemma":[0.99357224,0.00069808913,0.0004235361,0.00020470496,0.0013472422,0.0013860301,0.00004341982,0.00006614347,0.0022585774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973204,0.00013255095,0.00033059006,0.0006759152,0.00071056007,0.0008299917],"domain_scores_gemma":[0.99763525,0.00057468796,0.00009436337,0.0007690884,0.0005534723,0.00037312144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015125867,0.00021500792,0.00042178424,0.00026824832,0.00043365455,0.00012661295,0.00022664621,0.00014683689,0.0011092925],"category_scores_gemma":[0.00045043157,0.0001786571,0.0001807871,0.0003494071,0.00016685973,0.00011278923,0.000081217724,0.0004580657,0.00019890246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032975113,0.0022023963,0.51151234,0.0021145511,0.0015805383,0.00035416073,0.0025956878,0.000111107984,0.0220623,0.009291901,0.18939409,0.25548342],"study_design_scores_gemma":[0.005820588,0.0007022631,0.91638803,0.00028797783,0.0002047437,0.000017178923,0.00015631922,0.00021506367,0.01723895,0.0024191346,0.05629257,0.00025716203],"about_ca_topic_score_codex":0.005388616,"about_ca_topic_score_gemma":0.0005531985,"teacher_disagreement_score":0.4048757,"about_ca_system_score_codex":0.00051607564,"about_ca_system_score_gemma":0.00055821514,"threshold_uncertainty_score":0.99980384},"labels":[],"label_agreement":null},{"id":"W1988439318","doi":"10.1158/0008-5472.sabcs-09-902","title":"The Contribution of Founder Mutations to Early-Onset Breast Cancer in French-Canadian Women.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; University of Toronto; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Breast cancer; CHEK2; Cancer; Medicine; Founder effect; Population; Oncology; PALB2; Odds ratio; Mutation; Internal medicine; Allele; Genetics; Germline mutation; Biology; Gene; Haplotype; Environmental health","score_opus":0.025041967537032927,"score_gpt":0.3724026277504424,"score_spread":0.3473606602134095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988439318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895702,0.0012346769,0.00006637787,0.007873435,0.00014829102,0.00041211522,0.00029934515,0.0000035471924,0.00039203098],"genre_scores_gemma":[0.99788594,0.0003981372,0.000026470598,0.00030298647,0.00016457462,0.0005991734,0.000026212989,0.00001169158,0.0005848293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985336,0.00013352872,0.00019444348,0.0002716556,0.00027445628,0.0005922838],"domain_scores_gemma":[0.99878246,0.000041996158,0.00003330097,0.00033812592,0.00060567196,0.00019847584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065867754,0.000088582725,0.00009902639,0.00018744517,0.0002398724,0.00004592165,0.00031153343,0.00009838696,0.00014456832],"category_scores_gemma":[0.00013636627,0.00007746805,0.00003173209,0.00066635164,0.00017984341,0.0000062068216,0.000042964126,0.00018804787,0.000012615066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000937627,0.00024155306,0.16875659,0.000036414836,0.00032585752,0.000017786802,0.0057834783,0.010152855,0.5543849,0.0023937337,0.0645137,0.19245553],"study_design_scores_gemma":[0.00092072075,0.0003198437,0.890065,0.00006618145,0.0000070595675,0.000007726299,0.00080940436,0.000051258412,0.05539685,0.0029246786,0.04917356,0.00025767504],"about_ca_topic_score_codex":0.032048542,"about_ca_topic_score_gemma":0.25796777,"teacher_disagreement_score":0.72130847,"about_ca_system_score_codex":0.0012073197,"about_ca_system_score_gemma":0.0023348662,"threshold_uncertainty_score":0.9743971},"labels":[],"label_agreement":null},{"id":"W1988547264","doi":"10.1158/0008-5472.can-05-1041","title":"Leukemogenic MLL Fusion Proteins Bind across a Broad Region of the <i>Hox a9</i> Locus, Promoting Transcription and Multiple Histone Modifications","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Biology; Fusion protein; Hox gene; Histone methyltransferase; Histone; Chromosomal translocation; Transcription factor; Histone methylation; Histone H3; Molecular biology; Genetics; Gene; DNA methylation; Gene expression","score_opus":0.08448096084190837,"score_gpt":0.39670136655725086,"score_spread":0.3122204057153425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988547264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799115,0.0031196934,0.00014316331,0.013361122,0.00004652224,0.0028857149,0.000041047217,0.00004250985,0.00044871017],"genre_scores_gemma":[0.99177283,0.001396289,0.00024024142,0.0000909588,0.00028681068,0.0004142466,0.0000135242435,0.000049625512,0.0057354774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969599,0.00025584633,0.00040116132,0.0005288027,0.0011111455,0.0007431134],"domain_scores_gemma":[0.99804765,0.00012991385,0.00010562222,0.00077158277,0.00070585485,0.00023937154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013813993,0.0001688468,0.00028534335,0.00020443236,0.00060780696,0.00004199612,0.00036518188,0.0001831804,0.000051491243],"category_scores_gemma":[0.00038700222,0.0001237007,0.00010960111,0.0011574052,0.0008255366,0.00019038758,0.00021877665,0.0010921165,0.000019758761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051584275,0.00019003601,0.0021797111,0.0003925201,0.000037314312,0.000011094829,0.0045999684,0.000042473403,0.9217504,0.000045044944,0.0022881737,0.06794742],"study_design_scores_gemma":[0.007400035,0.00052301475,0.023132278,0.0011105536,0.00006301309,0.00019578173,0.0012443374,0.009526545,0.9140077,0.00009706281,0.042385884,0.0003137674],"about_ca_topic_score_codex":0.0027173993,"about_ca_topic_score_gemma":0.0010876866,"teacher_disagreement_score":0.06763365,"about_ca_system_score_codex":0.0017007025,"about_ca_system_score_gemma":0.0010870215,"threshold_uncertainty_score":0.5044368},"labels":[],"label_agreement":null},{"id":"W1988852157","doi":"10.1158/1538-7445.am2013-1406","title":"Abstract 1406: Tgfbr1 haploinsufficiency is a potent modifier of breast cancer risk.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Haploinsufficiency; Breast cancer; Cancer; Carcinogenesis; Mammary tumor; Medicine; Internal medicine; Pathology; Biology; Cancer research; Endocrinology; Phenotype; Gene; Genetics","score_opus":0.039708319799189304,"score_gpt":0.36912151816828664,"score_spread":0.3294131983690973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988852157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922157,0.0055967537,0.000044887667,0.00045989844,0.00010245716,0.00036988253,0.00041471838,0.000012471209,0.00078325183],"genre_scores_gemma":[0.9966516,0.0013332106,0.00004747591,0.00010194919,0.0003177646,0.0003749823,0.000017859249,0.000036303984,0.0011188803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980468,0.0000868645,0.00026191314,0.00047470452,0.0005819863,0.0005476948],"domain_scores_gemma":[0.99836993,0.000029959147,0.00010064688,0.00055506633,0.00072912266,0.00021526289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033687282,0.00015488388,0.00016478566,0.00010438429,0.00015480409,0.000043889042,0.0004848948,0.00014194913,0.002080188],"category_scores_gemma":[0.00008830105,0.00013558968,0.000110812434,0.0002262575,0.00031366837,0.000008999923,0.00020458896,0.00026738338,0.00009708398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013458915,0.0002869927,0.01698174,0.00012209224,0.00010889745,0.0000026868775,0.00021846419,0.0007321601,0.932622,0.000009678281,0.030469235,0.018311465],"study_design_scores_gemma":[0.00073321926,0.00016260333,0.3126382,0.00015059872,0.000019546644,0.0000038475623,0.00028103308,0.00020751124,0.6762971,0.00015868538,0.009007005,0.00034064305],"about_ca_topic_score_codex":0.00669838,"about_ca_topic_score_gemma":0.000115160954,"teacher_disagreement_score":0.29565644,"about_ca_system_score_codex":0.00007580455,"about_ca_system_score_gemma":0.00064173294,"threshold_uncertainty_score":0.9999161},"labels":[],"label_agreement":null},{"id":"W1988919208","doi":"10.1158/1538-7445.tumimm2012-b25","title":"Abstract B25: Porous silicon microparticles exhibit immunomodulatory effects leading to suppression of tumor growth.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Doxorubicin; Microparticle; Immune system; Biocompatibility; Chemistry; Cancer research; Proinflammatory cytokine; Paclitaxel; Pharmacology; Inflammation; Immunology; Cancer; Medicine; Chemotherapy; Biology; Internal medicine","score_opus":0.023243679501116457,"score_gpt":0.30212007706947897,"score_spread":0.2788763975683625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988919208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534094,0.0027190142,0.000050702933,0.00006232365,0.00041480118,0.00076733535,0.000015975296,0.0001246089,0.0005042871],"genre_scores_gemma":[0.99910694,0.00011596741,0.0001393921,0.00003537644,0.00013512414,0.00029161555,0.0000028724496,0.000086838576,0.00008585455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981719,0.000031170883,0.0003228067,0.0002585636,0.0004864648,0.000729069],"domain_scores_gemma":[0.9988128,0.00025505992,0.000033493,0.00040484968,0.0002719912,0.00022180426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034108272,0.00018839158,0.00028546216,0.0002678695,0.000094658906,0.00006579584,0.00038005004,0.00008129169,0.00041040528],"category_scores_gemma":[0.000114565584,0.00017570428,0.00006292755,0.0004321513,0.00010513235,0.00031134213,0.000109961504,0.0004127387,0.00044730032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040288072,0.000024426163,0.0010095695,0.0005981978,0.000038479964,0.000012119312,0.0004140377,0.0011347414,0.9841312,0.000026565242,0.0049382024,0.007632166],"study_design_scores_gemma":[0.0004041934,0.00009830227,0.013597215,0.00040313514,0.0000059240106,0.0000026552411,0.00008600468,0.00020950357,0.98424757,0.00031589915,0.0004337588,0.00019585408],"about_ca_topic_score_codex":0.00087220094,"about_ca_topic_score_gemma":0.00003211332,"teacher_disagreement_score":0.012587645,"about_ca_system_score_codex":0.00041782059,"about_ca_system_score_gemma":0.000079379555,"threshold_uncertainty_score":0.71650124},"labels":[],"label_agreement":null},{"id":"W1988965792","doi":"10.1158/0008-5472.can-05-4033","title":"Cyclooxygenase 2 Rescues LNCaP Prostate Cancer Cells from Sanguinarine-Induced Apoptosis by a Mechanism Involving Inhibition of Nitric Oxide Synthase Activity","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Sanguinarine; LNCaP; Apoptosis; Nitric oxide synthase; Nitric oxide; Cancer cell; Chemistry; Cyclooxygenase; Annexin; SOD2; Cancer research; Biology; Molecular biology; Biochemistry; Superoxide dismutase; Cancer; Oxidative stress; Enzyme; Alkaloid","score_opus":0.04703812225212697,"score_gpt":0.3656448100700598,"score_spread":0.31860668781793283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988965792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937945,0.0023641498,0.000020801575,0.0012338769,0.0000694069,0.0012979553,0.0005525391,0.000072379196,0.00059442007],"genre_scores_gemma":[0.9927139,0.0025444306,0.00015533317,0.000061033697,0.00041550168,0.0008424106,0.00010634061,0.00008509963,0.003075916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99577254,0.00037280275,0.00045041917,0.00075915596,0.0016206163,0.0010244905],"domain_scores_gemma":[0.9977046,0.00029687159,0.00013599744,0.0006401962,0.0008601951,0.00036212642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090955384,0.0002914124,0.0005711902,0.0005798453,0.0002548862,0.0000728994,0.00023284394,0.00021841151,0.0009766383],"category_scores_gemma":[0.00020790828,0.00026365145,0.00015356531,0.0014775475,0.00021927909,0.00025880823,0.0003076571,0.001099036,0.00003806682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009118804,0.0004998567,0.0011010049,0.00037188607,0.0000919446,0.0000694757,0.00013098061,0.00000641624,0.9737734,0.000053860076,0.016213736,0.006775557],"study_design_scores_gemma":[0.0019050598,0.00024810058,0.0033291646,0.00065303023,0.00004859289,0.0000019509434,0.00026342622,0.00016057616,0.99167496,0.0006188807,0.00085258053,0.00024370424],"about_ca_topic_score_codex":0.17369668,"about_ca_topic_score_gemma":0.0016093646,"teacher_disagreement_score":0.17208733,"about_ca_system_score_codex":0.00075904385,"about_ca_system_score_gemma":0.0008784682,"threshold_uncertainty_score":0.9999816},"labels":[],"label_agreement":null},{"id":"W1989126223","doi":"10.1158/1538-7445.am2011-447","title":"Abstract 447: A mechanism of hypoxia-induced immune escape in cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DU145; Hypoxia (environmental); Immune system; Cancer cell; Cancer research; Cell; Cell biology; Biology; Chemistry; Immunology; LNCaP; Cancer; Biochemistry","score_opus":0.08412099449528547,"score_gpt":0.3605129726237682,"score_spread":0.2763919781284827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989126223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831908,0.011460884,0.000015708927,0.00006347267,0.0010824568,0.0004120621,0.00006133181,0.0000081628195,0.0037051572],"genre_scores_gemma":[0.9867196,0.011042052,0.0000959498,0.000052660253,0.0007690455,0.00032420846,0.000010482149,0.000044126606,0.00094188337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801874,0.00010799708,0.00035223618,0.00048595158,0.00039474433,0.00064035546],"domain_scores_gemma":[0.99887866,0.000018150535,0.000098021985,0.0005588622,0.0003015627,0.00014474845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007704655,0.00017944246,0.0002977759,0.00020332972,0.000065487046,0.00001383546,0.00048013913,0.00023647804,0.00073764473],"category_scores_gemma":[0.000049569346,0.00017520244,0.00012071798,0.0003529697,0.00013776192,0.000008885612,0.0002070122,0.0003763962,0.00001875326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002700295,0.00012493563,0.000090565496,0.000073523544,0.000048592658,0.000003389576,0.00037458967,0.0000060601496,0.9868934,0.0002687579,0.0010909346,0.010755213],"study_design_scores_gemma":[0.0008496098,0.0001426413,0.007340114,0.000070723894,0.000009971948,0.0000013597331,0.00019452449,0.0000048638503,0.97730887,0.00030292073,0.013581828,0.00019258464],"about_ca_topic_score_codex":0.010324464,"about_ca_topic_score_gemma":0.002315652,"teacher_disagreement_score":0.012490894,"about_ca_system_score_codex":0.00007426716,"about_ca_system_score_gemma":0.0006829289,"threshold_uncertainty_score":0.9962659},"labels":[],"label_agreement":null},{"id":"W1989214140","doi":"10.1158/1538-7445.fbcr13-b22","title":"Abstract B22: Modulation of insulin-like growth factor binding proteins expression in human prostate cancer cells in vitro by american cranberry (<i>Vaccinium macrocarpon</i>) extract","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health PEI","funders":"","keywords":"DU145; Prostate cancer; Insulin-like growth factor-binding protein; Insulin-like growth factor; Cancer research; Growth factor; Cell growth; Biology; Endocrinology; Internal medicine; Growth inhibition; Androgen; Cancer; LNCaP; Medicine; Receptor; Biochemistry; Hormone","score_opus":0.03548871357390334,"score_gpt":0.3463816164856576,"score_spread":0.31089290291175425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989214140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945274,0.0009934952,0.000008895472,0.00054001226,0.00015808416,0.0032082652,0.00022541877,0.000049927537,0.00028849547],"genre_scores_gemma":[0.9959196,0.001580394,0.00016094455,0.00008415171,0.00014561215,0.001535758,0.000103393606,0.000107213666,0.00036292395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995379,0.00025754177,0.0010639136,0.0008323477,0.0012581815,0.0012090154],"domain_scores_gemma":[0.9979967,0.00015695885,0.00037186345,0.000507509,0.0005659376,0.0004010181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007059334,0.000403328,0.00081190706,0.001199532,0.00015610876,0.000073380696,0.0003663666,0.00025104173,0.00045238354],"category_scores_gemma":[0.00012329071,0.00035671538,0.00012812216,0.0017507313,0.00029320535,0.00067315466,0.00015368102,0.001561257,0.000038294475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007885373,0.00042726228,0.08411228,0.000424049,0.000027334632,0.000024971207,0.0014254159,0.000021506668,0.90244263,0.0000012725926,0.0015565127,0.008748201],"study_design_scores_gemma":[0.0018470183,0.00022003111,0.36271304,0.00046001744,0.0000060941334,9.3540035e-7,0.00037298666,0.00009918342,0.6337993,0.000036153553,0.00020908046,0.00023615919],"about_ca_topic_score_codex":0.035651166,"about_ca_topic_score_gemma":0.00042414773,"teacher_disagreement_score":0.27860075,"about_ca_system_score_codex":0.000989065,"about_ca_system_score_gemma":0.0005143204,"threshold_uncertainty_score":0.9998885},"labels":[],"label_agreement":null},{"id":"W1989240410","doi":"10.1158/1538-7445.am2013-5572","title":"Abstract 5572: Breastin a natural product from Nerium Oleander exhibits high activity in a panel of human tumor cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical and Pharmacological Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mining Association of Canada","funders":"","keywords":"Propidium iodide; IC50; Cell culture; In vitro; Chemistry; Traditional medicine; Biochemistry; Biology; Medicine; Apoptosis; Programmed cell death","score_opus":0.1428658513238591,"score_gpt":0.4125292985419445,"score_spread":0.2696634472180854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989240410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936719,0.0017830823,1.9723045e-7,0.00283803,0.00008122832,0.0007348595,0.000029647243,0.000021880158,0.00083918945],"genre_scores_gemma":[0.9982403,0.00008560181,0.000020570269,0.0001312459,0.0005456883,0.0003176323,0.000012050077,0.0000136450135,0.00063329126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837,0.0000740916,0.00021978628,0.00038945177,0.00047281993,0.00047385116],"domain_scores_gemma":[0.99903256,0.00022151263,0.000055989327,0.00018451407,0.0003434582,0.00016198453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024501592,0.00014143714,0.00037850748,0.00007447728,0.00006733692,0.000013659453,0.00016113787,0.00005305809,0.0016004863],"category_scores_gemma":[0.00013331762,0.00009573193,0.000059290225,0.00035594453,0.00025990285,0.00007853019,0.00017940075,0.00092933874,0.00004571254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003934523,0.00047285482,0.007829844,0.00023998923,0.000026915568,0.000027906639,0.00011054318,0.0000016590504,0.98107153,0.0000015029743,0.0056993556,0.004124467],"study_design_scores_gemma":[0.00091916445,0.00006924556,0.46936044,0.000106429434,0.0000065827576,6.886131e-7,0.000025025609,0.00001289993,0.5290774,0.0002471156,0.00010629733,0.00006871039],"about_ca_topic_score_codex":0.013774633,"about_ca_topic_score_gemma":0.0001489881,"teacher_disagreement_score":0.46153063,"about_ca_system_score_codex":0.0001478069,"about_ca_system_score_gemma":0.00011532992,"threshold_uncertainty_score":0.99931216},"labels":[],"label_agreement":null},{"id":"W1989245289","doi":"10.1158/1538-7445.am10-172","title":"Abstract 172: A role for the demethylation of microRNA-496 in MBD2-mediated repression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"microRNA; Gene knockdown; Transfection; Methylation; DNA methylation; In silico; Demethylation; Biology; Chromatin immunoprecipitation; Regulation of gene expression; Molecular biology; Cell biology; Luciferase; Cell culture; Psychological repression; Gene expression; Gene; Promoter; Genetics","score_opus":0.03356096926535593,"score_gpt":0.39388877923486143,"score_spread":0.36032780996950553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989245289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918693,0.0033232113,0.0020678744,0.0009288501,0.00022525497,0.0011763267,0.00006990147,0.00000734321,0.00033197235],"genre_scores_gemma":[0.99752104,0.0009168708,0.00032470917,0.000045589684,0.000231539,0.00055574515,0.000066304565,0.000034804856,0.00030337882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829656,0.000108563494,0.00025363968,0.0003995966,0.00043928478,0.000502331],"domain_scores_gemma":[0.998581,0.00020060621,0.000072873394,0.0005868032,0.00046579994,0.0000929117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019458878,0.000107065935,0.0001291958,0.0001669975,0.00012391644,0.000026990105,0.0004608124,0.0002792687,0.00014028212],"category_scores_gemma":[0.0010479116,0.00008469168,0.00008491062,0.0003738005,0.00019037064,0.0000069658263,0.00019604551,0.00067144056,0.0000072890284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042997047,0.000045228047,0.00018020075,0.000039297127,0.000030501664,0.0000012938683,0.000065457105,0.00031688888,0.9867031,0.00008758884,0.000980166,0.011120318],"study_design_scores_gemma":[0.0007965786,0.00011760104,0.003044414,0.000037752405,0.000004613258,0.000001444666,0.000097197524,0.0005458248,0.9634446,0.00029723556,0.03152003,0.00009273106],"about_ca_topic_score_codex":0.0008015555,"about_ca_topic_score_gemma":0.0019971537,"teacher_disagreement_score":0.030539865,"about_ca_system_score_codex":0.00005287882,"about_ca_system_score_gemma":0.0005144469,"threshold_uncertainty_score":0.34536263},"labels":[],"label_agreement":null},{"id":"W1989335738","doi":"10.1158/0008-5472.can-07-0373","title":"Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Lustgarten Foundation; Women's Health Initiative","keywords":"Medicine; Quartile; Pancreatic cancer; Internal medicine; Prospective cohort study; Endocrinology; Risk factor; Cancer; Insulin; Relative risk; Insulin-like growth factor-binding protein; Insulin-like growth factor; Cohort study; Oncology; Gastroenterology; Confidence interval; Growth factor","score_opus":0.06012127121469682,"score_gpt":0.36384173069514303,"score_spread":0.30372045948044624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989335738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899751,0.006344583,0.00006945391,0.0005580554,0.00014285013,0.0015826181,0.000054006792,0.000039446833,0.0012338615],"genre_scores_gemma":[0.9952843,0.003242196,0.00012519174,0.00007881914,0.000323095,0.00022452309,0.0000056347076,0.000051578998,0.0006646656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682015,0.00030440735,0.0005656569,0.00043297414,0.0010700654,0.0008067452],"domain_scores_gemma":[0.9977135,0.00068913493,0.00021001612,0.00041390795,0.00067163305,0.00030178475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028913107,0.00022520973,0.0005504679,0.0004121365,0.00040502212,0.00004194032,0.00022909552,0.00016433065,0.00018168335],"category_scores_gemma":[0.0012448737,0.00014321582,0.00013173657,0.0010977193,0.00081709394,0.00013859193,0.00016193706,0.0011018488,0.000011605519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029093095,0.00013306132,0.60543734,0.0011356814,0.000673322,0.00007769178,0.0052357274,0.000002781934,0.36097193,0.0013299795,0.0005098912,0.021583263],"study_design_scores_gemma":[0.013646052,0.000727504,0.6775318,0.0018161993,0.0004426318,0.000047102007,0.003120281,0.0003064679,0.29855025,0.0012396747,0.0019563802,0.00061571115],"about_ca_topic_score_codex":0.007182903,"about_ca_topic_score_gemma":0.00019150213,"teacher_disagreement_score":0.0720944,"about_ca_system_score_codex":0.00030289064,"about_ca_system_score_gemma":0.00043658126,"threshold_uncertainty_score":0.99942833},"labels":[],"label_agreement":null},{"id":"W1989347200","doi":"10.1158/1538-7445.am10-4318","title":"Abstract 4318: Biomarker evaluation during an image-guided intracranial murine glioma study of radiation and sunitinib","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; Medicine; Imaging biomarker; Glioma; Effective diffusion coefficient; Angiogenesis; Tyrosine-kinase inhibitor; Diffusion MRI; Nuclear medicine; Pathology; Magnetic resonance imaging; Cancer; Cancer research; Internal medicine; Radiology","score_opus":0.12325423337846203,"score_gpt":0.4693733863725481,"score_spread":0.3461191529940861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989347200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974729,0.00019739699,2.2200453e-7,0.00038100567,0.00013533798,0.0014932271,0.000014494157,0.000018266717,0.000287154],"genre_scores_gemma":[0.99921274,0.000079179845,0.00005084676,0.0000047567223,0.00022791313,0.00036040574,0.000029933208,0.00002159155,0.000012607832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981615,0.00014248614,0.00026734322,0.00030627297,0.00086042425,0.00026198433],"domain_scores_gemma":[0.9986186,0.00009569883,0.000069244896,0.00033957823,0.00069391594,0.00018297107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014359356,0.000107407825,0.00019866881,0.00040791856,0.00014427908,0.00004506039,0.000073269664,0.000068948255,0.0009061638],"category_scores_gemma":[0.00030272786,0.00009012123,0.00002728732,0.0003852093,0.00011351024,0.00017071847,0.000046115903,0.00027142584,0.000008036156],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043183257,0.0015201869,0.07734099,0.00009101498,0.000099173376,0.0001453489,0.00075078226,0.0000022319655,0.85433555,0.000008427312,0.00012233855,0.06515212],"study_design_scores_gemma":[0.0069430377,0.0004362356,0.81155443,0.000038390812,0.000067508314,0.00003637667,0.0005137838,0.00024093667,0.18005097,0.000027083015,0.00002839673,0.00006284278],"about_ca_topic_score_codex":0.0025054717,"about_ca_topic_score_gemma":0.001026541,"teacher_disagreement_score":0.7342135,"about_ca_system_score_codex":0.000115107236,"about_ca_system_score_gemma":0.00017780617,"threshold_uncertainty_score":0.99218583},"labels":[],"label_agreement":null},{"id":"W1989420021","doi":"10.1158/1538-7445.am2012-4912","title":"Abstract 4912: Systematic, comparative network analysis on non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; York University","funders":"","keywords":"Lung cancer; CXCL5; Cancer research; Biology; Cancer; Computational biology; Medicine; Immunology; Oncology; Chemokine; Genetics; Immune system","score_opus":0.047511714221720444,"score_gpt":0.3708109097992095,"score_spread":0.32329919557748904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989420021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967177,0.01816476,0.0010688538,0.000080211525,0.00041484373,0.00096272,0.00006325515,0.000010105268,0.01205828],"genre_scores_gemma":[0.9950313,0.0011028198,0.00012672416,0.0001824769,0.0013205087,0.00042426164,0.000070089045,0.000022111028,0.0017197095],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980454,0.00012453685,0.00035007345,0.00028116148,0.00032954186,0.00086932303],"domain_scores_gemma":[0.9987741,0.00007439578,0.00014006656,0.00053418323,0.00022119364,0.0002560749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012139516,0.00019637098,0.00039715716,0.00011971856,0.00023055456,0.00006381638,0.00036246533,0.00019017565,0.00023734932],"category_scores_gemma":[0.000011444503,0.00016154099,0.0001759946,0.0005381594,0.00008938141,0.0000071566565,0.00015907813,0.00037773428,0.000056870093],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010691164,0.00087208877,0.13060874,0.018536828,0.010253843,0.000011472778,0.0071265195,0.19346617,0.1622327,0.0009579448,0.47313067,0.001733901],"study_design_scores_gemma":[0.009000262,0.0019749498,0.22316137,0.011362991,0.005777806,0.000013391595,0.008220391,0.069640554,0.5701469,0.00033454256,0.09315634,0.0072104824],"about_ca_topic_score_codex":0.00029184864,"about_ca_topic_score_gemma":0.00047812672,"teacher_disagreement_score":0.40791422,"about_ca_system_score_codex":0.00011983106,"about_ca_system_score_gemma":0.00016901347,"threshold_uncertainty_score":0.65874505},"labels":[],"label_agreement":null},{"id":"W1989493029","doi":"10.1158/1538-7445.am10-1387","title":"Abstract 1387: Development of novel antiangiogenic biologics: multifunctional VEGF traps","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Antibody; Fibronectin; Cancer research; Angiogenesis; Recombinant DNA; Cancer; Extracellular matrix; Doxycycline; Chemistry; Molecular biology; Medicine; Biology; Immunology; Biochemistry; Internal medicine; Gene","score_opus":0.08732970321386567,"score_gpt":0.39908542174682937,"score_spread":0.3117557185329637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989493029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974305,0.0003538022,0.00035795756,0.00018090931,0.0001778171,0.0002856224,0.00004733167,0.000008083601,0.0011579571],"genre_scores_gemma":[0.9962085,0.000089980254,0.0022386415,0.000022524702,0.0002629408,0.00012729083,0.000112430236,0.000017001707,0.0009206751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984895,0.000035876248,0.00023854105,0.0003525184,0.0004786396,0.00040491374],"domain_scores_gemma":[0.9989352,0.000030809948,0.000047274774,0.00031583162,0.00053615164,0.00013469682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091073266,0.0001063517,0.00011079421,0.00016495315,0.00018030051,0.000022409564,0.00032605062,0.00020250327,0.000824801],"category_scores_gemma":[0.00021269165,0.00009235931,0.00007814078,0.0002527339,0.0002680381,0.0000047299113,0.00015177942,0.00039497993,0.000045717617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014025468,0.00014349715,0.0015244619,0.00003044963,0.000045393706,0.0000010409889,0.00004897882,0.000012917778,0.97565925,0.000097593926,0.00087478844,0.021421367],"study_design_scores_gemma":[0.00060356,0.000073618394,0.03192208,0.000012009773,0.0000012915282,0.0000028972713,0.000049328995,0.00002617631,0.8116165,0.000012396183,0.15557392,0.000106243875],"about_ca_topic_score_codex":0.00009530192,"about_ca_topic_score_gemma":0.0004386311,"teacher_disagreement_score":0.16404277,"about_ca_system_score_codex":0.000025402398,"about_ca_system_score_gemma":0.0007578335,"threshold_uncertainty_score":0.90309924},"labels":[],"label_agreement":null},{"id":"W1989519887","doi":"10.1158/1538-7445.am10-2059","title":"Abstract 2059: The role of microRNA-196b in cervical cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"microRNA; Biology; Transfection; Untranslated region; In silico; Luciferase; Three prime untranslated region; Molecular biology; Cervical cancer; Cancer; Cancer research; Gene; Messenger RNA; Bioinformatics; Genetics","score_opus":0.022436612721750366,"score_gpt":0.3710427814303673,"score_spread":0.34860616870861694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989519887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870754,0.0063001653,0.000027231756,0.0011702636,0.0002479663,0.00053186895,0.00007007613,0.000006652179,0.0029382196],"genre_scores_gemma":[0.9968018,0.0015662598,0.000044178185,0.00009296152,0.00043900538,0.00041312363,0.000018414818,0.00004570568,0.00057856285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770236,0.00015337754,0.0002751932,0.00048400924,0.00066703703,0.00071801874],"domain_scores_gemma":[0.99856657,0.00005897698,0.000057738318,0.00073969044,0.00042312502,0.0001538809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011899442,0.00015119852,0.00017591749,0.0001725755,0.0001209954,0.000039936593,0.0008428836,0.00031788604,0.0011698927],"category_scores_gemma":[0.00019698784,0.00012068077,0.000102664104,0.00052621675,0.00042058912,0.000005496444,0.00039896322,0.0013601874,0.000026029831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021142795,0.00006633911,0.00090223475,0.000033632452,0.000039752984,0.0000059283134,0.000084559,0.00009796959,0.9811,0.0002782547,0.0017727661,0.015407125],"study_design_scores_gemma":[0.00045196983,0.000070400165,0.004890026,0.00003726258,0.000003914956,0.0000040470386,0.00013637135,0.00005105501,0.8914061,0.00037577376,0.10244788,0.00012519961],"about_ca_topic_score_codex":0.005976945,"about_ca_topic_score_gemma":0.016427023,"teacher_disagreement_score":0.10067511,"about_ca_system_score_codex":0.000086854074,"about_ca_system_score_gemma":0.00096300314,"threshold_uncertainty_score":0.99974316},"labels":[],"label_agreement":null},{"id":"W1989715997","doi":"10.1158/0008-5472.can-09-0342","title":"Multipotent CD15+ Cancer Stem Cells in <i>Patched-1</i> –Deficient Mouse Medulloblastoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Hospital for Sick Children; Ontario Genomics Institute; Stem Cell Network; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada","keywords":"Patched; Cancer stem cell; Clonogenic assay; Cancer research; Biology; Medulloblastoma; Cancer; Stem cell; CD15; Cancer cell; Wnt signaling pathway; Hedgehog signaling pathway; Immunology; Cell biology; In vitro; Signal transduction; CD34; Genetics","score_opus":0.0619287701577962,"score_gpt":0.3723790747872186,"score_spread":0.3104503046294224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989715997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909311,0.006783265,0.00005882928,0.0010329137,0.00019208172,0.00051458617,0.00008024596,0.000021917493,0.0003850959],"genre_scores_gemma":[0.99353755,0.0025241356,0.00005736207,0.00038102092,0.0002806693,0.0003263885,0.0000079932415,0.000031932013,0.0028529307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748063,0.0001999436,0.0002835975,0.0006527507,0.0005516283,0.00083142373],"domain_scores_gemma":[0.9989727,0.00002890059,0.000048823502,0.00047132492,0.00031043118,0.00016780171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007277226,0.00020665345,0.00023735128,0.00015587383,0.00015202218,0.00003902589,0.00041179746,0.00016741265,0.000034520326],"category_scores_gemma":[0.000041026113,0.00019151991,0.000083368686,0.0004039853,0.0002073771,0.000004360072,0.00020431142,0.0003659475,0.000036544654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015399604,0.00013806763,0.000949186,0.00003023835,0.000027003603,0.00001924849,0.0003941584,0.0018902991,0.9786344,0.000014012453,0.005827869,0.011921479],"study_design_scores_gemma":[0.00074627774,0.0002861087,0.00070804456,0.00007243903,0.0000044669587,0.0000012104238,0.00050945126,0.0000910124,0.9702872,0.000012052543,0.0270574,0.00022434979],"about_ca_topic_score_codex":0.000535517,"about_ca_topic_score_gemma":0.0010565509,"teacher_disagreement_score":0.02122953,"about_ca_system_score_codex":0.00025352495,"about_ca_system_score_gemma":0.00035964028,"threshold_uncertainty_score":0.78099555},"labels":[],"label_agreement":null},{"id":"W1990179192","doi":"10.1158/1538-7445.am2011-1716","title":"Abstract 1716: Mechanisms of resistance in carboplatin, docetaxel and dual drug resistant ovarian cancer cell lines","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; Institute of Cancer Research; NOSM University","funders":"","keywords":"Carboplatin; Docetaxel; Ovarian cancer; Drug resistance; Chemotherapy; Medicine; Pharmacology; Clonogenic assay; Cancer research; Cancer; Oncology; Cell culture; Internal medicine; Biology; Cisplatin; Genetics","score_opus":0.04947577347129486,"score_gpt":0.358330955729298,"score_spread":0.3088551822580032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990179192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903036,0.0054935114,0.0003791587,0.00031104518,0.000038477716,0.00038564854,0.00012211099,0.000015132412,0.0042245374],"genre_scores_gemma":[0.9883832,0.0032067534,0.0072211954,0.000033441604,0.000073694035,0.00014682254,0.00001281356,0.000023363169,0.0008987332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998854,0.000045921875,0.00023321496,0.0003815297,0.00018789207,0.0002974733],"domain_scores_gemma":[0.99924314,0.000019450305,0.000082171166,0.00036037873,0.00021979194,0.000075073425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038902526,0.000115338,0.00014600616,0.0000576724,0.000082947554,0.000010501007,0.00016337179,0.000108263164,0.00003755841],"category_scores_gemma":[0.000029963998,0.00010822669,0.000030950563,0.00018681002,0.00018547922,0.0000065356317,0.00013391778,0.00017906535,5.720454e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022097834,0.000052881544,0.00013799619,0.000075882774,0.000008641869,0.0000048974475,0.00018157769,0.0000021185942,0.995915,0.0019267288,0.0008545345,0.000618745],"study_design_scores_gemma":[0.00031416933,0.000049843235,0.0055147656,0.00009212109,0.0000046133273,6.314919e-7,0.00023649515,0.0000042686033,0.98498166,0.005770418,0.0028949745,0.00013606512],"about_ca_topic_score_codex":0.0031883575,"about_ca_topic_score_gemma":0.012074537,"teacher_disagreement_score":0.010933382,"about_ca_system_score_codex":0.000047446923,"about_ca_system_score_gemma":0.00015745802,"threshold_uncertainty_score":0.6737875},"labels":[],"label_agreement":null},{"id":"W1990236719","doi":"10.1158/0008-5472.can-05-2516","title":"Melanosomal Targeting Sequences from gp100 Are Essential for MHC Class II–Restricted Endogenous Epitope Presentation and Mobilization to Endosomal Compartments","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"MHC class I; MHC class II; Endosome; Biology; CD74; CD8; MHC restriction; Epitope; Antigen presentation; Major histocompatibility complex; Antigen; Cell biology; Cross-presentation; Antigen processing; T cell; Immunology; Immune system; Intracellular","score_opus":0.0560335684438591,"score_gpt":0.3495175945289421,"score_spread":0.293484026085083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990236719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98079133,0.016158974,0.00019587955,0.00060663477,0.00058292603,0.0012121543,0.00031444954,0.00004690457,0.00009076439],"genre_scores_gemma":[0.99639463,0.000593375,0.00012741546,0.000043948687,0.00023250465,0.00065510016,0.00069225556,0.000026050897,0.0012347125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979336,0.00058383646,0.00033342492,0.00043751558,0.000116438576,0.00059514394],"domain_scores_gemma":[0.99876094,0.0005499002,0.00010945223,0.00024944873,0.000299229,0.000031017942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026244,0.00017301648,0.00026415303,0.00021315386,0.00094204146,0.0000748789,0.00031283687,0.00017681999,0.00032035128],"category_scores_gemma":[0.0002070531,0.00016145008,0.000054820008,0.00030554784,0.00024230653,0.00016758747,0.00017380592,0.00024384362,0.000035828787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019345366,0.0001311903,0.006585307,0.00002216087,0.00012291956,0.0000049062046,0.0005621549,0.00015695859,0.9837735,0.0001682104,0.004663009,0.0018751046],"study_design_scores_gemma":[0.0023973726,0.0004421799,0.01727997,0.00006365961,0.00002332621,0.0000074697828,0.00056459295,0.000034464018,0.94936633,0.00042507536,0.029202454,0.00019309597],"about_ca_topic_score_codex":0.0058384743,"about_ca_topic_score_gemma":0.00031496806,"teacher_disagreement_score":0.034407202,"about_ca_system_score_codex":0.0001332846,"about_ca_system_score_gemma":0.00017109311,"threshold_uncertainty_score":0.88260657},"labels":[],"label_agreement":null},{"id":"W1990301341","doi":"10.1158/1538-7445.am2012-3257","title":"Abstract 3257: Nodal signalling in choriocarcinoma cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Trophoblast; NODAL; Biology; Cytotrophoblast; Cell biology; Choriocarcinoma; Nodal signaling; Matrigel; Cancer research; Placenta; Angiogenesis; Anatomy; Embryo; Genetics; Embryogenesis; Fetus","score_opus":0.15244447017861415,"score_gpt":0.42144221438838947,"score_spread":0.2689977442097753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990301341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94873863,0.025896627,0.00000733307,0.00081355684,0.00024371217,0.000361459,0.000006314257,0.00002402687,0.023908323],"genre_scores_gemma":[0.99632585,0.001614327,0.00007652422,0.00009544645,0.00073961494,0.0001503573,0.0000029353373,0.000019553683,0.0009753976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982862,0.00007045706,0.00017875979,0.00020306617,0.0004815081,0.00078002625],"domain_scores_gemma":[0.99926,0.00021036166,0.000020789965,0.00021494838,0.0001005975,0.00019330425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010820036,0.00010267191,0.00021394517,0.00018688892,0.000113227085,0.000014444915,0.0001241987,0.00008695759,0.0006497063],"category_scores_gemma":[0.00007224681,0.000087415305,0.00005192797,0.00035520326,0.00012528845,0.0001286524,0.0000926583,0.0007255548,0.00020206487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045454697,0.0002823486,0.7466058,0.00059811695,0.000078336314,0.00010926979,0.0039583184,0.000015553707,0.22520892,0.0003568079,0.00670461,0.015627386],"study_design_scores_gemma":[0.0014557777,0.000097885524,0.8143709,0.000981271,0.00001654837,0.0000072836237,0.00059762725,0.000023965693,0.16225427,0.00019008722,0.019806812,0.00019762211],"about_ca_topic_score_codex":0.00076994486,"about_ca_topic_score_gemma":0.00013134188,"teacher_disagreement_score":0.06776505,"about_ca_system_score_codex":0.00022241852,"about_ca_system_score_gemma":0.00017521324,"threshold_uncertainty_score":0.71138287},"labels":[],"label_agreement":null},{"id":"W1990499986","doi":"10.1158/1538-7445.am2013-5154","title":"Abstract 5154: Regulatory roles of conserved phosphorylation sites in the activation loop of extracellular signal-regulated kinase 1.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kinase; ASK1; Biology; MAP2K7; Cyclin-dependent kinase 2; c-Raf; Protein kinase A; Cell biology; Phosphorylation; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; Kinome; Biochemistry; Cyclin-dependent kinase 9","score_opus":0.032853995218415435,"score_gpt":0.30315535168224966,"score_spread":0.27030135646383424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990499986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644834,0.0025603292,0.0000896273,0.00021676993,0.000014582797,0.00040418873,0.000008067714,0.0000020278287,0.00025604817],"genre_scores_gemma":[0.9993759,0.00018579495,0.00005503183,0.000026717933,0.00004969038,0.000057061367,0.00007118638,0.000009788646,0.00016884408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900836,0.00009350536,0.0003050837,0.00013907874,0.00025180005,0.00020215963],"domain_scores_gemma":[0.99917895,0.00006063384,0.00013071342,0.0003052195,0.00029159596,0.00003287914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008462144,0.00008087163,0.00011496124,0.00007190247,0.000046567468,0.000018583602,0.0002228063,0.00014125268,0.00015986312],"category_scores_gemma":[0.000035703888,0.000062750565,0.00004599985,0.00019501266,0.00019042032,0.000010543179,0.000050904804,0.00016559908,0.000004196881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007931381,0.000047722126,0.001628901,0.000069683476,0.000021491333,2.9911573e-7,0.00023688856,0.000868976,0.9876013,0.00011847233,0.001785235,0.007541721],"study_design_scores_gemma":[0.0003723414,0.00008705235,0.037450157,0.00006681996,0.0000036161,4.3140304e-7,0.00049106934,0.0014321445,0.9589374,0.00050327234,0.00057626254,0.000079439],"about_ca_topic_score_codex":0.00038391486,"about_ca_topic_score_gemma":0.000108305794,"teacher_disagreement_score":0.03582126,"about_ca_system_score_codex":0.000023222781,"about_ca_system_score_gemma":0.0001279115,"threshold_uncertainty_score":0.25588936},"labels":[],"label_agreement":null},{"id":"W1990518755","doi":"10.1158/0008-5472.can-04-1532","title":"A Gene Expression Signature for Relapse of Primary Wilms Tumors","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Wilms' tumor; Anaplasia; Cancer research; Primary tumor; Metastasis; Gene; Biology; Cancer; Gene expression; Medicine; Oncology; Pathology; Internal medicine; Genetics","score_opus":0.02491461253367555,"score_gpt":0.33995490915674204,"score_spread":0.3150402966230665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990518755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97806674,0.019018717,0.0001875373,0.0005761976,0.000092707676,0.00037249128,0.00006292616,0.0000062848967,0.001616375],"genre_scores_gemma":[0.98591745,0.003280604,0.0009900866,0.00016236455,0.0006384119,0.00022573299,0.00010405727,0.000028132547,0.0086531555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989944,0.00005100321,0.00014549252,0.00027700784,0.00024409343,0.00028799978],"domain_scores_gemma":[0.9993957,0.000019097175,0.000044459914,0.00023839058,0.00021762591,0.00008469628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029915787,0.0000829884,0.000120044606,0.000056789977,0.000080731676,0.000007605019,0.00019829688,0.00018998695,0.00004648908],"category_scores_gemma":[0.000043573826,0.00006386341,0.0000825088,0.00012984178,0.00014302765,0.00000379021,0.00009210328,0.00021988103,0.0000036837575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044405356,0.000029352477,0.00006679022,0.00007286051,0.000026300242,0.0000011839817,0.00003914324,0.00062130793,0.949969,0.0000104647115,0.037082277,0.011637281],"study_design_scores_gemma":[0.00055716845,0.00019587582,0.000075426164,0.00008610211,0.0000043897494,0.0000024625776,0.000022263232,0.000010101237,0.9132983,0.000044325025,0.08562432,0.000079278936],"about_ca_topic_score_codex":0.000026813777,"about_ca_topic_score_gemma":0.000013036752,"teacher_disagreement_score":0.048542045,"about_ca_system_score_codex":0.00006567471,"about_ca_system_score_gemma":0.00032339516,"threshold_uncertainty_score":0.26042742},"labels":[],"label_agreement":null},{"id":"W1990824482","doi":"10.1158/1538-7445.am2012-2879","title":"Abstract 2879: Pre-clinical characterization of Dacomitinib, an irreversible pan-HER inhibitor, combined with radiation therapy in head and neck cancer models","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cancer; Radiation therapy; Head and neck cancer; Cancer research; Oncology; Lung cancer; EGFR inhibitors; Clonogenic assay; Internal medicine; In vivo; Pathology; Epidermal growth factor receptor; Biology","score_opus":0.11863684387384996,"score_gpt":0.47501195519765516,"score_spread":0.35637511132380517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990824482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607646,0.0015127048,0.000011934427,0.00080032286,0.00012476872,0.0010222973,0.000056134963,0.000015294641,0.00038008002],"genre_scores_gemma":[0.99368864,0.0049191746,0.000071848655,0.00013010085,0.00028584682,0.0003340916,0.000130166,0.000027386974,0.0004127654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986868,0.00010841079,0.00028395993,0.00024081988,0.00035495457,0.0003250505],"domain_scores_gemma":[0.99920994,0.00007669401,0.00008908974,0.0002105776,0.00022137,0.00019233327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048471216,0.00011103427,0.00026314132,0.00016120411,0.00006854098,0.0000202548,0.000049341394,0.0000983544,0.00019118852],"category_scores_gemma":[0.000015739777,0.000084223924,0.000026901802,0.00032115343,0.00012397807,0.0005245603,0.000018006016,0.00026387602,0.000002090842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003448192,0.0014494235,0.885493,0.00015262263,0.00017770562,0.000004910462,0.0036379432,0.00004202055,0.027285961,0.00013792924,0.00025131696,0.077918984],"study_design_scores_gemma":[0.0064745536,0.0011560653,0.98492974,0.00027967666,0.000030536066,0.0000014313223,0.00010432107,0.00026344,0.005484101,0.00004419659,0.00113865,0.000093262184],"about_ca_topic_score_codex":0.0031364842,"about_ca_topic_score_gemma":0.00054330175,"teacher_disagreement_score":0.099436775,"about_ca_system_score_codex":0.00023982678,"about_ca_system_score_gemma":0.0005226935,"threshold_uncertainty_score":0.47414467},"labels":[],"label_agreement":null},{"id":"W1990858299","doi":"10.1158/0008-5472.can-03-2581","title":"Loss of Vascular Endothelial Growth Factor A Activity in Murine Epidermal Keratinocytes Delays Wound Healing and Inhibits Tumor Formation","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Medizinische Universität Wien","keywords":"Angiogenesis; Wound healing; Keratinocyte; Epidermis (zoology); Vascular endothelial growth factor; Cytokine; Pathology; Biology; Epidermal growth factor; Cancer research; Immunology; Medicine; VEGF receptors; Anatomy; Cell culture","score_opus":0.044420492296114604,"score_gpt":0.34780715309597116,"score_spread":0.30338666079985654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990858299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515414,0.0036693893,0.0006041823,0.0001695899,0.000034111876,0.00025053078,0.000065771805,0.0000034725617,0.00004879899],"genre_scores_gemma":[0.9971626,0.0023414413,0.00013189224,0.000047456884,0.00018660513,0.00008445065,0.000012687366,0.000015209987,0.000017704842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894893,0.00009253691,0.00017658797,0.00025155107,0.00022991428,0.00030049792],"domain_scores_gemma":[0.99953026,0.000027131662,0.000051082647,0.000149151,0.00017240999,0.00006998467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003614997,0.00010056294,0.00015320779,0.000092544586,0.00008254192,0.00002049114,0.00009630437,0.000077271805,0.000017344155],"category_scores_gemma":[0.000095052026,0.000092804716,0.00005577657,0.00014740645,0.00013540337,0.00001733602,0.000112609865,0.00011900687,9.564728e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001945682,0.000052181702,0.010091521,0.00016010995,0.000025328964,0.000005341343,0.0001814345,0.00024061672,0.9871374,0.00009160763,0.000024942805,0.001794955],"study_design_scores_gemma":[0.0010877819,0.00015495521,0.012609727,0.00007029595,0.0000033073475,0.0000073966526,0.000050898678,0.00004117301,0.98517,0.00011180011,0.00058946584,0.000103190774],"about_ca_topic_score_codex":0.0010227127,"about_ca_topic_score_gemma":0.0008395585,"teacher_disagreement_score":0.002518206,"about_ca_system_score_codex":0.00009770872,"about_ca_system_score_gemma":0.00022606396,"threshold_uncertainty_score":0.37844664},"labels":[],"label_agreement":null},{"id":"W1991005087","doi":"10.1158/0008-5472.sabcs10-p3-09-01","title":"Abstract P3-09-01: Higher Serum miR-21 Expression Correlates with Higher Levels of VEGF and bFGF in Patients with Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Angiogenesis; microRNA; Breast cancer; Cancer; Basic fibroblast growth factor; Medicine; Vascular endothelial growth factor; Oncomir; TaqMan; Cancer research; Carcinogenesis; Metastatic breast cancer; Metastasis; Internal medicine; Multiplex; Oncology; Biology; Pathology; Real-time polymerase chain reaction; Growth factor; Receptor; VEGF receptors; Bioinformatics","score_opus":0.024059127963480562,"score_gpt":0.3245784182892974,"score_spread":0.3005192903258168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991005087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981887,0.0007263305,0.0000035229357,0.0001545505,0.0000895574,0.00037415733,0.00035243874,0.000004768072,0.00010597302],"genre_scores_gemma":[0.99913436,0.000045010933,0.00013104493,0.000017990656,0.00007310671,0.00009720696,0.000047384594,0.000036119876,0.00041778074],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986635,0.00006662101,0.00017421333,0.0003855835,0.00038041332,0.000329657],"domain_scores_gemma":[0.9991281,0.000022958631,0.00009134563,0.00032126353,0.00031044005,0.0001258763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019721725,0.00015115368,0.0001664709,0.00009314723,0.000059644666,0.000025068413,0.00015321451,0.000112587135,0.0008287976],"category_scores_gemma":[0.000009534346,0.000108845124,0.000021332571,0.00018716478,0.00026153206,0.000017572429,0.00009463472,0.00027707394,0.0000024728743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009140376,0.00012270124,0.24317083,0.00011943224,0.000056253237,0.0000032473702,0.000042438343,0.00006116144,0.75279516,0.0000082558,0.0005430986,0.0021634055],"study_design_scores_gemma":[0.0015552223,0.000119437114,0.84437066,0.00019480192,0.0000132292,0.0000010405764,0.000012005838,0.0000045182255,0.15295552,0.00001903389,0.00062039914,0.00013413893],"about_ca_topic_score_codex":0.00033587942,"about_ca_topic_score_gemma":0.0005371609,"teacher_disagreement_score":0.6011998,"about_ca_system_score_codex":0.000044557062,"about_ca_system_score_gemma":0.00022948459,"threshold_uncertainty_score":0.90747523},"labels":[],"label_agreement":null},{"id":"W1991037807","doi":"10.1158/1538-7445.am2012-174","title":"Abstract 174: Keratin 8 and 18 knockdown increases cisplatin-induced apoptosis and invasive potential through claudin1/PI3K/NFkB up-regulation in epithelial carcinoma cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Apoptosis; Keratin 8; Biology; Gene knockdown; Cell biology; Cancer research; Cancer cell; Keratin; Programmed cell death; Cisplatin; Fas ligand; Flow cytometry; Cancer; Immunology","score_opus":0.05488864287805629,"score_gpt":0.35379272595581335,"score_spread":0.29890408307775707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991037807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441385,0.003888975,0.000016878254,0.00013861478,0.0002031733,0.0004842792,0.000056930687,0.0000068471363,0.00079045945],"genre_scores_gemma":[0.9956494,0.0025085467,0.000056742745,0.000050551833,0.00079902983,0.00014489137,0.00012407196,0.00003073178,0.0006360339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776536,0.00038211164,0.00025895104,0.00047716917,0.00034210813,0.00077431125],"domain_scores_gemma":[0.99909836,0.00011658125,0.000059807142,0.00031210494,0.0001891044,0.000224068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009227678,0.00020474759,0.00022351422,0.0001563605,0.00029071388,0.00008320393,0.00019120621,0.0003499987,0.00021732063],"category_scores_gemma":[0.000170447,0.0001888823,0.0000526192,0.00025130177,0.00036937997,0.00002762245,0.0003547906,0.00042346254,0.000014946275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036080176,0.00015088225,0.01721855,0.0000612821,0.00003633238,0.000005748533,0.0002078942,0.0000020207365,0.97624564,0.000025646179,0.0015395858,0.004145584],"study_design_scores_gemma":[0.0019450217,0.00021916606,0.03926707,0.00004147166,0.000009861195,0.000023919172,0.00043749515,0.00001552907,0.956809,0.00009625691,0.0009182892,0.00021690666],"about_ca_topic_score_codex":0.002329349,"about_ca_topic_score_gemma":0.00028582342,"teacher_disagreement_score":0.02204852,"about_ca_system_score_codex":0.00006528851,"about_ca_system_score_gemma":0.00026790195,"threshold_uncertainty_score":0.7702397},"labels":[],"label_agreement":null},{"id":"W1991120959","doi":"10.1158/1538-7445.am2014-3094","title":"Abstract 3094: Epigenetic classification of ependymal brain tumors across age groups","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Grading (engineering); Biology; Pathology; Medulloblastoma; Brain tumor; Epigenetics; Medicine; Gene; Genetics","score_opus":0.11992270923117229,"score_gpt":0.45042627490231446,"score_spread":0.33050356567114214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991120959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330366,0.00057415257,0.000013670953,0.0031478805,0.00006296311,0.00042381007,0.000023278826,0.000017115792,0.002433471],"genre_scores_gemma":[0.9989458,0.0001213125,0.000047678783,0.00006844992,0.000185849,0.00024468073,0.000030092897,0.000023027907,0.00033314253],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832636,0.00009488002,0.00024293216,0.0002940569,0.0006066723,0.00043507398],"domain_scores_gemma":[0.9988052,0.00030391506,0.000060460683,0.00042175173,0.00022449916,0.00018412035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096422905,0.000098664495,0.00023761901,0.00011705148,0.000106826155,0.000025529544,0.00013631431,0.00007201314,0.00039871997],"category_scores_gemma":[0.0002774449,0.00007967581,0.00007635227,0.00030281677,0.00021834554,0.000037233323,0.00005286073,0.00024096291,0.00010819261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030296828,0.00087036286,0.120242685,0.00045902518,0.000119481905,0.00021679308,0.001102294,0.000029569386,0.75746566,0.0022297858,0.006650268,0.11031112],"study_design_scores_gemma":[0.0012325259,0.00028356968,0.8918455,0.0001776415,0.000011154813,0.000006367576,0.0002070291,0.000054752996,0.10134291,0.0002488605,0.0045232465,0.00006643251],"about_ca_topic_score_codex":0.00078140484,"about_ca_topic_score_gemma":0.00033416259,"teacher_disagreement_score":0.7716028,"about_ca_system_score_codex":0.00018374446,"about_ca_system_score_gemma":0.00012387332,"threshold_uncertainty_score":0.43657044},"labels":[],"label_agreement":null},{"id":"W1991182145","doi":"10.1158/1538-7445.am10-4832","title":"Abstract 4832: Regulatory role of EF-2 kinase in crosstalk between autophagy and apoptosis and its impact on the activity of a novel AKT inhibitor, MK-2206, against human glioma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Protein kinase B; Autophagy; PI3K/AKT/mTOR pathway; Cell biology; Cancer research; Biology; Apoptosis; Kinase; Programmed cell death; Phosphorylation; Signal transduction; Biochemistry","score_opus":0.04756728452948548,"score_gpt":0.4047985541618152,"score_spread":0.3572312696323297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991182145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976632,0.0009224257,1.3003645e-7,0.00017503531,0.000037744958,0.0006248329,0.00017363817,0.0000105742665,0.00039243913],"genre_scores_gemma":[0.9995193,0.00012812909,0.0000043124887,0.000022174238,0.00018120269,0.000052671676,0.000004769568,0.000029757091,0.00005770326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983537,0.00008068549,0.0002618273,0.00032378826,0.0005887219,0.0003912512],"domain_scores_gemma":[0.99865735,0.00036269883,0.00011660291,0.00044557606,0.00018430733,0.00023349797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009472592,0.00017557124,0.00039107178,0.00030201554,0.00013498274,0.000025595222,0.00016143554,0.00017381829,0.00015937572],"category_scores_gemma":[0.00008817166,0.00012128911,0.00008602577,0.00036271758,0.00054988277,0.00010712344,0.00009840809,0.00075868063,0.0000021530454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005446266,0.00038759116,0.0070275245,0.00014606421,0.00008934666,0.000010687526,0.00045887195,0.0000034983561,0.98390317,0.00013302105,0.00006437184,0.0072312197],"study_design_scores_gemma":[0.0013444694,0.00022751695,0.3523549,0.00016452106,0.000009406608,6.7741695e-7,0.00006204546,0.000027816803,0.64563394,0.000074263306,0.00003539819,0.00006504287],"about_ca_topic_score_codex":0.0008941208,"about_ca_topic_score_gemma":0.000059800255,"teacher_disagreement_score":0.34532738,"about_ca_system_score_codex":0.00010541,"about_ca_system_score_gemma":0.00034502917,"threshold_uncertainty_score":0.49460262},"labels":[],"label_agreement":null},{"id":"W1991286589","doi":"10.1158/1538-7445.am2012-3247","title":"Abstract 3247: Identification of a novel TAZ/TEAD/BMP4/Smad1,5 signaling axis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hippo signaling pathway; Transcription factor; Cell biology; Biology; Bone morphogenetic protein 4; HEK 293 cells; Downregulation and upregulation; Embryonic stem cell; Transfection; Transactivation; Cancer research; Molecular biology; Signal transduction; Cell culture; Gene; Genetics","score_opus":0.11223663849412362,"score_gpt":0.41131637229621043,"score_spread":0.2990797338020868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991286589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934219,0.0034654168,0.0016482333,0.00008924566,0.00019714549,0.00020500389,0.00008301471,0.000011457893,0.0008785804],"genre_scores_gemma":[0.9975823,0.0002285906,0.00017707303,0.00002675681,0.00068571395,0.0000784585,0.00007277513,0.000030591953,0.001117706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831134,0.00008172307,0.0003170582,0.0003110571,0.0004440414,0.0005347505],"domain_scores_gemma":[0.998868,0.00004736761,0.000101565696,0.00042655284,0.00038842706,0.0001680862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001729933,0.000120302764,0.00014379589,0.00011559521,0.00015265962,0.000030719577,0.00030316156,0.00017021867,0.00014612034],"category_scores_gemma":[0.00019727748,0.00011684141,0.0000901043,0.00024204944,0.00016663162,0.000010685586,0.000075329575,0.00024976785,0.00004559989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000659487,0.00012170004,0.00096498634,0.00008009127,0.00004673622,5.870604e-7,0.00028730076,0.00020287221,0.99577194,0.00008495655,0.0002828558,0.0020900036],"study_design_scores_gemma":[0.00031938415,0.00006732461,0.0020812524,0.00005130853,0.000009212946,0.0000022687534,0.00016341229,0.000033458058,0.983893,0.000021722788,0.013225262,0.00013243908],"about_ca_topic_score_codex":0.00032049645,"about_ca_topic_score_gemma":0.000031473177,"teacher_disagreement_score":0.012942406,"about_ca_system_score_codex":0.000049199054,"about_ca_system_score_gemma":0.00027994634,"threshold_uncertainty_score":0.47646543},"labels":[],"label_agreement":null},{"id":"W1991395730","doi":"10.1158/1538-7445.am2011-1061","title":"Abstract 1061: Context dependent tumor suppressor activity of the ERK pathway explains its inverse correlation with malignancy in prostate neoplasms","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Carcinogenesis; Senescence; Protein kinase B; Kinase; Cell biology; PI3K/AKT/mTOR pathway; Cancer research; Biology; Signal transduction; Cancer; Genetics","score_opus":0.09502152367898448,"score_gpt":0.3352708240771181,"score_spread":0.24024930039813364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991395730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624777,0.0004171289,0.00002619022,0.00023813226,0.0001795619,0.0014482524,0.00006130474,0.000014111079,0.001367565],"genre_scores_gemma":[0.99832964,0.0001479546,0.000023205019,0.00007197324,0.000045363176,0.00037761044,0.0000027187139,0.000030768108,0.0009707613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825376,0.00011498407,0.00020724972,0.00031035303,0.0007130776,0.0004005998],"domain_scores_gemma":[0.99901134,0.00005845954,0.000108988905,0.00041459393,0.00028922153,0.00011738439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006029525,0.00013426357,0.0002666136,0.00014403931,0.000089188965,0.000012509185,0.0001714073,0.000058333724,0.00084317685],"category_scores_gemma":[0.000050216742,0.00008674119,0.00006443291,0.00038978265,0.00013608387,0.0001566014,0.00006437957,0.00055284845,0.00001646353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010586829,0.0009253186,0.03212766,0.0006174895,0.00020109395,0.0004044522,0.01743883,0.00016022347,0.9096583,0.001920732,0.00040445977,0.025554607],"study_design_scores_gemma":[0.0033623686,0.00055491965,0.10023146,0.00064869766,0.000014077331,0.000015749025,0.001002735,0.00012338282,0.8932693,0.00019413343,0.00046481407,0.00011834683],"about_ca_topic_score_codex":0.0040937113,"about_ca_topic_score_gemma":0.0076792925,"teacher_disagreement_score":0.068103805,"about_ca_system_score_codex":0.00028675984,"about_ca_system_score_gemma":0.0007698775,"threshold_uncertainty_score":0.9232195},"labels":[],"label_agreement":null},{"id":"W1991482686","doi":"10.1158/1538-7445.am2014-1121","title":"Abstract 1121: Extracellular matrix-integrin B1 signaling is a major mediator of epithelial-to-mesenchymal transition and contributes to prostate cancer invasion and metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Prostate cancer; Epithelial–mesenchymal transition; Metastasis; Cancer research; Bone metastasis; Extracellular matrix; Biology; Plasminogen activator inhibitor-1; Cancer; Integrin; microRNA; Cell; Cell biology; Plasminogen activator; Endocrinology; Genetics","score_opus":0.04669212744388089,"score_gpt":0.38298029672965606,"score_spread":0.33628816928577515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991482686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96129304,0.018110031,0.00019735581,0.017630557,0.00008404093,0.0021094882,0.0004917582,0.0000259261,0.000057787012],"genre_scores_gemma":[0.9924604,0.0045518307,0.00041297026,0.00018240041,0.00020515527,0.0007030514,0.000030498459,0.00004956949,0.001404106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701416,0.00019084397,0.0004229659,0.0006438447,0.000961753,0.000766417],"domain_scores_gemma":[0.99784803,0.00036799937,0.00006672436,0.00030363735,0.00075749145,0.0006561169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020107182,0.0002455713,0.0005864646,0.00063758885,0.00020919529,0.000081170205,0.00014205094,0.00013269017,0.00041825662],"category_scores_gemma":[0.0002568759,0.00018571196,0.00007988258,0.00074119633,0.00029685814,0.0001332188,0.000120018456,0.0005100225,0.000021075817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032252988,0.00011548086,0.006245835,0.0011584461,0.00025537732,0.00004529724,0.0035591167,0.000029440887,0.9520601,0.0001531367,0.0014178785,0.03173456],"study_design_scores_gemma":[0.0049927244,0.0010562856,0.011633109,0.0015904413,0.00016840255,0.000008628374,0.0011301549,0.00023512999,0.96805835,0.00035369635,0.010509002,0.00026407017],"about_ca_topic_score_codex":0.0030265746,"about_ca_topic_score_gemma":0.00025525448,"teacher_disagreement_score":0.031470492,"about_ca_system_score_codex":0.00029423466,"about_ca_system_score_gemma":0.00050776073,"threshold_uncertainty_score":0.75731146},"labels":[],"label_agreement":null},{"id":"W1991574980","doi":"10.1158/1538-7445.am2013-5313","title":"Abstract 5313: The potential role of cellular iron in head and neck squamous cell carcinoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Clonogenic assay; Ribonucleotide reductase; Chemistry; Cancer; Cell culture; Cell growth; Cell; Medicine; Biology; Head and neck cancer; Internal medicine; Biochemistry","score_opus":0.018594508190086824,"score_gpt":0.31866639400183416,"score_spread":0.3000718858117473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991574980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98365897,0.014169362,0.0000017501328,0.00023436459,0.000025519026,0.00048637728,0.000025962332,0.0000020555449,0.0013956386],"genre_scores_gemma":[0.9983997,0.0006927744,0.000011103667,0.000017369655,0.000114536626,0.00022210978,0.000024512723,0.000017513397,0.0005004249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869317,0.000090170186,0.00014291507,0.00029489558,0.000323049,0.0004558068],"domain_scores_gemma":[0.99936783,0.000021892241,0.000028929771,0.00033026133,0.00013041357,0.000120684155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023539545,0.00009971457,0.00010787218,0.000073541145,0.00009018052,0.00004027246,0.00023672529,0.00008525812,0.00019847807],"category_scores_gemma":[0.000023656903,0.00007358729,0.000043462613,0.00013573062,0.00021811188,0.0000069943703,0.00019551312,0.00023252607,0.000021005868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014928544,0.00010487054,0.023729814,0.00005856377,0.000007734768,0.000009593798,0.00008109145,0.000030105899,0.96994597,0.000007064969,0.0010603837,0.0048155067],"study_design_scores_gemma":[0.0015416126,0.0004063681,0.16290635,0.000013728262,0.000004179115,0.0000023191533,0.00032553394,0.000049788156,0.8317154,0.00021787951,0.002709758,0.00010709605],"about_ca_topic_score_codex":0.024878751,"about_ca_topic_score_gemma":0.0018194992,"teacher_disagreement_score":0.13917655,"about_ca_system_score_codex":0.000053070067,"about_ca_system_score_gemma":0.00020609798,"threshold_uncertainty_score":0.98161465},"labels":[],"label_agreement":null},{"id":"W1991668733","doi":"10.1158/1538-7445.am2011-1198","title":"Abstract 1198: Connexin 43 is an estrogen receptor β1 regulated gene in breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Manitoba","funders":"","keywords":"Estrogen receptor; Connexin; Cancer research; Cancer cell; Cell culture; Biology; Tamoxifen; Cell biology; Breast cancer; Cancer; Gap junction; Intracellular","score_opus":0.08554279477200798,"score_gpt":0.37302605233614605,"score_spread":0.28748325756413806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991668733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462265,0.00303292,0.000003697863,0.00069064164,0.00015951674,0.00028563695,0.00034077186,0.000014524448,0.000849647],"genre_scores_gemma":[0.99582005,0.002269741,0.00008857201,0.00027853777,0.00047167295,0.00020650409,0.00010295788,0.000041813233,0.00072016375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797744,0.00017592263,0.00026409078,0.00067655573,0.00020153304,0.0007044459],"domain_scores_gemma":[0.9988075,0.00001412218,0.00005721192,0.0005870228,0.00031715014,0.0002170119],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059062865,0.00018673061,0.00020847216,0.00014447147,0.000104355946,0.000023878301,0.00045446787,0.00032097442,0.005140335],"category_scores_gemma":[0.000026107979,0.0001726332,0.00007050369,0.00027150704,0.00028722742,0.000009850733,0.00017416776,0.00034330232,0.00005500486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007491469,0.00012362229,0.020583196,0.000019213467,0.00006028785,0.000012715848,0.0003627116,0.000005778856,0.96016407,0.00006151739,0.0046061417,0.013251591],"study_design_scores_gemma":[0.0010107866,0.0002944574,0.09051964,0.000045036217,0.000006960286,0.00001724948,0.0003073367,0.00001935159,0.87196225,0.000111242254,0.035361025,0.00034465946],"about_ca_topic_score_codex":0.008276155,"about_ca_topic_score_gemma":0.0021711383,"teacher_disagreement_score":0.08820182,"about_ca_system_score_codex":0.000102246384,"about_ca_system_score_gemma":0.00045342508,"threshold_uncertainty_score":0.9983278},"labels":[],"label_agreement":null},{"id":"W1991793875","doi":"10.1158/0008-5472.can-11-3059","title":"Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Cell growth; Cancer research; Tumor microenvironment; Cancer; Cytotoxic T cell; Chemotherapy; In vivo; Cancer cell; Context (archaeology); Cytotoxicity; Medicine; Biology; Endocrinology; Internal medicine; In vitro; Biochemistry","score_opus":0.04840759493442182,"score_gpt":0.35022431283903177,"score_spread":0.30181671790460995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991793875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890534,0.008418276,0.00029498173,0.00010272064,0.0006710595,0.00036027873,0.00006479039,0.000009222881,0.0010252595],"genre_scores_gemma":[0.99054533,0.005843817,0.0004843168,0.00017588914,0.0015352626,0.00015857899,0.000074627096,0.000027411077,0.0011547474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884194,0.00009045967,0.00013963427,0.000326689,0.0002135496,0.00038770505],"domain_scores_gemma":[0.9994982,0.000007685793,0.00003459946,0.00018880631,0.00014656091,0.00012418623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043404216,0.00009546211,0.00009785742,0.00005773334,0.00013646923,0.000024541901,0.00014371714,0.000051819756,0.00039302342],"category_scores_gemma":[0.000026248235,0.000092274895,0.000031526768,0.00009698019,0.00012108523,0.000005743271,0.00015612696,0.00012893269,0.000015103285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016055717,0.000025644282,0.000571102,0.000035868183,0.000022213455,0.0000012126102,0.00033534478,0.0000023754435,0.9653071,0.000024584757,0.027798178,0.00571579],"study_design_scores_gemma":[0.00045493664,0.000102200596,0.0019342003,0.000009499389,0.0000075363832,0.0000022333645,0.0002847885,0.000010761823,0.7529885,0.000060016297,0.24403317,0.00011213613],"about_ca_topic_score_codex":0.001054907,"about_ca_topic_score_gemma":0.00023077683,"teacher_disagreement_score":0.216235,"about_ca_system_score_codex":0.00003327061,"about_ca_system_score_gemma":0.00014912519,"threshold_uncertainty_score":0.43033308},"labels":[],"label_agreement":null},{"id":"W1991806411","doi":"10.1158/1538-7445.am10-4316","title":"Abstract 4316: A novel wide field-of-view imaging device for real-time, intra-operative tumor bed assessment","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Soft tissue sarcoma; Cancer; Sarcoma; Soft tissue; Radiation therapy; Adjuvant therapy; Minimal residual disease; Pathology; Primary tumor; Radiology; Nuclear medicine; Internal medicine; Metastasis","score_opus":0.03827015488863664,"score_gpt":0.4042426781971595,"score_spread":0.3659725233085228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991806411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840839,0.0007688244,0.0043125707,0.0005835073,0.000985546,0.0015985271,0.00023254681,0.00017896235,0.00725562],"genre_scores_gemma":[0.98939204,0.00041178265,0.008916636,0.00009546433,0.0003131733,0.00061932375,0.000018903513,0.00009649731,0.00013615807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824554,0.00001378046,0.00037142466,0.00028156463,0.00045227766,0.00063541543],"domain_scores_gemma":[0.99798965,0.00092940603,0.00005111575,0.00040527637,0.00047001368,0.00015455882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008149814,0.00020053546,0.00031761965,0.00017916175,0.00013254421,0.00008081475,0.00041324305,0.00008037235,0.0005921515],"category_scores_gemma":[0.0002155323,0.00018832361,0.00008674952,0.00036421427,0.000106151885,0.00026465926,0.000065329106,0.00080493547,0.000022535152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052504583,0.000033977503,0.00041900828,0.00043953452,0.0000731344,0.000005827172,0.0002401037,0.00035832467,0.9812572,0.0003455051,0.0024044735,0.014370399],"study_design_scores_gemma":[0.0014252968,0.000115350194,0.0019172658,0.00040770875,0.00002909706,0.0000048693364,0.0001643852,0.009393437,0.9625763,0.0005822615,0.022974312,0.00040965772],"about_ca_topic_score_codex":0.0005421583,"about_ca_topic_score_gemma":0.0004119725,"teacher_disagreement_score":0.020569839,"about_ca_system_score_codex":0.00029477343,"about_ca_system_score_gemma":0.00046737093,"threshold_uncertainty_score":0.7679614},"labels":[],"label_agreement":null},{"id":"W1991960619","doi":"10.1158/1538-7445.am10-3133","title":"Abstract 3133: In vitro modeling of human pancreatic duct epithelial cell transformation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"KRAS; Pancreatic duct; Pancreatic cancer; Cancer research; Oncogene; Carcinogenesis; Biology; Cell culture; Tumor suppressor gene; Pancreas; Cell growth; Cell; Cancer; Gene; Cell cycle; Mutation; Endocrinology; Genetics","score_opus":0.1005855806085296,"score_gpt":0.4434112644051682,"score_spread":0.3428256837966386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991960619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774516,0.00021577555,0.000049337617,0.0005862214,0.00006819447,0.0007408863,0.00002220699,0.000015659107,0.020850088],"genre_scores_gemma":[0.99846905,0.00030958577,0.00026782896,0.000020016325,0.00021447462,0.00018039663,0.000024863019,0.00002249339,0.00049127644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978666,0.00010991932,0.00045411655,0.00024399559,0.00076055224,0.0005648353],"domain_scores_gemma":[0.99884874,0.00020396568,0.000045571043,0.00034170478,0.00037062753,0.00018937927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020587093,0.000113314134,0.0004607482,0.00048333162,0.0001197683,0.000014000704,0.00019407092,0.00018769686,0.00082302914],"category_scores_gemma":[0.00016516831,0.00009606111,0.00007375279,0.00041456718,0.00029260915,0.00011521089,0.000034222827,0.0013491363,0.00004487541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006858211,0.00023108342,0.008335464,0.0005087151,0.000022799864,0.000023542581,0.0013329494,0.000036603145,0.9864561,0.00014924393,0.000048347287,0.002169333],"study_design_scores_gemma":[0.007094565,0.00066176493,0.05220936,0.00043736157,0.000087593464,0.000019565734,0.0015239161,0.02763306,0.907875,0.0018594313,0.00033169243,0.0002667113],"about_ca_topic_score_codex":0.0037314184,"about_ca_topic_score_gemma":0.0004346141,"teacher_disagreement_score":0.07858112,"about_ca_system_score_codex":0.000169668,"about_ca_system_score_gemma":0.00077418314,"threshold_uncertainty_score":0.9011592},"labels":[],"label_agreement":null},{"id":"W1992212767","doi":"10.1158/0008-5472.can-03-3978","title":"The CpG Island Methylator Phenotype Is Not Associated with a Personal or Family History of Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Microsatellite instability; Colorectal cancer; Family history; Cancer; DNA methylation; Biology; Epigenetics; Methylation; CpG site; Oncology; Genetics; Internal medicine; Medicine; Microsatellite; Gene; Allele; Gene expression","score_opus":0.07188062769096498,"score_gpt":0.3713519880433194,"score_spread":0.29947136035235444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992212767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678995,0.030249098,0.00012806343,0.00049301336,0.00015117473,0.00020161422,0.00008462501,0.000004080185,0.00078884565],"genre_scores_gemma":[0.9869044,0.0042679333,0.000038826794,0.00014741441,0.00017822253,0.00015588079,0.000015117138,0.000025935971,0.008266259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986936,0.000108448614,0.00014700303,0.00026966966,0.00046385993,0.00031742913],"domain_scores_gemma":[0.9989862,0.0000631566,0.000077527635,0.00022929802,0.0005689193,0.00007491616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005829565,0.000102432256,0.00012291297,0.0000425959,0.00013147033,0.000016070444,0.00020374029,0.00011619411,0.0001254609],"category_scores_gemma":[0.00016338954,0.000064027525,0.000047673315,0.00016894401,0.00030771017,0.0000030306417,0.000064614505,0.00019008535,0.0000025920297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009113701,0.000052741216,0.0016952177,0.00002204999,0.00022597425,0.0000024939689,0.0007606259,0.00012590147,0.9841055,0.000068696914,0.0051873364,0.006842065],"study_design_scores_gemma":[0.0018357692,0.00082107226,0.012805045,0.00008404662,0.000038677445,2.744032e-7,0.00020410675,0.000047908852,0.71728754,0.00020190184,0.26643974,0.00023392637],"about_ca_topic_score_codex":0.0016254346,"about_ca_topic_score_gemma":0.0066942233,"teacher_disagreement_score":0.266818,"about_ca_system_score_codex":0.00041994415,"about_ca_system_score_gemma":0.0020757134,"threshold_uncertainty_score":0.37355337},"labels":[],"label_agreement":null},{"id":"W1992238227","doi":"10.1158/0008-5472.can-05-1959","title":"Influence of Insulin-like Growth Factors on the Strength of the Relation of Vitamin D and Calcium Intakes to Mammographic Breast Density","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Health Sciences Centre; University of Toronto; McGill University; The Quebec Population Health Research Network; Hôpital Charles-Le Moyne; Centre hospitalier universitaire de Québec; Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Endocrinology; Vitamin D and neurology; Internal medicine; Calcium; Breast cancer; Medicine; Insulin-like growth factor; Vitamin; Risk factor; Cancer; Growth factor; Receptor","score_opus":0.04011682534404781,"score_gpt":0.33736597913632377,"score_spread":0.29724915379227596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992238227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833035,0.00014154418,0.000003395588,0.00082583266,0.000038220558,0.00043400444,0.000092019895,0.000004526809,0.00013011639],"genre_scores_gemma":[0.99972135,0.00010867561,0.0000050675435,0.000031300384,0.000035927325,0.000015918344,0.0000029519872,0.000010053076,0.000068763824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868506,0.00011325297,0.00024139803,0.0001717392,0.00060660276,0.00018196978],"domain_scores_gemma":[0.9987966,0.00028372576,0.00009653243,0.00031712782,0.0004443196,0.000061702114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040847296,0.00008748328,0.00020492848,0.00018868665,0.00007589274,0.0000056978797,0.00014571399,0.00006272002,0.000020278254],"category_scores_gemma":[0.00015224107,0.000047750153,0.000058801066,0.0008107684,0.0004694528,0.0000374319,0.00007923165,0.000315334,4.4804543e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003288847,0.00007621444,0.90265703,0.000121668265,0.000028761031,6.1808055e-7,0.0006616795,0.00008699313,0.09396024,0.0010314528,0.00031073275,0.00073572237],"study_design_scores_gemma":[0.0002860294,0.00015956543,0.8885651,0.00023331569,0.000016530454,0.0000013187438,0.00023503775,0.0000082599745,0.110266514,0.000116390525,0.0000738483,0.00003806538],"about_ca_topic_score_codex":0.025164977,"about_ca_topic_score_gemma":0.0019861984,"teacher_disagreement_score":0.023178779,"about_ca_system_score_codex":0.00008698405,"about_ca_system_score_gemma":0.0001688319,"threshold_uncertainty_score":0.9813265},"labels":[],"label_agreement":null},{"id":"W1992271457","doi":"10.1158/1538-7445.am2014-3145","title":"Abstract 3145: eIF4E, an adverse prognostic marker of melanoma patient survival, increases melanoma cell invasion","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Melanoma; Cancer research; Medicine; EIF4E; Metastasis; Vimentin; Cancer; Gene knockdown; Tumor progression; Pathology; Oncology; Biology; Immunohistochemistry; Internal medicine; Apoptosis; Messenger RNA; Gene","score_opus":0.0688017537894832,"score_gpt":0.3705132261218733,"score_spread":0.30171147233239015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992271457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774264,0.0010556391,0.0000033388058,0.0005374792,0.000117553,0.0008176312,0.000088822,0.000030990537,0.019922111],"genre_scores_gemma":[0.99619555,0.0008098378,0.00014806773,0.000095400785,0.0003393028,0.00014551838,0.00010705642,0.00004735064,0.0021118955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588215,0.0005188126,0.00046285323,0.00053324114,0.0017945602,0.0008084008],"domain_scores_gemma":[0.99686676,0.0009377635,0.000103355895,0.00059797114,0.0008424443,0.0006517057],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001567385,0.0002267098,0.00046988318,0.00037734467,0.00020892268,0.000026675229,0.0003460604,0.00015013917,0.0026461114],"category_scores_gemma":[0.00061160023,0.00017210036,0.0001421002,0.0004956595,0.00047110143,0.00014945178,0.00028272663,0.0006913635,0.00019799107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005894145,0.002192182,0.71814424,0.0024179795,0.0001685421,0.0003017497,0.0005727338,0.000022857865,0.20692416,0.00045753957,0.0092597725,0.053644095],"study_design_scores_gemma":[0.0020123553,0.0037760779,0.8603446,0.000717398,0.000048282087,0.000025690959,0.0006274471,0.0003174314,0.088871405,0.00021448969,0.04270903,0.0003358144],"about_ca_topic_score_codex":0.0094890725,"about_ca_topic_score_gemma":0.000640287,"teacher_disagreement_score":0.14220034,"about_ca_system_score_codex":0.0001449238,"about_ca_system_score_gemma":0.00063354365,"threshold_uncertainty_score":0.9982656},"labels":[],"label_agreement":null},{"id":"W1992299847","doi":"10.1158/0008-5472.can-14-3303","title":"Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Notch signaling pathway; Cancer research; Biology; Claudin; Cancer; Oncogene; Population; Cancer stem cell; Phenotype; Gene silencing; Stem cell; Cell biology; Signal transduction; Medicine; Tight junction; Genetics; Gene; Cell cycle","score_opus":0.19087313497346298,"score_gpt":0.43351485363152314,"score_spread":0.24264171865806017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992299847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637255,0.0111262705,0.00005687258,0.014580947,0.0013613562,0.0014506499,0.00026229542,0.00016360247,0.007272488],"genre_scores_gemma":[0.9865245,0.0041333837,0.00022340291,0.0005110323,0.0024320756,0.0007264724,0.000055658224,0.00009469489,0.005298748],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966617,0.00016040976,0.00031915662,0.0006439834,0.0013080725,0.00090667035],"domain_scores_gemma":[0.9975397,0.000074395,0.00008867477,0.00055554835,0.0012097846,0.0005319236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092781585,0.00024332808,0.00044008656,0.00023257149,0.00018096161,0.0000687811,0.0002370634,0.00019237913,0.0015253207],"category_scores_gemma":[0.0001847466,0.00020414633,0.00010407807,0.0012714275,0.00028774407,0.00026192723,0.00016636937,0.0010026182,0.00033556513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066014044,0.0014151172,0.018875059,0.0022818772,0.0010716568,0.00033242835,0.010735647,0.00014298156,0.4215477,0.00054508384,0.35541362,0.1810374],"study_design_scores_gemma":[0.020857269,0.0022204786,0.042848606,0.0037540202,0.00069967075,0.00036244435,0.0052208416,0.00035682204,0.2396228,0.0025518292,0.67961264,0.0018925876],"about_ca_topic_score_codex":0.013623924,"about_ca_topic_score_gemma":0.0012829802,"teacher_disagreement_score":0.324199,"about_ca_system_score_codex":0.0014661356,"about_ca_system_score_gemma":0.0021732578,"threshold_uncertainty_score":0.99938744},"labels":[],"label_agreement":null},{"id":"W1992301100","doi":"10.1158/0008-5472.can-06-1595","title":"Multiple Acquired Renal Carcinoma Tumor Capabilities Abolished upon Silencing of ADAM17","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa","funders":"","keywords":"Autocrine signalling; Cancer research; Carcinogenesis; Cancer; Gene silencing; Cancer cell; Biology; Epidermal growth factor receptor; Paracrine signalling; Receptor","score_opus":0.08061258326414547,"score_gpt":0.4013514787068154,"score_spread":0.32073889544267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992301100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860393,0.004650674,0.00001535077,0.0010551063,0.00021806298,0.0012529901,0.00012572363,0.00007557962,0.006567259],"genre_scores_gemma":[0.9930111,0.00013701737,0.0002918148,0.00005986794,0.0012179551,0.0006024618,0.000033064673,0.00008897269,0.0045577427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942781,0.00041890753,0.0006786631,0.00072601537,0.0025036496,0.001394668],"domain_scores_gemma":[0.99617594,0.00072261225,0.000103478,0.0010206976,0.0016036796,0.00037361393],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021973604,0.0002551618,0.000648387,0.000654086,0.00024674158,0.000060906954,0.00052185677,0.000155369,0.0019641828],"category_scores_gemma":[0.0011326015,0.00023085903,0.00018127791,0.0011919838,0.00084728503,0.00016743182,0.00027663907,0.00075479824,0.000062408224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021214401,0.00028281705,0.14316586,0.0017126242,0.000059932336,0.00025133582,0.0013627836,0.00017532267,0.8164502,0.00037216212,0.030592898,0.003452636],"study_design_scores_gemma":[0.0037551336,0.0009102671,0.124621764,0.0009286853,0.000034961013,0.000045557215,0.002022583,0.0011098932,0.84780496,0.00052816095,0.017899202,0.00033882132],"about_ca_topic_score_codex":0.047988586,"about_ca_topic_score_gemma":0.003160994,"teacher_disagreement_score":0.04482759,"about_ca_system_score_codex":0.0013546582,"about_ca_system_score_gemma":0.0027879777,"threshold_uncertainty_score":0.99894816},"labels":[],"label_agreement":null},{"id":"W1992324708","doi":"10.1158/0008-5472.can-09-1528","title":"MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Melanoma; Cell culture; Biology; Cancer; Cancer research; Cancer cell; Breast cancer; Cell; Genetics","score_opus":0.03632420191155754,"score_gpt":0.3677281534756322,"score_spread":0.33140395156407465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992324708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861724,0.006936501,0.0001644237,0.0015581454,0.00017120485,0.00022574232,0.00007769227,0.000009117735,0.0022399384],"genre_scores_gemma":[0.9881568,0.00731992,0.0001685451,0.0007954513,0.0009884175,0.00004170042,0.000039347102,0.00002300055,0.0024668442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984661,0.00006162679,0.0002047899,0.00047082844,0.00029219486,0.00050448393],"domain_scores_gemma":[0.99905336,0.00006270234,0.000033033877,0.00038945567,0.00022412502,0.00023731403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003945216,0.00014323603,0.0001588654,0.00007623525,0.00014766483,0.00010398541,0.00026579958,0.0001688804,0.000073786716],"category_scores_gemma":[0.0001919026,0.00013994538,0.00005975942,0.00013351766,0.00017890842,0.000004231725,0.00019999579,0.00025279794,0.000031947446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020759432,0.00007482907,0.00103286,0.000035027675,0.00001865374,0.00002192202,0.00005329716,0.000024398436,0.9726139,0.00040688025,0.01822586,0.0072848136],"study_design_scores_gemma":[0.000920504,0.0006289354,0.0050000735,0.000026106523,0.00001563205,0.000010427635,0.00010095128,0.000073809555,0.883585,0.0005616536,0.10881697,0.00025994255],"about_ca_topic_score_codex":0.0002746078,"about_ca_topic_score_gemma":0.00013169517,"teacher_disagreement_score":0.0905911,"about_ca_system_score_codex":0.000057091034,"about_ca_system_score_gemma":0.00029933848,"threshold_uncertainty_score":0.5706807},"labels":[],"label_agreement":null},{"id":"W1992400234","doi":"10.1158/1538-7445.am2014-2176","title":"Abstract 2176: Obesity and risk of colorectal cancer: A Mendelian randomization study","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Cancer Care Ontario","funders":"","keywords":"Mendelian randomization; Medicine; Odds ratio; Body mass index; Confounding; Observational study; Colorectal cancer; Obesity; Confidence interval; Logistic regression; Internal medicine; Demography; Oncology; Cancer; Genetics; Biology; Genotype; Genetic variants","score_opus":0.02189420252649013,"score_gpt":0.3536187213561872,"score_spread":0.3317245188296971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992400234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995934,0.0030526472,0.00006790116,0.000046275207,0.0000685873,0.00048951636,0.000101951984,0.0000048196257,0.00023429487],"genre_scores_gemma":[0.9906496,0.008811833,0.00003407881,0.000011782045,0.00021688739,0.00015942898,0.00002659233,0.000012936562,0.00007686844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886245,0.0002491181,0.00015520092,0.00028993867,0.00023837051,0.0002048996],"domain_scores_gemma":[0.99926776,0.000036450932,0.000057495203,0.00018859711,0.00032181063,0.00012789355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007573022,0.000083867,0.00014075742,0.000064525586,0.00013565217,0.000021091299,0.000117594725,0.00006813539,0.000056685112],"category_scores_gemma":[0.00019943561,0.000078568184,0.00003850748,0.00010619542,0.00015286895,0.0000032644166,0.00007824529,0.00009818657,0.0000014184785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026018773,0.0004901763,0.55838096,0.00012069884,0.00014809133,0.0000011049783,0.00023677286,0.00019486282,0.42915002,0.0000150389205,0.002439994,0.006220404],"study_design_scores_gemma":[0.0118924165,0.0009592861,0.5891402,0.000046004527,0.000085640575,7.788764e-7,0.0005699286,0.00017766921,0.39296222,0.00031535563,0.0036079036,0.00024262782],"about_ca_topic_score_codex":0.0014990603,"about_ca_topic_score_gemma":0.0015540286,"teacher_disagreement_score":0.03618781,"about_ca_system_score_codex":0.000023110912,"about_ca_system_score_gemma":0.0001547416,"threshold_uncertainty_score":0.32039177},"labels":[],"label_agreement":null},{"id":"W1992487239","doi":"10.1158/0008-5472.sabcs13-p2-02-10","title":"Abstract P2-02-10: Evaluation of apparent diffusion coefficient to predict grade, micro-invasion and invasion in DCIS","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Effective diffusion coefficient; Medicine; Breast cancer; Nuclear medicine; Diffusion MRI; Logistic regression; Biopsy; Radiology; Cancer; Magnetic resonance imaging; Internal medicine","score_opus":0.18425987573547203,"score_gpt":0.444629069551067,"score_spread":0.260369193815595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992487239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865163,0.0023185797,0.000013410112,0.0048401877,0.00015598461,0.003231485,0.000023144046,0.00001901421,0.0007465457],"genre_scores_gemma":[0.9945792,0.003342985,0.00013116862,0.00011370312,0.00013544863,0.001428863,0.000029658166,0.000030994117,0.00020799153],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99609005,0.0002407292,0.0004566109,0.00056763034,0.0021511756,0.0004937709],"domain_scores_gemma":[0.9976427,0.00033477249,0.0000829753,0.0005008066,0.0011006555,0.00033809806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027709429,0.0001623112,0.0003328354,0.0006644247,0.00008703212,0.000037093974,0.00018544852,0.00013754437,0.0028698691],"category_scores_gemma":[0.000500237,0.00013686903,0.00004846806,0.0008364697,0.00015790954,0.00010889697,0.00024666256,0.00040171403,0.00009976079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038067286,0.00073492434,0.107429504,0.0007342986,0.000027591694,0.000007864714,0.0017089372,0.0005772083,0.721652,0.000010343669,0.071858235,0.094878435],"study_design_scores_gemma":[0.0034701638,0.00066228077,0.70809436,0.0025576889,0.000045817233,0.0000042540455,0.00063722214,0.0023530766,0.27847248,0.0001304671,0.003393421,0.00017876083],"about_ca_topic_score_codex":0.004782185,"about_ca_topic_score_gemma":0.00066085946,"teacher_disagreement_score":0.60066485,"about_ca_system_score_codex":0.0010927225,"about_ca_system_score_gemma":0.0005623825,"threshold_uncertainty_score":0.9980416},"labels":[],"label_agreement":null},{"id":"W1992621490","doi":"10.1158/0008-5472.can-06-4556","title":"DJ-1 Binds Androgen Receptor Directly and Mediates Its Activity in Hormonally Treated Prostate Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Javna Agencija za Raziskovalno Dejavnost RS; Vanderbilt University","keywords":"Antiandrogens; Prostate cancer; Androgen receptor; Androgen; Prostate; Oncogene; Cancer research; Cancer; Internal medicine; Biology; Endocrinology; Immunohistochemistry; Medicine; Hormone; Cell cycle","score_opus":0.06302910905365398,"score_gpt":0.4051370833794658,"score_spread":0.3421079743258118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992621490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688572,0.024447946,6.050769e-7,0.0030737983,0.0001247613,0.0016755536,0.00018684211,0.00005999271,0.0015732452],"genre_scores_gemma":[0.945572,0.04253545,0.000027185013,0.000057371097,0.00027202693,0.0006446296,0.000040099603,0.00006275583,0.010788473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963369,0.00019559478,0.00030082327,0.0007100409,0.0010918232,0.0013648315],"domain_scores_gemma":[0.998131,0.0003425323,0.00005861185,0.00029285398,0.0005582293,0.00061677734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019457375,0.00027323086,0.00047215787,0.00074606785,0.00020831279,0.00006931628,0.00017740495,0.00020832753,0.0005428963],"category_scores_gemma":[0.0001037465,0.00020901884,0.0000791572,0.0015528802,0.00040009385,0.00021486005,0.00016199294,0.0009048477,0.00005351213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005178675,0.00028312363,0.13559315,0.00030685178,0.00018188897,0.00031334435,0.0011022722,0.000002383273,0.7864722,0.000007761599,0.0026756192,0.06788274],"study_design_scores_gemma":[0.004273999,0.0005655478,0.095216766,0.00036323647,0.00003150113,0.000005607713,0.00019665033,0.000042959142,0.8898194,0.000022341836,0.009231078,0.00023094137],"about_ca_topic_score_codex":0.0033777645,"about_ca_topic_score_gemma":0.0021244443,"teacher_disagreement_score":0.10334718,"about_ca_system_score_codex":0.0012073261,"about_ca_system_score_gemma":0.0010401302,"threshold_uncertainty_score":0.8523541},"labels":[],"label_agreement":null},{"id":"W1992628946","doi":"10.1158/0008-5472.can-09-4602","title":"Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Institute of Dental and Craniofacial Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"WWOX; Cancer research; Osteosarcoma; Ectopic expression; Cancer; Tumor suppressor gene; Suppressor; Chromosomal fragile site; Downregulation and upregulation; Medicine; Carcinogenesis; Biology; Cell culture; Internal medicine; Gene","score_opus":0.022161892925239922,"score_gpt":0.30373890607563814,"score_spread":0.28157701315039824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992628946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989799,0.00018642921,0.0000017155136,0.0002442268,0.00005176444,0.0003353677,0.000045028097,0.0000020024243,0.00015353353],"genre_scores_gemma":[0.99960446,0.00006425333,0.000035066376,0.00009523802,0.000011621742,0.00008043765,0.000018889077,0.000014095669,0.00007593675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892306,0.00013028288,0.00013910598,0.0002645114,0.00030724145,0.0002358082],"domain_scores_gemma":[0.99947673,0.00002338469,0.000056120152,0.00024535652,0.0001407584,0.000057635094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034684126,0.000088095796,0.000098081706,0.00004543944,0.00009313115,0.000015228386,0.00020172646,0.00006475565,0.000035615216],"category_scores_gemma":[0.00012809045,0.000060827497,0.000023483035,0.00016818455,0.00019995685,0.0000033076794,0.00017089894,0.00024314963,5.362103e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000888119,0.00005381132,0.05537704,0.00001372268,0.000009023475,0.0000015588614,0.00013937798,0.0000038850662,0.94390434,0.000004378047,0.00027596444,0.0001280784],"study_design_scores_gemma":[0.0005085607,0.00006758248,0.36724415,0.000035303576,0.0000021329777,0.0000015309059,0.000042718755,0.00001463502,0.6317385,0.000034347682,0.00025651275,0.000054012376],"about_ca_topic_score_codex":0.0005520707,"about_ca_topic_score_gemma":0.002647888,"teacher_disagreement_score":0.31216583,"about_ca_system_score_codex":0.00001877115,"about_ca_system_score_gemma":0.00019341025,"threshold_uncertainty_score":0.24804734},"labels":[],"label_agreement":null},{"id":"W1992792480","doi":"10.1158/1538-7445.am2011-lb-209","title":"Abstract LB-209: Expression of O6-methylguanine DNA-methyltransferase is regulated by Wnt/β-catenin signalling in cancer cells: A new strategy for DNA alkylators in cancer therapy","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Temozolomide; Cancer research; Wnt signaling pathway; DNA methyltransferase; Methyltransferase; Biology; DNA repair; O-6-methylguanine-DNA methyltransferase; Cancer; Clonogenic assay; Molecular biology; Cell culture; DNA; Glioma; Signal transduction; Cell biology; Methylation; Biochemistry; Genetics","score_opus":0.13077110019981295,"score_gpt":0.40114069389093404,"score_spread":0.2703695936911211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992792480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635021,0.034882914,0.00027870171,0.0001561655,0.00011915778,0.0007137276,0.00020553435,0.000007877469,0.00013381093],"genre_scores_gemma":[0.9707653,0.027517224,0.00021597213,0.00004649751,0.00017560249,0.0004413676,0.000075959826,0.00007056804,0.00069152063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741566,0.00018088236,0.00058606546,0.0007195398,0.00041069134,0.00068713055],"domain_scores_gemma":[0.9989632,0.000068982496,0.000133373,0.0002910051,0.00034101654,0.00020242347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009724412,0.00027624404,0.0003613385,0.00031766287,0.00007662632,0.000027141681,0.0003900066,0.00039326565,0.0007115391],"category_scores_gemma":[0.00003268552,0.00025750036,0.000120586534,0.00060711335,0.00013365736,0.000019449819,0.000055916986,0.00035639753,0.0000012990231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009979999,0.00018234941,0.0022040461,0.00006951459,0.00005493051,0.0000024310195,0.00080553134,0.0010794825,0.96476287,0.0000050702934,0.0011533444,0.028682461],"study_design_scores_gemma":[0.0019821296,0.00041206618,0.0034493736,0.00017991284,0.000009048727,8.368077e-8,0.00013016099,0.00009153719,0.99138904,0.00032917634,0.0017436574,0.00028384264],"about_ca_topic_score_codex":0.015635261,"about_ca_topic_score_gemma":0.0032313368,"teacher_disagreement_score":0.028398618,"about_ca_system_score_codex":0.00013602801,"about_ca_system_score_gemma":0.0007225369,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W1992810557","doi":"10.1158/0008-5472.can-08-1984","title":"Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Deutsche Forschungsgemeinschaft","keywords":"Immunostaining; Apoptosis; Biology; Cancer research; Colorectal cancer; Molecular biology; Immunohistochemistry; Chemistry; Cancer; Immunology; Biochemistry; Genetics","score_opus":0.09836094798681401,"score_gpt":0.4047407239282395,"score_spread":0.3063797759414255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992810557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864482,0.0042521865,0.000017237042,0.0009978674,0.0001379236,0.00060483214,0.000031981283,0.000024387782,0.007485361],"genre_scores_gemma":[0.9816231,0.004016077,0.0002025399,0.00007324997,0.00010914613,0.00022145326,0.00000971839,0.000031614705,0.013713099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977493,0.00008821149,0.00033317058,0.0003603194,0.0009267813,0.00054217863],"domain_scores_gemma":[0.9989734,0.00008123294,0.00006370942,0.00035049123,0.00035427674,0.00017685127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047281795,0.00013360094,0.0004012634,0.0003023904,0.00011869211,0.0000050223907,0.0001842264,0.00013724422,0.0011374139],"category_scores_gemma":[0.000054042386,0.00011131347,0.00007670822,0.00072646677,0.0004015713,0.000070485396,0.00003209041,0.00052891567,0.000011276328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032620097,0.00027689792,0.03507507,0.0010947647,0.000047399793,0.0002509798,0.0020373974,0.000041885563,0.9474015,0.0013227363,0.008570547,0.0006187763],"study_design_scores_gemma":[0.005525867,0.00026636283,0.13918775,0.0058047283,0.000031283424,0.000007708858,0.00059927255,0.00003648834,0.81383693,0.0007195292,0.033665817,0.0003182686],"about_ca_topic_score_codex":0.0011416643,"about_ca_topic_score_gemma":0.0023565083,"teacher_disagreement_score":0.1335646,"about_ca_system_score_codex":0.0003701458,"about_ca_system_score_gemma":0.0009936132,"threshold_uncertainty_score":0.9997757},"labels":[],"label_agreement":null},{"id":"W1992851893","doi":"10.1158/1538-7445.am2013-4775","title":"Abstract 4775: HPV16-E2/E4, -E6 and -E7 genes and HPV-disrupted human genes show large variation in expression levels in OSCC independent of the viral physical status.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Viral Oncogene; Gene; Gene expression; Oncogene; Real-time polymerase chain reaction; Virology; In situ hybridization; Fusion gene; Genetics; Cell cycle","score_opus":0.0916260687859613,"score_gpt":0.42635307211119144,"score_spread":0.33472700332523014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992851893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429184,0.00379353,0.0000022920456,0.0007293211,0.000054720094,0.00072557613,0.00003522568,0.000008297966,0.00035917625],"genre_scores_gemma":[0.9981893,0.0011630455,0.000021127335,0.000045410958,0.00014197717,0.00022451248,0.000003663429,0.000017023041,0.00019395411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981856,0.0001555266,0.00025692084,0.00033273842,0.00058567664,0.00048354114],"domain_scores_gemma":[0.99932224,0.00012326098,0.00005574035,0.0002245859,0.00015913455,0.00011505935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055065687,0.00013127267,0.00033960288,0.00018248444,0.00014606654,0.0000303093,0.00010055314,0.000091940536,0.0001778566],"category_scores_gemma":[0.0000702129,0.00008806505,0.000030791547,0.00027704317,0.0001837432,0.00016136286,0.00023563897,0.0004553205,0.0000026447578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010852236,0.00020269144,0.2108256,0.00027718488,0.000021866292,0.000007748384,0.0056708683,0.00000524984,0.7655466,0.00008869054,0.0002614127,0.016983522],"study_design_scores_gemma":[0.0018863714,0.0001320138,0.9320894,0.00030561638,0.0000066269768,0.0000010336838,0.0008868431,0.00015124663,0.06381046,0.00031737707,0.00032659553,0.000086434426],"about_ca_topic_score_codex":0.0048963237,"about_ca_topic_score_gemma":0.0022813969,"teacher_disagreement_score":0.72126377,"about_ca_system_score_codex":0.00018761058,"about_ca_system_score_gemma":0.00019705192,"threshold_uncertainty_score":0.7401809},"labels":[],"label_agreement":null},{"id":"W1992885500","doi":"10.1158/0008-5472.sabcs12-p5-18-14","title":"Abstract P5-18-14: Cardiac monitoring during adjuvant trastuzumab therapy for breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Asymptomatic; Cardiotoxicity; Cancer; Cardiomyopathy; Oncology; Cardiology; Heart failure; Toxicity","score_opus":0.07512661900908085,"score_gpt":0.4120774246903332,"score_spread":0.33695080568125235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992885500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515105,0.045565136,0.0000081681055,0.0003733672,0.00091831555,0.0005933189,0.00072692987,0.00002344789,0.0002808059],"genre_scores_gemma":[0.9752547,0.016953934,0.000054220032,0.000020949983,0.004709267,0.0023777196,0.000027402883,0.000073029914,0.0005287419],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978144,0.000070426024,0.00018918268,0.00046996295,0.00039443574,0.0010615597],"domain_scores_gemma":[0.9989241,0.000060773276,0.00005541234,0.0003873085,0.00036022332,0.00021218641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000394956,0.00024372643,0.0002702796,0.00008059386,0.00041185154,0.00004054119,0.0002504707,0.00013749255,0.00018259248],"category_scores_gemma":[0.000025762107,0.00021204144,0.0001699803,0.00015972392,0.00015183093,0.000018613624,0.00013528026,0.0002101206,0.000012140898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011931519,0.00017770361,0.21974453,0.00013706778,0.00062130677,0.000001632198,0.0004347988,0.000033201504,0.7106807,0.000007745326,0.004117964,0.062850155],"study_design_scores_gemma":[0.0011324892,0.00004887926,0.6477059,0.000075307755,0.000017418675,0.0000036076356,0.00026630782,2.801983e-7,0.3418085,0.000006207023,0.008731726,0.0002033397],"about_ca_topic_score_codex":0.0008986369,"about_ca_topic_score_gemma":0.00008042834,"teacher_disagreement_score":0.42796138,"about_ca_system_score_codex":0.00039264074,"about_ca_system_score_gemma":0.00029599512,"threshold_uncertainty_score":0.8646799},"labels":[],"label_agreement":null},{"id":"W1993025432","doi":"10.1158/1538-7445.am2012-lb-435","title":"Abstract LB-435: Double-blind randomized clinical trial of vitamin D3 showing effects on tissue calcitriol levels, gene expression and proliferation immunohistochemistry in prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Medicine; Calcitriol; Prostate; Vitamin D and neurology; Calcitriol receptor; Internal medicine; Prostatectomy; Immunohistochemistry; Cancer; Randomized controlled trial; Urology; Cholecalciferol; Endocrinology; Oncology","score_opus":0.17003112970941617,"score_gpt":0.5049360436617828,"score_spread":0.33490491395236666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993025432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811325,0.010053877,0.000005726719,0.0007385484,0.0003880499,0.0072516548,0.000033620527,0.000020250209,0.00037578834],"genre_scores_gemma":[0.9892376,0.004884557,0.00009654061,0.000030509465,0.0010466675,0.00300779,0.000060913393,0.000047090754,0.0015883122],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961042,0.000625943,0.00081731594,0.0005370447,0.0010829716,0.00083255954],"domain_scores_gemma":[0.99736995,0.0013147226,0.00016993338,0.0004086293,0.00035503964,0.00038171696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005896911,0.00025811867,0.0009735325,0.00035188618,0.00015482864,0.000043860695,0.00015018848,0.00027090465,0.00016238591],"category_scores_gemma":[0.0007075249,0.00018516826,0.00013582414,0.00041694276,0.00045264832,0.00021557036,0.0001237211,0.0011209357,0.000008205537],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.526122,0.00042867428,0.0031826408,0.0006133766,0.000088937646,0.000027814876,0.00052240194,0.000003716751,0.45494157,0.000004558285,0.00025867726,0.01380567],"study_design_scores_gemma":[0.43907103,0.00041850444,0.0018099365,0.0009373486,0.00003671691,0.0000022730949,0.000042498832,0.000013396343,0.55738956,0.000009740796,0.00015876011,0.000110263565],"about_ca_topic_score_codex":0.00068470475,"about_ca_topic_score_gemma":0.000016306567,"teacher_disagreement_score":0.10244797,"about_ca_system_score_codex":0.0006589271,"about_ca_system_score_gemma":0.0009998173,"threshold_uncertainty_score":0.75509423},"labels":[],"label_agreement":null},{"id":"W1993183417","doi":"10.1158/1538-7445.am2014-3395","title":"Abstract 3395: Role of the activating protein 2 transcription factor in regulating cell invasion and migration in malignant glioma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Western blot; Transcription factor; Biology; Cell culture; Cytoplasm; Transcription (linguistics); Gene expression; Cancer research; Molecular biology; Gene; Cell biology; Genetics","score_opus":0.028300795225888888,"score_gpt":0.30406388732874107,"score_spread":0.27576309210285216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993183417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989414,0.00035794574,0.00000714365,0.00013347462,0.000021903581,0.0004179007,0.000004463371,0.0000027048225,0.00011302793],"genre_scores_gemma":[0.9996925,0.000055058423,0.000046160614,0.000005723889,0.000053161628,0.00009839097,0.000005897382,0.000014084158,0.000029009609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888325,0.00022601413,0.00019712583,0.00024986686,0.00021922881,0.00022453057],"domain_scores_gemma":[0.9996333,0.000020970716,0.00006706976,0.00017000486,0.00007372388,0.000034932193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053689285,0.00008280796,0.000097093514,0.00011139341,0.000060178594,0.000018351931,0.00012737219,0.00013224562,0.000011991679],"category_scores_gemma":[0.00014716231,0.00006347797,0.000023943112,0.0002694881,0.00006816919,0.000013202125,0.000060640537,0.00024154747,3.6153105e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088287525,0.000032005482,0.023814578,0.00006435601,0.0000025386064,1.435804e-7,0.00039300925,0.0000611951,0.9695449,0.0000069637144,0.000004651798,0.0059873573],"study_design_scores_gemma":[0.00038411721,0.000067316396,0.03535202,0.00017652582,4.4768203e-7,4.3322714e-7,0.00025307667,0.00015100217,0.96326345,0.000064367654,0.00021998872,0.00006723017],"about_ca_topic_score_codex":0.00076133094,"about_ca_topic_score_gemma":0.0010293658,"teacher_disagreement_score":0.011537444,"about_ca_system_score_codex":0.00006453387,"about_ca_system_score_gemma":0.00009615192,"threshold_uncertainty_score":0.25885567},"labels":[],"label_agreement":null},{"id":"W1993322944","doi":"10.1158/1538-7445.am2013-1333","title":"Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Retinoblastoma; Germline mutation; Cancer research; Germline; Biology; CDKN2A; Frameshift mutation; Retinoblastoma protein; Genetics; Exon; Nonsense mutation; Missense mutation; Mutation; Medicine; Gene; Cell cycle","score_opus":0.04649574141735676,"score_gpt":0.36159153058844307,"score_spread":0.3150957891710863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993322944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953731,0.0017003298,0.0000025190873,0.00022646761,0.000094183575,0.0005738878,0.000050100538,0.000010160179,0.0019692848],"genre_scores_gemma":[0.9976085,0.0015625231,0.00014324574,0.0000040705195,0.00006597809,0.00010084908,0.000021446122,0.000015032649,0.0004783691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988,0.00012885465,0.00023742979,0.00020918642,0.00037241034,0.0002521607],"domain_scores_gemma":[0.9988248,0.00030676374,0.00008720832,0.00025298345,0.0003803107,0.0001479362],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044916465,0.00008662847,0.00024336451,0.00017233244,0.00008197293,0.000007487041,0.00007148817,0.000106512605,0.0009960349],"category_scores_gemma":[0.00010134221,0.000070295355,0.00005312315,0.00025156172,0.00067718,0.00008298611,0.000042174208,0.0003430684,0.00004395025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017238584,0.00022356774,0.9836691,0.00016232675,0.00027972198,0.00008072025,0.0004897484,0.000015662285,0.008016154,0.00004736077,0.001579051,0.005264209],"study_design_scores_gemma":[0.0010583301,0.0003639396,0.9713069,0.00013371682,0.000043467066,0.000009009362,0.00056617655,0.000027888042,0.025880141,0.00028482173,0.00027565984,0.00004992899],"about_ca_topic_score_codex":0.013572638,"about_ca_topic_score_gemma":0.001410456,"teacher_disagreement_score":0.017863987,"about_ca_system_score_codex":0.00009928172,"about_ca_system_score_gemma":0.00018543545,"threshold_uncertainty_score":0.9999172},"labels":[],"label_agreement":null},{"id":"W1993344194","doi":"10.1158/1538-7445.am2012-4692","title":"Abstract 4692: ABT-888 synergizes treatment of colon cancer cell lines with irinotecan","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Jewish General Hospital","funders":"","keywords":"PARP1; DNA damage; Cancer research; PARP inhibitor; DNA repair; Veliparib; Olaparib; Synthetic lethality; Topoisomerase; Poly ADP ribose polymerase; Molecular biology; Cancer; Comet assay; Irinotecan; Biology; Chemistry; Colorectal cancer; Polymerase; DNA; Biochemistry; Genetics","score_opus":0.1540170921789979,"score_gpt":0.47011049998236865,"score_spread":0.31609340780337075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993344194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623565,0.02755671,0.00000809758,0.0013088556,0.00026017136,0.0007966371,0.00011479755,0.00004698074,0.0075512584],"genre_scores_gemma":[0.9775549,0.015370875,0.00015921032,0.00010279535,0.0012299494,0.0011330863,0.000016091719,0.000060642153,0.0043724533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768513,0.00008048142,0.0002982214,0.0003209041,0.00084322674,0.0007720197],"domain_scores_gemma":[0.9983101,0.00018373632,0.00011522028,0.00047838574,0.0005420445,0.00037053874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035309268,0.0002159026,0.00042828245,0.0001700466,0.00012500279,0.000016505717,0.00013459154,0.00012394848,0.0033466362],"category_scores_gemma":[0.000013128115,0.0001541125,0.00009203953,0.00043664555,0.00038471576,0.00015807422,0.00002546988,0.00025408468,0.00004442312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005269203,0.0025100273,0.06838428,0.0008743054,0.00045355584,0.000052091524,0.0031819888,0.00017984846,0.86440873,0.00015034029,0.012360385,0.04217525],"study_design_scores_gemma":[0.004068507,0.0016434084,0.028519738,0.00046863174,0.00006418425,0.00001008539,0.00040198315,0.000009411718,0.8849294,0.0000139089525,0.079681255,0.00018946854],"about_ca_topic_score_codex":0.0093607325,"about_ca_topic_score_gemma":0.0012310673,"teacher_disagreement_score":0.06732087,"about_ca_system_score_codex":0.0016106698,"about_ca_system_score_gemma":0.00094037084,"threshold_uncertainty_score":0.99756444},"labels":[],"label_agreement":null},{"id":"W1993541158","doi":"10.1158/1538-7445.am2014-3410","title":"Abstract 3410: A novel regulatory region of the MYC oncogene decreases Myc transcriptional activity","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transcription factor; Carcinogenesis; Oncogene; Mutant; Biology; Cancer research; Proto-Oncogene Proteins c-myc; Lysine; Gene; Cell biology; Genetics; Cell cycle; Amino acid","score_opus":0.07387614714624875,"score_gpt":0.378223780811103,"score_spread":0.3043476336648543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993541158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628055,0.0012733421,0.00015735439,0.0005040466,0.00008323,0.00031265063,0.00007500496,0.000005588853,0.0013082066],"genre_scores_gemma":[0.99797595,0.00050834264,0.000026579799,0.00004939764,0.00030014536,0.00015202643,0.000022632805,0.000021868538,0.00094305706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983095,0.00014425482,0.00013440111,0.00036305678,0.0006443634,0.00040440971],"domain_scores_gemma":[0.9988998,0.00004648162,0.000054934277,0.0005654258,0.00027245196,0.00016089773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046066265,0.000119654826,0.00013463692,0.000065700064,0.00018930153,0.00002169128,0.0003636723,0.00011081632,0.00007791789],"category_scores_gemma":[0.00014896455,0.000088874265,0.00014875467,0.00020350963,0.00038702218,0.000007780858,0.00012251668,0.00022094615,0.0000054695342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058472913,0.00022162295,0.0034851453,0.000054032684,0.00008689411,0.000001901442,0.000023126517,0.000029913272,0.9803397,0.00020635099,0.0025755104,0.012391063],"study_design_scores_gemma":[0.0010932424,0.00021421551,0.11379797,0.000066179084,0.000009300655,0.000010106163,0.000015035444,0.000011558343,0.8517679,0.00015253031,0.03276139,0.00010059893],"about_ca_topic_score_codex":0.0020916425,"about_ca_topic_score_gemma":0.0013502868,"teacher_disagreement_score":0.12857184,"about_ca_system_score_codex":0.00012420822,"about_ca_system_score_gemma":0.0006518921,"threshold_uncertainty_score":0.3624187},"labels":[],"label_agreement":null},{"id":"W1993563907","doi":"10.1158/0008-5472.can-03-2877","title":"Insulin-Like Growth Factor Binding Protein-3 Interacts with Autocrine Motility Factor/Phosphoglucose Isomerase (AMF/PGI) and Inhibits the AMF/PGI Function","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute","keywords":"Biotinylation; Glucose-6-phosphate isomerase; Growth factor; Conjugate; Biology; Biochemistry; Chemistry; Molecular biology; Receptor; Enzyme","score_opus":0.050799240729036806,"score_gpt":0.3332064727612751,"score_spread":0.2824072320322383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993563907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901978,0.0020993766,0.00012752773,0.003491223,0.0003544251,0.0029882258,0.00013118403,0.00019078758,0.00041947555],"genre_scores_gemma":[0.9962923,0.0009382043,0.00010101507,0.00043847662,0.0003699885,0.00055249204,0.000057807705,0.000119397046,0.0011303317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949699,0.000267674,0.0006539988,0.0010992689,0.00166625,0.001342877],"domain_scores_gemma":[0.9969258,0.00019961793,0.0001888815,0.0008544138,0.001042094,0.0007892395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007538821,0.000574853,0.00066067796,0.00058806693,0.00075281673,0.00024005499,0.00038176452,0.00026612086,0.00034835722],"category_scores_gemma":[0.0005878123,0.00037176078,0.00014235098,0.001673764,0.0007263681,0.0007427042,0.0003533997,0.0022590626,0.0001322829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012627647,0.0021239398,0.10475647,0.0021768687,0.0011580202,0.0005467488,0.00992333,0.00003204762,0.8219198,0.001058286,0.002265311,0.041411515],"study_design_scores_gemma":[0.009633369,0.00399343,0.30440423,0.0014725542,0.00013106305,0.000099756275,0.001308317,0.00004775262,0.67076653,0.00057033094,0.006819183,0.00075350306],"about_ca_topic_score_codex":0.002813194,"about_ca_topic_score_gemma":0.00034312916,"teacher_disagreement_score":0.19964775,"about_ca_system_score_codex":0.0010619792,"about_ca_system_score_gemma":0.0010990535,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W1993712514","doi":"10.1158/1538-7445.am2012-1013","title":"Abstract 1013: Enriched miR-126 bioactivity marks the primitive compartment in human AML and regulates leukemia stem cell numbers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Leukemia; Myeloid leukemia; Biology; microRNA; Cancer research; Stem cell; Gene knockdown; Population; CD34; Haematopoiesis; CD117; Gene expression profiling; Immunology; Molecular biology; Cell culture; Medicine; Gene expression; Cell biology; Gene; Genetics","score_opus":0.043047242969830216,"score_gpt":0.35655702575659215,"score_spread":0.31350978278676195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993712514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451214,0.0034230729,0.0000062629206,0.0001951556,0.000048663776,0.0004933721,0.000021764932,0.000005849752,0.0012936947],"genre_scores_gemma":[0.9988995,0.00025613,0.000017347786,0.00003358216,0.00016471653,0.00013276176,0.000052632116,0.000019829848,0.00042350858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860597,0.00023343292,0.00015490374,0.00029623654,0.00024649172,0.00046295548],"domain_scores_gemma":[0.99932814,0.000055446457,0.00006028391,0.00033162814,0.00008944974,0.00013506708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007958679,0.00012736491,0.00011941443,0.000057372097,0.0001635893,0.000040301133,0.0001693517,0.000121238634,0.00005925046],"category_scores_gemma":[0.000012648668,0.00010237683,0.000040908,0.00013298474,0.00027672964,0.000012328246,0.00017410076,0.00023227425,0.0000070062956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100949466,0.00008255841,0.014838476,0.000057662226,0.000030837484,0.0000012543906,0.0002478069,0.000026292279,0.98048335,0.000053889424,0.0027029747,0.0013739475],"study_design_scores_gemma":[0.0004240778,0.00003082455,0.40523085,0.000020146037,0.000006714004,0.0000013294551,0.00025258635,0.000013403687,0.5882343,0.000032043976,0.0056409114,0.00011281623],"about_ca_topic_score_codex":0.0006142044,"about_ca_topic_score_gemma":0.0002896419,"teacher_disagreement_score":0.39224908,"about_ca_system_score_codex":0.00032704117,"about_ca_system_score_gemma":0.00016369142,"threshold_uncertainty_score":0.4174806},"labels":[],"label_agreement":null},{"id":"W1994008524","doi":"10.1158/1538-7445.am2013-lb-117","title":"Abstract LB-117: Myc phosphorylation suppresses transformation through novel regulatory regions.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carcinogenesis; Gene; Biology; Transcription factor; Mutant; Phosphorylation; Promoter; Gene expression; Transcription (linguistics); Cancer research; Regulation of gene expression; Cell biology; Genetics","score_opus":0.07061268630517271,"score_gpt":0.3540006957585905,"score_spread":0.2833880094534178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994008524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831857,0.0021632076,0.0008212005,0.0011880986,0.00012697197,0.0007055934,0.00004389641,0.00002459503,0.011740719],"genre_scores_gemma":[0.9964169,0.0010997871,0.00022836371,0.00015138689,0.00033823636,0.00049038476,0.00014875334,0.000026794381,0.0010993418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986759,0.00005807237,0.00019926621,0.00030791393,0.0003662247,0.00039262229],"domain_scores_gemma":[0.99910307,0.000026605805,0.000047081066,0.0003711557,0.00035829327,0.000093769784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038452348,0.0001222191,0.00010203995,0.00005347499,0.00021257963,0.00007467992,0.0002340329,0.00018605581,0.00067267823],"category_scores_gemma":[0.000065613494,0.00011460569,0.00006292642,0.00016124631,0.0001613146,0.00003618811,0.000054688047,0.00023980885,0.00012292695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058145444,0.00004549524,0.000104387815,0.00008106166,0.000022493705,4.3620764e-7,0.00044593494,0.000047962356,0.9725187,0.0010857431,0.019357353,0.0062322887],"study_design_scores_gemma":[0.00041432562,0.00008318395,0.0062500085,0.0000447546,0.000003297504,0.0000030596593,0.00025095828,0.000028200044,0.88805354,0.0009280132,0.10379296,0.000147714],"about_ca_topic_score_codex":0.00060640083,"about_ca_topic_score_gemma":0.000057989193,"teacher_disagreement_score":0.08446517,"about_ca_system_score_codex":0.000054148735,"about_ca_system_score_gemma":0.00020329315,"threshold_uncertainty_score":0.7365355},"labels":[],"label_agreement":null},{"id":"W1994236253","doi":"10.1158/0008-5472.can-03-3448","title":"Recent Advances in Stress Signaling in Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Signal transduction; Cancer; Apoptosis; Cancer cell; Biology; Mechanism (biology); Neuroscience; Cancer research; Cell biology; Genetics","score_opus":0.06743361268537813,"score_gpt":0.4287545266342851,"score_spread":0.361320913948907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994236253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90964794,0.0891492,0.000018377325,0.0004038584,0.0001385095,0.0002383119,0.000044028875,0.000006444085,0.00035335202],"genre_scores_gemma":[0.9681941,0.030825954,0.000052045485,0.00010472126,0.00025169863,0.0004365925,0.000022592661,0.00002352231,0.00008872021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844235,0.000122000754,0.00018542906,0.00042403734,0.00032591567,0.0005002797],"domain_scores_gemma":[0.99943405,0.00002224228,0.000027557448,0.00026165793,0.00014893968,0.00010557431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004884684,0.00010658013,0.00011562041,0.00012485648,0.000049446826,0.000021557045,0.0003045457,0.00009971949,0.00015894305],"category_scores_gemma":[0.00017633507,0.00010846586,0.000030027515,0.00046866387,0.00012291467,0.000007730493,0.00012401743,0.0002868049,0.0000068424365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003406612,0.00020246532,0.046427354,0.00009258595,0.000012326841,0.000057527108,0.00023316812,0.069272965,0.8443288,0.00008221043,0.0002333881,0.038716532],"study_design_scores_gemma":[0.0012032499,0.00008567431,0.0015262385,0.0003364749,0.0000018590525,6.133852e-7,0.00020657877,0.000008464551,0.9654864,0.00061557884,0.03035594,0.00017292883],"about_ca_topic_score_codex":0.0005947509,"about_ca_topic_score_gemma":0.0060735843,"teacher_disagreement_score":0.12115759,"about_ca_system_score_codex":0.00030769402,"about_ca_system_score_gemma":0.0006908587,"threshold_uncertainty_score":0.44231093},"labels":[],"label_agreement":null},{"id":"W1994332635","doi":"10.1158/0008-5472.sabcs12-p3-13-05","title":"Abstract P3-13-05: Evaluating efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal related events. TRIUMPH: A pragmatic multicentre trial.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Ottawa Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; N-terminal telopeptide; Internal medicine; Cancer; Dosing; Bisphosphonate; Metastatic breast cancer; Oncology; Surgery; Alkaline phosphatase; Osteoporosis; Osteocalcin","score_opus":0.06824312628986474,"score_gpt":0.4432206587552248,"score_spread":0.3749775324653601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994332635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911559,0.0038303917,4.0558908e-7,0.00020098206,0.00025535875,0.0042399485,0.00025379588,0.000020013911,0.000043200973],"genre_scores_gemma":[0.9961241,0.0027806023,0.000083821345,0.000029517474,0.000027463408,0.000536539,0.00008693997,0.00006111798,0.00026990008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526054,0.00083408784,0.0011113894,0.00036598518,0.0013307921,0.0010972338],"domain_scores_gemma":[0.9970019,0.00089007575,0.00055907056,0.0003996169,0.0006593977,0.0004899324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028863084,0.00025975108,0.00076417683,0.00037576896,0.000119428114,0.000006071376,0.00015840944,0.0001639256,0.0013262562],"category_scores_gemma":[0.0008189254,0.0001989903,0.0001808016,0.0009803803,0.00014954654,0.00015155878,0.00007089311,0.00069591904,0.000039136135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06571772,0.007303646,0.7714335,0.0012910212,0.00092470984,0.000017034215,0.004901634,0.00015014912,0.0056032524,0.0000016743573,0.00015679988,0.1424989],"study_design_scores_gemma":[0.11114133,0.0010183587,0.8814182,0.0011394407,0.00018338037,0.0000044367603,0.00010973818,0.00066091825,0.004152807,0.000016567217,0.00002137412,0.00013343726],"about_ca_topic_score_codex":0.020909801,"about_ca_topic_score_gemma":0.00060819817,"teacher_disagreement_score":0.14236546,"about_ca_system_score_codex":0.0013741836,"about_ca_system_score_gemma":0.0012042895,"threshold_uncertainty_score":0.99958664},"labels":[],"label_agreement":null},{"id":"W1994350539","doi":"10.1158/1538-7445.am2014-4792","title":"Abstract 4792: Elucidating stem cell-specific metabolic pathways in normal and malignant hematopoiesis to target human acute myeloid leukemia stem cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Progenitor cell; Myeloid leukemia; Myeloid; Leukemia; Cancer research; Hematopoietic stem cell; Cell biology; Immunology","score_opus":0.053982309339953426,"score_gpt":0.33564307272110006,"score_spread":0.28166076338114665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994350539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878592,0.003543206,0.00012070003,0.00072759495,0.00013528542,0.0016802611,0.0001055256,0.00009114519,0.0057371217],"genre_scores_gemma":[0.9919438,0.0016748282,0.0008726317,0.00024058095,0.00057958,0.0006150556,0.00002938252,0.00015779365,0.0038863437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933277,0.00048838963,0.00087461266,0.0012868713,0.0019287474,0.0020937067],"domain_scores_gemma":[0.99657786,0.0005002393,0.00013544137,0.001175518,0.00054695905,0.0010639742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004515788,0.00047150464,0.001014607,0.0012197106,0.0005166817,0.00024170999,0.00075320224,0.00031159428,0.0007990836],"category_scores_gemma":[0.000037698097,0.0004198168,0.00013765896,0.0015355312,0.00033529077,0.0003066853,0.00079968583,0.0019936406,0.00041439926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004371244,0.0000987625,0.0017921828,0.0006605754,0.000094027644,0.0005857777,0.0026706045,0.00009228718,0.9658076,0.0008425035,0.010921557,0.015997006],"study_design_scores_gemma":[0.0031260378,0.0004138697,0.009353643,0.0005350161,0.00003226235,0.00006596464,0.002506524,0.00029277257,0.93984735,0.000098831006,0.043194376,0.0005333673],"about_ca_topic_score_codex":0.001432462,"about_ca_topic_score_gemma":0.00013788152,"teacher_disagreement_score":0.03227282,"about_ca_system_score_codex":0.0020449306,"about_ca_system_score_gemma":0.00120104,"threshold_uncertainty_score":0.99982536},"labels":[],"label_agreement":null},{"id":"W1994358878","doi":"10.1158/1538-7445.am2014-3087","title":"Abstract 3087: Whole genome sequencing of rhabdoid tumors of the kidney","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Epigenetics; Biology; Genetics; SMARCB1; Chromatin; Genome; Carcinogenesis; Epigenomics; Gene; DNA methylation; Chromatin remodeling; Cancer research; Computational biology; Gene expression","score_opus":0.043888011085661004,"score_gpt":0.351623971977352,"score_spread":0.30773596089169103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994358878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566233,0.0007099669,0.00007810661,0.00028585517,0.000074398326,0.000116707524,0.000055265304,0.0000032034611,0.003014148],"genre_scores_gemma":[0.99874467,0.00013467023,0.00006541669,0.00010944326,0.00020021266,0.000020609836,0.000015241691,0.00001577973,0.0006939877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998977,0.00008263104,0.00019410525,0.00019927835,0.00031380943,0.00023317496],"domain_scores_gemma":[0.9991203,0.000018239263,0.00007760723,0.00045666605,0.00025059952,0.00007657056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006889529,0.00007138765,0.0001207746,0.00003439615,0.00007208131,0.0000077784825,0.0003616015,0.000071541624,0.000057044726],"category_scores_gemma":[0.00019026286,0.000052629464,0.00007991653,0.00014735541,0.00021911011,0.0000020381538,0.00014306561,0.00016220828,0.0000039451534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022959895,0.000010467103,0.00047877897,0.00015026961,0.000016193184,1.5509137e-7,0.000079496145,0.00093456765,0.9958244,0.000032198295,0.0013293597,0.0011211567],"study_design_scores_gemma":[0.00024514485,0.00007350612,0.002369572,0.00013892366,0.0000041115786,0.0000015051035,0.00008576418,0.00013705523,0.96948266,0.00014638057,0.027240414,0.00007496805],"about_ca_topic_score_codex":0.00042494293,"about_ca_topic_score_gemma":0.0000405846,"teacher_disagreement_score":0.026341744,"about_ca_system_score_codex":0.000055276527,"about_ca_system_score_gemma":0.00059733103,"threshold_uncertainty_score":0.21461673},"labels":[],"label_agreement":null},{"id":"W1994381373","doi":"10.1158/1538-7445.am2011-2579","title":"Abstract 2579: YK5, a small molecule inhibitor of Hsp70 and Hsc70, reveals a multifaceted role for the Hsp70 chaperones in regulating oncogenic and non-oncogenic addiction of tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cancer; Cancer research; Heat shock protein; Biology; Hsp70; Cancer cell; Suppressor; Dephosphorylation; Cell biology; Phosphorylation; Biochemistry; Phosphatase; Genetics","score_opus":0.05921696280413035,"score_gpt":0.3480635900620967,"score_spread":0.28884662725796634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994381373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935313,0.0047675623,0.00006617714,0.0000820809,0.00001938913,0.0013285539,0.00007124677,0.0000034807813,0.0001301941],"genre_scores_gemma":[0.99789244,0.001008791,0.0004196085,0.0000078487155,0.00008783858,0.00035907028,0.000012794013,0.00003376052,0.0001778646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983141,0.00016401942,0.0003559454,0.00042220548,0.0002825802,0.00046116798],"domain_scores_gemma":[0.9989273,0.00013465507,0.000095950025,0.00036697846,0.00036059503,0.00011454803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014758041,0.00013569207,0.00023628594,0.00018003637,0.000120109165,0.000013390954,0.00024518368,0.00017286347,0.000027894903],"category_scores_gemma":[0.0004627522,0.000113141185,0.00006234975,0.00028878526,0.00037530385,0.000009564576,0.00026701594,0.00025097106,7.3463843e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007168647,0.00005821192,0.002941681,0.00019498635,0.00005394754,0.00000193777,0.0005992672,0.000010944551,0.98469067,0.000006664803,0.00004171997,0.010683126],"study_design_scores_gemma":[0.0011301641,0.0005101202,0.030059572,0.00018284855,0.000008881678,0.000004114855,0.00063657475,0.0004265705,0.9666778,0.00003231054,0.00022125695,0.00010977156],"about_ca_topic_score_codex":0.0020788028,"about_ca_topic_score_gemma":0.0006656793,"teacher_disagreement_score":0.027117891,"about_ca_system_score_codex":0.00005396124,"about_ca_system_score_gemma":0.00032021303,"threshold_uncertainty_score":0.46137637},"labels":[],"label_agreement":null},{"id":"W1994637727","doi":"10.1158/0008-5472.sabcs-09-2085","title":"Interim Results of BACH: Randomized Phase II Trial Evaluating the Safety of Two Chemotherapy Regimens as Adjuvant Therapy in Patients with HER2-Positive Breast Cancer: PLD + Cyclophosphamide + Trastuzumab (PLD+C+H), or Doxorubicin + Cyclophosphomide (A+C), Each Followed by Paclitaxel + Trastuzumab (T+H).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Interim analysis; Breast cancer; Ejection fraction; Internal medicine; Regimen; Cardiotoxicity; Trastuzumab; Cyclophosphamide; Asymptomatic; Chemotherapy; Surgery; Cancer; Gastroenterology; Randomized controlled trial; Urology; Heart failure","score_opus":0.028256238657459576,"score_gpt":0.3933462065226312,"score_spread":0.3650899678651716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994637727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854979,0.0051368154,0.000028663131,0.0025136522,0.00017175033,0.0047268607,0.0015625092,0.000016275451,0.0003455969],"genre_scores_gemma":[0.9903916,0.0071069878,0.000112542,0.00026029896,0.00018663028,0.0011109969,0.00032487023,0.00007948029,0.0004265777],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941779,0.001273153,0.0012847093,0.0010732451,0.0012565017,0.00093450095],"domain_scores_gemma":[0.99688387,0.0005059604,0.00067697506,0.000867376,0.0009003411,0.00016546667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002503463,0.0006038985,0.0014604678,0.00016402858,0.0003577359,0.00003275123,0.0006689671,0.00020398671,0.00011255792],"category_scores_gemma":[0.00029414863,0.00037109174,0.0003279422,0.00079529436,0.0009526314,0.000029553277,0.00015042348,0.00051762,0.0000010911037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87004864,0.0030539453,0.0006775234,0.000021989685,0.0010002335,0.0000054217808,0.0028475036,0.00009264267,0.056596268,0.000009844669,0.0017164776,0.06392953],"study_design_scores_gemma":[0.7796133,0.023396274,0.0084685935,0.0005294817,0.00012377278,0.0000048857605,0.00063782034,0.00002941982,0.18636286,0.00005701197,0.00033061462,0.00044596533],"about_ca_topic_score_codex":0.0077880095,"about_ca_topic_score_gemma":0.00091307564,"teacher_disagreement_score":0.12976658,"about_ca_system_score_codex":0.0006701615,"about_ca_system_score_gemma":0.0012925537,"threshold_uncertainty_score":0.9998741},"labels":[],"label_agreement":null},{"id":"W1994693894","doi":"10.1158/1538-7445.am2014-ct205","title":"Abstract CT205: A phase I dose-escalation study of trametinib (T) in combination with continuous or intermittent GSK2126458 (GSK458) in patients (pts) with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Rash; Dosing; Internal medicine; Vomiting; Gastroenterology; Mucositis; Adverse effect; Toxicity","score_opus":0.03212406334622851,"score_gpt":0.38898812960617496,"score_spread":0.35686406625994643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994693894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982739,0.00007135622,0.00007480425,0.00003909195,0.000053615004,0.0013036156,0.00001413098,0.0000077095165,0.00016178974],"genre_scores_gemma":[0.99926186,0.00001964503,0.00006530014,0.000020854597,0.000038598904,0.00043908018,0.0000498013,0.00003874518,0.00006612559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978207,0.0002309915,0.0004197037,0.00051741616,0.00060350227,0.00040770258],"domain_scores_gemma":[0.9988434,0.000067166926,0.00017943187,0.00037372942,0.00046363464,0.00007264902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080740964,0.0001799205,0.000315724,0.00023922104,0.000046420093,0.00002564531,0.00027135797,0.000095935415,0.000036833702],"category_scores_gemma":[0.00018292898,0.00013741814,0.000025874457,0.00045802578,0.0001498121,0.000018046709,0.00006811864,0.0003269516,0.000001643757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03626834,0.012893247,0.33927363,0.0003324204,0.00017461902,0.000045302644,0.0029400422,0.0054023415,0.32440144,0.000015710139,0.00019371267,0.27805918],"study_design_scores_gemma":[0.0673514,0.054987434,0.642476,0.0011879785,0.000027286062,0.0000034592292,0.0023925414,0.00064693583,0.22939618,0.00003583342,0.00081295404,0.0006819966],"about_ca_topic_score_codex":0.00038208612,"about_ca_topic_score_gemma":0.0018984202,"teacher_disagreement_score":0.3032024,"about_ca_system_score_codex":0.00019431429,"about_ca_system_score_gemma":0.00024559617,"threshold_uncertainty_score":0.5603749},"labels":[],"label_agreement":null},{"id":"W1994726114","doi":"10.1158/1538-7445.am2011-2136","title":"Abstract 2136: Expression of fusion proteins in acute myeloid leukemia cells increases sensitivity to histone deacetylase inhibitors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Vorinostat; Programmed cell death; Biology; Histone deacetylase; DNA damage; Cancer research; Histone deacetylase inhibitor; Molecular biology; Histone; Apoptosis; Cell biology; DNA; Biochemistry","score_opus":0.05718878108002325,"score_gpt":0.369191659511069,"score_spread":0.3120028784310458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994726114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424136,0.00034661594,0.000034866665,0.00040644666,0.000095061,0.0025058866,0.000083426436,0.000058563044,0.002227782],"genre_scores_gemma":[0.9956302,0.00061574916,0.0015028388,0.000100858844,0.000242363,0.00047267313,0.000022075994,0.00008165545,0.0013315955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952001,0.00050283934,0.0006150007,0.00079959404,0.0017405758,0.0011419097],"domain_scores_gemma":[0.99701416,0.00034483083,0.00012121746,0.00092055893,0.00080387027,0.0007953748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030128853,0.00029942582,0.00064973946,0.001215739,0.00016459147,0.000020463613,0.00033413112,0.00031050155,0.0008679531],"category_scores_gemma":[0.00067894784,0.00025977264,0.00013320932,0.0015018999,0.00046052993,0.00023352518,0.0006976753,0.0016146487,0.00019320568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040694377,0.00043461198,0.0027866375,0.0004084382,0.00003372691,0.001070552,0.0016057983,0.00001677576,0.97325593,0.000011178283,0.008934809,0.00737208],"study_design_scores_gemma":[0.0020486566,0.00053415284,0.048916694,0.0012534332,0.000018545363,0.000025948542,0.00041499105,0.000043303884,0.9456108,0.000027131151,0.00088322983,0.00022311804],"about_ca_topic_score_codex":0.039351214,"about_ca_topic_score_gemma":0.0015434594,"teacher_disagreement_score":0.046130054,"about_ca_system_score_codex":0.0041282563,"about_ca_system_score_gemma":0.0030649449,"threshold_uncertainty_score":0.99998546},"labels":[],"label_agreement":null},{"id":"W1994855284","doi":"10.1158/0008-5472.can-10-2805","title":"YB-1 Bridges Neural Stem Cells and Brain Tumor–Initiating Cells via Its Roles in Differentiation and Cell Growth","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St Mary's Hospital Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Neurosphere; Nestin; Neural stem cell; Subventricular zone; Biology; Stem cell; Cellular differentiation; Stem cell marker; Cell biology; Cancer research; Cancer stem cell; Immunology; Adult stem cell; Genetics","score_opus":0.04467666729680214,"score_gpt":0.31425139436951666,"score_spread":0.2695747270727145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994855284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969648,0.002236325,0.000065378095,0.00012519417,0.00003724282,0.00026625942,0.000020072795,0.0000058305777,0.00027886053],"genre_scores_gemma":[0.9980495,0.00090667245,0.000031905678,0.00007882888,0.00009828556,0.000053374828,0.000007632959,0.000022575341,0.00075120025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984319,0.0002569091,0.00016275709,0.00039641742,0.0002495229,0.0005024652],"domain_scores_gemma":[0.99944574,0.00005928716,0.000038248516,0.00015199013,0.00013865774,0.00016609915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054810796,0.00012056173,0.00013060779,0.00013232423,0.00012880155,0.000064121814,0.00016041308,0.00007858356,0.000021818287],"category_scores_gemma":[0.000033525477,0.00011300557,0.00002368027,0.00012843192,0.000108118504,0.000014685341,0.00020043946,0.0002687062,0.0000041668754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009642792,0.000029969797,0.014780749,0.00011598583,0.0000073531764,0.000013655817,0.0002608943,0.00000411415,0.98181915,0.000013702338,0.00023361016,0.0026243718],"study_design_scores_gemma":[0.00052979885,0.00021396877,0.019681012,0.000033801574,0.0000022016714,0.000003156917,0.00032288456,0.0014459207,0.97755414,0.000026035576,0.00006299689,0.00012405016],"about_ca_topic_score_codex":0.0006464823,"about_ca_topic_score_gemma":0.00043328834,"teacher_disagreement_score":0.004900263,"about_ca_system_score_codex":0.000029352128,"about_ca_system_score_gemma":0.00006816699,"threshold_uncertainty_score":0.46082333},"labels":[],"label_agreement":null},{"id":"W1994870754","doi":"10.1158/0008-5472.can-05-0877","title":"Increased Efficacy and Safety in the Treatment of Experimental Liver Cancer with a Novel Adenovirus-Alphavirus Hybrid Vector","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Semliki Forest virus; Biology; Viral vector; Genetic enhancement; Transgene; Cancer research; Reporter gene; Replicon; Virology; Vector (molecular biology); Subgenomic mRNA; Suicide gene; Hepatocellular carcinoma; Oncolytic virus; Molecular biology; Gene; Virus; Gene expression; Plasmid; RNA; Genetics","score_opus":0.045726915735397416,"score_gpt":0.37394449288143766,"score_spread":0.3282175771460403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994870754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734732,0.025099777,0.0000054607535,0.00017102943,0.000016553538,0.00082109193,0.0001865756,0.0000042175643,0.00022210013],"genre_scores_gemma":[0.9947895,0.004012589,0.000022889755,0.00005040042,0.00023491781,0.0006094949,0.000042564698,0.00003104949,0.00020659318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982094,0.00024382447,0.00017885368,0.00042072637,0.00048962864,0.0004575634],"domain_scores_gemma":[0.99928075,0.00007723384,0.000038845537,0.00040289274,0.00012324941,0.00007704443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040749257,0.00016709993,0.00018279292,0.00011173529,0.00012592073,0.00003085088,0.0002731801,0.00006244574,0.000111855836],"category_scores_gemma":[0.000011338743,0.00011124012,0.000041646857,0.00026967603,0.00043294363,0.0000055814653,0.000057321562,0.00014643736,0.000002301699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01156154,0.0009047109,0.0024362367,0.000015812308,0.00006146208,0.000022620245,0.0002655305,0.00007366634,0.9803067,0.000021602602,0.00024671227,0.004083447],"study_design_scores_gemma":[0.0048282454,0.005474928,0.013683353,0.000032766482,0.000009084888,0.000008624419,0.00013239686,0.000026122156,0.9658257,0.0000023204886,0.009835775,0.0001407057],"about_ca_topic_score_codex":0.012155347,"about_ca_topic_score_gemma":0.0075395326,"teacher_disagreement_score":0.021316307,"about_ca_system_score_codex":0.00020458864,"about_ca_system_score_gemma":0.0004157609,"threshold_uncertainty_score":0.9944228},"labels":[],"label_agreement":null},{"id":"W1994918910","doi":"10.1158/1538-7445.am10-3363","title":"Abstract 3363: Identification and characterization of stem-like cells in human esophageal epithelial and adenocarcinoma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada); University of Saskatchewan","funders":"","keywords":"CD44; Flow cytometry; Stem cell; Molecular biology; Cell sorting; Population; Cell culture; Chemistry; Clonogenic assay; Pathology; Stem cell marker; Biology; Cell; Cancer research; Medicine; Cell biology; Biochemistry","score_opus":0.04855345811151868,"score_gpt":0.36131924307812613,"score_spread":0.31276578496660745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994918910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981642,0.00063185464,0.000006029229,0.00019930315,0.0002557654,0.000523669,0.000109720466,0.000007901804,0.00010157689],"genre_scores_gemma":[0.9972193,0.0010239481,0.000025635221,0.000024272118,0.00019995274,0.000055285156,0.000025964286,0.000020733234,0.001404891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998709,0.00005069025,0.00030031512,0.0003189547,0.0003657951,0.00025523364],"domain_scores_gemma":[0.99928886,0.000046399662,0.000085417756,0.0002540241,0.00018096909,0.0001443534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007967205,0.00009631979,0.00022872948,0.0002807707,0.000076905,0.00004018028,0.00007920119,0.00009628356,0.00024148621],"category_scores_gemma":[0.0000070945916,0.000090948226,0.000027495284,0.00024574954,0.00023422748,0.00011026323,0.000056286437,0.00043785424,0.000006403369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011557984,0.00006467226,0.012241783,0.00037582716,0.000011954662,0.000013226658,0.00047305488,3.2970965e-7,0.9700391,0.00004918896,0.000065575,0.016549695],"study_design_scores_gemma":[0.00067576516,0.00005916333,0.33768818,0.000054234028,0.000013176179,0.0000027104252,0.000064083695,0.000007854849,0.66059315,0.000015583835,0.0007758149,0.000050273888],"about_ca_topic_score_codex":0.0009966434,"about_ca_topic_score_gemma":0.00034258165,"teacher_disagreement_score":0.3254464,"about_ca_system_score_codex":0.000055895394,"about_ca_system_score_gemma":0.00014601336,"threshold_uncertainty_score":0.3708761},"labels":[],"label_agreement":null},{"id":"W1994947270","doi":"10.1158/1538-7445.am10-5724","title":"Abstract 5724: Capsaicin and lycopene in combination reduce proliferation and induce apoptosis in prostate cancer cells via TRPV6 mediated phenomenon","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Capsaicin; TRPV; TRPV1; LNCaP; Chemistry; Apoptosis; TRPV6; Pharmacology; Cancer research; Cancer cell; Receptor; Endocrinology; Internal medicine; Transient receptor potential channel; Cancer; Biochemistry; Biology; Medicine","score_opus":0.06489744581019628,"score_gpt":0.37207393477372885,"score_spread":0.30717648896353256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994947270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957904,0.0002113844,6.3024925e-7,0.0021942733,0.0004706623,0.0010562951,0.000023283965,0.000015547985,0.00023749235],"genre_scores_gemma":[0.9966976,0.0023442255,0.000008265505,0.00008318184,0.000101910984,0.00040140902,0.0000061312408,0.000023776236,0.00033347937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981248,0.00016914861,0.0002654226,0.00052612886,0.00045005,0.00046448252],"domain_scores_gemma":[0.99937403,0.00018946001,0.000068244626,0.00011431708,0.00011650951,0.00013742779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009863251,0.00013662243,0.00017916904,0.00041249106,0.00015462069,0.00011652684,0.00014893197,0.000120851146,0.00015076992],"category_scores_gemma":[0.00019365385,0.000120112745,0.000010271084,0.0007781955,0.000243143,0.00035840584,0.00008323914,0.0008445303,0.000011046556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011295016,0.000100080535,0.001417685,0.00007049629,0.0000013069347,0.0000039028932,0.002219617,0.000046904777,0.9858343,0.000041247647,0.00014842518,0.010003057],"study_design_scores_gemma":[0.0011728288,0.00007860702,0.0085580405,0.00008325583,0.0000012259359,0.0000012831006,0.00016310315,0.0008447389,0.988337,0.00022660522,0.00038849076,0.00014482538],"about_ca_topic_score_codex":0.0035784992,"about_ca_topic_score_gemma":0.0026896782,"teacher_disagreement_score":0.009858232,"about_ca_system_score_codex":0.00018165991,"about_ca_system_score_gemma":0.000232419,"threshold_uncertainty_score":0.5409644},"labels":[],"label_agreement":null},{"id":"W1994952696","doi":"10.1158/1538-7445.am2011-1442","title":"Abstract 1442: Expression of miRNA processing factor Dicer in cutaneous melanoma and its role in cell invasion","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dicer; Tissue microarray; Melanoma; microRNA; Gene knockdown; Cancer research; Cancer; Pathology; Drosha; Biology; Medicine; Metastasis; Immunohistochemistry; Small interfering RNA; Cell culture; Internal medicine; RNA interference; Gene; Transfection; Genetics; RNA","score_opus":0.053584707564105286,"score_gpt":0.3340334460305664,"score_spread":0.2804487384664611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994952696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224436,0.0067498055,0.000002620713,0.000009601296,0.000013315582,0.0002239551,0.000013253971,0.0000022937666,0.0007407969],"genre_scores_gemma":[0.99930215,0.00048649934,0.00004292684,0.0000044398594,0.00003019319,0.000035294965,0.000010588506,0.00001446588,0.000073447016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991351,0.00006242756,0.00016330127,0.00025428896,0.00017147015,0.00021343867],"domain_scores_gemma":[0.9996418,0.000011390159,0.00005074568,0.00013721998,0.00009441768,0.00006442797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001620947,0.00007474499,0.000091676695,0.00012072596,0.000027498096,0.000008970289,0.00012041167,0.000119683755,0.0001028125],"category_scores_gemma":[0.000042613705,0.0000690517,0.000016425052,0.00011962982,0.000050448525,0.000009111224,0.000112475675,0.00013182517,0.0000022309994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022053189,0.00007122801,0.016150841,0.00017241329,0.0000015444002,0.00000960299,0.0004131094,0.000010772516,0.97930783,7.9214107e-7,0.000026030702,0.0036153225],"study_design_scores_gemma":[0.00031656696,0.000052222716,0.08150403,0.00016350936,9.669751e-7,0.000001844901,0.00010054307,0.000041811087,0.9175611,0.00004061892,0.00014919088,0.00006760193],"about_ca_topic_score_codex":0.00026906308,"about_ca_topic_score_gemma":0.00026627167,"teacher_disagreement_score":0.065353185,"about_ca_system_score_codex":0.00004251093,"about_ca_system_score_gemma":0.00015072832,"threshold_uncertainty_score":0.28158465},"labels":[],"label_agreement":null},{"id":"W1994980021","doi":"10.1158/1538-7445.am2013-3774","title":"Abstract 3774: Regulation of the pro-invasive properties of neuroblastoma-stem cells by membrane type-1 matrix metalloproteinase.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Neuroblastoma; Metastasis; Cancer stem cell; Flow cytometry; Cancer research; Tissue microarray; Cancer; Immunohistochemistry; Stem cell; Immunofluorescence; Cell culture; Cancer cell; Pathology; Medicine; Antibody; Biology; Chemistry; Immunology; Internal medicine; Cell biology","score_opus":0.06560867286430842,"score_gpt":0.33871156843219763,"score_spread":0.2731028955678892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994980021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946914,0.0008970956,4.1881535e-7,0.0010608842,0.00006878731,0.0026626454,0.000026496049,0.000018588831,0.00057370693],"genre_scores_gemma":[0.9896178,0.00027885172,0.000022938762,0.00002041824,0.000041503707,0.00034980368,0.0000032495875,0.00003743581,0.009627967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974101,0.0002107586,0.00033495616,0.0003119225,0.0012735421,0.00045871572],"domain_scores_gemma":[0.99792606,0.000113383656,0.00012902812,0.00057442323,0.0010796898,0.00017739598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032752362,0.00015055278,0.0003103265,0.0001716251,0.00010553535,0.000025389905,0.00028587578,0.00007669305,0.00066709047],"category_scores_gemma":[0.00013182654,0.00008905263,0.00010966916,0.00065302674,0.00044467938,0.00015315367,0.00015022302,0.0003988966,0.00012025147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004910007,0.0002279366,0.00033208475,0.0010855522,0.00011143795,0.000007673982,0.000095807096,0.000018514538,0.992784,0.000017336566,0.0037571832,0.0010714406],"study_design_scores_gemma":[0.0008851107,0.0005495207,0.0060188463,0.00047622793,0.000024777488,0.000006560254,0.000086123524,0.000032456624,0.99141634,0.00002818592,0.00041193567,0.00006389602],"about_ca_topic_score_codex":0.0011931501,"about_ca_topic_score_gemma":0.000038517195,"teacher_disagreement_score":0.00905426,"about_ca_system_score_codex":0.00013093944,"about_ca_system_score_gemma":0.00063687185,"threshold_uncertainty_score":0.7304173},"labels":[],"label_agreement":null},{"id":"W1994988780","doi":"10.1158/0008-5472.can-04-3158","title":"A Lack of DNA Mismatch Repair on an Athymic Murine Background Predisposes to Hematologic Malignancy","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"MSH2; DNA mismatch repair; Cancer research; MSH6; Biology; Lymphoma; Malignancy; DNA repair; Leukemia; Cancer; Carcinogenesis; Germline mutation; Mutation; Immunology; Colorectal cancer; Genetics; Gene","score_opus":0.20835371416110493,"score_gpt":0.4723106526476516,"score_spread":0.26395693848654667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994988780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904986,0.0013363134,0.0000061974965,0.0027004583,0.00017712348,0.0011506991,0.000031640335,0.00010607864,0.0039928965],"genre_scores_gemma":[0.9923813,0.0002821523,0.0015459043,0.0005961263,0.00046338502,0.00038215428,0.000009834574,0.000052180818,0.004287003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997047,0.00017430076,0.00040220594,0.00063500565,0.0010508882,0.00069056806],"domain_scores_gemma":[0.9979712,0.00018310339,0.000059960636,0.0008794393,0.00049576623,0.0004105703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007397053,0.00020543137,0.00045929613,0.00030483134,0.000087231536,0.000018225002,0.00033606132,0.00015088427,0.0019866484],"category_scores_gemma":[0.00023569092,0.00016995655,0.00011770911,0.0007004369,0.00022845593,0.00006823241,0.000165059,0.00042845114,0.00023102581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007116457,0.0019767813,0.050307546,0.0021167865,0.00027272696,0.00020981676,0.0033968189,0.0005665696,0.822248,0.0011284063,0.09363655,0.017023547],"study_design_scores_gemma":[0.0024601072,0.0071197953,0.07174033,0.0013514817,0.00005344198,0.00008131459,0.0008094944,0.00020764119,0.86901945,0.00032450663,0.04641436,0.00041811084],"about_ca_topic_score_codex":0.00037623502,"about_ca_topic_score_gemma":0.0005175143,"teacher_disagreement_score":0.047222186,"about_ca_system_score_codex":0.00061412697,"about_ca_system_score_gemma":0.0005402374,"threshold_uncertainty_score":0.9989257},"labels":[],"label_agreement":null},{"id":"W1995175045","doi":"10.1158/0008-5472.can-06-1122","title":"Identification of the Benign Mesenchymal Tumor Gene <i>HMGA2</i> in Lymphangiomyomatosis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"HMGA2; Biology; Mesenchyme; Mesenchymal stem cell; Pathology; Carcinogenesis; Cancer research; In situ hybridization; Medicine; Cancer; Gene expression; Cell biology; Gene","score_opus":0.10298225467986849,"score_gpt":0.42305947689250556,"score_spread":0.32007722221263707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995175045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447477,0.001104845,0.0001068276,0.0020785597,0.00011846333,0.0009541476,0.000016841515,0.000019823714,0.0011257046],"genre_scores_gemma":[0.9982797,0.000081929524,0.00006920385,0.000098004304,0.00016629831,0.00015126185,0.0000034180175,0.00003193393,0.001118285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99625975,0.00027456728,0.0005346272,0.00037603872,0.0017646564,0.00079037255],"domain_scores_gemma":[0.99797946,0.00030612008,0.00008161911,0.0008135736,0.0006421138,0.00017709153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048034117,0.00011087025,0.0002522135,0.0005653209,0.0001490716,0.000028282822,0.00053009624,0.00007480166,0.00023211389],"category_scores_gemma":[0.00052552676,0.000082771425,0.00011230392,0.0024591642,0.00048554508,0.00007986882,0.00028201792,0.0004250969,0.00004943149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021198048,0.00014909635,0.10636436,0.0000963609,0.00002325408,0.000020230606,0.0003562841,0.000009990103,0.88766474,0.00043359268,0.0011704937,0.0034996008],"study_design_scores_gemma":[0.00067657244,0.0000462152,0.39176026,0.00012817838,0.000006249782,0.000016463515,0.00018780789,0.000079193924,0.60664296,0.00010417215,0.00030013963,0.0000517536],"about_ca_topic_score_codex":0.0014733218,"about_ca_topic_score_gemma":0.0007582303,"teacher_disagreement_score":0.28539592,"about_ca_system_score_codex":0.0006890155,"about_ca_system_score_gemma":0.0006258513,"threshold_uncertainty_score":0.33753207},"labels":[],"label_agreement":null},{"id":"W1995322447","doi":"10.1158/0008-5472.can-05-3236","title":"von Hippel-Lindau Tumor Suppressor Protein Regulates the Assembly of Intercellular Junctions in Renal Cancer Cells through Hypoxia-Inducible Factor–Independent Mechanisms","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adherens junction; Clear cell renal cell carcinoma; Cell biology; Biology; Cancer cell; Intracellular; Hypoxia-inducible factors; Cell junction; Tumor suppressor gene; Cancer research; Cell; Suppressor; Cancer; Renal cell carcinoma; Pathology; Cadherin; Carcinogenesis; Medicine; Gene; Genetics","score_opus":0.03920151724532447,"score_gpt":0.3278826258301724,"score_spread":0.28868110858484797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995322447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821497,0.007676448,0.00065326656,0.00051144505,0.0010436213,0.0011338763,0.00020745261,0.0000140263355,0.00054488255],"genre_scores_gemma":[0.99012303,0.0007574041,0.00014108537,0.000060403203,0.0013428741,0.000859936,0.00004540117,0.000058983424,0.006610898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698424,0.00033779105,0.00046470686,0.0007101321,0.00072316953,0.0007799864],"domain_scores_gemma":[0.998533,0.000034495984,0.0001538926,0.00076422316,0.00042034802,0.000094011855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007526238,0.00026270692,0.00033475435,0.00015786446,0.00020236293,0.000071856884,0.00062376366,0.00023144345,0.00029565507],"category_scores_gemma":[0.00006258338,0.0002064073,0.00017031629,0.0004651522,0.00027825506,0.000023240096,0.00030632736,0.00057573325,0.000010420132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024572498,0.00013239485,0.000049832644,0.00006487386,0.000054518787,0.000003790114,0.00018450888,0.0005041557,0.9921172,0.0004833932,0.005475129,0.0006844798],"study_design_scores_gemma":[0.0008577106,0.00015216574,0.000815201,0.00011820536,0.000019206811,0.0000039137544,0.00023701203,0.000050816565,0.9353091,0.0009982808,0.06121884,0.00021951101],"about_ca_topic_score_codex":0.0120440405,"about_ca_topic_score_gemma":0.0070066946,"teacher_disagreement_score":0.05680806,"about_ca_system_score_codex":0.0001743835,"about_ca_system_score_gemma":0.000716501,"threshold_uncertainty_score":0.99453485},"labels":[],"label_agreement":null},{"id":"W1995344604","doi":"10.1158/1538-7445.am2014-1458","title":"Abstract 1458: The precursor miR-138/2, but not miR-138/1, targets p53 mRNA and contributes to the acquisition of melanoma metastatic phenotype: Are the miRNAs precursors important to direct mature miRNA to mRNA targets","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"microRNA; Biology; Melanoma; Cancer research; Phenotype; Context (archaeology); Metastasis; Cancer; Anoikis; Genetics; Gene","score_opus":0.019583112619774763,"score_gpt":0.3155866394336914,"score_spread":0.2960035268139167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995344604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96501654,0.013347716,0.00016866747,0.017636579,0.00024666914,0.0026079665,0.0007581958,0.000015217046,0.00020246995],"genre_scores_gemma":[0.9964396,0.00029401632,0.00020056296,0.0013109053,0.00036931183,0.0007467555,0.0000989221,0.0000557911,0.00048413564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968986,0.00054296904,0.00046979447,0.00068300706,0.0006933696,0.00071224134],"domain_scores_gemma":[0.9975202,0.00029182024,0.00022222965,0.0010014565,0.0006711266,0.00029317438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021499123,0.00031114422,0.00035210562,0.00012545289,0.00042244015,0.00014430513,0.00084232393,0.00015264215,0.00008770356],"category_scores_gemma":[0.000876855,0.00017927376,0.0001382653,0.00045491563,0.00024857177,0.00001523483,0.00039217775,0.00032605004,0.000033916556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012087933,0.00007932114,0.000868132,0.0001370056,0.00028313271,0.000003882969,0.00060693006,0.00032807427,0.9400946,0.00010716405,0.054064546,0.0022184078],"study_design_scores_gemma":[0.00058799755,0.00031932266,0.10716816,0.00019112202,0.0000884151,0.0000050910735,0.00038540654,0.000081060505,0.7520288,0.00024425954,0.13861197,0.0002883591],"about_ca_topic_score_codex":0.0004091642,"about_ca_topic_score_gemma":0.0010545906,"teacher_disagreement_score":0.18806577,"about_ca_system_score_codex":0.00011244827,"about_ca_system_score_gemma":0.00020125863,"threshold_uncertainty_score":0.73105717},"labels":[],"label_agreement":null},{"id":"W1995407080","doi":"10.1158/1538-7445.am10-22","title":"Abstract 22: Cyclin E amplification, a novel mechanism of resistance to trastuzumab in HER2 amplified breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Trastuzumab; Cancer research; Breast cancer; Biology; Cyclin-dependent kinase; Medicine; Cancer; Oncology; Molecular biology; Cell cycle; Internal medicine","score_opus":0.0666644245371635,"score_gpt":0.41886504942162406,"score_spread":0.3522006248844606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995407080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863596,0.00064676895,0.0015064032,0.008026312,0.00035551592,0.0014835312,0.0005088543,0.00006546903,0.0010475247],"genre_scores_gemma":[0.99448353,0.00017686772,0.0018572137,0.00030102322,0.00044069576,0.0012426354,0.000013073596,0.000085103784,0.0013998367],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967086,0.00004934668,0.0006004645,0.00073533657,0.0010717657,0.00083449465],"domain_scores_gemma":[0.99732894,0.00017196866,0.00014404596,0.0009013746,0.0010662072,0.0003874552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010460608,0.00025217002,0.0005286654,0.000566368,0.00011821261,0.000031136515,0.0004736572,0.00019167659,0.0018266954],"category_scores_gemma":[0.00019731914,0.00023944168,0.00007625419,0.0014560117,0.00032212536,0.0001645255,0.000091247144,0.0012262912,0.000039836938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023875826,0.0003436419,0.0028029478,0.0002893816,0.000060415587,0.000015314732,0.0009913512,0.000055425495,0.9705885,0.0050437483,0.00052353257,0.016898176],"study_design_scores_gemma":[0.005646467,0.0001711697,0.71887404,0.0016549242,0.000033744815,0.000055951237,0.0012449268,0.000028011425,0.24628897,0.004435396,0.02097319,0.00059324043],"about_ca_topic_score_codex":0.0037221112,"about_ca_topic_score_gemma":0.013557258,"teacher_disagreement_score":0.7242995,"about_ca_system_score_codex":0.00075405824,"about_ca_system_score_gemma":0.0012369673,"threshold_uncertainty_score":0.9990858},"labels":[],"label_agreement":null},{"id":"W1995552970","doi":"10.1158/0008-5472.can-14-1603","title":"<i>In Vivo</i> Radioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Bradykinin; Receptor; Chemistry; Cancer; Phosphoramidon; Cancer cell; Cancer research; Bradykinin receptor; In vitro; Pharmacology; Biochemistry; Internal medicine; Biology; Medicine; Endothelin receptor","score_opus":0.05406336981846076,"score_gpt":0.4020861486313985,"score_spread":0.34802277881293775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995552970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98810786,0.0037701954,0.000031422,0.0024879836,0.00016295303,0.00057360035,0.000029224291,0.00002847783,0.0048082895],"genre_scores_gemma":[0.9944577,0.00044931917,0.00010138188,0.0005021494,0.0003887901,0.00024131425,0.000010963615,0.000054172066,0.0037942103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973172,0.00023706713,0.0005108624,0.00049162115,0.00075281085,0.0006904368],"domain_scores_gemma":[0.99878925,0.00023081982,0.000099911966,0.00044349662,0.00024777045,0.00018873297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011154377,0.00018341652,0.00050690694,0.00053088245,0.00008603795,0.000027174787,0.0002507754,0.00011158205,0.0021429693],"category_scores_gemma":[0.0002155977,0.0001815988,0.000095355535,0.0009466937,0.00025442024,0.0001785799,0.000095749514,0.00047306568,0.000010653694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034928392,0.00019138545,0.13261476,0.0003439802,0.000034157398,0.000020231193,0.0014767218,0.0001565103,0.8318506,0.0016094769,0.028342782,0.0030101172],"study_design_scores_gemma":[0.006731701,0.00031031852,0.051052812,0.0023529811,0.000024258561,0.00000536655,0.00023375273,0.001928837,0.87916976,0.0009829818,0.056814216,0.0003929953],"about_ca_topic_score_codex":0.014985122,"about_ca_topic_score_gemma":0.0018926865,"teacher_disagreement_score":0.081561945,"about_ca_system_score_codex":0.00040421766,"about_ca_system_score_gemma":0.0004573549,"threshold_uncertainty_score":0.9987692},"labels":[],"label_agreement":null},{"id":"W1995600184","doi":"10.1158/0008-5472.sabcs10-p4-11-07","title":"Abstract P4-11-07: Quantitative Coronary Angiography Findings of Patients Who Received Previous Breast Radiotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Right coronary artery; Coronary arteries; Coronary angiogram; Percutaneous coronary intervention; Coronary angiography; Cardiology; Artery; Internal medicine; Radiation therapy; Angiography; Breast cancer; Coronary artery disease; Revascularization; Radiology; Cancer; Myocardial infarction","score_opus":0.0281192449033075,"score_gpt":0.3626299934424514,"score_spread":0.33451074853914387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995600184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945617,0.003665739,0.000007450319,0.0003074767,0.00019412627,0.00043093713,0.00047129265,0.000009662714,0.00035166478],"genre_scores_gemma":[0.9968422,0.0022451403,0.00026460818,0.000050675124,0.00015148945,0.00015503253,0.00011694312,0.000038419723,0.00013551181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984463,0.00008091179,0.00021218827,0.00044719642,0.00038582427,0.0004275725],"domain_scores_gemma":[0.99877644,0.000067711684,0.00008095104,0.00038773115,0.0005791228,0.000108037624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027872264,0.00018387262,0.00023884795,0.00015325099,0.00014565668,0.000019689036,0.00031058583,0.00014496439,0.00032487314],"category_scores_gemma":[0.000053339347,0.00016336323,0.000184245,0.00029489127,0.0005330382,0.000009903358,0.00010958055,0.00024588828,0.00000918587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010126954,0.0003043052,0.7428393,0.00006813703,0.0005211399,0.0000034639554,0.0003451344,0.0000061189553,0.23832932,0.000057863785,0.009506742,0.007005823],"study_design_scores_gemma":[0.0012772769,0.000283415,0.9499174,0.000055614877,0.000017550168,0.0000030825656,0.000066715285,0.0000011433985,0.041402742,0.000036646044,0.00677428,0.00016412925],"about_ca_topic_score_codex":0.0008090253,"about_ca_topic_score_gemma":0.0004967659,"teacher_disagreement_score":0.20707814,"about_ca_system_score_codex":0.000051813728,"about_ca_system_score_gemma":0.0001601416,"threshold_uncertainty_score":0.66617596},"labels":[],"label_agreement":null},{"id":"W1995622679","doi":"10.1158/1538-7445.am2014-544","title":"Abstract 544: Recurrent DICER1 hotspot mutations in endometrial cancer and their impact on microRNA biogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; microRNA; Ribonuclease III; Genetics; Sanger sequencing; Cancer research; Gene; RNA interference; RNA; Mutation","score_opus":0.04581538776648144,"score_gpt":0.3984626749987442,"score_spread":0.3526472872322628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995622679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901289,0.007306541,0.00021300573,0.00063215673,0.00025987678,0.00067120016,0.00030920183,0.000012196803,0.00046695903],"genre_scores_gemma":[0.99188364,0.0066110417,0.000028287635,0.00007764484,0.0005554646,0.00050697924,0.00009629787,0.00005993174,0.00018074668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736947,0.00031013807,0.0002781693,0.0007353744,0.0004961035,0.0008107712],"domain_scores_gemma":[0.99867606,0.00018910278,0.00006574759,0.0004956541,0.00028536937,0.0002880686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012694751,0.00026563447,0.000274563,0.0006628813,0.0001863201,0.00009568074,0.0003785007,0.00025417018,0.0002577195],"category_scores_gemma":[0.0004690113,0.00021145902,0.0001392078,0.00086362165,0.0002366872,0.00000819401,0.00021569566,0.0005951276,0.000022167247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009908268,0.000093284776,0.00034853004,0.00003992522,0.00009676471,0.0000050847057,0.00009555435,0.0005007594,0.9137314,0.000032377273,0.0014365275,0.08262898],"study_design_scores_gemma":[0.002412462,0.0008885064,0.011020745,0.00015515753,0.000009420002,0.0000054256902,0.000095918054,0.00018172458,0.96348554,0.00016869458,0.021249242,0.00032714583],"about_ca_topic_score_codex":0.00322199,"about_ca_topic_score_gemma":0.0018676752,"teacher_disagreement_score":0.08230184,"about_ca_system_score_codex":0.0003738168,"about_ca_system_score_gemma":0.0006141118,"threshold_uncertainty_score":0.86230487},"labels":[],"label_agreement":null},{"id":"W1995922001","doi":"10.1158/1538-7445.am2013-86","title":"Abstract 86: Prolactin and testosterone induction of carboxypeptidase-D to promote cell survival is greater in prostate cancer cells than benign prostate cells, and their synergistic action in prostate cancer cells is effectively blocked by receptor antagonists Δ1-9-G129R and flutamide.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"LNCaP; Prostate cancer; Prostate; Endocrinology; Androgen receptor; Prolactin; Downregulation and upregulation; Cancer research; Internal medicine; PCA3; Testosterone (patch); Receptor; Cell culture; Chemistry; Biology; Medicine; Cancer; Hormone; Biochemistry","score_opus":0.03749523915747602,"score_gpt":0.3347341387463266,"score_spread":0.29723889958885064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995922001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98257524,0.0043500606,6.206509e-7,0.0026456795,0.0002575147,0.008823392,0.0012496363,0.00004053146,0.00005735587],"genre_scores_gemma":[0.97595567,0.016398177,0.000057636527,0.000075028336,0.00012683992,0.0039183074,0.000050625662,0.00014167825,0.0032760452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99494416,0.0003998882,0.0007425811,0.0015099655,0.00092969293,0.0014737217],"domain_scores_gemma":[0.9977354,0.00021152494,0.00025160456,0.00046250646,0.00068318855,0.0006558091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012177187,0.0006592567,0.0009776925,0.0008294953,0.00024215154,0.0002186586,0.00018898233,0.00026130467,0.00022594078],"category_scores_gemma":[0.00003699096,0.0005106628,0.000064595384,0.0011005423,0.0006477566,0.00050470734,0.00026158828,0.0012430006,0.000017175074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041805324,0.0003541631,0.06163293,0.0026302403,0.00012117607,0.000035962094,0.012014431,0.000015452688,0.89671504,2.2395852e-7,0.0019919379,0.020307908],"study_design_scores_gemma":[0.005407889,0.0013195808,0.07380425,0.0015017602,0.000043824202,0.0000045825445,0.0014780265,0.00017665123,0.9149494,0.000030367573,0.00081010733,0.0004735479],"about_ca_topic_score_codex":0.034240324,"about_ca_topic_score_gemma":0.0021565924,"teacher_disagreement_score":0.032083735,"about_ca_system_score_codex":0.0012549468,"about_ca_system_score_gemma":0.0007973226,"threshold_uncertainty_score":0.9997345},"labels":[],"label_agreement":null},{"id":"W1995944333","doi":"10.1158/1538-7445.am10-686","title":"Abstract 686: Potentiation of the cytocidal effect of streptozotocin on carcinoid neuroendocrine cells by a pharmacological inhibitor of poly(ADP-ribose) polymerase","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Poly ADP ribose polymerase; Streptozotocin; PARP inhibitor; Chemotherapy; Pharmacology; Medicine; Cancer; Cancer research; Polymerase; Internal medicine; Chemistry; Diabetes mellitus; Endocrinology; Enzyme; Biochemistry","score_opus":0.0315083783498445,"score_gpt":0.4015214390341645,"score_spread":0.37001306068432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995944333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994211,0.00052114343,0.0000022991685,0.0022875227,0.00057084224,0.0015848309,0.00036273984,0.000017886845,0.00044170266],"genre_scores_gemma":[0.99861574,0.00012998095,0.000009534168,0.00014464498,0.00045711914,0.0002543351,0.00001532235,0.00003390253,0.00033941187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701315,0.00036584103,0.0005246725,0.0003684978,0.0012865498,0.00044129186],"domain_scores_gemma":[0.9981838,0.0004803932,0.00028461055,0.0005116127,0.00036067405,0.00017890178],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006886773,0.00019576584,0.0004654972,0.00020867774,0.00008797348,0.000008391537,0.0003095639,0.000096232565,0.0015923566],"category_scores_gemma":[0.00017777133,0.00013171672,0.0002247342,0.000557248,0.00074355275,0.000060242637,0.0000944988,0.0011440822,0.000007568629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030160674,0.00034089608,0.008448745,0.0003321968,0.000075949,0.000013536099,0.0000670415,0.0000124057615,0.9693599,0.000016756796,0.014274465,0.004042051],"study_design_scores_gemma":[0.0042295153,0.0015356346,0.020569276,0.00018342894,0.000049528422,0.000008239593,0.000022596654,0.00001917366,0.97261524,0.000012825543,0.0006687021,0.00008583685],"about_ca_topic_score_codex":0.0008306457,"about_ca_topic_score_gemma":0.000022979619,"teacher_disagreement_score":0.013605763,"about_ca_system_score_codex":0.00014993384,"about_ca_system_score_gemma":0.00039324362,"threshold_uncertainty_score":0.9993203},"labels":[],"label_agreement":null},{"id":"W1996070083","doi":"10.1158/0008-5472.can-12-2102","title":"The FGFR4-G388R Single-Nucleotide Polymorphism Alters Pancreatic Neuroendocrine Tumor Progression and Response to mTOR Inhibition Therapy","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Everolimus; Neuroendocrine tumors; Medicine; Cancer research; Tumor progression; Genotype; Metastasis; PI3K/AKT/mTOR pathway; Pancreatic cancer; Internal medicine; Fibroblast growth factor receptor 4; Oncology; Cancer; Biology; Genetics; Apoptosis; Receptor; Gene; Fibroblast growth factor","score_opus":0.04592735063216059,"score_gpt":0.3700794912431898,"score_spread":0.3241521406110292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996070083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895019,0.005208401,0.00000983433,0.0040869727,0.0001676268,0.0008889764,0.00001621713,0.000019550278,0.00010050144],"genre_scores_gemma":[0.9967003,0.0009116955,0.000050668543,0.00025914283,0.000582678,0.0004440536,0.000012907991,0.000062351006,0.00097619294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966771,0.00093791,0.0002053103,0.00043466903,0.0006591936,0.0010858292],"domain_scores_gemma":[0.9985254,0.00024292283,0.000044695014,0.00052958773,0.00020692823,0.0004505122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013829651,0.00018545397,0.0001403906,0.00015637442,0.0004900943,0.00014352557,0.0002768799,0.00003848937,0.000035294936],"category_scores_gemma":[0.0006111736,0.0001315033,0.000051563085,0.0003516688,0.00039841238,0.000019835374,0.0004302759,0.00034129954,0.000037831363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004420539,0.00007307837,0.0055988375,0.000021559908,0.000023534936,0.00001597901,0.00011109968,0.0000010887644,0.97623235,0.000015213415,0.0048243934,0.008662326],"study_design_scores_gemma":[0.00070195127,0.0012665893,0.027890446,0.00007815248,0.000002959701,0.000045704855,0.000111524925,0.000005167013,0.8879222,0.000016525872,0.08179421,0.00016451906],"about_ca_topic_score_codex":0.000096908094,"about_ca_topic_score_gemma":0.000026269689,"teacher_disagreement_score":0.0883101,"about_ca_system_score_codex":0.00012713559,"about_ca_system_score_gemma":0.00018585284,"threshold_uncertainty_score":0.5362549},"labels":[],"label_agreement":null},{"id":"W1996090192","doi":"10.1158/1538-7445.am2011-51","title":"Abstract 51: International Cancer Genome Consortium Data Portal – A ‘one-stop-shop’ for genomic, transcriptomic, and epigenomic data","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Epigenomics; Computational biology; Biology; Genomics; Genome browser; Computer science; Ensembl; DNA methylation; Genetics; Gene; Gene expression","score_opus":0.2504550396893763,"score_gpt":0.4148055704400979,"score_spread":0.1643505307507216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996090192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95787597,0.01878746,0.0005925976,0.0007254367,0.0007860655,0.00091242575,0.01877422,0.000013989335,0.0015318624],"genre_scores_gemma":[0.96153486,0.030820146,0.0009986977,0.0002787073,0.001414469,0.00028312445,0.0040810676,0.00007765754,0.0005112828],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975917,0.000035026827,0.00036609883,0.0011550087,0.00024837645,0.0006038421],"domain_scores_gemma":[0.9976658,0.000057908695,0.000102660735,0.0016715853,0.0002652304,0.00023679735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088438863,0.00021057871,0.00023882222,0.00011431235,0.00018881117,0.000099365425,0.002062621,0.00016895609,0.00063482794],"category_scores_gemma":[0.00013384303,0.00022998662,0.00005177383,0.000072101655,0.00032989267,0.000030023486,0.0013672736,0.00024664993,0.000012042626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000955293,0.00015383259,0.0035774182,0.00011025678,0.00047176713,0.000013481482,0.00030428273,0.000019376295,0.96796787,0.0003378079,0.015166739,0.010921853],"study_design_scores_gemma":[0.003387945,0.00029924032,0.038892984,0.000065590866,0.00014873546,0.00002120258,0.00048671474,0.00047024913,0.063997276,0.0005770312,0.890756,0.0008970189],"about_ca_topic_score_codex":0.002121567,"about_ca_topic_score_gemma":0.004346098,"teacher_disagreement_score":0.9039706,"about_ca_system_score_codex":0.000102001366,"about_ca_system_score_gemma":0.0009517509,"threshold_uncertainty_score":0.9378582},"labels":[],"label_agreement":null},{"id":"W1996092371","doi":"10.1158/1538-7445.chtme14-a79","title":"Abstract A79: Mouse models of breast cancer identify oncogene-associated stroma subtypes","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; McGill University","funders":"","keywords":"Stromal cell; Stroma; Biology; Breast cancer; Tumor microenvironment; Oncogene; Cancer research; Cancer; Tumor progression; Laser capture microdissection; Genetically modified mouse; Pathology; Gene; Transgene; Immunology; Genetics; Medicine; Immunohistochemistry; Gene expression; Cell cycle","score_opus":0.21223189881684112,"score_gpt":0.45772378315539886,"score_spread":0.24549188433855773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996092371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98754394,0.0060501336,0.000012059231,0.0013849459,0.00026128482,0.00047264423,0.00079918094,0.00004198607,0.0034338222],"genre_scores_gemma":[0.9908,0.0030388215,0.000048200392,0.00008161942,0.00033943148,0.00016331305,0.000035421264,0.00005782241,0.005435372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99700874,0.00010377319,0.00037994378,0.00041447656,0.001422065,0.0006710249],"domain_scores_gemma":[0.9971316,0.000069782174,0.00012929163,0.0004722185,0.0016556387,0.0005414844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012363801,0.00017661831,0.000488744,0.00027564142,0.00007991111,0.000037647504,0.00025418578,0.00014236505,0.001186053],"category_scores_gemma":[0.00009359338,0.00015427452,0.00014728805,0.0006829883,0.000230339,0.00017599466,0.00012365603,0.0005160691,0.00004000712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035048919,0.0011364443,0.034470234,0.0008710968,0.0011709722,0.00016259882,0.0018967093,0.0021352782,0.79856074,0.00025469993,0.11598584,0.039850466],"study_design_scores_gemma":[0.018175203,0.0011420813,0.19145131,0.0022494753,0.00068559306,0.000074988304,0.003517332,0.0007844368,0.7539579,0.0017106313,0.025068687,0.0011823167],"about_ca_topic_score_codex":0.029711785,"about_ca_topic_score_gemma":0.0035943456,"teacher_disagreement_score":0.15698108,"about_ca_system_score_codex":0.0010800527,"about_ca_system_score_gemma":0.002362548,"threshold_uncertainty_score":0.999727},"labels":[],"label_agreement":null},{"id":"W1996177607","doi":"10.1158/1538-7445.am2014-5281","title":"Abstract 5281: Role of SHP-2 tyrosine phosphatase in colorectal carcinogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer research; Matrigel; Carcinogenesis; Protein kinase B; Protein tyrosine phosphatase; Cell growth; KRAS; Biology; Gene silencing; Molecular biology; Signal transduction; Cell biology; Colorectal cancer; Cancer; Angiogenesis; Gene; Biochemistry","score_opus":0.02359063725312362,"score_gpt":0.33617505022108374,"score_spread":0.31258441296796013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996177607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94978076,0.04901404,0.000012620329,0.00009734135,0.00005337487,0.00031073584,0.00024496787,0.000006447529,0.00047972173],"genre_scores_gemma":[0.9983413,0.0008918167,0.00010174487,0.000035209276,0.00017495223,0.00020696218,0.00017180377,0.000028534772,0.000047654994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984594,0.00011175923,0.00023664701,0.00039276844,0.00034128144,0.00045812907],"domain_scores_gemma":[0.9991683,0.000049070197,0.000057647325,0.00039742672,0.00021228082,0.0001152809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076975184,0.0001298713,0.00018712337,0.0001133505,0.00005825786,0.000017515871,0.00038397408,0.00012386093,0.00013641221],"category_scores_gemma":[0.0003518367,0.00012849322,0.000055825145,0.00031006703,0.00023176271,0.0000063332095,0.00023275353,0.00017683592,0.000017323355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039742538,0.00008219274,0.018091694,0.00005947463,0.000015824144,0.0000034544084,0.000023918095,0.00006996377,0.9668975,0.0009452383,0.0016995919,0.011713728],"study_design_scores_gemma":[0.00057153526,0.00021636857,0.04475181,0.00004335248,0.0000034128236,0.0000013517256,0.00003367199,0.000023298726,0.9447546,0.00019873271,0.009276275,0.00012559582],"about_ca_topic_score_codex":0.0026061467,"about_ca_topic_score_gemma":0.0007120418,"teacher_disagreement_score":0.048560567,"about_ca_system_score_codex":0.000056724486,"about_ca_system_score_gemma":0.00023696199,"threshold_uncertainty_score":0.52398014},"labels":[],"label_agreement":null},{"id":"W1996269302","doi":"10.1158/1538-7445.am2013-661","title":"Abstract 661: Identification of epigenomic markers on chromosome 11 that distinguish between choroid plexus carcinoma (CPC) and papilloma (CPP).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fetal and Pediatric Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Loss of heterozygosity; Biology; DNA methylation; Differentially methylated regions; Uniparental disomy; Genetics; Microdissection; Epigenomics; Cancer research; Methylation; SNP array; Genomic imprinting; Carcinogenesis; Single-nucleotide polymorphism; Molecular biology; Chromosome; Cancer; Allele; Karyotype; Gene; Gene expression; Genotype","score_opus":0.09196564603342995,"score_gpt":0.3588250065260941,"score_spread":0.2668593604926642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996269302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937314,0.0012848735,0.000001010291,0.0015172573,0.000091953065,0.0008420832,0.00007518727,0.000025636033,0.0024306064],"genre_scores_gemma":[0.99785644,0.0007577231,0.0000059324084,0.000089033725,0.0003125523,0.00014177003,0.000038155296,0.000024772431,0.0007736386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812967,0.00009775055,0.00032348867,0.00043341352,0.000564161,0.00045150754],"domain_scores_gemma":[0.99874485,0.00037421766,0.00010450603,0.00033355877,0.00018823044,0.00025466777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004926005,0.00014600335,0.00030091428,0.00017300938,0.00013060379,0.00004049053,0.0001834237,0.0001148882,0.0008602836],"category_scores_gemma":[0.00030729925,0.00011503749,0.000069868314,0.00027410474,0.0003074882,0.000077045006,0.000090119305,0.0004262408,0.000113197195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028410894,0.00011190786,0.89549327,0.00051303784,0.000045039244,0.000025785801,0.00016448386,0.0000026633923,0.07314106,0.000043588272,0.00817594,0.021999106],"study_design_scores_gemma":[0.00070750725,0.0003835221,0.9908555,0.000036161186,0.000023062345,0.0000025425154,0.00009764167,0.000014169829,0.006054909,0.0003617115,0.0013574306,0.000105829255],"about_ca_topic_score_codex":0.0033839557,"about_ca_topic_score_gemma":0.0000525412,"teacher_disagreement_score":0.09536224,"about_ca_system_score_codex":0.00009432944,"about_ca_system_score_gemma":0.00010297617,"threshold_uncertainty_score":0.9419502},"labels":[],"label_agreement":null},{"id":"W1996349796","doi":"10.1158/1538-7445.am10-3487","title":"Abstract 3487: Synergy with combined inhibition of upstream EGFR-HER2 and downstream RAF-MEK nodes in breast cancer cells with activating RAS and RAF mutations","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lapatinib; MAPK/ERK pathway; Cancer research; MEK inhibitor; Epidermal growth factor receptor; EGFR inhibitors; Kinase; Receptor tyrosine kinase; Chemistry; Cancer; Biology; Medicine; Breast cancer; Cell biology; Internal medicine; Trastuzumab","score_opus":0.019074516940063083,"score_gpt":0.340723013421331,"score_spread":0.3216484964812679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996349796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964581,0.0003666976,0.000029992252,0.002012685,0.00003695246,0.0006042578,0.00011898307,0.00003257352,0.0003397385],"genre_scores_gemma":[0.9982464,0.00038025,0.00063981605,0.000058908445,0.00011295486,0.00035899883,0.000020616955,0.00005733683,0.00012473192],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981899,0.000056980753,0.00026967743,0.00045744723,0.00054612383,0.00047982647],"domain_scores_gemma":[0.9986092,0.0002628041,0.00014065798,0.0002868012,0.00050356943,0.00019697697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003143197,0.00022625377,0.0003932591,0.000338084,0.0001500023,0.00004101853,0.000078747355,0.00010958407,0.00022545383],"category_scores_gemma":[0.000025450412,0.00016788195,0.000021909775,0.00063097535,0.0009704876,0.0003113055,0.000050798535,0.0008045113,0.0000011431422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004201743,0.0002357957,0.10847461,0.0004641913,0.00013871999,0.000052309773,0.0014942242,0.00034553275,0.828897,0.00009772819,0.000022207762,0.055575956],"study_design_scores_gemma":[0.009499429,0.0004491431,0.5214426,0.0022381577,0.000050421204,0.00013504257,0.0029251867,0.00011090432,0.46242633,0.00021259343,0.0001889692,0.00032118906],"about_ca_topic_score_codex":0.007454646,"about_ca_topic_score_gemma":0.004558092,"teacher_disagreement_score":0.412968,"about_ca_system_score_codex":0.00020840067,"about_ca_system_score_gemma":0.000610162,"threshold_uncertainty_score":0.9991548},"labels":[],"label_agreement":null},{"id":"W1996408347","doi":"10.1158/1538-7445.am2012-lb-169","title":"Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Jewish General Hospital","funders":"","keywords":"Metformin; Mitochondrial ROS; Cancer; DNA damage; Reactive oxygen species; Somatic cell; Cancer cell; Pharmacology; Cancer research; Medicine; Biology; Insulin; Internal medicine; Biochemistry; DNA; Gene","score_opus":0.04339413439020722,"score_gpt":0.38284795674700034,"score_spread":0.3394538223567931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996408347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8455299,0.15185164,0.00008314132,0.00019332826,0.001268998,0.00072685065,0.00004462412,0.000016489772,0.00028500945],"genre_scores_gemma":[0.9611529,0.02720696,0.00038500244,0.00011099823,0.0048174155,0.0016287105,0.00011024066,0.00005519259,0.0045325956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767536,0.00021758169,0.0003393147,0.0005363772,0.0004723546,0.00075903255],"domain_scores_gemma":[0.99891126,0.000033355187,0.00014049318,0.00030474062,0.00037033702,0.00023983672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010930503,0.00019108494,0.00020285502,0.00010043372,0.00024627402,0.000073803334,0.000221757,0.00014799362,0.00025398316],"category_scores_gemma":[0.00030669346,0.00018501563,0.00007915379,0.0003599893,0.00008763877,0.000056378303,0.00009228869,0.00026834148,0.000053545424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011857772,0.000074580974,0.00006989263,0.0001357113,0.000028630846,4.6078875e-7,0.00027583042,0.00013150802,0.8759233,0.000004318672,0.034431156,0.08880606],"study_design_scores_gemma":[0.00037875646,0.000076060554,0.00021077103,0.00011370303,0.00001755945,0.0000012360476,0.00028062734,0.000004602319,0.85930806,0.00005521071,0.13935411,0.0001993034],"about_ca_topic_score_codex":0.00019781555,"about_ca_topic_score_gemma":0.000121662866,"teacher_disagreement_score":0.12464468,"about_ca_system_score_codex":0.00016202715,"about_ca_system_score_gemma":0.00036391197,"threshold_uncertainty_score":0.75447184},"labels":[],"label_agreement":null},{"id":"W1996470451","doi":"10.1158/0008-5472.can-12-3902","title":"Notch3 Functions as a Tumor Suppressor by Controlling Cellular Senescence","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; School of Medicine, Stanford University; University of Toronto","keywords":"Senescence; Downregulation and upregulation; Notch signaling pathway; Cell biology; Biology; Suppressor; Cancer research; Carcinogenesis; Signal transduction; Cell; Cancer; Genetics; Gene","score_opus":0.019734025764531125,"score_gpt":0.32067238129837367,"score_spread":0.3009383555338425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996470451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946269,0.0020599798,0.00062489306,0.00086623133,0.00016372715,0.0003720997,0.000024550824,0.000011158589,0.0012504925],"genre_scores_gemma":[0.9875186,0.00012634163,0.00005419735,0.00022817536,0.00018870436,0.00036862787,0.00017682125,0.00001338339,0.011325166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890167,0.00011414957,0.00012467362,0.0003276956,0.00017269497,0.00035910195],"domain_scores_gemma":[0.9994222,0.000022171536,0.000026775277,0.00020721024,0.00021808292,0.000103585095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002610503,0.000093566996,0.0000872561,0.00004230433,0.00022127278,0.00003642132,0.00016543786,0.00010725548,0.00056550145],"category_scores_gemma":[0.00006567525,0.000084237734,0.000039106715,0.00012482872,0.00016628475,0.0000067143687,0.000096683005,0.00014457808,0.0003976915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058084268,0.000022436665,0.0016984186,0.000008464567,0.000027458242,0.0000012066341,0.000020671117,0.000012922825,0.96430135,0.00001219777,0.032479864,0.0013569216],"study_design_scores_gemma":[0.00034791816,0.00009865513,0.0011420537,0.000010544383,0.0000031723873,0.000004036456,0.00008187945,0.000039293805,0.9169077,0.00008520564,0.08117001,0.00010948303],"about_ca_topic_score_codex":0.00029553438,"about_ca_topic_score_gemma":0.000027272286,"teacher_disagreement_score":0.04869014,"about_ca_system_score_codex":0.000033680684,"about_ca_system_score_gemma":0.00015327266,"threshold_uncertainty_score":0.61918443},"labels":[],"label_agreement":null},{"id":"W1996471732","doi":"10.1158/1538-7445.am2014-4713","title":"Abstract 4713: High-throughput multiplex Sequenom MassARRAY clinical diagnostic assay for the identification of actionable genetic variants in hematologic malignancies","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"CEBPA; NPM1; Multiplex; Biology; Myeloid leukemia; Cancer research; Leukemia; Computational biology; Oncology; Medicine; Genetics; Gene; Mutation; Karyotype","score_opus":0.13507085675158792,"score_gpt":0.44778748288117304,"score_spread":0.3127166261295851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996471732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843019,0.0011343843,0.0050833514,0.006258787,0.00034918563,0.0025790604,0.00006775279,0.000031160354,0.00019438348],"genre_scores_gemma":[0.99367386,0.002015118,0.0011563482,0.00011864898,0.0004548738,0.0014334497,0.000031270934,0.000045213954,0.0010711856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996078,0.00061075663,0.0009904667,0.00059676514,0.0009545813,0.000769427],"domain_scores_gemma":[0.9849918,0.012829198,0.00021275082,0.0008753965,0.00092638994,0.00016450061],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009041486,0.00016628623,0.0004957527,0.0002780424,0.0002234104,0.000055845456,0.0005398648,0.0002558009,0.0003033761],"category_scores_gemma":[0.016419489,0.0001178195,0.00012907755,0.00065852696,0.00066990213,0.00011891529,0.00015369718,0.00091887993,0.00009624266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002199113,0.0009703744,0.21106172,0.0023202044,0.00041790353,0.00011192154,0.00060214143,0.0021013324,0.7211128,0.0041296254,0.02309969,0.031873174],"study_design_scores_gemma":[0.003597278,0.00039408868,0.93362916,0.00031767256,0.0000534264,0.000022829281,0.00036757145,0.006723337,0.04592003,0.0029398531,0.005849267,0.00018550294],"about_ca_topic_score_codex":0.0023691147,"about_ca_topic_score_gemma":0.00030578568,"teacher_disagreement_score":0.72256744,"about_ca_system_score_codex":0.000733531,"about_ca_system_score_gemma":0.0011627749,"threshold_uncertainty_score":0.99186563},"labels":[],"label_agreement":null},{"id":"W1996482349","doi":"10.1158/1538-7445.am10-5349","title":"Abstract 5349: Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type-I IFN production","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; P70-S6 Kinase 1; PI3K/AKT/mTOR pathway; Interferon; Cancer research; Cancer; mTORC1; Virology; Lactobacillus rhamnosus; Biology; Virus; Medicine; Cell biology; Signal transduction; Lactobacillus; Internal medicine","score_opus":0.029401459579153258,"score_gpt":0.3774638763532975,"score_spread":0.34806241677414423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996482349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548876,0.0021370116,0.000014698854,0.0007966747,0.00040035715,0.00054923876,0.00010589123,0.000036669,0.0004707057],"genre_scores_gemma":[0.9937124,0.0016074483,0.000034003733,0.00010654927,0.0007503488,0.00019838863,0.00013987008,0.000075303615,0.0033756637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698174,0.00020583221,0.00026425588,0.00077903,0.0009856549,0.00078346435],"domain_scores_gemma":[0.99801135,0.000019181485,0.00007086878,0.00090562203,0.00072803936,0.00026490923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015521271,0.00021155301,0.0001932024,0.00018793215,0.00034567446,0.00012495353,0.0005575115,0.00027711334,0.0014151719],"category_scores_gemma":[0.0002032859,0.00020895204,0.00010741932,0.0005149353,0.00023960591,0.000018014334,0.00022048228,0.0008386682,0.00018747197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070250535,0.00013099317,0.00044913552,0.00003902698,0.00014937163,0.000012141454,0.00007641142,0.000059460388,0.948615,0.0000014622725,0.03503433,0.01473012],"study_design_scores_gemma":[0.00046035188,0.00068200374,0.0012769279,0.000020789299,0.000010860232,0.000007776186,0.000051873296,0.00001854623,0.9692658,0.000030027359,0.02794463,0.0002303673],"about_ca_topic_score_codex":0.0012772083,"about_ca_topic_score_gemma":0.0035656057,"teacher_disagreement_score":0.020650802,"about_ca_system_score_codex":0.00015391265,"about_ca_system_score_gemma":0.0005714004,"threshold_uncertainty_score":0.99949765},"labels":[],"label_agreement":null},{"id":"W1996644155","doi":"10.1158/0008-5472.sabcs-09-2084","title":"Population-Based Comparison of CEF and AC/T, Two Adjuvant Chemotherapy 'Standards' for Early Stage Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer; Population; Stage (stratigraphy); Chemotherapy; Univariate analysis; Adjuvant; Paclitaxel; Multivariate analysis","score_opus":0.043008017395833285,"score_gpt":0.44863520628403514,"score_spread":0.4056271888882019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996644155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922616,0.006104069,0.00025009457,0.0019179131,0.00006261654,0.0005130981,0.0018332899,0.000010331438,0.0000824015],"genre_scores_gemma":[0.9982972,0.00065369107,0.0001924226,0.00013645527,0.00024666876,0.00021162549,0.00007961111,0.000023034534,0.00015927134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863756,0.000056564775,0.0001981322,0.0003714816,0.000372874,0.00036338242],"domain_scores_gemma":[0.9990099,0.000039714465,0.000079536854,0.00025738069,0.0005240708,0.00008941726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028146047,0.00015023694,0.00028099812,0.00006997402,0.00017371461,0.000024646917,0.00014504511,0.000073792464,0.00005783269],"category_scores_gemma":[0.000026268548,0.00013421525,0.000064382395,0.0001471111,0.00013785588,0.0000057457582,0.000033978322,0.0000998602,2.8095374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038846899,0.00027729044,0.7466224,0.00017787082,0.00023347647,0.0000011822895,0.00039800155,0.00046179432,0.13181871,0.00015319925,0.0053829625,0.11058845],"study_design_scores_gemma":[0.0045026843,0.00057323393,0.80578476,0.000120573946,0.00002764311,0.0000010131376,0.00012672052,0.00015471048,0.18082792,0.000119218785,0.0075320858,0.00022942535],"about_ca_topic_score_codex":0.0034070038,"about_ca_topic_score_gemma":0.0013420498,"teacher_disagreement_score":0.11035903,"about_ca_system_score_codex":0.00016883787,"about_ca_system_score_gemma":0.00036539388,"threshold_uncertainty_score":0.5473139},"labels":[],"label_agreement":null},{"id":"W1996677703","doi":"10.1158/1538-7445.am2014-lb-305","title":"Abstract LB-305: Identification of p21 as a novel substrate of LATS2 in lung cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Carcinogenesis; Lung cancer; Cancer research; Biology; Cell growth; Cancer; Hippo signaling pathway; Kinase; Cell cycle; Cell biology; Medicine; Genetics; Pathology","score_opus":0.054496756006157145,"score_gpt":0.43450207663041435,"score_spread":0.3800053206242572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996677703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967331,0.0013342294,0.00007900973,0.00020618332,0.00008458283,0.0003528829,0.00009667061,0.0000035859264,0.0011097512],"genre_scores_gemma":[0.99783736,0.0009091153,0.000020432492,0.000011972136,0.00012883541,0.00015349644,0.00004059806,0.000027323777,0.0008708678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794215,0.00012957628,0.0004142729,0.00040633796,0.0006408216,0.00046682562],"domain_scores_gemma":[0.9985062,0.000066693276,0.00012401328,0.0005214405,0.0006750916,0.00010656678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015387,0.00011456658,0.00020214813,0.00023682036,0.000039935694,0.000023546578,0.00047640793,0.00017724892,0.00027202634],"category_scores_gemma":[0.00039792506,0.00011273311,0.00006682807,0.00044908703,0.00027842313,0.000010283163,0.00015684789,0.00032694393,0.000010200395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018681932,0.00009887684,0.03687552,0.0002789728,0.00003609904,8.8032203e-7,0.000096175136,0.00021430741,0.95961815,0.00012665267,0.00062361173,0.0018439293],"study_design_scores_gemma":[0.00054728205,0.00008299021,0.12636292,0.00008750834,0.0000035425978,5.77838e-7,0.00007110378,0.00020527082,0.87124264,0.00006117029,0.001238327,0.00009668676],"about_ca_topic_score_codex":0.0059821904,"about_ca_topic_score_gemma":0.002559373,"teacher_disagreement_score":0.089487396,"about_ca_system_score_codex":0.00011387072,"about_ca_system_score_gemma":0.00068283384,"threshold_uncertainty_score":0.9043322},"labels":[],"label_agreement":null},{"id":"W1996797816","doi":"10.1158/1538-7445.am10-1317","title":"Abstract 1317: The 2-phenylbenzimidazole-5-sulfonic acid sunscreen agent photosensitizes oxidized guanines following UVA or UVB exposure","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Sherbrooke","funders":"","keywords":"Chemistry; Pyrimidine dimer; Guanine; DNA damage; DNA; Biochemistry; In vitro; Endonuclease; DNA glycosylase; Molecular biology; Nucleotide; Biology","score_opus":0.10205049011577179,"score_gpt":0.41862700713019474,"score_spread":0.31657651701442296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996797816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856863,0.0009170396,0.000015930751,0.0073737795,0.0010780711,0.001125292,0.00000879598,0.00014409998,0.0036507165],"genre_scores_gemma":[0.99323833,0.00026563247,0.0001711708,0.0005361269,0.0011955366,0.00035669483,0.000009231744,0.00006319973,0.0041641025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971338,0.00014842715,0.00034358658,0.0004818059,0.0010926473,0.00079975475],"domain_scores_gemma":[0.9981386,0.00042184835,0.000071967355,0.00074301596,0.00033774562,0.00028681126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018929973,0.00022758963,0.00034385535,0.00022118214,0.0006407686,0.00015317024,0.0003505257,0.00017238312,0.003215917],"category_scores_gemma":[0.000982049,0.00013571036,0.00022924364,0.00068625517,0.00023723011,0.00012703832,0.00015656944,0.0018517162,0.00015907027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078040035,0.00006219035,0.0012876752,0.00007249634,0.00013935952,0.00023111723,0.00063014025,0.0000035507105,0.9831836,0.000071484006,0.0041565155,0.009381468],"study_design_scores_gemma":[0.0043208576,0.00022266665,0.032687098,0.00045673826,0.000080338745,0.0001500405,0.0022046012,0.00007313619,0.8904111,0.00015459773,0.06890851,0.00033034405],"about_ca_topic_score_codex":0.0012545399,"about_ca_topic_score_gemma":0.0016696247,"teacher_disagreement_score":0.092772536,"about_ca_system_score_codex":0.00016036126,"about_ca_system_score_gemma":0.0006551577,"threshold_uncertainty_score":0.99769527},"labels":[],"label_agreement":null},{"id":"W1996982548","doi":"10.1158/0008-5472.can-07-0279","title":"Mainstream Tobacco Smoke Causes Paternal Germ-Line DNA Mutation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Canada","funders":"Canadian Institutes of Health Research","keywords":"Offspring; Biology; Genetics; Mutation; Mutation frequency; Tobacco smoke; Germline; Sidestream smoke; Mutagen; Sperm; Mutation rate; Cigarette smoke; Carcinogen; Andrology; Gene; Toxicology; Medicine; Pregnancy","score_opus":0.06716714224011391,"score_gpt":0.4164155214607808,"score_spread":0.34924837922066687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996982548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971869,0.00071631745,0.0005471144,0.00022703271,0.00015334364,0.00022305384,0.00005110132,0.000009305832,0.0008858417],"genre_scores_gemma":[0.9970081,0.0004571142,0.00008361166,0.00016860572,0.0007248257,0.000044763874,0.00008909421,0.0000208687,0.0014030572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855465,0.000059572318,0.00017288391,0.00032935044,0.0003934656,0.00049006834],"domain_scores_gemma":[0.99923116,0.000020751791,0.0000357463,0.00029443123,0.00027584864,0.00014208033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007905078,0.000105734725,0.000095680945,0.00009845057,0.00014402119,0.000045796765,0.00017763521,0.000113289265,0.0001489449],"category_scores_gemma":[0.00004395868,0.00009924367,0.00006217777,0.00017267698,0.00010899362,0.0000037788318,0.0001368868,0.00017205586,0.000015642057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001622847,0.0000646416,0.01758192,0.000017055072,0.000040989533,0.000046035537,0.00005376674,0.00005501843,0.95824283,0.000058881178,0.0011691327,0.022507425],"study_design_scores_gemma":[0.00042444706,0.00029955662,0.048924893,0.000015802236,0.000005632513,0.000013464379,0.0001793932,0.0000074047402,0.9315396,0.00005946468,0.018400645,0.00012967372],"about_ca_topic_score_codex":0.000975605,"about_ca_topic_score_gemma":0.0025850376,"teacher_disagreement_score":0.031342972,"about_ca_system_score_codex":0.000110170586,"about_ca_system_score_gemma":0.00022160319,"threshold_uncertainty_score":0.40470394},"labels":[],"label_agreement":null},{"id":"W1997002758","doi":"10.1158/0008-5472.sabcs10-s2-7","title":"Abstract S2-7: Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Number needed to treat; Breast cancer; Internal medicine; Odds ratio; Adverse effect; Oncology; Confidence interval; Gynecology; Cancer; Relative risk","score_opus":0.01679798544767068,"score_gpt":0.3554506913224492,"score_spread":0.3386527058747785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997002758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967759,0.001845357,2.2574228e-7,0.0002004061,0.00020536224,0.00033291444,0.0001297711,0.000004619478,0.0005054175],"genre_scores_gemma":[0.9963274,0.0031374663,0.000009950465,0.000041344018,0.00018749994,0.00010273227,0.00004097385,0.000022395485,0.00013023043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987692,0.00006708939,0.000179295,0.00028912126,0.00028975712,0.00040549686],"domain_scores_gemma":[0.99930257,0.000021085028,0.000047675483,0.00025728068,0.00026337232,0.00010804493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002746868,0.000117039934,0.00014687901,0.00009282551,0.000051696068,0.000011092423,0.00023880182,0.0001557895,0.00022325061],"category_scores_gemma":[0.000032719232,0.00009363349,0.000043456213,0.00018824599,0.00016797842,0.0000053095264,0.00009613401,0.000527061,0.000006807924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004480856,0.0002663109,0.070206136,0.000020120982,0.000036364247,0.0000060241514,0.000031800526,0.000010195558,0.9111529,0.000013995026,0.0005442938,0.017263802],"study_design_scores_gemma":[0.0010631356,0.00037297304,0.25550345,0.000025486679,0.0000018706288,0.0000028647012,0.0000090563835,0.0000032557812,0.7417503,0.000015582968,0.0011595724,0.000092416194],"about_ca_topic_score_codex":0.0013450569,"about_ca_topic_score_gemma":0.00043984156,"teacher_disagreement_score":0.18529733,"about_ca_system_score_codex":0.000033652745,"about_ca_system_score_gemma":0.00025441716,"threshold_uncertainty_score":0.3818263},"labels":[],"label_agreement":null},{"id":"W1997118617","doi":"10.1158/1538-7445.am2014-2945","title":"Abstract 2945: Characterization of a novel protein-coding gene named TIHL (Translocated in Hodgkin's Lymphoma)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Gene knockdown; CIITA; Cancer research; Leukemia; Haematopoiesis; Lymphoma; Gene expression; Cell culture; Progenitor cell; Molecular biology; Immune system; Gene; T cell; Stem cell; Cell biology; Immunology; Genetics","score_opus":0.05641619064323068,"score_gpt":0.338547494938527,"score_spread":0.2821313042952963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997118617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972299,0.00015040862,0.0011514755,0.00017217455,0.00004740382,0.000541833,0.000054195996,0.000008387191,0.00064422376],"genre_scores_gemma":[0.9987803,0.00014588544,0.00017555409,0.000038951966,0.00019798697,0.00028710425,0.00014382553,0.000026291313,0.00020406535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987187,0.00010336139,0.00022285337,0.00031961614,0.00027343392,0.0003620386],"domain_scores_gemma":[0.99935293,0.000014767878,0.00006739914,0.0002762737,0.0002111735,0.00007747042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089400314,0.000108279164,0.00014988068,0.00013096802,0.00006042211,0.000021435217,0.00024005177,0.00015621696,0.000059420036],"category_scores_gemma":[0.000120151475,0.00010803265,0.00004241701,0.00026474026,0.00011116858,0.000006399555,0.00006928572,0.00013210186,0.000005990387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018296648,0.000096991214,0.00038422746,0.00012506868,0.000013558655,0.0000012244047,0.000090284804,0.000010294317,0.985531,0.00008246966,0.0000129160335,0.013469003],"study_design_scores_gemma":[0.0010707846,0.00013401762,0.011460223,0.00011874003,0.0000016985,0.0000015680345,0.000013587998,0.00017065459,0.98340344,0.000022077977,0.0034846452,0.0001185587],"about_ca_topic_score_codex":0.00020953976,"about_ca_topic_score_gemma":0.00006864287,"teacher_disagreement_score":0.013350444,"about_ca_system_score_codex":0.00004618959,"about_ca_system_score_gemma":0.00023027435,"threshold_uncertainty_score":0.44054437},"labels":[],"label_agreement":null},{"id":"W1997299298","doi":"10.1158/0008-5472.can-03-3196","title":"Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Pathology; Tumor hypoxia; Lymph; Hypoxia (environmental); Primary tumor; Metastasis; Lymph node; In vivo; Cervical lymph nodes; Lung; Cancer research; Internal medicine; Cancer; Biology; Chemistry; Radiation therapy","score_opus":0.05150245850528798,"score_gpt":0.36867888608342214,"score_spread":0.31717642757813413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997299298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950053,0.0037212272,0.00012235127,0.00012381167,0.00017006812,0.00027860608,0.0001177653,0.000008782228,0.00045206127],"genre_scores_gemma":[0.99599147,0.0019650313,0.0004347118,0.00008984592,0.0006064367,0.00016778782,0.00007000656,0.00003551475,0.00063920405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798,0.00012484656,0.00031425347,0.000561171,0.0004354743,0.0005842501],"domain_scores_gemma":[0.99889416,0.000009907505,0.000058183785,0.0005946263,0.00025198315,0.00019114811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003918797,0.00018386339,0.00032560134,0.00018527047,0.00010554156,0.000024902767,0.0004684276,0.00016506929,0.00007465085],"category_scores_gemma":[0.000026687085,0.00017755767,0.00010673545,0.00028215064,0.00024120868,0.0000123113,0.00019905984,0.0002308589,0.0000037385357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002912987,0.00015474015,0.0007440166,0.00006635143,0.000050240982,0.000041413823,0.00023913782,0.0021229172,0.9941886,0.00023623565,0.000056717454,0.0018083005],"study_design_scores_gemma":[0.0023024306,0.00032383433,0.0077808066,0.00004302801,0.000042779186,0.000051910643,0.00015798735,0.00015654632,0.9863739,0.0006953388,0.0017708539,0.00030055814],"about_ca_topic_score_codex":0.0019511845,"about_ca_topic_score_gemma":0.004701142,"teacher_disagreement_score":0.0078147035,"about_ca_system_score_codex":0.00012267286,"about_ca_system_score_gemma":0.0006575427,"threshold_uncertainty_score":0.72405916},"labels":[],"label_agreement":null},{"id":"W1997352005","doi":"10.1158/1538-7445.am10-4574","title":"Abstract 4574: Mining the proteome of breast cancer cell lines and nipple aspirate fluid in the quest for novel breast cancer biomarkers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Cancer; Internal medicine; Oncology; Proteome; Cancer biomarkers; Medicine; Cancer research; Chemistry; Pathology; Bioinformatics; Biology","score_opus":0.05292104279474864,"score_gpt":0.39501155990360337,"score_spread":0.34209051710885474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997352005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862629,0.0010313308,0.00013556493,0.007615079,0.000044331744,0.0013628716,0.0025772694,0.000030657095,0.00094000134],"genre_scores_gemma":[0.98683476,0.0011944304,0.0014086497,0.000094786774,0.00042110067,0.009689953,0.000015270394,0.00004644874,0.00029457666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848914,0.000019324463,0.0003041911,0.00039945464,0.00031322028,0.00047464442],"domain_scores_gemma":[0.9986117,0.0002680654,0.00014256818,0.00052239106,0.00037872777,0.00007653382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008543418,0.00017280101,0.00018601227,0.000054894594,0.00029583857,0.000073545205,0.0006457796,0.0001454561,0.00046117953],"category_scores_gemma":[0.000029200406,0.00011142646,0.00005621041,0.00032167372,0.00042699339,0.00012567542,0.00012624796,0.0005903007,7.185249e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015068409,0.00008061681,0.0035985075,0.00029713896,0.000019965579,5.351669e-7,0.0002855899,0.000028112772,0.9862047,0.0001990523,0.0010373272,0.008097783],"study_design_scores_gemma":[0.0010872949,0.000027147447,0.015320251,0.0003825519,0.000024287117,0.00002547492,0.0010390108,0.0006923052,0.9649561,0.0006796033,0.015421034,0.00034492716],"about_ca_topic_score_codex":0.011629586,"about_ca_topic_score_gemma":0.0071772155,"teacher_disagreement_score":0.021248575,"about_ca_system_score_codex":0.00012766042,"about_ca_system_score_gemma":0.00036165037,"threshold_uncertainty_score":0.9949521},"labels":[],"label_agreement":null},{"id":"W1997353298","doi":"10.1158/0008-5472.can-06-1593","title":"Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Dihydrotestosterone; Androgen receptor; Androgen; Catabolism; Endocrinology; Internal medicine; Prostate cancer; Biology; Receptor; Prostate; Downregulation and upregulation; Cancer; Cancer research; Metabolism; Medicine; Biochemistry; Hormone","score_opus":0.04372021552373926,"score_gpt":0.4234314886908429,"score_spread":0.3797112731671036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997353298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97721666,0.01846442,0.0000024224873,0.0015040154,0.000116670526,0.0019863665,0.00024633977,0.000035979137,0.00042709694],"genre_scores_gemma":[0.9950895,0.0015658825,0.00014092692,0.000029272296,0.00032265304,0.0005815065,0.00008277195,0.00007925435,0.0021082596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954814,0.00023700442,0.0008123488,0.0006356281,0.0015306053,0.0013030259],"domain_scores_gemma":[0.99721605,0.0003512672,0.00012708292,0.00056534255,0.0011907486,0.00054949964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022084867,0.00026496607,0.0007549416,0.0007715233,0.00016830555,0.00002603959,0.00033842563,0.00022699364,0.000997604],"category_scores_gemma":[0.0003995732,0.00023122803,0.00012588034,0.0014296897,0.0010204635,0.00018201304,0.00021466531,0.0007842579,0.000016487931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047147926,0.00055043,0.059551917,0.00091097725,0.00013088257,0.00004274087,0.0038370169,0.00001718876,0.9199922,0.00022991165,0.0008301751,0.009191755],"study_design_scores_gemma":[0.004062789,0.0012683203,0.010096889,0.0016503592,0.00003946736,0.0000065464665,0.0010677148,0.000029205265,0.97787255,0.0004089019,0.0032872579,0.00021002139],"about_ca_topic_score_codex":0.009430806,"about_ca_topic_score_gemma":0.0004056443,"teacher_disagreement_score":0.057880312,"about_ca_system_score_codex":0.00091332436,"about_ca_system_score_gemma":0.0019554272,"threshold_uncertainty_score":0.9999156},"labels":[],"label_agreement":null},{"id":"W1997473252","doi":"10.1158/1538-7445.am2012-3583","title":"Abstract 3583: Elevated inflammatory and hematological markers and survival in patients with renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Renal cell carcinoma; Proportional hazards model; Gastroenterology; Confidence interval; Cancer; Hematocrit; White blood cell; Kidney cancer; Nephrectomy; Oncology; Urology; Kidney","score_opus":0.0345360417216188,"score_gpt":0.31983632756561003,"score_spread":0.28530028584399125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997473252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960713,0.0016638946,3.3798318e-7,0.00013093255,0.000055284996,0.00076232955,0.000014453167,0.000025585845,0.0012758774],"genre_scores_gemma":[0.99953383,0.0000846533,0.0000719771,0.000033856577,0.000073270356,0.000103081584,0.000015361707,0.000029809748,0.000054137225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977975,0.00018206691,0.00025098855,0.0003393615,0.0006988524,0.0007312333],"domain_scores_gemma":[0.9988141,0.00017817176,0.000051753705,0.00024609067,0.00022165192,0.00048823198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011028567,0.00017491811,0.00027655732,0.00026141695,0.00010627705,0.000029658191,0.00009115121,0.00014901912,0.0002383635],"category_scores_gemma":[0.00011855636,0.00013371809,0.000025035455,0.000292656,0.00048652635,0.00016936162,0.0001412094,0.0005042264,0.000010622433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033112648,0.00018931796,0.99160993,0.00050283055,0.00003407324,0.00007716498,0.00016187376,1.9071983e-7,0.0023478305,0.00002396769,0.0005069601,0.0012346113],"study_design_scores_gemma":[0.0034113529,0.00016473627,0.9912542,0.00016117145,0.000021592288,0.0000046553923,0.0001713058,0.0000066916778,0.004230703,0.00000963252,0.0004084312,0.00015554643],"about_ca_topic_score_codex":0.00007155636,"about_ca_topic_score_gemma":0.000015779917,"teacher_disagreement_score":0.0034625486,"about_ca_system_score_codex":0.00020026877,"about_ca_system_score_gemma":0.00020859546,"threshold_uncertainty_score":0.54528654},"labels":[],"label_agreement":null},{"id":"W1997514418","doi":"10.1158/1538-7445.am2013-1376","title":"Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proinflammatory cytokine; Hepatocyte growth factor; Breast cancer; Tumor necrosis factor alpha; Cancer; Medicine; Cancer research; Growth factor; Internal medicine; Vascular endothelial growth factor; Immunology; Endocrinology; Receptor; Inflammation","score_opus":0.0328371144040845,"score_gpt":0.33386092585553495,"score_spread":0.30102381145145046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997514418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852628,0.010444857,0.000009496224,0.0012505936,0.0010579248,0.00095878687,0.00024361514,0.000025333024,0.00074658816],"genre_scores_gemma":[0.978283,0.016531935,0.000048358663,0.00007844538,0.0024169856,0.001516185,0.000049157577,0.000063871485,0.0010120953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774957,0.000061413426,0.00031326877,0.00066288444,0.00041008898,0.00080277433],"domain_scores_gemma":[0.99866104,0.000019543262,0.00008347791,0.00049021444,0.000510877,0.00023486474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022065772,0.00025041017,0.00028404253,0.0001279524,0.00020298963,0.000094964154,0.00038924016,0.00019889804,0.00086393347],"category_scores_gemma":[0.00006639941,0.00023131804,0.00010694691,0.00035312318,0.0003428244,0.00004386002,0.00017955503,0.00046261333,0.00006558366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021434689,0.000086531974,0.0022870135,0.00012422651,0.00005194709,0.0000024013154,0.00048133612,0.000019025169,0.9686195,0.000017627199,0.018722733,0.009373301],"study_design_scores_gemma":[0.0016428512,0.00007874798,0.40585655,0.0002807713,0.000026049833,0.000010691044,0.00060486497,0.000007895265,0.56005186,0.00028464742,0.030538278,0.0006168228],"about_ca_topic_score_codex":0.010590652,"about_ca_topic_score_gemma":0.0016980696,"teacher_disagreement_score":0.40856767,"about_ca_system_score_codex":0.0001762665,"about_ca_system_score_gemma":0.00082522136,"threshold_uncertainty_score":0.9959979},"labels":[],"label_agreement":null},{"id":"W1997563278","doi":"10.1158/1538-7445.am2011-3836","title":"Abstract 3836: Identification of PTPsigma as an autophagic phosphatase","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Autophagy; Phosphatase; Phosphatidylinositol; Cell biology; Lysosome; Kinase; Protein tyrosine phosphatase; Vesicle; Biology; Chemistry; Biochemistry; Phosphorylation; Enzyme; Membrane; Apoptosis","score_opus":0.14615071680931138,"score_gpt":0.45624520722056755,"score_spread":0.31009449041125614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997563278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003106,0.004432021,0.000010211823,0.000113837326,0.00011489197,0.00039396845,0.000045637564,0.000040820723,0.004817551],"genre_scores_gemma":[0.9974112,0.000738627,0.000035807363,0.00010278701,0.00013575795,0.00011275246,0.00004501121,0.00002368454,0.0013943898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985384,0.000061864346,0.00026684627,0.00027584084,0.0005640293,0.0002930384],"domain_scores_gemma":[0.9986976,0.00003605141,0.00007192164,0.00060202513,0.00034580857,0.00024660298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007161425,0.00008696397,0.00016573667,0.00016630442,0.00008316979,0.000013500609,0.00021832877,0.0000761836,0.0069800653],"category_scores_gemma":[0.00007987515,0.00007589305,0.00006097351,0.0003131242,0.00022053237,0.00016755919,0.00003064423,0.00024996675,0.00032695534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046176324,0.0028982074,0.010441357,0.0008027469,0.00041480522,0.0006244017,0.0059710443,0.0000042335373,0.81268954,0.020028366,0.0067454805,0.13476221],"study_design_scores_gemma":[0.00078389124,0.0002462856,0.21427178,0.00006730485,0.000021902677,0.000004627186,0.00021660376,0.000023324023,0.7797023,0.0034141038,0.0011786383,0.00006925225],"about_ca_topic_score_codex":0.0012444102,"about_ca_topic_score_gemma":0.000011652755,"teacher_disagreement_score":0.20383042,"about_ca_system_score_codex":0.000086424,"about_ca_system_score_gemma":0.00044174684,"threshold_uncertainty_score":0.9939277},"labels":[],"label_agreement":null},{"id":"W1997833227","doi":"10.1158/1538-7445.am10-2559","title":"Abstract 2559: Development of carboplatin, docetaxel and combined carboplatin/docetaxel resistant ovarian cancer cell lines","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sudbury Regional Hospital; University of Sudbury; Laurentian University","funders":"","keywords":"Carboplatin; Docetaxel; Ovarian cancer; Drug resistance; Chemotherapy; Clonogenic assay; Medicine; Pharmacology; Paclitaxel; IC50; Cancer research; Cell culture; Cancer; Oncology; Internal medicine; Biology; Cisplatin; Microbiology; Genetics","score_opus":0.02646286224492996,"score_gpt":0.37610229796491584,"score_spread":0.3496394357199859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997833227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922714,0.005131332,0.000076149445,0.00012860152,0.00024775567,0.00027395447,0.000050950755,0.00001077457,0.001809051],"genre_scores_gemma":[0.9962988,0.0009799489,0.0015098894,0.000017948692,0.00028263332,0.00012601983,0.00003044609,0.000037861668,0.0007164453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984137,0.000028885413,0.00033539138,0.00042305267,0.00035093317,0.00044807966],"domain_scores_gemma":[0.99899644,0.000037159716,0.0000721456,0.0003893297,0.00032217204,0.00018277117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005216084,0.00018679138,0.00021822508,0.000073962874,0.00014663672,0.000034184814,0.00024452104,0.00018998873,0.00014513903],"category_scores_gemma":[0.000076557546,0.00017652725,0.00004710514,0.00015080126,0.00015286254,0.0000055165633,0.00019107618,0.00035735324,0.0000018411331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014769693,0.00004296836,0.0012330959,0.0002136942,0.000050924118,0.0000031060993,0.00030183635,0.00009987252,0.99271286,0.00002725365,0.0005239227,0.004642785],"study_design_scores_gemma":[0.00083241286,0.00008072004,0.039301068,0.000052363746,0.000011327768,0.0000015530437,0.00013790482,0.0000814294,0.9470921,0.000018877743,0.012171115,0.00021908568],"about_ca_topic_score_codex":0.0013281872,"about_ca_topic_score_gemma":0.0059673158,"teacher_disagreement_score":0.045620702,"about_ca_system_score_codex":0.000035960333,"about_ca_system_score_gemma":0.000526923,"threshold_uncertainty_score":0.7198572},"labels":[],"label_agreement":null},{"id":"W1997909013","doi":"10.1158/1538-7445.am2011-409","title":"Abstract 409: The influence of chronic low grade systemic inflammation on the progression of epithelial ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Ovarian cancer; Inflammation; Proinflammatory cytokine; Stromal cell; Tumor microenvironment; Cancer research; Carcinogenesis; Cancer; Tumor necrosis factor alpha; Medicine; Immunology; Biology; Immune system; Internal medicine","score_opus":0.05675387173483287,"score_gpt":0.3572814081907657,"score_spread":0.30052753645593283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997909013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880652,0.008995913,0.0000032868877,0.0004986656,0.00059152965,0.001001831,0.00004748662,0.00001651678,0.00077960186],"genre_scores_gemma":[0.99701166,0.0017524658,0.0000029129521,0.000022620152,0.000121336634,0.00066923245,0.0000052110445,0.000022372866,0.00039218794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980433,0.0005550865,0.00044191902,0.00026012643,0.00022860385,0.00047096048],"domain_scores_gemma":[0.998078,0.00044605535,0.0003103005,0.00071595004,0.0004330981,0.000016617058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016332507,0.00014932097,0.00023660374,0.00012376872,0.00027689702,0.000009659407,0.0008991014,0.0002127932,0.0016186675],"category_scores_gemma":[0.00014969532,0.00008116498,0.00007766761,0.0003619119,0.0012324939,0.00008863567,0.00016663625,0.0008849443,0.000115837516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043518076,0.00006196768,0.00084896054,0.00031098953,0.0001239175,0.0000016000657,0.0023841928,0.00032103583,0.98052096,0.001628751,0.0006737554,0.012688676],"study_design_scores_gemma":[0.00059039064,0.00020365653,0.030602058,0.001467213,0.000016182625,0.000005109753,0.00024670264,0.0000051478146,0.96434474,0.00017103595,0.0022548353,0.00009294655],"about_ca_topic_score_codex":0.0031093343,"about_ca_topic_score_gemma":0.0002217156,"teacher_disagreement_score":0.029753098,"about_ca_system_score_codex":0.00026832134,"about_ca_system_score_gemma":0.00077606214,"threshold_uncertainty_score":0.999294},"labels":[],"label_agreement":null},{"id":"W1998082963","doi":"10.1158/1538-7445.am2014-1184","title":"Abstract 1184: Modeling mechanisms of resistance of epidermal growth factor receptor (EGFR) mutations to targeted drugs through patient-derived xenografts (PDX) of non-small cell lung cancer (NSCLC)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Erlotinib; Medicine; Gefitinib; Epidermal growth factor receptor; Cetuximab; EGFR inhibitors; Lung cancer; Cancer research; Population; Oncology; Targeted therapy; Cancer; Erlotinib Hydrochloride; Internal medicine","score_opus":0.0393501112748828,"score_gpt":0.3739480744670184,"score_spread":0.3345979631921356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998082963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98371285,0.0015158479,0.009131728,0.000870673,0.0002764685,0.0017342444,0.0007651925,0.000028398552,0.0019645975],"genre_scores_gemma":[0.9899211,0.00042583465,0.00837572,0.00009143728,0.0001225072,0.00060216925,0.000086690474,0.0000674715,0.0003070821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707013,0.00012872764,0.0007814818,0.0005021363,0.0009161954,0.00060133246],"domain_scores_gemma":[0.9967334,0.0002657283,0.00030570794,0.0004894448,0.0019401618,0.0002655173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032400867,0.0002486589,0.00063455215,0.00033588882,0.00016609112,0.000014561537,0.00025210992,0.00013194609,0.00041550642],"category_scores_gemma":[0.00017404479,0.00022049512,0.0001748551,0.0008086265,0.00015999154,0.00016803078,0.000088402885,0.00032694623,0.0000066091843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072427175,0.0004247027,0.0012409074,0.0020353075,0.00038062394,0.0000035045873,0.017900571,0.0027607104,0.9704259,0.00034526575,0.0016260938,0.0021321424],"study_design_scores_gemma":[0.002649306,0.0004617313,0.0025007618,0.0015050898,0.00019316946,3.3011176e-7,0.0025456655,0.0012490157,0.9878498,0.0005357878,0.00026730183,0.00024208748],"about_ca_topic_score_codex":0.007189036,"about_ca_topic_score_gemma":0.00051132176,"teacher_disagreement_score":0.017423855,"about_ca_system_score_codex":0.0005088679,"about_ca_system_score_gemma":0.001197415,"threshold_uncertainty_score":0.9994222},"labels":[],"label_agreement":null},{"id":"W1998239623","doi":"10.1158/0008-5472.sabcs-09-26","title":"A Prospective Study of Breast Cancer Incidence and Stage Distribution in Women with a BRCA1 or BRCA2 Mutation under Surveillance with and without Magnetic Resonance Imaging.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Breast MRI; Cohort; Mammography; Cumulative incidence; Incidence (geometry); Oncology; Stage (stratigraphy); Internal medicine; Hazard ratio; Cancer; Magnetic resonance imaging; Prospective cohort study; Gynecology; Radiology; Confidence interval","score_opus":0.016426457814485197,"score_gpt":0.3474985363432593,"score_spread":0.33107207852877407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998239623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993,0.0052594515,0.00011373469,0.00049849605,0.000011941627,0.00091840734,0.00016822845,0.000007066616,0.000022714006],"genre_scores_gemma":[0.9981169,0.0007886784,0.00007190498,0.000055240176,0.000041708645,0.0006539467,0.000009657839,0.000019245605,0.00024272925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983427,0.00015890982,0.00017900945,0.00057767314,0.0003769958,0.00036473322],"domain_scores_gemma":[0.9990643,0.000026089665,0.00007818369,0.00026947755,0.0004810693,0.00008088273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045755808,0.00015270385,0.00019474508,0.000087052445,0.00010205733,0.000046594316,0.00012719427,0.000049424292,0.000020746482],"category_scores_gemma":[0.00003705963,0.000116623705,0.000005861429,0.0005848092,0.00037187806,0.000022720731,0.00006793459,0.00019062759,1.670888e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008241399,0.00023983407,0.9311337,0.00006606143,0.000033896482,0.000021547561,0.0028198655,0.00065764895,0.022463894,0.000021053536,0.000081657985,0.034219448],"study_design_scores_gemma":[0.0029996263,0.0019159127,0.9883618,0.00012214735,0.000006163225,0.00004212982,0.0033167466,0.00012505324,0.002748213,0.00005064078,0.00013616569,0.0001754236],"about_ca_topic_score_codex":0.0016090784,"about_ca_topic_score_gemma":0.013097987,"teacher_disagreement_score":0.057228085,"about_ca_system_score_codex":0.00047198753,"about_ca_system_score_gemma":0.0007661822,"threshold_uncertainty_score":0.73089844},"labels":[],"label_agreement":null},{"id":"W1998435018","doi":"10.1158/1538-7445.am2014-2167","title":"Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Infertility; Endometrial cancer; Odds ratio; Gynecology; Obstetrics; Confidence interval; Epidemiology; Cohort study; Cancer; Demography; Pregnancy; Internal medicine","score_opus":0.11625777657610123,"score_gpt":0.42674801396735434,"score_spread":0.31049023739125314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998435018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753452,0.021049414,0.000054682398,0.001506383,0.00025123806,0.000856219,0.00075355027,0.000008731218,0.00017457682],"genre_scores_gemma":[0.9915138,0.0072434684,0.00008327088,0.00007456291,0.00063370913,0.00038264785,0.00003162753,0.000016497788,0.000020455911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960588,0.0012939344,0.0008967235,0.0005699201,0.0006956893,0.00048489126],"domain_scores_gemma":[0.9841089,0.013753386,0.00047814476,0.00078761374,0.0006237312,0.0002482075],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053441194,0.00019256516,0.001339972,0.00064469187,0.00012314948,0.000010342345,0.00023123813,0.00015895747,0.0011943479],"category_scores_gemma":[0.009941854,0.00012168755,0.00036443045,0.0018947495,0.0007555627,0.00004689638,0.0001707257,0.00054312195,0.0000036733613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024453665,0.00022558108,0.97825485,0.0000729052,0.0042670956,0.0000047133126,0.000255458,0.000067724584,0.0011902838,0.00010436493,0.00039828176,0.012713362],"study_design_scores_gemma":[0.007447495,0.00042313518,0.9785454,0.00007913762,0.0031980996,5.461663e-7,0.000086063614,0.00010818823,0.00918319,0.00034472335,0.0004983058,0.00008568072],"about_ca_topic_score_codex":0.1943886,"about_ca_topic_score_gemma":0.008241111,"teacher_disagreement_score":0.18614748,"about_ca_system_score_codex":0.00036670803,"about_ca_system_score_gemma":0.00063577003,"threshold_uncertainty_score":0.99971867},"labels":[],"label_agreement":null},{"id":"W1998516698","doi":"10.1158/0008-5472.can-08-2489","title":"Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Institutes of Health; Swiss Bridge Foundation; National Cancer Institute; Ligue Contre le Cancer; Association pour la Recherche sur le Cancer","keywords":"DNA methylation; GSTP1; CDKN2A; Methylation; Lung cancer; Carcinogenesis; CDH1; Methylenetetrahydrofolate reductase; Cancer research; Biology; Cancer; Epigenetics; Oncology; Gene; Medicine; Genetics; Gene expression; Allele; Genotype; Cell","score_opus":0.08616207678213862,"score_gpt":0.3936481221442165,"score_spread":0.3074860453620779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998516698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93237126,0.066634245,0.0003288763,0.000031949206,0.00004418483,0.00034761347,0.00020899683,0.0000026535702,0.000030231255],"genre_scores_gemma":[0.91162175,0.08794049,0.00010913848,0.0000015522776,0.000038183993,0.00009590134,0.00007612742,0.000015259111,0.00010159359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981926,0.0003720122,0.00033193978,0.00038233862,0.00049625745,0.00022485334],"domain_scores_gemma":[0.99860734,0.0001546025,0.00032187786,0.00014548237,0.0007171068,0.000053588563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009412814,0.00013259004,0.00030624238,0.00044627616,0.00012145516,0.000018038658,0.000079408856,0.00014898299,0.000034501027],"category_scores_gemma":[0.000139036,0.00011383403,0.000051430405,0.0008325318,0.00012762887,0.000023847671,0.0000539829,0.00013764939,8.94803e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109091605,0.000017767994,0.40929946,0.00005567955,0.00048024763,2.6886974e-7,0.001162065,0.0031170256,0.5850283,0.000022156082,0.000011530706,0.00069639564],"study_design_scores_gemma":[0.00024054873,0.00006277889,0.4447654,0.000018196579,0.000121023644,3.603036e-8,0.00026029654,0.0014472388,0.5529353,0.00002676623,0.00004291803,0.00007952288],"about_ca_topic_score_codex":0.0026278435,"about_ca_topic_score_gemma":0.0026829247,"teacher_disagreement_score":0.03546594,"about_ca_system_score_codex":0.00012125017,"about_ca_system_score_gemma":0.00016914801,"threshold_uncertainty_score":0.4642017},"labels":[],"label_agreement":null},{"id":"W1998691610","doi":"10.1158/1538-7445.am2013-lb-173","title":"Abstract LB-173: Genome analysis informs chemotherapy decision-making in patients with advanced malignancies.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer; Amplicon; Colorectal cancer; Oncology; Chemotherapy; Internal medicine; Biology; Medicine; Bioinformatics; Gene; Genetics; Polymerase chain reaction","score_opus":0.01143698505295678,"score_gpt":0.3187261598805276,"score_spread":0.30728917482757084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998691610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767506,0.0008846772,0.00023997195,0.00008503317,0.000045325425,0.0005124078,0.00004723112,0.0000053000986,0.00050499314],"genre_scores_gemma":[0.99717695,0.0014820002,0.0005660344,0.00025800563,0.000088265915,0.0002354082,0.00007901301,0.000029916979,0.00008438108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840105,0.000016071184,0.00025011887,0.0004084314,0.00039936762,0.0005249637],"domain_scores_gemma":[0.99881047,0.00006581829,0.00007005733,0.0004830688,0.00045446627,0.000116127536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024496918,0.00015232184,0.00020656569,0.00027526112,0.00009044312,0.00009284204,0.00033018336,0.00011085359,0.00045913694],"category_scores_gemma":[0.00010485316,0.00012466703,0.00007424583,0.000749726,0.00010704341,0.000015509147,0.00013187875,0.00019002451,0.000028359096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015953338,0.00035261145,0.7039027,0.000078336,0.00059433904,0.000009226373,0.00038939048,0.017693432,0.0881169,0.00004495038,0.0020685857,0.18515417],"study_design_scores_gemma":[0.0013777396,0.00025326788,0.98592687,0.000050673592,0.000012967456,1.7015527e-7,0.00007742285,0.00003050737,0.00417307,0.00013384574,0.0077266344,0.00023682938],"about_ca_topic_score_codex":0.00041404163,"about_ca_topic_score_gemma":0.0008816401,"teacher_disagreement_score":0.28202415,"about_ca_system_score_codex":0.00017146998,"about_ca_system_score_gemma":0.00025457484,"threshold_uncertainty_score":0.5083774},"labels":[],"label_agreement":null},{"id":"W1998702544","doi":"10.1158/1538-7445.am10-3753","title":"Abstract 3753: Quantitation of EGFR and phosphoEGFR in FFPE tissue","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Microdissection; Phosphorylation; Immunohistochemistry; Epidermal growth factor receptor; Medicine; Cancer; Cancer research; Pathology; Oncology; Internal medicine; Biology; Biochemistry","score_opus":0.10855082583086909,"score_gpt":0.5201934375414861,"score_spread":0.411642611710617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998702544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891602,0.0002940906,0.0000648195,0.007848675,0.000027776925,0.00031520176,0.000004856089,0.000018025763,0.0022663916],"genre_scores_gemma":[0.99624795,0.0004995635,0.0027034865,0.00005872118,0.000055364377,0.00011555712,0.00000561,0.0000082803135,0.00030546653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993022,0.000012007699,0.0001366522,0.0001380137,0.00025785685,0.00015323694],"domain_scores_gemma":[0.9994653,0.000100891164,0.000021512504,0.00018716187,0.00012547724,0.000099661804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060139346,0.000038928356,0.00010575213,0.00011330676,0.00002811959,0.000007823887,0.00006901626,0.00005787179,0.0005033802],"category_scores_gemma":[0.00022789309,0.00003316188,0.000010277794,0.0002538471,0.00022688542,0.000032533277,0.00003175424,0.0004923177,0.000010882981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028865632,0.00007061123,0.008444322,0.00012722514,0.0000032290195,0.0000059286776,0.00013701367,1.3129265e-7,0.93206435,0.004392934,0.005487257,0.049238104],"study_design_scores_gemma":[0.00079443684,0.00013356571,0.19879994,0.00032000907,0.000007864409,0.000008818982,0.0001407335,0.000266789,0.713644,0.0028083944,0.08298621,0.0000891887],"about_ca_topic_score_codex":0.0020032756,"about_ca_topic_score_gemma":0.00025502747,"teacher_disagreement_score":0.21842033,"about_ca_system_score_codex":0.00002555972,"about_ca_system_score_gemma":0.0001263508,"threshold_uncertainty_score":0.55116606},"labels":[],"label_agreement":null},{"id":"W1999000187","doi":"10.1158/0008-5472.sabcs13-p1-13-01","title":"Abstract P1-13-01: Risk of recurrence following 5 years of adjuvant hormone therapy for hormone receptor positive early breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cohort; Internal medicine; Oncology; Cancer; Hormone therapy; Adjuvant therapy; Stage (stratigraphy); Hormonal therapy; Radiation therapy; Hormone receptor; Gynecology","score_opus":0.027484842613794167,"score_gpt":0.34627293035140216,"score_spread":0.318788087737608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999000187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96585995,0.03063397,0.000025389549,0.00034023362,0.0001432545,0.0009519808,0.0019480345,0.000007656595,0.00008955552],"genre_scores_gemma":[0.9731897,0.0250033,0.00018489691,0.000018970735,0.0002550469,0.0011452966,0.000065703316,0.00004145915,0.00009558754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816155,0.000103461265,0.00030911906,0.00048180248,0.00042399197,0.00052004296],"domain_scores_gemma":[0.9985514,0.00012771033,0.00019206326,0.00039106293,0.00062189245,0.0001158713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040418,0.0001960657,0.00035994253,0.00009420344,0.00013198778,0.000021017091,0.00033311956,0.00013927619,0.00007256192],"category_scores_gemma":[0.00007900838,0.00017833115,0.00021125506,0.00026529646,0.00031486645,0.000019274587,0.00013129847,0.00020454185,0.0000074598106],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016402138,0.00018655762,0.018060254,0.000036044155,0.0008239514,0.0000011634698,0.00054977974,0.000014144965,0.84052825,0.0000063213383,0.009225651,0.12892768],"study_design_scores_gemma":[0.0020497525,0.00062305725,0.79511976,0.000121241574,0.00003444772,9.0739496e-7,0.0002419929,0.0000031403495,0.20089345,0.00006869271,0.0006538785,0.00018968078],"about_ca_topic_score_codex":0.016903356,"about_ca_topic_score_gemma":0.00027792904,"teacher_disagreement_score":0.7770595,"about_ca_system_score_codex":0.00012204967,"about_ca_system_score_gemma":0.00032039738,"threshold_uncertainty_score":0.98964316},"labels":[],"label_agreement":null},{"id":"W1999018351","doi":"10.1158/0008-5472.can-12-2194","title":"Roles for Endothelin Receptor B and BCL2A1 in Spontaneous CNS Metastasis of Melanoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; University of Toronto; National Research Council Canada; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society Research Institute; Terry Fox Foundation; University of Arizona Cancer Center; Abbott Laboratories","keywords":"Melanoma; Metastasis; Medicine; Endothelin 3; Cancer research; Endothelin receptor; Receptor; Internal medicine; Cancer; Endothelins","score_opus":0.09996727932239921,"score_gpt":0.4209430972670904,"score_spread":0.3209758179446912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999018351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211277,0.015216206,0.000023063432,0.0012518411,0.000054380373,0.0007655152,0.00026044672,0.000006614673,0.00030916074],"genre_scores_gemma":[0.9951324,0.0013220235,0.0021011368,0.000045328303,0.00014835452,0.00032931197,0.000019273433,0.00002002132,0.0008821888],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886346,0.000118372904,0.00017306497,0.00016583745,0.00026900327,0.00041023936],"domain_scores_gemma":[0.99915147,0.00035848952,0.00002827019,0.00018503041,0.00011148702,0.00016524656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011228259,0.000084144325,0.0002693726,0.00018045843,0.00004040062,0.0000066993225,0.00005328931,0.00004451492,0.0004528618],"category_scores_gemma":[0.00017844267,0.00006313485,0.000054161002,0.00016550608,0.000104007384,0.000041369796,0.000039464194,0.00013845298,0.00000980876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007898833,0.0022566686,0.14493494,0.001883844,0.0011305471,0.0003471322,0.0053619137,0.000009509475,0.20798853,0.0072790245,0.0075516747,0.61335737],"study_design_scores_gemma":[0.016154636,0.0040010745,0.039242357,0.00083086523,0.0004403954,0.00060196716,0.0047089946,0.00009427321,0.62002015,0.00082837173,0.3125946,0.0004823217],"about_ca_topic_score_codex":0.00056452083,"about_ca_topic_score_gemma":0.00030029356,"teacher_disagreement_score":0.61287504,"about_ca_system_score_codex":0.00013701424,"about_ca_system_score_gemma":0.00011862072,"threshold_uncertainty_score":0.4958519},"labels":[],"label_agreement":null},{"id":"W1999046878","doi":"10.1158/0008-5472.sabcs10-pd03-01","title":"Abstract PD03-01: Significant Reduction of Triple-Negative Breast Cancers in Diabetic Women on Metformin","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Metformin; Medicine; Internal medicine; Breast cancer; Diabetes mellitus; Incidence (geometry); Triple-negative breast cancer; Cohort; Cancer; Type 2 diabetes; Oncology; Retrospective cohort study; Gynecology; Endocrinology","score_opus":0.030017724663942133,"score_gpt":0.3496607107530475,"score_spread":0.31964298608910535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999046878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022,0.007359117,0.0000014814508,0.000056931134,0.0005948787,0.00043396905,0.00014127896,0.0000058032533,0.0011865526],"genre_scores_gemma":[0.98634297,0.01190237,0.00003103658,0.0000363649,0.0005483641,0.0006090746,0.000021892876,0.000030613523,0.00047730855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979938,0.00012352917,0.00029768658,0.00047762608,0.00045265513,0.00065465766],"domain_scores_gemma":[0.9989781,0.000040134044,0.000100006684,0.00045081205,0.00025054073,0.00018043628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012054362,0.00016465144,0.00027843512,0.00022313344,0.00007223323,0.00002216876,0.00032098126,0.00018760325,0.0006442362],"category_scores_gemma":[0.00018396245,0.00014960715,0.00006877855,0.00042509765,0.00037471528,0.0000110363235,0.00006474598,0.0005822011,0.000011975556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005603765,0.00008767198,0.00038044073,0.00006766631,0.000049406146,0.0000019762733,0.00041216565,0.000067937515,0.8659351,0.000077534016,0.0019515764,0.13040814],"study_design_scores_gemma":[0.0012397994,0.00025478244,0.009704879,0.00006146048,0.000005952038,0.0000018706111,0.000793715,0.0000094054485,0.9607009,0.00039155112,0.026625654,0.00020999563],"about_ca_topic_score_codex":0.0017059852,"about_ca_topic_score_gemma":0.00079663936,"teacher_disagreement_score":0.13019814,"about_ca_system_score_codex":0.00025390417,"about_ca_system_score_gemma":0.0008366899,"threshold_uncertainty_score":0.7053935},"labels":[],"label_agreement":null},{"id":"W1999118823","doi":"10.1158/0008-5472.can-09-1710","title":"The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Hospital for Sick Children; Royal University Hospital; University of Regina","funders":"Canadian Institutes of Health Research","keywords":"Biology; Receptor tyrosine kinase; Cancer research; Erythropoietin-producing hepatocellular (Eph) receptor; Cancer; Cancer cell; Gene silencing; Phosphorylation; Tyrosine kinase; Cell biology; Signal transduction; Genetics; Gene","score_opus":0.07459320366352232,"score_gpt":0.39186203234630673,"score_spread":0.3172688286827844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999118823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917766,0.00014776523,0.0000029019495,0.006438728,0.00039550892,0.00084528414,0.00011051991,0.000019948115,0.00026277822],"genre_scores_gemma":[0.9938863,0.00055639126,0.000014128341,0.0004933699,0.00028782798,0.0011223439,3.1448056e-7,0.000034843142,0.0036044887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976345,0.00024059061,0.00020206456,0.00042311414,0.0008888039,0.000610938],"domain_scores_gemma":[0.9981459,0.0006667715,0.00006341405,0.0005397549,0.0004264921,0.00015769762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008106168,0.0001341054,0.00013955805,0.00006037204,0.0008503448,0.00013135269,0.0009786984,0.00005087532,0.0007224686],"category_scores_gemma":[0.00012138736,0.000065503635,0.000038794842,0.00092099764,0.0008515131,0.000106089756,0.0001928875,0.0007836207,0.000084534455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034060923,0.000029895815,0.0005422801,0.000008323806,0.0000037729574,0.000006570239,0.00018791282,0.00010300802,0.9851172,0.00039253297,0.0040600426,0.009207875],"study_design_scores_gemma":[0.00016970365,0.000114690185,0.0021063597,0.00005039351,0.0000060188713,0.000010141148,0.000076217286,0.000024173663,0.9617011,0.00001680216,0.03562595,0.00009847413],"about_ca_topic_score_codex":0.0007796538,"about_ca_topic_score_gemma":0.00096746767,"teacher_disagreement_score":0.03156591,"about_ca_system_score_codex":0.000054133146,"about_ca_system_score_gemma":0.00042447672,"threshold_uncertainty_score":0.7910524},"labels":[],"label_agreement":null},{"id":"W1999476676","doi":"10.1158/0008-5472.can-07-1593","title":"Deletion of the AU-Rich RNA Binding Protein Apobec-1 Reduces Intestinal Tumor Burden in <i>Apcmin</i> Mice","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"APOBEC; Messenger RNA; Cancer research; Biology; Molecular biology; RNA; Untranslated region; RNA-binding protein; Endocrinology; Biochemistry; Gene; Apolipoprotein B","score_opus":0.044282456566577186,"score_gpt":0.37321100308449445,"score_spread":0.32892854651791725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999476676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550575,0.00032946092,0.0000058931473,0.0007038228,0.00020087218,0.0011183051,0.0000028925783,0.000014593048,0.0021184222],"genre_scores_gemma":[0.9981091,0.000018296287,0.00008486903,0.000030241734,0.00063950644,0.00014746176,0.0000022479064,0.000022443914,0.00094583066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978544,0.00020338003,0.00031108674,0.00024144763,0.000807566,0.0005821263],"domain_scores_gemma":[0.9989806,0.00024409161,0.000087974055,0.00024602874,0.00030540035,0.0001359074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003923109,0.0001095542,0.00021484485,0.00032276686,0.00012089124,0.000011471462,0.00023043025,0.00007357286,0.00007077476],"category_scores_gemma":[0.0009712923,0.00007637249,0.000050655774,0.0010066605,0.00025338648,0.0000588861,0.00010432164,0.00075301935,0.000024290637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047445626,0.000042590047,0.021811178,0.00031155298,0.000010486048,0.00008399211,0.00090356206,0.000004294185,0.96956766,0.000077410594,0.00041599022,0.006296806],"study_design_scores_gemma":[0.000882288,0.00019386667,0.013749165,0.0015214407,0.000008082389,0.00002710531,0.00066090404,0.000041125437,0.981417,0.000034736175,0.0013798082,0.00008448956],"about_ca_topic_score_codex":0.00197658,"about_ca_topic_score_gemma":0.00061745994,"teacher_disagreement_score":0.011849307,"about_ca_system_score_codex":0.00075496954,"about_ca_system_score_gemma":0.0008094746,"threshold_uncertainty_score":0.32715362},"labels":[],"label_agreement":null},{"id":"W1999529779","doi":"10.1158/1538-7445.am2013-lb-165","title":"Abstract LB-165: Safety and pharmacokinetics of liposomal curcumin in healthy subjects:A randomized placebo-controlled double blind first-in human study.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nucro Technics","funders":"","keywords":"Curcumin; Pharmacology; Pharmacokinetics; Medicine; Hemolysis; Adverse effect; Cmax; Placebo; Diphenhydramine; Internal medicine; Histamine; Pathology","score_opus":0.044300491824980734,"score_gpt":0.4097050970869765,"score_spread":0.36540460526199575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999529779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907994,0.0017086883,0.000023290539,0.0015203513,0.00004192654,0.0052531348,0.000018399005,0.000005861305,0.0006289104],"genre_scores_gemma":[0.9956919,0.0009865637,0.00003035531,0.000041967407,0.00015324065,0.002715274,0.00003783118,0.000023374878,0.00031950176],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764025,0.0002779544,0.0006865216,0.00049032824,0.00040883315,0.0004961013],"domain_scores_gemma":[0.9988162,0.00029619792,0.00011952473,0.00035679614,0.00021625652,0.00019501957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002136457,0.00016627811,0.0005782643,0.0002597953,0.00010509169,0.00003215071,0.00031817233,0.00015807613,0.00031987813],"category_scores_gemma":[0.00018237035,0.00014341851,0.00007410377,0.00042392753,0.000466099,0.000008117612,0.00020510911,0.00040163193,0.000008467171],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4442531,0.0012570424,0.006420258,0.00021805387,0.00016090824,0.000007890713,0.0006990578,0.00008508797,0.54360443,0.00009957782,0.0009604784,0.0022341532],"study_design_scores_gemma":[0.91663843,0.0006387001,0.013048376,0.00007702277,0.00002970336,0.0000022338947,0.0005324966,0.00027132456,0.065182514,0.0001738632,0.0031113012,0.0002940326],"about_ca_topic_score_codex":0.0048676245,"about_ca_topic_score_gemma":0.0028905927,"teacher_disagreement_score":0.4784219,"about_ca_system_score_codex":0.00008217843,"about_ca_system_score_gemma":0.0002347981,"threshold_uncertainty_score":0.73584247},"labels":[],"label_agreement":null},{"id":"W1999546013","doi":"10.1158/1538-7445.am10-139","title":"Abstract 139: The identification of potent inhibitor of apoptosis protein (IAP) inhibitors for clinical development","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Inhibitor of apoptosis; Caspase; Programmed cell death; Apoptosis; Cancer cell; Pharmacology; Chemistry; Biology; Cancer research; Biochemistry; Cancer","score_opus":0.098661449507136,"score_gpt":0.4590331215981186,"score_spread":0.3603716720909826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999546013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775,0.00030038206,0.00012634203,0.0005184575,0.00016830015,0.0009809926,0.000047639063,0.0000030758367,0.00010480843],"genre_scores_gemma":[0.99787843,0.00019028016,0.00028114562,0.000009744202,0.00050495093,0.0004987924,0.00003831823,0.000019432648,0.0005789328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816513,0.00010427185,0.0006078383,0.00031345972,0.00050216337,0.0003071474],"domain_scores_gemma":[0.9984542,0.00010364255,0.00016024691,0.00044867702,0.0007433701,0.00008986349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030794293,0.00008819123,0.00014484859,0.000071585106,0.00014718698,0.000020994272,0.0004043099,0.0001697674,0.000032129272],"category_scores_gemma":[0.0007846578,0.000063391,0.00012090385,0.00016572671,0.00045011906,0.0000051136085,0.00018667689,0.00034314944,0.0000059090057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020651618,0.00013713719,0.0013250491,0.0001220419,0.000048382808,1.4970382e-7,0.000044343782,0.0000021089209,0.9509176,0.000049085043,0.0025514022,0.0445962],"study_design_scores_gemma":[0.0003147218,0.00013401838,0.0048213103,0.000039531475,0.000003919342,1.7260838e-7,0.000120350815,0.00000639602,0.96674997,0.000036071746,0.027704552,0.00006900049],"about_ca_topic_score_codex":0.0000726478,"about_ca_topic_score_gemma":0.000090590045,"teacher_disagreement_score":0.0445272,"about_ca_system_score_codex":0.000019487497,"about_ca_system_score_gemma":0.00085058005,"threshold_uncertainty_score":0.25850102},"labels":[],"label_agreement":null},{"id":"W1999586798","doi":"10.1158/1538-7445.am10-237","title":"Abstract 237: A novel proto-oncogene of TRIM59 characterized in mouse cancer models bridging Ras and pRb signal pathways","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Oncogene; Carcinogenesis; Cancer; Biology; Cancer research; Cell cycle; Genetics","score_opus":0.09670189998950132,"score_gpt":0.3654275415668511,"score_spread":0.2687256415773498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999586798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554753,0.0024424568,0.00003489174,0.0002270239,0.00020861697,0.0010159232,0.00022636847,0.000022031016,0.00027515742],"genre_scores_gemma":[0.9965779,0.0006995027,0.000022941473,0.000041378928,0.000058026762,0.00080736383,0.000018074537,0.00002951775,0.0017452479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983394,0.00018430079,0.00038376913,0.0003642273,0.00010787153,0.0006204428],"domain_scores_gemma":[0.99913394,0.00019796228,0.0001007824,0.00027636802,0.00024690336,0.00004406848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010624076,0.00017032737,0.00037971218,0.00035983825,0.00012660198,0.000027558997,0.00030276898,0.00025870642,0.0012018139],"category_scores_gemma":[0.00010260832,0.00014841222,0.00006154642,0.00020306691,0.00047586445,0.00017448423,0.00016876234,0.0011831801,0.000023728633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028685878,0.00017648953,0.0005542184,0.0000987048,0.000066841705,0.000005271293,0.000898517,0.000008056863,0.98223084,0.00019026201,0.00012649519,0.012775701],"study_design_scores_gemma":[0.0028933445,0.00014692085,0.00571279,0.0001627979,0.0000051064994,0.00001539565,0.0001475384,0.00007790131,0.98818207,0.000028342161,0.002468052,0.00015976145],"about_ca_topic_score_codex":0.0032999376,"about_ca_topic_score_gemma":0.0007243832,"teacher_disagreement_score":0.012615939,"about_ca_system_score_codex":0.000094620154,"about_ca_system_score_gemma":0.00069494493,"threshold_uncertainty_score":0.9997112},"labels":[],"label_agreement":null},{"id":"W2000126386","doi":"10.1158/1538-7445.am2013-1315","title":"Abstract 1315: Regulation of Nodal expression by estrogen in hormone responsive human breast cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Breast cancer; Estrogen receptor; NODAL; Estrogen; Biology; Cancer research; Cancer; Estrogen receptor alpha; Nodal signaling; Fulvestrant; Internal medicine; Endocrinology; Medicine; Cell biology; Embryogenesis; Embryo","score_opus":0.016164611110221862,"score_gpt":0.33702372654404744,"score_spread":0.32085911543382556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000126386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857453,0.012856605,0.0000033217357,0.00021912126,0.000042029194,0.00046847458,0.00007481824,0.000006785339,0.0005835342],"genre_scores_gemma":[0.9961571,0.0021965213,0.000030388646,0.00001713455,0.00016797594,0.00025795138,0.0001115649,0.0000316884,0.0010296392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984858,0.00015169794,0.0002574832,0.00036612997,0.00033401165,0.00040489066],"domain_scores_gemma":[0.9990971,0.000029266957,0.000089723326,0.00031954894,0.00033620914,0.00012814198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034289752,0.00014174459,0.00016354377,0.0000897303,0.000095513715,0.000022616674,0.0002311714,0.0002925291,0.00027871848],"category_scores_gemma":[0.000024046913,0.00012298061,0.0000619049,0.00019980472,0.00015843507,0.00001668219,0.00012930897,0.00031851418,0.000016279135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031018467,0.00010044964,0.0018239737,0.000039237264,0.000018366163,0.0000022048816,0.00006791811,0.00009147595,0.97589004,0.000005333819,0.020138802,0.0015120395],"study_design_scores_gemma":[0.0008119714,0.00016243063,0.0462817,0.00008011214,0.0000043565533,0.000002240321,0.000083877625,0.000023895356,0.9517231,0.000032663203,0.00066208787,0.00013157645],"about_ca_topic_score_codex":0.0043737455,"about_ca_topic_score_gemma":0.00008401724,"teacher_disagreement_score":0.044457726,"about_ca_system_score_codex":0.00010578565,"about_ca_system_score_gemma":0.00020157841,"threshold_uncertainty_score":0.6611824},"labels":[],"label_agreement":null},{"id":"W2000169115","doi":"10.1158/1538-7445.am2014-322","title":"Abstract 322: The integrin α6A splice variant regulates Wnt/β-catenin and colorectal cancer cell proliferation through autophagic degradation of DVL2","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Wnt signaling pathway; Cancer research; Catenin; Integrin; Integrin, beta 6; Autophagy; Cell biology; Biology; LRP5; Gene knockdown; Small interfering RNA; Chemistry; Signal transduction; Cell; Cell culture; Transfection; Genetics","score_opus":0.055214211365416994,"score_gpt":0.38114489663508033,"score_spread":0.32593068526966334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000169115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879135,0.0031182547,0.00009989446,0.0033396957,0.00008431467,0.0012241213,0.000014093178,0.000028505881,0.0032997767],"genre_scores_gemma":[0.99312186,0.0029934165,0.00022145674,0.00008703191,0.00023987933,0.00040684204,0.00002639755,0.000039705377,0.0028634232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721146,0.00033141908,0.00036198733,0.0004636903,0.0011221509,0.00050928985],"domain_scores_gemma":[0.99810797,0.0004984123,0.000106437525,0.00032859904,0.00079706725,0.00016152319],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017472389,0.0001689194,0.00029285336,0.00010403971,0.00023492718,0.00005962043,0.00026297293,0.00015124265,0.00091645564],"category_scores_gemma":[0.0003632693,0.000112161826,0.00006063217,0.00054706173,0.00043502517,0.00017107444,0.00017439328,0.00075638783,0.000030317313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007431978,0.00014773257,0.0020177828,0.0004786062,0.00005165341,0.000013401327,0.0012070688,0.000053682303,0.96865994,0.0006762187,0.0025061856,0.023444558],"study_design_scores_gemma":[0.001201561,0.0004012269,0.04464046,0.00022214297,0.000031773798,0.000018412593,0.00046520637,0.0031087247,0.94685555,0.0004018872,0.0025227387,0.00013029792],"about_ca_topic_score_codex":0.009208778,"about_ca_topic_score_gemma":0.001411181,"teacher_disagreement_score":0.042622678,"about_ca_system_score_codex":0.00038541722,"about_ca_system_score_gemma":0.00055421505,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W2000193382","doi":"10.1158/0008-5472.sabcs11-p1-06-07","title":"P1-06-07: TIMP-1 in Combination with HER2 and TOP2A for Prediction of Benefit from Adjuvant Anthracyclines in High Risk Breast Cancer Patients.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Oncology; Internal medicine; Adjuvant; Immunohistochemistry; Biomarker; Cancer; Clinical trial; Biology","score_opus":0.07569601257387051,"score_gpt":0.39045621716267986,"score_spread":0.3147602045888094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000193382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382603,0.0011665343,0.00002143378,0.00067388284,0.0001239297,0.0018964544,0.0020999338,0.000018080136,0.00017369486],"genre_scores_gemma":[0.9939526,0.0038938324,0.00023137429,0.000025899628,0.00016009675,0.0012928797,0.00016311601,0.000050257735,0.00022997423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997368,0.00015444933,0.0004566483,0.0005397428,0.0009060594,0.00057510403],"domain_scores_gemma":[0.99820244,0.00025605795,0.00011721169,0.0003399949,0.0008962547,0.00018805469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093344046,0.0001689968,0.00044229947,0.0005074538,0.00008073073,0.00001800835,0.00017946806,0.00015924082,0.00045756137],"category_scores_gemma":[0.0001683303,0.00013934029,0.00003478075,0.0006783789,0.0003489978,0.00019328862,0.000098989236,0.0006198917,0.0000044020107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030917984,0.0007154449,0.9457384,0.00032932445,0.00005169754,0.000008497843,0.0013944423,0.000020101808,0.0008132832,0.0000887102,0.0005546044,0.04719374],"study_design_scores_gemma":[0.007998114,0.0013971559,0.98130924,0.0011688286,0.00003013554,0.0000015190733,0.00029375745,0.0006855784,0.0057630655,0.00081880164,0.00041474178,0.00011906811],"about_ca_topic_score_codex":0.098677956,"about_ca_topic_score_gemma":0.02056908,"teacher_disagreement_score":0.07810888,"about_ca_system_score_codex":0.0007267076,"about_ca_system_score_gemma":0.0005265225,"threshold_uncertainty_score":0.997303},"labels":[],"label_agreement":null},{"id":"W2000211955","doi":"10.1158/1538-7445.am10-2536","title":"Abstract 2536: Therapeutic testing of a novel PKC inhibitor GAP-107B8 on ovarian cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micropharma (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cancer research; Ovarian cancer; Cell growth; Cancer; Cell culture; Oncogene; Biology; Kinase; Protein kinase C; Cell; Cancer cell; Cell cycle; Medicine; Internal medicine; Cell biology; Biochemistry","score_opus":0.1942330286169569,"score_gpt":0.43643164251929395,"score_spread":0.24219861390233705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000211955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813814,0.0010276946,0.000008264287,0.004941374,0.00090352976,0.0010626846,0.00016380988,0.0000463064,0.0104649225],"genre_scores_gemma":[0.9960747,0.00033280783,0.0006344144,0.00036434125,0.001222819,0.00065549236,0.000006517695,0.00006487392,0.00064403296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974677,0.000039251125,0.00035119453,0.000541163,0.0009396305,0.0006610843],"domain_scores_gemma":[0.99781543,0.00052776077,0.00011604729,0.0006362653,0.00059773354,0.00030674905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006888938,0.00022335348,0.0003966832,0.0002684326,0.00016170293,0.00004806118,0.00021207346,0.00017057887,0.0019702064],"category_scores_gemma":[0.00013092725,0.00017477597,0.0001129824,0.00067475653,0.00025178638,0.000069206166,0.00006777751,0.0010678978,0.000059679973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000395123,0.0012380652,0.016029606,0.00029198185,0.0002245246,0.00005186405,0.00030772766,0.000047135203,0.915673,0.00073494436,0.0029870025,0.06201901],"study_design_scores_gemma":[0.0054420405,0.00084481295,0.16145526,0.0012880483,0.00010912799,0.000009671347,0.000111614485,0.00012600647,0.8123072,0.00013832258,0.017900953,0.00026699566],"about_ca_topic_score_codex":0.0059305457,"about_ca_topic_score_gemma":0.00070383976,"teacher_disagreement_score":0.14542565,"about_ca_system_score_codex":0.00040700738,"about_ca_system_score_gemma":0.0013429918,"threshold_uncertainty_score":0.99894214},"labels":[],"label_agreement":null},{"id":"W2000238659","doi":"10.1158/0008-5472.sabcs13-p6-08-11","title":"Abstract P6-08-11: Count us, know us, join us global survey: Comparing the feelings and needs of advanced breast cancer patients in the United States with patients in Latin America, Europe, and Asia","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Latin Americans; Feeling; Family medicine; Cancer; General partnership; Global health; Political science; Public health; Internal medicine; Psychology; Pathology","score_opus":0.023780163724562927,"score_gpt":0.3222383974556819,"score_spread":0.29845823373111896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000238659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975466,0.0008784108,0.000003504573,0.00034899378,0.000037297952,0.0006675115,0.00042085777,0.0000028587622,0.000093978735],"genre_scores_gemma":[0.99652356,0.0026701952,0.000030092895,0.00021077701,0.000026898264,0.00022285082,0.00027019525,0.000021593749,0.000023820858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832505,0.00032943164,0.00027526796,0.00029301073,0.00038971417,0.00038754134],"domain_scores_gemma":[0.99860626,0.00008999516,0.00012110381,0.0002815366,0.000835829,0.00006528339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004917975,0.00016197843,0.00018630785,0.000110867375,0.000110490844,0.00007515876,0.00029921182,0.00006389418,0.000021648944],"category_scores_gemma":[0.00008610822,0.000106122934,0.000013634384,0.0011084792,0.00044864404,0.000019214236,0.00017746509,0.000255523,0.0000014828495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023405354,0.00009077398,0.99026823,0.00003814715,0.000027081318,5.310029e-7,0.0005361028,0.0029240926,0.0009974804,0.0000029055975,0.001196367,0.0036842139],"study_design_scores_gemma":[0.0012733903,0.00013910311,0.9935609,0.00009673368,0.0000051859,8.6975894e-7,0.0006294963,0.00030938417,0.0006645632,0.000007682416,0.0031826948,0.00013001375],"about_ca_topic_score_codex":0.07983985,"about_ca_topic_score_gemma":0.037951883,"teacher_disagreement_score":0.041887965,"about_ca_system_score_codex":0.00018908782,"about_ca_system_score_gemma":0.00028326362,"threshold_uncertainty_score":0.979603},"labels":[],"label_agreement":null},{"id":"W2000430706","doi":"10.1158/0008-5472.sabcs-09-1040","title":"Preventive Health Behaviors in Unaffected High-Risk Women: The Impact of Perceived vs Actual Risk and Preferred Involvement in Decision-Making.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; Risk assessment; Risk perception; Family medicine; Environmental health; Gynecology; Gerontology; Psychology; Cancer; Internal medicine","score_opus":0.022299916123960147,"score_gpt":0.3943237353078077,"score_spread":0.3720238191838475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000430706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958203,0.0031126346,0.000016374652,0.0000936097,0.000024493584,0.000724869,0.0001963708,0.0000029423854,0.000008408696],"genre_scores_gemma":[0.9906427,0.008995149,0.000053848147,0.000048370868,0.00005679934,0.00013703707,0.00003615111,0.000011090994,0.000018818653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981105,0.0005882508,0.00025280175,0.0003513187,0.00026588133,0.0004312978],"domain_scores_gemma":[0.9992225,0.00008496409,0.000088502806,0.00032020497,0.00014136966,0.00014245941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092395104,0.00012227116,0.00018894157,0.0001682201,0.000102198195,0.000022479351,0.00019611868,0.00008684566,0.000039277824],"category_scores_gemma":[0.00027193502,0.00009205628,0.00005603847,0.00028424076,0.00015788633,0.000005281605,0.0000923872,0.0002431441,5.642861e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009315324,0.002361809,0.67457753,0.000117548996,0.00013231943,0.000012717566,0.0108887525,0.0014910294,0.1396705,0.000010674215,0.004787755,0.15663403],"study_design_scores_gemma":[0.0017321915,0.0020737252,0.9910338,0.00012541181,0.0000053660597,4.3529184e-7,0.0008704825,0.000030783387,0.002789714,0.0011843924,0.000055974724,0.00009773016],"about_ca_topic_score_codex":0.003019447,"about_ca_topic_score_gemma":0.0020659356,"teacher_disagreement_score":0.31645626,"about_ca_system_score_codex":0.0002864261,"about_ca_system_score_gemma":0.0005414388,"threshold_uncertainty_score":0.45645207},"labels":[],"label_agreement":null},{"id":"W2000451721","doi":"10.1158/1538-7445.am2011-96","title":"Abstract 96: The functional role of DNA hypomethylation in liver cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; Chromatin immunoprecipitation; Biology; Promoter; Methylation; Liver cancer; Cancer research; Methylated DNA immunoprecipitation; Gene; Molecular biology; Cancer; Metastasis; Hepatocellular carcinoma; Gene expression; Genetics","score_opus":0.1094003855961721,"score_gpt":0.3643171049960595,"score_spread":0.2549167193998874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000451721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822583,0.013582114,0.00004619729,0.00005947049,0.00008380978,0.00015503023,0.000014692195,0.0000019042403,0.00379849],"genre_scores_gemma":[0.9960333,0.0032946593,0.000040269206,0.000014257495,0.00019448754,0.0001037041,0.000015078257,0.000011105225,0.00029311384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913156,0.00008784184,0.0001488037,0.0001881008,0.00024911854,0.00019456765],"domain_scores_gemma":[0.99945027,0.000032334072,0.000046601188,0.0002038308,0.00022995943,0.000036990532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006629814,0.00006118019,0.000065755914,0.00008061233,0.000059736223,0.0000078113635,0.00014369376,0.000090767826,0.00053187343],"category_scores_gemma":[0.00006580659,0.00004724882,0.000036322617,0.00020176881,0.000115420116,0.000004346366,0.000066043634,0.00015072912,0.000006890094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010727328,0.00003862272,0.03691024,0.000012122221,0.00001846213,4.2601147e-7,0.00023299934,0.00015912416,0.9393063,0.00012393438,0.00018006006,0.022910414],"study_design_scores_gemma":[0.00013170102,0.00004244223,0.37395805,0.000009311993,0.0000022081833,8.3691326e-8,0.0000705249,0.00002749509,0.62057495,0.0005647115,0.0045761284,0.000042369968],"about_ca_topic_score_codex":0.00270076,"about_ca_topic_score_gemma":0.0018414881,"teacher_disagreement_score":0.33704782,"about_ca_system_score_codex":0.000035943907,"about_ca_system_score_gemma":0.00018026434,"threshold_uncertainty_score":0.58236414},"labels":[],"label_agreement":null},{"id":"W2000781940","doi":"10.1158/1538-7445.am2014-ct230","title":"Abstract CT230: Pediatric phase 1 trial of moxetumomab pasudotox: Activity in chemotherapy refractory acute lymphoblastic leukemia (ALL)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Adverse effect; Refractory (planetary science); Dexamethasone; Chemotherapy; Cumulative incidence; Cytokine release syndrome; Surgery; Cohort; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.05100296528398559,"score_gpt":0.4072639929385653,"score_spread":0.35626102765457973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000781940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401784,0.00024235083,0.00014440999,0.0008727167,0.00028889911,0.0020532182,0.00005889827,0.00006825377,0.0022534211],"genre_scores_gemma":[0.9950648,0.0016988253,0.00012099824,0.00013971206,0.0014637747,0.0005646691,0.000023491655,0.00012149394,0.0008022557],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936336,0.0004911255,0.0007872974,0.00092756795,0.0026588484,0.0015015183],"domain_scores_gemma":[0.9955042,0.0017974577,0.00024236541,0.0011541535,0.00065514795,0.0006466783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003323944,0.0003917611,0.0009866267,0.0012686123,0.00012631994,0.000054210825,0.00067899516,0.00042760937,0.0008127749],"category_scores_gemma":[0.001410829,0.00034411167,0.00023094904,0.0017406651,0.00053545483,0.00027737656,0.00023084824,0.0015872812,0.00013569632],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.29862517,0.0048713917,0.003247305,0.0016854651,0.0005180229,0.0007151114,0.0009775996,0.000070548354,0.5879875,0.00010565564,0.015592052,0.0856042],"study_design_scores_gemma":[0.69285095,0.0125557715,0.033951867,0.0006989069,0.00032160728,0.0000913053,0.00021305133,0.0076152943,0.23756835,0.0003837498,0.012622006,0.001127128],"about_ca_topic_score_codex":0.0020984116,"about_ca_topic_score_gemma":0.000080007485,"teacher_disagreement_score":0.39422578,"about_ca_system_score_codex":0.006488623,"about_ca_system_score_gemma":0.007387559,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W2000786845","doi":"10.1158/0008-5472.can-06-1898","title":"ErbB-2 Induces the <i>Cyclin D1</i> Gene in Prostate Epithelial Cells <i>In vitro</i> and <i>In vivo</i>","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Cancer research; Cyclin D1; ErbB; LNCaP; Biology; Prostate cancer; DU145; Cyclin D; Cyclin B; Carcinogenesis; Prostate; Cell cycle; Cancer; Signal transduction; Cell biology","score_opus":0.06950052905009499,"score_gpt":0.41905375034486486,"score_spread":0.34955322129476984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000786845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828965,0.0042791544,0.000003664753,0.0059773736,0.00029816537,0.002327587,0.00009747514,0.000025131878,0.0040949476],"genre_scores_gemma":[0.9891264,0.006482796,0.0001318254,0.00096827897,0.00049050414,0.00040990525,0.0000060412585,0.000080595964,0.002303653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99417245,0.00056702463,0.0007349814,0.0008593491,0.0017008454,0.0019653721],"domain_scores_gemma":[0.9976348,0.0009649898,0.000063394255,0.0006925928,0.0002462314,0.00039793778],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010115395,0.00027615565,0.0005377839,0.0009426124,0.0001416298,0.0000942669,0.0005209991,0.0002159348,0.00018709038],"category_scores_gemma":[0.00032069828,0.00020991213,0.00006543712,0.002541137,0.00078496296,0.00014941282,0.00035896112,0.0026986466,0.000054524327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030988324,0.00021393939,0.013225412,0.0002374227,0.000013868341,0.000927303,0.0017323282,0.000025085938,0.96171916,0.000022426357,0.0026889194,0.01609528],"study_design_scores_gemma":[0.0036544476,0.0002032346,0.009790448,0.00037267793,0.0000054774823,0.000027788139,0.0010548391,0.00005177966,0.9505097,0.0002549474,0.03384908,0.00022552638],"about_ca_topic_score_codex":0.0088832835,"about_ca_topic_score_gemma":0.009483942,"teacher_disagreement_score":0.03116016,"about_ca_system_score_codex":0.0011167258,"about_ca_system_score_gemma":0.001256193,"threshold_uncertainty_score":0.99960214},"labels":[],"label_agreement":null},{"id":"W2001094166","doi":"10.1158/0008-5472.sabcs-6084","title":"Lifestyle, weight history, nutrition and breast cancer among non-gene carriers: a case-control study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Hôpital Notre-Dame; Hôtel-Dieu de Montréal","funders":"","keywords":"Breast cancer; Medicine; Body mass index; Cancer; Family history; Internal medicine; Gynecology; Case-control study; Obstetrics; Demography","score_opus":0.039333143104120755,"score_gpt":0.36101745751084485,"score_spread":0.32168431440672407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001094166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627076,0.026597416,0.0000049714795,0.0076519735,0.00018164812,0.0016251836,0.00028875368,0.000033910695,0.0009085519],"genre_scores_gemma":[0.9915678,0.0047075395,0.000026336293,0.00048037842,0.001498136,0.0008607664,0.000006992162,0.000021676242,0.00083037006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998111,0.00010493333,0.00021123345,0.00043540687,0.0006265029,0.0005109417],"domain_scores_gemma":[0.9987002,0.00008930647,0.00003897477,0.00023123235,0.0005729942,0.0003673103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046447405,0.00016311849,0.00035264774,0.00019382533,0.0003153845,0.000026447653,0.000077881894,0.00008675866,0.00056282996],"category_scores_gemma":[0.000038541275,0.00014039232,0.00006619893,0.00027689443,0.00024946118,0.000107421336,0.000040748884,0.0004311304,0.0000072142357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049944627,0.0035330108,0.6184297,0.0006767321,0.000849235,0.010671249,0.0027142246,0.0000053384383,0.014320731,0.00012024638,0.31127644,0.032408617],"study_design_scores_gemma":[0.011554901,0.0011870958,0.9545165,0.00046273865,0.00018151916,0.0007259631,0.0012884816,0.000074175885,0.0002524067,0.0000997316,0.029398497,0.00025800985],"about_ca_topic_score_codex":0.00670164,"about_ca_topic_score_gemma":0.0013724942,"teacher_disagreement_score":0.33608678,"about_ca_system_score_codex":0.001113257,"about_ca_system_score_gemma":0.00027348576,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W2001203244","doi":"10.1158/1538-7445.am2011-1323","title":"Abstract 1323: Reciprocal regulation of Stat3 and caveolin-1 in normal fibroblasts and breast carcinoma lines","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"STAT3; Downregulation and upregulation; STAT protein; Caveolin 1; Caveolae; Cell biology; Cancer research; Biology; Apoptosis; Chemistry; Signal transduction; Biochemistry; Gene","score_opus":0.0438251622950709,"score_gpt":0.3208935437254703,"score_spread":0.2770683814303994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001203244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624205,0.0028425318,0.000020840525,0.000047921065,0.000023474184,0.00012808006,0.00003202951,0.0000024910166,0.00066058134],"genre_scores_gemma":[0.9985921,0.0008003623,0.000070823946,0.000008928134,0.00011657348,0.000023396817,0.000023722756,0.000012844587,0.00035127765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991479,0.000035527188,0.00016758699,0.00026220412,0.00015134158,0.00023542959],"domain_scores_gemma":[0.9995243,0.000015010828,0.000038052887,0.00014748765,0.00019436222,0.00008078692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003185077,0.000084252424,0.00010944793,0.00008969088,0.0000438752,0.0000119066535,0.00008438451,0.000109596025,0.000056021596],"category_scores_gemma":[0.00003427089,0.0000793635,0.00001773424,0.00011730699,0.00022551138,0.000008970517,0.000118478245,0.00013049148,0.000001030679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005323083,0.00004212576,0.06493526,0.0002459536,0.000011051382,0.000005564031,0.00039490595,0.0000065824916,0.9247155,0.00003748858,0.00014388972,0.0089293765],"study_design_scores_gemma":[0.00043375453,0.00013841056,0.40981546,0.000050763847,0.000002879996,0.000020843641,0.00015327506,0.000028312914,0.5888027,0.00013947388,0.00032701765,0.00008710721],"about_ca_topic_score_codex":0.0012263336,"about_ca_topic_score_gemma":0.0009982983,"teacher_disagreement_score":0.3448802,"about_ca_system_score_codex":0.000013277624,"about_ca_system_score_gemma":0.00015041072,"threshold_uncertainty_score":0.32363495},"labels":[],"label_agreement":null},{"id":"W2001336681","doi":"10.1158/1538-7445.am2013-3940","title":"Abstract 3940: Ezrin is a key regulator in Src-induced angiogenesis and lymphangiogenesis in breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Queen's University","funders":"","keywords":"Ezrin; Podoplanin; Matrigel; Lymphangiogenesis; Proto-oncogene tyrosine-protein kinase Src; CD31; Angiogenesis; Cancer research; Pathology; Biology; Medicine; Metastasis; Cell biology; Lymphatic system; Cancer; Cell; Internal medicine; Kinase; Cytoskeleton","score_opus":0.04272398790308759,"score_gpt":0.3561644006024346,"score_spread":0.313440412699347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001336681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810663,0.015666133,0.0000015796496,0.0022301031,0.00010646161,0.0005449082,0.00011878239,0.000010138944,0.0002555852],"genre_scores_gemma":[0.98942053,0.0078637265,0.00004025977,0.00038491914,0.0004117283,0.0011986204,0.00001621454,0.00006418802,0.00059978117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99740654,0.00012639139,0.00036061188,0.00082366786,0.00041043785,0.0008723222],"domain_scores_gemma":[0.9988704,0.00003518908,0.00006742533,0.0005022702,0.00028280795,0.00024195452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005503821,0.00026639234,0.0003070158,0.00035659442,0.00011574545,0.00008131212,0.00036380906,0.00031136355,0.0010308331],"category_scores_gemma":[0.000025867319,0.00025555163,0.00013193881,0.0007114881,0.00016736022,0.000022966246,0.00025965957,0.0001055277,0.000036820613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014310266,0.0000774915,0.20997366,0.000074238604,0.00006382407,0.000010501902,0.00015793859,0.00003096563,0.7529575,0.000012616474,0.007892926,0.028605198],"study_design_scores_gemma":[0.0009658723,0.000056431745,0.75518644,0.00014873654,0.000008862856,0.0000100193565,0.00022356836,0.000047473688,0.23874047,0.000050860886,0.004203621,0.00035764303],"about_ca_topic_score_codex":0.02386582,"about_ca_topic_score_gemma":0.0041421484,"teacher_disagreement_score":0.54521275,"about_ca_system_score_codex":0.00026841403,"about_ca_system_score_gemma":0.00048175786,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W2001422772","doi":"10.1158/1538-7445.am2012-820","title":"Abstract 820: Somatic mutations to identify tumors for highly selective chemosensitization by Nrf2 depletion","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer research; Somatic cell; PTEN; KEAP1; Loss function; Cancer; PI3K/AKT/mTOR pathway; Mutation; Transcription factor; Biology; Medicine; Gene; Genetics; Signal transduction; Phenotype","score_opus":0.03938157868650366,"score_gpt":0.3943912912960465,"score_spread":0.35500971260954284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001422772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140877,0.0007036476,0.005927701,0.0008463013,0.00012998816,0.0006534373,0.00016829863,0.000014346957,0.00014752592],"genre_scores_gemma":[0.9978056,0.00007596371,0.00020366524,0.00017515574,0.00035522136,0.00045274931,0.00050081965,0.000032279906,0.00039853837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988576,0.00005797541,0.00015844444,0.00023807974,0.00022979584,0.0004580817],"domain_scores_gemma":[0.99931335,0.00004511001,0.000026386524,0.0001624063,0.00027382426,0.00017892792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041428674,0.000102611826,0.000097760065,0.00007858383,0.00021891283,0.00004080178,0.000105575935,0.0000921778,0.00004799623],"category_scores_gemma":[0.00010463042,0.00010465003,0.000056212048,0.00019701199,0.000048648675,0.000012736631,0.000024464935,0.00010783335,0.00004687197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008708758,0.00005751784,0.00076602655,0.000044385524,0.00002806672,3.5507227e-7,0.00027341233,0.000082463994,0.98198795,0.00008351582,0.015487433,0.0011017923],"study_design_scores_gemma":[0.00040732117,0.00014283702,0.0149528105,0.000027382837,0.0000129414475,0.0000037364155,0.00015011901,0.000021176567,0.97589964,0.00011005815,0.008118767,0.0001531995],"about_ca_topic_score_codex":0.00021649667,"about_ca_topic_score_gemma":0.00007853457,"teacher_disagreement_score":0.014186784,"about_ca_system_score_codex":0.00007714133,"about_ca_system_score_gemma":0.00012997871,"threshold_uncertainty_score":0.42675045},"labels":[],"label_agreement":null},{"id":"W2001683921","doi":"10.1158/0008-5472.sabcs12-pd03-05","title":"Abstract PD03-05: Analysis of tumour cell signaling in response to neoadjuvant metformin in women with early stage breast cancer.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital; Statistics Canada; Ontario Institute for Cancer Research","funders":"","keywords":"Metformin; Medicine; Hyperinsulinemia; Breast cancer; PI3K/AKT/mTOR pathway; Insulin; AMPK; Internal medicine; Cancer; Oncology; Diabetes mellitus; Endocrinology; Insulin resistance; Signal transduction; Protein kinase A; Biology; Phosphorylation","score_opus":0.028547296153987562,"score_gpt":0.34833302812149214,"score_spread":0.3197857319675046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001683921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657282,0.03345877,0.00000880418,0.000044512413,0.00005289564,0.00030039108,0.0003043212,0.0000035388837,0.0000985511],"genre_scores_gemma":[0.99349934,0.0053452756,0.000055615637,0.00009647185,0.00015328445,0.00045557745,0.000011264775,0.000031922318,0.00035125468],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99747545,0.00027290665,0.00034134954,0.00040867986,0.00050994847,0.0009916496],"domain_scores_gemma":[0.99892604,0.00006352038,0.00009011566,0.00039068676,0.00022755505,0.00030205978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027474524,0.000175196,0.00041312038,0.0007081613,0.00004432212,0.00002678613,0.00033734014,0.000117920936,0.0005391343],"category_scores_gemma":[0.00005460551,0.00015169587,0.00006444379,0.0017069973,0.000097498516,0.000020616913,0.00011968858,0.00029574093,0.000005009202],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005663585,0.00014041191,0.044275332,0.00006351332,0.00016823891,0.000010059081,0.0016129175,0.0030076574,0.92567295,0.0000029901291,0.0002010961,0.019181255],"study_design_scores_gemma":[0.0011224946,0.0002255491,0.51219475,0.000090862144,0.000039428003,4.981857e-7,0.0013209531,0.0000143292755,0.46860507,0.0000025330082,0.016118523,0.00026502658],"about_ca_topic_score_codex":0.0059346315,"about_ca_topic_score_gemma":0.0039831162,"teacher_disagreement_score":0.4679194,"about_ca_system_score_codex":0.00031179166,"about_ca_system_score_gemma":0.0005830864,"threshold_uncertainty_score":0.8971427},"labels":[],"label_agreement":null},{"id":"W2001947579","doi":"10.1158/0008-5472.sabcs13-p4-08-01","title":"Abstract P4-08-01: Effects of exercise during adjuvant chemotherapy on clinical outcomes in early stage breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Ottawa; BC Cancer Agency; University of British Columbia; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Cancer; Oncology; Chemotherapy; Disease; Clinical trial; Stage (stratigraphy); Aerobic exercise; Confidence interval","score_opus":0.05923827786872951,"score_gpt":0.4334800020549077,"score_spread":0.3742417241861782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001947579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943673,0.001612684,4.4916487e-7,0.0015636093,0.00048172715,0.0013956858,0.00006342678,0.000033874792,0.0004812465],"genre_scores_gemma":[0.991169,0.0045892885,0.0000047027293,0.00017761975,0.0002729056,0.000825787,0.0000034882662,0.000061309016,0.0028959382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971411,0.00012857687,0.0005188032,0.00051301025,0.0009891158,0.0007093762],"domain_scores_gemma":[0.9982198,0.00040895783,0.000097921475,0.00060407445,0.00033369166,0.00033557456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006813561,0.00021971502,0.0007400368,0.00032828757,0.0000626572,0.000035849804,0.0002672967,0.00019833518,0.0027745254],"category_scores_gemma":[0.000083400926,0.00017311792,0.00020805775,0.00048407854,0.00024073815,0.0001321642,0.000078126046,0.001056134,0.00011959786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017061596,0.00041634025,0.9421242,0.0015447285,0.000104815015,0.000086782995,0.0013226614,0.000007811956,0.013184453,0.000010503651,0.00083390664,0.038657673],"study_design_scores_gemma":[0.0038550263,0.00025721884,0.9729443,0.0019236818,0.000014392819,0.0000012099447,0.00021683052,0.000004620176,0.020352727,0.000019487416,0.0002495239,0.00016096012],"about_ca_topic_score_codex":0.06589529,"about_ca_topic_score_gemma":0.0049664327,"teacher_disagreement_score":0.060928855,"about_ca_system_score_codex":0.00046015548,"about_ca_system_score_gemma":0.00044583564,"threshold_uncertainty_score":0.99813706},"labels":[],"label_agreement":null},{"id":"W2002002282","doi":"10.1158/1538-7445.am2014-sy37-04","title":"Abstract SY37-04: Bcl-2 family proteins as a paradigm for protein:protein interactions as chemotherapy targets","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Cell biology; Biology; Bcl-2 family; Protein family; Cytoplasm; Membrane protein; Protein–protein interaction; Programmed cell death; Integral membrane protein; Signal transduction; Apoptosis; Biochemistry; Membrane; Gene","score_opus":0.04891056220765365,"score_gpt":0.3837727500358447,"score_spread":0.33486218782819105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002002282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704803,0.0009000423,0.008008426,0.004506272,0.00057424005,0.0042603463,0.00006519645,0.000048915816,0.011156231],"genre_scores_gemma":[0.9646047,0.00016878593,0.000882708,0.00087738887,0.0018067961,0.0060465354,0.000120808574,0.00007434504,0.025417944],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980001,0.00020071123,0.00026214472,0.00064051023,0.00029623634,0.00060030166],"domain_scores_gemma":[0.9988159,0.000036625912,0.000084910214,0.00054948515,0.00030747222,0.00020563792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006995346,0.00020303039,0.00021165388,0.00012534673,0.0003050016,0.00007293229,0.0003297518,0.00024074923,0.000668969],"category_scores_gemma":[0.0004530316,0.00018782583,0.00014433182,0.00016841521,0.00017084077,0.000011048109,0.00007610519,0.0003975206,0.0002704162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010060476,0.00010151751,0.000023552615,0.000071400675,0.00005080353,0.0000024995506,0.00006573701,0.000009806142,0.97765726,0.0017467397,0.010529762,0.008734876],"study_design_scores_gemma":[0.000810207,0.0006607074,0.00013104797,0.000045454042,0.0000029000275,0.000006007579,0.000034615365,0.00001105119,0.47851437,0.0021741122,0.51745707,0.00015246663],"about_ca_topic_score_codex":0.0005925392,"about_ca_topic_score_gemma":0.0002288365,"teacher_disagreement_score":0.5069273,"about_ca_system_score_codex":0.00007009537,"about_ca_system_score_gemma":0.00041481093,"threshold_uncertainty_score":0.7659315},"labels":[],"label_agreement":null},{"id":"W2002287427","doi":"10.1158/1538-7445.am2011-3847","title":"Abstract 3847: Cytoplasmic ECT2: Implications for invasion and migration and RAS-RAC cross-talk in glioma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"RHOA; CDC42; RAC1; Glioma; Biology; Cell biology; Cytoplasm; Cancer research; Small GTPase; Phenotype; Cell migration; Actin; Cell; Signal transduction; Gene; Biochemistry","score_opus":0.07472196193856759,"score_gpt":0.38994625253722787,"score_spread":0.3152242905986603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002287427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975958,0.0014544328,0.00009500257,0.00020266739,0.00002604422,0.000381333,0.000050479754,0.000003715145,0.00019051008],"genre_scores_gemma":[0.99726874,0.0019773536,0.0001817633,0.000034143657,0.00005847099,0.0002618662,0.000060421324,0.000013686765,0.00014353065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929416,0.000023511639,0.000121862126,0.00028667186,0.000053603977,0.00022019277],"domain_scores_gemma":[0.9995868,0.00002474937,0.000026249274,0.0001774392,0.00012203534,0.000062711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028970218,0.0000714771,0.00007175446,0.000085901724,0.00010559052,0.000036997724,0.00009199892,0.00011791545,0.000011707403],"category_scores_gemma":[0.00006292366,0.00006942446,0.00002007813,0.000106848536,0.0001210862,0.00000855432,0.000079745536,0.00009612221,0.0000012997014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001390132,0.000029185856,0.05550314,0.000040964078,0.0000080115915,7.432411e-7,0.00011723216,0.0000018375897,0.9399549,0.000094804695,0.00045213298,0.0036580635],"study_design_scores_gemma":[0.0005828364,0.00012352223,0.41261926,0.000024505556,0.000003265046,0.000007991442,0.0000473664,0.000016429245,0.58188015,0.00046952695,0.004120293,0.00010483189],"about_ca_topic_score_codex":0.00053142087,"about_ca_topic_score_gemma":0.0029183102,"teacher_disagreement_score":0.35807472,"about_ca_system_score_codex":0.000025194879,"about_ca_system_score_gemma":0.00008777597,"threshold_uncertainty_score":0.28310472},"labels":[],"label_agreement":null},{"id":"W2002761920","doi":"10.1158/0008-5472.can-07-1743","title":"The Alternative Reading Frame Tumor Suppressor Antagonizes Hypoxia-Induced Cancer Cell Migration via Interaction with the COOH-Terminal Binding Protein Corepressor","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cell migration; Cancer research; Gene knockdown; Small interfering RNA; Biology; Cancer cell; Kinase; Phosphatidylinositol; Cell biology; PI3K/AKT/mTOR pathway; Tumor suppressor gene; Transfection; Cell; Signal transduction; Cancer; Cell culture; Apoptosis; Carcinogenesis; Biochemistry","score_opus":0.04564163440641912,"score_gpt":0.3884826808193526,"score_spread":0.3428410464129335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002761920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958619,0.0005264045,0.00037528825,0.0011692075,0.00022185921,0.0013259901,0.000047893627,0.000015412785,0.0004560546],"genre_scores_gemma":[0.99548143,0.0003107766,0.00004048377,0.000045862664,0.0007071445,0.000831507,0.000037727754,0.00005785999,0.0024872154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968212,0.00042276827,0.00026628154,0.0006095592,0.00093917735,0.00094100024],"domain_scores_gemma":[0.99799734,0.00028746595,0.0001666389,0.0006015373,0.0007828125,0.00016418431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017756928,0.0002293816,0.0001644932,0.000102470985,0.0007869964,0.00027326864,0.00074411434,0.0001290836,0.00009487349],"category_scores_gemma":[0.00021814654,0.0001351212,0.00006950304,0.00035555675,0.0003989823,0.000038469425,0.0003031264,0.0008527732,0.00001786893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015332702,0.000046109883,0.001020245,0.00003500442,0.000077453165,0.000025170875,0.0004550594,0.000027545631,0.9923435,0.000012571813,0.0012980179,0.0031260913],"study_design_scores_gemma":[0.0005047493,0.0004663434,0.0007233458,0.000094474315,0.000010704589,0.000017127379,0.0017208967,0.00025534342,0.98615545,0.000012609909,0.009850359,0.0001886065],"about_ca_topic_score_codex":0.0072266054,"about_ca_topic_score_gemma":0.011015464,"teacher_disagreement_score":0.008552341,"about_ca_system_score_codex":0.00044129626,"about_ca_system_score_gemma":0.0004121375,"threshold_uncertainty_score":0.99938434},"labels":[],"label_agreement":null},{"id":"W2002793570","doi":"10.1158/0008-5472.can-06-3767","title":"Gene Expression Profiling of Childhood Adrenocortical Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; American Lebanese Syrian Associated Charities; Association pour la Recherche sur le Cancer","keywords":"Adrenocortical carcinoma; Gene expression profiling; Adrenal cortex; Gene expression; Microarray; Gene; Biology; Pathology; Disease; Epigenetics; Cancer research; Microarray analysis techniques; Northern blot; Bioinformatics; Medicine; Endocrinology; Genetics","score_opus":0.06823088002780182,"score_gpt":0.41768705293997055,"score_spread":0.34945617291216874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002793570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946808,0.0011098026,0.0002981141,0.00022068016,0.00006146532,0.0004064871,0.0000069156017,0.000026303926,0.0031893982],"genre_scores_gemma":[0.9974545,0.000027108024,0.0013032447,0.00004792925,0.00042052445,0.000030550014,0.0000103863895,0.000019885083,0.0006858711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982249,0.0000475515,0.00027910282,0.000237085,0.00071766676,0.0004936771],"domain_scores_gemma":[0.99903953,0.00012144242,0.000040163326,0.0002541375,0.00027678415,0.00026791694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009896319,0.000084696454,0.00021509765,0.00020793299,0.0000848076,0.0000052865616,0.00011948623,0.00006764536,0.0005749045],"category_scores_gemma":[0.00021544879,0.00006286638,0.00006343799,0.0004952585,0.00019817169,0.00003594613,0.000086666325,0.0004842695,0.000042919986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014662633,0.00047037358,0.034283187,0.0002827762,0.000045857727,0.0019698595,0.00087737053,0.00001733884,0.9435711,0.0007622157,0.0011657359,0.015087906],"study_design_scores_gemma":[0.00071642664,0.00022330388,0.075874425,0.00030807464,0.000008893004,0.00021552011,0.00019611881,0.0000084557105,0.9220819,0.00017053926,0.00013391217,0.00006241576],"about_ca_topic_score_codex":0.000072106785,"about_ca_topic_score_gemma":0.0000060092752,"teacher_disagreement_score":0.04159124,"about_ca_system_score_codex":0.00008840084,"about_ca_system_score_gemma":0.0003861997,"threshold_uncertainty_score":0.6294801},"labels":[],"label_agreement":null},{"id":"W2003165865","doi":"10.1158/1538-7445.am2013-1979","title":"Abstract 1979: Tripartite motif 14 (TRIM14) is a putative tumor suppressor gene in non-small-cell lung cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cell growth; Cancer research; Biology; Small hairpin RNA; Gene silencing; Lung cancer; Tumor suppressor gene; RNA interference; Cancer; Cell; Carcinogenesis; Gene; Pathology; Medicine; Gene knockdown; RNA; Genetics","score_opus":0.04001473496342847,"score_gpt":0.3689724047367529,"score_spread":0.3289576697733244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003165865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873697,0.0077595753,0.000094098476,0.0007841478,0.0001443246,0.0010444003,0.00018019152,0.000009019666,0.0026145026],"genre_scores_gemma":[0.9868432,0.0023187774,0.00013056309,0.00029099334,0.00035120547,0.0032246136,0.000059259706,0.000046604222,0.0067347586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780285,0.000106528656,0.00032211124,0.0006689868,0.00035388148,0.00074563123],"domain_scores_gemma":[0.9985887,0.0000348821,0.00008998289,0.0005465317,0.0005299886,0.00020994493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004295027,0.00020235944,0.00022490052,0.00016330184,0.00015810835,0.00010921929,0.0004762824,0.00014981274,0.0017257518],"category_scores_gemma":[0.000035815832,0.0001904227,0.00009094855,0.0004307276,0.00016684178,0.000017971306,0.00016232814,0.00042609178,0.00011631041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082248596,0.00012126376,0.0023271537,0.000105923405,0.000044614204,0.0000066532252,0.000478439,0.00041256446,0.93948746,0.0000039299166,0.054252427,0.0026773047],"study_design_scores_gemma":[0.0013072888,0.00009352468,0.024506629,0.00006276166,0.00001094454,0.0000013188583,0.0003105554,0.0006813773,0.9589066,0.000042321386,0.0138014965,0.00027521615],"about_ca_topic_score_codex":0.009006101,"about_ca_topic_score_gemma":0.00070651044,"teacher_disagreement_score":0.04045093,"about_ca_system_score_codex":0.00020696204,"about_ca_system_score_gemma":0.0006549099,"threshold_uncertainty_score":0.9991868},"labels":[],"label_agreement":null},{"id":"W2003171460","doi":"10.1158/1538-7445.am2011-1019","title":"Abstract 1019: Localization and activity of β-catenin is regulated by O-GlcNAc modification at Serine 23","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Phosphorylation; AXIN2; Serine; Molecular biology; Chemistry; Wnt signaling pathway; Catenin; DU145; Fusion protein; Mutant; Cell biology; Biology; Signal transduction; Biochemistry; Gene; LNCaP; Genetics; Cancer cell","score_opus":0.08540726901657913,"score_gpt":0.375203089481585,"score_spread":0.28979582046500585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003171460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970931,0.0006760733,0.00051817764,0.00020717143,0.000018064628,0.0003425805,0.000061221646,0.000007230116,0.0010763704],"genre_scores_gemma":[0.99487954,0.001115868,0.000036849597,0.000020338954,0.000029906398,0.00007472155,0.000117600735,0.000018042101,0.0037071276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884933,0.00009036017,0.00014416025,0.00032836985,0.0003326106,0.00025518727],"domain_scores_gemma":[0.99911726,0.000010021383,0.000056919485,0.00029469872,0.00040880567,0.00011232191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042308838,0.00008754777,0.0000999563,0.0000874989,0.00011762535,0.00001357592,0.00014587703,0.00014482083,0.00046891734],"category_scores_gemma":[0.000066188855,0.00008355306,0.000026662581,0.00023520697,0.00021569539,0.0000099493045,0.00014758587,0.00012952174,0.000019544304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004684116,0.00006265524,0.0020421688,0.000066700064,0.00002305166,6.282212e-7,0.00012365832,0.000014647361,0.9851804,0.000020618565,0.005680198,0.0063169026],"study_design_scores_gemma":[0.0003782147,0.00013202056,0.02117141,0.000014956477,0.000002265984,0.0000012867428,0.000019033347,0.00047872763,0.9678051,0.000048141166,0.009865774,0.00008308076],"about_ca_topic_score_codex":0.0012191965,"about_ca_topic_score_gemma":0.00015269323,"teacher_disagreement_score":0.01912924,"about_ca_system_score_codex":0.000053563548,"about_ca_system_score_gemma":0.00009616359,"threshold_uncertainty_score":0.5134316},"labels":[],"label_agreement":null},{"id":"W2003187570","doi":"10.1158/0008-5472.sabcs13-p2-15-01","title":"Abstract P2-15-01: Impact of adjuvant trastuzumab (AT) on survival in metastatic (M1) her2 positive breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Cohort; Oncology; Cancer; Hazard ratio; Surgery; Confidence interval","score_opus":0.0664768558664194,"score_gpt":0.44115381458796615,"score_spread":0.37467695872154677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003187570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913747,0.002959221,0.00001041828,0.0017770078,0.00015288359,0.0015124289,0.0007588572,0.000035376765,0.0014191502],"genre_scores_gemma":[0.99727017,0.0005212726,0.000062311105,0.00011697125,0.00024748768,0.00082920125,0.000037032976,0.00009916256,0.0008163798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99610853,0.00024464657,0.00054277206,0.0006384169,0.001337791,0.0011278496],"domain_scores_gemma":[0.9976041,0.00047242848,0.00016193427,0.0005842458,0.0007566577,0.00042065224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000670465,0.00036460563,0.0008561657,0.0005469729,0.00011216542,0.000030851006,0.0003056831,0.00010813986,0.01370561],"category_scores_gemma":[0.000084944775,0.00027947236,0.00023199299,0.0009129923,0.0005083751,0.00028592336,0.00011280689,0.0009530297,0.00017920167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017207947,0.002048063,0.11641869,0.0010351418,0.0019884696,0.00044206268,0.0053890175,0.003493003,0.5012422,0.00016402753,0.0046489416,0.34592244],"study_design_scores_gemma":[0.0042060013,0.00080463727,0.97311765,0.0011775711,0.00003844986,0.00005211601,0.0008182819,0.00008864681,0.018935906,0.0002755751,0.0002013716,0.00028382408],"about_ca_topic_score_codex":0.04427532,"about_ca_topic_score_gemma":0.00375228,"teacher_disagreement_score":0.85669893,"about_ca_system_score_codex":0.004560989,"about_ca_system_score_gemma":0.0015546974,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2003316492","doi":"10.1158/1538-7445.am2011-2037","title":"Abstract 2037: Investigation into the relationship between intracellular localization of APE1 and cellular stress","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"","keywords":"Base excision repair; AP site; DNA-(apurinic or apyrimidinic site) lyase; Biology; AP endonuclease; Cytoplasm; DNA repair; Cell biology; DNA damage; Molecular biology; Nuclear export signal; DNA; Cell nucleus; Genetics","score_opus":0.10464779047475986,"score_gpt":0.34361580829677013,"score_spread":0.23896801782201027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003316492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594617,0.0015244627,0.0018679439,0.00010605201,0.000038037746,0.00025141888,0.000009107467,0.000006795391,0.00024998366],"genre_scores_gemma":[0.9991758,0.00011351941,0.00021482646,0.000015330605,0.00012436103,0.0000484428,0.000073553514,0.000017123692,0.00021706092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989896,0.0001689818,0.00017802315,0.00023548992,0.00025404422,0.00017389003],"domain_scores_gemma":[0.99926615,0.00008276876,0.000066641805,0.00031512554,0.00019399427,0.000075344906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008538841,0.00007621307,0.0000781376,0.00006368562,0.00014169836,0.000015919843,0.00019425087,0.00013695606,0.000039885308],"category_scores_gemma":[0.00032176648,0.00006220127,0.000024420795,0.00018139694,0.00030637384,0.000008182892,0.00011617177,0.0001816932,0.000004900156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031917527,0.000015725329,0.21330194,0.0001063563,0.000026500249,0.0000011366045,0.0015727076,0.000030696603,0.781602,0.0013435606,0.00020957192,0.0017578547],"study_design_scores_gemma":[0.00013364606,0.00008363875,0.03475375,0.000040674575,0.000009466756,2.640271e-7,0.00035813815,0.000042786367,0.95927954,0.0047935615,0.00043540294,0.00006914529],"about_ca_topic_score_codex":0.00068907806,"about_ca_topic_score_gemma":0.00012508257,"teacher_disagreement_score":0.17854819,"about_ca_system_score_codex":0.000023242299,"about_ca_system_score_gemma":0.00011512856,"threshold_uncertainty_score":0.2536494},"labels":[],"label_agreement":null},{"id":"W2003463518","doi":"10.1158/1538-7445.am2012-4166","title":"Abstract 4166: Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; Signal transduction; Cell biology; Kinase; Biology; Senescence","score_opus":0.04202752112323867,"score_gpt":0.3331159407019406,"score_spread":0.29108841957870196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003463518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704033,0.0006090157,0.00004194402,0.00013907878,0.00008950004,0.0007362089,0.000100794125,0.0000064843216,0.0012366447],"genre_scores_gemma":[0.9984235,0.000011201958,0.000026330043,0.000014189267,0.00025081012,0.0003254349,0.000021569918,0.00002048697,0.0009064852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998514,0.00029834898,0.0001385481,0.0002446733,0.00034777776,0.00045666206],"domain_scores_gemma":[0.9992307,0.000024579296,0.00010210027,0.00032725016,0.0002143622,0.000101015576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010536297,0.00010526231,0.000110009365,0.00003093151,0.00016456575,0.000017545077,0.00026354907,0.00009789881,0.00004371425],"category_scores_gemma":[0.00032952955,0.00007655541,0.00006139642,0.00017379045,0.000121876656,0.000013294734,0.0001613885,0.00030015153,0.000005594629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060329327,0.00011161436,0.0014214127,0.00007515136,0.000022765415,3.2692063e-7,0.00016434297,8.3701116e-7,0.9928483,0.00003748729,0.0022005711,0.0030568691],"study_design_scores_gemma":[0.00020231357,0.00010398033,0.010307368,0.00004039949,0.000003116149,0.0000018476895,0.000047307698,0.0000062714353,0.9837247,0.000021720578,0.005452619,0.00008834524],"about_ca_topic_score_codex":0.00027829158,"about_ca_topic_score_gemma":0.00005479329,"teacher_disagreement_score":0.009123581,"about_ca_system_score_codex":0.00005740686,"about_ca_system_score_gemma":0.00028679764,"threshold_uncertainty_score":0.3121839},"labels":[],"label_agreement":null},{"id":"W2003492008","doi":"10.1158/0008-5472.sabcs12-s6-5","title":"Abstract S6-5: Primary results of BEATRICE, a randomized phase III trial evaluating adjuvant bevacizumab-containing therapy in triple-negative breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Taxane; Internal medicine; Breast cancer; Oncology; Bevacizumab; Anthracycline; Triple-negative breast cancer; Randomized controlled trial; Cancer; Mastectomy; Adjuvant; Chemotherapy","score_opus":0.08876426467014656,"score_gpt":0.4489294832525908,"score_spread":0.3601652185824442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003492008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724956,0.01775424,0.00000841205,0.00044215829,0.0003422676,0.0025720731,0.000584165,0.000011408775,0.0010357291],"genre_scores_gemma":[0.9892876,0.0063912417,0.00009890204,0.00007490631,0.0011081564,0.0027041102,0.000112700065,0.000043674812,0.00017867947],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99621373,0.0007789568,0.0008027751,0.0005713503,0.0007620911,0.00087109656],"domain_scores_gemma":[0.99786896,0.00060800364,0.0003453027,0.0004222857,0.00059367844,0.00016178476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004306148,0.00029886837,0.00088171015,0.0002559191,0.00017900491,0.000023198641,0.00029764182,0.00017703013,0.00013448905],"category_scores_gemma":[0.0006226686,0.00023831971,0.00022640626,0.0005198795,0.00041644723,0.000035729918,0.00018452988,0.0003903642,0.0000031094883],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8600504,0.0006470543,0.0009223935,0.000043938468,0.00052316516,0.0000037183693,0.0016078515,0.000029684566,0.06304931,0.000008250669,0.000596258,0.072518],"study_design_scores_gemma":[0.94087553,0.00095980306,0.01192335,0.00020524245,0.00006666267,0.000004549417,0.00063387,0.000021093294,0.04468533,0.000032077798,0.00030482037,0.00028768435],"about_ca_topic_score_codex":0.007799606,"about_ca_topic_score_gemma":0.0005824867,"teacher_disagreement_score":0.080825135,"about_ca_system_score_codex":0.0004659475,"about_ca_system_score_gemma":0.0010251739,"threshold_uncertainty_score":0.99880755},"labels":[],"label_agreement":null},{"id":"W2003612221","doi":"10.1158/1538-7445.am2013-2266","title":"Abstract 2266: The characterization of anti-breast cancer compounds isolated from the <i>Juniperus communis</i>.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of New Brunswick; Université de Moncton","funders":"","keywords":"Cancer; Breast cancer; Juniper; Medicine; Lignan; Cancer cell; Pharmacology; Chemistry; Cancer research; Traditional medicine; Biology; Internal medicine; Botany; Stereochemistry","score_opus":0.039274882909217976,"score_gpt":0.325606224664143,"score_spread":0.28633134175492503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003612221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863125,0.00069146545,0.000020341204,0.00948515,0.00012032611,0.000363065,0.00046186568,0.000007630996,0.0002189067],"genre_scores_gemma":[0.9957357,0.0026692748,0.0000049734995,0.0006114122,0.00042236332,0.00013189204,0.00023676154,0.000014660037,0.00017296722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876124,0.00024704728,0.00018654579,0.00024435934,0.00024323798,0.000317552],"domain_scores_gemma":[0.9988887,0.00009997236,0.00008916052,0.00051437423,0.0003472498,0.00006056702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037799086,0.00012631826,0.0001561111,0.000019404522,0.00033148157,0.000093329756,0.00073773885,0.00016548956,0.00065174646],"category_scores_gemma":[0.000022247252,0.000065069755,0.000073398885,0.00018059147,0.00055721943,0.0000129799355,0.00030609264,0.00041905552,0.000021368895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006963976,0.00007393392,0.009363592,0.0000071205486,0.000062566716,2.3550454e-7,0.00007462859,0.00000423598,0.97343665,0.000013361301,0.003868364,0.013025697],"study_design_scores_gemma":[0.0003096288,0.00014258524,0.71917564,0.000053974083,0.000009062816,0.0000015441835,0.00015769666,0.00008389107,0.25900173,0.00007672001,0.02084508,0.00014246919],"about_ca_topic_score_codex":0.009439684,"about_ca_topic_score_gemma":0.0003426165,"teacher_disagreement_score":0.71443486,"about_ca_system_score_codex":0.00002419942,"about_ca_system_score_gemma":0.00010176325,"threshold_uncertainty_score":0.99715656},"labels":[],"label_agreement":null},{"id":"W2003701881","doi":"10.1158/0008-5472.can-04-2369","title":"Mitogen- and Stress-Activated Protein Kinase 1 Activity and Histone H3 Phosphorylation in Oncogene-Transformed Mouse Fibroblasts","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Histone H3; Protein kinase A; c-Raf; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Cell biology; Kinase; Signal transduction; MAP kinase kinase kinase; Mitogen-Activated Protein Kinase 3; Molecular biology; MAP2K7; ASK1; Biology; Chemistry; Chromatin; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.031506656332913,"score_gpt":0.3431884818826738,"score_spread":0.3116818255497608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003701881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972905,0.0016454975,0.00006384678,0.00018878689,0.00003138722,0.0005501806,0.000075613636,0.000007980326,0.00014621411],"genre_scores_gemma":[0.99829036,0.00062294933,0.000071656956,0.000011183848,0.00006708514,0.00019519833,0.000041710467,0.000019264344,0.00068056653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894273,0.00008258347,0.00010657498,0.00036948468,0.00018302916,0.0003156082],"domain_scores_gemma":[0.9995777,0.0000099228655,0.000026151321,0.00018058524,0.00007992051,0.00012570506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021792029,0.00011553533,0.00011800065,0.000085589316,0.00009803614,0.000024531637,0.0000782189,0.00014584309,0.000016080183],"category_scores_gemma":[0.00005083853,0.00011330518,0.000019370387,0.00014225687,0.00015587523,0.0000111642585,0.00007037638,0.00019059442,0.0000016444973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053680333,0.000057433146,0.00068327616,0.00008707004,0.00001278091,0.000008422674,0.00018290823,0.000030146084,0.99181086,0.000036646303,0.000041746247,0.006511932],"study_design_scores_gemma":[0.0011660906,0.00029567102,0.0035677156,0.00006617748,0.000002110701,0.0000025575,0.000049058322,0.0000073531032,0.99305445,0.00006855855,0.0015923164,0.00012793847],"about_ca_topic_score_codex":0.0013617602,"about_ca_topic_score_gemma":0.002324188,"teacher_disagreement_score":0.0063839937,"about_ca_system_score_codex":0.00011696389,"about_ca_system_score_gemma":0.00026062803,"threshold_uncertainty_score":0.4620451},"labels":[],"label_agreement":null},{"id":"W2003771456","doi":"10.1158/1538-7445.am2014-2001","title":"Abstract 2001: GATA2: Potential role as a prostate cancer metastasis-driving gene","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Community College","funders":"","keywords":"Prostate cancer; Metastasis; Cancer research; Gene silencing; LNCaP; Cancer; Prostate; Biology; Medicine; Oncology; Internal medicine; Gene; Genetics","score_opus":0.0649036143851218,"score_gpt":0.4278472268013677,"score_spread":0.36294361241624595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003771456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678467,0.013042936,0.000023241506,0.008955691,0.00032021644,0.0015601959,0.0001244677,0.00011872535,0.008007833],"genre_scores_gemma":[0.9670276,0.012181211,0.00026054357,0.000247233,0.001183914,0.0013550672,0.00009861758,0.00010666156,0.017539123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949104,0.00024961328,0.00038058255,0.0008376217,0.0018582678,0.001763518],"domain_scores_gemma":[0.9973457,0.00015022137,0.00008248666,0.0007094621,0.0008802076,0.0008319563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018417974,0.00031180267,0.0005117005,0.00048753576,0.0004977112,0.000174501,0.000383706,0.00015935871,0.0049364767],"category_scores_gemma":[0.00023608148,0.00024235407,0.00018331598,0.0008478952,0.0004364804,0.00024378474,0.00026556547,0.0011123087,0.0005594366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027801634,0.00049526175,0.02012919,0.00056580664,0.0007797954,0.00051170145,0.0008822062,0.00022297184,0.7658715,0.0001928196,0.029328726,0.17823987],"study_design_scores_gemma":[0.011164402,0.0015916794,0.08085421,0.0013003997,0.00031720244,0.00011747671,0.0009773779,0.0011176665,0.685881,0.0024179865,0.21333219,0.0009283678],"about_ca_topic_score_codex":0.0059153177,"about_ca_topic_score_gemma":0.0004934777,"teacher_disagreement_score":0.18400346,"about_ca_system_score_codex":0.0008996191,"about_ca_system_score_gemma":0.0022255196,"threshold_uncertainty_score":0.99597317},"labels":[],"label_agreement":null},{"id":"W2003778270","doi":"10.1158/1538-7445.am2013-89","title":"Abstract 89: Parathyroid Hormone-related Protein (PTHrP) is critical for breast tumour metastasis and may constitute a novel target for therapeutic intervention.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cancer research; Western blot; Genetically modified mouse; Biology; Parathyroid hormone-related protein; Transgene; Metastasis; Matrigel; Cancer; Protein kinase B; Internal medicine; Angiogenesis; Endocrinology; Medicine; Signal transduction; Parathyroid hormone; Gene; Cell biology","score_opus":0.11533140638108921,"score_gpt":0.4561021226257742,"score_spread":0.340770716244685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003778270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89867383,0.029492892,0.0024017906,0.05305068,0.00012736053,0.013360117,0.0021811153,0.00008276838,0.00062941766],"genre_scores_gemma":[0.9893159,0.0001626885,0.0020154282,0.0002551236,0.00006560606,0.006573666,0.000051234732,0.00003614293,0.0015241642],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981707,0.000042029078,0.00035225676,0.00040644454,0.00032480533,0.00070378993],"domain_scores_gemma":[0.99842304,0.00021828717,0.00004804591,0.00020845988,0.0006703324,0.00043182768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006182351,0.00016784947,0.00033193294,0.00015135221,0.00026822762,0.0000741241,0.00008288352,0.000121928075,0.00052670995],"category_scores_gemma":[0.00014468298,0.00013026985,0.00013524285,0.00017585944,0.00034520277,0.00017048097,0.00003520073,0.00032627396,0.000060725906],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011747666,0.0058584637,0.004834139,0.0071988665,0.0033884929,0.00009214594,0.0011050228,0.000002388042,0.59739506,0.026488561,0.07264079,0.26924843],"study_design_scores_gemma":[0.13325445,0.019978587,0.48172793,0.0043603145,0.0018299549,0.0011217763,0.002917402,0.0052787536,0.16070482,0.050126273,0.13627747,0.0024222578],"about_ca_topic_score_codex":0.001485634,"about_ca_topic_score_gemma":0.000030130603,"teacher_disagreement_score":0.4768938,"about_ca_system_score_codex":0.00017020792,"about_ca_system_score_gemma":0.00045441216,"threshold_uncertainty_score":0.57671046},"labels":[],"label_agreement":null},{"id":"W2003792648","doi":"10.1158/1538-7445.am10-3550","title":"Abstract 3550: Role of TNFα in the cytotoxicity of docetaxel and in docetaxel resistance in MCF-7 cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Docetaxel; Paclitaxel; Cytotoxicity; Taxane; Pharmacology; MCF-7; Cancer research; Tumor necrosis factor alpha; Cancer cell; Cell culture; Medicine; Cancer; Internal medicine; Biology; In vitro; Breast cancer; Biochemistry","score_opus":0.05495347651965236,"score_gpt":0.43160454713153956,"score_spread":0.3766510706118872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003792648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883351,0.003483982,7.471088e-8,0.0011607793,0.000050866656,0.0006736811,0.000032328808,0.000002816051,0.006260408],"genre_scores_gemma":[0.99798226,0.0013481204,0.000043560238,0.000058376463,0.0000703162,0.00015893739,0.00000274069,0.000010170689,0.0003255112],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985923,0.00012556376,0.0003192559,0.00023944165,0.00037477637,0.00034862664],"domain_scores_gemma":[0.9991375,0.00037446516,0.00006438072,0.00026216346,0.00009881002,0.000062648774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013349566,0.00009720225,0.0003196052,0.00033592997,0.000023324128,0.000006844232,0.00018953749,0.000105428204,0.00033701418],"category_scores_gemma":[0.00007125175,0.00007187462,0.00003462416,0.0006490835,0.0003445268,0.000057301826,0.000048893857,0.0008921214,0.0000028589586],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001493303,0.0005065408,0.13400684,0.0002789758,0.000014980554,0.000056645753,0.0020396672,0.000006025966,0.8598062,0.00019519961,0.00059250375,0.0010031048],"study_design_scores_gemma":[0.003474879,0.00011599858,0.67142206,0.00018035423,0.000009119544,0.0000022218514,0.000422529,0.0000140870325,0.32142016,0.0007885634,0.0020856494,0.000064407424],"about_ca_topic_score_codex":0.0055578733,"about_ca_topic_score_gemma":0.051091604,"teacher_disagreement_score":0.53838605,"about_ca_system_score_codex":0.00011985253,"about_ca_system_score_gemma":0.0003324342,"threshold_uncertainty_score":0.9662235},"labels":[],"label_agreement":null},{"id":"W2003885794","doi":"10.1158/0008-5472.can-12-1339-t","title":"Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; University of Pennsylvania","keywords":"Trastuzumab; Cancer research; Tumor microenvironment; Cytotoxic T cell; CD8; PTEN; Medicine; PI3K/AKT/mTOR pathway; Breast cancer; T cell; Protein kinase B; Mammary tumor; Antibody; Cancer; Immunology; Antigen; Immune system; Biology; Internal medicine; Signal transduction; In vitro; Cell biology; Tumor cells","score_opus":0.05514960438187381,"score_gpt":0.39744508346180224,"score_spread":0.3422954790799284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003885794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120927,0.005034117,0.000012207,0.0011283878,0.00024435893,0.0014910224,0.0004605966,0.000023407269,0.0003966365],"genre_scores_gemma":[0.99756277,0.0005889439,0.00026050324,0.00005862496,0.00040946028,0.00050278165,0.0000034656216,0.00007382295,0.0005396201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99526554,0.0010194634,0.0005781989,0.0005008656,0.0015578826,0.0010780371],"domain_scores_gemma":[0.99652284,0.00099657,0.0001527696,0.00042174826,0.0012003758,0.0007056731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058002206,0.0002359519,0.0006596607,0.0006910034,0.00015241031,0.000024106805,0.0002286309,0.0001353365,0.00060986076],"category_scores_gemma":[0.00065723626,0.0002028111,0.00009422802,0.001288855,0.00063629,0.00016509151,0.0002604097,0.0008380672,0.000017756436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013366496,0.00026826712,0.014375802,0.0014842524,0.00007627568,0.000020129148,0.0021362586,0.000017953913,0.95929325,0.000028174467,0.0053350893,0.003598041],"study_design_scores_gemma":[0.0017357352,0.0010154976,0.08164292,0.0011566917,0.00004001738,0.000018083294,0.0015199353,0.000016569784,0.90964043,0.000009962232,0.0030280934,0.00017609113],"about_ca_topic_score_codex":0.0047127292,"about_ca_topic_score_gemma":0.00011368214,"teacher_disagreement_score":0.06726712,"about_ca_system_score_codex":0.0013300965,"about_ca_system_score_gemma":0.0016080717,"threshold_uncertainty_score":0.82703966},"labels":[],"label_agreement":null},{"id":"W2003938077","doi":"10.1158/1538-7445.am2011-1825","title":"Abstract 1825: Sustained aerobic exercise alone does not counteract the tumor-promoting effects of a westernized diet on prostate cancer progression <i>in vivo</i>","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"LNCaP; Prostate cancer; Ex vivo; Medicine; Aerobic exercise; Endocrinology; Internal medicine; Prostate; Cancer; Tumor progression; In vivo; Biology; Biotechnology","score_opus":0.04028172242255649,"score_gpt":0.37913045541876916,"score_spread":0.33884873299621265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003938077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903078,0.0040721414,1.3377972e-7,0.0011917326,0.00043005453,0.0028501614,0.000025938889,0.000037319118,0.0010846985],"genre_scores_gemma":[0.9910347,0.004961053,0.000023179788,0.00014231484,0.000202396,0.0019147678,0.0000030841377,0.000052277173,0.0016662612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971862,0.0001612713,0.00042016184,0.0004551471,0.0009623746,0.0008148813],"domain_scores_gemma":[0.9983274,0.0003634701,0.00017489342,0.0004464475,0.0005356665,0.00015216236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013220905,0.0002510776,0.00063265575,0.0002362154,0.00018261434,0.00003308591,0.00026523182,0.00006538066,0.00018926249],"category_scores_gemma":[0.00033129245,0.00013083596,0.000102645754,0.0004962457,0.0003747324,0.00013320366,0.00018389671,0.0006976349,0.000012164513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038704652,0.0016906373,0.107340924,0.009138561,0.00030882415,0.00094450306,0.04667044,0.0000038163776,0.7491238,0.00006755408,0.003725624,0.04228063],"study_design_scores_gemma":[0.005417708,0.00089812616,0.21947289,0.009251254,0.0001043725,0.0000015706897,0.001817684,0.00001417404,0.7606383,0.00006578041,0.0020881838,0.00022997125],"about_ca_topic_score_codex":0.0025974151,"about_ca_topic_score_gemma":0.0006016809,"teacher_disagreement_score":0.11213195,"about_ca_system_score_codex":0.00019057617,"about_ca_system_score_gemma":0.00038387536,"threshold_uncertainty_score":0.5335336},"labels":[],"label_agreement":null},{"id":"W2004178642","doi":"10.1158/0008-5472.sabcs11-s6-1","title":"S6-1: Menopause-Specific and Health-Related Qualities of Life among Post-Menopausal Women Taking Exemestane for Prevention of Breast Cancer: Results from the NCIC CTG MAP.3 Placebo-Controlled Randomized Controlled Trial.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); Menopause; Placebo; Psychosocial; Randomized controlled trial; Breast cancer; Physical therapy; Exemestane; Gerontology; Gynecology; Internal medicine; Tamoxifen; Cancer; Psychiatry; Alternative medicine","score_opus":0.05073091493838098,"score_gpt":0.34744589901911677,"score_spread":0.29671498408073577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004178642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550609,0.033759154,0.00003304028,0.0008195618,0.00028222374,0.009473063,0.0004030749,0.000012805488,0.00015615413],"genre_scores_gemma":[0.986672,0.0073079267,0.000054648004,0.00003814165,0.00021996765,0.0045042965,0.00012395925,0.00004356948,0.0010355109],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995015,0.0021009801,0.0013575908,0.000492785,0.00044497085,0.0005886194],"domain_scores_gemma":[0.9966247,0.0010655067,0.0010814528,0.0004346462,0.00059972034,0.00019395938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076357303,0.0002526964,0.0015899481,0.00012976729,0.00022545815,0.000030279061,0.00031578803,0.00027403014,0.00010576558],"category_scores_gemma":[0.0007650279,0.00016110086,0.00019791319,0.0001535154,0.00064752746,0.000016680953,0.000115309966,0.00034056586,9.273892e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8544584,0.00014047515,0.00003090665,0.000088192355,0.0016421889,0.0000011583086,0.0020749662,0.0000138305395,0.13990803,0.0002081306,0.0005607569,0.00087296165],"study_design_scores_gemma":[0.9805619,0.0026518975,0.00039315454,0.0002748393,0.00015101777,0.0000016182754,0.0013834797,0.00007842482,0.013844944,0.00037814313,0.000089992034,0.00019054771],"about_ca_topic_score_codex":0.0038524477,"about_ca_topic_score_gemma":0.00021100967,"teacher_disagreement_score":0.12610354,"about_ca_system_score_codex":0.00010951593,"about_ca_system_score_gemma":0.0007860651,"threshold_uncertainty_score":0.65695024},"labels":[],"label_agreement":null},{"id":"W2004314221","doi":"10.1158/1538-7445.am2011-1192","title":"Abstract 1192: Regulation of CCND2, HMGA2, and the IGF pathway by LIN28B in HPV negative head and neck squamous cell carcinoma (HNSCC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"microRNA; Cancer research; Drosha; Biology; Head and neck squamous-cell carcinoma; HMGA2; Cell growth; Cancer; Gene; RNA interference; Genetics; RNA; Head and neck cancer","score_opus":0.03457045297838952,"score_gpt":0.314372433660564,"score_spread":0.2798019806821745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004314221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985103,0.010078404,0.00010427072,0.00018277847,0.000050886814,0.00073155283,0.000054250122,0.0000043317455,0.0036905138],"genre_scores_gemma":[0.9977972,0.0011706218,0.00007986065,0.000042226282,0.00008163269,0.00017717676,0.000024381861,0.000035064946,0.00059182156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980255,0.0003166238,0.00026674746,0.00044355,0.00042815984,0.00051945983],"domain_scores_gemma":[0.9990014,0.000103118036,0.00007915351,0.00040728587,0.00025696075,0.00015208295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011179668,0.00015891531,0.00020878215,0.00013805681,0.00011694793,0.000028566492,0.00024484415,0.00022779904,0.000109280125],"category_scores_gemma":[0.00022564533,0.00012938955,0.000051234827,0.00028698833,0.00060328585,0.000012432491,0.00028056672,0.00047772157,0.0000030557626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016496691,0.00012259443,0.0010290573,0.000119387725,0.000021542992,0.000006105227,0.0013581021,0.000013285,0.98850083,0.0002674939,0.001282889,0.0056290617],"study_design_scores_gemma":[0.0035710067,0.00039066205,0.024335144,0.000029415398,0.000006015099,0.0000046126706,0.00038593356,0.00009468502,0.96951675,0.00042856808,0.001090689,0.00014651343],"about_ca_topic_score_codex":0.0048448807,"about_ca_topic_score_gemma":0.0008422679,"teacher_disagreement_score":0.023306087,"about_ca_system_score_codex":0.00008211475,"about_ca_system_score_gemma":0.00031664135,"threshold_uncertainty_score":0.73240423},"labels":[],"label_agreement":null},{"id":"W2004316225","doi":"10.1158/1538-7445.tumimm2012-b19","title":"Abstract B19: Tumor-specific structural rearrangements as potential targets for anticancer vaccines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"CD8; Point mutation; Biology; Somatic cell; Cancer; Cancer immunotherapy; Major histocompatibility complex; Cancer research; Immunotherapy; T cell; Cytotoxic T cell; Mutation; Computational biology; Antigen; Gene; Genetics; Immune system; In vitro","score_opus":0.031221218671259526,"score_gpt":0.35963025644091146,"score_spread":0.3284090377696519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004316225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98935944,0.0067458795,0.00014298136,0.000803387,0.00069845,0.0010431556,0.00015823955,0.000011312094,0.0010371864],"genre_scores_gemma":[0.99328935,0.0025559547,0.0002972977,0.00032215499,0.0016943839,0.0006695063,0.00014606598,0.00005353093,0.0009717464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816495,0.000030017101,0.00023435392,0.0005400577,0.0003420364,0.0006885835],"domain_scores_gemma":[0.9986445,0.000038513474,0.000060375365,0.0004370471,0.00061276613,0.0002068552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026168927,0.00017662156,0.0001704592,0.000083565086,0.00024197974,0.00015303816,0.00038144813,0.00010614922,0.001564728],"category_scores_gemma":[0.00011550752,0.0001664204,0.00010704016,0.00012873155,0.00011894254,0.000011337327,0.00018967288,0.00019059323,0.00011627078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027274725,0.000030108362,0.0010524587,0.00005458727,0.000070074406,0.0000066445546,0.00003226332,0.00013639142,0.84792024,0.00016358841,0.13785762,0.012403268],"study_design_scores_gemma":[0.0031799444,0.00059687375,0.057963718,0.000056726443,0.00002140839,0.000013608073,0.00024524998,0.00016134554,0.47613844,0.0034343344,0.45751247,0.0006758929],"about_ca_topic_score_codex":0.0010444538,"about_ca_topic_score_gemma":0.00011517745,"teacher_disagreement_score":0.3717818,"about_ca_system_score_codex":0.00010582018,"about_ca_system_score_gemma":0.00030191027,"threshold_uncertainty_score":0.999348},"labels":[],"label_agreement":null},{"id":"W2004520887","doi":"10.1158/0008-5472.sabcs11-p1-10-05","title":"P1-10-05: Is the 21-Gene Breast Cancer Test (Oncotype DX®) Cost-Effective?","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Concordance; Checklist; Oncology; Stage (stratigraphy); Gynecology; Test (biology); Family medicine; Internal medicine; Cancer","score_opus":0.6070628569322286,"score_gpt":0.5349717804925295,"score_spread":0.07209107643969914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004520887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6395922,0.03380147,0.00035679535,0.24528171,0.0037583492,0.013998781,0.009912171,0.00025185134,0.05304667],"genre_scores_gemma":[0.95716774,0.0030801566,0.00018379821,0.011771703,0.002090703,0.0090329265,0.000024217938,0.00013066392,0.01651811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953416,0.00061634014,0.0018003073,0.00088523544,0.00029687045,0.0010596454],"domain_scores_gemma":[0.9954328,0.0020168258,0.0007152285,0.0010568727,0.00041830956,0.0003599469],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01758286,0.00025431634,0.0007445301,0.00038185378,0.00067592744,0.00013654042,0.00092918036,0.0002101435,0.018448014],"category_scores_gemma":[0.0017764629,0.00024326245,0.00015223728,0.0007348215,0.00042777875,0.00041121038,0.00022029289,0.0006739224,0.0059258984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019069185,0.00030635938,0.17212607,0.00044876916,0.00027823137,0.0000068635954,0.008198619,0.000037923717,0.00016496361,0.014403733,0.79455537,0.009282402],"study_design_scores_gemma":[0.0014600503,0.00022016754,0.2302463,0.00022539326,0.00001637419,0.000018678507,0.0012509264,0.00079136086,0.001373468,0.008103025,0.7556318,0.0006624503],"about_ca_topic_score_codex":0.02411371,"about_ca_topic_score_gemma":0.002007026,"teacher_disagreement_score":0.3175755,"about_ca_system_score_codex":0.001983421,"about_ca_system_score_gemma":0.0007288327,"threshold_uncertainty_score":0.99484813},"labels":[],"label_agreement":null},{"id":"W2004778693","doi":"10.1158/1538-7445.am2013-3314","title":"Abstract 3314: Sensitization of human tumor cells to chemotherapy drugs by antisense downregulation of BRCA2 and thymidylate synthase (TS): Induction of synthetic lethality by targeting DNA repair.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Synthetic lethality; Olaparib; Cisplatin; Cancer research; DNA repair; Biology; Homologous recombination; PARP inhibitor; Cancer cell; Genome instability; Gene knockdown; DNA damage; Thymidylate synthase; Cancer; Poly ADP ribose polymerase; Molecular biology; Polymerase; DNA; Chemotherapy; Cell culture; Genetics","score_opus":0.022039150245826773,"score_gpt":0.33316653762959114,"score_spread":0.3111273873837644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004778693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966666,0.00084254745,0.00005394487,0.00083505467,0.000053314026,0.0011992175,0.00011076905,0.000028740547,0.00020978918],"genre_scores_gemma":[0.999164,0.0002973432,0.00015721007,0.00003532462,0.000055850167,0.00004346465,0.00006422023,0.000044666074,0.0001379244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778736,0.00018922766,0.00057450123,0.0004143072,0.00071585644,0.0003187533],"domain_scores_gemma":[0.9982323,0.00012318914,0.0002785675,0.0004081937,0.0007883468,0.00016937428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000946266,0.0001561064,0.00041253987,0.00025551158,0.000084058636,0.000013586958,0.00007277876,0.0001357181,0.00033131387],"category_scores_gemma":[0.00017101172,0.00015610724,0.000084172294,0.0004843395,0.000318895,0.00011489391,0.00004662356,0.00030074158,0.0000052754413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022011173,0.00014227633,0.0003848778,0.0006640708,0.00006810773,0.0000024146304,0.0008487768,0.00007078111,0.98825455,0.0000122416095,0.005805184,0.0035266215],"study_design_scores_gemma":[0.0009932186,0.00026628925,0.007873587,0.0006198385,0.000029854526,0.000004668287,0.00028507807,0.00027943973,0.98930544,0.000056740264,0.00016568146,0.00012015875],"about_ca_topic_score_codex":0.0045613656,"about_ca_topic_score_gemma":0.000017097884,"teacher_disagreement_score":0.007488709,"about_ca_system_score_codex":0.00022908089,"about_ca_system_score_gemma":0.00015440659,"threshold_uncertainty_score":0.6895451},"labels":[],"label_agreement":null},{"id":"W2004799019","doi":"10.1158/1538-7445.chtme14-b13","title":"Abstract B13: Hypoxia-induced chemokine activation and lymphnode metastases in primary cervix xenografts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tumor hypoxia; Pathology; Tumor microenvironment; Primary tumor; Cervix; Metastasis; Lymph node; CD31; Cancer; Immunohistochemistry; Radiation therapy; Internal medicine","score_opus":0.08482934440342114,"score_gpt":0.37106519344738126,"score_spread":0.2862358490439601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004799019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959893,0.0074886503,0.00001557798,0.00039729572,0.00035873457,0.00031598378,0.00003578748,0.000011829845,0.0017772263],"genre_scores_gemma":[0.9946522,0.0027341167,0.00010442761,0.00020405596,0.0015309863,0.00016683646,0.00011199303,0.000032744654,0.00046263752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833,0.000112420785,0.00020419886,0.00045928612,0.0004246748,0.0004693972],"domain_scores_gemma":[0.99908197,0.000030529405,0.000052299136,0.00035045124,0.00026192042,0.00022280907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009618446,0.00015651163,0.00021123255,0.00017870715,0.000071934504,0.000051555347,0.00020480108,0.00017190145,0.00003343273],"category_scores_gemma":[0.00021594178,0.00014948378,0.000043371376,0.00032173446,0.000120625176,0.000019360858,0.00019782955,0.00025288726,0.0000068682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032849688,0.00007171013,0.0008498916,0.00005649199,0.00003177586,0.0000023188595,0.00012452522,0.000019900723,0.94794804,0.000018056764,0.008093048,0.04245575],"study_design_scores_gemma":[0.0022016335,0.00015762901,0.04911168,0.00005039961,0.000010564416,0.0000069012144,0.00024139704,0.000005693402,0.7633925,0.00011720462,0.18445875,0.00024564975],"about_ca_topic_score_codex":0.0013426391,"about_ca_topic_score_gemma":0.00039501316,"teacher_disagreement_score":0.18455553,"about_ca_system_score_codex":0.00014967158,"about_ca_system_score_gemma":0.00066532457,"threshold_uncertainty_score":0.6095772},"labels":[],"label_agreement":null},{"id":"W2004836183","doi":"10.1158/0008-5472.sabcs10-p3-14-15","title":"Abstract P3-14-15: Lapatinib Plus Capecitabine in Trastuzumab Pre-Treated HER2- Positive Metastatic Breast Cancer: The Canadian Lapatinib Expanded Access Program Experience","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; Hôpital Charles-Le Moyne; Regional Municipality of Durham; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Capecitabine; Trastuzumab; Internal medicine; Metastatic breast cancer; Taxane; Oncology; Breast cancer; Cancer; Progressive disease; Gastroenterology; Tyrosine-kinase inhibitor; Chemotherapy; Colorectal cancer","score_opus":0.06690299879045916,"score_gpt":0.4538422047316935,"score_spread":0.3869392059412343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004836183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854515,0.0010900181,0.000007663044,0.0066655097,0.0003700742,0.0042613083,0.0007018936,0.00013400528,0.0013180209],"genre_scores_gemma":[0.9886551,0.0002573407,0.00024353692,0.00041819614,0.00046679404,0.009045812,0.000094336974,0.00012326459,0.0006956567],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948443,0.00026110542,0.0006358687,0.0009748804,0.0014648894,0.0018189482],"domain_scores_gemma":[0.99639094,0.00038149272,0.0001812722,0.0009495547,0.0012467416,0.00085001177],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008996317,0.0004926821,0.000721668,0.00057488214,0.00065998675,0.00031011575,0.0010294691,0.00021011716,0.003268576],"category_scores_gemma":[0.00021599648,0.00036031794,0.00012889589,0.002002373,0.0012884374,0.0005871975,0.00016461272,0.0024160368,0.000028675873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074675996,0.0013156044,0.12044249,0.00055840187,0.000645867,0.0009067784,0.030671157,0.00063687854,0.04983987,0.00016947881,0.0011406098,0.7862053],"study_design_scores_gemma":[0.007386359,0.0005372255,0.95497733,0.0010054522,0.00008167127,0.00028080124,0.0036010765,0.00063658925,0.023021825,0.00017619909,0.007571676,0.00072381424],"about_ca_topic_score_codex":0.6377947,"about_ca_topic_score_gemma":0.88357395,"teacher_disagreement_score":0.8345348,"about_ca_system_score_codex":0.002814785,"about_ca_system_score_gemma":0.0051798937,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W2004846994","doi":"10.1158/0008-5472.can-05-4605","title":"Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research Society","keywords":"MAPK/ERK pathway; Cancer research; Biology; Cancer cell; Receptor; Colorectal cancer; Cell biology; Molecular biology; Kinase; Cancer; Biochemistry","score_opus":0.053350607234186595,"score_gpt":0.37045606960049904,"score_spread":0.31710546236631243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004846994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926448,0.0010046961,0.000269561,0.004081559,0.00010526271,0.001249594,0.00004195602,0.000040623996,0.00056198175],"genre_scores_gemma":[0.98480827,0.0010416859,0.0003486302,0.00010318133,0.00027937783,0.00014986098,0.000100581834,0.000056513018,0.0131119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971784,0.00023694489,0.00023627629,0.00061335537,0.0010809323,0.0006541124],"domain_scores_gemma":[0.9985405,0.00034283122,0.0000512315,0.00024796103,0.00036663102,0.00045080614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000754996,0.00020593185,0.00031937676,0.000306044,0.00022660033,0.00016795308,0.00012550662,0.0001469729,0.00038315318],"category_scores_gemma":[0.00014821696,0.00019473972,0.000037542264,0.0005296201,0.00012544685,0.00015128439,0.00013071131,0.0005338628,0.00004482018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011163411,0.00010958491,0.040485032,0.00014860729,0.000019676665,0.000007413513,0.00028142586,0.0000033531578,0.888989,0.000020758504,0.062708884,0.0061099525],"study_design_scores_gemma":[0.0031684064,0.00057555555,0.021152886,0.00016074572,0.0000122509955,0.000004856425,0.00048019647,0.000115501265,0.84598535,0.000014243962,0.12813325,0.00019675773],"about_ca_topic_score_codex":0.014104256,"about_ca_topic_score_gemma":0.0008303224,"teacher_disagreement_score":0.06542437,"about_ca_system_score_codex":0.00065404514,"about_ca_system_score_gemma":0.0004347701,"threshold_uncertainty_score":0.9924609},"labels":[],"label_agreement":null},{"id":"W2005176113","doi":"10.1158/0008-5472.can-14-2789","title":"Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development","year":2015,"lang":"en","type":"review","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":370,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"PI3K/AKT/mTOR pathway; Biology; Carcinogenesis; Cancer; Cell biology; Translation (biology); Cancer cell; Angiogenesis; Protein kinase B; Cancer research; Signal transduction; Messenger RNA; Genetics; Gene","score_opus":0.4698480076737247,"score_gpt":0.554754726209358,"score_spread":0.08490671853563325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005176113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039557974,0.99463505,0.0021586625,0.00033430025,0.0005353291,0.0015950907,0.0004115951,0.000015842732,0.0002745808],"genre_scores_gemma":[0.00043877575,0.98772734,0.00092284224,0.00011489813,0.0023848496,0.0066404333,0.0013964118,0.000112413,0.0002620428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695826,0.0004978151,0.0005378214,0.0006587313,0.00065787387,0.0006894792],"domain_scores_gemma":[0.9977361,0.0003288612,0.00013553616,0.00039099544,0.0012572518,0.00015128376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022669046,0.00031251163,0.0005657975,0.00011592885,0.00040703017,0.00010720873,0.0006133677,0.00041026776,0.0001167165],"category_scores_gemma":[0.0004688424,0.00023443092,0.0001945573,0.00026639883,0.00025633382,0.000007579155,0.00014052619,0.00053383067,0.000013491669],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008595841,0.000034660352,0.0000032541175,0.006101538,0.00022855322,0.0000017380509,0.00025788156,0.00008588452,0.0025712764,0.000073010146,0.04170748,0.9488488],"study_design_scores_gemma":[0.00025146984,0.00008767027,9.4371154e-7,0.0015418343,0.00010397631,0.000002812173,0.000042613276,0.00006099778,0.0007667009,0.00007994679,0.99676794,0.000293081],"about_ca_topic_score_codex":0.00011488282,"about_ca_topic_score_gemma":0.00021697709,"teacher_disagreement_score":0.9550605,"about_ca_system_score_codex":0.00056078396,"about_ca_system_score_gemma":0.0042919535,"threshold_uncertainty_score":0.95598155},"labels":[],"label_agreement":null},{"id":"W2005636037","doi":"10.1158/0008-5472.can-11-4061","title":"Real-time Raman Spectroscopy for <i>In Vivo</i> Skin Cancer Diagnosis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":420,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Hydro","keywords":"Actinic keratoses; Medicine; Pathology; Skin cancer; Receiver operating characteristic; Raman spectroscopy; Dermatology; Melanoma; Cancer; Basal cell carcinoma; Seborrheic keratosis; Basal cell; Cancer research; Internal medicine; Optics","score_opus":0.03433088890838605,"score_gpt":0.4368720191339156,"score_spread":0.40254113022552956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005636037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850862,0.003551977,0.00014784321,0.0016321646,0.0001664606,0.0009088186,0.00022221338,0.00003532627,0.008248975],"genre_scores_gemma":[0.89747155,0.052525397,0.004228792,0.000520456,0.0047034826,0.02248834,0.00014147727,0.00015861016,0.017761914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971724,0.00011998532,0.00023427604,0.0004946685,0.00057684624,0.0014017973],"domain_scores_gemma":[0.9988308,0.00014611427,0.000033505366,0.00042681777,0.00018307696,0.00037969722],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012110805,0.00017531852,0.00022105659,0.00013905208,0.00012354112,0.000035698733,0.0005470438,0.0002796868,0.001995011],"category_scores_gemma":[0.00028087245,0.00015535757,0.00010969877,0.0004450086,0.00038988335,0.000009146087,0.00029676003,0.00037357435,0.000023066854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002171792,0.00014518399,0.0070339283,0.000050308347,0.000019623669,9.609444e-7,0.000024941619,2.4274817e-7,0.76900554,0.00011480066,0.22228684,0.0011004527],"study_design_scores_gemma":[0.0003616815,0.000180609,0.0002970665,0.000044702792,0.0000035786795,6.803467e-7,0.00001406155,0.000006640587,0.72037786,0.00025847234,0.2783158,0.00013882208],"about_ca_topic_score_codex":0.0008906184,"about_ca_topic_score_gemma":0.00009696842,"teacher_disagreement_score":0.08761469,"about_ca_system_score_codex":0.00031356633,"about_ca_system_score_gemma":0.00026428982,"threshold_uncertainty_score":0.9989173},"labels":[],"label_agreement":null},{"id":"W2005692436","doi":"10.1158/0008-5472.sabcs13-s5-04","title":"Abstract S5-04: Primary results of ROSE/TRIO-12, a randomized placebo controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology","funders":"","keywords":"Ramucirumab; Docetaxel; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Clinical endpoint; Breast cancer; Response Evaluation Criteria in Solid Tumors; Cancer; Taxane; Placebo; Interim analysis; Phases of clinical research; Progression-free survival; Chemotherapy regimen; Chemotherapy; Randomized controlled trial; Pathology","score_opus":0.09301979136539842,"score_gpt":0.4564439374470701,"score_spread":0.36342414608167173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005692436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96592534,0.003099991,0.00018905273,0.0107403165,0.00021007203,0.01868512,0.000698545,0.000034508605,0.00041708138],"genre_scores_gemma":[0.98466676,0.00095769024,0.0004599885,0.00046454638,0.000514185,0.0120516475,0.000072544935,0.00007592729,0.00073669746],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99404067,0.00091007823,0.0018034836,0.0006128261,0.0018497114,0.0007832158],"domain_scores_gemma":[0.9925353,0.004184495,0.000750727,0.00076230854,0.0015280375,0.00023911854],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007431141,0.00035512823,0.0022977353,0.0005539141,0.00014755639,0.000040643004,0.00041091262,0.000117471354,0.0036131528],"category_scores_gemma":[0.0020483728,0.00022945745,0.00036165514,0.0009978515,0.00063741853,0.0002524266,0.00008589358,0.0007739776,0.000013213796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83026934,0.0007965082,0.000009395342,0.00030306057,0.00058187236,0.0000058768464,0.0016636165,0.0010906177,0.05750937,0.000010869386,0.0010823086,0.10667718],"study_design_scores_gemma":[0.98387706,0.0015462358,0.00085412414,0.0013174854,0.00017474328,0.000010498146,0.00039784878,0.00196348,0.008909264,0.00039128374,0.00035105456,0.00020691237],"about_ca_topic_score_codex":0.007243609,"about_ca_topic_score_gemma":0.0009530058,"teacher_disagreement_score":0.15360774,"about_ca_system_score_codex":0.00093862106,"about_ca_system_score_gemma":0.0017095704,"threshold_uncertainty_score":0.99936724},"labels":[],"label_agreement":null},{"id":"W2005790386","doi":"10.1158/1538-7445.am2011-4923","title":"Abstract 4923: Myofibroblasts induce specific epithelial-to-mesenchymal transition (EMT) patterns in colorectal cancer cells by enhanced secretion of bone morphogenic protein (BMP) inhibitors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Desmoplasia; Stromal cell; Epithelial–mesenchymal transition; Biology; Bone morphogenetic protein; Cell biology; Cancer research; Cancer cell; Stable isotope labeling by amino acids in cell culture; Cancer; Pancreatic cancer; Proteomics; Metastasis; Genetics; Gene","score_opus":0.05183391276663807,"score_gpt":0.32650197641086515,"score_spread":0.2746680636442271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005790386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396235,0.0008285771,0.00012419885,0.00031933506,0.000531643,0.0032369916,0.00046055333,0.00004374836,0.0004926102],"genre_scores_gemma":[0.9965867,0.0006472727,0.00021678288,0.000049947124,0.0003776583,0.0017433374,0.000048911766,0.00010065565,0.00022875913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99556535,0.0002448455,0.00082409586,0.00090415054,0.0014293791,0.0010321818],"domain_scores_gemma":[0.99824744,0.000099126504,0.00018223046,0.00042872207,0.00060164754,0.0004408001],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096988014,0.00037078388,0.00065655704,0.0007143881,0.000090777925,0.000025353997,0.0002823145,0.0003804915,0.0039137797],"category_scores_gemma":[0.00007360398,0.00036630352,0.00016692412,0.0012971666,0.00032717708,0.00015259355,0.000109303284,0.0010849496,0.00007895675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031985168,0.00032577268,0.0013350473,0.00047559847,0.00005036192,0.00004037348,0.0046197604,0.000068427085,0.9821574,0.0000037553189,0.0010605772,0.0066643995],"study_design_scores_gemma":[0.0017727611,0.0012283598,0.04481982,0.0013613884,0.000017047785,0.000005365458,0.0005558462,0.000017905599,0.94963324,0.00003791695,0.00023014654,0.00032021088],"about_ca_topic_score_codex":0.0069486015,"about_ca_topic_score_gemma":0.0016955899,"teacher_disagreement_score":0.043484773,"about_ca_system_score_codex":0.0014279914,"about_ca_system_score_gemma":0.0008666038,"threshold_uncertainty_score":0.9998789},"labels":[],"label_agreement":null},{"id":"W2005802085","doi":"10.1158/0008-5472.can-08-3493","title":"Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Deutsche Krebshilfe","keywords":"Cancer research; Transforming growth factor; Carcinogenesis; L1; Pancreatic cancer; Gene knockdown; Biology; SMAD; Ectopic expression; Pathology; Cell culture; Cancer; Internal medicine; Medicine; Cell biology; Gene","score_opus":0.05204466049338307,"score_gpt":0.3831014304925938,"score_spread":0.33105676999921074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005802085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176884,0.0036009012,0.00005232102,0.0010872233,0.000043062497,0.0017470787,0.000057319718,0.00001055003,0.0016326801],"genre_scores_gemma":[0.9909786,0.008068852,0.000083085404,0.000038575574,0.000059922866,0.00024032083,0.000012146413,0.000021803044,0.0004967185],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964806,0.00041264764,0.000816075,0.00038735173,0.0011682005,0.0007351582],"domain_scores_gemma":[0.9985542,0.000398174,0.00010418392,0.00027621776,0.00048692967,0.00018029027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020066786,0.00019159324,0.000881852,0.001116269,0.000089120775,0.000015147082,0.00017367976,0.00023197368,0.000540385],"category_scores_gemma":[0.0001146946,0.00016398508,0.00007153706,0.0010993709,0.0003324338,0.00026526354,0.00002283107,0.0006556939,0.0000049489154],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015369923,0.00033025155,0.25037986,0.0014586515,0.00008686585,0.000015552612,0.023142897,0.000025923593,0.70286834,0.00051150226,0.00006210271,0.019581027],"study_design_scores_gemma":[0.004914944,0.000993139,0.541174,0.0022021357,0.00009863812,0.000011571074,0.003360477,0.0017719697,0.44299197,0.0022240225,0.00006771037,0.00018942615],"about_ca_topic_score_codex":0.010226778,"about_ca_topic_score_gemma":0.0016121237,"teacher_disagreement_score":0.29079413,"about_ca_system_score_codex":0.000591486,"about_ca_system_score_gemma":0.00083828537,"threshold_uncertainty_score":0.99636424},"labels":[],"label_agreement":null},{"id":"W2005965411","doi":"10.1158/1538-7445.am10-3339","title":"Abstract 3339: Elimination of cancer stem cells in pancreatic cancer cell lines by a combinatorial therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyclopamine; Cancer research; Cancer stem cell; Cytotoxic T cell; Pancreatic cancer; Stem cell; Cancer; Cancer cell; Metastasis; Chemistry; Biology; Hedgehog signaling pathway; In vitro; Medicine; Cell biology; Internal medicine; Signal transduction; Biochemistry","score_opus":0.06255586371888086,"score_gpt":0.4086758949317538,"score_spread":0.34612003121287294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005965411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736265,0.021149669,0.0000015069296,0.001133008,0.0015450639,0.0010124452,0.00025218638,0.000020378953,0.0012592361],"genre_scores_gemma":[0.9493716,0.046978395,0.000027799468,0.00008749469,0.0007213382,0.0008296371,0.000013808325,0.00005525827,0.0019147175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974141,0.00009231637,0.00046665533,0.00046213056,0.00095605216,0.0006087167],"domain_scores_gemma":[0.9983008,0.00019403067,0.00015403931,0.0004368036,0.0006807857,0.0002335374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008994976,0.00021514588,0.00052971864,0.00022374689,0.00007967778,0.00003262874,0.00024944602,0.00019962876,0.0029065255],"category_scores_gemma":[0.000022050353,0.00018057357,0.000113123715,0.00064583897,0.00026584422,0.00012764962,0.000052754334,0.00087924505,0.000011067672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009139136,0.00043401762,0.0083418,0.0005108878,0.00006179715,0.000009465776,0.0005838312,0.00001582514,0.91448367,0.000056109708,0.008038439,0.06655027],"study_design_scores_gemma":[0.004222904,0.00021437652,0.009738226,0.0003054783,0.000040465566,6.046261e-7,0.0003001475,0.0000296666,0.9378774,0.000050513714,0.047040142,0.00018007425],"about_ca_topic_score_codex":0.06883022,"about_ca_topic_score_gemma":0.011530326,"teacher_disagreement_score":0.0663702,"about_ca_system_score_codex":0.0005033596,"about_ca_system_score_gemma":0.001224785,"threshold_uncertainty_score":0.998005},"labels":[],"label_agreement":null},{"id":"W2006033598","doi":"10.1158/1538-7445.cansusc14-12","title":"Abstract 12: Germline BRCA mutations in an unselected cohort of patients with pancreatic adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Family history; Germline mutation; Germline; Oncology; Breast cancer; Adenocarcinoma; Ovarian cancer; Cancer; Internal medicine; BRCA mutation; Genetic testing; Gynecology; Mutation; Genetics; Biology","score_opus":0.02002195361386358,"score_gpt":0.32114624913673634,"score_spread":0.3011242955228728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006033598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872494,0.0003760293,0.00006674045,0.00003955646,0.000030539457,0.00034709836,0.00008997453,0.0000032827434,0.00032183653],"genre_scores_gemma":[0.99881494,0.00018089764,0.00011190481,0.00003832904,0.00012279116,0.0001139961,0.00052700477,0.000025331708,0.00006478943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889994,0.00007452537,0.00018851088,0.0003006058,0.00024874115,0.00028766837],"domain_scores_gemma":[0.99902743,0.000058117075,0.0000535139,0.00034462806,0.00041433095,0.00010196444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002831499,0.00009410834,0.00014288399,0.00010796934,0.000053547785,0.000019691368,0.00018075065,0.00007893468,0.000048271108],"category_scores_gemma":[0.00016064852,0.000087264016,0.000022696633,0.00020091698,0.00013943236,0.000003911015,0.000047056754,0.00013972787,0.0000025246488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031978192,0.00016048262,0.9460933,0.000038311606,0.000030635896,0.000001288795,0.00006303597,0.0005649508,0.05081805,0.000043234384,0.0003119053,0.0015550323],"study_design_scores_gemma":[0.0009719733,0.0006394444,0.97257346,0.000030286725,0.000010902015,3.161405e-7,0.000022358752,0.00006828505,0.02449736,0.000053914006,0.0010197988,0.000111912406],"about_ca_topic_score_codex":0.0007727724,"about_ca_topic_score_gemma":0.0037796455,"teacher_disagreement_score":0.026480155,"about_ca_system_score_codex":0.000054757133,"about_ca_system_score_gemma":0.0003187956,"threshold_uncertainty_score":0.35585234},"labels":[],"label_agreement":null},{"id":"W2006095014","doi":"10.1158/1538-7445.am10-1835","title":"Abstract 1835: Life Raft Group registry: An observational registry of gastrointestinal stromal tumor (GIST) patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"GiST; Medicine; Exon; PDGFRA; Internal medicine; Observational study; Gastroenterology; Pediatrics; Oncology; Stromal cell; Biology; Genetics","score_opus":0.13926358967174626,"score_gpt":0.4182371336286891,"score_spread":0.27897354395694285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006095014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956215,0.00006378931,0.00001888076,0.0012118368,0.000101637444,0.00082877633,0.00024127924,0.000056535602,0.0018557468],"genre_scores_gemma":[0.9922181,0.000009737593,0.00566099,0.00007089707,0.00055563234,0.0002256161,0.0003919579,0.000057406654,0.0008097073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953846,0.0001253351,0.0005647627,0.0006762152,0.0021732228,0.0010758839],"domain_scores_gemma":[0.9953907,0.00030973126,0.0002239049,0.0010151186,0.0017868725,0.0012736564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010425434,0.00028034273,0.0004435133,0.00027049764,0.0002307305,0.00008368958,0.00054421026,0.00006199893,0.0015093421],"category_scores_gemma":[0.0035718267,0.00024218793,0.00015057014,0.00050392,0.0008659823,0.00024157538,0.00017983108,0.0017844479,0.00006810346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025014237,0.0017708273,0.8387656,0.00038507348,0.000054346052,0.0005952009,0.000028730916,0.0000049709297,0.14735363,0.0007784626,0.00676929,0.0009924511],"study_design_scores_gemma":[0.0035212885,0.0032305894,0.9861679,0.0005654997,0.000023920853,0.00030316357,0.00013709396,0.00008472819,0.004012411,0.00017668286,0.0016128758,0.00016386245],"about_ca_topic_score_codex":0.0020304848,"about_ca_topic_score_gemma":0.00039125275,"teacher_disagreement_score":0.14740229,"about_ca_system_score_codex":0.00028906492,"about_ca_system_score_gemma":0.0019591232,"threshold_uncertainty_score":0.9994034},"labels":[],"label_agreement":null},{"id":"W2006371959","doi":"10.1158/0008-5472.sabcs12-p5-15-02","title":"Abstract P5-15-02: The benefit of targeted therapeutics in medical oncology since the development of trastuzumab","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.23133876086043306,"score_gpt":0.5183204141789531,"score_spread":0.2869816533185201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006371959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674124,0.009665901,0.000019130908,0.016093716,0.00020552463,0.0010665932,0.000016054197,0.000011345469,0.005509313],"genre_scores_gemma":[0.9971124,0.0014558607,0.00018282505,0.0002805946,0.0002915251,0.00035356963,0.000006144093,0.000035175464,0.00028190875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946992,0.00039896285,0.00073401455,0.00025939618,0.0028711823,0.0010372711],"domain_scores_gemma":[0.9967447,0.0016221649,0.000116954,0.0006346793,0.00059576414,0.00028575683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008545118,0.0001540418,0.00043427458,0.00024696658,0.00016340466,0.000010380608,0.0008732578,0.00024798288,0.0024193695],"category_scores_gemma":[0.00055386877,0.00008503131,0.00007784311,0.001077299,0.001202382,0.000060534367,0.0002805807,0.0017756146,0.00004197365],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021789062,0.00216439,0.0723716,0.0011847101,0.00056515815,0.00005503616,0.03807058,0.000037542988,0.12415501,0.0019347225,0.005452642,0.7518297],"study_design_scores_gemma":[0.0026795086,0.00061989523,0.5695731,0.00089516456,0.00003509126,0.00002984153,0.005374625,0.00013650858,0.21040125,0.0002347814,0.20980385,0.0002163503],"about_ca_topic_score_codex":0.00094620854,"about_ca_topic_score_gemma":0.0022589236,"teacher_disagreement_score":0.7516133,"about_ca_system_score_codex":0.0012159789,"about_ca_system_score_gemma":0.006212186,"threshold_uncertainty_score":0.99942166},"labels":[],"label_agreement":null},{"id":"W2006465145","doi":"10.1158/1538-7445.fbcr13-b11","title":"Abstract B11: The early autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Verteporfin; Autophagy; Gemcitabine; Pancreatic cancer; Cancer research; Medicine; Oncology; Cancer; Apoptosis; Internal medicine; Chemistry; Surgery","score_opus":0.0684090330884039,"score_gpt":0.37251532145104344,"score_spread":0.30410628836263953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006465145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990875,0.0047150766,0.00002824424,0.002202591,0.00008183914,0.001329627,0.000020519714,0.000023834924,0.0007232898],"genre_scores_gemma":[0.99738747,0.0006506435,0.000020164602,0.00013012715,0.00023622908,0.00071133435,0.0000032785467,0.00003272658,0.0008280113],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976888,0.00018619915,0.00032978793,0.0003592716,0.0008512874,0.0005847077],"domain_scores_gemma":[0.9985917,0.00027050124,0.00009584412,0.00056431914,0.00032807828,0.00014952658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007496238,0.00018717366,0.00037619547,0.00015866874,0.00019773324,0.0000665873,0.0003511975,0.00009665441,0.00052506843],"category_scores_gemma":[0.0001202967,0.000103717546,0.00011201045,0.00053515495,0.000550638,0.0002718071,0.00010099232,0.00079040456,0.00006211039],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014353751,0.0005465357,0.014415033,0.0002887541,0.00021846092,0.00013173057,0.0021913066,0.000299011,0.9738478,0.00043083166,0.0015568215,0.004638337],"study_design_scores_gemma":[0.0010486442,0.00017540506,0.7063504,0.00017651446,0.000025459738,0.000009205196,0.00020848105,0.010490632,0.28011522,0.0012797203,0.000015400377,0.00010493036],"about_ca_topic_score_codex":0.0061299265,"about_ca_topic_score_gemma":0.00013931718,"teacher_disagreement_score":0.69373256,"about_ca_system_score_codex":0.00016564374,"about_ca_system_score_gemma":0.000993327,"threshold_uncertainty_score":0.92666566},"labels":[],"label_agreement":null},{"id":"W2006619596","doi":"10.1158/1538-7445.tumimm2012-a26","title":"Abstract A26: Potent Th cell epitope modified HER2/neu dendritc cell vaccine magnify antitumor responses in HER2/neu tolerance transgenic mice.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"HER2/neu; Epitope; Immunology; Ovalbumin; Immune system; Cancer vaccine; Medicine; Immunotherapy; T cell; Cancer research; CD8; Antigen; Cytotoxic T cell; Cancer immunotherapy; Cancer; Biology; Breast cancer; Internal medicine; In vitro","score_opus":0.038861473847229065,"score_gpt":0.326109367461235,"score_spread":0.28724789361400593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006619596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92028296,0.073935024,0.000016157737,0.0016778,0.0009946659,0.0014511404,0.0000857634,0.00008497061,0.0014715084],"genre_scores_gemma":[0.9541729,0.01739023,0.00003944536,0.00030218888,0.00012522619,0.0006295814,0.00004357489,0.00009584852,0.027201016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945827,0.0015406664,0.0008764282,0.00092865666,0.00026556978,0.0018059531],"domain_scores_gemma":[0.9976725,0.0007219616,0.00016604889,0.00096004317,0.00038101416,0.00009845549],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015314082,0.00050485646,0.0007439473,0.0006901204,0.0005150068,0.00013787819,0.0011784404,0.00054216775,0.0058957003],"category_scores_gemma":[0.000097865275,0.00045379845,0.00025496905,0.0007965022,0.000395612,0.00043127738,0.00016229092,0.0020724616,0.0023505206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005291285,0.0006510827,0.0010814805,0.00022085934,0.00008030662,0.00004963251,0.0010181756,0.00008484648,0.9749048,0.000020017307,0.0076019564,0.008995569],"study_design_scores_gemma":[0.0053448086,0.0005493682,0.08326818,0.00027419746,0.000017200417,0.000032021253,0.00077407126,0.00001238438,0.87865764,0.00008325199,0.030420575,0.00056628324],"about_ca_topic_score_codex":0.009566468,"about_ca_topic_score_gemma":0.0004941204,"teacher_disagreement_score":0.09624713,"about_ca_system_score_codex":0.0003040825,"about_ca_system_score_gemma":0.00070628274,"threshold_uncertainty_score":0.9997914},"labels":[],"label_agreement":null},{"id":"W2006714333","doi":"10.1158/1538-7445.am2012-1970","title":"Abstract 1970: Liposomal nanoparticle siRNA delivery systems for <i>in vivo</i> silencing of the androgen receptor in human prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Gene silencing; Prostate cancer; Small interfering RNA; RNA interference; Cancer research; Androgen receptor; Small hairpin RNA; Cancer; Chemistry; Medicine; Internal medicine; RNA; Biochemistry","score_opus":0.04796743802954743,"score_gpt":0.35245300835262805,"score_spread":0.3044855703230806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006714333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881993,0.010618947,6.1822084e-7,0.00007687241,0.00024760893,0.0006154292,0.00010733364,0.000002573582,0.00013131979],"genre_scores_gemma":[0.9975147,0.0010587939,0.0000045374095,0.000034312332,0.00027209244,0.0005393266,0.0000063643834,0.00001817729,0.0005516696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986525,0.000096564974,0.00026486514,0.00023452145,0.00021522376,0.0005362838],"domain_scores_gemma":[0.9993903,0.000029114548,0.00006647709,0.00025777426,0.00018651671,0.0000698314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068458274,0.00009955661,0.00014399932,0.00006602284,0.000085330445,0.000020476722,0.00027881344,0.000097073935,0.000049214195],"category_scores_gemma":[0.000041166626,0.00007822582,0.00006121866,0.0001915055,0.00010443674,0.000015707139,0.00012175922,0.00015355677,0.000002497651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001695684,0.00006360749,0.07071285,0.00011406531,0.000018545894,4.6687106e-7,0.0003557437,0.0003596412,0.92529577,0.0000116950805,0.0024104996,0.00048755712],"study_design_scores_gemma":[0.00049062324,0.000111615285,0.0061830715,0.0002188343,0.0000037076647,7.3036153e-7,0.0004345291,0.000026612526,0.98906296,0.0000061926057,0.0033609206,0.00010018368],"about_ca_topic_score_codex":0.0042710113,"about_ca_topic_score_gemma":0.0021941273,"teacher_disagreement_score":0.06452978,"about_ca_system_score_codex":0.00010317664,"about_ca_system_score_gemma":0.00021234508,"threshold_uncertainty_score":0.645652},"labels":[],"label_agreement":null},{"id":"W2006722332","doi":"10.1158/1538-7445.am2012-1166","title":"Abstract 1166: <i>PTEN</i> loss and <i>ERG</i> over-expression as prognostic biomarkers in prostate cancer and identification of downstream biomarkers with potential therapeutic value","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; TMPRSS2; Cancer research; Biology; Fusion gene; PI3K/AKT/mTOR pathway; Prostate cancer; Protein kinase B; Gene knockdown; Carcinogenesis; Genome instability; Cancer; Signal transduction; Gene; Genetics; DNA damage; Medicine; Pathology; Disease","score_opus":0.015216123323141989,"score_gpt":0.32846991187767277,"score_spread":0.3132537885545308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006722332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96587527,0.032293733,0.000016580774,0.00023465324,0.0006621991,0.0006922195,0.00009253683,0.0000067954375,0.00012599486],"genre_scores_gemma":[0.9835916,0.014872144,0.000026711472,0.00004739354,0.0009489508,0.00031227412,0.000038801754,0.000031788462,0.00013032836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982656,0.000115384755,0.00027466423,0.00044190275,0.0003838428,0.0005185886],"domain_scores_gemma":[0.9992053,0.000032853077,0.00012490581,0.00028726665,0.00016960988,0.00018006722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073983415,0.00017854331,0.00019548192,0.00015371946,0.000106317886,0.000048470993,0.0001401065,0.00012158128,0.00002203253],"category_scores_gemma":[0.00004260636,0.00014542848,0.00003640523,0.0002742872,0.00051979773,0.000034884146,0.00010866417,0.00017008439,0.0000010735685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011425837,0.00009646672,0.093226254,0.00020128244,0.00012539075,5.89605e-7,0.00020628991,0.000024310279,0.8879041,0.000024802905,0.0009234,0.016124533],"study_design_scores_gemma":[0.0027258194,0.00020734893,0.39879286,0.0003319095,0.00007222922,0.000022543161,0.00048334387,0.000034257235,0.57364815,0.00008583247,0.023229396,0.00036633253],"about_ca_topic_score_codex":0.0022383933,"about_ca_topic_score_gemma":0.0003081084,"teacher_disagreement_score":0.31425598,"about_ca_system_score_codex":0.000047475914,"about_ca_system_score_gemma":0.0003054075,"threshold_uncertainty_score":0.5930401},"labels":[],"label_agreement":null},{"id":"W2007088808","doi":"10.1158/0008-5472.can-06-3329","title":"Molecular Mechanisms of RET Receptor–Mediated Oncogenesis in Multiple Endocrine Neoplasia 2B","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Biology; Proto-Oncogene Proteins c-ret; Carcinogenesis; Phenotype; Receptor; Cancer research; Mutation; Kinase; Genetics; Cancer; Gene; Germline mutation","score_opus":0.046136025936839686,"score_gpt":0.38380877650235923,"score_spread":0.33767275056551954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007088808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276483,0.001537329,0.000072185074,0.0023467178,0.00010349919,0.001208834,0.00007731151,0.00006182135,0.0018274524],"genre_scores_gemma":[0.99639505,0.00067789765,0.0007901112,0.000072427865,0.000114619754,0.00047228302,0.000071897775,0.00007590764,0.0013297877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99567354,0.00038647745,0.00051463454,0.0005965878,0.001685816,0.0011429249],"domain_scores_gemma":[0.99787986,0.00052836083,0.00008000195,0.0006115973,0.000617019,0.0002831646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058251136,0.00021371072,0.00051301566,0.0008629667,0.00007291605,0.000019792047,0.00036034736,0.000028865157,0.0006087657],"category_scores_gemma":[0.0012952468,0.00019913931,0.00010677961,0.0018524299,0.00033594936,0.00011637226,0.00023324385,0.0007675324,0.00008833699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086295296,0.00038285975,0.019439755,0.00028952974,0.000026634238,0.0030231765,0.00002083632,0.00014092364,0.9715542,0.000664196,0.0023051316,0.0012897919],"study_design_scores_gemma":[0.003230683,0.00058241276,0.005530677,0.00022366211,0.000008253407,0.00010665819,0.00013484833,0.0001840982,0.9796401,0.0010905818,0.009112046,0.00015596299],"about_ca_topic_score_codex":0.0055433647,"about_ca_topic_score_gemma":0.0015404335,"teacher_disagreement_score":0.013909078,"about_ca_system_score_codex":0.00044322424,"about_ca_system_score_gemma":0.00061354163,"threshold_uncertainty_score":0.83799464},"labels":[],"label_agreement":null},{"id":"W2007144276","doi":"10.1158/1538-7445.am10-2988","title":"Abstract 2988: A PP6-phosphatase complex is required for homology-directed repair of DNA double-strand breaks","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Heterotrimeric G protein; Phosphatase; Protein phosphatase 2; DNA repair; DNA; Chemistry; Phosphorylation; Molecular biology; Biology; Cancer research; Cell biology; Biochemistry; Signal transduction","score_opus":0.07219480584908312,"score_gpt":0.38965418658892914,"score_spread":0.31745938073984603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007144276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954785,0.0008635716,0.000056539022,0.00029011912,0.00028066812,0.00094661885,0.0007780046,0.000069185655,0.0012367966],"genre_scores_gemma":[0.9955662,0.00015478177,0.0016578501,0.00011149243,0.00029975007,0.0004485181,0.00037260656,0.000052003557,0.0013368091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998002,0.000056868732,0.00033415298,0.00063549087,0.00035029548,0.00062120694],"domain_scores_gemma":[0.99813616,0.0000680595,0.000100412246,0.0008683739,0.00062909414,0.00019787604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009856337,0.00018244518,0.0002695116,0.000105786516,0.00015349608,0.000024230001,0.00046907237,0.00033678848,0.0005420661],"category_scores_gemma":[0.00015046203,0.00017809965,0.00020362646,0.00021635792,0.00041025956,0.000007696709,0.00017340598,0.00033611446,0.000012906337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014233361,0.00011837182,0.00022421664,0.00014161695,0.00011354915,0.000008390637,0.00006750374,0.0000018344257,0.9590296,0.0004176009,0.03670508,0.0017488704],"study_design_scores_gemma":[0.0021601252,0.0003552254,0.0015713612,0.000023711511,0.000014119922,0.000010594034,0.00004113382,0.00005420862,0.9262432,0.00034330468,0.06900196,0.00018106418],"about_ca_topic_score_codex":0.000532051,"about_ca_topic_score_gemma":0.00063763617,"teacher_disagreement_score":0.032786436,"about_ca_system_score_codex":0.000030114254,"about_ca_system_score_gemma":0.00041982162,"threshold_uncertainty_score":0.7262693},"labels":[],"label_agreement":null},{"id":"W2007269128","doi":"10.1158/0008-5472.can-07-0561","title":"Androgen Withdrawal in Patients Reduces Prostate Cancer Hypoxia: Implications for Disease Progression and Radiation Response","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Bicalutamide; Prostate cancer; Medicine; Hypoxia (environmental); Androgen; Radiation therapy; Prostate; Androgen suppression; Urology; Internal medicine; Prostate-specific antigen; Oncology; Tumor hypoxia; Cancer; Androgen receptor; Hormone; Oxygen; Chemistry","score_opus":0.02343804214027647,"score_gpt":0.38877830595511303,"score_spread":0.3653402638148366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007269128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97704744,0.020129938,0.000027308679,0.0010004346,0.00023895605,0.001272265,0.00025168218,0.000007196096,0.00002475584],"genre_scores_gemma":[0.99183345,0.005410361,0.00008348835,0.000068763264,0.00065562106,0.0013088522,0.00013015333,0.00002661443,0.00048267125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998644,0.00010600599,0.00018669188,0.00042371708,0.0001934348,0.0004461834],"domain_scores_gemma":[0.99914724,0.000044819397,0.000056162902,0.0002208833,0.00030946574,0.0002214403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097117096,0.00010895091,0.0001121698,0.00014699202,0.0001805766,0.00003605474,0.00012172444,0.00008786599,0.0000052542896],"category_scores_gemma":[0.0002016583,0.000100676356,0.000033743574,0.0002419971,0.00014648966,0.000012767532,0.00007875023,0.00011420801,5.8729194e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013079094,0.00016354695,0.15577294,0.00007007277,0.00003066158,5.549188e-7,0.00030002755,0.00001810451,0.4704025,0.00003690399,0.0062285485,0.35389704],"study_design_scores_gemma":[0.0022411644,0.0002562094,0.754934,0.000055193595,0.000012718699,4.4596797e-7,0.000051052,0.000007924984,0.08467686,0.00012686301,0.15747058,0.00016694174],"about_ca_topic_score_codex":0.00008459764,"about_ca_topic_score_gemma":0.00026433644,"teacher_disagreement_score":0.5991611,"about_ca_system_score_codex":0.00010024622,"about_ca_system_score_gemma":0.00053068367,"threshold_uncertainty_score":0.41054627},"labels":[],"label_agreement":null},{"id":"W2007448716","doi":"10.1158/0008-5472.sabcs-09-3156","title":"Examining the Role of ErbB2 in a Mouse Model of Type I Insulin like Growth Factor Receptor-Induced Mammary Tumourigenesis.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Downregulation and upregulation; Biology; Insulin-Like Growth Factor Receptor; Cancer research; Insulin-like growth factor 1 receptor; Receptor tyrosine kinase; Cell growth; Epidermal growth factor receptor; Mammary gland; Insulin-like growth factor; Growth factor; Transfection; Receptor; Growth factor receptor; Cancer; Breast cancer; Cell culture; Internal medicine; Endocrinology; Kinase; Medicine; Cell biology; Gene","score_opus":0.10657626603059628,"score_gpt":0.34778356068266686,"score_spread":0.24120729465207058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007448716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455005,0.0026782458,0.0000121880985,0.0005541374,0.000062587,0.0005801238,0.000029961133,0.000027165734,0.0015055351],"genre_scores_gemma":[0.9969289,0.0020149155,0.0002035417,0.00015397054,0.00009488289,0.00004304671,0.000010328777,0.000033957775,0.000516461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997387,0.00022108995,0.0005557874,0.00037463187,0.0008913934,0.0005701076],"domain_scores_gemma":[0.99823534,0.00015795504,0.00012282211,0.0005869021,0.0007099795,0.00018699032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008804543,0.0001952559,0.000493939,0.0005159021,0.00007548355,0.000015364763,0.00047197405,0.0001912768,0.00006041752],"category_scores_gemma":[0.00040870448,0.00014322008,0.00008428997,0.0012015579,0.00013617145,0.00017177097,0.00012275964,0.000770571,0.000012430289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006699365,0.00023044083,0.018712819,0.00008740469,0.000037621994,0.0000045457264,0.0019820377,0.00002525492,0.9663024,0.00039786054,0.00036418907,0.011185476],"study_design_scores_gemma":[0.0014500716,0.0012640315,0.06916434,0.00019801843,0.000016974314,0.0000019243357,0.00076573045,0.0015461643,0.92427546,0.0008608147,0.0002577776,0.00019870704],"about_ca_topic_score_codex":0.0008709749,"about_ca_topic_score_gemma":0.000028914188,"teacher_disagreement_score":0.05045153,"about_ca_system_score_codex":0.00022499083,"about_ca_system_score_gemma":0.0009245845,"threshold_uncertainty_score":0.58403456},"labels":[],"label_agreement":null},{"id":"W2007830916","doi":"10.1158/1538-7445.am2014-4812","title":"Abstract 4812: A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin- and thrombospondin-dependent manner","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Angiogenesis; Cancer research; Biology; Metastasis; Cancer; Endothelial stem cell; Thrombospondin 1; HT1080; Cell biology; Biochemistry","score_opus":0.06719086257495165,"score_gpt":0.3518331450281205,"score_spread":0.28464228245316886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007830916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109685,0.006225388,0.00020016405,0.0009235642,0.00016444939,0.00049598556,0.00011798558,0.000014055094,0.00076152885],"genre_scores_gemma":[0.9941548,0.0033520174,0.00013871684,0.0005722849,0.00036050193,0.00028468773,0.00003842114,0.00007075832,0.0010278126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971729,0.0001260258,0.0003365994,0.0009457921,0.0005974362,0.00082126225],"domain_scores_gemma":[0.9987728,0.000044578803,0.00010132234,0.0005870087,0.0002380151,0.0002562549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097241753,0.00031799884,0.00037058638,0.00024510123,0.00018588934,0.000103378705,0.00040254186,0.00022118575,0.00021595776],"category_scores_gemma":[0.000057047495,0.00027829685,0.00018237058,0.00029665208,0.00026187848,0.000016368444,0.00048748995,0.0002945135,0.0000315323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016208633,0.00015924331,0.023871364,0.00009680531,0.000121548735,0.000015512162,0.0002302777,0.00004660603,0.96666014,0.00006542728,0.0041927877,0.0043782196],"study_design_scores_gemma":[0.0013691235,0.00022395072,0.18493584,0.00019035474,0.000024055204,0.0000196988,0.00038554094,0.00005271533,0.78271174,0.00003543818,0.029620476,0.0004310777],"about_ca_topic_score_codex":0.0013348897,"about_ca_topic_score_gemma":0.0008749786,"teacher_disagreement_score":0.18394838,"about_ca_system_score_codex":0.00015247466,"about_ca_system_score_gemma":0.0001967745,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W2008072660","doi":"10.1158/0008-5472.sabcs11-p4-11-13","title":"P4-11-13: Influence of Two Years of Exemestane on Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer; a Companion Study to the NCIC CTG MAP.3 Trial.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Queen's University","funders":"","keywords":"Medicine; Exemestane; Breast cancer; Bone mineral; Osteoporosis; Internal medicine; Gynecology; Population; Cancer; Oncology; Tamoxifen","score_opus":0.08519658291316434,"score_gpt":0.41297989051462647,"score_spread":0.3277833076014621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008072660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665624,0.00022415518,4.2866924e-7,0.00024331304,0.00006430457,0.002641541,0.00013589373,0.0000079612355,0.000026192878],"genre_scores_gemma":[0.9991101,0.0001616144,0.000072497,0.000090873466,0.000035664376,0.00041843022,0.0000059001036,0.000020803978,0.00008409301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720424,0.00053801737,0.00055081345,0.000323734,0.000846404,0.0005368041],"domain_scores_gemma":[0.99835044,0.00021308423,0.00020452171,0.0004779147,0.00050137454,0.00025266118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017871622,0.00014336414,0.00058918167,0.00034342307,0.00007410561,0.0000033529386,0.00018437643,0.00004866272,0.000073651776],"category_scores_gemma":[0.00018947668,0.00010725431,0.000033494365,0.00080674945,0.00016552309,0.00004265982,0.00016793452,0.0003029524,0.000008246695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06397095,0.0015318515,0.916778,0.0002242418,0.00013827758,0.000089462774,0.0079818545,0.00003732349,0.0067314915,0.00002058901,0.00009853216,0.0023973787],"study_design_scores_gemma":[0.021943744,0.0028560893,0.9710054,0.00043823716,0.000041310075,0.0000080105,0.0005361916,0.000008438553,0.0030362518,0.000024512172,0.000023204566,0.00007865814],"about_ca_topic_score_codex":0.24710307,"about_ca_topic_score_gemma":0.03833476,"teacher_disagreement_score":0.20876831,"about_ca_system_score_codex":0.0011742383,"about_ca_system_score_gemma":0.0011562117,"threshold_uncertainty_score":0.9792131},"labels":[],"label_agreement":null},{"id":"W2008124811","doi":"10.1158/1538-7445.am2014-lb-258","title":"Abstract LB-258: Neutrophil extracellular traps sequester circulating tumor cells via beta 1 integrin mediated interactions","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; McGill University","funders":"","keywords":"Neutrophil extracellular traps; Integrin; Intravital microscopy; Cancer cell; Cell adhesion; A549 cell; Cell biology; Extracellular; Transfection; Chemistry; Cancer research; Immunology; Molecular biology; Biology; Cell culture; In vitro; Cell; Cancer; Inflammation; In vivo; Biochemistry","score_opus":0.06170008158472725,"score_gpt":0.3395288279085321,"score_spread":0.2778287463238049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008124811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246293,0.0014962956,0.00087108096,0.0010997009,0.0012675838,0.000548768,0.000095892865,0.000132996,0.0020247286],"genre_scores_gemma":[0.9961974,0.00011373749,0.00009769208,0.00024526837,0.00026669967,0.00022483522,0.00017444187,0.00007328024,0.002606616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996634,0.0008426271,0.0005359161,0.00074477535,0.00019686324,0.0010457939],"domain_scores_gemma":[0.9980259,0.0006626247,0.00015387434,0.0006210017,0.00040908225,0.00012749709],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001300807,0.00033428686,0.00045289853,0.00042616602,0.00053666544,0.00008548681,0.0005918317,0.00022783688,0.0053680115],"category_scores_gemma":[0.00010429748,0.00029215688,0.00016415604,0.00046927854,0.00042209466,0.00028710923,0.00020847279,0.0020302888,0.0028663254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011611451,0.00012157126,0.00009041344,0.000055647903,0.00012789381,0.000057527308,0.00039556331,0.000026424643,0.9899786,0.0010320512,0.001622911,0.006375287],"study_design_scores_gemma":[0.00090784987,0.00018717915,0.0010722968,0.0001603349,0.000025003086,0.00004705845,0.00025775647,0.000044993314,0.89638674,0.00047272092,0.100118294,0.00031979886],"about_ca_topic_score_codex":0.0006952404,"about_ca_topic_score_gemma":0.00017938104,"teacher_disagreement_score":0.09849539,"about_ca_system_score_codex":0.00027035436,"about_ca_system_score_gemma":0.00017685763,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W2008198257","doi":"10.1158/1538-7445.am2013-4839","title":"Abstract 4839: SNP-SNP interactions in mitochondria-related pathways are associated with invasive Epithelial Ovarian Cancer (EOC) risk .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"SNP; Biology; Single-nucleotide polymorphism; Linkage disequilibrium; Genetics; Mitochondrion; Genotype; Gene","score_opus":0.04826066494331309,"score_gpt":0.34696556933157785,"score_spread":0.29870490438826475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008198257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926868,0.0016264261,0.00017700411,0.0010781304,0.000469551,0.0018184059,0.0005173366,0.000045006105,0.0015813434],"genre_scores_gemma":[0.9914304,0.002841797,0.0000683438,0.00011989753,0.00036587458,0.0025987793,0.00022734154,0.00013428304,0.002213281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953895,0.00063906517,0.00051344134,0.0010992675,0.0010073152,0.0013513742],"domain_scores_gemma":[0.99704146,0.0002005804,0.00026997546,0.0008228098,0.001256321,0.00040885402],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085590873,0.00038783124,0.0004028274,0.000501225,0.0003799945,0.00019719668,0.00070167764,0.00045200545,0.0022580535],"category_scores_gemma":[0.0011492827,0.0003564926,0.0001626932,0.001212885,0.00035358864,0.000043781554,0.0003649869,0.0020855244,0.00019439112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038296744,0.00024201878,0.0023000978,0.000044072724,0.00045119834,0.00008252134,0.0003131123,0.0018870486,0.9831693,0.000035507815,0.006796851,0.0042952644],"study_design_scores_gemma":[0.0055985013,0.00061500864,0.065276824,0.0011553371,0.0000607458,0.000018920751,0.0011541476,0.00044736653,0.91645527,0.00080873247,0.0074248007,0.0009843566],"about_ca_topic_score_codex":0.01906574,"about_ca_topic_score_gemma":0.046037715,"teacher_disagreement_score":0.066714086,"about_ca_system_score_codex":0.00090088655,"about_ca_system_score_gemma":0.0017899043,"threshold_uncertainty_score":0.9998887},"labels":[],"label_agreement":null},{"id":"W2008210460","doi":"10.1158/1538-7445.am10-1773","title":"Abstract 1773: The addition of Reolysin, an oncolytic reovirus, to irinotecan shows synergistic anticancer activity in colorectal cancer cell lines","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Irinotecan; Colorectal cancer; Oncolytic virus; KRAS; Medicine; Multiplicity of infection; Cetuximab; Cancer; Camptothecin; Cancer research; Immunology; Internal medicine; Pharmacology; Oncology; Biology; Virus","score_opus":0.042728756300851045,"score_gpt":0.41120740154395063,"score_spread":0.3684786452430996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008210460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962932,0.00085464754,0.000008089118,0.0004721795,0.00019765962,0.0007888314,0.00050935184,0.000008570932,0.00086750236],"genre_scores_gemma":[0.99599135,0.0018829873,0.000029939243,0.000057220277,0.0005830623,0.001012717,0.000053353855,0.000038132264,0.000351227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976958,0.00017311558,0.00023725288,0.0005841002,0.0006288761,0.00068087643],"domain_scores_gemma":[0.9985665,0.00010475118,0.00007734489,0.0005729265,0.00040250464,0.00027593752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007354758,0.00018954289,0.00023151329,0.00013053537,0.00017476759,0.00005587449,0.0005250795,0.00017050028,0.0006975239],"category_scores_gemma":[0.00021191749,0.00014787567,0.00007919548,0.00046679477,0.00038011261,0.000023238796,0.00020943301,0.000602096,0.000012683847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001183837,0.00035210006,0.0039915936,0.000060218674,0.000041757514,0.0000128933325,0.000092365706,0.0001532444,0.97453564,0.0000140864495,0.0024179516,0.017144281],"study_design_scores_gemma":[0.0006966797,0.0005999475,0.063121825,0.000052216576,0.000011073069,0.0000013440246,0.00006537111,0.00006215324,0.93045396,0.000034505756,0.0047346405,0.00016628965],"about_ca_topic_score_codex":0.05926266,"about_ca_topic_score_gemma":0.28488162,"teacher_disagreement_score":0.22561897,"about_ca_system_score_codex":0.000299754,"about_ca_system_score_gemma":0.0012013761,"threshold_uncertainty_score":0.9470018},"labels":[],"label_agreement":null},{"id":"W2008308871","doi":"10.1158/1538-7445.am2012-2375","title":"Abstract 2375: Rapid unbiased enrichment (negative selection) of circulating non-hematopoietic tumor cells directly from whole blood","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Centrifugation; Circulating tumor cell; Pipette; Whole blood; Differential centrifugation; Haematopoiesis; Chemistry; Chromatography; Biology; Molecular biology; Biomedical engineering; Cancer; Immunology; Medicine; Cell biology; Metastasis; Stem cell","score_opus":0.059771721317315875,"score_gpt":0.36974906672242835,"score_spread":0.30997734540511246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008308871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915334,0.0031020432,0.00002963164,0.00021625505,0.0002951031,0.0007292201,0.00014049545,0.000030279098,0.0039235926],"genre_scores_gemma":[0.99731076,0.00032305616,0.00069366506,0.00009172453,0.0007095208,0.00021448525,0.000024830284,0.000046708683,0.00058528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738896,0.000118248405,0.0004123763,0.00038083695,0.0009456999,0.0007539024],"domain_scores_gemma":[0.9982185,0.0004148328,0.0001539604,0.0003596667,0.00045261823,0.00040045622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009316164,0.00019121173,0.00048385898,0.00022944088,0.00015303919,0.000026542211,0.00013954724,0.000073060604,0.0037221836],"category_scores_gemma":[0.00013135615,0.00016963141,0.00015587405,0.00077106134,0.00016921716,0.0001323208,0.00007568829,0.00055411307,0.00009221553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019386246,0.00048972823,0.0071888124,0.0003807576,0.00027718628,0.000018228851,0.0016267735,0.000019837646,0.9783803,0.000007628897,0.0025530364,0.008863801],"study_design_scores_gemma":[0.0018488826,0.000175079,0.025081435,0.00042563825,0.00016421425,0.0000079140445,0.00090123445,0.0000215158,0.9664161,0.000031243515,0.004767159,0.00015957559],"about_ca_topic_score_codex":0.004455886,"about_ca_topic_score_gemma":0.00009021941,"teacher_disagreement_score":0.017892623,"about_ca_system_score_codex":0.0003547089,"about_ca_system_score_gemma":0.0005604041,"threshold_uncertainty_score":0.99718857},"labels":[],"label_agreement":null},{"id":"W2008621188","doi":"10.1158/0008-5472.sabcs-09-201","title":"Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Taxane; Internal medicine; Breast cancer; Lapatinib; Sunitinib; Cancer; Neutropenia; Pharmacokinetics; Metastatic breast cancer; Dosing; Clinical endpoint; Trastuzumab; Pharmacology; Oncology; Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.06576479026102895,"score_gpt":0.43729516599548707,"score_spread":0.37153037573445813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008621188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850115,0.0022886673,0.00014122334,0.007257513,0.000044844237,0.0038059605,0.0013754994,0.000022847811,0.00005193275],"genre_scores_gemma":[0.9961876,0.0019793084,0.00013913511,0.000044285833,0.00013808343,0.0011907003,0.000039651528,0.000028068054,0.00025311208],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981115,0.00013847095,0.00029444855,0.00048635926,0.0005386067,0.00043063224],"domain_scores_gemma":[0.99825346,0.0006255316,0.00012260288,0.00043150247,0.0004503301,0.00011654881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042161084,0.00020745103,0.0004634358,0.00017548689,0.0002868061,0.000017871263,0.00012497428,0.000055720295,0.00005055744],"category_scores_gemma":[0.000045144665,0.0001315449,0.00004579344,0.00055225944,0.00028565185,0.00016848007,0.000021915896,0.00024467436,2.487876e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10417625,0.0048762457,0.0011979466,0.000027110143,0.00019489911,0.0000142207955,0.008186115,0.00019294782,0.022743827,0.000031211464,0.000015534271,0.85834366],"study_design_scores_gemma":[0.2215268,0.052279197,0.6644914,0.00095343555,0.00025632442,0.0000217097,0.010262128,0.00076491927,0.039035562,0.0004894658,0.009494362,0.00042466988],"about_ca_topic_score_codex":0.005285217,"about_ca_topic_score_gemma":0.004321747,"teacher_disagreement_score":0.85791904,"about_ca_system_score_codex":0.0011124176,"about_ca_system_score_gemma":0.0004969799,"threshold_uncertainty_score":0.7989702},"labels":[],"label_agreement":null},{"id":"W2008621428","doi":"10.1158/0008-5472.can-14-0725","title":"Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"U.S. National Library of Medicine; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Pharmacogenomics; Drug response; Computational biology; Concordance; Drug; Standardization; Consistency (knowledge bases); Scale (ratio); Computer science; Medicine; Bioinformatics; Biology; Pharmacology; Artificial intelligence","score_opus":0.07989643579829994,"score_gpt":0.4166131072828331,"score_spread":0.3367166714845331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008621428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003396344,0.9965864,0.00037938714,0.0005693773,0.0003769219,0.0012001944,0.00010860965,0.000010077257,0.00042943787],"genre_scores_gemma":[0.00069648906,0.9908943,0.0002210064,0.000052449024,0.0017629582,0.00093977165,0.00012676675,0.0000851734,0.0052210838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956801,0.00050200213,0.00067539513,0.0017025316,0.00046931158,0.00097064814],"domain_scores_gemma":[0.996686,0.000097200835,0.00027402228,0.0024623033,0.00027184447,0.000208664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005839001,0.00042281262,0.001140659,0.00023139239,0.00015003572,0.00014974477,0.00087780907,0.00058320345,0.00008321483],"category_scores_gemma":[0.00038002324,0.00035665825,0.00037703407,0.00051565736,0.00021470798,0.0000073869096,0.0007735706,0.001268281,0.000018233997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002619377,0.000022141161,0.000023762126,0.008250033,0.00011876291,0.0000026629625,0.00009657581,0.000026406113,0.00019636081,0.000026004824,0.017810386,0.9734007],"study_design_scores_gemma":[0.00021363063,0.00004652204,0.000004182206,0.006666269,0.000044357163,0.000003467955,0.000057689354,0.000025852878,0.0007992232,0.00012072928,0.9916258,0.00039231472],"about_ca_topic_score_codex":0.00046372792,"about_ca_topic_score_gemma":0.0015620204,"teacher_disagreement_score":0.9738154,"about_ca_system_score_codex":0.00029172137,"about_ca_system_score_gemma":0.001180391,"threshold_uncertainty_score":0.99988854},"labels":[],"label_agreement":null},{"id":"W2008810235","doi":"10.1158/1538-7445.am2014-506","title":"Abstract 506: H2O2 upregulates xCT in human breast cancer cells via NRF-2","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Glutathione; GCLM; Oxidative stress; Cancer cell; Transcription factor; Glutathione synthetase; Cell biology; KEAP1; Intracellular; Chemistry; Biochemistry; Biology; GCLC; Cancer; Enzyme; Gene; Genetics","score_opus":0.028115498067203558,"score_gpt":0.3627609123919604,"score_spread":0.33464541432475686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008810235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647593,0.0012115093,0.00003924002,0.00039342555,0.00013519902,0.00025930788,0.000111445224,0.000009370404,0.0013645412],"genre_scores_gemma":[0.9972611,0.0005876135,0.00003703825,0.00014036662,0.00085414137,0.00016990323,0.00006192894,0.00004166947,0.00084621675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980809,0.00011907418,0.00024604576,0.00059269334,0.00027539776,0.00068590266],"domain_scores_gemma":[0.9989682,0.000030164774,0.000060724924,0.00048178644,0.0002899013,0.0001692091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005291666,0.00018909128,0.0002136172,0.00010101187,0.0001362783,0.000047021374,0.00047111182,0.00019376617,0.00044341478],"category_scores_gemma":[0.000032830732,0.00018434205,0.00007940384,0.00015997149,0.00031166262,0.000006866569,0.00022274244,0.00035871807,0.00003150329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008927639,0.00006596517,0.005789821,0.00006554842,0.000030052186,0.0000018993524,0.00005204813,0.00016801611,0.98622036,0.00003290906,0.0035018586,0.0039822473],"study_design_scores_gemma":[0.0005630229,0.000058644622,0.050501414,0.00006403655,0.000003980428,0.0000015498481,0.000034100663,0.000024762014,0.9360464,0.00042034665,0.012056397,0.0002253318],"about_ca_topic_score_codex":0.0014342852,"about_ca_topic_score_gemma":0.0010032017,"teacher_disagreement_score":0.050173946,"about_ca_system_score_codex":0.00011700869,"about_ca_system_score_gemma":0.00013633032,"threshold_uncertainty_score":0.7517251},"labels":[],"label_agreement":null},{"id":"W2008897709","doi":"10.1158/1538-7445.am2011-2491","title":"Abstract 2491: Metformin sensitizes human lung cancer xenografts to ionizing radiation: Response of the AMPK pathway","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"AMPK; Medicine; Metformin; Cancer research; Clonogenic assay; Ionizing radiation; Lung cancer; AMP-activated protein kinase; Radiation therapy; Cancer; A549 cell; Protein kinase A; Internal medicine; Pharmacology; Chemistry; Kinase; Apoptosis; Biochemistry","score_opus":0.07934220889723385,"score_gpt":0.3837362340249808,"score_spread":0.30439402512774694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008897709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9021333,0.096205726,0.000010924154,0.000110717876,0.00044740192,0.00041798642,0.0000891483,0.0000081786975,0.0005766485],"genre_scores_gemma":[0.9889817,0.008657659,0.000073817224,0.00022232329,0.0006706001,0.00029539288,0.00000976146,0.000035506506,0.0010531993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980747,0.00030226912,0.00026969207,0.00038518902,0.00046257107,0.00050559436],"domain_scores_gemma":[0.99869347,0.000037363814,0.00009446218,0.0006126372,0.00040137384,0.00016067672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014437299,0.00015155882,0.00019907128,0.00011814057,0.00026946992,0.000027979717,0.00044250122,0.00013531734,0.0004111016],"category_scores_gemma":[0.00017848454,0.00011750533,0.00012051368,0.0003933289,0.00019885814,0.000009702796,0.00021404195,0.00023589529,0.000006808349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053319806,0.000031981344,0.0016636628,0.00006817448,0.00008754322,0.000003026865,0.0011096916,0.00002688202,0.94514287,0.000109096574,0.008709969,0.0425139],"study_design_scores_gemma":[0.00034171305,0.000070376365,0.021542463,0.000076203825,0.00001265281,8.7549085e-7,0.0001757051,0.0000024006563,0.8437622,0.00003919167,0.13383682,0.00013939592],"about_ca_topic_score_codex":0.0014289104,"about_ca_topic_score_gemma":0.00074639975,"teacher_disagreement_score":0.12512685,"about_ca_system_score_codex":0.00010414708,"about_ca_system_score_gemma":0.00057733717,"threshold_uncertainty_score":0.47917286},"labels":[],"label_agreement":null},{"id":"W2009039155","doi":"10.1158/1538-7445.am2013-2983","title":"Abstract 2983: Gene resilencing following decitabine therapy is initiated by nucleosome reoccupancy and is related to CpG island shore methylation.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Decitabine; Epigenetics; DNA methylation; Methylation; Biology; CpG site; Cancer research; Epigenetic therapy; Promoter; Demethylating agent; Gene; Genetics; Gene expression","score_opus":0.05479330189517935,"score_gpt":0.3886777325893914,"score_spread":0.3338844306942121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009039155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768304,0.020187873,0.00015285052,0.0015013478,0.00009192722,0.0005631935,0.00007360703,0.000013449728,0.00058531464],"genre_scores_gemma":[0.99120027,0.0069736564,0.00026599757,0.00031590826,0.00011407702,0.00019985798,0.00010484785,0.000048489732,0.000776889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998126,0.00012047197,0.0003117471,0.0005704667,0.00040514424,0.00046621021],"domain_scores_gemma":[0.99890727,0.00006342111,0.000057291174,0.00039179216,0.0003635994,0.00021665148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066004123,0.00017892398,0.00018367673,0.00014592298,0.0002299189,0.00012281178,0.00020143145,0.00023921607,0.00062151917],"category_scores_gemma":[0.00014666592,0.00016615963,0.000069011374,0.00038292134,0.00006368088,0.000024924748,0.0001237199,0.00025011008,0.000034018183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000524362,0.000022371634,0.006337138,0.000010481965,0.00008653601,0.0000019961099,0.00057020626,0.000012041261,0.97211283,0.0000042757806,0.008125609,0.012664102],"study_design_scores_gemma":[0.0007723168,0.00023738567,0.028826572,0.000041912535,0.0000072598664,6.2459014e-7,0.0001419396,0.00005640105,0.9557079,0.0009775907,0.012981072,0.0002489915],"about_ca_topic_score_codex":0.0006182301,"about_ca_topic_score_gemma":0.000039596245,"teacher_disagreement_score":0.022489434,"about_ca_system_score_codex":0.00004877952,"about_ca_system_score_gemma":0.00011653335,"threshold_uncertainty_score":0.68051994},"labels":[],"label_agreement":null},{"id":"W2009055670","doi":"10.1158/1538-7445.chtme14-b78","title":"Abstract B78: Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signaling","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Paracrine signalling; Cancer research; Mesenchymal stem cell; Bone marrow; Stromal cell; Medicine; Receptor tyrosine kinase; Autocrine signalling; Biology; Pathology; Internal medicine; Receptor","score_opus":0.14716325825613116,"score_gpt":0.43125325808134607,"score_spread":0.2840899998252149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009055670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760326,0.015201143,0.000026845752,0.0041413484,0.0008073991,0.001983321,0.00009649831,0.00012226844,0.0015885626],"genre_scores_gemma":[0.9916543,0.0021810883,0.0010551041,0.00021349758,0.0012146445,0.0009990404,0.000028314222,0.00012042968,0.002533621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949453,0.00024009221,0.00058079034,0.00091588433,0.0020192065,0.0012987356],"domain_scores_gemma":[0.9972495,0.000115946714,0.00018930604,0.0005331958,0.0010973378,0.0008147286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016036145,0.00038483285,0.0007368078,0.00020622558,0.00026071098,0.00011998832,0.00031113898,0.0002236107,0.0016250834],"category_scores_gemma":[0.00006545636,0.0003081884,0.00019452145,0.00089916703,0.0003514767,0.00027098408,0.00024817785,0.0012197082,0.00013139038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026817012,0.00031588288,0.00084542204,0.0005614121,0.00014282565,0.0005194133,0.0015663222,0.0002178087,0.9205544,0.00001427689,0.014878292,0.057702232],"study_design_scores_gemma":[0.003302184,0.0007146619,0.000738293,0.0007290083,0.0000934027,0.000040357096,0.0007372663,0.00012710548,0.9184345,0.000067717105,0.07467501,0.00034047803],"about_ca_topic_score_codex":0.0028636453,"about_ca_topic_score_gemma":0.00050898,"teacher_disagreement_score":0.05979672,"about_ca_system_score_codex":0.0009567219,"about_ca_system_score_gemma":0.0022769915,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W2009075539","doi":"10.1158/1538-7445.am2013-4593","title":"Abstract 4593: Genome-wide association study identifies novel loci associated with osteosarcoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Genotyping; Osteosarcoma; Population; SNP genotyping; Genetic association; SNP; Concordance; Medicine; Population stratification; Genetics; Oncology; Genotype; Biology; Internal medicine; Pathology; Gene","score_opus":0.03371208546669466,"score_gpt":0.3390904845894136,"score_spread":0.3053783991227189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009075539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433756,0.0007681923,0.00048595684,0.0008822332,0.00011722276,0.0019506902,0.000058561818,0.000038641847,0.0013609705],"genre_scores_gemma":[0.9891513,0.00020427222,0.000032344775,0.00015444483,0.00024327486,0.0011776837,0.00020885644,0.00009298753,0.00873485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99575716,0.00031154515,0.0003366323,0.0008001047,0.0016792064,0.0011153367],"domain_scores_gemma":[0.9969593,0.00017818983,0.00015463107,0.0006881456,0.001759115,0.0002606018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018445932,0.00025798302,0.00026963677,0.00024932652,0.00037416606,0.00033157787,0.00063764834,0.00032711096,0.0007206349],"category_scores_gemma":[0.0013585028,0.00023932235,0.00009752429,0.0007134774,0.00014403007,0.000026190752,0.00039909504,0.0008298497,0.00019848451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013733275,0.00048801853,0.010907021,0.000027951595,0.00060287124,0.000017547929,0.00021138006,0.00024532506,0.97471553,0.0000057048924,0.012006216,0.00063510536],"study_design_scores_gemma":[0.006115876,0.0023452383,0.4244267,0.00013746,0.00008245916,0.000004126084,0.0026472677,0.00006536893,0.54714245,0.0001858618,0.015808726,0.0010384511],"about_ca_topic_score_codex":0.0019316083,"about_ca_topic_score_gemma":0.0025368799,"teacher_disagreement_score":0.42757306,"about_ca_system_score_codex":0.0008664068,"about_ca_system_score_gemma":0.0006567884,"threshold_uncertainty_score":0.97592825},"labels":[],"label_agreement":null},{"id":"W2009101885","doi":"10.1158/1538-7445.am2012-3667","title":"Abstract 3667: Inactivating BRAF mutations confer dasatinib sensitivity in lung cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Dasatinib; Cancer research; Mutation; Cancer; Lung cancer; Transfection; Kinase; Tyrosine kinase; Medicine; Biology; Gene; Internal medicine; Genetics; Receptor","score_opus":0.10635581743494316,"score_gpt":0.5078567328954511,"score_spread":0.4015009154605079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009101885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815264,0.0018804752,0.000032066768,0.0022935616,0.00022601809,0.0008687552,0.00007184299,0.000041967312,0.013058946],"genre_scores_gemma":[0.9967136,0.0002091099,0.00017152353,0.00021687,0.0005329265,0.0007738956,0.000053951248,0.00003726883,0.0012908506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981086,0.00010806154,0.00024278284,0.00028136894,0.00053198606,0.00072720327],"domain_scores_gemma":[0.99870634,0.00035694166,0.000057487603,0.00025158245,0.0003579932,0.00026964472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069992495,0.00014228105,0.00024671396,0.00028531047,0.00023114895,0.000038776663,0.00005472382,0.0000935314,0.0015623721],"category_scores_gemma":[0.00020448759,0.00012458726,0.000054161002,0.00064017944,0.00014123507,0.00033291866,0.000049986582,0.0006096803,0.00003558722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013675148,0.00045324097,0.9305909,0.00032797962,0.00022541084,0.000074450676,0.00542083,0.00013521229,0.039924584,0.00073343824,0.0036699683,0.018307216],"study_design_scores_gemma":[0.0020541616,0.00004322656,0.97448134,0.0005396845,0.0000766386,0.000014884016,0.0014588553,0.00027490803,0.016808521,0.00005475007,0.0040144413,0.00017856012],"about_ca_topic_score_codex":0.013795961,"about_ca_topic_score_gemma":0.0028619603,"teacher_disagreement_score":0.04389045,"about_ca_system_score_codex":0.0015316545,"about_ca_system_score_gemma":0.0011026285,"threshold_uncertainty_score":0.9993503},"labels":[],"label_agreement":null},{"id":"W2009205364","doi":"10.1158/0008-5472.can-09-1251","title":"Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor α as a Determinant of Breast Cancer Heterogeneity","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Immunovaccine (Canada); McGill University Health Centre","funders":"","keywords":"Biology; GATA3; Breast cancer; Estrogen receptor; Cancer research; Estrogen receptor alpha; Nuclear receptor; Gene; Genetics; Estrogen receptor beta; Cancer; Gene expression profiling; Computational biology; Transcription factor; Gene expression","score_opus":0.01630742964776805,"score_gpt":0.3488783831781531,"score_spread":0.33257095353038507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009205364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96690863,0.031926073,0.000013751056,0.00028711138,0.000086125816,0.00043885584,0.00019697174,0.0000122463025,0.00013022246],"genre_scores_gemma":[0.9893979,0.009872607,0.000049047874,0.000020358324,0.00009506809,0.00012421497,0.00010192152,0.000027784408,0.00031110784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806947,0.00021408082,0.0004514914,0.00048044912,0.0003367981,0.00044770492],"domain_scores_gemma":[0.99862987,0.00003087833,0.0002058305,0.0005038393,0.0004804949,0.00014906844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057231233,0.00017709652,0.0002788881,0.00013409648,0.00011225258,0.000017671413,0.0003882908,0.0002575596,0.0000704754],"category_scores_gemma":[0.00006652168,0.0001547531,0.00016337827,0.00038862228,0.00024988662,0.000009114131,0.00010275102,0.00020561538,0.000014763713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002931236,0.0001233079,0.012962411,0.000054771488,0.00015702083,0.0000025749546,0.00005292916,0.00016816136,0.9786462,0.00002896502,0.00016903349,0.007341459],"study_design_scores_gemma":[0.0003585281,0.00035175323,0.04289505,0.000046108922,0.000024919638,0.000012858617,0.000020311327,0.00002584005,0.9545743,0.00005714681,0.0014840858,0.00014909642],"about_ca_topic_score_codex":0.0002840514,"about_ca_topic_score_gemma":0.000012023616,"teacher_disagreement_score":0.029932639,"about_ca_system_score_codex":0.000071871706,"about_ca_system_score_gemma":0.0003252641,"threshold_uncertainty_score":0.6310648},"labels":[],"label_agreement":null},{"id":"W2009233027","doi":"10.1158/1538-7445.am2012-lb-168","title":"Abstract LB-168: A hexane fraction of American ginseng suppresses colon cancer associated with colitis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Azoxymethane; Colorectal cancer; Cancer; Apoptosis; Medicine; Colitis; Inflammation; Cancer research; Carcinogenesis; Gastroenterology; Internal medicine; Chemistry; Biochemistry","score_opus":0.052451617237670244,"score_gpt":0.40382184051405645,"score_spread":0.35137022327638623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009233027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757516,0.0011051168,0.00003778797,0.00032860163,0.000035810197,0.00031315134,0.00016094568,0.000011811418,0.00043161534],"genre_scores_gemma":[0.9977505,0.0011181484,0.00003716619,0.00007038018,0.00024825596,0.00046324448,0.0001029125,0.000017340995,0.00019205533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884135,0.00012598031,0.00012632422,0.00023134807,0.00023230835,0.00044269848],"domain_scores_gemma":[0.9991435,0.00012104533,0.00010031115,0.00021555295,0.00028464157,0.00013496345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037487232,0.00010228182,0.00017287766,0.00004180142,0.0001232778,0.000015595571,0.00014472644,0.000099995574,0.00015314062],"category_scores_gemma":[0.00016901904,0.000077774996,0.000038467337,0.000288807,0.00038464717,0.000006503045,0.000057421825,0.00021579226,0.0000047202957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021718338,0.0001880741,0.036802735,0.00003302744,0.00008379009,8.9182106e-7,0.000034715733,0.00004358381,0.9536423,0.00005465647,0.0034692548,0.005429767],"study_design_scores_gemma":[0.00034995336,0.00045039447,0.44787025,0.000061922314,0.0000143793295,0.0000013451564,0.00016806133,0.000006726071,0.5199363,0.000013839435,0.03098183,0.00014495634],"about_ca_topic_score_codex":0.0035233207,"about_ca_topic_score_gemma":0.0008423027,"teacher_disagreement_score":0.433706,"about_ca_system_score_codex":0.000083704275,"about_ca_system_score_gemma":0.00015472787,"threshold_uncertainty_score":0.53262305},"labels":[],"label_agreement":null},{"id":"W2009498018","doi":"10.1158/0008-5472.sabcs13-p6-07-12","title":"Abstract P6-07-12: Should adjuvant zoledronic acid be used in early-stage, endocrine-sensitive breast cancer?","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Adjuvant; Adverse effect; Oncology; Gynecology; Cancer; Internal medicine; Clinical trial; Zoledronic acid; Stage (stratigraphy); Endocrine system; Hormone","score_opus":0.17354891614359833,"score_gpt":0.46877663057754315,"score_spread":0.2952277144339448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009498018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97460973,0.0008047943,0.0000040661616,0.01741382,0.000051729465,0.0010570689,0.0002216269,0.00005953792,0.005777597],"genre_scores_gemma":[0.9930136,0.00082849676,0.00002363422,0.0004563111,0.0005466448,0.0014915917,0.000028712207,0.00004408772,0.0035668954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737805,0.000063164836,0.0003248569,0.00053384516,0.00076831743,0.0009317598],"domain_scores_gemma":[0.9983967,0.00018837328,0.00004721556,0.00047657348,0.00035231875,0.00053881545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034037256,0.00020540881,0.000351624,0.00013730284,0.0001412345,0.000061013914,0.0002513447,0.000127806,0.0061604474],"category_scores_gemma":[0.00006711003,0.0001819651,0.00008944872,0.00050939916,0.00035481775,0.00017540222,0.000102768114,0.0014970991,0.00036816965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036724683,0.00032436507,0.026022423,0.00037888013,0.000101152626,0.00024475783,0.0004990288,0.000055791283,0.952438,0.00013300666,0.00789817,0.011537179],"study_design_scores_gemma":[0.0024943682,0.00005355519,0.4121975,0.00032119648,0.000030441985,0.00004789878,0.00041278778,0.00037305302,0.5711899,0.000080479556,0.012535146,0.0002637008],"about_ca_topic_score_codex":0.006661622,"about_ca_topic_score_gemma":0.00043855925,"teacher_disagreement_score":0.38617507,"about_ca_system_score_codex":0.00073713093,"about_ca_system_score_gemma":0.0006221257,"threshold_uncertainty_score":0.9999531},"labels":[],"label_agreement":null},{"id":"W2009507265","doi":"10.1158/0008-5472.can-04-3814","title":"Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Cyclooxygenase; Cancer research; Ovarian cancer; Prostacyclin; Cancer; Biology; Prostaglandin; Apoptosis; Internal medicine; Medicine; Endocrinology; Enzyme; Biochemistry","score_opus":0.049846606129630676,"score_gpt":0.4076915854901067,"score_spread":0.35784497936047605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009507265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927622,0.0034228459,0.00012847755,0.0018598872,0.00017277627,0.0013322907,0.00019043831,0.00001314893,0.000117926575],"genre_scores_gemma":[0.99077076,0.0019593087,0.00068413804,0.00005951843,0.0019075326,0.0009960998,0.000018178283,0.000026847722,0.003577642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883,0.000067853856,0.00018178723,0.00024266013,0.0003312113,0.00034645642],"domain_scores_gemma":[0.99933696,0.00005187059,0.00004495565,0.00017135723,0.00022606995,0.00016878318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003417268,0.000104991464,0.00025056448,0.000137901,0.00010451503,0.000010640958,0.000044808905,0.00008710355,0.0006998479],"category_scores_gemma":[0.000031062526,0.000081743776,0.000093378236,0.00012294213,0.00010477768,0.000052946867,0.00001797684,0.00008972634,0.000007777394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004868038,0.0006048774,0.006468527,0.0007619249,0.00043637794,0.000031908072,0.0025430098,0.000057838228,0.5093907,0.00020883897,0.011867162,0.46276078],"study_design_scores_gemma":[0.008933353,0.0028777097,0.011704801,0.00026231198,0.00013810165,0.000010039856,0.00009363037,0.0015542494,0.79222155,0.00025142668,0.18179178,0.00016104965],"about_ca_topic_score_codex":0.0004684197,"about_ca_topic_score_gemma":0.00025213484,"teacher_disagreement_score":0.46259972,"about_ca_system_score_codex":0.00027932413,"about_ca_system_score_gemma":0.00040822703,"threshold_uncertainty_score":0.76628435},"labels":[],"label_agreement":null},{"id":"W2009546025","doi":"10.1158/1538-7445.am10-320","title":"Abstract 320: Fine structure genomic mapping of chromosome 10q23 interstitial deletions in prostate cancer reveals the <i>PTEN</i> gene locus as the minimum region deleted","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Princess Margaret Cancer Centre; Calgary Laboratory Services; University of Calgary; Toronto General Hospital; University Health Network; Queen's University","funders":"","keywords":"PTEN; Biology; Comparative genomic hybridization; Locus (genetics); Fluorescence in situ hybridization; Breakpoint; Genetics; Bacterial artificial chromosome; SNP array; Cancer research; Molecular biology; Gene; Chromosome; Genome; Single-nucleotide polymorphism; Genotype; PI3K/AKT/mTOR pathway","score_opus":0.05186825954907479,"score_gpt":0.36976373662065454,"score_spread":0.3178954770715797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009546025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679215,0.006973523,0.0000027996907,0.021831859,0.0003588388,0.0022376736,0.00021325095,0.000023968985,0.00043660525],"genre_scores_gemma":[0.9910929,0.0050824117,0.00002573456,0.0002488462,0.0007150919,0.0007578658,0.00006439369,0.000055554236,0.0019571884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692404,0.00020282355,0.00051041367,0.00051995856,0.0009066382,0.0009361494],"domain_scores_gemma":[0.9978046,0.00032658543,0.00015096832,0.0008103309,0.0006965036,0.0002110017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096569594,0.0002522444,0.00040692883,0.00036775268,0.0003831053,0.00007117755,0.00059168035,0.00016953661,0.0009357026],"category_scores_gemma":[0.00020338761,0.00014101317,0.0001269184,0.0011358798,0.0010949973,0.000110529334,0.00024024751,0.0020624818,0.000026432754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013242785,0.000092140945,0.009504511,0.00027341137,0.00016754135,0.00021864945,0.0020698714,0.00006224809,0.9665042,0.000064598615,0.0051125283,0.014606],"study_design_scores_gemma":[0.01532043,0.0013339854,0.19923335,0.0030706027,0.00022192966,0.00055421557,0.003288247,0.00055090955,0.7086272,0.003075674,0.06371578,0.0010076395],"about_ca_topic_score_codex":0.005135077,"about_ca_topic_score_gemma":0.005108867,"teacher_disagreement_score":0.257877,"about_ca_system_score_codex":0.000592319,"about_ca_system_score_gemma":0.0016936974,"threshold_uncertainty_score":0.9999776},"labels":[],"label_agreement":null},{"id":"W2009595418","doi":"10.1158/0008-5472.can-07-2733","title":"Distinct Loci Influence Radiation-Induced Alveolitis from Fibrosing Alveolitis in the Mouse","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Christie (Canada)","funders":"McGill University","keywords":"Pulmonary fibrosis; Bronchoalveolar lavage; Medicine; Fibrosis; Pathology; Idiopathic pulmonary fibrosis; Histopathology; Mast cell; Lung; Immunology; Internal medicine","score_opus":0.04815243848299394,"score_gpt":0.4144102226164649,"score_spread":0.36625778413347093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009595418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926289,0.0013073838,0.000044489134,0.0034992676,0.00007675621,0.0008235784,0.00005215699,0.000045868575,0.0015216025],"genre_scores_gemma":[0.9976793,0.00012950785,0.00010899744,0.0007694762,0.0006927237,0.0001270332,0.000091289156,0.000032877433,0.00036881887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970828,0.00033951286,0.00033636988,0.0003884654,0.0011149409,0.00073789223],"domain_scores_gemma":[0.9972555,0.0015734236,0.00006492297,0.0005835672,0.0003004678,0.00022212681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002376357,0.00014526311,0.00023155943,0.00030133026,0.00020475533,0.00008564006,0.00033814166,0.00014535911,0.00026435868],"category_scores_gemma":[0.0015638128,0.00011611555,0.00006817667,0.00088318996,0.0001800532,0.00021272928,0.000058622663,0.00088178815,0.00009636213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055407634,0.00020324107,0.7121297,0.00019845262,0.00009443195,0.00046591155,0.0081791645,0.00010467267,0.19229625,0.0011077428,0.013262691,0.07140364],"study_design_scores_gemma":[0.0013996273,0.00018786867,0.9489336,0.00012508819,0.000012579443,0.000010788311,0.00049211,0.00008678786,0.04005392,0.00031773426,0.008245396,0.00013451817],"about_ca_topic_score_codex":0.015248914,"about_ca_topic_score_gemma":0.0020830517,"teacher_disagreement_score":0.23680386,"about_ca_system_score_codex":0.0006923826,"about_ca_system_score_gemma":0.00039978573,"threshold_uncertainty_score":0.9913086},"labels":[],"label_agreement":null},{"id":"W2009706405","doi":"10.1158/1538-7445.cec13-a14","title":"Abstract A14: Understanding the role of ATRX in the development and progression of glioma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"ATRX; Carcinogenesis; Biology; Epigenetics; Glioma; Cancer research; Cancer; Forebrain; Chromatin; Synthetic lethality; Genetics; Gene; Neuroscience; Mutation; Central nervous system; DNA repair","score_opus":0.136944563351972,"score_gpt":0.42673032589409393,"score_spread":0.28978576254212196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009706405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922849,0.003531272,6.8209596e-7,0.0018084752,0.000009237288,0.0006476529,0.0000011026303,0.0000019479512,0.0017147327],"genre_scores_gemma":[0.99950093,0.0001315464,0.000051240928,0.000009894463,0.000015650765,0.00027685898,0.0000012005966,0.0000050147796,0.00000766287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910736,0.00005020246,0.0001462876,0.000096791046,0.0004313703,0.00016801183],"domain_scores_gemma":[0.999488,0.000211699,0.000034901706,0.00014684246,0.00008266144,0.000035899677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006080284,0.00004753347,0.00010226431,0.00010473278,0.000068998976,0.000014408893,0.000083144965,0.000027172997,0.000099462304],"category_scores_gemma":[0.000033887496,0.0000213338,0.000017243037,0.0002585233,0.00014451149,0.000028990567,0.00004376598,0.00012548774,0.0000039069264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022334298,0.0007923554,0.58736527,0.00040718247,0.00014864477,0.000052928674,0.01757582,0.0000053812983,0.20793414,0.0037045241,0.0011584276,0.18063197],"study_design_scores_gemma":[0.0009931877,0.00017552591,0.71719605,0.0005973086,0.000010330112,0.0000071061777,0.014071088,0.000023005177,0.2643194,0.0017605074,0.00080570846,0.00004077021],"about_ca_topic_score_codex":0.00052938255,"about_ca_topic_score_gemma":0.00013895935,"teacher_disagreement_score":0.1805912,"about_ca_system_score_codex":0.00012614708,"about_ca_system_score_gemma":0.00013145155,"threshold_uncertainty_score":0.10890424},"labels":[],"label_agreement":null},{"id":"W2009749006","doi":"10.1158/1538-7445.am2012-2690","title":"Abstract 2690: Evaluation of the hemostatic status in patients with prostate cancer using thromboelastography and tissue factor- microparticles","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood properties and coagulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Thromboelastography; Prostate cancer; Cancer; Prostate; Thrombosis; Internal medicine; Hemostasis; Fibrinolysis; Gastroenterology; Coagulopathy; Urology; Gynecology; Coagulation","score_opus":0.12949116830510912,"score_gpt":0.41781920050595867,"score_spread":0.28832803220084957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009749006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947504,0.0039501865,6.962067e-7,0.00019575276,0.000047289224,0.0010034143,0.000020425461,0.000003353976,0.000028491875],"genre_scores_gemma":[0.9996943,0.000119009805,0.000045300298,0.000023319039,0.000023876577,0.00006737168,0.0000029392302,0.000013910136,0.000009996749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985589,0.000115626746,0.00014574238,0.00012181848,0.00072508474,0.0003328352],"domain_scores_gemma":[0.9992422,0.000026358237,0.00005480327,0.000146321,0.00045270397,0.00007761585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046679692,0.00006890491,0.00012423287,0.000087341155,0.00007421334,0.000013528621,0.000035921214,0.000029798652,0.000120130244],"category_scores_gemma":[0.00003409161,0.000040396382,0.000012367881,0.00037371862,0.00016096067,0.00013945947,0.000033602926,0.0001636618,6.3440535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031790326,0.00010121748,0.9168863,0.0001158777,0.000027250659,7.527519e-8,0.002195064,0.000112069225,0.04663843,0.0000020101643,0.00001609871,0.033587683],"study_design_scores_gemma":[0.0015378117,0.000102323414,0.94572306,0.00030538556,0.000043831315,2.434813e-7,0.00031579225,0.0001642445,0.051656466,0.00001605512,0.00008585686,0.000048961596],"about_ca_topic_score_codex":0.0033677353,"about_ca_topic_score_gemma":0.00039064488,"teacher_disagreement_score":0.03353872,"about_ca_system_score_codex":0.00016694223,"about_ca_system_score_gemma":0.00027940873,"threshold_uncertainty_score":0.5091031},"labels":[],"label_agreement":null},{"id":"W2009770692","doi":"10.1158/1538-7445.am10-4000","title":"Abstract 4000: Cellular MRI of human breast cancer cells labeled with gadofluorine M","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Western University","funders":"","keywords":"Relaxometry; Magnetic resonance imaging; In vivo; Human breast; Cell; Metastasis; In vitro; Breast cancer; Cancer; Chemistry; Cancer cell; Metastatic breast cancer; Pathology; Nuclear medicine; Nuclear magnetic resonance; Medicine; Biology; Internal medicine; Biochemistry; Radiology","score_opus":0.055769519862061585,"score_gpt":0.41234785956256376,"score_spread":0.3565783397005022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009770692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762596,0.0008668331,0.0000035513817,0.00630301,0.00030269986,0.0008863207,0.00022096437,0.000054931133,0.003735713],"genre_scores_gemma":[0.99323505,0.0020968572,0.0002476765,0.000117973774,0.001121813,0.0006375638,0.000017932534,0.00009816033,0.0024269875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669075,0.00006201374,0.00038591737,0.0006015807,0.0014243952,0.00083533645],"domain_scores_gemma":[0.997095,0.00018132008,0.00013101286,0.0009394257,0.0012051456,0.00044807795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000863402,0.0002486147,0.00052178424,0.0003429899,0.00017642444,0.000036675025,0.0004283312,0.00019141022,0.0165064],"category_scores_gemma":[0.000015561613,0.00019765936,0.000095656986,0.000850746,0.00066450576,0.00011546446,0.00012434239,0.0015667039,0.0000800837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045225644,0.00029230028,0.05606766,0.0006725364,0.00013939624,0.00009313195,0.00021660318,0.000016573009,0.9082268,0.00011333016,0.03066193,0.0030475142],"study_design_scores_gemma":[0.0023200489,0.00031180764,0.06508481,0.0006303743,0.000071031725,0.000014188065,0.000099415825,0.000009026865,0.910624,0.000034984503,0.020579606,0.00022064829],"about_ca_topic_score_codex":0.011397844,"about_ca_topic_score_gemma":0.0036698391,"teacher_disagreement_score":0.016426316,"about_ca_system_score_codex":0.00034813595,"about_ca_system_score_gemma":0.0011217599,"threshold_uncertainty_score":0.9951853},"labels":[],"label_agreement":null},{"id":"W2009773330","doi":"10.1158/0008-5472.can-13-2817","title":"Cancer Affects microRNA Expression, Release, and Function in Cardiac and Skeletal Muscle","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Cancer; Skeletal muscle; microRNA; Function (biology); Expression (computer science); Biology; Cancer research; Internal medicine; Medicine; Cell biology; Endocrinology; Genetics; Gene; Computer science","score_opus":0.01631033813899503,"score_gpt":0.3184142725632241,"score_spread":0.30210393442422906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009773330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857116,0.0135339135,0.000055108005,0.00018923898,0.00009647519,0.00023623365,0.000016938377,0.000005721224,0.000154768],"genre_scores_gemma":[0.9969862,0.0021649678,0.000028499462,0.000043920434,0.00031653058,0.00015984883,0.000026347916,0.000018917051,0.00025478174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989228,0.0002252664,0.000082724815,0.0003601766,0.0001539265,0.00025511056],"domain_scores_gemma":[0.99955165,0.000026019277,0.000025077896,0.00020020979,0.00008454204,0.00011248308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041156265,0.00008817033,0.000100177574,0.00007482995,0.00008783868,0.0000292478,0.0000637344,0.00010873562,0.000026146417],"category_scores_gemma":[0.000079821715,0.000084686886,0.000023859819,0.000111530375,0.00013028589,0.0000070597875,0.00012712023,0.0001286461,0.0000020238504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006345617,0.000011653237,0.011851298,0.00007008891,0.000010588246,5.2886503e-7,0.000027800017,0.000025458416,0.9607851,0.000018414483,0.0037648075,0.023370838],"study_design_scores_gemma":[0.0007345064,0.00012347191,0.36433408,0.0001221492,0.000010298372,9.251701e-7,0.000039873805,0.0000967633,0.53102034,0.00011175628,0.10323008,0.00017574643],"about_ca_topic_score_codex":0.00023968647,"about_ca_topic_score_gemma":0.00016876608,"teacher_disagreement_score":0.42976472,"about_ca_system_score_codex":0.000043683875,"about_ca_system_score_gemma":0.0000870614,"threshold_uncertainty_score":0.34534308},"labels":[],"label_agreement":null},{"id":"W2009895771","doi":"10.1158/1538-7445.am2013-1451","title":"Abstract 1451: Microfluidic-based unbiased enrichment (negative selection) of circulating non-hematopoietic tumor cells directly from whole blood without centrifugation.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Circulating tumor cell; Haematopoiesis; Cytokeratin; Whole blood; Centrifugation; Cancer cell; Antibody; Cancer; Biology; Pathology; Molecular biology; Cancer research; Chemistry; Metastasis; Immunology; Medicine; Stem cell; Immunohistochemistry; Cell biology; Internal medicine; Chromatography","score_opus":0.03670149655737906,"score_gpt":0.3400979755910988,"score_spread":0.3033964790337197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009895771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457514,0.0018356688,0.0001740136,0.0005785049,0.00017121747,0.0015854797,0.00015177959,0.00004142304,0.00088674674],"genre_scores_gemma":[0.9969741,0.00022331688,0.0012639597,0.00018450628,0.00029312953,0.00048332624,0.00005718427,0.000055071643,0.00046538605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711084,0.00013313834,0.00053559506,0.0005594742,0.0010190953,0.0006418577],"domain_scores_gemma":[0.9975617,0.0003953041,0.00020977524,0.00041371596,0.0010765688,0.00034291725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052989804,0.0002330707,0.0005363173,0.00029764598,0.00021856584,0.00006763189,0.0001760484,0.00008818565,0.0040636407],"category_scores_gemma":[0.00014088629,0.00020895682,0.00016285789,0.0008829297,0.000218754,0.00012448539,0.000051585757,0.00053613156,0.00014979976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014817234,0.0003713714,0.010951662,0.00041296514,0.00020264767,0.000017740524,0.0005004942,0.000067825014,0.9790642,0.0000028469124,0.0051541575,0.0031059172],"study_design_scores_gemma":[0.0031593295,0.00018958053,0.020391745,0.00068561785,0.00014344993,0.0000033337703,0.00055015937,0.00019455251,0.97287476,0.000054698605,0.0015657184,0.00018704648],"about_ca_topic_score_codex":0.015948873,"about_ca_topic_score_gemma":0.00011081869,"teacher_disagreement_score":0.015838053,"about_ca_system_score_codex":0.0004548351,"about_ca_system_score_gemma":0.0012201845,"threshold_uncertainty_score":0.9968468},"labels":[],"label_agreement":null},{"id":"W2010052397","doi":"10.1158/1538-7445.am2014-4915","title":"Abstract 4915: High degree of G2/M arrest induced by Polo-like kinase 1 (PLK1) inhibition is associated with radiosensitization","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"PLK1; Cancer research; Clonogenic assay; Propidium iodide; Cell cycle; Cancer; Kinase; Cancer cell; Radiosensitizer; Colorectal cancer; Cell culture; Cell cycle checkpoint; Medicine; Biology; Chemistry; Radiation therapy; Apoptosis; Programmed cell death; Cell biology; Internal medicine; Genetics","score_opus":0.03552680497428885,"score_gpt":0.3127791576482474,"score_spread":0.27725235267395854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010052397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782157,0.00038412635,0.00015688037,0.0004811031,0.00013635725,0.00023255199,0.00027150617,0.000007963534,0.00050796295],"genre_scores_gemma":[0.9981602,0.0004932355,0.0000339249,0.0002929612,0.0002520001,0.000043599386,0.00054413034,0.000035009405,0.00014493318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986626,0.000092803995,0.00019847543,0.0003552632,0.00034536736,0.00034547484],"domain_scores_gemma":[0.9988488,0.00008274355,0.00011375096,0.00032656116,0.0005062872,0.00012187376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004530868,0.00013220705,0.0001712709,0.000082707214,0.00011143189,0.000035591278,0.00012720007,0.00019224327,0.000051571118],"category_scores_gemma":[0.00028820487,0.00012734825,0.00004037232,0.00024249933,0.00015243609,0.000006042027,0.00007330111,0.00020018218,0.0000057029147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018110957,0.000082576305,0.00095889997,0.000027999431,0.000054104778,0.0000031714028,0.00005172976,0.00006624205,0.9764012,0.00008263454,0.019063825,0.003026519],"study_design_scores_gemma":[0.0012762729,0.00054722646,0.015810162,0.000106894004,0.000016581525,0.0000012680952,0.0000445349,0.00004380975,0.9760687,0.00011624178,0.00576099,0.00020733182],"about_ca_topic_score_codex":0.0014374933,"about_ca_topic_score_gemma":0.0009533749,"teacher_disagreement_score":0.014851262,"about_ca_system_score_codex":0.00011786276,"about_ca_system_score_gemma":0.0002865028,"threshold_uncertainty_score":0.5193111},"labels":[],"label_agreement":null},{"id":"W2010176262","doi":"10.1158/0008-5472.can-07-0686","title":"IFN-β Signaling Positively Regulates Tumorigenesis in Aggressive Fibromatosis, Potentially by Modulating Mesenchymal Progenitors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Aggressive fibromatosis; Cancer research; Biology; Carcinogenesis; Progenitor cell; Fibromatosis; Mesenchymal stem cell; Cell growth; Stem cell; Cancer; Cell biology; Pathology; Medicine; Genetics","score_opus":0.04525374962849083,"score_gpt":0.4009180726217891,"score_spread":0.35566432299329825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010176262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870272,0.010534522,0.000045705416,0.0006233994,0.0001490577,0.00096174853,0.000026120302,0.00009062518,0.00054161355],"genre_scores_gemma":[0.9974118,0.00018253959,0.0008348205,0.00003984275,0.00051032944,0.00016957647,0.000021348453,0.00007130846,0.00075842644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962617,0.00018174633,0.000509468,0.00061658595,0.0012734552,0.001157031],"domain_scores_gemma":[0.998126,0.0004803682,0.00015298267,0.00029563563,0.00065362896,0.0002914271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016999545,0.00024929902,0.0004713464,0.0005366104,0.00033787306,0.000048637936,0.00019104817,0.000118648066,0.00013528002],"category_scores_gemma":[0.0008231844,0.00023214248,0.00010576099,0.0012704156,0.00034371187,0.00012892697,0.00019406434,0.00056890736,0.000027395341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006843116,0.00013873524,0.118749514,0.00027270793,0.00017058662,0.0023804929,0.0017330523,0.00004201067,0.8634754,0.000033252287,0.0017183232,0.010601649],"study_design_scores_gemma":[0.0013664785,0.0003245628,0.11857138,0.0013883743,0.00004550743,0.00016263085,0.0024102933,0.00007204355,0.8749682,0.000096773234,0.00030523745,0.00028857606],"about_ca_topic_score_codex":0.0017545149,"about_ca_topic_score_gemma":0.00014612977,"teacher_disagreement_score":0.01149278,"about_ca_system_score_codex":0.0006896334,"about_ca_system_score_gemma":0.00035441938,"threshold_uncertainty_score":0.9466496},"labels":[],"label_agreement":null},{"id":"W2010208199","doi":"10.1158/0008-5472.sabcs13-p4-12-16","title":"Abstract P4-12-16: Safety profile and costs of related adverse events of trastuzumab emtansine compared to other regimens in the Canadian health care system","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Trastuzumab emtansine; Medicine; Trastuzumab; Taxane; Lapatinib; Internal medicine; Capecitabine; Docetaxel; Adverse effect; Oncology; Breast cancer; Cancer","score_opus":0.08097982633674465,"score_gpt":0.42649058274963975,"score_spread":0.3455107564128951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010208199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738208,0.002016606,0.0000013979122,0.0072725355,0.00007907848,0.00556481,0.00041211327,0.000015523041,0.010817107],"genre_scores_gemma":[0.99863774,0.00013521474,0.000055919118,0.00017332083,0.0000501265,0.000458729,0.000040291037,0.000044102824,0.00040457465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961586,0.00053171854,0.0006471673,0.0004079577,0.0013636095,0.00089095935],"domain_scores_gemma":[0.9974927,0.00025042225,0.00010888066,0.00068241585,0.00083119975,0.00063438964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022402364,0.00016443705,0.00053515437,0.0006021531,0.00017985623,0.000012606874,0.00036638294,0.00013497772,0.0007427401],"category_scores_gemma":[0.00020165491,0.00012416606,0.00005407257,0.0010432921,0.0002774848,0.00006769335,0.0000702099,0.00079961773,0.00004858089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006951863,0.0012088197,0.47965178,0.027910594,0.0010273447,0.00054930925,0.15285477,0.0006371426,0.031279422,0.0025346624,0.21412152,0.08127276],"study_design_scores_gemma":[0.005527937,0.0013298431,0.93726355,0.008609486,0.000021691878,0.00003857976,0.03603424,0.0001328159,0.0032830297,0.00001570473,0.00745051,0.00029262295],"about_ca_topic_score_codex":0.79717296,"about_ca_topic_score_gemma":0.6717651,"teacher_disagreement_score":0.45761174,"about_ca_system_score_codex":0.0064844075,"about_ca_system_score_gemma":0.005590883,"threshold_uncertainty_score":0.99732953},"labels":[],"label_agreement":null},{"id":"W2010224550","doi":"10.1158/1538-7445.am2013-4765","title":"Abstract 4765: The role of estrogen receptor signalling in serous ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Serous carcinoma; Serous fluid; Ovarian cancer; Fallopian tube; Estrogen receptor; Tissue microarray; Cancer; Estrogen; Cancer research; Progesterone receptor; Biology; Oncology; Internal medicine; Medicine; Pathology; Breast cancer; Gynecology","score_opus":0.06389084324985113,"score_gpt":0.3843240378293947,"score_spread":0.3204331945795436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010224550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975714,0.012312327,0.0000012931952,0.007490053,0.00013494647,0.0012253522,0.000036216417,0.000016013815,0.0030697412],"genre_scores_gemma":[0.99433196,0.0027884482,0.00010841584,0.00009956693,0.00041413703,0.0018875126,0.000008097715,0.000031995776,0.00032984893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813926,0.00008881512,0.00030475846,0.00032666564,0.00060932816,0.00053117634],"domain_scores_gemma":[0.9988126,0.00022787083,0.00006923568,0.00037640668,0.0003461462,0.00016775395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055359356,0.00013562116,0.00028946705,0.00014873619,0.000099689845,0.000041331565,0.00022727222,0.000090159316,0.0060891868],"category_scores_gemma":[0.000051270967,0.00009039217,0.0000811233,0.0005363426,0.00015533026,0.00009073353,0.000066273984,0.00048867625,0.00013291759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046991714,0.0008111168,0.47948176,0.00031142432,0.00051932974,0.000044874443,0.0021106869,0.0004378577,0.19968551,0.0015257883,0.010744666,0.3038571],"study_design_scores_gemma":[0.0044858744,0.00059534615,0.6093115,0.0017505662,0.000092113136,0.000007800028,0.0024057317,0.00033117767,0.33195415,0.0021277575,0.046599206,0.00033876815],"about_ca_topic_score_codex":0.048224702,"about_ca_topic_score_gemma":0.0010849921,"teacher_disagreement_score":0.30351833,"about_ca_system_score_codex":0.00061201566,"about_ca_system_score_gemma":0.00076405605,"threshold_uncertainty_score":0.9948194},"labels":[],"label_agreement":null},{"id":"W2010341554","doi":"10.1158/1538-7445.cec13-a55","title":"Abstract A55: Histone deacetylase inhibitors as differentiation agents in breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"","keywords":"GATA3; FOXA1; Trichostatin A; Histone deacetylase; Cancer research; Breast cancer; Histone deacetylase inhibitor; Tamoxifen; Estrogen receptor; Transcription factor; Estrogen receptor alpha; Biology; Corepressor; Cancer; Endocrinology; Internal medicine; Histone; Medicine; Nuclear receptor; Genetics","score_opus":0.04175346754463438,"score_gpt":0.3906595533562019,"score_spread":0.3489060858115675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010341554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541587,0.002546891,0.000015027699,0.0007175402,0.00025569863,0.0003815999,0.000035110046,0.000006040681,0.00062623754],"genre_scores_gemma":[0.99386203,0.0040727006,0.000018063361,0.000060015183,0.00035431024,0.0003250627,0.000058415706,0.000027516831,0.0012218817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985697,0.000101293896,0.00021589086,0.0003670715,0.00034864532,0.00039739098],"domain_scores_gemma":[0.9992674,0.000018023218,0.000057040677,0.00025541164,0.00026257054,0.00013954462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031496352,0.00012168652,0.000109640605,0.00013219335,0.00008948313,0.000055273635,0.00017056578,0.00015988102,0.0010509312],"category_scores_gemma":[0.00002976468,0.00011741329,0.000047752063,0.00019651206,0.000079639714,0.000010273178,0.00010313789,0.00022461434,0.000110463276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003714109,0.000072687784,0.009605602,0.00002745902,0.000016250673,0.0000016627528,0.00006240422,0.00020284778,0.9742041,0.000005337532,0.004297436,0.01146702],"study_design_scores_gemma":[0.0003904557,0.000036921094,0.21042772,0.00003323897,0.0000030233302,2.930431e-7,0.000036306585,0.00005573929,0.78576213,0.00011190201,0.0030163508,0.00012591739],"about_ca_topic_score_codex":0.007986602,"about_ca_topic_score_gemma":0.00085388,"teacher_disagreement_score":0.20082211,"about_ca_system_score_codex":0.00018901673,"about_ca_system_score_gemma":0.00019947533,"threshold_uncertainty_score":0.99986225},"labels":[],"label_agreement":null},{"id":"W2010355081","doi":"10.1158/1538-7445.am10-233","title":"Abstract 233: OTX2 copy number gain is a driver event in Shh-independent medulloblastomas","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Sonic hedgehog; Oncogene; Wnt signaling pathway; Biology; Carcinogenesis; N-Myc; Gene silencing; Transcription factor; Cancer; Neuroblastoma; Genetics; Gene; Cell cycle; Cell culture","score_opus":0.022995311323339283,"score_gpt":0.3878688176278197,"score_spread":0.36487350630448045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010355081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915576,0.0005862154,0.00041034733,0.0012307498,0.0004635531,0.0008306489,0.00006954496,0.000019991261,0.004831341],"genre_scores_gemma":[0.99386054,0.0008510128,0.00014812575,0.00028125546,0.0004931139,0.00049963815,0.000045488672,0.00008675171,0.0037340783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99593,0.00019973223,0.00036255014,0.0009572383,0.0013498997,0.0012005434],"domain_scores_gemma":[0.99808234,0.00004573689,0.00006409781,0.000926057,0.00048236334,0.00039940726],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001604493,0.00026707657,0.00024587964,0.0002624892,0.0001704097,0.000097315606,0.0007932617,0.00054545945,0.0045158807],"category_scores_gemma":[0.00023587617,0.00027374178,0.00016110578,0.0005595234,0.00029586075,0.000011893554,0.0005596391,0.0018450601,0.0004793815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032105285,0.00015404634,0.0010299257,0.000055845754,0.000069298025,0.00009026783,0.00015470295,0.000094573435,0.975919,0.0001863166,0.017638495,0.004286484],"study_design_scores_gemma":[0.0013539687,0.0001502159,0.0024206163,0.00007138918,0.0000055408873,0.00002451792,0.000113949856,0.00009391454,0.9190294,0.00033292326,0.07608667,0.00031688585],"about_ca_topic_score_codex":0.0015588796,"about_ca_topic_score_gemma":0.005051543,"teacher_disagreement_score":0.058448177,"about_ca_system_score_codex":0.00028163113,"about_ca_system_score_gemma":0.0011665479,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W2010511984","doi":"10.1158/0008-5472.can-05-0086","title":"High Mobility Group A2 Potentiates Genotoxic Stress in Part through the Modulation of Basal and DNA Damage–Dependent Phosphatidylinositol 3-Kinase–Related Protein Kinase Activation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Biology; DNA damage; HMGA2; Cancer research; Kinase; Cell biology; Carcinogenesis; Molecular biology; Genetics; DNA; Cancer; Gene","score_opus":0.017229396852135155,"score_gpt":0.29745222434588153,"score_spread":0.2802228274937464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010511984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775285,0.0006458878,0.00013027836,0.00048597882,0.000039017938,0.0008370848,0.00006436557,0.000004413707,0.000040149735],"genre_scores_gemma":[0.9988564,0.000305771,0.00021527385,0.00002174368,0.000098017925,0.00020738722,0.00015810107,0.000018162118,0.000119143435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986258,0.00019824285,0.00028381852,0.00034795312,0.00027399135,0.00027018884],"domain_scores_gemma":[0.99932677,0.000024079045,0.00009911599,0.00035923196,0.00014823902,0.000042562573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000525234,0.000118295866,0.0001264266,0.000042502033,0.00012684515,0.000035374254,0.00020232817,0.00015476615,0.00003862338],"category_scores_gemma":[0.000051289284,0.000098760946,0.00003349825,0.00016744735,0.00016562274,0.000017016104,0.00017115033,0.00022521576,0.0000011086233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001181798,0.00017035002,0.002649507,0.000071686925,0.00002973307,8.926977e-7,0.00020605334,0.009351132,0.98493975,0.00030164357,0.000038185794,0.002122909],"study_design_scores_gemma":[0.00073274533,0.00013807735,0.050340552,0.000064144246,0.0000055207256,3.8156338e-7,0.00021110817,0.005392035,0.94195247,0.00087191054,0.00017356721,0.00011752006],"about_ca_topic_score_codex":0.0010311134,"about_ca_topic_score_gemma":0.00079871074,"teacher_disagreement_score":0.047691043,"about_ca_system_score_codex":0.00009688001,"about_ca_system_score_gemma":0.00009192429,"threshold_uncertainty_score":0.40273544},"labels":[],"label_agreement":null},{"id":"W2011044258","doi":"10.1158/1538-7445.am2014-ct104","title":"Abstract CT104: Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Monoclonal antibody; Antibody; Dosing; Pharmacodynamics; Internal medicine; CD8; Immunohistochemistry; Gastroenterology; Immunology; Pharmacokinetics; Immune system","score_opus":0.055149924063105524,"score_gpt":0.4019696920424806,"score_spread":0.3468197679793751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011044258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692535,0.0003987166,0.000069305504,0.0005892569,0.00016760919,0.0006954122,0.000034174172,0.00001187141,0.0011082778],"genre_scores_gemma":[0.9993167,0.00013242279,0.000067605804,0.000045373454,0.00008824557,0.000041118947,0.00000921502,0.000025862584,0.0002734594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778,0.0002068773,0.0004060575,0.00032042962,0.00091516646,0.00037146904],"domain_scores_gemma":[0.998656,0.00023899839,0.0002430856,0.0005345139,0.00025014082,0.0000772747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013461227,0.00015591351,0.0004434116,0.00025261266,0.00009969399,0.000014202504,0.00026115394,0.00009170725,0.00024931307],"category_scores_gemma":[0.00013445206,0.00009633813,0.000113279966,0.00067910843,0.000461187,0.00014320396,0.00008376881,0.00056930794,0.0000042446345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003120419,0.00015254623,0.44932392,0.00024168867,0.000027952077,0.00000663188,0.00012228213,0.00004769529,0.5449212,0.000014771507,0.00012960218,0.0018912824],"study_design_scores_gemma":[0.00203546,0.0002483649,0.6922691,0.00077008567,0.000011305173,0.0000078823805,0.00008396992,0.00019075266,0.3038929,0.000012293113,0.00039950365,0.00007836811],"about_ca_topic_score_codex":0.0036560458,"about_ca_topic_score_gemma":0.00034664728,"teacher_disagreement_score":0.24294516,"about_ca_system_score_codex":0.00020731242,"about_ca_system_score_gemma":0.00044575497,"threshold_uncertainty_score":0.55268717},"labels":[],"label_agreement":null},{"id":"W2011080945","doi":"10.1158/1538-7445.am2013-2324","title":"Abstract 2324: RhoGTPase-based regulation of cell motility by Plk4.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"RHOA; Cell biology; CDC42; Chemistry; Mitosis; Biology; Kinase; Signal transduction","score_opus":0.025423174456232593,"score_gpt":0.3259382407773326,"score_spread":0.3005150663211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011080945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689275,0.0008596482,0.00029606128,0.00017098681,0.0000416711,0.00031910712,0.00007446949,0.000005123252,0.0013402121],"genre_scores_gemma":[0.9979182,0.00019628098,0.00013061195,0.00005705832,0.000078083605,0.000096780575,0.00017835815,0.000016551247,0.0013281085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989974,0.00006577486,0.00016846068,0.00026963474,0.00022506011,0.0002736971],"domain_scores_gemma":[0.9991275,0.000020833128,0.00005024247,0.00038185535,0.00033556763,0.000083983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030230134,0.0000843553,0.00009680396,0.000045685443,0.00005873226,0.000020026131,0.0002015512,0.00013762887,0.0005473655],"category_scores_gemma":[0.00003685137,0.00008054982,0.00005579949,0.00010785725,0.00013676708,0.000004587561,0.000059439866,0.00014211908,0.000031730964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003199129,0.00007841905,0.0019193933,0.000080296944,0.00000857633,1.2864868e-7,0.000009966282,0.00006233137,0.965306,0.0000039022134,0.030854983,0.0016440159],"study_design_scores_gemma":[0.00032020445,0.00007852404,0.015102026,0.00001483791,0.0000025186541,1.0252784e-7,0.00002042999,0.00018375463,0.97619873,0.000047943933,0.007960353,0.00007058803],"about_ca_topic_score_codex":0.00085579796,"about_ca_topic_score_gemma":0.0000655204,"teacher_disagreement_score":0.02289463,"about_ca_system_score_codex":0.000038661972,"about_ca_system_score_gemma":0.00018499044,"threshold_uncertainty_score":0.59932685},"labels":[],"label_agreement":null},{"id":"W2011175592","doi":"10.1158/1538-7445.am2011-4187","title":"Abstract 4187: Phospho-Akt status as a predictor of disease free interval in patients with muscle invasive transitional cell carcinoma of the bladder","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Cystectomy; Protein kinase B; Medicine; Bladder cancer; Transitional cell carcinoma; Metastasis; Biomarker; Cancer; Immunohistochemistry; PI3K/AKT/mTOR pathway; Cancer research; Oncology; Pathology; Internal medicine; Biology; Signal transduction","score_opus":0.04321877947979669,"score_gpt":0.30171003302532173,"score_spread":0.25849125354552505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011175592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424726,0.000513401,0.000001056474,0.00012439207,0.00007135917,0.001006071,0.0009119625,0.0000055206856,0.0031189844],"genre_scores_gemma":[0.9994151,0.000047975584,0.000026037758,0.00006778694,0.000039254148,0.00017270018,0.00002688088,0.000028197926,0.00017604326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810284,0.00007544688,0.0002570793,0.00027117424,0.00091651274,0.00037694062],"domain_scores_gemma":[0.9986941,0.000063533415,0.00007353568,0.00047739362,0.00044840938,0.00024303258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013003004,0.00013434011,0.00023694185,0.0001284052,0.000043723692,0.000004788187,0.000238424,0.000053567608,0.0018669371],"category_scores_gemma":[0.000059028633,0.00008631332,0.00009164602,0.0003272847,0.00036978157,0.000085283165,0.00007696195,0.0003125242,0.0000059670356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008460876,0.0015910832,0.98222816,0.00042271146,0.00010321747,0.000028856555,0.0043660374,0.000003931867,0.0015038691,0.000027421564,0.00067984086,0.00058399583],"study_design_scores_gemma":[0.007152115,0.0010136968,0.9481415,0.00031299342,0.00006993209,2.294796e-7,0.00033662043,0.0000012254959,0.042648245,0.00020319299,0.000048067417,0.000072177325],"about_ca_topic_score_codex":0.007963514,"about_ca_topic_score_gemma":0.0007509454,"teacher_disagreement_score":0.041144375,"about_ca_system_score_codex":0.00022760867,"about_ca_system_score_gemma":0.0018329546,"threshold_uncertainty_score":0.9990455},"labels":[],"label_agreement":null},{"id":"W2011308545","doi":"10.1158/1538-7445.am2012-5534","title":"Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Centre hospitalier de l'Université Laval; Université de Sherbrooke; McGill University Health Centre; Jewish General Hospital; Hôtel-Dieu de Québec; Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Biobank; Translational research; Medicine; Clinical trial; Cancer; Knowledge management; Oncology; Internal medicine; Bioinformatics; Pathology; Computer science; Biology","score_opus":0.2271197899959883,"score_gpt":0.5221653518927746,"score_spread":0.29504556189678627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011308545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844194,0.0038036874,0.003051891,0.006822765,0.0005521445,0.0011815797,0.00008343924,0.000009277152,0.000075817145],"genre_scores_gemma":[0.99061,0.004449604,0.0005197017,0.00017724361,0.003225734,0.00063347566,0.00009063889,0.000069557675,0.00022401713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963534,0.000679556,0.0004316333,0.0005380571,0.00094145443,0.0010559381],"domain_scores_gemma":[0.99422544,0.002126167,0.00007281733,0.0006260428,0.0027694155,0.0001801038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058005,0.00014583147,0.00015712576,0.00018224496,0.0011225026,0.00022308798,0.00089609774,0.00033164065,0.00025300885],"category_scores_gemma":[0.0066497955,0.00010564933,0.000052584754,0.0023363745,0.00095147017,0.000028384966,0.00034109995,0.0011776438,0.000018135159],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058049656,0.00058968033,0.39668614,0.00015317317,0.00013784968,0.000003996464,0.009980119,0.0024709417,0.48322648,0.0463396,0.038446512,0.021385027],"study_design_scores_gemma":[0.0016843019,0.000286237,0.5374391,0.0003636038,0.000022565555,0.000008402982,0.0063169044,0.00031201798,0.22915392,0.005749529,0.21801051,0.0006529303],"about_ca_topic_score_codex":0.0055501163,"about_ca_topic_score_gemma":0.005693789,"teacher_disagreement_score":0.25407258,"about_ca_system_score_codex":0.00034910504,"about_ca_system_score_gemma":0.001869713,"threshold_uncertainty_score":0.86334956},"labels":[],"label_agreement":null},{"id":"W2011468952","doi":"10.1158/1538-7445.am2013-3133","title":"Abstract 3133: Identification and functional validation of novel genetically-linked breast cancer targets through pooled gain-of-function screening.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Breast cancer; Biology; Cancer; Cancer research; Gene; Fusion gene; Mutation; Oncogene; Genetics; Cell cycle","score_opus":0.08891700998474025,"score_gpt":0.3681177426299431,"score_spread":0.27920073264520284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011468952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739802,0.002695155,0.019032212,0.002251671,0.00030080482,0.0011812415,0.00013968255,0.000032506883,0.00038654116],"genre_scores_gemma":[0.99734217,0.0008516724,0.00058886816,0.00006905967,0.00028154868,0.0003882049,0.00011949423,0.000040271814,0.0003187356],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976465,0.00006938007,0.0005015434,0.0004360894,0.0010010655,0.00034538578],"domain_scores_gemma":[0.9973606,0.000108046625,0.00019587959,0.00036331228,0.0018228792,0.00014927685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000584119,0.00014955657,0.00027981497,0.00024337646,0.000112712274,0.000033117325,0.00009341556,0.00018412892,0.0018212564],"category_scores_gemma":[0.00014803208,0.00014271674,0.00008302147,0.00053506135,0.00032909596,0.00021666216,0.00006847638,0.0004370486,0.0000215926],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000592632,0.0001772565,0.002344566,0.0002748809,0.00020143879,0.0000011017614,0.00016411571,0.00090787566,0.97588736,0.00019655877,0.002228386,0.017023813],"study_design_scores_gemma":[0.0026715407,0.00016772043,0.63500196,0.00042387284,0.00014113425,0.000017117698,0.00012957274,0.001764149,0.3586842,0.0002822578,0.0005580287,0.00015841059],"about_ca_topic_score_codex":0.003509001,"about_ca_topic_score_gemma":0.00004594772,"teacher_disagreement_score":0.6326574,"about_ca_system_score_codex":0.00023971124,"about_ca_system_score_gemma":0.0005000884,"threshold_uncertainty_score":0.9990912},"labels":[],"label_agreement":null},{"id":"W2011478815","doi":"10.1158/0008-5472.can-08-3467","title":"Loss of the SMRT/NCoR2 Corepressor Correlates with JAG2 Overexpression in Multiple Myeloma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation","keywords":"Corepressor; Biology; Notch signaling pathway; Histone; Cancer research; Epigenetics; Carcinogenesis; Molecular biology; Genetics; Gene; Cell biology; Nuclear receptor; Transcription factor","score_opus":0.0693210404117872,"score_gpt":0.39363005011921515,"score_spread":0.32430900970742793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011478815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438566,0.0007456062,0.0000052516825,0.0014489011,0.000032347132,0.0012383875,0.0000316009,0.00001893983,0.002093307],"genre_scores_gemma":[0.99756753,0.00023497388,0.000092815055,0.00006447544,0.000068757094,0.00015008397,0.000011568676,0.00002171419,0.001788079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972498,0.00021606595,0.00024963295,0.00038639366,0.0012359389,0.0006621958],"domain_scores_gemma":[0.9983204,0.0003345608,0.00006562703,0.00068672124,0.00036413755,0.00022856926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042752104,0.00015484904,0.00030869077,0.00022771266,0.00015415714,0.000020919044,0.000311484,0.00010683716,0.00026615558],"category_scores_gemma":[0.0004786735,0.00008507338,0.00007487955,0.00082396355,0.00040493594,0.00009478294,0.00013369585,0.0007209604,0.000023862349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050459923,0.0005920513,0.8408782,0.00013742602,0.000063816886,0.00021931002,0.00045611462,0.00010969685,0.13531174,0.00010718243,0.0011851201,0.015893377],"study_design_scores_gemma":[0.0061004995,0.00073229184,0.8154682,0.001974749,0.000010211423,0.000024713314,0.00014139152,0.00071673136,0.17402978,0.00021780032,0.00048708275,0.000096566044],"about_ca_topic_score_codex":0.0012826581,"about_ca_topic_score_gemma":0.0002797262,"teacher_disagreement_score":0.038718045,"about_ca_system_score_codex":0.00029610138,"about_ca_system_score_gemma":0.0004699022,"threshold_uncertainty_score":0.34691918},"labels":[],"label_agreement":null},{"id":"W2011567222","doi":"10.1158/0008-5472.sabcs12-p1-13-03","title":"Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Breast cancer; Taxane; Tact; Internal medicine; Oncology; Pertuzumab; Population; Chemotherapy; Trastuzumab; Gynecology; Cancer; Psychology","score_opus":0.04978048749687294,"score_gpt":0.42496220901939524,"score_spread":0.3751817215225223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011567222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924519,0.0047123623,9.658369e-7,0.0004731469,0.00021261409,0.0012779249,0.0007150077,0.0000063662997,0.00014969464],"genre_scores_gemma":[0.98725694,0.011499934,0.000007707276,0.000034434997,0.0003090304,0.00029679172,0.00012970195,0.00002524648,0.00044020516],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832463,0.00013814053,0.00047714662,0.00026307476,0.00043301424,0.00036399617],"domain_scores_gemma":[0.99856865,0.00027907445,0.00038530113,0.00032095792,0.00026721915,0.00017882165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034408362,0.000198114,0.0009684329,0.000493493,0.00003365005,0.0000046044756,0.00009454973,0.00017222273,0.0033870982],"category_scores_gemma":[0.000019199282,0.00014843322,0.00022102604,0.0005408734,0.00017796608,0.000086628424,0.00003177077,0.00021314429,0.0000016552216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043036036,0.0017341911,0.3578415,0.0015229988,0.005213051,0.000008235515,0.0027631233,0.0000071543127,0.554,0.000014012129,0.00038178675,0.033477884],"study_design_scores_gemma":[0.02408767,0.0016382531,0.71586657,0.00032823847,0.001490168,0.0000035148325,0.0000999963,0.000010126173,0.25597623,0.0000040690597,0.0004068904,0.00008831255],"about_ca_topic_score_codex":0.016759094,"about_ca_topic_score_gemma":0.00073101703,"teacher_disagreement_score":0.35802504,"about_ca_system_score_codex":0.0004426277,"about_ca_system_score_gemma":0.00034762695,"threshold_uncertainty_score":0.99752396},"labels":[],"label_agreement":null},{"id":"W2011734597","doi":"10.1158/1538-7445.am2013-2003","title":"Abstract 2003: A molecular portrait of potentially curable prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Cancer; Germline; Pathology; Biology; Oncology; Internal medicine; Genetics; Gene","score_opus":0.024158720569315235,"score_gpt":0.37382221904249163,"score_spread":0.3496634984731764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011734597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799,0.004578336,0.0012319502,0.000992975,0.000048361548,0.0010953345,0.0001005385,0.000020311874,0.0039421567],"genre_scores_gemma":[0.9919259,0.0025039355,0.0013981917,0.00017206474,0.00007746167,0.0018451073,0.00010191824,0.00003276321,0.0019426559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986104,0.00006046639,0.00023927707,0.0004023789,0.0002445106,0.00044301772],"domain_scores_gemma":[0.9983957,0.000005404212,0.00008303755,0.00047669615,0.0009179689,0.00012118383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030566848,0.00012710647,0.00014585887,0.000073147814,0.00009535855,0.000026256032,0.000362304,0.00016934401,0.00070071657],"category_scores_gemma":[0.000052854935,0.0001171119,0.00006922971,0.00035181973,0.00026206422,0.0000053020253,0.00015091403,0.00022185998,0.000022493537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023044944,0.00005921995,0.0006195047,0.000039208724,0.00004859566,0.0000030267124,0.000010839254,0.000038066308,0.9628412,0.00048853696,0.023738306,0.012090443],"study_design_scores_gemma":[0.0002242349,0.00012135835,0.0032384521,0.000036515004,0.0000072262774,0.0000029566881,0.000025659467,0.0000133328695,0.93539184,0.0004901148,0.060302272,0.00014600894],"about_ca_topic_score_codex":0.0023590403,"about_ca_topic_score_gemma":0.000099036944,"teacher_disagreement_score":0.036563966,"about_ca_system_score_codex":0.00002695057,"about_ca_system_score_gemma":0.00046729235,"threshold_uncertainty_score":0.7672355},"labels":[],"label_agreement":null},{"id":"W2011773129","doi":"10.1158/0008-5472.can-13-1275","title":"LIMD2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institute of General Medical Sciences; U.S. Public Health Service","keywords":"Motility; Integrin-linked kinase; Cancer research; Integrin; Kinase; Cell; Tumor progression; Cell biology; Protein kinase A; Biology; Cancer; Cyclin-dependent kinase 2; Biochemistry; Genetics","score_opus":0.08848288320828929,"score_gpt":0.3939907565335562,"score_spread":0.3055078733252669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011773129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140996,0.0010590929,0.000030455776,0.0040487368,0.000017482515,0.0030638329,0.000021509892,0.000033481905,0.00031546553],"genre_scores_gemma":[0.99583733,0.00015096647,0.0009607632,0.00014155127,0.000042328695,0.0007685359,0.000008147304,0.000053412812,0.002036939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99624395,0.0008910074,0.00030972078,0.00075125473,0.0010022593,0.0008018338],"domain_scores_gemma":[0.99757594,0.0010704002,0.000077486315,0.00057068386,0.00025947244,0.00044602543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027526526,0.00023543497,0.00039072195,0.00032437753,0.0003541246,0.00017115555,0.00029199786,0.000083994884,0.00012794205],"category_scores_gemma":[0.0017624099,0.00015502216,0.000047719295,0.0008545341,0.00034219451,0.0000792785,0.0006682188,0.0012060226,0.000011415589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056638365,0.00017714643,0.016123561,0.0006356185,0.0000146263865,0.000025129499,0.0012306283,0.0000012157312,0.9250737,0.0000072288217,0.00072387786,0.05542088],"study_design_scores_gemma":[0.0017656639,0.0006218335,0.028829971,0.0018703744,0.0000127420135,0.000010505641,0.00130979,0.0021028994,0.9603864,0.00010164866,0.0028079685,0.0001801956],"about_ca_topic_score_codex":0.0012599819,"about_ca_topic_score_gemma":0.00020775342,"teacher_disagreement_score":0.055240687,"about_ca_system_score_codex":0.00026628166,"about_ca_system_score_gemma":0.00029874453,"threshold_uncertainty_score":0.63216203},"labels":[],"label_agreement":null},{"id":"W2011806679","doi":"10.1158/1538-7445.am2011-5068","title":"Abstract 5068: Proteomics based prognostic signature of head and neck cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IONICS Mass Spectrometry (Canada); Mount Sinai Hospital","funders":"","keywords":"Head and neck cancer; Medicine; Oncology; Internal medicine; Cancer; Proteomics; Cohort; Tissue microarray; Pathology; Biology; Gene","score_opus":0.07345392335989154,"score_gpt":0.3713836606381814,"score_spread":0.29792973727828986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011806679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937999,0.00439941,0.000042391548,0.0001222211,0.000045812623,0.00056945416,0.00006532403,0.000006049518,0.00094939745],"genre_scores_gemma":[0.99799484,0.0004657978,0.0006230726,0.00007029078,0.00016477409,0.00036382614,0.000013839237,0.00002298335,0.0002805741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901694,0.000042689422,0.00013115144,0.00029991317,0.00019639936,0.0003129144],"domain_scores_gemma":[0.9993394,0.000012352372,0.000045183588,0.00023952633,0.00026131558,0.00010224134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002608078,0.00010350319,0.0001179119,0.00005985482,0.000073930794,0.000014039389,0.00018266917,0.00015756699,0.00027928397],"category_scores_gemma":[0.00008217674,0.00008809842,0.000040422874,0.00013209553,0.00020587674,0.000004136272,0.000087787885,0.00024217847,0.0000022610075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030525358,0.00009105348,0.021116748,0.00018232835,0.000031799384,0.0000052258943,0.00009054913,0.0000112996095,0.97261596,0.000050557384,0.0010446496,0.004454575],"study_design_scores_gemma":[0.0005475087,0.00040106606,0.06390159,0.0001609127,0.000005997123,9.129345e-7,0.00004379773,0.000025568865,0.9302272,0.0000997987,0.0044550723,0.00013057012],"about_ca_topic_score_codex":0.0010264091,"about_ca_topic_score_gemma":0.00042756533,"teacher_disagreement_score":0.04278484,"about_ca_system_score_codex":0.000019164261,"about_ca_system_score_gemma":0.00038897016,"threshold_uncertainty_score":0.35925496},"labels":[],"label_agreement":null},{"id":"W2012350639","doi":"10.1158/1538-7445.am2012-3645","title":"Abstract 3645: Integrative molecular profiling in serous epithelial ovarian cancer for identification of biomarkers of chemoresistance","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; microRNA; Ovarian cancer; Serous fluid; Epigenetics; Cancer research; Gene expression profiling; Carboplatin; Pharmacogenomics; Cancer; Gene; Oncology; Bioinformatics; Gene expression; Genetics; Medicine; Cisplatin; Chemotherapy","score_opus":0.07255284684015388,"score_gpt":0.4325871401235289,"score_spread":0.360034293283375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012350639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000597,0.0060774935,0.00021315168,0.0012178465,0.0001843789,0.001564917,0.00030190567,0.0000075622365,0.00042677097],"genre_scores_gemma":[0.9964757,0.0007839965,0.0008007049,0.000020184174,0.00013135979,0.0016303593,0.000028419938,0.000027055132,0.00010220154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983571,0.000060590774,0.00044808123,0.00027404682,0.00044752305,0.00041262343],"domain_scores_gemma":[0.9986881,0.00015897164,0.00017241524,0.00029782535,0.00056932797,0.00011336919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010650482,0.00012551867,0.00034438577,0.00025187974,0.00003910784,0.000009092681,0.00012014333,0.00008790108,0.00010762076],"category_scores_gemma":[0.00017634242,0.00010261859,0.00009863031,0.0005340263,0.00017298767,0.000104715546,0.000026476962,0.0001817001,0.0000022002607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001726818,0.0006540158,0.0834893,0.001176102,0.00037234227,0.0000074298628,0.0013184506,0.000036921283,0.88871485,0.001803253,0.00034507367,0.020355437],"study_design_scores_gemma":[0.0018428206,0.000092086935,0.16603021,0.00058779423,0.000049220373,6.4097503e-7,0.0004047891,0.000043864507,0.8304708,0.00016585203,0.0002388475,0.00007306902],"about_ca_topic_score_codex":0.0021566541,"about_ca_topic_score_gemma":0.0003087596,"teacher_disagreement_score":0.082540914,"about_ca_system_score_codex":0.0006468626,"about_ca_system_score_gemma":0.0005630989,"threshold_uncertainty_score":0.41846648},"labels":[],"label_agreement":null},{"id":"W2012451630","doi":"10.1158/0008-5472.can-06-1279","title":"Distinct Roles for IFN Regulatory Factor (IRF)-3 and IRF-7 in the Activation of Antitumor Properties of Human Macrophages","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; McGill University","funders":"","keywords":"Tumor necrosis factor alpha; Cancer research; Biology; Signal transduction; Immunology; Fas ligand; Cancer cell; Apoptosis; Cell biology; Programmed cell death; Cancer","score_opus":0.07123809849663537,"score_gpt":0.3631362682664619,"score_spread":0.2918981697698265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012451630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295306,0.0063147848,0.0000035564115,0.00018340063,0.000035647907,0.00035190498,0.0000505426,0.0000046643195,0.00010243148],"genre_scores_gemma":[0.9981227,0.000053752985,0.000002185671,0.000006762367,0.000019166819,0.00008985105,0.000012657615,0.000007862178,0.0016850748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991347,0.00028586257,0.0001960928,0.00012644728,0.00005586118,0.00020104581],"domain_scores_gemma":[0.9994912,0.00015275374,0.00005863672,0.0001547248,0.00013852025,0.0000041236426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040246596,0.00006794499,0.00015923083,0.00013367615,0.00012177372,0.00000949573,0.00016977868,0.000068586756,0.000057849527],"category_scores_gemma":[0.00008322605,0.000042958905,0.000032292694,0.00009492106,0.00056817336,0.000051081006,0.000038110848,0.00016280146,0.0000013979791],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066872704,0.000066029,0.0038885807,0.00014500506,0.000019038978,2.9163783e-7,0.0006609629,5.024617e-7,0.99128234,0.00077073445,0.0012746614,0.0012231128],"study_design_scores_gemma":[0.0004871101,0.00021477067,0.15136272,0.00012496368,0.0000028798672,0.0000010999491,0.000591517,7.0938785e-7,0.8455158,0.000084336614,0.0015739897,0.000040083443],"about_ca_topic_score_codex":0.0019457806,"about_ca_topic_score_gemma":0.00051948556,"teacher_disagreement_score":0.14747414,"about_ca_system_score_codex":0.00003376627,"about_ca_system_score_gemma":0.00007065663,"threshold_uncertainty_score":0.2941451},"labels":[],"label_agreement":null},{"id":"W2012796832","doi":"10.1158/1538-7445.am2013-2841","title":"Abstract 2841: Widespread endothelial cell infection and tumor cell apoptosis after intravenous injection of oncolytic vaccinia virus JX-594 into RIP-Tag2 mice.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Oncolytic virus; Vaccinia; Virus; Cancer cell; Cancer research; Biology; Angiogenesis; Apoptosis; Cancer; Medicine; Immunology; Pathology; Virology; Internal medicine","score_opus":0.01749985035068533,"score_gpt":0.322864821324605,"score_spread":0.3053649709739196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012796832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959313,0.0018932201,0.00002425965,0.000105679304,0.00017229347,0.00092108245,0.00004607968,0.000015734304,0.0008903264],"genre_scores_gemma":[0.9957616,0.0023117657,0.000058671245,0.0000784309,0.00043242378,0.0006960258,0.000022816615,0.000064872605,0.0005734269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975894,0.00027975082,0.00035472517,0.0006062918,0.00052123517,0.00064861414],"domain_scores_gemma":[0.99854976,0.000087449065,0.00011160234,0.00049058313,0.00052049354,0.00024009486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007695535,0.00023670384,0.00025444783,0.00029189224,0.00017518099,0.00009607373,0.00027305938,0.0002225999,0.0006798661],"category_scores_gemma":[0.000082821214,0.0002305476,0.000095960866,0.00033704386,0.0002493271,0.000027034781,0.00021182159,0.00051829376,0.00011481295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025875475,0.00023403563,0.002193132,0.0002798126,0.000048028833,0.0000028764612,0.00025916361,0.000052559415,0.9794664,6.8862545e-7,0.001225567,0.013650223],"study_design_scores_gemma":[0.0010820766,0.0036796879,0.004987763,0.0000465528,0.000013297207,0.000005009172,0.00009375904,0.000034006924,0.98820084,0.00010428196,0.0015277022,0.0002249909],"about_ca_topic_score_codex":0.011130687,"about_ca_topic_score_gemma":0.002501402,"teacher_disagreement_score":0.013425232,"about_ca_system_score_codex":0.00021141022,"about_ca_system_score_gemma":0.0004939469,"threshold_uncertainty_score":0.99545425},"labels":[],"label_agreement":null},{"id":"W2012819199","doi":"10.1158/0008-5472.can-09-4519","title":"Tumor Antigen Epitopes Interpreted by the Immune System as Self or Abnormal-Self Differentially Affect Cancer Vaccine Responses","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Epitope; MUC1; Immune system; Glycopeptide; Biology; Antigen; T cell; Molecular biology; Immunology; Biochemistry","score_opus":0.01985421840707701,"score_gpt":0.34634553098852777,"score_spread":0.32649131258145075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012819199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93086374,0.06311518,0.000012345147,0.0013085869,0.0026368527,0.0012434775,0.00016971692,0.00032039356,0.00032970106],"genre_scores_gemma":[0.973163,0.005941234,0.000013706522,0.0001605086,0.00019364331,0.0010443416,0.000037778067,0.00009173639,0.019354032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943714,0.0027984423,0.0006279272,0.00064583874,0.00024375248,0.0013126374],"domain_scores_gemma":[0.996236,0.0018631059,0.00020854261,0.0011813856,0.00044430612,0.00006663109],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002427402,0.0004411485,0.0006528536,0.00033974813,0.0013648543,0.000188226,0.0016422746,0.00038447842,0.005915092],"category_scores_gemma":[0.00041966003,0.0002656458,0.00022124806,0.0006500301,0.00046928908,0.0002232369,0.0004376324,0.0021703383,0.00071240315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013537566,0.00019592818,0.0012976036,0.00012440879,0.0010240282,0.000034398734,0.001887625,5.7237037e-7,0.9653813,0.00022262524,0.009138762,0.0071551534],"study_design_scores_gemma":[0.0021692205,0.0006274284,0.013483499,0.0002804776,0.000052927262,0.00025519746,0.0006701159,0.000008276935,0.783108,0.000007470504,0.19900185,0.00033551911],"about_ca_topic_score_codex":0.006318148,"about_ca_topic_score_gemma":0.0006785219,"teacher_disagreement_score":0.18986309,"about_ca_system_score_codex":0.0002912507,"about_ca_system_score_gemma":0.001191399,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W2012905419","doi":"10.1158/0008-5472.can-03-3112","title":"Matrix Metalloproteinase Activity Modulates Tumor Size, Cell Motility, and Cell Invasiveness in Murine Aggressive Fibromatosis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Matrix metalloproteinase; Cancer research; Extracellular matrix; Biology; Tumor progression; Aggressive fibromatosis; Pathology; Cell biology; Fibromatosis; Cancer; Medicine","score_opus":0.04643467882533327,"score_gpt":0.38094333595015206,"score_spread":0.3345086571248188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012905419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869699,0.009702129,0.0000027382773,0.0012536832,0.00005576818,0.0014745706,0.000040696887,0.000058802874,0.00044174498],"genre_scores_gemma":[0.9971853,0.00088255137,0.00032355255,0.000035329856,0.00010372249,0.0005385948,0.0000031484471,0.000052948322,0.00087485794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973771,0.0001948748,0.00026438202,0.0006682913,0.00076425093,0.00073107576],"domain_scores_gemma":[0.9983178,0.0004639142,0.000110147404,0.00049272063,0.00032411504,0.00029131965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066621153,0.00026451077,0.0006029576,0.00031921483,0.00018647526,0.00004068361,0.00017313061,0.000080137885,0.0002066852],"category_scores_gemma":[0.0007885504,0.00023655617,0.00007964507,0.0008384295,0.000476479,0.00012512991,0.00047578118,0.00067065365,0.0000423827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015438666,0.0011180007,0.10987742,0.005298257,0.00011453728,0.0076249526,0.0019084243,0.00025991094,0.87070495,0.000029491233,0.00019577885,0.001324376],"study_design_scores_gemma":[0.004357525,0.0004016373,0.16025072,0.00072402303,0.000041872518,0.000092360366,0.00049417187,0.000030357858,0.8326888,0.0006323518,0.00008545195,0.00020071071],"about_ca_topic_score_codex":0.005944227,"about_ca_topic_score_gemma":0.0005363964,"teacher_disagreement_score":0.050373305,"about_ca_system_score_codex":0.00058134936,"about_ca_system_score_gemma":0.00050434994,"threshold_uncertainty_score":0.96464807},"labels":[],"label_agreement":null},{"id":"W2013042823","doi":"10.1158/1538-7445.am2011-5104","title":"Abstract 5104: Serum metabolomic profiles acquired by gas chromatography-mass spectrometry (GC-MS) distinguish patients with pancreatic adenocarcinoma from those with benign pancreatic disease","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pancreatitis; Gastroenterology; Adenocarcinoma; Internal medicine; Pancreas; Pancreatic cancer; Pancreatic disease; Pancreatic mass; Pathology; Cancer","score_opus":0.04756764028301436,"score_gpt":0.331408136078493,"score_spread":0.28384049579547865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013042823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378456,0.007878772,0.00008807492,0.0003537578,0.00007826363,0.0030568058,0.0009972717,0.00016093756,0.0036015576],"genre_scores_gemma":[0.99255484,0.0012188717,0.0027124884,0.00011306234,0.00034283733,0.0014696849,0.00051637,0.00018008404,0.00089177536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302864,0.00052246114,0.00068122,0.0013932667,0.0024218773,0.001952508],"domain_scores_gemma":[0.9949729,0.00073611917,0.00026898616,0.0014669541,0.0010120835,0.001542961],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009699633,0.00065299566,0.0014982838,0.0006758459,0.0005411227,0.00011698407,0.0007100828,0.00025511044,0.00386338],"category_scores_gemma":[0.00056426664,0.00045019956,0.00018908108,0.0015980896,0.0015623652,0.00030299972,0.00018152028,0.0009981141,0.0001288782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008599255,0.00106645,0.97908396,0.00054247415,0.0014042424,0.00050446484,0.000583302,3.851811e-7,0.004289131,0.00006566253,0.0032869824,0.0005737123],"study_design_scores_gemma":[0.0060596373,0.0019093369,0.983819,0.0011341483,0.0011241123,0.000007797365,0.00044208812,0.000052617183,0.004213889,0.0005067384,0.00020343336,0.00052721926],"about_ca_topic_score_codex":0.006405639,"about_ca_topic_score_gemma":0.00018480641,"teacher_disagreement_score":0.008770267,"about_ca_system_score_codex":0.0005571947,"about_ca_system_score_gemma":0.0018120391,"threshold_uncertainty_score":0.99979496},"labels":[],"label_agreement":null},{"id":"W2013049336","doi":"10.1158/1538-7445.am2013-942","title":"Abstract 942: Decreasing the AKT feedback loop with arsenic trioxide enhances mTORi anti-tumor effects.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Jewish General Hospital","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Temsirolimus; Arsenic trioxide; SKBR3; Everolimus; Cancer research; MAPK/ERK pathway; Cell growth; Pharmacology; Medicine; Chemistry; Apoptosis; Signal transduction; Cancer; Cancer cell; Internal medicine; Biochemistry; Discovery and development of mTOR inhibitors","score_opus":0.019550938529245825,"score_gpt":0.32043795304708483,"score_spread":0.300887014517839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013049336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871505,0.008302453,0.00011543852,0.00033959534,0.00014210666,0.0005655786,0.0000032733194,0.000015965048,0.0033651053],"genre_scores_gemma":[0.99535704,0.0014216315,0.0001247152,0.00014737832,0.00059640093,0.00039389604,0.00001396205,0.00004201906,0.001902975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980442,0.00016501964,0.0001864428,0.000489714,0.00047981017,0.00063481095],"domain_scores_gemma":[0.99871427,0.00014686986,0.00007645101,0.0005333986,0.00038120447,0.00014781136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056048407,0.00019420593,0.00018186437,0.0000517649,0.00031553165,0.00018050871,0.00056801416,0.00011661987,0.00017269216],"category_scores_gemma":[0.00023782713,0.0001201043,0.00007114357,0.00029919844,0.00047262097,0.000015276879,0.0001381116,0.00042165333,0.00011358929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007707507,0.000034642242,0.0013803416,0.00016958042,0.00006306694,0.000014376609,0.000051508094,0.000018719556,0.9886728,0.000023400942,0.003199428,0.00629507],"study_design_scores_gemma":[0.0004930216,0.00020634742,0.004941893,0.00013155537,0.000012326284,0.00002035986,0.0002786517,0.000009327175,0.9809659,0.000096103715,0.012652085,0.00019241586],"about_ca_topic_score_codex":0.0004854562,"about_ca_topic_score_gemma":0.00006150721,"teacher_disagreement_score":0.009452657,"about_ca_system_score_codex":0.00006875492,"about_ca_system_score_gemma":0.0006031235,"threshold_uncertainty_score":0.4897711},"labels":[],"label_agreement":null},{"id":"W2013147001","doi":"10.1158/1538-7445.am2013-1204","title":"Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Cohort; Tissue microarray; Invasive lobular carcinoma; Cancer; Lobular carcinoma; Oncology; Internal medicine; Trastuzumab; Pathology; Ductal carcinoma; Invasive ductal carcinoma","score_opus":0.052631365808196426,"score_gpt":0.38784232428669546,"score_spread":0.335210958478499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013147001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991532,0.0030103256,0.000008047564,0.0027848477,0.00033819687,0.00069385296,0.00041879885,0.000025744606,0.0011881375],"genre_scores_gemma":[0.9940861,0.0015237323,0.000078272176,0.00026925787,0.00078467425,0.0020544848,0.00003749745,0.000050724724,0.0011152925],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99769986,0.00013620275,0.0002522654,0.0006939063,0.0004905569,0.0007272202],"domain_scores_gemma":[0.99842834,0.00004933748,0.00008657496,0.0005149784,0.00069302064,0.00022777247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003173243,0.00026219708,0.00024752246,0.00009247897,0.00032897614,0.000082363134,0.00037211354,0.0001623596,0.0010839273],"category_scores_gemma":[0.000072588344,0.00021947808,0.00011144894,0.00028648114,0.00043415363,0.000018222809,0.00029293442,0.00033233562,0.0001877164],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001161148,0.0004873427,0.11341939,0.000204662,0.0015085256,0.000037643556,0.000996574,0.00025500177,0.7371778,0.00008615323,0.10249688,0.042168893],"study_design_scores_gemma":[0.001716488,0.00011015131,0.63208944,0.0000970029,0.000024880364,0.000020010979,0.00042351804,0.000011795017,0.36138865,0.00022758318,0.003490862,0.0003996373],"about_ca_topic_score_codex":0.01593611,"about_ca_topic_score_gemma":0.004398091,"teacher_disagreement_score":0.51867,"about_ca_system_score_codex":0.00027459682,"about_ca_system_score_gemma":0.00043013706,"threshold_uncertainty_score":0.99982923},"labels":[],"label_agreement":null},{"id":"W2013210844","doi":"10.1158/1538-7445.am10-716","title":"Abstract 716: CXCR4 antagonist, CTCE-9908, inhibits PC-3 cell invasiveness and metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastasis; Cancer research; Prostate cancer; CXCR4; CXCR4 antagonist; Chemokine receptor; Biology; Chemokine; Cell migration; Pathology; Cell; Cancer; Medicine; Immunology; Internal medicine; Inflammation","score_opus":0.0781496404450937,"score_gpt":0.40175885745162637,"score_spread":0.32360921700653267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013210844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066097,0.0019051615,0.000005889693,0.0014573378,0.00021957488,0.0003822733,0.000034200628,0.00003190364,0.0053026876],"genre_scores_gemma":[0.99626076,0.0011000946,0.00015870747,0.00011243321,0.0006803999,0.00007060565,0.000021048554,0.00004273318,0.0015532027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980748,0.000048446593,0.00023563656,0.0004299959,0.0006612786,0.0005498409],"domain_scores_gemma":[0.9986084,0.00021789332,0.000047940564,0.00034409948,0.00039479526,0.0003868663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010482713,0.0001628751,0.00032490055,0.00021706944,0.00022972081,0.000091291666,0.00014616958,0.00014685608,0.0022167033],"category_scores_gemma":[0.00016543358,0.00013492249,0.00007822828,0.0004011079,0.0002803038,0.000103655155,0.00014339451,0.0011828167,0.00006219438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014346729,0.00009933646,0.009335496,0.0004345041,0.00003726988,0.00006159071,0.00024013895,0.0000011842828,0.9680134,0.000053355485,0.0039714887,0.017608747],"study_design_scores_gemma":[0.0011819227,0.00008561152,0.005404386,0.00014031035,0.000029951827,0.000030013814,0.00022023721,0.000012260604,0.94643617,0.000087887405,0.046221733,0.00014950034],"about_ca_topic_score_codex":0.00093151274,"about_ca_topic_score_gemma":0.00025362844,"teacher_disagreement_score":0.042250242,"about_ca_system_score_codex":0.0000951021,"about_ca_system_score_gemma":0.00052923633,"threshold_uncertainty_score":0.99869543},"labels":[],"label_agreement":null},{"id":"W2013255214","doi":"10.1158/0008-5472.sabcs-09-4109","title":"What Is the Actual Rate of Acute Skin Toxicity in Women Undergoing Adjuvant Radiation Therapy for Early Breast Cancer? Preliminary Results of a Single Institution Phase II Study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Regimen; Acute toxicity; Radiation therapy; Toxicity; Adverse effect; Surgery; Adjuvant therapy; Dose fractionation; Adjuvant; Cancer; Internal medicine","score_opus":0.06539870980418967,"score_gpt":0.4127660526083329,"score_spread":0.3473673428041432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013255214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818399,0.0045612333,0.00001519293,0.010335785,0.00017588977,0.0027279716,0.00028032434,0.000010981247,0.00005273228],"genre_scores_gemma":[0.98559815,0.012934746,0.00001702335,0.00027439813,0.00022315443,0.0007637802,0.00000832006,0.000018083732,0.00016233331],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779034,0.00024000424,0.00049955386,0.00040747365,0.0005589587,0.00050365657],"domain_scores_gemma":[0.9984598,0.00037578557,0.00020724833,0.00041288935,0.00046031154,0.00008397578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001597972,0.00017051179,0.0004631887,0.00028776572,0.00023519724,0.000031709,0.00022724464,0.000076955,0.00002363252],"category_scores_gemma":[0.00010585251,0.00012346494,0.00007418686,0.00079155475,0.00030347492,0.0003737201,0.000085710955,0.00028705245,6.350365e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12335232,0.0042344388,0.003941197,0.00019319642,0.0007483399,0.000026730113,0.10319004,0.00009432725,0.073136345,0.000027823558,0.002185014,0.68887025],"study_design_scores_gemma":[0.055410165,0.05597426,0.636571,0.0018005165,0.0001184748,0.000011177882,0.0130485315,0.00019588412,0.23475206,0.00047182958,0.0013389159,0.00030720304],"about_ca_topic_score_codex":0.0012764611,"about_ca_topic_score_gemma":0.00046265117,"teacher_disagreement_score":0.68856305,"about_ca_system_score_codex":0.0012693446,"about_ca_system_score_gemma":0.0009264247,"threshold_uncertainty_score":0.5034754},"labels":[],"label_agreement":null},{"id":"W2013425855","doi":"10.1158/0008-5472.can-06-2350","title":"Oncogenes, Trousseau Syndrome, and Cancer-Related Changes in the Coagulome of Mice and Humans","year":2006,"lang":"en","type":"review","venue":"Cancer Research","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University Medical Centre; Montreal Children's Hospital","funders":"","keywords":"Cancer; Cancer research; Medicine; Fibrinolysis; Thrombosis; Plasminogen activator inhibitor-1; Plasminogen activator; Tissue factor pathway inhibitor; Tissue factor; Epigenetics; Inflammation; Immunology; Pathology; Biology; Internal medicine; Coagulation; Gene; Genetics","score_opus":0.19038392943204988,"score_gpt":0.4646003215586693,"score_spread":0.2742163921266194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013425855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011080391,0.98571694,4.974801e-7,0.0008226785,0.00008851327,0.0017345401,0.00008456649,0.000018567833,0.00045330566],"genre_scores_gemma":[0.0057792077,0.992408,0.000024668409,0.000055153563,0.000081315404,0.0006962922,0.000051994048,0.000050225262,0.0008531473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975605,0.00048478317,0.00044430932,0.00045331457,0.0006465604,0.00041050997],"domain_scores_gemma":[0.9989068,0.00030677303,0.0001590252,0.00036637063,0.00015592083,0.000105107974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012735968,0.00025438174,0.0013292441,0.0005546994,0.000110964735,0.000031128322,0.00022576566,0.0003265067,0.00012221484],"category_scores_gemma":[0.000032230884,0.00016853311,0.00008900377,0.0009849996,0.00024670974,0.00003078013,0.000106348525,0.0007924699,0.0000038845683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044644003,0.0003560138,0.00032079403,0.054085057,0.0006146725,0.00018983702,0.0010244676,7.3577456e-7,0.0005645684,0.002877032,0.0015481537,0.93837404],"study_design_scores_gemma":[0.0012823766,0.00055912486,0.0013339869,0.019994237,0.00091385393,0.00021917757,0.00017845105,0.000009031371,0.000092558475,0.00022057521,0.9749157,0.00028096902],"about_ca_topic_score_codex":0.0028005962,"about_ca_topic_score_gemma":0.0026818418,"teacher_disagreement_score":0.9733675,"about_ca_system_score_codex":0.00021315117,"about_ca_system_score_gemma":0.00059478084,"threshold_uncertainty_score":0.68725806},"labels":[],"label_agreement":null},{"id":"W2013694269","doi":"10.1158/0008-5472.can-07-0480","title":"Human Polynucleotide Kinase Participates in Repair of DNA Double-Strand Breaks by Nonhomologous End Joining but not Homologous Recombination","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"DNA repair protein XRCC4; Non-homologous end joining; DNA repair; Homologous recombination; Ku80; Molecular biology; Homology directed repair; Biology; DNA-PKcs; DNA ligase; DNA damage; DNA; Cell biology; Nucleotide excision repair; Chemistry; Biochemistry; DNA-binding protein; Gene","score_opus":0.05205972837960695,"score_gpt":0.37459466978145217,"score_spread":0.32253494140184524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013694269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725133,0.0007620951,0.000063175794,0.000115331335,0.000115404895,0.00040291803,0.00003592261,0.000032218333,0.0012216204],"genre_scores_gemma":[0.99800974,0.000104038394,0.00019081429,0.000067065506,0.000083975516,0.00010727959,0.00006965736,0.000040043906,0.0013274001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976299,0.00020002277,0.00045682414,0.00055366143,0.00041048438,0.00074910006],"domain_scores_gemma":[0.998997,0.000051542884,0.00008082199,0.00047584702,0.0002415497,0.00015326681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026291586,0.00016849188,0.00024761155,0.00022696877,0.00012880338,0.000020682792,0.0003042431,0.00025808916,0.00010517489],"category_scores_gemma":[0.00013696573,0.00017748847,0.000098657874,0.00029316128,0.0002863745,0.000009967286,0.00018273102,0.00034250255,0.000006259185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052223256,0.00018997295,0.0024127967,0.000054272205,0.000039804512,0.00007031872,0.00015772697,0.000033308246,0.99335563,0.00023610344,0.0006513825,0.0022764266],"study_design_scores_gemma":[0.0017346265,0.0007151603,0.0041345805,0.000048595008,0.000009403196,0.000012818436,0.00019666537,0.00003518296,0.9920626,0.00013565327,0.0007348187,0.0001798826],"about_ca_topic_score_codex":0.0027844294,"about_ca_topic_score_gemma":0.0024116293,"teacher_disagreement_score":0.002492193,"about_ca_system_score_codex":0.00012615787,"about_ca_system_score_gemma":0.00015719228,"threshold_uncertainty_score":0.723777},"labels":[],"label_agreement":null},{"id":"W2013745473","doi":"10.1158/1538-7445.am10-3206","title":"Abstract 3206: A novel prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate inhibits the telomerase gene by modifying DNA methylation and histone acetylation in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Telomerase reverse transcriptase; Telomerase; Cancer research; Chemistry; Molecular biology; DNA methylation; Chromatin immunoprecipitation; Cancer cell; Biology; Cancer; Promoter; Gene expression; Biochemistry; Gene","score_opus":0.04381424701100735,"score_gpt":0.3614209718959755,"score_spread":0.31760672488496816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013745473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97735,0.0022920258,0.000009381189,0.018550482,0.00016627228,0.0013225549,0.00014236255,0.000018649083,0.00014825507],"genre_scores_gemma":[0.997584,0.0010193153,0.0000536244,0.00021354236,0.00021735519,0.00044052073,0.000008166948,0.000043721735,0.00041976315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977212,0.000098389566,0.0004107598,0.0004440228,0.00086466904,0.00046093384],"domain_scores_gemma":[0.99864054,0.00010531368,0.00017140825,0.00048557532,0.0004644568,0.00013269926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014211267,0.00019267584,0.000298615,0.00019044874,0.00024646413,0.00004142248,0.00027170157,0.0001602571,0.00018808946],"category_scores_gemma":[0.00006250732,0.000118775395,0.000069147805,0.0008193457,0.00041252535,0.00016183918,0.00015951322,0.0011824702,0.000002948055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023120186,0.00015881617,0.009493259,0.00021180029,0.0000436856,7.0573134e-7,0.0012233307,0.00005618208,0.9577215,0.000021055352,0.0005860792,0.030252388],"study_design_scores_gemma":[0.0013177162,0.00003528391,0.16170968,0.00027435375,0.00003693214,0.000006278439,0.00014725332,0.00059175893,0.8347882,0.000029628653,0.0009272116,0.00013570598],"about_ca_topic_score_codex":0.02293528,"about_ca_topic_score_gemma":0.0031271647,"teacher_disagreement_score":0.15221643,"about_ca_system_score_codex":0.00034602385,"about_ca_system_score_gemma":0.0005312981,"threshold_uncertainty_score":0.98357105},"labels":[],"label_agreement":null},{"id":"W2013850167","doi":"10.1158/0008-5472.can-06-1101","title":"A Systematic Assessment of Common Genetic Variation in <i>CYP11A</i> and Risk of Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Haplotype; Single-nucleotide polymorphism; Breast cancer; Linkage disequilibrium; Odds ratio; Genetics; Oncology; Biology; Internal medicine; Medicine; Genotype; Cancer; Gene","score_opus":0.020754706237103616,"score_gpt":0.3760858636431968,"score_spread":0.35533115740609317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013850167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444926,0.0044312617,0.00037978694,0.00011215741,0.00003365823,0.0003287526,0.00011883354,0.0000013161279,0.00014497606],"genre_scores_gemma":[0.9949588,0.0042708274,0.0004135297,0.000009163635,0.00006205435,0.00019125272,0.000011038201,0.0000088506185,0.000074448646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984914,0.00055273174,0.0003842564,0.00019500476,0.00017375381,0.00020287414],"domain_scores_gemma":[0.9992577,0.000093669725,0.00019592488,0.000208408,0.00021561516,0.00002869768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011539903,0.000068974565,0.00026087216,0.0000884673,0.00003884157,0.0000050692174,0.00010652781,0.00010443027,0.000016850243],"category_scores_gemma":[0.00007021552,0.00006132075,0.00003376211,0.00018072188,0.00009639812,0.0000017496458,0.00007515745,0.00010866216,2.6547278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017148948,0.00007097766,0.83749896,0.0009966485,0.000062003346,3.5919498e-7,0.00003820338,0.0028665215,0.15784436,0.00006820034,0.00027933173,0.0002572977],"study_design_scores_gemma":[0.00036305145,0.00007066035,0.99546576,0.00035448192,0.00002657484,0.0000019482065,0.00004107786,0.001126177,0.0021827735,0.0002928803,0.000017752654,0.00005684094],"about_ca_topic_score_codex":0.015030112,"about_ca_topic_score_gemma":0.0051540146,"teacher_disagreement_score":0.15796684,"about_ca_system_score_codex":0.000061973675,"about_ca_system_score_gemma":0.00018243885,"threshold_uncertainty_score":0.99152887},"labels":[],"label_agreement":null},{"id":"W2013878239","doi":"10.1158/1538-7445.am10-897","title":"Abstract 897: Association of inherited variants in HGF and ovarian cancer survival time","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Single-nucleotide polymorphism; Hazard ratio; Internal medicine; Serous fluid; Ovarian cancer; Oncology; SNP; Medicine; Proportional hazards model; Genome-wide association study; Cancer; Confidence interval; Biology; Gene; Genotype; Genetics","score_opus":0.07599708435192871,"score_gpt":0.4178503120534894,"score_spread":0.3418532277015607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013878239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878456,0.00056516536,5.046771e-7,0.00642947,0.00027426356,0.0005083422,0.000101049925,0.000014294686,0.0042613274],"genre_scores_gemma":[0.9968445,0.0011399803,0.00007927659,0.00007482008,0.00029685104,0.00024622443,0.000014672448,0.000025268324,0.001278439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998288,0.00008590327,0.00026598145,0.00032794147,0.0006218108,0.00041039093],"domain_scores_gemma":[0.99886864,0.00027222556,0.00008784182,0.00025890823,0.00034665925,0.00016573591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001264,0.00011624467,0.0003390737,0.00023259298,0.000059234673,0.000030984855,0.00008825035,0.00017853187,0.0027491206],"category_scores_gemma":[0.00022245923,0.00010292581,0.00004016282,0.00051160454,0.00008699936,0.00008819165,0.000054147,0.0006346702,0.000028440549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038635943,0.0004746459,0.78003216,0.000189633,0.00022978101,0.00006661886,0.00047973535,0.000004584037,0.19018494,0.00033287267,0.004159826,0.023458868],"study_design_scores_gemma":[0.0029606707,0.000096259835,0.98523,0.00022848764,0.000030762345,0.0000017667162,0.00003491123,0.00005147439,0.006668719,0.0001304317,0.0044780695,0.00008843563],"about_ca_topic_score_codex":0.010886781,"about_ca_topic_score_gemma":0.005242689,"teacher_disagreement_score":0.20519787,"about_ca_system_score_codex":0.00053476566,"about_ca_system_score_gemma":0.0006499075,"threshold_uncertainty_score":0.9981625},"labels":[],"label_agreement":null},{"id":"W2014014305","doi":"10.1158/1538-7445.am2012-3050","title":"Abstract 3050: Inducing apoptosis in mantle cell lymphoma using inhibitors of cyclin-dependent kinases and the Bcl-2 inhibitor ABT-737","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cyclin-dependent kinase; Cell cycle; Kinase; Mantle cell lymphoma; Cyclin D1; Apoptosis; Cancer research; Cell growth; Cell biology; Cyclin-dependent kinase 7; Biology; Cell cycle checkpoint; Chemistry; Cyclin-dependent kinase 2; Biochemistry; Immunology; Lymphoma","score_opus":0.06915437361735097,"score_gpt":0.369116455162064,"score_spread":0.29996208154471304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014014305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440915,0.0124181835,0.0000065781246,0.00039923863,0.00040494866,0.000867062,0.000018835866,0.000022767248,0.001453219],"genre_scores_gemma":[0.9976912,0.0013464442,0.000069448215,0.00005905996,0.0005692531,0.00010359121,0.0000046571577,0.00005672395,0.000099580415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972539,0.00021880446,0.0004853314,0.0003576148,0.00093964965,0.0007447106],"domain_scores_gemma":[0.99864846,0.0003150168,0.00013682283,0.00045519107,0.00019988524,0.00024464566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020617477,0.0001906287,0.00041544193,0.00044132784,0.00014298798,0.000033892018,0.00015973815,0.00020149969,0.00008932637],"category_scores_gemma":[0.0002585777,0.00014479093,0.00009885443,0.00065695023,0.0004753656,0.00015723826,0.00023327595,0.00065212883,0.000014272935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009350657,0.00041730626,0.011786982,0.0005567501,0.00006284907,0.000027819053,0.002492399,0.00008354131,0.9728393,0.00005569186,0.00068156695,0.010060752],"study_design_scores_gemma":[0.006855513,0.00008923479,0.01142539,0.001073847,0.000056905254,0.00002317606,0.0015234912,0.00010482034,0.97792834,0.000031857722,0.00071210286,0.0001753347],"about_ca_topic_score_codex":0.0068481066,"about_ca_topic_score_gemma":0.0001902106,"teacher_disagreement_score":0.013282075,"about_ca_system_score_codex":0.0007605845,"about_ca_system_score_gemma":0.00054305565,"threshold_uncertainty_score":0.9997654},"labels":[],"label_agreement":null},{"id":"W2014298811","doi":"10.1158/1538-7445.am2013-lb-47","title":"Abstract LB-47: SPEN is a novel candidate tumor suppressor gene that regulates response to tamoxifen in estrogen receptor positive breast cancers.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Jewish General Hospital; McGill University","funders":"","keywords":"Tamoxifen; Breast cancer; Estrogen receptor; Cancer research; Estrogen; Biology; Estrogen receptor alpha; Cancer; Internal medicine; Endocrinology; Medicine","score_opus":0.05524917409467897,"score_gpt":0.3835509574379317,"score_spread":0.3283017833432528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014298811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651735,0.0022425212,0.0000020646708,0.026609391,0.00014651805,0.0037435314,0.0014241809,0.000052767442,0.00060556596],"genre_scores_gemma":[0.98744756,0.0006914079,0.0003148394,0.00065185176,0.00037422014,0.0024311086,0.0001372088,0.000114616196,0.007837162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948615,0.00025785668,0.00043636642,0.0010567739,0.001565311,0.0018222108],"domain_scores_gemma":[0.9967481,0.00037632626,0.00008547556,0.0008434621,0.000889355,0.0010572695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014140086,0.0003981485,0.0006302787,0.0008555792,0.00026178508,0.00021732734,0.00055474887,0.00017818101,0.0064058653],"category_scores_gemma":[0.0001851395,0.00032157818,0.00014245124,0.0013131778,0.00042206622,0.00038271496,0.0003733396,0.0009750445,0.0008939175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018731745,0.00027895643,0.019502733,0.00015292356,0.00026827367,0.00027868335,0.0028146536,0.000023463903,0.91588104,0.000008673113,0.03857971,0.0034791762],"study_design_scores_gemma":[0.005060287,0.00057764805,0.3373654,0.00084483763,0.000025834206,0.00007592975,0.00080375845,0.000052762356,0.64897174,0.00005525588,0.0057969275,0.000369589],"about_ca_topic_score_codex":0.0488358,"about_ca_topic_score_gemma":0.0008080055,"teacher_disagreement_score":0.31786266,"about_ca_system_score_codex":0.0038699314,"about_ca_system_score_gemma":0.0028559607,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W2014365795","doi":"10.1158/0008-5472.sabcs-5095","title":"The future of breast cancer research and practice in Asia, Latin America, and the Middle East/North Africa: a qualitative horizon scanning analysis.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Latin Americans; Nonprobability sampling; Breast cancer; Middle East; Capacity building; Medicine; Family medicine; Qualitative research; Political science; Economic growth; Medical education; Cancer; Sociology; Population; Environmental health; Social science; Internal medicine","score_opus":0.2892606493755611,"score_gpt":0.5040123707814737,"score_spread":0.21475172140591253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014365795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8670519,0.0664339,0.000016184844,0.06201918,0.000035438767,0.00077682285,0.000051501418,0.000009982935,0.0036050912],"genre_scores_gemma":[0.98654896,0.012059173,0.00015372026,0.00016184834,0.00031174585,0.00020583396,0.000004033638,0.000012324617,0.0005423811],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99476933,0.0019641833,0.00038069597,0.00046162857,0.0016655882,0.00075857004],"domain_scores_gemma":[0.99478424,0.0029202849,0.0001439887,0.0004237364,0.0015213714,0.00020636884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066800686,0.00015122813,0.0004780283,0.00041913445,0.00055474124,0.00011519786,0.000291749,0.00008158882,0.000036078553],"category_scores_gemma":[0.0012814516,0.00008736125,0.000070320144,0.0047114827,0.0016791138,0.00022310678,0.00015871227,0.0013134959,0.0000018067342],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040346883,0.0003766197,0.0544998,0.00030748546,0.0019545597,0.00022405367,0.3678945,0.00036345253,0.0038003833,0.0120334,0.014767098,0.50343174],"study_design_scores_gemma":[0.0042721657,0.0016808233,0.38333276,0.0008366465,0.00036996053,0.00005227895,0.58770806,0.00067602965,0.00011850508,0.0023825022,0.018283868,0.00028642142],"about_ca_topic_score_codex":0.014190773,"about_ca_topic_score_gemma":0.0074878796,"teacher_disagreement_score":0.50314534,"about_ca_system_score_codex":0.00031811473,"about_ca_system_score_gemma":0.00062082504,"threshold_uncertainty_score":0.9923738},"labels":[],"label_agreement":null},{"id":"W2014574103","doi":"10.1158/0008-5472.can-12-0538","title":"Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; National Center for Advancing Translational Sciences; Atomic Energy of Canada Limited","keywords":"Tumor microenvironment; Cancer research; Cytotoxic T cell; CD8; Immunotherapy; Adoptive cell transfer; T cell; Cancer immunotherapy; Immune system; Immunology; Medicine; Biology; In vitro","score_opus":0.20493459240133882,"score_gpt":0.3980267460676145,"score_spread":0.1930921536662757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014574103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945262,0.00060226885,0.00006724469,0.002331998,0.00021119243,0.0017630624,0.00003816967,0.000014725732,0.0004451142],"genre_scores_gemma":[0.99502575,0.0005069914,0.000023720857,0.0018488144,0.00016107676,0.001211864,0.0000011363205,0.0000266181,0.0011940232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979279,0.00035389088,0.00019812377,0.00030826774,0.000686915,0.0005248839],"domain_scores_gemma":[0.9990021,0.00037685694,0.00008091994,0.00034046918,0.00006638594,0.00013325992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069869024,0.00012200131,0.00012831067,0.0000996291,0.00032102168,0.00003621382,0.00032864435,0.00002602723,0.00032676948],"category_scores_gemma":[0.000027025768,0.00007644975,0.000042780426,0.00040307923,0.0002668676,0.00015683933,0.00008082861,0.00030504196,0.00008009195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017235635,0.00022277524,0.00021176062,0.000008280457,0.0000074533646,0.0000016006351,0.0006301506,0.000036466838,0.9901682,0.0005425945,0.0009894434,0.007008905],"study_design_scores_gemma":[0.00042725066,0.00060225365,0.001522122,0.00004091244,0.0000041010676,0.000002422736,0.00014653828,0.00000875043,0.963962,0.00010596806,0.03308595,0.00009173849],"about_ca_topic_score_codex":0.000048093236,"about_ca_topic_score_gemma":0.000007378119,"teacher_disagreement_score":0.032096505,"about_ca_system_score_codex":0.00020238177,"about_ca_system_score_gemma":0.00009423923,"threshold_uncertainty_score":0.35778967},"labels":[],"label_agreement":null},{"id":"W2014607304","doi":"10.1158/1538-7445.am10-240","title":"Abstract 240: Amplification status of GAS41 and MDM2 in lung adenocarcinomas","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Carcinogenesis; Lung cancer; Adenocarcinoma; Gene duplication; Biology; Cancer research; Gene knockdown; Cancer; Comparative genomic hybridization; Gene; Mdm2; Copy-number variation; Tumor suppressor gene; Molecular biology; Genome; Genetics; Pathology; Medicine","score_opus":0.05110268843355053,"score_gpt":0.39970208719078304,"score_spread":0.3485993987572325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014607304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471545,0.003455113,0.000031836687,0.00017011244,0.000058255464,0.00017404478,0.00002732465,0.0000022758447,0.0013655847],"genre_scores_gemma":[0.99641395,0.0029119973,0.00008901049,0.000012993261,0.00010299871,0.00011697704,0.00002837265,0.000010944948,0.00031274502],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99916625,0.000030024079,0.00013733812,0.0002394407,0.00015262044,0.00027432502],"domain_scores_gemma":[0.9993854,0.00001603536,0.00003532051,0.00030878666,0.00016929698,0.00008514654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034047343,0.000056245015,0.0000707927,0.000087070024,0.000048557406,0.000018561808,0.00012661675,0.000091127324,0.00010382319],"category_scores_gemma":[0.000073004325,0.00005444521,0.000017749107,0.00014798323,0.00016950752,0.000004655155,0.000051849533,0.00022473896,0.0000024594292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004396071,0.000025445246,0.06167569,0.00003739011,0.0000053826334,4.3336362e-7,0.00007043048,0.000006513683,0.93016076,0.00036062766,0.00078240776,0.0068309694],"study_design_scores_gemma":[0.00032497503,0.00003870571,0.662974,0.000014871944,0.0000022285049,0.0000011226393,0.000120484045,0.000031043284,0.3139632,0.00011565336,0.022335283,0.00007842188],"about_ca_topic_score_codex":0.001076242,"about_ca_topic_score_gemma":0.0008870329,"teacher_disagreement_score":0.6161975,"about_ca_system_score_codex":0.000028065346,"about_ca_system_score_gemma":0.00024286658,"threshold_uncertainty_score":0.22202112},"labels":[],"label_agreement":null},{"id":"W2014671990","doi":"10.1158/0008-5472.can-06-1876","title":"A Prospective Nested Case-Control Study of Vitamin D Status and Pancreatic Cancer Risk in Male Smokers","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Pancreatic cancer; Internal medicine; Prospective cohort study; Nested case-control study; Odds ratio; Gastroenterology; Cancer; Vitamin D and neurology; Case-control study; Vitamin; Endocrinology; Cancer prevention; Confidence interval; Cohort study; Pancreatic disease; Physiology; Pancreas","score_opus":0.03554524019163343,"score_gpt":0.39466802034508913,"score_spread":0.3591227801534557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014671990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923093,0.0059048925,0.0000021963547,0.0002496934,0.00003600717,0.0038133555,0.00016035674,0.000019651497,0.00058289757],"genre_scores_gemma":[0.99395645,0.0017096798,0.000022947086,0.000009121677,0.00012205774,0.0024787316,0.0000017269333,0.000035692483,0.0016636172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965669,0.0006078188,0.00037514875,0.00054019643,0.000989063,0.0009208714],"domain_scores_gemma":[0.9979603,0.0006948284,0.0000815604,0.00037754295,0.0006935694,0.00019219871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013650476,0.00018973826,0.0006091723,0.0006033852,0.00020409729,0.000028000915,0.00010119646,0.00007771203,0.0001893148],"category_scores_gemma":[0.0007044009,0.00015059367,0.000040667135,0.0012263404,0.0005433059,0.00009185567,0.00014814561,0.0008191053,0.0000034024147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082748884,0.0006980423,0.98588395,0.00032915123,0.00028518145,0.0019008275,0.0032482862,0.000085234824,0.0033533897,0.000011869139,0.0005103281,0.00286627],"study_design_scores_gemma":[0.010234759,0.0013759776,0.97442424,0.00026480985,0.00012111395,0.000064941974,0.01237631,0.00021202363,0.0007132213,0.00005099893,0.000035899124,0.0001257061],"about_ca_topic_score_codex":0.17250809,"about_ca_topic_score_gemma":0.06707385,"teacher_disagreement_score":0.10543424,"about_ca_system_score_codex":0.00091327436,"about_ca_system_score_gemma":0.0005190066,"threshold_uncertainty_score":0.9499496},"labels":[],"label_agreement":null},{"id":"W2014801436","doi":"10.1158/1538-7445.am2012-3067","title":"Abstract 3067: Regulation of PAX2 expression/activity by hypoxia and EGF in breast cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université du Québec à Trois-Rivières","funders":"","keywords":"Breast cancer; Metastasis; Cancer research; Cancer; Cancer cell; Transcription factor; Biology; Metastatic breast cancer; Lung cancer; Internal medicine; Medicine; Gene; Genetics","score_opus":0.029520902236378228,"score_gpt":0.34890962491654304,"score_spread":0.3193887226801648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014801436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98068005,0.017889958,0.00001421905,0.00020817443,0.00039608468,0.0002239261,0.00022669803,0.0000039735637,0.00035693252],"genre_scores_gemma":[0.98825973,0.009899561,0.000027301723,0.000030485153,0.00098706,0.00012289411,0.000017658951,0.000021922904,0.00063335395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998676,0.000107117354,0.00016342459,0.00029701606,0.00030002242,0.00045642213],"domain_scores_gemma":[0.9993225,0.000027375812,0.000069931695,0.00027614553,0.00014127919,0.00016277598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056713365,0.00011982179,0.00017589462,0.00008387729,0.00006577314,0.000015560268,0.00013286741,0.00016347032,0.00020929931],"category_scores_gemma":[0.000022003134,0.00011109173,0.000040065785,0.0001678157,0.00017260211,0.00002133357,0.00011837403,0.00021430507,0.0000025216216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000222969,0.00008847357,0.00705248,0.00006631381,0.000012759617,1.1450609e-7,0.000099203586,0.000015541307,0.9543548,0.0000060488683,0.019482084,0.018599186],"study_design_scores_gemma":[0.00043493722,0.0000139515305,0.221655,0.00004675517,0.000004204597,0.0000014066959,0.00003942557,0.0000040263967,0.73602057,0.000013533938,0.041663926,0.00010226464],"about_ca_topic_score_codex":0.0022062815,"about_ca_topic_score_gemma":0.00025270978,"teacher_disagreement_score":0.21833426,"about_ca_system_score_codex":0.00005850459,"about_ca_system_score_gemma":0.00018338782,"threshold_uncertainty_score":0.45301893},"labels":[],"label_agreement":null},{"id":"W2014862652","doi":"10.1158/1538-7445.prca2012-b14","title":"Abstract B14: Developing small-molecule inhibitors to the androgen receptor N-terminus domain for the treatment of advanced prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Androgen receptor; Prostate cancer; Antiandrogens; Intracrine; Transactivation; Cancer research; Medicine; Androgen; Cancer; Internal medicine; Pharmacology; Endocrinology; Receptor; Chemistry; Transcription factor; Hormone; Biochemistry; Paracrine signalling","score_opus":0.09851968613890107,"score_gpt":0.427689093179413,"score_spread":0.32916940704051195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014862652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93765146,0.03977223,0.000016401638,0.015888527,0.00044756007,0.0058071036,0.00020824144,0.00002403147,0.0001844437],"genre_scores_gemma":[0.96158034,0.018651504,0.0004826902,0.00020274082,0.0012549273,0.013062705,0.000048060425,0.00008590929,0.004631121],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733204,0.000102495265,0.00033171187,0.00037408568,0.0006903668,0.001169318],"domain_scores_gemma":[0.99808687,0.0004120674,0.000081352286,0.00052134733,0.0005667722,0.000331599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009653012,0.00023652152,0.00033628033,0.00017466814,0.0004940747,0.000044518732,0.00028704148,0.00008330348,0.00023302664],"category_scores_gemma":[0.000059315287,0.00011725782,0.00015741336,0.00066723983,0.0002844928,0.000091206835,0.00008926954,0.00023118578,0.0000342098],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072727706,0.00074209424,0.02904349,0.0006623452,0.0009820048,0.000035396566,0.023007583,0.00006166824,0.18252698,0.00017664248,0.01777223,0.7377168],"study_design_scores_gemma":[0.0034769522,0.0010116943,0.009401097,0.00033855607,0.00006211385,0.0000057958478,0.0029105027,0.000003329761,0.59957564,0.000025505095,0.38300648,0.0001823324],"about_ca_topic_score_codex":0.0010325388,"about_ca_topic_score_gemma":0.000716578,"teacher_disagreement_score":0.73753446,"about_ca_system_score_codex":0.0014263906,"about_ca_system_score_gemma":0.0012761215,"threshold_uncertainty_score":0.4781635},"labels":[],"label_agreement":null},{"id":"W2014928083","doi":"10.1158/0008-5472.can-04-0729","title":"Phosphorylated Histone H2AX in Spheroids, Tumors, and Tissues of Mice Exposed to Etoposide and 3-Amino-1,2,4-Benzotriazine-1,3-Dioxide","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Etoposide; Molecular biology; Tirapazamine; Cancer research; Biochemistry; In vitro; Cytotoxicity; Chemotherapy","score_opus":0.06039675301573228,"score_gpt":0.3988629651731032,"score_spread":0.33846621215737094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014928083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96158427,0.0349706,0.000013720433,0.0020449609,0.00006571763,0.0007866967,0.000028949824,0.000018982617,0.00048607172],"genre_scores_gemma":[0.9916086,0.00537958,0.0010743703,0.00017905165,0.0000947029,0.000093988485,0.000007756887,0.00003594185,0.0015259933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811316,0.00007125638,0.0003601981,0.00045911694,0.0005091578,0.00048714358],"domain_scores_gemma":[0.9989724,0.00009305119,0.00005033883,0.00029226913,0.00023659065,0.00035534464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006834663,0.00016387527,0.00050142634,0.00032721955,0.000058300237,0.000018321685,0.00010916863,0.00008496426,0.00019461014],"category_scores_gemma":[0.00016493972,0.00015254122,0.000036389636,0.00079254573,0.00024161987,0.000069656686,0.00012655412,0.0003707325,0.000008660752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013173291,0.00012810047,0.004348407,0.00041052382,0.000046577246,0.00017078176,0.0018102163,0.000045357072,0.968963,0.00014054046,0.001174497,0.021444663],"study_design_scores_gemma":[0.0049442574,0.00070048415,0.018726127,0.0008932654,0.00003590801,0.00003533142,0.000759685,0.000003912919,0.960218,0.0001958243,0.0133021055,0.00018506107],"about_ca_topic_score_codex":0.014497416,"about_ca_topic_score_gemma":0.0031085524,"teacher_disagreement_score":0.030024314,"about_ca_system_score_codex":0.00047710608,"about_ca_system_score_gemma":0.00046339465,"threshold_uncertainty_score":0.99206513},"labels":[],"label_agreement":null},{"id":"W2015023486","doi":"10.1158/0008-5472.can-14-1009","title":"AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"Cancer research; Mesenchymal stem cell; Cancer; Epithelial–mesenchymal transition; Receptor tyrosine kinase; AXL receptor tyrosine kinase; Cancer cell; Tyrosine kinase; Medicine; Breast cancer; Drug resistance; Cabozantinib; Biology; Pharmacology; Metastasis; Internal medicine; Pathology; Receptor","score_opus":0.04002763065304726,"score_gpt":0.35834410385034493,"score_spread":0.31831647319729767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015023486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926307,0.0018282696,0.00012445293,0.002485157,0.00089995924,0.00036497,0.000030624895,0.00005292167,0.0015829433],"genre_scores_gemma":[0.9941458,0.00036514222,0.000030288023,0.00028479463,0.00024402501,0.0001441139,0.000035732453,0.000024929723,0.00472519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806356,0.0005282688,0.00022613742,0.00039144247,0.0001430356,0.00064756203],"domain_scores_gemma":[0.99909335,0.00015245611,0.00004639897,0.00032239416,0.0003270225,0.00005836317],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008649919,0.00014278248,0.00024367162,0.00025610274,0.0003622991,0.00004310317,0.00015945394,0.0001786614,0.0011168653],"category_scores_gemma":[0.00007187729,0.00012782543,0.00006818295,0.00041946187,0.00021405586,0.00011967455,0.00014992483,0.0004030853,0.0011234808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011012553,0.00003526095,0.00018915934,0.000027307746,0.00003988451,9.4442316e-7,0.00055300444,0.00014219794,0.9492528,0.00033458733,0.02676331,0.022551425],"study_design_scores_gemma":[0.0006506421,0.0001164829,0.004606022,0.0001280808,0.000011606253,0.0000034528723,0.00014882335,0.00004484374,0.9442419,0.0001298766,0.04975875,0.00015952715],"about_ca_topic_score_codex":0.0012673078,"about_ca_topic_score_gemma":0.000113724134,"teacher_disagreement_score":0.02299544,"about_ca_system_score_codex":0.00021236665,"about_ca_system_score_gemma":0.00015054356,"threshold_uncertainty_score":0.9997963},"labels":[],"label_agreement":null},{"id":"W2015080154","doi":"10.1158/0008-5472.sabcs-09-78","title":"Tumor Ki67 Proliferation Index within 4 Weeks of Initiating Neoadjuvant Endocrine Therapy for Early Identification of Non-Responders.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Neoadjuvant therapy; Cancer; Endocrine system; Surrogate endpoint; Biopsy; Clinical endpoint; Stage (stratigraphy); Sample size determination; Randomized controlled trial; Hormone","score_opus":0.049305103603889976,"score_gpt":0.4011720458804437,"score_spread":0.35186694227655374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015080154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660474,0.0009930436,0.00089071464,0.0005720182,0.00006106924,0.00073115254,0.00006458696,0.0000049614882,0.00007769136],"genre_scores_gemma":[0.9988348,0.00022764764,0.0001717526,0.00005990221,0.00018228164,0.00034944064,0.000046766305,0.000014831894,0.000112610294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988342,0.00007306532,0.0003173313,0.00026997185,0.0002755878,0.00022986885],"domain_scores_gemma":[0.99888474,0.000036140722,0.00016959487,0.00025038017,0.00062296045,0.00003619604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044064195,0.00010099891,0.00016619933,0.000107363405,0.000097883094,0.000015582707,0.0001542656,0.00004654594,0.0000065154877],"category_scores_gemma":[0.00012607122,0.000090248635,0.000057347745,0.00018564926,0.000112659254,0.00000981026,0.00003462161,0.00008765556,6.557086e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001555476,0.00012166909,0.013302236,0.000047391713,0.000080040445,7.843064e-7,0.0006245802,0.00010583919,0.97146267,0.00007465753,0.00025429056,0.012370378],"study_design_scores_gemma":[0.0014354833,0.0007123489,0.14657292,0.000040517993,0.000006790799,0.0000013592398,0.0001891829,0.00010386834,0.8505214,0.0002310586,0.000112571055,0.00007249419],"about_ca_topic_score_codex":0.00017325586,"about_ca_topic_score_gemma":0.00005110698,"teacher_disagreement_score":0.13327068,"about_ca_system_score_codex":0.000046193454,"about_ca_system_score_gemma":0.00024269792,"threshold_uncertainty_score":0.36802325},"labels":[],"label_agreement":null},{"id":"W2015093111","doi":"10.1158/1538-7445.am10-4682","title":"Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Oncology; Carboplatin; Clinical trial; Refractory (planetary science); Urology; Confidence interval; Chemotherapy; Cisplatin","score_opus":0.2759975305520465,"score_gpt":0.46815694096608995,"score_spread":0.19215941041404344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015093111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937555,0.00016851387,0.0000102040585,0.00053235947,0.00013271555,0.00074785366,0.000008442967,0.00002041118,0.004623979],"genre_scores_gemma":[0.99897164,0.00004258693,0.00054677087,0.000022681372,0.00011146152,0.00010568751,0.000034281537,0.000027015441,0.00013790335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982268,0.00011010911,0.00049169717,0.0002947517,0.000516813,0.00035982384],"domain_scores_gemma":[0.99857503,0.0005289198,0.00010129411,0.00031586262,0.00030832124,0.00017059651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016968525,0.00011235076,0.00032162725,0.00027787528,0.000061879226,0.0000150812375,0.000095684394,0.00015602249,0.0005690834],"category_scores_gemma":[0.00044313472,0.000087852,0.00008728312,0.0005659842,0.00024722633,0.000093664814,0.000031445303,0.00089303934,0.00002151748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007053935,0.00014590094,0.9287541,0.000105553074,0.000056133602,0.000126888,0.00010315657,0.000002821503,0.025394207,0.000058780395,0.000024927751,0.04452217],"study_design_scores_gemma":[0.0031141895,0.00029970828,0.9898768,0.00026818513,0.000027670516,0.000008710946,0.00017868,0.00055160775,0.005077154,0.00002123103,0.0004809842,0.000095082716],"about_ca_topic_score_codex":0.000696851,"about_ca_topic_score_gemma":0.000532206,"teacher_disagreement_score":0.06112273,"about_ca_system_score_codex":0.00008763697,"about_ca_system_score_gemma":0.00036698033,"threshold_uncertainty_score":0.62310636},"labels":[],"label_agreement":null},{"id":"W2015271494","doi":"10.1158/1538-7445.am2013-1991","title":"Abstract 1991: PDCD4 de-repression of Bcl-xl IRES-mediated translation leads to enhanced chemo-resistance of glioblastoma multiforme tumors.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Internal ribosome entry site; Cancer research; Programmed cell death; Gene silencing; Biology; Apoptosis; Regulator; Downregulation and upregulation; Bcl-xL; Untranslated region; Translation (biology); RNA; Messenger RNA; Genetics; Gene","score_opus":0.03495717114017805,"score_gpt":0.3466817916539795,"score_spread":0.31172462051380145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015271494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606466,0.0013104503,0.00014045334,0.00024600347,0.000037986243,0.0007136299,0.000099859935,0.000010716072,0.0013762203],"genre_scores_gemma":[0.9980194,0.00020413953,0.0005449609,0.000036591362,0.00011394455,0.00033963253,0.00006891445,0.000027787808,0.0006446123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998336,0.00009960222,0.0003393472,0.00035806844,0.00041419375,0.00045274955],"domain_scores_gemma":[0.9988089,0.00006808587,0.00010773684,0.00038625774,0.00045188595,0.00017710139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053209637,0.00013994167,0.0002150313,0.00012225492,0.00006831227,0.00001555592,0.00032027846,0.00017254577,0.00028890633],"category_scores_gemma":[0.00024155791,0.00012938151,0.00008419685,0.00029963805,0.00016675114,0.000011754203,0.00007570957,0.00020057491,0.000037066926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005925479,0.0000676096,0.00033677957,0.0002622271,0.000017759545,9.589967e-7,0.00031983812,0.00008197547,0.9885522,0.000005017888,0.0014877401,0.00827534],"study_design_scores_gemma":[0.00061138545,0.00024707272,0.0066922284,0.00022826521,0.0000031550344,5.2833246e-7,0.00006944614,0.000041698422,0.9896496,0.00004364001,0.0022790215,0.00013397109],"about_ca_topic_score_codex":0.0005326665,"about_ca_topic_score_gemma":0.00028315056,"teacher_disagreement_score":0.00814137,"about_ca_system_score_codex":0.00005116254,"about_ca_system_score_gemma":0.0002162844,"threshold_uncertainty_score":0.5276025},"labels":[],"label_agreement":null},{"id":"W2015371087","doi":"10.1158/0008-5472.sabcs13-p4-12-14","title":"Abstract P4-12-14: Metal chelating polymer-conjugated trastuzumab labeled to high specific activity with indium-111 is cytotoxic to trastuzumab-sensitive and resistant breast cancer cells through the emission of auger electrons","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Trastuzumab; Chemistry; DOTA; Cancer research; Chelation; Cancer; Breast cancer; Medicine; Internal medicine","score_opus":0.04980454479126923,"score_gpt":0.37250235294524736,"score_spread":0.32269780815397814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015371087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840299,0.0003384244,0.00003416234,0.012695656,0.000020993355,0.0017723031,0.00031199018,0.000030319386,0.00076628284],"genre_scores_gemma":[0.99703217,0.00019255409,0.00010492741,0.0002932497,0.00021844612,0.0007035421,0.000009199671,0.000046871868,0.0013990399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974389,0.00010278728,0.00031352474,0.00062510936,0.0007759571,0.0007437012],"domain_scores_gemma":[0.99822366,0.00030310752,0.000095610405,0.00044335242,0.0004399231,0.00049431657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034547117,0.00026388653,0.00044452437,0.00009314902,0.00036799425,0.00005982718,0.00020280034,0.00012711163,0.0012182494],"category_scores_gemma":[0.000029525283,0.00017485129,0.000064608896,0.0008925644,0.0003705567,0.00014598796,0.00008282345,0.0009375101,0.000025980316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019882629,0.00018848547,0.00011635765,0.0001212074,0.0001733782,0.00001014926,0.0014318629,0.000011894196,0.9909011,0.00003369922,0.0019523301,0.0030712832],"study_design_scores_gemma":[0.0010703744,0.00029092428,0.03636725,0.00026422553,0.00006895604,0.000021059264,0.0005358459,0.000022607455,0.96050316,0.000022067723,0.0006425856,0.00019091576],"about_ca_topic_score_codex":0.004617082,"about_ca_topic_score_gemma":0.00010509917,"teacher_disagreement_score":0.036250893,"about_ca_system_score_codex":0.0005411265,"about_ca_system_score_gemma":0.0005310443,"threshold_uncertainty_score":0.99969476},"labels":[],"label_agreement":null},{"id":"W2015517688","doi":"10.1158/1538-7445.am2014-2060","title":"Abstract 2060: Quantifying vascular biomarkers with contrast-enhanced molecular ultrasound imaging","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Microbubbles; Endoglin; Angiogenesis; Molecular imaging; In vivo; Pathology; Preclinical imaging; Ultrasound; Medicine; Cancer research; Cell biology; Biology; Chemistry; Stem cell; Genetics","score_opus":0.029080298459985766,"score_gpt":0.32024472582456487,"score_spread":0.2911644273645791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015517688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945619,0.0020998765,0.034370545,0.00019034666,0.00008930835,0.00041935017,0.0000157556,0.0002926785,0.016903155],"genre_scores_gemma":[0.99846774,0.00039218296,0.00050778966,0.000040171,0.0001279825,0.00032904092,0.000014983708,0.000082369384,0.000037758917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830663,0.00005125899,0.00017908859,0.00033589258,0.0004827317,0.0006444022],"domain_scores_gemma":[0.9988625,0.0002994826,0.000020832631,0.00045488836,0.0001845528,0.00017773641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005494351,0.00018117766,0.00019125247,0.00016632848,0.0002276116,0.00015776411,0.00030775726,0.000060210332,0.00026160615],"category_scores_gemma":[0.000060390572,0.00016199415,0.00006412408,0.000503122,0.00019260623,0.00011868899,0.000018133049,0.00040943938,0.000091424954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012958207,0.00001860736,0.0007040695,0.000089559115,0.00013384304,0.000004022606,0.00013922213,0.0036597392,0.9834508,0.00067865656,0.0003383295,0.010770218],"study_design_scores_gemma":[0.002525186,0.00006603085,0.026888799,0.00049594615,0.00007596806,0.000025034818,0.000985999,0.0062146913,0.87542737,0.00095965795,0.08509642,0.0012389091],"about_ca_topic_score_codex":0.0002346923,"about_ca_topic_score_gemma":0.00014198707,"teacher_disagreement_score":0.10802342,"about_ca_system_score_codex":0.00013549167,"about_ca_system_score_gemma":0.000063919375,"threshold_uncertainty_score":0.660593},"labels":[],"label_agreement":null},{"id":"W2015569024","doi":"10.1158/0008-5472.sabcs11-s6-2","title":"S6-2: Patient-Reported Predictors of Early Treatment Discontinuation: NCIC JMA.27/E1Z03 Quality of Life Study of Postmenopausal Women with Primary Breast Cancer Randomized to Exemestane or Anastrozole.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Anastrozole; Exemestane; Discontinuation; Internal medicine; Quality of life (healthcare); Breast cancer; Randomized controlled trial; Aromatase inhibitor; Adverse effect; Oncology; Cancer; Physical therapy; Tamoxifen","score_opus":0.09674473056512146,"score_gpt":0.39480204656842566,"score_spread":0.2980573160033042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015569024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306786,0.00073746045,0.000046917598,0.00021930759,0.0001222082,0.0052655274,0.0003399317,0.000033573786,0.00016721056],"genre_scores_gemma":[0.99603605,0.00014350202,0.0003113403,0.00005835691,0.000108266286,0.0027704237,0.000015550013,0.00006628755,0.00049021374],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.994898,0.000704099,0.0013705941,0.0005979475,0.0017629319,0.0006664101],"domain_scores_gemma":[0.99570227,0.0003047169,0.00077085086,0.00087261596,0.001865485,0.00048409018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012499653,0.0003418455,0.0018531461,0.00042151686,0.00006784157,0.000008560715,0.0002444723,0.00007869219,0.0009014477],"category_scores_gemma":[0.00017496501,0.00021562129,0.00009172315,0.0010836689,0.00068869727,0.0002377647,0.00011734539,0.0002443892,0.0000014710029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6639763,0.0037850868,0.24908224,0.0003081965,0.003009033,0.000039961702,0.03601006,0.000041836873,0.022321634,0.000014767196,0.000027621694,0.02138326],"study_design_scores_gemma":[0.14645275,0.023346065,0.8062164,0.00064336625,0.00033182724,0.000013843194,0.013111149,0.0000021077622,0.009515713,0.0000127198,0.00008251529,0.0002715309],"about_ca_topic_score_codex":0.012673489,"about_ca_topic_score_gemma":0.0009385885,"teacher_disagreement_score":0.55713415,"about_ca_system_score_codex":0.0011778069,"about_ca_system_score_gemma":0.002497129,"threshold_uncertainty_score":0.9939012},"labels":[],"label_agreement":null},{"id":"W2015596469","doi":"10.1158/0008-5472.can-06-4801","title":"A Variant in the Cytochrome P450 Oxidoreductase Gene Is Associated with Breast Cancer Risk in African Americans","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"Breast cancer; Cytochrome P450; Oxidoreductase; Cancer; Gene; Medicine; Oncology; Internal medicine; Genetics; Biology; Enzyme; Biochemistry; Metabolism","score_opus":0.03823883600774599,"score_gpt":0.3734138633870154,"score_spread":0.3351750273792694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015596469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952065,0.0008435834,0.00016589946,0.0025282109,0.00002729472,0.0003702893,0.00037570755,0.00000407974,0.00047848708],"genre_scores_gemma":[0.9971217,0.0013832945,0.00014837772,0.0005159456,0.00019621408,0.0003063899,0.000053354932,0.00002227359,0.0002524401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974899,0.0006360275,0.00027766183,0.00045009068,0.0003287074,0.0008175791],"domain_scores_gemma":[0.99902,0.00016352213,0.000118111886,0.0003782678,0.00022117652,0.000098916535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033005609,0.00014360221,0.00022750709,0.0001632222,0.00013916745,0.000020576803,0.00037856036,0.00016120845,0.00008490436],"category_scores_gemma":[0.00029760887,0.000101137965,0.000046461504,0.0010380021,0.00029025288,0.0000035358632,0.000088696834,0.00047465446,0.0000038133785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011981915,0.00083606277,0.59435487,0.000024366926,0.00047787835,0.00044176826,0.00503316,0.002133113,0.3594603,0.00006251865,0.021462457,0.014515332],"study_design_scores_gemma":[0.0009223793,0.00022430558,0.9923546,0.000030048002,0.000015200833,0.00003819458,0.0012739613,0.000102558144,0.0023536782,0.00012827113,0.0023677326,0.00018907225],"about_ca_topic_score_codex":0.019278841,"about_ca_topic_score_gemma":0.027264385,"teacher_disagreement_score":0.39799973,"about_ca_system_score_codex":0.00030859702,"about_ca_system_score_gemma":0.000499442,"threshold_uncertainty_score":0.9904855},"labels":[],"label_agreement":null},{"id":"W2015597738","doi":"10.1158/0008-5472.can-10-2523","title":"Plasminogen Activator <i>uPA</i> Is a Direct Transcriptional Target of the JAG1-Notch Receptor Signaling Pathway in Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Notch signaling pathway; JAG1; Cancer research; Gene knockdown; Breast cancer; Biology; Urokinase receptor; Plasminogen activator; Metastasis; Signal transduction; Cancer; Medicine; Internal medicine; Endocrinology; Cell biology; Cell culture","score_opus":0.04206128287526834,"score_gpt":0.307020145675896,"score_spread":0.26495886280062764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015597738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679005,0.0012366627,0.000007294538,0.00041432783,0.0001816825,0.00022670123,0.00034160816,0.000003273053,0.0007983783],"genre_scores_gemma":[0.9982669,0.00024952285,0.00010445543,0.00013884797,0.00011960268,0.00016715509,0.000034534827,0.000013470352,0.0009055082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988539,0.00017005412,0.00017391755,0.00029685334,0.000221969,0.00028330047],"domain_scores_gemma":[0.99956375,0.000013177179,0.000047649777,0.00017756858,0.00014539552,0.00005246459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039593343,0.00010142,0.00011677209,0.000054702043,0.00009806545,0.000005045498,0.00025299305,0.0001574033,0.0008694718],"category_scores_gemma":[0.000013880128,0.000076467215,0.00006841101,0.00024696972,0.00020162098,0.000006699432,0.00007959461,0.00016401907,0.000005488359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054244744,0.000053570173,0.06319908,0.00002222527,0.0000483923,3.6873453e-7,0.00044369418,0.000013041315,0.9320999,0.000016223998,0.0015420882,0.0020189832],"study_design_scores_gemma":[0.00030001058,0.000033108707,0.07423316,0.00005147321,0.0000020967348,0.0000017648314,0.000074599884,0.0000029954938,0.9134487,0.00006363916,0.011697037,0.00009144965],"about_ca_topic_score_codex":0.0004263092,"about_ca_topic_score_gemma":0.00019418335,"teacher_disagreement_score":0.018651227,"about_ca_system_score_codex":0.00007085005,"about_ca_system_score_gemma":0.00047789927,"threshold_uncertainty_score":0.95201063},"labels":[],"label_agreement":null},{"id":"W2015643425","doi":"10.1158/1538-7445.am10-1133","title":"Abstract 1133: Inactivation of BRG1 in non-small cell lung cancer (NSCLC) cell lines","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Molecular biology; SWI/SNF; Chromatin remodeling; Point mutation; Gene; Mutation; Biology; SMARCA4; Chromatin; Cancer research; Genetics","score_opus":0.02875812891690767,"score_gpt":0.36806917544395623,"score_spread":0.3393110465270486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015643425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936718,0.0021024453,0.00008628247,0.00012207065,0.00024869107,0.00029208776,0.000031587304,0.0000059138806,0.003439135],"genre_scores_gemma":[0.99621785,0.0016541024,0.00015511524,0.000038132224,0.0005079097,0.00017115509,0.000026815296,0.00003149887,0.0011974399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987046,0.00003927279,0.00025304026,0.0003644807,0.0002683667,0.00037021248],"domain_scores_gemma":[0.99906814,0.000032497766,0.000087472945,0.00036743193,0.00036191434,0.000082518316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049267616,0.00012797833,0.000155299,0.00011951276,0.000062278355,0.000021705855,0.00028863474,0.00021777,0.00016801836],"category_scores_gemma":[0.000048979306,0.00012292789,0.00006083474,0.00024587318,0.00009809705,0.0000064618207,0.00010439269,0.0005046982,0.000004131355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009199516,0.000082617255,0.0063291565,0.0002906849,0.000008905169,0.0000013544663,0.00015879066,0.0007023548,0.98630726,0.0000036493038,0.0017663148,0.0042569293],"study_design_scores_gemma":[0.00067646813,0.000050904226,0.011188029,0.00010488675,0.000004805211,4.057839e-7,0.000100720994,0.000652943,0.98521334,0.000024285802,0.0018400789,0.00014310643],"about_ca_topic_score_codex":0.0044316924,"about_ca_topic_score_gemma":0.0029899916,"teacher_disagreement_score":0.0048588724,"about_ca_system_score_codex":0.00007328404,"about_ca_system_score_gemma":0.0006496309,"threshold_uncertainty_score":0.6699423},"labels":[],"label_agreement":null},{"id":"W2015780669","doi":"10.1158/0008-5472.can-06-3235","title":"IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth <i>In vivo</i>","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Angiogenesis; Biology; Signal transduction; Vascular endothelial growth factor; Cell biology; Vascular endothelial growth factor A; Unfolded protein response; Cancer research; Hypoxia-inducible factors; Hypoxia (environmental); Endoplasmic reticulum; Chemistry; Biochemistry","score_opus":0.02081380386750536,"score_gpt":0.3313516516987955,"score_spread":0.3105378478312901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015780669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947221,0.003257258,0.0008274408,0.0001964154,0.00006491181,0.0005885727,0.0002575932,0.0000069612565,0.0000787103],"genre_scores_gemma":[0.99841154,0.0005868197,0.0001886898,0.00023149948,0.0002664407,0.00019770101,0.000015711948,0.000029331346,0.000072270785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983903,0.000058006208,0.0002026854,0.00054666743,0.00025532898,0.0005469756],"domain_scores_gemma":[0.9991299,0.00012736139,0.00003407349,0.00017295763,0.00026394273,0.00027179363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004577186,0.00016263568,0.00019363085,0.00013719352,0.00015559443,0.00006324982,0.00014845304,0.00011930935,0.00002587573],"category_scores_gemma":[0.00033358677,0.00014813403,0.000079228295,0.00015861602,0.00009683498,0.000008666045,0.0001813123,0.00010015182,8.635282e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005365659,0.000036063328,0.0140312705,0.0001222516,0.00003442234,0.000009970267,0.000073327465,0.0000014436831,0.983698,0.000050868224,0.0011144051,0.00029142696],"study_design_scores_gemma":[0.0016510857,0.00012139288,0.001229889,0.00008732206,0.0000141389,0.0000017213833,0.00012938022,0.000010409178,0.9946123,0.00010096279,0.0018664171,0.00017501165],"about_ca_topic_score_codex":0.00032273523,"about_ca_topic_score_gemma":0.000058098794,"teacher_disagreement_score":0.012801381,"about_ca_system_score_codex":0.000034923614,"about_ca_system_score_gemma":0.00011396696,"threshold_uncertainty_score":0.604073},"labels":[],"label_agreement":null},{"id":"W2015930054","doi":"10.1158/0008-5472.can-07-6100","title":"Genetic Deletion of <i>mPGES-1</i> Suppresses Intestinal Tumorigenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"National Cancer Institute","keywords":"Colorectal cancer; Aberrant crypt foci; Azoxymethane; Cancer research; Cancer; Carcinogenesis; Medicine; Prostaglandin E2; Cyclooxygenase; Internal medicine; Biology; Enzyme; Biochemistry","score_opus":0.07969791047385742,"score_gpt":0.38386770580552604,"score_spread":0.3041697953316686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015930054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642944,0.002036724,0.00004226725,0.00020920228,0.00015982408,0.00034686748,0.0000055552027,0.000026493517,0.0007436314],"genre_scores_gemma":[0.9971981,0.0012132105,0.00027170256,0.00004412969,0.0005179413,0.00012946295,0.0000042624897,0.000023473416,0.00059771125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842066,0.00012905255,0.00020643274,0.0002102666,0.0006689069,0.00036467522],"domain_scores_gemma":[0.9987826,0.00019288385,0.00003981366,0.00027147666,0.00053622626,0.00017702264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004191316,0.000092767594,0.00022983635,0.00019767956,0.00011939979,0.000004367981,0.00011536574,0.000058743335,0.00044284435],"category_scores_gemma":[0.00033613513,0.00007743441,0.00005968781,0.0004022327,0.00032083844,0.000037704893,0.00004933137,0.00026740262,0.000058453814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006194102,0.00014317378,0.39823768,0.00082466844,0.000042209645,0.00061366806,0.00047813024,0.000033205008,0.5707371,0.00004493274,0.022120623,0.0061051934],"study_design_scores_gemma":[0.00088375405,0.0005318968,0.33288726,0.0002903312,0.000023312188,0.00024485355,0.0000476873,0.00008765589,0.6574371,0.00003207597,0.0074312873,0.000102784295],"about_ca_topic_score_codex":0.00044862024,"about_ca_topic_score_gemma":0.000023311273,"teacher_disagreement_score":0.08669999,"about_ca_system_score_codex":0.00011101787,"about_ca_system_score_gemma":0.0005984717,"threshold_uncertainty_score":0.48488352},"labels":[],"label_agreement":null},{"id":"W2015931889","doi":"10.1158/0008-5472.sabcs-09-4068","title":"A Quantitative Immunofluorescence Assay (AQUA) Suggests Significant Misclassification (15%) of Estrogen Receptor Status in Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estrogen receptor; Breast cancer; Estrogen; Cancer; Biology; Medicine; Oncology; Internal medicine","score_opus":0.04903312932946203,"score_gpt":0.4122431608567914,"score_spread":0.3632100315273294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015931889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992019,0.0023954527,0.0015274881,0.0028016043,0.00004524221,0.00060972,0.0003637176,0.000022055343,0.00021572782],"genre_scores_gemma":[0.9896583,0.005461403,0.0042878417,0.000048763715,0.00008472472,0.00018841516,0.00009981564,0.000017657307,0.00015310569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840987,0.00016778885,0.00026815265,0.00043219476,0.00028138762,0.00044059698],"domain_scores_gemma":[0.998854,0.00004202394,0.00010772193,0.00043281648,0.0004677203,0.00009575398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004884117,0.00012765617,0.00016165266,0.000111977206,0.000087833425,0.000018323153,0.00027773788,0.00013100407,0.00003439839],"category_scores_gemma":[0.00008926314,0.000122054036,0.000050057963,0.00050216296,0.0002610049,0.000008248792,0.000058523314,0.00025055674,0.0000043155396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027563682,0.00011277773,0.0022465258,0.000014340255,0.000011481942,8.2874175e-7,0.000056789268,0.000045472796,0.9767599,0.0013838495,0.0029212479,0.016171161],"study_design_scores_gemma":[0.000323228,0.00030787056,0.022542221,0.00013435331,0.0000047322037,0.0000019128702,0.00020278602,0.00013891449,0.9672369,0.00047855193,0.008440847,0.00018768154],"about_ca_topic_score_codex":0.00078363164,"about_ca_topic_score_gemma":0.00012779344,"teacher_disagreement_score":0.020295696,"about_ca_system_score_codex":0.0001637507,"about_ca_system_score_gemma":0.00041285602,"threshold_uncertainty_score":0.4977219},"labels":[],"label_agreement":null},{"id":"W2015996956","doi":"10.1158/1538-7445.am2011-5534","title":"Abstract 5534: Evaluation of clinical safety and immunogenicity of DPX-0907, a multi-epitope vaccine for the treatment of breast, ovarian and prostate cancers","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Immunovaccine (Canada)","funders":"","keywords":"Medicine; Immunogenicity; Immune system; Cancer vaccine; Vaccination; Peptide vaccine; Prostate cancer; Immunology; Antigen; Population; Cancer; Vaccine therapy; Epitope; Immunotherapy; Oncology; Internal medicine","score_opus":0.21979347273758315,"score_gpt":0.4640692563681058,"score_spread":0.24427578363052266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015996956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327175,0.06526685,0.000025271489,0.00013155097,0.00018912797,0.0013521786,0.00027779306,0.0000039329225,0.000035823592],"genre_scores_gemma":[0.96038294,0.039066266,0.00006033076,0.000005817848,0.000018062836,0.00018455292,0.000013548351,0.0000126388595,0.00025584208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981025,0.0006548952,0.0006458355,0.00023009164,0.00009986224,0.0002668518],"domain_scores_gemma":[0.9977473,0.00093216763,0.00026650442,0.0003394283,0.0006972417,0.000017339682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037624168,0.000120642864,0.00043501676,0.000095103394,0.0001670471,0.0000039842703,0.0001646241,0.00014639038,0.0003513272],"category_scores_gemma":[0.0001795509,0.00007729545,0.000110088986,0.00012917939,0.00065606326,0.000059102185,0.000043738586,0.00016842039,0.0000011025938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039704952,0.00054692815,0.012327167,0.00010359052,0.0013401998,3.0458725e-7,0.004973128,0.000008413227,0.4745746,0.00007381854,0.000057289424,0.46628964],"study_design_scores_gemma":[0.011070638,0.0018073759,0.69162166,0.00010444576,0.00014968745,0.00000845155,0.00070866325,0.000059200782,0.29051912,0.00005040485,0.003813307,0.000087055734],"about_ca_topic_score_codex":0.010544072,"about_ca_topic_score_gemma":0.00058317464,"teacher_disagreement_score":0.67929447,"about_ca_system_score_codex":0.00010127409,"about_ca_system_score_gemma":0.00064152305,"threshold_uncertainty_score":0.9960448},"labels":[],"label_agreement":null},{"id":"W2016133306","doi":"10.1158/0008-5472.can-14-2643-t","title":"Serine Deprivation Enhances Antineoplastic Activity of Biguanides","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Biguanide; Phenformin; Metformin; Serine; Pharmacology; Oxidative phosphorylation; Medicine; Cancer; Chemistry; Phosphorylation; Biochemistry; Diabetes mellitus; Endocrinology; Internal medicine","score_opus":0.03734112941835305,"score_gpt":0.36861544070147095,"score_spread":0.3312743112831179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016133306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791331,0.019020636,0.0008974078,0.000046002322,0.00015997217,0.00010559506,0.000011813556,0.0000058412443,0.00061960466],"genre_scores_gemma":[0.98176706,0.017239021,0.00007357977,0.000035002602,0.00045792112,0.000063042506,0.000011251768,0.000014229362,0.0003388815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989543,0.00013902696,0.00011682913,0.000259366,0.00026214562,0.0002683387],"domain_scores_gemma":[0.9993044,0.00004195493,0.000052865893,0.00028094088,0.00025930727,0.000060521656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000547419,0.00008081803,0.00013805988,0.000065109285,0.000070787515,0.000014364855,0.0001897585,0.00007308709,0.00011797244],"category_scores_gemma":[0.00029891825,0.000072536175,0.000039870236,0.00021416342,0.00014243588,0.000005559901,0.000096795855,0.00010851916,0.000009311585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007509203,0.00003403353,0.0013982012,0.0000709863,0.000018667653,1.01343396e-7,0.000015111197,0.000028033352,0.8655013,0.00013237495,0.00080657646,0.13191955],"study_design_scores_gemma":[0.00026810204,0.000112613714,0.00631671,0.00001886412,0.0000043130503,2.6625648e-7,0.00000936223,0.000046759375,0.85881937,0.00010885448,0.13422348,0.0000712876],"about_ca_topic_score_codex":0.00013337735,"about_ca_topic_score_gemma":0.00016823287,"teacher_disagreement_score":0.1334169,"about_ca_system_score_codex":0.000013794379,"about_ca_system_score_gemma":0.00012924963,"threshold_uncertainty_score":0.29579395},"labels":[],"label_agreement":null},{"id":"W2016183508","doi":"10.1158/1538-7445.am2011-5024","title":"Abstract 5024: Effects of aerobic training to improve cardiovascular function and prevent cardiac remodeling after cytotoxic therapy in early breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ejection fraction; Aerobic exercise; Doxorubicin; Cardiology; Internal medicine; Placebo; Mitochondrial biogenesis; Endocrinology; Heart failure; Treadmill; Chemotherapy; Mitochondrion; Pathology; Chemistry","score_opus":0.056254489712686824,"score_gpt":0.32662085476159947,"score_spread":0.27036636504891265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016183508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906567,0.007062888,0.00007884043,0.000095631636,0.00020859459,0.0017139666,0.000017014187,0.000020585823,0.00014583257],"genre_scores_gemma":[0.99581325,0.0025518762,0.00006509112,0.000091273985,0.000336845,0.0010376811,0.0000022944007,0.00004473649,0.00005696247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981062,0.0001465201,0.00025360365,0.0004565994,0.0005949229,0.00044220203],"domain_scores_gemma":[0.99907863,0.000061695915,0.000038551338,0.00037602743,0.000250597,0.00019446982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011359539,0.00016598872,0.00048658438,0.0002965285,0.000053500113,0.000017833938,0.00007660965,0.00015854144,0.00006270695],"category_scores_gemma":[0.000029900988,0.0001511889,0.00022703595,0.00041402926,0.000087213164,0.00013717166,0.000035375833,0.0004749201,0.0000030770016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013467239,0.000063619365,0.004554305,0.00032202344,0.00039311714,0.000012969355,0.0056479196,0.00003699519,0.83039767,0.0000059357862,0.000014277398,0.15720445],"study_design_scores_gemma":[0.0017003876,0.00037418812,0.44584468,0.00089816033,0.0000570381,0.00000473628,0.00025344142,0.000011880274,0.55050546,0.00008436745,0.000121336576,0.0001443012],"about_ca_topic_score_codex":0.0038440917,"about_ca_topic_score_gemma":0.000103098726,"teacher_disagreement_score":0.44129038,"about_ca_system_score_codex":0.00034542207,"about_ca_system_score_gemma":0.00030274,"threshold_uncertainty_score":0.6165304},"labels":[],"label_agreement":null},{"id":"W2016194889","doi":"10.1158/0008-5472.can-03-2733","title":"The Tumor Invasion Inhibitor Dihydromotuporamine C Activates RHO, Remodels Stress Fibers and Focal Adhesions, and Stimulates Sodium–Proton Exchange","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Stress fiber; Focal adhesion; Cytoskeleton; Chemistry; Exoenzyme; Actin; 3T3 cells; Cell; Biophysics; Cell biology; Biochemistry; Biology; Enzyme","score_opus":0.07319950636054777,"score_gpt":0.3912342132016256,"score_spread":0.3180347068410778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016194889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804393,0.008828387,0.0000058118785,0.008694749,0.000048721795,0.0016161638,0.000030342077,0.000039580114,0.00029695037],"genre_scores_gemma":[0.98593336,0.010964151,0.00010299084,0.00009574238,0.00037676017,0.00038600492,0.000016634503,0.000049287657,0.0020750684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973092,0.00015720504,0.00025023014,0.00054132834,0.00094360753,0.0007984174],"domain_scores_gemma":[0.9982661,0.00047271873,0.000042128137,0.00042799176,0.0003172997,0.00047376717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010130383,0.00020671786,0.0002983466,0.00022138872,0.00068521104,0.00017038331,0.00018665179,0.00011391653,0.00007760521],"category_scores_gemma":[0.00039537525,0.00013286207,0.00004725794,0.0004711037,0.00074073987,0.00020532923,0.00049427635,0.00091171055,0.000013562348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053581926,0.0007706253,0.030584646,0.0046380893,0.00028900377,0.0008808412,0.0030109393,0.00008293618,0.73525846,0.00045140518,0.007489036,0.21118584],"study_design_scores_gemma":[0.0068900776,0.0024464154,0.008766036,0.0022635725,0.00004091089,0.00013786844,0.0015512806,0.0010607204,0.9462449,0.002806237,0.02735707,0.00043494414],"about_ca_topic_score_codex":0.0019751536,"about_ca_topic_score_gemma":0.00031826957,"teacher_disagreement_score":0.21098644,"about_ca_system_score_codex":0.00024044453,"about_ca_system_score_gemma":0.00042749662,"threshold_uncertainty_score":0.5417958},"labels":[],"label_agreement":null},{"id":"W2016224591","doi":"10.1158/0008-5472.can-06-1396","title":"Tumor-Suppressive Effects of Pannexin 1 in C6 Glioma Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Pannexin; Gap junction; Connexin; Biology; Cell biology; Transfection; Cell culture; Intracellular; Cell growth; Molecular biology; Biochemistry","score_opus":0.02174735407820134,"score_gpt":0.37200373600980047,"score_spread":0.35025638193159914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016224591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953392,0.0031806203,0.00007958316,0.000074379124,0.00015360942,0.000262205,0.0000116878755,0.0000033545068,0.00089536293],"genre_scores_gemma":[0.9990221,0.00022848422,0.000042566033,0.000058175152,0.00017887166,0.00004699312,0.000010297654,0.000014513599,0.00039797928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987226,0.00014858907,0.00018224963,0.00030590073,0.00016274999,0.00047791796],"domain_scores_gemma":[0.99932206,0.00009572809,0.000040203133,0.00029651704,0.00016280107,0.00008267449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071743835,0.00009216887,0.00014960566,0.000169986,0.00003635102,0.0000061844535,0.00024441924,0.00013030328,0.000056179244],"category_scores_gemma":[0.00012855351,0.00008286107,0.000050479244,0.00027621313,0.00027649992,0.000001824162,0.00017535193,0.00020551446,0.000009048484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028440228,0.000058159334,0.0020261873,0.000070415226,0.000012964127,0.000089624366,0.00008117541,0.000006680844,0.9901565,0.00010792525,0.0015603682,0.005545644],"study_design_scores_gemma":[0.00061654375,0.00036163145,0.005732163,0.000043134365,0.0000019870286,0.0000065080194,0.000103308346,0.0000034609527,0.97796476,0.00007047583,0.015004618,0.00009140589],"about_ca_topic_score_codex":0.00037112375,"about_ca_topic_score_gemma":0.00047312648,"teacher_disagreement_score":0.0134442495,"about_ca_system_score_codex":0.00003435576,"about_ca_system_score_gemma":0.00013741825,"threshold_uncertainty_score":0.33789766},"labels":[],"label_agreement":null},{"id":"W2016320036","doi":"10.1158/0008-5472.can-06-1042","title":"Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Vanderbilt University","keywords":"Epidermal growth factor receptor; Geldanamycin; Hsp90; Mutant; Ubiquitin ligase; Cell biology; Tyrosine kinase; GRB2; Receptor; Signal transducing adaptor protein; Receptor tyrosine kinase; Biology; Epidermal growth factor; Cancer research; Growth factor receptor; Phosphorylation; Chemistry; Molecular biology; Signal transduction; Ubiquitin; Biochemistry; Heat shock protein","score_opus":0.025130404649052876,"score_gpt":0.3290442043960595,"score_spread":0.30391379974700666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016320036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968645,0.00033886728,0.00018649585,0.0008871835,0.000053751668,0.00061156956,0.00009893404,0.0000125298375,0.0009461603],"genre_scores_gemma":[0.9963568,0.00017829263,0.000099578414,0.000017629947,0.00034824753,0.00017235681,0.0002431656,0.000036268717,0.002547685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716145,0.00040923792,0.0002914498,0.00040901697,0.0010985115,0.00063034944],"domain_scores_gemma":[0.9981516,0.00009892052,0.000100404715,0.00029229288,0.0012333426,0.00012343102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096947,0.00013926974,0.00018573411,0.00020013803,0.00013609011,0.000033277793,0.0002206309,0.00026369444,0.0002978982],"category_scores_gemma":[0.00064292114,0.00011883533,0.00005263095,0.0006121563,0.00015793821,0.0000133350095,0.00012950275,0.00033671912,0.000028921017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022910415,0.00006117719,0.047529195,0.00005770465,0.000049313647,0.0000017851054,0.000034402758,0.00006296525,0.9472623,0.00003572318,0.004058309,0.00061803294],"study_design_scores_gemma":[0.0006881684,0.00031127027,0.03515517,0.000042395422,0.0000041346566,0.0000013748273,0.00002438825,0.000027488268,0.9570096,0.00005173568,0.0065504992,0.00013378279],"about_ca_topic_score_codex":0.0019756246,"about_ca_topic_score_gemma":0.0007074022,"teacher_disagreement_score":0.012374026,"about_ca_system_score_codex":0.00034939506,"about_ca_system_score_gemma":0.00059178844,"threshold_uncertainty_score":0.4845964},"labels":[],"label_agreement":null},{"id":"W2016425492","doi":"10.1158/1538-7445.am2011-4035","title":"Abstract 4035: The breast cancer associated gene 2 (BCA2) binds to Ubc9 and is involved in sumoylation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"SUMO protein; Ubiquitin ligase; Ubiquitin; Cell biology; Chemistry; Subcellular localization; DNA ligase; Target protein; Biochemistry; Lysine; Molecular biology; Cytoplasm; Biology; Gene","score_opus":0.09963653521215896,"score_gpt":0.3634556058618546,"score_spread":0.2638190706496957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016425492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629873,0.0012596062,0.0000029281193,0.0009500952,0.000060276845,0.00035131534,0.00021298055,0.0000062911936,0.00085776806],"genre_scores_gemma":[0.9973642,0.0010744105,0.000015148668,0.0004263571,0.00016714675,0.00042088045,0.00002412368,0.000019745064,0.00048798794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877834,0.00011463738,0.00013891977,0.00031212415,0.00022816501,0.0004277867],"domain_scores_gemma":[0.9993792,0.000018912328,0.000034955006,0.00023631664,0.00020297276,0.00012764958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008633839,0.00010057581,0.00010003539,0.000080545935,0.00012168031,0.00003295822,0.00021672243,0.00013793638,0.0004484635],"category_scores_gemma":[0.00006939769,0.00007850212,0.00002513567,0.00028214158,0.00010226888,0.0000058755645,0.00015219323,0.00023656458,0.000014464699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025563684,0.00005021179,0.07021257,0.000022691971,0.000040927036,0.0000036481863,0.0018771611,0.0000048368497,0.9148909,0.000017995346,0.003022572,0.009600872],"study_design_scores_gemma":[0.00044997575,0.000102858845,0.3855082,0.00004616691,0.0000030500494,0.0000015319399,0.0002640791,0.000013815381,0.60837775,0.00016179428,0.004926079,0.00014469051],"about_ca_topic_score_codex":0.0039367685,"about_ca_topic_score_gemma":0.0030971214,"teacher_disagreement_score":0.31529564,"about_ca_system_score_codex":0.00011320334,"about_ca_system_score_gemma":0.00024067682,"threshold_uncertainty_score":0.59512424},"labels":[],"label_agreement":null},{"id":"W2016698729","doi":"10.1158/1538-7445.am10-3277","title":"Abstract 3277: The Fps/Fes protein-tyrosine kinase serves a stromal tissue-specific supporting role in an orthotopic mouse model of breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Metastasis; Carcinogenesis; Stromal cell; Angiogenesis; Mammary tumor; Biology; Cancer; Pathology; Medicine; Breast cancer; Internal medicine","score_opus":0.04562214584898767,"score_gpt":0.3884515271412491,"score_spread":0.3428293812922614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016698729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965631,0.0013437489,0.0000049008036,0.0004455016,0.000038104623,0.000870277,0.0005730656,0.000008875105,0.00015243841],"genre_scores_gemma":[0.99719083,0.00045896496,0.00008470276,0.000015962507,0.00028615652,0.00085033843,0.0000726359,0.00004038999,0.0010000145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997799,0.00010444915,0.000296638,0.0005114268,0.00054136995,0.0007471309],"domain_scores_gemma":[0.9986477,0.000016877226,0.000088466375,0.00067534664,0.0003606476,0.00021099228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006248603,0.0001798102,0.00019434596,0.000118500444,0.00017353665,0.00007983796,0.0005317056,0.00014277357,0.0003838961],"category_scores_gemma":[0.000037762537,0.0001359355,0.000064768436,0.00024467177,0.0003265193,0.00002616049,0.00021799217,0.0005899679,0.000004645641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047036502,0.00022143585,0.017573332,0.0000649332,0.00003183763,0.000011443166,0.00014150146,0.0002448162,0.96665716,0.00006140753,0.0001761768,0.014345558],"study_design_scores_gemma":[0.0009062783,0.00022071392,0.03206473,0.000048959046,0.000003964838,0.0000034417176,0.00017715697,0.00021127822,0.9650166,0.00011288183,0.0010793351,0.00015468388],"about_ca_topic_score_codex":0.008890352,"about_ca_topic_score_gemma":0.04321542,"teacher_disagreement_score":0.034325067,"about_ca_system_score_codex":0.00008119151,"about_ca_system_score_gemma":0.00072088384,"threshold_uncertainty_score":0.9977095},"labels":[],"label_agreement":null},{"id":"W2016701073","doi":"10.1158/0008-5472.can-08-0085","title":"Epigenetic Inactivation of the Groucho Homologue Gene <i>TLE1</i> in Hematologic Malignancies","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Ministerio de Economía y Competitividad","keywords":"Epigenetics; Biology; Gene; Cancer; Genetics; Cancer research","score_opus":0.0763513671295902,"score_gpt":0.3565755400875923,"score_spread":0.28022417295800206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016701073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291724,0.0059457123,0.00021427989,0.00023385134,0.000086228356,0.00025181286,0.000009746119,0.0000027525737,0.00033839035],"genre_scores_gemma":[0.9947807,0.004518011,0.00012738511,0.000034604433,0.000072754476,0.000095908996,0.000013917713,0.000012231352,0.0003444578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879736,0.00023459861,0.00020321061,0.00024166875,0.00026408082,0.00025905736],"domain_scores_gemma":[0.99930745,0.000037866863,0.00006419382,0.00035301378,0.00020324846,0.00003421537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004277095,0.00008084434,0.00011793932,0.00007830098,0.00011830815,0.000005445437,0.00026254758,0.00012668355,0.000016273263],"category_scores_gemma":[0.0002009643,0.0000616616,0.000049775885,0.00036580442,0.0002861619,0.0000030320173,0.00014962858,0.00015408704,0.000002654913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029258432,0.000039154755,0.04022313,0.000016611566,0.000007266146,0.0000032916894,0.00009704108,0.0002814822,0.95871156,0.000069375565,0.00014332081,0.00037853335],"study_design_scores_gemma":[0.00021474218,0.00008916829,0.09965516,0.000016075617,0.0000016248908,0.000003928866,0.000034885445,0.000009795618,0.8977869,0.00048345164,0.0016400899,0.0000641471],"about_ca_topic_score_codex":0.00035801213,"about_ca_topic_score_gemma":0.0002466265,"teacher_disagreement_score":0.060924605,"about_ca_system_score_codex":0.000048116784,"about_ca_system_score_gemma":0.00021217488,"threshold_uncertainty_score":0.25144872},"labels":[],"label_agreement":null},{"id":"W2016705807","doi":"10.1158/1538-7445.am2011-5255","title":"Abstract 5255: The role of IGF1 signaling in site specific tumor metastasis: Regulating matrix metalloproteinase (MMP) expression","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Matrix metalloproteinase; Metastasis; Cancer research; IκB kinase; Ectopic expression; Signal transduction; Downregulation and upregulation; Biology; NF-κB; Cell biology; Cell culture; Chemistry; Cancer; Gene; Genetics","score_opus":0.05659076197896009,"score_gpt":0.34270580962123903,"score_spread":0.28611504764227896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016705807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544122,0.043425977,0.000018371893,0.000029959463,0.00016440888,0.00043889438,0.000045051045,0.00000681975,0.0014583245],"genre_scores_gemma":[0.99659985,0.0014002612,0.0006849525,0.00001662416,0.00071304967,0.00021191656,0.000015929538,0.000034806606,0.00032263104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980554,0.00022595152,0.0003542508,0.00043100794,0.00044654575,0.00048684585],"domain_scores_gemma":[0.9989434,0.0000365736,0.00013061729,0.0005688375,0.00022052218,0.000100070225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015469199,0.00015774615,0.00023866523,0.00013592961,0.0001339437,0.000028291872,0.00040753587,0.0000929197,0.0004079907],"category_scores_gemma":[0.000100192694,0.00011852398,0.00012723422,0.00029761082,0.00019828409,0.00001098549,0.00022855542,0.00034290363,0.000010820218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034079325,0.000056273337,0.00036901928,0.000045720037,0.000027869684,0.0000034184773,0.00048761483,0.00007162586,0.9898571,0.00009330043,0.00039644202,0.008250864],"study_design_scores_gemma":[0.0004198686,0.00005566518,0.0018298673,0.000095544034,0.00001033707,0.0000033002348,0.0008559158,0.000007673235,0.93492854,0.00031227383,0.061351515,0.00012949316],"about_ca_topic_score_codex":0.0012227895,"about_ca_topic_score_gemma":0.00026024485,"teacher_disagreement_score":0.060955074,"about_ca_system_score_codex":0.00003662057,"about_ca_system_score_gemma":0.00019351464,"threshold_uncertainty_score":0.4833268},"labels":[],"label_agreement":null},{"id":"W2016761742","doi":"10.1158/1538-7445.am2014-2988","title":"Abstract 2988: Microenvironmental distribution of trastuzumab is heterogeneous and decreases sharply when administered following a single dose of bevacizumab in Her2+ve xenografts and metastases models","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trastuzumab; Medicine; Context (archaeology); Distribution (mathematics); Bevacizumab; Tumor microenvironment; CD31; Pathology; Perfusion; Cancer; Cancer research; Breast cancer; Immunohistochemistry; Internal medicine; Chemotherapy; Biology","score_opus":0.04313930601089163,"score_gpt":0.3248451702347699,"score_spread":0.2817058642238783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016761742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98150253,0.017543849,0.00008032536,0.000040922238,0.00006853266,0.00026990587,0.00045690898,0.0000025357062,0.00003450028],"genre_scores_gemma":[0.99714535,0.0023316324,0.00011461027,0.000026146578,0.00012486138,0.00005528934,0.00015071782,0.0000193761,0.000031995223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986652,0.00010590419,0.00027519357,0.00038741133,0.0002521267,0.00031414616],"domain_scores_gemma":[0.999465,0.000033882232,0.000078902944,0.00024283839,0.000049425656,0.00012996898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003403481,0.0001446782,0.00028217156,0.000075016476,0.000059283637,0.000023930537,0.00012780928,0.00009412859,0.000020299627],"category_scores_gemma":[0.00005503959,0.00014364242,0.00008819234,0.00007705125,0.00024156846,0.000014952843,0.00015010049,0.00010064792,3.0670947e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056685676,0.00020635827,0.00090324954,0.00013217899,0.00009417818,0.000002781142,0.00037387473,0.000046848145,0.9743648,0.000006424391,0.00030174165,0.023000669],"study_design_scores_gemma":[0.002362371,0.00065299944,0.0058264714,0.0001372576,0.000053805652,0.000018442825,0.00030393573,0.000098396085,0.9816253,0.00020537576,0.008507364,0.00020825396],"about_ca_topic_score_codex":0.00079417636,"about_ca_topic_score_gemma":0.0004963264,"teacher_disagreement_score":0.022792416,"about_ca_system_score_codex":0.000053928976,"about_ca_system_score_gemma":0.0000983882,"threshold_uncertainty_score":0.5857568},"labels":[],"label_agreement":null},{"id":"W2016892262","doi":"10.1158/1538-7445.am10-198","title":"Abstract 198: Two novel insertion polymorphisms of the BRM gene are associated with loss of BRM expression and lung cancer risk","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Lung cancer; Cancer research; Gene silencing; Cancer; Chromatin remodeling; Cell cycle; Chromatin; Genetics; Gene; Molecular biology; Medicine; Oncology","score_opus":0.02462960578409523,"score_gpt":0.3448729653028784,"score_spread":0.3202433595187832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016892262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670863,0.0024689718,0.00005038581,0.00012747085,0.0001170195,0.00020097391,0.00022323681,0.0000043036757,0.00009900303],"genre_scores_gemma":[0.9985422,0.0009243102,0.00006631824,0.000020807302,0.00014776103,0.00005244552,0.000014400388,0.000017200717,0.00021457089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988425,0.000053469346,0.00017716936,0.0002657906,0.00042877713,0.00023233044],"domain_scores_gemma":[0.9988951,0.000028230656,0.00020906307,0.00034781964,0.00045675077,0.000063017804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040407528,0.00010327776,0.00014422594,0.000037617625,0.00012897224,0.000012477844,0.00020946549,0.00015445735,0.000042311356],"category_scores_gemma":[0.000117503994,0.000069528156,0.000046199097,0.00015722471,0.00029567006,0.0000055430164,0.00012210872,0.0003973563,1.4880688e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015183898,0.000052771895,0.062096745,0.000045655663,0.000051634972,3.925821e-7,0.00008113244,0.00047059188,0.93576473,0.0000031804498,0.00025802592,0.0010233169],"study_design_scores_gemma":[0.00088360667,0.000038256767,0.12194933,0.00025203114,0.000017694547,0.0000016241407,0.00003420605,0.0002608975,0.8763091,0.000012823022,0.0001553261,0.000085082],"about_ca_topic_score_codex":0.0032836916,"about_ca_topic_score_gemma":0.0036944665,"teacher_disagreement_score":0.059852585,"about_ca_system_score_codex":0.000043001,"about_ca_system_score_gemma":0.0002963872,"threshold_uncertainty_score":0.49639812},"labels":[],"label_agreement":null},{"id":"W2016963394","doi":"10.1158/1538-7445.am2012-462","title":"Abstract 462: Fer protein-tyrosine kinase promotes lung tumor progression and metastases","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Biology; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Lung cancer; Receptor tyrosine kinase; Epidermal growth factor receptor; Cancer; Kinase; Pathology; Medicine; Signal transduction; Cell biology","score_opus":0.09470060349463752,"score_gpt":0.4543773971826142,"score_spread":0.35967679368797667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016963394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635432,0.027447216,0.0000020492705,0.004245864,0.0000587094,0.0016632103,0.00006185818,0.000044365897,0.0029335278],"genre_scores_gemma":[0.9926434,0.00049945974,0.00046202375,0.00009880048,0.00068936765,0.0005957623,0.000035883626,0.000042169555,0.0049330983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678105,0.00016601538,0.0002501043,0.000377829,0.001289961,0.001135061],"domain_scores_gemma":[0.998344,0.0001647998,0.000045508226,0.00030219517,0.00039527635,0.00074820063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015469457,0.0002038414,0.00032359446,0.0002634869,0.00035652443,0.00008057981,0.00015304456,0.00007524016,0.001677371],"category_scores_gemma":[0.00032506417,0.00013615497,0.000073772826,0.00043461565,0.0004917148,0.00024721352,0.00027603094,0.00081825716,0.00010125241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022456038,0.00090332667,0.09169028,0.0028998628,0.00016783355,0.00035438035,0.00036950212,2.516921e-7,0.8342122,0.0014268723,0.010920768,0.054809127],"study_design_scores_gemma":[0.0016499702,0.0006905238,0.20649144,0.0017255684,0.000050478866,0.00014660953,0.00016516703,0.000057788136,0.67977893,0.00016536994,0.10872614,0.0003519819],"about_ca_topic_score_codex":0.0005268068,"about_ca_topic_score_gemma":0.000020034766,"teacher_disagreement_score":0.15443324,"about_ca_system_score_codex":0.00014325058,"about_ca_system_score_gemma":0.0003263446,"threshold_uncertainty_score":0.9992352},"labels":[],"label_agreement":null},{"id":"W2017146972","doi":"10.1158/0008-5472.can-04-2269","title":"Development of Magnetic Resonance Imaging Contrast Material for <i>In vivo</i> Mapping of Tissue Transglutaminase Activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood properties and coagulation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Tissue transglutaminase; Magnetic resonance imaging; In vivo; Nuclear magnetic resonance; Contrast (vision); Pathology; Chemistry; Medicine; Radiology; Enzyme; Biology; Optics; Physics","score_opus":0.060894636457544796,"score_gpt":0.3572137818963044,"score_spread":0.29631914543875965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017146972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952028,0.0027234803,0.0002676905,0.0007894036,0.00004057786,0.0007013525,0.000034798693,0.0000058009928,0.00023413122],"genre_scores_gemma":[0.9964016,0.000075122254,0.0027718407,0.00002289307,0.00011041068,0.00018228815,0.000002661917,0.0000132435825,0.00041994025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902767,0.000037457903,0.00024060681,0.00016044217,0.00027301186,0.0002608231],"domain_scores_gemma":[0.9995906,0.000038371138,0.0000342351,0.0001200847,0.00017199673,0.0000447565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052186265,0.00006411777,0.00020993325,0.000112469366,0.000042772088,0.0000060453053,0.00006675287,0.00003396658,0.00024797276],"category_scores_gemma":[0.000022234106,0.00005779455,0.000022138389,0.00017192922,0.0000862774,0.00005843276,0.00002035538,0.0000929,8.835368e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007329114,0.00006368333,0.0006678784,0.00028947898,0.0000030046504,0.0000011575911,0.0009200123,0.0000033610795,0.64836216,0.000011426502,0.000082887746,0.34886205],"study_design_scores_gemma":[0.0016282512,0.000098372664,0.015075172,0.00039351833,0.0000065327163,0.0000016466773,0.0001954861,0.00037417596,0.94201607,0.000007926912,0.04014773,0.000055142857],"about_ca_topic_score_codex":0.00025685446,"about_ca_topic_score_gemma":0.0002451487,"teacher_disagreement_score":0.34880692,"about_ca_system_score_codex":0.0001258347,"about_ca_system_score_gemma":0.00030833803,"threshold_uncertainty_score":0.2715128},"labels":[],"label_agreement":null},{"id":"W2017558890","doi":"10.1158/1538-7445.am2012-666","title":"Abstract 666: The effect of comorbidity, smoking and alcohol on survival of head and neck cancer anatomic subsites: A retrospective analysis of 4689 patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Charlson comorbidity index; Head and neck cancer; Cancer; Retrospective cohort study; Population; Surgery","score_opus":0.09146974711314432,"score_gpt":0.44720544075016777,"score_spread":0.35573569363702345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017558890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920826,0.006208851,2.4539773e-7,0.00018157253,0.00009825591,0.0004943475,0.00016798766,0.0000049518617,0.0007612148],"genre_scores_gemma":[0.99658984,0.0031904841,0.0000019200897,0.000018704119,0.00008006099,0.0000708844,0.0000064553683,0.000015127996,0.000026546457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981157,0.0001879315,0.00028829725,0.00023850737,0.00079814263,0.0003714235],"domain_scores_gemma":[0.9984135,0.00065309997,0.00013950553,0.00028324395,0.00038682515,0.0001238261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001383698,0.00013862342,0.0008057001,0.00034734874,0.00010611738,0.000006558973,0.00009865093,0.00007026788,0.000098654564],"category_scores_gemma":[0.00026237388,0.000087739405,0.0001033542,0.00096566376,0.00049961865,0.000061699946,0.00011801741,0.00036170633,3.7249893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081942347,0.00009519092,0.9869547,0.00044010268,0.0013286386,0.0000010207518,0.001568815,0.0000048952115,0.0043836394,0.000027018159,0.00024028959,0.0041362816],"study_design_scores_gemma":[0.0018662243,0.0009483762,0.9708729,0.00047429762,0.0004747996,2.1761907e-7,0.00017289436,0.000029170447,0.025011064,0.000005194146,0.000078128694,0.000066739274],"about_ca_topic_score_codex":0.0077544376,"about_ca_topic_score_gemma":0.0017713072,"teacher_disagreement_score":0.020627426,"about_ca_system_score_codex":0.0002334243,"about_ca_system_score_gemma":0.0000941851,"threshold_uncertainty_score":0.998853},"labels":[],"label_agreement":null},{"id":"W2017905687","doi":"10.1158/0008-5472.can-09-1298","title":"Up-regulation of <i>miR-200</i> and <i>let-7</i> by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":658,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Gemcitabine; Pancreatic cancer; Vimentin; Epithelial–mesenchymal transition; microRNA; Cancer research; Slug; Cancer; Biology; Transfection; Cancer cell; Mesenchymal stem cell; Cell biology; Metastasis; Immunology; Cell culture; Immunohistochemistry; Gene; Genetics","score_opus":0.01613831642948406,"score_gpt":0.31886724326413085,"score_spread":0.3027289268346468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017905687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940744,0.002735738,0.0001069224,0.0019970015,0.00008583929,0.00069299375,0.00026604393,0.0000030969727,0.00003798961],"genre_scores_gemma":[0.99863434,0.00038709672,0.00006715143,0.00026981052,0.00010604705,0.00007280078,0.000064249325,0.000014459681,0.00038405624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985361,0.00018595882,0.000273269,0.00032039592,0.00038699072,0.00029725165],"domain_scores_gemma":[0.99929523,0.000023694642,0.00006413686,0.0002818886,0.00023758544,0.00009744157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046637107,0.000120049655,0.00017539362,0.000109350236,0.000058837984,0.000014355691,0.00018518316,0.00008862018,0.00003155312],"category_scores_gemma":[0.000047075995,0.00010070318,0.000047976795,0.0003934196,0.000105777384,0.000009911723,0.000047114696,0.00012052875,0.0000017438676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075909507,0.000037157202,0.0003561269,0.000067735615,0.000016444454,6.2993564e-7,0.00034936547,0.0010017989,0.9854715,0.00001123423,0.01003449,0.0018944546],"study_design_scores_gemma":[0.00065378327,0.00022271439,0.029581843,0.00014007273,0.000016682341,7.705442e-7,0.000065359294,0.00015880159,0.9655867,0.000029478502,0.0034254594,0.00011829042],"about_ca_topic_score_codex":0.0006527238,"about_ca_topic_score_gemma":0.00039458447,"teacher_disagreement_score":0.029225716,"about_ca_system_score_codex":0.000093922354,"about_ca_system_score_gemma":0.00015032914,"threshold_uncertainty_score":0.41065565},"labels":[],"label_agreement":null},{"id":"W2017994145","doi":"10.1158/1538-7445.am2014-1183","title":"Abstract 1183: Establishment,characterization and utilization of models of central nervous system metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Pathology; Metastasis; Medicine; Lung; Malignancy; Brain metastasis; Squamous-cell carcinoma of the lung; Lung cancer; Breast cancer; Cancer; Breast carcinoma; Carcinoma; Small Cell Lung Carcinoma; Cancer research; Small-cell carcinoma; Internal medicine","score_opus":0.13064291804524134,"score_gpt":0.38883218386518265,"score_spread":0.2581892658199413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017994145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926676,0.0006038856,0.005359693,0.00020091377,0.000055786284,0.00047956666,0.00013734147,0.000013757962,0.0004814499],"genre_scores_gemma":[0.9988678,0.0005333768,0.0002724034,0.000011639626,0.000052764764,0.000042446372,0.000119535674,0.000015465366,0.000084584135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987066,0.00012227414,0.00026346356,0.00019602566,0.0004713836,0.00024025314],"domain_scores_gemma":[0.99911594,0.00007690397,0.00010309272,0.00023009612,0.00034959064,0.00012437411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066109246,0.00008303103,0.00027550597,0.00016484785,0.000046973095,0.000015276155,0.00005420828,0.000045145287,0.00006783255],"category_scores_gemma":[0.000054056447,0.00006616767,0.000043698554,0.00026493255,0.00009716914,0.00012123812,0.000036018442,0.00009730957,0.0000010235912],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013269971,0.00081212335,0.021886311,0.008537422,0.0006996658,0.000026175216,0.0017817342,0.0010680773,0.32885927,0.02712107,0.00040550064,0.60747564],"study_design_scores_gemma":[0.0067644822,0.0016011051,0.54264873,0.0025053672,0.0006348473,0.000036117697,0.0016454754,0.03802631,0.40082952,0.0006131857,0.0043444955,0.0003503794],"about_ca_topic_score_codex":0.00064714876,"about_ca_topic_score_gemma":0.000016549217,"teacher_disagreement_score":0.6071253,"about_ca_system_score_codex":0.00011029715,"about_ca_system_score_gemma":0.0001185865,"threshold_uncertainty_score":0.26982394},"labels":[],"label_agreement":null},{"id":"W2018275684","doi":"10.1158/1538-7445.am2012-1428","title":"Abstract 1428: A CpG island methylator phenotype defines a clinically aggressive subgroup of posterior fossa ependymoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Ependymoma; Biology; DNA methylation; CpG site; Carcinogenesis; Cancer research; Methylation; Cancer; Pathology; Genetics; Gene; Medicine; Gene expression","score_opus":0.07099459327256624,"score_gpt":0.4207485500102821,"score_spread":0.34975395673771587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018275684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97315514,0.02462697,0.00014106909,0.00011109112,0.0002897768,0.00026132909,0.00008162568,0.0000054037923,0.0013276082],"genre_scores_gemma":[0.9965584,0.0017162625,0.0003406357,0.00003707314,0.0008317963,0.0001041968,0.000050526174,0.000032519092,0.00032857803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982154,0.00017654167,0.00038317265,0.0003146579,0.00039281428,0.0005174583],"domain_scores_gemma":[0.99858195,0.000105528394,0.00021506102,0.00042782692,0.00047509794,0.0001945255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013079562,0.00014231808,0.00021660406,0.00009024041,0.000090553025,0.00002352134,0.00026836118,0.00022213894,0.00028444175],"category_scores_gemma":[0.00062198314,0.00012421617,0.00010947646,0.0001842045,0.00019058921,0.00000927418,0.00020323839,0.00022703716,0.00003001405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004094744,0.00011162514,0.020794133,0.00006778571,0.00007984025,0.0000033076183,0.00017031207,0.000007577215,0.9558465,0.00005939686,0.00048648936,0.021963574],"study_design_scores_gemma":[0.0008644257,0.000574274,0.15493271,0.000073925825,0.000025078636,0.0000041001445,0.00009321318,0.000006268466,0.8310328,0.0003803286,0.011762294,0.0002505548],"about_ca_topic_score_codex":0.00026869916,"about_ca_topic_score_gemma":0.00017040041,"teacher_disagreement_score":0.13413857,"about_ca_system_score_codex":0.000026528203,"about_ca_system_score_gemma":0.00021826407,"threshold_uncertainty_score":0.5065388},"labels":[],"label_agreement":null},{"id":"W2018297869","doi":"10.1158/1538-7445.am2013-506","title":"Abstract 506: Targeting Y-box binding protein-1 (YB-1) overcomes drug resistance in triple-negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Cancer research; Triple-negative breast cancer; CD44; Breast cancer; Epirubicin; Medicine; Cancer; Drug resistance; Chemotherapy; Paclitaxel; CD24; Internal medicine; Oncology; Biology; Cell","score_opus":0.030391830494028944,"score_gpt":0.3520845693254546,"score_spread":0.3216927388314257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018297869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967063,0.0042440505,0.0000134328275,0.002543347,0.00012290671,0.0010430125,0.00014655897,0.000014516959,0.0022015471],"genre_scores_gemma":[0.9777986,0.0016200332,0.00027331663,0.00005285298,0.00037663302,0.0026538614,0.000035308418,0.000043231434,0.01714617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773973,0.00016032996,0.00032640202,0.0006230032,0.00043768543,0.0007128352],"domain_scores_gemma":[0.9988226,0.000041299245,0.000107776126,0.00042679958,0.00044884757,0.0001526541],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070888386,0.00019086675,0.0001992592,0.00016605723,0.0002740982,0.00012349493,0.00044291042,0.00013288924,0.0010364947],"category_scores_gemma":[0.00012968271,0.00017763332,0.00007205687,0.00053852145,0.00022236373,0.000032004977,0.000140195,0.00046193996,0.00006220614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001442839,0.00005759172,0.0036352878,0.000092847666,0.00003490309,0.0000034150162,0.00020608958,0.00003382895,0.96336883,0.00012034825,0.028886853,0.003415713],"study_design_scores_gemma":[0.0019822598,0.00004708924,0.06378048,0.0005923753,0.0000074489953,0.000001996183,0.0014451322,0.000024585901,0.8968741,0.00073409436,0.033811014,0.0006993667],"about_ca_topic_score_codex":0.0055060186,"about_ca_topic_score_gemma":0.0033870016,"teacher_disagreement_score":0.06649468,"about_ca_system_score_codex":0.0003464031,"about_ca_system_score_gemma":0.00056102907,"threshold_uncertainty_score":0.9998767},"labels":[],"label_agreement":null},{"id":"W2018354944","doi":"10.1158/1538-7445.am2012-935","title":"Abstract 935: Lapatinib and other tyrosine kinase inhibitors greatly potentiate doxorubicin-induced damage to cardiac myocytes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lapatinib; Doxorubicin; Pharmacology; Tyrosine-kinase inhibitor; Dexrazoxane; Cardiotoxicity; Myocyte; Tyrosine kinase; Medicine; Chemistry; Trastuzumab; Endocrinology; Internal medicine; Cancer; Receptor; Toxicity; Anthracycline; Chemotherapy; Breast cancer","score_opus":0.09045827497978133,"score_gpt":0.398494587570989,"score_spread":0.3080363125912077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018354944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910879,0.001788444,0.0000052529313,0.0015943925,0.00034283256,0.0009539925,0.000054461758,0.000062162646,0.0041105687],"genre_scores_gemma":[0.9961508,0.0002313743,0.000090050766,0.0007673356,0.0016529479,0.00016244719,0.000015093681,0.0000674476,0.00086250744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977831,0.000121078025,0.00024368186,0.0003770747,0.00071567943,0.00075938925],"domain_scores_gemma":[0.998555,0.00011026819,0.000047387934,0.00041664022,0.0002673078,0.00060338376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011988438,0.00020345565,0.00037100373,0.000289395,0.00020332141,0.00006766807,0.00010054481,0.00017511193,0.00029099427],"category_scores_gemma":[0.00015919087,0.00018006687,0.00011371637,0.00053265766,0.00012486277,0.00019723387,0.00008632659,0.00054884696,0.00009758128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023115947,0.00008255767,0.014314018,0.00012724574,0.000092780916,0.000010793679,0.0012560068,0.0000014293157,0.95956755,0.00007641534,0.00267015,0.02156991],"study_design_scores_gemma":[0.00097590766,0.00015846547,0.11548685,0.00027368916,0.000035429057,0.0000058477963,0.00041000947,0.0000023039386,0.8656327,0.000020678295,0.0168214,0.00017673685],"about_ca_topic_score_codex":0.001445773,"about_ca_topic_score_gemma":0.00004854914,"teacher_disagreement_score":0.101172835,"about_ca_system_score_codex":0.0002968038,"about_ca_system_score_gemma":0.00017473781,"threshold_uncertainty_score":0.73429143},"labels":[],"label_agreement":null},{"id":"W2018542708","doi":"10.1158/1538-7445.am10-3932","title":"Abstract 3932: Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; Cancer research; DU145; RAD51; PARP inhibitor; Biology; DNA repair; PI3K/AKT/mTOR pathway; Protein kinase B; Molecular biology; Prostate cancer; Cancer; Poly ADP ribose polymerase; Cell biology; Signal transduction; DNA; Genetics; Polymerase","score_opus":0.05148932896282031,"score_gpt":0.3995983601674608,"score_spread":0.3481090312046405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018542708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972271,0.00026088807,0.000021176142,0.00042441217,0.00046036244,0.00032412002,0.000051514668,0.0000075295184,0.001222917],"genre_scores_gemma":[0.9981919,0.000121876445,0.00015474366,0.00015461139,0.00042506523,0.00007937005,0.00001634216,0.0000398293,0.0008162872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980016,0.00008645205,0.0002646367,0.0005115947,0.0005500922,0.0005856447],"domain_scores_gemma":[0.9988399,0.000042700176,0.00005695885,0.0005784059,0.00029296367,0.00018903663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010041653,0.00015118369,0.00019098942,0.00020081126,0.00006366182,0.0000443653,0.0004730814,0.00018247929,0.00030682638],"category_scores_gemma":[0.00011040633,0.00015111058,0.00006910342,0.00026933936,0.00017601965,0.000007937621,0.00029346053,0.0005358056,0.000041120627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016864933,0.000051491606,0.0043108673,0.000059250975,0.00003130294,0.000054514003,0.00018003151,0.00033746773,0.98836374,0.000015022329,0.0039945515,0.0024331277],"study_design_scores_gemma":[0.00054498075,0.00006983511,0.013300411,0.000076057084,0.000003763907,0.0000049819037,0.00010294371,0.000028722912,0.9704236,0.00004515319,0.015227186,0.00017240278],"about_ca_topic_score_codex":0.00091548206,"about_ca_topic_score_gemma":0.0011783091,"teacher_disagreement_score":0.017940162,"about_ca_system_score_codex":0.00009047837,"about_ca_system_score_gemma":0.00033536355,"threshold_uncertainty_score":0.61621106},"labels":[],"label_agreement":null},{"id":"W2018574812","doi":"10.1158/1538-7445.am2012-4405","title":"Abstract 4405: Immune modulation and Treg suppression with metronomic cyclophosphamide enhances the anti-tumor effect of a therapeutic peptide vaccine in a murine model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Immunovaccine (Canada)","funders":"","keywords":"Immune system; Cancer vaccine; ELISPOT; Immunology; Adjuvant; Immunogenicity; Vaccination; Cancer research; Antigen; Peptide vaccine; Cancer; Immunopotentiator; Ovarian cancer; Medicine; T cell; Biology; Immunotherapy; Epitope; Internal medicine","score_opus":0.022343917149772716,"score_gpt":0.33196698040776645,"score_spread":0.3096230632579937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018574812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311522,0.06786053,0.000034787205,0.00017281095,0.000101700614,0.00058664236,0.000009405507,0.0000119938095,0.00006989793],"genre_scores_gemma":[0.9965362,0.0026534605,0.000010970048,0.000015369595,0.000021886317,0.0002140662,0.000011105253,0.000024585996,0.00051233853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816436,0.00063349697,0.00031474722,0.00022511516,0.00009407202,0.00056824106],"domain_scores_gemma":[0.9986934,0.00074524974,0.00012532776,0.000351016,0.000065852575,0.000019162673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018281672,0.00018758728,0.00039125592,0.00023108067,0.00021104475,0.000015867816,0.00025170273,0.00010063556,0.0002422006],"category_scores_gemma":[0.00005505985,0.00010640862,0.000056238463,0.00028125307,0.00028746304,0.00023641379,0.00008371166,0.0005176712,0.000016965781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060824435,0.0001010452,0.01696112,0.000073612784,0.00014296577,8.341424e-7,0.00083760655,0.00043302256,0.96507066,0.00003210446,0.00003546333,0.010229136],"study_design_scores_gemma":[0.0019511293,0.0002945539,0.3608599,0.00015096077,0.000014535512,0.000008708839,0.00012430306,0.00013345674,0.63598,0.000019300338,0.00037027383,0.00009288861],"about_ca_topic_score_codex":0.00089305046,"about_ca_topic_score_gemma":0.000054696862,"teacher_disagreement_score":0.34389877,"about_ca_system_score_codex":0.00009095046,"about_ca_system_score_gemma":0.000091681286,"threshold_uncertainty_score":0.43392175},"labels":[],"label_agreement":null},{"id":"W2018608405","doi":"10.1158/1538-7445.am2013-3575","title":"Abstract 3575: Integration of estradiol signaling at the translational and transcriptional level in prostate cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Biology; Cell biology; Signal transduction; Transcription factor; Transcriptional regulation; Estrogen receptor; Post-transcriptional regulation; Regulation of gene expression; Messenger RNA; PI3K/AKT/mTOR pathway; Gene expression; Cancer research; Cancer; Gene; Genetics; Breast cancer","score_opus":0.052340863281096404,"score_gpt":0.3471264646922486,"score_spread":0.29478560141115223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018608405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899343,0.008613339,0.00002241329,0.0007450286,0.000044905537,0.00040988816,0.000073928095,0.00000192363,0.00015424033],"genre_scores_gemma":[0.9969494,0.0021680454,0.000046010467,0.000022008946,0.00006925542,0.00020349033,0.00005375415,0.000010711616,0.00047734438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991776,0.00007473144,0.00015053885,0.00018903324,0.0002123551,0.00019577466],"domain_scores_gemma":[0.9996804,0.000034384757,0.000027881786,0.00008709025,0.00012270948,0.000047538786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032310793,0.000076421566,0.00007602818,0.00005062576,0.00008492396,0.000018191433,0.000087077715,0.00008744269,0.00018067226],"category_scores_gemma":[0.000009140617,0.00005300826,0.00003543021,0.00010986988,0.00020137956,0.000008676544,0.000016508053,0.00023506104,0.0000038030912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010671085,0.000021044887,0.0013675465,0.000029350795,0.000024462764,7.0248865e-7,0.0003405483,0.0007525394,0.9892502,0.000058738675,0.0004198891,0.007628305],"study_design_scores_gemma":[0.00047916188,0.000069185764,0.044711802,0.00006217614,0.0000045357924,0.000002508082,0.00010321113,0.0001670883,0.95373785,0.00013228615,0.00045621756,0.00007398308],"about_ca_topic_score_codex":0.0012762294,"about_ca_topic_score_gemma":0.0004069586,"teacher_disagreement_score":0.043344256,"about_ca_system_score_codex":0.00003263868,"about_ca_system_score_gemma":0.00016410182,"threshold_uncertainty_score":0.21616141},"labels":[],"label_agreement":null},{"id":"W2018755246","doi":"10.1158/0008-5472.sabcs13-p1-14-05","title":"Abstract P1-14-05: Is there a correlation between androgen receptor (AR) expression in metastatic breast cancer (MBC) ER+/Her2- and response to anti-estrogen treatment?","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Estrogen receptor; Metastatic breast cancer; Breast cancer; Antiestrogen; Internal medicine; Oncology; Cancer; Estrogen; Immunohistochemistry; Antiandrogen; Endocrine system; Androgen receptor; Gynecology; Gastroenterology; Prostate cancer; Hormone","score_opus":0.06780505961093732,"score_gpt":0.4060702453788812,"score_spread":0.3382651857679439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018755246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810181,0.008557733,0.00004601785,0.00745965,0.00009679523,0.0021826182,0.0005141851,0.0000548939,0.00006995114],"genre_scores_gemma":[0.99308664,0.002514436,0.00053583103,0.00019186076,0.00029013032,0.0017922556,0.00003453908,0.00009784624,0.001456438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968793,0.00035448663,0.00042716227,0.0007368078,0.00076834345,0.0008339276],"domain_scores_gemma":[0.9980063,0.00043030642,0.00011031899,0.0005280668,0.00039849215,0.0005265184],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006840495,0.00033861515,0.00059600995,0.0004816004,0.00019181597,0.000083749816,0.00016792137,0.00014838103,0.0037647292],"category_scores_gemma":[0.000087414395,0.00026691888,0.00008060535,0.0007846674,0.0002314775,0.00040637748,0.000104272214,0.00048468192,0.00018939722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006899281,0.0003758616,0.37025988,0.00025068448,0.00039937004,0.000093367205,0.006447795,0.00018053508,0.34213868,0.0000055662554,0.0034863383,0.26946265],"study_design_scores_gemma":[0.005448701,0.00073751784,0.8867882,0.0015179344,0.00007491408,0.000045292993,0.0015693859,0.000051422598,0.08005397,0.00017074394,0.02312991,0.00041201923],"about_ca_topic_score_codex":0.006122877,"about_ca_topic_score_gemma":0.00020066467,"teacher_disagreement_score":0.5165283,"about_ca_system_score_codex":0.0015825809,"about_ca_system_score_gemma":0.0007195314,"threshold_uncertainty_score":0.9999783},"labels":[],"label_agreement":null},{"id":"W2018769494","doi":"10.1158/0008-5472.can-12-4576","title":"The 19th Annual Prostate Cancer Foundation Scientific Retreat","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Prostate cancer; Cancer; Multidisciplinary approach; Medicine; Disease; Tumor microenvironment; Resistance (ecology); Prostate; Cancer research; Oncology; Internal medicine; Biology; Political science","score_opus":0.08146201446562601,"score_gpt":0.44546998162997364,"score_spread":0.36400796716434763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018769494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95138705,0.01129825,0.0000020692853,0.029079188,0.00065598055,0.0027785753,0.000064274594,0.000071442104,0.0046631983],"genre_scores_gemma":[0.7663032,0.007399265,0.000022577133,0.00008172041,0.00049023,0.0036372128,0.00006668217,0.000043541768,0.22195557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634236,0.0001935669,0.00024235134,0.0005637539,0.0015276112,0.001130377],"domain_scores_gemma":[0.9965949,0.00021957935,0.00004736744,0.0006372524,0.0021364624,0.0003644521],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013542239,0.00016639571,0.00019912564,0.00027007307,0.0016881643,0.0006326068,0.00031709205,0.0000822357,0.0023482342],"category_scores_gemma":[0.00017367979,0.00009470397,0.000077684184,0.0013255265,0.0013680161,0.0003694429,0.00018451529,0.00067295856,0.0010671704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012928827,0.00021852786,0.057351593,0.00028422402,0.00029051313,0.000053585616,0.0030921565,0.00000976783,0.056427088,0.00052557833,0.3799274,0.5005267],"study_design_scores_gemma":[0.0044347877,0.0007736649,0.08415738,0.00055095763,0.00006080258,0.000016625176,0.0030958308,0.00039028877,0.057766207,0.002189662,0.84619343,0.00037037188],"about_ca_topic_score_codex":0.004208753,"about_ca_topic_score_gemma":0.00067171146,"teacher_disagreement_score":0.50015634,"about_ca_system_score_codex":0.0010822953,"about_ca_system_score_gemma":0.0018532189,"threshold_uncertainty_score":0.9997106},"labels":[],"label_agreement":null},{"id":"W2018803305","doi":"10.1158/1538-7445.am2011-5464","title":"Abstract 5464: Determination of total and encapsulated drug pharmacokinetics for CPX-351, a nanoscale liposomal fixed molar ratio of cytarabine-daunorubicin (Cyt:Daun)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Daunorubicin; Chemistry; Chromatography; Liposome; Drug; Pharmacology; High-performance liquid chromatography; Analyte; Cytarabine; Medicine; Leukemia; Biochemistry; Immunology","score_opus":0.06071223234617322,"score_gpt":0.3480366389079805,"score_spread":0.28732440656180724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018803305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781054,0.0005089301,0.00021015976,0.00010103657,0.00020952338,0.0008481296,0.00020030432,0.000027120932,0.00008425687],"genre_scores_gemma":[0.99799234,0.00009140546,0.0014141093,0.000015230336,0.00007807343,0.0001601413,0.000008761563,0.000029142002,0.00021077937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978015,0.00017972876,0.00051149604,0.00038464917,0.0005975568,0.00052508246],"domain_scores_gemma":[0.9982595,0.0003145162,0.00018314784,0.0003083806,0.000779686,0.00015476451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013578488,0.00015312895,0.00029181287,0.00021801725,0.000117727046,0.000032438846,0.0002757658,0.00008419717,0.00058504374],"category_scores_gemma":[0.00022232287,0.00014546799,0.000060617604,0.00034117067,0.0004054689,0.00031005385,0.00012725497,0.00016729928,0.000014383265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007243783,0.0001806571,0.00067512074,0.00029714513,0.000011552993,0.0000074248146,0.001388589,0.000059867565,0.9939199,0.000053725842,0.00028390586,0.0023977277],"study_design_scores_gemma":[0.0014753276,0.00027757083,0.004934957,0.00010679754,0.000027739094,0.000003170381,0.0001391959,0.0027595425,0.98994344,0.00014584835,0.000043471744,0.00014291817],"about_ca_topic_score_codex":0.0010238327,"about_ca_topic_score_gemma":0.000085267,"teacher_disagreement_score":0.004259836,"about_ca_system_score_codex":0.000105920626,"about_ca_system_score_gemma":0.0003025044,"threshold_uncertainty_score":0.64058185},"labels":[],"label_agreement":null},{"id":"W2018947262","doi":"10.1158/1538-7445.am2012-1195","title":"Abstract 1195: Erk activity promotes Notch-dependent HES1 expression in pancreatic cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"HES1; Notch signaling pathway; MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Cancer research; MEK inhibitor; Chemistry; Oncogene; Protein kinase B; Cell biology; Signal transduction; Biology; Cell; Cell cycle; Biochemistry","score_opus":0.07044844550364578,"score_gpt":0.40333529898802917,"score_spread":0.3328868534843834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018947262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897156,0.008073095,0.000049481543,0.00022852888,0.00050277275,0.0005547372,0.00008336706,0.000017784128,0.0007746741],"genre_scores_gemma":[0.99526316,0.0014559298,0.00009951908,0.000060775663,0.001168794,0.0008188026,0.000016147427,0.000060671977,0.0010562164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971932,0.00024555734,0.00024172959,0.0005832163,0.0006730541,0.0010632247],"domain_scores_gemma":[0.9987762,0.00008498143,0.00009061657,0.00059462327,0.00018163567,0.0002719347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011551076,0.00023636248,0.00025271982,0.00013140893,0.0001461863,0.000051913143,0.00044417533,0.00027486694,0.000682971],"category_scores_gemma":[0.00011400777,0.00021430952,0.00008231624,0.0002619704,0.00017656296,0.000027149128,0.00027995635,0.00060021365,0.000052399348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000279906,0.00019116912,0.018922321,0.00013655116,0.00003391023,0.0000059077474,0.00020839048,0.00013736883,0.9720258,0.0000026689847,0.0027789806,0.005277],"study_design_scores_gemma":[0.00052083685,0.00008830028,0.024238545,0.00022752958,0.000008159084,0.000001963343,0.000059786005,0.000013512271,0.96820635,0.000023027333,0.0063545094,0.00025749402],"about_ca_topic_score_codex":0.002100857,"about_ca_topic_score_gemma":0.0007633418,"teacher_disagreement_score":0.0066171656,"about_ca_system_score_codex":0.00041178995,"about_ca_system_score_gemma":0.0005128153,"threshold_uncertainty_score":0.87392884},"labels":[],"label_agreement":null},{"id":"W2018948966","doi":"10.1158/1538-7445.am2014-2114","title":"Abstract 2114: UGT2B17 is a unique co-regulator of the androgen receptor and androgen receptor splice variants in prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Enzalutamide; Androgen receptor; Dihydrotestosterone; Prostate cancer; Androgen; Cancer research; Endocrinology; Internal medicine; Biology; splice; Cancer; Medicine; Genetics; Hormone; Gene","score_opus":0.05141161238189077,"score_gpt":0.39401230057858455,"score_spread":0.34260068819669376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018948966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319876,0.007035859,7.133488e-7,0.0052266046,0.0001436387,0.002076311,0.00040881417,0.00002390962,0.0018853755],"genre_scores_gemma":[0.9818398,0.011016071,0.00006000092,0.00023074602,0.00024025432,0.00080825784,0.000031817424,0.000067678644,0.005705379],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966525,0.00031753228,0.00042769697,0.0006538795,0.0010576575,0.0008907593],"domain_scores_gemma":[0.99809706,0.0002149409,0.00012081855,0.0006749613,0.0005247147,0.00036748662],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016604938,0.00025600387,0.0005155166,0.00031059847,0.00022658437,0.000043960405,0.00035217986,0.0001804513,0.0015383369],"category_scores_gemma":[0.00016157977,0.00016965436,0.00009728395,0.0009708114,0.0007094642,0.0001525424,0.00020988294,0.0007912856,0.000039950024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042774356,0.00044938707,0.47394314,0.0016855093,0.00041978798,0.000029885046,0.004756453,0.00000904428,0.43249193,0.00022899985,0.038756605,0.04295182],"study_design_scores_gemma":[0.008148857,0.0006186258,0.18289922,0.0021023608,0.00005602672,0.000016327573,0.0006149853,0.00011823387,0.70098716,0.00036196318,0.10367704,0.0003991771],"about_ca_topic_score_codex":0.004003859,"about_ca_topic_score_gemma":0.00054335885,"teacher_disagreement_score":0.2910439,"about_ca_system_score_codex":0.0006108729,"about_ca_system_score_gemma":0.0014049675,"threshold_uncertainty_score":0.9993744},"labels":[],"label_agreement":null},{"id":"W2019026183","doi":"10.1158/1538-7445.am2011-2883","title":"Abstract 2883: Vimentin downregulation modulates p53 levels and apoptosis in cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Vimentin; Protein kinase B; Downregulation and upregulation; Cancer research; PI3K/AKT/mTOR pathway; Gene knockdown; Apoptosis; Cell biology; Biology; Epithelial–mesenchymal transition; Phosphorylation; Signal transduction; Immunology; Biochemistry","score_opus":0.10007322023771642,"score_gpt":0.38614920864413194,"score_spread":0.2860759884064155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019026183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967404,0.0018755482,0.00002045174,0.00014753622,0.000045284243,0.00027379123,0.00002596498,0.000005452451,0.0008655714],"genre_scores_gemma":[0.9963064,0.0014380071,0.00011164503,0.00003063563,0.000118211516,0.00016418444,0.000010172914,0.000020278985,0.0018004309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856496,0.00008294989,0.00016156399,0.00038285993,0.00028602718,0.0005216563],"domain_scores_gemma":[0.9994243,0.000019515664,0.00002931251,0.00023768669,0.00014891454,0.00014031459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062872824,0.00010596309,0.00011410313,0.00014729245,0.00010483691,0.000039992974,0.00018510594,0.00011960612,0.00037673354],"category_scores_gemma":[0.00003577144,0.0000978619,0.00003091102,0.00019908459,0.0001446067,0.000011753952,0.00015709306,0.00022356957,0.000011060521],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114833056,0.00003840973,0.008519153,0.000042404135,0.000023629664,0.0000021605651,0.00013366,0.000050866565,0.9809266,0.000022876207,0.0006922196,0.009433223],"study_design_scores_gemma":[0.0003635609,0.000071658425,0.12327502,0.0000455006,0.000001934111,3.995545e-7,0.00007768967,0.00010563269,0.8751212,0.00009461708,0.0007360693,0.00010672095],"about_ca_topic_score_codex":0.004994043,"about_ca_topic_score_gemma":0.00093983376,"teacher_disagreement_score":0.11475586,"about_ca_system_score_codex":0.000066872584,"about_ca_system_score_gemma":0.00015212361,"threshold_uncertainty_score":0.75495327},"labels":[],"label_agreement":null},{"id":"W2019026643","doi":"10.1158/1538-7445.am2011-2835","title":"Abstract 2835: BRCA1 signature in high-risk fallopian tube epithelium","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Fallopian tube; Serous fluid; Carcinogenesis; Epithelium; Ovarian cancer; BRCA mutation; Cancer; Biology; Pathology; Cancer research; Oncology; Medicine; Internal medicine; Gynecology","score_opus":0.08298439581336467,"score_gpt":0.3729413838780354,"score_spread":0.28995698806467074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019026643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791738,0.003953341,0.000003687585,0.0027337405,0.00029359895,0.00080897246,0.00008489633,0.000043113247,0.012904899],"genre_scores_gemma":[0.99329764,0.0041649207,0.00023481864,0.0002332109,0.00039154786,0.00048285787,0.000016962747,0.000045659115,0.0011323744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779224,0.00010567342,0.000261604,0.00052209897,0.0006261492,0.00069224054],"domain_scores_gemma":[0.9987613,0.00012869274,0.00004906519,0.0005390818,0.0002312995,0.00029059293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006952199,0.00018074371,0.0003315693,0.00032414863,0.00010563992,0.000027430628,0.00020848146,0.00019141615,0.004440856],"category_scores_gemma":[0.000090746464,0.00014185879,0.00008852113,0.0005789382,0.00014970316,0.0000954348,0.00007611793,0.0010655741,0.00026662354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014845345,0.0018914301,0.8319312,0.00039436418,0.00047701848,0.0018892199,0.004145816,0.000024027186,0.0048069875,0.0028486254,0.02334126,0.12676553],"study_design_scores_gemma":[0.0031312588,0.00042915903,0.96082765,0.0004070796,0.000041502328,0.000006065997,0.0001687909,0.00000532486,0.01774308,0.0013681103,0.015705967,0.00016600385],"about_ca_topic_score_codex":0.02187621,"about_ca_topic_score_gemma":0.0035664416,"teacher_disagreement_score":0.12889647,"about_ca_system_score_codex":0.0006668012,"about_ca_system_score_gemma":0.00054465875,"threshold_uncertainty_score":0.9964692},"labels":[],"label_agreement":null},{"id":"W2019089983","doi":"10.1158/0008-5472.sabcs-09-5114","title":"Pertuzumab and Trastuzumab: Re-Responses to 2 Biological Agents in Patients with HER2-Positive Breast Cancer Which Had Previously Progressed during Therapy with Each Agent Given Separately: A New Biological and Clinical Observation.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency; Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Internal medicine; Cohort; Metastatic breast cancer; Breast cancer; Cancer; Pharmacology","score_opus":0.22807095443971398,"score_gpt":0.4791410790961227,"score_spread":0.2510701246564087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019089983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815622,0.0022000049,0.000006705908,0.011689715,0.0000359475,0.004298599,0.000096902746,0.000047721896,0.00006218358],"genre_scores_gemma":[0.9920927,0.0055243983,0.0003492877,0.0005959896,0.00024363404,0.0006711911,0.000035766967,0.00004817978,0.00043882008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946032,0.0010344179,0.00056933216,0.0013131611,0.0012389236,0.0012409311],"domain_scores_gemma":[0.9970831,0.0003831332,0.00009913877,0.00045774062,0.0009902705,0.0009865864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014241032,0.0004019727,0.00078237086,0.0003481057,0.00027143836,0.00014987994,0.00031945322,0.00029800241,0.0003405096],"category_scores_gemma":[0.00033628655,0.00024749446,0.000054069304,0.0014411976,0.0005787105,0.00016653189,0.00016892802,0.001215268,0.000009743968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037483394,0.0009385481,0.9031129,0.00005886729,0.00014008646,0.00014443757,0.0013743482,0.0000117577865,0.0005460023,0.0000031130842,0.00076895393,0.055417623],"study_design_scores_gemma":[0.008146276,0.012865623,0.975897,0.0010190287,0.000017834978,0.000027064925,0.0002157185,0.00003601583,0.0003692203,0.000012756214,0.0010746296,0.0003187911],"about_ca_topic_score_codex":0.0015842724,"about_ca_topic_score_gemma":0.00092876167,"teacher_disagreement_score":0.07278417,"about_ca_system_score_codex":0.0011149644,"about_ca_system_score_gemma":0.0017477564,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W2019200981","doi":"10.1158/1538-7445.am2013-lb-124","title":"Abstract LB-124: RHAMM acts near chromosomes to promote mitotic spindle assembly by regulating the location and abundance of TPX2 and the downstream activation of Aurora A.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute","funders":"","keywords":"Centrosome; Cell biology; Kinetochore; Mitosis; Spindle apparatus; Spindle checkpoint; Spindle pole body; Multipolar spindles; Biology; Aurora A kinase; Aurora B kinase; Microtubule; Cell cycle; Cell division; Cell; Genetics; Gene","score_opus":0.017843513235592013,"score_gpt":0.31416370040049063,"score_spread":0.2963201871648986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019200981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663866,0.0010848022,0.000105595645,0.0013540931,0.000019414721,0.0006831682,0.000009629611,0.0000022070544,0.00010243324],"genre_scores_gemma":[0.99894214,0.00050985184,0.00013591316,0.000046122408,0.00006027432,0.00010208424,0.000015694559,0.000012146056,0.00017579633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915874,0.00007507443,0.00017170636,0.00021364071,0.00018869877,0.00019215577],"domain_scores_gemma":[0.9992056,0.000056992674,0.000095619034,0.00028466064,0.0003089127,0.000048215617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004398804,0.00008341004,0.000116774914,0.000025945437,0.0001408081,0.000055251614,0.00016510038,0.000076713004,0.000009067845],"category_scores_gemma":[0.00018083431,0.0000530933,0.000018850636,0.00016202527,0.000346524,0.000013467563,0.000117098905,0.00012499538,0.0000013141349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006974381,0.000021316386,0.0003145292,0.00010690515,0.000026378693,3.98706e-8,0.00030885477,0.00006516581,0.98457927,0.000046469977,0.0008287677,0.013632546],"study_design_scores_gemma":[0.00047687071,0.00014688757,0.014578856,0.0001245124,0.0000067058745,0.000001402937,0.00019741434,0.00043483422,0.98228675,0.00006948029,0.0016055332,0.000070768765],"about_ca_topic_score_codex":0.0009595065,"about_ca_topic_score_gemma":0.00008250443,"teacher_disagreement_score":0.014264327,"about_ca_system_score_codex":0.000020585392,"about_ca_system_score_gemma":0.00012405173,"threshold_uncertainty_score":0.2165082},"labels":[],"label_agreement":null},{"id":"W2019295382","doi":"10.1158/1538-7445.am2012-3430","title":"Abstract 3430: Role of Tip60 in human melanoma cell migration, melanoma metastasis and patient survival","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Melanoma; Medicine; Metastasis; Cancer; Tissue microarray; Cancer research; Proportional hazards model; Oncology; Survival analysis; Internal medicine; Pathology","score_opus":0.03121789308150017,"score_gpt":0.36044104586230574,"score_spread":0.32922315278080555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019295382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926891,0.0049030418,0.000048055655,0.00012045242,0.000015356793,0.00024716268,0.00004751333,0.000004505307,0.0019248535],"genre_scores_gemma":[0.9988009,0.00054493715,0.00021535321,0.000023880615,0.00005336085,0.00020734234,0.0000735666,0.000013303823,0.000067409164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990737,0.00009985247,0.00018454884,0.00021779227,0.00013766694,0.00028642945],"domain_scores_gemma":[0.99948066,0.000014444019,0.00005133305,0.0002656198,0.00010507303,0.000082860584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039558797,0.00008632998,0.000116215444,0.00007844569,0.00007170794,0.000008879756,0.0001353135,0.00011982287,0.000057626465],"category_scores_gemma":[0.000016599237,0.00007981554,0.000036009464,0.00012569597,0.00013372574,0.000004202791,0.00012508736,0.00013317262,0.0000022560305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020011905,0.00009809578,0.033881776,0.0000160839,0.000013977811,4.2000565e-7,0.00012465335,0.0000018846783,0.961666,0.00044664656,0.0006016684,0.0031287791],"study_design_scores_gemma":[0.00015386082,0.00014483448,0.024210464,0.0000078284775,0.000004288352,0.0000012089491,0.00020955704,0.0000022945696,0.9363098,0.00013780473,0.03873096,0.00008707282],"about_ca_topic_score_codex":0.00078363,"about_ca_topic_score_gemma":0.00038053837,"teacher_disagreement_score":0.038129292,"about_ca_system_score_codex":0.00001965602,"about_ca_system_score_gemma":0.00004718986,"threshold_uncertainty_score":0.32547832},"labels":[],"label_agreement":null},{"id":"W2019330676","doi":"10.1158/1538-7445.am2014-196","title":"Abstract 196: Targeting breast cancer stem cells with a panel of potential ALDH1A3 inhibitors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Aldehyde dehydrogenase; Cancer research; Breast cancer; Retinoic acid; Cancer; Medicine; Cancer stem cell; Stem cell; Biology; Internal medicine; Gene; Cell biology; Biochemistry","score_opus":0.024781239365414588,"score_gpt":0.30614750334606017,"score_spread":0.28136626398064557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019330676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150085,0.0061699427,0.000110090485,0.00037848897,0.00086453045,0.00029388146,0.00019180171,0.000011591686,0.00047882667],"genre_scores_gemma":[0.991507,0.0030635835,0.0000643533,0.00006543941,0.0039160145,0.00012775151,0.00002008423,0.00004906278,0.0011867088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979885,0.00011672612,0.00025947415,0.00049182604,0.0005466728,0.0005968016],"domain_scores_gemma":[0.99880296,0.00001848459,0.00011613007,0.0003771067,0.000493592,0.00019174957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065529335,0.00018119559,0.00025076777,0.0000972693,0.00013695192,0.000036831745,0.00030883573,0.00015651922,0.00016565809],"category_scores_gemma":[0.000012753673,0.00015064847,0.00009638576,0.00022785347,0.00033157616,0.0000088338375,0.00014493905,0.00029956608,0.000008336724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037442366,0.00005011768,0.0005960699,0.00013102865,0.00007262354,0.0000015069929,0.00008495552,0.0006606431,0.9560037,0.0000146695,0.018167218,0.023843046],"study_design_scores_gemma":[0.0010083439,0.00013348895,0.003935286,0.000117259515,0.00002456758,0.0000073876527,0.00021419014,0.000034006945,0.8512308,0.000011044074,0.14304194,0.00024167223],"about_ca_topic_score_codex":0.0023115478,"about_ca_topic_score_gemma":0.00039334997,"teacher_disagreement_score":0.124874726,"about_ca_system_score_codex":0.000050812276,"about_ca_system_score_gemma":0.0005216399,"threshold_uncertainty_score":0.61432666},"labels":[],"label_agreement":null},{"id":"W2019395117","doi":"10.1158/0008-5472.sabcs-4162","title":"A new enrichment model for high sensitivity detection and downstream analyses of circulating tumor cells in breast cancer patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Circulating tumor cell; DAPI; Breast cancer; Cytokeratin; Cancer; Cancer research; Antibody; Metastatic breast cancer; Pathology; Immunohistochemistry; Medicine; Staining; Internal medicine; Metastasis; Immunology","score_opus":0.07770663305705865,"score_gpt":0.4063285853761307,"score_spread":0.32862195231907204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019395117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964359,0.0005991985,0.0014005676,0.0005282236,0.000055151337,0.00070583326,0.00020936843,0.000009239571,0.000056561807],"genre_scores_gemma":[0.998548,0.0004831714,0.00053207105,0.00009038179,0.00012825087,0.0000768031,0.000007906809,0.000012856396,0.000120587996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986298,0.000057551162,0.00024033857,0.00031984688,0.00040391344,0.0003485137],"domain_scores_gemma":[0.9991801,0.00007468533,0.00007267804,0.00016018611,0.0003466467,0.00016572194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004120003,0.000112063644,0.00032154733,0.0002612121,0.000060371618,0.000014723627,0.00003403056,0.000043740572,0.000039893763],"category_scores_gemma":[0.000029527853,0.00009798279,0.00006034601,0.00045436612,0.000047691512,0.0000677933,0.000027524458,0.00018926675,3.6531753e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073368597,0.00016618078,0.006905554,0.00021706354,0.000044726883,0.000006316207,0.0003083587,0.002924918,0.7451237,0.000011082887,0.00027756745,0.24328086],"study_design_scores_gemma":[0.006017652,0.0005489386,0.17350326,0.0005681461,0.00018255963,0.000010033614,0.00018183776,0.029538898,0.78877074,0.0003137348,0.00011476093,0.00024944308],"about_ca_topic_score_codex":0.020725256,"about_ca_topic_score_gemma":0.0018723381,"teacher_disagreement_score":0.24303141,"about_ca_system_score_codex":0.00045832197,"about_ca_system_score_gemma":0.00043372397,"threshold_uncertainty_score":0.9857958},"labels":[],"label_agreement":null},{"id":"W2019465092","doi":"10.1158/1538-7445.am10-3890","title":"Abstract 3890: Induction of cell cycle arrest and apoptosis in mantle cell lymphoma by AZD5438, a novel cyclin-dependent kinase inhibitor","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cyclin-dependent kinase; Cell cycle; Cyclin-dependent kinase 1; Mantle cell lymphoma; Cell cycle checkpoint; Cyclin B; Cyclin B1; Cyclin D1; Cancer research; Cyclin A; Cell growth; Cyclin D; Kinase; Biology; Chemistry; Molecular biology; Cell biology; Apoptosis; Biochemistry; Immunology; Lymphoma","score_opus":0.032264068446668334,"score_gpt":0.339952562499045,"score_spread":0.30768849405237664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019465092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995553,0.0008815324,8.9314585e-7,0.0006104304,0.00031234144,0.00058827514,0.00009940784,0.000014245373,0.001939882],"genre_scores_gemma":[0.9979778,0.0009409262,0.000107200765,0.00003922937,0.00021733524,0.00026261475,0.000025040463,0.000030842646,0.0003989975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981752,0.000033798016,0.00031272147,0.00043858928,0.0006040272,0.00043564648],"domain_scores_gemma":[0.99901265,0.00014037454,0.00007981376,0.0003542623,0.00015898155,0.00025394664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004667545,0.00016315097,0.00029021173,0.00025944677,0.00008349481,0.000035806082,0.00010833356,0.00018217356,0.00019907478],"category_scores_gemma":[0.000052413216,0.00013921983,0.000056533492,0.00029581337,0.0001819744,0.00010486513,0.00009510166,0.00034085347,0.000035564874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025754195,0.0029702995,0.03198444,0.00026518668,0.000021062307,0.000029193106,0.00026154032,0.0000026238713,0.95207757,0.000015164768,0.0017017059,0.010413699],"study_design_scores_gemma":[0.0063061826,0.00020025174,0.12892412,0.00013595876,0.000021203949,0.0000046887694,0.00027686547,0.00001513178,0.8625677,0.00002356967,0.0014120511,0.00011224997],"about_ca_topic_score_codex":0.007738354,"about_ca_topic_score_gemma":0.00070435076,"teacher_disagreement_score":0.096939676,"about_ca_system_score_codex":0.0003434842,"about_ca_system_score_gemma":0.00034618448,"threshold_uncertainty_score":0.9988692},"labels":[],"label_agreement":null},{"id":"W2019768177","doi":"10.1158/0008-5472.sabcs11-p5-14-01","title":"P5-14-01: Differences in Efficacy by Assessment Method: NCIC CTG Adjuvant Breast Cancer Trials MA.5, MA.12, MA.14, MA.21, MA.27 Meta-Analysis.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; McGill University; McMaster University; Queen's University; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Proportional hazards model; Oncology; Internal medicine; Clinical endpoint; Meta-analysis; Anthracycline; Cancer; Randomization; Clinical trial; Gynecology","score_opus":0.2910404505560149,"score_gpt":0.4860565158815054,"score_spread":0.19501606532549048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019768177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76433545,0.17831382,0.004361821,0.018118706,0.0022978156,0.0074088625,0.013975946,0.00020388325,0.010983677],"genre_scores_gemma":[0.97168875,0.011147812,0.001955838,0.0004013789,0.0005723855,0.0037697956,0.00038539077,0.0001270874,0.009951551],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9907976,0.0029311017,0.0012163323,0.0019554652,0.0014679225,0.0016315806],"domain_scores_gemma":[0.99655926,0.0004944418,0.00045030357,0.0014201886,0.0006343309,0.00044148293],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004592896,0.000810957,0.0027333638,0.00056495913,0.00034784674,0.0001309583,0.0011097211,0.0004412842,0.005695424],"category_scores_gemma":[0.0002388168,0.0006006317,0.0013096823,0.0012647827,0.00052368635,0.000031483105,0.0007823184,0.0007861593,0.000054698394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0118403835,0.005045241,0.24394085,0.00072250154,0.33241487,0.00035669317,0.0028135763,0.00034294097,0.17290924,0.000637652,0.16584949,0.06312658],"study_design_scores_gemma":[0.014770019,0.0012733921,0.66964996,0.00019530338,0.06469949,0.000060615923,0.0019189601,0.00014501883,0.17839427,0.0006667935,0.064707525,0.0035186748],"about_ca_topic_score_codex":0.014281345,"about_ca_topic_score_gemma":0.0094405925,"teacher_disagreement_score":0.4257091,"about_ca_system_score_codex":0.00072181947,"about_ca_system_score_gemma":0.000925951,"threshold_uncertainty_score":0.9996445},"labels":[],"label_agreement":null},{"id":"W2019831277","doi":"10.1158/0008-5472.sabcs12-s3-3","title":"Abstract S3-3: The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Medicine; Tolerability; Internal medicine; Breast cancer; Capecitabine; Regimen; Oncology; Chemotherapy; Cancer; Adverse effect","score_opus":0.11327829894834737,"score_gpt":0.44796877722044864,"score_spread":0.3346904782721013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019831277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936223,0.0026669572,0.0000124011385,0.001184774,0.00034299353,0.0014836829,0.0005393648,0.000008802972,0.0001386984],"genre_scores_gemma":[0.9972626,0.00075979327,0.000028601278,0.00011512161,0.0005658131,0.0010616914,0.00005974537,0.000052839463,0.00009377425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977598,0.00012849241,0.0004240676,0.000388576,0.00050175237,0.00079730334],"domain_scores_gemma":[0.99860084,0.0001059655,0.00017358815,0.0004248154,0.00058259384,0.00011219643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007545212,0.0002284941,0.00041256173,0.00010098789,0.00020301591,0.00003851673,0.0003644991,0.00015388656,0.00012750292],"category_scores_gemma":[0.00007087875,0.00016919992,0.00011067573,0.00032159066,0.0002523847,0.000019543291,0.00013575442,0.00026775702,0.0000027649533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05880937,0.000548768,0.8713991,0.000111261565,0.00037410363,3.8612902e-7,0.0012319288,0.000047292193,0.035568167,0.000018735123,0.012547375,0.019343505],"study_design_scores_gemma":[0.022726165,0.00059028884,0.78891236,0.00013097521,0.000024073666,3.6624257e-7,0.0002793427,0.0000030248973,0.18140349,0.000015531119,0.005699602,0.00021476501],"about_ca_topic_score_codex":0.004013891,"about_ca_topic_score_gemma":0.0011532607,"teacher_disagreement_score":0.14583533,"about_ca_system_score_codex":0.00029449665,"about_ca_system_score_gemma":0.00029908473,"threshold_uncertainty_score":0.6899772},"labels":[],"label_agreement":null},{"id":"W2020097362","doi":"10.1158/1538-7445.am2013-lb-59","title":"Abstract LB-59: ERG induces taxane resistance in castration-resistant prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Taxane; Prostate cancer; Clusterin; Cabazitaxel; Cancer research; Docetaxel; Erg; LNCaP; In vivo; Medicine; Pharmacology; Biology; Cancer; Apoptosis; Internal medicine; Androgen deprivation therapy; Biochemistry; Genetics","score_opus":0.10195020055496534,"score_gpt":0.4387683774564336,"score_spread":0.33681817690146826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020097362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802754,0.005913654,9.61056e-7,0.0065156394,0.00020942239,0.0015951128,0.00008489652,0.00004681576,0.0053581246],"genre_scores_gemma":[0.98898417,0.001101105,0.000121213416,0.00020633136,0.00029309926,0.0028948868,0.000025186524,0.000048088932,0.0063259075],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971131,0.000160936,0.00046617453,0.00059843605,0.00077957753,0.00088174787],"domain_scores_gemma":[0.99816877,0.00020351257,0.000098099925,0.0005667217,0.0006133335,0.00034956489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000690554,0.00019721477,0.00035399018,0.0003700568,0.00014576002,0.000084767846,0.000264301,0.00014994777,0.0040397476],"category_scores_gemma":[0.00037424595,0.00017972037,0.000057769663,0.0007811918,0.00040662856,0.00020860146,0.00012286409,0.00084175786,0.00018087686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020534156,0.00033525962,0.031220496,0.0011631204,0.00007171322,0.0010119111,0.0014676852,0.0001480888,0.91742194,0.00022456444,0.037117008,0.007764785],"study_design_scores_gemma":[0.0021880942,0.00015976377,0.969276,0.0010484539,0.000017562486,0.000011118612,0.0008253871,0.000039248695,0.019005371,0.00051561894,0.0066192695,0.00029411848],"about_ca_topic_score_codex":0.010456598,"about_ca_topic_score_gemma":0.017815847,"teacher_disagreement_score":0.9380555,"about_ca_system_score_codex":0.0008648326,"about_ca_system_score_gemma":0.0011703536,"threshold_uncertainty_score":0.9968707},"labels":[],"label_agreement":null},{"id":"W2020097637","doi":"10.1158/1538-7445.am10-2511","title":"Abstract 2511: Differential cell cycle-dependent Chk1 inhibitor sensitization of genotoxic agents","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mitosis; Mitotic catastrophe; Chromatin; Cell biology; Gemcitabine; Biology; Spindle checkpoint; Mad2; Cell cycle; Cell cycle checkpoint; Cancer research; Chemistry; Molecular biology; Spindle apparatus; Cell; Cell division; Genetics; DNA; Cancer","score_opus":0.024076927385956882,"score_gpt":0.33596926788935205,"score_spread":0.31189234050339515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020097637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772984,0.000097918106,0.00010335732,0.00007350311,0.00046870697,0.00030203426,0.00004704949,0.000009984251,0.0011676184],"genre_scores_gemma":[0.9977086,0.00013512785,0.00009097742,0.000019187128,0.00059163134,0.00004837445,0.00006373101,0.000035017052,0.001307348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985798,0.00006738054,0.00018862776,0.00035418934,0.00046510863,0.00034491732],"domain_scores_gemma":[0.9991179,0.000015084899,0.00006440645,0.00042264495,0.00025647396,0.00012345011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031957513,0.000111610425,0.00011528567,0.000085053725,0.00008230431,0.000026857671,0.00023357294,0.00020485869,0.00056177936],"category_scores_gemma":[0.00006376743,0.00010951786,0.000067071625,0.00010002999,0.00010168252,0.000004489427,0.00020749122,0.00030855509,0.0000386443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007679319,0.00009272923,0.0003220796,0.000062616935,0.000018632527,0.0000045977654,0.000041620224,0.000027194334,0.99722946,0.000030537347,0.00076153665,0.0013321898],"study_design_scores_gemma":[0.00046428875,0.00009757339,0.0031259158,0.000013310972,0.0000053553717,0.0000020226196,0.000022725728,0.00006659182,0.9950943,0.000099807985,0.00089935376,0.0001087438],"about_ca_topic_score_codex":0.00013756004,"about_ca_topic_score_gemma":0.00020103191,"teacher_disagreement_score":0.0028038363,"about_ca_system_score_codex":0.000030093086,"about_ca_system_score_gemma":0.00017135084,"threshold_uncertainty_score":0.615109},"labels":[],"label_agreement":null},{"id":"W2020152109","doi":"10.1158/0008-5472.can-07-6569","title":"Transforming Growth Factor β1 Promotes Chromosomal Instability in Human Papillomavirus 16 E6E7–Infected Cervical Epithelial Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Chromosome instability; Telomere; Autocrine signalling; Telomerase; Biology; Transforming growth factor; Cancer research; Genome instability; Telomerase reverse transcriptase; Cervical intraepithelial neoplasia; Cell culture; Transforming growth factor beta; Immortalised cell line; Cervical cancer; Cancer; Cell biology; Genetics; Chromosome; Gene; DNA damage; DNA","score_opus":0.10650399650290227,"score_gpt":0.4028865640570369,"score_spread":0.2963825675541346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020152109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984367,0.00062656007,0.000019871324,0.0010487216,0.00011715045,0.0019617768,0.00015130074,0.000109946406,0.011597654],"genre_scores_gemma":[0.997119,0.00087458163,0.000024656489,0.00010909723,0.0006879819,0.0005007708,0.000039723458,0.000074655174,0.0005695416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944247,0.00045995097,0.00062594784,0.00090094475,0.0019981503,0.0015903204],"domain_scores_gemma":[0.99736446,0.0003409424,0.000040727267,0.0005861189,0.00091646216,0.0007513156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009955856,0.00031741033,0.0007204552,0.00056755316,0.0005303607,0.000051457566,0.00044470973,0.00032986223,0.015140338],"category_scores_gemma":[0.00031911623,0.000273304,0.00022174728,0.0016613094,0.0009679555,0.0002448566,0.00020704542,0.0022328307,0.000120395445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022633155,0.0013170735,0.15267499,0.0014952574,0.00008491794,0.00058447017,0.0028738468,0.0000018719354,0.81532705,0.00031925828,0.00037105847,0.022686878],"study_design_scores_gemma":[0.005054947,0.0011063564,0.3617696,0.000109363544,0.000013818456,0.00003383829,0.00013486814,0.000042891916,0.6281271,0.000545509,0.0027266778,0.00033506626],"about_ca_topic_score_codex":0.011770306,"about_ca_topic_score_gemma":0.0035156747,"teacher_disagreement_score":0.20909458,"about_ca_system_score_codex":0.0018873338,"about_ca_system_score_gemma":0.001571671,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W2020232583","doi":"10.1158/1538-7445.am10-3698","title":"Abstract 3698: Development of a hydrophobic docetaxel prodrug nanoparticle with enhanced plasma circulation lifetime and improved efficacy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada); Celator Pharmaceuticals (Canada)","funders":"","keywords":"Docetaxel; Prodrug; Paclitaxel; Chemistry; Pharmacology; Nanoparticle; Drug; Pharmacokinetics; Chemotherapy; Medicine; Materials science; Nanotechnology; Internal medicine","score_opus":0.026483841246087717,"score_gpt":0.3161867180451059,"score_spread":0.2897028767990182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020232583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874777,0.00008945464,0.000016205055,0.00015030781,0.00011970133,0.00070258015,0.000008738726,0.000052035684,0.00011320415],"genre_scores_gemma":[0.9979136,0.000007895728,0.0016760562,0.000011435229,0.000064946966,0.00020822752,0.000002169276,0.000028065308,0.00008759012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977726,0.0000810702,0.00037066572,0.00049573806,0.000694966,0.00058499596],"domain_scores_gemma":[0.99864817,0.00020884599,0.0001221825,0.00040091627,0.00040138356,0.0002185006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013595221,0.0001513397,0.00021953,0.00013882818,0.0002462874,0.00010022472,0.00026722226,0.00007236993,0.0004016809],"category_scores_gemma":[0.00012972581,0.00012287767,0.000020933205,0.00042360064,0.00041510662,0.00026965997,0.00012497348,0.00031851706,0.000114865055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005866454,0.00017209188,0.00040625923,0.000095453914,0.000011340176,0.0000040624172,0.0014083327,0.000095198855,0.992803,0.000015684318,0.000020472251,0.0043814755],"study_design_scores_gemma":[0.0014147023,0.000105776264,0.012595157,0.00008890523,0.000007279495,0.0000027053723,0.00007242751,0.00060247706,0.984811,0.000019399093,0.000117217875,0.00016295028],"about_ca_topic_score_codex":0.00021362436,"about_ca_topic_score_gemma":0.00035643255,"teacher_disagreement_score":0.0121888975,"about_ca_system_score_codex":0.00010355182,"about_ca_system_score_gemma":0.0008367911,"threshold_uncertainty_score":0.50108063},"labels":[],"label_agreement":null},{"id":"W2020236438","doi":"10.1158/1538-7445.cansusc14-16","title":"Abstract 16: Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Breast cancer; Genotype; Germline; Cancer; Oncology; Allele frequency; Germline mutation; Genetics; Medicine; Single-nucleotide polymorphism; Internal medicine; Sanger sequencing; Allele; Li–Fraumeni syndrome; International HapMap Project; Biology; Mutation; Gene","score_opus":0.0324280164467912,"score_gpt":0.3795239540102671,"score_spread":0.3470959375634759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020236438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958159,0.0013506121,0.000039649993,0.00085553125,0.00003665584,0.00056391244,0.00016777421,0.000020714342,0.001149253],"genre_scores_gemma":[0.998797,0.000321957,0.00003444357,0.00004909267,0.00014889934,0.0003528611,0.000014490838,0.0000475928,0.00023368701],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980828,0.000080335885,0.0002628415,0.00035140672,0.00061844965,0.000604159],"domain_scores_gemma":[0.9988261,0.00009044817,0.00007534835,0.00034018673,0.00036034724,0.00030757257],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000642765,0.00015668075,0.00033716293,0.0004085345,0.00006211331,0.0000205707,0.000109369,0.000098044155,0.0014560518],"category_scores_gemma":[0.00006241497,0.00012184667,0.00003185986,0.00072066014,0.0003407956,0.00008904899,0.00005434518,0.0005670903,0.000006650697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062750755,0.00040121813,0.063546754,0.00040522742,0.0004317654,0.00009212298,0.0021712275,0.0017822306,0.8563703,0.00008275532,0.0016301979,0.06681115],"study_design_scores_gemma":[0.00463543,0.0013102626,0.9774458,0.0009080475,0.000038458442,0.000083543455,0.00014500302,0.00021529022,0.014487704,0.000117224125,0.0004158194,0.00019740987],"about_ca_topic_score_codex":0.012477394,"about_ca_topic_score_gemma":0.0020407331,"teacher_disagreement_score":0.91389906,"about_ca_system_score_codex":0.0014999954,"about_ca_system_score_gemma":0.0013296669,"threshold_uncertainty_score":0.99945676},"labels":[],"label_agreement":null},{"id":"W2020313340","doi":"10.1158/1538-7445.am2014-3347","title":"Abstract 3347: Post-translational modifications of Akt isoform in chemoresistance of endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Protein kinase B; AKT2; Cancer research; AKT1; PI3K/AKT/mTOR pathway; Cell growth; Cancer; Phosphorylation; HeLa; Endometrial cancer; Kinase; Biology; Chemistry; Cell biology; Cell; Signal transduction; Biochemistry; Genetics","score_opus":0.043293530192459975,"score_gpt":0.3786568311627041,"score_spread":0.33536330097024414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020313340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438566,0.002985709,0.0002586758,0.0004978276,0.00012491681,0.0003172981,0.00017501865,0.0000036382123,0.0012512375],"genre_scores_gemma":[0.9983388,0.00068890734,0.00013826211,0.000010476924,0.0003044991,0.00013931021,0.000095664975,0.00001835104,0.0002657324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985887,0.000066516855,0.00035943743,0.0002870155,0.00043727885,0.00026107937],"domain_scores_gemma":[0.9988094,0.000083917446,0.00012468427,0.00032570583,0.0005999949,0.000056300643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065716496,0.00009329734,0.00017442105,0.0002618657,0.00004610519,0.0000073990277,0.00023099953,0.0001518676,0.00019956108],"category_scores_gemma":[0.00023016703,0.00009757066,0.00007602465,0.00057243556,0.00021700909,0.000008455515,0.000038650454,0.00016911588,0.000002290674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005371113,0.00006231866,0.003220295,0.00009363699,0.000035288685,9.8487824e-8,0.000082605504,0.0048075565,0.97851187,0.00037695814,0.0005968695,0.011675362],"study_design_scores_gemma":[0.0013988137,0.00010441622,0.116789974,0.00008735139,0.000007729189,4.0770374e-7,0.000034194214,0.00024911333,0.8757615,0.0002526776,0.0051961015,0.0001177201],"about_ca_topic_score_codex":0.001428979,"about_ca_topic_score_gemma":0.0032045909,"teacher_disagreement_score":0.113569684,"about_ca_system_score_codex":0.00008840623,"about_ca_system_score_gemma":0.00053687906,"threshold_uncertainty_score":0.3978816},"labels":[],"label_agreement":null},{"id":"W2020416066","doi":"10.1158/0008-5472.can-12-0699","title":"Ricardo Renzo Brentani: In Memoriam (1937–2011)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Latin Americans; Medicine; Library science; Political science; Gerontology; Family medicine; History; Law","score_opus":0.1037953614945275,"score_gpt":0.4490130213497139,"score_spread":0.3452176598551864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020416066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8804063,0.021562368,0.000014486969,0.059222866,0.0019932908,0.00053115905,0.000005011729,0.000105724095,0.03615875],"genre_scores_gemma":[0.98907584,0.0038711373,0.00005703818,0.00039642715,0.00081533607,0.00006977371,0.0000040275695,0.000016839369,0.005693561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986634,0.000082876584,0.00014193272,0.00018706813,0.00031018473,0.0006144881],"domain_scores_gemma":[0.9993819,0.00006476311,0.00001615422,0.00032540175,0.000081068196,0.00013072597],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008036341,0.0000768626,0.00017584822,0.0002964299,0.00007713159,0.000005210235,0.00013613013,0.0013827157,0.0016364837],"category_scores_gemma":[0.00008591265,0.000059918362,0.0000400846,0.00047269562,0.00022405123,0.000061056344,0.00009560131,0.0037808022,0.00063633313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011125597,0.00087082596,0.28412062,0.00028181903,0.0002763817,0.00025805982,0.0019733298,0.0000029240637,0.08751696,0.009880728,0.576781,0.036924798],"study_design_scores_gemma":[0.002397742,0.00029173034,0.1125644,0.0002615515,0.000039355444,0.00010425958,0.0005998324,0.000017102573,0.06338708,0.0003643665,0.81976134,0.00021121521],"about_ca_topic_score_codex":0.0003520485,"about_ca_topic_score_gemma":0.000045484718,"teacher_disagreement_score":0.24298038,"about_ca_system_score_codex":0.00019805232,"about_ca_system_score_gemma":0.0001327254,"threshold_uncertainty_score":0.9999137},"labels":[],"label_agreement":null},{"id":"W2020432672","doi":"10.1158/1538-7445.am10-5271","title":"Abstract 5271: Ibuprofen, an inhibitor of angiogenesis, enhances radiosensitivity and suppresses glioma invasion: Role of p75NTR and VEGF","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Glioma; Radiosensitivity; Clonogenic assay; Radiosensitizer; Cancer research; Angiogenesis; Gentamicin protection assay; Matrigel; Transfection; Biology; Chemistry; Immunology; Medicine; Cell culture; Cancer; Radiation therapy; Internal medicine; Metastasis","score_opus":0.03366991860643829,"score_gpt":0.3594976876314702,"score_spread":0.3258277690250319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020432672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798229,0.019057909,4.1606825e-7,0.00036072204,0.000119131335,0.00039576658,0.000052993084,0.000015816677,0.00017437253],"genre_scores_gemma":[0.9945083,0.00473489,0.000066537265,0.000014213202,0.00052145263,0.0000433587,0.000010470316,0.000026068354,0.00007465896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982702,0.00015577684,0.00029557396,0.00036763938,0.00054663105,0.00036414142],"domain_scores_gemma":[0.99834824,0.00041362608,0.00010185351,0.00046018758,0.0004422695,0.0002338515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009136142,0.00015607834,0.000474326,0.00029950083,0.00012647771,0.0000287293,0.00012715238,0.00015908695,0.00012886773],"category_scores_gemma":[0.00027691794,0.00013323282,0.000064274616,0.0003296199,0.0010005024,0.00019976147,0.000094261624,0.00036753033,0.0000016687992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023230813,0.00016621622,0.0155423945,0.0005758677,0.000047084777,0.000035323596,0.000796968,2.6635865e-7,0.94952166,0.000028743614,0.0003533943,0.030608976],"study_design_scores_gemma":[0.0008087866,0.00045790538,0.2149136,0.00028343918,0.000026685333,0.00008982378,0.00083764247,0.000008854928,0.77969164,0.000044975397,0.0027377496,0.00009890894],"about_ca_topic_score_codex":0.002462558,"about_ca_topic_score_gemma":0.0010206478,"teacher_disagreement_score":0.19937122,"about_ca_system_score_codex":0.00003039808,"about_ca_system_score_gemma":0.00051847333,"threshold_uncertainty_score":0.54330766},"labels":[],"label_agreement":null},{"id":"W2020673901","doi":"10.1158/0008-5472.can-08-2534","title":"Consistent Up-regulation of Stat3 Independently of Jak2 Mutations in a New Murine Model of Essential Thrombocythemia","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Essential thrombocythemia; Janus kinase 2; STAT3; Polycythemia vera; Myelofibrosis; Cancer research; Biology; Bone marrow; Hyperactivation; Thrombocytosis; Gene; Medicine; Platelet; Immunology; Genetics","score_opus":0.15815529313159693,"score_gpt":0.42582512310290316,"score_spread":0.26766982997130623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020673901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751085,0.00042181404,0.00019045499,0.0004213675,0.000029418854,0.0006421175,0.00006653802,0.000004342149,0.0007130681],"genre_scores_gemma":[0.99763566,0.00059214863,0.0005717973,0.000009117533,0.000030255782,0.00008523454,0.000035845183,0.000013088311,0.0010268652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983582,0.00007158874,0.00042417034,0.00019981264,0.0007441035,0.00020214988],"domain_scores_gemma":[0.99881816,0.00014329948,0.000116546726,0.00022846718,0.0005914925,0.000102031896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023025034,0.00009104437,0.00038662401,0.00030550294,0.00003852785,0.0000023281666,0.00006725991,0.00006224899,0.00041009468],"category_scores_gemma":[0.00009638836,0.00007779905,0.000072595685,0.00038599444,0.00027644305,0.000054740736,0.000047755588,0.00017131714,0.0000025574298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020456514,0.0020999475,0.40994996,0.0008571224,0.00051598775,0.000038939692,0.010507672,0.016690625,0.5452822,0.006167285,0.0023924063,0.0034522],"study_design_scores_gemma":[0.0051315627,0.0004311634,0.1823074,0.0003734004,0.000052491585,0.000010273924,0.0003239932,0.004418511,0.8060536,0.00079997163,0.000026022977,0.0000716167],"about_ca_topic_score_codex":0.0026630543,"about_ca_topic_score_gemma":0.0008389517,"teacher_disagreement_score":0.2607714,"about_ca_system_score_codex":0.00020346808,"about_ca_system_score_gemma":0.0018805581,"threshold_uncertainty_score":0.44902492},"labels":[],"label_agreement":null},{"id":"W2020946925","doi":"10.1158/1538-7445.tumimm2012-b88","title":"Abstract B88: Clinical significance of FOXP3+ T cell heterogeneity in ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"FOXP3; Interleukin-7 receptor; IL-2 receptor; CD8; T-cell receptor; CD28; Tumor-infiltrating lymphocytes; Cancer research; Biology; Immunology; Flow cytometry; Medicine; T cell; Immune system","score_opus":0.16749013932249332,"score_gpt":0.47606689554371295,"score_spread":0.3085767562212196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020946925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794496,0.005411771,0.0000074083523,0.0018563474,0.00030061396,0.0012801501,0.000037702877,0.000017416342,0.003143631],"genre_scores_gemma":[0.9925809,0.0049952446,0.00009793816,0.0002997341,0.00033016255,0.00067975646,0.0000062432982,0.000033889395,0.00097614084],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997247,0.00020771248,0.00072407746,0.00049334543,0.00068481284,0.00064309564],"domain_scores_gemma":[0.9983646,0.00029551744,0.00013344942,0.00055319426,0.0004179929,0.00023523782],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00177108,0.00016200148,0.00047913464,0.00022828572,0.00006811396,0.000028231585,0.00031211323,0.00020455077,0.004417229],"category_scores_gemma":[0.00008577345,0.00013808356,0.00018430273,0.0007257368,0.0005279143,0.000118190634,0.00007360358,0.0007993335,0.00007072865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021481498,0.00050921325,0.27151233,0.00049643515,0.00011509986,0.000028105274,0.00020218319,0.000013127772,0.65208155,0.000012833536,0.013129305,0.059751693],"study_design_scores_gemma":[0.0034198205,0.00028768188,0.7737681,0.000334296,0.0000121052535,0.0000018454433,0.00014925514,0.000032164156,0.214028,0.000066295426,0.0077473316,0.00015309028],"about_ca_topic_score_codex":0.03611681,"about_ca_topic_score_gemma":0.0027755783,"teacher_disagreement_score":0.5022558,"about_ca_system_score_codex":0.0004277333,"about_ca_system_score_gemma":0.0011614765,"threshold_uncertainty_score":0.99649286},"labels":[],"label_agreement":null},{"id":"W2021156021","doi":"10.1158/1538-7445.am2014-135","title":"Abstract 135: Phosphorylation and furin-mediated processing are critical posttranslational modifications of the KISS1 metastasis suppressor","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Furin; Proteases; Proprotein Convertases; Phosphorylation; Serine; Biology; Proprotein convertase; Gene knockdown; Serine protease; Cell biology; Enzyme; Biochemistry; Molecular biology; Protease; Apoptosis","score_opus":0.10516110625789991,"score_gpt":0.42293572963199283,"score_spread":0.3177746233740929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021156021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97592676,0.00067531015,0.0003393508,0.021296084,0.000013918598,0.00023536642,0.00014363787,0.000019815314,0.001349786],"genre_scores_gemma":[0.99938226,0.00003811414,0.00013332466,0.000120498364,0.00007743058,0.000054024385,0.00003180771,0.000010543965,0.00015199372],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987274,0.00009492995,0.00020775665,0.00019317033,0.0005919158,0.00018487404],"domain_scores_gemma":[0.99865764,0.00029511054,0.000051618812,0.00018598686,0.0006926275,0.000117009535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049725454,0.00006772143,0.00015008707,0.00013954764,0.00021715023,0.000030157595,0.00007332056,0.000055924338,0.0005060856],"category_scores_gemma":[0.0007317884,0.000048480462,0.00006107467,0.00044940913,0.0003079199,0.00009087108,0.000022999722,0.0002727218,0.000008836276],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027398995,0.00042586974,0.016952977,0.0011113286,0.000120817676,0.0000043062914,0.0008945164,0.00014330637,0.95989525,0.0031563097,0.0025372875,0.014484014],"study_design_scores_gemma":[0.0014729754,0.000068801965,0.7200732,0.0015545696,0.0001568133,0.000010269646,0.0006811796,0.009942776,0.26162916,0.0013846573,0.0028413914,0.0001842136],"about_ca_topic_score_codex":0.00009006768,"about_ca_topic_score_gemma":0.000035483794,"teacher_disagreement_score":0.70312023,"about_ca_system_score_codex":0.00004356195,"about_ca_system_score_gemma":0.00017476967,"threshold_uncertainty_score":0.5541282},"labels":[],"label_agreement":null},{"id":"W2021181403","doi":"10.1158/0008-5472.can-2148-2","title":"Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":283,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"LNCaP; Prostate cancer; Sterol regulatory element-binding protein; Endocrinology; Androgen; Internal medicine; Lipogenesis; Biology; Cancer research; Tumor progression; Bicalutamide; Dihydrotestosterone; Fatty acid synthase; Androgen receptor; Cancer; Sterol; Medicine; Cholesterol; Lipid metabolism; Hormone","score_opus":0.017837418308945596,"score_gpt":0.3644949958557796,"score_spread":0.346657577546834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021181403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955861,0.0022643635,0.000015144982,0.00023921848,0.00031578462,0.0015055581,0.000049683775,0.000006485422,0.000017634791],"genre_scores_gemma":[0.99709576,0.0008854165,0.00011534714,0.000013398836,0.0006394391,0.0010307688,0.000011073731,0.000021920327,0.00018688285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983282,0.00018847114,0.00021832722,0.00042656588,0.0004189585,0.0004194805],"domain_scores_gemma":[0.99939054,0.000013574477,0.000062992556,0.00023502766,0.00016516802,0.00013269734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000918182,0.00012637534,0.00016584016,0.00023999873,0.000098058656,0.000028650587,0.0001398642,0.00009658662,0.00001343829],"category_scores_gemma":[0.000102628284,0.00011607741,0.000027555881,0.00034905787,0.00010822963,0.000014607075,0.00018481242,0.00017687732,0.0000011684799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030334727,0.00004110123,0.043689404,0.00015043009,0.000017697348,6.345227e-7,0.0005533958,0.000484945,0.9433885,0.000006932008,0.00005633531,0.008577149],"study_design_scores_gemma":[0.001951156,0.00035860977,0.062719375,0.00042512492,0.0000049517835,0.0000031723007,0.00016596977,0.0000031373247,0.93103987,0.000017160019,0.0031791748,0.00013230796],"about_ca_topic_score_codex":0.0008339091,"about_ca_topic_score_gemma":0.0016205626,"teacher_disagreement_score":0.019029973,"about_ca_system_score_codex":0.00018686737,"about_ca_system_score_gemma":0.00043210818,"threshold_uncertainty_score":0.47334996},"labels":[],"label_agreement":null},{"id":"W2021291110","doi":"10.1158/1538-7445.am2014-5008","title":"Abstract 5008: The acetylenic tricyclic bis(cyanoeneone), TBE-31 inhibits non-small cell lung cancer cell migration through direct binding with actin","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell migration; Chemistry; Cell; Actin; Stress fiber; Cancer research; Cancer cell; Cell biology; Cancer; Biochemistry; Biology; Medicine; Internal medicine; Cytoskeleton","score_opus":0.06326090767832017,"score_gpt":0.4001251519401802,"score_spread":0.33686424426186007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021291110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555673,0.007963498,0.000017937042,0.0047544898,0.0003884418,0.0017393255,0.000039404502,0.00006775826,0.029461851],"genre_scores_gemma":[0.9648742,0.012123988,0.00006474389,0.00040841615,0.0011170217,0.0013371288,0.00004372333,0.00008425341,0.019946527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705136,0.0002226807,0.0003305188,0.00067651115,0.0007386641,0.0009802802],"domain_scores_gemma":[0.9981301,0.0006232008,0.00016961579,0.0005131768,0.00032198054,0.00024193962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080250285,0.00033888273,0.00046673528,0.00018373279,0.00051205856,0.00009570283,0.00030916202,0.000184627,0.0012746458],"category_scores_gemma":[0.000033781223,0.00021644938,0.00013976423,0.0008872338,0.00021993088,0.00023454335,0.000101213554,0.00093190576,0.00008542258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026176039,0.00061587285,0.042251028,0.0009661889,0.00035848282,0.00004764482,0.0044671576,0.00027903178,0.8509662,0.000009332055,0.08946091,0.007960535],"study_design_scores_gemma":[0.0071160872,0.00088703155,0.014276298,0.0004777671,0.00042678966,0.000011085842,0.00058002234,0.00031113945,0.8478028,0.0000072763123,0.1277069,0.00039677793],"about_ca_topic_score_codex":0.016293535,"about_ca_topic_score_gemma":0.010950544,"teacher_disagreement_score":0.03824599,"about_ca_system_score_codex":0.0013466013,"about_ca_system_score_gemma":0.001264127,"threshold_uncertainty_score":0.9996383},"labels":[],"label_agreement":null},{"id":"W2021316249","doi":"10.1158/0008-5472.can-03-2664","title":"Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"European Commission","keywords":"Clusterin; Gene silencing; Small interfering RNA; Oxidative stress; RNA interference; Apoptosis; Cancer research; Gene expression; Sensitization; Gene; Cancer; Biology; Molecular biology; Cell biology; Chemistry; RNA; Immunology; Genetics; Biochemistry","score_opus":0.06507516048349106,"score_gpt":0.3680186268848295,"score_spread":0.30294346640133846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021316249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747384,0.0004952876,0.000064707485,0.00032337185,0.00009364072,0.0014580406,0.000043482964,0.00001103887,0.000036581445],"genre_scores_gemma":[0.99892086,0.00017918118,0.00053091825,0.000047250014,0.000120753415,0.00014077306,0.000003118352,0.000035399346,0.000021722572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981225,0.00028842472,0.00033694506,0.0005025823,0.00034014843,0.00040941196],"domain_scores_gemma":[0.99904656,0.0000924246,0.0000961709,0.00033651388,0.00024402856,0.00018429723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044068348,0.00017149627,0.0003126321,0.0002998302,0.00016374887,0.000030097955,0.00015982112,0.00011960604,0.000026604921],"category_scores_gemma":[0.00013013465,0.00014418516,0.000030152205,0.0004008335,0.00027009496,0.00006409381,0.00072728156,0.00039740544,3.5735698e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003332746,0.00007249244,0.0015296324,0.00078283146,0.00000883713,0.000044894034,0.0049057864,0.001983321,0.98997366,0.0000027216036,0.0000012995359,0.00036122947],"study_design_scores_gemma":[0.00096323405,0.00016111344,0.01032059,0.0019302058,0.000019387378,0.000037719386,0.0008319508,0.00010275693,0.98541665,0.0000885347,3.3974882e-7,0.00012749367],"about_ca_topic_score_codex":0.00996301,"about_ca_topic_score_gemma":0.0017911657,"teacher_disagreement_score":0.008790958,"about_ca_system_score_codex":0.0008212563,"about_ca_system_score_gemma":0.00031007492,"threshold_uncertainty_score":0.9966297},"labels":[],"label_agreement":null},{"id":"W2021320698","doi":"10.1158/0008-5472.sabcs13-p6-07-07","title":"Abstract P6-07-07: Febrile neutropenia primary prophylaxis with granulocyte-colony stimulating factors (G-CSF) in breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Febrile neutropenia; Granulocyte colony-stimulating factor; Breast cancer; Internal medicine; Chemotherapy; Adjuvant; Neutropenia; Secondary prophylaxis; Oncology; Cancer; Intensive care medicine","score_opus":0.0523358663017213,"score_gpt":0.3656102577403273,"score_spread":0.31327439143860597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021320698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779666,0.0006618983,0.0000036379283,0.001966733,0.00021340926,0.0025775298,0.000084803694,0.000099284836,0.0065960186],"genre_scores_gemma":[0.99391,0.00038264788,0.000049441598,0.00028404102,0.0005040616,0.0023866396,0.000028888551,0.00010606889,0.002348188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632907,0.0001431774,0.00045170763,0.00078404305,0.0011283066,0.0011637015],"domain_scores_gemma":[0.99775237,0.00019273823,0.000108007844,0.0006069722,0.000873309,0.0004665896],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042141916,0.00034663337,0.0006089447,0.0004408473,0.00037285197,0.00019319938,0.00031223783,0.00018117028,0.011938834],"category_scores_gemma":[0.00003257774,0.00025759355,0.00010759632,0.0011898876,0.00037960976,0.0005559503,0.00015243504,0.0016122194,0.00053068984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008664337,0.0002824094,0.87720525,0.0005251077,0.00010859958,0.000094887626,0.0005670102,0.0005331535,0.100607246,0.000017998047,0.007636223,0.011555695],"study_design_scores_gemma":[0.0024466382,0.00049326586,0.98919904,0.00063596066,0.00003071068,0.00003712644,0.00021669452,0.000041362593,0.0045199534,0.000034538443,0.0020283142,0.00031641973],"about_ca_topic_score_codex":0.054796554,"about_ca_topic_score_gemma":0.0034639584,"teacher_disagreement_score":0.111993775,"about_ca_system_score_codex":0.0018182182,"about_ca_system_score_gemma":0.001693598,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W2021413944","doi":"10.1158/1538-7445.am2014-4704","title":"Abstract 4704: Prognostic significance of T gene SNP s2305089 in individuals with spinal column chordoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; University of British Columbia","funders":"","keywords":"Brachyury; Chordoma; SNP; Oncology; Medicine; Internal medicine; Single-nucleotide polymorphism; Cohort; Retrospective cohort study; Biology; Genotype; Pathology; Gene; Genetics","score_opus":0.08832744911272082,"score_gpt":0.40755073983946566,"score_spread":0.3192232907267448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021413944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467415,0.0012937577,0.0000054033662,0.0009324821,0.00003317911,0.0012156507,0.000030308855,0.00001626886,0.0017987826],"genre_scores_gemma":[0.99792194,0.00018377711,0.00038780228,0.00004917212,0.000116743526,0.00092228584,0.000015951462,0.000032343545,0.0003699734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781203,0.00010712679,0.00029116048,0.0003901127,0.00086530816,0.0005342783],"domain_scores_gemma":[0.99882513,0.00023629912,0.000084964944,0.00036613902,0.0002855419,0.0002019203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008486551,0.000143705,0.00039858907,0.00024984483,0.00006374343,0.000025009309,0.00016114987,0.000067605826,0.00028298513],"category_scores_gemma":[0.00021462755,0.00011169031,0.000043299264,0.0006296428,0.00028477891,0.00006625056,0.00003760636,0.00040184407,0.000043470078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004150948,0.00074811216,0.9740322,0.00032589174,0.00009146081,0.00012060357,0.00013168488,0.00001681026,0.011156761,0.00009462175,0.0006955771,0.012171152],"study_design_scores_gemma":[0.0029352023,0.0016261747,0.96192336,0.0008995485,0.000033805733,0.00001178907,0.00006836463,0.000010363041,0.030835364,0.000081772894,0.0014688876,0.00010535669],"about_ca_topic_score_codex":0.0022538358,"about_ca_topic_score_gemma":0.0005880087,"teacher_disagreement_score":0.019678604,"about_ca_system_score_codex":0.00021369227,"about_ca_system_score_gemma":0.00046298956,"threshold_uncertainty_score":0.45545983},"labels":[],"label_agreement":null},{"id":"W2021452884","doi":"10.1158/1538-7445.am10-3097","title":"Abstract 3097: The leukemogenic protein E2A-PBX1 blocks B-lymphoid commitment in early hematopoietic progenitors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lymphopoiesis; Myeloid; Haematopoiesis; Biology; Progenitor cell; Bone marrow; CD19; Stromal cell; Interleukin 3; Immunophenotyping; Cancer research; B cell; Immunology; Leukemia; Molecular biology; Stem cell; T cell; Cell biology; Antibody; Antigen; Interleukin 21","score_opus":0.04155184444068739,"score_gpt":0.369512048476246,"score_spread":0.32796020403555864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021452884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854081,0.00071393896,0.0000062289587,0.0059771906,0.00028489684,0.004360947,0.000020204232,0.000078400466,0.0031500447],"genre_scores_gemma":[0.9915967,0.00008374628,0.0001435987,0.00015224653,0.0008667844,0.0032221663,0.000010310251,0.000100561694,0.0038239013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940877,0.00026238765,0.0006002793,0.00076789566,0.0025998875,0.0016818641],"domain_scores_gemma":[0.9967091,0.00054949865,0.000088375,0.0014299129,0.00064420345,0.00057892845],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003022765,0.00033380045,0.00047160918,0.00052076025,0.000404653,0.00016361354,0.0010389321,0.00034483074,0.001439416],"category_scores_gemma":[0.0007096654,0.00022591537,0.00017517188,0.0014587421,0.0010621819,0.0001524659,0.00047634682,0.003163115,0.0005358289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019134054,0.0010591634,0.05939744,0.0007319506,0.00033109848,0.0012875134,0.003206117,0.000018549856,0.89556867,0.00080863375,0.015981672,0.019695776],"study_design_scores_gemma":[0.018796979,0.0015010274,0.113598,0.0013430483,0.00010646107,0.0009114112,0.0019917365,0.0009887649,0.7990802,0.0017863332,0.058773004,0.0011230771],"about_ca_topic_score_codex":0.0052681803,"about_ca_topic_score_gemma":0.0012065616,"teacher_disagreement_score":0.09648852,"about_ca_system_score_codex":0.0027255728,"about_ca_system_score_gemma":0.0048851846,"threshold_uncertainty_score":0.9994734},"labels":[],"label_agreement":null},{"id":"W2021483935","doi":"10.1158/1538-7445.pedcan-a20","title":"Abstract A20: hTERT promoter hypermethylation is a cancer signature which predicts survival and response to targeted therapy in pediatric nervous system tumors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Telomerase; Methylation; Telomerase reverse transcriptase; DNA methylation; Cancer; Cancer research; Malignancy; Biomarker; Oncology; Medicine; Targeted therapy; Biology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.04295232720178995,"score_gpt":0.36188176719238707,"score_spread":0.31892943999059714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021483935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880587,0.0038670679,0.000002024791,0.006011788,0.00016103976,0.0015796772,0.000048023125,0.000043749165,0.00022796956],"genre_scores_gemma":[0.99730384,0.000812253,0.000028553644,0.00012983567,0.00044700113,0.0010735363,0.0000124146745,0.000045611632,0.00014692712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738175,0.00042023917,0.00027896755,0.00054746267,0.0008178213,0.0005537608],"domain_scores_gemma":[0.99843884,0.00035363264,0.000052971154,0.00034346266,0.0004851181,0.00032597888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017658784,0.00019844084,0.0003659394,0.0005863386,0.00011234954,0.00006163348,0.000119930715,0.00016877986,0.0001453518],"category_scores_gemma":[0.00024994157,0.00014864004,0.000042801254,0.0012367034,0.00003737272,0.00008046918,0.00005576635,0.000479179,0.000023179533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009715048,0.00061587803,0.7559825,0.00097029505,0.00015109127,0.00040461478,0.005063153,0.00019827757,0.18329278,0.00003051615,0.0043021045,0.039273757],"study_design_scores_gemma":[0.002962332,0.0007513306,0.9734762,0.00041827877,0.000021521666,0.0000085628435,0.00016222704,0.00030510104,0.020945147,0.000009470458,0.0007936145,0.00014623794],"about_ca_topic_score_codex":0.0023647205,"about_ca_topic_score_gemma":0.0006685648,"teacher_disagreement_score":0.21749368,"about_ca_system_score_codex":0.0005784776,"about_ca_system_score_gemma":0.00046629886,"threshold_uncertainty_score":0.6061365},"labels":[],"label_agreement":null},{"id":"W2021522995","doi":"10.1158/0008-5472.can-08-1259","title":"Ugene, a Newly Identified Protein That Is Commonly Overexpressed in Cancer and Binds Uracil DNA Glycosylase","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service; Howard Hughes Medical Institute","keywords":"Uracil-DNA glycosylase; DNA glycosylase; Molecular biology; MUTYH; Western blot; Biology; Colorectal cancer; Cancer research; Base excision repair; Cancer; DNA repair; DNA; Gene; Biochemistry; Genetics","score_opus":0.17108897233066037,"score_gpt":0.41264802639649667,"score_spread":0.2415590540658363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021522995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986758,0.0065366304,0.0000050167596,0.0032482026,0.00017012136,0.0017720774,0.00011547458,0.00004397771,0.001350488],"genre_scores_gemma":[0.9858443,0.002843317,0.00011594712,0.00050193636,0.00023080845,0.0016142079,0.000009969064,0.000066879,0.008772651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964339,0.00017841578,0.00033498698,0.000739248,0.0014141059,0.00089934067],"domain_scores_gemma":[0.9983428,0.00015244323,0.00007331827,0.0006364794,0.00037876162,0.00041616196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005726611,0.0002686278,0.00047227173,0.00045345252,0.00023756395,0.00005847719,0.0003077088,0.00022997659,0.001797103],"category_scores_gemma":[0.00020367229,0.00024497256,0.00007757721,0.0009370534,0.0005814632,0.00014352321,0.00027546717,0.0009434646,0.00004112514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002772973,0.0002996087,0.22481854,0.00070821587,0.00014973033,0.00041407827,0.003812659,0.000029994548,0.70687467,0.000026403053,0.046064623,0.014028522],"study_design_scores_gemma":[0.005594571,0.00056144973,0.16181049,0.00093893736,0.000031440675,0.00006378129,0.0003268534,0.00021457409,0.80585414,0.00021066339,0.023975814,0.0004173172],"about_ca_topic_score_codex":0.014962183,"about_ca_topic_score_gemma":0.0062441924,"teacher_disagreement_score":0.098979466,"about_ca_system_score_codex":0.000922123,"about_ca_system_score_gemma":0.0016466834,"threshold_uncertainty_score":0.9991154},"labels":[],"label_agreement":null},{"id":"W2021643794","doi":"10.1158/0008-5472.can-07-2976","title":"3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; Golfers Against Cancer; National Cancer Institute; Samuel Waxman Cancer Research Foundation","keywords":"Cancer research; Cancer; Kinase; MEK inhibitor; Growth inhibition; Apoptosis; Positron emission tomography; Biology; MAPK/ERK pathway; Medicine; Internal medicine; Cell biology; Nuclear medicine; Biochemistry","score_opus":0.03009618755797126,"score_gpt":0.3947596411696007,"score_spread":0.36466345361162944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021643794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96892697,0.000545126,0.027572274,0.0015634726,0.00008111024,0.000911517,0.00013681325,0.000009197423,0.00025353133],"genre_scores_gemma":[0.9959877,0.00004219981,0.002296875,0.00050133764,0.0002481941,0.00014665475,0.000033564076,0.000030528336,0.0007129208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998054,0.0003843283,0.0002500359,0.0004284062,0.0003909463,0.0004922804],"domain_scores_gemma":[0.9986196,0.00022845312,0.00006841224,0.00037509724,0.00054151745,0.00016689807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043814806,0.00013581208,0.00015828048,0.00021684862,0.00020521667,0.000024783318,0.00018056722,0.000074985364,0.000018441819],"category_scores_gemma":[0.00030818323,0.000104741775,0.00012374196,0.00033999217,0.00010036742,0.000005660744,0.00018330208,0.00017320307,0.0000026473483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004656869,0.000035434085,0.0003972663,0.000039489427,0.00003078194,0.0000149513735,0.00056101294,0.000007395497,0.9833148,0.000050566352,0.005008827,0.00588259],"study_design_scores_gemma":[0.0005254942,0.0005346448,0.0024176955,0.00008744982,0.000011195337,0.000022218434,0.00065658416,0.000036048074,0.98838776,0.00010019716,0.0070962193,0.00012449014],"about_ca_topic_score_codex":0.0002320594,"about_ca_topic_score_gemma":0.000055453995,"teacher_disagreement_score":0.027060766,"about_ca_system_score_codex":0.00006720302,"about_ca_system_score_gemma":0.00020476243,"threshold_uncertainty_score":0.42712456},"labels":[],"label_agreement":null},{"id":"W2022004236","doi":"10.1158/1538-7445.am10-4830","title":"Abstract 4830: Insulin-like growth factors and kidney cancer risk in men","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Kidney cancer; Renal function; Cancer; Internal medicine; Context (archaeology); Risk factor; Kidney disease; Kidney; Prospective cohort study; Cancer prevention; Endocrinology; Oncology","score_opus":0.05768916631081179,"score_gpt":0.4074585116296643,"score_spread":0.3497693453188525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022004236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196506,0.0018295589,0.000001047408,0.0018544265,0.000529548,0.00058056123,0.0002264827,0.00003811242,0.0029752096],"genre_scores_gemma":[0.9850923,0.013183768,0.000026346961,0.00019111583,0.00047279673,0.00019790442,0.00001834287,0.00004861665,0.00076881674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772745,0.00006309704,0.00028401503,0.00052587455,0.0006891055,0.00071047846],"domain_scores_gemma":[0.9983823,0.00018931682,0.00006643755,0.00037478923,0.0002773124,0.00070985575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008094222,0.0002107868,0.00036989772,0.00040138143,0.00017247668,0.00006627856,0.00019023009,0.00021517879,0.0022673728],"category_scores_gemma":[0.00048924226,0.00016188687,0.00006659822,0.0005896426,0.0003650119,0.00015001124,0.000119535674,0.0021399874,0.000019906158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003251754,0.00008524477,0.9335533,0.00015826836,0.00005678393,0.00003157333,0.001253831,0.0000012578419,0.039618164,0.00005767593,0.015088967,0.009769773],"study_design_scores_gemma":[0.0019398695,0.00009246678,0.93759346,0.0001556878,0.000021899996,0.000002861063,0.00028480944,0.00003330916,0.010048021,0.00015426378,0.049485017,0.00018835314],"about_ca_topic_score_codex":0.14331263,"about_ca_topic_score_gemma":0.016811777,"teacher_disagreement_score":0.12650084,"about_ca_system_score_codex":0.0003676282,"about_ca_system_score_gemma":0.001100138,"threshold_uncertainty_score":0.9986447},"labels":[],"label_agreement":null},{"id":"W2022065883","doi":"10.1158/1538-7445.am2011-2989","title":"Abstract 2989: Integrin-linked kinase regulates mitotic spindle dynamics and its overexpression leads to resistance to paclitaxel-induced cell death","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Integrin-linked kinase; Mitosis; PLK1; Cell biology; Spindle apparatus; Kinetochore; Multipolar spindles; Spindle checkpoint; Spindle pole body; Polo-like kinase; Biology; Aurora B kinase; Mitotic exit; Chemistry; Cancer research; Cell; Kinase; Cell cycle; Cell division; Protein kinase A; Genetics; Cyclin-dependent kinase 2; Chromosome","score_opus":0.05649496062791774,"score_gpt":0.3425839585438333,"score_spread":0.2860889979159155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022065883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951924,0.0012222937,0.00010543582,0.00023352176,0.00012139942,0.0006607165,0.00008024946,0.00001560759,0.0023683861],"genre_scores_gemma":[0.9926187,0.0005547593,0.00077504874,0.00016703735,0.00018374366,0.0001549685,0.000043261392,0.000053699714,0.0054487996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796516,0.00009287237,0.00025737454,0.0007265933,0.00029591497,0.0006620728],"domain_scores_gemma":[0.99856526,0.000027224267,0.000052950312,0.00058966497,0.00034990124,0.00041503113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004349324,0.00023081474,0.00020918077,0.00015468925,0.00018225973,0.00005520333,0.0004283674,0.00026103004,0.000075992655],"category_scores_gemma":[0.00016620912,0.00021692125,0.00006410068,0.00023606796,0.000051705047,0.000011545415,0.00042434726,0.0003643397,0.000048176084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045877218,0.00008840929,0.0009882754,0.00013268803,0.000016494987,0.000010540872,0.00025689346,0.000009069182,0.99448,0.0001978938,0.0020657743,0.0012952031],"study_design_scores_gemma":[0.00040411483,0.00035659454,0.012467656,0.000310209,0.000007757383,0.0000018806301,0.00015519513,0.00005935354,0.98346096,0.00009052081,0.002387561,0.0002982145],"about_ca_topic_score_codex":0.00027040677,"about_ca_topic_score_gemma":0.0012163508,"teacher_disagreement_score":0.011479381,"about_ca_system_score_codex":0.00015987482,"about_ca_system_score_gemma":0.00019638476,"threshold_uncertainty_score":0.8845792},"labels":[],"label_agreement":null},{"id":"W2022155058","doi":"10.1158/1538-7445.am2013-827","title":"Abstract 827: Identification of the insulin-like growth factor 2 mRNA binding protein (IGF2BP1) as an important regulator of cIAP1 translation and apoptosis in rhabdomyosarcomas.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Children's Hospital of Eastern Ontario","funders":"","keywords":"Regulator; Biology; Rhabdomyosarcoma; Apoptosis; Cancer research; Cell culture; Translation (biology); Programmed cell death; Internal ribosome entry site; Messenger RNA; Genetics; Medicine; Sarcoma; Pathology; Gene","score_opus":0.032721981121015806,"score_gpt":0.33243062219336655,"score_spread":0.29970864107235073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022155058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968023,0.0011427619,0.00006783912,0.0003297983,0.00006093831,0.0014541596,0.00007338262,0.0000048562833,0.00006400568],"genre_scores_gemma":[0.99862677,0.00066511426,0.000075016294,0.000009028309,0.000045872694,0.00034670936,0.00003442966,0.000033618242,0.00016343946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977339,0.00025047406,0.0005175098,0.00044454195,0.0006798766,0.00037371906],"domain_scores_gemma":[0.99866766,0.000026778505,0.00018732867,0.0005156706,0.00048677175,0.00011581942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009348644,0.00013669123,0.00018209388,0.00025069623,0.00009658407,0.00004536104,0.0004020269,0.00022609177,0.00009715295],"category_scores_gemma":[0.00020865504,0.000116336996,0.00007139958,0.0005511568,0.00025646688,0.000029485307,0.00013146704,0.00035232562,0.000002457456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012903786,0.000072900744,0.0007327269,0.0001471589,0.000032410157,4.7455535e-7,0.00018446532,0.0000103072725,0.9914476,0.000100291196,0.00004128351,0.0071013416],"study_design_scores_gemma":[0.0005880279,0.00016681048,0.016136553,0.00010189177,0.000004670265,0.0000013599097,0.00015703408,0.00011401888,0.9820179,0.00043956764,0.00015789224,0.00011431589],"about_ca_topic_score_codex":0.0022975714,"about_ca_topic_score_gemma":0.00032033748,"teacher_disagreement_score":0.015403826,"about_ca_system_score_codex":0.00009734951,"about_ca_system_score_gemma":0.0004287341,"threshold_uncertainty_score":0.4744085},"labels":[],"label_agreement":null},{"id":"W2022321737","doi":"10.1158/0008-5472.sabcs-09-15","title":"A Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer Entered on NCIC CTG Trial MA.27. A Pharmacogenetics Research Network-RIKEN Collaboration.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Exemestane; Adverse effect; Breast cancer; Internal medicine; Oncology; Discontinuation; Population; Tamoxifen; Cancer","score_opus":0.024083096383875534,"score_gpt":0.3885579377211611,"score_spread":0.3644748413372856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022321737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463946,0.0008605668,2.3588666e-7,0.00034907367,0.0004013144,0.0035842748,0.00007699562,0.000010635243,0.000077464276],"genre_scores_gemma":[0.9964326,0.0016156053,0.000003235609,0.00012507074,0.00061949313,0.0008352733,0.00012902357,0.00004147662,0.00019822239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99459165,0.0017470078,0.00046487048,0.00074640935,0.0013908863,0.0010591891],"domain_scores_gemma":[0.9986628,0.00012760374,0.00012951653,0.00038327725,0.0004878788,0.00020891166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022486884,0.00026117498,0.0002892493,0.0004214198,0.00024701128,0.000047806585,0.000348798,0.00029512108,0.00004000524],"category_scores_gemma":[0.00025397603,0.00024025593,0.00009167743,0.0012589773,0.000057222584,0.000023181887,0.00012376571,0.00089688005,0.000029808214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08745765,0.0051189237,0.8014613,0.000023465744,0.0002718613,0.00009883025,0.0038995221,0.004337104,0.08536681,0.0000026470752,0.0031980071,0.0087639075],"study_design_scores_gemma":[0.06372548,0.018855928,0.88944095,0.00025655248,0.000016804714,4.969872e-7,0.0010361547,0.00003870167,0.025355428,0.000030670824,0.0007370151,0.00050584023],"about_ca_topic_score_codex":0.000652255,"about_ca_topic_score_gemma":0.0003591385,"teacher_disagreement_score":0.08797966,"about_ca_system_score_codex":0.001289334,"about_ca_system_score_gemma":0.0006611521,"threshold_uncertainty_score":0.97973526},"labels":[],"label_agreement":null},{"id":"W2022383336","doi":"10.1158/1538-7445.am2012-1077","title":"Abstract 1077: Bufalin inhibited cell proliferation and expression of insulin-like growth factor 2 and type 1 receptor in human colorectal cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bufalin; Insulin-like growth factor 1 receptor; Cell growth; Cell cycle; Insulin-like growth factor; Chemistry; Molecular biology; Flow cytometry; Receptor; Cell; Growth factor; Endocrinology; Internal medicine; Biology; Apoptosis; Biochemistry; Medicine","score_opus":0.1999447531325063,"score_gpt":0.48570431621688287,"score_spread":0.28575956308437656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022383336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942859,0.004173884,9.0936095e-7,0.0001145672,0.0004962311,0.00048810823,0.00012087993,0.000012124081,0.00030741518],"genre_scores_gemma":[0.99525857,0.0040715793,0.000024136203,0.000070131166,0.00023696566,0.000089446774,0.000018554629,0.000018707306,0.00021193431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850273,0.0003561476,0.00024077744,0.00025282253,0.00021353265,0.00043401567],"domain_scores_gemma":[0.9992338,0.00016930778,0.00008772753,0.00006948575,0.00023191478,0.00020777018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006767466,0.00013772896,0.00020079048,0.00019586063,0.0001945445,0.00002225737,0.00010637614,0.00023056027,0.0011352919],"category_scores_gemma":[0.000029215467,0.00012223712,0.0000201778,0.000290776,0.00029252665,0.000191961,0.00012229425,0.0007305868,0.000008211699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044634475,0.00025960442,0.19168767,0.00017995172,0.000012835423,0.0000017727587,0.0012035763,0.0000027207177,0.8032179,0.000019014356,0.0019341302,0.0010345101],"study_design_scores_gemma":[0.0010623995,0.000110544825,0.09925781,0.00007327333,0.000007391323,4.8696137e-7,0.00012870043,0.000027117127,0.89562017,0.000019551393,0.0035705606,0.00012197241],"about_ca_topic_score_codex":0.0004566152,"about_ca_topic_score_gemma":0.00011275394,"teacher_disagreement_score":0.09242987,"about_ca_system_score_codex":0.0001230022,"about_ca_system_score_gemma":0.00010764342,"threshold_uncertainty_score":0.9997778},"labels":[],"label_agreement":null},{"id":"W2022576348","doi":"10.1158/1538-7445.am10-94","title":"Abstract 94: DrugPath: A web database for academic investigators to identify drugs that match oncology molecular targets","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Perl; Pipeline (software); Medicine; Database; Biosimilar; Computer science; World Wide Web; Internal medicine","score_opus":0.14553626594686397,"score_gpt":0.5137193492664098,"score_spread":0.36818308331954586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022576348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9141961,0.00042380704,0.068816006,0.013024673,0.0015348906,0.001181049,0.00012680302,0.0001145356,0.0005821764],"genre_scores_gemma":[0.91050035,0.000071002214,0.08593773,0.0015397577,0.00040876935,0.0012005568,0.0000309567,0.000051605246,0.00025928562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959282,0.00040582602,0.00036311083,0.0010029981,0.0013233774,0.0009764576],"domain_scores_gemma":[0.99597543,0.0017238638,0.000101980935,0.00097233726,0.0005204846,0.0007059234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054147416,0.00022253762,0.00029226896,0.0005826543,0.00028560663,0.0002602972,0.0026671463,0.00020920266,0.00009455955],"category_scores_gemma":[0.001182807,0.00022476922,0.00011120637,0.0011184615,0.00026322252,0.0007561091,0.0014138741,0.0016586415,0.00017807844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007414974,0.00008288992,0.00027166045,0.00015067309,0.00004159512,0.000089096466,0.0024480326,0.0018093659,0.8826525,0.033968545,0.035427738,0.04298371],"study_design_scores_gemma":[0.0018128976,0.00022037252,0.006962585,0.0002473427,0.00001926167,0.0000358576,0.00043839755,0.038871974,0.5903442,0.10331621,0.25669736,0.0010335555],"about_ca_topic_score_codex":0.0003257508,"about_ca_topic_score_gemma":0.0001074429,"teacher_disagreement_score":0.29230836,"about_ca_system_score_codex":0.00037043708,"about_ca_system_score_gemma":0.0028360512,"threshold_uncertainty_score":0.9165823},"labels":[],"label_agreement":null},{"id":"W2022685865","doi":"10.1158/0008-5472.can-07-1998","title":"Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Paxillin; Biology; Focal adhesion; Cancer research; Gene silencing; Lung cancer; Cell biology; Cell growth; Molecular biology; Pathology; Signal transduction; Gene; Genetics; Medicine","score_opus":0.06652381914643084,"score_gpt":0.4038766210703563,"score_spread":0.33735280192392547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022685865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848339,0.0040025353,0.003779674,0.004633518,0.000029456993,0.0021540252,0.0003718836,0.0000071176196,0.00018787313],"genre_scores_gemma":[0.98731637,0.0037776637,0.0015524685,0.00011726279,0.000113979855,0.005758146,0.00017366523,0.00002546248,0.0011649806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884903,0.00006222367,0.0001770596,0.00036200718,0.00015923257,0.0003904649],"domain_scores_gemma":[0.9991902,0.00009326206,0.000032123757,0.00020976523,0.00035861437,0.00011601888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003263704,0.00008943917,0.00011224083,0.0001685969,0.0003520697,0.000026719283,0.00016365228,0.00010479618,0.00004440274],"category_scores_gemma":[0.00019332515,0.000087407076,0.000047488233,0.00024990088,0.00013313933,0.0000088349425,0.000075633216,0.0001241422,0.0000017384789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020187664,0.00011411206,0.03864537,0.00052513095,0.000025432337,8.6391634e-7,0.00048345522,0.00008207144,0.9432497,0.00026170255,0.014212998,0.0021972866],"study_design_scores_gemma":[0.003106574,0.00043609983,0.019336578,0.000061945815,0.000008908539,0.0000050926847,0.00015845874,0.0028135008,0.9457054,0.0024203898,0.025677234,0.0002697961],"about_ca_topic_score_codex":0.00042014473,"about_ca_topic_score_gemma":0.00030428846,"teacher_disagreement_score":0.019308794,"about_ca_system_score_codex":0.00006142753,"about_ca_system_score_gemma":0.0005230564,"threshold_uncertainty_score":0.35643572},"labels":[],"label_agreement":null},{"id":"W2023184594","doi":"10.1158/1538-7445.am2014-3133","title":"Abstract 3133: The anti-tumor effects of acetazolamide and sulforaphane on bronchial carcinoids: Preclinical modeling and mechanism","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Clonogenic assay; Cancer research; Metastasis; Downregulation and upregulation; Sulforaphane; Medicine; Viability assay; In vivo; Pathology; Parthenolide; Cell culture; Cancer; Chemistry; Internal medicine; Biology; Apoptosis","score_opus":0.037436789928106756,"score_gpt":0.35525842492969506,"score_spread":0.31782163500158833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023184594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968598,0.0020743967,0.00028327553,0.00018552996,0.00008794443,0.00033181414,0.000017623386,0.000003629459,0.00015598789],"genre_scores_gemma":[0.9981372,0.0012390582,0.00006089276,0.000104225874,0.00034160793,0.00005108583,0.000009481099,0.000018550176,0.00003789947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879277,0.00013701676,0.00017938859,0.00038510066,0.0002031368,0.0003025691],"domain_scores_gemma":[0.9992357,0.00017425873,0.000050247578,0.00031222505,0.00012547638,0.00010211663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067505223,0.000122044716,0.00019017089,0.000040586965,0.00011686933,0.000025703634,0.00020496258,0.00010190442,0.0000042493934],"category_scores_gemma":[0.0003578843,0.000090115725,0.00004599585,0.000050944076,0.00030672448,0.0000036248962,0.00019865,0.0002796585,0.0000011377113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017476548,0.000031632622,0.00090187637,0.00015616504,0.000033050557,9.030966e-7,0.000067358575,0.000081334416,0.99625367,0.0003221444,0.000115725205,0.0018613894],"study_design_scores_gemma":[0.00076742645,0.00037008763,0.005957537,0.00007180332,0.000011543415,0.0000018843521,0.00005658546,0.0006743877,0.9901589,0.0015118787,0.00030279174,0.00011517368],"about_ca_topic_score_codex":0.0001213718,"about_ca_topic_score_gemma":0.000041329346,"teacher_disagreement_score":0.006094754,"about_ca_system_score_codex":0.00001167449,"about_ca_system_score_gemma":0.00007119952,"threshold_uncertainty_score":0.36748126},"labels":[],"label_agreement":null},{"id":"W2023246576","doi":"10.1158/0008-5472.can-08-4363","title":"Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Bismuth; Medicine; Astatine; Nuclear medicine; Radiochemistry; Antibody; Chemistry; Immunology","score_opus":0.07381338612274349,"score_gpt":0.4487279393472816,"score_spread":0.37491455322453815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023246576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864093,0.00073944515,0.000051736926,0.011736842,0.000003546004,0.0005671419,0.000074906035,0.00004701809,0.0003700584],"genre_scores_gemma":[0.99769753,0.00069981493,0.00025427033,0.0002680877,0.000110728746,0.000105777544,0.00010547282,0.000015090411,0.00074319926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851555,0.00012462887,0.00019335533,0.0003606604,0.00035984942,0.00044598157],"domain_scores_gemma":[0.9989556,0.00025606094,0.000044880686,0.00027107142,0.00024467512,0.00022769792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045586558,0.0001514521,0.00024105923,0.00008855227,0.00038664808,0.00007342286,0.00015379593,0.00006896232,0.000104123355],"category_scores_gemma":[0.00009920385,0.000078926314,0.00001517946,0.00097184896,0.0004991873,0.00012125467,0.00002332551,0.0005543342,0.0000023784626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024465434,0.00029907038,0.017366674,0.0001398665,0.000057874266,0.00013003734,0.00051149965,0.000031294723,0.9740051,0.0002465186,0.0013119408,0.003453573],"study_design_scores_gemma":[0.0065031312,0.0013841883,0.056906972,0.0010268221,0.00012282388,0.00029470565,0.003885217,0.0013958679,0.9194185,0.00006132087,0.008633693,0.0003667324],"about_ca_topic_score_codex":0.00014102094,"about_ca_topic_score_gemma":0.000032444972,"teacher_disagreement_score":0.054586582,"about_ca_system_score_codex":0.00009762194,"about_ca_system_score_gemma":0.0002464571,"threshold_uncertainty_score":0.32185215},"labels":[],"label_agreement":null},{"id":"W2023718926","doi":"10.1158/1538-7445.am2013-509","title":"Abstract 509: RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Ubiquitin ligase; Ubiquitin; Cell growth; Cancer research; Gene silencing; Cancer; Breast cancer; Gene knockdown; Estrogen receptor; Small interfering RNA; Chemistry; Cancer cell; Kinase; Cell biology; Biology; Medicine; Apoptosis; Biochemistry; Internal medicine; Gene; Transfection","score_opus":0.05859053874130141,"score_gpt":0.3708776636178828,"score_spread":0.3122871248765814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023718926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730825,0.005047127,0.00063286186,0.009967951,0.0004713663,0.007530455,0.0006215268,0.00027343875,0.0023727966],"genre_scores_gemma":[0.9846741,0.0016563314,0.0010838204,0.0005487595,0.0016423687,0.0075538903,0.0008834266,0.00019420011,0.0017631094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99533284,0.00022908796,0.0007751332,0.0009562519,0.0013083748,0.0013983343],"domain_scores_gemma":[0.99584347,0.0003773655,0.00027603257,0.0005807208,0.0024647654,0.00045763416],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014109953,0.0004140896,0.000523841,0.00024767232,0.0005807222,0.00023406504,0.0003119759,0.0004025753,0.0031800019],"category_scores_gemma":[0.0006886475,0.00038387862,0.00019412734,0.00079882884,0.0002359681,0.00074400683,0.00012933747,0.0012205251,0.00025069554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007936955,0.0003667742,0.00079302513,0.0013264029,0.00013152389,0.000026428894,0.0013645561,0.00011108418,0.92910993,0.00007080259,0.05022953,0.015676238],"study_design_scores_gemma":[0.004379484,0.00053359766,0.005495422,0.0011197715,0.000113119284,0.000033554163,0.0011386625,0.0028110389,0.9724061,0.00032079456,0.011067075,0.0005813756],"about_ca_topic_score_codex":0.009648591,"about_ca_topic_score_gemma":0.001027036,"teacher_disagreement_score":0.043296166,"about_ca_system_score_codex":0.0017053116,"about_ca_system_score_gemma":0.002036224,"threshold_uncertainty_score":0.9998613},"labels":[],"label_agreement":null},{"id":"W2023799789","doi":"10.1158/1538-7445.am2011-1092","title":"Abstract 1092: Insulin-like growth factors modulate chemosensitivity to cisplatin and 5-fluorouracil in human esophageal cell lines","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cisplatin; Cell growth; Cell culture; Cancer research; Insulin-like growth factor 1 receptor; Biology; Endocrinology; Internal medicine; Receptor; Medicine; Chemotherapy; Growth factor; Biochemistry","score_opus":0.0609187056703413,"score_gpt":0.3392887135913224,"score_spread":0.2783700079209811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023799789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953038,0.0025400214,0.00001565459,0.000056342116,0.00030758456,0.00033928212,0.000054532025,0.000011564481,0.0013712333],"genre_scores_gemma":[0.9968142,0.0012976239,0.00013446868,0.000091260794,0.0006990711,0.00005963689,0.000034895544,0.000036512567,0.0008323185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998243,0.000104012775,0.00023034286,0.0005730028,0.0002870455,0.0005626477],"domain_scores_gemma":[0.99910015,0.000025944324,0.000046526802,0.00033354567,0.0002348446,0.0002589801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062515575,0.0001993426,0.00023894847,0.00016083718,0.0001414591,0.000036613714,0.00021410006,0.00019043546,0.000072797564],"category_scores_gemma":[0.00008894093,0.00019184197,0.00005760544,0.00024916788,0.00014510991,0.000012695467,0.00025768048,0.0003507492,0.000009145437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019320619,0.00009800149,0.0065258094,0.00006804195,0.000017385082,0.000011197651,0.00084293116,0.000011417941,0.9853239,0.000022685494,0.0012096155,0.0056757997],"study_design_scores_gemma":[0.0007248566,0.00012870044,0.26255518,0.000023334358,0.000005505934,0.0000021241747,0.00011729503,0.000007065076,0.73233837,0.00010650859,0.0037752283,0.00021586464],"about_ca_topic_score_codex":0.004059972,"about_ca_topic_score_gemma":0.0016716678,"teacher_disagreement_score":0.25602937,"about_ca_system_score_codex":0.000052961143,"about_ca_system_score_gemma":0.0001621311,"threshold_uncertainty_score":0.7823088},"labels":[],"label_agreement":null},{"id":"W2023982750","doi":"10.1158/0008-5472.can-04-3550","title":"B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Serous fluid; Immunohistochemistry; Breast cancer; Biomarker; Antibody; Biology; Cancer; Ascites; Pathology; Cancer research; Medicine; Internal medicine; Immunology; Biochemistry","score_opus":0.04894298712538232,"score_gpt":0.3975865397363008,"score_spread":0.3486435526109185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023982750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855087,0.009028707,0.00013570179,0.0027711845,0.00004650145,0.0015581715,0.0006787623,0.000011357933,0.0002609317],"genre_scores_gemma":[0.98805463,0.0011332391,0.00018636129,0.00022640672,0.0004278892,0.0017845391,0.000060687857,0.00007010652,0.008056111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783057,0.00011362972,0.00019110502,0.00070425833,0.0003849909,0.00077543006],"domain_scores_gemma":[0.9990012,0.00003105902,0.000040978954,0.00039959626,0.00033359183,0.00019354298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085107685,0.0002006096,0.00019694898,0.00015727166,0.00034156296,0.0001491083,0.000245429,0.0001931873,0.0002113194],"category_scores_gemma":[0.000039425806,0.00018647955,0.000040640167,0.00028038927,0.0004201622,0.000010320908,0.00020598367,0.00020449751,0.000003185957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023617116,0.000046526427,0.0010178208,0.0001756828,0.00009568015,0.000003231586,0.000058020458,0.0000045824786,0.97913814,0.000054486656,0.0042970185,0.012747098],"study_design_scores_gemma":[0.0021976843,0.0007875496,0.0016636273,0.000053545307,0.000009934052,0.0000061485475,0.0000308633,0.000118488955,0.89218146,0.00019047013,0.10252309,0.00023714529],"about_ca_topic_score_codex":0.0068582757,"about_ca_topic_score_gemma":0.016005965,"teacher_disagreement_score":0.09822607,"about_ca_system_score_codex":0.000079737314,"about_ca_system_score_gemma":0.0005230049,"threshold_uncertainty_score":0.99975514},"labels":[],"label_agreement":null},{"id":"W2024039874","doi":"10.1158/1538-7445.am2014-ct411","title":"Abstract CT411: Immune profiling of patients vaccinated with the survivin targeted therapeutic vaccine DPX-Survivac demonstrates durable polyfunctional CD4+ and CD8+ T cells in ovarian cancer patients","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Granzyme B; CD8; Immunology; Immune system; Cytotoxic T cell; Survivin; FOXP3; IL-2 receptor; Immunotherapy; Medicine; Cancer research; Ovarian cancer; ELISPOT; Ex vivo; T cell; Cancer; Biology; Internal medicine; In vivo; In vitro","score_opus":0.0181541160724482,"score_gpt":0.28411805387335387,"score_spread":0.26596393780090566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024039874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871736,0.010936498,0.000016188382,0.0004189062,0.0003642587,0.0008222601,0.00010542813,0.0000191906,0.00014362679],"genre_scores_gemma":[0.99777436,0.00109914,0.000009761069,0.000055640787,0.00002141988,0.00021419786,0.00010873528,0.000041262076,0.0006754703],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971422,0.0010442275,0.00048125698,0.00041005784,0.00020101029,0.00072123617],"domain_scores_gemma":[0.99800414,0.00079916813,0.00020768477,0.00036706435,0.00059242354,0.000029535207],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014557404,0.00026459433,0.00042468647,0.00028700815,0.0004280239,0.00003857069,0.00039492425,0.00022279985,0.00096578925],"category_scores_gemma":[0.000086993576,0.00017268077,0.000056525605,0.00064253144,0.00028106908,0.0001784594,0.00010102866,0.0008256412,0.000019403455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048330557,0.0003687811,0.20523532,0.00007022442,0.0002997747,4.2388368e-7,0.00039817128,0.000054715485,0.7824931,0.000076055105,0.00016242621,0.0060079494],"study_design_scores_gemma":[0.0033266544,0.00038311197,0.5809686,0.000095248826,0.000013830968,5.824868e-7,0.00018725143,0.000008585937,0.41384584,0.000029961684,0.0009932898,0.0001470047],"about_ca_topic_score_codex":0.006480801,"about_ca_topic_score_gemma":0.0006841609,"teacher_disagreement_score":0.37573332,"about_ca_system_score_codex":0.00012551043,"about_ca_system_score_gemma":0.00032103818,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W2024102326","doi":"10.1158/1538-7445.am10-lb-75","title":"Abstract LB-75: Concomitant use of panitumumab (Pmab) had no clinically significant effect on irinotecan (Iri) pharmacokinetics (PK)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Cmax; Pharmacokinetics; Irinotecan; Adverse effect; Concomitant; Colorectal cancer; Internal medicine; Clinical endpoint; Gastroenterology; Urology; Pharmacology; Oncology; Cancer; Clinical trial","score_opus":0.1335512705088349,"score_gpt":0.463908290944604,"score_spread":0.3303570204357691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024102326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885453,0.00029124506,0.0000014546051,0.0009681683,0.0007529595,0.0013647442,0.00015992836,0.00004923655,0.007866946],"genre_scores_gemma":[0.99592537,0.0012424083,0.000090766756,0.0002233706,0.00059303263,0.00032876074,0.00001449933,0.000053733565,0.0015280627],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99688053,0.00015750522,0.0005970091,0.00057659764,0.0010898901,0.0006984398],"domain_scores_gemma":[0.99608403,0.0018680096,0.00014439567,0.00062066247,0.0009223063,0.00036059142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010985764,0.00029007642,0.0007171724,0.00020613028,0.00018889358,0.000049914397,0.00024719918,0.00016423227,0.0011169439],"category_scores_gemma":[0.0010934141,0.0002050375,0.00021948712,0.00035230658,0.0006937806,0.00006552761,0.0001521619,0.0015558384,0.00014964423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019075831,0.0017450335,0.073832065,0.0006883076,0.0009507102,0.0005248296,0.00044246283,0.000020988251,0.75654554,0.0001308545,0.020925872,0.12511748],"study_design_scores_gemma":[0.013047334,0.024991598,0.5446321,0.00084206846,0.00037016996,0.000013192646,0.000110817295,0.00014716378,0.28930977,0.00005411965,0.12589097,0.00059074373],"about_ca_topic_score_codex":0.0014998555,"about_ca_topic_score_gemma":0.00023742653,"teacher_disagreement_score":0.47079998,"about_ca_system_score_codex":0.0003149986,"about_ca_system_score_gemma":0.0005283619,"threshold_uncertainty_score":0.99979615},"labels":[],"label_agreement":null},{"id":"W2024284445","doi":"10.1158/1538-7445.am2012-lb-214","title":"Abstract LB-214: Interim results from a randomized Phase 1-2 first-in-human (FIH) study of PK/PD guided escalating doses of SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA) in relapsed/refractory MDS and AML","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Medicine; Tolerability; Neutropenia; Adverse effect; Pharmacology; Phases of clinical research; Oncology; Internal medicine; Hypomethylating agent; Lethargy; Clinical trial; Toxicity; Chemistry","score_opus":0.1592843577178699,"score_gpt":0.4433153469677062,"score_spread":0.2840309892498363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024284445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351877,0.002021274,0.000017359112,0.00018011563,0.00013103518,0.0031271055,0.00018766623,0.000022026836,0.0007946226],"genre_scores_gemma":[0.99792606,0.0002673484,0.000559762,0.000021031668,0.00039614044,0.00034912664,0.00010775455,0.0000739452,0.00029883924],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939894,0.0009239308,0.0019575846,0.0007379225,0.0014263702,0.00096475525],"domain_scores_gemma":[0.9942907,0.0034955603,0.0005152249,0.0007407935,0.00059766526,0.00036003735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008489789,0.00032801382,0.0014141935,0.0012304496,0.00017106201,0.000051191157,0.00032455777,0.0002525583,0.0004619133],"category_scores_gemma":[0.0053712553,0.00028919266,0.00012825914,0.000946473,0.00046352056,0.00026856826,0.00037170853,0.0015678845,0.0000044136755],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05508871,0.0027328413,0.006763685,0.00042406502,0.00026229175,0.00017325359,0.022900391,0.00015411618,0.9044523,0.000009656671,0.00051482866,0.0065238285],"study_design_scores_gemma":[0.7188078,0.004696455,0.05704071,0.002618457,0.00018971476,0.000059819336,0.015432766,0.011669562,0.18827751,0.00007538124,0.00034731688,0.00078451977],"about_ca_topic_score_codex":0.024038726,"about_ca_topic_score_gemma":0.007611728,"teacher_disagreement_score":0.71617484,"about_ca_system_score_codex":0.0013629433,"about_ca_system_score_gemma":0.0005547657,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2024412406","doi":"10.1158/0008-5472.can-04-1608","title":"Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of Southern California","keywords":"Progesterone receptor; Breast cancer; Myoepithelial cell; Cancer research; Internal medicine; Biology; Cancer; Endocrinology; Cell growth; Immunohistochemistry; Medicine; Estrogen receptor; Biochemistry","score_opus":0.01478263704467588,"score_gpt":0.3343208502416724,"score_spread":0.31953821319699655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024412406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956714,0.0036667667,0.0000087257995,0.000290338,0.000020873584,0.00026883782,0.000037530383,0.0000026511216,0.000032884043],"genre_scores_gemma":[0.99880904,0.0008549759,0.000009913987,0.000019098494,0.00014902878,0.000099948214,0.000009980297,0.000015238119,0.000032777127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991444,0.00007486252,0.000101617414,0.00029067116,0.0001313426,0.00025712512],"domain_scores_gemma":[0.99968785,0.000014878962,0.0000258579,0.00011574333,0.0000896503,0.000066019864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002764259,0.00010281606,0.00014099841,0.00007710954,0.000059929185,0.000013329715,0.00006946871,0.0000820212,0.0000063283196],"category_scores_gemma":[0.000010039379,0.00007949593,0.00001907972,0.00013152673,0.00018794677,0.000004299343,0.00008794305,0.00017763123,5.2462383e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062592264,0.000058759662,0.008398709,0.00011528979,0.000060189912,0.000009012775,0.00018973656,0.00015746393,0.98171717,0.000015777681,0.00001499989,0.008636961],"study_design_scores_gemma":[0.0012356116,0.00048016766,0.011654852,0.00015991436,0.0000041456046,0.000021238542,0.000060903625,0.000004255479,0.9861096,0.0000664716,0.00011502237,0.00008780499],"about_ca_topic_score_codex":0.0005128549,"about_ca_topic_score_gemma":0.00016598747,"teacher_disagreement_score":0.008549156,"about_ca_system_score_codex":0.000051652092,"about_ca_system_score_gemma":0.00019315716,"threshold_uncertainty_score":0.32417497},"labels":[],"label_agreement":null},{"id":"W2024506184","doi":"10.1158/0008-5472.sabcs-3158","title":"Cardiac toxicity and adjuvant trastuzumab for breast cancer – the Cancer Centre of Southeastern Ontario experience.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Taxane; Trastuzumab; Anthracycline; Internal medicine; Breast cancer; Oncology; Cardiotoxicity; Population; Cancer; Adjuvant; Radiation therapy; Docetaxel; Surgery; Chemotherapy","score_opus":0.038599804251410304,"score_gpt":0.36436671671246945,"score_spread":0.32576691246105915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024506184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208046,0.011907013,0.000019687157,0.004014773,0.00019219142,0.00062870467,0.0010076232,0.0000066403036,0.00014293396],"genre_scores_gemma":[0.99522763,0.0025279976,0.000024577037,0.00015409269,0.00043871792,0.0006269851,0.000014771026,0.000019852752,0.00096534216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983633,0.00008338312,0.00018930066,0.00050753733,0.00032644067,0.000530033],"domain_scores_gemma":[0.99905884,0.000036613612,0.00006641105,0.00036625264,0.00036302596,0.00010885449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002298903,0.00019202362,0.0002771767,0.000039161252,0.00026807876,0.0000293375,0.00028253,0.00009123305,0.00010967151],"category_scores_gemma":[0.000016624006,0.00013335134,0.000110149456,0.00013178117,0.00035967413,0.000007774072,0.00013100781,0.00015463885,7.502727e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029173219,0.00038575812,0.4571493,0.0001314624,0.0008567819,0.0000032266078,0.023987701,0.00009912369,0.34238037,0.00013221156,0.0066007925,0.16535597],"study_design_scores_gemma":[0.0023226507,0.00032630938,0.7754434,0.00021182446,0.00011378564,0.0000066203456,0.0043950896,0.000013129154,0.1919538,0.00013208484,0.024688546,0.00039282278],"about_ca_topic_score_codex":0.033968307,"about_ca_topic_score_gemma":0.088550486,"teacher_disagreement_score":0.31829405,"about_ca_system_score_codex":0.00018233655,"about_ca_system_score_gemma":0.00051533227,"threshold_uncertainty_score":0.97246456},"labels":[],"label_agreement":null},{"id":"W2024533807","doi":"10.1158/0008-5472.sabcs13-p5-11-08","title":"Abstract P5-11-08: SRA/SRAP contributes to TGF-b1 induced cell motility in cancer cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Biology; Transcriptome; Carcinogenesis; Gene; RNA interference; Cancer research; Estrogen receptor; Transcription factor; Gene expression; RNA; Breast cancer; Cell biology; Cancer; Genetics","score_opus":0.07197624592965582,"score_gpt":0.3967151346933822,"score_spread":0.32473888876372636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024533807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922488,0.0028264152,0.000034018012,0.0019943889,0.00023004542,0.0009307537,0.000105818006,0.000009919115,0.0016198708],"genre_scores_gemma":[0.99382055,0.0011844728,0.00003527035,0.000386232,0.00023674496,0.0018097304,0.000031151583,0.000030924806,0.0024649422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997922,0.000119968034,0.00029753955,0.00062114885,0.00032840256,0.00071091903],"domain_scores_gemma":[0.9984623,0.000039597275,0.000052253436,0.0006386897,0.0005778708,0.00022928952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058079127,0.00017479135,0.00020559765,0.00015843516,0.00013870344,0.0001012622,0.00048724335,0.00021589428,0.0008977592],"category_scores_gemma":[0.000064388645,0.00016517747,0.0000671445,0.00047346263,0.00012303608,0.000012574376,0.00018195399,0.00034806877,0.00018907752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004362883,0.00010920619,0.007110051,0.000041542604,0.00001723448,0.0000018360361,0.00006826291,0.00023207316,0.95354086,0.000021855525,0.034398347,0.004415126],"study_design_scores_gemma":[0.0005992396,0.000072232564,0.09975531,0.000039248065,0.0000035223395,1.9662761e-7,0.00018695313,0.000020875772,0.85298795,0.00007347193,0.0460929,0.00016811844],"about_ca_topic_score_codex":0.012670514,"about_ca_topic_score_gemma":0.003935781,"teacher_disagreement_score":0.10055291,"about_ca_system_score_codex":0.0002642628,"about_ca_system_score_gemma":0.00059143576,"threshold_uncertainty_score":0.9939042},"labels":[],"label_agreement":null},{"id":"W2024533819","doi":"10.1158/1538-7445.am10-1799","title":"Abstract 1799: Utilizing metformin to enhance the efficacy of androgen deprivation therapy in the treatment of prostate cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; DU145; Metformin; Medicine; Hyperinsulinemia; Bicalutamide; LNCaP; Internal medicine; Cancer; Biguanide; Endocrinology; Androgen deprivation therapy; Endometrial cancer; Oncology; Prostate; Cancer research; Insulin resistance; Insulin; Androgen receptor","score_opus":0.05398973437786282,"score_gpt":0.4159727039835828,"score_spread":0.36198296960572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024533819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911121,0.08765766,0.0000020982661,0.00015696397,0.0001038465,0.00075449346,0.000034539662,0.0000016992856,0.00016770039],"genre_scores_gemma":[0.8866828,0.112265274,0.000024513087,0.00008128161,0.00020709696,0.00064604916,0.0000094418665,0.000012747944,0.00007076424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988424,0.00009900178,0.00021739485,0.00024467296,0.00030259148,0.00029391926],"domain_scores_gemma":[0.999121,0.000082143626,0.00007305874,0.00047879643,0.00020253837,0.000042443804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008083368,0.00010291478,0.00015101535,0.000060759074,0.000071081864,0.0000167855,0.00035791335,0.000070324764,0.00008857196],"category_scores_gemma":[0.000069967755,0.000057271627,0.00006414711,0.00030746375,0.00015085978,0.000005456511,0.000030792016,0.00014626769,0.0000016562617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020816439,0.00010323809,0.002635921,0.000013247114,0.000030464178,3.1360372e-7,0.0012659017,0.00003424068,0.5406218,0.000025540246,0.0002390223,0.45482215],"study_design_scores_gemma":[0.0004237009,0.00021085828,0.01322856,0.000016717986,0.000004313375,2.1385131e-7,0.00020303698,0.0000025375223,0.80494434,0.00003912319,0.18087207,0.00005455702],"about_ca_topic_score_codex":0.0014360197,"about_ca_topic_score_gemma":0.0022613136,"teacher_disagreement_score":0.45476758,"about_ca_system_score_codex":0.000029604358,"about_ca_system_score_gemma":0.00030720592,"threshold_uncertainty_score":0.23354693},"labels":[],"label_agreement":null},{"id":"W2024560367","doi":"10.1158/0008-5472.can-03-3605","title":"The RET Receptor Is Linked to Stress Response Pathways","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Cell biology; Gene expression; HSF1; Heat shock protein; Transcription factor; Gene; Heat shock; Hsp70; Cellular stress response; Regulation of gene expression; Signal transduction; Genetics; Fight-or-flight response","score_opus":0.0683439849032965,"score_gpt":0.4052666009831292,"score_spread":0.3369226160798327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024560367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780494,0.0015349021,0.00012276917,0.01841315,0.00012305194,0.0009362358,0.00016090137,0.000014160516,0.00064541603],"genre_scores_gemma":[0.98973763,0.0013737448,0.00021440514,0.00042656373,0.0005902503,0.00094591524,0.000021538086,0.000053528096,0.006636399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671704,0.0006409938,0.00020691825,0.00057235686,0.00088970806,0.0009729643],"domain_scores_gemma":[0.9977641,0.0001253498,0.000019791085,0.0010537558,0.0006472873,0.00038967907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029686405,0.00014244544,0.00011896018,0.00011822597,0.0006498895,0.00013791429,0.0009212687,0.00019926378,0.00016277636],"category_scores_gemma":[0.0016929851,0.00010695487,0.00007198115,0.00055253133,0.00029123639,0.0000044441945,0.00064018264,0.0005537123,0.00039610843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021428845,0.000035157525,0.00010374637,0.000015580115,0.00002731791,0.000008774121,0.0003178405,0.00005009502,0.9723912,0.00010322783,0.019935137,0.0048690746],"study_design_scores_gemma":[0.00036884498,0.00048461053,0.0005039246,0.00004080134,7.76112e-7,0.000001471077,0.00018389047,0.0000011658078,0.68113995,0.00014928647,0.31702042,0.00010487571],"about_ca_topic_score_codex":0.00042316355,"about_ca_topic_score_gemma":0.00033406133,"teacher_disagreement_score":0.2970853,"about_ca_system_score_codex":0.00030231653,"about_ca_system_score_gemma":0.0015712619,"threshold_uncertainty_score":0.5091305},"labels":[],"label_agreement":null},{"id":"W2024760098","doi":"10.1158/1538-7445.pedcan-b43","title":"Abstract B43: Role of activated SHP2 in high-risk neuroblastoma pathogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neuroblastoma; Zebrafish; Cancer research; Biology; Pediatric cancer; Ganglioneuroma; Carcinogenesis; Oncogene; Transgene; Genetically modified mouse; N-Myc; Penetrance; Cancer; Gene; Genetics; Phenotype; Cell culture","score_opus":0.03250106973838113,"score_gpt":0.3611948288178176,"score_spread":0.3286937590794365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024760098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703133,0.00020176827,0.0000015965238,0.00032909293,0.000042331973,0.00055140996,0.00004694701,0.00003312846,0.0017623707],"genre_scores_gemma":[0.99873894,0.00051824114,0.0000507319,0.00003012313,0.00010455312,0.0001721239,0.00001087695,0.00004801684,0.00032640476],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971714,0.00035074115,0.00028750292,0.00044960759,0.0010017318,0.0007390111],"domain_scores_gemma":[0.9983216,0.00042482238,0.00007030878,0.0005238145,0.00031708297,0.00034236125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007275136,0.00015860204,0.00035789912,0.0005976387,0.00008900553,0.00001995934,0.00022072454,0.00009764814,0.00047366702],"category_scores_gemma":[0.0005535899,0.00013217509,0.00008078349,0.0009298588,0.0001990856,0.00009235933,0.00012845745,0.00070851657,0.0001223551],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013678949,0.00044268343,0.053795334,0.00012518754,0.00005540369,0.00012522968,0.000070201415,0.00003565843,0.8815637,0.000058109337,0.0002442304,0.06211637],"study_design_scores_gemma":[0.0019851134,0.00072826876,0.517164,0.00013753954,0.000009794244,0.0000055647515,0.000040912448,0.00005809125,0.47875053,0.0002190567,0.000833449,0.00006767823],"about_ca_topic_score_codex":0.004035173,"about_ca_topic_score_gemma":0.00044164126,"teacher_disagreement_score":0.46336865,"about_ca_system_score_codex":0.00020415982,"about_ca_system_score_gemma":0.00034215156,"threshold_uncertainty_score":0.61000013},"labels":[],"label_agreement":null},{"id":"W2024823531","doi":"10.1158/0008-5472.sabcs13-p4-12-11","title":"Abstract P4-12-11: Patient preference for subcutaneous trastuzumab via handheld syringe versus intravenous infusion in HER2-positive early breast cancer: Cohort 2 of the PrefHer study","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Cohort; Crossover study; Breast cancer; Clinical endpoint; Randomization; Randomized controlled trial; Internal medicine; Oncology; Cancer; Pathology","score_opus":0.08074014626197955,"score_gpt":0.3842851056611099,"score_spread":0.30354495939913034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024823531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985234,0.0005394574,0.0000059456506,0.0009345677,0.00041156274,0.011699196,0.00027265368,0.00003135611,0.0008712179],"genre_scores_gemma":[0.99220437,0.00041381657,0.00002146865,0.000037599726,0.00023260328,0.006575524,0.000010721563,0.00008964643,0.00041426346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945559,0.00038204674,0.00070646644,0.0008395241,0.0022487505,0.0012673221],"domain_scores_gemma":[0.99643946,0.00056668377,0.00016622097,0.0009296061,0.0015370401,0.0003610024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010971546,0.0003305011,0.00064021436,0.00035402627,0.00026916832,0.00009382271,0.0007163343,0.00022574402,0.0013670854],"category_scores_gemma":[0.00022737047,0.00024337132,0.00014124395,0.0008848202,0.00049605005,0.0001677428,0.0003903951,0.0013433929,0.000031232463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013785906,0.0034362914,0.6810864,0.0012524428,0.0005593176,0.00016377207,0.014571995,0.00020713345,0.06459246,0.000018757622,0.0019883632,0.21833715],"study_design_scores_gemma":[0.0045199106,0.005354808,0.96936023,0.0012287813,0.000064482825,0.000026428457,0.001313642,0.00014363561,0.017359985,0.00004677051,0.00030796288,0.0002733628],"about_ca_topic_score_codex":0.1398055,"about_ca_topic_score_gemma":0.027125712,"teacher_disagreement_score":0.2882738,"about_ca_system_score_codex":0.0025600025,"about_ca_system_score_gemma":0.0018063756,"threshold_uncertainty_score":0.9995458},"labels":[],"label_agreement":null},{"id":"W2024918098","doi":"10.1158/0008-5472.can-05-1602","title":"Inducible IκB Kinase/IκB Kinase ε Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-κB Activation in Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"IκB kinase; Cancer research; Kinase; Biology; Ectopic expression; RELB; Cancer cell; Molecular biology; Cancer; Transcription factor; Signal transduction; NFKB1; NF-κB; Cell biology; Cell culture; Biochemistry; Gene","score_opus":0.054794064513326135,"score_gpt":0.3526123365050121,"score_spread":0.297818271991686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024918098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965058,0.0008218145,0.000009224795,0.0017943535,0.0000692026,0.00046250783,0.00016802295,0.00001719378,0.00015187207],"genre_scores_gemma":[0.99805665,0.00066314015,0.000077407414,0.0002560126,0.00033016416,0.0001565726,0.000039450177,0.000061075305,0.00035954476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782485,0.00018309323,0.00023475234,0.00072025077,0.00044728603,0.0005897856],"domain_scores_gemma":[0.9990705,0.000027665956,0.00007609496,0.000421232,0.00021205358,0.00019244886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038942578,0.00021546094,0.00019310889,0.00015677437,0.00017857777,0.00008331019,0.00028049987,0.0003160821,0.0004904868],"category_scores_gemma":[0.00004188875,0.00020269309,0.00004114889,0.0002988113,0.0001245541,0.000029450435,0.00023993278,0.00050623366,0.000019073384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001997669,0.00011955254,0.001090757,0.000060519244,0.000017179163,0.0000021099106,0.00059737684,0.00001416897,0.9784768,0.0000031878792,0.009010641,0.010407913],"study_design_scores_gemma":[0.00079753704,0.00012005782,0.0018739467,0.00021536468,0.0000032412004,0.0000014886214,0.00012212056,0.000055829663,0.9847597,0.000015420348,0.011794716,0.0002405895],"about_ca_topic_score_codex":0.0017721268,"about_ca_topic_score_gemma":0.00017640828,"teacher_disagreement_score":0.010167323,"about_ca_system_score_codex":0.00022259224,"about_ca_system_score_gemma":0.00029976628,"threshold_uncertainty_score":0.8265584},"labels":[],"label_agreement":null},{"id":"W2024960352","doi":"10.1158/1538-7445.pedcan-b45","title":"Abstract B45: A novel therapeutic approach for neuroblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroblastoma; SOX2; Cancer research; Tumor progression; Metastasis; Biology; Cell culture; Cancer; Chemistry; Molecular biology; Internal medicine; Medicine; Biochemistry; Transcription factor","score_opus":0.07683666766544858,"score_gpt":0.3962251027473787,"score_spread":0.31938843508193016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024960352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647323,0.0009245993,0.02457179,0.00064319326,0.00017209945,0.001157041,0.000090247115,0.000031538253,0.007677224],"genre_scores_gemma":[0.994063,0.00007840749,0.00084848993,0.00016359844,0.0009365457,0.0008632352,0.000074243,0.000069408736,0.0029030293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784917,0.00011765183,0.00018068346,0.0006030046,0.0005150558,0.00073444436],"domain_scores_gemma":[0.9986819,0.000094217445,0.00003448746,0.0005742892,0.00042697645,0.00018812719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013000276,0.00014966281,0.00015174139,0.0001398106,0.00025547898,0.000062898405,0.00048740467,0.00017152085,0.00004407361],"category_scores_gemma":[0.00031014316,0.00013982001,0.00011188926,0.00023768624,0.00028776642,0.0000047827857,0.00016043913,0.00036370003,0.00002876138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025429286,0.00012649022,0.00003243159,0.00009562854,0.000030307056,4.7378208e-7,0.00003533926,0.00018189926,0.97997206,0.00023400928,0.011068947,0.007968142],"study_design_scores_gemma":[0.0010677068,0.0004833021,0.00054015167,0.000016835995,0.0000043597656,0.000006139271,0.000042990967,0.0010792407,0.747219,0.00005871652,0.24927293,0.00020857563],"about_ca_topic_score_codex":0.00008917487,"about_ca_topic_score_gemma":0.000040395655,"teacher_disagreement_score":0.23820399,"about_ca_system_score_codex":0.000074365584,"about_ca_system_score_gemma":0.00029563688,"threshold_uncertainty_score":0.57016945},"labels":[],"label_agreement":null},{"id":"W2025143946","doi":"10.1158/0008-5472.can-09-1805","title":"Identification of a Small Molecule Inhibitor of the Human DNA Repair Enzyme Polynucleotide Kinase/Phosphatase","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Phosphatase; Molecular biology; Biology; DNA repair; Kinase; Biochemistry; DNA damage; DNA; Enzyme; Chemistry","score_opus":0.029273277237818005,"score_gpt":0.3365909548558806,"score_spread":0.30731767761806256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025143946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973659,0.0015887143,0.000047292968,0.00023553715,0.00007651953,0.00036426948,0.000066236076,0.000012979943,0.00024258062],"genre_scores_gemma":[0.99842894,0.000069219604,0.00007300791,0.00007177161,0.000104400606,0.000042288324,0.000025096622,0.00001681141,0.0011684707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985524,0.00017520518,0.00031114626,0.00032493728,0.000368821,0.00026753536],"domain_scores_gemma":[0.998635,0.000011173811,0.00012865523,0.0008408401,0.000317723,0.00006662872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007423943,0.00009474077,0.00012447486,0.00006604068,0.00010120592,0.000011957523,0.00044527088,0.00009900509,0.000029980758],"category_scores_gemma":[0.00018681352,0.000079339254,0.00014165568,0.00027533752,0.0001802392,0.000003898482,0.00017677007,0.00014245522,0.0000034941793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053423402,0.00009634176,0.00018428653,0.000038655584,0.000021916638,0.000001834102,0.000048253354,0.000012721363,0.9948546,0.0011841396,0.002970133,0.00053368957],"study_design_scores_gemma":[0.00027394964,0.00024646008,0.0018876892,0.000044137465,0.000009847451,0.0000011588432,0.00004890606,0.000025182455,0.9958181,0.00028925875,0.0012787192,0.00007659969],"about_ca_topic_score_codex":0.00016187299,"about_ca_topic_score_gemma":0.0000705822,"teacher_disagreement_score":0.0017034027,"about_ca_system_score_codex":0.000042976048,"about_ca_system_score_gemma":0.00017758452,"threshold_uncertainty_score":0.3235361},"labels":[],"label_agreement":null},{"id":"W2025147250","doi":"10.1158/0008-5472.can-08-0889","title":"Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; Melanocyte; Tensin; Cancer research; Biology; Protein kinase B; Melanoma; Tumor suppressor gene; PI3K/AKT/mTOR pathway; Cancer; Carcinogenesis; Cell biology; Phosphorylation; Signal transduction; Genetics","score_opus":0.08574903373484599,"score_gpt":0.37964098533897084,"score_spread":0.29389195160412485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025147250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648136,0.0010572817,0.000024851524,0.0006439233,0.000051573465,0.0004876552,0.000024730665,0.0000052469622,0.0012233704],"genre_scores_gemma":[0.99814874,0.00033373784,0.00032179107,0.0000984548,0.00006665917,0.00017067604,0.000017905819,0.000013907514,0.0008281497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818313,0.00024209831,0.00025097575,0.00059698854,0.0002948779,0.0004319078],"domain_scores_gemma":[0.99931216,0.000047855505,0.00002218049,0.0003400567,0.00012552658,0.00015223914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010759567,0.00010732497,0.00014273131,0.00022621913,0.00012180429,0.000019109746,0.00020039974,0.000100005826,0.000009184179],"category_scores_gemma":[0.00040738305,0.000107459564,0.000020789088,0.00057082623,0.00006074794,0.000006079644,0.00015715846,0.00014257191,0.000008342514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006014956,0.000032700995,0.13827346,0.000028121862,0.0000029142502,0.000026062542,0.0012250232,0.000048969217,0.85720456,0.000016935111,0.0013964997,0.0011432755],"study_design_scores_gemma":[0.00075790216,0.00019180139,0.4531484,0.00004523543,0.0000011127464,0.0000029209268,0.0003871957,0.0000084016665,0.5440101,0.000030793635,0.0012624157,0.00015372156],"about_ca_topic_score_codex":0.0015174554,"about_ca_topic_score_gemma":0.023550885,"teacher_disagreement_score":0.31487492,"about_ca_system_score_codex":0.00015061797,"about_ca_system_score_gemma":0.0001766465,"threshold_uncertainty_score":0.99426675},"labels":[],"label_agreement":null},{"id":"W2025574724","doi":"10.1158/1538-7445.am2014-2996","title":"Abstract 2996: Sunitinib withdrawal uncovers complementary stromal- and tumor-mediated mechanisms of resistance and rebound growth in metastatic mouse models","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Stromal cell; In vivo; Cancer research; Primary tumor; Melanoma; Metastasis; Drug resistance; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Breast cancer; Biology","score_opus":0.042266360022782674,"score_gpt":0.347360926055825,"score_spread":0.30509456603304236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025574724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997225,0.0011081657,0.00015322916,0.00017681338,0.000015033972,0.00040182547,0.0003907948,0.00000458444,0.00052455644],"genre_scores_gemma":[0.9980866,0.0010040901,0.00036445024,0.00005348541,0.000026233623,0.00011612501,0.00016033929,0.000024683155,0.00016399389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982767,0.00019137238,0.00022125043,0.0004097791,0.00043493725,0.00046595326],"domain_scores_gemma":[0.9992431,0.00010530151,0.000058244255,0.0002302435,0.00017845222,0.00018466554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007217848,0.00014176607,0.00021610291,0.00015749046,0.000100692916,0.00004088547,0.00016493112,0.00004102189,0.00003539739],"category_scores_gemma":[0.000109754816,0.00013368603,0.000026628537,0.00018752253,0.0003333232,0.000018669358,0.00017480558,0.0001992184,0.0000010647176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002597395,0.00024491147,0.009699368,0.000635026,0.00028899687,0.00006204309,0.00027774432,0.00008572413,0.97968364,0.0040556523,0.0014034358,0.00096604397],"study_design_scores_gemma":[0.011958809,0.0020726447,0.01700547,0.0003423727,0.000040356925,0.000014640427,0.001708498,0.00037601596,0.93347025,0.030260626,0.0021201763,0.00063015695],"about_ca_topic_score_codex":0.0062008514,"about_ca_topic_score_gemma":0.015363098,"teacher_disagreement_score":0.046213422,"about_ca_system_score_codex":0.00007994332,"about_ca_system_score_gemma":0.000239556,"threshold_uncertainty_score":0.9373874},"labels":[],"label_agreement":null},{"id":"W2025575829","doi":"10.1158/0008-5472.sabcs12-p5-13-01","title":"Abstract P5-13-01: Does empowering patients improve accrual to breast cancer trials?","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Clinical trial; Accrual; Breast cancer; Informed consent; Clinical research; Cancer; Internal medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.5780233049453019,"score_gpt":0.6721888250182877,"score_spread":0.09416552007298584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025575829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726752,0.00093191845,0.0000083071955,0.016004262,0.0020407808,0.0019827518,0.00045553496,0.00006730922,0.0058339075],"genre_scores_gemma":[0.9825688,0.0016373531,0.00011753327,0.0007260179,0.004204704,0.0010413869,0.000016191145,0.000097579374,0.009590454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920163,0.0004680292,0.0009378043,0.0007526182,0.0038551558,0.001970081],"domain_scores_gemma":[0.9866867,0.008156351,0.00013571931,0.0009861655,0.0023031714,0.0017319059],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02053705,0.00026599722,0.0007655421,0.00042439142,0.00031209888,0.00013892297,0.00067259936,0.0005217296,0.007255946],"category_scores_gemma":[0.023669591,0.0001790353,0.00023142381,0.00082846166,0.0004247569,0.00032921304,0.0007874532,0.0043860185,0.0005954386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009965157,0.0021553668,0.5936713,0.0027928713,0.00071125577,0.000056659603,0.004738672,0.000011471309,0.1487942,0.0010653263,0.046542436,0.18949524],"study_design_scores_gemma":[0.005610701,0.00050627993,0.8804974,0.002109595,0.00007442604,0.0000030660362,0.0009632358,0.0000060375114,0.058552805,0.0013832421,0.049702432,0.00059079845],"about_ca_topic_score_codex":0.0033411982,"about_ca_topic_score_gemma":0.0025579836,"teacher_disagreement_score":0.28682604,"about_ca_system_score_codex":0.0012792337,"about_ca_system_score_gemma":0.0019147942,"threshold_uncertainty_score":0.9979109},"labels":[],"label_agreement":null},{"id":"W2025807499","doi":"10.1158/1538-7445.am2012-93","title":"Abstract 93: Defining the roles of COIL and WIPI1 in breast cancer metastasis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Metastasis; Cancer research; Ectopic expression; Cancer; Autophagy; Biology; Cancer cell; Medicine; Pathology; Cell culture; Apoptosis; Internal medicine; Genetics","score_opus":0.05273320443088912,"score_gpt":0.3805802582687279,"score_spread":0.32784705383783874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025807499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98061424,0.01715955,0.000009620579,0.0008762961,0.000174075,0.00010611404,0.00008748187,0.000001945786,0.00097066694],"genre_scores_gemma":[0.99562025,0.0036583329,0.00003103982,0.00011533305,0.00025426035,0.00008946118,0.0000093300005,0.000009637957,0.0002123447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991782,0.00013197785,0.00011840545,0.00015257833,0.00013724602,0.0002816055],"domain_scores_gemma":[0.99959797,0.000043320044,0.00003192919,0.00017151158,0.00009121758,0.00006407477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067834987,0.00006379986,0.00009787854,0.000053532185,0.000063328975,0.000009558907,0.00011108573,0.00007834455,0.0002751272],"category_scores_gemma":[0.000052328476,0.000045220982,0.000026724034,0.0001288286,0.00017947449,0.000004516174,0.00009215747,0.00017547203,0.000005410846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027532878,0.000040354465,0.08397852,0.000043419615,0.000039170416,0.0000011000099,0.00041027597,0.000031189826,0.8865742,0.00047225558,0.0046798526,0.023454294],"study_design_scores_gemma":[0.0013538367,0.00013294956,0.31063613,0.000111338486,0.000027936423,0.00004632465,0.0017362664,0.000010968073,0.54166394,0.00009815476,0.1438985,0.00028366415],"about_ca_topic_score_codex":0.00071936636,"about_ca_topic_score_gemma":0.0014013561,"teacher_disagreement_score":0.3449103,"about_ca_system_score_codex":0.000016891812,"about_ca_system_score_gemma":0.00010853237,"threshold_uncertainty_score":0.301245},"labels":[],"label_agreement":null},{"id":"W2026102933","doi":"10.1158/0008-5472.sabcs12-es7-2","title":"Abstract ES7-2: Tumor Dormancy from an Experimental Biologist's Perspective","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spaceflight effects on biology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Breast cancer; Cancer; Medicine; Metastatic breast cancer; Metastasis; Population; Disease; Dormancy; Cancer cell; Oncology; Internal medicine; Immunology; Cancer research; Biology","score_opus":0.12700008752822017,"score_gpt":0.5075632638830497,"score_spread":0.38056317635482956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026102933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747306,0.014641669,0.0000024081146,0.0014749906,0.00041350737,0.00056864397,0.000052560114,0.00008409046,0.008031517],"genre_scores_gemma":[0.99690866,0.00015707818,0.00014655123,0.00035511356,0.0017947726,0.00027703508,0.0000455395,0.000033401193,0.0002818529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806637,0.00019000922,0.00014574258,0.0004057102,0.00036886628,0.0008232902],"domain_scores_gemma":[0.99861616,0.00019994173,0.00003897029,0.00046032478,0.00023532183,0.0004493061],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00062616006,0.00015805014,0.00027458102,0.00019608666,0.00013255015,0.000022065631,0.00020081643,0.00013339931,0.0040074196],"category_scores_gemma":[0.00018955016,0.00011833053,0.00006398246,0.00025257375,0.0004389893,0.00019759056,0.00010971045,0.00060615904,0.0007931855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007835013,0.00047096284,0.045190226,0.000014544621,0.00006784729,0.0000584136,0.0016395556,1.9997098e-7,0.94468254,0.00048607663,0.0057280483,0.0008781042],"study_design_scores_gemma":[0.0014926863,0.0009416814,0.26350397,0.00006835419,0.00001404514,0.00002410788,0.0050615603,0.0000073802285,0.71325016,0.00009675734,0.015339812,0.00019945898],"about_ca_topic_score_codex":0.005284575,"about_ca_topic_score_gemma":0.000092060065,"teacher_disagreement_score":0.23143235,"about_ca_system_score_codex":0.0008877012,"about_ca_system_score_gemma":0.00022520428,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2026326021","doi":"10.1158/0008-5472.sabcs10-p4-11-06","title":"Abstract P4-11-06: Population Based Outcomes after Whole Brain Radiotherapy in Patients with Metastatic Breast Cancer in the Pre and Post Trastuzumab Eras","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Brain metastasis; Oncology; Internal medicine; Proportional hazards model; Radiation therapy; Metastatic breast cancer; Cancer; Population; Log-rank test; Multivariate analysis; Metastasis","score_opus":0.02201766904032287,"score_gpt":0.37264178116134933,"score_spread":0.35062411212102645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026326021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817225,0.00038822682,0.000003021453,0.016085204,0.000036693826,0.001350775,0.00039732785,0.000007741412,0.000008529159],"genre_scores_gemma":[0.9980037,0.000019826386,0.0001610659,0.0008884537,0.000047991383,0.00064536737,0.00009814154,0.000030735515,0.00010469454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982241,0.00018912635,0.00021630403,0.00032233226,0.00065795507,0.0003902028],"domain_scores_gemma":[0.99912536,0.0002783493,0.000043728654,0.00031440024,0.0001302961,0.000107835156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075492286,0.00016768943,0.00028460013,0.0002502062,0.00007109609,0.00005763667,0.000098263066,0.00005140939,0.00053340645],"category_scores_gemma":[0.00004226011,0.00009357209,0.000040414645,0.00035282288,0.000105600084,0.00012334845,0.0000137413845,0.0005137931,0.0000025050933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012202584,0.00051139924,0.98315173,0.00009487943,0.00006134449,0.000044431024,0.0006352431,0.000044549855,0.00056670135,0.000010693652,0.00014361765,0.0135151595],"study_design_scores_gemma":[0.006768979,0.00022455325,0.99213886,0.00015142163,0.000025800744,0.0000044070193,0.00010031779,0.00005657909,0.000029934641,0.000013813952,0.0003862524,0.00009909581],"about_ca_topic_score_codex":0.015243116,"about_ca_topic_score_gemma":0.02864861,"teacher_disagreement_score":0.016281243,"about_ca_system_score_codex":0.0002851057,"about_ca_system_score_gemma":0.0002628814,"threshold_uncertainty_score":0.9913145},"labels":[],"label_agreement":null},{"id":"W2026364548","doi":"10.1158/0008-5472.sabcs-3117","title":"Incidence of postmenopausal symptoms and current mamagement: a survey of 260 breast cancer patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Incidence (geometry); Menopause; Cancer; Internal medicine; Gynecology; Pediatrics; Obstetrics","score_opus":0.07324103792604446,"score_gpt":0.464679967230813,"score_spread":0.39143892930476853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026364548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861814,0.009118072,0.0000010074675,0.00072161393,0.00015095765,0.0006123734,0.00047503316,0.000008497516,0.00029428786],"genre_scores_gemma":[0.9938061,0.0056611984,0.0000063465536,0.00008286743,0.00008036423,0.00007901584,0.000046376997,0.000011281112,0.00022640255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841684,0.00016844532,0.0002648222,0.00026828292,0.0005390752,0.00034254827],"domain_scores_gemma":[0.99850917,0.00012449973,0.00009084641,0.00018698814,0.0009271271,0.00016139726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048707222,0.00011883406,0.0003259844,0.00021809553,0.000050510807,0.0000070317215,0.00011983822,0.000047569967,0.0006807849],"category_scores_gemma":[0.000040250798,0.000098593555,0.000028237058,0.0005356636,0.00026113508,0.00006912257,0.00008176908,0.00024679434,0.000003153732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021176129,0.00090523344,0.8507082,0.00029356603,0.000120841316,0.0000063986267,0.00034172556,0.00000259872,0.019091403,0.00006013067,0.003895607,0.12245667],"study_design_scores_gemma":[0.0027018792,0.0016282956,0.9878774,0.00030584415,0.00006910766,0.000002918536,0.000010689333,0.000016591986,0.0067319055,0.000037608985,0.00054167263,0.00007608242],"about_ca_topic_score_codex":0.0073744087,"about_ca_topic_score_gemma":0.0006708328,"teacher_disagreement_score":0.1371692,"about_ca_system_score_codex":0.00025731884,"about_ca_system_score_gemma":0.00047889727,"threshold_uncertainty_score":0.9992356},"labels":[],"label_agreement":null},{"id":"W2026429388","doi":"10.1158/0008-5472.can-06-2925","title":"Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":583,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Indoleamine 2,3-dioxygenase; Cancer research; Biology; Chemistry; Immunology; Tryptophan; Biochemistry","score_opus":0.047109739234006236,"score_gpt":0.3536550443331169,"score_spread":0.30654530509911065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026429388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807274,0.0006528986,0.00004881875,0.000080763035,0.00006556815,0.0004272322,0.00009107346,0.000016318558,0.0005445678],"genre_scores_gemma":[0.9989615,0.00033853995,0.00004893101,0.000067644265,0.000019208253,0.000027187147,0.000003331364,0.000026138288,0.00050752005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975782,0.00033978277,0.00037675267,0.00039685346,0.000743269,0.0005651185],"domain_scores_gemma":[0.99833465,0.0010206874,0.00010894065,0.00026845853,0.00014789276,0.000119354794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010183146,0.00013653174,0.0002571288,0.00070304016,0.00006644209,0.000018114537,0.0002518442,0.00008210125,0.00012605106],"category_scores_gemma":[0.0004734804,0.000120056546,0.000039789655,0.0016519128,0.0007989618,0.00016601286,0.00007770044,0.00040022712,0.000010595812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014239707,0.00023698343,0.001376435,0.0001707137,0.000004257063,0.0001048322,0.0005232643,0.00002204807,0.9943056,0.00013858992,0.00033931655,0.0013539711],"study_design_scores_gemma":[0.001471484,0.00042452273,0.0038761874,0.0002633507,0.0000011730247,0.000005665511,0.00112603,0.000012406362,0.9924568,0.00009347177,0.00014338017,0.0001255248],"about_ca_topic_score_codex":0.00035259177,"about_ca_topic_score_gemma":0.00032968345,"teacher_disagreement_score":0.0024997524,"about_ca_system_score_codex":0.000099886136,"about_ca_system_score_gemma":0.00021159492,"threshold_uncertainty_score":0.4895764},"labels":[],"label_agreement":null},{"id":"W2026666467","doi":"10.1158/0008-5472.can-08-3935","title":"Polychlorinated Biphenyls and Risk of Testicular Germ Cell Tumors","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; U.S. Department of Defense","keywords":"Seminoma; Odds ratio; Confidence interval; Endocrine system; Internal medicine; Endocrinology; Physiology; Germ cell tumors; Medicine; Oncology; Hormone","score_opus":0.039044624911717146,"score_gpt":0.3843721803528881,"score_spread":0.345327555441171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026666467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772645,0.010358918,0.0000054943785,0.0002483424,0.000019394043,0.00035617998,0.000041438823,0.000024012223,0.0012197803],"genre_scores_gemma":[0.9975151,0.001454577,0.0001588103,0.000029223394,0.000051319817,0.000025119782,0.000008450713,0.000012023161,0.0007453693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988749,0.00006328554,0.00013537455,0.0002226707,0.00041042815,0.00029331757],"domain_scores_gemma":[0.999111,0.000096055206,0.000048140577,0.0002559982,0.00022599402,0.00026278573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001972816,0.00009155674,0.00019432222,0.00013429168,0.00008057845,0.00001268785,0.000058356687,0.000039272018,0.00014891362],"category_scores_gemma":[0.00026288925,0.000069277994,0.000050885814,0.00034807646,0.00013734469,0.00003008115,0.000029253024,0.00018921249,0.000017006549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055087596,0.0009794153,0.90609723,0.00026037492,0.00017946807,0.00061046984,0.00017554157,0.000010349252,0.03856764,0.00022017134,0.00093179184,0.051416673],"study_design_scores_gemma":[0.0022128862,0.0010118869,0.95368046,0.0001984847,0.0001881116,0.000017136952,0.000047513546,0.000109395034,0.041294355,0.00050081004,0.000650203,0.00008878522],"about_ca_topic_score_codex":0.00084560784,"about_ca_topic_score_gemma":0.000004160358,"teacher_disagreement_score":0.051327888,"about_ca_system_score_codex":0.00007535898,"about_ca_system_score_gemma":0.00022741691,"threshold_uncertainty_score":0.28250748},"labels":[],"label_agreement":null},{"id":"W2026673361","doi":"10.1158/0008-5472.can-04-3071","title":"BRCA2 Regulates Homologous Recombination in Response to DNA Damage: Implications for Genome Stability and Carcinogenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"RAD51; Homologous recombination; Non-allelic homologous recombination; Gene conversion; Biology; Sister chromatids; Mitotic crossover; Genetics; Direct repeat; FLP-FRT recombination; Homologous chromosome; Non-homologous end joining; BRCA2 Protein; DNA repair; Genome instability; Molecular biology; DNA; DNA damage; Gene; Genetic recombination; Recombination; Genome; Mutation; Chromosome; Germline mutation","score_opus":0.053368009707727676,"score_gpt":0.37574157926798707,"score_spread":0.3223735695602594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026673361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925708,0.00069389906,0.00013977365,0.005550553,0.000023939307,0.000875202,0.00007984631,0.000008800928,0.00005717864],"genre_scores_gemma":[0.9972142,0.00011648458,0.0009485868,0.00009296874,0.00007471002,0.0009992298,0.00003464519,0.000020872594,0.0004982801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868685,0.00025759597,0.000155536,0.0004584148,0.000105681596,0.0003359447],"domain_scores_gemma":[0.99903804,0.000091826696,0.000021523658,0.0004484198,0.00028823907,0.00011197707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017504516,0.000083178886,0.00010120562,0.00014573502,0.000117069605,0.0000320584,0.0001950316,0.00010787535,0.000025207737],"category_scores_gemma":[0.0004658617,0.00008919136,0.000029581177,0.00023914372,0.00007957122,0.0000058410783,0.00016462516,0.000079567784,0.000003416695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005635013,0.000044858858,0.0016090047,0.000018632114,0.000007537669,3.2052162e-7,0.00013850276,0.000033055207,0.9912942,0.00011744886,0.00017342961,0.005999528],"study_design_scores_gemma":[0.00044665002,0.0003195587,0.15317506,0.000006036398,0.0000029591722,0.0000024730296,0.00008889876,0.000026274714,0.8371611,0.00075763586,0.00790732,0.000106016145],"about_ca_topic_score_codex":0.00008729825,"about_ca_topic_score_gemma":0.00074702833,"teacher_disagreement_score":0.15413305,"about_ca_system_score_codex":0.00020838513,"about_ca_system_score_gemma":0.0002115059,"threshold_uncertainty_score":0.3637118},"labels":[],"label_agreement":null},{"id":"W2026679145","doi":"10.1158/0008-5472.can-05-1684","title":"The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Johns Hopkins University; National Institutes of Health; American Cancer Society","keywords":"Carcinogenesis; Cancer; Cancer research; Oncogene; Biology; Transfection; Malignant transformation; Uterus; Uterine cancer; Internal medicine; Cell cycle; Medicine; Endocrinology; Cell culture","score_opus":0.017481793216956754,"score_gpt":0.35684705451429743,"score_spread":0.3393652612973407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026679145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005324,0.00886003,0.000058544076,0.00017901685,0.00031759948,0.0003876647,0.000011743447,0.0000123851705,0.000119808436],"genre_scores_gemma":[0.99373776,0.0040596128,0.00009086379,0.000023749606,0.00036591658,0.00013801409,0.000044101642,0.000027985621,0.0015120283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980497,0.00024745153,0.00023744315,0.00044216978,0.0003441751,0.00067906966],"domain_scores_gemma":[0.9990228,0.000101558224,0.000038830585,0.0005504734,0.00012733298,0.00015902339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021254143,0.00014424912,0.0001283696,0.00008037124,0.00030779856,0.000038469057,0.00036563264,0.00020454031,0.000029744144],"category_scores_gemma":[0.00010822554,0.00009757198,0.00006707527,0.0003143398,0.00026255802,0.000005041737,0.0002800851,0.00035331066,0.000013657277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006010841,0.00006969275,0.0014789691,0.000022308905,0.000020917214,0.000028542781,0.000031681215,0.000028114624,0.9892577,0.000036273355,0.0009896415,0.007435111],"study_design_scores_gemma":[0.0005731866,0.0001908009,0.015840724,0.000025263902,0.000002545635,0.0000067350916,0.00006157191,0.000009229185,0.97024935,0.000108572254,0.012808599,0.0001234198],"about_ca_topic_score_codex":0.00042052515,"about_ca_topic_score_gemma":0.0003578388,"teacher_disagreement_score":0.019008312,"about_ca_system_score_codex":0.000098064185,"about_ca_system_score_gemma":0.00010879934,"threshold_uncertainty_score":0.397887},"labels":[],"label_agreement":null},{"id":"W2027306043","doi":"10.1158/0008-5472.sabcs13-p6-05-07","title":"Abstract P6-05-07: Discordance in estrogen receptor, progesterone receptor and HER-2/neu status between primary and metastatic breast cancer: A systematic review","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Oncology; Breast cancer; Metastatic breast cancer; Internal medicine; Estrogen receptor; Interquartile range; Gynecology; Cancer; Progesterone receptor; Metastasis","score_opus":0.11986107829085137,"score_gpt":0.4504060065157053,"score_spread":0.33054492822485393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027306043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019185813,0.97918934,0.0000044516632,0.0011034892,0.00016282962,0.015654555,0.0018567876,0.00007618285,0.00003380793],"genre_scores_gemma":[0.00007020622,0.97898763,0.0006758483,0.0001658688,0.00036092062,0.018311303,0.00035371815,0.00030607844,0.0007684307],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9918337,0.0011541896,0.0020602457,0.0016319806,0.0015473441,0.0017725527],"domain_scores_gemma":[0.99539334,0.0009348113,0.0009287433,0.0012674326,0.00053943554,0.0009362712],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021421623,0.0011129285,0.0069809137,0.0006289875,0.00018592404,0.00016909884,0.00056344515,0.00030532907,0.0005798369],"category_scores_gemma":[0.0002814669,0.0008166881,0.00029956887,0.0013543906,0.00084057084,0.0005150186,0.00042839264,0.0023818526,0.00014389778],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059816295,0.00006600544,0.00025266298,0.59974706,0.0006084374,0.000030437188,0.00011590691,9.0485315e-8,0.000037884063,0.0000068921663,0.00040637542,0.39866844],"study_design_scores_gemma":[0.0012402993,0.00020535736,0.0005348016,0.8296257,0.0018208917,0.0002635767,0.00011378553,4.5030816e-7,0.00000889599,0.00002290434,0.16543539,0.0007279387],"about_ca_topic_score_codex":0.0019770432,"about_ca_topic_score_gemma":0.000113194124,"teacher_disagreement_score":0.39794052,"about_ca_system_score_codex":0.0031723096,"about_ca_system_score_gemma":0.0030129987,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W2027586113","doi":"10.1158/1538-7445.am2012-2590","title":"Abstract 2590: A novel use of E2f and Cdk inhibitors to prevent <i>RB</i>-null tumours in genetically engineered models of retinoblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Toronto Western Hospital","funders":"","keywords":"Retinoblastoma; Cyclin-dependent kinase; E2F; Retinoblastoma protein; Cancer research; Biology; Carcinogenesis; CDK inhibitor; Cyclin-dependent kinase 2; Cell cycle; Cell biology; Cancer; Genetics; Gene","score_opus":0.08630163325758261,"score_gpt":0.35833147872016663,"score_spread":0.272029845462584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027586113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523425,0.0024555211,0.00033490473,0.00047401403,0.00009570809,0.0010304004,0.00006991541,0.000014034801,0.0002912592],"genre_scores_gemma":[0.9977102,0.00037163647,0.0014653788,0.000047907033,0.00011617223,0.00013256408,0.0000052178225,0.00004989791,0.000100973455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771994,0.00006065414,0.00046130037,0.00030858026,0.00081669114,0.0006328261],"domain_scores_gemma":[0.99856704,0.00015016193,0.000066715875,0.00041007577,0.00036559085,0.000440392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082576415,0.00015626929,0.00037988965,0.00047826034,0.000020821839,0.000009993409,0.00012273491,0.00015184742,0.000058419988],"category_scores_gemma":[0.0003575542,0.00015195161,0.00006938089,0.00065623224,0.00017708135,0.00011110266,0.0001614049,0.0005356933,0.000004398485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064009946,0.00047491366,0.0020863889,0.00038419777,0.00004591562,0.000013801815,0.0011396125,0.003617978,0.98787284,0.00018607588,0.0009619012,0.0025762923],"study_design_scores_gemma":[0.002146623,0.00065558933,0.06449857,0.0017279761,0.000043497832,0.000024650533,0.00012604536,0.0012461788,0.92804503,0.000044739998,0.0012133035,0.00022777285],"about_ca_topic_score_codex":0.0010890217,"about_ca_topic_score_gemma":0.00015480156,"teacher_disagreement_score":0.062412184,"about_ca_system_score_codex":0.00030100043,"about_ca_system_score_gemma":0.00044975575,"threshold_uncertainty_score":0.61964065},"labels":[],"label_agreement":null},{"id":"W2027821425","doi":"10.1158/1538-7445.am10-4548","title":"Abstract 4548: Erythrose kill cancer cell in vitro and inhibit tumor growth in vivo","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"In vivo; Carcinogenesis; Cancer cell; Warburg effect; Cancer research; Cancer; Cell growth; Cell culture; Biology; Biochemistry; Chemistry; Genetics","score_opus":0.01986992381009826,"score_gpt":0.33252469738760193,"score_spread":0.31265477357750365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027821425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98303044,0.013402998,9.0561224e-7,0.00031361176,0.00070461433,0.00034446002,0.00011416443,0.000006599553,0.0020822003],"genre_scores_gemma":[0.9844694,0.012446825,0.00005607952,0.00021243033,0.0013907433,0.00032553074,0.000013051968,0.000037978894,0.001047964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818367,0.000063832085,0.00023724746,0.00056605705,0.0002905133,0.0006587092],"domain_scores_gemma":[0.9992594,0.000030167479,0.00004580452,0.00030862255,0.00016675224,0.00018923935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006412054,0.00017271268,0.00022372976,0.00014694073,0.00007347577,0.000049277816,0.00024565295,0.00018524835,0.00032294658],"category_scores_gemma":[0.000095782736,0.00016948217,0.0000483578,0.00026765425,0.00025588632,0.000015362903,0.00019723248,0.0006646691,0.000005756818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026946608,0.00007712021,0.0029536935,0.000083546875,0.0000068753043,0.000009045064,0.00015327481,0.0000044223575,0.98836076,0.000019577852,0.004319741,0.003742486],"study_design_scores_gemma":[0.0012073523,0.000035874793,0.012250683,0.00003199181,0.0000032170365,0.000004107492,0.00011178411,0.0000064926403,0.88734347,0.00007711873,0.09873087,0.00019706386],"about_ca_topic_score_codex":0.014271095,"about_ca_topic_score_gemma":0.03132811,"teacher_disagreement_score":0.10101731,"about_ca_system_score_codex":0.000083866056,"about_ca_system_score_gemma":0.00054133177,"threshold_uncertainty_score":0.99229294},"labels":[],"label_agreement":null},{"id":"W2027832172","doi":"10.1158/1538-7445.am10-1240","title":"Abstract 1240: Functional deregulation of NF-kB and abnormal TNFa response in acute promyelocytic leukemia","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Acute promyelocytic leukemia; Microarray analysis techniques; Leukemia; Fusion gene; Biology; Gene; Cancer research; Retinoic acid; Chromosomal translocation; Gene expression; Promyelocyte; Pathogenesis; Signal transduction; Microarray; NF-κB; Gene expression profiling; Molecular biology; Immunology; Genetics","score_opus":0.024917498866903406,"score_gpt":0.33971950028982245,"score_spread":0.31480200142291903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027832172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827254,0.00058856024,0.000052521395,0.00015428058,0.000096576194,0.0001836616,0.000011382317,0.0000044052545,0.0006360895],"genre_scores_gemma":[0.99843514,0.00029918566,0.00013667253,0.000019475772,0.00016727652,0.0000785649,0.000033524106,0.00001558671,0.0008145653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988708,0.00008650023,0.00019140015,0.0002967802,0.00028261202,0.00027194037],"domain_scores_gemma":[0.9993593,0.000058482856,0.00004863318,0.00023738176,0.00022229197,0.00007392973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009850073,0.00009418837,0.00010683026,0.00011730484,0.000076612334,0.000024056391,0.00014769376,0.00019212226,0.00012449874],"category_scores_gemma":[0.00020460393,0.000088205416,0.000029823328,0.00017638221,0.00029798472,0.000010515793,0.00010242148,0.00038291185,0.0000037904688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016857667,0.00001778747,0.006026502,0.00007593108,0.000020822219,0.0000070488027,0.000058970378,0.000082392515,0.9882653,0.000054254284,0.00044182883,0.0032634262],"study_design_scores_gemma":[0.00063333,0.00014820948,0.14413877,0.000026819704,0.0000050071817,0.000017021548,0.000043339034,0.0000744355,0.85155934,0.00018155423,0.0030719298,0.00010022999],"about_ca_topic_score_codex":0.00010066958,"about_ca_topic_score_gemma":0.00008534904,"teacher_disagreement_score":0.13811228,"about_ca_system_score_codex":0.00007078736,"about_ca_system_score_gemma":0.0010485074,"threshold_uncertainty_score":0.35969126},"labels":[],"label_agreement":null},{"id":"W2027848021","doi":"10.1158/1538-7445.am2011-2843","title":"Abstract 2843: Tumor macrophages utilize ATF3 to promote breast cancer metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Stromal cell; Cancer; Primary tumor; Cancer research; Breast cancer; Cancer cell; Tumor microenvironment; Biology; Lung cancer; Mammary tumor; Immunology; Medicine; Pathology; Internal medicine","score_opus":0.07401793602432748,"score_gpt":0.3832873469896638,"score_spread":0.30926941096533633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027848021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992221,0.0042492826,0.00004237618,0.00075484277,0.0003044957,0.00067409576,0.0003619537,0.000026858766,0.0013650943],"genre_scores_gemma":[0.99533826,0.00092232303,0.00030757452,0.00012672401,0.00064053753,0.00054801075,0.00003251454,0.00006808795,0.002015939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977353,0.00009463532,0.0002550225,0.0006956887,0.00050017505,0.000719137],"domain_scores_gemma":[0.99850017,0.000009858976,0.000068003996,0.00060889585,0.00050955295,0.00030349402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055156095,0.00021327064,0.00020055857,0.00016367323,0.00018098792,0.000046806286,0.0004265926,0.00014393388,0.0022467424],"category_scores_gemma":[0.000048347643,0.00020258834,0.00010839808,0.0004961153,0.00016889643,0.000011178597,0.00025671042,0.0002901973,0.00011985927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000645911,0.00007917942,0.0010056113,0.000073870804,0.00016928709,0.000016265687,0.00022083968,0.00018286837,0.91007817,0.000019987514,0.014515224,0.07299279],"study_design_scores_gemma":[0.00053491275,0.0001774269,0.06327671,0.000098239914,0.000028453818,0.000025348887,0.000080405305,0.000021854967,0.8843894,0.00006446948,0.050987232,0.00031554644],"about_ca_topic_score_codex":0.0028916597,"about_ca_topic_score_gemma":0.0012476357,"teacher_disagreement_score":0.07267724,"about_ca_system_score_codex":0.00021933815,"about_ca_system_score_gemma":0.00052892027,"threshold_uncertainty_score":0.99866533},"labels":[],"label_agreement":null},{"id":"W2027976855","doi":"10.1158/1538-7445.am2014-3367","title":"Abstract 3367: Understanding the role of metabolic reprogramming in breast cancer progression and metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Warburg effect; Metastasis; Cancer; Metastatic breast cancer; Breast cancer; Cancer research; Tumor progression; Cancer cell; Biology; Primary tumor; Mammary tumor; Glycolysis; Anaerobic glycolysis; Bioenergetics; Phenotype; Mitochondrion; Metabolism; Cell biology; Endocrinology; Biochemistry; Genetics","score_opus":0.04988552724222799,"score_gpt":0.38293786344936254,"score_spread":0.33305233620713454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027976855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9172735,0.08059598,0.00006903629,0.0006259125,0.00021453858,0.00037222225,0.000043356576,0.000006108885,0.0007993117],"genre_scores_gemma":[0.9835189,0.015346632,0.00006559223,0.000035572204,0.00070976716,0.00022886481,0.0000066931143,0.000021924583,0.00006605503],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844795,0.00017520318,0.00021021154,0.00038844484,0.00034862597,0.00042958194],"domain_scores_gemma":[0.99928474,0.00004317585,0.000079356534,0.00036194958,0.0001348791,0.00009589509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014857509,0.00012275421,0.00021102667,0.00011592075,0.00014541831,0.000044837197,0.00022850263,0.00009579306,0.000048537575],"category_scores_gemma":[0.00007014924,0.00008782272,0.000060770515,0.00032055148,0.0003112763,0.0000094557245,0.00017078288,0.00025601737,8.667737e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021951328,0.00004654431,0.015041964,0.000066235276,0.000072696595,3.7801686e-7,0.0002970569,0.000039752613,0.5968102,0.0015378197,0.00030306025,0.38556477],"study_design_scores_gemma":[0.0016773865,0.000109531706,0.10491743,0.00028644226,0.00007280035,0.000017441802,0.002821362,0.0001294105,0.4133982,0.0020930534,0.4740845,0.0003924439],"about_ca_topic_score_codex":0.0014496986,"about_ca_topic_score_gemma":0.0010172796,"teacher_disagreement_score":0.47378144,"about_ca_system_score_codex":0.000037318965,"about_ca_system_score_gemma":0.00018869394,"threshold_uncertainty_score":0.35813066},"labels":[],"label_agreement":null},{"id":"W2028074766","doi":"10.1158/0008-5472.sabcs13-p1-07-12","title":"Abstract P1-07-12: Kaiso is a novel regulator of epithelial-to-mesenchymal transition in triple negative breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Triple-negative breast cancer; Metastasis; Cancer research; Epithelial–mesenchymal transition; Breast cancer; Estrogen receptor; Progesterone receptor; Cancer; Metastatic breast cancer; Transcription factor; Medicine; Biology; Oncology; Internal medicine","score_opus":0.06258253959860112,"score_gpt":0.3750082645042793,"score_spread":0.3124257249056782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028074766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852844,0.00064406043,0.0000499017,0.0095131295,0.0002702728,0.001971494,0.0012468243,0.00001904956,0.001000862],"genre_scores_gemma":[0.9942872,0.0010935698,0.0003187581,0.0005375059,0.0004490779,0.0008299343,0.000010021416,0.000053351512,0.0024206084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711245,0.00007432284,0.00050037814,0.0005618328,0.0009909213,0.00076007436],"domain_scores_gemma":[0.9981927,0.00012508844,0.000094935625,0.00045654923,0.0006988144,0.0004319074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006734229,0.00022086636,0.0005663042,0.00051398616,0.000081605715,0.0000372727,0.00020931954,0.0001471865,0.011363882],"category_scores_gemma":[0.000042994132,0.00019248546,0.0001629335,0.00096862257,0.00025165724,0.00020216672,0.000059655635,0.000581534,0.00017594546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011452561,0.0003700397,0.0006596368,0.0004788279,0.00010002126,0.000010783198,0.0037340554,0.00012154737,0.9471372,0.000021001597,0.016268047,0.029953599],"study_design_scores_gemma":[0.0055603376,0.00029452637,0.17729223,0.0011944196,0.000058411675,0.000010965062,0.00122122,0.00014369033,0.80812556,0.00010264239,0.005691996,0.00030398267],"about_ca_topic_score_codex":0.080131814,"about_ca_topic_score_gemma":0.0029125044,"teacher_disagreement_score":0.1766326,"about_ca_system_score_codex":0.00064624957,"about_ca_system_score_gemma":0.0010934683,"threshold_uncertainty_score":0.98953986},"labels":[],"label_agreement":null},{"id":"W2028085912","doi":"10.1158/1538-7445.am10-3842","title":"Abstract 3842: Identification of distinct apoptosis and myeloid signaling profiles within acute myeloid leukemia (AML) blast subpopulations","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Myeloid; PI3K/AKT/mTOR pathway; Biology; Staurosporine; Signal transduction; Myeloid leukemia; Intracellular; Flow cytometry; Immunology; Cell biology; Protein kinase C","score_opus":0.047422226889339426,"score_gpt":0.3781963677225734,"score_spread":0.330774140833234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028085912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570495,0.0002578162,0.00007689441,0.0013903971,0.00022032454,0.0012919394,0.00018720698,0.00007635775,0.0007940895],"genre_scores_gemma":[0.9957504,0.0003335366,0.00079835876,0.000029960009,0.0004928233,0.00043851242,0.00016275578,0.00008258892,0.001911017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959663,0.00014884672,0.0008245917,0.00074719754,0.0015235128,0.000789565],"domain_scores_gemma":[0.9966443,0.00046423828,0.00025447787,0.0008470687,0.0013212257,0.00046867135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024735164,0.0002643803,0.00048149205,0.0007046825,0.00047680977,0.0001416184,0.00043790092,0.00029644516,0.0006966166],"category_scores_gemma":[0.0011022778,0.00023460168,0.00011086124,0.0011646086,0.001031399,0.00032278363,0.00026633003,0.0021238476,0.00007286786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042300724,0.00007284689,0.020079866,0.00044901457,0.00016514033,0.000014864999,0.0007234138,0.000030622727,0.9700616,0.00048890937,0.0015122911,0.0059784134],"study_design_scores_gemma":[0.0012516025,0.00014436075,0.12860201,0.0002441551,0.00009617251,0.000031354793,0.00067499786,0.00083519635,0.86681217,0.00035957995,0.00071039767,0.00023797981],"about_ca_topic_score_codex":0.0020583037,"about_ca_topic_score_gemma":0.00036518107,"teacher_disagreement_score":0.108522154,"about_ca_system_score_codex":0.0006587797,"about_ca_system_score_gemma":0.0020316197,"threshold_uncertainty_score":0.9566779},"labels":[],"label_agreement":null},{"id":"W2028224771","doi":"10.1158/0008-5472.can-05-0132","title":"A Haplotype-Based Case-Control Study of <i>BRCA1</i> and Sporadic Breast Cancer Risk","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Breast cancer; Single-nucleotide polymorphism; Haplotype; Genetics; Linkage disequilibrium; Biology; Case-control study; Locus (genetics); Population; Genotype; Cancer; Medicine; Internal medicine; Gene","score_opus":0.027972269528959932,"score_gpt":0.36360631135562393,"score_spread":0.335634041826664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028224771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090785,0.0067632664,0.00010582019,0.000770937,0.00008397352,0.00064376567,0.00060036033,0.0000100713105,0.00011393946],"genre_scores_gemma":[0.9978063,0.0006739111,0.000121636964,0.00014260362,0.00050636596,0.00048298098,0.000005341033,0.000039142113,0.00022170666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983191,0.00027143984,0.0002285579,0.00047781956,0.00034270197,0.00036036188],"domain_scores_gemma":[0.99883795,0.0000545485,0.00008778395,0.00047768807,0.00041607264,0.00012596764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072747684,0.00014070254,0.0001852884,0.00013018269,0.00018851382,0.00002707112,0.00020615378,0.00010754148,0.00022655625],"category_scores_gemma":[0.00005154364,0.00013279148,0.000043577264,0.0002966166,0.00025970198,0.0000064306087,0.000084324165,0.00026467553,0.0000047305384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029859177,0.0013864115,0.388876,0.00020916747,0.001080131,0.00019081702,0.0021259726,0.024774631,0.30720538,0.000032411357,0.015629936,0.25550324],"study_design_scores_gemma":[0.043623727,0.00547837,0.43929827,0.00032969983,0.0008848094,0.0009899662,0.0078732595,0.009476654,0.40010974,0.0001552734,0.0894787,0.0023015281],"about_ca_topic_score_codex":0.0034738646,"about_ca_topic_score_gemma":0.008166224,"teacher_disagreement_score":0.2532017,"about_ca_system_score_codex":0.00019703753,"about_ca_system_score_gemma":0.0007419279,"threshold_uncertainty_score":0.54150796},"labels":[],"label_agreement":null},{"id":"W2028248984","doi":"10.1158/0008-5472.sabcs13-p6-06-12","title":"Abstract P6-06-12: Prognostic significance of pretreatment neutrophil/-lymphocyte ratio in breast cancer: A meta-analysis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Quartile; Subgroup analysis; Neutrophil to lymphocyte ratio; Odds ratio; Meta-analysis; Estrogen receptor; Stage (stratigraphy); Lymphocyte; Confidence interval; Biology","score_opus":0.10171998775638268,"score_gpt":0.38682643576782627,"score_spread":0.2851064480114436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028248984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778048,0.012542611,0.000009927334,0.0042855893,0.000056547564,0.0041436474,0.0003774657,0.000051967334,0.00072747533],"genre_scores_gemma":[0.98648375,0.0012765144,0.0002050084,0.000111602814,0.00011627569,0.011069243,0.00004481248,0.000051499424,0.00064128864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99577475,0.00034668262,0.0007868997,0.0007911122,0.0014331059,0.0008674788],"domain_scores_gemma":[0.99699354,0.00037482887,0.00022388756,0.0008990349,0.001085562,0.00042316687],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009542048,0.00033338403,0.0012472334,0.0009796345,0.000115447314,0.00007085573,0.00038415188,0.00015897295,0.007749334],"category_scores_gemma":[0.00012785221,0.0002594798,0.00076040596,0.0021969983,0.0004808623,0.00023302158,0.00012916022,0.0004209227,0.00011249358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016759485,0.0013497984,0.81962556,0.0016061584,0.09546508,0.00030249215,0.0007796521,0.0010372937,0.06657498,0.000055091597,0.004444899,0.0070830714],"study_design_scores_gemma":[0.0018465989,0.00012330562,0.94586337,0.00013914747,0.026673447,0.000006623369,0.00016860352,0.00063107384,0.02395779,0.00008466901,0.0002195466,0.0002858226],"about_ca_topic_score_codex":0.012623415,"about_ca_topic_score_gemma":0.0009116853,"teacher_disagreement_score":0.12623784,"about_ca_system_score_codex":0.0014296116,"about_ca_system_score_gemma":0.0016715899,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W2028380205","doi":"10.1158/0008-5472.can-13-3119","title":"VEGF Regulates Region-Specific Localization of Perivascular Bone Marrow–Derived Cells in Glioblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; SickKids Foundation","funders":"Canadian Institutes of Health Research; Agence Nationale pour la Gestion des Déchets Radioactifs","keywords":"Radiation therapy; Bone marrow; Glioblastoma; Cancer research; Progenitor cell; Medicine; Pathology; Cancer; Angiogenesis; Biology; Stem cell; Cell biology; Internal medicine","score_opus":0.028853629350777378,"score_gpt":0.3092681082678291,"score_spread":0.2804144789170517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028380205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887432,0.008168103,0.0023464158,0.00015267049,0.000107094944,0.00020303047,0.0000065498953,0.0000062687786,0.0002666696],"genre_scores_gemma":[0.9939238,0.0050959107,0.0000656154,0.00005070537,0.0002938455,0.00007771057,0.000014688802,0.00003225579,0.00044549876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985148,0.00021159493,0.00023237885,0.00038937986,0.00030965105,0.00034224163],"domain_scores_gemma":[0.9991017,0.000020802318,0.00005813786,0.00046046116,0.00028266342,0.00007624374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005276196,0.000115872834,0.00018491787,0.00014087184,0.00007319531,0.000017956154,0.0002241781,0.00015784096,0.00008555027],"category_scores_gemma":[0.000036466336,0.00011184992,0.00009600796,0.00034577295,0.00024802837,0.0000048666616,0.00012248827,0.00010206362,0.0000087636845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022966211,0.00004212866,0.0018770539,0.00006229575,0.000019749239,0.0000034462912,0.000100409045,0.0010354386,0.9855836,0.00011998223,0.0061871605,0.0047390787],"study_design_scores_gemma":[0.000488289,0.00021509215,0.0010473952,0.000076007185,0.000002988536,0.000002596311,0.00010536105,0.0002463777,0.8979067,0.000068587746,0.09971493,0.0001256769],"about_ca_topic_score_codex":0.00012530196,"about_ca_topic_score_gemma":0.00011668622,"teacher_disagreement_score":0.09352777,"about_ca_system_score_codex":0.00006134522,"about_ca_system_score_gemma":0.000100125784,"threshold_uncertainty_score":0.45611075},"labels":[],"label_agreement":null},{"id":"W2028598713","doi":"10.1158/0008-5472.sabcs10-p5-13-09","title":"Abstract P5-13-09: Feasibility of a Randomized Controlled Trial of Vitamin D vs. Placebo in Recently Diagnosed Breast Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Population; Placebo; Internal medicine; Cohort; Cancer; Vitamin D and neurology; vitamin D deficiency; Clinical trial","score_opus":0.03860766003565889,"score_gpt":0.4033578890759887,"score_spread":0.3647502290403298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028598713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841205,0.0005422868,0.0000043513433,0.0013330884,0.00074898574,0.012436249,0.00025365737,0.000024122248,0.00053677126],"genre_scores_gemma":[0.99335057,0.0008509916,0.00007062574,0.00005129086,0.00035199427,0.005006742,0.000018097253,0.000054545708,0.00024516697],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99500215,0.0006855282,0.001435896,0.0005920306,0.0015615298,0.0007228712],"domain_scores_gemma":[0.9941951,0.0025360335,0.00055339816,0.00072036154,0.0017244015,0.00027068934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00487598,0.00029772794,0.0027404819,0.0005260946,0.00006264651,0.000015667993,0.00035370074,0.00031491803,0.0018678474],"category_scores_gemma":[0.0032221265,0.00022327778,0.0004542732,0.0007385196,0.0011276607,0.0001697195,0.00009944219,0.0015788123,0.0000065837676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90754837,0.001692219,0.041503552,0.0003457737,0.00029615033,0.000010023878,0.00067215256,0.000020031097,0.034098323,0.000024422932,0.00010504757,0.013683925],"study_design_scores_gemma":[0.88493854,0.00034592964,0.106086984,0.00059245306,0.00008366138,0.0000016566131,0.00011865149,0.000032414762,0.007391139,0.00013906813,0.00010743865,0.00016209182],"about_ca_topic_score_codex":0.0057994835,"about_ca_topic_score_gemma":0.0034048513,"teacher_disagreement_score":0.064583436,"about_ca_system_score_codex":0.0005883049,"about_ca_system_score_gemma":0.0015499007,"threshold_uncertainty_score":0.9990446},"labels":[],"label_agreement":null},{"id":"W2028625191","doi":"10.1158/1538-7445.am2011-124","title":"Abstract 124: Cellular context in epigenetics: Per-cell quantitation of miR-let-7d and its putative target in caspase-3 in reovirus-infected cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ATCO (Canada)","funders":"","keywords":"Oncolytic virus; Biology; microRNA; Population; Context (archaeology); Computational biology; Epigenetics; Cancer cell; Cancer; Cell type; Cell; Cancer research; Genetics; Gene; Medicine","score_opus":0.08117630299904603,"score_gpt":0.37972103170073296,"score_spread":0.2985447287016869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028625191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97583234,0.02248987,0.000009265331,0.00008289831,0.00005664,0.0008459511,0.00014057996,0.0000040074906,0.00053841586],"genre_scores_gemma":[0.9922242,0.0070042866,0.00007360026,0.00003732281,0.000046050736,0.00033780214,0.000045573535,0.000046744077,0.00018440737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972718,0.00055571453,0.000454083,0.00060545787,0.0004183248,0.00069461623],"domain_scores_gemma":[0.99894714,0.00010217084,0.00009789976,0.00031424745,0.00039653745,0.00014200961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013836521,0.00020536085,0.00030795333,0.00053480954,0.000049840655,0.000018620292,0.0003126387,0.00023803495,0.00040402464],"category_scores_gemma":[0.00011269193,0.00021615354,0.000043194268,0.00058570754,0.00026099032,0.000016350237,0.0001373082,0.0005430754,0.000019531102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021556008,0.00025530887,0.012385248,0.0001749298,0.000024234112,0.000043214935,0.0022644473,0.00041175986,0.9800279,0.000012837411,0.00007394406,0.0021705574],"study_design_scores_gemma":[0.0017686943,0.001057295,0.013446235,0.00009352256,0.0000028207446,3.6723455e-7,0.00081444776,0.0002331674,0.98199695,0.00009353136,0.00028204327,0.00021094987],"about_ca_topic_score_codex":0.010434031,"about_ca_topic_score_gemma":0.03265621,"teacher_disagreement_score":0.02222218,"about_ca_system_score_codex":0.00019105019,"about_ca_system_score_gemma":0.0007271434,"threshold_uncertainty_score":0.99615556},"labels":[],"label_agreement":null},{"id":"W2028662696","doi":"10.1158/0008-5472.can-10-3590","title":"Interaction between <i>MYC</i> and <i>MCL1</i> in the Genesis and Outcome of Non–Small-Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"MCL1; KRAS; Carcinogenesis; Cancer research; Lung cancer; Adenocarcinoma; Apoptosis; Cancer; Medicine; Lung; Biology; Cell; Oncology; Internal medicine; Gene; Downregulation and upregulation; Colorectal cancer; Genetics","score_opus":0.07862494546113312,"score_gpt":0.3791732443580748,"score_spread":0.3005482988969417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028662696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945957,0.0043084873,0.00016903736,0.00008782002,0.000053785676,0.00026052765,0.00001232184,0.0000014786907,0.0005108548],"genre_scores_gemma":[0.99547404,0.0038515662,0.000092454706,0.000048389316,0.00012509337,0.00008348244,0.000008289263,0.0000105992995,0.0003060767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926865,0.00008556599,0.00014366703,0.00020771143,0.00012393927,0.00017047548],"domain_scores_gemma":[0.99966043,0.000022562092,0.00004079405,0.00016293341,0.00007479315,0.000038457565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048055986,0.00007097957,0.00009954072,0.000060253875,0.000059147646,0.000013220589,0.00011085744,0.00008742829,0.000024991554],"category_scores_gemma":[0.000008994028,0.000051333376,0.000022587366,0.00010659995,0.000073421084,0.000004754064,0.00009888313,0.00012094862,3.526798e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006721047,0.000025609677,0.34666345,0.00013525487,0.000019364552,0.0000013970356,0.0008261631,0.000007071174,0.6399173,0.000020558798,0.0003227437,0.011993903],"study_design_scores_gemma":[0.00090538774,0.00023665105,0.29482484,0.00007240221,0.00004563629,0.000004228526,0.0009870852,0.00017658474,0.6976521,0.00010416567,0.0048046764,0.00018622147],"about_ca_topic_score_codex":0.0032137115,"about_ca_topic_score_gemma":0.00086554314,"teacher_disagreement_score":0.05773482,"about_ca_system_score_codex":0.000016512624,"about_ca_system_score_gemma":0.000041646283,"threshold_uncertainty_score":0.4858192},"labels":[],"label_agreement":null},{"id":"W2028667429","doi":"10.1158/0008-5472.can-05-4253","title":"Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Barrett's esophagus; Adenocarcinoma; Esophagus; Reflux esophagitis; Metaplasia; Aspirin; Odds ratio; Population; Reflux; Cancer; Disease","score_opus":0.03607031422063794,"score_gpt":0.35921434672425484,"score_spread":0.3231440325036169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028667429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588645,0.027906656,0.0000119615515,0.007994104,0.00007880345,0.0014625061,0.00002930539,0.000060926548,0.003591214],"genre_scores_gemma":[0.99346304,0.0009842239,0.000079843325,0.00010215942,0.00082395575,0.0006397893,0.000025505646,0.000037719943,0.0038437822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653333,0.0003900833,0.0003493782,0.00050150254,0.0014029142,0.0008228104],"domain_scores_gemma":[0.9981953,0.00046493957,0.00006524286,0.00055046997,0.00042510178,0.000298984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015743304,0.00021713265,0.0003793934,0.0002851567,0.00053130666,0.00016325708,0.00026324086,0.00010161889,0.0003053922],"category_scores_gemma":[0.00011297097,0.0001400761,0.000110208835,0.00053357816,0.0015522934,0.00020334845,0.00019775688,0.0007745927,0.00013374849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063345972,0.00030484246,0.8565366,0.0014074307,0.00075420394,0.0038060872,0.0030717114,0.000106640015,0.024739377,0.046983693,0.011516127,0.044438638],"study_design_scores_gemma":[0.03617387,0.0011310034,0.8053924,0.00064100465,0.0003049768,0.0008161278,0.0012688455,0.001155689,0.13562095,0.008685797,0.008088434,0.0007209379],"about_ca_topic_score_codex":0.002384435,"about_ca_topic_score_gemma":0.00022277272,"teacher_disagreement_score":0.110881574,"about_ca_system_score_codex":0.0003961542,"about_ca_system_score_gemma":0.0008368634,"threshold_uncertainty_score":0.571949},"labels":[],"label_agreement":null},{"id":"W2028681637","doi":"10.1158/1538-7445.tim2013-a65","title":"Abstract A65: ShcA is required for the TGFβ-induced repression of Chordin-like-1 in ErbB2-expressing breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene silencing; Cancer research; Metastasis; Chordin; Signal transducing adaptor protein; Signal transduction; Transforming growth factor; Breast cancer; Biology; Cell biology; Cancer; Medicine; Internal medicine; Gene","score_opus":0.0757527634321417,"score_gpt":0.40819016380012557,"score_spread":0.33243740036798386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028681637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353427,0.0042960667,0.000026876774,0.0007378143,0.00021310833,0.0008469511,0.00017077783,0.0000086750215,0.00016545215],"genre_scores_gemma":[0.9971126,0.00054693944,0.00006687415,0.00011574882,0.0004184279,0.0010640153,0.000020818612,0.00004351701,0.00061107526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981205,0.00010018007,0.00031967962,0.000520292,0.00040305592,0.000536332],"domain_scores_gemma":[0.99846107,0.0001402652,0.00011661683,0.0006913189,0.00046861317,0.0001221475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053711364,0.00015708465,0.00018623068,0.00008902753,0.00018178631,0.00006560728,0.0005665113,0.00017727652,0.0005137583],"category_scores_gemma":[0.000102782986,0.00011773948,0.00010514025,0.00020205519,0.00019457753,0.000016475957,0.00023147016,0.0002383117,0.000009801458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000271563,0.00007905235,0.0015976662,0.00012782928,0.000044335407,8.6431356e-7,0.00016210084,0.00024407386,0.964552,0.0000012218566,0.021253414,0.011665888],"study_design_scores_gemma":[0.0006078844,0.00005482721,0.02178844,0.00031152827,0.000009785117,7.688881e-7,0.00018405124,0.00015115875,0.9719206,0.00004225562,0.0047788443,0.00014982425],"about_ca_topic_score_codex":0.0033586598,"about_ca_topic_score_gemma":0.0001559719,"teacher_disagreement_score":0.020190774,"about_ca_system_score_codex":0.00008474432,"about_ca_system_score_gemma":0.00049099687,"threshold_uncertainty_score":0.56252927},"labels":[],"label_agreement":null},{"id":"W2028853380","doi":"10.1158/0008-5472.can-04-0788","title":"A Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein Can Reduce Tumor Growth, Experimental Skeletal Metastases, and Malignancy-Associated Hypercalcemia","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Prostate cancer; Medicine; Prostate; In vivo; Malignancy; Syngenic; Endocrinology; Cancer; Internal medicine; Pathology; Biology; Transplantation","score_opus":0.044433615377309395,"score_gpt":0.35654409205703275,"score_spread":0.31211047667972336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028853380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764061,0.015744958,0.0000030742003,0.0033285862,0.00009986907,0.0030734604,0.0006023563,0.00011637305,0.0006252355],"genre_scores_gemma":[0.9928399,0.000826183,0.00027367656,0.00017248919,0.00022910621,0.0025805435,0.00029100795,0.0001246724,0.002662436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952154,0.00041350874,0.00042781633,0.0010916166,0.0014322818,0.00141937],"domain_scores_gemma":[0.99786663,0.00012629553,0.00009720108,0.0005268828,0.0005891135,0.0007938866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007105475,0.00042777025,0.0006551727,0.00035399487,0.0005339293,0.00013225203,0.00027651887,0.00016041285,0.00074569305],"category_scores_gemma":[0.00032299227,0.0003503889,0.00015368989,0.0006938295,0.0011402083,0.00020043437,0.00029277446,0.0010142626,0.000069200105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017791437,0.0006140724,0.0023246922,0.00024041923,0.00048338083,0.0013579566,0.0022928887,0.0000031865386,0.9888726,0.000088556524,0.0008566317,0.0010865116],"study_design_scores_gemma":[0.009452819,0.001415466,0.005599084,0.0016961308,0.00011668165,0.00006232601,0.0022226516,0.000015576737,0.9776214,0.00063628523,0.0007080083,0.0004535746],"about_ca_topic_score_codex":0.01156002,"about_ca_topic_score_gemma":0.0005077497,"teacher_disagreement_score":0.016433798,"about_ca_system_score_codex":0.0023667885,"about_ca_system_score_gemma":0.002392431,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W2028912406","doi":"10.1158/1538-7445.am10-4296a","title":"Abstract 4296A: Myeloproliferative disease induced by leukemogenic Ptpn11 (Shp-2) phosphatase arises from hematopoietic stem cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"PTPN11; Juvenile myelomonocytic leukemia; Stem cell; Cancer research; Haematopoiesis; Biology; Germline mutation; Protein tyrosine phosphatase; Mutation; Immunology; Cell biology; Genetics; Signal transduction; KRAS","score_opus":0.03520919450919877,"score_gpt":0.3389603575419125,"score_spread":0.3037511630327137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028912406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95809823,0.036695834,0.00003380662,0.00046829204,0.00039502533,0.0008345986,0.003357588,0.000033288296,0.00008331238],"genre_scores_gemma":[0.9959866,0.0010000499,0.00008773356,0.0002500991,0.00057252985,0.0006831088,0.000827492,0.00007632006,0.00051610806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970758,0.00013739533,0.00034057896,0.0009660557,0.0006717673,0.000808382],"domain_scores_gemma":[0.9976869,0.000097723394,0.00011059461,0.0011206077,0.00034447157,0.0006396581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046431812,0.00033151827,0.00027504965,0.00007606285,0.00031445766,0.00016139893,0.0008020613,0.00026119695,0.0006752844],"category_scores_gemma":[0.00016771305,0.00031485638,0.00012482115,0.00026053278,0.00036499707,0.000023528162,0.00045260787,0.0008401647,0.00019165926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004655122,0.00013843836,0.0006059131,0.000054334898,0.00008690121,0.00003227741,0.000054800596,0.0000054979027,0.9554189,0.00020275087,0.038599223,0.0043354407],"study_design_scores_gemma":[0.0007942691,0.00010803715,0.0012701678,0.00004611276,0.00002116731,0.0000011841825,0.00007092943,0.0000071889563,0.96883786,0.0002998692,0.028185965,0.000357255],"about_ca_topic_score_codex":0.0013633048,"about_ca_topic_score_gemma":0.00028399323,"teacher_disagreement_score":0.037888303,"about_ca_system_score_codex":0.000090526446,"about_ca_system_score_gemma":0.0010538021,"threshold_uncertainty_score":0.9999303},"labels":[],"label_agreement":null},{"id":"W2028987548","doi":"10.1158/1538-7445.am10-4150","title":"Abstract 4150: Exploration of the role of Hsps in exosome derived from prostate cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"","keywords":"Prostate cancer; Exosome; Cancer research; Metastasis; Hsp27; Androgen deprivation therapy; Cancer; Medicine; Androgen receptor; Cancer cell; Androgen; Internal medicine; Microvesicles; Biology; Endocrinology; Heat shock protein; Hormone; Hsp70; microRNA","score_opus":0.042663715568889655,"score_gpt":0.36927378958081536,"score_spread":0.3266100740119257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028987548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969786,0.0013275511,0.0000052803894,0.0003523392,0.000093234295,0.0006701835,0.00014989608,0.0000020564169,0.0004208575],"genre_scores_gemma":[0.99777037,0.001301004,0.00005506395,0.0000104065475,0.00015638676,0.0004412138,0.00001730705,0.000022187915,0.00022606873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841106,0.00015948321,0.00024889756,0.00030184502,0.00051557017,0.00036312998],"domain_scores_gemma":[0.9988843,0.000040023293,0.00006149306,0.0005442197,0.00039296807,0.0000769616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049353874,0.00009140761,0.00014165424,0.00009299355,0.000059111942,0.000015355776,0.00047202792,0.00016707703,0.00026350448],"category_scores_gemma":[0.00016651528,0.00007093845,0.000051313495,0.00030484868,0.0002984737,0.000013910883,0.00026911026,0.0005530252,0.0000061377473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016851562,0.00005707428,0.00980225,0.000041248593,0.000016974436,8.7522966e-7,0.000357639,0.00013968552,0.9826077,0.000012056643,0.00009394842,0.0067020305],"study_design_scores_gemma":[0.0003444139,0.000056563058,0.017319577,0.00005377297,0.0000014510694,9.858065e-8,0.00021503783,0.000034943416,0.97837657,0.00033332428,0.0031948956,0.00006935389],"about_ca_topic_score_codex":0.009377209,"about_ca_topic_score_gemma":0.008692957,"teacher_disagreement_score":0.0075173276,"about_ca_system_score_codex":0.000047077632,"about_ca_system_score_gemma":0.0008010745,"threshold_uncertainty_score":0.99721944},"labels":[],"label_agreement":null},{"id":"W2029189277","doi":"10.1158/1538-7445.am10-3136","title":"Abstract 3136: Activated Src increases total Rac levels and requires Rac and IL6 for full neoplastic transformation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"STAT3; Proto-oncogene tyrosine-protein kinase Src; Cancer research; STAT protein; Malignant transformation; Neoplastic transformation; Oncogene; Gene knockdown; Glycoprotein 130; Biology; Cell biology; Chemistry; Cancer; Signal transduction; Cell culture; Carcinogenesis; Cell cycle; Genetics","score_opus":0.09893241549697411,"score_gpt":0.42213839495342104,"score_spread":0.3232059794564469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029189277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996769,0.00016317819,0.00014488949,0.0014442157,0.00015439131,0.000624235,0.0001670149,0.00003416042,0.00049889076],"genre_scores_gemma":[0.998926,0.000109667264,0.00012423332,0.0000442342,0.00036355256,0.00016955458,0.00003816604,0.000020973488,0.00020366297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989843,0.000026752637,0.0002019522,0.00022525889,0.0002629098,0.0002988691],"domain_scores_gemma":[0.9987779,0.0005339799,0.00003922022,0.00013788322,0.0003264965,0.0001845038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004318166,0.00010784244,0.00018166991,0.00019692727,0.00024504928,0.000075764314,0.00004471716,0.00008477058,0.00038917115],"category_scores_gemma":[0.00054280297,0.00008910532,0.000041223157,0.00014719025,0.00016650521,0.00029294015,0.000023138598,0.00052955805,0.0000063649945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009373112,0.00006468938,0.00022111688,0.0002266622,0.00003758765,0.0000044451403,0.00044997298,0.0000034833631,0.97799975,0.00014768122,0.0011851877,0.01872212],"study_design_scores_gemma":[0.0033839692,0.0009911221,0.079149604,0.0005058479,0.00006740992,0.0002070063,0.00053013826,0.0011056981,0.8976475,0.00030061175,0.015877463,0.00023360588],"about_ca_topic_score_codex":0.0011726866,"about_ca_topic_score_gemma":0.00041645393,"teacher_disagreement_score":0.08035222,"about_ca_system_score_codex":0.000052945834,"about_ca_system_score_gemma":0.00024335092,"threshold_uncertainty_score":0.4261151},"labels":[],"label_agreement":null},{"id":"W2029224100","doi":"10.1158/1538-7445.am2012-4889","title":"Abstract 4889: ERa-targeted therapy in ovarian cancer cells using novel Estradiol-Platinum(II) hybrids","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Cisplatin; Ovarian cancer; Cancer research; Apoptosis; Annexin; Estrogen receptor; In vivo; Cancer; Cancer cell; Breast cancer; Biology; Internal medicine; Medicine; Chemotherapy; Biochemistry; Genetics","score_opus":0.3095181941254356,"score_gpt":0.43246536714380995,"score_spread":0.12294717301837438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029224100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98063064,0.014462184,0.000019626066,0.0006562734,0.00040504002,0.00065567455,0.00004989589,0.000025601461,0.0030950536],"genre_scores_gemma":[0.9953032,0.0016243166,0.00086960493,0.00018210667,0.0009964455,0.00015858117,0.000008195658,0.000061949235,0.000795577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973361,0.00014263361,0.00038158245,0.0003567814,0.0007614453,0.001021449],"domain_scores_gemma":[0.9988349,0.00015341984,0.00006677853,0.00042244076,0.00021410352,0.0003083348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001571115,0.00021995661,0.00043920163,0.00032108522,0.00025834495,0.00004992344,0.00022769516,0.0001197364,0.004848985],"category_scores_gemma":[0.00008475644,0.00016730327,0.00009985567,0.0005487706,0.00018726135,0.00023021111,0.00008039142,0.0008535176,0.00003509649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046189118,0.00023273834,0.016706876,0.00011342382,0.000094312156,0.0000076117403,0.00094323367,0.00007393798,0.97038907,0.000065012435,0.00068888924,0.010222988],"study_design_scores_gemma":[0.0015871887,0.00017577138,0.17006464,0.00045083128,0.000018164717,0.000015530804,0.00018867328,0.0003328729,0.8072714,0.000037026104,0.019577906,0.00027997754],"about_ca_topic_score_codex":0.0113962805,"about_ca_topic_score_gemma":0.00018486555,"teacher_disagreement_score":0.16311768,"about_ca_system_score_codex":0.00045314632,"about_ca_system_score_gemma":0.0006357886,"threshold_uncertainty_score":0.9960607},"labels":[],"label_agreement":null},{"id":"W2029242138","doi":"10.1158/1538-7445.am10-3269","title":"Abstract 3269: Calpain knockdown in human breast carcinoma cells reduced xenograft tumor growth rates and inhibited in vitro cell migration and proliferation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Calpain; Gene knockdown; Cancer research; Biology; Calpastatin; Small hairpin RNA; Cell growth; Anoikis; Cell migration; Cell culture; Focal adhesion; Molecular biology; Cancer cell; Cell biology; Cancer; Signal transduction; Genetics","score_opus":0.014122885282712062,"score_gpt":0.30346275060860906,"score_spread":0.289339865325897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029242138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984362,0.00024718072,0.0000070641086,0.0005885125,0.000054536515,0.00056713884,0.000018298388,0.00000663416,0.00007444581],"genre_scores_gemma":[0.99909633,0.00006994722,0.000037955917,0.00004131158,0.00018426006,0.00016569148,0.00014565489,0.000016402211,0.0002424603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885947,0.00014274777,0.00020587193,0.00037331315,0.00016653213,0.00025208088],"domain_scores_gemma":[0.99953777,0.00001976279,0.00004374509,0.00014039481,0.00015882243,0.000099520345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007049019,0.00011314529,0.000106304244,0.00023362372,0.00012279939,0.00007107683,0.000055444783,0.00015060147,0.000018620962],"category_scores_gemma":[0.00004454546,0.00010717883,0.00001956958,0.00022731253,0.00014181872,0.000015318561,0.00005271113,0.00035088847,0.0000012179804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025620704,0.00012089749,0.016809076,0.000073279916,0.0000025222148,0.0000037871705,0.00012577453,0.000004743242,0.98163635,0.000010144938,0.00029146185,0.0006657424],"study_design_scores_gemma":[0.0013881458,0.00005761662,0.10137491,0.000019559244,0.0000017619956,0.000007559452,0.00008313548,0.00034064896,0.896293,0.000046129124,0.0002748724,0.00011266517],"about_ca_topic_score_codex":0.0013411575,"about_ca_topic_score_gemma":0.0038164745,"teacher_disagreement_score":0.08534336,"about_ca_system_score_codex":0.000038703514,"about_ca_system_score_gemma":0.0001267552,"threshold_uncertainty_score":0.4370626},"labels":[],"label_agreement":null},{"id":"W2029322713","doi":"10.1158/1538-7445.am10-4324","title":"Abstract 4324: Establishing a high-resolution <i>in vivo</i> imaging technique for examining the dynamic contribution of bone marrow derived progenitor cells to intracranial tumor vasculature","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Centre for Social Innovation; Hospital for Sick Children","funders":"","keywords":"Glioma; Pathology; Bone marrow; Nestin; Progenitor cell; Biology; Green fluorescent protein; Stem cell; Medicine; Cancer research; Neural stem cell; Cell biology","score_opus":0.012066421039485086,"score_gpt":0.3053258898971443,"score_spread":0.29325946885765924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029322713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912213,0.0017935161,0.003426513,0.00037145065,0.0009934898,0.001968215,0.00018952318,0.000011197047,0.000024774474],"genre_scores_gemma":[0.99515384,0.00021599501,0.0016414067,0.00007728509,0.0014076936,0.0013750604,0.00004487979,0.000036040925,0.00004777336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827856,0.000100112564,0.00029149916,0.00043563975,0.00032143935,0.00057275675],"domain_scores_gemma":[0.9987699,0.000080727405,0.000100424375,0.00039385792,0.0005474428,0.00010764524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018397555,0.00015311479,0.00022453394,0.00014200523,0.0001719073,0.00007476777,0.00031083197,0.00016145076,0.000023545248],"category_scores_gemma":[0.00047416062,0.00013094863,0.00008915962,0.00029542134,0.00016662061,0.000020485682,0.000133963,0.0005365938,8.686092e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040479368,0.00003942474,0.00014736876,0.00006128257,0.00001764574,0.0000022319712,0.000071835035,0.000091750015,0.9935008,0.000035612793,0.0011189014,0.004508298],"study_design_scores_gemma":[0.0008867002,0.000072439434,0.0034126923,0.00007556686,0.0000147491455,0.000010238585,0.00009209919,0.00013493394,0.97286624,0.00007888254,0.022199279,0.00015617415],"about_ca_topic_score_codex":0.00083865033,"about_ca_topic_score_gemma":0.0026165734,"teacher_disagreement_score":0.021080378,"about_ca_system_score_codex":0.00008644115,"about_ca_system_score_gemma":0.00039173078,"threshold_uncertainty_score":0.533993},"labels":[],"label_agreement":null},{"id":"W2029549287","doi":"10.1158/1538-7445.am2011-2562","title":"Abstract 2562: Efficacy of RG7204 (PLX4032), a selective BRAFV600E inhibitor, in combination with pegylated interferon alpha-2a (Pegasys), paclitaxel, carboplatin, and anti-VEGF MAb B20-4.1 in the LOX-IMVI human melanoma xenograft model","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Carboplatin; Medicine; Dacarbazine; Combination therapy; Bevacizumab; Melanoma; Pharmacology; Paclitaxel; Regimen; Oncology; Chemotherapy; Internal medicine; Cancer research; Cisplatin","score_opus":0.07699664315181229,"score_gpt":0.36154422795142693,"score_spread":0.2845475847996146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029549287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896205,0.00030069574,0.000008331747,0.0002042567,0.000006920278,0.00045911662,0.00005416122,0.000028717064,0.0093172835],"genre_scores_gemma":[0.9991818,0.00008024998,0.00003509652,0.000012160248,0.000045962603,0.0003738111,0.000060153525,0.000036232348,0.00017450876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789166,0.000083662344,0.0004720005,0.00054148806,0.0005037183,0.00050747505],"domain_scores_gemma":[0.9986948,0.0002697764,0.00015810422,0.0005100955,0.0002671058,0.000100145975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006430834,0.00023513546,0.00032381088,0.00018914885,0.00017479682,0.000052647265,0.0004566209,0.00020899488,0.00019217607],"category_scores_gemma":[0.000073313204,0.00019068505,0.000047283465,0.0007810278,0.00041043732,0.0001866837,0.0001226198,0.0010687733,0.0000032155706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077537686,0.0013443892,0.031321097,0.0005259394,0.00008215942,0.000031918204,0.01566802,0.00012877223,0.94767064,0.0007021146,0.00027650336,0.0014730939],"study_design_scores_gemma":[0.0046875114,0.00026206736,0.06717986,0.0007269783,0.000023847679,0.000014870454,0.0029794679,0.0011009814,0.92096823,0.0016054106,0.00006816317,0.00038258443],"about_ca_topic_score_codex":0.0034046113,"about_ca_topic_score_gemma":0.0018406978,"teacher_disagreement_score":0.035858765,"about_ca_system_score_codex":0.0002712294,"about_ca_system_score_gemma":0.00023816848,"threshold_uncertainty_score":0.77759105},"labels":[],"label_agreement":null},{"id":"W2029596562","doi":"10.1158/1538-7445.am10-3509","title":"Abstract 3509: Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agents","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis of Organic Compounds","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Netropsin; Topoisomerase; DNA; Intercalation (chemistry); Cytotoxicity; Stereochemistry; Chemistry; Biochemistry; In vitro","score_opus":0.22039487841013175,"score_gpt":0.43520565418500956,"score_spread":0.2148107757748778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029596562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643165,0.0013383633,0.000026218579,0.0008938713,0.000084905594,0.00072490255,0.000031979274,0.000022251868,0.00044588035],"genre_scores_gemma":[0.9968429,0.0010196345,0.0018106847,0.000022110637,0.00012488203,0.00011480099,0.000004750446,0.000032560863,0.000027675387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973489,0.00014072967,0.00033706203,0.00045579302,0.0013532328,0.00036425743],"domain_scores_gemma":[0.9970683,0.000777211,0.00014120358,0.00072164286,0.0011318624,0.00015981508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029856036,0.00016864757,0.00047176023,0.00025012577,0.00009453875,0.00002430131,0.00032790177,0.00016360657,0.0007909647],"category_scores_gemma":[0.0019452631,0.00012069141,0.000037657122,0.00040601005,0.0012569848,0.00013692793,0.00016357041,0.00041009093,0.0000029999312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012539751,0.00027974293,0.031478222,0.0001493169,0.0001880322,0.0000057176735,0.00023763717,0.000015170221,0.9479913,0.000039403854,0.00014135863,0.018220115],"study_design_scores_gemma":[0.0013299978,0.0004118717,0.43706137,0.00040936994,0.00014819278,0.00003448,0.00046315047,0.000799884,0.5589362,0.00008520472,0.00019249179,0.0001278008],"about_ca_topic_score_codex":0.0012004811,"about_ca_topic_score_gemma":0.0003094957,"teacher_disagreement_score":0.40558314,"about_ca_system_score_codex":0.000098792385,"about_ca_system_score_gemma":0.0012990487,"threshold_uncertainty_score":0.8660509},"labels":[],"label_agreement":null},{"id":"W2029779613","doi":"10.1158/1538-7445.am2014-5071","title":"Abstract 5071: A genome-wide association study suggests evidence of variants at 6p21.32 associated with marginal zone lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Biology; Single-nucleotide polymorphism; Genetic association; Linkage disequilibrium; Odds ratio; Genotyping; Genetics; Oncology; Internal medicine; Medicine; Genotype; Gene","score_opus":0.07008695964899038,"score_gpt":0.37841343394587834,"score_spread":0.308326474296888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029779613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952365,0.0010293908,0.0000038128612,0.0013368521,0.00006432664,0.0011485664,0.000027096981,0.00003361321,0.0011198332],"genre_scores_gemma":[0.9966985,0.0004081984,0.000023854898,0.00010366762,0.00012477791,0.00042474415,0.000024794455,0.000035625624,0.0021558346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627465,0.00036730262,0.00035624704,0.00049183035,0.0018599334,0.0006500113],"domain_scores_gemma":[0.9957973,0.0022600438,0.00024693098,0.00048452071,0.0009584395,0.00025277946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002544516,0.0001961709,0.000515439,0.00021127531,0.00020365072,0.000045129666,0.00019261266,0.00012555801,0.0004882257],"category_scores_gemma":[0.00201571,0.00014815049,0.0000775402,0.0006255045,0.00009702429,0.00013338414,0.00012023466,0.00017694334,0.00010220761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011273137,0.002127883,0.9878287,0.00010983593,0.00063311553,0.00015813831,0.00059618516,0.000014179447,0.0024681287,0.000007748594,0.0015604066,0.0033683751],"study_design_scores_gemma":[0.006633398,0.002156325,0.987187,0.0008670582,0.00016657026,0.0000034212735,0.00015196714,0.000020001364,0.0021093069,0.0000126416435,0.00055695756,0.00013532984],"about_ca_topic_score_codex":0.0032950903,"about_ca_topic_score_gemma":0.002606214,"teacher_disagreement_score":0.0055060848,"about_ca_system_score_codex":0.0052220123,"about_ca_system_score_gemma":0.0007412326,"threshold_uncertainty_score":0.9985968},"labels":[],"label_agreement":null},{"id":"W2029792093","doi":"10.1158/1538-7445.am10-447","title":"Abstract 447: Hypoxia upregulates Nodal expression via the HIF-1 pathway in poorly metastatic breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"NODAL; Hypoxia (environmental); Breast cancer; Cancer research; Cancer cell; Metastatic breast cancer; Medicine; Metastasis; Cancer; Stem cell; Biology; Internal medicine; Chemistry; Oxygen; Cell biology","score_opus":0.024140929027099953,"score_gpt":0.3316710010418494,"score_spread":0.3075300720147494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029792093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856026,0.0073701236,0.000023535222,0.0010363247,0.0017676369,0.0005313577,0.0002724181,0.000013766439,0.00042459095],"genre_scores_gemma":[0.99273777,0.002466229,0.000109513654,0.000179307,0.0025002244,0.00046561542,0.00003241067,0.000057851656,0.0014510875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751014,0.00017629388,0.00030922907,0.0006244958,0.00056881795,0.00081100006],"domain_scores_gemma":[0.9985866,0.00007072811,0.00008860753,0.000746648,0.00029280962,0.00021461133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009853027,0.00024707214,0.00025500797,0.00012742003,0.0002532007,0.000096277945,0.0006711767,0.00019593709,0.0008789511],"category_scores_gemma":[0.000052429998,0.00017711865,0.00012747364,0.0003598378,0.00038617488,0.000018679295,0.0002616168,0.00087292265,0.000036683094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020557812,0.000085046806,0.00034128857,0.00004368793,0.00003276137,0.000004444084,0.00018537177,0.00009158345,0.956472,0.000017655339,0.008198128,0.034322485],"study_design_scores_gemma":[0.0007867339,0.00003599101,0.029878834,0.00005412245,0.000009863356,0.00001411289,0.0001116383,0.000031034895,0.8591044,0.00018444365,0.10954951,0.00023933293],"about_ca_topic_score_codex":0.003971065,"about_ca_topic_score_gemma":0.006080718,"teacher_disagreement_score":0.10135138,"about_ca_system_score_codex":0.000062279025,"about_ca_system_score_gemma":0.0006417453,"threshold_uncertainty_score":0.9623898},"labels":[],"label_agreement":null},{"id":"W2029812152","doi":"10.1158/0008-5472.sabcs13-p6-08-10","title":"Abstract P6-08-10: Breast cancer in young women in Canada: A needs assessment","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Psychosocial; Family medicine; Cancer; Population; Survivorship curve; Needs assessment; Disease; Gerontology; Gynecology; Internal medicine; Psychiatry; Environmental health","score_opus":0.02640393439202246,"score_gpt":0.365142151268555,"score_spread":0.3387382168765325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029812152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926611,0.0010557971,0.0000029486685,0.0020352814,0.00022776799,0.00047677677,0.00014409142,0.000004242211,0.003391973],"genre_scores_gemma":[0.9934486,0.0007539238,0.000029259209,0.00013108108,0.00025109568,0.0031425722,0.000023680801,0.000034631088,0.0021851321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977235,0.000114561,0.00028475406,0.00041641697,0.000492823,0.00096791383],"domain_scores_gemma":[0.9990161,0.000029915958,0.000046647245,0.00040281075,0.0003137031,0.00019082891],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006375423,0.0001536591,0.0001827422,0.00024216695,0.000069262474,0.000055752644,0.00039558948,0.00011491247,0.0048304116],"category_scores_gemma":[0.000034787503,0.00015596715,0.00002737524,0.00069548003,0.000102818805,0.000013676209,0.0001810309,0.00042829773,0.000026134576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00016260309,0.0001275187,0.5025828,0.00013367692,0.00010700257,0.000025375279,0.0011354096,0.00505944,0.40682828,0.000022984534,0.04996715,0.03384775],"study_design_scores_gemma":[0.0008030227,0.00003585815,0.9811518,0.00006705928,0.0000016953568,0.000005486107,0.002342059,0.0001523212,0.009703307,0.000071787304,0.0054268204,0.0002387725],"about_ca_topic_score_codex":0.9327685,"about_ca_topic_score_gemma":0.96750396,"teacher_disagreement_score":0.478569,"about_ca_system_score_codex":0.008832867,"about_ca_system_score_gemma":0.012984553,"threshold_uncertainty_score":0.9960793},"labels":[],"label_agreement":null},{"id":"W2029893048","doi":"10.1158/1538-7445.am2014-3093","title":"Abstract 3093: Unravelling the biology of aggressive and therapy-resistant embryonal tumors with multilayered rosettes (ETMR)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; Pathology; Brain tumor; Neuropil; Cancer; DNA methylation; Atypical teratoid rhabdoid tumor; Pathological; Cancer research; Gene; Gene expression; Genetics; Medicine; Central nervous system; Neuroscience","score_opus":0.06685707945531727,"score_gpt":0.3852637224622921,"score_spread":0.31840664300697485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029893048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870447,0.009925715,0.000003544049,0.0022382275,0.000023240511,0.0004416535,0.000026778062,0.000008582971,0.00028757827],"genre_scores_gemma":[0.99739313,0.0021226143,0.00006656442,0.00008132747,0.00010143837,0.00016429623,0.000006851886,0.000018113962,0.000045687968],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988415,0.00010299146,0.00016229031,0.00025539767,0.00031882714,0.00031899108],"domain_scores_gemma":[0.99865055,0.0005829704,0.00013040207,0.00026434966,0.00026631617,0.00010541597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048346113,0.00011492763,0.0002450421,0.00010801092,0.00014660634,0.000020207242,0.00010500768,0.000050392962,0.00012250041],"category_scores_gemma":[0.00012974908,0.000056422545,0.000038655533,0.00018528577,0.00047713507,0.000020614856,0.000036494213,0.0002368475,0.000004556777],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031113008,0.0005420235,0.20866627,0.00021383181,0.0005618316,0.00016707309,0.0011909123,0.00010517626,0.6960393,0.0013656098,0.00078997226,0.08724668],"study_design_scores_gemma":[0.0048173657,0.0015672094,0.56886524,0.0008496764,0.000037808528,0.000026371721,0.00046747935,0.00024514008,0.4186672,0.00035065715,0.0039595137,0.00014636233],"about_ca_topic_score_codex":0.0011199801,"about_ca_topic_score_gemma":0.00010973605,"teacher_disagreement_score":0.36019897,"about_ca_system_score_codex":0.000045691024,"about_ca_system_score_gemma":0.00015038704,"threshold_uncertainty_score":0.23008446},"labels":[],"label_agreement":null},{"id":"W2029919723","doi":"10.1158/1538-7445.am2014-2201","title":"Abstract 2201: Long-term risk of colorectal cancer in patients with sessile serrated adenomas, traditional serrated adenomas, and hyperplastic polyps","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hyperplastic Polyp; Colonoscopy; Colorectal cancer; Internal medicine; Odds ratio; Adenoma; Population; Cancer; Gastroenterology; Oncology","score_opus":0.03792684702408762,"score_gpt":0.3220540462503356,"score_spread":0.284127199226248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029919723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973733,0.00092127995,0.000016579585,0.00011542841,0.00016919251,0.00064842735,0.00022280228,0.00004407075,0.00048894883],"genre_scores_gemma":[0.9990968,0.00016960296,0.000028424143,0.000018324923,0.00018123422,0.0002361446,0.00007760323,0.000040908388,0.00015097603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977332,0.00017770597,0.00031905214,0.00048318968,0.00079911255,0.00048776474],"domain_scores_gemma":[0.99863344,0.00024816065,0.00013943833,0.00019264278,0.00053000764,0.0002563312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045163906,0.00020542939,0.0004010132,0.0003921762,0.0001627087,0.00003560929,0.000114542236,0.00016740887,0.0005603675],"category_scores_gemma":[0.00014969912,0.00016994489,0.00004226478,0.00082513527,0.00032143196,0.00015515374,0.00004256241,0.000820253,0.0000062388663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01286988,0.00024246432,0.9703894,0.0002437305,0.00012528452,0.000012992098,0.0002798155,0.00022873213,0.005933375,0.0000053579924,0.00022232592,0.009446619],"study_design_scores_gemma":[0.0044388585,0.0029343911,0.98507357,0.00061725674,0.00005888905,0.00000941423,0.00006143909,0.00069342466,0.005883164,0.000014628694,0.000034360935,0.000180608],"about_ca_topic_score_codex":0.003541738,"about_ca_topic_score_gemma":0.0037830407,"teacher_disagreement_score":0.014684143,"about_ca_system_score_codex":0.00044030958,"about_ca_system_score_gemma":0.0005872309,"threshold_uncertainty_score":0.6930151},"labels":[],"label_agreement":null},{"id":"W2029939216","doi":"10.1158/0008-5472.can-07-5835","title":"Cancers Exhibit a Mutator Phenotype: Clinical Implications","year":2008,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Phenotype; Biology; Mutation; Carcinogenesis; Cancer; Genetics; Mutation rate; Cancer research; Gene","score_opus":0.21534448527475647,"score_gpt":0.5239203215470013,"score_spread":0.30857583627224483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029939216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018273479,0.99583966,0.000037801994,0.00016007885,0.000577739,0.00096782926,0.00074558903,0.000014303562,0.001474254],"genre_scores_gemma":[0.000094377276,0.99301726,0.00009602247,0.00015398498,0.0031257512,0.0013500762,0.0005181375,0.00012590906,0.0015184778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696267,0.00031981542,0.00068538025,0.001002169,0.00031935034,0.0007105998],"domain_scores_gemma":[0.99758273,0.00025190585,0.00019916968,0.0011703735,0.00043353142,0.00036227665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000513497,0.00034551093,0.0008920128,0.00016252494,0.00028531736,0.000062561536,0.0008073577,0.0006155798,0.00010650171],"category_scores_gemma":[0.00046896024,0.00032171787,0.00056816835,0.00048364603,0.00052420195,0.0000024638878,0.0004802927,0.00085030805,0.00016683788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022453309,0.00004824568,0.000027338365,0.00088184234,0.00021597554,0.000009578407,0.000010100216,0.0000046604773,0.000059857153,0.00017754601,0.18313462,0.8154078],"study_design_scores_gemma":[0.00023712973,0.00015210481,0.000015761718,0.00078143174,0.000085712294,0.000024607703,0.000005644756,5.9657714e-7,0.000039401533,0.000054004755,0.99825776,0.00034586096],"about_ca_topic_score_codex":0.00046741043,"about_ca_topic_score_gemma":0.0004195276,"teacher_disagreement_score":0.81512314,"about_ca_system_score_codex":0.0005371207,"about_ca_system_score_gemma":0.008222873,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W2030053544","doi":"10.1158/1538-7445.am2014-3460","title":"Abstract 3460: Regulatory roles of conserved phosphorylation sites in the activation loop of the MAP kinase","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"MAP2K7; Kinase; c-Raf; MAPK14; Biology; Cyclin-dependent kinase 2; Phosphorylation; ASK1; Mitogen-activated protein kinase kinase; Protein kinase A; MAP kinase kinase kinase; Cell biology; Kinome; Cyclin-dependent kinase 9; Protein phosphorylation; Biochemistry","score_opus":0.044308071823775906,"score_gpt":0.3607981967870644,"score_spread":0.3164901249632885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030053544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787754,0.0003903275,0.000024565255,0.0008656058,0.000039739316,0.00027633543,0.0000090118465,0.0000016011994,0.0005152858],"genre_scores_gemma":[0.99950427,0.00003923388,0.00001821918,0.000046455345,0.00006983282,0.00008377981,0.000013926321,0.000007885765,0.00021639626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909216,0.00023037782,0.00015757221,0.00013884647,0.00025457295,0.00012648442],"domain_scores_gemma":[0.99914604,0.00010770785,0.00009021555,0.00040274116,0.00023789967,0.000015420435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008200061,0.000053303134,0.000066792934,0.000046608435,0.00006311535,0.000010224019,0.0002628747,0.000074046155,0.000052771567],"category_scores_gemma":[0.00035817912,0.0000356728,0.000044737124,0.00015222475,0.00018505985,0.000005902087,0.00006522727,0.0001789685,0.000002376033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091693866,0.000039895018,0.008567582,0.000041958403,0.000010805536,7.4344484e-8,0.00012497323,0.00014601323,0.9879032,0.00019964206,0.0014451251,0.0014290782],"study_design_scores_gemma":[0.00017046533,0.00004452392,0.110635296,0.000062251405,0.0000020465757,2.5302165e-7,0.00020145475,0.000033538116,0.8857483,0.00025555326,0.0028130773,0.00003322836],"about_ca_topic_score_codex":0.00045903987,"about_ca_topic_score_gemma":0.0006306359,"teacher_disagreement_score":0.10215485,"about_ca_system_score_codex":0.000032423795,"about_ca_system_score_gemma":0.00012577872,"threshold_uncertainty_score":0.14546946},"labels":[],"label_agreement":null},{"id":"W2030123605","doi":"10.1158/1538-7445.am2011-3534","title":"Abstract 3534: PBI-1402, a first-in-class erythropoiesis regulating agent, possesses differentiation properties and demonstrates synergistic anticancer activity in combination with chemotherapy","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Liminal BioSciences (Canada)","funders":"","keywords":"Gemcitabine; Pharmacology; Cancer research; Erythropoietin; Medicine; Anemia; Chemotherapy; Chemistry; Internal medicine","score_opus":0.10812204651924785,"score_gpt":0.3464588619104462,"score_spread":0.2383368153911984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030123605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947284,0.00080095476,0.000019837289,0.0027092702,0.000034281766,0.00070401793,0.0000036724846,0.000029441031,0.0009701651],"genre_scores_gemma":[0.9969122,0.002327792,0.00018746054,0.000026522965,0.000041383533,0.00023907828,0.000005859437,0.00003107186,0.00022866164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848217,0.00007713433,0.00021240256,0.00038717646,0.00042690872,0.0004141962],"domain_scores_gemma":[0.99933076,0.00012090228,0.000073183015,0.0002051195,0.0001749942,0.000095070325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031695186,0.00017607657,0.00029893615,0.0002541352,0.000152812,0.000048023594,0.00006713921,0.000090857844,0.0002432215],"category_scores_gemma":[0.00007137744,0.00012747082,0.00002638937,0.00042207388,0.00042896078,0.00018150637,0.000031808064,0.00032813696,0.0000032956882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023720101,0.0017649493,0.8692744,0.0014583362,0.00015612552,0.00012307463,0.004138431,0.000024444967,0.09941475,0.00028237727,0.00012944221,0.020861667],"study_design_scores_gemma":[0.0031653189,0.00044352261,0.8691393,0.0015695338,0.000025865653,0.000007243613,0.0009780695,0.0005076889,0.12383696,0.00014883136,0.000024618193,0.00015301388],"about_ca_topic_score_codex":0.0066154795,"about_ca_topic_score_gemma":0.0040325685,"teacher_disagreement_score":0.0244222,"about_ca_system_score_codex":0.00046772536,"about_ca_system_score_gemma":0.00023282375,"threshold_uncertainty_score":0.9999996},"labels":[],"label_agreement":null},{"id":"W2030125872","doi":"10.1158/1538-7445.am2014-1162","title":"Abstract 1162: Fibroblast RHAMM promotes breast cancer aggression by promoting expression of a subset of ERK1,2 target genes","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tumor progression; Biology; Tumor microenvironment; Cancer research; Stromal cell; Cancer cell; Cancer; Breast cancer; Cell biology; Stroma; Immunology; Immunohistochemistry; Genetics","score_opus":0.021182464342589746,"score_gpt":0.3347987994265355,"score_spread":0.31361633508394576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030125872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762934,0.021901613,0.0000960468,0.00022479861,0.00027179284,0.0004281556,0.000621481,0.000010657782,0.0001520893],"genre_scores_gemma":[0.9911898,0.00668234,0.00018701509,0.000017278166,0.0011925579,0.00019623159,0.00011466839,0.00004912295,0.0003710352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768513,0.0002359235,0.0004083919,0.0005401728,0.0005799744,0.00055039173],"domain_scores_gemma":[0.9984741,0.000047277983,0.00027469278,0.00045117928,0.00056340004,0.00018935303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010227466,0.00020533921,0.00034005434,0.00010881933,0.00013013602,0.000022490367,0.000385461,0.00022180945,0.00028750868],"category_scores_gemma":[0.00016336268,0.00017182261,0.00011942091,0.0002391318,0.0002900624,0.000014577876,0.00025113756,0.00026489902,0.0000025539935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029232298,0.00012891964,0.0020954858,0.00046879618,0.000030865092,3.1859844e-7,0.00015475528,0.000035618494,0.9424155,0.0000027633291,0.012618036,0.041756615],"study_design_scores_gemma":[0.000659467,0.00015456307,0.0027566908,0.0011158915,0.00000892695,0.000003826938,0.000057210455,0.000053701493,0.9604302,0.000033394743,0.03454849,0.0001776465],"about_ca_topic_score_codex":0.0008742669,"about_ca_topic_score_gemma":0.00012862762,"teacher_disagreement_score":0.04157897,"about_ca_system_score_codex":0.00003617851,"about_ca_system_score_gemma":0.00037799287,"threshold_uncertainty_score":0.70067227},"labels":[],"label_agreement":null},{"id":"W2030250065","doi":"10.1158/1538-7445.am2013-3796","title":"Abstract 3796: Endophilin II promotes breast tumor progression and metastasis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Invadopodia; Cancer research; Internalization; Metastasis; Gene silencing; Tumor progression; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Biology; Cancer; Extracellular matrix; Pathology; Chemistry; Kinase; Cell; Medicine; Biochemistry","score_opus":0.037824030357539486,"score_gpt":0.3763689764661919,"score_spread":0.3385449461086524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030250065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947813,0.0025517496,0.000016402802,0.0011136588,0.00008856026,0.00044156864,0.000038529295,0.000008654496,0.00095957477],"genre_scores_gemma":[0.9977206,0.00046138247,0.00013957024,0.000049778464,0.00023865297,0.0003358848,0.00004087865,0.000020589086,0.0009926497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895775,0.000052649746,0.00012853775,0.0003280326,0.00021364332,0.0003194089],"domain_scores_gemma":[0.9993026,0.000012925303,0.000034485518,0.0002491851,0.00026241704,0.00013834589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003116585,0.00009880813,0.00009308196,0.0000651443,0.0002511172,0.00007633948,0.00014436469,0.000059267062,0.00081409764],"category_scores_gemma":[0.00005902006,0.00008020597,0.000043145483,0.00009868365,0.00008452416,0.000010363697,0.00026085807,0.00022416806,0.000038378854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000259743,0.00007047296,0.000112316644,0.000026389149,0.000027720667,0.0000031452225,0.000024024244,5.28594e-7,0.96521884,0.00009801553,0.0043828716,0.03000972],"study_design_scores_gemma":[0.00030126207,0.00028344715,0.0020352812,0.000056047833,0.0000061561714,0.000057432095,0.000094458366,0.000072015246,0.9395975,0.00034586774,0.057008218,0.00014233611],"about_ca_topic_score_codex":0.0002625974,"about_ca_topic_score_gemma":0.000045624885,"teacher_disagreement_score":0.052625347,"about_ca_system_score_codex":0.000022363945,"about_ca_system_score_gemma":0.00010406946,"threshold_uncertainty_score":0.89137983},"labels":[],"label_agreement":null},{"id":"W2030452983","doi":"10.1158/1538-7445.fbcr13-b29","title":"Abstract B29: Defining subclonal signaling heterogeneity in glioblastoma multiforme (GBM)","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Temozolomide; Phenotype; Cancer research; Fluorescence in situ hybridization; Brain tumor; Somatic evolution in cancer; Erlotinib; Cell sorting; Oncogene; Genetic heterogeneity; Cancer; Glioblastoma; Cell; Genetics; Epidermal growth factor receptor; Pathology; Gene; Cell cycle; Medicine","score_opus":0.08579618997135796,"score_gpt":0.4070662053141568,"score_spread":0.32127001534279886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030452983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955742,0.0016684701,9.439761e-7,0.0011996174,0.00006549319,0.00063550554,0.000012815406,0.000029366789,0.0008136015],"genre_scores_gemma":[0.9985856,0.00017014031,0.00014898978,0.00010592567,0.00010886701,0.0007999402,0.000009658967,0.000028752453,0.000042128264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796975,0.00005694386,0.0002654999,0.00036186678,0.0006568667,0.0006890867],"domain_scores_gemma":[0.99893,0.00024740878,0.000025954814,0.0002620965,0.0002585735,0.00027599526],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00050661864,0.00014315365,0.00025381742,0.00034535103,0.000121385565,0.00006964854,0.00011877471,0.000095851035,0.0016881546],"category_scores_gemma":[0.0001210874,0.000116140036,0.0000884044,0.00044325125,0.0000997113,0.00012929137,0.00007870253,0.00045378396,0.00078693667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031109454,0.00070809654,0.6158449,0.00018030002,0.000112133595,0.00051404635,0.00035942686,0.00018736473,0.35324386,0.0001394384,0.0020737671,0.026325569],"study_design_scores_gemma":[0.00296213,0.00034524853,0.6002402,0.00049269816,0.000012860173,0.000025746773,0.00023836766,0.00031428784,0.3941718,0.0001345841,0.0008967954,0.00016529273],"about_ca_topic_score_codex":0.004751775,"about_ca_topic_score_gemma":0.0011376878,"teacher_disagreement_score":0.040927943,"about_ca_system_score_codex":0.0004957194,"about_ca_system_score_gemma":0.00023404993,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2030698572","doi":"10.1158/1538-7445.am2011-4336","title":"Abstract 4336: Oncolytic reovirus as a novel therapy for neuroblastoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuroblastoma; Oncolytic virus; Cancer research; Cytotoxic T cell; Immunotherapy; Cytotoxicity; Biology; In vitro; In vivo; Transplantation; Virology; Cell culture; Immunology; Medicine; Immune system; Internal medicine; Tumor cells","score_opus":0.1567325980719433,"score_gpt":0.4333821494366362,"score_spread":0.27664955136469294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030698572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990552,0.0017639984,0.00008480125,0.00032417924,0.00014466133,0.0011959237,0.000071062146,0.000024117,0.0058392747],"genre_scores_gemma":[0.9928484,0.0019661887,0.0001818619,0.0004885315,0.0005660995,0.0011313022,0.000026869287,0.00009902854,0.0026917106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975375,0.00011124883,0.0002287992,0.000669174,0.0005506288,0.00090267946],"domain_scores_gemma":[0.9983264,0.00007732051,0.000052088097,0.00075436966,0.00052940444,0.0002603923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011728102,0.00020144248,0.00018087977,0.00017784456,0.00024703812,0.00005318765,0.0007394777,0.00019473296,0.0006582096],"category_scores_gemma":[0.0001826916,0.00018584434,0.00014666446,0.00030621374,0.00030596968,0.000008164155,0.00015797143,0.0003802971,0.0001312652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0121443,0.00024598828,0.0000958843,0.000031383915,0.0000883474,0.000008074359,0.00015863645,0.000009891226,0.95691216,0.000061930106,0.0041286517,0.026114734],"study_design_scores_gemma":[0.001979394,0.0065847947,0.0009750028,0.000021261345,0.0000031010582,0.0000064151372,0.00006286423,0.000014627682,0.9302744,0.00031408726,0.05954663,0.00021740297],"about_ca_topic_score_codex":0.00044150528,"about_ca_topic_score_gemma":0.00055058685,"teacher_disagreement_score":0.05541798,"about_ca_system_score_codex":0.00009211501,"about_ca_system_score_gemma":0.0010220411,"threshold_uncertainty_score":0.75785124},"labels":[],"label_agreement":null},{"id":"W2030794949","doi":"10.1158/1538-7445.am2014-5072","title":"Abstract 5072: Meta-analysis of genome-wide association studies identifies novel susceptibility loci for follicular lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Genome-wide association study; Expression quantitative trait loci; Follicular lymphoma; Single-nucleotide polymorphism; Biology; Genetic association; Imputation (statistics); Genetics; Human leukocyte antigen; 1000 Genomes Project; Lymphoma; Gene; Immunology; Genotype","score_opus":0.21861907413139953,"score_gpt":0.44950131877676913,"score_spread":0.2308822446453696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030794949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843325,0.010127133,0.0001080299,0.003964076,0.00005961545,0.0009350706,0.00022014233,0.000019570585,0.00023384222],"genre_scores_gemma":[0.99613374,0.0007613695,0.00015814765,0.0002002524,0.0000969213,0.0009979057,0.00009724341,0.000018097893,0.0015363413],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99747145,0.00012047289,0.00046997966,0.00047368807,0.0010301583,0.00043422575],"domain_scores_gemma":[0.9941497,0.003159425,0.00021028289,0.00055950606,0.001799721,0.000121394456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003300427,0.0001631897,0.0012481019,0.00036482123,0.00017099752,0.000038880553,0.00014047396,0.000102176404,0.00032305208],"category_scores_gemma":[0.0031960679,0.00011594131,0.0011733326,0.0007724914,0.0001305223,0.00007796238,0.00007654435,0.00007276943,0.000014697907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039195808,0.0019533068,0.4089877,0.00094977714,0.5540777,0.000008563252,0.0013062672,0.00049313914,0.017114837,0.0003840016,0.011841223,0.0024915226],"study_design_scores_gemma":[0.0025368235,0.00023841171,0.8664469,0.000016939952,0.09338373,2.3116351e-7,0.0004804849,0.00009710467,0.029005889,0.00031484867,0.007338386,0.00014023905],"about_ca_topic_score_codex":0.0013794242,"about_ca_topic_score_gemma":0.0015923185,"teacher_disagreement_score":0.46069396,"about_ca_system_score_codex":0.0016927834,"about_ca_system_score_gemma":0.00021610541,"threshold_uncertainty_score":0.47279492},"labels":[],"label_agreement":null},{"id":"W2030861318","doi":"10.1158/1538-7445.am2013-4660","title":"Abstract 4660: A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small cell lung cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Pemetrexed; Internal medicine; Oncology; Tolerability; Lung cancer; Carboplatin; Population; Bevacizumab; non-small cell lung cancer (NSCLC); Induction chemotherapy; Hazard ratio; Maintenance therapy; Chemotherapy; Surgery; Adverse effect; Cisplatin; Confidence interval","score_opus":0.026225747910628573,"score_gpt":0.39626715821636965,"score_spread":0.37004141030574106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030861318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820395,0.0073081753,0.000028730155,0.00037081243,0.00019504347,0.00954088,0.0001851579,0.0000080197,0.0003236887],"genre_scores_gemma":[0.9774819,0.0045100856,0.00005432068,0.000089050394,0.00024166903,0.014381585,0.000028698412,0.000057722926,0.0031549914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972695,0.00025360065,0.00040687225,0.0006477526,0.0005799203,0.00084235595],"domain_scores_gemma":[0.997833,0.00016681284,0.00017022011,0.00073146226,0.0008684335,0.00023006115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008060341,0.00026666294,0.00046961504,0.00011144884,0.00042277362,0.00006349673,0.0006247208,0.000107339554,0.00033403598],"category_scores_gemma":[0.00021185653,0.00017175222,0.00027316486,0.00035235303,0.00032431018,0.000017192575,0.00029926543,0.00031346935,0.000006387969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046157602,0.002019772,0.0007648776,0.00014025056,0.0004667822,0.0000049343766,0.00069053535,0.00007455472,0.9065839,0.000003267571,0.010639162,0.032454334],"study_design_scores_gemma":[0.1945465,0.0029243007,0.00034422625,0.00009909158,0.000030356849,8.785214e-7,0.00062446017,0.00007157269,0.7975738,0.000072081515,0.0034991968,0.00021354578],"about_ca_topic_score_codex":0.011125,"about_ca_topic_score_gemma":0.0015992239,"teacher_disagreement_score":0.1483889,"about_ca_system_score_codex":0.00017037136,"about_ca_system_score_gemma":0.000994613,"threshold_uncertainty_score":0.99546003},"labels":[],"label_agreement":null},{"id":"W2031020124","doi":"10.1158/0008-5472.sabcs13-p4-07-19","title":"Abstract P4-07-19: MicroRNA miR-24 enhances tumor angiogenesis and metastasis in breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"microRNA; Angiogenesis; Cancer research; Metastasis; Biology; Transfection; Ectopic expression; Breast cancer; Cancer; Cancer cell; Cell growth; Cell culture; Gene","score_opus":0.031059664430293885,"score_gpt":0.3545999168204672,"score_spread":0.3235402523901733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031020124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97437656,0.021187125,0.000078045596,0.0026414061,0.00017485891,0.0009128626,0.0002519593,0.000017035547,0.00036016948],"genre_scores_gemma":[0.9868414,0.009628901,0.00017798098,0.0003554075,0.00033460328,0.0016265799,0.0000379349,0.00008171162,0.0009154752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966496,0.00024968598,0.00034334898,0.0009471381,0.00069700286,0.0011132121],"domain_scores_gemma":[0.99835753,0.000052460025,0.00007450508,0.00057155,0.0005044721,0.00043945367],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008270973,0.00028732273,0.0003086613,0.00037688477,0.00020359545,0.00017156114,0.0005396758,0.0002255764,0.0027062518],"category_scores_gemma":[0.00010762132,0.0002759209,0.0001229887,0.0006463583,0.000366319,0.000026084821,0.0004404955,0.00053012103,0.00013042879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018669754,0.00006888937,0.0007662843,0.00012475628,0.00013135643,0.000029213146,0.000063079504,0.0000559425,0.97106874,0.000011756715,0.014948109,0.012545153],"study_design_scores_gemma":[0.0008907115,0.0001036565,0.015501339,0.000121031495,0.000016117705,0.000037939455,0.00021373539,0.00003693837,0.9644143,0.000110692694,0.018187603,0.00036592947],"about_ca_topic_score_codex":0.01658965,"about_ca_topic_score_gemma":0.0033556211,"teacher_disagreement_score":0.014735054,"about_ca_system_score_codex":0.000271268,"about_ca_system_score_gemma":0.0008261873,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W2031038471","doi":"10.1158/0008-5472.sabcs-09-4101","title":"Clinical Data Do Not Support the Hypothesis That Irradiation Promotes Biologically Aggressive Local Recurrences through Stromal Activation.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Chemotherapy; Mastectomy; Breast cancer; Clinical trial; Cancer; Survival analysis; Randomized controlled trial; Proportional hazards model; Oncology; Surgery","score_opus":0.2994056510230007,"score_gpt":0.4737053535786149,"score_spread":0.17429970255561417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031038471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757019,0.0035219518,0.0004345264,0.017846983,0.00025456224,0.00075826835,0.0004270997,0.00002886261,0.0010257903],"genre_scores_gemma":[0.99272096,0.005045112,0.00038694995,0.00058849104,0.00075665175,0.00013111727,0.000244646,0.000011661106,0.00011442933],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977082,0.0004214447,0.0002494051,0.0007381648,0.0004416135,0.00044118948],"domain_scores_gemma":[0.99836177,0.00031558197,0.0001664143,0.0008433385,0.0002422341,0.000070675924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093524274,0.00016984018,0.00020029994,0.000030254485,0.00036146658,0.00007263258,0.0008768261,0.00017154464,0.00010791861],"category_scores_gemma":[0.00080982875,0.000103907194,0.00007054037,0.00019727109,0.0006979758,0.000024929268,0.00036919594,0.00030869787,0.000020154615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001537064,0.0005122498,0.04242124,0.000023755198,0.00048530838,0.000018063438,0.00042103755,0.000024733179,0.02284968,0.0003097056,0.071427,0.85997015],"study_design_scores_gemma":[0.001954104,0.002288448,0.79357636,0.00017790921,0.00008795808,0.000022822007,0.0013066999,0.000039936953,0.10735099,0.0023759434,0.09022877,0.0005900649],"about_ca_topic_score_codex":0.00012757757,"about_ca_topic_score_gemma":0.000067705965,"teacher_disagreement_score":0.85938007,"about_ca_system_score_codex":0.00006835036,"about_ca_system_score_gemma":0.00038910413,"threshold_uncertainty_score":0.42372125},"labels":[],"label_agreement":null},{"id":"W2031084875","doi":"10.1158/1538-7445.am2014-3089","title":"Abstract 3089: (Epi)genetic profiling enables molecular re-classification of CNS-primitive neuroectodermal tumors","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; DNA methylation; Biology; Atypical teratoid rhabdoid tumor; Pathology; Brain tumor; Ependymoma; Glioma; Gene expression profiling; Immunohistochemistry; Oligodendroglioma; Cancer research; Gene; Gene expression; Medicine; Astrocytoma; Genetics","score_opus":0.08802446169920979,"score_gpt":0.3965623642108844,"score_spread":0.3085379025116746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031084875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253595,0.0011333646,0.00003420747,0.0012840988,0.00004521483,0.00065249996,0.000011640183,0.000022493581,0.0042805257],"genre_scores_gemma":[0.9988503,0.00022267408,0.00029708777,0.00006867882,0.000099131816,0.00034965726,0.00002089006,0.000031525633,0.00006004032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981839,0.0001403795,0.00026183107,0.00036174498,0.0006527428,0.00039939693],"domain_scores_gemma":[0.9987156,0.000201483,0.00007726736,0.00039946352,0.00043732685,0.0001689041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019172,0.00012264276,0.00025132985,0.00022350017,0.000086248234,0.000022350187,0.00012386,0.0000599007,0.00018364117],"category_scores_gemma":[0.00029898624,0.000102409314,0.00007983694,0.00032698308,0.00016873144,0.000041523996,0.000049329246,0.0002611866,0.00003751968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013087205,0.00027577725,0.033653006,0.00026522347,0.00006825263,0.00012482068,0.00011943848,0.00015166734,0.9540364,0.00072507997,0.00036809995,0.010081348],"study_design_scores_gemma":[0.0007181256,0.0002268467,0.38548368,0.00019150546,0.00003078915,0.0000063149373,0.00010594727,0.00038683604,0.6122908,0.00011232599,0.00038383657,0.00006300302],"about_ca_topic_score_codex":0.0004091251,"about_ca_topic_score_gemma":0.000025426161,"teacher_disagreement_score":0.3518307,"about_ca_system_score_codex":0.00015179724,"about_ca_system_score_gemma":0.0002574913,"threshold_uncertainty_score":0.41761306},"labels":[],"label_agreement":null},{"id":"W2031165260","doi":"10.1158/0008-5472.sabcs10-s1-4","title":"Abstract S1-4: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of AMG 479 With Exemestane (E) or Fulvestrant (F) in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic (M) or Locally Advanced (LA) Breast Cancer (BC)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Placebo; Internal medicine; Exemestane; Metastatic breast cancer; Clinical endpoint; Breast cancer; Oncology; Cancer; Estrogen receptor; Clinical trial; Tamoxifen; Pathology","score_opus":0.03862540612205098,"score_gpt":0.38073727639355,"score_spread":0.34211187027149903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031165260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392946,0.00048851187,0.000024316329,0.0007215329,0.00011669983,0.013855907,0.00028956763,0.000059974693,0.000514022],"genre_scores_gemma":[0.98802036,0.0007910068,0.00027028227,0.00008013906,0.0001578612,0.00963151,0.00005268987,0.0001573267,0.00083883066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933035,0.0005529686,0.0012978402,0.0010768906,0.002203861,0.0015649655],"domain_scores_gemma":[0.99512637,0.0012600521,0.00044624243,0.00077388453,0.0015291052,0.00086437317],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027292743,0.00073361327,0.0026829478,0.0010093027,0.00021087735,0.00011165837,0.0004903372,0.00021721047,0.0016998611],"category_scores_gemma":[0.0002308117,0.00039969498,0.0001187234,0.0018953698,0.0011361734,0.00053898094,0.00009860574,0.002301906,0.000024612826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.901717,0.005324382,0.00062373857,0.00030238763,0.0019923544,0.0015042577,0.006269533,0.000076399505,0.07585331,0.000024690411,0.000117177755,0.0061947857],"study_design_scores_gemma":[0.9555102,0.020838363,0.0057341517,0.00072868756,0.00055836997,0.00022094067,0.010823732,0.000073710595,0.004814171,0.000009763807,0.00010294342,0.00058498984],"about_ca_topic_score_codex":0.008778118,"about_ca_topic_score_gemma":0.007725186,"teacher_disagreement_score":0.07103913,"about_ca_system_score_codex":0.0006256222,"about_ca_system_score_gemma":0.0045365132,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2031176449","doi":"10.1158/0008-5472.can-05-2156","title":"BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Establishment of sister chromatid cohesion; Sister chromatids; Genetics; Biology; RAD51; DNA damage; DNA replication; Chromatid; DNA repair; Carcinogenesis; Sister chromatid exchange; Cohesin; DNA; Chromosome; Gene; Chromatin","score_opus":0.042077101800012756,"score_gpt":0.34168805644505973,"score_spread":0.29961095464504695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031176449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917236,0.0011642168,0.00031980244,0.0050522676,0.000028042567,0.0015036355,0.0001407655,0.000023102702,0.000044559612],"genre_scores_gemma":[0.99639314,0.00023206479,0.0011036664,0.0002658278,0.00015118861,0.0012213084,0.00012814195,0.000044526896,0.00046015423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978755,0.0003250264,0.00031846509,0.00087124354,0.00019866791,0.00041110077],"domain_scores_gemma":[0.9982556,0.0001879371,0.000060008613,0.0010017334,0.0003176519,0.00017704577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015373871,0.00017260262,0.0001992554,0.00018581309,0.00021221119,0.000101739766,0.00021780262,0.00016108924,0.00004495878],"category_scores_gemma":[0.00045394702,0.00017460184,0.00004389418,0.00024051213,0.00013731672,0.000025939928,0.00027727443,0.00009696115,0.0000039480014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001435533,0.00005282795,0.0013664083,0.00012823149,0.000021684691,0.000001915568,0.00021370787,0.000029639301,0.9938546,0.000036051566,0.000497378,0.0023620331],"study_design_scores_gemma":[0.0006784531,0.0005646157,0.17751071,0.000034354234,0.000018638575,0.000046685764,0.00012979885,0.000088849265,0.80115986,0.00021916538,0.01933455,0.00021430472],"about_ca_topic_score_codex":0.00006610209,"about_ca_topic_score_gemma":0.0009801509,"teacher_disagreement_score":0.19269472,"about_ca_system_score_codex":0.00020333377,"about_ca_system_score_gemma":0.00017014937,"threshold_uncertainty_score":0.7120056},"labels":[],"label_agreement":null},{"id":"W2031191883","doi":"10.1158/1538-7445.am2013-lb-67","title":"Abstract LB-67: REGARD: A phase III, randomized, double-blind trial of ramucirumab and best supportive care (BSC) versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line p","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Ramucirumab; Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Placebo; Gastroenterology; Cancer; Progression-free survival; Bevacizumab; Oncology; Randomized controlled trial; Chemotherapy; Confidence interval; Pathology","score_opus":0.13317937399463572,"score_gpt":0.44163372845297294,"score_spread":0.30845435445833724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031191883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499477,0.0037711624,0.0000122409965,0.00071425235,0.00021069143,0.010088887,0.000025557249,0.000010118253,0.00017230732],"genre_scores_gemma":[0.99499613,0.0016355674,0.00006000588,0.0000117234895,0.00018651935,0.0027087962,0.000066637986,0.000023468358,0.0003111652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972654,0.00024382668,0.0006113747,0.00044679572,0.00096864026,0.00046396817],"domain_scores_gemma":[0.99809366,0.00089266273,0.00022691197,0.0003571785,0.00019678174,0.0002328286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009164907,0.00025658062,0.00084921176,0.00055564026,0.00014678089,0.000057304704,0.00011997542,0.000053139676,0.00022031515],"category_scores_gemma":[0.00022423657,0.00014611303,0.00020435016,0.00053730066,0.00028910706,0.00015136013,0.000051671414,0.00025750572,0.0000025964534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95929044,0.0013114595,0.0030936843,0.00048473213,0.0003576004,0.000248371,0.0022202248,0.000020588517,0.000035520752,0.000008060667,0.0002298991,0.03269944],"study_design_scores_gemma":[0.9778618,0.012425975,0.003586045,0.0004666506,0.0008513555,0.000003770602,0.004094982,0.00012245918,0.0003673326,0.0000133394415,0.000106418316,0.00009982842],"about_ca_topic_score_codex":0.0017246626,"about_ca_topic_score_gemma":0.0003912266,"teacher_disagreement_score":0.032599613,"about_ca_system_score_codex":0.00038634957,"about_ca_system_score_gemma":0.00034301376,"threshold_uncertainty_score":0.59583163},"labels":[],"label_agreement":null},{"id":"W2031195353","doi":"10.1158/0008-5472.sabcs11-p1-11-13","title":"P1-11-13: Improvement in the Quality of Care for Patients with Locally Advanced Breast Cancer through Implementation of an Integrated Electronic Care Pathway.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Referral; Radiation oncologist; Breast cancer; Multidisciplinary approach; Clinical pathway; Quality assurance; Cancer; Medical physics; Radiation therapy; Internal medicine; Family medicine; Nursing; Pathology","score_opus":0.033918014608521486,"score_gpt":0.4007867665721617,"score_spread":0.3668687519636402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031195353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949727,0.0017510724,0.00006736584,0.000058520007,0.00003304703,0.0014167321,0.0016572413,0.0000035232636,0.000039772276],"genre_scores_gemma":[0.99700576,0.00038775508,0.0001470277,0.00003766763,0.000036479716,0.0018810247,0.00047741772,0.000022513188,0.0000043352425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841136,0.00015415277,0.00028240716,0.0003668908,0.00036158634,0.00042361056],"domain_scores_gemma":[0.9981937,0.000021127285,0.00014189523,0.0003557969,0.0012566722,0.000030797506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002229326,0.00015390529,0.0002168559,0.000044530076,0.00009154599,0.000006242775,0.00027616305,0.000060649778,0.000029742168],"category_scores_gemma":[0.000011009933,0.0001031712,0.000052336723,0.00023327468,0.0001751603,0.000015827818,0.000068726265,0.00010665007,9.794195e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010575618,0.0008101475,0.59113765,0.0011282779,0.00045826094,9.680917e-7,0.03759967,0.00008176695,0.06344269,0.00039459972,0.00007942827,0.2942909],"study_design_scores_gemma":[0.0064602564,0.003826438,0.5062761,0.00013188746,0.000037677884,3.254055e-7,0.06994777,9.0386106e-7,0.4121947,0.000066907065,0.00083190796,0.00022514342],"about_ca_topic_score_codex":0.030772697,"about_ca_topic_score_gemma":0.16386268,"teacher_disagreement_score":0.34875202,"about_ca_system_score_codex":0.00032105634,"about_ca_system_score_gemma":0.00080758194,"threshold_uncertainty_score":0.9756815},"labels":[],"label_agreement":null},{"id":"W2031398056","doi":"10.1158/1538-7445.am2012-lb-449","title":"Abstract LB-449: KRAS mutation and amplification status predicts sensitivity to antifolate therapies in non-small-cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"KRAS; Antifolate; Pemetrexed; Cancer research; Biology; Cancer; Mutation; Molecular biology; Antimetabolite; Chemotherapy; Gene; Genetics; Cisplatin","score_opus":0.05520699532945354,"score_gpt":0.4316036562978303,"score_spread":0.37639666096837676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031398056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898062,0.005998653,0.00013378369,0.0012994324,0.0001684686,0.0014542466,0.000096808646,0.00002857866,0.0010138795],"genre_scores_gemma":[0.99605536,0.0020014201,0.00022631258,0.0001557296,0.00024398125,0.0006576593,0.000052228264,0.000032078628,0.0005752509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983748,0.00009123192,0.00019713814,0.00031782012,0.00037991337,0.0006390514],"domain_scores_gemma":[0.99893814,0.00015573426,0.000049766266,0.00022594693,0.00028660905,0.00034378824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006552053,0.00013811316,0.00019914341,0.00029212298,0.00015817548,0.000052285064,0.00004014521,0.00008061186,0.00013761836],"category_scores_gemma":[0.00005168973,0.000118748285,0.000026795438,0.0004698483,0.000070833674,0.00022685788,0.000039002913,0.00028779218,0.000020128537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036495898,0.00037638142,0.79088265,0.0005420379,0.00016778172,0.000047139147,0.019303532,0.00019089572,0.14282507,0.000054766424,0.0015625759,0.043682218],"study_design_scores_gemma":[0.0015105631,0.00007856563,0.98074776,0.00028088802,0.00006436293,0.000004759981,0.0009285921,0.00025526155,0.014235174,0.000019302279,0.0017526895,0.0001220735],"about_ca_topic_score_codex":0.011054266,"about_ca_topic_score_gemma":0.002424768,"teacher_disagreement_score":0.18986513,"about_ca_system_score_codex":0.0007824631,"about_ca_system_score_gemma":0.0004827382,"threshold_uncertainty_score":0.9955312},"labels":[],"label_agreement":null},{"id":"W2031575594","doi":"10.1158/1538-7445.am2013-5269","title":"Abstract 5269: Divergent roles of Akt isoforms in insulin-like growth factor-mediated lung tumorigenesis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"AKT1; AKT2; Protein kinase B; Carcinogenesis; PI3K/AKT/mTOR pathway; Cancer research; Biology; Genetically modified mouse; Growth factor; Transgene; Lewis lung carcinoma; Cancer; Endocrinology; Signal transduction; Internal medicine; Receptor; Cell biology; Medicine; Biochemistry; Gene","score_opus":0.028053380784136238,"score_gpt":0.32756678676691725,"score_spread":0.29951340598278103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031575594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97386163,0.02439973,0.000009902752,0.00013983785,0.0006445076,0.0004890619,0.000108223496,0.00000922849,0.0003378951],"genre_scores_gemma":[0.97611535,0.02206834,0.000023749646,0.00007825234,0.00073436886,0.00027541586,0.00008034548,0.00003254095,0.0005916505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980415,0.00008323871,0.000344375,0.00042756676,0.00047686786,0.0006264498],"domain_scores_gemma":[0.99883753,0.00003693984,0.00008319661,0.00037107387,0.0004703826,0.00020085125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003733232,0.00017640962,0.000264247,0.00020111805,0.00007890501,0.000030041556,0.00041173378,0.00018253163,0.000500805],"category_scores_gemma":[0.00016050466,0.00015192847,0.00009951085,0.0003535477,0.00018324962,0.000016096481,0.00022894463,0.00024711437,0.000035480374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012954035,0.00011626748,0.018889168,0.00013241057,0.000058232643,0.0000018667721,0.00030264957,0.00002436661,0.96097046,0.0000202905,0.011568952,0.007785794],"study_design_scores_gemma":[0.0014253642,0.00013502593,0.37775904,0.00007168428,0.00000851134,0.0000015608626,0.00030088454,0.00002802072,0.5169064,0.0001169273,0.10291345,0.0003331653],"about_ca_topic_score_codex":0.0043627447,"about_ca_topic_score_gemma":0.0015268809,"teacher_disagreement_score":0.4440641,"about_ca_system_score_codex":0.000094506664,"about_ca_system_score_gemma":0.0004472254,"threshold_uncertainty_score":0.6595194},"labels":[],"label_agreement":null},{"id":"W2031666275","doi":"10.1158/1538-7445.am2013-810","title":"Abstract 810: Integrative genomic and transcriptomic analysis in idenfitication of biomarkers of chemoresistance in serous epithelial ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Queen's University","funders":"","keywords":"Ovarian cancer; Serous fluid; Gene expression profiling; Chemotherapy; Microarray; Oncology; Microarray analysis techniques; Cancer research; Biology; Copy-number variation; Transcriptome; Internal medicine; Medicine; Cancer; Gene; Gene expression; Genetics; Genome","score_opus":0.04237829536080324,"score_gpt":0.37955481067024355,"score_spread":0.3371765153094403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031666275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923656,0.004164952,0.000010522838,0.002036099,0.000032092572,0.00083536416,0.00009827624,0.000004325537,0.0004527819],"genre_scores_gemma":[0.9950959,0.003971678,0.00014445501,0.000025502017,0.000030340963,0.00064761145,0.000013668832,0.000015598329,0.000055208046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984363,0.00009080642,0.0004631502,0.00036437166,0.00033128657,0.00031409736],"domain_scores_gemma":[0.99907684,0.00015844077,0.00010116429,0.00027489083,0.00028188457,0.00010678444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050334854,0.00013346616,0.0005351207,0.00076253235,0.000024359133,0.000013638996,0.0001160245,0.000085962536,0.0006849418],"category_scores_gemma":[0.000049977945,0.00011107307,0.00008605886,0.0013728675,0.00028059207,0.00010006379,0.000021277028,0.00023924447,0.0000031798718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007996568,0.00035630655,0.6101457,0.00044796328,0.00091163313,0.000017809749,0.0025302481,0.000075096985,0.36287332,0.00024764924,0.00014632284,0.021448288],"study_design_scores_gemma":[0.0021272895,0.000093861934,0.9209544,0.0004357067,0.00013328748,5.7849275e-7,0.0006685588,0.00019872024,0.07505826,0.00023329853,0.000019575686,0.00007648543],"about_ca_topic_score_codex":0.08114511,"about_ca_topic_score_gemma":0.03470712,"teacher_disagreement_score":0.3108087,"about_ca_system_score_codex":0.0008089306,"about_ca_system_score_gemma":0.0004975724,"threshold_uncertainty_score":0.98290694},"labels":[],"label_agreement":null},{"id":"W2031701557","doi":"10.1158/0008-5472.can-05-3633","title":"Role of p53 Up-regulated Modulator of Apoptosis and Phosphorylated Akt in Melanoma Cell Growth, Apoptosis, and Patient Survival","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Puma; Protein kinase B; Melanoma; Cancer research; Apoptosis; PI3K/AKT/mTOR pathway; Metastasis; Biology; Phosphorylation; Cancer; Medicine; Internal medicine; Cell biology","score_opus":0.01267129819663095,"score_gpt":0.28102718809731353,"score_spread":0.2683558899006826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031701557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805976,0.011006851,0.0000056431677,0.000053702337,0.00009200904,0.00029607542,0.0000900805,0.000005795565,0.00039005614],"genre_scores_gemma":[0.9988096,0.0007984457,0.00006436239,0.0000107028045,0.00005774077,0.000067270244,0.00003911595,0.000033112097,0.00011964764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982454,0.00016089412,0.0003558095,0.00045603298,0.00038481777,0.00039700416],"domain_scores_gemma":[0.9990786,0.000042821055,0.00010944103,0.0003021536,0.00037386714,0.00009315212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036134146,0.00016439929,0.00028115904,0.00015088379,0.000052641408,0.00001571815,0.00018719205,0.00021678084,0.000042949705],"category_scores_gemma":[0.000043429816,0.00016428524,0.000047031415,0.00035070252,0.0003192914,0.000007086514,0.00020333356,0.00018497012,6.483633e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033717332,0.00008585457,0.018630026,0.00010764206,0.00003768485,3.777668e-7,0.00013133141,0.00014241236,0.978168,0.00004166906,0.0004950043,0.0018227949],"study_design_scores_gemma":[0.0009479471,0.00036648868,0.006958301,0.00006392827,0.000010449512,6.677115e-7,0.00015148283,0.00010548772,0.99051,0.00017856687,0.00054467184,0.00016199183],"about_ca_topic_score_codex":0.0044220774,"about_ca_topic_score_gemma":0.0001438808,"teacher_disagreement_score":0.012341986,"about_ca_system_score_codex":0.00006724257,"about_ca_system_score_gemma":0.00017639215,"threshold_uncertainty_score":0.66993576},"labels":[],"label_agreement":null},{"id":"W2031738797","doi":"10.1158/1538-7445.am2011-lb-348","title":"Abstract LB-348: Integrated analysis of microRNA and mRNA expression in microsatellite-stable colon cancer using next-generation sequencing and cDNA microarrays","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"microRNA; Biology; Colorectal cancer; DNA microarray; Gene expression; Epigenetics; Gene expression profiling; Gene; Cancer; CpG site; Molecular biology; Genetics; DNA methylation","score_opus":0.16112335646923512,"score_gpt":0.37192985052534017,"score_spread":0.21080649405610505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031738797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983293,0.015363358,0.0006630454,0.000028338136,0.00006232808,0.00040814394,0.00010296823,0.0000054950856,0.00007334239],"genre_scores_gemma":[0.98931175,0.009172125,0.001104562,0.000030452387,0.00006523615,0.00008471898,0.00009710534,0.000037535403,0.00009649487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978635,0.00022541982,0.00036547735,0.00067147845,0.000320119,0.0005540221],"domain_scores_gemma":[0.99891794,0.000024840469,0.000114159935,0.00035088081,0.0004354145,0.00015677036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091239746,0.00019556354,0.00032170874,0.0006455295,0.00015048536,0.00007141529,0.00021414085,0.00029305645,0.0001623163],"category_scores_gemma":[0.00008355949,0.00019300262,0.000069056216,0.0010593353,0.0002727008,0.000025462414,0.00022911215,0.00042952865,6.7735203e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031443418,0.000036428475,0.0017692373,0.00009114783,0.00019415811,0.0000117451245,0.00061013683,0.0006601794,0.9930603,0.000003944241,0.000079540216,0.0031687377],"study_design_scores_gemma":[0.00051925925,0.00009595765,0.001321348,0.00016542722,0.000063902844,0.0000033830468,0.00048096073,0.002829017,0.99393785,0.0000134441225,0.0003807534,0.00018871066],"about_ca_topic_score_codex":0.018396145,"about_ca_topic_score_gemma":0.0077725286,"teacher_disagreement_score":0.010623616,"about_ca_system_score_codex":0.0003386384,"about_ca_system_score_gemma":0.0006376408,"threshold_uncertainty_score":0.98814046},"labels":[],"label_agreement":null},{"id":"W2031769180","doi":"10.1158/1538-7445.am2014-3404","title":"Abstract 3404: Identifying genes involved in retinoic-acid-mediated breast tumor progression by total-genome-knockdown screen","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Gene knockdown; Cancer research; Breast cancer; Biology; Wnt signaling pathway; Small hairpin RNA; Metastasis; Cancer; Tumor progression; Medicine; Gene; Genetics","score_opus":0.041274384805836194,"score_gpt":0.3691970527743592,"score_spread":0.32792266796852304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031769180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98938733,0.008608017,0.0001296498,0.0004714775,0.00008504356,0.00040182917,0.0001542183,0.000017975088,0.0007444576],"genre_scores_gemma":[0.9967088,0.0011863121,0.000087330285,0.00007365883,0.00035753453,0.00042278692,0.00046066247,0.000040936717,0.00066196296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979274,0.00017429126,0.00029053655,0.0005876409,0.00043871798,0.00058141194],"domain_scores_gemma":[0.9989037,0.00002304389,0.00008499087,0.0005224466,0.00028691278,0.00017888873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096385326,0.00016612475,0.00017294675,0.00013756778,0.00019125566,0.00009911011,0.00038908003,0.00014929207,0.00022480906],"category_scores_gemma":[0.00009862828,0.00015302097,0.000058858084,0.0003724806,0.00019579988,0.000013766809,0.00018979088,0.00030924077,0.000047902464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013136347,0.00006655739,0.008209544,0.000052399697,0.000016899465,0.000003023919,0.00003515655,0.000026417405,0.9727415,0.000009587717,0.0037901101,0.014917467],"study_design_scores_gemma":[0.0014289671,0.00020572905,0.14491186,0.00020983051,0.000007681212,0.000010329479,0.00027324542,0.000174309,0.78144336,0.000055109474,0.07078841,0.0004911504],"about_ca_topic_score_codex":0.0006612362,"about_ca_topic_score_gemma":0.00035033355,"teacher_disagreement_score":0.1912981,"about_ca_system_score_codex":0.00011554766,"about_ca_system_score_gemma":0.00022866973,"threshold_uncertainty_score":0.6240014},"labels":[],"label_agreement":null},{"id":"W2031916784","doi":"10.1158/0008-5472.sabcs13-p3-12-11","title":"Abstract P3-12-11: Provincial variation in utilization of adjuvant chemotherapy regimens in early stage breast cancer: Data from the cancer care Ontario new drug funding program (NDFP)","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Docetaxel; Cancer; Regimen; Internal medicine; Stage (stratigraphy); Oncology; Chemotherapy","score_opus":0.15713021348266476,"score_gpt":0.3633880796856708,"score_spread":0.206257866203006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031916784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445404,0.006749059,0.000059628062,0.0027465788,0.00051403174,0.0019327528,0.0023648767,0.000022458618,0.0011565663],"genre_scores_gemma":[0.99406564,0.002870883,0.00013896821,0.00013627061,0.0006002754,0.0006651369,0.00011550295,0.000056019144,0.0013513175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972802,0.000049353574,0.0008789569,0.00084828935,0.00018189797,0.00076134945],"domain_scores_gemma":[0.9981881,0.00010075819,0.0004790731,0.00089148607,0.00018569727,0.00015492778],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010284949,0.00023734274,0.00055191846,0.00031486616,0.00013464296,0.00024617682,0.0011037828,0.00018405542,0.0033548698],"category_scores_gemma":[0.000076756565,0.00023123389,0.00006435264,0.0005389004,0.00014708635,0.0012192532,0.00023060397,0.0006355236,0.000046800884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019653843,0.00011341765,0.91821295,0.00007178808,0.000040561896,0.0000018059856,0.012306897,0.0003874018,0.00012380235,0.0011935362,0.005293727,0.062057547],"study_design_scores_gemma":[0.001480967,0.000040968698,0.97455335,0.00023558129,0.0000045652273,1.373958e-7,0.0004757601,0.0006879673,0.00012600499,0.0013920628,0.020749114,0.0002535283],"about_ca_topic_score_codex":0.96234816,"about_ca_topic_score_gemma":0.920167,"teacher_disagreement_score":0.06180402,"about_ca_system_score_codex":0.0030683177,"about_ca_system_score_gemma":0.002037844,"threshold_uncertainty_score":0.9975562},"labels":[],"label_agreement":null},{"id":"W2032012145","doi":"10.1158/1538-7445.am2013-1852","title":"Abstract 1852: Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxia in human colorectal cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Warburg effect; Pyruvate dehydrogenase kinase; Glycolysis; Pyruvate dehydrogenase complex; Cancer cell; Apoptosis; Anaerobic glycolysis; Lactate dehydrogenase; Biology; Pyruvate kinase; Cell culture; Chemistry; Biochemistry; Metabolism; Enzyme; Cancer","score_opus":0.02823364109387947,"score_gpt":0.33382790581907834,"score_spread":0.30559426472519885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032012145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389971,0.05946471,9.699609e-7,0.00018737811,0.00041631755,0.00072282675,0.000042832067,0.000011836519,0.00015604307],"genre_scores_gemma":[0.97914296,0.018055338,0.000029989144,0.00009339056,0.0007616661,0.001457201,0.00003654702,0.000053452357,0.00036945325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760956,0.00017956451,0.00028600794,0.00070073205,0.00037766568,0.0008464951],"domain_scores_gemma":[0.99921817,0.000026044476,0.00006947165,0.0003230558,0.00011607459,0.0002472114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006532205,0.00025571662,0.0003590845,0.00029952856,0.00017175009,0.000092924216,0.0002888399,0.00023226805,0.00017075521],"category_scores_gemma":[0.00004591754,0.0002400464,0.00008165709,0.00038366325,0.00018073467,0.000029121438,0.00025960777,0.0004491687,0.0000071692893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106369545,0.000067915724,0.0056985356,0.00006167565,0.000032381093,0.00001504023,0.00045519625,0.00006510262,0.983436,0.0000057401803,0.001025368,0.009030715],"study_design_scores_gemma":[0.0016325659,0.00007969579,0.038711157,0.00012663689,0.000010389642,0.0000011265427,0.00021939777,0.000014850594,0.942502,0.000047893926,0.016380163,0.00027408596],"about_ca_topic_score_codex":0.0075949314,"about_ca_topic_score_gemma":0.015520012,"teacher_disagreement_score":0.041409373,"about_ca_system_score_codex":0.00007602127,"about_ca_system_score_gemma":0.00022587027,"threshold_uncertainty_score":0.9990136},"labels":[],"label_agreement":null},{"id":"W2032086812","doi":"10.1158/0008-5472.can-06-4477","title":"Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Immunovaccine (Canada); University Health Network","funders":"Hospital for Sick Children","keywords":"Cancer research; MAPK/ERK pathway; Fibroblast growth factor receptor 1; Thyroid cancer; Fibroblast growth factor receptor; Fibroblast growth factor receptor 2; Biology; Cancer; Fibroblast growth factor; Carcinogenesis; Fibroblast growth factor receptor 4; Protein kinase A; Signal transduction; Kinase; Cell biology; Receptor; Genetics","score_opus":0.03997370418213184,"score_gpt":0.36555693093298325,"score_spread":0.3255832267508514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032086812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128556,0.0009578765,0.00026529387,0.00215367,0.0001918041,0.0046008653,0.00021843256,0.00005315428,0.00027333],"genre_scores_gemma":[0.99400395,0.00015492055,0.00021171365,0.00019800923,0.00084045186,0.0021513528,0.000049687085,0.00014760258,0.0022423037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99386114,0.0008635565,0.0005926779,0.0011805538,0.0016685337,0.0018335595],"domain_scores_gemma":[0.99666977,0.000340165,0.00014157683,0.0008752037,0.001271776,0.00070151646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021000917,0.00048559395,0.00046142822,0.0003376833,0.00063371996,0.00021664693,0.001049861,0.00038372973,0.00069308456],"category_scores_gemma":[0.0015937653,0.00032839974,0.00022435894,0.0009317301,0.00042337793,0.000018103485,0.00060518924,0.0009977829,0.00011421019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008509729,0.00015513066,0.0004419161,0.0000921234,0.0001639116,0.000014682695,0.00019402147,0.000109839835,0.98375183,0.00013419912,0.0015009461,0.0049316795],"study_design_scores_gemma":[0.0023245052,0.0019762763,0.0011239529,0.0004954276,0.0000048464512,0.0000012551129,0.00010334911,0.000025864954,0.9880562,0.000046883084,0.005431855,0.00040961872],"about_ca_topic_score_codex":0.00035547145,"about_ca_topic_score_gemma":0.00015580306,"teacher_disagreement_score":0.006185224,"about_ca_system_score_codex":0.0003772595,"about_ca_system_score_gemma":0.00090185716,"threshold_uncertainty_score":0.9999168},"labels":[],"label_agreement":null},{"id":"W2032262403","doi":"10.1158/1538-7445.am10-2591","title":"Abstract 2591: Differential oncolysis by vesicular stomatitis virus in prostate cancers arising in transgenic mice","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Prostate cancer; Cancer research; Terminal deoxynucleotidyl transferase; Genetically modified mouse; Tramp; Prostate; Cancer; Biology; Virus; PTEN; Cancer cell; TUNEL assay; Medicine; Pathology; Transgene; Apoptosis; Virology; Immunology; Internal medicine; PI3K/AKT/mTOR pathway; Immunohistochemistry","score_opus":0.02371709510788639,"score_gpt":0.3710636073440041,"score_spread":0.34734651223611773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032262403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962137,0.0020980826,0.000011387274,0.0004076173,0.00017445705,0.0006745734,0.00013673662,0.000010713504,0.00027276878],"genre_scores_gemma":[0.995986,0.0027118337,0.000026634041,0.00006740276,0.0002453487,0.0004809062,0.000097628756,0.00005986585,0.0003243684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707544,0.00027349737,0.00034181614,0.0006770275,0.0006691721,0.0009630617],"domain_scores_gemma":[0.9990453,0.00004783778,0.000051191582,0.00049884384,0.00015584227,0.00020094562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010675155,0.00021175551,0.00025596112,0.0003223677,0.00012752977,0.0000898619,0.0005473457,0.0002295514,0.00047593872],"category_scores_gemma":[0.00007490884,0.00021882278,0.00009413849,0.00063473475,0.00028732396,0.0000146993425,0.00010272251,0.0011594554,0.000021335745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014170907,0.00011965036,0.0016338412,0.000052279127,0.000046118326,0.00001984491,0.00023439995,0.00018007416,0.97461206,0.0000018403077,0.001219463,0.020463355],"study_design_scores_gemma":[0.0016754942,0.00047173552,0.005397461,0.000052762636,0.000004349251,0.0000017785383,0.00009426879,0.00009857563,0.9857897,0.00003821427,0.006115763,0.00025985914],"about_ca_topic_score_codex":0.01007273,"about_ca_topic_score_gemma":0.12338389,"teacher_disagreement_score":0.11331116,"about_ca_system_score_codex":0.0003493594,"about_ca_system_score_gemma":0.0009969638,"threshold_uncertainty_score":0.99651927},"labels":[],"label_agreement":null},{"id":"W2032347134","doi":"10.1158/1538-7445.am2014-992","title":"Abstract 992: LIMD2 is a small LIM-only protein overexpressed in metastatic lesions which regulates cell motility and tumor progression by directly binding to and activating the integrin-linked-kinase","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Motility; LIM domain; Effector; Cell biology; Tumor progression; Metastasis; Cancer research; Focal adhesion; Scaffold protein; Integrin; Integrin-linked kinase; Cytoplasm; Gene knockdown; Signal transduction; Cell; Cancer; Cell culture; Kinase; Transcription factor; Protein kinase A; Gene; Genetics","score_opus":0.068249639759962,"score_gpt":0.3905374617361272,"score_spread":0.3222878219761652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032347134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113077,0.000964615,0.000014981281,0.0042457744,0.00001908919,0.0029722806,0.00002914372,0.000036173336,0.0005871615],"genre_scores_gemma":[0.9969869,0.00015133232,0.00075377425,0.000106099564,0.00005689948,0.0007010459,0.000010559096,0.00006048587,0.001172886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961318,0.0006498049,0.00042080454,0.00083288655,0.001076651,0.00088809547],"domain_scores_gemma":[0.9970951,0.0012054186,0.00009552567,0.0006189262,0.0004543966,0.000530646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032987762,0.000265099,0.00042093097,0.00035127127,0.00038727143,0.00020079587,0.0003234484,0.00010393996,0.00020057162],"category_scores_gemma":[0.0027264687,0.0001795977,0.000046862824,0.0011736264,0.00027855742,0.00009338697,0.00060592924,0.0015559419,0.000017677698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000560424,0.00023416507,0.009802654,0.0008373602,0.000016835484,0.000025576077,0.0010516037,0.0000032974906,0.9345178,0.000007170867,0.0007773286,0.052165784],"study_design_scores_gemma":[0.0017893593,0.0006361341,0.07600165,0.0024255854,0.000013825431,0.000011556357,0.0011437997,0.0015556553,0.9136932,0.00010209628,0.0024053978,0.0002217282],"about_ca_topic_score_codex":0.0015753458,"about_ca_topic_score_gemma":0.00046975107,"teacher_disagreement_score":0.066199,"about_ca_system_score_codex":0.00028723225,"about_ca_system_score_gemma":0.00043759414,"threshold_uncertainty_score":0.7323782},"labels":[],"label_agreement":null},{"id":"W2032402605","doi":"10.1158/0008-5472.can-04-4553","title":"Observation of Incipient Tumor Angiogenesis That Is Independent of Hypoxia and Hypoxia Inducible Factor-1 Activation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Angiogenesis; Hypoxia (environmental); Neovascularization; Cancer research; Hypoxia-inducible factors; Biology; HIF1A; Tumor hypoxia; Vascular endothelial growth factor; Pathology; Chemistry; Internal medicine; Medicine; Biochemistry; Radiation therapy","score_opus":0.08899114713952935,"score_gpt":0.3525286556283976,"score_spread":0.26353750848886826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032402605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933039,0.0056472695,0.00008039454,0.00026670378,0.00015976618,0.00030384323,0.0000911936,0.000004505679,0.00014243014],"genre_scores_gemma":[0.99590856,0.002505109,0.00020465089,0.0001242608,0.00056493154,0.000073605675,0.000028539485,0.000021740556,0.0005686179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985198,0.00008590429,0.00023910576,0.00036240986,0.00050810137,0.00028467225],"domain_scores_gemma":[0.9989778,0.000025521873,0.00013569422,0.00036069413,0.00040240574,0.00009788453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004079234,0.00012310727,0.00019879077,0.00016687662,0.00007111094,0.00001583596,0.00018870125,0.000131528,0.0000961835],"category_scores_gemma":[0.00008579224,0.00011902613,0.00007062368,0.00026820332,0.00014211134,0.000020010373,0.00016481768,0.00012670676,0.0000017733997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001471032,0.00005966869,0.008673739,0.000063658015,0.000057389767,1.01460486e-7,0.00029731682,0.00002875819,0.9631757,0.000034588676,0.0017465506,0.025715386],"study_design_scores_gemma":[0.00047582234,0.000094554714,0.13249823,0.00003217438,0.000011735617,0.0000012371826,0.00012665447,0.0000132613795,0.8181696,0.000027258031,0.04845274,0.00009675505],"about_ca_topic_score_codex":0.00070178375,"about_ca_topic_score_gemma":0.0001646674,"teacher_disagreement_score":0.14500616,"about_ca_system_score_codex":0.00006615976,"about_ca_system_score_gemma":0.00031166643,"threshold_uncertainty_score":0.48537448},"labels":[],"label_agreement":null},{"id":"W2032451420","doi":"10.1158/0008-5472.can-08-2513","title":"Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; Lymphoma Research Foundation; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Radioimmunotherapy; DOTA; Medicine; Cancer research; Transplantation; Monoclonal antibody; In vivo; Antibody; Streptavidin; Pretargeting; Chemistry; Immunology; Internal medicine; Biotin; Biology","score_opus":0.12855162264181452,"score_gpt":0.4584482067561254,"score_spread":0.3298965841143109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032451420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295074,0.0046314877,0.00012788671,0.0011985805,0.000025253948,0.0007010996,0.000021499343,0.000048974613,0.0002944655],"genre_scores_gemma":[0.9947956,0.0020954798,0.0011687139,0.00031400207,0.00032024996,0.00013705328,0.00002252845,0.00003115402,0.0011151925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984974,0.00004471823,0.00022464397,0.00038768566,0.0004265455,0.00041895034],"domain_scores_gemma":[0.9990561,0.00005949982,0.000026005882,0.0002837222,0.0001981266,0.00037652956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022797678,0.00014537972,0.0002766393,0.00016140673,0.0004826526,0.000030112682,0.0001229567,0.00007596093,0.00028060496],"category_scores_gemma":[0.000043981763,0.00013869576,0.000040006544,0.00050548895,0.00020770988,0.000081341735,0.000064197404,0.0002597151,0.00002548864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017430692,0.000050801373,0.012243542,0.00010232963,0.000057458594,0.000038224323,0.00059145974,0.0001508896,0.9818096,0.00006226195,0.0019352441,0.002783873],"study_design_scores_gemma":[0.0012829348,0.00010703731,0.031587817,0.00013325427,0.000021100162,0.00018598925,0.0000583897,0.0007007687,0.9401297,0.00002374737,0.025582403,0.00018686913],"about_ca_topic_score_codex":0.00040431813,"about_ca_topic_score_gemma":0.0000028682318,"teacher_disagreement_score":0.04167992,"about_ca_system_score_codex":0.00047949742,"about_ca_system_score_gemma":0.00020902346,"threshold_uncertainty_score":0.5655849},"labels":[],"label_agreement":null},{"id":"W2032533639","doi":"10.1158/1538-7445.am2012-2790","title":"Abstract 2790: Localization of the binding site for Peloruside A and Laulimalide on beta-tubulin by physical and biological means","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epothilones; Tubulin; Microtubule; Epothilone; Mutant; Chemistry; Biology; Biochemistry; Cell biology; Stereochemistry; Gene","score_opus":0.15761413907772068,"score_gpt":0.46713093610348977,"score_spread":0.30951679702576906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032533639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515784,0.0018316219,0.000014615773,0.0019292483,0.00005892275,0.0005482764,0.00011669864,0.00000693068,0.00033582063],"genre_scores_gemma":[0.9983882,0.00071535143,0.000013994239,0.00016617215,0.00027688078,0.00012499899,0.000027851134,0.000009853963,0.00027672807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924916,0.000060318762,0.000093187075,0.00015344734,0.00017396033,0.00026995497],"domain_scores_gemma":[0.9993836,0.00032758602,0.00003112511,0.000085728396,0.00006682326,0.00010510637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032566112,0.00007418252,0.00016726885,0.000048062007,0.000109908884,0.0000077350005,0.000039240218,0.000055656088,0.00008346342],"category_scores_gemma":[0.000051748386,0.000043887547,0.000038044436,0.00013478733,0.00022873253,0.000036121077,0.000043058255,0.00016582909,0.0000043352625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021947843,0.0006582706,0.32903433,0.00033310472,0.00018320658,0.0000028214072,0.0021830485,0.000013863939,0.62052923,0.0004673487,0.030621907,0.013778101],"study_design_scores_gemma":[0.008228778,0.0026061449,0.34073225,0.00037486167,0.00029424584,0.00001609876,0.00041469658,0.00073589047,0.49816248,0.00027217387,0.14786483,0.0002975407],"about_ca_topic_score_codex":0.00013353946,"about_ca_topic_score_gemma":0.000025026873,"teacher_disagreement_score":0.12236674,"about_ca_system_score_codex":0.00008634612,"about_ca_system_score_gemma":0.000049962346,"threshold_uncertainty_score":0.17896822},"labels":[],"label_agreement":null},{"id":"W2032605394","doi":"10.1158/1538-7445.am10-140","title":"Abstract 140: XIAP expression in non-small cell lung cancer cells is a key determinant of threshold to TRAIL-induced apoptotic cell death","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"XIAP; Apoptosis; Cancer research; Transfection; Programmed cell death; clone (Java method); Molecular biology; Inhibitor of apoptosis; Cell culture; Biology; Western blot; Lung cancer; Cell; Chemistry; Caspase; Medicine; Oncology; Genetics; Gene","score_opus":0.04561546925232161,"score_gpt":0.359838540275207,"score_spread":0.3142230710228854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032605394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937166,0.0018931772,0.0000065158683,0.00017354634,0.0009820702,0.00089193357,0.000077831726,0.000017957876,0.0022403928],"genre_scores_gemma":[0.99221104,0.0004570114,0.00005379137,0.00011359751,0.00006041671,0.00035891848,0.0000065274517,0.00005006339,0.0066886456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997491,0.0001965677,0.0005085177,0.0005891517,0.0001583409,0.0010564257],"domain_scores_gemma":[0.9986212,0.00025986796,0.000116531184,0.000647853,0.0002527249,0.0001018132],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080796255,0.00028084914,0.00046808482,0.0005398935,0.00018300489,0.000033855675,0.00077621074,0.000473234,0.003307107],"category_scores_gemma":[0.000040290466,0.00023707299,0.00013565762,0.00031591824,0.00017370631,0.0000958653,0.00028786118,0.0016871329,0.00028136064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010488321,0.000261403,0.0013943964,0.00026179894,0.000021009993,0.0000136165645,0.0033945236,0.000010390245,0.98784184,0.000004748744,0.0042573307,0.0014901219],"study_design_scores_gemma":[0.001389659,0.00028337722,0.0101882275,0.00042877728,0.000012469335,0.000002932306,0.00042311757,0.000015654994,0.98417544,0.000005702148,0.0028147106,0.00025994983],"about_ca_topic_score_codex":0.00361676,"about_ca_topic_score_gemma":0.0012023728,"teacher_disagreement_score":0.008793831,"about_ca_system_score_codex":0.00017833203,"about_ca_system_score_gemma":0.0006124907,"threshold_uncertainty_score":0.997604},"labels":[],"label_agreement":null},{"id":"W2032653612","doi":"10.1158/0008-5472.sabcs10-p1-02-02","title":"Abstract P1-02-02: Processing of GPNMB by ADAM-10 in Breast Tumors Releases an Extracellular Domain with Angiogenic Properties","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Cancer research; Medicine; Angiogenesis; Cancer; Triple-negative breast cancer; Metastasis; Cancer cell; Internal medicine","score_opus":0.049653125975210995,"score_gpt":0.3524308370245079,"score_spread":0.3027777110492969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032653612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781166,0.019448169,0.0000025092445,0.0007709411,0.000019695115,0.0006842814,0.000026753845,0.000029493041,0.0009015926],"genre_scores_gemma":[0.9976533,0.00018409781,0.00013918288,0.000024853794,0.00013172225,0.00024297896,0.000011660194,0.00004127969,0.0015709234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979559,0.00006016976,0.00029561814,0.00037783984,0.00079662085,0.0005138269],"domain_scores_gemma":[0.99904454,0.000031999916,0.000073730036,0.0003306826,0.0003351363,0.00018393439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065154745,0.00016461553,0.0003546126,0.0002015795,0.00015483462,0.000038147482,0.00016828721,0.00009366398,0.0003917847],"category_scores_gemma":[0.000051571395,0.00011391388,0.000048987957,0.00048148545,0.0007038647,0.00023261887,0.00007632671,0.00067256746,0.000016080076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020194415,0.00044802108,0.02601665,0.0007477803,0.000045882105,0.00017499164,0.00088446855,0.0000026368334,0.950758,0.000013207929,0.0017728711,0.017116096],"study_design_scores_gemma":[0.0051812497,0.0018628235,0.16814929,0.0043475353,0.00006945443,0.0003664031,0.010215952,0.000086200766,0.8028684,0.00017712396,0.0059876735,0.0006878633],"about_ca_topic_score_codex":0.0035149227,"about_ca_topic_score_gemma":0.0014468353,"teacher_disagreement_score":0.14788952,"about_ca_system_score_codex":0.000093977964,"about_ca_system_score_gemma":0.0005387445,"threshold_uncertainty_score":0.53135353},"labels":[],"label_agreement":null},{"id":"W2032688406","doi":"10.1158/1538-7445.am2012-4603","title":"Abstract 4603: Optically-guided surgical approach using fluorescence visualization can significantly improve locoregional recurrence and overall survival for early stage oral cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Dysplasia; Surgery; Cancer; Stage (stratigraphy); Subclinical infection; Lesion; Carcinoma; Basal cell; Internal medicine","score_opus":0.26017571538106765,"score_gpt":0.47875818674596915,"score_spread":0.2185824713649015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032688406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937209,0.002480518,0.0005880267,0.0005106788,0.00040973074,0.0015302973,0.00023825384,0.00004188036,0.00047972464],"genre_scores_gemma":[0.9949533,0.0016731212,0.0009477353,0.00006127475,0.0010604073,0.0006146397,0.00004007016,0.000056196535,0.00059330754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658686,0.00016543029,0.00040187765,0.0006179874,0.0010169887,0.0012108538],"domain_scores_gemma":[0.99784774,0.0003682238,0.00009063332,0.0002701695,0.00082159706,0.0006016472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018315422,0.00026630386,0.0005552298,0.00017274126,0.00037363736,0.00008144228,0.00016554592,0.00016923912,0.00014880385],"category_scores_gemma":[0.000277517,0.0002236074,0.00009067797,0.00039484832,0.0005475253,0.00024734775,0.00013642135,0.0005268813,0.0000024962112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007046279,0.002041301,0.7258344,0.0057516117,0.0008091702,0.00011364205,0.00878721,0.00016761407,0.1904964,0.0109525295,0.008851231,0.039148577],"study_design_scores_gemma":[0.020293841,0.0024612735,0.8656003,0.0028194094,0.00042971896,0.00008748596,0.0029739307,0.0177064,0.0549422,0.00025171816,0.029898236,0.0025354763],"about_ca_topic_score_codex":0.005427786,"about_ca_topic_score_gemma":0.00022611136,"teacher_disagreement_score":0.13976587,"about_ca_system_score_codex":0.0006130377,"about_ca_system_score_gemma":0.0010574539,"threshold_uncertainty_score":0.91184455},"labels":[],"label_agreement":null},{"id":"W2032699899","doi":"10.1158/0008-5472.sabcs-4058","title":"Combination effects of herceptin, pertuzumab and bevacizumab in a HER2-overexpressing breast cancer xenograft model.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Bevacizumab; Breast cancer; Metastatic breast cancer; Combination therapy; Metastasis; Internal medicine; Chemotherapy; Oncology; Cancer; Pharmacology; Cancer research","score_opus":0.06386456340538994,"score_gpt":0.4504525453210939,"score_spread":0.386587981915704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032699899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484284,0.0060866443,0.000054506952,0.005930121,0.00006805172,0.0013635112,0.0000389885,0.000039614853,0.0015757267],"genre_scores_gemma":[0.99388313,0.0041866507,0.00020184032,0.0002199887,0.00014730023,0.00036679037,0.000007686404,0.000048741225,0.0009378624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961955,0.00032906362,0.0003999172,0.00060644775,0.0015571356,0.0009119355],"domain_scores_gemma":[0.99814165,0.00022357087,0.00007107191,0.0004940932,0.0007304512,0.0003391472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010802712,0.00022320078,0.0005282762,0.00068003585,0.0001474067,0.000065484586,0.00026672517,0.0002087416,0.00027341273],"category_scores_gemma":[0.00025299098,0.00020591395,0.000073152056,0.0011089679,0.00040761306,0.0002081816,0.00014456069,0.0011038375,0.0000070074348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003113389,0.0011259138,0.033378135,0.004032788,0.000096766,0.00019704638,0.005540428,0.0006166189,0.50047183,0.00057266664,0.006838366,0.44401607],"study_design_scores_gemma":[0.026533682,0.003844015,0.7229454,0.019472381,0.00012824526,0.00019922368,0.0012901273,0.07847883,0.1387752,0.005084866,0.0020555982,0.0011924206],"about_ca_topic_score_codex":0.0038429038,"about_ca_topic_score_gemma":0.00033982767,"teacher_disagreement_score":0.68956727,"about_ca_system_score_codex":0.0015412441,"about_ca_system_score_gemma":0.0013484816,"threshold_uncertainty_score":0.8396927},"labels":[],"label_agreement":null},{"id":"W2032722949","doi":"10.1158/0008-5472.can-07-2953","title":"T-cadherin Supports Angiogenesis and Adiponectin Association with the Vasculature in a Mouse Mammary Tumor Model","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; McGill University; U.S. Department of Defense","keywords":"Angiogenesis; Adiponectin; Cadherin; Mammary tumor; Cancer research; Mouse mammary tumor virus; VE-cadherin; Medicine; Biology; Pathology; Internal medicine; Cancer; Breast cancer; Immunology; Obesity; Insulin resistance; Cell; Genetics","score_opus":0.03531903664772469,"score_gpt":0.31954765959400805,"score_spread":0.28422862294628337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032722949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926193,0.003879958,0.00004477017,0.0022950273,0.000018806706,0.0005220704,0.000016741944,0.000029070367,0.0005742954],"genre_scores_gemma":[0.9872404,0.0018896704,0.0001457925,0.00027771245,0.00017286548,0.00029169812,0.000015245371,0.000023742463,0.009942902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853075,0.00011208332,0.00013361729,0.00023774232,0.00063988584,0.00034590674],"domain_scores_gemma":[0.99916136,0.000084787986,0.00004581978,0.00026432326,0.00029737485,0.00014631695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000624153,0.00010186292,0.00019310198,0.00016579912,0.00016218219,0.000021966676,0.000087433225,0.000064107226,0.000047486355],"category_scores_gemma":[0.00017159995,0.000065962726,0.00004513778,0.00044877885,0.000099123536,0.00014222143,0.000040361658,0.00025134956,0.000004194949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017041552,0.00037384706,0.89197636,0.0004642436,0.0005536211,0.0007074909,0.0071493164,0.0023475527,0.043304525,0.00064867,0.043066617,0.0077036256],"study_design_scores_gemma":[0.0037292093,0.00015668673,0.95586544,0.00015166623,0.00014452572,0.00015885412,0.00043348834,0.0030092674,0.014722514,0.00014031347,0.02118441,0.00030361486],"about_ca_topic_score_codex":0.00060776755,"about_ca_topic_score_gemma":0.0004596796,"teacher_disagreement_score":0.063889116,"about_ca_system_score_codex":0.00020301001,"about_ca_system_score_gemma":0.000689849,"threshold_uncertainty_score":0.2689882},"labels":[],"label_agreement":null},{"id":"W2032816915","doi":"10.1158/0008-5472.sabcs-09-4116","title":"Survival Outcomes in Women with Ipsilateral Breast Tumor Relapse: An Analysis of Cohorts Classified Clinically as 'True Recurrence' Versus 'New Primary'.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Log-rank test; Oncology; Internal medicine; Primary tumor; Retrospective cohort study; Stage (stratigraphy); Cancer; Mastectomy; Histology; Proportional hazards model; Metastasis","score_opus":0.05251160009730312,"score_gpt":0.40417353741689827,"score_spread":0.35166193731959516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032816915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742967,0.00030092555,0.000007415325,0.00090305466,0.00011879196,0.00026146998,0.00010786488,0.000010698055,0.0008601155],"genre_scores_gemma":[0.9986885,0.00036306836,0.00011451809,0.00013326727,0.000117616815,0.00010451311,0.000103725295,0.000018569695,0.0003561737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745804,0.00025430464,0.00040303892,0.00067722274,0.00058740925,0.0006199961],"domain_scores_gemma":[0.9986323,0.000094040515,0.00011982334,0.00062486005,0.00028846195,0.00024051205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070371124,0.00021923846,0.0006411222,0.00027106097,0.000087068736,0.000033473723,0.00036205837,0.00011609888,0.000096697695],"category_scores_gemma":[0.00009846406,0.00017413271,0.000096355354,0.0008861788,0.00028222514,0.000014901516,0.00011897016,0.00027789306,0.000003607142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026570883,0.0006396664,0.93638295,0.000024550103,0.002121075,0.000055772463,0.00072771864,0.00023548018,0.008618322,0.000075861775,0.00036583067,0.024181888],"study_design_scores_gemma":[0.0032767877,0.0018287634,0.992629,0.000038400423,0.00012513992,0.0000035528208,0.00031057192,0.000007442242,0.0011850108,0.00005521499,0.00032939107,0.00021075914],"about_ca_topic_score_codex":0.0017148509,"about_ca_topic_score_gemma":0.002674421,"teacher_disagreement_score":0.056246012,"about_ca_system_score_codex":0.00035137704,"about_ca_system_score_gemma":0.00092125783,"threshold_uncertainty_score":0.7100926},"labels":[],"label_agreement":null},{"id":"W2032821673","doi":"10.1158/1538-7445.am2012-4420","title":"Abstract 4420: Serum regulates reovirus-mediated cytopathy in K-Ras activated colorectal cancer and intestinal epithelial cell lines","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"KRAS; Multiplicity of infection; Cell culture; Oncogene; Colorectal cancer; Molecular biology; Biology; Western blot; Cancer research; Mutant; Cell growth; MTT assay; Cell; Cancer; Gene; Cell cycle; Biochemistry","score_opus":0.03591019096163497,"score_gpt":0.3670160841338596,"score_spread":0.33110589317222466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032821673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046624,0.0078775585,9.677318e-7,0.00033410112,0.00013061502,0.0004623493,0.00026872638,0.000015521306,0.00044392835],"genre_scores_gemma":[0.9933889,0.004714135,0.000029973466,0.00004034013,0.0006172113,0.00043546318,0.00010374994,0.00004346493,0.000626761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977349,0.00014098815,0.00022157405,0.0004687936,0.00040952986,0.0010241824],"domain_scores_gemma":[0.99901587,0.00009430699,0.000056636993,0.00023435798,0.00023026404,0.00036856686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005996652,0.00021332884,0.00020949099,0.00019432994,0.00015347166,0.000056458437,0.00022664704,0.00018256537,0.0002193456],"category_scores_gemma":[0.00021836774,0.00018798189,0.000050174163,0.000406543,0.00030445037,0.0000261118,0.000259141,0.00046235698,0.000030377267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010391308,0.00017159239,0.11470318,0.00006327239,0.00004019047,0.000019505102,0.0001339453,0.000009531033,0.8777588,0.000002811015,0.0009556644,0.005102351],"study_design_scores_gemma":[0.0013353894,0.00020979396,0.167331,0.00007273168,0.000005567468,0.0000069672783,0.00008433607,0.0000103874245,0.8257214,0.00002137216,0.005024448,0.00017665596],"about_ca_topic_score_codex":0.006526528,"about_ca_topic_score_gemma":0.0051335935,"teacher_disagreement_score":0.052627813,"about_ca_system_score_codex":0.00022771585,"about_ca_system_score_gemma":0.0005154349,"threshold_uncertainty_score":0.9866202},"labels":[],"label_agreement":null},{"id":"W2032834594","doi":"10.1158/1538-7445.am2013-1949","title":"Abstract 1949: The identification of potentially prognostic microRNAs in human nasopharyngeal carcinoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; microRNA; Disease; Medicine; Radiation therapy; Oncology; Cancer; Bonferroni correction; Biology; Internal medicine; Bioinformatics; Cancer research; Gene; Genetics","score_opus":0.03100829810797666,"score_gpt":0.35251433730917914,"score_spread":0.32150603920120246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032834594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951409,0.0021851966,0.00022385831,0.0006320247,0.00009608961,0.0011744575,0.00002002546,0.0000057460443,0.00052168895],"genre_scores_gemma":[0.9979344,0.00027377668,0.00002516808,0.000033984907,0.0001724059,0.0006578335,0.000063073094,0.000035727906,0.00080365327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977695,0.00022661379,0.00041091494,0.00044018935,0.0006123372,0.00054044963],"domain_scores_gemma":[0.9985549,0.00003834272,0.000098347955,0.00060991675,0.00060196716,0.00009651029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011529829,0.00012671511,0.00013847879,0.00019690888,0.0001606348,0.00008051643,0.0006693867,0.0001669037,0.00025683324],"category_scores_gemma":[0.00020950216,0.00010659396,0.00008145951,0.0004268428,0.00029668506,0.000010198007,0.00027066167,0.00049440295,0.00004420753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047909187,0.00006809449,0.00068117626,0.00006621605,0.00003112245,0.000006027893,0.00006253555,0.00014355851,0.99360293,0.00008206123,0.0023890834,0.0028192569],"study_design_scores_gemma":[0.00048014836,0.00012766883,0.052683853,0.000037196423,0.000005531965,0.000003505951,0.00010520802,0.000054636446,0.9451148,0.00025787269,0.0010212299,0.00010834564],"about_ca_topic_score_codex":0.0031064325,"about_ca_topic_score_gemma":0.00060967525,"teacher_disagreement_score":0.05200268,"about_ca_system_score_codex":0.00011238807,"about_ca_system_score_gemma":0.00043614974,"threshold_uncertainty_score":0.46960172},"labels":[],"label_agreement":null},{"id":"W2032894916","doi":"10.1158/1538-7445.am2011-2829","title":"Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Gene silencing; RNA interference; Small interfering RNA; PLK1; Polo-like kinase; Biology; Cytokinesis; Cell biology; Cancer research; Dicer; Kinase; Cell cycle; Cell; RNA; Cell division; Gene; Biochemistry","score_opus":0.12958117488475496,"score_gpt":0.37699707267003035,"score_spread":0.2474158977852754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032894916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983417,0.0002711687,0.0002772881,0.000042979278,0.000106202875,0.00026282007,0.000057475358,0.000010808564,0.0006295835],"genre_scores_gemma":[0.9985285,0.0007564903,0.00016898333,0.000019515785,0.00011089975,0.00011898525,0.00009415403,0.00001902508,0.00018344198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891555,0.00007647113,0.00035013419,0.00025849135,0.00016572505,0.0002336534],"domain_scores_gemma":[0.9990008,0.000019092968,0.00013947455,0.00035451664,0.0004099427,0.00007617664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041078732,0.000086065695,0.00014007027,0.00008268186,0.000054610875,0.000010308313,0.00020138855,0.0001084508,0.00012303868],"category_scores_gemma":[0.00010775136,0.000082406004,0.00006358782,0.0002128395,0.000098986944,0.000011801201,0.00009701499,0.00011732432,0.0000042096667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004170356,0.0001351426,0.0032108952,0.00006642522,0.000032749012,4.746836e-7,0.0002324214,0.000013212341,0.97964007,0.00004432154,0.000043130323,0.016164145],"study_design_scores_gemma":[0.0003152093,0.00019578739,0.07210034,0.00007345949,0.0000063051375,3.138038e-7,0.00003806399,0.00021681585,0.9256879,0.00001493685,0.00126994,0.00008090176],"about_ca_topic_score_codex":0.00022248442,"about_ca_topic_score_gemma":0.00008197066,"teacher_disagreement_score":0.06888945,"about_ca_system_score_codex":0.0000344151,"about_ca_system_score_gemma":0.00016672343,"threshold_uncertainty_score":0.33604193},"labels":[],"label_agreement":null},{"id":"W2032901020","doi":"10.1158/1538-7445.am2014-ct201","title":"Abstract CT201: Phase I study of 5-azacytidine and oxaliplatin in patients with advanced cancers relapsed or refractory to platinum compounds","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oxaliplatin; Medicine; Carboplatin; Cisplatin; Internal medicine; Refractory (planetary science); DNA methylation; Gastroenterology; Cancer; Oncology; Chemotherapy; Colorectal cancer; Chemistry; Gene expression; Biology","score_opus":0.036664652859707644,"score_gpt":0.3886147165408582,"score_spread":0.35195006368115056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032901020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987287,0.0002041494,0.000028752098,0.000027515445,0.000044188848,0.00067246886,0.000022998393,0.0000032738492,0.00026798644],"genre_scores_gemma":[0.9994242,0.000081832535,0.00016942337,0.000014886564,0.00005358239,0.000096183714,0.00003630991,0.000022941464,0.000100610654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986782,0.0001183837,0.00024061016,0.0003622081,0.00035011207,0.00025046145],"domain_scores_gemma":[0.99917406,0.0000661955,0.000079062556,0.00030551016,0.00025983044,0.000115340794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005298174,0.00011474114,0.00018070695,0.00013366624,0.000066831984,0.000011868294,0.00013110269,0.00007069209,0.000019629124],"category_scores_gemma":[0.00016993204,0.000091470785,0.00001198501,0.0002440977,0.000070598864,0.0000068456075,0.00008453845,0.00016613798,8.587923e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071151922,0.0008878023,0.23176795,0.000071293754,0.00005830161,0.0000021129852,0.00082253694,0.0019827278,0.72364604,0.0000054785787,0.00016307233,0.03347748],"study_design_scores_gemma":[0.019658329,0.019626783,0.76920015,0.00014946816,0.000013329945,1.320283e-7,0.0007946489,0.00008988081,0.18529727,0.000027098611,0.004770311,0.0003725916],"about_ca_topic_score_codex":0.00065096334,"about_ca_topic_score_gemma":0.0025033467,"teacher_disagreement_score":0.5383488,"about_ca_system_score_codex":0.000080651145,"about_ca_system_score_gemma":0.00015687103,"threshold_uncertainty_score":0.37300706},"labels":[],"label_agreement":null},{"id":"W2032955478","doi":"10.1158/1538-7445.am2012-1150","title":"Abstract 1150: Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett's esophagus","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"dNaM; DNA methylation; Genome; Biology; CpG site; Adenocarcinoma; Methylation; DNA; Molecular biology; Gene; Genetics; Cancer; Gene expression","score_opus":0.039220029538159396,"score_gpt":0.33932114697841087,"score_spread":0.3001011174402515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032955478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89955753,0.09944886,0.00008741864,0.000087743065,0.000089753274,0.00033247625,0.000036064106,0.000004344325,0.00035579543],"genre_scores_gemma":[0.99743706,0.0014766296,0.00047548374,0.000016500924,0.00031476,0.00006148456,0.0000525838,0.00002999996,0.00013549173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983472,0.00016773131,0.00030081245,0.00033229284,0.0003435214,0.0005084015],"domain_scores_gemma":[0.99909323,0.00007733808,0.00008603403,0.00040610874,0.00017634513,0.00016093803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014668517,0.00013728642,0.00017083384,0.00017612825,0.00008293997,0.000023862549,0.0002314492,0.00019315213,0.00005097614],"category_scores_gemma":[0.00020861893,0.0001392436,0.00004579539,0.00023403348,0.0001242971,0.000016450202,0.00022021485,0.000246262,0.0000039249953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051347397,0.000037200425,0.36107868,0.0000840149,0.000012323685,0.0000017437966,0.00015361047,0.00005511139,0.6375565,0.000024499624,0.000018777386,0.0009262011],"study_design_scores_gemma":[0.00032739012,0.000060800747,0.45235077,0.000008259349,0.000004139816,2.7583238e-7,0.000060749517,0.000012732213,0.5469114,0.00012773574,0.000062960404,0.00007275827],"about_ca_topic_score_codex":0.000116261086,"about_ca_topic_score_gemma":0.000062746316,"teacher_disagreement_score":0.09797223,"about_ca_system_score_codex":0.00006172231,"about_ca_system_score_gemma":0.00015265359,"threshold_uncertainty_score":0.5678189},"labels":[],"label_agreement":null},{"id":"W2032955575","doi":"10.1158/1538-7445.am2011-5334","title":"Abstract 5334: Genome-wide copy number analysis reveals two novel loci for susceptibility to sporadic osteosarcoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation","funders":"","keywords":"Copy-number variation; Copy number analysis; SNP array; Biology; Genetics; Osteosarcoma; Gene dosage; Cancer; Germline; SNP; Malignancy; Single-nucleotide polymorphism; Genome; Gene; Cancer research; Genotype","score_opus":0.08434023763230578,"score_gpt":0.39459980804570655,"score_spread":0.3102595704134008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032955575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221706,0.00064039504,0.0029693367,0.00027787214,0.000120405166,0.0008966056,0.00071575615,0.000011173969,0.0021513787],"genre_scores_gemma":[0.9949412,0.00033299814,0.0021619173,0.000464047,0.00048567317,0.00040626645,0.00029604996,0.00004770565,0.0008641589],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99773747,0.00004753948,0.0003577338,0.0007922271,0.00031707206,0.0007479881],"domain_scores_gemma":[0.9978568,0.00012422181,0.00008041091,0.00089405885,0.00066091254,0.00038361287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011908783,0.00020159308,0.00032125012,0.00016304739,0.00018381303,0.00005861731,0.0005334372,0.0001467633,0.00081177196],"category_scores_gemma":[0.00039192734,0.00020682171,0.00025433177,0.0006177375,0.00018091392,0.000005750152,0.00026352628,0.00020029057,0.00007126793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011560058,0.00031369372,0.33444238,0.00011485181,0.0007022262,0.000009581526,0.00039675046,0.00032685825,0.64257735,0.00028612078,0.017529605,0.00214456],"study_design_scores_gemma":[0.0027123913,0.0007935486,0.5053816,0.0000335426,0.0002945801,0.0000042191386,0.0003522113,0.000030936313,0.341529,0.0013351183,0.14661282,0.00092005084],"about_ca_topic_score_codex":0.0024932423,"about_ca_topic_score_gemma":0.00434958,"teacher_disagreement_score":0.30104837,"about_ca_system_score_codex":0.00021298537,"about_ca_system_score_gemma":0.00041445845,"threshold_uncertainty_score":0.88883334},"labels":[],"label_agreement":null},{"id":"W2032971344","doi":"10.1158/0008-5472.sabcs-09-4030","title":"Duplication of Chromosome 17 CEP Predicts for Anthracycline Benefit: A Meta-Analysis of 4 Trials.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anthracycline; Gene duplication; Internal medicine; Biomarker; Oncology; Medicine; Breast cancer; Cancer; Biology; Genetics; Gene","score_opus":0.2272972166863967,"score_gpt":0.4830564525052689,"score_spread":0.25575923581887217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032971344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483041,0.040536094,0.00096360873,0.0052373204,0.0000588644,0.0014871377,0.0029994962,0.0000116316805,0.00040171907],"genre_scores_gemma":[0.99650335,0.0018442294,0.00030278624,0.000053202093,0.00015268891,0.0005008332,0.00028162316,0.0000101228015,0.0003511344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985613,0.0001054338,0.00043367132,0.0003521987,0.00031153357,0.00023583014],"domain_scores_gemma":[0.998391,0.00015558394,0.00022013986,0.00048002566,0.0006998754,0.00005341279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010879585,0.00011541591,0.00085187174,0.00020054198,0.00006659974,0.000006441211,0.00020946731,0.00008794156,0.00012228206],"category_scores_gemma":[0.00034455123,0.000088147935,0.0006755866,0.0005686584,0.00014371709,0.000003925668,0.00005556184,0.000054987955,4.5728615e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012819009,0.00045335176,0.0011142612,0.000081418446,0.08869525,4.745959e-7,0.00017554661,0.0008816443,0.8925514,0.0003567887,0.004416701,0.009991258],"study_design_scores_gemma":[0.0016236268,0.0007907595,0.025645878,0.000011109862,0.04215049,5.569946e-7,0.000050803952,0.00010043938,0.92437977,0.00046750327,0.004628861,0.00015023044],"about_ca_topic_score_codex":0.00023098632,"about_ca_topic_score_gemma":0.0002144062,"teacher_disagreement_score":0.04819925,"about_ca_system_score_codex":0.000037807516,"about_ca_system_score_gemma":0.00011221284,"threshold_uncertainty_score":0.35945684},"labels":[],"label_agreement":null},{"id":"W2032988124","doi":"10.1158/1538-7445.am2013-1960","title":"Abstract 1960: Implication of miR-34a in radioresistance of bladder cancer .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Radioresistance; Clonogenic assay; Ectopic expression; Cancer research; Bladder cancer; Radiation sensitivity; microRNA; Methylation; DNA methylation; Cell culture; Radiosensitivity; CpG site; Biology; Cancer; Medicine; Cell cycle; Radiation therapy; Molecular biology; Gene expression; Internal medicine; Gene; Genetics; Irradiation","score_opus":0.03222722447552778,"score_gpt":0.3790247494666241,"score_spread":0.34679752499109634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032988124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768383,0.008744057,0.00026260558,0.0005768828,0.00007821559,0.0008967017,0.00007643694,0.0000054407183,0.0016758515],"genre_scores_gemma":[0.9953871,0.0026651649,0.000121550176,0.000029812183,0.000111597226,0.00085360784,0.000030928066,0.000039454528,0.0007607986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786043,0.00012840843,0.0003884966,0.0004656862,0.00060947373,0.00054750737],"domain_scores_gemma":[0.99826884,0.00003966284,0.00011501671,0.00063262053,0.00081858935,0.00012523803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005961104,0.00013860798,0.00023022512,0.00025133163,0.00004587712,0.000018210778,0.0004915149,0.00022117341,0.0012964718],"category_scores_gemma":[0.0001397652,0.00013950112,0.000085566564,0.00061796216,0.00028942627,0.000010875062,0.00017100276,0.0003665365,0.000020977202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015155092,0.000076148615,0.00032113606,0.00014595006,0.00005922604,0.0000014391301,0.000060968476,0.00026485918,0.98600274,0.00011429877,0.008166397,0.004635301],"study_design_scores_gemma":[0.0006326538,0.000116819516,0.017774407,0.00011392054,0.000004507821,0.0000010007594,0.00008182173,0.00004569879,0.97483283,0.00021870395,0.0060460554,0.0001315569],"about_ca_topic_score_codex":0.0075294995,"about_ca_topic_score_gemma":0.0017905791,"teacher_disagreement_score":0.01745327,"about_ca_system_score_codex":0.00017111005,"about_ca_system_score_gemma":0.00072480703,"threshold_uncertainty_score":0.9996165},"labels":[],"label_agreement":null},{"id":"W2033011771","doi":"10.1158/1538-7445.am2014-2467","title":"Abstract 2467: Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis <i>in vivo</i>","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Melanoma; Carcinogenesis; Gap junction; Connexin; Biology; Cancer research; Cell growth; In vivo; Keratinocyte; Cell culture; Tumor microenvironment; Intracellular; Cell biology; Cancer; Tumor cells; Genetics","score_opus":0.02041150354941045,"score_gpt":0.3007768171640559,"score_spread":0.28036531361464545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033011771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961458,0.002265281,0.000004391243,0.00046540174,0.00008323009,0.00020423562,0.000021685231,0.0000062162208,0.0008037804],"genre_scores_gemma":[0.9968703,0.0017932225,0.00006606593,0.00011548634,0.00031747547,0.00011734436,0.000010858278,0.00002306758,0.0006862043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849296,0.00016581014,0.0002171837,0.00053184095,0.00015019324,0.00044201865],"domain_scores_gemma":[0.9994874,0.000038192044,0.0000474283,0.00025687498,0.000053155283,0.00011694798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063876365,0.00014705412,0.00017347593,0.00009218893,0.00014705492,0.00003746046,0.00019060739,0.00012651426,0.0001262186],"category_scores_gemma":[0.00007763609,0.00013342951,0.000036452384,0.00008932518,0.0002545895,0.0000046163677,0.0001891282,0.00020133825,0.000007740779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002128496,0.000030967884,0.01044124,0.000045375622,0.000020596382,0.000010272213,0.00011466294,0.000013670809,0.9878558,0.00008674612,0.00045742295,0.00071037724],"study_design_scores_gemma":[0.00067773927,0.00020649654,0.038444288,0.00003657497,0.0000032494854,0.0000137439265,0.00013527715,0.000012315077,0.9507778,0.00005973363,0.009460542,0.00017220939],"about_ca_topic_score_codex":0.0006210279,"about_ca_topic_score_gemma":0.00072324387,"teacher_disagreement_score":0.03707799,"about_ca_system_score_codex":0.000055776785,"about_ca_system_score_gemma":0.0000826313,"threshold_uncertainty_score":0.5441097},"labels":[],"label_agreement":null},{"id":"W2033024271","doi":"10.1158/0008-5472.sabcs12-p1-15-06","title":"Abstract P1-15-06: The impact of musculoskeletal toxicity on adherence to endocrine therapy in women with early stage breast cancer– observations in a non-trial setting","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Exemestane; Letrozole; Tamoxifen; Anastrozole; Discontinuation; Breast cancer; Internal medicine; Cancer; Stage (stratigraphy); Metastatic breast cancer; Aromatase inhibitor; Gynecology","score_opus":0.11716135688310408,"score_gpt":0.4737847756195197,"score_spread":0.3566234187364156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033024271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956723,0.00018726845,4.3911933e-7,0.0014740451,0.000042977976,0.0022608077,0.00016956803,0.000008665706,0.00018395863],"genre_scores_gemma":[0.99741393,0.00028476457,0.000018637074,0.00011369359,0.00016455377,0.0017637967,0.0000061795913,0.00002316921,0.0002112495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977807,0.00012940053,0.0002879739,0.00023908766,0.0006050616,0.0009577848],"domain_scores_gemma":[0.99882966,0.00022754002,0.0000731151,0.0003471,0.00016408555,0.00035850602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092841365,0.00015159191,0.0002953104,0.00023363862,0.00009256024,0.000016440561,0.00014626399,0.000050665283,0.00037356847],"category_scores_gemma":[0.00006783104,0.00008766072,0.000045837143,0.00095276424,0.00008905201,0.00014726419,0.00003761181,0.00061943184,0.000012701838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038367324,0.0010285286,0.91511774,0.000113231035,0.00008679443,0.000025221303,0.004130099,0.00011432098,0.0063497634,0.0000073470796,0.00021527504,0.03444438],"study_design_scores_gemma":[0.014645055,0.0030122981,0.9807643,0.00034910263,0.00000278654,0.0000020687078,0.00032275353,0.000009279218,0.00075198116,0.0000052735213,0.00006003615,0.00007505354],"about_ca_topic_score_codex":0.12131698,"about_ca_topic_score_gemma":0.00679708,"teacher_disagreement_score":0.1145199,"about_ca_system_score_codex":0.0013401755,"about_ca_system_score_gemma":0.0011660622,"threshold_uncertainty_score":0.88453424},"labels":[],"label_agreement":null},{"id":"W2033314544","doi":"10.1158/0008-5472.can-10-1295","title":"Maternal Embryonic Leucine Zipper Kinase Is Upregulated and Required in Mammary Tumor-Initiating Cells <i>In vivo</i>","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Carcinogenesis; Biology; Cancer research; Mammary tumor; Progenitor cell; Mammary gland; Cancer; Transplantation; Breast cancer; Stem cell; Cell biology; Internal medicine; Medicine","score_opus":0.027238277655468345,"score_gpt":0.3258103453895097,"score_spread":0.2985720677340414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033314544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980793,0.00053749373,0.000015859005,0.0005663071,0.0001472726,0.00024165741,0.000034476856,0.000009133262,0.00036848866],"genre_scores_gemma":[0.99834484,0.00022581441,0.00012752348,0.00013904716,0.00010784118,0.00005486184,0.000017513801,0.000024300387,0.00095828815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864984,0.00011200603,0.00020097871,0.00040441728,0.00023797005,0.00039478217],"domain_scores_gemma":[0.99945384,0.000014155714,0.00003359924,0.00030201016,0.00010292861,0.00009344857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049509696,0.00011800022,0.00012309938,0.00016185312,0.00005733099,0.000053309417,0.00018068113,0.00013934918,0.0001752286],"category_scores_gemma":[0.0000285219,0.000121720936,0.000028789202,0.00022759027,0.00012932616,0.00001857446,0.00009548192,0.00034237403,0.0000065587164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113530354,0.00002236027,0.017901966,0.000047200792,0.0000068502045,0.000019716163,0.0000840196,0.000026620024,0.9803048,0.000033960674,0.00066355756,0.0007754374],"study_design_scores_gemma":[0.00096673775,0.00006789265,0.042806357,0.000057823483,0.0000017020318,0.000008618111,0.000023285182,0.0003444109,0.95111823,0.000073028445,0.0044018934,0.00013004523],"about_ca_topic_score_codex":0.00068502245,"about_ca_topic_score_gemma":0.0012502355,"teacher_disagreement_score":0.029186575,"about_ca_system_score_codex":0.00004593468,"about_ca_system_score_gemma":0.00013685031,"threshold_uncertainty_score":0.49636358},"labels":[],"label_agreement":null},{"id":"W2033475362","doi":"10.1158/0008-5472.sabcs12-s5-6","title":"Abstract S5-6: Activating HER2 mutations in HER2 gene amplification negative breast cancers.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lapatinib; Biology; Breast cancer; Mutation; Germline mutation; Somatic cell; Cancer research; Genetics; Trastuzumab; Cancer; COLD-PCR; Exon; Gefitinib; Gene; Point mutation; Molecular biology; Epidermal growth factor receptor","score_opus":0.20732919088547383,"score_gpt":0.5058111658886728,"score_spread":0.29848197500319895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033475362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353225,0.0016608336,0.00005676656,0.00459475,0.0002597065,0.0015744744,0.00012096385,0.00007581655,0.008124439],"genre_scores_gemma":[0.99478406,0.0007015857,0.00046811343,0.00015339644,0.0012243696,0.0014986717,0.000060869006,0.00008949497,0.0010194193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954707,0.0002473263,0.00048802292,0.00057600054,0.0016430033,0.0015749651],"domain_scores_gemma":[0.997188,0.00054568605,0.00010678776,0.0006567748,0.0008713417,0.0006314395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025777915,0.00023139156,0.00038224782,0.00067386765,0.000321039,0.0000866679,0.00034207906,0.00019936498,0.002573287],"category_scores_gemma":[0.00076748495,0.00022400553,0.000083820705,0.0021109886,0.0004443965,0.00047141252,0.00013849049,0.0017634813,0.00031849113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013300988,0.00093651994,0.30311435,0.0011128252,0.00026493604,0.000105216015,0.013162555,0.0005172682,0.43656638,0.0007092142,0.012505338,0.22967531],"study_design_scores_gemma":[0.0019361696,0.00013601554,0.8656869,0.00079445366,0.000015750533,0.00006166639,0.003715836,0.00020592645,0.11803489,0.00029002505,0.008770095,0.0003522478],"about_ca_topic_score_codex":0.03044012,"about_ca_topic_score_gemma":0.0021361245,"teacher_disagreement_score":0.5625726,"about_ca_system_score_codex":0.005188732,"about_ca_system_score_gemma":0.0026004442,"threshold_uncertainty_score":0.99863017},"labels":[],"label_agreement":null},{"id":"W2033586061","doi":"10.1158/1538-7445.am2014-ct313","title":"Abstract CT313: An exploratory analysis of efficacy and safety of abiraterone acetate (AA) in black patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (ctx)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Abiraterone acetate; Medicine; Prostate cancer; Tolerability; Internal medicine; Placebo; Urology; Docetaxel; Prednisone; Hazard ratio; Gastroenterology; Oncology; Cancer; Androgen deprivation therapy; Adverse effect; Confidence interval; Pathology","score_opus":0.06204232408946977,"score_gpt":0.3943474755229883,"score_spread":0.3323051514335186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033586061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650335,0.0008905209,0.000008616319,0.00042357133,0.0000202662,0.0018080735,0.00019489933,0.000015035782,0.00013564782],"genre_scores_gemma":[0.99659586,0.0023924266,0.0001765654,0.000036754394,0.0000303658,0.00032008358,0.00009847748,0.000054114407,0.0002953774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666804,0.00031369936,0.0006179486,0.00060191663,0.0011721723,0.0006262161],"domain_scores_gemma":[0.997797,0.00015623348,0.00023224666,0.0005276014,0.000977061,0.000309872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013267758,0.00026323638,0.00088684843,0.0008688987,0.00010280481,0.000038656075,0.0001814407,0.00007337733,0.000239037],"category_scores_gemma":[0.00006368112,0.0001851672,0.00006966636,0.001724424,0.00082148093,0.0002661995,0.00005184996,0.00040598423,0.0000025050947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042456474,0.002142529,0.7001895,0.0021562884,0.003493853,0.000041457715,0.015634557,0.0018123242,0.17700909,0.00003809655,0.00008897886,0.054936852],"study_design_scores_gemma":[0.017553383,0.0021381534,0.9357511,0.0007048067,0.00044170694,4.439932e-7,0.00097575295,0.0006726142,0.04129255,0.000019396664,0.00022767589,0.00022241368],"about_ca_topic_score_codex":0.002418835,"about_ca_topic_score_gemma":0.005480508,"teacher_disagreement_score":0.23556161,"about_ca_system_score_codex":0.0004254284,"about_ca_system_score_gemma":0.0008683325,"threshold_uncertainty_score":0.75508994},"labels":[],"label_agreement":null},{"id":"W2033763396","doi":"10.1158/1538-7445.am2011-2103","title":"Abstract 2103: Reduced Tip60 expression as a predictive biomarker for advanced melanoma and patient outcome","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Melanoma; Medicine; Tissue microarray; Oncology; Proportional hazards model; Biomarker; Cancer; Internal medicine; Survival analysis; Immunohistochemistry; Cancer research; Pathology; Biology","score_opus":0.07970847481782033,"score_gpt":0.41623915073762935,"score_spread":0.336530675919809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033763396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411917,0.0010312537,0.0010812816,0.00017450807,0.00004111169,0.0008938612,0.00008787788,0.000018931063,0.0025520106],"genre_scores_gemma":[0.9951868,0.0003563786,0.0020203916,0.00010858069,0.00004050431,0.0019415971,0.00006483345,0.000023151253,0.00025777548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894494,0.000047321748,0.00016740286,0.00043183187,0.000114206254,0.00029428717],"domain_scores_gemma":[0.99929315,0.000018301364,0.00005279928,0.0003339439,0.00019123442,0.000110598776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002080303,0.000110525296,0.00010524226,0.00005558566,0.00015292886,0.000011073974,0.00016937191,0.0001697858,0.000062613864],"category_scores_gemma":[0.00008481259,0.0000935175,0.00005264657,0.000074486736,0.000171412,0.0000039207757,0.00016829392,0.00012040031,0.0000038452768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005387173,0.000051130475,0.00070472213,0.000017455039,0.000023570297,0.0000015839809,0.000073733456,3.663912e-7,0.98107356,0.0001337813,0.002355116,0.01502626],"study_design_scores_gemma":[0.00036273096,0.0006812281,0.006462307,0.000025283427,0.0000052001737,0.0000042441916,0.000102457394,0.0000054192,0.9612595,0.00060383906,0.030365838,0.000121981495],"about_ca_topic_score_codex":0.00006794322,"about_ca_topic_score_gemma":0.000010143386,"teacher_disagreement_score":0.028010722,"about_ca_system_score_codex":0.00002337572,"about_ca_system_score_gemma":0.000076378536,"threshold_uncertainty_score":0.3813533},"labels":[],"label_agreement":null},{"id":"W2033989463","doi":"10.1158/1538-7445.am10-396","title":"Abstract 396: Reovirus successfully purges multiple myeloma <i>ex vivo</i> and does not affect human CD34+ cell engraftment in a murine transplantation model.","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Calgary Laboratory Services","funders":"","keywords":"Stem cell; Ex vivo; CD34; Transplantation; CD38; Multiple myeloma; Apheresis; Bone marrow; Cancer research; Biology; Immunology; Medicine; In vivo; Cell biology; Internal medicine","score_opus":0.030509841684790463,"score_gpt":0.36611543067350827,"score_spread":0.3356055889887178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033989463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974008,0.0005968983,0.000015431497,0.00035373206,0.00007061441,0.00076385046,0.00017576327,0.000016331944,0.00060657196],"genre_scores_gemma":[0.9953992,0.002762984,0.00008306884,0.00008502927,0.00022856038,0.0004215296,0.00008398203,0.00005381568,0.0008818412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756706,0.00018975981,0.00026482434,0.0006832459,0.00057556515,0.0007195636],"domain_scores_gemma":[0.99897707,0.00008389214,0.000043269538,0.00049199566,0.00018582339,0.00021796471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013185292,0.00022362861,0.00020563233,0.00024438274,0.00022596883,0.00009526108,0.00039680605,0.0002255,0.00017665394],"category_scores_gemma":[0.000050239,0.0001883024,0.00006807002,0.00020118705,0.00028327233,0.000017505336,0.00012149299,0.0007099293,0.000010578278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025545708,0.00014734312,0.0038876121,0.00019894484,0.000024334931,0.000030196003,0.00020317477,0.00037919145,0.98918337,0.0000090377725,0.00018744927,0.0031947521],"study_design_scores_gemma":[0.0018796839,0.00066611456,0.004891119,0.00003145088,0.000005524585,0.0000029624089,0.00004536792,0.00035071088,0.9908217,0.000057879686,0.0010132255,0.00023425597],"about_ca_topic_score_codex":0.0014398434,"about_ca_topic_score_gemma":0.034410957,"teacher_disagreement_score":0.032971114,"about_ca_system_score_codex":0.00006145057,"about_ca_system_score_gemma":0.0002776157,"threshold_uncertainty_score":0.98320854},"labels":[],"label_agreement":null},{"id":"W2034061313","doi":"10.1158/0008-5472.can-13-3306","title":"Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; Lymphocytic choriomeningitis; Virology; Biology; Potency; Vesicular Stomatitis; Virus; Immunology; Cancer research; Immune system; In vitro","score_opus":0.03040364961271001,"score_gpt":0.3740332363651805,"score_spread":0.34362958675247046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034061313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958592,0.0014657117,0.0004623484,0.00082428777,0.00009905614,0.0006948058,0.000021032783,0.000027826898,0.00054571324],"genre_scores_gemma":[0.9971761,0.0009840219,0.00012902432,0.00033063936,0.00033749413,0.00039387814,0.000015309759,0.00006507052,0.00056842796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973947,0.00040671302,0.00022037441,0.0005651265,0.00062802754,0.0007850647],"domain_scores_gemma":[0.9985362,0.000060134756,0.000033011915,0.0007516577,0.000256704,0.00036226178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014014489,0.00019960465,0.00021530678,0.00020710604,0.00025383476,0.00011244963,0.0005748613,0.00012308471,0.00009918126],"category_scores_gemma":[0.00031431514,0.00021098508,0.0000631282,0.00040353776,0.00014940728,0.000009985684,0.0005977808,0.00047644918,0.000059960053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031001316,0.000048135924,0.00021528505,0.000078355806,0.00003562808,0.000012063621,0.000096221236,0.0006578936,0.98329496,0.000023936002,0.0008266994,0.0144008035],"study_design_scores_gemma":[0.00045944212,0.0027107187,0.001572209,0.00008472876,0.0000048232955,0.0000057055336,0.000039096503,0.0004710379,0.97989434,0.00008110009,0.0144156935,0.00026111392],"about_ca_topic_score_codex":0.0005420407,"about_ca_topic_score_gemma":0.0011875513,"teacher_disagreement_score":0.0141396895,"about_ca_system_score_codex":0.00012529285,"about_ca_system_score_gemma":0.00020489878,"threshold_uncertainty_score":0.8603722},"labels":[],"label_agreement":null},{"id":"W2034232160","doi":"10.1158/0008-5472.can-06-4580","title":"Complex <i>N</i> -Glycan and Metabolic Control in Tumor Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Cell biology; Biology; Brefeldin A; Golgi apparatus; Cancer research; Endoplasmic reticulum","score_opus":0.04397894933433544,"score_gpt":0.3831712070081822,"score_spread":0.33919225767384675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034232160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322295,0.0027148183,0.00028634036,0.00046019457,0.00004578758,0.0005108889,0.00003508715,0.0000066144967,0.0027172964],"genre_scores_gemma":[0.9976905,0.0005256357,0.00010041644,0.00041769503,0.00019542675,0.00008209437,0.000016083306,0.000019307687,0.0009528146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831206,0.00016359965,0.00018058477,0.00034610258,0.0003873858,0.00061028387],"domain_scores_gemma":[0.99927187,0.000047287613,0.000022154569,0.00025609168,0.00020382369,0.00019878992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017615221,0.0000978129,0.00014274569,0.00021363808,0.000104733524,0.0000419612,0.0002023818,0.00007655131,0.0001760998],"category_scores_gemma":[0.0000945926,0.00009173684,0.000030831852,0.00034788236,0.00023176309,0.0000041792487,0.00012459327,0.0002881588,0.000024520103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032323634,0.00003513958,0.0068338774,0.000018344597,0.000012707532,0.000022245431,0.000034021647,0.000011977965,0.98363155,0.00019201313,0.0026710185,0.0062138424],"study_design_scores_gemma":[0.0016264234,0.00012736215,0.028601892,0.000011190582,0.0000018097236,0.000006333271,0.00010233278,0.00009755379,0.6343149,0.00005882217,0.33492687,0.00012448961],"about_ca_topic_score_codex":0.0008312347,"about_ca_topic_score_gemma":0.0021287275,"teacher_disagreement_score":0.34931666,"about_ca_system_score_codex":0.000032626398,"about_ca_system_score_gemma":0.0001656635,"threshold_uncertainty_score":0.37409198},"labels":[],"label_agreement":null},{"id":"W2034280545","doi":"10.1158/0008-5472.can-10-3782","title":"Epithelial Cell Organization Suppresses Myc Function by Attenuating Myc Expression","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Function (biology); Expression (computer science); Cell biology; Cancer research; Cell; Cell function; Biology; Chemistry; Genetics; Computer science","score_opus":0.0981033097411551,"score_gpt":0.3736901686500969,"score_spread":0.2755868589089418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034280545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420745,0.0014683765,0.00023714281,0.0007591024,0.00021388714,0.0004677576,0.00007256892,0.000065894754,0.012507829],"genre_scores_gemma":[0.9767965,0.0010681582,0.0002484109,0.00016437705,0.0006071547,0.0000872464,0.00014305949,0.00005444316,0.02083066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740124,0.00020887387,0.00024586334,0.0004276355,0.0010816704,0.00063470285],"domain_scores_gemma":[0.99830925,0.00015406798,0.000050170675,0.00030441876,0.0008844532,0.00029760756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005770866,0.00015418902,0.00021355631,0.00019686115,0.00040587017,0.000043999033,0.00021900325,0.00013730214,0.0075087906],"category_scores_gemma":[0.00022461009,0.000120233,0.000053237967,0.00068357313,0.0002021183,0.00016745919,0.00021447742,0.0006468769,0.0005935147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076334225,0.00018647237,0.021848334,0.00023994241,0.000023072465,0.000021653721,0.0008635004,0.0000011154877,0.9218976,0.00004431406,0.04894635,0.0051643094],"study_design_scores_gemma":[0.00078243075,0.00044582502,0.011014214,0.00016531748,0.000017464175,0.000008454511,0.0003794852,0.000037003705,0.9484475,0.00013219297,0.038428783,0.00014132698],"about_ca_topic_score_codex":0.0011842892,"about_ca_topic_score_gemma":0.000018352424,"teacher_disagreement_score":0.026549913,"about_ca_system_score_codex":0.0001316909,"about_ca_system_score_gemma":0.00028713566,"threshold_uncertainty_score":0.9933985},"labels":[],"label_agreement":null},{"id":"W2034353227","doi":"10.1158/0008-5472.can-07-6388","title":"Identification of p18INK4c as a Tumor Suppressor Gene in Glioblastoma Multiforme","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; London Health Sciences Centre; Georgetown University","keywords":"Cyclin-dependent kinase; Cancer research; Biology; Tumor suppressor gene; CDK inhibitor; Cyclin; Gene; Suppressor; Pathogenesis; Cyclin-dependent kinase 6; Cyclin D1; Cell cycle; Carcinogenesis; Genetics; Immunology","score_opus":0.07104284680478015,"score_gpt":0.4085966167341634,"score_spread":0.33755376992938324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034353227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997161,0.0010551506,0.0000014421419,0.0008434036,0.00004925046,0.00061309803,0.000024872275,0.000012834167,0.00023896423],"genre_scores_gemma":[0.99843657,0.00046345676,0.000037079753,0.000031943568,0.000063244224,0.0005256932,0.000006447487,0.00001684854,0.0004187224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985084,0.00006177433,0.00028101326,0.00024596552,0.00058820326,0.00031463403],"domain_scores_gemma":[0.99910724,0.000091565955,0.00004993784,0.00032248572,0.00030864135,0.00012011946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033446154,0.0000797191,0.00020911384,0.00039182376,0.000069025795,0.000007881723,0.00010330846,0.000043533502,0.00030592244],"category_scores_gemma":[0.00020102956,0.00006639932,0.00005569391,0.0005804998,0.00016291178,0.00006218369,0.000048460115,0.00017620169,0.00013824357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060375716,0.00085862365,0.06557209,0.00011245636,0.000046100125,0.00068852725,0.00080800464,0.000026431362,0.9282138,0.00008580613,0.0016919572,0.0012924579],"study_design_scores_gemma":[0.0019287998,0.00028744646,0.15041006,0.00010245924,0.000009288105,0.00007851064,0.000093961906,0.00012834373,0.8462348,0.000046724457,0.00063199806,0.000047621805],"about_ca_topic_score_codex":0.0014216262,"about_ca_topic_score_gemma":0.00021515432,"teacher_disagreement_score":0.08483796,"about_ca_system_score_codex":0.00026405757,"about_ca_system_score_gemma":0.00028899603,"threshold_uncertainty_score":0.33496362},"labels":[],"label_agreement":null},{"id":"W2034433640","doi":"10.1158/1538-7445.am2011-4725","title":"Abstract 4725: The 3D nuclear telomere organization of Hodgkin-cells is different between patients entering rapid remission and patients with refractory or relapsing disease","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Manitoba","funders":"","keywords":"ABVD; Telomere; Medicine; Refractory (planetary science); Lymphoma; Biopsy; Pathology; Internal medicine; Gastroenterology; Chemotherapy; Biology; Cyclophosphamide","score_opus":0.04552779341475147,"score_gpt":0.29962963049476676,"score_spread":0.25410183708001527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034433640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991527,0.0002515674,0.000024815196,0.000038872306,0.00004365327,0.00027757938,0.000072412935,0.000004555836,0.00013384003],"genre_scores_gemma":[0.99860907,0.0010224839,0.000040927254,0.000027346821,0.00005810985,0.000016389406,0.000055363747,0.000032372973,0.00013793677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990234,0.00006363763,0.0001612815,0.0002766824,0.00028495994,0.00019003567],"domain_scores_gemma":[0.9990817,0.00001544177,0.000094362294,0.00034217656,0.00034881404,0.000117542266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011753027,0.000102519036,0.00009615681,0.000046328536,0.00019387498,0.000023694642,0.00018036854,0.00006348283,0.00033349742],"category_scores_gemma":[0.000046214573,0.000061317616,0.000018792309,0.00012867685,0.00013663406,0.000011650502,0.00013146676,0.00013811397,0.0000023094153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009612671,0.0003430845,0.7109766,0.0001857555,0.00008666129,8.301002e-7,0.0010505755,0.000002214212,0.23211537,0.0000065582085,0.0019325818,0.05233853],"study_design_scores_gemma":[0.00069045875,0.00028948102,0.912629,0.00013957845,0.000021385573,5.3660496e-8,0.000107846485,0.000002924516,0.081140146,0.0000055144023,0.0048529007,0.00012070297],"about_ca_topic_score_codex":0.000050216404,"about_ca_topic_score_gemma":0.000004495682,"teacher_disagreement_score":0.20165244,"about_ca_system_score_codex":0.00004564385,"about_ca_system_score_gemma":0.00008051394,"threshold_uncertainty_score":0.3651563},"labels":[],"label_agreement":null},{"id":"W2034455695","doi":"10.1158/1538-7445.am2013-575","title":"Abstract 575: Cdk1 prevents DNA rereplication in G2/M by phosphorylating and facilitating the removal of Cdc7 from chromatin at the end of S phase.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"DNA replication factor CDT1; DNA re-replication; Cyclin-dependent kinase 1; Biology; Cell biology; Origin recognition complex; Pre-replication complex; Licensing factor; Eukaryotic DNA replication; Cyclin-dependent kinase; Control of chromosome duplication; Phosphorylation; DNA replication; Chromatin; Cancer research; Cell cycle; Genetics; Cancer; DNA","score_opus":0.026755553935698284,"score_gpt":0.3532355856132947,"score_spread":0.3264800316775964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034455695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934474,0.005368914,0.000021664213,0.00023556924,0.000014342041,0.00042936383,0.0001404588,0.0000014111384,0.00034086892],"genre_scores_gemma":[0.99841535,0.0007928245,0.00010720003,0.000019830686,0.000030290352,0.00011111376,0.000087683475,0.00000952585,0.0004261911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904895,0.00011663865,0.00024350904,0.00022526941,0.00018546799,0.00018017348],"domain_scores_gemma":[0.9992829,0.0001412746,0.000107556596,0.00034089715,0.00009966361,0.000027683967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005205851,0.00007097438,0.0001010805,0.000018698109,0.00008561325,0.000013625888,0.00020617805,0.000072122,0.00013299413],"category_scores_gemma":[0.00015854905,0.00004761566,0.00002938109,0.000090049994,0.00023688845,0.0000056117838,0.00016500123,0.00014142803,0.000002472202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033879416,0.000032721313,0.00083431666,0.00003380915,0.00001924935,2.2237803e-7,0.00047187792,0.000006563287,0.95989865,0.000003421303,0.001285612,0.03737966],"study_design_scores_gemma":[0.00046710114,0.00006790515,0.006689425,0.000068611254,0.0000037889963,0.0000016591481,0.0005659529,0.00021739675,0.98961544,0.000104733816,0.0021414706,0.000056539626],"about_ca_topic_score_codex":0.0045892,"about_ca_topic_score_gemma":0.0003857749,"teacher_disagreement_score":0.037323117,"about_ca_system_score_codex":0.000035064226,"about_ca_system_score_gemma":0.00006210081,"threshold_uncertainty_score":0.6937528},"labels":[],"label_agreement":null},{"id":"W2034484244","doi":"10.1158/0008-5472.can-05-2542","title":"Chemical Enhancers of Cytokine Signaling that Suppress Microfilament Turnover and Tumor Cell Growth","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Cell biology; Biology; Microfilament; Cell growth; Autocrine signalling; Transforming growth factor beta; Epidermal growth factor; Signal transduction; Cell; Receptor; Cytoskeleton; Biochemistry","score_opus":0.021316458746567398,"score_gpt":0.31254143649095895,"score_spread":0.29122497774439154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034484244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312365,0.0060302755,0.00006234721,0.00004892719,0.000044666645,0.0001802049,0.00007851883,0.0000072239523,0.0004241841],"genre_scores_gemma":[0.9988527,0.00009964987,0.00021219229,0.00003412019,0.00028511923,0.00006515114,0.00006394941,0.00002773754,0.00035934898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986565,0.00006876682,0.00017358366,0.00038169525,0.00034675404,0.0003726783],"domain_scores_gemma":[0.9993729,0.00004186877,0.00005703129,0.0002327014,0.00020033531,0.00009514212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002350195,0.00012727756,0.00014708932,0.00006266489,0.000061297374,0.000028546554,0.00023731988,0.00007994925,0.0000941144],"category_scores_gemma":[0.000036065463,0.0001211215,0.00005433362,0.000104316896,0.00029410742,0.0000043645787,0.00020625796,0.00014735406,0.0000027472474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019218675,0.00007751659,0.0042858063,0.00016924247,0.000020377065,0.000005292853,0.000027639535,0.00003515472,0.99064165,0.000011331246,0.004464277,0.00006952613],"study_design_scores_gemma":[0.00052578683,0.000058879246,0.00071691955,0.00005561369,0.000010439785,0.0000021689875,0.000046571837,0.0000049377245,0.995007,0.000044073524,0.0033944827,0.00013313942],"about_ca_topic_score_codex":0.0003418295,"about_ca_topic_score_gemma":0.00001492237,"teacher_disagreement_score":0.005930626,"about_ca_system_score_codex":0.00005091608,"about_ca_system_score_gemma":0.00017892777,"threshold_uncertainty_score":0.49391913},"labels":[],"label_agreement":null},{"id":"W2034710772","doi":"10.1158/0008-5472.can-03-3998","title":"Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":304,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Foundation","keywords":"Hsp27; Prostate cancer; LNCaP; Cancer research; Androgen; Endocrinology; Internal medicine; Biology; Cancer; Heat shock protein; Medicine; Hsp70; Hormone","score_opus":0.019068388445771224,"score_gpt":0.3330668488047378,"score_spread":0.31399846035896656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034710772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976572,0.020072635,0.000028655722,0.0004858049,0.000016180351,0.0025043094,0.000116074465,0.000011348797,0.00019302043],"genre_scores_gemma":[0.9901476,0.0030239816,0.00007063816,0.000041668853,0.00020652059,0.005906914,0.000028713712,0.00005055359,0.00052344403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738777,0.0003109575,0.00023433096,0.0007005912,0.00057774346,0.0007885923],"domain_scores_gemma":[0.99901015,0.000019666195,0.000018698716,0.00037957047,0.00032493228,0.0002469775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007924628,0.00020359806,0.00020262692,0.00026488272,0.00015922065,0.00007658258,0.0002134625,0.00024134874,0.000085528554],"category_scores_gemma":[0.00020543458,0.00019134638,0.00004223909,0.0004315048,0.00028000167,0.000029229064,0.00034182618,0.00058830937,0.000014522797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018494857,0.000119353805,0.0063616578,0.000078863515,0.000036545738,0.000039932915,0.0003449414,0.00021747418,0.98717,0.00000958537,0.00007842012,0.0036937795],"study_design_scores_gemma":[0.0020890152,0.00083490106,0.016024854,0.00020689298,0.0000041287185,0.000009314409,0.00022524963,0.000041203664,0.9740696,0.00038090668,0.0058176247,0.0002962946],"about_ca_topic_score_codex":0.016311258,"about_ca_topic_score_gemma":0.0077462,"teacher_disagreement_score":0.017048653,"about_ca_system_score_codex":0.0005134659,"about_ca_system_score_gemma":0.0011231389,"threshold_uncertainty_score":0.9902392},"labels":[],"label_agreement":null},{"id":"W2034750602","doi":"10.1158/1538-7445.am10-3694","title":"Abstract 3694: The mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase as an inhibitory target for cancer therapeutics","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Biochemistry; Dehydrogenase; Biology; Reactive oxygen species; Oxidoreductase; Enzyme; Glycerol-3-phosphate dehydrogenase; Molecular biology","score_opus":0.04397301407373559,"score_gpt":0.3855210675544196,"score_spread":0.341548053480684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034750602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697957,0.010327271,0.00007106322,0.0014887253,0.016385745,0.001235538,0.00033394442,0.000026794365,0.0003352286],"genre_scores_gemma":[0.89271325,0.0076998323,0.00054163387,0.0015083818,0.09015998,0.0028750761,0.00022468778,0.00016271652,0.0041144155],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975023,0.00011982727,0.00030100497,0.00069684605,0.0005086367,0.000871335],"domain_scores_gemma":[0.9980702,0.000070963346,0.000097454846,0.0008724281,0.0006017383,0.00028722914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074713817,0.00026657732,0.00024139845,0.00007513875,0.00052000454,0.00013210723,0.0007400624,0.00036942435,0.0003645016],"category_scores_gemma":[0.000117865166,0.00020331825,0.00019422293,0.00018929319,0.00050506345,0.000018952673,0.00014480542,0.00075668725,0.000022560902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011565078,0.000085055166,0.00012712232,0.000034670036,0.000114897186,3.3110467e-7,0.00023924843,0.00005967583,0.9538543,0.00021767123,0.02750395,0.01660653],"study_design_scores_gemma":[0.001013409,0.00016493945,0.00024219386,0.0000096029735,0.000020346322,0.0000021786955,0.00008894232,0.000024505267,0.39733753,0.0005041977,0.60041374,0.0001784388],"about_ca_topic_score_codex":0.0018926179,"about_ca_topic_score_gemma":0.0060373778,"teacher_disagreement_score":0.5729098,"about_ca_system_score_codex":0.000060833296,"about_ca_system_score_gemma":0.0016886339,"threshold_uncertainty_score":0.82910776},"labels":[],"label_agreement":null},{"id":"W2034784629","doi":"10.1158/0008-5472.sabcs12-p6-09-02","title":"Abstract P6-09-02: Pre-treatment cognitive function (CF) in women with locally advanced breast cancer (LABC) and in healthy controls.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cognition; Mood; Cancer; Confounding; Internal medicine; Physical therapy; Clinical psychology; Psychiatry","score_opus":0.03735690168665415,"score_gpt":0.39157272837927765,"score_spread":0.3542158266926235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034784629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97573286,0.017170735,0.0000095206915,0.0030454344,0.00016218147,0.002957375,0.00015173545,0.00003862118,0.0007315115],"genre_scores_gemma":[0.9843179,0.008600614,0.000006086981,0.00045320782,0.00026245654,0.0057796524,0.000013181071,0.000051312712,0.0005156109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969974,0.00015513603,0.00034802407,0.00054628495,0.0005929616,0.0013601482],"domain_scores_gemma":[0.99848604,0.00034000172,0.00009162455,0.00017702565,0.00052478636,0.00038052787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069560966,0.0002943482,0.0005627646,0.0004554295,0.00015055886,0.000026644218,0.00005791722,0.00012197623,0.0005010081],"category_scores_gemma":[0.000081968166,0.00022843682,0.000029106357,0.00079497864,0.00038663502,0.00033701264,0.00006536711,0.0007104528,0.000024184183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1384508,0.0014034326,0.50834143,0.00046673807,0.00063490105,0.00007102563,0.0060278666,0.00007534477,0.0034712951,0.000006288357,0.00022767708,0.3408232],"study_design_scores_gemma":[0.021450387,0.0031093357,0.9679431,0.002037926,0.00006918343,0.000023332292,0.0036153356,0.000013549028,0.0006112506,0.000014863348,0.000888004,0.00022374735],"about_ca_topic_score_codex":0.006408556,"about_ca_topic_score_gemma":0.008495198,"teacher_disagreement_score":0.45960167,"about_ca_system_score_codex":0.004080911,"about_ca_system_score_gemma":0.0010062779,"threshold_uncertainty_score":0.99974227},"labels":[],"label_agreement":null},{"id":"W2035159547","doi":"10.1158/1538-7445.am2012-4285","title":"Abstract 4285: Visualizing cancer vaccine clearance <i>in vivo</i> using magnetic resonance imaging","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics; Immunovaccine (Canada)","funders":"","keywords":"Adjuvant; Biodistribution; Immunotherapy; Immune system; Medicine; Cancer vaccine; Context (archaeology); Magnetic resonance imaging; Cancer; Antigen; Vaccination; Cancer immunotherapy; Cytotoxic T cell; Cancer research; Immunology; In vivo; Internal medicine; Chemistry; Biology; In vitro; Radiology","score_opus":0.05411076212939193,"score_gpt":0.3744896363811363,"score_spread":0.3203788742517444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035159547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7832494,0.21322823,0.00010373542,0.00008140885,0.0011461617,0.00043650137,0.000062113475,0.0001767805,0.0015156983],"genre_scores_gemma":[0.99062467,0.007455942,0.000270937,0.000096351825,0.00093703775,0.00021781052,0.0000017431653,0.00018021329,0.00021531987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965838,0.000046548932,0.00045682714,0.00037039616,0.0007318864,0.0018105392],"domain_scores_gemma":[0.9989118,0.0001532671,0.000042469022,0.0004579119,0.00015805135,0.0002764836],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008549761,0.0003104845,0.00035376544,0.00040212565,0.00018382905,0.00009471409,0.00044995267,0.00011942314,0.0011021108],"category_scores_gemma":[0.000046126654,0.00033054006,0.0000727253,0.001230346,0.00009613175,0.0007909155,0.00010783547,0.0009128134,0.000059034497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002009634,0.000059445712,0.040504478,0.0004507175,0.000019828456,0.00003797522,0.0011265514,0.009169634,0.8898375,0.00011562642,0.003552869,0.054924402],"study_design_scores_gemma":[0.0043534646,0.00007138414,0.09440477,0.0034204402,0.000047937636,0.000034543693,0.0007970502,0.04234231,0.5618919,0.0004286229,0.29016972,0.0020378472],"about_ca_topic_score_codex":0.0020971592,"about_ca_topic_score_gemma":0.00056318345,"teacher_disagreement_score":0.3279456,"about_ca_system_score_codex":0.001498956,"about_ca_system_score_gemma":0.00016455246,"threshold_uncertainty_score":0.99991465},"labels":[],"label_agreement":null},{"id":"W2035246749","doi":"10.1158/1538-7445.prca2012-a19","title":"Abstract A19: Blocking autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Protein kinase B; PI3K/AKT/mTOR pathway; LNCaP; Cancer research; Autophagy; PTEN; Prostate cancer; Apoptosis; Cell growth; Medicine; Cancer; Signal transduction; Chemistry; Biology; Cell biology; Internal medicine; Biochemistry","score_opus":0.08503292225527195,"score_gpt":0.38930407824313656,"score_spread":0.3042711559878646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035246749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406993,0.0033114038,0.00009994756,0.00042171584,0.00095783785,0.0006847311,0.000173903,0.000022752261,0.00025779434],"genre_scores_gemma":[0.99514407,0.00015127881,0.00039532088,0.0004685419,0.002665482,0.00013682745,0.000019201118,0.000081520644,0.0009377815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969478,0.00016760283,0.00033708557,0.00057601917,0.00076353824,0.0012079526],"domain_scores_gemma":[0.99838394,0.000062821826,0.00010701949,0.0007096416,0.00039949451,0.0003370618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011964922,0.00025384463,0.0002166202,0.00012462496,0.00044512667,0.00013114976,0.00047662103,0.00013476558,0.00014169945],"category_scores_gemma":[0.00017326034,0.00020455866,0.000106894084,0.00038456393,0.00020359093,0.000015531625,0.00043600262,0.00044301836,0.000060530798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023745405,0.00006801658,0.00037528976,0.00007241686,0.000068996815,0.000017914475,0.00029960953,0.0008229202,0.9906255,0.000010483961,0.0066602705,0.0007410998],"study_design_scores_gemma":[0.00043595405,0.00012040106,0.0022169673,0.000145492,0.000015773108,0.000011803255,0.00012637675,0.00007256075,0.916155,0.0000075461435,0.080443084,0.0002490561],"about_ca_topic_score_codex":0.0005996284,"about_ca_topic_score_gemma":0.000106568135,"teacher_disagreement_score":0.07447054,"about_ca_system_score_codex":0.00035161097,"about_ca_system_score_gemma":0.0005406317,"threshold_uncertainty_score":0.834166},"labels":[],"label_agreement":null},{"id":"W2035296409","doi":"10.1158/0008-5472.can-11-2781","title":"Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Synthetic lethality; Multiple myeloma; Biology; RNA interference; Gene; MCL1; Cancer research; Proteasome; Druggability; Computational biology; Genetics; RNA; DNA repair; Downregulation and upregulation; Immunology","score_opus":0.07274175709907843,"score_gpt":0.3408318186999264,"score_spread":0.268090061600848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035296409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973981,0.00083459594,0.0004685251,0.000026362644,0.000029807525,0.0003047966,0.000094257724,0.0000023071218,0.00084124476],"genre_scores_gemma":[0.9992101,0.00005814793,0.00006741406,0.0000116009205,0.000018791017,0.0001040134,0.000014357116,0.000011198759,0.0005043298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987111,0.00033912435,0.00027445954,0.00024286244,0.00021195447,0.00022046131],"domain_scores_gemma":[0.99918914,0.000021406982,0.000094508774,0.00044582953,0.00021423695,0.000034857596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001031019,0.000073423784,0.000113231385,0.00005052242,0.00006634682,0.000008579054,0.00045034042,0.00008006889,0.000075898526],"category_scores_gemma":[0.00010862449,0.00006243379,0.000052375795,0.00016298266,0.00033236356,0.000005059478,0.00023188775,0.00018641922,0.0000010486358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053294974,0.000059000264,0.0026776488,0.000093167415,0.000012361837,2.8222516e-7,0.0006417967,0.000025006762,0.99579847,0.00008313201,0.00006606949,0.0004897851],"study_design_scores_gemma":[0.00018874198,0.00010056487,0.0030938522,0.000040567444,0.0000020377233,1.8932795e-7,0.00033867254,0.000017159111,0.9956871,0.00025615,0.00021148413,0.00006346371],"about_ca_topic_score_codex":0.0015713898,"about_ca_topic_score_gemma":0.0001699885,"teacher_disagreement_score":0.0018120444,"about_ca_system_score_codex":0.000025173433,"about_ca_system_score_gemma":0.000080683516,"threshold_uncertainty_score":0.2545976},"labels":[],"label_agreement":null},{"id":"W2035353347","doi":"10.1158/0008-5472.can-05-1169","title":"Overexpressed β-Catenin Blocks Nitric Oxide–Induced Apoptosis in Colonic Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nitric oxide; Apoptosis; Nitric oxide synthase; Carcinogenesis; Cancer research; Programmed cell death; Cytochrome c; Inflammation; Protein kinase B; Cell biology; Chemistry; Biology; Cancer; Endocrinology; Internal medicine; Biochemistry; Immunology; Medicine","score_opus":0.10566290959866784,"score_gpt":0.41823309899441735,"score_spread":0.31257018939574954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035353347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540705,0.0067537264,0.0000036526903,0.003709482,0.00017834234,0.0010354804,0.00006200145,0.00004857087,0.0028016951],"genre_scores_gemma":[0.9823398,0.0074589727,0.00018619506,0.00056250225,0.0006976793,0.0011116611,0.000009576814,0.0000667312,0.007566894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99650496,0.0001675417,0.00043905512,0.00068376824,0.0010434143,0.0011612624],"domain_scores_gemma":[0.9983746,0.00017984673,0.00007882736,0.00054004125,0.00040240903,0.00042430396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090561225,0.00025043427,0.0005449632,0.00069346564,0.00014131198,0.000056346675,0.00032044394,0.00019792591,0.0046460507],"category_scores_gemma":[0.00008221866,0.00022773311,0.00014842922,0.001795524,0.00014538904,0.00013114772,0.00016168805,0.0010886241,0.00019682081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061691535,0.00025247165,0.0022062373,0.00016013179,0.000080748054,0.000021719903,0.00027150518,0.00018988707,0.94214976,0.000017285205,0.027812526,0.026220817],"study_design_scores_gemma":[0.003108137,0.00012021002,0.004599704,0.00033659837,0.00005682135,0.0000036848626,0.00016398709,0.00009591602,0.9050057,0.000018254164,0.086249925,0.00024105112],"about_ca_topic_score_codex":0.017170623,"about_ca_topic_score_gemma":0.0024049534,"teacher_disagreement_score":0.058437396,"about_ca_system_score_codex":0.0018222049,"about_ca_system_score_gemma":0.0015096127,"threshold_uncertainty_score":0.99626386},"labels":[],"label_agreement":null},{"id":"W2035409136","doi":"10.1158/0008-5472.can-07-6302","title":"p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition through Snail Induction in Ovarian Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Epithelial–mesenchymal transition; Biology; Vimentin; Cancer research; Ribosomal protein s6; Snail; Gene knockdown; Ovarian cancer; P70-S6 Kinase 1; PI3K/AKT/mTOR pathway; Signal transduction; Cancer; Cell biology; Cell culture; Metastasis; Immunology; Immunohistochemistry","score_opus":0.1404704524765201,"score_gpt":0.4130899992080153,"score_spread":0.27261954673149524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035409136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828687,0.001377363,0.00021930164,0.012232123,0.0005888466,0.0013746594,0.00012514755,0.0000347843,0.0011791214],"genre_scores_gemma":[0.9902437,0.003799212,0.00066524494,0.00069035304,0.0013690965,0.00084420625,0.00002154264,0.000051659314,0.0023150097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972173,0.00019133138,0.00032479383,0.00059499755,0.00091097923,0.00076062366],"domain_scores_gemma":[0.9988708,0.0000484494,0.0000388132,0.00036852722,0.00036834786,0.00030505177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006522,0.00019418298,0.00037993977,0.0003766489,0.0002183654,0.000025047328,0.00014441974,0.00015053106,0.0017912185],"category_scores_gemma":[0.000054758668,0.0001758642,0.00010179081,0.0013915342,0.0002112599,0.00026151838,0.000051251205,0.0007352721,0.00008886468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001249128,0.00029078056,0.00051847915,0.00023173088,0.000052324012,0.00027226747,0.0070631974,0.00021394364,0.9632168,0.00008722504,0.0070745507,0.019729616],"study_design_scores_gemma":[0.0026536467,0.00048441114,0.005852678,0.00040898862,0.00003718202,0.00004152375,0.00053215213,0.000024902485,0.9281296,0.00009260422,0.061498042,0.00024425425],"about_ca_topic_score_codex":0.027464107,"about_ca_topic_score_gemma":0.0027583234,"teacher_disagreement_score":0.054423492,"about_ca_system_score_codex":0.0009195651,"about_ca_system_score_gemma":0.0011978985,"threshold_uncertainty_score":0.9991213},"labels":[],"label_agreement":null},{"id":"W2035908075","doi":"10.1158/1538-7445.am2012-4652","title":"Abstract 4652: The autophagy-senescence connection in chemotherapy of breast tumor cells; senescence accelerated by autophagy but not dependent on autophagy","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Autophagy; Senescence; ATG5; Cell biology; Biology; Flow cytometry; Programmed cell death; Apoptosis; Chemistry; Cancer research; Molecular biology; Biochemistry","score_opus":0.03460615299428581,"score_gpt":0.3414202441792645,"score_spread":0.30681409118497865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035908075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581605,0.002512855,0.000086240936,0.00022288256,0.00033445796,0.00043847982,0.00008357831,0.000018875422,0.00048657396],"genre_scores_gemma":[0.9965445,0.0014536015,0.000023808192,0.00026559774,0.0003787024,0.00016298618,0.000041813197,0.00004510605,0.0010838791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974082,0.00024507078,0.00037959023,0.00053931924,0.0006448703,0.0007829429],"domain_scores_gemma":[0.9987294,0.0000939652,0.00014922008,0.0005625772,0.0003100639,0.00015473847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011844484,0.0002512636,0.00024600813,0.00010261332,0.00018749751,0.000056043384,0.00063855405,0.00022236761,0.00025634895],"category_scores_gemma":[0.000089176865,0.00019762674,0.00008140751,0.00040857252,0.00033317265,0.000023345352,0.00013049843,0.0005418243,0.000028802811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043669395,0.0002336788,0.0012825131,0.00011481386,0.000028072485,0.000007657095,0.000107631306,0.00010349575,0.9924562,0.00003897652,0.001221415,0.0039688377],"study_design_scores_gemma":[0.0007703371,0.00014323342,0.014490198,0.00007426672,0.0000049808496,0.000025436753,0.00019039444,0.00008607192,0.9819474,0.000012132047,0.0020467613,0.00020874731],"about_ca_topic_score_codex":0.0007786305,"about_ca_topic_score_gemma":0.00004115868,"teacher_disagreement_score":0.013207684,"about_ca_system_score_codex":0.00019818128,"about_ca_system_score_gemma":0.0004883227,"threshold_uncertainty_score":0.8058985},"labels":[],"label_agreement":null},{"id":"W2036365736","doi":"10.1158/1538-7445.am10-3207","title":"Abstract 3207: Telomerase inhibition affects fludarabine sensitivity in quiescent primary chronic lymphocytic leukemia lymphocytes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parks Canada; McGill University","funders":"","keywords":"Telomerase; Chronic lymphocytic leukemia; Fludarabine; Telomere; Medicine; Cancer; Cancer research; Leukemia; Shelterin; Immunology; Oncology; Internal medicine; Biology; Chemotherapy; Genetics; DNA; Cyclophosphamide","score_opus":0.032693441251548085,"score_gpt":0.364059816966657,"score_spread":0.3313663757151089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036365736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902428,0.0021361078,0.0000068143486,0.0007531088,0.00049521273,0.002063514,0.000038380178,0.00018353829,0.0040805177],"genre_scores_gemma":[0.99458027,0.0016525561,0.00009123502,0.00028670763,0.0014811405,0.00055168447,0.0001249604,0.00013756134,0.0010938707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9930119,0.0003353066,0.00062482065,0.0012393242,0.002584604,0.002204038],"domain_scores_gemma":[0.99604106,0.001061338,0.00011598065,0.0013427365,0.00059843244,0.00084042666],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043057515,0.0004827137,0.00083792524,0.001174543,0.0003195884,0.00014990268,0.00030031212,0.00053317705,0.001131823],"category_scores_gemma":[0.0010124679,0.00044869914,0.00020451775,0.0019575502,0.0011465155,0.00039009715,0.00048961694,0.0025814727,0.00061415334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017376232,0.00020222085,0.0019235819,0.0023363447,0.000079600606,0.0044509997,0.00027298153,0.000551504,0.957797,0.00015940523,0.006000226,0.024488518],"study_design_scores_gemma":[0.048100747,0.00063750613,0.07082725,0.002419158,0.000050240822,0.001163511,0.0001421584,0.013431102,0.85455227,0.0001597881,0.007684259,0.0008320253],"about_ca_topic_score_codex":0.017115138,"about_ca_topic_score_gemma":0.008985589,"teacher_disagreement_score":0.17087811,"about_ca_system_score_codex":0.30601043,"about_ca_system_score_gemma":0.13513231,"threshold_uncertainty_score":0.99979645},"labels":[],"label_agreement":null},{"id":"W2036415288","doi":"10.1158/1538-7445.am2012-3161","title":"Abstract 3161: Identification of HPV/p16-associated microRNAs in primary oropharyngeal carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"microRNA; TaqMan; Biology; RNA extraction; Carcinogenesis; Biopsy; Carcinoma; Cancer research; Pathology; RNA; Internal medicine; Cancer; Oncology; Medicine; Real-time polymerase chain reaction; Gene; Genetics","score_opus":0.03723234436623378,"score_gpt":0.35838150177597494,"score_spread":0.32114915740974115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036415288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902591,0.006774254,0.00012068849,0.00014041849,0.00021377315,0.00051901344,0.000077933655,0.0000084261155,0.0018863538],"genre_scores_gemma":[0.99743325,0.00095000525,0.000029941697,0.000042086896,0.00023788208,0.00019098498,0.00018934764,0.00004957417,0.00087692746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730515,0.00028067324,0.00042730197,0.00041876762,0.0007018674,0.00086625136],"domain_scores_gemma":[0.99866974,0.00003948618,0.00011865064,0.00052685966,0.00045575693,0.00018951346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019913202,0.00015203853,0.00022499675,0.00030623822,0.000088941124,0.00002764784,0.00044849084,0.00029197926,0.00027933205],"category_scores_gemma":[0.00025578725,0.00016368352,0.00009440712,0.00060242694,0.00019396492,0.000016445223,0.00027514828,0.00053056504,0.000036045327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023166454,0.00020962434,0.0031596306,0.00010218842,0.00004612679,0.000006542041,0.0001242548,0.00003730743,0.98840785,0.000034154375,0.0018980134,0.0057426654],"study_design_scores_gemma":[0.00073530775,0.00009729904,0.16723245,0.000025062203,0.0000060255898,0.0000029122514,0.00006212461,0.000012673494,0.82939345,0.0000281665,0.0022662797,0.00013824026],"about_ca_topic_score_codex":0.0009574161,"about_ca_topic_score_gemma":0.00024174427,"teacher_disagreement_score":0.16407283,"about_ca_system_score_codex":0.0005014896,"about_ca_system_score_gemma":0.00066083856,"threshold_uncertainty_score":0.667482},"labels":[],"label_agreement":null},{"id":"W2036614336","doi":"10.1158/0008-5472.sabcs11-p1-08-15","title":"P1-08-15: Pattern of Cardiac Monitoring and Risk of Trastuzumab Associated-Cardiac Dysfunction in a Clinical Practice: A Population Based Study.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Breast cancer; Ejection fraction; Anthracycline; Population; Cardiology; Incidence (geometry); Oncology; Logistic regression; Cancer; Gynecology; Heart failure","score_opus":0.16977714133355037,"score_gpt":0.5030539515384683,"score_spread":0.33327681020491795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036614336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965493,0.0015747113,0.0000032630971,0.00006627095,0.0004893172,0.0009850851,0.000048927814,0.000010646455,0.00027246855],"genre_scores_gemma":[0.99755853,0.0018526871,0.000044074688,0.0000058883843,0.00023272929,0.00021452188,0.000012659821,0.000017251748,0.00006165072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973899,0.0011457546,0.00045366472,0.00027705677,0.0004942727,0.00023932352],"domain_scores_gemma":[0.998434,0.00074268575,0.00020391087,0.00018898083,0.00033529638,0.000095090145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002836047,0.00009648213,0.0004750362,0.0002335288,0.000049769777,0.000004969749,0.000049680024,0.00011462498,0.00010114007],"category_scores_gemma":[0.00050945074,0.00008732831,0.00010163257,0.00036679537,0.00006882607,0.00009501742,0.00003913818,0.00051335094,0.0000020535122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018268024,0.0012511897,0.933404,0.00007212831,0.0005226266,0.000009219422,0.0014800307,0.000003094198,0.0009158707,5.5924465e-7,0.0001246383,0.060389835],"study_design_scores_gemma":[0.0031566485,0.002048876,0.9901182,0.00012287662,0.0004751035,2.4225605e-7,0.0012632946,0.000034568297,0.002593442,0.000007671542,0.00012018741,0.000058879425],"about_ca_topic_score_codex":0.025030332,"about_ca_topic_score_gemma":0.00043638013,"teacher_disagreement_score":0.060330957,"about_ca_system_score_codex":0.0003969027,"about_ca_system_score_gemma":0.00026862175,"threshold_uncertainty_score":0.98146206},"labels":[],"label_agreement":null},{"id":"W2036637802","doi":"10.1158/0008-5472.sabcs11-ot2-03-01","title":"OT2-03-01: Incidence of Mastalgia as a Presenting Complaint in Iranian Population with Regard to Age, BMI, Education, Residency (City or Rural), State of Marriage and Compare with Western Countries.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Family medicine; Population; Complaint; Breast pain; Demography; Pediatrics; Gynecology; Cancer; Internal medicine; Environmental health","score_opus":0.0858304688457745,"score_gpt":0.3833599863311644,"score_spread":0.2975295174853899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036637802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745363,0.00023889172,0.000029271941,0.0004353621,0.000018578608,0.0010583376,0.000023947034,0.000010084379,0.00073191954],"genre_scores_gemma":[0.99799025,0.00007283316,0.0006482645,0.000043208438,0.000027574535,0.00010162449,0.00001365643,0.000022325046,0.0010802893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982186,0.00014898495,0.00034941453,0.000279642,0.0006793088,0.0003240481],"domain_scores_gemma":[0.99855214,0.000079548816,0.00012770972,0.0003812237,0.00065521145,0.0002041386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060947204,0.00012789368,0.000355553,0.00033016858,0.000083742976,0.000022614699,0.0001491737,0.000034739613,0.00021757589],"category_scores_gemma":[0.00008327551,0.00008925753,0.000016039345,0.0006340765,0.000259768,0.00015009784,0.00011766911,0.0002623733,0.0000031155766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047440934,0.00011236138,0.9870282,0.00072818133,0.000023188953,0.00009299066,0.0050070863,0.000009333544,0.0008824571,0.00013078899,0.00016276112,0.0010785643],"study_design_scores_gemma":[0.001053568,0.00055917504,0.9917987,0.0026278372,0.000019966938,0.00008044909,0.0017448675,0.00001405392,0.0017291469,0.00018673277,0.00008234722,0.00010315498],"about_ca_topic_score_codex":0.049784254,"about_ca_topic_score_gemma":0.057308163,"teacher_disagreement_score":0.007523911,"about_ca_system_score_codex":0.00017708853,"about_ca_system_score_gemma":0.00099455,"threshold_uncertainty_score":0.9598935},"labels":[],"label_agreement":null},{"id":"W2036660348","doi":"10.1158/1538-7445.am2014-4720","title":"Abstract 4720: Evaluation of a genomic classifier (Decipher®) in subsets of primary tumors with common prostate cancer genomic alterations","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"PTEN; Prostate cancer; Erg; Metastasis; Microarray; Cancer research; Receiver operating characteristic; Exon; Cancer; Medicine; Biology; Oncology; Internal medicine; Gene; Genetics; Gene expression; PI3K/AKT/mTOR pathway","score_opus":0.05794445348167718,"score_gpt":0.382544202494316,"score_spread":0.32459974901263877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036660348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938507,0.0029438671,0.00018736218,0.00018034768,0.000057695313,0.0012229126,0.00009554616,0.0000047156714,0.0014568546],"genre_scores_gemma":[0.99763733,0.0009522808,0.000113268354,0.00003698756,0.00010883343,0.0007735414,0.00012853299,0.00005544874,0.00019377748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693704,0.00050075573,0.00044721994,0.0005193148,0.0010680938,0.0005276067],"domain_scores_gemma":[0.9980828,0.0000491069,0.00016786154,0.00061224564,0.0009666594,0.00012129596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025667634,0.00017336945,0.0003120497,0.00030230542,0.000083467596,0.000027324812,0.0003816481,0.00016340261,0.00024151255],"category_scores_gemma":[0.00009230452,0.00016352219,0.00006725487,0.00041139944,0.00030037537,0.00001200678,0.00017870803,0.00043351884,0.0000068389595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068325613,0.00009815044,0.002103098,0.00015831944,0.00007348123,0.0000023801292,0.00021458173,0.015331308,0.967044,0.00004522788,0.00031906817,0.013927109],"study_design_scores_gemma":[0.002994193,0.0005348192,0.09381367,0.00029626215,0.00003482857,0.0000044669127,0.00013166621,0.0021450443,0.8979199,0.00022376644,0.0016375098,0.00026389532],"about_ca_topic_score_codex":0.0023160595,"about_ca_topic_score_gemma":0.007195408,"teacher_disagreement_score":0.09171057,"about_ca_system_score_codex":0.0005609456,"about_ca_system_score_gemma":0.0023905472,"threshold_uncertainty_score":0.6668241},"labels":[],"label_agreement":null},{"id":"W2036765699","doi":"10.1158/1538-7445.am2011-lb-327","title":"Abstract LB-327: Analytical performance of the nCounter analysis system for gene expression cancer signatures","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Subtyping; Breast cancer; Computational biology; Gene signature; Gene; Gold standard (test); Biology; Cancer; False positive paradox; Gene expression; Correlation; Pathology; Oncology; Medicine; Internal medicine; Computer science; Genetics; Mathematics; Artificial intelligence","score_opus":0.05660916585290038,"score_gpt":0.3895091777798545,"score_spread":0.3329000119269541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036765699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606264,0.0010627809,0.0014920864,0.000078682926,0.000047069014,0.00043295155,0.00013489062,0.000008706793,0.0006802204],"genre_scores_gemma":[0.9978398,0.0003798832,0.00045330697,0.000043190907,0.000114367016,0.00078557886,0.00003357593,0.0000144609285,0.0003358154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989857,0.00005625392,0.0001865291,0.0003219361,0.00018586457,0.00026371656],"domain_scores_gemma":[0.9989912,0.000014390574,0.00007693408,0.00053654955,0.00032640155,0.000054504395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003859966,0.000096478216,0.00014782631,0.00007887238,0.00015142282,0.000008220756,0.0004519984,0.0001824971,0.000076227145],"category_scores_gemma":[0.000020348522,0.00006351639,0.0001780434,0.0003222639,0.00020551967,0.0000026553723,0.00015449205,0.00016219425,9.3229653e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012585935,0.000034147077,0.009010069,0.00007075668,0.0001792046,2.457301e-7,0.00002659668,0.00010888438,0.98769903,0.00013966899,0.0020666984,0.00053883705],"study_design_scores_gemma":[0.00013076683,0.000065936416,0.016343718,0.00003972164,0.000070071874,4.6409144e-7,0.000028767634,0.00029650188,0.97909653,0.000011846899,0.0038345677,0.00008109019],"about_ca_topic_score_codex":0.00023513078,"about_ca_topic_score_gemma":0.00007703125,"teacher_disagreement_score":0.008602485,"about_ca_system_score_codex":0.00004072008,"about_ca_system_score_gemma":0.00012810827,"threshold_uncertainty_score":0.2590123},"labels":[],"label_agreement":null},{"id":"W2036805994","doi":"10.1158/1538-7445.am2011-283","title":"Abstract 283: Vascular ageing as a modulator of tumor angiogenesis, antiangiogenesis and metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Angiogenesis; Metastasis; Cancer; Ageing; Internal medicine; Oncology; Lewis lung carcinoma; Pathology","score_opus":0.05557347266298389,"score_gpt":0.337373089371898,"score_spread":0.2817996167089141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036805994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535399,0.04472935,0.00006057274,0.00002572356,0.00066718686,0.00025684095,0.00007299077,0.000009109208,0.0006383123],"genre_scores_gemma":[0.9888892,0.008253345,0.0004058097,0.00005915063,0.002016501,0.0001062366,0.000015399444,0.000044169556,0.00021017944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983406,0.00010545409,0.0002379976,0.0004822874,0.00037161214,0.00046204784],"domain_scores_gemma":[0.9989178,0.000015721927,0.000071231116,0.000507648,0.00029117914,0.00019642415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006747526,0.00016541286,0.0002702002,0.00018078259,0.00011722019,0.000020344354,0.0002700371,0.00010306194,0.00025940483],"category_scores_gemma":[0.00009279817,0.00015736293,0.00020094593,0.00027687574,0.0002546886,0.000011709905,0.00019341127,0.00009732341,0.00000940509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015635636,0.00006358763,0.0027023782,0.0001264206,0.00030646852,0.0000022636796,0.00019846938,0.0000071542718,0.9803725,0.00011064748,0.0030054238,0.012948329],"study_design_scores_gemma":[0.00059719896,0.0001319134,0.061650045,0.000046104087,0.00007947711,0.000009588975,0.00022826486,0.0000036610759,0.7992235,0.00011022963,0.13768348,0.000236584],"about_ca_topic_score_codex":0.003682367,"about_ca_topic_score_gemma":0.00024614562,"teacher_disagreement_score":0.18114904,"about_ca_system_score_codex":0.000021188856,"about_ca_system_score_gemma":0.00028225157,"threshold_uncertainty_score":0.6417074},"labels":[],"label_agreement":null},{"id":"W2037058615","doi":"10.1158/0008-5472.can-09-0381","title":"Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro","keywords":"Combretastatin; Vascular endothelial growth factor; Tumor necrosis factor alpha; Stromal cell; Medicine; Granulocyte colony-stimulating factor; Cancer research; Internal medicine; Chemotherapy; Pathology; Biology; Cell biology","score_opus":0.034194358172091315,"score_gpt":0.38251372949065093,"score_spread":0.3483193713185596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037058615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942854,0.0015638942,0.002850698,0.00015722323,0.00008480906,0.0006050709,0.0003946103,0.0000036401784,0.000054668322],"genre_scores_gemma":[0.99848485,0.0008507879,0.000061703024,0.00007273574,0.00015227901,0.00006929533,0.00007041137,0.0000123066475,0.00022561077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875784,0.0001391482,0.00022360323,0.00024750273,0.00035525026,0.00027664696],"domain_scores_gemma":[0.99908376,0.000031230058,0.00008975896,0.00026339185,0.0004694097,0.000062446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044579964,0.00009230767,0.000151407,0.00003912824,0.00011277097,0.0000134972215,0.00023154833,0.000089077046,0.00003940568],"category_scores_gemma":[0.00011083291,0.00007065604,0.00010012241,0.00021323524,0.000073904375,0.0000045455486,0.000069044254,0.00007563368,0.000002502227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016445352,0.00003762053,0.0018716035,0.000015201037,0.00006168403,2.319696e-7,0.00012094134,0.0017521258,0.98942894,0.000015102539,0.0023432132,0.0041888934],"study_design_scores_gemma":[0.00042243113,0.00040090646,0.0025503843,0.000037669302,0.000018750485,2.2714558e-7,0.000030883115,0.0003909595,0.98115754,0.0000085844595,0.014904427,0.00007725546],"about_ca_topic_score_codex":0.00010388032,"about_ca_topic_score_gemma":0.000027554877,"teacher_disagreement_score":0.012561214,"about_ca_system_score_codex":0.000053242722,"about_ca_system_score_gemma":0.00009454607,"threshold_uncertainty_score":0.28812698},"labels":[],"label_agreement":null},{"id":"W2037144887","doi":"10.1158/0008-5472.sabcs10-p3-04-08","title":"Abstract P3-04-08: Epigenetic Changes Due to DNA Methylation in CpG Islands during Breast Cancer Progression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CpG site; DNA methylation; Breast cancer; Epigenetics; Cancer; Oncology; Methylation; Epigenome; Microarray; Biology; Disease; Internal medicine; Medicine; Prospective cohort study; Bioinformatics; Cancer research; Gene; Genetics; Gene expression","score_opus":0.034694838433606524,"score_gpt":0.3976855789149495,"score_spread":0.36299074048134294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037144887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951409,0.0020818599,0.00005718138,0.0013893434,0.0003146527,0.0005169256,0.000062021565,0.000011470086,0.000425654],"genre_scores_gemma":[0.9964583,0.0013674792,0.000151886,0.000033752352,0.0008892573,0.0006757609,0.000047452682,0.000041924322,0.00033419605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980924,0.00010868833,0.0002283361,0.00055184535,0.000442624,0.0005761154],"domain_scores_gemma":[0.9989857,0.000028829721,0.000062831954,0.0004077001,0.00031570907,0.00019924177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008810397,0.00016827535,0.00016973571,0.00026291428,0.00016758083,0.00007702599,0.0002613696,0.00025481166,0.00034112608],"category_scores_gemma":[0.000098660355,0.00015640394,0.000043497035,0.00040717004,0.00008286595,0.000009078148,0.00017922094,0.00042619207,0.000019948584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017347341,0.000043092394,0.011426399,0.000050019593,0.000014056614,0.000007393548,0.0001469065,0.00015046982,0.9257349,0.000006769422,0.0000721061,0.062174425],"study_design_scores_gemma":[0.0003456326,0.00007993142,0.30696324,0.000055272252,0.0000031224765,0.0000020170728,0.00003440276,0.000024808976,0.6894245,0.00007873981,0.0028368805,0.00015140341],"about_ca_topic_score_codex":0.0004609347,"about_ca_topic_score_gemma":0.007875364,"teacher_disagreement_score":0.29553685,"about_ca_system_score_codex":0.000078067555,"about_ca_system_score_gemma":0.00021213772,"threshold_uncertainty_score":0.63779676},"labels":[],"label_agreement":null},{"id":"W2037261412","doi":"10.1158/0008-5472.sabcs-09-2109","title":"Comparative Biomarker Analysis in 523 Matched Male and Female Breast Cancers.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Breast cancer; Male breast cancer; Biomarker; Internal medicine; Medicine; Oncology; Cancer; Pathology; Incidence (geometry); Stage (stratigraphy); Gastroenterology; Biology","score_opus":0.16649735030504126,"score_gpt":0.4957622464965257,"score_spread":0.32926489619148447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037261412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97726744,0.0055489894,0.000008455295,0.009130444,0.000028122768,0.0005948838,0.000042674634,0.000020740375,0.007358267],"genre_scores_gemma":[0.99577034,0.0010749717,0.00010837981,0.00032731917,0.00009478628,0.00013541846,0.000011008522,0.000008808842,0.002468983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795914,0.00016496915,0.0002669307,0.0004357022,0.0005375526,0.00063572725],"domain_scores_gemma":[0.998955,0.00012333308,0.000042882137,0.0002919594,0.00031880508,0.0002680129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079315854,0.00014030818,0.0006229328,0.00072640844,0.00013756096,0.000023310802,0.00009772134,0.00007388545,0.00087169994],"category_scores_gemma":[0.000034153163,0.00011970555,0.000057206293,0.0023452102,0.00029499215,0.00006509798,0.00006915938,0.00040310776,0.000027549719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001992696,0.00020564662,0.95906365,0.00036658475,0.0007014597,0.00021220626,0.0047651795,0.000044530683,0.0059527084,0.00013745353,0.0075806,0.018977279],"study_design_scores_gemma":[0.0011746365,0.00011975784,0.9950045,0.0001481628,0.000087652836,0.00004791838,0.0014857101,0.00054064044,0.00032253444,0.00004113756,0.0009192934,0.00010805403],"about_ca_topic_score_codex":0.0072863894,"about_ca_topic_score_gemma":0.005538562,"teacher_disagreement_score":0.03594085,"about_ca_system_score_codex":0.0006856804,"about_ca_system_score_gemma":0.00044584277,"threshold_uncertainty_score":0.9993242},"labels":[],"label_agreement":null},{"id":"W2037403354","doi":"10.1158/0008-5472.sabcs13-p4-15-04","title":"Abstract P4-15-04: Synthesis and characterization of EGFR antibody-mediated tumor targeted “gold nanobombs” for treatment of locally advanced breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Conjugate; PEGylation; Chemistry; Antibody; Cancer research; PEG ratio; Internalization; Breast cancer; Cancer; Medicine; Molecular biology; Cell; Immunology; Internal medicine; Biochemistry; Biology; Polyethylene glycol","score_opus":0.04792026201860468,"score_gpt":0.40534183252380235,"score_spread":0.3574215705051977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037403354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430156,0.00075805106,0.000028812816,0.002370867,0.000025101044,0.0014090246,0.0009665228,0.000018603308,0.000121431156],"genre_scores_gemma":[0.9948208,0.0023052946,0.00009681954,0.000041631803,0.00012378194,0.0021079213,0.00014524149,0.00002560663,0.00033290306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877083,0.000023864375,0.00031340503,0.00028729613,0.000283692,0.00032092878],"domain_scores_gemma":[0.99853295,0.00027378817,0.00010875121,0.00022863306,0.0006321619,0.00022370831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013152864,0.00013301574,0.00036132886,0.00008300962,0.00006070149,0.00001164517,0.00009054225,0.00007404539,0.0009616519],"category_scores_gemma":[0.00008043376,0.00010666901,0.00006133621,0.0003182046,0.00026156337,0.00009328934,0.000017430426,0.000090089154,0.0000063064663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005188914,0.00031445888,0.0032641485,0.00072135666,0.00009179112,0.0000018623577,0.000058544454,0.000005023057,0.969931,0.000015376903,0.00011669473,0.024960848],"study_design_scores_gemma":[0.001306021,0.00012383358,0.13244556,0.00028680218,0.00005026309,0.0000045915926,0.000042232463,0.00040746437,0.86385566,0.000013474955,0.001379716,0.000084395186],"about_ca_topic_score_codex":0.0004573772,"about_ca_topic_score_gemma":0.000007574845,"teacher_disagreement_score":0.12918141,"about_ca_system_score_codex":0.0001763176,"about_ca_system_score_gemma":0.00029963412,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W2037737356","doi":"10.1158/0008-5472.can-11-3513","title":"Uncoupling of PI3K from ErbB3 Impairs Mammary Gland Development but Does Not Impact on ErbB2-Induced Mammary Tumorigenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Mammary gland; Carcinogenesis; ERBB3; Cancer; PI3K/AKT/mTOR pathway; Internal medicine; Cancer research; Biology; Endocrinology; Medicine; Breast cancer; Cell biology; Signal transduction; Epidermal growth factor receptor","score_opus":0.13422335716945008,"score_gpt":0.4469408649623257,"score_spread":0.31271750779287566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037737356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919712,0.0027468663,0.00011595851,0.0015894794,0.0006189011,0.0012049085,0.00016047228,0.00009408781,0.0014981461],"genre_scores_gemma":[0.9932195,0.001295076,0.0011190149,0.00017327862,0.0013556993,0.0005369624,0.000060148253,0.00011782944,0.0021224997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99301785,0.00035881082,0.0007302506,0.0007893873,0.003101897,0.002001776],"domain_scores_gemma":[0.9955747,0.0008882962,0.0001380319,0.0013770066,0.0008204212,0.001201537],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034722812,0.00043208967,0.0008255499,0.000790168,0.0002961731,0.00009123784,0.0008687382,0.0002936111,0.0011862569],"category_scores_gemma":[0.00046734037,0.00029728079,0.00022944922,0.001031453,0.0002226735,0.00033384797,0.000585952,0.0014121496,0.00019595852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032564595,0.00071160746,0.2262598,0.00094723934,0.0007436349,0.00026441802,0.0024176997,0.000021689544,0.6675004,0.00011038583,0.0048337528,0.09293291],"study_design_scores_gemma":[0.001832088,0.0006235827,0.21565937,0.0008275213,0.000031995583,0.000015056983,0.00037567844,0.00009768569,0.7749468,0.00009212064,0.0051232167,0.00037487363],"about_ca_topic_score_codex":0.008829351,"about_ca_topic_score_gemma":0.00025605605,"teacher_disagreement_score":0.10744641,"about_ca_system_score_codex":0.002926534,"about_ca_system_score_gemma":0.004849358,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2037794622","doi":"10.1158/0008-5472.can-14-3687","title":"Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Toxicity; Pharmacology; Metabolite; Drug resistance; Drug metabolism; Tyrosine-kinase inhibitor; Internal medicine; Pharmacokinetics; Drug; CYP3A4; Oncology; Cancer research; Cancer; Metabolism; Biology","score_opus":0.14917089979099976,"score_gpt":0.3506493435283729,"score_spread":0.20147844373737314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037794622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853402,0.010574477,0.0000023946102,0.0008214309,0.00005821555,0.0011710661,0.000008267963,0.000017820405,0.0020061512],"genre_scores_gemma":[0.996787,0.00041654182,0.00010517879,0.00005955209,0.00007875902,0.0002132279,0.000008656669,0.000025556965,0.0023054888],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794877,0.00029567294,0.000224867,0.00039478566,0.0006862526,0.00044968363],"domain_scores_gemma":[0.9987698,0.00025157933,0.000043881166,0.00033557907,0.000262641,0.0003365096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009358232,0.00015211159,0.00038886614,0.0003586231,0.000055306184,0.000015640704,0.00011802471,0.00012737856,0.000034314395],"category_scores_gemma":[0.0002764715,0.00013270689,0.00006063532,0.000690547,0.00021671009,0.000074645824,0.00008565863,0.00023559737,0.000018730552],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023616403,0.00031540735,0.87868696,0.0009379173,0.000040104802,0.00093268894,0.0010845783,3.939192e-7,0.11187314,0.00016750312,0.002660621,0.00093901524],"study_design_scores_gemma":[0.0067314543,0.0010612613,0.07565019,0.0007536996,0.00005043994,0.0000047777016,0.0001588464,0.00027525742,0.91277105,0.00051238213,0.0018623035,0.00016834798],"about_ca_topic_score_codex":0.0008972244,"about_ca_topic_score_gemma":0.00010283657,"teacher_disagreement_score":0.8030368,"about_ca_system_score_codex":0.00041016456,"about_ca_system_score_gemma":0.0004550628,"threshold_uncertainty_score":0.54116297},"labels":[],"label_agreement":null},{"id":"W2037807718","doi":"10.1158/1538-7445.am2013-2493","title":"Abstract 2493: Identification of MGMT-binding proteins involved in the negative regulation of angiogenesis and invasion.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tandem affinity purification; Angiogenesis; Proteome; Cancer research; Molecular biology; Biology; Affinity chromatography; Chemistry; Biochemistry; Enzyme","score_opus":0.05735030711343588,"score_gpt":0.3445753106267745,"score_spread":0.28722500351333863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037807718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962583,0.0026735393,0.000021903836,0.00020917786,0.000061785766,0.00065454043,0.000018096283,0.0000013356894,0.00010132485],"genre_scores_gemma":[0.99771154,0.0015994894,0.00005642113,0.000011395843,0.00017236937,0.0002817373,0.000020477988,0.000008053407,0.00013849341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908537,0.00011980909,0.00021735813,0.00018830107,0.00024003975,0.00014910153],"domain_scores_gemma":[0.99930555,0.000040221414,0.00010013178,0.00024197611,0.00028308955,0.000029040086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078475586,0.000058510122,0.00009919716,0.00011102407,0.00005292856,0.000018914707,0.00015536015,0.000074222495,0.00002930243],"category_scores_gemma":[0.00017490945,0.000045542176,0.00003338212,0.0002609492,0.00017114551,0.000012339725,0.000055197233,0.000079268815,0.0000018129741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003841784,0.000025571515,0.00258933,0.000064429114,0.000013122049,4.5711513e-8,0.0003978867,0.000013350829,0.98982763,0.0000578204,0.0007217567,0.0062506455],"study_design_scores_gemma":[0.00022707426,0.0000309297,0.2712805,0.000031251064,0.0000036900842,2.6679476e-7,0.0005716684,0.000011531544,0.7268528,0.00027711506,0.00067450263,0.00003868352],"about_ca_topic_score_codex":0.001595696,"about_ca_topic_score_gemma":0.0005632476,"teacher_disagreement_score":0.26869118,"about_ca_system_score_codex":0.000019276165,"about_ca_system_score_gemma":0.00012410429,"threshold_uncertainty_score":0.24122256},"labels":[],"label_agreement":null},{"id":"W2037876920","doi":"10.1158/1538-7445.am2011-3207","title":"Abstract 3207: Automated quantitative analysis of p53, cyclin D1 and pErk expression in breast carcinoma does not differ from expert pathologist scoring and correlates well with clinico-pathological characteristics","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lymphovascular invasion; Breast cancer; Biomarker; Oncology; Stage (stratigraphy); Pathological; Tissue microarray; Cancer; Kappa; Internal medicine; Imaging biomarker; Pathology; Immunohistochemistry; Radiology; Magnetic resonance imaging; Metastasis; Biology","score_opus":0.09172998430771552,"score_gpt":0.38244946773090144,"score_spread":0.29071948342318593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037876920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984156,0.00092790386,0.000075583666,0.00007915171,0.00006588486,0.00016740187,0.00018632806,0.0000141470655,0.000068013294],"genre_scores_gemma":[0.9968112,0.0024168992,0.0004386678,0.00003168816,0.00003911865,0.00008973618,0.00011000636,0.000015345557,0.000047337136],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984384,0.00020977983,0.00031744616,0.0005746755,0.0002117492,0.00024795008],"domain_scores_gemma":[0.9991935,0.00008660034,0.00014396156,0.0003102924,0.00016059927,0.00010507521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039283506,0.00015172643,0.00031133197,0.00019668721,0.000083297025,0.000026713578,0.00015527889,0.00020082456,0.00009434326],"category_scores_gemma":[0.00007738344,0.00009897654,0.000042999287,0.00025055747,0.00044388187,0.000009951608,0.00015368097,0.0002394657,0.0000012399288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075383054,0.00007151427,0.38844183,0.000013845565,0.0000360384,0.000012002098,0.0005752198,0.0000025197787,0.60932577,0.0000050711214,0.00004020018,0.00072212535],"study_design_scores_gemma":[0.00044153584,0.00014655245,0.79960555,0.000081691804,0.000028788065,0.0000017518187,0.001049658,0.0004328214,0.19804834,0.000010632989,0.000034848108,0.00011782533],"about_ca_topic_score_codex":0.00047390716,"about_ca_topic_score_gemma":0.00013269544,"teacher_disagreement_score":0.41127744,"about_ca_system_score_codex":0.000024280302,"about_ca_system_score_gemma":0.00006371834,"threshold_uncertainty_score":0.4036146},"labels":[],"label_agreement":null},{"id":"W2038031312","doi":"10.1158/0008-5472.can-07-5187","title":"Frequency of the <i>CHEK2</i> 1100delC Mutation among Women with Breast Cancer: An International Study","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Sunnybrook Health Science Centre; Hôtel-Dieu de Montréal; Université Laval; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"CHEK2; Breast cancer; Allele; Odds ratio; Internal medicine; Medicine; Oncology; Allele frequency; Genotype; Cancer; Gynecology; Genetics; Biology; Germline mutation; Mutation; Gene","score_opus":0.03513586835258627,"score_gpt":0.3653102774931941,"score_spread":0.33017440914060786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038031312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981517,0.00019371971,0.000029472183,0.00032087276,0.00019725866,0.00044725774,0.00013082052,0.000007068832,0.00052183185],"genre_scores_gemma":[0.9979021,0.00020711434,0.00006626039,0.00005955694,0.00032775782,0.00083434914,0.000016322829,0.000026601507,0.0005599464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984098,0.00017983056,0.000172588,0.0003599858,0.00059512036,0.00028266275],"domain_scores_gemma":[0.9985716,0.000012062708,0.00008113526,0.0004980301,0.00075996434,0.00007723131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036598174,0.000103493505,0.000100081925,0.000073128926,0.00021013572,0.000019529041,0.0005764586,0.00006419978,0.00019659297],"category_scores_gemma":[0.00002806463,0.000075402495,0.000025930267,0.00036959542,0.00046635434,0.000020160966,0.00013504787,0.00020070538,0.0000017664431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023638549,0.00025365534,0.8449164,0.0000149083835,0.00020492589,0.000009127694,0.0034401906,0.0019837094,0.14461112,0.000018199706,0.00090415834,0.0034072034],"study_design_scores_gemma":[0.0010648759,0.00036625427,0.9198542,0.000028831626,0.00001082092,0.00003640621,0.002425024,0.000041504507,0.07527475,0.00005083588,0.00068850844,0.00015794027],"about_ca_topic_score_codex":0.0024019629,"about_ca_topic_score_gemma":0.002519672,"teacher_disagreement_score":0.07493783,"about_ca_system_score_codex":0.00042569204,"about_ca_system_score_gemma":0.0011341458,"threshold_uncertainty_score":0.36310652},"labels":[],"label_agreement":null},{"id":"W2038083698","doi":"10.1158/0008-5472.can-04-4424","title":"Src Homology 2–Containing Inositol 5′-Phosphatase 1 Negatively Regulates IFN-γ Production by Natural Killer Cells Stimulated with Antibody-Coated Tumor Cells and Interleukin-12","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Interleukin 12; Janus kinase 3; Interleukin 21; Cell biology; Cytokine; Biology; Molecular biology; Immune system; Chemistry; T cell; Immunology; Cytotoxic T cell; In vitro; Biochemistry","score_opus":0.01888988464740017,"score_gpt":0.3144597215425297,"score_spread":0.29556983689512956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038083698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876945,0.006818443,0.000018862029,0.0009990737,0.0035228236,0.00064255117,0.00002001547,0.00010414302,0.00017958989],"genre_scores_gemma":[0.9647849,0.0003724472,0.000047170208,0.00020839181,0.00010936327,0.00007749256,0.0003881593,0.00004010971,0.03397194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976613,0.0004949461,0.00035590498,0.0006667456,0.0001170402,0.00070405094],"domain_scores_gemma":[0.9988329,0.00018231299,0.00014988722,0.00029873714,0.00047907382,0.000057079928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045699836,0.0002746515,0.0003383091,0.0003088423,0.000497618,0.000071739465,0.00020723254,0.00020425725,0.0013364465],"category_scores_gemma":[0.00007336451,0.00022425468,0.00004537597,0.0003686513,0.0006374329,0.00044094893,0.00012613194,0.0012076182,0.00029859281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026511583,0.00012151734,0.00028221976,0.000027408143,0.0001834808,0.000012889258,0.0008407677,0.00006843989,0.8806511,0.000017169661,0.11203026,0.0031136014],"study_design_scores_gemma":[0.0016268863,0.00062956865,0.00061631855,0.00012793457,0.000025450894,0.00011276564,0.0006387749,0.00010356029,0.8498333,0.0000038020587,0.14604472,0.00023694028],"about_ca_topic_score_codex":0.0011381155,"about_ca_topic_score_gemma":0.00015405907,"teacher_disagreement_score":0.034014456,"about_ca_system_score_codex":0.0002980942,"about_ca_system_score_gemma":0.00014485195,"threshold_uncertainty_score":0.99957645},"labels":[],"label_agreement":null},{"id":"W2038220960","doi":"10.1158/1538-7445.am2012-1757","title":"Abstract 1757: Elesclomol (STA-4783) is a potent inhibitor of topoisomerase II","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Topoisomerase; Etoposide; Chemistry; Cell growth; Cancer research; DNA; Molecular biology; Pharmacology; Biology; Biochemistry; Genetics; Chemotherapy","score_opus":0.06745592443568806,"score_gpt":0.3946315291965324,"score_spread":0.32717560476084434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038220960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963726,0.0075304015,0.00007086365,0.00052593916,0.00029679554,0.0002720162,0.000101590886,0.000006404323,0.001558705],"genre_scores_gemma":[0.99448186,0.0018939532,0.00007245272,0.00032375744,0.00088628515,0.00010575342,0.000023170067,0.000031179068,0.002181616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850994,0.00004372211,0.00020187299,0.00026786615,0.00039902324,0.00057757186],"domain_scores_gemma":[0.99905246,0.000010809555,0.000057937534,0.00042318963,0.00025124135,0.0002043676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005436199,0.00012712665,0.00015148257,0.000082884995,0.00013704177,0.000015594629,0.00023387212,0.0001384711,0.0005321019],"category_scores_gemma":[0.00002186805,0.00011678291,0.00010425429,0.00015987578,0.00011094292,0.000006747268,0.00022344077,0.00020985019,0.000022945464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001637002,0.00014924111,0.00024841717,0.000051459043,0.0000617414,0.0000012689877,0.00027237073,0.0000030615872,0.9744919,0.00029198112,0.00586998,0.018394867],"study_design_scores_gemma":[0.00038594674,0.0002196349,0.00047873706,0.000026908712,0.0000074842546,0.0000023206367,0.0001300009,0.0000017405719,0.80156696,0.00014524705,0.19692057,0.00011446996],"about_ca_topic_score_codex":0.00025963562,"about_ca_topic_score_gemma":0.000036062127,"teacher_disagreement_score":0.19105059,"about_ca_system_score_codex":0.00007113518,"about_ca_system_score_gemma":0.00023768398,"threshold_uncertainty_score":0.58261424},"labels":[],"label_agreement":null},{"id":"W2038285213","doi":"10.1158/0008-5472.fbcr09-b1","title":"Abstract B1: Chemotherapy induces NEDP1-mediated destabilization of MDM2","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mdm2; Ubiquitin ligase; Gene knockdown; DNA damage; Ubiquitin; Cancer research; NEDD8; Biology; Programmed cell death; Endogeny; Cell biology; Chemistry; Apoptosis; DNA; Biochemistry; Gene","score_opus":0.08299639437011,"score_gpt":0.41649904731830756,"score_spread":0.3335026529481976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038285213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900208,0.0024050816,0.000054243934,0.0026255823,0.00009473416,0.0006275615,0.000014770755,0.000055165776,0.00410202],"genre_scores_gemma":[0.9973314,0.0017896197,0.00010262476,0.00029323337,0.00017223186,0.000041812807,0.00003835838,0.000030955696,0.00019976453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816376,0.000060794664,0.00027842622,0.00029917623,0.0007931057,0.0004047113],"domain_scores_gemma":[0.9986806,0.000091048525,0.00007360528,0.00039068382,0.00058319786,0.00018086552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005700897,0.00011974035,0.00025130258,0.00030038613,0.00006434959,0.000016760448,0.00015150309,0.0001691051,0.0008086782],"category_scores_gemma":[0.00030530102,0.000109959095,0.000070606045,0.00097119866,0.00016886364,0.00007668258,0.000018897555,0.0005213246,0.000028615934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039171803,0.00016206257,0.0006828851,0.000073743344,0.00002838365,0.000019407853,0.00041891768,0.000041937783,0.9635393,0.00007334244,0.0023184724,0.032249797],"study_design_scores_gemma":[0.0026342757,0.00068464247,0.07940959,0.00044292677,0.000019403435,0.00000890739,0.0001425926,0.00007244203,0.90696603,0.00031788702,0.00914256,0.00015873012],"about_ca_topic_score_codex":0.00023474415,"about_ca_topic_score_gemma":0.00004128582,"teacher_disagreement_score":0.07872671,"about_ca_system_score_codex":0.0003655771,"about_ca_system_score_gemma":0.0008203978,"threshold_uncertainty_score":0.8854459},"labels":[],"label_agreement":null},{"id":"W2038448422","doi":"10.1158/0008-5472.sabcs10-p4-06-12","title":"Abstract P4-06-12: The Urokinase-Type Plasminogen Activator Is a Direct JAG1- Mediated Notch Target in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"JAG1; Notch signaling pathway; Cancer research; Gene knockdown; Breast cancer; Plasminogen activator; Urokinase receptor; Metastasis; Tissue microarray; HES1; Biology; Cancer; Medicine; Signal transduction; Internal medicine; Cell biology; Cell culture","score_opus":0.025833953203530734,"score_gpt":0.3480513386940874,"score_spread":0.3222173854905567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038448422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892178,0.001941659,0.000014153483,0.004497724,0.0005528379,0.0009855357,0.0006345431,0.000028444747,0.0021272928],"genre_scores_gemma":[0.9934048,0.0025692435,0.000038950016,0.000538469,0.00081643916,0.00074088795,0.0001330933,0.00011768534,0.0016404554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995894,0.00027537427,0.00035122878,0.0009811042,0.0011844372,0.0013138275],"domain_scores_gemma":[0.997644,0.00014589803,0.00009100299,0.0010876991,0.00066997344,0.00036142385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014235248,0.00033366398,0.000302336,0.00028341956,0.00031631227,0.00012853456,0.0011298419,0.0005480674,0.003100681],"category_scores_gemma":[0.0004095522,0.00026882908,0.00013919112,0.0010054176,0.0004395349,0.000018324417,0.00052049855,0.0020340658,0.000147023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007079025,0.00010904603,0.0012805642,0.00004519326,0.00013202846,0.000038951453,0.00016201223,0.00009044989,0.96442807,0.000015828122,0.03081915,0.0021707974],"study_design_scores_gemma":[0.00093780603,0.00009633767,0.00770822,0.000059993687,0.000009423397,0.00001663962,0.00007454917,0.00013351916,0.84663576,0.000046730955,0.14396815,0.00031284607],"about_ca_topic_score_codex":0.005198125,"about_ca_topic_score_gemma":0.004571914,"teacher_disagreement_score":0.11779229,"about_ca_system_score_codex":0.0002701009,"about_ca_system_score_gemma":0.0020900427,"threshold_uncertainty_score":0.9999764},"labels":[],"label_agreement":null},{"id":"W2038548965","doi":"10.1158/1538-7445.chtme14-a54","title":"Abstract A54: Pantoprazole enhances the activity of docetaxel chemotherapy for solid tumors by inhibition of autophagy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Docetaxel; Cancer cell; Cytotoxicity; In vivo; Pharmacology; Apoptosis; Cancer research; Transfection; In vitro; Chemistry; Cancer; Cell culture; Biology; Biochemistry","score_opus":0.09357294206208051,"score_gpt":0.447807592584549,"score_spread":0.3542346505224685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038548965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939476,0.0027259132,0.000102012295,0.001501754,0.0000699768,0.0007788446,0.00010395525,0.00001677344,0.00075316225],"genre_scores_gemma":[0.99799293,0.0007533777,0.00002812591,0.00013160116,0.0001965226,0.00024410228,0.000014445099,0.00002257573,0.000616309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854445,0.000064277876,0.00023692526,0.00020469297,0.0006348252,0.00031480106],"domain_scores_gemma":[0.99870545,0.00018142199,0.00013838481,0.00031909492,0.00051399844,0.00014166065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010156069,0.000105521896,0.00030932235,0.00008250937,0.00007410841,0.0000106938105,0.00015013057,0.00007395006,0.00023913947],"category_scores_gemma":[0.00010740123,0.00007097358,0.000105885854,0.00024707417,0.00038180372,0.000102087135,0.00002564941,0.00022841927,0.0000053159074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016769483,0.00035607896,0.00015026791,0.00023587488,0.000102005215,0.0000030417152,0.00070340367,0.0000057826946,0.9703117,0.00010854532,0.01094483,0.015401528],"study_design_scores_gemma":[0.002212583,0.00041895185,0.0070223855,0.00014927839,0.000015380905,0.0000014839461,0.0002796971,0.00006959437,0.9857416,0.0010895324,0.002935425,0.000064093394],"about_ca_topic_score_codex":0.00044507385,"about_ca_topic_score_gemma":0.00001502637,"teacher_disagreement_score":0.015429902,"about_ca_system_score_codex":0.00010581587,"about_ca_system_score_gemma":0.000676424,"threshold_uncertainty_score":0.2894219},"labels":[],"label_agreement":null},{"id":"W2038639277","doi":"10.1158/0008-5472.sabcs-09-109","title":"<i>Wnt</i> Signaling Prognosticates Outcome in Breast Cancer Cohorts.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wnt signaling pathway; Breast cancer; Cancer; Carcinogenesis; Cohort; Oncology; Medicine; Cancer research; Internal medicine; PTEN; Biology; Gene; Genetics; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.06416252146801978,"score_gpt":0.4111908433245334,"score_spread":0.3470283218565136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038639277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987784,0.005439009,0.000056110686,0.0052806213,0.00008560942,0.00036570153,0.00006315529,0.000012967321,0.000912787],"genre_scores_gemma":[0.9953207,0.0023940485,0.000050188915,0.00045133178,0.00036196716,0.00040383113,0.000027576676,0.000018581415,0.0009717871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847806,0.00008275803,0.0002289048,0.00042816554,0.00029046347,0.0004916801],"domain_scores_gemma":[0.99926245,0.000018190496,0.000036545753,0.00031093773,0.00025945628,0.00011243368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049029716,0.00012371439,0.00015156726,0.0001049444,0.0001158443,0.000052658772,0.00030009943,0.00011085529,0.0001910383],"category_scores_gemma":[0.000040310755,0.00010894402,0.00005142538,0.00037331265,0.00011753988,0.000006814028,0.00005696443,0.00025586865,0.000014795288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012001008,0.00010398409,0.11829382,0.000021976988,0.000020094178,0.000006109201,0.00005736217,0.0006063961,0.8599284,0.00022589431,0.0042089997,0.016406922],"study_design_scores_gemma":[0.0016326702,0.00029103653,0.371124,0.00023363806,0.000022487673,0.00001947142,0.0002859521,0.0001688093,0.57400346,0.00073024543,0.050760835,0.0007274379],"about_ca_topic_score_codex":0.0005027952,"about_ca_topic_score_gemma":0.00013341993,"teacher_disagreement_score":0.285925,"about_ca_system_score_codex":0.00011002826,"about_ca_system_score_gemma":0.00027480573,"threshold_uncertainty_score":0.44426084},"labels":[],"label_agreement":null},{"id":"W2038689662","doi":"10.1158/0008-5472.can-09-2036","title":"p53 Pre- and Post-Binding Event Theories Revisited: Stresses Reveal Specific and Dynamic p53-Binding Patterns on the <i>p21</i> Gene Promoter","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Faculty of Medicine and Health, University of Sydney; Université de Sherbrooke","keywords":"Transcription factor; Transcription (linguistics); Biology; Response element; Binding site; Cell biology; Gene; Effector; Genetics; Gene expression; Computational biology; Promoter","score_opus":0.0318322419603176,"score_gpt":0.35672279628398634,"score_spread":0.32489055432366876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038689662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819751,0.00807664,0.00005248686,0.0074784826,0.000115660936,0.0014679608,0.00018340701,0.000049110047,0.0006011973],"genre_scores_gemma":[0.9908055,0.00687058,0.000048146718,0.00038543454,0.00026329505,0.000106036205,0.00005502744,0.000052621665,0.0014133614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972337,0.00027401964,0.00029967606,0.0006591976,0.00084545603,0.00068793696],"domain_scores_gemma":[0.9985819,0.0002334532,0.00008241458,0.00061433093,0.0002527928,0.0002351196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010961121,0.0002569463,0.00033264246,0.0002802488,0.00041282462,0.00017229271,0.00020597252,0.00014258186,0.0001704947],"category_scores_gemma":[0.00018975206,0.00018117666,0.0000697792,0.00042849145,0.00025393727,0.00010041901,0.00015187696,0.0010329875,0.000018719054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097318285,0.00012115447,0.0029687565,0.0003516316,0.00013017071,0.00024912486,0.0020229989,0.000008488263,0.94305307,0.0012666119,0.0016728906,0.04718194],"study_design_scores_gemma":[0.006681049,0.0066951956,0.1774534,0.013127215,0.00030327172,0.000756361,0.0031301256,0.00026794669,0.77284586,0.0025581026,0.014747886,0.0014335731],"about_ca_topic_score_codex":0.000091512724,"about_ca_topic_score_gemma":0.000036429894,"teacher_disagreement_score":0.17448466,"about_ca_system_score_codex":0.00046842024,"about_ca_system_score_gemma":0.00019528324,"threshold_uncertainty_score":0.7388169},"labels":[],"label_agreement":null},{"id":"W2038751486","doi":"10.1158/1538-7445.am2014-103","title":"Abstract 103: 64-Cu-NOTA-panitumumab F(ab')2 fragments for PET/CT imaging of pancreatic cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic cancer; Biodistribution; Cancer; Cancer research; Pancreas; Panitumumab; Radioimmunotherapy; Imaging agent; Epidermal growth factor receptor; Chemistry; Pathology; Medicine; Molecular biology; Nuclear medicine; Monoclonal antibody; Cetuximab; Internal medicine; Antibody; Biology; Colorectal cancer; Immunology; In vivo","score_opus":0.1135385626504268,"score_gpt":0.48605891293219594,"score_spread":0.3725203502817691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038751486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876787,0.0018953126,0.0001564686,0.00245412,0.0000704703,0.00082530786,0.00010577265,0.00003563838,0.006778174],"genre_scores_gemma":[0.9953584,0.0006300571,0.00024124052,0.00019154561,0.00046545573,0.0012409169,0.000028222468,0.000035776487,0.0018083568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982518,0.00003590905,0.00029775617,0.00036597083,0.0005265161,0.00052207976],"domain_scores_gemma":[0.9984397,0.0003877732,0.00006903183,0.00041978914,0.00040325813,0.00028042152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061876193,0.0001358743,0.00030818058,0.00007949615,0.00017400978,0.000024377698,0.0002287179,0.00001609255,0.0014645187],"category_scores_gemma":[0.00026203974,0.00011949086,0.000101484555,0.0002931636,0.0002599057,0.00006279156,0.000048796403,0.0004252353,0.00003065042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005257961,0.00032949995,0.014884884,0.002657333,0.0002005843,0.00003718257,0.000094726376,0.000054344302,0.9381091,0.0006326955,0.0173003,0.025173543],"study_design_scores_gemma":[0.0041670874,0.000105444335,0.016329573,0.0009241819,0.00023165662,0.000051307667,0.00026977522,0.0036983476,0.8811476,0.00085817225,0.09190566,0.0003111521],"about_ca_topic_score_codex":0.00050812116,"about_ca_topic_score_gemma":0.0000107332235,"teacher_disagreement_score":0.07460536,"about_ca_system_score_codex":0.00026013478,"about_ca_system_score_gemma":0.00031679144,"threshold_uncertainty_score":0.9994483},"labels":[],"label_agreement":null},{"id":"W2038998968","doi":"10.1158/1538-7445.am2012-4515","title":"Abstract 4515: Low serum levels of a novel anti-inflammatory fatty acid as a new risk factor for colorectal cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region; University of Saskatchewan; Saskatchewan Disease Control Laboratory; Saskatchewan Cancer Agency; Phenomenome Discoveries (Canada)","funders":"","keywords":"Colonoscopy; Medicine; Colorectal cancer; Gastroenterology; Internal medicine; Incidence (geometry); Population; Risk factor; Percentile; Cancer","score_opus":0.06421743979311265,"score_gpt":0.38301171149281643,"score_spread":0.31879427169970376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038998968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800149,0.010773711,0.00042609603,0.00014759366,0.003641471,0.0007668471,0.004005672,0.000013323141,0.00021039307],"genre_scores_gemma":[0.980672,0.0029184523,0.00023582189,0.00008124379,0.014747739,0.0003060879,0.000017481605,0.00005926438,0.0009619156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978565,0.00006266131,0.00030830974,0.00043274535,0.00043441975,0.00090539316],"domain_scores_gemma":[0.99851924,0.00005453677,0.00015455463,0.0003737865,0.0004236338,0.0004742679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006095551,0.00022160492,0.00032564087,0.00010840521,0.00015608575,0.000029674151,0.00036308597,0.0002699618,0.0007623455],"category_scores_gemma":[0.00035480573,0.00020628405,0.000201741,0.00018053077,0.00021840876,0.000021445632,0.00015849051,0.00031977016,0.000011843499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039937062,0.000094109564,0.009871875,0.00016700062,0.00015046017,6.4455485e-8,0.00038269177,0.000029635019,0.947236,0.000037832382,0.011926039,0.029704921],"study_design_scores_gemma":[0.0013692696,0.000095735144,0.16970028,0.000049603994,0.000019704077,0.0000018214776,0.00008630072,0.000006117146,0.68166554,0.000011898452,0.1467971,0.00019665237],"about_ca_topic_score_codex":0.0013219968,"about_ca_topic_score_gemma":0.0012434397,"teacher_disagreement_score":0.2655705,"about_ca_system_score_codex":0.000115326075,"about_ca_system_score_gemma":0.0020641559,"threshold_uncertainty_score":0.84120196},"labels":[],"label_agreement":null},{"id":"W2039034415","doi":"10.1158/1538-7445.am2011-560","title":"Abstract 560: The use of molecular biomarkers to quantify drug distribution in solid tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Doxorubicin; Distribution (mathematics); Melphalan; Cancer research; Monoclonal antibody; Medicine; Pathology; Antibody; Chemotherapy; Pharmacology; Immunology; Internal medicine","score_opus":0.18756626663913897,"score_gpt":0.4119885921487813,"score_spread":0.22442232550964233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039034415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956181,0.00074781757,0.00022038471,0.0017144354,0.0001154754,0.0010124447,0.00009533078,0.000021382895,0.00045460687],"genre_scores_gemma":[0.99919844,0.0001642347,0.00011865598,0.0001436928,0.000033467535,0.0001788296,0.00003336398,0.00003370136,0.0000956259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997869,0.00015678635,0.00035000738,0.0003447763,0.00073820946,0.00054119766],"domain_scores_gemma":[0.9986226,0.00010594297,0.00006293261,0.0006283069,0.0003743036,0.00020592149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001004103,0.00013004406,0.0002505247,0.0002690172,0.00006491806,0.00001972114,0.00024471694,0.000088801746,0.00024494104],"category_scores_gemma":[0.00054981274,0.000101021345,0.00009821631,0.0011701874,0.00027752068,0.00006930525,0.00012744556,0.00059957715,0.000050704624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017324504,0.00026215622,0.0051829424,0.00020554289,0.00016183322,0.00048468605,0.0021458727,0.00027048273,0.9626825,0.00053239666,0.017184367,0.009154786],"study_design_scores_gemma":[0.0011249137,0.00022286207,0.1448619,0.00087862805,0.000030525618,0.000014887709,0.00047056325,0.00013328424,0.84227276,0.000108958106,0.009702157,0.00017856933],"about_ca_topic_score_codex":0.01188835,"about_ca_topic_score_gemma":0.0008596134,"teacher_disagreement_score":0.13967897,"about_ca_system_score_codex":0.0004899929,"about_ca_system_score_gemma":0.00057621364,"threshold_uncertainty_score":0.99469155},"labels":[],"label_agreement":null},{"id":"W2039057822","doi":"10.1158/0008-5472.sabcs10-p1-09-02","title":"Abstract P1-09-02: Health Care Costs Incurred by Post-Menopausal Women with Hormone-Positive Breast Cancer Following the Initial Diagnosis of Metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Cancer; Internal medicine; Oncology; Retrospective cohort study; Cohort; Population; Metastasis; Metastatic breast cancer; Surgery","score_opus":0.030991878451271195,"score_gpt":0.41523695897847773,"score_spread":0.3842450805272065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039057822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96735394,0.016496105,0.0000095552205,0.010114904,0.000266459,0.0016323669,0.003832938,0.00005249501,0.0002412646],"genre_scores_gemma":[0.99447846,0.0011297492,0.00009943796,0.0006851809,0.00045000535,0.0028993494,0.00009358094,0.0001113017,0.000052951105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958571,0.00022880324,0.00045007587,0.00063763664,0.0015684853,0.0012578996],"domain_scores_gemma":[0.99690485,0.00046241752,0.00022735106,0.00067695795,0.0011934047,0.0005350188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092780055,0.00035804074,0.00071454444,0.00024968464,0.0004961926,0.00006569002,0.0004727093,0.00012842742,0.0006237852],"category_scores_gemma":[0.00008546927,0.00024222412,0.000078244426,0.00088758237,0.0007979986,0.00032315275,0.00016462883,0.0016123471,0.000009491063],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010518249,0.00044367547,0.010510577,0.0004373346,0.0017745727,0.00010901482,0.018287793,0.000016249232,0.2790207,0.000046294386,0.0026768548,0.67615867],"study_design_scores_gemma":[0.020743748,0.010807004,0.6330692,0.003224741,0.0005378641,0.0002692218,0.05796592,0.000007183781,0.24315134,0.000088272136,0.028454717,0.0016807807],"about_ca_topic_score_codex":0.017274914,"about_ca_topic_score_gemma":0.0041229855,"teacher_disagreement_score":0.67447793,"about_ca_system_score_codex":0.00213403,"about_ca_system_score_gemma":0.0027333766,"threshold_uncertainty_score":0.98926914},"labels":[],"label_agreement":null},{"id":"W2039162017","doi":"10.1158/1538-7445.am2012-2972","title":"Abstract 2972: Neutrophil extracellular traps sequester circulating tumor cells <i>in vitro</i> and in a murine model of metastasis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Neutrophil extracellular traps; Extracellular; Cancer cell; Molecular biology; Intravital microscopy; Chemistry; Cell biology; In vivo; Biology; Cancer research; Cancer; Inflammation; Immunology","score_opus":0.08815386897649738,"score_gpt":0.3369217873305187,"score_spread":0.24876791835402132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039162017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892251,0.009743316,0.000039608512,0.00014521074,0.00010572325,0.00040107992,0.00012244865,0.000011943473,0.00020557233],"genre_scores_gemma":[0.9989035,0.00037917198,0.00020929922,0.000055052617,0.000039319984,0.00012191149,0.000020794738,0.00003192084,0.00023904204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978659,0.000364259,0.000425916,0.0003692472,0.00011638169,0.0008583104],"domain_scores_gemma":[0.99931175,0.00016258965,0.00008660109,0.00027925672,0.00009404356,0.00006575903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407784,0.00019429118,0.0004249454,0.0004234451,0.00008252504,0.000013949839,0.00020981218,0.00013496145,0.00023240966],"category_scores_gemma":[0.000026483178,0.00017601314,0.00006290101,0.00035564424,0.00026001313,0.0002466061,0.0001432208,0.00077869947,0.000032916298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033989208,0.00018790991,0.00047017113,0.00012704275,0.00003753433,0.000032864584,0.0006739691,0.00019537064,0.995374,0.00033218303,0.000033756365,0.0021953047],"study_design_scores_gemma":[0.0012051252,0.000047752663,0.0015611879,0.00009828179,0.000011581771,0.000013025475,0.00025545672,0.00006799877,0.99583155,0.00023393144,0.0005071982,0.00016689199],"about_ca_topic_score_codex":0.0005021469,"about_ca_topic_score_gemma":0.000057447196,"teacher_disagreement_score":0.00967839,"about_ca_system_score_codex":0.0001232223,"about_ca_system_score_gemma":0.00011404042,"threshold_uncertainty_score":0.7177608},"labels":[],"label_agreement":null},{"id":"W2039208380","doi":"10.1158/1538-7445.am2013-1336","title":"Abstract 1336: A population-based study of Transforming Growth Factor-Beta1 (TGFB1) polymorphisms and risk of breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Single-nucleotide polymorphism; Breast cancer; Odds ratio; Genotyping; Genotype; Medicine; Haplotype; SNP; Oncology; Case-control study; Internal medicine; SNP genotyping; Risk factor; Confidence interval; Cancer; Population; Biology; Genetics; Gene","score_opus":0.03136745829413461,"score_gpt":0.34514277903968554,"score_spread":0.3137753207455509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039208380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972307,0.00171173,0.000017370952,0.000053205567,0.000035094217,0.00057584926,0.00034683905,0.0000067492047,0.000022466871],"genre_scores_gemma":[0.99943626,0.00016148214,0.000017424769,0.00000764747,0.00009137837,0.00020833593,0.000026481133,0.000026024945,0.00002498165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985887,0.00011915931,0.00028337698,0.0003166851,0.00040480026,0.00028729253],"domain_scores_gemma":[0.9990095,0.00006788362,0.000114021546,0.00027508763,0.00040268977,0.00013081204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022503738,0.00013007657,0.0001975435,0.00012063991,0.00010944118,0.000020782816,0.0002201832,0.00008919217,0.00033013438],"category_scores_gemma":[0.00006295371,0.000116373674,0.000057884536,0.00017195466,0.000116158786,0.0000105360305,0.000047640813,0.00015771098,0.0000011598369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011514256,0.00018719613,0.5542517,0.000108125736,0.00010273048,5.1428196e-7,0.00016064045,0.0001494034,0.44082597,0.0000019077122,0.000051274226,0.0040454403],"study_design_scores_gemma":[0.00072290783,0.00015737822,0.7473253,0.00006106889,0.000021812333,2.512121e-7,0.00019578025,0.000021943559,0.25136334,0.00001576304,0.000014549479,0.0000998961],"about_ca_topic_score_codex":0.025570825,"about_ca_topic_score_gemma":0.0016625443,"teacher_disagreement_score":0.19307363,"about_ca_system_score_codex":0.00004046049,"about_ca_system_score_gemma":0.00028460292,"threshold_uncertainty_score":0.980918},"labels":[],"label_agreement":null},{"id":"W2039297648","doi":"10.1158/1538-7445.am2014-5217","title":"Abstract 5217: The role of miR-526b in COX-2 mediated breast cancer progression via EP4 signaling","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"SKBR3; Cancer research; Breast cancer; Transfection; microRNA; Cancer; Biology; Cell growth; Cell culture; Medicine; Internal medicine; Gene; Genetics","score_opus":0.031871450494070516,"score_gpt":0.3857030348053634,"score_spread":0.35383158431129286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039297648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743161,0.019674167,0.000003991352,0.0036784445,0.000138373,0.000831664,0.000038612285,0.0000320883,0.0012865427],"genre_scores_gemma":[0.99591917,0.0024559996,0.000013773707,0.000109398905,0.0006721871,0.00043947276,0.000016592678,0.00004848363,0.0003249231],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970021,0.00037522518,0.00044763112,0.00038304785,0.0010830268,0.00070896867],"domain_scores_gemma":[0.99798214,0.00067385554,0.00013994174,0.0005303311,0.00048544363,0.00018829356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001999731,0.00019439991,0.00044790175,0.00031047896,0.00016603358,0.000032889257,0.0003607445,0.00016435253,0.0011202677],"category_scores_gemma":[0.00024126764,0.00013014658,0.00011062283,0.0007837073,0.0005085745,0.00009810857,0.00008722558,0.0008316289,0.000034660487],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054396093,0.00031488782,0.059734907,0.00043845904,0.00008691259,0.000030602507,0.0014910112,0.000088763016,0.62948453,0.000039666425,0.0015497286,0.30130094],"study_design_scores_gemma":[0.004981787,0.0005411064,0.5552771,0.0045235553,0.00007019571,0.000091646274,0.0018539587,0.0019150856,0.30450302,0.00024796926,0.12554932,0.00044522723],"about_ca_topic_score_codex":0.0089893015,"about_ca_topic_score_gemma":0.0008963479,"teacher_disagreement_score":0.4955422,"about_ca_system_score_codex":0.00036448234,"about_ca_system_score_gemma":0.0008999888,"threshold_uncertainty_score":0.9997928},"labels":[],"label_agreement":null},{"id":"W2039370099","doi":"10.1158/0008-5472.can-14-0847","title":"STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"STAT1; Endometrial cancer; Cancer research; Serous fluid; Tumor progression; Oncogene; Cancer; Biology; Gene signature; Downregulation and upregulation; Medicine; Internal medicine; Immunology; Gene; Gene expression; Interferon; Cell cycle; Genetics","score_opus":0.0911110160771737,"score_gpt":0.4587854207470959,"score_spread":0.3676744046699222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039370099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828092,0.009191564,0.000011195637,0.0019501371,0.00055751647,0.0012535509,0.00003617643,0.000062539155,0.0041281623],"genre_scores_gemma":[0.99299103,0.0022940454,0.0001494848,0.00034451115,0.001418134,0.0012264287,0.000020240192,0.000046302855,0.0015097936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99657786,0.00038204892,0.0003571794,0.0005552579,0.0012774457,0.0008502251],"domain_scores_gemma":[0.99830955,0.00054938893,0.000066070665,0.00037140585,0.00030555876,0.00039802195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011134356,0.0001994255,0.0005146657,0.0007640944,0.00014091632,0.00004594187,0.0002166805,0.000105512954,0.0018872088],"category_scores_gemma":[0.0008338085,0.00014426382,0.00010257515,0.0023315852,0.000204277,0.00010755573,0.00015558649,0.0006735,0.00008350821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008848833,0.00089284166,0.37417987,0.0006721675,0.00020577153,0.00037949823,0.00070881925,0.000031148134,0.05145047,0.0002626133,0.0037144972,0.5586535],"study_design_scores_gemma":[0.07990306,0.008877082,0.36883038,0.004618956,0.0002255639,0.00005264118,0.000674076,0.00035668944,0.22501966,0.0028555181,0.30736092,0.0012254217],"about_ca_topic_score_codex":0.003088928,"about_ca_topic_score_gemma":0.00075632555,"teacher_disagreement_score":0.55742806,"about_ca_system_score_codex":0.0011107175,"about_ca_system_score_gemma":0.0008222019,"threshold_uncertainty_score":0.9990252},"labels":[],"label_agreement":null},{"id":"W2039643947","doi":"10.1158/1538-7445.am2013-824","title":"Abstract 824: Regulation of PAR-4 activity in chemoresistant ovarian cancer cells: A major role for the cleaved fragment in the control of apoptosis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Cisplatin; Apoptosis; Ovarian cancer; Cancer research; In vivo; Cancer cell; Chemistry; In vitro; Cancer; Prostate cancer; Cell culture; Molecular biology; Biology; Chemotherapy; Medicine; Internal medicine; Biochemistry; Genetics","score_opus":0.032790366644780876,"score_gpt":0.3383811690952405,"score_spread":0.30559080245045966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039643947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599504,0.0013360102,0.00012205539,0.0010488222,0.000042812742,0.0012876688,0.00009229692,0.0000015683381,0.000073746894],"genre_scores_gemma":[0.9977218,0.00013054481,0.000029157822,0.000061212435,0.00009671715,0.0019065742,0.00000773309,0.000013840271,0.000032424156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880093,0.00016617695,0.00021952615,0.00022872313,0.00030794754,0.00027670304],"domain_scores_gemma":[0.9990308,0.00020930805,0.00010034649,0.00041107336,0.00021206489,0.000036390367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011357317,0.00008769252,0.00014345109,0.00004671047,0.0000543245,0.000017262442,0.0003644792,0.00009163248,0.00008543194],"category_scores_gemma":[0.00013558162,0.000057698002,0.00006996087,0.00017294419,0.00017140822,0.0000054745983,0.000050402523,0.00015617146,8.191654e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074535236,0.00012813501,0.002165362,0.000098352444,0.000038119208,1.6371705e-7,0.00022757176,0.00071617775,0.99174213,0.00003072144,0.0007993381,0.003308543],"study_design_scores_gemma":[0.0010971072,0.00006021611,0.103693664,0.000052304364,0.00000962185,4.640428e-8,0.0002527691,0.00046183856,0.89377236,0.0002354509,0.00030685778,0.000057790665],"about_ca_topic_score_codex":0.004715617,"about_ca_topic_score_gemma":0.0008812129,"teacher_disagreement_score":0.1015283,"about_ca_system_score_codex":0.000072628405,"about_ca_system_score_gemma":0.00027914037,"threshold_uncertainty_score":0.7128634},"labels":[],"label_agreement":null},{"id":"W2039915506","doi":"10.1158/0008-5472.can-09-2905","title":"Surface Charge: A Key Determinant of Protein Localization and Function","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Charge (physics); Surface charge; Cell biology; Surface (topology); Surface protein; Function (biology); Cancer; Key (lock); Molecule; Biophysics; Chemistry; Biology; Chemical physics; Nanotechnology; Materials science; Physics; Genetics; Ecology; Mathematics","score_opus":0.09555372226987734,"score_gpt":0.4338909916840481,"score_spread":0.33833726941417075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039915506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033089367,0.99463123,0.00015939049,0.000023790344,0.000016526297,0.00072988815,0.000105636595,0.000047613103,0.0039550452],"genre_scores_gemma":[0.0006113026,0.9937199,0.00014549895,0.0000012852756,0.00012738645,0.0012251515,0.0000684558,0.000046069326,0.004054965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998621,0.000050622522,0.00032106636,0.00038169837,0.00035337344,0.00027224113],"domain_scores_gemma":[0.9989609,0.00006484163,0.00018036187,0.0004935791,0.0002148329,0.00008549613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042762054,0.0001715502,0.0005240034,0.00013302673,0.00011759259,0.000037258815,0.0002574383,0.00039279708,0.003108782],"category_scores_gemma":[0.000053159656,0.00014255219,0.00008852228,0.00052982895,0.00015573505,0.00003543333,0.00013215875,0.00088589784,0.000012559051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007197673,0.000039901217,0.000008963595,0.02599929,0.000022022872,0.0000010899224,0.000012430293,7.0432556e-8,0.010483495,0.0030106618,0.0003810449,0.96003383],"study_design_scores_gemma":[0.0000505437,0.000024388073,2.9145897e-7,0.004287895,0.00004661851,0.0000035489043,0.0000035107278,0.000023516734,0.012370785,0.00029151668,0.9827682,0.00012918023],"about_ca_topic_score_codex":0.00019875438,"about_ca_topic_score_gemma":0.000024353829,"teacher_disagreement_score":0.9823872,"about_ca_system_score_codex":0.00014196424,"about_ca_system_score_gemma":0.00031877484,"threshold_uncertainty_score":0.9978025},"labels":[],"label_agreement":null},{"id":"W2039937945","doi":"10.1158/0008-5472.sabcs12-p6-11-06","title":"Abstract P6-11-06: A phase Ib study of LCL161, an oral inhibitor of apoptosis (IAP) antagonist, in combination with weekly paclitaxel in patients with advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Paclitaxel; Pharmacokinetics; Pharmacology; Inhibitor of apoptosis; Pharmacodynamics; Cancer; Febrile neutropenia; Internal medicine; Cytokine release syndrome; Nausea; Oncology; Gastroenterology; Chemotherapy; Apoptosis; Immunotherapy","score_opus":0.028641782163421687,"score_gpt":0.3668788085511367,"score_spread":0.338237026387715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039937945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989378,0.000106493746,0.000024686111,0.000017063861,0.00003204881,0.000831312,0.000025814534,0.000002719226,0.000022076623],"genre_scores_gemma":[0.99952406,0.000029962523,0.00009237322,0.00000376214,0.0000365045,0.00011159449,0.00013943786,0.000022090677,0.00004021857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.00011902295,0.00028326057,0.00026376534,0.00042595802,0.00032824543],"domain_scores_gemma":[0.9992225,0.000010898719,0.0001234926,0.00025990576,0.00029576776,0.00008744261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025885,0.00011954358,0.0002156106,0.00018757721,0.00004352602,0.000009816379,0.00011931721,0.00007862562,0.000013704693],"category_scores_gemma":[0.000019684052,0.00009367727,0.000018947567,0.00032456545,0.00009360514,0.000030308423,0.000051128627,0.00013158261,3.485284e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031533446,0.007762866,0.32387507,0.00011540313,0.000032223237,0.0000015686056,0.0012177625,0.0004924532,0.6568103,0.000025088066,0.000037043625,0.006476909],"study_design_scores_gemma":[0.011650165,0.0071829376,0.5610658,0.00012849926,0.000009031809,2.9287813e-7,0.0013672018,0.00004719224,0.41829956,0.000013231981,0.00006747147,0.00016863499],"about_ca_topic_score_codex":0.0007613715,"about_ca_topic_score_gemma":0.0014316773,"teacher_disagreement_score":0.2385107,"about_ca_system_score_codex":0.00007003439,"about_ca_system_score_gemma":0.000116584706,"threshold_uncertainty_score":0.38200483},"labels":[],"label_agreement":null},{"id":"W2040006430","doi":"10.1158/0008-5472.can-04-3478","title":"The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Universität Basel","keywords":"CD44; P-glycoprotein; Glycoprotein; Phenotype; Cancer cell; Cancer; Biology; Cancer research; Multiple drug resistance; Colocalization; Receptor; Cell; Immunology; Cell biology; Drug resistance; Molecular biology; Gene; Genetics","score_opus":0.03478895370094683,"score_gpt":0.3651162845761239,"score_spread":0.33032733087517707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040006430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879365,0.0019025728,0.000031833482,0.008451839,0.000031831245,0.0011012675,0.000010285785,0.0000057403636,0.00052815216],"genre_scores_gemma":[0.9899255,0.0022157575,0.00032409487,0.00015615056,0.00024292491,0.0010466138,0.000015450581,0.000023564404,0.006049942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983916,0.00017084756,0.00015746758,0.00040112733,0.00042851013,0.0004504062],"domain_scores_gemma":[0.99917775,0.000027112434,0.00002959176,0.00030273997,0.0002992522,0.00016356054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080581754,0.000109049266,0.00008849697,0.00012711046,0.00022318136,0.000115198636,0.00023078997,0.000088509536,0.00012140313],"category_scores_gemma":[0.00013571393,0.00007509108,0.000017160553,0.00039276865,0.00011387184,0.00001341339,0.00018233506,0.0003196266,0.000038712882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411369,0.000044794324,0.0015864294,0.000027048718,0.0000074868344,0.0000017883243,0.0002840119,0.00016522282,0.9080232,0.000014925844,0.0054809013,0.08362306],"study_design_scores_gemma":[0.00047071624,0.0003332594,0.0012566034,0.00007218582,7.6174126e-7,0.0000012267353,0.0001048902,0.000086612614,0.68300307,0.000008231021,0.3145721,0.0000903363],"about_ca_topic_score_codex":0.0018174377,"about_ca_topic_score_gemma":0.045053825,"teacher_disagreement_score":0.3090912,"about_ca_system_score_codex":0.00013449926,"about_ca_system_score_gemma":0.00031618524,"threshold_uncertainty_score":0.97237146},"labels":[],"label_agreement":null},{"id":"W2040023167","doi":"10.1158/1538-7445.am2014-2382","title":"Abstract 2382: Synthetic lethal killing of RAD54B-deficient colorectal cancer cells by targeting SOD1","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Synthetic lethality; SOD1; Cancer cell; Gene silencing; Cancer; RNA interference; Biology; Cancer research; Homologous recombination; Gene; Genetics; DNA repair; Mutant; RNA","score_opus":0.020754931725703755,"score_gpt":0.35804621517467927,"score_spread":0.3372912834489755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040023167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225545,0.00289614,0.0029528656,0.00032900702,0.00007979674,0.00031184903,0.000104420404,0.000016265352,0.0010542029],"genre_scores_gemma":[0.9971981,0.0015187693,0.00041567817,0.000060386945,0.00016030969,0.00034103487,0.00007751362,0.000030469762,0.00019775922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985142,0.00012329646,0.00023615616,0.00044781467,0.00023982003,0.00043873957],"domain_scores_gemma":[0.99924356,0.000046574056,0.00008881908,0.00029779947,0.00022518032,0.000098067765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007743571,0.00013161679,0.00016469853,0.000055617857,0.00015778124,0.000016918073,0.00034912615,0.00019667923,0.00013832266],"category_scores_gemma":[0.000067577035,0.00012201015,0.000085464286,0.00015941536,0.00030705926,0.0000020979194,0.00016025959,0.0002631219,0.000007748734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036049252,0.000053621094,0.0002601573,0.000037227663,0.000022244767,4.927422e-7,0.000024239152,0.00012816589,0.98628926,0.0001296761,0.009036388,0.0039824955],"study_design_scores_gemma":[0.00013908304,0.00011766276,0.00009379666,0.000033756955,0.0000059545496,0.0000010461529,0.000034506378,0.00012932988,0.9319795,0.000052697895,0.0672843,0.00012839658],"about_ca_topic_score_codex":0.0004519555,"about_ca_topic_score_gemma":0.000022501683,"teacher_disagreement_score":0.058247913,"about_ca_system_score_codex":0.000044685206,"about_ca_system_score_gemma":0.00012640408,"threshold_uncertainty_score":0.49754295},"labels":[],"label_agreement":null},{"id":"W2040030637","doi":"10.1158/1538-7445.am10-5172","title":"Abstract 5172: Role of CEACAM1 on cancer cell endothelial adhesion and liver metastasis in vivo","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Cancer; Cancer research; Pathology; Population; Cell adhesion molecule; Antibody; Cancer cell; Biology; Chemistry; Immunology; Medicine","score_opus":0.07980251311140757,"score_gpt":0.4371734595097214,"score_spread":0.35737094639831385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040030637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865082,0.0017562307,2.3939134e-7,0.0005954895,0.000025660294,0.00027560568,0.00010813302,0.0000078987305,0.010722526],"genre_scores_gemma":[0.9960723,0.0027135657,0.00004981691,0.00005357665,0.00020228211,0.00018141614,0.0000021813892,0.000012787466,0.00071206485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903876,0.00002167707,0.00014335621,0.00022869364,0.00032340302,0.00024411641],"domain_scores_gemma":[0.99932575,0.00016522947,0.000026204942,0.00020745127,0.000097953016,0.00017740158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031764252,0.00007669333,0.00015320722,0.000056517893,0.00005058977,0.0000083185605,0.00009802767,0.00008325287,0.0032963138],"category_scores_gemma":[0.000048210855,0.00006384572,0.00003236942,0.00017230764,0.0001780179,0.000039073497,0.000033859582,0.00065092073,0.000011625803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026425,0.00016277973,0.0017423271,0.00017760968,0.000010061672,0.000007812746,0.00011658446,0.0000027015674,0.9845014,0.00013524402,0.000510767,0.012368416],"study_design_scores_gemma":[0.0007227003,0.00004417908,0.006193983,0.00006934304,0.000014690416,0.0000020381271,0.000094929565,0.000062000276,0.9684949,0.00006512685,0.02418194,0.000054153865],"about_ca_topic_score_codex":0.0017164282,"about_ca_topic_score_gemma":0.00022859109,"teacher_disagreement_score":0.023671173,"about_ca_system_score_codex":0.00007917854,"about_ca_system_score_gemma":0.0001646451,"threshold_uncertainty_score":0.9976148},"labels":[],"label_agreement":null},{"id":"W2040201361","doi":"10.1158/1538-7445.am2012-4423","title":"Abstract 4423: Transgenic liver expression of human arylamine <i>N</i>-acetyltransferase NAT2 restores sensitivity of male Nat1/2 null mice to 4-aminobiphenyl-induced liver tumorigenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biopolymer Synthesis and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genetically modified mouse; Carcinogen; Carcinogenesis; Endocrinology; Internal medicine; Ratón; Liver tumor; Biology; Transgene; Medicine; Cancer; Hepatocellular carcinoma; Genetics; Gene","score_opus":0.06686798213280928,"score_gpt":0.36003122876303223,"score_spread":0.293163246630223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040201361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940739,0.0044824313,0.000115479445,0.00011568253,0.000059879003,0.00043342347,0.00019821583,0.000007634732,0.00051335583],"genre_scores_gemma":[0.99798363,0.00086994533,0.00015408405,0.000035063524,0.00031344232,0.00015898011,0.000036547528,0.000037048558,0.00041127094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981578,0.00021487976,0.0003176372,0.0004036998,0.0004102733,0.0004956841],"domain_scores_gemma":[0.99876434,0.00008973184,0.000072262315,0.0005465681,0.00029449613,0.00023261613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086257444,0.00018045053,0.0002581059,0.00012031618,0.00015888568,0.000010156574,0.00028132627,0.00018667057,0.00026395853],"category_scores_gemma":[0.000045757468,0.00017043992,0.0001366712,0.00025897397,0.0001992058,0.000014012747,0.00009882853,0.00019675378,0.000011947261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017677013,0.00032112727,0.00096960657,0.00020114965,0.00003367976,0.0000024566757,0.00033942235,0.0000033776146,0.99404395,0.000030875708,0.0011663036,0.002711298],"study_design_scores_gemma":[0.00025192948,0.00015296311,0.016593596,0.000089279754,0.000015791811,0.0000045123575,0.00016446614,0.0000021001435,0.9798512,0.0000018993309,0.0026916675,0.0001805945],"about_ca_topic_score_codex":0.0015354316,"about_ca_topic_score_gemma":0.00057622103,"teacher_disagreement_score":0.015623989,"about_ca_system_score_codex":0.000039843333,"about_ca_system_score_gemma":0.00012566149,"threshold_uncertainty_score":0.6950338},"labels":[],"label_agreement":null},{"id":"W2040268937","doi":"10.1158/1538-7445.am2013-5139","title":"Abstract 5139: Molecular docking exploration of potential RET tyrosine kinase inhibitors at non ATP-binding sites.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Receptor tyrosine kinase; Proto-Oncogene Proteins c-ret; Glial cell line-derived neurotrophic factor; Biology; Tyrosine kinase; Protein kinase domain; ROR1; Cancer research; Cell biology; Platelet-derived growth factor receptor; Biochemistry; Signal transduction; Receptor; Neurotrophic factors","score_opus":0.05344253080158533,"score_gpt":0.3573007710933084,"score_spread":0.30385824029172304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040268937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962873,0.0017278019,0.00034115426,0.0005539704,0.000119236625,0.00037645525,0.000024761153,0.0000071455866,0.00056218205],"genre_scores_gemma":[0.99772877,0.0007551884,0.000078893514,0.00003369173,0.00029356143,0.00027100855,0.00015946402,0.000029835506,0.0006495672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986272,0.00005249702,0.00024018968,0.00036137228,0.0003779674,0.0003407635],"domain_scores_gemma":[0.99893993,0.000008523136,0.00009143926,0.00040560032,0.00045095308,0.00010356814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003096511,0.000115694915,0.00011856923,0.000115420255,0.00017152292,0.000055700864,0.0002061532,0.00013327708,0.00034726362],"category_scores_gemma":[0.000047439535,0.00011244907,0.00007533753,0.0002404196,0.0001366563,0.000028295199,0.0001653664,0.00016329363,0.00005017777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004839018,0.00003422375,0.00050331507,0.000043601412,0.000022594666,0.0000032252988,0.00008781681,0.001032834,0.98877436,0.000019895475,0.005555196,0.0038745576],"study_design_scores_gemma":[0.00032604072,0.00008951593,0.0024443336,0.000051224553,0.0000061153446,0.0000011559134,0.00012798552,0.0001577051,0.9920919,0.000048473696,0.004527336,0.00012824128],"about_ca_topic_score_codex":0.00044893063,"about_ca_topic_score_gemma":0.000039377708,"teacher_disagreement_score":0.0037463163,"about_ca_system_score_codex":0.00012239911,"about_ca_system_score_gemma":0.00013106814,"threshold_uncertainty_score":0.45855397},"labels":[],"label_agreement":null},{"id":"W2040308430","doi":"10.1158/1538-7445.tim2013-c35","title":"Abstract C35: The development of metastatic mouse models of neuroblastoma to bone and brain to identify the molecular mechanisms governing metastasis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Bioluminescence imaging; Neuroblastoma; Metastasis; Luciferase; Pathology; In vivo; Medicine; Bone marrow; Cancer research; Ex vivo; Bone metastasis; Primary tumor; Lymph; Cancer; Biology; Cell culture; Internal medicine; Transfection","score_opus":0.09531272218779972,"score_gpt":0.41457733020472926,"score_spread":0.3192646080169295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040308430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890811,0.00030229718,0.0019406361,0.0063799247,0.000018740304,0.0020108575,0.000042585638,0.00001155024,0.00021233782],"genre_scores_gemma":[0.9952383,0.00003873494,0.0030226528,0.00037101243,0.000009674978,0.00071128464,0.0000030696413,0.000039952098,0.00056532427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686086,0.00025428378,0.00041146445,0.00036076942,0.0015404786,0.0005721669],"domain_scores_gemma":[0.9979969,0.0005067488,0.000080148624,0.00053376134,0.0005075307,0.00037488109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013676857,0.0001670455,0.000343958,0.00028314834,0.00018446131,0.00006131588,0.00030655423,0.000026826083,0.00021317118],"category_scores_gemma":[0.0004798864,0.000095952026,0.0000749281,0.0006908862,0.0001576341,0.00011627041,0.00043319946,0.00035628577,0.0000790689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024580027,0.00015634621,0.000015701475,0.00020935721,0.0002868584,0.000045648714,0.0013098716,0.0003010828,0.98128647,0.00050283544,0.0013571297,0.014282917],"study_design_scores_gemma":[0.000992985,0.0006727999,0.009622723,0.00020139272,0.00005041259,0.000017822704,0.0010016501,0.0002476494,0.98556244,0.0009165907,0.000598096,0.00011541679],"about_ca_topic_score_codex":0.00077862677,"about_ca_topic_score_gemma":0.00017215694,"teacher_disagreement_score":0.014167501,"about_ca_system_score_codex":0.00012040825,"about_ca_system_score_gemma":0.00039783507,"threshold_uncertainty_score":0.391281},"labels":[],"label_agreement":null},{"id":"W2040449973","doi":"10.1158/1538-7445.am10-1422","title":"Abstract 1422: Cancer-associated fibroblasts influence the sensitivity of pancreatic cancer cells to gemcitabine in pancreatic ductal adenocarcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Cancer research; Cancer; Cancer-Associated Fibroblasts; Medicine; CA19-9; Oncology; Adenocarcinoma; Internal medicine; Cancer cell","score_opus":0.04661437395910609,"score_gpt":0.3964613281799427,"score_spread":0.34984695422083656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040449973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046576,0.0014436702,0.000003405961,0.0046355734,0.00022692817,0.0021466657,0.00019389024,0.000037216763,0.00084691716],"genre_scores_gemma":[0.9950658,0.0014654472,0.000093740586,0.00025371104,0.00035611523,0.0012814822,0.000011866473,0.000061039995,0.0014108099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948596,0.00066135766,0.00072385086,0.00073206396,0.0015648509,0.0014582895],"domain_scores_gemma":[0.9946743,0.0024046125,0.00018267416,0.00090999383,0.001270818,0.00055755913],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042481786,0.0003376508,0.001118284,0.00054498843,0.0002719398,0.000044126995,0.00048012377,0.0003377472,0.0012878908],"category_scores_gemma":[0.0023500426,0.00024724595,0.0001377568,0.0019294777,0.0010409261,0.0001554419,0.00030424012,0.0023256002,0.00007532478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056870887,0.00019741505,0.5409183,0.0002862138,0.00016564137,0.00015374323,0.0008488825,0.00012725654,0.45492232,0.000036722024,0.0011349346,0.00063990045],"study_design_scores_gemma":[0.0016836947,0.0003368327,0.9480312,0.0011086663,0.00013913085,0.0000211095,0.00034933764,0.0005877779,0.04721137,0.00007872425,0.0002284865,0.00022366375],"about_ca_topic_score_codex":0.1099027,"about_ca_topic_score_gemma":0.05741037,"teacher_disagreement_score":0.40771094,"about_ca_system_score_codex":0.00093783677,"about_ca_system_score_gemma":0.0037170558,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W2040639376","doi":"10.1158/1538-7445.am10-4826","title":"Abstract 4826: International Lung Cancer Consortium: Pooled analysis of previous lung diseases and lung cancer risk","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Chronic bronchitis; Internal medicine; Lung cancer; Relative risk; Population; Odds ratio; Confidence interval; Cancer; Cohort; Bronchitis; Environmental health","score_opus":0.02951456155646122,"score_gpt":0.43713899757708485,"score_spread":0.40762443602062365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040639376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963908,0.031044899,0.0000074998497,0.0016622281,0.00042629527,0.0008516028,0.0010753206,0.000033449112,0.0009907047],"genre_scores_gemma":[0.9620404,0.033944163,0.000022243745,0.000072133436,0.0006442583,0.00056658033,0.00007532757,0.000042211574,0.0025926707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640757,0.00013588213,0.00048276724,0.0006572175,0.0015812825,0.0007352699],"domain_scores_gemma":[0.9969812,0.0004178254,0.00016288817,0.00056984415,0.0013417868,0.00052645383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092454377,0.0002269166,0.0006263821,0.0011408549,0.00022384683,0.00010043778,0.00040162666,0.00018229595,0.0077554113],"category_scores_gemma":[0.0004517257,0.00018610177,0.00022691205,0.0015270584,0.0005997026,0.00020672532,0.00025653068,0.0013677115,0.0000050919857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065668684,0.00019655468,0.8981664,0.00060225633,0.006749063,0.00006254152,0.0003923622,0.00009373646,0.06698953,0.000031960844,0.010324377,0.015734486],"study_design_scores_gemma":[0.0016580119,0.000060615395,0.9652419,0.00035406012,0.003412832,0.000003260729,0.0001117075,0.019769238,0.0061485306,0.000012523897,0.003000731,0.00022659295],"about_ca_topic_score_codex":0.022404954,"about_ca_topic_score_gemma":0.0065044407,"teacher_disagreement_score":0.06707545,"about_ca_system_score_codex":0.00044789456,"about_ca_system_score_gemma":0.0012892677,"threshold_uncertainty_score":0.9931516},"labels":[],"label_agreement":null},{"id":"W2040648628","doi":"10.1158/0008-5472.can-07-5698","title":"Role of PELP1/MNAR Signaling in Ovarian Tumorigenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Ovarian cancer; Biology; Carcinogenesis; Cancer research; Protein kinase B; Ovarian tumor; Proto-oncogene tyrosine-protein kinase Src; Internal medicine; Endocrinology; Signal transduction; Cancer; Cell biology; Medicine; Genetics","score_opus":0.03124680866525708,"score_gpt":0.34068473602091537,"score_spread":0.3094379273556583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040648628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986626,0.00824996,0.0000071660284,0.00005190476,0.00003421789,0.00015012325,0.000005243888,0.0000032901153,0.0016318519],"genre_scores_gemma":[0.99767363,0.0015146214,0.0000727575,0.000011748057,0.00013844695,0.000046512705,0.00001116238,0.000016910697,0.0005142077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989886,0.00013683032,0.00013887281,0.0002244194,0.00022022547,0.0002910331],"domain_scores_gemma":[0.99956137,0.000020416028,0.00002502542,0.00020537004,0.00011482743,0.00007299013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003731598,0.0000728203,0.0001131078,0.00010848861,0.00007757535,0.000004164123,0.00017783945,0.00012778271,0.000044094173],"category_scores_gemma":[0.00005137241,0.00006695953,0.000050072646,0.0002816944,0.000141327,0.00000223661,0.00008040324,0.00020086742,0.000011229689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012313377,0.00004467968,0.010011447,0.000016168959,0.000022257163,0.000019865165,0.00013024334,0.00017663921,0.988559,0.000055095137,0.00034026685,0.0005011981],"study_design_scores_gemma":[0.00035659084,0.00016727282,0.0043075862,0.000027718132,0.0000024076603,0.000011302883,0.00010954875,0.000019014795,0.99308777,0.000065927605,0.0017680445,0.00007682305],"about_ca_topic_score_codex":0.0004295476,"about_ca_topic_score_gemma":0.00002600735,"teacher_disagreement_score":0.0078073903,"about_ca_system_score_codex":0.00003093337,"about_ca_system_score_gemma":0.00026395152,"threshold_uncertainty_score":0.27305305},"labels":[],"label_agreement":null},{"id":"W2040672289","doi":"10.1158/1538-7445.am2014-2094","title":"Abstract 2094: Regulation of site-specific liver metastasis by collagen IV-conveyed signals","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Amphiregulin; Metastasis; Cancer research; Transcriptome; Blot; Small hairpin RNA; Pathology; Type IV collagen; Lung; Biology; Chemokine; Carcinoma; Gene expression; Medicine; Cancer; Gene; Immunology; Internal medicine; Extracellular matrix; RNA; Inflammation; Cell biology","score_opus":0.04939598835974908,"score_gpt":0.3421669516647732,"score_spread":0.2927709633050241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040672289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716407,0.02465084,0.00030382615,0.00015976689,0.00037185405,0.00037814357,0.00022294337,0.000009752628,0.0022621634],"genre_scores_gemma":[0.9852402,0.009308601,0.00009873288,0.00006622553,0.0012272358,0.00009001506,0.00016497364,0.0000327119,0.0037712674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982356,0.0002071881,0.00025983845,0.00042959346,0.00046834457,0.0003994253],"domain_scores_gemma":[0.99874234,0.00006105407,0.00009681536,0.00048154878,0.00047533814,0.00014290401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010782361,0.00013885756,0.0002345008,0.00010196579,0.000112410686,0.00003541777,0.00026274013,0.00015851358,0.0010651354],"category_scores_gemma":[0.000101975726,0.00013462946,0.00010723675,0.00023938414,0.00021356107,0.0000071087347,0.000102441394,0.000120624325,0.000046557947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016721325,0.00003521203,0.00007015733,0.000043468925,0.000042700212,2.2659626e-7,0.000058332265,0.000044048185,0.8189715,0.00005052939,0.15686747,0.0236491],"study_design_scores_gemma":[0.000384443,0.00006492528,0.0022535385,0.0000126172135,0.000009340776,5.756816e-7,0.000019867688,0.000012416643,0.5465826,0.000035523746,0.45053187,0.000092291135],"about_ca_topic_score_codex":0.00041655733,"about_ca_topic_score_gemma":0.00014589437,"teacher_disagreement_score":0.29366437,"about_ca_system_score_codex":0.00004224049,"about_ca_system_score_gemma":0.00016821404,"threshold_uncertainty_score":0.999848},"labels":[],"label_agreement":null},{"id":"W2040757096","doi":"10.1158/0008-5472.sabcs-09-13","title":"Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA17 Trial.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Hazard ratio; Randomization; Internal medicine; Aromatase inhibitor; Gynecology; Oncology; Proportional hazards model; Anastrozole; Cancer; Mastectomy; Randomized controlled trial; Confidence interval","score_opus":0.02902427794691775,"score_gpt":0.3749096226068227,"score_spread":0.34588534465990495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040757096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429965,0.0036405849,4.082117e-7,0.000779915,0.000060497583,0.0006584603,0.00013804337,0.0000029718465,0.00041948448],"genre_scores_gemma":[0.9938101,0.0040841983,0.0000029503767,0.00006264271,0.0000967145,0.00040321657,0.00000805724,0.000013966429,0.0015181198],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998243,0.00030991138,0.00024788422,0.00026505542,0.00043824082,0.0004959265],"domain_scores_gemma":[0.999239,0.000069069756,0.00008193343,0.0003921049,0.00013241272,0.000085438995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009878118,0.00012293736,0.00025962482,0.000090352776,0.00006487941,0.0000137672305,0.00040148947,0.00016232228,0.0001579816],"category_scores_gemma":[0.00005886711,0.00008206061,0.000069012225,0.00026134786,0.00016577088,0.000005509677,0.00010704274,0.00026738158,0.0000028993534],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01791286,0.00056590117,0.30842468,0.00015305598,0.0003084158,0.00002173979,0.001976924,0.00012764573,0.6551779,0.00013761522,0.0042649433,0.010928326],"study_design_scores_gemma":[0.012061584,0.003786631,0.5455591,0.0001436323,0.00002537346,0.0000031370146,0.0003942622,0.000006017019,0.43345952,0.000062579566,0.0042527053,0.00024544337],"about_ca_topic_score_codex":0.0011165519,"about_ca_topic_score_gemma":0.00021966959,"teacher_disagreement_score":0.23713443,"about_ca_system_score_codex":0.00017651841,"about_ca_system_score_gemma":0.00025077464,"threshold_uncertainty_score":0.33463344},"labels":[],"label_agreement":null},{"id":"W2040876482","doi":"10.1158/1538-7445.am2011-2756","title":"Abstract 2756: Heavy smoking in Northeastern Ontario women is associated with polymorphisms in nicotinic acetylcholine receptor genes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Odds ratio; Medicine; Nicotine; Internal medicine; Genotyping; Population; Genotype; Breast cancer; Logistic regression; Confidence interval; Oncology; Genetics; Cancer; Gene; Environmental health; Biology","score_opus":0.06355722704469655,"score_gpt":0.3226601533987036,"score_spread":0.259102926354007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040876482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643433,0.0024174652,0.0000022548293,0.00012363336,0.000079290316,0.00029083152,0.00006400029,0.0000072649723,0.00058089895],"genre_scores_gemma":[0.9971527,0.0008334847,0.000031972802,0.00018010229,0.0001481401,0.00021874928,0.00008656368,0.000035080564,0.001313193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813867,0.00011114263,0.0002601294,0.0004828164,0.00032364362,0.0006835783],"domain_scores_gemma":[0.99917823,0.000015666867,0.000059196824,0.0003521325,0.00018712663,0.00020762206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005728323,0.00015868722,0.00018913389,0.00017419744,0.00006939122,0.000028035216,0.00027710182,0.00016885932,0.00086646335],"category_scores_gemma":[0.00004780941,0.0001537447,0.000043301992,0.00026820553,0.00014828675,0.000008730705,0.000106354695,0.00031544382,0.000011900603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015603175,0.00054412585,0.9063439,0.00003097474,0.00006653526,0.00002139858,0.0027271258,0.000015189196,0.086300656,0.000003184099,0.0006170633,0.0017695396],"study_design_scores_gemma":[0.003999264,0.00056357373,0.7915974,0.00025387475,0.000007717195,0.0000023691498,0.0006504803,0.0000039712368,0.19662097,0.00014365747,0.0057406705,0.00041602238],"about_ca_topic_score_codex":0.019241402,"about_ca_topic_score_gemma":0.20569432,"teacher_disagreement_score":0.18645293,"about_ca_system_score_codex":0.00042175374,"about_ca_system_score_gemma":0.0007870175,"threshold_uncertainty_score":0.98728955},"labels":[],"label_agreement":null},{"id":"W2040905618","doi":"10.1158/1538-7445.tim2013-ia29","title":"Abstract IA29: Models of postsurgical early and late stage metastasis for improving preclinical adjuvant and metastatic therapy investigations","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Cancer; Primary tumor; Metastatic breast cancer; Metastasis; Melanoma; Oncology; In vivo; Breast cancer; Disease; Clinical trial; Adjuvant therapy; Pathology; Internal medicine; Cancer research","score_opus":0.16609173357174653,"score_gpt":0.442236077101436,"score_spread":0.2761443435296894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040905618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049383,0.0076022493,0.00012750708,0.00037881813,0.0000143699845,0.000998147,0.00029899302,0.0000042709876,0.00008181257],"genre_scores_gemma":[0.99429953,0.0036107185,0.0008424312,0.000030892694,0.00003834664,0.00073132303,0.000042746015,0.00002114922,0.0003828346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986973,0.00010368158,0.00021482033,0.00036194402,0.0002580422,0.00036421156],"domain_scores_gemma":[0.9990207,0.00014743354,0.0000530156,0.0002241427,0.00030950803,0.00024521552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005491352,0.00011110501,0.00019372659,0.00007712122,0.00011732963,0.00006972525,0.0001205257,0.000062371524,0.000059831415],"category_scores_gemma":[0.00013154955,0.000087454624,0.00005840934,0.000096042,0.00036847254,0.000023897182,0.00012394677,0.00015078916,0.0000015647161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074582023,0.00018393807,0.0042209714,0.00028622724,0.00048135725,0.0000044813014,0.00023374485,0.00010826674,0.8845426,0.00033530884,0.00034344458,0.10851385],"study_design_scores_gemma":[0.015277225,0.006638887,0.118506625,0.00018643927,0.00012557923,0.000009348134,0.0004972171,0.0050140987,0.8301097,0.01435417,0.008411312,0.0008693867],"about_ca_topic_score_codex":0.0040497785,"about_ca_topic_score_gemma":0.00028175066,"teacher_disagreement_score":0.114285655,"about_ca_system_score_codex":0.000021284965,"about_ca_system_score_gemma":0.00025956662,"threshold_uncertainty_score":0.61220807},"labels":[],"label_agreement":null},{"id":"W2040912576","doi":"10.1158/0008-5472.can-07-1161","title":"Functional Interplay of p53 and Mus81 in DNA Damage Responses and Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University; University Health Network; University of Toronto","funders":"National Cancer Institute; National Medical Research Council; Medical Research Council; National University of Singapore","keywords":"Biology; DNA damage; Genome instability; Chromosome instability; Cancer research; DNA repair; Phenotype; Mutation; Cell biology; Genetics; DNA; Gene","score_opus":0.07362644822441834,"score_gpt":0.43373576561023164,"score_spread":0.3601093173858133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040912576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878011,0.009377456,0.00006401729,0.00095971307,0.00013196503,0.0003510286,0.000033045224,0.000012071938,0.0012696328],"genre_scores_gemma":[0.99637866,0.0017413737,0.000057879115,0.00012312815,0.00012916485,0.000064571745,0.0000051392885,0.000023315253,0.0014767944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852204,0.00009501013,0.0002275057,0.00030604593,0.00047902658,0.00037034825],"domain_scores_gemma":[0.99908483,0.00026702153,0.000035082925,0.00020798754,0.00023151528,0.0001735588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013483766,0.00009714083,0.00021354646,0.00053618697,0.00005192752,0.0000120753075,0.00005952073,0.000109742185,0.00046769535],"category_scores_gemma":[0.00029423763,0.00009000106,0.000026296719,0.00052186934,0.00041024087,0.000054962864,0.000115857496,0.0005389197,0.000003411692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00544115,0.00008106381,0.050067738,0.00029288774,0.0000715393,0.00021454341,0.001145028,0.000010667112,0.90153885,0.00024486487,0.004203678,0.036687996],"study_design_scores_gemma":[0.004293836,0.00054681354,0.6569219,0.0011245239,0.000032425265,0.00006686893,0.0007695913,0.000094839634,0.31485415,0.00014693209,0.020962909,0.00018519176],"about_ca_topic_score_codex":0.002175317,"about_ca_topic_score_gemma":0.0036000726,"teacher_disagreement_score":0.6068542,"about_ca_system_score_codex":0.0003397275,"about_ca_system_score_gemma":0.0005460285,"threshold_uncertainty_score":0.5120936},"labels":[],"label_agreement":null},{"id":"W2041133690","doi":"10.1158/1538-7445.tim2013-b91","title":"Abstract B91: A novel role for the secreted growth factor progranulin in angiogenesis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Angiogenesis; Biology; Cancer research; Genetically modified mouse; Transgene; Vascular endothelial growth factor; Stromal cell; Germline; Pathology; Internal medicine; Endocrinology; Medicine; Genetics","score_opus":0.12953231407581636,"score_gpt":0.41043123340536225,"score_spread":0.2808989193295459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041133690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814881,0.0016965746,0.000053878503,0.01192857,0.000050669612,0.0043481616,0.000059589347,0.0000401025,0.00033433634],"genre_scores_gemma":[0.9921574,0.00046064396,0.00023557029,0.00015377904,0.00034912108,0.005402679,0.000017180946,0.00005453741,0.0011690719],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99713403,0.00007190461,0.0002861683,0.00042898484,0.001025551,0.0010533744],"domain_scores_gemma":[0.9977372,0.0006113706,0.000035059194,0.00043446818,0.0008904361,0.0002914354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084105186,0.00015785318,0.0002664737,0.00027486446,0.00019897273,0.000119888144,0.00042903097,0.00014931824,0.0023092146],"category_scores_gemma":[0.00046968236,0.00009578129,0.00013836127,0.00092400674,0.0002738868,0.0001507126,0.00014290257,0.00062772084,0.00017442585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067027577,0.00026168092,0.035733566,0.00029639382,0.00013638241,0.000008611791,0.0006538583,0.00000977398,0.90120655,0.00009752602,0.0042300555,0.05669533],"study_design_scores_gemma":[0.0024214864,0.00027108865,0.97249985,0.00018203878,0.000010715627,0.0000031761087,0.000265148,0.0012782775,0.017705983,0.00022653108,0.0049868226,0.00014886266],"about_ca_topic_score_codex":0.013734776,"about_ca_topic_score_gemma":0.0004533727,"teacher_disagreement_score":0.9367663,"about_ca_system_score_codex":0.00045605813,"about_ca_system_score_gemma":0.00048191927,"threshold_uncertainty_score":0.9986028},"labels":[],"label_agreement":null},{"id":"W2041154020","doi":"10.1158/0008-5472.sabcs10-p3-10-17","title":"Abstract P3-10-17: The Fractal Analysis of Tumor Histology Is an Independent Prognostic Factor in Breast Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Fractal dimension; Univariate; Proportional hazards model; Fractal analysis; Multivariate analysis; Lymph node; Univariate analysis; Fractal; Cancer; Pathology; Multivariate statistics; Mathematics; Statistics","score_opus":0.03363363490030733,"score_gpt":0.40242294624933694,"score_spread":0.3687893113490296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041154020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941032,0.00016842304,0.0000038575618,0.004669564,0.00019443812,0.0003787452,0.00011659308,0.00001146025,0.00035372662],"genre_scores_gemma":[0.99883235,0.00006394589,0.000025040616,0.00041825915,0.00016949384,0.00011977706,0.000032862306,0.000022893075,0.00031535488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978204,0.000113232476,0.00033603096,0.0003679998,0.0008873118,0.0004750427],"domain_scores_gemma":[0.9985526,0.00026068793,0.00011622785,0.00038791168,0.000442081,0.0002404763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007948957,0.00012557575,0.0003863079,0.00055708876,0.00009949393,0.000026192314,0.00033566024,0.00009889423,0.0074270032],"category_scores_gemma":[0.0004344324,0.00008372697,0.00010081008,0.0009005108,0.0004001581,0.000079959864,0.000087210865,0.0018095869,0.000009237605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002062576,0.00034524885,0.96416694,0.000056491896,0.00023148373,0.000033611384,0.0009177088,0.00004110393,0.013534917,0.000009308177,0.0019615944,0.018495357],"study_design_scores_gemma":[0.0007648193,0.00009545984,0.992274,0.00006129195,0.00012435239,0.0000053957538,0.000095747186,0.0036607287,0.0003486525,0.000014309638,0.0024720202,0.000083242085],"about_ca_topic_score_codex":0.010308958,"about_ca_topic_score_gemma":0.0024038884,"teacher_disagreement_score":0.028107062,"about_ca_system_score_codex":0.00022316705,"about_ca_system_score_gemma":0.00053060515,"threshold_uncertainty_score":0.9962815},"labels":[],"label_agreement":null},{"id":"W2041350522","doi":"10.1158/1538-7445.am2014-1268","title":"Abstract 1268: High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the norwegian women and cancer study: A population-based prospective study","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endometrial cancer; Medicine; Hazard ratio; Population; Gynecology; Cancer; Norwegian; Proportional hazards model; Prospective cohort study; Confidence interval; Demography; Obstetrics; Internal medicine; Environmental health","score_opus":0.08673291461147792,"score_gpt":0.46800807406511585,"score_spread":0.38127515945363794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041350522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931152,0.0007047941,0.000037389505,0.00058907125,0.00020901675,0.005248118,0.000059429058,0.000017275761,0.00001972617],"genre_scores_gemma":[0.9954666,0.0003341757,0.000054061835,0.000087202,0.00027543394,0.00371685,0.000007688772,0.00003144929,0.000026574671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996547,0.0011249036,0.00042119913,0.0006303643,0.00076132256,0.000515208],"domain_scores_gemma":[0.9979837,0.0012433978,0.000114351365,0.00030874548,0.00015787473,0.00019193243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037432234,0.00021644685,0.00050670834,0.0007981855,0.00022638455,0.00010594845,0.00011975496,0.00008761316,0.00018326739],"category_scores_gemma":[0.0005414945,0.00015338165,0.000022375236,0.0009194079,0.00008303262,0.00011073006,0.00007559171,0.0008602994,0.0000014179896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002296648,0.0004652322,0.927458,0.00006562584,0.00007636377,0.000007778776,0.013662097,0.00024401756,0.0018184097,0.000010993608,0.000014745977,0.05388011],"study_design_scores_gemma":[0.008584688,0.0016609202,0.9866853,0.00015574586,0.00005423352,5.747622e-7,0.0022107104,0.00017990236,0.000118040145,0.00012019679,0.00006986178,0.00015983576],"about_ca_topic_score_codex":0.12350442,"about_ca_topic_score_gemma":0.04237228,"teacher_disagreement_score":0.081132144,"about_ca_system_score_codex":0.0020072667,"about_ca_system_score_gemma":0.00021719834,"threshold_uncertainty_score":0.97510195},"labels":[],"label_agreement":null},{"id":"W2041373214","doi":"10.1158/1538-7445.am2013-281","title":"Abstract 281: Hsp27 is an essential effector of EGF-induced epithelial to mesenchymal transition in prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epithelial–mesenchymal transition; LNCaP; Prostate cancer; Cancer research; Hsp27; Cancer; Tumor progression; Metastasis; Biology; Cancer cell; Heat shock protein; Medicine; Internal medicine; Hsp70","score_opus":0.038754950615555894,"score_gpt":0.39846407522587846,"score_spread":0.35970912461032256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041373214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570954,0.0002619947,0.000022464888,0.0014590315,0.00008953634,0.002054338,0.00020464054,0.0000072537377,0.00019120636],"genre_scores_gemma":[0.99691,0.0002438146,0.00007181147,0.00008115966,0.0004188738,0.0018499207,0.000049646023,0.000043667413,0.0003311302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997105,0.00034811316,0.0003238075,0.0006131443,0.00077839685,0.0008315173],"domain_scores_gemma":[0.9984813,0.000031711734,0.00003486272,0.0005036395,0.00060509506,0.00034339505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010172302,0.00017326129,0.00024073977,0.0002817316,0.00010201041,0.000059674603,0.00043551545,0.00019218925,0.0012288444],"category_scores_gemma":[0.00013560678,0.00016365417,0.00007319405,0.0005098084,0.00014469307,0.000025199375,0.00015216136,0.00045501662,0.00009019338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049021066,0.00013050967,0.0008275525,0.0001842391,0.000029287821,0.000009072451,0.0007041283,0.00009897723,0.9818025,0.0000033741358,0.0012736702,0.014446449],"study_design_scores_gemma":[0.00082800345,0.00072068034,0.016911604,0.00010565104,0.0000025412805,0.0000013020923,0.00015952313,0.000071438,0.9800843,0.00002818001,0.0009106031,0.00017617372],"about_ca_topic_score_codex":0.02275215,"about_ca_topic_score_gemma":0.002432845,"teacher_disagreement_score":0.020319307,"about_ca_system_score_codex":0.000160753,"about_ca_system_score_gemma":0.00083334796,"threshold_uncertainty_score":0.99968415},"labels":[],"label_agreement":null},{"id":"W2041665132","doi":"10.1158/1538-7445.fbcr13-b67","title":"Abstract B67: Elucidating the mechanism of targeting WNT ligands to exosomes","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Wnt signaling pathway; Microvesicles; Cell biology; Palmitoylation; Chemistry; Cancer research; Biology; Signal transduction; Biochemistry; microRNA; Cysteine","score_opus":0.03530381223573336,"score_gpt":0.363896935294283,"score_spread":0.32859312305854965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041665132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952927,0.0019672613,0.0002578521,0.00081540865,0.00008088077,0.00043596578,0.000009540056,0.00000740941,0.0011329663],"genre_scores_gemma":[0.9980684,0.00017356395,0.00032792846,0.00013386083,0.00031059378,0.00025503067,0.000013167406,0.000026805557,0.00069066574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867064,0.00006595661,0.00020585579,0.00029141625,0.00036560316,0.00040052275],"domain_scores_gemma":[0.99899745,0.000052823354,0.00005281992,0.00042079896,0.00032942125,0.00014666603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008288911,0.00009635623,0.00009699277,0.00005125636,0.00015340053,0.000048502035,0.0004979646,0.00007628292,0.0003285296],"category_scores_gemma":[0.0004322404,0.0000719961,0.00006198052,0.00018094938,0.00011184298,0.000005841736,0.00034727677,0.00019879566,0.00006762474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020402764,0.000024546354,0.0002652251,0.000039654537,0.000022746188,0.0000016742149,0.00012695507,0.00004156217,0.9895929,0.00037270144,0.005327545,0.004164104],"study_design_scores_gemma":[0.00012631076,0.000068980036,0.0014148542,0.000034863555,0.000003207346,6.40365e-7,0.00042126008,0.000032432206,0.9949127,0.00074525987,0.0021487242,0.00009075907],"about_ca_topic_score_codex":0.00030086085,"about_ca_topic_score_gemma":0.00002095058,"teacher_disagreement_score":0.005319825,"about_ca_system_score_codex":0.000028206172,"about_ca_system_score_gemma":0.00015613076,"threshold_uncertainty_score":0.35971686},"labels":[],"label_agreement":null},{"id":"W2041882103","doi":"10.1158/0008-5472.can-04-1384","title":"Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Melanoma; Tissue microarray; Immunohistochemistry; Skin cancer; Cancer; Stage (stratigraphy); Disease; Medicine; Metastasis; Oncology; Cancer research; Pathology; Biology; Internal medicine","score_opus":0.05336013029120566,"score_gpt":0.39108786978837595,"score_spread":0.3377277394971703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041882103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818426,0.0001796481,0.00016668129,0.0005457998,0.000027424921,0.00061731844,0.00003701019,0.000052045307,0.00018981051],"genre_scores_gemma":[0.9974093,0.000095934,0.0002266571,0.0000366219,0.000011905121,0.0001167094,0.000014680576,0.000013526928,0.0020746696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985582,0.00010838415,0.00024410857,0.00028072228,0.000541231,0.00026732867],"domain_scores_gemma":[0.99922454,0.0000887065,0.000099269375,0.00020668065,0.00022114704,0.0001596664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005797684,0.00009322912,0.0003084321,0.0007327732,0.000058823436,0.000024892563,0.000056189063,0.000052824777,0.00011994405],"category_scores_gemma":[0.00017344335,0.00007012232,0.00005104928,0.0011089162,0.00006244511,0.000063116975,0.000056395285,0.00019749832,0.0000030968863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027089936,0.0002466942,0.82180864,0.00025000478,0.00082121533,0.00029674752,0.0014862082,0.0011022893,0.17048846,0.00023194823,0.000058504662,0.0005003075],"study_design_scores_gemma":[0.0029565261,0.00071034924,0.9663217,0.00024008873,0.0004339576,0.0000013329901,0.0010321364,0.006485209,0.021453148,0.000025277483,0.00020242044,0.00013786324],"about_ca_topic_score_codex":0.0025184334,"about_ca_topic_score_gemma":0.002719344,"teacher_disagreement_score":0.14903532,"about_ca_system_score_codex":0.0006382005,"about_ca_system_score_gemma":0.00014132692,"threshold_uncertainty_score":0.38071346},"labels":[],"label_agreement":null},{"id":"W2041925104","doi":"10.1158/1538-7445.am2014-3121","title":"Abstract 3121: Evaluation of novel combinations of PI3K-mTOR inhibitors with dacomitinib (dac) or chemotherapy in PTEN-deficient genomically characterized patient-derived tumor xenografts (gPTX)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; PI3K/AKT/mTOR pathway; Medicine; Cisplatin; Cancer; Chemotherapy; Lung cancer; Pharmacology; Internal medicine; Cancer research; Oncology; Biology; Apoptosis","score_opus":0.07112794891730727,"score_gpt":0.3747977470136105,"score_spread":0.30366979809630323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041925104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979202,0.0002625829,0.00013280485,0.00027845253,0.00014912307,0.0009060195,0.00010380078,0.0000073058713,0.00023970238],"genre_scores_gemma":[0.99879116,0.00009355546,0.0003422203,0.00010424961,0.00014641658,0.00037070058,0.000078335295,0.000046048845,0.000027315908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974391,0.00022511184,0.00051884406,0.00046486635,0.00093672663,0.00041537447],"domain_scores_gemma":[0.99781895,0.00009969019,0.00029301658,0.0004723462,0.0012146966,0.00010130582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017148519,0.0001824855,0.0003081379,0.0002161711,0.00007042739,0.00002326668,0.00033398005,0.00012763802,0.00016104577],"category_scores_gemma":[0.00033569633,0.0001530392,0.0000728661,0.0003858119,0.00033017356,0.00001149365,0.000095515556,0.00024117592,0.0000020351988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013160581,0.00079196045,0.0012058278,0.00007537745,0.000057049845,6.600773e-7,0.00029666076,0.00037542652,0.9893885,0.0000182025,0.00023168039,0.006242552],"study_design_scores_gemma":[0.008510819,0.0010717672,0.025834339,0.00023394325,0.000018264487,0.000002149528,0.00015116655,0.000626196,0.96075386,0.00001531318,0.0025688696,0.00021332562],"about_ca_topic_score_codex":0.00020894519,"about_ca_topic_score_gemma":0.00019230247,"teacher_disagreement_score":0.028634697,"about_ca_system_score_codex":0.0002072736,"about_ca_system_score_gemma":0.0009483222,"threshold_uncertainty_score":0.6240758},"labels":[],"label_agreement":null},{"id":"W2042096367","doi":"10.1158/1538-7445.am2012-3995","title":"Abstract 3995: C-terminal fragment of prostate apoptosis response-4 (Par-4) generated by caspase-3 cleavage induces apoptosis in cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Transfection; Molecular biology; Apoptosis; Biology; HeLa; c-jun; Western blot; Cleavage (geology); Annexin; Kinase; Flow cytometry; Cell culture; Cell biology; Cell; Biochemistry; Gene; Transcription factor","score_opus":0.05025592930115879,"score_gpt":0.37569926904705736,"score_spread":0.32544333974589856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042096367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880339,0.010152917,0.000003239593,0.00019297325,0.00023091477,0.00065949047,0.0005709412,0.000009805666,0.00014585326],"genre_scores_gemma":[0.9954472,0.0029068717,0.000038424405,0.00008076681,0.00025914682,0.00075214583,0.00009540315,0.000056477584,0.00036356787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971469,0.00042680773,0.000409662,0.0005138824,0.00059633015,0.0009064157],"domain_scores_gemma":[0.99871314,0.000072361196,0.00012627922,0.00054049,0.0002446855,0.00030307233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001223775,0.0002319295,0.00026955525,0.0002034767,0.00012384687,0.000042252435,0.00042236916,0.00022143582,0.00028521425],"category_scores_gemma":[0.00015236782,0.00023102565,0.00009848147,0.00044689735,0.00030772886,0.000020427244,0.00024225931,0.00034632697,0.000014829072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011427857,0.0003708448,0.011925049,0.0001857871,0.00007524112,0.0000034711081,0.00021888372,0.00007142097,0.96521574,0.0000011742035,0.018608235,0.0021813412],"study_design_scores_gemma":[0.0006245176,0.00015281352,0.013032986,0.00021512144,0.000016971855,0.0000011209186,0.0002045735,0.0000029676105,0.9824857,0.0000028276058,0.00300912,0.00025124653],"about_ca_topic_score_codex":0.0020469327,"about_ca_topic_score_gemma":0.00017869285,"teacher_disagreement_score":0.017269969,"about_ca_system_score_codex":0.00024474427,"about_ca_system_score_gemma":0.0006272127,"threshold_uncertainty_score":0.9420953},"labels":[],"label_agreement":null},{"id":"W2042259472","doi":"10.1158/1538-7445.pedcan-b33","title":"Abstract B33: Toll-like receptor ligands delay acute lymphoblastic leukemia onset via depletion of pre-leukemic cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Leukemia; Immunology; Receptor; Population; Immune system; Cancer research; Toll-like receptor; Splenocyte; Cancer; Acute leukemia; Biology; Medicine; Innate immune system; Internal medicine","score_opus":0.017105050636802555,"score_gpt":0.30478673912991133,"score_spread":0.28768168849310877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042259472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965102,0.001204392,0.00043208312,0.00013134922,0.0008216546,0.00036426864,0.00003658547,0.000049006052,0.00045046498],"genre_scores_gemma":[0.99380827,0.0011013311,0.000027470793,0.000050421742,0.00008910972,0.00012991345,0.0001624677,0.00003276288,0.0045982427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979377,0.00039605756,0.00048472933,0.00036627997,0.00017394368,0.0006413177],"domain_scores_gemma":[0.99838424,0.00055945024,0.00016640988,0.00049795187,0.00034411438,0.000047852216],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014114975,0.00019075786,0.00033487662,0.00033237206,0.00026524274,0.000025175977,0.00042041787,0.00039529777,0.0014051034],"category_scores_gemma":[0.00014541556,0.00017259973,0.00011161904,0.0003215917,0.00036401497,0.00016567582,0.00012721072,0.0005650959,0.0012971455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018867713,0.000037339116,0.00020739829,0.00007837651,0.0001619782,0.0000025250092,0.00038934613,0.000096210184,0.9714065,0.000041533676,0.016930375,0.008761646],"study_design_scores_gemma":[0.001311738,0.00033670713,0.0066454727,0.00015639878,0.000027684671,0.000025749416,0.00005104061,0.00007480568,0.9601587,0.000068911446,0.030964874,0.0001779189],"about_ca_topic_score_codex":0.00077327824,"about_ca_topic_score_gemma":0.000053967415,"teacher_disagreement_score":0.0140344985,"about_ca_system_score_codex":0.0006697837,"about_ca_system_score_gemma":0.00072777935,"threshold_uncertainty_score":0.9995077},"labels":[],"label_agreement":null},{"id":"W2042379375","doi":"10.1158/0008-5472.sabcs-09-4095","title":"A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Medicine; Tolerability; Discontinuation; Breast cancer; Internal medicine; Dosing; Cancer; Hazard ratio; Oncology; Urology; Estrogen receptor; Gastroenterology; Confidence interval; Adverse effect","score_opus":0.05101035564151347,"score_gpt":0.40964159348978224,"score_spread":0.3586312378482688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042379375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336326,0.0023210533,0.000063370615,0.0015225792,0.000060053444,0.0022576903,0.000109090375,0.00006006647,0.00024285342],"genre_scores_gemma":[0.9982447,0.00012535925,0.0004893696,0.000110523,0.00018186333,0.00066014344,0.000011705751,0.000066662986,0.00010966916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996165,0.00017358862,0.00050639,0.0007693284,0.0011624113,0.0012232774],"domain_scores_gemma":[0.9981096,0.00009157116,0.00017617647,0.00059845747,0.00066332886,0.0003608865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067052146,0.0003597926,0.00086802646,0.00046989231,0.00025789186,0.00002786255,0.00030958827,0.00008800767,0.0002404822],"category_scores_gemma":[0.000021177795,0.0003026488,0.000042580148,0.0014016408,0.0004176653,0.00031924594,0.0001057531,0.0009177161,0.0000032221003],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07034595,0.007356373,0.049993075,0.00015811619,0.00063562475,0.0002946219,0.017474812,0.0013336906,0.5663816,0.00015138478,0.000029488485,0.28584528],"study_design_scores_gemma":[0.13631271,0.09339905,0.61763525,0.0070761214,0.00026405143,0.00042012671,0.034469213,0.00032266768,0.107019305,0.00085344404,0.00057422277,0.0016538285],"about_ca_topic_score_codex":0.0013994161,"about_ca_topic_score_gemma":0.00075188,"teacher_disagreement_score":0.56764215,"about_ca_system_score_codex":0.0021916595,"about_ca_system_score_gemma":0.0011037332,"threshold_uncertainty_score":0.99994254},"labels":[],"label_agreement":null},{"id":"W2042438565","doi":"10.1158/0008-5472.can-10-0705","title":"Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma Phenotype","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"NODAL; Nodal signaling; Morphogen; Notch signaling pathway; Biology; Melanoma; Cancer research; Phenotype; Embryonic stem cell; Cell biology; Signal transduction; Genetics; Gene; Gastrulation","score_opus":0.015040302928236333,"score_gpt":0.31096383521002274,"score_spread":0.2959235322817864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042438565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981771,0.0005774279,0.000012170001,0.00047816572,0.00021360998,0.00024066759,0.00006421441,0.0000016018286,0.00023503914],"genre_scores_gemma":[0.9975833,0.00007232241,0.000034927856,0.000018215866,0.00004918097,0.000028704037,0.000065103195,0.000006249634,0.00214194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999222,0.00013737794,0.00013159547,0.00016421155,0.00020418355,0.0001406326],"domain_scores_gemma":[0.9993084,0.000029412378,0.00012887936,0.0002845159,0.00022849873,0.000020311705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031683358,0.00006222573,0.00006590434,0.000021330594,0.00012200878,0.000004404885,0.00026000763,0.00012334096,0.00006206397],"category_scores_gemma":[0.00016014664,0.00003832741,0.00004722442,0.0001517871,0.00036729831,0.000003782698,0.00013470654,0.00013997094,0.0000029612065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007187807,0.000014148159,0.014126565,0.00001754181,0.000023523882,4.949191e-8,0.00009181885,0.000034229794,0.98009485,0.00009085199,0.0018148675,0.0036196539],"study_design_scores_gemma":[0.0001277304,0.000046694,0.2039307,0.000015579459,0.0000037736227,0.0000015685847,0.000039419596,0.000014507456,0.792869,0.00023794871,0.002675011,0.00003808039],"about_ca_topic_score_codex":0.00009745515,"about_ca_topic_score_gemma":0.00027873312,"teacher_disagreement_score":0.18980414,"about_ca_system_score_codex":0.000017247121,"about_ca_system_score_gemma":0.00018690579,"threshold_uncertainty_score":0.15629464},"labels":[],"label_agreement":null},{"id":"W2042521915","doi":"10.1158/0008-5472.can-07-1960","title":"p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gene knockdown; Cancer research; Ectopic expression; Biology; Cell culture; Cell; Metastasis; Mdm2; Cell migration; Cell growth; Suppressor; Cancer; Genetics","score_opus":0.07459894844683339,"score_gpt":0.34768848510869826,"score_spread":0.27308953666186486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042521915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740285,0.0006229752,0.00003511782,0.00038032178,0.0000724709,0.0011432726,0.00010775553,0.00000756016,0.00022770104],"genre_scores_gemma":[0.9931605,0.00023839367,0.000056510482,0.000026347288,0.00017875468,0.00029998054,0.00005288083,0.000048159098,0.005938505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697274,0.00037414805,0.00028211068,0.000556082,0.0010011189,0.0008137922],"domain_scores_gemma":[0.9985623,0.00005140017,0.00006319912,0.0006386485,0.00042280956,0.00026166058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010803354,0.00018080979,0.00019932877,0.00024529398,0.000374393,0.000039167313,0.00076615915,0.0001794026,0.00008675105],"category_scores_gemma":[0.00021638467,0.00014088374,0.00009113938,0.00070935424,0.00039712194,0.000009309124,0.00071170426,0.00049155124,0.00009133196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015149434,0.00010625264,0.016066717,0.000071394454,0.000018983776,0.000028822878,0.00019557975,0.0000021916082,0.9682422,0.0000044061962,0.014630227,0.00048169284],"study_design_scores_gemma":[0.0006077897,0.00041316063,0.0002278508,0.00007701898,0.0000025684265,0.000013785535,0.00016284164,0.000019752613,0.98603415,0.0000032942958,0.012279836,0.00015795078],"about_ca_topic_score_codex":0.0007548797,"about_ca_topic_score_gemma":0.000047810478,"teacher_disagreement_score":0.017791914,"about_ca_system_score_codex":0.0001614156,"about_ca_system_score_gemma":0.00063558924,"threshold_uncertainty_score":0.57450724},"labels":[],"label_agreement":null},{"id":"W2042632928","doi":"10.1158/1538-7445.am2014-3386","title":"Abstract 3386: Post-translational mechanisms related to PAR-4 regulation in endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Cisplatin; Apoptosis; Endometrial cancer; Cancer research; Cancer; Lactacystin; Prostate cancer; Proteasome; Cancer cell; Chemistry; Cell culture; Molecular biology; Biology; Proteasome inhibitor; Internal medicine; Cell biology; Medicine; Biochemistry; Chemotherapy","score_opus":0.038197831802819576,"score_gpt":0.4005748747243405,"score_spread":0.36237704292152095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042632928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215865,0.0003248159,0.0012922765,0.0027940886,0.00047135114,0.0006897008,0.00007060694,0.000014754822,0.0021837456],"genre_scores_gemma":[0.99720806,0.00007494537,0.0004175555,0.000120653414,0.0003486564,0.0005460118,0.00010400606,0.000028096567,0.0011520201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983685,0.00016964378,0.00025671104,0.00041302197,0.00041835482,0.0003737406],"domain_scores_gemma":[0.9990556,0.00008940986,0.000044650336,0.00028999583,0.00039974364,0.00012056877],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009302542,0.00010692787,0.00011943301,0.00032413926,0.000118298776,0.00004009826,0.00021771966,0.00017722914,0.0012797057],"category_scores_gemma":[0.00056323525,0.000112416514,0.000058247286,0.00051626604,0.000054393702,0.000011531477,0.00007024796,0.0003233503,0.00007497674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003811433,0.000034959234,0.00092150964,0.000012248811,0.000026512715,9.989619e-7,0.000076789824,0.0014030079,0.9863874,0.00082403806,0.0015705399,0.008360898],"study_design_scores_gemma":[0.001380987,0.00027020683,0.06555215,0.00008973858,0.0000052973446,0.0000027692297,0.00004139976,0.00010985346,0.8945903,0.0035606734,0.034168947,0.00022768432],"about_ca_topic_score_codex":0.001536409,"about_ca_topic_score_gemma":0.0027518938,"teacher_disagreement_score":0.09179706,"about_ca_system_score_codex":0.0001202331,"about_ca_system_score_gemma":0.00026671423,"threshold_uncertainty_score":0.99963325},"labels":[],"label_agreement":null},{"id":"W2043144737","doi":"10.1158/0008-5472.can-08-1718","title":"Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Michael Smith Health Research BC","keywords":"Prostate cancer; Androgen receptor; Wnt signaling pathway; Colocalization; Cancer research; Androgen; LNCaP; Biology; Prostate; Dihydrotestosterone; Endocrinology; Internal medicine; Cancer; Signal transduction; Hormone; Medicine; Cell biology; Genetics","score_opus":0.13127130669302153,"score_gpt":0.4273878702266003,"score_spread":0.29611656353357874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043144737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685658,0.020848041,4.875579e-7,0.008020031,0.00006514455,0.0015285402,0.00021285971,0.000029586368,0.0007294756],"genre_scores_gemma":[0.9678915,0.02031775,0.000028615814,0.00006592058,0.00029653026,0.0011244855,0.000037177204,0.000046104724,0.010191891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969862,0.00022751545,0.00031311437,0.0005406929,0.00091413833,0.0010183196],"domain_scores_gemma":[0.9986861,0.00020057331,0.000045463745,0.00034523688,0.00037931142,0.0003433315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009826586,0.0002055734,0.0003733324,0.00029949815,0.00055967073,0.000071799754,0.00021556889,0.00011703148,0.0004797681],"category_scores_gemma":[0.00007114216,0.00012631153,0.000058668014,0.0011181552,0.0012572998,0.00013082642,0.00017089261,0.0009008151,0.000039952432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026374073,0.00013516856,0.8813294,0.00031366362,0.00022166957,0.00064994575,0.0053282287,0.000006153723,0.07809996,0.00002895689,0.012319794,0.01892964],"study_design_scores_gemma":[0.00813064,0.0008885521,0.79586124,0.0006818199,0.00004255854,0.00006549844,0.0016906398,0.000029194385,0.12921286,0.00021356245,0.06278667,0.00039675154],"about_ca_topic_score_codex":0.0070545534,"about_ca_topic_score_gemma":0.00096834026,"teacher_disagreement_score":0.08546816,"about_ca_system_score_codex":0.00067833,"about_ca_system_score_gemma":0.0015740291,"threshold_uncertainty_score":0.99955755},"labels":[],"label_agreement":null},{"id":"W2043402433","doi":"10.1158/1538-7445.am2012-sy26-02","title":"Abstract SY26-02: SWOG S0701 phase III randomized trial of three antibiotic regimens to eradicate helicobacter pylori: efficacy and failure at one year","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lansoprazole; Clarithromycin; Internal medicine; Metronidazole; Urea breath test; Cancer; Amoxicillin; Helicobacter pylori; Randomized controlled trial; Concomitant; Gastroenterology; Antibiotics; Helicobacter pylori infection","score_opus":0.08382939233511101,"score_gpt":0.3903939582576579,"score_spread":0.3065645659225469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043402433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835236,0.0014254578,0.000020848198,0.010315506,0.00039983616,0.0036923278,0.000048512942,0.000055894365,0.00051803637],"genre_scores_gemma":[0.9964542,0.0010580885,0.00018714581,0.00023415824,0.0010023054,0.00020749935,0.000026662383,0.000064898355,0.0007650748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996271,0.0003346603,0.0007384308,0.00055521895,0.000861925,0.0012387753],"domain_scores_gemma":[0.9973022,0.00064722437,0.00018064829,0.00068837905,0.00045438486,0.0007272159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027356388,0.0003096767,0.0014097546,0.00048483838,0.00020495761,0.000026421012,0.00022807388,0.00024922978,0.0004405235],"category_scores_gemma":[0.0009424759,0.00024864226,0.00016760465,0.0005177927,0.00094223366,0.00014840488,0.000363908,0.0009162243,0.00020900472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8617948,0.0012039057,0.010009689,0.00021928547,0.0018011017,0.000025688396,0.0014775993,0.0000012520411,0.11377284,0.000052398234,0.007424192,0.0022172108],"study_design_scores_gemma":[0.942936,0.0019692485,0.03273418,0.00055913685,0.00047110158,0.000017602273,0.00011020221,0.0000040795826,0.015903369,0.000010912429,0.005058902,0.00022526522],"about_ca_topic_score_codex":0.0002176373,"about_ca_topic_score_gemma":0.00014975831,"teacher_disagreement_score":0.09786947,"about_ca_system_score_codex":0.00033814766,"about_ca_system_score_gemma":0.00015488577,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2043696314","doi":"10.1158/1538-7445.am2013-1931","title":"Abstract 1931: Development of a functional assay for the determination of BRCA1 carrier status.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Gene; Germline mutation; Mutation; Breast cancer; Genetics; Cancer; Cancer research; Molecular biology","score_opus":0.059546021934910334,"score_gpt":0.36942358144715004,"score_spread":0.3098775595122397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043696314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992894,0.002405128,0.003567157,0.00014331694,0.00009365725,0.00049822766,0.00012144904,0.0000017541507,0.00027532675],"genre_scores_gemma":[0.9979706,0.00026962603,0.0006053501,0.000023951094,0.000147913,0.00045652306,0.00008658215,0.000009240148,0.00043021838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922705,0.000032700897,0.00016131738,0.00014648163,0.00024165191,0.00019077545],"domain_scores_gemma":[0.9988992,0.000052454758,0.000046678986,0.00016842101,0.00076550414,0.00006770822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037113274,0.00005257448,0.00006138387,0.000041659514,0.000095025585,0.000011386137,0.0001074661,0.00005314554,0.00020871703],"category_scores_gemma":[0.00013919006,0.000040942316,0.00004494189,0.00005980706,0.00013345147,0.0000033112267,0.000042794676,0.000046876565,0.0000021458272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001492986,0.00006913956,0.0020257859,0.00014009101,0.000035348967,7.034164e-8,0.00012704688,0.00002230888,0.9503692,0.000030513236,0.0065228506,0.04050837],"study_design_scores_gemma":[0.00071409746,0.000090958994,0.112915605,0.000023594943,0.000008756561,2.5646844e-7,0.00032679303,0.00007390283,0.84115744,0.00033721622,0.044270404,0.000080979786],"about_ca_topic_score_codex":0.0001015723,"about_ca_topic_score_gemma":0.00010508961,"teacher_disagreement_score":0.110889815,"about_ca_system_score_codex":0.00002992979,"about_ca_system_score_gemma":0.0005691331,"threshold_uncertainty_score":0.22853051},"labels":[],"label_agreement":null},{"id":"W2044153248","doi":"10.1158/1538-7445.am10-3422","title":"Abstract 3422: Synthetic lethal siRNA screening reveals novel modifiers of insulin-like growth factor-1 receptor (IGF1R) inhibitor activity in childhood sarcomas","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Insulin-like growth factor 1 receptor; Insulin-like growth factor; Growth factor; Cancer research; Receptor; Medicine; Growth factor receptor; Internal medicine; Endocrinology; Biology","score_opus":0.07936962632415012,"score_gpt":0.37162326131041606,"score_spread":0.29225363498626594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044153248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949204,0.0010996658,0.000011043814,0.0016590772,0.000320493,0.0010794501,0.00014937586,0.00003642958,0.0007241157],"genre_scores_gemma":[0.99800456,0.0004468941,0.0007003065,0.00005489115,0.00034684024,0.00030146708,0.00001646501,0.00006505535,0.0000635032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99681,0.00013397027,0.00045809572,0.00064621144,0.0011470113,0.0008046893],"domain_scores_gemma":[0.9976764,0.0007795088,0.00014415542,0.0006248523,0.00038227483,0.00039281455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010736695,0.00028245506,0.00061756256,0.000560049,0.00013865672,0.000040127154,0.00028959705,0.00027677751,0.0007115168],"category_scores_gemma":[0.00078713504,0.00024119804,0.0001857753,0.0006980717,0.00035444082,0.00018192237,0.00015736249,0.0016945273,0.00002865818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005359817,0.0023887968,0.2170784,0.00018637022,0.00014805746,0.00007382161,0.00066014583,0.0000048620673,0.72841245,0.00011923288,0.00047247493,0.049919374],"study_design_scores_gemma":[0.0031053952,0.00021185896,0.78425545,0.00062195945,0.000022563234,0.000013452616,0.0001333186,0.000016191787,0.21088874,0.000070026836,0.0004713397,0.00018973029],"about_ca_topic_score_codex":0.0048096008,"about_ca_topic_score_gemma":0.0006033219,"teacher_disagreement_score":0.567177,"about_ca_system_score_codex":0.00037296396,"about_ca_system_score_gemma":0.0004955333,"threshold_uncertainty_score":0.9835771},"labels":[],"label_agreement":null},{"id":"W2044246392","doi":"10.1158/1538-7445.am2014-3251","title":"Abstract 3251: Assessing risk markers for oral cancer recurrence","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Medicine; Cancer; Stage (stratigraphy); Dysplasia; Basal cell; Internal medicine; Oncology; Gastroenterology","score_opus":0.20275929192949313,"score_gpt":0.52334900294821,"score_spread":0.3205897110187168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044246392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97155607,0.0071100835,0.00029896444,0.005495355,0.0008560451,0.0010175366,0.00010159751,0.000073729614,0.0134906145],"genre_scores_gemma":[0.98995304,0.005472298,0.0005896655,0.00027744364,0.0009722561,0.0010437138,0.000008650739,0.00004274918,0.0016401588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771327,0.00013183737,0.00024557,0.00047608977,0.0006312354,0.0008019701],"domain_scores_gemma":[0.998103,0.00060091564,0.000071491864,0.00033482342,0.0006276772,0.00026205438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002154888,0.00015981995,0.0004048219,0.00015978309,0.0004728268,0.0000734051,0.0001759777,0.00009844345,0.00051762623],"category_scores_gemma":[0.0009295472,0.00012985338,0.00010418525,0.00040411405,0.00027171973,0.00014041738,0.000076054006,0.0006726401,0.000030829648],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009110884,0.00009632581,0.07221176,0.00085904455,0.00018465615,0.000008303872,0.00046286095,0.00001855027,0.00950892,0.00012016575,0.15750915,0.75810915],"study_design_scores_gemma":[0.0040821387,0.00077256537,0.45405462,0.002378919,0.000120675184,0.00000492643,0.0006674381,0.0010170846,0.011227389,0.0006812467,0.5245442,0.0004488193],"about_ca_topic_score_codex":0.003671884,"about_ca_topic_score_gemma":0.0011828208,"teacher_disagreement_score":0.7576603,"about_ca_system_score_codex":0.00047274918,"about_ca_system_score_gemma":0.0007934428,"threshold_uncertainty_score":0.5667644},"labels":[],"label_agreement":null},{"id":"W2044463263","doi":"10.1158/0008-5472.sabcs11-pd04-09","title":"PD04-09: Self-Reported Cognitive Attributes and Fatigue Improve over Long-Term Follow-Up in Breast Cancer Survivors; Some Cognitive Attributes Are Worse in Breast Cancer Survivors Than in Non-Cancer Controls.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Statistics Canada; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Mood; Cancer; Cognition; Statistical significance; Profile of mood states; Cancer-related fatigue; Internal medicine; Physical therapy; Clinical psychology; Psychiatry","score_opus":0.07268451735292393,"score_gpt":0.37094374644797035,"score_spread":0.29825922909504643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044463263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648264,0.015758574,0.0000130996095,0.0033623532,0.001152121,0.006110052,0.008425102,0.00013507009,0.00021719602],"genre_scores_gemma":[0.95879805,0.028625168,0.0000036356798,0.0005060506,0.0006378145,0.01008879,0.00018970638,0.0002248033,0.00092600833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9905231,0.000846582,0.0015805787,0.0023185858,0.0017056628,0.0030255134],"domain_scores_gemma":[0.99347556,0.0014047072,0.0006803731,0.00055411656,0.0031697238,0.00071555143],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022036182,0.0011968049,0.0023130316,0.0019222338,0.00037308995,0.00013701712,0.000438019,0.0006817228,0.0021672233],"category_scores_gemma":[0.00054214767,0.0011274276,0.00029343247,0.0035872485,0.0013862103,0.0010346391,0.00067130703,0.0028921377,0.00003301225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01125507,0.0012588738,0.96578133,0.00094448647,0.0022163088,0.0011361768,0.005372241,0.000009405848,0.0019782993,0.000006201635,0.00034546645,0.009696156],"study_design_scores_gemma":[0.026606034,0.00035400636,0.9505533,0.012715854,0.0006296492,0.000069694885,0.003913144,0.00014865265,0.0037969605,0.000054809672,0.000021995584,0.0011358814],"about_ca_topic_score_codex":0.29914257,"about_ca_topic_score_gemma":0.47141248,"teacher_disagreement_score":0.17226991,"about_ca_system_score_codex":0.0039207693,"about_ca_system_score_gemma":0.0022795135,"threshold_uncertainty_score":0.999903},"labels":[],"label_agreement":null},{"id":"W2044512951","doi":"10.1158/0008-5472.sabcs10-p3-10-35","title":"Abstract P3-10-35: Using Automated Image Analysis To Validate Ki67 as a Clinical Prognostic Biomarker for Estrogen-Receptor Positive Breast Cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Tissue microarray; Immunohistochemistry; Medicine; Estrogen receptor; Oncology; Progesterone receptor; Internal medicine; Tamoxifen; Cancer; Biomarker; Pathology; Estrogen; Biology","score_opus":0.07385166877567328,"score_gpt":0.48178233889778443,"score_spread":0.40793067012211115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044512951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480724,0.0003892795,0.00017876369,0.0009164837,0.00032753492,0.0010959241,0.0020143758,0.000063397725,0.00020699836],"genre_scores_gemma":[0.99486077,0.00011626709,0.002610982,0.00013568165,0.00060466916,0.0008728725,0.00048600204,0.00006967235,0.00024309293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971142,0.00015501492,0.000415736,0.0009882649,0.0004357808,0.0008910221],"domain_scores_gemma":[0.9976313,0.00018492335,0.000120745935,0.00057526113,0.0010815078,0.00040627137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087971386,0.0003035294,0.00042440742,0.00027160448,0.00036464215,0.00012053854,0.00040050453,0.00024557527,0.0004450266],"category_scores_gemma":[0.0004202301,0.00027770735,0.00035383654,0.0009359895,0.00046045316,0.000015140085,0.00028907426,0.00029711268,0.000073908406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022424103,0.00022697494,0.033318657,0.000046377216,0.0044178264,0.00001619051,0.00009270239,0.00010712731,0.939789,0.000013850012,0.01053276,0.0091961445],"study_design_scores_gemma":[0.004983174,0.0011488362,0.58600485,0.00021503986,0.0019409617,0.00005986047,0.00044079978,0.0022311092,0.38228145,0.000041928663,0.019188618,0.0014633755],"about_ca_topic_score_codex":0.004005231,"about_ca_topic_score_gemma":0.0011470696,"teacher_disagreement_score":0.5575075,"about_ca_system_score_codex":0.0002822149,"about_ca_system_score_gemma":0.0011494325,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2044582224","doi":"10.1158/1538-7445.am2014-lb-276","title":"Abstract LB-276: Prospective study of body mass index and adult weight change with colorectal cancer survival, overall and by tumor microsatellite instability status","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; CARE Canada; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Medicine; Microsatellite instability; Body mass index; Hazard ratio; Colorectal cancer; Cancer; Internal medicine; Proportional hazards model; Cohort; Prospective cohort study; Cancer registry; Oncology; Confidence interval; Microsatellite; Allele; Biology","score_opus":0.04293122520811841,"score_gpt":0.35417327555874134,"score_spread":0.3112420503506229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044582224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949123,0.0021276476,0.000009090309,0.00017277684,0.000105165105,0.002001153,0.000111110836,0.00004090154,0.00051985105],"genre_scores_gemma":[0.99761045,0.0010396298,0.000020156083,0.000036772646,0.00022637309,0.00093909807,0.000008719117,0.00003737991,0.000081409235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756294,0.00018650111,0.0002615722,0.0006694381,0.00076707004,0.000552474],"domain_scores_gemma":[0.998363,0.00017941101,0.00011009487,0.0002543807,0.0007944489,0.0002986511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069665303,0.00021729115,0.00047169495,0.0001755391,0.00018397371,0.00005342874,0.00008180592,0.00008914445,0.00007535686],"category_scores_gemma":[0.00011656672,0.00016987664,0.000027773009,0.0004474409,0.00041992782,0.00016483606,0.00009067773,0.000653652,8.7942396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019158263,0.00032530478,0.9272839,0.00038221822,0.00013283353,0.00001021662,0.0021693034,0.0000015971093,0.042565297,0.000009918111,0.00012315609,0.007838034],"study_design_scores_gemma":[0.005209923,0.007443799,0.9556084,0.00019129024,0.000042276617,0.0000062225863,0.0010707589,0.00015525843,0.029218743,0.000042251224,0.0008183802,0.00019268256],"about_ca_topic_score_codex":0.044611707,"about_ca_topic_score_gemma":0.01591928,"teacher_disagreement_score":0.028692426,"about_ca_system_score_codex":0.00046941353,"about_ca_system_score_gemma":0.00026473447,"threshold_uncertainty_score":0.9617503},"labels":[],"label_agreement":null},{"id":"W2044787343","doi":"10.1158/1538-7445.am2012-2608","title":"Abstract 2608: Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute","funders":"","keywords":"Breast cancer; Carcinogenesis; Cancer research; Progenitor cell; Penetrance; Biology; Cell polarity; Stem cell; Cell biology; Genetics; Cell; Cancer; Phenotype; Gene","score_opus":0.021250713514476483,"score_gpt":0.36156432522981724,"score_spread":0.34031361171534075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044787343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381286,0.0054916004,0.000027942187,0.00020309015,0.00006573361,0.00014968829,0.0001976096,0.0000035695118,0.000047899786],"genre_scores_gemma":[0.99545956,0.003429677,0.00005281695,0.0000108962195,0.00070467935,0.00001944119,0.00001862748,0.00001640328,0.0002879091],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990431,0.00007229179,0.00015255799,0.00028367265,0.00017350257,0.00027485812],"domain_scores_gemma":[0.99939626,0.000017193322,0.000073452764,0.00018256108,0.00021464817,0.00011587599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005407541,0.000093851726,0.00011168819,0.000059432223,0.00011022905,0.000022789949,0.00008900464,0.0001266808,0.000030210671],"category_scores_gemma":[0.00005701422,0.00007969427,0.000022371154,0.00010110377,0.00030548315,0.000012769871,0.00014785849,0.00016644485,0.0000013777898],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006998487,0.000011561484,0.4199995,0.00003409192,0.0000350446,8.368575e-8,0.00007127791,0.000013425348,0.57073015,0.000011304016,0.00007843135,0.008945126],"study_design_scores_gemma":[0.00014648975,0.00006140714,0.68494856,0.000027540433,0.000012793546,0.0000034997797,0.000034078847,0.000004091893,0.31334195,0.000027762613,0.0013232909,0.000068559195],"about_ca_topic_score_codex":0.001440985,"about_ca_topic_score_gemma":0.00007423418,"teacher_disagreement_score":0.26494902,"about_ca_system_score_codex":0.000019732594,"about_ca_system_score_gemma":0.000074083844,"threshold_uncertainty_score":0.3249838},"labels":[],"label_agreement":null},{"id":"W2044795911","doi":"10.1158/0008-5472.can-08-0160","title":"Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université de Montréal","funders":"U.S. Army Medical Research Acquisition Activity; Canadian Institutes of Health Research","keywords":"Mesenchymal stem cell; Cancer research; Stromal cell; Bone marrow; Organoid; Immune system; Cancer; Breast cancer; In vivo; Genetic enhancement; Medicine; Cancer cell; Immunology; Biology; Pathology; Cell biology; Internal medicine; Gene","score_opus":0.14454224558292025,"score_gpt":0.42347094711598465,"score_spread":0.27892870153306437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044795911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885674,0.0026570521,0.00006454876,0.0023636892,0.00029497963,0.0021543596,0.00032067756,0.000049826256,0.003527459],"genre_scores_gemma":[0.9778797,0.0039316993,0.0004925174,0.000110131485,0.0011184139,0.0007382236,0.000020194184,0.000116497074,0.015592595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99473476,0.0003465308,0.0005868793,0.00074884447,0.0020832124,0.0014997439],"domain_scores_gemma":[0.99621487,0.0006383067,0.00013467565,0.00070506084,0.0017096027,0.00059746485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019117015,0.00030056224,0.00068770506,0.00050853717,0.00038031908,0.00003679695,0.0005995409,0.00022986582,0.0064437925],"category_scores_gemma":[0.00020861842,0.0002488503,0.00025434914,0.0008712235,0.0008042289,0.0001452672,0.00025367894,0.0010245455,0.000045847362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033900705,0.00020772539,0.034080848,0.00065924943,0.00018955364,0.000111396716,0.0011104932,0.000015370511,0.92974854,0.000057621957,0.011602936,0.018826213],"study_design_scores_gemma":[0.0050317138,0.0012857508,0.031886578,0.0006363119,0.000025320558,0.0001783859,0.00068554323,0.0003693714,0.9470742,0.000048568105,0.012440519,0.00033778138],"about_ca_topic_score_codex":0.0030757212,"about_ca_topic_score_gemma":0.0002557898,"teacher_disagreement_score":0.018488431,"about_ca_system_score_codex":0.0007320922,"about_ca_system_score_gemma":0.0023495727,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W2044889475","doi":"10.1158/1538-7445.am2011-2356","title":"Abstract 2356: Investigating the role of mammalian RNA binding protein Musashi-2 (MSI2) in breast cancer invasion and nodal metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Wnt signaling pathway; Biology; NUMB; Cancer stem cell; Cancer research; Notch signaling pathway; Carcinogenesis; Stem cell; Molecular biology; Cancer; Cell biology; Signal transduction; Genetics","score_opus":0.06197555380760617,"score_gpt":0.3388146531300414,"score_spread":0.2768390993224352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044889475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469584,0.0028715683,0.000017573506,0.00046762358,0.000044575077,0.00077495695,0.000113965034,0.0000071033287,0.0010067837],"genre_scores_gemma":[0.99789476,0.0009496281,0.00020351505,0.000033496377,0.0001180671,0.00054377335,0.000015017102,0.000050280694,0.0001914847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751484,0.00031418118,0.00032085087,0.00054667256,0.0006293561,0.00067409757],"domain_scores_gemma":[0.99892056,0.000028408407,0.000093459166,0.0004746451,0.00028987645,0.0001930269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015855939,0.00018720441,0.00020657635,0.00025754812,0.00018702119,0.000046632143,0.00049926824,0.00020464486,0.0002908833],"category_scores_gemma":[0.00015486802,0.00015207786,0.00006845537,0.0006067497,0.00044958986,0.000016875329,0.0004987632,0.00069315184,0.0000057436246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019099361,0.000041917603,0.001259984,0.00009862114,0.000056853554,0.00000910041,0.00039438967,0.000027163054,0.97467506,0.00015809575,0.00009189675,0.02299594],"study_design_scores_gemma":[0.0005577292,0.00010712328,0.004692854,0.00025332876,0.000009496098,0.000009261716,0.00080449006,0.00005455008,0.9922687,0.00029721923,0.0007789538,0.00016634194],"about_ca_topic_score_codex":0.011492477,"about_ca_topic_score_gemma":0.0032512217,"teacher_disagreement_score":0.022829596,"about_ca_system_score_codex":0.00013584044,"about_ca_system_score_gemma":0.00063276134,"threshold_uncertainty_score":0.99509007},"labels":[],"label_agreement":null},{"id":"W2044934700","doi":"10.1158/1538-7445.am2014-5028","title":"Abstract 5028: Metronomic cyclophosphamide enhances the immunogenicity and anti-tumor activity of a DepoVax based vaccine and may be further enhanced with inhibitors of CTLA-4 or PD-1","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Cytotoxic T cell; Immune system; Immunogenicity; Immunology; Cancer vaccine; CD8; Cyclophosphamide; Antigen; Granzyme B; Cancer research; Medicine; Immunotherapy; Biology; Internal medicine; Chemotherapy; In vitro","score_opus":0.022794840295334292,"score_gpt":0.3172420910421991,"score_spread":0.2944472507468648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044934700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984527,0.014182187,0.00008385162,0.0004892004,0.00010077263,0.00047703847,0.00003419044,0.00001330343,0.00009244409],"genre_scores_gemma":[0.99739087,0.0020297267,0.000028020786,0.000051206505,0.000020508845,0.00007510677,0.000003909508,0.000027320268,0.00037333125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980845,0.00064791937,0.0003412694,0.0003514851,0.00011736054,0.00045749114],"domain_scores_gemma":[0.99768674,0.0013530407,0.0002478915,0.0004577064,0.00022958705,0.000025048428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014881685,0.0002159462,0.0005285753,0.00017632487,0.00024245579,0.000021182332,0.0003053996,0.00013242094,0.00038896519],"category_scores_gemma":[0.00022074755,0.00012658256,0.00006064246,0.00037068682,0.0010286614,0.00012997832,0.00010859452,0.00048323878,0.0000044215512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01104406,0.000111285306,0.0025886677,0.000103396,0.00030984994,9.903124e-7,0.00049908546,0.000011200382,0.97562945,0.000016325952,0.00009530564,0.009590394],"study_design_scores_gemma":[0.0022751372,0.0006296967,0.11476718,0.00015387412,0.000026256565,0.0000075597623,0.00028442912,0.0000045695997,0.8799336,0.000007864509,0.0017724175,0.00013740863],"about_ca_topic_score_codex":0.002706331,"about_ca_topic_score_gemma":0.00035733738,"teacher_disagreement_score":0.11217851,"about_ca_system_score_codex":0.000051956515,"about_ca_system_score_gemma":0.0003796233,"threshold_uncertainty_score":0.5161887},"labels":[],"label_agreement":null},{"id":"W2044948447","doi":"10.1158/1538-7445.fbcr13-c41","title":"Abstract C41: Chc1L is a tumor suppressor involved in development of histiocyte-rich neoplasms","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Centre for Phenogenomics; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Pathology; Biology; Cancer research; Carcinogenesis; Knockout mouse; Prostate cancer; Histiocyte; Histiocytic sarcoma; Mesenteric lymph nodes; Cancer; Bone marrow; Tumor suppressor gene; Multiple myeloma; Spleen; Medicine; Immunology; Gene; Genetics","score_opus":0.10367429989856271,"score_gpt":0.4029268421346082,"score_spread":0.2992525422360455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044948447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894005,0.0028684048,0.0000019978897,0.0023142677,0.000085750864,0.0015447953,0.000023859839,0.000025039217,0.0037353819],"genre_scores_gemma":[0.9928602,0.00038037283,0.0003992664,0.00010790529,0.0000957817,0.0014811,0.000033761826,0.000039514896,0.0046021147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684966,0.00007547543,0.00048587273,0.00046613507,0.0012097511,0.00091313454],"domain_scores_gemma":[0.9982654,0.00017990102,0.00006721136,0.0004252296,0.00072838744,0.00033389436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007495725,0.00018848071,0.00042059738,0.0006033676,0.00012468448,0.000042574233,0.0002850481,0.00010657593,0.00505697],"category_scores_gemma":[0.0001360645,0.00014584365,0.00006343516,0.000881165,0.000302751,0.00016152221,0.00017662226,0.00069115765,0.00037392083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022065134,0.0013118975,0.14543971,0.0024447937,0.00035165,0.00030403084,0.009042726,0.0000091912725,0.75490427,0.00006826901,0.053503036,0.030413896],"study_design_scores_gemma":[0.0043100724,0.00024308315,0.27653018,0.0007156459,0.000011302984,0.000004513775,0.00096203573,0.00006283163,0.705637,0.0001685794,0.011151721,0.00020307006],"about_ca_topic_score_codex":0.00306107,"about_ca_topic_score_gemma":0.00051936315,"teacher_disagreement_score":0.13109046,"about_ca_system_score_codex":0.001167212,"about_ca_system_score_gemma":0.0024450512,"threshold_uncertainty_score":0.99585253},"labels":[],"label_agreement":null},{"id":"W2045027538","doi":"10.1158/0008-5472.can-04-2940","title":"Inhibition of Integrin-Linked Kinase by a Selective Small Molecule Inhibitor, QLT0254, Inhibits the PI3K/PKB/mTOR, Stat3, and FKHR Pathways and Tumor Growth, and Enhances Gemcitabine-Induced Apoptosis in Human Orthotopic Primary Pancreatic Cancer Xenografts","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Protein kinase B; GSK-3; Integrin-linked kinase; PI3K/AKT/mTOR pathway; Kinase; P70-S6 Kinase 1; Cancer research; FOXO1; GSK3B; Ribosomal s6 kinase; Chemistry; Phosphorylation; Signal transduction; Biology; Protein kinase A; Cell biology; Cyclin-dependent kinase 2","score_opus":0.04145909334888549,"score_gpt":0.336223627554926,"score_spread":0.29476453420604054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045027538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877717,0.0076681143,0.000008048261,0.0017101647,0.000034641682,0.0021899065,0.00004928759,0.000033696917,0.0005344459],"genre_scores_gemma":[0.99278814,0.005176077,0.00010984964,0.00025919467,0.00018568255,0.0011267778,0.000034970333,0.000067859866,0.0002514622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99593294,0.0005996742,0.00063400035,0.000892273,0.0010464725,0.00089463475],"domain_scores_gemma":[0.9979858,0.00044347098,0.00015144408,0.00037541048,0.0006400157,0.00040389365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011908575,0.00036446273,0.0006734686,0.00054414227,0.00031727925,0.00009840125,0.00017689989,0.00018870637,0.000065519394],"category_scores_gemma":[0.00038394635,0.00028430688,0.000064985536,0.001202964,0.0007925603,0.00020474549,0.00041816157,0.001379835,0.000002200604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047603095,0.00026711586,0.012309833,0.0009064785,0.0000665867,0.000035559136,0.0023723147,7.9601404e-7,0.97604823,0.000059158265,0.000426657,0.007031215],"study_design_scores_gemma":[0.0033684107,0.0009911775,0.024093216,0.0011137575,0.000049405044,0.000017543973,0.0009171643,0.00006646735,0.96881086,0.00010338057,0.00019381735,0.00027481097],"about_ca_topic_score_codex":0.0057465592,"about_ca_topic_score_gemma":0.002685802,"teacher_disagreement_score":0.011783384,"about_ca_system_score_codex":0.00055464904,"about_ca_system_score_gemma":0.0005912753,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W2045058534","doi":"10.1158/0008-5472.sabcs10-p3-14-07","title":"Abstract P3-14-07: A Phase 1 Study To Assess the Safety, Tolerability and PK of ARRY-380 — An Oral HER2 Inhibitor","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cmax; Nausea; Tolerability; Rash; Dosing; Adverse effect; Lapatinib; Trastuzumab; Internal medicine; Pharmacokinetics; Gastroenterology; Pharmacology; Cancer; Breast cancer","score_opus":0.2525772356432266,"score_gpt":0.5622187609640096,"score_spread":0.309641525320783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045058534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820895,0.00022089611,0.000009687643,0.005832156,0.0003595156,0.0035494196,0.000114167524,0.00004127178,0.0016639066],"genre_scores_gemma":[0.9975332,0.00008362281,0.00015596078,0.00015999486,0.00079816947,0.00057490234,0.00000862125,0.00006267249,0.00062287546],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945706,0.00064460427,0.00061086967,0.0008385971,0.0023616892,0.0009736325],"domain_scores_gemma":[0.99528027,0.00070515065,0.000072039235,0.001612425,0.0014516677,0.00087843166],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009088592,0.00024288041,0.0005979352,0.00029444776,0.00035224872,0.00014217629,0.0006994085,0.00014900317,0.0029276756],"category_scores_gemma":[0.0015130867,0.00016907125,0.00007950444,0.0009795959,0.00089320855,0.0001936331,0.0004916233,0.002555559,0.00007007775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010556092,0.009013863,0.21423991,0.0010834765,0.00027968,0.00027005214,0.010442156,0.000019603956,0.5082555,0.00017144594,0.014733595,0.23093466],"study_design_scores_gemma":[0.01678376,0.017833492,0.728973,0.00066644285,0.000117546515,0.00006344219,0.014119705,0.00033969726,0.12741621,0.00055671873,0.092291966,0.00083803973],"about_ca_topic_score_codex":0.0068151206,"about_ca_topic_score_gemma":0.008558055,"teacher_disagreement_score":0.5147331,"about_ca_system_score_codex":0.00038077898,"about_ca_system_score_gemma":0.0020085596,"threshold_uncertainty_score":0.9997986},"labels":[],"label_agreement":null},{"id":"W2045146082","doi":"10.1158/0008-5472.sabcs13-p1-08-24","title":"Abstract P1-08-24: High tumor RNA disruption is associated with increased survival in patients with locally advanced breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Laurentian University; University of Waterloo","funders":"","keywords":"RNA; Medicine; Breast cancer; Epirubicin; Chemotherapy; Cancer; Docetaxel; Internal medicine; Oncology; Cancer research; Biology; Gene","score_opus":0.012584521740116842,"score_gpt":0.31443282118830895,"score_spread":0.30184829944819214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045146082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768037,0.00012327718,0.00013972176,0.0005234328,0.000024241313,0.00095434184,0.0003150348,0.000021172316,0.00021839186],"genre_scores_gemma":[0.99720055,0.00014222403,0.00013983985,0.0002385216,0.000057660614,0.0015906633,0.00041047487,0.00004076209,0.00017929259],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832594,0.00010713722,0.00019052031,0.00052516884,0.0003500542,0.0005011804],"domain_scores_gemma":[0.99877816,0.000019551122,0.00009340113,0.0003932906,0.00057744916,0.00013813665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023638798,0.00018325048,0.00018839762,0.00008150541,0.00012187734,0.00003763232,0.0002726981,0.00015189976,0.00039589187],"category_scores_gemma":[0.000026255462,0.00013964498,0.00003324136,0.00033770106,0.00022869249,0.000012775487,0.0000960217,0.00031663253,0.0000122249285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013793095,0.0006661378,0.36269307,0.00004842599,0.00019850272,0.000010942883,0.000037357306,0.00013607074,0.6151441,0.00007699409,0.005218844,0.014390279],"study_design_scores_gemma":[0.002031798,0.00037833155,0.9387896,0.00014348593,0.000009391324,0.0000011078907,0.000026620019,0.000017553168,0.057430226,0.000050530674,0.00084908947,0.00027224363],"about_ca_topic_score_codex":0.0041686697,"about_ca_topic_score_gemma":0.0022687418,"teacher_disagreement_score":0.57609653,"about_ca_system_score_codex":0.00015335869,"about_ca_system_score_gemma":0.00028765097,"threshold_uncertainty_score":0.63018095},"labels":[],"label_agreement":null},{"id":"W2045181115","doi":"10.1158/0008-5472.can-05-3719","title":"Hypoxia-Inducible Factor-1-Dependent Repression of <i>E-cadherin</i> in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Public Health Service; National Cancer Institute; National Institutes of Health; University of Pennsylvania; York University; Johns Hopkins University","keywords":"Cadherin; Biology; Cancer research; Null cell; Suppressor; Hypoxia-inducible factors; Tumor suppressor gene; Small hairpin RNA; Psychological repression; Renal cell carcinoma; Transcription factor; Cell; Cancer; Gene expression; Gene; Pathology; Carcinogenesis; Medicine; RNA; Genetics","score_opus":0.02422788873021449,"score_gpt":0.304691158773868,"score_spread":0.2804632700436535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045181115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97082734,0.026398724,0.000017019933,0.00011793457,0.0003602444,0.00048268863,0.0004477651,0.000011488929,0.0013367825],"genre_scores_gemma":[0.9932817,0.002180259,0.00003459807,0.000055652294,0.00075801753,0.00014133345,0.00019092836,0.00005601612,0.0033014757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969009,0.0002900312,0.00047653742,0.0008827861,0.0006699267,0.00077977794],"domain_scores_gemma":[0.9986535,0.00006346592,0.00014698003,0.00065300515,0.00026675715,0.0002163194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006560357,0.00026692208,0.0003886613,0.00019418543,0.000111781126,0.00004395751,0.0003972917,0.00028310693,0.00015299999],"category_scores_gemma":[0.00010199876,0.00025409806,0.00008662243,0.00032098638,0.00027042703,0.000017571281,0.00035930675,0.00050689164,0.000007127832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041671717,0.00015113158,0.007042594,0.00010901928,0.000012816836,0.000011304179,0.00011470768,0.000033122877,0.9717213,0.0000061783576,0.01950642,0.0008746706],"study_design_scores_gemma":[0.0020409203,0.00020730266,0.011719406,0.0000506682,0.00001079664,0.000008346902,0.000104841114,0.000023764711,0.9122009,0.00004176466,0.073335506,0.00025574048],"about_ca_topic_score_codex":0.0072326446,"about_ca_topic_score_gemma":0.0011286356,"teacher_disagreement_score":0.059520375,"about_ca_system_score_codex":0.00008989968,"about_ca_system_score_gemma":0.00042130132,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W2045591013","doi":"10.1158/1538-7445.am2011-5603","title":"Abstract 5603: Common genetic variations in VDR, CYP27B1 and CYP24A1 genes and breast cancer risk in African American and European American women in the Women's Circle of Health Study","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute","funders":"","keywords":"Calcitriol receptor; Single-nucleotide polymorphism; Breast cancer; Linkage disequilibrium; Haplotype; Vitamin D and neurology; Medicine; Genotype; Oncology; Internal medicine; Cancer; SNP; Genetics; Gynecology; Biology; Gene","score_opus":0.06921348988259238,"score_gpt":0.40285608861110994,"score_spread":0.33364259872851754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045591013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403536,0.002776773,7.1861814e-7,0.001587797,0.000012155527,0.0012469741,0.00008130402,0.000008395113,0.00025050045],"genre_scores_gemma":[0.98423535,0.014719603,0.000032818207,0.00007906717,0.00004000531,0.0008423447,0.0000011899197,0.000029494315,0.000020141495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99566597,0.0018082412,0.0004637862,0.00048195067,0.0006159622,0.0009640669],"domain_scores_gemma":[0.99863255,0.00041264476,0.00016716188,0.00038724873,0.00013138668,0.00026897938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004845331,0.00016542911,0.000631553,0.0006628025,0.0001724705,0.000031918364,0.00022951401,0.000019775822,0.000035555575],"category_scores_gemma":[0.00019961096,0.00012869152,0.000014657761,0.001594702,0.0014380544,0.00006660914,0.00030727594,0.0007262359,9.433576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017716493,0.00050371385,0.7799213,0.00014341711,0.000054659675,0.00005581151,0.08116343,0.000005065829,0.00029735555,0.0000016396074,0.000020428837,0.137656],"study_design_scores_gemma":[0.0014140181,0.0011049929,0.9021738,0.00012102353,0.0000060406906,0.0000068859204,0.09495428,0.000020609003,0.000009825313,0.000053634423,0.000036547048,0.00009834399],"about_ca_topic_score_codex":0.18519029,"about_ca_topic_score_gemma":0.04235756,"teacher_disagreement_score":0.14283273,"about_ca_system_score_codex":0.00069284387,"about_ca_system_score_gemma":0.00032074377,"threshold_uncertainty_score":0.9751169},"labels":[],"label_agreement":null},{"id":"W2045596194","doi":"10.1158/1538-7445.am10-65","title":"Abstract 65: Metformin inhibits in vivo growth of MC38 colon carcinoma in the absence of LKB1 expression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metformin; AMPK; Endocrinology; Internal medicine; Hyperinsulinemia; Cancer; Gene knockdown; In vivo; Medicine; Cancer research; Insulin; Cell growth; Insulin resistance; Biology; Kinase; Protein kinase A; Apoptosis; Cell biology; Biochemistry","score_opus":0.03474131947255303,"score_gpt":0.35518670190119705,"score_spread":0.320445382428644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045596194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748815,0.02387706,0.0000010942547,0.000032967444,0.00010624695,0.00027128565,0.000039212908,0.0000012280037,0.00078942487],"genre_scores_gemma":[0.9927693,0.0068189255,0.00003243016,0.00003959498,0.00013669675,0.00013551637,0.0000067031638,0.00001188197,0.000048944465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986229,0.00012514109,0.00026948022,0.00025910322,0.00039202403,0.00033134734],"domain_scores_gemma":[0.9992202,0.00006420566,0.000079093996,0.00036956544,0.0002168998,0.000050042472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013806083,0.00009475376,0.00018056674,0.00013254353,0.00003225347,0.000009214062,0.00044133587,0.00015598338,0.00014525378],"category_scores_gemma":[0.00021254273,0.00006970991,0.00004826065,0.0003332813,0.00024089988,0.000008674494,0.00011266599,0.0003945956,0.000001383094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114642884,0.00007166093,0.014445589,0.0001045691,0.0000036696538,0.000002608694,0.0004800799,0.000004062215,0.97826594,0.000094160605,0.001033476,0.005379568],"study_design_scores_gemma":[0.00047265686,0.00007835312,0.027973339,0.00006127264,0.0000014451133,7.5487543e-7,0.00020161616,0.00000475049,0.96394783,0.00022601594,0.0069596833,0.00007228721],"about_ca_topic_score_codex":0.001297688,"about_ca_topic_score_gemma":0.0022647274,"teacher_disagreement_score":0.017887827,"about_ca_system_score_codex":0.000018609218,"about_ca_system_score_gemma":0.0002903073,"threshold_uncertainty_score":0.28426877},"labels":[],"label_agreement":null},{"id":"W2045648679","doi":"10.1158/0008-5472.can-04-3671","title":"Prostaglandin E2 Enhances Intestinal Adenoma Growth via Activation of the Ras-Mitogen-Activated Protein Kinase Cascade","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Prostaglandin E2; Cancer research; Protein kinase A; Tumor promotion; Biology; Kinase; Prostaglandin E; Endocrinology; Prostaglandin; Mitogen-activated protein kinase; Signal transduction; Internal medicine; Cell growth; Cyclooxygenase; Cell biology; Cancer; Enzyme; Medicine; Carcinogenesis; Biochemistry","score_opus":0.03823075063330117,"score_gpt":0.3545545471805322,"score_spread":0.31632379654723103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045648679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994052,0.0002683618,0.000052568368,0.0034145727,0.00013231908,0.0017659174,0.00000589986,0.000031044998,0.00027735074],"genre_scores_gemma":[0.9966126,0.00002473439,0.00007121137,0.000053141965,0.00081269635,0.0005509697,0.0000064502547,0.000028968116,0.0018392025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795103,0.0002716538,0.00021262454,0.0002790623,0.00083826476,0.00044735565],"domain_scores_gemma":[0.99875355,0.00014705361,0.00011324433,0.00031147423,0.0005225023,0.0001521551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077418867,0.00014568705,0.00023298881,0.00017836518,0.00018216588,0.000022925286,0.00020448647,0.000111212576,0.00018060974],"category_scores_gemma":[0.00079956197,0.00009393038,0.000070011316,0.0006809318,0.0002853393,0.0001605393,0.00008731167,0.00067037344,0.000017452197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007964798,0.000074041585,0.007148913,0.0003850783,0.000031205578,0.000010256101,0.0006984131,0.0000018747451,0.9824371,0.000068843794,0.0012258592,0.0071219327],"study_design_scores_gemma":[0.0010961012,0.0003046169,0.013894148,0.0007013904,0.000012054328,0.00001197481,0.00011269986,0.0000990954,0.98080873,0.000043136006,0.002819022,0.000097041695],"about_ca_topic_score_codex":0.00040237923,"about_ca_topic_score_gemma":0.00006574554,"teacher_disagreement_score":0.007024891,"about_ca_system_score_codex":0.00040698407,"about_ca_system_score_gemma":0.0005810985,"threshold_uncertainty_score":0.38303694},"labels":[],"label_agreement":null},{"id":"W2045735832","doi":"10.1158/1538-7445.am2014-239","title":"Abstract 239: Capsaicin may reduce the metastatic burden in the transgenic adenocarcioma of the mouse prostate (TRAMP) model","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coconut Research and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Tramp; Capsaicin; Medicine; Prostate; Prostate cancer; Adenocarcinoma; Pathology; Saline; Internal medicine; Cancer; Gastroenterology","score_opus":0.10087810892377556,"score_gpt":0.4081688845231823,"score_spread":0.3072907755994067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045735832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756961,0.00065496244,0.000026122008,0.017387047,0.000008472675,0.0008083135,0.00012155656,0.000013920104,0.005283542],"genre_scores_gemma":[0.9938218,0.00032067657,0.000023463288,0.000058545913,0.00010565451,0.0015178801,0.000010640506,0.000027886997,0.0041134595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972095,0.0002953106,0.00032444982,0.00033559976,0.0011544876,0.00068064034],"domain_scores_gemma":[0.99770045,0.0006949083,0.00006852731,0.001226892,0.00020914072,0.00010008682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002305762,0.00014460032,0.00017684656,0.00007269176,0.0003465517,0.0000948891,0.0018368424,0.000057980058,0.00038650937],"category_scores_gemma":[0.00023912956,0.0000713615,0.000121017685,0.0006640059,0.0006679564,0.00006667377,0.00013148744,0.0012007146,0.000020027877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012262458,0.00012960174,0.0001874726,0.00036727794,0.00005433128,0.000002112681,0.0065315333,0.0034793206,0.9665165,0.0021484285,0.0051241997,0.015336574],"study_design_scores_gemma":[0.0016426251,0.00005553111,0.0031329875,0.00022949967,0.000043481028,0.000008623186,0.008770383,0.013527109,0.94350606,0.010378605,0.018387124,0.00031797864],"about_ca_topic_score_codex":0.0033447035,"about_ca_topic_score_gemma":0.0012699184,"teacher_disagreement_score":0.023010468,"about_ca_system_score_codex":0.00014180123,"about_ca_system_score_gemma":0.0005915327,"threshold_uncertainty_score":0.5216574},"labels":[],"label_agreement":null},{"id":"W2045913828","doi":"10.1158/0008-5472.sabcs-09-4059","title":"A Genomic Biomarker for Breast Cancer Development in High-Risk Women.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Breast cancer; Biomarker; Family history; Cancer; Oncology; Medicine; Disease; Internal medicine; Bioinformatics; Biology; Genetics","score_opus":0.038904399999549824,"score_gpt":0.3759158862873485,"score_spread":0.3370114862877987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045913828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470544,0.0025984684,0.000251063,0.0013274077,0.00017927572,0.0005619395,0.00025157398,0.000008912887,0.000115932],"genre_scores_gemma":[0.99379116,0.0013693904,0.0008837924,0.00026389273,0.0003382759,0.0021528378,0.000037377547,0.000030079464,0.0011332039],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825877,0.00009376976,0.00022552785,0.000505288,0.0002377921,0.0006788599],"domain_scores_gemma":[0.99921316,0.00002382482,0.00004873034,0.00031983023,0.00027865323,0.00011578792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008040424,0.0001375957,0.00014239598,0.00018329432,0.00016565833,0.00003724354,0.00031431,0.0001337511,0.00021144794],"category_scores_gemma":[0.000047939273,0.00013661226,0.00003787911,0.00034295794,0.00009650295,0.000004806683,0.000090711364,0.00017625086,0.000012127426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008172571,0.000102520156,0.01566479,0.000040616145,0.0001054161,0.0000027676824,0.00067361933,0.0006039811,0.6267851,0.000059022113,0.011883098,0.34326184],"study_design_scores_gemma":[0.0026996979,0.00023073147,0.59907764,0.00006511404,0.000008525458,0.000006498317,0.00030350106,0.00008063198,0.2033445,0.00074750814,0.19298542,0.00045026885],"about_ca_topic_score_codex":0.0003903317,"about_ca_topic_score_gemma":0.0010503599,"teacher_disagreement_score":0.5834128,"about_ca_system_score_codex":0.0014734175,"about_ca_system_score_gemma":0.0017718137,"threshold_uncertainty_score":0.5570887},"labels":[],"label_agreement":null},{"id":"W2045944150","doi":"10.1158/1538-7445.chtme14-b34","title":"Abstract B34: Signaling in the tumor microenvironment: Proteomics analyses of stromal-tumor interaction in oral cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer-Associated Fibroblasts; Tumor microenvironment; Stromal cell; Biology; Tumor progression; Microvesicles; Cancer research; Stroma; Cancer cell; Cell biology; Cell signaling; Cancer; Paracrine signalling; Crosstalk; Signal transduction; Immunology; microRNA; Receptor; Biochemistry; Genetics; Tumor cells","score_opus":0.11227350845574866,"score_gpt":0.4265513882458704,"score_spread":0.3142778797901218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045944150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996862,0.0015504675,0.00018544366,0.00021246672,0.00007588841,0.0007588283,0.000029245766,0.0000031121454,0.00032254096],"genre_scores_gemma":[0.9988162,0.00026123924,0.00022756861,0.00007732402,0.0001120906,0.00038548344,0.00003224929,0.000030654766,0.000057219833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975476,0.00040537995,0.00035277096,0.00043733531,0.0006983738,0.000558501],"domain_scores_gemma":[0.99915445,0.000040197057,0.0000994181,0.00043072272,0.00016522386,0.00010997314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018543404,0.00015104967,0.00020419392,0.00030994785,0.00005116173,0.000044292326,0.00052151486,0.000093673196,0.000070714945],"category_scores_gemma":[0.00023938867,0.00012871824,0.00007346489,0.0005665461,0.00019779759,0.0000140906,0.0001823914,0.0006907727,0.000007643211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061630417,0.000080520986,0.00055222417,0.000048274756,0.000033477307,0.000048632453,0.00023842625,0.014597841,0.98272026,0.00000858238,0.00046675027,0.0005887282],"study_design_scores_gemma":[0.0010602745,0.00033047827,0.0011127073,0.000121590776,0.000006553048,0.000010628812,0.001852241,0.00032103425,0.9931009,0.00007134712,0.0018764717,0.0001357692],"about_ca_topic_score_codex":0.0077528516,"about_ca_topic_score_gemma":0.0032752107,"teacher_disagreement_score":0.014276806,"about_ca_system_score_codex":0.0006996956,"about_ca_system_score_gemma":0.0009289616,"threshold_uncertainty_score":0.99885464},"labels":[],"label_agreement":null},{"id":"W2046396781","doi":"10.1158/0008-5472.sabcs13-ot2-6-11","title":"Abstract OT2-6-11: PENELOPE: Phase III study evaluating palbociclib (PD-0332991), a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with hormone-receptor-positive, HER2-normal primary breast cancer with high relapse risk after neoadjuvant chemotherapy (GBG-78/BIG1-13)","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Oncology; Clinical endpoint; Breast cancer; Taxane; Letrozole; Cancer; Placebo; Hormonal therapy; Clinical trial; Tamoxifen; Metastatic breast cancer; Pathology","score_opus":0.01863472530708059,"score_gpt":0.3456849310833449,"score_spread":0.3270502057762643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046396781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873219,0.0021169598,0.00002924693,0.0013163297,0.00024475748,0.00798451,0.0007410038,0.00014189005,0.00010338344],"genre_scores_gemma":[0.9886157,0.000719589,0.0006700908,0.00045962812,0.0008095187,0.0075503085,0.00015832928,0.00035745814,0.0006594054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906913,0.00062936055,0.001151646,0.0018011304,0.0036960973,0.002030446],"domain_scores_gemma":[0.9949234,0.00029500976,0.000543077,0.0012440741,0.0021459348,0.00084846735],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016133075,0.00096292974,0.0013140624,0.0006439184,0.00047443918,0.00021713827,0.00057443377,0.00028588824,0.0034465103],"category_scores_gemma":[0.00006248579,0.00071728235,0.00014904646,0.0014121961,0.00070012454,0.0012192467,0.00028850918,0.0023491622,0.00010236513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09564058,0.0063037667,0.702984,0.00026269295,0.00082780974,0.00031952318,0.0055616694,0.00042878382,0.018611744,0.000001605974,0.00046381366,0.16859406],"study_design_scores_gemma":[0.082173936,0.00549025,0.9041033,0.001589961,0.00015258329,0.00001966026,0.002129056,0.00004569836,0.0032051,0.000016600658,0.00018483934,0.00088902685],"about_ca_topic_score_codex":0.030779213,"about_ca_topic_score_gemma":0.004775558,"teacher_disagreement_score":0.20111935,"about_ca_system_score_codex":0.0032001003,"about_ca_system_score_gemma":0.0018903003,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W2046558969","doi":"10.1158/0008-5472.can-05-2638","title":"The Secretory Leukocyte Protease Inhibitor Is a Type 1 Insulin-Like Growth Factor Receptor–Regulated Protein that Protects against Liver Metastasis by Attenuating the Host Proinflammatory Response","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences","keywords":"Proinflammatory cytokine; Tumor necrosis factor alpha; Biology; Cancer research; Immunology; Inflammation","score_opus":0.03387343348523485,"score_gpt":0.30491456539351086,"score_spread":0.271041131908276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046558969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844292,0.007040061,0.000017081515,0.002306716,0.00012347726,0.0056950403,0.0002317263,0.000056872126,0.00009983045],"genre_scores_gemma":[0.98673224,0.00040707478,0.00009394606,0.00012277644,0.00047309347,0.0031721855,0.000099812125,0.00015294249,0.0087459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.992643,0.0027712544,0.00046793598,0.0010014344,0.0017003466,0.0014160356],"domain_scores_gemma":[0.99673307,0.00028848508,0.00021544976,0.0011739875,0.0013104209,0.00027857922],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003483883,0.00044191786,0.00027803567,0.00017044635,0.0013862642,0.00037433585,0.0011847032,0.00035397706,0.000108777385],"category_scores_gemma":[0.0014514987,0.00028924464,0.00016974444,0.0008892007,0.0010778744,0.000039272098,0.0007933728,0.0013085101,0.00013820281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004427094,0.00006507472,0.0003697183,0.0001568666,0.00012997881,0.000014463344,0.00021668902,0.000003984097,0.94689304,0.00001077032,0.046410494,0.0013018163],"study_design_scores_gemma":[0.00077715004,0.00049195753,0.0024058563,0.0001580848,0.000006883864,0.000003775855,0.00015766242,0.00005445495,0.8764116,0.00001795618,0.11917414,0.00034048743],"about_ca_topic_score_codex":0.00064545847,"about_ca_topic_score_gemma":0.00013933452,"teacher_disagreement_score":0.072763644,"about_ca_system_score_codex":0.00047663806,"about_ca_system_score_gemma":0.0019188332,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W2046632683","doi":"10.1158/1538-7445.am2014-2508","title":"Abstract 2508: The development of anti-androgens with a novel mechanism of action for treatment of castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Androgen receptor; Prostate cancer; Enzalutamide; LNCaP; Coactivator; Cancer research; Docking (animal); Androgen Receptor Antagonists; In silico; Mechanism of action; Binding site; Chemistry; Cancer; Computational biology; Pharmacology; Medicine; Biology; Transcription factor; Biochemistry; Internal medicine; In vitro; Gene","score_opus":0.16582030833316927,"score_gpt":0.43818341111575015,"score_spread":0.2723631027825809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046632683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555546,0.0008139576,0.00027862182,0.0006794343,0.000048966525,0.0021858495,0.00023624525,0.000007784093,0.00019368881],"genre_scores_gemma":[0.9961897,0.00082664215,0.00079341215,0.000004639943,0.00006841568,0.0013007283,0.000035541565,0.000027286902,0.0007536208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981327,0.000041116004,0.00039373443,0.000269633,0.00077057135,0.00039225703],"domain_scores_gemma":[0.99816525,0.00019530617,0.00018068639,0.00030186036,0.0010520393,0.000104856415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064193376,0.00014746228,0.00040094717,0.00018619964,0.00016610138,0.000010780452,0.000111600224,0.00006126569,0.000087716195],"category_scores_gemma":[0.00003095452,0.00007996532,0.000082154016,0.0003605924,0.0002788586,0.00005246143,0.000022259881,0.00009403069,7.206133e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004099572,0.0005745145,0.0026151016,0.0010078604,0.0005391052,0.0000018911917,0.002910494,0.000066407134,0.9670993,0.0004534873,0.000057840105,0.020574436],"study_design_scores_gemma":[0.0047826366,0.0018206189,0.017861672,0.0004184786,0.000086150496,0.0000020458363,0.0009160874,0.000095806645,0.9718839,0.000064885964,0.0019876517,0.00008006903],"about_ca_topic_score_codex":0.0011972165,"about_ca_topic_score_gemma":0.0017704895,"teacher_disagreement_score":0.020494366,"about_ca_system_score_codex":0.00046786116,"about_ca_system_score_gemma":0.002132504,"threshold_uncertainty_score":0.37829706},"labels":[],"label_agreement":null},{"id":"W2046705215","doi":"10.1158/0008-5472.sabcs-903","title":"Bevacizumab (BV) maintenance therapy significantly delays disease progression (PD) or death compared with placebo (PL) in the AVADO trial (BV + docetaxel [D] vs D + PL in 1st-line HER2-negative locally recurrent [LR] or metastatic breast cancer [mBC]).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Discontinuation; Concomitant; Docetaxel; Taxane; Chemotherapy; Oncology; Gastroenterology; Cancer; Urology; Breast cancer","score_opus":0.16377481921600498,"score_gpt":0.477930570792345,"score_spread":0.31415575157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046705215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574084,0.004702689,0.000054647044,0.025352951,0.0003100765,0.011252538,0.0005707851,0.000064227475,0.00028368187],"genre_scores_gemma":[0.9834425,0.00704774,0.00021086146,0.0012163991,0.00057317107,0.0060174586,0.000095383504,0.00006544603,0.0013310594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99402064,0.0013677314,0.0007445782,0.0010083901,0.001496402,0.0013622505],"domain_scores_gemma":[0.99719894,0.00085347856,0.00023507164,0.00059804774,0.00059158646,0.00052289676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015104053,0.0005516843,0.0009981543,0.00046943864,0.00026191756,0.00010151152,0.00058257655,0.00011529427,0.0016226488],"category_scores_gemma":[0.00016429403,0.00027992285,0.00013431475,0.0017748582,0.0005563369,0.00019944173,0.000069195645,0.0013671088,0.000018388942],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9157144,0.004660061,0.0041142902,0.00022722722,0.00031351388,0.002624344,0.003440006,0.000419311,0.0006316694,0.00005457932,0.007436766,0.060363863],"study_design_scores_gemma":[0.7825587,0.04997578,0.12343827,0.008874772,0.0009369057,0.00038693528,0.004754871,0.007169075,0.0045326035,0.001081076,0.014375507,0.0019155511],"about_ca_topic_score_codex":0.0039626467,"about_ca_topic_score_gemma":0.015123206,"teacher_disagreement_score":0.13315572,"about_ca_system_score_codex":0.0019413787,"about_ca_system_score_gemma":0.0042874296,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W2046799971","doi":"10.1158/0008-5472.sabcs13-p5-14-15","title":"Abstract P5-14-15: Discovery and validation of simple heart measurements to screen patients who will benefit from deep inspiration breath hold for left breast irradiation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nuclear medicine; Left breast; Breast cancer; Cohort; Cutoff; Radiation therapy; Radiology; Cardiology; Internal medicine; Cancer","score_opus":0.047215463285367215,"score_gpt":0.33539121276381306,"score_spread":0.2881757494784458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046799971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969729,0.0003598269,0.00020048661,0.0005026418,0.000052584786,0.0009776149,0.00087113195,0.0000052635964,0.000057544312],"genre_scores_gemma":[0.9980761,0.00008494802,0.00013819135,0.00010583222,0.00019504233,0.00036038502,0.0009577327,0.000024654526,0.000057153607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986834,0.000039530994,0.00021098748,0.00039862923,0.00038715597,0.00028031704],"domain_scores_gemma":[0.9988522,0.0000353902,0.00007261036,0.00024284876,0.0006993205,0.0000976568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018542199,0.00013769678,0.00016820041,0.00008139034,0.00014972234,0.00007262059,0.00010947827,0.000088168454,0.00004003869],"category_scores_gemma":[0.00007030128,0.00012902053,0.000044725875,0.00009308814,0.00005989097,0.000065902845,0.000101380814,0.0000595193,0.0000048086063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040547785,0.00014925956,0.7362157,0.0000538271,0.00017336861,6.446019e-8,0.0002523849,0.00024818047,0.24369004,0.000008556826,0.0033703283,0.015432791],"study_design_scores_gemma":[0.0010332891,0.00020000807,0.88532186,0.000044983808,0.000017226523,2.4867472e-7,0.00004557321,0.000016930946,0.11249251,0.00016195302,0.00054738915,0.00011800707],"about_ca_topic_score_codex":0.0058391197,"about_ca_topic_score_gemma":0.0013316233,"teacher_disagreement_score":0.14910616,"about_ca_system_score_codex":0.00012832394,"about_ca_system_score_gemma":0.00006977628,"threshold_uncertainty_score":0.88270414},"labels":[],"label_agreement":null},{"id":"W2046835245","doi":"10.1158/1538-7445.tim2013-ia28","title":"Abstract IA28: Targeting stress-induced molecular chaperones CLU and Hsp27 to inhibit EMT and metastases","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hsp27; Proteostasis; Clusterin; Epithelial–mesenchymal transition; Cancer research; Biology; Heat shock protein; Vimentin; Cancer; Metastasis; Medicine; Cell biology; Immunology; Apoptosis; Internal medicine; Hsp70; Gene","score_opus":0.07796611160501193,"score_gpt":0.4213044203880965,"score_spread":0.3433383087830846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046835245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097484,0.0036097676,0.000012191071,0.0038769434,0.00006136076,0.0009131743,0.000049146725,0.000031721393,0.00047087186],"genre_scores_gemma":[0.9981034,0.00021595939,0.0005329422,0.00037603368,0.00015268226,0.0004273445,0.000015192555,0.000035096684,0.00014135198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982562,0.00010766768,0.00020796702,0.0004566797,0.00043677204,0.0005347094],"domain_scores_gemma":[0.99872315,0.00017198685,0.00003003688,0.00028434573,0.00028770918,0.0005027869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004754194,0.00014522481,0.0002664992,0.00023749849,0.00012735126,0.00007442375,0.00010069287,0.000078452096,0.0009948058],"category_scores_gemma":[0.00061192765,0.00012615582,0.000030193132,0.00022653941,0.00018727794,0.00009515638,0.0003800849,0.00035299815,0.000089972666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012810393,0.00006553696,0.0076890695,0.00044663434,0.000050677372,0.00024152795,0.0004969241,0.0000063122116,0.97014624,0.00006139885,0.0026330973,0.018034503],"study_design_scores_gemma":[0.0034739159,0.0010303416,0.46793634,0.0011369713,0.00012940576,0.000112346075,0.0035515968,0.00017994843,0.5163024,0.0007944766,0.0046781166,0.0006741497],"about_ca_topic_score_codex":0.0010590422,"about_ca_topic_score_gemma":0.000049981878,"teacher_disagreement_score":0.46024728,"about_ca_system_score_codex":0.000080326376,"about_ca_system_score_gemma":0.00011405248,"threshold_uncertainty_score":0.9999184},"labels":[],"label_agreement":null},{"id":"W2046947683","doi":"10.1158/1538-7445.am2011-2880","title":"Abstract 2880: Role of Akt isoforms in chemoresistance of endometrial carcinoma cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Protein kinase B; AKT2; AKT1; Cancer research; Cisplatin; Apoptosis; XIAP; Cell growth; Western blot; Transfection; AKT3; Biology; Chemistry; Cell culture; Medicine; Internal medicine; Programmed cell death; Caspase; Chemotherapy; Biochemistry","score_opus":0.06692704896650366,"score_gpt":0.3569089178530806,"score_spread":0.28998186888657695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046947683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912373,0.0022457992,0.000004833937,0.000015478076,0.00007717648,0.00036149586,0.00009462088,0.0000029431003,0.0059603485],"genre_scores_gemma":[0.9987056,0.00052053237,0.00010506763,0.000004274457,0.00012474034,0.00007288007,0.00001653195,0.000028562456,0.0004217927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785334,0.00010824953,0.00038200623,0.00038585902,0.0006622279,0.0006083459],"domain_scores_gemma":[0.99866354,0.00006737491,0.000097116055,0.0005716258,0.0004700473,0.0001302836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010753799,0.00013103857,0.00027073626,0.0003849453,0.000032390813,0.0000085463325,0.0006394302,0.00019074413,0.00035655638],"category_scores_gemma":[0.00031773193,0.00011930931,0.0001029259,0.00065105705,0.00040007147,0.000008374619,0.00027781882,0.00030502124,0.000011218302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001061083,0.00033850377,0.04008165,0.00013052124,0.000026447227,0.0000056707913,0.00024118471,0.000002149513,0.9551123,0.000036856563,0.0005759855,0.002387655],"study_design_scores_gemma":[0.0018202007,0.0002932609,0.042995878,0.000035096662,0.0000021009948,5.468409e-7,0.0002957201,0.0000035869273,0.9530417,0.0001325062,0.001273394,0.00010605237],"about_ca_topic_score_codex":0.003656325,"about_ca_topic_score_gemma":0.0007650922,"teacher_disagreement_score":0.007468314,"about_ca_system_score_codex":0.00009326201,"about_ca_system_score_gemma":0.0005695182,"threshold_uncertainty_score":0.55272937},"labels":[],"label_agreement":null},{"id":"W2047060378","doi":"10.1158/1538-7445.am2013-4650","title":"Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; GDF15; Internal medicine; Cachexia; Cancer; Gastroenterology; FGF21; Endocrinology; Oncology; Fibroblast growth factor","score_opus":0.055330916054309884,"score_gpt":0.3796706978658581,"score_spread":0.3243397818115482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047060378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441006,0.01810143,0.00016630892,0.0032703476,0.0013862954,0.0013160029,0.0010782945,0.00002392034,0.00024733038],"genre_scores_gemma":[0.9813834,0.006565116,0.0005883711,0.00074152474,0.0049239267,0.003042301,0.00018984974,0.00009571085,0.0024698332],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973763,0.000069514484,0.0003091948,0.00083573436,0.00047463668,0.00093461],"domain_scores_gemma":[0.997996,0.00008931177,0.00009571895,0.0006217564,0.0007994406,0.0003977724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046028776,0.00025758805,0.00030495325,0.00016653794,0.00020689057,0.00013213183,0.0004928831,0.00020658734,0.00063820387],"category_scores_gemma":[0.00029446735,0.0002384134,0.00014069525,0.00029972257,0.00015236954,0.000018175238,0.0002371988,0.00026092847,0.000046061174],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020432637,0.00003280312,0.0024680397,0.0000691979,0.00015472063,0.0000012753804,0.0001746249,0.000094049195,0.80558974,0.0000081357775,0.15721884,0.033984255],"study_design_scores_gemma":[0.0009139617,0.00008822612,0.0445201,0.00012540446,0.000027125267,7.419206e-7,0.00049606117,0.00003428516,0.3349157,0.00020290364,0.61829984,0.00037564884],"about_ca_topic_score_codex":0.021843951,"about_ca_topic_score_gemma":0.005071365,"teacher_disagreement_score":0.47067404,"about_ca_system_score_codex":0.00016794738,"about_ca_system_score_gemma":0.0005664417,"threshold_uncertainty_score":0.9846697},"labels":[],"label_agreement":null},{"id":"W2047106219","doi":"10.1158/0008-5472.sabcs12-p2-10-20","title":"Abstract P2-10-20: A tumor DNA complexity index is an independent predictor of survival in a dataset of 1950 breast cancers; a METABRIC group study.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Breast cancer; Oncology; Medicine; Estrogen receptor; Proportional hazards model; Hazard ratio; Internal medicine; Carcinogenesis; Cancer; Confidence interval","score_opus":0.09386412704919658,"score_gpt":0.38618475397101754,"score_spread":0.2923206269218209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047106219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98157215,0.0017077632,0.000016207074,0.00003512023,0.0001573531,0.0006134087,0.015754394,0.0000031428604,0.00014044535],"genre_scores_gemma":[0.9978329,0.00027622338,0.000030804036,0.00003983063,0.00035363573,0.00016427478,0.001240758,0.000030576168,0.000030991603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975914,0.00020243357,0.00047717238,0.00045506004,0.00066557055,0.0006084058],"domain_scores_gemma":[0.9984856,0.000061988205,0.00017304227,0.0007416745,0.0002750657,0.00026262552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015712951,0.00018429554,0.00038257835,0.00019310384,0.000058043628,0.000023084918,0.0005444189,0.00010423014,0.0004674453],"category_scores_gemma":[0.000091525566,0.00018121621,0.00006785682,0.00036913485,0.0002980099,0.000019512716,0.00043735802,0.00028533352,0.0000035081791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026129258,0.0028780925,0.66777647,0.00034055056,0.00036680765,0.00001845182,0.001371119,0.00014090716,0.31022725,0.00009622389,0.01195662,0.0022146031],"study_design_scores_gemma":[0.0035056213,0.0010513369,0.93988425,0.00007805846,0.00004900341,0.000010263778,0.0020956292,0.00011411139,0.04065947,0.00007099592,0.012089261,0.00039201236],"about_ca_topic_score_codex":0.024336195,"about_ca_topic_score_gemma":0.031088904,"teacher_disagreement_score":0.27210778,"about_ca_system_score_codex":0.00021382305,"about_ca_system_score_gemma":0.00074784533,"threshold_uncertainty_score":0.9865912},"labels":[],"label_agreement":null},{"id":"W2047310369","doi":"10.1158/0008-5472.sabcs11-pd01-09","title":"PD01-09: Identifying Novel Mechanisms of Resistance to Lapatinib in ERBB2+ Breast Cancer Cells through Whole Genome Mutational Analysis.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; SKBR3; Trastuzumab; Breast cancer; Cancer research; Cancer; Biology; Genetics; Medicine","score_opus":0.1400050392613686,"score_gpt":0.42376446790017974,"score_spread":0.28375942863881115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047310369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9064207,0.0057882927,0.07391758,0.004054624,0.00047102984,0.0026019835,0.0031340502,0.00010951704,0.0035022083],"genre_scores_gemma":[0.9809766,0.00017346344,0.015378951,0.0003423584,0.00016922572,0.0007909029,0.000047685004,0.00006845874,0.0020523705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99651515,0.00011717022,0.00058897876,0.0007140493,0.001273561,0.0007911071],"domain_scores_gemma":[0.99786144,0.000116081195,0.00016536856,0.0006050876,0.0010103887,0.00024163895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008159952,0.00023912189,0.00065349555,0.00081752107,0.00012410042,0.000023387793,0.00041445874,0.00011463811,0.002713258],"category_scores_gemma":[0.000049083985,0.0002328692,0.00015748742,0.0033833561,0.0002622037,0.0002913429,0.0001633933,0.000514535,0.00004878044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022308307,0.00031503264,0.004088568,0.0003677259,0.0006640771,0.000054781918,0.009796062,0.0011393083,0.9768679,0.002523392,0.00009288597,0.0018594147],"study_design_scores_gemma":[0.006388263,0.00028551352,0.4182937,0.0015422347,0.0004759592,0.000024625459,0.0058593405,0.0001518197,0.5451548,0.014069023,0.0068872334,0.0008674337],"about_ca_topic_score_codex":0.0051829247,"about_ca_topic_score_gemma":0.0072615054,"teacher_disagreement_score":0.4317131,"about_ca_system_score_codex":0.00093926815,"about_ca_system_score_gemma":0.0007180252,"threshold_uncertainty_score":0.9981984},"labels":[],"label_agreement":null},{"id":"W2047458509","doi":"10.1158/1538-7445.am2014-3285","title":"Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation of <i>BNC2</i> as a mechanism in ovarian cancer predisposition","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Locus (genetics); DNA methylation; Allele; Genome-wide association study; Minor allele frequency; Expression quantitative trait loci; Gene; Regulation of gene expression; Gene expression; Genotype","score_opus":0.052239728658023836,"score_gpt":0.364721173259026,"score_spread":0.31248144460100213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047458509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809956,0.00090427167,0.00025799227,0.015405697,0.0001588034,0.0008494762,0.00018950844,0.000007893211,0.0012307583],"genre_scores_gemma":[0.9984362,0.00032355817,0.000016911908,0.00015626819,0.00016352072,0.00067122397,0.000049324106,0.000013666385,0.00016930715],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980879,0.00015345571,0.00034704796,0.00029229352,0.0008778563,0.0002414617],"domain_scores_gemma":[0.998808,0.00019798595,0.00012373351,0.00041142543,0.00039400725,0.000064823886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085766346,0.00010885654,0.00028749413,0.00028641577,0.000121930345,0.000014792208,0.00015353973,0.00008529295,0.001183673],"category_scores_gemma":[0.000042779782,0.00006475176,0.00020942374,0.0014023953,0.00016611173,0.00006522461,0.000031255477,0.00026292674,0.0000034830157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019454783,0.0010251693,0.16020717,0.00032519063,0.002844553,0.0000027017602,0.0012918003,0.008325966,0.71468735,0.09323782,0.0016868005,0.014420027],"study_design_scores_gemma":[0.0011584056,0.00011374317,0.9258355,0.00019154894,0.00048792022,0.0000016070146,0.00007876545,0.0006242753,0.06649128,0.0044300305,0.00053237035,0.00005454364],"about_ca_topic_score_codex":0.0058232094,"about_ca_topic_score_gemma":0.0015271599,"teacher_disagreement_score":0.76562834,"about_ca_system_score_codex":0.0004077883,"about_ca_system_score_gemma":0.0004438245,"threshold_uncertainty_score":0.9997294},"labels":[],"label_agreement":null},{"id":"W2047515951","doi":"10.1158/0008-5472.can-08-4747","title":"Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Colorectal cancer; Oxaliplatin; Internal medicine; Oncology; Quality of life (healthcare); Circadian rhythm; Cancer; Hazard ratio; Performance status; Chemotherapy; Confidence interval","score_opus":0.11215954963745767,"score_gpt":0.3802042766258988,"score_spread":0.2680447269884411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047515951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848294,0.0005444881,0.000001968573,0.0001323518,0.000033647924,0.0005384358,0.00016990038,0.0000038938565,0.00009234484],"genre_scores_gemma":[0.99940616,0.00049013016,0.000008284808,0.000019238618,0.000009791057,0.000043851272,9.97171e-7,0.0000070117294,0.000014512082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797386,0.0005922589,0.00031591795,0.00034806415,0.00043998825,0.0003299156],"domain_scores_gemma":[0.99890465,0.0005781495,0.00013391663,0.00013427259,0.00010047764,0.00014851798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081967015,0.000099643876,0.00044509847,0.00026630217,0.000028635672,0.000007665376,0.00009227635,0.00007087729,0.000020601436],"category_scores_gemma":[0.0008320924,0.0000794352,0.00001995528,0.00071437843,0.0006757113,0.000102536964,0.000054697663,0.00033553067,1.8355183e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019781787,0.0002252808,0.93573594,0.00011678331,0.000007143075,0.000008980427,0.00088870944,0.000027905113,0.057372343,0.0008781815,0.0000033296026,0.0027572303],"study_design_scores_gemma":[0.002278666,0.00062472565,0.96900564,0.00014272341,0.0000025882975,8.3440074e-7,0.00005982953,0.00008704226,0.027626654,0.00008714037,0.000007981386,0.000076182056],"about_ca_topic_score_codex":0.0020717608,"about_ca_topic_score_gemma":0.0018671006,"teacher_disagreement_score":0.0332697,"about_ca_system_score_codex":0.00008248376,"about_ca_system_score_gemma":0.00034179373,"threshold_uncertainty_score":0.32392734},"labels":[],"label_agreement":null},{"id":"W2047572353","doi":"10.1158/0008-5472.sabcs-09-2125","title":"Elevated Tumor Markers in the Different Breast Cancer Subtypes; Percentage and Correlation with Outcome.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; CA15-3; Cancer; Internal medicine; Tissue microarray; Oncology; CA 15-3; Breast carcinoma; Immunohistochemistry; Basal (medicine); Breast disease; Pathology","score_opus":0.027826378162847304,"score_gpt":0.3671748909677658,"score_spread":0.3393485128049185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047572353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953978,0.001269148,0.000008988919,0.002435136,0.000024371719,0.00048858474,0.0000703814,0.0000046966034,0.0003009134],"genre_scores_gemma":[0.99772936,0.0012291016,0.0000048486863,0.00023874493,0.000091408976,0.00020300316,0.000048805923,0.000012297121,0.00044241932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856293,0.000171249,0.00011460986,0.0003238674,0.00039706618,0.00043025392],"domain_scores_gemma":[0.9995143,0.000023114595,0.000024243063,0.00024567917,0.000092417424,0.00010023759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030094112,0.000120916025,0.00011079476,0.00008143173,0.00013082454,0.000060751518,0.00017983724,0.00004792165,0.00008698455],"category_scores_gemma":[0.000016361108,0.0000727033,0.000025421927,0.00020727453,0.0001328255,0.000007174611,0.000045607238,0.0002669549,0.000003407309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026868214,0.00019176236,0.91717666,0.00003344509,0.00006608412,0.00005732067,0.00018065146,0.000037002366,0.061600793,0.000050815474,0.0025866805,0.015331973],"study_design_scores_gemma":[0.0016176455,0.00047636963,0.99122095,0.000047080397,0.000009201872,0.000027826018,0.0002398397,0.000060992505,0.0042024637,0.000033744636,0.001942601,0.00012126118],"about_ca_topic_score_codex":0.0028884322,"about_ca_topic_score_gemma":0.0062072645,"teacher_disagreement_score":0.074044324,"about_ca_system_score_codex":0.00014708455,"about_ca_system_score_gemma":0.00014513332,"threshold_uncertainty_score":0.4366465},"labels":[],"label_agreement":null},{"id":"W2047658455","doi":"10.1158/1538-7445.chtme14-b70","title":"Abstract B70: Targeting the Tie2/angiopoietin signaling pathway in glioblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Angiopoietin receptor; Angiogenesis; Medicine; Cancer research; Bevacizumab; Angiopoietin; Vascular endothelial growth factor; Myeloid; Immunology; Chemotherapy; Internal medicine; VEGF receptors","score_opus":0.08801451371010298,"score_gpt":0.38754821263188766,"score_spread":0.29953369892178466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047658455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979913,0.007493819,0.000006715904,0.0038034609,0.00028403295,0.0004465262,0.000006224575,0.0000359158,0.008010301],"genre_scores_gemma":[0.9976056,0.000119073,0.00005117907,0.000289215,0.00087052135,0.00012880434,0.0000044327603,0.00002971564,0.0009014126],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978497,0.00015442369,0.00024244041,0.00027175294,0.00086799194,0.0006136623],"domain_scores_gemma":[0.99888504,0.00020251602,0.000036963676,0.00029726938,0.00032347647,0.00025474504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029854605,0.00011191794,0.00020431099,0.00020513771,0.000110623216,0.00004611527,0.00022516026,0.000082023646,0.00040893367],"category_scores_gemma":[0.0008717812,0.000073713774,0.00006240929,0.0007019438,0.00017239575,0.00009105578,0.00010461241,0.0005880969,0.00015776485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042808168,0.0007550244,0.04100429,0.0006737134,0.0001307652,0.0005049194,0.028241046,0.0013251981,0.5356468,0.001742332,0.29379845,0.09189668],"study_design_scores_gemma":[0.008514826,0.00052133366,0.012266777,0.0008248462,0.000029136627,0.00001525893,0.031839754,0.0002813498,0.29120645,0.0021005778,0.65184784,0.00055184716],"about_ca_topic_score_codex":0.0009798922,"about_ca_topic_score_gemma":0.00023245327,"teacher_disagreement_score":0.3580494,"about_ca_system_score_codex":0.00015009429,"about_ca_system_score_gemma":0.0007678769,"threshold_uncertainty_score":0.4477537},"labels":[],"label_agreement":null},{"id":"W2047746881","doi":"10.1158/1538-7445.am2012-2311","title":"Abstract 2311: microRNA-196b regulates HOXB7 in cervical cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Clonogenic assay; microRNA; Biology; Cancer research; Cancer; Gene knockdown; Gene silencing; Transfection; Viability assay; Molecular biology; Cell culture; Gene; Genetics","score_opus":0.04537967306006375,"score_gpt":0.3911974560610997,"score_spread":0.34581778300103594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047746881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96960807,0.02568442,0.00012863062,0.001513817,0.00045057695,0.000677438,0.00007280727,0.000022858645,0.0018413761],"genre_scores_gemma":[0.99197257,0.0038449368,0.00010780247,0.00021043788,0.0011812098,0.00064652547,0.000059740512,0.000093126284,0.0018836794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962173,0.0002609357,0.0003360512,0.0006697801,0.0008328833,0.0016830446],"domain_scores_gemma":[0.9983728,0.000050272705,0.000056766985,0.00071480457,0.00035234782,0.00045302653],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014275219,0.00025417388,0.00025636613,0.00032769056,0.00016894622,0.00007260018,0.0006478665,0.00045062866,0.0011397788],"category_scores_gemma":[0.00018008686,0.00025400484,0.00012714652,0.0007250825,0.0002770888,0.000018734114,0.0005034307,0.0009770625,0.00013217377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003057589,0.00014224507,0.002192915,0.00009260423,0.00006847104,0.000014750555,0.0001224381,0.00015258219,0.9799875,0.00025834443,0.008577509,0.008084854],"study_design_scores_gemma":[0.00087034033,0.00009783389,0.014609835,0.00011528404,0.0000069369553,0.000009357182,0.00011584738,0.000024464533,0.8729623,0.0001197338,0.11075588,0.00031217732],"about_ca_topic_score_codex":0.002892949,"about_ca_topic_score_gemma":0.0022936529,"teacher_disagreement_score":0.10702522,"about_ca_system_score_codex":0.0005076168,"about_ca_system_score_gemma":0.0007604372,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W2047770011","doi":"10.1158/1538-7445.am2013-3743","title":"Abstract 3743: Effect of folic acid supplementation on epigenetics and cancer stem cell populations in established colorectal cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"DNA methylation; Cancer stem cell; Stem cell; Epigenetics; Biology; Cancer research; Cancer; Metastasis; Colorectal cancer; Progenitor cell; Methylation; Cell biology; Biochemistry; Genetics; DNA; Gene expression","score_opus":0.07778329172757605,"score_gpt":0.432500110934612,"score_spread":0.35471681920703596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047770011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986757,0.0061206305,0.0000013294995,0.00051968417,0.00010480078,0.0019016617,0.00012886086,0.000013075519,0.0013423623],"genre_scores_gemma":[0.9884303,0.008557777,0.00003675447,0.000027375516,0.00015544317,0.001398266,0.0000549833,0.000042330907,0.001296724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975375,0.00019928899,0.00037183688,0.00039752698,0.0008292709,0.0006645775],"domain_scores_gemma":[0.9986855,0.00024745596,0.00007147828,0.00024699557,0.00049815775,0.0002504534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006977764,0.00018239372,0.00035936458,0.00040568362,0.00013030878,0.00006116667,0.00015419764,0.00014307997,0.002473458],"category_scores_gemma":[0.000043229935,0.00014737096,0.00005597738,0.0007429681,0.00026731056,0.00019973179,0.00009043775,0.0005523157,0.000027110911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006229348,0.00020255939,0.23274897,0.00119542,0.000031755655,0.000012523344,0.00086342666,0.00014970433,0.7084697,0.000006020808,0.0031880755,0.052508906],"study_design_scores_gemma":[0.0023322692,0.0009144574,0.39414603,0.00025267323,0.000021086831,6.356559e-7,0.00026906264,0.00033765432,0.6013541,0.000017371112,0.00024872978,0.000105902596],"about_ca_topic_score_codex":0.06962737,"about_ca_topic_score_gemma":0.015177968,"teacher_disagreement_score":0.16139705,"about_ca_system_score_codex":0.00076238875,"about_ca_system_score_gemma":0.00048858195,"threshold_uncertainty_score":0.9984384},"labels":[],"label_agreement":null},{"id":"W2047887604","doi":"10.1158/1538-7445.am2013-400","title":"Abstract 400: Coordinated loss of CD9 and IGSF8 expression on the prostate cancer cell surface contributes to metastasis and hormone responsiveness.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"LNCaP; Gene knockdown; Prostate cancer; Tetraspanin; Cancer research; Androgen receptor; Biology; Fetal bovine serum; Metastasis; Cell; Cancer; Cell culture","score_opus":0.053360517335658615,"score_gpt":0.379672813127103,"score_spread":0.3263122957914444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047887604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96897024,0.014798682,0.000005619182,0.01326976,0.000023486147,0.002413738,0.00012689801,0.000016030252,0.0003755196],"genre_scores_gemma":[0.98816186,0.008303232,0.000060113452,0.00020596044,0.000026072536,0.00054478267,0.000008360785,0.000041750587,0.0026478474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718946,0.0004016844,0.00030159898,0.0005037217,0.0009541717,0.00064934],"domain_scores_gemma":[0.9963473,0.0012835831,0.000069204405,0.0004995443,0.0014098954,0.0003904605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015498156,0.0001902761,0.00039969903,0.00016332348,0.00023127155,0.00009086282,0.00022295563,0.00010520269,0.00094225956],"category_scores_gemma":[0.00063294574,0.00011986717,0.000043744967,0.0006716063,0.0005038055,0.00010137737,0.00037339478,0.00060850097,0.000041078525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029041278,0.00010338718,0.004025026,0.00027484004,0.00005748948,0.00003389787,0.00036007896,0.000034804183,0.9659727,0.000024575911,0.021505285,0.0047037494],"study_design_scores_gemma":[0.0017125444,0.00055043044,0.07296921,0.00049295154,0.000019500398,0.000002605089,0.0008283454,0.00008245595,0.9174992,0.00008205032,0.005635384,0.00012535893],"about_ca_topic_score_codex":0.007490758,"about_ca_topic_score_gemma":0.00011055948,"teacher_disagreement_score":0.068944186,"about_ca_system_score_codex":0.00025616915,"about_ca_system_score_gemma":0.00037291987,"threshold_uncertainty_score":0.99997103},"labels":[],"label_agreement":null},{"id":"W2047942417","doi":"10.1158/1538-7445.am10-5049","title":"Abstract 5049: Functional significance of <i>L1CAM</i> in non-small cell lung cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Lung cancer; Medicine; Cancer research; Oncology; Carcinogenesis; Small hairpin RNA; Internal medicine; Gene knockdown; Cancer; Matrigel; Metastasis; Pathology; Cell culture; Biology","score_opus":0.028203820324293874,"score_gpt":0.33472869028692626,"score_spread":0.3065248699626324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047942417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831384,0.009501163,0.00003732514,0.00017594134,0.002037064,0.0005218802,0.000107849635,0.000006107859,0.004474275],"genre_scores_gemma":[0.98854995,0.0042968285,0.00008732374,0.00009550636,0.003204568,0.0006506711,0.0000313639,0.00004007162,0.0030437454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978534,0.00008585053,0.00029981896,0.00057456986,0.00051116565,0.00067521934],"domain_scores_gemma":[0.99857634,0.000063001986,0.00008087261,0.00051113375,0.00060153176,0.00016713465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011857889,0.00016515613,0.00022969859,0.00019563528,0.000119382035,0.000028269775,0.0004076049,0.00026612828,0.0005866073],"category_scores_gemma":[0.00007859342,0.00016475929,0.0000968676,0.00045053466,0.00034399208,0.0000085364345,0.00015412373,0.0009356583,0.000012075577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001813667,0.000105030456,0.006412342,0.00015613133,0.00002119987,0.0000015519487,0.00010599943,0.00021736992,0.9545174,0.000038385468,0.03365763,0.0045855423],"study_design_scores_gemma":[0.0009258864,0.00005083415,0.04824521,0.000051471587,0.000008679434,0.0000012503241,0.000103941966,0.000023343011,0.73440564,0.000047269732,0.21593875,0.00019773828],"about_ca_topic_score_codex":0.003977607,"about_ca_topic_score_gemma":0.009727642,"teacher_disagreement_score":0.22011182,"about_ca_system_score_codex":0.00006894057,"about_ca_system_score_gemma":0.0013043449,"threshold_uncertainty_score":0.67186886},"labels":[],"label_agreement":null},{"id":"W2048091229","doi":"10.1158/0008-5472.sabcs-2140","title":"The thiazolidinedione peroxisome proliferator-activated receptor gamma (PPARγ) agonist troglitazone alters histone post-translational modifications in MCF7 breast cancer cells.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Plant Biotechnology Institute; University of Saskatchewan","funders":"","keywords":"Thiazolidinedione; Ciglitazone; Protein kinase B; Histone deacetylase; Cancer research; Acetylation; Chemistry; Troglitazone; PI3K/AKT/mTOR pathway; Pharmacology; Histone deacetylase inhibitor; Vorinostat; Histone; Biology; Peroxisome proliferator-activated receptor; Endocrinology; Biochemistry; Receptor; Signal transduction","score_opus":0.028183958575833872,"score_gpt":0.35033852006241245,"score_spread":0.32215456148657856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048091229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95047325,0.017394131,0.00005531121,0.026807893,0.0028552986,0.0010554221,0.00088700984,0.000033070115,0.00043859056],"genre_scores_gemma":[0.9718979,0.014888517,0.000082422615,0.00043341576,0.008596144,0.00082227075,0.00023204256,0.000046594094,0.0030006713],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974249,0.00024175958,0.00037767188,0.0006161554,0.00058099476,0.00075853046],"domain_scores_gemma":[0.99841774,0.00004520049,0.0000830678,0.00054593117,0.00068259466,0.00022549494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065687305,0.00023289956,0.00023753766,0.0001314946,0.00055356266,0.00010027687,0.00047360914,0.00019083475,0.00014249393],"category_scores_gemma":[0.000055700406,0.00019317387,0.00011470203,0.0005224581,0.00038288857,0.000023444527,0.00005355788,0.0004950508,0.000017941666],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094869523,0.00014652968,0.00024202098,0.000017498129,0.000043653865,2.0676617e-7,0.0002800243,0.00025117255,0.957479,0.00037736722,0.031508088,0.008705764],"study_design_scores_gemma":[0.0019804623,0.0002232777,0.02212236,0.00006669779,0.000020367312,0.000010161878,0.00036405947,0.000078686375,0.45909244,0.00013496733,0.51544726,0.0004592281],"about_ca_topic_score_codex":0.0011048999,"about_ca_topic_score_gemma":0.0012596903,"teacher_disagreement_score":0.49838653,"about_ca_system_score_codex":0.00029806906,"about_ca_system_score_gemma":0.001186511,"threshold_uncertainty_score":0.7877402},"labels":[],"label_agreement":null},{"id":"W2048257545","doi":"10.1158/1538-7445.am2012-lb-354","title":"Abstract LB-354: A novel orally-bioavailable small-molecule inhibitor of Stat3 regresses human breast and lung cancer xenografts","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"STAT3; Survivin; Cancer research; STAT protein; Cyclin D1; Cancer; In vivo; Biology; Chemistry; Signal transduction; Medicine; Cell biology; Internal medicine; Cell cycle","score_opus":0.12357757258882454,"score_gpt":0.4372013728968876,"score_spread":0.313623800308063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048257545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879173,0.0072389566,0.000015052877,0.001015331,0.00025635777,0.0003666927,0.00028845973,0.000033960285,0.0028678912],"genre_scores_gemma":[0.9956231,0.0005819849,0.00012322007,0.000071406284,0.00093599176,0.0001805017,0.000027856464,0.000047224476,0.0024086842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814796,0.00003896178,0.0003219589,0.0003054765,0.00052096724,0.00066465826],"domain_scores_gemma":[0.9984339,0.00009784171,0.00010278274,0.00032590496,0.00068479194,0.00035478672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056215463,0.00016855514,0.00031714048,0.00029160894,0.00022466989,0.000049764254,0.00012447144,0.00009738495,0.0021712321],"category_scores_gemma":[0.00007897296,0.00014158087,0.00007573729,0.00042493382,0.00027772225,0.00019510802,0.00012329881,0.00057567505,0.000012764048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023938376,0.0003755652,0.023834076,0.0006180795,0.00013491698,0.000009108393,0.0005525511,0.0000036672916,0.9554668,0.00015210084,0.017376432,0.001237293],"study_design_scores_gemma":[0.00226924,0.00033987768,0.053446494,0.0025193512,0.00012424249,0.00007757095,0.00060844515,0.000052589552,0.90839005,0.0000075075645,0.03185636,0.00030830092],"about_ca_topic_score_codex":0.009811865,"about_ca_topic_score_gemma":0.0007548012,"teacher_disagreement_score":0.047076803,"about_ca_system_score_codex":0.00023474898,"about_ca_system_score_gemma":0.0004295818,"threshold_uncertainty_score":0.9987409},"labels":[],"label_agreement":null},{"id":"W2048302389","doi":"10.1158/1538-7445.am2012-lb-483","title":"Abstract LB-483: p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"HMGB1; Secretion; Biology; Cell biology; Senescence; Endogeny; Cancer research; Immunology; Inflammation; Biochemistry","score_opus":0.048833694098695986,"score_gpt":0.4001544704154786,"score_spread":0.3513207763167826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048302389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939323,0.008657458,0.000104255036,0.00047868796,0.00018667802,0.0003761364,0.00018950172,0.0000057817715,0.0006082753],"genre_scores_gemma":[0.9944865,0.0033428173,0.0002445767,0.000039904888,0.0005920718,0.00006207925,0.00004690503,0.00003123601,0.0011538698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976435,0.0001557819,0.00030238382,0.0003434401,0.000817776,0.00073715113],"domain_scores_gemma":[0.99830776,0.00005219411,0.000103720195,0.0005955507,0.00064424606,0.00029653462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008653457,0.00012686577,0.0001866648,0.00011857555,0.0000639067,0.000008181532,0.0003635987,0.00012477388,0.0006279958],"category_scores_gemma":[0.00048212407,0.00011712703,0.00007290445,0.00026598762,0.00027808346,0.000014474179,0.0002228344,0.0002795044,0.000025510108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033299264,0.00021405482,0.008038316,0.00024556555,0.00006231041,0.0000015563384,0.00033291552,0.000056954603,0.9759684,0.00009443281,0.0038235325,0.01082897],"study_design_scores_gemma":[0.00035400403,0.00011267977,0.007617601,0.00003321669,0.0000063425505,0.0000017759332,0.00020918885,0.000004428439,0.96231955,0.000045507462,0.029185629,0.00011007277],"about_ca_topic_score_codex":0.00024771426,"about_ca_topic_score_gemma":0.000027509097,"teacher_disagreement_score":0.025362097,"about_ca_system_score_codex":0.000093849,"about_ca_system_score_gemma":0.00056529895,"threshold_uncertainty_score":0.6876114},"labels":[],"label_agreement":null},{"id":"W2048598013","doi":"10.1158/0008-5472.can-09-2112","title":"Fingerprint of Cell Metabolism in the Experimentally Observed Interstitial pH and pO2 in Solid Tumors","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fields Institute for Research in Mathematical Sciences; Princess Margaret Cancer Centre; University of Toronto; University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Glycolysis; Metabolism; In vivo; Respiration; Chemistry; Cancer cell; Cellular respiration; Cancer; Biophysics; Biochemistry; Biology; Mitochondrion","score_opus":0.05363299848990976,"score_gpt":0.3700605044065754,"score_spread":0.31642750591666563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048598013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830898,0.015032791,0.000008944707,0.0003207289,0.00015943385,0.00025349352,0.000010733934,0.0000019234578,0.0011221659],"genre_scores_gemma":[0.99592066,0.003133379,0.000055173787,0.00023191517,0.0004164337,0.00006929768,0.000007930862,0.000008900942,0.00015632724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988253,0.00016415775,0.00020182904,0.0002684881,0.00022441612,0.0003158171],"domain_scores_gemma":[0.9995835,0.000017292195,0.00003510695,0.00024996191,0.00006222289,0.000051947456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006095652,0.00009717255,0.0001768328,0.00010374561,0.00003529107,0.000022530896,0.00028665602,0.000070698145,0.000028551509],"category_scores_gemma":[0.000045069508,0.00007840262,0.00004430798,0.00018527632,0.00014290414,0.000005561438,0.000106991065,0.00022044216,9.4366146e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020474652,0.0000862407,0.00022736436,0.000015779067,0.000005128718,0.0000032946043,0.0011128096,0.00002082263,0.99357927,0.00010145702,0.00060232705,0.004040782],"study_design_scores_gemma":[0.0011157217,0.00017277512,0.026884172,0.000045879922,0.000003865371,0.0000033166812,0.0011489075,0.000014189821,0.9552429,0.00014438927,0.015110176,0.00011375012],"about_ca_topic_score_codex":0.00077138125,"about_ca_topic_score_gemma":0.000601963,"teacher_disagreement_score":0.038336392,"about_ca_system_score_codex":0.000028137465,"about_ca_system_score_gemma":0.00016992736,"threshold_uncertainty_score":0.3197166},"labels":[],"label_agreement":null},{"id":"W2048600890","doi":"10.1158/0008-5472.can-05-4572","title":"Novel 5′ Untranslated Region Variants of <i>BCRP</i> mRNA Are Differentially Expressed in Drug-Selected Cancer Cells and in Normal Human Tissues: Implications for Drug Resistance, Tissue-Specific Expression, and Alternative Promoter Usage","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Exon; Gene isoform; Biology; Abcg2; Untranslated region; Alternative splicing; Molecular biology; Promoter; Gene; Gene expression; Cell culture; Serial analysis of gene expression; Cancer cell; Cancer research; Cancer; Messenger RNA; Genetics; Transcriptome; ATP-binding cassette transporter; Transporter","score_opus":0.04222226744865033,"score_gpt":0.3388837418925684,"score_spread":0.2966614744439181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048600890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915899,0.0033733326,0.0009599927,0.0012226935,0.00007481326,0.0021699907,0.0003578175,0.000026079064,0.00022534982],"genre_scores_gemma":[0.9920775,0.002094056,0.000752427,0.000016552773,0.00013462383,0.0008353018,0.00007823781,0.000055812496,0.003955447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762434,0.00010753649,0.00057215913,0.0006747791,0.000410704,0.000610486],"domain_scores_gemma":[0.998742,0.00012739074,0.00016038737,0.0003355598,0.000493203,0.00014146547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039248122,0.00024231842,0.0005299067,0.0004648057,0.0001751394,0.00003993992,0.00020468196,0.00013776952,0.000043415457],"category_scores_gemma":[0.000012136226,0.00021402189,0.00003715507,0.00077526213,0.00026795198,0.00014856987,0.00003736766,0.00042320782,3.3122876e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012190467,0.00035979206,0.0067204083,0.00068589806,0.000022698368,0.000029745946,0.0015364297,0.000014764263,0.9870845,0.0002202171,0.0017336492,0.00037286538],"study_design_scores_gemma":[0.0063381596,0.000054349894,0.15870774,0.0025068256,0.000029507044,0.0000021191097,0.00016444174,0.000022766228,0.8268868,0.0011277908,0.0039014318,0.00025809003],"about_ca_topic_score_codex":0.002142253,"about_ca_topic_score_gemma":0.020764355,"teacher_disagreement_score":0.1601977,"about_ca_system_score_codex":0.00015721933,"about_ca_system_score_gemma":0.00017792384,"threshold_uncertainty_score":0.99710417},"labels":[],"label_agreement":null},{"id":"W2048756941","doi":"10.1158/0008-5472.can-06-4645","title":"Hint1 Inhibits Growth and Activator Protein-1 Activity in Human Colon Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Natural Science Foundation of China; National Cancer Institute; National Foundation for Cancer Research; T.J. Martell Foundation","keywords":"Transfection; Molecular biology; Cell culture; Activator (genetics); Biology; Cancer cell; Expression vector; Luciferase; Transcription factor; Chemistry; Gene; Cancer; Biochemistry; Genetics","score_opus":0.035159041822793946,"score_gpt":0.36366722105740307,"score_spread":0.3285081792346091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048756941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979757,0.0005512573,0.000010845004,0.00025590582,0.00005250549,0.00047848868,0.000014153248,0.000004538913,0.0006565768],"genre_scores_gemma":[0.9983755,0.0007662093,0.000029584033,0.000075171636,0.000044263583,0.00015843562,0.0000054316333,0.000023585706,0.0005218407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871767,0.000072183575,0.000116756084,0.00040481563,0.00023314179,0.0004554345],"domain_scores_gemma":[0.99961424,0.000011698101,0.00002949629,0.00014547241,0.000079889825,0.000119230885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040319146,0.00011469524,0.000102822116,0.000105990446,0.00013115203,0.000026385524,0.00013956304,0.00011657421,0.000026785347],"category_scores_gemma":[0.000028803483,0.000115249735,0.000020721713,0.00021301811,0.00015252685,0.000004690338,0.00021455594,0.00025130506,0.0000016701978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015273689,0.00006089618,0.0042960965,0.000052320436,0.000010161947,0.0000044665385,0.00007613649,0.0000027679607,0.9922415,0.000020018479,0.00033251333,0.0027503765],"study_design_scores_gemma":[0.00047749188,0.00014424488,0.049360104,0.000031671865,0.0000011193424,5.0144735e-7,0.000045106914,0.0000011507142,0.9476707,0.000050712108,0.0020874923,0.00012970017],"about_ca_topic_score_codex":0.001101253,"about_ca_topic_score_gemma":0.0024175474,"teacher_disagreement_score":0.04506401,"about_ca_system_score_codex":0.00006594046,"about_ca_system_score_gemma":0.00016949521,"threshold_uncertainty_score":0.4699748},"labels":[],"label_agreement":null},{"id":"W2048873407","doi":"10.1158/0008-5472.sabcs12-s6-3","title":"Abstract S6-3: Neurocognitive impact in adjuvant chemotherapy for breast cancer linked to fatigue: A Prospective functional MRI study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"","keywords":"Medicine; Neurocognitive; Breast cancer; Internal medicine; Chemotherapy; Prospective cohort study; Oncology; Magnetic resonance imaging; Regimen; Chemotherapy regimen; Cognition; Cancer; Radiation therapy; Radiology; Psychiatry","score_opus":0.1261902672185666,"score_gpt":0.4786184567641696,"score_spread":0.35242818954560295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048873407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98000425,0.0012421125,0.0000818987,0.006390876,0.0004195695,0.010477371,0.0006954703,0.000065395834,0.0006230424],"genre_scores_gemma":[0.984596,0.00041200238,0.000022156439,0.0007029606,0.0015979661,0.011733981,0.00001795497,0.00009404643,0.0008229001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964141,0.0001253291,0.0003939335,0.000689869,0.001040209,0.0013365173],"domain_scores_gemma":[0.99702436,0.00042380788,0.0000856192,0.00026558072,0.0017022858,0.0004983536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011140988,0.00034724636,0.0005881821,0.00063337537,0.00026823417,0.000042254444,0.00013798439,0.00011409731,0.0017552949],"category_scores_gemma":[0.00028006238,0.00028434323,0.0001662084,0.0013170793,0.00019105701,0.00033397716,0.00011315394,0.00093761476,0.00005868306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016564837,0.00266425,0.91591877,0.00015439345,0.0009609923,0.000022951606,0.0063209226,0.000094905095,0.0076026847,0.000008913169,0.013061804,0.036624573],"study_design_scores_gemma":[0.009841396,0.0016243672,0.98249435,0.00048323924,0.00008081272,0.00001403835,0.0033446846,0.000022113492,0.0010847645,0.00003169909,0.00069958006,0.00027894718],"about_ca_topic_score_codex":0.002410462,"about_ca_topic_score_gemma":0.0009769117,"teacher_disagreement_score":0.06657559,"about_ca_system_score_codex":0.002888255,"about_ca_system_score_gemma":0.0009568596,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W2049044463","doi":"10.1158/1538-7445.am2014-lb-90","title":"Abstract LB-90: Molecular mechanism of TAZ-induced lung tumorigenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Carcinogenesis; Hippo signaling pathway; Biology; Cancer research; Activator (genetics); Cell culture; Cell growth; Cell biology; Nude mouse; Cell; Neoplastic transformation; Gene; Molecular biology; Signal transduction; Genetics","score_opus":0.04366336451047736,"score_gpt":0.3689347610638837,"score_spread":0.3252713965534063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049044463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443316,0.00090342504,0.0011526269,0.00013894294,0.00015988384,0.00020418355,0.000020292939,0.000013846974,0.0029736196],"genre_scores_gemma":[0.99851346,0.00017560415,0.00012953379,0.00006996132,0.00031264228,0.00008871376,0.000029408744,0.00004224823,0.0006384081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981591,0.00018777413,0.00023319697,0.00044353417,0.0004814802,0.00049493136],"domain_scores_gemma":[0.9988206,0.0000367554,0.00006713237,0.000546546,0.00036205104,0.00016693499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011485971,0.00014849054,0.00019866123,0.000113387236,0.000119831995,0.000024907826,0.0003990478,0.00018703817,0.00015498043],"category_scores_gemma":[0.00020298794,0.00014254481,0.000112845904,0.00021179032,0.00009103731,0.0000032325781,0.00013264005,0.00023688511,0.000024029085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005301005,0.000039478713,0.00009957756,0.00008429247,0.000045788867,0.00000748954,0.000046487137,0.000055371293,0.99566436,0.001186137,0.00020460722,0.002513419],"study_design_scores_gemma":[0.00032610592,0.00021433922,0.0002467231,0.00005299942,0.000009245996,0.000002229841,0.000042907523,0.000088861365,0.9940229,0.00038877776,0.0044436324,0.0001612919],"about_ca_topic_score_codex":0.00031541052,"about_ca_topic_score_gemma":0.00003223194,"teacher_disagreement_score":0.004239025,"about_ca_system_score_codex":0.000041118306,"about_ca_system_score_gemma":0.00029176244,"threshold_uncertainty_score":0.5812808},"labels":[],"label_agreement":null},{"id":"W2049158008","doi":"10.1158/1538-7445.am2014-4747","title":"Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fatty acid synthase; Chemistry; Drug discovery; Pharmacology; Cell growth; Apoptosis; Cancer; Cancer research; Biochemistry; Fatty acid; Biology; Medicine; Internal medicine","score_opus":0.033137659339917205,"score_gpt":0.3237863425352825,"score_spread":0.2906486831953653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049158008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97754484,0.017902652,0.000894321,0.0010008671,0.0012649666,0.0007909797,0.00014442751,0.000010473887,0.00044645014],"genre_scores_gemma":[0.97012883,0.019741016,0.0018976525,0.00007811488,0.0050664623,0.001088071,0.000011051331,0.00005027371,0.0019385446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871546,0.00010563035,0.00019120965,0.00039599687,0.00020645629,0.00038527275],"domain_scores_gemma":[0.9992164,0.00010438722,0.000061772866,0.00023866237,0.00023911263,0.00013968638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009516204,0.00013701592,0.00023533426,0.00008761609,0.00014545988,0.000038795428,0.0001303087,0.0001355064,0.000031199266],"category_scores_gemma":[0.00017475958,0.000120728895,0.00004964328,0.000104534854,0.00037756356,0.000010267532,0.00010231862,0.000090084024,0.0000012631399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055924966,0.000031404612,0.00050138123,0.00028027088,0.00006567235,7.0719345e-8,0.00009530177,0.000031109408,0.91928315,0.00021791026,0.043010253,0.035924207],"study_design_scores_gemma":[0.00051159464,0.00016726564,0.0010645007,0.00007077642,0.000015677697,0.0000017111216,0.00013229414,0.000009953669,0.5264688,0.00022841347,0.47120285,0.00012612624],"about_ca_topic_score_codex":0.00096697983,"about_ca_topic_score_gemma":0.00045196587,"teacher_disagreement_score":0.42819262,"about_ca_system_score_codex":0.000031465283,"about_ca_system_score_gemma":0.00025799012,"threshold_uncertainty_score":0.49231812},"labels":[],"label_agreement":null},{"id":"W2049241540","doi":"10.1158/1538-7445.tumimm2012-b76","title":"Abstract B76: CD8+FoxP3+ T cells: A new player in the immune response to ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"FOXP3; Tumor-infiltrating lymphocytes; Biology; CD8; Population; Immunology; Immunohistochemistry; Cancer research; Immune system; Pathology; Medicine","score_opus":0.08648452376026432,"score_gpt":0.41508885413319574,"score_spread":0.3286043303729314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049241540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93130165,0.006813315,0.0000052397527,0.057316132,0.0003228144,0.0019475517,0.000022428441,0.000030918225,0.0022399416],"genre_scores_gemma":[0.9835356,0.001337052,0.00008106756,0.002529464,0.00054438383,0.0011875412,0.000004565457,0.000046544665,0.0107337935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99694765,0.00034418845,0.00040509217,0.00045385925,0.00096952356,0.0008797192],"domain_scores_gemma":[0.9981393,0.00048702338,0.000052312003,0.00079345645,0.0002369845,0.00029088728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027876322,0.00020160925,0.00030906024,0.0004062953,0.00018619974,0.00014853753,0.0005826999,0.00014645296,0.010467161],"category_scores_gemma":[0.0001660615,0.000137024,0.00012205647,0.0014094897,0.00017250018,0.00014146764,0.000094691444,0.00088417804,0.0005071378],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013229704,0.00011131249,0.00071280333,0.00006379971,0.00008485053,0.00007054333,0.003545755,0.000017377342,0.8041736,0.000016658283,0.11085882,0.06711481],"study_design_scores_gemma":[0.0053413757,0.0006342572,0.5157366,0.00076862087,0.000019063487,0.000019811408,0.0021319715,0.000016161455,0.13409074,0.00015234365,0.3407643,0.00032479956],"about_ca_topic_score_codex":0.09997059,"about_ca_topic_score_gemma":0.0030335977,"teacher_disagreement_score":0.6700828,"about_ca_system_score_codex":0.00082401466,"about_ca_system_score_gemma":0.0018726181,"threshold_uncertainty_score":0.9904374},"labels":[],"label_agreement":null},{"id":"W2049306725","doi":"10.1158/1538-7445.am2014-987","title":"Abstract 987: Comprehensive characterization of urothelial bladder cancer: a TCGA Project update","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Cancer research; ARID1A; CDKN2A; Epigenetics; DNA methylation; Exome sequencing; Cancer; Gene; Genetics; Gene expression; Mutation","score_opus":0.09173370945119375,"score_gpt":0.41718682064677737,"score_spread":0.3254531111955836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049306725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921737,0.00056245306,0.000054539243,0.0017565866,0.00032631605,0.0014188242,0.0003348214,0.000055249453,0.0033175405],"genre_scores_gemma":[0.99379283,0.0026014165,0.000053750628,0.000502054,0.0008767857,0.0006542346,0.00010442333,0.00006268219,0.0013518503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769735,0.00014434064,0.00033884696,0.00044596178,0.00083232706,0.0005411486],"domain_scores_gemma":[0.9983947,0.00007692559,0.000112416994,0.00044045754,0.0008054773,0.0001700077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029613287,0.00020402063,0.00044000323,0.00028913282,0.00013598062,0.000032443382,0.0001909285,0.00012431155,0.0014620527],"category_scores_gemma":[0.00004689717,0.0001679105,0.00010889593,0.0005259333,0.00025956746,0.000121098856,0.000073674804,0.0004123308,0.00008335734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018065987,0.00032699306,0.011086888,0.0006226317,0.00040162093,0.000019361572,0.00078101514,0.0000071199215,0.91788745,0.00021473653,0.0037504805,0.063095085],"study_design_scores_gemma":[0.007656385,0.0011829259,0.30240318,0.00089231296,0.0002167033,0.000014177864,0.00018613569,0.00016528656,0.4611756,0.00018863565,0.22548562,0.00043304503],"about_ca_topic_score_codex":0.0035816303,"about_ca_topic_score_gemma":0.00010440183,"teacher_disagreement_score":0.4567119,"about_ca_system_score_codex":0.00025447703,"about_ca_system_score_gemma":0.0010457579,"threshold_uncertainty_score":0.99945074},"labels":[],"label_agreement":null},{"id":"W2049657582","doi":"10.1158/0008-5472.sabcs13-p6-11-05","title":"Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; Brain tumor; In vivo; Cancer research; Receptor; Medicine; Monoclonal antibody; Pharmacology; Internal medicine; Biology; Antibody; Pathology; Immunology","score_opus":0.0437908769327742,"score_gpt":0.3827641558444934,"score_spread":0.33897327891171924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049657582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852233,0.0017425203,0.0000031374948,0.008565669,0.00032015282,0.002302538,0.00020864909,0.00010697487,0.0015270506],"genre_scores_gemma":[0.9951762,0.0010915541,0.00011726672,0.00035817892,0.0011930338,0.00078275485,0.0000289569,0.00012120753,0.0011308494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9933351,0.0004304805,0.0006710581,0.0010465422,0.002350193,0.0021666083],"domain_scores_gemma":[0.99629235,0.001139943,0.00010288584,0.0007191953,0.0009898726,0.0007557768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024988723,0.00043580946,0.0008960103,0.00081196224,0.0003364215,0.00025500858,0.0007047802,0.0001637579,0.0038610783],"category_scores_gemma":[0.00072174816,0.00037839118,0.0001754104,0.0013426705,0.00063315977,0.0004601421,0.0005661116,0.0018468967,0.0005151066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016691041,0.0012512489,0.250767,0.0021533123,0.0004007877,0.0029714713,0.0014201044,0.00005256614,0.67911303,0.00010215916,0.04612546,0.0139737725],"study_design_scores_gemma":[0.005106328,0.00034371778,0.9640355,0.0012851871,0.00003286631,0.00020099629,0.00115352,0.0001412923,0.02361423,0.00012126829,0.003472756,0.00049234775],"about_ca_topic_score_codex":0.18541662,"about_ca_topic_score_gemma":0.014560121,"teacher_disagreement_score":0.7132685,"about_ca_system_score_codex":0.0014969176,"about_ca_system_score_gemma":0.0016132868,"threshold_uncertainty_score":0.9998668},"labels":[],"label_agreement":null},{"id":"W2049782797","doi":"10.1158/1538-7445.am2013-4855","title":"Abstract 4855: Poor performance of published clinical screening criteria for the population-based identification of endometrial cancer patients with Lynch Syndrome.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lynch syndrome; MSH6; Medicine; PMS2; Endometrial cancer; MLH1; Family history; Population; Oncology; Internal medicine; Cancer; Gynecology; Colorectal cancer; MSH2; Microsatellite instability; DNA mismatch repair; Genetics; Biology","score_opus":0.11535879876768622,"score_gpt":0.4425482140917131,"score_spread":0.32718941532402684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049782797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504274,0.00033272794,0.00012381941,0.00084253104,0.0005758883,0.0029014123,0.00013799395,0.000012863685,0.000030036423],"genre_scores_gemma":[0.99747163,0.000081152015,0.00047241303,0.00004709495,0.00022566727,0.0014715119,0.00007587081,0.000037305745,0.00011733797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970808,0.00011174652,0.00084098533,0.00038263202,0.001195822,0.0003879841],"domain_scores_gemma":[0.99498254,0.0014214502,0.00036641775,0.00049231324,0.0026078515,0.00012940812],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019258328,0.00013872108,0.0004106709,0.00032711294,0.0001401965,0.000058613434,0.00034236576,0.00012643897,0.0018446451],"category_scores_gemma":[0.0016685268,0.00009021098,0.000115815164,0.00084555417,0.00030282256,0.00020705801,0.000053055304,0.00037394578,0.000004599816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00282309,0.00020524324,0.9628759,0.0005789662,0.00015692468,2.646976e-7,0.00004493427,0.00035397746,0.008524638,0.000003953115,0.0022215196,0.02221056],"study_design_scores_gemma":[0.0036600633,0.0009396279,0.9735805,0.00030858032,0.00006143229,4.1428606e-7,0.000029744937,0.0022133968,0.018959338,0.000009312761,0.00014563982,0.00009198059],"about_ca_topic_score_codex":0.0037488334,"about_ca_topic_score_gemma":0.00011429697,"teacher_disagreement_score":0.02211858,"about_ca_system_score_codex":0.00021599517,"about_ca_system_score_gemma":0.00067751226,"threshold_uncertainty_score":0.9990678},"labels":[],"label_agreement":null},{"id":"W2049867386","doi":"10.1158/1538-7445.fbcr11-a53","title":"Abstract A53: Genome-wide profile of somatic copy number alterations in Wilms tumor: Comparison between samples derived from patients with and without relapse","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Loss of heterozygosity; Wilms' tumor; Somatic cell; Cancer; Chromosome; Malignancy; Biology; Oncology; Cancer research; Genetics; Medicine; Internal medicine; Gene; Allele","score_opus":0.050727970748266654,"score_gpt":0.3348846999148715,"score_spread":0.28415672916660484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049867386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807507,0.00061294413,0.000041508312,0.000022740876,0.000022328642,0.00036318225,0.00012751845,0.000004093916,0.00073063147],"genre_scores_gemma":[0.9988001,0.00019098264,0.00055716897,0.000014513022,0.00004598459,0.000092924645,0.00021556698,0.000018731833,0.00006402042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894994,0.000075487704,0.00023594488,0.0002735749,0.00021808533,0.00024694233],"domain_scores_gemma":[0.9994455,0.0000311574,0.000085094696,0.00020360712,0.0001412955,0.00009335333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013488349,0.00010674065,0.000196845,0.000051710387,0.00007151923,0.000015090824,0.00013938134,0.00008663941,0.00013278886],"category_scores_gemma":[0.000032375676,0.000081463695,0.000022511787,0.000121573816,0.00023008301,0.000008347769,0.00006654478,0.00022120438,0.000006997106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028219813,0.000063402615,0.93876743,0.000046831876,0.00008715839,9.918269e-7,0.00054096006,0.000022393104,0.059617937,0.0000024203634,0.00013364278,0.0004346485],"study_design_scores_gemma":[0.0008985748,0.00015988247,0.7944469,0.00012579259,0.000013106636,2.2303195e-7,0.00015551745,0.000005941109,0.20381276,0.000059873266,0.00021506913,0.000106378735],"about_ca_topic_score_codex":0.0023062665,"about_ca_topic_score_gemma":0.0005848752,"teacher_disagreement_score":0.14432053,"about_ca_system_score_codex":0.000038581707,"about_ca_system_score_gemma":0.00016762872,"threshold_uncertainty_score":0.34864002},"labels":[],"label_agreement":null},{"id":"W2050044827","doi":"10.1158/0008-5472.sabcs13-p4-03-08","title":"Abstract P4-03-08: Pathological analysis of intraductal papillary lesions in 3690 patients","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Nipple discharge; Papillomatosis; Pathological; Adenomyomatosis; Papilloma; Intraductal papilloma; Histopathology; Radiology; Breast cancer; Lesion; Pathology; Gastroenterology; Mammography; Internal medicine; Cancer; Gallbladder","score_opus":0.0855103779273897,"score_gpt":0.3899790080635103,"score_spread":0.30446863013612063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050044827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958766,0.00058581424,0.0000017459031,0.0011885182,0.000037438112,0.00040691055,0.000034721248,0.000011978075,0.0018562572],"genre_scores_gemma":[0.9990436,0.0003629362,0.00005776591,0.00009256825,0.00006409413,0.00013487392,0.00005180743,0.0000122967385,0.00018006105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981891,0.00011648161,0.00032079915,0.00030873716,0.0006337822,0.00043111638],"domain_scores_gemma":[0.9988055,0.00012630333,0.00004396124,0.00037213022,0.0004352718,0.00021683278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004616015,0.000102248916,0.00037232914,0.0006794768,0.00006494025,0.000014840703,0.00015694287,0.0001298007,0.004321126],"category_scores_gemma":[0.00016581075,0.000074379604,0.00013771554,0.0016540057,0.00023085241,0.00007318107,0.00011306144,0.0005339413,0.00011234809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015862261,0.00078369194,0.8704869,0.000097715405,0.00019947051,0.0001033087,0.00033831384,0.000022365577,0.05911873,0.00012739243,0.0034604834,0.06510299],"study_design_scores_gemma":[0.0006177909,0.00015326077,0.997248,0.00007415781,0.00006656127,0.0000022224954,0.00018159898,0.000083140476,0.0011789525,0.00008304832,0.00023935172,0.00007191399],"about_ca_topic_score_codex":0.0029441265,"about_ca_topic_score_gemma":0.00013908351,"teacher_disagreement_score":0.12676108,"about_ca_system_score_codex":0.0001671356,"about_ca_system_score_gemma":0.00019399563,"threshold_uncertainty_score":0.99658906},"labels":[],"label_agreement":null},{"id":"W2050270950","doi":"10.1158/1538-7445.am2012-1447","title":"Abstract 1447: Investigating susceptibility to sporadic osteosarcoma by genome-wide copy number analysis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Copy-number variation; Germline; Biology; Copy number analysis; SNP array; Genetics; Cancer; Germline mutation; Gene dosage; Malignancy; Comparative genomic hybridization; Genome-wide association study; Gene; Cancer research; Single-nucleotide polymorphism; Genome; Mutation; Genotype","score_opus":0.04459464788518841,"score_gpt":0.37765074423078326,"score_spread":0.33305609634559485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050270950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942232,0.0026554572,0.00017189392,0.0005708673,0.00013257588,0.00034681289,0.00026635855,0.000011447702,0.001621393],"genre_scores_gemma":[0.99674106,0.0004827564,0.00042082305,0.00065215904,0.00063825655,0.00013633414,0.00032071024,0.00003819565,0.00056968053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977738,0.00010293642,0.00029405183,0.0005305605,0.00041460703,0.00088402],"domain_scores_gemma":[0.99818605,0.00012159324,0.00006560574,0.00068576244,0.0002807261,0.00066025206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012474087,0.00018156561,0.00024383004,0.00011793901,0.00020277945,0.000081033046,0.0003884587,0.00015204088,0.00070509553],"category_scores_gemma":[0.00052182947,0.00018832616,0.00013995706,0.00079110055,0.00020778182,0.000009153422,0.00031020938,0.0002872787,0.00015219983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004776572,0.00006761705,0.6161954,0.000026672458,0.00016295916,0.0000014137692,0.00015727011,0.0001871322,0.35745633,0.000020134388,0.024855088,0.00082222756],"study_design_scores_gemma":[0.000550264,0.00017008901,0.41683444,0.000021374277,0.00010894061,0.000002282254,0.0003307449,0.00001251442,0.33476362,0.000107980384,0.24654426,0.00055348605],"about_ca_topic_score_codex":0.0017773322,"about_ca_topic_score_gemma":0.001056087,"teacher_disagreement_score":0.22168916,"about_ca_system_score_codex":0.0002307678,"about_ca_system_score_gemma":0.00030263205,"threshold_uncertainty_score":0.7720301},"labels":[],"label_agreement":null},{"id":"W2050379741","doi":"10.1158/0008-5472.sabcs13-p3-13-03","title":"Abstract P3-13-03: A phase III, open-label, randomized study of eribulin versus capecitabine in patients (pts) with metastatic breast cancer (MBC): Effect of post-progression anti-cancer treatments (PPT) and metastatic progression events on overall survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Eribulin; Hazard ratio; Anthracycline; Proportional hazards model; Oncology; Progression-free survival; Taxane; Breast cancer; Metastatic breast cancer; Cancer; Confidence interval; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.07583385628773552,"score_gpt":0.4838298686528856,"score_spread":0.40799601236515004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050379741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818801,0.0018852205,3.438635e-7,0.000345141,0.0002712705,0.015083691,0.00044468004,0.000016285207,0.00007321258],"genre_scores_gemma":[0.9896006,0.0014064126,0.000058090514,0.00002453353,0.00005483231,0.008414169,0.00015843066,0.00007096424,0.00021196537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99485415,0.0012669098,0.00085020514,0.00080996327,0.0014667928,0.0007519815],"domain_scores_gemma":[0.99692625,0.0010027653,0.000494985,0.00043314035,0.00079516816,0.00034772232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013381103,0.00051716284,0.0021364684,0.0005259808,0.00014380789,0.0000439477,0.00030142357,0.00008307302,0.0018788647],"category_scores_gemma":[0.00009778065,0.00031165892,0.00009167669,0.00068681757,0.0003575728,0.00034666687,0.00022091721,0.00049699686,0.000008599051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7652365,0.027512059,0.105675794,0.00092370703,0.0037145966,0.000088502566,0.0010472541,0.000054806456,0.02043486,0.0000016733987,0.00026570918,0.07504452],"study_design_scores_gemma":[0.8465556,0.035555307,0.10277509,0.0018971694,0.0013576864,0.0000024040482,0.00020563195,0.00020356718,0.011155102,0.0000055286146,0.000011464963,0.00027544884],"about_ca_topic_score_codex":0.023505172,"about_ca_topic_score_gemma":0.0014749331,"teacher_disagreement_score":0.081319086,"about_ca_system_score_codex":0.0007822653,"about_ca_system_score_gemma":0.00054517813,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W2051045103","doi":"10.1158/0008-5472.can-06-1680","title":"Smad4 Regulates Claudin-1 Expression in a Transforming Growth Factor-β–Independent Manner in Colon Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Claudin; Cancer research; Colorectal cancer; Carcinogenesis; Signal transduction; Metastasis; Biology; Transforming growth factor beta; Cancer; Transforming growth factor; Internal medicine; Medicine; Endocrinology; Tight junction; Cell biology","score_opus":0.04100081861370134,"score_gpt":0.379425348475214,"score_spread":0.3384245298615126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051045103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940892,0.0048299846,0.000078645,0.000096450465,0.00013979137,0.00044685186,0.000036751375,0.000011074339,0.0002712482],"genre_scores_gemma":[0.9979069,0.0006718331,0.000059691367,0.000052997635,0.0002227279,0.00021963485,0.000027652384,0.00003957057,0.0007989411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977819,0.00013409377,0.0003083324,0.0005327182,0.00047884893,0.0007641444],"domain_scores_gemma":[0.9993098,0.000060997958,0.000043739667,0.00026835426,0.0001511331,0.00016602053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007769333,0.00016826819,0.00017421595,0.0002845987,0.00009075794,0.00003182814,0.0003506372,0.00024766123,0.0002240479],"category_scores_gemma":[0.000061681654,0.0001598473,0.00006090912,0.0003415292,0.00012559953,0.000011050951,0.0001254684,0.00038765828,0.000007192483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005536199,0.00009977199,0.021948569,0.000093148425,0.000012099356,0.000040087813,0.00038916836,0.00025603754,0.97319716,0.0000068964882,0.0006363687,0.002767056],"study_design_scores_gemma":[0.0008476087,0.000078186175,0.018898861,0.0002447427,0.000002513148,8.7971097e-7,0.00019203118,0.000011859875,0.9748916,0.000052620002,0.0045873406,0.00019174028],"about_ca_topic_score_codex":0.001168342,"about_ca_topic_score_gemma":0.0062604193,"teacher_disagreement_score":0.0050920774,"about_ca_system_score_codex":0.00029293218,"about_ca_system_score_gemma":0.00035457718,"threshold_uncertainty_score":0.65183836},"labels":[],"label_agreement":null},{"id":"W2051101327","doi":"10.1158/1538-7445.am10-2307","title":"Abstract 2307: Cellular expression of E-cadherin but not its plasma membrane localization is regulated by the PTEN/PI 3 Kinase pathway via transcription factors twist and snail","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PTEN; Biology; Cadherin; Transfection; Epithelial–mesenchymal transition; Cancer research; Transcription factor; Cancer cell; Twist transcription factor; CDH1; Cell biology; Metastasis; Cell culture; Cell; Cancer; Signal transduction; PI3K/AKT/mTOR pathway; Gene","score_opus":0.03114290087082192,"score_gpt":0.30529896217796765,"score_spread":0.2741560613071457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051101327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970385,0.0012066608,0.00067372405,0.00024682021,0.00008834896,0.00032933243,0.0003111084,0.000008179941,0.0000973259],"genre_scores_gemma":[0.997643,0.0007869098,0.00001577629,0.000037222977,0.00011604261,0.00008671274,0.00026281443,0.000022641747,0.0010288935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886614,0.00006986334,0.0002007904,0.00032623624,0.00028835668,0.00024858591],"domain_scores_gemma":[0.9992332,0.00002348494,0.00006783555,0.00037432395,0.00019455381,0.000106589716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003127583,0.00012666099,0.000121709396,0.00004480296,0.00018762417,0.000030045834,0.00023367116,0.00018926694,0.00013354755],"category_scores_gemma":[0.00003759151,0.00009338689,0.000045121124,0.0001615302,0.00024582437,0.000010566296,0.000048787053,0.00025808,0.000004470145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076638804,0.000049398994,0.00007122798,0.00005754904,0.000010274742,3.7339845e-7,0.00015838629,0.000011208342,0.9949949,0.000032901604,0.00097361667,0.0035635266],"study_design_scores_gemma":[0.00036638058,0.000032248845,0.0010989391,0.000017656434,0.000007383863,9.343996e-7,0.000068730216,0.00023730115,0.95926267,0.000020917927,0.03878641,0.00010045124],"about_ca_topic_score_codex":0.00036984455,"about_ca_topic_score_gemma":0.00007832605,"teacher_disagreement_score":0.037812795,"about_ca_system_score_codex":0.00000909326,"about_ca_system_score_gemma":0.00006988444,"threshold_uncertainty_score":0.3808207},"labels":[],"label_agreement":null},{"id":"W2051195861","doi":"10.1158/1538-7445.am2013-4045","title":"Abstract 4045: Hypoxia induces Plk4 expression and promotes immortalization of proliferating cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Biology; Cell biology; Cancer research","score_opus":0.03809854349968518,"score_gpt":0.3423996511322568,"score_spread":0.3043011076325716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051195861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284804,0.005923921,0.000021896283,0.00007467066,0.0002124724,0.00047381394,0.000014903688,0.0000065267477,0.00042378236],"genre_scores_gemma":[0.9958838,0.0024011885,0.00019295841,0.000020513393,0.00080615527,0.00022259701,0.000024888277,0.000020936724,0.0004269356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988898,0.00006532098,0.0001908766,0.0003051304,0.00026958037,0.00027926144],"domain_scores_gemma":[0.9992665,0.00001674255,0.00007234009,0.00021983858,0.00032533077,0.00009924642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003134422,0.00010253721,0.00013363097,0.000070995615,0.000111758345,0.00005150331,0.00013709375,0.00012614105,0.000121421996],"category_scores_gemma":[0.00009154154,0.00008760044,0.000030952564,0.00012117654,0.00014405014,0.000015680898,0.00012407589,0.00014724437,0.000004430902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025485982,0.000030240386,0.000586736,0.000105722545,0.000013466285,1.7437567e-7,0.00016446642,0.000010613851,0.98692924,0.000011649831,0.0032264846,0.0088957185],"study_design_scores_gemma":[0.00029470923,0.00007322601,0.00866454,0.000070431204,0.000003989374,9.9571e-7,0.0001203302,0.000014689431,0.9848419,0.000075392745,0.005740281,0.000099525016],"about_ca_topic_score_codex":0.0004987332,"about_ca_topic_score_gemma":0.000050460985,"teacher_disagreement_score":0.008796194,"about_ca_system_score_codex":0.000011972749,"about_ca_system_score_gemma":0.00017037363,"threshold_uncertainty_score":0.35722426},"labels":[],"label_agreement":null},{"id":"W2051571422","doi":"10.1158/1538-7445.am2011-3155","title":"Abstract 3155: Identification of biomarkers of chemoresistance in serous epithelial ovarian cancer by integrative molecular profiling","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Serous fluid; Ovarian cancer; Cancer research; PTEN; PI3K/AKT/mTOR pathway; Computational biology; microRNA; PDGFRA; Cancer; Bioinformatics; Signal transduction; Genetics; Stromal cell","score_opus":0.03604284185589902,"score_gpt":0.3595697016818314,"score_spread":0.3235268598259324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051571422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919564,0.0051568416,0.003259582,0.00010148884,0.00012221577,0.00083516096,0.00031344127,0.0000072495095,0.0010083935],"genre_scores_gemma":[0.99701834,0.0017443259,0.00036810728,0.000015204935,0.00004316608,0.00044600028,0.00007221648,0.00004941376,0.00024321915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740934,0.00022660002,0.00055676646,0.000605394,0.0006684949,0.00053337787],"domain_scores_gemma":[0.9982677,0.000024984925,0.00021443273,0.0005712232,0.00080621586,0.00011545836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012524766,0.00019132228,0.0002766776,0.00029180507,0.00005400519,0.000015464135,0.00057783496,0.00026055067,0.00014328596],"category_scores_gemma":[0.00025748365,0.00019071499,0.00010721344,0.00076474866,0.0004128412,0.000013094533,0.00017272847,0.0004198067,0.0000033706895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009668164,0.00013955202,0.00029877006,0.00018665378,0.00015491685,0.000009881376,0.0003001662,0.000062432446,0.99317604,0.00022412029,0.0003640031,0.00411666],"study_design_scores_gemma":[0.0007739249,0.00014473284,0.0014310138,0.00016663516,0.000010474858,0.0000010712149,0.00035163094,0.000062978026,0.99640447,0.00025910506,0.00022552478,0.00016841837],"about_ca_topic_score_codex":0.004364304,"about_ca_topic_score_gemma":0.0008352363,"teacher_disagreement_score":0.007822719,"about_ca_system_score_codex":0.00021049244,"about_ca_system_score_gemma":0.00077285914,"threshold_uncertainty_score":0.7777132},"labels":[],"label_agreement":null},{"id":"W2051582074","doi":"10.1158/1538-7445.am2011-4830","title":"Abstract 4830: Identification of differentially expressed genes and protein in bone invasive non-invasive meningiomas","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Meningioma; Pathology; Skull; Biology; Tissue microarray; Medicine; Immunohistochemistry; Anatomy","score_opus":0.10380126853611141,"score_gpt":0.36561361348092347,"score_spread":0.2618123449448121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051582074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609226,0.0020238566,0.0000022785164,0.00017456053,0.000029552286,0.0011453979,0.000022798966,0.000009068997,0.0005002264],"genre_scores_gemma":[0.99739975,0.0010665994,0.00009143093,0.000005680266,0.00003607575,0.00088269595,0.000014463849,0.00002133142,0.0004819712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986028,0.00005789556,0.00032931103,0.00032015354,0.0004053504,0.0002844795],"domain_scores_gemma":[0.99912155,0.00010013744,0.000106149644,0.00028184024,0.00027049327,0.00011983151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003464421,0.000112597954,0.00027467104,0.00028253905,0.000055621058,0.000018297607,0.00009036434,0.00006528404,0.00019860014],"category_scores_gemma":[0.00014833208,0.0000949179,0.0000422965,0.0002463621,0.00018455206,0.000096088355,0.00007374782,0.00017864302,0.000014044894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003168455,0.00043767277,0.0803568,0.00040522302,0.00006915068,0.00016471438,0.0014807226,2.4871048e-7,0.9132134,0.000062686784,0.00008212555,0.0034104264],"study_design_scores_gemma":[0.0010608786,0.00012774534,0.41578883,0.0004167969,0.0000152084785,0.000002300861,0.00017341813,0.0000018139235,0.5821375,0.0002194606,0.000009619669,0.00004636533],"about_ca_topic_score_codex":0.0024983294,"about_ca_topic_score_gemma":0.00082887436,"teacher_disagreement_score":0.33543205,"about_ca_system_score_codex":0.00010487903,"about_ca_system_score_gemma":0.00028965177,"threshold_uncertainty_score":0.38706395},"labels":[],"label_agreement":null},{"id":"W2051715245","doi":"10.1158/1538-7445.am2012-4901","title":"Abstract 4901: Impact of the TGF-β1 isoform on p53 signalling in ovarian cancer cell lines in response to cisplatin","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Cisplatin; XIAP; Apoptosis; Cancer research; Protein kinase B; Cell culture; Ovarian cancer; Biology; Cell growth; Chemistry; Cell biology; Molecular biology; Programmed cell death; Caspase; Cancer; Chemotherapy; Biochemistry; Genetics","score_opus":0.09112454820002754,"score_gpt":0.4380267215110756,"score_spread":0.34690217331104806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051715245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920655,0.0026564226,0.0000072373705,0.0015616597,0.00023362122,0.0012244903,0.000064799955,0.00001226113,0.0021739954],"genre_scores_gemma":[0.998276,0.00037686972,0.00004428263,0.00015708439,0.00029690188,0.00029278742,0.0000037924349,0.000060350812,0.0004919528],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969884,0.0002775826,0.0004649824,0.0003487687,0.0009288079,0.0009914526],"domain_scores_gemma":[0.9983111,0.00044091174,0.00009441602,0.0005862978,0.0002461916,0.00032110402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028175788,0.00020715532,0.0003711438,0.00052754197,0.00007241697,0.000018511337,0.00031550013,0.00020399783,0.0010215194],"category_scores_gemma":[0.00059578934,0.00014915646,0.00015909229,0.0014837608,0.000103874925,0.00010951377,0.00013734278,0.0011912914,0.000042207834],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007743462,0.00029402052,0.02849429,0.00013402766,0.00003729624,0.000033341472,0.0032982249,0.006399907,0.94916093,0.000014243954,0.0011487385,0.0032415038],"study_design_scores_gemma":[0.002762834,0.000535027,0.59544975,0.0017916228,0.000015680871,0.0000044332714,0.00038232215,0.00017294189,0.3974457,0.000021827143,0.0012163309,0.00020152148],"about_ca_topic_score_codex":0.025987664,"about_ca_topic_score_gemma":0.0061460477,"teacher_disagreement_score":0.56695545,"about_ca_system_score_codex":0.003186548,"about_ca_system_score_gemma":0.0018678317,"threshold_uncertainty_score":0.9998917},"labels":[],"label_agreement":null},{"id":"W2051827896","doi":"10.1158/0008-5472.sabcs11-ot1-02-02","title":"OT1-02-02: HALT MBC: HER2 Suppression with the Addition of Lapatinib to Trastuzumab in HER2−Positive Metastatic Breast Cancer (LPT112515).","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lapatinib; Trastuzumab; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Discontinuation; Paclitaxel; Cancer; Chemotherapy","score_opus":0.13753868251921628,"score_gpt":0.4509132527718353,"score_spread":0.31337457025261906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051827896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769894,0.0012350237,0.00011641694,0.010129708,0.00017451475,0.003778074,0.0013035638,0.00004648498,0.0062268353],"genre_scores_gemma":[0.9931733,0.0005685073,0.00034160682,0.00038138824,0.0002702155,0.0031932935,0.000045202083,0.00010424469,0.0019222549],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940432,0.0009729486,0.0005277834,0.00079613144,0.0023728504,0.0012871389],"domain_scores_gemma":[0.99660933,0.00046235885,0.00012956861,0.00087654433,0.001397261,0.0005249131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021750075,0.000325608,0.0006607802,0.00064624293,0.00020518577,0.000047602534,0.00063388865,0.00013207171,0.009573545],"category_scores_gemma":[0.0002102251,0.00021161557,0.000106896965,0.0021211118,0.00073698343,0.00021691356,0.00024870504,0.0015007133,0.000121727455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04644396,0.005135656,0.07967512,0.005053833,0.0017859994,0.0017913616,0.09152138,0.00061142835,0.20251098,0.0010610392,0.22747475,0.33693448],"study_design_scores_gemma":[0.010076784,0.0073114564,0.48222342,0.010996338,0.00027303968,0.00025910485,0.012135124,0.00046741514,0.45873782,0.00040455646,0.016075086,0.0010398584],"about_ca_topic_score_codex":0.035183113,"about_ca_topic_score_gemma":0.015109069,"teacher_disagreement_score":0.40254828,"about_ca_system_score_codex":0.0015420081,"about_ca_system_score_gemma":0.0021381804,"threshold_uncertainty_score":0.9913318},"labels":[],"label_agreement":null},{"id":"W2051862762","doi":"10.1158/0008-5472.sabcs-4086","title":"Breast complaints and cancer: age stratified predictors of risk from a prospective database.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Breast cancer; Nipple discharge; Malignancy; Prospective cohort study; Cancer; Odds ratio; Breast disease; Internal medicine; Gynecology; Mammography","score_opus":0.07736496850916258,"score_gpt":0.4308964482259522,"score_spread":0.3535314797167896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051862762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743206,0.005574995,0.000010170281,0.0014553318,0.000091713424,0.0010152061,0.0029847163,0.000033036184,0.0014027889],"genre_scores_gemma":[0.9945353,0.0044130976,0.00015354922,0.00006059226,0.0004512969,0.0001426435,0.000051511408,0.000014657104,0.00017733285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997957,0.00015196089,0.00027366477,0.00043310088,0.0007281352,0.00045613488],"domain_scores_gemma":[0.9985694,0.0002545292,0.000087788765,0.00036383476,0.0004445117,0.00027990015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052857795,0.00013830823,0.00041901658,0.00015299364,0.00019500962,0.000014766187,0.00012101296,0.000063861626,0.00031352817],"category_scores_gemma":[0.0001520495,0.00011400773,0.00003089655,0.00037073574,0.0004157012,0.00006906101,0.00009436256,0.0005971051,0.0000049912805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003685083,0.00035522404,0.8940443,0.0005604653,0.00035488268,0.00013293703,0.005126373,0.0000041313383,0.013266728,0.00039938447,0.0089259995,0.07314451],"study_design_scores_gemma":[0.0018690731,0.00025006893,0.9935252,0.0006575605,0.00005741368,0.000016623131,0.00063113624,0.000045304663,0.0020995457,0.0004252084,0.00033388173,0.00008899811],"about_ca_topic_score_codex":0.0202741,"about_ca_topic_score_gemma":0.0035590015,"teacher_disagreement_score":0.099480905,"about_ca_system_score_codex":0.00027791288,"about_ca_system_score_gemma":0.0004763452,"threshold_uncertainty_score":0.98625},"labels":[],"label_agreement":null},{"id":"W2051901634","doi":"10.1158/1538-7445.am2013-2532","title":"Abstract 2532: Pediatric osteosarcoma patients are taller than average from birth to age twelve: a report from the Children's Oncology Group.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Percentile; Osteosarcoma; Pediatrics; Population; Incidence (geometry); Anthropometry; Demography; Internal medicine; Pathology","score_opus":0.049783331037097506,"score_gpt":0.3642607254181301,"score_spread":0.3144773943810326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051901634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98681283,0.0026018482,0.0000017905124,0.0065184752,0.00031088473,0.0024637764,0.00037272996,0.00005453421,0.00086311135],"genre_scores_gemma":[0.9938365,0.000848018,0.00011800658,0.0009596597,0.0014162309,0.0018023326,0.0005597746,0.00006442383,0.00039505435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965851,0.00021642332,0.0004599028,0.000788945,0.0011753216,0.0007743413],"domain_scores_gemma":[0.9970502,0.00086457364,0.00016074788,0.0010305374,0.00037906948,0.00051484746],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039437012,0.000272122,0.0004848836,0.00018622793,0.00026908398,0.0001202131,0.00041158492,0.00018207611,0.004069169],"category_scores_gemma":[0.00034152204,0.00017409994,0.00017407043,0.0005068591,0.00011728609,0.00011120654,0.00034374517,0.00073432294,0.0011808369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002043534,0.0009774008,0.92340374,0.000012020805,0.0002088507,0.0012409167,0.00055061094,0.0000016362953,0.0002550343,0.0000032008745,0.05138842,0.021753803],"study_design_scores_gemma":[0.0024015214,0.00034799697,0.9825193,0.00009062946,0.00006254514,0.000010098736,0.00016318643,0.0000017329029,0.00027980594,0.00016095214,0.013790855,0.00017132093],"about_ca_topic_score_codex":0.056547675,"about_ca_topic_score_gemma":0.0036099358,"teacher_disagreement_score":0.0591156,"about_ca_system_score_codex":0.0006582695,"about_ca_system_score_gemma":0.00028517336,"threshold_uncertainty_score":0.99959683},"labels":[],"label_agreement":null},{"id":"W2052025852","doi":"10.1158/0008-5472.sabcs13-p6-06-04","title":"Abstract P6-06-04: Breast cancer in young women: Have the prognostic and predictive implications of breast cancer subtypes changed over time?","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Oncology; Internal medicine; Cancer; Trastuzumab; Cohort; Estrogen receptor; Proportional hazards model; Gynecology","score_opus":0.020187240074377975,"score_gpt":0.33217597919481023,"score_spread":0.31198873912043223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052025852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98333275,0.0054553384,0.0000018008567,0.0072574774,0.000055273817,0.0010023045,0.002615978,0.000008943726,0.0002701565],"genre_scores_gemma":[0.988413,0.0042604585,0.000003895989,0.00008601356,0.00033486247,0.0063869143,0.000044873388,0.000035430618,0.00043458873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982367,0.00010361975,0.00022597096,0.0005049214,0.00030735717,0.0006214361],"domain_scores_gemma":[0.99876016,0.00008425975,0.000096234144,0.00038952802,0.00054390216,0.00012590874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027903466,0.00020789681,0.00023977034,0.000105497515,0.0001974306,0.000043161348,0.0002781257,0.000119942524,0.0007371286],"category_scores_gemma":[0.000033501597,0.00015131268,0.000045929177,0.0002981803,0.00048623898,0.000021877948,0.0002544446,0.0002539405,0.000011920776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031254042,0.0001501744,0.88101274,0.000095191484,0.00034854116,0.0000011339929,0.0015395669,0.00005607111,0.10437482,0.000009056541,0.005014329,0.007085815],"study_design_scores_gemma":[0.0006687269,0.000050456205,0.9950689,0.0001244445,0.000023906641,0.000013029885,0.00048317478,0.000029934547,0.0030871427,0.00008746702,0.00021310712,0.00014970016],"about_ca_topic_score_codex":0.015755743,"about_ca_topic_score_gemma":0.008685068,"teacher_disagreement_score":0.11405615,"about_ca_system_score_codex":0.000361703,"about_ca_system_score_gemma":0.0003725252,"threshold_uncertainty_score":0.9907984},"labels":[],"label_agreement":null},{"id":"W2052080762","doi":"10.1158/0008-5472.sabcs12-p5-18-08","title":"Abstract P5-18-08: Identification of ErbB2 function in the heart: implication for anti-ErbB2 therapy in breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Trastuzumab; Cardiotoxicity; Medicine; Cancer; Breast cancer; Cardiac function curve; Heart development; Pressure overload; Receptor tyrosine kinase; Lapatinib; Internal medicine; Endocrinology; Heart failure; Receptor; Biology; Chemotherapy; Embryonic stem cell","score_opus":0.2143064985937281,"score_gpt":0.5200085182150096,"score_spread":0.3057020196212815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052080762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786083,0.005051341,0.000040353305,0.012504237,0.00025558,0.0029741344,0.00013282665,0.000018719962,0.00041449303],"genre_scores_gemma":[0.9912548,0.003532122,0.000019033345,0.00020836586,0.0007268186,0.0039491877,0.00004264001,0.00004652048,0.00022048439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99662066,0.00028978227,0.0005850625,0.00041413563,0.0011960253,0.0008943186],"domain_scores_gemma":[0.99787104,0.00041543145,0.00011598313,0.0007114546,0.00073663273,0.00014943036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006154838,0.00015447778,0.00031739112,0.00057141075,0.00012888951,0.00005067613,0.00035969188,0.00016786641,0.0008836513],"category_scores_gemma":[0.00016411766,0.000117545256,0.000093590344,0.0015170225,0.00023530002,0.0002959301,0.00004543417,0.000777601,0.000047452173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013441372,0.00056291505,0.3230415,0.00054991525,0.000038634134,0.0000012987713,0.0014444988,0.000047396526,0.59797585,0.00029698058,0.017826704,0.05687019],"study_design_scores_gemma":[0.0015837407,0.00013739141,0.9393252,0.00024343806,0.000008637806,0.000008349071,0.0005545557,0.000071581315,0.043062255,0.00020243664,0.014696827,0.000105556945],"about_ca_topic_score_codex":0.005791512,"about_ca_topic_score_gemma":0.00058083906,"teacher_disagreement_score":0.6162837,"about_ca_system_score_codex":0.00089255493,"about_ca_system_score_gemma":0.0008284857,"threshold_uncertainty_score":0.9675362},"labels":[],"label_agreement":null},{"id":"W2052175813","doi":"10.1158/1538-7445.am10-1751","title":"Abstract 1751: The influence of sex on prognostic markers for non-small cell lung cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Oncology; Lung cancer; Proportional hazards model; Medicine; Internal medicine; Transcriptome; Etiology; Disease; Survival analysis; Univariate analysis; Microarray; Hazard ratio; Bioinformatics; Biology; Gene; Multivariate analysis; Gene expression; Confidence interval; Genetics","score_opus":0.03670504911382957,"score_gpt":0.42789456925241237,"score_spread":0.3911895201385828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052175813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904384,0.0004350994,0.000005117802,0.0018310193,0.00017486731,0.0023868738,0.00011367348,0.000014251548,0.0046007154],"genre_scores_gemma":[0.9932991,0.00021561982,0.00012404266,0.00019234298,0.00023630084,0.002534739,0.000012139415,0.000030041496,0.003355644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871796,0.00002267201,0.00018681282,0.0002658908,0.0004111563,0.00039552056],"domain_scores_gemma":[0.9983721,0.00054559135,0.000065329186,0.00037708442,0.0005027736,0.00013716191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004568652,0.000113583264,0.00017792192,0.00010405184,0.00018773024,0.000024166377,0.00019483866,0.00007766336,0.00030580777],"category_scores_gemma":[0.0001616537,0.00007074969,0.0000737345,0.0002547629,0.00019406731,0.000045910394,0.000033398763,0.00050730933,0.000009412465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002198761,0.0010978576,0.4575392,0.00414722,0.0009726692,0.000046758123,0.0061715944,0.002119755,0.42481855,0.0004426406,0.046019047,0.054425932],"study_design_scores_gemma":[0.0039629326,0.0007411734,0.8936447,0.000867071,0.0003235468,0.0000027393296,0.0006861025,0.0004468776,0.07997367,0.0001301991,0.019007795,0.00021321588],"about_ca_topic_score_codex":0.0027669065,"about_ca_topic_score_gemma":0.0008304504,"teacher_disagreement_score":0.43610546,"about_ca_system_score_codex":0.0002014229,"about_ca_system_score_gemma":0.0014154689,"threshold_uncertainty_score":0.41827533},"labels":[],"label_agreement":null},{"id":"W2052217528","doi":"10.1158/1538-7445.am2014-3142","title":"Abstract 3142: Derivation and analysis of preclinical models of human her-2 positive breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Trastuzumab; Medicine; Breast cancer; Cancer; Cancer research; Luciferase; Cell culture; Transfection; Combination therapy; Internal medicine; Oncology; Biology","score_opus":0.14884588193653311,"score_gpt":0.49156702290588966,"score_spread":0.3427211409693566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052217528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940573,0.00076280435,0.000038412643,0.0018904011,0.000017014818,0.00025340356,0.00027084292,0.0000061934616,0.0027036252],"genre_scores_gemma":[0.99779737,0.0010574642,0.000055152683,0.00005645711,0.00014224603,0.000046044966,0.00005029108,0.000013241633,0.0007817558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799466,0.0001462733,0.00037468423,0.0002983037,0.0008651064,0.00032097034],"domain_scores_gemma":[0.9980758,0.00043463646,0.00009045844,0.0002399837,0.0009631985,0.00019592926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010349893,0.00009971847,0.00049015647,0.00044789095,0.00009920718,0.000012024142,0.00013451243,0.0000969915,0.0010034905],"category_scores_gemma":[0.00007913261,0.000077870754,0.00013304314,0.0008023253,0.00052782777,0.000082460516,0.000113998525,0.0003869081,0.0000020319453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028423455,0.00049509085,0.5185654,0.0011074678,0.002693184,0.000009924168,0.0008510965,0.0004641203,0.3933732,0.004000075,0.0011243442,0.07447371],"study_design_scores_gemma":[0.00062412984,0.0002765788,0.9721324,0.00029202065,0.00020658382,0.0000023005957,0.000056280172,0.0049974266,0.020714741,0.0005053641,0.000113844544,0.00007833377],"about_ca_topic_score_codex":0.009521233,"about_ca_topic_score_gemma":0.0007717651,"teacher_disagreement_score":0.45356697,"about_ca_system_score_codex":0.00007709909,"about_ca_system_score_gemma":0.0002092329,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W2052320208","doi":"10.1158/0008-5472.can-11-3364","title":"19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biocenter, University of Oulu; Medical Research Council; Deutsche Gesetzliche Unfallversicherung; National Institutes of Health; Oulun Yliopisto; Deutsche Krebshilfe; National Cancer Institute; Kuopion Yliopistollinen Sairaala; Breast Cancer Research Trust; Breast Cancer Campaign; National Health and Medical Research Council; Wellcome Trust; Cancer Research UK; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Itä-Suomen Yliopisto; Lon V. Smith Foundation; Deutsches Krebsforschungszentrum; Robert Bosch Stiftung; Helsingin ja Uudenmaan Sairaanhoitopiiri; Roswell Park Cancer Institute; Cancer Care Ontario; European Commission; Breast Cancer Research Foundation; American Association for Cancer Research","keywords":"Triple-negative breast cancer; Breast cancer; Locus (genetics); Triple negative; Oncology; Medicine; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.06055195613054159,"score_gpt":0.3869044733136166,"score_spread":0.326352517183075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052320208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889356,0.006906369,0.0000970396,0.0009785508,0.0005397835,0.00055051723,0.00035495934,0.000027934386,0.0016092496],"genre_scores_gemma":[0.98878086,0.0020370637,0.00013125519,0.00020645888,0.0014070831,0.0004137622,0.000020535228,0.000050111623,0.0069528827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973112,0.00028907604,0.0002119864,0.00061134616,0.00057150295,0.0010049057],"domain_scores_gemma":[0.99832875,0.000033542194,0.000051376577,0.0007839441,0.00045444345,0.00034794593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011365594,0.00019647024,0.00019185845,0.000091679416,0.0001986687,0.000046397457,0.00042781615,0.00020917559,0.0028011834],"category_scores_gemma":[0.00007545343,0.00017944751,0.00012229421,0.00037765363,0.00030285347,0.000014877679,0.00033233574,0.0003654218,0.00016238194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030050613,0.00012565883,0.010162311,0.00003987635,0.000061046936,0.0000019056075,0.00026322922,0.00000259604,0.9269175,0.00011049842,0.049954046,0.012060816],"study_design_scores_gemma":[0.0007104224,0.00011553887,0.0064816484,0.000030898165,0.0000078481735,0.000011242431,0.00022684677,0.000007088722,0.8772583,0.0001892889,0.11470399,0.00025685754],"about_ca_topic_score_codex":0.0008593854,"about_ca_topic_score_gemma":0.00033770344,"teacher_disagreement_score":0.06474995,"about_ca_system_score_codex":0.00027249186,"about_ca_system_score_gemma":0.00035652056,"threshold_uncertainty_score":0.9981104},"labels":[],"label_agreement":null},{"id":"W2052370726","doi":"10.1158/0008-5472.can-06-2027","title":"A Src/Abl Kinase Inhibitor, SKI-606, Blocks Breast Cancer Invasion, Growth, and Metastasis <i>In vitro</i> and <i>In vivo</i>","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Cancer research; Protein kinase B; Proto-oncogene tyrosine-protein kinase Src; Cancer; Angiogenesis; Breast cancer; Biology; Tyrosine kinase; In vivo; Kinase; Medicine; Pathology; Internal medicine; Receptor; Signal transduction; Cell biology","score_opus":0.035183164792797095,"score_gpt":0.35392657920397075,"score_spread":0.31874341441117365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052370726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98074794,0.0133257145,0.0000029767816,0.0033031236,0.00012485137,0.0010488942,0.00017811442,0.000031698473,0.0012366658],"genre_scores_gemma":[0.9899324,0.0077259378,0.00017447132,0.00055375695,0.00034669103,0.00035332996,0.000011728679,0.00006232342,0.0008393444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963899,0.0001677317,0.00048190085,0.0008555156,0.0009120919,0.0011928552],"domain_scores_gemma":[0.9983251,0.00037172466,0.000063303516,0.0004289904,0.0002354749,0.0005754056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016214683,0.0003123973,0.0005848447,0.0007474101,0.0001438323,0.00006281786,0.00015528366,0.00020408569,0.00038784955],"category_scores_gemma":[0.00016278592,0.00027424973,0.00005938145,0.0013094874,0.00042476968,0.00018446374,0.0002705923,0.000927849,0.000007717245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055507077,0.00060205406,0.18656181,0.000854165,0.00018528193,0.0023068662,0.0012832766,0.0000047643935,0.74031353,0.000049054674,0.006729267,0.0555592],"study_design_scores_gemma":[0.019994207,0.00029849046,0.05801153,0.0016865468,0.00013681097,0.00046740222,0.0008508619,0.000070649534,0.9075624,0.00019329201,0.010162989,0.00056486897],"about_ca_topic_score_codex":0.021666067,"about_ca_topic_score_gemma":0.0074770395,"teacher_disagreement_score":0.1672488,"about_ca_system_score_codex":0.0022085996,"about_ca_system_score_gemma":0.0011711954,"threshold_uncertainty_score":0.999971},"labels":[],"label_agreement":null},{"id":"W2052562237","doi":"10.1158/0008-5472.can-05-1785","title":"Gonadotropins Activate Proteolysis and Increase Invasion through Protein Kinase A and Phosphatidylinositol 3-Kinase Pathways in Human Epithelial Ovarian Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Proteolysis; Phosphatidylinositol; Kinase; Ovarian cancer; Cancer research; Cancer; Biology; Protein kinase A; Cell biology; Internal medicine; Medicine; Enzyme; Biochemistry","score_opus":0.05080814047093385,"score_gpt":0.3478654305532728,"score_spread":0.29705729008233894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052562237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762494,0.0043194736,0.000010458535,0.0037774672,0.000054473407,0.0034713617,0.00020072011,0.00003815074,0.0005029705],"genre_scores_gemma":[0.9921168,0.0017512362,0.0004214775,0.00014804647,0.00043208955,0.004594219,0.000034231423,0.000060234037,0.00044164347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970838,0.00025693027,0.00039481593,0.0008630438,0.0006581249,0.00074331043],"domain_scores_gemma":[0.9988573,0.0000863584,0.00010133682,0.00044899574,0.00020974867,0.00029626084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044432018,0.00031550342,0.0005209404,0.0002857802,0.00036851023,0.00011368394,0.00012306604,0.00017409363,0.00030995696],"category_scores_gemma":[0.00004335943,0.00026452227,0.00006874092,0.00065250404,0.00033133038,0.00023027304,0.0001873141,0.0005801973,0.0000071154677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012658555,0.0011757173,0.049725052,0.0007651842,0.0001224301,0.0010464817,0.00090599945,0.000016822234,0.9231139,0.0016896863,0.0007521764,0.019420717],"study_design_scores_gemma":[0.008000584,0.0006540985,0.11258568,0.001627555,0.000086250904,0.00001069404,0.00013711663,0.000058708705,0.8714222,0.0012629934,0.0038286415,0.0003254949],"about_ca_topic_score_codex":0.10669816,"about_ca_topic_score_gemma":0.005025832,"teacher_disagreement_score":0.10167233,"about_ca_system_score_codex":0.0008874799,"about_ca_system_score_gemma":0.000668551,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W2052707876","doi":"10.1158/0008-5472.sabcs13-p1-08-09","title":"Abstract P1-08-09: EGFR expression is associated with decreased response from HER2 targeted therapeutics in the neo-adjuvant setting in the NeoALTTO trial","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Adjuvant; Cancer; Pathological; Randomized controlled trial","score_opus":0.13457686107845843,"score_gpt":0.4477739577996906,"score_spread":0.3131970967212322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052707876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634606,0.0021671006,0.0000043943555,0.028356034,0.000111211244,0.0048215436,0.00008894767,0.00004258781,0.0009475697],"genre_scores_gemma":[0.9931938,0.00038527252,0.000078412995,0.0027136959,0.0004756905,0.0025934335,0.000067464825,0.00008945996,0.00040276413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.98883796,0.0046825903,0.0006892495,0.00076725637,0.0035037466,0.0015191745],"domain_scores_gemma":[0.99067247,0.006950444,0.00015944018,0.001343766,0.00059282215,0.00028106826],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011774105,0.00034012125,0.0005585279,0.00047119224,0.00036563634,0.000327269,0.0012494841,0.00034056083,0.002240503],"category_scores_gemma":[0.0024195781,0.00018387394,0.00011816148,0.0020837344,0.0004744812,0.00021698189,0.00015785145,0.0033195287,0.00015531215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26859277,0.0031796223,0.0652519,0.00028429853,0.00047467757,0.0024848063,0.074920155,0.00012066681,0.40025964,0.000018316701,0.10253819,0.08187494],"study_design_scores_gemma":[0.08573823,0.0033833066,0.79943854,0.0042980607,0.000082887775,0.0000224306,0.02560048,0.0013949389,0.045080148,0.0008789676,0.03326426,0.00081772957],"about_ca_topic_score_codex":0.021690791,"about_ca_topic_score_gemma":0.00274953,"teacher_disagreement_score":0.73418665,"about_ca_system_score_codex":0.0013587417,"about_ca_system_score_gemma":0.0026820637,"threshold_uncertainty_score":0.99897987},"labels":[],"label_agreement":null},{"id":"W2052926537","doi":"10.1158/0008-5472.sabcs11-p2-12-28","title":"P2-12-28: Studies of a Malignancy-Associated Protein, Osteopontin, in NCIC CTG MA.14, a Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR in Adjuvant Treatment of Women with Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Osteopontin; Internal medicine; Tamoxifen; Proportional hazards model; Oncology; Breast cancer; Univariate analysis; Hazard ratio; Immunohistochemistry; Cancer; Gastroenterology; Multivariate analysis; Confidence interval","score_opus":0.09427986712061383,"score_gpt":0.37366138938540533,"score_spread":0.2793815222647915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052926537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825677,0.010122821,3.0675102e-7,0.00021971563,0.000070659364,0.0064545525,0.00009759371,0.000013399677,0.00045320357],"genre_scores_gemma":[0.99035484,0.004168323,0.000044439214,0.0000064260853,0.000033113505,0.0047867964,0.0000039844126,0.000034156797,0.0005679543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99653476,0.0006211341,0.000888633,0.0004306771,0.0008184799,0.0007063051],"domain_scores_gemma":[0.9980788,0.00037852195,0.0003745876,0.00033299782,0.00068857125,0.0001464737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019222443,0.00028460927,0.002301968,0.00045705185,0.000055509212,0.000006498732,0.00013432749,0.00011431136,0.000076301425],"category_scores_gemma":[0.0004513006,0.00019520365,0.000112380505,0.0007909883,0.0010715808,0.00009691341,0.00014666894,0.00025315792,0.0000010447162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92531645,0.0015817523,0.04073136,0.00065745093,0.0014795728,0.0001318125,0.020748794,0.0000010193522,0.007175359,0.000030558927,0.000040690193,0.0021052046],"study_design_scores_gemma":[0.875258,0.013312661,0.06634203,0.0028399897,0.00018976998,0.0000029462217,0.004152826,0.0000051762136,0.03743041,0.00025547724,0.0000075635267,0.00020312132],"about_ca_topic_score_codex":0.039939508,"about_ca_topic_score_gemma":0.011088572,"teacher_disagreement_score":0.0500584,"about_ca_system_score_codex":0.0010064908,"about_ca_system_score_gemma":0.0006018467,"threshold_uncertainty_score":0.9664536},"labels":[],"label_agreement":null},{"id":"W2052953726","doi":"10.1158/1538-7445.am2013-lb-63","title":"Abstract LB-63: Relationship between tumor biomarkers (BM) and efficacy in EMILIA, a phase III study of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab emtansine; Lapatinib; Medicine; Trastuzumab; Hazard ratio; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Cancer; Antibody-drug conjugate; Progression-free survival; Capecitabine; Proportional hazards model; Chemotherapy; Antibody; Confidence interval; Monoclonal antibody; Immunology","score_opus":0.15458355897690865,"score_gpt":0.48886552015526247,"score_spread":0.33428196117835385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052953726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914117,0.0019858205,0.0000037690804,0.0025141418,0.000058222766,0.005540346,0.0003036806,0.0000270216,0.0004258483],"genre_scores_gemma":[0.9971889,0.00030473954,0.00005230396,0.00004288452,0.00014933047,0.0018791547,0.000034221874,0.00008833765,0.00026008527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409676,0.0008318365,0.0010950849,0.0009381321,0.0018216451,0.0012165637],"domain_scores_gemma":[0.9957941,0.002031468,0.0001618767,0.00066319725,0.00077440933,0.00057493494],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029096426,0.0003562946,0.001010272,0.0015862323,0.00016266882,0.00007916025,0.00038636706,0.0001314331,0.0013979189],"category_scores_gemma":[0.0008033966,0.00032310493,0.0000839686,0.002844251,0.0006942938,0.00031588113,0.00019887881,0.0017551475,0.000036747548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033898351,0.0051883115,0.9196471,0.0011955393,0.000467965,0.00065134006,0.0093453415,0.000051452935,0.015315865,0.0000129596365,0.001809661,0.042924657],"study_design_scores_gemma":[0.02046168,0.0014278726,0.96767235,0.0017203827,0.00007711963,0.000022017988,0.0062961318,0.00011261402,0.0018252454,0.00007687646,0.00004375218,0.00026392925],"about_ca_topic_score_codex":0.11057312,"about_ca_topic_score_gemma":0.01398658,"teacher_disagreement_score":0.09658654,"about_ca_system_score_codex":0.0021065937,"about_ca_system_score_gemma":0.0021575943,"threshold_uncertainty_score":0.9999221},"labels":[],"label_agreement":null},{"id":"W2053126030","doi":"10.1158/1538-7445.am2013-864","title":"Abstract 864: ANG4043: A new brain-penetrant peptide-antibody conjugate that reduces tumor growth in a HER2-positive orthotopic tumor model.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; LRP1; Monoclonal antibody; Conjugate; Peptide; Receptor; Blood–brain barrier; Cancer research; Antibody; In vitro; Receptor tyrosine kinase; Tumor microenvironment; Biology; Cell biology; Chemistry; Pharmacology; Biochemistry; Immunology; Endocrinology; Central nervous system; LDL receptor; Lipoprotein; Endocytosis; Cholesterol","score_opus":0.04524306884702095,"score_gpt":0.3740412239470097,"score_spread":0.3287981550999888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053126030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896087,0.0009983213,0.00010171833,0.0037130953,0.000055905384,0.0015052516,0.000047152083,0.000018609338,0.0039512515],"genre_scores_gemma":[0.9912784,0.0004192777,0.0002048168,0.00060848834,0.00023595654,0.0005258463,0.00010912228,0.000053935684,0.0065641254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968285,0.0002380747,0.00033472534,0.000784902,0.00079881225,0.0010149876],"domain_scores_gemma":[0.998462,0.00006293334,0.00007454723,0.00044175217,0.0005392366,0.00041950986],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080692634,0.0002586911,0.00027862418,0.00030788092,0.000183015,0.00020460435,0.0005685331,0.00013800681,0.0010579352],"category_scores_gemma":[0.00030819533,0.00023429396,0.00011601426,0.0004593464,0.00027065282,0.000037568574,0.00025835773,0.0006682161,0.00019271352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026571672,0.000106328975,0.003835051,0.00007844099,0.000042353844,0.000080864025,0.00017906753,0.00019510144,0.9785885,0.00011097065,0.014748001,0.0017695788],"study_design_scores_gemma":[0.0017472677,0.00039635628,0.056528453,0.00021110961,0.000004531335,0.000025517675,0.00027055404,0.0010583947,0.9332361,0.00078351493,0.0052835415,0.00045464418],"about_ca_topic_score_codex":0.012471718,"about_ca_topic_score_gemma":0.0015604154,"teacher_disagreement_score":0.0526934,"about_ca_system_score_codex":0.00013098585,"about_ca_system_score_gemma":0.001178247,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W2053311062","doi":"10.1158/0008-5472.sabcs-09-5044","title":"Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Brief Pain Inventory; Grip strength; Internal medicine; Discontinuation; Joint pain; Physical therapy; Cancer; Stage (stratigraphy); Chronic pain","score_opus":0.13473932912777978,"score_gpt":0.48232960110874196,"score_spread":0.34759027198096215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053311062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900279,0.0010999521,0.000005549351,0.0018624888,0.00013140199,0.0049621454,0.0008450311,0.000037871578,0.001027642],"genre_scores_gemma":[0.9939562,0.00019254765,0.00007506028,0.00011063682,0.0005304492,0.0047488543,0.000040054387,0.00005758805,0.00028861716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939086,0.000485448,0.000658885,0.0006930472,0.0029770934,0.0012769243],"domain_scores_gemma":[0.9961258,0.0002326669,0.0001534979,0.0005331782,0.0025708776,0.00038399035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0070912633,0.00022976944,0.00055300555,0.00083329756,0.00015825695,0.000061862636,0.00025785246,0.00016473579,0.00094810774],"category_scores_gemma":[0.0009037971,0.00021485747,0.000071044415,0.0015266102,0.00028290876,0.00025113096,0.00010808631,0.00091395766,0.000012483951],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008707812,0.0016594061,0.26165673,0.00214262,0.00038549866,0.00011823348,0.01766389,0.00060141995,0.48958558,0.00079028297,0.004365115,0.21232341],"study_design_scores_gemma":[0.01173905,0.005397621,0.8538862,0.002512992,0.000063430096,0.000018769888,0.0028565382,0.0014756118,0.1191187,0.0021375015,0.0003762788,0.00041730085],"about_ca_topic_score_codex":0.004367654,"about_ca_topic_score_gemma":0.0004641612,"teacher_disagreement_score":0.5922295,"about_ca_system_score_codex":0.006853378,"about_ca_system_score_gemma":0.004542062,"threshold_uncertainty_score":0.99996513},"labels":[],"label_agreement":null},{"id":"W2053409548","doi":"10.1158/1538-7445.am2013-5266","title":"Abstract 5266: Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Queen's University","funders":"","keywords":"Lucifer yellow; Gap junction; Proto-oncogene tyrosine-protein kinase Src; Biology; Cell culture; Cell biology; Transfection; Cancer research; Downregulation and upregulation; Intracellular; Phosphorylation; Chemistry; Biochemistry","score_opus":0.042169695434120594,"score_gpt":0.364084945459453,"score_spread":0.32191525002533244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053409548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953289,0.002296444,0.00001290814,0.0004861693,0.0000404241,0.00031550662,0.00005109596,0.0000028610782,0.0014657127],"genre_scores_gemma":[0.9979418,0.00030220367,0.000060643317,0.000084670995,0.00008835696,0.000115675306,0.00016833769,0.0000133562025,0.0012249838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893206,0.0001504686,0.00021381532,0.00027966447,0.00015777838,0.00026621876],"domain_scores_gemma":[0.9990556,0.000022917653,0.000057380956,0.0004067091,0.00039452492,0.000062868465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032141648,0.00009652126,0.00013044862,0.00009800648,0.00008824582,0.000019330198,0.0002731102,0.00015589749,0.0005696439],"category_scores_gemma":[0.000018726065,0.00008736561,0.000058407706,0.00012628445,0.00025395653,0.0000067628976,0.00018877054,0.0002602567,0.000014016201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070389884,0.00012664897,0.00434257,0.000034670564,0.000029161934,0.0000013263963,0.00036266696,0.0000038750322,0.9818879,0.00017067783,0.012231934,0.0007381938],"study_design_scores_gemma":[0.0011751371,0.000203619,0.070613444,0.00006378349,0.0000047893705,0.0000022686263,0.0005759406,0.000056673907,0.9193224,0.00024583787,0.0075856005,0.00015055927],"about_ca_topic_score_codex":0.004439417,"about_ca_topic_score_gemma":0.0006212158,"teacher_disagreement_score":0.06627087,"about_ca_system_score_codex":0.00008147225,"about_ca_system_score_gemma":0.00011978378,"threshold_uncertainty_score":0.67111},"labels":[],"label_agreement":null},{"id":"W2053457803","doi":"10.1158/1538-7445.am2011-5157","title":"Abstract 5157: A role of the FGF-pathway in the VEGF/VEGFR targeting","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Angiogenesis; Sunitinib; Basic fibroblast growth factor; Bevacizumab; Vascular endothelial growth factor; Medicine; Neovascularization; Fibroblast growth factor; Internal medicine; Endocrinology; Pharmacology; VEGF receptors; Receptor; Growth factor; Cancer; Chemotherapy","score_opus":0.08604068684261341,"score_gpt":0.3722748830348459,"score_spread":0.2862341961922325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053457803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873085,0.0029179687,0.0000018509198,0.00023761498,0.000065512664,0.00042997673,0.0000198652,0.0000031157206,0.009015574],"genre_scores_gemma":[0.9991495,0.0001265363,0.000012081392,0.00003260376,0.00015264048,0.00017484807,0.000004822147,0.000019335948,0.00032761143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980702,0.00040743194,0.00018178066,0.0003051146,0.00053864595,0.00049687485],"domain_scores_gemma":[0.9989936,0.0000880453,0.000046553916,0.00056181854,0.00025467627,0.000055351316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018195821,0.00009913548,0.00010633616,0.00008069354,0.00013490098,0.000019998433,0.0009955249,0.0000995585,0.00028394358],"category_scores_gemma":[0.00054961035,0.00006130364,0.00007778837,0.00042264877,0.00032459007,0.0000052149844,0.00037849354,0.00052404084,0.000017214232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010041989,0.000068808666,0.02550395,0.000031005766,0.000018049246,0.000004336696,0.0014692714,0.0000022871563,0.9672351,0.00022971927,0.00072725606,0.004609796],"study_design_scores_gemma":[0.00018337074,0.00009615202,0.101360336,0.00003164814,0.0000012485169,0.0000017590642,0.0013677438,0.0000035935093,0.8718533,0.00046362143,0.024558969,0.00007824914],"about_ca_topic_score_codex":0.0022052631,"about_ca_topic_score_gemma":0.00084245106,"teacher_disagreement_score":0.0953818,"about_ca_system_score_codex":0.000051403786,"about_ca_system_score_gemma":0.00035247867,"threshold_uncertainty_score":0.3333713},"labels":[],"label_agreement":null},{"id":"W2053620639","doi":"10.1158/0008-5472.sabcs12-p2-10-09","title":"Abstract P2-10-09: The incidence of false negative of HER2/Neu status in primary breast cancer in the era of standardized testing: a Canadian prospective study.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Ottawa Hospital; Kingston General Hospital; Saskatoon City Hospital","funders":"","keywords":"Medicine; Breast cancer; Trastuzumab; Immunohistochemistry; Internal medicine; Oncology; Incidence (geometry); Fluorescence in situ hybridization; Cancer; Companion diagnostic; Pathology; Gynecology","score_opus":0.038501501216123134,"score_gpt":0.3720088018066682,"score_spread":0.33350730059054506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053620639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235463,0.0038721622,4.1699192e-7,0.0005253985,0.00003849532,0.0011791887,0.0010585317,0.0000016510128,0.0009695342],"genre_scores_gemma":[0.9986611,0.00045241174,0.00002235258,0.000029908637,0.000080814905,0.000707166,0.000006931025,0.000017206461,0.000022099515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787736,0.00035045657,0.0003375338,0.00027809408,0.0005558221,0.00060071144],"domain_scores_gemma":[0.9983908,0.00029560606,0.00015516471,0.0004059539,0.0006613653,0.00009109482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013711152,0.00015693106,0.00031387783,0.00011493963,0.00009383023,0.000009636361,0.00037750817,0.000067257795,0.00005956084],"category_scores_gemma":[0.0003434356,0.0000997502,0.000048197424,0.0007813519,0.00056039356,0.000014210756,0.0001574008,0.00035788422,5.9481147e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000988459,0.00035787676,0.95976293,0.00008428467,0.00016399237,0.0000065485788,0.009100658,0.00009663972,0.023675526,0.000016451577,0.00020942069,0.005537188],"study_design_scores_gemma":[0.0012576567,0.00018693645,0.9731871,0.00016194026,0.000017183766,0.0000029096425,0.0059636855,0.0000010368409,0.019005783,0.00003739148,0.00008955064,0.0000888615],"about_ca_topic_score_codex":0.51268566,"about_ca_topic_score_gemma":0.4985174,"teacher_disagreement_score":0.01416826,"about_ca_system_score_codex":0.00064112165,"about_ca_system_score_gemma":0.002374762,"threshold_uncertainty_score":0.51063335},"labels":[],"label_agreement":null},{"id":"W2053837161","doi":"10.1158/1538-7445.nonrna12-b6","title":"Abstract B6: Human genome contains a large number of very long intergenic transcribed regions, some of which are associated with cancer outcome","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; RNA; Human genome; Genetics; Genome; Computational biology; Transcriptome; Cancer; Gene; Gene expression","score_opus":0.08445422738136438,"score_gpt":0.4114042542370846,"score_spread":0.3269500268557202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053837161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927256,0.0058207572,0.00006500439,0.0002309432,0.00008506471,0.00030876632,0.00039619094,0.000007572832,0.00036006115],"genre_scores_gemma":[0.9966092,0.001291092,0.00000769673,0.00004828637,0.00020713532,0.00028049332,0.00014106586,0.000040497194,0.0013745402],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99823755,0.00012416411,0.0003654409,0.00029433673,0.00038837414,0.00059010665],"domain_scores_gemma":[0.9984394,0.000023727564,0.00020521459,0.00047082594,0.0007165313,0.00014434308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007124984,0.00015382124,0.00029646963,0.000087485816,0.00013143124,0.000013241366,0.0003241149,0.00017433429,0.00044398452],"category_scores_gemma":[0.00006135319,0.00013294656,0.000108316235,0.00033436864,0.00018254599,0.000020918771,0.00006756913,0.00028850534,0.0000045949464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019339184,0.00029709988,0.3400898,0.000128287,0.0003169277,0.0000013867718,0.00027388142,0.00002291396,0.65747947,0.00039216474,0.00071106246,0.00009366274],"study_design_scores_gemma":[0.0015009564,0.0001386782,0.8652511,0.00020661017,0.000055070064,0.000001920358,0.000475975,0.00000226801,0.12776446,0.000032168547,0.0043050693,0.00026567694],"about_ca_topic_score_codex":0.0009957025,"about_ca_topic_score_gemma":0.0051401863,"teacher_disagreement_score":0.529715,"about_ca_system_score_codex":0.0001713635,"about_ca_system_score_gemma":0.00031147766,"threshold_uncertainty_score":0.5421403},"labels":[],"label_agreement":null},{"id":"W2054001521","doi":"10.1158/1538-7445.am2013-4062","title":"Abstract 4062: Clusterin downregulation sensitize prostate cancer cells to taxane by modulating mitosis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia Hospital","funders":"","keywords":"Clusterin; Taxane; Cancer research; Mitosis; LNCaP; Cancer cell; Downregulation and upregulation; Cell cycle; Prostate cancer; Clonogenic assay; Biology; Cancer; Cell biology; Cell; Apoptosis; Internal medicine; Medicine; Breast cancer","score_opus":0.05395965547436744,"score_gpt":0.4051495422660739,"score_spread":0.3511898867917065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054001521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863979,0.0006431338,0.0000463579,0.0090404805,0.0002961931,0.0023521862,0.00015873322,0.00008590958,0.0009790731],"genre_scores_gemma":[0.9908377,0.00018578279,0.000550786,0.0007927155,0.0004815839,0.0016609968,0.00005040545,0.00007546031,0.0053645927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707973,0.00015452637,0.0004001996,0.0006504271,0.00080300623,0.0009121105],"domain_scores_gemma":[0.9978893,0.00016881646,0.000085452084,0.00057774223,0.0006984714,0.00058024144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054099574,0.00021985419,0.0003545366,0.0002615814,0.00018163682,0.00009521624,0.00017404874,0.00014974682,0.0033097959],"category_scores_gemma":[0.00016745333,0.00020572905,0.000074125324,0.00050980656,0.0001817892,0.00014988855,0.0002778227,0.0005046897,0.00060010405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028554094,0.00006537099,0.0025031853,0.00031706045,0.000036122343,0.00004122043,0.0005768904,0.0010791149,0.89436704,0.0000017369538,0.06634433,0.034382377],"study_design_scores_gemma":[0.0037466087,0.0004529744,0.40840608,0.0013062521,0.00007200118,0.0000467054,0.0008992076,0.0064333812,0.5624073,0.00013446026,0.015285784,0.00080925797],"about_ca_topic_score_codex":0.0063343667,"about_ca_topic_score_gemma":0.00018794886,"teacher_disagreement_score":0.4059029,"about_ca_system_score_codex":0.0006808115,"about_ca_system_score_gemma":0.00028542496,"threshold_uncertainty_score":0.99760133},"labels":[],"label_agreement":null},{"id":"W2054107940","doi":"10.1158/0008-5472.can-08-0245","title":"Inhibition of DNA Methyltransferase Activates Tumor Necrosis Factor α–Induced Monocytic Differentiation in Acute Myeloid Leukemia Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Chromatin immunoprecipitation; Biology; Chromatin; Myeloid leukemia; DNA methylation; Cancer research; Transcription factor; Epigenetics; Promoter; Cellular differentiation; Tumor necrosis factor alpha; Cell biology; Molecular biology; Gene expression; Immunology; Genetics; Gene","score_opus":0.05952452182535865,"score_gpt":0.345628822960368,"score_spread":0.28610430113500934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054107940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986327,0.000445904,0.0003301229,0.000046073557,0.00007751305,0.00032616447,0.00005983054,0.0000056930376,0.00007597949],"genre_scores_gemma":[0.99629223,0.0031998365,0.00007858339,0.000013965778,0.00008002869,0.00009656879,0.00008107116,0.000024459046,0.00013325816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857426,0.00019190962,0.0002633908,0.0003395396,0.000316679,0.00031422218],"domain_scores_gemma":[0.9993496,0.000044849094,0.000060195263,0.0002490107,0.00021220476,0.000084156214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023590415,0.00012776791,0.00017509445,0.00019078475,0.00009575987,0.00001536716,0.00012291194,0.00013534301,0.000047130947],"category_scores_gemma":[0.000054421922,0.00012508313,0.000070138536,0.00030587637,0.000094118004,0.000010825215,0.000057867128,0.0002095655,0.000003997266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015828338,0.00004892518,0.002847391,0.00002808831,0.000039596238,0.000004049301,0.00026688923,0.0000878881,0.99502116,0.0000049530513,0.000026684183,0.0014660857],"study_design_scores_gemma":[0.0006811125,0.00021487399,0.02830304,0.00002692681,0.00000893991,5.332946e-7,0.000035856785,0.00008634626,0.970342,0.00009907502,0.000077224024,0.00012411558],"about_ca_topic_score_codex":0.0006530243,"about_ca_topic_score_gemma":0.00015486847,"teacher_disagreement_score":0.02545565,"about_ca_system_score_codex":0.00019011927,"about_ca_system_score_gemma":0.00033595756,"threshold_uncertainty_score":0.5100742},"labels":[],"label_agreement":null},{"id":"W2054241093","doi":"10.1158/0008-5472.can-07-6276","title":"Thrombin Up-regulates Cathepsin D which Enhances Angiogenesis, Growth, and Metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Thrombin; Angiogenesis; Matrigel; Molecular biology; Hirudin; Biology; Chemistry; Cancer research; Immunology; Platelet","score_opus":0.05261152278931608,"score_gpt":0.3438309231643298,"score_spread":0.2912194003750137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054241093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98377067,0.015050877,0.00004635778,0.0003597625,0.00012849341,0.00023292826,0.000031763055,0.000012422572,0.00036671682],"genre_scores_gemma":[0.98844373,0.009686432,0.00017229025,0.00006156453,0.0002971806,0.0001715475,0.0000310001,0.000025593787,0.0011106347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985567,0.00015634345,0.00013090773,0.0004358435,0.0003034702,0.00041675655],"domain_scores_gemma":[0.9992728,0.00001789272,0.000028699653,0.0002857196,0.00025871018,0.00013614434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036497548,0.00013214977,0.00014704748,0.00008361403,0.00031172906,0.000027474094,0.00020919027,0.000121952056,0.00007374162],"category_scores_gemma":[0.00009906043,0.0001168646,0.000054125267,0.00027914337,0.0002150632,0.000009008409,0.00018952333,0.00012124039,0.000013502366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005746266,0.000026857102,0.00030387365,0.000025698355,0.000055863617,0.000004278835,0.000085217536,5.8077586e-7,0.9932766,0.00017764293,0.005414429,0.0005715125],"study_design_scores_gemma":[0.00028230026,0.00020704615,0.00023557428,0.00001806279,0.00000910231,0.00002764843,0.00006360902,0.000002510821,0.99509716,0.00039820708,0.0035124284,0.00014637112],"about_ca_topic_score_codex":0.0004067317,"about_ca_topic_score_gemma":0.000114719565,"teacher_disagreement_score":0.0053644455,"about_ca_system_score_codex":0.000018665896,"about_ca_system_score_gemma":0.00023000465,"threshold_uncertainty_score":0.47656},"labels":[],"label_agreement":null},{"id":"W2054312364","doi":"10.1158/0008-5472.can-13-1310","title":"MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Suppressor; Breast cancer; Cancer research; Cancer; Cell cycle; Kinase; Cyclin-dependent kinase 4; MAPK/ERK pathway; Biology; Cell growth; Protein kinase A; Cyclin-dependent kinase 2; Cell biology; Genetics","score_opus":0.02897470359871875,"score_gpt":0.34534608945878104,"score_spread":0.3163713858600623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054312364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429876,0.00039594018,0.000004367956,0.0016989291,0.000076365985,0.0006589973,0.00016461416,0.00000876192,0.0026932594],"genre_scores_gemma":[0.99300015,0.00017691546,0.00007101015,0.00042778606,0.00034590618,0.0021720987,0.00002929855,0.000037817987,0.0037390217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831873,0.00011004028,0.00014950689,0.00048584706,0.00031996873,0.0006159051],"domain_scores_gemma":[0.99900883,0.0000132759915,0.00003336132,0.0004320879,0.00032156406,0.00019086293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019694936,0.00015061803,0.00015870147,0.0000661388,0.00008230683,0.000056904984,0.0002952416,0.00010174439,0.0040868428],"category_scores_gemma":[0.000016045515,0.00012038921,0.00003805327,0.00025017327,0.00016398197,0.000009604466,0.00014826945,0.00026533852,0.00017730394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028160488,0.00006302731,0.02566784,0.000055166496,0.000026490341,0.0000270862,0.00011008804,0.000004017746,0.8813705,0.00003094624,0.09147652,0.0008867223],"study_design_scores_gemma":[0.0011136477,0.00013171897,0.025117327,0.00012276588,0.0000044668805,0.000036492802,0.00013647923,0.0000149352445,0.9425308,0.00006679143,0.030492062,0.00023250235],"about_ca_topic_score_codex":0.006081692,"about_ca_topic_score_gemma":0.00073852355,"teacher_disagreement_score":0.061160322,"about_ca_system_score_codex":0.000080057,"about_ca_system_score_gemma":0.0004708179,"threshold_uncertainty_score":0.99682355},"labels":[],"label_agreement":null},{"id":"W2054468883","doi":"10.1158/1538-7445.am2014-3476","title":"Abstract 3476: Profiling CD antigens signature in human hepatocellular carcinoma (HCC) by cell-based high-throughput screening flow cytometry (HTS-FC)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"CD90; CD44; Flow cytometry; Antigen; CD24; Antibody; Hepatocellular carcinoma; Cancer research; Cluster of differentiation; Epithelial cell adhesion molecule; Cancer stem cell; Cytometry; Biology; Cancer; Cell; Molecular biology; Immunology; Medicine; Internal medicine","score_opus":0.03813180872879339,"score_gpt":0.319187581419699,"score_spread":0.2810557726909056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054468883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040085,0.0029866293,0.0052067204,0.00015528685,0.00017345295,0.00047753667,0.00011368811,0.000026063966,0.0004597654],"genre_scores_gemma":[0.9968941,0.00013095322,0.0010638564,0.00017350327,0.0005408414,0.00008660293,0.0006400025,0.000086643486,0.00038346552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970535,0.00023925549,0.0003657848,0.0008464194,0.0005900035,0.000905028],"domain_scores_gemma":[0.9988013,0.000057475732,0.00007599468,0.0005932911,0.00026065225,0.00021131757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010726788,0.0002946344,0.00032733523,0.00023463512,0.00032426292,0.0000963182,0.0005419195,0.00047066226,0.000096696276],"category_scores_gemma":[0.00007182636,0.0002982774,0.00013019175,0.0004638336,0.00021817426,0.000011800245,0.000109254805,0.000909908,0.000011650329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000182777,0.00013888505,0.06279439,0.00019111135,0.000019812038,0.000021933198,0.00004215598,0.00085526,0.9330962,0.000010082413,0.0016190178,0.0010284369],"study_design_scores_gemma":[0.0015331854,0.00033861303,0.0040183715,0.00008437256,0.000008395654,8.7424536e-7,0.000044481792,0.002804586,0.9828835,0.000025991618,0.007888888,0.00036873648],"about_ca_topic_score_codex":0.0015667824,"about_ca_topic_score_gemma":0.00025180294,"teacher_disagreement_score":0.058776014,"about_ca_system_score_codex":0.000109160785,"about_ca_system_score_gemma":0.0002598672,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2054653709","doi":"10.1158/1538-7445.am2012-5480","title":"Abstract 5480: Consumption of Lake Ontario sport fish and the incidence of melanoma in the New York State Angler Cohort Study (NYSACS)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Poisson regression; Demography; Confounding; Incidence (geometry); Cohort study; Environmental health; Confidence interval; Gerontology; Population; Internal medicine","score_opus":0.054361018885849814,"score_gpt":0.3633918247314425,"score_spread":0.30903080584559267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054653709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979149,0.00087900535,0.000004015042,0.00014841829,0.000043391017,0.00075825216,0.000022198892,8.545088e-7,0.00022894052],"genre_scores_gemma":[0.9990086,0.00038927325,0.000009161651,0.00004996906,0.00006744248,0.00007752582,0.000012531773,0.0000060289485,0.00037944317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989431,0.00010694774,0.00019856238,0.00016021247,0.0003647319,0.0002264375],"domain_scores_gemma":[0.9994331,0.00004648844,0.000067608984,0.00031372075,0.00009007566,0.000049015616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020966462,0.0000715296,0.0001469602,0.000037603193,0.000049748214,0.000014946158,0.0002024308,0.000043621258,0.0000995146],"category_scores_gemma":[0.000022034848,0.000044526594,0.00003443275,0.000098473094,0.00022784337,0.0000051836014,0.00011094683,0.00018713952,9.0982786e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029741897,0.00011225715,0.9665224,0.000024240364,0.000048010465,0.0000014470257,0.0023908385,0.000012745255,0.028796239,0.000017161536,0.0011863043,0.0005909443],"study_design_scores_gemma":[0.0007067718,0.0001221121,0.97643304,0.000016530954,0.0000123287045,0.0000029008127,0.00061211875,8.109765e-7,0.019255282,0.000017667608,0.0027711848,0.000049241717],"about_ca_topic_score_codex":0.03667196,"about_ca_topic_score_gemma":0.40664715,"teacher_disagreement_score":0.36997518,"about_ca_system_score_codex":0.000036434194,"about_ca_system_score_gemma":0.0002756049,"threshold_uncertainty_score":0.96974295},"labels":[],"label_agreement":null},{"id":"W2054783485","doi":"10.1158/1538-7445.am2014-2105","title":"Abstract 2105: Regulation of estrogen receptor turnover by lysine 302 methylation","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; University of Toronto","funders":"","keywords":"Tamoxifen; Estrogen receptor; Methylation; Downregulation and upregulation; Estrogen; Estrogen receptor alpha; MG132; Cancer research; Chemistry; SUMO protein; Estrogen receptor beta; Internal medicine; Endocrinology; Cancer; Breast cancer; Biology; Ubiquitin; Medicine; Proteasome inhibitor; Proteasome; Biochemistry; Gene","score_opus":0.019118675914804525,"score_gpt":0.34241603843422386,"score_spread":0.3232973625194193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054783485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445796,0.0031872639,0.00020540443,0.00022102505,0.000114645685,0.00018890513,0.000020832736,0.000007883038,0.0015961078],"genre_scores_gemma":[0.9977468,0.000427178,0.00011401956,0.000015110045,0.00031423615,0.000031197156,0.00022891328,0.000021813517,0.0011006795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998868,0.00014835942,0.00017169338,0.0002575752,0.00030868748,0.00024568313],"domain_scores_gemma":[0.99930125,0.00003837849,0.00007127416,0.0002735158,0.0002327591,0.00008281063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007134377,0.00009217632,0.00011654862,0.00006412086,0.00007170667,0.000014640348,0.00014407108,0.00020420451,0.00014455931],"category_scores_gemma":[0.00013860509,0.00008117085,0.000062927356,0.0001887257,0.00011670878,0.0000062157865,0.000054637625,0.0001903083,0.000028589187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001306512,0.00003308731,0.0005877689,0.000028165638,0.000048185706,1.1103997e-7,0.000019609084,0.00010564833,0.97172916,0.000118278556,0.01774213,0.009457202],"study_design_scores_gemma":[0.00038953242,0.00019462936,0.0019780896,0.000024238467,0.000007755882,6.1508024e-7,0.000008826385,0.00006916581,0.9519601,0.00009304984,0.04518787,0.00008612339],"about_ca_topic_score_codex":0.00011040223,"about_ca_topic_score_gemma":0.000004557497,"teacher_disagreement_score":0.027445737,"about_ca_system_score_codex":0.000036765858,"about_ca_system_score_gemma":0.000081099206,"threshold_uncertainty_score":0.33100513},"labels":[],"label_agreement":null},{"id":"W2054894450","doi":"10.1158/0008-5472.can-2401-2","title":"Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; University of California, San Diego","keywords":"PTEN; Microsatellite instability; Cancer research; Biology; DNA methylation; Methylation; Tumor suppressor gene; Gene silencing; Allele; Microsatellite; Genetics; Gene; Carcinogenesis; PI3K/AKT/mTOR pathway; Gene expression","score_opus":0.029406418278028753,"score_gpt":0.3480613607289994,"score_spread":0.31865494245097065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054894450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649316,0.0022129281,0.00013029634,0.00027521627,0.00013193072,0.00051804207,0.00008902966,0.0000071619834,0.00014222082],"genre_scores_gemma":[0.9987988,0.00038461317,0.00017143668,0.00003742176,0.00012624357,0.00019294291,0.00019724338,0.000027751248,0.00006353815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983656,0.00014750114,0.00028769183,0.00044857728,0.0003704723,0.00038018424],"domain_scores_gemma":[0.99921346,0.000021652158,0.00008742426,0.00028219813,0.00032071056,0.000074572374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071438495,0.0001302237,0.0001750214,0.00013962465,0.00005947763,0.000018039182,0.00023006824,0.00018830935,0.000051624247],"category_scores_gemma":[0.00011516086,0.00013250178,0.00004504871,0.00044647025,0.00029683608,0.000014183353,0.0000732271,0.0002885979,0.0000031824131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003446935,0.00007051855,0.0074804965,0.00005944616,0.000023896187,0.000002233086,0.00026252595,0.0010799253,0.9874281,0.000040520034,0.00012460053,0.0030830076],"study_design_scores_gemma":[0.00094367104,0.00032457823,0.0064941403,0.00011117489,0.000003550014,0.0000015202003,0.00006485345,0.0000113711,0.9893903,0.000502368,0.0020146759,0.00013779872],"about_ca_topic_score_codex":0.0076024993,"about_ca_topic_score_gemma":0.001074898,"teacher_disagreement_score":0.0065276013,"about_ca_system_score_codex":0.0011843463,"about_ca_system_score_gemma":0.0009386214,"threshold_uncertainty_score":0.999006},"labels":[],"label_agreement":null},{"id":"W2054948699","doi":"10.1158/0008-5472.sabcs10-pd03-03","title":"Abstract PD03-03: Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis, with Special Emphasis to Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Meta-analysis; Internal medicine; Population; Publication bias; Relative risk; Oncology; Cochrane Library; Epidemiology; Incidence (geometry); Funnel plot; Colorectal cancer; Confidence interval; Environmental health","score_opus":0.06270347185684248,"score_gpt":0.4039681505140503,"score_spread":0.3412646786572078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054948699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018126793,0.9900925,0.0000010161393,0.000055099055,0.00011221935,0.0042225197,0.0036212949,0.0000063680377,0.00007631488],"genre_scores_gemma":[0.00014744561,0.9864014,0.000025454518,0.0002810559,0.00061531697,0.011887029,0.00013482451,0.0000925999,0.0004148789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950265,0.0007581428,0.0010593269,0.0013982395,0.00083211774,0.0009256172],"domain_scores_gemma":[0.997135,0.00012421234,0.0005560818,0.0010633299,0.00064086035,0.00048054173],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020230555,0.00074377155,0.0054114694,0.0005825649,0.0001647348,0.00015035314,0.0006192519,0.00045694382,0.0013535043],"category_scores_gemma":[0.00022441424,0.00047746408,0.00072460074,0.0015640025,0.00027032895,0.000020936417,0.0003118784,0.0010118147,0.0000132835075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054880442,0.000119939024,0.0003117509,0.43763524,0.047721174,0.0000075104945,0.00007653035,0.0000036456443,0.000007664143,0.00000659835,0.00246598,0.5115891],"study_design_scores_gemma":[0.00042230336,0.00008303076,0.00021884768,0.018431468,0.24779432,0.000004457669,0.00001743282,2.9735918e-7,0.000034033998,0.0000042908837,0.7322429,0.0007466433],"about_ca_topic_score_codex":0.0024177802,"about_ca_topic_score_gemma":0.014368926,"teacher_disagreement_score":0.7297769,"about_ca_system_score_codex":0.00022244621,"about_ca_system_score_gemma":0.00096241897,"threshold_uncertainty_score":0.9997677},"labels":[],"label_agreement":null},{"id":"W2055397152","doi":"10.1158/0008-5472.sabcs12-p2-12-03","title":"Abstract P2-12-03: A pilot study evaluating the benefits and feasibility of an exercise program for breast cancer patients receiving adjuvant chemotherapy.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Breast cancer; Cardiorespiratory fitness; Physical therapy; Cancer; Quality of life (healthcare); Internal medicine; Breast cancer chemotherapy; Waist; Aerobic exercise; Clinical endpoint; Repeated measures design; Randomized controlled trial; Body mass index","score_opus":0.23474017785194168,"score_gpt":0.4923870897692721,"score_spread":0.2576469119173304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055397152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761785,0.0052602743,4.324582e-7,0.00035867863,0.00025623472,0.0061617694,0.00021018331,0.00003449833,0.00010007951],"genre_scores_gemma":[0.99560255,0.00056999584,0.00004326143,0.000050740175,0.0004107602,0.003184008,0.000014170364,0.000051615374,0.00007290011],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973105,0.00018291324,0.00034196372,0.00043968487,0.0010372421,0.0006876471],"domain_scores_gemma":[0.99777377,0.00022565271,0.00011713712,0.00053780945,0.0010454492,0.00030021454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032415155,0.00018535306,0.00038634075,0.00009840301,0.00026830932,0.00004908395,0.00021368677,0.000055192537,0.00023140256],"category_scores_gemma":[0.00013605812,0.00012645771,0.00006134514,0.00034483307,0.00019472034,0.00020535987,0.00009701052,0.00038474626,0.0000012075485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030861322,0.0019547113,0.4500588,0.0003453356,0.00004917439,2.2425851e-7,0.0053442284,0.000003368563,0.0013539906,0.00000153243,0.00006755653,0.537735],"study_design_scores_gemma":[0.00362386,0.005247772,0.98656875,0.0005890977,0.00008839528,0.0000015236274,0.0026858135,0.000076756405,0.00090014655,0.000014184917,0.000066346336,0.00013734473],"about_ca_topic_score_codex":0.00881053,"about_ca_topic_score_gemma":0.010073596,"teacher_disagreement_score":0.5375976,"about_ca_system_score_codex":0.00035432237,"about_ca_system_score_gemma":0.00037215996,"threshold_uncertainty_score":0.99778986},"labels":[],"label_agreement":null},{"id":"W2055506105","doi":"10.1158/1538-7445.am10-220","title":"Abstract 220: 14-3-3 zeta downregulation sensitizes head and neck cancer cells to chemotherapeutic agents","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Transfection; Head and neck squamous-cell carcinoma; Small interfering RNA; Cancer cell; Cancer research; Viability assay; Lipofectamine; Cancer; Flow cytometry; Cell; Chemistry; Gene silencing; Medicine; Molecular biology; Cell culture; Head and neck cancer; Biology; Internal medicine; Biochemistry","score_opus":0.05598756699774281,"score_gpt":0.4204554975244232,"score_spread":0.36446793052668036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055506105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995842,0.0004574667,0.000029514484,0.0017775224,0.00038370068,0.000494929,0.000058086258,0.000014056642,0.00094275083],"genre_scores_gemma":[0.9945405,0.0004339833,0.0002917191,0.0003860262,0.00063760113,0.00022525087,0.000022981041,0.00003738935,0.0034245607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863684,0.000050467,0.00015457258,0.00045460986,0.00028852047,0.00041501617],"domain_scores_gemma":[0.99899554,0.000027278898,0.00003855112,0.00041082766,0.00033074926,0.0001970255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029988025,0.00013848618,0.000118654716,0.00010203886,0.00018323158,0.00008847208,0.00017868563,0.00016871774,0.0006934875],"category_scores_gemma":[0.000058426445,0.00013546407,0.000045129116,0.00016804993,0.00012888282,0.000010041635,0.00013506757,0.0003958423,0.000068216286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011971745,0.000030468274,0.00078767154,0.000028986597,0.00004291576,0.0000019028164,0.00009745621,0.00006298985,0.9776445,0.00001118012,0.008114277,0.013057949],"study_design_scores_gemma":[0.00034610357,0.000074889,0.037228975,0.00004232566,0.000005970998,0.000004762231,0.000029270403,0.000031886477,0.86448896,0.000042812117,0.09755408,0.00014996491],"about_ca_topic_score_codex":0.001404139,"about_ca_topic_score_gemma":0.0027247705,"teacher_disagreement_score":0.11315553,"about_ca_system_score_codex":0.000057749927,"about_ca_system_score_gemma":0.00018103617,"threshold_uncertainty_score":0.7593202},"labels":[],"label_agreement":null},{"id":"W2055624432","doi":"10.1158/1538-7445.am2013-4598","title":"Abstract 4598: Identification of driver genes in hepatocellular carcinoma by exome sequencing.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Exome sequencing; Hepatocellular carcinoma; Exome; Cancer research; Biology; Sorafenib; Genetics; Mutation; Gene; Histone; Cancer; Methyltransferase; Methylation","score_opus":0.04283227610811663,"score_gpt":0.3258003939619403,"score_spread":0.2829681178538237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055624432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210846,0.0069336104,0.00003790613,0.00015668116,0.00008221098,0.00034030483,0.00007020462,0.0000025783436,0.00026806482],"genre_scores_gemma":[0.99628925,0.0026468378,0.00002447794,0.00003476168,0.000120349934,0.00020928285,0.00007964107,0.0000196353,0.0005757314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988706,0.000041678202,0.00026160787,0.00030415924,0.00022495544,0.00029700078],"domain_scores_gemma":[0.99918133,0.00002872272,0.00006411267,0.00034880452,0.00029708503,0.000079935824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003509362,0.00008753847,0.00011362559,0.000094306415,0.000044030225,0.000034220568,0.00024747264,0.00010837914,0.00016301704],"category_scores_gemma":[0.0000742654,0.00009153019,0.00004165584,0.00016848966,0.00013598669,0.000006696544,0.00010740127,0.00012851223,0.000031779793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016054102,0.000026971611,0.06449707,0.0000423618,0.000009305749,0.0000023572081,0.00005863127,0.0000594932,0.9277464,0.00002436122,0.0052563148,0.0022606535],"study_design_scores_gemma":[0.00027640653,0.000053689313,0.055990484,0.000014730427,0.000002425422,8.080113e-7,0.00011955956,0.00017478192,0.9369978,0.00015545277,0.0061069294,0.00010697897],"about_ca_topic_score_codex":0.0056105,"about_ca_topic_score_gemma":0.0002377993,"teacher_disagreement_score":0.00925133,"about_ca_system_score_codex":0.00013663975,"about_ca_system_score_gemma":0.0003070764,"threshold_uncertainty_score":0.8481435},"labels":[],"label_agreement":null},{"id":"W2055782773","doi":"10.1158/1538-7445.am2012-sy37-02","title":"Abstract SY37-02: Cell polarity proteins and cancer progression","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Downregulation and upregulation; Metastasis; Cancer; Cancer research; Cell polarity; Biology; Cell biology; Cell; Cell migration; Cancer cell; Cortactin; Tumor progression; Actin; Cytoskeleton; Genetics; Gene","score_opus":0.06803886404663068,"score_gpt":0.41721679106074405,"score_spread":0.3491779270141134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055782773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971364,0.026551243,0.000018467981,0.0002525343,0.0001248998,0.00037456065,0.00005038716,0.000013401996,0.0012505003],"genre_scores_gemma":[0.9958133,0.0016476134,0.00013062097,0.000053614916,0.0008285261,0.00030581933,0.000023220566,0.00002685795,0.0011704214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985237,0.00010682778,0.00012248446,0.00031034503,0.00032099112,0.00061566074],"domain_scores_gemma":[0.9992554,0.000015391452,0.00003778275,0.00026365469,0.00016189282,0.00026588372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008168386,0.000121563,0.00010832313,0.000054480377,0.00022986298,0.00004348934,0.00016465397,0.00018168658,0.0001573484],"category_scores_gemma":[0.000052803065,0.00010189028,0.000037857168,0.00011935554,0.0001620149,0.000008841087,0.00015433495,0.0003504846,0.000021778289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072631636,0.000087084656,0.015833288,0.00011229621,0.0000139676,0.0000019315344,0.00016888921,0.0000022295114,0.9685436,0.000012127051,0.00042665598,0.0147253],"study_design_scores_gemma":[0.00028415778,0.00011422617,0.008826387,0.000073954885,0.00000491241,0.0000021023604,0.00004943783,0.0000034531888,0.9140586,0.000018624321,0.0764197,0.00014442067],"about_ca_topic_score_codex":0.0007348591,"about_ca_topic_score_gemma":0.0000781709,"teacher_disagreement_score":0.075993046,"about_ca_system_score_codex":0.000046209043,"about_ca_system_score_gemma":0.00026371676,"threshold_uncertainty_score":0.4154965},"labels":[],"label_agreement":null},{"id":"W2055909310","doi":"10.1158/0008-5472.can-05-4165","title":"<i>Caspase Recruitment Domain-Containing Protein 15</i> Mutations in Patients with Colorectal Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Colorectal cancer; Medicine; Internal medicine; Odds ratio; Oncology; Cancer; Disease; Immunology; Gastroenterology","score_opus":0.05470026542350796,"score_gpt":0.36571181006813347,"score_spread":0.3110115446446255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055909310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242926,0.00039068106,0.000009311741,0.0029216437,0.0000769211,0.0031709443,0.000056209585,0.00004397273,0.00090107875],"genre_scores_gemma":[0.99281085,0.000024004248,0.00023201549,0.0001779404,0.00015060125,0.0060223215,0.00006204398,0.00003991896,0.00048029365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975918,0.00020121332,0.0003094921,0.00044143322,0.00063491333,0.0008211789],"domain_scores_gemma":[0.9989191,0.000066341716,0.000064931206,0.00020776468,0.0006012042,0.00014062277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042727005,0.00018200664,0.00032280944,0.0003374326,0.00019613934,0.000022783222,0.00011119394,0.00009823378,0.00017052211],"category_scores_gemma":[0.00005777856,0.00014543887,0.000034551114,0.0007491076,0.0003525663,0.00009610788,0.000089403424,0.0007461747,0.000024943389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030055807,0.00037586235,0.9876646,0.000048634196,0.00015713884,0.00012770118,0.00072922494,0.000065016124,0.004979555,0.00004568756,0.0012370258,0.0015640134],"study_design_scores_gemma":[0.008722843,0.0020271738,0.9811559,0.00054984353,0.000037087277,0.0000037607215,0.00037446825,0.00000806794,0.004599228,0.00008806157,0.0022863997,0.00014717558],"about_ca_topic_score_codex":0.003776524,"about_ca_topic_score_gemma":0.0108229,"teacher_disagreement_score":0.0070463754,"about_ca_system_score_codex":0.0012343591,"about_ca_system_score_gemma":0.00043979732,"threshold_uncertainty_score":0.60394317},"labels":[],"label_agreement":null},{"id":"W2055922098","doi":"10.1158/1538-7445.am2011-4718","title":"Abstract 4718: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor dinaciclib (SCH 727965) in patients with advanced breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Taxane; Anthracycline; Clinical endpoint; Febrile neutropenia; Neutropenia; Oncology; Breast cancer; Cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","score_opus":0.04744629479669468,"score_gpt":0.3890347226297202,"score_spread":0.34158842783302557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055922098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922856,0.00095667323,0.0000062823447,0.00028957898,0.00027609698,0.0055706846,0.00016557291,0.000038655267,0.00041085074],"genre_scores_gemma":[0.9968253,0.00015347516,0.00007044991,0.00007434295,0.00016435093,0.002353672,0.000006335496,0.00009353253,0.00025854885],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955237,0.00043491612,0.00074586895,0.0007178161,0.0017488346,0.0008288755],"domain_scores_gemma":[0.997192,0.00023434016,0.00031725882,0.0009737439,0.0010168584,0.00026576276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011237769,0.00035909124,0.0010287159,0.00037298584,0.00016461036,0.000019907458,0.00049441255,0.00010851932,0.0011643353],"category_scores_gemma":[0.0001640924,0.00021644111,0.00014315499,0.0010673995,0.00070353824,0.00029368163,0.00022008896,0.0010483686,0.000009004763],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5912575,0.009855495,0.3109728,0.00033767748,0.00055055565,0.00008781201,0.007851465,0.0001057653,0.009817908,0.000028637352,0.000054814926,0.06907954],"study_design_scores_gemma":[0.44839045,0.0013578201,0.5297429,0.0012410077,0.00012829376,0.000005433564,0.0027569912,0.000009046897,0.015851151,0.000100496305,0.00010230547,0.0003140949],"about_ca_topic_score_codex":0.0047415756,"about_ca_topic_score_gemma":0.0018593835,"teacher_disagreement_score":0.2187701,"about_ca_system_score_codex":0.0007902361,"about_ca_system_score_gemma":0.0007026792,"threshold_uncertainty_score":0.9997487},"labels":[],"label_agreement":null},{"id":"W2056048124","doi":"10.1158/1538-7445.am2011-lb-215","title":"Abstract LB-215: Inhibition of Polo-like kinase 4 as an anti-cancer strategy","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Polo-like kinase; Mitosis; Centrosome; Kinase; Cell biology; Biology; Cancer research; Cancer cell; Cancer; Cell cycle; Genetics","score_opus":0.07806118954772033,"score_gpt":0.38716150651898695,"score_spread":0.3091003169712666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056048124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946786,0.001398724,0.000019360938,0.000049764654,0.0000967816,0.00023086164,0.000118274824,0.0000084060275,0.0033992182],"genre_scores_gemma":[0.99518985,0.003389325,0.00006350102,0.0000933895,0.00022264043,0.00008956336,0.00011084059,0.000029737888,0.0008111845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986867,0.00008301236,0.00020363365,0.00038646243,0.0002393241,0.000400897],"domain_scores_gemma":[0.998909,0.0000067267124,0.00006585861,0.0005295832,0.0003473143,0.00014154296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035208307,0.00012685785,0.00014242313,0.00009670239,0.000088610075,0.000019789413,0.00030415226,0.00019698185,0.00074180495],"category_scores_gemma":[0.000028722996,0.00012238881,0.000065340144,0.00015489005,0.00022923526,0.000012750384,0.00015042319,0.00022972537,0.000022135222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017911327,0.00016717106,0.0014335357,0.00006510644,0.00003761039,0.000007634522,0.00011166414,0.0000142108765,0.9919327,0.00021902614,0.0021319205,0.0037003257],"study_design_scores_gemma":[0.00039636367,0.00039056313,0.006850597,0.000041696574,0.0000076849365,0.000002435426,0.00022872009,0.0000069983043,0.9875092,0.0002469051,0.004170392,0.00014845541],"about_ca_topic_score_codex":0.0037555764,"about_ca_topic_score_gemma":0.0010071361,"teacher_disagreement_score":0.005417061,"about_ca_system_score_codex":0.00003799369,"about_ca_system_score_gemma":0.0004341179,"threshold_uncertainty_score":0.8122244},"labels":[],"label_agreement":null},{"id":"W2056122762","doi":"10.1158/0008-5472.can-10-3369","title":"MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; microRNA; Cancer research; Oncogene; Breast cancer; Cancer; Biology; Gene silencing; Gene; Cell cycle; Signal transduction; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.05972763804990382,"score_gpt":0.36051443351846363,"score_spread":0.3007867954685598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056122762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966637,0.002539665,0.000007399602,0.00019152889,0.000041147683,0.00030467336,0.00003522627,0.00000556517,0.00021108528],"genre_scores_gemma":[0.9983023,0.00092569005,0.00003721525,0.00004212887,0.00022058503,0.00022186695,0.00005114454,0.000017900107,0.00018117603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990335,0.00011258051,0.0001322798,0.00031006796,0.0001599497,0.00025160302],"domain_scores_gemma":[0.99952364,0.0000057349753,0.00003075092,0.00018711132,0.00016465993,0.000088109526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035194898,0.000082844206,0.00007758244,0.00010531936,0.00009331935,0.00002241308,0.000117326534,0.00010631947,0.00019508517],"category_scores_gemma":[0.000024990399,0.000078512545,0.00001801073,0.00013689138,0.00013330793,0.000008603542,0.00011663887,0.00012105695,0.0000039338656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106831045,0.00003660846,0.08452496,0.000041967458,0.000010666766,0.0000020238663,0.00017754362,0.0000037361208,0.91202915,0.00004034849,0.0012401147,0.0017860371],"study_design_scores_gemma":[0.00043826737,0.00004617098,0.2813368,0.000058248148,0.0000037006319,0.000004280802,0.000042314994,0.000014106741,0.7169899,0.00019369429,0.0007733869,0.00009916246],"about_ca_topic_score_codex":0.0008992953,"about_ca_topic_score_gemma":0.0019447894,"teacher_disagreement_score":0.19681185,"about_ca_system_score_codex":0.00007174379,"about_ca_system_score_gemma":0.00016916274,"threshold_uncertainty_score":0.32016486},"labels":[],"label_agreement":null},{"id":"W2056174508","doi":"10.1158/1538-7445.am2013-3305","title":"Abstract 3305: Sustained production of a soluble IGF-I receptor by gutless adenovirus - transduced host cells protects from tumor growth in the liver .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; McGill University","funders":"","keywords":"Genetic enhancement; Cancer research; Metastasis; Stromal cell; Angiogenesis; Biology; Cancer; Cancer cell; Gene delivery; Immunology; Gene","score_opus":0.04533340664370897,"score_gpt":0.31707526099457706,"score_spread":0.27174185435086806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056174508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898609,0.0017866772,0.0000038013632,0.0040147235,0.0002409829,0.0034268247,0.0000502896,0.000032369604,0.000583421],"genre_scores_gemma":[0.9967552,0.00075360807,0.000045502497,0.00014142453,0.00035089056,0.0010723532,0.000044025714,0.000048980222,0.00078801764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968965,0.0002469302,0.00047839858,0.0005488066,0.0010875831,0.0007418055],"domain_scores_gemma":[0.99826604,0.00017164231,0.000112430644,0.0004894812,0.0007699494,0.0001904543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009971237,0.00022673965,0.00040138292,0.0002998024,0.00014862989,0.00006100917,0.00041930666,0.00015439381,0.001241461],"category_scores_gemma":[0.0003255657,0.00016011947,0.00009666133,0.0009896761,0.00031121363,0.00033831396,0.000053543587,0.0010851647,0.0001752817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006033979,0.00039740175,0.0012185454,0.00043723846,0.00004751369,0.000022621394,0.0031655522,6.5766466e-7,0.93873507,0.000016503387,0.054079738,0.0012757364],"study_design_scores_gemma":[0.0016462987,0.0004416128,0.046519708,0.0002691911,0.000021843116,0.0000028563359,0.0030815795,0.000015228285,0.94523746,0.00011403327,0.0024508194,0.00019934261],"about_ca_topic_score_codex":0.027387863,"about_ca_topic_score_gemma":0.00017316571,"teacher_disagreement_score":0.051628917,"about_ca_system_score_codex":0.000315653,"about_ca_system_score_gemma":0.0005936947,"threshold_uncertainty_score":0.9996715},"labels":[],"label_agreement":null},{"id":"W2056326822","doi":"10.1158/1538-7445.am2013-4579","title":"Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"International HapMap Project; Genome-wide association study; Single-nucleotide polymorphism; Biology; SNP; Genetic association; Long non-coding RNA; Population; Ovarian cancer; Logistic regression; 1000 Genomes Project; Genetics; Oncology; Genotype; Cancer; Medicine; Gene; Internal medicine; RNA","score_opus":0.031213832514953806,"score_gpt":0.34201225786459477,"score_spread":0.31079842534964097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056326822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940504,0.0024672155,0.0013405014,0.0005751966,0.000083154344,0.001089121,0.00021704934,0.000008582752,0.00016881479],"genre_scores_gemma":[0.9941628,0.004320882,0.00003663497,0.00007318802,0.00010366092,0.0008543805,0.00009192631,0.00005514421,0.00030139292],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960957,0.00044875406,0.0005542646,0.0007665738,0.001106631,0.0010280735],"domain_scores_gemma":[0.99722606,0.00035133635,0.00041618745,0.00052393106,0.00132314,0.00015934912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002776248,0.000253973,0.00065240136,0.0010411106,0.00013780176,0.00007149417,0.000473848,0.00040484982,0.00031989155],"category_scores_gemma":[0.0025369446,0.00023957175,0.00015329437,0.0030626303,0.0001301707,0.000025685002,0.00027454,0.00096056337,0.000009332752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052488357,0.0002652071,0.38615984,0.00010532459,0.0070618847,0.00007489292,0.0005259379,0.020400438,0.58179456,0.0000051424618,0.00041964784,0.0026622352],"study_design_scores_gemma":[0.0022067064,0.00014889672,0.919058,0.000301621,0.00024004058,2.2912276e-7,0.00029994687,0.0013445918,0.07600392,0.00007771689,0.000043840933,0.0002744768],"about_ca_topic_score_codex":0.022738514,"about_ca_topic_score_gemma":0.15081735,"teacher_disagreement_score":0.5328982,"about_ca_system_score_codex":0.0019526728,"about_ca_system_score_gemma":0.0008259227,"threshold_uncertainty_score":0.9837692},"labels":[],"label_agreement":null},{"id":"W2056664647","doi":"10.1158/0008-5472.sabcs13-pd6-2","title":"Abstract PD6-2: Identifying genomic signatures in circulating tumour cells from breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University of Toronto; Ottawa Hospital; University Health Network","funders":"","keywords":"Breast cancer; Circulating tumor cell; Metastasis; Cancer research; Biology; Metastatic breast cancer; Primary tumor; Cancer; Oncology; Medicine; Genetics","score_opus":0.03732151400816188,"score_gpt":0.34763710055129937,"score_spread":0.3103155865431375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056664647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965424,0.008303046,0.000019456844,0.00037023865,0.00035462502,0.00040933795,0.0003934376,0.000008594556,0.0004870247],"genre_scores_gemma":[0.994877,0.0030383684,0.00008481148,0.00021454277,0.0010847127,0.0003413202,0.000059639933,0.0000520667,0.00024756812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981319,0.000066583736,0.00028207616,0.0005763743,0.0003017235,0.0006413861],"domain_scores_gemma":[0.9990736,0.00008980468,0.00007333312,0.00035819144,0.0002374168,0.00016761264],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031522353,0.00017666885,0.0001864438,0.00012911342,0.00013747346,0.00018187694,0.00040890888,0.00018691862,0.0016675786],"category_scores_gemma":[0.000052209904,0.00018260392,0.0000770567,0.0002001371,0.00010767114,0.000012400578,0.00028517537,0.0004531503,0.000077718374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036437672,0.000032148444,0.008723235,0.00003321313,0.000030998235,0.000012390649,0.00009718746,0.0032387318,0.9721032,0.000008918905,0.009514241,0.006169295],"study_design_scores_gemma":[0.0009890748,0.000037071197,0.46744022,0.00020925417,0.000011592053,0.0000025137829,0.00035932468,0.00035454344,0.524028,0.00057634554,0.0055066017,0.00048545573],"about_ca_topic_score_codex":0.03197555,"about_ca_topic_score_gemma":0.0057283747,"teacher_disagreement_score":0.458717,"about_ca_system_score_codex":0.00026332962,"about_ca_system_score_gemma":0.0004534108,"threshold_uncertainty_score":0.99924505},"labels":[],"label_agreement":null},{"id":"W2056737836","doi":"10.1158/1538-7445.am2014-491","title":"Abstract 491: Selective killing of oncogenically transformed cells by arsenic trioxide and trolox","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Trolox; Propidium iodide; Arsenic trioxide; Apoptosis; Cytotoxic T cell; Cancer cell; Population; Cell biology; Programmed cell death; Chemistry; Biology; Cancer research; Biochemistry; Medicine; Oxidative stress; Cancer; In vitro","score_opus":0.018196282380466187,"score_gpt":0.33067794808458545,"score_spread":0.3124816657041193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056737836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920634,0.004427426,0.000847412,0.00011031475,0.000042336564,0.00018653156,0.000020517406,0.0000057973625,0.0022962408],"genre_scores_gemma":[0.9932281,0.005748812,0.00013098185,0.00004778558,0.00013787672,0.000052600328,0.000019033982,0.000022577096,0.0006122347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986798,0.00010997251,0.00021750235,0.00035893734,0.0002738667,0.00035989375],"domain_scores_gemma":[0.9993038,0.00009455913,0.000052473446,0.00019998575,0.00023447584,0.000114678274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073664234,0.000114892275,0.00017749025,0.000048353257,0.0000866237,0.000019126175,0.00021767414,0.00018105103,0.000030663654],"category_scores_gemma":[0.0001176572,0.000102572085,0.000065254695,0.00014326427,0.0002725256,0.000004608109,0.00004408525,0.00027457206,0.0000031156794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021575701,0.0000322444,0.00020281908,0.00010683136,0.000051929175,7.122912e-7,0.00006891185,0.000020260164,0.98646146,0.000016851593,0.0016515206,0.011170673],"study_design_scores_gemma":[0.00064763165,0.0003248187,0.0001342,0.00002735399,0.000011255046,0.0000021340607,0.00005751622,0.00003109225,0.9699641,0.000138093,0.028549103,0.00011271915],"about_ca_topic_score_codex":0.000090683716,"about_ca_topic_score_gemma":0.000036481306,"teacher_disagreement_score":0.026897583,"about_ca_system_score_codex":0.000036171215,"about_ca_system_score_gemma":0.0002963551,"threshold_uncertainty_score":0.41827682},"labels":[],"label_agreement":null},{"id":"W2056901969","doi":"10.1158/1538-7445.am10-5566","title":"Abstract 5566: Phosphoproteomic profiling of Met / K-Ras signaling in colorectal cancer by label-free LTQ-Orbitrap mass spectrometry","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Chemistry; Receptor tyrosine kinase; Orbitrap; Cancer research; Signal transduction; Colorectal cancer; Autocrine signalling; Cancer cell; Molecular biology; Mass spectrometry; Cancer; Receptor; Biochemistry; Biology; Genetics","score_opus":0.03373564428262543,"score_gpt":0.3817847109467214,"score_spread":0.34804906666409596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056901969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439865,0.0010099157,0.00043845683,0.00029779374,0.000052074673,0.00066741306,0.00053831644,0.00008733494,0.0025100412],"genre_scores_gemma":[0.95417166,0.0006227895,0.04226422,0.000014671957,0.00019341013,0.002376056,0.000034868444,0.00007052836,0.0002517867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757105,0.000024075583,0.00047670858,0.00059174135,0.00059122336,0.0007452292],"domain_scores_gemma":[0.9985813,0.00020113037,0.00017864195,0.00060699426,0.0002750492,0.00015691905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080998766,0.00022300408,0.00034513685,0.0002086231,0.00015896588,0.000047149184,0.00094038894,0.0002915239,0.002315204],"category_scores_gemma":[0.0001650189,0.00022912996,0.00007796883,0.0008069424,0.0003106684,0.00013783333,0.00019239794,0.002175136,0.00000840114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013976853,0.00010725168,0.005620112,0.0002110506,0.000028505905,0.000005222622,0.000057414585,0.000034117198,0.99120694,0.00092862954,0.00038307722,0.001277927],"study_design_scores_gemma":[0.000676692,0.00003195646,0.0001309566,0.00014496347,0.000006660782,0.0000014950443,0.00010549569,0.00009248415,0.9907806,0.0072984216,0.0004920373,0.00023822354],"about_ca_topic_score_codex":0.0026062608,"about_ca_topic_score_gemma":0.00039958736,"teacher_disagreement_score":0.041825764,"about_ca_system_score_codex":0.00042113737,"about_ca_system_score_gemma":0.00044017954,"threshold_uncertainty_score":0.9985968},"labels":[],"label_agreement":null},{"id":"W2056921347","doi":"10.1158/1538-7445.am2013-4148","title":"Abstract 4148: Sensitive detection of tumor nucleic acids in plasma by mutation-enriched next generation sequencing.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"DNA sequencing; Nucleic acid; Concordance; Computational biology; Germline mutation; Mutation; Biology; COLD-PCR; DNA; Somatic cell; Mutation rate; Ion semiconductor sequencing; Molecular biology; Genetics; Gene; Point mutation","score_opus":0.05098829926744705,"score_gpt":0.322365382947146,"score_spread":0.2713770836796989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056921347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835324,0.000595552,0.0001728736,0.00011649823,0.000110944966,0.0003415879,0.000040527575,0.0000039606675,0.00026480615],"genre_scores_gemma":[0.99868584,0.00052819814,0.00011090157,0.00007751514,0.00023207796,0.00016043284,0.00008628763,0.000020637664,0.00009808788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989837,0.00006227032,0.00020889573,0.0002814034,0.00020021007,0.000263548],"domain_scores_gemma":[0.9992398,0.000049347465,0.00006406884,0.00018590293,0.0003889843,0.00007192021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027883414,0.00009256849,0.00011040513,0.000100180645,0.0000662078,0.000048214304,0.000098680845,0.000097196935,0.000054798642],"category_scores_gemma":[0.00019484347,0.0000984667,0.000034660276,0.00019961139,0.00009596123,0.000012760942,0.00005362867,0.00016962652,0.000022072176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004445619,0.000023829953,0.00036742818,0.000020377394,0.000014264021,0.0000036223985,0.0001262212,0.00060617726,0.99117273,0.00000937133,0.0015800156,0.006031497],"study_design_scores_gemma":[0.00043974398,0.00014908137,0.0050840527,0.00001355705,0.0000029928794,0.0000035829062,0.00037915254,0.00239955,0.990599,0.000050926174,0.0007696971,0.00010871028],"about_ca_topic_score_codex":0.0043001613,"about_ca_topic_score_gemma":0.0018492244,"teacher_disagreement_score":0.005922787,"about_ca_system_score_codex":0.00022490488,"about_ca_system_score_gemma":0.00030918227,"threshold_uncertainty_score":0.6500586},"labels":[],"label_agreement":null},{"id":"W2056984964","doi":"10.1158/0008-5472.can-05-3092","title":"Functional Coupling of p38-Induced Up-regulation of BiP and Activation of RNA-Dependent Protein Kinase–Like Endoplasmic Reticulum Kinase to Drug Resistance of Dormant Carcinoma Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University at Albany; National Institutes of Health; York University","keywords":"Unfolded protein response; Endoplasmic reticulum; EIF-2 kinase; Cell biology; Protein kinase R; Kinase; p38 mitogen-activated protein kinases; Protein kinase A; Cancer research; Cancer cell; Biology; Small interfering RNA; Cyclin-dependent kinase 2; Transfection; Cancer; Cell culture","score_opus":0.02019861469956693,"score_gpt":0.28407986152180636,"score_spread":0.26388124682223946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056984964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826413,0.00061143737,0.00015326943,0.000084796484,0.000066273766,0.00055284624,0.000105451516,0.0000026916025,0.0001590942],"genre_scores_gemma":[0.9987935,0.00006030289,0.000119430544,0.000004076742,0.000065726614,0.000091973496,0.00005854503,0.000016660586,0.0007897978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984257,0.00006264248,0.00041256013,0.00032072136,0.0005529032,0.0002254337],"domain_scores_gemma":[0.99868053,0.00003997806,0.00022708364,0.00031854634,0.00064901146,0.00008485159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035841382,0.00012099329,0.000217052,0.00016105523,0.000054040873,0.000007411112,0.00012866217,0.00008501498,0.000023015793],"category_scores_gemma":[0.00006883545,0.000116677395,0.00006333668,0.00022368597,0.00017711306,0.000010002528,0.00010741819,0.000100138386,4.3870298e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009790206,0.00017931046,0.0023245967,0.000523368,0.000021363037,0.0000010165562,0.00005287527,0.001147881,0.9938583,0.0002635647,0.0005144683,0.00013425054],"study_design_scores_gemma":[0.0013955578,0.00014362078,0.012241496,0.00021485088,0.000014117049,3.9304345e-7,0.00013566228,0.00019478204,0.985382,0.00008602637,0.00009234965,0.00009913989],"about_ca_topic_score_codex":0.0011514076,"about_ca_topic_score_gemma":0.00021371379,"teacher_disagreement_score":0.009916899,"about_ca_system_score_codex":0.00004308197,"about_ca_system_score_gemma":0.00026379726,"threshold_uncertainty_score":0.4757966},"labels":[],"label_agreement":null},{"id":"W2057076082","doi":"10.1158/0008-5472.can-07-5528","title":"Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McGill University","funders":"National Cancer Institute; McGill University","keywords":"Deoxycytidine kinase; Nucleoside; Biology; Uridine; Exon; Cytarabine; Point mutation; Molecular biology; Nucleoside transporter; Cell culture; Cytotoxic T cell; Gene; RNA splicing; Mutation; Genetics; RNA; Deoxycytidine; Leukemia; Transporter; In vitro; Cancer","score_opus":0.10121974724297761,"score_gpt":0.400036906685898,"score_spread":0.29881715944292037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057076082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98376495,0.0021558416,0.002635052,0.0007008519,0.0001573557,0.0007814725,0.0000150593005,0.00008375503,0.00970565],"genre_scores_gemma":[0.9857095,0.0004184432,0.0015882478,0.00012920202,0.000075127005,0.00021746356,0.000029748036,0.00007418142,0.011758083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967099,0.00013583152,0.00041307716,0.0006432447,0.00115764,0.00094033126],"domain_scores_gemma":[0.9987735,0.000059491562,0.00005526881,0.0005850989,0.00023875189,0.00028789422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008597057,0.00023538848,0.0004546233,0.0004278993,0.00037506787,0.000021256961,0.00031622354,0.0001278206,0.00040112532],"category_scores_gemma":[0.000026870137,0.00021521303,0.00012300328,0.0009859059,0.00031359177,0.00008577529,0.00005566446,0.0009232943,0.00004702336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030466347,0.00014558008,0.0004892877,0.0002327698,0.00002886168,0.0024066053,0.00042765538,0.000038325372,0.98517835,0.010216409,0.00040284154,0.00012865782],"study_design_scores_gemma":[0.0056093833,0.00024380125,0.012445335,0.0011379431,0.00003850065,0.000031991854,0.00040453963,0.00004465664,0.9579165,0.018479796,0.0031645992,0.00048293744],"about_ca_topic_score_codex":0.0008052808,"about_ca_topic_score_gemma":0.0021263335,"teacher_disagreement_score":0.027261825,"about_ca_system_score_codex":0.00084732426,"about_ca_system_score_gemma":0.00064162706,"threshold_uncertainty_score":0.8776133},"labels":[],"label_agreement":null},{"id":"W2057113805","doi":"10.1158/1538-7445.am2011-1071","title":"Abstract 1071: Repression of ERK1/2 signaling by RanBPM","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell biology; Signal transduction; Gene knockdown; Transcription factor; Phosphorylation; Small interfering RNA; Biology; Apoptosis; Cell culture; Transfection; Gene; Genetics","score_opus":0.08899115028775095,"score_gpt":0.3764841726719043,"score_spread":0.28749302238415336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057113805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394137,0.0026361118,0.00015626049,0.000020882273,0.000047222322,0.00012909221,0.0000072915236,0.0000025228364,0.0030592734],"genre_scores_gemma":[0.99777454,0.0008832662,0.00011454335,0.000007567463,0.00006537633,0.00002555042,0.000020902777,0.000010574343,0.0010976805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926436,0.00004160153,0.00013394603,0.00020770506,0.00017189243,0.00018052325],"domain_scores_gemma":[0.99961907,0.000008301562,0.000033267876,0.00020059684,0.00009700531,0.000041771476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046795013,0.00005078086,0.00007244832,0.000053105803,0.000034728626,0.0000044528283,0.000118280055,0.00010160007,0.00034414066],"category_scores_gemma":[0.00002672357,0.00004353136,0.000031340416,0.000095077616,0.00005425035,0.0000025170439,0.00005654479,0.000100604615,0.000003294581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012381014,0.000037782418,0.0006144852,0.000028073835,0.0000064650258,0.0000016185264,0.00009577132,0.00003452376,0.99059236,0.000038690516,0.0011921402,0.0072342586],"study_design_scores_gemma":[0.000267678,0.00006809536,0.003235272,0.00005077953,0.0000013557735,4.2284654e-7,0.000059078273,0.000019848678,0.99187416,0.00024046891,0.004129541,0.000053298838],"about_ca_topic_score_codex":0.0005340228,"about_ca_topic_score_gemma":0.000040647654,"teacher_disagreement_score":0.00718096,"about_ca_system_score_codex":0.000014368573,"about_ca_system_score_gemma":0.000056616045,"threshold_uncertainty_score":0.3768099},"labels":[],"label_agreement":null},{"id":"W2057128934","doi":"10.1158/1538-7445.am2013-267","title":"Abstract 267: MYC maintains the self-renewal of cancer stem cells through the regulation of the glutathione redox system.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"SOD2; Cancer stem cell; Glutathione; Stem cell; Cancer research; Biology; Downregulation and upregulation; Mitochondrial ROS; Superoxide dismutase; Chemistry; Mitochondrion; Cell biology; Oxidative stress; Biochemistry","score_opus":0.06550069837704849,"score_gpt":0.3763647384960248,"score_spread":0.31086404011897634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057128934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844274,0.0010014953,0.0000108167405,0.008129755,0.00052104495,0.0014111759,0.00008274866,0.000027405707,0.0043881815],"genre_scores_gemma":[0.99732494,0.0003231887,0.00001819875,0.00009028291,0.0003707472,0.00035423515,0.0000029844873,0.00002548694,0.0014899209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979195,0.00022670794,0.00042814543,0.00021723684,0.00088337844,0.00032501144],"domain_scores_gemma":[0.99768674,0.00039715314,0.00022027087,0.00073985907,0.00090004026,0.000055905362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071341963,0.00011932167,0.0002469957,0.0000722313,0.000337062,0.00003471757,0.00037555562,0.00008053073,0.000869146],"category_scores_gemma":[0.000039128998,0.000053970434,0.00015868842,0.00061753805,0.00038353898,0.00009677207,0.00011385891,0.00056316715,0.000024632258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011330428,0.00009981379,0.0006266545,0.00039980802,0.00027779533,8.2804775e-7,0.004563258,0.0010904524,0.9728297,0.0035885721,0.014622548,0.0017872417],"study_design_scores_gemma":[0.0007894211,0.0001818955,0.05308199,0.0018379726,0.00019351952,0.000010178191,0.0117694065,0.0013333594,0.9162519,0.00030898573,0.014117707,0.00012366928],"about_ca_topic_score_codex":0.026412046,"about_ca_topic_score_gemma":0.00088634866,"teacher_disagreement_score":0.056577828,"about_ca_system_score_codex":0.0004400492,"about_ca_system_score_gemma":0.000639475,"threshold_uncertainty_score":0.9800712},"labels":[],"label_agreement":null},{"id":"W2057332580","doi":"10.1158/0008-5472.can-14-3602","title":"PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Boehringer Ingelheim Stiftung","keywords":"Prostate cancer; Mediator; Androgen deprivation therapy; Suppressor; Castration; Androgen; Cancer; Medicine; Oncology; Prostate; Internal medicine; Cancer research; Hormone","score_opus":0.1323011254307638,"score_gpt":0.43091777429584993,"score_spread":0.2986166488650861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057332580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97099847,0.01562616,0.000008736541,0.009401181,0.000085413965,0.0029616312,0.00040989835,0.000018961673,0.00048956065],"genre_scores_gemma":[0.9910842,0.0032205319,0.0007377692,0.00030601455,0.00014028928,0.001988757,0.0000424055,0.000060182552,0.0024198582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958325,0.00029032858,0.0005754553,0.0006253943,0.0018156439,0.0008606666],"domain_scores_gemma":[0.99697167,0.00018582564,0.000098582976,0.000541802,0.0015396919,0.00066245144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013540805,0.0002339679,0.00052437617,0.00059504283,0.0000851816,0.00005718636,0.0002993104,0.0000687863,0.00041727224],"category_scores_gemma":[0.00037510067,0.00018491036,0.00007403011,0.0016797127,0.00031230508,0.0001433572,0.00010643716,0.00041403854,0.00004279567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034098197,0.0010111643,0.07780124,0.0010989633,0.000469278,0.0006436472,0.014540239,0.00011143006,0.8365058,0.00021130125,0.026156249,0.007352516],"study_design_scores_gemma":[0.01105189,0.0015167918,0.023057299,0.0008577284,0.00004455525,0.0000070295378,0.001539561,0.00011422686,0.94467354,0.0006878366,0.016140418,0.00030915617],"about_ca_topic_score_codex":0.0017948974,"about_ca_topic_score_gemma":0.002714994,"teacher_disagreement_score":0.10816773,"about_ca_system_score_codex":0.0009982808,"about_ca_system_score_gemma":0.004014497,"threshold_uncertainty_score":0.75404257},"labels":[],"label_agreement":null},{"id":"W2057424941","doi":"10.1158/1538-7445.am2011-4491","title":"Abstract 4491: AZD5363, a novel Akt inhibitor, delays prostate cancer progression by inhibiting androgen-receptor activity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"LNCaP; Prostate cancer; Cancer research; Medicine; Protein kinase B; Population; Transactivation; PI3K/AKT/mTOR pathway; Cancer; Biology; Signal transduction; Internal medicine; Cell biology; Biochemistry; Transcription factor","score_opus":0.12379443124574548,"score_gpt":0.4253914490580969,"score_spread":0.30159701781235143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057424941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810722,0.010344739,0.000012348393,0.0019227004,0.00031644592,0.0026349714,0.00047840446,0.0001543695,0.003063844],"genre_scores_gemma":[0.98772943,0.0043762275,0.00026125473,0.00008374234,0.00061932317,0.0025923073,0.00010638207,0.00013057914,0.004100735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948353,0.00014159003,0.0004293671,0.0010292612,0.0018211051,0.001743331],"domain_scores_gemma":[0.9974255,0.00012417846,0.00015594564,0.0004986576,0.00097577536,0.0008199197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012830355,0.0004145784,0.0005360301,0.0004112574,0.0006108549,0.00011767072,0.00031458435,0.00030512395,0.002083124],"category_scores_gemma":[0.00013462991,0.0003171487,0.00016947767,0.0011020369,0.0006531323,0.00046772548,0.00033844478,0.0016164237,0.00015335438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046193595,0.0011596711,0.022650266,0.0005991397,0.00023127378,0.00011546546,0.0018294834,9.234863e-7,0.8654639,0.000018507795,0.019424217,0.083887756],"study_design_scores_gemma":[0.0054412037,0.0008154554,0.0055713877,0.0014692995,0.000043745964,0.000014658729,0.00037657013,0.00003777383,0.96916,0.00003333891,0.01665471,0.00038182168],"about_ca_topic_score_codex":0.003963193,"about_ca_topic_score_gemma":0.00020259808,"teacher_disagreement_score":0.1036961,"about_ca_system_score_codex":0.001353074,"about_ca_system_score_gemma":0.0018790963,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W2057511062","doi":"10.1158/0008-5472.sabcs10-p6-12-01","title":"Abstract P6-12-01: A Meta Analysis of Risk of Cardiovascular Events in Patients with Metastatic Breast Cancer (MBC) Treated with Anti Vascular Endothelial Growth Factor (VEGF) Therapy — Bevacizumab","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Heart failure; Oncology; Breast cancer; Metastatic breast cancer; Cancer; Cardiology; Chemotherapy","score_opus":0.05645698675753663,"score_gpt":0.36759500238185533,"score_spread":0.3111380156243187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057511062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923133,0.0035940418,0.0000052376417,0.00006551078,0.000046643778,0.0014548975,0.0024587228,0.00001530994,0.000046297606],"genre_scores_gemma":[0.99492127,0.0042376323,0.000056588222,0.0000134726815,0.000053984055,0.00051030493,0.00011033266,0.000057128073,0.000039292252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646825,0.0003610001,0.00044364692,0.0006043079,0.0015390194,0.0005838076],"domain_scores_gemma":[0.9976974,0.00025373444,0.00022477405,0.00069183164,0.0009158902,0.00021636806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000618667,0.0003405211,0.00184387,0.0010507536,0.00007652787,0.000009489874,0.0002518032,0.00010634453,0.0026730797],"category_scores_gemma":[0.00003141172,0.00020849778,0.00087339233,0.002017197,0.00032280997,0.00013406825,0.000039017414,0.00068179786,0.0000021001358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058312044,0.0014423411,0.7650603,0.00015061692,0.21847025,0.000030253277,0.00058428047,0.00041521262,0.005509922,0.000002169156,0.000012335576,0.0024911163],"study_design_scores_gemma":[0.014848672,0.00070066884,0.9173198,0.000048900052,0.048966397,0.0000017962233,0.00004150548,0.000020720723,0.017760305,0.0000050921603,0.00010068393,0.00018550782],"about_ca_topic_score_codex":0.06560362,"about_ca_topic_score_gemma":0.008950424,"teacher_disagreement_score":0.16950384,"about_ca_system_score_codex":0.0002750796,"about_ca_system_score_gemma":0.0006427048,"threshold_uncertainty_score":0.9982386},"labels":[],"label_agreement":null},{"id":"W2057626539","doi":"10.1158/0008-5472.can-05-3444","title":"The Novel Tumor Suppressor p33ING2 Enhances Nucleotide Excision Repair via Inducement of Histone H4 Acetylation and Chromatin Relaxation","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Nucleotide excision repair; Xeroderma pigmentosum; DNA damage; Chromatin; DNA repair; Biology; Histone; Molecular biology; Chromatin remodeling; Genome instability; Proliferating cell nuclear antigen; Cancer research; Cell biology; DNA; Genetics","score_opus":0.02588766631585483,"score_gpt":0.3584334584268292,"score_spread":0.3325457921109744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057626539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962295,0.0016682778,0.00096913637,0.0002551855,0.0001020652,0.00037996838,0.000011874776,0.000015171221,0.0003687839],"genre_scores_gemma":[0.99748284,0.00022868927,0.0009165292,0.000016687145,0.00016959083,0.00012337953,0.000034660326,0.000019009118,0.0010086114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986516,0.000117489355,0.00025491492,0.00031278978,0.0004129057,0.00025027315],"domain_scores_gemma":[0.9991865,0.000055910823,0.00013034091,0.00034281376,0.00024376242,0.000040669387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015015,0.000092267124,0.00010067016,0.000054763805,0.00022438525,0.000024850673,0.00016109692,0.00007416756,0.000026347974],"category_scores_gemma":[0.00016993578,0.00007293884,0.000043814558,0.00013776666,0.00017636575,0.000009401131,0.00016557188,0.0001227886,0.00000289493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011149745,0.000042661213,0.000106994004,0.00003473324,0.000015051066,5.7776424e-7,0.000051389896,0.000036625228,0.99582714,0.00028531888,0.0018346442,0.0016533514],"study_design_scores_gemma":[0.00035682804,0.00022579609,0.0036201635,0.0000428562,0.000005840159,0.0000025099669,0.00007612523,0.00043050645,0.9859543,0.00034565272,0.008858831,0.000080611804],"about_ca_topic_score_codex":0.00067552266,"about_ca_topic_score_gemma":0.00035370368,"teacher_disagreement_score":0.009872877,"about_ca_system_score_codex":0.00008617672,"about_ca_system_score_gemma":0.000099,"threshold_uncertainty_score":0.29743594},"labels":[],"label_agreement":null},{"id":"W2057846398","doi":"10.1158/0008-5472.can-09-1149","title":"Candidate Gene Association Study of Esophageal Squamous Cell Carcinoma in a High-Risk Region in Iran","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Odds ratio; Confidence interval; Allele; Oncology; Medicine; Esophageal squamous cell carcinoma; Internal medicine; Genetics; Incidence (geometry); Cancer; Gene; Biology","score_opus":0.0228129516844715,"score_gpt":0.323354478730865,"score_spread":0.3005415270463935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057846398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975053,0.0015505248,0.000009437974,0.00014205251,0.000076753815,0.0006052652,0.000013689914,0.0000040989794,0.00009287384],"genre_scores_gemma":[0.99904245,0.00030309835,0.000009625782,0.000012144126,0.00016976119,0.000068862944,0.000039695726,0.000015427102,0.00033891003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817437,0.00040491042,0.0002873882,0.00037896037,0.00038813605,0.00036625372],"domain_scores_gemma":[0.99933106,0.000026366686,0.00012693598,0.0003193884,0.00014198937,0.000054265573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073457987,0.000104566425,0.00017361494,0.00026207377,0.000049925733,0.000013152304,0.00016864976,0.00019027338,0.000008696279],"category_scores_gemma":[0.000086271706,0.00011397872,0.000032899712,0.0005700477,0.00002498643,0.000006185533,0.000052518615,0.0002986731,0.000001858455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005726965,0.0004287085,0.6969791,0.000019269908,0.000010681376,0.000022063412,0.0010105262,0.008536748,0.2880081,0.0000030142542,0.00072706974,0.003682052],"study_design_scores_gemma":[0.0033679402,0.0010370223,0.7605888,0.000010163125,0.000008981962,7.538165e-7,0.00021541066,0.00017220595,0.23435107,0.000055776447,0.00008136388,0.00011046406],"about_ca_topic_score_codex":0.011743809,"about_ca_topic_score_gemma":0.019752419,"teacher_disagreement_score":0.063609764,"about_ca_system_score_codex":0.00058801007,"about_ca_system_score_gemma":0.00019030734,"threshold_uncertainty_score":0.99813455},"labels":[],"label_agreement":null},{"id":"W2057937360","doi":"10.1158/0008-5472.sabcs-1119","title":"Effect of airplane travel on women treated for breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Lymphedema; Medicine; Breast cancer; Mastectomy; Cancer; Exacerbation; Gynecology; Internal medicine","score_opus":0.046209999845524756,"score_gpt":0.43561439930151835,"score_spread":0.3894043994559936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057937360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387574,0.0009692325,0.000002810474,0.0009245905,0.000059994483,0.0011971942,0.0004104874,0.000022245715,0.002537731],"genre_scores_gemma":[0.9955622,0.00012063012,0.0000023881835,0.00013025329,0.00032219564,0.0006930278,0.000017234535,0.000015355188,0.0031367252],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99855846,0.00012302652,0.00016758601,0.00022809883,0.00048597553,0.00043683924],"domain_scores_gemma":[0.9988645,0.00036577135,0.00003524306,0.00025133378,0.00022178248,0.0002613847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006150011,0.00010968711,0.0003665524,0.00016093846,0.00006552246,0.000010291269,0.00010048866,0.000059738784,0.0006257719],"category_scores_gemma":[0.0001176742,0.000073834206,0.00007297406,0.00027564817,0.00007253468,0.000025157658,0.000007815476,0.000035396803,0.000014369429],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05570712,0.0009864152,0.05339085,0.005423553,0.00045319216,0.00010948904,0.0014459923,0.000028073022,0.19692087,0.0003060835,0.058227878,0.6270005],"study_design_scores_gemma":[0.026033353,0.019831099,0.47779143,0.0032912155,0.00021568472,0.00006031853,0.00051891746,0.00017742971,0.46984392,0.0001450587,0.0017452389,0.00034633334],"about_ca_topic_score_codex":0.0005443424,"about_ca_topic_score_gemma":0.000011257832,"teacher_disagreement_score":0.62665415,"about_ca_system_score_codex":0.00051274535,"about_ca_system_score_gemma":0.0004060675,"threshold_uncertainty_score":0.6851763},"labels":[],"label_agreement":null},{"id":"W2058026592","doi":"10.1158/0008-5472.can-14-0957","title":"Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Blocking (statistics); Chemistry; Adenosine A2A receptor; Adenosine; Receptor; Adenosine receptor; Pharmacology; Medicine; Agonist; Biochemistry; Computer science","score_opus":0.01740714486105991,"score_gpt":0.3366179294889171,"score_spread":0.3192107846278572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058026592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806442,0.017485607,0.00055921637,0.0006459555,0.000070496,0.00021016637,0.000002748241,0.0000033463928,0.00037825658],"genre_scores_gemma":[0.99737775,0.0012612008,0.00013343459,0.00009595618,0.00031770792,0.000044820394,0.000006327304,0.000013244007,0.00074954686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902314,0.00028188416,0.00011294988,0.0001836096,0.00019157727,0.00020684492],"domain_scores_gemma":[0.9993487,0.00022993659,0.00003741547,0.00021137821,0.00012583681,0.00004673214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079233275,0.000069937996,0.00012869158,0.00004054357,0.00010075306,0.000017296232,0.0001596055,0.000047127294,0.000033107375],"category_scores_gemma":[0.0003018577,0.00004615085,0.000033825287,0.00013076975,0.00031128718,0.000001918376,0.00013372675,0.00012822196,0.000003480849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027400875,0.000022892666,0.00095804693,0.00023272198,0.00009651715,0.0000011549647,0.00017761317,0.000047202,0.975932,0.0008557579,0.017502049,0.003900057],"study_design_scores_gemma":[0.0017524438,0.00024636168,0.0004957278,0.00011452795,0.000027027738,0.0000037641914,0.000049941624,0.00015645675,0.9690286,0.00026008324,0.027767733,0.000097368276],"about_ca_topic_score_codex":0.00012423212,"about_ca_topic_score_gemma":0.0000031827885,"teacher_disagreement_score":0.016733555,"about_ca_system_score_codex":0.0000057397624,"about_ca_system_score_gemma":0.000048019287,"threshold_uncertainty_score":0.1881977},"labels":[],"label_agreement":null},{"id":"W2058200456","doi":"10.1158/1538-7445.fbcr13-c55","title":"Abstract C55: Investigating mechanisms of gastrointestinal polyposis and osteoblastic tumor formation induced by mesenchymal Lkb1 deficiency","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Mesenchymal stem cell; Cancer research; Carcinogenesis; Biology; AMPK; Cancer; Cell biology; Kinase; Genetics; Protein kinase A","score_opus":0.07182785566994904,"score_gpt":0.3549724075102907,"score_spread":0.28314455184034165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058200456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666464,0.0002919391,0.0002831957,0.0006642525,0.000065584994,0.0007965059,0.000017306389,0.000025434943,0.0011911255],"genre_scores_gemma":[0.99732053,0.000015755923,0.0021770792,0.000081872226,0.000049403363,0.00024759732,0.00000689349,0.000025606367,0.00007528056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978794,0.00007337927,0.00036239135,0.00029929058,0.00085523445,0.00053032045],"domain_scores_gemma":[0.9985394,0.0002606004,0.000118476986,0.00021665584,0.000565507,0.0002993999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005175726,0.00014998023,0.0002422952,0.00021466955,0.00013074579,0.000046066092,0.00014906473,0.000056580742,0.00068408303],"category_scores_gemma":[0.0008690453,0.0001295922,0.000036960253,0.00043340962,0.00026673268,0.0001757349,0.00012428904,0.0005023289,0.000028186236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044367895,0.000035414374,0.0034051905,0.0003609172,0.0000065000263,0.0000025770082,0.000264569,0.000006027999,0.99254614,0.00009070962,0.0008019422,0.0024356376],"study_design_scores_gemma":[0.000872792,0.0015799478,0.07521535,0.00088631065,0.000021533335,0.00010683349,0.0011076166,0.0010328185,0.9175281,0.0014645297,0.000017762382,0.0001663924],"about_ca_topic_score_codex":0.0017096442,"about_ca_topic_score_gemma":0.00005428815,"teacher_disagreement_score":0.075018026,"about_ca_system_score_codex":0.00026194568,"about_ca_system_score_gemma":0.00040887244,"threshold_uncertainty_score":0.74902296},"labels":[],"label_agreement":null},{"id":"W2058264133","doi":"10.1158/0008-5472.sabcs13-p4-03-09","title":"Abstract P4-03-09: Time points to diagnosis and treatment of invasive breast cancer in southwestern Ontario","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Breast cancer; Malignancy; Cancer; Cohort; Incidence (geometry); Stage (stratigraphy); Pathological; Internal medicine","score_opus":0.1560933833801113,"score_gpt":0.41717402286081223,"score_spread":0.2610806394807009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058264133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918166,0.0011201411,2.089663e-7,0.0045717526,0.000042010626,0.0010850329,0.00009958267,0.000009988858,0.001254718],"genre_scores_gemma":[0.9956537,0.0011571146,0.000043339493,0.00021350323,0.00013305993,0.0012634139,0.0000057745074,0.000019590068,0.0015104979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982045,0.000045341658,0.00027014661,0.00038503125,0.0005664798,0.0005284896],"domain_scores_gemma":[0.9987897,0.00015303535,0.00004692898,0.00027354635,0.00037293753,0.00036382172],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023788441,0.00015700719,0.0003793539,0.00025391692,0.000056085384,0.000040794283,0.00012467471,0.00008488516,0.0069690486],"category_scores_gemma":[0.000047666883,0.00012594121,0.000053950553,0.0003561998,0.00012376066,0.0001614936,0.000105932144,0.00022087975,0.00030488952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003851978,0.00013042292,0.9139786,0.00006742092,0.000066794666,0.00006838137,0.0033309243,0.000023272056,0.012005526,0.0000033051767,0.0017043159,0.06823589],"study_design_scores_gemma":[0.0012711498,0.0005012588,0.9879889,0.0009735618,0.000019646479,0.000012603496,0.00038111597,0.0000049579494,0.007960465,0.000053911946,0.0007164838,0.0001159626],"about_ca_topic_score_codex":0.69565094,"about_ca_topic_score_gemma":0.4471208,"teacher_disagreement_score":0.24853016,"about_ca_system_score_codex":0.0017638791,"about_ca_system_score_gemma":0.0010156198,"threshold_uncertainty_score":0.99393874},"labels":[],"label_agreement":null},{"id":"W2058283232","doi":"10.1158/0008-5472.can-06-3399","title":"Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell–Mediated Killing of MHC Class I–Negative LNCaP Prostate Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"NKG2D; Cancer research; LNCaP; MHC class I; Biology; NK-92; Interleukin 12; Immunology; Natural killer cell; Nod; Immunotherapy; Major histocompatibility complex; Immune system; Cancer cell; Interleukin 21; Cancer; Cytotoxic T cell; T cell; Endocrinology; In vitro","score_opus":0.028566873158237888,"score_gpt":0.326863755537234,"score_spread":0.2982968823789961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058283232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400955,0.0022714403,0.0000076176157,0.00024613494,0.0024621896,0.00071066135,0.0000121351895,0.000017772993,0.0002625192],"genre_scores_gemma":[0.974638,0.0003868443,0.0000050563917,0.000019909688,0.00003624246,0.00007265794,0.000024215129,0.000018159057,0.024798907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980402,0.0006313467,0.00045529057,0.00027159572,0.00016738292,0.00043420517],"domain_scores_gemma":[0.99833786,0.00068990444,0.0002758683,0.00027887142,0.00039592534,0.000021581534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008173345,0.0001472069,0.00024549468,0.00024983878,0.00023131333,0.000008666933,0.00017164624,0.00012818561,0.0005782567],"category_scores_gemma":[0.0002776865,0.00010157778,0.00011046194,0.00041816616,0.0003584513,0.00012036718,0.00007060529,0.00050573464,0.00010721575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008294259,0.00012728751,0.0018688594,0.00005358924,0.0001054241,0.0000019137442,0.0031470065,0.000040385992,0.98548496,0.000010086034,0.0002084573,0.0006577697],"study_design_scores_gemma":[0.0015051846,0.00041599903,0.08183322,0.00014264292,0.000014674072,0.0000040922873,0.0021196743,0.000011798833,0.91054296,0.0000030391254,0.0033173976,0.00008933412],"about_ca_topic_score_codex":0.0007518877,"about_ca_topic_score_gemma":0.00016630597,"teacher_disagreement_score":0.07996436,"about_ca_system_score_codex":0.00053089834,"about_ca_system_score_gemma":0.00029266762,"threshold_uncertainty_score":0.6331505},"labels":[],"label_agreement":null},{"id":"W2058344326","doi":"10.1158/0008-5472.can-05-1986","title":"<i>Pten</i> Deficiency Activates Distinct Downstream Signaling Pathways in a Tissue-Specific Manner","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Cancer Institute; Washington University in St. Louis; National Institutes of Health; Harvard University; U.S. Department of Defense","keywords":"PTEN; Cancer research; Carcinogenesis; Protein kinase B; Biology; Prostate; PI3K/AKT/mTOR pathway; Signal transduction; Epithelium; Prostate cancer; Hyperplasia; Tumor suppressor gene; Cancer; Cell biology; Endocrinology; Genetics","score_opus":0.04872348623038871,"score_gpt":0.3425641450293687,"score_spread":0.29384065879898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058344326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292136,0.009878901,0.0002724754,0.00017642589,0.00020279337,0.0003501504,0.00007324434,0.000027090771,0.006097585],"genre_scores_gemma":[0.9968893,0.0004073957,0.00015546272,0.000042538883,0.00086952426,0.00031086412,0.00009518799,0.0000551769,0.0011745397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997297,0.00017864865,0.00032120678,0.0007574937,0.0005636856,0.0008819687],"domain_scores_gemma":[0.9989716,0.00007511684,0.00006594731,0.0005273039,0.00024919224,0.00011086448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007447509,0.00022658533,0.00020944499,0.00018227732,0.00019804323,0.00009185235,0.0005125036,0.00020569796,0.00030240952],"category_scores_gemma":[0.00007099152,0.00021427947,0.00007294185,0.0005735856,0.0002933416,0.000010510163,0.00020849165,0.0004234281,0.000065806795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001431515,0.00011302649,0.0051134396,0.00003939471,0.000007753438,0.000032434145,0.000049016104,0.0006961512,0.9777928,0.00019642679,0.009111505,0.0067049237],"study_design_scores_gemma":[0.0005688808,0.00016842314,0.0016680032,0.0000869245,0.0000032197834,0.0000063786465,0.000089730536,0.000020274127,0.8910966,0.0005149934,0.10549676,0.00027984742],"about_ca_topic_score_codex":0.0009104964,"about_ca_topic_score_gemma":0.00041956152,"teacher_disagreement_score":0.096385255,"about_ca_system_score_codex":0.00023723902,"about_ca_system_score_gemma":0.00030792892,"threshold_uncertainty_score":0.8738063},"labels":[],"label_agreement":null},{"id":"W2058360832","doi":"10.1158/1538-7445.am2014-lb-169","title":"Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bortezomib; Medicine; Proteasome inhibitor; Chemotherapy; Refractory (planetary science); Internal medicine; Leukemia; In vivo; Oncology; Ex vivo; Clinical trial; Pharmacology; Cancer research; Biology; Multiple myeloma","score_opus":0.05144887532731268,"score_gpt":0.39021148127625394,"score_spread":0.33876260594894125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058360832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925147,0.00022914258,0.00025706238,0.0019552521,0.000060333998,0.0047872593,0.000044099408,0.00003312794,0.000118972974],"genre_scores_gemma":[0.99688476,0.00028634365,0.00067561725,0.00017853316,0.0005113697,0.0012562942,0.000030028325,0.000053024043,0.0001240117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99698436,0.0003670028,0.00042453173,0.0006940228,0.00084009796,0.00068997976],"domain_scores_gemma":[0.99791276,0.00046777024,0.00018545671,0.000520218,0.0005252735,0.0003885258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004152341,0.00021029053,0.00052437984,0.0008105998,0.00016587724,0.000044558703,0.00015643938,0.0002638971,0.00006306714],"category_scores_gemma":[0.0014670329,0.00018879138,0.00005878298,0.0005875935,0.00026078345,0.0003358937,0.00011403447,0.0010191383,0.000006901919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071649193,0.00022217854,0.076312244,0.0006113052,0.000048074802,0.000027287315,0.0018216551,0.000030184945,0.905669,0.000098685516,0.00077097694,0.007223491],"study_design_scores_gemma":[0.009914227,0.0016928049,0.6129847,0.0006830434,0.000025542064,0.000018036266,0.0009614089,0.00053940533,0.37127814,0.0002085883,0.001370832,0.0003232308],"about_ca_topic_score_codex":0.0012518351,"about_ca_topic_score_gemma":0.00019529325,"teacher_disagreement_score":0.5366725,"about_ca_system_score_codex":0.0010778356,"about_ca_system_score_gemma":0.0010900602,"threshold_uncertainty_score":0.7698689},"labels":[],"label_agreement":null},{"id":"W2058555983","doi":"10.1158/1538-7445.am2011-672","title":"Abstract 672: PBI-1402, a first-in-class erythropoiesis regulating agent, inhibits tumor growth and metastasis of murine mastocytoma and does not overshoot hemoglobin: Comparison with erythropoietin","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Liminal BioSciences (Canada)","funders":"","keywords":"Medicine; Erythropoietin; Mastocytoma; Metastasis; Anemia; Hemoglobin; Internal medicine; Erythropoiesis; Endocrinology; Cancer; Hematocrit; Pharmacology; Cancer research; Tumor cells","score_opus":0.08027348310969293,"score_gpt":0.3482930390094226,"score_spread":0.2680195558997297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058555983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127316,0.002199063,0.000004700605,0.0031361203,0.00005416539,0.0009498445,0.00006326972,0.000043424876,0.0022762727],"genre_scores_gemma":[0.9952125,0.0015130378,0.0025528737,0.00007420007,0.00008943267,0.0001586444,0.000011425629,0.00006467153,0.00032322752],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968279,0.00012034249,0.00061051495,0.0007663176,0.00090360886,0.000771298],"domain_scores_gemma":[0.9983895,0.00027816874,0.0002156447,0.00044751615,0.00030193775,0.0003672593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070392305,0.000365222,0.00085862837,0.00042301664,0.00024272814,0.00004232553,0.00013897703,0.00011495013,0.0006699148],"category_scores_gemma":[0.00015350833,0.00025069332,0.0000823996,0.00061403326,0.0012589558,0.00014178515,0.00024804947,0.0005829418,0.000005895388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009239009,0.0024345606,0.87356126,0.0071599293,0.0009831509,0.0013010986,0.0113647,0.000009767963,0.07691042,0.00085282204,0.0025935355,0.013589711],"study_design_scores_gemma":[0.009120453,0.0022183752,0.32160598,0.002821308,0.00023945396,0.0001898778,0.008773521,0.000074716685,0.6536968,0.00012219785,0.00065084256,0.00048651302],"about_ca_topic_score_codex":0.0064306282,"about_ca_topic_score_gemma":0.0028345103,"teacher_disagreement_score":0.57678634,"about_ca_system_score_codex":0.00029912914,"about_ca_system_score_gemma":0.00023988522,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2058573524","doi":"10.1158/0008-5472.can-08-0238","title":"Oncolytic Vesicular Stomatitis Viruses Are Potent Agents for Intravesical Treatment of High-Risk Bladder Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Bladder cancer; Bioluminescence imaging; Medicine; Vesicular Stomatitis; Cancer; Cancer research; In vivo; Vesicular stomatitis Indiana virus; Cell culture; Pathology; Internal medicine; Virology; Virus; Biology; Luciferase","score_opus":0.09752426056907403,"score_gpt":0.4120985029481728,"score_spread":0.31457424237909876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058573524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914061,0.0062457593,0.00012911059,0.000315564,0.00012460243,0.0011472395,0.00055829325,0.000012142015,0.000061189414],"genre_scores_gemma":[0.9761711,0.019870048,0.00013073965,0.000108777516,0.0006111785,0.0015855931,0.000053678486,0.00006511136,0.0014037987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745584,0.00029887736,0.00028966062,0.0005671381,0.00067923055,0.00070926716],"domain_scores_gemma":[0.9984116,0.00007720582,0.00010872522,0.00060817326,0.00055791845,0.00023635964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508716,0.00021812422,0.00034001024,0.00015281452,0.000304675,0.000020604002,0.0003610749,0.00017769217,0.00027174837],"category_scores_gemma":[0.000106414234,0.0001870119,0.00017877793,0.00027056716,0.00044963983,0.0000065257445,0.000099730634,0.00016464868,0.000017696118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007431951,0.0011962112,0.013327891,0.00016731833,0.0014959004,0.00008295312,0.0005661731,0.0019230288,0.86437774,0.000040364346,0.024417188,0.084973305],"study_design_scores_gemma":[0.0026391926,0.0066395323,0.008612166,0.000044375014,0.000038107173,0.0000059821677,0.00008558378,0.000110447734,0.95406944,0.00007894324,0.02745389,0.00022234512],"about_ca_topic_score_codex":0.00261871,"about_ca_topic_score_gemma":0.0025513445,"teacher_disagreement_score":0.08969172,"about_ca_system_score_codex":0.0003752927,"about_ca_system_score_gemma":0.0009156473,"threshold_uncertainty_score":0.7626124},"labels":[],"label_agreement":null},{"id":"W2058634279","doi":"10.1158/1538-7445.am2014-3256","title":"Abstract 3256: Variation in treatment of severe oral dysplasia: Knowledge translation in the COOLS trial points to a pressing concern","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"West Fraser (Canada); Fraser Institute","funders":"","keywords":"Medicine; Cohort; Dysplasia; Cancer; Clinical trial; Knowledge translation; Randomized controlled trial; Clinical endpoint; Surgery; Family medicine; Pediatrics; Internal medicine","score_opus":0.31070455401196145,"score_gpt":0.5174747922605064,"score_spread":0.20677023824854496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058634279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950574,0.00047289062,0.00002868326,0.00066356495,0.00024824895,0.0016100139,0.00003317083,0.000008382981,0.0018776398],"genre_scores_gemma":[0.9988796,0.00004441337,0.00007836657,0.000020142208,0.00016310783,0.0005978486,0.000013280172,0.0000105208765,0.00019272728],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779725,0.0009629875,0.00034346592,0.00026549312,0.00028937674,0.0003414271],"domain_scores_gemma":[0.9986779,0.0008814876,0.00006202447,0.00023546485,0.000085985674,0.00005710844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015868853,0.000102200174,0.00023424892,0.00018049555,0.00009659133,0.0000250227,0.00013799992,0.00013813733,0.00012840443],"category_scores_gemma":[0.00011577798,0.00007352166,0.000038519825,0.0003925909,0.000061617706,0.00009113816,0.000014081967,0.00022530356,0.000098257246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0886506,0.007100017,0.12253714,0.00088743103,0.000163562,0.00043410424,0.087723814,0.0017222018,0.011428703,0.0026238959,0.0012358029,0.6754927],"study_design_scores_gemma":[0.053690717,0.0022521112,0.93615186,0.00032881054,0.000027230652,0.000011506054,0.0005989489,0.00045103434,0.0023580382,0.0011760521,0.0027860198,0.00016769535],"about_ca_topic_score_codex":0.0022034661,"about_ca_topic_score_gemma":0.009761368,"teacher_disagreement_score":0.81361467,"about_ca_system_score_codex":0.0004665932,"about_ca_system_score_gemma":0.00025069033,"threshold_uncertainty_score":0.54470724},"labels":[],"label_agreement":null},{"id":"W2058673653","doi":"10.1158/1538-7445.am2011-1793","title":"Abstract 1793: 5-Fluorouracil chemotherapy acts synergistically with adoptive dendritic cell immunotherapy to induce durable anti-tumor responses <i>in vivo</i>","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Dendritic cell; Immune system; Immunotherapy; Immunology; Medicine; Cancer research; CD8; Antigen; Adoptive cell transfer; Population; In vivo; Tumor antigen; T cell; Biology","score_opus":0.05118373380940566,"score_gpt":0.32266907834212116,"score_spread":0.2714853445327155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058673653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813689,0.009494164,0.00006311576,0.0005098122,0.0003184685,0.0010852629,0.00007991698,0.00009351271,0.0069868476],"genre_scores_gemma":[0.98425746,0.0030176335,0.0002671071,0.00082083204,0.000043425574,0.00052743417,0.000007883132,0.00012174621,0.010936504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956949,0.00097180065,0.0005874014,0.0008149126,0.00027676288,0.0016542533],"domain_scores_gemma":[0.997395,0.0009638211,0.00013354674,0.00090104644,0.00049864664,0.00010794012],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001745294,0.00046618722,0.00066162477,0.00070230995,0.000491544,0.00008481073,0.0009796201,0.0003313879,0.006324271],"category_scores_gemma":[0.00021284044,0.00038819708,0.00011939413,0.0010533342,0.0007617697,0.00031770312,0.000112380934,0.0014048921,0.0007131494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023385901,0.00068254716,0.0010710394,0.000055523487,0.00019553427,0.00019050071,0.0037374687,0.000007948376,0.9654738,0.00022958666,0.0015989145,0.0033712462],"study_design_scores_gemma":[0.0038079105,0.001314569,0.03537327,0.00040140358,0.00000994167,0.0000712914,0.0013444235,3.8837322e-7,0.9114149,0.00005478355,0.045695767,0.00051132793],"about_ca_topic_score_codex":0.0025084422,"about_ca_topic_score_gemma":0.00020348544,"teacher_disagreement_score":0.054058865,"about_ca_system_score_codex":0.00037860364,"about_ca_system_score_gemma":0.0011136603,"threshold_uncertainty_score":0.999857},"labels":[],"label_agreement":null},{"id":"W2058726041","doi":"10.1158/1538-7445.pedcan-b20","title":"Abstract B20: Innate and adaptive immune control of neoantigen-bearing acute lymphoblastic leukemia (ALL) enhanced by epitope spread","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Leukemia; Biology; Immunology; Adoptive cell transfer; Immune system; Epitope; Bone marrow; Cancer research; Antigen; Molecular biology; T cell","score_opus":0.022187151357118573,"score_gpt":0.3367076261530409,"score_spread":0.3145204747959223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058726041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914754,0.005898236,0.0010827136,0.00015801353,0.00006844416,0.00044506392,0.00009341422,0.000011250094,0.0007674629],"genre_scores_gemma":[0.9943513,0.0046276795,0.000037102516,0.00008225884,0.00016449207,0.00012244229,0.00003683614,0.00005257991,0.000525275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975298,0.00029484526,0.00031727567,0.00057033007,0.0005400456,0.0007477068],"domain_scores_gemma":[0.9985589,0.0001386018,0.000099720535,0.000561976,0.00043137747,0.00020944304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012791427,0.00020964142,0.00032379627,0.00013494847,0.00014746515,0.000047715555,0.00049319817,0.0001962351,0.000108323744],"category_scores_gemma":[0.00017382774,0.00019915048,0.00007998851,0.00021484864,0.00049175567,0.000011321527,0.00023904875,0.00037279577,0.000026531394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038403857,0.0000334989,0.00017215965,0.00004695093,0.00027955673,0.0000026341343,0.000073657524,0.00015940426,0.96856725,0.000023466364,0.00033558937,0.026465425],"study_design_scores_gemma":[0.0021091425,0.0019705826,0.0011113271,0.000066786844,0.000015432455,0.0000020297527,0.000041582905,0.00034645933,0.9916071,0.00007737426,0.0024496552,0.0002024898],"about_ca_topic_score_codex":0.00058736355,"about_ca_topic_score_gemma":0.00016414518,"teacher_disagreement_score":0.026262937,"about_ca_system_score_codex":0.00014939705,"about_ca_system_score_gemma":0.0004894928,"threshold_uncertainty_score":0.8121121},"labels":[],"label_agreement":null},{"id":"W2058752290","doi":"10.1158/1538-7445.am10-3165","title":"Abstract 3165: Anti-tumor activity of the eIF4E-targeted drug ribavirin in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Cancer research; EIF4E; Oncogene; Breast cancer; Cancer; Medicine; Ribavirin; Internal medicine; Biology; Immunology; Cell cycle; Translation (biology); Messenger RNA; Biochemistry","score_opus":0.030994318691018253,"score_gpt":0.3675388529047714,"score_spread":0.33654453421375313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058752290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734814,0.00021698515,2.0609927e-7,0.00967889,0.0003372726,0.0007291303,0.00011608574,0.000017257382,0.0015560561],"genre_scores_gemma":[0.99132484,0.00025618848,0.000030174839,0.00005071958,0.00015502253,0.00021774339,0.000004228891,0.000028041126,0.007933064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798167,0.00009720172,0.00023674977,0.00034756132,0.0007883584,0.000548491],"domain_scores_gemma":[0.9988956,0.00012659252,0.00007579761,0.00047900726,0.00025671866,0.0001662808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007583501,0.00016280073,0.00032612684,0.0002170268,0.000121164005,0.000019409867,0.00027192675,0.00007674205,0.001872918],"category_scores_gemma":[0.00003996108,0.000105014784,0.000091651505,0.0007315911,0.00029583296,0.00009281955,0.00013386674,0.0010854434,0.00006031524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002242961,0.0003987877,0.25552806,0.00014009172,0.000067036366,0.00005279801,0.00053392694,0.0000065373024,0.72831523,0.000015639785,0.009562774,0.0051548346],"study_design_scores_gemma":[0.00093956495,0.0000065020354,0.56176186,0.00016809348,0.000011356382,0.0000042656898,0.000057598703,0.000016131356,0.43378904,0.000013575281,0.0031590136,0.000073003604],"about_ca_topic_score_codex":0.005821275,"about_ca_topic_score_gemma":0.004804508,"teacher_disagreement_score":0.3062338,"about_ca_system_score_codex":0.0003382652,"about_ca_system_score_gemma":0.0013604357,"threshold_uncertainty_score":0.99903953},"labels":[],"label_agreement":null},{"id":"W2058966918","doi":"10.1158/1538-7445.am2014-1409","title":"Abstract 1409: The BP1 homeobox gene is dysregulated in triple negative breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Gene knockdown; Biology; Breast cancer; Small hairpin RNA; Cell culture; Cancer; Molecular biology; Genetics","score_opus":0.057266059045237704,"score_gpt":0.40912095228014733,"score_spread":0.35185489323490965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058966918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662595,0.004697222,0.000044362652,0.025536427,0.00033524973,0.0012882786,0.00019736237,0.000074193405,0.001567422],"genre_scores_gemma":[0.99265635,0.0009880422,0.00008749922,0.001332248,0.0009146209,0.0008173053,0.000010390755,0.000081460676,0.0031120868],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967687,0.00021993347,0.00036895036,0.00060822145,0.0010456861,0.0009885231],"domain_scores_gemma":[0.9979019,0.00033046943,0.00010015972,0.0007629824,0.0006458902,0.0002585791],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011253395,0.00026230648,0.00045871935,0.00032289038,0.00025140817,0.00005519934,0.00043608533,0.00015021897,0.004055247],"category_scores_gemma":[0.00012796414,0.00018124854,0.0001023657,0.0014281728,0.00065768283,0.00018917256,0.0001290647,0.0011242651,0.00009902704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007878905,0.00049243605,0.035950363,0.00051229284,0.0006575274,0.00013728364,0.009471556,0.0009905013,0.21586215,0.00040170862,0.018275758,0.70936954],"study_design_scores_gemma":[0.009810058,0.00024046598,0.81213653,0.001043735,0.000053487554,0.00011934549,0.001268183,0.0011841652,0.12059056,0.0029794823,0.050011195,0.0005627631],"about_ca_topic_score_codex":0.010046555,"about_ca_topic_score_gemma":0.0022171652,"teacher_disagreement_score":0.77618617,"about_ca_system_score_codex":0.0011185657,"about_ca_system_score_gemma":0.00075625116,"threshold_uncertainty_score":0.9968552},"labels":[],"label_agreement":null},{"id":"W2058980784","doi":"10.1158/0008-5472.sabcs-09-2017","title":"Steroid Receptor RNA Activator Protein (SRAP): A Potential New Prognostic Marker for Estrogen Receptor-Positive/Node-Negative/Younger Breast Cancer Patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Breast cancer; Estrogen receptor; Oncology; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Progesterone receptor; Tissue microarray; Immunohistochemistry; Medicine; Estrogen; Biology; Endocrinology; Confidence interval","score_opus":0.0186628325050867,"score_gpt":0.3290331626118317,"score_spread":0.310370330106745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058980784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111813,0.0010208992,0.00034416458,0.0034234081,0.00015529376,0.00303536,0.0007176541,0.000024328385,0.00016073737],"genre_scores_gemma":[0.9843448,0.00046128477,0.0008833666,0.00027241974,0.0014151566,0.001443706,0.00028149868,0.00008571327,0.010812099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962892,0.00033531073,0.00033229595,0.0008967478,0.0008626719,0.0012837605],"domain_scores_gemma":[0.99772465,0.000055789893,0.00011203523,0.00043964857,0.0011055395,0.00056232687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000592245,0.0003208157,0.00029848036,0.00016314618,0.0004088992,0.00017445291,0.0005532728,0.00025762527,0.00051232375],"category_scores_gemma":[0.0003725518,0.00028860103,0.00019197578,0.00038027312,0.00020602002,0.000047516845,0.00018962011,0.00049165904,0.000031916577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041209348,0.00021268055,0.0032640537,0.000058541977,0.0001635973,0.00000209749,0.00005037513,0.000011974219,0.9296943,0.000026124764,0.024702568,0.037692763],"study_design_scores_gemma":[0.0040212628,0.0019250843,0.028453965,0.00034571104,0.00002266353,0.0000033031738,0.00009025715,0.00007861018,0.9507361,0.00010796951,0.013629186,0.00058590365],"about_ca_topic_score_codex":0.00080962194,"about_ca_topic_score_gemma":0.000042110554,"teacher_disagreement_score":0.03710686,"about_ca_system_score_codex":0.00033674415,"about_ca_system_score_gemma":0.0012002997,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W2058989718","doi":"10.1158/1538-7445.am10-lb-176","title":"Abstract LB-176: Discovery of CWP232291: A novel and potent small molecule inhibitor of Wnt signaling in hematological malignacies","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Medicine; Cancer; Wnt signaling pathway; Cancer research; Pharmacology; Small molecule; Oncology; Internal medicine; Chemistry; Signal transduction; Biochemistry","score_opus":0.05946039371143162,"score_gpt":0.36444974963310417,"score_spread":0.30498935592167253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058989718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982032,0.00087535527,0.000060889754,0.00019755839,0.000059434453,0.00032558912,0.00007401029,0.000003484394,0.00020047504],"genre_scores_gemma":[0.9991691,0.00026767072,0.00023010677,0.000012762215,0.00008946104,0.00006652202,0.000015969155,0.00002209886,0.00012628692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981503,0.00008181022,0.000351794,0.00043055255,0.00048472857,0.0005008438],"domain_scores_gemma":[0.9990238,0.00010167873,0.000076374905,0.000341738,0.00033435502,0.00012206961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009160209,0.00014295628,0.00027323418,0.00019719548,0.000043110278,0.00003710896,0.00034362116,0.00024481697,0.00004355798],"category_scores_gemma":[0.00048457988,0.00012108074,0.000075358425,0.00025222544,0.00059888983,0.000010583286,0.000453151,0.0005595963,0.0000015818532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020875732,0.00020290604,0.017069751,0.0002129507,0.00002591108,0.000013047033,0.00008183763,0.000018973098,0.981559,0.00019872577,0.00006465391,0.00034348157],"study_design_scores_gemma":[0.0005724743,0.00021901977,0.016334847,0.00008833609,0.0000026512312,0.000008179285,0.00028933998,0.000014876018,0.9821425,0.0000646737,0.00014176847,0.00012130227],"about_ca_topic_score_codex":0.0011024169,"about_ca_topic_score_gemma":0.000809259,"teacher_disagreement_score":0.000965919,"about_ca_system_score_codex":0.00003109486,"about_ca_system_score_gemma":0.00036924967,"threshold_uncertainty_score":0.49375293},"labels":[],"label_agreement":null},{"id":"W2059092369","doi":"10.1158/0008-5472.sabcs12-p5-12-02","title":"Abstract P5-12-02: Tangled in the Breast Cancer Web: An Evaluation of the Usage of Web-based Information Resources by Breast Cancer Patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; The Internet; Medicine; Cancer; Information quality; Family medicine; World Wide Web; Internal medicine; Information system; Computer science","score_opus":0.12921645476078505,"score_gpt":0.5182452291401566,"score_spread":0.38902877437937156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059092369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888936,0.0003329333,0.000001839181,0.002430944,0.00043245862,0.0024888117,0.002909503,0.000014480394,0.002495383],"genre_scores_gemma":[0.9964407,0.00012931412,0.0000058767187,0.0013435526,0.00019335345,0.0017362221,0.0000982484,0.000012600843,0.00004012782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921739,0.0031141697,0.0015151865,0.00016499299,0.0022686853,0.00076307723],"domain_scores_gemma":[0.9952728,0.0005451879,0.0008983472,0.0006186229,0.0024881628,0.00017687478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01577617,0.00015238924,0.00025224918,0.00025494295,0.00065840466,0.000032483847,0.0006846706,0.00020394013,0.0039663943],"category_scores_gemma":[0.00040892884,0.00008931872,0.00005858651,0.0009943895,0.00022608301,0.0025441276,0.00010454895,0.0010691679,0.000024657664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039112044,0.00025477164,0.9326537,0.0009329205,0.00000967635,1.1814382e-8,0.018318934,0.00015329587,0.00042354056,0.000023274986,0.01037683,0.03646187],"study_design_scores_gemma":[0.002083459,0.000025390113,0.9773462,0.00064923917,0.000013372284,1.3413356e-7,0.002679577,0.0036040104,0.00022644877,0.000016099333,0.013261607,0.000094491785],"about_ca_topic_score_codex":0.014554423,"about_ca_topic_score_gemma":0.0042606546,"teacher_disagreement_score":0.044692416,"about_ca_system_score_codex":0.0011293491,"about_ca_system_score_gemma":0.0031065382,"threshold_uncertainty_score":0.9969441},"labels":[],"label_agreement":null},{"id":"W2059124237","doi":"10.1158/0008-5472.can-07-6168","title":"Inflammatory Signaling and Aryl Hydrocarbon Receptor Mediate Synergistic Induction of Interleukin 6 in MCF-7 Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Center for Research Resources; National Institute of Environmental Health Sciences","keywords":"Aryl hydrocarbon receptor; Signal transduction; Chromatin immunoprecipitation; Biology; Gene silencing; Cell biology; Immune system; Interleukin; Chromatin; Cytokine; Regulation of gene expression; Transcription factor; Gene expression; Cancer research; Immunology; Biochemistry; Promoter; Gene","score_opus":0.051553102984452114,"score_gpt":0.3408307847200843,"score_spread":0.28927768173563223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059124237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974541,0.0012822686,0.000004228679,0.00014442392,0.00036379803,0.00048776375,0.00000423462,0.000022374516,0.00023677197],"genre_scores_gemma":[0.99788445,0.0012848541,0.000034877627,0.000029703633,0.00041387294,0.00012123791,0.0000060608263,0.000031011463,0.00019390472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981472,0.00016607814,0.00036880287,0.0003009293,0.00060348347,0.00041351575],"domain_scores_gemma":[0.9990515,0.00025857985,0.000078167344,0.00022392337,0.00017765735,0.0002101428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012360783,0.00013695845,0.00034703652,0.00055296195,0.0000772937,0.0000064455344,0.00009433511,0.00015489927,0.00012663672],"category_scores_gemma":[0.00027757144,0.0001233321,0.000042130625,0.00045186185,0.00039745038,0.000089410205,0.00006907195,0.0006772075,0.000022358025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004763025,0.000048876685,0.026409222,0.00051857746,0.00002616215,0.00017589293,0.0018657013,0.000040315866,0.96775657,0.00003204421,0.0007425385,0.0019078181],"study_design_scores_gemma":[0.0017706204,0.00032728232,0.014634998,0.00089192914,0.000014016946,0.000017889099,0.00026865903,0.00030081888,0.98043877,0.00005347668,0.0011303435,0.00015120553],"about_ca_topic_score_codex":0.000409448,"about_ca_topic_score_gemma":0.00006199255,"teacher_disagreement_score":0.012682212,"about_ca_system_score_codex":0.00028500563,"about_ca_system_score_gemma":0.00043579654,"threshold_uncertainty_score":0.5029337},"labels":[],"label_agreement":null},{"id":"W2059287676","doi":"10.1158/0008-5472.can-10-1513","title":"Tumor Cell Invasion Is Promoted by Interstitial Flow-Induced Matrix Priming by Stromal Fibroblasts","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Oncosuisse; Whitaker International Fellows and Scholars Program","keywords":"Fibroblast; Stromal cell; Cancer-Associated Fibroblasts; Tumor microenvironment; Cell biology; Chemistry; Cancer research; Extracellular matrix; Cell; Pathology; Biology; Medicine; Tumor cells; In vitro; Biochemistry","score_opus":0.061589141059955874,"score_gpt":0.3507503020176765,"score_spread":0.2891611609577206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059287676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566317,0.0007096232,0.0016831182,0.00009637201,0.00019738721,0.00030631697,0.0001151392,0.000012322136,0.0012165656],"genre_scores_gemma":[0.99555814,0.00017935372,0.0003309502,0.00007530539,0.00016296816,0.000083814484,0.00015900804,0.000038015034,0.0034124337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858314,0.00009499659,0.00017983049,0.00044868185,0.00026128985,0.00043208624],"domain_scores_gemma":[0.9992779,0.000008701208,0.000048950427,0.00032223517,0.00018570693,0.00015654527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023490394,0.00013814977,0.00011190175,0.00006973034,0.00016051582,0.000047074478,0.00030015124,0.00012176668,0.0010511151],"category_scores_gemma":[0.000031166783,0.00013637656,0.00007523541,0.00012676146,0.000045216097,0.000010141591,0.00026328804,0.00032893842,0.00005931078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015549174,0.000100051984,0.000020230951,0.00003167016,0.000021209122,0.000004662012,0.00017586823,3.072903e-7,0.9387162,0.000007170245,0.05933592,0.00143122],"study_design_scores_gemma":[0.00037414677,0.000699668,0.000008972905,0.000045036177,0.000006313156,0.0000055409428,0.0001313762,0.00035303266,0.9595743,0.00002240824,0.03863285,0.00014636022],"about_ca_topic_score_codex":0.0006584067,"about_ca_topic_score_gemma":0.000035204885,"teacher_disagreement_score":0.020858094,"about_ca_system_score_codex":0.00008082072,"about_ca_system_score_gemma":0.000154896,"threshold_uncertainty_score":0.9998621},"labels":[],"label_agreement":null},{"id":"W2059326803","doi":"10.1158/1538-7445.am2014-5392","title":"Abstract 5392: High-throughput screening of compounds for targeting system Xc(-) in human breast cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Glutamate receptor; Cancer cell; Cancer; Pharmacology; Cancer research; Chemistry; Neurotransmitter; Medicine; Biochemistry; Internal medicine; Central nervous system","score_opus":0.057603912985262386,"score_gpt":0.3910986562071521,"score_spread":0.3334947432218897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059326803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294764,0.0033594219,0.00016949492,0.0010396906,0.00030696276,0.0010783975,0.00014302402,0.000054058593,0.0009012822],"genre_scores_gemma":[0.99652416,0.0004440419,0.00025499563,0.000053731474,0.0014646705,0.00045729443,0.00003479463,0.000075290016,0.00069100346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702406,0.00022598906,0.0006261395,0.0005024886,0.0007670203,0.00085431855],"domain_scores_gemma":[0.99800855,0.0005331993,0.0001851151,0.00047938418,0.0006091623,0.00018457665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022384773,0.00022511136,0.00071224186,0.00041105459,0.00026615142,0.000047773967,0.0003135206,0.0001626356,0.00020042184],"category_scores_gemma":[0.000086641754,0.00020771244,0.00015873424,0.0004977773,0.00032530475,0.00012582207,0.0000827614,0.00056913786,0.0000072257008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054546315,0.00028231222,0.018622123,0.006578234,0.00018535095,0.000037246464,0.0011584562,0.0008790736,0.923744,0.0006797574,0.016992904,0.025385913],"study_design_scores_gemma":[0.017201314,0.0012584161,0.34557402,0.01582623,0.00017472226,0.00008534981,0.0055353586,0.0028190573,0.5279436,0.000098082666,0.082381316,0.0011025275],"about_ca_topic_score_codex":0.025710687,"about_ca_topic_score_gemma":0.0007202665,"teacher_disagreement_score":0.3958004,"about_ca_system_score_codex":0.0007173404,"about_ca_system_score_gemma":0.0005171499,"threshold_uncertainty_score":0.9807772},"labels":[],"label_agreement":null},{"id":"W2059358140","doi":"10.1158/1538-7445.am2012-761","title":"Abstract 761: Phase I interaction study of docetaxel with supplementation of St. John's wort","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Hyperforin; Hypericum perforatum; Pharmacokinetics; Pharmacology; Medicine; CYP3A4; Midazolam; Cancer; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.20223898097076431,"score_gpt":0.5716591254635875,"score_spread":0.36942014449282323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059358140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651843,0.0003851542,0.0000038957874,0.00025324934,0.00014333092,0.0009390485,0.000041642452,0.000007310876,0.0017079468],"genre_scores_gemma":[0.9987231,0.00019581556,0.000025850275,0.000015410345,0.00024227632,0.00024848676,0.000051461146,0.000013263225,0.0004843498],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988776,0.000067031295,0.0002130479,0.00013304847,0.00045497192,0.00025433415],"domain_scores_gemma":[0.9992795,0.00009234382,0.00009246294,0.00015151498,0.00027953903,0.000104648876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004151261,0.000075590724,0.0002051432,0.00022014408,0.0000404124,0.0000043687432,0.00005364336,0.000026520089,0.0044048773],"category_scores_gemma":[0.000011250608,0.000057021898,0.00002772067,0.0003098325,0.000077157565,0.0001522426,0.000022704238,0.00021361056,0.000006375403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018627817,0.018275883,0.5690171,0.0005641414,0.0010870978,0.00003595189,0.010818195,0.000025973444,0.31901,0.00003516246,0.023724964,0.038777698],"study_design_scores_gemma":[0.04429057,0.015189909,0.41271648,0.0003085952,0.00058183447,0.000018210078,0.016787214,0.000017677221,0.49102053,0.000012912864,0.018860193,0.00019587483],"about_ca_topic_score_codex":0.0024552823,"about_ca_topic_score_gemma":0.00062030274,"teacher_disagreement_score":0.17201056,"about_ca_system_score_codex":0.00022818724,"about_ca_system_score_gemma":0.00017508278,"threshold_uncertainty_score":0.99650526},"labels":[],"label_agreement":null},{"id":"W2059396214","doi":"10.1158/1538-7445.am2012-4109","title":"Abstract 4109: The unfolded protein response promotes tolerance to extreme hypoxia through autophagy dependent maintenance of cellular metabolism","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Autophagy; ATG5; Biology; Hypoxia (environmental); Cell biology; Unfolded protein response; Programmed cell death; PI3K/AKT/mTOR pathway; Homeostasis; Cancer research; Mechanistic target of rapamycin; Signal transduction; Chemistry; Apoptosis; Biochemistry; Endoplasmic reticulum","score_opus":0.0650586621003947,"score_gpt":0.34563762791220315,"score_spread":0.28057896581180847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059396214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602782,0.035272647,0.00037585036,0.0010295672,0.00090566854,0.0014826733,0.0000958233,0.000017566737,0.00054196187],"genre_scores_gemma":[0.99032223,0.0010243425,0.00056446076,0.00023403793,0.0023546163,0.00093466527,0.000011340719,0.000060356226,0.004493967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965883,0.00048038253,0.0004214448,0.0005647511,0.00081390725,0.0011312302],"domain_scores_gemma":[0.99793935,0.0000737637,0.00013696436,0.0010637594,0.0005172945,0.0002688815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026511915,0.0002725394,0.00035730927,0.00009827278,0.0002334107,0.00004925252,0.0008131846,0.00019429646,0.00018328807],"category_scores_gemma":[0.00056545186,0.00020329666,0.00016462288,0.00046081474,0.0003285648,0.000028514187,0.00034944675,0.00042121852,0.000043182514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015460848,0.00012652963,0.000039294762,0.00006834778,0.000065108376,0.0000022747595,0.0007203954,0.00003723,0.9863701,0.00042676617,0.005249231,0.0053486596],"study_design_scores_gemma":[0.00053136586,0.00007820243,0.0063524414,0.000059833597,0.00001366165,0.000004477355,0.00016702861,0.000002693913,0.70652765,0.00014136075,0.28593752,0.00018378405],"about_ca_topic_score_codex":0.0006690804,"about_ca_topic_score_gemma":0.00012143682,"teacher_disagreement_score":0.2806883,"about_ca_system_score_codex":0.00008043052,"about_ca_system_score_gemma":0.0005619036,"threshold_uncertainty_score":0.8290197},"labels":[],"label_agreement":null},{"id":"W2059397356","doi":"10.1158/0008-5472.sabcs11-ot3-02-01","title":"OT3-02-01: A 1-Year Prospective Longitudinal Study of the Role of Psychosocial Factors in Adherence to Adjuvant Endocrine Therapy in Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Psychological intervention; Coping (psychology); Anxiety; Cancer; Prospective cohort study; Disease; Clinical psychology; Oncology; Internal medicine; Psychiatry","score_opus":0.18892392638976604,"score_gpt":0.4526784622858814,"score_spread":0.2637545358961153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059397356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956564,0.00042642537,9.724654e-7,0.0002338283,0.00008619103,0.0020200608,0.000029006462,0.0000068026343,0.0015403277],"genre_scores_gemma":[0.99832046,0.00021319269,0.000012000457,0.000021583523,0.00006512217,0.00093467877,4.970576e-7,0.000014258369,0.00041821922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791014,0.00017302517,0.00035547794,0.00035721334,0.0008294764,0.000374651],"domain_scores_gemma":[0.99888796,0.000048463047,0.000103472965,0.00042150638,0.00041500552,0.0001235983],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037808577,0.00012182548,0.00035502753,0.0002117531,0.000045302728,0.0000056569447,0.00043079103,0.00004433384,0.0021011762],"category_scores_gemma":[0.00007119208,0.000083163344,0.00004617177,0.0013871395,0.00019365005,0.00006354033,0.00009107978,0.0005051939,0.000024723884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001503841,0.0009406992,0.9742322,0.000028729524,0.000035802244,0.0000048437155,0.0124377,9.495936e-7,0.0058436994,0.00009829981,0.00013674353,0.0047364985],"study_design_scores_gemma":[0.0024025699,0.001430338,0.9744965,0.00041101387,0.0000053362264,0.0000011779907,0.006424078,0.0000025296836,0.014436192,0.00027613362,0.000042661322,0.00007147313],"about_ca_topic_score_codex":0.058372375,"about_ca_topic_score_gemma":0.009270859,"teacher_disagreement_score":0.049101517,"about_ca_system_score_codex":0.00019778531,"about_ca_system_score_gemma":0.0006041269,"threshold_uncertainty_score":0.99881107},"labels":[],"label_agreement":null},{"id":"W2059441475","doi":"10.1158/1538-7445.am10-2854","title":"Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Single-nucleotide polymorphism; Minor allele frequency; Serous fluid; Population; Ovarian cancer; Biology; Linkage disequilibrium; Genetics; Genotype; International HapMap Project; Lumican; Cancer; Odds ratio; Oncology; Medicine; Internal medicine; Gene; Decorin","score_opus":0.03136600882750874,"score_gpt":0.37280486019240694,"score_spread":0.3414388513648982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059441475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969709,0.0012238772,0.000047378748,0.0007264214,0.00011508233,0.00069015834,0.00009066937,0.00000708698,0.0001284375],"genre_scores_gemma":[0.997085,0.001159329,0.0005435306,0.000050964434,0.00034473863,0.0004497389,0.000012685947,0.000027690412,0.00032636712],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99795264,0.0001199989,0.0002169755,0.0007215119,0.0003461143,0.0006427601],"domain_scores_gemma":[0.9989319,0.000036678608,0.000029387491,0.00043445078,0.00023514136,0.00033248277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088598795,0.00015817521,0.00016642238,0.00018502677,0.00015615455,0.0001049828,0.00026827815,0.00020464491,0.0005918963],"category_scores_gemma":[0.00015864478,0.00015434591,0.000024542307,0.00028745906,0.00023686352,0.000010766459,0.0003184548,0.0005171268,0.0000029543514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002242918,0.000038425103,0.10144588,0.00005258231,0.000015893927,0.00000964957,0.00011650184,0.000028049757,0.8541924,0.000029930365,0.00013760212,0.043708794],"study_design_scores_gemma":[0.0006650361,0.0002331482,0.8801633,0.000020241861,0.0000034320256,0.000008169641,0.000056876648,0.00007271554,0.11385455,0.00013708894,0.004593023,0.00019241576],"about_ca_topic_score_codex":0.017760897,"about_ca_topic_score_gemma":0.08792289,"teacher_disagreement_score":0.7787174,"about_ca_system_score_codex":0.00007425532,"about_ca_system_score_gemma":0.00047656498,"threshold_uncertainty_score":0.9887799},"labels":[],"label_agreement":null},{"id":"W2059456825","doi":"10.1158/1538-7445.am2013-4831","title":"Abstract 4831: Additive and multiplicative gene-environment interactions for colorectal cancer risk.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ontario Institute for Cancer Research; Toronto General Hospital","funders":"","keywords":"Colorectal cancer; Genetic association; Genome-wide association study; Genetic predisposition; Bayes' theorem; Logistic regression; Genetics; Gene–environment interaction; Cancer; Biology; Medicine; Oncology; Internal medicine; Genotype; Statistics; Gene; Single-nucleotide polymorphism; Mathematics","score_opus":0.03240012399189526,"score_gpt":0.3708194317223886,"score_spread":0.33841930773049334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059456825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308914,0.0035694316,0.00016179016,0.0004284387,0.00008252246,0.00096796796,0.0014786582,0.0000061228293,0.00021595004],"genre_scores_gemma":[0.98191535,0.011640236,0.00033880645,0.000068777525,0.0005241579,0.004705095,0.00019154408,0.000023739463,0.0005922914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989487,0.00006000696,0.0001241794,0.00041052751,0.00014336217,0.0003132133],"domain_scores_gemma":[0.99923795,0.000070902184,0.0000504155,0.00017938258,0.0002616495,0.00019968858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012669245,0.00011037694,0.00009249076,0.00004930376,0.0002477615,0.00004200738,0.00011713076,0.0000734872,0.0006010214],"category_scores_gemma":[0.00008915989,0.000107021486,0.000056270208,0.000045361627,0.000265605,0.000008165764,0.00009644917,0.0001422241,0.00002545522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030914007,0.00014620947,0.006924948,0.0000333371,0.00010895958,5.608385e-7,0.00016060448,0.000042745494,0.9375246,0.000009232035,0.032376997,0.02236267],"study_design_scores_gemma":[0.0012663142,0.00024913385,0.16701014,0.000026247757,0.000024060191,0.0000013589676,0.0005406605,0.00013467265,0.7582084,0.00046058247,0.07185059,0.00022785657],"about_ca_topic_score_codex":0.0008485209,"about_ca_topic_score_gemma":0.0003024341,"teacher_disagreement_score":0.17931621,"about_ca_system_score_codex":0.000087156055,"about_ca_system_score_gemma":0.00012956653,"threshold_uncertainty_score":0.6580763},"labels":[],"label_agreement":null},{"id":"W2059569756","doi":"10.1158/1538-7445.am2012-4258","title":"Abstract 4258: <i>In vivo</i> anti-leukemia activity of novel C-ring modified prodigiosenes in a zebrafish xenograft model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; In vivo; Leukemia; K562 cells; Cancer research; Myeloid leukemia; Toxicity; Pharmacology; Medicine; Chemistry; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.0773455164601545,"score_gpt":0.3762552424487851,"score_spread":0.29890972598863064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059569756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971843,0.00070149195,0.0002772567,0.000077324745,0.000034742774,0.0003722862,0.00008787451,0.00000461907,0.0012601501],"genre_scores_gemma":[0.99879646,0.0004487489,0.0002147427,0.000024630435,0.00014525716,0.00019181441,0.0000064490055,0.000019528969,0.00015237491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882776,0.000037304435,0.00018959159,0.00028172787,0.00017735278,0.0004862831],"domain_scores_gemma":[0.9994114,0.000017619966,0.000049787956,0.00034123973,0.000093400886,0.000086528686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057523197,0.0001052031,0.00017263184,0.00012816762,0.00004612098,0.000014729483,0.00024588872,0.00012823514,0.000010659086],"category_scores_gemma":[0.000051166553,0.000105656945,0.00004587871,0.00032335988,0.00011293967,0.00001579807,0.00014902493,0.00023349712,0.0000017138515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010341443,0.00023060216,0.0013144114,0.00006778314,0.0000071133586,2.4870565e-7,0.0001044794,0.0029112992,0.99406844,0.00020908278,0.000303975,0.00067915546],"study_design_scores_gemma":[0.0006506517,0.00001508528,0.013833111,0.000043803084,0.0000024251917,6.3011606e-7,0.000026616362,0.0006892528,0.9830887,0.000025806634,0.0015043735,0.00011960166],"about_ca_topic_score_codex":0.00097459863,"about_ca_topic_score_gemma":0.00044623984,"teacher_disagreement_score":0.0125187,"about_ca_system_score_codex":0.00005922927,"about_ca_system_score_gemma":0.00028779317,"threshold_uncertainty_score":0.43085653},"labels":[],"label_agreement":null},{"id":"W2059638529","doi":"10.1158/0008-5472.sabcs-09-4012","title":"Breast Lesions of Uncertain Malignant Potential: A Challenge for Surgeons.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lobular carcinoma; Ductal carcinoma; Biopsy; Scars; Breast cancer; Carcinoma; Radiology; Surgery; Atypical hyperplasia; Cancer; Pathology; Internal medicine","score_opus":0.11536447579467335,"score_gpt":0.41090597787566896,"score_spread":0.2955415020809956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059638529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652224,0.004150909,0.0002943033,0.026821967,0.00009819384,0.001138026,0.00020208015,0.000041363157,0.0020307302],"genre_scores_gemma":[0.99703854,0.00071308995,0.00016626969,0.0000912471,0.00018527232,0.00013945463,0.000021008023,0.00001990154,0.0016252333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983885,0.000074570955,0.00022518956,0.0002865306,0.0005106479,0.000514538],"domain_scores_gemma":[0.9985908,0.00008316984,0.00003823357,0.00039285983,0.0006578535,0.00023704141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075251487,0.00010411129,0.00028442108,0.00024021606,0.00014662501,0.000010940612,0.00014493008,0.00009720022,0.00030088396],"category_scores_gemma":[0.000042845106,0.0000808278,0.00015350578,0.0003756502,0.00013589332,0.00003762676,0.00004116438,0.0002407377,0.000010392699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003551677,0.0017513171,0.0022378734,0.0008367465,0.00023275173,0.00029226832,0.000587236,0.000040775474,0.33011505,0.023934707,0.037802372,0.59861726],"study_design_scores_gemma":[0.014119341,0.0058553442,0.84925634,0.0039145844,0.00041369497,0.0017056455,0.0037598247,0.002060647,0.043496408,0.011172332,0.06322426,0.0010215756],"about_ca_topic_score_codex":0.00063803483,"about_ca_topic_score_gemma":0.00003844953,"teacher_disagreement_score":0.8470185,"about_ca_system_score_codex":0.00012019157,"about_ca_system_score_gemma":0.00060283224,"threshold_uncertainty_score":0.32960618},"labels":[],"label_agreement":null},{"id":"W2059806537","doi":"10.1158/1538-7445.am2013-3920","title":"Abstract 3920: In vivo tyrosinase reporter gene imaging with multispectral photoacoustic technology.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; FujiFilm VisualSonics (Canada)","funders":"","keywords":"Tyrosinase; Melanin; In vivo; Photoacoustic imaging in biomedicine; Reporter gene; Chemistry; Gene expression; Biomedical engineering; Pathology; Materials science; Gene; Medicine; Biology; Optics; Biochemistry; Enzyme","score_opus":0.01706201286235175,"score_gpt":0.2958231212567569,"score_spread":0.27876110839440515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059806537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254304,0.0012312869,0.0009929887,0.00024811836,0.00014260485,0.00061276014,0.000018560899,0.00029284004,0.003917789],"genre_scores_gemma":[0.99790674,0.00016024386,0.0008148017,0.00003274908,0.000091875576,0.00066116615,0.0000025679653,0.00007110737,0.00025874865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792784,0.000017242,0.00027395788,0.00037449482,0.0003988845,0.0010075496],"domain_scores_gemma":[0.9991705,0.00008557897,0.000027098093,0.00041363874,0.0001650178,0.00013818125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035049897,0.00019855122,0.0002159127,0.00053288206,0.000102452614,0.00010655766,0.0002739977,0.000081464364,0.0010726164],"category_scores_gemma":[0.000065083084,0.00017664793,0.000028883764,0.0008000876,0.0002513632,0.00026981055,0.000046104273,0.0007845169,0.000057117577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013604713,0.00003258238,0.007204943,0.00010041441,0.00002229375,0.0004297779,0.00021174896,0.0048809806,0.9798042,0.000008299246,0.0033258733,0.0039652693],"study_design_scores_gemma":[0.0016914764,0.000045495744,0.022660177,0.00059126515,0.000019903204,0.00028543916,0.0017750845,0.11125963,0.8593176,0.00043143608,0.0011719902,0.0007505142],"about_ca_topic_score_codex":0.0013459331,"about_ca_topic_score_gemma":0.00018068784,"teacher_disagreement_score":0.120486625,"about_ca_system_score_codex":0.00052670325,"about_ca_system_score_gemma":0.00014938228,"threshold_uncertainty_score":0.99984056},"labels":[],"label_agreement":null},{"id":"W2059868114","doi":"10.1158/1538-7445.am2013-1713","title":"Abstract 1713: BAX and BAK are preferentially activated by BIM and BID, respectively, affecting clinical chemotherapy response.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Apoptosis; Programmed cell death; Etoposide; Cell biology; Bcl-2-associated X protein; Topotecan; Effector; Homeostasis; Topoisomerase; Chemistry; Doxorubicin; Biology; In vitro; Caspase 3; Biochemistry; Chemotherapy; Genetics","score_opus":0.06877213115355302,"score_gpt":0.4174913506886138,"score_spread":0.3487192195350608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059868114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966275,0.0016681344,0.000016296906,0.0009323765,0.000077445344,0.00036723397,0.000028134245,0.000012164708,0.00027071137],"genre_scores_gemma":[0.9943835,0.0037926827,0.000033684566,0.00015166338,0.00024360468,0.00008063221,0.000013370732,0.000028413493,0.0012724233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983102,0.0003264277,0.00021183841,0.00056310743,0.0002080454,0.000380393],"domain_scores_gemma":[0.9990344,0.00016853046,0.000073118106,0.00026203043,0.00029114823,0.00017077288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009527988,0.00014765354,0.00018218672,0.000082727674,0.00015790148,0.00013046834,0.00018780126,0.00023099688,0.00022167276],"category_scores_gemma":[0.00030931778,0.00012889307,0.0000462716,0.000120605626,0.00026682985,0.000015623302,0.00017740468,0.00038436629,0.00002019028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012923416,0.000053648026,0.012751176,0.000021429518,0.00008030798,0.000002162864,0.00005335333,4.909643e-7,0.9543464,0.0000016715812,0.020759542,0.010637458],"study_design_scores_gemma":[0.0008375606,0.0006035184,0.27565283,0.00007421542,0.000004284587,0.0000039144757,0.00033169656,0.000007659658,0.715667,0.0000727973,0.00656705,0.00017750387],"about_ca_topic_score_codex":0.00040904398,"about_ca_topic_score_gemma":0.00012953622,"teacher_disagreement_score":0.26290163,"about_ca_system_score_codex":0.000031521486,"about_ca_system_score_gemma":0.00014089957,"threshold_uncertainty_score":0.5256107},"labels":[],"label_agreement":null},{"id":"W2059933925","doi":"10.1158/1538-7445.am2011-1548","title":"Abstract 1548: The effects of synthetic triterpenoids on GSK3β and focal adhesions","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Focal adhesion; Cell migration; GSK-3; Cancer; Cancer research; Cell; Chemistry; Cancer cell; Cell adhesion; Metastasis; Cell biology; Biochemistry; Biology; Kinase; Medicine; Internal medicine","score_opus":0.05670267457060088,"score_gpt":0.3519986476334245,"score_spread":0.2952959730628236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059933925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952567,0.00220602,0.000020190439,0.00012788846,0.000079145364,0.00027770447,0.000019308412,0.0000028168722,0.0020101964],"genre_scores_gemma":[0.9981848,0.0011558454,0.000031420335,0.000059740727,0.00012568718,0.00009039521,0.0000052979412,0.000014945742,0.00033183955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991042,0.000096517535,0.00011796056,0.00026518118,0.00016016247,0.0002559495],"domain_scores_gemma":[0.9992976,0.00013418507,0.00003396789,0.00034637534,0.00010433336,0.00008351894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000275339,0.00009248557,0.00011250605,0.000041108306,0.0000981627,0.000010432482,0.0002544678,0.00009057449,0.000051526098],"category_scores_gemma":[0.0002478855,0.00006449327,0.000050421815,0.00006596578,0.0004214369,0.0000019378622,0.00013765087,0.00020569217,0.000007661855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020592695,0.00007454802,0.00095033285,0.00009963574,0.000033901648,0.0000024556768,0.00023363615,4.373233e-7,0.9909923,0.0001480748,0.0012416112,0.0060171583],"study_design_scores_gemma":[0.00030952162,0.00040547625,0.020192614,0.000074681426,0.0000072816033,0.0000011065522,0.00009838574,0.000001187852,0.9760701,0.00041066596,0.00235327,0.00007569204],"about_ca_topic_score_codex":0.000108982196,"about_ca_topic_score_gemma":0.000025293115,"teacher_disagreement_score":0.019242281,"about_ca_system_score_codex":0.000014291542,"about_ca_system_score_gemma":0.0000721392,"threshold_uncertainty_score":0.26299593},"labels":[],"label_agreement":null},{"id":"W2060063962","doi":"10.1158/0008-5472.can-07-2091","title":"Risk Stratification in Cancer Predisposition Syndromes: Lessons Learned from Novel Molecular Developments in Li-Fraumeni Syndrome","year":2008,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Cancer; Risk stratification; Biology; Bioinformatics; Medicine; Internal medicine; Genetics; Mutation; Gene; Germline mutation","score_opus":0.2790590123684907,"score_gpt":0.4804119867226902,"score_spread":0.20135297435419952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060063962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020252068,0.97328615,0.00015267392,0.0003741297,0.00033592322,0.0040804087,0.001097371,0.000068441834,0.000352835],"genre_scores_gemma":[0.011464915,0.9802236,0.00033257395,0.000030312747,0.00010830734,0.0057452577,0.0014857554,0.0002304493,0.00037880382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993221,0.00079214387,0.0013337673,0.001731825,0.001738341,0.0011829428],"domain_scores_gemma":[0.997425,0.00025537,0.00043045694,0.0011466487,0.0003648548,0.0003776485],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091477606,0.0006938304,0.0021257575,0.0019184335,0.00016928487,0.00007794186,0.0006243783,0.0010962914,0.00027115518],"category_scores_gemma":[0.0003411116,0.0006960415,0.0003477633,0.0033288912,0.00026186538,0.00016673852,0.00023301547,0.003950169,0.00014612304],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021612446,0.00079010025,0.0002516671,0.007434168,0.0009044915,0.0029424552,0.0007871829,0.00031108453,0.0030822817,0.000073134535,0.00059115596,0.9826161],"study_design_scores_gemma":[0.009307782,0.0006991244,0.009697822,0.200826,0.0013264262,0.0010645479,0.00024750567,0.00027205358,0.001453758,0.0003649165,0.7720913,0.0026487077],"about_ca_topic_score_codex":0.0136154555,"about_ca_topic_score_gemma":0.0027878173,"teacher_disagreement_score":0.9799675,"about_ca_system_score_codex":0.0074621714,"about_ca_system_score_gemma":0.00797726,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W2060220051","doi":"10.1158/1538-7445.am2013-2764","title":"Abstract 2764: Impaired tumor growth and extended animal survival with Abraxane treatment in neuroblastoma xenograft models.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Hospital for Sick Children","funders":"","keywords":"Paclitaxel; In vivo; Pharmacology; Neuroblastoma; Toxicity; Metastatic breast cancer; Cell culture; Medicine; Cancer; EC50; Chemistry; In vitro; Cancer research; Breast cancer; Internal medicine; Biology; Biochemistry","score_opus":0.06347492270192649,"score_gpt":0.36138017126299615,"score_spread":0.29790524856106965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060220051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351746,0.00042205388,0.0000021047408,0.001864516,0.000025902895,0.0019697607,0.000028221659,0.00006782842,0.0021021338],"genre_scores_gemma":[0.99734074,0.0005922703,0.00012002551,0.000059921676,0.00009101026,0.0011720118,0.000012823366,0.00007373391,0.000537455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965993,0.00018293898,0.00026913607,0.0007256401,0.0010347812,0.0011881654],"domain_scores_gemma":[0.99827164,0.000223693,0.000043404787,0.0004105321,0.0002977479,0.00075295294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024128643,0.0003102367,0.0004590603,0.0005475045,0.00016023102,0.0001236233,0.00015723243,0.00006640675,0.00039474512],"category_scores_gemma":[0.000056582994,0.00021340889,0.00006440538,0.0006977706,0.00039153674,0.00035882054,0.00011478024,0.00055518583,0.00008330248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031715423,0.010050919,0.16080743,0.0016547984,0.0011534647,0.0229147,0.002094579,0.000128591,0.70619655,0.0007004764,0.0024459308,0.060137123],"study_design_scores_gemma":[0.012587965,0.012222623,0.9295619,0.0003250781,0.00003547196,0.0002690606,0.00036950977,0.0013575866,0.04236072,0.00043869068,0.00013630133,0.0003350703],"about_ca_topic_score_codex":0.009471383,"about_ca_topic_score_gemma":0.001392866,"teacher_disagreement_score":0.7687545,"about_ca_system_score_codex":0.00038946714,"about_ca_system_score_gemma":0.00065082824,"threshold_uncertainty_score":0.9971246},"labels":[],"label_agreement":null},{"id":"W2060234566","doi":"10.1158/1538-7445.am2012-770","title":"Abstract 770: Overcoming Trastuzumab resistance with the novel pan-erbb inhibitor AZD8931","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University; Jewish General Hospital","funders":"","keywords":"Trastuzumab; SKBR3; Medicine; Cancer research; Breast cancer; Monoclonal antibody; Tyrosine-kinase inhibitor; ErbB; Tyrosine kinase; Cancer; Internal medicine; Oncology; Pharmacology; Antibody; Immunology; Receptor","score_opus":0.14736024053927196,"score_gpt":0.4481766815643935,"score_spread":0.3008164410251215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060234566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93713427,0.009895686,0.000118527176,0.020486841,0.00038387126,0.0019962618,0.00008191034,0.000111713016,0.029790899],"genre_scores_gemma":[0.9837658,0.000552543,0.00032956115,0.0004175701,0.0025469789,0.00059021084,0.000009631555,0.00012704637,0.011660668],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99375343,0.00019472532,0.00036750973,0.00060541206,0.0030267576,0.0020521702],"domain_scores_gemma":[0.9965913,0.00078416895,0.00008502777,0.0011509788,0.00073094916,0.000657524],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038117957,0.0002988299,0.00042901895,0.00028867603,0.00060652447,0.0001486172,0.000619972,0.00018561381,0.0015326535],"category_scores_gemma":[0.00041126614,0.00018870833,0.0001150341,0.0013397716,0.0009080326,0.00032807002,0.0002275373,0.002359722,0.00027490518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005335618,0.0011267754,0.021104587,0.0018184341,0.00047198543,0.00018514637,0.0070368117,0.00001372724,0.5900534,0.0017324456,0.34391412,0.027206957],"study_design_scores_gemma":[0.003951608,0.0004781168,0.19017263,0.0017467235,0.000065339285,0.000068125155,0.003114772,0.000021373617,0.09402149,0.000050993884,0.70578235,0.00052649056],"about_ca_topic_score_codex":0.0011311775,"about_ca_topic_score_gemma":0.00095994765,"teacher_disagreement_score":0.4960319,"about_ca_system_score_codex":0.0018163191,"about_ca_system_score_gemma":0.0018845762,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W2060258650","doi":"10.1158/1538-7445.am2012-5157","title":"Abstract 5157: Prolactin plays a role in regulating fatty acid synthesis and metabolism in the prostate cancer cell line PC-3","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Carnitine; Fatty acid synthase; Endocrinology; Fatty acid synthesis; Prolactin; Prostate cancer; Biology; Prolactin receptor; Lipid metabolism; Internal medicine; Fatty acid metabolism; Metabolism; Fatty acid; Beta oxidation; Cancer; Biochemistry; Hormone; Medicine","score_opus":0.03390133336449504,"score_gpt":0.3408763973992435,"score_spread":0.3069750640347485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060258650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301698,0.06704936,0.0000033489805,0.00047022584,0.0005731037,0.0006343565,0.00006607728,0.000006106828,0.001027625],"genre_scores_gemma":[0.9813595,0.0115346145,0.000081921666,0.00012530257,0.005311887,0.0012898851,0.0000123863565,0.00003602835,0.00024851342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781877,0.00027941813,0.00028312314,0.0004187495,0.00036817172,0.00083178666],"domain_scores_gemma":[0.99921155,0.000085686435,0.00007784921,0.0003812805,0.00010806854,0.00013557242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020101888,0.00018936199,0.00025103538,0.000107406864,0.000130273,0.00006143407,0.00029018687,0.00016354816,0.00008608468],"category_scores_gemma":[0.00018685915,0.00014449324,0.000054011405,0.00029833196,0.00014849064,0.000030648607,0.00015817926,0.0004653812,0.0000036405788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047482477,0.00012454734,0.014026698,0.000118425945,0.00002097344,3.6861297e-7,0.0026371675,0.00007270953,0.95325303,0.000028042608,0.0018187407,0.027424496],"study_design_scores_gemma":[0.0008726577,0.00003374225,0.13752118,0.00009733883,0.000019172743,0.0000045002403,0.0021775526,0.00003816736,0.7017912,0.000043881624,0.15712385,0.0002767228],"about_ca_topic_score_codex":0.0046162014,"about_ca_topic_score_gemma":0.0061358833,"teacher_disagreement_score":0.25146177,"about_ca_system_score_codex":0.00008808104,"about_ca_system_score_gemma":0.00028498334,"threshold_uncertainty_score":0.6978347},"labels":[],"label_agreement":null},{"id":"W2060360091","doi":"10.1158/1538-7445.am2011-lb-282","title":"Abstract LB-282: Cancer-specific motogenic signals induce collective migratory pattern in myofibroblasts via increased tight junction formation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Myofibroblast; Desmoplasia; Autocrine signalling; Cancer; Cell biology; Cancer cell; Fibroblast; Cancer research; Cell migration; Biology; Paracrine signalling; Pathology; Cell; Chemistry; Cell culture; Medicine; Fibrosis; Biochemistry; Genetics; Pancreatic cancer","score_opus":0.08766472340344603,"score_gpt":0.3721114318808597,"score_spread":0.2844467084774137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060360091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936391,0.0015059569,0.0008838082,0.000673616,0.00025140453,0.00082344236,0.000012172283,0.0000465607,0.0021639029],"genre_scores_gemma":[0.99734765,0.00082459825,0.000083649145,0.0002780072,0.00038904545,0.00045919864,0.000023740728,0.000045689747,0.00054841326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99755734,0.0002496154,0.0004002214,0.00041751025,0.00077363255,0.00060169474],"domain_scores_gemma":[0.99877983,0.00015861393,0.00011129006,0.0002837277,0.00036035627,0.00030619054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013154788,0.00018131992,0.00031568273,0.00064114487,0.00018614552,0.000037849873,0.00018838387,0.00015828374,0.0014971589],"category_scores_gemma":[0.00015028648,0.00016268021,0.00007971202,0.0008868321,0.00018706813,0.0002539757,0.00006155588,0.001323263,0.00007103021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012396576,0.00040201968,0.115506545,0.00048454208,0.00012941136,0.00019402866,0.0068794945,0.0000738047,0.65589225,0.00001442513,0.01713884,0.20204496],"study_design_scores_gemma":[0.004254549,0.0004456232,0.8061961,0.0015002973,0.000035778565,0.000037867307,0.0008256435,0.005154046,0.1747212,0.0003923014,0.006038697,0.00039792657],"about_ca_topic_score_codex":0.020536475,"about_ca_topic_score_gemma":0.0012412018,"teacher_disagreement_score":0.6906895,"about_ca_system_score_codex":0.0014144512,"about_ca_system_score_gemma":0.0007173908,"threshold_uncertainty_score":0.99941564},"labels":[],"label_agreement":null},{"id":"W2060384221","doi":"10.1158/1538-7445.tim2013-a58","title":"Abstract A58: Loss of Par3 promotes metastasis of ErbB2 transformed mammary epithelial cells by inhibiting E-cadherin adhesion junction maturation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Metastasis; Cadherin; Downregulation and upregulation; Cancer research; Cell biology; Cancer; Cell; Cell junction; Cell adhesion; Biology; Biochemistry","score_opus":0.031514731807030384,"score_gpt":0.31435946008012683,"score_spread":0.2828447282730964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060384221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971793,0.0012499305,0.00038781113,0.00023390555,0.0001225897,0.00045613624,0.00004416921,0.00000799425,0.00031812943],"genre_scores_gemma":[0.99709797,0.0014378695,0.00037348166,0.00001514416,0.00012430018,0.00019710971,0.000114788505,0.000021953394,0.0006173913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985552,0.00008847508,0.0003509773,0.00029036173,0.0004112837,0.0003037009],"domain_scores_gemma":[0.9991908,0.000025958514,0.00012157536,0.00016653498,0.00042794915,0.00006716899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006071757,0.00012828357,0.00017512588,0.000079736674,0.000075675365,0.000027305849,0.00019995357,0.00015620737,0.00029151057],"category_scores_gemma":[0.00003932001,0.00011271582,0.000077322904,0.00020214602,0.00014237313,0.00002563666,0.000058083846,0.00017224773,0.000011561689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018134795,0.000047425452,0.00017966234,0.000222279,0.000055399814,5.4351176e-7,0.00012879662,0.000014402455,0.9789857,0.000006992372,0.0052658115,0.0149115855],"study_design_scores_gemma":[0.0004135391,0.00015969202,0.001050612,0.00008519739,0.000008595223,8.4113645e-7,0.000100646146,0.000014007953,0.99554265,0.000102127065,0.0023997917,0.00012229911],"about_ca_topic_score_codex":0.00043376212,"about_ca_topic_score_gemma":0.000021898913,"teacher_disagreement_score":0.016556898,"about_ca_system_score_codex":0.0000455196,"about_ca_system_score_gemma":0.00022626032,"threshold_uncertainty_score":0.45964175},"labels":[],"label_agreement":null},{"id":"W2060808619","doi":"10.1158/1538-7445.am2013-539","title":"Abstract 539: Characterization of the functional roles of RET isoforms in breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University","funders":"","keywords":"Biology; Proto-Oncogene Proteins c-ret; Glial cell line-derived neurotrophic factor; Carcinogenesis; Receptor tyrosine kinase; Cancer research; Gene isoform; Multiple endocrine neoplasia type 2; Breast cancer; Cancer; Germline mutation; Neurotrophic factors; Receptor; Gene; Genetics; Mutation","score_opus":0.03393541599525113,"score_gpt":0.32980024337525726,"score_spread":0.29586482738000613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060808619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976155,0.00037290584,0.000018272169,0.0012691804,0.00007463663,0.0002153461,0.00013452806,0.0000012881395,0.00029834732],"genre_scores_gemma":[0.99771017,0.0011518778,0.0000035036435,0.00003663994,0.00012594141,0.00026686265,0.000037095724,0.000008748863,0.0006591675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925715,0.000036716414,0.00017200572,0.0001529675,0.00022322829,0.00015790985],"domain_scores_gemma":[0.9992807,0.000006487277,0.00007461826,0.0002540614,0.00035602122,0.000028113966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020429681,0.000053499785,0.00007575906,0.000049730315,0.000048132566,0.000010030797,0.00018927552,0.00006957516,0.00066539116],"category_scores_gemma":[0.000013472503,0.000037361246,0.00003827472,0.0002204866,0.00016085885,0.000009112613,0.00006349309,0.00011178005,0.0000034276393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004603293,0.00003406432,0.037408162,0.00003097176,0.000011919656,3.1278752e-8,0.000033441476,0.00007891426,0.952738,0.00006070722,0.0010288768,0.008528884],"study_design_scores_gemma":[0.00013922686,0.000011630404,0.6954043,0.000038144248,0.0000011899045,4.5875092e-7,0.000046371195,0.000021757176,0.30283535,0.000042104206,0.0014259294,0.00003353039],"about_ca_topic_score_codex":0.0011752722,"about_ca_topic_score_gemma":0.00035474566,"teacher_disagreement_score":0.6579961,"about_ca_system_score_codex":0.000044673678,"about_ca_system_score_gemma":0.00029159416,"threshold_uncertainty_score":0.7285567},"labels":[],"label_agreement":null},{"id":"W2060817903","doi":"10.1158/0008-5472.can-08-3879","title":"Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute; National Institutes of Health","keywords":"Tissue microarray; Hazard ratio; Oncology; Medicine; Pancreatic cancer; Internal medicine; Proportional hazards model; Population; Cancer; MUC1; Adenocarcinoma; Pathology; Confidence interval","score_opus":0.07765255560254787,"score_gpt":0.4462511567353189,"score_spread":0.36859860113277104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060817903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841343,0.0018059553,0.000015683125,0.011896237,0.000021602074,0.0013797763,0.00010493358,0.00004221645,0.0005992655],"genre_scores_gemma":[0.9970627,0.0005064145,0.0005218246,0.00015658893,0.00018054064,0.0004677108,0.00014479384,0.000020863772,0.0009386075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747705,0.0003859035,0.00035829516,0.0004122024,0.0006464771,0.00072007254],"domain_scores_gemma":[0.9982665,0.0006838862,0.000063426516,0.00019868145,0.0005089026,0.00027857695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011956353,0.0001454296,0.0005717298,0.00060986035,0.00022358327,0.00004130328,0.00012069256,0.00020667317,0.00037013646],"category_scores_gemma":[0.00078019203,0.00013035623,0.000033365835,0.0018229149,0.0001481104,0.00006911993,0.000025077974,0.0005688156,0.000013153403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018829093,0.000123682,0.97295034,0.00007481331,0.000118867574,0.0000219293,0.00022010814,0.0000020612715,0.01333555,0.000017254932,0.0014142974,0.011532786],"study_design_scores_gemma":[0.001782709,0.00047252985,0.99321634,0.0002995878,0.00009084735,0.0000019272766,0.0000378764,0.0002173192,0.0032481004,0.00015066235,0.00036041226,0.000121672914],"about_ca_topic_score_codex":0.013785952,"about_ca_topic_score_gemma":0.0018655099,"teacher_disagreement_score":0.020265996,"about_ca_system_score_codex":0.0011196672,"about_ca_system_score_gemma":0.0014499655,"threshold_uncertainty_score":0.99278134},"labels":[],"label_agreement":null},{"id":"W2060868558","doi":"10.1158/1538-7445.am2014-4971","title":"Abstract 4971: Splicing factor kinase regulates metastatic dissemination of human prostate cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Calgary; University of Alberta","funders":"","keywords":"Metastasis; Prostate cancer; Cancer research; Cancer; Biology; Cancer cell; Pathology; Medicine; Genetics","score_opus":0.04245941757315462,"score_gpt":0.41942687387841865,"score_spread":0.376967456305264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060868558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977058,0.0012177888,0.000029570718,0.00020914494,0.000040446113,0.0003509638,0.000057685153,0.000008033594,0.00038053328],"genre_scores_gemma":[0.9946942,0.0005389997,0.000048575657,0.000015531585,0.00016511216,0.000172801,0.000049610262,0.000031602187,0.0042835902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982048,0.00014438978,0.00024298417,0.00036824596,0.00051880785,0.0005207709],"domain_scores_gemma":[0.99884486,0.000088380744,0.00008221194,0.00037779508,0.00044631524,0.00016043612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085756433,0.00012812515,0.00018270298,0.00015052818,0.00019304297,0.000047836944,0.00028063075,0.0000674584,0.00023078939],"category_scores_gemma":[0.00035606604,0.00011069131,0.00006651298,0.00023132838,0.0002026695,0.000011152719,0.00012944352,0.00023293158,0.000005897539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085729764,0.00003882752,0.0037525047,0.00021828886,0.000043187498,0.000002034961,0.00012570008,0.00006175598,0.9758247,0.000077102006,0.0014368246,0.018333338],"study_design_scores_gemma":[0.00028536812,0.00023989305,0.024648858,0.00022230769,0.00000560731,6.074751e-7,0.00012529832,0.000114015165,0.9727768,0.000099781944,0.0013551118,0.00012637381],"about_ca_topic_score_codex":0.0016475527,"about_ca_topic_score_gemma":0.0007195283,"teacher_disagreement_score":0.020896355,"about_ca_system_score_codex":0.00007056496,"about_ca_system_score_gemma":0.00015696716,"threshold_uncertainty_score":0.45138606},"labels":[],"label_agreement":null},{"id":"W2060893345","doi":"10.1158/1538-7445.am2014-2207","title":"Abstract 2207: An analysis of circulating sex steroid hormones in relation to Barrett's esophagus","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Testosterone (patch); Internal medicine; Odds ratio; Gastroenterology; Hormone; Population; Sex hormone-binding globulin; Esophagus; Body mass index; Quartile; Barrett's esophagus; Endocrinology; Confidence interval; Cancer; Androgen; Adenocarcinoma","score_opus":0.07975609935364085,"score_gpt":0.4369834556512083,"score_spread":0.3572273562975674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060893345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921951,0.005826778,0.000069289075,0.0005707781,0.000026757667,0.00060997356,0.000020316309,0.000021116955,0.00065987423],"genre_scores_gemma":[0.99909014,0.00008687832,0.00014504591,0.00005595838,0.0001370628,0.00019455611,0.00005283566,0.000024372805,0.0002131261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972766,0.00022830474,0.0003598513,0.00045396326,0.0011205162,0.00056077994],"domain_scores_gemma":[0.99840873,0.00023562166,0.000054947257,0.0005308601,0.00033769463,0.00043211997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017583079,0.00012888263,0.0004419834,0.001320753,0.000091937414,0.000033631124,0.00016941938,0.00008708461,0.00042795975],"category_scores_gemma":[0.00029793318,0.0001131035,0.00010224053,0.0021567163,0.00008876558,0.0001454378,0.00006854849,0.00042678742,0.000025697387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005515961,0.00022372784,0.94502735,0.0001567924,0.0003665444,0.00009798472,0.001302607,0.0033811314,0.010066894,0.00013467787,0.000077642806,0.038613074],"study_design_scores_gemma":[0.001034823,0.00065575185,0.98380584,0.0001062619,0.000088548324,0.0000014294475,0.00024908996,0.0035987415,0.010256621,0.000094974646,0.00002472375,0.00008320447],"about_ca_topic_score_codex":0.005257517,"about_ca_topic_score_gemma":0.0016393707,"teacher_disagreement_score":0.038778502,"about_ca_system_score_codex":0.00067162624,"about_ca_system_score_gemma":0.00026672904,"threshold_uncertainty_score":0.7947829},"labels":[],"label_agreement":null},{"id":"W2061019805","doi":"10.1158/1538-7445.am2013-314","title":"Abstract 314: Effect of dietary carbohydrates and exercise on prostate cancer progression in LNCaP xenograft model.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"LNCaP; Prostate cancer; Endocrinology; Medicine; Internal medicine; Carbohydrate; Insulin; Cancer; Prostate; Diabetes mellitus; Physical exercise","score_opus":0.024570079638287164,"score_gpt":0.3700537675453618,"score_spread":0.3454836879070746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061019805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609131,0.037338473,4.7739144e-7,0.00018530515,0.00018219597,0.0010633883,0.000042996053,0.0000068793897,0.0002671794],"genre_scores_gemma":[0.96717495,0.030432664,0.000026927282,0.00002578532,0.00028317023,0.001541775,0.000025785668,0.00003149408,0.00045742278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998441,0.00009384698,0.00020787159,0.00044459914,0.00033132182,0.00048137162],"domain_scores_gemma":[0.99928343,0.000030240613,0.000056402725,0.00030960477,0.0001749351,0.00014535812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044903875,0.00017678828,0.00027010197,0.00015178918,0.000071216935,0.000032911183,0.00017719653,0.0001470766,0.0000473443],"category_scores_gemma":[0.000039588143,0.00013657832,0.000055853998,0.00020205275,0.00023093905,0.000012935244,0.00013637677,0.00028404157,0.000004374713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006371558,0.00005948607,0.004540062,0.00030037246,0.000022391341,0.0000014607126,0.0001934469,0.00071067363,0.8917687,0.0000021709748,0.0026790185,0.09908508],"study_design_scores_gemma":[0.0015382282,0.00062869006,0.027873402,0.0006389059,0.00001815088,8.45614e-7,0.000059631464,0.00065492815,0.9644152,0.00009707879,0.003811269,0.0002636815],"about_ca_topic_score_codex":0.0028466133,"about_ca_topic_score_gemma":0.00042933444,"teacher_disagreement_score":0.098821394,"about_ca_system_score_codex":0.000039072253,"about_ca_system_score_gemma":0.00020848397,"threshold_uncertainty_score":0.5569502},"labels":[],"label_agreement":null},{"id":"W2061108069","doi":"10.1158/1538-7445.am2012-2463","title":"Abstract 2463: Protease nexin 1 modulates prostate adenocarcinoma by regulating the Hedgehog pathway in humans and mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Cancer research; Hedgehog signaling pathway; Tramp; Biology; Cancer; Hedgehog; MMP9; GLI1; Internal medicine; Endocrinology; Medicine; Signal transduction; Cell biology; Downregulation and upregulation; Genetics","score_opus":0.06198872007892443,"score_gpt":0.35313342914110735,"score_spread":0.2911447090621829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061108069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706867,0.027638799,0.0000090813355,0.0005617292,0.000054779397,0.0007021565,0.00004563358,0.000009965457,0.00029117256],"genre_scores_gemma":[0.99799716,0.0002705973,0.000041470896,0.00007329556,0.0003103038,0.00044244752,0.000025438185,0.00003512223,0.0008041614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818486,0.00021320474,0.00021866107,0.00038398366,0.000276836,0.00072245754],"domain_scores_gemma":[0.99928904,0.00006623896,0.00005256021,0.00032749813,0.00013273966,0.00013190575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014220637,0.0001618077,0.00014467286,0.000063164596,0.00030560288,0.000055339242,0.00023019874,0.000109765606,0.000017983552],"category_scores_gemma":[0.00023893296,0.0001221358,0.000035605983,0.00018416239,0.0003295566,0.00001244458,0.00026728323,0.0003569115,0.00000776937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007581862,0.00004544226,0.080364674,0.00008367136,0.000025035804,0.0000025699826,0.0014215305,0.000024436184,0.9139017,0.00002426461,0.0018383771,0.002192497],"study_design_scores_gemma":[0.00062749645,0.00013600141,0.12860635,0.00011638894,0.000004632822,0.0000037842249,0.0012468026,0.00003246039,0.8556398,0.00010851583,0.013204012,0.00027375048],"about_ca_topic_score_codex":0.00050112983,"about_ca_topic_score_gemma":0.000112376714,"teacher_disagreement_score":0.05826187,"about_ca_system_score_codex":0.000059714468,"about_ca_system_score_gemma":0.00012124779,"threshold_uncertainty_score":0.49805534},"labels":[],"label_agreement":null},{"id":"W2061154379","doi":"10.1158/1538-7445.am2014-1395","title":"Abstract 1395: Identification of genes and pathways related to lymphovascular invasion in axillary-node negative breast cancer: A bioinformatic analysis of gene expression data","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphovascular invasion; Breast cancer; Biology; Cancer; Cancer research; Medicine; Oncology; Internal medicine; Metastasis","score_opus":0.045531413262690855,"score_gpt":0.3486444919230855,"score_spread":0.30311307866039466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061154379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952116,0.0033367346,0.00013846699,0.00018679586,0.00003240435,0.00029676929,0.00076198677,0.000004267128,0.000030992418],"genre_scores_gemma":[0.994012,0.005240122,0.00024346607,0.000016737717,0.000024498071,0.00012450373,0.00031558322,0.000014085764,0.000009034474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983462,0.00013361855,0.0004477987,0.00045252097,0.00037797555,0.00024188343],"domain_scores_gemma":[0.9985335,0.00005738085,0.00017333821,0.00082724204,0.0003294679,0.00007908002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008943923,0.00013266796,0.00032382953,0.00039475676,0.00007853708,0.000015726002,0.00035627116,0.00010236379,0.000021851009],"category_scores_gemma":[0.00014142634,0.000113993825,0.0000581991,0.00093771465,0.00016499564,0.000023304421,0.0004234726,0.000076289776,0.0000014596676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021809715,0.00006641432,0.057221927,0.00014435052,0.000536322,7.996221e-7,0.00069540495,0.0016211914,0.918662,0.0000072213084,0.000073758936,0.02075252],"study_design_scores_gemma":[0.0006429717,0.00003267889,0.4211266,0.00013753575,0.000109208064,0.0000015765933,0.00033685393,0.000725159,0.57670826,0.000027324291,0.000050162726,0.00010165044],"about_ca_topic_score_codex":0.0041830805,"about_ca_topic_score_gemma":0.0012035089,"teacher_disagreement_score":0.36390468,"about_ca_system_score_codex":0.00009471789,"about_ca_system_score_gemma":0.00016213939,"threshold_uncertainty_score":0.63235945},"labels":[],"label_agreement":null},{"id":"W2061204768","doi":"10.1158/0008-5472.sabcs12-es8-2","title":"Abstract ES8-2: Breast Cancer Stroma: A Predictor of Clinical Outcome and Tumour Heterogeneity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Stroma; Stromal cell; Cancer; Tumor microenvironment; Oncology; Tumour heterogeneity; Biology; Genetic heterogeneity; Pathology; Medicine; Internal medicine; Phenotype; Gene; Cancer research; Immunohistochemistry; Genetics","score_opus":0.11652767379658639,"score_gpt":0.4648595827713864,"score_spread":0.3483319089748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061204768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880172,0.010139202,0.00001118664,0.00024731067,0.00037405305,0.00027276468,0.00077217503,0.000004773666,0.00016134161],"genre_scores_gemma":[0.992345,0.005921987,0.000049254508,0.00009677552,0.0013319862,0.00011620038,0.000019281104,0.000026270032,0.00009328637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983743,0.000094785835,0.0004303671,0.00032213028,0.00028254642,0.00049590174],"domain_scores_gemma":[0.99886775,0.00010562155,0.000110480185,0.0003343608,0.000255156,0.00032661564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011159391,0.00012873745,0.00029440224,0.000050919873,0.00007419653,0.000022660797,0.00022048649,0.00016507287,0.00009885107],"category_scores_gemma":[0.0002565982,0.000114630944,0.000106721505,0.0000912854,0.00029102582,0.000007304852,0.0002826009,0.00026746545,0.000004684303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023077022,0.0001380017,0.80165964,0.00041002547,0.00009564274,0.0000015700792,0.0000269525,0.000008778426,0.19379646,0.000044965178,0.0021853545,0.0014018115],"study_design_scores_gemma":[0.00076750515,0.00012716242,0.95602745,0.000096451375,0.000027719194,0.0000070891265,0.000040122042,0.0000068166096,0.039209306,0.000012800595,0.003532082,0.000145519],"about_ca_topic_score_codex":0.0006839313,"about_ca_topic_score_gemma":0.00039531608,"teacher_disagreement_score":0.15458715,"about_ca_system_score_codex":0.000044095057,"about_ca_system_score_gemma":0.00030943053,"threshold_uncertainty_score":0.46745142},"labels":[],"label_agreement":null},{"id":"W2061222476","doi":"10.1158/0008-5472.can-08-0265","title":"Interplay between the Nuclear Receptor Pregnane X Receptor and the Uptake Transporter Organic Anion Transporter Polypeptide 1A2 Selectively Enhances Estrogen Effects in Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Institute of General Medical Sciences; U.S. Public Health Service; Deutsche Forschungsgemeinschaft","keywords":"Pregnane X receptor; Organic anion-transporting polypeptide; Nuclear receptor; Estrogen receptor; Transporter; Biology; Chromatin immunoprecipitation; Breast cancer; Solute carrier family; Multidrug resistance-associated protein 2; Organic anion transporter 1; Cancer research; Pharmacology; Transcription factor; Gene expression; Cancer; ATP-binding cassette transporter; Promoter; Biochemistry; Gene; Genetics","score_opus":0.0210427082642996,"score_gpt":0.3178692647205235,"score_spread":0.2968265564562239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061222476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984408,0.0045354897,0.0000710705,0.008434976,0.00023318682,0.001906873,0.00014011134,0.000064441156,0.00020584042],"genre_scores_gemma":[0.98874533,0.008239615,0.00009500953,0.0003120738,0.0005753835,0.0004951246,0.000034933564,0.00010148655,0.0014010655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99666977,0.00029843257,0.0005224565,0.00068912725,0.0009193043,0.0009009076],"domain_scores_gemma":[0.99873453,0.00023534195,0.00009387891,0.00043271188,0.00024221673,0.00026130275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001136646,0.0003500914,0.0006742417,0.00020331246,0.0004890303,0.000039389226,0.00043810386,0.000216212,0.0014967766],"category_scores_gemma":[0.000018886023,0.00019502128,0.00017479766,0.00095166307,0.0010854626,0.00018293233,0.000026934116,0.0012667776,0.000037279533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015306941,0.00047528444,0.26044026,0.0013673058,0.0011630418,0.0002761756,0.037807643,0.000005925402,0.63932645,0.00068703,0.00517166,0.037972264],"study_design_scores_gemma":[0.01116212,0.00057738257,0.84779394,0.0032693758,0.00033832542,0.00010947067,0.0015146085,0.00002579443,0.11303465,0.00019149961,0.021328822,0.0006540086],"about_ca_topic_score_codex":0.0012878621,"about_ca_topic_score_gemma":0.0012598953,"teacher_disagreement_score":0.5873537,"about_ca_system_score_codex":0.0003144001,"about_ca_system_score_gemma":0.00050808274,"threshold_uncertainty_score":0.999416},"labels":[],"label_agreement":null},{"id":"W2061278069","doi":"10.1158/1538-7445.am2011-290","title":"Abstract 290: Use of serum and tissue biomarker analysis embedded in a phase II clinical trial of cytarabine in castration-refractory prostate cancer to investigate prostate cancer biology","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"TMPRSS2; Prostate cancer; Docetaxel; Medicine; PCA3; Oncology; Internal medicine; Cytarabine; Prostate; Cancer; Mitoxantrone; Cancer research; Urology; Chemotherapy","score_opus":0.3606366684749604,"score_gpt":0.5433848099392202,"score_spread":0.18274814146425983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061278069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069816,0.0031616588,0.0000010554677,0.0013321843,0.00015668992,0.0037250994,0.00082137017,0.000014267508,0.00008954423],"genre_scores_gemma":[0.98440486,0.012646153,0.00016484426,0.000063167536,0.00009382509,0.0015418611,0.000067162495,0.000039623286,0.0009784958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578285,0.00050786324,0.0013550043,0.0008366345,0.00062921585,0.0008884166],"domain_scores_gemma":[0.99759823,0.00031767844,0.00027565638,0.0005288548,0.0007605416,0.000519044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023323486,0.00028657753,0.0011612178,0.001783139,0.00008248408,0.0000220404,0.00020933348,0.00025436183,0.0008537368],"category_scores_gemma":[0.00044753196,0.0002256433,0.00013181721,0.0029945297,0.0010112089,0.00026312078,0.0002091305,0.00078051956,0.0000032322746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10962593,0.0026158511,0.6108987,0.0005276842,0.001086715,0.00018626687,0.006825696,0.00006464774,0.15861882,0.000016747908,0.00034734927,0.10918565],"study_design_scores_gemma":[0.10315679,0.009165644,0.8007829,0.0010048194,0.00035346337,0.0000020930952,0.00050054135,0.00030193987,0.08233566,0.00013707692,0.0018456028,0.00041343283],"about_ca_topic_score_codex":0.04814374,"about_ca_topic_score_gemma":0.023099959,"teacher_disagreement_score":0.18988429,"about_ca_system_score_codex":0.00045521694,"about_ca_system_score_gemma":0.0024868345,"threshold_uncertainty_score":0.99472594},"labels":[],"label_agreement":null},{"id":"W2061307034","doi":"10.1158/0008-5472.can-11-1874","title":"The <i>Pax-5</i> Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer Disease","year":2011,"lang":"en","type":"review","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Université de Moncton","funders":"Canadian Institutes of Health Research","keywords":"Biology; Transcription factor; PAX5; Cancer research; Oncogene; B cell; Carcinogenesis; Cancer; Gene; Cell growth; Regulation of gene expression; Lymphopoiesis; Genetics; Cell cycle; Haematopoiesis; Stem cell; Antibody","score_opus":0.09306024624241326,"score_gpt":0.4063794572088625,"score_spread":0.3133192109664492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061307034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013377729,0.99496317,0.00001377188,0.00026987345,0.00019279457,0.0026151848,0.00028136116,0.000022954257,0.0003031396],"genre_scores_gemma":[0.0005537156,0.9867285,0.000028251847,0.00002453075,0.0005783365,0.0022187692,0.000064300475,0.0001260281,0.00967759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954984,0.0005701119,0.00068871526,0.00074554497,0.0015709881,0.0009262114],"domain_scores_gemma":[0.99628997,0.00071165105,0.00027705435,0.0011429584,0.00082833547,0.0007500589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001142011,0.0003965739,0.0012444136,0.0003751574,0.0003300133,0.00006958142,0.0006030826,0.00029866642,0.0002603649],"category_scores_gemma":[0.00033929053,0.00023117839,0.00034629938,0.0007607241,0.0009138001,0.000058193593,0.0006075351,0.0011509117,0.000035660207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056466623,0.00016982667,0.000086552354,0.0427607,0.00051019684,0.000058215788,0.00013435548,3.4796406e-7,0.00022815457,0.00023785292,0.01254362,0.9427055],"study_design_scores_gemma":[0.0012540214,0.00013216093,0.00020322297,0.011232225,0.0009450125,0.000015075955,0.00001988526,0.000055775257,0.00036314523,0.00007670208,0.98547024,0.00023253095],"about_ca_topic_score_codex":0.0008927181,"about_ca_topic_score_gemma":0.000048779817,"teacher_disagreement_score":0.9729266,"about_ca_system_score_codex":0.001859193,"about_ca_system_score_gemma":0.008464729,"threshold_uncertainty_score":0.9971564},"labels":[],"label_agreement":null},{"id":"W2061379637","doi":"10.1158/0008-5472.sabcs-09-2137","title":"Delineating the Secretome of Eleven Breast Cell Lines in the Quest for Novel Breast Cancer Biomarkers.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Cancer; Cancer research; Chemistry; Tandem mass spectrometry; Oncology; Medicine; Internal medicine; Mass spectrometry; Chromatography","score_opus":0.05992824951102188,"score_gpt":0.4167159344403139,"score_spread":0.356787684929292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061379637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473927,0.0021405537,0.010436556,0.032008547,0.00003108735,0.0018961027,0.0029581925,0.00008406705,0.003052167],"genre_scores_gemma":[0.9938613,0.0005396211,0.0029371567,0.00015259442,0.00037590327,0.001752434,0.00002645612,0.00002202959,0.00033246455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877346,0.00002727332,0.000267991,0.00026341106,0.0002904102,0.00037746542],"domain_scores_gemma":[0.9987641,0.00026952755,0.000098803015,0.00044902085,0.00037748856,0.00004107818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007461054,0.00011370594,0.0001375015,0.000055657507,0.00020852953,0.000035528108,0.00068854284,0.00008571614,0.00009905995],"category_scores_gemma":[0.000035016437,0.00007152623,0.000063220104,0.0004627446,0.00014241181,0.000057524612,0.000061926345,0.00038961016,9.0339665e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014606438,0.00013109251,0.0010340324,0.00014250669,0.000013468148,5.637778e-7,0.00034409025,0.00017053598,0.9664112,0.0012774032,0.0014041986,0.028924853],"study_design_scores_gemma":[0.0015785869,0.00007048145,0.0040343893,0.0006491757,0.00003133799,0.000045068875,0.0020449464,0.007324842,0.9574614,0.0077931327,0.018511243,0.00045536997],"about_ca_topic_score_codex":0.0015542655,"about_ca_topic_score_gemma":0.000266597,"teacher_disagreement_score":0.046468616,"about_ca_system_score_codex":0.00014741144,"about_ca_system_score_gemma":0.0002030311,"threshold_uncertainty_score":0.29167548},"labels":[],"label_agreement":null},{"id":"W2061398775","doi":"10.1158/1538-7445.am2014-1224","title":"Abstract 1224: A patient derived xenograft (PDX) platform for development of next generation KIT kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors (GIST)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"GiST; Imatinib; Medicine; Dasatinib; Stromal tumor; Imatinib mesylate; Cancer; Oncology; Cancer research; Drug resistance; Internal medicine; Stromal cell; Biology","score_opus":0.14295138676773061,"score_gpt":0.38339462369096,"score_spread":0.2404432369232294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061398775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967468,0.00020060778,0.0004118631,0.00032797013,0.000040760795,0.0019047371,0.000048574453,0.000029207546,0.00028949592],"genre_scores_gemma":[0.97148925,0.000008636755,0.026981814,0.000018606403,0.00017743222,0.001064348,0.0001605044,0.000047454723,0.00005194098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99614114,0.00009549913,0.00085068174,0.0005444084,0.0012560583,0.001112221],"domain_scores_gemma":[0.9978272,0.00032056926,0.00018405898,0.00035959855,0.0007954068,0.0005131728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012301543,0.0002822101,0.000475123,0.0005533167,0.00023320141,0.000069929476,0.00019227657,0.000045599787,0.0001296674],"category_scores_gemma":[0.0010400203,0.00023811677,0.00012887461,0.00044480275,0.00025709058,0.00015093811,0.00012795885,0.00052433,0.000019169585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028835018,0.0008351839,0.011406052,0.0007152127,0.0000425347,0.00020304309,0.0005563516,0.00007864215,0.94741976,0.00014549516,0.0004177031,0.03529652],"study_design_scores_gemma":[0.007601682,0.008813288,0.107541464,0.0037233522,0.000029598188,0.00016372622,0.0013722894,0.0026915427,0.8663439,0.00014570072,0.0011906723,0.00038276426],"about_ca_topic_score_codex":0.00074223307,"about_ca_topic_score_gemma":0.00087484025,"teacher_disagreement_score":0.09613541,"about_ca_system_score_codex":0.0010334511,"about_ca_system_score_gemma":0.0014918941,"threshold_uncertainty_score":0.97101206},"labels":[],"label_agreement":null},{"id":"W2061539831","doi":"10.1158/0008-5472.can-03-2861","title":"Association of Homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Genotype; Genotyping; Breast cancer; Glutathione S-transferase; Allele; Confidence interval; Biology; Internal medicine; Cancer; Wild type; Oncology; Glutathione; Case-control study; Genetics; Molecular biology; Medicine; Gene; Mutant; Enzyme","score_opus":0.014632848413714209,"score_gpt":0.30455652518184856,"score_spread":0.28992367676813435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061539831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346995,0.0037705617,0.00047230936,0.0009929107,0.00010956341,0.00034796906,0.0007102675,0.000015810238,0.00011065639],"genre_scores_gemma":[0.9883288,0.010504584,0.00015935578,0.000120483994,0.00031058604,0.00009620938,0.000094844036,0.000046577657,0.00033853197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807924,0.00016840809,0.0002270425,0.0004138465,0.00058857066,0.0005228902],"domain_scores_gemma":[0.9986257,0.00003410338,0.00007110723,0.00035047223,0.0007374391,0.00018117933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055088394,0.00018214603,0.00022277235,0.000090054404,0.00020674262,0.000027779042,0.00023136014,0.00020304922,0.00019808239],"category_scores_gemma":[0.000038485745,0.00015572144,0.00009971225,0.000500214,0.0001596392,0.000010008268,0.000036389836,0.0003705089,0.000012823511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002486061,0.00026093816,0.0338571,0.00009137802,0.00052593654,0.000026604137,0.000371358,0.0028290101,0.95334363,0.000079800426,0.0011245951,0.0050036],"study_design_scores_gemma":[0.0076032905,0.0019256985,0.07305182,0.00027684332,0.0002722691,0.00006881681,0.00018314214,0.000026026853,0.90670425,0.00024127342,0.0089768395,0.00066975824],"about_ca_topic_score_codex":0.015708407,"about_ca_topic_score_gemma":0.005241228,"teacher_disagreement_score":0.046639394,"about_ca_system_score_codex":0.0002068518,"about_ca_system_score_gemma":0.0009859693,"threshold_uncertainty_score":0.9908461},"labels":[],"label_agreement":null},{"id":"W2061563398","doi":"10.1158/0008-5472.can-08-2893","title":"Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; U.S. Public Health Service; Universität Hamburg; Universitat Pompeu Fabra","keywords":"Histone deacetylase; Histone deacetylase 2; HDAC1; Cancer research; Azoxymethane; Snail; Colorectal cancer; Biology; Histone; Chemistry; Cancer; Biochemistry; Genetics","score_opus":0.045492192536351804,"score_gpt":0.38897439182148624,"score_spread":0.34348219928513446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061563398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367524,0.015150879,0.0000048642382,0.00017808529,0.0000761442,0.0004874354,0.00008654424,0.000009473079,0.00033131655],"genre_scores_gemma":[0.9902628,0.007525983,0.000052669744,0.000024336012,0.00018071075,0.00041185672,0.000046151854,0.000042073825,0.0014534184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973988,0.0003355313,0.00034134393,0.00066032936,0.0006377241,0.0006262653],"domain_scores_gemma":[0.9989252,0.00006509798,0.00007347537,0.0003811411,0.00030237416,0.0002526821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080335635,0.00017950857,0.00028273053,0.00032690988,0.00021134586,0.000012441965,0.00027887555,0.00022926762,0.00013660234],"category_scores_gemma":[0.00034742375,0.00017222551,0.00006513906,0.0005162166,0.0010093356,0.000012501408,0.00037358596,0.00046222747,0.0000071930776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069696305,0.00012835501,0.020933982,0.000105627434,0.000024787842,0.000079563295,0.00054568186,0.000103775754,0.96798104,0.000006789339,0.00867106,0.00072237954],"study_design_scores_gemma":[0.0012855963,0.00028498934,0.004630083,0.0001271033,0.0000034509826,0.000027211354,0.00009879049,0.00012946434,0.98855335,0.000014012779,0.004662637,0.00018333778],"about_ca_topic_score_codex":0.0047010607,"about_ca_topic_score_gemma":0.0046031903,"teacher_disagreement_score":0.02057229,"about_ca_system_score_codex":0.00025919938,"about_ca_system_score_gemma":0.00081979367,"threshold_uncertainty_score":0.7106629},"labels":[],"label_agreement":null},{"id":"W2061631365","doi":"10.1158/1538-7445.am2012-4989","title":"Abstract 4989: Selective inhibitors of the inositol-requiring enzyme 1 kinase domain","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Autophosphorylation; Unfolded protein response; Endoplasmic reticulum; Kinase; Phosphorylation; Protein kinase domain; Cell biology; Protein kinase A; Biology; Biochemistry; Stress granule; Chemistry; Messenger RNA; Translation (biology)","score_opus":0.02962042976811745,"score_gpt":0.3569612831673089,"score_spread":0.32734085339919144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061631365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323976,0.0036775665,0.00000843376,0.00017942532,0.00022167846,0.00019222504,0.00004022343,0.0000042309953,0.0024364658],"genre_scores_gemma":[0.9989329,0.00017579105,0.00002825848,0.00003823856,0.0005697701,0.000078219964,0.000008988019,0.000017171682,0.00015068779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987243,0.000118000935,0.00015267174,0.00020275735,0.00034428167,0.0004579795],"domain_scores_gemma":[0.9992352,0.00004125647,0.00005343504,0.00033803374,0.0001681123,0.00016394275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037787936,0.00009887031,0.00009835481,0.000045442233,0.0001432953,0.000016508067,0.00025220445,0.00009176443,0.00004598497],"category_scores_gemma":[0.00016988597,0.000070982926,0.00009394972,0.00020615119,0.00026073572,0.0000073661513,0.00022846516,0.00021341472,0.000006887667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009843986,0.000090376096,0.04416193,0.000050973573,0.000030626343,0.0000014859228,0.00022179043,0.000026247704,0.9450036,0.00024131175,0.009329439,0.0007437297],"study_design_scores_gemma":[0.0002999784,0.000029999925,0.03747703,0.00005392258,0.000005935143,0.0000016167294,0.0002517367,0.0000010109192,0.9550783,0.000099901416,0.0066105677,0.00008996803],"about_ca_topic_score_codex":0.00025209403,"about_ca_topic_score_gemma":0.000048154245,"teacher_disagreement_score":0.01007468,"about_ca_system_score_codex":0.000053743217,"about_ca_system_score_gemma":0.0002057256,"threshold_uncertainty_score":0.28945997},"labels":[],"label_agreement":null},{"id":"W2061884616","doi":"10.1158/1538-7445.am10-1035","title":"Abstract 1035: Bcl2 is regulated by PKC and Akt and is associated with resistance to cisplatin in endometrial cancer cells.","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and Characterization of Heterocyclic Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Cisplatin; XIAP; Protein kinase B; Downregulation and upregulation; Cancer research; Apoptosis; MAPK/ERK pathway; Chemistry; Cell culture; Endometrial cancer; Kinase; Cancer; Biology; Medicine; Programmed cell death; Caspase; Internal medicine; Cell biology; Chemotherapy; Gene; Biochemistry","score_opus":0.03064073371686233,"score_gpt":0.3296041094685865,"score_spread":0.29896337575172416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061884616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951767,0.0005594134,8.1684635e-7,0.0018766223,0.00007313984,0.00016916572,0.00036162528,0.000025210611,0.00175734],"genre_scores_gemma":[0.9925915,0.0004926391,0.000020751902,0.0001464455,0.00014070785,0.00015512365,0.000018560268,0.000038464677,0.0063957903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980471,0.000036838806,0.0002853698,0.0005478058,0.0005946845,0.00048818876],"domain_scores_gemma":[0.99876165,0.00040673214,0.00009666817,0.00031089713,0.00019865771,0.00022538059],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004537041,0.0001804348,0.00029426967,0.0001972146,0.0001673907,0.00017741123,0.00021958147,0.00019488821,0.0043697194],"category_scores_gemma":[0.00018688577,0.00016397174,0.00002422628,0.0005422695,0.00016411694,0.00011182156,0.00009554252,0.0006016719,0.000005923244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000436478,0.00006344448,0.009509359,0.00006433555,0.00004400994,0.000009835231,0.00054266304,5.92038e-7,0.9725312,0.0000034846191,0.012382561,0.0044120476],"study_design_scores_gemma":[0.0019095091,0.000032045486,0.025186,0.00038998647,0.000009548491,0.0000011922949,0.000092030656,0.000028118808,0.9184325,0.000032464523,0.05359997,0.00028667835],"about_ca_topic_score_codex":0.0009974614,"about_ca_topic_score_gemma":0.0024726966,"teacher_disagreement_score":0.05409873,"about_ca_system_score_codex":0.00017151404,"about_ca_system_score_gemma":0.00013433493,"threshold_uncertainty_score":0.9965404},"labels":[],"label_agreement":null},{"id":"W2061909637","doi":"10.1158/1538-7445.am2012-4028","title":"Abstract 4028: Therapeutic relevance of two novel cancer candidate genes, <i>RASAL2</i> and <i>NENF</i>, activated by DNA hypomethylation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cancer research; Cancer; Metastasis; DNA methylation; Cancer cell; Viability assay; Molecular biology; Cell culture; Gene; Gene expression; Genetics","score_opus":0.056030292761726025,"score_gpt":0.3936116377663677,"score_spread":0.33758134500464165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061909637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91569805,0.08274985,0.0004347877,0.00018029916,0.00015053104,0.00026895475,0.00014718213,0.0000057615707,0.00036460982],"genre_scores_gemma":[0.9722554,0.026567329,0.00014199699,0.000054428394,0.00030763497,0.00011103363,0.00008597648,0.000038307684,0.00043786463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844384,0.00010246079,0.00024790646,0.00033799637,0.00036696764,0.0005008055],"domain_scores_gemma":[0.9990239,0.00008029107,0.00012419699,0.0003131008,0.00029294263,0.00016555692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079498027,0.00015755875,0.00017414651,0.00008240897,0.00012689148,0.000027069502,0.00016459507,0.00014889639,0.00007457298],"category_scores_gemma":[0.00006465102,0.00014699159,0.000041199328,0.00026872163,0.00018129761,0.000019571127,0.000096313495,0.0002084307,0.0000033095619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001162312,0.00006942156,0.0122111095,0.000044866403,0.00006629006,1.2112987e-7,0.00006824893,0.00008582237,0.9633197,0.000031700754,0.00040456196,0.02358191],"study_design_scores_gemma":[0.0006834417,0.00007224262,0.01198836,0.000025964731,0.000014027277,4.3909597e-7,0.000020412564,0.000021037458,0.9417818,0.00006750604,0.04516278,0.00016197232],"about_ca_topic_score_codex":0.0018001165,"about_ca_topic_score_gemma":0.00023857706,"teacher_disagreement_score":0.056557406,"about_ca_system_score_codex":0.00006615378,"about_ca_system_score_gemma":0.00017759897,"threshold_uncertainty_score":0.5994143},"labels":[],"label_agreement":null},{"id":"W2061916308","doi":"10.1158/1538-7445.am2012-1558","title":"Abstract 1558: Innovative biotherapy for brain tumors: Myxoma virus accelerates NK clearance of malignant gliomas","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Calgary","funders":"","keywords":"Myxoma virus; Oncolytic virus; Degranulation; Downregulation and upregulation; Biology; MHC class I; NK-92; Cancer research; Lymphokine-activated killer cell; Major histocompatibility complex; Immunology; Virus; Receptor; Immune system; Interleukin 21; CD8","score_opus":0.09512086004788038,"score_gpt":0.4046301093204646,"score_spread":0.3095092492725842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061916308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860577,0.009254654,0.00013917193,0.0009984176,0.0015680812,0.0006008235,0.000066313645,0.000036914076,0.0012779281],"genre_scores_gemma":[0.9890781,0.0003900134,0.00002665889,0.00024446117,0.00016969063,0.00023507721,0.00006627958,0.000029884357,0.00975983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985399,0.00019701853,0.000338623,0.00023174737,0.000079968595,0.0006126926],"domain_scores_gemma":[0.9985617,0.00037059092,0.00013759873,0.00022883267,0.0006744286,0.000026879747],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011159353,0.00013796093,0.000241395,0.00030811067,0.00022429603,0.00002152058,0.00021913066,0.00017561331,0.0038663584],"category_scores_gemma":[0.00014806043,0.00011663152,0.00007356003,0.00059278525,0.00029801737,0.00028830665,0.00004573007,0.00042931302,0.00032610368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016377027,0.00017041131,0.0011587192,0.00007315396,0.00011839662,4.778207e-7,0.00065619027,0.00000131279,0.91467917,0.00096761127,0.07396573,0.006571135],"study_design_scores_gemma":[0.0007499733,0.00023843069,0.014314669,0.000096812626,0.0000022630659,0.000006983188,0.0004088791,0.0000010443632,0.75625324,0.000037533755,0.2277909,0.000099230456],"about_ca_topic_score_codex":0.00061110297,"about_ca_topic_score_gemma":0.00001862387,"teacher_disagreement_score":0.1584259,"about_ca_system_score_codex":0.00012864252,"about_ca_system_score_gemma":0.00014831351,"threshold_uncertainty_score":0.99704427},"labels":[],"label_agreement":null},{"id":"W2062038960","doi":"10.1158/1538-7445.am10-lb-65","title":"Abstract LB-65: A gene expression predictor of pathological node stage of urothelial bladder cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Oncology; Lymph node; Stage (stratigraphy); Internal medicine; Pathology; Cancer; Biology","score_opus":0.08556634410160663,"score_gpt":0.4168279943365776,"score_spread":0.33126165023497095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062038960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315655,0.0012386097,0.00002616196,0.00039110973,0.00039088906,0.0008577233,0.0011167291,0.00003390453,0.0027883146],"genre_scores_gemma":[0.99424326,0.00089936785,0.0005734136,0.000086904925,0.000635764,0.00046787315,0.000018893048,0.000048347654,0.003026153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973509,0.000086726104,0.0004263939,0.00046460365,0.0011254352,0.00054596557],"domain_scores_gemma":[0.99825376,0.0001256003,0.00012832202,0.0006054963,0.00059240183,0.00029438885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052391586,0.00020024502,0.00047842343,0.00019922071,0.0000907237,0.000012743213,0.0002790073,0.00025436308,0.010516865],"category_scores_gemma":[0.00016306815,0.00014337337,0.00014873262,0.00031245314,0.00054709817,0.0000810876,0.00013247265,0.00087176077,0.000019416748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014943661,0.00044767704,0.044334594,0.00030791707,0.00010056228,0.000060501017,0.00040427575,0.000011417771,0.9472692,0.00003138678,0.0017115537,0.003826526],"study_design_scores_gemma":[0.0029874034,0.00045501144,0.114170775,0.00023207681,0.000048492206,0.0000064409537,0.000089669185,0.000012978257,0.8772732,0.00007579088,0.0045272955,0.00012083802],"about_ca_topic_score_codex":0.0024413744,"about_ca_topic_score_gemma":0.00022083762,"teacher_disagreement_score":0.06999599,"about_ca_system_score_codex":0.00011634493,"about_ca_system_score_gemma":0.0010680163,"threshold_uncertainty_score":0.9903877},"labels":[],"label_agreement":null},{"id":"W2062128435","doi":"10.1158/0008-5472.sabcs13-p5-14-01","title":"Abstract P5-14-01: Chest wall bolus in post-mastectomy radiotherapy – Is it really necessary?","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bolus (digestion); Radiation therapy; Mastectomy; Breast cancer; Hazard ratio; Surgery; Radiology; Internal medicine; Cancer","score_opus":0.07522058219777994,"score_gpt":0.41458479825015754,"score_spread":0.3393642160523776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062128435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8929971,0.009377473,0.0000013877628,0.08440294,0.000146507,0.0016705815,0.0000334363,0.000036583915,0.011334019],"genre_scores_gemma":[0.97515297,0.013606346,0.00010457958,0.003658448,0.00041573856,0.001705762,0.000027488446,0.00006614511,0.0052625146],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99730587,0.00007037105,0.0003484085,0.000573808,0.00086442137,0.00083714304],"domain_scores_gemma":[0.99827856,0.00021643328,0.00005673085,0.00058314996,0.00049954344,0.0003655969],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048429487,0.00022604114,0.00043045628,0.00035431338,0.00010636231,0.000109063585,0.0002460989,0.0001558057,0.0184526],"category_scores_gemma":[0.000062441075,0.00018035762,0.000122060206,0.00058324554,0.00015493594,0.00020734547,0.00006207058,0.0006628101,0.0005400097],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013735836,0.0017645897,0.1324455,0.000714174,0.0006152955,0.0006095802,0.004826302,0.000025642505,0.045689333,0.00010428281,0.5235838,0.28824788],"study_design_scores_gemma":[0.0059645763,0.0007177795,0.8156666,0.000615797,0.00002436157,0.000017583903,0.0004723538,0.0000642745,0.011686662,0.000082768696,0.16442603,0.0002611836],"about_ca_topic_score_codex":0.053407088,"about_ca_topic_score_gemma":0.0044487943,"teacher_disagreement_score":0.6832211,"about_ca_system_score_codex":0.001515727,"about_ca_system_score_gemma":0.00088527537,"threshold_uncertainty_score":0.98244464},"labels":[],"label_agreement":null},{"id":"W2062128863","doi":"10.1158/1538-7445.am2011-2815","title":"Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"TMPRSS2; Medicine; Prostate cancer; Biopsy; PCA3; Urology; Erg; Internal medicine; Prostate biopsy; Prostatectomy; Cancer; Oncology; Gynecology; Ophthalmology","score_opus":0.11246886914826054,"score_gpt":0.4201569551074045,"score_spread":0.30768808595914393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062128863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858861,0.0026433233,0.000013358916,0.0018953109,0.00006270382,0.004120122,0.0003682445,0.00006529009,0.004945537],"genre_scores_gemma":[0.97696567,0.007793408,0.0002308441,0.000026267287,0.00018527641,0.0050163753,0.00011864883,0.00007371734,0.009589804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695134,0.00011522556,0.00036468788,0.00067269703,0.000827244,0.0010688282],"domain_scores_gemma":[0.9980035,0.00012020802,0.0001082002,0.00050709397,0.00093686837,0.0003241625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012008022,0.0002400535,0.00035829828,0.00044407928,0.0002335533,0.00005124674,0.00023514373,0.00013501744,0.001077192],"category_scores_gemma":[0.000081473496,0.00016894985,0.00006160805,0.0009846977,0.0003120902,0.00021688938,0.000055185985,0.0008016819,0.000034882334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030791307,0.0014894269,0.7410337,0.0018551277,0.0008330847,0.0002954014,0.007392219,0.00009878193,0.109631225,0.00033554048,0.010416577,0.09582763],"study_design_scores_gemma":[0.011313741,0.0017844462,0.7401024,0.00076565566,0.00008555463,0.0000061048163,0.0013028645,0.000497332,0.23842679,0.00074191927,0.004605612,0.00036756106],"about_ca_topic_score_codex":0.011461105,"about_ca_topic_score_gemma":0.004368376,"teacher_disagreement_score":0.12879556,"about_ca_system_score_codex":0.0009013785,"about_ca_system_score_gemma":0.0017046442,"threshold_uncertainty_score":0.99983597},"labels":[],"label_agreement":null},{"id":"W2062155843","doi":"10.1158/1538-7445.cec13-pr03","title":"Abstract PR03: Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for DNA methylation maintenance","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chromatin; Biology; Epigenomics; Histone code; Histone; Histone methylation; DNA methylation; Epigenetics; Genetics; Cell biology; Effector; Epigenetics of physical exercise; Chromatin remodeling; Computational biology; DNA; Nucleosome; Gene; Gene expression","score_opus":0.07007667014875797,"score_gpt":0.38875339631153316,"score_spread":0.3186767261627752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062155843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888224,0.0056067603,0.0008829977,0.0027488226,0.000107246,0.0015587473,0.000075054784,0.0000066790676,0.00019131934],"genre_scores_gemma":[0.99411905,0.0015740163,0.00019061442,0.0000616864,0.0001885889,0.00073002087,0.00006618429,0.000025010408,0.003044819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986541,0.00011708126,0.0002521472,0.0003532031,0.0003066876,0.0003167589],"domain_scores_gemma":[0.99894035,0.000087913926,0.00012004301,0.00033736276,0.00044478066,0.000069558744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091012695,0.00011416415,0.00013369623,0.000049072172,0.00018637688,0.000026796575,0.00017367298,0.00013681747,0.0001089434],"category_scores_gemma":[0.00015487541,0.0000880389,0.000062284074,0.00012656154,0.00024623852,0.000010451247,0.00009788769,0.00016114787,0.0000040443792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111152774,0.000030923944,0.00012599761,0.000058563663,0.00007217014,8.372781e-8,0.0002547391,0.000052392243,0.9337614,0.000024689922,0.042428758,0.023079082],"study_design_scores_gemma":[0.001411525,0.00023021901,0.01664476,0.000062514366,0.000019879679,8.934912e-7,0.00023824282,0.00044038607,0.90306777,0.00032407037,0.077412695,0.00014702433],"about_ca_topic_score_codex":0.00034004622,"about_ca_topic_score_gemma":0.00007418672,"teacher_disagreement_score":0.034983933,"about_ca_system_score_codex":0.00017702563,"about_ca_system_score_gemma":0.00014043311,"threshold_uncertainty_score":0.35901222},"labels":[],"label_agreement":null},{"id":"W2062360007","doi":"10.1158/1538-7445.am2011-4512","title":"Abstract 4512: A novel orally-bioavailable salicylic acid-based small molecular Stat3 inhibitor suppress growth of human breast tumor xenografts","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amorfix (Canada)","funders":"","keywords":"STAT3; STAT protein; Survivin; Cancer research; Cyclin D1; Stromal cell; Chemistry; Cell culture; Biology; Cell; Cell biology; Signal transduction; Cell cycle; Biochemistry; Genetics","score_opus":0.11765673969617872,"score_gpt":0.3694582208739232,"score_spread":0.2518014811777445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062360007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948894,0.00091638934,0.00017199389,0.0003941159,0.00017061758,0.0009559469,0.00032191182,0.00006976584,0.0021098836],"genre_scores_gemma":[0.99759656,0.00005064093,0.00089999347,0.00033640585,0.00028894973,0.00031069564,0.000042876283,0.00010368929,0.00037018445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970905,0.00007231001,0.00044392442,0.0005823749,0.00093840016,0.0008724566],"domain_scores_gemma":[0.9976824,0.000040466075,0.00013554563,0.0007069712,0.0010058103,0.00042881738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079961325,0.00027113166,0.00051336683,0.0004642794,0.00014899022,0.000041233743,0.00040645467,0.00013279277,0.003418985],"category_scores_gemma":[0.000038093207,0.00024235819,0.00018281244,0.0007052573,0.00036094507,0.000099050914,0.00010884875,0.0006179381,0.00003818679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014495533,0.0007046566,0.0012995409,0.00062230485,0.00012299094,0.00017297923,0.00046803668,0.0000016116093,0.9921024,0.0013353064,0.0010528637,0.000667779],"study_design_scores_gemma":[0.004292438,0.0009800027,0.009261448,0.00054379285,0.00003906998,0.000021812712,0.00016158569,0.000019903035,0.98319167,0.0003234366,0.00091573055,0.00024909162],"about_ca_topic_score_codex":0.010986407,"about_ca_topic_score_gemma":0.00061459385,"teacher_disagreement_score":0.010371814,"about_ca_system_score_codex":0.0002855889,"about_ca_system_score_gemma":0.00094657356,"threshold_uncertainty_score":0.997492},"labels":[],"label_agreement":null},{"id":"W2062382244","doi":"10.1158/0008-5472.sabcs13-p3-14-11","title":"Abstract P3-14-11: Microarray data analysis and long term outcomes of NCIC-CTG MA.22: Neoadjuvant epirubicin and docetaxel with pegfilgrastim support for locally advanced breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Oncology; Epirubicin; Internal medicine; Breast cancer; Tissue microarray; Cohort; Cancer; Significance analysis of microarrays; Microarray; Gene expression; Biology; Gene","score_opus":0.04157488977611171,"score_gpt":0.40996808868242873,"score_spread":0.368393198906317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062382244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866618,0.0017124743,0.0028288753,0.0071231327,0.00006548488,0.0010932427,0.00039279895,0.000025170279,0.00009702054],"genre_scores_gemma":[0.9932962,0.0012843686,0.0031938741,0.00032370567,0.00013327166,0.0002228806,0.00018586458,0.000056211804,0.0013036082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972975,0.00005778418,0.00044650267,0.0007838067,0.0007136139,0.0007007655],"domain_scores_gemma":[0.9976708,0.00035301785,0.00016333563,0.00073393976,0.00059725955,0.00048159063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010866768,0.00025614744,0.00082492863,0.00043784085,0.00016817875,0.000092982584,0.00037578834,0.00009749106,0.0009149857],"category_scores_gemma":[0.0002462773,0.00017678998,0.000079305864,0.0005377983,0.00070487306,0.00026560994,0.00023757223,0.00062788074,0.0000029918046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052759744,0.00009989497,0.8044545,0.00072811835,0.000914441,0.000040109942,0.00017302646,0.000102530634,0.03652943,0.000007810715,0.0024706004,0.15395191],"study_design_scores_gemma":[0.0033072662,0.00021557481,0.98831487,0.00044310576,0.00054900575,0.000054591204,0.00016255048,0.0047956887,0.001276188,0.000022134169,0.0006354568,0.00022355953],"about_ca_topic_score_codex":0.0065231454,"about_ca_topic_score_gemma":0.0016799724,"teacher_disagreement_score":0.18386035,"about_ca_system_score_codex":0.00011498155,"about_ca_system_score_gemma":0.00050487556,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W2062391703","doi":"10.1158/1538-7445.am2012-2044","title":"Abstract 2044: Three-dimensional nuclear telomeric architecture defines cytopenias of myelodysplastic syndrome and its transformation to acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Telomere; Myelodysplastic syndromes; Myeloid leukemia; Medicine; Internal medicine; Oncology; Bone marrow failure; Cancer research; Bone marrow; Biology; Stem cell; Genetics; Haematopoiesis","score_opus":0.04644432822869763,"score_gpt":0.33989549144023556,"score_spread":0.2934511632115379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062391703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944797,0.0025153717,0.000031174473,0.0014017905,0.00016862091,0.0008274147,0.00007936321,0.00004720186,0.0004493405],"genre_scores_gemma":[0.9983544,0.0004946251,0.00036184612,0.00021805512,0.00017091709,0.00007222209,0.000022653672,0.000049989725,0.0002552871],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973964,0.000062462954,0.0003955472,0.00034447506,0.0009906729,0.000810439],"domain_scores_gemma":[0.99849546,0.00022296527,0.000068031484,0.0002914338,0.00032480573,0.0005973162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060243014,0.00023512365,0.00047537847,0.0005195747,0.0002084523,0.0000277647,0.00020095188,0.00014839345,0.0006680275],"category_scores_gemma":[0.00014647555,0.0001916004,0.00007768492,0.0008076052,0.00019871976,0.0002753303,0.00009824488,0.0006416336,0.00018879845],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028844427,0.00024463577,0.0067964615,0.0019365278,0.00035030366,0.0001622824,0.00534508,0.00028318475,0.9249216,0.00066176796,0.0018369491,0.05457681],"study_design_scores_gemma":[0.0027742558,0.0011276103,0.92791927,0.001346367,0.00018642512,0.0012159015,0.00040571927,0.00032472002,0.053126365,0.00012538287,0.010822609,0.0006253518],"about_ca_topic_score_codex":0.00034055658,"about_ca_topic_score_gemma":0.000083826126,"teacher_disagreement_score":0.92112285,"about_ca_system_score_codex":0.00026344362,"about_ca_system_score_gemma":0.00039914047,"threshold_uncertainty_score":0.78132373},"labels":[],"label_agreement":null},{"id":"W2062398224","doi":"10.1158/0008-5472.sabcs13-p6-07-02","title":"Abstract P6-07-02: Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; Amgen (Canada)","funders":"","keywords":"Denosumab; Medicine; Zoledronic acid; Adverse effect; Breast cancer; Oncology; Internal medicine; Clinical trial; Cancer; Osteoporosis","score_opus":0.08175064590748415,"score_gpt":0.43868823499735143,"score_spread":0.3569375890898673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062398224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902075,0.004498778,1.9385536e-7,0.00082288083,0.00006053255,0.0038520196,0.0005270414,0.0000015890818,0.000029493132],"genre_scores_gemma":[0.99497116,0.0012898035,0.000016201457,0.000029716215,0.000016192414,0.0035901729,0.000034046054,0.000015896747,0.00003683765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851745,0.00006492919,0.00033089027,0.00019996687,0.0005302589,0.00035651363],"domain_scores_gemma":[0.99876505,0.00022413772,0.00011255523,0.00020035726,0.0005897395,0.00010814138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035972,0.00010509676,0.00031644787,0.00013804583,0.000038654518,0.0000038195626,0.00005498355,0.000022301583,0.0009626867],"category_scores_gemma":[0.000020509644,0.00006407612,0.00002855907,0.00019136838,0.000058894486,0.00008289933,0.000007816414,0.000091801536,0.0000027295052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002848762,0.00069236633,0.6118723,0.00019517647,0.00017280139,0.0000021177268,0.00022109103,0.0012690481,0.00038704145,0.0000012375828,0.00027763654,0.3820604],"study_design_scores_gemma":[0.015660966,0.00045421676,0.97883075,0.0001727415,0.000086005915,4.7193933e-7,0.00016573198,0.00036484806,0.00408002,0.000009567625,0.00012493374,0.00004976822],"about_ca_topic_score_codex":0.94713926,"about_ca_topic_score_gemma":0.90662247,"teacher_disagreement_score":0.38201064,"about_ca_system_score_codex":0.003801295,"about_ca_system_score_gemma":0.0051366086,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2062497844","doi":"10.1158/0008-5472.sabcs12-p3-11-03","title":"Abstract P3-11-03: Treatment outcomes for early stage male breast cancer: a single centre retrospective case-control study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Male breast cancer; Breast cancer; Stage (stratigraphy); Retrospective cohort study; Cancer; Radiation therapy; Incidence (geometry); Internal medicine; Population; Mastectomy; Surgery; Cancer registry; Chemotherapy; Gynecology","score_opus":0.11650332785836331,"score_gpt":0.4505509331611681,"score_spread":0.3340476053028048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062497844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810722,0.002152279,0.000004927652,0.006339862,0.00038207776,0.006396756,0.002725312,0.00007683094,0.000849784],"genre_scores_gemma":[0.9810494,0.00015457613,0.000047407375,0.0001277387,0.0012199589,0.0029240742,0.0000067019323,0.00008124624,0.014388874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611163,0.0001842346,0.00044264933,0.0006199035,0.00091464916,0.0017269219],"domain_scores_gemma":[0.99717176,0.00050220493,0.00013209855,0.00059312297,0.0009132513,0.00068756373],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011318502,0.00035404338,0.0008438061,0.00026186707,0.00056473986,0.000053267548,0.00014483617,0.00011619781,0.002348208],"category_scores_gemma":[0.00016000506,0.00026479692,0.00018481574,0.0003738232,0.0001869118,0.00019393755,0.00008209274,0.00041075228,0.00007111231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016628613,0.0022369626,0.98007154,0.00034531154,0.0005943429,0.00048611127,0.004712825,0.0000028544302,0.0003314571,0.00002936528,0.0019666941,0.0075596706],"study_design_scores_gemma":[0.008168131,0.001231964,0.9810728,0.00012179792,0.00020805205,0.00016160178,0.005313848,0.000011110008,0.00014260506,0.000004369877,0.0033494567,0.00021430908],"about_ca_topic_score_codex":0.03584531,"about_ca_topic_score_gemma":0.018469386,"teacher_disagreement_score":0.017375922,"about_ca_system_score_codex":0.0041038985,"about_ca_system_score_gemma":0.00061406405,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W2062565707","doi":"10.1158/0008-5472.can-05-2445","title":"Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with <i>In vivo</i> Differentiation of Human Male Germ Cell Tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Biology; Stem cell; Embryonal carcinoma; Homeobox protein NANOG; SOX2; Stem cell marker; Wnt signaling pathway; Induced pluripotent stem cell; Cancer stem cell; Cancer research; Germ cell; Cellular differentiation; Gene; Genetics; Embryonic stem cell","score_opus":0.05042442645922004,"score_gpt":0.34538776761290235,"score_spread":0.29496334115368233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062565707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952325,0.003071175,0.0000067372184,0.00004827697,0.000014743127,0.0007567739,0.00010946225,0.000009428433,0.0007509015],"genre_scores_gemma":[0.99555117,0.000078153505,0.000028158938,0.000013265563,0.00003291176,0.00010232489,0.00013166478,0.000027968086,0.004034389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981637,0.00014420244,0.000372639,0.00029664263,0.000672879,0.00034992478],"domain_scores_gemma":[0.999152,0.00007993824,0.0002015235,0.00025058063,0.0002350026,0.000080948346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028551338,0.0001389851,0.00033068768,0.00031018662,0.00007710338,0.000010415842,0.00007974427,0.000084357176,0.00021809943],"category_scores_gemma":[0.0000072919756,0.000114729955,0.00006220835,0.00054144877,0.00007567039,0.000060403898,0.00008211871,0.00013558865,0.0000030991287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027672763,0.00068101665,0.6705165,0.0002501559,0.000026007363,0.00003840744,0.00025523404,0.00023839946,0.3270822,0.000004230927,0.00036266196,0.00026849244],"study_design_scores_gemma":[0.003935111,0.00020053309,0.6133652,0.00041916707,0.000054334127,0.0000015821253,0.000056691923,0.000517727,0.38132933,0.000023303768,0.000015518786,0.000081525395],"about_ca_topic_score_codex":0.0036799603,"about_ca_topic_score_gemma":0.0020310536,"teacher_disagreement_score":0.0571513,"about_ca_system_score_codex":0.0008878697,"about_ca_system_score_gemma":0.0002031119,"threshold_uncertainty_score":0.55630237},"labels":[],"label_agreement":null},{"id":"W2062608132","doi":"10.1158/1538-7445.am2011-3447","title":"Abstract 3447: FSTL5 improves prognostic subclassification of medulloblastoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Wnt signaling pathway; Biology; Transcriptome; Oncology; Internal medicine; Molecular marker; Cancer research; Pathology; Bioinformatics; Gene; Medicine; Genetics; Gene expression; Immunology","score_opus":0.18619458407095474,"score_gpt":0.4095033534976462,"score_spread":0.22330876942669148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062608132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98497057,0.001376251,0.000012261815,0.0007133526,0.00012809924,0.0007313968,0.000013105126,0.000041811407,0.012013156],"genre_scores_gemma":[0.99766326,0.0007226091,0.00021592127,0.000047590314,0.00016390074,0.00058741367,0.000007729214,0.00003277409,0.0005587979],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981373,0.000055163277,0.0003122656,0.00034566593,0.0007108899,0.0004387245],"domain_scores_gemma":[0.99849373,0.00008460803,0.0000894225,0.00042403722,0.0007059409,0.0002022738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006470194,0.00011895234,0.0002545562,0.00023154824,0.00008129041,0.000014319229,0.0002087747,0.00010728541,0.0015822616],"category_scores_gemma":[0.0002040408,0.00009672425,0.0000918259,0.0005364247,0.00033875107,0.00009803497,0.000060004313,0.00037672443,0.00007362874],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001076377,0.0007063177,0.1249861,0.0009842583,0.0001557819,0.00001720256,0.0014473131,3.6191372e-7,0.763808,0.0010182527,0.005636428,0.10016358],"study_design_scores_gemma":[0.0005458545,0.0005570818,0.6323603,0.0002858938,0.00003663695,0.0000035163985,0.00038217087,0.000019576039,0.36313793,0.00014077142,0.0024390938,0.00009117615],"about_ca_topic_score_codex":0.00092180155,"about_ca_topic_score_gemma":0.00007411188,"teacher_disagreement_score":0.5073742,"about_ca_system_score_codex":0.00016578588,"about_ca_system_score_gemma":0.00053031975,"threshold_uncertainty_score":0.9993304},"labels":[],"label_agreement":null},{"id":"W2062711358","doi":"10.1158/0008-5472.can-05-1069","title":"High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":781,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"JAG1; Tissue microarray; Breast cancer; Medicine; Notch signaling pathway; Internal medicine; Cancer; Survival rate; Oncology; Survival analysis; Receptor; Cancer research; Pathology","score_opus":0.06266336039111539,"score_gpt":0.3559054139079137,"score_spread":0.29324205351679833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062711358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973119,0.0009887399,0.0000027534825,0.0012605399,0.00002186171,0.00014564626,0.00020920082,0.0000024119718,0.00005693852],"genre_scores_gemma":[0.997213,0.00076804834,0.000058834597,0.00014854565,0.00006169925,0.00003544438,0.00008298826,0.00001032585,0.0016210801],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991202,0.000083327606,0.00013122763,0.00028281353,0.00016164123,0.00022080936],"domain_scores_gemma":[0.9996418,0.000015575917,0.000046627538,0.00010263447,0.0001371095,0.000056279787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002927145,0.00009147779,0.00013944914,0.000051300907,0.00008482418,0.000010353474,0.00007801779,0.00015262241,0.0000898311],"category_scores_gemma":[0.000011778504,0.00007483249,0.00001288106,0.00009716665,0.00018293336,0.0000076075294,0.000111532885,0.00011325011,5.235199e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029518644,0.000039487815,0.15557934,0.000021565047,0.000051430095,8.8776795e-7,0.00015103797,0.000011664273,0.83736485,0.000014946998,0.0015211579,0.0049484638],"study_design_scores_gemma":[0.0010526441,0.00007900922,0.5762392,0.0000845486,0.0000035830278,0.0000014487945,0.000027091713,0.00001349262,0.42175257,0.000028157589,0.0006316592,0.000086584456],"about_ca_topic_score_codex":0.00106924,"about_ca_topic_score_gemma":0.0027171352,"teacher_disagreement_score":0.42065987,"about_ca_system_score_codex":0.000052209154,"about_ca_system_score_gemma":0.00011138031,"threshold_uncertainty_score":0.30515805},"labels":[],"label_agreement":null},{"id":"W2062988953","doi":"10.1158/0008-5472.sabcs-2118","title":"Canadian pattern of care for anemia: comparison of chemotherapies in adjuvant breast cancer setting.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Regional Cancer Foundation; Robarts Clinical Trials","funders":"","keywords":"Medicine; Anemia; Breast cancer; Chemotherapy; Internal medicine; Cancer; Adjuvant; Oncology; Hemoglobin; Surgery; Gastroenterology","score_opus":0.043635333145343805,"score_gpt":0.42635436984110997,"score_spread":0.3827190366957662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062988953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96743757,0.011315273,0.0000024002302,0.019501872,0.000046258658,0.0007361223,0.00038915154,0.000007310463,0.00056401896],"genre_scores_gemma":[0.99845845,0.00074737956,0.00010016056,0.00016944484,0.000108046705,0.000101778736,0.000033401655,0.000016062355,0.00026528613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987789,0.00003366652,0.00024859654,0.00020757884,0.00031282828,0.00041842138],"domain_scores_gemma":[0.9990933,0.000057104517,0.00005287494,0.00020547058,0.00042509742,0.00016616809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018273016,0.00010155864,0.00039035117,0.00023062067,0.000053186945,0.0000051341585,0.00010441605,0.00009151045,0.0003066746],"category_scores_gemma":[0.000015980537,0.000084535954,0.0000620103,0.00025332745,0.00010918101,0.000020244412,0.000011592973,0.00023242051,0.0000013025308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003976932,0.0002033329,0.6381071,0.001344154,0.00004196939,0.00001539781,0.01011956,0.000026881395,0.0151620805,0.000016635022,0.006677668,0.3278875],"study_design_scores_gemma":[0.008597064,0.0020134498,0.6855197,0.0044645295,0.000076853896,0.000015650272,0.02319688,0.00017760128,0.26707965,0.000068966576,0.008475644,0.00031399424],"about_ca_topic_score_codex":0.28253895,"about_ca_topic_score_gemma":0.32165992,"teacher_disagreement_score":0.3275735,"about_ca_system_score_codex":0.00090552063,"about_ca_system_score_gemma":0.0011508566,"threshold_uncertainty_score":0.72223866},"labels":[],"label_agreement":null},{"id":"W2063076947","doi":"10.1158/1538-7445.am10-1950","title":"Abstract 1950: Suppression of RISC-independent decoy and RISC-mediated RNA-pairing activities of microRNA-328 is required for maturation-arrest and enhanced survival of blast crisis CML progenitors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Cancer research; CEBPA; Cell biology; Progenitor cell; microRNA; Molecular biology; Stem cell; Transcription factor; Genetics","score_opus":0.024316116531458,"score_gpt":0.34850955119667343,"score_spread":0.32419343466521544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063076947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978911,0.00085114996,0.00008386851,0.00008927928,0.00016932076,0.00051778625,0.00035978394,0.000003934383,0.0000337539],"genre_scores_gemma":[0.99907935,0.0003071487,0.00024330463,0.0000029424898,0.00013643286,0.00008281237,0.000079407735,0.000023879224,0.000044707296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998735,0.00006866523,0.00032178595,0.00032654437,0.00030898763,0.0002389906],"domain_scores_gemma":[0.9988499,0.000106252606,0.00021147478,0.00028317768,0.00045263037,0.000096529984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047524873,0.00012524084,0.00021656723,0.00011741482,0.00008021944,0.000020398864,0.00014908053,0.00019317136,0.000052170777],"category_scores_gemma":[0.00019755251,0.00011667296,0.00006245261,0.0001009875,0.00029436446,0.000020168032,0.0001369478,0.0001503035,4.2627653e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007243392,0.00006065297,0.0030141468,0.00048251209,0.000077446704,3.257526e-7,0.00024328702,0.0000068731797,0.9938535,0.000003627008,0.00074133853,0.0007919392],"study_design_scores_gemma":[0.0007065872,0.00010655707,0.034944013,0.00008346157,0.00001768487,7.301883e-7,0.000396356,0.000028567232,0.9633475,0.00003816723,0.00022959107,0.00010080312],"about_ca_topic_score_codex":0.00017305563,"about_ca_topic_score_gemma":0.00028639552,"teacher_disagreement_score":0.03192987,"about_ca_system_score_codex":0.00001965846,"about_ca_system_score_gemma":0.0002115616,"threshold_uncertainty_score":0.47577855},"labels":[],"label_agreement":null},{"id":"W2063314981","doi":"10.1158/0008-5472.can-09-0454","title":"Targeting Focal Adhesion Kinase with Dominant-Negative FRNK or Hsp90 Inhibitor 17-DMAG Suppresses Tumor Growth and Metastasis of SiHa Cervical Xenografts","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Focal adhesion; Cancer research; Metastasis; Signal transduction; Kinase; Biology; Pathology; Medicine; Cell biology; Cancer; Internal medicine","score_opus":0.03451185750868568,"score_gpt":0.3592810259299558,"score_spread":0.3247691684212701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063314981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955622,0.0021462815,0.0001838861,0.0008496426,0.000026922306,0.00087073754,0.000101208236,0.000009351679,0.00024974922],"genre_scores_gemma":[0.9968433,0.00071885006,0.0014901458,0.00006791415,0.0003530576,0.00020755338,0.000029881965,0.000038690825,0.00025062502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676406,0.0005103496,0.00031853656,0.00069699105,0.00087674806,0.0008333296],"domain_scores_gemma":[0.9982958,0.00018113895,0.000064766005,0.00039154806,0.0007180098,0.000348725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089030113,0.00023822662,0.00035043794,0.000212954,0.00025145928,0.00006423117,0.00036812355,0.00015755638,0.00015185378],"category_scores_gemma":[0.0009591646,0.00016864907,0.00006286654,0.0005769014,0.0005657662,0.000021415524,0.00030110928,0.00049110246,0.0000038302155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035553784,0.00016592615,0.0009344929,0.0002189015,0.000059494498,0.00010387807,0.00017562933,0.000010092139,0.98849005,0.00002191871,0.0023894305,0.0038748288],"study_design_scores_gemma":[0.0013465561,0.0035803786,0.0011894658,0.0001474854,0.000015309664,0.000015713831,0.00042133985,0.000028799874,0.9911687,0.00006130371,0.0018059,0.00021909714],"about_ca_topic_score_codex":0.00047532227,"about_ca_topic_score_gemma":0.00018622442,"teacher_disagreement_score":0.0036557314,"about_ca_system_score_codex":0.000059396112,"about_ca_system_score_gemma":0.00066524924,"threshold_uncertainty_score":0.6877309},"labels":[],"label_agreement":null},{"id":"W2063374686","doi":"10.1158/0008-5472.sabcs13-p1-13-04","title":"Abstract P1-13-04: A comparison of cardiovascular outcomes in postmenopausal women treated with aromatase inhibitors versus tamoxifen in breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Internal medicine; Comorbidity; Cancer; Stroke (engine); Oncology; Aromatase; Retrospective cohort study; Gynecology","score_opus":0.021964151442293474,"score_gpt":0.33753008808023177,"score_spread":0.3155659366379383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063374686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932038,0.005642251,2.763724e-7,0.00012712876,0.00006088568,0.00064983784,0.00009212017,0.000007739367,0.00021596164],"genre_scores_gemma":[0.9983486,0.00071439455,0.000008629525,0.000009500824,0.00006392094,0.0006912989,0.000059939266,0.00003323679,0.00007050352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980379,0.00017075607,0.00028888768,0.0004195167,0.00045394772,0.00062900956],"domain_scores_gemma":[0.99917406,0.000037050213,0.000058813475,0.00042229882,0.00014384338,0.00016391269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041508017,0.0001962348,0.00043933906,0.00021449813,0.000046308727,0.000025557976,0.0002293309,0.00022438068,0.00009936298],"category_scores_gemma":[0.000026447635,0.00014941157,0.00007668107,0.00043958105,0.00020469238,0.000013935909,0.000104134226,0.00042444104,0.000013244433],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023526512,0.00058351096,0.42464125,0.00014845953,0.0011612709,0.00007842313,0.00058402296,0.0031996586,0.5584011,0.0000030203755,0.0014863019,0.007360337],"study_design_scores_gemma":[0.009515813,0.0016907132,0.63512254,0.000304245,0.000051432882,0.000009062204,0.0013923583,0.000092341405,0.3504931,0.000010057264,0.0007785767,0.0005397489],"about_ca_topic_score_codex":0.018826727,"about_ca_topic_score_gemma":0.0007630412,"teacher_disagreement_score":0.21048129,"about_ca_system_score_codex":0.00025671683,"about_ca_system_score_gemma":0.00028858043,"threshold_uncertainty_score":0.987707},"labels":[],"label_agreement":null},{"id":"W2063381313","doi":"10.1158/1538-7445.am10-92","title":"Abstract 92: dbCPCO: The database of genetic predictive and prognostic factors in colorectal cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research","funders":"","keywords":"Colorectal cancer; Disease; Medicine; Cancer; Personalized medicine; Oncology; Germline mutation; Germline; Database; Bioinformatics; Internal medicine; Mutation; Genetics; Biology; Gene","score_opus":0.06511545284470384,"score_gpt":0.4080837525134313,"score_spread":0.3429682996687275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063381313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253035,0.004591803,3.7131454e-7,0.0006303269,0.00016494849,0.0010777039,0.00022088714,0.000010386659,0.00077323115],"genre_scores_gemma":[0.9967012,0.0022705614,0.000016445367,0.000017047514,0.00012857383,0.00073646486,0.000009482853,0.00001627679,0.00010394078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867076,0.000045305584,0.00018911903,0.00028825243,0.00045321585,0.0003533369],"domain_scores_gemma":[0.99900866,0.00041736156,0.000043113567,0.00017662272,0.00024269427,0.000111559566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029705916,0.0001240209,0.00024379001,0.00012907125,0.00012986182,0.000016030564,0.00011060687,0.000060124206,0.00039290078],"category_scores_gemma":[0.00028510886,0.00007286319,0.00003385492,0.0003536001,0.00060933124,0.000050680334,0.00013118482,0.000627019,0.0000017427204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068424054,0.00014452502,0.9154768,0.00015762314,0.00012418248,0.000031710195,0.002215908,0.0000041557337,0.074103735,0.00001934021,0.00052575755,0.006511993],"study_design_scores_gemma":[0.0008794411,0.00038177456,0.97823143,0.00017653198,0.00004218586,0.0000038421535,0.0007782352,0.000036020738,0.018852064,0.0000375856,0.00051638874,0.00006451285],"about_ca_topic_score_codex":0.009515336,"about_ca_topic_score_gemma":0.02149059,"teacher_disagreement_score":0.06275459,"about_ca_system_score_codex":0.00014942238,"about_ca_system_score_gemma":0.00045484665,"threshold_uncertainty_score":0.9970804},"labels":[],"label_agreement":null},{"id":"W2063436193","doi":"10.1158/1538-7445.am2012-4400","title":"Abstract 4400: Novel combination of carbonic anhydrase inhibitor with a phytochemical for treatment of human bronchial carcinoids","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Cancer research; Neuroendocrine tumors; Sunitinib; Chromogranin A; Metastasis; Internal medicine; Pharmacology; Endocrinology; Medicine; Cancer; Immunology; Immunohistochemistry","score_opus":0.10570430885160298,"score_gpt":0.4509517234330602,"score_spread":0.34524741458145725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063436193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962249,0.0010734635,0.0000071969644,0.0003579404,0.000051903033,0.0017257493,0.000085001666,0.000015326157,0.0004585512],"genre_scores_gemma":[0.99819094,0.00007667165,0.00018590043,0.000006205449,0.00039875598,0.0007087817,0.00003850055,0.00004036145,0.00035387152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978006,0.000040732193,0.0002864338,0.0002651093,0.00090389844,0.00070323463],"domain_scores_gemma":[0.99844563,0.00022276978,0.00009183889,0.00035090552,0.0005907246,0.00029813027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025614444,0.00014851712,0.00041013843,0.00026524937,0.00007314375,0.000007349875,0.000119863056,0.000021105965,0.00006100406],"category_scores_gemma":[0.00013323956,0.00011165785,0.00009460436,0.00033901026,0.000444927,0.0001231386,0.0000429908,0.0001894966,0.0000015684601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019673102,0.0019742493,0.03234118,0.00068496534,0.000070305316,0.000020559899,0.00023118508,0.0000032682065,0.9611643,0.00024150503,0.00026212042,0.001039038],"study_design_scores_gemma":[0.0073664403,0.005069843,0.027806666,0.00018097497,0.00003837308,0.000027852262,0.00016054271,0.0000148813115,0.9584704,0.000040187515,0.0007331402,0.00009069476],"about_ca_topic_score_codex":0.00091732386,"about_ca_topic_score_gemma":0.00012366052,"teacher_disagreement_score":0.0053991303,"about_ca_system_score_codex":0.0004896668,"about_ca_system_score_gemma":0.0004837502,"threshold_uncertainty_score":0.45532748},"labels":[],"label_agreement":null},{"id":"W2063475905","doi":"10.1158/0008-5472.sabcs-4012","title":"The impact of preoperative breast magnetic resonance imaging (MRI) on surgical decision-making in young patients with breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Breast MRI; Mammography; Breast ultrasound; Radiology; Magnetic resonance imaging; Mastectomy; Breast surgery; Ultrasound; Physical examination; Breast imaging; Breast disease; Cancer; Internal medicine","score_opus":0.011045501892895977,"score_gpt":0.35957370078171413,"score_spread":0.34852819888881814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063475905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889802,0.0089517245,0.0000046995347,0.0005666633,0.000047286827,0.0004413788,0.00035516074,0.000005576784,0.0006473304],"genre_scores_gemma":[0.9980796,0.00146465,0.000024805837,0.000020283442,0.00014239231,0.00017338026,0.000011377748,0.0000228052,0.000060725877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979728,0.00017099468,0.00022609103,0.0004927765,0.000541441,0.0005959012],"domain_scores_gemma":[0.998751,0.00014194401,0.00006415239,0.00040832808,0.0005574253,0.00007714275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002975429,0.00021499688,0.00021874403,0.00009269951,0.00027020992,0.00004918667,0.00032391452,0.00005646745,0.00005780353],"category_scores_gemma":[0.00004162719,0.00012673656,0.00007589796,0.00045132157,0.00033462435,0.000012804963,0.00011967092,0.0002546989,0.0000021868398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049777864,0.0002237884,0.8145255,0.0000055991113,0.000036961806,0.000015022239,0.00019544065,0.00050171104,0.00047318294,0.000023058623,0.00095671264,0.17806524],"study_design_scores_gemma":[0.0018041204,0.00047200063,0.99633884,0.00042504663,0.0000075924645,0.000024626912,0.00008429905,0.000044433662,0.00048627154,0.00005826254,0.00011582917,0.00013868601],"about_ca_topic_score_codex":0.0017711009,"about_ca_topic_score_gemma":0.0020021976,"teacher_disagreement_score":0.18181334,"about_ca_system_score_codex":0.00041862158,"about_ca_system_score_gemma":0.00039204452,"threshold_uncertainty_score":0.51681674},"labels":[],"label_agreement":null},{"id":"W2063609124","doi":"10.1158/0008-5472.sabcs12-p6-08-04","title":"Abstract P6-08-04: The Impact of a Breast Cancer Diagnosis in Young Women on their Relationship with their Mothers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Worry; Cancer; Ethnic group; Gynecology; Obstetrics; Pediatrics; Internal medicine; Psychiatry; Anxiety","score_opus":0.058123580620930114,"score_gpt":0.3899135510773533,"score_spread":0.3317899704564232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063609124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949124,0.0023139038,0.0000068188624,0.00072297506,0.00007279745,0.00041643155,0.00040135666,0.000005586817,0.0011477458],"genre_scores_gemma":[0.99599534,0.00094326766,0.000010844489,0.000046089703,0.00031676254,0.0024482333,0.000015742575,0.000043032283,0.00018070752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984641,0.00018503431,0.00018185939,0.00027288785,0.00027987047,0.000616216],"domain_scores_gemma":[0.9989105,0.0001697622,0.00008029104,0.0005225777,0.00020391977,0.00011294418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009477295,0.0001644829,0.00014948944,0.00013272093,0.00013281568,0.000026741864,0.00034619818,0.000120190394,0.00048642818],"category_scores_gemma":[0.00006633204,0.00009429108,0.00007334224,0.00050598703,0.00030187878,0.000014444976,0.00007258726,0.00037690817,0.00000713097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000645109,0.00018559651,0.9382191,0.00003150166,0.00021764293,6.234538e-7,0.006292591,0.005010665,0.038958773,0.000032441032,0.004225481,0.006180517],"study_design_scores_gemma":[0.00051502633,0.00016390334,0.96201,0.000084768035,0.0000039709153,0.000005198788,0.0017687072,0.000016881802,0.034474675,0.00009087772,0.0007283736,0.00013759435],"about_ca_topic_score_codex":0.0032261794,"about_ca_topic_score_gemma":0.001664714,"teacher_disagreement_score":0.023790965,"about_ca_system_score_codex":0.0009878086,"about_ca_system_score_gemma":0.00080336,"threshold_uncertainty_score":0.53260475},"labels":[],"label_agreement":null},{"id":"W2063756018","doi":"10.1158/0008-5472.sabcs11-p3-16-01","title":"P3-16-01: Safety Profile and Clinical Activity of Single-Agent BKM120, a Pan-Class I PI3K Inhibitor, for the Treatment of Patients with Metastatic Breast Carcinoma.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Adverse effect; Gastroenterology; Metastatic breast cancer; Cancer; Oncology","score_opus":0.16235293003586573,"score_gpt":0.4113457694450203,"score_spread":0.2489928394091546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063756018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391943,0.0015400292,0.0005341687,0.00033917022,0.000099983874,0.0028113236,0.00059711566,0.000012526669,0.00014625593],"genre_scores_gemma":[0.99777985,0.00032834543,0.0008771156,0.000018829347,0.00011569816,0.0005567015,0.000018208855,0.000042518022,0.00026273515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979846,0.0002015122,0.0004000668,0.00039702674,0.00059149886,0.00042531578],"domain_scores_gemma":[0.9977903,0.0006299391,0.00020248805,0.00051032467,0.0007019507,0.00016501304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000515746,0.00019252143,0.0005628458,0.00010605624,0.00012014634,0.0000070464653,0.00012810012,0.00005851504,0.00014846592],"category_scores_gemma":[0.00006372654,0.000109222696,0.00012119273,0.00028242441,0.0009256686,0.00009407778,0.00005611237,0.00019139971,0.0000013516357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04970901,0.004986425,0.28392038,0.00063313585,0.0011568049,0.000007319444,0.0026183964,0.000002100454,0.005678876,0.000057523546,0.00011032334,0.6511197],"study_design_scores_gemma":[0.017279157,0.01688466,0.8900426,0.0003497566,0.0005076271,0.000012295285,0.0009432242,0.00007369209,0.0683413,0.000108289125,0.0052411063,0.00021631157],"about_ca_topic_score_codex":0.0010779224,"about_ca_topic_score_gemma":0.0003827787,"teacher_disagreement_score":0.6509034,"about_ca_system_score_codex":0.00058217417,"about_ca_system_score_gemma":0.00047870586,"threshold_uncertainty_score":0.44539723},"labels":[],"label_agreement":null},{"id":"W2063798988","doi":"10.1158/1538-7445.am2014-3119","title":"Abstract 3119: Predicting drug resistance in metastatic renal cell carcinoma: Personalized medicine by xenografting patient tumors into chicken embryos","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sunitinib; Medicine; Chorioallantoic membrane; Renal cell carcinoma; Angiogenesis; In vivo; Cancer research; Cell culture; Internal medicine; Pathology; Oncology; Biology","score_opus":0.04032324083987818,"score_gpt":0.3402777968596722,"score_spread":0.29995455601979404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063798988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96877825,0.014655713,0.000026724672,0.0030520072,0.00010822866,0.001333972,0.000019354185,0.000060241233,0.01196553],"genre_scores_gemma":[0.9943396,0.00017394856,0.0006526668,0.00018205405,0.00029773774,0.0005786361,0.00009327845,0.00009520703,0.003586859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942268,0.00064626726,0.0009000043,0.00095959805,0.002095626,0.0011716967],"domain_scores_gemma":[0.99705714,0.0009575286,0.00024200472,0.0006923831,0.0004484284,0.0006025286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028804224,0.0004056527,0.0008267419,0.0005861957,0.0003310326,0.00004695046,0.0003357962,0.00009008776,0.00051432155],"category_scores_gemma":[0.0008346387,0.00032257685,0.00014049215,0.0010111214,0.00057845475,0.00013986498,0.00015713433,0.0012947915,0.000040630905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006216026,0.0015352045,0.14585276,0.0069865542,0.00034136057,0.0023103126,0.0648546,0.000094992836,0.6772047,0.00023454295,0.07607116,0.01829778],"study_design_scores_gemma":[0.046796955,0.0048570572,0.20850752,0.012375648,0.000691179,0.00012831703,0.024623394,0.0017024102,0.61838305,0.0017314474,0.07780776,0.0023952497],"about_ca_topic_score_codex":0.007469581,"about_ca_topic_score_gemma":0.0013109801,"teacher_disagreement_score":0.062654756,"about_ca_system_score_codex":0.0014881352,"about_ca_system_score_gemma":0.0005707538,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W2063855693","doi":"10.1158/0008-5472.sabcs10-p3-15-02","title":"Abstract P3-15-02: Underreporting of Myelotoxicity with Emerging Breast Cancer Regimens","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Western University","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Internal medicine; Breast cancer; Clinical trial; Intensive care medicine; Cancer; Oncology; Chemotherapy","score_opus":0.07291985692153878,"score_gpt":0.4380415032144272,"score_spread":0.3651216462928884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063855693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193765,0.00023811864,0.000018121338,0.004010157,0.00030310504,0.00051056355,0.00004014363,0.000057156303,0.0128850145],"genre_scores_gemma":[0.9969879,0.00025108413,0.00008048742,0.00012152116,0.0006323122,0.00029761408,0.000004233123,0.00004841512,0.0015764713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977883,0.000036615336,0.00035094438,0.00040963595,0.0008199927,0.0005944937],"domain_scores_gemma":[0.9981164,0.00008306885,0.00017378831,0.0005263221,0.0008266209,0.00027382345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068622385,0.00015483935,0.00032451618,0.00023739925,0.00027112348,0.0000315962,0.00015998601,0.000100460034,0.003606595],"category_scores_gemma":[0.000056210316,0.00012049706,0.000081407845,0.00075789815,0.00040424752,0.00013988344,0.00007384661,0.0012893376,0.000017795368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005675055,0.00015389746,0.16253057,0.00031892702,0.00016711002,0.0000870811,0.00029770928,0.00006742279,0.81757957,0.00030068733,0.0028349487,0.015094563],"study_design_scores_gemma":[0.0020692288,0.00030632183,0.6451995,0.0009732459,0.000115244715,0.0004215416,0.0007179747,0.000037125927,0.3372316,0.00015237661,0.0124406535,0.0003351875],"about_ca_topic_score_codex":0.008367331,"about_ca_topic_score_gemma":0.006294052,"teacher_disagreement_score":0.4826689,"about_ca_system_score_codex":0.00025123238,"about_ca_system_score_gemma":0.0014804082,"threshold_uncertainty_score":0.99823606},"labels":[],"label_agreement":null},{"id":"W2064083647","doi":"10.1158/0008-5472.sabcs12-p1-05-20","title":"Abstract P1-05-20: Fluorescent Hyaluronan Probes Distinguish Heterogeneous Breast Cancer Cell Subsets and Predict their Invasive Behavior","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"CD44; Biology; Receptor; Cell; Cell culture; Phenotype; Molecular biology; Flow cytometry; Cancer cell; Cancer research; Cytoplasm; Cell sorting; Chemistry; Cancer; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.03962476870799958,"score_gpt":0.3412884883626776,"score_spread":0.30166371965467803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064083647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97537804,0.021298815,0.000003536337,0.0002244369,0.00020310201,0.0011641731,0.0011244608,0.000021151314,0.00058231043],"genre_scores_gemma":[0.9909586,0.005177082,0.00003552115,0.000056925644,0.0011374102,0.0016300237,0.00012919314,0.00007969764,0.0007955676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654984,0.00019561556,0.00029619146,0.00070684653,0.0006718251,0.0015796602],"domain_scores_gemma":[0.99818313,0.000050866038,0.000078797624,0.0006007165,0.00043914493,0.0006473157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078338897,0.00032285645,0.0002646492,0.00010198457,0.0004164075,0.00012663778,0.00054491515,0.0002515267,0.00039782072],"category_scores_gemma":[0.00007373903,0.00026799197,0.00010627794,0.000194601,0.00051931513,0.000025045289,0.0006399772,0.0005068306,0.000012000133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003702914,0.0004134726,0.095408894,0.00030787475,0.00008015883,0.000040116043,0.00037311547,0.00001555065,0.86297494,0.0000064946976,0.0049531627,0.0350559],"study_design_scores_gemma":[0.0008893214,0.0003907425,0.105407216,0.00013612937,0.000024622404,0.00009112997,0.0002976944,0.000011848427,0.86454546,0.000010612502,0.027755145,0.00044007046],"about_ca_topic_score_codex":0.003128737,"about_ca_topic_score_gemma":0.0034209026,"teacher_disagreement_score":0.03461583,"about_ca_system_score_codex":0.00023061651,"about_ca_system_score_gemma":0.0006433423,"threshold_uncertainty_score":0.99997723},"labels":[],"label_agreement":null},{"id":"W2064216603","doi":"10.1158/0008-5472.can-04-2599","title":"TRAIL Inhibits Tumor Growth but Is Nontoxic to Human Hepatocytes in Chimeric Mice","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Fas ligand; Apoptosis; Tumor necrosis factor alpha; Cancer research; Programmed cell death; Recombinant DNA; In vivo; Biology; Caspase; Necrosis; In vitro; Immunology; Molecular biology; Chemistry; Biochemistry","score_opus":0.04011806806955863,"score_gpt":0.3592248785587301,"score_spread":0.31910681048917144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064216603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969578,0.0013718524,0.000110322275,0.00060890237,0.00005726976,0.00035555108,0.0000197761,0.000007336756,0.00051119656],"genre_scores_gemma":[0.99739784,0.00033357507,0.00016601998,0.00031352477,0.00026178316,0.00014347385,0.000027331418,0.000024323972,0.0013321047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987571,0.00004876727,0.00015084707,0.00039214344,0.00025690452,0.00039424206],"domain_scores_gemma":[0.99950904,0.0000050851454,0.000022004207,0.0002045293,0.00013165975,0.00012765816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002886908,0.00010775084,0.000112550544,0.00013727795,0.00011948213,0.000029818526,0.00018619212,0.00008685045,0.00008297155],"category_scores_gemma":[0.000028277289,0.0001020402,0.00004544894,0.0003067388,0.0000581144,0.0000045099446,0.00011348157,0.00015460867,0.00003501968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051289575,0.000048333623,0.00039883156,0.000025533904,0.000007945061,0.0000073992187,0.0001895041,0.000061870756,0.9968285,0.00020102042,0.0004074044,0.0017723421],"study_design_scores_gemma":[0.0006504131,0.0002731646,0.0055454005,0.00005188011,0.000002118073,0.000004867219,0.00007383002,0.000005285827,0.9885601,0.00055976235,0.004133638,0.00013953811],"about_ca_topic_score_codex":0.0013832907,"about_ca_topic_score_gemma":0.0013475134,"teacher_disagreement_score":0.008268422,"about_ca_system_score_codex":0.00011255517,"about_ca_system_score_gemma":0.00018594277,"threshold_uncertainty_score":0.41610783},"labels":[],"label_agreement":null},{"id":"W2064297266","doi":"10.1158/1538-7445.am10-3532","title":"Abstract 3532: P-glycoprotein downregulation using RNAi decreases cholesterol efflux from human renal cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cholesterol; Kidney; Biology; HMG-CoA reductase; Internal medicine; Endocrinology; RNA interference; Knockout mouse; Medicine; Reductase; Biochemistry; Enzyme; Receptor","score_opus":0.05067886461738437,"score_gpt":0.39041069616642116,"score_spread":0.3397318315490368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064297266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413174,0.0017178972,0.00007851676,0.00012252513,0.0029026251,0.00047497338,0.0002131064,0.000019255838,0.00033935157],"genre_scores_gemma":[0.9701205,0.00065562763,0.00023255401,0.00010915971,0.02747205,0.00026169867,0.000144913,0.00006019087,0.0009433341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781644,0.000105205596,0.00029758544,0.00065357646,0.0005195528,0.00060761103],"domain_scores_gemma":[0.9986003,0.000028330143,0.00011050399,0.0006439525,0.00034326783,0.0002736159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049449207,0.00022263189,0.00023015866,0.00012437455,0.0003433904,0.00012648346,0.00039472143,0.0002971638,0.001156398],"category_scores_gemma":[0.0000637429,0.00021614486,0.000116899006,0.00018220436,0.00029053207,0.000018888471,0.00016674159,0.0005584409,0.000020517406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011323819,0.00005147528,0.0011518891,0.000027793145,0.000052689287,2.4420078e-7,0.000065208165,0.00023374958,0.9803061,0.00001786096,0.010983483,0.006996269],"study_design_scores_gemma":[0.00081964594,0.000039469312,0.028946286,0.000072770104,0.000019265455,0.0000016123832,0.00002557832,0.000030536226,0.7906045,0.00007875642,0.17913936,0.00022223464],"about_ca_topic_score_codex":0.023606079,"about_ca_topic_score_gemma":0.011117848,"teacher_disagreement_score":0.1897016,"about_ca_system_score_codex":0.00009389982,"about_ca_system_score_gemma":0.0005992419,"threshold_uncertainty_score":0.9997567},"labels":[],"label_agreement":null},{"id":"W2064456484","doi":"10.1158/1538-7445.am10-213","title":"Abstract 213: Combinative treatment for prostate cancer by adenoviral-mediated gene therapy expressing a novel apoptosis gene and chemotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"DU145; Prostate cancer; Docetaxel; Cancer research; Cisplatin; Cancer; In vivo; Carcinogenesis; Apoptosis; Cancer cell; Medicine; Genetic enhancement; Prostate; Biology; Chemotherapy; Gene; Internal medicine; LNCaP; Genetics","score_opus":0.0545480668412711,"score_gpt":0.3969562827917899,"score_spread":0.3424082159505188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064456484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634046,0.0088249585,0.000050528364,0.0017563957,0.000121702404,0.0018171687,0.0010093864,0.000021931473,0.000057448506],"genre_scores_gemma":[0.9668089,0.027030881,0.00027719882,0.00031437355,0.00040008416,0.0034196258,0.00034297805,0.00012221215,0.0012837165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745184,0.000095339536,0.00025141324,0.0008254803,0.00047284938,0.0009030985],"domain_scores_gemma":[0.99848974,0.00010607774,0.00009086563,0.0005159887,0.0005166351,0.00028068112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006791112,0.00031969644,0.0002885546,0.00014055907,0.00039139495,0.00014055507,0.0003713141,0.00026053662,0.0001631245],"category_scores_gemma":[0.00005338534,0.00027063835,0.00009968805,0.0002524578,0.0004898537,0.000016178521,0.00008514603,0.0003842874,0.0000040872046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049075517,0.00034515336,0.00055316644,0.000026143742,0.00025042315,8.306877e-7,0.00042807212,0.00001028443,0.9282828,0.0000021824571,0.0023013623,0.06289206],"study_design_scores_gemma":[0.00627748,0.0025581243,0.00049665826,0.000019882107,0.0000060970683,0.0000014069914,0.000072736744,0.000058265086,0.9558177,0.000034082863,0.03436601,0.00029153778],"about_ca_topic_score_codex":0.0008328549,"about_ca_topic_score_gemma":0.00045786626,"teacher_disagreement_score":0.06260052,"about_ca_system_score_codex":0.00015660234,"about_ca_system_score_gemma":0.0006700619,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W2064488799","doi":"10.1158/0008-5472.can-03-3734","title":"Identification of Mechanisms Underlying Transporter Associated with Antigen Processing Deficiency in Metastatic Murine Carcinomas","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; McGill University; University of British Columbia","funders":"","keywords":"Biology; Transporter associated with antigen processing; Molecular biology; Cancer research; Taproot; Antigen; Major histocompatibility complex; MHC class I; Immunology","score_opus":0.10397716213549815,"score_gpt":0.39087661898853765,"score_spread":0.2868994568530395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064488799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897291,0.0015404483,0.0070049777,0.00048467919,0.000024860434,0.0006393704,0.000014038691,0.000029278217,0.0005332267],"genre_scores_gemma":[0.99782217,0.000091487294,0.00073840574,0.000022277043,0.000015122606,0.00010444143,0.000027826802,0.000032949858,0.001145339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978145,0.00006361478,0.00044256775,0.0003364291,0.00087825814,0.00046467013],"domain_scores_gemma":[0.99918365,0.000032724478,0.000106872234,0.00021164471,0.00036696356,0.000098132215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012372038,0.00012682322,0.0003191214,0.00041393924,0.00010406546,0.000018303735,0.00013901522,0.00006016698,0.0001453926],"category_scores_gemma":[0.000020908461,0.00009906471,0.00004931238,0.0010563164,0.00013606086,0.000152228,0.000007341798,0.00032276096,0.000004836231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052306324,0.0006659153,0.026926553,0.00083457294,0.00007122133,0.00014011207,0.0033999442,0.0004423445,0.9504601,0.0012566146,0.0000120578825,0.015267514],"study_design_scores_gemma":[0.0044727786,0.0004600268,0.4072669,0.0021096256,0.0001760503,0.000013759437,0.003004748,0.0024324297,0.577799,0.0017196226,0.0001825545,0.000362481],"about_ca_topic_score_codex":0.000142698,"about_ca_topic_score_gemma":0.001953138,"teacher_disagreement_score":0.38034037,"about_ca_system_score_codex":0.00026703667,"about_ca_system_score_gemma":0.0005324826,"threshold_uncertainty_score":0.40397418},"labels":[],"label_agreement":null},{"id":"W2064528520","doi":"10.1158/1538-7445.am2013-3789","title":"Abstract 3789: The alternatively spliced PRMT1 isoform PRMT1v2 promotes breast cancer cell survival and invasiveness.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Biology; Cancer; Gene isoform; Cancer research; Breast cancer; Cancer cell; Cell; Subcellular localization; Cell culture; Methyltransferase; Methylation; Cell biology; Cytoplasm; Gene; Biochemistry; Genetics","score_opus":0.038646675985974904,"score_gpt":0.34459599765855714,"score_spread":0.30594932167258226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064528520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966986,0.004953004,0.000018858933,0.0025811943,0.00020592073,0.001001876,0.00009314871,0.000013154268,0.0014629603],"genre_scores_gemma":[0.9919668,0.004452563,0.00001755974,0.000055168093,0.0007139771,0.00075405533,0.00003378123,0.000043778167,0.0019623071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982101,0.00012009175,0.00020487788,0.0005020036,0.00044409896,0.00051887037],"domain_scores_gemma":[0.99875385,0.00005661525,0.000094972616,0.00039450292,0.00055657024,0.00014347766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005006913,0.00018550368,0.00015142954,0.00004992793,0.00026633218,0.0001295623,0.00035776664,0.00016826009,0.0005849123],"category_scores_gemma":[0.000034782995,0.00013736976,0.00005579357,0.00019570677,0.00030997163,0.000027534652,0.00025738994,0.00029751478,0.000028895307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001236335,0.000044995646,0.003860627,0.000097103155,0.000086109554,0.0000010207006,0.00017815384,0.00014387831,0.9686933,0.000033407032,0.0035658209,0.023171961],"study_design_scores_gemma":[0.0009583547,0.00014338849,0.2945831,0.000099658704,0.000017627603,0.000012250113,0.0003894051,0.00016816353,0.6926981,0.00019323775,0.010420643,0.00031600695],"about_ca_topic_score_codex":0.011051873,"about_ca_topic_score_gemma":0.0036303024,"teacher_disagreement_score":0.2907225,"about_ca_system_score_codex":0.00018779843,"about_ca_system_score_gemma":0.0004847072,"threshold_uncertainty_score":0.99553365},"labels":[],"label_agreement":null},{"id":"W2064553896","doi":"10.1158/1538-7445.am2011-4835","title":"Abstract 4835: Gonosome-linked expression of PPP2R3B in cutaneous melanoma correlates with distant metastasis free survival","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University","funders":"","keywords":"Biology; Comparative genomic hybridization; X chromosome; Metastasis; XIST; Survival analysis; Gene; Melanoma; Cancer; X-inactivation; Genetics; Chromosome; Internal medicine; Molecular biology; Oncology; Medicine","score_opus":0.06367728295720992,"score_gpt":0.29833366668449207,"score_spread":0.23465638372728215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064553896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259335,0.0021273086,0.0002174177,0.0000114640125,0.00035872532,0.00041554196,0.00016313737,0.000091846545,0.0040212045],"genre_scores_gemma":[0.9983182,0.00088432257,0.0004494373,0.0000023762068,0.000054356977,0.0001139125,0.000011116645,0.00008874767,0.00007754665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795234,0.000038995855,0.00039599786,0.00029326833,0.00066773436,0.00065167877],"domain_scores_gemma":[0.9987296,0.00025052927,0.000057446046,0.00064105104,0.00017035844,0.00015102972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000401863,0.00022485449,0.0003851269,0.0003144495,0.00005895487,0.000023315159,0.0005862833,0.00013680269,0.00063036603],"category_scores_gemma":[0.00006701289,0.00018042463,0.0000588501,0.0006309701,0.00020479881,0.00020443107,0.00011014752,0.0006542054,0.00002253126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022752443,0.00023096308,0.025116501,0.0008952853,0.000276301,0.0005461973,0.004410109,0.004827478,0.9503043,0.00052296615,0.0007477888,0.009846857],"study_design_scores_gemma":[0.0023454262,0.0004323326,0.015561436,0.0008940511,0.00003652551,0.00001871053,0.0009573406,0.00050962815,0.9749336,0.002484047,0.0012681421,0.0005587611],"about_ca_topic_score_codex":0.0011494245,"about_ca_topic_score_gemma":0.0016852629,"teacher_disagreement_score":0.02462929,"about_ca_system_score_codex":0.00035897281,"about_ca_system_score_gemma":0.00014416667,"threshold_uncertainty_score":0.7357503},"labels":[],"label_agreement":null},{"id":"W2064582293","doi":"10.1158/0008-5472.can-14-2387","title":"SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"RHOA; Cancer research; SMAD; Ubiquitin ligase; Metastasis; Downregulation and upregulation; Chemistry; Transforming growth factor; Breast cancer; Epithelial–mesenchymal transition; Cancer; Signal transduction; Cell biology; Ubiquitin; Biology; Internal medicine; Medicine; Biochemistry; Gene","score_opus":0.13555168209820181,"score_gpt":0.4510824402073585,"score_spread":0.31553075810915665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064582293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899709,0.003163288,0.00002745522,0.004188345,0.00013139374,0.0008008945,0.00038781762,0.000016912545,0.0013129804],"genre_scores_gemma":[0.99665797,0.001343427,0.00042190828,0.00011442496,0.00021423865,0.00019569584,0.0000053206245,0.00003481102,0.0010122227],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803853,0.00007304352,0.00026778,0.00034193444,0.0008478186,0.0004308783],"domain_scores_gemma":[0.9979472,0.000038936003,0.00007582357,0.00042818068,0.0009794856,0.00053034164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081709446,0.00014644286,0.0004753203,0.00029328442,0.000047588303,0.000014381184,0.0001607504,0.0000773718,0.00067058264],"category_scores_gemma":[0.00006020949,0.00011449098,0.00006606951,0.00070210465,0.0001858729,0.00007278057,0.000121221594,0.00024121912,0.000006814529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048647323,0.00050130795,0.012237745,0.0007966702,0.00059996714,0.000036496473,0.004676056,0.000039135964,0.4195427,0.001393448,0.007680859,0.54763085],"study_design_scores_gemma":[0.004726507,0.0019384613,0.009492568,0.0011032631,0.00013368225,0.000054498065,0.0012399082,0.000032339252,0.9416826,0.0009307829,0.038415637,0.00024975857],"about_ca_topic_score_codex":0.007910122,"about_ca_topic_score_gemma":0.00076991506,"teacher_disagreement_score":0.5473811,"about_ca_system_score_codex":0.00025829326,"about_ca_system_score_gemma":0.001038409,"threshold_uncertainty_score":0.99869627},"labels":[],"label_agreement":null},{"id":"W2064590689","doi":"10.1158/1538-7445.am2014-3233","title":"Abstract 3233: Targeting system xc- in breast cancer cells: Development of novel therapeutics","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Glutathione; Cancer cell; Glutamate receptor; Breast cancer; Cancer; Glutathione synthetase; Pharmacology; Chemistry; Transfection; Cysteine; Biochemistry; Cancer research; Molecular biology; Biology; Gene; Genetics; Enzyme","score_opus":0.050000471797374824,"score_gpt":0.35859919396509193,"score_spread":0.3085987221677171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064590689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947436,0.0033616177,0.0005262572,0.00012118899,0.00020959495,0.00017297137,0.00004197335,0.000006322527,0.00081650255],"genre_scores_gemma":[0.9977813,0.0007341812,0.0007104667,0.000052647738,0.00037712703,0.000099715806,0.000014137826,0.000026110412,0.00020431202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865204,0.0000567535,0.0002789372,0.00029328596,0.00030040988,0.00041856966],"domain_scores_gemma":[0.99936944,0.000018312474,0.00007082126,0.0002292251,0.00023580078,0.00007638275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091046083,0.000116464675,0.00017253772,0.00007882618,0.00007673232,0.000014822153,0.00026353597,0.0001250346,0.00003483396],"category_scores_gemma":[0.0000106676525,0.000101866,0.000040346273,0.00016350421,0.000085804495,0.0000037289392,0.00012716942,0.00019556667,0.000004329986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056554312,0.00005317056,0.0014852815,0.00017224529,0.000031783195,4.8684143e-7,0.00019773733,0.00025432737,0.9831006,0.00008469139,0.00040143833,0.014161704],"study_design_scores_gemma":[0.00062664977,0.000016670483,0.016422654,0.0001387377,0.00000482561,0.0000013197302,0.00040592265,0.00017378948,0.9130747,0.0000015814587,0.06898396,0.00014919425],"about_ca_topic_score_codex":0.0004941174,"about_ca_topic_score_gemma":0.00020610938,"teacher_disagreement_score":0.070025876,"about_ca_system_score_codex":0.00008772783,"about_ca_system_score_gemma":0.0003976085,"threshold_uncertainty_score":0.4153975},"labels":[],"label_agreement":null},{"id":"W2064656431","doi":"10.1158/0008-5472.can-07-2310","title":"Metformin Inhibits Mammalian Target of Rapamycin–Dependent Translation Initiation in Breast Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":929,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McGill University; University of Toronto; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Metformin; AMPK; PI3K/AKT/mTOR pathway; Protein kinase A; Endocrinology; Ribosomal protein s6; P70-S6 Kinase 1; Internal medicine; EIF4E; AMP-activated protein kinase; Chemistry; Kinase; Cancer research; Translation (biology); Biology; Cell biology; Medicine; Signal transduction; Messenger RNA; Diabetes mellitus; Biochemistry","score_opus":0.04508992630572592,"score_gpt":0.3679437936049077,"score_spread":0.32285386729918175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064656431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099405,0.08823889,0.00023709306,0.00008439845,0.00023298505,0.00034011426,0.0001924886,0.000004612204,0.0007289206],"genre_scores_gemma":[0.9638909,0.03504408,0.00013442531,0.00009966108,0.0004380633,0.000117598385,0.00006425398,0.000026262363,0.00018475176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816966,0.00013589734,0.0003514341,0.00034781158,0.0004837571,0.0005114359],"domain_scores_gemma":[0.99921745,0.000026276093,0.000082873295,0.00024045343,0.00031991728,0.000113023096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016716351,0.00012938127,0.00019268019,0.00023968077,0.000053490126,0.0000156291,0.00019567677,0.00018232508,0.0004115881],"category_scores_gemma":[0.00001826641,0.00012710143,0.000062847444,0.0004228928,0.00010495754,0.000015984675,0.00004620922,0.00022777208,0.000005631886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033881338,0.00006323159,0.0050460044,0.00009762304,0.000023951321,0.0000026269608,0.0002732334,0.00020399192,0.8562123,0.000028888624,0.00061289966,0.13709645],"study_design_scores_gemma":[0.00093245564,0.000052336727,0.0063151466,0.00005163069,0.0000075903163,0.0000013041791,0.00015937701,0.00001608909,0.9636075,0.00008928681,0.028627431,0.00013989174],"about_ca_topic_score_codex":0.0007832504,"about_ca_topic_score_gemma":0.0021528152,"teacher_disagreement_score":0.13695656,"about_ca_system_score_codex":0.000108094435,"about_ca_system_score_gemma":0.0003530621,"threshold_uncertainty_score":0.5183046},"labels":[],"label_agreement":null},{"id":"W2064681832","doi":"10.1158/0008-5472.sabcs12-p2-14-01","title":"Abstract P2-14-01: Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors – a meta-analysis of EFECT and SoFEA (CRUKE/03/021 &amp; CRUK/09/007)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Exemestane; Medicine; Fulvestrant; Internal medicine; Anastrozole; Breast cancer; Aromatase; Placebo; Oncology; Aromatase inhibitor; Tamoxifen; Metastatic breast cancer; Cancer; Gastroenterology; Gynecology","score_opus":0.04533935526388984,"score_gpt":0.35901265385275993,"score_spread":0.3136732985888701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064681832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876882,0.008855377,0.000027652983,0.0001341348,0.000038917424,0.00128893,0.0019408525,0.0000033575654,0.000022608709],"genre_scores_gemma":[0.9978645,0.0005164678,0.00035507552,0.00001319737,0.000043434655,0.0007137093,0.00025334532,0.000035743535,0.00020454342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788344,0.00016199095,0.0004247026,0.00048069766,0.00044913008,0.00060002506],"domain_scores_gemma":[0.998702,0.00009734435,0.00016968616,0.00046946006,0.00029621646,0.0002652935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053516834,0.00026886593,0.0008548064,0.0003390938,0.00007089375,0.000018997325,0.00015501774,0.00012517873,0.000057652072],"category_scores_gemma":[0.000031998945,0.0001852916,0.00031403493,0.00066074025,0.00019603012,0.000019765408,0.000057319052,0.0000774668,0.0000014878032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01758716,0.0023850624,0.0912701,0.000878753,0.057283215,0.000015036226,0.001373549,0.0010149479,0.8239515,0.000013159525,0.00096150674,0.003266039],"study_design_scores_gemma":[0.007574261,0.0030660746,0.38242328,0.00017864219,0.02198067,0.0000036851977,0.00019122963,0.00001899712,0.58283633,0.000010590642,0.0010408886,0.00067537854],"about_ca_topic_score_codex":0.000815991,"about_ca_topic_score_gemma":0.0020969117,"teacher_disagreement_score":0.2911532,"about_ca_system_score_codex":0.00012423447,"about_ca_system_score_gemma":0.00020025359,"threshold_uncertainty_score":0.75559723},"labels":[],"label_agreement":null},{"id":"W2064753657","doi":"10.1158/0008-5472.sabcs12-p6-07-10","title":"Abstract P6-07-10: Luminal A vs. Basal-like Breast Cancer: time dependent changes in the risk of relapse in the absence of treatment","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Proportional hazards model; Oncology; Tamoxifen; Cancer; Progesterone receptor; Adjuvant therapy; Basal (medicine); Estrogen receptor; Gynecology; Confidence interval","score_opus":0.03696913430263896,"score_gpt":0.35225186302260236,"score_spread":0.3152827287199634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064753657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878876,0.0088491505,4.905611e-7,0.0017733452,0.00007643349,0.0005077868,0.00043657218,0.0000023651796,0.00046625666],"genre_scores_gemma":[0.9882551,0.010232114,0.000007956447,0.00006671063,0.00030784745,0.00085358036,0.000021755111,0.000016240267,0.00023871113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810874,0.00037871228,0.00022710982,0.00029341804,0.00046159027,0.0005303992],"domain_scores_gemma":[0.9990078,0.00016526753,0.000120280514,0.00051500136,0.00013988379,0.000051735038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012114049,0.00017834648,0.00023993812,0.00009776958,0.00009156086,0.0000119870265,0.00044763292,0.00009386062,0.00021135964],"category_scores_gemma":[0.000040626852,0.00010256349,0.00007662758,0.0002936288,0.00032267402,0.000009203832,0.0001172551,0.0002104124,0.000016234571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002913082,0.0017635438,0.8564695,0.00021687853,0.0005548161,0.000028353887,0.013499551,0.00021336517,0.09378117,0.000032201024,0.008017803,0.02250969],"study_design_scores_gemma":[0.0012228356,0.00036198075,0.9606171,0.00012031417,0.000040700474,0.000014196469,0.0016914229,0.0000050345766,0.032663163,0.000020080497,0.003104798,0.00013832678],"about_ca_topic_score_codex":0.022000369,"about_ca_topic_score_gemma":0.015288538,"teacher_disagreement_score":0.104147606,"about_ca_system_score_codex":0.00028002853,"about_ca_system_score_gemma":0.0002678508,"threshold_uncertainty_score":0.9845122},"labels":[],"label_agreement":null},{"id":"W2064928294","doi":"10.1158/1538-7445.fbcr13-b47","title":"Abstract B47: Characterization of carcinoma-associated fibroblasts from head and neck squamous cell carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Cancer-Associated Fibroblasts; Head and neck squamous-cell carcinoma; Vimentin; Cancer research; Extracellular matrix; Pathology; Biology; Metastasis; Stromal cell; Cancer cell; Fibroblast; Cell; Tumor microenvironment; Cell culture; Cancer; Medicine; Immunohistochemistry; Head and neck cancer; Cell biology","score_opus":0.051630784869174176,"score_gpt":0.3322994835492704,"score_spread":0.28066869868009625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064928294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956398,0.0015398903,0.0000028226025,0.0005452635,0.0001172493,0.0007280881,0.00020662407,0.000019934234,0.0012003481],"genre_scores_gemma":[0.99763745,0.0002823301,0.00003733449,0.00008181866,0.00021348933,0.00012493716,0.0001701392,0.00003946767,0.0014130172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816793,0.00007631472,0.0003157759,0.00038291753,0.000584807,0.00047222772],"domain_scores_gemma":[0.9986052,0.00012377754,0.000111215704,0.00034865967,0.0005242977,0.0002868815],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024979666,0.00015393314,0.00037763309,0.00018462726,0.000090500675,0.00004177256,0.000113641385,0.00012778392,0.001949263],"category_scores_gemma":[0.00006975178,0.00013849474,0.00007251855,0.00036099626,0.00014972105,0.00014079563,0.00008966632,0.00036549568,0.000047320285],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018503613,0.00015457383,0.118282095,0.00031417518,0.000021313093,0.000014672896,0.0005367477,9.836097e-7,0.8725012,0.0000038223034,0.0014656042,0.0065197684],"study_design_scores_gemma":[0.0018428846,0.00025249852,0.7493843,0.00010176311,0.000028790264,0.000001229808,0.00010066591,0.00003118411,0.2471268,0.000023284012,0.0010085547,0.000098050616],"about_ca_topic_score_codex":0.039116938,"about_ca_topic_score_gemma":0.0005520299,"teacher_disagreement_score":0.6311022,"about_ca_system_score_codex":0.00025085482,"about_ca_system_score_gemma":0.00038621062,"threshold_uncertainty_score":0.9989631},"labels":[],"label_agreement":null},{"id":"W2065043201","doi":"10.1158/0008-5472.can-13-0275","title":"Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University","funders":"National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Tyson","keywords":"Tetraspanin; Integrin; Biology; Cancer research; Prostate cancer; Metastasis; Tumor progression; Carcinogenesis; Motility; Cancer; Laminin; Cell; Cell biology; Extracellular matrix","score_opus":0.07795624073554985,"score_gpt":0.4484302757799247,"score_spread":0.37047403504437487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065043201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874116,0.002681678,0.0000069697658,0.0050536934,0.00009014485,0.0027266636,0.000085098254,0.000039182214,0.00057539326],"genre_scores_gemma":[0.9938162,0.0022262875,0.0004290248,0.00021484957,0.00018049807,0.00096805696,0.0000096947615,0.00006847896,0.0020869223],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951902,0.00048759754,0.00076071476,0.0008759307,0.0017144148,0.0009711246],"domain_scores_gemma":[0.9967551,0.00034510417,0.00016704973,0.00094964635,0.00091796916,0.0008651289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021435444,0.0002467141,0.0005975388,0.00036171707,0.00015737196,0.000078806996,0.00048453617,0.0002016054,0.0024579405],"category_scores_gemma":[0.00079414505,0.00019011088,0.00011810991,0.00074689585,0.00084298535,0.00014051345,0.0012572904,0.001883777,0.00006105689],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012277393,0.00067975436,0.5541524,0.0028958318,0.00008571243,0.00011448615,0.0018409952,0.0000021816966,0.2873211,0.000004729811,0.01340527,0.13826978],"study_design_scores_gemma":[0.0059865774,0.002024075,0.43828475,0.001958797,0.00004734286,0.000023256396,0.0012234632,0.0015562512,0.5432299,0.00016965564,0.0051448676,0.00035108562],"about_ca_topic_score_codex":0.0075096404,"about_ca_topic_score_gemma":0.0010342884,"teacher_disagreement_score":0.2559088,"about_ca_system_score_codex":0.0004473497,"about_ca_system_score_gemma":0.0013017391,"threshold_uncertainty_score":0.99909943},"labels":[],"label_agreement":null},{"id":"W2065077716","doi":"10.1158/0008-5472.can-08-4626","title":"Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Hepatocyte growth factor; Chondroitin sulfate proteoglycan; Cancer research; Motility; Epithelial–mesenchymal transition; Cell biology; Cell growth; Biology; Mesenchymal stem cell; Melanoma; Proteoglycan; Cancer; Metastasis; Extracellular matrix; Biochemistry; Genetics","score_opus":0.0295947565508463,"score_gpt":0.34141688367040735,"score_spread":0.31182212711956103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065077716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097687,0.00057370565,0.002632228,0.0030660597,0.000058710895,0.0019003493,0.0002254545,0.000024232164,0.0005423916],"genre_scores_gemma":[0.99564886,0.00025269235,0.0016879978,0.0004731435,0.00040836548,0.0005245062,0.000047452304,0.00003872548,0.000918227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671566,0.00030405784,0.00028063732,0.0009538843,0.0007642136,0.0009815393],"domain_scores_gemma":[0.9982867,0.000027181131,0.00003228587,0.00057688006,0.00041098663,0.0006659389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075775845,0.00026849753,0.00026404386,0.00032253086,0.00036126058,0.00013457613,0.00049446675,0.00016980452,0.000056041245],"category_scores_gemma":[0.00015175091,0.00024400759,0.00007590753,0.00048547497,0.00016116005,0.000018034474,0.00029119023,0.0003981991,0.000027633861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001003526,0.00010757144,0.00023579129,0.00007872196,0.00001104475,0.00003337529,0.0003493549,0.00035860966,0.9920385,0.000020014226,0.0008777508,0.0048857443],"study_design_scores_gemma":[0.0008229899,0.0018468951,0.0039953026,0.00006993454,0.000005025551,0.000012639877,0.000081804676,0.00013390834,0.99040586,0.0002763315,0.0020808775,0.00026843668],"about_ca_topic_score_codex":0.0006257211,"about_ca_topic_score_gemma":0.00007674042,"teacher_disagreement_score":0.0046720216,"about_ca_system_score_codex":0.000074933654,"about_ca_system_score_gemma":0.00031296047,"threshold_uncertainty_score":0.9950341},"labels":[],"label_agreement":null},{"id":"W2065401393","doi":"10.1158/1538-7445.am2012-476","title":"Abstract 476: The effects of the synthetic triterpenoid acetylenic tricyclic bis-(cyano enone) on cell migration and epithelial-to-mesenchymal transition","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and Characterization of Pyrroles","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell migration; Chemistry; Microtubule polymerization; Cell; Actin; Epithelial–mesenchymal transition; Cell biology; Microtubule; Cell polarity; Metastasis; Cancer; Cancer research; Biology; Biochemistry; Transition (genetics); Tubulin","score_opus":0.025355394629249735,"score_gpt":0.3031341591639795,"score_spread":0.27777876453472977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065401393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949134,0.00089612143,0.000009850262,0.002469451,0.00013867297,0.00034585182,0.000058403555,0.000015537782,0.001152724],"genre_scores_gemma":[0.9975854,0.0007256656,0.0000050214785,0.00010879102,0.0003632047,0.00018867847,0.000005468155,0.000027872666,0.0009898846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983728,0.00018570451,0.00023149363,0.00023311819,0.00058541005,0.000391454],"domain_scores_gemma":[0.99843603,0.0008407745,0.0000911229,0.00041994124,0.00009282497,0.00011928425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063476444,0.00014433033,0.000173536,0.0000985315,0.000266711,0.00005502385,0.00030796562,0.000113438684,0.00044405254],"category_scores_gemma":[0.00021922038,0.000086326596,0.00009284514,0.00028601618,0.00014822133,0.00010694269,0.00004950498,0.0003291687,0.000031727966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111340334,0.00014142103,0.0004713051,0.00034758062,0.000015917758,4.5177046e-7,0.0018551042,0.0000064184815,0.9864627,0.000044122982,0.0001896176,0.010353979],"study_design_scores_gemma":[0.00035265926,0.00004599056,0.025766846,0.00028385766,0.00002293576,0.0000015084303,0.00027981683,0.00001734227,0.9675921,0.000014484687,0.0055208057,0.00010164767],"about_ca_topic_score_codex":0.00016479395,"about_ca_topic_score_gemma":0.000026132062,"teacher_disagreement_score":0.02529554,"about_ca_system_score_codex":0.000085065054,"about_ca_system_score_gemma":0.00007837701,"threshold_uncertainty_score":0.48620638},"labels":[],"label_agreement":null},{"id":"W2065721281","doi":"10.1158/1538-7445.am2011-1830","title":"Abstract 1830: Factors associated with fatigue, sleep dysfunction, and joint symptoms in breast cancer survivors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Bioelectrical impedance analysis; Cancer-related fatigue; Body mass index; Pittsburgh Sleep Quality Index; Physical therapy; Cancer; Insomnia","score_opus":0.2320540918985002,"score_gpt":0.4135477410543628,"score_spread":0.1814936491558626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065721281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994737,0.00070673646,0.000006381417,0.0018991499,0.00015601364,0.00048229026,0.00005776057,0.000049192055,0.0019054557],"genre_scores_gemma":[0.99833703,0.000753888,0.000011329126,0.0002231146,0.00010064514,0.0001801172,0.000018518082,0.0000320807,0.00034327677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981805,0.00009706536,0.000271344,0.00032944814,0.00055153825,0.0005701185],"domain_scores_gemma":[0.9988928,0.000088940586,0.00006620267,0.00017798562,0.00044871672,0.00032538452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007824328,0.00013506867,0.00029311466,0.00039604574,0.00016990161,0.00002478553,0.000061171915,0.00011229631,0.002108443],"category_scores_gemma":[0.00006396127,0.000103709885,0.000026340602,0.00063209183,0.00021944147,0.00011567094,0.000032955344,0.0007266671,0.0000069906546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033992447,0.00016294491,0.9930519,0.00027515297,0.000060835275,0.000022098095,0.0013968264,0.0000027463084,0.0012677773,0.00006481828,0.00084665895,0.0025083055],"study_design_scores_gemma":[0.0018889547,0.00011193294,0.9944295,0.001008471,0.000011075451,0.0000039436804,0.0006562741,0.00003296494,0.0013484611,0.000072281975,0.00032048053,0.000115626266],"about_ca_topic_score_codex":0.027451064,"about_ca_topic_score_gemma":0.013749904,"teacher_disagreement_score":0.01370116,"about_ca_system_score_codex":0.0006190777,"about_ca_system_score_gemma":0.00036046698,"threshold_uncertainty_score":0.9988038},"labels":[],"label_agreement":null},{"id":"W2065803223","doi":"10.1158/0008-5472.sabcs11-pd05-05","title":"PD05-05: Meta Analysis of Discordant HER2 Status in Matched Primary and Metastatic Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Primary tumor; Metastatic breast cancer; Cancer; Disease; Meta-analysis; Metastasis","score_opus":0.15646634666622575,"score_gpt":0.4306198504474446,"score_spread":0.27415350378121883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065803223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662706,0.030309618,0.00019906631,0.0010815992,0.000059735044,0.00080420496,0.0007026266,0.000030301473,0.00054220925],"genre_scores_gemma":[0.9931665,0.0039364207,0.0013873322,0.00018320327,0.000037771984,0.00063455116,0.000024265495,0.000049570946,0.00058037834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972148,0.00024093421,0.00045264378,0.0005414277,0.0007810294,0.00076916337],"domain_scores_gemma":[0.9984597,0.0001666274,0.00012766775,0.0005637418,0.00038280617,0.0002994733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007592156,0.0002292008,0.0013319426,0.0009849049,0.000060187213,0.000014616614,0.00019536514,0.000042869557,0.0027633575],"category_scores_gemma":[0.000031619067,0.00017487607,0.00023646887,0.0025768816,0.00059500796,0.00020597508,0.00015970989,0.00045246343,0.0000029989353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014950726,0.0022530628,0.4315757,0.004256603,0.22074223,0.0009694173,0.02377432,0.000550583,0.15224671,0.0014965815,0.0004180703,0.146766],"study_design_scores_gemma":[0.0033968845,0.0003151666,0.9523518,0.00021137466,0.026542021,0.000054712782,0.002845602,0.00018710908,0.012239196,0.0008000884,0.0006797157,0.000376317],"about_ca_topic_score_codex":0.029451676,"about_ca_topic_score_gemma":0.0075268312,"teacher_disagreement_score":0.52077615,"about_ca_system_score_codex":0.0005526829,"about_ca_system_score_gemma":0.00070741307,"threshold_uncertainty_score":0.99814826},"labels":[],"label_agreement":null},{"id":"W2065830704","doi":"10.1158/1538-7445.am2011-1168","title":"Abstract 1168: Integrated genomic, microRNA (miRNA) and proteomic profiling by stable isotope labeling with amino acids in cell culture (SILAC) of ovarian carcinoma for biomarker discovery","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Toronto General Hospital; University Health Network; University of Toronto; SickKids Foundation; Mount Sinai Hospital","funders":"","keywords":"microRNA; Stable isotope labeling by amino acids in cell culture; Biology; Biomarker; Cancer research; Ovarian cancer; Gene silencing; Gene expression profiling; Proteomics; Gene expression; Gene; Computational biology; Cancer; Genetics","score_opus":0.06398212003329445,"score_gpt":0.3235935168182553,"score_spread":0.25961139678496087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065830704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914913,0.0055225585,0.00010453947,0.000113759146,0.000044108063,0.0020616332,0.00016931316,0.00001726851,0.00047552533],"genre_scores_gemma":[0.99475485,0.00032371434,0.0023217683,0.000027756883,0.000060486807,0.00031741912,0.00009906057,0.00005115015,0.002043819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983138,0.000052389732,0.00035619325,0.00045564104,0.00027604526,0.0005459521],"domain_scores_gemma":[0.9990714,0.000058768182,0.000116697236,0.000262617,0.00034646346,0.00014404219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006480035,0.00020149478,0.00037634323,0.00022055773,0.00011830435,0.000050451526,0.00015211683,0.00014550527,0.000078606325],"category_scores_gemma":[0.000044691595,0.00015150831,0.00005246241,0.00038454542,0.0002200713,0.00023797463,0.000061877254,0.00034595764,0.0000019660276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018040714,0.00011588705,0.3393876,0.0006002376,0.000045456825,0.000012271852,0.0014883899,0.0000016171942,0.6553267,0.000029095738,0.00038203542,0.0008066266],"study_design_scores_gemma":[0.003145262,0.0003716925,0.20935689,0.00042125685,0.00003741285,0.0000058155415,0.0009286322,0.00019682199,0.78456765,0.000058374895,0.0007254414,0.00018471568],"about_ca_topic_score_codex":0.004396139,"about_ca_topic_score_gemma":0.00029469185,"teacher_disagreement_score":0.13003069,"about_ca_system_score_codex":0.00021781171,"about_ca_system_score_gemma":0.00062543846,"threshold_uncertainty_score":0.6645677},"labels":[],"label_agreement":null},{"id":"W2066019345","doi":"10.1158/0008-5472.can-07-0974","title":"Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Senescence; Pituitary tumors; Hypoplasia; Endocrinology; Pituitary gland; Internal medicine; Medicine; Biology; Hormone","score_opus":0.1047989962851857,"score_gpt":0.45700008579021617,"score_spread":0.3522010895050305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066019345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97028726,0.01985803,0.00003050479,0.005227951,0.00018388961,0.0011790487,0.000040677816,0.00009286438,0.0030997742],"genre_scores_gemma":[0.99103045,0.005131958,0.00039269615,0.0013260979,0.00090532616,0.00015562879,0.000013317006,0.00007478271,0.00096970994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99457484,0.00024649553,0.0004554742,0.00075764186,0.002200231,0.0017653028],"domain_scores_gemma":[0.9957563,0.0012387474,0.0000485524,0.00055553316,0.00087945047,0.0015214043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005009515,0.00023323715,0.00039132667,0.00077348464,0.0004141306,0.000044021675,0.0003486458,0.00015776537,0.0003639735],"category_scores_gemma":[0.0020953019,0.00020459635,0.000059774466,0.0011918744,0.0010721812,0.00021582692,0.000321842,0.0017397653,0.00015727962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072574834,0.00060577545,0.30080667,0.007925791,0.00019218239,0.015641186,0.0017770372,0.0000016331277,0.4105892,0.0035871959,0.020570625,0.23104522],"study_design_scores_gemma":[0.0048699114,0.0023602613,0.7741656,0.0012597697,0.0000397533,0.00065719016,0.0018375028,0.000073754854,0.12712984,0.0022498718,0.08466588,0.0006906832],"about_ca_topic_score_codex":0.0016243414,"about_ca_topic_score_gemma":0.000675112,"teacher_disagreement_score":0.4733589,"about_ca_system_score_codex":0.00060767547,"about_ca_system_score_gemma":0.002067685,"threshold_uncertainty_score":0.83431965},"labels":[],"label_agreement":null},{"id":"W2066075932","doi":"10.1158/0008-5472.can-04-3957","title":"Tumor-Infiltrating Dendritic Cell Subsets of Progressive or Regressive Tumors Induce Suppressive or Protective Immune Responses","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Ohio State University","keywords":"Immune system; CTL*; Immunity; Immunology; Dendritic cell; Cancer research; T cell; Biology; CD8","score_opus":0.06029179845438355,"score_gpt":0.37940802509115223,"score_spread":0.3191162266367687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066075932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552074,0.04099823,0.000010213289,0.0005823043,0.0002906455,0.00211404,0.0001876444,0.000087192195,0.0005222967],"genre_scores_gemma":[0.9793778,0.0005704401,0.00016158806,0.00008386055,0.00013597042,0.0016221626,0.00002954931,0.000089622925,0.017929012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99356997,0.0029621185,0.00094167364,0.00075746124,0.00034080094,0.0014279947],"domain_scores_gemma":[0.9947607,0.0025598058,0.0005670512,0.0008662883,0.001173771,0.000072403476],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00159561,0.0004591192,0.00083678967,0.0006710305,0.0008735183,0.00007350469,0.0010454586,0.00037867294,0.005180046],"category_scores_gemma":[0.0023632394,0.0003244223,0.00019545367,0.0010807116,0.001815419,0.00044239688,0.00034093863,0.0018234025,0.0002844075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03345543,0.00042690494,0.00026674577,0.00021800089,0.00029717927,0.00025147357,0.0045720255,0.000011801151,0.9483751,0.000070294715,0.001372311,0.01068271],"study_design_scores_gemma":[0.0033877396,0.001740269,0.0026896961,0.0012567294,0.000032911328,0.0004218385,0.004723232,0.000004523955,0.97817284,0.00004259772,0.0071099275,0.00041770513],"about_ca_topic_score_codex":0.00072980113,"about_ca_topic_score_gemma":0.00014097481,"teacher_disagreement_score":0.04042779,"about_ca_system_score_codex":0.0003801792,"about_ca_system_score_gemma":0.0026819617,"threshold_uncertainty_score":0.9999208},"labels":[],"label_agreement":null},{"id":"W2066136001","doi":"10.1158/1538-7445.am2011-4226","title":"Abstract 4226: Curcumin induced CaSR stimulates calpain autolysis in colon cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Calpain; Chemistry; Calcium-sensing receptor; Curcumin; Calcium metabolism; Colorectal cancer; Receptor; Calcium; Blot; Endocrinology; Cancer; Internal medicine; Cancer research; Molecular biology; Enzyme; Biochemistry; Biology; Medicine","score_opus":0.12030591907177898,"score_gpt":0.4051298831994957,"score_spread":0.2848239641277167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066136001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968822,0.0011831425,0.00006208488,0.00026456203,0.00018314962,0.00040008163,0.000017913291,0.000014991442,0.0009918462],"genre_scores_gemma":[0.9968146,0.00031309854,0.00003131162,0.00008479743,0.00024088542,0.00037654978,0.00003570093,0.000025191544,0.0020778659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985235,0.00016318848,0.00021283215,0.00040785447,0.00028270396,0.00040994718],"domain_scores_gemma":[0.9993052,0.000026189395,0.00004784353,0.00028861375,0.00020411387,0.00012805068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007500719,0.00012583195,0.00013827086,0.00018671909,0.00011306295,0.000022777864,0.00017362389,0.00023581524,0.0014999766],"category_scores_gemma":[0.00009882689,0.00011624248,0.0000630002,0.00037648604,0.00011760941,0.0000074957816,0.00007236092,0.00030075441,0.000026128831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033704058,0.00009173187,0.009762842,0.000041257288,0.000040768242,0.00001238712,0.00027920972,0.00019215806,0.9698336,0.000038594295,0.0030659905,0.016304437],"study_design_scores_gemma":[0.0010055621,0.00020072666,0.089790426,0.00009105313,0.000010006308,0.000002513304,0.00018101784,0.0004465632,0.88521063,0.00018559137,0.022598535,0.00027736597],"about_ca_topic_score_codex":0.0062836474,"about_ca_topic_score_gemma":0.003367108,"teacher_disagreement_score":0.08462294,"about_ca_system_score_codex":0.00014367622,"about_ca_system_score_gemma":0.0003225633,"threshold_uncertainty_score":0.9994128},"labels":[],"label_agreement":null},{"id":"W2066150850","doi":"10.1158/0008-5472.sabcs11-p4-10-02","title":"P4-10-02: A Meta-Analysis of the Association of Blood Levels of Vitamin-D and the Risk of Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Odds ratio; Confidence interval; Internal medicine; Meta-analysis; Cancer; Oncology; Vitamin D and neurology; Incidence (geometry); Relative risk; Gastroenterology","score_opus":0.17865873096847304,"score_gpt":0.4193064807911226,"score_spread":0.24064774982264955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066150850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865462,0.007818767,0.0000037350376,0.0018108368,0.00002312989,0.00075673027,0.0016818895,0.0000033719805,0.0013553196],"genre_scores_gemma":[0.99365777,0.0030963689,0.000031710246,0.00001195213,0.000028601038,0.00018734958,0.0000011994955,0.000012833385,0.002972219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959926,0.0010696287,0.00053427933,0.00024054892,0.0018229038,0.00034006286],"domain_scores_gemma":[0.99481386,0.0013896512,0.0005471438,0.0006712177,0.0025078563,0.00007024342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005448492,0.00012162779,0.001269326,0.00036637002,0.00011113463,0.000004555201,0.0003850596,0.00008342248,0.0014221119],"category_scores_gemma":[0.0020486135,0.000057591296,0.0006642228,0.002022841,0.0014516106,0.00004580959,0.00037159267,0.00041159737,6.0824806e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012203038,0.00058071193,0.50790274,0.0011541053,0.40176123,0.000002817552,0.011068265,0.00003757833,0.07160736,0.0005855258,0.002149126,0.0019302404],"study_design_scores_gemma":[0.001753412,0.00013920697,0.83891046,0.000058209098,0.075241536,8.074685e-7,0.00073075586,0.00005262199,0.08293008,0.00010876347,0.000026725593,0.000047414487],"about_ca_topic_score_codex":0.017483495,"about_ca_topic_score_gemma":0.0032339585,"teacher_disagreement_score":0.33100772,"about_ca_system_score_codex":0.000119340555,"about_ca_system_score_gemma":0.00043897284,"threshold_uncertainty_score":0.99949074},"labels":[],"label_agreement":null},{"id":"W2066247052","doi":"10.1158/1538-7445.am2014-1191","title":"Abstract 1191: Translational Proof-of-Concept (TransPoC), a not-for-profit research organization enabling access to large-scale translational oncology platforms: The Patient-Derived Xenograft network","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Translational research; Computational biology; Clinical trial; Proof of concept; Medicine; Bioinformatics; Computer science; Oncology; Biology; Internal medicine; Pathology","score_opus":0.06575593130679036,"score_gpt":0.41011326098083156,"score_spread":0.3443573296740412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066247052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9062055,0.0006594141,0.088066444,0.002410851,0.000053521162,0.001960894,0.000110665715,0.00002577547,0.0005069783],"genre_scores_gemma":[0.99610066,0.00011477977,0.0014880886,0.0002758121,0.00059933454,0.0006001531,0.0006775913,0.0000535525,0.00009001764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706364,0.00025952223,0.00046934455,0.00058731454,0.0008543094,0.0007658774],"domain_scores_gemma":[0.9969579,0.00036131474,0.00009699266,0.00048579316,0.0019558014,0.00014219162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027280722,0.00016978434,0.00024886176,0.00023296557,0.0005838781,0.00009950575,0.0007883729,0.0002677928,0.00023231353],"category_scores_gemma":[0.000303223,0.00013964789,0.00012724979,0.0011911207,0.000337397,0.000037612223,0.00013533689,0.00048627748,0.0000034668242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073559623,0.000083198946,0.0065177833,0.000112748756,0.00015329126,0.0000011280499,0.0021997038,0.009668291,0.9266042,0.0002896921,0.010897858,0.042736504],"study_design_scores_gemma":[0.0006383534,0.00039395917,0.0042682565,0.000054716147,0.000020487438,0.0000011330156,0.00022045933,0.0005378437,0.95199186,0.00090744614,0.040777672,0.0001878094],"about_ca_topic_score_codex":0.00010679543,"about_ca_topic_score_gemma":0.0009500074,"teacher_disagreement_score":0.08989521,"about_ca_system_score_codex":0.000069624904,"about_ca_system_score_gemma":0.0006194818,"threshold_uncertainty_score":0.5694676},"labels":[],"label_agreement":null},{"id":"W2066529202","doi":"10.1158/0008-5472.sabcs13-p2-10-07","title":"Abstract P2-10-07: Ep-ICD overexpression associates with poor prognosis in invasive ductal carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Cancer; Medicine; Cancer research; Epithelial cell adhesion molecule; Epithelial–mesenchymal transition; Pathology; Carcinoma; Oncology; Internal medicine; Metastasis","score_opus":0.050225894277848716,"score_gpt":0.34714902857971586,"score_spread":0.2969231343018671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066529202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774934,0.001740342,9.073324e-7,0.0026634156,0.00007650543,0.0019439496,0.000032462685,0.000054386943,0.00573867],"genre_scores_gemma":[0.99557585,0.0002539362,0.00010292993,0.00012221781,0.00024711248,0.0014679001,0.000044120934,0.00008074784,0.0021051911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99674106,0.00014097815,0.00031703868,0.00062056154,0.0012382406,0.00094215036],"domain_scores_gemma":[0.9982082,0.00022861667,0.00009837798,0.00036408307,0.0007415381,0.00035915757],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048669305,0.00023751457,0.0003858944,0.00039406394,0.00013830734,0.00008629283,0.00024006228,0.00024965746,0.0043730186],"category_scores_gemma":[0.00045823108,0.00018902218,0.00008731586,0.0007597964,0.00024202607,0.0002271812,0.00016201187,0.0011743185,0.00062356406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072843017,0.00035232413,0.16470416,0.00038065764,0.00013162327,0.000632769,0.00082969863,0.000029001589,0.7900618,0.000022583668,0.039247803,0.0028791616],"study_design_scores_gemma":[0.0037262565,0.00078327616,0.5185641,0.0021330153,0.000029601943,0.000048007838,0.00065223506,0.000053421372,0.4723911,0.00009748071,0.0012149179,0.00030657186],"about_ca_topic_score_codex":0.009960863,"about_ca_topic_score_gemma":0.0010201146,"teacher_disagreement_score":0.35385996,"about_ca_system_score_codex":0.0013264145,"about_ca_system_score_gemma":0.0015655847,"threshold_uncertainty_score":0.9966319},"labels":[],"label_agreement":null},{"id":"W2066539641","doi":"10.1158/0008-5472.sabcs11-p2-12-27","title":"P2-12-27: Simply Adding Together the Diameters of Tumor Foci in Patients with Multicentric or Multifocal Disease Does Not Add Any Additional Prognostic Information: An Analysis from NCIC CTG MA.12 Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women with Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Vancouver Hospital and Health Sciences Centre; Queen's University; University of Toronto; Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Calgary; University of Ottawa; University of British Columbia; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Tamoxifen; Stage (stratigraphy)","score_opus":0.01159275448118707,"score_gpt":0.2746183427524221,"score_spread":0.263025588271235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066539641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902753,0.00011025093,0.000023905159,0.00007372553,0.000044190627,0.0040547587,0.005402135,0.00000622776,0.000009457249],"genre_scores_gemma":[0.9884331,0.000081463506,0.00018047253,0.00008258228,0.00009508349,0.01075363,0.00031756752,0.000029946106,0.000026112002],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971813,0.00060108845,0.0005890329,0.00043305304,0.0006672968,0.00052824407],"domain_scores_gemma":[0.9982389,0.000449467,0.0003417968,0.00039519317,0.00040636864,0.00016825482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058113557,0.0002891857,0.0008282246,0.00030386503,0.00006865188,0.000030284275,0.00029323297,0.00007583775,0.0011951267],"category_scores_gemma":[0.00022067454,0.00014969966,0.000090385394,0.0004875049,0.0005211165,0.00006692759,0.000091355265,0.0001889491,7.978571e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7564704,0.00060598576,0.23696129,0.00003518991,0.0014805448,0.000005211215,0.0031089506,0.00015523391,0.00012094343,5.063063e-7,0.000019412633,0.0010363453],"study_design_scores_gemma":[0.39535424,0.0008520297,0.6023475,0.00011124536,0.00027200513,1.6470408e-7,0.00029297,0.00017432694,0.0004240806,0.0000042126285,0.000008811828,0.00015842888],"about_ca_topic_score_codex":0.0060643977,"about_ca_topic_score_gemma":0.01021435,"teacher_disagreement_score":0.3653862,"about_ca_system_score_codex":0.0002831448,"about_ca_system_score_gemma":0.00060760585,"threshold_uncertainty_score":0.9997179},"labels":[],"label_agreement":null},{"id":"W2066559291","doi":"10.1158/1538-7445.am2012-3217","title":"Abstract 3217: Mechanistic analysis of the ketogenic diet versus KetoCal® as adjuvant treatments for malignant glioma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ketogenic diet; Glioma; Medicine; Cancer; Internal medicine; Radiation therapy; Epilepsy; Carbohydrate; Adjuvant; Chemotherapy; Endocrinology; Cancer research; Oncology","score_opus":0.16285885881069023,"score_gpt":0.4603990236426961,"score_spread":0.29754016483200585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066559291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868374,0.0076114098,0.000011164483,0.00037346306,0.00069654116,0.0009118498,0.00014215277,0.00001318026,0.0034028227],"genre_scores_gemma":[0.9962978,0.0009824403,0.00003810414,0.00002848218,0.00027549427,0.00055107503,0.000017598064,0.000022264625,0.001786788],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980972,0.00007427318,0.00024492224,0.00023499757,0.0007075884,0.0006410515],"domain_scores_gemma":[0.9985815,0.00034129666,0.000076760145,0.0004532486,0.00035625388,0.00019089281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008116234,0.00013980434,0.0004929825,0.0002881531,0.00021974191,0.000011197884,0.00018321806,0.00006598082,0.00039146296],"category_scores_gemma":[0.00046824248,0.00008214828,0.000364734,0.0011260438,0.00017910023,0.000049328868,0.000120661425,0.00017287245,0.000027902457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03709051,0.003087221,0.15199226,0.001205847,0.05534056,0.00007075713,0.007177333,0.00003491747,0.6486008,0.014966142,0.017020268,0.06341337],"study_design_scores_gemma":[0.006157743,0.0013659729,0.8191349,0.00020425134,0.011853789,0.0000020240084,0.0019197364,0.00005288608,0.14118375,0.00044023088,0.017432105,0.0002526178],"about_ca_topic_score_codex":0.00063081604,"about_ca_topic_score_gemma":0.00014282903,"teacher_disagreement_score":0.6671426,"about_ca_system_score_codex":0.00019768826,"about_ca_system_score_gemma":0.0002246959,"threshold_uncertainty_score":0.42862448},"labels":[],"label_agreement":null},{"id":"W2066616838","doi":"10.1158/0008-5472.sabcs10-p6-11-11","title":"Abstract P6-11-11: Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Metastatic breast cancer; Cancer; Oncology; Chemotherapy; Disease; Adjuvant; Surgery","score_opus":0.034655863913858005,"score_gpt":0.4599737779359959,"score_spread":0.4253179140221379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066616838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311317,0.0017446749,6.672438e-7,0.010610774,0.0007531762,0.0014778697,0.00012891533,0.00003851762,0.0021322519],"genre_scores_gemma":[0.9928734,0.00065997156,0.00003865154,0.00025361482,0.00076907995,0.0025993406,0.000024725381,0.00004237408,0.0027388756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739605,0.00012734378,0.0002822823,0.0005733674,0.0007664317,0.00085449725],"domain_scores_gemma":[0.99874973,0.00018682473,0.00007392046,0.000393459,0.00031794002,0.0002781283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005140091,0.00023284044,0.00032959093,0.00017937717,0.00029273424,0.000051965257,0.00035779458,0.00016412308,0.0049895598],"category_scores_gemma":[0.0000343623,0.00015647626,0.00008544039,0.00057999615,0.0006499543,0.00013966375,0.00013071456,0.0012298406,0.000031682597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052576037,0.0013479029,0.35398227,0.00019583335,0.00013506034,0.000594675,0.01042197,0.00007494675,0.29666948,0.00013117775,0.016654458,0.3145346],"study_design_scores_gemma":[0.00507279,0.00039304057,0.9096799,0.00044197377,0.000047201596,0.00005945241,0.0010082052,0.0001306308,0.059238534,0.00006574986,0.023582095,0.00028046174],"about_ca_topic_score_codex":0.009621128,"about_ca_topic_score_gemma":0.021242395,"teacher_disagreement_score":0.55569756,"about_ca_system_score_codex":0.0007220951,"about_ca_system_score_gemma":0.0009664139,"threshold_uncertainty_score":0.9969739},"labels":[],"label_agreement":null},{"id":"W2066640676","doi":"10.1158/0008-5472.can-06-3792","title":"Faithful Companions: A Proposal for Neurooncology Trials in Pet Dogs","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research","keywords":"Preclinical testing; Medicine; Clinical trial; Cancer; Human disease; Neurooncology; Oncology; Animal model; Animal testing; Disease; Medical physics; Pathology; Cancer research; Internal medicine; Biology","score_opus":0.1503991134437441,"score_gpt":0.5151419137944451,"score_spread":0.36474280035070095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066640676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922384,0.0019993323,0.00050439476,0.0016961236,0.00019481382,0.002177114,0.00014331806,0.000010631486,0.0010358726],"genre_scores_gemma":[0.99571514,0.00069353887,0.00053744955,0.00011263897,0.00056241895,0.0011776066,0.000118642914,0.000030743842,0.0010518086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974514,0.00050196395,0.0003738222,0.00046983984,0.00033548687,0.00086743914],"domain_scores_gemma":[0.99878347,0.00038766756,0.000056535966,0.00029975153,0.00027889435,0.00019369986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00560389,0.00012503628,0.0003185303,0.00024181056,0.00013016358,0.00003969649,0.0002899679,0.0000947711,0.000080807935],"category_scores_gemma":[0.0013074881,0.00010663198,0.0001222471,0.0003166308,0.00020219707,0.0000049853143,0.000156089,0.00025496457,0.000015257317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008873656,0.0006197801,0.019701941,0.00014528286,0.00020368356,0.00020924624,0.00013952806,0.000030663192,0.8893098,0.0017701343,0.044356093,0.03464018],"study_design_scores_gemma":[0.014867701,0.005116916,0.020005397,0.000101429316,0.000027377659,0.00007098542,0.0004142315,0.000058908183,0.52652824,0.0047465684,0.42754933,0.00051293365],"about_ca_topic_score_codex":0.0016670923,"about_ca_topic_score_gemma":0.019421833,"teacher_disagreement_score":0.38319322,"about_ca_system_score_codex":0.00020052413,"about_ca_system_score_gemma":0.0011718451,"threshold_uncertainty_score":0.99847114},"labels":[],"label_agreement":null},{"id":"W2066697593","doi":"10.1158/0008-5472.can-07-0905","title":"Antiangiogenic Strategies on Defense: On the Possibility of Blocking Rebounds by the Tumor Vasculature after Chemotherapy","year":2007,"lang":"en","type":"review","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Homing (biology); Cytotoxic T cell; Bone marrow; Cancer research; Chemotherapy; Medicine; Angiogenesis; Neovascularization; Immunology; Biology; Internal medicine; In vitro","score_opus":0.09314178367977236,"score_gpt":0.4375364814281667,"score_spread":0.3443946977483944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066697593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02059975,0.97694653,0.000008615393,0.00025480465,0.00014417288,0.00091628125,0.00020921389,0.0000062179297,0.00091438275],"genre_scores_gemma":[0.04336767,0.95420724,0.000005709286,0.00037248968,0.000760582,0.00043135247,0.00005888854,0.00008406489,0.00071203196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970467,0.00052660337,0.00040993065,0.00071316457,0.00070712174,0.0005964944],"domain_scores_gemma":[0.9977906,0.00022376417,0.0001890392,0.0014044637,0.0003177817,0.00007438811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019278757,0.00038660332,0.00059370825,0.000091599715,0.00023497596,0.00010585639,0.00089344825,0.00041780912,0.00027463387],"category_scores_gemma":[0.00007276321,0.0001942888,0.0008733462,0.00048642157,0.0006325586,0.0000032267671,0.00015485907,0.0007117881,0.000011821975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012334146,0.00035160437,0.00013940533,0.0063970997,0.0026168625,0.00002499307,0.00030615245,0.000016568714,0.0059453994,0.00085427624,0.113871664,0.86824256],"study_design_scores_gemma":[0.00014865467,0.00023263779,0.000051284256,0.0018123409,0.00008661903,0.000007841056,0.00010896645,4.2871736e-7,0.005441225,0.000056030665,0.99181503,0.00023894686],"about_ca_topic_score_codex":0.00012116202,"about_ca_topic_score_gemma":0.00008135881,"teacher_disagreement_score":0.87794334,"about_ca_system_score_codex":0.00014002589,"about_ca_system_score_gemma":0.00096002774,"threshold_uncertainty_score":0.79228675},"labels":[],"label_agreement":null},{"id":"W2067058585","doi":"10.1158/0008-5472.sabcs-09-4115","title":"Radiological Assessment of the Anatomic Adequacy of Locoregional Lymphatic Radiotherapy Target Volumes for Locally Advanced Breast Cancer (LABC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Lymphatic system; DICOM; Lymphedema; Radiology; Lymph node; Nuclear medicine; Cancer; Internal medicine; Pathology","score_opus":0.02885066839005829,"score_gpt":0.4014214989396537,"score_spread":0.3725708305495954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067058585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739447,0.016822888,0.001887618,0.0053917784,0.00018111961,0.0011187512,0.0005311628,0.000009259287,0.00011272092],"genre_scores_gemma":[0.9939501,0.0035606022,0.0012191514,0.0002547167,0.00026566436,0.0005250441,0.000028027225,0.00002078697,0.0001758865],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829364,0.00015937802,0.00028948887,0.00041732105,0.000405228,0.00043492913],"domain_scores_gemma":[0.99877363,0.00007760348,0.0001467682,0.00041229816,0.0005166368,0.000073062525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032646905,0.00018245152,0.00034142114,0.00006126963,0.00014578419,0.00000914568,0.00046583434,0.000115023744,0.00008895485],"category_scores_gemma":[0.000042462158,0.00012383336,0.00018459705,0.00025945425,0.00053999096,0.0000072362236,0.00008664671,0.00011276695,2.2501293e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029092813,0.00064450584,0.11863094,0.00021904988,0.00087696203,0.0000024172764,0.00021713125,0.0037821676,0.7592268,0.0017059703,0.010173833,0.10161095],"study_design_scores_gemma":[0.0075570587,0.001286168,0.794858,0.00036270957,0.0000711486,0.00002492227,0.00025763863,0.0012079633,0.1832153,0.0014369936,0.00927752,0.00044460394],"about_ca_topic_score_codex":0.00016785062,"about_ca_topic_score_gemma":0.000058672973,"teacher_disagreement_score":0.67622703,"about_ca_system_score_codex":0.00029726548,"about_ca_system_score_gemma":0.0009994769,"threshold_uncertainty_score":0.5049778},"labels":[],"label_agreement":null},{"id":"W2067697669","doi":"10.1158/0008-5472.can-06-0984","title":"Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Carcinogenesis; Cancer research; E2F; Biology; Retinoblastoma protein; Dysplasia; Cervical cancer; Context (archaeology); Cervical intraepithelial neoplasia; Cell cycle; Cancer; Genetics","score_opus":0.10466521998381184,"score_gpt":0.47556721165627547,"score_spread":0.3709019916724636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067697669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96289873,0.007965772,0.000058602625,0.0040628402,0.00013433099,0.0013424589,0.00010534571,0.000029769852,0.023402158],"genre_scores_gemma":[0.99709487,0.00027329804,0.000092495175,0.00013122801,0.00074816734,0.00043004975,0.000048885227,0.000050974573,0.0011300257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99683577,0.00013665797,0.00043758444,0.00049253425,0.0011155633,0.0009818889],"domain_scores_gemma":[0.9973066,0.0004909471,0.000024275461,0.00042176121,0.0014655329,0.00029087852],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010600614,0.00016083149,0.0005167943,0.0004412841,0.00016264827,0.000030799216,0.00028820272,0.000189801,0.003943721],"category_scores_gemma":[0.0004106164,0.00014070333,0.00014100662,0.0008305894,0.0004957276,0.000068069734,0.00016626922,0.0005730434,0.000030190577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00858692,0.0018551401,0.34907457,0.005720103,0.00011993019,0.00021013145,0.00041802184,0.000026991827,0.53491455,0.015400025,0.043127444,0.04054619],"study_design_scores_gemma":[0.005277979,0.0019764944,0.7003873,0.00023287832,0.00005246118,0.0000069062817,0.0003187197,0.00024658488,0.26608196,0.00947331,0.015615701,0.0003296695],"about_ca_topic_score_codex":0.007971597,"about_ca_topic_score_gemma":0.006062775,"teacher_disagreement_score":0.35131276,"about_ca_system_score_codex":0.0006091107,"about_ca_system_score_gemma":0.0006894821,"threshold_uncertainty_score":0.9986344},"labels":[],"label_agreement":null},{"id":"W2067886336","doi":"10.1158/1538-7445.am2013-4636","title":"Abstract 4636: AMF-1c-120: an antibody specific for misfolded prion protein expressed on ovarian cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Amorfix (Canada)","funders":"","keywords":"Epitope; Ovarian cancer; Antibody; Monoclonal antibody; Biology; Cancer research; Cancer; Cancer cell; Cell; Molecular biology; Cell biology; Chemistry; Biochemistry; Immunology; Genetics","score_opus":0.1305254298373891,"score_gpt":0.445991377009292,"score_spread":0.3154659471719029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067886336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765249,0.0018466448,0.00003284362,0.010785794,0.00024823885,0.0054644174,0.0002522285,0.00008136078,0.004763574],"genre_scores_gemma":[0.95329034,0.0037119421,0.00071581424,0.00043370746,0.002565873,0.004673538,0.0002444848,0.00013713539,0.034227192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99519235,0.00018421483,0.00045860765,0.00096271705,0.0017060367,0.0014960824],"domain_scores_gemma":[0.99684614,0.00028625733,0.00008942337,0.00080369256,0.001142546,0.000831926],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00100378,0.00034964233,0.00051641883,0.00044219097,0.0005002865,0.0002284145,0.00055674877,0.00025050115,0.010176665],"category_scores_gemma":[0.00008761854,0.00027136452,0.0001969632,0.00054587936,0.00037811257,0.00027841376,0.00013627432,0.0011443504,0.0005601362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002417627,0.00051778683,0.00051015493,0.0006047891,0.00008831961,0.00005067341,0.00026208675,0.000016874557,0.89330715,0.00037230254,0.05976007,0.042092174],"study_design_scores_gemma":[0.0029946675,0.0012920302,0.030663751,0.0008758867,0.000014090025,0.000004122079,0.00019181483,0.0003136764,0.6614759,0.0006170884,0.30115744,0.00039950688],"about_ca_topic_score_codex":0.008389686,"about_ca_topic_score_gemma":0.00019196949,"teacher_disagreement_score":0.24139738,"about_ca_system_score_codex":0.00042909235,"about_ca_system_score_gemma":0.00079491985,"threshold_uncertainty_score":0.99997383},"labels":[],"label_agreement":null},{"id":"W2068142600","doi":"10.1158/1538-7445.fbcr13-b62","title":"Abstract B62: Proteomic dynamics of stromal exosomes during processing in cancer cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Microvesicles; Tetraspanin; Biology; Exosome; Cell biology; Stromal cell; Cancer cell; Endocytic cycle; CD81; Tumor microenvironment; Cancer; Cancer research; Metastasis; Cell; Immunology; microRNA; Endocytosis; Biochemistry","score_opus":0.026545827864580544,"score_gpt":0.3568732129688433,"score_spread":0.33032738510426274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068142600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570894,0.0030485885,0.000012578965,0.00017334535,0.00004854136,0.00065536273,0.00004295213,0.000006965244,0.00030270903],"genre_scores_gemma":[0.997902,0.00044601172,0.00018386893,0.000009083133,0.00015426398,0.00057413353,0.000017882609,0.000036488636,0.00067628967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985048,0.00006792827,0.0002497993,0.00037154014,0.00031601446,0.00048988394],"domain_scores_gemma":[0.99924433,0.000008360504,0.00007564167,0.00031869285,0.0002345148,0.000118461256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025774635,0.00012422721,0.00014177163,0.00011928226,0.00006909189,0.000040543153,0.0003562272,0.00012612402,0.00027468638],"category_scores_gemma":[0.000044961744,0.0001239876,0.000050154737,0.00021041161,0.00021938562,0.000015192351,0.00018615046,0.00028333144,0.000012004918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000793722,0.00008482212,0.016597478,0.00041804017,0.0000109985085,0.0000070255237,0.000056873956,0.00029579177,0.9770434,0.0000052950904,0.00014227806,0.0052586305],"study_design_scores_gemma":[0.00045038847,0.000042318607,0.082156,0.00014925707,0.0000029854207,8.517208e-7,0.00014473806,0.00030706832,0.9164939,0.00007560441,0.00004228805,0.00013460906],"about_ca_topic_score_codex":0.0012109881,"about_ca_topic_score_gemma":0.0005159451,"teacher_disagreement_score":0.06555852,"about_ca_system_score_codex":0.00018341256,"about_ca_system_score_gemma":0.000480489,"threshold_uncertainty_score":0.5056067},"labels":[],"label_agreement":null},{"id":"W2068276080","doi":"10.1158/1538-7445.am2011-1404","title":"Abstract 1404: L1CAM in non-small-cell lung carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Vinorelbine; Cancer research; Cisplatin; Small hairpin RNA; L1; Lung cancer; Gene knockdown; Matrigel; Cell culture; Oncology; Chemotherapy; Pathology; Internal medicine; Biology; Angiogenesis","score_opus":0.07964099165054422,"score_gpt":0.35936630364045113,"score_spread":0.2797253119899069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068276080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95973366,0.0036956768,0.000038312915,0.00007371406,0.00010514519,0.0003005303,0.0000127340645,0.000004309056,0.036035925],"genre_scores_gemma":[0.99523467,0.0010480226,0.00009082577,0.000042661974,0.00024327995,0.00041524516,0.000016431828,0.000025513522,0.0028833481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862593,0.000080007674,0.0001640676,0.00040749658,0.00022172798,0.00050079264],"domain_scores_gemma":[0.9990794,0.0000136573,0.000027494249,0.0005075614,0.0002663611,0.00010550194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007558361,0.00009659992,0.00009471526,0.00014532107,0.00012168538,0.000025222747,0.0003838532,0.00014369113,0.00033497365],"category_scores_gemma":[0.000022660548,0.000093592374,0.000044596203,0.0002974726,0.00013934601,0.0000043366604,0.000128582,0.00035430348,0.000049822604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097034856,0.00015331568,0.045259908,0.0000773149,0.000013298569,0.000014827423,0.0005582244,0.000016998916,0.93676025,0.00011100591,0.012422499,0.0045153107],"study_design_scores_gemma":[0.0006606881,0.0001246253,0.29899567,0.000038044276,0.0000038534545,0.0000016840662,0.00053345243,0.00003324097,0.67445344,0.00011294423,0.024834944,0.00020740018],"about_ca_topic_score_codex":0.0025684198,"about_ca_topic_score_gemma":0.000763329,"teacher_disagreement_score":0.2623068,"about_ca_system_score_codex":0.00010055401,"about_ca_system_score_gemma":0.0003573291,"threshold_uncertainty_score":0.38826996},"labels":[],"label_agreement":null},{"id":"W2068355597","doi":"10.1158/0008-5472.sabcs-09-4042","title":"Using Ki67 To Improve and Simplify Outcome Modeling for Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphovascular invasion; Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Estrogen receptor; Hormonal therapy; Population; Stage (stratigraphy); Prognostic variable; Cohort; Chemotherapy; Gynecology; Metastasis; Biology","score_opus":0.1410516679872525,"score_gpt":0.4759152364194149,"score_spread":0.3348635684321624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068355597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814124,0.0031066434,0.0028676775,0.004439147,0.0001407493,0.00065737835,0.00054830604,0.00001336736,0.000085491694],"genre_scores_gemma":[0.99703306,0.00039161067,0.0008180421,0.00055580685,0.0006799213,0.00031238442,0.000009807483,0.000026216632,0.0001731618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985827,0.000029189516,0.00015812616,0.00050263084,0.00019142508,0.0005359213],"domain_scores_gemma":[0.99920714,0.000017068804,0.000024206143,0.00025523396,0.00033541134,0.00016093753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023320365,0.0001525321,0.00018271674,0.00007274863,0.00026679464,0.000043346903,0.00015300757,0.00008744572,0.0000134412385],"category_scores_gemma":[0.00004289787,0.00013821862,0.00005268538,0.000144074,0.00006104417,0.000005920854,0.0001435211,0.00010890311,0.0000013633228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010494461,0.00007019008,0.011056231,0.00009243796,0.00016088742,0.0000026754446,0.00019999845,0.0044967774,0.88389605,0.0001330529,0.001589958,0.0972523],"study_design_scores_gemma":[0.022957643,0.0043991604,0.16588616,0.0010899563,0.0006389313,0.00018550208,0.003073701,0.049995333,0.70045626,0.006242888,0.03991316,0.0051613054],"about_ca_topic_score_codex":0.0009956873,"about_ca_topic_score_gemma":0.00032276878,"teacher_disagreement_score":0.18343979,"about_ca_system_score_codex":0.00017765674,"about_ca_system_score_gemma":0.0001774316,"threshold_uncertainty_score":0.56363916},"labels":[],"label_agreement":null},{"id":"W2068473940","doi":"10.1158/0008-5472.can-14-2607","title":"When Will Resistance Be Futile?","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Drug resistance; Cancer; Drug; Biology; Cancer research; Pharmacology; Medicine; Genetics","score_opus":0.2093229256531513,"score_gpt":0.510930318427078,"score_spread":0.30160739277392673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068473940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010354403,0.96767294,0.000012704889,0.0013071467,0.0003369421,0.0029106967,0.0001220607,0.00011492203,0.027512228],"genre_scores_gemma":[0.000011798023,0.8527102,0.000134245,0.00015923906,0.0023412795,0.0018719292,0.00014708865,0.00025037458,0.14237384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908192,0.001114931,0.0009535141,0.0014794804,0.0035616842,0.0020711725],"domain_scores_gemma":[0.993644,0.0015907404,0.00020048434,0.0026245576,0.0010134099,0.00092678354],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0037608587,0.0006244904,0.0030524554,0.0009825482,0.0003124085,0.00015174948,0.001359825,0.0008606333,0.0038473143],"category_scores_gemma":[0.0015051449,0.00047843545,0.0007320815,0.0015097408,0.0010019044,0.00012096415,0.00077934103,0.003409469,0.0012756339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014560741,0.000062579034,6.3746916e-7,0.09720604,0.00035570914,0.00042184032,0.0001173401,1.2977897e-7,0.0000030123392,0.000824501,0.37439096,0.5264717],"study_design_scores_gemma":[0.0028053457,0.0001257861,3.283992e-7,0.042712077,0.00031800463,0.0001272148,0.000019513644,0.00001166998,0.000012707873,0.00021345206,0.95326644,0.00038743365],"about_ca_topic_score_codex":0.00084065,"about_ca_topic_score_gemma":0.00038533087,"teacher_disagreement_score":0.57887554,"about_ca_system_score_codex":0.049827535,"about_ca_system_score_gemma":0.059367653,"threshold_uncertainty_score":0.9997667},"labels":[],"label_agreement":null},{"id":"W2068525838","doi":"10.1158/1538-7445.am2014-lb-202","title":"Abstract LB-202: The rare, highly malignant small cell carcinoma of the ovary displays common inactivating germline and somatic mutations in the tumor suppressor SMARCA4","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"SMARCA4; Germline; Biology; Germline mutation; Ovarian cancer; Cancer research; Ovarian carcinoma; Ovary; Somatic cell; Pathology; Cancer; Mutation; Internal medicine; Medicine; Endocrinology; Chromatin remodeling; Genetics; Epigenetics; Gene","score_opus":0.03393921870807376,"score_gpt":0.31728990618068387,"score_spread":0.2833506874726101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068525838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611944,0.0012826589,0.000036957797,0.0012645983,0.00005689438,0.00039750634,0.00004094296,0.0000029481002,0.0007980436],"genre_scores_gemma":[0.99927026,0.00006469137,0.000043652715,0.00015905457,0.00014482942,0.00016595119,0.000020196236,0.00001876642,0.000112613525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851924,0.00038492895,0.0002611991,0.00024297454,0.0002937603,0.0002978795],"domain_scores_gemma":[0.99889976,0.00030751652,0.00010263568,0.0005536415,0.0000989735,0.00003746174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010882319,0.00011591172,0.00013806572,0.000037696238,0.00026465117,0.000044527133,0.0005175887,0.000060875278,0.000014303889],"category_scores_gemma":[0.000116223804,0.000060606693,0.000059288508,0.00018020748,0.00033152182,0.0000048376764,0.00020953774,0.00034442203,0.0000010437018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000720945,0.00008534018,0.01310133,0.00034259533,0.000014691301,0.0000033076965,0.001011887,0.0009766428,0.9818706,0.00013774827,0.00074178755,0.0016419656],"study_design_scores_gemma":[0.00094413845,0.00015572082,0.18930434,0.00022565963,0.000023045204,0.000016609622,0.002277744,0.004396872,0.8008195,0.00059796777,0.001051929,0.00018643867],"about_ca_topic_score_codex":0.002101244,"about_ca_topic_score_gemma":0.0009173405,"teacher_disagreement_score":0.18105106,"about_ca_system_score_codex":0.00003521604,"about_ca_system_score_gemma":0.00017752222,"threshold_uncertainty_score":0.31764662},"labels":[],"label_agreement":null},{"id":"W2068717542","doi":"10.1158/0008-5472.sabcs12-p4-16-14","title":"Abstract P4-16-14: Salvage Radiotherapy and Cisplatin for Triple Negative Breast Cancer: A Multi-Centre Study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Triple-negative breast cancer; Radiation therapy; Breast cancer; Cancer; Oncology; Mastectomy; Internal medicine; Chemotherapy; Surgery","score_opus":0.061188634116711306,"score_gpt":0.4116749408356718,"score_spread":0.35048630671896047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068717542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805873,0.015444198,0.00008875402,0.0011613419,0.00024647202,0.001631551,0.0007505131,0.000016479453,0.00007336678],"genre_scores_gemma":[0.99367774,0.0027721429,0.00026927708,0.00010213696,0.00090018776,0.0013549245,0.000032519558,0.00005428604,0.0008368003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817425,0.00012271924,0.00018815033,0.0004940107,0.0002797105,0.0007411489],"domain_scores_gemma":[0.99903244,0.00009591629,0.000067892084,0.00030531868,0.00029636998,0.00020207159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047863022,0.00023159946,0.00026312273,0.00007391697,0.00032263985,0.000043277825,0.0001780743,0.00010587133,0.0001659566],"category_scores_gemma":[0.000060946688,0.00019747365,0.00007304484,0.00015553854,0.00020769303,0.000015847314,0.000126,0.00018274711,0.0000040270143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042454586,0.0023661375,0.7005619,0.0002146188,0.0019394349,0.000006333694,0.008236807,0.000019809086,0.15557258,0.000028991144,0.029288664,0.09751931],"study_design_scores_gemma":[0.013355926,0.00033497025,0.9228273,0.000087285334,0.00008239958,0.000010905551,0.0034929183,0.000017810034,0.046144202,0.000017960514,0.013128198,0.0005001146],"about_ca_topic_score_codex":0.0040508243,"about_ca_topic_score_gemma":0.0033865317,"teacher_disagreement_score":0.22226545,"about_ca_system_score_codex":0.0003171981,"about_ca_system_score_gemma":0.00018975363,"threshold_uncertainty_score":0.8052742},"labels":[],"label_agreement":null},{"id":"W2068728061","doi":"10.1158/1538-7445.am2013-2243a","title":"Abstract 2243A: Discovery of potent hedgehog pathway inhibitors as potential anticancer agents.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Vismodegib; Hedgehog signaling pathway; Hedgehog; Cancer; Basal cell carcinoma; Medicine; Pharmacology; Cancer research; Biology; Chemistry; Signal transduction; Internal medicine; Basal cell; Biochemistry","score_opus":0.04759224253651414,"score_gpt":0.3620676568536678,"score_spread":0.3144754143171537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068728061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257594,0.0033629318,0.000076430704,0.0005166689,0.00040961948,0.0005121178,0.00006259705,0.000013043052,0.0024706477],"genre_scores_gemma":[0.9951424,0.0014199865,0.000038457292,0.00011309634,0.00073189376,0.00023263437,0.000036662354,0.00004589941,0.0022389812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976063,0.000118724565,0.00036139146,0.0005503215,0.00069829536,0.0006650181],"domain_scores_gemma":[0.99862456,0.00003252487,0.00009641994,0.0005058213,0.0005860851,0.0001545758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235305,0.0002064906,0.00025782443,0.00013015355,0.00017996151,0.000077754514,0.00039691894,0.000173738,0.00024127093],"category_scores_gemma":[0.00021512891,0.00017980728,0.00016279843,0.0002493519,0.0004943272,0.00002048341,0.00040951313,0.0003034284,0.00013627195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007668937,0.00010702167,0.0015652382,0.00010246856,0.00013206119,0.000017209422,0.00010128283,0.00013175285,0.97785664,0.000039852453,0.011230815,0.008638976],"study_design_scores_gemma":[0.0004736222,0.00024819552,0.01735195,0.00010244523,0.0000094159495,0.0000036744964,0.00042315014,0.000009995518,0.97291666,0.00016059758,0.008075256,0.0002250273],"about_ca_topic_score_codex":0.0015042129,"about_ca_topic_score_gemma":0.000050409573,"teacher_disagreement_score":0.015786711,"about_ca_system_score_codex":0.00008288775,"about_ca_system_score_gemma":0.00047796074,"threshold_uncertainty_score":0.7332328},"labels":[],"label_agreement":null},{"id":"W2068732147","doi":"10.1158/1538-7445.am10-2901","title":"Abstract 2901: Visualization and delineation of high-risk fields in the oral cavity","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Medicine; Dysplasia; Lesion; Cancer; Pathology; Disease; Stage (stratigraphy); Biopsy; Field cancerization; Internal medicine; Oncology; Biology","score_opus":0.10182704801010395,"score_gpt":0.5030237953235438,"score_spread":0.40119674731343985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068732147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892515,0.00016356788,0.000088177585,0.0003055229,0.00017143249,0.00021339269,0.00002772261,0.0000051026327,0.000099921876],"genre_scores_gemma":[0.9994735,0.00018970217,0.00003451799,0.000033267832,0.000068886395,0.000055831413,0.000014635301,0.0000039668903,0.00012569169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999193,0.00020356973,0.00013456089,0.00012263293,0.00019633674,0.00014991297],"domain_scores_gemma":[0.9994713,0.0001975105,0.000039996416,0.00015372375,0.00011048976,0.000026983476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011893378,0.000040590938,0.00007549048,0.00006391735,0.00011002068,0.000011971214,0.00007924246,0.00011632255,0.00017187367],"category_scores_gemma":[0.00012743475,0.000028147706,0.0000107225615,0.000165482,0.000099556186,0.00005489718,0.000023763192,0.0004514514,0.00001668416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016615157,0.00017507977,0.91330606,0.00011465196,0.000009487867,0.00004949573,0.0010552816,0.000021914133,0.0015220798,0.0042023677,0.00067834253,0.07869909],"study_design_scores_gemma":[0.0004380446,0.00006667681,0.9949365,0.000012268025,0.000004527276,0.000004005203,0.00011044206,0.000092351875,0.0029932985,0.0009162689,0.0003983154,0.0000273011],"about_ca_topic_score_codex":0.012352223,"about_ca_topic_score_gemma":0.04636093,"teacher_disagreement_score":0.08163044,"about_ca_system_score_codex":0.000025446892,"about_ca_system_score_gemma":0.00006807659,"threshold_uncertainty_score":0.9942246},"labels":[],"label_agreement":null},{"id":"W2068873298","doi":"10.1158/1538-7445.am2013-3633","title":"Abstract 3633: Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Lung cancer; Medicine; Odds ratio; Confidence interval; Confounding; Tobacco smoke; Cannabis; Cancer; Risk factor; Internal medicine; Oncology; Logistic regression; Environmental health; Psychiatry","score_opus":0.032234779708406554,"score_gpt":0.40782766097528966,"score_spread":0.3755928812668831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068873298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049035,0.023959745,0.0000063684815,0.067232095,0.00023409656,0.0014120293,0.00016762862,0.000025143308,0.0020594269],"genre_scores_gemma":[0.9751227,0.009725889,0.000008407833,0.00077480765,0.0006029718,0.004120518,0.000028178249,0.000043407228,0.009573113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528545,0.00028634846,0.0005006254,0.00074670184,0.0020927633,0.0010881034],"domain_scores_gemma":[0.99760157,0.0001158775,0.00013092108,0.0005946419,0.0011806195,0.00037635033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024586373,0.0002592677,0.0004947437,0.0011066805,0.00037043152,0.00039406455,0.00063143537,0.00018016757,0.010762306],"category_scores_gemma":[0.00038191356,0.00018342052,0.00019686898,0.0022732269,0.00047142906,0.0002551952,0.00025672576,0.0018264764,0.000009406322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016326821,0.00010777903,0.7038962,0.00024329721,0.0016624905,0.0000721602,0.0016196809,0.00036412096,0.005508165,0.00007637452,0.26463902,0.02164741],"study_design_scores_gemma":[0.0013749462,0.000039091345,0.96497303,0.0002367838,0.0005641706,0.00000584178,0.0011767498,0.007405955,0.0011780092,0.0000382313,0.022776505,0.00023068563],"about_ca_topic_score_codex":0.24388954,"about_ca_topic_score_gemma":0.033660952,"teacher_disagreement_score":0.26107678,"about_ca_system_score_codex":0.0014553427,"about_ca_system_score_gemma":0.0015063601,"threshold_uncertainty_score":0.990142},"labels":[],"label_agreement":null},{"id":"W2068951398","doi":"10.1158/1538-7445.am2011-2885","title":"Abstract 2885: The NCI-Nature Pathway Interaction Database: A comprehensive resource for cell signaling information","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science; World Wide Web; Database; XML; SQL; Metadata; Resource (disambiguation); Information retrieval","score_opus":0.1190194912533565,"score_gpt":0.39290945894353185,"score_spread":0.2738899676901754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068951398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896189,0.003190535,0.0020186165,0.0006490765,0.0003042289,0.0005343659,0.00019089888,0.000024730067,0.0034686397],"genre_scores_gemma":[0.9979238,0.00016108433,0.0005795592,0.00039303975,0.00028098476,0.00016665677,0.00024182494,0.0000098065175,0.00024326393],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991284,0.00006948056,0.00014329178,0.00017551068,0.00021291609,0.00027037805],"domain_scores_gemma":[0.99921775,0.00011074965,0.000060015554,0.00027353116,0.00028003953,0.000057944995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050271174,0.00008163813,0.00007345358,0.000050221308,0.00020002038,0.00003556548,0.00028290224,0.0001969319,0.000061524595],"category_scores_gemma":[0.0002034205,0.00005549346,0.00004907074,0.00010186412,0.00016789502,0.000010881444,0.00012777343,0.00045814013,0.000014036761],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075951417,0.000054005577,0.00008444627,0.00018286439,0.000045087476,0.0000021682695,0.0011337232,0.000015000634,0.8649411,0.00010400048,0.06640849,0.06626956],"study_design_scores_gemma":[0.00026389677,0.00014585271,0.00043308092,0.000034649584,0.000003350638,0.0000017696856,0.0019431718,0.0000234965,0.41144463,0.00005461347,0.5855837,0.000067821165],"about_ca_topic_score_codex":0.00011194706,"about_ca_topic_score_gemma":0.000028630182,"teacher_disagreement_score":0.5191752,"about_ca_system_score_codex":0.000027707229,"about_ca_system_score_gemma":0.00013064263,"threshold_uncertainty_score":0.22629575},"labels":[],"label_agreement":null},{"id":"W2069088959","doi":"10.1158/1538-7445.am10-4023","title":"Abstract 4023: Novel role of neurofibromin in transport of RNA granules","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Neurofibromin 1; Biology; Dynein; Immunoprecipitation; Cell biology; Microtubule; RNA; Prohibitin; RNA editing; RNA-binding protein; Molecular biology; Neurofibromatosis; Mitochondrion; Genetics; Gene","score_opus":0.05504601075863422,"score_gpt":0.4024993969988291,"score_spread":0.34745338624019484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069088959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950178,0.00018387577,8.293539e-7,0.00028012585,0.000043342156,0.0004517307,0.00007786261,0.000008409107,0.0039359694],"genre_scores_gemma":[0.99929816,0.00016562338,0.00009198474,0.000008377509,0.00004669965,0.000065327724,0.000008878036,0.000023568125,0.00029139232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820405,0.000028100181,0.00028614563,0.00024696923,0.00080152415,0.00043319966],"domain_scores_gemma":[0.9990041,0.00014688654,0.000043184562,0.00034756228,0.00025198256,0.00020624655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043461134,0.00009529084,0.00028861914,0.00043027988,0.000027480855,0.000003903011,0.00016673772,0.00007394396,0.0005073727],"category_scores_gemma":[0.00011706844,0.000078912155,0.00008077106,0.0004948187,0.00032234806,0.000064518106,0.00003356532,0.00073556905,0.000014069028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008844145,0.0005568668,0.053888213,0.0002451759,0.00002669587,0.00009021835,0.00011920978,0.0000023228822,0.9377669,0.0001327647,0.00005699184,0.0062301937],"study_design_scores_gemma":[0.001515263,0.00024356916,0.4605868,0.000103624836,0.000004624894,0.000005126436,0.000041095096,0.000009060908,0.53702986,0.00008319452,0.00034597752,0.000031820404],"about_ca_topic_score_codex":0.00302161,"about_ca_topic_score_gemma":0.0013190678,"teacher_disagreement_score":0.40669858,"about_ca_system_score_codex":0.00004163468,"about_ca_system_score_gemma":0.00048346625,"threshold_uncertainty_score":0.5555376},"labels":[],"label_agreement":null},{"id":"W2069475544","doi":"10.1158/1538-7445.am10-3777","title":"Abstract 3777: Diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Confounding; Odds ratio; Environmental health; Confidence interval; Epidemiology; Logistic regression; Job-exposure matrix; Case-control study; Cancer; Demography; Toxicology; Internal medicine; Occupational exposure; Biology","score_opus":0.08424021238042816,"score_gpt":0.42979824198685296,"score_spread":0.3455580296064248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069475544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916354,0.004934166,0.0000017067771,0.0024736314,0.00007879692,0.00038320295,0.00036057245,0.000005383332,0.00012714944],"genre_scores_gemma":[0.9946129,0.0046044905,0.000034922945,0.00037328785,0.0000705992,0.00014285451,0.0000016451686,0.000010982051,0.00014833655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798054,0.00025876085,0.00027482334,0.00043563623,0.00045104022,0.00059918314],"domain_scores_gemma":[0.9986698,0.0006878946,0.000066151784,0.00022447265,0.000044738543,0.00030692536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016165315,0.00012894072,0.0003225906,0.00015130744,0.00025231438,0.00004074928,0.00013957039,0.00007106746,0.00094819977],"category_scores_gemma":[0.0006197101,0.000110366534,0.00001485749,0.00081809773,0.00042313407,0.00016657164,0.0001703367,0.00088433607,0.0000032360522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011997169,0.000022961647,0.9871082,0.000058672296,0.00016584946,0.00040827415,0.0022637038,0.00048294367,0.0016101566,0.0000027104318,0.00220475,0.0055518346],"study_design_scores_gemma":[0.000727608,0.000019299956,0.9942008,0.00003735211,0.000075019016,0.0000023961552,0.0009085168,0.003053785,0.00006567084,0.00004090575,0.00074238447,0.00012622564],"about_ca_topic_score_codex":0.99246854,"about_ca_topic_score_gemma":0.99892586,"teacher_disagreement_score":0.0070926645,"about_ca_system_score_codex":0.0007166141,"about_ca_system_score_gemma":0.00033185797,"threshold_uncertainty_score":0.9999651},"labels":[],"label_agreement":null},{"id":"W2069595219","doi":"10.1158/0008-5472.sabcs11-p1-06-17","title":"P1-06-17: A New Pathological Response Index (PRI) for Neoadjuvant Chemotherapy Accurately Predicts Clinical Outcomes of Locally Advanced Breast Cancers (LAPBC).","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Neoadjuvant therapy; Oncology; Taxane; Chemotherapy; Pathological; Surrogate endpoint; Anthracycline; Lymph node; Cancer; Regimen; Proportional hazards model","score_opus":0.15478736520600941,"score_gpt":0.4501930441897269,"score_spread":0.2954056789837175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069595219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917905,0.0027583535,0.001315054,0.0017461078,0.00028633836,0.0012748678,0.00041905258,0.000036900958,0.00037286954],"genre_scores_gemma":[0.99385464,0.0020014518,0.0010084783,0.0005364195,0.00035970414,0.00050960004,0.000046460616,0.00006331884,0.0016199274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967202,0.00036728053,0.00060136017,0.0010354653,0.000474213,0.00080148794],"domain_scores_gemma":[0.99771035,0.0003030216,0.00019551578,0.0008791427,0.0005907196,0.00032125995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015451537,0.00032434586,0.00060474634,0.0001085115,0.00015737557,0.000018046583,0.0006000366,0.00034191879,0.00012312815],"category_scores_gemma":[0.00064602436,0.00025506338,0.00029799514,0.0002635443,0.000737646,0.000014058656,0.00029510126,0.0003256155,0.0000058013006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.108819574,0.0010573255,0.5702723,0.00013046467,0.0018575846,0.00006134184,0.0016154646,0.000105323685,0.07066343,0.00014939523,0.049162954,0.19610484],"study_design_scores_gemma":[0.009476984,0.0022709428,0.9294744,0.00011878677,0.00005187173,0.000022634245,0.00042582737,0.00001716947,0.03627241,0.00040747144,0.021052351,0.00040915777],"about_ca_topic_score_codex":0.0005672351,"about_ca_topic_score_gemma":0.0004949166,"teacher_disagreement_score":0.3592021,"about_ca_system_score_codex":0.00021390128,"about_ca_system_score_gemma":0.0018157689,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W2069632351","doi":"10.1158/1538-7445.am10-3404","title":"Abstract 3404: Identification of potential oncogenes in osteosarcoma pathogenesis by high-resolution array comparative genomic hybridization","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Comparative genomic hybridization; Osteosarcoma; Biology; Cancer research; Copy number analysis; Gene dosage; Copy-number variation; Gene duplication; Gene; Cancer; Genetics; Gene expression; Genome","score_opus":0.0246104365639974,"score_gpt":0.3203939752227683,"score_spread":0.2957835386587709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069632351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783164,0.0006460782,0.00055639696,0.00012311799,0.00019335993,0.00025731273,0.00029435626,0.0000045557426,0.00009315301],"genre_scores_gemma":[0.9985168,0.000284712,0.00014283255,0.0000076029332,0.00019666977,0.00011049507,0.00047273462,0.000013907148,0.00025422123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987923,0.00011012729,0.000345402,0.0002902211,0.00021902872,0.00024295128],"domain_scores_gemma":[0.9992434,0.000015000143,0.00012357807,0.00026499256,0.00030240562,0.000050638435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005382973,0.00009657099,0.0001300018,0.000112955284,0.00011586508,0.00003316656,0.00021257333,0.00011714032,0.0000867738],"category_scores_gemma":[0.000030865864,0.000101209764,0.00004305175,0.00016783457,0.00013995821,0.000011592276,0.00005763301,0.00015294206,0.0000115916655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008019848,0.00007767284,0.0031350267,0.000025865953,0.000019163415,6.684221e-7,0.00013912091,0.0007157417,0.9946032,0.00013235101,0.00037038396,0.0007005938],"study_design_scores_gemma":[0.0003337968,0.00005542252,0.08973953,0.0000074109344,0.0000054656657,0.0000023404261,0.00022983493,0.000051977102,0.9081457,0.00010103305,0.0012295721,0.00009791077],"about_ca_topic_score_codex":0.0010128024,"about_ca_topic_score_gemma":0.00082217687,"teacher_disagreement_score":0.086604506,"about_ca_system_score_codex":0.00005322856,"about_ca_system_score_gemma":0.00022410789,"threshold_uncertainty_score":0.41272146},"labels":[],"label_agreement":null},{"id":"W2069925950","doi":"10.1158/1538-7445.am2012-2907","title":"Abstract 2907: Novel liposomal compositions of PharmaGap's lead peptide: Effect on ovarian cancer cell proliferation and signaling pathways","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Liposome; Ovarian cancer; Cell growth; Cancer research; Cancer; Protein kinase B; Cancer cell; Biology; Chemistry; Signal transduction; Medicine; Cell biology; Biochemistry; Internal medicine","score_opus":0.06531940837103081,"score_gpt":0.3901461091653199,"score_spread":0.3248267007942891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069925950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992339,0.0051254327,0.000045074692,0.00012077983,0.000093359966,0.0006038284,0.00029002153,0.000007819392,0.0013746833],"genre_scores_gemma":[0.99748176,0.000979102,0.00006448616,0.0000402405,0.00058839255,0.00049483916,0.000117745476,0.000028589498,0.00020484092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984408,0.00011293885,0.00016483381,0.00030773273,0.00042694947,0.000546737],"domain_scores_gemma":[0.99923205,0.00006669942,0.000052906795,0.00022496909,0.00019870843,0.00022463537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049486087,0.00014961365,0.00015731585,0.00008150307,0.00021250422,0.000042865468,0.00013329936,0.00009818852,0.00014886363],"category_scores_gemma":[0.000032028303,0.00013123894,0.000062151346,0.0001340784,0.00014384852,0.000021456484,0.00009630381,0.00024197271,0.000009633336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006545692,0.0003009454,0.01014215,0.00016045867,0.00009167883,0.000002378952,0.00013115047,0.000056010453,0.98269427,0.00003467158,0.00081750937,0.004914231],"study_design_scores_gemma":[0.0016162422,0.0007557861,0.008514747,0.000088885565,0.000017250748,0.000003298935,0.000037239814,0.000024570947,0.9873237,0.000006538189,0.0014869587,0.00012478088],"about_ca_topic_score_codex":0.0020589223,"about_ca_topic_score_gemma":0.00039615273,"teacher_disagreement_score":0.0051427637,"about_ca_system_score_codex":0.00014253466,"about_ca_system_score_gemma":0.00025004646,"threshold_uncertainty_score":0.5351768},"labels":[],"label_agreement":null},{"id":"W2070090424","doi":"10.1158/0008-5472.can-08-4754","title":"Peroxisome Proliferator-Activated Receptor-γ Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"XIAP; Peroxisome proliferator-activated receptor; Chemistry; Apoptosis; Carcinogenesis; Cancer research; Receptor; Endocrinology; Internal medicine; Colorectal cancer; Cancer; Biology; Medicine; Biochemistry; Programmed cell death; Caspase","score_opus":0.17425735658433236,"score_gpt":0.5030674927568697,"score_spread":0.3288101361725373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070090424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868673,0.0027164214,0.000005995294,0.0074701207,0.0009530545,0.0013230841,0.000067007626,0.000034068893,0.0005629344],"genre_scores_gemma":[0.9953025,0.00061078026,0.0000068292647,0.002687064,0.0004367673,0.00029604568,0.000007692479,0.000018881294,0.000633437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727225,0.001108862,0.00024588022,0.0003654292,0.00039748597,0.00061009685],"domain_scores_gemma":[0.99820167,0.00075197883,0.00006768174,0.0002704284,0.00049589516,0.00021236786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011326919,0.00018223868,0.00029073277,0.00021695642,0.00048323118,0.000029840108,0.00044272607,0.00021460647,0.0002553979],"category_scores_gemma":[0.00027842127,0.00013125206,0.000083097715,0.000760589,0.00027073445,0.000050795144,0.00009403371,0.0008979936,0.00011508292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014680595,0.00040476193,0.0056688725,0.000070129165,0.000115084855,0.000013133027,0.0003566616,0.00006200517,0.93104655,0.0006066284,0.049895205,0.010292895],"study_design_scores_gemma":[0.0010377472,0.0007948503,0.015466291,0.00011143146,0.000022558761,6.763129e-7,0.00006970781,0.000023054612,0.87705654,0.00009071965,0.1052046,0.000121820165],"about_ca_topic_score_codex":0.000060022714,"about_ca_topic_score_gemma":0.000020893034,"teacher_disagreement_score":0.055309393,"about_ca_system_score_codex":0.00029936526,"about_ca_system_score_gemma":0.0002477611,"threshold_uncertainty_score":0.5352304},"labels":[],"label_agreement":null},{"id":"W2070317104","doi":"10.1158/0008-5472.can-03-0969","title":"p53 Activation in Chronic Radiation-Treated Breast Cancer Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Atomic Energy of Canada Limited; City of Hope; Harvard University","keywords":"Radioresistance; Mdm2; Biology; DNA damage; Cancer research; MCF-7; Western blot; Molecular biology; Cancer cell; Cell culture; Cancer; DNA; Gene; Biochemistry","score_opus":0.04175609784155685,"score_gpt":0.3863324564284015,"score_spread":0.34457635858684466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070317104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902017,0.0028090412,0.00008644382,0.0055841156,0.00019099325,0.0010744674,0.00005636672,0.00006783896,0.0011105486],"genre_scores_gemma":[0.9954037,0.0025518588,0.000022435426,0.00016581305,0.0005247932,0.0005512719,0.000041531475,0.000056075805,0.0006825013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978771,0.00008939163,0.00024321566,0.00044077844,0.00071685214,0.000632614],"domain_scores_gemma":[0.99898404,0.000044583092,0.0000516936,0.0003781632,0.00033878605,0.00020273121],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003477422,0.00015320143,0.00023494608,0.00050619623,0.00010485823,0.0000314217,0.00013918855,0.00018112673,0.0009608777],"category_scores_gemma":[0.00004261156,0.00014999471,0.00006313711,0.0015176178,0.00013331804,0.00013363583,0.00004946078,0.00081327546,0.00013203813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036009363,0.000100810765,0.0014147776,0.00012715235,0.000060152644,0.00004883735,0.00032206427,0.0069513726,0.9666894,0.000113369606,0.0017276633,0.022084313],"study_design_scores_gemma":[0.00561593,0.00018355924,0.030235354,0.0009937702,0.000023621335,0.000014632376,0.000060201684,0.00021415109,0.95624876,0.000107985885,0.006105906,0.00019615234],"about_ca_topic_score_codex":0.01856291,"about_ca_topic_score_gemma":0.0024251163,"teacher_disagreement_score":0.028820576,"about_ca_system_score_codex":0.010194216,"about_ca_system_score_gemma":0.0037647102,"threshold_uncertainty_score":0.9999524},"labels":[],"label_agreement":null},{"id":"W2070468980","doi":"10.1158/1538-7445.am10-4027","title":"Abstract 4027: The lectin concanavalin-A induces cyclooxygenase-2 expression through an IKKgamma/NFkB-dependent pathway in U87 glioblastoma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Concanavalin A; Lectin; Protein kinase B; Cell biology; Proinflammatory cytokine; Signal transduction; IκB kinase; Intracellular; Biology; NF-κB; Cancer research; Phosphorylation; Chemistry; Molecular biology; Biochemistry; Inflammation; Immunology; In vitro","score_opus":0.0755049799164515,"score_gpt":0.41430090284531285,"score_spread":0.33879592292886135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070468980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897968,0.000634165,0.000006984277,0.0025131318,0.0005630545,0.0015612126,0.000028683906,0.00007151722,0.0048244093],"genre_scores_gemma":[0.9948028,0.0005928558,0.00013845782,0.00026609242,0.00082296494,0.00048391908,0.000015648193,0.00010617745,0.0027711184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936551,0.000627796,0.0005687051,0.0009778264,0.0027447643,0.0014258488],"domain_scores_gemma":[0.99643445,0.00072802784,0.000107927284,0.0014120849,0.0007221012,0.00059539697],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031357901,0.00032599556,0.00044107222,0.00036507015,0.000457507,0.00021079143,0.001009073,0.00039705835,0.004889789],"category_scores_gemma":[0.00062774296,0.0002250373,0.00013090405,0.0011665815,0.00065647485,0.00036493494,0.00045683808,0.0046210163,0.0003886139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092215196,0.0003845952,0.0008502153,0.00011524625,0.00001870493,0.00055462494,0.0013380202,0.000023706914,0.97621953,0.00006306419,0.0034559881,0.01605412],"study_design_scores_gemma":[0.0016759343,0.0005007918,0.008134811,0.00020118931,0.0000056922418,0.000029775418,0.0012268217,0.000048155278,0.9491577,0.00019447981,0.038589247,0.00023541703],"about_ca_topic_score_codex":0.007556634,"about_ca_topic_score_gemma":0.010818079,"teacher_disagreement_score":0.035133258,"about_ca_system_score_codex":0.0004567168,"about_ca_system_score_gemma":0.0015429605,"threshold_uncertainty_score":0.9990521},"labels":[],"label_agreement":null},{"id":"W2070731070","doi":"10.1158/0008-5472.can-06-2381","title":"Toll-like Receptor-7 Tolerizes Malignant B Cells and Enhances Killing by Cytotoxic Agents","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); University of Toronto; Sanofi (Canada); Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Chronic lymphocytic leukemia; TLR7; Toll-like receptor; Cancer research; Receptor; Biology; Tumor necrosis factor alpha; Kinase; Cell biology; Signal transduction; Immunology; Leukemia; Immune system; Innate immune system; Biochemistry","score_opus":0.036779376317135806,"score_gpt":0.34654889899481034,"score_spread":0.30976952267767455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070731070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853828,0.012499815,0.00013889681,0.0002792464,0.0006881423,0.0002871924,0.000015596615,0.00003218651,0.00067614217],"genre_scores_gemma":[0.9782493,0.006129987,0.000029258872,0.00008080428,0.000066161796,0.000056101526,0.00004379962,0.00001787201,0.015326724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983879,0.00028242092,0.00026659598,0.00030510867,0.000106862026,0.00065113517],"domain_scores_gemma":[0.9993162,0.00025896725,0.00005750988,0.00020366015,0.00012284878,0.000040801053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015967436,0.00012629287,0.00018416398,0.0001766435,0.000369072,0.00003784204,0.00020351874,0.00020279938,0.0012160095],"category_scores_gemma":[0.000041754378,0.000109319124,0.000037197504,0.00021009991,0.00029988555,0.00013203578,0.00010574222,0.00037613235,0.00049288914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041150014,0.00002557798,0.00013591228,0.000026932665,0.00005034482,0.000004472546,0.0005330315,6.363562e-7,0.9601113,0.000045042172,0.025766982,0.012888251],"study_design_scores_gemma":[0.00036061782,0.00009560669,0.00024648925,0.00006341695,0.000003783858,0.000004394785,0.00041971914,0.0000014397381,0.75250924,0.00001702007,0.24617852,0.000099745055],"about_ca_topic_score_codex":0.0002592158,"about_ca_topic_score_gemma":0.000032058146,"teacher_disagreement_score":0.22041155,"about_ca_system_score_codex":0.0001050677,"about_ca_system_score_gemma":0.00009171531,"threshold_uncertainty_score":0.999697},"labels":[],"label_agreement":null},{"id":"W2070810697","doi":"10.1158/1538-7445.am2011-5152","title":"Abstract 5152: The role of CCL21/CCR7 chemokine axis in breast cancer induced lymphangiogenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"CCL21; Lymphangiogenesis; C-C chemokine receptor type 7; Chemokine; Cancer research; Lymphatic system; Podoplanin; Metastasis; Lymphatic Endothelium; Chemokine receptor; Biology; Immunology; Medicine; Cancer; Receptor; Internal medicine","score_opus":0.10721085673213211,"score_gpt":0.3854392865284295,"score_spread":0.2782284297962974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070810697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336214,0.006885234,2.6763823e-7,0.00078692666,0.000095878604,0.00056895503,0.00007893563,0.000018344246,0.008203346],"genre_scores_gemma":[0.9982842,0.0004900293,0.000006304716,0.00010806822,0.00030530378,0.00049807725,0.000004615467,0.00003049836,0.00027285336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980448,0.000098991106,0.00032803314,0.00029256492,0.000745261,0.0004903497],"domain_scores_gemma":[0.998659,0.00013104243,0.000075575306,0.0005154529,0.0004071766,0.00021171829],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070073176,0.00013788519,0.0003189646,0.0002556555,0.00007264676,0.000012228789,0.00029512998,0.000098011325,0.003224262],"category_scores_gemma":[0.000089674315,0.00008924458,0.000110467015,0.0007826369,0.00018240925,0.000075837524,0.00009474559,0.00004410089,0.0000433162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012340873,0.0005409709,0.7083883,0.00047048173,0.00018957518,0.000053173615,0.0024981822,0.000001591744,0.23558979,0.00014424896,0.0012850895,0.04960446],"study_design_scores_gemma":[0.0014579563,0.0000472505,0.8225079,0.00048731966,0.000040355622,0.000017542192,0.0013785627,0.00001231361,0.1733819,0.00013519565,0.00043655612,0.00009711285],"about_ca_topic_score_codex":0.044168487,"about_ca_topic_score_gemma":0.0006073641,"teacher_disagreement_score":0.11411959,"about_ca_system_score_codex":0.00038614013,"about_ca_system_score_gemma":0.0011873475,"threshold_uncertainty_score":0.9976869},"labels":[],"label_agreement":null},{"id":"W2070826508","doi":"10.1158/0008-5472.sabcs-4116","title":"Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Bevacizumab; Internal medicine; Clinical endpoint; Hazard ratio; Docetaxel; Population; Neutropenia; Taxane; Placebo; Breast cancer; Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Confidence interval; Pathology","score_opus":0.08245026851302782,"score_gpt":0.45017309410043804,"score_spread":0.3677228255874102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070826508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887038,0.0018857575,0.000015405789,0.004641645,0.00012385061,0.0039478377,0.00046971245,0.000024938809,0.00018708436],"genre_scores_gemma":[0.9953123,0.0011632795,0.00005086605,0.00033324712,0.00013116129,0.0008658696,0.000048748905,0.000040601477,0.002053929],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959379,0.00065913505,0.0006874705,0.00062414084,0.0012369615,0.0008544272],"domain_scores_gemma":[0.99801785,0.0003218084,0.00018881644,0.00047496508,0.0007300354,0.00026650325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001099508,0.00034786065,0.0008857755,0.0004395319,0.0002626563,0.000034305267,0.0003612442,0.000054365104,0.0018314196],"category_scores_gemma":[0.00009002518,0.00020028335,0.00008651935,0.0015885843,0.00034433164,0.00016195998,0.00012503208,0.0007114791,0.000008074273],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44487658,0.022753268,0.0724048,0.0013163378,0.0042424323,0.0013245203,0.016654583,0.0008746303,0.004974432,0.000072257055,0.014448051,0.4160581],"study_design_scores_gemma":[0.31737608,0.021098483,0.6364393,0.002339979,0.0013638694,0.00010364299,0.003719601,0.00027761282,0.009040631,0.000042417105,0.007333325,0.00086499617],"about_ca_topic_score_codex":0.0034106006,"about_ca_topic_score_gemma":0.010323325,"teacher_disagreement_score":0.5640345,"about_ca_system_score_codex":0.0020609496,"about_ca_system_score_gemma":0.0024821612,"threshold_uncertainty_score":0.999081},"labels":[],"label_agreement":null},{"id":"W2071040673","doi":"10.1158/0008-5472.sabcs13-p5-13-06","title":"Abstract P5-13-06: Seasonal variation in onset of inflammatory breast cancer: Evidence of an infectious trigger","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Inflammatory breast cancer; Breast cancer; Rash; Internal medicine; Cancer; Referral; Disease; Oncology; Dermatology; Family medicine","score_opus":0.05104685611728175,"score_gpt":0.39490904172381397,"score_spread":0.3438621856065322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071040673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426156,0.0032429586,0.000002610751,0.001366281,0.00010506554,0.0007752328,0.000058011407,0.000016140038,0.00017215394],"genre_scores_gemma":[0.99626976,0.0028561002,0.00001457773,0.00007162872,0.00016610375,0.00036107487,0.000007048271,0.000021261078,0.00023242726],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979676,0.00017405613,0.00044443223,0.00027829083,0.00077501027,0.000360597],"domain_scores_gemma":[0.9983894,0.00024566174,0.0001507365,0.00035823556,0.00072278304,0.0001331824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013313284,0.00012251624,0.0003104441,0.00037368076,0.000049573817,0.000020922695,0.00017961813,0.00013311511,0.0029712995],"category_scores_gemma":[0.000108772285,0.000106640946,0.000079581645,0.0007295627,0.0002859758,0.00038503628,0.00003936256,0.00041495764,0.000018958644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004571678,0.00035960204,0.32051596,0.0011424369,0.00016913807,0.000017475792,0.001230164,0.00008262564,0.61294913,0.000015997985,0.0026870775,0.056258682],"study_design_scores_gemma":[0.0019616727,0.00024369817,0.9800745,0.0015086344,0.000013917651,0.000018598073,0.0001067606,0.0001578307,0.015469618,0.000065864944,0.00027863032,0.00010023575],"about_ca_topic_score_codex":0.038065545,"about_ca_topic_score_gemma":0.0031692751,"teacher_disagreement_score":0.6595586,"about_ca_system_score_codex":0.0006193328,"about_ca_system_score_gemma":0.0016694579,"threshold_uncertainty_score":0.9979401},"labels":[],"label_agreement":null},{"id":"W2071259232","doi":"10.1158/0008-5472.can-11-1748","title":"Plasminogen Receptor S100A10 Is Essential for the Migration of Tumor-Promoting Macrophages into Tumor Sites","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Institute","keywords":"Cancer research; Macrophage; Tumor progression; Metastasis; Biology; Homing (biology); Plasmin; Receptor; Immunology; Cancer; In vitro; Biochemistry; Enzyme","score_opus":0.05961616999212257,"score_gpt":0.3634560229192712,"score_spread":0.30383985292714866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071259232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957476,0.0029110573,0.00024333427,0.0003246643,0.00007961858,0.0004858429,0.00006485529,0.0000052195337,0.00013778878],"genre_scores_gemma":[0.99761593,0.00029019843,0.00067139405,0.000084720654,0.00044691106,0.000326445,0.000027314654,0.00002253921,0.0005145603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990241,0.00006343755,0.00016159505,0.00027444164,0.00019691433,0.00027952882],"domain_scores_gemma":[0.9992405,0.000035460933,0.000065505395,0.00027400508,0.00033293915,0.00005155594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004702296,0.0000920178,0.00009850672,0.00004474612,0.000239183,0.000024228142,0.00030623996,0.00005335628,0.0003252612],"category_scores_gemma":[0.00013598496,0.000066898574,0.00008204704,0.00012565052,0.00020094994,0.00000533814,0.00013794428,0.000109152505,0.000009175404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019796185,0.000034180135,0.0016001301,0.00008406882,0.00004426849,9.238682e-7,0.000867724,0.0000011610047,0.98933065,0.000050965453,0.0048804213,0.0029075227],"study_design_scores_gemma":[0.00024640764,0.00030733814,0.0005551839,0.000027779368,0.000008152563,0.0000013324019,0.00039380087,0.000092706236,0.98062706,0.000114544666,0.017545214,0.00008047113],"about_ca_topic_score_codex":0.0009805595,"about_ca_topic_score_gemma":0.000475068,"teacher_disagreement_score":0.012664793,"about_ca_system_score_codex":0.000017785791,"about_ca_system_score_gemma":0.00012539864,"threshold_uncertainty_score":0.3561382},"labels":[],"label_agreement":null},{"id":"W2071275412","doi":"10.1158/0008-5472.can-05-4045","title":"Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor–Positive, HER-2/<i>neu</i>-Positive Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Fulvestrant; Endocrinology; Internal medicine; Estrogen receptor; Estrogen; Gefitinib; Protein kinase B; Breast cancer; Medicine; Cancer research; Tamoxifen; Epidermal growth factor receptor; Cancer; Biology; Phosphorylation","score_opus":0.04513150536202543,"score_gpt":0.38115746349442364,"score_spread":0.3360259581323982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071275412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894938,0.0040737973,0.0004789929,0.003144091,0.000038961352,0.0015449915,0.0007264718,0.00001691377,0.00048199587],"genre_scores_gemma":[0.99388015,0.0009864251,0.004024853,0.0000765339,0.000091606984,0.00049320806,0.000022401167,0.000058821337,0.00036600465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964509,0.00026918764,0.0005529249,0.0007080631,0.0013093948,0.00070952665],"domain_scores_gemma":[0.9980156,0.00018897127,0.00013278729,0.00041257864,0.00092696055,0.00032309335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011614765,0.00023862591,0.00057257724,0.00055106013,0.000110918765,0.000029460054,0.00022027522,0.00014076187,0.000083783714],"category_scores_gemma":[0.00010956206,0.00021485153,0.000056418754,0.0010614484,0.00045853326,0.0001491847,0.00021944832,0.00057692605,0.000001987093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038871036,0.00020254872,0.030176777,0.0007537007,0.00005688337,0.00004308003,0.0007151936,0.00036338565,0.9536425,0.004136315,0.0009989634,0.0050235586],"study_design_scores_gemma":[0.0029717837,0.0005956574,0.0859918,0.005861696,0.000052658914,0.000035360237,0.00039722183,0.0016621494,0.89636135,0.005613191,0.00012532446,0.00033180663],"about_ca_topic_score_codex":0.0078114215,"about_ca_topic_score_gemma":0.0018732309,"teacher_disagreement_score":0.05728114,"about_ca_system_score_codex":0.0006495716,"about_ca_system_score_gemma":0.0011640362,"threshold_uncertainty_score":0.9987956},"labels":[],"label_agreement":null},{"id":"W2071291729","doi":"10.1158/0008-5472.can-03-2789","title":"Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Androgen receptor; LNCaP; Prostate cancer; Selenium; Androgen; Prostate-specific antigen; Endocrinology; Internal medicine; Cancer research; Antigen; Receptor; Prostate; Signal transduction; Biology; Chemistry; Cancer; Medicine; Cell biology; Immunology; Hormone","score_opus":0.08522459686861125,"score_gpt":0.38541433657061414,"score_spread":0.3001897397020029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071291729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126834,0.0055532297,0.000084482206,0.0011152383,0.0005054334,0.0010211007,0.00015301419,0.00009407279,0.00020506368],"genre_scores_gemma":[0.9980342,0.00072913687,0.00039484436,0.00004776026,0.0003501519,0.00012856534,0.00008782412,0.00004472642,0.00018281372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968559,0.00040710915,0.00048751422,0.00063085544,0.0008738566,0.00074473314],"domain_scores_gemma":[0.99873173,0.00012556596,0.00015807892,0.00041068843,0.00043777324,0.00013614535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008551197,0.00020274353,0.00033923076,0.00010424264,0.00028632837,0.00007119527,0.00038346119,0.0002650909,0.00065060053],"category_scores_gemma":[0.000058468326,0.00015802213,0.00009193969,0.0008485953,0.00032274707,0.00023573948,0.000106566185,0.0004520133,0.00012446106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092164724,0.00010159676,0.0020368546,0.00010476127,0.00001977866,9.453216e-7,0.0023709694,0.00009613547,0.97817117,0.000021515307,0.014803914,0.0013507247],"study_design_scores_gemma":[0.00090074685,0.000320973,0.00040558405,0.00045779676,0.0000038082633,0.0000019327636,0.0004116028,0.000006958268,0.9589373,0.0006659809,0.037695054,0.00019224796],"about_ca_topic_score_codex":0.0010338699,"about_ca_topic_score_gemma":0.0000048729758,"teacher_disagreement_score":0.02289114,"about_ca_system_score_codex":0.0005679012,"about_ca_system_score_gemma":0.000073871066,"threshold_uncertainty_score":0.71236193},"labels":[],"label_agreement":null},{"id":"W2071540205","doi":"10.1158/0008-5472.sabcs-09-14","title":"Treatment-Emergent Symptoms and the Risk of Breast Cancer Recurrence in the NCIC CTG MA.27 Adjuvant Aromatase Inhibitor Trial.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Robarts Clinical Trials","funders":"","keywords":"Medicine; Exemestane; Anastrozole; Aromatase inhibitor; Internal medicine; Breast cancer; Vasomotor; Tamoxifen; Hazard ratio; Interim analysis; Oncology; Clinical endpoint; Cancer; Proportional hazards model; Randomized controlled trial; Gynecology; Confidence interval","score_opus":0.0200110901908741,"score_gpt":0.3532914507238533,"score_spread":0.3332803605329792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071540205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625219,0.034298684,0.0000012111766,0.001762006,0.00014550927,0.00095292437,0.00018009658,0.000002997041,0.00013467766],"genre_scores_gemma":[0.95338905,0.045817465,0.0000036074143,0.000047087895,0.0002660974,0.00027437913,0.000026316233,0.000008899128,0.00016708518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998181,0.0006949724,0.0002073294,0.00030180768,0.00028147118,0.00033346235],"domain_scores_gemma":[0.9992999,0.000084051026,0.0000742508,0.00039028586,0.00008008587,0.00007145532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087543734,0.00013715979,0.00018925754,0.00005656851,0.00012971001,0.000023600891,0.00025818008,0.00011767172,0.000019114887],"category_scores_gemma":[0.000069216694,0.00006759781,0.000086300155,0.0002687908,0.00033441104,0.0000044441836,0.000057285415,0.00028467624,0.0000030204983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10960484,0.0016207105,0.015868172,0.00013444167,0.0008697875,0.000082578925,0.0030518868,0.00026788126,0.49645194,0.00072340004,0.026519258,0.34480512],"study_design_scores_gemma":[0.18652105,0.014834878,0.081786074,0.0008728431,0.0006519834,0.00024525277,0.0026373682,0.00082107936,0.6789376,0.0013623118,0.029980468,0.0013491054],"about_ca_topic_score_codex":0.0013584798,"about_ca_topic_score_gemma":0.0001667531,"teacher_disagreement_score":0.343456,"about_ca_system_score_codex":0.000055302982,"about_ca_system_score_gemma":0.0002082636,"threshold_uncertainty_score":0.27565587},"labels":[],"label_agreement":null},{"id":"W2071662039","doi":"10.1158/1538-7445.am2011-4883","title":"Abstract 4883: Peptide-based PET imaging agents using novel bifunctional chelates and 64Cu","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordion (Canada); BC Cancer Agency","funders":"","keywords":"DOTA; Peptide; Chemistry; In vivo; Angiogenesis; Chelation; Receptor; In vitro; Competitive binding; Molecular biology; Cancer research; Biochemistry; Medicine; Biology","score_opus":0.36989184315074275,"score_gpt":0.4880786670681061,"score_spread":0.11818682391736335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071662039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890106,0.00043120843,0.00018200604,0.0009744524,0.00003393728,0.0002042052,0.000026384863,0.000027483042,0.009109724],"genre_scores_gemma":[0.9978003,0.000042756034,0.0009724138,0.00020753506,0.00021615365,0.00006514623,0.000013088305,0.000016574651,0.0006660604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901223,0.00001024208,0.00012689894,0.00024974608,0.00031006435,0.00029080003],"domain_scores_gemma":[0.9993342,0.00007463348,0.000022199465,0.00016235487,0.00016771872,0.00023885154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028558247,0.00008192979,0.000100913516,0.00008966903,0.00018024244,0.00002199113,0.000074012096,0.000029919844,0.0024497763],"category_scores_gemma":[0.00005292983,0.00007405769,0.000033852575,0.0002617523,0.00022060008,0.000062564606,0.000034365847,0.00040378238,0.00002457006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020112008,0.00020460013,0.027381588,0.00021551941,0.000038910566,0.00003604808,0.00007989515,0.000020283378,0.9694287,0.00017389565,0.0011295989,0.0010898478],"study_design_scores_gemma":[0.0037073707,0.000054266682,0.23603523,0.00047021007,0.00010912867,0.00019351594,0.00028426887,0.01199858,0.71340173,0.00046029277,0.032939594,0.00034581657],"about_ca_topic_score_codex":0.00014017617,"about_ca_topic_score_gemma":0.0000011707058,"teacher_disagreement_score":0.25602695,"about_ca_system_score_codex":0.00012473484,"about_ca_system_score_gemma":0.00023219585,"threshold_uncertainty_score":0.99846214},"labels":[],"label_agreement":null},{"id":"W2071686643","doi":"10.1158/1538-7445.am10-4709","title":"Abstract 4709: NXF2 is a Candidate Biomarker of Mechanical Stress in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Stromal cell; Gene expression; Microarray; Cancer research; Cancer; Microarray analysis techniques; Gene expression profiling; Biomarker; Biology; Cell; Cell culture; Gene; Pathology; Medicine; Genetics","score_opus":0.03663655143372924,"score_gpt":0.4123297219889749,"score_spread":0.37569317055524565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071686643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952064,0.0011519989,0.0000024258147,0.0011053125,0.00014389538,0.0003386898,0.0014373752,0.0000050477865,0.0006088265],"genre_scores_gemma":[0.9964992,0.002353152,0.000021270982,0.000057323577,0.00020049744,0.00036116023,0.000059874717,0.000030905227,0.00041665824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979474,0.00007442854,0.00023494616,0.0005038709,0.0005556076,0.00068374997],"domain_scores_gemma":[0.99883854,0.000028458531,0.000050973176,0.0005163241,0.00031724692,0.00024842937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048670752,0.00015355606,0.0001966309,0.00018635199,0.0000771551,0.000034688608,0.0004125302,0.00019392624,0.0019512806],"category_scores_gemma":[0.000046436784,0.0001342326,0.00008590046,0.00037801758,0.00026132344,0.000009228694,0.00024750584,0.0004928186,0.000016112761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075836387,0.0002020074,0.045414798,0.00008407197,0.00011007945,0.00002471416,0.000045576235,0.0000034638922,0.9335515,0.000030142915,0.006311922,0.013463362],"study_design_scores_gemma":[0.0016371497,0.000102334925,0.10234913,0.000112328395,0.000006979189,0.000008210111,0.00005356121,0.00002515941,0.88695675,0.000108116044,0.00846016,0.00018012266],"about_ca_topic_score_codex":0.037223913,"about_ca_topic_score_gemma":0.05678363,"teacher_disagreement_score":0.056934334,"about_ca_system_score_codex":0.00009676077,"about_ca_system_score_gemma":0.0008443029,"threshold_uncertainty_score":0.9989611},"labels":[],"label_agreement":null},{"id":"W2071842182","doi":"10.1158/1538-7445.am2011-1098","title":"Abstract 1098: Interactions between P53 and IGF2 in human esophageal adenocarcinoma tissues and cell lines","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immunohistochemistry; Biology; Genomic imprinting; Messenger RNA; Imprinting (psychology); Cancer research; Insulin-like growth factor 2; Adenocarcinoma; Cell culture; Growth factor; Internal medicine; Gene expression; Cancer; Oncology; Pathology; Gene; Medicine; Genetics; Immunology; Receptor; DNA methylation","score_opus":0.12133146304106689,"score_gpt":0.41038256515244836,"score_spread":0.28905110211138146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071842182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973244,0.0075989254,0.0000108978265,0.00011409684,0.00003089051,0.00014178721,0.000024517827,0.0000043494615,0.0023420735],"genre_scores_gemma":[0.9962837,0.0014027121,0.00006926242,0.0000150381775,0.00025698417,0.00009342856,0.000024225314,0.000014360339,0.0018402784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99922043,0.000044455617,0.00013175786,0.0002901835,0.000097186006,0.00021601199],"domain_scores_gemma":[0.99958295,0.000014728371,0.000026049855,0.00020220544,0.00008730664,0.00008676142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021184601,0.00007922524,0.00009035585,0.00009736905,0.00012570484,0.00003242998,0.000120540215,0.00007381452,0.00013173935],"category_scores_gemma":[0.000013025189,0.00007604646,0.000016440536,0.000093306866,0.00016424617,0.000008994315,0.000100736834,0.0001954491,0.00000488618],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049016722,0.00006179932,0.18444908,0.00006733692,0.000023270915,0.00000834222,0.0006805839,0.0000013387183,0.8024385,0.00010176149,0.0015561574,0.010562831],"study_design_scores_gemma":[0.00029950283,0.000109948865,0.6679245,0.000022948107,0.0000052565065,0.0000018227114,0.00024715232,0.0000024419737,0.32496116,0.00016453175,0.006161033,0.000099718854],"about_ca_topic_score_codex":0.0015042976,"about_ca_topic_score_gemma":0.0006326763,"teacher_disagreement_score":0.48347542,"about_ca_system_score_codex":0.00002274999,"about_ca_system_score_gemma":0.00005811347,"threshold_uncertainty_score":0.31010848},"labels":[],"label_agreement":null},{"id":"W2071998244","doi":"10.1158/1538-7445.am10-123","title":"Abstract 123: Cooperative regulation between proliferative signals by activated Ras and inhibitors of apoptosis (IAPs) in gliomagenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Survivin; XIAP; Gene knockdown; Cancer research; Inhibitor of apoptosis; Glioma; Apoptosis; Biology; Chemistry; Programmed cell death; Caspase; Biochemistry","score_opus":0.02855511288025338,"score_gpt":0.3501135626357965,"score_spread":0.32155844975554315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071998244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987788,0.00031938954,0.00006941024,0.00017530013,0.00004689727,0.00043835447,0.00004703997,0.0000039713746,0.00012083248],"genre_scores_gemma":[0.9990246,0.00022446425,0.00006587833,0.0000070115343,0.00017509775,0.00008649582,0.00011917732,0.000017069839,0.00028015263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989132,0.000109961795,0.00021195813,0.00031178462,0.00023830756,0.0002147821],"domain_scores_gemma":[0.9993451,0.000044012402,0.00006797079,0.00015756061,0.00031018938,0.00007512958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055055466,0.00010642953,0.00015314735,0.00013612166,0.000091926355,0.00002640831,0.00008648219,0.00021407427,0.00006819196],"category_scores_gemma":[0.00008561682,0.00009335776,0.000026841832,0.0002884121,0.00016251097,0.0000126408595,0.000067289,0.00020578214,0.0000013094783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109717184,0.000034108656,0.0031483166,0.000027966858,0.00002695649,2.4661813e-7,0.00014256708,0.00004995924,0.9897485,0.000022003138,0.0006548264,0.0060348553],"study_design_scores_gemma":[0.00043672737,0.00013589146,0.022435777,0.00003029617,0.000004504006,3.192338e-7,0.00008252667,0.000024496701,0.9758353,0.00008776185,0.0008259989,0.00010040713],"about_ca_topic_score_codex":0.00028153998,"about_ca_topic_score_gemma":0.00016945039,"teacher_disagreement_score":0.01928746,"about_ca_system_score_codex":0.000023883316,"about_ca_system_score_gemma":0.00012598954,"threshold_uncertainty_score":0.3807019},"labels":[],"label_agreement":null},{"id":"W2072023803","doi":"10.1158/1538-7445.am2014-sy13-01","title":"Abstract SY13-01: Genetic and non-genetic mechanisms contribute to long term clonal growth dynamics and therapy resistance","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Somatic evolution in cancer; Cancer stem cell; Genetic heterogeneity; Epigenetics; Biology; Stem cell; Cancer; Genetics; Tumor progression; Point mutation; Tumour heterogeneity; Gene; Cancer research; Mutation; Phenotype; Computational biology","score_opus":0.0148418146025404,"score_gpt":0.31032617897107073,"score_spread":0.2954843643685303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072023803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856001,0.006946486,0.0056539024,0.00079342513,0.00013129307,0.00047089354,0.00015123225,0.0000066995694,0.00024596346],"genre_scores_gemma":[0.9811602,0.016558863,0.00094771903,0.00042647816,0.00034865033,0.00015181262,0.000040058003,0.000042961183,0.00032321064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983398,0.00006033669,0.00020466927,0.0005859236,0.00027986756,0.0005294226],"domain_scores_gemma":[0.99893457,0.00009130299,0.000047150734,0.00036507656,0.00025371095,0.0003081851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042234318,0.00018537477,0.0001960396,0.00008705696,0.00021969179,0.00012783092,0.00025199776,0.0001472612,0.000022602888],"category_scores_gemma":[0.00013271222,0.00018374514,0.000038283255,0.00013017707,0.00017757136,0.0000039337156,0.00022879799,0.00018762023,0.000005406628],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008517241,0.00008325,0.038512576,0.0002184443,0.00012857576,0.00003348772,0.00012747562,0.00008231454,0.89864415,0.0015490208,0.0032359362,0.056533072],"study_design_scores_gemma":[0.002159212,0.00076455896,0.8328409,0.0001244452,0.000017792318,0.000014634238,0.000033544773,0.00018891289,0.15586415,0.0027563805,0.004676138,0.0005593367],"about_ca_topic_score_codex":0.00021572808,"about_ca_topic_score_gemma":0.0019053128,"teacher_disagreement_score":0.79432833,"about_ca_system_score_codex":0.000077536904,"about_ca_system_score_gemma":0.00018076421,"threshold_uncertainty_score":0.74929094},"labels":[],"label_agreement":null},{"id":"W2072185042","doi":"10.1158/0008-5472.can-06-1660","title":"GRP78 as a Novel Predictor of Responsiveness to Chemotherapy in Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Taxane; Hazard ratio; Cancer; Chemotherapy; Doxorubicin; Retrospective cohort study; Confidence interval","score_opus":0.019624288489797578,"score_gpt":0.3638432976445337,"score_spread":0.34421900915473613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072185042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956771,0.0012742779,0.00003395914,0.0013802,0.00006441948,0.00030812182,0.00036050664,0.0000043868554,0.00089703745],"genre_scores_gemma":[0.99729127,0.00053923874,0.000040550767,0.00018461798,0.0002684949,0.00034059177,0.000022635852,0.000023267818,0.0012893644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987228,0.00006717271,0.00017906616,0.00034564806,0.00032277172,0.00036255587],"domain_scores_gemma":[0.9992315,0.000022976945,0.000031869822,0.00030085086,0.00028620646,0.00012658903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023663431,0.00010404736,0.00014235194,0.00013051921,0.00003876601,0.000015335962,0.00023673048,0.000089417576,0.00020817918],"category_scores_gemma":[0.000049549515,0.00009565154,0.00005091973,0.0003307149,0.00012798466,0.0000033577485,0.00010095273,0.000108456334,0.0000049937744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017980223,0.00016383755,0.051378824,0.00006143973,0.000017406548,0.0000068756704,0.000041372386,0.0005628996,0.9393327,0.00019391601,0.005476219,0.00096648344],"study_design_scores_gemma":[0.0022163966,0.00017468193,0.2634955,0.00020128649,0.0000054425855,0.000006356633,0.000094140065,0.00003028256,0.7171274,0.000161918,0.016287377,0.00019924826],"about_ca_topic_score_codex":0.0062875575,"about_ca_topic_score_gemma":0.00095252163,"teacher_disagreement_score":0.22220534,"about_ca_system_score_codex":0.000076317316,"about_ca_system_score_gemma":0.00058095664,"threshold_uncertainty_score":0.9504948},"labels":[],"label_agreement":null},{"id":"W2072331709","doi":"10.1158/1538-7445.am2012-3851","title":"Abstract 3851: Killing of Kras mutant colon cancer cells by the αGBP cytokine, a physiological PI3K inhibitor therapeutically effective <i>in vivo</i>","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Cancer research; PI3K/AKT/mTOR pathway; Biology; Cancer; Carcinogenesis; Colorectal cancer; Signal transduction; Cell biology","score_opus":0.2041251391819229,"score_gpt":0.5047044591029548,"score_spread":0.30057931992103193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072331709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908114,0.00670004,0.000008841231,0.0007939471,0.0009358355,0.0010262858,0.0003479028,0.000021829115,0.0010841745],"genre_scores_gemma":[0.993518,0.004175213,0.000007890427,0.0008373232,0.00063530315,0.00058473443,0.000004776968,0.000028709454,0.00020807797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99680173,0.0010065981,0.0003476845,0.00037392037,0.000428291,0.0010417489],"domain_scores_gemma":[0.99797654,0.001223371,0.00012215642,0.00021054468,0.00023660963,0.00023077779],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020111226,0.00023791975,0.00037278346,0.0000968898,0.00032237335,0.000024357809,0.00047080117,0.000306379,0.0021196532],"category_scores_gemma":[0.000045560286,0.0001567202,0.000120681696,0.00050298916,0.00090960076,0.00012324727,0.00017611055,0.0017113445,0.000039945327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009010971,0.0007774576,0.0073503377,0.00008817356,0.00015030561,0.000012093932,0.00061842636,0.00006519466,0.97242045,0.00016556297,0.009904502,0.0075463946],"study_design_scores_gemma":[0.0011171823,0.00020063351,0.013156421,0.00008847675,0.000035052468,0.0000019661788,0.00019858856,0.00014224935,0.91437995,0.00007301772,0.0704152,0.00019127557],"about_ca_topic_score_codex":0.0006576093,"about_ca_topic_score_gemma":0.000099248995,"teacher_disagreement_score":0.0605107,"about_ca_system_score_codex":0.00031182182,"about_ca_system_score_gemma":0.0001643647,"threshold_uncertainty_score":0.9987925},"labels":[],"label_agreement":null},{"id":"W2072364504","doi":"10.1158/0008-5472.can-05-3353","title":"The Aurora Kinase Inhibitor VX-680 Induces Endoreduplication and Apoptosis Preferentially in Cells with Compromised p53-Dependent Postmitotic Checkpoint Function","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Endoreduplication; Biology; Cell biology; Retinoblastoma protein; Kinase; Cell cycle; Cancer research; Cyclin B1; Cyclin-dependent kinase 2; Aurora inhibitor; Cyclin A; Programmed cell death; Apoptosis; Cell cycle checkpoint; Cyclin-dependent kinase; Molecular biology; Cyclin-dependent kinase 1; Protein kinase A; Biochemistry","score_opus":0.01817513777544695,"score_gpt":0.28414212063743827,"score_spread":0.26596698286199133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072364504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976345,0.0009183671,0.0001659654,0.00030043736,0.00009204595,0.0006164133,0.000016976399,0.000007719933,0.00024762336],"genre_scores_gemma":[0.9978251,0.0008496043,0.0000530261,0.00002753991,0.00024756585,0.00030817388,0.00007696944,0.000023209273,0.000588814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986697,0.00013294807,0.00019532737,0.0004013582,0.00025439225,0.00034627767],"domain_scores_gemma":[0.99935204,0.000026099473,0.000058450936,0.00030872115,0.00019170104,0.00006296266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038040604,0.00012840614,0.00010325681,0.00007517384,0.00019916732,0.00010706709,0.00017424618,0.00012137205,0.000008674393],"category_scores_gemma":[0.000015575426,0.00009371178,0.000027326965,0.00016092713,0.00016558633,0.00000803214,0.00012546688,0.00024531304,0.0000040577024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045476784,0.000080367114,0.0008690287,0.000031077063,0.00002103115,5.8148515e-7,0.000028885113,0.00010965992,0.99473166,0.00007619992,0.00043653377,0.0031602297],"study_design_scores_gemma":[0.00091922126,0.00030889516,0.0073253596,0.000034718643,0.0000117946465,0.0000014152718,0.00012178112,0.00005909401,0.9882081,0.0000804847,0.0028010737,0.00012804467],"about_ca_topic_score_codex":0.0009308881,"about_ca_topic_score_gemma":0.0021196203,"teacher_disagreement_score":0.006523521,"about_ca_system_score_codex":0.00007669308,"about_ca_system_score_gemma":0.00018684236,"threshold_uncertainty_score":0.38214555},"labels":[],"label_agreement":null},{"id":"W2072632648","doi":"10.1158/0008-5472.can-06-3944","title":"Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Cancer Institute","keywords":"Vascularity; Prostate cancer; Prostate; Tramp; Medicine; Angiogenesis; Pathology; Neovascularization; Blood flow; Cancer; Cancer research; Internal medicine","score_opus":0.03867918596906849,"score_gpt":0.315668021455968,"score_spread":0.2769888354868995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072632648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783386,0.0044242404,0.0065691704,0.00010802493,0.00018262403,0.00033563963,0.00015141832,0.00010251073,0.00029253768],"genre_scores_gemma":[0.99729055,0.00019949801,0.0018077991,0.000034638026,0.00022889812,0.00008675355,0.000021231735,0.00007843656,0.00025221225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817485,0.000019907033,0.00029657377,0.0002750605,0.00060450344,0.00062911824],"domain_scores_gemma":[0.9988211,0.00026669368,0.000025734642,0.0002808782,0.0004275251,0.00017807026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046216682,0.00017002047,0.00017932602,0.00025745455,0.00016243762,0.000036174286,0.00018331668,0.000074658674,0.0012100703],"category_scores_gemma":[0.000028148532,0.00016619645,0.00008328726,0.0005960399,0.00018772029,0.000094602554,0.000038619513,0.00027170134,0.000022674238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003893547,0.000034116063,0.008851889,0.000041553052,0.0000911226,0.0000036390536,0.00012961274,0.07093536,0.91640615,0.0001689286,0.0015284155,0.0017702434],"study_design_scores_gemma":[0.0016031611,0.000050053153,0.09328518,0.00018555867,0.00009787521,0.00009385508,0.00025205323,0.02345517,0.86448085,0.0005900263,0.014913883,0.0009923257],"about_ca_topic_score_codex":0.0005755859,"about_ca_topic_score_gemma":0.00028602086,"teacher_disagreement_score":0.084433295,"about_ca_system_score_codex":0.0002814686,"about_ca_system_score_gemma":0.00019702566,"threshold_uncertainty_score":0.99970293},"labels":[],"label_agreement":null},{"id":"W2072739003","doi":"10.1158/1538-7445.am2012-lb-376","title":"Abstract LB-376: Deregulation of promoter methylation of the polo-like kinases in myelodysplastic syndromes (MDS) and other blood neoplasms","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor","funders":"","keywords":"Polo-like kinase; PLK1; Biology; Cancer research; DNA methylation; Methylation; Cytokinesis; Myelodysplastic syndromes; Kinase; Myeloid leukemia; Leukemia; Cell cycle; Cancer; Bone marrow; Gene; Cell; Genetics; Gene expression; Cell division; Immunology","score_opus":0.04130316321725103,"score_gpt":0.3274741753961089,"score_spread":0.2861710121788579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072739003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816394,0.0012210839,0.000011262288,0.00007498116,0.00005715464,0.00017291805,0.000031553907,0.0000012975107,0.00026583037],"genre_scores_gemma":[0.99953634,0.00007368094,0.000056076897,0.000009776166,0.000058612215,0.000030456671,0.0000067520396,0.000009020799,0.00021930905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993148,0.00008515748,0.00016233935,0.0001111003,0.00014545397,0.0001811391],"domain_scores_gemma":[0.99962896,0.000038185004,0.00006421759,0.00015851039,0.00008062196,0.000029480405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033788048,0.000060653398,0.00008671443,0.000060945244,0.000044703957,0.00000776448,0.00008995228,0.0000741722,0.00007483617],"category_scores_gemma":[0.000051856427,0.000045168978,0.000025750911,0.00011513681,0.00012766801,0.000008633656,0.00007562917,0.00007176308,7.322633e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042580035,0.00007700658,0.18255313,0.0001176406,0.00003901301,1.6676985e-7,0.000487202,0.00011958025,0.8155503,0.0003071474,0.000036920086,0.00066932035],"study_design_scores_gemma":[0.00028809183,0.000067590045,0.3995197,0.000048194604,0.000011645047,0.000005203835,0.00019436491,0.0000114710765,0.5991918,0.00012338131,0.000484331,0.000054220178],"about_ca_topic_score_codex":0.0005370617,"about_ca_topic_score_gemma":0.00018395465,"teacher_disagreement_score":0.21696658,"about_ca_system_score_codex":0.000014100104,"about_ca_system_score_gemma":0.000083682295,"threshold_uncertainty_score":0.18419375},"labels":[],"label_agreement":null},{"id":"W2072739386","doi":"10.1158/0008-5472.can-10-0673","title":"Breast Carcinoma–Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Comparative genomic hybridization; Biology; Cancer research; Breast cancer; Cancer-Associated Fibroblasts; Cancer; Chromosome instability; Metastasis; Mutation; Phenotype; Tumor progression; Breast carcinoma; Karyotype; Copy-number variation; Genetics; Pathology; Chromosome; Gene; Genome; Medicine","score_opus":0.033110139945259576,"score_gpt":0.35379715560137565,"score_spread":0.32068701565611607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072739386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961226,0.00030050764,0.00006759139,0.00077611126,0.0003359099,0.00031503622,0.00069124193,0.000014914114,0.0013760932],"genre_scores_gemma":[0.9949485,0.00013646211,0.00011047091,0.000120271776,0.00068253436,0.00026517984,0.00041278749,0.000036599427,0.0032871591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998652,0.00007715814,0.00018812023,0.00037140783,0.00025006087,0.00046129373],"domain_scores_gemma":[0.99876815,0.00010106196,0.00004996244,0.00038448407,0.00050020457,0.00019614116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027375706,0.00013133939,0.00012808952,0.00008282705,0.00032367936,0.000073731055,0.00027143626,0.00018489944,0.000463548],"category_scores_gemma":[0.0003200076,0.00012355023,0.00006560684,0.00030567832,0.0002706996,0.0000066427015,0.00015042254,0.00038233266,0.00003354282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021075163,0.0001740841,0.007108302,0.000017807883,0.00007057983,0.000018414987,0.00015043293,0.00013062684,0.9573555,0.0008216059,0.031759,0.0021828657],"study_design_scores_gemma":[0.006881716,0.0023348436,0.19140628,0.00013037474,0.00009865329,0.00031621233,0.0007852055,0.0009891539,0.57798547,0.001397159,0.21616739,0.0015075611],"about_ca_topic_score_codex":0.0010721075,"about_ca_topic_score_gemma":0.015964337,"teacher_disagreement_score":0.37937006,"about_ca_system_score_codex":0.000091732516,"about_ca_system_score_gemma":0.0011851351,"threshold_uncertainty_score":0.89084744},"labels":[],"label_agreement":null},{"id":"W2072742199","doi":"10.1158/0008-5472.sabcs12-p6-07-43","title":"Abstract P6-07-43: The Maximum Standardized Uptake Value of18F-FDG to Prognosticate Prognosis of Hormone-Receptor Positive Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Metastatic breast cancer; Prospective cohort study; Univariate analysis; Internal medicine; Breast cancer; Mann–Whitney U test; Standardized uptake value; Cancer; Proportional hazards model; Multivariate analysis; Receiver operating characteristic; Oncology; Stage (stratigraphy); Nuclear medicine; Positron emission tomography","score_opus":0.08998005813897152,"score_gpt":0.44197953686184427,"score_spread":0.35199947872287274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072742199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9012895,0.003425161,0.0014096416,0.08424142,0.00014448911,0.005844934,0.0017742518,0.00014766771,0.0017229064],"genre_scores_gemma":[0.9876375,0.0009433075,0.0055666124,0.000546186,0.0003751902,0.0044893036,0.000034864523,0.00005673845,0.000350289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968624,0.00014853649,0.000440587,0.0003640972,0.001317136,0.00086725614],"domain_scores_gemma":[0.9974642,0.00035162628,0.00010651815,0.0005357594,0.000903425,0.00063849473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020020977,0.00019911534,0.00042811077,0.00016471355,0.0002138602,0.000044170232,0.00033413703,0.000069787566,0.0013315936],"category_scores_gemma":[0.0002891554,0.00012779754,0.00012898953,0.00082423387,0.0005291584,0.00011525437,0.0001852522,0.00068519945,0.00012272022],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001718797,0.0017131286,0.008722611,0.0006353114,0.000844935,0.000013979892,0.0027164603,0.000008419456,0.46858284,0.003502996,0.42505583,0.086484686],"study_design_scores_gemma":[0.004039752,0.00097040954,0.4680866,0.0025151167,0.0009366672,0.00011224637,0.001850212,0.00023096695,0.33328074,0.0010796756,0.18606679,0.0008308399],"about_ca_topic_score_codex":0.0019408673,"about_ca_topic_score_gemma":0.000019209034,"teacher_disagreement_score":0.45936397,"about_ca_system_score_codex":0.00036441785,"about_ca_system_score_gemma":0.00065228203,"threshold_uncertainty_score":0.99958134},"labels":[],"label_agreement":null},{"id":"W2072816545","doi":"10.1158/1538-7445.am2011-4215","title":"Abstract 4215: Apoptosis induction in breast cancer cell lines by the dietary flavonoid fisetin","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Fisetin; Propidium iodide; Viability assay; Apoptosis; Cancer research; Biology; Cancer cell; Cell cycle; Programmed cell death; Molecular biology; Cancer; Medicine; Internal medicine; Biochemistry","score_opus":0.15758018777137336,"score_gpt":0.4353842120941211,"score_spread":0.27780402432274776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072816545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714849,0.0045974855,0.0000023597934,0.012595801,0.00035016582,0.000901604,0.00010140488,0.00004321011,0.009923069],"genre_scores_gemma":[0.9828446,0.010518995,0.000062913976,0.0004755025,0.0008911323,0.0009852037,0.000026109838,0.00006491805,0.0041306545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99575865,0.00031767643,0.00042888147,0.00060943444,0.0017502403,0.0011351069],"domain_scores_gemma":[0.9978775,0.000373608,0.000060632898,0.00069581566,0.0005243084,0.00046818497],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025427733,0.0002211614,0.0003352162,0.0002475214,0.00023523887,0.000041709172,0.00064249604,0.0002708898,0.010378274],"category_scores_gemma":[0.0004195696,0.00014983035,0.00009731226,0.0010219866,0.0008184306,0.00019149338,0.0002660224,0.0024359256,0.00020294309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016464781,0.0008078291,0.016586006,0.00065546244,0.00008741254,0.000046263296,0.0021881007,0.000005859899,0.60298246,0.000018114382,0.2815418,0.09343425],"study_design_scores_gemma":[0.0029088939,0.00043483483,0.3328449,0.0011044545,0.000052072133,0.000011271255,0.0035285584,0.00018096085,0.6505419,0.0002549102,0.0076465155,0.00049071084],"about_ca_topic_score_codex":0.04334229,"about_ca_topic_score_gemma":0.001531486,"teacher_disagreement_score":0.3162589,"about_ca_system_score_codex":0.00093502,"about_ca_system_score_gemma":0.000948266,"threshold_uncertainty_score":0.9998655},"labels":[],"label_agreement":null},{"id":"W2072857315","doi":"10.1158/1538-7445.am2014-2246","title":"Abstract 2246: Senescence as a result of impaired ribosome biogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ribosome biogenesis; Senescence; Biology; Protein degradation; Cell biology; Biogenesis; Telomere; Ribosome; Carcinogenesis; Proteasome; DNA damage; Genetics; RNA; Cancer; DNA; Gene","score_opus":0.0551593491215188,"score_gpt":0.39014938782915504,"score_spread":0.3349900387076362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072857315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936979,0.0016831207,0.00014645193,0.00044153506,0.00007939424,0.00017103078,0.000054678974,0.000007862506,0.0037180241],"genre_scores_gemma":[0.99632317,0.0016278994,0.00008086808,0.00006136332,0.0002779912,0.00012195745,0.000033531906,0.000019307477,0.0014539289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987242,0.0000975105,0.00019370583,0.00034638605,0.00032047922,0.000317668],"domain_scores_gemma":[0.998816,0.000028406761,0.000060772447,0.0005790247,0.00040687478,0.000108915636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006739979,0.000092502065,0.000119155615,0.00008594047,0.00010935762,0.000021078677,0.00033886777,0.00011236311,0.00013664292],"category_scores_gemma":[0.00018266599,0.00008389013,0.00006958444,0.00026567053,0.0002214135,0.0000041014387,0.000092774375,0.000106758685,0.000038540824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011973501,0.00004100018,0.0015770238,0.000040026684,0.000022866769,6.3201065e-7,0.000027407083,0.000028162782,0.98370034,0.00030692207,0.0038737643,0.010262097],"study_design_scores_gemma":[0.00033544796,0.00015976773,0.030570382,0.000037694528,0.0000044804387,0.0000017723536,0.000058392045,0.000020783964,0.90674704,0.00015281067,0.061795034,0.000116415154],"about_ca_topic_score_codex":0.0008849105,"about_ca_topic_score_gemma":0.00006654648,"teacher_disagreement_score":0.076953344,"about_ca_system_score_codex":0.000036339585,"about_ca_system_score_gemma":0.00029896994,"threshold_uncertainty_score":0.34209403},"labels":[],"label_agreement":null},{"id":"W2072903143","doi":"10.1158/0008-5472.can-07-3046","title":"The Estrogen Receptor Pathway in Rhabdomyosarcoma: A Role for Estrogen Receptor-β in Proliferation and Response to the Antiestrogen 4′OH-Tamoxifen","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Antiestrogen; Estrogen receptor; Tamoxifen; Cancer research; Biology; Estrogen; Estrogen receptor alpha; Signal transduction; Cell growth; Rhabdomyosarcoma; Internal medicine; Progesterone receptor; Endocrinology; Medicine; Sarcoma; Cancer; Pathology; Cell biology; Breast cancer","score_opus":0.06575741624045725,"score_gpt":0.37270531154250164,"score_spread":0.30694789530204436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072903143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96127665,0.010707624,0.000002784001,0.024172876,0.00007194499,0.0036321583,0.000066178596,0.000019470812,0.000050303177],"genre_scores_gemma":[0.9898937,0.0017551493,0.00038642908,0.0002197354,0.0002490604,0.006895804,0.000023694955,0.000042121417,0.0005343487],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727994,0.0005784812,0.0003583563,0.00046665076,0.00058803475,0.00072851026],"domain_scores_gemma":[0.99788827,0.0011091016,0.000047561334,0.0004983135,0.00024488682,0.000211888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023628576,0.0001874148,0.0002961214,0.00024697484,0.00050832727,0.00007008154,0.00024699108,0.00010278178,0.00002799091],"category_scores_gemma":[0.00084074883,0.00011339953,0.0000802005,0.0006994869,0.00022854903,0.00008265237,0.00012752686,0.000372982,0.00003555034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016641019,0.00073043944,0.81518376,0.000057102807,0.0001482195,0.000109031535,0.007516299,0.000036862733,0.08025938,0.0010013619,0.008879786,0.06943674],"study_design_scores_gemma":[0.010138654,0.002976688,0.24652633,0.00053245004,0.000036580375,0.00014217383,0.004194092,0.00030336002,0.28108495,0.0005107018,0.45305684,0.0004971646],"about_ca_topic_score_codex":0.0007145492,"about_ca_topic_score_gemma":0.0005070975,"teacher_disagreement_score":0.56865746,"about_ca_system_score_codex":0.0006494701,"about_ca_system_score_gemma":0.0009092727,"threshold_uncertainty_score":0.46242985},"labels":[],"label_agreement":null},{"id":"W2072930665","doi":"10.1158/1538-7445.am2012-1607","title":"Abstract 1607: Airway gene expression alterations associated with lung cancer chemoprevention using green tea extract","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lung cancer; Medicine; Cancer; Gene expression profiling; Lung; Oncology; Gene expression; Internal medicine; Pathology; Cancer research; Biology; Gene","score_opus":0.12264522545414538,"score_gpt":0.4398365841896443,"score_spread":0.31719135873549886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072930665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890615,0.007697477,0.0003013014,0.0008684095,0.00020907134,0.0008586943,0.000057843405,0.00005960764,0.0010414303],"genre_scores_gemma":[0.99510175,0.0007966565,0.0003776171,0.000108312306,0.0010667491,0.0007098255,0.000065084154,0.00006680258,0.0017071984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973163,0.00013377167,0.00029469872,0.000381204,0.0010280965,0.00084592274],"domain_scores_gemma":[0.99852324,0.00008257688,0.00012726817,0.0003503848,0.00055004633,0.00036649124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00097542355,0.00019966897,0.000304369,0.0002115726,0.0004178043,0.00006372972,0.00014338933,0.00016326823,0.0029064524],"category_scores_gemma":[0.000058480222,0.00015551195,0.00009991418,0.00061702967,0.00012309446,0.00045709117,0.00007124026,0.00065560034,0.000012565044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003179643,0.000534464,0.1764616,0.0002518696,0.00023269723,0.000009657877,0.0006941621,0.00016621413,0.8017446,0.000011764802,0.005303832,0.014271194],"study_design_scores_gemma":[0.0020900443,0.00017442001,0.2314527,0.002594921,0.0002225859,0.000010956261,0.00020927998,0.00088631455,0.7584504,0.000006806878,0.0035372477,0.00036435417],"about_ca_topic_score_codex":0.0022358166,"about_ca_topic_score_gemma":0.0003111574,"teacher_disagreement_score":0.0549911,"about_ca_system_score_codex":0.0012410552,"about_ca_system_score_gemma":0.0006277585,"threshold_uncertainty_score":0.99800503},"labels":[],"label_agreement":null},{"id":"W2073020674","doi":"10.1158/0008-5472.sabcs12-p5-01-01","title":"Abstract P5-01-01: Predicting OncoDX Recurrence Scores with Immunohistochemical Markers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Immunohistochemistry; Medicine; Oncology; Internal medicine; Breast cancer; Pathological; Cohort; Stage (stratigraphy); Cancer; Lymph node; Biology","score_opus":0.044810402099107007,"score_gpt":0.3775424606071101,"score_spread":0.3327320585080031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073020674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980271,0.01322096,0.000016793458,0.00037596418,0.00021195807,0.00029649696,0.000059469305,0.000022340264,0.005525031],"genre_scores_gemma":[0.9970421,0.001107258,0.00022345585,0.00005120214,0.00080487545,0.00040261025,0.000061241255,0.000037560978,0.0002697038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804616,0.00007609656,0.00016929249,0.00042268884,0.0004723291,0.00081340777],"domain_scores_gemma":[0.9990548,0.00006961069,0.00006098588,0.00043044297,0.00019016289,0.00019397914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005033345,0.00019426557,0.0001698431,0.00006276751,0.000287854,0.00003068559,0.00029283972,0.00011942123,0.00015424],"category_scores_gemma":[0.00013352548,0.00015782878,0.000057273202,0.00021224609,0.0004952355,0.000014593189,0.00023786617,0.00035668514,0.00002704774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029646768,0.00032248054,0.42002982,0.0001805055,0.00053941755,0.000012905571,0.00069187215,0.00001562642,0.5206536,0.00005285836,0.035258416,0.01927781],"study_design_scores_gemma":[0.002124273,0.0004689173,0.5398372,0.00050228747,0.00005981015,0.000043761913,0.0010474853,0.000003681806,0.41331515,0.000030729574,0.041940022,0.0006267269],"about_ca_topic_score_codex":0.00073533173,"about_ca_topic_score_gemma":0.0001332943,"teacher_disagreement_score":0.11980733,"about_ca_system_score_codex":0.0002597118,"about_ca_system_score_gemma":0.00029726853,"threshold_uncertainty_score":0.643607},"labels":[],"label_agreement":null},{"id":"W2073078104","doi":"10.1158/1538-7445.am2011-lb-271","title":"Abstract LB-271: Benign ovarian serous tumors: A redefining moment","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous Cystadenoma; Ovarian cancer; Cystadenocarcinoma; Pathology; Ovary; Serous carcinoma; Biology; Clear cell; Medicine; Cancer research; Cancer; Internal medicine; Carcinoma","score_opus":0.2230265689919213,"score_gpt":0.41272523664993144,"score_spread":0.18969866765801013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073078104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86195606,0.0030162963,0.000026678603,0.0042472235,0.0003303651,0.0012144484,0.000053937707,0.00012261281,0.12903236],"genre_scores_gemma":[0.99509925,0.00074751495,0.00077416206,0.00029562492,0.0004396362,0.00092501106,0.000017117365,0.000057165344,0.0016445112],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99736744,0.00007200389,0.00032518018,0.0005891074,0.0008387587,0.0008075118],"domain_scores_gemma":[0.99847203,0.0000893749,0.000064170636,0.00065453345,0.00029030748,0.00042956416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078437437,0.00020321843,0.00036104987,0.00026422922,0.00021919067,0.000053469015,0.00019985525,0.00010721122,0.006385396],"category_scores_gemma":[0.000052941818,0.00016861678,0.00011479554,0.00048050872,0.00015006764,0.00009616138,0.00010901443,0.000553523,0.0003802609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006415352,0.007780637,0.34287727,0.0019853294,0.0032427358,0.010713098,0.027070355,0.000046383197,0.023777591,0.03734876,0.13861084,0.40013167],"study_design_scores_gemma":[0.007914117,0.0024104377,0.85069627,0.0024096156,0.00018940287,0.00011746479,0.0017805763,0.000028796812,0.055673905,0.0020506154,0.07610098,0.0006278085],"about_ca_topic_score_codex":0.005959148,"about_ca_topic_score_gemma":0.00019380504,"teacher_disagreement_score":0.507819,"about_ca_system_score_codex":0.000887639,"about_ca_system_score_gemma":0.0007659598,"threshold_uncertainty_score":0.9945229},"labels":[],"label_agreement":null},{"id":"W2073149046","doi":"10.1158/1538-7445.am2011-1352","title":"Abstract 1352: Mechanism of action of AL622, a molecule rationally designed to release an EGFR and a Src kinase inhibitor","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Gefitinib; Transfection; EGFR inhibitors; Proto-oncogene tyrosine-protein kinase Src; Chemistry; Cancer research; Epidermal growth factor receptor; Cell growth; Western blot; Kinase; Pharmacology; Receptor; Biology; Biochemistry; Gene","score_opus":0.23121162410328822,"score_gpt":0.4647197616200853,"score_spread":0.2335081375167971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073149046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953625,0.00034036543,0.00030501204,0.00077242765,0.00007966573,0.0012476258,0.00005063421,0.000022679858,0.0018190738],"genre_scores_gemma":[0.9968143,0.00028202566,0.0016936769,0.00009566087,0.00017088334,0.00034788589,0.000010835253,0.000045677447,0.0005390376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709505,0.00022223973,0.0003848802,0.0004509614,0.0013583576,0.0004885233],"domain_scores_gemma":[0.9974006,0.00013634773,0.00008014633,0.0005208502,0.0012851353,0.0005769362],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015849009,0.00014155784,0.00031913794,0.00054608413,0.00009153884,0.000018332741,0.00021813018,0.00013714927,0.0014341499],"category_scores_gemma":[0.0005929342,0.00013302219,0.0000563739,0.0006738027,0.00024430733,0.00016301453,0.00012636339,0.0004667191,0.000023890074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025237068,0.00035268872,0.00060569705,0.00065218966,0.00004726877,0.00007611534,0.0014002958,0.0000035349515,0.98082036,0.0012805731,0.0016739314,0.010563668],"study_design_scores_gemma":[0.0012811034,0.0018675238,0.010350282,0.00045670732,0.000018343362,0.000010033787,0.000585383,0.00007819629,0.98409426,0.000694775,0.0004442044,0.00011920234],"about_ca_topic_score_codex":0.0037754744,"about_ca_topic_score_gemma":0.00046103817,"teacher_disagreement_score":0.010444465,"about_ca_system_score_codex":0.0003524681,"about_ca_system_score_gemma":0.0015592999,"threshold_uncertainty_score":0.9994787},"labels":[],"label_agreement":null},{"id":"W2073151077","doi":"10.1158/0008-5472.can-10-2426","title":"CARM1 Is an Important Determinant of ERα-Dependent Breast Cancer Cell Differentiation and Proliferation in Breast Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; University of Manitoba; Canadian Institutes of Health Research; Uehara Memorial Foundation; Greater Milwaukee Foundation; Breast Cancer Alliance","keywords":"Coactivator; Biology; Cancer research; Breast cancer; Estrogen receptor; Cancer; Cell growth; Cellular differentiation; Epigenetics; Aromatase; Gene; Genetics; Transcription factor","score_opus":0.03073244746958075,"score_gpt":0.3242798784857608,"score_spread":0.29354743101618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073151077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953665,0.0031412712,0.000025394424,0.0001679892,0.00019029189,0.00054528186,0.0004996775,0.0000062396666,0.00005731786],"genre_scores_gemma":[0.98898685,0.010021674,0.00002280808,0.000030147303,0.00026648203,0.00034567353,0.00004606409,0.00003715175,0.00024315988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815404,0.00014200735,0.0003708098,0.0005453979,0.00038647698,0.00040127212],"domain_scores_gemma":[0.99894595,0.0000059952376,0.00015813498,0.00034866403,0.0004039486,0.0001373297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035252646,0.0001754086,0.00019733918,0.00012457778,0.00008322777,0.000026599513,0.0001744202,0.00021840494,0.00036417317],"category_scores_gemma":[0.0000030653434,0.00016604946,0.000044367847,0.00019035608,0.00012118708,0.000029987403,0.000110901776,0.00018506206,9.921396e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048005788,0.000115929455,0.117425635,0.00011230643,0.000030449979,0.0000018510688,0.0007435401,0.00008813915,0.8716461,0.000004350281,0.0002118937,0.009139715],"study_design_scores_gemma":[0.0006842961,0.000104830404,0.25497258,0.00007150827,0.000021085641,0.0000084919775,0.00012385481,0.0007102693,0.7430627,0.000022784192,0.0000555942,0.00016204317],"about_ca_topic_score_codex":0.016192136,"about_ca_topic_score_gemma":0.01749266,"teacher_disagreement_score":0.13754693,"about_ca_system_score_codex":0.00028455205,"about_ca_system_score_gemma":0.0004919892,"threshold_uncertainty_score":0.9903591},"labels":[],"label_agreement":null},{"id":"W2073171184","doi":"10.1158/1538-7445.am10-4004","title":"Abstract 4004: Reciprocal regulation of Stat3 and the caveolae protein, cav1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Cell biology; Caveolae; STAT protein; Signal transduction; STAT3; Phosphorylation; Biology; Kinase; Caveolin; Caveolin 1; Receptor tyrosine kinase; Tyrosine phosphorylation; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Chemistry","score_opus":0.02404902106477092,"score_gpt":0.3478094897579237,"score_spread":0.3237604686931528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073171184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554473,0.0018062075,0.000052630967,0.0005474682,0.000057719644,0.0003578797,0.0000137273055,0.000003645748,0.0016159941],"genre_scores_gemma":[0.99728745,0.00033545992,0.00004843413,0.000024451838,0.00026899987,0.00012578732,0.000019391033,0.000012967287,0.0018770313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912703,0.000050998853,0.00013918217,0.00022118588,0.00025192252,0.0002096836],"domain_scores_gemma":[0.9992422,0.000029743256,0.00004679668,0.00028275826,0.00033838887,0.00006009968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090257725,0.00007070967,0.00009322208,0.00003484853,0.00011496936,0.000028318525,0.00016741686,0.0001130775,0.00010097582],"category_scores_gemma":[0.00022317213,0.000048940743,0.00003338119,0.00010835992,0.00057179993,0.0000043297746,0.00010512205,0.00029536439,0.0000031850113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034865856,0.000016552627,0.0002868009,0.000079690784,0.000015811433,6.6767615e-7,0.000090827176,0.000003617965,0.9911462,0.0005930138,0.00063410355,0.0067840405],"study_design_scores_gemma":[0.000695988,0.000059465186,0.0036700417,0.000019481595,0.0000040950727,0.000003973569,0.00008320431,0.000015211602,0.97065496,0.0010334735,0.023691226,0.000068879024],"about_ca_topic_score_codex":0.0004722283,"about_ca_topic_score_gemma":0.00066192064,"teacher_disagreement_score":0.023057122,"about_ca_system_score_codex":0.000007708583,"about_ca_system_score_gemma":0.00023377452,"threshold_uncertainty_score":0.21068206},"labels":[],"label_agreement":null},{"id":"W2073354258","doi":"10.1158/1538-7445.am2012-4897","title":"Abstract 4897: Involvement of Akt isoforms in chemoresistance of carcinoma endometrial cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Protein kinase B; AKT2; AKT1; Cancer research; Cisplatin; Cell growth; AKT3; XIAP; Cell culture; Biology; Gene isoform; PI3K/AKT/mTOR pathway; Apoptosis; Chemistry; Cell biology; Signal transduction; Programmed cell death; Caspase; Biochemistry; Gene","score_opus":0.07482913688226994,"score_gpt":0.38748905555736707,"score_spread":0.3126599186750971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073354258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944231,0.0037037346,0.000008659263,0.00004845672,0.00016810454,0.00044921983,0.000082512524,0.0000023646278,0.0011138822],"genre_scores_gemma":[0.9983626,0.0006540029,0.00006612476,0.000009485691,0.00030420674,0.00009730317,0.00003045001,0.000026507281,0.00044929318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974978,0.00011984744,0.0004044785,0.0002984754,0.00086888403,0.0008105331],"domain_scores_gemma":[0.99868256,0.000095653784,0.000101716956,0.00054696115,0.00039174617,0.00018136941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018323002,0.00013385898,0.00026715986,0.00036970284,0.000034410004,0.000010771907,0.00050091435,0.00016695887,0.00029239058],"category_scores_gemma":[0.000329395,0.00012000376,0.000097984805,0.0006533213,0.00032849674,0.000012628768,0.0003183374,0.00028611775,0.000010161411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051460456,0.00020183774,0.12909555,0.0002368256,0.000026976779,0.0000016144198,0.00014063084,0.000008054318,0.8668592,0.00003453502,0.0017378309,0.0011423568],"study_design_scores_gemma":[0.0011048296,0.00019297296,0.071528755,0.00004040034,0.0000022439951,2.944165e-7,0.00021276213,0.000001561013,0.92343026,0.000021672135,0.0033605264,0.000103719925],"about_ca_topic_score_codex":0.0014943792,"about_ca_topic_score_gemma":0.0004495649,"teacher_disagreement_score":0.057566803,"about_ca_system_score_codex":0.00017879246,"about_ca_system_score_gemma":0.00047754424,"threshold_uncertainty_score":0.48936114},"labels":[],"label_agreement":null},{"id":"W2073375464","doi":"10.1158/1538-7445.am2013-2199","title":"Abstract 2199: Associations of genetic polymorphisms in <i>VEGFR1</i> with progression-free and overall survival in patients with neuroendocrine tumors treated with the VEGFA inhibitor bevacizumab.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Single-nucleotide polymorphism; Internal medicine; Oncology; Hazard ratio; Proportional hazards model; Medicine; Progression-free survival; Genotyping; Minor allele frequency; Vascular endothelial growth factor A; Genotype; Vascular endothelial growth factor; Biology; Chemotherapy; VEGF receptors; Confidence interval; Gene; Genetics","score_opus":0.025019235486734636,"score_gpt":0.3319644849082787,"score_spread":0.30694524942154405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073375464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298763,0.0003410341,3.3503355e-7,0.0035631647,0.00001418716,0.0027377582,0.00005553562,0.000024415727,0.00027595917],"genre_scores_gemma":[0.9985236,0.00010386898,0.00012165104,0.000059784397,0.00004699414,0.00081401644,0.000021684753,0.00006880294,0.00023959235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597657,0.0002683107,0.00037292406,0.00054221693,0.00188919,0.0009507925],"domain_scores_gemma":[0.99794835,0.00039268585,0.00014918772,0.00062086,0.000612243,0.00027668104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022844457,0.0002611078,0.00047310189,0.0004682255,0.00012202103,0.00006601444,0.00034096633,0.000013783394,0.00009768676],"category_scores_gemma":[0.00026266617,0.00014245168,0.000026057409,0.0012098969,0.00065506116,0.00027851365,0.00019847382,0.00096259185,0.000004904053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022570677,0.00048621534,0.99172467,0.00012052213,0.000039217808,0.0008454241,0.000101295605,0.000055348602,0.002406122,0.000011862635,0.00038730397,0.0015649748],"study_design_scores_gemma":[0.008938214,0.002709944,0.9827544,0.0005805793,0.000012946135,0.000041591033,0.00012186595,0.00001853013,0.0045639756,0.000029890498,0.00007950075,0.00014855117],"about_ca_topic_score_codex":0.005577113,"about_ca_topic_score_gemma":0.004268189,"teacher_disagreement_score":0.008970235,"about_ca_system_score_codex":0.00027572585,"about_ca_system_score_gemma":0.0004975117,"threshold_uncertainty_score":0.8430964},"labels":[],"label_agreement":null},{"id":"W2073480888","doi":"10.1158/1538-7445.am2012-1424","title":"Abstract 1424: KCNJ2 comprises a marker of poor prognosis and a therapeutic target in non-WNT/non-SHH medulloblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Gene knockdown; Cancer research; Biology; Internal medicine; Oncology; Medicine; Genetics; Cell culture; Signal transduction","score_opus":0.06668011223918463,"score_gpt":0.39915718552746454,"score_spread":0.3324770732882799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073480888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987486,0.008455941,0.0000010375264,0.0016647567,0.00006448566,0.0010722822,0.000020062158,0.000010920985,0.0012245186],"genre_scores_gemma":[0.99786556,0.00080705713,0.00014586766,0.00009747323,0.00011243353,0.00084696215,0.0000064734795,0.000030664934,0.00008750551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981879,0.000073561074,0.0002631009,0.00026378478,0.0005716171,0.0006400269],"domain_scores_gemma":[0.9990083,0.00026186643,0.00005447572,0.0002071368,0.00019051449,0.00027769315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072191405,0.00015686124,0.0003759548,0.00034421898,0.000063898806,0.000019848292,0.000101033955,0.00009443754,0.00060117943],"category_scores_gemma":[0.00005303743,0.000117114476,0.000068483074,0.00046359497,0.00021923368,0.000078869074,0.00008284973,0.00030261584,0.000030333378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005000723,0.0014352044,0.9172346,0.00040751035,0.00020265956,0.00005798994,0.00090405106,0.0000021800615,0.059456322,0.000031586398,0.0017026797,0.018065138],"study_design_scores_gemma":[0.0021886504,0.00029088557,0.9053049,0.00045940577,0.00003614081,0.0000109275425,0.0003585274,0.000056099238,0.08967746,0.000042243682,0.0014769051,0.00009784655],"about_ca_topic_score_codex":0.001561625,"about_ca_topic_score_gemma":0.00015574426,"teacher_disagreement_score":0.030221136,"about_ca_system_score_codex":0.00018363375,"about_ca_system_score_gemma":0.00017202727,"threshold_uncertainty_score":0.6582493},"labels":[],"label_agreement":null},{"id":"W2073525017","doi":"10.1158/1538-7445.am2011-1051","title":"Abstract 1051: Atypical PKC and TGFβ receptors co-operate to phosphorylate Par6","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Phosphorylation; Cell biology; Biology; Gene silencing; Signal transducing adaptor protein; Protein kinase C; Signal transduction; Gene; Biochemistry","score_opus":0.09690067557529687,"score_gpt":0.399794448428203,"score_spread":0.30289377285290614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073525017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571526,0.0023879134,0.000016229646,0.000112418464,0.00012050596,0.0002470225,0.00003099683,0.000015708869,0.001353926],"genre_scores_gemma":[0.9975042,0.00045055276,0.00017698959,0.00016510213,0.00023216991,0.00013583706,0.00002635682,0.000032962802,0.0012758787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985882,0.0000800235,0.00015539133,0.0004606515,0.0002530345,0.00046271502],"domain_scores_gemma":[0.9990873,0.000022516337,0.000021764905,0.00034191192,0.00016888238,0.00035767458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035633644,0.00012913567,0.000119067634,0.00006153713,0.00015074092,0.00004311188,0.0002767197,0.00012879902,0.0011156325],"category_scores_gemma":[0.00014099786,0.00011896227,0.000038554223,0.000116706615,0.00021412205,0.000004606127,0.00017600956,0.00020779438,0.00017803464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013986491,0.00011120556,0.022354271,0.000056799832,0.00007794659,0.000021890251,0.00046635396,0.000016111633,0.92411494,0.000043006294,0.039769147,0.011569674],"study_design_scores_gemma":[0.00029998002,0.0002110507,0.039013542,0.000039498693,0.0000050409226,0.0000017656856,0.00013714985,0.0000018777666,0.8653607,0.000039543535,0.09470015,0.00018971281],"about_ca_topic_score_codex":0.00022113934,"about_ca_topic_score_gemma":0.000079747406,"teacher_disagreement_score":0.058754258,"about_ca_system_score_codex":0.0000375703,"about_ca_system_score_gemma":0.0002452922,"threshold_uncertainty_score":0.99979746},"labels":[],"label_agreement":null},{"id":"W2073559248","doi":"10.1158/0008-5472.can-05-2498","title":"Constitutive Activation of Extracellular Signal-Regulated Kinase Predisposes Diffuse Large B-Cell Lymphoma Cell Lines to CD40-Mediated Cell Death","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"CD40; MAPK/ERK pathway; Signal transduction; Cell culture; Cell biology; Apoptosis; Programmed cell death; Cancer research; Biology; Kinase; Extracellular; Cell growth; B cell; Immunology; Antibody; In vitro; Cytotoxic T cell; Genetics","score_opus":0.025375312568618726,"score_gpt":0.2970357570355793,"score_spread":0.2716604444669605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073559248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985978,0.00354308,0.000676075,0.000129775,0.0008474673,0.0007063784,0.00009638039,0.000080718884,0.007942092],"genre_scores_gemma":[0.9532954,0.00016348045,0.000025457826,0.000055972305,0.00010350329,0.00010684221,0.0006137384,0.00003446291,0.045601107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976719,0.0005629945,0.0004774618,0.0004628218,0.00016948557,0.00065534195],"domain_scores_gemma":[0.9983265,0.00035263546,0.0001793699,0.0003518584,0.00073120993,0.00005847517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005595425,0.00023719291,0.00030206173,0.0004624892,0.00033839908,0.00003367643,0.00027142547,0.0002928432,0.0017677229],"category_scores_gemma":[0.000079186524,0.00022136047,0.00011149977,0.0005578591,0.00023262698,0.00019342145,0.00012591408,0.00040315336,0.0007742015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010460503,0.002728168,0.00070343073,0.00009516229,0.000035913974,0.000008168768,0.00033260058,0.00010092732,0.9725014,0.00011272767,0.021929359,0.00040611762],"study_design_scores_gemma":[0.005608973,0.00029427782,0.001629649,0.00009055476,0.000022801165,0.0000023093437,0.0004531092,0.00006004064,0.89880055,0.000018642202,0.09282131,0.00019778102],"about_ca_topic_score_codex":0.00185827,"about_ca_topic_score_gemma":0.000048784248,"teacher_disagreement_score":0.07370082,"about_ca_system_score_codex":0.00028524894,"about_ca_system_score_gemma":0.00029967428,"threshold_uncertainty_score":0.9991448},"labels":[],"label_agreement":null},{"id":"W2073674817","doi":"10.1158/1538-7445.cec13-b21","title":"Abstract B21: Epigenetic and post-transcriptional regulation of the kallikrein gene family as a novel panel of prostate cancer biomarkers","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"DNA methylation; Epigenetics; Prostate cancer; Biology; Cancer; Methylation; Carcinogenesis; CpG site; Cancer research; microRNA; Oncology; Medicine; Gene expression; Gene; Genetics","score_opus":0.03893830458445072,"score_gpt":0.32193004105108436,"score_spread":0.28299173646663367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073674817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973835,0.008071241,0.0000358474,0.00091440737,0.00013178776,0.00079331273,0.00015519743,0.0000038922644,0.00015595321],"genre_scores_gemma":[0.99660957,0.0021028288,0.00010795883,0.000041018156,0.000112751586,0.00022372947,0.000055762317,0.000025842059,0.00072055886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985485,0.000072291026,0.0002990415,0.00033516219,0.0004660984,0.0002788962],"domain_scores_gemma":[0.9986675,0.000023314613,0.00013295289,0.0003341657,0.00076507794,0.0000769913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031549486,0.00012477956,0.00013713322,0.00009509933,0.00009318318,0.000019244735,0.00019972229,0.00016010899,0.00014341423],"category_scores_gemma":[0.000047270438,0.00010206933,0.00007568722,0.00027849563,0.00042155822,0.000011691879,0.00008970684,0.00013638606,0.000002887603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020956995,0.000035504523,0.0028703434,0.000097014905,0.00011093443,8.201104e-8,0.00012689983,0.0013937206,0.9861133,0.000034477755,0.00040202655,0.008606118],"study_design_scores_gemma":[0.00041848508,0.00007806472,0.45666042,0.00006429128,0.0000115321145,0.0000016385326,0.000058975515,0.00010435858,0.54168075,0.000109396875,0.0007381018,0.00007397445],"about_ca_topic_score_codex":0.006234577,"about_ca_topic_score_gemma":0.0004298683,"teacher_disagreement_score":0.4537901,"about_ca_system_score_codex":0.00007895316,"about_ca_system_score_gemma":0.0005814371,"threshold_uncertainty_score":0.9424857},"labels":[],"label_agreement":null},{"id":"W2073724573","doi":"10.1158/1538-7445.am2011-4847","title":"Abstract 4847: Purifying tumor gene expression profiles leads to predictive models of patient outcome","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Gene signature; Correlation; Cohort; Oncology; Lung cancer; Gene expression; Medicine; Internal medicine; Cancer; Pipeline (software); Gene; Computational biology; Computer science; Biology; Genetics; Mathematics","score_opus":0.12912873320684184,"score_gpt":0.4204885123956065,"score_spread":0.29135977918876466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073724573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165124,0.00053887285,0.0014095367,0.00050943624,0.00016070016,0.0007429478,0.000018663051,0.00003918039,0.004929428],"genre_scores_gemma":[0.99437153,0.00007286352,0.004664948,0.00020634182,0.0001704029,0.00023924459,0.0000065786953,0.00003899751,0.00022907367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977922,0.00008293078,0.00037964166,0.0003607375,0.00090412825,0.0004804038],"domain_scores_gemma":[0.998729,0.000088591834,0.00008300663,0.00035613475,0.00036381508,0.000379481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008145065,0.00012741485,0.0003140717,0.00028566655,0.00010967683,0.000013268758,0.00021405841,0.00006137253,0.00040107474],"category_scores_gemma":[0.0004398601,0.00009723953,0.00007372061,0.00027469062,0.00017937017,0.00010694227,0.00018146118,0.0008151379,0.000019003539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013565046,0.0003913717,0.10495174,0.0006949663,0.00006700463,0.0001899239,0.008150753,0.0015177055,0.8583317,0.00018143,0.0035493982,0.020617539],"study_design_scores_gemma":[0.0014364226,0.0010279297,0.059478402,0.0016249042,0.000036740967,0.000022373366,0.00095250184,0.0054934984,0.9278979,0.0007672544,0.0010045613,0.0002575379],"about_ca_topic_score_codex":0.00060383056,"about_ca_topic_score_gemma":0.0000028139034,"teacher_disagreement_score":0.069566205,"about_ca_system_score_codex":0.00017327591,"about_ca_system_score_gemma":0.0002406455,"threshold_uncertainty_score":0.4391487},"labels":[],"label_agreement":null},{"id":"W2073789788","doi":"10.1158/1538-7445.am2011-2074","title":"Abstract 2074: Hsp27 inhibition activates the unfold protein response and autophagy pathway through inhibition of proteasome activity in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Unfolded protein response; Hsp27; MG132; Autophagy; Proteasome; Cell biology; Endoplasmic reticulum; Proteostasis; Gene knockdown; Programmed cell death; Proteasome inhibitor; Viability assay; Cancer cell; Heat shock protein; Chemistry; Cancer research; Apoptosis; Biology; Hsp70; Cancer; Biochemistry","score_opus":0.047009402406998156,"score_gpt":0.339036258930092,"score_spread":0.29202685652309385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073789788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963882,0.0013764211,0.000004956959,0.00036216853,0.00002704005,0.0012993739,0.0001416405,0.0000075596704,0.0003926425],"genre_scores_gemma":[0.997308,0.0007166613,0.000030559393,0.000026957412,0.00005633036,0.0016047545,0.000013316246,0.000020738156,0.00022264461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984375,0.00032694792,0.00019825222,0.0003794701,0.0002982586,0.00035954],"domain_scores_gemma":[0.9992982,0.000041086212,0.00010451987,0.00029525146,0.00017998861,0.000080948594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007152914,0.00014241178,0.00014649655,0.00007249273,0.000116905656,0.000026421132,0.000101765916,0.000109412416,0.00008385687],"category_scores_gemma":[0.00018730259,0.00010468075,0.00004579248,0.00021705023,0.00038015377,0.00003035992,0.00014850571,0.0002884291,0.0000018229922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038984849,0.00015223598,0.00209463,0.00018783419,0.000018834988,0.000018975792,0.0006193318,0.000009958871,0.98997533,0.000102965605,0.00011728244,0.0028041068],"study_design_scores_gemma":[0.00076579273,0.00020971082,0.06612191,0.000260562,0.0000035167225,0.000001622051,0.00021398495,0.000006667658,0.9313771,0.0005861433,0.00033659415,0.00011635854],"about_ca_topic_score_codex":0.0029030317,"about_ca_topic_score_gemma":0.0004571627,"teacher_disagreement_score":0.06402729,"about_ca_system_score_codex":0.00006659912,"about_ca_system_score_gemma":0.00043225865,"threshold_uncertainty_score":0.43885347},"labels":[],"label_agreement":null},{"id":"W2073904860","doi":"10.1158/0008-5472.can-13-3109","title":"Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"BAP1; DNA damage; DNA repair; Carcinogenesis; DNA; Cancer research; Biology; Ubiquitin; Poly ADP ribose polymerase; Germline; DNA Damage Repair; Cell biology; Genetics; Melanoma; Cancer; Gene","score_opus":0.04138457941416873,"score_gpt":0.366899732357368,"score_spread":0.32551515294319927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073904860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965101,0.0005427434,0.00018797978,0.0003131758,0.000134075,0.00039854535,0.000013062805,0.000028508264,0.0018718503],"genre_scores_gemma":[0.9969781,0.00013141101,0.00009286604,0.000074441625,0.00024035711,0.00031055644,0.0000768477,0.000026422425,0.0020689876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840665,0.00020846624,0.00022461743,0.00044414925,0.00027773704,0.0004383924],"domain_scores_gemma":[0.99929494,0.000032280965,0.000028818577,0.00035404568,0.00018962572,0.00010031817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001266274,0.00011004382,0.00013014826,0.00021211794,0.00006377966,0.000024585383,0.00017381705,0.0001677739,0.000119742166],"category_scores_gemma":[0.00013185803,0.00011151845,0.00006322654,0.0004072868,0.000063297426,0.000009666541,0.000099089455,0.00027169805,0.000032571174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005777766,0.0000995444,0.005496621,0.00006222995,0.000019284264,0.000008416604,0.000095788346,0.000549335,0.9890076,0.00040846303,0.0013217588,0.0023531662],"study_design_scores_gemma":[0.004863953,0.00079333136,0.027533174,0.00010638655,0.000010054114,0.000010273756,0.00017216975,0.002012445,0.9217317,0.00087507267,0.041550152,0.00034129518],"about_ca_topic_score_codex":0.00038015272,"about_ca_topic_score_gemma":0.0033215804,"teacher_disagreement_score":0.06727593,"about_ca_system_score_codex":0.00010404853,"about_ca_system_score_gemma":0.00021248327,"threshold_uncertainty_score":0.45475903},"labels":[],"label_agreement":null},{"id":"W2074039588","doi":"10.1158/0008-5472.sabcs12-p6-09-01","title":"Abstract P6-09-01: Investigating the effectiveness of a psycho-educational behavioral intervention for cancer-related cognitive dysfunction in women with breast and gynecological cancer: Knowledge, self-efficacy, and behavioral change.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Distress; Cancer; Survivorship curve; Quality of life (healthcare); Likert scale; Intervention (counseling); Cognition; Clinical psychology; Physical therapy; Psychology; Internal medicine; Psychiatry; Nursing","score_opus":0.11460669889360862,"score_gpt":0.45981926217021757,"score_spread":0.34521256327660893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074039588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98849416,0.0061092232,0.00000346662,0.0008684648,0.00029277639,0.0039487197,0.00017389038,0.000035846104,0.000073446725],"genre_scores_gemma":[0.985324,0.0009801193,0.0000220657,0.000026489868,0.00027259096,0.013254697,0.000032579468,0.00003728551,0.000050137794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774575,0.00040758625,0.00034590703,0.00044200016,0.00038074338,0.00067798636],"domain_scores_gemma":[0.99749243,0.0012048329,0.00016359566,0.000117081,0.0007856149,0.00023644773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019793203,0.0002369044,0.00042115574,0.00028180119,0.0002786792,0.000029059127,0.00007875577,0.00015969574,0.00017170096],"category_scores_gemma":[0.00014731995,0.0001716304,0.000046425983,0.00068441726,0.00068115466,0.00026779753,0.000103506776,0.00066475745,0.0000018168108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008348483,0.0048599658,0.81267315,0.0016756584,0.00055052247,0.0000028838128,0.020494195,0.000003059828,0.0045737927,0.0000430218,0.0001279945,0.14664727],"study_design_scores_gemma":[0.0087369,0.0019316499,0.9807333,0.0033205473,0.0002892031,0.000023427714,0.0036023504,0.000023236344,0.0010288106,0.00006294052,0.0000648268,0.00018284291],"about_ca_topic_score_codex":0.0037159026,"about_ca_topic_score_gemma":0.0019187025,"teacher_disagreement_score":0.16806011,"about_ca_system_score_codex":0.0013937972,"about_ca_system_score_gemma":0.0004466542,"threshold_uncertainty_score":0.69988847},"labels":[],"label_agreement":null},{"id":"W2074225152","doi":"10.1158/0008-5472.sabcs13-p3-10-04","title":"Abstract P3-10-04: Prevalence of pain and barriers to pain management in breast cancer survivors in Vietnam","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Vietnamese; Population; Cancer pain; Quality of life (healthcare); Physical therapy; Internal medicine; Nursing","score_opus":0.03104320894225435,"score_gpt":0.35529230025039926,"score_spread":0.3242490913081449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074225152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871776,0.0029303827,0.000009823327,0.006349219,0.00011461124,0.0015539981,0.00007526745,0.000016083906,0.0017729821],"genre_scores_gemma":[0.9924331,0.0027736453,0.000022735941,0.0005841699,0.00008527557,0.001621513,0.0000036991646,0.000032020394,0.002443878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971735,0.0004763208,0.00037629518,0.0005165125,0.0007732015,0.0006842078],"domain_scores_gemma":[0.9985144,0.00024674847,0.000044213793,0.00041236487,0.00027854327,0.00050369825],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045559,0.00017365126,0.00033956926,0.0005656922,0.00005149349,0.00003251964,0.00024380766,0.00010086029,0.006323686],"category_scores_gemma":[0.000189176,0.00016049626,0.000047781923,0.0011021878,0.00018365946,0.000121991055,0.0001532853,0.00044047617,0.000020601356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068637345,0.00009030266,0.7044916,0.00439054,0.000054739638,0.000062686086,0.0038289274,0.00007813742,0.0029334964,0.000037299393,0.007788061,0.27555782],"study_design_scores_gemma":[0.0011205557,0.00021622433,0.98174304,0.0023033835,0.000012975742,0.0000020286532,0.006968786,0.00023137651,0.0004362789,0.00008697869,0.0066388003,0.00023956789],"about_ca_topic_score_codex":0.09865847,"about_ca_topic_score_gemma":0.08351966,"teacher_disagreement_score":0.27725142,"about_ca_system_score_codex":0.00059423596,"about_ca_system_score_gemma":0.00035254704,"threshold_uncertainty_score":0.9945847},"labels":[],"label_agreement":null},{"id":"W2074503707","doi":"10.1158/0008-5472.can-05-3304","title":"Reduction of Cytosolic p27Kip1 Inhibits Cancer Cell Motility, Survival, and Tumorigenicity","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Motility; Protein kinase B; PI3K/AKT/mTOR pathway; Gene knockdown; Cancer research; Cytoplasm; Small hairpin RNA; Cell cycle; Cell growth; Biology; Cell; Cytosol; Cancer cell; Apoptosis; Chemistry; Cell biology; Cancer; Signal transduction; Biochemistry","score_opus":0.06688301017974434,"score_gpt":0.38351410935066516,"score_spread":0.3166310991709208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074503707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761874,0.015013075,0.000032267995,0.00064289855,0.00034159687,0.0006970893,0.000074505915,0.000043949054,0.00696718],"genre_scores_gemma":[0.9936194,0.0038172377,0.00005415428,0.000015812424,0.0005421389,0.0001543808,0.000018624602,0.000045931458,0.001732345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751437,0.00017499868,0.00035067124,0.0005090861,0.0009051325,0.0005457234],"domain_scores_gemma":[0.9985589,0.000048873295,0.00008825189,0.0004517407,0.00065910816,0.00019315103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074536615,0.00016618278,0.00036850784,0.0001939927,0.00013410028,0.00002158707,0.00012365385,0.00015903225,0.00043402883],"category_scores_gemma":[0.000057013738,0.00016176175,0.00008421569,0.00069189456,0.0004245593,0.00009480797,0.00014785191,0.00058654184,0.000010548703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002997115,0.00019794387,0.007559407,0.00050363963,0.000041460793,0.000016393653,0.00020257244,0.00011558542,0.9840018,0.0001931023,0.00421457,0.0026537864],"study_design_scores_gemma":[0.0017559453,0.00024393585,0.028095255,0.00028449902,0.00005763168,0.00002414094,0.00019659294,0.00009342276,0.9655453,0.00028156105,0.0032794925,0.00014221648],"about_ca_topic_score_codex":0.04813856,"about_ca_topic_score_gemma":0.0037647013,"teacher_disagreement_score":0.04437386,"about_ca_system_score_codex":0.0007735285,"about_ca_system_score_gemma":0.0008654918,"threshold_uncertainty_score":0.9582},"labels":[],"label_agreement":null},{"id":"W2074565879","doi":"10.1158/1538-7445.am2013-2637","title":"Abstract 2637: Examining the function of the serine protease, Granzyme B, in ALK-positive, anaplastic large cell lymphoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Cancer research; Granzyme; Anaplastic large-cell lymphoma; Granzyme B; Cytotoxic T cell; Biology; Lymphoma; Medicine; Immunology; Pathology; T cell; Perforin; Lung cancer; Genetics; Immune system; In vitro","score_opus":0.04677557367154738,"score_gpt":0.3309162721922856,"score_spread":0.2841406985207382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074565879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081224,0.0011862407,0.000002223573,0.0013357309,0.00010240154,0.0016339326,0.000023993229,0.000010316743,0.0048929434],"genre_scores_gemma":[0.997277,0.00020663174,0.0000075566786,0.00012948015,0.00009998011,0.0012332074,0.000009000405,0.000018316177,0.0010187972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839896,0.00013808464,0.00021902815,0.00024717278,0.00057218835,0.00042458423],"domain_scores_gemma":[0.9989262,0.00029410585,0.00006168981,0.0003887663,0.00023637644,0.00009286473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984735,0.00011860821,0.00018928782,0.00010745869,0.00016326073,0.000031233612,0.00015921803,0.00006101813,0.0005723685],"category_scores_gemma":[0.0000863265,0.000060665876,0.000059157574,0.0005376176,0.00014279349,0.000084414816,0.00010872911,0.00019223939,0.00007643354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016197559,0.0056257523,0.7902577,0.0009251666,0.0003142401,0.00013784065,0.0018680099,0.0000912242,0.09161544,0.00055503024,0.017666198,0.08932362],"study_design_scores_gemma":[0.0041428055,0.00033900645,0.95513326,0.00032050643,0.000025194568,0.000004208386,0.00034624914,0.00006938844,0.037101757,0.000059298305,0.002399272,0.0000590584],"about_ca_topic_score_codex":0.004074993,"about_ca_topic_score_gemma":0.0005495018,"teacher_disagreement_score":0.16487554,"about_ca_system_score_codex":0.00038769146,"about_ca_system_score_gemma":0.0003584344,"threshold_uncertainty_score":0.6267034},"labels":[],"label_agreement":null},{"id":"W2074708554","doi":"10.1158/0008-5472.can-06-1344","title":"Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health; George Mason University","keywords":"Rhabdomyosarcoma; PI3K/AKT/mTOR pathway; Protein kinase B; Phosphoprotein; Cancer research; Phosphorylation; Medicine; Survival analysis; Oncology; Internal medicine; Biology; Signal transduction; Sarcoma; Pathology; Cell biology","score_opus":0.06903887174658498,"score_gpt":0.3517123035260021,"score_spread":0.2826734317794171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074708554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328786,0.0008244532,0.0001718675,0.0023037675,0.000054158372,0.0013540816,0.00005639132,0.00004233097,0.0019050844],"genre_scores_gemma":[0.9981694,0.00006372279,0.00042446415,0.00016202219,0.00013314231,0.00024298084,0.00006467205,0.00005180012,0.0006877574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695414,0.00017531759,0.00036884358,0.000452078,0.0013398941,0.00070974464],"domain_scores_gemma":[0.99792445,0.0004593062,0.00017024517,0.00038599293,0.00080368435,0.00025631848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016045677,0.00021969518,0.00047070105,0.00036343135,0.0001760253,0.00002500654,0.0001638845,0.00014691635,0.0006403081],"category_scores_gemma":[0.00035777508,0.00016717963,0.000110727815,0.0013145942,0.00023295064,0.00010695123,0.00006333216,0.00049860287,0.000017121787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018487612,0.0033718415,0.8735083,0.00013576109,0.0010388308,0.00026638532,0.005375223,0.0000047911326,0.06524395,0.00048489016,0.0018766805,0.04684459],"study_design_scores_gemma":[0.0029583573,0.00053204014,0.51166433,0.0004472134,0.000016807511,0.0000029123614,0.00069499103,0.000004831618,0.48177812,0.00018676049,0.0016019017,0.00011176203],"about_ca_topic_score_codex":0.0017382156,"about_ca_topic_score_gemma":0.0002411722,"teacher_disagreement_score":0.41653416,"about_ca_system_score_codex":0.0006520647,"about_ca_system_score_gemma":0.0006342727,"threshold_uncertainty_score":0.7010924},"labels":[],"label_agreement":null},{"id":"W2074886277","doi":"10.1158/1538-7445.am2014-lb-177","title":"Abstract LB-177: Handling of liquid biopsy samples can dramatically change the numbers of PSMA-positive microparticles","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microvesicles; Prostate cancer; Microvesicle; Liquid biopsy; Overdiagnosis; Biomarker; Medicine; Prostate; Biomarker discovery; Prostate biopsy; Cancer; Glutamate carboxypeptidase II; Circulating tumor cell; Pathology; Internal medicine; Metastasis; Chemistry; microRNA; Proteomics; Biochemistry","score_opus":0.06192121559737536,"score_gpt":0.367999396151505,"score_spread":0.30607818055412966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074886277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959489,0.0023856794,0.0001803288,0.00066120113,0.000048494523,0.00030078873,0.0001103025,0.0000048401675,0.00035943088],"genre_scores_gemma":[0.99890566,0.00025101658,0.0003585312,0.000068798305,0.00022876756,0.00008164377,0.00002747473,0.000024642895,0.000053442905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855024,0.00021757782,0.00026212336,0.00026745995,0.0003367974,0.00036579583],"domain_scores_gemma":[0.9987802,0.00014760828,0.00009783967,0.0004959569,0.0003588113,0.00011961632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009328979,0.00011043742,0.0001591723,0.000048782127,0.000107794796,0.000021103884,0.00042713332,0.0000919739,0.000059095222],"category_scores_gemma":[0.0003931265,0.0000855392,0.00009035698,0.00016663043,0.00071996514,0.0000046280015,0.00018972908,0.00016574151,0.000004918068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028644627,0.000075262375,0.001998033,0.00013083764,0.000056392542,0.00000207884,0.00044067952,0.000017795528,0.99377805,0.00032726466,0.00018852769,0.0026986247],"study_design_scores_gemma":[0.00028560442,0.00021103706,0.008253659,0.000113004586,0.00001660105,0.0000024604312,0.00030389288,0.000029720353,0.9896554,0.00017651728,0.0008537532,0.00009838021],"about_ca_topic_score_codex":0.0009899496,"about_ca_topic_score_gemma":0.00027388203,"teacher_disagreement_score":0.006255626,"about_ca_system_score_codex":0.000027397504,"about_ca_system_score_gemma":0.00016911811,"threshold_uncertainty_score":0.34881875},"labels":[],"label_agreement":null},{"id":"W2074908827","doi":"10.1158/0008-5472.can-13-1657","title":"miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Agilent Technologies","keywords":"Radioresistance; Cancer research; Cancer; Prostate cancer; Biology; microRNA; Cancer cell; Sphingolipid; Downregulation and upregulation; Radiation therapy; Medicine; Cell biology; Internal medicine","score_opus":0.016787091329330404,"score_gpt":0.3178918316999802,"score_spread":0.30110474037064977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074908827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490792,0.048984174,0.00001681011,0.0011944951,0.000071771836,0.00046658985,0.000054525233,0.000007543625,0.00012489983],"genre_scores_gemma":[0.9965646,0.0017433004,0.000059807408,0.00014319357,0.00032273302,0.00044083435,0.0001806091,0.000027283173,0.0005176351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984439,0.00020941229,0.00019933413,0.0003468993,0.00031893502,0.00048152302],"domain_scores_gemma":[0.99924445,0.000053810083,0.00005156461,0.0003628559,0.00016925746,0.000118049866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007246454,0.00011360607,0.00010196584,0.000038072863,0.00014373609,0.00006850553,0.00041122234,0.00007935718,0.00028200532],"category_scores_gemma":[0.00030400458,0.00008792764,0.000041048115,0.00026265666,0.00022827026,0.000010271176,0.00014478793,0.00021953564,0.000049765535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035407786,0.000022789214,0.0027523001,0.000027622247,0.000010351299,0.0000017741987,0.00004627699,0.00003862098,0.7829367,0.00002545085,0.21343376,0.0006689313],"study_design_scores_gemma":[0.00049001037,0.00003494968,0.013116124,0.00005748853,0.000003215121,0.0000012204001,0.00019011674,0.00017157945,0.9087525,0.00021055643,0.076792456,0.00017975547],"about_ca_topic_score_codex":0.0010945848,"about_ca_topic_score_gemma":0.00012760777,"teacher_disagreement_score":0.1366413,"about_ca_system_score_codex":0.00009868093,"about_ca_system_score_gemma":0.00016825541,"threshold_uncertainty_score":0.3585585},"labels":[],"label_agreement":null},{"id":"W2074941863","doi":"10.1158/1538-7445.am2011-lb-283","title":"Abstract LB-283: JX-594, a targeted multi-mechanistic oncolytic poxvirus, selectively infects tumor vasculature and causes acute tumor vascular disruption and necrosis in advanced cancer patients","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Cancer research; Vascular endothelial growth factor; Medicine; Cancer; Tumor necrosis factor alpha; Pathology; Immunology; Internal medicine","score_opus":0.03691756451402433,"score_gpt":0.35933225982598077,"score_spread":0.32241469531195643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074941863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925294,0.0057524377,0.000021431611,0.000033494973,0.00009245231,0.0013264687,0.00018243227,0.000021549473,0.000040341598],"genre_scores_gemma":[0.9933514,0.005008455,0.00018313137,0.0001298463,0.00008682804,0.000990123,0.00006453243,0.000086317064,0.00009939377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968672,0.000313794,0.0003115301,0.00096961745,0.00059491605,0.000942939],"domain_scores_gemma":[0.9985197,0.000050719762,0.00009876665,0.00042586555,0.0005776625,0.0003272949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007006351,0.00034234632,0.00036761074,0.0003101861,0.00026814974,0.00008372273,0.0002935756,0.00019945811,0.000108545486],"category_scores_gemma":[0.00025971132,0.00032323127,0.00008868714,0.00058673794,0.0003196116,0.000040826835,0.0002891065,0.00066455937,0.0000080301215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030167992,0.00037641803,0.04181726,0.00019200139,0.00030309786,0.000044913595,0.00048521004,0.00004993833,0.94796544,0.0000071964814,0.00008611455,0.005655639],"study_design_scores_gemma":[0.0051952647,0.0028788035,0.39510968,0.0002285641,0.000058072244,0.0000059248982,0.00010784325,0.00020987078,0.59492916,0.00013216093,0.0005586206,0.00058600307],"about_ca_topic_score_codex":0.0024956504,"about_ca_topic_score_gemma":0.008189558,"teacher_disagreement_score":0.35329244,"about_ca_system_score_codex":0.00031140217,"about_ca_system_score_gemma":0.0005856778,"threshold_uncertainty_score":0.999922},"labels":[],"label_agreement":null},{"id":"W2075037683","doi":"10.1158/1538-7445.am2011-2113","title":"Abstract 2113: Programmed cell death 4 (PDCD4) regulates apoptotic resistance of human gliomas","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"XIAP; Internal ribosome entry site; Gene silencing; Biology; Programmed cell death; Cancer research; Apoptosis; Translation (biology); Cell biology; Inhibitor of apoptosis; microRNA; Glioma; Caspase; Gene; Messenger RNA; Genetics","score_opus":0.11026715033801407,"score_gpt":0.38143960810609845,"score_spread":0.2711724577680844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075037683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98232186,0.003485487,0.000020555779,0.00007140913,0.000050554456,0.00032254195,0.00002051673,0.000010773501,0.013696284],"genre_scores_gemma":[0.99116445,0.00050644565,0.0003761438,0.000011687921,0.00013328438,0.0002552428,0.000033008804,0.000029413235,0.0074902996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998586,0.0000670851,0.00023861269,0.0003895486,0.00030302515,0.00041574365],"domain_scores_gemma":[0.9987539,0.000010782672,0.00008805749,0.00063029036,0.00040267644,0.00011429367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045741757,0.00011787423,0.00013711145,0.000098052544,0.0001569924,0.000021870459,0.00040638482,0.00012671796,0.0002475994],"category_scores_gemma":[0.000029420895,0.00010911122,0.00007237965,0.00025746156,0.0002669414,0.000005796005,0.000089060304,0.00014478735,0.00000946506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013253694,0.00013981783,0.0018573012,0.00012340292,0.000030368938,0.0000022148274,0.0001409503,0.0000026985672,0.9918179,0.0005131386,0.004100738,0.0011389179],"study_design_scores_gemma":[0.00035123277,0.00016470731,0.019329567,0.000045743123,0.000008008364,5.607403e-7,0.00011632286,0.000001280695,0.9643781,0.0004939687,0.014978777,0.00013168386],"about_ca_topic_score_codex":0.0004656155,"about_ca_topic_score_gemma":0.00043213047,"teacher_disagreement_score":0.027439767,"about_ca_system_score_codex":0.00004895672,"about_ca_system_score_gemma":0.00021244626,"threshold_uncertainty_score":0.44494262},"labels":[],"label_agreement":null},{"id":"W2075087690","doi":"10.1158/0008-5472.can-12-0254","title":"Clusterin Mediates TGF-β–Induced Epithelial–Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Clusterin; Epithelial–mesenchymal transition; Cancer research; Prostate cancer; Metastasis; Transforming growth factor; Transcription factor; Twist transcription factor; Biology; Transforming growth factor beta; Cancer; Medicine; Internal medicine; Cell biology; Gene; Apoptosis","score_opus":0.0919629242679457,"score_gpt":0.42609764144201745,"score_spread":0.3341347171740717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075087690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892814,0.0052095708,0.00002122591,0.0038285647,0.00042901313,0.001175819,0.00017845567,0.000036621102,0.00019259272],"genre_scores_gemma":[0.9954476,0.0021323673,0.00015080224,0.00032101173,0.00052784465,0.0010653898,0.00002380373,0.000053845994,0.00027736314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971824,0.00043821463,0.00033897557,0.00044592295,0.00059308426,0.0010013981],"domain_scores_gemma":[0.9987231,0.00018789673,0.00005013917,0.00033376852,0.00020338666,0.00050173333],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001373482,0.00020595809,0.00041312948,0.000442035,0.000096597774,0.00002681186,0.00012632765,0.00012506024,0.00092004973],"category_scores_gemma":[0.00009600963,0.00018411342,0.00006294907,0.0005454675,0.00031631175,0.00019550411,0.00015411951,0.00060272875,0.00005602608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015678395,0.0002647457,0.021555698,0.00076812267,0.00007761316,0.00017819002,0.007216139,0.000027042766,0.93925804,0.000010511335,0.0006779483,0.028398134],"study_design_scores_gemma":[0.009157103,0.00080851646,0.23589742,0.0008369361,0.00026633998,0.00020582575,0.0019375905,0.0010547573,0.7419559,0.00030282594,0.006796792,0.0007800214],"about_ca_topic_score_codex":0.0023856757,"about_ca_topic_score_gemma":0.0006916585,"teacher_disagreement_score":0.21434173,"about_ca_system_score_codex":0.0004358794,"about_ca_system_score_gemma":0.00030231744,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2075137329","doi":"10.1158/0008-5472.can-14-0992","title":"CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Prostate cancer; Blockade; Medicine; Cancer research; Paracrine signalling; Cancer; Tumor microenvironment; Prostate; Macrophage; Angiogenesis; Internal medicine; Receptor; Biology","score_opus":0.06563949501974964,"score_gpt":0.37412172488193346,"score_spread":0.3084822298621838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075137329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8068978,0.18514128,0.0000022386703,0.0035841607,0.0017195593,0.001217199,0.00020670994,0.00007920512,0.0011518493],"genre_scores_gemma":[0.91873354,0.0201223,0.00020139653,0.0006023844,0.00028627348,0.0022159372,0.00011297052,0.0001153261,0.057609867],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636286,0.0008483327,0.00046142453,0.00072959956,0.000263471,0.0013343203],"domain_scores_gemma":[0.9983191,0.0002620591,0.00009850859,0.0005134378,0.00067109714,0.00013579936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021133872,0.00026781426,0.0004114379,0.0003791413,0.00024076925,0.000046852434,0.0006893304,0.00025530398,0.0024017997],"category_scores_gemma":[0.00057089556,0.00024557422,0.00005856339,0.001353013,0.00043350525,0.00014519095,0.00027202544,0.0011413677,0.0012051779],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002374912,0.000074544034,0.007168576,0.00004596392,0.000085206135,0.000030400573,0.003725856,0.000082295446,0.6960233,0.000017649298,0.2864179,0.00395344],"study_design_scores_gemma":[0.0019063839,0.00009325816,0.00034188348,0.00016124634,0.0000026286234,0.00000141207,0.00067519315,7.134785e-7,0.43795934,0.000043609823,0.5586058,0.00020855211],"about_ca_topic_score_codex":0.0031485516,"about_ca_topic_score_gemma":0.0010674148,"teacher_disagreement_score":0.2721879,"about_ca_system_score_codex":0.0012097798,"about_ca_system_score_gemma":0.0012028713,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2075167686","doi":"10.1158/1538-7445.am10-2529","title":"Abstract 2529: The anti-malarial agent Mefloquine preferentially demonstrates pre-clinical activity in leukemia and myeloma cells through STAT1-induced reactive oxygen species production","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Mefloquine; Leukemia; Pharmacology; Programmed cell death; Reactive oxygen species; Immunology; Medicine; Chemistry; Apoptosis; Chloroquine; Malaria; Biochemistry","score_opus":0.10265259022210882,"score_gpt":0.40973627950265046,"score_spread":0.30708368928054164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075167686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967492,0.00026756135,0.000038841725,0.0006732756,0.0010723453,0.00075412315,0.0000397905,0.000009157456,0.00039565586],"genre_scores_gemma":[0.9951507,0.0027497117,0.000087312896,0.000041686257,0.0012642466,0.00013204025,0.000028456718,0.000028828752,0.0005170428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998093,0.00021270943,0.0002587956,0.00063764106,0.00034578712,0.0004520411],"domain_scores_gemma":[0.9990412,0.00006705856,0.00009862969,0.00048398733,0.00021477851,0.0000943338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012852577,0.00017780438,0.00020868487,0.00004962446,0.00020883512,0.000096037984,0.00027858437,0.00026198543,0.00007001926],"category_scores_gemma":[0.00010773513,0.00013679761,0.00006913994,0.00016124533,0.00031368318,0.000020913792,0.00020514696,0.00093545497,0.000003959878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006780583,0.000097610435,0.00035434295,0.000025133288,0.000086112756,0.0000026562404,0.00029095486,0.000014098383,0.98787946,0.00010762267,0.00036049928,0.010103458],"study_design_scores_gemma":[0.0005926495,0.0002857726,0.0649099,0.000021814672,0.000014624387,0.0000028688464,0.0001257196,0.000013322689,0.91766083,0.00033477272,0.015884034,0.00015367813],"about_ca_topic_score_codex":0.00089268666,"about_ca_topic_score_gemma":0.0052623097,"teacher_disagreement_score":0.07021861,"about_ca_system_score_codex":0.00010722143,"about_ca_system_score_gemma":0.0009794139,"threshold_uncertainty_score":0.55784446},"labels":[],"label_agreement":null},{"id":"W2075365779","doi":"10.1158/1538-7445.am2013-5125","title":"Abstract 5125: Predictive markers on risk of developing lymph node metastasis in early-staged oral cancer patients.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pathological; Cancer; Stage (stratigraphy); Lymph node; Pathological staging; Internal medicine; Metastasis; Dissection (medical); Primary tumor; Disease; Neck dissection; Surgery; Oncology","score_opus":0.07036709203400726,"score_gpt":0.3916544203178549,"score_spread":0.32128732828384765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994947,0.0011227654,0.0000037967257,0.0010408328,0.00014410379,0.0013501991,0.0003056197,0.000017778202,0.0010678759],"genre_scores_gemma":[0.9925522,0.0045761634,0.00015972934,0.00012175495,0.00007190764,0.0022831634,0.00002402128,0.00003951898,0.00017149955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742,0.00017624378,0.00038673915,0.00046451113,0.00094481534,0.0006076607],"domain_scores_gemma":[0.99838066,0.00032955653,0.00012537284,0.0003331296,0.0006266218,0.00020464788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005673773,0.00019717772,0.0004461517,0.0004111325,0.00010045163,0.000030745927,0.00014899336,0.00009397646,0.0014173771],"category_scores_gemma":[0.00020262173,0.00015590427,0.000108051245,0.0006461064,0.00017651316,0.00013863966,0.00008222195,0.0004529524,0.000058278034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011785069,0.0004951355,0.9517968,0.00020017552,0.0004659579,0.000012909164,0.0005314159,0.00016896072,0.00027455177,0.000017226937,0.0027625884,0.04209574],"study_design_scores_gemma":[0.0036096044,0.00043134982,0.9828578,0.0009615579,0.00006916748,2.0045285e-7,0.0002222249,0.000028302988,0.011012653,0.000052102216,0.00062377827,0.00013123832],"about_ca_topic_score_codex":0.09237355,"about_ca_topic_score_gemma":0.0019051444,"teacher_disagreement_score":0.0904684,"about_ca_system_score_codex":0.0023070227,"about_ca_system_score_gemma":0.00079472386,"threshold_uncertainty_score":0.99949545},"labels":[],"label_agreement":null},{"id":"W2075831004","doi":"10.1158/1538-7445.am2013-3644","title":"Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Odds ratio; Serous fluid; Ovarian cancer; Internal medicine; Biology; Serous carcinoma; Cancer; Oncology; Endometrial cancer; Genotype; Bioinformatics; Genetics; Medicine; Gene","score_opus":0.02798176977780684,"score_gpt":0.33638881005537385,"score_spread":0.308407040277567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075831004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944587,0.0037316987,0.0000748636,0.00056616496,0.00009552597,0.0007044442,0.00014578964,0.000013241416,0.00020960916],"genre_scores_gemma":[0.98733705,0.011173158,0.00008093337,0.000052049443,0.00020701173,0.00060676015,0.000033194665,0.00003463184,0.00047518712],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976245,0.0002593979,0.0002929774,0.00064807135,0.00048339294,0.0006916708],"domain_scores_gemma":[0.9989286,0.00005503387,0.000058184887,0.00038480124,0.00037800227,0.00019538186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010433737,0.00018576368,0.00020909056,0.00021441096,0.00014496966,0.00005274942,0.00036042277,0.00028262305,0.00063982385],"category_scores_gemma":[0.00014056457,0.00016868273,0.0000531176,0.00034187426,0.0003150034,0.000029072122,0.00006816484,0.0005940303,0.000036777095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015870579,0.000048240738,0.13228424,0.00007549725,0.000016470047,0.000013512906,0.00025272727,0.0002749074,0.8543393,0.000010964617,0.00008524284,0.012440207],"study_design_scores_gemma":[0.00077624456,0.00012573297,0.86249846,0.000035431687,0.000006254208,0.0000036440485,0.0000446104,0.000046434223,0.13264075,0.00016792477,0.0034540782,0.00020043907],"about_ca_topic_score_codex":0.032804053,"about_ca_topic_score_gemma":0.0054982323,"teacher_disagreement_score":0.73021424,"about_ca_system_score_codex":0.0001599978,"about_ca_system_score_gemma":0.0005402909,"threshold_uncertainty_score":0.97363657},"labels":[],"label_agreement":null},{"id":"W2075872996","doi":"10.1158/1538-7445.am2011-1096","title":"Abstract 1096: Prostate tumor growth in pbARR2-Cre PTEN knockout mice is delayed in GH/IGF-I deficient mice","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Prostate cancer; Biology; Endocrinology; Prostate; Internal medicine; Cancer research; Cancer; Medicine; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology","score_opus":0.10565667778009134,"score_gpt":0.3981641655475185,"score_spread":0.29250748776742713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075872996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716167,0.0066671656,9.873014e-7,0.0023042182,0.0001312757,0.0020550787,0.00011754567,0.000049048213,0.01705802],"genre_scores_gemma":[0.99095523,0.0028575691,0.00012616854,0.00030978542,0.00012871627,0.0010096069,0.000045810288,0.000081767765,0.0044853524],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952612,0.00021486764,0.0005831097,0.0009247314,0.0012934392,0.0017226809],"domain_scores_gemma":[0.99806666,0.00018103315,0.00008088824,0.00050071,0.000676989,0.0004937279],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016900285,0.00032662164,0.0005263838,0.0010786584,0.0001657832,0.000053507072,0.000478049,0.0001688504,0.0015563718],"category_scores_gemma":[0.00016980668,0.00026547204,0.000118421114,0.0017654586,0.00051536906,0.0002032721,0.00025918742,0.0015389598,0.00043311363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036962166,0.0053726453,0.48048297,0.0040759672,0.00061961147,0.011965278,0.063399814,0.00002360093,0.3516303,0.0006761619,0.02378931,0.021002183],"study_design_scores_gemma":[0.022687258,0.0023940543,0.4336793,0.0033132704,0.0000896046,0.000117248506,0.010992231,0.00040455765,0.5144866,0.002346451,0.008220262,0.001269158],"about_ca_topic_score_codex":0.022316702,"about_ca_topic_score_gemma":0.0022946515,"teacher_disagreement_score":0.16285631,"about_ca_system_score_codex":0.0016804258,"about_ca_system_score_gemma":0.0018091348,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W2075985899","doi":"10.1158/1538-7445.am2013-4591","title":"Abstract 4591: Whole genome sequencing of SHH medulloblastomas predicts molecular groups of responders and non-responders to SMO-inhibition .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PTCH1; Sonic hedgehog; GLI2; Transcriptome; Biology; Germline mutation; Genetics; Gene; Germline; Whole genome sequencing; Medicine; Cancer research; Genome; Oncology; Mutation; Gene expression","score_opus":0.04279592682923148,"score_gpt":0.3357785422620193,"score_spread":0.2929826154327878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075985899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671966,0.001400641,0.00034096473,0.0004390823,0.000044545304,0.00060032465,0.00008352414,0.000007910027,0.00036337326],"genre_scores_gemma":[0.9990334,0.00015940215,0.00023182762,0.00009080733,0.00007930449,0.00015940855,0.000029826022,0.000034272984,0.00018173154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981485,0.00012939486,0.00031614542,0.00044634272,0.0005001958,0.00045942832],"domain_scores_gemma":[0.9987191,0.00006051056,0.00008381394,0.00037317647,0.00057173596,0.00019166472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008424406,0.00015857746,0.00023792396,0.00025852316,0.00009311492,0.000023069088,0.00020274156,0.00014527726,0.000042720152],"category_scores_gemma":[0.00033583998,0.00015677407,0.000065602544,0.0003314003,0.00036835228,0.000011624216,0.0002678097,0.00019224954,0.000011895507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020305559,0.000022418726,0.00033677975,0.00018009044,0.0000813809,0.000008861103,0.00076656515,0.0004422037,0.99667025,0.000015662654,0.00086156314,0.00041115624],"study_design_scores_gemma":[0.0004705728,0.0004978552,0.010072647,0.00015205886,0.000008911444,0.0000021979624,0.0014147782,0.000017773455,0.9863486,0.000111117806,0.00075242436,0.0001510603],"about_ca_topic_score_codex":0.000479296,"about_ca_topic_score_gemma":0.00008467275,"teacher_disagreement_score":0.01032166,"about_ca_system_score_codex":0.000103198414,"about_ca_system_score_gemma":0.00035225975,"threshold_uncertainty_score":0.63930607},"labels":[],"label_agreement":null},{"id":"W2076007110","doi":"10.1158/1538-7445.am2011-267","title":"Abstract 267: E2F1 regulates human TRAIL promoter and mediates Interferon alpha 2a response","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"E2F1; E2F; Transcription factor; Transactivation; NFAT; Biology; Chromatin immunoprecipitation; Reporter gene; Transfection; Molecular biology; Cell biology; Promoter; Cancer research; Gene expression; Cell culture; Gene; Genetics","score_opus":0.11003279211677686,"score_gpt":0.37864306838071504,"score_spread":0.2686102762639382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076007110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742205,0.008961847,0.0000010760933,0.00057828525,0.00032965423,0.00035628732,0.000028981096,0.00007064611,0.0022511696],"genre_scores_gemma":[0.98247904,0.00039912015,0.00001227801,0.00006444125,0.000048200964,0.00013380253,0.000018158304,0.00003919548,0.016805759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746734,0.00086436694,0.00033678897,0.0004663372,0.00009771462,0.0007674522],"domain_scores_gemma":[0.99885744,0.00037533152,0.00006395505,0.00042634856,0.00021076792,0.00006613338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016902018,0.00021967836,0.00029665334,0.00037478344,0.0003761939,0.000047183235,0.00043855637,0.00030300912,0.008067557],"category_scores_gemma":[0.00023965862,0.00017845197,0.00007373538,0.00016211864,0.0010946983,0.00017017763,0.00024748495,0.0008404991,0.0006052225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008807009,0.000120510864,0.0003842951,0.00004529183,0.00013408648,0.000022168571,0.005580209,2.6178814e-8,0.97029674,0.0001916217,0.007531327,0.0068867286],"study_design_scores_gemma":[0.0010724452,0.0012303374,0.07273733,0.00017384744,0.000011898684,0.00003949421,0.00096430094,2.7316142e-7,0.89850587,0.00032381486,0.024727352,0.00021303662],"about_ca_topic_score_codex":0.0008356193,"about_ca_topic_score_gemma":0.00015335676,"teacher_disagreement_score":0.07235303,"about_ca_system_score_codex":0.00011255372,"about_ca_system_score_gemma":0.00016356766,"threshold_uncertainty_score":0.9928392},"labels":[],"label_agreement":null},{"id":"W2076133821","doi":"10.1158/0008-5472.can-05-3555","title":"Recombinant Human Insulin-like Growth Factor Binding Protein 3 Inhibits Growth of Human Epidermal Growth Factor Receptor-2–Overexpressing Breast Tumors and Potentiates Herceptin Activity <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; MAPK/ERK pathway; Epidermal growth factor receptor; Protein kinase B; SKBR3; Growth factor receptor; Growth factor; Trastuzumab; Epidermal growth factor; Biology; Tyrosine kinase; Phosphorylation; Signal transduction; Endocrinology; Internal medicine; Breast cancer; Receptor; Cancer; Medicine; Cell biology","score_opus":0.046016946297390685,"score_gpt":0.32981422385102427,"score_spread":0.2837972775536336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076133821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478173,0.0004990379,0.000008560698,0.00079803896,0.00017998628,0.0019947817,0.00040979186,0.00013496028,0.001193098],"genre_scores_gemma":[0.99737793,0.00022245046,0.0001302803,0.00004528037,0.00036378452,0.00023606146,0.00008258686,0.00018550082,0.0013561329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99298567,0.00078769604,0.0013099771,0.0013972261,0.0016832883,0.001836171],"domain_scores_gemma":[0.9970706,0.00021189304,0.00050305296,0.0005990346,0.001022317,0.0005931199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001234019,0.00076027605,0.0013759336,0.0015138699,0.0008056244,0.0001855947,0.0005048604,0.000511749,0.00063974876],"category_scores_gemma":[0.00029435262,0.0007010901,0.00027703657,0.0017497854,0.0008614657,0.0009770041,0.00048934284,0.0019966653,0.000021587253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050505466,0.00066163647,0.17764357,0.001056343,0.000064588516,0.000051834613,0.0005144612,2.8444765e-7,0.8172257,0.0003698093,0.0013024261,0.0006043039],"study_design_scores_gemma":[0.0035444638,0.0006673256,0.31752506,0.0015933511,0.000025089315,0.0000324451,0.0002270952,0.000009201286,0.67523646,0.00050425937,0.000060846844,0.000574398],"about_ca_topic_score_codex":0.016156333,"about_ca_topic_score_gemma":0.00038012094,"teacher_disagreement_score":0.14198922,"about_ca_system_score_codex":0.0009015388,"about_ca_system_score_gemma":0.00048644893,"threshold_uncertainty_score":0.999544},"labels":[],"label_agreement":null},{"id":"W2076186704","doi":"10.1158/1538-7445.cansusc14-34","title":"Abstract 34: Investigating PIN1 as a genetic modifier in Li-Fraumeni syndrome","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Cancer; Germline; Phenotype; Cancer research; Medicine; Mutation; PIN1; Germline mutation; Genetics; Werner syndrome; Biology; Gene; Isomerase; RNA","score_opus":0.08894490715384026,"score_gpt":0.400786883089139,"score_spread":0.3118419759352987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076186704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98374116,0.0019462135,0.000058037283,0.0018521996,0.00016531798,0.00073981547,0.0000057508046,0.00005912129,0.011432391],"genre_scores_gemma":[0.99714965,0.000247775,0.00039495502,0.0004757101,0.00022033381,0.000366666,0.000009225874,0.00007514793,0.001060553],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969975,0.0001782925,0.00037067215,0.00056674914,0.0010453631,0.00084144116],"domain_scores_gemma":[0.99846625,0.00015912754,0.000058277223,0.00064668123,0.00022766483,0.00044198983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011392548,0.00018478054,0.00034497702,0.00048187657,0.00011313053,0.000051893203,0.00025632896,0.00021416087,0.00074746844],"category_scores_gemma":[0.0008531558,0.0001830494,0.0000793991,0.00090382656,0.000285751,0.00006968817,0.00014305931,0.001371366,0.0005186816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036263646,0.00031065635,0.014391017,0.0011971904,0.00018478645,0.0019328044,0.002117006,0.0030569572,0.8790729,0.0009871214,0.0071108015,0.0892761],"study_design_scores_gemma":[0.015544711,0.00319333,0.68805987,0.008289831,0.00013561138,0.0013882213,0.00093228096,0.012700679,0.18941799,0.011347543,0.06725566,0.0017342874],"about_ca_topic_score_codex":0.0043584867,"about_ca_topic_score_gemma":0.0003886581,"teacher_disagreement_score":0.68965495,"about_ca_system_score_codex":0.0008604992,"about_ca_system_score_gemma":0.0009986127,"threshold_uncertainty_score":0.81842554},"labels":[],"label_agreement":null},{"id":"W2076210163","doi":"10.1158/1538-7445.am2014-5340","title":"Abstract 5340: Bioinformatic analyses approaches for personalized oncogenomics","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Transcriptome; Genome; Biology; Computational biology; Genetics; Cancer genome sequencing; Genomics; Whole genome sequencing; DNA sequencing; Gene; Gene expression","score_opus":0.36297669028808754,"score_gpt":0.529471534395429,"score_spread":0.1664948441073415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076210163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94371724,0.0031465762,0.0030065004,0.0046673287,0.00018167011,0.0022932745,0.00012195393,0.00007959517,0.04278586],"genre_scores_gemma":[0.9918082,0.00020283752,0.0022517014,0.0001973628,0.00033545858,0.0008251366,0.00010085745,0.000026575859,0.0042519164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989371,0.000026513784,0.0001794705,0.00018980165,0.00031994664,0.0003472127],"domain_scores_gemma":[0.99912876,0.00020397516,0.000042313666,0.00023643867,0.00022471233,0.00016378479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004651546,0.000096980904,0.00021708639,0.00017663176,0.00020489047,0.00004718221,0.0000934883,0.000054035238,0.00025045947],"category_scores_gemma":[0.00013171913,0.00007142005,0.00011476703,0.00022569057,0.00011097726,0.00008033931,0.0000220651,0.00014801222,0.00005255309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032660118,0.001401513,0.010744773,0.006139877,0.0046064113,0.000022784605,0.015412063,0.0009283124,0.062348958,0.034961328,0.06250822,0.79765975],"study_design_scores_gemma":[0.021079702,0.0018782618,0.0347918,0.00079341064,0.001369814,0.00003334003,0.007885679,0.01519608,0.039823007,0.0046591796,0.8716927,0.0007969834],"about_ca_topic_score_codex":0.00029201186,"about_ca_topic_score_gemma":0.000046029316,"teacher_disagreement_score":0.80918455,"about_ca_system_score_codex":0.00039072757,"about_ca_system_score_gemma":0.0005063305,"threshold_uncertainty_score":0.2912425},"labels":[],"label_agreement":null},{"id":"W2076261865","doi":"10.1158/0008-5472.can-04-0633","title":"Growth Factor Independence-1 Is Expressed in Primary Human Neuroendocrine Lung Carcinomas and Mediates the Differentiation of Murine Pulmonary Neuroendocrine Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Biology; Chromogranin A; Neuroendocrine differentiation; Autocrine signalling; Cancer research; Paracrine signalling; Neuroendocrine cell; Internal medicine; Endocrinology; Immunology; Cancer; Cell culture; Genetics; Receptor; Immunohistochemistry; Medicine; Prostate cancer","score_opus":0.03945784331271621,"score_gpt":0.34302921737900993,"score_spread":0.3035713740662937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076261865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943328,0.00092412304,0.0000018177481,0.0031094018,0.000061112696,0.0011538542,0.00008957691,0.000023836034,0.00030350604],"genre_scores_gemma":[0.9965073,0.002519587,0.000009243587,0.00012916986,0.000097448035,0.0002317004,0.000029506573,0.00004378612,0.00043226813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968434,0.00023776655,0.00035564802,0.00053810934,0.0012973647,0.0007277261],"domain_scores_gemma":[0.99868983,0.00023964289,0.00007463603,0.0004558187,0.00026583843,0.0002742238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014647424,0.00022013811,0.00036722035,0.00048920274,0.00016833183,0.00003841153,0.0002821478,0.000027576021,0.00017505762],"category_scores_gemma":[0.00010459551,0.00015387614,0.00006935897,0.00060151034,0.00035160244,0.0001719991,0.00036791456,0.00087504537,0.00000645958],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065171014,0.0005547791,0.19954991,0.0006982972,0.000057950165,0.0019881867,0.00023230829,0.0000058225937,0.79494226,0.00005307451,0.00024366713,0.0010220346],"study_design_scores_gemma":[0.002457879,0.00038545814,0.5170149,0.000117783195,0.000015599793,0.000058589452,0.000033112236,0.000027564958,0.47958305,0.00019512002,0.000041324198,0.00006961423],"about_ca_topic_score_codex":0.0022581876,"about_ca_topic_score_gemma":0.00016037204,"teacher_disagreement_score":0.31746498,"about_ca_system_score_codex":0.00027210318,"about_ca_system_score_gemma":0.0003041712,"threshold_uncertainty_score":0.62748873},"labels":[],"label_agreement":null},{"id":"W2076265633","doi":"10.1158/1538-7445.am2012-993","title":"Abstract 993: A high-throughput peptide array screen of H3K9 methyl effectors identifies UHRF1 as an exception to the “phospho/methyl switch.”","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chromatin; Histone; Cell biology; Mitosis; DNA methylation; Ubiquitin ligase; Biology; Methylation; Effector; Histone H3; Epigenetics; Chromatin immunoprecipitation; Molecular biology; Chemistry; DNA; Ubiquitin; Genetics; Gene expression; Promoter; Gene","score_opus":0.039648043551720344,"score_gpt":0.3914433972625757,"score_spread":0.35179535371085535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076265633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305046,0.003823974,0.0006829451,0.00063014985,0.0005702004,0.000810587,0.00005589488,0.00001805889,0.00035772705],"genre_scores_gemma":[0.9958854,0.00058727484,0.0001670886,0.000056539822,0.0014443584,0.00026994923,0.00012973903,0.000054941404,0.0014047368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739915,0.0003433165,0.00032524363,0.0005037876,0.00073997537,0.00068851275],"domain_scores_gemma":[0.99823695,0.000088739886,0.000114080176,0.0008696585,0.00043253315,0.00025803063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021539254,0.00020834825,0.00023501524,0.0001501209,0.00022888111,0.00005959928,0.00047814185,0.00025020257,0.0003608448],"category_scores_gemma":[0.0002858628,0.00016891793,0.00012589502,0.0005210623,0.00022846159,0.000036533394,0.0001829885,0.00034705538,0.000119396704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034173534,0.00005895036,0.0014920909,0.00004829995,0.000109653214,4.4323008e-7,0.0007280416,0.00068625837,0.9751095,0.00005340062,0.0062809805,0.015090611],"study_design_scores_gemma":[0.00034397712,0.00029678072,0.07160224,0.000059554328,0.000025623898,0.0000028305815,0.00031930732,0.0000034521386,0.90397686,0.00018338008,0.022995375,0.00019060483],"about_ca_topic_score_codex":0.008148047,"about_ca_topic_score_gemma":0.0023205548,"teacher_disagreement_score":0.07113266,"about_ca_system_score_codex":0.00019784679,"about_ca_system_score_gemma":0.0003031377,"threshold_uncertainty_score":0.9984568},"labels":[],"label_agreement":null},{"id":"W2076312642","doi":"10.1158/1538-7445.tim2013-a9","title":"Abstract A9: Immune suppressive myeloid cells induced by hypoxic mammary tumor cells persist after primary tumor resection and promote metastatic growth","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Immune system; Tirapazamine; Mammary tumor; Primary tumor; Myeloid-derived Suppressor Cell; Biology; Spleen; Metastasis; Myeloid; Tumor progression; Integrin alpha M; In vivo; Tumor hypoxia; Tumor microenvironment; Immunology; Medicine; Cancer; In vitro; Breast cancer; Suppressor; Internal medicine; Cytotoxicity; Radiation therapy","score_opus":0.02155657260515477,"score_gpt":0.2852144963211555,"score_spread":0.2636579237160007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076312642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669906,0.027459448,0.000008371413,0.0007054272,0.0012159996,0.0017784147,0.00019254896,0.00007440845,0.0015748003],"genre_scores_gemma":[0.98913896,0.0013381207,0.0001262141,0.00028853113,0.000092746406,0.0017777764,0.00010452058,0.00009578556,0.00703733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99610996,0.000707699,0.0005876865,0.0009463126,0.0002956586,0.0013526971],"domain_scores_gemma":[0.99789816,0.00040113536,0.00021144179,0.0007658051,0.00060064596,0.00012284018],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010268312,0.0004276967,0.0005855866,0.00038816684,0.0004962546,0.0001918015,0.0007311064,0.00024198407,0.004658346],"category_scores_gemma":[0.0000938739,0.00038956947,0.00014053388,0.0004682786,0.0008399701,0.0006350884,0.00060388487,0.0019134509,0.0013503702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539688,0.00016244386,0.00006331089,0.00048082796,0.00025414617,0.000051595194,0.0006344644,7.4075786e-7,0.9633266,0.0000070738856,0.03216756,0.0023115745],"study_design_scores_gemma":[0.0016079824,0.00036525985,0.008447725,0.0002065235,0.000041585132,0.000038602768,0.00039326784,0.0000027491965,0.9803671,0.00017329915,0.007922853,0.0004330267],"about_ca_topic_score_codex":0.003314057,"about_ca_topic_score_gemma":0.00003552758,"teacher_disagreement_score":0.026121328,"about_ca_system_score_codex":0.00060871633,"about_ca_system_score_gemma":0.000534378,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W2076320230","doi":"10.1158/1538-7445.am2014-lb-198","title":"Abstract LB-198: Epigenomic alterations define lethal CIMP-positive ependymomas of infancy","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; DNA methylation; CpG site; Ependymoma; Methylation; Exome sequencing; Epigenomics; Somatic cell; Exome; Genetics; Cancer research; Bioinformatics; Gene; Pathology; Medicine; Mutation; Gene expression","score_opus":0.0707818789400567,"score_gpt":0.4141928804628157,"score_spread":0.343411001522759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076320230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823139,0.001433668,0.000023190347,0.0024826785,0.000089662804,0.0005216151,0.000072631046,0.00001582962,0.01304686],"genre_scores_gemma":[0.9986294,0.0002783401,0.00015912563,0.00007259166,0.00024540085,0.00026205208,0.000054567467,0.000023923609,0.00027463675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851304,0.00008769516,0.00025903553,0.00028112336,0.00046780935,0.00039127818],"domain_scores_gemma":[0.99865675,0.00033726325,0.00005724025,0.00036936998,0.00038578545,0.00019356525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000445754,0.00011825767,0.0002789019,0.00024345491,0.00014091306,0.000024007823,0.00010696264,0.0000705007,0.0009049426],"category_scores_gemma":[0.00016861121,0.000097697135,0.000093493036,0.00028014672,0.00015486858,0.00006230529,0.000059418857,0.00028293842,0.00016295182],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008046443,0.002373058,0.25262818,0.0005628417,0.00079461397,0.0005248912,0.0024840394,0.00020730885,0.6306728,0.016619923,0.014751324,0.07757636],"study_design_scores_gemma":[0.0023828747,0.0005638733,0.62244415,0.0003190755,0.00005821579,0.000029083736,0.000084049854,0.000048287162,0.36817846,0.00044827725,0.0053187343,0.00012489768],"about_ca_topic_score_codex":0.0024337834,"about_ca_topic_score_gemma":0.0003905401,"teacher_disagreement_score":0.369816,"about_ca_system_score_codex":0.00014666827,"about_ca_system_score_gemma":0.00024408652,"threshold_uncertainty_score":0.99084866},"labels":[],"label_agreement":null},{"id":"W2076490269","doi":"10.1158/0008-5472.sabcs12-p4-03-04","title":"Abstract P4-03-04: The potential use of Optical Coherence Tomography for intraoperative breast tumour margin width estimation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tornado Spectral Systems (Canada); University Health Network","funders":"","keywords":"Lumpectomy; Medicine; Margin (machine learning); Optical coherence tomography; Mastectomy; Breast-conserving surgery; Breast cancer; Ultrasound; Radiology; Medical physics; Surgery; Computer science; Cancer; Machine learning; Internal medicine","score_opus":0.05102248520032292,"score_gpt":0.3683371278341888,"score_spread":0.3173146426338659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076490269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494123,0.0014578311,0.0011289469,0.0012244683,0.00013664315,0.00063645927,0.00033525913,0.000006785375,0.0001323602],"genre_scores_gemma":[0.99770594,0.00017346645,0.0010478356,0.000040604078,0.00035635158,0.0005204738,0.00007005523,0.00001814211,0.00006714148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988095,0.000075914555,0.0001615002,0.00023623984,0.00028155665,0.00043527028],"domain_scores_gemma":[0.9991247,0.000099647805,0.000049835216,0.00024267811,0.00039326597,0.000089840236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038275923,0.00012754813,0.00013784657,0.00005040158,0.00019451678,0.000039530718,0.000182674,0.00007796619,0.000053267075],"category_scores_gemma":[0.0000935351,0.00008844152,0.00008576822,0.00016199304,0.00042047712,0.00001961252,0.00011703754,0.00014219059,0.0000059030117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015423236,0.00040948327,0.025486145,0.00013498127,0.00050216465,0.0000020914786,0.0004910288,0.0005504662,0.92428756,0.00074750953,0.008127619,0.037718628],"study_design_scores_gemma":[0.00093189714,0.00019738777,0.48292163,0.000072249684,0.000053878583,0.000019497593,0.00025373197,0.00010066611,0.5135941,0.00015233115,0.001507675,0.00019492398],"about_ca_topic_score_codex":0.00041077647,"about_ca_topic_score_gemma":0.00009680043,"teacher_disagreement_score":0.4574355,"about_ca_system_score_codex":0.000051177296,"about_ca_system_score_gemma":0.0001386853,"threshold_uncertainty_score":0.36065406},"labels":[],"label_agreement":null},{"id":"W2076658539","doi":"10.1158/0008-5472.can-06-2763","title":"Shared MHC Class II–Dependent Melanoma Ribosomal Protein L8 Identified by Phage Display","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Antigen; Melanoma; Biology; clone (Java method); MHC class I; Immunology; Major histocompatibility complex; Context (archaeology); Phage display; Human leukocyte antigen; Cancer; Cancer research; Virology; Antibody; Gene; Genetics","score_opus":0.036977039574715105,"score_gpt":0.3584584528210617,"score_spread":0.3214814132463466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076658539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635884,0.031290703,0.00012675693,0.00073216984,0.0007337454,0.0009980164,0.00021938988,0.00009156224,0.0022192458],"genre_scores_gemma":[0.87119883,0.0002881425,0.000009826893,0.00009899738,0.000083527884,0.0003168764,0.00016731366,0.000048247213,0.12778823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965683,0.0007440929,0.00048479863,0.00060042145,0.00026246128,0.0013399208],"domain_scores_gemma":[0.9986061,0.00031446514,0.00010632481,0.0006480452,0.00025957724,0.00006550697],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025750236,0.00027243557,0.00035508155,0.00032677132,0.0010789961,0.00008975105,0.0008407038,0.00043736547,0.0052509783],"category_scores_gemma":[0.00017879701,0.00024037142,0.00013567004,0.00045292656,0.00060515327,0.0002487892,0.0003576206,0.0012111628,0.0011531457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042754975,0.00024699594,0.00028208352,0.00003385507,0.00025944517,0.000041651474,0.0006075688,3.944928e-7,0.96293515,0.00056880724,0.022355095,0.008393438],"study_design_scores_gemma":[0.002142984,0.0004660337,0.0020923251,0.00008836091,0.000009635241,0.000027451095,0.00031199455,6.7015844e-7,0.7833565,0.00007915795,0.21118876,0.0002361194],"about_ca_topic_score_codex":0.0010806355,"about_ca_topic_score_gemma":0.00022309687,"teacher_disagreement_score":0.18883367,"about_ca_system_score_codex":0.00034055,"about_ca_system_score_gemma":0.00029736865,"threshold_uncertainty_score":0.99962455},"labels":[],"label_agreement":null},{"id":"W2076724914","doi":"10.1158/1538-7445.am10-3510","title":"Abstract 3510: The molecular docking-based design and biological evaluation of a novel series of bisintercalating DNA-binding bisanthrapyrazole compounds containing amine linkers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Topoisomerase; DNA; Chemistry; Docking (animal); Biochemistry; Enzyme; Doxorubicin; Stereochemistry; Biology; Medicine; Genetics","score_opus":0.18573615849315728,"score_gpt":0.4273102026070942,"score_spread":0.2415740441139369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076724914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958263,0.0006497944,0.0026927067,0.00022635901,0.000106251515,0.00039615744,0.00002165409,0.000004046475,0.00007669757],"genre_scores_gemma":[0.99896353,0.00011053709,0.0007006309,0.000039480594,0.000065934466,0.000080048805,0.000019790496,0.00001614965,0.0000039124016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877894,0.00011594727,0.00022510851,0.00025005304,0.00038633813,0.00024360103],"domain_scores_gemma":[0.99898,0.00010731222,0.000119587436,0.0002474222,0.0004954215,0.00005027539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026279828,0.000106260195,0.00015301014,0.00008038393,0.00012585691,0.000028834238,0.00019781734,0.0001318549,0.00003029578],"category_scores_gemma":[0.00017021975,0.00007886686,0.00005383503,0.0001540091,0.0004308263,0.0000050890326,0.00009049829,0.00025451073,1.6155452e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002963236,0.000039856026,0.000397839,0.000024691459,0.000052534837,6.173061e-7,0.00012336721,0.0016119578,0.99223006,0.00026051822,0.000007754657,0.0049544936],"study_design_scores_gemma":[0.0010170933,0.000468874,0.00090391154,0.00006611804,0.000018738627,0.000004126771,0.00034425154,0.0065601543,0.9900704,0.0001180631,0.00033625428,0.00009200295],"about_ca_topic_score_codex":0.00010715096,"about_ca_topic_score_gemma":0.000080799924,"teacher_disagreement_score":0.0049481965,"about_ca_system_score_codex":0.000025856421,"about_ca_system_score_gemma":0.00030932465,"threshold_uncertainty_score":0.32160974},"labels":[],"label_agreement":null},{"id":"W2076835217","doi":"10.1158/0008-5472.sabcs12-p5-12-01","title":"Abstract P5-12-01: ARE WEB-BASED RESOURCES THE BREAST?: AN EVALUATION OF THE QUALITY OF ONLINE RESOURCES FOR BREAST CANCER PATIENTS","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Thames Valley Children's Centre; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Breast cancer; Readability; Medicine; The Internet; Quality (philosophy); Information quality; Cancer; Computer science; World Wide Web; Internal medicine; Information system","score_opus":0.31074806124903115,"score_gpt":0.5930609729346072,"score_spread":0.2823129116855761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076835217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850485,0.00042301786,0.0000045238335,0.0045944997,0.0004281061,0.0029250807,0.0060754684,0.000018432122,0.00048240952],"genre_scores_gemma":[0.9972719,0.00003258587,0.000027114096,0.00083442347,0.0005556503,0.0010994406,0.000059826965,0.000019386638,0.00009969389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99112535,0.004256265,0.0015956864,0.00023728191,0.002034834,0.00075057143],"domain_scores_gemma":[0.99162406,0.0016922541,0.0013305242,0.0008425181,0.004288578,0.00022208603],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.024490215,0.00014300688,0.00031202583,0.00013363866,0.0012264994,0.000018939858,0.0007078503,0.00018938803,0.0018130621],"category_scores_gemma":[0.0014527136,0.00007823251,0.000107352666,0.0005252776,0.00036068508,0.0006642963,0.00014940866,0.00087385956,0.0000065261283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009631778,0.00043974834,0.95405865,0.0017889675,0.000018131388,4.1257793e-9,0.0092679635,0.00010393184,0.00023810433,0.000040108847,0.0028023291,0.030278908],"study_design_scores_gemma":[0.0017271693,0.000033431355,0.9800178,0.0006342422,0.000017715547,6.119527e-8,0.0040968824,0.001429836,0.000141752,0.00007642755,0.011741159,0.00008356793],"about_ca_topic_score_codex":0.0072575845,"about_ca_topic_score_gemma":0.0054879147,"teacher_disagreement_score":0.03019534,"about_ca_system_score_codex":0.0006134695,"about_ca_system_score_gemma":0.0019968424,"threshold_uncertainty_score":0.9993532},"labels":[],"label_agreement":null},{"id":"W2076918272","doi":"10.1158/1538-7445.am2014-5185","title":"Abstract 5185: Redefining the somatic landscape of pancreatic adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Somatic cell; CDKN2A; Biology; Laser capture microdissection; DNA sequencing; Deep sequencing; Computational biology; Somatic evolution in cancer; Adenocarcinoma; Pancreatic cancer; Genome; Genetics; Cancer; Gene","score_opus":0.03948597515164738,"score_gpt":0.3355892497301859,"score_spread":0.2961032745785385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076918272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871546,0.0061582606,0.00007069702,0.0004742025,0.00010359531,0.00016764503,0.000021827263,0.000004263249,0.0058449307],"genre_scores_gemma":[0.9977973,0.0012135288,0.0000735519,0.00010373969,0.0004163525,0.00008155698,0.000020281785,0.000021455851,0.00027224442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893093,0.000083757855,0.00019027757,0.00023040544,0.00025496466,0.00030968402],"domain_scores_gemma":[0.99898666,0.00021185017,0.000063792875,0.00050470553,0.00016230816,0.00007067086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007809901,0.00008975365,0.00013714297,0.00004993469,0.00013069886,0.000034447876,0.0003390136,0.00007597021,0.00010265356],"category_scores_gemma":[0.00043868725,0.000066673936,0.00006119037,0.00014047885,0.00016611298,0.0000018891823,0.00015505217,0.0001658466,0.00001733053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024528685,0.00008566566,0.07982309,0.00032091065,0.00016304833,0.0000038845033,0.0004807158,0.00068433804,0.8698468,0.0023321903,0.029605638,0.01640843],"study_design_scores_gemma":[0.0023060855,0.0011178247,0.3597979,0.00037956156,0.00008924726,0.000018408984,0.0012816528,0.00083699933,0.52868843,0.0032106233,0.10165572,0.0006175503],"about_ca_topic_score_codex":0.00029943086,"about_ca_topic_score_gemma":0.00015195817,"teacher_disagreement_score":0.34115836,"about_ca_system_score_codex":0.000021454525,"about_ca_system_score_gemma":0.0002118405,"threshold_uncertainty_score":0.2718884},"labels":[],"label_agreement":null},{"id":"W2077192459","doi":"10.1158/0008-5472.can-07-0090","title":"Up-regulation of 14-3-3ζ in Lung Cancer and Its Implication as Prognostic and Therapeutic Target","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cisplatin; Lung cancer; Oncogene; Apoptosis; Cancer research; Medicine; Cancer; Immunohistochemistry; Cell growth; Biomarker; Molecular medicine; Cell cycle; A549 cell; Programmed cell death; Oncology; Cell; Internal medicine; Biology; Chemotherapy","score_opus":0.04055709466716592,"score_gpt":0.43615098590063783,"score_spread":0.3955938912334719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077192459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98516834,0.01344351,0.00013076921,0.00042094002,0.000056755358,0.0005365418,0.00001240697,0.0000034795685,0.00022728008],"genre_scores_gemma":[0.99775815,0.0011142839,0.000042846437,0.00002932312,0.00009052469,0.00025829193,0.000014995034,0.000013266272,0.00067831384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991841,0.000054968266,0.0001440529,0.00024086908,0.000155866,0.00022014456],"domain_scores_gemma":[0.99946135,0.000045952762,0.000042517604,0.0001353319,0.0002599693,0.000054850294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047824509,0.00006618492,0.000075679665,0.00011180808,0.000059044505,0.000014044345,0.00007395794,0.000090178684,0.00005911079],"category_scores_gemma":[0.000119355784,0.00006474173,0.000013326556,0.00018142669,0.00007996783,0.0000068603076,0.000066446846,0.00013796365,0.0000011930046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012764182,0.000019515028,0.04220727,0.00007147183,0.000021136362,3.3508945e-7,0.00014072921,0.000025254203,0.9504104,0.00024722263,0.00012240854,0.006606563],"study_design_scores_gemma":[0.00035463015,0.0001066914,0.20076643,0.00006399694,0.000006551116,0.0000042427364,0.000067290144,0.00023256154,0.7951239,0.00034696702,0.0028469933,0.00007979423],"about_ca_topic_score_codex":0.0004889916,"about_ca_topic_score_gemma":0.00047890024,"teacher_disagreement_score":0.15855916,"about_ca_system_score_codex":0.00006177313,"about_ca_system_score_gemma":0.0001368678,"threshold_uncertainty_score":0.26400912},"labels":[],"label_agreement":null},{"id":"W2077212116","doi":"10.1158/0008-5472.can-13-1706","title":"p53 Is Positively Regulated by miR-542-3p","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Internal medicine; Biology; Cancer research; Medicine","score_opus":0.04991566871114073,"score_gpt":0.3951614647225334,"score_spread":0.34524579601139266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077212116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94650584,0.0060860934,0.00044912548,0.016877046,0.00034582755,0.001124145,0.00013693588,0.0001802534,0.028294731],"genre_scores_gemma":[0.9778959,0.0005275693,0.00013051924,0.0015424878,0.00038616583,0.00018606165,0.00007294626,0.00009738304,0.019160973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969988,0.00023731748,0.00025198422,0.0005973629,0.0011089834,0.0008055818],"domain_scores_gemma":[0.9980948,0.00010699472,0.000049729453,0.0006736733,0.00065151905,0.00042328372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082969066,0.00018761189,0.00032267606,0.00025554205,0.00019424298,0.00005234223,0.00024377638,0.00023903356,0.0014681343],"category_scores_gemma":[0.00023650056,0.00017671636,0.00011286475,0.000849259,0.00030959025,0.00007209007,0.00012737713,0.00091655226,0.00049893686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003468791,0.00007196835,0.00030034722,0.000075101954,0.00010075044,0.000034983237,0.00030160637,0.0000033449935,0.65515256,0.00016396369,0.330457,0.012991512],"study_design_scores_gemma":[0.0023202256,0.00053315784,0.0026422143,0.0003627889,0.000044425076,0.000035658486,0.000056296274,0.00032173697,0.5607407,0.00016212661,0.4325667,0.00021396516],"about_ca_topic_score_codex":0.0012647031,"about_ca_topic_score_gemma":0.000051595827,"teacher_disagreement_score":0.102109715,"about_ca_system_score_codex":0.0006670011,"about_ca_system_score_gemma":0.000505889,"threshold_uncertainty_score":0.99944466},"labels":[],"label_agreement":null},{"id":"W2077360795","doi":"10.1158/1538-7445.am2012-4381","title":"Abstract 4381: The novel direct-acting vascular targeting agent NGR-TNF exerts <i>in vivo</i> antitumor activity by inducing endothelial and tumor cell death in the absence of proangiogenic bone-marrow derived cell recruitment","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cancer research; Lewis lung carcinoma; Angiogenesis; Bone marrow; Tumor necrosis factor alpha; Medicine; Homing (biology); Osteopontin; Cytokine; Tumor microenvironment; Immunology; Biology; Cancer; Immune system; Metastasis; Internal medicine","score_opus":0.09705653656665787,"score_gpt":0.36177330542871483,"score_spread":0.264716768862057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077360795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384046,0.0023472223,0.00001896431,0.00045591645,0.00003217754,0.001102859,0.000043451826,0.000011171345,0.0021477898],"genre_scores_gemma":[0.998577,0.0005084915,0.000086906424,0.00017360938,0.00014164337,0.00033663635,0.0000060322322,0.000024551158,0.00014515921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975021,0.00031652936,0.0003513359,0.000362101,0.0007807276,0.0006872465],"domain_scores_gemma":[0.9988693,0.00038381654,0.00016115916,0.0003360544,0.00010027822,0.0001493865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034141378,0.0001796474,0.00034678093,0.00019950457,0.00020475009,0.000044724806,0.00017270753,0.000059136546,0.00014892768],"category_scores_gemma":[0.00018956067,0.000116503,0.00013779814,0.0005617763,0.0001418695,0.00017003668,0.00010242644,0.00063326047,0.000004384644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008639697,0.0004468808,0.011688683,0.00023110255,0.000023811166,0.000030218664,0.0022033677,0.000024705345,0.9837981,0.0000017311884,0.000424845,0.0010401779],"study_design_scores_gemma":[0.0012430246,0.00004596247,0.01506842,0.0005683326,0.000027526454,0.0000059047115,0.0019526804,0.00018130083,0.9781817,0.0000021982532,0.0025758883,0.0001470127],"about_ca_topic_score_codex":0.002640069,"about_ca_topic_score_gemma":0.00016999168,"teacher_disagreement_score":0.005616331,"about_ca_system_score_codex":0.0002647625,"about_ca_system_score_gemma":0.00019744455,"threshold_uncertainty_score":0.47508544},"labels":[],"label_agreement":null},{"id":"W2077669730","doi":"10.1158/0008-5472.can-09-0387","title":"Evaluation of the 8q24 Prostate Cancer Risk Locus and <i>MYC</i> Expression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Prostate cancer; Locus (genetics); Oncology; Medicine; Internal medicine; Cancer; Biology; Gynecology; Cancer research; Genetics; Gene","score_opus":0.11016710765636818,"score_gpt":0.47507448636224997,"score_spread":0.3649073787058818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077669730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575297,0.031915005,0.0000014327702,0.0066066943,0.000106430416,0.0017673885,0.00006272559,0.00001601826,0.0019946091],"genre_scores_gemma":[0.98189116,0.0150067285,0.000018370998,0.000073120485,0.00020254352,0.00041379966,0.0000054270345,0.000016419706,0.0023724416],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960778,0.0005471475,0.00020090245,0.000345876,0.0023716637,0.0004566202],"domain_scores_gemma":[0.9977635,0.000084344225,0.00007694626,0.0004302862,0.0014779766,0.00016690315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002910892,0.000121989506,0.00020937099,0.00014499387,0.00028322244,0.000029560884,0.00015732703,0.00008127093,0.00029261407],"category_scores_gemma":[0.0002239815,0.00006863233,0.00006013629,0.00061325904,0.00035027182,0.00009618959,0.000103607395,0.00054641266,0.0000053462204],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014818137,0.0002443363,0.07209503,0.00018969718,0.0001216402,0.000008201292,0.0020426677,0.00011003762,0.42135206,0.0000341233,0.015172575,0.4871478],"study_design_scores_gemma":[0.0075020934,0.00076059235,0.17667857,0.0013761454,0.00031816203,0.000007695072,0.00046997954,0.0006861909,0.800535,0.0030583804,0.008427091,0.00018005524],"about_ca_topic_score_codex":0.0008817218,"about_ca_topic_score_gemma":0.00009345339,"teacher_disagreement_score":0.48696774,"about_ca_system_score_codex":0.0005287715,"about_ca_system_score_gemma":0.0014327093,"threshold_uncertainty_score":0.3203919},"labels":[],"label_agreement":null},{"id":"W2077710101","doi":"10.1158/1538-7445.am2013-2732","title":"Abstract 2732: The role of Cdx transcription factors in intestinal tumorigenesis.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"CDX2; Intestinal epithelium; Azoxymethane; Biology; Conditional gene knockout; Cancer research; Knockout mouse; Transcription factor; Colorectal cancer; ATP-binding cassette transporter; Phenotype; Cancer; Epithelium; Receptor; Genetics; Gene; Transporter","score_opus":0.042922954573083025,"score_gpt":0.3615036799631443,"score_spread":0.31858072539006127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077710101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309915,0.003053544,0.0000051254233,0.0002573263,0.00007733296,0.0003582936,0.000006904985,0.0000030237163,0.0031393142],"genre_scores_gemma":[0.9988573,0.00052040414,0.0000060741254,0.000013814989,0.00008764022,0.00010267477,0.0000121270605,0.0000112251055,0.00038873666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990206,0.00012246678,0.00018665075,0.00018097126,0.00020506597,0.00028426963],"domain_scores_gemma":[0.99948263,0.00003195608,0.00003804745,0.00017945658,0.00020434306,0.000063587184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047650695,0.000072050534,0.00009597601,0.000067463414,0.000066605724,0.000013933455,0.00019918723,0.00009203979,0.00012502486],"category_scores_gemma":[0.0000576465,0.00004554777,0.00004029615,0.00017521615,0.0001443659,0.0000045734464,0.000029311215,0.0002195339,0.000019389752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026871221,0.00003585417,0.05467939,0.00004284374,0.000010350316,5.471704e-7,0.00020920463,0.00003097431,0.9418066,0.0000960399,0.00038531623,0.002675973],"study_design_scores_gemma":[0.00018712327,0.00013196233,0.4851245,0.00008611984,0.0000018791364,0.000001522331,0.0011616535,0.0000094617035,0.5071971,0.00023040456,0.0058003874,0.000067918154],"about_ca_topic_score_codex":0.005351978,"about_ca_topic_score_gemma":0.0004070485,"teacher_disagreement_score":0.43460956,"about_ca_system_score_codex":0.00004197917,"about_ca_system_score_gemma":0.00022828484,"threshold_uncertainty_score":0.80906254},"labels":[],"label_agreement":null},{"id":"W2077730686","doi":"10.1158/1538-7445.am2013-2482","title":"Abstract 2482: Development of novel small-molecule inhibitors of androgen receptor variants lacking the ligand-binding domain.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Androgen receptor; Bicalutamide; Antiandrogens; Prostate cancer; Cancer research; Enzalutamide; Chemistry; Androgen; Mutant; Small molecule; Cancer; Internal medicine; Biology; Medicine; Biochemistry; Gene; Hormone","score_opus":0.11123254847496239,"score_gpt":0.3868492150700276,"score_spread":0.27561666659506523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077730686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935884,0.0015669754,0.000015554346,0.0013304672,0.00011241878,0.0012671428,0.000022477238,0.000014598923,0.0020819893],"genre_scores_gemma":[0.9968556,0.00043606324,0.0007493387,0.000020758527,0.00015430282,0.00036998483,0.000022463208,0.000036478832,0.0013549746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976071,0.00006387882,0.00044204685,0.00031375018,0.0009347686,0.00063845085],"domain_scores_gemma":[0.9984426,0.0001800459,0.000117802614,0.0003584064,0.00069809693,0.00020303375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00126478,0.00015302979,0.00031703382,0.00027542972,0.0002448878,0.000039339055,0.0002966602,0.00010719324,0.00052004604],"category_scores_gemma":[0.00008280225,0.00009608087,0.00008427615,0.000693063,0.00038558448,0.00009074294,0.00020781813,0.00047366045,0.000056452427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023639611,0.0002476275,0.007275632,0.0003806324,0.0002569043,0.000008143942,0.0028492054,0.0000017308806,0.9714012,0.00004113851,0.002762098,0.014539246],"study_design_scores_gemma":[0.0022354731,0.00014852875,0.012012333,0.0007171851,0.000013468037,0.0000035123278,0.002067306,0.000006192383,0.98002213,0.000025569336,0.0026432544,0.00010504461],"about_ca_topic_score_codex":0.00077676104,"about_ca_topic_score_gemma":0.00003910211,"teacher_disagreement_score":0.014434203,"about_ca_system_score_codex":0.00038471544,"about_ca_system_score_gemma":0.00199219,"threshold_uncertainty_score":0.56941396},"labels":[],"label_agreement":null},{"id":"W2077809631","doi":"10.1158/0008-5472.can-08-2169","title":"An Epigenetic Genome-Wide Screen Identifies <i>SPINT2</i> as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Hospital for Sick Children","funders":"","keywords":"Cancer research; Biology; SOCS5; Tumor suppressor gene; Medulloblastoma; SOCS6; Epigenetics; Suppressor; Gene; DNA methylation; Carcinogenesis; Molecular biology; Genetics; Gene expression; SOCS3","score_opus":0.05550844363505932,"score_gpt":0.35594598156610013,"score_spread":0.30043753793104083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077809631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906599,0.007896702,0.00017507318,0.00018886915,0.00012714294,0.00048284399,0.00009487037,0.00002356558,0.0003510651],"genre_scores_gemma":[0.99454874,0.0029213282,0.00022331833,0.00021863918,0.00079204096,0.00037164165,0.00006735527,0.00006690391,0.0007900106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703926,0.00022779645,0.00036530403,0.0008250242,0.0006376494,0.0009049706],"domain_scores_gemma":[0.99850506,0.00006744324,0.00006553317,0.0006873583,0.0004178415,0.00025674645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077644107,0.00024305814,0.00028196548,0.0003218628,0.00032247006,0.000047392616,0.00071541866,0.00014457482,0.00007119129],"category_scores_gemma":[0.00045337048,0.0002476928,0.00008885927,0.0005930201,0.00039884413,0.000011660417,0.0003870733,0.0003563862,0.00008148486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016041347,0.00015207723,0.03578042,0.0000505037,0.00003821759,0.0001082171,0.00039723617,0.000453087,0.961721,0.0000032607913,0.0010721963,0.00006336515],"study_design_scores_gemma":[0.00089240266,0.00050095184,0.12433191,0.00001952003,0.000011945128,0.000034409983,0.00017517678,0.00001886306,0.86995125,0.000034983248,0.0036936693,0.00033494178],"about_ca_topic_score_codex":0.0008413493,"about_ca_topic_score_gemma":0.0009799442,"teacher_disagreement_score":0.09176978,"about_ca_system_score_codex":0.00009939258,"about_ca_system_score_gemma":0.0006785577,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W2077826878","doi":"10.1158/1538-7445.am2013-2292","title":"Abstract 2292: Enforced expression of miR-125b promotes the in vivo expansion of human Lin- CB multi-lymphoid progenitors (MLP) and AML leukemia stem cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Progenitor cell; microRNA; Population; Cancer research; CD34; Leukemia; Myeloid; Immunology; Molecular biology; Cell biology; Genetics; Gene; Medicine","score_opus":0.03854270983651613,"score_gpt":0.34290282531419214,"score_spread":0.304360115477676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077826878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973147,0.0016387153,0.0000071812956,0.000022306627,0.00003324881,0.00090331497,0.000022523596,0.000004200221,0.000053822365],"genre_scores_gemma":[0.9991501,0.00021036367,0.0000805116,0.0000043813234,0.000068074776,0.00021208067,0.000013610574,0.00002164861,0.00023924495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987246,0.00013320272,0.00029040314,0.00029720686,0.00029248773,0.0002620907],"domain_scores_gemma":[0.9991122,0.000032341384,0.00011914932,0.0003776501,0.0002779826,0.00008070726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038353555,0.00011708183,0.00014493101,0.00008849796,0.000083555235,0.000021455075,0.00023697974,0.00015428018,0.00008490979],"category_scores_gemma":[0.000029066565,0.000085989785,0.00004920507,0.00013347408,0.0002523668,0.00001208704,0.00018560728,0.00013506254,0.0000019500046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006708117,0.000044110096,0.0026342876,0.00022924168,0.000011843574,6.602873e-7,0.00028506955,0.000050297098,0.9945184,0.000002583086,0.0004812748,0.001675151],"study_design_scores_gemma":[0.0006550444,0.00009539345,0.010591271,0.0001865503,0.0000038693747,7.592277e-7,0.00028943288,0.00012632387,0.9877748,0.000013020864,0.00017607445,0.00008749663],"about_ca_topic_score_codex":0.00090351567,"about_ca_topic_score_gemma":0.00007806758,"teacher_disagreement_score":0.007956984,"about_ca_system_score_codex":0.00009034934,"about_ca_system_score_gemma":0.00028232054,"threshold_uncertainty_score":0.35065615},"labels":[],"label_agreement":null},{"id":"W2077973333","doi":"10.1158/0008-5472.sabcs12-p4-13-04","title":"Abstract P4-13-04: Estrogen and Avoidance of Invasive Breast Cancer, Coronary Heart Disease and All-cause Mortality. Public Health Impact of Estrogen Guidelines for Women entering Menopause.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Menopause; Estrogen; Medicine; Breast cancer; Placebo; Hormone replacement therapy (female-to-male); Population; Coronary heart disease; Internal medicine; Gynecology; Disease; Cancer; Environmental health; Alternative medicine; Pathology","score_opus":0.3436850023075891,"score_gpt":0.5243996315733385,"score_spread":0.18071462926574938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077973333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559526,0.03470545,0.0000026590933,0.0053952863,0.00008223372,0.0018489023,0.001982417,0.000017659844,0.000012822034],"genre_scores_gemma":[0.98536533,0.0129350545,0.00013843557,0.0003820643,0.00029430832,0.00069857057,0.000059439604,0.00005498647,0.000071795315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671304,0.00013796733,0.00068872696,0.00040677248,0.0006548583,0.0013986572],"domain_scores_gemma":[0.99591607,0.00022517031,0.00026851206,0.00045618403,0.0007704394,0.0023636306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017023194,0.0002714209,0.000697654,0.00024288881,0.00017231071,0.00003175403,0.00012705135,0.00007369016,0.0001685687],"category_scores_gemma":[0.00036415586,0.00021065967,0.00003414117,0.00023396082,0.00029169227,0.000356328,0.00013813654,0.00023718402,0.0000014095954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023743312,0.000565311,0.9406937,0.0043363497,0.0021903114,0.00001856784,0.001268365,0.000010556383,0.040721644,0.000045847242,0.00222842,0.0055466015],"study_design_scores_gemma":[0.0042008036,0.0025641907,0.99011654,0.0008032484,0.00016317061,0.00006283545,0.00027209727,0.000021364798,0.00090929,0.000081066384,0.0006414755,0.0001639303],"about_ca_topic_score_codex":0.011660957,"about_ca_topic_score_gemma":0.0002587701,"teacher_disagreement_score":0.049422834,"about_ca_system_score_codex":0.0010208093,"about_ca_system_score_gemma":0.0031948914,"threshold_uncertainty_score":0.9949205},"labels":[],"label_agreement":null},{"id":"W2078073947","doi":"10.1158/1538-7445.am2011-3451","title":"Abstract 3451: Interactions between N-myc and Sox9 promote medulloblastoma and determine cell fate decisions in cerebellar neural stem cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Neural stem cell; Biology; Cancer research; Stem cell; SOX9; Cerebellum; Cell biology; Endocrinology; Transcription factor; Genetics; Signal transduction","score_opus":0.07860031454256207,"score_gpt":0.35558728181032706,"score_spread":0.276986967267765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078073947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811697,0.001109419,0.00002476246,0.000061643026,0.00005579758,0.0003516029,0.000058110065,0.000006715161,0.00021497344],"genre_scores_gemma":[0.998811,0.00056017603,0.00014769394,0.000011234616,0.0001047325,0.00005277175,0.000015883552,0.000024872632,0.00027164424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987842,0.00009746689,0.00020938793,0.00040385328,0.0001724761,0.00033265224],"domain_scores_gemma":[0.9993161,0.00005394887,0.000051153456,0.0002745065,0.00011684361,0.00018746211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029445093,0.00012522518,0.00012857375,0.00014262412,0.00010691646,0.000038152397,0.00015507117,0.00010463539,0.000059165897],"category_scores_gemma":[0.00002459161,0.00012012963,0.000031693922,0.00013711627,0.00015393915,0.000013820163,0.00023486128,0.00022729787,0.000008787941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000921784,0.00004169496,0.009976164,0.000041056297,0.000016117345,0.000011893624,0.00022869842,0.000006986705,0.9703059,0.0000012720883,0.0002622473,0.019015752],"study_design_scores_gemma":[0.00047910682,0.00012511917,0.09772774,0.00006541923,0.000010778584,0.000005933064,0.00012729177,0.000088360546,0.89892846,0.0000554168,0.0022404948,0.00014590315],"about_ca_topic_score_codex":0.00023943569,"about_ca_topic_score_gemma":0.0004212582,"teacher_disagreement_score":0.08775157,"about_ca_system_score_codex":0.000044663408,"about_ca_system_score_gemma":0.000093341354,"threshold_uncertainty_score":0.48987442},"labels":[],"label_agreement":null},{"id":"W2078190084","doi":"10.1158/0008-5472.can-06-1500","title":"Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1047,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; McGill University","funders":"Terry Fox Foundation; Canadian Breast Cancer Research Alliance","keywords":"Metformin; Hyperinsulinemia; Endocrinology; Cancer; Internal medicine; Cancer research; Population; Kinase; Insulin resistance; Growth inhibition; Cell growth; Insulin; Medicine; Biology; Pharmacology; Cell biology; Biochemistry","score_opus":0.041367970758387974,"score_gpt":0.3632792139167324,"score_spread":0.3219112431583444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078190084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.880326,0.115645476,0.00015701544,0.00022774257,0.00058483233,0.00064785284,0.0019671582,0.000017075134,0.00042690372],"genre_scores_gemma":[0.9265161,0.055262506,0.00034763166,0.0008812978,0.007431115,0.0023308897,0.0002758463,0.0001296185,0.006824978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975524,0.00011465033,0.00026581553,0.00069622643,0.0005259957,0.00084488996],"domain_scores_gemma":[0.99848014,0.00002084809,0.00005086647,0.0005062552,0.0007226863,0.00021918837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069299113,0.00021954061,0.00023993701,0.00011647265,0.00022710142,0.0000932395,0.00043021626,0.00021263844,0.0007114569],"category_scores_gemma":[0.000020095405,0.00020057464,0.0001308169,0.00023008412,0.0001772827,0.00001750608,0.00013558636,0.0002134183,0.000023666425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026175755,0.00011617493,0.0004789252,0.00011680072,0.00005282429,0.0000016487132,0.000057892204,0.000025471665,0.8345376,0.0001642908,0.100540586,0.063645996],"study_design_scores_gemma":[0.000639908,0.00007979194,0.00030348677,0.000019254398,0.000015881684,0.0000014263279,0.000040633495,0.000008522888,0.6406532,0.00027379175,0.35777318,0.00019092699],"about_ca_topic_score_codex":0.0030150628,"about_ca_topic_score_gemma":0.0024251658,"teacher_disagreement_score":0.2572326,"about_ca_system_score_codex":0.00014033841,"about_ca_system_score_gemma":0.00052441965,"threshold_uncertainty_score":0.8179196},"labels":[],"label_agreement":null},{"id":"W2078311993","doi":"10.1158/1538-7445.am2011-3059","title":"Abstract 3059: CCL2 overexpression in an epithelial ovarian cancer cell line results in reduced tumorigenic potential","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Biology; Cancer research; Cell culture; Ovarian cancer; Gene; Cell; Molecular biology; Chromosome; Cancer; Genetics","score_opus":0.12338130120418801,"score_gpt":0.41174985492027466,"score_spread":0.28836855371608666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078311993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944604,0.0017012572,0.0000012896644,0.0012587475,0.00037003966,0.0010893,0.00023128065,0.00003340397,0.005868655],"genre_scores_gemma":[0.99433345,0.0029291608,0.00018027984,0.00009545767,0.0008840243,0.0007874767,0.00006221314,0.00006275912,0.000665155],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965365,0.00021378664,0.00061701605,0.0008847281,0.0008119096,0.0009360846],"domain_scores_gemma":[0.99841005,0.000073309915,0.00011135695,0.00072650996,0.00025950425,0.00041924827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010272147,0.0002625685,0.0004477757,0.0003869951,0.000108138316,0.000042713466,0.00029155388,0.00021953796,0.0030260542],"category_scores_gemma":[0.00006387824,0.00022117398,0.000098462864,0.00061771163,0.00012479219,0.00027591232,0.00011688578,0.000856657,0.000058151345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021622505,0.006768798,0.039603494,0.0005164835,0.00012863627,0.0028290804,0.0070271585,0.00030173134,0.8753007,0.00014093409,0.00411507,0.04164539],"study_design_scores_gemma":[0.012832736,0.0009004887,0.6186711,0.0017687272,0.000030595253,0.0000068572344,0.0003787382,0.00013547011,0.36382228,0.00023587447,0.0009209278,0.00029617577],"about_ca_topic_score_codex":0.06814341,"about_ca_topic_score_gemma":0.010346604,"teacher_disagreement_score":0.57906765,"about_ca_system_score_codex":0.0016602887,"about_ca_system_score_gemma":0.00136979,"threshold_uncertainty_score":0.9978853},"labels":[],"label_agreement":null},{"id":"W2078348632","doi":"10.1158/0008-5472.sabcs10-p3-10-26","title":"Abstract P3-10-26: Quantitative Protein and Gene Expression Biomarkers of Tamoxifen and Letrozole Recurrence in the NCIC CTG MA.17 Cohort","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Medicine; Breast cancer; Tamoxifen; Oncology; Internal medicine; Cancer; Cohort; Gynecology","score_opus":0.04544722533407717,"score_gpt":0.387443802668295,"score_spread":0.3419965773342178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078348632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933435,0.004958588,0.0000052212986,0.00051977165,0.00003457296,0.00052570086,0.000055911703,0.0000033826789,0.00055338285],"genre_scores_gemma":[0.99813324,0.0008818271,0.0003775362,0.00001709187,0.000055347482,0.00041212118,0.000014931131,0.000012969477,0.00009494374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988781,0.00011400053,0.00014100967,0.00035019577,0.0002602636,0.00025637946],"domain_scores_gemma":[0.99940825,0.00006940288,0.00005447658,0.00027160865,0.0001452039,0.000051037037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071492995,0.00011240499,0.00013029408,0.00006834645,0.00011562793,0.000022625534,0.0001806458,0.000088242465,0.00003586664],"category_scores_gemma":[0.0001483745,0.00007913752,0.00002190394,0.00014881551,0.00055601296,0.00000809903,0.00016115808,0.00019942706,0.0000014795826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044650558,0.000048930233,0.033718336,0.000051477677,0.000051246952,0.0000040990994,0.0002993401,5.7115324e-7,0.96071154,0.000016302733,0.0018313183,0.0028203037],"study_design_scores_gemma":[0.00055262615,0.00015968553,0.29978243,0.00009365213,0.000007591396,0.000004177528,0.000284097,0.000003045164,0.6974038,0.00009044216,0.0015200941,0.00009837175],"about_ca_topic_score_codex":0.0007282577,"about_ca_topic_score_gemma":0.00066605915,"teacher_disagreement_score":0.2660641,"about_ca_system_score_codex":0.000020400896,"about_ca_system_score_gemma":0.00011603301,"threshold_uncertainty_score":0.32271343},"labels":[],"label_agreement":null},{"id":"W2078467208","doi":"10.1158/1538-7445.am2012-2477","title":"Abstract 2477: Autophagy is correlated with chemoresistance in neuroblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Autophagy; ATG5; Vacuole; Autophagosome; Programmed cell death; Cancer research; Neuroblastoma; Biology; Cancer cell; Chemotherapy; Viability assay; Cell; Apoptosis; Cancer; Cell biology; Cell culture; Biochemistry","score_opus":0.061918235449249286,"score_gpt":0.40806119552599274,"score_spread":0.34614296007674344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078467208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98746824,0.0049617416,0.000004053642,0.00093795673,0.00010347572,0.00039894527,0.000009202106,0.00005151224,0.0060648867],"genre_scores_gemma":[0.9952598,0.00047614283,0.000026787855,0.00065691717,0.00024355,0.00014427355,0.000006324741,0.0000423434,0.0031438123],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981404,0.00004970136,0.00017724576,0.00026729566,0.0006264796,0.00073888013],"domain_scores_gemma":[0.9990136,0.00008459558,0.000036237565,0.00038143984,0.00015389868,0.0003301965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003864248,0.00013524004,0.00022338296,0.00020007284,0.000079567195,0.00001786218,0.00014118812,0.000095784395,0.0025411856],"category_scores_gemma":[0.000036840407,0.00010550699,0.000043534284,0.00069476635,0.0001926395,0.00014857423,0.000033382406,0.000660056,0.00023493671],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02084239,0.0040776106,0.3906197,0.0015556258,0.0006701703,0.0030600599,0.009283312,0.00008082272,0.4379694,0.0018196864,0.08327733,0.046743892],"study_design_scores_gemma":[0.0026140534,0.00019241247,0.8391646,0.0003407726,0.000015326492,0.000023326553,0.00011903087,0.00005228695,0.14750798,0.000074016585,0.009742296,0.000153892],"about_ca_topic_score_codex":0.00024182085,"about_ca_topic_score_gemma":0.000040369236,"teacher_disagreement_score":0.44854492,"about_ca_system_score_codex":0.00023968543,"about_ca_system_score_gemma":0.0003743629,"threshold_uncertainty_score":0.99837065},"labels":[],"label_agreement":null},{"id":"W2078505530","doi":"10.1158/1538-7445.am2011-4294","title":"Abstract 4294: Using the zebrafish model to determine the role of the HACE1 tumor suppressor in apoptosis, cell proliferation and development","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Nova Scotia Health Authority; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Morpholino; Gene knockdown; Tumor suppressor gene; Carcinogenesis; Cell biology; Genetics; Gene; Cancer research","score_opus":0.06249129445239987,"score_gpt":0.31910138860198123,"score_spread":0.25661009414958136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078505530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978008,0.00095930684,0.000028952027,0.0002124278,0.00003212957,0.00040539246,0.0000055801197,0.0000012097548,0.0005541715],"genre_scores_gemma":[0.99935097,0.000106161206,0.00011856297,0.00010302996,0.000041106257,0.00011691161,0.0000014999679,0.000009663157,0.000152104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992262,0.00006561666,0.00013705897,0.00017013901,0.00019145095,0.00020953824],"domain_scores_gemma":[0.9996043,0.000010932681,0.00003726763,0.0002154229,0.00009334435,0.000038738555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000367557,0.00006932374,0.000063380314,0.000028156766,0.00015076413,0.000018025166,0.0002708779,0.000053934975,0.000010182841],"category_scores_gemma":[0.000021286189,0.000033164135,0.000021271926,0.00011546116,0.00012536594,0.0000040189598,0.00017142147,0.00018572691,7.034646e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010848443,0.000021092981,0.0011937412,0.000021602302,0.000012356801,2.1586091e-7,0.0012623165,0.0019841576,0.9936953,0.0000062196737,0.00017244506,0.0015220582],"study_design_scores_gemma":[0.00015632735,0.000027198883,0.0022727333,0.000036869762,0.0000031298332,0.0000012166399,0.00028877857,0.0010173161,0.994711,0.00004930835,0.0013834797,0.00005263132],"about_ca_topic_score_codex":0.0003441443,"about_ca_topic_score_gemma":0.00029726452,"teacher_disagreement_score":0.0015501309,"about_ca_system_score_codex":0.00003663993,"about_ca_system_score_gemma":0.0003230501,"threshold_uncertainty_score":0.13523942},"labels":[],"label_agreement":null},{"id":"W2078541106","doi":"10.1158/1538-7445.am10-4573","title":"Abstract 4573: Discovery of candidate biomarkers for colorectal cancer using mass spectrometry-based proteomic analysis of cell line conditioned media","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Colorectal cancer; Orbitrap; Proteome; Cancer; Proteomics; Tandem mass spectrometry; Computational biology; Mass spectrometry; Cancer biomarkers; Biomarker discovery; Bioinformatics; Chemistry; Biology; Chromatography; Biochemistry; Gene; Genetics","score_opus":0.039389119814844116,"score_gpt":0.39561275876688856,"score_spread":0.35622363895204445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078541106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97574675,0.000080547055,0.018183557,0.00009998689,0.000032211054,0.00065307674,0.0049935156,0.000024846784,0.00018550007],"genre_scores_gemma":[0.96307695,0.00009640716,0.035003945,0.0000048291217,0.00010144695,0.0013195926,0.00030473588,0.000034622994,0.000057490746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984531,0.000015538913,0.0004009194,0.00037136927,0.00037597818,0.0003831243],"domain_scores_gemma":[0.9984525,0.00030018014,0.00030743054,0.00039688905,0.0004470037,0.00009599995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041807484,0.00014659048,0.00037493533,0.00048215291,0.00012887886,0.000027549158,0.0003516241,0.00015859558,0.00089193834],"category_scores_gemma":[0.00008949337,0.00014237035,0.00019343907,0.0012141475,0.00038328045,0.0001031566,0.000046672045,0.0004189425,4.5172843e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036215936,0.00008538291,0.0029417167,0.00030265644,0.0002655585,7.4015713e-7,0.000029741432,0.00080270745,0.9949474,0.0001079483,0.00004165311,0.00011233683],"study_design_scores_gemma":[0.0005734412,0.000026402127,0.0007620465,0.00005711163,0.00017429267,1.2949111e-7,0.000045166238,0.0052216426,0.9922923,0.00066569314,0.000037097077,0.00014466519],"about_ca_topic_score_codex":0.0025611275,"about_ca_topic_score_gemma":0.0008831326,"teacher_disagreement_score":0.016820388,"about_ca_system_score_codex":0.00026649932,"about_ca_system_score_gemma":0.00065142656,"threshold_uncertainty_score":0.9766099},"labels":[],"label_agreement":null},{"id":"W2078584919","doi":"10.1158/1538-7445.pedcan-a18","title":"Abstract A18: Uncovering molecular subgroups and a novel cancer driver, ACVR1, in diffuse intrinsic pontine gliomas","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Medicine; Cancer; DNA methylation; Genetics; Genome instability; Biology; Gene; Bioinformatics; Gene expression; DNA damage; DNA","score_opus":0.03017854423695546,"score_gpt":0.3442198406344846,"score_spread":0.3140412963975291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078584919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993327,0.004516651,0.0006149554,0.0005590413,0.00010269471,0.00024306795,0.000029466055,0.000009212776,0.0005978805],"genre_scores_gemma":[0.99594235,0.002816733,0.00009164186,0.00012826506,0.00025547645,0.00031072184,0.00002069758,0.0000345962,0.0003995017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846196,0.000059129212,0.00020055864,0.00051772635,0.00028787312,0.0004727562],"domain_scores_gemma":[0.9991873,0.00002484231,0.000049349557,0.00042286524,0.00017692643,0.00013872232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049325416,0.00015224944,0.00016416801,0.00016158818,0.00010684091,0.0000668539,0.00026196594,0.000137373,0.000053888183],"category_scores_gemma":[0.00009599608,0.00014816636,0.000044090677,0.00034298046,0.00017602532,0.000011372343,0.00020888359,0.00027704446,0.000004987958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010808196,0.00009781893,0.007171101,0.000046608413,0.000028762297,0.00000523127,0.00005484485,0.00019873618,0.97524834,0.00038877325,0.0004471822,0.016204504],"study_design_scores_gemma":[0.0051742964,0.00027499377,0.20460092,0.00021272818,0.000018416527,0.000009762203,0.0001597169,0.00026419509,0.6770928,0.00042678305,0.11111926,0.0006461545],"about_ca_topic_score_codex":0.0022467526,"about_ca_topic_score_gemma":0.0016856913,"teacher_disagreement_score":0.29815558,"about_ca_system_score_codex":0.000112388145,"about_ca_system_score_gemma":0.0001873981,"threshold_uncertainty_score":0.6042049},"labels":[],"label_agreement":null},{"id":"W2078826990","doi":"10.1158/0008-5472.sabcs10-p3-08-04","title":"Abstract P3-08-04: Germline Copy Number Polymorphisms Associated with Toxicity from Adjuvant Docetaxel","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Docetaxel; Medicine; Internal medicine; Oncology; Single-nucleotide polymorphism; Population; Toxicity; Pharmacogenetics; Copy-number variation; Pharmacology; Cancer; Biology; Genetics; Genotype; Gene","score_opus":0.028231056067927945,"score_gpt":0.34390330043614026,"score_spread":0.3156722443682123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078826990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946727,0.00083804294,0.000050083363,0.00061403506,0.00035904042,0.00027168452,0.00087371055,0.0000176983,0.0023029689],"genre_scores_gemma":[0.9961045,0.0007335607,0.00021228359,0.00030530497,0.0010395829,0.00010957985,0.00044760434,0.000055168555,0.0009924293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980594,0.0000525978,0.00022511807,0.00058400305,0.000456704,0.0006222068],"domain_scores_gemma":[0.9984507,0.00013771147,0.00009136135,0.0006178963,0.00043068363,0.0002716523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046242616,0.00020385212,0.00023317688,0.00004787456,0.00019502737,0.0000958875,0.00040778806,0.0002807611,0.0016123947],"category_scores_gemma":[0.0003464945,0.00017875017,0.00008007915,0.00019919187,0.0003138141,0.000006695252,0.00020052175,0.00066132273,0.000103784965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035144095,0.0001642546,0.034781765,0.0000075592743,0.00012739566,0.000029399707,0.000042894357,0.000032889027,0.944917,0.00006732776,0.016796352,0.002681696],"study_design_scores_gemma":[0.0020163134,0.0002864698,0.12633537,0.00006586482,0.0000319312,0.00000655027,0.000039834107,0.00003964399,0.81754756,0.00041647183,0.052737106,0.00047691053],"about_ca_topic_score_codex":0.0028773479,"about_ca_topic_score_gemma":0.009532426,"teacher_disagreement_score":0.1273695,"about_ca_system_score_codex":0.00009091216,"about_ca_system_score_gemma":0.0006600411,"threshold_uncertainty_score":0.99930024},"labels":[],"label_agreement":null},{"id":"W2078885057","doi":"10.1158/0008-5472.sabcs11-pd06-06","title":"PD06-06: Is Adjuvant Trastuzumab Economically Justified in Her-2/neu Positive T1bNO Breast Cancer?","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Cardiotoxicity; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Disease; Cancer; Relative risk; Surgery; Gynecology; Confidence interval","score_opus":0.06298054715846647,"score_gpt":0.3583302731207851,"score_spread":0.2953497259623186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078885057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880317,0.003964521,0.000012906268,0.002002708,0.0001989457,0.000494778,0.0011379705,0.000017646795,0.0041388525],"genre_scores_gemma":[0.9946013,0.0025981655,0.00006827654,0.00040303284,0.00041976033,0.0007399308,0.00006814509,0.00005421957,0.001047138],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99764425,0.00015311937,0.00029096456,0.00082464685,0.00026397844,0.0008230214],"domain_scores_gemma":[0.99894583,0.00003231255,0.00006542173,0.00046730897,0.0002988307,0.00019026408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002943037,0.00027054822,0.0003270865,0.00014690374,0.00017080593,0.00003058114,0.00042215697,0.0001853317,0.00079608394],"category_scores_gemma":[0.000021067208,0.00025458785,0.00010637974,0.00025956673,0.00037917585,0.000012908097,0.00031220913,0.00033638737,0.000083386854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010237889,0.0022018456,0.35441253,0.00037029706,0.0023569926,0.00026926954,0.012589103,0.00011798804,0.38415906,0.00073293655,0.08229774,0.15025435],"study_design_scores_gemma":[0.0036442196,0.00040127075,0.77646506,0.0002465369,0.000065528984,0.00004479353,0.0011868656,0.000023014421,0.20922154,0.00028826424,0.007718066,0.0006948285],"about_ca_topic_score_codex":0.00980805,"about_ca_topic_score_gemma":0.006189009,"teacher_disagreement_score":0.42205253,"about_ca_system_score_codex":0.0005740824,"about_ca_system_score_gemma":0.00064159813,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2078893488","doi":"10.1158/1538-7445.am2012-825","title":"Abstract 825: Wnt/beta-catenin signaling regulates the expression of O6-methylguanine DNA-methyltransferase in cancer cells: a new strategy to overcome resistance for DNA alkylators in cancer therapy","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Wnt signaling pathway; Cancer research; DNA methyltransferase; Biology; Temozolomide; Methyltransferase; O-6-methylguanine-DNA methyltransferase; DNA repair; Gene knockdown; Molecular biology; Cancer; Cell culture; Signal transduction; DNA; Glioma; Cell biology; Methylation; Biochemistry; Genetics","score_opus":0.07844784005330059,"score_gpt":0.39505621744503366,"score_spread":0.3166083773917331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078893488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96093434,0.0368278,0.000060573166,0.00071658223,0.0001581894,0.0010836775,0.0001699548,0.000007670398,0.000041205563],"genre_scores_gemma":[0.99454105,0.0029322384,0.00016118899,0.00008724869,0.0004882968,0.00091184746,0.000040346895,0.00006517578,0.0007726258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973902,0.00025791573,0.0005070797,0.0005485999,0.00046879204,0.0008274296],"domain_scores_gemma":[0.99878144,0.00013069666,0.000119193166,0.00045930015,0.0002627859,0.00024659597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013801036,0.00026053263,0.00032391396,0.0002708904,0.000105544634,0.00003800008,0.00047396644,0.0002294422,0.0003398349],"category_scores_gemma":[0.000059216818,0.0002064782,0.0001289636,0.00072662695,0.00013857777,0.000033139713,0.00008093889,0.00029004997,0.0000018600679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013777975,0.00012274385,0.0029107283,0.00012486672,0.00004862788,0.0000011150048,0.0006313641,0.0037658557,0.9827988,0.000022875465,0.003009852,0.0051853447],"study_design_scores_gemma":[0.0011712832,0.00010249077,0.027613835,0.00031660634,0.000010382434,1.7816308e-7,0.00016809309,0.000011266427,0.9657607,0.00011266251,0.004497076,0.00023542091],"about_ca_topic_score_codex":0.0032729956,"about_ca_topic_score_gemma":0.0037459326,"teacher_disagreement_score":0.03389556,"about_ca_system_score_codex":0.00029088705,"about_ca_system_score_gemma":0.0006770451,"threshold_uncertainty_score":0.8419937},"labels":[],"label_agreement":null},{"id":"W2078907103","doi":"10.1158/0008-5472.sabcs-09-2087","title":"Incidence of Febrile Neutropenia with Taxane-Based Systemic Therapy in Women with Early Stage Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Febrile neutropenia; Docetaxel; Breast cancer; Internal medicine; Taxane; Neutropenia; Epirubicin; Regimen; Cancer; Gynecology; Chemotherapy","score_opus":0.039125630882427286,"score_gpt":0.36920427571811953,"score_spread":0.33007864483569227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078907103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546087,0.00095470925,0.000017048302,0.0014814821,0.00003752925,0.0012470251,0.000076480275,0.000039285227,0.00068555836],"genre_scores_gemma":[0.9966053,0.00091745926,0.000027156673,0.00035317778,0.00013455986,0.001020888,0.0000025646016,0.000038593724,0.00090031035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752057,0.00016147763,0.00027527707,0.00044642168,0.0008841615,0.0007120993],"domain_scores_gemma":[0.99837536,0.00006391137,0.00011151928,0.0005264238,0.0006667538,0.00025605128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048651863,0.00019592307,0.00046914115,0.00037155993,0.000116733194,0.000045208104,0.00025532767,0.00007292835,0.0007770076],"category_scores_gemma":[0.000008071974,0.00013485768,0.0000324142,0.0015822076,0.0002839741,0.00017662397,0.000022319311,0.0006295775,0.000009574028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031058615,0.00049093645,0.64643234,0.0004981778,0.00014016785,0.0003775983,0.0017336789,0.002504511,0.2888294,0.00013255312,0.0007245936,0.027077453],"study_design_scores_gemma":[0.008036568,0.0057288124,0.94471174,0.0026217422,0.000019216426,0.000118463075,0.0006555034,0.000027891816,0.03661413,0.000010388405,0.0011792589,0.0002762842],"about_ca_topic_score_codex":0.014979326,"about_ca_topic_score_gemma":0.0026784062,"teacher_disagreement_score":0.2982794,"about_ca_system_score_codex":0.001150689,"about_ca_system_score_gemma":0.0024450102,"threshold_uncertainty_score":0.99158},"labels":[],"label_agreement":null},{"id":"W2078929667","doi":"10.1158/1538-7445.am2013-288","title":"Abstract 288: TGF-beta induced epithelial-to-mesenchymal transition is attenuated when the MNK/eIF4E pathway is functionally impaired.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epithelial–mesenchymal transition; EIF4E; Cancer research; Gene silencing; Phosphorylation; Transforming growth factor beta; Metastasis; Biology; Breast cancer; Cancer; Cell biology; Signal transduction; Translation (biology); Messenger RNA; Gene; Genetics","score_opus":0.04600972992611128,"score_gpt":0.3341873745922054,"score_spread":0.2881776446660941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078929667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676299,0.00092164683,0.0013382075,0.02586132,0.0003648912,0.0020730547,0.00032795907,0.00004063395,0.0014423853],"genre_scores_gemma":[0.9890546,0.00042404162,0.00008166776,0.0031255314,0.0008498322,0.0013142234,0.00015143283,0.00010408997,0.0048945392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99565643,0.00033413083,0.00040158682,0.0009860367,0.0014470676,0.0011747663],"domain_scores_gemma":[0.9970009,0.00006539103,0.00007434754,0.0010683782,0.0013433082,0.00044768513],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012450711,0.0003263394,0.00025229485,0.00025748994,0.0005136068,0.0002391215,0.0008642047,0.00045170847,0.004711279],"category_scores_gemma":[0.00012232238,0.0002635097,0.00023044989,0.00066560996,0.00022231876,0.00002638704,0.00033537517,0.0010112096,0.0011029134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025597052,0.00007009333,0.000015808913,0.00003574573,0.00016841649,0.000009090617,0.00064911443,0.00008768353,0.9122441,0.00003664237,0.07338503,0.01304232],"study_design_scores_gemma":[0.00085323426,0.0005504161,0.002311641,0.000069735106,0.000014401632,0.00001311903,0.00030806515,0.00018996318,0.93564034,0.00039701763,0.05929972,0.00035234872],"about_ca_topic_score_codex":0.0034209674,"about_ca_topic_score_gemma":0.00032294978,"teacher_disagreement_score":0.023396254,"about_ca_system_score_codex":0.00025921664,"about_ca_system_score_gemma":0.0011671262,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W2078950638","doi":"10.1158/0008-5472.can-06-2217","title":"Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase–Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer research; Biology; Gonadotropin-releasing hormone; Cell migration; Matrix metalloproteinase; Endocrinology; Internal medicine; Chemistry; Cell; Cancer; Medicine; Hormone; Luteinizing hormone","score_opus":0.03009958796958749,"score_gpt":0.33148329635806395,"score_spread":0.30138370838847645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078950638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859093,0.011977679,0.00059079216,0.0002579617,0.00006505499,0.00080307067,0.00009435759,0.000013018527,0.00028878887],"genre_scores_gemma":[0.995447,0.002320428,0.00060775573,0.000038882103,0.00046361625,0.00043101306,0.0001293011,0.000042092513,0.0005199148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812055,0.00020043753,0.00028183518,0.0005054451,0.0004163401,0.00047537618],"domain_scores_gemma":[0.99903417,0.000027815473,0.00013485867,0.00032555257,0.00038233172,0.00009527632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027917477,0.00020181545,0.00023580482,0.00007675812,0.00019372757,0.000047022946,0.00021312814,0.00021400054,0.000080260754],"category_scores_gemma":[0.00007505331,0.00019044966,0.00006801723,0.0002601626,0.00020013397,0.000036263722,0.00018926129,0.00022861606,0.0000031127577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003746657,0.000117372576,0.00012218794,0.0002123682,0.000036928668,0.000014010856,0.000046957302,0.000016484533,0.997039,0.00021733901,0.00045757153,0.0013451067],"study_design_scores_gemma":[0.0010376719,0.00040906668,0.00091141404,0.0001370092,0.000021161031,0.0000051672355,0.000070159265,0.00004299469,0.99379414,0.00061374536,0.0027431338,0.00021433647],"about_ca_topic_score_codex":0.010598672,"about_ca_topic_score_gemma":0.00026255424,"teacher_disagreement_score":0.010336117,"about_ca_system_score_codex":0.00011773789,"about_ca_system_score_gemma":0.00048242733,"threshold_uncertainty_score":0.99598986},"labels":[],"label_agreement":null},{"id":"W2079360025","doi":"10.1158/1538-7445.am2012-943","title":"Abstract 943: Characterization of RET and integrin signaling in thyroid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen's University","funders":"","keywords":"Thyroid carcinoma; Thyroid; Cancer research; Tissue microarray; Medullary carcinoma; Proto-Oncogene Proteins c-ret; Biology; Tyrosine kinase; Integrin; Neural crest; Pathology; Medicine; Receptor tyrosine kinase; Phenotype; Immunohistochemistry; Internal medicine; Receptor; Gene; Genetics","score_opus":0.08063573989715536,"score_gpt":0.3998649134784605,"score_spread":0.3192291735813051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079360025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506676,0.0034761403,0.000002274258,0.0006922687,0.000052779,0.00033701994,0.000014002236,0.000012133732,0.0003466373],"genre_scores_gemma":[0.99748963,0.0019826463,0.000030062236,0.000040434352,0.00017594775,0.00016017926,0.000014583962,0.000019835412,0.00008668998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898297,0.00004501598,0.00019535788,0.00015396834,0.00030478465,0.0003179112],"domain_scores_gemma":[0.9994955,0.00007640687,0.00004402609,0.00014421453,0.00010487628,0.00013497208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060158875,0.00007651615,0.00019919574,0.00019134882,0.00003062569,0.000010244547,0.000045899298,0.00004886536,0.0001471143],"category_scores_gemma":[0.000051874165,0.00006171696,0.000025215766,0.00026907175,0.0000829185,0.00011401187,0.000036920595,0.00025554793,0.000007549161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017594588,0.00019699759,0.3213012,0.00016347338,0.00002224604,0.000010671254,0.00091883546,0.0000019242966,0.6678235,0.00018587586,0.00009098937,0.00910837],"study_design_scores_gemma":[0.00074673584,0.00013076147,0.7289043,0.00045322668,0.000008020174,0.0000033680772,0.00018859991,0.000004192207,0.26885682,0.000021305897,0.00063434866,0.00004828097],"about_ca_topic_score_codex":0.00071888586,"about_ca_topic_score_gemma":0.00004052512,"teacher_disagreement_score":0.4076031,"about_ca_system_score_codex":0.00024193192,"about_ca_system_score_gemma":0.00012990391,"threshold_uncertainty_score":0.25167444},"labels":[],"label_agreement":null},{"id":"W2079371087","doi":"10.1158/1538-7445.am2014-3184","title":"Abstract 3184: Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease region","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hepatitis B virus; Lymphoma; Medicine; Hepatitis B; Virology; Antigen; Immunology; Virus; Cancer; Disease; Antibody; Internal medicine","score_opus":0.02637095418322482,"score_gpt":0.32680950035326684,"score_spread":0.300438546170042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079371087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829966,0.0005266512,0.000026135569,0.00004472944,0.000057433248,0.0006761474,0.00018907881,0.000016518989,0.00016363438],"genre_scores_gemma":[0.998618,0.0007750842,0.0000096345675,0.000021642745,0.00013128888,0.00008857109,0.00010776154,0.000045588404,0.00020243194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971485,0.00021058768,0.00038892752,0.00047794584,0.0012068877,0.0005671103],"domain_scores_gemma":[0.99845976,0.00021833576,0.00013231185,0.00048666727,0.00031423074,0.00038871088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030383872,0.00019850985,0.0004835095,0.00044666545,0.00010108702,0.00002910685,0.00019247734,0.00014310186,0.00025586114],"category_scores_gemma":[0.00013561195,0.00015177859,0.00005970092,0.0003014413,0.0004328577,0.00014119764,0.00022764862,0.0002558184,0.00000940473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076661967,0.0059002787,0.92557395,0.00090051896,0.000044374785,0.00005763671,0.0005558945,0.0000032441594,0.035610475,0.000036930873,0.00051227666,0.023138233],"study_design_scores_gemma":[0.025341162,0.00043544167,0.933671,0.0008619426,0.000023583632,3.497629e-7,0.000037252168,0.00018266625,0.038474943,0.00013982492,0.0006872543,0.00014456843],"about_ca_topic_score_codex":0.005247927,"about_ca_topic_score_gemma":0.0003058809,"teacher_disagreement_score":0.022993663,"about_ca_system_score_codex":0.00027271954,"about_ca_system_score_gemma":0.0002860553,"threshold_uncertainty_score":0.79333305},"labels":[],"label_agreement":null},{"id":"W2079627692","doi":"10.1158/0008-5472.sabcs-2136","title":"Safety of the anti-IGF-1R antibody CP-751,871 in combination with exemestane in patients with advanced breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Exemestane; Medicine; Breast cancer; Tolerability; Internal medicine; Tamoxifen; Metastatic breast cancer; Oncology; Cancer; Estrogen receptor; Adverse effect","score_opus":0.016697769769858192,"score_gpt":0.33870764392506025,"score_spread":0.32200987415520205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079627692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528724,0.00040167448,0.000006636415,0.0020689478,0.000057356934,0.0013028559,0.000050486466,0.000014589922,0.0008102417],"genre_scores_gemma":[0.99895805,0.0005908524,0.00003021774,0.00013404392,0.00002959953,0.00005442596,0.000037426293,0.000026522679,0.00013887475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974692,0.00013954402,0.00036776977,0.0003701231,0.001089632,0.0005637264],"domain_scores_gemma":[0.99862236,0.000048456826,0.000112136695,0.0004313907,0.0006626328,0.00012302838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004064574,0.00018251398,0.0004101005,0.0003563978,0.000092318376,0.000013390964,0.00024346638,0.00009375195,0.00007166497],"category_scores_gemma":[0.00005271436,0.00011137859,0.000036431862,0.0019831464,0.0002461581,0.00022965678,0.000048432226,0.0006845257,0.000002109963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004189137,0.00065948477,0.97196144,0.00009857149,0.000023828334,0.000016235008,0.00045316826,0.00007830905,0.008459351,0.00011126199,0.00013916154,0.013810071],"study_design_scores_gemma":[0.009037376,0.0011979274,0.9834818,0.001080727,0.000014264194,0.0000029706132,0.00016319413,0.000032275777,0.0046244557,0.00003519105,0.00019347426,0.00013630056],"about_ca_topic_score_codex":0.0014606952,"about_ca_topic_score_gemma":0.00063418114,"teacher_disagreement_score":0.01367377,"about_ca_system_score_codex":0.00057292794,"about_ca_system_score_gemma":0.00071026786,"threshold_uncertainty_score":0.45418873},"labels":[],"label_agreement":null},{"id":"W2079631262","doi":"10.1158/0008-5472.sabcs10-pd03-06","title":"Abstract PD03-06: Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; AMPK; Cancer; Interim analysis; Protein kinase B; Endocrinology; Oncology; Insulin; Apoptosis; Kinase; Clinical trial; Protein kinase A; Biology","score_opus":0.04593141411069683,"score_gpt":0.4225587540942484,"score_spread":0.3766273399835516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079631262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9225742,0.07646257,0.0000018292791,0.000038327264,0.00033091297,0.00030120226,0.00012000604,0.0000044774592,0.00016648191],"genre_scores_gemma":[0.9118674,0.08700527,0.000036758065,0.0000745556,0.0004999814,0.00018902254,0.000011059688,0.000019233219,0.00029671594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99837875,0.00015145894,0.00030837255,0.00045023975,0.00023776157,0.00047343693],"domain_scores_gemma":[0.9990911,0.0001077951,0.0000753677,0.00036560267,0.00019476784,0.00016540526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013286142,0.00013798541,0.00028979185,0.00010496779,0.000050350238,0.000022900387,0.00028336677,0.00029345963,0.00021347149],"category_scores_gemma":[0.00021553106,0.00011206693,0.00007287271,0.00019758003,0.00055778516,0.000008907094,0.0001654901,0.00060047564,0.0000063394186],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000200861,0.00009724495,0.22509299,0.00021990862,0.000055192402,0.000007235346,0.00005858445,0.000002234777,0.59552926,0.00010197381,0.0010597673,0.17757477],"study_design_scores_gemma":[0.0013238692,0.00017280763,0.6043573,0.00006892225,0.000010456132,0.0000016385684,0.000035835696,0.000004389425,0.31457233,0.00012499047,0.079135925,0.00019151051],"about_ca_topic_score_codex":0.0017022383,"about_ca_topic_score_gemma":0.0022272817,"teacher_disagreement_score":0.37926435,"about_ca_system_score_codex":0.000015827458,"about_ca_system_score_gemma":0.00034247566,"threshold_uncertainty_score":0.4569957},"labels":[],"label_agreement":null},{"id":"W2079744640","doi":"10.1158/1538-7445.am2011-2300","title":"Abstract 2300: Insulin receptor kinase inhibition is better tolerated than hypoinsulinemia and more effective than metformin in treating breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Insulin; Insulin receptor; Metformin; Medicine; Endocrinology; Internal medicine; Breast cancer; Cancer; Tyrosine kinase; Insulin resistance; Pharmacology; Receptor","score_opus":0.033063646146610795,"score_gpt":0.3314615255950036,"score_spread":0.2983978794483928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079744640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92758685,0.07084474,0.0000045010142,0.00015037059,0.00012365865,0.00055725843,0.00039200988,0.000012675803,0.00032793923],"genre_scores_gemma":[0.9683413,0.029443277,0.000112357455,0.00034463528,0.0005932635,0.0008873565,0.00009966877,0.000049725306,0.00012844626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979423,0.00017201852,0.0002903923,0.0006552853,0.00031721202,0.0006227894],"domain_scores_gemma":[0.9990509,0.000033348748,0.000087938926,0.00031496334,0.00032214326,0.0001906885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063214026,0.00025048573,0.0002879582,0.00018539288,0.00013696878,0.000047288024,0.0001626423,0.00025983164,0.0006742205],"category_scores_gemma":[0.00006305565,0.0002227537,0.00007046,0.0004063669,0.00023041399,0.000028803688,0.00013664221,0.00043470867,0.000014346044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009768152,0.00014631738,0.038330108,0.00017719898,0.00010371286,0.0000169043,0.0018464088,0.0000056446756,0.52709854,0.000009050745,0.0039379443,0.42735136],"study_design_scores_gemma":[0.0018197175,0.00015033294,0.1694055,0.0002771961,0.000017882463,0.0000048427023,0.00039299054,0.0000254083,0.8186132,0.000075612195,0.0088778315,0.00033952613],"about_ca_topic_score_codex":0.005406677,"about_ca_topic_score_gemma":0.0014169764,"teacher_disagreement_score":0.42701185,"about_ca_system_score_codex":0.00014675986,"about_ca_system_score_gemma":0.00025111318,"threshold_uncertainty_score":0.9083632},"labels":[],"label_agreement":null},{"id":"W2079894826","doi":"10.1158/0008-5472.can-08-2755","title":"Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Child and Family Research Institute; McGill University; University of British Columbia","funders":"National Cancer Institute; Tenovus; Canadian Breast Cancer Research Alliance","keywords":"Breast cancer; Tamoxifen; Insulin-like growth factor; Cancer research; Cancer; Growth factor; Insulin-Like Growth Factor Receptor; Receptor; Internal medicine; Tissue microarray; Endocrinology; Medicine; Biology","score_opus":0.07321209807396699,"score_gpt":0.3615376137989332,"score_spread":0.2883255157249662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079894826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657282,0.009524687,0.0000013513605,0.021148851,0.0005575172,0.0015371991,0.000591244,0.00011826213,0.0007926553],"genre_scores_gemma":[0.9628199,0.029507585,0.00005004803,0.0019260802,0.0002858012,0.00032819778,0.000057994755,0.0001351591,0.0048892535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943621,0.00032202978,0.00085244153,0.001276394,0.0016633932,0.0015235993],"domain_scores_gemma":[0.9966446,0.00020735672,0.00011516956,0.0006458518,0.0012582204,0.001128756],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078073994,0.0005199579,0.00089106476,0.00090693403,0.0003034147,0.00006428442,0.00044353842,0.00051033584,0.0030997316],"category_scores_gemma":[0.00022942745,0.00046129338,0.0001508993,0.0025061672,0.0004607503,0.00031363688,0.00035868448,0.0016923904,0.00037931514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00632426,0.00083085935,0.71467817,0.0004495202,0.0007000879,0.00041082752,0.01743317,0.000009795864,0.07006156,0.00007399488,0.17683068,0.012197095],"study_design_scores_gemma":[0.006692266,0.0007769106,0.8699131,0.0005367403,0.00006133648,0.000086595595,0.00068059,0.00017107649,0.060514156,0.00011498489,0.05958671,0.00086553826],"about_ca_topic_score_codex":0.026850386,"about_ca_topic_score_gemma":0.00038313522,"teacher_disagreement_score":0.15523495,"about_ca_system_score_codex":0.001062697,"about_ca_system_score_gemma":0.0011930299,"threshold_uncertainty_score":0.9997839},"labels":[],"label_agreement":null},{"id":"W2079917842","doi":"10.1158/1538-7445.am2012-2532","title":"Abstract 2532: Integrated therapeutic antibody development at the National Research Council of Canada","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Antibody; Monoclonal antibody; Computational biology; Panning (audio); Immunization; Biology; Immunology","score_opus":0.3682078230712844,"score_gpt":0.4825595258693855,"score_spread":0.11435170279810108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079917842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9339935,0.008691315,0.0000019031928,0.0077742045,0.0001692352,0.00065014703,0.00008019576,0.00001078437,0.048628677],"genre_scores_gemma":[0.9586334,0.00055917085,0.00003825259,0.00029449182,0.00042045748,0.00016153473,0.00003841623,0.000027567032,0.03982667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9853793,0.0003636004,0.00038136166,0.00029218092,0.012227056,0.0013565223],"domain_scores_gemma":[0.9876328,0.0012685605,0.000050909224,0.00028511093,0.010343687,0.0004189507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015529984,0.0001586781,0.00026831217,0.00020008354,0.0008125221,0.000029004443,0.00043234442,0.00009722772,0.0043457462],"category_scores_gemma":[0.0013638387,0.00009391514,0.000062511775,0.0010491782,0.0008123267,0.00008153057,0.00032506217,0.0013466465,0.00014450648],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0041904994,0.00066310243,0.06228334,0.00088094274,0.0007067257,0.000051903913,0.0040953844,0.000022639048,0.4386694,0.0023834046,0.4661876,0.019865029],"study_design_scores_gemma":[0.00040018195,0.00006716971,0.20078859,0.00015448469,0.000004603881,0.000019727404,0.00047341408,0.00002020297,0.06574914,0.000067981025,0.7321539,0.00010060397],"about_ca_topic_score_codex":0.24167912,"about_ca_topic_score_gemma":0.2080566,"teacher_disagreement_score":0.3729203,"about_ca_system_score_codex":0.011114643,"about_ca_system_score_gemma":0.048654374,"threshold_uncertainty_score":0.9965644},"labels":[],"label_agreement":null},{"id":"W2079941204","doi":"10.1158/0008-5472.sabcs10-p4-11-03","title":"Abstract P4-11-03: The Impact of Fractionation on Local Relapse for Patients with Grade 3 Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lumpectomy; Medicine; Breast cancer; Mastectomy; Radiation therapy; Population; Internal medicine; Hormonal therapy; Oncology; Dose fractionation; Surgery; Cancer","score_opus":0.02542802306409509,"score_gpt":0.383046882921576,"score_spread":0.35761885985748093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079941204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972754,0.00016000053,0.000025545229,0.0010137998,0.00013990793,0.00049955864,0.000734336,0.000005091516,0.00014632675],"genre_scores_gemma":[0.9986268,0.00014523117,0.000020065365,0.00003078636,0.00033989485,0.0006256979,0.00009945405,0.000026545607,0.00008551248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891424,0.000032672717,0.000118852055,0.00028703565,0.00035130506,0.00029587158],"domain_scores_gemma":[0.99882334,0.00008567825,0.00007704582,0.00030574822,0.00064420304,0.0000639786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018962794,0.00013139623,0.00011524238,0.00005482166,0.00020501173,0.0000163429,0.00017711023,0.00009582933,0.00012695613],"category_scores_gemma":[0.00004357049,0.00007594146,0.00008363478,0.00014217402,0.00031455597,0.000008110656,0.00004649846,0.00023479109,0.0000035795724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064523355,0.0012999534,0.78802097,0.00009579741,0.0009756076,0.0000014172597,0.0002659054,0.0022157496,0.13610071,0.00022849142,0.028437747,0.03590529],"study_design_scores_gemma":[0.0014612144,0.00033167642,0.96864074,0.000034834244,0.000016276983,0.0000015002735,0.00004047183,0.000012786231,0.026909105,0.000057549147,0.0023915328,0.000102314894],"about_ca_topic_score_codex":0.0049139867,"about_ca_topic_score_gemma":0.003020559,"teacher_disagreement_score":0.18061975,"about_ca_system_score_codex":0.00017495536,"about_ca_system_score_gemma":0.0003413993,"threshold_uncertainty_score":0.742851},"labels":[],"label_agreement":null},{"id":"W2080009731","doi":"10.1158/1538-7445.am2012-3116","title":"Abstract 3116: Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Loss of heterozygosity; Ovarian cancer; Biology; Homologous recombination; Cancer research; DNA repair; Breast cancer; Gene; Genetics; Cancer; Allele","score_opus":0.028556479772308487,"score_gpt":0.3759917350272013,"score_spread":0.3474352552548928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080009731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956091,0.0035789667,0.00019001275,0.000025970641,0.00017683479,0.00021362744,0.000059558923,0.0000051710294,0.00014077364],"genre_scores_gemma":[0.9983243,0.0012766903,0.000045708814,0.0000071075992,0.00014531655,0.00007827339,0.000021691347,0.000016587366,0.00008433264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99901634,0.0000669263,0.00020887326,0.00019400258,0.00017350292,0.00034033105],"domain_scores_gemma":[0.9994734,0.000022181637,0.000050329112,0.00026522757,0.00011655359,0.0000723367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000601482,0.00008368175,0.0001393412,0.0001079185,0.000024417452,0.000003564249,0.00015293564,0.00011934675,0.00008908775],"category_scores_gemma":[0.00004667574,0.0000862103,0.00006438233,0.00010361938,0.000059251062,0.0000051210695,0.00010556491,0.00016325532,0.000001409689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054954966,0.00006833123,0.34821302,0.00017486651,0.000027343594,0.0000014988839,0.00012500497,0.0005324829,0.64967036,0.000008687872,0.00014689827,0.00097653037],"study_design_scores_gemma":[0.0002813617,0.00007005988,0.53460175,0.000043873428,0.000003890619,0.0000015745044,0.000024244306,0.000012959453,0.46462744,0.000008628938,0.00026892,0.000055309592],"about_ca_topic_score_codex":0.0017611029,"about_ca_topic_score_gemma":0.0007642298,"teacher_disagreement_score":0.18638872,"about_ca_system_score_codex":0.000080204125,"about_ca_system_score_gemma":0.000103448496,"threshold_uncertainty_score":0.35155538},"labels":[],"label_agreement":null},{"id":"W2080034938","doi":"10.1158/0008-5472.can-07-6215","title":"Dual Function of Pancreatic Endoplasmic Reticulum Kinase in Tumor Cell Growth Arrest and Survival","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University at Albany; National Institutes of Health; York University; Ariad Pharmaceuticals","keywords":"Endoplasmic reticulum; Unfolded protein response; Cancer research; Cell biology; Kinase; Apoptosis; Biology; Cell growth; Biochemistry","score_opus":0.02448635380534486,"score_gpt":0.29787994820210556,"score_spread":0.2733935943967607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080034938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949673,0.002748985,0.000013475671,0.000064527085,0.0001224385,0.00020996497,0.00004200226,0.000004839096,0.00182647],"genre_scores_gemma":[0.99634254,0.0029549757,0.000027440137,0.000024487652,0.00014209359,0.000095248266,0.00003243746,0.000018722676,0.00036207333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986086,0.00017649951,0.00020041065,0.00036002984,0.00030295434,0.00035149296],"domain_scores_gemma":[0.9993427,0.000051450646,0.000045963898,0.00023956448,0.00016719301,0.00015315681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026280302,0.000119673314,0.00017491971,0.00010683734,0.00008703992,0.000011016283,0.00010345677,0.00007048608,0.000044029908],"category_scores_gemma":[0.0001652827,0.00011136476,0.00004446022,0.00019907189,0.00035913516,0.0000057225607,0.00011814326,0.00017829236,0.0000047997564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067715556,0.00017489723,0.2080181,0.00026240828,0.000022919356,0.000130865,0.000088505374,0.000043293705,0.7888765,0.0001764925,0.0013876158,0.00014130304],"study_design_scores_gemma":[0.002265663,0.0005326732,0.10572167,0.00008937402,0.000020390306,0.000018491983,0.00036779747,0.000071353046,0.88951045,0.00014729246,0.0010215574,0.00023330364],"about_ca_topic_score_codex":0.0006932703,"about_ca_topic_score_gemma":0.00019759047,"teacher_disagreement_score":0.10229643,"about_ca_system_score_codex":0.000023125942,"about_ca_system_score_gemma":0.000244122,"threshold_uncertainty_score":0.4541323},"labels":[],"label_agreement":null},{"id":"W2080125220","doi":"10.1158/0008-5472.sabcs12-p3-12-04","title":"Abstract P3-12-04: A phase 2, multi-center, open label study evaluating the efficacy and safety of GRN1005 alone or in combination with trastuzumab in patients with brain metastases from breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Brain metastasis; Trastuzumab; Breast cancer; Internal medicine; Clinical endpoint; Oncology; Metastatic breast cancer; Phases of clinical research; Concomitant; Cancer; Toxicity; Metastasis; Clinical trial","score_opus":0.20231088575032055,"score_gpt":0.49494336067325667,"score_spread":0.2926324749229361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080125220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238396,0.00073249266,0.000008155996,0.0009191353,0.000025855672,0.004994258,0.0009173489,0.000005797405,0.000012984327],"genre_scores_gemma":[0.99841195,0.00007206116,0.0004014924,0.00007477056,0.00003135848,0.000775212,0.0001549274,0.00003298887,0.000045236113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718475,0.00065910944,0.00039339613,0.00037844747,0.0009123105,0.00047197932],"domain_scores_gemma":[0.9983584,0.0007368729,0.00014130927,0.00034634813,0.00025731165,0.00015975593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024513477,0.0001973712,0.00048807543,0.00018119438,0.00012437342,0.000046328976,0.00019518337,0.000034939778,0.00027083445],"category_scores_gemma":[0.00015610093,0.000102862236,0.000015674936,0.0005298699,0.00017584003,0.00026357328,0.00014729027,0.00037756554,0.000001416218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05016997,0.06106829,0.7514681,0.00009840616,0.0005763098,0.00003706469,0.004358852,0.00002439897,0.0003506373,0.0000048880916,0.00010906816,0.131734],"study_design_scores_gemma":[0.18859653,0.0055940594,0.8030774,0.000657107,0.0001148169,0.0000030032534,0.0015944305,0.00011642633,0.00011136819,0.0000016047302,0.00003201298,0.00010124247],"about_ca_topic_score_codex":0.024964312,"about_ca_topic_score_gemma":0.01985532,"teacher_disagreement_score":0.13842656,"about_ca_system_score_codex":0.00046684645,"about_ca_system_score_gemma":0.00043423945,"threshold_uncertainty_score":0.99802977},"labels":[],"label_agreement":null},{"id":"W2080126527","doi":"10.1158/1538-7445.prca2012-b19","title":"Abstract B19: Induction of apoptosis and antitumor activity of the AKT inhibitor AZD5363 is enhanced by combination with hormonal therapies in preclinical models of prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of British Columbia","funders":"","keywords":"LNCaP; PTEN; Prostate cancer; Cancer research; Protein kinase B; Bicalutamide; Growth inhibition; Androgen receptor; In vivo; Enzalutamide; Medicine; Cancer; Cell growth; PI3K/AKT/mTOR pathway; Apoptosis; Internal medicine; Biology; Biochemistry","score_opus":0.10309099558510108,"score_gpt":0.42445592780645836,"score_spread":0.32136493222135726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080126527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210083,0.005008797,0.000004408257,0.0014177533,0.000060731534,0.0011129068,0.00012188047,0.000004627003,0.00016804128],"genre_scores_gemma":[0.99430937,0.0050004236,0.000020199068,0.000010342125,0.000049871578,0.0002909977,0.000006478137,0.000018036542,0.00029427392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981293,0.00013888172,0.000288206,0.0002297874,0.00085376494,0.0003600764],"domain_scores_gemma":[0.9988519,0.0001420552,0.00016780592,0.00022848173,0.0005110955,0.00009864489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008484374,0.00011828713,0.00034323698,0.00017329573,0.00006270172,0.000008064793,0.000103027174,0.00009768641,0.0000705825],"category_scores_gemma":[0.00004474097,0.00007101816,0.000047843685,0.00057017815,0.0007347743,0.00031449462,0.00007462091,0.00045697237,2.8110395e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039569326,0.0008595561,0.10901787,0.00067900354,0.00015340626,2.1986082e-7,0.0037040582,0.000012232307,0.86095196,0.000032818025,0.00042354682,0.020208368],"study_design_scores_gemma":[0.0024098312,0.00046514402,0.16727452,0.00054863916,0.000021243164,4.1798864e-7,0.00032947687,0.000034125645,0.82872653,0.00010204288,0.000029526786,0.0000585226],"about_ca_topic_score_codex":0.0023417166,"about_ca_topic_score_gemma":0.00009463449,"teacher_disagreement_score":0.05825664,"about_ca_system_score_codex":0.00021724138,"about_ca_system_score_gemma":0.00056102837,"threshold_uncertainty_score":0.35399905},"labels":[],"label_agreement":null},{"id":"W2080129684","doi":"10.1158/1538-7445.am2011-1373","title":"Abstract 1373: Identification of potential anti-tumor therapeutics targeting the Six1 transcriptional complex","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Homeobox; Cancer research; Carcinogenesis; In silico; Breast cancer; Cancer; Transcription factor; Biology; Metastasis; Computational biology; Gene; Genetics","score_opus":0.14999278858897833,"score_gpt":0.3735884610470238,"score_spread":0.22359567245804549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080129684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961444,0.0014817357,0.000538948,0.00023496206,0.00011581553,0.00027226395,0.00009290395,0.0000061084597,0.00111285],"genre_scores_gemma":[0.99893755,0.00034633582,0.000094989846,0.00007955386,0.00025162596,0.00006645045,0.00006284399,0.000015385414,0.0001452784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890673,0.0001226652,0.00021909305,0.0002053186,0.00030010391,0.00024610336],"domain_scores_gemma":[0.99933755,0.000012921269,0.00007130113,0.0002390151,0.00029882905,0.00004040127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008697741,0.00007480732,0.0000776025,0.00003794546,0.00018475488,0.00002143541,0.00033058345,0.000059250047,0.00040801882],"category_scores_gemma":[0.000025424839,0.000057180478,0.00007065643,0.00010755238,0.00027076132,0.000004579712,0.000050649745,0.00018026867,0.000013874057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008044458,0.000052899748,0.00049384026,0.000034543842,0.00003842166,0.000001179492,0.00024058066,0.00001484164,0.9968504,0.00034420876,0.00049148337,0.0013571895],"study_design_scores_gemma":[0.00018815802,0.000059480975,0.038674176,0.000009819998,0.0000074957247,0.0000023923285,0.00023605055,0.00004563953,0.951722,0.00030698674,0.008676263,0.00007154101],"about_ca_topic_score_codex":0.00012286266,"about_ca_topic_score_gemma":0.0000135798355,"teacher_disagreement_score":0.045128368,"about_ca_system_score_codex":0.000012829299,"about_ca_system_score_gemma":0.00013528479,"threshold_uncertainty_score":0.44675198},"labels":[],"label_agreement":null},{"id":"W2080171336","doi":"10.1158/1538-7445.am2013-5620","title":"Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Neuroblastoma; In vivo; Nanocarriers; Phage display; Cancer research; Ex vivo; In vitro; Doxorubicin; Biology; Molecular biology; Cell culture; Chemistry; Pharmacology; Peptide; Drug; Biochemistry; Chemotherapy","score_opus":0.03696372408983262,"score_gpt":0.39246272395004084,"score_spread":0.3554989998602082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080171336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945204,0.0004913207,0.0000025504294,0.0020968956,0.000105866835,0.0020767709,0.00002860339,0.00003482818,0.0006427169],"genre_scores_gemma":[0.9981897,0.00017112547,0.00006290493,0.0000926626,0.00012423801,0.00060913095,0.000013173079,0.000058018188,0.00067907444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961233,0.0005106412,0.00051885523,0.00057743746,0.0012190589,0.0010507205],"domain_scores_gemma":[0.99697274,0.0017038238,0.00012146391,0.00051791756,0.0002930466,0.0003909989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020194051,0.000246695,0.00047785003,0.0002721876,0.00022626166,0.00007772829,0.00041105907,0.00009047239,0.00044182147],"category_scores_gemma":[0.0016582973,0.00015107,0.0001930057,0.00066566886,0.00061472633,0.00020438716,0.00028273996,0.0013402834,0.00015213674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001429171,0.00026246218,0.040724207,0.00065161515,0.00016463546,0.00020651275,0.00035989337,0.000056257464,0.9449593,0.000005729646,0.0043563484,0.0068238755],"study_design_scores_gemma":[0.0065148273,0.0015351892,0.3723896,0.0008190615,0.000043151962,0.000022366452,0.000266458,0.00055634434,0.6172732,0.000029392366,0.0003685907,0.00018182547],"about_ca_topic_score_codex":0.0018201016,"about_ca_topic_score_gemma":0.00007775667,"teacher_disagreement_score":0.3316654,"about_ca_system_score_codex":0.00018001997,"about_ca_system_score_gemma":0.00029083932,"threshold_uncertainty_score":0.61604553},"labels":[],"label_agreement":null},{"id":"W2080593350","doi":"10.1158/1538-7445.cansusc14-35","title":"Abstract 35: Novel genetic and clinical determinants of Constitutional Mismatch Repair Deficiency syndrome: Report from the CMMRD consortium","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"PMS2; MSH6; Lynch syndrome; Microsatellite instability; Medicine; MLH1; Germline mutation; Germline; Cancer; Genetic testing; Asymptomatic; DNA mismatch repair; MSH2; Internal medicine; Oncology; Mutation; Allele; Colorectal cancer; Genetics; Gene; Biology; Microsatellite","score_opus":0.12417976929699713,"score_gpt":0.4417877204325879,"score_spread":0.31760795113559076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080593350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947542,0.0021913534,0.000100938785,0.0004596543,0.00052894925,0.0005838237,0.000069070484,0.000027825065,0.001284194],"genre_scores_gemma":[0.99771655,0.00045530344,0.0011629849,0.00013497753,0.00021613203,0.00007642405,0.000007152062,0.000017353535,0.00021312636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971544,0.00014150603,0.00076147664,0.00056104874,0.0009653292,0.0004162269],"domain_scores_gemma":[0.9968596,0.0015523504,0.00017579147,0.0007013918,0.0004876818,0.00022316436],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002102081,0.00014488329,0.00041732538,0.000071659575,0.00016243217,0.00002021733,0.00023852773,0.00017414326,0.00057947374],"category_scores_gemma":[0.0023612813,0.000101943784,0.00012497495,0.00024179793,0.003274907,0.00003043704,0.00017744087,0.00060529204,0.00001774576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024138449,0.00016307116,0.9793048,0.00013225741,0.00006619417,0.0002034616,0.00007797318,0.0000101131045,0.009417466,0.000058221518,0.0025015988,0.007823447],"study_design_scores_gemma":[0.0009935711,0.0003276625,0.9900713,0.000298795,0.000060873055,0.0006359231,0.00007044342,0.00021016247,0.0027416667,0.00016692674,0.0043116426,0.000111016416],"about_ca_topic_score_codex":0.0015966188,"about_ca_topic_score_gemma":0.0003172104,"teacher_disagreement_score":0.010766504,"about_ca_system_score_codex":0.00012367706,"about_ca_system_score_gemma":0.0014125708,"threshold_uncertainty_score":0.99943763},"labels":[],"label_agreement":null},{"id":"W2080727558","doi":"10.1158/1538-7445.am2012-466","title":"Abstract 466: Synthetic triterpenoids target cell migration and cell adhesion via GSK3β","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Focal adhesion; Paxillin; IQGAP1; PTK2; Cell biology; GSK-3; Cell migration; Cell adhesion; Chemistry; Biology; Biochemistry; Phosphorylation; Cell; Cytoskeleton; Protein kinase A","score_opus":0.02830520753558344,"score_gpt":0.3204126542851789,"score_spread":0.29210744674959543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080727558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820363,0.015683241,0.000060213944,0.00051760685,0.00016618543,0.00022869869,0.000024063436,0.000007680963,0.001276016],"genre_scores_gemma":[0.99348694,0.0024636828,0.0001958148,0.000051204486,0.000636309,0.000047968155,0.000028722325,0.000024692186,0.0030646487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986687,0.000121910794,0.00013475584,0.00033596155,0.0002579008,0.0004807836],"domain_scores_gemma":[0.9993555,0.000047183927,0.000040527266,0.0002978975,0.000100544654,0.00015834729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062814704,0.00012929707,0.00012000866,0.00007241723,0.00017737747,0.000044541404,0.00014379737,0.00016487388,0.00018768465],"category_scores_gemma":[0.000053681957,0.00010882554,0.00005214739,0.00010227634,0.00012200509,0.000017170576,0.000109695706,0.0002396781,0.000028128956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011125057,0.000077676224,0.0017000312,0.00008878916,0.000007911678,8.082192e-7,0.00009552664,0.0000014834548,0.9861791,0.0000034190666,0.002991632,0.008742365],"study_design_scores_gemma":[0.00017125043,0.0001035709,0.003797599,0.000013850179,0.0000058017163,0.000002202757,0.000121029174,0.000009534304,0.9275951,0.000025161775,0.068016924,0.00013799593],"about_ca_topic_score_codex":0.00038854132,"about_ca_topic_score_gemma":0.000028917184,"teacher_disagreement_score":0.06502529,"about_ca_system_score_codex":0.0000425077,"about_ca_system_score_gemma":0.000052210213,"threshold_uncertainty_score":0.44377765},"labels":[],"label_agreement":null},{"id":"W2080761866","doi":"10.1158/0008-5472.can-06-1637","title":"Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in <i>Nkx3.1; Pten</i> Mice","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"PTEN; Prostate cancer; Intraepithelial neoplasia; Androgen; Prostate; Cancer research; Cancer; Carcinogenesis; Biology; Medicine; Internal medicine; Oncology; Hormone; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology","score_opus":0.05460971642570126,"score_gpt":0.4281768162950432,"score_spread":0.37356709986934195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080761866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678087,0.027938524,0.0000010531024,0.000875542,0.00008476241,0.0015606974,0.00016985674,0.000018752076,0.0015420901],"genre_scores_gemma":[0.98068,0.010558909,0.00007026785,0.0000118861235,0.00009734689,0.00073117303,0.00002834616,0.000037778253,0.007784289],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99620456,0.00018669225,0.0005259961,0.0005229363,0.0017327421,0.00082708494],"domain_scores_gemma":[0.99818176,0.00010495233,0.00015119245,0.00039811325,0.0009855884,0.00017837947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009799057,0.00019149829,0.00046378502,0.00046939752,0.000108844,0.000014027249,0.00029293573,0.00015333075,0.00069437065],"category_scores_gemma":[0.00005509827,0.00014627504,0.0000856539,0.0013937748,0.0006333742,0.00016340245,0.00027117878,0.0005652555,0.000011938817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021500564,0.00028339436,0.69158286,0.00076356926,0.000046476158,0.000097414224,0.00066455937,0.00003203697,0.29196462,0.000030036688,0.0028518469,0.009533119],"study_design_scores_gemma":[0.0031711054,0.00061678234,0.1317898,0.0014823315,0.000024761472,0.0000054337797,0.00029420067,0.000039993058,0.8607357,0.00016361561,0.0015131449,0.00016313486],"about_ca_topic_score_codex":0.016275218,"about_ca_topic_score_gemma":0.0021464755,"teacher_disagreement_score":0.56877106,"about_ca_system_score_codex":0.00038273458,"about_ca_system_score_gemma":0.0013087223,"threshold_uncertainty_score":0.9902755},"labels":[],"label_agreement":null},{"id":"W2080856530","doi":"10.1158/1538-7445.am10-3109","title":"Abstract 3109: Myc confers aggressive medulloblastoma phenotypes by regulating cell migration and adhesion genes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Cell migration; Cell culture; Phenotype; Cell growth; Gene; Genetics","score_opus":0.045072217860446864,"score_gpt":0.40630516272781025,"score_spread":0.3612329448673634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080856530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887427,0.0059510223,0.0000010804179,0.0027144062,0.00024049723,0.00043137747,0.000025699632,0.000029242654,0.0018639741],"genre_scores_gemma":[0.9941354,0.0022527913,0.00008852143,0.000103437036,0.0004400021,0.00013199136,0.000043377077,0.00002298522,0.0027814982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882615,0.000049992283,0.00014801325,0.00030192515,0.0003389635,0.00033495476],"domain_scores_gemma":[0.9991506,0.00017837733,0.00008160868,0.00015696426,0.00023181445,0.00020066142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027168295,0.00011914236,0.00017739553,0.00011640844,0.00019053365,0.000033419627,0.000068731715,0.00012352962,0.0012694856],"category_scores_gemma":[0.000052168285,0.00009865665,0.000034097076,0.00014976058,0.00022964072,0.00007841071,0.000042447984,0.0004669496,0.000028048622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048462092,0.00008475407,0.012318123,0.00011218663,0.000033947228,0.000024154448,0.00036019756,0.0000012397749,0.92805773,0.000018901159,0.020143803,0.03836036],"study_design_scores_gemma":[0.0021876954,0.00039152626,0.019864745,0.000110203924,0.00005085659,0.000015317735,0.00021273788,0.00009763563,0.93335545,0.00007484889,0.043512244,0.00012674485],"about_ca_topic_score_codex":0.0016883616,"about_ca_topic_score_gemma":0.0015021312,"teacher_disagreement_score":0.038233615,"about_ca_system_score_codex":0.000112968846,"about_ca_system_score_gemma":0.00026490187,"threshold_uncertainty_score":0.9996435},"labels":[],"label_agreement":null},{"id":"W2081011802","doi":"10.1158/1538-7445.am2011-1644","title":"Abstract 1644: siRNA targeting of cell cycle kinase Wee1 inhibits hepatocullar carconima growth <i>in vitro</i> and <i>in vivo</i>","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Wee1; Cell cycle; Cancer research; Gene silencing; Biology; Small interfering RNA; Cell cycle checkpoint; Cell growth; Gene knockdown; Kinase; Cyclin-dependent kinase 1; Apoptosis; Chemistry; Molecular biology; Cell biology; Cell culture; Transfection; Gene; Biochemistry; Genetics","score_opus":0.0343672369633217,"score_gpt":0.30595678515388286,"score_spread":0.27158954819056114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081011802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851764,0.0054217125,0.000008803167,0.00007169594,0.000038721028,0.00025867147,0.00005831353,0.0000037259658,0.0056207282],"genre_scores_gemma":[0.9961493,0.0031797825,0.00019307704,0.000045721452,0.0000750634,0.00013505846,0.00001318971,0.000024585117,0.00018420226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998605,0.000086900574,0.0002744942,0.00039785454,0.00021807197,0.00041764],"domain_scores_gemma":[0.99937826,0.00001980665,0.000063627136,0.00025019937,0.00018595306,0.000102137456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063414307,0.00012111665,0.00016388393,0.00013010786,0.00006081278,0.000015706175,0.00021023305,0.00012618725,0.0000748964],"category_scores_gemma":[0.000045795605,0.00012141058,0.000043355656,0.00026818356,0.00018375259,0.0000110891,0.00012740014,0.00024146402,0.0000032392456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023261578,0.00009864501,0.0068713683,0.000105467276,0.000006442289,0.000009204392,0.00020555455,0.000010783771,0.9912774,0.000024619165,0.0005030515,0.0006548754],"study_design_scores_gemma":[0.0006143065,0.00006180209,0.0039034875,0.000039767016,0.0000024452922,8.836941e-7,0.00021231723,0.000026694357,0.9932205,0.00008749706,0.0016995464,0.00013072588],"about_ca_topic_score_codex":0.0030357703,"about_ca_topic_score_gemma":0.00033337894,"teacher_disagreement_score":0.0076316916,"about_ca_system_score_codex":0.000052265164,"about_ca_system_score_gemma":0.00020393224,"threshold_uncertainty_score":0.495098},"labels":[],"label_agreement":null},{"id":"W2081098836","doi":"10.1158/0008-5472.can-03-2031","title":"Accelerated Induction of Bladder Cancer in <b> <i>Patched</i> </b> Heterozygous Mutant Mice","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Occupational Cancer Research Centre","funders":"National Cancer Institute","keywords":"Carcinogenesis; Patched; Bladder cancer; Cancer; Mutant; Cancer research; Wild type; Tumor suppressor gene; Suppressor; Nitrosamine; Basal (medicine); Biology; Pathology; Gene; Internal medicine; Endocrinology; Medicine; Carcinogen; Genetics","score_opus":0.10159924432278329,"score_gpt":0.40621107772822684,"score_spread":0.30461183340544357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081098836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948246,0.003906881,0.000045145134,0.00047731955,0.0001770372,0.00027484077,0.00004945789,0.000008988282,0.0002357349],"genre_scores_gemma":[0.9971414,0.0020472968,0.0000371767,0.00007566128,0.00024581136,0.0002190061,0.00001265171,0.00002754387,0.00019342074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985398,0.000107782005,0.00023828348,0.00038521033,0.00029951133,0.0004294303],"domain_scores_gemma":[0.99923164,0.000013909588,0.00005148097,0.00024601,0.00038898704,0.00006800227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041683728,0.0001252903,0.00017819644,0.0001341769,0.00007792109,0.000014876258,0.00022466305,0.0001537705,0.00006233318],"category_scores_gemma":[0.0000926895,0.0001191508,0.000044700635,0.00048979535,0.00021833042,0.0000056231593,0.000147134,0.0002834871,0.000008698351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012846217,0.000071670765,0.0015032599,0.000041843276,0.000051047202,0.0000094903135,0.0004256208,0.0022225736,0.99327147,0.000007771507,0.00026993785,0.0019968448],"study_design_scores_gemma":[0.0008907322,0.00016732479,0.0021947536,0.00008883151,0.0000051677803,0.0000029441028,0.00029136604,0.0000050152953,0.9940221,0.00006980704,0.0021336586,0.00012831688],"about_ca_topic_score_codex":0.0033656508,"about_ca_topic_score_gemma":0.002517709,"teacher_disagreement_score":0.0023168358,"about_ca_system_score_codex":0.00017161627,"about_ca_system_score_gemma":0.00054749794,"threshold_uncertainty_score":0.50878793},"labels":[],"label_agreement":null},{"id":"W2081166852","doi":"10.1158/1538-7445.am2011-3038","title":"Abstract 3038: Characterization of ZHX1 in node-negative breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Lymphovascular invasion; Transcription factor; Metastasis; Cancer; Cancer research; Oncology; Medicine; Biology; Tissue microarray; Gene; Internal medicine; Pathology; Genetics","score_opus":0.050445107014978466,"score_gpt":0.3543129234053671,"score_spread":0.3038678163903886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081166852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979109,0.00034144727,0.000037628106,0.00018262118,0.0001404718,0.00029262388,0.0001623215,0.000005394515,0.00092656584],"genre_scores_gemma":[0.99788815,0.0011751712,0.000029666808,0.000021900994,0.00023454594,0.00016753226,0.000065401415,0.000024863552,0.00039279062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988425,0.00007507197,0.0002227884,0.00031100208,0.00025567785,0.00029298544],"domain_scores_gemma":[0.99921227,0.00001016312,0.00009008439,0.00025973035,0.0003649418,0.000062811574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031122213,0.00010056043,0.00012828976,0.00014731576,0.000042552627,0.0000085556885,0.00017783197,0.00016057292,0.000694057],"category_scores_gemma":[0.000028239147,0.000101937716,0.000041670624,0.0003619025,0.0001565804,0.000011243012,0.00007812021,0.00018533316,0.000008512709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003808094,0.000056846384,0.013765481,0.00004638483,0.000032701595,0.0000011341401,0.0003409082,0.00008185077,0.9745713,0.000018953575,0.00022776508,0.010475848],"study_design_scores_gemma":[0.0003349163,0.000033500575,0.44916072,0.000072592484,0.0000030263236,0.0000012261673,0.00003376754,0.000028848688,0.5497816,0.000034745466,0.0004371632,0.00007784564],"about_ca_topic_score_codex":0.0036139358,"about_ca_topic_score_gemma":0.0018139774,"teacher_disagreement_score":0.43539524,"about_ca_system_score_codex":0.00014280854,"about_ca_system_score_gemma":0.0003771299,"threshold_uncertainty_score":0.75994366},"labels":[],"label_agreement":null},{"id":"W2081167504","doi":"10.1158/1538-7445.am10-4467","title":"Abstract 4467: Differential response of ERa-targeted therapy in breast and ovarian cancer cells by 17b-estradiol-linked platinum(II) hybrid (E2-Pt(II)), VP-128","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Cisplatin; Ovarian cancer; Breast cancer; Cancer research; Cancer cell; In vivo; XIAP; Apoptosis; In vitro; Chemistry; Western blot; Protein kinase B; Cancer; Molecular biology; Internal medicine; Biology; Medicine; Caspase; Chemotherapy; Programmed cell death; Biochemistry","score_opus":0.06895469401684566,"score_gpt":0.35235846179463814,"score_spread":0.28340376777779247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081167504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225295,0.0031065866,0.0000019343206,0.0027328564,0.0002944897,0.00077266013,0.00048248802,0.000026863032,0.00032918964],"genre_scores_gemma":[0.99587774,0.0019342118,0.00008351312,0.000078639874,0.00032606957,0.00018743335,0.000029852252,0.00005872479,0.0014238082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970425,0.000378724,0.00052948954,0.00054672436,0.00081946113,0.0006831179],"domain_scores_gemma":[0.99835724,0.00038657893,0.00011801712,0.0005420944,0.00029792346,0.00029816982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015558988,0.00027806402,0.0006338042,0.00034478403,0.00028751808,0.000055715856,0.0003065842,0.000168557,0.004559891],"category_scores_gemma":[0.00014554961,0.00020798136,0.000103504346,0.00033364506,0.0005267825,0.000119540455,0.00014043796,0.0013149269,0.000007107621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010094929,0.00026699062,0.006094264,0.00013641783,0.00010261007,0.000024075222,0.0007899312,0.0000019686129,0.9612402,0.000017961938,0.0040233093,0.017207377],"study_design_scores_gemma":[0.0026534896,0.0005176614,0.30946934,0.00026820268,0.000017356415,0.000026189231,0.000078612786,0.00011701882,0.680685,0.0000667007,0.0058763307,0.0002241039],"about_ca_topic_score_codex":0.0065938695,"about_ca_topic_score_gemma":0.00046043337,"teacher_disagreement_score":0.30337507,"about_ca_system_score_codex":0.00011888748,"about_ca_system_score_gemma":0.0007078541,"threshold_uncertainty_score":0.99680024},"labels":[],"label_agreement":null},{"id":"W2081229942","doi":"10.1158/1538-7445.am2011-317","title":"Abstract 317: 1q32.1 and 16q21 genomic alterations implicate KIF14/MDM4/PIK3C2ß and CDH11 as independent prognostic markers of relapse in localized Ewing Family of Tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Centrosome; Biology; Comparative genomic hybridization; Fluorescence in situ hybridization; Interphase; In situ hybridization; Oncology; Biomarker; Pathogenesis; Tumor progression; Internal medicine; Cancer research; Pathology; Cancer; Gene; Medicine; Genetics; Chromosome; Cell cycle; Immunology; Gene expression","score_opus":0.05179070001556365,"score_gpt":0.33960193327157684,"score_spread":0.2878112332560132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081229942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933149,0.0050913487,0.00003298432,0.000061320636,0.000046100664,0.0004766544,0.00007926571,0.00000272559,0.0008946672],"genre_scores_gemma":[0.99467057,0.004792349,0.00023260449,0.00004880892,0.000045844226,0.00011653351,0.000022944394,0.000024813706,0.00004555257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867594,0.00006795279,0.00035905305,0.00038442347,0.00018668157,0.00032596718],"domain_scores_gemma":[0.99921167,0.000086144144,0.00009935503,0.0002946883,0.0001747547,0.00013341721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005760819,0.00012850476,0.00022206786,0.00015793189,0.00006169836,0.00002120459,0.00017876382,0.000116685005,0.000035846573],"category_scores_gemma":[0.00020145648,0.00013186039,0.00004018467,0.0001495875,0.00030721867,0.000007577237,0.00023998441,0.00020813494,0.0000018140846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006085299,0.00008783745,0.06406399,0.00015226193,0.00005511648,0.0000140806,0.00042397375,0.000057573,0.93020123,0.00026345067,0.0002558505,0.0038160984],"study_design_scores_gemma":[0.002417295,0.00086023007,0.63627774,0.00025324593,0.000032269196,0.000018604245,0.00082373625,0.00010091186,0.35594648,0.0011823985,0.0017504577,0.0003366423],"about_ca_topic_score_codex":0.0032435071,"about_ca_topic_score_gemma":0.00079985335,"teacher_disagreement_score":0.57425475,"about_ca_system_score_codex":0.00005691541,"about_ca_system_score_gemma":0.00043009073,"threshold_uncertainty_score":0.537711},"labels":[],"label_agreement":null},{"id":"W2081240150","doi":"10.1158/0008-5472.sabcs10-p1-01-18","title":"Abstract P1-01-18: Survey of the Current Practice of Sentinel Lymph Node Biopsy in Latin America","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Sentinel lymph node; Breast cancer; Subspecialty; General surgery; Latin Americans; Sentinel node; Biopsy; Cancer; Family medicine; Surgery; Radiology; Internal medicine","score_opus":0.2646443390772213,"score_gpt":0.5063186613718916,"score_spread":0.24167432229467034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081240150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028784,0.001132331,0.0000058338637,0.0013895957,0.00024044073,0.0002541955,0.000051144623,0.000006552738,0.0066320403],"genre_scores_gemma":[0.9991253,0.00037220508,0.00014191678,0.00009430004,0.00010687223,0.00003318161,0.000008265603,0.000013773826,0.00010416852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976991,0.00022417011,0.00038326837,0.0002476839,0.0010588146,0.00038697763],"domain_scores_gemma":[0.9976682,0.00061475305,0.00019129421,0.0005235102,0.00089457346,0.000107668704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023212375,0.00009797115,0.00027315694,0.00014605385,0.000055859353,0.000013237001,0.00032883423,0.000066046865,0.00043555614],"category_scores_gemma":[0.0034563616,0.00006975739,0.000061978935,0.0012742054,0.00040674352,0.000102615384,0.00015577681,0.0009836517,0.000013471834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006064122,0.00016609706,0.8908623,0.00018974177,0.000024690062,0.000012885792,0.00021089485,0.000033228687,0.07941311,0.000030978645,0.0019210848,0.026528591],"study_design_scores_gemma":[0.0006330083,0.000016361708,0.98838985,0.0003991649,0.000011719023,0.000005921608,0.00019855157,0.000094737035,0.0067178416,0.00001649588,0.0034535613,0.00006280478],"about_ca_topic_score_codex":0.043674007,"about_ca_topic_score_gemma":0.0007084649,"teacher_disagreement_score":0.09752754,"about_ca_system_score_codex":0.0001227146,"about_ca_system_score_gemma":0.0010971379,"threshold_uncertainty_score":0.9626942},"labels":[],"label_agreement":null},{"id":"W2081358841","doi":"10.1158/1538-7445.am10-3168","title":"Abstract 3168: Knock down of m-calpain in a mouse breast carcinoma cell line reduced tumor growth in mouse engraftment studies and compromises the Akt pathway and in vitro cell migration","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Calpain; Gene knockdown; Small hairpin RNA; Calpastatin; Protein kinase B; Cell biology; Biology; Cell growth; Cell culture; PI3K/AKT/mTOR pathway; Focal adhesion; Cancer research; Molecular biology; Signal transduction","score_opus":0.025337487870619495,"score_gpt":0.30480009750036086,"score_spread":0.27946260962974134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081358841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968088,0.0019887255,0.0000022479212,0.00048862176,0.0000318908,0.00060276786,0.00005045021,0.0000029136854,0.000023552477],"genre_scores_gemma":[0.99882466,0.00052320666,0.00003767453,0.000025184065,0.000061705934,0.00019382584,0.00003359364,0.000009972256,0.00029020754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989284,0.00017379239,0.00023512008,0.00028742352,0.00016470322,0.0002105157],"domain_scores_gemma":[0.99952143,0.00006012233,0.00005613237,0.00016481454,0.0001419405,0.000055569788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008049367,0.000108271845,0.00014933143,0.00014872185,0.000057686735,0.000020136828,0.00007981727,0.00008812099,0.0000065990207],"category_scores_gemma":[0.00007342729,0.00007906317,0.00002355319,0.00015589621,0.00020952054,0.000007603425,0.00009271588,0.0003004432,4.6852927e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006010104,0.0001341071,0.0058913617,0.00016754039,0.000005515399,0.0000035306439,0.00040062124,0.00003666343,0.991851,0.0000031730722,0.00008594324,0.0008195777],"study_design_scores_gemma":[0.0012574076,0.000088083485,0.028539672,0.00002267125,0.0000017981295,0.000002935495,0.00060039153,0.0001752579,0.96906084,0.000024292563,0.00014282095,0.00008381477],"about_ca_topic_score_codex":0.0013609211,"about_ca_topic_score_gemma":0.004000068,"teacher_disagreement_score":0.0227901,"about_ca_system_score_codex":0.00004728006,"about_ca_system_score_gemma":0.00012933054,"threshold_uncertainty_score":0.32241026},"labels":[],"label_agreement":null},{"id":"W2081493266","doi":"10.1158/1538-7445.am2011-3576","title":"Abstract 3576: Lapatinib in combination with doxorubicin is highly damaging to cardiac myocytes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lapatinib; Dexrazoxane; Cardiotoxicity; Doxorubicin; Pharmacology; Medicine; Myocyte; Trastuzumab; Tyrosine-kinase inhibitor; Cancer; Internal medicine; Breast cancer; Chemotherapy; Anthracycline","score_opus":0.1372126624056593,"score_gpt":0.44257092687625355,"score_spread":0.3053582644705942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081493266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97706807,0.0007060467,0.000002038508,0.0033208109,0.00015002023,0.00081656757,0.000019744914,0.000029442039,0.01788729],"genre_scores_gemma":[0.9963499,0.0003141176,0.00013216122,0.00049949734,0.00014741074,0.0004433844,0.000015699405,0.000026382315,0.002071479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986145,0.000070347196,0.0001561536,0.00030940495,0.00040439688,0.00044520717],"domain_scores_gemma":[0.99922144,0.00009774844,0.00002696977,0.0002227155,0.00024392182,0.0001871873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044969155,0.00011528057,0.00024540393,0.00037984469,0.000072270144,0.000015662463,0.0001083597,0.000055067085,0.0014678399],"category_scores_gemma":[0.000020612213,0.00009305379,0.00003431707,0.0006345356,0.000095415526,0.000087309476,0.000046855275,0.00037422183,0.00011050638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055470807,0.0011343092,0.7109624,0.00032949433,0.000314414,0.00040856606,0.01952455,0.000009467638,0.16153616,0.000576184,0.05021489,0.049442466],"study_design_scores_gemma":[0.004432932,0.0013337098,0.67430145,0.00031657176,0.000048869802,0.0000034694058,0.0006024856,0.0000125533015,0.29479098,0.0001407533,0.02383675,0.00017949408],"about_ca_topic_score_codex":0.009003289,"about_ca_topic_score_gemma":0.0007344746,"teacher_disagreement_score":0.13325483,"about_ca_system_score_codex":0.0004832175,"about_ca_system_score_gemma":0.00035067776,"threshold_uncertainty_score":0.99944496},"labels":[],"label_agreement":null},{"id":"W2081495601","doi":"10.1158/0008-5472.sabcs10-s1-1","title":"Abstract S1-1: Final Analysis of NCIC CTG MA.27: A Randomized Phase III Trial of Exemestane Versus Anastrozole in Postmenopausal Women with Hormone Receptor Positive Primary Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"","keywords":"Exemestane; Medicine; Anastrozole; Breast cancer; Internal medicine; Aromatase inhibitor; Oncology; Tamoxifen; Celecoxib; Cancer; Aromatase","score_opus":0.01571514218510403,"score_gpt":0.3453919765753511,"score_spread":0.3296768343902471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081495601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965071,0.0012931135,0.000007737947,0.000117834476,0.0001473786,0.0010571128,0.0004901535,0.00000497815,0.0003746026],"genre_scores_gemma":[0.99730396,0.001535022,0.000075064156,0.0000120382465,0.0001583762,0.0004027148,0.00032076077,0.000027256172,0.00016480012],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997745,0.000271363,0.00044808505,0.00044102676,0.0005367464,0.0005577784],"domain_scores_gemma":[0.99864686,0.00015322008,0.00021768978,0.00037556025,0.00041821445,0.0001884399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204589,0.00020935132,0.0007796251,0.00040961432,0.00005795264,0.000016373753,0.00026975464,0.00025129205,0.0003155301],"category_scores_gemma":[0.000073164236,0.00016200214,0.00014410491,0.0009722653,0.00059453753,0.0000127720095,0.00009580831,0.0006073437,0.0000023038956],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4852205,0.00039345716,0.00005567742,0.000020002122,0.00127086,0.0000115305975,0.00012277545,0.000049417613,0.51076704,0.0000070970773,0.00013401634,0.001947663],"study_design_scores_gemma":[0.7508075,0.0056201355,0.0038571134,0.000075867036,0.0005082881,0.000005266168,0.0002538734,0.000064020795,0.23834766,0.000004384915,0.00015345302,0.00030239392],"about_ca_topic_score_codex":0.0013912088,"about_ca_topic_score_gemma":0.0003185292,"teacher_disagreement_score":0.27241936,"about_ca_system_score_codex":0.00015237853,"about_ca_system_score_gemma":0.00092244294,"threshold_uncertainty_score":0.6606255},"labels":[],"label_agreement":null},{"id":"W2081516478","doi":"10.1158/0008-5472.can-12-3925","title":"β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Cancer research; Tumor progression; Mammary tumor; Cancer; Catenin; Breast cancer; Wnt signaling pathway; Metastasis; Biology; Tumor initiation; Genetically modified mouse; Signal transduction; Transgene; Cell biology; Gene; Genetics","score_opus":0.13100631178326783,"score_gpt":0.5175240876879034,"score_spread":0.38651777590463554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081516478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332862,0.0066161724,0.00007972641,0.052590966,0.00020811302,0.0032056617,0.000034825032,0.00013357181,0.0038447988],"genre_scores_gemma":[0.99195856,0.0005820102,0.0007084497,0.00091852614,0.00043628967,0.0035527474,0.000022169612,0.00008205971,0.0017391634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939724,0.000543032,0.0005440508,0.0007970693,0.0024553551,0.0016880742],"domain_scores_gemma":[0.9965458,0.0007560246,0.0000379456,0.0006485157,0.001182115,0.000829578],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024256639,0.00023259017,0.00045267757,0.0007668521,0.00017373453,0.00015790928,0.00053005037,0.00019576731,0.0074150097],"category_scores_gemma":[0.0018524226,0.00019384071,0.00010316885,0.0017292448,0.0005163866,0.00027224835,0.00043391055,0.0020385997,0.0014445318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093770475,0.0010538214,0.06486081,0.0024636928,0.00009146413,0.0021498632,0.0017542178,0.000009899434,0.71276504,0.00061867194,0.13790743,0.0753874],"study_design_scores_gemma":[0.013464323,0.004811689,0.11133107,0.017196393,0.00006562759,0.00035715775,0.003570688,0.016236478,0.713592,0.006835266,0.110548675,0.0019906443],"about_ca_topic_score_codex":0.0027619225,"about_ca_topic_score_gemma":0.00006912011,"teacher_disagreement_score":0.07339676,"about_ca_system_score_codex":0.0012886993,"about_ca_system_score_gemma":0.0021990389,"threshold_uncertainty_score":0.99933296},"labels":[],"label_agreement":null},{"id":"W2081555496","doi":"10.1158/0008-5472.sabcs12-ot1-1-07","title":"Abstract OT1-1-07: Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LTP112515)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Metastatic breast cancer; Tolerability; Internal medicine; Discontinuation; Oncology; Breast cancer; Chemotherapy; Adverse effect; Cancer","score_opus":0.10302319983605311,"score_gpt":0.44882617489008764,"score_spread":0.3458029750540345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081555496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98395365,0.00088621053,0.000018577086,0.00871872,0.00017372456,0.0026415319,0.0018906549,0.000034705616,0.001682228],"genre_scores_gemma":[0.99536806,0.0003050514,0.00013595463,0.00025343636,0.00072141,0.0022280933,0.00010997327,0.00010936282,0.00076863205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939891,0.00075948023,0.0005883718,0.00063603255,0.0024161073,0.0016108789],"domain_scores_gemma":[0.9966054,0.0007264593,0.00016181085,0.00064299995,0.0011521267,0.0007111961],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021840283,0.00035435485,0.0006775186,0.00056021643,0.00027683793,0.00006121122,0.0005177455,0.00015122285,0.020445049],"category_scores_gemma":[0.0002775742,0.00023249642,0.00011937812,0.0014510792,0.0005892706,0.00037872465,0.00019462609,0.0016679832,0.00020572341],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0099527035,0.0032352782,0.18306673,0.0034376378,0.00089323975,0.00016526674,0.027025284,0.00014469816,0.52366734,0.00038197378,0.1731347,0.07489516],"study_design_scores_gemma":[0.0025744003,0.0010422776,0.8491528,0.002243545,0.000055855904,0.000033966055,0.002126045,0.000013901218,0.13716404,0.000026330714,0.005207715,0.00035914328],"about_ca_topic_score_codex":0.015860368,"about_ca_topic_score_gemma":0.002765113,"teacher_disagreement_score":0.6660861,"about_ca_system_score_codex":0.0018729884,"about_ca_system_score_gemma":0.0011556017,"threshold_uncertainty_score":0.9906931},"labels":[],"label_agreement":null},{"id":"W2081685193","doi":"10.1158/0008-5472.can-10-0337","title":"Cancer Stem Cells Promote Tumor Vascular Development – Response","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cancer; Medicine; Cancer research; Internal medicine","score_opus":0.03221371975247626,"score_gpt":0.34590132052910516,"score_spread":0.3136876007766289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081685193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957371,0.0023335468,0.000054349304,0.00046095654,0.00067719846,0.00045288933,0.00006858309,0.000012684946,0.00020269716],"genre_scores_gemma":[0.9928284,0.0012376865,0.00055424514,0.00027247894,0.00076090434,0.0007086211,0.00001538812,0.00006249459,0.003559749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808145,0.00012260782,0.00021362309,0.00054701656,0.00042141235,0.0006138669],"domain_scores_gemma":[0.99865174,0.000050124992,0.000047944468,0.0005981627,0.00040383954,0.00024817942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012714156,0.00016706427,0.00015306426,0.00009979121,0.0002428372,0.00008061059,0.00044502647,0.00013903156,0.00025567305],"category_scores_gemma":[0.00008715838,0.00016142699,0.000072914394,0.00020834456,0.0002183409,0.0000036600986,0.00033237902,0.0004374977,0.00006609174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004099506,0.00004941408,0.0004778694,0.00003158275,0.000056665926,0.000012676753,0.00014010607,0.000057703997,0.97729224,0.00003288219,0.0086071165,0.012831791],"study_design_scores_gemma":[0.00028461352,0.00006377025,0.00086147897,0.000015212594,0.000003999792,0.0000016069511,0.00002628667,0.000008375131,0.54589844,0.000011555897,0.45269448,0.00013021159],"about_ca_topic_score_codex":0.00029044095,"about_ca_topic_score_gemma":0.0013431865,"teacher_disagreement_score":0.44408736,"about_ca_system_score_codex":0.00013053317,"about_ca_system_score_gemma":0.0020815895,"threshold_uncertainty_score":0.65828013},"labels":[],"label_agreement":null},{"id":"W2081753042","doi":"10.1158/0008-5472.can-06-2722","title":"Suppression of the Hypoxia-Inducible Factor-1 Response in Cervical Carcinoma Xenografts by Proteasome Inhibitors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Bortezomib; MG132; Proteasome inhibitor; In vivo; Hypoxia (environmental); Cancer research; Vascular endothelial growth factor; Tumor hypoxia; Hypoxia-inducible factors; Biology; Chemistry; Pharmacology; Immunology; Internal medicine; Medicine; Radiation therapy; Multiple myeloma; VEGF receptors; Biochemistry","score_opus":0.036075479050316,"score_gpt":0.3510025553392713,"score_spread":0.31492707628895533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081753042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991006,0.006747269,0.000013805083,0.0004429691,0.0008128296,0.0006506974,0.00008132289,0.0000054820716,0.00023957988],"genre_scores_gemma":[0.9970839,0.00033116768,0.00001908953,0.00006420518,0.0009230617,0.0001093859,0.000011813995,0.000029890367,0.0014274719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756634,0.00043719466,0.00030327844,0.00044836287,0.00060516066,0.0006396322],"domain_scores_gemma":[0.9988507,0.000070590766,0.0000688917,0.0006308105,0.00021586138,0.0001631354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016947552,0.0001477955,0.0001903696,0.00015817239,0.00011825185,0.00001928505,0.0004789476,0.00025505546,0.0000655596],"category_scores_gemma":[0.00032928717,0.00011079331,0.00010450064,0.00057522685,0.00028875406,0.000007708076,0.00034863286,0.00045976904,0.0000034962832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019430717,0.000081144884,0.011838887,0.000038439022,0.000009795771,0.0000014877857,0.00021908997,0.0000048156894,0.9725481,0.000006437307,0.010643734,0.002664948],"study_design_scores_gemma":[0.0006598522,0.00013721737,0.111181945,0.000044185592,0.0000025024685,0.0000021492294,0.00012338329,0.0000011810747,0.7465494,0.0000150903215,0.14118177,0.00010128827],"about_ca_topic_score_codex":0.00089183974,"about_ca_topic_score_gemma":0.00034135394,"teacher_disagreement_score":0.22599871,"about_ca_system_score_codex":0.000103588834,"about_ca_system_score_gemma":0.0005358665,"threshold_uncertainty_score":0.45180202},"labels":[],"label_agreement":null},{"id":"W2081760425","doi":"10.1158/1538-7445.am10-3173","title":"Abstract 3173: The role of the Src/Stat3 axis in autocrine HGF signalling in invasive human breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Autocrine signalling; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Oncogene; STAT3; Biology; Breast cancer; Dasatinib; Metastasis; Cancer; Signal transduction; Internal medicine; Cell culture; Medicine; Cell cycle; Cell biology","score_opus":0.059176275295398775,"score_gpt":0.40843532597112675,"score_spread":0.349259050675728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081760425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388427,0.0005362831,9.5488204e-8,0.003162134,0.0001284288,0.00052226515,0.000038627622,0.0000064626392,0.0017214315],"genre_scores_gemma":[0.998829,0.0001665783,0.0000042334677,0.00021146929,0.00025567148,0.00022369337,0.000004138062,0.000014379522,0.00029084878],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986021,0.00020969582,0.00023236324,0.00025084798,0.0002838528,0.00042114424],"domain_scores_gemma":[0.99896437,0.0003380407,0.000058443897,0.00038242797,0.00019798196,0.00005875146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086174504,0.000097872,0.00022823163,0.00014487393,0.00013117775,0.0000065714166,0.00037937667,0.00012428213,0.0015470969],"category_scores_gemma":[0.00010238462,0.000056377095,0.00005403063,0.000447133,0.0006526335,0.000049967264,0.00015393324,0.001794555,0.000014062916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020455167,0.000090476606,0.20808698,0.000065873995,0.000020743451,0.000028411401,0.0017617303,0.00006510333,0.78678143,0.000497321,0.00025208728,0.0021452908],"study_design_scores_gemma":[0.00072868523,0.000057961995,0.8994582,0.00020792767,0.000007612715,0.000012532722,0.0005552418,0.000023795084,0.09549933,0.002809762,0.0005791334,0.000059791517],"about_ca_topic_score_codex":0.0164369,"about_ca_topic_score_gemma":0.041039355,"teacher_disagreement_score":0.69137126,"about_ca_system_score_codex":0.000112846,"about_ca_system_score_gemma":0.00070253806,"threshold_uncertainty_score":0.9993656},"labels":[],"label_agreement":null},{"id":"W2081781900","doi":"10.1158/0008-5472.sabcs10-p6-09-09","title":"Abstract P6-09-09: Dual Estrogen Effects on Breast Cancer: Endogenous Estrogen Stimulates, Exogenous Estrogen Protects. Further Investigation of Estrogen Chemoprevention Is Warranted","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Estrogen; Medicine; Breast cancer; Tamoxifen; Internal medicine; Oophorectomy; Raloxifene; Selective estrogen receptor modulator; Progestin; Estrogen receptor; Endocrinology; Hormone replacement therapy (female-to-male); Cancer; Oncology; Hysterectomy","score_opus":0.026093682635591708,"score_gpt":0.31893571917583113,"score_spread":0.29284203654023944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081781900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988966,0.0065760165,0.000013759076,0.00053288747,0.00048334617,0.002702836,0.0004436461,0.00008166799,0.0001998396],"genre_scores_gemma":[0.9957262,0.0010293361,0.00024847113,0.00009037463,0.0011889266,0.0010242988,0.00031524565,0.0001975185,0.00017959502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99499184,0.00041301656,0.0007169598,0.0012833914,0.0011730904,0.0014217128],"domain_scores_gemma":[0.996904,0.00012920047,0.00038845628,0.0011970871,0.0007497481,0.00063148834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011356301,0.00067929865,0.00063414924,0.0003429617,0.0004984083,0.000097654796,0.00076439977,0.0009774534,0.00023697986],"category_scores_gemma":[0.00015347157,0.0006307623,0.0004413332,0.0007191382,0.0006092209,0.000038388218,0.0002782361,0.0015601548,0.000106071624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011109267,0.00023660519,0.009687882,0.0003779969,0.00072199816,0.00008087901,0.0004697897,0.00023173913,0.9612768,0.00007089544,0.00035685132,0.025377586],"study_design_scores_gemma":[0.0022925418,0.0010791213,0.0041189026,0.00027243124,0.00012747677,0.0002098614,0.00006266883,0.00010181674,0.9900084,0.00019358784,0.00095493626,0.0005782365],"about_ca_topic_score_codex":0.0019076277,"about_ca_topic_score_gemma":0.00007243861,"teacher_disagreement_score":0.028731568,"about_ca_system_score_codex":0.000211631,"about_ca_system_score_gemma":0.0012266837,"threshold_uncertainty_score":0.99961436},"labels":[],"label_agreement":null},{"id":"W2081986994","doi":"10.1158/1538-7445.am2013-4647","title":"Abstract 4647: Tie2-expressing monocytes (TEMs) as potential biomarkers of angiopoietin-Tie2 (Ang/Tie2) directed therapies: correlative analysis of a phase I study of AMG386 + temsirolimus (T).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Angiopoietin receptor; Angiogenesis; Medicine; Staining; Flow cytometry; Pathology; Immunology; Cancer research","score_opus":0.045644734543356685,"score_gpt":0.39386167361304203,"score_spread":0.3482169390696853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081986994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941517,0.008944018,0.000103683495,0.00003659628,0.00008863011,0.00071207306,0.00014482981,0.000010629316,0.0005443979],"genre_scores_gemma":[0.9981684,0.0009938219,0.000068705565,0.000012092241,0.00011040305,0.00020578197,0.00007370298,0.000038745125,0.00032832322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975114,0.00028275125,0.0006063445,0.000523629,0.0006458552,0.00043003363],"domain_scores_gemma":[0.99770373,0.000105091225,0.000399368,0.0006054319,0.0010597919,0.0001265993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057201483,0.00022689652,0.000565539,0.00047989847,0.00011821332,0.000029718742,0.00043269043,0.000193691,0.00083574717],"category_scores_gemma":[0.00009564868,0.0001950504,0.00035627722,0.0010900041,0.00046595765,0.000017831095,0.00018667083,0.00015708749,0.0000046078976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095727475,0.00097639795,0.014429408,0.00007550043,0.004779732,0.0000031200068,0.0013638552,0.00046097077,0.96599764,0.0000031271327,0.0018285305,0.009124428],"study_design_scores_gemma":[0.0044064443,0.0025747267,0.079921566,0.00016831014,0.00080197956,0.0000013302655,0.0119013,0.0016963937,0.8969852,0.000041848547,0.0010346796,0.0004662512],"about_ca_topic_score_codex":0.008209405,"about_ca_topic_score_gemma":0.00016506022,"teacher_disagreement_score":0.069012485,"about_ca_system_score_codex":0.000059367736,"about_ca_system_score_gemma":0.00026500336,"threshold_uncertainty_score":0.998395},"labels":[],"label_agreement":null},{"id":"W2082001543","doi":"10.1158/1538-7445.am2014-5226","title":"Abstract 5226: Liver and blood miRNA alterations as putative biomarkers of hepatotoxic response to short-term furan exposure in mice","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Carleton University","funders":"","keywords":"microRNA; Carcinogen; Biology; Fold change; Epigenetics; RNA; Microarray; Andrology; Molecular biology; Gene expression; Biochemistry; Medicine; Gene","score_opus":0.031258425379054426,"score_gpt":0.36092202882810437,"score_spread":0.32966360344904994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082001543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531585,0.0032129236,0.000025584122,0.00029023396,0.00035270324,0.0003974468,0.000074710326,0.0000040379796,0.00032652487],"genre_scores_gemma":[0.9968453,0.0014407927,0.000104040504,0.00008454389,0.0009560958,0.00016297083,0.000020191526,0.000019922069,0.00036610907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852574,0.00029993503,0.00021740315,0.00038942954,0.00023997811,0.00032752386],"domain_scores_gemma":[0.99921966,0.00010592649,0.000031772965,0.00025999828,0.0002109691,0.00017167098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010310487,0.000119671946,0.00017335553,0.00020216458,0.00007793771,0.00003099743,0.0001775272,0.000111200265,0.000046165012],"category_scores_gemma":[0.0003123262,0.00011807514,0.000047462745,0.00023139545,0.00018257668,0.000008706836,0.00010678274,0.00015961936,0.000005399399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013618915,0.00006231405,0.0038928322,0.000050032944,0.00005402058,0.0000011201836,0.0008372273,0.00001648726,0.9859168,0.000021104548,0.0015975526,0.0061886315],"study_design_scores_gemma":[0.0012986701,0.0006749513,0.14075033,0.0000998322,0.000018381676,0.0000106293255,0.0004516901,0.000016563426,0.8217002,0.00003321438,0.034714654,0.0002308434],"about_ca_topic_score_codex":0.000850733,"about_ca_topic_score_gemma":0.0016037003,"teacher_disagreement_score":0.16421655,"about_ca_system_score_codex":0.000032803768,"about_ca_system_score_gemma":0.00030485573,"threshold_uncertainty_score":0.48149645},"labels":[],"label_agreement":null},{"id":"W2082065034","doi":"10.1158/1538-7445.pedcan-a65","title":"Abstract A65: Unraveling the rhabdomyosarcoma genome using mouse mosaicism","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Rhabdomyosarcoma; KRAS; Myocyte; Biology; Cancer research; Cell sorting; Green fluorescent protein; Molecular biology; Cell; Cell biology; Pathology; Medicine; Mutation; Sarcoma; Genetics; Gene","score_opus":0.14691031099623514,"score_gpt":0.42563023762226104,"score_spread":0.2787199266260259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082065034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993754,0.0037806185,0.00005696289,0.0036842625,0.00009199697,0.0005620479,0.000012725412,0.0000365132,0.0018373525],"genre_scores_gemma":[0.99748826,0.0005302388,0.00025512386,0.00044030495,0.00059360435,0.00016440969,0.000010136391,0.000044025586,0.00047389473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979651,0.00012718452,0.0002217163,0.00033759937,0.00074191135,0.0006064949],"domain_scores_gemma":[0.99847245,0.00041932808,0.000042838346,0.0006024297,0.00025761424,0.0002053659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011311008,0.00014583777,0.00024232497,0.00015220042,0.00039107972,0.000074861484,0.00022394033,0.000077234254,0.00050250714],"category_scores_gemma":[0.00016186807,0.00009131974,0.0001046028,0.000333402,0.00019320431,0.000052104748,0.000113898415,0.0005066169,0.00014809586],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065033295,0.0014556422,0.13117884,0.00045353395,0.000780905,0.00046613332,0.0022687777,0.0011813493,0.7062968,0.003327026,0.004946896,0.14699377],"study_design_scores_gemma":[0.0069076857,0.00057706045,0.6629584,0.00075595104,0.00026458054,0.00016513621,0.0012824442,0.0043666414,0.16361135,0.0014821485,0.15692952,0.00069909834],"about_ca_topic_score_codex":0.0018504858,"about_ca_topic_score_gemma":0.000067345565,"teacher_disagreement_score":0.54268545,"about_ca_system_score_codex":0.00041197543,"about_ca_system_score_gemma":0.00023178868,"threshold_uncertainty_score":0.55021006},"labels":[],"label_agreement":null},{"id":"W2082096114","doi":"10.1158/1538-7445.am2014-lb-272","title":"Abstract LB-272: Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Linkage disequilibrium; Diffuse large B-cell lymphoma; Single-nucleotide polymorphism; Odds ratio; Genetic association; Genotyping; Biology; Genetics; Locus (genetics); Imputation (statistics); 1000 Genomes Project; Oncology; Internal medicine; Lymphoma; Medicine; Genotype; Immunology; Gene; Missing data","score_opus":0.028828888241243883,"score_gpt":0.34935241224896946,"score_spread":0.32052352400772555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082096114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907264,0.00077452126,0.0051293983,0.00032820745,0.0002456952,0.0021546688,0.00019817949,0.00003309579,0.00040981543],"genre_scores_gemma":[0.99272937,0.0003058897,0.00006277606,0.00015089697,0.0005524604,0.001073253,0.00028283888,0.00008919079,0.004753328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957641,0.00051795715,0.00039638512,0.001010435,0.0010931614,0.001217985],"domain_scores_gemma":[0.9970754,0.00041086832,0.000137762,0.00097312516,0.001143803,0.00025903853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044043586,0.00025210806,0.00029427043,0.00018834879,0.000501193,0.00019194388,0.0006653941,0.0004671891,0.00013307495],"category_scores_gemma":[0.0030761345,0.00026294205,0.00020430807,0.00033745443,0.00009728998,0.00001500914,0.0004739728,0.00049058313,0.00007430563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005912697,0.0026117512,0.013548831,0.00018208174,0.00018017307,0.000004514406,0.00027587943,0.000079465295,0.9695452,0.000010530345,0.011464541,0.0015057675],"study_design_scores_gemma":[0.017256875,0.0012921104,0.04829701,0.000027397682,0.0000438503,5.691676e-7,0.0010747191,0.00032230688,0.80817306,0.00026140362,0.12267084,0.00057987025],"about_ca_topic_score_codex":0.0006179982,"about_ca_topic_score_gemma":0.0042368155,"teacher_disagreement_score":0.16137214,"about_ca_system_score_codex":0.0007786001,"about_ca_system_score_gemma":0.00046089632,"threshold_uncertainty_score":0.9999823},"labels":[],"label_agreement":null},{"id":"W2082241903","doi":"10.1158/0008-5472.can-07-0082","title":"Targeting Multiple Arms of the Apoptotic Regulatory Machinery","year":2007,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Apoptosis; Cancer research; Lethality; Synthetic lethality; Cancer; Long-term potentiation; Biology; DNA repair; Gene; Genetics","score_opus":0.09989099309926043,"score_gpt":0.4229009395753835,"score_spread":0.3230099464761231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082241903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013078598,0.99727076,0.00010969216,0.000013389123,0.00039007748,0.0006509306,0.000032833104,0.0000047200724,0.00021975036],"genre_scores_gemma":[0.0025103563,0.99350387,0.000089138404,0.000009665804,0.00077725033,0.00008203078,0.00012507987,0.000056129335,0.002846504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998119,0.00027937326,0.000376842,0.0003974863,0.0004517753,0.00037550036],"domain_scores_gemma":[0.99887866,0.00006134283,0.00018191666,0.00061969884,0.00018979731,0.000068565736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012408345,0.00019468382,0.00042313663,0.00011672677,0.00013687703,0.0000145730555,0.00047630593,0.00039993084,0.00004573001],"category_scores_gemma":[0.00015420081,0.00012077295,0.00032965513,0.000322773,0.0001902242,0.0000015329216,0.00035481388,0.00045108955,0.000005874346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020943722,0.000038320366,0.000023786748,0.0068243854,0.00012469842,0.0000017341462,0.000022908716,0.0000834859,0.05218256,0.00010361394,0.0025498127,0.93802375],"study_design_scores_gemma":[0.0001099225,0.00003443248,0.000019920657,0.0017463962,0.000046604277,0.000004008951,0.000011657366,0.000017121509,0.0074246787,0.000024387258,0.99041325,0.00014763884],"about_ca_topic_score_codex":0.00007291888,"about_ca_topic_score_gemma":0.00002360236,"teacher_disagreement_score":0.9878634,"about_ca_system_score_codex":0.00008166144,"about_ca_system_score_gemma":0.0004602736,"threshold_uncertainty_score":0.4924978},"labels":[],"label_agreement":null},{"id":"W2082436593","doi":"10.1158/1538-7445.am10-3546","title":"Abstract 3546: Role of the “1C” Aldo-Keto Reductases in Resistance to Doxorubicin in MCF-7 breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; NOSM University; Laurentian University","funders":"","keywords":"MCF-7; Doxorubicin; Anthracycline; Epirubicin; Cancer research; Cancer cell; Daunorubicin; Pharmacology; Chemistry; Biology; Cancer; Medicine; Internal medicine; Breast cancer; Chemotherapy; Human breast","score_opus":0.017197141405367662,"score_gpt":0.34584816645809063,"score_spread":0.328651025052723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082436593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428743,0.0024958798,2.1697498e-7,0.0014058597,0.00015746534,0.00036891672,0.00018064954,0.0000031517827,0.0011004005],"genre_scores_gemma":[0.99788785,0.0005400431,0.000043031323,0.00007483245,0.00033485948,0.00019000376,0.000011110496,0.000025376698,0.00089290435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983779,0.00008448182,0.00027197794,0.00042433757,0.00034417806,0.0004971326],"domain_scores_gemma":[0.9990227,0.00002641712,0.000055796012,0.0006072063,0.00017382625,0.00011404889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005389933,0.00013616173,0.00017652339,0.0001350561,0.00007062064,0.000017844395,0.0005107958,0.00014066495,0.00020711086],"category_scores_gemma":[0.000060431972,0.00010728072,0.000052460247,0.0005194012,0.00020406424,0.0000069282983,0.0002294751,0.00050715695,0.000009956387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027292751,0.00009922317,0.005442247,0.000047499274,0.00001703018,0.000005614211,0.00015284488,0.00007468471,0.98741025,0.000042484662,0.0037691193,0.0026660832],"study_design_scores_gemma":[0.0003139896,0.000019214458,0.055172026,0.00012477177,0.0000022137885,0.000002156652,0.00016825153,0.000001105149,0.9080113,0.00006441736,0.036004115,0.0001164341],"about_ca_topic_score_codex":0.0039799004,"about_ca_topic_score_gemma":0.04098192,"teacher_disagreement_score":0.07939894,"about_ca_system_score_codex":0.000075929944,"about_ca_system_score_gemma":0.0006355437,"threshold_uncertainty_score":0.9765177},"labels":[],"label_agreement":null},{"id":"W2082645549","doi":"10.1158/0008-5472.sabcs13-p3-09-02","title":"Abstract P3-09-02: Optimal anti-emetic choice for breast cancer patients receiving anthracycline and cyclophosphamide-based chemotherapy - A systematic review and network meta-analysis of randomized controlled trials","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Nausea and vomiting management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Vomiting; Nausea; Aprepitant; Regimen; Chemotherapy-induced nausea and vomiting; Cyclophosphamide; Breast cancer; Anthracycline; Internal medicine; Randomized controlled trial; Chemotherapy; Oncology; Palonosetron; Meta-analysis; Antiemetic; Cancer","score_opus":0.20776218945235844,"score_gpt":0.493208029850567,"score_spread":0.28544584039820853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082645549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007220469,0.9523957,0.000104305596,0.00070895004,0.00006080798,0.0457114,0.00025334785,0.000023817458,0.000019639703],"genre_scores_gemma":[0.0021421579,0.9650685,0.00035430692,0.00025803348,0.00015984414,0.03158355,0.00008749481,0.00008720926,0.00025886318],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9888169,0.0037543476,0.0046980376,0.00088494015,0.0011191531,0.000726634],"domain_scores_gemma":[0.9722405,0.021941967,0.003228133,0.00075354666,0.0015330926,0.00030276232],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033817325,0.0006822198,0.043061238,0.000865402,0.00019526499,0.00012524339,0.00031084166,0.00020472564,0.0011463324],"category_scores_gemma":[0.009750977,0.00036093552,0.0055354387,0.0016348884,0.0003262263,0.000094645875,0.000090141046,0.00046477452,0.0000023607984],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068998304,0.0001912917,0.00007688831,0.6948319,0.27135277,0.0000020588534,0.000015563846,0.000032643256,0.000003892671,0.0000073069746,0.0002991188,0.026286712],"study_design_scores_gemma":[0.09898798,0.00010472574,0.00015327948,0.13029307,0.7683566,0.0000015095719,0.0000062692443,0.00025759614,0.0000031510556,0.0000047664644,0.0015143135,0.00031672453],"about_ca_topic_score_codex":0.000498695,"about_ca_topic_score_gemma":0.000024685176,"teacher_disagreement_score":0.56453884,"about_ca_system_score_codex":0.00021228171,"about_ca_system_score_gemma":0.00041851177,"threshold_uncertainty_score":0.99988425},"labels":[],"label_agreement":null},{"id":"W2082692236","doi":"10.1158/0008-5472.can-13-2351","title":"LRH-1 Governs Vital Transcriptional Programs in Endocrine-Sensitive and -Resistant Breast Cancer Cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Endocrine system; Breast cancer; Cancer; Cancer research; Medicine; Internal medicine; Oncology; Biology; Endocrinology; Hormone","score_opus":0.03083106486123527,"score_gpt":0.33054144550866554,"score_spread":0.2997103806474303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082692236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928719,0.0020433941,0.0011246884,0.0015988981,0.00020396216,0.0008517517,0.0003864733,0.000017716222,0.00090123224],"genre_scores_gemma":[0.9956928,0.0019175072,0.00008699242,0.00011476436,0.0004041076,0.00049237313,0.00006314782,0.000055617096,0.0011727135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711376,0.0003239048,0.00022056312,0.0007305546,0.0007539607,0.00085727323],"domain_scores_gemma":[0.9989683,0.000032164106,0.000035929424,0.0003378927,0.00036922313,0.0002564807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066714885,0.000205516,0.00020802952,0.0001658967,0.00013935889,0.00008530716,0.0002612391,0.00014999216,0.00012402832],"category_scores_gemma":[0.000046745303,0.00020470649,0.0000802215,0.00037496258,0.00033950715,0.000011771027,0.00020985646,0.00054271205,0.000012767243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071190717,0.0000884373,0.00017304842,0.00006798599,0.000056476514,0.000030328945,0.00008824475,0.00010133342,0.9847922,0.000474285,0.0006963141,0.012719478],"study_design_scores_gemma":[0.001924003,0.00047579245,0.004099025,0.00016175624,0.000012832972,0.00004590811,0.00025198914,0.0002708988,0.9530967,0.00015225,0.039146673,0.00036218856],"about_ca_topic_score_codex":0.0030044722,"about_ca_topic_score_gemma":0.0048839534,"teacher_disagreement_score":0.03845036,"about_ca_system_score_codex":0.00026617423,"about_ca_system_score_gemma":0.0004411935,"threshold_uncertainty_score":0.83476883},"labels":[],"label_agreement":null},{"id":"W2082765320","doi":"10.1158/0008-5472.can-11-3548","title":"Tumor-Initiating Cells in Childhood Neuroblastoma—Response","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroblastoma; Medicine; Cancer research; Biology; Oncology; Internal medicine; Genetics; Cell culture","score_opus":0.06968673253809923,"score_gpt":0.4125454724505739,"score_spread":0.3428587399124746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082765320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951341,0.0005051984,0.000001561189,0.0008599013,0.00013579009,0.0007532003,0.000022050042,0.00005175452,0.0025364575],"genre_scores_gemma":[0.99781597,0.00011250757,0.00007879103,0.00033584246,0.0003023157,0.00030061218,0.0000038799667,0.00005677969,0.0009932828],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962337,0.00070103793,0.00023772343,0.00034907708,0.0010013629,0.0014770746],"domain_scores_gemma":[0.99809843,0.00062405237,0.000031873475,0.0004000098,0.00016075672,0.0006848646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015211552,0.00016520284,0.00025599013,0.00064041367,0.0001540417,0.00003925534,0.00017712933,0.000054885975,0.0007161959],"category_scores_gemma":[0.0006083663,0.00014331802,0.000074279145,0.0009829765,0.00015669147,0.00021093723,0.00018681896,0.00097647135,0.0007413732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007559856,0.0029278279,0.109965585,0.00023821337,0.00011287821,0.0025431956,0.0018631594,0.000017595792,0.8544979,0.00008820626,0.005726074,0.014459517],"study_design_scores_gemma":[0.0035334371,0.0009448205,0.6487313,0.00026434782,0.000010802952,0.00013100923,0.00023334724,0.00002960897,0.3409499,0.000029249546,0.004984262,0.0001579453],"about_ca_topic_score_codex":0.00019980638,"about_ca_topic_score_gemma":0.000031980097,"teacher_disagreement_score":0.53876567,"about_ca_system_score_codex":0.00041509085,"about_ca_system_score_gemma":0.0005920503,"threshold_uncertainty_score":0.95291},"labels":[],"label_agreement":null},{"id":"W2082769359","doi":"10.1158/1538-7445.am10-3995","title":"Abstract 3995: Differential expression of CD10 immunohistochemistry in stroma and epithelium of prostatic adenocarcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Prostate cancer; Prostate; Stromal cell; Immunohistochemistry; Tissue microarray; Stroma; Adenocarcinoma; PCA3; Pathology; Cancer; Epithelium; Cancer research; Lymph node; Medicine; Internal medicine","score_opus":0.03924448107238381,"score_gpt":0.3981601632851226,"score_spread":0.3589156822127388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082769359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954979,0.0028462752,0.0000013011486,0.00028645527,0.00007044581,0.0006542405,0.00005958701,0.000007572718,0.0005762265],"genre_scores_gemma":[0.9983306,0.00058476056,0.00009507801,0.0000027232343,0.00007825754,0.00016468257,0.000023284223,0.000022477634,0.0006981569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998245,0.000047158257,0.00032348832,0.0002992989,0.00067143975,0.00041361534],"domain_scores_gemma":[0.99892944,0.00014485071,0.000076839315,0.00037786862,0.00030879615,0.00016219397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040721797,0.00012428728,0.00033870692,0.00026502463,0.000055077726,0.000011751222,0.00015932182,0.00013269736,0.00062329054],"category_scores_gemma":[0.00012474015,0.000094331444,0.000052314146,0.00027179325,0.00063727435,0.00006344098,0.00013543673,0.0008562922,0.0000024604292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012870723,0.00021991857,0.112409145,0.0011117209,0.000023153858,0.000033889366,0.0005334877,2.431849e-7,0.882131,0.000016762291,0.00013438282,0.0020992153],"study_design_scores_gemma":[0.0019445149,0.00019994589,0.35284758,0.00043091402,0.0000086635655,0.0000052819723,0.00022301197,0.000010490015,0.6441765,0.00007854064,0.000021905014,0.000052681204],"about_ca_topic_score_codex":0.00076678983,"about_ca_topic_score_gemma":0.000031991047,"teacher_disagreement_score":0.24043845,"about_ca_system_score_codex":0.0001118759,"about_ca_system_score_gemma":0.00055031566,"threshold_uncertainty_score":0.6824595},"labels":[],"label_agreement":null},{"id":"W2082826346","doi":"10.1158/1538-7445.am2013-lb-225","title":"Abstract LB-225: Resistance to paclitaxel in triple negative breast cancer cells is associated with ABCB1 overexpression and gene amplification, and can be reversed by anti-EGFR targeting.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triple-negative breast cancer; Lapatinib; Efflux; Paclitaxel; Cancer research; Drug resistance; Breast cancer; Abcg2; Cancer; Chemotherapy; Medicine; Biology; Pharmacology; Internal medicine; Gene; ATP-binding cassette transporter; Transporter; Trastuzumab; Genetics","score_opus":0.027405716601090722,"score_gpt":0.3192348043898835,"score_spread":0.2918290877887928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082826346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98400646,0.0016287044,0.000015812575,0.01138932,0.000050477425,0.0015334924,0.0010464743,0.000028847719,0.00030038165],"genre_scores_gemma":[0.99028355,0.0023309458,0.0002852311,0.00058267685,0.000069395115,0.00048785342,0.00007326277,0.00005073647,0.0058363425],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99744034,0.000096172174,0.00034151124,0.0006827093,0.0007646945,0.0006745972],"domain_scores_gemma":[0.99835855,0.00013178762,0.00011598594,0.00029949253,0.0006563583,0.0004378546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006368408,0.00023433958,0.00043567177,0.00020306675,0.00023691244,0.00008114621,0.0001409246,0.00016009396,0.0006003974],"category_scores_gemma":[0.00007463672,0.00018240181,0.000030422325,0.0006694148,0.00024131093,0.00017496922,0.00003723546,0.0005112888,0.000005193478],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007482265,0.00013339866,0.017631995,0.00023761374,0.00006550909,0.000023765679,0.002297921,0.0000042424804,0.9148768,0.000015026318,0.063519426,0.00044607703],"study_design_scores_gemma":[0.004713311,0.00013467464,0.5310112,0.0025493016,0.000036398105,0.0000022026618,0.002021184,0.00002054838,0.45401943,0.0001625162,0.0048954566,0.0004337906],"about_ca_topic_score_codex":0.010313098,"about_ca_topic_score_gemma":0.0040760604,"teacher_disagreement_score":0.5133792,"about_ca_system_score_codex":0.00047281513,"about_ca_system_score_gemma":0.00043779743,"threshold_uncertainty_score":0.99627733},"labels":[],"label_agreement":null},{"id":"W2082926976","doi":"10.1158/1538-7445.am2014-5081","title":"Abstract 5081: Systematic identification of germline mutations in rhabdomyosarcoma and neuroblastoma using massively paralleled sequencing","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germline; Pediatric cancer; Rhabdomyosarcoma; Germline mutation; Neuroblastoma; Massive parallel sequencing; Biology; Somatic cell; Cancer; Population; Cancer research; Genetics; Oncology; Medicine; Mutation; Gene; Genome; Sarcoma; Pathology","score_opus":0.10212749011923763,"score_gpt":0.41865674323579716,"score_spread":0.31652925311655955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082926976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980835,0.0002622726,0.00010006652,0.00027048498,0.000028699309,0.0011262364,0.000011221452,0.000017312648,0.00010021951],"genre_scores_gemma":[0.99932545,0.00007597098,0.00019732006,0.000015970296,0.000038437953,0.00018017465,0.0000062762756,0.000026363896,0.00013404783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976997,0.0003319982,0.0005227258,0.00032916185,0.0007012906,0.00041511975],"domain_scores_gemma":[0.99854934,0.00042685078,0.00013668991,0.00031833263,0.00037772913,0.00019108452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010778252,0.000119854216,0.00037033332,0.00061581965,0.000112327136,0.000041584157,0.00011338766,0.00005573746,0.00003948284],"category_scores_gemma":[0.0008120886,0.000103032515,0.000046883626,0.0006095178,0.00021568962,0.0001380894,0.0000639977,0.00034969766,0.000015785201],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028718944,0.00016768371,0.00906132,0.011309035,0.00007044337,0.0001757085,0.00022396934,0.00040956648,0.97734267,0.00019910873,0.00001970971,0.0007335845],"study_design_scores_gemma":[0.008015103,0.001110159,0.5957407,0.01325015,0.00015416632,0.00022178031,0.00083500805,0.06279547,0.3165286,0.0009648857,0.000018559931,0.00036545383],"about_ca_topic_score_codex":0.0005310955,"about_ca_topic_score_gemma":0.00017734946,"teacher_disagreement_score":0.6608141,"about_ca_system_score_codex":0.00032549002,"about_ca_system_score_gemma":0.00034998974,"threshold_uncertainty_score":0.4201544},"labels":[],"label_agreement":null},{"id":"W2083080188","doi":"10.1158/1538-7445.am2014-55","title":"Abstract 55: Separation of tetraspanin CD151 from its integrin partner α3β1 reflects an alter migratory state and predicts prostate cancer progression","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Tetraspanin; Integrin; Metastasis; Biology; Cancer research; Prostate cancer; Tumor progression; Cell migration; Cancer cell; Cancer; Cell; Immunology","score_opus":0.08388669884263922,"score_gpt":0.47824750980360947,"score_spread":0.39436081096097025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083080188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992945,0.0035518452,0.000017834072,0.0008409416,0.00009330004,0.0014468054,0.00010731805,0.000041469044,0.00095544424],"genre_scores_gemma":[0.99322534,0.00256596,0.00019999854,0.00009613534,0.00028211894,0.0005819676,0.00008033254,0.00006904223,0.002899095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99583733,0.00048805043,0.00046641487,0.0007530915,0.0016790828,0.0007760205],"domain_scores_gemma":[0.99733025,0.0002670968,0.00013146408,0.000555955,0.0010866488,0.0006286002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015155077,0.00024083158,0.00041739485,0.00030823893,0.00015551804,0.00008214714,0.00023991446,0.00017365826,0.000982923],"category_scores_gemma":[0.0003744916,0.00018643193,0.000054606608,0.0005315296,0.00038623362,0.00032891965,0.00018313114,0.0010585679,0.000079962556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017546639,0.0002352111,0.021081358,0.0005505987,0.00006633008,0.00004352781,0.0017728398,0.000027474009,0.8675896,0.00001579707,0.004408046,0.10245458],"study_design_scores_gemma":[0.0023049472,0.0010791314,0.14881101,0.001229185,0.00002793157,0.0000036335318,0.00020054501,0.0019627877,0.8310914,0.00018207259,0.012871253,0.00023611487],"about_ca_topic_score_codex":0.0019870286,"about_ca_topic_score_gemma":0.001646719,"teacher_disagreement_score":0.12772965,"about_ca_system_score_codex":0.00030911286,"about_ca_system_score_gemma":0.00076760136,"threshold_uncertainty_score":0.9999303},"labels":[],"label_agreement":null},{"id":"W2083430251","doi":"10.1158/1538-7445.am2011-4289","title":"Abstract 4289: Using the right tools: A catalog of ovarian cancer cell lines by subtype","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre for Advancing Health Outcomes; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Serous fluid; Serous carcinoma; Clear cell; Cancer; Disease; Oncology; Ovarian carcinoma; Biology; Cancer research; Medicine; Internal medicine; Bioinformatics; Immunohistochemistry","score_opus":0.09514112550036821,"score_gpt":0.39788731880085937,"score_spread":0.30274619330049113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083430251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854094,0.007858193,0.0010680953,0.00026324423,0.000057617643,0.00043754748,0.00028784366,0.0000111188765,0.0046069464],"genre_scores_gemma":[0.9959045,0.0024735897,0.00050267985,0.00010601931,0.00013111239,0.0002619444,0.00009207305,0.000020728996,0.0005073341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990495,0.00007042728,0.00016867538,0.0002896064,0.00013557014,0.00028622508],"domain_scores_gemma":[0.9991177,0.000015936836,0.000073280455,0.00049455115,0.00023929331,0.000059288326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035583347,0.00010064617,0.00010467223,0.000023571662,0.00014810779,0.00001333842,0.0004431367,0.00016227963,0.0003571281],"category_scores_gemma":[0.000023948933,0.000071258066,0.000060450267,0.00014459099,0.0002985585,0.0000041776984,0.00015476305,0.00017824942,0.000003079333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043531214,0.000055580374,0.0005489183,0.000020363332,0.00002755029,0.0000010365787,0.000050255654,0.0000024911055,0.9890326,0.00021455903,0.008866329,0.0011367798],"study_design_scores_gemma":[0.00011745789,0.000059632086,0.00091576553,0.000014167288,0.000009633967,0.0000017202223,0.000038717324,0.000009205585,0.94445074,0.00012621282,0.05416688,0.00008986288],"about_ca_topic_score_codex":0.006854832,"about_ca_topic_score_gemma":0.0007698455,"teacher_disagreement_score":0.04530055,"about_ca_system_score_codex":0.000031889886,"about_ca_system_score_gemma":0.00023741135,"threshold_uncertainty_score":0.9997586},"labels":[],"label_agreement":null},{"id":"W2083465944","doi":"10.1158/1538-7445.am2013-967","title":"Abstract 967: Establishing mechanisms of acquired resistance to Met inhibitor in Met-addicted gastric cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Hepatocyte growth factor; Cell growth; Biology; C-Met; Hepatocyte Growth Factor Receptor; Cancer research; Cell culture; Receptor tyrosine kinase; Cancer; Cancer cell; Growth inhibition; Signal transduction; Tyrosine kinase; Cell biology; Receptor; Genetics","score_opus":0.06245113066548625,"score_gpt":0.37278967105114946,"score_spread":0.3103385403856632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083465944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330294,0.0022375402,0.00005607942,0.0010160223,0.000331821,0.000992257,0.00008164737,0.000029745901,0.0019519308],"genre_scores_gemma":[0.99453545,0.00048031312,0.0012112994,0.0003537872,0.00033665574,0.00072937,0.00002537946,0.000034714507,0.0022930084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975376,0.00024738422,0.00043138023,0.0005144092,0.00053122925,0.0007380017],"domain_scores_gemma":[0.9980728,0.00036485805,0.00009966424,0.0004674961,0.00072651217,0.00026865766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093072763,0.00017469744,0.0004983582,0.00043510966,0.000084512714,0.00002223671,0.00033233882,0.00023352396,0.0029786543],"category_scores_gemma":[0.00034265008,0.00015098753,0.000066247914,0.0012203628,0.00017457333,0.0002615588,0.00017484068,0.00043686398,0.00009576683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006003384,0.00013791682,0.0026396436,0.00029333867,0.000033982124,0.00004794756,0.0007017686,0.000040610335,0.9809923,0.00013574431,0.012563392,0.0018130208],"study_design_scores_gemma":[0.0022900833,0.0006136279,0.1658558,0.0007581656,0.000032977026,0.0000028831848,0.0008857636,0.000018553179,0.8261172,0.0015777062,0.0016047183,0.00024252951],"about_ca_topic_score_codex":0.0088458,"about_ca_topic_score_gemma":0.0023407529,"teacher_disagreement_score":0.16321616,"about_ca_system_score_codex":0.00039763533,"about_ca_system_score_gemma":0.00073665025,"threshold_uncertainty_score":0.99793273},"labels":[],"label_agreement":null},{"id":"W2083488461","doi":"10.1158/1538-7445.am2011-3916","title":"Abstract 3916: PML nuclear bodies are juxtaposed to DNA-DSBs following IR-induced DNA damage","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"DNA damage; Promyelocytic leukemia protein; DNA; Molecular biology; Comet assay; DNA repair; RAD51; Biology; DNA replication; Nuclear protein; Cell biology; Chemistry; Genetics; Transcription factor","score_opus":0.08848663283380707,"score_gpt":0.36184518226771434,"score_spread":0.27335854943390725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083488461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98107904,0.00078294636,0.000012839338,0.0002123656,0.0002738941,0.0003145943,0.000015049947,0.00003230316,0.017276982],"genre_scores_gemma":[0.99697435,0.0002417772,0.00017216052,0.00024113175,0.0004228466,0.00011067589,0.000021334992,0.000071306764,0.0017443997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978218,0.00010377474,0.00023826012,0.0006375887,0.00047509378,0.0007234993],"domain_scores_gemma":[0.99873734,0.000023632696,0.00006220063,0.000645849,0.00026642976,0.0002645606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006166268,0.00021509427,0.00021988704,0.00011987894,0.00031707154,0.00010360251,0.00069527293,0.00024280383,0.00036806086],"category_scores_gemma":[0.00028831174,0.00020338353,0.00014647796,0.00021836757,0.00012257826,0.000016510456,0.00036659028,0.00037971785,0.00018309118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017044938,0.000053185624,0.0011859862,0.000092272676,0.000076578,0.00006707113,0.00061552675,0.0000020919897,0.98939526,0.000033433014,0.0065179737,0.0017901923],"study_design_scores_gemma":[0.00042887457,0.00024541497,0.009011706,0.000102105514,0.000012333268,0.0000027737406,0.0011935139,0.0000021719718,0.96231383,0.00009698972,0.02630013,0.00029013283],"about_ca_topic_score_codex":0.00024861126,"about_ca_topic_score_gemma":0.00012116429,"teacher_disagreement_score":0.027081385,"about_ca_system_score_codex":0.00009725348,"about_ca_system_score_gemma":0.0002942184,"threshold_uncertainty_score":0.829374},"labels":[],"label_agreement":null},{"id":"W2083507983","doi":"10.1158/1538-7445.am2014-2462","title":"Abstract 2462: Coiled-coil domain 68 (CCDC68) plays a tumor suppressive role in pancreatic adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University Health Network","funders":"","keywords":"KRAS; Cancer research; Biology; Downregulation and upregulation; Adenocarcinoma; Cell culture; Cell growth; Gene; Cancer; Mutation; Genetics","score_opus":0.05254741334758412,"score_gpt":0.3955389444292103,"score_spread":0.34299153108162617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083507983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494657,0.0034187823,0.000022050353,0.0023054373,0.00008577628,0.0012333923,0.00003461301,0.000053126656,0.043381117],"genre_scores_gemma":[0.99383485,0.00045790581,0.00033530596,0.0002907633,0.0005622939,0.0012042869,0.000033816454,0.00007075575,0.0032100144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949132,0.00065969874,0.00059311534,0.00078351225,0.0014608797,0.0015896012],"domain_scores_gemma":[0.9965366,0.001334492,0.00010354387,0.0008800956,0.0004850656,0.0006601894],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0032241829,0.00029584003,0.0010084243,0.00068531046,0.00027102575,0.0000674667,0.00051122694,0.00025529903,0.0036988955],"category_scores_gemma":[0.0011598716,0.00024930693,0.00012803823,0.0008545795,0.0007408177,0.00014609593,0.0002412571,0.0017634674,0.00091169524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024282583,0.00055979105,0.9226587,0.00065601344,0.00014639663,0.0011672165,0.0022091456,0.000012683316,0.052523762,0.0010911155,0.013241041,0.0033059188],"study_design_scores_gemma":[0.0071488037,0.001066767,0.96739626,0.0010877984,0.00007868929,0.00020300878,0.0023242906,0.00107914,0.005665731,0.0035363147,0.010041216,0.00037198912],"about_ca_topic_score_codex":0.0045773,"about_ca_topic_score_gemma":0.00081527355,"teacher_disagreement_score":0.046858028,"about_ca_system_score_codex":0.00085982535,"about_ca_system_score_gemma":0.0016722779,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2083572039","doi":"10.1158/1538-7445.am2012-lb-499","title":"Abstract LB-499: Malignancy-sustaining characteristics of cancer-associated plasma: role of systemic cytokines in maintaining tumor latency","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cytokine; Malignancy; Multiple myeloma; Cancer; Internal medicine; Disease; Oncology; Immunology","score_opus":0.057754898910380326,"score_gpt":0.3924109688898448,"score_spread":0.33465606997946445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083572039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252343,0.0052466816,6.417272e-7,0.00011014391,0.00010029828,0.0008426461,0.0002270516,0.000023214809,0.0009258744],"genre_scores_gemma":[0.9976694,0.0013624748,0.00003771305,0.000008199555,0.00018300992,0.00038787271,0.00004833555,0.00005081855,0.0002521819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648255,0.00019925625,0.0006906338,0.0003031221,0.0010600686,0.0012643505],"domain_scores_gemma":[0.9978578,0.00038706727,0.00026988308,0.0003392611,0.0007869829,0.0003589944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015862066,0.0002056217,0.0007308505,0.0005888841,0.000091132424,0.000015326674,0.00023235516,0.00013334441,0.00036294962],"category_scores_gemma":[0.000941757,0.00017745228,0.000099032855,0.00084820244,0.00020046743,0.00015529171,0.00014604098,0.0006322338,0.000016060561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008902848,0.00042655997,0.83738005,0.00086747966,0.00020743223,0.00014484928,0.0015048255,0.000013460951,0.14758281,0.00011334389,0.00003863356,0.010830287],"study_design_scores_gemma":[0.0032096056,0.00027814644,0.92859906,0.004261282,0.000041812204,0.000015234083,0.0032247126,0.00028836698,0.059816256,0.000036467383,0.00007587834,0.00015317817],"about_ca_topic_score_codex":0.008665064,"about_ca_topic_score_gemma":0.00038329232,"teacher_disagreement_score":0.09121904,"about_ca_system_score_codex":0.0012023054,"about_ca_system_score_gemma":0.0011629844,"threshold_uncertainty_score":0.9979363},"labels":[],"label_agreement":null},{"id":"W2083633779","doi":"10.1158/1538-7445.am2013-3829","title":"Abstract 3829: TP53 mutation status defines two distinct classes of diffuse anaplastic Wilms tumor.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sanger sequencing; Wilms' tumor; Exon; Mutation; Anaplasia; Biology; Microdissection; Medicine; Cancer research; Pathology; Genetics; Gene","score_opus":0.027157508280027737,"score_gpt":0.35068161605527326,"score_spread":0.32352410777524554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083633779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935618,0.0029695935,0.000034678815,0.00013595709,0.0001476352,0.00024785657,0.00004149203,0.000009002961,0.002852005],"genre_scores_gemma":[0.9973904,0.0015018772,0.000041441475,0.00003210018,0.00017931477,0.00014357734,0.00007575466,0.000023107526,0.0006124414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864876,0.00006336484,0.0002143126,0.00029878764,0.00032887913,0.00044590147],"domain_scores_gemma":[0.99912894,0.00005968757,0.0000767521,0.00023555395,0.0003463165,0.00015273759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001436269,0.00012195935,0.00013970815,0.00008534152,0.00009438621,0.000038059155,0.00018263541,0.0000828606,0.00019524783],"category_scores_gemma":[0.00012870223,0.00009439505,0.00006288538,0.0002214551,0.000281909,0.000010150112,0.00007963643,0.00022563018,0.000035551828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027029467,0.000115963005,0.0047288784,0.000202329,0.00011927546,0.00001985987,0.00009162529,0.0013182514,0.9711986,0.00012713463,0.009436932,0.012370862],"study_design_scores_gemma":[0.00421892,0.0013823073,0.106014974,0.00042097265,0.00005351793,0.00003556192,0.00086936523,0.00064247934,0.8581164,0.002277503,0.025258584,0.00070940127],"about_ca_topic_score_codex":0.0027458942,"about_ca_topic_score_gemma":0.00065159565,"teacher_disagreement_score":0.11308218,"about_ca_system_score_codex":0.000059141927,"about_ca_system_score_gemma":0.000329277,"threshold_uncertainty_score":0.4150989},"labels":[],"label_agreement":null},{"id":"W2083652600","doi":"10.1158/1538-7445.am2012-5261","title":"Abstract 5261: Irinophore C, a liposomal formulation of irinotecan, has anti-vascular effects in primary tumors of colorectal cancer grown orthotopically in mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Irinotecan; Medicine; Colorectal cancer; Cancer; Pathology; Primary tumor; Apoptosis; Internal medicine; Metastasis; Biology","score_opus":0.028534955673774332,"score_gpt":0.34374505595851873,"score_spread":0.3152101002847444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083652600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246764,0.0062479144,0.0000054839334,0.00006151065,0.000061880615,0.00082040863,0.000049600665,0.000003499009,0.00028206702],"genre_scores_gemma":[0.9980172,0.001231922,0.00007423781,0.0000131200695,0.00011302622,0.00043528786,0.000059954953,0.000024985351,0.000030277428],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979444,0.00015056114,0.00033952302,0.0003294471,0.00054153753,0.0006945301],"domain_scores_gemma":[0.9992554,0.00006301107,0.00008473335,0.00024088533,0.00019962266,0.000156321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005441284,0.00015326095,0.00031228698,0.00026254097,0.00004632357,0.0000133085105,0.0002440142,0.00016392222,0.000049387185],"category_scores_gemma":[0.00011018811,0.00014326378,0.00010273,0.000462311,0.00021267211,0.000023133625,0.00018414881,0.00030498224,0.000002541476],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005016925,0.0003057909,0.41034037,0.00037859773,0.00005368599,0.000011839973,0.00010061888,0.00008582577,0.5847795,0.000016984382,0.000053460477,0.00337162],"study_design_scores_gemma":[0.0011511144,0.00022888322,0.5639686,0.00015018723,0.0000043783534,0.0000011054462,0.000014565379,0.000008869538,0.43414658,0.000012630023,0.00023448732,0.000078592886],"about_ca_topic_score_codex":0.011985593,"about_ca_topic_score_gemma":0.007969446,"teacher_disagreement_score":0.15362822,"about_ca_system_score_codex":0.00031119213,"about_ca_system_score_gemma":0.0007753547,"threshold_uncertainty_score":0.9945937},"labels":[],"label_agreement":null},{"id":"W2083719370","doi":"10.1158/1538-7445.am10-3423","title":"Abstract 3423: Immunohistochemical expression and cluster analysis of mesenchymal and neural stem cell-associated proteins in pediatric undifferentiated soft tissue sarcomas","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Histogenesis; Pathology; Sarcoma; Rhabdomyosarcoma; Mesenchymal stem cell; Immunohistochemistry; Embryonal rhabdomyosarcoma; Stem cell marker; Stem cell; Biology; Medicine","score_opus":0.03650466378584712,"score_gpt":0.36466615076544007,"score_spread":0.32816148697959296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083719370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431103,0.0044523412,0.0000011954966,0.00037280633,0.000038811275,0.00069965044,0.000028461685,0.000014106728,0.00008157991],"genre_scores_gemma":[0.999025,0.00050304946,0.00003213107,0.000013521083,0.00004393235,0.00019628748,0.000041995077,0.000019174022,0.0001249382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998317,0.000109679895,0.00031644347,0.00037313378,0.00050742447,0.00037632886],"domain_scores_gemma":[0.99897283,0.00031551858,0.00008900888,0.00027036507,0.00017059487,0.00018170555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042144116,0.0001491896,0.0004484384,0.0006305268,0.0000791174,0.000028767854,0.00009303979,0.0001773499,0.0001867048],"category_scores_gemma":[0.000070398826,0.00011598696,0.00006580798,0.00085530576,0.00015088287,0.000059211583,0.00013509222,0.0006301436,0.00000164912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018646002,0.0004922192,0.55808705,0.00011977708,0.00010963047,0.000036986712,0.0003263335,0.0000023961534,0.43753487,0.0000022827685,0.00012258458,0.002979407],"study_design_scores_gemma":[0.0022001478,0.00013415376,0.893012,0.00006121375,0.00030128774,0.0000025276759,0.000071135684,0.0003898528,0.10369425,0.000010198482,0.000025288084,0.00009795734],"about_ca_topic_score_codex":0.0012280882,"about_ca_topic_score_gemma":0.0005644288,"teacher_disagreement_score":0.33492494,"about_ca_system_score_codex":0.0001256904,"about_ca_system_score_gemma":0.00010908714,"threshold_uncertainty_score":0.4729811},"labels":[],"label_agreement":null},{"id":"W2083736260","doi":"10.1158/0008-5472.sabcs12-pd08-03","title":"Abstract PD08-03: Barriers to Breast Reconstructive Surgery in an Underprivileged Community: Does Income Really Matter?","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Population; Poverty; Health care; Socioeconomic status; Demography; Family medicine; Cancer; Gerontology; Environmental health; Economic growth; Internal medicine","score_opus":0.07298490598438215,"score_gpt":0.3841203935897593,"score_spread":0.3111354876053771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083736260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948962,0.00007705504,0.0000027832186,0.001438824,0.0007745213,0.00050298334,0.00012703412,0.000046042613,0.0021346097],"genre_scores_gemma":[0.99879384,0.00003169212,0.00008250451,0.0001435048,0.00057498727,0.000121567544,0.00004026077,0.000040736762,0.00017091117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973769,0.00061411876,0.00036708167,0.0002567987,0.00048531865,0.0008997454],"domain_scores_gemma":[0.997531,0.0005063894,0.00006249979,0.0005249232,0.00026004144,0.0011151658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026098972,0.00018141884,0.00041897013,0.00086989667,0.00033238454,0.000055876342,0.00020632938,0.00018982761,0.0022358003],"category_scores_gemma":[0.000096146,0.00013978158,0.0000734501,0.00069222046,0.0003583374,0.0004831652,0.00011976318,0.0014819907,0.00021625996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074288296,0.00008701544,0.90235466,0.00016506201,0.000046415626,0.000018330054,0.0015940104,0.0000013202783,0.004911381,0.000029293113,0.0006501073,0.08939953],"study_design_scores_gemma":[0.0005265975,0.000045069777,0.9860351,0.0006128768,0.000012374745,0.004490839,0.005660736,0.0000022227644,0.0020736877,0.00022309143,0.0001221343,0.00019527068],"about_ca_topic_score_codex":0.005941503,"about_ca_topic_score_gemma":0.0046354253,"teacher_disagreement_score":0.08920426,"about_ca_system_score_codex":0.00067716505,"about_ca_system_score_gemma":0.0007918466,"threshold_uncertainty_score":0.9986763},"labels":[],"label_agreement":null},{"id":"W2083824552","doi":"10.1158/1538-7445.am2013-4050","title":"Abstract 4050: Progesterone receptor signaling induces cellular senescence in ovarian cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer; Downregulation and upregulation; Senescence; Biology; Estrogen; Progesterone receptor; Estrogen receptor; Endocrinology; Internal medicine; Medicine; Breast cancer; Gene","score_opus":0.09061545127984535,"score_gpt":0.3816497879168134,"score_spread":0.2910343366369681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083824552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391366,0.00460726,0.0000069536304,0.008521285,0.00036456596,0.0018061552,0.000033169625,0.00003698176,0.00070997427],"genre_scores_gemma":[0.9923963,0.0023430705,0.00029820928,0.00022673132,0.0006109941,0.0032266339,0.000019887313,0.000059073493,0.0008191071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702734,0.00012112727,0.00039798178,0.0006930093,0.00085069844,0.0009098436],"domain_scores_gemma":[0.99851036,0.00014626446,0.00008058329,0.00046764204,0.0004125487,0.00038259584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063861936,0.00024498408,0.00040003096,0.00032044595,0.00014414112,0.000130103,0.00023553341,0.00018046577,0.007099322],"category_scores_gemma":[0.000037170455,0.00020406295,0.00007771578,0.0007762837,0.00017222205,0.00023820713,0.00009416079,0.00077309314,0.00044098447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011059179,0.00044077905,0.03801669,0.0003171855,0.00009449597,0.00010566698,0.0007713254,0.000035828907,0.93380564,0.000034542376,0.0062338626,0.0200334],"study_design_scores_gemma":[0.0020611123,0.00020335968,0.08929563,0.0014158017,0.000026543434,0.0000021693209,0.00036024264,0.000021988915,0.90116423,0.00006504981,0.005140399,0.00024346323],"about_ca_topic_score_codex":0.023937048,"about_ca_topic_score_gemma":0.00048069877,"teacher_disagreement_score":0.05127894,"about_ca_system_score_codex":0.0011721683,"about_ca_system_score_gemma":0.0009439422,"threshold_uncertainty_score":0.9938083},"labels":[],"label_agreement":null},{"id":"W2083836971","doi":"10.1158/1538-7445.am10-4417","title":"Abstract 4417: Uptake of the new paclitaxel-derivative (ANG1005) by the low-density lipoprotein receptor-related protein1 (LRP1) is related to the aggressive phenotype of glioblastoma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada); National Research Council Canada; Université du Québec à Montréal","funders":"","keywords":"LRP1; Cancer research; Taxane; Paclitaxel; U87; Medicine; Cancer; Immunohistochemistry; Temozolomide; Glioma; Internal medicine; Breast cancer; Lipoprotein; LDL receptor; Cholesterol","score_opus":0.012633296934190288,"score_gpt":0.30257436397631465,"score_spread":0.28994106704212436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083836971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98675686,0.0050857975,0.00000964652,0.004373997,0.0010861439,0.0019367245,0.00025425508,0.000009777775,0.00048682152],"genre_scores_gemma":[0.99073374,0.0009960249,0.000049852973,0.00022972033,0.00064580026,0.00020789029,0.000013734351,0.000049824117,0.007073412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742985,0.00026786054,0.0004756209,0.00052149897,0.00074182835,0.00056331424],"domain_scores_gemma":[0.99726963,0.000084626,0.00040253426,0.0012641158,0.0007967534,0.00018235143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011640217,0.0002411407,0.00029357162,0.000058086738,0.00031053435,0.000036217112,0.0011167976,0.0003404361,0.0005917492],"category_scores_gemma":[0.0007242238,0.00013523475,0.00020538295,0.0007349003,0.0007472434,0.0000105686095,0.00044353795,0.0010662675,0.000038031667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044109504,0.00005453973,0.00002097009,0.000032501204,0.00012950385,3.927169e-7,0.0012704369,0.000016837546,0.86859477,0.00005848063,0.102004535,0.027375953],"study_design_scores_gemma":[0.00046401334,0.0001738412,0.0017900832,0.00011788216,0.000017242672,0.0000019987458,0.0002285205,0.0000026322737,0.8028846,0.00016724916,0.1940196,0.00013235705],"about_ca_topic_score_codex":0.0032491037,"about_ca_topic_score_gemma":0.0015432463,"teacher_disagreement_score":0.09201507,"about_ca_system_score_codex":0.000044595647,"about_ca_system_score_gemma":0.0008611839,"threshold_uncertainty_score":0.6479239},"labels":[],"label_agreement":null},{"id":"W2083839003","doi":"10.1158/0008-5472.can-07-5163","title":"TREK-1 Is a Novel Molecular Target in Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"LNCaP; Prostate cancer; Cell growth; Cancer research; Prostate; Potassium channel; Cell culture; Cancer; Hyperplasia; Cancer cell; Biology; Internal medicine; Endocrinology; Medicine; Genetics","score_opus":0.06301724446040077,"score_gpt":0.374563721283446,"score_spread":0.31154647682304526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083839003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474895,0.0021327136,0.00038287448,0.0013630625,0.00021258836,0.00027536598,0.00004357635,0.000007932127,0.0008329514],"genre_scores_gemma":[0.98848516,0.0014324968,0.00009569089,0.0004342402,0.00030433788,0.00032125541,0.00004559467,0.000022846996,0.008858365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988472,0.00005374486,0.00013122076,0.00033106943,0.0002943193,0.00034243314],"domain_scores_gemma":[0.9994622,0.000005396158,0.000023534734,0.00019959705,0.00022680992,0.000082477054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022993055,0.000090258174,0.0000901313,0.00012451367,0.00010147118,0.000012195451,0.000117862975,0.00008986021,0.00035118614],"category_scores_gemma":[0.000037326423,0.00008663272,0.000043903798,0.00033527226,0.000121331024,0.0000048360444,0.00006887218,0.0001665881,0.000017620094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022972259,0.00006706153,0.008147556,0.000020312935,0.000020366757,0.000011923073,0.00037060987,0.0014314916,0.96501416,0.000049033024,0.023574496,0.0010632812],"study_design_scores_gemma":[0.0012285329,0.000120472054,0.0060252147,0.000028922203,0.0000017720811,0.000009142032,0.000097457836,0.0006952549,0.76455635,0.00007246198,0.2269842,0.00018019024],"about_ca_topic_score_codex":0.000500874,"about_ca_topic_score_gemma":0.000111125795,"teacher_disagreement_score":0.20340972,"about_ca_system_score_codex":0.00008201484,"about_ca_system_score_gemma":0.0003215916,"threshold_uncertainty_score":0.38452423},"labels":[],"label_agreement":null},{"id":"W2084039866","doi":"10.1158/1538-7445.am2012-350","title":"Abstract 350: Claudin 1 expression in the basal-like breast cancer subtype (BLBC) is age related and higher in postmenopausal women","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Claudin; Tight junction; Gene knockdown; Breast cancer; Transfection; Cancer research; Biology; Cancer; Cell culture; Internal medicine; Cell biology; Medicine; Genetics","score_opus":0.09145624510205128,"score_gpt":0.3814289627925229,"score_spread":0.2899727176904716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084039866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891229,0.0025245291,1.8403306e-7,0.0034493243,0.00056880666,0.0003250777,0.00006344594,0.000019027157,0.003926705],"genre_scores_gemma":[0.99469846,0.0015758543,0.0000024318585,0.0014567565,0.00020094463,0.00034837838,0.0000010812721,0.000021490938,0.0016945803],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976208,0.00031822454,0.00022318398,0.0004094808,0.00059675996,0.000831545],"domain_scores_gemma":[0.9991676,0.00030892072,0.00004929204,0.0002831271,0.000052918364,0.00013812809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009383632,0.00015536447,0.00019107341,0.0002180015,0.00025255274,0.00007224007,0.0002736187,0.0001203724,0.0020016169],"category_scores_gemma":[0.00006493475,0.00010176839,0.000017686045,0.0009129186,0.00033354308,0.00031671947,0.0001785666,0.00086328323,0.00003520546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085686625,0.00017208098,0.14480722,0.00010029961,0.000019239591,0.000119843266,0.029878909,0.0000061303335,0.7674938,0.00045203525,0.046935122,0.009158489],"study_design_scores_gemma":[0.0006735407,0.000050193554,0.95675004,0.000072366485,0.000002624698,0.0000071813824,0.00089983735,0.0000017568036,0.01264068,0.0005752521,0.028167753,0.00015876917],"about_ca_topic_score_codex":0.0011570728,"about_ca_topic_score_gemma":0.0002292547,"teacher_disagreement_score":0.8119428,"about_ca_system_score_codex":0.00028102117,"about_ca_system_score_gemma":0.00009400734,"threshold_uncertainty_score":0.99891067},"labels":[],"label_agreement":null},{"id":"W2084075389","doi":"10.1158/1538-7445.am10-554","title":"Abstract 554: Crosstalk between TNF-α and IGF signalling increases IL-6 production and protects tumor cells from TNF-α-induced apoptosis in the liver","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Tumor necrosis factor alpha; Cancer research; Cytokine; Metastasis; Biology; Apoptosis; Lewis lung carcinoma; Flow cytometry; Immunology; Medicine; Cancer; Internal medicine","score_opus":0.04529363112813916,"score_gpt":0.3324614265401341,"score_spread":0.28716779541199494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084075389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949433,0.003671304,0.000003403422,0.0002299164,0.00025162296,0.0007175893,0.00011138049,0.000007427071,0.00006401672],"genre_scores_gemma":[0.99438703,0.0021543545,0.000071633396,0.00005393522,0.0029451675,0.00026556052,0.000029582705,0.000023727873,0.00006901511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845856,0.00013889489,0.00017231859,0.0005385309,0.0003056404,0.00038604208],"domain_scores_gemma":[0.99927616,0.00008108696,0.000055704593,0.00031931128,0.00014919021,0.000118543154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092554395,0.00014999093,0.00017107541,0.00008449597,0.00022504517,0.00013339538,0.00021766212,0.00014431716,0.00003528233],"category_scores_gemma":[0.000269884,0.00011865268,0.000035516277,0.00016507372,0.00025061544,0.000016845293,0.00013720302,0.00059021666,0.0000033539939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012867383,0.000038204176,0.00095464167,0.000052043157,0.000023224948,0.0000017836695,0.00028215843,0.0000024531703,0.97817355,0.0000031604923,0.00057552475,0.019764608],"study_design_scores_gemma":[0.00036872414,0.000081362276,0.049580988,0.0000481291,0.000013858353,0.0000032179958,0.00021419326,0.0000034627274,0.9331991,0.00008174012,0.01624955,0.00015567133],"about_ca_topic_score_codex":0.007733708,"about_ca_topic_score_gemma":0.0032553596,"teacher_disagreement_score":0.048626345,"about_ca_system_score_codex":0.000019779505,"about_ca_system_score_gemma":0.00023826842,"threshold_uncertainty_score":0.9988739},"labels":[],"label_agreement":null},{"id":"W2084296747","doi":"10.1158/1538-7445.am2012-347","title":"Abstract 347: The role of the epithelial-mesenchymal transition in the maintenance of stemness in neural and glioma stem cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Noggin; Cancer research; Stem cell; Biology; Glioma; Epithelial–mesenchymal transition; Mesenchymal stem cell; Neural stem cell; Cancer stem cell; Context (archaeology); Cell biology; Bone morphogenetic protein; Cancer; Genetics; Metastasis","score_opus":0.02406093868646006,"score_gpt":0.3187531056440073,"score_spread":0.2946921669575472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084296747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220335,0.006030454,0.00003305318,0.00067038124,0.000083510364,0.00066579116,0.000038731792,0.0000012203898,0.0002735193],"genre_scores_gemma":[0.9991476,0.00050770945,0.0000036078711,0.00004146614,0.00009231647,0.00014068274,0.000002430709,0.000016248905,0.000047949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793077,0.00057414104,0.00024260707,0.0002162249,0.0005467491,0.0004894959],"domain_scores_gemma":[0.99918056,0.00008735123,0.00006324009,0.00047257167,0.00014915818,0.000047106765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020083538,0.000103402745,0.00013632793,0.0000930094,0.00007895901,0.00001765634,0.0005480514,0.00012591548,0.000017419194],"category_scores_gemma":[0.00003840301,0.000057548026,0.0000667434,0.0005249081,0.0003750728,0.000010024292,0.00015739477,0.00047766016,0.000001001279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020756602,0.00006254151,0.0003780584,0.000062596446,0.000013117007,0.0000025374547,0.0011499196,0.00038115526,0.99160904,0.0001872451,0.00005972427,0.0058864835],"study_design_scores_gemma":[0.00048831635,0.000086838496,0.011428348,0.00008051133,0.0000042281367,0.000010065997,0.0025683062,0.00022185521,0.9840031,0.00009028017,0.00094937126,0.000068746005],"about_ca_topic_score_codex":0.0012304098,"about_ca_topic_score_gemma":0.00076747127,"teacher_disagreement_score":0.0110502895,"about_ca_system_score_codex":0.0000519293,"about_ca_system_score_gemma":0.00018705681,"threshold_uncertainty_score":0.23467404},"labels":[],"label_agreement":null},{"id":"W2084559102","doi":"10.1158/1538-7445.prca2012-c47","title":"Abstract C47: Quantitative mass spectrometry reveals that enzymes of the ketogenic pathway are upregulated during high-grade prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"LNCaP; Prostate cancer; Cancer research; Androgen; Stable isotope labeling by amino acids in cell culture; Androgen deprivation therapy; DU145; Cancer; Endocrinology; Internal medicine; Cancer cell; Biology; Medicine; Proteomics; Biochemistry; Hormone","score_opus":0.05051296052146476,"score_gpt":0.35225201594772265,"score_spread":0.3017390554262579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084559102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432217,0.052566405,0.0000054549764,0.00033337792,0.0027592236,0.00055152085,0.00037007107,0.000012157233,0.00018012848],"genre_scores_gemma":[0.98476344,0.0076216436,0.00009032219,0.000042600714,0.004085744,0.00026537158,0.000020630368,0.000053132007,0.0030571083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756306,0.0002444911,0.0002839631,0.00043051422,0.0006057944,0.00087214453],"domain_scores_gemma":[0.9986273,0.00004714066,0.00021431193,0.00062995934,0.0002974331,0.00018382705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073018164,0.00021925404,0.00031522088,0.0001280522,0.00021904586,0.00003258611,0.0004675548,0.00017747504,0.00025528122],"category_scores_gemma":[0.00012388096,0.00016454302,0.00017179339,0.0004920618,0.00035374338,0.000021217644,0.00022040261,0.0004000405,0.0000073597894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002509543,0.000058785325,0.04525083,0.00018585264,0.00015862015,2.226899e-7,0.00034235665,0.00006719722,0.9470421,0.00017523504,0.00617002,0.0002978244],"study_design_scores_gemma":[0.00053638185,0.00003404459,0.27516004,0.00012183203,0.000016416489,0.0000018891258,0.00034393746,7.4002276e-7,0.708603,0.000081371414,0.014942806,0.00015752985],"about_ca_topic_score_codex":0.0009220294,"about_ca_topic_score_gemma":0.00040842142,"teacher_disagreement_score":0.23843908,"about_ca_system_score_codex":0.00015546416,"about_ca_system_score_gemma":0.0003741171,"threshold_uncertainty_score":0.67098695},"labels":[],"label_agreement":null},{"id":"W2084629943","doi":"10.1158/0008-5472.sabcs-09-2023","title":"Biopsy Confirmation of Metastatic Disease in Breast Cancer: Results from a Large Prospective Study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Biopsy; Metastatic breast cancer; Progesterone receptor; Malignancy; Breast cancer; Concordance; Internal medicine; Cancer; Prospective cohort study; Estrogen receptor; Oncology; Hormone receptor; Pathology","score_opus":0.03575272923900764,"score_gpt":0.3915186230259625,"score_spread":0.3557658937869549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084629943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911402,0.0026080182,0.000014091771,0.0019467149,0.000054921522,0.00077291403,0.0033133165,0.00000800473,0.00014182203],"genre_scores_gemma":[0.9985022,0.0006426172,0.000028021921,0.00004715837,0.00013341774,0.00041941562,0.00013936947,0.000013066967,0.00007475321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998284,0.00020895082,0.00027607323,0.00048446466,0.0003840493,0.00036246594],"domain_scores_gemma":[0.99905604,0.00003942302,0.00008352035,0.00037119104,0.0003484146,0.00010140896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003818696,0.00014465873,0.0002251551,0.00011914991,0.000087065266,0.000017274548,0.00018789145,0.000031504405,0.000045475514],"category_scores_gemma":[0.0000888803,0.00012748175,0.000048123577,0.0003868771,0.0001065752,0.000009177547,0.00009523181,0.00013896765,0.00000423186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01346594,0.003165114,0.891273,0.000062899184,0.0006203229,0.00009619482,0.00394084,0.00026759726,0.07776396,0.00019826736,0.0019029024,0.0072429534],"study_design_scores_gemma":[0.004687596,0.00017663308,0.983414,0.00009429358,0.00003975788,0.0000011152837,0.00090251263,0.000026027941,0.0099882195,0.00036159292,0.00017394159,0.00013433458],"about_ca_topic_score_codex":0.0073016076,"about_ca_topic_score_gemma":0.0017057809,"teacher_disagreement_score":0.092140965,"about_ca_system_score_codex":0.00018286002,"about_ca_system_score_gemma":0.00034343352,"threshold_uncertainty_score":0.9993089},"labels":[],"label_agreement":null},{"id":"W2084704553","doi":"10.1158/0008-5472.can-11-2520","title":"Phosphorylation of Carbonic Anhydrase IX Controls Its Ability to Mediate Extracellular Acidification in Hypoxic Tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Extracellular; Intracellular pH; Dephosphorylation; Carbonic anhydrase; Cotransporter; Phosphorylation; Tumor microenvironment; Bicarbonate; Intracellular; Chemistry; Cell biology; Biochemistry; Biology; Enzyme; Phosphatase; Sodium; Cancer research; Tumor cells","score_opus":0.07212802017520464,"score_gpt":0.3431796983774124,"score_spread":0.27105167820220777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084704553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647933,0.0016952871,0.0002047293,0.00015602742,0.00007558297,0.0004614475,0.00001795828,0.000006143655,0.00090347166],"genre_scores_gemma":[0.99897444,0.00023977287,0.000042746164,0.00004536054,0.000080718375,0.00021250457,0.000043028696,0.000011927544,0.00034950886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988218,0.00016898401,0.00023876833,0.0003010346,0.00023308038,0.0002363384],"domain_scores_gemma":[0.9992567,0.00001685548,0.000052027895,0.00028152592,0.00029542472,0.00009749227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095087034,0.00007598624,0.00010795138,0.000118118136,0.000037547234,0.00000668127,0.00011909761,0.000102072954,0.0002139918],"category_scores_gemma":[0.00029997423,0.00007671721,0.00003672593,0.00028590322,0.00007294075,0.000008038874,0.000043233304,0.00013875392,0.00001939722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033068188,0.00007530279,0.0027519774,0.000026781365,0.0000046330883,0.0000010490965,0.0002075365,0.000051639086,0.9952646,0.00013278554,0.00034048758,0.0008125345],"study_design_scores_gemma":[0.00046647686,0.00022626546,0.015574252,0.00002587914,0.0000025539641,4.4623033e-7,0.000091029484,0.00007708576,0.9823741,0.00008654417,0.000997819,0.00007755038],"about_ca_topic_score_codex":0.00029494916,"about_ca_topic_score_gemma":0.00027659073,"teacher_disagreement_score":0.0128904935,"about_ca_system_score_codex":0.00008241468,"about_ca_system_score_gemma":0.00016455547,"threshold_uncertainty_score":0.3128437},"labels":[],"label_agreement":null},{"id":"W2084773521","doi":"10.1158/0008-5472.can-14-2598","title":"Mechanisms of Hypoxia-Mediated Immune Escape in Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Hypoxia (environmental); Cancer cell; Biology; Tumor progression; Cancer research; Tumor hypoxia; Effector; Immunity; Metastasis; Acquired immune system; Immunology; Cancer; Immunoediting; Tumor microenvironment; Immunotherapy; Medicine; Chemistry; Internal medicine","score_opus":0.0439474447943562,"score_gpt":0.3552951660396481,"score_spread":0.3113477212452919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084773521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95155543,0.03739112,0.00026161963,0.0010839173,0.0026089682,0.0007344604,0.00008032068,0.000065533604,0.0062186117],"genre_scores_gemma":[0.99210936,0.0018725822,0.000044063432,0.00010280192,0.000044389824,0.00045230376,0.000032019154,0.00004245216,0.0053000576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734825,0.0007166029,0.00047145554,0.0004233311,0.00016998088,0.0008703687],"domain_scores_gemma":[0.9983985,0.00053608,0.00011464978,0.0005842116,0.00033518934,0.000031398875],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018885124,0.00017898736,0.00044911666,0.00042861467,0.00012293283,0.000010669792,0.0006874421,0.00033657672,0.0069278427],"category_scores_gemma":[0.0003072486,0.00016670267,0.00008110459,0.00078478636,0.0005652151,0.00007991702,0.0002788876,0.0009969382,0.0004895828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024737406,0.00009368722,0.00065310544,0.00008197926,0.00007223803,0.000002106826,0.00035755182,0.000041875028,0.98204905,0.0022172376,0.003405459,0.010778341],"study_design_scores_gemma":[0.0020634404,0.00019481833,0.008090192,0.00023102797,0.000010347027,0.0000028555244,0.00021157865,0.00002310338,0.94406945,0.0019069342,0.042986326,0.00020994034],"about_ca_topic_score_codex":0.006096423,"about_ca_topic_score_gemma":0.00089705735,"teacher_disagreement_score":0.04055388,"about_ca_system_score_codex":0.00034228005,"about_ca_system_score_gemma":0.00041726208,"threshold_uncertainty_score":0.99397993},"labels":[],"label_agreement":null},{"id":"W2084839375","doi":"10.1158/0008-5472.sabcs10-p2-06-16","title":"Abstract P2-06-16: Total Choline Measurement in Human Breast Using High-Speed MR Spectroscopic Imaging at 3T","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Voxel; Nuclear medicine; Choline; Breast tissue; Breast cancer; Breast tumor; Echo-planar imaging; Medicine; Magnetic resonance imaging; Radiology; Cancer; Internal medicine","score_opus":0.11503043008964267,"score_gpt":0.4699812777103909,"score_spread":0.35495084762074824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084839375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939638,0.0002510668,0.00066603883,0.002459844,0.000060850623,0.00078373327,0.00002167296,0.000077945086,0.0017150468],"genre_scores_gemma":[0.99666584,0.000057713867,0.0017395125,0.000064092164,0.0005492262,0.00012770566,0.000026573161,0.000042101154,0.00072726264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796164,0.000022387889,0.00027021463,0.00040715246,0.0007534528,0.0005851533],"domain_scores_gemma":[0.9988697,0.000022147788,0.000054748925,0.0004993159,0.00035653726,0.00019755091],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007294323,0.00014197582,0.00022617847,0.00023967976,0.0002551334,0.000032572196,0.00016263107,0.00007195324,0.0010884339],"category_scores_gemma":[0.000038572674,0.00013226649,0.000048872753,0.00039624405,0.00019566018,0.00009618393,0.00013805156,0.0010347926,0.000033619785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004519415,0.00012847972,0.0068716058,0.00004160676,0.0000050527387,0.000019893903,0.000038969574,0.00003445265,0.9891239,0.00065346324,0.0007135625,0.0023238498],"study_design_scores_gemma":[0.0026336426,0.00008279997,0.20595922,0.0005694318,0.000024776504,0.00013022282,0.00011060342,0.000449975,0.78010994,0.0024829763,0.0070932335,0.00035320272],"about_ca_topic_score_codex":0.0027854438,"about_ca_topic_score_gemma":0.0009721417,"teacher_disagreement_score":0.20901395,"about_ca_system_score_codex":0.001533819,"about_ca_system_score_gemma":0.00023975172,"threshold_uncertainty_score":0.9998247},"labels":[],"label_agreement":null},{"id":"W2084867225","doi":"10.1158/1538-7445.am10-lb-204","title":"Abstract LB-204: Gene expression profiling of hormone-regulating pathways in tumoral and peritumoral breast tissues","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Estrogen; Aromatase; Androgen; Steroid sulfatase; Breast cancer; Cancer research; Gene expression; Messenger RNA; Biology; Internal medicine; Endocrinology; Hormone; Cancer; Medicine; Gene; Steroid; Biochemistry","score_opus":0.025205371861918197,"score_gpt":0.33698335432002413,"score_spread":0.31177798245810595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084867225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946224,0.0047611175,0.0000034266716,0.000054440483,0.00006307257,0.00023843793,0.000025331423,0.0000069873586,0.00022477415],"genre_scores_gemma":[0.9985393,0.00037640933,0.0007191038,0.0000039452457,0.00020652075,0.000050688926,0.000035869423,0.000022637205,0.000045523004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988494,0.00006725079,0.00018723306,0.00031563823,0.00022690525,0.00035357752],"domain_scores_gemma":[0.9994833,0.000019487383,0.000049658367,0.00022403526,0.000115119336,0.00010842281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005353304,0.00011316184,0.0001473459,0.00008965836,0.00009249579,0.000025464278,0.0001485862,0.00018410312,0.0000150574115],"category_scores_gemma":[0.000054791068,0.00009691025,0.000034838897,0.00012766992,0.00021903182,0.000008868159,0.00017052374,0.0004985041,0.0000020751886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018157784,0.00004093564,0.011830813,0.000043864155,0.000007944609,0.000015137625,0.00011118046,0.000018953868,0.9847337,0.00003738568,0.00008720709,0.0028912965],"study_design_scores_gemma":[0.00050565077,0.0001370572,0.026071291,0.000054460408,0.0000021342103,0.000031502674,0.00011906775,0.00006780003,0.9727865,0.00004910203,0.0000667593,0.00010867548],"about_ca_topic_score_codex":0.0001833976,"about_ca_topic_score_gemma":0.00003602467,"teacher_disagreement_score":0.014240477,"about_ca_system_score_codex":0.000014190252,"about_ca_system_score_gemma":0.00013234373,"threshold_uncertainty_score":0.3951885},"labels":[],"label_agreement":null},{"id":"W2084915584","doi":"10.1158/1538-7445.am10-1239","title":"Abstract 1239: The transcription factor Kaiso negatively regulates the hypoxia inducible factor-1 alpha","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Transcription factor; Hypoxia-inducible factors; Cell biology; Carcinogenesis; Hypoxia (environmental); G alpha subunit; HIF1A; Biology; Hypoxia-Inducible Factor 1; Transcription (linguistics); Cellular adaptation; Cancer research; Protein subunit; Chemistry; Gene; Genetics; Oxygen","score_opus":0.06758518143222655,"score_gpt":0.3636634679935109,"score_spread":0.2960782865612843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084915584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988812,0.005314523,0.000019228226,0.0022258442,0.001698531,0.00056092005,0.00015800082,0.000017815079,0.0011931183],"genre_scores_gemma":[0.9903726,0.0020664474,0.000024316842,0.0002226282,0.0033136006,0.00022310454,0.00002792009,0.00004148835,0.0037079086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798656,0.00014977113,0.00022009727,0.0004972867,0.00052862964,0.00061764504],"domain_scores_gemma":[0.99856776,0.00007797026,0.000069895104,0.0007973836,0.00033857132,0.00014841909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000670712,0.00020326814,0.00016431349,0.000066575834,0.00053777575,0.00015179439,0.00074137264,0.00025046148,0.0006127677],"category_scores_gemma":[0.00018503152,0.00012048665,0.00014765961,0.00027374318,0.0005836645,0.00001768052,0.00011313241,0.0009822324,0.000037204172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000994736,0.0000307697,0.0001746823,0.000015475332,0.00005690978,4.1106483e-7,0.00063757546,0.0000059342087,0.9621294,0.00013640703,0.010120717,0.026592257],"study_design_scores_gemma":[0.00028045458,0.00004256305,0.05429943,0.000008014108,0.0000067661326,0.0000028038487,0.00014147034,0.0000027281171,0.4916006,0.00016227062,0.45334026,0.00011262832],"about_ca_topic_score_codex":0.0012855643,"about_ca_topic_score_gemma":0.0018646895,"teacher_disagreement_score":0.47052878,"about_ca_system_score_codex":0.000046816876,"about_ca_system_score_gemma":0.0006865962,"threshold_uncertainty_score":0.67093766},"labels":[],"label_agreement":null},{"id":"W2085009726","doi":"10.1158/1538-7445.am2013-4339","title":"Abstract 4339: RGD-conjugated nanoparticles for targeted inhibition of adhesion and migration of integrin αvβ3-overexpressing breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Integrin; Chemistry; Adhesion; Biodistribution; Cancer cell; Cell adhesion; Biophysics; Cancer research; Receptor; Cell; In vitro; Molecular biology; Cancer; Biochemistry; Medicine; Biology; Internal medicine","score_opus":0.05033411487054505,"score_gpt":0.37121998879468987,"score_spread":0.3208858739241448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085009726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555683,0.0012164698,0.000017925928,0.0015136923,0.000040195977,0.0014155506,0.00013442755,0.00001864712,0.00008622999],"genre_scores_gemma":[0.9978935,0.00094377686,0.0003003948,0.00003592331,0.000087718705,0.00043439187,0.00003694429,0.000036518966,0.00023081133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997824,0.000118406984,0.00045318555,0.00036067815,0.0007876296,0.00045606378],"domain_scores_gemma":[0.99751323,0.00026733076,0.0001352157,0.00026865292,0.0015894203,0.00022613717],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006248019,0.00014206293,0.0003273047,0.00026987525,0.000105729065,0.0000420799,0.00009925822,0.00014003749,0.0012485763],"category_scores_gemma":[0.00017062652,0.000117437965,0.000074161486,0.0004642324,0.00035996226,0.00021505915,0.00010175511,0.00035634736,0.000012580215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008473267,0.00015442206,0.0032953324,0.001050032,0.00003426016,0.0000030163592,0.00031141195,0.000014601693,0.97061837,0.000016947473,0.0037736534,0.019880626],"study_design_scores_gemma":[0.001390738,0.0002418358,0.07604039,0.00097304146,0.000014800547,0.0000030700498,0.0003746651,0.00077731395,0.9197809,0.000117648975,0.00019186805,0.00009372775],"about_ca_topic_score_codex":0.009503116,"about_ca_topic_score_gemma":0.00032687915,"teacher_disagreement_score":0.072745055,"about_ca_system_score_codex":0.00020600202,"about_ca_system_score_gemma":0.000354873,"threshold_uncertainty_score":0.9996644},"labels":[],"label_agreement":null},{"id":"W2085050696","doi":"10.1158/1538-7445.am2013-398","title":"Abstract 398: Genome-wide comparison of matched canine osteosarcoma primary tumours and metastases by array comparative genomic hybridization.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Guelph","funders":"","keywords":"Osteosarcoma; CDKN2A; Comparative genomic hybridization; Cancer; Biology; Genome; Gene; Cancer research; Genetics","score_opus":0.12112370404104685,"score_gpt":0.43479480405877696,"score_spread":0.31367110001773013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085050696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848013,0.008621114,0.000063000654,0.0025849058,0.000043308843,0.0017301954,0.00016024473,0.00003220496,0.0019637435],"genre_scores_gemma":[0.9964856,0.0004892343,0.0009437559,0.000121888086,0.00008953019,0.00042227973,0.000233761,0.000044030458,0.0011699025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969852,0.00036243504,0.00054883363,0.0005077638,0.000851295,0.0007444798],"domain_scores_gemma":[0.997468,0.0006695322,0.00014715065,0.00043809466,0.000843673,0.00043357085],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009402904,0.00022339037,0.00088235096,0.00037034316,0.00020047628,0.00005476259,0.00030905727,0.00010088453,0.0019626461],"category_scores_gemma":[0.00014258896,0.00019780974,0.00006288461,0.00048732685,0.0010002066,0.0001979094,0.00022107644,0.00080540153,0.00013445353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048052694,0.00030583594,0.1472468,0.00037890597,0.00016462243,0.000031422303,0.00092957943,0.000021722668,0.82570845,0.000005841909,0.023956623,0.0007696687],"study_design_scores_gemma":[0.002486597,0.0016892703,0.8823477,0.00013495849,0.000055836503,0.00010440634,0.0024026877,0.00008272211,0.10549803,0.00005212189,0.0049017416,0.00024394496],"about_ca_topic_score_codex":0.002609545,"about_ca_topic_score_gemma":0.00012590972,"teacher_disagreement_score":0.7351009,"about_ca_system_score_codex":0.0005758722,"about_ca_system_score_gemma":0.0008477264,"threshold_uncertainty_score":0.9989497},"labels":[],"label_agreement":null},{"id":"W2085171058","doi":"10.1158/0008-5472.sabcs12-p4-16-04","title":"Abstract P4-16-04: Outcome of stage II/III breast cancer treated with neoadjuvant versus adjuvant radiotherapy in British Columbia.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Oncology; Neoadjuvant therapy; Stage (stratigraphy); Internal medicine; Chemotherapy; Cancer; Adjuvant","score_opus":0.04521200788693053,"score_gpt":0.3701153866608867,"score_spread":0.3249033787739562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085171058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798074,0.017856231,0.0000042512515,0.000280612,0.0001814088,0.00052046234,0.00087469595,0.000015544432,0.0004594308],"genre_scores_gemma":[0.99140716,0.0055010277,0.000039780363,0.00005255756,0.0003888916,0.0005508836,0.00007467691,0.00006264891,0.001922391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758136,0.00009775752,0.00034971835,0.0005311043,0.0005064283,0.00093365565],"domain_scores_gemma":[0.9988522,0.00004598063,0.00011926487,0.00047026356,0.0003080072,0.00020430882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004172817,0.00020993606,0.00045510396,0.00008783199,0.00020373063,0.000050723374,0.00028985972,0.00016127882,0.0009918098],"category_scores_gemma":[0.000021188296,0.00023993573,0.000090047135,0.00040671218,0.0004984844,0.000022473829,0.00015816864,0.00029204026,0.0000024060023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022317246,0.0004504954,0.9290862,0.000086851716,0.00045673174,0.000025679645,0.0002652835,0.000059391525,0.037030123,0.0000026271948,0.0031270206,0.027177889],"study_design_scores_gemma":[0.008329636,0.00039952254,0.96838444,0.00021264813,0.000033594133,0.000019716657,0.0005887334,0.0000025917002,0.014336153,0.0000015855921,0.0073493808,0.00034198494],"about_ca_topic_score_codex":0.30061096,"about_ca_topic_score_gemma":0.35093024,"teacher_disagreement_score":0.050319307,"about_ca_system_score_codex":0.0006338772,"about_ca_system_score_gemma":0.00032614893,"threshold_uncertainty_score":0.99992144},"labels":[],"label_agreement":null},{"id":"W2085314493","doi":"10.1158/0008-5472.can-06-2782","title":"<i>O6-Methylguanine-DNA Methyltransferase</i> Regulation by p53 in Astrocytic Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; Methyltransferase; Gene knockdown; Cancer research; Biology; Glioma; DNA methyltransferase; Gene silencing; DNA methylation; RNA interference; O-6-methylguanine-DNA methyltransferase; Methylation; Promoter; Regulation of gene expression; Small hairpin RNA; DNA repair; Molecular biology; Gene expression; Cell culture; Gene; Genetics; RNA","score_opus":0.04988643726170104,"score_gpt":0.4009289218561215,"score_spread":0.35104248459442045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085314493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922621,0.002596591,0.00017658398,0.0018616379,0.00010423768,0.00072907,0.000022912069,0.00002891477,0.0022179382],"genre_scores_gemma":[0.99779683,0.0005989292,0.00025951624,0.0001903107,0.00014756659,0.00015991896,0.000037487574,0.000032486714,0.000776954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777794,0.0001155555,0.00028876503,0.000379773,0.0007647564,0.000673187],"domain_scores_gemma":[0.99888295,0.0003204165,0.000023500485,0.00031336828,0.00019919622,0.0002605783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001442424,0.00014063742,0.00026397506,0.0003857942,0.00008203052,0.000026364978,0.00010310854,0.000110771434,0.00057851436],"category_scores_gemma":[0.000061265004,0.00012024625,0.00007047402,0.0009090748,0.00010534278,0.00007062856,0.000028376753,0.00039676222,0.00010275365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038437598,0.00038601458,0.016090607,0.00006132716,0.000055130055,0.00018312302,0.00021342505,0.000022208334,0.9527395,0.0001303609,0.012433239,0.017300729],"study_design_scores_gemma":[0.0029143542,0.00031115103,0.023282088,0.00014564887,0.000030914336,0.000006461027,0.00014320579,0.000032666572,0.95613563,0.00009598723,0.01680004,0.00010186571],"about_ca_topic_score_codex":0.0010625813,"about_ca_topic_score_gemma":0.0004949493,"teacher_disagreement_score":0.017198864,"about_ca_system_score_codex":0.00073373516,"about_ca_system_score_gemma":0.00019309501,"threshold_uncertainty_score":0.6334326},"labels":[],"label_agreement":null},{"id":"W2085329564","doi":"10.1158/1538-7445.am2011-4919","title":"Abstract 4919: Multiplexed EGFR signaling pathway analysis in FFPE tissue using quantitative mass spectrometry","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"KRAS; Epidermal growth factor receptor; Cancer research; Signal transduction; Phosphorylation; Tyrosine kinase; Cetuximab; Receptor tyrosine kinase; Receptor; Biology; Targeted therapy; Colorectal cancer; Cancer; Cell biology; Biochemistry; Genetics","score_opus":0.18101438138683726,"score_gpt":0.45263244858511437,"score_spread":0.2716180671982771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085329564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96148527,0.0005494165,0.03232476,0.000038884602,0.00001085393,0.00025928474,0.00008427437,0.000075059994,0.0051722205],"genre_scores_gemma":[0.8578058,0.00009431568,0.14163804,0.0000065374143,0.000054005097,0.00017191682,0.000016491178,0.000031829615,0.00018109666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982574,0.000039286428,0.00032474144,0.00047935842,0.00035384152,0.0005453744],"domain_scores_gemma":[0.9989501,0.0001794406,0.00010630307,0.00044197185,0.00020460595,0.000117535354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057945214,0.0001495023,0.00026920138,0.00051703746,0.0001763177,0.000039328646,0.0003875793,0.00013279138,0.0027217371],"category_scores_gemma":[0.00009377051,0.00015608178,0.00008585622,0.0018579372,0.00014063039,0.00013820823,0.00009486226,0.0007196455,0.000019972671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054841646,0.00005914731,0.0046582245,0.000054268916,0.00008108834,0.000020531059,0.0005136252,0.00069649797,0.99193734,0.0010646628,0.000005006195,0.0008547786],"study_design_scores_gemma":[0.00018164942,0.000015548529,0.0006688462,0.00007247266,0.000020555275,5.122843e-7,0.00078722753,0.0012740588,0.9919135,0.004716511,0.00016244828,0.00018666137],"about_ca_topic_score_codex":0.0031791737,"about_ca_topic_score_gemma":0.0002845432,"teacher_disagreement_score":0.10931328,"about_ca_system_score_codex":0.000552252,"about_ca_system_score_gemma":0.00014550405,"threshold_uncertainty_score":0.9981899},"labels":[],"label_agreement":null},{"id":"W2085422756","doi":"10.1158/0008-5472.sabcs12-s4-6","title":"Abstract S4-6: An international Ki67 reproducibility study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ontario Institute for Cancer Research","funders":"","keywords":"Concordance; Intraclass correlation; Reproducibility; Medicine; Breast cancer; Concordance correlation coefficient; Cancer; Nuclear medicine; Pathology; Medical physics; Statistics; Mathematics; Internal medicine","score_opus":0.25524922145127793,"score_gpt":0.5060120228200258,"score_spread":0.25076280136874785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085422756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080855,0.00021877862,0.0018616895,0.0010430455,0.0025441865,0.00048640018,0.000005199332,0.00015219649,0.0028799393],"genre_scores_gemma":[0.99730486,0.00003548588,0.0006845828,0.000050538187,0.0013997264,0.00024784057,0.000001438867,0.000012735781,0.00026276993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678415,0.00027828253,0.00021534115,0.0010431806,0.0011269336,0.00055208185],"domain_scores_gemma":[0.99662524,0.0001051118,0.000050072245,0.002544039,0.00045554858,0.00021995463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007643544,0.00009673024,0.000104518236,0.00019088354,0.00022362596,0.00021113212,0.0015985472,0.00004972742,0.00036845604],"category_scores_gemma":[0.00038038017,0.00009130186,0.000031991087,0.0006377952,0.000091368434,0.0020902862,0.00054178224,0.0005088413,0.00015850962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014876612,0.0021967676,0.49102485,0.000039725874,0.00010237613,0.00001710251,0.012491942,0.00018366084,0.024740685,0.0028456508,0.0059581785,0.4602503],"study_design_scores_gemma":[0.00042532635,0.00027961936,0.95086855,0.00001624091,0.0000026901996,0.0000060354955,0.0005280088,0.00061264733,0.022688312,0.001034195,0.023318065,0.00022029558],"about_ca_topic_score_codex":0.001164167,"about_ca_topic_score_gemma":0.0001666023,"teacher_disagreement_score":0.46003,"about_ca_system_score_codex":0.00071162876,"about_ca_system_score_gemma":0.00022079691,"threshold_uncertainty_score":0.40343353},"labels":[],"label_agreement":null},{"id":"W2085471026","doi":"10.1158/1538-7445.am10-901","title":"Abstract 901: Prediagnostic body mass index (BMI), plasma C-peptide levels, and cigarette smoking predict prostate cancer-specific and overall mortality: A 27-year survival analysis in men with PCa","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Body mass index; Hazard ratio; Prostate cancer; Internal medicine; Proportional hazards model; Cancer; Confidence interval; Hyperinsulinemia; Multivariate analysis; Oncology; Obesity; Insulin resistance","score_opus":0.037889141416986384,"score_gpt":0.3310938366855573,"score_spread":0.2932046952685709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085471026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943747,0.0024666297,0.00000859206,0.000479752,0.00008940366,0.0010254208,0.00037227047,0.000038911727,0.0011443143],"genre_scores_gemma":[0.9957321,0.003205092,0.000017271737,0.000026013024,0.00033033272,0.0002596622,0.00006265569,0.000047059184,0.00031977062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668825,0.0001473044,0.00031169527,0.00080194155,0.0013312176,0.0007195695],"domain_scores_gemma":[0.99834865,0.00023214232,0.00007016691,0.0006036194,0.0002256155,0.0005198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012690539,0.00025929135,0.0006422062,0.00050016394,0.00015883983,0.00016306684,0.00015244207,0.00017250575,0.0001987207],"category_scores_gemma":[0.00010314293,0.00021969852,0.00013684391,0.00088429404,0.00039381313,0.00020706294,0.000137715,0.001368036,0.0000014085057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008669635,0.00007485491,0.9875128,0.000266308,0.002739808,0.00051862455,0.00020114823,0.00017959197,0.0058597117,0.000024932984,0.00040684102,0.0013483892],"study_design_scores_gemma":[0.0034743252,0.00009870934,0.991955,0.0003302078,0.0009255455,0.000010298397,0.00017663601,0.00068727625,0.0012957545,0.00004846513,0.0007586821,0.00023912592],"about_ca_topic_score_codex":0.004467458,"about_ca_topic_score_gemma":0.004396919,"teacher_disagreement_score":0.004563957,"about_ca_system_score_codex":0.00017370189,"about_ca_system_score_gemma":0.0005183486,"threshold_uncertainty_score":0.89590454},"labels":[],"label_agreement":null},{"id":"W2085643068","doi":"10.1158/0008-5472.can-05-0134","title":"A Novel Function for Galectin-7: Promoting Tumorigenesis by Up-regulating<i>MMP-9</i>Gene Expression","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Lymphoma; Cancer research; Biology; Cancer cell; Transfection; Carcinogenesis; Metastasis; Galectin-3; Cancer; Galectin-1; Galectin; Immunology; Gene; Genetics","score_opus":0.05974444788732284,"score_gpt":0.36292706599268293,"score_spread":0.30318261810536007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085643068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98199755,0.010168278,0.0035620246,0.0010725318,0.0014418671,0.0010259683,0.0001517065,0.00012103171,0.00045903597],"genre_scores_gemma":[0.98218024,0.00016747617,0.00040126726,0.00016005151,0.00059458293,0.0013138747,0.00015554161,0.000049356488,0.01497762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977545,0.00021394703,0.0003235765,0.00065326807,0.00010635446,0.0009483455],"domain_scores_gemma":[0.99887234,0.00023148872,0.00011534099,0.0003206392,0.00040301966,0.00005719378],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010073176,0.00020007111,0.00027553155,0.000162694,0.00080604345,0.000034011446,0.00029862762,0.00029808303,0.0010169342],"category_scores_gemma":[0.00016920008,0.00017544384,0.000104002625,0.00035147052,0.0002162084,0.00010466158,0.00012380342,0.0004821783,0.000092104565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005802396,0.000105681356,0.00073154597,0.000040905088,0.00005866239,7.9499884e-8,0.00032614236,0.000012750016,0.9193974,0.00004410874,0.043835998,0.03486649],"study_design_scores_gemma":[0.0014843182,0.000363625,0.00035141682,0.00004721339,0.0000142768895,0.000016168127,0.0001259532,0.000014312162,0.78090847,0.000052067167,0.21646011,0.00016209675],"about_ca_topic_score_codex":0.00039215566,"about_ca_topic_score_gemma":0.00022695746,"teacher_disagreement_score":0.17262411,"about_ca_system_score_codex":0.00028710568,"about_ca_system_score_gemma":0.0002589119,"threshold_uncertainty_score":0.9998963},"labels":[],"label_agreement":null},{"id":"W2085907988","doi":"10.1158/1538-7445.am2011-2355","title":"Abstract 2355: Full-length wild-type CD99 increases the migration and invasiveness of human malignant glioma cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CD99; Glioma; Anoikis; Biology; Cancer research; CD44; Cell migration; Pathology; Cell; Cell biology; Cancer; Cancer cell; Stem cell; Medicine; Genetics","score_opus":0.06759107846898636,"score_gpt":0.34321750920446104,"score_spread":0.27562643073547466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085907988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848206,0.010415268,0.000004598945,0.000045615907,0.00022072095,0.00025721267,0.000037153703,0.00000443076,0.0005329511],"genre_scores_gemma":[0.99191946,0.0070535606,0.000022509577,0.000033104025,0.0005916663,0.000061055056,0.000024905665,0.000018592269,0.00027513446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988875,0.0001223172,0.00017650696,0.00028971728,0.0002465316,0.00027743267],"domain_scores_gemma":[0.99911517,0.000027918326,0.000069286325,0.00037302857,0.0003228404,0.000091781716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005395752,0.000109941655,0.00014318817,0.00007564047,0.00016174778,0.000022675791,0.00025570058,0.00010368071,0.00013116785],"category_scores_gemma":[0.000057466877,0.00008097622,0.00004871822,0.0001771724,0.0003256137,0.00000772773,0.00014099157,0.00013741005,0.000003876502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023079042,0.000058916656,0.0008598918,0.00006189037,0.000043996853,0.0000022271304,0.00024270822,0.0000024396966,0.99313205,0.00012523556,0.002712058,0.0025277624],"study_design_scores_gemma":[0.00034654117,0.00024307074,0.021346504,0.00004169277,0.00001820405,0.0000064750025,0.0002889772,0.0000015013745,0.95932096,0.0001230661,0.018155728,0.00010728702],"about_ca_topic_score_codex":0.0054161954,"about_ca_topic_score_gemma":0.0023995773,"teacher_disagreement_score":0.03381113,"about_ca_system_score_codex":0.000015959033,"about_ca_system_score_gemma":0.00024692822,"threshold_uncertainty_score":0.81877035},"labels":[],"label_agreement":null},{"id":"W2086233075","doi":"10.1158/1538-7445.am2013-2932","title":"Abstract 2932: HIF-2 alpha is required for the tumor stemness switch of cancer cells during hypoxia/oxidative stress.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Homeobox protein NANOG; Cancer stem cell; Cancer research; Biology; Cancer cell; Stem cell; Population; Side population; Immunology; Cell biology; Induced pluripotent stem cell; Cancer; Medicine; Embryonic stem cell","score_opus":0.04743009392600597,"score_gpt":0.3593994257250037,"score_spread":0.3119693317989978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086233075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686911,0.02710449,0.000041907042,0.00080380705,0.0009383701,0.001492416,0.0006299895,0.000010097513,0.00028783712],"genre_scores_gemma":[0.98103696,0.010556962,0.000056774843,0.00015383236,0.0023310245,0.002293889,0.000024710782,0.00006282706,0.0034830414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976994,0.00008038608,0.00036311182,0.0005876296,0.0005208221,0.00074869883],"domain_scores_gemma":[0.9979075,0.00012024353,0.00017116708,0.00070356386,0.0009301354,0.0001673673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047530915,0.00022966413,0.0003122961,0.00009324537,0.00030961682,0.0000731303,0.0006693821,0.00014332394,0.0007837569],"category_scores_gemma":[0.00008473072,0.0001730922,0.00018055322,0.00028600404,0.0003500943,0.000021146801,0.00023963672,0.00027682318,0.000018804227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025510867,0.00005952196,0.00024348519,0.00027102628,0.00019498712,6.2862676e-7,0.00029540932,0.00008061025,0.96281695,0.000015240211,0.024337593,0.0114294235],"study_design_scores_gemma":[0.0010281891,0.000079771606,0.008974128,0.000097308155,0.00003143141,9.868382e-7,0.0006185326,0.000021419628,0.93149704,0.000081213955,0.05736477,0.00020521121],"about_ca_topic_score_codex":0.0058668344,"about_ca_topic_score_gemma":0.00095709716,"teacher_disagreement_score":0.033027176,"about_ca_system_score_codex":0.000091635964,"about_ca_system_score_gemma":0.00057440915,"threshold_uncertainty_score":0.88689375},"labels":[],"label_agreement":null},{"id":"W2086266172","doi":"10.1158/1538-7445.am2013-857","title":"Abstract 857: Anti-tumor and anti-metastatic activity of the eIF4E-targeted drug ribavirin in human and murine models of breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Clonogenic assay; Ribavirin; EIF4E; Cancer; Metastasis; Metastatic breast cancer; Breast cancer; Oncogene; In vivo; Medicine; Cancer cell; Biology; Immunology; Internal medicine; Cell cycle; Translation (biology); Messenger RNA; Virus; Biochemistry","score_opus":0.05163084837579567,"score_gpt":0.3702067618812005,"score_spread":0.3185759135054048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086266172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951358,0.0010867349,9.5202194e-7,0.0024312316,0.0000249659,0.0009505565,0.000078856065,0.0000074238533,0.00028347076],"genre_scores_gemma":[0.99781436,0.0007238861,0.000045583984,0.000015137686,0.000022451626,0.00017174774,0.000004530976,0.000019561676,0.0011827248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984593,0.00011036886,0.00028196664,0.00029182818,0.00050040876,0.00035616267],"domain_scores_gemma":[0.9991664,0.000105609826,0.00009815871,0.00027195064,0.00022889124,0.00012896859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049985806,0.00014745526,0.00043618973,0.0002240905,0.00009585543,0.000017398053,0.00011903302,0.000031630756,0.00033252794],"category_scores_gemma":[0.000024913057,0.00009746791,0.000040018986,0.00041728542,0.00038913076,0.00017042819,0.00014610756,0.0003293312,0.0000021488897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001617277,0.000642284,0.55753046,0.0012148798,0.00023574117,0.00003772865,0.0017344924,0.00007634355,0.4278537,0.00008267651,0.0015758483,0.008854119],"study_design_scores_gemma":[0.0019459139,0.00002664931,0.91210264,0.0005541319,0.00002770752,0.0000087101425,0.00020976391,0.00037049083,0.08445242,0.00017961107,0.000034069737,0.00008788837],"about_ca_topic_score_codex":0.012079336,"about_ca_topic_score_gemma":0.0011209075,"teacher_disagreement_score":0.35457218,"about_ca_system_score_codex":0.00014357528,"about_ca_system_score_gemma":0.00035477013,"threshold_uncertainty_score":0.9944993},"labels":[],"label_agreement":null},{"id":"W2086283917","doi":"10.1158/1538-7445.am2013-88","title":"Abstract 88: Comparative tumorigenesis of progranulin and fibroblast growth factor 4 and in adrenocortical carcinoma cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Adrenocortical carcinoma; Carcinogenesis; Transcriptome; Cancer research; Fibroblast growth factor; Cell growth; Cancer cell; Cell biology; Cancer; Gene expression; Endocrinology; Gene; Genetics; Receptor","score_opus":0.047488383642681035,"score_gpt":0.3461847441148167,"score_spread":0.29869636047213566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086283917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926271,0.0064983675,0.0000047126837,0.00008158903,0.00006905167,0.00048327274,0.00004798738,0.000002909411,0.00018500509],"genre_scores_gemma":[0.9972926,0.0019782744,0.00009474107,0.00001356373,0.0002710757,0.00018833506,0.00000969331,0.000012900643,0.00013884288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888915,0.0000672551,0.00018867107,0.00033123686,0.00018774508,0.00033592715],"domain_scores_gemma":[0.99941504,0.000029015544,0.000035303754,0.00015475594,0.00021245245,0.00015343234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014270065,0.00011448237,0.00021309766,0.00008869728,0.00004710062,0.000030793086,0.00011145983,0.00009266408,0.00007683356],"category_scores_gemma":[0.000026648477,0.0001012323,0.000030064039,0.00014307856,0.00036127976,0.000008534932,0.00011355267,0.00016452029,0.000004222398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012249775,0.000103962346,0.010457595,0.00013131234,0.000016919688,9.211921e-7,0.00028374026,0.0000012505516,0.983835,0.000016697171,0.0011142163,0.0039159106],"study_design_scores_gemma":[0.00105159,0.00014095244,0.37989762,0.000031693413,0.0000036021202,0.0000018503338,0.00019478408,0.000013205014,0.61655575,0.000047146565,0.0019501438,0.00011161759],"about_ca_topic_score_codex":0.0020646125,"about_ca_topic_score_gemma":0.0005594929,"teacher_disagreement_score":0.36944005,"about_ca_system_score_codex":0.000018579281,"about_ca_system_score_gemma":0.00015990772,"threshold_uncertainty_score":0.41281334},"labels":[],"label_agreement":null},{"id":"W2086331395","doi":"10.1158/0008-5472.fbcr09-a54","title":"Abstract A54: CnABP, a novel modulator of the Calcineurin-NFAT signaling pathway, is overexpressed in Wilms' tumors and promotes cell migration","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"NFAT; Calcineurin; Biology; Cancer research; Molecular biology; Cell growth; Pronephros; Cell biology; Internal medicine; Transplantation; Gene; Biochemistry; Medicine","score_opus":0.02569331136609136,"score_gpt":0.310623772195205,"score_spread":0.2849304608291136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086331395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971338,0.0016632219,0.0000067958395,0.0006031743,0.000029943982,0.00027433637,0.000036426794,0.000002707254,0.0002496272],"genre_scores_gemma":[0.99915063,0.00038751125,0.00001860705,0.00009331875,0.00007003177,0.00002275531,0.000007330694,0.000008385997,0.00024143982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990206,0.00003901475,0.00017540288,0.0002715183,0.00024918598,0.00024432052],"domain_scores_gemma":[0.99955577,0.000013750656,0.00005806931,0.0002085221,0.000105606894,0.000058265236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021440968,0.00009630368,0.000109991975,0.000054680528,0.000066479864,0.000018679559,0.00016713495,0.00011768849,0.00001509475],"category_scores_gemma":[0.000030318623,0.000066305685,0.000048726855,0.00019109332,0.000107742955,0.0000058712294,0.00005541952,0.00024643977,6.7914397e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084291445,0.0000568583,0.001579683,0.000063326035,0.0000086575865,0.0000014919945,0.00020592131,0.00059501774,0.9963169,0.000007733744,0.00037720648,0.00070288783],"study_design_scores_gemma":[0.0005069926,0.00013771052,0.0104485415,0.00014738651,0.000002553399,0.0000017834863,0.0000634352,0.00012691387,0.9877918,0.000068436166,0.0006215213,0.000082965445],"about_ca_topic_score_codex":0.0005348762,"about_ca_topic_score_gemma":0.00006703248,"teacher_disagreement_score":0.008868859,"about_ca_system_score_codex":0.00003304918,"about_ca_system_score_gemma":0.00020275201,"threshold_uncertainty_score":0.27038676},"labels":[],"label_agreement":null},{"id":"W2086372842","doi":"10.1158/1538-7445.am2011-853","title":"Abstract 853: The effect of maternal folic acid supplementation during pregnancy and lactation on global DNA methylation in the offspring","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Offspring; Lactation; Pregnancy; Weaning; DNA methylation; Biology; Epigenetics; Methylation; Endocrinology; Gestation; Internal medicine; Physiology; Andrology; Medicine; Biochemistry; Genetics; DNA; Gene; Gene expression","score_opus":0.08122868065629975,"score_gpt":0.4277348627517608,"score_spread":0.3465061820954611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086372842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966511,0.00052059785,0.0000029534658,0.0003767893,0.000026228256,0.00083059625,0.000009425636,0.000005542555,0.0015767359],"genre_scores_gemma":[0.99930984,0.00039310465,0.000009368455,0.000008081626,0.00004962446,0.00016960387,0.000006642086,0.000007833663,0.000045930647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984801,0.00027473608,0.00016981829,0.00016107601,0.0006517892,0.000262489],"domain_scores_gemma":[0.99949896,0.00015933992,0.000039675302,0.00018364657,0.00008025351,0.000038140755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010841605,0.00007323016,0.000111039,0.00013098428,0.00010726905,0.00002652583,0.00013116983,0.000042058746,0.000139737],"category_scores_gemma":[0.000097218,0.000039826227,0.000028323451,0.0003465105,0.00011433895,0.000107217274,0.000042047588,0.00028930974,0.000008852825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024137192,0.00008129403,0.49406067,0.0009413493,0.000075292606,0.00005967788,0.0040920465,0.000005684116,0.4009981,0.00029602705,0.000060392325,0.09691576],"study_design_scores_gemma":[0.0008783718,0.00037598328,0.6343408,0.00028639683,0.000007894052,0.0000044259355,0.00019591219,0.000020978809,0.36380416,0.000053615462,0.000008911114,0.000022535743],"about_ca_topic_score_codex":0.0016809952,"about_ca_topic_score_gemma":0.00037514037,"teacher_disagreement_score":0.14028013,"about_ca_system_score_codex":0.00015347282,"about_ca_system_score_gemma":0.00005356196,"threshold_uncertainty_score":0.2541173},"labels":[],"label_agreement":null},{"id":"W2086435807","doi":"10.1158/0008-5472.can-05-1149","title":"Angiopoietin 2 Induces Glioma Cell Invasion by Stimulating Matrix Metalloprotease 2 Expression through the αvβ1 Integrin and Focal Adhesion Kinase Signaling Pathway","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; James S. McDonnell Foundation","keywords":"Focal adhesion; Integrin; Glioma; Cancer research; Signal transduction; Cell biology; Integrin-linked kinase; Biology; Extracellular matrix; Kinase; MAPK/ERK pathway; Cell adhesion; Cell migration; Chemistry; Protein kinase A; Cell; Biochemistry; Cyclin-dependent kinase 2","score_opus":0.060771392069380425,"score_gpt":0.3767620630240295,"score_spread":0.31599067095464906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086435807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854764,0.00997104,0.00025582506,0.00175235,0.000053640662,0.0015466877,0.000025090148,0.00006578007,0.0008532241],"genre_scores_gemma":[0.99555475,0.00022379226,0.0010547378,0.00007674158,0.00033835656,0.0003227988,0.000057229587,0.00008050713,0.0022910817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994835,0.00085902424,0.00050055113,0.0008188895,0.002059584,0.0009269044],"domain_scores_gemma":[0.9975912,0.00082262326,0.000111520625,0.0006246963,0.0005318898,0.0003180754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020322325,0.00030214086,0.0003836098,0.00023304208,0.00070417044,0.00021159963,0.00039379575,0.00025151408,0.00060440507],"category_scores_gemma":[0.00056322257,0.00019642118,0.00013537567,0.0010198123,0.00043891824,0.00022652908,0.00070000085,0.0015349721,0.000058210226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006029475,0.00021715002,0.00048891356,0.00030348913,0.000012643895,0.00025259505,0.00040247184,0.000095400916,0.9855686,0.000032076394,0.0069940356,0.0050296704],"study_design_scores_gemma":[0.0016605508,0.0004898634,0.00022429532,0.00059222145,0.000021494154,0.000021568347,0.0010739574,0.00049695163,0.98751205,0.00034061132,0.007354772,0.00021166043],"about_ca_topic_score_codex":0.0038433047,"about_ca_topic_score_gemma":0.000042534964,"teacher_disagreement_score":0.010078392,"about_ca_system_score_codex":0.00031886957,"about_ca_system_score_gemma":0.00035873108,"threshold_uncertainty_score":0.8009823},"labels":[],"label_agreement":null},{"id":"W2086609246","doi":"10.1158/1538-7445.am2011-3906","title":"Abstract 3906: Gene expression profiling of ductal carcinoma in situ reveals novel alterations in the tumor and stromal compartments related to progession and outcome of invasive breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Myoepithelial cell; Biology; Ductal carcinoma; Stromal cell; Breast cancer; Metastasis; Gene expression profiling; Cancer research; Pathology; Gene expression; Gene signature; Cancer; Estrogen receptor; Gene; Medicine; Immunohistochemistry; Immunology; Genetics","score_opus":0.07945914663754859,"score_gpt":0.38201013886330426,"score_spread":0.30255099222575565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086609246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975091,0.00095880654,0.000030407491,0.00012033353,0.000031691354,0.0011058883,0.00014646968,0.0000019185484,0.00009534175],"genre_scores_gemma":[0.99894464,0.0001570274,0.00041155363,0.000022715389,0.000023789082,0.0003733957,0.000028054206,0.000019173109,0.000019660965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829113,0.00017924496,0.0003856622,0.0004006625,0.0003928353,0.00035046224],"domain_scores_gemma":[0.99924445,0.0000354167,0.00009090795,0.00028551,0.00024225182,0.000101448466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079518807,0.00012587408,0.00020979413,0.00022079117,0.00006850469,0.000015322048,0.0002315693,0.00010629183,0.000031711115],"category_scores_gemma":[0.00009793404,0.00009989446,0.000028825561,0.00033805048,0.00015669836,0.000013871436,0.00027592282,0.00032865882,4.964439e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040025427,0.00012610658,0.07836998,0.00012172495,0.000015874037,0.000019527277,0.0007708413,0.00006346403,0.9198987,0.000039782582,0.000027668662,0.00014607959],"study_design_scores_gemma":[0.00078973843,0.00015010974,0.23686104,0.00019417777,0.0000038321837,0.00001746284,0.00045663965,0.00001758096,0.76139927,0.000032522283,0.0000023514087,0.00007528792],"about_ca_topic_score_codex":0.0013226303,"about_ca_topic_score_gemma":0.0009470219,"teacher_disagreement_score":0.15849943,"about_ca_system_score_codex":0.00007557497,"about_ca_system_score_gemma":0.0002750379,"threshold_uncertainty_score":0.40735778},"labels":[],"label_agreement":null},{"id":"W2086634671","doi":"10.1158/0008-5472.sabcs11-p2-12-07","title":"P2-12-07: Pooled Analysis of Outcomes of T1a/bN0, HER2−Amplified Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Breast cancer; Oncology; Hazard ratio; Odds ratio; Confidence interval; Cancer; Chemotherapy; Hormone receptor; Gastroenterology","score_opus":0.08168951850329031,"score_gpt":0.39427103372460987,"score_spread":0.31258151522131955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086634671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303734,0.0030106332,0.00004180889,0.00040313587,0.00011754916,0.0002563639,0.0011319155,0.000010183166,0.001991083],"genre_scores_gemma":[0.9971558,0.0015178433,0.00008867995,0.000059789138,0.00009257018,0.00022764299,0.000060074297,0.000028659073,0.0007689371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807256,0.0001380748,0.00035879546,0.00048631823,0.00046824515,0.00047600656],"domain_scores_gemma":[0.9983789,0.000046419536,0.00015603317,0.00066853355,0.0006336421,0.00011647678],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003495734,0.00020142298,0.00057845557,0.00028919807,0.0000960202,0.000007741118,0.0004226793,0.00013193197,0.0010233363],"category_scores_gemma":[0.000050313527,0.00016751465,0.00027547058,0.00072332023,0.0004496124,0.0000058827345,0.0002854328,0.00014204728,0.0000069384673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010136317,0.0003801937,0.8636687,0.00009520187,0.011645988,0.0000048555007,0.0007585586,0.00006968751,0.112697855,0.0001677147,0.0023752416,0.0071223853],"study_design_scores_gemma":[0.00078824995,0.000108818436,0.8475935,0.00003311104,0.00079028314,0.0000012813194,0.00027217396,0.0000069188945,0.14963484,0.00004908125,0.00055679743,0.00016498352],"about_ca_topic_score_codex":0.01862493,"about_ca_topic_score_gemma":0.0066524977,"teacher_disagreement_score":0.03693698,"about_ca_system_score_codex":0.00010818458,"about_ca_system_score_gemma":0.00031978817,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2086634689","doi":"10.1158/1538-7445.am2014-314","title":"Abstract 314: Low-dose NAMPT inhibition by FK866 initiates autophagy to counteract cellular energy crisis, which is overridden by apoptosis at higher drug concentrations","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; NAD+ kinase; Biology; Autophagy; Programmed cell death; Nicotinamide adenine dinucleotide; Apoptosis; Cell biology; Cancer research; Chronic lymphocytic leukemia; Cancer cell; Viability assay; Cell culture; Cell growth; Biochemistry; Leukemia; Cancer; Enzyme; Immunology","score_opus":0.025702185378591935,"score_gpt":0.35246202596682624,"score_spread":0.3267598405882343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086634689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96338135,0.0045072823,0.00007473954,0.025932912,0.0007733426,0.00057929,0.00031653274,0.00008162115,0.0043529416],"genre_scores_gemma":[0.97644943,0.0018434959,0.000021376663,0.0076893615,0.0012460813,0.00032731207,0.00063476036,0.00007571613,0.011712464],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961523,0.00020278769,0.0005067793,0.00071676663,0.0015323075,0.00088909693],"domain_scores_gemma":[0.9974096,0.00031854789,0.000099953635,0.0006034013,0.0008655466,0.0007029465],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081023877,0.00030648243,0.00048477782,0.00023679472,0.00042432104,0.00011907354,0.00022381142,0.00021596478,0.0075082467],"category_scores_gemma":[0.00015866799,0.00025428724,0.00010378525,0.0006900294,0.00018066121,0.00019599193,0.0001321601,0.0006802472,0.00023941099],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021509915,0.00015228371,0.00023968701,0.00008827569,0.00006634321,0.000009949698,0.00035430887,0.000010273497,0.43131033,0.000080243,0.56703913,0.00043406337],"study_design_scores_gemma":[0.0020769483,0.00028320754,0.0007521332,0.00040268488,0.00004682769,0.0000029937105,0.0002337152,0.00021166832,0.59209716,0.00004923306,0.40361097,0.0002324419],"about_ca_topic_score_codex":0.0037838148,"about_ca_topic_score_gemma":0.00018451095,"teacher_disagreement_score":0.16342819,"about_ca_system_score_codex":0.0008022714,"about_ca_system_score_gemma":0.00033015735,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W2086901983","doi":"10.1158/0008-5472.sabcs11-p1-08-04","title":"P1-08-04: Obesity, Adjuvant Therapy, and Survival Outcomes in Early-Stage Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Body mass index; Oncology; Adjuvant therapy; Overweight; Underweight; Stage (stratigraphy); Proportional hazards model; Tamoxifen; Cancer; Cohort; Gynecology","score_opus":0.18507410888658848,"score_gpt":0.42889013932048903,"score_spread":0.24381603043390054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086901983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915682,0.003965854,0.0000022135687,0.00103931,0.0002960191,0.0006507634,0.00020976448,0.0000386146,0.0022292365],"genre_scores_gemma":[0.984805,0.0109731965,0.000017782608,0.00014036978,0.00020709336,0.00022187506,0.000004458459,0.00004607899,0.0035841432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997679,0.00013372496,0.00026009657,0.00048501536,0.0007143503,0.00072783174],"domain_scores_gemma":[0.99891484,0.00009042272,0.000045920748,0.00041596,0.00020031666,0.00033251848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006899798,0.00020551895,0.00052210357,0.0003092599,0.00012514267,0.00004127028,0.0002136604,0.00012683388,0.003077001],"category_scores_gemma":[0.000026366433,0.00015609754,0.000079848556,0.0004595515,0.00034020538,0.00013554034,0.00017331586,0.00070882513,0.000030301904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007544482,0.00019057418,0.9731132,0.00007904444,0.00007458833,0.000091145674,0.00223295,6.724101e-7,0.0011418954,0.00015831109,0.0005295637,0.0216336],"study_design_scores_gemma":[0.002414672,0.00021827719,0.99130243,0.00014226805,0.000011038696,0.000006307479,0.00044040818,0.000011173323,0.0015743781,0.00009119022,0.0036140971,0.0001737602],"about_ca_topic_score_codex":0.14221533,"about_ca_topic_score_gemma":0.022804959,"teacher_disagreement_score":0.11941036,"about_ca_system_score_codex":0.00039503525,"about_ca_system_score_gemma":0.00049830286,"threshold_uncertainty_score":0.9978343},"labels":[],"label_agreement":null},{"id":"W2087045665","doi":"10.1158/1538-7445.am10-2594","title":"Abstract 2594: Reovirus replication in ovarian and peritoneal tumors after intravenous administration","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Ovarian cancer; Oncolytic virus; Medicine; Ascites; Immunohistochemistry; Population; Virology; Pathology; Viral replication; Virus; Cancer research; Internal medicine; Cancer","score_opus":0.03290396076926438,"score_gpt":0.39123071850542657,"score_spread":0.3583267577361622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087045665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702376,0.00056124484,0.00000536271,0.0010137937,0.000059299033,0.00040518385,0.00002482291,0.0000068775603,0.00089964183],"genre_scores_gemma":[0.9982921,0.0004246789,0.000072076495,0.00008920264,0.00034844232,0.0004475441,0.000047831218,0.00002862073,0.0002494936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835753,0.000114150454,0.00019506132,0.0005686856,0.00033196987,0.00043258336],"domain_scores_gemma":[0.9989401,0.000023687104,0.000031135554,0.0006727297,0.00017850228,0.00015384334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013527825,0.000110726265,0.00010118748,0.00014302481,0.000107417814,0.0000769381,0.00022646954,0.00018101934,0.00018458825],"category_scores_gemma":[0.00016490924,0.00011294202,0.000026208729,0.00020164596,0.00026118354,0.000009228599,0.00009393362,0.0006148492,0.000018069803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00242178,0.00006621219,0.0035581843,0.000024654584,0.000009123726,0.000023864666,0.00010674128,0.0000025816178,0.96809936,0.000031786694,0.0001343228,0.025521403],"study_design_scores_gemma":[0.00052619446,0.0010406583,0.106536604,0.000019481708,0.0000014153545,0.000018577122,0.00006290479,0.000016821341,0.88574904,0.00015659905,0.0057153013,0.0001564201],"about_ca_topic_score_codex":0.00043600664,"about_ca_topic_score_gemma":0.00927788,"teacher_disagreement_score":0.102978416,"about_ca_system_score_codex":0.000049150494,"about_ca_system_score_gemma":0.00056284416,"threshold_uncertainty_score":0.5177275},"labels":[],"label_agreement":null},{"id":"W2087355395","doi":"10.1158/0008-5472.can-10-2041","title":"Overexpression of the Protein Tyrosine Phosphatase PRL-2 Correlates with Breast Tumor Formation and Progression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Mammary tumor; Biology; Protein tyrosine phosphatase; Genetically modified mouse; Carcinogenesis; Mammary gland; Tumor progression; Metastasis; Internal medicine; Endocrinology; Cancer; Mouse mammary tumor virus; Transgene; Signal transduction; Breast cancer; Medicine; Cell biology; Immunology","score_opus":0.013160730577689086,"score_gpt":0.31781265788845,"score_spread":0.3046519273107609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087355395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296606,0.0053801695,0.00002834559,0.0003344385,0.000038961367,0.0009960599,0.00020588876,0.0000067287747,0.000043328597],"genre_scores_gemma":[0.99896383,0.00006274127,0.00032253764,0.000020815487,0.00007933597,0.00034678457,0.00006738796,0.000017693414,0.00011886494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989672,0.00007324368,0.00013219503,0.0002353551,0.00035357976,0.0002384296],"domain_scores_gemma":[0.99914783,0.000012313277,0.00009846174,0.00040444164,0.0002619379,0.000074993666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032756338,0.00010287727,0.000087818094,0.00003121005,0.00017413899,0.000031929194,0.00023383746,0.0000742507,0.000034010103],"category_scores_gemma":[0.00012617245,0.000059458558,0.000020808138,0.00016852675,0.0003881334,0.00001898892,0.00030430272,0.0002919712,0.0000014478026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232668,0.000046022084,0.0033326023,0.00010739103,0.000006907057,9.689629e-7,0.000021095175,0.0000028730942,0.9882015,0.0005619527,0.0013136655,0.0058817826],"study_design_scores_gemma":[0.00058069464,0.00021300928,0.004635136,0.00042718241,0.0000041640255,0.00003503183,0.000019814695,0.000034895522,0.9912031,0.0000867145,0.0026761012,0.00008409928],"about_ca_topic_score_codex":0.00010026853,"about_ca_topic_score_gemma":0.000068393405,"teacher_disagreement_score":0.0059977598,"about_ca_system_score_codex":0.000012833067,"about_ca_system_score_gemma":0.00016565339,"threshold_uncertainty_score":0.24246496},"labels":[],"label_agreement":null},{"id":"W2087454200","doi":"10.1158/0008-5472.can-08-1771","title":"Early Therapy Evaluation of Combined Anti–Death Receptor 5 Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts by Diffusion-Weighted Magnetic Resonance Imaging","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gemcitabine; Magnetic resonance imaging; Effective diffusion coefficient; Apoptosis; Medicine; Pancreatic cancer; Nuclear medicine; Immunohistochemistry; Pathology; Saline; Urology; Chemotherapy; Cancer; Internal medicine; Chemistry; Radiology","score_opus":0.05424293647279768,"score_gpt":0.3795943034604951,"score_spread":0.3253513669876974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087454200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94350255,0.053885173,5.869253e-7,0.00078372424,0.000054406162,0.0015572554,0.000027270606,0.000016624886,0.00017242983],"genre_scores_gemma":[0.98396397,0.015154186,0.000069245645,0.00004903554,0.000048483165,0.00048176624,0.00005511559,0.000027296584,0.00015088698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974493,0.00032089962,0.00032726285,0.00040368526,0.0010816626,0.00041720064],"domain_scores_gemma":[0.9987372,0.00016975269,0.00006394138,0.00033590442,0.000552152,0.00014106138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080333056,0.00016422219,0.00041602482,0.0003507756,0.00013131251,0.00001782515,0.00009556984,0.000044979814,0.00040715278],"category_scores_gemma":[0.00011519425,0.000117776304,0.000045599078,0.0007242957,0.00023357305,0.0000817255,0.000049292525,0.00022442862,0.000006894121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037932588,0.0005732156,0.8382302,0.00004344289,0.000017215083,0.0000704813,0.00042821252,3.1935062e-7,0.1397525,0.0000149766565,0.000496432,0.01999366],"study_design_scores_gemma":[0.01153334,0.00066541875,0.961761,0.00045417438,0.00003160601,0.000016386157,0.00005624465,0.0006277594,0.023472905,0.000046798865,0.0012238601,0.00011052844],"about_ca_topic_score_codex":0.0028550175,"about_ca_topic_score_gemma":0.000029681465,"teacher_disagreement_score":0.12353077,"about_ca_system_score_codex":0.00020054622,"about_ca_system_score_gemma":0.00031373207,"threshold_uncertainty_score":0.48027784},"labels":[],"label_agreement":null},{"id":"W2087607884","doi":"10.1158/1538-7445.am2013-3829a","title":"Abstract 3829A: Pantoprazole enhances the activity of chemotherapy for solid tumors by inhibition of autophagy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Autophagy; Docetaxel; Cancer cell; In vivo; Cytotoxicity; Cancer research; Apoptosis; Transfection; Pharmacology; In vitro; Chemistry; Cell culture; Cancer; Biology; Biochemistry","score_opus":0.0274947828000657,"score_gpt":0.36707567096391236,"score_spread":0.3395808881638467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087607884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951453,0.0026663325,0.00015811987,0.00052131293,0.00049520895,0.0005928528,0.00011219111,0.0000038410863,0.0003047986],"genre_scores_gemma":[0.9939939,0.0026844796,0.00003091078,0.00006654966,0.001961551,0.00044146823,0.00002244151,0.000017493496,0.0007812035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990021,0.000050420538,0.0001841046,0.00022830418,0.00024401634,0.0002910638],"domain_scores_gemma":[0.99915737,0.00004784812,0.00011172213,0.00027995202,0.00035038733,0.000052729087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047503572,0.000093614115,0.00018254269,0.000037010446,0.00008372689,0.00001618147,0.0001904746,0.00009062299,0.0001540294],"category_scores_gemma":[0.000060682316,0.00006914884,0.00009255371,0.00010890428,0.0002946321,0.000010559879,0.00004776293,0.00012409448,0.000002475771],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013588436,0.000060765484,0.000033922563,0.00008268646,0.000031947086,6.829382e-9,0.00009485024,0.000005623212,0.91888136,0.000023162804,0.06267486,0.01797493],"study_design_scores_gemma":[0.00048743823,0.00012498733,0.0040760613,0.000027227072,0.0000039139063,3.2358798e-7,0.000096534146,0.0000111305935,0.9218365,0.00014268894,0.073124036,0.000069168396],"about_ca_topic_score_codex":0.0012453666,"about_ca_topic_score_gemma":0.00011404865,"teacher_disagreement_score":0.017905762,"about_ca_system_score_codex":0.000021871034,"about_ca_system_score_gemma":0.00023981671,"threshold_uncertainty_score":0.28198078},"labels":[],"label_agreement":null},{"id":"W2087619366","doi":"10.1158/0008-5472.sabcs13-ot3-2-08","title":"Abstract OT3-2-08: A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Enzalutamide; Androgen receptor; Triple-negative breast cancer; Medicine; Breast cancer; Bicalutamide; Internal medicine; Oncology; Clinical endpoint; Estrogen receptor; Cancer; Clinical trial; Cancer research; Prostate cancer","score_opus":0.024525369213811897,"score_gpt":0.37010402586971625,"score_spread":0.34557865665590437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087619366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972442,0.0005364744,0.0000010020103,0.00007093566,0.000060694736,0.0018190155,0.00017955957,0.0000029215523,0.00008520977],"genre_scores_gemma":[0.9992621,0.00044602551,0.000013753271,0.0000103261045,0.000037373997,0.00017096494,0.000008794988,0.000018782517,0.00003187183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824184,0.0004590046,0.00029177289,0.00037923397,0.00034081843,0.0002873449],"domain_scores_gemma":[0.9988693,0.00012807023,0.00017335727,0.0002851952,0.0004429135,0.00010114924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044448287,0.0001419312,0.00027751256,0.000058012545,0.00008264961,0.000010616559,0.00018634777,0.00014625951,0.00003986002],"category_scores_gemma":[0.00010651537,0.00009125969,0.000053306878,0.0002918282,0.00041690498,0.000016871936,0.00016087078,0.00042532792,9.1731465e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01393157,0.005855553,0.33520657,0.00006523851,0.00044633553,0.0000019263643,0.00070187746,0.000073910865,0.5495357,0.0000015922549,0.00019216101,0.093987554],"study_design_scores_gemma":[0.010309848,0.004053612,0.68805766,0.00016835477,0.000020875468,6.5227437e-7,0.00034962638,0.000007391195,0.29688364,0.000005125673,0.000021971546,0.00012124471],"about_ca_topic_score_codex":0.001333416,"about_ca_topic_score_gemma":0.00047442727,"teacher_disagreement_score":0.3528511,"about_ca_system_score_codex":0.0000780228,"about_ca_system_score_gemma":0.00024321896,"threshold_uncertainty_score":0.37214622},"labels":[],"label_agreement":null},{"id":"W2087703306","doi":"10.1158/1538-7445.am2011-1292","title":"Abstract 1292: Pharmacokinetics of CPX-351: A nano-scale liposomal fixed molar ratio of cytarabine-daunorubicin (Cyt:Daun) in patients with advanced leukemia","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Cmax; Pharmacokinetics; Medicine; Pharmacology; Daunorubicin; Cytarabine; Gastroenterology; Internal medicine; Leukemia","score_opus":0.03749578536470349,"score_gpt":0.33848637250749675,"score_spread":0.30099058714279325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087703306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951202,0.00049267453,0.000056788973,0.00009936632,0.00009028253,0.001762019,0.00011227483,0.000027841157,0.0022385498],"genre_scores_gemma":[0.9973396,0.00041837766,0.0012621213,0.000047283684,0.00009466011,0.00023006047,0.000047293197,0.00009210279,0.00046848482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99509895,0.00020666639,0.000829269,0.00063298416,0.002180679,0.0010514569],"domain_scores_gemma":[0.99660486,0.00032011405,0.0002262985,0.00079522416,0.0016617045,0.00039177394],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008943744,0.00031325375,0.0007653417,0.000742678,0.00007614866,0.000012540254,0.0005584061,0.00021603038,0.0011238528],"category_scores_gemma":[0.00032518627,0.0002534432,0.00010412144,0.0014530728,0.0007663112,0.00024510795,0.00024604308,0.001013542,0.000033806522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022330556,0.0014886678,0.2691546,0.0016202951,0.00029838362,0.00016872413,0.0030515792,0.00042852637,0.68544996,0.000054745004,0.0015706853,0.014383273],"study_design_scores_gemma":[0.017734628,0.0022801193,0.39363658,0.000956232,0.000055546854,0.000005581558,0.00027272134,0.0005178843,0.5839392,0.000030321864,0.00031869617,0.0002525082],"about_ca_topic_score_codex":0.0027860156,"about_ca_topic_score_gemma":0.0002767002,"teacher_disagreement_score":0.124481976,"about_ca_system_score_codex":0.0020758633,"about_ca_system_score_gemma":0.0036059788,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2087791044","doi":"10.1158/0008-5472.can-06-0494","title":"High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; National Institutes of Health; Vetenskapsrådet; Università degli Studi di Padova; Cancerfonden; Consejo Nacional de Ciencia y Tecnología; National Health and Medical Research Council; Cancer Research UK; Huntsman Cancer Foundation; University of Utah; University of Sydney; Australian Cancer Research Foundation; Huntsman Cancer Institute; Utah Department of Health; National Cancer Institute; Melanoma Research Alliance","keywords":"CDKN2A; Melanoma; Founder effect; p14arf; Cancer; Mutation; Pancreatic cancer; Genetics; Oncology; Medicine; Biology; Cancer research; Internal medicine; Gene; Allele; Haplotype; Tumor suppressor gene; Carcinogenesis","score_opus":0.03524421162704441,"score_gpt":0.37010159277199584,"score_spread":0.33485738114495145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087791044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96727186,0.03080035,0.0000031439097,0.0004465118,0.00015328302,0.00084734784,0.00024002716,0.000057424993,0.00018002675],"genre_scores_gemma":[0.9961618,0.001706397,0.000105842315,0.00002568933,0.00048506376,0.00034313637,0.00004019746,0.000034030836,0.0010978034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757314,0.00035302067,0.00029553342,0.00062967406,0.00041385167,0.00073480053],"domain_scores_gemma":[0.9988611,0.00018606371,0.000079611935,0.0003960506,0.00021542102,0.00026176992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007428046,0.00021980504,0.0005403779,0.00010120872,0.0005314759,0.00005579945,0.000107340034,0.0001677915,0.00007801337],"category_scores_gemma":[0.000039127823,0.00017319457,0.00005467492,0.0002574697,0.0005994873,0.000085464424,0.00015597635,0.00043993056,0.000015133634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005790544,0.00010523947,0.9783893,0.0005094277,0.00018099234,0.00043152715,0.00026681984,0.000010171087,0.004160641,0.00013381458,0.00020461244,0.015028406],"study_design_scores_gemma":[0.0038068693,0.00083916495,0.98864746,0.0001632064,0.00017619427,0.00015462674,0.0006226685,0.00021209328,0.004615314,0.00011749923,0.00047389505,0.00017101724],"about_ca_topic_score_codex":0.04581436,"about_ca_topic_score_gemma":0.009964539,"teacher_disagreement_score":0.035849825,"about_ca_system_score_codex":0.0006247276,"about_ca_system_score_gemma":0.00028546806,"threshold_uncertainty_score":0.96053964},"labels":[],"label_agreement":null},{"id":"W2087797579","doi":"10.1158/0008-5472.can-03-3830","title":"Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Complementary and Integrative Health; National Cancer Institute","keywords":"Castration; Prostate cancer; Medicine; Androgen; Internal medicine; Prostate; Endocrinology; Cancer; Hormone","score_opus":0.04231164477874217,"score_gpt":0.4556033153417651,"score_spread":0.41329167056302296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087797579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855365,0.0058891377,0.0000057227207,0.0036703162,0.00020315831,0.0037868833,0.000085072104,0.00005940805,0.000763813],"genre_scores_gemma":[0.9910249,0.0039821677,0.000047742476,0.000107516746,0.0003067218,0.002908898,0.000026628595,0.00006368215,0.0015317199],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99543524,0.00025218117,0.0003094691,0.0006953552,0.002213644,0.0010941416],"domain_scores_gemma":[0.9978877,0.00018837147,0.00006466153,0.00056406,0.0006840209,0.0006112415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012805943,0.00027943336,0.00051829213,0.0005676907,0.00024432832,0.000045057946,0.00032263703,0.00017592094,0.00024763608],"category_scores_gemma":[0.00019110346,0.00018282952,0.00012913597,0.0016762496,0.0003717499,0.00011688508,0.0002298409,0.00090877514,0.00013563644],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10058451,0.0016704281,0.1572498,0.0061139367,0.0006829558,0.0011060579,0.004752262,0.0009174641,0.34210646,0.00018116266,0.007099108,0.37753585],"study_design_scores_gemma":[0.0074113584,0.017333155,0.00537756,0.003820698,0.000049156773,0.000006084673,0.00009066606,0.000012013095,0.96285945,0.0001142456,0.0027025945,0.00022303613],"about_ca_topic_score_codex":0.0012140638,"about_ca_topic_score_gemma":0.0001275007,"teacher_disagreement_score":0.620753,"about_ca_system_score_codex":0.0013565439,"about_ca_system_score_gemma":0.0010990951,"threshold_uncertainty_score":0.7455571},"labels":[],"label_agreement":null},{"id":"W2088068141","doi":"10.1158/1538-7445.am10-1646","title":"Abstract 1646: Molecular pathways associated with Reolysin and gemcitabine synergy in ras-mutated human HCT116 cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; In vivo; Gene; Cell culture; In vitro; Gene expression; Cancer research; Biology; RNA interference; Interferon; Molecular biology; RNA; Virology; Virus; Biochemistry; Genetics","score_opus":0.029033854739396056,"score_gpt":0.3275619576715728,"score_spread":0.29852810293217674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088068141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587214,0.0016716936,0.0000021752096,0.0002235841,0.00017684666,0.0002633804,0.000033888722,0.000042976953,0.0017133055],"genre_scores_gemma":[0.99638635,0.00013266674,0.000005192899,0.00005441768,0.0000148092595,0.00008569476,0.00006385727,0.000034429584,0.0032225596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981269,0.00041147615,0.00025953582,0.0003905539,0.000106690226,0.00070481567],"domain_scores_gemma":[0.9990645,0.00025941647,0.00006473179,0.00032486994,0.00024000468,0.00004647411],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009873536,0.00018060513,0.00029474712,0.00036509067,0.00022159812,0.000044994147,0.00027376515,0.00031409637,0.0015139894],"category_scores_gemma":[0.00020677914,0.00014702408,0.00003910433,0.00037924357,0.0006313238,0.000083079954,0.00012450168,0.0014684029,0.000105204876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005558144,0.0001285471,0.0006737895,0.00001605419,0.000109464345,0.00010740745,0.00031293184,0.0000040029413,0.9954977,0.00047152647,0.00086105656,0.0012616998],"study_design_scores_gemma":[0.0019345722,0.00030070308,0.033807117,0.0001349825,0.000008698104,0.000013410964,0.00020522813,0.0000023554878,0.95977134,0.0000976749,0.0035274734,0.00019643272],"about_ca_topic_score_codex":0.0017670413,"about_ca_topic_score_gemma":0.0020989312,"teacher_disagreement_score":0.035726354,"about_ca_system_score_codex":0.000111782894,"about_ca_system_score_gemma":0.00021958943,"threshold_uncertainty_score":0.99939877},"labels":[],"label_agreement":null},{"id":"W2088086449","doi":"10.1158/1538-7445.am2013-5191","title":"Abstract 5191: Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Phosphorylation; Cell biology; GRB2; MAPK/ERK pathway; Signal transducing adaptor protein; Cancer research; Motility; Biology; Ribosomal s6 kinase; Scaffold protein; Signal transduction; Kinase; Protein tyrosine phosphatase; Cell growth; Protein kinase B; P70-S6 Kinase 1; Biochemistry","score_opus":0.06130620004583876,"score_gpt":0.3613047384904771,"score_spread":0.29999853844463836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088086449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94961905,0.04783801,0.00003986253,0.0005501917,0.000053795124,0.0010846353,0.000113114635,0.000011292977,0.00069005246],"genre_scores_gemma":[0.99408656,0.002752185,0.0001235519,0.00012409208,0.00011238896,0.00082675664,0.00019002467,0.000024322615,0.0017601184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986387,0.00007049616,0.00016255939,0.00043923504,0.0002923397,0.00039667048],"domain_scores_gemma":[0.9992008,0.000026055912,0.00004196092,0.0003464086,0.00021993143,0.00016482438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039381848,0.00012674845,0.00010262894,0.00003893038,0.00012595019,0.000079537924,0.0001733058,0.00012199015,0.0004233826],"category_scores_gemma":[0.00008689913,0.0001199398,0.00002852868,0.000112860944,0.00015878354,0.000012767702,0.00020687086,0.00019663302,0.00007918772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041868756,0.000052047064,0.00206163,0.000055610188,0.000011591037,8.513403e-7,0.000022144854,0.000005328667,0.91649526,0.000022448474,0.063985266,0.017245973],"study_design_scores_gemma":[0.000362691,0.00013410834,0.010650652,0.000022901608,0.000002561538,7.5309225e-7,0.00003056578,0.000012582873,0.9531447,0.00017080775,0.035357814,0.00010984944],"about_ca_topic_score_codex":0.0014007499,"about_ca_topic_score_gemma":0.000050574894,"teacher_disagreement_score":0.045085825,"about_ca_system_score_codex":0.00006209202,"about_ca_system_score_gemma":0.000117234864,"threshold_uncertainty_score":0.4891003},"labels":[],"label_agreement":null},{"id":"W2088174971","doi":"10.1158/0008-5472.can-14-1996","title":"Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Metastasis; EIF4E; Ribavirin; Cancer research; Gene silencing; Breast cancer; Medicine; Oncogene; Cancer; Triple-negative breast cancer; Matrix metalloproteinase inhibitor; Oncology; Internal medicine; Matrix metalloproteinase; Immunology; Biology; Cell cycle; Translation (biology); Messenger RNA; Gene","score_opus":0.08558364637481267,"score_gpt":0.39084066303295145,"score_spread":0.30525701665813876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088174971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96395725,0.034612022,0.000025371042,0.00071827887,0.000111814166,0.00024557105,0.00015092734,0.000006311611,0.00017246242],"genre_scores_gemma":[0.9841307,0.014763947,0.00021441928,0.000108597844,0.00031086247,0.0001965844,0.000017797893,0.000019903604,0.00023719999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986198,0.00019749226,0.00019492819,0.000396644,0.00031928168,0.00027184337],"domain_scores_gemma":[0.99892265,0.000025379051,0.00007665218,0.00017316088,0.0006169138,0.00018524879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005672313,0.00012266006,0.00015039314,0.0000685992,0.00008524848,0.00003154295,0.00011980379,0.00010835386,0.00011019466],"category_scores_gemma":[0.000046882902,0.00010987213,0.000026369553,0.00018363651,0.00035379286,0.000012678751,0.0001675511,0.00013000288,0.0000015381851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018096261,0.000037742546,0.005479468,0.00007250203,0.000039932773,0.0000023535665,0.00018481932,0.00009312137,0.9739992,0.000004889789,0.014903652,0.0050013615],"study_design_scores_gemma":[0.0007700397,0.00023635267,0.003345717,0.000044520773,0.000031140233,0.000011854279,0.00026869055,0.000036624504,0.9893406,0.00011367442,0.0056640254,0.00013675848],"about_ca_topic_score_codex":0.0015207764,"about_ca_topic_score_gemma":0.0005773156,"teacher_disagreement_score":0.020173447,"about_ca_system_score_codex":0.000088822606,"about_ca_system_score_gemma":0.0004703709,"threshold_uncertainty_score":0.44804555},"labels":[],"label_agreement":null},{"id":"W2088194014","doi":"10.1158/1538-7445.am2013-lb-234","title":"Abstract LB-234: A comparative genomic approach for identifying synthetic lethal interactions in human cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Synthetic lethality; Olaparib; Computational biology; Biology; Cancer; PARP inhibitor; CRISPR; Model organism; Yeast; Small hairpin RNA; Cancer cell; Genetics; Cancer research; Mutant; Gene; RNA; Poly ADP ribose polymerase; Polymerase","score_opus":0.15724096308421256,"score_gpt":0.501505030764063,"score_spread":0.3442640676798505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088194014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246526,0.0018093031,0.003517191,0.000087028835,0.00011185041,0.00070794416,0.000026815042,0.00000776533,0.00126685],"genre_scores_gemma":[0.9962797,0.00013217983,0.00046235466,0.000013633079,0.00028102996,0.0020021412,0.00004572271,0.000024018755,0.000759177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887794,0.00004054392,0.00018369421,0.00035688514,0.00013305902,0.00040786847],"domain_scores_gemma":[0.9994817,0.000033537857,0.00002851248,0.00022821932,0.00014603935,0.00008201725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026481028,0.00011355692,0.00014345221,0.00012189252,0.00014002864,0.000066775414,0.00022497051,0.000058800473,0.00020120227],"category_scores_gemma":[0.000023024393,0.00011584804,0.0000620332,0.00012151269,0.00008677728,0.000007748143,0.00009693482,0.00026075912,0.000010074233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002059671,0.000043794902,0.0004558366,0.00008921867,0.000035850662,5.76973e-7,0.00037572795,0.005033729,0.99051684,0.000022203263,0.0023123035,0.0010933134],"study_design_scores_gemma":[0.0009472578,0.0001081853,0.031719945,0.0001271051,0.000012286463,0.0000062350264,0.0021246043,0.0030361614,0.9545561,0.0001394593,0.0068458817,0.00037675817],"about_ca_topic_score_codex":0.0022509038,"about_ca_topic_score_gemma":0.0011177722,"teacher_disagreement_score":0.03596073,"about_ca_system_score_codex":0.00012045912,"about_ca_system_score_gemma":0.00009658313,"threshold_uncertainty_score":0.47241458},"labels":[],"label_agreement":null},{"id":"W2088266974","doi":"10.1158/0008-5472.sabcs12-pd03-02","title":"Abstract PD03-02: Evidence for the anti-cancer action of metformin mediated via tumor AMPK, Akt and Ki67, in a preoperative window of opportunity trial","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Metformin; Medicine; Breast cancer; AMPK; Internal medicine; Cancer; Oncology; Endocrinology; Insulin; Protein kinase A; Kinase; Biology","score_opus":0.2830740800016184,"score_gpt":0.4801392701035769,"score_spread":0.1970651901019585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088266974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85878587,0.13977139,0.000042339354,0.000057412584,0.00020888039,0.0009898742,0.00010976774,0.0000019157453,0.000032582084],"genre_scores_gemma":[0.9303477,0.06821407,0.000022766668,0.000050617975,0.00046441494,0.00079164235,0.000016181551,0.000015154193,0.00007749344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985644,0.00017733988,0.00030701264,0.00023981863,0.00032049388,0.00039091235],"domain_scores_gemma":[0.9987919,0.00030077706,0.00014846343,0.00026635334,0.00036832353,0.00012419495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047504,0.00011921796,0.00026932242,0.000082812745,0.00007739678,0.000013248987,0.00021762136,0.00010508786,0.00016585705],"category_scores_gemma":[0.00083486614,0.000085072556,0.00006727204,0.00021337064,0.00030232794,0.00003421491,0.0000873641,0.00020794135,6.116882e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073831575,0.00018366246,0.005787384,0.0003084158,0.00012691283,3.0544368e-7,0.00043822793,0.00003172886,0.9031871,0.000020288786,0.0008052509,0.081727564],"study_design_scores_gemma":[0.004946166,0.00032500344,0.0128863165,0.00010509119,0.000030949064,4.306511e-7,0.00033736974,0.00003836334,0.9667238,0.000024503948,0.014464997,0.0001169891],"about_ca_topic_score_codex":0.0010497703,"about_ca_topic_score_gemma":0.0005828194,"teacher_disagreement_score":0.081610575,"about_ca_system_score_codex":0.000047785,"about_ca_system_score_gemma":0.0005772482,"threshold_uncertainty_score":0.3469158},"labels":[],"label_agreement":null},{"id":"W2088268059","doi":"10.1158/1538-7445.am2013-5661","title":"Abstract 5661: Nanoparticle based combinatorial siRNA therapy against human hepatocellular carcinoma (HCC) .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Small interfering RNA; Hepatocellular carcinoma; Gene silencing; Cancer research; Medicine; Pharmacology; RNA interference; Combination therapy; Transplantation; Chemistry; RNA; Internal medicine; Biochemistry","score_opus":0.06646164061120197,"score_gpt":0.3481758534175153,"score_spread":0.2817142128063133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088268059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614316,0.0014620353,0.0000066703096,0.00034328655,0.00026247898,0.0004449732,0.000012317001,0.0000147559,0.0013103134],"genre_scores_gemma":[0.9978773,0.00032949058,0.0000117115405,0.00028511853,0.00054615433,0.00031623585,0.00006264104,0.00003336534,0.0005379589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829787,0.0001226101,0.00020896384,0.00043079111,0.00037477628,0.00056500256],"domain_scores_gemma":[0.9987887,0.000020144582,0.000042890166,0.0005212204,0.00044636813,0.00018067218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037429252,0.000157681,0.00015141042,0.000075646865,0.00024466476,0.000112130474,0.0004345593,0.00015610913,0.00065222004],"category_scores_gemma":[0.000032846783,0.00014262563,0.000096526695,0.00015345575,0.00018584046,0.0000115123885,0.000104144885,0.00025269922,0.00020577155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009130951,0.00011023294,0.016619598,0.000013474687,0.00002667776,0.000009691316,0.00003467742,0.00001576251,0.967079,0.00003454019,0.013147503,0.0028175605],"study_design_scores_gemma":[0.0010872909,0.00041868596,0.011650172,0.00001964986,0.0000015383108,4.673941e-7,0.000061830135,0.00012441065,0.9697796,0.00017574347,0.016495714,0.00018491561],"about_ca_topic_score_codex":0.0011432752,"about_ca_topic_score_gemma":0.00003915867,"teacher_disagreement_score":0.0049694274,"about_ca_system_score_codex":0.000055627326,"about_ca_system_score_gemma":0.00025665338,"threshold_uncertainty_score":0.71413517},"labels":[],"label_agreement":null},{"id":"W2088416509","doi":"10.1158/1538-7445.am2014-ct404","title":"Abstract CT404: Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Tolerability; Bevacizumab; Oncology; Clinical trial; Phases of clinical research; Internal medicine; Cancer; Radiation therapy; Brain tumor; Chemotherapy; Cancer research; Pathology; Adverse effect","score_opus":0.05514589239297792,"score_gpt":0.4188260267205755,"score_spread":0.3636801343275976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088416509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978743,0.00010356238,3.4949085e-7,0.00022553273,0.000058567945,0.0014716624,0.000020632784,0.0000112936095,0.00023410657],"genre_scores_gemma":[0.9994238,0.000027108694,0.000017246433,0.0000111779145,0.00004860317,0.0003962745,0.000011666574,0.000021296752,0.00004281538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980466,0.000078599216,0.00026586396,0.00031602243,0.00090224727,0.0003906625],"domain_scores_gemma":[0.99888504,0.00010942063,0.000063728214,0.00037373352,0.00039689746,0.0001711581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044562775,0.00012906015,0.00030804405,0.00036505994,0.000084456224,0.000011269074,0.00010609437,0.000042636464,0.00020341128],"category_scores_gemma":[0.00009978558,0.00007824716,0.000035159148,0.0004885588,0.00007574043,0.00005905665,0.000074718344,0.00027540413,0.000020995863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007154062,0.036351573,0.7796686,0.00016686656,0.00015523053,0.000056970002,0.0021000172,0.000026219466,0.0010866721,0.00001078959,0.0008947727,0.17232819],"study_design_scores_gemma":[0.035997815,0.036908366,0.9186607,0.00046579336,0.000034184737,5.866974e-7,0.0003867707,0.000044953773,0.0062984303,0.00000843344,0.0010923992,0.00010153673],"about_ca_topic_score_codex":0.0011201991,"about_ca_topic_score_gemma":0.0015902377,"teacher_disagreement_score":0.17222665,"about_ca_system_score_codex":0.0002643244,"about_ca_system_score_gemma":0.000113276255,"threshold_uncertainty_score":0.31908268},"labels":[],"label_agreement":null},{"id":"W2088475775","doi":"10.1158/1538-7445.am2013-4048","title":"Abstract 4048: Aggresome formation is regulated by RanBPM through an interaction with HDAC6.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Aggresome; MG132; Cell biology; Ubiquitin; HDAC6; Proteasome; Downregulation and upregulation; Cytoplasm; Proteasome inhibitor; Chemistry; Gene knockdown; Biology; Cell culture; Histone deacetylase; Histone; Biochemistry; Genetics","score_opus":0.056600013228429315,"score_gpt":0.3911922183987178,"score_spread":0.3345922051702885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088475775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946814,0.0012944575,0.0004281292,0.0012092923,0.000053542546,0.00038488806,0.000038942675,0.000014049068,0.0018952711],"genre_scores_gemma":[0.9948464,0.0018822358,0.00010138268,0.00020575353,0.00016938346,0.00043003936,0.00029030765,0.00002367933,0.0020508268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989171,0.000058937654,0.00015222197,0.00030511076,0.0002730451,0.00029360098],"domain_scores_gemma":[0.99900204,0.00000760588,0.00006467234,0.00041314788,0.0004266424,0.00008587166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017291524,0.000101893595,0.000081462014,0.000046418987,0.0001732197,0.000107082175,0.00019180041,0.000109279244,0.00082961126],"category_scores_gemma":[0.000011914964,0.000082576036,0.000028491226,0.00018122233,0.00010586859,0.00008524238,0.00003377732,0.00018682804,0.00008509949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121134275,0.000048836722,0.000092759634,0.000020580792,0.000026199868,4.100703e-7,0.00021369175,0.000042493513,0.89206636,0.000023253962,0.091181636,0.016162656],"study_design_scores_gemma":[0.0005898978,0.00028382684,0.003389442,0.000051514227,0.000005214177,0.000005905361,0.00048203446,0.00017648647,0.78983665,0.00013310897,0.2048696,0.0001763382],"about_ca_topic_score_codex":0.0016358683,"about_ca_topic_score_gemma":0.0001397578,"teacher_disagreement_score":0.113687955,"about_ca_system_score_codex":0.00008689246,"about_ca_system_score_gemma":0.00010150779,"threshold_uncertainty_score":0.90836614},"labels":[],"label_agreement":null},{"id":"W2088513700","doi":"10.1158/1538-7445.tim2013-a10","title":"Abstract A10: Stromal CAIX expression in oral squamous cell carcinoma and corresponding lymph node metastases","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Stromal cell; Immunohistochemistry; Lymph node; Pathology; Head and neck squamous-cell carcinoma; Radiation therapy; Primary tumor; Cancer research; Lymph; Oncology; Internal medicine; Metastasis; Cancer; Head and neck cancer","score_opus":0.036883383884339795,"score_gpt":0.33920797141041553,"score_spread":0.3023245875260757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088513700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983252,0.015171951,0.000016351392,0.00008542924,0.00035991563,0.00032721722,0.00006999354,0.0000073950055,0.0007097796],"genre_scores_gemma":[0.9966976,0.0008553873,0.00017648753,0.00006490262,0.00061868713,0.00023549511,0.0000458736,0.000032673004,0.0012728892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982104,0.00016017504,0.00020438095,0.0004915975,0.00031585916,0.0006176382],"domain_scores_gemma":[0.99920374,0.00005321616,0.000046305915,0.00033645227,0.00015075432,0.00020954694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046065924,0.00016788517,0.00020356645,0.00018166879,0.00013140397,0.00008770669,0.00023435912,0.00014292984,0.00033802917],"category_scores_gemma":[0.0000984645,0.00015283392,0.000053074113,0.00018256449,0.00015973653,0.000018824621,0.0002411727,0.00024649958,0.000020048907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019089373,0.000054292046,0.011250785,0.000064022446,0.000004677732,0.0000072075577,0.000102671744,0.00003869284,0.9738548,0.000005083997,0.008407059,0.006019856],"study_design_scores_gemma":[0.0019304259,0.000098407334,0.1628359,0.000032360953,0.000008686164,0.000008196413,0.0004956673,0.00003860396,0.80092555,0.000027992344,0.033347733,0.00025047097],"about_ca_topic_score_codex":0.004273885,"about_ca_topic_score_gemma":0.00031609775,"teacher_disagreement_score":0.1729292,"about_ca_system_score_codex":0.00006901831,"about_ca_system_score_gemma":0.00030191723,"threshold_uncertainty_score":0.6460864},"labels":[],"label_agreement":null},{"id":"W2088574505","doi":"10.1158/1538-7445.tim2013-b53","title":"Abstract B53: Differential functions of splicing factors in breast-cancer initiation and metastasis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"RNA splicing; Alternative splicing; Splicing factor; Biology; Cancer research; Cancer; Metastasis; Cancer cell; Cell biology; Gene; Gene isoform; Genetics; RNA","score_opus":0.05324854234129232,"score_gpt":0.3712889593061414,"score_spread":0.3180404169648491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088574505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847895,0.0005767373,0.000046086105,0.00035838477,0.000043045264,0.00025219636,0.00007028622,0.0000032246871,0.00017107248],"genre_scores_gemma":[0.99805665,0.0012468426,0.00001103444,0.000012987102,0.00010571557,0.0001586672,0.00002962432,0.000013974453,0.00036448345],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988789,0.00007973237,0.00016734182,0.00024955597,0.00027554733,0.0003489435],"domain_scores_gemma":[0.9994053,0.000040657913,0.000035617075,0.00016972156,0.00023760069,0.00011109375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024357982,0.00008658954,0.0001264144,0.00018002394,0.00008630923,0.000040419935,0.00011669607,0.000079111756,0.00065560266],"category_scores_gemma":[0.000054851047,0.00007294644,0.000037365997,0.00021010179,0.00011971553,0.000015953057,0.000113087306,0.00022017198,0.000005180783],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053021962,0.00003178081,0.092708394,0.00005108294,0.000032342265,4.6875417e-7,0.00004325913,0.000027292095,0.89806885,0.000010694198,0.00058984006,0.008383002],"study_design_scores_gemma":[0.0004081028,0.000060365346,0.73264337,0.00005302562,0.000004540685,0.000001055262,0.00032654236,0.00008395367,0.2661261,0.00003116641,0.00017450604,0.00008728833],"about_ca_topic_score_codex":0.007592105,"about_ca_topic_score_gemma":0.0007716821,"teacher_disagreement_score":0.63993496,"about_ca_system_score_codex":0.00004675712,"about_ca_system_score_gemma":0.00013321832,"threshold_uncertainty_score":0.9990164},"labels":[],"label_agreement":null},{"id":"W2088637810","doi":"10.1158/1538-7445.am10-4329","title":"Abstract 4329: In vivo visualization of epithelial-mesenchymal transition in real time using a rapidly tuneable E-cadherin","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cadherin; Adherens junction; Epithelial–mesenchymal transition; In vivo; Mesenchymal stem cell; Cancer research; Cancer; Cell; Cancer cell; Pathology; Cell biology; Chemistry; Biology; Metastasis; Medicine; Internal medicine","score_opus":0.07567332521439002,"score_gpt":0.42135999102012345,"score_spread":0.34568666580573343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088637810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959293,0.00018809029,0.000025965486,0.00023597456,0.00011854569,0.00051813555,0.000041588726,0.000012728888,0.0029296607],"genre_scores_gemma":[0.99825096,0.0007440739,0.0002742364,0.00002225404,0.00020547501,0.00005113356,0.0000122435,0.000029166993,0.00041043982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998333,0.00009014371,0.00035727356,0.00028102341,0.00052982866,0.00040875628],"domain_scores_gemma":[0.9993262,0.000072425566,0.000055230637,0.0002273725,0.00021070182,0.00010802396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013686477,0.00010446129,0.0003100695,0.00051312253,0.00003731264,0.00001540743,0.00008730865,0.00013275762,0.0026319283],"category_scores_gemma":[0.000069600974,0.00010154806,0.000059735034,0.00091468496,0.00013846191,0.00012814748,0.000023466397,0.0004779633,0.000014197058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005813011,0.0001774383,0.0019724176,0.0002672586,0.0000117987,0.00003483406,0.0009727024,0.00018648771,0.99109995,0.000052982163,0.00016241528,0.0044803913],"study_design_scores_gemma":[0.0034253153,0.00022030385,0.023312781,0.0006168559,0.000022047829,0.00001148894,0.00033983705,0.0024760864,0.96656173,0.000098822406,0.0027384523,0.00017625529],"about_ca_topic_score_codex":0.02247609,"about_ca_topic_score_gemma":0.0041744555,"teacher_disagreement_score":0.024538219,"about_ca_system_score_codex":0.0002624464,"about_ca_system_score_gemma":0.00069209916,"threshold_uncertainty_score":0.9982798},"labels":[],"label_agreement":null},{"id":"W2088690703","doi":"10.1158/0008-5472.can-03-3193","title":"Detection of an Involvement of the Human Mismatch Repair Genes <b> <i>hMLH1</i> </b> and <b> <i>hMSH2</i> </b> in Nucleotide Excision Repair Is Dependent on UVC Fluence to Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; McMaster University","funders":"","keywords":"Nucleotide excision repair; DNA mismatch repair; Biology; Reporter gene; Molecular biology; Cockayne syndrome; Gene; DNA repair; Gene expression; Genetics","score_opus":0.056404469770187794,"score_gpt":0.37130834176750555,"score_spread":0.31490387199731773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088690703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692154,0.00064890785,0.000013713826,0.00053101615,0.0002104585,0.0014104649,0.000024566301,0.000040029805,0.00019931472],"genre_scores_gemma":[0.9982769,0.00030194432,0.00047301542,0.00045783006,0.00008387494,0.00016436994,0.0000012142699,0.000038992606,0.00020185852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969119,0.00020189774,0.00047986294,0.00063739833,0.0013312331,0.00043771314],"domain_scores_gemma":[0.998265,0.000099171375,0.00010779572,0.000917466,0.00039602854,0.00021450061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012403125,0.00018532507,0.00034485405,0.00030852627,0.00013610783,0.000012520154,0.00029323745,0.0001272508,0.00006261365],"category_scores_gemma":[0.00011786984,0.00014370221,0.00011536745,0.0007958514,0.00028051916,0.00006274216,0.00022415281,0.00045581957,0.000005573528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005489046,0.0002296079,0.009177545,0.00028479475,0.000018556853,0.000011159177,0.0019059769,0.0010694461,0.9825731,0.000014243468,0.00023462574,0.003932047],"study_design_scores_gemma":[0.0013832772,0.001726557,0.040222064,0.0007271904,0.000018094366,0.000004358312,0.0006872215,0.00004287465,0.9543251,0.00020605646,0.0005363333,0.00012090136],"about_ca_topic_score_codex":0.0065817214,"about_ca_topic_score_gemma":0.0044246726,"teacher_disagreement_score":0.031044519,"about_ca_system_score_codex":0.00077893445,"about_ca_system_score_gemma":0.00034995764,"threshold_uncertainty_score":0.9949638},"labels":[],"label_agreement":null},{"id":"W2088751530","doi":"10.1158/1538-7445.tumimm2012-a24","title":"Abstract A24: Enhancing chemotherapy efficacy and antitumor immune activity by combined antisense downregulation of TS and IDO.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Gene knockdown; Thymidylate synthase; Suicide gene; Downregulation and upregulation; Immune system; Cancer cell; Biology; Cancer; Immunology; Apoptosis; Genetic enhancement; Gene; Fluorouracil","score_opus":0.023139049914912502,"score_gpt":0.3488724332596646,"score_spread":0.3257333833447521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088751530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952753,0.0037122671,0.000056105666,0.00043308796,0.00002200715,0.0003412925,0.000016186012,0.0000044320323,0.00013928876],"genre_scores_gemma":[0.99482703,0.0045637195,0.00004647313,0.000016865768,0.00005138807,0.000060446062,0.000018413386,0.000014243033,0.00040144502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999217,0.000046051096,0.0001318503,0.00025720953,0.00015009427,0.00019783922],"domain_scores_gemma":[0.9994274,0.000025838859,0.000059097583,0.0002399088,0.00018152678,0.00006626026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020029278,0.00008369314,0.00012383505,0.00004479407,0.00010638803,0.0000407451,0.00007954959,0.00007683126,0.0000827276],"category_scores_gemma":[0.000030667587,0.00007712946,0.000020015294,0.000099328805,0.00020806596,0.000012723182,0.000050530947,0.000102803555,0.0000023683062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011070968,0.000051831226,0.0009840913,0.00004327728,0.000022731556,1.8668007e-7,0.00004610549,0.000003309964,0.97136277,0.00001375505,0.0009969971,0.026364213],"study_design_scores_gemma":[0.00064770854,0.000081368395,0.2921328,0.000023910343,0.0000021683109,9.0214854e-7,0.0000274634,0.000032034503,0.70619583,0.000020788008,0.00076889596,0.00006610376],"about_ca_topic_score_codex":0.00070478895,"about_ca_topic_score_gemma":0.000024035951,"teacher_disagreement_score":0.29114872,"about_ca_system_score_codex":0.000018466477,"about_ca_system_score_gemma":0.00006947823,"threshold_uncertainty_score":0.3145248},"labels":[],"label_agreement":null},{"id":"W2088766251","doi":"10.1158/1538-7445.am10-3037","title":"Abstract 3037: Integrated Genomic, MicroRNA (miRNA) and Proteomic Profiling of Ovarian Carcinoma for Biomarker Discovery","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; SickKids Foundation; Toronto General Hospital; University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"microRNA; Biomarker; Biology; Ovarian cancer; Locus (genetics); Genome instability; Malignancy; Gene expression profiling; Cancer research; Oncology; Bioinformatics; Computational biology; DNA damage; Gene expression; Cancer; Gene; Genetics; Medicine; DNA","score_opus":0.04819289675544176,"score_gpt":0.37135609184489077,"score_spread":0.323163195089449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088766251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968021,0.00065138895,0.00014889645,0.0002504889,0.00015067722,0.0014171824,0.00038822895,0.0000065374056,0.00018452383],"genre_scores_gemma":[0.99737585,0.00015867822,0.0010599138,0.000012847463,0.00022603804,0.00040798238,0.00014857762,0.000052924323,0.00055721164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982033,0.00008513633,0.00025912654,0.0005544955,0.00028538037,0.0006125642],"domain_scores_gemma":[0.9986662,0.00006223162,0.0000734945,0.0004888824,0.0005452509,0.00016391449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010638282,0.00016939583,0.00020469888,0.00018437179,0.00013121372,0.00009738754,0.00042501415,0.0002547319,0.000059281163],"category_scores_gemma":[0.0003472184,0.00014727574,0.00008501382,0.00018654158,0.00048033753,0.000015355954,0.0002950931,0.0005249373,0.0000041704498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072327536,0.00004726277,0.03334006,0.00021708621,0.0000692813,0.0000031614736,0.000034617093,8.1118884e-7,0.9617235,0.000055894536,0.00066637713,0.0031186966],"study_design_scores_gemma":[0.0007722071,0.00016637727,0.05708118,0.000023614992,0.0000059317827,0.0000049907653,0.00006642872,0.000042605305,0.9371008,0.0000690728,0.004513372,0.00015341537],"about_ca_topic_score_codex":0.00085344,"about_ca_topic_score_gemma":0.00030857723,"teacher_disagreement_score":0.024622677,"about_ca_system_score_codex":0.0000643319,"about_ca_system_score_gemma":0.00097196386,"threshold_uncertainty_score":0.60057306},"labels":[],"label_agreement":null},{"id":"W2088936113","doi":"10.1158/0008-5472.sabcs-09-2092","title":"Chemotherapy Induced Febrile Neutropenia of Docetaxel with Cyclophosphamide (TC) for Adjuvant Therapy of Breast Cancer in the Community – Reality Check.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Febrile neutropenia; Docetaxel; Medicine; Neutropenia; Cyclophosphamide; Breast cancer; Internal medicine; Cancer; Chemotherapy; Antibiotics; Cohort; Adjuvant therapy; Oncology; Surgery","score_opus":0.1319252071171725,"score_gpt":0.4477921810003058,"score_spread":0.31586697388313334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088936113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866575,0.0010669786,0.000009207107,0.008593144,0.000054605138,0.0019246129,0.00018818343,0.000016785703,0.0014889836],"genre_scores_gemma":[0.99487907,0.003251961,0.00002546902,0.0007924457,0.00015902992,0.0007018474,0.0000119624465,0.000030066209,0.00014818032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772406,0.0005657428,0.00038770185,0.00023663226,0.00061213446,0.00047371228],"domain_scores_gemma":[0.9979257,0.00026157714,0.00015084524,0.0008219829,0.00073606125,0.000103828876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019214606,0.00018339456,0.00054562173,0.00016652224,0.00027973836,0.00002073914,0.00046463776,0.000097963784,0.0001992974],"category_scores_gemma":[0.000025125597,0.000114165574,0.00011455361,0.0010899319,0.00031820184,0.00010272883,0.00002973489,0.0011892568,8.8351266e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017082933,0.0025620223,0.055134006,0.00048293386,0.00028228233,0.000009265325,0.008791413,0.0001006097,0.8025046,0.0007284507,0.0053203553,0.10700113],"study_design_scores_gemma":[0.0066690394,0.0020194794,0.81608427,0.0004122656,0.000025693198,0.000022961602,0.0014645419,0.0000069876783,0.17009073,0.0004965584,0.0025690095,0.00013846657],"about_ca_topic_score_codex":0.038016584,"about_ca_topic_score_gemma":0.0055473987,"teacher_disagreement_score":0.76095027,"about_ca_system_score_codex":0.00029741417,"about_ca_system_score_gemma":0.000935859,"threshold_uncertainty_score":0.96838933},"labels":[],"label_agreement":null},{"id":"W2088942787","doi":"10.1158/0008-5472.can-07-1570","title":"Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gefitinib; Epidermal growth factor receptor; Cancer research; Paclitaxel; Hsp90 inhibitor; EGFR inhibitors; Tyrosine kinase; Erlotinib; Growth inhibition; Hsp90; Tyrosine-kinase inhibitor; Mutant; Cyclin-dependent kinase 8; Cancer; Pharmacology; Biology; Medicine; Cell growth; Internal medicine; Receptor; Biochemistry","score_opus":0.042122920979725115,"score_gpt":0.3427420356342801,"score_spread":0.30061911465455493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088942787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661756,0.00090697745,0.0001063447,0.0010055137,0.000051415882,0.0008769923,0.00024845247,0.000015223115,0.00017150742],"genre_scores_gemma":[0.9972037,0.001282479,0.0003566876,0.00007151292,0.00029556727,0.0002093498,0.000060406717,0.000048870483,0.0004714392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968644,0.000403177,0.00038520002,0.00069674227,0.00084169814,0.00080880785],"domain_scores_gemma":[0.998143,0.000100542245,0.000057843772,0.0004805727,0.0007665782,0.00045146607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075450167,0.00022229427,0.00031648684,0.00027387968,0.00031936626,0.00003170128,0.00021998252,0.00022815647,0.00019215982],"category_scores_gemma":[0.0008470176,0.00019307241,0.00008026883,0.00041117385,0.00054111384,0.000018011262,0.00054445775,0.0003794796,0.000026788988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050420343,0.00006322098,0.0014362289,0.00014100986,0.000025160663,0.000048576716,0.00049870444,0.000010313675,0.99429363,0.000019042847,0.001931922,0.00102796],"study_design_scores_gemma":[0.0006488496,0.0005787306,0.0029083749,0.00021750834,0.0000021923706,0.000039811224,0.0002421729,0.000013118791,0.9933994,0.000053402724,0.001676801,0.0002196464],"about_ca_topic_score_codex":0.0007150505,"about_ca_topic_score_gemma":0.000059428345,"teacher_disagreement_score":0.001472146,"about_ca_system_score_codex":0.00014509821,"about_ca_system_score_gemma":0.00046351957,"threshold_uncertainty_score":0.78732646},"labels":[],"label_agreement":null},{"id":"W2088951542","doi":"10.1158/1538-7445.am10-lb-171","title":"Abstract LB-171: A phase 1 dose escalation study of BBI608, a first-in-class cancer stem cell pathway inhibitor in patients with advanced malignancies","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Cancer; Cancer stem cell; Discontinuation; Adverse effect; Internal medicine; Oncology; Stem cell; Pharmacology; Biology","score_opus":0.041487466565924655,"score_gpt":0.3647758183299043,"score_spread":0.32328835176397963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088951542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958182,0.0006253007,0.0000010387429,0.00020880133,0.00026993052,0.002593553,0.00012348521,0.000016303815,0.0003433848],"genre_scores_gemma":[0.9981834,0.00023986552,0.000041830415,0.000023512861,0.00012893409,0.000990057,0.000015140015,0.000049685932,0.0003275467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705315,0.0000784839,0.0005288066,0.00056054804,0.0011470531,0.00063195446],"domain_scores_gemma":[0.99839306,0.00011661982,0.00016212706,0.0005109499,0.0005955318,0.00022171381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006650634,0.00022544732,0.0005235157,0.0005082437,0.000080854836,0.000026383972,0.00017697971,0.00011196249,0.0004026584],"category_scores_gemma":[0.000035485726,0.00017877191,0.000056182827,0.0010902433,0.00017688885,0.00019722851,0.00007880264,0.0008803341,0.0000070346423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011795099,0.010808718,0.59066516,0.0013166512,0.00007996302,0.00012868879,0.007670023,0.0005007146,0.24272637,0.000011307172,0.00043171522,0.13386557],"study_design_scores_gemma":[0.052936003,0.00487382,0.7755656,0.0013720928,0.00005572117,8.49513e-7,0.0038701394,0.000053022344,0.15411425,0.000008836924,0.0067285183,0.0004211456],"about_ca_topic_score_codex":0.0059445547,"about_ca_topic_score_gemma":0.042186897,"teacher_disagreement_score":0.18490042,"about_ca_system_score_codex":0.0005017664,"about_ca_system_score_gemma":0.0009252591,"threshold_uncertainty_score":0.9752907},"labels":[],"label_agreement":null},{"id":"W2089256006","doi":"10.1158/1538-7445.tim2013-a97","title":"Abstract A97: Antitumor effect of metformin in breast cancer is associated with AMPK and FOXO3a activation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"AMPK; Metformin; Cancer; Breast cancer; Medicine; Metastasis; Internal medicine; Oncology; Cancer research; Biology; Cell biology; Kinase","score_opus":0.02399867314330503,"score_gpt":0.3420174114996861,"score_spread":0.3180187383563811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089256006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987012,0.00030786503,0.000010877003,0.00036480403,0.000021302008,0.0004285191,0.00005588727,0.0000044561043,0.00010509197],"genre_scores_gemma":[0.999289,0.000252406,0.000008479997,0.000021616659,0.00003458339,0.00018124007,0.000043166052,0.00001525196,0.00015428741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990866,0.00008111683,0.00012886494,0.00022612802,0.00025660542,0.00022068806],"domain_scores_gemma":[0.99949086,0.000033986275,0.000054248205,0.00013734924,0.0002313099,0.000052263546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034733294,0.00009157159,0.0001336314,0.00010633332,0.00004105437,0.00002342867,0.00008066189,0.00009758121,0.00021025268],"category_scores_gemma":[0.000036093217,0.00007213241,0.000022466913,0.00022529095,0.0001284955,0.000022484142,0.000022575856,0.00013621604,0.000002384155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020957657,0.000022877299,0.08275155,0.000064261156,0.000039140636,5.0729955e-7,0.00005737979,0.000030339756,0.9111344,0.000003974968,0.0006153566,0.0050706305],"study_design_scores_gemma":[0.000629543,0.000114713126,0.4857682,0.00009334834,0.0000034611069,9.706222e-7,0.000016516668,0.000031049014,0.51312846,0.00000866947,0.00014624401,0.00005885124],"about_ca_topic_score_codex":0.003241378,"about_ca_topic_score_gemma":0.00051726284,"teacher_disagreement_score":0.40301663,"about_ca_system_score_codex":0.000081541926,"about_ca_system_score_gemma":0.000100625315,"threshold_uncertainty_score":0.4900016},"labels":[],"label_agreement":null},{"id":"W2089290845","doi":"10.1158/0008-5472.can-07-5428","title":"Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"T790M; Cancer research; Gefitinib; Protein kinase B; Epidermal growth factor receptor; EGFR inhibitors; Erlotinib; PI3K/AKT/mTOR pathway; Kinase; Tyrosine kinase; Phosphorylation; Tyrosine-kinase inhibitor; Chemistry; Biology; Signal transduction; Pharmacology; Cancer; Cell biology; Medicine; Receptor; Internal medicine; Biochemistry","score_opus":0.0647584607196473,"score_gpt":0.4074752702221794,"score_spread":0.3427168095025321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089290845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985048,0.00847513,0.000023096844,0.0028818634,0.00011113595,0.00059870095,0.00008929304,0.00005627227,0.002716493],"genre_scores_gemma":[0.9908367,0.0028120074,0.00030216572,0.00018628109,0.00038318994,0.00029399578,0.000043060514,0.000032818323,0.0051098084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982678,0.0000820476,0.00020701076,0.00039190977,0.0006240143,0.0004271886],"domain_scores_gemma":[0.99892163,0.00016509074,0.000038620074,0.00025847479,0.00037722374,0.00023893337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002215841,0.00014060845,0.00023065179,0.00021249813,0.0004741949,0.00004205674,0.000052289437,0.00007658486,0.00034460772],"category_scores_gemma":[0.00012691048,0.000116994066,0.000049426657,0.00042714292,0.00033303403,0.00018293693,0.0000602553,0.00030845831,0.000022186952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019936296,0.00077851856,0.048332047,0.0014476391,0.00047043242,0.0029510574,0.0076252394,0.000031551142,0.8699865,0.0025921487,0.05756386,0.006227402],"study_design_scores_gemma":[0.007039463,0.0006077769,0.029426023,0.0018443698,0.00018016997,0.00016490066,0.0013439,0.000022058422,0.8677768,0.0014027952,0.08975022,0.00044150546],"about_ca_topic_score_codex":0.0004651425,"about_ca_topic_score_gemma":0.00017772612,"teacher_disagreement_score":0.032186367,"about_ca_system_score_codex":0.00047907472,"about_ca_system_score_gemma":0.0006018035,"threshold_uncertainty_score":0.47708797},"labels":[],"label_agreement":null},{"id":"W2089449071","doi":"10.1158/1538-7445.am2014-2195","title":"Abstract 2195: Genome-wide interaction analyses between genetic variants and alcohol consumption and risk of colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome-wide association study; Colorectal cancer; Heritability; Logistic regression; Missing heritability problem; Medicine; Genetic association; Twin study; Genetics; Cancer; Oncology; Biology; Internal medicine; Single-nucleotide polymorphism; Genotype; Gene","score_opus":0.08336894031233766,"score_gpt":0.4210463558874604,"score_spread":0.33767741557512276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089449071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914048,0.007820032,0.00014768733,0.000043446784,0.000056029476,0.00022190841,0.00021924489,0.0000044390417,0.00008244826],"genre_scores_gemma":[0.97610277,0.023301749,0.000111246394,0.000017894252,0.00027746358,0.00007123494,0.000065405344,0.000015667518,0.000036564932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988719,0.00017045489,0.00019093744,0.00034886991,0.00018662351,0.00023119818],"domain_scores_gemma":[0.99927145,0.00008325081,0.00008627075,0.00017069798,0.00022211093,0.00016622804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032667263,0.00010614568,0.00015299948,0.00010525165,0.00012438314,0.0000350658,0.000091734095,0.000102259175,0.000090585716],"category_scores_gemma":[0.00016028988,0.000104252285,0.00003797439,0.00007695787,0.00027676334,0.000007045892,0.000087327804,0.00013015805,0.0000025164754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017700158,0.000025315687,0.5434264,0.0000989643,0.000103158134,5.2487985e-7,0.000037386206,0.000055174674,0.45113978,0.0000011651995,0.00022147727,0.0047136447],"study_design_scores_gemma":[0.00067919237,0.0001437977,0.86776394,0.00003282584,0.000068101835,0.0000010718712,0.000041635594,0.000045540175,0.1299098,0.00010969092,0.0011012104,0.00010321094],"about_ca_topic_score_codex":0.0009232504,"about_ca_topic_score_gemma":0.0005136037,"teacher_disagreement_score":0.3243375,"about_ca_system_score_codex":0.000029175028,"about_ca_system_score_gemma":0.00009443097,"threshold_uncertainty_score":0.4251285},"labels":[],"label_agreement":null},{"id":"W2089762788","doi":"10.1158/0008-5472.can-05-3343","title":"Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; University of Chicago","keywords":"Azoxymethane; Gefitinib; Epidermal growth factor receptor; Aberrant crypt foci; Endocrinology; Internal medicine; Cancer research; Growth factor receptor; Epidermal growth factor; Carcinogenesis; Biology; Medicine; Colorectal cancer; Cancer; Receptor","score_opus":0.1753062094947612,"score_gpt":0.4178793860194869,"score_spread":0.24257317652472568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089762788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921717,0.0032120566,0.00037121578,0.002440122,0.000033460237,0.0014004187,0.00017472407,0.000009623309,0.00018669589],"genre_scores_gemma":[0.9977678,0.0006734364,0.0003493747,0.0001977802,0.000106342115,0.00046381634,0.0000210207,0.000019089734,0.00040131315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983869,0.00007893235,0.00033880144,0.00022368238,0.00047932932,0.00049231097],"domain_scores_gemma":[0.99875873,0.00041027126,0.00007224285,0.0001888117,0.0005006261,0.000069337206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010884043,0.00011808323,0.00029671326,0.00023914705,0.00015090109,0.000012612732,0.00014915642,0.00007749963,0.000053675973],"category_scores_gemma":[0.00016585921,0.00008104278,0.00010437083,0.00042376967,0.0001238179,0.000092951836,0.000046352503,0.00017604919,0.00000253306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041498654,0.00020446439,0.008720703,0.000584234,0.00014013333,0.000009572623,0.015998254,0.000052456966,0.9600239,0.00012210854,0.0030327998,0.006961524],"study_design_scores_gemma":[0.0022701218,0.00070621865,0.0063376953,0.000086888074,0.000040698364,0.0000039919605,0.002076721,0.00064367626,0.9871967,0.00014030733,0.00039781732,0.00009915512],"about_ca_topic_score_codex":0.0011337929,"about_ca_topic_score_gemma":0.00061501557,"teacher_disagreement_score":0.027172824,"about_ca_system_score_codex":0.00060426764,"about_ca_system_score_gemma":0.00021474545,"threshold_uncertainty_score":0.33048287},"labels":[],"label_agreement":null},{"id":"W2089775846","doi":"10.1158/1538-7445.am2011-4162","title":"Abstract 4162: The importance of age-related cytokines in chronic lymphocytic leukemia","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Cytokine; Internal medicine; Population; Proinflammatory cytokine; CD38; Immunology; Disease; Interleukin 6; Gastroenterology; Leukemia; Inflammation; Biology","score_opus":0.11168896844047446,"score_gpt":0.3968589435594796,"score_spread":0.2851699751190051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089775846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707171,0.006885537,0.0000014102569,0.0002199275,0.000117185766,0.0011283742,0.000010520265,0.00004580999,0.02087419],"genre_scores_gemma":[0.99460006,0.0020888275,0.00003142797,0.00006995255,0.00020045106,0.00033329407,0.000010170953,0.0000657719,0.0026000496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99582356,0.00018674742,0.0007375859,0.0005709021,0.0014921828,0.0011890465],"domain_scores_gemma":[0.99747,0.0004749729,0.00013088487,0.0012190198,0.00045141572,0.00025367778],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024763118,0.00022972054,0.000511834,0.00047509297,0.00012534959,0.000023417908,0.0007773432,0.000241537,0.0027689133],"category_scores_gemma":[0.0005372393,0.00015773467,0.00014778927,0.0018122206,0.0014544863,0.00013120701,0.00030761518,0.0011441124,0.00018348549],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015034535,0.0009475612,0.095414646,0.013411036,0.0023746402,0.024033062,0.033157,0.0044988147,0.6847341,0.01728779,0.045282837,0.063823976],"study_design_scores_gemma":[0.08572363,0.00219458,0.46868107,0.0060472433,0.00019386687,0.00079480954,0.0027467627,0.021375585,0.38979676,0.008068346,0.013018868,0.0013584718],"about_ca_topic_score_codex":0.027400706,"about_ca_topic_score_gemma":0.003784216,"teacher_disagreement_score":0.37326643,"about_ca_system_score_codex":0.13550365,"about_ca_system_score_gemma":0.076654695,"threshold_uncertainty_score":0.9981427},"labels":[],"label_agreement":null},{"id":"W2090007046","doi":"10.1158/1538-7445.am2012-1123","title":"Abstract 1123: AML cells have low reserve capacity in their respiratory chain complexes leading to increased sensitivity to palmitate-induced cell death","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Respiratory chain; Mitochondrial respiratory chain; Mitochondrial biogenesis; Haematopoiesis; Respiratory system; Stem cell; Hematopoietic stem cell; Mitochondrion; Biology; Antimycin A; Cell biology; Chemistry; Cancer research; Anatomy","score_opus":0.16754770225166601,"score_gpt":0.37116146927195787,"score_spread":0.20361376702029185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090007046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672014,0.00015158998,0.00015828897,0.00020826305,0.00037624995,0.0006775199,0.00012417189,0.0000138153255,0.0015699567],"genre_scores_gemma":[0.99743116,0.000022942722,0.00019835294,0.00087747443,0.0008088817,0.00016224844,0.000029147584,0.000037154896,0.0004326276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970729,0.0008799526,0.0002617767,0.0005571107,0.0002989417,0.0009293704],"domain_scores_gemma":[0.9984622,0.00016577958,0.000047406982,0.00055448007,0.0002540387,0.00051607995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002379242,0.00020921827,0.00027009257,0.0002600993,0.00016707781,0.00003883798,0.00023037965,0.00024947608,0.00008609512],"category_scores_gemma":[0.000390562,0.00019762202,0.00007761132,0.00029066738,0.00007535949,0.000011811033,0.00025191103,0.0005044359,0.0001652232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043181505,0.00010593561,0.012399035,0.000045862427,0.00001053189,0.000017002312,0.0005691863,0.0001062366,0.9822649,0.000029822308,0.0036331327,0.00038657195],"study_design_scores_gemma":[0.00046110808,0.00025422717,0.018212235,0.00004461521,0.000002112314,0.0000025647096,0.00031847975,0.000013134626,0.96516585,0.000011505922,0.01528848,0.00022566004],"about_ca_topic_score_codex":0.0034423636,"about_ca_topic_score_gemma":0.007750842,"teacher_disagreement_score":0.017098991,"about_ca_system_score_codex":0.00018122536,"about_ca_system_score_gemma":0.00017271271,"threshold_uncertainty_score":0.80587924},"labels":[],"label_agreement":null},{"id":"W2090166561","doi":"10.1158/1538-7445.am2012-805","title":"Abstract 805: The role of aldo-keto reductases and estrogen signalling in acquired anthracycline resistance","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Anthracycline; Breast cancer; Doxorubicin; Cancer research; Estrogen receptor; Estrogen; Cyclin D1; Biology; Epirubicin; Cancer; Internal medicine; Chemotherapy; Endocrinology; Medicine; Cell cycle","score_opus":0.03858045290691804,"score_gpt":0.37113562610135736,"score_spread":0.33255517319443934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090166561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9261876,0.07284568,0.0000022888826,0.00022384398,0.000028236485,0.00016400722,0.00002378149,0.000002728178,0.00052186113],"genre_scores_gemma":[0.9960886,0.0031306758,0.00009275867,0.000015832795,0.00039270558,0.000041981195,0.000029450206,0.000016267355,0.00019172505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988982,0.00008430399,0.00019557976,0.00020987382,0.00021660356,0.00039542766],"domain_scores_gemma":[0.9994563,0.000050189134,0.00005225585,0.00026085414,0.000092431386,0.00008796498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072168245,0.00009184362,0.00012167852,0.000054486267,0.00010154752,0.00001401656,0.00018531882,0.000074242605,0.000047762143],"category_scores_gemma":[0.000092655624,0.000070070964,0.000030337522,0.00015537959,0.0002780423,0.000009856151,0.00012384071,0.00012659936,0.000002821301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019339584,0.00007856375,0.0060225027,0.00003881391,0.000032295087,0.0000020394973,0.00017385061,0.000009621352,0.9880287,0.00012269945,0.0003709406,0.0049265493],"study_design_scores_gemma":[0.00022225482,0.00003057556,0.004147988,0.00005380991,0.000004582841,0.0000026910466,0.00047299446,0.0000021620706,0.9490171,0.00011423388,0.04585292,0.000078677665],"about_ca_topic_score_codex":0.0001947035,"about_ca_topic_score_gemma":0.0001683668,"teacher_disagreement_score":0.069901034,"about_ca_system_score_codex":0.000021372569,"about_ca_system_score_gemma":0.00014154674,"threshold_uncertainty_score":0.28574112},"labels":[],"label_agreement":null},{"id":"W2090266806","doi":"10.1158/0008-5472.can-09-3813","title":"Autotaxin Promotes Cancer Invasion via the Lysophosphatidic Acid Receptor 4: Participation of the Cyclic AMP/EPAC/Rac1 Signaling Pathway in Invadopodia Formation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Autotaxin; Invadopodia; Lysophosphatidic acid; RAC1; Cancer cell; Cancer research; Metastasis; Cell biology; Cancer; Receptor; Biology; Signal transduction; Chemistry; Biochemistry","score_opus":0.050954059752367255,"score_gpt":0.35134950296591594,"score_spread":0.30039544321354866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090266806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956376,0.002334032,0.00013767311,0.0007509792,0.00042826077,0.00063365925,0.000021132675,0.0000070981423,0.00004957763],"genre_scores_gemma":[0.99820775,0.00046275262,0.00009047436,0.00010638819,0.00044375306,0.0005277358,0.000031386233,0.000021890131,0.00010784885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819535,0.00034054366,0.00034040186,0.00027633968,0.00045683008,0.0003905066],"domain_scores_gemma":[0.99895084,0.00006486606,0.0001555894,0.00047218375,0.00028597825,0.000070545626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016711944,0.00012779344,0.00015022959,0.00007984235,0.00025421524,0.000045164783,0.00044305966,0.00015964654,0.00015293743],"category_scores_gemma":[0.0005786746,0.000080884005,0.00007519429,0.00048656552,0.00021209485,0.000024228746,0.00018839217,0.00048125963,0.000007627204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010312885,0.00003736017,0.0039999564,0.000051095638,0.000011852509,1.5625122e-7,0.00096265867,0.00017306571,0.98581064,0.00006602718,0.00022796234,0.008556099],"study_design_scores_gemma":[0.000474257,0.000035076206,0.0033184055,0.00008651945,0.000006582113,7.521188e-7,0.00010048009,0.00018758605,0.9893912,0.00019025379,0.006108577,0.000100302146],"about_ca_topic_score_codex":0.0010929938,"about_ca_topic_score_gemma":0.0032937897,"teacher_disagreement_score":0.008455797,"about_ca_system_score_codex":0.000046347686,"about_ca_system_score_gemma":0.00035638796,"threshold_uncertainty_score":0.3298354},"labels":[],"label_agreement":null},{"id":"W2090409255","doi":"10.1158/1538-7445.am2014-1220","title":"Abstract 1220: Investigation of the biological properties of human breast cancer in a nude rat model","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Breast cancer; Nude mouse; Cancer; Magnetic resonance imaging; Metastasis; Cancer research; Immunohistochemistry; Human breast; Medicine; Pathology; Animal model; Preclinical imaging; In vivo; Biology; Internal medicine; Radiology","score_opus":0.11774197593727752,"score_gpt":0.39220806244092604,"score_spread":0.2744660865036485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090409255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798846,0.00093965954,0.0000021417084,0.00047888115,0.00002331501,0.00030046093,0.0000683481,0.0000021713433,0.00019655534],"genre_scores_gemma":[0.9989413,0.0005267992,0.0000064624464,0.000030417437,0.000070031434,0.00022834266,0.000008932291,0.000010529113,0.00017720604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988295,0.00015451584,0.00018242947,0.00023687219,0.00031292764,0.00028377326],"domain_scores_gemma":[0.99933606,0.000010330538,0.000054964617,0.00029329726,0.000224313,0.00008104003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044107763,0.000084059735,0.00013340922,0.00006567522,0.00007141505,0.000010140536,0.0002995159,0.00008985855,0.000048293325],"category_scores_gemma":[0.00007407957,0.00005184859,0.000055564193,0.00019734887,0.000510955,0.0000052086757,0.00017286453,0.00017762095,9.953777e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018206687,0.000045540648,0.04277852,0.00007114944,0.000020230824,2.3790386e-7,0.00008777585,0.00037086534,0.9545183,0.00005922529,0.00027984046,0.0015862124],"study_design_scores_gemma":[0.00055425003,0.00010711599,0.05727058,0.00013889032,0.0000023411255,6.4234234e-7,0.00003076471,0.00013522447,0.9413031,0.0003214399,0.00007665474,0.0000590522],"about_ca_topic_score_codex":0.0044679437,"about_ca_topic_score_gemma":0.0037454085,"teacher_disagreement_score":0.014492055,"about_ca_system_score_codex":0.00008080312,"about_ca_system_score_gemma":0.0004651624,"threshold_uncertainty_score":0.67542243},"labels":[],"label_agreement":null},{"id":"W2090651585","doi":"10.1158/0008-5472.can-11-3589","title":"The Mixed Lineage Leukemia (MLL) Fusion–Associated Gene <i>AF4</i> Promotes CD133 Transcription","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research","keywords":"Fusion gene; Gene; Leukemia; Biology; Genetics; Lineage (genetic); Transcription factor; Cancer research; Computational biology","score_opus":0.10541274828704732,"score_gpt":0.40275766184470135,"score_spread":0.297344913557654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090651585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893155,0.008586926,0.0000148218205,0.004388838,0.0005686671,0.0016889515,0.000040669744,0.00011595295,0.0056636026],"genre_scores_gemma":[0.9258929,0.004718208,0.000038398754,0.00017369694,0.0014935967,0.0005725756,0.000071348964,0.00009217608,0.06694714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949014,0.0005932989,0.00037951025,0.00041056797,0.0020375543,0.0016776212],"domain_scores_gemma":[0.99723506,0.0005241439,0.00006126611,0.0007545977,0.0008490287,0.0005759167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054458375,0.00022010977,0.00033959476,0.00023272973,0.0008096838,0.00012600476,0.00044299738,0.0002518456,0.0024025897],"category_scores_gemma":[0.0006906357,0.00015092077,0.00018893646,0.0011988041,0.00043043756,0.00017464002,0.00014706657,0.0015723242,0.00025235926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083867443,0.00019682308,0.0028981774,0.000076718134,0.00015069304,0.000024750798,0.0008883073,0.0000018012364,0.9233236,0.000083140425,0.022448804,0.049068548],"study_design_scores_gemma":[0.002660062,0.0004439443,0.01788158,0.00016502618,0.000047485715,0.000025443065,0.00050661294,0.00019462615,0.7105027,0.00010462351,0.26724175,0.00022616117],"about_ca_topic_score_codex":0.0013609626,"about_ca_topic_score_gemma":0.00060794735,"teacher_disagreement_score":0.24479292,"about_ca_system_score_codex":0.0019751727,"about_ca_system_score_gemma":0.0010424991,"threshold_uncertainty_score":0.99850935},"labels":[],"label_agreement":null},{"id":"W2090736087","doi":"10.1158/1538-7445.am2013-adv25","title":"Abstract ADV25: Relentless in the fight against blood cancer: The Leukemia &amp; Lymphoma Society.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; General partnership; Government (linguistics); Oncology; Internal medicine; Family medicine; Gerontology; Political science","score_opus":0.08789433755833446,"score_gpt":0.3285448332004054,"score_spread":0.24065049564207092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090736087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253559,0.021012349,0.000011166876,0.013228401,0.00044788906,0.0010489144,0.0002080298,0.000024141189,0.038663168],"genre_scores_gemma":[0.9649717,0.024214517,0.00002492912,0.0041779876,0.00077668397,0.0023584843,0.000013531333,0.00005026262,0.0034118914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997476,0.00005850527,0.00067427714,0.00058297405,0.00017093089,0.0010373312],"domain_scores_gemma":[0.99830896,0.00034026935,0.00024344135,0.00082452426,0.00014892753,0.00013388357],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019514998,0.00023499622,0.00040581916,0.00015856761,0.00046915407,0.00039891043,0.0013651982,0.0002090913,0.0023373757],"category_scores_gemma":[0.00015810708,0.00017183859,0.00021759233,0.0006552673,0.00036690637,0.00051401294,0.00015997949,0.00076456176,0.0014647457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079007914,0.00031892938,0.06130421,0.00021578753,0.0003134951,0.000014584401,0.008599632,0.001055649,0.00085904443,0.042914275,0.7723014,0.11202401],"study_design_scores_gemma":[0.0012950727,0.00003462083,0.2000812,0.000111131056,0.0000063896373,0.0000022748197,0.00070710684,0.00021375103,0.00029402474,0.014032641,0.7828285,0.00039329912],"about_ca_topic_score_codex":0.02857066,"about_ca_topic_score_gemma":0.003415251,"teacher_disagreement_score":0.13877699,"about_ca_system_score_codex":0.0011503974,"about_ca_system_score_gemma":0.00053028826,"threshold_uncertainty_score":0.99931276},"labels":[],"label_agreement":null},{"id":"W2090786825","doi":"10.1158/0008-5472.can-06-4304","title":"A Tribute to George F. Vande Woude, a Man of Character: 2006 Scientific Symposium <i>Winning the War against Cancer: From Genomics to Bedside and Back</i>","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tribute; George (robot); Biology; Sociology; Law; Political science; History; Art history","score_opus":0.034545202693743754,"score_gpt":0.3530414660894554,"score_spread":0.3184962633957117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090786825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875124,0.004705787,0.0005669424,0.00542439,0.00024217367,0.0005813435,0.00067594514,0.0000051100715,0.00028590416],"genre_scores_gemma":[0.98325956,0.004382859,0.0004115364,0.0012627401,0.00077182736,0.0003432011,0.00017538313,0.000046622034,0.0093462905],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822015,0.000070230635,0.0002665246,0.00055393024,0.00033174775,0.00055739377],"domain_scores_gemma":[0.9986415,0.00003888643,0.00006290559,0.0006230142,0.0003924267,0.0002412625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011915845,0.000135827,0.00016532364,0.0001354161,0.000338208,0.00008799883,0.0004545565,0.0000989418,0.000052130024],"category_scores_gemma":[0.00003808242,0.00011149944,0.000053105054,0.00047641736,0.00022048685,0.000008028835,0.00030946167,0.00019663051,0.00002171829],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020597258,0.000027992613,0.0031893856,0.00001672688,0.00004200469,0.0000016623745,0.00043872342,0.00011117331,0.958276,0.00001667961,0.028486485,0.00918724],"study_design_scores_gemma":[0.00024157028,0.00005754074,0.005276525,0.00004106747,0.000007643891,6.282878e-7,0.00012806508,0.0000107633805,0.4485316,0.000014376752,0.54558235,0.000107888125],"about_ca_topic_score_codex":0.0017175729,"about_ca_topic_score_gemma":0.0026557832,"teacher_disagreement_score":0.51709586,"about_ca_system_score_codex":0.00014326861,"about_ca_system_score_gemma":0.00035526959,"threshold_uncertainty_score":0.45468152},"labels":[],"label_agreement":null},{"id":"W2090899778","doi":"10.1158/1538-7445.am2013-1405","title":"Abstract 1405: Deficiency of Fes tyrosine kinase expression correlates with delayed mammary tumor onset in a HER2/Neu over-expressing transgenic mouse model.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetically modified mouse; Mammary tumor; Cancer research; Metastasis; Tumor progression; Tumor microenvironment; Angiogenesis; Breast cancer; Cancer; Biology; Medicine; Pathology; Transgene; Internal medicine","score_opus":0.032436578169616065,"score_gpt":0.3296861540575692,"score_spread":0.2972495758879531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090899778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950023,0.0031124763,0.000958425,0.00015717116,0.000021314125,0.0004126741,0.000078100325,0.000009099618,0.00024841315],"genre_scores_gemma":[0.99733233,0.00096938555,0.00051362294,0.000036635152,0.000029733454,0.0004352004,0.00004997213,0.00003106187,0.0006020677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849087,0.00007696778,0.00026406135,0.00042149983,0.00033231615,0.000414277],"domain_scores_gemma":[0.9990431,0.00002057804,0.00007744332,0.0005007517,0.00025127587,0.00010681713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026312817,0.00014928784,0.00016362067,0.00013092205,0.00011341178,0.000051726507,0.0003408262,0.00011094749,0.00009069259],"category_scores_gemma":[0.000026189962,0.000121036406,0.000052372776,0.00025208652,0.00019083104,0.0000293395,0.0000803095,0.00026928724,0.000003897952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025736267,0.0001516908,0.0019351825,0.000067499415,0.000010654735,0.0000022018492,0.00012639043,0.0040329164,0.99069005,0.000018885217,0.0011141319,0.001593028],"study_design_scores_gemma":[0.0008000984,0.00019535386,0.00920339,0.00014849004,0.0000050939484,0.0000021116314,0.00015484144,0.0016559204,0.9874388,0.0000879513,0.00012222189,0.0001857253],"about_ca_topic_score_codex":0.001208249,"about_ca_topic_score_gemma":0.00021556094,"teacher_disagreement_score":0.007268208,"about_ca_system_score_codex":0.00006490867,"about_ca_system_score_gemma":0.00042487978,"threshold_uncertainty_score":0.49357215},"labels":[],"label_agreement":null},{"id":"W2090980417","doi":"10.1158/0008-5472.can-11-4067","title":"Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility Loci","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; U.S. Public Health Service; National Institute on Aging; National Cancer Institute; National Institutes of Health","keywords":"Single-nucleotide polymorphism; Genome-wide association study; Genetics; Quantitative trait locus; SNP; Biology; Colorectal cancer; Genetic association; Body mass index; Oncology; Medicine; Internal medicine; Cancer; Gene; Genotype","score_opus":0.06333181184076536,"score_gpt":0.39937811303730775,"score_spread":0.3360463011965424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090980417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522024,0.00046313027,0.0030284955,0.0004006133,0.0001966388,0.00037437998,0.00023033384,0.0000026911973,0.000083480605],"genre_scores_gemma":[0.9965356,0.0008121075,0.00042087396,0.000040743278,0.00052224187,0.0006290309,0.00030164892,0.0000129491655,0.00072479964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990445,0.00014236713,0.00017919176,0.00019162575,0.00010732531,0.00033498355],"domain_scores_gemma":[0.99947804,0.000040124312,0.00007656722,0.00016210861,0.00016795749,0.000075175856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068851723,0.00006647986,0.00011561693,0.0000372304,0.000102954604,0.000004264525,0.00010109389,0.000091432674,0.00022553402],"category_scores_gemma":[0.000120953926,0.00006385555,0.00006057087,0.00006684755,0.00011255756,0.0000046588193,0.00006175775,0.00008336179,0.0000058240735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060248807,0.00006541992,0.124551184,0.000014863704,0.000039260525,1.3048315e-8,0.000089011504,0.000047260964,0.8719886,0.000018418368,0.001033616,0.0020921335],"study_design_scores_gemma":[0.00021251143,0.00011493769,0.27137703,0.000004464108,0.000010989794,4.905499e-7,0.00007575405,0.000055214845,0.6897597,0.000024059225,0.038289756,0.00007509454],"about_ca_topic_score_codex":0.00017719153,"about_ca_topic_score_gemma":0.00015654477,"teacher_disagreement_score":0.18222888,"about_ca_system_score_codex":0.000118101314,"about_ca_system_score_gemma":0.000102327365,"threshold_uncertainty_score":0.26039538},"labels":[],"label_agreement":null},{"id":"W2090991004","doi":"10.1158/1538-7445.am2014-sy09-03","title":"Abstract SY09-03: How deregulation of histone methyltransferases drive malignant transformation of B-cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"EZH2; Biology; Methyltransferase; Epigenetics; Germinal center; Histone methyltransferase; Cancer research; DNA methylation; Malignant transformation; Chromatin; Carcinogenesis; B cell; Histone; Methylation; Gene; Genetics; Gene expression; Antibody","score_opus":0.041991518905055064,"score_gpt":0.37987252754357875,"score_spread":0.33788100863852366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090991004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867614,0.0018170357,0.009783804,0.00025377015,0.00007001878,0.0002443323,0.000038247286,0.0000034065986,0.0010280091],"genre_scores_gemma":[0.99771243,0.0015962523,0.00033924857,0.000006498019,0.00008702384,0.000028687251,0.000074916694,0.000014799776,0.00014016648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889195,0.00014338498,0.00023485789,0.00019621772,0.0003406057,0.00019298354],"domain_scores_gemma":[0.99913496,0.000053557935,0.0000799848,0.00024096017,0.00043348235,0.000057065947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008124295,0.00008641183,0.00014991239,0.00011224045,0.000053354033,0.0000107349915,0.00013443647,0.00012122505,0.00004225991],"category_scores_gemma":[0.00006450393,0.0000806975,0.00007345086,0.00014629369,0.00014926087,0.000007988268,0.000016954473,0.000087136825,0.0000017647825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007834161,0.000043563552,0.00019113027,0.00014173432,0.000027315959,1.0549747e-7,0.00019748967,0.00060557516,0.9833595,0.0002568961,0.000078973266,0.015019375],"study_design_scores_gemma":[0.00039344307,0.00024145449,0.0038641198,0.00004098722,0.000011303645,1.3505432e-7,0.000066712935,0.00013385862,0.99078923,0.00028816346,0.004088575,0.00008199547],"about_ca_topic_score_codex":0.00019493057,"about_ca_topic_score_gemma":0.00009284136,"teacher_disagreement_score":0.014937379,"about_ca_system_score_codex":0.000026698772,"about_ca_system_score_gemma":0.00009996898,"threshold_uncertainty_score":0.32907486},"labels":[],"label_agreement":null},{"id":"W2091031746","doi":"10.1158/0008-5472.sabcs12-p2-10-02","title":"Abstract P2-10-02: Clinical validation of the PAM50 risk of recurrence (ROR) score for predicting residual risk of distant-recurrence (DR) after endocrine therapy in postmenopausal women with ER+ early breast cancer (EBC): An ABCSG study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health","funders":"","keywords":"Medicine; Anastrozole; Internal medicine; Breast cancer; Oncology; Tamoxifen; Population; Aromatase inhibitor; Hormonal therapy; Cancer; Gynecology","score_opus":0.09064113353943677,"score_gpt":0.44428192924448795,"score_spread":0.3536407957050512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091031746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920509,0.00256015,0.000028590552,0.00016031548,0.00024358231,0.0030056331,0.0019141829,0.000018551264,0.00001813008],"genre_scores_gemma":[0.99611247,0.0014127274,0.0001523622,0.000012310335,0.00047130405,0.0017143108,0.000013993926,0.00006709838,0.000043441443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950549,0.00086661224,0.0010850456,0.0006264758,0.001407051,0.0009599187],"domain_scores_gemma":[0.99570197,0.00086368906,0.00083738036,0.00095044443,0.0013626791,0.00028384535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039643846,0.00031302462,0.00078068563,0.00025110616,0.0001360879,0.000021422122,0.00051342626,0.00010839857,0.00030909717],"category_scores_gemma":[0.0004493096,0.00020590608,0.000086726664,0.00090936816,0.0009136604,0.000555063,0.00013970313,0.0010569817,9.976994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030547565,0.0014824292,0.88806784,0.0002613504,0.00034506878,0.0000035885673,0.0071967994,0.0000791365,0.004425769,0.000005796821,0.000015848664,0.06756884],"study_design_scores_gemma":[0.0059616533,0.004655781,0.97338027,0.0010545058,0.00009826927,0.0000063611883,0.0033091314,0.000013252968,0.011151002,0.00010016725,0.000079970036,0.0001896251],"about_ca_topic_score_codex":0.0054104785,"about_ca_topic_score_gemma":0.0014037784,"teacher_disagreement_score":0.08531247,"about_ca_system_score_codex":0.00047898444,"about_ca_system_score_gemma":0.0010400001,"threshold_uncertainty_score":0.83966064},"labels":[],"label_agreement":null},{"id":"W2091189556","doi":"10.1158/1538-7445.am2012-4819","title":"Abstract 4819: Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Sorafenib; KRAS; Gene signature; Lung cancer; Medicine; Cancer; Adenocarcinoma; Internal medicine; Cancer research; Oncology; Hepatocellular carcinoma; Gene expression; Biology; Gene; Colorectal cancer","score_opus":0.05708683597365023,"score_gpt":0.43128345273831864,"score_spread":0.3741966167646684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091189556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746672,0.015517776,0.000014142737,0.00080925046,0.0005778472,0.0020747418,0.00008061648,0.000059366612,0.0061990665],"genre_scores_gemma":[0.98970735,0.0028044947,0.00038741858,0.00009934287,0.0011369227,0.0011766155,0.00010022359,0.00007915001,0.0045084944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971843,0.00009837824,0.00035701322,0.0005001326,0.0007496638,0.0011105387],"domain_scores_gemma":[0.99836147,0.00016442471,0.000086502325,0.0005120009,0.00036624717,0.0005093826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055532134,0.00025430875,0.00036175718,0.0003585217,0.00022645084,0.00004728228,0.00023016047,0.0001906023,0.001197837],"category_scores_gemma":[0.00006332422,0.00020007214,0.0000932457,0.0007288429,0.00013166832,0.00024280137,0.00011885405,0.0007470263,0.000095087606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009182255,0.00176541,0.62339956,0.00097423955,0.00020982043,0.000087905704,0.005117784,0.00022412787,0.32690585,0.000018987741,0.029508084,0.010870021],"study_design_scores_gemma":[0.0066556907,0.00024179484,0.6193579,0.001821937,0.00019738887,0.000008199575,0.000536004,0.00010738488,0.36049622,0.0000110571245,0.010206225,0.0003602262],"about_ca_topic_score_codex":0.0033475016,"about_ca_topic_score_gemma":0.00022694244,"teacher_disagreement_score":0.033590373,"about_ca_system_score_codex":0.0013167491,"about_ca_system_score_gemma":0.0018027382,"threshold_uncertainty_score":0.9997152},"labels":[],"label_agreement":null},{"id":"W2091214711","doi":"10.1158/1538-7445.am2013-911","title":"Abstract 911: Tyrosine kinase inhibitor Gefitinib selectivley induces apoptosis in Zap70+ chronic lymphocytic leukemia cells and inhibits B cell receptor signaling.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"ZAP70; Chronic lymphocytic leukemia; Gefitinib; Cancer research; Tyrosine kinase; Syk; Jurkat cells; Tyrosine phosphorylation; Bruton's tyrosine kinase; T cell; Biology; IL-2 receptor; Leukemia; Immunology; Cell biology; Signal transduction; Receptor; Epidermal growth factor receptor; Biochemistry; Immune system","score_opus":0.03923150567184174,"score_gpt":0.3347939954721717,"score_spread":0.29556248980032995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091214711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772854,0.0068074553,0.000002106217,0.0005430899,0.00025254695,0.0026299588,0.00004214864,0.00011277567,0.001881392],"genre_scores_gemma":[0.9902822,0.0036934637,0.00015787416,0.00018462959,0.0011450433,0.001266641,0.0000422317,0.00016312122,0.003064794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931825,0.00033615387,0.00087068416,0.0013559747,0.0020097112,0.0022450255],"domain_scores_gemma":[0.99610394,0.0009517554,0.00015136521,0.0008110683,0.0009924616,0.0009893897],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001897971,0.000528797,0.0008278325,0.0011057388,0.00031895036,0.0003039642,0.00048292687,0.0005491716,0.0030026422],"category_scores_gemma":[0.00046500875,0.00048119496,0.00013413717,0.0021800522,0.00079462293,0.0004962252,0.00049481634,0.0019610813,0.001125589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00045386556,0.00013350506,0.00023327243,0.0016315156,0.000054175576,0.000066496475,0.00072190556,0.00024367585,0.97161525,0.000012445531,0.015673842,0.0091600465],"study_design_scores_gemma":[0.016655445,0.00065546844,0.00074955483,0.0014995433,0.000024848772,0.000025395595,0.00046673208,0.0020863328,0.9746919,0.000061702085,0.002601457,0.00048157357],"about_ca_topic_score_codex":0.030644126,"about_ca_topic_score_gemma":0.00039132425,"teacher_disagreement_score":0.076261975,"about_ca_system_score_codex":0.1293304,"about_ca_system_score_gemma":0.05306843,"threshold_uncertainty_score":0.99976397},"labels":[],"label_agreement":null},{"id":"W2091287667","doi":"10.1158/1538-7445.am2012-1398","title":"Abstract 1398: Using zebrafish xenotransplantation to study the role of Y-Box binding protein (YB-1) in the metastasis of Ewing family tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Xenotransplantation; Zebrafish; Ex vivo; Cancer; Metastasis; Sarcoma; Cancer research; Leukemia; Medicine; In vivo; Pathology; Ewing's sarcoma; Cancer cell; Biology; Immunology; Transplantation; Internal medicine","score_opus":0.09082659679351374,"score_gpt":0.42180285152722086,"score_spread":0.3309762547337071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091287667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712,0.0006171033,0.00009163076,0.00022497149,0.000012201902,0.0015357939,0.00006497133,0.00000240845,0.000330902],"genre_scores_gemma":[0.9990183,0.00004187066,0.00018749278,0.00002656268,0.00009662337,0.00058357365,0.000015516347,0.000016073822,0.000014000313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997787,0.00040088544,0.00028838136,0.000218352,0.00082664046,0.00047872445],"domain_scores_gemma":[0.99909884,0.00012868196,0.00006502804,0.0004050555,0.00019447123,0.00010793198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003634532,0.00008979241,0.0001323383,0.00015537666,0.00014745924,0.00002460037,0.00063167454,0.000056415673,0.0000356211],"category_scores_gemma":[0.00032319844,0.00005894025,0.00004869369,0.00082134217,0.0002006031,0.000010338813,0.00014201822,0.00029110533,0.000004320314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085213425,0.00023032616,0.0049029887,0.000033198146,0.000046250836,8.6765044e-7,0.0010712423,0.000018869774,0.9886013,0.00006743725,0.000053721353,0.004888547],"study_design_scores_gemma":[0.0002794547,0.00016302806,0.03787055,0.000057373047,0.000011877769,0.000001124703,0.0071318913,0.000008198345,0.95346457,0.000058908347,0.0008807285,0.00007232209],"about_ca_topic_score_codex":0.0016719273,"about_ca_topic_score_gemma":0.00018058892,"teacher_disagreement_score":0.03513679,"about_ca_system_score_codex":0.000051143015,"about_ca_system_score_gemma":0.0002297778,"threshold_uncertainty_score":0.25274652},"labels":[],"label_agreement":null},{"id":"W2091425287","doi":"10.1158/1538-7445.am2014-2214","title":"Abstract 2214: Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Pancreatic cancer; Diabetes mellitus; Genome-wide association study; Genotype; Medicine; Cancer; Internal medicine; Single-nucleotide polymorphism; Obesity; Bioinformatics; Oncology; Endocrinology; Genetics; Gene; Biology","score_opus":0.06346920844543075,"score_gpt":0.4082309277585655,"score_spread":0.34476171931313476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091425287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98935944,0.0037873092,0.00003423187,0.003439174,0.000092900686,0.001391825,0.00004780461,0.000022461789,0.0018248825],"genre_scores_gemma":[0.99493414,0.0021671215,0.00005973794,0.0008884337,0.0004863304,0.0010085787,0.000011296508,0.00002927959,0.00041507345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966877,0.0008472469,0.00039984105,0.0004898626,0.0006818821,0.0008934331],"domain_scores_gemma":[0.99616617,0.0025472217,0.00008443061,0.0005103441,0.0003828229,0.00030900512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040709334,0.0001992096,0.00060600607,0.00033636624,0.0003559131,0.000081427635,0.00022238266,0.00016615608,0.00084160484],"category_scores_gemma":[0.00094287907,0.00013895248,0.00006681445,0.000414011,0.000635506,0.000116542455,0.00007811912,0.0010974291,0.00004564971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042518068,0.00016395278,0.96768767,0.0002953248,0.00018650536,0.0006361724,0.0010402664,0.000021050895,0.023231424,0.000032760356,0.0008963889,0.005383296],"study_design_scores_gemma":[0.0029682578,0.0003569664,0.98878205,0.000205539,0.0001573659,0.00027307318,0.0010196497,0.0016566346,0.0025158613,0.00016433366,0.0017363704,0.0001638947],"about_ca_topic_score_codex":0.0052904785,"about_ca_topic_score_gemma":0.002665217,"teacher_disagreement_score":0.021094376,"about_ca_system_score_codex":0.000628893,"about_ca_system_score_gemma":0.0007693297,"threshold_uncertainty_score":0.9214983},"labels":[],"label_agreement":null},{"id":"W2091520604","doi":"10.1158/0008-5472.can-06-3896","title":"Lipid Rafts and Nonrafts Mediate Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptotic and Nonapoptotic Signals in Non–Small Cell Lung Carcinoma Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lipid raft; Apoptosis; Cell biology; Caspase 8; Biology; Tumor necrosis factor alpha; Flip; Programmed cell death; Fas ligand; Kinase; Small interfering RNA; Cancer research; Signal transduction; Cell culture; Caspase; Immunology; Transfection; Biochemistry","score_opus":0.025079860378797853,"score_gpt":0.3037859232620029,"score_spread":0.27870606288320504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091520604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968564,0.0016577019,0.00012333084,0.00008826447,0.00027518946,0.00078826403,0.00001403633,0.000012116082,0.0001847308],"genre_scores_gemma":[0.99784285,0.0010167379,0.00012743834,0.000057540925,0.00026231605,0.00005999782,0.000030405372,0.00006050203,0.00054219324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973548,0.0001423989,0.00043372347,0.0008123396,0.00037323398,0.00088350446],"domain_scores_gemma":[0.9989018,0.00010811484,0.00010712399,0.00034202132,0.00019430133,0.00034663067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012741798,0.0002905672,0.00032697918,0.00033466268,0.00021693841,0.00009821879,0.0002050577,0.00034593354,0.000027213884],"category_scores_gemma":[0.0000526751,0.00027616238,0.00006736451,0.00040529895,0.0001245548,0.000015896863,0.00027382182,0.0004685371,0.0000059786094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010813732,0.00011529864,0.005744251,0.00018792418,0.000024510933,0.000013543224,0.00061151595,0.00005207863,0.99045473,0.0000036202619,0.000055096025,0.0026292712],"study_design_scores_gemma":[0.0022796919,0.00028786875,0.025078688,0.00011792459,0.000021264932,0.000006228053,0.00022887741,0.00092197146,0.9706128,0.000027720056,0.000092019254,0.00032493586],"about_ca_topic_score_codex":0.00057827577,"about_ca_topic_score_gemma":0.00032029548,"teacher_disagreement_score":0.019841941,"about_ca_system_score_codex":0.00011268344,"about_ca_system_score_gemma":0.00019349033,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W2091598738","doi":"10.1158/1538-7445.am2012-lb-210","title":"Abstract LB-210: Abrogation of mutant <i>TP53</i> radiation resistance by lithium induced <i>CTNNB1</i> (β-catenin) activation in medulloblastoma.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Clonogenic assay; Wnt signaling pathway; Transfection; Cancer research; DNA damage; Mutant; Medulloblastoma; Somatic cell; Mutation; Biology; Radiation sensitivity; Catenin; DNA repair; Cell culture; Molecular biology; Gene; DNA; Genetics","score_opus":0.04753345955582885,"score_gpt":0.3686922218526971,"score_spread":0.3211587622968683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091598738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045974,0.0026929453,0.00010043583,0.0016042503,0.00028053476,0.001085617,0.000042530064,0.000047314217,0.0036866406],"genre_scores_gemma":[0.9979887,0.00060609373,0.00007930489,0.00013215508,0.00028579886,0.0002531905,0.00011403098,0.000061000606,0.00047972007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968463,0.00019683575,0.0005557465,0.000405402,0.0012451069,0.00075061363],"domain_scores_gemma":[0.9983712,0.00018856926,0.00022704626,0.00044888197,0.0004934767,0.0002708583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015446494,0.00019845688,0.00035330185,0.00048169738,0.00008804536,0.00002312194,0.00017645728,0.0003029915,0.000183536],"category_scores_gemma":[0.00047140828,0.00020254332,0.00008060742,0.0014451441,0.00014027487,0.0004186104,0.00005281136,0.00095263816,0.000046899502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088437874,0.0002552603,0.002649512,0.00025768927,0.00004342824,0.000004634209,0.0008832894,0.000020977322,0.9811387,0.00014627306,0.0067577832,0.006958093],"study_design_scores_gemma":[0.0020866923,0.00013345863,0.030859232,0.00065479416,0.000021317415,0.0000031080046,0.00018420977,0.000024615654,0.95380265,0.00006612731,0.011993876,0.00016995276],"about_ca_topic_score_codex":0.0011724869,"about_ca_topic_score_gemma":0.00029045722,"teacher_disagreement_score":0.02820972,"about_ca_system_score_codex":0.0015232924,"about_ca_system_score_gemma":0.00072354823,"threshold_uncertainty_score":0.8259477},"labels":[],"label_agreement":null},{"id":"W2091615985","doi":"10.1158/0008-5472.sabcs13-p1-08-41","title":"Abstract P1-08-41: Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near infrared imaging and tumor pathologic criteria","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Chemotherapy; Receiver operating characteristic; Biopsy; Area under the curve; Nuclear medicine; Internal medicine; Oncology; Pathology; Radiology","score_opus":0.041908073661846,"score_gpt":0.3986300854668011,"score_spread":0.3567220118049551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091615985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826521,0.0015617951,0.0001416896,0.013033355,0.00020763364,0.0012988772,0.000019827117,0.00014129102,0.00094342086],"genre_scores_gemma":[0.9921164,0.0005587463,0.003594366,0.0022115326,0.00025623318,0.00053759885,0.000015399432,0.00005494395,0.0006547835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972985,0.0003367138,0.000353881,0.0006450621,0.00060323294,0.0007626337],"domain_scores_gemma":[0.9984111,0.0002956266,0.00006644331,0.00044921797,0.0002656699,0.00051193114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021939497,0.00023052697,0.00036807088,0.0002872918,0.00037031164,0.0002571827,0.0001762387,0.00008280513,0.0011058168],"category_scores_gemma":[0.0012028482,0.00017804514,0.00006631644,0.00036781267,0.0003883903,0.00018000604,0.00015253764,0.000868068,0.00009390974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020750866,0.00022632838,0.07719795,0.00022371866,0.000057348,0.0017458884,0.0034030182,0.000041678344,0.7028179,0.00001299508,0.02051558,0.19168249],"study_design_scores_gemma":[0.0032543913,0.00092635193,0.9618227,0.00071344816,0.000029297578,0.0005011901,0.0012256908,0.009780936,0.0056658196,0.0004414907,0.015353496,0.00028518972],"about_ca_topic_score_codex":0.00046051847,"about_ca_topic_score_gemma":0.0000018429415,"teacher_disagreement_score":0.8846248,"about_ca_system_score_codex":0.0003876695,"about_ca_system_score_gemma":0.00025413634,"threshold_uncertainty_score":0.9998073},"labels":[],"label_agreement":null},{"id":"W2091871111","doi":"10.1158/1538-7445.am2013-2751","title":"Abstract 2751: Wnt/β-catenin regulates the expression of MGMT through TCF/LEF transcription: new strategy for DNA alkylators in cancer therapy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Temozolomide; Wnt signaling pathway; Cancer research; Methyltransferase; DNA methyltransferase; DNA repair; Cancer; Biology; Glioma; Signal transduction; DNA; Methylation; Cell biology; Biochemistry; Genetics","score_opus":0.19654912452833162,"score_gpt":0.4409427562155277,"score_spread":0.24439363168719608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091871111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967976,0.019808449,0.0000026672471,0.009721952,0.00012044919,0.0017217132,0.000026141232,0.00001752635,0.0006051354],"genre_scores_gemma":[0.99023,0.00611731,0.00006207973,0.00009730244,0.00027309306,0.0021566588,0.00001754388,0.00003748564,0.0010085308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814224,0.00007236207,0.0003490551,0.0003635869,0.0005513371,0.0005213909],"domain_scores_gemma":[0.9989199,0.0002089732,0.000076621465,0.00032850672,0.00031987033,0.00014611596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034853164,0.00018111928,0.000335926,0.0001606358,0.00012593894,0.00004832798,0.00021237193,0.00013193795,0.002461386],"category_scores_gemma":[0.000023755198,0.00010539498,0.00014087555,0.0004958335,0.00017940243,0.00019914727,0.000023002109,0.00029265738,0.000016375563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000569776,0.00046983498,0.00781632,0.00015066283,0.00012186133,0.000010214427,0.0017751777,0.00019781453,0.8735034,0.00030261866,0.03907641,0.07600589],"study_design_scores_gemma":[0.0035072183,0.0003687058,0.15490738,0.0005078788,0.000020056767,0.0000019787883,0.00057063997,0.000022152704,0.83172816,0.0017965965,0.006458562,0.00011071057],"about_ca_topic_score_codex":0.017450698,"about_ca_topic_score_gemma":0.0010343685,"teacher_disagreement_score":0.14709105,"about_ca_system_score_codex":0.00022897808,"about_ca_system_score_gemma":0.00043964142,"threshold_uncertainty_score":0.9984505},"labels":[],"label_agreement":null},{"id":"W2091889220","doi":"10.1158/0008-5472.fbcr09-c53","title":"Abstract C53: The genetic evolution of oral cancer fields","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Field cancerization; Microdissection; Breakpoint; Dysplasia; Cancer; Biology; Pathology; Genetics; Medicine; Gene; Chromosome","score_opus":0.04202692835379069,"score_gpt":0.4200937308723265,"score_spread":0.3780668025185358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091889220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865523,0.005955053,0.0027393673,0.0029540923,0.000035343997,0.00031612001,0.000023740118,0.000009150248,0.0014148315],"genre_scores_gemma":[0.9971282,0.0017135512,0.0002464463,0.00020104015,0.00012463861,0.00018640632,0.000011045488,0.0000068127492,0.0003818753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925125,0.000054377928,0.0001235775,0.00020780017,0.00014100387,0.00022200734],"domain_scores_gemma":[0.99936974,0.000008639395,0.00003699877,0.00037068521,0.00017483576,0.00003912575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025483067,0.0000660771,0.00007112746,0.000032693282,0.00010923478,0.000008893718,0.00030331075,0.00013160781,0.00009203209],"category_scores_gemma":[0.000024324061,0.000047790225,0.000052525873,0.00015606689,0.0001630722,0.0000012711465,0.000058142967,0.00017454408,0.0000031696043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003052715,0.000031540567,0.0010843306,0.0000067827013,0.000016446615,5.735914e-7,0.000012694235,0.000081728445,0.96344364,0.0009323783,0.012071064,0.022288326],"study_design_scores_gemma":[0.00023237524,0.00031084087,0.09599619,0.00002664398,0.000011508249,0.0000035348878,0.000036745045,0.000042669235,0.79969394,0.002758687,0.10074403,0.00014280027],"about_ca_topic_score_codex":0.0007347792,"about_ca_topic_score_gemma":0.00024456845,"teacher_disagreement_score":0.16374964,"about_ca_system_score_codex":0.00003360137,"about_ca_system_score_gemma":0.00017287265,"threshold_uncertainty_score":0.19488288},"labels":[],"label_agreement":null},{"id":"W2091911272","doi":"10.1158/1538-7445.am10-3661","title":"Abstract 3661: Vascular changes and potentiating secondary drug delivery in colorectal cancer with Irinophore C","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Colorectal cancer; Irinotecan; Fluorouracil; Toxicity; Pharmacology; Perfusion; Cancer; Pathology; Internal medicine","score_opus":0.035562699177785095,"score_gpt":0.38118300437124364,"score_spread":0.34562030519345854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091911272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891926,0.0063907644,8.106714e-8,0.002454139,0.00021499362,0.000616696,0.00003542178,0.000023363813,0.0013452776],"genre_scores_gemma":[0.99393183,0.0043113553,0.00005007475,0.00018241217,0.0004525975,0.00056360615,0.000016869017,0.000031344578,0.0004599089],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985341,0.00004822111,0.00012379358,0.00037704842,0.0003656376,0.0005512341],"domain_scores_gemma":[0.99931693,0.000112017595,0.000035462694,0.00013461786,0.0001904765,0.0002104983],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045224236,0.00014405987,0.00025679282,0.00025235358,0.0001462591,0.000030163941,0.000090989124,0.00009570969,0.002218243],"category_scores_gemma":[0.000013870254,0.00011408154,0.00003230956,0.0003298078,0.0002675855,0.000079387726,0.00007584351,0.0011227456,0.000008612615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011888487,0.00015899142,0.24087147,0.00032902125,0.0002128642,0.00034342144,0.0014203956,0.0000058447977,0.6790107,0.000010139685,0.0026135386,0.07383477],"study_design_scores_gemma":[0.0056492966,0.00038455625,0.82630754,0.00027542346,0.00008598808,0.000034944285,0.0005430456,0.000064195665,0.15481935,0.000030894564,0.011582594,0.00022216323],"about_ca_topic_score_codex":0.01350351,"about_ca_topic_score_gemma":0.076909386,"teacher_disagreement_score":0.5854361,"about_ca_system_score_codex":0.00023904622,"about_ca_system_score_gemma":0.0007563821,"threshold_uncertainty_score":0.9986939},"labels":[],"label_agreement":null},{"id":"W2092113162","doi":"10.1158/1538-7445.am10-228","title":"Abstract 228: Cucurbitacin-I (JSI-124) induces apoptosis in chronic lymphocytic leukemia (CLL) cells through inhibiting STAT3 activation and XIAP expression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canola Council of Canada; Research Manitoba","funders":"","keywords":"XIAP; Chronic lymphocytic leukemia; STAT3; Apoptosis; Cancer research; Phosphorylation; Inhibitor of apoptosis; Tyrosine phosphorylation; Protein tyrosine phosphatase; Leukemia; Caspase; Programmed cell death; Biology; Chemistry; Immunology; Cell biology; Biochemistry","score_opus":0.04940752342525346,"score_gpt":0.3720087113157958,"score_spread":0.3226011878905424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092113162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997311,0.001002314,0.000072801886,0.000103156584,0.00012462356,0.00030918693,0.00001867498,0.00001093802,0.0010473006],"genre_scores_gemma":[0.99656796,0.0021628053,0.00015123663,0.00005066659,0.00041642247,0.000265151,0.000041005216,0.000030330724,0.0003144125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984265,0.00007012676,0.00023575778,0.00052013836,0.00029767375,0.00044982703],"domain_scores_gemma":[0.9992455,0.000046321748,0.00008259665,0.0003600721,0.0001721533,0.00009331324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046859827,0.00014871359,0.00013435759,0.000109587476,0.0002352052,0.00009146595,0.0002115479,0.0002326687,0.00011526657],"category_scores_gemma":[0.00006383087,0.00013972734,0.000028701863,0.0002597669,0.00020942964,0.00003883025,0.00014964382,0.0005057804,0.000010232045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056617588,0.0000124843245,0.00010017845,0.00007048074,0.000008422453,5.5516983e-7,0.00021263068,0.00030228563,0.99114597,0.00004495089,0.001076963,0.0069684437],"study_design_scores_gemma":[0.00065318786,0.000075464704,0.0009899407,0.00012430975,0.0000024791125,9.1974044e-7,0.00031234662,0.00008770666,0.9904206,0.00011138766,0.0070568197,0.00016487851],"about_ca_topic_score_codex":0.0023308096,"about_ca_topic_score_gemma":0.00038759652,"teacher_disagreement_score":0.006803565,"about_ca_system_score_codex":0.001092041,"about_ca_system_score_gemma":0.00197729,"threshold_uncertainty_score":0.5697916},"labels":[],"label_agreement":null},{"id":"W2092265599","doi":"10.1158/1538-7445.am2014-4575","title":"Abstract 4575: Structure-based design, synthesis and biological testing of highly potent semi-synthetic epipodophyllotoxin-derived hybrid etoposide analogs","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Etoposide; Topoisomerase; DNA; Chemistry; Cell cycle; Biology; Biochemistry; Cell; Genetics","score_opus":0.0842697062649842,"score_gpt":0.330991049870687,"score_spread":0.2467213436057028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092265599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276954,0.0011603059,0.0051838285,0.00022953073,0.00007860005,0.00033799684,0.000090470516,0.000013738362,0.0001360169],"genre_scores_gemma":[0.99725074,0.00035746684,0.0018945733,0.00015061306,0.00017211206,0.00010297091,0.00001465534,0.00003445973,0.000022423277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813783,0.00028392734,0.0002612978,0.0005370232,0.00030137683,0.00047855877],"domain_scores_gemma":[0.9986764,0.0003542454,0.00010276223,0.0004112845,0.00028831817,0.00016698358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008890351,0.00019495269,0.0002730924,0.000112275855,0.0001541883,0.00003752273,0.00029553624,0.0001514945,0.000056069577],"category_scores_gemma":[0.00046946493,0.00016287959,0.000073242794,0.00015918273,0.00033466963,0.0000034680597,0.00012936817,0.00022563049,0.0000018279453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002227853,0.000035370056,0.00034405518,0.000058518766,0.000047786452,0.000003939505,0.000010633581,0.00041079705,0.9685841,0.00006458426,0.0000483487,0.030169046],"study_design_scores_gemma":[0.0003856405,0.00053143746,0.0028043936,0.00008340452,0.000017398406,0.0000070792653,0.000019320523,0.00046606234,0.99308294,0.0009131139,0.0014960013,0.00019322903],"about_ca_topic_score_codex":0.00025078477,"about_ca_topic_score_gemma":0.000030097091,"teacher_disagreement_score":0.029975817,"about_ca_system_score_codex":0.000050841074,"about_ca_system_score_gemma":0.00024100301,"threshold_uncertainty_score":0.66420364},"labels":[],"label_agreement":null},{"id":"W2092412612","doi":"10.1158/1538-7445.am2012-156","title":"Abstract 156: Screening and characterization of inhibitors of G-protein coupled receptor kinase GRK6 as potential therapeutics for multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"G protein-coupled receptor kinase; Kinome; Cell biology; Kinase; Biology; Beta adrenergic receptor kinase; G protein-coupled receptor; Gene silencing; Cancer research; Signal transduction; Gene; Biochemistry","score_opus":0.052972220156396486,"score_gpt":0.35340991071939787,"score_spread":0.3004376905630014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092412612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943057,0.0017774177,0.0029204728,0.00012211784,0.00015226143,0.0005682256,0.00013612554,0.0000037594587,0.000013955175],"genre_scores_gemma":[0.9978282,0.00083418033,0.00042864226,0.000038698912,0.0004142742,0.00013942987,0.00012824642,0.000030477473,0.00015785423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990188,0.000047488356,0.00020562952,0.00019121802,0.00022722554,0.00030966685],"domain_scores_gemma":[0.9992732,0.00002147723,0.00011158272,0.00018556457,0.00032031478,0.00008788264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060038397,0.00010015874,0.00014136144,0.00006998597,0.00008094573,0.000013462154,0.000110841,0.00013210037,0.000039733895],"category_scores_gemma":[0.00003395775,0.00009743266,0.000061843224,0.000096406155,0.000118940115,0.000009683431,0.00007403809,0.000095209056,6.8470325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067416695,0.00006007258,0.0003951304,0.00010725087,0.00006819678,1.1655369e-7,0.00011808185,0.0000033009212,0.96906394,0.000101102145,0.000011503259,0.029397143],"study_design_scores_gemma":[0.0008347804,0.0002927162,0.0018785573,0.00005946092,0.000013326635,6.328761e-7,0.0001163556,0.0001442861,0.9858073,0.000034981174,0.010715251,0.000102325284],"about_ca_topic_score_codex":0.00014470526,"about_ca_topic_score_gemma":0.000015928186,"teacher_disagreement_score":0.029294819,"about_ca_system_score_codex":0.0000195348,"about_ca_system_score_gemma":0.00010844479,"threshold_uncertainty_score":0.39731884},"labels":[],"label_agreement":null},{"id":"W2092434292","doi":"10.1158/0008-5472.can-08-4290","title":"Thrombin Induces Tumor Cell Cycle Activation and Spontaneous Growth by Down-regulation of p27Kip1, in Association with the Up-regulation of Skp2 and MiR-222","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; Howard Hughes Medical Institute","keywords":"LNCaP; Tramp; Thrombin; Cell cycle; Cancer research; Biology; Cancer cell; Endocrinology; Chemistry; Prostate cancer; Internal medicine; Cancer; Medicine; Immunology; Platelet","score_opus":0.011221878538205173,"score_gpt":0.2878103487513981,"score_spread":0.27658847021319294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092434292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981113,0.000668501,0.000041685376,0.0006629936,0.000013833125,0.000372421,0.000019787502,0.0000029715302,0.00010650171],"genre_scores_gemma":[0.9995855,0.00012464469,0.000028385713,0.000020569974,0.00004191894,0.000021401966,0.00007728943,0.000009304353,0.00009100335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989512,0.00016976755,0.00017131654,0.00022139607,0.00032629518,0.00016003306],"domain_scores_gemma":[0.99933195,0.000050844534,0.00017116075,0.00014165763,0.00027045148,0.00003395007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050796865,0.00008415112,0.00011602921,0.00008423413,0.00006654323,0.00001955339,0.00007626847,0.00009603294,0.000011334698],"category_scores_gemma":[0.000064197135,0.00006789329,0.00001592774,0.00022557644,0.00010005838,0.000019322268,0.000031367334,0.000098363904,2.0902328e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003066111,0.00004627682,0.00561426,0.00004360504,0.000012501174,2.8045335e-7,0.00018558331,0.00012847688,0.9919834,0.00004567078,0.00086383935,0.00076945976],"study_design_scores_gemma":[0.00045583787,0.00013021042,0.31145427,0.000031099713,0.000006561787,0.0000025206655,0.000071762,0.000088742105,0.6873091,0.00032842063,0.000067895046,0.0000536055],"about_ca_topic_score_codex":0.0003679428,"about_ca_topic_score_gemma":0.00012445309,"teacher_disagreement_score":0.30584,"about_ca_system_score_codex":0.00010134923,"about_ca_system_score_gemma":0.000089023146,"threshold_uncertainty_score":0.2768608},"labels":[],"label_agreement":null},{"id":"W2092609093","doi":"10.1158/0008-5472.can-05-4402","title":"Prognostic Significance of Nuclear Factor-κB p105/p50 in Human Melanoma and Its Role in Cell Migration","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Cancer research; P50; Pathogenesis; NFKB1; NF-κB; Biology; Gene knockdown; Cancer; Cell; Medicine; Pathology; Transcription factor; Cell culture; Immunology; Internal medicine; Gene; Inflammation; Genetics","score_opus":0.03341196776711778,"score_gpt":0.324322556302173,"score_spread":0.2909105885350552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092609093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969127,0.0020128952,0.0000031068437,0.000060072507,0.0000143812,0.00034602112,0.000027818294,0.0000040787513,0.00061893143],"genre_scores_gemma":[0.99947613,0.00010923273,0.000025600315,0.000008738258,0.00006350972,0.000068973524,0.00003372344,0.000016213546,0.00019789446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989098,0.00012995464,0.00018761386,0.00029839668,0.00019983912,0.0002744259],"domain_scores_gemma":[0.99963325,0.000024973391,0.00004149601,0.00015313277,0.00010868383,0.000038470618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029066345,0.00008425289,0.00011360255,0.0001196781,0.00004126614,0.00001719596,0.00014643256,0.000109956585,0.00003633587],"category_scores_gemma":[0.000045129178,0.000087720364,0.000019178764,0.00019468143,0.0000794343,0.0000049622695,0.00007100765,0.00016927159,0.0000045722777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041997853,0.0000657691,0.054033756,0.00006553002,0.0000024501676,0.000004660893,0.00014190671,0.0001139941,0.9451191,0.000065257846,0.00014987754,0.00019572774],"study_design_scores_gemma":[0.00041934324,0.00019993233,0.041598134,0.000043103006,0.0000013697344,4.903199e-7,0.000085378335,0.00007609173,0.95604527,0.000115476374,0.0013204016,0.00009500942],"about_ca_topic_score_codex":0.0016693422,"about_ca_topic_score_gemma":0.0029668,"teacher_disagreement_score":0.012435622,"about_ca_system_score_codex":0.000048515532,"about_ca_system_score_gemma":0.00010691496,"threshold_uncertainty_score":0.35771325},"labels":[],"label_agreement":null},{"id":"W2092681867","doi":"10.1158/0008-5472.can-06-4249","title":"Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Pittsburgh; Cancer Institute, University of Pittsburgh; National Cancer Institute; National Institutes of Health; DOD Prostate Cancer Research Program; Cancer Research Institute","keywords":"Adenosine; Cytotoxic T cell; Adenosine A2B receptor; Cytokine; Adenosine A3 receptor; Protein kinase A; Chemistry; Adenosine kinase; CD8; Biology; Cell biology; Adenosine receptor; Molecular biology; Biochemistry; Agonist; Receptor; Kinase; Immune system; Immunology; In vitro; Adenosine deaminase","score_opus":0.037322317008083764,"score_gpt":0.33718935974627157,"score_spread":0.2998670427381878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092681867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914456,0.010304877,0.00012692629,0.000054419237,0.00002322533,0.00025489787,0.000019468258,0.000004419761,0.00006718754],"genre_scores_gemma":[0.99872696,0.00066704734,0.000092867274,0.0000046125347,0.0002430371,0.000011388404,0.000027816897,0.000016746362,0.00020954892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990039,0.00007326482,0.00017827767,0.00031026397,0.00021345154,0.00022082549],"domain_scores_gemma":[0.9994159,0.000018403058,0.000084561725,0.00016674756,0.00025049102,0.00006392001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066150003,0.00009889466,0.0001473156,0.000112236485,0.000100317644,0.000012237747,0.000058297806,0.00010283087,0.00002541131],"category_scores_gemma":[0.000058112724,0.00009668381,0.000021746782,0.00023781449,0.00024361745,0.000010035446,0.00008699968,0.00011423835,3.8551124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043467776,0.000059306876,0.0013087334,0.00012809466,0.00002441477,0.0000041862904,0.00006466924,0.000008066073,0.9960909,0.000020820587,0.0009162472,0.00093988376],"study_design_scores_gemma":[0.00039674403,0.0004679133,0.0009135925,0.00013414805,0.0000069927387,0.000006654047,0.00007346541,0.00000313946,0.9974933,0.000046490302,0.00036215186,0.00009538217],"about_ca_topic_score_codex":0.00021667707,"about_ca_topic_score_gemma":0.000013146405,"teacher_disagreement_score":0.00963783,"about_ca_system_score_codex":0.0000314898,"about_ca_system_score_gemma":0.00006808505,"threshold_uncertainty_score":0.39426515},"labels":[],"label_agreement":null},{"id":"W2092715192","doi":"10.1158/0008-5472.can-08-0054","title":"Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"MHC class I; Immune system; Hypoxia (environmental); Biology; Nitric oxide; NKG2D; Cancer research; Tumor microenvironment; Immunology; Cytotoxic T cell; Cancer cell; Pharmacology; Major histocompatibility complex; Chemistry; Cancer; Endocrinology; Biochemistry; In vitro","score_opus":0.025872157278940097,"score_gpt":0.2977205555665763,"score_spread":0.2718483982876362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092715192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790138,0.009580967,0.000007110529,0.000028833836,0.00023243572,0.00020006466,0.000010046833,0.000026089921,0.010900641],"genre_scores_gemma":[0.9844215,0.0008053578,0.000009265041,0.00003249023,0.00001640954,0.000040827523,0.000032188873,0.000019412824,0.014622575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985428,0.00037922227,0.0003695434,0.00022944334,0.000110386274,0.00036863037],"domain_scores_gemma":[0.998908,0.00024074997,0.0001472536,0.00025829283,0.00041748153,0.000028217723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038264043,0.000113479924,0.00026063636,0.00042767375,0.00018808934,0.000003914605,0.00022491417,0.0001451721,0.0028165367],"category_scores_gemma":[0.0001567467,0.00010600443,0.000097817865,0.0005627047,0.0003810281,0.00008351988,0.00010553186,0.0005759096,0.00025564423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040233802,0.00019040811,0.0016649372,0.000039749215,0.00007306836,0.0000055789087,0.00019779438,0.000027338705,0.9899818,0.00015185321,0.0069037583,0.00036141044],"study_design_scores_gemma":[0.0008862792,0.00016324258,0.00747545,0.0000620313,0.000012861829,0.000044223867,0.00071201514,0.000027533824,0.9728608,0.000027967908,0.017632157,0.00009540671],"about_ca_topic_score_codex":0.003045027,"about_ca_topic_score_gemma":0.000008580898,"teacher_disagreement_score":0.017120935,"about_ca_system_score_codex":0.00012079473,"about_ca_system_score_gemma":0.00023917692,"threshold_uncertainty_score":0.99809504},"labels":[],"label_agreement":null},{"id":"W2092978511","doi":"10.1158/1538-7445.am2013-2286","title":"Abstract 2286: Short term reduction in mammographic density predicts survival in breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Mammography; Cancer; Internal medicine; Oncology; Prospective cohort study; Observational study; Proportional hazards model; Biomarker; Surrogate endpoint","score_opus":0.047109707922575864,"score_gpt":0.3634045102780533,"score_spread":0.31629480235547747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092978511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048287,0.00061933947,0.000001013908,0.0035410596,0.0002665592,0.0007402551,0.000033542605,0.000045107186,0.0042702854],"genre_scores_gemma":[0.9981343,0.000814079,0.000010124297,0.000034926772,0.00036372113,0.00038820808,0.000017877002,0.000027849786,0.00020889094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976351,0.00007854457,0.0003023621,0.00046251563,0.00075617305,0.0007652493],"domain_scores_gemma":[0.99901557,0.00005232204,0.000026831261,0.00031704197,0.0003087116,0.0002795129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007711564,0.00016053233,0.0002965492,0.0010709105,0.00006961599,0.00009512397,0.00017789805,0.00010742333,0.00044565313],"category_scores_gemma":[0.000028059674,0.0001462934,0.00009196949,0.0019085738,0.00045353468,0.0005144419,0.00006956257,0.0008841985,0.000022891825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026315116,0.00022041945,0.8821761,0.00016917521,0.00003356897,0.000096819866,0.00013675903,0.000009951536,0.020492718,0.000024986184,0.0012418733,0.09513446],"study_design_scores_gemma":[0.0007408137,0.00004219771,0.99605286,0.0007368219,0.000007770591,0.00010594612,0.00035754812,0.000037863745,0.0015243974,0.00018359056,0.00007799589,0.00013218154],"about_ca_topic_score_codex":0.025761755,"about_ca_topic_score_gemma":0.0028067876,"teacher_disagreement_score":0.11387675,"about_ca_system_score_codex":0.00038776352,"about_ca_system_score_gemma":0.00035719786,"threshold_uncertainty_score":0.98072577},"labels":[],"label_agreement":null},{"id":"W2093084585","doi":"10.1158/1538-7445.am10-158","title":"Abstract 158: The landscape of DNA hypomethylation in liver cancer, its correlation with other cancers, and its potential role in cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Biology; DNA methylation; Cancer; Liver cancer; Promoter; CpG site; Metastasis; Methylation; Cancer research; DNA demethylation; Cancer cell; Gene; Molecular biology; Genetics; Gene expression","score_opus":0.027831668083480962,"score_gpt":0.3388795157059705,"score_spread":0.31104784762248955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093084585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758765,0.022832463,0.000015150573,0.00021596705,0.00012595825,0.00038273825,0.000050377217,0.000002371263,0.0004984671],"genre_scores_gemma":[0.9903673,0.008914188,0.000018593593,0.00001844423,0.0002282564,0.00015323662,0.000015755306,0.000021095786,0.0002631186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998864,0.00009162388,0.00019025127,0.0002937979,0.00029089669,0.0002694418],"domain_scores_gemma":[0.9993971,0.000039494935,0.00008781235,0.00017061134,0.00025076728,0.00005418761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000626938,0.00010600348,0.00012087279,0.00013998912,0.00006344229,0.00002306735,0.00014220583,0.00016369419,0.00018633057],"category_scores_gemma":[0.000056219003,0.00008010348,0.000020594474,0.00031944967,0.00008673858,0.0000141504115,0.00005485612,0.00035927523,0.0000015428012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022659582,0.000025912297,0.06366455,0.0000345173,0.000018827774,0.0000010954673,0.0002764488,0.0073634004,0.9174182,0.000040066538,0.000037194764,0.010893223],"study_design_scores_gemma":[0.0010498745,0.0001521152,0.43484285,0.00008340513,0.000010726344,6.4504496e-7,0.00013086053,0.0035502943,0.5572091,0.00009343938,0.0027079885,0.00016869346],"about_ca_topic_score_codex":0.009225113,"about_ca_topic_score_gemma":0.071263984,"teacher_disagreement_score":0.37117833,"about_ca_system_score_codex":0.00005849551,"about_ca_system_score_gemma":0.00039906974,"threshold_uncertainty_score":0.99737257},"labels":[],"label_agreement":null},{"id":"W2093189076","doi":"10.1158/1538-7445.am2012-3254","title":"Abstract 3254: Cadherin-11 function is required for full neoplastic transformation by v-Src","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"STAT3; Gene knockdown; STAT protein; Downregulation and upregulation; E2F; Cancer research; Transcription factor; Biology; Cell biology; Small hairpin RNA; STAT4; Signal transduction; Apoptosis; stat; Gene; Genetics","score_opus":0.08623183393238175,"score_gpt":0.38796447931263006,"score_spread":0.3017326453802483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093189076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438276,0.005640136,0.009902191,0.003056622,0.001112897,0.0021583454,0.00024679131,0.000119672826,0.00338061],"genre_scores_gemma":[0.99631464,0.00038879897,0.000075062184,0.0002668226,0.000646755,0.0007159329,0.00015895042,0.00006426728,0.001368759],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977985,0.00004669575,0.0003043615,0.00028587348,0.0007325892,0.0008319561],"domain_scores_gemma":[0.9987692,0.000118179065,0.000057056823,0.00032013212,0.00037685,0.0003585425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007970002,0.00016225061,0.00022800725,0.00020118494,0.00019282186,0.000034395143,0.00010411395,0.00021754489,0.0011394402],"category_scores_gemma":[0.00012439032,0.00015541854,0.0001221887,0.00041254668,0.00010115006,0.0003060953,0.000020159601,0.00045719786,0.00020952949],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00201412,0.00016154986,0.00023284073,0.00060003164,0.000109375236,0.000002833483,0.0014072573,0.00002554606,0.8498084,0.00020010662,0.12165352,0.023784453],"study_design_scores_gemma":[0.0049839434,0.0010470803,0.0036372128,0.0003687785,0.00016072618,0.00003310095,0.0005212545,0.0004826893,0.31113905,0.0001262114,0.6771624,0.00033753493],"about_ca_topic_score_codex":0.00050083495,"about_ca_topic_score_gemma":0.00013633075,"teacher_disagreement_score":0.5555089,"about_ca_system_score_codex":0.0007469176,"about_ca_system_score_gemma":0.00039738682,"threshold_uncertainty_score":0.9997737},"labels":[],"label_agreement":null},{"id":"W2093264973","doi":"10.1158/0008-5472.can-03-2631","title":"The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Fludarabine; Histone deacetylase inhibitor; XIAP; Cancer research; Sodium butyrate; Jurkat cells; Histone deacetylase; Apoptosis; Chemistry; Myeloid leukemia; Programmed cell death; Molecular biology; Biology; Caspase; Histone; Biochemistry; Immunology","score_opus":0.026681745987962146,"score_gpt":0.37270066592405676,"score_spread":0.3460189199360946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093264973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489075,0.0005795505,0.00011536307,0.0019406624,0.000183362,0.0008540914,0.000034042692,0.000019766923,0.0013823882],"genre_scores_gemma":[0.9942777,0.00025214723,0.00023701912,0.0001805315,0.0005818216,0.0007164889,0.00003746951,0.000088321925,0.0036284882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996045,0.00032141947,0.00043163108,0.00087523804,0.0010740254,0.0012526808],"domain_scores_gemma":[0.99771535,0.00011289546,0.00005919336,0.0009585968,0.0006354147,0.0005185216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014024365,0.00029088644,0.00027182035,0.0003264837,0.0006479912,0.00014957253,0.0008593411,0.0002324412,0.000047970145],"category_scores_gemma":[0.0005414667,0.00022360915,0.00007656093,0.00095081335,0.0007028739,0.000014286599,0.0005450379,0.0010854789,0.00012201085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006804315,0.00012849718,0.000026690215,0.000037641108,0.00003260194,0.000045583638,0.00027477337,0.0013240385,0.98282474,0.00019412837,0.01332037,0.0011104824],"study_design_scores_gemma":[0.0013580888,0.00090581947,0.00015648376,0.00020224707,0.000004991216,0.000007605557,0.00016004636,0.0000049386167,0.9575561,0.000037148122,0.039320506,0.00028600616],"about_ca_topic_score_codex":0.0033043209,"about_ca_topic_score_gemma":0.007174536,"teacher_disagreement_score":0.026000135,"about_ca_system_score_codex":0.0021318444,"about_ca_system_score_gemma":0.0018498015,"threshold_uncertainty_score":0.91185164},"labels":[],"label_agreement":null},{"id":"W2093282527","doi":"10.1158/0008-5472.can-03-2558","title":"Normal Cells Control the Growth of Neighboring Transformed Cells Independent of Gap Junctional Communication and Src Activity","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cell biology; Biology; Proto-oncogene tyrosine-protein kinase Src; Cancer cell; Growth factor; Cadherin; Transcription factor; Gap junction; Intracellular; Signal transduction; Cell; Cancer; Receptor; Genetics; Gene","score_opus":0.03514104437295568,"score_gpt":0.32844888559348734,"score_spread":0.29330784122053166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093282527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972083,0.00085957744,0.0005203082,0.00058945105,0.00004662423,0.00020938307,0.00004126526,0.0000014850667,0.00052361964],"genre_scores_gemma":[0.99812824,0.0016530859,0.000022384273,0.000030823103,0.00005751018,0.00003608752,0.000006624272,0.000005982046,0.000059292735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999279,0.0001357906,0.00011948799,0.00013994102,0.00015629145,0.00016946805],"domain_scores_gemma":[0.999433,0.00005778337,0.000046255944,0.00021856728,0.00020785269,0.000036544625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051754207,0.00006020449,0.00010349796,0.000038620827,0.00009015616,0.00000623407,0.00018215271,0.000089121764,0.000030108378],"category_scores_gemma":[0.000019048583,0.000044343884,0.00004167726,0.00007833757,0.00032811222,0.0000043240166,0.00007009099,0.00018439686,5.6074964e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035127572,0.000047384387,0.0008769091,0.000031986914,0.00003951393,2.1861538e-7,0.00010986611,0.00008366544,0.99594766,0.0005136079,0.00004069842,0.0019572063],"study_design_scores_gemma":[0.0010735927,0.00022731564,0.008668305,0.000013866491,0.000007694052,0.0000016199908,0.000084273364,0.000013244429,0.9886625,0.00016797608,0.0010313449,0.000048265927],"about_ca_topic_score_codex":0.0010462523,"about_ca_topic_score_gemma":0.0005381252,"teacher_disagreement_score":0.0077913958,"about_ca_system_score_codex":0.000025615378,"about_ca_system_score_gemma":0.00019251718,"threshold_uncertainty_score":0.18082911},"labels":[],"label_agreement":null},{"id":"W2093363596","doi":"10.1158/1538-7445.prca2012-a16","title":"Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Université Laval","funders":"","keywords":"Medicine; MUC1; Glycopeptide; Peptide vaccine; Immunotherapy; Cancer vaccine; Antigen; Epitope; Clinical trial; Immune system; Internal medicine; Vaccination; Immunology; Oncology; Microbiology; Biology","score_opus":0.08959077077601033,"score_gpt":0.44693497056923825,"score_spread":0.35734419979322796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093363596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97853386,0.017965518,0.0000012377071,0.00014999519,0.0011395945,0.0017297423,0.00022283744,0.000015197112,0.00024202268],"genre_scores_gemma":[0.9917261,0.004175982,0.000016467344,0.000054937896,0.00009243241,0.0006256181,0.000055887278,0.00004660357,0.0032059648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99570745,0.0011979726,0.0012263636,0.00041256944,0.00020169477,0.0012539749],"domain_scores_gemma":[0.9981216,0.0006577891,0.00029408667,0.00047612813,0.00036666248,0.00008369572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032643892,0.00026182557,0.0006868029,0.00042471982,0.00026069555,0.000021445696,0.00042594734,0.00021979153,0.001475018],"category_scores_gemma":[0.00037175935,0.00022183862,0.0001761303,0.0005659105,0.00036733795,0.00026466223,0.00016458733,0.0011609282,0.00011831004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24745885,0.007938604,0.008018121,0.00025056122,0.00022323204,0.000021153417,0.0022924738,0.0000055611686,0.70964,0.000011729102,0.003424592,0.020715076],"study_design_scores_gemma":[0.38072237,0.015119403,0.11778357,0.0010031901,0.00010988128,0.000008009981,0.0011953322,0.000003851255,0.43501946,0.00004331717,0.04827445,0.00071716256],"about_ca_topic_score_codex":0.0031413524,"about_ca_topic_score_gemma":0.00039295986,"teacher_disagreement_score":0.2746206,"about_ca_system_score_codex":0.00022665277,"about_ca_system_score_gemma":0.0009216694,"threshold_uncertainty_score":0.99943775},"labels":[],"label_agreement":null},{"id":"W2093577168","doi":"10.1158/0008-5472.sabcs10-p3-15-05","title":"Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Internal medicine; Cancer; Docetaxel; Joint pain; Chemotherapy; Paclitaxel; Oncology; Physical therapy","score_opus":0.04545014354277371,"score_gpt":0.40371468875381733,"score_spread":0.3582645452110436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093577168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907113,0.00056783133,4.1741552e-7,0.007931754,0.00045696675,0.00073840236,0.00008044868,0.000030676143,0.001122354],"genre_scores_gemma":[0.9966376,0.0009987883,0.000027954868,0.000803592,0.000485933,0.0004707529,0.000021969634,0.00004308121,0.00051033316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982442,0.000056586097,0.0002387722,0.0004277032,0.00044468156,0.0005880034],"domain_scores_gemma":[0.999048,0.00012520872,0.0000615781,0.00023561757,0.0002628116,0.0002668033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045087622,0.00017100605,0.0003024955,0.0003077676,0.000112674024,0.000034757708,0.0000994184,0.0001449152,0.004687985],"category_scores_gemma":[0.000030749597,0.00014640484,0.000054109754,0.00039822358,0.00024116354,0.000087119704,0.000042587686,0.0008951875,0.000018160803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012291962,0.00068921066,0.53659356,0.00021741338,0.000074150856,0.000046962567,0.00045166942,0.000007874075,0.26029712,0.000008076699,0.008825247,0.19155952],"study_design_scores_gemma":[0.0076551246,0.00023845,0.97119254,0.00023820267,0.000019126368,0.0000048820352,0.000029859557,0.00008443563,0.012356869,0.000025543235,0.008006442,0.00014853089],"about_ca_topic_score_codex":0.0067130653,"about_ca_topic_score_gemma":0.0040634954,"teacher_disagreement_score":0.43459898,"about_ca_system_score_codex":0.00048374117,"about_ca_system_score_gemma":0.000624506,"threshold_uncertainty_score":0.9999013},"labels":[],"label_agreement":null},{"id":"W2093590450","doi":"10.1158/0008-5472.sabcs13-p6-07-06","title":"Abstract P6-07-06: Primary prophylaxis of febrile neutropenia during adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Febrile neutropenia; Docetaxel; Internal medicine; Cyclophosphamide; Breast cancer; Retrospective cohort study; Neutropenia; Oncology; Cohort; Chemotherapy; Cancer; Surgery","score_opus":0.03081496174628027,"score_gpt":0.3512942451903671,"score_spread":0.3204792834440868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093590450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880658,0.0049390565,0.000005021033,0.0027987652,0.00016580024,0.002566305,0.0002255938,0.000046972138,0.0011867268],"genre_scores_gemma":[0.9868599,0.0057535493,0.000102516184,0.00023996326,0.0005982299,0.0026856335,0.000012242811,0.00008157161,0.003666361],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977486,0.000041851712,0.00039017963,0.0005456169,0.0005633815,0.00071032735],"domain_scores_gemma":[0.99815714,0.00010296232,0.00011601871,0.0004451642,0.00085217564,0.000326552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003102831,0.00023012275,0.0005359507,0.00021060601,0.00027573097,0.00007327112,0.0001993898,0.00012644524,0.0034468807],"category_scores_gemma":[0.000024468203,0.00018905914,0.00012893806,0.00042742933,0.0003620362,0.00027622984,0.00010257702,0.0005358204,0.000058521786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033322,0.0002627769,0.07482031,0.0023976718,0.00023287225,0.000013338963,0.00038232066,0.000023534447,0.8474447,0.000039318205,0.011334257,0.06154558],"study_design_scores_gemma":[0.0038637603,0.0002932771,0.89744735,0.00044999048,0.00003511405,0.00004783438,0.00009316552,0.0000074594946,0.09254873,0.00009226228,0.004920144,0.00020093551],"about_ca_topic_score_codex":0.0071453624,"about_ca_topic_score_gemma":0.00024188757,"teacher_disagreement_score":0.822627,"about_ca_system_score_codex":0.000504019,"about_ca_system_score_gemma":0.0007561798,"threshold_uncertainty_score":0.9994661},"labels":[],"label_agreement":null},{"id":"W2093944165","doi":"10.1158/1538-7445.cansusc14-09","title":"Abstract 09: Contribution of known and novel BRCA-mediated DNA repair pathway genes to pancreatic cancer susceptibility","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Ontario Institute for Cancer Research; McGill University and Génome Québec Innovation Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University","funders":"","keywords":"PALB2; Genetics; Mutation; Founder effect; Cancer; BRCA2 Protein; Pancreatic cancer; Biology; Population; Gene; DNA repair; Germline mutation; Cancer research; Allele; Medicine; Haplotype","score_opus":0.02926902163242774,"score_gpt":0.3394597497967123,"score_spread":0.31019072816428456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093944165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938902,0.004167334,0.00030601147,0.0003709135,0.00014937739,0.00045099188,0.00043519796,0.0000123612845,0.0002176071],"genre_scores_gemma":[0.9958702,0.0030039155,0.00009875437,0.0001279851,0.00043417435,0.00019212902,0.00009289855,0.000023132472,0.00015682817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848133,0.000072534174,0.0002712136,0.0004892799,0.0002635159,0.00042209416],"domain_scores_gemma":[0.9984367,0.00017124559,0.00006989059,0.0004489484,0.000648553,0.00022469119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009434394,0.00013984933,0.00023587131,0.000073379284,0.00010560816,0.000027081898,0.00017740771,0.00014905317,0.00007109521],"category_scores_gemma":[0.0009778229,0.0001330982,0.00006908177,0.00019310307,0.00020784567,0.000004451491,0.00020165028,0.00014226722,0.000006778472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024319762,0.00006813483,0.019956809,0.0000903634,0.000049676564,6.6433523e-7,0.000042547646,0.0001057831,0.9699827,0.00019991412,0.0016877423,0.0075724856],"study_design_scores_gemma":[0.0011991926,0.00048727312,0.10709612,0.00010164609,0.000019873492,0.0000013818116,0.000055733257,0.00015967716,0.7915577,0.00010496854,0.09896341,0.0002529741],"about_ca_topic_score_codex":0.0027431094,"about_ca_topic_score_gemma":0.0047679334,"teacher_disagreement_score":0.17842492,"about_ca_system_score_codex":0.000120101184,"about_ca_system_score_gemma":0.0004485832,"threshold_uncertainty_score":0.5427587},"labels":[],"label_agreement":null},{"id":"W2094013887","doi":"10.1158/1538-7445.pedcan-a63","title":"Abstract A63: YB-1 is critical for stress granule assembly and protects cells from oxidative stress","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Stress granule; Gene knockdown; Cell biology; Messenger RNA; RNA-binding protein; Downregulation and upregulation; Chemistry; Nucleolin; Molecular biology; Biology; Cell culture; Translation (biology); Cytoplasm; Biochemistry; Gene; Genetics","score_opus":0.04615960965425307,"score_gpt":0.40433229213752936,"score_spread":0.3581726824832763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094013887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512255,0.0010009563,0.001067788,0.0008220354,0.000054599328,0.0006577813,0.00069157773,0.000008492718,0.0005742249],"genre_scores_gemma":[0.99695367,0.0003745206,0.00037000107,0.00010355596,0.0006137033,0.0004365168,0.000081533406,0.000032513435,0.0010340024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802417,0.00015169797,0.00015370808,0.0005718288,0.00041899024,0.0006795872],"domain_scores_gemma":[0.9986044,0.0002889961,0.000026905398,0.00036179533,0.000426906,0.00029100393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006208065,0.0001434384,0.00017123854,0.00007029615,0.0002652218,0.00013845,0.0003037472,0.00016999776,0.00007868453],"category_scores_gemma":[0.00056873343,0.00012823084,0.000058825946,0.00009377991,0.0002865897,0.000011230548,0.00019343963,0.00032009353,0.000011758683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024920626,0.000056684832,0.00051800587,0.00015969931,0.00003979751,0.0000029137748,0.00006108672,0.0000056699473,0.98477125,0.0000929621,0.004816087,0.009226623],"study_design_scores_gemma":[0.00061837333,0.00037396973,0.0018927469,0.00010337192,0.0000046761675,3.643559e-7,0.00020099757,0.00022819659,0.98714256,0.00034095105,0.008938094,0.00015566804],"about_ca_topic_score_codex":0.0013940398,"about_ca_topic_score_gemma":0.00058454875,"teacher_disagreement_score":0.009070955,"about_ca_system_score_codex":0.00003334795,"about_ca_system_score_gemma":0.00017258803,"threshold_uncertainty_score":0.5229102},"labels":[],"label_agreement":null},{"id":"W2094297819","doi":"10.1158/1538-7445.am10-1256","title":"Abstract 1256: Protein kinase G type Iα activity in human ovarian cancer cells contributes to enhanced Src activation and DNA synthesis/cell proliferation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; cGMP-dependent protein kinase; Tyrosine phosphorylation; Tyrosine kinase; Phosphorylation; Cell biology; Cancer cell; Biology; Cell growth; Cancer research; Signal transduction; Chemistry; Protein kinase A; Molecular biology; Cancer; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.04107561570590065,"score_gpt":0.38099440195859663,"score_spread":0.339918786252696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094297819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944221,0.00008024455,0.000055434473,0.0021882686,0.00011855613,0.0023008715,0.000011916681,0.00003094195,0.0007916854],"genre_scores_gemma":[0.99721026,0.000057142235,0.00008020482,0.0000989021,0.0003462713,0.0013610678,0.0000049219125,0.000031475793,0.00080972206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983972,0.00012947424,0.00018856606,0.00040933158,0.0004124016,0.00046304977],"domain_scores_gemma":[0.9987891,0.0002997881,0.000055222496,0.0002951864,0.0003635404,0.00019718416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010849056,0.00014971726,0.00027385118,0.00037124136,0.00016138252,0.000067524015,0.000101397665,0.00017689492,0.0003136362],"category_scores_gemma":[0.00062732754,0.00013265629,0.000026171516,0.00061150733,0.000080835736,0.00016197178,0.000051954616,0.0008264382,0.000027303802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010543327,0.00017893012,0.0014470128,0.00031519632,0.000017873139,0.000010790645,0.00018728404,0.000009425484,0.9818921,0.000044101573,0.0003744606,0.014468511],"study_design_scores_gemma":[0.0012146977,0.0001525431,0.03761887,0.00037794418,0.00001140273,3.7914825e-7,0.00003616759,0.00003220709,0.959651,0.00010779124,0.00067460566,0.00012237445],"about_ca_topic_score_codex":0.0036751304,"about_ca_topic_score_gemma":0.0019100239,"teacher_disagreement_score":0.036171857,"about_ca_system_score_codex":0.00030086347,"about_ca_system_score_gemma":0.00047766799,"threshold_uncertainty_score":0.5555722},"labels":[],"label_agreement":null},{"id":"W2094431079","doi":"10.1158/1538-7445.am10-lb-100","title":"Abstract LB-100: Optimal modulation of DNA repair in CLL therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nilotinib; Imatinib; Cancer research; Chronic lymphocytic leukemia; Sensitization; Tyrosine kinase; DNA damage; Chlorambucil; ABL; DNA repair; Pharmacology; Chemistry; Leukemia; DNA; Medicine; Immunology; Chemotherapy; Biochemistry; Internal medicine; Receptor; Myeloid leukemia","score_opus":0.09851134286018154,"score_gpt":0.45117826284608603,"score_spread":0.3526669199859045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094431079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464846,0.00056822126,0.000003856272,0.0007496686,0.0001289924,0.0007997014,0.000013650828,0.000043313357,0.0030441387],"genre_scores_gemma":[0.9972338,0.00066165125,0.00030458046,0.000040875257,0.0003563951,0.00015901543,0.000012205216,0.00003791107,0.0011935303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722123,0.00008898747,0.00035993042,0.00039759558,0.0012874868,0.0006447772],"domain_scores_gemma":[0.9981895,0.00030954732,0.000048657537,0.0007141851,0.0005305867,0.00020749419],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021584595,0.000119091834,0.00028471233,0.00048120765,0.0000589305,0.0000140695,0.00025060776,0.00020379746,0.001731562],"category_scores_gemma":[0.00043535285,0.00010046339,0.00010299454,0.0007875818,0.00040079176,0.000118068834,0.00010172962,0.0011897132,0.00006451639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001863443,0.00033860965,0.0073327473,0.000316666,0.00006102948,0.00015866748,0.00077340426,0.0002957748,0.9592466,0.0002940132,0.00451677,0.024802282],"study_design_scores_gemma":[0.032098576,0.00091036485,0.4348547,0.0005358754,0.000010199421,0.0000699484,0.0003817778,0.03213294,0.47281617,0.00043167945,0.025400985,0.00035679253],"about_ca_topic_score_codex":0.0066491347,"about_ca_topic_score_gemma":0.000729215,"teacher_disagreement_score":0.4864304,"about_ca_system_score_codex":0.0039666034,"about_ca_system_score_gemma":0.007981314,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W2094698717","doi":"10.1158/0008-5472.sabcs-1137","title":"Managing cancer treatment-induced bone loss: 24-month results from the Study of Anastrozole with the Bisphosphonate RisedronatE (SABRE).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anastrozole; Medicine; Bisphosphonate; Urology; Bone mineral; Lumbar spine; Osteoporosis; Placebo; Internal medicine; Hip fracture; Breast cancer; Surgery; Cancer; Aromatase","score_opus":0.08716927652693543,"score_gpt":0.41036981193559113,"score_spread":0.3232005354086557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094698717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587519,0.0039560134,0.0000011299478,0.033770893,0.00009464863,0.0023539697,0.00017224242,0.00003312467,0.0008660549],"genre_scores_gemma":[0.99396634,0.001995296,0.000019615069,0.0004854673,0.00010553607,0.0005125417,0.000030307223,0.000032828557,0.0028520501],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99704385,0.0002723631,0.0003612681,0.00054494845,0.0010040354,0.0007735207],"domain_scores_gemma":[0.9980419,0.0002980287,0.00014906636,0.0009498662,0.0003025319,0.0002585769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005800621,0.00024691896,0.0004338604,0.000106486106,0.0004847157,0.000038085305,0.0002636061,0.00006484042,0.000086777916],"category_scores_gemma":[0.000033858065,0.000114824456,0.00006548208,0.0007699279,0.00017541113,0.00007714607,0.000054458535,0.000539767,0.000017592627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049262155,0.005821536,0.18172273,0.00008251466,0.002472844,0.0011453072,0.02478462,0.0003655585,0.0044488558,0.00004995443,0.016976656,0.71286726],"study_design_scores_gemma":[0.047429964,0.013545097,0.8952492,0.0007192393,0.000629203,0.00001472975,0.009589843,0.00026317226,0.01564059,0.00017339477,0.016409906,0.00033568413],"about_ca_topic_score_codex":0.17682905,"about_ca_topic_score_gemma":0.04002048,"teacher_disagreement_score":0.7135264,"about_ca_system_score_codex":0.00065578136,"about_ca_system_score_gemma":0.00076256157,"threshold_uncertainty_score":0.9774966},"labels":[],"label_agreement":null},{"id":"W2094951222","doi":"10.1158/1538-7445.am2012-4377","title":"Abstract 4377: Metronomic oral prodrug of gemcitabine (LY2334737) causes antitumor effects with concomitant increase in intratumoral blood flow","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gemcitabine; Prodrug; Cyclophosphamide; Chemotherapy; Pharmacology; Paclitaxel; Concomitant; Ovarian cancer; Cancer; Doxorubicin; Internal medicine; Bone marrow; Combination therapy","score_opus":0.028751301902188046,"score_gpt":0.3426794584253977,"score_spread":0.31392815652320966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094951222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848915,0.010520817,0.000014095502,0.00006498662,0.0001478975,0.00044626073,0.000054833123,0.000006615913,0.00025536606],"genre_scores_gemma":[0.99809635,0.00063061854,0.0003352751,0.000040770916,0.0004203083,0.00022287206,0.00003963591,0.00004038488,0.00017376448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826163,0.00015346135,0.0002527769,0.0003540893,0.00029280115,0.0006852338],"domain_scores_gemma":[0.999109,0.000054436758,0.00008042999,0.00037399237,0.00019067386,0.00019145024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009020517,0.00018669938,0.00030457735,0.00014580249,0.00006295567,0.000022042846,0.0002564454,0.0001048536,0.0000883967],"category_scores_gemma":[0.00010984072,0.0001478475,0.00007158925,0.00029371784,0.0002882262,0.000018597597,0.00013571644,0.00022769136,0.000007722252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071686466,0.0003148159,0.24959123,0.00023754664,0.00014479889,0.000023043798,0.000069341004,0.000074399955,0.74604046,0.000055065946,0.0013210757,0.0014113213],"study_design_scores_gemma":[0.0017706031,0.00043554473,0.17525297,0.00013860343,0.00003581116,0.000010353933,0.00007889942,0.000014881151,0.82004124,0.0000069722614,0.0019869616,0.00022716644],"about_ca_topic_score_codex":0.001480451,"about_ca_topic_score_gemma":0.0009282583,"teacher_disagreement_score":0.07433826,"about_ca_system_score_codex":0.000087746725,"about_ca_system_score_gemma":0.0004758907,"threshold_uncertainty_score":0.6029046},"labels":[],"label_agreement":null},{"id":"W2095068343","doi":"10.1158/0008-5472.sabcs12-pd09-01","title":"Abstract PD09-01: BRCA1 inactivation induces NF-κB in human breast cancer cells and in murine and human mammary glands","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"RELB; Cancer research; Breast cancer; Cancer; Biology; Carcinogenesis; Tumor suppressor gene; Mammary tumor; IκB kinase; Kinase; NF-κB; Signal transduction; NFKB1; Gene; Genetics; Transcription factor","score_opus":0.07644863616462073,"score_gpt":0.42594822209673544,"score_spread":0.3494995859321147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095068343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547875,0.0009194798,4.3851753e-7,0.00047394968,0.000057192767,0.000378101,0.000024578578,0.000013907055,0.0026536323],"genre_scores_gemma":[0.99819684,0.00086298323,0.000010099276,0.000037794503,0.00022648387,0.00022459253,0.000014927862,0.000019154792,0.0004071236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988167,0.00006617902,0.0001916064,0.00024603645,0.0002520195,0.00042740605],"domain_scores_gemma":[0.99950325,0.000049931194,0.000033938693,0.0001685142,0.00006851728,0.00017586145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000521439,0.000120016106,0.00020414202,0.00043936068,0.00015319789,0.00003715087,0.000048473823,0.0001110961,0.00037549454],"category_scores_gemma":[0.000010809572,0.00010289888,0.000015468904,0.0003917077,0.000107875196,0.00029591634,0.000073664596,0.0004887583,0.000004908771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111521476,0.00043693464,0.82070816,0.00017872867,0.000043713055,0.00003853517,0.00053376635,0.0000015482398,0.13568464,0.00011084091,0.00024066147,0.04191096],"study_design_scores_gemma":[0.001960793,0.00006391596,0.959318,0.00027415226,0.000008007353,0.000013405056,0.00009796871,0.0000022765012,0.03599029,0.00006829086,0.0021097334,0.000093202],"about_ca_topic_score_codex":0.027506094,"about_ca_topic_score_gemma":0.005156566,"teacher_disagreement_score":0.13860981,"about_ca_system_score_codex":0.00051535043,"about_ca_system_score_gemma":0.00011602369,"threshold_uncertainty_score":0.9789698},"labels":[],"label_agreement":null},{"id":"W2095253522","doi":"10.1158/0008-5472.can-09-0813","title":"c-Myc and eIF4F Constitute a Feedforward Loop That Regulates Cell Growth: Implications for Anticancer Therapy","year":2009,"lang":"en","type":"review","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cell growth; Transcription factor; Biology; Cell biology; Cancer research; Transcription (linguistics); Genetics; Gene","score_opus":0.19870801157884496,"score_gpt":0.4712796005296029,"score_spread":0.27257158895075795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095253522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007309484,0.994968,0.00023887971,0.00039876215,0.0002241393,0.0021866623,0.000642339,0.000024742494,0.0005855593],"genre_scores_gemma":[0.0008740667,0.9927388,0.00035128987,0.00017388105,0.0009699303,0.002352172,0.0003531564,0.00011087187,0.0020758645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971042,0.00020241749,0.00040931202,0.0011206642,0.00032379906,0.0008395503],"domain_scores_gemma":[0.9978799,0.00020703938,0.00020676623,0.00087591866,0.0005919916,0.00023833317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075165986,0.00047041147,0.0009099826,0.00021832655,0.00033841064,0.0001487491,0.0007507152,0.000598995,0.000047846883],"category_scores_gemma":[0.00010671372,0.00040053503,0.00035969165,0.00038969767,0.0006504166,0.000009941296,0.00019517053,0.0004913717,0.000009892083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012765465,0.000082603125,0.000103049606,0.005207549,0.00038878925,0.0000025050379,0.000026199808,0.0000023196108,0.01749008,0.00041056186,0.04268561,0.93347305],"study_design_scores_gemma":[0.0005882237,0.00029203543,0.000023725092,0.0015323452,0.00012248012,0.000015710651,0.0000068215254,0.0000013346489,0.013271282,0.00034078016,0.98334247,0.00046280585],"about_ca_topic_score_codex":0.00007939382,"about_ca_topic_score_gemma":0.00002656592,"teacher_disagreement_score":0.94065684,"about_ca_system_score_codex":0.00021055312,"about_ca_system_score_gemma":0.0019034041,"threshold_uncertainty_score":0.9998447},"labels":[],"label_agreement":null},{"id":"W2095362984","doi":"10.1158/1538-7445.am2013-3573","title":"Abstract 3573: 17β-estradiol enhances hPygopus2 expression via ERα-SP1 promoter complexes.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Chromatin immunoprecipitation; Sp1 transcription factor; Molecular biology; Cell cycle; Promoter; Biology; Estrogen receptor; Transcription factor; Estrogen receptor alpha; Chemistry; Gene expression; Cell; Gene; Cancer; Biochemistry","score_opus":0.03088977560593533,"score_gpt":0.3561254022314077,"score_spread":0.3252356266254724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095362984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908538,0.0045800926,0.0000740344,0.00035741436,0.00018609101,0.0007216589,0.000011276265,0.000026048057,0.0031895896],"genre_scores_gemma":[0.99581575,0.0010581531,0.0001850515,0.00006611126,0.0005647543,0.0004203795,0.000072630726,0.000041624822,0.0017755398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980239,0.00015125833,0.00021672997,0.0005252007,0.0004121091,0.00067076186],"domain_scores_gemma":[0.9989753,0.000033718028,0.000055808196,0.00045840457,0.00022792911,0.0002488854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036284182,0.00019600167,0.00017694947,0.00008306168,0.0002324827,0.000090614165,0.00040674425,0.00029847005,0.0006823433],"category_scores_gemma":[0.00004255846,0.00015280698,0.00009670294,0.00016312436,0.00027040893,0.000016243628,0.00017105689,0.0005252224,0.0004940136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006740882,0.00007303809,0.0003242926,0.00006335664,0.000043386757,0.00000985114,0.000056201912,0.000010700386,0.96704876,0.000007661432,0.025573345,0.0067219627],"study_design_scores_gemma":[0.00043369833,0.00032620493,0.003562256,0.00009348145,0.000004386299,0.000012015198,0.000038973074,0.000027456446,0.98392355,0.00013030534,0.011241015,0.00020662465],"about_ca_topic_score_codex":0.00035839627,"about_ca_topic_score_gemma":0.000015613661,"teacher_disagreement_score":0.016874788,"about_ca_system_score_codex":0.000048106667,"about_ca_system_score_gemma":0.0001574159,"threshold_uncertainty_score":0.7471181},"labels":[],"label_agreement":null},{"id":"W2095422041","doi":"10.1158/1538-7445.am2014-lb-89","title":"Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Concordia University; McGill University; Children's Hospital of Eastern Ontario; Jewish General Hospital; University of Ottawa; McGill University Health Centre; Montreal Children's Hospital; McGill University and Génome Québec Innovation Centre","funders":"","keywords":"SMARCA4; Biology; Exome sequencing; Germline; Germline mutation; Exome; Genetics; Mutation; Epigenetics; Chromatin remodeling; Gene","score_opus":0.05665759486628451,"score_gpt":0.3337488057415924,"score_spread":0.27709121087530786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095422041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971849,0.0013991878,0.00007754908,0.00030179866,0.000120406476,0.0001940774,0.000030451709,0.0000053027843,0.00068638247],"genre_scores_gemma":[0.99840707,0.00034562877,0.000107755994,0.00008279966,0.0002262954,0.00003675129,0.000034271463,0.000022467217,0.0007369706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989977,0.000099433,0.00019138002,0.0002545836,0.00020215595,0.00025475567],"domain_scores_gemma":[0.99917495,0.000048460803,0.0000653065,0.00040672164,0.00022994161,0.00007462643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003861805,0.00010096175,0.00012880197,0.00004003506,0.0001281203,0.000021609494,0.00024641881,0.00009915127,0.000058292197],"category_scores_gemma":[0.0001076506,0.00007614018,0.00005346355,0.00014092811,0.00019020266,0.0000030159918,0.00014814209,0.00019520849,0.0000062015715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004429369,0.00003085603,0.0026619078,0.00017557634,0.000009890076,4.1260486e-7,0.00010430611,0.00008428269,0.9909791,0.000008530643,0.00024322976,0.0056576296],"study_design_scores_gemma":[0.0007679257,0.00022147072,0.08166035,0.000102330116,0.00002165385,0.000008562489,0.00010046249,0.0010881205,0.9117109,0.0002842797,0.00385039,0.00018354008],"about_ca_topic_score_codex":0.0003640095,"about_ca_topic_score_gemma":0.00008994542,"teacher_disagreement_score":0.07926817,"about_ca_system_score_codex":0.000029139774,"about_ca_system_score_gemma":0.000271108,"threshold_uncertainty_score":0.31049067},"labels":[],"label_agreement":null},{"id":"W2095667591","doi":"10.1158/0008-5472.can-06-1021","title":"Leukemia Inhibitory Factor: A Newly Identified Metastatic Factor in Rhabdomyosarcomas","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Rhabdomyosarcoma; Leukemia inhibitory factor; Bone marrow; Cancer research; Chemotaxis; Stromal cell; Chemistry; Receptor; Immunology; Biology; Sarcoma; Medicine; Pathology; Cytokine; Biochemistry","score_opus":0.16430742730465617,"score_gpt":0.45796347306035723,"score_spread":0.29365604575570103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095667591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945178,0.0011442326,0.00040729687,0.00052471587,0.0003913567,0.00053325645,0.000043099837,0.000050542665,0.0023876864],"genre_scores_gemma":[0.9965607,0.00011553072,0.00019501863,0.00013708163,0.00037917437,0.000048598973,0.000017838962,0.000036554236,0.0025095062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770224,0.00009682861,0.00036815845,0.00036950086,0.0007823017,0.0006809406],"domain_scores_gemma":[0.9986611,0.0003424326,0.00004984496,0.0003527192,0.00030842453,0.00028546585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085619517,0.0001429054,0.00029308087,0.0006023952,0.00014189526,0.000056733796,0.00015559258,0.00007844167,0.0034401289],"category_scores_gemma":[0.00030831146,0.00012953168,0.000113695736,0.0006308473,0.00014983352,0.0001503767,0.00008047041,0.0010585274,0.00025060007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004264897,0.00014366471,0.011146812,0.0001454304,0.00006688879,0.00034828743,0.0022230796,0.000013951046,0.955831,0.000080953636,0.008874377,0.02069905],"study_design_scores_gemma":[0.005117251,0.00056706596,0.17155132,0.0010444216,0.000038141887,0.000086027416,0.0028721727,0.0002545986,0.7109875,0.00041381165,0.10664146,0.00042620295],"about_ca_topic_score_codex":0.0055784164,"about_ca_topic_score_gemma":0.004222906,"teacher_disagreement_score":0.24484348,"about_ca_system_score_codex":0.0012450946,"about_ca_system_score_gemma":0.00090829213,"threshold_uncertainty_score":0.99747086},"labels":[],"label_agreement":null},{"id":"W2095708380","doi":"10.1158/0008-5472.can-06-2559","title":"Transcriptional Cooperation between the Transforming Growth Factor-β and Wnt Pathways in Mammary and Intestinal Tumorigenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Wnt signaling pathway; Transforming growth factor; Biology; Cancer research; Mouse mammary tumor virus; Carcinogenesis; Transforming growth factor beta; CTGF; LRP5; Cancer; Mammary tumor; Signal transduction; Growth factor; Cell biology; Breast cancer; Receptor; Gene; Genetics","score_opus":0.06617246695962845,"score_gpt":0.338108685371252,"score_spread":0.2719362184116235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095708380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934542,0.0032625098,0.0023650383,0.0005142732,0.00004169071,0.00019028637,0.000010241146,0.0000048150528,0.00015690527],"genre_scores_gemma":[0.9978845,0.0014977669,0.0001290725,0.00005744125,0.00021025001,0.00005637407,0.000025437832,0.000010547699,0.00012858889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990707,0.000059971935,0.000153715,0.0002409141,0.00020218398,0.00027252582],"domain_scores_gemma":[0.99966586,0.000052245643,0.00001380414,0.000070515474,0.0001321033,0.00006548706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008973518,0.00008723237,0.0000805015,0.00007266689,0.00016068199,0.00004286072,0.0001269284,0.00007254544,0.000015745198],"category_scores_gemma":[0.000034732417,0.00006686626,0.000016713513,0.00015943781,0.00015130923,0.0000104953715,0.000040062572,0.00017959645,5.958215e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097822725,0.000009410522,0.079544365,0.000036885318,0.00001797852,0.0000049001596,0.00051258877,0.0000024441806,0.90042526,0.00045876176,0.00009947507,0.01879011],"study_design_scores_gemma":[0.00053682766,0.0001297446,0.27257547,0.000054354823,0.000004829393,0.000009897077,0.00017359648,0.000009343456,0.7227467,0.0003761613,0.0032224995,0.00016060047],"about_ca_topic_score_codex":0.000121855956,"about_ca_topic_score_gemma":0.00021692393,"teacher_disagreement_score":0.1930311,"about_ca_system_score_codex":0.000042879194,"about_ca_system_score_gemma":0.00017851511,"threshold_uncertainty_score":0.2726727},"labels":[],"label_agreement":null},{"id":"W2096051237","doi":"10.1158/0008-5472.can-06-3682","title":"Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Telomere; Li–Fraumeni syndrome; Cancer; Anticipation (artificial intelligence); Age of onset; Chromosome instability; Oncology; Biology; Genetics; Internal medicine; Medicine; Germline mutation; Chromosome; Mutation; Disease; Gene","score_opus":0.07253402887595015,"score_gpt":0.402177289759971,"score_spread":0.32964326088402085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096051237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909672,0.0029054997,0.000050145612,0.00080738694,0.00012965516,0.0008908909,0.00007160391,0.00003744856,0.004140181],"genre_scores_gemma":[0.9972949,0.0006366499,0.000040103576,0.00032621482,0.000091092705,0.00021150554,0.000057926663,0.00007137878,0.0012702418],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969109,0.000116043106,0.00043360412,0.00045720616,0.0012975723,0.0007846737],"domain_scores_gemma":[0.99850166,0.000136475,0.00010844058,0.00042111095,0.0006241371,0.00020819846],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013788032,0.00018978576,0.00045511682,0.0007123141,0.00006764345,0.000019535844,0.00017044802,0.000265136,0.0010153949],"category_scores_gemma":[0.00017019793,0.00016772447,0.000073775635,0.0018041895,0.00025782638,0.0001445265,0.000069810485,0.0010262898,0.000018574368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048881522,0.0013079467,0.3286042,0.0009479358,0.0017997756,0.009087353,0.012776792,0.0002468208,0.59769684,0.00024929634,0.007890858,0.034504037],"study_design_scores_gemma":[0.007687399,0.0014705125,0.8072969,0.0037897073,0.00019172548,0.00009328504,0.0007590354,0.00013015156,0.17132075,0.000103963815,0.006621844,0.00053475477],"about_ca_topic_score_codex":0.0039312937,"about_ca_topic_score_gemma":0.006674018,"teacher_disagreement_score":0.47869268,"about_ca_system_score_codex":0.0017873459,"about_ca_system_score_gemma":0.0009506705,"threshold_uncertainty_score":0.99989784},"labels":[],"label_agreement":null},{"id":"W2096151138","doi":"10.1158/0008-5472.can-04-1330","title":"HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Androgen receptor; Transactivation; Prostate cancer; Repressor; LNCaP; Cancer research; Biology; Internal medicine; Endocrinology; Transcription factor; Cell biology; Cancer; Medicine; Gene; Genetics","score_opus":0.07033288674640714,"score_gpt":0.4032703358494214,"score_spread":0.33293744910301426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096151138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824674,0.013065797,0.000002093985,0.001896595,0.00013108649,0.0016439072,0.0002233417,0.000038050952,0.00053173077],"genre_scores_gemma":[0.9776334,0.019735161,0.00015365942,0.000027308644,0.00015569362,0.0006148699,0.00005091453,0.000062656174,0.0015662952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964202,0.00019877833,0.0005003011,0.00059601176,0.00148608,0.00079863716],"domain_scores_gemma":[0.997277,0.00015389275,0.00019237855,0.0004770346,0.0015451713,0.0003544881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007832912,0.00023594343,0.00058822974,0.0004833726,0.00016884468,0.000028311015,0.00030464656,0.00019658278,0.0005307486],"category_scores_gemma":[0.00015103308,0.00017514608,0.00013705036,0.0012737293,0.0005869375,0.00021369438,0.00016277118,0.0007010765,0.00002068533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057444167,0.00037918863,0.0029898852,0.00059774297,0.00030029155,0.00005110189,0.0029486602,0.00008723941,0.98329973,0.00004107309,0.0019355465,0.0016251344],"study_design_scores_gemma":[0.005003848,0.0011854643,0.0009356489,0.0012680738,0.000050572075,0.0000041743237,0.00064425083,0.000003628465,0.98955876,0.0003495934,0.00083413895,0.00016187089],"about_ca_topic_score_codex":0.007383146,"about_ca_topic_score_gemma":0.000023127472,"teacher_disagreement_score":0.0073600183,"about_ca_system_score_codex":0.00062529417,"about_ca_system_score_gemma":0.0019967277,"threshold_uncertainty_score":0.99922675},"labels":[],"label_agreement":null},{"id":"W2096217287","doi":"10.1158/0008-5472.can-05-2303","title":"Expression of RASSF1A, an Epigenetically Silenced Tumor Suppressor, Overcomes Resistance to Apoptosis Induction by Interferons","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"National Cancer Institute; National Institutes of Health; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"DNMT1; Apoptosis; Biology; Cancer research; Gene silencing; Molecular biology; DNA methylation; DNA methyltransferase; Interferon; Tumor suppressor gene; Programmed cell death; Gene expression; Carcinogenesis; Immunology; Cancer; Gene","score_opus":0.030539469774301848,"score_gpt":0.36214401891908754,"score_spread":0.3316045491447857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096217287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942705,0.0024554248,0.0017933663,0.0002784404,0.000113177404,0.00031422838,0.00009655886,0.000008719671,0.00066960603],"genre_scores_gemma":[0.9969013,0.00032170577,0.0009387501,0.000029094705,0.00022981726,0.00015255122,0.000111241774,0.000029050929,0.0012865126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816674,0.0002508542,0.00028735973,0.00048506868,0.0004324023,0.00037757074],"domain_scores_gemma":[0.99887496,0.00003606361,0.00006711134,0.00048549633,0.0003912779,0.00014506468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004950175,0.00013120807,0.000156781,0.000115692725,0.000118730204,0.00003672671,0.00031507073,0.00012898451,0.00007688699],"category_scores_gemma":[0.0001348274,0.00012727232,0.000049778035,0.00024944026,0.00014342046,0.000009916604,0.00015323382,0.00015730187,0.0000044620647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023292667,0.00010139897,0.0013225982,0.000027094866,0.000007489032,2.5498116e-7,0.000045923305,0.00019721079,0.9899822,0.00004675937,0.0072962674,0.0007398752],"study_design_scores_gemma":[0.00026123508,0.00035106437,0.0036669571,0.000051952276,0.00000472174,1.08786e-7,0.000071021335,0.0000057601665,0.9810378,0.00038115712,0.01402514,0.00014308999],"about_ca_topic_score_codex":0.0003705164,"about_ca_topic_score_gemma":0.00030374262,"teacher_disagreement_score":0.008944408,"about_ca_system_score_codex":0.000054717202,"about_ca_system_score_gemma":0.0001138396,"threshold_uncertainty_score":0.5190014},"labels":[],"label_agreement":null},{"id":"W2096492598","doi":"10.1158/0008-5472.can-08-4372","title":"Atopic Disease and Risk of Non–Hodgkin Lymphoma: An InterLymph Pooled Analysis","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Medicine; Hodgkin lymphoma; Disease; Lymphoma; Oncology; Internal medicine","score_opus":0.030241294010157675,"score_gpt":0.39969619878988105,"score_spread":0.36945490477972337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096492598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347836,0.0048769577,0.000048473714,0.000694633,0.00002318313,0.00020257085,0.00003868623,0.0000178919,0.00061922014],"genre_scores_gemma":[0.9979946,0.0012212985,0.000039400456,0.00014882516,0.000065852364,0.000030306403,0.00002324568,0.000007052224,0.0004694143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987265,0.00021109139,0.00017909706,0.0002809388,0.0003252012,0.0002771752],"domain_scores_gemma":[0.9988205,0.00008888663,0.000041755826,0.00041621586,0.00020572354,0.00042691233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031294333,0.00008998782,0.00031565066,0.0004061678,0.00009605783,0.000015757538,0.00012523652,0.00006104605,0.00025462682],"category_scores_gemma":[0.00018648396,0.0000737603,0.000106407344,0.0006872456,0.0002656535,0.000079877726,0.000037132195,0.00011770468,0.000008183848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010644873,0.00041656094,0.9358231,0.00010231849,0.0010026325,0.000210983,0.00031892897,0.0000098226255,0.0008042597,0.000083306004,0.0018066167,0.058357008],"study_design_scores_gemma":[0.0013716769,0.0001549966,0.99387896,0.000059577327,0.001465854,0.0000048419593,0.00012324873,0.00079566526,0.0011766794,0.0006637238,0.0002353401,0.00006940729],"about_ca_topic_score_codex":0.0003350788,"about_ca_topic_score_gemma":0.000073076386,"teacher_disagreement_score":0.058287602,"about_ca_system_score_codex":0.00006212858,"about_ca_system_score_gemma":0.0002929493,"threshold_uncertainty_score":0.30078575},"labels":[],"label_agreement":null},{"id":"W2096788030","doi":"10.1158/0008-5472.can-09-2153","title":"Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Melanoma; CD34; Cancer research; In vitro; Cancer; Biology; Cell; Cancer cell; Immunology; Stem cell; Cell biology; Genetics","score_opus":0.05491447992069664,"score_gpt":0.3415602234350235,"score_spread":0.28664574351432687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096788030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960952,0.00016138097,0.000034789206,0.00013781403,0.00018968625,0.00042082992,0.00014421265,0.0000098158,0.002806285],"genre_scores_gemma":[0.9973092,0.000096612755,0.0007312929,0.000019143643,0.00024776693,0.000048167294,0.000039619328,0.000024873409,0.001483294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868447,0.000051848026,0.00027977207,0.00022136139,0.00049533247,0.0002672082],"domain_scores_gemma":[0.99891233,0.00006802742,0.00013130487,0.0003175974,0.0004520355,0.00011872981],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041503934,0.00008115878,0.00028562886,0.00014489068,0.00004289936,0.000010604577,0.000116682335,0.00006373785,0.0013466653],"category_scores_gemma":[0.000054824508,0.000070428745,0.0000584049,0.00037858705,0.00016587762,0.000057339323,0.00005800975,0.00035311922,0.0000114984805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014277696,0.00016447548,0.0024890353,0.000360767,0.000017676613,0.000005722647,0.00048707367,0.0000013756468,0.98876315,0.000011281569,0.0001303783,0.0074263127],"study_design_scores_gemma":[0.00063978013,0.00021420514,0.002168485,0.00018603486,0.000024470868,0.000001063819,0.00015196537,0.0000315976,0.99284786,0.000018573282,0.0036573343,0.00005862872],"about_ca_topic_score_codex":0.0040785964,"about_ca_topic_score_gemma":0.00025761066,"teacher_disagreement_score":0.007367684,"about_ca_system_score_codex":0.000064039494,"about_ca_system_score_gemma":0.0004443158,"threshold_uncertainty_score":0.99956626},"labels":[],"label_agreement":null},{"id":"W2096871147","doi":"10.1158/0008-5472.can-11-1310","title":"The First AACR Special Conference on Stem Cells, Development, and Cancer: Some of These Cells Are Not Like the Others","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"School of Medicine, Stanford University; Cancer Research Institute; American Association for Cancer Research","keywords":"Cancer; Medicine; Gerontology; Library science; Cancer research; Internal medicine","score_opus":0.10925757342874419,"score_gpt":0.3311319353601494,"score_spread":0.2218743619314052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096871147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151504,0.003332174,0.000004902069,0.001066155,0.0003298305,0.00064830045,0.00007989646,0.0000060577513,0.0030176453],"genre_scores_gemma":[0.97750366,0.014194393,0.0000151053855,0.0001666953,0.0005023887,0.00025085357,0.0000023306386,0.000034453325,0.0073300935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978036,0.00023413429,0.00022736358,0.00044897955,0.000654866,0.0006310333],"domain_scores_gemma":[0.9987653,0.00011089384,0.00009968149,0.00058462546,0.00030695036,0.00013255804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010331047,0.0001694378,0.00016375062,0.00006164731,0.0004491135,0.000065919885,0.00090203335,0.00012598836,0.00011940744],"category_scores_gemma":[0.000017909313,0.000101532925,0.000052395302,0.00016678806,0.0007783286,0.0000068424824,0.0004468669,0.00038163486,0.000033885328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001771818,0.00017132117,0.0020384977,0.00024137177,0.00027258138,0.000018803748,0.0037204563,0.000029831459,0.9285428,0.0007454982,0.029618196,0.03282884],"study_design_scores_gemma":[0.0002862039,0.00011936745,0.00107308,0.00006229738,0.00000377338,6.5043423e-7,0.00071426365,0.000012550313,0.76218593,0.000031126237,0.23540077,0.00011000207],"about_ca_topic_score_codex":0.0004807343,"about_ca_topic_score_gemma":0.0019146216,"teacher_disagreement_score":0.20578256,"about_ca_system_score_codex":0.000089388675,"about_ca_system_score_gemma":0.00057214504,"threshold_uncertainty_score":0.41403925},"labels":[],"label_agreement":null},{"id":"W2096872389","doi":"10.1158/0008-5472.can-08-1343","title":"Evidence for an Important Role of CIDEA in Human Cancer Cachexia","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"PDK4; Lipolysis; Endocrinology; Internal medicine; Adipose tissue; Adipocyte; Cachexia; White adipose tissue; Biology; Weight loss; Cancer; Chemistry; Pyruvate dehydrogenase complex; Biochemistry; Medicine; Enzyme; Obesity","score_opus":0.36897986273591493,"score_gpt":0.5346747186043932,"score_spread":0.16569485586847826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096872389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514445,0.04681403,0.000004647288,0.00042817806,0.000054544234,0.00077102333,0.000020345995,0.000012654472,0.00045004702],"genre_scores_gemma":[0.98929995,0.0067771305,0.00010935928,0.00007434242,0.0004338274,0.00057347625,0.000008132178,0.000027425305,0.0026963637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983703,0.000069935355,0.00031050888,0.00029778417,0.0004908844,0.00046058398],"domain_scores_gemma":[0.9988849,0.00009915609,0.000056426947,0.00036479527,0.0003979511,0.00019672925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082561944,0.00009295853,0.00032031047,0.00022744601,0.000106852196,0.0000044546073,0.00017489944,0.00008187834,0.00036134446],"category_scores_gemma":[0.00021533565,0.00008073282,0.000055006127,0.00039110077,0.00021907291,0.00012988965,0.000043722706,0.0003048191,0.000003254046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005149059,0.00013367434,0.17756411,0.00019275206,0.00003742611,0.00004670836,0.0025889766,0.0000093104645,0.803792,0.0006528003,0.0026599918,0.01180735],"study_design_scores_gemma":[0.0030557783,0.0010370656,0.377896,0.0012173143,0.000072869836,0.00003115966,0.00068807846,0.00014980014,0.56718737,0.0013473398,0.047059987,0.0002572226],"about_ca_topic_score_codex":0.019128451,"about_ca_topic_score_gemma":0.0037721174,"teacher_disagreement_score":0.23660462,"about_ca_system_score_codex":0.00017053801,"about_ca_system_score_gemma":0.00092296785,"threshold_uncertainty_score":0.9874033},"labels":[],"label_agreement":null},{"id":"W2096889391","doi":"10.1158/0008-5472.can-08-1320","title":"Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell Survival","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Pancreatic cancer; Biology; Cancer research; Gene silencing; Cancer; Metastasis; Cell growth; Cancer cell; Pathology; Carcinogenesis; Pancreatic Intraepithelial Neoplasia; Small hairpin RNA; Cell culture; Gene knockdown; Medicine","score_opus":0.033417549803318826,"score_gpt":0.3242658967755338,"score_spread":0.29084834697221496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096889391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741081,0.025166756,0.0000050288145,0.00013623972,0.000046483412,0.00029601506,0.000098186225,0.000003946753,0.0001392542],"genre_scores_gemma":[0.9734039,0.025357189,0.00005122477,0.000021252918,0.0000777714,0.00037831542,0.000006229552,0.00001711124,0.00068700657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988305,0.00007470886,0.00018212534,0.00033600134,0.0002609929,0.00031569565],"domain_scores_gemma":[0.99941736,0.000024421215,0.00005404648,0.00021844788,0.000151162,0.00013454074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015609959,0.00012428476,0.00015971735,0.000028447013,0.00028269974,0.000018781106,0.00013951046,0.00005615094,0.000075087715],"category_scores_gemma":[0.000025063115,0.00008754693,0.00002940515,0.0000830247,0.00032312988,0.0000053813496,0.00020138378,0.00009722651,3.5015861e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019048853,0.00003123847,0.07737266,0.00034997458,0.00006558505,0.000004865253,0.0014690143,0.000004650345,0.91933244,0.0000017050868,0.00017608546,0.0010012746],"study_design_scores_gemma":[0.00073205866,0.00004972149,0.09062495,0.00013659889,0.000013554796,0.0000026553075,0.00036581597,0.000031390224,0.90663034,0.000004107812,0.0012839327,0.00012487125],"about_ca_topic_score_codex":0.0013059739,"about_ca_topic_score_gemma":0.0008647868,"teacher_disagreement_score":0.013252294,"about_ca_system_score_codex":0.000042792235,"about_ca_system_score_gemma":0.00034117588,"threshold_uncertainty_score":0.35700598},"labels":[],"label_agreement":null},{"id":"W2097007811","doi":"10.1158/0008-5472.can-08-3767","title":"Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Melanoma; Notch signaling pathway; Biology; Cancer research; Phenotype; Oncogene; Transactivation; Carcinogenesis; Cancer; Signal transduction; Immunology; Cell biology; Genetics; Gene; Gene expression; Cell cycle","score_opus":0.04242292939271815,"score_gpt":0.39433074197639206,"score_spread":0.35190781258367393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097007811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891534,0.0003775153,0.00008825162,0.0013912796,0.000054817763,0.0003263217,0.0000156351,0.000009806169,0.008583012],"genre_scores_gemma":[0.9967454,0.00014166685,0.0001368566,0.0006650215,0.00015545248,0.00004265255,0.00018100004,0.000008282818,0.0019236747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990731,0.000063535954,0.00010036733,0.0002876728,0.00016051334,0.00031482952],"domain_scores_gemma":[0.9995959,0.000007876963,0.0000140082075,0.00015294987,0.0001274451,0.0001018562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022843636,0.0000889029,0.00009631086,0.00007193463,0.0001680839,0.000013812633,0.00016373386,0.00012342636,0.00007905595],"category_scores_gemma":[0.000019584873,0.00008141855,0.00003450868,0.00015133592,0.00008739385,0.000003866113,0.000037217687,0.00011914853,0.000031353145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037592792,0.000026645088,0.00022004926,0.0000068402037,0.000027346814,0.0000012255963,0.00019462725,0.000007840024,0.93243366,0.00013810808,0.0025401765,0.06402753],"study_design_scores_gemma":[0.00039032742,0.00046993693,0.05950195,0.000013435064,0.0000032200192,0.0000013715659,0.00007418118,5.115042e-7,0.89541805,0.00031183084,0.043690983,0.0001242229],"about_ca_topic_score_codex":0.000028652084,"about_ca_topic_score_gemma":0.00010010671,"teacher_disagreement_score":0.06390331,"about_ca_system_score_codex":0.00008132971,"about_ca_system_score_gemma":0.00020393866,"threshold_uncertainty_score":0.33201522},"labels":[],"label_agreement":null},{"id":"W2097027924","doi":"10.1158/0008-5472.can-14-3229","title":"Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"GNAQ; Melanoma; Melanocyte; Cancer research; Biology; Intravasation; Carcinogenesis; Cancer; Genetically modified mouse; Pathology; Metastasis; Transgene; Medicine; Mutation; Genetics; Gene","score_opus":0.14106041248778634,"score_gpt":0.44639078807644433,"score_spread":0.305330375588658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097027924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298286,0.0020509847,0.0000011539979,0.0021075674,0.000041027106,0.00059941935,0.0000023658697,0.00000967146,0.0022049225],"genre_scores_gemma":[0.9979568,0.00008931764,0.00010525753,0.00004771387,0.0001020393,0.00022169281,0.000007987401,0.000008225179,0.0014609371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990974,0.00015262762,0.00009577374,0.00017936663,0.00025540948,0.00021942312],"domain_scores_gemma":[0.99958634,0.000034494937,0.000015749663,0.00009567318,0.00012564364,0.00014212316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063791766,0.000055361645,0.00012393414,0.00015095522,0.000039102364,0.000009796356,0.000044342847,0.00010129413,0.000060818507],"category_scores_gemma":[0.00013285833,0.000045446883,0.000011028125,0.000227036,0.00011575786,0.000060034563,0.000040206523,0.00030042918,0.00007694085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002912053,0.0007593032,0.56342024,0.0002380755,0.00026996367,0.0010526208,0.004895993,0.0000030375115,0.27527428,0.0006385354,0.002907363,0.14762858],"study_design_scores_gemma":[0.021127885,0.0051059276,0.52823514,0.00063828763,0.00008794224,0.00014360617,0.0024087923,0.00009141113,0.41941833,0.0041872878,0.018220896,0.00033449975],"about_ca_topic_score_codex":0.0011164519,"about_ca_topic_score_gemma":0.00045156368,"teacher_disagreement_score":0.14729407,"about_ca_system_score_codex":0.0003629146,"about_ca_system_score_gemma":0.0005936217,"threshold_uncertainty_score":0.18532701},"labels":[],"label_agreement":null},{"id":"W2097121410","doi":"10.1158/0008-5472.can-13-2921-t","title":"High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Prostatectomy; Transdifferentiation; Adenocarcinoma; Oncology; Androgen receptor; Cancer research; PTEN; Internal medicine; Bioinformatics; Biology; PI3K/AKT/mTOR pathway; Stem cell","score_opus":0.08682408592693788,"score_gpt":0.3958406394443298,"score_spread":0.3090165535173919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097121410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321605,0.006230925,0.000018134286,0.00598229,0.00020441665,0.00408571,0.0000918604,0.000046866964,0.00012377612],"genre_scores_gemma":[0.9788104,0.0029958442,0.0013233472,0.00023076782,0.00031303713,0.010191595,0.00010037403,0.00005462822,0.0059799557],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712765,0.00010912744,0.0003638089,0.00060819933,0.00076987635,0.0010213471],"domain_scores_gemma":[0.9980678,0.00021192803,0.000066305896,0.00028658257,0.0009886964,0.0003787194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054315955,0.0002243689,0.00035169907,0.00020985078,0.00059570366,0.00029533877,0.00013978838,0.00007796694,0.0003813311],"category_scores_gemma":[0.00011483692,0.00016266396,0.000058459664,0.00036700183,0.00029697272,0.00046632165,0.00024560528,0.00043850823,0.000022152177],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022710478,0.0003866723,0.061791852,0.0019367367,0.00056746096,0.00003823512,0.009871605,0.000024917344,0.3898544,0.00010930337,0.04713046,0.4860173],"study_design_scores_gemma":[0.009029214,0.0008206474,0.10203096,0.001312351,0.000062573265,0.0000070661417,0.0033111328,0.00020104117,0.845935,0.0006930648,0.035946816,0.00065015786],"about_ca_topic_score_codex":0.005036749,"about_ca_topic_score_gemma":0.00044207243,"teacher_disagreement_score":0.48536715,"about_ca_system_score_codex":0.000739373,"about_ca_system_score_gemma":0.0013861639,"threshold_uncertainty_score":0.76140916},"labels":[],"label_agreement":null},{"id":"W2097261126","doi":"10.1158/0008-5472.can-04-3468","title":"An Identity Crisis for <i>fps/fes</i>: Oncogene or Tumor Suppressor?","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University","funders":"","keywords":"Cancer research; Mutation; Mdm2; Suppressor; Biology; Oncogene; Cancer; Somatic cell; Genetically modified mouse; Tyrosine kinase; Transgene; Gene; Genetics; Signal transduction; Cell cycle","score_opus":0.24452441533077324,"score_gpt":0.5695611574949402,"score_spread":0.32503674216416695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097261126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509462,0.004877318,0.0006771045,0.033021428,0.0006357366,0.0048830537,0.0006452434,0.00028049745,0.0040333774],"genre_scores_gemma":[0.97578317,0.0011940993,0.0028987017,0.0023189543,0.0045118337,0.0035651776,0.00006588445,0.00019023036,0.009471932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99388367,0.00036159292,0.0005061286,0.0009958578,0.0024839276,0.0017688471],"domain_scores_gemma":[0.9954144,0.00041833636,0.00006423601,0.0013744166,0.0016901039,0.0010385247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034263928,0.00027292452,0.00055759866,0.00055498106,0.00047817404,0.00023809726,0.0009689839,0.00018488945,0.006390319],"category_scores_gemma":[0.0008142827,0.00022514915,0.00018643751,0.0012644712,0.00037701055,0.00062228384,0.0002657037,0.0011096073,0.0004037841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059320237,0.0009915713,0.0025621837,0.001347564,0.00021448506,0.00031974673,0.0010905142,0.000064866545,0.32290968,0.0007137676,0.60894555,0.054908056],"study_design_scores_gemma":[0.003689142,0.0018282697,0.0014534068,0.0002455896,0.000060447812,0.00007293429,0.00082623615,0.0005682847,0.3421716,0.0003950868,0.6483496,0.00033941324],"about_ca_topic_score_codex":0.0024452421,"about_ca_topic_score_gemma":0.0038569227,"teacher_disagreement_score":0.054568645,"about_ca_system_score_codex":0.0015857312,"about_ca_system_score_gemma":0.002862808,"threshold_uncertainty_score":0.994518},"labels":[],"label_agreement":null},{"id":"W2097293117","doi":"10.1158/0008-5472.can-08-2530","title":"Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Anoikis; Ouabain; Metastasis; Cancer cell; Cancer research; Chemistry; Apoptosis; Cancer; Cell biology; Pharmacology; Programmed cell death; Biology; Internal medicine; Biochemistry; Medicine; Sodium","score_opus":0.026319178010474176,"score_gpt":0.34909357947113406,"score_spread":0.3227744014606599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097293117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950231,0.0018163058,0.000110271,0.0019302127,0.00007049607,0.0005876144,0.00037360154,0.000004403219,0.00008404584],"genre_scores_gemma":[0.99771917,0.0010520791,0.000027286807,0.00028485898,0.00017920915,0.000091396796,0.00005325071,0.000012196682,0.00058053725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985335,0.00016031874,0.00019514473,0.00028358604,0.00045291075,0.00037457194],"domain_scores_gemma":[0.9992296,0.000018859362,0.000054568965,0.00031242592,0.00024230625,0.00014224021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039569382,0.00010771247,0.00012693327,0.00006908079,0.00017841454,0.000039665454,0.00015899389,0.00006395107,0.000045030436],"category_scores_gemma":[0.00007173874,0.00007962411,0.000050398638,0.00029381106,0.00013511388,0.000013778389,0.00018106027,0.00016614085,0.0000031486686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039693006,0.000055594974,0.00015281496,0.00006484193,0.00001198596,0.000005427664,0.00010714546,0.000030381754,0.9855353,0.000014110174,0.0082351975,0.0053902483],"study_design_scores_gemma":[0.00046734334,0.00026337343,0.0022211915,0.000120576624,0.000007896757,0.0000018823067,0.00010552487,0.00005420136,0.9910269,0.000057911064,0.0055775503,0.00009566683],"about_ca_topic_score_codex":0.00037397194,"about_ca_topic_score_gemma":0.00013867165,"teacher_disagreement_score":0.0054915603,"about_ca_system_score_codex":0.00007509384,"about_ca_system_score_gemma":0.00020452111,"threshold_uncertainty_score":0.32469767},"labels":[],"label_agreement":null},{"id":"W2097535790","doi":"10.1158/0008-5472.can-09-2472","title":"Insulin-Like Growth Factor-I Regulates the Liver Microenvironment in Obese Mice and Promotes Liver Metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research","keywords":"Metastasis; Paracrine signalling; Tumor microenvironment; Medicine; Endocrinology; Internal medicine; Insulin-like growth factor; Cancer; Growth factor; Inflammation; Cancer research; Biology; Receptor","score_opus":0.049167777199838926,"score_gpt":0.321487011235095,"score_spread":0.27231923403525604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097535790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244655,0.013505621,0.0000018434076,0.0024006073,0.0001606868,0.0010870118,0.000038854454,0.000030688963,0.00032811827],"genre_scores_gemma":[0.985019,0.013232686,0.00021529736,0.00034099873,0.00021828324,0.00018863958,0.000012648031,0.000052667896,0.000719758],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99717987,0.00025109635,0.00035774068,0.0006178704,0.00079224375,0.0008011943],"domain_scores_gemma":[0.99852127,0.00030902956,0.00006476566,0.0005576739,0.00021574396,0.00033153532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010042619,0.0002765004,0.000377566,0.00035890713,0.0002597116,0.000084851425,0.00034865443,0.00020897096,0.00069015817],"category_scores_gemma":[0.0003118549,0.00018408449,0.00009137994,0.00061910803,0.0007936833,0.00022249082,0.00033500473,0.0017029346,0.000100683654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007558199,0.00062699744,0.11603924,0.0005691285,0.00024866793,0.0002989093,0.006792342,6.3621826e-7,0.82752836,0.00033584374,0.00569665,0.041107435],"study_design_scores_gemma":[0.0018504099,0.00040120567,0.73734325,0.0001552716,0.00006825329,0.00006710908,0.00046664564,0.00011096552,0.24119702,0.00021049767,0.017825065,0.00030431946],"about_ca_topic_score_codex":0.0029018915,"about_ca_topic_score_gemma":0.000574569,"teacher_disagreement_score":0.621304,"about_ca_system_score_codex":0.00019293226,"about_ca_system_score_gemma":0.00019080311,"threshold_uncertainty_score":0.75567484},"labels":[],"label_agreement":null},{"id":"W2097672049","doi":"10.1158/0008-5472.can-09-3074","title":"Immune Infiltration of Spontaneous Mouse Astrocytomas Is Dominated by Immunosuppressive Cells from Early Stages of Tumor Development","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Immune system; Granzyme B; Glioma; Granzyme; CD8; Biology; Cancer research; Cytotoxic T cell; Tumor microenvironment; Immunology; Tumor progression; Cancer; Perforin","score_opus":0.034505085091723085,"score_gpt":0.31805367700746145,"score_spread":0.2835485919157384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097672049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986327,0.000032598626,0.00007062377,0.00010826319,0.00024382872,0.00046712093,0.00030926886,0.000033513777,0.00010206699],"genre_scores_gemma":[0.99759597,0.000062659026,0.00036106756,0.00006506048,0.00003165764,0.00007492691,0.000014853907,0.000028271676,0.0017655519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975835,0.00028190485,0.00051833957,0.00041017547,0.00089513697,0.00031090897],"domain_scores_gemma":[0.99854535,0.0003246248,0.00025321808,0.00042457753,0.00035403314,0.00009821054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003100367,0.0001466376,0.00022671022,0.00020447378,0.00017709218,0.00006571464,0.0004697451,0.00006863087,0.0010866128],"category_scores_gemma":[0.00025418386,0.00014172716,0.000046590783,0.000354688,0.00020984416,0.00020402779,0.00012119071,0.00048718633,0.00004711611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024348737,0.00007203548,0.000030229094,0.000021309506,0.000005755658,0.000037123442,0.0009294459,0.000020302557,0.9974504,0.00014134886,0.00048300062,0.0005655559],"study_design_scores_gemma":[0.0005895735,0.00013729095,0.00028544836,0.000020771256,0.000003027807,0.000007857118,0.000044031105,0.00005944248,0.9974866,0.000037871952,0.001213685,0.00011441522],"about_ca_topic_score_codex":0.00023819886,"about_ca_topic_score_gemma":0.000050394436,"teacher_disagreement_score":0.0016634848,"about_ca_system_score_codex":0.000043224096,"about_ca_system_score_gemma":0.0003126535,"threshold_uncertainty_score":0.99982655},"labels":[],"label_agreement":null},{"id":"W2097726306","doi":"10.1158/0008-5472.can-07-1528","title":"A <i>CDKN2A</i> Mutation in Familial Melanoma that Abrogates Binding of p16INK4a to CDK4 but not CDK6","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CDKN2A; p14arf; Cyclin-dependent kinase 6; Biology; Cancer research; Exon; Melanoma; Mutation; Genetics; Senescence; Molecular biology; Cell cycle; Gene; Tumor suppressor gene; Carcinogenesis; Cyclin-dependent kinase","score_opus":0.08538413017698315,"score_gpt":0.4106412235089448,"score_spread":0.3252570933319616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097726306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379975,0.00078796846,0.00021980454,0.00093610433,0.00026771636,0.0010466961,0.000051244468,0.000038239847,0.002852463],"genre_scores_gemma":[0.9980364,0.00020142655,0.00034336103,0.00022153636,0.00021244303,0.00013192902,0.000025648122,0.000050530307,0.0007767237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711907,0.00010166048,0.0003861533,0.00045013902,0.0011623449,0.00078066083],"domain_scores_gemma":[0.99864554,0.00023806594,0.000067516565,0.00039463252,0.0003573969,0.00029685776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001756043,0.00015826491,0.0003436922,0.0010233776,0.00007670518,0.000020527059,0.00020585774,0.00018393234,0.00022236285],"category_scores_gemma":[0.0003870306,0.00015786401,0.000087695305,0.0014267387,0.00016168448,0.0000802527,0.0001217991,0.00068392017,0.000096683536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001833681,0.00009953518,0.010184839,0.00019747755,0.00004809271,0.00048178737,0.00168735,0.00011286848,0.9644898,0.00017122427,0.00077733747,0.019916],"study_design_scores_gemma":[0.002604162,0.0005982795,0.028839553,0.00064799254,0.000020499108,0.00003486893,0.0011041056,0.000059664817,0.96331185,0.0000508448,0.0025695884,0.0001586208],"about_ca_topic_score_codex":0.0039628595,"about_ca_topic_score_gemma":0.0027941554,"teacher_disagreement_score":0.019757379,"about_ca_system_score_codex":0.0010794288,"about_ca_system_score_gemma":0.00062842417,"threshold_uncertainty_score":0.6437508},"labels":[],"label_agreement":null},{"id":"W2097813641","doi":"10.1158/0008-5472.can-11-3092","title":"Effects of a Caloric Restriction Weight Loss Diet and Exercise on Inflammatory Biomarkers in Overweight/Obese Postmenopausal Women: A Randomized Controlled Trial","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Dietary Effects on Health","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; U.S. Public Health Service; Canadian Institutes of Health Research; Ohio State University","keywords":"Medicine; Overweight; Internal medicine; Weight loss; Body mass index; Confidence interval; Endocrinology; Randomized controlled trial; Obesity; Serum amyloid A; Biomarker; Caloric theory; Inflammation; Biology","score_opus":0.018051618821611798,"score_gpt":0.3554404643633363,"score_spread":0.33738884554172455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097813641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719191,0.011822231,0.000001298984,0.00039314415,0.00073622883,0.014648637,0.000006121045,0.000030315568,0.00044292564],"genre_scores_gemma":[0.97938025,0.01234742,0.000016212034,0.00007202704,0.00048157814,0.007476702,0.0000054015272,0.00004056994,0.00017983647],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99491894,0.0019348379,0.0006960978,0.00037748113,0.0010784462,0.0009942066],"domain_scores_gemma":[0.99420905,0.0044905576,0.00017522866,0.0003432628,0.00019579704,0.00058612955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007040092,0.00024976672,0.0018141421,0.0008975066,0.00008438057,0.000015264153,0.00010819944,0.0001965481,0.000070291055],"category_scores_gemma":[0.0022433144,0.00017626531,0.00013291796,0.0008301844,0.000397193,0.00018063154,0.000071140916,0.0006434412,0.000016561424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9851927,0.0010624274,0.0030007262,0.0016947465,0.0003535633,0.00011032456,0.0009992454,8.236209e-7,0.00560284,0.00018845277,0.00045866592,0.0013354735],"study_design_scores_gemma":[0.9790128,0.0058729313,0.010550124,0.0011654772,0.00014254963,0.0000030283275,0.00006970393,0.000080289916,0.0025985064,0.00013436415,0.00021617221,0.00015405515],"about_ca_topic_score_codex":0.0005971116,"about_ca_topic_score_gemma":0.000016078344,"teacher_disagreement_score":0.007549397,"about_ca_system_score_codex":0.00094344374,"about_ca_system_score_gemma":0.0006121582,"threshold_uncertainty_score":0.71878904},"labels":[],"label_agreement":null},{"id":"W2097842049","doi":"10.1158/0008-5472.can-12-0656","title":"Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; St. Michael's Hospital; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; CDKN2A; Clear cell renal cell carcinoma; Comparative genomic hybridization; FHIT; DNA methylation; Cancer research; Gene; Copy-number variation; Methylation; microRNA; Genetics; Gene dosage; Cancer; Copy number analysis; Genome; Renal cell carcinoma; Gene expression; Carcinogenesis; Tumor suppressor gene; Oncology; Medicine","score_opus":0.08414714634864989,"score_gpt":0.37426265030623124,"score_spread":0.29011550395758134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097842049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815607,0.008690011,0.000019219562,0.00049041136,0.00008933693,0.000977343,0.00016483896,0.000028305518,0.007979805],"genre_scores_gemma":[0.98987025,0.0002771304,0.0003088747,0.00009622628,0.00030953618,0.0003062837,0.0001927491,0.00006920261,0.008569717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955764,0.0004794079,0.00051673333,0.000678824,0.0011666976,0.0015819388],"domain_scores_gemma":[0.9975972,0.00019332799,0.00010328566,0.00093292026,0.00030628796,0.0008669437],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018733448,0.00030771072,0.00066806015,0.0015932192,0.00016067634,0.00004602056,0.00030712274,0.00018906135,0.0011820359],"category_scores_gemma":[0.00005861377,0.00026242566,0.00028480875,0.0024095566,0.00022156557,0.00016510439,0.00020977788,0.0007278964,0.00042716434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009286118,0.00043398095,0.40573093,0.00026042122,0.00036969988,0.0002885854,0.0012380591,0.000050633196,0.5878428,0.000003530852,0.0021319322,0.00072076806],"study_design_scores_gemma":[0.0032436121,0.00043828777,0.838083,0.00006251194,0.00053383375,0.000011677258,0.00053230615,0.00018483974,0.1492072,0.000009312049,0.0073685814,0.00032479054],"about_ca_topic_score_codex":0.0073743355,"about_ca_topic_score_gemma":0.0004006053,"teacher_disagreement_score":0.43863562,"about_ca_system_score_codex":0.0019013091,"about_ca_system_score_gemma":0.00045437773,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2097849707","doi":"10.1158/0008-5472.can-12-2687","title":"Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Vaccinia; Virus; Virology; Biology; Cancer research; Cancer; Immunology; Medicine; Genetics; Gene","score_opus":0.0403253010125256,"score_gpt":0.39461104247766154,"score_spread":0.3542857414651359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097849707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933394,0.0032653203,0.0000022358597,0.0006577686,0.00007919156,0.00087070896,0.000028313332,0.000018838346,0.0017382033],"genre_scores_gemma":[0.9949277,0.00092020386,0.000015986547,0.00027086376,0.00023603177,0.00079175294,0.000064661755,0.00006606237,0.0027067235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678695,0.0005335727,0.00026702308,0.00064022053,0.0007271818,0.0010450467],"domain_scores_gemma":[0.9984553,0.00006057745,0.00004421528,0.00072405924,0.00047749505,0.00023839601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012363213,0.00020011899,0.00023791681,0.00024588217,0.00018405393,0.00011534432,0.00066567975,0.00023487495,0.0011755405],"category_scores_gemma":[0.00030513006,0.00018723904,0.00010976774,0.000718859,0.00017477457,0.000013044181,0.00030110808,0.0007767851,0.0002987249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070852035,0.00018703051,0.006216187,0.00002686194,0.000080671256,0.000022217298,0.000119621094,0.00009978399,0.9795698,0.000019379144,0.009918675,0.003031271],"study_design_scores_gemma":[0.00454645,0.0055854577,0.080982246,0.00017962023,0.000013334771,0.0000050202107,0.00032594954,0.00032485276,0.8812419,0.0009674644,0.02497748,0.0008502338],"about_ca_topic_score_codex":0.0020388146,"about_ca_topic_score_gemma":0.01204,"teacher_disagreement_score":0.09832789,"about_ca_system_score_codex":0.00033819987,"about_ca_system_score_gemma":0.0005895235,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W2097949328","doi":"10.1158/0008-5472.can-07-6453","title":"The Spy1/RINGO Family Represents a Novel Mechanism Regulating Mammary Growth and Tumorigenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Windsor","funders":"","keywords":"Carcinogenesis; Biology; Mammary gland; Cell cycle; Morphogenesis; Cancer research; Ectopic expression; Oncogene; Cell growth; Mammary tumor; Cell biology; Apoptosis; Genetics; Cancer; Breast cancer; Gene","score_opus":0.07993966797452691,"score_gpt":0.3540465433044062,"score_spread":0.2741068753298793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097949328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870813,0.0058796606,0.0040872204,0.0010057077,0.00021515012,0.00040370005,0.000022331567,0.000021764527,0.0012832031],"genre_scores_gemma":[0.9847908,0.010201528,0.0022483193,0.00016960046,0.00043023028,0.00029003795,0.000008558071,0.000045639605,0.0018153146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773455,0.00016990908,0.00022829417,0.00061694084,0.00064200116,0.00060830987],"domain_scores_gemma":[0.99863756,0.000075940225,0.00006753539,0.00073732977,0.00030037644,0.00018126826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009582455,0.00016341858,0.0001617464,0.0000813705,0.0008128596,0.00007298987,0.00058048766,0.000109730594,0.000008302615],"category_scores_gemma":[0.0003640874,0.0001317103,0.00006789827,0.00027161074,0.000252618,0.00001113434,0.00068647723,0.0002367441,0.00000409204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010052824,0.000018214963,0.0002522919,0.000026677768,0.000059108334,0.0000114641925,0.000052687796,0.0000038247927,0.99041814,0.0038276212,0.0016878193,0.003541613],"study_design_scores_gemma":[0.00060533546,0.00015088689,0.0023822405,0.000028413673,0.000008092682,0.000054096847,0.000120136465,0.000057231075,0.9839386,0.0018756831,0.010579964,0.00019936883],"about_ca_topic_score_codex":0.00038201644,"about_ca_topic_score_gemma":0.000042141713,"teacher_disagreement_score":0.008892145,"about_ca_system_score_codex":0.000045142602,"about_ca_system_score_gemma":0.00032953676,"threshold_uncertainty_score":0.62519413},"labels":[],"label_agreement":null},{"id":"W2098114306","doi":"10.1158/0008-5472.can-05-0508","title":"Plasminogen Kringle 5–Engineered Glioma Cells Block Migration of Tumor-Associated Macrophages and Suppress Tumor Vascularization and Progression","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Jewish General Hospital; McGill University and Génome Québec Innovation Centre; McGill University; Montreal Neurological Institute and Hospital","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Canadian Prostate Cancer Research Initiative","keywords":"Angiostatin; Cancer research; Matrigel; Glioma; Genetic enhancement; Biology; Chemistry; Angiogenesis; Gene; Biochemistry","score_opus":0.018904840520186556,"score_gpt":0.32196179226932914,"score_spread":0.3030569517491426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098114306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914404,0.0080194995,0.000030277133,0.000105905914,0.00003734625,0.0002573371,0.0000646973,0.000007634772,0.000036907935],"genre_scores_gemma":[0.9980921,0.0011840434,0.000209252,0.000021253316,0.00016507242,0.00007980696,0.000046442645,0.000022395989,0.00017964563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989575,0.00008500213,0.0001602127,0.00029653762,0.00025572194,0.00024498766],"domain_scores_gemma":[0.9994509,0.000017764864,0.000059461745,0.00016069417,0.00023038159,0.00008079234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029853528,0.000106348496,0.00013020745,0.00008214797,0.000102915146,0.000031603402,0.0000976524,0.00008483451,0.000024646015],"category_scores_gemma":[0.00004051789,0.000096696414,0.000038561066,0.00016170448,0.00012301264,0.000008495108,0.00011400224,0.00007421056,8.841661e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007397925,0.000050521674,0.004306856,0.00006692667,0.0000480902,0.0000029033315,0.00007308592,0.00018506385,0.99188155,0.000006154049,0.0010338145,0.002271082],"study_design_scores_gemma":[0.00044738295,0.00017861207,0.00643213,0.00006036636,0.000015643172,0.000005896013,0.00004649238,0.00055773294,0.9880049,0.0000048067545,0.004138063,0.00010793781],"about_ca_topic_score_codex":0.0001017028,"about_ca_topic_score_gemma":0.00013004814,"teacher_disagreement_score":0.0068354565,"about_ca_system_score_codex":0.00003380666,"about_ca_system_score_gemma":0.00007670165,"threshold_uncertainty_score":0.39431652},"labels":[],"label_agreement":null},{"id":"W2098115324","doi":"10.1158/0008-5472.46.65.1","title":"A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Biology; Molecular biology; Promoter; Allele; Transfection; Genotype; Haplotype; Transcription factor; Gene; Epidermal growth factor receptor; Cell culture; Sp1 transcription factor; Electrophoretic mobility shift assay; Epidermal growth factor; Gene expression; Genetics; Receptor","score_opus":0.09712728811643104,"score_gpt":0.40229234579723866,"score_spread":0.3051650576808076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098115324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435384,0.0006705623,0.000008789165,0.013190131,0.000120080236,0.0007076064,0.00018226053,0.000011475644,0.00075527525],"genre_scores_gemma":[0.9963235,0.00014687516,0.00020965717,0.00029374004,0.0003663275,0.00029537606,0.00007560486,0.000017286093,0.002271613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987575,0.00012204684,0.00020568848,0.00019877825,0.0004506225,0.0002653634],"domain_scores_gemma":[0.9993525,0.00007280235,0.000045973087,0.00018903805,0.00025644485,0.000083253566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020806788,0.00008228405,0.00015559052,0.00016539638,0.000092772534,0.000010409225,0.00006234433,0.00006121612,0.0017928969],"category_scores_gemma":[0.00006274726,0.00005511648,0.00006694368,0.0004160278,0.00011945761,0.00009668963,0.000045280492,0.00029945595,0.000086160006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015899873,0.0013476735,0.39669403,0.00031637214,0.0003579751,0.000021788022,0.005129992,0.00002490346,0.42532223,0.00015555734,0.020893252,0.14814623],"study_design_scores_gemma":[0.0038652532,0.0002582225,0.75606185,0.000403373,0.000058312686,0.00002036098,0.00009982218,0.0000640002,0.23146841,0.00030727158,0.007267358,0.00012578384],"about_ca_topic_score_codex":0.0017567943,"about_ca_topic_score_gemma":0.00072918803,"teacher_disagreement_score":0.3593678,"about_ca_system_score_codex":0.00059337786,"about_ca_system_score_gemma":0.00045118784,"threshold_uncertainty_score":0.9991196},"labels":[],"label_agreement":null},{"id":"W2098203510","doi":"10.1158/0008-5472.can-09-0187","title":"Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Protein kinase B; Cancer research; Metastasis; Breast cancer; Viability assay; Medicine; Signal transduction; Apoptosis; Cancer; Biology; Internal medicine; Cell biology","score_opus":0.0768615230717123,"score_gpt":0.350214048322536,"score_spread":0.2733525252508237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098203510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964799,0.0014201518,0.000019207395,0.000980506,0.000058632824,0.00046839123,0.00011060498,0.000020625479,0.00044194827],"genre_scores_gemma":[0.9987296,0.0006371048,0.00031090964,0.00006450244,0.0001255368,0.000045070028,0.0000064077753,0.00002905434,0.000051850555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976986,0.00023945664,0.00033072516,0.00047008047,0.00076212635,0.00049900095],"domain_scores_gemma":[0.99889535,0.00020309865,0.00009437345,0.0002244417,0.00033695088,0.00024577684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009778135,0.00019545213,0.0005059548,0.00027912093,0.00012541092,0.000051985568,0.000096382326,0.00007169595,0.00018804231],"category_scores_gemma":[0.00002800661,0.00015964013,0.000032654974,0.00060149597,0.00015959497,0.000120029115,0.000065539614,0.00043166755,9.207591e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034633398,0.000192072,0.022838954,0.00033148847,0.000048074566,0.000035597004,0.0007719591,0.00011208676,0.9722706,0.00025457554,0.000029838464,0.0027684232],"study_design_scores_gemma":[0.0024745788,0.00050058775,0.05459286,0.00062052935,0.0000707156,0.00001790983,0.0017207816,0.00017738248,0.9395029,0.000118383956,0.000022196235,0.00018119797],"about_ca_topic_score_codex":0.001630397,"about_ca_topic_score_gemma":0.0007928509,"teacher_disagreement_score":0.03276772,"about_ca_system_score_codex":0.000071842995,"about_ca_system_score_gemma":0.00042356408,"threshold_uncertainty_score":0.6509936},"labels":[],"label_agreement":null},{"id":"W2098379074","doi":"10.1158/0008-5472.can-03-3227","title":"Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Medicine; Immunology; Autoimmunity; Immunization; Adjuvant; Immune system; Immunity; Antigen; Vaccination; Autoimmune disease; Melanoma; Antibody; Cancer research","score_opus":0.05666467751730755,"score_gpt":0.37621553329443774,"score_spread":0.3195508557771302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098379074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715045,0.01581332,0.000041000687,0.010596312,0.00039128616,0.0006123997,0.00006746552,0.000027964617,0.00094573916],"genre_scores_gemma":[0.99463093,0.0005465283,0.000021821861,0.0006166009,0.000026977259,0.00024789915,0.000009696307,0.000021510497,0.0038780116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818796,0.0005120319,0.00033492778,0.00029248578,0.00013071057,0.00054186967],"domain_scores_gemma":[0.99856895,0.00036455732,0.000070765134,0.00060562807,0.00036811782,0.000021998456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011590802,0.00014462485,0.00025585206,0.00025965186,0.0004558839,0.000025986494,0.0007113889,0.0001745536,0.0040729092],"category_scores_gemma":[0.0001749914,0.00010647888,0.000103441416,0.0006551573,0.00028442254,0.00010128449,0.00012939984,0.0007143473,0.00054529187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007717673,0.00007944447,0.0000115745115,0.00002346624,0.00013575584,0.000006473087,0.0041688257,0.000010868288,0.90406764,0.0004751235,0.0023547923,0.08789427],"study_design_scores_gemma":[0.0014849182,0.00038659983,0.012776107,0.000088344175,0.000006452227,0.00005735005,0.0010512559,2.5422372e-7,0.90898955,0.0003610651,0.0746815,0.000116575895],"about_ca_topic_score_codex":0.0040440992,"about_ca_topic_score_gemma":0.00023287823,"teacher_disagreement_score":0.08777769,"about_ca_system_score_codex":0.00020317826,"about_ca_system_score_gemma":0.000900591,"threshold_uncertainty_score":0.9968375},"labels":[],"label_agreement":null},{"id":"W2098487554","doi":"10.1158/0008-5472.can-07-2602","title":"Identification and Characterization of a Membrane Receptor for Proteolysis-Inducing Factor on Skeletal Muscle","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Alberta","keywords":"Skeletal muscle; Biochemistry; Proteolysis; Chemistry; Muscle atrophy; Receptor; Protein degradation; Binding protein; Molecular biology; Biology; Endocrinology; Enzyme","score_opus":0.039268505840700595,"score_gpt":0.3682561833164676,"score_spread":0.328987677475767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098487554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830675,0.00007469986,0.0008648032,0.00014323651,0.000058154987,0.00046058488,0.00004494858,0.0000033046374,0.00004350999],"genre_scores_gemma":[0.99913,0.00015075455,0.000027715369,0.000027045253,0.00013493479,0.0001308005,0.00012901495,0.000009754867,0.0002599849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993352,0.000045050667,0.00012280124,0.0002232117,0.0001032448,0.0001704865],"domain_scores_gemma":[0.9995835,0.000026511978,0.000049584403,0.00014561263,0.00015609428,0.000038710845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043646927,0.00005259241,0.00007011667,0.00006547932,0.000086039036,0.000007695162,0.00007191126,0.000086705055,0.000027520018],"category_scores_gemma":[0.00010792195,0.0000500665,0.000027910575,0.00009007495,0.000088842804,0.0000045147135,0.000027046483,0.00006774444,0.0000016659063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023679576,0.00003264608,0.00015005948,0.0000702657,0.000014477702,4.028253e-8,0.0000803953,0.0000020344573,0.9820833,0.00006929023,0.000039901995,0.017220799],"study_design_scores_gemma":[0.00028426285,0.00020866666,0.028261809,0.000012765263,0.0000022845143,8.069518e-8,0.000045210265,0.000013187322,0.9683174,0.00002974619,0.002771802,0.00005280123],"about_ca_topic_score_codex":0.000018610042,"about_ca_topic_score_gemma":0.00001921607,"teacher_disagreement_score":0.028111748,"about_ca_system_score_codex":0.0000121566545,"about_ca_system_score_gemma":0.000047752314,"threshold_uncertainty_score":0.20416526},"labels":[],"label_agreement":null},{"id":"W2099153170","doi":"10.1158/0008-5472.can-10-0226","title":"WNT11 Expression Is Induced by Estrogen-Related Receptor α and β-Catenin and Acts in an Autocrine Manner to Increase Cancer Cell Migration","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; McGill University","keywords":"Autocrine signalling; Wnt signaling pathway; Biology; Cancer research; Gene silencing; Estrogen receptor; Cell biology; Receptor; Signal transduction; Cancer; Genetics; Breast cancer; Gene","score_opus":0.02793283891660656,"score_gpt":0.3564939775800751,"score_spread":0.32856113866346853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099153170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957857,0.0026295865,0.0000025839825,0.00089629326,0.00013490886,0.0003765068,0.00005440898,0.000011207769,0.00010876963],"genre_scores_gemma":[0.9956727,0.0016127111,0.00023904818,0.00018983411,0.00012843644,0.00043575332,0.00013530825,0.000028156503,0.0015580506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847776,0.000105381674,0.00019828367,0.0005658087,0.00025088937,0.00040185964],"domain_scores_gemma":[0.99924886,0.000014540307,0.00004276026,0.00022104353,0.000187871,0.00028490458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043506073,0.0001642381,0.0001391899,0.00009936546,0.00012533297,0.00006813806,0.00019046619,0.00023243828,0.00040332042],"category_scores_gemma":[0.000040967352,0.00015059729,0.000017291819,0.00021913124,0.0000884328,0.000024149094,0.0001914044,0.00034312112,0.0000076269694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020044515,0.000043253647,0.012331205,0.00002239596,0.000009961664,0.0000012986736,0.0005734089,0.000002896811,0.969363,0.0000070286687,0.013855472,0.003589681],"study_design_scores_gemma":[0.00070976117,0.00015269568,0.0042565283,0.000043910495,0.0000035042826,0.0000010417991,0.00013027573,0.000026352958,0.95531774,0.000016463096,0.039132595,0.00020912732],"about_ca_topic_score_codex":0.0026693034,"about_ca_topic_score_gemma":0.002020569,"teacher_disagreement_score":0.025277121,"about_ca_system_score_codex":0.000058524733,"about_ca_system_score_gemma":0.00023066661,"threshold_uncertainty_score":0.6141179},"labels":[],"label_agreement":null},{"id":"W2099406205","doi":"10.1158/0008-5472.can-04-2367","title":"Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Gene silencing; Small interfering RNA; Biology; Cell biology; Transfection; Small hairpin RNA; Gap junction; Angiogenesis; RNA interference; Cancer research; Intracellular; Cell growth; Cell culture; Cell signaling; Cancer cell; Cancer; RNA; Signal transduction; Gene knockdown; Gene; Genetics","score_opus":0.0279769526119907,"score_gpt":0.32529531286234586,"score_spread":0.2973183602503552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099406205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269545,0.0062721944,0.00005360828,0.00016854284,0.000055531473,0.00017323306,0.00018702565,0.0000045337893,0.0003899079],"genre_scores_gemma":[0.9976412,0.0013383904,0.00010127319,0.00002928477,0.00032776178,0.00003900972,0.00007432513,0.000018410748,0.00043035563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989224,0.00012452134,0.00021033612,0.00031065478,0.00014260349,0.00028948323],"domain_scores_gemma":[0.9991398,0.000015470672,0.0001369578,0.00028991982,0.000345474,0.00007237529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002463018,0.00010700734,0.00015905003,0.000052775977,0.00004985215,0.000009114514,0.00024552617,0.00014537587,0.00028416677],"category_scores_gemma":[0.00002053204,0.00009580255,0.000051506006,0.00010216133,0.00020493337,0.000009377015,0.00014832159,0.00013847512,0.0000017144538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043950405,0.00007660306,0.002009561,0.000052,0.000032090073,4.307674e-7,0.00013680711,0.000072870826,0.9358307,0.000010108247,0.0005647583,0.060774576],"study_design_scores_gemma":[0.00044239883,0.0005158874,0.004594697,0.00006357644,0.000008821282,0.0000019229892,0.000100964346,0.00027002624,0.99102753,0.000011930498,0.0028470943,0.00011514448],"about_ca_topic_score_codex":0.002805513,"about_ca_topic_score_gemma":0.0024546157,"teacher_disagreement_score":0.06065943,"about_ca_system_score_codex":0.0000726499,"about_ca_system_score_gemma":0.0001981664,"threshold_uncertainty_score":0.42411152},"labels":[],"label_agreement":null},{"id":"W2099638559","doi":"10.1158/0008-5472.can-11-2393","title":"Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":396,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Metastasis; Cancer cell; Cancer; Neutrophil extracellular traps; Intravital microscopy; Liver cancer; Lipopolysaccharide; Cancer research; Medicine; Pathology; Inflammation; Immunology; In vivo; Biology; Internal medicine","score_opus":0.06740669829977594,"score_gpt":0.3579699404436513,"score_spread":0.2905632421438754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099638559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97628385,0.01708072,0.0002612244,0.00042512946,0.0020859744,0.00092736486,0.000107429856,0.000121125515,0.0027072],"genre_scores_gemma":[0.9953442,0.0002574158,0.00020757892,0.00013041904,0.00022113831,0.00039712831,0.00005685548,0.00006247161,0.003322749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973818,0.0005679224,0.00027830387,0.00038732658,0.0001609917,0.0012236215],"domain_scores_gemma":[0.998571,0.00036766252,0.00011074073,0.0005073827,0.00036014174,0.00008311243],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00085199624,0.00021792264,0.000294232,0.00027712667,0.00045432014,0.000036696918,0.00037575245,0.000115846386,0.00666073],"category_scores_gemma":[0.00006692633,0.00017824462,0.00007852461,0.000611301,0.0005100191,0.000321479,0.00021964537,0.0012975882,0.0022992766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021113965,0.00015240659,0.00081627344,0.000068820606,0.00030417528,0.000023190232,0.0011298965,0.00002145667,0.98571706,0.000047449535,0.004486202,0.007021935],"study_design_scores_gemma":[0.0009202238,0.00014117401,0.0014962004,0.000118062075,0.0000621208,0.00014573548,0.00028432053,0.000018542249,0.82780427,0.000016290718,0.16872062,0.00027246575],"about_ca_topic_score_codex":0.0011746279,"about_ca_topic_score_gemma":0.00009152963,"teacher_disagreement_score":0.16423441,"about_ca_system_score_codex":0.00045674248,"about_ca_system_score_gemma":0.00023570769,"threshold_uncertainty_score":0.9984776},"labels":[],"label_agreement":null},{"id":"W2099647354","doi":"10.1158/0008-5472.can-05-4111","title":"Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor alpha; Estrogen receptor; Estrogen receptor beta; Chromatin immunoprecipitation; Estrogen; Promoter; Biology; Cancer research; Kinase; Hormone response element; Phosphorylation; Endocrinology; Internal medicine; Molecular biology; Chemistry; Gene expression; Cell biology; Medicine; Gene; Breast cancer; Cancer; Biochemistry","score_opus":0.02026614662751885,"score_gpt":0.32055294090773817,"score_spread":0.3002867942802193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099647354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807273,0.016306063,0.000005111021,0.0016283111,0.00010377854,0.000913493,0.00015610903,0.000014171511,0.0001456735],"genre_scores_gemma":[0.9905193,0.0012153718,0.000077510915,0.0001460627,0.00029524972,0.00023191691,0.00012665788,0.000059285838,0.007328678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977004,0.00023727688,0.00029121252,0.0006491834,0.0005245914,0.0005973476],"domain_scores_gemma":[0.9987692,0.000037633537,0.00009513496,0.00063953805,0.0002527139,0.00020574534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037318826,0.00024005686,0.00023816219,0.00007401673,0.00032507122,0.000037545433,0.00033959353,0.00030617803,0.00026931934],"category_scores_gemma":[0.000023108374,0.00017213955,0.0001149083,0.0002986834,0.00031672357,0.000007003851,0.0007326643,0.00023462468,0.000037807615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010321261,0.000056609202,0.0017733435,0.000050878873,0.00013752477,0.000005876287,0.0001561726,0.00011495387,0.9321152,0.000012797415,0.06204681,0.0024977277],"study_design_scores_gemma":[0.0007353702,0.00038301578,0.0008031109,0.0000950511,0.000018728939,0.000021192624,0.000027662636,0.00009895545,0.9472474,0.000018810575,0.050366532,0.00018416456],"about_ca_topic_score_codex":0.0011009246,"about_ca_topic_score_gemma":0.000029879933,"teacher_disagreement_score":0.015132225,"about_ca_system_score_codex":0.00013579328,"about_ca_system_score_gemma":0.00013668997,"threshold_uncertainty_score":0.7019647},"labels":[],"label_agreement":null},{"id":"W2099771643","doi":"10.1158/0008-5472.can-10-4366","title":"Resuscitating Cancer Immunosurveillance: Selective Stimulation of DLL1-Notch Signaling in T cells Rescues T-cell Function and Inhibits Tumor Growth","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; Genentech; University of Toronto; National Cancer Institute; University of Pennsylvania","keywords":"Immunosurveillance; Immunoediting; Immune system; Cancer; Biology; T cell; Cancer research; Tumor microenvironment; Cell biology; Signal transduction; Immunology; Chemistry; Immunotherapy; Genetics","score_opus":0.04248419755643276,"score_gpt":0.3381845961267093,"score_spread":0.2957003985702765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099771643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942809,0.0040940233,0.00004278668,0.000027664697,0.00010825116,0.0005040478,0.000034688004,0.000009006872,0.0008986711],"genre_scores_gemma":[0.99828386,0.00079554494,0.00018850419,0.000015404683,0.00017142802,0.00021212242,0.000019796533,0.000039672206,0.0002736867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975598,0.0004930481,0.00035958373,0.0005505721,0.0005121188,0.000524911],"domain_scores_gemma":[0.9985411,0.000104487604,0.000106335094,0.0002455425,0.00090223254,0.000100296675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016038676,0.00015508111,0.0002141903,0.00032998098,0.00015533312,0.000023242903,0.00018313526,0.00014123086,0.00005041191],"category_scores_gemma":[0.0002728616,0.00015959983,0.000044467182,0.0007066185,0.00028054166,0.000018575545,0.00018419512,0.00045116013,0.0000041827498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009874704,0.00007543594,0.018699676,0.00018181922,0.000022809625,0.000003817598,0.0008981588,0.00018271113,0.9776817,0.000012813233,0.0005291424,0.0007244725],"study_design_scores_gemma":[0.0009460536,0.0004006878,0.011936513,0.00014841069,0.000004501904,8.303539e-7,0.00037760026,0.00009620733,0.985672,0.00013614891,0.00011876072,0.00016229786],"about_ca_topic_score_codex":0.004160011,"about_ca_topic_score_gemma":0.0011362259,"teacher_disagreement_score":0.007990315,"about_ca_system_score_codex":0.00019048803,"about_ca_system_score_gemma":0.00047127914,"threshold_uncertainty_score":0.65082926},"labels":[],"label_agreement":null},{"id":"W2100084105","doi":"10.1158/0008-5472.can-06-2574","title":"Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Carcinogenesis; Telomerase; Biology; Drug resistance; Cancer research; Multiple drug resistance; Cancer; Tumor progression; Telomerase reverse transcriptase; Cancer cell; Genetics; Gene","score_opus":0.024053143297301453,"score_gpt":0.3725923966235004,"score_spread":0.34853925332619895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100084105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958686,0.0011098727,0.00011729832,0.0007208641,0.00012356084,0.00053105946,0.000013516552,0.000023904315,0.0014913289],"genre_scores_gemma":[0.9886866,0.00007723408,0.000120381206,0.00009516381,0.00039503686,0.00025824216,0.0000029339267,0.000031185496,0.010333222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979603,0.00012517153,0.00018523402,0.00053508865,0.0005453668,0.0006488124],"domain_scores_gemma":[0.99860007,0.000046113262,0.000033036416,0.0007180141,0.00042327555,0.00017949012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018316209,0.00012415659,0.000107589105,0.00006355281,0.00036232278,0.00005517482,0.0006274419,0.00007625386,0.00006352539],"category_scores_gemma":[0.0002755982,0.000095956544,0.000057864294,0.0004338088,0.00017176375,0.000005812745,0.00024909523,0.00019073486,0.000025865143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047516922,0.000030420531,0.004380502,0.000109084394,0.000015864991,0.000010009621,0.00043436667,0.000019517898,0.99207765,0.000043788914,0.0015743137,0.0008293022],"study_design_scores_gemma":[0.00015361204,0.00004427757,0.02838463,0.00003064032,0.0000029846105,0.0000014291765,0.00034088315,4.8606694e-7,0.95734495,0.00014855333,0.013418876,0.00012865392],"about_ca_topic_score_codex":0.00015931742,"about_ca_topic_score_gemma":0.0013461717,"teacher_disagreement_score":0.034732684,"about_ca_system_score_codex":0.00012464751,"about_ca_system_score_gemma":0.00022306693,"threshold_uncertainty_score":0.39129943},"labels":[],"label_agreement":null},{"id":"W2100201127","doi":"10.1158/0008-5472.can-06-1271","title":"Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective EP4 Receptor Antagonism","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Instituto de Salud Carlos III; Vanderbilt University","keywords":"Metastasis; Lewis lung carcinoma; Cancer research; Prostaglandin E2 receptor; Receptor; Prostaglandin E; Agonist; Cancer; Biology; Internal medicine; Medicine; Endocrinology","score_opus":0.017698553718358115,"score_gpt":0.33487247767374817,"score_spread":0.31717392395539007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100201127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419504,0.0030170912,0.0000027575734,0.00036808476,0.00014316123,0.0014565503,0.000010720576,0.000033604123,0.00077300123],"genre_scores_gemma":[0.9980224,0.00040616278,0.00014523377,0.000023299628,0.00046037443,0.0004385589,0.000010106763,0.000035988913,0.00045788704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981719,0.00027135338,0.00015860588,0.00045172792,0.00044522018,0.00050115405],"domain_scores_gemma":[0.9992514,0.00018133149,0.00004424957,0.0001626297,0.00020154606,0.00015884665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009793589,0.00016622216,0.00036066296,0.0003645804,0.00017522625,0.000047510326,0.00004275986,0.00006103678,0.000020180645],"category_scores_gemma":[0.00012773866,0.00012486077,0.000020493711,0.00063949334,0.00035075334,0.00014750236,0.000039723003,0.00047399735,0.0000075280036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002450116,0.00019341263,0.1410095,0.0018343506,0.000103717524,0.00053603534,0.00074381696,0.0000028750737,0.8447968,0.0001925678,0.0033403956,0.0047964305],"study_design_scores_gemma":[0.0032505759,0.001251884,0.23532413,0.00065562816,0.00005560792,0.00017159691,0.00017209607,0.00003569734,0.7567121,0.000053016178,0.0020994048,0.00021826843],"about_ca_topic_score_codex":0.0017548397,"about_ca_topic_score_gemma":0.00027703505,"teacher_disagreement_score":0.094314635,"about_ca_system_score_codex":0.0002885454,"about_ca_system_score_gemma":0.00032838297,"threshold_uncertainty_score":0.5091675},"labels":[],"label_agreement":null},{"id":"W2100311133","doi":"10.1158/0008-5472.can-14-0809","title":"Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non–Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Pemetrexed; Cancer research; Dihydrofolate reductase; Lung cancer; Poly ADP ribose polymerase; Nicotinamide phosphoribosyltransferase; Cancer; NAD+ kinase; Biology; Pharmacology; Chemistry; Medicine; Biochemistry; Cisplatin; Enzyme; Chemotherapy; Internal medicine; Genetics; Polymerase","score_opus":0.03422166177405551,"score_gpt":0.3617999967562424,"score_spread":0.3275783349821869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100311133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918664,0.0055788676,0.00014208621,0.0037836886,0.00016977514,0.0008484892,0.00003608703,0.0000182026,0.00023617416],"genre_scores_gemma":[0.9876354,0.009714927,0.00002389437,0.00055813126,0.0006379412,0.00029283293,0.000045507375,0.000033260985,0.0010581417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978646,0.000244715,0.00030363447,0.00046138617,0.000623592,0.0005020825],"domain_scores_gemma":[0.99840426,0.00075801555,0.00008441708,0.00027590158,0.00022952964,0.00024787762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012099673,0.00018571403,0.00037265843,0.00025002394,0.00018510844,0.00004080694,0.00011919752,0.00019357984,0.0002387838],"category_scores_gemma":[0.00016873702,0.00012326732,0.000028183715,0.00042455777,0.0003484779,0.000075436685,0.00008864654,0.0007552902,0.000005562948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026336126,0.00004831048,0.05257281,0.00049249176,0.00006215464,0.0000033898398,0.0014867038,0.0000055633895,0.9096729,0.0000029981202,0.016311768,0.019077545],"study_design_scores_gemma":[0.005678001,0.0003665265,0.08910945,0.0009738063,0.000088467015,0.0000011864852,0.000523758,0.0022575194,0.8932839,0.000017647622,0.007466307,0.0002334015],"about_ca_topic_score_codex":0.003065137,"about_ca_topic_score_gemma":0.00031108316,"teacher_disagreement_score":0.036536638,"about_ca_system_score_codex":0.00024329373,"about_ca_system_score_gemma":0.00017605328,"threshold_uncertainty_score":0.5026696},"labels":[],"label_agreement":null},{"id":"W2100386875","doi":"10.1158/1538-7445.am2012-1032","title":"Abstract 1032: Post-menopausal women with luminal A subtype might not require breast radiotherapy: Preliminary results from a randomized clinical trial of tamoxifen + radiation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Oncology; Internal medicine; Tissue microarray; Radiation therapy; Cancer; Immunohistochemistry","score_opus":0.04790267200729713,"score_gpt":0.3904779602941867,"score_spread":0.34257528828688955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100386875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918163,0.0040944237,0.00001904107,0.0013575134,0.00038942153,0.0011870239,0.0008859401,0.000013778623,0.00023659879],"genre_scores_gemma":[0.9931783,0.002037954,0.00017895363,0.0000920825,0.0031161448,0.0007408973,0.00029684894,0.000047926693,0.00031088426],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99666935,0.0008060505,0.00065531995,0.0005654444,0.0006080279,0.0006958219],"domain_scores_gemma":[0.99779856,0.0006568371,0.00030882383,0.0005751421,0.00041131588,0.0002493312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003238957,0.00024567012,0.00067097857,0.000098888304,0.00013535914,0.000025907248,0.00028577354,0.00023089872,0.0001305056],"category_scores_gemma":[0.00052494596,0.0001822514,0.0000965122,0.00019315579,0.0007284438,0.00002997049,0.00012281412,0.0002941683,0.000009454372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91556466,0.0005867009,0.0011028411,0.00002993933,0.0010340366,0.000006643061,0.0011871805,0.0000049434307,0.06429743,0.0000065553127,0.0013804915,0.014798568],"study_design_scores_gemma":[0.82234246,0.008191291,0.12801117,0.00016043663,0.00018253512,0.000023512104,0.00048594997,0.000008275365,0.032656163,0.000027741436,0.0074186306,0.00049186946],"about_ca_topic_score_codex":0.0018398693,"about_ca_topic_score_gemma":0.00009999205,"teacher_disagreement_score":0.12690832,"about_ca_system_score_codex":0.00023125533,"about_ca_system_score_gemma":0.0006253326,"threshold_uncertainty_score":0.74319965},"labels":[],"label_agreement":null},{"id":"W2100416170","doi":"10.1158/0008-5472.can-08-1290","title":"Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Ciliogenesis; Pancreatic Intraepithelial Neoplasia; Cilium; Pancreatic cancer; Cancer research; KRAS; Biology; Pancreas; Adenocarcinoma; Pancreatic duct; Cancer; Cell biology; Endocrinology; Genetics; Pancreatic ductal adenocarcinoma","score_opus":0.029956858405215114,"score_gpt":0.33575943501357725,"score_spread":0.30580257660836213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100416170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784251,0.019319331,0.000033584813,0.00073984725,0.000062801366,0.00038682643,0.00021603273,0.000009123676,0.00080737384],"genre_scores_gemma":[0.9873776,0.010099699,0.00018302175,0.0002480649,0.0002665088,0.00015459323,0.000043262233,0.000019782181,0.0016074608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850035,0.00013510842,0.00021141881,0.0004017585,0.00032746757,0.0004239214],"domain_scores_gemma":[0.9990176,0.000039464034,0.00006856588,0.00035366724,0.00025291863,0.00026777803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022829146,0.00015701893,0.0002621341,0.00008092801,0.00013034475,0.000023889637,0.00022300049,0.00012623076,0.00009012732],"category_scores_gemma":[0.00019968122,0.00013798148,0.00006288675,0.00019030127,0.00026323457,0.00000486284,0.00009940053,0.00015625703,0.000005444187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046805106,0.000121384976,0.02182689,0.0002354722,0.00008719981,0.000006395467,0.00013058694,0.000025325257,0.9470145,0.00002729432,0.011905716,0.018151145],"study_design_scores_gemma":[0.0016134152,0.0008998606,0.46442124,0.00049182866,0.00013598076,0.000012348572,0.00036101797,0.000027435684,0.5158905,0.00062339095,0.015128745,0.0003942369],"about_ca_topic_score_codex":0.00025911303,"about_ca_topic_score_gemma":0.00012859887,"teacher_disagreement_score":0.44259438,"about_ca_system_score_codex":0.000051543393,"about_ca_system_score_gemma":0.00071879075,"threshold_uncertainty_score":0.56267214},"labels":[],"label_agreement":null},{"id":"W2100431264","doi":"10.1158/1538-7445.am2014-4972","title":"Abstract 4972: In vivo whole genome shRNA screen reveals novel targets to block cancer metastasis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metastasis; Cancer; Cancer research; Gene knockdown; Prostate cancer; Small hairpin RNA; Biology; Cancer cell; Melanoma; Medicine; Pathology; Gene; Genetics","score_opus":0.058329989684892995,"score_gpt":0.3997125445801029,"score_spread":0.3413825548952099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100431264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747426,0.0056841173,0.00008565733,0.0018919118,0.00009845055,0.0009108122,0.0014047428,0.000014013919,0.0024360272],"genre_scores_gemma":[0.9927538,0.0012689065,0.00024457654,0.0003365985,0.00057532766,0.0009629908,0.00008867251,0.000059199785,0.003709915],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687713,0.0001387922,0.00029037544,0.00080466585,0.000737766,0.0011512456],"domain_scores_gemma":[0.9983997,0.0000441368,0.0000491225,0.00065758836,0.0003399942,0.0005094596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011179773,0.0002355607,0.00029943677,0.00030003028,0.00017670967,0.00008992446,0.00059564057,0.00014324697,0.0005485171],"category_scores_gemma":[0.00020597308,0.00021943437,0.00010556551,0.000559663,0.00013535042,0.000012462459,0.00041014407,0.00036007343,0.00010663945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036449695,0.00015361876,0.0041318526,0.000052829906,0.000141962,0.00001270279,0.00006581306,0.0004960371,0.9759346,0.000018851857,0.011937591,0.0066895997],"study_design_scores_gemma":[0.0021453034,0.0005007904,0.035135966,0.00011725755,0.000014577981,0.0000037979576,0.000055954704,0.00001779754,0.4152343,0.00008029794,0.54628575,0.0004082432],"about_ca_topic_score_codex":0.016441202,"about_ca_topic_score_gemma":0.017584473,"teacher_disagreement_score":0.56070036,"about_ca_system_score_codex":0.00034758833,"about_ca_system_score_gemma":0.00045405288,"threshold_uncertainty_score":0.99010843},"labels":[],"label_agreement":null},{"id":"W2100468603","doi":"10.1158/0008-5472.can-10-3298","title":"Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"EIF4E; Cancer research; Kinase; Phosphorylation; PI3K/AKT/mTOR pathway; Biology; EIF4G; Cancer; MAPK/ERK pathway; Signal transduction; Cell biology; Biochemistry; Translation (biology); Messenger RNA","score_opus":0.08483750821684355,"score_gpt":0.3790111072819373,"score_spread":0.29417359906509377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100468603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838913,0.010646662,0.0002550621,0.000023292425,0.00013669551,0.00027575233,0.000102975595,0.0000066146877,0.00016382718],"genre_scores_gemma":[0.99925923,0.0002582123,0.0001616218,0.000018298766,0.00009080954,0.000084821244,0.000066486944,0.000023613238,0.00003688943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987652,0.00017786423,0.00026071543,0.0002924739,0.0002808001,0.00022297632],"domain_scores_gemma":[0.9992018,0.00007151419,0.00014537068,0.00021377474,0.00030547558,0.0000620911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030516405,0.00012329793,0.0001563208,0.00012407424,0.0000700825,0.00001631348,0.00011044665,0.00008975137,0.00033035406],"category_scores_gemma":[0.00010396593,0.0001205868,0.000049789604,0.00012733163,0.00019966712,0.00002440118,0.00011801203,0.00014361169,9.54e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041794727,0.000111834626,0.009329325,0.00014019269,0.000072825824,0.0000027543815,0.00093894784,0.0000131049355,0.9876115,0.000044466822,0.0001600365,0.0011570876],"study_design_scores_gemma":[0.0005088449,0.00040701916,0.0029210793,0.00014884702,0.000021368818,0.0000016148938,0.0005487106,0.00007899181,0.9951058,0.00005366542,0.00009157688,0.00011246441],"about_ca_topic_score_codex":0.00039210022,"about_ca_topic_score_gemma":0.000027932969,"teacher_disagreement_score":0.010870129,"about_ca_system_score_codex":0.00006899836,"about_ca_system_score_gemma":0.00015123386,"threshold_uncertainty_score":0.4917387},"labels":[],"label_agreement":null},{"id":"W2100525241","doi":"10.1158/0008-5472.can-09-1178","title":"Functional Restoration of BRCA2 Protein by Secondary <i>BRCA2</i> Mutations in <i>BRCA2</i> -Mutated Ovarian Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Searle Scholars Program; National Institutes of Health; Pfizer","keywords":"Cisplatin; Ovarian cancer; BRCA2 Protein; Cancer research; Ovarian carcinoma; Mutation; Biology; Cancer; Medicine; Chemotherapy; Genetics; Germline mutation; Gene","score_opus":0.022712221383821406,"score_gpt":0.35096565398464996,"score_spread":0.32825343260082857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100525241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929131,0.0027606338,0.0018608978,0.0007582999,0.00007782793,0.00043362105,0.000079524514,0.0000106337975,0.001105431],"genre_scores_gemma":[0.99795514,0.00007333595,0.00018102955,0.00007793852,0.0001512379,0.00012753658,0.0003543104,0.000017671706,0.0010617711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868184,0.000102290935,0.00025534572,0.0003342078,0.0003006671,0.00032562797],"domain_scores_gemma":[0.99934924,0.000015308056,0.00003994621,0.0002703836,0.0002369497,0.000088193905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004061722,0.00011618703,0.00012781304,0.0001429827,0.00008077682,0.000022550765,0.00015558979,0.0001349741,0.00009552756],"category_scores_gemma":[0.00007315226,0.00012649928,0.000044491087,0.00041043165,0.00008909078,0.0000094237075,0.000041852654,0.00028098837,0.000005469708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001293341,0.000063010906,0.000673125,0.00003077968,0.000013575991,0.000003755298,0.000089113215,0.0010516162,0.98425806,0.000085370644,0.009911538,0.0036907077],"study_design_scores_gemma":[0.0009638352,0.00031917563,0.020229463,0.00003376387,0.0000044775275,0.0000045106012,0.00009925207,0.00014403486,0.9677838,0.00022974108,0.010034406,0.00015352905],"about_ca_topic_score_codex":0.00030612206,"about_ca_topic_score_gemma":0.00023787402,"teacher_disagreement_score":0.019556338,"about_ca_system_score_codex":0.00007506479,"about_ca_system_score_gemma":0.00039857454,"threshold_uncertainty_score":0.51584905},"labels":[],"label_agreement":null},{"id":"W2100685583","doi":"10.1158/0008-5472.can-08-3385","title":"Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Vaccination; Adjuvant; Neoadjuvant therapy; Immunization; Lymph; Melanoma; Oncology; Immunotherapy; Surgical resection; Vaccine therapy; Antigen; Immunology; Internal medicine; Cancer research; Immune system; Pathology; Cancer","score_opus":0.04751805548350425,"score_gpt":0.3297337685976022,"score_spread":0.28221571311409793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100685583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98298293,0.01313304,0.00014842869,0.0011762294,0.0006799131,0.0013812614,0.000010376714,0.00015536131,0.0003324437],"genre_scores_gemma":[0.9964318,0.00057289586,0.00002739493,0.00014946543,0.00008449557,0.00047936116,0.00008335572,0.000036119138,0.002135091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971523,0.0009841615,0.00042276786,0.00048154863,0.00021497406,0.00074419717],"domain_scores_gemma":[0.9985332,0.00032081845,0.00013285944,0.0004003686,0.00057745894,0.000035307316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015893485,0.00024587204,0.0004359783,0.0005844279,0.00081174617,0.00009733694,0.00026063292,0.00017599593,0.00039263655],"category_scores_gemma":[0.0005043596,0.00019819092,0.00014842961,0.0007454938,0.00006816441,0.00050223613,0.000039342514,0.000754165,0.0001251292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045157103,0.00021591716,0.0009774797,0.00004859288,0.00015162597,0.000030481564,0.00096820964,0.00006002255,0.81597066,0.00004428605,0.0020354534,0.17498158],"study_design_scores_gemma":[0.0043279254,0.0012929754,0.11446025,0.00059952703,0.00003892399,0.00005935505,0.0010679214,0.00007998134,0.83381546,0.00011095264,0.043569192,0.00057753595],"about_ca_topic_score_codex":0.00034022832,"about_ca_topic_score_gemma":0.00010037046,"teacher_disagreement_score":0.17440404,"about_ca_system_score_codex":0.00045826577,"about_ca_system_score_gemma":0.0005746167,"threshold_uncertainty_score":0.8081991},"labels":[],"label_agreement":null},{"id":"W2100732823","doi":"10.1158/0008-5472.can-12-3565","title":"ATIP3, a Novel Prognostic Marker of Breast Cancer Patient Survival, Limits Cancer Cell Migration and Slows Metastatic Progression by Regulating Microtubule Dynamics","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Metastasis; Breast cancer; Cancer research; Metastatic breast cancer; Cancer; Gene silencing; Motility; Cell migration; Microtubule; Biology; Oncology; Medicine; Internal medicine; Cell; Cell biology; Gene; Genetics","score_opus":0.021978662308717964,"score_gpt":0.32224037047059284,"score_spread":0.30026170816187486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100732823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98582834,0.0110279815,0.00028996912,0.000579446,0.00011725003,0.0013268959,0.00073086127,0.000009198653,0.00009002858],"genre_scores_gemma":[0.9898192,0.006881442,0.00072936405,0.000062680294,0.00009149657,0.001458431,0.00021231365,0.000058647252,0.00068638416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796253,0.000168979,0.00037433038,0.00054942054,0.00041136568,0.00053337787],"domain_scores_gemma":[0.998522,0.00005413673,0.00019299162,0.00033006494,0.00073889614,0.0001619533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032035276,0.00023072632,0.00025578713,0.00006713054,0.00016421656,0.00007196073,0.00020630022,0.00015089536,0.00015300531],"category_scores_gemma":[0.000049377053,0.00020098362,0.00006386957,0.00019120489,0.00020831762,0.00002600178,0.00019934603,0.00021088928,0.0000021966462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111670495,0.00019301189,0.02921274,0.0003394706,0.00007935312,4.203552e-7,0.00015715466,0.00006679192,0.94696146,0.000007748177,0.0037167913,0.019153362],"study_design_scores_gemma":[0.0019926548,0.0006270707,0.029010773,0.000903875,0.000112171256,0.000012032133,0.0009177164,0.015072397,0.9458459,0.000027588289,0.0047438224,0.0007339717],"about_ca_topic_score_codex":0.009655638,"about_ca_topic_score_gemma":0.008513711,"teacher_disagreement_score":0.01841939,"about_ca_system_score_codex":0.00017412519,"about_ca_system_score_gemma":0.0003185377,"threshold_uncertainty_score":0.9969391},"labels":[],"label_agreement":null},{"id":"W2100743480","doi":"10.1158/0008-5472.can-13-2775","title":"A Meta-analysis of Lung Cancer Gene Expression Identifies <i>PTK7</i> as a Survival Gene in Lung Adenocarcinoma","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Adenocarcinoma; Lung cancer; Cancer research; Gene signature; Biology; Cancer; Gene; Gene expression; Pathology; Medicine; Genetics","score_opus":0.19682232174945372,"score_gpt":0.4574054528975547,"score_spread":0.26058313114810094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100743480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008673159,0.98895305,0.0000889407,0.000025024603,0.00025873774,0.00098244,0.0007001041,0.000007800625,0.00031072946],"genre_scores_gemma":[0.0056611337,0.98718,0.00004539872,0.000025817279,0.00046558568,0.0022940564,0.00074286736,0.000089983536,0.0034951873],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456656,0.0014844427,0.0009786754,0.0012432727,0.0009469456,0.00078009284],"domain_scores_gemma":[0.9973825,0.00015313835,0.00041925634,0.0013857362,0.0004416069,0.0002177551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021272977,0.0005131213,0.0034135517,0.0009221706,0.000116780146,0.00006371749,0.0010424996,0.0006346261,0.00071567995],"category_scores_gemma":[0.00014336617,0.00039958098,0.0020629144,0.0014312654,0.00019616194,0.000007705058,0.0007177402,0.00061016425,0.000010452855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000520169,0.000495219,0.003162677,0.07107078,0.37548575,0.00027856146,0.0006518537,0.00047624073,0.4859235,0.00013338492,0.02419024,0.03761164],"study_design_scores_gemma":[0.0007112174,0.00020230042,0.00012191202,0.0018986104,0.17195933,0.000012758806,0.00004473048,0.00006155342,0.17458817,0.000019329906,0.64910424,0.0012758423],"about_ca_topic_score_codex":0.0024983818,"about_ca_topic_score_gemma":0.0017418443,"teacher_disagreement_score":0.624914,"about_ca_system_score_codex":0.00018370252,"about_ca_system_score_gemma":0.0013342131,"threshold_uncertainty_score":0.9998456},"labels":[],"label_agreement":null},{"id":"W2100751052","doi":"10.1158/0008-5472.can-08-2819","title":"Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":862,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; American Cancer Society","keywords":"Pancreatic cancer; Epithelial–mesenchymal transition; Gemcitabine; Cancer research; Cisplatin; Biology; Gene silencing; Drug resistance; Gene expression profiling; Cancer; Gene expression; Internal medicine; Gene; Medicine; Metastasis; Chemotherapy; Genetics","score_opus":0.05468919991588315,"score_gpt":0.43534375002003717,"score_spread":0.380654550104154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100751052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88902235,0.0025503638,0.00024806737,0.10126003,0.000091583446,0.0019835855,0.00005550498,0.00003644233,0.0047520464],"genre_scores_gemma":[0.9765401,0.00086025574,0.00076120504,0.0031379005,0.00039662747,0.00123435,0.000010899872,0.000024484247,0.017034205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965328,0.0003710243,0.0004060017,0.0005741553,0.00097788,0.0011381288],"domain_scores_gemma":[0.9979538,0.0003982477,0.000025715284,0.0004295957,0.0006206755,0.00057197193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020185239,0.00018356366,0.0006921505,0.00076963427,0.00018764363,0.00004144863,0.0002704411,0.00013534025,0.00074842374],"category_scores_gemma":[0.000666714,0.00016000212,0.00007100211,0.0018565872,0.0001652769,0.00007998056,0.00004810577,0.0007230257,0.00018598005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026297482,0.0013015448,0.13140358,0.00075630425,0.0003630066,0.0011056588,0.01810028,0.00018483197,0.56920743,0.007586937,0.21551797,0.028175002],"study_design_scores_gemma":[0.009428009,0.0015012329,0.84187263,0.0040572924,0.00016765585,0.000012352388,0.0012125447,0.00027498847,0.049931724,0.0063759615,0.084546216,0.00061938405],"about_ca_topic_score_codex":0.0027132109,"about_ca_topic_score_gemma":0.008043862,"teacher_disagreement_score":0.71046907,"about_ca_system_score_codex":0.0013972602,"about_ca_system_score_gemma":0.0013701924,"threshold_uncertainty_score":0.81947154},"labels":[],"label_agreement":null},{"id":"W2100761288","doi":"10.1158/0008-5472.can-04-0341","title":"A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"CHEK2; Prostate cancer; Missense mutation; Prostate; Medicine; Internal medicine; Allele; Odds ratio; Cancer; Oncology; Genetics; Mutation; Biology; Gene; Germline mutation","score_opus":0.040960422754314656,"score_gpt":0.373611442611032,"score_spread":0.33265101985671736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100761288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994479,0.0017192968,0.001071469,0.0011152271,0.00011016929,0.0006089554,0.00040343052,0.000024433995,0.00046802874],"genre_scores_gemma":[0.9953277,0.0009629203,0.00052463566,0.00041321624,0.00027384015,0.0011524062,0.00016033865,0.000063615385,0.0011213033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802244,0.000108023865,0.00018494732,0.0005701411,0.0005763258,0.0005381065],"domain_scores_gemma":[0.99845624,0.000032751766,0.00011048444,0.00038859568,0.00087798474,0.00013396406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000579784,0.00017360646,0.00014690976,0.00011657835,0.00030671564,0.00007538405,0.0002477278,0.00016770611,0.00015445692],"category_scores_gemma":[0.00021604759,0.00015615307,0.000052090152,0.0006124266,0.00030094964,0.000012154197,0.000095301424,0.00034937862,0.00001658727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008955053,0.00034662933,0.017761752,0.00006887015,0.00088855927,0.000022520655,0.0025306873,0.013253457,0.9483217,0.000090599686,0.0080006225,0.007819101],"study_design_scores_gemma":[0.008167454,0.0007490757,0.043643914,0.000264002,0.00010114667,0.000021721444,0.0007110019,0.00015856221,0.92747146,0.0010352044,0.017002283,0.0006742022],"about_ca_topic_score_codex":0.006964484,"about_ca_topic_score_gemma":0.0067274235,"teacher_disagreement_score":0.02588216,"about_ca_system_score_codex":0.0011070735,"about_ca_system_score_gemma":0.0027462996,"threshold_uncertainty_score":0.9996482},"labels":[],"label_agreement":null},{"id":"W2100762111","doi":"10.1158/0008-5472.can-14-3173","title":"TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Tumor microenvironment; Medicine; Tumor necrosis factor alpha; Colonization; Receptor; Immunology; Biology; Internal medicine; Immune system; Microbiology","score_opus":0.08870786698966812,"score_gpt":0.3757663479476867,"score_spread":0.28705848095801856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100762111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414927,0.002629521,0.0000067168057,0.0023692602,0.000027534523,0.00073759793,0.000036741523,0.0000027056687,0.00004067421],"genre_scores_gemma":[0.9987928,0.0005533516,0.00010745885,0.0002289168,0.00003259177,0.00018080737,0.000023840821,0.0000051159445,0.000075109725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986101,0.00074660697,0.000108638815,0.00015833505,0.00020284181,0.00017351338],"domain_scores_gemma":[0.99939513,0.00017812748,0.000023361652,0.00021622804,0.00013132142,0.000055806264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010619279,0.000057681085,0.00013034682,0.00006211363,0.00006667847,0.00000646434,0.00014589346,0.000038103444,0.00007188424],"category_scores_gemma":[0.00022805191,0.00003071382,0.000012503305,0.00018797696,0.00038019512,0.000049533002,0.00008553655,0.00020752705,0.000015826812],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028705562,0.0006550899,0.09399078,0.00033579144,0.00015521153,0.000079760204,0.13154018,0.000069242684,0.7510983,0.0006465507,0.008400386,0.010158164],"study_design_scores_gemma":[0.0026141002,0.0060714157,0.68343246,0.00024905888,0.00009597513,0.00004644451,0.009967814,0.0001222564,0.28904447,0.001966578,0.0061993785,0.00019002684],"about_ca_topic_score_codex":0.0008155551,"about_ca_topic_score_gemma":0.00006307354,"teacher_disagreement_score":0.5894417,"about_ca_system_score_codex":0.00005706017,"about_ca_system_score_gemma":0.000092217495,"threshold_uncertainty_score":0.14008448},"labels":[],"label_agreement":null},{"id":"W2100970263","doi":"10.1158/0008-5472.can-04-2446","title":"Increased Insulin-Like Growth Factor I Receptor Expression and Signaling Are Components of Androgen-Independent Progression in a Lineage-Derived Prostate Cancer Progression Model","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"LNCaP; Androgen receptor; Prostate cancer; Cancer research; Androgen; Endocrinology; Biology; Bicalutamide; Internal medicine; Tumor progression; Insulin-like growth factor; Growth factor; Protein kinase B; Signal transduction; Cancer; Receptor; Medicine; Cell biology; Hormone","score_opus":0.06546374376710422,"score_gpt":0.36817776051732154,"score_spread":0.3027140167502173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100970263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924994,0.0072657396,0.000041678417,0.0005567335,0.00013452115,0.0024919163,0.00015473194,0.00007620811,0.000028521354],"genre_scores_gemma":[0.99278516,0.004779509,0.001156977,0.00008703531,0.0001322208,0.000820688,0.00009606946,0.000094034716,0.000048324215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953823,0.00029509267,0.0008191079,0.0008908675,0.0016835396,0.0009290622],"domain_scores_gemma":[0.9976622,0.00009116134,0.00033895447,0.00041242453,0.00088458427,0.00061069144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008193369,0.00041253888,0.0007854832,0.00072571565,0.00026214763,0.00005783997,0.0002768237,0.00036241589,0.000060931976],"category_scores_gemma":[0.00023510413,0.0003203805,0.00011109049,0.00088055775,0.00037074095,0.00035726567,0.00035021134,0.0011728441,0.00000621113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037929069,0.0007472372,0.12013232,0.0009112938,0.000050804003,0.000070404145,0.002542156,0.00016719088,0.86833614,0.00000640315,0.000108335764,0.0031348069],"study_design_scores_gemma":[0.009766157,0.0006710447,0.048185073,0.007071678,0.0000312682,0.000007616039,0.00052263244,0.0010478632,0.9321044,0.00011011563,0.00011284399,0.00036931367],"about_ca_topic_score_codex":0.0013916504,"about_ca_topic_score_gemma":0.00006675464,"teacher_disagreement_score":0.07194725,"about_ca_system_score_codex":0.0006837967,"about_ca_system_score_gemma":0.0010299184,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W2101009063","doi":"10.1158/0008-5472.can-07-0478","title":"Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"T.J. Martell Foundation; U.S. Department of Defense","keywords":"Dihydrotestosterone; Wnt signaling pathway; Androgen receptor; Prostate cancer; Cell growth; Endocrinology; Paracrine signalling; Androgen; Chemistry; Internal medicine; Cancer research; Signal transduction; Biology; Cell biology; Receptor; Cancer; Medicine; Hormone; Biochemistry","score_opus":0.09344612595770783,"score_gpt":0.4287663579007316,"score_spread":0.33532023194302374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101009063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891276,0.0047324183,0.000001764425,0.0019966408,0.00012566827,0.0028792166,0.000038431008,0.000031848416,0.0010664107],"genre_scores_gemma":[0.99527407,0.0012236208,0.000024830693,0.000054026023,0.00030956746,0.0006782653,0.000015890566,0.00006299021,0.0023567337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99586576,0.00025352466,0.0005489991,0.0005714418,0.0014555287,0.0013047478],"domain_scores_gemma":[0.99783164,0.00035665443,0.00011264635,0.00045388014,0.0009388399,0.0003063614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031448635,0.00024755392,0.0004519455,0.0005678979,0.00030224284,0.000051276653,0.0003911089,0.00015232764,0.00033938795],"category_scores_gemma":[0.00011422366,0.0001588257,0.00011204005,0.001575368,0.000506876,0.00012776739,0.00021047768,0.0010681323,0.000017030112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013344674,0.0002913853,0.04481537,0.0006484898,0.00013545837,0.00018267435,0.003607419,0.000008457576,0.9416553,0.000101990605,0.00041146608,0.006807546],"study_design_scores_gemma":[0.0030834568,0.00073754863,0.012104402,0.000920534,0.000030238018,0.000005949307,0.0008140474,0.000020753432,0.9814889,0.0002957648,0.0003359168,0.00016248545],"about_ca_topic_score_codex":0.00560072,"about_ca_topic_score_gemma":0.0019303866,"teacher_disagreement_score":0.039833628,"about_ca_system_score_codex":0.00091903895,"about_ca_system_score_gemma":0.0012347952,"threshold_uncertainty_score":0.8466651},"labels":[],"label_agreement":null},{"id":"W2101082817","doi":"10.1158/0008-5472.can-05-0729","title":"Evidence for the Direct Binding of Phosphorylated p53 to Sites of DNA Breaks <i>In vivo</i>","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA damage; Chromatin; Biology; G2-M DNA damage checkpoint; DNA; DNA repair; Molecular biology; Cell biology; Cell cycle; Phosphorylation; Carcinogenesis; Genome instability; Histone; Cell cycle checkpoint; Cell; Biochemistry; Gene","score_opus":0.09208331176881217,"score_gpt":0.4058169437503644,"score_spread":0.31373363198155224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101082817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932132,0.005156896,0.00007942602,0.00048937346,0.000042532658,0.0005518299,0.000049859995,0.0000040344507,0.00041286353],"genre_scores_gemma":[0.99685633,0.00095772976,0.00032984721,0.000057173376,0.000091837996,0.00021624849,0.0000029913679,0.000014447788,0.0014733677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989591,0.00006955269,0.00017513396,0.00024778282,0.0002621777,0.00028624284],"domain_scores_gemma":[0.9991037,0.0002008835,0.000040759976,0.0003446617,0.00025958533,0.000050406827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011494163,0.0000708296,0.00012435313,0.00007456489,0.000045292152,0.000008559821,0.00035020264,0.00007825974,0.00006449484],"category_scores_gemma":[0.00048330144,0.00005499076,0.00006122238,0.00031137213,0.000082002785,0.0000040647897,0.00015288383,0.00008742513,0.000003034539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002948847,0.000024128532,0.0005899305,0.000042866555,0.000023157814,3.2196692e-7,0.00010964931,0.00018362417,0.9908561,0.000033595028,0.0032362337,0.00460552],"study_design_scores_gemma":[0.00021890136,0.00022045264,0.00017508201,0.00012714491,0.000005160764,4.7517793e-7,0.00006762938,0.00010845934,0.9845899,0.000013374895,0.014413823,0.000059610684],"about_ca_topic_score_codex":0.00027078576,"about_ca_topic_score_gemma":0.0005733571,"teacher_disagreement_score":0.01117759,"about_ca_system_score_codex":0.000049269074,"about_ca_system_score_gemma":0.00016546904,"threshold_uncertainty_score":0.22424582},"labels":[],"label_agreement":null},{"id":"W2101243737","doi":"10.1158/0008-5472.can-09-1794","title":"Down-regulation of c-FLIP Enhances Death of Cancer Cells by Smac Mimetic Compound","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Cancer cell; Autocrine signalling; FADD; Caspase 8; Tumor necrosis factor alpha; Apoptosis; Cancer research; Programmed cell death; Cancer; Receptor; Biology; Cell biology; Flip; Caspase; Chemistry; Immunology; Biochemistry; Genetics","score_opus":0.032580262117367115,"score_gpt":0.37035809175016027,"score_spread":0.3377778296327931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101243737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989161,0.009084285,0.000554407,0.00016778788,0.000114472656,0.00024973825,0.00005032666,0.000003948714,0.0006140289],"genre_scores_gemma":[0.9942385,0.0033714615,0.00018402805,0.000024630343,0.00015581053,0.000025760262,0.00006312267,0.000011109369,0.0019255673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988353,0.000082193765,0.00022652802,0.00026416362,0.00034711033,0.00024469494],"domain_scores_gemma":[0.999253,0.000017290791,0.00009932589,0.00025082854,0.0003171099,0.000062485065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030861553,0.00009792742,0.00016255166,0.00007612069,0.00006664488,0.000011121838,0.00017373824,0.00012553939,0.00017583283],"category_scores_gemma":[0.000011599024,0.00008626535,0.00006334083,0.00017169333,0.00011073846,0.000004801212,0.00004049375,0.000087042725,0.0000019434458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010654541,0.000060518523,0.00024789685,0.00003906803,0.000025951551,2.235082e-7,0.00003939168,0.0002940474,0.98309606,0.00025172508,0.0017789479,0.014059612],"study_design_scores_gemma":[0.00033099757,0.0002933022,0.0049319626,0.000050508625,0.000011897435,3.7116226e-7,0.000021018195,0.0001246285,0.98506933,0.00049096666,0.008583474,0.00009153372],"about_ca_topic_score_codex":0.000695928,"about_ca_topic_score_gemma":0.00008891627,"teacher_disagreement_score":0.013968078,"about_ca_system_score_codex":0.000036834193,"about_ca_system_score_gemma":0.00013325922,"threshold_uncertainty_score":0.35177985},"labels":[],"label_agreement":null},{"id":"W2101275022","doi":"10.1158/1538-7445.am2014-315","title":"Abstract 315: Regulation of the transcription factor TFEB and the autophagic/lysosomal network by GSK3 in pancreatic cancer cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Autophagy; TFEB; PI3K/AKT/mTOR pathway; Programmed cell death; Pancreatic cancer; Cell biology; Cancer research; Apoptosis; Transcription factor; Chemistry; Cancer cell; Biology; Small hairpin RNA; Signal transduction; Cancer; Biochemistry; Gene knockdown; Gene","score_opus":0.03381195289388746,"score_gpt":0.34638440333527964,"score_spread":0.3125724504413922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101275022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876602,0.0087317135,0.000018790155,0.0020471753,0.00015824856,0.0007470101,0.000025556701,0.000011447664,0.00059981213],"genre_scores_gemma":[0.99616116,0.0022248656,0.0000066085354,0.00021615,0.00030067848,0.00017054533,0.000005105415,0.000018281575,0.0008965911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984481,0.00029054476,0.00023770095,0.00020889562,0.00049971533,0.00031507396],"domain_scores_gemma":[0.99918205,0.00024800806,0.00006949382,0.00031755678,0.00010351009,0.000079356825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007262186,0.00010504932,0.0002474584,0.00004996784,0.00013176752,0.000020352902,0.00015116001,0.000086744825,0.00058122876],"category_scores_gemma":[0.000038061018,0.000058104182,0.00007252239,0.00032988188,0.00040476417,0.00006463507,0.000023382712,0.00036246947,0.0000036740623],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029695474,0.00016454705,0.033480737,0.00048304652,0.00019228505,0.0000029650512,0.0025971422,0.00073690206,0.91948485,0.001772161,0.0069258865,0.031189905],"study_design_scores_gemma":[0.004289815,0.00008146914,0.8676062,0.00045518987,0.00005313435,0.0000010792961,0.00009453852,0.0018541223,0.11988755,0.0021899578,0.0033885355,0.000098366014],"about_ca_topic_score_codex":0.0017497555,"about_ca_topic_score_gemma":0.00020109981,"teacher_disagreement_score":0.8341255,"about_ca_system_score_codex":0.00012123522,"about_ca_system_score_gemma":0.00017842886,"threshold_uncertainty_score":0.63640475},"labels":[],"label_agreement":null},{"id":"W2101300154","doi":"10.1158/0008-5472.can-08-1790","title":"Differential p53 Engagement in Response to Oxidative and Oncogenic Stresses in Fanconi Anemia Mice","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Université Laval; National Cancer Institute; National Heart, Lung, and Blood Institute; Cincinnati Children's Hospital Medical Center","keywords":"FANCA; Fanconi anemia; DNA damage; Genome instability; Oxidative stress; DNA repair; Biology; Cell biology; Cancer research; DNA; Genetics; Biochemistry","score_opus":0.056189437496753064,"score_gpt":0.3806907511889854,"score_spread":0.32450131369223234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101300154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998389,0.0006783348,0.000034420234,0.00027968574,0.000053541487,0.0004120847,0.000023436503,0.000005209818,0.00012429827],"genre_scores_gemma":[0.9977888,0.0008523536,0.0001626649,0.00006469354,0.000071477705,0.00019586529,0.000011210852,0.000015130104,0.0008378305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982133,0.00056337216,0.00015005605,0.0004317791,0.00024996948,0.00039151422],"domain_scores_gemma":[0.99946433,0.000076003846,0.000018213044,0.00024552952,0.00008480406,0.00011113822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062847644,0.00010524192,0.00012638299,0.00019768797,0.00006779048,0.000015655662,0.00019868194,0.000095786105,0.00008435875],"category_scores_gemma":[0.00030057618,0.00010602286,0.00002184972,0.00026025253,0.00009999874,0.0000043482855,0.00033563699,0.0002605546,0.000009984264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015230104,0.000058415764,0.0043382444,0.000018711295,0.0000098860055,0.00005885098,0.0006412636,0.00002321737,0.990942,0.000009649271,0.00060905534,0.0017676734],"study_design_scores_gemma":[0.00087850826,0.00037576674,0.030053847,0.00004298065,0.000001504629,0.0000051163724,0.00034663014,0.00000920843,0.96341544,0.000024595189,0.0047208606,0.000125541],"about_ca_topic_score_codex":0.0004865134,"about_ca_topic_score_gemma":0.0015532122,"teacher_disagreement_score":0.027526582,"about_ca_system_score_codex":0.00013258203,"about_ca_system_score_gemma":0.00029972475,"threshold_uncertainty_score":0.43234867},"labels":[],"label_agreement":null},{"id":"W2101335366","doi":"10.1158/0008-5472.can-07-6849","title":"Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":428,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cell biology; Biology; Cytoskeleton; Stress fiber; Cell growth; Cancer cell; Integrin; In vivo; Cancer research; Cell; Signal transduction; Focal adhesion; Cancer; Biochemistry","score_opus":0.08797069542300204,"score_gpt":0.3588059303752352,"score_spread":0.27083523495223316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101335366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020696,0.0062854066,0.00015699764,0.0010636104,0.00014054109,0.0005061951,0.00026702936,0.000019078323,0.0013541596],"genre_scores_gemma":[0.9963521,0.0016069497,0.00044792605,0.00024469377,0.00025545357,0.00009547433,0.00007439664,0.000031115334,0.0008919309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979327,0.00017998801,0.00032030942,0.00028269176,0.00085761864,0.0004267038],"domain_scores_gemma":[0.9989186,0.00022435511,0.00009720487,0.00030847528,0.00030260748,0.00014873616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069787353,0.00012218628,0.0003104077,0.000110551184,0.00019957066,0.000015547515,0.00012377324,0.000029503106,0.00083355396],"category_scores_gemma":[0.000095103474,0.00008210664,0.000105394734,0.00046888442,0.00035143702,0.00007308477,0.00008301033,0.0004077467,0.000042538246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018695,0.00014623057,0.00030111716,0.00011905168,0.000061543906,0.000051422554,0.00086152914,0.000008345658,0.93129873,0.000007855919,0.064361356,0.002595848],"study_design_scores_gemma":[0.0009542925,0.00022205609,0.00017253788,0.00013552535,0.000052912677,0.000008116357,0.00065210735,0.000029160308,0.95659465,0.000059666476,0.041035514,0.000083459796],"about_ca_topic_score_codex":0.005816972,"about_ca_topic_score_gemma":0.00007961605,"teacher_disagreement_score":0.0252959,"about_ca_system_score_codex":0.00023537605,"about_ca_system_score_gemma":0.00034409034,"threshold_uncertainty_score":0.9126831},"labels":[],"label_agreement":null},{"id":"W2101603734","doi":"10.1158/1538-7445.prca2012-a15","title":"Abstract A15: A phase 2 study of neoadjuvant metformin in prostatic carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Metformin; Prostate cancer; Tolerability; Prostatectomy; Internal medicine; Adverse effect; Cancer; Diabetes mellitus; Prostate; Urology; Oncology; Insulin; Endocrinology","score_opus":0.08716477341715514,"score_gpt":0.4417522101149123,"score_spread":0.35458743669775716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101603734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.863792,0.13514854,0.0000022707202,0.00000793414,0.00012535069,0.00059622945,0.000029898141,0.0000026262169,0.00029517405],"genre_scores_gemma":[0.9930399,0.005956222,0.000022191822,0.000024161247,0.0003106154,0.00045269544,0.000017866396,0.00002287173,0.00015349359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983303,0.00014333885,0.0002749094,0.00026420597,0.00038969005,0.0005975437],"domain_scores_gemma":[0.99921525,0.000025674697,0.00006004447,0.00038107645,0.00016939186,0.00014858884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011405796,0.00011814527,0.00022205371,0.00014167486,0.000047802605,0.0000128391275,0.00023457095,0.000077453566,0.00017963775],"category_scores_gemma":[0.00009587319,0.00010255985,0.00004370752,0.0002831878,0.00009529098,0.000010871627,0.00010877679,0.0002149425,0.000008827247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000720895,0.0030053877,0.07977114,0.0002189839,0.00009880771,0.000013349563,0.00386977,0.000024879413,0.5016025,0.000042720665,0.0027480011,0.40788358],"study_design_scores_gemma":[0.008096209,0.0016811254,0.07449504,0.000070533184,0.000030861833,0.0000025653158,0.0052015325,0.000018151552,0.8062158,0.00005350939,0.10376437,0.00037031012],"about_ca_topic_score_codex":0.0009434076,"about_ca_topic_score_gemma":0.00046754925,"teacher_disagreement_score":0.40751326,"about_ca_system_score_codex":0.000054105294,"about_ca_system_score_gemma":0.0002492661,"threshold_uncertainty_score":0.41822693},"labels":[],"label_agreement":null},{"id":"W2101690600","doi":"10.1158/0008-5472.can-05-3617","title":"Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Acetylation; NAD+ kinase; SIRT2; BCL6; Cancer research; Cell cycle checkpoint; Regulator; Lymphoma; Cell cycle; Apoptosis; Biology; Carcinogenesis; Chemistry; Cell growth; Cell biology; Enzyme; Biochemistry; Sirtuin; Immunology; B cell; Antibody","score_opus":0.046512944904185824,"score_gpt":0.38601868171643033,"score_spread":0.3395057368122445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101690600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531317,0.00084063824,0.000030737643,0.00058561313,0.00010570076,0.00043842988,0.00001625876,0.000014143278,0.002655329],"genre_scores_gemma":[0.9986563,0.0000769291,0.0000600944,0.00003233239,0.00038968038,0.00004249538,0.000018097278,0.000010568362,0.0007135404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850816,0.00006818825,0.00031304854,0.00012611266,0.00072925916,0.00025524068],"domain_scores_gemma":[0.9988713,0.00005041703,0.00011160999,0.00029346647,0.00058810384,0.00008506451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059378776,0.00008582375,0.0002948875,0.00030380976,0.00007161613,0.000008542684,0.00009786226,0.00007783253,0.00017738539],"category_scores_gemma":[0.000101473444,0.00006477769,0.000069653564,0.00039980272,0.00031149804,0.00009382487,0.000059122904,0.00027880067,0.0000044856306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003366024,0.00019182287,0.0050665345,0.00065119006,0.000034500477,0.000009350372,0.00017931947,0.000012286909,0.9817914,0.0008911529,0.008810376,0.0020255093],"study_design_scores_gemma":[0.0016230657,0.0006534736,0.043188244,0.00042239958,0.000022504282,0.0000036749263,0.00014330533,0.00009340445,0.95177376,0.000040938314,0.0019770018,0.000058212325],"about_ca_topic_score_codex":0.002270721,"about_ca_topic_score_gemma":0.00007376802,"teacher_disagreement_score":0.03812171,"about_ca_system_score_codex":0.00011946307,"about_ca_system_score_gemma":0.000308814,"threshold_uncertainty_score":0.34326658},"labels":[],"label_agreement":null},{"id":"W2101878233","doi":"10.1158/0008-5472.can-03-1944","title":"Angiogenic Acceleration of Neu Induced Mammary Tumor Progression and Metastasis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Child Health and Human Development; California Breast Cancer Research Program; U.S. Department of Defense","keywords":"Mouse mammary tumor virus; Mammary tumor; Biology; Mammary gland; Angiogenesis; Metastasis; Genetically modified mouse; Cancer research; Vascular endothelial growth factor; Oncogene; Tumor progression; HER2/neu; Pathology; Transgene; Cancer; Breast cancer; Medicine; Immunology; Cell cycle; Gene; VEGF receptors","score_opus":0.08256764040317038,"score_gpt":0.41477135429186546,"score_spread":0.3322037138886951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101878233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883665,0.010130965,0.00019454435,0.00035144444,0.000051362284,0.00021887981,0.000014065191,0.0000049231526,0.00019718223],"genre_scores_gemma":[0.99735,0.0017200081,0.00046280047,0.000068163215,0.0001632206,0.00012866777,0.000019352958,0.0000152466755,0.000072586125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907655,0.00006468925,0.00013237598,0.00027209477,0.00023130183,0.00022300327],"domain_scores_gemma":[0.9994373,0.000007145435,0.000043301352,0.00023343688,0.0002042013,0.00007465868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032395782,0.00008139566,0.0001053499,0.00007563368,0.000091460155,0.000023775892,0.00015118862,0.000072744086,0.00002356603],"category_scores_gemma":[0.00003199534,0.00006949887,0.00005825955,0.00019574899,0.00009035447,0.000007976756,0.00016029458,0.00007663203,0.0000016840877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007858953,0.000034048422,0.0010974414,0.000036287198,0.000042071806,0.0000026985635,0.0000352449,0.000013767461,0.97449005,0.0002373188,0.00039154117,0.023540962],"study_design_scores_gemma":[0.00043762193,0.00029633375,0.0042294357,0.000036293757,0.000008645756,0.0000056060653,0.00003569325,0.0000036784907,0.9906066,0.00013873211,0.004116811,0.000084541236],"about_ca_topic_score_codex":0.00011718515,"about_ca_topic_score_gemma":0.000055116456,"teacher_disagreement_score":0.023456423,"about_ca_system_score_codex":0.000034559656,"about_ca_system_score_gemma":0.0002930657,"threshold_uncertainty_score":0.28340816},"labels":[],"label_agreement":null},{"id":"W2101908524","doi":"10.1158/0008-5472.can-10-4261","title":"Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":756,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; Cancer research; Breast cancer; Tumor hypoxia; Metastatic breast cancer; Mammary tumor; Primary tumor; Cancer; Biology; Medicine; Pathology; Internal medicine; Radiation therapy","score_opus":0.0329006188135935,"score_gpt":0.3005830990729407,"score_spread":0.26768248025934716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101908524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962941,0.0021561373,0.00011458231,0.0001063567,0.00011681125,0.0001861513,0.00020930385,0.000009275264,0.00080729247],"genre_scores_gemma":[0.99894094,0.00031333638,0.0001648929,0.000080786136,0.00016875567,0.00006113717,0.0000805852,0.000024420251,0.00016513705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987389,0.00010520221,0.00020654984,0.0003605358,0.0002686192,0.00032020453],"domain_scores_gemma":[0.999351,0.000015938514,0.00007278218,0.00018646682,0.00023387883,0.00013993253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042953575,0.00012041354,0.00013943226,0.00009230709,0.00011380107,0.000015437345,0.000115837734,0.00007004864,0.00014572382],"category_scores_gemma":[0.00012692902,0.00010648733,0.00004788525,0.00018692718,0.00022026338,0.000012456885,0.00016753904,0.00019819633,0.0000022965114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019530149,0.000090595335,0.0012876798,0.00006225871,0.000023100049,0.0000024832264,0.000062261875,9.2699673e-7,0.9803067,0.000034039545,0.017759575,0.00017507549],"study_design_scores_gemma":[0.0005651967,0.00022001153,0.0007586991,0.000052408515,0.000010796292,0.000017134116,0.0002156714,0.00001653807,0.9963346,0.000020270765,0.0016692523,0.00011940951],"about_ca_topic_score_codex":0.00071040133,"about_ca_topic_score_gemma":0.000021827358,"teacher_disagreement_score":0.016090322,"about_ca_system_score_codex":0.00002435454,"about_ca_system_score_gemma":0.00011680547,"threshold_uncertainty_score":0.43424273},"labels":[],"label_agreement":null},{"id":"W2101973145","doi":"10.1158/0008-5472.can-04-3037","title":"Peroxisome Proliferator-Activated Receptor γ Inhibition Prevents Adhesion to the Extracellular Matrix and Induces Anoikis in Hepatocellular Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; McMaster University","keywords":"Anoikis; Peroxisome proliferator-activated receptor; Cancer research; Troglitazone; Cell biology; Cell adhesion; Extracellular matrix; Apoptosis; Programmed cell death; Focal adhesion; Chemistry; Biology; Signal transduction; Receptor; Cell; Biochemistry","score_opus":0.03272274786993503,"score_gpt":0.3284587805990044,"score_spread":0.2957360327290694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101973145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959804,0.0072103003,0.000017771288,0.0015049814,0.00014038973,0.0014306116,0.000049648857,0.00002113041,0.000027112828],"genre_scores_gemma":[0.99572676,0.0009971355,0.00017441252,0.00009927699,0.00065824116,0.00073015195,0.00006167378,0.000067862195,0.0014844958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690586,0.0005873075,0.00037123202,0.0008023014,0.00057787565,0.0007554214],"domain_scores_gemma":[0.99886906,0.000034973855,0.00007640466,0.00049641664,0.00023632727,0.00028681193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011115696,0.00028502903,0.00024187165,0.0002863094,0.0002885691,0.00011306484,0.00034849648,0.00034262764,0.0001100812],"category_scores_gemma":[0.00011582231,0.00023224007,0.000060577884,0.0007071717,0.00015962079,0.000037097972,0.00035302932,0.00062954694,0.00006878396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034161445,0.00026729517,0.008633698,0.000048957845,0.000023791525,0.0000052465107,0.00045812852,0.000033259268,0.98565257,0.0000113001415,0.002484134,0.0020400241],"study_design_scores_gemma":[0.0011563674,0.00030285536,0.000500634,0.000082284634,0.0000046636196,0.0000049595765,0.00022046013,0.00006042498,0.95219016,0.000008374205,0.045201674,0.00026714272],"about_ca_topic_score_codex":0.0002207943,"about_ca_topic_score_gemma":0.000078566765,"teacher_disagreement_score":0.04271754,"about_ca_system_score_codex":0.00027622556,"about_ca_system_score_gemma":0.0003180151,"threshold_uncertainty_score":0.94704753},"labels":[],"label_agreement":null},{"id":"W2101994706","doi":"10.1158/0008-5472.can-09-3592","title":"Vascular Endothelial Growth Factor—A Positive and Negative Regulator of Tumor Growth","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Tumor progression; Vascular endothelial growth factor; Cancer research; Biology; Tumor microenvironment; Metastasis; Haematopoiesis; Context (archaeology); Genetically modified mouse; Tumor initiation; Regulator; Vascular endothelial growth factor A; Cancer; Immunology; Transgene; Cell biology; VEGF receptors; Stem cell; Tumor cells; Genetics; Gene","score_opus":0.022675998196544922,"score_gpt":0.33221109570524526,"score_spread":0.30953509750870034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101994706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971953,0.0013210295,0.00004468678,0.00015402454,0.0001368588,0.00023433883,0.00022538484,0.000004712026,0.0006836488],"genre_scores_gemma":[0.99791825,0.0009169424,0.00016958636,0.0000751235,0.00050598884,0.00007619248,0.000011656258,0.00002777189,0.00029847058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987499,0.000102575075,0.00014454886,0.00037347936,0.00031112725,0.00031835862],"domain_scores_gemma":[0.9988803,0.00006161127,0.000051968666,0.00025059836,0.000625337,0.0001301828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029615377,0.00012459044,0.0001661026,0.00007414161,0.00011441833,0.000020957355,0.00020868196,0.00011676891,0.00014250125],"category_scores_gemma":[0.00025292972,0.00010729008,0.00009377384,0.00014811556,0.00047116485,0.000006327825,0.0001697178,0.00021570787,0.0000032643093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001280115,0.000027190657,0.011104034,0.000037774982,0.00008626016,0.00000231233,0.00012081981,3.516256e-7,0.9856317,0.0009806732,0.0007814096,0.0010994355],"study_design_scores_gemma":[0.0004721189,0.00019256568,0.037545785,0.0000208897,0.000009359986,0.0000038761564,0.00006842866,0.0000039841275,0.9576339,0.000331088,0.0035913854,0.00012660683],"about_ca_topic_score_codex":0.0008085306,"about_ca_topic_score_gemma":0.00017807912,"teacher_disagreement_score":0.027997816,"about_ca_system_score_codex":0.000021516818,"about_ca_system_score_gemma":0.00024654565,"threshold_uncertainty_score":0.43751624},"labels":[],"label_agreement":null},{"id":"W2102000647","doi":"10.1158/0008-5472.can-04-3936","title":"Gene Expression Profiling and Genetic Markers in Glioblastoma Survival","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":315,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Tensin; Biology; Gene; Survival analysis; Gene expression profiling; Glioblastoma; Proportional hazards model; Oncology; Bioinformatics; Gene expression; PTEN; Computational biology; Genetics; Internal medicine; Medicine; Cancer research; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.027435504680128526,"score_gpt":0.3481900456140119,"score_spread":0.3207545409338834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102000647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854753,0.013843205,0.000029249128,0.00013595734,0.000053461223,0.00017290955,0.000017315648,0.000005194589,0.0002674324],"genre_scores_gemma":[0.99607474,0.0023047805,0.00070373825,0.000044522276,0.0004053258,0.000095627904,0.000007774769,0.000016272666,0.00034722209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890554,0.00014137615,0.0001119144,0.00031548293,0.00020832823,0.0003173339],"domain_scores_gemma":[0.99957556,0.000014747669,0.000014975504,0.00020539384,0.000067247405,0.0001221068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002582998,0.000080627215,0.00008906463,0.0000818317,0.000066841225,0.000025747731,0.00011990209,0.000073615534,0.00005220513],"category_scores_gemma":[0.00007162237,0.000074190095,0.000022677687,0.00012757115,0.000107714346,0.0000044239887,0.0001697327,0.00011064799,0.0000070532938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035621412,0.00003218756,0.021294791,0.00002235559,0.0000041369317,0.0000071100817,0.000019362127,0.000071996474,0.96369857,0.000006612959,0.00083941745,0.01364726],"study_design_scores_gemma":[0.00061837403,0.00007144065,0.035024345,0.000021665115,0.0000026871048,0.00000305759,0.000071133705,0.000042144176,0.9558496,0.000025028236,0.008163524,0.00010698799],"about_ca_topic_score_codex":0.0000643673,"about_ca_topic_score_gemma":0.0001799394,"teacher_disagreement_score":0.013729554,"about_ca_system_score_codex":0.000018261975,"about_ca_system_score_gemma":0.00013093608,"threshold_uncertainty_score":0.30253842},"labels":[],"label_agreement":null},{"id":"W2102028478","doi":"10.1158/0008-5472.can-07-5876","title":"c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Transcription (linguistics); Cell biology; Transcription factor; Protein biosynthesis; Promoter; Molecular biology; Genetics; Gene expression; Gene","score_opus":0.16441722452039928,"score_gpt":0.37450389538601436,"score_spread":0.21008667086561508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102028478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628074,0.0126244165,0.0003118587,0.000300659,0.00006974924,0.000217446,0.000047745165,0.000006052042,0.00014131276],"genre_scores_gemma":[0.9928601,0.006497497,0.00014193328,0.000046358044,0.0001220676,0.000045428373,0.000035688918,0.00001808481,0.00023285902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896693,0.000093314215,0.00013062099,0.000292699,0.00029079092,0.00022565207],"domain_scores_gemma":[0.999535,0.000021398864,0.00004307758,0.00016695364,0.0001471974,0.00008635485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002821748,0.0000945207,0.00013824734,0.000076295524,0.000117859294,0.000012425912,0.000101157166,0.00020008883,0.000022263339],"category_scores_gemma":[0.000016589453,0.000092672555,0.000035877398,0.000104038016,0.00032816673,0.000007820054,0.000030513276,0.0002337193,0.0000010399108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025134473,0.000023445302,0.019395042,0.00011335633,0.000035609562,0.0000027784642,0.00029222816,0.000023610244,0.97386706,0.0000052700216,0.00046869193,0.0055215643],"study_design_scores_gemma":[0.0016599703,0.00035884808,0.053430364,0.00015945439,0.000018723144,0.000023732124,0.00014649023,0.00024976634,0.92822415,0.000067199486,0.015455203,0.00020608255],"about_ca_topic_score_codex":0.00020919969,"about_ca_topic_score_gemma":0.00008258791,"teacher_disagreement_score":0.04564289,"about_ca_system_score_codex":0.000026399335,"about_ca_system_score_gemma":0.00007553744,"threshold_uncertainty_score":0.3779077},"labels":[],"label_agreement":null},{"id":"W2102067890","doi":"10.1158/0008-5472.can-15-2171-t","title":"The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Cancer Research UK; Francis Crick Institute","keywords":"Downregulation and upregulation; Protein kinase C; Cancer research; Signal transduction; RELB; Biology; Diacylglycerol kinase; NF-κB; Cell biology; NFKB1; Transcription factor; Biochemistry","score_opus":0.1638880539157025,"score_gpt":0.4024737416748425,"score_spread":0.23858568775914002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102067890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940968,0.0035584394,0.000054573316,0.00019039218,0.00026702686,0.00036813828,0.000019839059,0.00001337599,0.0014314216],"genre_scores_gemma":[0.99697936,0.00016231762,0.00008304206,0.00006174988,0.00057105196,0.00036331176,0.000033673627,0.000043926288,0.0017015589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974415,0.00043929042,0.00026703172,0.0005166595,0.0006269218,0.000708625],"domain_scores_gemma":[0.9987133,0.000102516664,0.00006954411,0.0005399401,0.0003544859,0.00022022489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020890203,0.0001682351,0.00015511137,0.000106309315,0.00044304653,0.000096228876,0.00064663275,0.00019135054,0.000043263557],"category_scores_gemma":[0.00043938291,0.00012845204,0.00005811431,0.00031160255,0.0002983262,0.000009242846,0.0003498899,0.0004995417,0.000039950937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013803785,0.000024979849,0.001459831,0.00001497537,0.000013350052,0.000007635646,0.00041570028,0.001046138,0.98994905,0.000028948773,0.004911277,0.0019900918],"study_design_scores_gemma":[0.0007796884,0.0001663403,0.00008704004,0.00009674028,0.0000015015044,0.0000012636315,0.0008074981,0.000029077468,0.95702994,0.00017482706,0.040657055,0.00016902928],"about_ca_topic_score_codex":0.0020691853,"about_ca_topic_score_gemma":0.0026921192,"teacher_disagreement_score":0.035745777,"about_ca_system_score_codex":0.00033364148,"about_ca_system_score_gemma":0.0010110654,"threshold_uncertainty_score":0.52381223},"labels":[],"label_agreement":null},{"id":"W2102218442","doi":"10.1158/0008-5472.can-08-0029","title":"Glucagon-like Peptide-2 Does Not Modify the Growth or Survival of Murine or Human Intestinal Tumor Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Glucagon-like peptide-2; Cell growth; Cancer research; Biology; Intestinal epithelium; Enteroendocrine cell; Cancer cell; Internal medicine; Gastrointestinal epithelium; Cancer; Endocrinology; Epithelium; Medicine; Peptide; Endocrine system; Biochemistry","score_opus":0.13879719428475934,"score_gpt":0.3963507674668255,"score_spread":0.2575535731820662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102218442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174255,0.00014266085,0.000006321846,0.0016882273,0.00021977996,0.00090413244,0.000026938302,0.000041783114,0.0052275765],"genre_scores_gemma":[0.9200965,0.00044396071,0.0001314186,0.00019104131,0.00031280014,0.00027106013,0.000013879864,0.000033386972,0.07850594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977732,0.00012559145,0.00027895957,0.00033612794,0.0009262591,0.00055986183],"domain_scores_gemma":[0.9985734,0.00031760614,0.00006548667,0.00048279855,0.00040086728,0.00015983527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066726445,0.00017069007,0.0003424648,0.00019429282,0.00026903933,0.000021909414,0.00034212592,0.000033815984,0.0014146687],"category_scores_gemma":[0.00014862203,0.00007728386,0.00008800439,0.0004818502,0.0005668518,0.00006672729,0.00027953568,0.00035146446,0.000064682674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017329335,0.005249706,0.13068569,0.005583192,0.0025636838,0.0061884876,0.0057665333,0.00004458057,0.5598578,0.006024643,0.2443906,0.01631578],"study_design_scores_gemma":[0.009662052,0.005518094,0.071338244,0.0010702529,0.00035298918,0.000053232397,0.0020136393,0.00017814922,0.85184455,0.0003097322,0.05713696,0.0005221035],"about_ca_topic_score_codex":0.0017484737,"about_ca_topic_score_gemma":0.000603807,"teacher_disagreement_score":0.2919868,"about_ca_system_score_codex":0.00019680544,"about_ca_system_score_gemma":0.00034973896,"threshold_uncertainty_score":0.9994982},"labels":[],"label_agreement":null},{"id":"W2102230986","doi":"10.1158/0008-5472.can-04-3999","title":"E2F-Dependent Repression of Topoisomerase II Regulates Heterochromatin Formation and Apoptosis in Cells with Melanoma-Prone Mutation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; National Cancer Institute; Weizmann Institute of Science; Ludwig Institute for Cancer Research","keywords":"Topoisomerase; Biology; Heterochromatin; Chromatin; Cancer research; Melanoma; Heterochromatin protein 1; Gene silencing; Genetics; Cell biology; DNA; Gene","score_opus":0.024641110378502157,"score_gpt":0.3273425908422361,"score_spread":0.30270148046373396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102230986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779445,0.001206007,0.00029929227,0.000274709,0.000022506463,0.0002763342,0.000012101388,0.0000034930588,0.000111084824],"genre_scores_gemma":[0.99804443,0.00096491986,0.0004734482,0.000033819506,0.00006274245,0.00010019279,0.000025533442,0.0000122771025,0.00028260914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916124,0.00006151943,0.00016219911,0.00021615154,0.00021582513,0.00018307446],"domain_scores_gemma":[0.99959075,0.000008960359,0.000059179674,0.00018893553,0.0001064506,0.000045730532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002983897,0.000074635434,0.00009883706,0.00008964159,0.00007290171,0.000014664083,0.00007894869,0.000070295275,0.00002646423],"category_scores_gemma":[0.000006669339,0.00006294889,0.000015589445,0.00010102972,0.00005497999,0.000012813892,0.00008462817,0.000084624175,8.103715e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002529363,0.00004068053,0.000044852724,0.000051335126,0.000012211156,6.1851773e-7,0.00041709933,0.0004951011,0.97153986,0.00002772563,0.00006081721,0.027056774],"study_design_scores_gemma":[0.00080761174,0.0004537635,0.00021837898,0.000081157465,0.000004696618,0.0000042362644,0.00019878332,0.00037953796,0.9967829,0.00007765206,0.00091355544,0.00007772246],"about_ca_topic_score_codex":0.00018969664,"about_ca_topic_score_gemma":0.0005081334,"teacher_disagreement_score":0.026979052,"about_ca_system_score_codex":0.000055733137,"about_ca_system_score_gemma":0.00005256159,"threshold_uncertainty_score":0.25669816},"labels":[],"label_agreement":null},{"id":"W2102352112","doi":"10.1158/0008-5472.can-05-4578","title":"Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Institutes of Health; University of Southern California","keywords":"Alveolar rhabdomyosarcoma; Biology; Fusion gene; Ectopic expression; Phenotype; Gene signature; Gene expression profiling; Gene; Gene expression; Microarray analysis techniques; Cancer research; Rhabdomyosarcoma; Genetics; Pathology; Sarcoma; Medicine","score_opus":0.05260115122936483,"score_gpt":0.3703975485946334,"score_spread":0.3177963973652686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102352112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95510596,0.04236565,0.000027755183,0.0016625752,0.000029012703,0.0007102888,0.000026136591,0.000010466337,0.00006215666],"genre_scores_gemma":[0.9970381,0.002026949,0.00025216443,0.000027571394,0.000060229057,0.0004905289,0.000016910637,0.000019157991,0.000068367306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850965,0.00014082342,0.0002617195,0.00025907488,0.0006088744,0.00021983698],"domain_scores_gemma":[0.9988314,0.0002710983,0.00011663846,0.00034728166,0.00038188937,0.000051721843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003802677,0.00011367591,0.00023829186,0.00015044754,0.00009483455,0.000023672563,0.00012791889,0.00008469077,0.000023931161],"category_scores_gemma":[0.00008951431,0.000068396825,0.00008267473,0.00030990978,0.00027182046,0.00005754526,0.00008435691,0.00015517347,0.0000010883294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008102913,0.00024114411,0.2804471,0.00015887152,0.000041160372,0.000020954534,0.000075530384,0.0000043570426,0.71436185,0.00014348853,0.0006416111,0.0037829191],"study_design_scores_gemma":[0.00054488407,0.000087638866,0.20237301,0.0002251203,0.000053452408,0.000009559647,0.00009427708,0.000023145418,0.7957381,0.0003333408,0.0004707909,0.00004668079],"about_ca_topic_score_codex":0.0004830043,"about_ca_topic_score_gemma":0.00005169237,"teacher_disagreement_score":0.08137626,"about_ca_system_score_codex":0.00004416351,"about_ca_system_score_gemma":0.00009929403,"threshold_uncertainty_score":0.27891415},"labels":[],"label_agreement":null},{"id":"W2102392020","doi":"10.1158/0008-5472.can-04-4458","title":"The Heat Shock Protein 90 Inhibitor, 17-Allylamino-17-demethoxygeldanamycin, Enhances Osteoclast Formation and Potentiates Bone Metastasis of a Human Breast Cancer Cell Line","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Osteoclast; Cancer research; Bone marrow; RANKL; Breast cancer; Bone metastasis; Medicine; Metastasis; Cancer; Internal medicine; Pathology; Endocrinology; Activator (genetics); Receptor","score_opus":0.03293359724252151,"score_gpt":0.3619336302769378,"score_spread":0.3290000330344163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102392020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698485,0.024675852,0.00019423536,0.0029740487,0.000032525917,0.001371345,0.0001957751,0.000011797176,0.0006958818],"genre_scores_gemma":[0.9871638,0.0059019383,0.00028299104,0.000047084963,0.0005977654,0.0010518124,0.00005054177,0.0000451615,0.004858925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967177,0.0005183523,0.00050913903,0.0005452319,0.00086139113,0.0008481817],"domain_scores_gemma":[0.998154,0.00006526038,0.000089179346,0.00057992287,0.0008856289,0.00022601802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00199194,0.00024098798,0.00029058635,0.00014191534,0.0006406303,0.000121970006,0.0004551741,0.00020185453,0.00021567881],"category_scores_gemma":[0.00010705489,0.0001812496,0.00010237513,0.00037139008,0.000488003,0.00004871057,0.00053715386,0.0004634937,0.000006085223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028543745,0.00008638614,0.00011455352,0.00020638194,0.000063168925,0.0000022024597,0.00014238516,0.00006259059,0.9739595,0.00001802988,0.0032930542,0.021766318],"study_design_scores_gemma":[0.0007220244,0.00047496663,0.00030605105,0.00012802682,0.000014970969,0.0000103362445,0.00037906348,0.00014461094,0.9824709,0.00003235827,0.015125354,0.00019130683],"about_ca_topic_score_codex":0.002329566,"about_ca_topic_score_gemma":0.010646987,"teacher_disagreement_score":0.021575011,"about_ca_system_score_codex":0.00020127873,"about_ca_system_score_gemma":0.00041012367,"threshold_uncertainty_score":0.73911446},"labels":[],"label_agreement":null},{"id":"W2102541302","doi":"10.1158/0008-5472.can-04-0401","title":"Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Monoclonal antibody; Vascular endothelial growth factor; Medicine; Pharmacodynamics; Antibody; Pharmacology; Kinase insert domain receptor; Monoclonal; Pharmacokinetics; Cancer research; Immunology; Vascular endothelial growth factor A; VEGF receptors","score_opus":0.050287313681114,"score_gpt":0.36137347368104394,"score_spread":0.31108615999992995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102541302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927089,0.0056699975,0.0003710836,0.0001479528,0.000118743425,0.00049170776,0.00024308091,0.000011059775,0.0002374714],"genre_scores_gemma":[0.9947782,0.003213767,0.00073563104,0.000081072954,0.0005110169,0.00026255887,0.00007663391,0.00005812241,0.00028299633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981091,0.0001339822,0.0002545323,0.0004957129,0.00043337216,0.0005732801],"domain_scores_gemma":[0.9988641,0.000082318154,0.00007979288,0.00031825344,0.0005233,0.00013222288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050430885,0.00020589847,0.00026561625,0.0001086698,0.0001982204,0.000040455227,0.00033031002,0.00019228109,0.00016623968],"category_scores_gemma":[0.00013696088,0.0001834759,0.00028384972,0.00017165203,0.00031524285,0.000010582299,0.00013048614,0.00014885029,0.000010274815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013038,0.000087999135,0.0064483467,0.00012526682,0.000346946,0.0000020805473,0.00013273647,0.00010998557,0.9884257,0.00027614867,0.00039941166,0.0023415808],"study_design_scores_gemma":[0.0020976183,0.00047258032,0.0034831369,0.00008866964,0.000026134398,0.0000034678385,0.00011164013,0.000028658264,0.9723178,0.00015064297,0.020991683,0.00022792455],"about_ca_topic_score_codex":0.0010051297,"about_ca_topic_score_gemma":0.00007223239,"teacher_disagreement_score":0.020592272,"about_ca_system_score_codex":0.00011843978,"about_ca_system_score_gemma":0.00070182746,"threshold_uncertainty_score":0.748193},"labels":[],"label_agreement":null},{"id":"W2102612417","doi":"10.1158/0008-5472.can-04-0580","title":"A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cyclophosphamide; Toxicity; Medicine; Pharmacology; Maximum tolerated dose; Toxicology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.06633478806082845,"score_gpt":0.4347610397646431,"score_spread":0.36842625170381466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102612417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921807,0.0010560772,0.000015203879,0.0038583865,0.00017046393,0.002197598,0.00013788429,0.000022105474,0.00036158238],"genre_scores_gemma":[0.9967578,0.00056196505,0.00007629072,0.00044904437,0.00014800533,0.00034606617,0.000039279566,0.000021228441,0.001600286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974272,0.00042738306,0.00044436427,0.0005114985,0.00063461,0.00055493665],"domain_scores_gemma":[0.99764645,0.00091693987,0.00016686007,0.00052538124,0.00047218654,0.00027220196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056228385,0.0002538597,0.0011090892,0.0006831982,0.00012468024,0.000014923308,0.00020869906,0.00009820196,0.00020006708],"category_scores_gemma":[0.0001088562,0.0001647365,0.00021913224,0.0026881143,0.0003321759,0.00004424149,0.00010315896,0.00039425388,0.00004433658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019501125,0.0024103047,0.0016048007,0.00058539765,0.008001103,0.00041585203,0.011627115,0.013786323,0.9327729,0.00020886886,0.007715387,0.0013708647],"study_design_scores_gemma":[0.0045376057,0.0028688598,0.052610237,0.0005839329,0.0009770973,0.0000029145256,0.00043752292,0.00009735308,0.9372083,0.00004226901,0.00047899625,0.00015493677],"about_ca_topic_score_codex":0.003614356,"about_ca_topic_score_gemma":0.002008541,"teacher_disagreement_score":0.051005434,"about_ca_system_score_codex":0.0013868937,"about_ca_system_score_gemma":0.00062616786,"threshold_uncertainty_score":0.67177594},"labels":[],"label_agreement":null},{"id":"W2103201992","doi":"10.1158/0008-5472.can-06-1499","title":"Activation of EDTA-Resistant Gelatinases in Malignant Human Tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; National Institutes of Health","keywords":"Fibroblast activation protein, alpha; Gelatinase; Dipeptidyl peptidase; Gelatinases; Metalloproteinase; Cancer-Associated Fibroblasts; Chemistry; Matrix metalloproteinase; Cancer research; Cancer; Molecular biology; Pathology; Biology; Cancer cell; Medicine; Biochemistry; Enzyme; Internal medicine","score_opus":0.08418576516492325,"score_gpt":0.4244297779889028,"score_spread":0.34024401282397954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103201992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189496,0.000081787395,0.0000098117425,0.0008447723,0.000003006591,0.000154212,0.000008711681,0.000010961799,0.0069917827],"genre_scores_gemma":[0.9965362,0.000009762652,0.00002754764,0.000035181783,0.000098472716,0.00004622115,0.00003537429,0.000009010352,0.0032022048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988208,0.00007767501,0.00024101148,0.00016194436,0.00048097334,0.00021759956],"domain_scores_gemma":[0.99948114,0.000052215462,0.000045011853,0.00016020694,0.0002114356,0.00004999056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000401461,0.000056911424,0.0001752269,0.00043702577,0.000062581734,0.000009096345,0.00004986323,0.000036826634,0.0007535268],"category_scores_gemma":[0.0000663998,0.000047741618,0.000053910524,0.00066908385,0.00011679956,0.000048046262,0.000023680142,0.00018750987,0.000009810196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099291115,0.00016023892,0.021719176,0.00009550849,0.000008994515,0.00003880012,0.00005133344,0.00003980275,0.97351986,0.0016599698,0.0022998874,0.00030711413],"study_design_scores_gemma":[0.00094151206,0.00013035661,0.16930263,0.0016418685,0.000007904174,0.0000015450813,0.00029851383,0.00006829228,0.8260545,0.0007631992,0.000718746,0.00007090347],"about_ca_topic_score_codex":0.007232984,"about_ca_topic_score_gemma":0.0010306305,"teacher_disagreement_score":0.14758345,"about_ca_system_score_codex":0.00021695172,"about_ca_system_score_gemma":0.00015421146,"threshold_uncertainty_score":0.99937797},"labels":[],"label_agreement":null},{"id":"W2103621568","doi":"10.1158/0008-5472.can-05-2399","title":"The Octamer Binding Transcription Factor Oct-1 Is a Stress Sensor","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Immunovaccine (Canada)","funders":"National Cancer Institute; Massachusetts Institute of Technology","keywords":"Transcription factor; Gene; Oxidative stress; Gene expression profiling; Microarray analysis techniques; Biology; Gene expression; Microarray; Cell biology; Molecular biology; Genetics; Biochemistry","score_opus":0.07581898666061936,"score_gpt":0.41291395583498663,"score_spread":0.33709496917436726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103621568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777175,0.0027418842,0.00011269743,0.007636141,0.000081320984,0.00058261334,0.00015850502,0.000011475735,0.00090361095],"genre_scores_gemma":[0.97947466,0.002941845,0.000070823444,0.00014084326,0.00083069166,0.00031369552,0.000021784128,0.000038055005,0.016167572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747896,0.0003159397,0.00018253033,0.0004374576,0.00074661605,0.00083850004],"domain_scores_gemma":[0.9988452,0.000046601268,0.000020565134,0.00054302195,0.0003502113,0.00019435323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007383453,0.00013113768,0.000103024344,0.000103557,0.00057884486,0.00013797311,0.0004846702,0.00016427044,0.000344711],"category_scores_gemma":[0.00015965663,0.00009622051,0.00008602434,0.00029387244,0.000237487,0.000008814753,0.00014928824,0.00050076883,0.00018941237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013399264,0.000028648625,0.0006270457,0.000022429711,0.000040370443,0.0000023167054,0.00020208702,0.000011479892,0.9629743,0.000018771267,0.008883302,0.027055271],"study_design_scores_gemma":[0.00024249213,0.00009153595,0.0002475515,0.000017447324,0.0000015056944,0.0000018872837,0.00020664961,0.00003720144,0.68424433,0.000004997609,0.31481656,0.000087837994],"about_ca_topic_score_codex":0.00022325659,"about_ca_topic_score_gemma":0.00048701398,"teacher_disagreement_score":0.30593324,"about_ca_system_score_codex":0.00015981426,"about_ca_system_score_gemma":0.00035673086,"threshold_uncertainty_score":0.4452065},"labels":[],"label_agreement":null},{"id":"W2103667298","doi":"10.1158/0008-5472.can-05-3826","title":"Reversible Kinetic Analysis of Myc Targets <i>In vivo</i> Provides Novel Insights into Myc-Mediated Tumorigenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Carcinogenesis; Biology; Cancer research; Gene; In vivo; Proto-Oncogene Proteins c-myc; Transcription factor; Transgene; Gene expression profiling; Microarray analysis techniques; Cell growth; Gene expression; Genetics","score_opus":0.021159484707208402,"score_gpt":0.3148560833244042,"score_spread":0.29369659861719577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103667298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936199,0.0042313985,0.0002600748,0.00019856743,0.00006465807,0.0003129723,0.00003926801,0.0000077518525,0.0012653781],"genre_scores_gemma":[0.99669266,0.0006372849,0.00024294322,0.00005805748,0.00013920803,0.00012255757,0.0001645861,0.000016415668,0.0019262631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850917,0.000109742505,0.0002950422,0.0003898848,0.00038474594,0.00031139998],"domain_scores_gemma":[0.99915206,0.000033048498,0.0000739561,0.0003388382,0.00032761417,0.000074455296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003449502,0.00011693981,0.00021898751,0.0005275502,0.00007191663,0.000019150444,0.00025665673,0.00012071277,0.000121719466],"category_scores_gemma":[0.00015342803,0.00010823058,0.0000986276,0.0016671902,0.00016469233,0.0000083940395,0.00011585953,0.00012653113,0.000005574017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007524308,0.00010830558,0.005747118,0.000043611544,0.000084450454,0.0000027995102,0.000049838756,0.00044246664,0.98704344,0.00008000153,0.006166411,0.00015633636],"study_design_scores_gemma":[0.00042951005,0.000097877055,0.0042782133,0.000025230198,0.000029432947,2.227729e-7,0.00005019661,0.00029510024,0.9433622,0.00005953179,0.051247466,0.00012501852],"about_ca_topic_score_codex":0.0051126913,"about_ca_topic_score_gemma":0.0054514506,"teacher_disagreement_score":0.045081057,"about_ca_system_score_codex":0.000088685134,"about_ca_system_score_gemma":0.0002618348,"threshold_uncertainty_score":0.77288944},"labels":[],"label_agreement":null},{"id":"W2103759933","doi":"10.1158/0008-5472.can-03-1185","title":"Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Royal Ottawa Mental Health Centre; University of Toronto; Royal Victoria Hospital; SickKids Foundation; Hospital for Sick Children; Canadian Institutes of Health Research","funders":"","keywords":"Biology; Cancer research; Carcinogenesis; Angiogenesis; Extracellular matrix; Transfection; Transcription factor; Plasminogen activator; Molecular biology; Cell culture; Cell biology; Cancer; Endocrinology; Gene","score_opus":0.039506478914802655,"score_gpt":0.3441579797488458,"score_spread":0.3046515008340432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103759933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773246,0.0012420095,0.00021570113,0.00003557517,0.00009665685,0.00045677743,0.00007215197,0.000004845542,0.00014379562],"genre_scores_gemma":[0.9991342,0.0002061876,0.00008807714,0.0000069674143,0.00017782557,0.000106892054,0.000042210766,0.000019312018,0.00021835206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987378,0.00010676107,0.00022594308,0.0003139725,0.00034186448,0.00027364554],"domain_scores_gemma":[0.99925524,0.0000055641644,0.00008665113,0.0003292607,0.00024728375,0.00007598438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024284841,0.00011621662,0.00016939973,0.00008866912,0.0001340347,0.000008457746,0.0002722329,0.00014893287,0.000051877367],"category_scores_gemma":[0.000019459872,0.00010250562,0.00008252798,0.00012504905,0.00015076927,0.000010771703,0.00013808107,0.00014785094,0.000001222156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011194797,0.0002760139,0.00018560985,0.00024474572,0.0000145441045,0.0000016648288,0.00039465577,0.000006496613,0.9983493,0.00004599151,0.00009138492,0.00027762895],"study_design_scores_gemma":[0.0011121272,0.0007827736,0.00018713524,0.00026201544,0.000005803562,7.235415e-7,0.00009739828,8.0036676e-7,0.9970039,0.00029521764,0.00014783387,0.00010425868],"about_ca_topic_score_codex":0.00041079722,"about_ca_topic_score_gemma":0.00006170019,"teacher_disagreement_score":0.0014016886,"about_ca_system_score_codex":0.000046951664,"about_ca_system_score_gemma":0.00026019267,"threshold_uncertainty_score":0.4180058},"labels":[],"label_agreement":null},{"id":"W2103934194","doi":"10.1158/0008-5472.can-10-2470","title":"Insulin Increases <i>De Novo</i> Steroidogenesis in Prostate Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; University of British Columbia","funders":"Prostate Cancer Foundation of Australia; National Cancer Institute; Prostate Cancer Foundation; American Association for Cancer Research","keywords":"Prostate cancer; Endocrinology; Dihydrotestosterone; Internal medicine; Androgen deprivation therapy; Insulin; Downregulation and upregulation; Testosterone (patch); Medicine; Cancer; Androgen; Androgen receptor; Prostate; Cancer research; Biology; Hormone","score_opus":0.13231598041086023,"score_gpt":0.4080896529445855,"score_spread":0.27577367253372526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103934194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778696,0.015708644,0.0000016288411,0.0009789933,0.0001132756,0.001328471,0.00012984533,0.000053536147,0.0038160349],"genre_scores_gemma":[0.959837,0.030269107,0.00014430373,0.00025293662,0.000232229,0.0019569122,0.00001785495,0.000068337744,0.0072212885],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967294,0.00027992565,0.0003166171,0.00057213183,0.0008285255,0.0012734452],"domain_scores_gemma":[0.9984388,0.000118255215,0.000043035998,0.00046422408,0.00045062782,0.00048507145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010644092,0.00021840874,0.00037590394,0.0005696743,0.00014895636,0.00004037845,0.00028998428,0.00011764277,0.0019413772],"category_scores_gemma":[0.0000711299,0.00017461053,0.00008350272,0.0012423334,0.00039162426,0.00014799445,0.00019539085,0.00070101913,0.00013424378],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009467127,0.0015964255,0.50702673,0.0009097586,0.00024637443,0.0021865754,0.006249544,0.000016604758,0.4188681,0.00007011762,0.0062155602,0.047147058],"study_design_scores_gemma":[0.007467611,0.0007818648,0.10777494,0.0008912424,0.00005216544,0.000033775108,0.0009872912,0.000043577063,0.869948,0.0002776023,0.011386092,0.00035583568],"about_ca_topic_score_codex":0.024712564,"about_ca_topic_score_gemma":0.002051751,"teacher_disagreement_score":0.4510799,"about_ca_system_score_codex":0.0012787638,"about_ca_system_score_gemma":0.002107412,"threshold_uncertainty_score":0.998971},"labels":[],"label_agreement":null},{"id":"W2104004482","doi":"10.1158/0008-5472.can-06-2477","title":"Low Dietary Folate Initiates Intestinal Tumors in Mice, with Altered Expression of G2-M Checkpoint Regulators <i>Polo-Like Kinase 1</i> and <i>Cell Division Cycle 25c</i>","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Polo-like kinase; Division (mathematics); Kinase; Cell cycle; Biology; Cell division; Cancer research; Cell biology; Cancer; Cell; Biochemistry; Genetics","score_opus":0.030220107480157934,"score_gpt":0.33375893672828566,"score_spread":0.30353882924812775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104004482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482197,0.0024243444,0.000010011915,0.00032316256,0.000038777038,0.0007102416,0.000021639331,0.000029443521,0.0016203952],"genre_scores_gemma":[0.99802494,0.00047859433,0.00029397564,0.000047829246,0.00011907063,0.00010116455,0.000042179785,0.000054942557,0.00083732436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968312,0.00022454449,0.00048050596,0.0005949281,0.0010569571,0.0008118734],"domain_scores_gemma":[0.99857235,0.00024387336,0.000096012074,0.00041901652,0.00039362797,0.00027510672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096597866,0.00024043181,0.0004682827,0.0006040829,0.0001390797,0.00004182937,0.00022111522,0.00012572571,0.000115888106],"category_scores_gemma":[0.00008502235,0.00017814984,0.00006516134,0.0009706305,0.0005929661,0.00021261578,0.00031421258,0.0008734247,0.000011981271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019252248,0.0005365077,0.07594277,0.0008699816,0.000013334782,0.00031386965,0.00025805194,0.00006284032,0.91610783,0.0000079663205,0.0014241703,0.002537447],"study_design_scores_gemma":[0.0035209137,0.001726672,0.1135929,0.0026587963,0.0000148850195,0.00003600028,0.0003033992,0.0005344001,0.8770065,0.00020095837,0.0001964307,0.00020818689],"about_ca_topic_score_codex":0.0047162725,"about_ca_topic_score_gemma":0.0005297055,"teacher_disagreement_score":0.039101385,"about_ca_system_score_codex":0.0001840377,"about_ca_system_score_gemma":0.0003763038,"threshold_uncertainty_score":0.726474},"labels":[],"label_agreement":null},{"id":"W2104666297","doi":"10.1158/0008-5472.can-14-3000","title":"Carbonic Anhydrase IX Promotes Myeloid-Derived Suppressor Cell Mobilization and Establishment of a Metastatic Niche by Stimulating G-CSF Production","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Cancer research; Metastatic breast cancer; Metastasis; Breast cancer; Medicine; Cancer; Cancer cell; Myeloid; Immunology; Biology; Internal medicine","score_opus":0.06768286038666609,"score_gpt":0.3572377341055846,"score_spread":0.2895548737189185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104666297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716867,0.025931124,0.000063031155,0.0004910233,0.00049321266,0.0010094183,0.000046117566,0.00003276114,0.00024659623],"genre_scores_gemma":[0.996194,0.0006053556,0.0001444029,0.000016714079,0.00003393559,0.00031147912,0.00009018856,0.00003299416,0.0025709516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978303,0.0006620172,0.0003388581,0.00048636584,0.00018460609,0.00049790053],"domain_scores_gemma":[0.9985514,0.00020747687,0.000137253,0.00040800116,0.00064458733,0.000051269137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014492457,0.00016123385,0.0002936662,0.00016971702,0.00015168826,0.00003221299,0.00021740278,0.00015989943,0.00016399134],"category_scores_gemma":[0.00061326014,0.00014751425,0.000030892927,0.00039606768,0.00052341307,0.00020330746,0.00020580129,0.0004996753,0.000014118679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022986256,0.00015064036,0.00093053875,0.00023740176,0.000071725975,0.00000127553,0.0024592155,0.00044340416,0.9857523,0.000009374447,0.008029743,0.0016845516],"study_design_scores_gemma":[0.0014298337,0.00032085512,0.00013746182,0.000091341164,0.00004089739,0.0000054371403,0.0011995737,0.00013670028,0.99277806,0.00011265789,0.0036023012,0.00014485444],"about_ca_topic_score_codex":0.0010486392,"about_ca_topic_score_gemma":0.00007010446,"teacher_disagreement_score":0.025325768,"about_ca_system_score_codex":0.0002779062,"about_ca_system_score_gemma":0.00045819327,"threshold_uncertainty_score":0.60154563},"labels":[],"label_agreement":null},{"id":"W2105098105","doi":"10.1158/0008-5472.can-10-3982","title":"Myeloid Suppressor Cells Regulate the Lung Environment—Letter","year":2011,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bone marrow; Green fluorescent protein; Cancer research; Biology; Immune system; Metastasis; Pathology; Immunology; Cancer; Medicine","score_opus":0.04772477593397916,"score_gpt":0.3078832434401286,"score_spread":0.2601584675061494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105098105","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003581023,0.1031477,0.00003259418,0.86105734,0.013109984,0.0030308666,0.0006847626,0.00017407534,0.015181672],"genre_scores_gemma":[0.0038405396,0.008331594,0.000025367488,0.41190684,0.0060487436,0.0021674875,0.00056652946,0.00038550477,0.5667274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939462,0.0018582757,0.00053433573,0.0011446673,0.00038589805,0.0021306083],"domain_scores_gemma":[0.99646777,0.00069740677,0.0002218763,0.0024120656,0.00016850927,0.000032359745],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0013432498,0.0005826774,0.0006195695,0.00030868853,0.0007683548,0.00008824297,0.002715046,0.0021559345,0.04469713],"category_scores_gemma":[0.000032146523,0.00041529912,0.00029802168,0.00023449321,0.0026653523,0.0001042898,0.001148418,0.010454804,0.010228695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092555056,0.00001935629,0.0000129099235,0.000146249,0.00041748196,0.00008658717,0.00047234073,0.0000029950731,0.21012162,0.000009796,0.7880064,0.0006116727],"study_design_scores_gemma":[0.00042950414,0.00004397623,0.00003666504,0.00010985995,0.00006987662,0.000016494661,0.000017711945,3.7811606e-7,0.27858225,0.00010219227,0.7202387,0.00035243024],"about_ca_topic_score_codex":0.0008750341,"about_ca_topic_score_gemma":0.000008709258,"teacher_disagreement_score":0.55154574,"about_ca_system_score_codex":0.00071656785,"about_ca_system_score_gemma":0.00033771427,"threshold_uncertainty_score":0.9998299},"labels":[],"label_agreement":null},{"id":"W2105356762","doi":"10.1158/0008-5472.can-09-3155","title":"Y-Box Binding Protein-1 Induces the Expression of <i>CD44</i> and <i>CD49f</i> Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"CD44; Cancer research; Gene silencing; Downregulation and upregulation; Chemistry; Cell culture; Molecular biology; Biology; Cell; Biochemistry; Gene","score_opus":0.029367092055174567,"score_gpt":0.34753429265596986,"score_spread":0.3181672006007953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105356762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898174,0.0025923657,0.000018426155,0.0031598778,0.00015549327,0.0011613694,0.000021299547,0.000034227945,0.0030395796],"genre_scores_gemma":[0.99088365,0.0013723498,0.001964266,0.00012205689,0.00025502668,0.00038260545,0.0000020211091,0.00004124152,0.0049767788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784625,0.00012905065,0.0002798937,0.0005145229,0.0007073363,0.00052292825],"domain_scores_gemma":[0.99862534,0.00021812397,0.00009112321,0.00044113593,0.00030346838,0.00032078082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010714404,0.00018333198,0.0003565366,0.00012224176,0.00034219545,0.00007697066,0.00022719115,0.00009923194,0.00010714125],"category_scores_gemma":[0.00022948334,0.00012691475,0.000047244062,0.0005461815,0.0003212864,0.00012264858,0.00024761094,0.0007797034,0.0000061662936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034637225,0.000040443843,0.00041292136,0.0005845253,0.000027159513,0.000006911842,0.0019328638,2.1548398e-7,0.9906633,0.00018912922,0.0023788875,0.0034172644],"study_design_scores_gemma":[0.00075976236,0.00008075778,0.000012220411,0.0007597198,0.00003027446,0.000005062127,0.0007461245,1.3102866e-8,0.9862164,0.00012441342,0.011128247,0.00013700077],"about_ca_topic_score_codex":0.00049312034,"about_ca_topic_score_gemma":0.0010508046,"teacher_disagreement_score":0.008749359,"about_ca_system_score_codex":0.0000661235,"about_ca_system_score_gemma":0.00031138153,"threshold_uncertainty_score":0.5175433},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2105374417","doi":"10.1158/0008-5472.can-12-4152","title":"c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Estrogen receptor; Proto-oncogene tyrosine-protein kinase Src; AMPK; Protein kinase A; Kinase; Unfolded protein response; Cancer cell; Downregulation and upregulation; Biology; Cell biology; Chemistry; Internal medicine; Endocrinology; Breast cancer; Cancer; Medicine; Biochemistry; Endoplasmic reticulum","score_opus":0.023054666255149976,"score_gpt":0.32581512735404106,"score_spread":0.3027604610988911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105374417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453664,0.003898448,0.0000041546446,0.00056736654,0.0000929266,0.0004890277,0.00021435747,0.00001083834,0.0001862155],"genre_scores_gemma":[0.9937769,0.0048403605,0.00004975676,0.00006940961,0.00020512404,0.0007530167,0.000033674667,0.00003689961,0.0002348137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998076,0.00013473928,0.00021014926,0.00060504087,0.00031098386,0.0006630902],"domain_scores_gemma":[0.99894035,0.000027400347,0.000044334676,0.00040201086,0.0002501659,0.00033574115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014554219,0.00019985178,0.00019440238,0.000110469606,0.000117088945,0.000101992104,0.00028020362,0.00016318745,0.0003519783],"category_scores_gemma":[0.000031649262,0.00018062045,0.0000637933,0.00020258252,0.00019311535,0.0000142734,0.0002700543,0.0002513901,0.000027217675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081119346,0.0000860072,0.08536681,0.00006700367,0.00004834184,0.000004689922,0.00005165882,0.00018155455,0.90669507,0.000036579586,0.00071957655,0.006661571],"study_design_scores_gemma":[0.0009047638,0.000073058305,0.03129913,0.000102004444,0.00001096197,0.0000032329945,0.00025511847,0.00025999662,0.9664262,0.00007448788,0.0003467957,0.00024424258],"about_ca_topic_score_codex":0.0066720904,"about_ca_topic_score_gemma":0.00025430712,"teacher_disagreement_score":0.05973112,"about_ca_system_score_codex":0.00006869949,"about_ca_system_score_gemma":0.00025383383,"threshold_uncertainty_score":0.99994254},"labels":[],"label_agreement":null},{"id":"W2105545710","doi":"10.1158/0008-5472.can-13-3725","title":"A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Repertoire; Cancer; Antigen; Gene; Biology; Lung cancer; Immunology; Cancer research; Computational biology; Medicine; Genetics; Oncology","score_opus":0.05271481639112094,"score_gpt":0.38467694977373795,"score_spread":0.33196213338261704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105545710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78190154,0.21328244,0.0008953371,0.0016536146,0.0010164176,0.0010344385,0.00015824674,0.00002734364,0.00003059183],"genre_scores_gemma":[0.97019315,0.023481427,0.000030307148,0.00014614264,0.00015091375,0.0014260705,0.000028744205,0.00006701666,0.0044762036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965283,0.0009419341,0.00061201834,0.0005391098,0.00023452935,0.001144057],"domain_scores_gemma":[0.9976161,0.0010244114,0.00015823038,0.0006510268,0.00052281603,0.000027412732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027697715,0.0002680116,0.00052661635,0.0004447274,0.00086677104,0.0000681145,0.0008815677,0.00028060446,0.0008130147],"category_scores_gemma":[0.00016219019,0.0002029887,0.00019905213,0.00065897434,0.00097266166,0.00016608325,0.00020059916,0.0007548133,0.000010746853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020558604,0.00011777733,0.0063299392,0.00022030609,0.00044392096,0.0000014594963,0.0024247228,0.00036503165,0.9577167,0.00015541038,0.0009538533,0.029215002],"study_design_scores_gemma":[0.003053695,0.00020394627,0.017663013,0.0005575865,0.00004465093,0.0000133169815,0.0009075929,0.00028152205,0.95467144,0.000048970112,0.02226887,0.00028536608],"about_ca_topic_score_codex":0.017593963,"about_ca_topic_score_gemma":0.0010141297,"teacher_disagreement_score":0.18980102,"about_ca_system_score_codex":0.00034536776,"about_ca_system_score_gemma":0.0007884483,"threshold_uncertainty_score":0.988948},"labels":[],"label_agreement":null},{"id":"W2105559278","doi":"10.1158/0008-5472.can-05-2191","title":"A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Institutes of Health","keywords":"Prostate cancer; Heterocyclic amine; Prostate; Medicine; Red meat; Cancer; Internal medicine; Confidence interval; Prospective cohort study; Mutagen; Carcinogen; Gynecology; Chemistry; Pathology; Biochemistry","score_opus":0.030745454639470288,"score_gpt":0.385382524625625,"score_spread":0.35463706998615474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105559278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991673,0.0069060964,0.0000051526918,0.0001831468,0.000022219436,0.0009043144,0.00010234295,0.0000036174868,0.00020012679],"genre_scores_gemma":[0.99259645,0.0058601424,0.000050378596,0.00002092007,0.00015528296,0.00026520767,0.0000034167733,0.00001604593,0.0010321542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988096,0.0001187616,0.0001314648,0.0004006433,0.0002685344,0.00027101315],"domain_scores_gemma":[0.99937195,0.0000144808255,0.000041722502,0.00022416524,0.00024991826,0.00009777533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003146817,0.000104152496,0.00014807768,0.00006278426,0.00014727403,0.00002827752,0.000084659514,0.000057280835,0.000033258984],"category_scores_gemma":[0.000028131079,0.00008937209,0.000022650556,0.00012803912,0.0001719323,0.000004425421,0.00022682306,0.00016466372,6.8801114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030301206,0.00019338545,0.3810217,0.000043663527,0.00016101361,0.000003427642,0.0023665193,0.00009597992,0.6026537,0.000017174916,0.00047987784,0.012660574],"study_design_scores_gemma":[0.0024036032,0.0015280424,0.31001943,0.00003145151,0.00005256446,0.000005650447,0.0033369293,0.000073393494,0.6751149,0.000046713227,0.007169372,0.00021789956],"about_ca_topic_score_codex":0.0024177746,"about_ca_topic_score_gemma":0.0125297345,"teacher_disagreement_score":0.07246129,"about_ca_system_score_codex":0.000041405296,"about_ca_system_score_gemma":0.00012938457,"threshold_uncertainty_score":0.6991886},"labels":[],"label_agreement":null},{"id":"W2105572099","doi":"10.1158/0008-5472.can-07-0598","title":"The Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human Leukemia Cells in Association with Mcl-1 and cFLIPL Down-regulation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Sorafenib; FADD; Apoptosis; Ectopic expression; Cancer research; Programmed cell death; Caspase 8; Leukemia; Chemistry; Caspase; Pharmacology; Medicine; Immunology; Biochemistry","score_opus":0.020905154878348157,"score_gpt":0.3303280778070381,"score_spread":0.30942292292868995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105572099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984546,0.00065591396,0.00015802955,0.0001924193,0.00006224592,0.00033148256,0.0000059763283,0.000004208235,0.00013514873],"genre_scores_gemma":[0.99820566,0.00030916964,0.00005332748,0.000014523019,0.00017167229,0.00003755919,0.000038740374,0.000013178653,0.0011561926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987027,0.00014916467,0.00019508328,0.00028082743,0.00031114844,0.00036105514],"domain_scores_gemma":[0.99952376,0.000053427422,0.00006266923,0.00016190695,0.00014423468,0.000054026754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022418327,0.000089040645,0.00008849612,0.00009274699,0.00020355183,0.000052765048,0.00008461118,0.0001761705,0.000008347151],"category_scores_gemma":[0.000042000916,0.00006579414,0.000021606944,0.00021221626,0.00008866025,0.000009109676,0.00005472613,0.00021610536,9.866644e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016580244,0.000025912876,0.01595615,0.000017255607,0.000008523449,0.0000029140592,0.00013828113,0.00032585333,0.97699577,0.00012102028,0.000119214696,0.0061233025],"study_design_scores_gemma":[0.0010147312,0.00010318174,0.19501986,0.000031773216,0.0000030974716,7.8917435e-7,0.00019601411,0.00017369259,0.8004669,0.00027045398,0.002619731,0.00009978109],"about_ca_topic_score_codex":0.0012803514,"about_ca_topic_score_gemma":0.010445856,"teacher_disagreement_score":0.17906371,"about_ca_system_score_codex":0.00034274271,"about_ca_system_score_gemma":0.000106590385,"threshold_uncertainty_score":0.58290327},"labels":[],"label_agreement":null},{"id":"W2105616386","doi":"10.1158/0008-5472.can-06-3591","title":"A Common 8q24 Variant in Prostate and Breast Cancer from a Large Nested Case-Control Study","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Prostate cancer; Breast cancer; Medicine; Oncology; Nested case-control study; Internal medicine; Case-control study; Minor allele frequency; Prostate; Confidence interval; Genotype; Gynecology; Cohort; Cancer; Single-nucleotide polymorphism; Allele; Biology; Genetics; Gene","score_opus":0.05620664064524062,"score_gpt":0.43526204054601153,"score_spread":0.3790553999007709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105616386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473763,0.007067726,0.000010429222,0.003018938,0.00011149355,0.003703433,0.001022254,0.000044405184,0.0002837092],"genre_scores_gemma":[0.9962285,0.001052887,0.000015769638,0.00016515255,0.0003030438,0.0009853827,0.000021848566,0.00005419356,0.0011731933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963295,0.0003839744,0.00039489963,0.00068347395,0.0009091842,0.0012989846],"domain_scores_gemma":[0.998148,0.00044632354,0.00004936696,0.00045133356,0.0004079246,0.0004970248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028813842,0.00023591229,0.00052374584,0.00055113767,0.0002774599,0.00008956397,0.00014785871,0.00011030788,0.0006635474],"category_scores_gemma":[0.00005731402,0.00017790981,0.0000486819,0.0011069712,0.00022570582,0.00014756467,0.00017056342,0.0010438995,0.000017383234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008290969,0.0012389751,0.8908111,0.00013064432,0.0003288804,0.057659853,0.005092768,0.00000331626,0.0036148203,0.000022301494,0.00045638287,0.03234999],"study_design_scores_gemma":[0.023324782,0.00079951994,0.9664295,0.00043172267,0.00010629811,0.0009924099,0.005742605,0.0003560056,0.0006322096,0.00010391298,0.00084449595,0.00023656711],"about_ca_topic_score_codex":0.052680217,"about_ca_topic_score_gemma":0.048236713,"teacher_disagreement_score":0.07561837,"about_ca_system_score_codex":0.0009279744,"about_ca_system_score_gemma":0.00074030925,"threshold_uncertainty_score":0.96913046},"labels":[],"label_agreement":null},{"id":"W2105933366","doi":"10.1158/0008-5472.can-05-0922","title":"Epidermal Growth Factor–Induced Signaling in Breast Cancer Cells Results in Selective Target Gene Activation by Orphan Nuclear Receptor Estrogen-Related Receptor α","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Molecular biology; Estrogen-related receptor alpha; Orphan receptor; Hormone response element; Estrogen receptor; Transcription factor; Chromatin immunoprecipitation; Estrogen receptor alpha; Coactivator; Estrogen-related receptor gamma; Cancer research; Nuclear receptor; Cell biology; Promoter; Biochemistry; Gene expression; Gene; Cancer; Genetics","score_opus":0.017562336456012417,"score_gpt":0.3101333991273342,"score_spread":0.29257106267132177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105933366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952877,0.0017609379,0.0000041105063,0.001688982,0.00014123654,0.0006205265,0.0002960321,0.000024013525,0.00017642636],"genre_scores_gemma":[0.9965217,0.0020500321,0.00018167705,0.000089148074,0.00036626135,0.00016329096,0.0002572843,0.00008006846,0.00029054796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968716,0.0005784104,0.00046055863,0.0007961248,0.00041455668,0.0008787382],"domain_scores_gemma":[0.99902934,0.00006768512,0.00012664184,0.00026123566,0.00029633456,0.00021879212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000704559,0.00027563,0.00027748366,0.0002629038,0.0001578612,0.000044839795,0.00031882667,0.00056870916,0.00024694073],"category_scores_gemma":[0.00010750059,0.00027110445,0.00008559852,0.0008355378,0.000109688546,0.000035910223,0.00012377536,0.0010313418,0.000058499692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013456343,0.00017304656,0.0014309114,0.00001875667,0.00009063531,0.0000041821363,0.00040969797,0.000726244,0.98595756,0.000011159708,0.006237334,0.0035948483],"study_design_scores_gemma":[0.002067269,0.00021472081,0.0008786919,0.00010667294,0.0000045300385,0.000003451602,0.00008408589,0.00020654064,0.99260867,0.0000075952944,0.003512199,0.00030560305],"about_ca_topic_score_codex":0.0016089309,"about_ca_topic_score_gemma":0.000063007115,"teacher_disagreement_score":0.0066510905,"about_ca_system_score_codex":0.0006760176,"about_ca_system_score_gemma":0.00044241408,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2106022704","doi":"10.1158/0008-5472.can-05-0088","title":"β-Tubulin Mutations Are Associated with Resistance to 2-Methoxyestradiol in MDA-MB-435 Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"School of Medicine, Indiana University; Breast Cancer Research Foundation","keywords":"2-Methoxyestradiol; Vinblastine; Paclitaxel; Biology; Cancer cell; Cell culture; Metabolite; Cancer research; Internal medicine; Chemistry; Molecular biology; Endocrinology; Cancer; Medicine; Genetics","score_opus":0.047912704531435715,"score_gpt":0.4087379409218306,"score_spread":0.3608252363903949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106022704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907178,0.0016439345,0.00021917559,0.0047273687,0.00010316318,0.00071840925,0.00022819049,0.000018633864,0.0016232707],"genre_scores_gemma":[0.9822785,0.00035093442,0.0010133988,0.00030185087,0.00036586792,0.0015478432,0.00004053986,0.000044931905,0.014056136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998051,0.00025951528,0.00022104384,0.00052117655,0.00038046122,0.00056679104],"domain_scores_gemma":[0.9987986,0.00008543378,0.000069669484,0.00039668893,0.00047353745,0.00017604927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051671104,0.00014951176,0.00016765276,0.00019007691,0.00016386717,0.00005377392,0.00032017622,0.00014590529,0.00027653133],"category_scores_gemma":[0.00035181333,0.00014526499,0.000044053737,0.0007043646,0.00012910074,0.000012079653,0.0000811659,0.00046251432,0.00004841544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003241689,0.00014366793,0.0054116305,0.000026608526,0.000086753935,0.00001901443,0.00032907177,0.005596522,0.9555489,0.000029781066,0.030630583,0.0018533368],"study_design_scores_gemma":[0.00075624906,0.00014995506,0.015707115,0.000354085,0.000010118926,0.0000018189274,0.0003000964,0.000036774563,0.8616231,0.000041269108,0.120731965,0.00028743295],"about_ca_topic_score_codex":0.00071105314,"about_ca_topic_score_gemma":0.048803527,"teacher_disagreement_score":0.093925744,"about_ca_system_score_codex":0.00051501486,"about_ca_system_score_gemma":0.000533254,"threshold_uncertainty_score":0.9685533},"labels":[],"label_agreement":null},{"id":"W2106141944","doi":"10.1158/0008-5472.can-05-1061","title":"Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Tumor necrosis factor alpha; Apoptosis; Programmed cell death; Receptor; Fas ligand; Cell biology; Caspase; Biology; Necroptosis; Fas receptor; Cancer research; Chemistry; Immunology; Biochemistry","score_opus":0.04177600888919953,"score_gpt":0.3143796648450956,"score_spread":0.2726036559558961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106141944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960777,0.0007024344,0.0020640357,0.00015199305,0.0002175238,0.000429013,0.00011985684,0.00001168499,0.00022576466],"genre_scores_gemma":[0.9955222,0.00020555766,0.000732249,0.00005762092,0.0002024648,0.0000747759,0.00008272398,0.000035527606,0.0030868505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983706,0.0001345169,0.00028129888,0.00045430017,0.00039298728,0.00036632866],"domain_scores_gemma":[0.99897563,0.000021823636,0.00009834621,0.00041341645,0.00038658624,0.00010421291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043479368,0.00013840577,0.00015729497,0.00014105243,0.00013157437,0.0000534728,0.00020792565,0.000087329994,0.000030113715],"category_scores_gemma":[0.000033960125,0.0001292766,0.00008695105,0.00023900523,0.00007654868,0.000004260208,0.00012121914,0.000106469,0.000014386228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016603309,0.00003877675,0.0002030977,0.000048047874,0.000014291232,0.000004525754,0.00003578189,0.00036703938,0.9957535,0.0001996372,0.0022379844,0.0009312632],"study_design_scores_gemma":[0.00021141802,0.0001389444,0.009745273,0.000038137194,0.000007736152,0.0000012781294,0.000090329355,0.00009247302,0.97820425,0.00019924282,0.011122866,0.0001480793],"about_ca_topic_score_codex":0.0013891183,"about_ca_topic_score_gemma":0.00031913648,"teacher_disagreement_score":0.017549299,"about_ca_system_score_codex":0.00008376901,"about_ca_system_score_gemma":0.00014936258,"threshold_uncertainty_score":0.52717465},"labels":[],"label_agreement":null},{"id":"W2106245323","doi":"10.1158/0008-5472.can-04-2820","title":"Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"Furin; Proprotein convertase; Proprotein Convertases; Zymogen; Transfection; Biology; Cell growth; Head and neck squamous-cell carcinoma; Cancer research; Cell culture; Cell biology; Endocrinology; Cancer; Biochemistry; Enzyme","score_opus":0.026384806614833896,"score_gpt":0.29175773376584013,"score_spread":0.26537292715100624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106245323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994793,0.003136299,0.000026800137,0.0011004759,0.000017651319,0.0006344068,0.00004284169,0.0000027202605,0.00024581671],"genre_scores_gemma":[0.99792653,0.00020704672,0.0000048171437,0.0000906158,0.00012508269,0.00012711482,0.00009350238,0.000015738156,0.0014095518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990123,0.00012994406,0.000134486,0.00024083556,0.0002504125,0.00023205313],"domain_scores_gemma":[0.99943954,0.0000062494437,0.000041783158,0.0003216921,0.00013608341,0.000054660843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031362785,0.00008976914,0.00008746341,0.000020419073,0.00020399714,0.000018758512,0.00028918587,0.0000825295,0.00004646185],"category_scores_gemma":[0.000010931431,0.00005333227,0.000051622075,0.00009002444,0.00029493522,0.0000038486746,0.00010661594,0.00017461937,0.0000014993838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006341571,0.0000363063,0.013268175,0.00009976755,0.000011411645,0.000001170203,0.00032174902,0.0000010556164,0.9849752,0.000019824432,0.00075442326,0.00044746266],"study_design_scores_gemma":[0.00044373702,0.00013262307,0.0054982495,0.000018835532,0.000007887638,0.0000023552777,0.00012169913,0.0000064525993,0.9852429,0.000026916736,0.008424219,0.00007414679],"about_ca_topic_score_codex":0.0015727384,"about_ca_topic_score_gemma":0.0005547403,"teacher_disagreement_score":0.0077699255,"about_ca_system_score_codex":0.000020327818,"about_ca_system_score_gemma":0.00016571138,"threshold_uncertainty_score":0.23775205},"labels":[],"label_agreement":null},{"id":"W2106369801","doi":"10.1158/0008-5472.can-07-0828","title":"Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Vanderbilt-Ingram Cancer Center; National Institutes of Health; National Cancer Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Kinase; Cyclooxygenase; Cancer research; Peroxisome proliferator-activated receptor; Signal transduction; Receptor; Prostaglandin E2 receptor; In vivo; Ovarian cancer; Pharmacology; Cancer; Biology; Cell biology; Internal medicine; Medicine; Biochemistry; Enzyme","score_opus":0.030610386478227128,"score_gpt":0.3364879631850707,"score_spread":0.30587757670684357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106369801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013203,0.0075747264,0.00020395247,0.00032114575,0.00028010728,0.0010690312,0.00028809236,0.00003958395,0.00009134632],"genre_scores_gemma":[0.99648416,0.00068860326,0.0005268953,0.00010990649,0.00074022886,0.00037056478,0.00011862539,0.00014118568,0.00081985793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99499834,0.00051541,0.00088410417,0.0011145117,0.0009949743,0.0014926617],"domain_scores_gemma":[0.99763596,0.000085550535,0.00024195235,0.0006870661,0.0008995434,0.00044993492],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024916285,0.0004693549,0.00056959136,0.0006464065,0.00022525236,0.000058490612,0.0006812095,0.00070062984,0.0017004154],"category_scores_gemma":[0.00020779842,0.000462399,0.0001815166,0.0016999607,0.00044215217,0.000035405028,0.00025369786,0.0009730209,0.000023510584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020781076,0.00033138215,0.010815464,0.00013282985,0.00021775694,0.000029600526,0.00050413917,0.00061722327,0.9820636,0.00002878004,0.0009658761,0.0022152518],"study_design_scores_gemma":[0.0018856919,0.0003352035,0.00057514996,0.00022937893,0.0000114830955,0.0000038395247,0.0002541793,0.000081798375,0.98099923,0.000054870856,0.015070563,0.00049860385],"about_ca_topic_score_codex":0.0012568227,"about_ca_topic_score_gemma":0.00018384749,"teacher_disagreement_score":0.014104688,"about_ca_system_score_codex":0.0004649657,"about_ca_system_score_gemma":0.0011769037,"threshold_uncertainty_score":0.9997828},"labels":[],"label_agreement":null},{"id":"W2106489800","doi":"10.1158/0008-5472.can-09-0625","title":"Modification of Ovarian Cancer Risk by <i>BRCA1/2</i> -Interacting Genes in a Multicenter Cohort of <i>BRCA1/2</i> Mutation Carriers","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; University of California, Los Angeles; Medical Research Council; Universität Wien; Creighton University; Jonsson Comprehensive Cancer Center; Women's College Hospital; Nebraska Department of Health and Human Services; National Health and Medical Research Council; Georgetown University; Northwestern University; National Breast Cancer Foundation; City of Hope; National Center for Research Resources; University of Pennsylvania; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Haplotype; Ovarian cancer; RAD51; Oncology; Genetics; Cancer; Internal medicine; Medicine; BRCA2 Protein; Mutation; Genotype; Biology; Gene; DNA repair; Germline mutation","score_opus":0.031420129461801595,"score_gpt":0.3849872172255892,"score_spread":0.3535670877637876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106489800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148506,0.0058547766,0.0007203645,0.00041449408,0.0001890402,0.0005904096,0.00024270681,0.000006842044,0.0004962931],"genre_scores_gemma":[0.99503446,0.0036898325,0.00045172306,0.000072835704,0.00013834542,0.00029841458,0.000114372335,0.000026242695,0.00017375342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979354,0.0002779044,0.0004797531,0.0004935284,0.00044200712,0.00037136677],"domain_scores_gemma":[0.9985078,0.000064899024,0.00026659245,0.00044321507,0.0006380563,0.00007943442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086479314,0.00014876011,0.00022414983,0.00019213055,0.000085328305,0.000019557629,0.0003145398,0.00015799572,0.000057831217],"category_scores_gemma":[0.00024673104,0.00015736533,0.00007485885,0.0005257372,0.00017633836,0.000018625242,0.000060066093,0.0002793447,0.0000017457216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003207932,0.000104859355,0.045279905,0.000050957897,0.00008868775,0.0000012421821,0.0006990373,0.0051467507,0.91787195,0.00001725303,0.002094473,0.028324105],"study_design_scores_gemma":[0.0012009281,0.00015886003,0.023163885,0.00009970839,0.000028309982,0.000001464348,0.0005606377,0.0013098151,0.9693746,0.00006710007,0.0038642527,0.00017042478],"about_ca_topic_score_codex":0.0042189066,"about_ca_topic_score_gemma":0.0008178368,"teacher_disagreement_score":0.05150268,"about_ca_system_score_codex":0.00037362758,"about_ca_system_score_gemma":0.00054596266,"threshold_uncertainty_score":0.64171714},"labels":[],"label_agreement":null},{"id":"W2106671241","doi":"10.1158/0008-5472.can-12-0103","title":"MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fred Hutchinson Cancer Research Center; Howard Hughes Medical Institute","keywords":"RAD51; Cisplatin; DNA damage; DNA repair; PARP inhibitor; Cancer research; Homologous recombination; Poly ADP ribose polymerase; Molecular biology; Biology; DNA; Genome instability; Cancer cell; Cancer; Chemistry; Polymerase; Genetics; Chemotherapy","score_opus":0.03314217075410196,"score_gpt":0.3418350767209125,"score_spread":0.30869290596681054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106671241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694395,0.00095625926,0.00028449934,0.0010334667,0.000055924535,0.00054029864,0.000020714351,0.000011323801,0.00015354824],"genre_scores_gemma":[0.99739456,0.00008892876,0.0012302917,0.00016683292,0.0002638342,0.00009960669,0.000020574733,0.00002212972,0.00071326597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869365,0.00016809655,0.000100769066,0.00036247357,0.00021839225,0.0004565966],"domain_scores_gemma":[0.9992472,0.000018129153,0.00001726636,0.00026022378,0.00012347773,0.0003337058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011253483,0.00010961573,0.00011482461,0.00007365034,0.00011683778,0.000039213763,0.00004599946,0.00010933595,0.000018007579],"category_scores_gemma":[0.00014112258,0.000105575455,0.000020144853,0.00015068376,0.00006897661,0.00000856605,0.000317234,0.00011841435,0.000017499262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009145947,0.000021445914,0.00080451317,0.000039132487,0.000011462208,0.000005741304,0.00022556572,0.0000024610886,0.991427,0.00007244469,0.0016404057,0.0056583905],"study_design_scores_gemma":[0.00019985592,0.0002319222,0.00311247,0.00004936681,0.000004843653,0.000014481396,0.000053089574,0.000018388027,0.9760216,0.00008022296,0.020078102,0.00013569012],"about_ca_topic_score_codex":0.00009362758,"about_ca_topic_score_gemma":0.00008614682,"teacher_disagreement_score":0.018437697,"about_ca_system_score_codex":0.00003808895,"about_ca_system_score_gemma":0.000041790925,"threshold_uncertainty_score":0.4305242},"labels":[],"label_agreement":null},{"id":"W2106693434","doi":"10.1158/0008-5472.can-10-2958","title":"Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; York University","keywords":"Biology; Melanoma; Gene; DNA microarray; Gene expression profiling; Epigenetics; Gene expression; Genetics; Computational biology; Cancer research; Microarray; Tumor progression","score_opus":0.11641375932717822,"score_gpt":0.39053884997294436,"score_spread":0.2741250906457661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106693434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565096,0.005762026,0.004153941,0.0004291481,0.00012066334,0.00045909322,0.000112805756,0.0000050613257,0.0033062848],"genre_scores_gemma":[0.99307185,0.0052917283,0.0007574339,0.00006056216,0.00012582459,0.00023563278,0.000034333418,0.000023974208,0.00039866034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989986,0.0000882268,0.00016083207,0.00026857422,0.00022423937,0.00025955128],"domain_scores_gemma":[0.9990316,0.000030172705,0.00006449144,0.0004461884,0.0003604365,0.00006707897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037498897,0.00010897532,0.00011391788,0.000057140955,0.0001507495,0.000023958011,0.00037389953,0.00009356876,0.00003365019],"category_scores_gemma":[0.000090213434,0.000076572665,0.00007476074,0.0000940119,0.0003008576,0.000005036234,0.00027161842,0.00018958269,0.0000047636927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017492354,0.00010783868,0.00024634993,0.000032948778,0.00009148538,0.0000034230889,0.002543155,0.0008876951,0.98770046,0.0035849526,0.0018219766,0.0028048048],"study_design_scores_gemma":[0.00020847264,0.00023524369,0.00008585636,0.0000338987,0.000012768526,0.0000010976767,0.00055850076,0.0019049956,0.992132,0.001990178,0.002733296,0.00010368628],"about_ca_topic_score_codex":0.00017739597,"about_ca_topic_score_gemma":0.0003881999,"teacher_disagreement_score":0.0074208737,"about_ca_system_score_codex":0.00004425157,"about_ca_system_score_gemma":0.00036286435,"threshold_uncertainty_score":0.31225425},"labels":[],"label_agreement":null},{"id":"W2106769277","doi":"10.1158/0008-5472.can-08-4540","title":"Differential Response of Glioma Cells to FOXO1-Directed Therapy","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"FOXO1; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; PTEN; Glioma; Biology; Phosphorylation; Programmed cell death; Signal transduction; Cell biology; Apoptosis; Biochemistry","score_opus":0.05191442848415234,"score_gpt":0.3838924650050119,"score_spread":0.33197803652085955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106769277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834317,0.00035652463,0.00022417301,0.00054631097,0.00010419151,0.0002941152,0.000029079172,0.000015724347,0.00008672018],"genre_scores_gemma":[0.99878424,0.00012616957,0.00008847428,0.000055881465,0.00011755314,0.00002805994,0.00002009119,0.000012294981,0.00076722837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881524,0.00024783344,0.0001348373,0.0002461132,0.0003121222,0.00024387092],"domain_scores_gemma":[0.99928945,0.000018279083,0.000022171465,0.00029787043,0.0002761305,0.00009607468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273485,0.000080568745,0.000097134995,0.00014780987,0.000053603744,0.000016862852,0.00019060793,0.00009212475,0.00020186191],"category_scores_gemma":[0.00004528145,0.00007451132,0.000055373293,0.00029773085,0.00006475361,0.0000027542674,0.000022269362,0.00008393822,0.000011195071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004135457,0.00006087813,0.00010452248,0.0000041523313,0.00001562681,0.0000011117892,0.00009409098,0.000033563778,0.98672545,0.00001493213,0.0039321003,0.004878139],"study_design_scores_gemma":[0.0005600096,0.00072971464,0.034399696,0.0000114687755,0.0000013973219,6.204794e-7,0.000012595115,0.000009755449,0.95174855,0.000027181435,0.012423617,0.00007538211],"about_ca_topic_score_codex":0.00004555439,"about_ca_topic_score_gemma":0.000015915457,"teacher_disagreement_score":0.034976862,"about_ca_system_score_codex":0.000033384797,"about_ca_system_score_gemma":0.000110950095,"threshold_uncertainty_score":0.30384836},"labels":[],"label_agreement":null},{"id":"W2106771830","doi":"10.1158/0008-5472.can-05-0425","title":"Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Protein kinase B; Cytochrome c; Apoptosis; Cancer research; Cisplatin; Mitochondrion; Caspase; Biology; XIAP; Cancer cell; Intrinsic apoptosis; Cell biology; Programmed cell death; Chemistry; Cancer; Biochemistry; Chemotherapy; Genetics","score_opus":0.043803605035775246,"score_gpt":0.34629401099432155,"score_spread":0.3024904059585463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106771830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963924,0.00089615467,0.0007240198,0.00023534437,0.00035194744,0.00047156526,0.00008486608,0.000008164849,0.0008355358],"genre_scores_gemma":[0.99578005,0.0003845198,0.0001695444,0.0000136865465,0.0006793951,0.00017872434,0.00022154668,0.00002671503,0.002545841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833894,0.00016685318,0.00028133084,0.00041516658,0.00047732398,0.00032039805],"domain_scores_gemma":[0.99929625,0.000031732165,0.00010188191,0.00029272505,0.0002229236,0.000054505796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034987438,0.00012550908,0.00014869987,0.00018066682,0.00009595932,0.00002020197,0.00012830133,0.00021984169,0.000072068375],"category_scores_gemma":[0.000050304363,0.00012060061,0.000050477858,0.00027481443,0.000048978745,0.000008100619,0.000045242312,0.0001970112,0.0000042943975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007194109,0.00007807474,0.0010564807,0.000041595227,0.0000118842245,0.0000057628654,0.000034280598,0.0054406887,0.98912764,0.00077556266,0.0006418484,0.002066765],"study_design_scores_gemma":[0.0015229165,0.00018007564,0.02926431,0.000103391,0.0000053163108,8.51568e-7,0.00003168218,0.00053787953,0.96278733,0.00089122384,0.0045052655,0.00016973095],"about_ca_topic_score_codex":0.004694452,"about_ca_topic_score_gemma":0.020485101,"teacher_disagreement_score":0.02820783,"about_ca_system_score_codex":0.00020955119,"about_ca_system_score_gemma":0.00025190847,"threshold_uncertainty_score":0.9973885},"labels":[],"label_agreement":null},{"id":"W2106980930","doi":"10.1158/0008-5472.can-05-3810","title":"Inhibition of Cyclooxygenase-2 Disrupts Tumor Vascular Mural Cell Recruitment and Survival Signaling","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Mural cell; Angiogenesis; Vascular endothelial growth inhibitor; Cancer research; Vascular endothelial growth factor; Endothelial stem cell; Biology; Neovascularization; Endothelium; Cyclooxygenase; Vascular endothelial growth factor A; Endocrinology; Cell biology; Enzyme; Biochemistry","score_opus":0.06712685829914344,"score_gpt":0.37050319373097845,"score_spread":0.303376335431835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106980930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493515,0.0031106018,0.000015819218,0.0001064979,0.00012906965,0.0008327913,0.000012566805,0.000019189496,0.000838284],"genre_scores_gemma":[0.9987821,0.00015848689,0.000060534916,0.000023125138,0.00048651636,0.00019596983,0.000018001567,0.000023289029,0.00025194944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983131,0.00018548522,0.00022048553,0.00023939334,0.0006711967,0.00037029813],"domain_scores_gemma":[0.9992788,0.00012419099,0.000047374742,0.00018873363,0.00021687089,0.00014402847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011758694,0.0001064048,0.00024796167,0.00015736121,0.00009935946,0.000014456954,0.00004083374,0.000056316432,0.00011809146],"category_scores_gemma":[0.000046440004,0.00008788933,0.00006517659,0.00023174987,0.00015489066,0.000051860578,0.000049032755,0.00026445952,0.000012147863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025434978,0.00012821669,0.018607501,0.0009400269,0.00003074172,0.00019236695,0.00025796337,0.00004404007,0.976754,0.00013934971,0.00093641813,0.0017149876],"study_design_scores_gemma":[0.0023629942,0.0003452209,0.028656164,0.00039276222,0.000046711895,0.00000707903,0.00023290871,0.00017069715,0.96466064,0.00014810545,0.0028417187,0.00013499954],"about_ca_topic_score_codex":0.0009615948,"about_ca_topic_score_gemma":0.00007316882,"teacher_disagreement_score":0.012093399,"about_ca_system_score_codex":0.00014762774,"about_ca_system_score_gemma":0.00018145442,"threshold_uncertainty_score":0.35840228},"labels":[],"label_agreement":null},{"id":"W2107089643","doi":"10.1158/0008-5472.can-13-3415","title":"Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"PTEN; Biology; Cancer research; PI3K/AKT/mTOR pathway; Cell biology; Tensin; Protein kinase B; Carcinogenesis; Tumor suppressor gene; Cancer; Signal transduction; Genetics","score_opus":0.020981822959535962,"score_gpt":0.2893642031662838,"score_spread":0.2683823802067479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975687,0.00079597055,0.00026782765,0.00070839457,0.000022951648,0.0003242124,0.00012109854,0.000006332405,0.0001844715],"genre_scores_gemma":[0.99825394,0.00008194487,0.000042410495,0.00009562515,0.0000932057,0.00009888382,0.000016165837,0.000019334091,0.0012984939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874884,0.00027857072,0.00011203261,0.0002830372,0.00031270407,0.0002647902],"domain_scores_gemma":[0.9991733,0.000015429707,0.000060797676,0.00027494904,0.0004039177,0.00007163983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005945804,0.000096041775,0.00011515124,0.00003346073,0.00017203767,0.000029530269,0.0002130123,0.00010852955,0.000031662454],"category_scores_gemma":[0.00007128796,0.00006598909,0.00003002731,0.00024040585,0.00018668361,0.0000050825906,0.00011421842,0.00014687375,6.3384226e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006915172,0.000047941776,0.01691459,0.00008164894,0.000027824364,4.716477e-7,0.000088345274,0.000013437284,0.98167074,0.000021260892,0.00019754945,0.0008670232],"study_design_scores_gemma":[0.00038723391,0.00014656388,0.009293541,0.00014469007,0.000009560585,0.000001445268,0.000021334768,0.0002473166,0.98869526,0.000092004215,0.0008614099,0.00009961439],"about_ca_topic_score_codex":0.0014529595,"about_ca_topic_score_gemma":0.0004665467,"teacher_disagreement_score":0.0076210494,"about_ca_system_score_codex":0.00003537002,"about_ca_system_score_gemma":0.00039539533,"threshold_uncertainty_score":0.2690957},"labels":[],"label_agreement":null},{"id":"W2107275684","doi":"10.1158/0008-5472.can-04-3137","title":"Effects of the Mammalian Target of Rapamycin Inhibitor CCI-779 Used Alone or with Chemotherapy on Human Prostate Cancer Cells and Xenografts","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"DU145; PTEN; Cancer research; Clonogenic assay; Mitoxantrone; Protein kinase B; LNCaP; PI3K/AKT/mTOR pathway; Chemotherapy; Docetaxel; Cell growth; Prostate cancer; Cell culture; Medicine; Cancer; Biology; Apoptosis; Internal medicine","score_opus":0.02592769367430632,"score_gpt":0.35281381930220784,"score_spread":0.32688612562790154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107275684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958174,0.0023457701,0.0000059860477,0.0007131237,0.000105393585,0.0008728297,0.00006113908,0.0000063778,0.00007195912],"genre_scores_gemma":[0.996105,0.00080970075,0.00015432315,0.00021603431,0.00047630892,0.00029056714,0.0000065910745,0.00005448093,0.0018869657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820906,0.00018982022,0.00023410529,0.00042253287,0.0005202947,0.00042416248],"domain_scores_gemma":[0.999019,0.000058965386,0.00013601371,0.00043439606,0.00024945653,0.00010212837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000410426,0.00018816131,0.00025844862,0.00008105794,0.000121431956,0.000019481597,0.00032456222,0.00012886459,0.00009821868],"category_scores_gemma":[0.000028141207,0.00011922559,0.000058120335,0.00030242294,0.00050371524,0.0000065971026,0.00010248251,0.00025524112,0.0000013497947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013340566,0.000115515664,0.0045608496,0.00030823244,0.00009899342,0.0000024661044,0.0004202235,0.00021730435,0.9869306,0.000005119436,0.003914424,0.0020922304],"study_design_scores_gemma":[0.0024137294,0.0010656255,0.002959552,0.00031623192,0.000013523741,0.0000010727935,0.00003421395,0.0000055093933,0.97507167,0.000008598413,0.017957795,0.0001524557],"about_ca_topic_score_codex":0.00037714126,"about_ca_topic_score_gemma":0.0006946521,"teacher_disagreement_score":0.014043371,"about_ca_system_score_codex":0.00009343721,"about_ca_system_score_gemma":0.00040229084,"threshold_uncertainty_score":0.48618785},"labels":[],"label_agreement":null},{"id":"W2107398189","doi":"10.1158/0008-5472.can-05-2203","title":"Cyclin D1 Is Transcriptionally Regulated by and Required for Transformation by Activated Signal Transducer and Activator of Transcription 3","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Breast Cancer Alliance","keywords":"Cyclin D1; Cyclin D; Cancer research; Cyclin A2; Cyclin-dependent kinase complex; Cyclin-dependent kinase; Biology; Cyclin A; Cyclin B; Molecular biology; Cyclin E; Cell biology; Cell cycle; Cancer; Genetics","score_opus":0.039713829359555045,"score_gpt":0.34034237392762295,"score_spread":0.3006285445680679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107398189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138833,0.004721647,0.0053859106,0.0053690313,0.00006382172,0.0017615063,0.0010423531,0.000047819685,0.00021955349],"genre_scores_gemma":[0.9968707,0.0011246462,0.00013612174,0.00010014538,0.000069117246,0.00029732776,0.0004861288,0.000055664645,0.0008601618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979136,0.0001090494,0.00045408125,0.0004367781,0.0006551905,0.00043131833],"domain_scores_gemma":[0.9991259,0.000079297126,0.00006895867,0.00016518729,0.00039114495,0.00016951848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051046495,0.00019920262,0.00036421925,0.00023755852,0.00015267279,0.000030184705,0.0000752464,0.0002859741,0.00022105116],"category_scores_gemma":[0.000014479572,0.00019586697,0.000105821375,0.00043893856,0.00031632633,0.00027684672,0.0000043748964,0.0003697212,7.217829e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031903693,0.00015840106,0.00002785064,0.0005145808,0.00011626806,0.0000012629786,0.0010022868,0.00000849889,0.9697389,0.00009843264,0.015554495,0.009588636],"study_design_scores_gemma":[0.006563876,0.00058630784,0.00066716445,0.00028937493,0.00010740979,0.000012987051,0.00013228979,0.0004639019,0.96539676,0.00035056166,0.025250884,0.00017845137],"about_ca_topic_score_codex":0.0008766477,"about_ca_topic_score_gemma":0.00006381786,"teacher_disagreement_score":0.01548233,"about_ca_system_score_codex":0.00023284428,"about_ca_system_score_gemma":0.00024450192,"threshold_uncertainty_score":0.7987223},"labels":[],"label_agreement":null},{"id":"W2107400826","doi":"10.1158/0008-5472.can-11-2126","title":"Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Neoplastic transformation; Carcinogenesis; MAPK/ERK pathway; Nuclear localization sequence; Cell biology; Biology; Phosphorylation; Cancer research; Nuclear export signal; Signal transduction; Kinase; Subcellular localization; Malignant transformation; Cancer; Cell growth; Cell nucleus; Nucleus; Genetics; Cytoplasm; Gene","score_opus":0.04321457610070474,"score_gpt":0.3559262528742646,"score_spread":0.3127116767735599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107400826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955139,0.00082615664,0.001740135,0.00069816347,0.00011875811,0.0004069183,0.000047688438,0.000014306406,0.00063393917],"genre_scores_gemma":[0.9983667,0.00014073883,0.00011553493,0.00027307743,0.0002443329,0.000084082974,0.00005198921,0.000025850695,0.00069768366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998811,0.00009047776,0.0001485323,0.00023060922,0.00025071783,0.00046864856],"domain_scores_gemma":[0.9993659,0.00002371331,0.000018175448,0.00017416294,0.000093168215,0.00032486403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041473904,0.00010922069,0.00012401817,0.000107860156,0.00016523658,0.000048884172,0.00011375424,0.00010270773,0.00010016916],"category_scores_gemma":[0.0000702307,0.0001036012,0.000025575024,0.00018390376,0.000049153452,0.000018244778,0.000069193935,0.00010463872,0.00008773727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019254898,0.000020598638,0.00057622994,0.000041235297,0.000018139268,3.8196316e-7,0.0009645827,0.00003954432,0.98343796,0.00018488127,0.010538672,0.003985224],"study_design_scores_gemma":[0.00078486453,0.0004925583,0.0045895698,0.000055289354,0.00001520728,0.000010545596,0.0003879279,0.00006288113,0.6531685,0.000025053007,0.34012303,0.00028456855],"about_ca_topic_score_codex":0.00021808491,"about_ca_topic_score_gemma":0.00012498832,"teacher_disagreement_score":0.33026946,"about_ca_system_score_codex":0.000055179982,"about_ca_system_score_gemma":0.000048928407,"threshold_uncertainty_score":0.42247343},"labels":[],"label_agreement":null},{"id":"W2107529783","doi":"10.1158/0008-5472.can-09-4072","title":"The Antidepressant Sertraline Inhibits Translation Initiation by Curtailing Mammalian Target of Rapamycin Signaling","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Sertraline; PI3K/AKT/mTOR pathway; Tensin; Pharmacology; Cancer research; Antidepressant; Phosphorylation; Phosphatase; Chemistry; mTORC1; Signal transduction; Cell biology; PTEN; Biology; Endocrinology","score_opus":0.043224255030609324,"score_gpt":0.37190171893703167,"score_spread":0.32867746390642233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107529783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930909,0.00445563,0.0008518765,0.0006230155,0.00030406547,0.00031371354,0.00008986253,0.00001084856,0.00026003303],"genre_scores_gemma":[0.9979525,0.00060261454,0.00043067205,0.00004635403,0.00048617568,0.00009505912,0.00012997662,0.000034833804,0.00022177621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982337,0.00019698027,0.00032357793,0.00035017828,0.0004754505,0.0004201567],"domain_scores_gemma":[0.99885845,0.00011957158,0.000106704545,0.00037023184,0.00045674536,0.00008830967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015580392,0.0001293045,0.000131965,0.00006637317,0.00026673343,0.000052295498,0.0003434695,0.00018671395,0.00009073176],"category_scores_gemma":[0.00019420986,0.00010656289,0.000071749586,0.00025698123,0.00025247614,0.000012806577,0.000057268673,0.00047860513,0.0000033412903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016532362,0.000023516901,0.003047764,0.000037649384,0.000029657858,6.8085376e-7,0.00010784525,0.0003436796,0.99105954,0.00003536291,0.001993009,0.0031559628],"study_design_scores_gemma":[0.00044023854,0.00010766272,0.00018998802,0.000038257607,0.0000069908633,0.0000015350115,0.000061195686,0.0002403937,0.9686877,0.00013608835,0.029967124,0.0001228],"about_ca_topic_score_codex":0.00014992784,"about_ca_topic_score_gemma":0.00022971805,"teacher_disagreement_score":0.027974116,"about_ca_system_score_codex":0.000025091193,"about_ca_system_score_gemma":0.00027200097,"threshold_uncertainty_score":0.43455085},"labels":[],"label_agreement":null},{"id":"W2107561601","doi":"10.1158/0008-5472.can-08-0295","title":"Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast Cancer<i>In vivo</i>","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Endostatin; Angiogenesis; Matrix metalloproteinase; In vivo; Breast cancer; Tamoxifen; Cancer; Vascular endothelial growth factor; Cancer research; Medicine; Tumor progression; Angiogenesis inhibitor; Neovascularization; Internal medicine; Biology; VEGF receptors","score_opus":0.03835151330073712,"score_gpt":0.34873140794676377,"score_spread":0.31037989464602667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107561601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922757,0.0065744943,0.000026169866,0.00014682124,0.00008092193,0.00038711162,0.00029519622,0.0000037266711,0.00020983779],"genre_scores_gemma":[0.99631953,0.002649426,0.000080534366,0.000021643684,0.00022069203,0.00022818425,0.000007908322,0.000022544567,0.00044955162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985163,0.00014508923,0.0002685887,0.00031742867,0.00042231233,0.00033028028],"domain_scores_gemma":[0.9992769,0.000009510108,0.000046210786,0.00030876778,0.00027118425,0.00008746682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004072969,0.00012567523,0.00024096295,0.00013349073,0.00006340108,0.0000036259069,0.00026939623,0.000118337346,0.0002318536],"category_scores_gemma":[0.000023739818,0.000101151585,0.00009045625,0.00030785598,0.00020273791,0.0000077837885,0.0000902033,0.00018993054,0.0000014612199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005354817,0.00008866205,0.00029578435,0.000102089885,0.000028607252,0.000017846307,0.00006306521,0.000020909585,0.9977191,0.000036485566,0.0005784063,0.00051354675],"study_design_scores_gemma":[0.00060532195,0.00020378525,0.0004249139,0.00016963163,0.0000056810486,0.000019601253,0.000038621118,0.000004683508,0.99759597,0.000071378374,0.00075401133,0.000106381034],"about_ca_topic_score_codex":0.0015437782,"about_ca_topic_score_gemma":0.00014236364,"teacher_disagreement_score":0.0040437947,"about_ca_system_score_codex":0.000039327602,"about_ca_system_score_gemma":0.00050009496,"threshold_uncertainty_score":0.4124842},"labels":[],"label_agreement":null},{"id":"W2107578540","doi":"10.1158/0008-5472.can-10-1907","title":"Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; NIH Office of the Director; Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa; Norris Cotton Cancer Center; University of California, Irvine; National Institutes of Health; Istituto Oncologico Veneto; Fox Chase Cancer Center; Alleanza Contro il Cancro; Uppsala Universitet; Fondazione Italiana per la Ricerca sul Cancro; Università degli Studi di Torino; Radboud Universitair Medisch Centrum; lékařská fakulta Univerzity Karlovy; Leids Universitair Medisch Centrum; Associazione Italiana per la Ricerca sul Cancro; Ministerio de Ciencia e Innovación; Cancer Research UK; KWF Kankerbestrijding; University of Pennsylvania; Universiteit Gent; Israel Cancer Association; Lunds Universitet; Vlaamse regering; Sahlgrenska Universitetssjukhuset; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Mayo Clinic; Grantová Agentura České Republiky; Institut National de la Santé et de la Recherche Médicale; Universitair Medisch Centrum Groningen; Royal Marsden NHS Foundation Trust; Huntsman Cancer Institute; Universiteit Leiden; Centre National de la Recherche Scientifique; Deutsches Krebsforschungszentrum; Univerzita Karlova v Praze; Radboud Universiteit; Ohio State University; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Ministero della Salute; Akademiska Sjukhuset; Cancer Care Ontario; Vlaamse Liga Tegen Kanker; Breast Cancer Research Foundation","keywords":"Breast cancer; Single-nucleotide polymorphism; Genotype; Allele; Cancer; Oncology; Medicine; Genetics; Internal medicine; Biology; Gene","score_opus":0.02224373511308771,"score_gpt":0.3622945977655861,"score_spread":0.3400508626524984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107578540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636357,0.004328901,0.0011724661,0.0050288085,0.00027398867,0.0020168158,0.023501221,0.000013305819,0.000028783508],"genre_scores_gemma":[0.9833089,0.009836201,0.0003901869,0.00008795502,0.00068986753,0.005400771,0.00016376706,0.00004160973,0.00008074692],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826896,0.00022321154,0.00033067417,0.00059972383,0.0002042381,0.0003731775],"domain_scores_gemma":[0.9976065,0.0003236239,0.00022182301,0.0005577645,0.0011663421,0.00012391307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015791289,0.0001741206,0.00023209347,0.000070266644,0.00064588094,0.000061266706,0.00025983338,0.00020825214,0.000028068132],"category_scores_gemma":[0.00021586381,0.00013714368,0.00010098835,0.00021125657,0.0012144735,0.000020562919,0.00012642307,0.0003565811,1.7510068e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032313713,0.00010094252,0.33912706,0.00035219017,0.0006820414,8.415075e-8,0.0012299408,0.00092421845,0.5272189,0.0006744753,0.01411935,0.11233944],"study_design_scores_gemma":[0.01023044,0.00038094926,0.83750695,0.00010040888,0.0006259713,0.000052389154,0.0014174706,0.0027446758,0.11364445,0.007994753,0.024744725,0.0005567932],"about_ca_topic_score_codex":0.0061661303,"about_ca_topic_score_gemma":0.025932865,"teacher_disagreement_score":0.49837992,"about_ca_system_score_codex":0.00014725131,"about_ca_system_score_gemma":0.0006998233,"threshold_uncertainty_score":0.9918413},"labels":[],"label_agreement":null},{"id":"W2107653037","doi":"10.1158/0008-5472.can-10-1584","title":"Novel Matrix Metalloproteinase Inhibitor [18F]Marimastat-Aryltrifluoroborate as a Probe for <i>In vivo</i> Positron Emission Tomography Imaging in Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; TRIUMF; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Matrix metalloproteinase; In vivo; Matrix metalloproteinase inhibitor; Cancer; Positron emission tomography; Pathology; Metalloproteinase; Cancer research; Chemistry; Medicine; Nuclear medicine; Internal medicine; Biochemistry; Biology","score_opus":0.021137818375755187,"score_gpt":0.3594636108010529,"score_spread":0.3383257924252977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107653037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988974,0.004513438,0.0011198308,0.0010599727,0.00040205766,0.0024858129,0.00021162587,0.000020852603,0.00029664396],"genre_scores_gemma":[0.990351,0.00038139868,0.0030166467,0.00022030085,0.0006433783,0.0038477306,0.000059325044,0.000079346275,0.0014008292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756485,0.000096891614,0.00033398118,0.00075594144,0.00039490676,0.0008534445],"domain_scores_gemma":[0.9989179,0.000025109977,0.0000788234,0.00042553872,0.0003364316,0.00021623925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011481519,0.00024398365,0.00023898562,0.0004546446,0.00014659666,0.00008076559,0.0003647215,0.00019260221,0.00010505494],"category_scores_gemma":[0.00015501441,0.00023112718,0.00012528336,0.00072255556,0.00012402171,0.000029496454,0.00022809248,0.0006152024,0.0000033611732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007546722,0.00019623128,0.0010048031,0.0001078133,0.000015594098,0.000016245482,0.000052475785,0.000011239984,0.99323416,0.00021468698,0.0017965673,0.002595532],"study_design_scores_gemma":[0.0018619833,0.00025264034,0.000053402295,0.00016344426,0.000008032047,0.0000073504616,0.000051375377,0.000103202205,0.97054327,0.0006342209,0.026042782,0.00027829432],"about_ca_topic_score_codex":0.0032655075,"about_ca_topic_score_gemma":0.002021166,"teacher_disagreement_score":0.024246214,"about_ca_system_score_codex":0.000102076534,"about_ca_system_score_gemma":0.00077927293,"threshold_uncertainty_score":0.9425093},"labels":[],"label_agreement":null},{"id":"W2107880288","doi":"10.1158/0008-5472.can-08-0786","title":"Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Glioma; Cancer stem cell; Biology; Carcinogenesis; Cancer research; Stem cell; Population; Cancer; Cancer cell; Cell sorting; Side population; Immunology; Flow cytometry; Cell biology; Genetics; Medicine","score_opus":0.17522802655427003,"score_gpt":0.4041754007980124,"score_spread":0.22894737424374237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107880288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948711,0.0029752029,0.000019566321,0.00081148266,0.0000745758,0.000816222,0.00009956183,0.000009579057,0.00032271974],"genre_scores_gemma":[0.9930879,0.003966685,0.00007004862,0.00014412818,0.0001069866,0.00035885497,0.0000046582772,0.000028674349,0.0022321048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770975,0.0002159372,0.00037372642,0.00032918164,0.00088511844,0.0004863055],"domain_scores_gemma":[0.99904084,0.00011608157,0.000090333975,0.00043361608,0.00021670319,0.00010244467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086368714,0.00013271422,0.00037780954,0.0004599306,0.00006621634,0.000010600591,0.00022243628,0.00009478199,0.00009229347],"category_scores_gemma":[0.000019828469,0.00009861616,0.00008026683,0.0011268413,0.0001530185,0.00007718034,0.000060453483,0.0005180806,0.0000071093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059468445,0.00026082658,0.020508809,0.00036382533,0.000024916155,0.00010393721,0.0042615086,0.013371665,0.9543691,0.000041219908,0.0020330972,0.0040663695],"study_design_scores_gemma":[0.0034627418,0.00014498501,0.020142702,0.0003461306,0.000029173987,0.000007274952,0.0018478077,0.0041702753,0.9684182,0.00010889564,0.0011019388,0.00021988082],"about_ca_topic_score_codex":0.025968427,"about_ca_topic_score_gemma":0.011976832,"teacher_disagreement_score":0.01404905,"about_ca_system_score_codex":0.0006114374,"about_ca_system_score_gemma":0.0005270039,"threshold_uncertainty_score":0.98051775},"labels":[],"label_agreement":null},{"id":"W2107885941","doi":"10.1158/0008-5472.can-08-2520","title":"IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor–Initiated Apoptosis via Repression of FLICE-like Protein Expression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"IRF8; Apoptosis; Biology; Cancer research; Cell biology; Transcription factor; Gene; Biochemistry","score_opus":0.046316899745770225,"score_gpt":0.3548585755600838,"score_spread":0.3085416758143136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107885941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949765,0.00075380603,0.0026650869,0.00026087745,0.00017414925,0.00087582815,0.000040914994,0.00002589722,0.00022694256],"genre_scores_gemma":[0.99380785,0.00020232784,0.0018504703,0.00007020024,0.00031050234,0.000078327525,0.00008625767,0.000035034864,0.0035590183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779963,0.00026303992,0.00030481143,0.0006076827,0.0005694091,0.000455443],"domain_scores_gemma":[0.9985601,0.000020433807,0.00009996676,0.00065214856,0.00044095836,0.00022642822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004117223,0.0001936701,0.00022990437,0.0001606731,0.00018417853,0.000027894994,0.00024762918,0.00030225614,0.0001896458],"category_scores_gemma":[0.00005488785,0.00016828484,0.00007881658,0.00025318377,0.00006428719,0.0000107458845,0.00017680725,0.00019732451,0.000019205627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003724344,0.00007705494,0.000021898673,0.00004600589,0.000013911709,0.000001820679,0.00012770605,0.00013310037,0.96767294,0.000013594786,0.0034974872,0.028022064],"study_design_scores_gemma":[0.0003856394,0.000607398,0.0010711903,0.00022902012,0.000005049855,0.0000014327493,0.00003941504,0.000034652177,0.98070776,0.000098798184,0.01661799,0.00020164612],"about_ca_topic_score_codex":0.00015080092,"about_ca_topic_score_gemma":0.000012731936,"teacher_disagreement_score":0.027820418,"about_ca_system_score_codex":0.00007036088,"about_ca_system_score_gemma":0.00013076271,"threshold_uncertainty_score":0.6862456},"labels":[],"label_agreement":null},{"id":"W2107967405","doi":"10.1158/0008-5472.can-07-6790","title":"Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; U.S. Public Health Service; Robert Bosch Stiftung; National Institute of Environmental Health Sciences; American Lebanese Syrian Associated Charities","keywords":"Thiopurine methyltransferase; Toxicity; Pharmacology; Biology; ITPA; Myeloid; Medicine; Cancer research; Biochemistry; Azathioprine; Gene; Internal medicine; Genotype","score_opus":0.10776046107583791,"score_gpt":0.3735899687325245,"score_spread":0.26582950765668656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107967405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858154,0.00020205653,0.00023112855,0.004246914,0.00013496564,0.0018700995,0.000020084915,0.0001909532,0.0045222607],"genre_scores_gemma":[0.99453014,0.0006773014,0.0000768904,0.00028776427,0.0004897907,0.00087976956,0.000033962333,0.00007399468,0.002950413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99558514,0.00021985258,0.00039769302,0.0006308599,0.0020771201,0.0010893391],"domain_scores_gemma":[0.99773115,0.00018406152,0.000051794566,0.0006528905,0.00079398195,0.0005861007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088552263,0.00022856386,0.00042518062,0.0005071382,0.00044357008,0.000025065567,0.00031270526,0.00027373686,0.000644128],"category_scores_gemma":[0.0004721092,0.00019270109,0.00013209948,0.0014780038,0.00043564776,0.00014410233,0.00009248836,0.0014364605,0.0005115563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010899631,0.00042730302,0.004739591,0.00053510035,0.00010765132,0.0018578536,0.0014517601,0.000011637793,0.97699505,0.000035814905,0.009729439,0.0030188258],"study_design_scores_gemma":[0.010799671,0.001667759,0.04168489,0.0007592752,0.000043883698,0.0009933172,0.00050531176,0.0021482445,0.92834496,0.00012141796,0.012326128,0.0006051156],"about_ca_topic_score_codex":0.0005814197,"about_ca_topic_score_gemma":0.000121873556,"teacher_disagreement_score":0.04865007,"about_ca_system_score_codex":0.0019724707,"about_ca_system_score_gemma":0.0029240467,"threshold_uncertainty_score":0.78581226},"labels":[],"label_agreement":null},{"id":"W2108075715","doi":"10.1158/0008-5472.can-08-1490","title":"Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Leukemia and Lymphoma Society; National Institutes of Health; New York State Department of Health","keywords":"Cytotoxic T cell; Pharmacology; Medicine; Antineoplastic Drugs; Cancer research; Chemistry; Biochemistry; In vitro","score_opus":0.038721421840201276,"score_gpt":0.37024502929826597,"score_spread":0.3315236074580647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108075715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944271,0.0019019715,0.000026613725,0.0016321801,0.00046639383,0.0006120861,0.0000150778815,0.000038384856,0.00088019104],"genre_scores_gemma":[0.9959565,0.0012418975,0.000029117151,0.000065903776,0.00034315497,0.00012815603,0.000002516572,0.00004080065,0.002191953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99660134,0.00055794616,0.00025736206,0.00035805625,0.0013622431,0.00086303],"domain_scores_gemma":[0.99683243,0.002083725,0.00005554638,0.00050289766,0.00038707646,0.00013834462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093615096,0.00015257049,0.00027303665,0.00029289708,0.0006894641,0.000041558567,0.00066424685,0.00009174723,0.00015808153],"category_scores_gemma":[0.0007492736,0.00010172862,0.000102250175,0.0011696155,0.001174199,0.00012883247,0.00020239314,0.00073306134,0.00014377925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003262305,0.00016756839,0.008404041,0.00071864395,0.00004420529,0.00008743883,0.0024233263,0.000011833237,0.9619111,0.00013141635,0.016265064,0.009509164],"study_design_scores_gemma":[0.001087289,0.00039110467,0.043126803,0.00042164495,0.000011945027,0.000029618031,0.00040686515,0.00014998083,0.9497763,0.000114433504,0.0043229302,0.00016111041],"about_ca_topic_score_codex":0.00056632736,"about_ca_topic_score_gemma":0.000028594184,"teacher_disagreement_score":0.03472276,"about_ca_system_score_codex":0.0001205215,"about_ca_system_score_gemma":0.0002253235,"threshold_uncertainty_score":0.530287},"labels":[],"label_agreement":null},{"id":"W2108215484","doi":"10.1158/0008-5472.can-10-2754","title":"miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; University of Pennsylvania","keywords":"Survivin; Nasopharyngeal carcinoma; Cancer research; microRNA; Downregulation and upregulation; Biology; Gene silencing; Tumor progression; Cancer; Medicine; Internal medicine; Radiation therapy; Gene","score_opus":0.07283608088084334,"score_gpt":0.38263295357178295,"score_spread":0.3097968726909396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108215484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117065,0.016876487,0.00009933974,0.0002678079,0.00008646396,0.0006167272,0.00007516011,0.000007956111,0.0007994136],"genre_scores_gemma":[0.99721175,0.001666598,0.00022222096,0.000024461768,0.00020146354,0.00032483882,0.00005727107,0.000022280003,0.0002690905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847746,0.00036043863,0.0002007329,0.00033575625,0.00034450178,0.0002811386],"domain_scores_gemma":[0.99904877,0.00004665341,0.000092495466,0.00038874277,0.0003595533,0.00006377918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006554923,0.00011664266,0.00014874045,0.00004060684,0.00014305807,0.000021721582,0.00023608087,0.000120411816,0.00021177852],"category_scores_gemma":[0.00008995541,0.0000800213,0.000045991335,0.00016821874,0.00066524633,0.000014745071,0.00022392061,0.00012383322,0.0000019483703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011459918,0.000072751376,0.0033426622,0.00014675007,0.00007029025,9.598139e-7,0.00066538167,0.000013926648,0.98335564,0.00074960536,0.0018349441,0.008601088],"study_design_scores_gemma":[0.0013251138,0.00010080911,0.029248971,0.00009886669,0.000016756732,0.0000019901404,0.000082057086,0.00006385221,0.9631817,0.00071605644,0.005050848,0.00011298552],"about_ca_topic_score_codex":0.0010341709,"about_ca_topic_score_gemma":0.00030309625,"teacher_disagreement_score":0.02590631,"about_ca_system_score_codex":0.000032493488,"about_ca_system_score_gemma":0.00024112476,"threshold_uncertainty_score":0.3263174},"labels":[],"label_agreement":null},{"id":"W2108281860","doi":"10.1158/0008-5472.can-12-2907","title":"Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Metformin; AMPK; Glutamine; Glycolysis; Pharmacology; Oxidative phosphorylation; Cancer cell; Glucose uptake; Cell growth; Endocrinology; Internal medicine; Chemistry; Cancer; Cancer research; Medicine; Biochemistry; Phosphorylation; Metabolism; Protein kinase A; Diabetes mellitus; Insulin","score_opus":0.05674381811932331,"score_gpt":0.39360261844118277,"score_spread":0.33685880032185944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108281860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83976096,0.15951756,0.000023707997,0.000038124872,0.00006470884,0.0001494758,0.000009769348,0.000002431371,0.00043325694],"genre_scores_gemma":[0.96812874,0.03083932,0.000027141961,0.000067563786,0.00042186322,0.00013908856,0.0000035679327,0.0000107024325,0.00036200476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990753,0.00014996802,0.00010184691,0.00015412422,0.0002192512,0.00029952513],"domain_scores_gemma":[0.99941194,0.000034873585,0.00003848853,0.00025341235,0.00017577143,0.00008551772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056875194,0.00007142008,0.000095959214,0.000037843827,0.0001337985,0.000013780426,0.00014397573,0.00007148691,0.000024890702],"category_scores_gemma":[0.00009492645,0.000047308884,0.000025975236,0.0001310702,0.00025732574,0.0000089243085,0.00013751163,0.00016049309,0.0000011584231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005395043,0.000021588425,0.0073990272,0.000026719059,0.000023138133,6.990696e-8,0.00056885846,0.000022123246,0.9602076,0.00006318114,0.0008882965,0.030725446],"study_design_scores_gemma":[0.00014419005,0.00003746716,0.0027314555,0.000018603347,0.0000063884427,0.0000010470548,0.0003392173,0.0000075141743,0.8096488,0.00002707705,0.18698543,0.000052766536],"about_ca_topic_score_codex":0.00018243979,"about_ca_topic_score_gemma":0.000022338601,"teacher_disagreement_score":0.18609715,"about_ca_system_score_codex":0.0000141849205,"about_ca_system_score_gemma":0.00010439283,"threshold_uncertainty_score":0.19292003},"labels":[],"label_agreement":null},{"id":"W2108383176","doi":"10.1158/0008-5472.can-05-3297","title":"Adeno-Associated Virus–Mediated Delivery of a Mutant Endostatin in Combination with Carboplatin Treatment Inhibits Orthotopic Growth of Ovarian Cancer and Improves Long-term Survival","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute; University of Minnesota; National Institute on Drug Abuse; Minnesota Ovarian Cancer Alliance","keywords":"Carboplatin; Ovarian cancer; Endostatin; Cancer research; Genetic enhancement; Metastasis; Medicine; Cisplatin; Adeno-associated virus; Cancer; Sleeping Beauty transposon system; Biology; Pathology; Chemotherapy; Internal medicine; Mutant; Angiogenesis; Gene; Recombinant DNA; Vector (molecular biology); Transposable element","score_opus":0.024486870078329233,"score_gpt":0.3244487853369105,"score_spread":0.2999619152585813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108383176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674016,0.002111615,0.0000028897973,0.0001068433,0.000022327436,0.000706638,0.0002288616,0.000005272141,0.00007537275],"genre_scores_gemma":[0.99717665,0.002140119,0.000012120888,0.000007634974,0.000039217426,0.0002651229,0.00019087647,0.000030138675,0.00013810938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981185,0.00032783314,0.00029863018,0.00037204908,0.00047100434,0.00041196175],"domain_scores_gemma":[0.99899864,0.00008892058,0.0001199218,0.00021224115,0.0005066007,0.00007369638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049486785,0.00015466494,0.0002738632,0.00022709927,0.00005547282,0.000015906944,0.00014025366,0.00013276526,0.000024922969],"category_scores_gemma":[0.000058144255,0.00013571655,0.000035204925,0.00049339846,0.0002710526,0.000008622845,0.0000742954,0.00016707934,3.7708762e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024164044,0.0002836248,0.17248808,0.000071490314,0.00009759531,0.000013112462,0.00012532032,0.000020378331,0.8212271,0.000014140202,0.000005026665,0.003237764],"study_design_scores_gemma":[0.003923616,0.0029250297,0.1880069,0.000087538836,0.000010596182,8.155557e-7,0.000045318953,0.00004025878,0.8048228,0.000021235319,0.000005499486,0.00011037354],"about_ca_topic_score_codex":0.02218177,"about_ca_topic_score_gemma":0.104390964,"teacher_disagreement_score":0.0822092,"about_ca_system_score_codex":0.00021318386,"about_ca_system_score_gemma":0.00073265156,"threshold_uncertainty_score":0.9843296},"labels":[],"label_agreement":null},{"id":"W2108792487","doi":"10.1158/0008-5472.can-04-0731","title":"Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":444,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Melanoma; Biology; Ectopic expression; Cancer research; Gene expression profiling; Gene; Gene expression; Malignant transformation; DNA methylation; Regulation of gene expression; Microphthalmia-associated transcription factor; DNA microarray; Cell biology; Transcription factor; Genetics","score_opus":0.10642266039167278,"score_gpt":0.38361471248798323,"score_spread":0.2771920520963105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108792487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804384,0.00019807991,0.0014378631,0.0029800253,0.000065569555,0.0013892736,0.000008913443,0.000018401168,0.0058580525],"genre_scores_gemma":[0.9986125,0.000093475384,0.0005308752,0.0001973125,0.00007555697,0.00028637357,0.000005815585,0.0000099706485,0.00018809544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872345,0.00006252281,0.00022977057,0.00015849117,0.0005842303,0.00024154459],"domain_scores_gemma":[0.9994851,0.00006181401,0.000027293714,0.0002311947,0.00012826447,0.00006633184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010212671,0.000067661946,0.00014167059,0.00029348204,0.00007131203,0.000015720394,0.00013446827,0.00004502839,0.000062783445],"category_scores_gemma":[0.00009548728,0.000045106033,0.000038019465,0.0005558297,0.00003096103,0.000051171675,0.00003153764,0.00023966312,0.000021642783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003589152,0.00013382614,0.00027685406,0.00023789075,0.0000095708465,0.000021867105,0.0056368276,0.00030329498,0.9848065,0.003532874,0.00018963523,0.0044919415],"study_design_scores_gemma":[0.0016430423,0.00048064915,0.003547885,0.00056429574,0.000009635248,0.000036129037,0.004330036,0.000024165245,0.9841606,0.0005174386,0.0046091285,0.00007699089],"about_ca_topic_score_codex":0.00028476233,"about_ca_topic_score_gemma":0.0001155445,"teacher_disagreement_score":0.0105687035,"about_ca_system_score_codex":0.00022419645,"about_ca_system_score_gemma":0.00011760746,"threshold_uncertainty_score":0.18393707},"labels":[],"label_agreement":null},{"id":"W2108852443","doi":"10.1158/0008-5472.can-05-3173","title":"Inhibition of the Phosphatidylinositol 3′-Kinase Pathway Promotes Autocrine Fas-Induced Death of Phosphatase and Tensin Homologue–Deficient Prostate Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"PTEN; LNCaP; Autocrine signalling; PI3K/AKT/mTOR pathway; Cancer research; Fas ligand; Tensin; Apoptosis; Protein kinase B; Prostate cancer; DU145; Programmed cell death; Biology; Cancer cell; Cancer; Signal transduction; Cell biology; Medicine; Internal medicine; Receptor; Biochemistry","score_opus":0.02405354628853981,"score_gpt":0.30286758151774196,"score_spread":0.2788140352292022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108852443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927665,0.0058472287,0.000032561296,0.00019979052,0.00011891995,0.0007415735,0.00021773325,0.000004761681,0.00007094817],"genre_scores_gemma":[0.9983539,0.0006636257,0.00008300091,0.000017020626,0.00009039352,0.000112131354,0.00007569116,0.000017905233,0.00058630767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874985,0.00009713404,0.00024460972,0.0003171646,0.00031464896,0.00027657757],"domain_scores_gemma":[0.99913144,0.000014040613,0.00012455006,0.00029781618,0.00038388517,0.000048267968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031237974,0.000120842735,0.00015079495,0.0000553112,0.00012928802,0.000015646783,0.000104481485,0.00010388513,0.000019100273],"category_scores_gemma":[0.000021013462,0.000085152744,0.00005596192,0.00019918734,0.00017523645,0.0000055946684,0.00016444517,0.00012212132,5.15665e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010588055,0.00010672826,0.0014063425,0.000119547425,0.000013586615,0.000004313138,0.00006886943,0.00023541391,0.99226254,0.0005087993,0.0002597492,0.004908198],"study_design_scores_gemma":[0.0005610687,0.00023174641,0.00820429,0.00011015604,0.000012549134,0.000002377607,0.00004282879,0.00016594207,0.989164,0.00029128743,0.0011154708,0.00009827946],"about_ca_topic_score_codex":0.0029806714,"about_ca_topic_score_gemma":0.00028062804,"teacher_disagreement_score":0.006797947,"about_ca_system_score_codex":0.00004085938,"about_ca_system_score_gemma":0.00023957773,"threshold_uncertainty_score":0.45059034},"labels":[],"label_agreement":null},{"id":"W2108973736","doi":"10.1158/0008-5472.can-07-0722","title":"Role of Tumor Necrosis Factor-α and TRAIL in High-Dose Radiation–Induced Bystander Signaling in Lung Adenocarcinoma","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Bystander effect; A549 cell; Tumor necrosis factor alpha; Apoptosis; Cancer research; Biology; Chemistry; Cell biology; Molecular biology; Immunology; Biochemistry","score_opus":0.0422857995273306,"score_gpt":0.3770235591128301,"score_spread":0.3347377595854995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108973736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354094,0.0050743376,0.0000064027927,0.00045282993,0.000040041217,0.0007000797,0.0000121553885,0.000012766102,0.00016046647],"genre_scores_gemma":[0.9995021,0.00010374449,0.00006715119,0.000060487477,0.000109684275,0.000054519875,0.0000063491807,0.000025611755,0.00007032638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981748,0.00015006315,0.00034344406,0.00028846227,0.00058864674,0.0004545915],"domain_scores_gemma":[0.9988929,0.0005088812,0.00006127446,0.00019551937,0.00016742198,0.0001740291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015340091,0.00010823021,0.00029502748,0.0007373511,0.00004332546,0.000018154471,0.00009747912,0.00010427674,0.00015104297],"category_scores_gemma":[0.00036980392,0.00010525935,0.0000302279,0.00081609824,0.00008215594,0.00013003167,0.00003245205,0.0005228549,0.0000024712283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003453064,0.00005472255,0.52905154,0.00016416075,0.000014904132,0.00003759606,0.0018596187,0.00002903039,0.46074462,0.00007288707,0.00005490775,0.0075707193],"study_design_scores_gemma":[0.0028919962,0.00018591787,0.8437469,0.00017467586,0.0000063244356,0.0000036959882,0.00060429727,0.00025640082,0.15193607,0.000072727526,0.00004034405,0.00008066875],"about_ca_topic_score_codex":0.0027057414,"about_ca_topic_score_gemma":0.00097641675,"teacher_disagreement_score":0.31469536,"about_ca_system_score_codex":0.0005534741,"about_ca_system_score_gemma":0.00035651363,"threshold_uncertainty_score":0.42923516},"labels":[],"label_agreement":null},{"id":"W2109067479","doi":"10.1158/0008-5472.can-06-3608","title":"Modulation of Angiogenic Phenotype Alters Tumorigenicity in Rat Ovarian Epithelial Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Angiogenesis; Ovarian cancer; Cancer research; Biology; Oncogene; Metastasis; Vascular endothelial growth factor; Endostatin; Phenotype; Neovascularization; Cancer; Cell cycle; VEGF receptors","score_opus":0.04079022603336591,"score_gpt":0.36235699958508316,"score_spread":0.32156677355171726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109067479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960063,0.0016128105,0.0013631127,0.000057553934,0.0002592502,0.0002165033,0.000026750773,0.0000035385256,0.00045415538],"genre_scores_gemma":[0.9983487,0.00050211156,0.00016891705,0.000046744706,0.00046813395,0.00002508012,0.000022756842,0.000020366657,0.00039716667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986831,0.00009025172,0.00023510055,0.00030340333,0.00028190468,0.00040622908],"domain_scores_gemma":[0.99936396,0.00002430581,0.00005127729,0.000281797,0.00019835324,0.00008033349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011436065,0.00009352831,0.00012877346,0.0001374626,0.00005536632,0.000008776989,0.00020839693,0.00011842781,0.000099398734],"category_scores_gemma":[0.000031270443,0.000090654525,0.000093342336,0.0003426286,0.00012644462,0.000004298537,0.000089460926,0.00010831488,0.000008342425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035347356,0.00003912585,0.005554809,0.000020548221,0.000022256381,0.0000032919377,0.00007122113,0.00040931848,0.98727053,0.0001059679,0.000603309,0.0055461717],"study_design_scores_gemma":[0.00043189438,0.000112011985,0.017237702,0.000014764462,0.0000040186237,6.2710285e-7,0.00005447089,0.000051671603,0.9745337,0.0000943511,0.007362047,0.000102754115],"about_ca_topic_score_codex":0.00086727185,"about_ca_topic_score_gemma":0.00092637364,"teacher_disagreement_score":0.012736821,"about_ca_system_score_codex":0.00009542225,"about_ca_system_score_gemma":0.00021546769,"threshold_uncertainty_score":0.36967844},"labels":[],"label_agreement":null},{"id":"W2109317370","doi":"10.1158/0008-5472.can-07-6620","title":"<i>LKB1</i> and Lung Cancer: More Than the Usual Suspects","year":2008,"lang":"en","type":"review","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Biology; PTEN; Suppressor; Cancer; Lung cancer; Gene; Tumor suppressor gene; Genetics; Function (biology); Cancer research; Carcinogenesis; PI3K/AKT/mTOR pathway; Signal transduction; Medicine; Oncology","score_opus":0.16291746479417019,"score_gpt":0.5048719610331135,"score_spread":0.3419544962389433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109317370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025304514,0.98982227,6.971722e-7,0.0013013326,0.0007706264,0.0031423573,0.00015687507,0.000054449036,0.002220931],"genre_scores_gemma":[0.0006936279,0.9885499,0.000018366907,0.0001966994,0.0019281054,0.0029731719,0.000032590284,0.00016973433,0.005437792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953647,0.00043909336,0.0004953845,0.0009546377,0.0016377048,0.001108449],"domain_scores_gemma":[0.99721503,0.0007297421,0.00015252843,0.0010075736,0.00046655483,0.00042854034],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006115097,0.0005430831,0.0016141515,0.00034142012,0.00046830694,0.00008017606,0.0006571796,0.00046973274,0.0006752698],"category_scores_gemma":[0.00026311533,0.00032962984,0.00034685925,0.0012448266,0.0012485007,0.00004443634,0.00053968723,0.0026327502,0.000030187308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105020124,0.000045439087,0.000638908,0.018734474,0.00062072155,0.00022667945,0.00065901096,0.000001413814,0.000025340336,0.000035404,0.1331924,0.84571517],"study_design_scores_gemma":[0.0004545729,0.00017543967,0.0001691071,0.012033618,0.00043951222,0.0003472621,0.00007551291,0.0000085291485,0.00008450286,0.000010777216,0.98587906,0.00032207242],"about_ca_topic_score_codex":0.0019276415,"about_ca_topic_score_gemma":0.00055203843,"teacher_disagreement_score":0.8526867,"about_ca_system_score_codex":0.0017194318,"about_ca_system_score_gemma":0.005251792,"threshold_uncertainty_score":0.9999156},"labels":[],"label_agreement":null},{"id":"W2109389570","doi":"10.1158/0008-5472.can-11-3951","title":"Embryonic Protein Nodal Promotes Breast Cancer Vascularization","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Breast cancer; Chorioallantoic membrane; NODAL; Cancer; Biology; Cancer research; Tumor progression; In vivo; Pathology; Embryonic stem cell; Medicine; Internal medicine; Anatomy; Gene","score_opus":0.07931077273088076,"score_gpt":0.40961116900845734,"score_spread":0.33030039627757657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109389570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754109,0.012770621,0.00013752356,0.0073536327,0.0003593613,0.0017113698,0.00009820499,0.00006984899,0.0020885782],"genre_scores_gemma":[0.9865855,0.0011166031,0.00019349597,0.0001470993,0.0017632906,0.0012577468,0.00002279143,0.000056273373,0.008857177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975948,0.00013375962,0.00017379712,0.00031722584,0.00090003305,0.00088043226],"domain_scores_gemma":[0.9986316,0.000024995441,0.000042828262,0.00039755862,0.00048875925,0.00041424978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000964294,0.00014765377,0.0002589998,0.00020077995,0.00018193483,0.000041866282,0.000132341,0.00010179923,0.003596057],"category_scores_gemma":[0.00005736724,0.000120132085,0.00010950434,0.00076302054,0.00015388227,0.00020170334,0.00009744922,0.0005025812,0.00013437502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006666566,0.00059274695,0.05487967,0.001231781,0.0003647277,0.000018494608,0.00095805834,0.000012100791,0.77423024,0.00087400264,0.01051993,0.15565158],"study_design_scores_gemma":[0.0047920328,0.00033653624,0.13064967,0.0015081062,0.00030125564,0.0001369528,0.00041058369,0.00009021618,0.57829934,0.0001443335,0.28267118,0.0006598034],"about_ca_topic_score_codex":0.002567366,"about_ca_topic_score_gemma":0.00018056447,"teacher_disagreement_score":0.27215123,"about_ca_system_score_codex":0.000627953,"about_ca_system_score_gemma":0.00087241986,"threshold_uncertainty_score":0.9973148},"labels":[],"label_agreement":null},{"id":"W2109396389","doi":"10.1158/0008-5472.can-04-2263","title":"The FLT3 Internal Tandem Duplication Mutation Prevents Apoptosis in Interleukin-3-Deprived BaF3 Cells Due to Protein Kinase A and Ribosomal S6 Kinase 1–Mediated BAD Phosphorylation at Serine 112","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"National Cancer Institute","keywords":"Ribosomal s6 kinase; Cyclin-dependent kinase 9; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; MAP2K7; Cyclin-dependent kinase 2; Protein kinase B; Cyclin-dependent kinase 4; MAPK/ERK pathway; ASK1; c-Raf; Kinase; Protein kinase A; Biology; Cancer research; Phosphorylation; Molecular biology; Cell biology; P70-S6 Kinase 1","score_opus":0.03250012436646472,"score_gpt":0.3618831588247091,"score_spread":0.3293830344582444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109396389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914502,0.00086125557,0.00009372603,0.004041167,0.0000466603,0.0032919946,0.00003534124,0.000033332293,0.0001463141],"genre_scores_gemma":[0.9942904,0.0005778208,0.00031716822,0.00006483228,0.00015650566,0.002197707,0.000094440256,0.000037751317,0.0022633795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971779,0.0003142874,0.0003865119,0.000547125,0.0008857684,0.00068842573],"domain_scores_gemma":[0.99847364,0.0002429666,0.00007807813,0.00039389406,0.00035145157,0.00045994835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009335643,0.00019924712,0.00024875987,0.00034047986,0.00027771562,0.000091088594,0.00020999023,0.000106432475,0.00021630595],"category_scores_gemma":[0.00048478314,0.00015209414,0.000051748015,0.0006169463,0.00015687701,0.00021894323,0.0002737023,0.0004775948,0.00018675318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050376644,0.0004630324,0.044983797,0.00012418511,0.000121181714,0.00015089446,0.0010160522,0.000059630616,0.7060463,0.000029023795,0.0005396602,0.24142858],"study_design_scores_gemma":[0.0057929046,0.0006743263,0.22148164,0.00051419414,0.000016541235,0.000014913324,0.00018584555,0.0048842863,0.7606643,0.000051730247,0.005539066,0.0001802378],"about_ca_topic_score_codex":0.0015773794,"about_ca_topic_score_gemma":0.0027429627,"teacher_disagreement_score":0.24124834,"about_ca_system_score_codex":0.0018131139,"about_ca_system_score_gemma":0.00024239733,"threshold_uncertainty_score":0.6202219},"labels":[],"label_agreement":null},{"id":"W2109471257","doi":"10.1158/1538-7445.am10-996","title":"Abstract 996: Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of <i>LARGE</i>","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Dystroglycan; Laminin; Cancer research; Gene silencing; Cell biology; Biology; Cancer cell; Glycosylation; Cancer; Extracellular matrix; Biochemistry; Genetics","score_opus":0.02808699869243617,"score_gpt":0.3603092438411969,"score_spread":0.3322222451487607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109471257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977572,0.0008689113,0.000011109239,0.00019162676,0.000109160545,0.00026612252,0.0003885464,0.000004316468,0.0004029982],"genre_scores_gemma":[0.99857396,0.0006739183,0.00005432093,0.000047738307,0.0001341272,0.000081877806,0.00003680848,0.00003059517,0.0003666473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998362,0.000056588313,0.00031606448,0.0003790083,0.00034971375,0.00053659367],"domain_scores_gemma":[0.99912083,0.00003231751,0.00012084574,0.00038454265,0.00023365996,0.00010778054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007428692,0.0001384735,0.00023334635,0.00013536288,0.00006795909,0.000013614425,0.00036085953,0.00018941316,0.00026720593],"category_scores_gemma":[0.000103225786,0.00013446104,0.00007567875,0.000290177,0.00026526794,0.000008131787,0.00013528048,0.00042770331,0.0000035341513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009268748,0.000055607736,0.009952842,0.000094441195,0.000034136614,0.0000057115953,0.0002876491,0.000009425176,0.98661524,0.000017295833,0.0017912239,0.0010437137],"study_design_scores_gemma":[0.00080255064,0.00016114161,0.0049326196,0.000101539394,0.0000035318446,9.628685e-7,0.00046609016,0.000011314151,0.9889937,0.000012421882,0.004380765,0.00013335011],"about_ca_topic_score_codex":0.0038011002,"about_ca_topic_score_gemma":0.0031251153,"teacher_disagreement_score":0.0050202226,"about_ca_system_score_codex":0.000064683896,"about_ca_system_score_gemma":0.00058215833,"threshold_uncertainty_score":0.5746152},"labels":[],"label_agreement":null},{"id":"W2109475403","doi":"10.1158/0008.5472.can-04-2781","title":"Cyclooxygenase-2 Functions as a Downstream Mediator of Lysophosphatidic Acid to Promote Aggressive Behavior in Ovarian Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Lysophosphatidic acid; Ovarian cancer; Cancer research; Metastasis; Ovarian carcinoma; Biology; Amphiregulin; Transactivation; Internal medicine; Epidermal growth factor receptor; Cancer; Endocrinology; Medicine; Receptor; Gene expression","score_opus":0.023499174484087434,"score_gpt":0.3391048644650601,"score_spread":0.31560568998097266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109475403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934629,0.005067089,0.000033870238,0.00025187506,0.00021022026,0.00059489417,0.000100772544,0.0000058907503,0.00027246383],"genre_scores_gemma":[0.997117,0.0004138271,0.00034209265,0.00008832386,0.00075637724,0.0005770421,0.000040900748,0.000029217865,0.0006352509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982695,0.00010838404,0.0002768208,0.00044574525,0.00039986247,0.00049967575],"domain_scores_gemma":[0.99894714,0.000016002354,0.00008131534,0.00043111772,0.00027423902,0.0002501953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047980557,0.00014406814,0.00020600819,0.00023110211,0.00009341639,0.000022055367,0.00031224414,0.0001478553,0.00020189944],"category_scores_gemma":[0.00018746874,0.00013752794,0.000078573656,0.00048169392,0.000104958264,0.000008048169,0.00016804012,0.0002264303,0.000056600307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019520677,0.00026789028,0.0028860667,0.000021945407,0.00001795946,0.000022148643,0.00035144438,0.000050815273,0.98774344,0.00001649749,0.0012342231,0.0071923775],"study_design_scores_gemma":[0.0013959412,0.00021086528,0.0038253758,0.00004121119,0.000015367132,0.0000062749864,0.00019056941,0.000007223879,0.98093796,0.0000076048013,0.01322148,0.00014015309],"about_ca_topic_score_codex":0.00088832324,"about_ca_topic_score_gemma":0.00043832388,"teacher_disagreement_score":0.011987257,"about_ca_system_score_codex":0.00007003839,"about_ca_system_score_gemma":0.0005373198,"threshold_uncertainty_score":0.56082267},"labels":[],"label_agreement":null},{"id":"W2109495319","doi":"10.1158/0008-5472.can-11-0588","title":"Combined Blockade of Integrin-α4β1 Plus Cytokines SDF-1α or IL-1β Potently Inhibits Tumor Inflammation and Growth","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cancer research; Angiogenesis; Inflammation; Stromal cell; Integrin; Myeloid; Macrophage; Immunology; Medicine; Biology; In vitro; Receptor; Internal medicine","score_opus":0.07083086979317371,"score_gpt":0.32707436542348417,"score_spread":0.25624349563031046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109495319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165964,0.0043147192,0.000022172737,0.00034894957,0.0006185048,0.000566691,0.000053249118,0.00004671505,0.0023693787],"genre_scores_gemma":[0.9928019,0.0014563517,0.00008036116,0.000037504644,0.00008295502,0.00018955163,0.000026062795,0.000035780948,0.005289548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980882,0.00035233924,0.00042980685,0.0003939707,0.00014312698,0.0005925923],"domain_scores_gemma":[0.9985594,0.00022415692,0.00014353628,0.00038562427,0.00064298185,0.0000442969],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077716383,0.00019859588,0.00037605586,0.0003349667,0.0002000501,0.000017257498,0.0004240819,0.00022622033,0.0015900956],"category_scores_gemma":[0.00032798285,0.0001569893,0.000055501696,0.00043899613,0.00095374946,0.00015339753,0.00039939725,0.0007691279,0.0001338549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026859595,0.00006833944,0.0023768554,0.00028249045,0.00015415218,0.000018145207,0.0028069695,0.0000015114616,0.9829256,0.0011863617,0.0026825957,0.004811032],"study_design_scores_gemma":[0.002388449,0.00048704026,0.0060423333,0.0002329383,0.000023599941,0.000030380215,0.00057144766,0.0000042878055,0.98387545,0.0006171846,0.0055439156,0.000182985],"about_ca_topic_score_codex":0.0017378953,"about_ca_topic_score_gemma":0.00022530009,"teacher_disagreement_score":0.0046280473,"about_ca_system_score_codex":0.00021449018,"about_ca_system_score_gemma":0.00048857013,"threshold_uncertainty_score":0.9993226},"labels":[],"label_agreement":null},{"id":"W2109519833","doi":"10.1158/1538-7445.am2014-554","title":"Abstract 554: GPNMB methylation: a new marker of potentially colonic adenoma in African Americans","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Methylation; Epigenetics; DNA methylation; Colorectal cancer; CpG site; Cancer research; Malignant transformation; Colorectal adenoma; Adenoma; Immunohistochemistry; Biology; Microsatellite instability; Cancer; Pathology; Molecular biology; Medicine; Internal medicine; Gene expression; Gene; Genetics; Allele","score_opus":0.05216958375374868,"score_gpt":0.41813036254488767,"score_spread":0.365960778791139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109519833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599817,0.0011445703,0.0016420844,0.017858893,0.00013896354,0.00039024386,0.000003134693,0.000025080524,0.01881536],"genre_scores_gemma":[0.99561214,0.00026567266,0.0014222625,0.0002271019,0.00032846772,0.000030408492,0.00000583168,0.000026246691,0.0020818894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981344,0.00017909297,0.0002983854,0.0002733093,0.00069153105,0.0004233025],"domain_scores_gemma":[0.9988799,0.00031102975,0.000078562945,0.00028796578,0.00016642602,0.00027608164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017020176,0.00009443298,0.00031872178,0.00032820718,0.000052324212,0.00002085581,0.00019880262,0.00006505168,0.00092003535],"category_scores_gemma":[0.00096595864,0.000082899234,0.000066419765,0.00069992023,0.00027595114,0.000047910347,0.00006588215,0.0008534159,0.000020992902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010930586,0.00027953167,0.07866629,0.00047279874,0.00016741223,0.00013133,0.0020622974,0.0007036695,0.17864458,0.0010619861,0.022469377,0.71424764],"study_design_scores_gemma":[0.003257384,0.00053621817,0.84171385,0.0005799931,0.0000412249,0.000018954759,0.000338773,0.005998708,0.0028523642,0.0010961217,0.14335087,0.00021554784],"about_ca_topic_score_codex":0.0067221522,"about_ca_topic_score_gemma":0.00018515672,"teacher_disagreement_score":0.7630476,"about_ca_system_score_codex":0.00019701067,"about_ca_system_score_gemma":0.0007561309,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2109572137","doi":"10.1158/0008-5472.can-03-3410","title":"Increased Susceptibility of Poly(ADP-Ribose) Polymerase-1 Knockout Cells to Antitumor Triazoloacridone C-1305 Is Associated with Permanent G2 Cell Cycle Arrest","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Poly ADP ribose polymerase; Biology; Molecular biology; Comet assay; DNA damage; Cell cycle; Apoptosis; Polymerase; DNA repair; Cell culture; Mutant; DNA; Biochemistry; Genetics; Gene","score_opus":0.0296058833365456,"score_gpt":0.33334812920094037,"score_spread":0.30374224586439474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109572137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567544,0.0018085347,0.0001545714,0.00069201324,0.00021028021,0.000669626,0.0004297501,0.000015476833,0.00034428682],"genre_scores_gemma":[0.9975905,0.0004337124,0.0000965093,0.0005121773,0.0003165574,0.00011360278,0.00008892007,0.000054847686,0.0007931978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753386,0.00015570859,0.00030603624,0.00067126553,0.0006147105,0.0007184052],"domain_scores_gemma":[0.9984,0.00003119287,0.000106601794,0.0007035081,0.0004238346,0.00033487147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006731984,0.00023693417,0.00033330833,0.00013775374,0.00017015594,0.00004035896,0.00042057753,0.00017047586,0.00017270842],"category_scores_gemma":[0.00004020502,0.00021426241,0.00012046024,0.00044938314,0.00020941043,0.000006630586,0.00019375708,0.00027414426,0.000020949534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010188486,0.00040151202,0.00025391058,0.00005000442,0.00010038737,0.00001260499,0.00025767906,0.00010313488,0.9963958,0.00003724136,0.00063299737,0.0007358509],"study_design_scores_gemma":[0.0028123388,0.0012182948,0.0008699299,0.00008384507,0.000030894153,0.0000020414805,0.00018686049,0.0000055141713,0.9915528,0.000093547394,0.0028771667,0.00026670948],"about_ca_topic_score_codex":0.004375588,"about_ca_topic_score_gemma":0.0019911078,"teacher_disagreement_score":0.004842971,"about_ca_system_score_codex":0.0002566301,"about_ca_system_score_gemma":0.0009641128,"threshold_uncertainty_score":0.8737368},"labels":[],"label_agreement":null},{"id":"W2109674742","doi":"10.1158/0008-5472.can-05-1341","title":"Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Androgen receptor; Prostate cancer; DU145; LNCaP; Androgen; Hypoxia (environmental); Endocrinology; Internal medicine; Enzalutamide; Cancer research; Androgen deprivation therapy; Tumor hypoxia; Biology; Chemistry; Medicine; Cancer; Hormone; Oxygen","score_opus":0.026210213870071077,"score_gpt":0.33915831345485675,"score_spread":0.3129480995847857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109674742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977739,0.019760039,0.0000049169707,0.00028022222,0.0005534912,0.0005027558,0.00027336917,0.00001376493,0.00087245676],"genre_scores_gemma":[0.97296137,0.016507864,0.000051921746,0.00008220128,0.0026784446,0.00071005797,0.000057344598,0.00004571611,0.006905069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979331,0.00022354614,0.00018767329,0.0005700004,0.00037808064,0.00070762436],"domain_scores_gemma":[0.9991767,0.00002712539,0.00005312096,0.0003844867,0.0002186227,0.00013996864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005394014,0.00017812199,0.00022073051,0.00014494994,0.0001244888,0.000050923307,0.00026822928,0.00013900579,0.00023738832],"category_scores_gemma":[0.00004367337,0.00017283659,0.00007722307,0.00040570804,0.0002094782,0.000011541596,0.0001790327,0.00029846354,0.000024861045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040109383,0.00012394109,0.004198688,0.000043545268,0.00002093807,0.0000027969827,0.000033041393,0.000116061616,0.9366189,0.000015572065,0.0459728,0.012452571],"study_design_scores_gemma":[0.00067818724,0.000052632877,0.006110681,0.000028328277,0.0000051202624,0.0000012726889,0.00002436015,0.0000058149412,0.6289635,0.000044039363,0.36392605,0.00016003815],"about_ca_topic_score_codex":0.0258208,"about_ca_topic_score_gemma":0.01112908,"teacher_disagreement_score":0.31795323,"about_ca_system_score_codex":0.00014927589,"about_ca_system_score_gemma":0.00071760145,"threshold_uncertainty_score":0.98066634},"labels":[],"label_agreement":null},{"id":"W2109719470","doi":"10.1158/0008-5472.can-03-2327","title":"Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, α-TEA","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Apoptosis; Vitamin E; Chemistry; Cell culture; Osteosarcoma; Biochemistry; Molecular biology; Biology; Internal medicine; Endocrinology; Cancer research; Medicine; Antioxidant","score_opus":0.05130261511196066,"score_gpt":0.38854001974794544,"score_spread":0.3372374046359848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109719470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712765,0.00014446123,0.00025200236,0.0015150004,0.00009197944,0.000509587,0.00025942482,0.000011746663,0.00008814289],"genre_scores_gemma":[0.9984202,0.00037736443,0.000055845656,0.000025471183,0.000101257414,0.00008382047,0.000016331782,0.000023483257,0.0008962628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811274,0.0002807378,0.00027506714,0.0003682052,0.0005882104,0.00037502585],"domain_scores_gemma":[0.9989152,0.00012723137,0.00009477305,0.0002681019,0.00039174216,0.00020296275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057079986,0.00014569603,0.0004010087,0.000446954,0.00014148945,0.000015073023,0.00013228595,0.00013046504,0.0002957847],"category_scores_gemma":[0.00010851757,0.00013226936,0.00005894246,0.0006659345,0.00038423066,0.00011798767,0.00011419522,0.000399258,0.000003095627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026583292,0.00025733814,0.0033145184,0.0002240831,0.00008967052,0.0000041590465,0.0009797522,0.000007683684,0.98880804,0.00017248275,0.0009572615,0.002526675],"study_design_scores_gemma":[0.0019230364,0.00078083796,0.10777689,0.0004396787,0.000039717586,0.0000012973154,0.00045269172,0.0000023209932,0.88829917,0.0000413138,0.00013849509,0.00010455456],"about_ca_topic_score_codex":0.007847349,"about_ca_topic_score_gemma":0.00042311032,"teacher_disagreement_score":0.10446236,"about_ca_system_score_codex":0.00027538047,"about_ca_system_score_gemma":0.00026758388,"threshold_uncertainty_score":0.9987595},"labels":[],"label_agreement":null},{"id":"W2109765959","doi":"10.1158/0008-5472.can-05-0755","title":"Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Biology; Amplicon; Receptor tyrosine kinase; Carcinogenesis; Cancer research; Locus (genetics); Genetics; Copy-number variation; Gene; Signal transduction; Genome","score_opus":0.06851699653895069,"score_gpt":0.4221883660174637,"score_spread":0.35367136947851296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109765959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860508,0.0050737187,0.0000044049825,0.0067879683,0.000062390274,0.0011611903,0.00012075578,0.00004012596,0.0006986859],"genre_scores_gemma":[0.9888075,0.0031779765,0.0005810712,0.00017698364,0.0007460962,0.00069706456,0.000045562643,0.00008303371,0.0056847236],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957688,0.000352595,0.0007238495,0.0007169524,0.0012386155,0.0011992299],"domain_scores_gemma":[0.9982585,0.00019368556,0.00006716775,0.0005119673,0.00045458853,0.0005141174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026871387,0.0002368651,0.0004820774,0.00060606824,0.0001710752,0.00008851008,0.00026418763,0.0001572234,0.0029574486],"category_scores_gemma":[0.00027069464,0.00022598305,0.00006033377,0.001587664,0.0004235144,0.00020812836,0.00017774128,0.0014217679,0.00016114255],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090849254,0.00037410067,0.59974724,0.00040399123,0.00003291485,0.00035069595,0.0012929253,0.00012922072,0.36851427,0.00017575982,0.0148820095,0.013188374],"study_design_scores_gemma":[0.014214874,0.0009564112,0.13399187,0.0037718704,0.000044178913,0.0006792487,0.0035094873,0.0020511125,0.7775723,0.0004216888,0.061233625,0.0015533308],"about_ca_topic_score_codex":0.0064294967,"about_ca_topic_score_gemma":0.0068265866,"teacher_disagreement_score":0.46575537,"about_ca_system_score_codex":0.0019652585,"about_ca_system_score_gemma":0.0018666513,"threshold_uncertainty_score":0.997954},"labels":[],"label_agreement":null},{"id":"W2109799459","doi":"10.1158/0008-5472.can-10-0738","title":"Cooperation between <i>Pik3ca</i> and p53 Mutations in Mouse Mammary Tumor Formation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"Hospital for Sick Children; Genome Canada; Breast Cancer Alliance; Breast Cancer Research Foundation","keywords":"Mammary tumor; Cancer research; Cre recombinase; Mutant; Biology; Genetically modified mouse; Cancer; Breast cancer; Adenocarcinoma; Gene; Transgene; Pathology; Medicine; Genetics","score_opus":0.09218817969964216,"score_gpt":0.37119338732108265,"score_spread":0.2790052076214405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109799459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956865,0.0011102124,0.0016621982,0.00014439342,0.00004518561,0.00027027147,0.000041476724,0.000010468021,0.0010293197],"genre_scores_gemma":[0.9981977,0.00039143048,0.0003815365,0.00010027804,0.00015921157,0.00021481031,0.00009469333,0.000016330228,0.00044402404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990535,0.000121239886,0.00016241834,0.00024082664,0.00016896852,0.00025303994],"domain_scores_gemma":[0.9994755,0.00001979254,0.000029570183,0.00021139045,0.00019058368,0.00007317018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004593523,0.00007850248,0.00008400561,0.000107614855,0.00009821424,0.0000350374,0.0001593327,0.0000792836,0.000034915185],"category_scores_gemma":[0.00007510938,0.00008039543,0.000017189559,0.00018629515,0.00010292911,0.000023749819,0.00009998101,0.00017291293,0.000009163393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007924207,0.00003118796,0.014407351,0.000056125817,0.00001961366,0.000005673357,0.0005978711,0.000040332296,0.97697455,0.00023075101,0.0022164197,0.0053409114],"study_design_scores_gemma":[0.00053515215,0.00018589388,0.0050403173,0.000029184685,0.00000419237,0.000004123295,0.00009143926,0.000099760306,0.9882524,0.00024537172,0.0053747394,0.00013739818],"about_ca_topic_score_codex":0.0003125229,"about_ca_topic_score_gemma":0.00034333428,"teacher_disagreement_score":0.011277907,"about_ca_system_score_codex":0.00007326224,"about_ca_system_score_gemma":0.00018980938,"threshold_uncertainty_score":0.32784304},"labels":[],"label_agreement":null},{"id":"W2109980609","doi":"10.1158/0008-5472.can-04-1843","title":"Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Odds ratio; Breast cancer; Confidence interval; Genotype; Medicine; Myeloperoxidase; Population; Internal medicine; Oncology; Logistic regression; Physiology; Cancer; Gastroenterology; Biology; Genetics; Environmental health; Gene","score_opus":0.04211412772794069,"score_gpt":0.333936521024719,"score_spread":0.2918223932967783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109980609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96381354,0.0335503,0.00004722126,0.0013508219,0.0002600323,0.00042707476,0.00035935405,0.000046481393,0.00014514898],"genre_scores_gemma":[0.97150356,0.025966559,0.00006825972,0.00021547232,0.00008211246,0.00025240635,0.000019980878,0.000032485106,0.0018591858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981639,0.00028979493,0.00020084709,0.0005646073,0.00010240941,0.00067845616],"domain_scores_gemma":[0.99915534,0.00011781976,0.00005729592,0.0002809157,0.00028549554,0.00010315764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057240104,0.00020438376,0.0002794128,0.00019475856,0.0007140693,0.00006119883,0.00019154504,0.0001991191,0.0017024523],"category_scores_gemma":[0.000043084645,0.00017111476,0.00003102315,0.00024511997,0.0007782877,0.0001846408,0.0002448194,0.00072898576,0.00039401551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028393845,0.0000635388,0.018671665,0.00007565716,0.00017901775,0.000020213829,0.00055995106,0.000012586445,0.96187264,0.004163504,0.00076339446,0.013333901],"study_design_scores_gemma":[0.00461514,0.0002243849,0.14818174,0.0002899916,0.0000771821,0.00017129898,0.00023677522,0.0000011536217,0.8150614,0.0046730554,0.025998138,0.00046976202],"about_ca_topic_score_codex":0.0040332186,"about_ca_topic_score_gemma":0.000782918,"teacher_disagreement_score":0.14681125,"about_ca_system_score_codex":0.00016742665,"about_ca_system_score_gemma":0.00026929748,"threshold_uncertainty_score":0.9992101},"labels":[],"label_agreement":null},{"id":"W2110064443","doi":"10.1158/0008-5472.can-06-4478","title":"Oncogenic Potential of the <i>miR-106-363</i> Cluster and Its Implication in Human T-Cell Leukemia","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":242,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"microRNA; Biology; Retrovirus; Gene; Provirus; Leukemia; Cancer research; Genetics","score_opus":0.03151364309701292,"score_gpt":0.3464779174352021,"score_spread":0.3149642743381892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110064443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845094,0.011802916,0.000004997984,0.0003003749,0.00019606968,0.00030461716,0.000013687864,0.000007106711,0.002860843],"genre_scores_gemma":[0.99235505,0.00062547106,0.0000017957135,0.00005191501,0.00004836835,0.000029481664,0.000004736866,0.000008999625,0.0068741585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894583,0.00015966961,0.00020575934,0.00021205097,0.000072289244,0.00040442593],"domain_scores_gemma":[0.9995388,0.00008399996,0.000052594227,0.00018821335,0.00011924304,0.00001714773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007869517,0.000079243495,0.00014147059,0.00010795966,0.0002765881,0.0000057963657,0.00022836962,0.00015385699,0.00009664656],"category_scores_gemma":[0.000022659578,0.000053194,0.000043556276,0.00023591502,0.00035139333,0.000030859435,0.00027725403,0.00047550723,0.000043172186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111578454,0.000034692002,0.0037476684,0.000039973183,0.000023180504,9.596545e-7,0.00033467743,0.000004110346,0.9916599,0.00018070404,0.0024826198,0.0013799443],"study_design_scores_gemma":[0.0012373477,0.00008123474,0.033356387,0.000031286967,0.000010029845,0.0000058650903,0.0002969447,0.000001178854,0.9532279,0.00012598054,0.011550532,0.00007532378],"about_ca_topic_score_codex":0.0011380402,"about_ca_topic_score_gemma":0.0008367839,"teacher_disagreement_score":0.038432006,"about_ca_system_score_codex":0.00016816647,"about_ca_system_score_gemma":0.000120725985,"threshold_uncertainty_score":0.21691883},"labels":[],"label_agreement":null},{"id":"W2110212786","doi":"10.1158/0008-5472.can-07-2950","title":"Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Unfolded protein response; Angiogenesis; Cancer research; Biology; Carcinogenesis; Tumor promotion; Endoplasmic reticulum; Tumor initiation; Tumor progression; Transgene; Mammary tumor; Cancer; Immunology; Cell biology; Breast cancer; Genetics","score_opus":0.03861502594150171,"score_gpt":0.3309333852695458,"score_spread":0.29231835932804406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110212786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565184,0.0034009453,0.000008038703,0.0003257304,0.000042928375,0.00037494232,0.00003679662,0.0000035153053,0.00015524204],"genre_scores_gemma":[0.9990344,0.00036796837,0.00007923114,0.00005438859,0.000061885075,0.00032814822,0.000012319162,0.000017766493,0.000043875716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834245,0.00022820436,0.0002835562,0.0003831863,0.00036644939,0.00039616498],"domain_scores_gemma":[0.9993354,0.000040467443,0.000029825796,0.00028512042,0.00017779937,0.00013139738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000310161,0.00013101101,0.00018136998,0.00010184304,0.00012685516,0.000018159435,0.00026250066,0.00005144327,0.000017293682],"category_scores_gemma":[0.00019490831,0.00010554467,0.00004404654,0.00026700317,0.00022935968,0.000010297295,0.00015170229,0.00014874723,8.6891987e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022062472,0.00022846264,0.30666125,0.00015029711,0.0000164842,0.0000623443,0.000348065,0.000044582725,0.6915785,0.00016528994,0.00005135232,0.00047272598],"study_design_scores_gemma":[0.0007052528,0.000067166104,0.27430826,0.000084714455,0.0000030902852,0.000014129616,0.00027916319,0.000054988763,0.7240977,0.00003637964,0.00022204501,0.00012706894],"about_ca_topic_score_codex":0.0003090562,"about_ca_topic_score_gemma":0.0011740957,"teacher_disagreement_score":0.03251922,"about_ca_system_score_codex":0.000048030346,"about_ca_system_score_gemma":0.0007738455,"threshold_uncertainty_score":0.43039867},"labels":[],"label_agreement":null},{"id":"W2110362524","doi":"10.1158/0008-5472.can-07-0999","title":"Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Mesenchymal stem cell; Side population; Population; Cancer research; Progenitor cell; Pathology; Efflux; Biology; Transplantation; Tumor progression; Cancer stem cell; Stem cell; Immunology; Medicine; Cancer; Internal medicine; Cell biology; Biochemistry; Genetics","score_opus":0.06698889976118792,"score_gpt":0.4022808876160348,"score_spread":0.3352919878548469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110362524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927597,0.0012073887,0.0010407099,0.0004632712,0.00054824003,0.0005096512,0.00007981163,0.000055851837,0.0033353507],"genre_scores_gemma":[0.9960233,0.00016261895,0.00089811493,0.00028411148,0.0012722097,0.000032581313,0.000112067544,0.00004699679,0.0011679888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973468,0.00010828498,0.00038852563,0.00044812783,0.0009427163,0.00076550676],"domain_scores_gemma":[0.99865633,0.00020047493,0.000085490276,0.00033110694,0.00037534875,0.00035124386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011060128,0.00015782345,0.00030816495,0.00029896377,0.00022293498,0.00006059239,0.00012794252,0.00010537332,0.0015378322],"category_scores_gemma":[0.00012414863,0.00014581622,0.000112755224,0.00047805495,0.00009612406,0.00011956697,0.000101501886,0.0006914369,0.00009498684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018396808,0.000133649,0.014274635,0.00011773852,0.00015086662,0.0007944153,0.00088134396,0.00017512472,0.9181221,0.000033164826,0.0030531054,0.06042414],"study_design_scores_gemma":[0.0049733273,0.000641098,0.08136313,0.0005454816,0.00020853373,0.000058136466,0.0020101815,0.0020494342,0.88849854,0.00043178775,0.018698893,0.0005214223],"about_ca_topic_score_codex":0.025232414,"about_ca_topic_score_gemma":0.0025692885,"teacher_disagreement_score":0.06708849,"about_ca_system_score_codex":0.0004693268,"about_ca_system_score_gemma":0.00031500403,"threshold_uncertainty_score":0.9993749},"labels":[],"label_agreement":null},{"id":"W2110368472","doi":"10.1158/0008-5472.can-13-3021","title":"Ly49 Family Receptors Are Required for Cancer Immunosurveillance Mediated by Natural Killer Cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Immunoediting; Immunosurveillance; Biology; NKG2D; Natural killer cell; MHC class I; Immune system; Cancer research; Receptor; Major histocompatibility complex; Interleukin 12; Lymphokine-activated killer cell; Cancer cell; Immunology; Interleukin 21; Cell biology; Cancer; Cytotoxic T cell; Immunotherapy; T cell; Genetics","score_opus":0.0359361781749221,"score_gpt":0.3369864935975878,"score_spread":0.3010503154226657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110368472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81661505,0.073110245,0.00034920726,0.0052099917,0.09861325,0.0020051787,0.00015936591,0.00034778065,0.0035899377],"genre_scores_gemma":[0.80441564,0.003839906,0.00001127183,0.0007008596,0.00024190576,0.0007635562,0.00044985843,0.000055351407,0.18952166],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976739,0.0005833966,0.00034051263,0.0004947837,0.00013026963,0.0007770981],"domain_scores_gemma":[0.9981203,0.00062684884,0.00014772211,0.00037242484,0.0006897002,0.00004297737],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009637068,0.00020961241,0.0003326509,0.00017881005,0.00048564115,0.00004634413,0.00037169567,0.00029928697,0.0028269803],"category_scores_gemma":[0.00036473174,0.00018244807,0.0001233985,0.0003334073,0.0003013984,0.00015909543,0.000088055465,0.000778371,0.0009098842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047580694,0.000027748949,0.00021062481,0.000021063912,0.0000763514,1.1716143e-7,0.00009041134,0.0000035800124,0.5314107,0.000015916596,0.46345302,0.004214636],"study_design_scores_gemma":[0.001229888,0.0001307296,0.00074577593,0.00006412723,0.0000065240965,0.0000010046369,0.00028823756,0.000028955697,0.24370523,0.000010971535,0.75361055,0.00017801452],"about_ca_topic_score_codex":0.0015817002,"about_ca_topic_score_gemma":0.00019036113,"teacher_disagreement_score":0.29015753,"about_ca_system_score_codex":0.00036780376,"about_ca_system_score_gemma":0.00013855347,"threshold_uncertainty_score":0.99986804},"labels":[],"label_agreement":null},{"id":"W2110437484","doi":"10.1158/0008-5472.can-06-0761","title":"IQGAP1 Protein Specifies Amplifying Cancer Cells in Glioblastoma Multiforme","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Nestin; IQGAP1; Progenitor cell; Glioma; Biology; Oligodendroglioma; Cancer stem cell; Cancer cell; Neural stem cell; Cancer research; Population; Glioblastoma; Cancer; Stem cell; Pathology; Cell biology; Scaffold protein; Medicine; Genetics; Signal transduction; Astrocytoma","score_opus":0.07877685881142431,"score_gpt":0.4014252855897452,"score_spread":0.3226484267783209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110437484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908898,0.0034358131,0.0000027519786,0.0022629427,0.0001002636,0.0013285109,0.0000381387,0.00003775777,0.0019040472],"genre_scores_gemma":[0.9945455,0.0004989929,0.00013170151,0.000047938218,0.00044937388,0.0022460727,0.0000054531947,0.00003747282,0.0020374896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785066,0.00006917796,0.00026234394,0.00040790223,0.000683435,0.00072647154],"domain_scores_gemma":[0.9992025,0.00008633623,0.000038375,0.00030927965,0.000221081,0.00014241987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003413307,0.00016060135,0.0002835607,0.0004402514,0.00012680615,0.000057432728,0.00012388501,0.00009310897,0.00094504585],"category_scores_gemma":[0.000029776558,0.00012925924,0.00007237222,0.0007533749,0.00014358375,0.00008327874,0.000080004436,0.00039789738,0.00016660843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069316017,0.000891417,0.10072025,0.00034787145,0.0000611095,0.000772824,0.00034028557,0.00024493475,0.8654004,0.0005299303,0.013687724,0.0163101],"study_design_scores_gemma":[0.0029141475,0.0002434577,0.058574658,0.00080866244,0.000013136875,0.0000061276555,0.00020393745,0.00008616065,0.9090579,0.00023432355,0.027695682,0.00016176344],"about_ca_topic_score_codex":0.021504398,"about_ca_topic_score_gemma":0.011620328,"teacher_disagreement_score":0.043657545,"about_ca_system_score_codex":0.000948347,"about_ca_system_score_gemma":0.00029951392,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W2110600280","doi":"10.1158/0008-5472.can-08-2645","title":"Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Autocrine signalling; Receptor; Insulin-like growth factor; Endocrinology; Growth factor; Insulin-like growth factor 2; Internal medicine; Insulin receptor; Biology; Insulin; Receptor tyrosine kinase; Tyrosine kinase; Medicine; Insulin resistance","score_opus":0.05445602932394555,"score_gpt":0.3652539995875316,"score_spread":0.310797970263586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110600280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844253,0.0044737915,0.0000014852772,0.004876363,0.00013069705,0.0011873703,0.00070296513,0.0000827844,0.0041192127],"genre_scores_gemma":[0.99079233,0.003986336,0.00015285632,0.0007444048,0.00048735537,0.00039359715,0.0007316887,0.00004896686,0.00266245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99650204,0.00015794058,0.00055441516,0.0007484826,0.0009990212,0.0010380774],"domain_scores_gemma":[0.9982998,0.00016169992,0.000083250095,0.0003979111,0.0004342221,0.00062313554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003650229,0.0003805027,0.0005890291,0.0008260716,0.0005127487,0.000062147235,0.00022123236,0.00028551914,0.005166234],"category_scores_gemma":[0.0002793223,0.00031834788,0.00012911457,0.0009202362,0.00028901163,0.00030765406,0.00012977676,0.0008592164,0.00016099459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091510955,0.009025488,0.050519224,0.0005707023,0.0007204801,0.0012193485,0.020688422,0.0000024452916,0.36060905,0.008457839,0.21480201,0.3242339],"study_design_scores_gemma":[0.016431907,0.018833196,0.5999641,0.0006870624,0.000055960594,0.00009134806,0.0008525839,0.000036216345,0.069910355,0.0046815537,0.2874683,0.0009874101],"about_ca_topic_score_codex":0.0012826057,"about_ca_topic_score_gemma":0.00016355947,"teacher_disagreement_score":0.54944485,"about_ca_system_score_codex":0.0012068953,"about_ca_system_score_gemma":0.00073986343,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2110687454","doi":"10.1158/0008-5472.can-07-5869","title":"Rictor and Integrin-Linked Kinase Interact and Regulate Akt Phosphorylation and Cancer Cell Survival","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Canadian Breast Cancer Research Alliance; Cancer Research Society","keywords":"Protein kinase B; mTORC2; Integrin-linked kinase; PI3K/AKT/mTOR pathway; Phosphorylation; Cell biology; Cancer research; Kinase; Biology; Chemistry; Signal transduction; mTORC1; Protein kinase A; Cyclin-dependent kinase 2","score_opus":0.061319918341768136,"score_gpt":0.3687465738661013,"score_spread":0.3074266555243332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110687454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637826,0.03493591,0.000057252095,0.00024059105,0.00025332425,0.00024891784,0.000038224018,0.0000116504925,0.00043151213],"genre_scores_gemma":[0.97219,0.024833858,0.000107537315,0.00007549683,0.0003922123,0.00011483058,0.000018807184,0.00003625322,0.0022309863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844897,0.00014009046,0.00018033241,0.00056222937,0.0002806809,0.00038767452],"domain_scores_gemma":[0.99915546,0.00006443021,0.000056642977,0.0002726967,0.0002573579,0.00019339392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041383368,0.00017446191,0.00018304805,0.00006195058,0.00022010245,0.000051255804,0.0001428621,0.00016670533,0.00010877287],"category_scores_gemma":[0.0000759439,0.00016293961,0.000029892017,0.00012953245,0.00042178557,0.000016295564,0.00024931505,0.0002998575,0.00000207055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004731772,0.000031858566,0.017850222,0.00009905164,0.000054589233,0.000015215644,0.00050673285,0.000041346666,0.9678984,0.000021529222,0.0029007578,0.01010706],"study_design_scores_gemma":[0.001945101,0.0005219134,0.035597485,0.00015995183,0.000025184607,0.00002733411,0.00024830565,0.0004146811,0.88605773,0.00009581986,0.07442221,0.00048429196],"about_ca_topic_score_codex":0.0023204852,"about_ca_topic_score_gemma":0.0006070614,"teacher_disagreement_score":0.08184074,"about_ca_system_score_codex":0.00012474321,"about_ca_system_score_gemma":0.00023949171,"threshold_uncertainty_score":0.66444844},"labels":[],"label_agreement":null},{"id":"W2110746374","doi":"10.1158/1538-7445.am2014-4055","title":"Abstract 4055: The transcriptional regulator TBX3 promotes progression of cells representing early premalignant breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Matrigel; Breast cancer; Cancer research; Biology; Cancer; Regulator; Downregulation and upregulation; Tumor progression; Cancer cell; Vimentin; Pathology; Medicine; Immunohistochemistry; Angiogenesis; Immunology; Gene; Genetics","score_opus":0.03545445611164403,"score_gpt":0.3576566594202092,"score_spread":0.32220220330856514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110746374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608725,0.0020514627,0.000057427562,0.0008452368,0.00019055099,0.000415865,0.000040578714,0.000006930994,0.0003046817],"genre_scores_gemma":[0.9969339,0.0005429946,0.00007211738,0.000013269322,0.000984155,0.0001432267,0.000010429592,0.000025119745,0.0012747885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833804,0.00013437164,0.00022532803,0.00047150865,0.0004914725,0.00033926085],"domain_scores_gemma":[0.9988969,0.00001654962,0.00009540433,0.00044096468,0.00047647615,0.00007371205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010094981,0.0001116729,0.000118297736,0.000043882632,0.00021207811,0.00003716089,0.00027849723,0.00011491686,0.0001012193],"category_scores_gemma":[0.000039764123,0.000072427836,0.00008593706,0.00016023443,0.00031308967,0.0000060477887,0.000105757834,0.0001982829,0.0000037977948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001760223,0.00006090202,0.0042187306,0.00008706602,0.000038245515,3.936002e-7,0.00010666521,0.00010885259,0.9822688,0.00008034644,0.00083079847,0.01202319],"study_design_scores_gemma":[0.00019180341,0.00015517435,0.12565278,0.000118696036,0.000009372247,0.0000044034573,0.000042829623,0.000061691615,0.8645621,0.00008131311,0.009024651,0.000095194555],"about_ca_topic_score_codex":0.00029233829,"about_ca_topic_score_gemma":0.00005378497,"teacher_disagreement_score":0.12143404,"about_ca_system_score_codex":0.000021835269,"about_ca_system_score_gemma":0.00017511313,"threshold_uncertainty_score":0.29535213},"labels":[],"label_agreement":null},{"id":"W2110895221","doi":"10.1158/0008-5472.can-08-1812","title":"Black Cohosh Increases Metastatic Mammary Cancer in Transgenic Mice Expressing c-<i>erb</i>B2","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Black cohosh; Medicine; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Internal medicine; Estrogen; Menopause; Mammary gland; Carcinogenesis; Physiology; Traditional medicine","score_opus":0.04697026457749243,"score_gpt":0.3673499890064097,"score_spread":0.32037972442891727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110895221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658368,0.0325842,0.00009379705,0.00028285664,0.0000915278,0.0003723702,0.00003552323,0.000014983374,0.0006879301],"genre_scores_gemma":[0.9734516,0.024189996,0.00013757835,0.00012637401,0.00022792313,0.00025282768,0.000035649813,0.000039410836,0.0015386459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792886,0.00039512446,0.00021991778,0.00047850504,0.00035640693,0.00062119117],"domain_scores_gemma":[0.9992449,0.00006293393,0.000038482154,0.0003383003,0.00013555567,0.000179826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000429317,0.00017615585,0.00021452924,0.00014811971,0.00017340794,0.000028474758,0.00035509473,0.00015942707,0.000080390404],"category_scores_gemma":[0.00006583016,0.0001607497,0.00009584682,0.00040652812,0.00035851425,0.000013287302,0.00012391855,0.00046833922,0.000019879215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027351646,0.00012322344,0.0037148832,0.00009436126,0.00011869212,0.000095347634,0.00028411025,0.0005312689,0.98588854,0.000015639693,0.00672069,0.0021397413],"study_design_scores_gemma":[0.0018571281,0.00024971043,0.004263753,0.00021236167,0.000028111048,0.000048440965,0.00013369504,0.00023656202,0.9816095,0.000056336816,0.010941534,0.0003628653],"about_ca_topic_score_codex":0.0019637113,"about_ca_topic_score_gemma":0.00034771502,"teacher_disagreement_score":0.008394206,"about_ca_system_score_codex":0.00009295642,"about_ca_system_score_gemma":0.0006638621,"threshold_uncertainty_score":0.65551823},"labels":[],"label_agreement":null},{"id":"W2111089430","doi":"10.1158/0008-5472.can-06-3401","title":"N-Cadherin Signaling Potentiates Mammary Tumor Metastasis via Enhanced Extracellular Signal-Regulated Kinase Activation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Cancer Institute","keywords":"MAPK/ERK pathway; Cancer research; Motility; Biology; Cadherin; Kinase; Metastasis; Signal transduction; Cell biology; Internal medicine; Medicine; Cancer; Cell","score_opus":0.03511553358423066,"score_gpt":0.3342712330590182,"score_spread":0.29915569947478754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111089430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9192398,0.004384938,0.07522736,0.00017963086,0.00016606874,0.00039698827,0.00000773948,0.000042208863,0.00035528012],"genre_scores_gemma":[0.9939117,0.0002558577,0.0018516802,0.00011198809,0.00044594286,0.00015346835,0.00014343858,0.00006246719,0.0030634766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99717844,0.0001808064,0.00040480978,0.00069366366,0.0006807241,0.000861535],"domain_scores_gemma":[0.99859804,0.000061026833,0.00012182723,0.0004103316,0.0005994067,0.00020935525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019660145,0.0002598781,0.00022321685,0.00023234266,0.00030832272,0.00009255091,0.0004940627,0.00019606567,0.00057899946],"category_scores_gemma":[0.000072407536,0.00025806972,0.00012374378,0.00064451405,0.00016943918,0.00002503495,0.00022051988,0.00036187607,0.000036168127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003977799,0.000060610746,0.00017758932,0.000052034233,0.00015713483,0.000027502672,0.00008928329,0.00033841043,0.97802,0.000033079094,0.0011584653,0.019488078],"study_design_scores_gemma":[0.00059501844,0.00013518517,0.0004518039,0.000076597855,0.000016762575,0.000004635602,0.000114556824,0.000062283856,0.9881074,0.00022521267,0.009878592,0.00033194668],"about_ca_topic_score_codex":0.00014774298,"about_ca_topic_score_gemma":0.000028188375,"teacher_disagreement_score":0.074671894,"about_ca_system_score_codex":0.00016406168,"about_ca_system_score_gemma":0.00033305032,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2111338227","doi":"10.1158/0008-5472.can-04-2898","title":"Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Antibody; Chemistry; Cell; Protein kinase B; Cancer research; Cell biology; Apoptosis; Molecular biology; Biochemistry; Biology; Immunology","score_opus":0.07255394647327673,"score_gpt":0.3785975475159622,"score_spread":0.30604360104268546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111338227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159586,0.003496337,0.00016573607,0.0003709884,0.0001437721,0.00031876052,0.00004206303,0.000015721453,0.0038507276],"genre_scores_gemma":[0.9946152,0.00061978033,0.00038975736,0.0000535394,0.0006236387,0.00007934524,0.000013700407,0.000043027092,0.0035620076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799424,0.0001788418,0.00020595844,0.0005022986,0.0004977786,0.00062089023],"domain_scores_gemma":[0.998822,0.000047857367,0.00008406991,0.00054411835,0.00038467345,0.00011727814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006947552,0.00016806959,0.00023363472,0.00011960743,0.00014079404,0.000034432378,0.00040189462,0.00017663137,0.00023372177],"category_scores_gemma":[0.00013532466,0.00016287519,0.00009244528,0.00027241005,0.0003822825,0.00001131476,0.00023293353,0.0002972263,0.000023413328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001225967,0.00018400684,0.0021514352,0.0001419182,0.000043039876,0.0000022164288,0.000097923534,0.0008146934,0.98616076,0.000013209475,0.0041242028,0.006143985],"study_design_scores_gemma":[0.00044031706,0.0003045147,0.00060315896,0.00006384583,0.000008739162,0.0000024305375,0.000043585635,0.00015252622,0.97571355,0.00002018772,0.022469303,0.0001778482],"about_ca_topic_score_codex":0.00020372125,"about_ca_topic_score_gemma":0.00010072407,"teacher_disagreement_score":0.018345099,"about_ca_system_score_codex":0.00014802118,"about_ca_system_score_gemma":0.0004248294,"threshold_uncertainty_score":0.66418576},"labels":[],"label_agreement":null},{"id":"W2111348546","doi":"10.1158/0008-5472.can-06-0186","title":"Divergent Routes to Oral Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Cancer; Head and neck squamous-cell carcinoma; Head and neck cancer; Basal cell; Phenotype; Tissue microarray; Cancer research; Medicine; Pathology; Biology; Gene; Internal medicine; Genetics","score_opus":0.1571529683774886,"score_gpt":0.4815161179822199,"score_spread":0.3243631496047313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111348546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95756537,0.009386941,0.0000148314,0.017635299,0.00040701582,0.0005683822,0.00004790586,0.00006127647,0.014312994],"genre_scores_gemma":[0.9672549,0.0013572061,0.000116940646,0.00084987836,0.0011060464,0.00077573134,0.000005737172,0.000028320528,0.028505262],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805075,0.00005175116,0.00016707243,0.0003436896,0.0007214955,0.0006652355],"domain_scores_gemma":[0.999017,0.00005173747,0.000014238145,0.0002507094,0.0004238404,0.000242463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035250097,0.00011713521,0.00028836282,0.00017627621,0.00022888467,0.000025538993,0.0001305109,0.000051086598,0.0019432838],"category_scores_gemma":[0.00005883688,0.000092290495,0.000060721875,0.00064825284,0.00011437431,0.000044013083,0.0001650193,0.00028825284,0.00023449551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041606033,0.00013807228,0.14605364,0.00014562499,0.00008888487,0.000069979986,0.00053828245,0.00005631345,0.0427496,0.00052629947,0.776966,0.03225129],"study_design_scores_gemma":[0.0011832416,0.0003802212,0.21860582,0.00034539588,0.000029513709,0.0000029574007,0.00018934242,0.000020020476,0.04010023,0.00017669979,0.73877513,0.00019140703],"about_ca_topic_score_codex":0.022611408,"about_ca_topic_score_gemma":0.007393843,"teacher_disagreement_score":0.07255218,"about_ca_system_score_codex":0.00060334516,"about_ca_system_score_gemma":0.0004454149,"threshold_uncertainty_score":0.9989691},"labels":[],"label_agreement":null},{"id":"W2111485737","doi":"10.1158/0008-5472.can-11-2739","title":"Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Cachexia; Anorexia; PI3K/AKT/mTOR pathway; Medicine; Cytokine; Weight loss; Cancer; Cancer research; Endocrinology; Phenotype; Skeletal muscle; Internal medicine; Biology; Obesity; Signal transduction; Cell biology; Gene","score_opus":0.08649127049100554,"score_gpt":0.3353709732935846,"score_spread":0.2488797028025791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111485737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799335,0.00095126906,0.00004397302,0.000056915473,0.000015506332,0.00042914183,0.000040444666,0.0000050507056,0.0004643539],"genre_scores_gemma":[0.998847,0.00028746613,0.00024300665,0.0000139831,0.00001844655,0.00044009413,0.000013708956,0.000019038613,0.00011725371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986901,0.00022775424,0.0001767554,0.00036805755,0.00015573682,0.00038157974],"domain_scores_gemma":[0.99950165,0.000026471565,0.00004692702,0.00021327854,0.000133209,0.00007845178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005568388,0.00011196767,0.00018322833,0.00009575415,0.00006933564,0.0000055428773,0.00022369661,0.00017440933,0.000054650427],"category_scores_gemma":[0.0002259826,0.00010689641,0.000034848264,0.00013882873,0.00024913062,0.000007218747,0.0001962136,0.00021389598,0.000003034253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628373,0.000108644155,0.01705721,0.00016634946,0.000043848853,0.000006987615,0.0003823579,0.00024381057,0.9806533,0.00010717903,0.00011184401,0.00035564764],"study_design_scores_gemma":[0.0015322873,0.001110413,0.05198861,0.0002762208,0.000023146104,0.0000093638655,0.00083970756,0.007288285,0.93430716,0.0018873048,0.00011886993,0.0006186415],"about_ca_topic_score_codex":0.00037181954,"about_ca_topic_score_gemma":0.00018194971,"teacher_disagreement_score":0.04634613,"about_ca_system_score_codex":0.000018159551,"about_ca_system_score_gemma":0.00021165417,"threshold_uncertainty_score":0.4359109},"labels":[],"label_agreement":null},{"id":"W2111489144","doi":"10.1158/0008-5472.can-05-4411","title":"Highly Efficacious Nontoxic Preclinical Treatment for Advanced Metastatic Breast Cancer Using Combination Oral UFT-Cyclophosphamide Metronomic Chemotherapy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Combination therapy; Pharmacology; Breast cancer; Prodrug; Cancer; Oncology; Combination chemotherapy; Internal medicine","score_opus":0.07068284038228259,"score_gpt":0.4304638379663733,"score_spread":0.35978099758409066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111489144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855093,0.01031994,0.0016786525,0.00073131075,0.00028761575,0.0010410857,0.00034880603,0.000017423214,0.00006588513],"genre_scores_gemma":[0.991507,0.0028980596,0.0014653165,0.000117183634,0.00063961156,0.0011809758,0.00014234353,0.00007756197,0.0019719373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797964,0.00013484956,0.00034811103,0.00064567494,0.00026728047,0.0006244508],"domain_scores_gemma":[0.9989752,0.00007768632,0.00011585463,0.0003705781,0.0003440716,0.00011656398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046228542,0.00024327765,0.00033161187,0.000094996176,0.00023653965,0.000049622755,0.00023778193,0.00013407013,0.00010331749],"category_scores_gemma":[0.000020980933,0.0002132265,0.00023432194,0.00021346493,0.00017578484,0.0000114190725,0.00005206532,0.000095242576,0.000004835512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025635494,0.0007251611,0.0088177305,0.00007904753,0.00046009396,0.0000029707467,0.00003656145,0.0068075415,0.8869817,0.00014930526,0.0041574007,0.089218885],"study_design_scores_gemma":[0.012993893,0.0016078973,0.019768272,0.00011116109,0.00017887677,0.00001170266,0.00008386836,0.0025112424,0.8851198,0.0004092871,0.076438405,0.00076560467],"about_ca_topic_score_codex":0.0018140149,"about_ca_topic_score_gemma":0.0009609784,"teacher_disagreement_score":0.08845328,"about_ca_system_score_codex":0.0007041081,"about_ca_system_score_gemma":0.0005812064,"threshold_uncertainty_score":0.8695125},"labels":[],"label_agreement":null},{"id":"W2111537434","doi":"10.1158/0008-5472.can-09-4439","title":"Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pseudopodia; Epithelial–mesenchymal transition; Cell migration; Biology; Metastasis; Cell biology; Cancer cell; Cancer; Actin; Actin cytoskeleton; Cancer research; Cytoskeleton; Cell; Biochemistry","score_opus":0.023588798669023067,"score_gpt":0.3630279464619603,"score_spread":0.3394391477929372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111537434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949165,0.00025454277,0.0015737563,0.001347933,0.00082401,0.00037385724,0.00031540034,0.0000064713354,0.00038750083],"genre_scores_gemma":[0.997476,0.0006516915,0.00009447749,0.00013529338,0.00047158985,0.00029819534,0.00007515358,0.000028044124,0.00076958793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864197,0.00014688788,0.00018882663,0.0003489418,0.00025254017,0.00042083173],"domain_scores_gemma":[0.99933106,0.000036953385,0.000038217007,0.000275853,0.0002054476,0.00011245481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056297524,0.00011915622,0.00014265475,0.00013385285,0.000112371636,0.00004616638,0.00020414995,0.00012593911,0.00062245067],"category_scores_gemma":[0.000058824447,0.00011686464,0.00008287925,0.00019963802,0.000087093445,0.000009055625,0.00004100356,0.00064076355,0.00002331582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001839118,0.00007947752,0.00006290874,0.00001647532,0.000032500273,0.000007905838,0.000073646435,0.0002031279,0.99466854,0.0002850972,0.000663108,0.0037233273],"study_design_scores_gemma":[0.001217903,0.00015796491,0.00017050977,0.00002202242,0.000016323243,0.0000069066314,0.00019446934,0.008027339,0.97047013,0.00020867876,0.019322127,0.00018561499],"about_ca_topic_score_codex":0.0022579376,"about_ca_topic_score_gemma":0.016102413,"teacher_disagreement_score":0.024198372,"about_ca_system_score_codex":0.00009100328,"about_ca_system_score_gemma":0.00035925218,"threshold_uncertainty_score":0.8985524},"labels":[],"label_agreement":null},{"id":"W2111608713","doi":"10.1158/0008-5472.can-10-0215","title":"eIF2α Kinase PKR Modulates the Hypoxic Response by Stat3-Dependent Transcriptional Suppression of HIF-1α","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Protein kinase R; Phosphorylation; Biology; Integrated stress response; eIF2; STAT3; Cell biology; Kinase; Transcription factor; STAT protein; Translational regulation; EIF-2 kinase; Signal transduction; Stress granule; Molecular biology; Protein kinase A; Messenger RNA; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 2; Translation (biology); Biochemistry; Gene","score_opus":0.028311881164752483,"score_gpt":0.35906676639293045,"score_spread":0.330754885228178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111608713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994918,0.0016604019,0.00006899882,0.0025084482,0.00015534235,0.0002305724,0.00024709807,0.000005933104,0.0002051915],"genre_scores_gemma":[0.99473065,0.00020440412,0.00003675126,0.000108661545,0.000115425464,0.00007792725,0.00008575064,0.000016759603,0.004623671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854916,0.00028937613,0.0001567994,0.00026649074,0.00047766455,0.00026048446],"domain_scores_gemma":[0.99908453,0.000057784033,0.00003599363,0.00042221206,0.00024868757,0.00015078814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007792248,0.00009077472,0.000080612364,0.00005510757,0.00016627,0.000029893623,0.0002995971,0.0001106579,0.0007324058],"category_scores_gemma":[0.00018356182,0.00006484696,0.00007069171,0.0001229526,0.0003079816,0.0000060464563,0.00007735006,0.0002294943,0.000010325457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018306953,0.00008403229,0.0008185028,0.000013318995,0.000016725991,0.0000018957693,0.000054577824,0.00005818184,0.97033644,0.00013731417,0.025512375,0.0011359223],"study_design_scores_gemma":[0.00073381315,0.00011533184,0.017806066,0.000010552317,0.0000056697736,0.0000021639355,0.00010510918,0.00014354254,0.90954524,0.00024243422,0.071195945,0.000094111594],"about_ca_topic_score_codex":0.00010291952,"about_ca_topic_score_gemma":0.00006195929,"teacher_disagreement_score":0.060791202,"about_ca_system_score_codex":0.000016154025,"about_ca_system_score_gemma":0.00028943064,"threshold_uncertainty_score":0.80193305},"labels":[],"label_agreement":null},{"id":"W2111713436","doi":"10.1158/0008-5472.can-07-5597","title":"Transforming Growth Factor–β Regulates Mammary Carcinoma Cell Survival and Interaction with the Adjacent Microenvironment","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Mayo Clinic","keywords":"Biology; Mammary tumor; Cancer research; Mouse mammary tumor virus; Stromal cell; Transforming growth factor; Tumor microenvironment; Progenitor cell; Tumor progression; Endocrinology; Immunology; Cancer; Cell biology; Stem cell; Virus; Breast cancer","score_opus":0.03403631635389183,"score_gpt":0.29277439481791956,"score_spread":0.25873807846402774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111713436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433124,0.004654918,0.00016360416,0.00037814616,0.00003813754,0.00022667299,0.000012811827,0.0000059342838,0.00018854155],"genre_scores_gemma":[0.9976346,0.001406962,0.00004005586,0.000031769134,0.00011733041,0.00007032586,0.000019047879,0.000019393527,0.00066051685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999026,0.00010271331,0.00008265583,0.00027922817,0.00024493478,0.00026445818],"domain_scores_gemma":[0.9995823,0.00002939088,0.000022844355,0.00022015738,0.00005962143,0.00008570763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001203754,0.000101840495,0.000074277785,0.000033315697,0.00024451292,0.000024719573,0.00017310634,0.000048776383,0.000025219018],"category_scores_gemma":[0.000007734991,0.00007003316,0.000028377108,0.000060388462,0.00023196926,0.0000075371695,0.00008763907,0.00015670857,0.0000025229426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025373252,0.000046231846,0.021627748,0.000052198357,0.000029844163,0.000014578258,0.00038991132,0.000028978515,0.97576356,0.0000056143185,0.00078669155,0.0010009214],"study_design_scores_gemma":[0.00036729718,0.00016309823,0.03896672,0.00001707965,0.000005664746,0.000014751379,0.00025762396,0.0000072077937,0.94770676,0.0000033186006,0.012388478,0.000102027356],"about_ca_topic_score_codex":0.00016281554,"about_ca_topic_score_gemma":0.000080383485,"teacher_disagreement_score":0.028056815,"about_ca_system_score_codex":0.000054575525,"about_ca_system_score_gemma":0.00012327326,"threshold_uncertainty_score":0.28558692},"labels":[],"label_agreement":null},{"id":"W2111777421","doi":"10.1158/0008-5472.can-10-3757","title":"Fes Tyrosine Kinase Expression in the Tumor Niche Correlates with Enhanced Tumor Growth, Angiogenesis, Circulating Tumor Cells, Metastasis, and Infiltrating Macrophages","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Metastasis; Angiogenesis; Tumor microenvironment; Cancer research; Tumor progression; Cancer; Biology; Cancer cell; Immunology; Medicine; Tumor cells; Internal medicine","score_opus":0.023213345933631193,"score_gpt":0.3090703218787083,"score_spread":0.28585697594507714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111777421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656297,0.011929406,0.000011822598,0.0003183836,0.00034177632,0.000537312,0.00005657688,0.00003459193,0.00020716434],"genre_scores_gemma":[0.9986371,0.00026506596,0.00017323198,0.0002150706,0.000108708286,0.00042553063,0.000029496086,0.00003348982,0.000112305686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744195,0.00069334364,0.00032343506,0.0005977815,0.00013526206,0.0008082295],"domain_scores_gemma":[0.99863666,0.00056359544,0.00014165053,0.00038144406,0.00022621253,0.000050423318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012332781,0.00025604994,0.0003504978,0.0002042128,0.00059929205,0.00007863748,0.00043624532,0.0001257882,0.00036432056],"category_scores_gemma":[0.00022085306,0.00016176933,0.00005541302,0.0005815439,0.0007103456,0.00011066301,0.00017046845,0.0013010697,0.000022030117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023759557,0.000072104864,0.018214907,0.000069665206,0.000039077728,0.00006518701,0.000929987,0.0000058816127,0.97800404,0.00009088605,0.0005259242,0.0017447697],"study_design_scores_gemma":[0.0011025328,0.00028617933,0.020040018,0.00013540463,0.000023641,0.00021885296,0.0020049154,0.0000050583476,0.9747843,0.000083848616,0.0010962113,0.00021901607],"about_ca_topic_score_codex":0.001247376,"about_ca_topic_score_gemma":0.0013776532,"teacher_disagreement_score":0.012074134,"about_ca_system_score_codex":0.000049874696,"about_ca_system_score_gemma":0.0002294733,"threshold_uncertainty_score":0.6596762},"labels":[],"label_agreement":null},{"id":"W2111973486","doi":"10.1158/0008-5472.can-05-1829","title":"Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Gefitinib; Epidermal growth factor receptor; Cancer research; Growth factor receptor inhibitor; Epidermal growth factor; Transformation (genetics); Mutant; Cancer; Biology; Cell biology; Chemistry; Internal medicine; Receptor; Medicine; Genetics; Gene","score_opus":0.08131793499971414,"score_gpt":0.40494700614049417,"score_spread":0.32362907114078004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111973486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854651,0.0012942548,0.00013573625,0.00587246,0.00029253087,0.003320544,0.0009958021,0.00012217698,0.0025013941],"genre_scores_gemma":[0.99288005,0.0037782693,0.0006258467,0.00019848761,0.0009198447,0.0008235533,0.00008299973,0.00016830237,0.0005226321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9907029,0.0009503986,0.0010783034,0.0011377992,0.004080233,0.00205035],"domain_scores_gemma":[0.99467516,0.0005999819,0.00035912337,0.00064871804,0.0026986632,0.0010183332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014316187,0.00060017884,0.0010619126,0.00082430773,0.00045178464,0.00011560024,0.00061872596,0.0004772996,0.0033573783],"category_scores_gemma":[0.00024231429,0.0004776565,0.00022281567,0.0013642027,0.0008723433,0.0008165968,0.00020880325,0.0022848146,0.00016408524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033271154,0.00063439325,0.007653458,0.0019779645,0.00022498872,0.00011789511,0.008411945,0.00010574484,0.9247961,0.000037716738,0.0013624517,0.051350225],"study_design_scores_gemma":[0.0042392444,0.0012540881,0.024027577,0.0015585711,0.00005049989,0.00002754793,0.001535038,0.000323054,0.96526444,0.000019604726,0.0012023333,0.0004980133],"about_ca_topic_score_codex":0.004248712,"about_ca_topic_score_gemma":0.0008972368,"teacher_disagreement_score":0.05085221,"about_ca_system_score_codex":0.0020152426,"about_ca_system_score_gemma":0.003102413,"threshold_uncertainty_score":0.9997675},"labels":[],"label_agreement":null},{"id":"W2112012653","doi":"10.1158/0008-5472.can-04-3271","title":"Altered Immunity Accompanies Disease Progression in a Mouse Model of Prostate Dysplasia","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Immune system; IL-2 receptor; Tumor progression; Prostate cancer; Biology; Prostate; Cancer research; Tumor microenvironment; Immunology; FOXP3; Genetically modified mouse; T cell; Immunity; Cancer; Transgene","score_opus":0.06467756936887632,"score_gpt":0.3893495910207262,"score_spread":0.3246720216518499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112012653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97819734,0.020254675,0.000010255483,0.0005880453,0.00007884745,0.0005909138,0.00009708999,0.00003166404,0.00015114463],"genre_scores_gemma":[0.9887627,0.0026600712,0.000059607686,0.00003313746,0.0000193586,0.00031002262,0.000032299682,0.000024395107,0.008098435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795514,0.0007357162,0.00035128774,0.00025143038,0.00011632984,0.0005901113],"domain_scores_gemma":[0.9990608,0.00016256908,0.00007857764,0.00047046115,0.00019468635,0.00003288413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008937775,0.00014853363,0.00026984207,0.00035630626,0.00020824767,0.00001925809,0.00043662105,0.00012239754,0.0003326089],"category_scores_gemma":[0.00012878963,0.00012387896,0.000067534864,0.00028742792,0.0005571377,0.00021017241,0.00019141691,0.00069428526,0.00007882167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075628967,0.0004051515,0.002483425,0.00006994137,0.00005581548,0.0000012137571,0.0021702906,0.0006416426,0.96098197,0.00014712263,0.00050318526,0.024977358],"study_design_scores_gemma":[0.002492317,0.00018766228,0.0062665306,0.0002602486,0.000006058774,0.0000018715658,0.0003503278,0.00039354875,0.9837972,0.00015757699,0.0059125875,0.00017410384],"about_ca_topic_score_codex":0.0003231506,"about_ca_topic_score_gemma":0.000091117276,"teacher_disagreement_score":0.024803255,"about_ca_system_score_codex":0.0001567267,"about_ca_system_score_gemma":0.0005181758,"threshold_uncertainty_score":0.5051637},"labels":[],"label_agreement":null},{"id":"W2112168902","doi":"10.1158/0008-5472.can-10-2840","title":"Transcriptional Control of the <i>ERBB2</i> Amplicon by ERRα and PGC-1β Promotes Mammary Gland Tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Carcinogenesis; Amplicon; Coactivator; Cancer research; Promoter; Estrogen receptor; Gene; Transcriptional regulation; Genetics; Cancer; Breast cancer; Transcription factor; Gene expression; Polymerase chain reaction","score_opus":0.049304997911372044,"score_gpt":0.3891240746085691,"score_spread":0.3398190766971971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112168902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707272,0.0061283344,0.00010594493,0.019063579,0.00027015182,0.0015718588,0.00030298618,0.000030044499,0.0017998777],"genre_scores_gemma":[0.9948064,0.0009621924,0.000082143684,0.00032665627,0.00037309589,0.00048340295,0.000010900765,0.00004190077,0.002913278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968394,0.00025273697,0.0003001557,0.00046091067,0.0014803199,0.00066650234],"domain_scores_gemma":[0.99801266,0.000316299,0.000049969163,0.00067045423,0.0006107879,0.0003398329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647768,0.00016313168,0.00034329886,0.00015084173,0.00023292421,0.00006105001,0.00047676626,0.00015994959,0.0006645551],"category_scores_gemma":[0.0003128522,0.0001118203,0.000097957665,0.0005390782,0.0009481192,0.00009771962,0.00011847031,0.0012813563,0.000011524719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039116293,0.00012499036,0.048772007,0.00040446897,0.0000713956,0.00001141412,0.00021752369,4.9369453e-7,0.92441195,0.0011113079,0.014010205,0.01047308],"study_design_scores_gemma":[0.007315629,0.0008098608,0.15910505,0.0005053193,0.00007852173,0.00013803711,0.00014703913,0.00028978012,0.49868822,0.0015419637,0.33101958,0.00036098337],"about_ca_topic_score_codex":0.0014208729,"about_ca_topic_score_gemma":0.00044033845,"teacher_disagreement_score":0.42572373,"about_ca_system_score_codex":0.0001374136,"about_ca_system_score_gemma":0.0012530651,"threshold_uncertainty_score":0.7276413},"labels":[],"label_agreement":null},{"id":"W2112192251","doi":"10.1158/1538-7445.am2012-lb-323","title":"Abstract LB-323: Self-reported sleep duration and subsequent risk of colorectal cancer in two large cohorts of women and men","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Body mass index; Colorectal cancer; Overweight; Confidence interval; Relative risk; Proportional hazards model; Internal medicine; Demography; Cancer; Sleep (system call)","score_opus":0.040687065278282857,"score_gpt":0.39996399562041535,"score_spread":0.3592769303421325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112192251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059194,0.007809691,5.0916236e-7,0.000259639,0.000037948852,0.00046481233,0.000104234954,0.0000059273625,0.00072532357],"genre_scores_gemma":[0.9892734,0.010299656,0.000025786743,0.000010343285,0.00009388099,0.00024965047,0.000009436496,0.000008701079,0.000029111965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987471,0.00005381095,0.00028054012,0.00014681797,0.00038420645,0.000387485],"domain_scores_gemma":[0.99930394,0.000107742984,0.000099741264,0.00007842953,0.00025411908,0.0001560012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014077143,0.000069602014,0.00025956795,0.000103944185,0.00006318351,0.0000047662875,0.00002548222,0.000038580285,0.0002249108],"category_scores_gemma":[0.00011037021,0.00005778052,0.000018280052,0.00020216312,0.00012245259,0.00007069814,0.000057764046,0.00018733281,5.8096936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006079931,0.00025533675,0.97357434,0.00029329315,0.00022182436,0.000009738288,0.0017645343,0.000002231804,0.021862289,0.000106934654,0.00045761792,0.0008438629],"study_design_scores_gemma":[0.0021258462,0.000133281,0.986099,0.00010085212,0.00003012513,0.0000048370703,0.00075152074,0.000049742182,0.009678597,0.00012730065,0.00084478734,0.000054120355],"about_ca_topic_score_codex":0.006068722,"about_ca_topic_score_gemma":0.0014879871,"teacher_disagreement_score":0.012524648,"about_ca_system_score_codex":0.00042073987,"about_ca_system_score_gemma":0.000119075354,"threshold_uncertainty_score":0.91741323},"labels":[],"label_agreement":null},{"id":"W2112284243","doi":"10.1158/0008-5472.can-11-1431","title":"Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Osteoprotegerin; Breast cancer; Bone metastasis; Metastasis; Cancer research; Medicine; Cancer; Downregulation and upregulation; RANKL; Internal medicine; Metastatic breast cancer; Estrogen receptor; Oncology; Receptor; Biology","score_opus":0.13163492136553884,"score_gpt":0.4172518366093255,"score_spread":0.2856169152437867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112284243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469966,0.0035689403,0.00000625861,0.0008611404,0.000018377186,0.00050965906,0.000056508365,0.0000040039167,0.0002754613],"genre_scores_gemma":[0.99743885,0.002085202,0.00007662668,0.00001995737,0.0000164201,0.00028620366,0.000007493386,0.000006434482,0.00006281019],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99927557,0.000039426235,0.00019688423,0.00012469056,0.00020041053,0.00016300437],"domain_scores_gemma":[0.9995073,0.000019559984,0.00005766923,0.00012003675,0.00019903928,0.000096399635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032137535,0.000051069444,0.00016803325,0.00017582024,0.00003214296,0.0000023902876,0.00001562316,0.00004283929,0.00011179964],"category_scores_gemma":[0.0000111112795,0.000041923475,0.000011899932,0.0002553081,0.00009773634,0.00010415329,0.000026363177,0.00011405763,0.0000012282856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005907107,0.00040557704,0.3967306,0.0031557102,0.0001336185,0.000013379249,0.0044095083,6.1644056e-7,0.057272065,0.0006140755,0.0004897913,0.53086793],"study_design_scores_gemma":[0.001894367,0.00031798464,0.9727937,0.00018845021,0.000032000196,0.00003071917,0.00030304535,0.000016511565,0.024031712,0.00018507929,0.00017187922,0.00003458192],"about_ca_topic_score_codex":0.012627712,"about_ca_topic_score_gemma":0.0009289925,"teacher_disagreement_score":0.57606304,"about_ca_system_score_codex":0.00008887463,"about_ca_system_score_gemma":0.00016160125,"threshold_uncertainty_score":0.99394727},"labels":[],"label_agreement":null},{"id":"W2112288351","doi":"10.1158/0008-5472.can-10-3172","title":"Disruption of a <i>Sirt1</i>-Dependent Autophagy Checkpoint in the Prostate Results in Prostatic Intraepithelial Neoplasia Lesion Formation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Autophagy; Prostate cancer; Cancer research; Prostate; Biology; Androgen receptor; Histone; Sirtuin 1; Sirtuin; BAG3; Intraepithelial neoplasia; Cancer; Cell biology; Gene; Genetics; Apoptosis; Downregulation and upregulation; Acetylation","score_opus":0.056730006606063865,"score_gpt":0.4115998480632752,"score_spread":0.35486984145721134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112288351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906114,0.00022503608,0.000016380423,0.0064964276,0.00025619494,0.0017199966,0.00002203784,0.000011909655,0.0006406563],"genre_scores_gemma":[0.99825686,0.0006022758,0.000091510454,0.00011009128,0.00025883724,0.00033274773,0.000038325496,0.000015650568,0.00029370075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974541,0.00024761294,0.0005906211,0.0002568951,0.00103446,0.0004163109],"domain_scores_gemma":[0.99899554,0.00019670656,0.000102080005,0.00037495384,0.00024464968,0.00008607195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040104184,0.000115572395,0.00025535372,0.00040418177,0.00006830847,0.000024121504,0.00017794056,0.00011763385,0.000046472232],"category_scores_gemma":[0.0006685906,0.00006824321,0.000041475378,0.00069092266,0.00022582394,0.00013577151,0.000051947893,0.0013141725,0.000010300808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004527448,0.0004737774,0.0044205124,0.0006766244,0.000012304974,0.00019565859,0.01875876,0.00008077823,0.9238419,0.0002696799,0.00074264524,0.045999907],"study_design_scores_gemma":[0.03156523,0.0038335593,0.37638298,0.0031930606,0.00005756656,0.00026836726,0.013890902,0.009555191,0.5525745,0.0017195431,0.0065614316,0.00039766714],"about_ca_topic_score_codex":0.0012095718,"about_ca_topic_score_gemma":0.0024625356,"teacher_disagreement_score":0.37196246,"about_ca_system_score_codex":0.00017516469,"about_ca_system_score_gemma":0.00035956083,"threshold_uncertainty_score":0.57094985},"labels":[],"label_agreement":null},{"id":"W2112302797","doi":"10.1158/0008-5472.can-07-6833","title":"Inhibition of the Sodium/Potassium ATPase Impairs <i>N</i>-Glycan Expression and Function","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Jurkat cells; Glycan; Chemistry; Concanavalin A; Glycoconjugate; Programmed cell death; Biochemistry; Lectin; Molecular biology; Glycoprotein; Biology; In vitro; T cell; Apoptosis; Immunology","score_opus":0.03827017549658254,"score_gpt":0.32801386975039,"score_spread":0.2897436942538074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112302797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969736,0.0009796493,0.00009608387,0.00044990034,0.000077165,0.00035116874,0.00001991534,0.000006136107,0.0010464293],"genre_scores_gemma":[0.99706006,0.00082318037,0.0000274941,0.000060930044,0.00016972267,0.00011073469,0.000020007956,0.000014538465,0.0017133357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986218,0.00022535832,0.00014064442,0.00026450446,0.00047983468,0.00026782084],"domain_scores_gemma":[0.9991982,0.000018084022,0.000042214204,0.00033473867,0.0003075665,0.0000992111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042834517,0.00008051367,0.00008151909,0.000078951765,0.0003331437,0.000014299603,0.00012729829,0.00010972232,0.000093663686],"category_scores_gemma":[0.00012601432,0.000057611367,0.000050226474,0.00026097038,0.00040686136,0.000007658956,0.00024582108,0.00023488824,0.0000055525593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030179127,0.000033712247,0.00444928,0.000034787437,0.000007434026,0.0000018215554,0.00007777905,0.000011817069,0.98566496,0.000029063513,0.007759159,0.0016283755],"study_design_scores_gemma":[0.0006136438,0.00020381695,0.0119583355,0.00004283924,0.000002167069,0.0000086291575,0.000097500466,0.00002302254,0.9628424,0.00007000933,0.024068976,0.000068630274],"about_ca_topic_score_codex":0.00022572592,"about_ca_topic_score_gemma":0.00010096299,"teacher_disagreement_score":0.02282255,"about_ca_system_score_codex":0.000031702468,"about_ca_system_score_gemma":0.000248357,"threshold_uncertainty_score":0.25623056},"labels":[],"label_agreement":null},{"id":"W2112392406","doi":"10.1158/1538-7445.am2011-1778","title":"Abstract 1778: Anticancer activities and regulatory effects on apoptotic gene expression of Bufalin in the orthotopic transplantation model of human colorectal cancer in nude mice","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bufalin; Apoptosis; Transplantation; TUNEL assay; H&E stain; Colorectal cancer; Cancer; Medicine; Immunohistochemistry; Saline; Nude mouse; Pharmacology; Internal medicine; Pathology; Biology; Biochemistry","score_opus":0.0788656998403976,"score_gpt":0.38416950266096633,"score_spread":0.30530380282056874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112392406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978458,0.00096960115,0.000014029181,0.0000671052,0.00004821698,0.00072423014,0.000030004536,0.0000050468534,0.0002959411],"genre_scores_gemma":[0.9972449,0.0022230984,0.00006342143,0.000041563824,0.00006631862,0.00030656136,0.000003533539,0.000018061097,0.00003255578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870396,0.00012091074,0.00023382272,0.0002349103,0.00045980178,0.00024662685],"domain_scores_gemma":[0.99949986,0.00014399634,0.00007032683,0.00017520977,0.0000644264,0.000046183763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005985637,0.00010876498,0.0002815054,0.00025407123,0.00004480307,0.000005027479,0.00011045846,0.00009034699,0.000095310286],"category_scores_gemma":[0.000009237669,0.00007981795,0.000038043927,0.00021875439,0.00015893063,0.00006952819,0.000013553512,0.0003385747,1.9983464e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017483417,0.00014817058,0.0070390794,0.00083374954,0.000015624068,0.000014550134,0.008203546,0.000112149144,0.97830063,0.00037036298,0.000010242674,0.0032035457],"study_design_scores_gemma":[0.001549741,0.00033381846,0.17429072,0.0011115262,0.000012170533,0.0000011665081,0.00032131956,0.00012686366,0.82174164,0.00044851567,0.0000013281337,0.00006117655],"about_ca_topic_score_codex":0.0037390152,"about_ca_topic_score_gemma":0.0023282266,"teacher_disagreement_score":0.16725163,"about_ca_system_score_codex":0.00014307986,"about_ca_system_score_gemma":0.00021869667,"threshold_uncertainty_score":0.5652297},"labels":[],"label_agreement":null},{"id":"W2112511860","doi":"10.1158/0008-5472.can-07-2913","title":"Identification of 14-3-3𝛉 as an Antigen that Induces a Humoral Response in Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Lung cancer; Autoantibody; Antigen; Adenocarcinoma; Annexin A2; Cancer; Antibody; Medicine; Lung; Immunology; Immune system; Internal medicine; Cancer research; Oncology; Annexin","score_opus":0.08259505488474898,"score_gpt":0.4897560037325559,"score_spread":0.4071609488478069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112511860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968777,0.001858554,0.00008839724,0.00031786785,0.00017352974,0.0004016616,0.00003155625,0.000006516999,0.0002442715],"genre_scores_gemma":[0.9974516,0.00053044263,0.00003548059,0.000040004143,0.0001770649,0.00022759818,0.000021025022,0.000022237988,0.0014945592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833643,0.00030609473,0.0002529355,0.000364919,0.00036385373,0.00037578357],"domain_scores_gemma":[0.9989838,0.00005184011,0.0000860385,0.0004232221,0.00036147868,0.000093646006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023742323,0.00009099207,0.000109401604,0.00027597134,0.00009299933,0.000035276233,0.00032343663,0.00014441255,0.0001926179],"category_scores_gemma":[0.00033338394,0.00009396392,0.000040015846,0.00036950177,0.0001628221,0.00001906515,0.00011068084,0.00027931345,0.000007954289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016133885,0.0000674242,0.019243259,0.000025791276,0.00002397692,0.0000068073587,0.00039948814,0.000029925051,0.97633815,0.00003034505,0.0006640191,0.0015574294],"study_design_scores_gemma":[0.00026455708,0.00014659076,0.09025504,0.000052857813,0.0000027918263,0.000002699092,0.000457528,0.000015595531,0.9057162,0.000057025907,0.0029371197,0.00009200813],"about_ca_topic_score_codex":0.0029543638,"about_ca_topic_score_gemma":0.003226793,"teacher_disagreement_score":0.071011774,"about_ca_system_score_codex":0.00016831566,"about_ca_system_score_gemma":0.0004847835,"threshold_uncertainty_score":0.4466134},"labels":[],"label_agreement":null},{"id":"W2112533682","doi":"10.1158/0008-5472.can-13-3293","title":"Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"Epigenetics; Phenotype; Tumor cells; Biology; Tumor heterogeneity; Cancer research; Tumor progression; Cancer; Genetics; Gene","score_opus":0.029036029971432366,"score_gpt":0.34020379855713545,"score_spread":0.3111677685857031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112533682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917433,0.0066732005,0.0010476711,0.000017251277,0.00005183304,0.00021372558,0.00004877618,0.0000030388785,0.00020118813],"genre_scores_gemma":[0.9981841,0.00096664275,0.0006407901,0.000015081555,0.00009885475,0.000023320723,0.000017777646,0.00001968234,0.00003374106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866813,0.00024111368,0.0002537443,0.00032908883,0.00023564145,0.00027226616],"domain_scores_gemma":[0.9991085,0.000083595274,0.00013410949,0.00023462789,0.00033639852,0.00010277082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072922703,0.000111898386,0.00018338325,0.00008239725,0.000085716085,0.000016087908,0.00011219174,0.000048766633,0.000011352168],"category_scores_gemma":[0.00010579371,0.00010859336,0.000031775708,0.00012365893,0.000259412,0.00000456092,0.00014478214,0.000111779314,0.00000116113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005763013,0.00002938664,0.031232035,0.00019055844,0.000014813577,6.524225e-7,0.00008047828,0.0002575127,0.9670592,0.000045189365,0.00001964668,0.0010129086],"study_design_scores_gemma":[0.00039997336,0.0004850924,0.019469494,0.000035540612,0.000011969535,5.78188e-7,0.00009060582,0.0007534214,0.97743374,0.00055207085,0.0006585165,0.00010897556],"about_ca_topic_score_codex":0.00041149938,"about_ca_topic_score_gemma":0.0001387093,"teacher_disagreement_score":0.011762543,"about_ca_system_score_codex":0.000024480616,"about_ca_system_score_gemma":0.00012938147,"threshold_uncertainty_score":0.4428309},"labels":[],"label_agreement":null},{"id":"W2112734666","doi":"10.1158/0008-5472.can-10-0621","title":"Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"HPV infection; Medicine; Immunology; Immunity; Serology; Cohort; Relative risk; Incidence (geometry); Human papillomavirus; Confidence interval; Internal medicine; Demography; Virology; Cancer; Antibody; Immune system; Cervical cancer","score_opus":0.035053982321790945,"score_gpt":0.41568901349390286,"score_spread":0.3806350311721119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112734666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966478,0.00048617017,3.161392e-7,0.0004804892,0.00006109198,0.00039707214,0.0000038451867,0.000011899479,0.0019113556],"genre_scores_gemma":[0.9988571,0.0004965916,0.0000017072774,0.000034889552,0.00016528076,0.00016776941,0.0000017523996,0.000010913514,0.00026402582],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869037,0.00020301204,0.00012031224,0.00021368002,0.00043281086,0.00033983716],"domain_scores_gemma":[0.9990845,0.00014457345,0.000025468076,0.00025231685,0.0003698158,0.00012332878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012734073,0.00007855491,0.00017449312,0.00020131667,0.00024210197,0.000032751945,0.00006527956,0.000098712895,0.0003773572],"category_scores_gemma":[0.00029211756,0.000055092645,0.000014816291,0.0004452306,0.0005178372,0.0001093982,0.0001578184,0.0018379486,0.0000017098362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004986504,0.00007733156,0.1134318,0.00017749271,0.000017330196,0.0000018517119,0.0008141516,3.5733166e-7,0.6757638,0.00028176422,0.000025401436,0.20891011],"study_design_scores_gemma":[0.0010165764,0.00048406047,0.94691026,0.000016017802,0.0000052850305,0.000009653919,0.00039738038,0.00011823757,0.049617536,0.0005671799,0.00080150476,0.00005632567],"about_ca_topic_score_codex":0.035355803,"about_ca_topic_score_gemma":0.018257258,"teacher_disagreement_score":0.83347845,"about_ca_system_score_codex":0.0001849797,"about_ca_system_score_gemma":0.0001531799,"threshold_uncertainty_score":0.999657},"labels":[],"label_agreement":null},{"id":"W2112975932","doi":"10.1158/0008-5472.can-04-0240","title":"Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Podocalyxin; Breast cancer; Tissue microarray; Cancer; Cancer research; Cell; Medicine; Cell adhesion; Biology; Pathology; Oncology; Internal medicine","score_opus":0.03816233983023243,"score_gpt":0.3884061346745992,"score_spread":0.3502437948443668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112975932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778193,0.0008402671,0.0000568973,0.0005251478,0.00015468268,0.00026685852,0.00025042132,0.0000029213074,0.00012086512],"genre_scores_gemma":[0.99875057,0.00065454043,0.000029865572,0.000039823182,0.00016540858,0.000059517944,0.000016755914,0.000017284556,0.0002662343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876934,0.00009604696,0.00018451574,0.00026513846,0.00046698746,0.0002179927],"domain_scores_gemma":[0.999013,0.0000054873362,0.00009572302,0.00044947144,0.00035867933,0.00007764957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025195887,0.00008493124,0.00011058795,0.00005234781,0.00010123008,0.000012948262,0.0003337249,0.00012100016,0.00026642723],"category_scores_gemma":[0.00002458044,0.000057746565,0.00008147157,0.00017646798,0.00011652685,0.000008659121,0.00024696413,0.00020899728,0.0000012331856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112339214,0.00017036441,0.0026711554,0.00004255089,0.000026249136,3.929353e-7,0.00011175788,0.000077250326,0.9944593,0.000110565685,0.0007731151,0.0014450102],"study_design_scores_gemma":[0.00044254013,0.00016357182,0.012203247,0.00033871946,0.000006691003,0.000004443109,0.00009669054,0.000040735802,0.98399204,0.00014130988,0.0025061937,0.00006381119],"about_ca_topic_score_codex":0.000969705,"about_ca_topic_score_gemma":0.00012556218,"teacher_disagreement_score":0.010467202,"about_ca_system_score_codex":0.00006479322,"about_ca_system_score_gemma":0.00043241642,"threshold_uncertainty_score":0.29171914},"labels":[],"label_agreement":null},{"id":"W2113304916","doi":"10.1158/0008-5472.can-04-0340","title":"Heritability and Linkage Analysis of Sensitivity to Cisplatin-Induced Cytotoxicity","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Plant Genetic and Mutation Studies","field":"Agricultural and Biological Sciences","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Heritability; Cytotoxicity; Cisplatin; Pedigree chart; Genetics; Biology; Locus (genetics); Quantitative trait locus; Genetic linkage; Gene; In vitro; Chemotherapy","score_opus":0.12127860500379983,"score_gpt":0.3864829870449897,"score_spread":0.26520438204118985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113304916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800056,0.00007311304,0.000012821869,0.0014163709,0.000011913738,0.00015748179,0.00012350343,0.000008922639,0.00019531434],"genre_scores_gemma":[0.99975574,0.00006189395,0.000042730648,0.0000541325,0.00003242585,0.000019420846,0.0000064510737,2.5870753e-7,0.000026951624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999146,0.0001089355,0.00010532377,0.0002073581,0.00025251595,0.0001799023],"domain_scores_gemma":[0.9993922,0.00026866616,0.000020319067,0.00004031946,0.00018950291,0.00008901032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066927343,0.0000502041,0.00016991369,0.00003177944,0.0001439478,0.000014951489,0.00005362929,0.000035838635,0.00004664397],"category_scores_gemma":[0.00013504934,0.000020654585,0.000038501825,0.0010533893,0.000100441765,0.000023780258,0.00009278998,0.00008449074,0.0000035109745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022294344,0.000024226978,0.022870654,0.000005029604,0.00005767988,0.0000020073912,0.00027229256,0.00009258856,0.9693631,0.000051750903,0.000012759665,0.0072256145],"study_design_scores_gemma":[0.00005386861,0.00008152887,0.8519566,0.000008154929,0.00002080133,3.5598703e-7,0.0003523792,0.00001814882,0.1472753,0.00011475616,0.00007053501,0.00004758888],"about_ca_topic_score_codex":0.0034328073,"about_ca_topic_score_gemma":0.010145496,"teacher_disagreement_score":0.82908595,"about_ca_system_score_codex":0.00003872576,"about_ca_system_score_gemma":0.000017798631,"threshold_uncertainty_score":0.5661425},"labels":[],"label_agreement":null},{"id":"W2113390110","doi":"10.1158/0008-5472.can-07-0644","title":"<i>CUL7</i> Is a Novel Antiapoptotic Oncogene","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs; National Cancer Institute; University of Pennsylvania; Leukemia and Lymphoma Society","keywords":"Gene knockdown; Oncogene; Ectopic expression; Apoptosis; Cell growth; Cancer research; Biology; Small interfering RNA; Cell cycle; Cell biology; Cell culture; Chemistry; Genetics; Transfection","score_opus":0.12046914729660639,"score_gpt":0.4509095885900685,"score_spread":0.3304404412934621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113390110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636921,0.006348194,0.0035885847,0.0039660023,0.00047441127,0.0009295555,0.000047257694,0.000111244735,0.020842643],"genre_scores_gemma":[0.9915503,0.00077866635,0.0007824193,0.0015825228,0.0006959539,0.00006537367,0.000014748242,0.00008014525,0.004449843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969788,0.000035661516,0.0002848731,0.0005042626,0.0012274759,0.00096888246],"domain_scores_gemma":[0.9981947,0.000098210505,0.000041213018,0.0006339898,0.0005822192,0.00044968197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014218506,0.00016055763,0.00027435907,0.0003917729,0.00015889193,0.000030344983,0.00021156255,0.00018942262,0.0010417321],"category_scores_gemma":[0.00017091953,0.000151495,0.00013069024,0.0012573896,0.00025300813,0.000053061758,0.00013436841,0.00090569013,0.00036905537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044002823,0.000178019,0.00078060705,0.00011857563,0.0001097865,0.00018094867,0.00040257073,0.0000084979165,0.9607389,0.00022776656,0.022602709,0.014211576],"study_design_scores_gemma":[0.0026476723,0.00033636848,0.0029733009,0.0003160463,0.000049693706,0.00011442239,0.0001501454,0.00006281811,0.77202475,0.00004590583,0.22108524,0.00019365233],"about_ca_topic_score_codex":0.0007924008,"about_ca_topic_score_gemma":0.00017801985,"teacher_disagreement_score":0.19848253,"about_ca_system_score_codex":0.0007750154,"about_ca_system_score_gemma":0.00094668247,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W2113467627","doi":"10.1158/0008-5472.can-05-2119","title":"Hypoxia-Induced Down-regulation of <i>BRCA1</i> Expression by E2Fs","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; U.S. Department of Defense","keywords":"Homologous recombination; Psychological repression; Biology; DNA repair; Genome instability; E2F; Genetics; Non-homologous end joining; Hypoxia (environmental); Gene; Cancer research; Gene expression; Cell biology; DNA; DNA damage; Chemistry","score_opus":0.03689567987208659,"score_gpt":0.35498574378648284,"score_spread":0.31809006391439626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113467627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956667,0.0012016187,0.00022699367,0.00033449524,0.00007502554,0.00023912705,0.000024997873,0.00001266526,0.0022183673],"genre_scores_gemma":[0.99561816,0.00019627003,0.00046580588,0.00006645308,0.0003034115,0.00009210447,0.000054176333,0.000024058803,0.0031795334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864614,0.00012689289,0.0001704118,0.00033052306,0.00041503602,0.0003110098],"domain_scores_gemma":[0.99918866,0.000016125472,0.000050671966,0.0004276001,0.00022220498,0.00009470689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047242467,0.00009339519,0.00010661273,0.0000596485,0.00007532527,0.000014215335,0.0002525414,0.00015755273,0.00021004367],"category_scores_gemma":[0.00007019951,0.000086875036,0.000053134787,0.00014688133,0.00006859883,0.0000068447207,0.00016280095,0.00013967187,0.000024791501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008538279,0.00004697361,0.000050759747,0.000016591517,0.000011198961,2.4426674e-7,0.000035533067,0.000032161934,0.9649873,0.000057496614,0.023570059,0.011106318],"study_design_scores_gemma":[0.00038013485,0.00014989564,0.00018100512,0.000026932588,0.0000024700014,0.0000010183829,0.000028507186,0.000050911705,0.93793607,0.000076777396,0.06107757,0.00008873741],"about_ca_topic_score_codex":0.000062517815,"about_ca_topic_score_gemma":0.000029635421,"teacher_disagreement_score":0.03750751,"about_ca_system_score_codex":0.000054997978,"about_ca_system_score_gemma":0.00012982263,"threshold_uncertainty_score":0.3542661},"labels":[],"label_agreement":null},{"id":"W2113933978","doi":"10.1158/0008-5472.can-09-4562","title":"Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medulloblastoma; Cancer research; Chromatin immunoprecipitation; Gene silencing; Biology; Gene knockdown; Small hairpin RNA; Cell migration; RNA interference; Cell culture; Molecular biology; Gene expression; Gene; Promoter; Genetics; RNA","score_opus":0.0878867786349158,"score_gpt":0.4538704070984603,"score_spread":0.36598362846354454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113933978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975402,0.00090566,0.0001649708,0.00053647015,0.00018176954,0.0002686634,0.00007030984,0.0000032783503,0.00032868123],"genre_scores_gemma":[0.99813,0.00014301897,0.00087081816,0.000108333246,0.00026565715,0.00024668092,0.000008118513,0.000025509677,0.00020183998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998759,0.000061385545,0.00020116926,0.00032853286,0.00025072234,0.00039921163],"domain_scores_gemma":[0.9991149,0.00012975388,0.000030401665,0.00028886038,0.0003518739,0.00008421181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006975851,0.00009877819,0.00017880937,0.00010375938,0.00007247794,0.000014656759,0.00024538874,0.00011316104,0.00021999981],"category_scores_gemma":[0.00041514452,0.00008962501,0.00009132203,0.00019981663,0.0001949655,0.0000050679746,0.000091318405,0.00018574597,0.000004689781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013186906,0.00005045915,0.0012204157,0.00009360002,0.000031569445,0.0000010269556,0.00012586861,0.0000036377944,0.99305314,0.0011207026,0.0015211557,0.0026465806],"study_design_scores_gemma":[0.00038892424,0.00026111602,0.0018004631,0.000035291254,0.000010717996,0.0000014491076,0.0002571085,0.00006268982,0.9924463,0.00051421404,0.0041132686,0.00010843096],"about_ca_topic_score_codex":0.00026857769,"about_ca_topic_score_gemma":0.0006627227,"teacher_disagreement_score":0.0025921126,"about_ca_system_score_codex":0.000026778565,"about_ca_system_score_gemma":0.00035935343,"threshold_uncertainty_score":0.3654802},"labels":[],"label_agreement":null},{"id":"W2114033240","doi":"10.1158/0008-5472.can-08-0092","title":"Histone Deacetylase Inhibitors Reverse SS18-SSX–Mediated Polycomb Silencing of the Tumor Suppressor <i>Early Growth Response 1</i> in Synovial Sarcoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver General Hospital","funders":"Hokkaido University","keywords":"Romidepsin; Synovial sarcoma; Cancer research; Chromatin remodeling; Biology; Histone deacetylase; Fusion gene; SWI/SNF; Histone; Fusion protein; Gene silencing; Medicine; Sarcoma; Gene; Pathology; Genetics","score_opus":0.027327512351905385,"score_gpt":0.3297181208927174,"score_spread":0.302390608540812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114033240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569446,0.0016096778,0.000004053973,0.0011073886,0.00030546414,0.00083479163,0.00014979007,0.000018714072,0.00027564756],"genre_scores_gemma":[0.9968145,0.00024180385,0.000045804194,0.00013292341,0.00033708062,0.00023429975,0.000022039998,0.0000818318,0.0020897565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942381,0.0017961203,0.00062316627,0.00077636604,0.0014578593,0.0011084176],"domain_scores_gemma":[0.99752223,0.0003445988,0.00014934722,0.0010409037,0.00063992455,0.00030301762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024231721,0.00028735632,0.00038381765,0.00048164863,0.00040495262,0.000023576236,0.0009976045,0.0002717076,0.00008996528],"category_scores_gemma":[0.0030624007,0.00024996305,0.00021497112,0.0013224225,0.0015420379,0.000022943317,0.0007486424,0.0011417455,0.00004795235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041497312,0.00021099228,0.0036582912,0.00007255073,0.000027452017,0.00017125493,0.00072781,0.000021504811,0.96579546,0.000008117567,0.025111903,0.00004493887],"study_design_scores_gemma":[0.0018383678,0.000565618,0.0085231885,0.00017186867,0.000005651001,0.00005831752,0.00018625346,0.000019207451,0.98419446,0.000009730257,0.0041633635,0.0002639663],"about_ca_topic_score_codex":0.005319803,"about_ca_topic_score_gemma":0.000582396,"teacher_disagreement_score":0.02094854,"about_ca_system_score_codex":0.00060514524,"about_ca_system_score_gemma":0.0021072247,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2114067189","doi":"10.1158/0008-5472.can-13-2381","title":"ERKs in Cancer: Friends or Foes?","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.207352210794642,"score_gpt":0.5086070552722703,"score_spread":0.30125484447762835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114067189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042972775,0.9947413,0.000013699549,0.000044493256,0.0004297271,0.00065876154,0.00015859463,0.000009068554,0.0035145923],"genre_scores_gemma":[0.00021439345,0.98511213,0.000021448512,0.000046306523,0.0015316344,0.0020101871,0.00021505603,0.00008135809,0.010767461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971898,0.000469806,0.00040863606,0.00078531855,0.00037379854,0.00077262626],"domain_scores_gemma":[0.99872965,0.00006953529,0.000108864406,0.000750292,0.00015190155,0.00018977823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091888185,0.00031538328,0.0008970902,0.0002634352,0.000093369476,0.000045921835,0.0007455641,0.0006335603,0.00052534783],"category_scores_gemma":[0.00014176904,0.00023003641,0.00022111105,0.0004853336,0.00014906243,0.0000022959582,0.00039453473,0.00077219796,0.00007946293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005402098,0.000035778437,0.000026707088,0.007714448,0.0000970388,0.000035311525,0.000020355183,0.00000122105,0.0005462838,0.00009430394,0.022513228,0.9688613],"study_design_scores_gemma":[0.00024210243,0.00021506526,0.0000035005182,0.0034315567,0.000040449948,0.000009949733,0.0000088496645,0.0000011971504,0.0005796151,0.00001457639,0.99516666,0.00028649552],"about_ca_topic_score_codex":0.0006878316,"about_ca_topic_score_gemma":0.0022901522,"teacher_disagreement_score":0.9726534,"about_ca_system_score_codex":0.00019963049,"about_ca_system_score_gemma":0.0022077824,"threshold_uncertainty_score":0.9380613},"labels":[],"label_agreement":null},{"id":"W2114121264","doi":"10.1158/0008-5472.can-08-2331","title":"Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Universität Salzburg; Austrian Science Fund","keywords":"MAPK/ERK pathway; Hedgehog signaling pathway; Cancer research; Hedgehog; Epidermal growth factor receptor; Signal transduction; Transformation (genetics); Biology; Cell biology; Receptor; Chemistry; Genetics; Gene","score_opus":0.04475892353568176,"score_gpt":0.33191412432261375,"score_spread":0.28715520078693196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114121264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961668,0.0008487084,0.0012153991,0.0010410891,0.000057466972,0.00046473846,0.000029130857,0.000009791434,0.00016686387],"genre_scores_gemma":[0.99917346,0.00022969893,0.00012293908,0.00009642603,0.00017535123,0.000081248705,0.000020820917,0.000019379606,0.00008068757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982184,0.00030107115,0.00030366427,0.0003109893,0.00046632433,0.00039955575],"domain_scores_gemma":[0.99912727,0.00006424541,0.00009239758,0.00026179248,0.0003939428,0.00006036213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058579125,0.00015664945,0.00019975865,0.0001243074,0.00016479174,0.000018458542,0.00029574608,0.00013565015,0.000024503493],"category_scores_gemma":[0.00017944005,0.00011007684,0.00007912466,0.00047530603,0.00015119919,0.00001825087,0.00004720601,0.0002936895,0.0000024704327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027902337,0.00005306661,0.0010554044,0.00005622738,0.000038781774,7.092373e-7,0.0008552736,0.0004370796,0.9906695,0.00007594052,0.00008877726,0.006390234],"study_design_scores_gemma":[0.00059654313,0.00034852308,0.0041044992,0.00015499658,0.0000048307647,0.0000012854366,0.00024258254,0.000038318118,0.9931799,0.00008870286,0.0011013694,0.0001384292],"about_ca_topic_score_codex":0.00015165954,"about_ca_topic_score_gemma":0.00009089307,"teacher_disagreement_score":0.006251805,"about_ca_system_score_codex":0.00012092178,"about_ca_system_score_gemma":0.00032992836,"threshold_uncertainty_score":0.44888034},"labels":[],"label_agreement":null},{"id":"W2114163915","doi":"10.1158/0008-5472.can-09-1591","title":"β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Trastuzumab; Cancer research; Breast cancer; Metastatic breast cancer; Medicine; Protein kinase B; Integrin; Epidermal growth factor receptor; Cancer; Growth factor receptor; Internal medicine; Oncology; Signal transduction; Biology; Receptor; Cell biology","score_opus":0.06515304618792937,"score_gpt":0.4467056461121283,"score_spread":0.38155259992419893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114163915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799196,0.0022743286,0.000021005857,0.012454842,0.0002258271,0.0028742433,0.00027156866,0.000037857782,0.0019207387],"genre_scores_gemma":[0.9958853,0.0013699753,0.000017661892,0.0005205152,0.00064236653,0.0007477104,0.000020371168,0.000060820985,0.0007352943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99396884,0.0011691703,0.0005994743,0.0007729082,0.0021100962,0.0013794902],"domain_scores_gemma":[0.9967159,0.00074460934,0.00011997687,0.0006306684,0.0013007148,0.00048809778],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014560077,0.00034160764,0.0007675652,0.0006090713,0.0003206023,0.000064117914,0.000681849,0.0002295823,0.0016532291],"category_scores_gemma":[0.0006821146,0.00024369275,0.00018477492,0.0017152018,0.0007697659,0.00020211628,0.00015665371,0.0023624538,0.000038008457],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028246124,0.0014271555,0.1699949,0.0015410752,0.00041785275,0.00037712228,0.010890977,0.000022561531,0.69992816,0.0013417631,0.018402228,0.09283159],"study_design_scores_gemma":[0.0029797906,0.0012028746,0.5923154,0.0020553574,0.000025627063,0.000028734807,0.00050379336,0.00004213062,0.39990517,0.00035476562,0.00033849428,0.00024788413],"about_ca_topic_score_codex":0.007885813,"about_ca_topic_score_gemma":0.00064422836,"teacher_disagreement_score":0.4223205,"about_ca_system_score_codex":0.0023936718,"about_ca_system_score_gemma":0.0021534567,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W2114164056","doi":"10.1158/0008-5472.can-04-0866","title":"Blocking the Raf/MEK/ERK Pathway Sensitizes Acute Myelogenous Leukemia Cells to Lovastatin-Induced Apoptosis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"University of Pennsylvania","keywords":"MAPK/ERK pathway; MEK inhibitor; Lovastatin; Signal transduction; Kinase; Cancer research; Apoptosis; Statin; Protein kinase A; ASK1; Cell biology; MAP kinase kinase kinase; Chemistry; Biology; Mitogen-activated protein kinase kinase; Medicine; Endocrinology; Internal medicine; Biochemistry; Cholesterol","score_opus":0.03698977345083481,"score_gpt":0.33853956165412,"score_spread":0.3015497882032852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114164056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991921,0.0013672707,0.00024964963,0.0015943759,0.0033404282,0.0006466279,0.0001061412,0.000023855282,0.000750667],"genre_scores_gemma":[0.98226607,0.001807662,0.00035104746,0.0011837377,0.011884559,0.00028205226,0.000032160668,0.00007025645,0.0021224767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974532,0.00018751406,0.0002502847,0.00063884055,0.0005589232,0.0009112172],"domain_scores_gemma":[0.9984715,0.000046358404,0.00005589077,0.0007553094,0.00040228327,0.00026864556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076710805,0.00023401006,0.0002514564,0.00011629919,0.0004541851,0.00011430066,0.00052342133,0.0001774892,0.000045265704],"category_scores_gemma":[0.00008765386,0.00018470017,0.00014551831,0.0004549246,0.00017575687,0.0000062617523,0.0003524376,0.0004629097,0.00008505373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017694692,0.000022330274,0.000011615056,0.000018958419,0.00012034977,0.0000011995327,0.0007684638,0.00073542865,0.9655621,0.00006742318,0.01974753,0.012767651],"study_design_scores_gemma":[0.0006198796,0.00015649995,0.00009971274,0.00003072696,0.000019872015,0.000008732313,0.0003426308,0.0000022731263,0.7547733,0.000062297746,0.24369015,0.0001939212],"about_ca_topic_score_codex":0.0021426047,"about_ca_topic_score_gemma":0.0008479546,"teacher_disagreement_score":0.22394262,"about_ca_system_score_codex":0.00031122877,"about_ca_system_score_gemma":0.0016516822,"threshold_uncertainty_score":0.75318545},"labels":[],"label_agreement":null},{"id":"W2114208523","doi":"10.1158/0008-5472.can-05-1427","title":"Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute","keywords":"Genetics; Locus (genetics); Biology; Loss of heterozygosity; Pheochromocytoma; Genetic linkage; Allele; Gene; Endocrinology","score_opus":0.0818485344130876,"score_gpt":0.4213268063049918,"score_spread":0.3394782718919042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114208523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890447,0.0016462001,0.0005913965,0.003335978,0.00008218448,0.00050857733,0.00009745857,0.00004851915,0.004644965],"genre_scores_gemma":[0.97699696,0.00008153818,0.00028057862,0.0002849593,0.00060812663,0.00008465665,0.00006090262,0.000025792056,0.021576503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810797,0.00008640423,0.00024400387,0.00042663916,0.00058469817,0.00055028184],"domain_scores_gemma":[0.9987135,0.00012175012,0.000040257608,0.00038959604,0.00044708862,0.00028779637],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082623155,0.00014421972,0.00026533176,0.00011638972,0.00017129122,0.000037553793,0.00021081342,0.00009625411,0.0024504608],"category_scores_gemma":[0.00019040918,0.00011039602,0.00008982099,0.0004515744,0.00041021776,0.00010251349,0.000108944136,0.00073115696,0.00041842816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016945525,0.00080976903,0.0014566015,0.00018795735,0.0001895684,0.00039552714,0.00367767,0.00003464833,0.7028943,0.0008975274,0.25630218,0.031459715],"study_design_scores_gemma":[0.004658333,0.0006493216,0.009508833,0.00025188926,0.000058124653,0.0006631036,0.0021694899,0.000790097,0.8679419,0.00050215767,0.1123565,0.0004502528],"about_ca_topic_score_codex":0.0008193618,"about_ca_topic_score_gemma":0.0009979968,"teacher_disagreement_score":0.16504763,"about_ca_system_score_codex":0.00094415026,"about_ca_system_score_gemma":0.00060307956,"threshold_uncertainty_score":0.9984614},"labels":[],"label_agreement":null},{"id":"W2114308127","doi":"10.1158/0008-5472.can-13-0730-t","title":"MyoD Is a Tumor Suppressor Gene in Medulloblastoma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medulloblastoma; MyoD; Biology; Cancer research; Sleeping Beauty transposon system; Cerebellum; Tumor suppressor gene; Sonic hedgehog; Carcinogenesis; Cancer; Myogenesis; Genetics; Neuroscience; Gene; Transposable element; Mutant","score_opus":0.06775033544760407,"score_gpt":0.40466652720290375,"score_spread":0.3369161917552997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114308127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839443,0.00173452,3.9057792e-7,0.0117220115,0.000058971687,0.0008937019,0.000016887467,0.000019293746,0.0016099015],"genre_scores_gemma":[0.9959669,0.00018303965,0.00011200437,0.0005369902,0.00013405323,0.0021227098,0.0000056910153,0.000023967517,0.0009146122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835235,0.000066382214,0.00016294673,0.00030963114,0.00056385726,0.00054480915],"domain_scores_gemma":[0.99904865,0.000096671196,0.000017543442,0.00034786534,0.00024831676,0.00024092435],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022248435,0.000102381215,0.00021529898,0.00028423723,0.000057809986,0.00003999046,0.00011929257,0.000048025526,0.006225297],"category_scores_gemma":[0.00008124589,0.00007760504,0.000054428725,0.0004748109,0.000098193865,0.00006963124,0.00008489114,0.00026758743,0.0010694598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027582748,0.0013041896,0.1769947,0.00019614323,0.00016717611,0.0012220796,0.0012951371,0.000004949768,0.5994116,0.00019692535,0.20629312,0.01263817],"study_design_scores_gemma":[0.0033243992,0.0003845844,0.25565812,0.00023475577,0.000016090773,0.00004243873,0.00022055984,0.000116121344,0.724155,0.00034876945,0.015379864,0.0001192697],"about_ca_topic_score_codex":0.0049235784,"about_ca_topic_score_gemma":0.00023381622,"teacher_disagreement_score":0.19091325,"about_ca_system_score_codex":0.00032558857,"about_ca_system_score_gemma":0.00021564889,"threshold_uncertainty_score":0.9997083},"labels":[],"label_agreement":null},{"id":"W2114369115","doi":"10.1158/0008-5472.can-12-0157","title":"Accumulation of Multipotent Progenitors with a Basal Differentiation Bias during Aging of Human Mammary Epithelia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; National Institute on Aging; U.S. Department of Energy; Laboratory Directed Research and Development; U.S. Department of Defense","keywords":"Progenitor cell; Basal (medicine); Cell biology; Biology; Progenitor; Cellular differentiation; Stem cell; Endocrinology; Genetics","score_opus":0.26307930176905714,"score_gpt":0.46085766287794366,"score_spread":0.19777836110888652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114369115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979453,0.0009722097,0.00014855474,0.000121893434,0.000079133715,0.00057545095,0.00001033391,0.000012265438,0.00013483386],"genre_scores_gemma":[0.99876654,0.00019724265,0.0003438417,0.000005099132,0.00024802715,0.00009729937,0.000013814045,0.00002148575,0.0003066275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858737,0.00009018054,0.000228702,0.00015124754,0.00062446867,0.00031802623],"domain_scores_gemma":[0.9991462,0.000035636305,0.00010690441,0.0002470502,0.00033717317,0.00012698583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004875757,0.00008442015,0.00021729365,0.00026321327,0.00007411316,0.000007943103,0.000072450326,0.000040558283,0.000110653455],"category_scores_gemma":[0.000035335,0.00006450302,0.000059430942,0.00034493866,0.00008332877,0.00013488429,0.00006104056,0.00017717619,0.0000016669275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025009693,0.00015856323,0.37475628,0.00078073476,0.00009588177,0.0000016508908,0.0009254805,0.000016843303,0.6160678,0.000052568877,0.000027520227,0.0068665594],"study_design_scores_gemma":[0.0010371666,0.0001097746,0.3918294,0.0002753916,0.00003914515,0.0000019635604,0.0001593322,0.000025309344,0.606396,0.0000069353428,0.00007223153,0.000047318215],"about_ca_topic_score_codex":0.0010593705,"about_ca_topic_score_gemma":0.00005845938,"teacher_disagreement_score":0.017073127,"about_ca_system_score_codex":0.0001806657,"about_ca_system_score_gemma":0.00013048358,"threshold_uncertainty_score":0.26303568},"labels":[],"label_agreement":null},{"id":"W2114446753","doi":"10.1158/0008-5472.can-13-2138","title":"shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Kinome; Cancer research; TANK-binding kinase 1; Breast cancer; IκB kinase; Kinase; Cancer; Lapatinib; Small hairpin RNA; Cancer cell; Biology; Metastatic breast cancer; Gene knockdown; Medicine; Protein kinase A; Apoptosis; Internal medicine; Signal transduction; Cell biology; Cyclin-dependent kinase 2; NF-κB; Biochemistry","score_opus":0.0701144827518984,"score_gpt":0.41314429059983443,"score_spread":0.343029807847936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114446753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9172692,0.03082184,0.0033670526,0.029375566,0.0017978041,0.005526716,0.000963599,0.00037274594,0.010505496],"genre_scores_gemma":[0.9853255,0.0009960172,0.00018089067,0.0011460591,0.0015072898,0.0017737527,0.000059987036,0.00014482034,0.008865679],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966405,0.00020178148,0.00032628558,0.0006980039,0.0010896401,0.0010438137],"domain_scores_gemma":[0.9976677,0.00019067725,0.000078451005,0.00074948225,0.00091542193,0.000398289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012532489,0.00025489525,0.00045396062,0.00036886428,0.0003077887,0.00011103251,0.0003972586,0.00021763724,0.0034358085],"category_scores_gemma":[0.00016813533,0.00022710326,0.00021593772,0.00068411394,0.00035813177,0.00012345656,0.00015039262,0.00075227383,0.0002138233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050010276,0.0004272213,0.007160685,0.0013700818,0.0013897443,0.00009160748,0.0013591603,0.0003288916,0.6851855,0.00547542,0.0847233,0.20748737],"study_design_scores_gemma":[0.011214582,0.0019444434,0.033225752,0.0019262928,0.00040010462,0.00023223281,0.0005064204,0.0029221326,0.21130441,0.008130529,0.7271044,0.0010886636],"about_ca_topic_score_codex":0.0066394685,"about_ca_topic_score_gemma":0.00094416796,"teacher_disagreement_score":0.64238113,"about_ca_system_score_codex":0.0008046683,"about_ca_system_score_gemma":0.0012851763,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W2114492926","doi":"10.1158/0008-5472.can-07-6559","title":"Identification of 6-Benzylthioinosine as a Myeloid Leukemia Differentiation–Inducing Compound","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Myeloid; Myeloid leukemia; Cancer research; Leukemia; Cellular differentiation; Biology; Cell growth; Chronic myelogenous leukemia; Cell culture; Immunology; Cell biology; Pharmacology; Chemistry; Biochemistry","score_opus":0.0890473418401391,"score_gpt":0.4010026533048339,"score_spread":0.3119553114646948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114492926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993007,0.0010180146,0.00019765057,0.0019373604,0.00013635319,0.00089172035,0.000023255167,0.00005979579,0.0027288555],"genre_scores_gemma":[0.9875677,0.0018253368,0.00011491217,0.00009743757,0.00040803137,0.00021082388,0.00006133322,0.000054228844,0.009660156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960129,0.0002667078,0.0006166837,0.00053697475,0.0018655959,0.00070108456],"domain_scores_gemma":[0.99687874,0.0003310381,0.000146644,0.0007988042,0.0015268726,0.0003178793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012773721,0.0001753549,0.00042563747,0.0007339936,0.0004246721,0.000036598245,0.0003847756,0.00017745323,0.0009241917],"category_scores_gemma":[0.0007391009,0.00016097378,0.000117264026,0.0013783429,0.00065065874,0.00019601086,0.00021618334,0.0010801197,0.00033463354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053378445,0.00015574972,0.012356127,0.0003873754,0.00013210441,0.00012001099,0.0013560008,0.000039811945,0.96612483,0.0007210278,0.015058037,0.0030151634],"study_design_scores_gemma":[0.003078959,0.00039405958,0.15915918,0.00033283955,0.00004516329,0.00027593787,0.00049248035,0.0017683469,0.82973474,0.0004293963,0.0040509673,0.00023794077],"about_ca_topic_score_codex":0.0020723166,"about_ca_topic_score_gemma":0.000044408316,"teacher_disagreement_score":0.14680307,"about_ca_system_score_codex":0.0024598136,"about_ca_system_score_gemma":0.0034402865,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2114592067","doi":"10.1158/0008-5472.can-05-0765","title":"Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Oncosuisse; National Cancer Institute; National Science Foundation; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Cyclophosphamide; Medicine; Regimen; Toxicity; Chemotherapy; Bolus (digestion); Pharmacology; Nitrogen mustard; Oncology; Internal medicine; Urology","score_opus":0.0321332893579331,"score_gpt":0.3684955812790895,"score_spread":0.3363622919211564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114592067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932591,0.004805959,0.00007719078,0.00049062795,0.0000734767,0.00092203525,0.00004908191,0.000017085957,0.0003054833],"genre_scores_gemma":[0.99120396,0.004149437,0.00008367523,0.00039532807,0.0006525633,0.0008557044,0.00008606618,0.00007339468,0.0024998814],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795926,0.00014785423,0.00020439038,0.0007282005,0.0002745729,0.0006856979],"domain_scores_gemma":[0.9986478,0.000021593465,0.00006730118,0.0008077996,0.00020951414,0.00024600243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028029,0.00029204143,0.00027830468,0.00009395623,0.00018364364,0.00007730014,0.0004342253,0.00014771611,0.00039908604],"category_scores_gemma":[0.0000067343854,0.00022462376,0.00014144892,0.00017477387,0.00023493101,0.000015462438,0.00012434732,0.00015103546,0.000037818365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060857795,0.0010296525,0.054403204,0.000057737638,0.000780426,0.000025292458,0.0003881518,0.00040053576,0.36930388,0.000024822926,0.0031818314,0.5643187],"study_design_scores_gemma":[0.0041715205,0.0049190754,0.1762853,0.000058797916,0.000029739307,0.0000068846543,0.00010043205,0.00006366564,0.8070166,0.000010385859,0.0069924556,0.00034514823],"about_ca_topic_score_codex":0.00033993478,"about_ca_topic_score_gemma":0.0008746208,"teacher_disagreement_score":0.56397355,"about_ca_system_score_codex":0.00055767875,"about_ca_system_score_gemma":0.0003639191,"threshold_uncertainty_score":0.91598904},"labels":[],"label_agreement":null},{"id":"W2114701172","doi":"10.1158/0008-5472.can-05-3773","title":"Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":620,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Glioma; Immune system; FOXP3; IL-2 receptor; Cytokine; Malignancy; T cell; Immunosuppression; Immunology; Biology; Cancer research; Medicine; Pathology","score_opus":0.01738557026723409,"score_gpt":0.26895215760812574,"score_spread":0.25156658734089166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114701172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388427,0.0022108438,0.00003404708,0.0000480877,0.0008670578,0.00069434894,0.000009445723,0.000060746926,0.00219113],"genre_scores_gemma":[0.99521166,0.00003851061,0.000007861601,0.00003401873,0.000047921814,0.00026330564,0.00054055394,0.000033621665,0.0038225402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978049,0.0005672832,0.00038424804,0.0004364315,0.00019719299,0.0006099434],"domain_scores_gemma":[0.99901134,0.00011840653,0.00013155857,0.00041462944,0.00029045902,0.000033635923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005145776,0.00020401704,0.00028990957,0.00046926207,0.00031903674,0.000038205453,0.00018021555,0.00019540441,0.0013713879],"category_scores_gemma":[0.00001881648,0.00017451408,0.00006971617,0.00046199412,0.0002069352,0.00020287652,0.00007433064,0.0006412604,0.00047352296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025068056,0.0010069992,0.053257544,0.00004119667,0.000045430486,0.000014898699,0.000109325425,0.000047942543,0.9325227,0.00010386734,0.01006849,0.00027475925],"study_design_scores_gemma":[0.004617594,0.00051320967,0.26313666,0.00010742979,0.000014807471,0.0000026135033,0.00027567337,0.0000071851837,0.70810026,0.000014824947,0.023013985,0.00019574353],"about_ca_topic_score_codex":0.0038544326,"about_ca_topic_score_gemma":0.00027946458,"teacher_disagreement_score":0.22442245,"about_ca_system_score_codex":0.00077894906,"about_ca_system_score_gemma":0.00015089796,"threshold_uncertainty_score":0.9995415},"labels":[],"label_agreement":null},{"id":"W2114787204","doi":"10.1158/0008-5472.can-06-0419","title":"Determinants of Sensitivity and Resistance to Rapamycin-Chemotherapy Drug Combinations <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"PTEN; PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Chemotherapy; Drug resistance; Biology; Lymphoma; Carcinogenesis; Apoptosis; Cancer; Immunology; Genetics","score_opus":0.02090201333244551,"score_gpt":0.35835003343814914,"score_spread":0.3374480201057036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114787204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964343,0.0015181453,0.000051018353,0.0005240983,0.000059895818,0.00026756246,0.00006541964,0.000004712103,0.0010748483],"genre_scores_gemma":[0.9965053,0.00029262892,0.000266796,0.00012943371,0.00010856186,0.00007686532,0.0000039494844,0.00002101431,0.0025954172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873453,0.00016724654,0.00017844516,0.0003441029,0.00026251763,0.0003131779],"domain_scores_gemma":[0.9993048,0.00007037258,0.000039776034,0.0002909253,0.00023042031,0.00006373549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007900886,0.000095577954,0.00015360754,0.00011030477,0.00007105546,0.000016792976,0.00012730579,0.00007217023,0.0000184912],"category_scores_gemma":[0.00006246248,0.00010092009,0.000029241513,0.0002909084,0.00018329822,0.0000043699274,0.0000809164,0.0001205702,0.0000015170336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016438575,0.0000634494,0.034945667,0.00004499624,0.000005736495,0.0000064740116,0.00007066441,0.000044037224,0.95118654,0.00009686462,0.012720533,0.0006506283],"study_design_scores_gemma":[0.0006987168,0.00006351005,0.014628125,0.00008595245,0.0000018486679,0.0000015055062,0.000031394877,0.000017024266,0.96671396,0.00027926877,0.017362503,0.00011620591],"about_ca_topic_score_codex":0.0009819891,"about_ca_topic_score_gemma":0.011936224,"teacher_disagreement_score":0.02031754,"about_ca_system_score_codex":0.00006843464,"about_ca_system_score_gemma":0.00016724867,"threshold_uncertainty_score":0.6660693},"labels":[],"label_agreement":null},{"id":"W2114882691","doi":"10.1158/0008-5472.can-06-4724","title":"Distinct ErbB-2–Coupled Signaling Pathways Promote Mammary Tumors with Unique Pathologic and Transcriptional Profiles","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"ErbB; Cancer research; Biology; HER2/neu; Receptor tyrosine kinase; Signal transduction; Metastasis; Mammary tumor; Proto-oncogene tyrosine-protein kinase Src; Carcinogenesis; Cancer; Breast cancer; Cell biology; Genetics","score_opus":0.11648727915294524,"score_gpt":0.40277159034118404,"score_spread":0.2862843111882388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114882691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879097,0.0030687624,0.0021440473,0.0022207554,0.00005635153,0.0019743566,0.000059676462,0.00013883041,0.002427525],"genre_scores_gemma":[0.9946804,0.00043407295,0.0026241585,0.00014050401,0.00039260028,0.00037990537,0.000051336447,0.0000758384,0.0012211875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954936,0.0002635255,0.00039102187,0.0007883407,0.0017926187,0.0012708942],"domain_scores_gemma":[0.9976979,0.00031738015,0.00005667791,0.00049421575,0.00081704435,0.00061676744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004717494,0.0002653367,0.00041702366,0.0004607615,0.00036058042,0.000102163904,0.00032404714,0.00018290081,0.00045426923],"category_scores_gemma":[0.0002962756,0.00019779567,0.00006654061,0.0009979915,0.0008253763,0.00015988041,0.0001413501,0.0015210225,0.000019317189],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032109828,0.0003420305,0.038602535,0.0016437225,0.00011677259,0.0071086157,0.0024104097,0.000009224384,0.910989,0.0048056236,0.0005901898,0.030170925],"study_design_scores_gemma":[0.011742406,0.009524065,0.476261,0.0063571194,0.00013116164,0.0035192508,0.0033118676,0.001553665,0.46255082,0.006180117,0.017077662,0.001790881],"about_ca_topic_score_codex":0.0005351626,"about_ca_topic_score_gemma":0.0002775162,"teacher_disagreement_score":0.44843814,"about_ca_system_score_codex":0.0006892193,"about_ca_system_score_gemma":0.0019509715,"threshold_uncertainty_score":0.80658734},"labels":[],"label_agreement":null},{"id":"W2115054742","doi":"10.1158/0008-5472.can-08-4425","title":"Transcript Level Modulates the Inherent Oncogenicity of RET/PTC Oncoproteins","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Queen's University","funders":"","keywords":"Cancer research; Proto-Oncogene Proteins c-ret; Medullary thyroid cancer; Biology; Fusion gene; RET proto-oncogene; Oncogene; Fusion protein; Carcinogenesis; Mutation; Cancer; Gene; Thyroid cancer; Genetics; Cell cycle; Receptor; Recombinant DNA; Germline mutation","score_opus":0.2372133478102012,"score_gpt":0.4517700918389119,"score_spread":0.21455674402871072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115054742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963274,0.013292079,0.000025294568,0.019604225,0.000089384186,0.0011647299,0.000068460235,0.000024067722,0.0024577526],"genre_scores_gemma":[0.9947803,0.0029174269,0.00008337404,0.00034990392,0.00023239566,0.00031821762,0.000007383955,0.000017087043,0.001293884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980612,0.000117613155,0.00026221373,0.00030240673,0.0008211598,0.00043543038],"domain_scores_gemma":[0.9988343,0.00008583652,0.000048618873,0.00053523167,0.0003340159,0.0001620135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005346965,0.00013600086,0.00030685324,0.000100197525,0.00014679375,0.000019080013,0.00022093077,0.00007653235,0.0004494493],"category_scores_gemma":[0.000050211886,0.00008260189,0.00015443808,0.00043900908,0.00020821621,0.000047196692,0.000029471314,0.00042532184,0.000020212348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001959213,0.002380403,0.013812639,0.00028750513,0.000584363,0.00011038121,0.003907715,0.00013440703,0.5294005,0.0036451255,0.03429063,0.40948713],"study_design_scores_gemma":[0.0033971036,0.0024487735,0.22989665,0.0005104548,0.00010891269,0.000012712617,0.00033017754,0.000053390253,0.73217523,0.0017494176,0.029156707,0.00016050086],"about_ca_topic_score_codex":0.0033900635,"about_ca_topic_score_gemma":0.00065164664,"teacher_disagreement_score":0.4093266,"about_ca_system_score_codex":0.00060416764,"about_ca_system_score_gemma":0.0005645734,"threshold_uncertainty_score":0.5124785},"labels":[],"label_agreement":null},{"id":"W2115602300","doi":"10.1158/0008-5472.can-14-0130","title":"Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"University of Pennsylvania","keywords":"Medicine; Pharmacology; Mevalonate pathway; Statin; In vivo; HMG-CoA reductase; Cancer research; Reductase; Internal medicine; Biology; Enzyme; Biochemistry","score_opus":0.056249204547992676,"score_gpt":0.3701558982658539,"score_spread":0.3139066937178612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115602300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630215,0.0187173,0.00019611859,0.000812221,0.0015356214,0.00071054953,0.00017574648,0.000007221657,0.0015430722],"genre_scores_gemma":[0.98964787,0.003348578,0.00009832676,0.00033341447,0.0036559806,0.0002444983,0.000027345079,0.000029016086,0.002615005],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978425,0.00053246634,0.00022910521,0.0004890501,0.00042922207,0.00047769505],"domain_scores_gemma":[0.99870473,0.00005339013,0.00007304883,0.0005140386,0.00043673522,0.0002180634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017422052,0.00016136284,0.00027293022,0.00007278255,0.00015912102,0.00003123225,0.0003914844,0.0000904635,0.00007174538],"category_scores_gemma":[0.00040114738,0.000117456,0.00007079145,0.00027960108,0.0002586573,0.000008113059,0.0003402219,0.0002380006,0.000011417649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005147144,0.00006286909,0.00076981954,0.00007116671,0.00011602626,1.690003e-7,0.0009419435,0.00004555654,0.94670063,0.0009941888,0.032415614,0.017367288],"study_design_scores_gemma":[0.0008681484,0.00010809668,0.008045894,0.00001497589,0.000012945066,0.0000011521456,0.00010294864,0.00017927469,0.295515,0.00033148617,0.6946886,0.0001314616],"about_ca_topic_score_codex":0.0005471307,"about_ca_topic_score_gemma":0.00039408368,"teacher_disagreement_score":0.662273,"about_ca_system_score_codex":0.000017248947,"about_ca_system_score_gemma":0.00031784637,"threshold_uncertainty_score":0.4789717},"labels":[],"label_agreement":null},{"id":"W2115751699","doi":"10.1158/0008-5472.can-04-2502","title":"RNA Silencing of Checkpoint Regulators Sensitizes <i>p53</i> -Defective Prostate Cancer Cells to Chemotherapy while Sparing Normal Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"LNCaP; Cancer research; Gene knockdown; Cancer cell; Prostate cancer; Cell cycle checkpoint; Cell cycle; Biology; Doxorubicin; DNA damage; CHEK1; Cisplatin; Gene silencing; Cancer; Cell biology; Cell culture; Chemotherapy; Gene; DNA; Genetics","score_opus":0.03040453193459476,"score_gpt":0.33294608838350154,"score_spread":0.3025415564489068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115751699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896443,0.0022634568,0.00011934908,0.0019681368,0.00036682066,0.0018791419,0.0000891137,0.00008856159,0.003581158],"genre_scores_gemma":[0.99336004,0.0017879388,0.00087449996,0.00058018946,0.00080067356,0.0003457674,0.0000063578136,0.00013879963,0.0021057467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961415,0.00014860895,0.0005426156,0.00077737775,0.0012594627,0.0011304565],"domain_scores_gemma":[0.9975502,0.000103791775,0.0001518537,0.0007212302,0.00095026445,0.000522643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010388655,0.000322634,0.0006168004,0.00048821716,0.00018004757,0.000041587344,0.00023977981,0.00019853964,0.0006022968],"category_scores_gemma":[0.000058908503,0.00031628038,0.00020704343,0.0012269955,0.00025759317,0.00014206885,0.00020309215,0.00095244724,0.00009749436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010486525,0.00010462439,0.00025541594,0.00028471166,0.00016647625,0.000037181228,0.004498555,0.010165502,0.9586591,0.000012739609,0.005866844,0.018900182],"study_design_scores_gemma":[0.0021996573,0.00037648613,0.0008413066,0.0010159647,0.000049852748,0.000011509425,0.00049017876,0.00052683795,0.9853946,0.000011312126,0.008782762,0.00029953205],"about_ca_topic_score_codex":0.0037420823,"about_ca_topic_score_gemma":0.0007964111,"teacher_disagreement_score":0.026735486,"about_ca_system_score_codex":0.0019024629,"about_ca_system_score_gemma":0.0012682592,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W2115774673","doi":"10.1158/0008-5472.can-08-2243","title":"Do Placental Genes Affect Maternal Breast Cancer? Association between Offspring's <i>CGB5</i> and <i>CSH1</i> Gene Variants and Maternal Breast Cancer Risk","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; University of Melbourne; U.S. Department of Defense; Huntsman Cancer Institute; Cancer Care Ontario","keywords":"Offspring; Breast cancer; Pregnancy; Odds ratio; Single-nucleotide polymorphism; Obstetrics; Oncology; Medicine; Cancer; Gynecology; Biology; Internal medicine; Genotype; Genetics; Gene","score_opus":0.03841336680773756,"score_gpt":0.354872000869114,"score_spread":0.3164586340613765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115774673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845211,0.008537818,0.000008253874,0.001305376,0.00040391288,0.00068626355,0.0043301242,0.000067100686,0.00014003238],"genre_scores_gemma":[0.92873496,0.06760158,0.000030812786,0.00011780407,0.0021514725,0.00023464793,0.000020203119,0.00008502564,0.0010235262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961326,0.00023332727,0.00040614227,0.0008128296,0.0013413443,0.0010737145],"domain_scores_gemma":[0.99818224,0.000144529,0.00023589979,0.00033575387,0.00046102612,0.0006405814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008174332,0.0003704007,0.0006579214,0.00026840708,0.00062591105,0.0001901583,0.00021554991,0.00025665844,0.00078458997],"category_scores_gemma":[0.00002550867,0.000322,0.00010264705,0.0004126065,0.00033735292,0.00030213146,0.00027100247,0.00089462387,0.00001951035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094553037,0.000047689835,0.9439646,0.00019702558,0.00043890483,0.00011178142,0.00037129226,0.0000128380525,0.01722728,0.000002883064,0.002917759,0.03376244],"study_design_scores_gemma":[0.0032322004,0.00011060832,0.979584,0.00042381938,0.00019617815,0.00049820216,0.00005762522,0.000057235797,0.013633308,0.0000124468015,0.0018765553,0.00031783726],"about_ca_topic_score_codex":0.10509071,"about_ca_topic_score_gemma":0.0022771826,"teacher_disagreement_score":0.10281352,"about_ca_system_score_codex":0.0017345961,"about_ca_system_score_gemma":0.00068333425,"threshold_uncertainty_score":0.9999232},"labels":[],"label_agreement":null},{"id":"W2115850999","doi":"10.1158/0008-5472.can-04-0715","title":"Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute on Drug Abuse","keywords":"Epidermal growth factor receptor; Growth factor receptor inhibitor; Insulin receptor; Insulin-like growth factor; Epidermal growth factor; Cancer research; Endocrinology; Factor (programming language); Biology; TGF alpha; Internal medicine; Receptor; Growth factor; Cell biology; Insulin; Medicine; Insulin resistance; Computer science","score_opus":0.06871447638720567,"score_gpt":0.34825782853602916,"score_spread":0.2795433521488235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115850999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928455,0.0016729288,0.00006130114,0.0019491065,0.000420941,0.0019721868,0.0002073597,0.00015809067,0.00071258686],"genre_scores_gemma":[0.9955042,0.0010667938,0.0008348317,0.00009285933,0.0004981706,0.00034298195,0.000084267296,0.00014112765,0.0014347439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940869,0.00033123672,0.0010263023,0.0009874386,0.0020895922,0.0014784868],"domain_scores_gemma":[0.99649507,0.00020379698,0.00028786183,0.000783184,0.0014431983,0.00078687427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080482266,0.00052475696,0.000966135,0.0009479341,0.0004037931,0.00006896966,0.00059709896,0.00049561827,0.0009708407],"category_scores_gemma":[0.0010199235,0.00042628302,0.00031883162,0.0014928145,0.00060372695,0.0005627333,0.0003326218,0.0015684755,0.000200843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010679859,0.00037940365,0.011532607,0.00081972417,0.00010486337,0.00005174899,0.0016979192,0.0000024776944,0.9808142,0.0004314782,0.0019272007,0.0011703784],"study_design_scores_gemma":[0.0038832058,0.000905049,0.026658006,0.0015692866,0.000026621145,0.000013843226,0.0003751079,0.0000038988683,0.9639983,0.0006413997,0.0014975517,0.00042772683],"about_ca_topic_score_codex":0.0015831485,"about_ca_topic_score_gemma":0.000020580668,"teacher_disagreement_score":0.01681591,"about_ca_system_score_codex":0.00094814866,"about_ca_system_score_gemma":0.0011599034,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2115859321","doi":"10.1158/0008-5472.can-05-1841","title":"BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological repression; Biology; Gene; DNA; Cancer research; Regulation of gene expression; Gene expression; Molecular biology; Genetics; Cell biology","score_opus":0.05111549810357508,"score_gpt":0.37141861304168605,"score_spread":0.320303114938111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115859321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933689,0.0014390489,0.00019635106,0.0028560008,0.00011730836,0.00035370007,0.00006435225,0.00002083654,0.0015834512],"genre_scores_gemma":[0.986023,0.0004631146,0.0017134659,0.000659195,0.0009978815,0.00023883066,0.00003858713,0.00004128418,0.009824661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812335,0.00016039642,0.0001629862,0.0006198722,0.00043549069,0.000497915],"domain_scores_gemma":[0.9989962,0.000018076138,0.0000261313,0.00043785688,0.0002902628,0.0002314979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009955863,0.00012553908,0.00013503467,0.00009494938,0.0001579689,0.00007090397,0.0002932434,0.00015604659,0.00014012303],"category_scores_gemma":[0.00012456406,0.00012891929,0.000054812957,0.00021620275,0.00007375694,0.000008846547,0.0001880624,0.00020183611,0.000038175036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010927939,0.000040790677,0.00017375409,0.00001296109,0.000049524286,0.000004707479,0.00011793336,0.000049534523,0.979645,0.00014218976,0.012703707,0.006950609],"study_design_scores_gemma":[0.00046481466,0.00016334325,0.0023906187,0.000015745516,0.000006928408,0.0000053712633,0.00003853712,0.000022599705,0.86132836,0.00016652435,0.1352539,0.00014322202],"about_ca_topic_score_codex":0.00015144453,"about_ca_topic_score_gemma":0.00033522517,"teacher_disagreement_score":0.1225502,"about_ca_system_score_codex":0.00010204471,"about_ca_system_score_gemma":0.00021133188,"threshold_uncertainty_score":0.52571756},"labels":[],"label_agreement":null},{"id":"W2115896347","doi":"10.1158/0008-5472.can-09-0496","title":"Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Apoptosis; CD8; Biology; Cytotoxic T cell; Immune system; Cell biology; Transforming growth factor; Cancer research; CTL*; T cell; Molecular biology; Chemistry; In vitro; Immunology; Biochemistry","score_opus":0.04897837990844208,"score_gpt":0.3304775497277957,"score_spread":0.28149916981935363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115896347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727478,0.025429199,0.000019315316,0.00052355597,0.0001546896,0.00048621057,0.00006030051,0.000063226624,0.0005157106],"genre_scores_gemma":[0.99357754,0.0035888,0.000026009307,0.000099262805,0.000053463806,0.00004376606,0.000033786873,0.000034953697,0.0025424075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668586,0.0011895421,0.00047227074,0.00058497937,0.00018175703,0.0008855839],"domain_scores_gemma":[0.9984061,0.0007392972,0.00012346999,0.00038004015,0.00025819553,0.00009290342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013072877,0.0003327643,0.0005201309,0.0006017758,0.0011627381,0.00014676659,0.00028191885,0.00025200608,0.0001769066],"category_scores_gemma":[0.00022536212,0.00029927774,0.000082768776,0.00035626962,0.000754981,0.0004901273,0.00013302558,0.00095426023,0.000022387529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020778307,0.00013246575,0.0012576919,0.00017268283,0.000043227767,0.000014763905,0.0024773113,0.0000018869409,0.98865056,0.0000773528,0.00012512485,0.00496913],"study_design_scores_gemma":[0.0019450589,0.0006596671,0.04086926,0.00018166212,0.000030116955,0.00009200214,0.0008334602,0.000008417817,0.9534182,0.00021024457,0.0014180514,0.00033387088],"about_ca_topic_score_codex":0.0015164904,"about_ca_topic_score_gemma":0.00011489164,"teacher_disagreement_score":0.039611567,"about_ca_system_score_codex":0.0001708131,"about_ca_system_score_gemma":0.0003351471,"threshold_uncertainty_score":0.99994594},"labels":[],"label_agreement":null},{"id":"W2116201594","doi":"10.1158/0008-5472.can-09-0042","title":"Loss of <i>Phosphatase and Tensin Homologue Deleted on Chromosome 10</i> Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Vanderbilt University; Breast Cancer Research Foundation","keywords":"Tensin; PTEN; Fulvestrant; Cancer research; Biology; PI3K/AKT/mTOR pathway; Protein kinase B; Estrogen receptor; Endocrinology; Internal medicine; Signal transduction; Cell biology; Cancer; Breast cancer; Medicine","score_opus":0.027176257880605105,"score_gpt":0.32312748655089063,"score_spread":0.2959512286702855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116201594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97499484,0.021777587,0.000011343574,0.0013847001,0.00009039113,0.00053996925,0.001149328,0.000013933689,0.000037933474],"genre_scores_gemma":[0.99364233,0.004948475,0.00036140284,0.0004143763,0.00023033647,0.00011471457,0.00006105394,0.000041176125,0.00018615316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974941,0.0002685157,0.00034310203,0.000801368,0.000444061,0.00064884307],"domain_scores_gemma":[0.9986846,0.00007712325,0.000097864555,0.0003984166,0.00049585366,0.00024614795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006647871,0.0002675009,0.00035726142,0.0001975771,0.00014980593,0.00004764397,0.00031693708,0.00022421747,0.000074387695],"category_scores_gemma":[0.00018777818,0.00025929604,0.000044476015,0.0005235482,0.00033348863,0.000016688145,0.00015141,0.0004418333,0.000003082189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017379858,0.0000939041,0.005150175,0.0001440598,0.000054800592,0.00004040475,0.00027838297,0.00005192355,0.98263615,0.000040213297,0.0051890695,0.004582914],"study_design_scores_gemma":[0.0012986338,0.00073691044,0.013083843,0.00060982,0.0000105466825,0.000010033532,0.000054269458,0.000007642408,0.9743921,0.0000955135,0.009331088,0.0003695623],"about_ca_topic_score_codex":0.0005344662,"about_ca_topic_score_gemma":0.00030466507,"teacher_disagreement_score":0.018647498,"about_ca_system_score_codex":0.00018113921,"about_ca_system_score_gemma":0.00038820866,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W2116233222","doi":"10.1158/0008-5472.can-07-1938","title":"Pediatric <i>KIT</i> –Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"PDGFRA; GiST; Cancer research; Growth factor receptor; Biology; Stromal tumor; Proto-Oncogene Proteins c-kit; Malignancy; Stromal cell; Wild type; Cancer; Pathology; Medicine; Mutant; Stem cell factor; Genetics; Stem cell","score_opus":0.04092622421768243,"score_gpt":0.33658178762818164,"score_spread":0.2956555634104992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116233222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551624,0.00015410074,0.0013300766,0.00046282227,0.00005181372,0.0021215514,0.00014595718,0.00013338153,0.000084043815],"genre_scores_gemma":[0.9589566,0.00006415051,0.039889067,0.000041938965,0.00045118984,0.00013472383,0.00015625345,0.00014231881,0.00016376842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9927011,0.0002810393,0.0008839497,0.0012162916,0.002793293,0.0021242863],"domain_scores_gemma":[0.99298054,0.0005054759,0.00042353786,0.0005701665,0.0041260235,0.0013942643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008379443,0.0006766672,0.00084669504,0.0008926499,0.00040460654,0.00011612051,0.00043785505,0.000094311945,0.0004273038],"category_scores_gemma":[0.0019997512,0.00053314393,0.0001258237,0.0017786705,0.0006322495,0.0002894408,0.00032518076,0.0016165056,0.00004061888],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015258756,0.00061281613,0.39186743,0.0008249439,0.00006808044,0.0019200551,0.00009078841,0.000012896302,0.5873989,0.00011380975,0.00021581104,0.0016157659],"study_design_scores_gemma":[0.005410787,0.031282216,0.5590824,0.003960058,0.0000877565,0.005161721,0.0007627216,0.00014575876,0.39357823,0.00007368918,0.0000081479975,0.00044652962],"about_ca_topic_score_codex":0.0008656984,"about_ca_topic_score_gemma":0.00008390997,"teacher_disagreement_score":0.19382061,"about_ca_system_score_codex":0.00073879387,"about_ca_system_score_gemma":0.0019847075,"threshold_uncertainty_score":0.999712},"labels":[],"label_agreement":null},{"id":"W2116407378","doi":"10.1158/0008-5472.can-06-4038","title":"Targeting HER-2/ <i>neu</i> in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of Pennsylvania; National Institutes of Health; Cleveland Clinic; American Cancer Society","keywords":"Dendritic cell; Interleukin 12; Immunology; Medicine; HER2/neu; Breast cancer; CD8; CD80; Immunotherapy; Cancer research; Cytotoxic T cell; Antigen; Immune system; Cancer; Biology; Internal medicine; CD40; In vitro","score_opus":0.037676585433522834,"score_gpt":0.33424291890214863,"score_spread":0.2965663334686258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116407378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885177,0.009792106,0.00042413687,0.00012655613,0.00048667105,0.00047995028,0.000023382383,0.000039041493,0.000110460416],"genre_scores_gemma":[0.9965478,0.0006021338,0.00012766833,0.00008903936,0.00006756221,0.000105036685,0.000021774687,0.00005082887,0.0023881353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714595,0.00057902996,0.0004477893,0.00044285803,0.00018289236,0.0012014662],"domain_scores_gemma":[0.99905133,0.00028006453,0.00009496603,0.0002526299,0.00027633307,0.000044695233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020893938,0.00023718778,0.00030600908,0.00047724295,0.00048367627,0.000059499926,0.00035020578,0.00023366133,0.0007574015],"category_scores_gemma":[0.000025793986,0.00020617867,0.000043879416,0.0005579105,0.00042448426,0.00021098478,0.000115865216,0.0010806881,0.00007955738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038897991,0.00010951205,0.01631618,0.000060982864,0.00013304559,0.00004752791,0.0035540066,0.00012780302,0.96895164,0.000012930128,0.0001691887,0.006627389],"study_design_scores_gemma":[0.0027531537,0.00021047026,0.045219295,0.00089912146,0.000012563485,0.000067039866,0.0023678797,0.000008419298,0.93413514,0.000006438897,0.013901094,0.00041936833],"about_ca_topic_score_codex":0.0063098436,"about_ca_topic_score_gemma":0.0020471055,"teacher_disagreement_score":0.034816477,"about_ca_system_score_codex":0.001110363,"about_ca_system_score_gemma":0.00083444687,"threshold_uncertainty_score":0.9538638},"labels":[],"label_agreement":null},{"id":"W2116651685","doi":"10.1158/0008-5472.can-06-3834","title":"Lysis of Dysplastic but not Normal Oral Keratinocytes and Tissue-Engineered Epithelia with Conditionally Replicating Adenoviruses","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Lytic cycle; Dysplasia; Oral mucosa; Biology; Cancer research; Epithelial dysplasia; Ex vivo; Epithelium; Cancer; Pathology; Immunology; Virology; In vivo; Virus; Medicine","score_opus":0.0410476032337075,"score_gpt":0.37767713748892845,"score_spread":0.33662953425522096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116651685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966581,0.0015448885,0.00094637444,0.00016414053,0.000017512493,0.000278216,0.00013065267,0.00001016887,0.00024993927],"genre_scores_gemma":[0.99769175,0.000290806,0.0008669389,0.000072196104,0.0001752644,0.00008759433,0.00006439541,0.00003593353,0.0007151391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981798,0.00009794419,0.00023288601,0.00041336397,0.0005713624,0.0005046603],"domain_scores_gemma":[0.9986759,0.00015893482,0.000058394446,0.00039000087,0.0005549538,0.00016180854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011815021,0.00013856811,0.00017872565,0.00017091476,0.00016086803,0.000035551537,0.00025793366,0.00010335261,0.00015622804],"category_scores_gemma":[0.0002112405,0.0001207517,0.000028704131,0.0003106927,0.00043967564,0.000008583953,0.00013548078,0.00025002795,0.0000074158443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026187932,0.000036759022,0.0024163704,0.0000625585,0.0001096299,0.000009284359,0.000050642164,0.0001715965,0.9881966,0.000054544573,0.00026410428,0.0060091116],"study_design_scores_gemma":[0.0007568502,0.0017299507,0.0043851216,0.000037198566,0.00001081741,0.000009868233,0.00010157986,0.00004147784,0.9914111,0.000013464935,0.0013597312,0.00014283873],"about_ca_topic_score_codex":0.00019871705,"about_ca_topic_score_gemma":0.00081232993,"teacher_disagreement_score":0.005866273,"about_ca_system_score_codex":0.000042816628,"about_ca_system_score_gemma":0.00032506176,"threshold_uncertainty_score":0.49241114},"labels":[],"label_agreement":null},{"id":"W2116935659","doi":"10.1158/0008-5472.can-06-1769","title":"Estrogen Receptor Positive Breast Cancer Metastasis: Altered Hormonal Sensitivity and Tumor Aggressiveness in Lymphatic Vessels and Lymph Nodes","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Cancer Center, University of Colorado; National Cancer Institute; National Institutes of Health; Avon Foundation for Women; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Estrogen receptor; Primary tumor; Lymphangiogenesis; Cancer research; Metastasis; Lymphatic system; Tumor microenvironment; Breast cancer; Lymph; Cancer; Estrogen; CD44; Pathology; Medicine; Biology; Internal medicine; Cell","score_opus":0.03449068499429694,"score_gpt":0.35615126172411665,"score_spread":0.32166057672981974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116935659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96310997,0.03280676,0.000015798549,0.0022274302,0.00010865162,0.00059525477,0.000958579,0.000021632839,0.0001559318],"genre_scores_gemma":[0.9934141,0.005127643,0.0002017165,0.0001712856,0.00043785007,0.0003550189,0.00004075433,0.0000476029,0.00020404535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99725854,0.00038725344,0.0003069881,0.0006650441,0.0006540074,0.00072813843],"domain_scores_gemma":[0.99871427,0.00024583415,0.000094886665,0.00025243356,0.0003933776,0.00029922772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009608738,0.0002580207,0.0005773341,0.00033652096,0.00018045427,0.0000919299,0.000077288896,0.000076807984,0.00018992096],"category_scores_gemma":[0.000047373916,0.00022532845,0.00006777488,0.0005987005,0.0005029741,0.00018769105,0.00014981529,0.00026616917,0.0000058715405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034563993,0.00045654151,0.2936794,0.001054947,0.00040655475,0.0007918478,0.00054955203,0.0000655717,0.52635556,0.0004551011,0.0011296811,0.17159887],"study_design_scores_gemma":[0.0058878423,0.00012738691,0.8406549,0.0020392272,0.00023606159,0.00061730016,0.000593663,0.00023055566,0.14762679,0.0001845581,0.0013373565,0.0004643473],"about_ca_topic_score_codex":0.027317047,"about_ca_topic_score_gemma":0.0011705776,"teacher_disagreement_score":0.54697555,"about_ca_system_score_codex":0.00068307755,"about_ca_system_score_gemma":0.0008696225,"threshold_uncertainty_score":0.97916013},"labels":[],"label_agreement":null},{"id":"W2117113786","doi":"10.1158/0008-5472.can-08-1191","title":"<i>Helicobacter pylori</i> Cytotoxin-Associated Gene A Activates the Signal Transducer and Activator of Transcription 3 Pathway <i>In vitro</i> and <i>In vivo</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"CagA; STAT3; Biology; STAT protein; Helicobacter pylori; Signal transduction; Transactivation; Carcinogenesis; Cancer research; Autocrine signalling; Molecular biology; Cell biology; Transcription factor; Receptor; Cancer; Gene","score_opus":0.03591302373547205,"score_gpt":0.31362324996273494,"score_spread":0.2777102262272629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117113786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851799,0.0015917282,0.0000063532098,0.012007957,0.000054279746,0.00088898826,0.000089920264,0.000024633071,0.00015623323],"genre_scores_gemma":[0.9965903,0.0019786065,0.000026444086,0.0010002054,0.000088672125,0.00016426,0.000008459983,0.000029096163,0.00011395731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973642,0.00040118117,0.0004538701,0.00050183537,0.0005079601,0.0007709322],"domain_scores_gemma":[0.99904215,0.000250102,0.00007645302,0.00024548746,0.00022461839,0.00016120511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010725748,0.0002509017,0.00057240186,0.0003271401,0.000123686,0.000025901814,0.00014455128,0.0002173824,0.00003874698],"category_scores_gemma":[0.000087730135,0.00018472256,0.00006858428,0.00074682897,0.00047668774,0.00018732689,0.00003907919,0.0010751478,0.0000012059903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034688856,0.00028326517,0.019779645,0.000054220538,0.00012567097,0.00003734694,0.0021965455,0.0000026371492,0.9693131,0.0000057837956,0.0001630082,0.004569896],"study_design_scores_gemma":[0.004302068,0.00061533315,0.1345975,0.00025023535,0.00003308523,0.000019312498,0.0003318395,0.000025308058,0.85874057,0.00006292521,0.0008959132,0.00012589764],"about_ca_topic_score_codex":0.00035777848,"about_ca_topic_score_gemma":0.00030618894,"teacher_disagreement_score":0.11481786,"about_ca_system_score_codex":0.00026521183,"about_ca_system_score_gemma":0.0001669981,"threshold_uncertainty_score":0.7532767},"labels":[],"label_agreement":null},{"id":"W2117321015","doi":"10.1158/0008-5472.can-0482-2","title":"Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Multiple drug resistance; Replication (statistics); Virology; Cancer; Biology; Cancer research; Medicine; Genetics; Drug resistance","score_opus":0.07738280225605983,"score_gpt":0.40683370124218865,"score_spread":0.32945089898612884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117321015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103093,0.005325349,0.00012437742,0.0016707671,0.00015216733,0.00078744045,0.00023307488,0.000027833674,0.0006480466],"genre_scores_gemma":[0.9886879,0.0039397236,0.00009110654,0.00017822481,0.00043368945,0.00094253453,0.000079899546,0.00006169002,0.005585232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649155,0.0002823171,0.00028690297,0.0010162327,0.0009935936,0.00092937675],"domain_scores_gemma":[0.99777126,0.000025533986,0.000058083497,0.0013010567,0.0005617171,0.00028233847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013681252,0.00021322684,0.00018397724,0.00017355307,0.00031138814,0.000077691126,0.0007097636,0.00019969349,0.0002952234],"category_scores_gemma":[0.0001020448,0.00020431087,0.00011331784,0.00041464603,0.00033415938,0.000010671601,0.0002868308,0.00050943444,0.00018141163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024389955,0.00009797669,0.0001442126,0.000045909743,0.00007433321,0.000010848306,0.00019423966,0.0017544917,0.9821976,0.00003379429,0.0020275095,0.0109801],"study_design_scores_gemma":[0.0013788589,0.0011055843,0.0004709949,0.00003861949,0.0000056973668,0.0000015882371,0.00014052216,0.000020800662,0.9643611,0.00016954997,0.03207107,0.00023563551],"about_ca_topic_score_codex":0.0028736412,"about_ca_topic_score_gemma":0.0053107315,"teacher_disagreement_score":0.030043561,"about_ca_system_score_codex":0.00053619646,"about_ca_system_score_gemma":0.0011863662,"threshold_uncertainty_score":0.8331555},"labels":[],"label_agreement":null},{"id":"W2117415427","doi":"10.1158/0008-5472.can-07-2665","title":"Spontaneous Expression of Embryonic Factors and p53 Point Mutations in Aged Mesenchymal Stem Cells: A Model of Age-Related Tumorigenesis In Mice","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Mesenchymal stem cell; Biology; Carcinogenesis; Cancer research; Stem cell; Embryonic stem cell; Cancer; Cancer stem cell; Bone marrow; Phenotype; Immunology; Pathology; Cell biology; Genetics; Medicine; Gene","score_opus":0.07466519593034915,"score_gpt":0.3683747441583855,"score_spread":0.29370954822803635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117415427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962645,0.002619414,0.0000473007,0.000074623975,0.000053269,0.0005624739,0.000042268814,0.0000075913686,0.00032853484],"genre_scores_gemma":[0.99795073,0.0009915095,0.00021039184,0.0000069168764,0.000014025077,0.000030187019,0.0000070039296,0.00002259312,0.0007666171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981603,0.00013123412,0.00047307796,0.00029715034,0.0005256291,0.0004125953],"domain_scores_gemma":[0.99907976,0.0002973257,0.00009015733,0.00021545221,0.00016137156,0.00015592838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012850312,0.00012285257,0.00041822356,0.0006842524,0.000036870213,0.000005945426,0.00010196551,0.000100020494,0.00008513362],"category_scores_gemma":[0.00005337656,0.000103358034,0.00006363426,0.0008022131,0.00020549961,0.000056418772,0.000070567534,0.0004120943,8.780625e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007202358,0.00016219744,0.0050829714,0.0004020191,0.000018521441,0.0005568578,0.0045656683,0.0013798536,0.9842271,0.000018226327,0.000046184356,0.0028201651],"study_design_scores_gemma":[0.0019119625,0.00018075627,0.013327843,0.00063539034,0.000026557094,0.000025438709,0.0033288156,0.00056904805,0.97979844,0.00006527974,0.000028221413,0.000102224076],"about_ca_topic_score_codex":0.0048443805,"about_ca_topic_score_gemma":0.005522557,"teacher_disagreement_score":0.008244871,"about_ca_system_score_codex":0.00037609923,"about_ca_system_score_gemma":0.0004586655,"threshold_uncertainty_score":0.73232865},"labels":[],"label_agreement":null},{"id":"W2117627118","doi":"10.1158/0008-5472.can-04-3373","title":"Susceptibility to Aflatoxin B1-Induced Carcinogenesis Correlates with Tissue-Specific Differences in DNA Repair Activity in Mouse and in Rat","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Centre National de la Recherche Scientifique","keywords":"Guanine; Carcinogenesis; In vivo; DNA repair; Molecular biology; Aflatoxin; DNA damage; Carcinogen; Biology; DNA; Chemistry; Biochemistry; Nucleotide; Gene; Genetics","score_opus":0.05138897008924374,"score_gpt":0.33615037790742464,"score_spread":0.2847614078181809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117627118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981201,0.0007747489,0.000007015807,0.00030932244,0.000033135097,0.0006674501,0.00000952838,0.000014825785,0.000063848136],"genre_scores_gemma":[0.998631,0.0003910003,0.00013519739,0.000024346678,0.00006010377,0.00025382996,0.000004254706,0.000024164116,0.0004760769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978933,0.0003399892,0.00019518693,0.0007492938,0.00029107975,0.00053118536],"domain_scores_gemma":[0.9992367,0.000050682393,0.000025924583,0.00046633338,0.00007879247,0.00014158622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009063235,0.00016441116,0.00024112225,0.00024559637,0.000045861198,0.000028632996,0.00020726994,0.00017271355,0.000033461474],"category_scores_gemma":[0.00008591363,0.00014739725,0.00002484024,0.0004784978,0.000106964995,0.000012561411,0.00021623528,0.00031477472,0.0000058110554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005827062,0.00009736316,0.20247887,0.000021765616,0.0000051366087,0.000014777279,0.0002439333,0.000044458156,0.7923123,0.0000059135696,0.000051547322,0.00414118],"study_design_scores_gemma":[0.0006239378,0.00032825733,0.12466279,0.000042424097,0.0000010136415,0.0000019015358,0.00020125422,0.00006240793,0.87356,0.000016023132,0.00033734686,0.00016264991],"about_ca_topic_score_codex":0.0010983301,"about_ca_topic_score_gemma":0.07497679,"teacher_disagreement_score":0.08124765,"about_ca_system_score_codex":0.00025934872,"about_ca_system_score_gemma":0.0001860635,"threshold_uncertainty_score":0.94190246},"labels":[],"label_agreement":null},{"id":"W2117635193","doi":"10.1158/0008-5472.can-04-3153","title":"Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Institute of Dental and Craniofacial Research","keywords":"OPLS; Toluidine; Stain; Staining; Pathology; Medicine; Internal medicine; Biology; Chemistry","score_opus":0.1337270775125882,"score_gpt":0.4556147568142325,"score_spread":0.3218876793016443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117635193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411815,0.0021791905,0.00008006461,0.0018550473,0.00030003855,0.00062865607,0.00017643697,0.00010318543,0.0005592119],"genre_scores_gemma":[0.9780478,0.00037979675,0.00076132745,0.00019751553,0.00031703745,0.00040126088,0.000038747767,0.000042928285,0.019813612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684083,0.00053490995,0.00041070525,0.0005442406,0.00074964284,0.00091967755],"domain_scores_gemma":[0.9986178,0.00022222279,0.000106911204,0.0005106852,0.00029427608,0.00024805745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014335061,0.00019693653,0.00036689334,0.00022326873,0.0007781697,0.000073223055,0.00027461041,0.00015456846,0.0008861936],"category_scores_gemma":[0.00009917302,0.00014409784,0.00006321966,0.00040253007,0.0003034762,0.00024331258,0.0002205182,0.00076193875,0.000905356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022710864,0.0011336021,0.85737187,0.00087626564,0.0004984145,0.003993,0.0023672134,0.0007905756,0.008041975,0.002998687,0.03301975,0.08663758],"study_design_scores_gemma":[0.0063071176,0.0014652634,0.9146195,0.0005240036,0.00020282154,0.00020899675,0.0014803318,0.00009106214,0.048062205,0.0005773684,0.025756301,0.00070503366],"about_ca_topic_score_codex":0.0030940457,"about_ca_topic_score_gemma":0.0061543984,"teacher_disagreement_score":0.085932545,"about_ca_system_score_codex":0.0006827686,"about_ca_system_score_gemma":0.0004654717,"threshold_uncertainty_score":0.99987257},"labels":[],"label_agreement":null},{"id":"W2117638862","doi":"10.1158/0008-5472.can-04-1121","title":"Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Tufts University School of Medicine; Adobe Systems","keywords":"LNCaP; Androgen receptor; MAPK/ERK pathway; CREB; Androgen; Cancer research; Signal transduction; Biology; Endocrinology; Internal medicine; Cell biology; Chemistry; Prostate cancer; Transcription factor; Medicine; Cancer; Hormone; Biochemistry","score_opus":0.053671819372918705,"score_gpt":0.362093116561756,"score_spread":0.3084212971888373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117638862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993514,0.0018851027,0.00012765294,0.002758507,0.000054454347,0.0013713001,0.00005043678,0.000018766159,0.00021977072],"genre_scores_gemma":[0.99695647,0.0016577926,0.0003555311,0.000083738756,0.00010301987,0.00035028683,0.000022111642,0.000033343607,0.0004377231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768543,0.000092005386,0.00019428975,0.00040170882,0.0010071388,0.0006194377],"domain_scores_gemma":[0.99895376,0.000050343402,0.000033032054,0.00025295498,0.00043361363,0.00027629084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543194,0.00014270957,0.00030927794,0.0004948481,0.00008776557,0.000019600642,0.00015576037,0.00012031561,0.0003380956],"category_scores_gemma":[0.000017876935,0.00010827236,0.00003692545,0.001155866,0.00018811648,0.00008015871,0.00004559913,0.0005157878,0.000045995483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040487866,0.0002607133,0.0062810313,0.00042805512,0.000118620235,0.00027882194,0.005533933,0.0017111732,0.97459877,0.000036120655,0.000105555235,0.006598428],"study_design_scores_gemma":[0.0046481453,0.0019802696,0.0017276141,0.0012066491,0.00002424999,0.000012246755,0.0007231464,0.00001762555,0.9888935,0.00008394307,0.00054401695,0.00013859222],"about_ca_topic_score_codex":0.001530428,"about_ca_topic_score_gemma":0.0015115138,"teacher_disagreement_score":0.014294739,"about_ca_system_score_codex":0.00069936126,"about_ca_system_score_gemma":0.00089949113,"threshold_uncertainty_score":0.44152188},"labels":[],"label_agreement":null},{"id":"W2117701806","doi":"10.1158/0008-5472.can-08-1952","title":"Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Leptin; Endocrinology; Epidermal growth factor receptor; Internal medicine; Cancer research; Breast cancer; Leptin receptor; Protein kinase B; Lapatinib; Insulin receptor; Phosphorylation; Autocrine signalling; Growth factor receptor; Biology; Chemistry; Medicine; Cancer; Receptor; Insulin; Cell biology; Insulin resistance; Trastuzumab","score_opus":0.07022020547242627,"score_gpt":0.3269190220914856,"score_spread":0.25669881661905936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117701806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585176,0.0014233545,0.00026884707,0.00085974735,0.00011352828,0.00080506626,0.00061332196,0.000035602545,0.000028802406],"genre_scores_gemma":[0.9945798,0.0046428796,0.00020431801,0.000034162185,0.0002580503,0.000078016885,0.000067008754,0.00005071285,0.00008508779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970604,0.0002354756,0.0006803088,0.000546974,0.0009978783,0.0004789628],"domain_scores_gemma":[0.9976192,0.00036404512,0.00024055027,0.00018354862,0.001283664,0.0003090042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004439092,0.0002833007,0.0006180194,0.0005621914,0.00029662135,0.00002454229,0.00011918821,0.0002714996,0.00037026897],"category_scores_gemma":[0.00012420364,0.00024767674,0.000103718805,0.0007966175,0.0006264017,0.00048819906,0.000055724428,0.00059522083,0.0000028794118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052224344,0.00011067373,0.29104555,0.00053514534,0.00010184582,0.0000027876183,0.0019125338,0.0000013433034,0.7013457,0.0000058359487,0.00018014417,0.004236229],"study_design_scores_gemma":[0.001015755,0.00030373002,0.45455536,0.0002048518,0.000026580856,0.00001134423,0.00009274114,0.000029120643,0.54353017,0.00003230679,0.0000622945,0.00013577168],"about_ca_topic_score_codex":0.006771123,"about_ca_topic_score_gemma":0.00012441943,"teacher_disagreement_score":0.1635098,"about_ca_system_score_codex":0.00024999343,"about_ca_system_score_gemma":0.00054432655,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W2117721137","doi":"10.1158/0008-5472.can-09-1923","title":"Eukaryotic Initiation Factor 4E Binding Protein Family of Proteins: Sentinels at a Translational Control Checkpoint in Lung Tumor Defense","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; National Institute on Drug Abuse; Knut och Alice Wallenbergs Stiftelse; University of Minnesota","keywords":"Carcinogenesis; Translational regulation; Biology; Tumor initiation; Initiation factor; Cancer research; Eukaryotic translation; Cell biology; Messenger RNA; Translation (biology); Genetics; Cancer; Gene","score_opus":0.04779396716123303,"score_gpt":0.3380817456809079,"score_spread":0.29028777851967486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117721137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954534,0.001068111,0.0009992017,0.00043685746,0.000025793755,0.0016409381,0.00008055976,0.000007777091,0.00028731985],"genre_scores_gemma":[0.9985825,0.00006003557,0.00038186627,0.00005286006,0.00011392565,0.00044108438,0.0000319619,0.000019092566,0.0003166843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817747,0.00030302917,0.0003331711,0.00034877652,0.00044618538,0.00039139047],"domain_scores_gemma":[0.9993825,0.000029938827,0.00009659032,0.00021552818,0.00019606842,0.000079397934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007637125,0.00013525793,0.0001941018,0.00017972729,0.000090882604,0.00002093588,0.00017982251,0.00012086416,0.000108132095],"category_scores_gemma":[0.00014840612,0.00012893182,0.0000841395,0.0002443332,0.000064233274,0.000011111798,0.000032514396,0.00016884999,0.000007852867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005051838,0.00006149005,0.0020062209,0.00008239821,0.00001970283,0.000008024149,0.00009362766,0.00004478327,0.99529284,0.00011747779,0.000024437364,0.0017438196],"study_design_scores_gemma":[0.0011890117,0.00023883574,0.011716459,0.00017265113,0.000004661036,0.0000026848231,0.000032975557,0.00011531704,0.9859007,0.0003100937,0.00017554751,0.00014104332],"about_ca_topic_score_codex":0.000055297216,"about_ca_topic_score_gemma":0.000040465646,"teacher_disagreement_score":0.009710238,"about_ca_system_score_codex":0.000089126195,"about_ca_system_score_gemma":0.00029292467,"threshold_uncertainty_score":0.5257687},"labels":[],"label_agreement":null},{"id":"W2117906220","doi":"10.1158/0008-5472.can-05-2857","title":"Characterization of Common UGT1A8, UGT1A9, and UGT2B7 Variants with Different Capacities to Inactivate Mutagenic 4-Hydroxylated Metabolites of Estradiol and Estrone","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement; Hôtel-Dieu de Québec","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"UGT2B7; Carcinogen; Estrone; Aromatase; Carcinogenesis; Isozyme; Enzyme; Chemistry; Allele; Glucuronosyltransferase; Biology; Biochemistry; Estrogen; Endocrinology; Genetics; Gene; Microsome; Glucuronidation; Cancer; Breast cancer","score_opus":0.01773078836526327,"score_gpt":0.28925307855254767,"score_spread":0.2715222901872844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117906220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987235,0.0004998952,0.00017715925,0.000052635052,0.000021253374,0.0003390357,0.00010646105,0.0000060023394,0.000074055984],"genre_scores_gemma":[0.99911803,0.00029541476,0.00012050416,0.000008188334,0.000050421575,0.000061502935,0.000077681194,0.000020744506,0.00024752208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989896,0.000116311545,0.00017875496,0.000264547,0.00021499007,0.00023582358],"domain_scores_gemma":[0.999463,0.00001827467,0.00007046509,0.00022664566,0.00014652962,0.0000750682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001912601,0.000118538796,0.00022762822,0.000109109096,0.00004983604,0.000015948932,0.00010004356,0.00007815929,0.000011916576],"category_scores_gemma":[0.000017996901,0.000097765296,0.00001856317,0.00014737638,0.00023842072,0.0000084170915,0.00009707005,0.00009501849,2.0240093e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002387644,0.00005561526,0.005331547,0.00008807106,0.000058023514,0.0000016632234,0.00013460938,0.0000128572565,0.99310684,0.0002739495,0.0000064199385,0.0006916192],"study_design_scores_gemma":[0.00044263896,0.00047241725,0.05544061,0.0000593165,0.000016646794,0.000006087049,0.00008727654,0.00003714269,0.94313926,0.000117410826,0.00008667936,0.00009452719],"about_ca_topic_score_codex":0.000682451,"about_ca_topic_score_gemma":0.00014127592,"teacher_disagreement_score":0.050109062,"about_ca_system_score_codex":0.000021097383,"about_ca_system_score_gemma":0.00006096637,"threshold_uncertainty_score":0.39867532},"labels":[],"label_agreement":null},{"id":"W2117991861","doi":"10.1158/0008-5472.can-05-1400","title":"OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Transcription factor; OLIG2; Biology; Transcription (linguistics); Genetics; Gene; Neuroscience; Linguistics","score_opus":0.08823737294699335,"score_gpt":0.41583509566814575,"score_spread":0.3275977227211524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117991861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675542,0.0029025879,0.00028671263,0.025057811,0.000059325932,0.0019973423,0.00006571816,0.000076903954,0.0019993808],"genre_scores_gemma":[0.99020106,0.0010707196,0.00041844047,0.0012393668,0.00042855408,0.0009973185,0.000022850483,0.00007618274,0.005545491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959117,0.00026889265,0.0003850632,0.0007010406,0.0013699237,0.0013633663],"domain_scores_gemma":[0.9977236,0.00026197784,0.00003027513,0.0005912885,0.00082611485,0.0005667609],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010836797,0.0002503504,0.0005350292,0.0010152771,0.00016573242,0.00008177826,0.00039421994,0.00020226248,0.0010294068],"category_scores_gemma":[0.00027340936,0.0001999366,0.00008127902,0.0021603403,0.00034385177,0.00016574623,0.00010126939,0.0010858946,0.00036446154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008534747,0.00030950367,0.062786475,0.0003704662,0.00028392364,0.0003925782,0.0028849079,0.0004967648,0.7938331,0.00058336736,0.034002673,0.09552152],"study_design_scores_gemma":[0.015845535,0.0016914834,0.13844378,0.0011830551,0.000057131754,0.00007635795,0.0012754588,0.0010186328,0.49059975,0.0000883568,0.34908968,0.0006307606],"about_ca_topic_score_codex":0.0038815138,"about_ca_topic_score_gemma":0.0046115387,"teacher_disagreement_score":0.31508702,"about_ca_system_score_codex":0.005251309,"about_ca_system_score_gemma":0.00255814,"threshold_uncertainty_score":0.9998838},"labels":[],"label_agreement":null},{"id":"W2118185746","doi":"10.1158/0008-5472.can-05-3295","title":"Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Hypoxia (environmental); Vascular endothelial growth factor; Tumor hypoxia; Internal medicine; Medicine; Endocrinology; Perfusion; Kinase insert domain receptor; Cancer research; Vascular endothelial growth factor A; Radiation therapy; Chemistry; Oxygen; VEGF receptors","score_opus":0.019568984123032294,"score_gpt":0.3016559831089308,"score_spread":0.2820869989858985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118185746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745196,0.024225637,0.000057663055,0.000049461323,0.00024880568,0.00075058744,0.00011277871,0.000008977406,0.000026465612],"genre_scores_gemma":[0.9852119,0.0133406175,0.000040951283,0.00006006087,0.000928062,0.00020397558,0.00007777987,0.000037850936,0.00009879945],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99805844,0.00021162978,0.00027128993,0.0005696857,0.00040613438,0.00048281354],"domain_scores_gemma":[0.9991991,0.00002202776,0.00004060036,0.0003367055,0.00021617315,0.00018538829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005195347,0.00020703506,0.00030801416,0.00022126116,0.00008899589,0.000042277286,0.00016295952,0.00012771656,0.000073959614],"category_scores_gemma":[0.000051823732,0.0001904241,0.0000951841,0.00025266552,0.00019389117,0.000014027613,0.0001442669,0.0001923304,0.0000019178726],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004907838,0.00011119625,0.17489423,0.00007374574,0.000054746783,0.0000023563362,0.0000525912,0.000006054737,0.8190496,0.000013229451,0.00040372353,0.004847779],"study_design_scores_gemma":[0.0016155201,0.00037337557,0.6271114,0.00003824337,0.000011385817,0.000002824185,0.000017283683,0.0000016137357,0.3661456,0.000016320131,0.0044888756,0.00017756868],"about_ca_topic_score_codex":0.0016090841,"about_ca_topic_score_gemma":0.0005703724,"teacher_disagreement_score":0.45290396,"about_ca_system_score_codex":0.000062532315,"about_ca_system_score_gemma":0.00020123426,"threshold_uncertainty_score":0.7765269},"labels":[],"label_agreement":null},{"id":"W2118212749","doi":"10.1158/0008-5472.can-12-2081","title":"A Classification Model for <i>BRCA2</i> DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Missense mutation; Biology; Genetics; Pathogenicity; Clinical significance; Mutation; Computational biology; Gene; Medicine; Internal medicine","score_opus":0.1083409742346956,"score_gpt":0.4087373595042383,"score_spread":0.3003963852695427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118212749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868628,0.00029952184,0.009528811,0.0010504399,0.0002856188,0.00077489443,0.00019932087,0.00006731859,0.0009313028],"genre_scores_gemma":[0.99077153,0.00006373964,0.005585654,0.00022002523,0.00047532836,0.0013138248,0.00012025149,0.000052906344,0.0013967151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804366,0.00030004676,0.00016117621,0.0005225096,0.00030859376,0.0006640003],"domain_scores_gemma":[0.9986702,0.00012659741,0.000068811125,0.00064100715,0.00033123838,0.00016214038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014184702,0.0001535575,0.00014183833,0.00016831637,0.00030973024,0.000025499518,0.0002192591,0.000251746,0.00003475714],"category_scores_gemma":[0.0003340844,0.00015617273,0.00010789218,0.00033201382,0.00017211917,0.000010743979,0.00006715381,0.00024069709,0.000015077922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068689766,0.00017593498,0.00062074914,0.000044738623,0.000054040847,9.820336e-7,0.00013677217,0.0008615671,0.9712605,0.00016342907,0.024437053,0.0015573511],"study_design_scores_gemma":[0.0023413843,0.00043266153,0.0066109803,0.00006890954,0.00003871258,0.000010070802,0.00016908774,0.15398878,0.80600774,0.00035514578,0.029442966,0.0005335662],"about_ca_topic_score_codex":0.000028015846,"about_ca_topic_score_gemma":0.000051049785,"teacher_disagreement_score":0.16525275,"about_ca_system_score_codex":0.00051097147,"about_ca_system_score_gemma":0.00087448786,"threshold_uncertainty_score":0.63685393},"labels":[],"label_agreement":null},{"id":"W2118411662","doi":"10.1158/0008-5472.can-04-4603","title":"Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Flight Attendant Medical Research Institute","keywords":"Biology; Genetics; Single-nucleotide polymorphism; Chromosome; Molecular biology; Genotype; Gene","score_opus":0.027898090491397194,"score_gpt":0.320537504308701,"score_spread":0.2926394138173038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118411662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322367,0.0040592817,0.00022922902,0.0011343086,0.000021319329,0.00020858276,0.00017486038,0.000009643891,0.0009391331],"genre_scores_gemma":[0.9952053,0.0004439812,0.00016630416,0.000070575414,0.00024877535,0.00019294329,0.00027413332,0.000019528654,0.003378487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986729,0.0001301451,0.00024467867,0.00039187397,0.00017342952,0.00038694975],"domain_scores_gemma":[0.99929965,0.000019941881,0.000046180485,0.0003778081,0.0001378543,0.00011859467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002947711,0.00011562125,0.00016231972,0.00025099507,0.00032730144,0.000068995236,0.00020098282,0.00009873664,0.00018361844],"category_scores_gemma":[0.000023440829,0.0001238064,0.000064952124,0.00054740725,0.00017566652,0.0000104899855,0.00008268116,0.0001707672,0.0000066911525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009794778,0.000103736245,0.028100692,0.000013720416,0.00011457526,0.0000023299901,0.00026722904,0.00013280562,0.9680687,0.00024406557,0.0027109378,0.00023138741],"study_design_scores_gemma":[0.002477017,0.00047017756,0.16066691,0.000073089366,0.00036874838,0.000055477914,0.0016284293,0.00026124046,0.67667663,0.0003964042,0.15573266,0.0011931995],"about_ca_topic_score_codex":0.0013750247,"about_ca_topic_score_gemma":0.0024911044,"teacher_disagreement_score":0.2913921,"about_ca_system_score_codex":0.0001609295,"about_ca_system_score_gemma":0.00010580138,"threshold_uncertainty_score":0.50486785},"labels":[],"label_agreement":null},{"id":"W2118424365","doi":"10.1158/0008-5472.can-11-1357","title":"Metastatic Cells Can Escape the Proapoptotic Effects of TNF-α through Increased Autocrine IL-6/STAT3 Signaling","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Autocrine signalling; Cancer research; Tumor necrosis factor alpha; Cytokine; Proinflammatory cytokine; Paracrine signalling; Biology; Tumor microenvironment; Metastasis; Apoptosis; Cancer cell; Cancer; Immunology; Cell culture; Inflammation; Receptor","score_opus":0.1390622161704273,"score_gpt":0.39887703678686665,"score_spread":0.25981482061643935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118424365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938869,0.0007149285,0.00026094483,0.0006052535,0.0002550698,0.0014744787,0.000041956497,0.00004649986,0.0027139946],"genre_scores_gemma":[0.99755484,0.0001499718,0.0008104568,0.00019114588,0.00017402502,0.00039029238,0.000011093932,0.00004452439,0.0006736765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779296,0.00032738206,0.00034822623,0.00031465877,0.0006897525,0.0005269925],"domain_scores_gemma":[0.99802154,0.0006516169,0.00010027611,0.00051179656,0.0005526461,0.00016212699],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007258475,0.00016739417,0.00036043255,0.00017972967,0.00020816461,0.000023587716,0.00025202724,0.00003984184,0.0013499738],"category_scores_gemma":[0.00037933068,0.000108648055,0.00014121259,0.0006593301,0.0003128413,0.00008450605,0.00009806522,0.0006682964,0.000041691113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003542272,0.00033923244,0.00026023402,0.00089379976,0.00026621536,0.00008160404,0.004295886,0.000026189651,0.988571,0.0006236118,0.0025761446,0.0017118552],"study_design_scores_gemma":[0.0010499012,0.0008159164,0.00088921085,0.0006185223,0.00017525139,0.000018863651,0.00068262435,0.00023043857,0.9921401,0.0005015554,0.0027661615,0.000111435],"about_ca_topic_score_codex":0.010276839,"about_ca_topic_score_gemma":0.00015666593,"teacher_disagreement_score":0.010120174,"about_ca_system_score_codex":0.00016995796,"about_ca_system_score_gemma":0.00065064186,"threshold_uncertainty_score":0.9995629},"labels":[],"label_agreement":null},{"id":"W2118530235","doi":"10.1158/0008-5472.can-08-3492","title":"GEMS (Gene Expression Metasignatures), a Web Resource for Querying Meta-analysis of Expression Microarray Datasets: 17β-Estradiol in MCF-7 Cells","year":2008,"lang":"en","type":"review","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"MCF-7; Microarray analysis techniques; Microarray; Computational biology; Gene expression; Resource (disambiguation); Expression (computer science); Meta-analysis; Biology; Gene; World Wide Web; Computer science; Cancer; Internal medicine; Genetics; Medicine; Cancer cell; Programming language","score_opus":0.2371698887392748,"score_gpt":0.45580057240370214,"score_spread":0.21863068366442734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118530235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002587931,0.9919555,0.0003460178,0.000038358514,0.00011819503,0.0019854857,0.0052010566,0.00001180311,0.00008478102],"genre_scores_gemma":[0.00078770664,0.9854806,0.0010324756,0.000043664437,0.00026068633,0.0036928428,0.0076491623,0.000115490075,0.0009373826],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939098,0.0014949518,0.0012247919,0.001710522,0.00088360574,0.0007763691],"domain_scores_gemma":[0.9964381,0.0002742299,0.0007065113,0.0020278574,0.00030464865,0.0002486425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015782501,0.0006165796,0.002811885,0.0015135974,0.00022652539,0.000057495956,0.0013916702,0.0009372298,0.00015610618],"category_scores_gemma":[0.0001976593,0.00046369102,0.0022293765,0.0018971501,0.00024654245,0.000014430511,0.00042719117,0.0008281584,0.0000038313833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016168498,0.00013385974,0.0000014635708,0.002104672,0.009044884,0.000006210483,0.000055947818,0.00019889725,0.88956344,0.0000027081278,0.08328211,0.015444118],"study_design_scores_gemma":[0.0002838822,0.000055269178,5.9794473e-7,0.00052361924,0.008447586,0.0000029229366,0.000036363122,0.0000075415633,0.33836597,0.000002292022,0.65197426,0.00029971328],"about_ca_topic_score_codex":0.00008286045,"about_ca_topic_score_gemma":0.000066751876,"teacher_disagreement_score":0.5686921,"about_ca_system_score_codex":0.00018982425,"about_ca_system_score_gemma":0.0011482675,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W2118645534","doi":"10.1158/0008-5472.can-13-1346","title":"Taccalonolide Binding to Tubulin Imparts Microtubule Stability and Potent <i>In Vivo</i> Activity","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; National Cancer Institute; U.S. Food and Drug Administration","keywords":"Tubulin; Microtubule; In vivo; Cell biology; Chemistry; Biology; Genetics","score_opus":0.0459998472877606,"score_gpt":0.3490478255572117,"score_spread":0.3030479782694511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118645534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653363,0.000612974,0.000009047556,0.0016003674,0.000042789074,0.0005407525,0.000038999715,0.000005465051,0.00061598705],"genre_scores_gemma":[0.9984367,0.00052130537,0.000044778157,0.0001310445,0.00013649886,0.0004225553,0.000002950779,0.000012006623,0.0002921574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986761,0.00008450537,0.0001122859,0.00042757305,0.00017565531,0.0005238494],"domain_scores_gemma":[0.9994431,0.000037603622,0.000017513572,0.00022307262,0.000107406435,0.00017130989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334858,0.000116253184,0.00015228608,0.000047683014,0.000121233,0.000054633823,0.00014355133,0.00008777573,0.00013134976],"category_scores_gemma":[0.00008108386,0.00009948285,0.000036294667,0.00016919253,0.000162616,0.000008394363,0.00044631137,0.00019527314,0.0000184741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009778061,0.000054918874,0.0100127505,0.000030017478,0.0000141422115,0.0000010264604,0.000053538595,0.0000010660848,0.9807898,0.00000194133,0.006250127,0.0026929108],"study_design_scores_gemma":[0.00022973905,0.00013204788,0.009029621,0.00002184946,0.0000013534265,0.0000011363443,0.00017233922,0.00000530906,0.9776419,0.0000425513,0.012595045,0.00012712844],"about_ca_topic_score_codex":0.0022396925,"about_ca_topic_score_gemma":0.000717812,"teacher_disagreement_score":0.006344918,"about_ca_system_score_codex":0.00010718261,"about_ca_system_score_gemma":0.00006520381,"threshold_uncertainty_score":0.4056793},"labels":[],"label_agreement":null},{"id":"W2118957304","doi":"10.1158/0008-5472.can-15-1107","title":"Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Prodrug; Hypoxia (environmental); Cancer research; Biology; Gene knockdown; Tirapazamine; Pharmacology; Chemistry; Apoptosis; Biochemistry; Cytotoxicity; In vitro","score_opus":0.053241704957024905,"score_gpt":0.38779522292896107,"score_spread":0.33455351797193617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118957304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972466,0.0013090296,0.00007818381,0.00023754641,0.0003329083,0.0005093282,0.0001140438,0.0000054086618,0.00016693604],"genre_scores_gemma":[0.99747914,0.00026592292,0.00009758722,0.000033215612,0.00051778916,0.0001311001,0.000029187597,0.000022071457,0.0014239942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836105,0.0002227339,0.0002785879,0.00037380916,0.0004500807,0.0003137078],"domain_scores_gemma":[0.99811953,0.000019397688,0.0001078817,0.00051813317,0.0010191854,0.00021585198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012759615,0.000107338536,0.00021148534,0.00014243755,0.000044040436,0.000014148786,0.00018347202,0.00009944569,0.000012839514],"category_scores_gemma":[0.0006387006,0.00010207654,0.00006343591,0.00037961427,0.00019795213,0.000007786834,0.00016886058,0.00012010005,0.000011788617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005801156,0.00008512451,0.000065434906,0.00006127416,0.00003408705,0.0000017638595,0.0003420233,0.000028874241,0.98504007,0.000026714362,0.00524692,0.008487624],"study_design_scores_gemma":[0.00049111,0.00019486531,0.0014284558,0.000030357513,0.000013804833,0.000008957036,0.00030301587,0.000008979251,0.9740233,0.000059648493,0.023330756,0.00010674776],"about_ca_topic_score_codex":0.0013595652,"about_ca_topic_score_gemma":0.00024803728,"teacher_disagreement_score":0.018083837,"about_ca_system_score_codex":0.000056691646,"about_ca_system_score_gemma":0.0008059022,"threshold_uncertainty_score":0.41625604},"labels":[],"label_agreement":null},{"id":"W2119014749","doi":"10.1158/0008-5472.can-10-3823","title":"Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Canadian Institute for Advanced Research","keywords":"DNA methylation; Biology; Promoter; Cancer research; Epigenomics; Methylation; DNA demethylation; Cancer; CpG site; Metastasis; Carcinogenesis; Cancer cell; Epigenetics of physical exercise; Molecular biology; Gene; Gene expression; Genetics","score_opus":0.12310665414172484,"score_gpt":0.3611509538554072,"score_spread":0.23804429971368235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119014749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289423,0.0033299727,0.000043174467,0.000035746143,0.00005786416,0.00019029746,0.00001776352,9.4918767e-7,0.0034299872],"genre_scores_gemma":[0.9976992,0.001879933,0.00019615056,0.000006740088,0.000050991126,0.00005964267,0.0000078045205,0.0000084219255,0.000091090355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992444,0.00013915043,0.00015094646,0.00013944128,0.00019139452,0.00013464737],"domain_scores_gemma":[0.9994753,0.000014530948,0.00006234251,0.00020190359,0.00022491103,0.000021025187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004608202,0.000047287747,0.000071688315,0.00007573424,0.000025475469,0.0000028005777,0.00013534275,0.00008307302,0.0001418871],"category_scores_gemma":[0.000071931056,0.000035542245,0.00003539839,0.00024146735,0.00009477082,0.0000030412514,0.00007583213,0.00009027145,9.967915e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007086212,0.00004415388,0.07674429,0.000039416136,0.000011595115,1.9428384e-7,0.00034446374,0.0000132664,0.9179943,0.00018196573,0.000049718783,0.004505782],"study_design_scores_gemma":[0.0001923042,0.000099094075,0.18372272,0.00003190151,0.0000034925988,7.7995445e-8,0.000025754438,0.000015286194,0.81439215,0.0012567751,0.00022402036,0.00003642115],"about_ca_topic_score_codex":0.0009731119,"about_ca_topic_score_gemma":0.0011435337,"teacher_disagreement_score":0.10697844,"about_ca_system_score_codex":0.000017064578,"about_ca_system_score_gemma":0.00012992186,"threshold_uncertainty_score":0.15535642},"labels":[],"label_agreement":null},{"id":"W2119036448","doi":"10.1158/0008-5472.can-05-1840","title":"Increased Hsp27 after Androgen Ablation Facilitates Androgen-Independent Progression in Prostate Cancer via Signal Transducers and Activators of Transcription 3–Mediated Suppression of Apoptosis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Foundation","keywords":"LNCaP; Prostate cancer; Androgen; Cancer research; Hsp27; Gene knockdown; Biology; Endocrinology; Androgen receptor; Internal medicine; Apoptosis; Medicine; Cancer; Hormone; Heat shock protein; Gene","score_opus":0.021434622151708098,"score_gpt":0.34168360451554214,"score_spread":0.32024898236383403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119036448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934234,0.0046519865,0.00006528427,0.00031334852,0.000019059058,0.0012622882,0.00024074678,0.0000056975837,0.000018176062],"genre_scores_gemma":[0.996457,0.0023179955,0.00009032512,0.000007809371,0.000050380444,0.0008938516,0.00010360525,0.00002824428,0.000050793387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974023,0.00045831566,0.00040726774,0.00047983677,0.00075928366,0.00049297337],"domain_scores_gemma":[0.99912804,0.000042969037,0.00006798155,0.00023312408,0.00034363425,0.00018424865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009798137,0.00017211222,0.00025587968,0.0003202458,0.000067533234,0.00001650611,0.0001687359,0.0002141054,0.0002248098],"category_scores_gemma":[0.00005889671,0.00015065873,0.000063653904,0.0004132369,0.00028351642,0.00003638417,0.000075454846,0.00030636493,0.0000012229629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002971867,0.00015398333,0.039079357,0.00033856794,0.000048090842,0.0000018067208,0.0008489727,0.00014028943,0.9314,4.7661368e-7,0.00004020014,0.024976382],"study_design_scores_gemma":[0.0016730793,0.00041794364,0.009931718,0.00026825152,0.000008684006,0.0000013894993,0.00018655956,0.00034056048,0.9863981,0.000012145577,0.0006180647,0.00014352043],"about_ca_topic_score_codex":0.0017570249,"about_ca_topic_score_gemma":0.0006953925,"teacher_disagreement_score":0.054998077,"about_ca_system_score_codex":0.00014793352,"about_ca_system_score_gemma":0.00043186496,"threshold_uncertainty_score":0.61436844},"labels":[],"label_agreement":null},{"id":"W2119101863","doi":"10.1158/0008-5472.can-12-1170","title":"Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Cancer research; Radioresistance; Cancer; Imatinib; Bladder cancer; Lapatinib; Medicine; Olaparib; Cancer cell; Homologous recombination; Tyrosine-kinase inhibitor; Radiation therapy; Biology; Internal medicine; Breast cancer; Poly ADP ribose polymerase; DNA","score_opus":0.0504590839508199,"score_gpt":0.3939906157245511,"score_spread":0.3435315317737312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119101863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628352,0.012355431,0.000025682826,0.0117322,0.0004917687,0.0018449908,0.00006920686,0.00012018773,0.010525366],"genre_scores_gemma":[0.9755506,0.0033503869,0.00022691177,0.0006936152,0.00049503363,0.002150812,0.000067931986,0.000063985324,0.017400755],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976266,0.00019866333,0.0002965576,0.0004508385,0.00071785355,0.00070947164],"domain_scores_gemma":[0.99848074,0.0001495536,0.00006344821,0.00029205135,0.00074419804,0.00027002572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004700024,0.00019099293,0.00038924575,0.00018108734,0.00026757928,0.000083473125,0.00014031457,0.00013235156,0.007909789],"category_scores_gemma":[0.00014462271,0.00015203166,0.00009665817,0.00043532476,0.00020039637,0.00018325546,0.000064129,0.0005106069,0.0003997989],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026926716,0.0002523463,0.0070161913,0.00015720235,0.00039718547,0.000038665807,0.00083910197,0.0000060190723,0.20378512,0.000062944615,0.7031535,0.08402247],"study_design_scores_gemma":[0.024058236,0.0021625054,0.041107547,0.001138282,0.00047298818,0.00012980457,0.0027301267,0.00104218,0.80729115,0.0045218626,0.11390542,0.0014398675],"about_ca_topic_score_codex":0.009361634,"about_ca_topic_score_gemma":0.000054648408,"teacher_disagreement_score":0.603506,"about_ca_system_score_codex":0.0006074994,"about_ca_system_score_gemma":0.0004687626,"threshold_uncertainty_score":0.9972351},"labels":[],"label_agreement":null},{"id":"W2119122462","doi":"10.1158/0008-5472.can-03-3780","title":"Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; McGill University Health Centre; McGill University","keywords":"Extracellular; Cancer research; Insulin-like growth factor; Carcinoma; Internal medicine; Endocrinology; Receptor; Growth factor; Biology; Medicine; Chemistry; Oncology; Cell biology","score_opus":0.04850953812163934,"score_gpt":0.32435127958582227,"score_spread":0.27584174146418294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119122462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919607,0.005993217,0.0000485265,0.00078079826,0.00029517256,0.00079233747,0.000047190577,0.000007881029,0.000074168136],"genre_scores_gemma":[0.9987191,0.00071505597,0.000233654,0.000044698987,0.000093997085,0.000031425745,0.0000038782746,0.000031479467,0.00012674266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973941,0.0003722101,0.0005079937,0.00033399477,0.0008996147,0.00049211073],"domain_scores_gemma":[0.9986318,0.0001432707,0.00014998503,0.00048859563,0.00044273122,0.00014365981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008742719,0.00018214245,0.00041737602,0.00021167038,0.00015847659,0.000021676738,0.00036697346,0.00009577036,0.000076344055],"category_scores_gemma":[0.00018363651,0.00010760176,0.000111960544,0.0009796098,0.0008162426,0.0001111039,0.00020801557,0.00076034456,0.0000052167106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007033597,0.00044679374,0.036151536,0.00043870517,0.00007118039,0.000044237546,0.004033875,0.000021138427,0.95716333,0.00032534503,0.000201333,0.00039913485],"study_design_scores_gemma":[0.005470345,0.00043844612,0.14997196,0.00036868177,0.000058625228,0.000015864382,0.0015140262,0.000025782769,0.84018755,0.0012513042,0.0005229269,0.00017447054],"about_ca_topic_score_codex":0.0029024242,"about_ca_topic_score_gemma":0.00007011546,"teacher_disagreement_score":0.11697579,"about_ca_system_score_codex":0.00022195542,"about_ca_system_score_gemma":0.0007363597,"threshold_uncertainty_score":0.43878722},"labels":[],"label_agreement":null},{"id":"W2119143004","doi":"10.1158/0008-5472.can-03-2678","title":"Are <b> <i>ATM</i> </b> Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"National Cancer Institute","keywords":"Breast cancer; Allele; Mutation; Odds ratio; Cancer; Genetics; Population; Oncology; Internal medicine; Medicine; Biology; Gene; Environmental health","score_opus":0.032139888504958185,"score_gpt":0.365814454410776,"score_spread":0.3336745659058178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119143004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897662,0.004042798,0.00036372777,0.00334545,0.00025061955,0.00056820555,0.00131222,0.000035163295,0.00031564414],"genre_scores_gemma":[0.99317485,0.003872569,0.00050956727,0.00034594757,0.0007369817,0.00070801616,0.00010216468,0.00006222906,0.00048767816],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974079,0.00024040378,0.00029394688,0.0009014197,0.0005060817,0.00065024087],"domain_scores_gemma":[0.9980232,0.00004812389,0.00016150589,0.0007427942,0.00076689274,0.00025749305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006979146,0.00023407945,0.00022679428,0.000118154116,0.00050947233,0.000097624936,0.00038976187,0.00024085086,0.00019547818],"category_scores_gemma":[0.00018710038,0.00023379909,0.00008037433,0.00046664794,0.0006800838,0.000016424063,0.00029996329,0.0004935412,0.000025602518],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008346855,0.00053195277,0.17818923,0.00039634685,0.0005845359,0.00005426978,0.001286932,0.020694565,0.71376634,0.00082864,0.035439074,0.047393423],"study_design_scores_gemma":[0.006546154,0.0006544555,0.63718027,0.000313837,0.00015738329,0.00009084223,0.0019520178,0.00005542609,0.2915074,0.007352081,0.05284869,0.0013414731],"about_ca_topic_score_codex":0.006678264,"about_ca_topic_score_gemma":0.02123436,"teacher_disagreement_score":0.45899102,"about_ca_system_score_codex":0.0007064582,"about_ca_system_score_gemma":0.0013917299,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W2119229783","doi":"10.1158/0008-5472.can-08-3160","title":"Intracellular Bacterial Vectors That Induce CD8+ T Cells with Similar Cytolytic Abilities but Disparate Memory Phenotypes Provide Contrasting Tumor Protection","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences; University of Ottawa","funders":"Canadian Institutes of Health Research; Cancer Research Institute","keywords":"Cytotoxic T cell; Adoptive cell transfer; Biology; CD8; Immunology; Antigen; T cell; Immune system; In vitro","score_opus":0.04201708198491766,"score_gpt":0.3168431139582314,"score_spread":0.27482603197331373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119229783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625635,0.0011230924,0.00008532869,0.00053979806,0.00012647145,0.0014110501,0.00006666054,0.00002747976,0.00036376086],"genre_scores_gemma":[0.9974234,0.00016763716,0.00006340066,0.000051652285,0.00071701244,0.0004976737,0.00005152833,0.00003846641,0.0009892364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749136,0.00025955474,0.00018758388,0.00063792674,0.00058415916,0.0008394097],"domain_scores_gemma":[0.9989565,0.000037762955,0.000072831484,0.0004143282,0.00027993566,0.00023866208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047424997,0.0002423458,0.000233333,0.00011210666,0.00031472396,0.00019032352,0.00026797384,0.00011071621,0.00009848744],"category_scores_gemma":[0.00012507106,0.00019475566,0.00006409324,0.00022713553,0.0002965629,0.000025765448,0.000086597334,0.0004076051,0.000018926488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002099474,0.00011634,0.0003505477,0.00008399388,0.00009493483,0.000046873552,0.00012421203,0.00011359847,0.99113667,0.000010145832,0.0004080004,0.0054151937],"study_design_scores_gemma":[0.0013322099,0.0015536002,0.00078782835,0.00009438225,0.000016892911,0.000010568002,0.00023608255,0.00003650419,0.9927186,0.00009384037,0.0028901154,0.00022939115],"about_ca_topic_score_codex":0.0016723642,"about_ca_topic_score_gemma":0.0006125338,"teacher_disagreement_score":0.005185803,"about_ca_system_score_codex":0.0002663024,"about_ca_system_score_gemma":0.00078014226,"threshold_uncertainty_score":0.7941905},"labels":[],"label_agreement":null},{"id":"W2119259252","doi":"10.1158/0008-5472.can-08-3718","title":"Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"RHOB; Cancer research; Gene silencing; Cell growth; Biology; Signal transduction; Transcription factor; Cell biology; RHOA","score_opus":0.04130808368899289,"score_gpt":0.3870035545585404,"score_spread":0.3456954708695475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119259252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96693295,0.015005226,0.005968937,0.007631147,0.001825346,0.0011812679,0.00070551847,0.000009872545,0.00073974015],"genre_scores_gemma":[0.99168104,0.0042056357,0.00008192313,0.00019745655,0.003326827,0.00023471809,0.00002944744,0.000013371054,0.00022957067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890184,0.000069800284,0.00020163777,0.000246542,0.00030494697,0.0002752551],"domain_scores_gemma":[0.99866,0.00015672544,0.00005721656,0.00025243004,0.0008176927,0.000055908677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003750203,0.00008738568,0.00015390376,0.00007039659,0.00009192351,0.000012770831,0.0001525127,0.000102946906,0.00005331665],"category_scores_gemma":[0.00041914717,0.0000678713,0.00008349973,0.0001988786,0.00022854467,0.000008556022,0.000037874936,0.00012848798,4.4582362e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008576825,0.000055238426,0.000073596566,0.00010058957,0.000029336185,2.236011e-8,0.000109362874,0.00001802406,0.9345754,0.0014067224,0.05812596,0.00464806],"study_design_scores_gemma":[0.00082987256,0.0005825719,0.0026936135,0.00007346767,0.00002935032,6.613229e-7,0.00015287592,0.00010266849,0.94181037,0.0007597983,0.05287646,0.00008831622],"about_ca_topic_score_codex":0.0005964056,"about_ca_topic_score_gemma":0.0002083218,"teacher_disagreement_score":0.024748106,"about_ca_system_score_codex":0.000029937497,"about_ca_system_score_gemma":0.00033004544,"threshold_uncertainty_score":0.27677113},"labels":[],"label_agreement":null},{"id":"W2119327914","doi":"10.1158/0008-5472.can-13-2712","title":"YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; McGill University Health Centre; Queen's University","funders":"","keywords":"Hippo signaling pathway; Cyclin-dependent kinase 1; Phosphorylation; Cancer; Cancer research; Apoptosis; Cancer cell; Biology; Carcinogenesis; Kinase; Cell biology; Cell cycle; Biochemistry; Genetics","score_opus":0.02850525633545364,"score_gpt":0.3467548448874143,"score_spread":0.31824958855196067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119327914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527246,0.0020976053,0.00018043848,0.0007020877,0.00020761618,0.00039321164,0.00030648723,0.000017253931,0.0008228639],"genre_scores_gemma":[0.9906055,0.0004782835,0.000091989576,0.00036543462,0.000282043,0.00019011543,0.000036398313,0.00005265219,0.007897625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731785,0.0002232783,0.00033234403,0.00073173124,0.00071846007,0.0006763614],"domain_scores_gemma":[0.9982871,0.000038823415,0.000089399706,0.00070517993,0.0005825089,0.0002970274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010666498,0.00021003518,0.00028748327,0.00012842854,0.00015820676,0.000039584582,0.0005408312,0.0002543222,0.00021475236],"category_scores_gemma":[0.000092733855,0.00020242923,0.000103119324,0.00041868578,0.000110001245,0.0000050264616,0.0001896987,0.00030711968,0.00005327818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002295803,0.00006324142,0.00018914335,0.00007943423,0.000052540643,0.000002001686,0.00038505025,0.00012608789,0.9847701,0.00001871783,0.010439961,0.00364411],"study_design_scores_gemma":[0.00051618385,0.00022091324,0.00008968674,0.00012232842,0.0000068766753,2.514482e-7,0.00006645791,0.000056231707,0.9074876,0.00005260622,0.09115783,0.00022305385],"about_ca_topic_score_codex":0.0015925764,"about_ca_topic_score_gemma":0.00052450446,"teacher_disagreement_score":0.08071788,"about_ca_system_score_codex":0.000096548974,"about_ca_system_score_gemma":0.00045427616,"threshold_uncertainty_score":0.8254824},"labels":[],"label_agreement":null},{"id":"W2119370602","doi":"10.1158/0008-5472.can-04-3208","title":"<i>In vitro</i> Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K- <i>ras</i> Oncogenic Activation in Pancreatic Carcinogenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; U.S. Public Health Service; National Cancer Institute; University of Pennsylvania","keywords":"Carcinogenesis; Pancreatic Intraepithelial Neoplasia; Pancreatic cancer; Cancer research; Biology; Oncogene; Pancreatic duct; Pancreas; Neoplastic transformation; Gene expression profiling; Pathology; Gene expression; Cancer; Cell cycle; Gene; Medicine; Endocrinology; Genetics","score_opus":0.09212148298241804,"score_gpt":0.3901470592209111,"score_spread":0.298025576238493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119370602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936661,0.0016261332,0.00013329706,0.0019807068,0.000034331664,0.0014718644,0.000036162823,0.000022287455,0.0010290914],"genre_scores_gemma":[0.9957983,0.0020729702,0.00040902378,0.00014121643,0.00028292168,0.0008256409,0.00010471814,0.00005060695,0.00031459524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965061,0.0004023372,0.0007183968,0.000489128,0.0010491094,0.0008349563],"domain_scores_gemma":[0.99865085,0.00025093462,0.00011973848,0.00042191683,0.00034928357,0.00020729749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017138905,0.00025160928,0.00085390056,0.0008725799,0.0001622209,0.000018247682,0.00024627234,0.00029263756,0.00015802027],"category_scores_gemma":[0.00010989047,0.00022477502,0.00008943553,0.0009787874,0.00013706408,0.00028199452,0.000065237764,0.00069531286,0.00001553074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012925615,0.00041371927,0.009568195,0.00052128395,0.000029306368,0.000006625024,0.0021219032,0.00016437017,0.98425394,0.000011834848,0.00011014671,0.0015060853],"study_design_scores_gemma":[0.004109475,0.00041977983,0.00224768,0.00047751,0.00006504502,0.0000046077516,0.00058630196,0.0059110993,0.9858154,0.00009178845,0.00008594673,0.00018534377],"about_ca_topic_score_codex":0.0055169393,"about_ca_topic_score_gemma":0.00052030256,"teacher_disagreement_score":0.007320515,"about_ca_system_score_codex":0.00093922013,"about_ca_system_score_gemma":0.0006364637,"threshold_uncertainty_score":0.91660595},"labels":[],"label_agreement":null},{"id":"W2119410505","doi":"10.1158/0008-5472.can-10-2460","title":"Acquired <i>TNFRSF14</i> Mutations in Follicular Lymphoma Are Associated with Worse Prognosis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Nonsynonymous substitution; Follicular lymphoma; Biology; Hazard ratio; Loss of heterozygosity; Exon; Genetics; Oncology; Gene; Cancer research; Confidence interval; Allele; Lymphoma; Internal medicine; Medicine; Immunology; Genome","score_opus":0.051380995128582206,"score_gpt":0.3698850732634636,"score_spread":0.3185040781348814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119410505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928449,0.0004687662,7.4343865e-7,0.004172392,0.00007921488,0.0010725908,0.000041331772,0.00005365528,0.0012664271],"genre_scores_gemma":[0.99609584,0.00012043771,0.00009174686,0.00019252351,0.00010126489,0.0025149407,0.0000736069,0.00003533421,0.0007743192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797124,0.000105344996,0.00019862062,0.000399052,0.00074571656,0.000580057],"domain_scores_gemma":[0.9986742,0.00022417396,0.00005959489,0.0003450316,0.00044735402,0.0002496163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046639616,0.00015266452,0.00029518869,0.00027708983,0.00016683998,0.000057885773,0.00012745039,0.00013630558,0.00029923482],"category_scores_gemma":[0.0003185611,0.00011141562,0.00006816273,0.0011739428,0.00022713248,0.000091874404,0.000050742772,0.00018659519,0.00005760384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022894077,0.001834333,0.9762033,0.00004020667,0.00020681658,0.00083843764,0.00044407116,0.000007848547,0.005811787,0.00014444126,0.0031807912,0.011059005],"study_design_scores_gemma":[0.0069499738,0.0002974203,0.9607984,0.0005300357,0.000074767355,0.00001911646,0.00032842066,0.00005456718,0.025820434,0.0000770268,0.0048983567,0.00015149903],"about_ca_topic_score_codex":0.0012669015,"about_ca_topic_score_gemma":0.0071335123,"teacher_disagreement_score":0.020008648,"about_ca_system_score_codex":0.00063517503,"about_ca_system_score_gemma":0.0007323188,"threshold_uncertainty_score":0.4543397},"labels":[],"label_agreement":null},{"id":"W2119525612","doi":"10.1158/0008-5472.sabcs11-ot1-02-13","title":"OT1-02-13: Cardiac Biomarkers on Trastuzumab (Cabot Trial): Determining the Cardiac Biomarker Profile in Breast Cancer Patients Receiving Adjuvant Trastuzumab Therapy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Cardiotoxicity; Internal medicine; Breast cancer; Ejection fraction; Cardiology; Biomarker; Heart failure; Troponin; Brain natriuretic peptide; Oncology; Cancer; Natriuretic peptide; Chemotherapy; Myocardial infarction","score_opus":0.1620393432808645,"score_gpt":0.4198216100360337,"score_spread":0.2577822667551692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119525612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773955,0.003831633,0.0000013101705,0.0014242947,0.0020227986,0.00752076,0.00068140455,0.00011003402,0.007012286],"genre_scores_gemma":[0.98347235,0.006655001,0.000037841965,0.0002220442,0.0010776077,0.0073391763,0.00006493331,0.00026233392,0.000868702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9890812,0.00231159,0.0010389478,0.0015881294,0.0034368092,0.002543295],"domain_scores_gemma":[0.995335,0.00095164776,0.00021579501,0.0015389026,0.0012586395,0.00070005574],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053870277,0.0006819359,0.0012590078,0.0011287449,0.0005410009,0.00016933803,0.0011101005,0.00041779762,0.0021589892],"category_scores_gemma":[0.00055660144,0.00048479153,0.0005037688,0.0027596336,0.0009413666,0.00028685533,0.00034645677,0.0022433088,0.0001538792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04794694,0.0013309487,0.4173092,0.00027894965,0.00083700503,0.00006201005,0.005677173,0.000003116225,0.0055433433,0.000008161712,0.02309931,0.49790385],"study_design_scores_gemma":[0.027372679,0.0025147828,0.9475425,0.0014192146,0.00007789549,0.0000037476714,0.0010168098,0.000081080296,0.0094789015,0.00002186389,0.009825159,0.00064535055],"about_ca_topic_score_codex":0.01376071,"about_ca_topic_score_gemma":0.00079748925,"teacher_disagreement_score":0.5302333,"about_ca_system_score_codex":0.0042226976,"about_ca_system_score_gemma":0.0032729863,"threshold_uncertainty_score":0.9997604},"labels":[],"label_agreement":null},{"id":"W2119624022","doi":"10.1158/0008-5472.can-14-0876","title":"Cellular Factors Promoting Resistance to Effective Treatment of Glioma with Oncolytic Myxoma Virus","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Smiths Detection (Canada); Alberta Cancer Foundation","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Oncolytic virus; Myxoma virus; Glioma; Virotherapy; Population; Immune system; Cancer research; Immunology; Medicine; Microglia; Cyclophosphamide; Biology; Virus; Chemotherapy; Internal medicine; Inflammation","score_opus":0.032218688770673305,"score_gpt":0.37058985463178373,"score_spread":0.33837116586111043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119624022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996413,0.0011538841,0.00013130491,0.0002070155,0.000034245906,0.0013017579,0.000034246175,0.000011623425,0.00071291893],"genre_scores_gemma":[0.99755716,0.000098476354,0.00007519135,0.000016566612,0.00022364184,0.000625153,0.000019759744,0.00005508226,0.0013289832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974819,0.00049985026,0.00018084158,0.0005792965,0.0006229779,0.00063515414],"domain_scores_gemma":[0.9984927,0.00011476343,0.000054041502,0.0006609002,0.00042939797,0.0002481768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071489793,0.00019748377,0.00026225086,0.00019332513,0.00016819402,0.00003113334,0.00033785033,0.000103309234,0.000045293604],"category_scores_gemma":[0.00014194967,0.00015007907,0.000073289324,0.0005622161,0.00022438067,0.000004339763,0.00009519932,0.00013411083,0.000016769733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045476216,0.00017013046,0.0016462111,0.00007179227,0.000115801515,0.000010096329,0.0004949362,0.000069353526,0.9848121,0.000012389451,0.00020460783,0.007844985],"study_design_scores_gemma":[0.0010317479,0.01525637,0.00085142703,0.00007293254,0.000008795522,8.881582e-7,0.00007827889,0.000014811409,0.9698627,0.000022798587,0.012637496,0.00016174553],"about_ca_topic_score_codex":0.00031441508,"about_ca_topic_score_gemma":0.00288765,"teacher_disagreement_score":0.01508624,"about_ca_system_score_codex":0.000288052,"about_ca_system_score_gemma":0.00034137047,"threshold_uncertainty_score":0.61200464},"labels":[],"label_agreement":null},{"id":"W2119651686","doi":"10.1158/0008-5472.can-05-2305","title":"<i>Mist1-KrasG12D</i> Knock-In Mice Develop Mixed Differentiation Metastatic Exocrine Pancreatic Carcinoma and Hepatocellular Carcinoma","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; Purdue University; Pancreatic Cancer Action Network; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Defense","keywords":"Hepatocellular carcinoma; Exocrine pancreas; Pancreatic carcinoma; Cancer research; Pancreas; Internal medicine; Pathology; Medicine; Pancreatic cancer; Cancer","score_opus":0.054008194238436814,"score_gpt":0.3208252853609626,"score_spread":0.2668170911225258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119651686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916304,0.00670963,0.00009462987,0.00075609743,0.00012644884,0.00076922623,0.000019170984,0.000046828576,0.0023148987],"genre_scores_gemma":[0.99411386,0.00019640388,0.0003754342,0.000106534804,0.00018700358,0.00036864495,0.00010663561,0.00004245967,0.004502994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974032,0.00029375317,0.00043155078,0.00051702134,0.00066268607,0.00069181074],"domain_scores_gemma":[0.9986283,0.00036979024,0.00006529859,0.00030950998,0.00039326109,0.00023384213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064827374,0.00023047799,0.0005152021,0.00046618382,0.00016008198,0.00005830482,0.00010659986,0.00007673067,0.00034423659],"category_scores_gemma":[0.00032224544,0.00020279468,0.00005644124,0.0009756058,0.00018229407,0.0001006912,0.00008304421,0.00038984287,0.000047188838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023821306,0.00015176588,0.8333892,0.00056733354,0.000041998046,0.00013307598,0.0001448667,0.0000034049415,0.16137777,0.00029100396,0.0026257432,0.0010355953],"study_design_scores_gemma":[0.004016175,0.00020619639,0.8534203,0.0002217174,0.00013706362,0.000043309585,0.0002738597,0.0031311135,0.13574466,0.000497035,0.0020608993,0.00024766632],"about_ca_topic_score_codex":0.0065069357,"about_ca_topic_score_gemma":0.00037461394,"teacher_disagreement_score":0.025633112,"about_ca_system_score_codex":0.00042524218,"about_ca_system_score_gemma":0.00048835715,"threshold_uncertainty_score":0.9836584},"labels":[],"label_agreement":null},{"id":"W2119891255","doi":"10.1158/0008-5472.can-09-4563","title":"Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional Assays","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Howard Hughes Medical Institute","keywords":"Missense mutation; Biology; Genetics; Computational biology; Gene; Mutant; Mutation; Loss function; Ovarian cancer; Cancer; Phenotype","score_opus":0.037003235939757566,"score_gpt":0.37738061484199253,"score_spread":0.34037737890223496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119891255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978239,0.0008060273,0.00021108938,0.00053434394,0.00006251191,0.00013391742,0.00020353109,9.433998e-7,0.00022375083],"genre_scores_gemma":[0.99924105,0.00009179761,0.00032440753,0.000049530307,0.000059364207,0.00004457959,0.00011391541,0.000005657989,0.000069692906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909574,0.00016282067,0.00015495952,0.000190907,0.00025990486,0.00013565006],"domain_scores_gemma":[0.99917614,0.00012328805,0.00004994826,0.00027262096,0.00035062453,0.000027344817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042081915,0.000056870533,0.00011222462,0.00012335026,0.00006794664,0.000011483872,0.00013800478,0.00007895767,0.00012361354],"category_scores_gemma":[0.000080797654,0.000045114568,0.00004518581,0.00063512666,0.00031167213,0.0000029473636,0.000058336944,0.00019451774,2.9597942e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055227436,0.000016868538,0.01093252,0.000013004753,0.00022880346,4.9457725e-7,0.00038343962,0.00032277853,0.98430973,0.00063910097,0.0025312786,0.0005667384],"study_design_scores_gemma":[0.0012838906,0.00018754628,0.66672873,0.000011665199,0.00017302705,0.000013213989,0.001891735,0.0011061091,0.30312592,0.0016912582,0.0235689,0.00021797491],"about_ca_topic_score_codex":0.00058803556,"about_ca_topic_score_gemma":0.0013515329,"teacher_disagreement_score":0.6811838,"about_ca_system_score_codex":0.000026885225,"about_ca_system_score_gemma":0.00022672303,"threshold_uncertainty_score":0.18397187},"labels":[],"label_agreement":null},{"id":"W2120122600","doi":"10.1158/1538-7445.am2011-lb-411","title":"Abstract LB-411: A phase II study of combination epigenetic therapy in advanced non-small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Cancer; Azacitidine; Regimen; Phases of clinical research; Progressive disease; Epigenetic therapy; Chemotherapy; DNA methylation; Biology; Gene","score_opus":0.061126527416377995,"score_gpt":0.4104860179981775,"score_spread":0.34935949058179955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120122600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926489,0.0042432416,0.000014264363,0.000029907733,0.000118175856,0.0017015465,0.00003110623,0.0000068244553,0.0012060243],"genre_scores_gemma":[0.9956059,0.0021471016,0.00004023756,0.000013636387,0.00009181507,0.001192325,0.000020581781,0.000050371276,0.0008380189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757105,0.00023910716,0.00038547697,0.00059059827,0.0005939432,0.0006198375],"domain_scores_gemma":[0.99854344,0.000032137603,0.000098637756,0.0005894351,0.0005873289,0.00014899862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009290466,0.0001853812,0.00025731386,0.0003315953,0.00016122319,0.000013725636,0.000512331,0.00015700753,0.00034548927],"category_scores_gemma":[0.000060941464,0.0001832606,0.0000642826,0.00054615183,0.00016735584,0.000009804524,0.00022668144,0.00045336818,0.0000059476897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010104205,0.003774205,0.009504523,0.000097502256,0.000042227282,0.000018883718,0.003635304,0.00008288939,0.96743345,0.0000016118278,0.000718441,0.013680554],"study_design_scores_gemma":[0.0073434655,0.004557538,0.017368173,0.00007394781,0.0000047295043,4.2094646e-7,0.0008828017,0.00006653439,0.9688231,0.0000100264,0.0006728427,0.00019643975],"about_ca_topic_score_codex":0.0049819113,"about_ca_topic_score_gemma":0.0036761374,"teacher_disagreement_score":0.013484114,"about_ca_system_score_codex":0.00019566772,"about_ca_system_score_gemma":0.00067098544,"threshold_uncertainty_score":0.7531193},"labels":[],"label_agreement":null},{"id":"W2120261661","doi":"10.1158/0008-5472.can-11-1659","title":"B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF-β Receptor II Induce Potent Antitumor Immunity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Ectodomain; Antigen; Medicine; Cancer research; Immunology; CD8; Cytotoxic T cell; Tumor antigen; Molecular biology; Immune system; Biology; Receptor; Immunotherapy; In vitro; Internal medicine","score_opus":0.05778358443386004,"score_gpt":0.37915640540113293,"score_spread":0.3213728209672729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120261661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916444,0.0040272716,0.0000045966895,0.0007474777,0.0000723726,0.002627947,0.00008051042,0.000017001363,0.0007784298],"genre_scores_gemma":[0.99660933,0.000517021,0.000097311786,0.000027634811,0.00013690231,0.00032108522,0.000012486023,0.000042144482,0.0022360673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962751,0.0013961456,0.0003491892,0.00024877556,0.0010179447,0.0007127929],"domain_scores_gemma":[0.9975842,0.0009711934,0.00014339236,0.00056859816,0.00048401472,0.00024857672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004771297,0.00016530095,0.00054941647,0.00022286047,0.00027494805,0.000016682985,0.0002644722,0.00010653667,0.0013448459],"category_scores_gemma":[0.00096749223,0.00011065443,0.000093791685,0.0008371251,0.001489993,0.00008353039,0.0003604204,0.0010803571,0.000010178684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035853232,0.0002927434,0.0012365885,0.00050694443,0.00019859687,0.0000018054684,0.0011347533,3.1819187e-7,0.9830912,0.000046270532,0.0017578849,0.008147593],"study_design_scores_gemma":[0.003705949,0.0006503266,0.00209002,0.00039634237,0.000026972759,0.0000070417536,0.0003946535,0.0000137947445,0.9886096,0.00001349385,0.0039943294,0.00009748405],"about_ca_topic_score_codex":0.0044367807,"about_ca_topic_score_gemma":0.000010730831,"teacher_disagreement_score":0.008050109,"about_ca_system_score_codex":0.00021236292,"about_ca_system_score_gemma":0.00043508632,"threshold_uncertainty_score":0.99956805},"labels":[],"label_agreement":null},{"id":"W2120632911","doi":"10.1158/0008-5472.can-04-3156","title":"<i>In vitro</i> Procoagulant Activity Induced in Endothelial Cells by Chemotherapy and Antiangiogenic Drug Combinations: Modulation by Lower-Dose Chemotherapy","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; McMaster University Medical Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Gemcitabine; Medicine; Chemotherapy; Pharmacology; Bevacizumab; Adverse effect; Tissue factor; Oncology; Internal medicine; Coagulation","score_opus":0.022052836785603054,"score_gpt":0.3408324192619628,"score_spread":0.31877958247635974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120632911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933932,0.003459458,0.00006006416,0.0022043055,0.00006867578,0.00060330797,0.000115003284,0.0000069822836,0.00008902946],"genre_scores_gemma":[0.99190044,0.0056927195,0.00006026978,0.0005048331,0.0002160045,0.0002671663,0.000042435437,0.000040640574,0.0012754695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984557,0.00013905279,0.00019092501,0.0004994487,0.00027811612,0.00043675053],"domain_scores_gemma":[0.99950427,0.000023999597,0.000054077766,0.00024822832,0.000085259926,0.00008413693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004965667,0.00016766545,0.00018720597,0.00011794563,0.000080128135,0.000039338753,0.0001875986,0.00016394837,0.000051610226],"category_scores_gemma":[0.000010427743,0.00016888484,0.00006089916,0.00028233769,0.00010184997,0.000022675442,0.000053418204,0.00018748037,0.0000054776897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054742704,0.00030890442,0.0005729565,0.000015861377,0.000021552429,0.0000010012674,0.00011089868,0.000019145107,0.96000725,0.000004291111,0.011594391,0.026796347],"study_design_scores_gemma":[0.0026137782,0.00008797219,0.00085807935,0.000017015846,0.0000018812831,0.0000010773808,0.000018981656,0.00038958836,0.94957155,0.00002454632,0.046233613,0.00018189108],"about_ca_topic_score_codex":0.0006292911,"about_ca_topic_score_gemma":0.00028610072,"teacher_disagreement_score":0.03463922,"about_ca_system_score_codex":0.00016116488,"about_ca_system_score_gemma":0.00015436664,"threshold_uncertainty_score":0.6886924},"labels":[],"label_agreement":null},{"id":"W2120672212","doi":"10.1158/0008-5472.can-06-4309","title":"Regression of Experimental Medulloblastoma following Transfer of HER2-Specific T Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medulloblastoma; Cancer research; Adoptive cell transfer; Medicine; Immunology; T cell; Biology; Immune system","score_opus":0.09518931613407072,"score_gpt":0.44727331356468614,"score_spread":0.3520839974306154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120672212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98442644,0.0063094525,0.00008890052,0.00018541339,0.00022169009,0.00073216646,0.00000899922,0.000019672198,0.008007275],"genre_scores_gemma":[0.99361455,0.0009585546,0.00015717659,0.000017051048,0.00021198619,0.000045365698,0.000004573578,0.000054695432,0.0049360306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99627745,0.0001638344,0.00044668114,0.000370559,0.0020364781,0.0007049713],"domain_scores_gemma":[0.99845356,0.00031256126,0.000030832736,0.00053835276,0.00037305953,0.0002916304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024061755,0.00015533595,0.0004544108,0.0005200905,0.00008320828,0.000010158752,0.00028004745,0.00014745402,0.0067856032],"category_scores_gemma":[0.00003403849,0.0001222793,0.0002627422,0.0008910582,0.0004282762,0.000065663604,0.00008753051,0.00058913464,0.000022422995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003068786,0.00033126582,0.0013561422,0.00013296354,0.00008591781,0.00010851913,0.0015456905,0.0000015786081,0.97537345,0.00008527943,0.0017733772,0.016137019],"study_design_scores_gemma":[0.0021753027,0.00081167516,0.0014221012,0.0005311123,0.0000066681837,0.000006621642,0.0017306797,0.000005843836,0.9729601,0.000013243839,0.020244583,0.000092072914],"about_ca_topic_score_codex":0.000413237,"about_ca_topic_score_gemma":0.000041574585,"teacher_disagreement_score":0.018471207,"about_ca_system_score_codex":0.00040049848,"about_ca_system_score_gemma":0.00030786401,"threshold_uncertainty_score":0.9941223},"labels":[],"label_agreement":null},{"id":"W2120768573","doi":"10.1158/0008-5472.can-14-3781","title":"Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"American Association for Cancer Research","keywords":"CXCR4; Metastasis; Lung cancer; Cancer research; Epithelial cell adhesion molecule; Primary tumor; Cancer; Tumor microenvironment; Cancer stem cell; Cancer cell; Medicine; Pathology; Biology; Immunology; Internal medicine; Immune system; Chemokine","score_opus":0.05469023123657602,"score_gpt":0.3938636622156093,"score_spread":0.3391734309790333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120768573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983648,0.011405596,0.00014293421,0.0021528115,0.00015464638,0.0018133166,0.00011681641,0.000049137027,0.00051671424],"genre_scores_gemma":[0.99225396,0.0021136522,0.00095529284,0.00018577206,0.00016777882,0.0008552457,0.000049916187,0.00008784127,0.0033305597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689054,0.00023798567,0.00035581895,0.00063723116,0.0010359697,0.00084244803],"domain_scores_gemma":[0.99827164,0.00018423217,0.00014747509,0.00028171274,0.0005025557,0.00061238237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010407811,0.00027208612,0.00046884653,0.0003070613,0.00022495362,0.000106085245,0.00013828091,0.00006020191,0.0003457957],"category_scores_gemma":[0.00013318962,0.00021843187,0.000058597965,0.00075214606,0.0003342747,0.00019340609,0.00013694605,0.0005922814,0.000014034311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004235403,0.00085543917,0.055350386,0.0041148225,0.0014379898,0.0013040256,0.008666911,0.00081998896,0.78771454,0.0000771114,0.04024935,0.09517403],"study_design_scores_gemma":[0.020398209,0.004013975,0.033005107,0.0067403126,0.0029123945,0.00036584673,0.0186065,0.012438193,0.849094,0.000119896766,0.05040502,0.001900541],"about_ca_topic_score_codex":0.0026695437,"about_ca_topic_score_gemma":0.00030521947,"teacher_disagreement_score":0.09327349,"about_ca_system_score_codex":0.0010772106,"about_ca_system_score_gemma":0.0008139583,"threshold_uncertainty_score":0.8907393},"labels":[],"label_agreement":null},{"id":"W2120788872","doi":"10.1158/0008-5472.can-08-4652","title":"Biological Significance of Prolactin in Gynecologic Cancers","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Autocrine signalling; Prolactin; Biology; Internal medicine; Endocrinology; MAPK/ERK pathway; Endometrial cancer; Ovarian cancer; Carcinogenesis; Oncogene; Kinase; Cancer; Medicine; Receptor; Cell cycle; Hormone; Cell biology","score_opus":0.16394448193465957,"score_gpt":0.4511173490119096,"score_spread":0.28717286707725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120788872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844101,0.0025580593,0.0000030290457,0.0066587366,0.0000739447,0.0010305563,0.00001337335,0.000020352893,0.005231816],"genre_scores_gemma":[0.9964402,0.0022112466,0.00015976929,0.00031034584,0.00010919369,0.0004924905,0.0000047239578,0.000008017193,0.00026401872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837416,0.00013348785,0.0002567981,0.0003787701,0.0003767655,0.00048003905],"domain_scores_gemma":[0.99912816,0.00022301075,0.000051287752,0.00027447278,0.00018863402,0.00013444388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063919777,0.00011080442,0.0003496546,0.00021095577,0.000044277425,0.0000091313,0.00013221781,0.000108968394,0.00073824404],"category_scores_gemma":[0.00019803116,0.000080571765,0.000063856445,0.00074892474,0.00018225977,0.000039074304,0.000025511332,0.00038355507,0.000017800245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003949989,0.001949319,0.68695027,0.0002092573,0.00012544019,0.00048506574,0.00077230675,0.00020641145,0.08917334,0.002782571,0.008435694,0.20496033],"study_design_scores_gemma":[0.002339687,0.0023639305,0.9409594,0.00022858141,0.000012923057,0.0000044566737,0.00019569744,0.000026585798,0.04693709,0.00084686466,0.0059709144,0.00011389761],"about_ca_topic_score_codex":0.0008927323,"about_ca_topic_score_gemma":0.00025991298,"teacher_disagreement_score":0.2540091,"about_ca_system_score_codex":0.0012499715,"about_ca_system_score_gemma":0.00089405914,"threshold_uncertainty_score":0.80832547},"labels":[],"label_agreement":null},{"id":"W2121355864","doi":"10.1158/0008-5472.can-06-2843","title":"Activation of Tumor-Specific Splice Variant Rac1b by Dishevelled Promotes Canonical Wnt Signaling and Decreased Adhesion of Colorectal Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Wnt signaling pathway; Dishevelled; RAC1; Cancer research; Biology; Cell biology; Transcription factor; Colorectal cancer; Gene; Signal transduction; Cancer; Genetics; Frizzled","score_opus":0.03006832500979648,"score_gpt":0.3314666871090025,"score_spread":0.301398362099206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121355864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954782,0.0034005947,0.00039199882,0.00007621562,0.00008640503,0.00039728396,0.00003750132,0.000005829227,0.00012594527],"genre_scores_gemma":[0.9976281,0.0014255691,0.00043415558,0.000023217786,0.00013797963,0.00009118332,0.000046488713,0.000026922411,0.00018636319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825364,0.00011008774,0.00036180572,0.00041645824,0.00046051224,0.00039749002],"domain_scores_gemma":[0.9989798,0.00012747059,0.0001442376,0.00015695406,0.00045431353,0.00013719083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011798983,0.00014797451,0.00022709416,0.000092551636,0.00010653565,0.000014579024,0.00021576826,0.0001463555,0.00017056885],"category_scores_gemma":[0.00007456702,0.00013369616,0.000050764254,0.00029640686,0.0002695903,0.000008674925,0.00012749452,0.00019480874,8.714274e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093411416,0.00008119815,0.0024857956,0.00009247372,0.000058012945,0.0000024952924,0.00017705034,0.00002628163,0.99205625,0.000015430884,0.0021480646,0.0019228158],"study_design_scores_gemma":[0.00077096815,0.00019786533,0.002116675,0.00016359822,0.000009988321,0.0000014978889,0.00016364193,0.000021554251,0.9942184,0.000021534666,0.0021565442,0.0001577227],"about_ca_topic_score_codex":0.0008103316,"about_ca_topic_score_gemma":0.000091772876,"teacher_disagreement_score":0.0021621427,"about_ca_system_score_codex":0.00010774334,"about_ca_system_score_gemma":0.00060030783,"threshold_uncertainty_score":0.5451971},"labels":[],"label_agreement":null},{"id":"W2121435941","doi":"10.1158/0008-5472.can-04-3666","title":"Gene Therapy for Prostate Cancer by Controlling Adenovirus <i>E1a</i> and <i>E4</i> Gene Expression with PSES Enhancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Enhancer; Genetic enhancement; Prostate cancer; Cancer research; Gene; Gene expression; Prostate; Biology; Cancer; Medicine; Oncology; Internal medicine; Genetics","score_opus":0.030405480702095214,"score_gpt":0.3702478676122567,"score_spread":0.3398423869101615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121435941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.904929,0.09102508,0.0003738457,0.0015006146,0.00005224979,0.0016139434,0.00040998476,0.000021308875,0.000073971096],"genre_scores_gemma":[0.91698563,0.07357945,0.0006642134,0.0008816761,0.0010551952,0.003780514,0.00011373189,0.00012468071,0.0028149062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970058,0.00021299305,0.00025493695,0.00087985664,0.0006376223,0.0010087651],"domain_scores_gemma":[0.99846584,0.000076712764,0.00008079644,0.00051381474,0.0005884524,0.00027436178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085481,0.000293278,0.0002910807,0.00010493651,0.00042410707,0.00012267292,0.00040686908,0.00018510554,0.00011653654],"category_scores_gemma":[0.000033439035,0.00022879864,0.00006923364,0.00023839207,0.00037799706,0.000021797905,0.00013338603,0.0003352858,0.0000059399003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016048053,0.00009114717,0.0006648778,0.000035785713,0.00012078719,0.000001883904,0.0001286379,0.00029976765,0.9096319,8.425963e-7,0.010676397,0.06229988],"study_design_scores_gemma":[0.004271107,0.00231328,0.000020525142,0.000050222774,0.000007790505,0.0000027463,0.000049120445,0.00005368731,0.8917524,0.000014518243,0.101182714,0.00028186745],"about_ca_topic_score_codex":0.00024393648,"about_ca_topic_score_gemma":0.0006314879,"teacher_disagreement_score":0.090506315,"about_ca_system_score_codex":0.000119069075,"about_ca_system_score_gemma":0.00060158136,"threshold_uncertainty_score":0.9330138},"labels":[],"label_agreement":null},{"id":"W2121606147","doi":"10.1158/0008-5472.can-03-3938","title":"Microarray Analyses Uncover UBE1L as a Candidate Target Gene for Lung Cancer Chemoprevention","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Dartmouth College","keywords":"Carcinogenesis; Cancer research; Lung cancer; Biology; Retinoic acid; Carcinogen; Molecular biology; Cancer; Cyclin D1; Cell culture; Microarray analysis techniques; Gene expression; Gene; Pathology; Cell cycle; Medicine; Biochemistry; Genetics","score_opus":0.042718707796176765,"score_gpt":0.4366767360138161,"score_spread":0.39395802821763937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121606147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680068,0.021261938,0.00878555,0.0004503296,0.00021743604,0.00053127646,0.00011201636,0.000013020157,0.0006216299],"genre_scores_gemma":[0.98414534,0.0050629857,0.001168553,0.00023075429,0.0008839683,0.0009708706,0.00029232312,0.00005146603,0.007193763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832374,0.00006392368,0.00019789336,0.0005436037,0.0003210708,0.0005497419],"domain_scores_gemma":[0.9989967,0.000014814561,0.000063487816,0.0003502967,0.00044539516,0.00012935583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042267222,0.00016743578,0.00017310279,0.00008496933,0.00023549417,0.00006333688,0.00033553675,0.00018141381,0.00021527828],"category_scores_gemma":[0.00011992629,0.00015242581,0.00013758127,0.00026903496,0.00015357671,0.000009607907,0.000112604466,0.00018705307,0.000007222207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022404369,0.00004078805,0.00068649295,0.00018531043,0.00014949526,0.0000043319833,0.00006629873,0.0023065573,0.99012005,0.000031911346,0.0053869123,0.0007978251],"study_design_scores_gemma":[0.0010598967,0.00013271227,0.000059808437,0.00006373864,0.000032247113,0.000005206203,0.000048861417,0.000033443266,0.9572161,0.0006109707,0.040542677,0.0001943446],"about_ca_topic_score_codex":0.0013035455,"about_ca_topic_score_gemma":0.00023050293,"teacher_disagreement_score":0.035155766,"about_ca_system_score_codex":0.00028039026,"about_ca_system_score_gemma":0.0013953362,"threshold_uncertainty_score":0.6215744},"labels":[],"label_agreement":null},{"id":"W2121614183","doi":"10.1158/1538-7445.am10-3258","title":"Abstract 3258: Imaging HER-2 positive breast cancer tumors with trastuzumab radiolabeled with DOTA, Oxo and PCTA and positron emission tomography (PET)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Nordion (Canada); BC Cancer Agency","funders":"","keywords":"Biodistribution; DOTA; Trastuzumab; Breast cancer; Nuclear medicine; Positron emission tomography; Medicine; Imaging agent; Monoclonal antibody; Cancer; Receptor expression; Molecular imaging; Chemistry; Cancer research; Receptor; Antibody; In vivo; Chelation; In vitro; Internal medicine; Biochemistry; Immunology; Biology","score_opus":0.017775632031201315,"score_gpt":0.37101562117153997,"score_spread":0.35323998914033866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121614183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889372,0.0015594921,0.0000075547587,0.007263841,0.000013810591,0.00056161784,0.00010587208,0.0000396784,0.0015109221],"genre_scores_gemma":[0.99840826,0.00035964826,0.0001735913,0.00015144622,0.00023812302,0.00026007026,0.00002019207,0.00003751069,0.00035118425],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983509,0.000028335506,0.00015469441,0.0005139406,0.00045752805,0.0004945994],"domain_scores_gemma":[0.998661,0.00010711206,0.000045509216,0.00025461675,0.0003503254,0.0005814672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025573862,0.00019581919,0.00024891386,0.00011057364,0.00032413623,0.000094544645,0.000115028946,0.00005082804,0.00028503765],"category_scores_gemma":[0.000013632374,0.00013532107,0.000026903746,0.00046868366,0.0007025425,0.00014648991,0.00004176405,0.0011341815,0.000001646526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016002639,0.00012007361,0.082227275,0.00021159713,0.00010629324,0.00014972956,0.0001868347,0.000001102779,0.9036297,0.000035295252,0.000648345,0.011083489],"study_design_scores_gemma":[0.004897526,0.0002463785,0.5783272,0.0011915122,0.00020294948,0.0024282003,0.00044877318,0.00033310414,0.410203,0.000047160942,0.0012473562,0.00042685916],"about_ca_topic_score_codex":0.0008481836,"about_ca_topic_score_gemma":0.00006942837,"teacher_disagreement_score":0.49609992,"about_ca_system_score_codex":0.000116062074,"about_ca_system_score_gemma":0.0003400309,"threshold_uncertainty_score":0.5518233},"labels":[],"label_agreement":null},{"id":"W2121643017","doi":"10.1158/0008-5472.can-06-3891","title":"Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Armand-Frappier Foundation","keywords":"Lymphoma; Cancer research; Biology; Malignancy; Cancer; BCL10; Galectin-3; Transfection; Cancer cell; Tumor progression; Galectin; Pathology; Cell culture; Immunology; Medicine","score_opus":0.029324341390501357,"score_gpt":0.37298394256546175,"score_spread":0.3436596011749604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121643017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921925,0.009679037,0.00003447926,0.000046888556,0.000085956824,0.0003624686,0.000018125062,0.000023587467,0.00053023617],"genre_scores_gemma":[0.99877965,0.00048020997,0.000023644614,0.000026984779,0.000014178112,0.00018541451,0.00006691823,0.000021881415,0.00040110084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782336,0.00033342332,0.00038959112,0.00053036626,0.00009869003,0.00082457624],"domain_scores_gemma":[0.999455,0.0001708312,0.00006246457,0.00018523529,0.00008088904,0.000045622968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001054362,0.00019429116,0.0002927614,0.0005948316,0.00016727761,0.000034100554,0.00018804046,0.0003359587,0.00008534827],"category_scores_gemma":[0.00005560455,0.00018791117,0.000026211903,0.00059795845,0.00038930197,0.0001666285,0.00011349911,0.00021055725,0.0000036828292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006206383,0.0003730637,0.028083231,0.000022070733,0.0000065164886,0.00003077362,0.0013853866,0.000017460718,0.9662452,0.00017844126,0.0007012318,0.0023360294],"study_design_scores_gemma":[0.003807307,0.00015542086,0.07353769,0.00020806713,0.0000014858009,0.000029537105,0.0034913663,0.000050091803,0.9181035,0.0002712765,0.00014945115,0.00019477542],"about_ca_topic_score_codex":0.0038560235,"about_ca_topic_score_gemma":0.0043536257,"teacher_disagreement_score":0.04814163,"about_ca_system_score_codex":0.00082640245,"about_ca_system_score_gemma":0.0003000705,"threshold_uncertainty_score":0.76627946},"labels":[],"label_agreement":null},{"id":"W2121699071","doi":"10.1158/0008-5472.can-06-3607","title":"Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"National Cancer Institute; National Science Council","keywords":"Prodrug; Neuroblastoma; Progenitor cell; Carboxylesterase; Pharmacology; In vivo; Cancer research; Suicide gene; Cell culture; Genetic enhancement; Cytotoxicity; Medicine; Stem cell; Enzyme; Biology; In vitro; Biochemistry; Cell biology; Gene","score_opus":0.05281070467650965,"score_gpt":0.39018600758317445,"score_spread":0.3373753029066648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121699071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935746,0.0034255479,0.000011724977,0.00088842015,0.00019736346,0.00120066,0.00009381607,0.000101592006,0.00050628156],"genre_scores_gemma":[0.9967577,0.0011296822,0.000031333395,0.00006763363,0.00028666703,0.00013138686,0.000060918977,0.00009943028,0.001435265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950761,0.00027208513,0.0004555915,0.00070161454,0.0021225237,0.0013720808],"domain_scores_gemma":[0.99620813,0.0008272851,0.00009943286,0.000962191,0.00080566603,0.0010972965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013439041,0.00029784613,0.0004774481,0.00066166423,0.0002152812,0.000047878617,0.0006297516,0.000076355536,0.00053986034],"category_scores_gemma":[0.0009532468,0.00024329321,0.00016790867,0.0012841905,0.0005333339,0.00015743657,0.00035249698,0.00085066113,0.000056057677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102318395,0.0011947338,0.26323357,0.00056259974,0.00032218057,0.0043495256,0.00028220657,0.0000047001618,0.7061306,0.000048855803,0.0015371405,0.0121020265],"study_design_scores_gemma":[0.002886343,0.0006424664,0.5626437,0.0002641666,0.0000211948,0.000017558408,0.000050738374,0.000017351844,0.43314067,0.000053067983,0.0001331955,0.0001295697],"about_ca_topic_score_codex":0.0003675895,"about_ca_topic_score_gemma":0.00026402957,"teacher_disagreement_score":0.2994101,"about_ca_system_score_codex":0.00026987473,"about_ca_system_score_gemma":0.0006255106,"threshold_uncertainty_score":0.9921209},"labels":[],"label_agreement":null},{"id":"W2121765586","doi":"10.1158/0008-5472.can-05-1522","title":"Transforming Growth Factor-β Activation of Phosphatidylinositol 3-Kinase Is Independent of Smad2 and Smad3 and Regulates Fibroblast Responses via p21-Activated Kinase-2","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of General Medical Sciences; Mayo Foundation for Medical Education and Research","keywords":"Phosphatidylinositol; Kinase; Cell biology; Fibroblast growth factor; Cancer research; Chemistry; Biology; Biochemistry; Receptor","score_opus":0.031063871049760355,"score_gpt":0.3337636538396633,"score_spread":0.30269978278990295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121765586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686486,0.0023838817,0.00011838767,0.00018076433,0.000013084462,0.00030798564,0.00009316134,0.000007821794,0.00003005122],"genre_scores_gemma":[0.99909973,0.00041303862,0.000152637,0.000020590398,0.000073733274,0.000039469793,0.000026420272,0.00002452528,0.00014982723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986676,0.00012207813,0.00025749634,0.00034646748,0.00034035626,0.00026601422],"domain_scores_gemma":[0.9991336,0.00010184958,0.000093836454,0.00022036475,0.00033294235,0.00011743713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002304241,0.00014173122,0.00018039864,0.00014411536,0.000106437714,0.000021629186,0.00014325704,0.00014825167,0.00005955597],"category_scores_gemma":[0.00014367014,0.00013682463,0.00004209673,0.00017646949,0.00028890924,0.000022328126,0.00009288608,0.0001392539,4.4331404e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010421321,0.000085349275,0.0058580562,0.00024688698,0.00006428774,0.0000010013243,0.00045336393,0.000022416525,0.98185253,0.000010293753,0.0001075369,0.010256165],"study_design_scores_gemma":[0.0006983675,0.00034021947,0.017774386,0.00021002555,0.000009424144,0.0000018853702,0.000120023426,0.000031369553,0.97992337,0.0000375828,0.0007224116,0.00013095529],"about_ca_topic_score_codex":0.00027954127,"about_ca_topic_score_gemma":0.00002758684,"teacher_disagreement_score":0.011916329,"about_ca_system_score_codex":0.000042205607,"about_ca_system_score_gemma":0.00020450284,"threshold_uncertainty_score":0.5579546},"labels":[],"label_agreement":null},{"id":"W2121877441","doi":"10.1158/0008-5472.can-04-4585","title":"Transforming Growth Factor-β Suppresses Nonmetastatic Colon Cancer through Smad4 and Adaptor Protein ELF at an Early Stage of Tumorigenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Carcinogenesis; Biology; Cancer research; Transforming growth factor beta; Signal transducing adaptor protein; Progenitor cell; Cancer; Epithelial–mesenchymal transition; Wnt signaling pathway; SMAD; Stem cell; Transforming growth factor; Signal transduction; Endocrinology; Cell biology; Metastasis","score_opus":0.0628780832858573,"score_gpt":0.38089233484754953,"score_spread":0.3180142515616922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121877441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252427,0.0057814643,0.00009193668,0.00010349449,0.00003100957,0.00065757986,0.00074006704,0.000012982026,0.000057200476],"genre_scores_gemma":[0.9961188,0.0008068011,0.00041293088,0.000026036307,0.00019869799,0.0005000835,0.00004559666,0.00004710357,0.0018439885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981979,0.00017035352,0.00024258414,0.0004680717,0.00044312657,0.00047793792],"domain_scores_gemma":[0.9991395,0.00003823223,0.000067680056,0.00030909246,0.00027270286,0.00017283203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021365158,0.00017468487,0.00021047819,0.00006651455,0.00018614346,0.000036981368,0.00029062352,0.00009979945,0.00028782914],"category_scores_gemma":[0.00007096396,0.00016288251,0.000054188018,0.00015058329,0.0002995217,0.000029570609,0.00011568956,0.00013732459,0.000002659891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004666255,0.00009391068,0.00827925,0.00036451197,0.00007370456,0.000004122086,0.00056601316,0.000080945225,0.98840606,0.000026535527,0.00015050755,0.0014878303],"study_design_scores_gemma":[0.00052660174,0.00036372308,0.0040355083,0.00008239863,0.000015487069,7.764107e-7,0.00012523965,0.00001666415,0.98384863,0.000012225587,0.010787193,0.00018556009],"about_ca_topic_score_codex":0.002106073,"about_ca_topic_score_gemma":0.0019687843,"teacher_disagreement_score":0.010636685,"about_ca_system_score_codex":0.000104717146,"about_ca_system_score_gemma":0.00041470764,"threshold_uncertainty_score":0.6642156},"labels":[],"label_agreement":null},{"id":"W2121958456","doi":"10.1158/0008-5472.can-05-0308","title":"Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Epidermal growth factor receptor; Biology; Proliferating cell nuclear antigen; Pathology; Epidermal growth factor; Aberrant crypt foci; Cyclin D1; Kinase; Growth factor receptor; Molecular biology; Cancer research; Growth factor; Receptor; Signal transduction; Colorectal cancer; Immunohistochemistry; Cancer; Medicine; Cell cycle; Immunology; Cell biology","score_opus":0.0910226049181531,"score_gpt":0.41029196697121395,"score_spread":0.31926936205306083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121958456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882384,0.0045484295,0.0000018267473,0.004062193,0.00016269092,0.00078114256,0.000057187637,0.000046810615,0.0021013017],"genre_scores_gemma":[0.9918102,0.00034949672,0.000025706599,0.00013997272,0.00034279315,0.0003991204,0.000031730473,0.00003694938,0.006864053],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976611,0.00009913185,0.000343502,0.00046487988,0.00066577276,0.0007655854],"domain_scores_gemma":[0.9990793,0.0001339652,0.000049876646,0.0002184311,0.00038863433,0.00012977688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003368395,0.00019429658,0.0004380156,0.0002900481,0.0003227926,0.0000377548,0.00013025035,0.00011449544,0.002525672],"category_scores_gemma":[0.00005628428,0.00015886057,0.00010633842,0.0006991928,0.00022887933,0.000074567455,0.000096477306,0.0004872269,0.000043902863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024475057,0.00076494954,0.25762925,0.00047711446,0.0004944707,0.00027167413,0.004920756,0.000028287242,0.63477474,0.00080995326,0.0902323,0.0071489853],"study_design_scores_gemma":[0.009227916,0.0016748066,0.5509115,0.00073527877,0.00007430407,0.000011150209,0.00067498954,0.00007973399,0.41483948,0.0015154626,0.019735483,0.0005199312],"about_ca_topic_score_codex":0.017109832,"about_ca_topic_score_gemma":0.0027066637,"teacher_disagreement_score":0.2932822,"about_ca_system_score_codex":0.0012814571,"about_ca_system_score_gemma":0.00034268585,"threshold_uncertainty_score":0.99838614},"labels":[],"label_agreement":null},{"id":"W2122051587","doi":"10.1158/0008-5472.can-08-2067","title":"Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and Angiogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Montreal Children's Hospital; University of Toronto; McGill University; McMaster University Medical Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; McGill University","keywords":"Tissue factor; Cancer research; Angiogenesis; Epidermal growth factor; Epidermal growth factor receptor; Vimentin; Biology; A431 cells; Mesenchymal stem cell; Epithelial–mesenchymal transition; Growth factor receptor inhibitor; Tumor progression; Vascular endothelial growth factor; Growth factor; Metastasis; Growth factor receptor; Cell biology; Cancer; Signal transduction; Cell culture; Immunology; Receptor; Medicine; Internal medicine; Coagulation; Cell cycle; Oncogene","score_opus":0.05539906762808636,"score_gpt":0.3721671444604446,"score_spread":0.3167680768323582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122051587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928112,0.0008782709,0.00014221288,0.0038642138,0.000057943224,0.0016214116,0.0003661839,0.00004909844,0.00020944278],"genre_scores_gemma":[0.9968517,0.00073109445,0.00017140465,0.00021500101,0.00024201356,0.0003346629,0.00009139355,0.00005617647,0.0013065538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682677,0.0005617649,0.00026822693,0.0006130777,0.0011455886,0.00058457576],"domain_scores_gemma":[0.99807835,0.0006082069,0.000037842572,0.00027974165,0.00042018102,0.0005756978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004996292,0.00021377309,0.00034799983,0.00045346166,0.0003992816,0.000047596586,0.00010080937,0.00012984157,0.0012280674],"category_scores_gemma":[0.0007146002,0.000185807,0.000056985657,0.00067372463,0.00028616123,0.00014522525,0.00006997573,0.0004150734,0.0001481302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010398575,0.000077209676,0.0072112107,0.00022999788,0.00003481767,0.000074861695,0.00067663816,0.000001536273,0.957149,0.000019000632,0.004852476,0.028633367],"study_design_scores_gemma":[0.0015298987,0.0020704055,0.1714387,0.00013947093,0.00001322025,0.000066688015,0.00003829403,0.00005071445,0.81936044,0.000015495423,0.005087617,0.00018905522],"about_ca_topic_score_codex":0.00034410783,"about_ca_topic_score_gemma":0.000015411457,"teacher_disagreement_score":0.16422749,"about_ca_system_score_codex":0.00029528994,"about_ca_system_score_gemma":0.00019310862,"threshold_uncertainty_score":0.99968493},"labels":[],"label_agreement":null},{"id":"W2122099856","doi":"10.1158/0008-5472.can-13-0062","title":"Docetaxel Conjugate Nanoparticles That Target α-Smooth Muscle Actin–Expressing Stromal Cells Suppress Breast Cancer Metastasis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Docetaxel; Paclitaxel; Population; Stromal cell; Chemistry; Medicine; Metastasis; Cancer research; Stroma; Pathology; Conjugate; Cancer; Pharmacology; Internal medicine; Immunohistochemistry","score_opus":0.08672540501212414,"score_gpt":0.3775819497488755,"score_spread":0.2908565447367514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122099856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98329395,0.006144373,0.000028012486,0.006159449,0.0006001642,0.0013251231,0.0007775306,0.00011278118,0.0015585899],"genre_scores_gemma":[0.99079984,0.002420757,0.0009865119,0.00046886722,0.00073732814,0.0011770772,0.000024771296,0.0001226763,0.003262165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950802,0.0003372154,0.0004538023,0.0009216617,0.001531033,0.0016761064],"domain_scores_gemma":[0.9970937,0.00020504819,0.00015163596,0.0008772022,0.0008010185,0.00087139226],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000853054,0.0004012762,0.00073216343,0.00032376428,0.00046188573,0.00037511846,0.00045352397,0.00015573677,0.019954683],"category_scores_gemma":[0.000045693025,0.0003292998,0.00025399175,0.00070871855,0.0005608886,0.00063756993,0.00032944535,0.0009093766,0.0002930671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003426658,0.00022765466,0.0026759184,0.00035965256,0.00022176487,0.00005223409,0.00047413382,0.000085654356,0.9007867,0.000019084853,0.03618294,0.058571596],"study_design_scores_gemma":[0.002412277,0.00014251267,0.019075839,0.00040565943,0.00018628778,0.000022261716,0.0011718327,0.0001444521,0.88841647,0.000076701486,0.08754962,0.00039610374],"about_ca_topic_score_codex":0.017251147,"about_ca_topic_score_gemma":0.00033043764,"teacher_disagreement_score":0.058175493,"about_ca_system_score_codex":0.00053340086,"about_ca_system_score_gemma":0.000806413,"threshold_uncertainty_score":0.9999159},"labels":[],"label_agreement":null},{"id":"W2122310551","doi":"10.1158/0008-5472.can-05-3450","title":"Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven","year":2006,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer stem cell; Cancer; Leukemia; Stem cell; Cancer research; Cancer cell; Solid tumor; Identification (biology); Biology; Pathology; Medicine; Immunology; Genetics","score_opus":0.18562613836872036,"score_gpt":0.451678719219322,"score_spread":0.2660525808506017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122310551","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30899662,0.035672367,0.000032965945,0.63259053,0.0041633323,0.008565411,0.0034270436,0.0002297949,0.0063219424],"genre_scores_gemma":[0.19603959,0.011610923,0.0003135852,0.34071884,0.042798053,0.01220859,0.0005622272,0.0012715847,0.39447662],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99364173,0.00036713487,0.0008386448,0.0013125907,0.0019636438,0.0018762806],"domain_scores_gemma":[0.997649,0.00020743864,0.0002175229,0.0010281868,0.00063082547,0.0002669865],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012544075,0.00053063367,0.0012547805,0.0011925037,0.00020127329,0.00019635906,0.00043904717,0.00073225825,0.0018151253],"category_scores_gemma":[0.000019675315,0.0004909567,0.00030920436,0.0011832035,0.00039312718,0.00013535535,0.00030334087,0.0061041205,0.00017415262],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015476884,0.0000708817,0.00021670652,0.004119551,0.00013271163,0.059610743,0.0003220518,0.000030482377,0.018570744,0.0000022291918,0.8985348,0.01823433],"study_design_scores_gemma":[0.0018204956,0.00013476914,0.00007225122,0.0036879147,0.00016220154,0.00045563726,0.00021322531,0.000019218995,0.11363085,0.000030924617,0.8792237,0.00054880744],"about_ca_topic_score_codex":0.0717459,"about_ca_topic_score_gemma":0.011142103,"teacher_disagreement_score":0.3881547,"about_ca_system_score_codex":0.0032394067,"about_ca_system_score_gemma":0.0029548858,"threshold_uncertainty_score":0.9997542},"labels":[],"label_agreement":null},{"id":"W2122384916","doi":"10.1158/0008-5472.can-09-0419","title":"A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Heme oxygenase; Prostate cancer; Cancer research; Cell growth; Cancer cell; Biology; Cancer; Chemistry; Medicine; Internal medicine; Heme; Biochemistry","score_opus":0.052008103858576425,"score_gpt":0.3904050451728698,"score_spread":0.3383969413142934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122384916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491531,0.04827806,0.00008753585,0.00074081635,0.0001342891,0.0010178513,0.00021051579,0.000025584213,0.00035220216],"genre_scores_gemma":[0.986929,0.006597334,0.00023797089,0.00090501993,0.0007769903,0.0014581064,0.00013379652,0.000053784705,0.0029079719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790746,0.000067725,0.00022818444,0.00061888184,0.0003879032,0.00078985834],"domain_scores_gemma":[0.99894345,0.00001726868,0.00005385047,0.00043611135,0.0003107761,0.00023852338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004190649,0.00022486672,0.00019551581,0.000092219496,0.00021139113,0.000058410227,0.0003446453,0.00017757578,0.000108517925],"category_scores_gemma":[0.000040278792,0.00020258105,0.00014088587,0.00020416456,0.0001281236,0.00001060146,0.00006455268,0.00022459145,0.0000070862056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001183541,0.00024673357,0.000065371954,0.000009277562,0.00006078211,0.0000027389906,0.00019490859,0.000018530314,0.9595814,0.00003117424,0.027488772,0.011116809],"study_design_scores_gemma":[0.001988081,0.0011132426,0.0012932823,0.000013691754,0.0000030981466,0.0000017038857,0.00018402906,0.000030347039,0.8144373,0.00003081106,0.18066554,0.00023887113],"about_ca_topic_score_codex":0.0003044184,"about_ca_topic_score_gemma":0.00008186848,"teacher_disagreement_score":0.15317677,"about_ca_system_score_codex":0.00014503741,"about_ca_system_score_gemma":0.0005413712,"threshold_uncertainty_score":0.82610154},"labels":[],"label_agreement":null},{"id":"W2122472408","doi":"10.1158/0008-5472.can-08-1082","title":"Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"STAT3; Cancer research; Apoptosis; PI3K/AKT/mTOR pathway; Biology; Small interfering RNA; Carcinogenesis; Growth inhibition; Signal transduction; Molecular biology; Chemistry; Cell culture; Cancer; Cell biology; Transfection","score_opus":0.06029612913443132,"score_gpt":0.35413242465876016,"score_spread":0.2938362955243288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122472408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941827,0.0024570741,0.0000088775605,0.0021971697,0.0001766412,0.00043528923,0.000098010765,0.000020947178,0.00042330942],"genre_scores_gemma":[0.99708724,0.0017283962,0.00006296767,0.00021639056,0.0004176733,0.00028283495,0.0000070229594,0.00003762904,0.00015982997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789834,0.00023306011,0.00033252206,0.000418639,0.0005160108,0.0006014243],"domain_scores_gemma":[0.99891317,0.00040092974,0.00007079848,0.00018135324,0.00029338888,0.00014038921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059314584,0.00017112364,0.0002908857,0.00031895135,0.00031450938,0.00006492671,0.00017935211,0.0000709743,0.00061688054],"category_scores_gemma":[0.00014137455,0.00012511955,0.00004698814,0.00069466204,0.00028191388,0.00024099124,0.00013700218,0.0010220648,0.00000747588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023367509,0.0001234044,0.020232592,0.0001546545,0.000020528136,0.000060037193,0.00248107,0.00006842966,0.9727918,0.000012122274,0.0028094563,0.0010122637],"study_design_scores_gemma":[0.0010531233,0.000080353515,0.028691137,0.0011893184,0.0000095073465,0.00007271137,0.0012930993,0.0003611961,0.9653331,0.000049007624,0.001685523,0.0001819388],"about_ca_topic_score_codex":0.027461063,"about_ca_topic_score_gemma":0.0006207216,"teacher_disagreement_score":0.026840342,"about_ca_system_score_codex":0.0003581847,"about_ca_system_score_gemma":0.00053073,"threshold_uncertainty_score":0.9790152},"labels":[],"label_agreement":null},{"id":"W2122683704","doi":"10.1158/0008-5472.can-11-1679","title":"Keystone Symposia 40th Season: MicroRNAs and Noncoding RNAs in Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"microRNA; Cancer; Carcinogenesis; Biology; Medicine; Cancer research; Bioinformatics; Genetics; Gene","score_opus":0.07647159790067197,"score_gpt":0.37896186234548696,"score_spread":0.30249026444481497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122683704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147446,0.01632664,0.00003210471,0.00016675194,0.00008731386,0.00028395516,0.000022423546,0.0000073245733,0.0015990078],"genre_scores_gemma":[0.99566364,0.0028609964,0.00013856006,0.00006066172,0.00023461632,0.00018345876,0.00001598686,0.000027603604,0.00081444817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998727,0.0001241136,0.00014450353,0.00040454743,0.00019659668,0.00040322723],"domain_scores_gemma":[0.9993893,0.000010785822,0.000036564175,0.00027209768,0.000149628,0.00014162717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004045336,0.0001137474,0.000116928226,0.000109275876,0.00008940925,0.00002623506,0.00018888518,0.0001250727,0.00023493748],"category_scores_gemma":[0.000035284138,0.00011385463,0.000032641812,0.00021415604,0.0001828133,0.000007539938,0.00018891737,0.00017721037,0.0000091256925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017437166,0.000040344534,0.029376263,0.0000627896,0.00002773158,0.0000112883645,0.00025385252,0.000009387318,0.96441036,0.00012824159,0.0018454241,0.0036599217],"study_design_scores_gemma":[0.0007719923,0.00009517036,0.082000576,0.00014311814,0.000009396895,0.000007770384,0.0001072382,0.00004346197,0.8914282,0.00010149887,0.025081566,0.00021004975],"about_ca_topic_score_codex":0.001411351,"about_ca_topic_score_gemma":0.0011404898,"teacher_disagreement_score":0.07298222,"about_ca_system_score_codex":0.00013415495,"about_ca_system_score_gemma":0.00027204354,"threshold_uncertainty_score":0.4642857},"labels":[],"label_agreement":null},{"id":"W2122903478","doi":"10.1158/0008-5472.can-04-3927","title":"The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of the North Atlantic; Memorial University of Newfoundland; University of Manitoba; Research Manitoba","funders":"","keywords":"Protein kinase B; Transfection; Cancer research; Biology; Western blot; Signal transduction; Immunoprecipitation; Cell culture; Molecular biology; Cell biology; Gene; Biochemistry; Genetics","score_opus":0.03788023532054388,"score_gpt":0.34474407650459127,"score_spread":0.3068638411840474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122903478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938589,0.0009745396,0.00005165966,0.00328884,0.00007971645,0.00084347883,0.000069639915,0.0000132453615,0.00081997673],"genre_scores_gemma":[0.99398416,0.0007433722,0.00009528663,0.00006024397,0.0008500581,0.0019293225,0.000020587808,0.000032855696,0.0022841184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979626,0.00024654664,0.00022779257,0.00045290202,0.00044541236,0.0006647744],"domain_scores_gemma":[0.9992753,0.000028726754,0.00006788636,0.00034136418,0.00019402061,0.00009266786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011958311,0.00015549899,0.00012442912,0.00009625296,0.0004305831,0.00011319577,0.00039169245,0.00014509683,0.00010635154],"category_scores_gemma":[0.00005709772,0.00011248452,0.00005683506,0.0003689223,0.000208909,0.000018849409,0.00017491021,0.00037253156,0.00001876926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022697546,0.000054307755,0.00093946524,0.000022427193,0.000017144184,0.000001822945,0.0001211939,0.000026096632,0.95662355,0.00041775,0.0006641858,0.040885083],"study_design_scores_gemma":[0.00045496714,0.000086158856,0.0015487027,0.00013051038,8.494395e-7,0.0000019878828,0.00034997854,0.000018739054,0.92999446,0.00016640294,0.06708454,0.00016267518],"about_ca_topic_score_codex":0.0006784191,"about_ca_topic_score_gemma":0.0031058334,"teacher_disagreement_score":0.066420354,"about_ca_system_score_codex":0.00020050275,"about_ca_system_score_gemma":0.0005682538,"threshold_uncertainty_score":0.45869857},"labels":[],"label_agreement":null},{"id":"W2122917991","doi":"10.1158/0008-5472.can-06-3212","title":"Novel Chemical Enhancers of Heat Shock Increase Thermal Radiosensitization through a Mitotic Catastrophe Pathway","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Chemistry; Moiety; Biophysics; Sensitization; Ionizing radiation; Hyperthermia; Small molecule; Cancer research; Combinatorial chemistry; Stereochemistry; Biochemistry; Irradiation; Biology; Immunology","score_opus":0.03543337315482145,"score_gpt":0.35940649014025855,"score_spread":0.32397311698543707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122917991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882825,0.00113413,0.008325281,0.00017202728,0.00006594833,0.0005692601,0.000075786375,0.000009591003,0.0013654808],"genre_scores_gemma":[0.9972395,0.00019530617,0.0012903527,0.00006176138,0.00057641586,0.00008274098,0.0001265896,0.000046217596,0.00038114292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736327,0.00017121295,0.0003151158,0.00051000447,0.00080161355,0.00083878305],"domain_scores_gemma":[0.998469,0.00008029212,0.000032212054,0.0005821144,0.000601158,0.00023524574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013176318,0.00016378955,0.00020700693,0.00011577592,0.00012248564,0.000022601549,0.00039029677,0.00023075528,0.00010667802],"category_scores_gemma":[0.00047142967,0.00015488757,0.00008797478,0.0004891013,0.0004515912,0.0000107351,0.0003032945,0.00041790926,0.000015124537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067101186,0.00011953596,0.00028259432,0.00008244444,0.00004838969,0.000014427668,0.00012785365,0.00015634303,0.9955462,0.000054376822,0.00047061685,0.0024261766],"study_design_scores_gemma":[0.0007542454,0.0002286311,0.0004875791,0.000052260722,0.000004319278,0.000014636461,0.00011890035,0.00006433858,0.9950129,0.000010216537,0.0031059422,0.0001460428],"about_ca_topic_score_codex":0.0018410528,"about_ca_topic_score_gemma":0.0001363661,"teacher_disagreement_score":0.008956977,"about_ca_system_score_codex":0.00022969533,"about_ca_system_score_gemma":0.00083707954,"threshold_uncertainty_score":0.6316132},"labels":[],"label_agreement":null},{"id":"W2122931235","doi":"10.1158/0008-5472.can-07-2607","title":"Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of California, Los Angeles; Jonsson Comprehensive Cancer Center; National Institutes of Health","keywords":"Aromatase; Estrogen; Internal medicine; Breast cancer; Oncology; Medicine; Lung cancer; Cancer; Estrogen receptor; Aromatase inhibitor; Tissue microarray; Stage (stratigraphy); Cancer research; Population; Endocrinology; Biology","score_opus":0.01641846419282227,"score_gpt":0.32882037539480263,"score_spread":0.31240191120198035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122931235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940356,0.0037742155,0.000095437324,0.000040882453,0.00011324671,0.00052938476,0.000048801732,0.0000117970585,0.0013506196],"genre_scores_gemma":[0.9951451,0.0012482571,0.000059957947,0.00003461794,0.0002479547,0.00030423177,0.000032212036,0.00004256342,0.0028851137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797887,0.00013173529,0.00017380761,0.00046361945,0.00037682703,0.00087512826],"domain_scores_gemma":[0.99916506,0.00003716749,0.000045333945,0.00036424035,0.00011111226,0.0002771099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010685888,0.00016292046,0.00016183646,0.00013702008,0.00011001284,0.00003212159,0.00027677513,0.00024312153,0.00007207649],"category_scores_gemma":[0.000021966362,0.00012819745,0.000027692176,0.00032718363,0.00010872867,0.0000069885364,0.00017843147,0.0005128351,0.0000075922317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017754589,0.000093921684,0.03919727,0.0001277381,0.000033716766,0.00013375792,0.00046449102,0.00024311026,0.9551924,0.0000016836783,0.0017980934,0.00093839446],"study_design_scores_gemma":[0.0018324291,0.00051578233,0.021829955,0.00019180728,0.000005734564,0.0000018158903,0.0002955029,0.000040711704,0.9708227,0.000002649411,0.004249045,0.00021185054],"about_ca_topic_score_codex":0.0011196584,"about_ca_topic_score_gemma":0.0005789852,"teacher_disagreement_score":0.017367315,"about_ca_system_score_codex":0.00022203037,"about_ca_system_score_gemma":0.00038435147,"threshold_uncertainty_score":0.52277404},"labels":[],"label_agreement":null},{"id":"W2122955089","doi":"10.1158/0008-5472.can-04-3218","title":"Evidence for the Presence of Disease-Perturbed Networks in Prostate Cancer Cells by Genomic and Proteomic Analyses: A Systems Approach to Disease","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Public Safety and Security; Canadian Institute for Theoretical Astrophysics","keywords":"LNCaP; Prostate cancer; Androgen; Biology; Chromoplexy; Computational biology; Cancer research; KEGG; Cancer; Gene; Bioinformatics; Transcriptome; Genetics; Gene expression; Endocrinology; PCA3","score_opus":0.11852094602251899,"score_gpt":0.4325674994616021,"score_spread":0.3140465534390831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122955089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90097773,0.060927603,0.027208524,0.0025147258,0.000024356974,0.0074146586,0.00082035916,0.000053150874,0.000058873895],"genre_scores_gemma":[0.9539522,0.008804812,0.0015886265,0.000042113625,0.00017332193,0.034137074,0.0000123411355,0.000036803074,0.0012527079],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998327,0.000055749624,0.00030383313,0.0005423622,0.0002944098,0.00047663634],"domain_scores_gemma":[0.99842566,0.00040854342,0.00009407478,0.0005994224,0.00019219493,0.0002800904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050069595,0.00015288148,0.00020616325,0.00006919664,0.00017915301,0.000076811535,0.00055748795,0.00004762008,0.000017618717],"category_scores_gemma":[0.00012309183,0.00011537567,0.000049424347,0.00036976807,0.0002124525,0.00011644416,0.00018400648,0.00031659554,7.735946e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012865947,0.000115948416,0.0022633858,0.0010679072,0.000036707344,6.3308784e-7,0.0003179073,0.18274288,0.8029565,0.00017897128,0.004366454,0.0046660546],"study_design_scores_gemma":[0.0013359102,0.00007201776,0.0021945261,0.0029225606,0.00012444037,8.5370965e-7,0.00047340462,0.7320236,0.24149652,0.0005491508,0.018026335,0.0007806842],"about_ca_topic_score_codex":0.001243575,"about_ca_topic_score_gemma":0.00003781147,"teacher_disagreement_score":0.56146,"about_ca_system_score_codex":0.00038104164,"about_ca_system_score_gemma":0.00031132472,"threshold_uncertainty_score":0.4704883},"labels":[],"label_agreement":null},{"id":"W2123063653","doi":"10.1158/0008-5472.can-10-1697","title":"Hepatocyte Nuclear Factor-4α Promotes Gut Neoplasia in Mice and Protects against the Production of Reactive Oxygen Species","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Carcinogenesis; Wnt signaling pathway; Hepatocyte nuclear factors; Transcription factor; Biology; Cancer research; Microarray analysis techniques; Hepatocyte nuclear factor 4; Intestinal epithelium; Downregulation and upregulation; Cancer; Epithelium; Cell biology; Gene expression; Nuclear receptor; Signal transduction; Gene; Genetics","score_opus":0.03961787761774947,"score_gpt":0.33456202884088443,"score_spread":0.29494415122313494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123063653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974994,0.0007216692,0.0000028226475,0.00053423236,0.000096975615,0.00063518266,0.000009286342,0.0000032287455,0.00049718184],"genre_scores_gemma":[0.9982911,0.0010097196,0.00009639224,0.000008036069,0.0002046867,0.00006132747,0.000007796745,0.000015204752,0.00030577782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991204,0.00011656659,0.00011927172,0.00026360637,0.00019112321,0.00018900556],"domain_scores_gemma":[0.9994412,0.0000258551,0.00005014436,0.00023053434,0.00021385428,0.000038382488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048895174,0.0000743535,0.00008239271,0.00006253938,0.00010307932,0.00002457023,0.00013305894,0.00010293162,0.000010243227],"category_scores_gemma":[0.0004192797,0.000055862904,0.000020491496,0.00015611065,0.0002274268,0.0000059265985,0.000104174236,0.00030466588,0.0000012288267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008327439,0.000022975966,0.0032793295,0.00002879417,0.000012844356,6.1729133e-7,0.000501273,0.0000060007665,0.99143785,0.000039395,0.00004752606,0.0045400886],"study_design_scores_gemma":[0.00010870514,0.00010918223,0.048841346,0.00002095084,0.0000014422263,0.0000010585862,0.00016707179,0.000024345743,0.940295,0.00011577466,0.0102518285,0.00006330095],"about_ca_topic_score_codex":0.00022612172,"about_ca_topic_score_gemma":0.00095407123,"teacher_disagreement_score":0.051142886,"about_ca_system_score_codex":0.000019844247,"about_ca_system_score_gemma":0.00011361722,"threshold_uncertainty_score":0.2278023},"labels":[],"label_agreement":null},{"id":"W2123088183","doi":"10.1158/0008-5472.can-08-2524","title":"Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; China Medical University; National Taiwan University; National Health Research Institutes; Academia Sinica; Leonard M. Miller School of Medicine; York University; National Science Council; University of Miami","keywords":"CTGF; Cancer research; Growth factor; Bcl-xL; Biology; Doxorubicin; Apoptosis; Internal medicine; Medicine; Programmed cell death; Chemotherapy; Receptor","score_opus":0.04126546135861347,"score_gpt":0.38528262475846825,"score_spread":0.3440171633998548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123088183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861265,0.00739205,0.0000792063,0.0040227207,0.00009315223,0.00077076495,0.00033351904,0.000010387656,0.00117173],"genre_scores_gemma":[0.9956996,0.0022780464,0.00004496916,0.000071914255,0.00014127266,0.00013245715,0.00002603473,0.000028622362,0.0015770755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974563,0.00039452987,0.00030210262,0.00066794147,0.00056434004,0.00061478117],"domain_scores_gemma":[0.9983134,0.00014875225,0.00008981099,0.00035710106,0.0009463308,0.00014460745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054045813,0.0002065123,0.00032711346,0.00018448522,0.0001256027,0.00004096374,0.00031347328,0.00016273138,0.00025941926],"category_scores_gemma":[0.0002553576,0.00020468343,0.00004661629,0.00050475704,0.0004842229,0.000028381788,0.00014211383,0.0003740267,0.0000035791427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011078062,0.000061344064,0.019879388,0.00010519327,0.000054591183,0.0000065245654,0.0012034227,0.0000046657715,0.96812284,0.0022914233,0.0026497708,0.0045130234],"study_design_scores_gemma":[0.0016720224,0.00017015402,0.27383766,0.00017440686,0.000006593235,0.0000038149938,0.0004229905,0.000011385434,0.71547115,0.0023327528,0.005627477,0.0002695763],"about_ca_topic_score_codex":0.0027141655,"about_ca_topic_score_gemma":0.003369919,"teacher_disagreement_score":0.25395826,"about_ca_system_score_codex":0.00028698085,"about_ca_system_score_gemma":0.0005211657,"threshold_uncertainty_score":0.8346748},"labels":[],"label_agreement":null},{"id":"W2123235948","doi":"10.1158/0008-5472.can-09-1902","title":"Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Loss of heterozygosity; Biology; Tumor suppressor gene; Chromosome; Gene; Suppressor; Genetics; Osteosarcoma; Gene duplication; Cancer research; Gene dosage; Copy-number variation; Genome; Gene expression; Carcinogenesis; Allele","score_opus":0.08835924388213272,"score_gpt":0.4131465533807543,"score_spread":0.32478730949862156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123235948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917274,0.0033966498,5.886594e-7,0.0036351313,0.000098738536,0.0008432928,0.00010787468,0.000013780885,0.00017653627],"genre_scores_gemma":[0.99716794,0.0017912709,0.00018086722,0.00007162821,0.00019809799,0.0004734096,0.000019690551,0.000027681022,0.00006939328],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815214,0.000094050636,0.00024269967,0.00049040234,0.00047335206,0.0005473749],"domain_scores_gemma":[0.9988271,0.00025874755,0.00006371057,0.00037664475,0.00016682086,0.00030696593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050849357,0.00017227625,0.00045795823,0.00016363728,0.00012176262,0.000029332808,0.00011636646,0.00007753605,0.00023947061],"category_scores_gemma":[0.00006608588,0.00014514735,0.00004308178,0.00023620849,0.00042186026,0.000057217596,0.0003849913,0.00049123884,0.00001352811],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000491479,0.0004261225,0.60760736,0.0002446136,0.000063165084,0.00022084697,0.00033132284,1.2003741e-7,0.37604594,0.00007174676,0.00024633462,0.014250919],"study_design_scores_gemma":[0.0040179705,0.00041521675,0.38433453,0.00030920768,0.00004111483,0.00021960739,0.000030517047,0.00003242208,0.6090502,0.00010806325,0.0013070089,0.00013409858],"about_ca_topic_score_codex":0.0015025283,"about_ca_topic_score_gemma":0.005042107,"teacher_disagreement_score":0.2330043,"about_ca_system_score_codex":0.00025761404,"about_ca_system_score_gemma":0.00011511281,"threshold_uncertainty_score":0.59189373},"labels":[],"label_agreement":null},{"id":"W2123349002","doi":"10.1158/0008-5472.can-12-1881","title":"A Tumorigenic MLL-Homeobox Network in Human Glioblastoma Stem Cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Homeobox; Biology; Carcinogenesis; Epigenetics; Cancer stem cell; Homeobox A1; Stem cell; Cancer research; HNF1B; Cancer; Homeobox protein Nkx-2.5; Phenotype; Genetics; Gene; Transcription factor","score_opus":0.05354349550308239,"score_gpt":0.38652425634337745,"score_spread":0.33298076084029504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123349002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857232,0.012943641,0.000076965174,0.0000646069,0.0002585073,0.00024280006,0.0000062100785,0.000006943039,0.00067715714],"genre_scores_gemma":[0.9956792,0.0010400903,0.000038786296,0.000025820813,0.0012917201,0.00012298937,0.000008033586,0.000030084353,0.0017633026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982676,0.00022994056,0.00019179446,0.00027648377,0.00028374733,0.00075045787],"domain_scores_gemma":[0.9993227,0.000023260089,0.000037060057,0.00033894987,0.000113111164,0.00016490972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011541435,0.00010950556,0.00012050094,0.00009614636,0.00016155263,0.000028663077,0.00022139706,0.00013461312,0.00008221725],"category_scores_gemma":[0.000011938471,0.00010856614,0.000049708004,0.000355647,0.00008372232,0.000005284666,0.00016975348,0.00023690752,0.000034838584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005746499,0.00005247579,0.017794454,0.000018548588,0.000015064355,0.0000028255736,0.00011250024,0.0004842915,0.97690195,0.00011316117,0.0015476067,0.0028996554],"study_design_scores_gemma":[0.00032996992,0.0002260425,0.006653636,0.000021748067,0.0000031451666,5.56802e-7,0.00005623873,0.000015805734,0.94049776,0.00017751465,0.05186677,0.00015082935],"about_ca_topic_score_codex":0.00013550921,"about_ca_topic_score_gemma":0.0005056042,"teacher_disagreement_score":0.050319165,"about_ca_system_score_codex":0.00010496273,"about_ca_system_score_gemma":0.00010443053,"threshold_uncertainty_score":0.44271988},"labels":[],"label_agreement":null},{"id":"W2123467807","doi":"10.1158/0008-5472.can-08-4287","title":"Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"AKT2; AKT1; Mammary tumor; Biology; Protein kinase B; Genetically modified mouse; Cancer research; Tumor progression; Metastasis; Mammary gland; PI3K/AKT/mTOR pathway; Transgene; Mouse mammary tumor virus; Involution (esoterism); Cancer; Pathology; Signal transduction; Immunology; Cell biology; Medicine; Breast cancer; Virus; Gene","score_opus":0.05633121808714555,"score_gpt":0.4257378210336421,"score_spread":0.3694066029464966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123467807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878673,0.011053495,0.00007936916,0.00050849444,0.000017437129,0.0002443568,0.000029569814,0.0000028367538,0.00019711576],"genre_scores_gemma":[0.99876577,0.000730211,0.0001884905,0.00010843262,0.00007474806,0.00007980882,0.000023786304,0.0000061527844,0.000022624827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990649,0.00017130884,0.00013007836,0.0002129947,0.00023558502,0.00018511362],"domain_scores_gemma":[0.9995997,0.00006481172,0.000043912318,0.00017038625,0.00008397955,0.000037200425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059639296,0.0000736145,0.00009657085,0.0000609516,0.000062348074,0.000030999992,0.00015055183,0.000033499502,0.000008514643],"category_scores_gemma":[0.00014005299,0.000051767984,0.00001527843,0.00014109521,0.0001483014,0.000007945086,0.00004611676,0.00012747086,2.0470354e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175883,0.00010740779,0.007889367,0.00008855268,0.000021125818,0.000022632554,0.0004216794,0.00001522849,0.9431895,0.00018110608,0.0016025435,0.04614324],"study_design_scores_gemma":[0.0018469774,0.0014048063,0.07942242,0.00037802596,0.000022225584,0.000029713003,0.00036545846,0.00015944733,0.9070268,0.0018703295,0.0072313743,0.00024241052],"about_ca_topic_score_codex":0.000038789836,"about_ca_topic_score_gemma":0.00008929654,"teacher_disagreement_score":0.071533054,"about_ca_system_score_codex":0.000017648179,"about_ca_system_score_gemma":0.00011630794,"threshold_uncertainty_score":0.21110371},"labels":[],"label_agreement":null},{"id":"W2123611729","doi":"10.1158/0008-5472.can-08-2223","title":"Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"U.S. Public Health Service; Chung Shan Medical University; National Cancer Institute; National Institutes of Health; Chiba University; Samuel Waxman Cancer Research Foundation","keywords":"KRAS; Cancer research; MAPK/ERK pathway; Lung cancer; Epidermal growth factor receptor; Kinase; MEK inhibitor; V600E; Tyrosine kinase; Biology; Receptor tyrosine kinase; Protein kinase domain; Cancer; Mutant; Medicine; Signal transduction; Internal medicine; Colorectal cancer; Cell biology; Genetics; Gene","score_opus":0.053975531625271134,"score_gpt":0.4196293516469179,"score_spread":0.36565382002164676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123611729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984579,0.010095501,0.000035446043,0.00028315574,0.00015992214,0.0008882418,0.00004192157,0.000013973449,0.003902806],"genre_scores_gemma":[0.9880795,0.005689839,0.00029778824,0.000053895714,0.00017028973,0.00073259836,0.0000060392913,0.000026829373,0.0049432204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983979,0.000058107224,0.00024303804,0.00030919866,0.0005563225,0.00043545003],"domain_scores_gemma":[0.9990882,0.00007850932,0.000045565554,0.0002912067,0.0003189988,0.00017748734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016608252,0.0001102323,0.00023938375,0.0002754237,0.00009451492,0.000006004379,0.00014971044,0.00007415433,0.00055026216],"category_scores_gemma":[0.000031713185,0.000092802504,0.00005279601,0.0006245208,0.00018044512,0.000050930696,0.000055723154,0.00031123558,0.000010389839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013384038,0.00021264314,0.97423685,0.0003900567,0.00009882981,0.0002206822,0.003142509,0.00041154047,0.015482149,0.000007704755,0.0036817514,0.0019814624],"study_design_scores_gemma":[0.0032685325,0.00028250585,0.9506505,0.00050050404,0.000120042976,0.000018511599,0.00033288667,0.00048637384,0.042115808,0.000022797414,0.0020597135,0.0001418273],"about_ca_topic_score_codex":0.012051392,"about_ca_topic_score_gemma":0.0029082801,"teacher_disagreement_score":0.026633658,"about_ca_system_score_codex":0.00065166294,"about_ca_system_score_gemma":0.0018193513,"threshold_uncertainty_score":0.99452746},"labels":[],"label_agreement":null},{"id":"W2123842138","doi":"10.1158/1538-7445.am2014-4968","title":"Abstract 4968: Msi2 directly linked to Hedgehog and Wnt signaling in non-triple negative breast cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Wnt signaling pathway; Triple-negative breast cancer; Biology; GLI1; Cancer research; Tissue microarray; Hedgehog; Cancer stem cell; Carcinogenesis; Stem cell; Notch signaling pathway; Cancer; Breast cancer; Signal transduction; Cell biology; Genetics","score_opus":0.04469383280137198,"score_gpt":0.37558790780847734,"score_spread":0.3308940750071054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123842138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959576,0.0015770516,0.00006987524,0.0009482902,0.00015952336,0.00048700502,0.00007598386,0.00001322794,0.0007114479],"genre_scores_gemma":[0.9972791,0.00063646294,0.00011396154,0.00025043602,0.0006880718,0.00043550428,0.000009792223,0.000042709606,0.00054398325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979028,0.00016198348,0.0002538548,0.0006628536,0.00034267223,0.0006758086],"domain_scores_gemma":[0.9989314,0.00012218911,0.00004652488,0.0002914453,0.00037200947,0.00023639732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011405589,0.00020358719,0.0002736038,0.00018526908,0.0002002232,0.00006375633,0.00027391777,0.00015553767,0.00007069716],"category_scores_gemma":[0.0003545681,0.00019094326,0.000049692448,0.00039911622,0.00020332579,0.000007380602,0.00030355138,0.000371673,0.000020910813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021568166,0.00003826924,0.007813732,0.000086114094,0.000053317264,0.000006313133,0.00077360997,0.00046461646,0.97599226,0.000010197562,0.0017200209,0.012825888],"study_design_scores_gemma":[0.001449043,0.0002749534,0.14704517,0.00046753208,0.000011179463,0.0000042210404,0.00055306643,0.00012083619,0.8396747,0.000115687064,0.009773012,0.0005106009],"about_ca_topic_score_codex":0.003292364,"about_ca_topic_score_gemma":0.0026200484,"teacher_disagreement_score":0.13923144,"about_ca_system_score_codex":0.0001341637,"about_ca_system_score_gemma":0.00024167354,"threshold_uncertainty_score":0.778644},"labels":[],"label_agreement":null},{"id":"W2123908321","doi":"10.1158/0008-5472.can-05-0470","title":"Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Matrix metalloproteinase; Tenascin C; Tenascin; Extracellular matrix; Pathology; Cancer research; Biology; Chemistry; Medicine; Cell biology; Fibronectin; Biochemistry","score_opus":0.08288029181419136,"score_gpt":0.41858254293642794,"score_spread":0.33570225112223656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123908321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96898746,0.006667895,0.00010939287,0.002762136,0.00008921351,0.0017435425,0.000021949209,0.00011807852,0.019500354],"genre_scores_gemma":[0.95437837,0.0005897868,0.001517301,0.000091813126,0.0005264075,0.00034599833,0.000062795625,0.00010360609,0.042383924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950503,0.00033363103,0.0004269287,0.0007839247,0.002143265,0.0012619684],"domain_scores_gemma":[0.9975533,0.00032648133,0.0000593275,0.00090737885,0.0008106067,0.00034292],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012477332,0.00026267656,0.00044166727,0.00041617622,0.00035907188,0.00012278656,0.0004520541,0.0002165291,0.0037196064],"category_scores_gemma":[0.00024440384,0.00020882321,0.00019014544,0.0015135813,0.00042704656,0.00018000587,0.0004621206,0.0011032122,0.001225716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057281385,0.0003601403,0.0018377207,0.00044617456,0.000031425072,0.0009010227,0.00007665565,0.00009932068,0.9667304,0.0002714227,0.026950246,0.001722631],"study_design_scores_gemma":[0.00254015,0.00055353815,0.002425907,0.00018729137,0.000032099684,0.000048213155,0.00013850184,0.00028470138,0.911849,0.0014950773,0.08020522,0.00024030148],"about_ca_topic_score_codex":0.0076830927,"about_ca_topic_score_gemma":0.00030372865,"teacher_disagreement_score":0.054881427,"about_ca_system_score_codex":0.0005971049,"about_ca_system_score_gemma":0.0006471161,"threshold_uncertainty_score":0.99955195},"labels":[],"label_agreement":null},{"id":"W2123944872","doi":"10.1158/0008-5472.can-03-2546","title":"Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":325,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Biology; Apoptosis; Programmed cell death; Cancer research; Transactivation; Signal transduction; Glucocorticoid receptor; Protein kinase A; Kinase; Glucocorticoid; Molecular biology; Cell biology; Gene expression; Gene; Endocrinology; Genetics","score_opus":0.05746242358807266,"score_gpt":0.3455361891619261,"score_spread":0.28807376557385345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123944872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977552,0.00014931183,0.000081931204,0.0010161634,0.00007584164,0.0004507494,0.000313903,0.000022527802,0.00013433452],"genre_scores_gemma":[0.9992069,0.00015292241,0.000038033217,0.00003607651,0.00007690286,0.00006363467,0.000107857384,0.00002743336,0.0002902628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803776,0.00017684657,0.00033863707,0.00034930723,0.0006971804,0.0004002454],"domain_scores_gemma":[0.998572,0.00012419786,0.00016838765,0.00029922184,0.00071991567,0.00011626479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006577865,0.00014016159,0.0005177161,0.00079843437,0.00007496602,0.000025742422,0.00008278,0.00011325878,0.00037755616],"category_scores_gemma":[0.00006367112,0.000113584494,0.00015568531,0.0024576427,0.00015314894,0.000088008586,0.00003575454,0.0003957362,0.000011766481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049870287,0.00030436934,0.08209894,0.000069145586,0.00048937177,0.0000169217,0.00024644413,0.0027283696,0.9132692,0.000012249269,0.00006495273,0.0002013267],"study_design_scores_gemma":[0.0019210402,0.00016648737,0.1771345,0.0007601186,0.00021125648,0.0000038892636,0.00044428813,0.00004667149,0.8191525,0.000024650642,0.00003045044,0.00010419383],"about_ca_topic_score_codex":0.004759086,"about_ca_topic_score_gemma":0.0020765064,"teacher_disagreement_score":0.09503556,"about_ca_system_score_codex":0.00063115754,"about_ca_system_score_gemma":0.0003571502,"threshold_uncertainty_score":0.71943456},"labels":[],"label_agreement":null},{"id":"W2123964647","doi":"10.1158/0008-5472.can-08-2132","title":"The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Cancer research; Metastasis; Stromal cell; Thyroid cancer; Gene silencing; Tumor progression; Fibronectin; Lung cancer; Melanoma; Cancer; Biology; Cancer cell; Pathology; Medicine; Cell; Internal medicine; Gene","score_opus":0.05053803041567812,"score_gpt":0.39253733820841524,"score_spread":0.34199930779273713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123964647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96248317,0.034719873,0.0000040883106,0.0013595283,0.00011892886,0.0008668116,0.000058325153,0.000019821022,0.00036944178],"genre_scores_gemma":[0.97248155,0.023606943,0.000032717944,0.000029693889,0.00027884744,0.0008806956,0.000033523425,0.000048003403,0.0026080182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671775,0.0006613656,0.0002654819,0.0005467125,0.0008783586,0.00093030365],"domain_scores_gemma":[0.9983904,0.0003139902,0.00008557792,0.00042582996,0.0005456004,0.00023864153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015082726,0.0002015389,0.00029467297,0.00011317023,0.0010992127,0.00009626776,0.0004635593,0.00018703297,0.000105679945],"category_scores_gemma":[0.0009788839,0.00013011692,0.00010481204,0.00039873185,0.00072834495,0.00001104725,0.00045005887,0.00045414074,0.000014358091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016367506,0.00007162436,0.048548076,0.00003757768,0.00047953473,0.000019168088,0.00020738038,0.000009904559,0.91943884,0.000023636621,0.017483477,0.012044013],"study_design_scores_gemma":[0.005958696,0.0009753273,0.0817558,0.00012135219,0.000029115552,0.000021016825,0.0001954969,0.00013572251,0.857103,0.00011710018,0.053148042,0.00043931766],"about_ca_topic_score_codex":0.0004868049,"about_ca_topic_score_gemma":0.0007554888,"teacher_disagreement_score":0.06233584,"about_ca_system_score_codex":0.00011302317,"about_ca_system_score_gemma":0.0006379429,"threshold_uncertainty_score":0.84543663},"labels":[],"label_agreement":null},{"id":"W2124072908","doi":"10.1158/0008-5472.can-08-0673","title":"Cisplatin Induces p53-Dependent FLICE-Like Inhibitory Protein Ubiquitination in Ovarian Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); University of Ottawa","funders":"Canadian Institutes of Health Research; Ministry of Health and Medical Education; University of Ottawa","keywords":"Cisplatin; Ovarian cancer; Flip; Cancer research; Ubiquitin ligase; Ubiquitin; Apoptosis; In vitro; Inhibitory postsynaptic potential; Chemistry; Cancer; Cell biology; Biology; Internal medicine; Medicine; Chemotherapy; Biochemistry; Gene","score_opus":0.08676990945216195,"score_gpt":0.3775201852156641,"score_spread":0.29075027576350215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124072908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877528,0.0029918652,0.00005133195,0.0017554514,0.00048321264,0.0021780555,0.000040059804,0.00006771675,0.004679504],"genre_scores_gemma":[0.9899089,0.0010088888,0.00013087451,0.00020340171,0.00066138763,0.0018950114,0.000021034839,0.00008388071,0.0060866703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959931,0.000313814,0.00047077204,0.0007087193,0.0016385432,0.00087508705],"domain_scores_gemma":[0.9984161,0.0000731627,0.000105880914,0.0005228835,0.0005689005,0.0003130316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010663812,0.00024144274,0.00037784904,0.00077308196,0.0002423009,0.000034685934,0.00025543966,0.0003271654,0.0010018491],"category_scores_gemma":[0.00014474064,0.00024385413,0.000086832435,0.0012533402,0.00028783007,0.0001733305,0.00017076002,0.001648261,0.00013603615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041600468,0.00018463534,0.0007280226,0.0001969645,0.000045459725,0.0005275981,0.002219316,0.00018899464,0.98496586,0.000085821026,0.0042898473,0.0061514885],"study_design_scores_gemma":[0.0033719402,0.00033171033,0.006198587,0.0009794958,0.00001768686,0.000037677946,0.00028957313,0.00011992974,0.97805834,0.000056415814,0.010259061,0.00027960129],"about_ca_topic_score_codex":0.008317551,"about_ca_topic_score_gemma":0.0020591845,"teacher_disagreement_score":0.006907527,"about_ca_system_score_codex":0.0023858426,"about_ca_system_score_gemma":0.0027099065,"threshold_uncertainty_score":0.99991137},"labels":[],"label_agreement":null},{"id":"W2124145066","doi":"10.1158/0008-5472.can-08-4783","title":"Epidermal Growth Factor Receptor Variant III–Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"MARCKS; Epidermal growth factor receptor; Biology; Cancer research; Carcinogenesis; Epidermal growth factor; Small interfering RNA; Phosphorylation; Protein kinase C; Cell biology; Receptor; Cancer; Cell culture; Transfection; Biochemistry; Genetics","score_opus":0.056691668944088336,"score_gpt":0.3439024480642679,"score_spread":0.28721077912017956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124145066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952986,0.0011623008,0.0002234927,0.0016557182,0.000078597695,0.0010283499,0.0000934812,0.000050533905,0.00040889162],"genre_scores_gemma":[0.9977744,0.00024537364,0.00028688833,0.00031560936,0.0003893276,0.00016277008,0.0003204496,0.00004140083,0.00046375694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691945,0.00042363032,0.0004162673,0.00077279686,0.00073245686,0.00073541206],"domain_scores_gemma":[0.9984418,0.000031934323,0.00014780737,0.0005127931,0.00059505797,0.0002705793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056428014,0.00029248066,0.00026871604,0.00015682651,0.00035428858,0.000086623746,0.00036812236,0.00041469553,0.0007433873],"category_scores_gemma":[0.00032733343,0.00025720702,0.00010264254,0.00065446517,0.000103039216,0.000031991185,0.00014523351,0.0004677375,0.000055096378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006278781,0.000110017914,0.00006696397,0.0000418272,0.000034345314,0.0000516306,0.00018857134,0.000006843566,0.99374706,0.0001307312,0.0041226954,0.00087146414],"study_design_scores_gemma":[0.0015280664,0.00044539815,0.0008769792,0.00024947216,0.0000056466406,0.000009593249,0.000043696527,0.000089985304,0.99294806,0.00038033084,0.003096288,0.00032651494],"about_ca_topic_score_codex":0.00040698596,"about_ca_topic_score_gemma":0.000014579753,"teacher_disagreement_score":0.0024757897,"about_ca_system_score_codex":0.00012853928,"about_ca_system_score_gemma":0.00043537893,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W2124146356","doi":"10.1158/0008-5472.can-07-2580","title":"Multiple Alternative Splicing Markers for Ovarian Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ovarian cancer; RNA splicing; Alternative splicing; Biology; Gene expression profiling; Cancer; Computational biology; Gene; Microarray; Serous ovarian cancer; Cancer research; Splicing factor; Bioinformatics; Gene expression; Genetics; Exon; RNA","score_opus":0.08250446163454854,"score_gpt":0.41083902092298946,"score_spread":0.3283345592884409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124146356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948126,0.0014827632,0.0014411084,0.0005934159,0.0001431578,0.0006694917,0.000089372275,0.00001026248,0.0007578452],"genre_scores_gemma":[0.98066854,0.0024262206,0.00040922087,0.00014939862,0.00088267244,0.0010233304,0.00003886061,0.000041252704,0.0143605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813616,0.00011290668,0.00014616069,0.00046087446,0.0004000422,0.00074383384],"domain_scores_gemma":[0.99889153,0.00009383052,0.00003232205,0.00031991198,0.00045282173,0.0002095776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006183928,0.00012122138,0.00013701848,0.000112338035,0.0004500871,0.000029218932,0.00035747996,0.00009766592,0.00011660284],"category_scores_gemma":[0.00035887427,0.00011172116,0.00008705049,0.00020478529,0.00022721913,0.0000069133657,0.00017240699,0.00024392376,0.0000103429875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007427407,0.000028068247,0.011294431,0.00004112732,0.000093900424,0.000011668536,0.00009807695,0.000242171,0.9550586,0.000050294308,0.025721049,0.0066179195],"study_design_scores_gemma":[0.002331758,0.0004461064,0.006899647,0.00007822504,0.0000058588976,0.00001125388,0.00020751666,0.0023999815,0.8902187,0.00008578025,0.09702678,0.00028843814],"about_ca_topic_score_codex":0.004404183,"about_ca_topic_score_gemma":0.0013016313,"teacher_disagreement_score":0.07130574,"about_ca_system_score_codex":0.00012935688,"about_ca_system_score_gemma":0.00049734395,"threshold_uncertainty_score":0.66578364},"labels":[],"label_agreement":null},{"id":"W2124289149","doi":"10.1158/0008-5472.can-05-3635","title":"Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Gene knockdown; Paracrine signalling; Biology; Cadherin; Autocrine signalling; Cyclooxygenase; Prostaglandin E2; Metastasis; Cancer; Cell; Cell culture; Endocrinology; Receptor","score_opus":0.0324729560858078,"score_gpt":0.3364601835515381,"score_spread":0.3039872274657303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124289149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225515,0.004837575,0.000010176795,0.00029673797,0.00016163796,0.0011642412,0.000037065016,0.000015123057,0.0012223062],"genre_scores_gemma":[0.9960242,0.00057479815,0.00004010557,0.00002179724,0.0004064138,0.0004951706,0.000026257912,0.000029211935,0.0023820414],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979838,0.00014747326,0.00035413474,0.00038569278,0.0006947225,0.00043414743],"domain_scores_gemma":[0.9992437,0.000093659444,0.000078481375,0.00022667812,0.00022476149,0.00013273057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010419927,0.0001466129,0.00030760453,0.0003275293,0.00008074926,0.00002041276,0.00009227984,0.00016232894,0.00034288765],"category_scores_gemma":[0.000035066943,0.00012826841,0.00004844562,0.00035897893,0.00015384587,0.00009643833,0.000037907164,0.00045864432,0.000003125631],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064095773,0.00011362703,0.24706407,0.0011912875,0.00002086324,0.000040894403,0.00087610324,0.0002595247,0.74729943,0.000084275496,0.0012997878,0.0011091883],"study_design_scores_gemma":[0.0027875667,0.00012963703,0.62762684,0.0005407799,0.000026049527,0.000004562542,0.000111776295,0.0005721137,0.3672021,0.00007398454,0.0007926603,0.00013190706],"about_ca_topic_score_codex":0.006026967,"about_ca_topic_score_gemma":0.0017971457,"teacher_disagreement_score":0.38056278,"about_ca_system_score_codex":0.00030273074,"about_ca_system_score_gemma":0.0003653857,"threshold_uncertainty_score":0.9111011},"labels":[],"label_agreement":null},{"id":"W2124470568","doi":"10.1158/0008-5472.can-10-2352","title":"Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Cancer Research UK; Abbott Laboratories","keywords":"PARP inhibitor; PARP1; Poly ADP ribose polymerase; Clonogenic assay; Cancer research; RAD51; Synthetic lethality; Biology; Cancer cell; DNA damage; DNA repair; In vivo; Molecular biology; Cancer; Polymerase; DNA; Genetics","score_opus":0.07678439385390248,"score_gpt":0.4114094948835611,"score_spread":0.3346251010296586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124470568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771431,0.00123677,0.000018586632,0.013290711,0.0003352785,0.0009404046,0.0001754318,0.000020503494,0.006839198],"genre_scores_gemma":[0.99476206,0.0003940443,0.000051999716,0.0022311676,0.00030836993,0.00082741614,0.0000045620313,0.000038694012,0.001381663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975846,0.00026163636,0.00027929465,0.00038354608,0.0010188309,0.00047211058],"domain_scores_gemma":[0.9980396,0.00059804204,0.000093121,0.00086091086,0.00022599565,0.00018231595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013381292,0.00015407252,0.00026801485,0.00008309939,0.00015517921,0.000015904798,0.00029603008,0.000080049205,0.014116614],"category_scores_gemma":[0.000118146854,0.00010374248,0.00011291625,0.00021514592,0.0009423313,0.000031889107,0.000053546617,0.000994044,0.000080081765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068671675,0.0003332554,0.0046378137,0.00014366317,0.000033906497,0.000013387226,0.0002489471,0.000049062128,0.98207825,0.00033639066,0.00910469,0.0023339326],"study_design_scores_gemma":[0.0017671956,0.00030067467,0.008197361,0.00029294527,0.000022074855,0.0000030464753,0.00022861826,0.00018953868,0.91393185,0.00008648985,0.07486118,0.000119049575],"about_ca_topic_score_codex":0.0034044029,"about_ca_topic_score_gemma":0.0007057317,"teacher_disagreement_score":0.06814641,"about_ca_system_score_codex":0.0005307477,"about_ca_system_score_gemma":0.000632363,"threshold_uncertainty_score":0.98678464},"labels":[],"label_agreement":null},{"id":"W2124714673","doi":"10.1158/0008-5472.can-06-4336","title":"Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"McMaster University","keywords":"Epitope; Immunogenicity; CD8; T cell; Cytotoxic T cell; Immunology; Immunization; Antigen; Biology; Immunity; Immune system; Genetics; In vitro","score_opus":0.026244699398194,"score_gpt":0.3138550345029631,"score_spread":0.2876103351047691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124714673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98635924,0.011719008,0.0003975829,0.00021506194,0.00023047999,0.0008046116,0.000029718844,0.000026290052,0.00021801387],"genre_scores_gemma":[0.99747115,0.0005328459,0.00009842901,0.000059398008,0.000019546313,0.000081785685,0.000010936369,0.000030281439,0.0016956255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977113,0.0007804575,0.00038421986,0.0002841312,0.00020038163,0.00063948135],"domain_scores_gemma":[0.9975844,0.0009973412,0.00017395608,0.00058325747,0.00063395407,0.000027066166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017882789,0.00017157568,0.00036324683,0.00029616064,0.00031680946,0.000018528357,0.00061075506,0.00015765849,0.00017463864],"category_scores_gemma":[0.00018329351,0.00011559872,0.000097245764,0.0008822999,0.00037903534,0.00013653372,0.00013268761,0.0004788017,0.00005016173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016931709,0.00016154072,0.0022186777,0.0000725096,0.00034133423,0.000011804408,0.00829931,0.000040180523,0.98602134,0.000023181183,0.00022556637,0.0008913608],"study_design_scores_gemma":[0.000863804,0.0005350569,0.008310263,0.00028152994,0.000027563703,0.000011308713,0.0041892733,0.000002006705,0.9798208,0.000012670898,0.0058118594,0.00013385755],"about_ca_topic_score_codex":0.002059948,"about_ca_topic_score_gemma":0.00021345625,"teacher_disagreement_score":0.011186163,"about_ca_system_score_codex":0.00014484933,"about_ca_system_score_gemma":0.00040743488,"threshold_uncertainty_score":0.47139788},"labels":[],"label_agreement":null},{"id":"W2124992150","doi":"10.1158/0008-5472.can-06-3824","title":"New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise","funders":"","keywords":"HT1080; Mitochondrion; Cytotoxicity; Apoptosis; Cancer cell; Respiratory chain; Biology; Biochemistry; Cytochrome c; Chemistry; Cancer research; Cell biology; Pharmacology; Cell; Cancer; In vitro","score_opus":0.0488894808389108,"score_gpt":0.3686851308029646,"score_spread":0.3197956499640538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124992150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792658,0.00076431973,0.016822383,0.00035509825,0.00021655273,0.00042339312,0.00002189743,0.000013283414,0.0021172536],"genre_scores_gemma":[0.9864454,0.00082885084,0.002787838,0.0015919294,0.0008579937,0.000060125392,0.000013419774,0.00004405019,0.0073703877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847025,0.00007299157,0.0001710568,0.00047598287,0.0002843175,0.00052542536],"domain_scores_gemma":[0.9991282,0.000035622987,0.00004354933,0.00028322314,0.0002042097,0.0003051602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004847653,0.00014252478,0.00014536854,0.00008602346,0.00017026777,0.000036250734,0.00016062602,0.0001514003,0.00018211645],"category_scores_gemma":[0.000050236667,0.00012440246,0.000028365379,0.00026085367,0.000094250936,0.0000038221333,0.00010950103,0.00022423809,0.000011663928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010358696,0.000014591651,0.00030045465,0.000020860098,0.00003345621,0.000006562544,0.00021350304,0.000067823945,0.9738273,0.00000898728,0.0052907094,0.01917985],"study_design_scores_gemma":[0.00063425413,0.00032363334,0.0012613509,0.00003993878,0.000005689602,0.0000015631935,0.00010904803,0.000010018596,0.94442654,0.000011652745,0.053016033,0.00016026925],"about_ca_topic_score_codex":0.00034091927,"about_ca_topic_score_gemma":0.0022518039,"teacher_disagreement_score":0.047725324,"about_ca_system_score_codex":0.00007504043,"about_ca_system_score_gemma":0.0003074926,"threshold_uncertainty_score":0.5072985},"labels":[],"label_agreement":null},{"id":"W2125211913","doi":"10.1158/0008-5472.can-06-1098","title":"A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Cyclin-dependent kinase 6; Cancer research; Multiple myeloma; Bone marrow; Palbociclib; Biology; Cyclin; Cell cycle; Cyclin D; Cell cycle checkpoint; Apoptosis; Cyclin D1; Cancer; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.041712005282019564,"score_gpt":0.32537681740634117,"score_spread":0.2836648121243216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125211913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949977,0.0012705032,0.000030199524,0.00035080742,0.000048573063,0.0015314776,0.00035006384,0.000016507978,0.0014041701],"genre_scores_gemma":[0.9976096,0.0005938586,0.00031582857,0.000039832248,0.00011596021,0.00031797643,0.00018420491,0.000042116222,0.000780632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970162,0.00020166082,0.0003922783,0.0005941291,0.001080263,0.0007154648],"domain_scores_gemma":[0.9988296,0.00014538362,0.00010088259,0.0002854427,0.00034722756,0.0002914358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005263943,0.00021565639,0.00039189626,0.00048402432,0.0000964652,0.000044028056,0.00014728152,0.000107763735,0.00007691867],"category_scores_gemma":[0.00007256669,0.00019118651,0.000062215775,0.00055646786,0.00028909527,0.00014299291,0.00019175996,0.00060944876,0.000016213591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020128617,0.001543315,0.011618843,0.00035168903,0.000058294976,0.0005605847,0.0001105783,0.000002660467,0.9783438,0.000025881358,0.00077137025,0.0046001403],"study_design_scores_gemma":[0.0058642193,0.00046750842,0.20414683,0.00043635038,0.000012505871,0.000012488408,0.00011583637,0.00001553554,0.78859925,0.000120362456,0.000074707394,0.0001343906],"about_ca_topic_score_codex":0.006267535,"about_ca_topic_score_gemma":0.00052968186,"teacher_disagreement_score":0.192528,"about_ca_system_score_codex":0.0007276315,"about_ca_system_score_gemma":0.00047877547,"threshold_uncertainty_score":0.947468},"labels":[],"label_agreement":null},{"id":"W2125233609","doi":"10.1158/0008-5472.can-03-2871","title":"A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth <b> <i>in Vivo</i> </b>","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pharmacology; In vivo; Tyrosine kinase; Tyrosine-kinase inhibitor; Angiogenesis; Kinase insert domain receptor; Pharmacokinetics; Chemistry; Vascular endothelial growth factor; Biology; Receptor; Medicine; Cancer research; Internal medicine; Cancer; Vascular endothelial growth factor A; Biochemistry","score_opus":0.025422329411100543,"score_gpt":0.31836301244596965,"score_spread":0.2929406830348691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125233609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899061,0.009049172,0.000058552152,0.0001764124,0.0001269886,0.0004447864,0.00005578037,0.0000064691417,0.0001757559],"genre_scores_gemma":[0.99696004,0.0014148912,0.00079469755,0.00014202292,0.00025468552,0.00020187907,0.000012315549,0.00003878656,0.00018066244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834216,0.000093669696,0.00025653094,0.0004999422,0.0003071195,0.0005005606],"domain_scores_gemma":[0.9993179,0.000031490617,0.000079128105,0.00024143171,0.00019368978,0.00013637691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005975098,0.00017327172,0.000245291,0.00016912565,0.00009780584,0.000027436288,0.0002451041,0.00014282175,0.00003494158],"category_scores_gemma":[0.00009112773,0.00016167325,0.00008803662,0.0004244326,0.00023207939,0.000013661957,0.0002294586,0.00015219794,0.0000041540047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003533383,0.00013100247,0.0077401893,0.00020231745,0.00004800859,0.000009520011,0.00013667936,0.00000931083,0.99011546,0.00011326158,0.0006973048,0.00044357675],"study_design_scores_gemma":[0.0020298164,0.00063827186,0.0016802629,0.00034428472,0.000007981162,0.0000060789184,0.00012179403,7.601617e-7,0.99142677,0.00008387634,0.0034725238,0.0001875934],"about_ca_topic_score_codex":0.0013644939,"about_ca_topic_score_gemma":0.0002963321,"teacher_disagreement_score":0.0076342802,"about_ca_system_score_codex":0.00010610897,"about_ca_system_score_gemma":0.000525819,"threshold_uncertainty_score":0.65928435},"labels":[],"label_agreement":null},{"id":"W2125292266","doi":"10.1158/0008-5472.can-12-3989","title":"Posttranscriptional Regulation of <i>PER1</i> Underlies the Oncogenic Function of IREα","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Function (biology); Cell biology; Biology; Cancer research","score_opus":0.03824356123510098,"score_gpt":0.33436354737594,"score_spread":0.296119986140839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125292266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952197,0.002582241,0.00015463689,0.0005465501,0.00006758876,0.00020679331,0.00002764775,0.0000021764538,0.0011926393],"genre_scores_gemma":[0.9983728,0.0005827653,0.000019575298,0.00004395635,0.00010050428,0.00008781803,0.00004200671,0.000007455861,0.00074314524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992355,0.00008438837,0.00013584581,0.00013539699,0.00027126638,0.000137598],"domain_scores_gemma":[0.99931246,0.000024054192,0.000040154508,0.00021700845,0.00036483555,0.000041504707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016913572,0.000051274485,0.00006458002,0.0000321092,0.00006472347,0.000009938613,0.00012479475,0.000052755317,0.00028747378],"category_scores_gemma":[0.00003742456,0.000035759196,0.00006248401,0.00010464401,0.00025963667,0.0000049346118,0.000038807255,0.00006853877,0.000006615031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001106115,0.00003074452,0.0018333467,0.000041027757,0.000031855423,5.751084e-8,0.000030444246,0.00014126794,0.98940843,0.0009411943,0.0052933963,0.0021376351],"study_design_scores_gemma":[0.00048232847,0.00026496808,0.06215378,0.00003488805,0.000018906818,0.0000011517013,0.00031968014,0.000074981406,0.927707,0.0019007623,0.006965385,0.000076124634],"about_ca_topic_score_codex":0.00031985977,"about_ca_topic_score_gemma":0.00003215648,"teacher_disagreement_score":0.061701372,"about_ca_system_score_codex":0.0000134233105,"about_ca_system_score_gemma":0.00014794346,"threshold_uncertainty_score":0.31476364},"labels":[],"label_agreement":null},{"id":"W2125446878","doi":"10.1158/0008-5472.can-05-0399","title":"Somatic Mosaicism and Cancer: A Micro-Genetic Examination into the Role of the Androgen Receptor Gene in Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"John Abbott College; McGill University; Immunovaccine (Canada); Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen receptor; Prostate; Somatic cell; Cancer; Biology; Genetic heterogeneity; Cancer research; Gene; Genetics; Phenotype","score_opus":0.02907656777478963,"score_gpt":0.36201813686124296,"score_spread":0.33294156908645334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125446878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8808264,0.108489,3.7574537e-7,0.008648746,0.000065475564,0.0017374668,0.000050412273,0.0000104756355,0.0001716113],"genre_scores_gemma":[0.95053,0.04417909,0.00010384019,0.00009248915,0.00021794622,0.0019812132,0.000008481539,0.00003462229,0.0028523093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760807,0.00033445307,0.0003148951,0.00037308154,0.0008005052,0.00056901504],"domain_scores_gemma":[0.9988755,0.0001299228,0.00007968556,0.0004182029,0.00036208602,0.00013463148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008532016,0.00016267014,0.00027213877,0.00021128618,0.00024780873,0.000039722592,0.00028786287,0.0000791885,0.00028984962],"category_scores_gemma":[0.00006531875,0.00009058894,0.00005482893,0.00091474626,0.00056497904,0.00009101774,0.00020765894,0.000497351,0.000008301184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032798186,0.00010896088,0.14931592,0.0002496807,0.000098280645,0.0000050476356,0.009998313,0.000079545935,0.46569878,0.000012994876,0.0004323414,0.37367213],"study_design_scores_gemma":[0.002907469,0.00019187434,0.14294735,0.0007615164,0.000055446144,0.000008918702,0.0015623801,0.0007616645,0.82905734,0.00035578437,0.021232266,0.0001580106],"about_ca_topic_score_codex":0.008125492,"about_ca_topic_score_gemma":0.0040742657,"teacher_disagreement_score":0.37351412,"about_ca_system_score_codex":0.00097425224,"about_ca_system_score_gemma":0.0010641909,"threshold_uncertainty_score":0.9984795},"labels":[],"label_agreement":null},{"id":"W2125887187","doi":"10.1158/0008-5472.can-04-4392","title":"Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Goldhirsh Foundation; Ziering Family Foundation; Accelerate Brain Cancer Cure; National Cancer Institute; Brain Tumor Funders' Collaborative; National Foundation for Cancer Research; T.J. Martell Foundation","keywords":"PTEN; Cancer research; PI3K/AKT/mTOR pathway; Epidermal growth factor receptor; Erlotinib; Biology; EGFR inhibitors; Kinase; Signal transduction; Cancer; Cell biology","score_opus":0.01903221103852813,"score_gpt":0.312673352069945,"score_spread":0.29364114103141686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125887187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963709,0.0014000761,0.00007603385,0.00084906287,0.00019718459,0.00072911,0.00028502507,0.000014026747,0.000078574725],"genre_scores_gemma":[0.99850243,0.00008224275,0.0003031102,0.000072940085,0.0003460292,0.00021688156,0.000035717563,0.000051492614,0.000389136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970468,0.0005607747,0.00045071988,0.0007045895,0.0005494486,0.0006876399],"domain_scores_gemma":[0.9988108,0.00010842519,0.00010217413,0.0003624984,0.00041244327,0.00020364841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001324793,0.00023673299,0.00027381608,0.0004406575,0.00010234043,0.00004607572,0.00021579645,0.00022969418,0.00012605757],"category_scores_gemma":[0.00034385943,0.00023459941,0.00007801248,0.0006182128,0.00026168363,0.00001514895,0.00023982799,0.0003177317,0.00001442908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002922358,0.00013452525,0.007348581,0.00011060511,0.000012096701,0.000020402425,0.0001871558,0.00015372585,0.98284405,0.000012681107,0.005464189,0.0007896287],"study_design_scores_gemma":[0.0008976411,0.00097328355,0.0069741537,0.00019042825,0.0000034296345,0.0000036894694,0.000092704366,0.000019231324,0.9847036,0.000058005047,0.0058309305,0.00025288292],"about_ca_topic_score_codex":0.0009088254,"about_ca_topic_score_gemma":0.00038295725,"teacher_disagreement_score":0.002131544,"about_ca_system_score_codex":0.0002618215,"about_ca_system_score_gemma":0.0003827943,"threshold_uncertainty_score":0.9566686},"labels":[],"label_agreement":null},{"id":"W2125981387","doi":"10.1158/0008-5472.can-07-6777","title":"Knockdown of the Transforming Growth Factor-β Type III Receptor Impairs Motility and Invasion of Metastatic Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; AstraZeneca","keywords":"Gene knockdown; Motility; Transforming growth factor; Cancer research; Cancer; Receptor; Biology; Internal medicine; Cell biology; Medicine; Cell culture; Genetics","score_opus":0.07431001306633829,"score_gpt":0.3605192100496204,"score_spread":0.2862091969832821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125981387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944567,0.004928643,0.000016817407,0.00005460666,0.00008280578,0.0002795806,0.000121832825,0.0000032312878,0.000055747125],"genre_scores_gemma":[0.9975743,0.002048932,0.00004924392,0.000013664988,0.00004611151,0.000033815355,0.000006630567,0.0000141067885,0.00021316543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988912,0.00015012431,0.00019530875,0.00023055103,0.00031159542,0.00022123395],"domain_scores_gemma":[0.9991999,0.00004752019,0.00005924959,0.00025979802,0.00035357306,0.00007992338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024144586,0.00009085721,0.00015273807,0.000043118172,0.00011732098,0.0000042327842,0.00023665714,0.000058862053,0.00015831555],"category_scores_gemma":[0.000116276104,0.00006517892,0.00006245015,0.0002140478,0.0004246285,0.000004068594,0.00010616643,0.00013099401,7.8387217e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016992066,0.000047554164,0.01575799,0.00019984186,0.000051013136,4.3558597e-7,0.0003990043,0.000035344616,0.98156613,0.0000026236646,0.00075202226,0.0010181131],"study_design_scores_gemma":[0.0003362832,0.000112127585,0.010958146,0.00006886126,0.000011096515,7.935726e-7,0.00008678589,0.000008464552,0.987475,0.000014783744,0.0008683252,0.000059354305],"about_ca_topic_score_codex":0.0010003115,"about_ca_topic_score_gemma":0.00015964115,"teacher_disagreement_score":0.0059088413,"about_ca_system_score_codex":0.00003479854,"about_ca_system_score_gemma":0.000580481,"threshold_uncertainty_score":0.26579195},"labels":[],"label_agreement":null},{"id":"W2126015139","doi":"10.1158/0008-5472.can-09-2408","title":"Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Provincial Laboratory of Public Health; Oncolytics Biotech (Canada); Bio-Rad (Canada); University of Calgary; Memorial University of Newfoundland","funders":"","keywords":"Oncolytic virus; Prostate cancer; Cancer research; In vivo; Medicine; Cancer; Apoptosis; Virology; Virus; Biology; Internal medicine","score_opus":0.08611561862416536,"score_gpt":0.45399505772469434,"score_spread":0.367879439100529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126015139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947746,0.007021067,0.000013410222,0.0009213253,0.00020575868,0.0018715534,0.00012125649,0.000017768973,0.0003504179],"genre_scores_gemma":[0.9864254,0.009209392,0.00006532881,0.0002998733,0.0006398128,0.0017604212,0.00004503806,0.00006245994,0.0014922655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974133,0.0002902765,0.00028989997,0.00064493204,0.00051158085,0.00085004716],"domain_scores_gemma":[0.9981991,0.00018196733,0.00008052931,0.00070337654,0.0006369846,0.00019801839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015035981,0.00021211257,0.00027811594,0.00015192857,0.00021740091,0.00004455326,0.0007413386,0.00028476346,0.00037584436],"category_scores_gemma":[0.00023243287,0.00016609965,0.00017796321,0.00033829486,0.00071968586,0.000005944468,0.00015328213,0.0005886974,0.000020271269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014909767,0.00019794477,0.0013550052,0.000026022168,0.00012712872,0.0000018819819,0.000110042216,0.00001870459,0.8525551,0.0001071422,0.0007038857,0.1298874],"study_design_scores_gemma":[0.002971771,0.0077839796,0.0010459545,0.000018935745,0.000005358626,0.0000025433699,0.00004197556,0.00002589209,0.92076266,0.0006102292,0.066526905,0.00020379205],"about_ca_topic_score_codex":0.0004937349,"about_ca_topic_score_gemma":0.00059770717,"teacher_disagreement_score":0.1296836,"about_ca_system_score_codex":0.000067685825,"about_ca_system_score_gemma":0.0014209213,"threshold_uncertainty_score":0.6773347},"labels":[],"label_agreement":null},{"id":"W2126147061","doi":"10.1158/0008-5472.can-07-0762","title":"LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cyclin D1; Cancer research; Cancer; Suppressor; Mutant; Cell cycle; Biology; Oncogene; Cyclin; Kinase; Cyclin D; Cell growth; Tumor suppressor gene; Cell biology; Genetics; Carcinogenesis; Gene","score_opus":0.09554415433898664,"score_gpt":0.48498362723545835,"score_spread":0.38943947289647174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126147061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842298,0.0020998223,0.000607869,0.00072407536,0.00074624113,0.00071708165,0.000013054035,0.00006346131,0.0107985735],"genre_scores_gemma":[0.9936643,0.00031909827,0.0007221107,0.00028021217,0.00044971652,0.00011934528,0.000007187163,0.00004771178,0.0043903147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961614,0.00007793271,0.0003625209,0.0006043961,0.0017359002,0.0010578542],"domain_scores_gemma":[0.99784595,0.00037613887,0.00004744283,0.00064383127,0.0005937236,0.0004929201],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020011514,0.0001742075,0.00027802953,0.00027347045,0.00028740396,0.000028730878,0.0003373796,0.00018452431,0.0014839651],"category_scores_gemma":[0.00073162327,0.00014418909,0.000079337784,0.0007742869,0.0003812331,0.00004814598,0.00052029407,0.00083773426,0.00026621245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010206231,0.00017063408,0.009875466,0.00013326421,0.00002019392,0.00013892015,0.0006430689,0.000014005988,0.954242,0.000038214934,0.0071933814,0.026510213],"study_design_scores_gemma":[0.0006919769,0.0004116623,0.028993214,0.00037138464,0.000013739143,0.000023601826,0.00021464704,0.0000307744,0.9584193,0.00019844927,0.010460534,0.00017066799],"about_ca_topic_score_codex":0.00032336917,"about_ca_topic_score_gemma":0.00022731171,"teacher_disagreement_score":0.026339544,"about_ca_system_score_codex":0.0008914669,"about_ca_system_score_gemma":0.0005948143,"threshold_uncertainty_score":0.9994288},"labels":[],"label_agreement":null},{"id":"W2126404730","doi":"10.1158/0008-5472.can-05-3739","title":"A Single Nucleotide Polymorphism Chip-Based Method for Combined Genetic and Epigenetic Profiling: Validation in Decitabine Therapy and Tumor/Normal Comparisons","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Decitabine; Epigenetics; DNA methylation; Biology; Epigenetic therapy; Azacitidine; Bisulfite sequencing; SNP array; Single-nucleotide polymorphism; Computational biology; SNP genotyping; Bisulfite; Genetics; Cancer research; Gene; Genotype; Gene expression","score_opus":0.06567182772991258,"score_gpt":0.3727433693542575,"score_spread":0.3070715416243449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126404730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740926,0.011485376,0.0131198075,0.00031785588,0.00005318801,0.0008186142,0.000028336473,0.000007340842,0.000076854616],"genre_scores_gemma":[0.9791719,0.00056127727,0.01952439,0.00004637449,0.00018254142,0.00028945244,0.000113306494,0.000034561977,0.000076250435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849224,0.00024055426,0.0002629917,0.00042959096,0.00019504168,0.0003795553],"domain_scores_gemma":[0.99935305,0.00011336206,0.00006375517,0.00021257345,0.00017108017,0.00008616729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007391926,0.0001419425,0.00017468071,0.00016137562,0.00014313571,0.00006401956,0.00010754215,0.0000968922,0.000007964086],"category_scores_gemma":[0.00005661452,0.00014221566,0.000035310917,0.00019073773,0.0001325926,0.000004708051,0.000056591125,0.00011723995,4.5433896e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037043,0.000112689006,0.039174624,0.000032156873,0.000011539953,0.0000012168231,0.000024652732,0.0007169426,0.9518621,0.00006350343,0.00007018939,0.0076266997],"study_design_scores_gemma":[0.002187426,0.00066357286,0.066804536,0.000018209861,0.0000072705984,9.45989e-7,0.000026973506,0.003906391,0.9222085,0.0007701125,0.0032369178,0.00016913383],"about_ca_topic_score_codex":0.00058826734,"about_ca_topic_score_gemma":0.00034284528,"teacher_disagreement_score":0.029653575,"about_ca_system_score_codex":0.000036076457,"about_ca_system_score_gemma":0.00014218857,"threshold_uncertainty_score":0.57993865},"labels":[],"label_agreement":null},{"id":"W2126482839","doi":"10.1158/0008-5472.can-04-3448","title":"Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Bone sialoprotein; Osteocalcin; Osteopontin; Endocrinology; Internal medicine; Prostate cancer; Stromal cell; Chemistry; LNCaP; Biology; Cancer research; Medicine; Cancer; Biochemistry; Alkaline phosphatase","score_opus":0.040025414058673096,"score_gpt":0.35658354206810594,"score_spread":0.31655812800943284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126482839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97338766,0.02277494,0.0000033979852,0.0006600366,0.000026517022,0.0025186366,0.00009420157,0.000026500487,0.0005081341],"genre_scores_gemma":[0.9966537,0.0003373198,0.0004197391,0.000040428407,0.0002889714,0.0011488404,0.0000060052066,0.000047420333,0.0010575899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997122,0.00018163917,0.00063165405,0.00045648075,0.0010267822,0.0005814714],"domain_scores_gemma":[0.9986425,0.00007134477,0.0002289498,0.00031889093,0.00053462427,0.00020366901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012820092,0.00021335212,0.00061135204,0.00026961276,0.00021218079,0.000021326032,0.0001261253,0.000125611,0.00017830689],"category_scores_gemma":[0.00012108675,0.00018139582,0.00008422655,0.0003822266,0.00045374912,0.000117157135,0.00030694905,0.00058305,0.0000072244397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047570307,0.00014669949,0.0014316879,0.0010502674,0.00007557597,0.00004366377,0.0030926312,0.000031398515,0.9544427,0.000052964235,0.00004646877,0.03911028],"study_design_scores_gemma":[0.0021918796,0.00056748354,0.00033448252,0.0012978583,0.000031809257,0.000005893122,0.0030377503,0.000040718303,0.9918559,0.00016884546,0.00030403284,0.00016335097],"about_ca_topic_score_codex":0.005853587,"about_ca_topic_score_gemma":0.0008599264,"teacher_disagreement_score":0.03894693,"about_ca_system_score_codex":0.00024458874,"about_ca_system_score_gemma":0.00043794003,"threshold_uncertainty_score":0.88489115},"labels":[],"label_agreement":null},{"id":"W2126543235","doi":"10.1158/0008-5472.can-10-1656","title":"Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Mesenchymal stem cell; Aggressive fibromatosis; Fibromatosis; Cancer research; Progenitor cell; Biology; Carcinogenesis; Pathology; Progenitor; Stem cell; Cancer; Medicine; Cell biology; Genetics","score_opus":0.05777166771401318,"score_gpt":0.4004054677269309,"score_spread":0.34263380001291777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126543235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101746,0.0032953767,0.0000018637619,0.0025356936,0.00072561903,0.0009487448,0.00017292256,0.00012445737,0.0011778459],"genre_scores_gemma":[0.9943767,0.00026520595,0.00091020635,0.00027794827,0.0016100176,0.00063534325,0.000016945847,0.00007439662,0.0018332215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695283,0.00011423823,0.00028137866,0.0006494104,0.0011655103,0.00083661976],"domain_scores_gemma":[0.99756366,0.00041103526,0.000109590415,0.00073594257,0.00074337696,0.00043638865],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003450254,0.00024407361,0.00046132624,0.0002201969,0.00034072832,0.000060917104,0.00030198295,0.00012080694,0.004625076],"category_scores_gemma":[0.0006724984,0.00020704877,0.00013454327,0.000550693,0.0006932195,0.000094888775,0.0003135847,0.0012070299,0.0008814138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028327177,0.00008924194,0.027001178,0.00011032162,0.0001971619,0.0011012041,0.0017339939,1.1977988e-7,0.9318739,0.000011187396,0.035543058,0.0020553658],"study_design_scores_gemma":[0.0012366204,0.00021350625,0.026851283,0.00027405503,0.000068085734,0.00008136379,0.0007701637,0.00001827185,0.9550485,0.00013791281,0.015083237,0.0002170221],"about_ca_topic_score_codex":0.0019479296,"about_ca_topic_score_gemma":0.00019056104,"teacher_disagreement_score":0.023174582,"about_ca_system_score_codex":0.00017439232,"about_ca_system_score_gemma":0.0006837282,"threshold_uncertainty_score":0.9998965},"labels":[],"label_agreement":null},{"id":"W2126632735","doi":"10.1158/0008-5472.can-13-3531","title":"Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"National Institutes of Health","keywords":"Gene isoform; Chemistry; Pharmacology; Internal medicine; Medicine; Biochemistry; Gene","score_opus":0.02131215016680877,"score_gpt":0.35533211698472733,"score_spread":0.33401996681791857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126632735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971413,0.00067363866,0.00017039728,0.00005752413,0.000047605514,0.00044956317,0.000015277386,0.0000034899474,0.0014411885],"genre_scores_gemma":[0.99925816,0.00012568058,0.00007649604,0.000012434845,0.00012427509,0.00015608981,0.000022024373,0.00002261293,0.0002022543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981289,0.00039772596,0.00025106053,0.0003261799,0.0004844669,0.0004116744],"domain_scores_gemma":[0.9989481,0.000090488225,0.000061604485,0.0003434654,0.0004748267,0.000081492144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011470777,0.00009862204,0.00022014978,0.00032303933,0.00004689234,0.000006240042,0.00018685195,0.00013054909,0.000016944823],"category_scores_gemma":[0.00058574433,0.000098019045,0.00006521762,0.0005583601,0.0003619696,0.0000063018106,0.00016158629,0.00027954535,0.000008035799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027098804,0.000102017526,0.013542924,0.00028742256,0.000013558797,0.00000414056,0.00011844692,0.000026053298,0.9823885,0.00027028722,0.0012964037,0.0016792658],"study_design_scores_gemma":[0.0008088427,0.00079406594,0.013047656,0.00014256871,0.0000020277785,0.0000019773013,0.000030621435,0.00011401774,0.98400223,0.00020642002,0.00076213817,0.000087445194],"about_ca_topic_score_codex":0.0008989846,"about_ca_topic_score_gemma":0.00047734147,"teacher_disagreement_score":0.0021168166,"about_ca_system_score_codex":0.0001104433,"about_ca_system_score_gemma":0.00033775973,"threshold_uncertainty_score":0.39971006},"labels":[],"label_agreement":null},{"id":"W2126958361","doi":"10.1158/0008-5472.can-12-1321","title":"Bcl3 Selectively Promotes Metastasis of ERBB2-Driven Mammary Tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council; Cardiff University; Breast Cancer Research Trust; Breast Cancer Campaign; Cancer Research UK","keywords":"Cancer research; Mammary tumor; Biology; Oncogene; Metastasis; Cell growth; Cyclin D1; Primary tumor; Cell culture; Tumor progression; Cell cycle; Cell; Cancer; Breast cancer","score_opus":0.153016155710065,"score_gpt":0.44409401627896955,"score_spread":0.29107786056890456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126958361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896263,0.0016660191,0.00020378098,0.0013040609,0.0001267563,0.00045497814,0.000042592495,0.00003828079,0.006537257],"genre_scores_gemma":[0.9973855,0.00012729022,0.0007627287,0.000047762907,0.0003377128,0.00013482188,0.000009557417,0.000023019005,0.0011716158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985474,0.00012482908,0.0001975577,0.00017865366,0.00049264426,0.00045894764],"domain_scores_gemma":[0.99877906,0.00013977384,0.000049509163,0.0002556716,0.00056869956,0.00020727178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000626454,0.00009149346,0.00024111068,0.0002843734,0.00009756823,0.000013640411,0.00012547066,0.00004523274,0.0008949049],"category_scores_gemma":[0.00027681648,0.00007442905,0.00009626297,0.0006110825,0.00011480119,0.00018321649,0.000085995795,0.000449282,0.000048104626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017300402,0.00036889478,0.022096548,0.00021189277,0.00020008521,0.00001086684,0.000983624,0.000004329943,0.9566683,0.0012960867,0.009408663,0.00857767],"study_design_scores_gemma":[0.0005023345,0.0004392786,0.03026772,0.00028633862,0.000045854056,0.00004721179,0.00023864444,0.00007627763,0.94629854,0.000101542864,0.021598818,0.00009741438],"about_ca_topic_score_codex":0.0005520332,"about_ca_topic_score_gemma":0.000015660933,"teacher_disagreement_score":0.012190156,"about_ca_system_score_codex":0.0001914951,"about_ca_system_score_gemma":0.00040512206,"threshold_uncertainty_score":0.9798581},"labels":[],"label_agreement":null},{"id":"W2126999423","doi":"10.1158/0008-5472.can-03-4080","title":"BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bristol-Myers Squibb","keywords":"MAP kinase kinase kinase; Protein kinase A; ASK1; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 9; Cyclin-dependent kinase 2; Cell biology; Biology; Kinase; c-Raf; Cyclin-dependent kinase 4; MAP2K7; Protein kinase R; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases","score_opus":0.06861207986172817,"score_gpt":0.38883290331020204,"score_spread":0.32022082344847386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126999423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955785,0.00060486415,0.0006246948,0.0015171206,0.00007909092,0.0013825333,0.00011139023,0.000011245404,0.00009052445],"genre_scores_gemma":[0.99680376,0.00009630614,0.0011023592,0.0001169436,0.00019473131,0.0011648142,0.000085559484,0.00005187109,0.0003836807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837327,0.00009336024,0.00023467527,0.0005579617,0.00033291895,0.0004078086],"domain_scores_gemma":[0.99842876,0.000035135505,0.000118574506,0.00047725672,0.0008070955,0.00013317377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003556995,0.00017772964,0.00018247472,0.00015671282,0.0001598406,0.000042742355,0.00020375807,0.00016858797,0.000027105747],"category_scores_gemma":[0.00029819517,0.00016282169,0.000051108163,0.0003799565,0.00023406633,0.000023910101,0.000112117494,0.00019608646,0.0000018753026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015903651,0.00008716664,0.00009387587,0.00016412597,0.00009899335,0.0000024452584,0.0005737867,0.0000594421,0.98763466,0.0000741375,0.000569456,0.009051528],"study_design_scores_gemma":[0.0025311292,0.0010321046,0.00035390764,0.00024618505,0.000012141698,0.0000028120576,0.00035867997,0.0000096228905,0.9893218,0.0003488737,0.005589449,0.0001932535],"about_ca_topic_score_codex":0.0006992081,"about_ca_topic_score_gemma":0.00021155235,"teacher_disagreement_score":0.008858275,"about_ca_system_score_codex":0.00042411214,"about_ca_system_score_gemma":0.0010854368,"threshold_uncertainty_score":0.66396755},"labels":[],"label_agreement":null},{"id":"W2127118734","doi":"10.1158/0008-5472.can-04-4292","title":"Inhibition of HER-2/neu Kinase Impairs Androgen Receptor Recruitment to the Androgen Responsive Enhancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Androgen receptor; LNCaP; Cancer research; Prostate cancer; Androgen; Endocrinology; Biology; Tyrosine kinase; Epidermal growth factor; Internal medicine; Signal transduction; Medicine; Cancer; Receptor; Cell biology","score_opus":0.12704880667327142,"score_gpt":0.4416002549281202,"score_spread":0.3145514482548488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127118734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521521,0.009513049,0.000011361904,0.03230877,0.00012502765,0.0037915087,0.00016510597,0.000036969883,0.0018961468],"genre_scores_gemma":[0.9787369,0.0049552824,0.00024620813,0.00048337693,0.0008116048,0.0030540372,0.0000632769,0.000054757074,0.01159455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99659455,0.00039427239,0.00036136224,0.0005200839,0.001301469,0.00082829],"domain_scores_gemma":[0.9976294,0.00022547302,0.0000641632,0.00066943653,0.00096657523,0.0004449695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016800482,0.00019874016,0.00034515758,0.0003959892,0.0002899266,0.000040482995,0.00023339683,0.0001195604,0.0019211831],"category_scores_gemma":[0.0002289191,0.00012715247,0.00013731747,0.0011990393,0.0003343701,0.00012159825,0.0002208567,0.000534792,0.00039109355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010672475,0.00060062844,0.0030440527,0.00027034178,0.00038588594,0.000101032645,0.0062032673,0.000078413104,0.68626994,0.00013241594,0.12522049,0.16702107],"study_design_scores_gemma":[0.0019334876,0.0011207337,0.0006639838,0.00035502552,0.000029873334,0.0000092928185,0.0008339649,0.000015226171,0.7305712,0.000044275836,0.264303,0.000119943375],"about_ca_topic_score_codex":0.0003484467,"about_ca_topic_score_gemma":0.0003079721,"teacher_disagreement_score":0.16690113,"about_ca_system_score_codex":0.0013278703,"about_ca_system_score_gemma":0.0011458246,"threshold_uncertainty_score":0.9989912},"labels":[],"label_agreement":null},{"id":"W2127276650","doi":"10.1158/0008-5472.sabcs13-p3-13-04","title":"Abstract P3-13-04: Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Eribulin; Internal medicine; Tolerability; Metastatic breast cancer; Adverse effect; Breast cancer; Gastroenterology; Post-hoc analysis; Cancer; Progression-free survival; Incidence (geometry); Toxicity; Oncology; Overall survival","score_opus":0.04003991238900451,"score_gpt":0.41036733114484597,"score_spread":0.37032741875584146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127276650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595624,0.0005331167,2.5709376e-8,0.00022248806,0.000021027183,0.0031021615,0.000080770034,0.000004930942,0.00007926259],"genre_scores_gemma":[0.9991111,0.00014625386,0.0000035378994,0.000011836476,0.000017816821,0.00062493276,0.000014526024,0.000016225667,0.000053749485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840313,0.0002751037,0.0003111572,0.0003393882,0.00036802,0.00030322286],"domain_scores_gemma":[0.9989381,0.00050451135,0.00006612882,0.00019432584,0.00017406495,0.00012285981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050426036,0.0001585723,0.000627126,0.00028010286,0.000023934508,0.000008161961,0.000058845937,0.000040562503,0.0007031112],"category_scores_gemma":[0.000044931403,0.00010442188,0.000021882683,0.0004607321,0.00024988427,0.000061680366,0.00003875569,0.00030580943,0.000001656915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010975882,0.0025163821,0.9593055,0.00042731196,0.00015372178,0.000034036086,0.0007831901,0.0000292878,0.0028862734,3.648431e-7,0.00007226436,0.022815784],"study_design_scores_gemma":[0.026092373,0.0057812147,0.96518946,0.00028674694,0.00007287313,8.180016e-7,0.00008179087,0.000019596533,0.0023937651,0.0000030445615,0.0000056563363,0.00007266446],"about_ca_topic_score_codex":0.039728846,"about_ca_topic_score_gemma":0.007014069,"teacher_disagreement_score":0.03271478,"about_ca_system_score_codex":0.00029486738,"about_ca_system_score_gemma":0.00011187101,"threshold_uncertainty_score":0.9666657},"labels":[],"label_agreement":null},{"id":"W2127860417","doi":"10.1158/0008-5472.can-11-2745","title":"Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Howard Hughes Medical Institute","keywords":"Wnt signaling pathway; AXIN2; Cancer research; Signal transduction; Cell growth; Chemistry; Cell biology; Cancer; Biology; Biochemistry; Genetics","score_opus":0.08857323231083071,"score_gpt":0.35729583055797687,"score_spread":0.26872259824714617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127860417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413824,0.0033569955,0.000052384028,0.000053362703,0.000146257,0.00029003847,0.000017431734,0.000007990748,0.0019372891],"genre_scores_gemma":[0.99649006,0.0009188235,0.00059114734,0.00005098418,0.00022805337,0.00019516045,0.000019740868,0.000032015076,0.0014740056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797183,0.0001600239,0.00036178055,0.00047808167,0.00047367022,0.0005545936],"domain_scores_gemma":[0.99917865,0.00002584658,0.00009189451,0.00027091117,0.0003179779,0.00011472997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012091553,0.00015338785,0.00020772967,0.00018009765,0.00007472986,0.000013828702,0.0004892017,0.00017708652,0.00037244562],"category_scores_gemma":[0.00009287189,0.00014869709,0.000060509148,0.00041144917,0.00025261813,0.000010001525,0.0002150762,0.00028373196,0.0000130224835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035990946,0.000030222436,0.025509601,0.00006108174,0.000027493523,0.000008535861,0.000488471,0.00011595581,0.96968555,0.000050393417,0.0018995071,0.0017632538],"study_design_scores_gemma":[0.0005047648,0.0001740571,0.0050630756,0.00020541601,0.000005363439,0.0000015935574,0.00024567798,0.0000055444707,0.9925267,0.0002189504,0.0008522987,0.00019652295],"about_ca_topic_score_codex":0.0031433085,"about_ca_topic_score_gemma":0.0007594658,"teacher_disagreement_score":0.022841161,"about_ca_system_score_codex":0.00018982792,"about_ca_system_score_gemma":0.00070126087,"threshold_uncertainty_score":0.60636914},"labels":[],"label_agreement":null},{"id":"W2127969966","doi":"10.1158/0008-5472.can-07-0467","title":"Haplotype Analysis of <i>CYP11A1</i> Identifies Promoter Variants Associated with Breast Cancer Risk","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Breast cancer; Odds ratio; Genotype; Biology; Haplotype; Genetics; Oncology; Locus (genetics); Cancer; Internal medicine; Cholesterol side-chain cleavage enzyme; Gene; Medicine; Messenger RNA","score_opus":0.017016047621930833,"score_gpt":0.34386612867121674,"score_spread":0.3268500810492859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127969966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966392,0.0021454531,0.00013274491,0.000086389315,0.00006777799,0.00025392685,0.00021695593,0.000010870664,0.0004466794],"genre_scores_gemma":[0.9972373,0.0012421324,0.000017224585,0.000022702747,0.00009977896,0.000047375,0.00007579036,0.000027716836,0.0012299821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983137,0.00019216613,0.0001995833,0.00036874347,0.00044636347,0.00047943322],"domain_scores_gemma":[0.99881047,0.000050353126,0.000116352516,0.000333051,0.0005646138,0.00012516703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012856564,0.00012931605,0.00023227322,0.00025207922,0.00013824989,0.000026075013,0.00022669818,0.00021330488,0.00011143007],"category_scores_gemma":[0.00008711543,0.00009706239,0.00010974184,0.0012889794,0.00024201667,0.0000064276114,0.00009868035,0.00032633592,0.0000048275356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008846373,0.00016878436,0.16025753,0.000028174925,0.0048998394,0.000024309673,0.00018976843,0.00040043742,0.82867736,0.000012894171,0.0014507953,0.0030054883],"study_design_scores_gemma":[0.000896812,0.000351378,0.462381,0.00010587569,0.000755293,0.0000045939255,0.00006867781,0.00012955548,0.5346932,0.00002507108,0.00035348817,0.00023508818],"about_ca_topic_score_codex":0.0015607005,"about_ca_topic_score_gemma":0.0020257449,"teacher_disagreement_score":0.30212346,"about_ca_system_score_codex":0.00006923515,"about_ca_system_score_gemma":0.00022499092,"threshold_uncertainty_score":0.39580894},"labels":[],"label_agreement":null},{"id":"W2128019032","doi":"10.1158/0008-5472.can-04-0012","title":"Excellent <b> <i>In vivo</i> </b> Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the <b> <i>Escherichia coli</i> </b> Purine Nucleoside Phosphorylase Gene","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Bystander effect; Purine nucleoside phosphorylase; Fludarabine; In vivo; Nucleoside analogue; Cancer research; Cytotoxic T cell; Glioma; Escherichia coli; Prodrug; Chemistry; Pharmacology; Biology; Nucleoside; Purine; Immunology; In vitro; Biochemistry; Chemotherapy; Gene; Enzyme","score_opus":0.040769092534909165,"score_gpt":0.34291215606098213,"score_spread":0.30214306352607295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128019032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893354,0.0076707983,0.00006494673,0.0007238315,0.00014267005,0.0012233712,0.0001285365,0.000023351413,0.00068706356],"genre_scores_gemma":[0.9920023,0.006039015,0.00005447623,0.00025053718,0.00028056322,0.0005968865,0.000027355176,0.00011009933,0.00063873763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99579746,0.00050317094,0.000407389,0.00086552213,0.001224119,0.0012023526],"domain_scores_gemma":[0.9977355,0.00006148334,0.00014166659,0.0013155576,0.0004021868,0.00034360727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016939283,0.00037364953,0.00041229723,0.0002020122,0.00040377091,0.00008192222,0.0011533068,0.00023886036,0.00030318068],"category_scores_gemma":[0.00006906653,0.00030838145,0.00020075607,0.0008643225,0.00084256206,0.00002174849,0.0005786283,0.0007193783,0.000016869433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004060406,0.0004939529,0.00042768862,0.000079169375,0.0000891396,0.00006279589,0.00020210257,0.0013298099,0.9895817,0.000026421927,0.002410373,0.0012364433],"study_design_scores_gemma":[0.0033647276,0.0013030656,0.0004284261,0.00009257884,0.000008182032,0.0000024203803,0.00013147616,0.000013512075,0.9785247,0.000100581405,0.015714245,0.00031611658],"about_ca_topic_score_codex":0.0016963579,"about_ca_topic_score_gemma":0.0023717051,"teacher_disagreement_score":0.013303871,"about_ca_system_score_codex":0.000306195,"about_ca_system_score_gemma":0.00076901936,"threshold_uncertainty_score":0.9999368},"labels":[],"label_agreement":null},{"id":"W2128345622","doi":"10.1158/0008-5472.can-08-4631","title":"Lack of T-Cell Receptor–Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Cutaneous T-cell lymphoma; Fas receptor; T-cell receptor; T cell; Cancer research; Jurkat cells; Apoptosis; Fas ligand; Mycosis fungoides; Biology; Programmed cell death; Lymphoma; Immunology; Medicine; Immune system; Biochemistry","score_opus":0.11259233558359417,"score_gpt":0.3940674276130476,"score_spread":0.2814750920294534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128345622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270546,0.0004054697,0.00018774037,0.0009059212,0.0001097744,0.004256993,0.000116704745,0.000043830518,0.0012681294],"genre_scores_gemma":[0.9949444,0.00025226854,0.0007725364,0.00020741153,0.0004436739,0.0003101852,0.00007219222,0.00008519991,0.0029121442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596894,0.00024259964,0.0005557061,0.0009065998,0.0014416748,0.00088447705],"domain_scores_gemma":[0.99672943,0.0006498173,0.0002006651,0.0005341204,0.0015084273,0.00037755724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006260924,0.00034381272,0.0006283791,0.00047959608,0.00039894218,0.00011701785,0.00028563282,0.00036569335,0.00034580342],"category_scores_gemma":[0.0002601716,0.0003346823,0.00014612325,0.0006769125,0.0001322417,0.00015666909,0.00009300083,0.00044861733,0.000029498333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00371291,0.00055808673,0.00030769513,0.00044555907,0.00004631186,0.000014795766,0.0025724487,0.000027322847,0.9806637,0.000011964992,0.0012420025,0.010397165],"study_design_scores_gemma":[0.0062371073,0.0019308748,0.00025624922,0.0002909241,0.00003618155,0.000011497486,0.00059552555,0.0015486313,0.9876644,0.000714907,0.00041473782,0.00029897437],"about_ca_topic_score_codex":0.0016533674,"about_ca_topic_score_gemma":0.000048153845,"teacher_disagreement_score":0.01009819,"about_ca_system_score_codex":0.00070251664,"about_ca_system_score_gemma":0.0016659204,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W2128356343","doi":"10.1158/0008-5472.can-11-2266","title":"Monoallelic Expression Determines Oncogenic Progression and Outcome in Benign and Malignant Brain Tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Toronto General Hospital; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Carcinogenesis; Brain tumor; Tumor progression; Gene; IDH1; Cancer research; Biology; Cancer; Neuroblastoma; Medicine; Pathology; Genetics; Mutation","score_opus":0.09370436671842969,"score_gpt":0.39691019496942026,"score_spread":0.30320582825099057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128356343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958812,0.0034989496,0.000017560546,0.00012483099,0.000032565415,0.00024505408,0.0000023222526,0.000004138364,0.00019339878],"genre_scores_gemma":[0.99814403,0.0006331981,0.0006384254,0.00003893799,0.00005449497,0.00010530937,0.000003160282,0.000017425366,0.00036502807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884945,0.0001046184,0.0001802407,0.00038186202,0.00014727343,0.00033653804],"domain_scores_gemma":[0.9995805,0.000016373042,0.000033561802,0.00020980921,0.000051124243,0.00010859991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503981,0.000100455465,0.00012248155,0.00008797245,0.00007970181,0.000022954722,0.00012930103,0.000092678274,0.000025720776],"category_scores_gemma":[0.00009249352,0.000080845995,0.000021411699,0.00008446512,0.00011717215,0.000004382363,0.00035695173,0.00012227501,0.0000015461682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024878082,0.000018724793,0.20433405,0.000041388543,0.000003813395,0.000007697442,0.00022256782,5.2534693e-7,0.7697162,0.000005598626,0.00007127527,0.025553254],"study_design_scores_gemma":[0.00069548155,0.00039155284,0.3408877,0.00017675657,0.00000266063,0.00004202874,0.00031282246,0.00005048439,0.6552371,0.00013200431,0.0018869555,0.00018444534],"about_ca_topic_score_codex":0.00017678949,"about_ca_topic_score_gemma":0.00007755112,"teacher_disagreement_score":0.13655365,"about_ca_system_score_codex":0.000012918399,"about_ca_system_score_gemma":0.0000522664,"threshold_uncertainty_score":0.32968038},"labels":[],"label_agreement":null},{"id":"W2128595912","doi":"10.1158/0008-5472.can-04-2552","title":"Functional Characterization of EBV-Encoded Nuclear Antigen 1–Specific CD4+ Helper and Regulatory T Cells Elicited by<i>In vitro</i>Peptide Stimulation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"IL-2 receptor; Biology; FOXP3; Antigen; Immune system; Antigen-presenting cell; Interleukin 21; T cell; Cytotoxic T cell; Immunology; Cell biology; In vitro","score_opus":0.030136011309257776,"score_gpt":0.2930306065263518,"score_spread":0.262894595217094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128595912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127257,0.0076260627,0.000047182348,0.00038134883,0.00020371133,0.00030461545,0.000057282727,0.000023274617,0.000083955805],"genre_scores_gemma":[0.99037856,0.0050340164,0.000024173783,0.0001007858,0.00005367557,0.000029784447,0.00019918712,0.000027153586,0.004152659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847454,0.00045062412,0.00032107343,0.0002829425,0.00011464776,0.0003561668],"domain_scores_gemma":[0.9993549,0.00013488544,0.00008271331,0.00023295979,0.00017531769,0.00001924839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061179884,0.00012552035,0.00021966275,0.00031821107,0.00019446321,0.00002125276,0.00013501802,0.00020263935,0.0014602768],"category_scores_gemma":[0.000019491143,0.00012330424,0.000042222957,0.0003109211,0.00034131552,0.00021450456,0.00005374981,0.00035259768,0.00012468718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027742854,0.00010581044,0.00038540224,0.000014083229,0.00004588829,4.7253505e-7,0.00055002654,0.00002924677,0.97965413,0.000054132204,0.0031333766,0.013253141],"study_design_scores_gemma":[0.0012410393,0.00007328903,0.045086447,0.000042516378,0.0000022013494,0.0000030626798,0.000079897545,0.000035371373,0.8240708,0.0000075943462,0.1292534,0.000104378065],"about_ca_topic_score_codex":0.00011279956,"about_ca_topic_score_gemma":0.0000046050245,"teacher_disagreement_score":0.15558334,"about_ca_system_score_codex":0.00013068243,"about_ca_system_score_gemma":0.00008821051,"threshold_uncertainty_score":0.99945253},"labels":[],"label_agreement":null},{"id":"W2128730281","doi":"10.1158/0008-5472.can-10-0358","title":"Cyclins, Cdks, E2f, Skp2, and More at the First International RB Tumor Suppressor Meeting","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Retinoblastoma; Biology; Retinoblastoma protein; Cancer research; Cyclin-dependent kinase; Cell cycle; Cancer; Tumor suppressor gene; Gene; E2F; Cell biology; Genetics; Carcinogenesis","score_opus":0.03744079036234635,"score_gpt":0.3875357155463828,"score_spread":0.3500949251840364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128730281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621671,0.0020608273,0.0000046745968,0.027931504,0.0007196052,0.0005656343,0.00006365975,0.000041965395,0.006445051],"genre_scores_gemma":[0.99438965,0.0004802961,0.00008873251,0.0007170987,0.000897793,0.00025252308,0.000030180545,0.000049753628,0.0030939823],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979646,0.00005394465,0.00020359777,0.00041947977,0.00089620193,0.00046212957],"domain_scores_gemma":[0.99868596,0.00021833478,0.000051353167,0.0005180058,0.0003427943,0.00018358536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008525533,0.00013153629,0.00017066942,0.00014054438,0.00036312247,0.00006980004,0.0003094924,0.0001044013,0.0010969177],"category_scores_gemma":[0.0006873793,0.00009520448,0.000065915265,0.00024448975,0.0005240249,0.00005901499,0.00045006422,0.0012532462,0.00008096743],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000725583,0.00009968211,0.024667079,0.00017286229,0.0002013107,0.00029190656,0.001313095,0.0000353653,0.8702605,0.00033526897,0.09605273,0.005844629],"study_design_scores_gemma":[0.0025217985,0.0001176158,0.022485403,0.0003566829,0.000046609468,0.00016877288,0.00037772357,0.0008440062,0.28026718,0.00009704015,0.6925085,0.00020863808],"about_ca_topic_score_codex":0.0009939806,"about_ca_topic_score_gemma":0.003845669,"teacher_disagreement_score":0.5964558,"about_ca_system_score_codex":0.00029032418,"about_ca_system_score_gemma":0.0002873797,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W2128989133","doi":"10.1158/0008-5472.can-08-1101","title":"BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Biology; Cancer research; Philadelphia chromosome; Imatinib mesylate; Chronic myelogenous leukemia; Genome instability; Tyrosine kinase; Progenitor cell; ABL; DNA damage; Cell biology; Stem cell; Molecular biology; Leukemia; Imatinib; Myeloid leukemia; Signal transduction; Genetics; DNA; Chromosomal translocation","score_opus":0.11099369996061127,"score_gpt":0.3906695035664544,"score_spread":0.27967580360584315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128989133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98633003,0.009194094,0.00001758127,0.0006621886,0.00011025323,0.0014810289,0.00024812834,0.00019624509,0.0017604424],"genre_scores_gemma":[0.99428034,0.0024758535,0.00021551756,0.00015436135,0.00070961856,0.0002531409,0.00012833391,0.000112189366,0.0016706631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963516,0.00023454997,0.00041192005,0.001049988,0.00095233676,0.0009996329],"domain_scores_gemma":[0.9980337,0.00025747146,0.00008253723,0.000760368,0.00026187944,0.0006040133],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004051227,0.00040054467,0.000597933,0.0002513863,0.0005335841,0.00006840787,0.00020733685,0.00023816015,0.0012727923],"category_scores_gemma":[0.00006754631,0.00034050478,0.00012792574,0.00046996947,0.0009844579,0.00027870256,0.00009633307,0.00071733166,0.000042562635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021628378,0.0030125375,0.7566013,0.0014342024,0.0038068919,0.0019740213,0.023916483,0.0021090982,0.123909116,0.00017285,0.00911172,0.052323442],"study_design_scores_gemma":[0.17362194,0.015567689,0.42042154,0.0042800554,0.0010891219,0.0006709391,0.0027248752,0.012042925,0.23146294,0.0013481199,0.13345191,0.0033179228],"about_ca_topic_score_codex":0.01839856,"about_ca_topic_score_gemma":0.0062007005,"teacher_disagreement_score":0.3361797,"about_ca_system_score_codex":0.0019931325,"about_ca_system_score_gemma":0.0018358729,"threshold_uncertainty_score":0.9999047},"labels":[],"label_agreement":null},{"id":"W2129099526","doi":"10.1158/0008-5472.can-07-5237","title":"<i>ASAP1</i>, a Gene at 8q24, Is Associated with Prostate Cancer Metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"Canadian Prostate Cancer Research Initiative; Michael Smith Health Research BC; Canadian Institutes of Health Research; Cancer Research Society; National Cancer Institute; Prostate Cancer Foundation","keywords":"Prostate cancer; Metastasis; Prostate; Cancer research; Cancer; Biology; Pathology; PCA3; Medicine; Internal medicine","score_opus":0.1407281959343804,"score_gpt":0.4234833091770286,"score_spread":0.2827551132426482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129099526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681618,0.018212743,0.0000022362915,0.008421653,0.0000974246,0.0017411362,0.0005779711,0.00011421535,0.0026707763],"genre_scores_gemma":[0.85231185,0.02876259,0.000086565604,0.00066247856,0.00025581146,0.0021951853,0.00017063065,0.00012213924,0.11543273],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99480414,0.00024419202,0.00031418688,0.00084164145,0.002240762,0.0015550677],"domain_scores_gemma":[0.996994,0.00017072096,0.000088074645,0.0006345931,0.0014479468,0.00066461635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007538017,0.00033016477,0.00060991815,0.0004215783,0.00088076567,0.000046553458,0.00027616965,0.00015619372,0.0033651618],"category_scores_gemma":[0.00011143287,0.00022551735,0.00014551038,0.0018745888,0.00096333434,0.00017002547,0.00025086384,0.00086251495,0.00019689855],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019394683,0.0013745415,0.40736964,0.00057312136,0.004677975,0.00675521,0.0096651465,0.000057313595,0.17939639,0.000023034505,0.354896,0.015816947],"study_design_scores_gemma":[0.017790796,0.002502985,0.07997658,0.001094988,0.0003717369,0.00032173708,0.00037582224,0.00010947695,0.76281494,0.00007141747,0.13374619,0.0008233495],"about_ca_topic_score_codex":0.0024555158,"about_ca_topic_score_gemma":0.0007543238,"teacher_disagreement_score":0.58341855,"about_ca_system_score_codex":0.0026821592,"about_ca_system_score_gemma":0.0025586113,"threshold_uncertainty_score":0.9975459},"labels":[],"label_agreement":null},{"id":"W2129115386","doi":"10.1158/0008-5472.can-04-3272","title":"Effect of Conditional Knockout of the Type II <i>TGF-β</i> Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); McGill University","funders":"National Cancer Institute; Vanderbilt-Ingram Cancer Center; Vanderbilt University","keywords":"Carcinogenesis; Biology; Mammary tumor; Mammary gland; Cancer research; Transforming growth factor; Conditional gene knockout; Metastasis; Mouse mammary tumor virus; Internal medicine; Cancer; Endocrinology; Pathology; Breast cancer; Immunology; Medicine; Phenotype; Gene; Virus","score_opus":0.03813312648499063,"score_gpt":0.3346635005458449,"score_spread":0.2965303740608543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129115386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553907,0.0039099003,0.0000144930755,0.00011500853,0.000029224831,0.00027938662,0.000063235624,0.0000025552372,0.0000471066],"genre_scores_gemma":[0.9991507,0.00027559095,0.00028570025,0.00005129343,0.00004717592,0.000054641587,0.000060828832,0.000009516641,0.000064546126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989955,0.000212137,0.00019096803,0.00018903635,0.00024262801,0.00016977197],"domain_scores_gemma":[0.999541,0.000052577838,0.000065656284,0.00018655918,0.00010005932,0.000054182125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052422285,0.00009168786,0.00013071069,0.000084855164,0.00009231115,0.000010455541,0.0001621928,0.000057483085,0.000014935792],"category_scores_gemma":[0.00009713614,0.00006894957,0.000023548291,0.00013864647,0.00009307624,0.00001148918,0.00021386846,0.000099640245,0.0000012387102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004643604,0.000052301963,0.0055825566,0.00015387432,0.000044844957,0.000001093437,0.00015172457,0.00001831108,0.972027,0.000014908467,0.0003274383,0.021161575],"study_design_scores_gemma":[0.00064178766,0.00031325768,0.023094932,0.00009291273,0.0000051005845,0.00000320095,0.000010309658,0.000014931724,0.97238976,0.000010143521,0.003353666,0.000069988586],"about_ca_topic_score_codex":0.000035039244,"about_ca_topic_score_gemma":0.000040047566,"teacher_disagreement_score":0.021091586,"about_ca_system_score_codex":0.000040094525,"about_ca_system_score_gemma":0.0002494823,"threshold_uncertainty_score":0.2811682},"labels":[],"label_agreement":null},{"id":"W2129207518","doi":"10.1158/0008-5472.can-07-2113","title":"Potential Use of Quantitative Tissue Phenotype to Predict Malignant Risk for Oral Premalignant Lesions","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Dental and Craniofacial Research","keywords":"Dysplasia; Carcinoma in situ; Medicine; Hyperplasia; Epithelial dysplasia; Cancer; Pathology; OPLS; Internal medicine; Carcinoma; Loss of heterozygosity; Phenotype; Relative risk; Oncology; Gastroenterology; Biology; Confidence interval; Genetics; Chemistry","score_opus":0.21916378320794935,"score_gpt":0.4484027967488118,"score_spread":0.22923901354086243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129207518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906253,0.00092927035,0.0041653,0.00058078126,0.00039918823,0.0025932293,0.00055661093,0.00003303724,0.00011727308],"genre_scores_gemma":[0.9810206,0.00083102664,0.014546326,0.000068114816,0.0001899781,0.0006953273,0.000019966117,0.00005668915,0.0025719306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973081,0.00020832494,0.00036846264,0.00049867603,0.00096848677,0.00064795744],"domain_scores_gemma":[0.9973016,0.00043191007,0.00008504762,0.00048293182,0.0013488965,0.00034962725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006428442,0.0001694791,0.00042182943,0.0003036967,0.00025464303,0.000015350284,0.00021935119,0.00012399227,0.00041550625],"category_scores_gemma":[0.0014267478,0.00013704094,0.00010640978,0.0006246619,0.00039549457,0.000073832285,0.00016695933,0.00033134586,0.00003762465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008151212,0.0004036556,0.022657784,0.00044415426,0.00030433788,0.000102760576,0.0031616709,0.0021139092,0.8904423,0.00035179712,0.05955638,0.01231002],"study_design_scores_gemma":[0.0033195687,0.01070912,0.12451237,0.0007445657,0.00021642934,0.000045557597,0.0005043286,0.0012129501,0.8071871,0.00038287783,0.050747626,0.0004174996],"about_ca_topic_score_codex":0.0026610717,"about_ca_topic_score_gemma":0.00035727397,"teacher_disagreement_score":0.101854585,"about_ca_system_score_codex":0.00030212261,"about_ca_system_score_gemma":0.0010984937,"threshold_uncertainty_score":0.55883676},"labels":[],"label_agreement":null},{"id":"W2129356845","doi":"10.1158/0008-5472.can-06-3948","title":"Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":417,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Cancer; Biodistribution; Cancer research; In vivo; Cancer cell; Bioconjugation; Chemistry; Pathology; Rous sarcoma virus; In vitro; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.051121064041238756,"score_gpt":0.403344496111974,"score_spread":0.35222343207073525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129356845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95036024,0.005376474,0.039304778,0.00011058854,0.0008065554,0.002676077,0.00032584814,0.00019335201,0.00084608566],"genre_scores_gemma":[0.9967723,0.0009261343,0.00030013852,0.00005850215,0.00044925945,0.0011080789,0.000020081912,0.00010184989,0.00026367183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814737,0.000024571487,0.0003933057,0.00025237942,0.00046094824,0.00072141615],"domain_scores_gemma":[0.99867344,0.0002671896,0.000050244857,0.00024246314,0.0006221523,0.0001445314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011788234,0.00018130409,0.0002723184,0.00030964013,0.00012713336,0.000037576778,0.000272953,0.000101681755,0.00024345904],"category_scores_gemma":[0.00011347204,0.00017126962,0.000075992786,0.0007629904,0.0001781558,0.00017971925,0.00004241124,0.00025260047,0.0000098101245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040515538,0.000037711696,0.00092124933,0.0007696501,0.0001928946,0.000006286292,0.0017459374,0.0036154175,0.96114826,0.0028538224,0.0021777258,0.026125884],"study_design_scores_gemma":[0.00096630806,0.00016203572,0.00033872758,0.00020566194,0.000015409165,7.876651e-7,0.00023870432,0.0044098767,0.97323775,0.0008207404,0.019383704,0.0002202796],"about_ca_topic_score_codex":0.00050461455,"about_ca_topic_score_gemma":0.0012792422,"teacher_disagreement_score":0.046412043,"about_ca_system_score_codex":0.00072727917,"about_ca_system_score_gemma":0.00022817221,"threshold_uncertainty_score":0.69841725},"labels":[],"label_agreement":null},{"id":"W2129442897","doi":"10.1158/0008-5472.can-13-0359","title":"Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; LNCaP; Prostate cancer; Androgen receptor; Cancer research; MAPK/ERK pathway; Gene knockdown; Protein kinase B; Medicine; Gene silencing; Cancer; Signal transduction; Apoptosis; Internal medicine; Biology; Cell biology","score_opus":0.0636125630649237,"score_gpt":0.394329954245643,"score_spread":0.3307173911807193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129442897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585105,0.008478007,0.0000074523487,0.0024493358,0.00006485406,0.002401372,0.00061775744,0.00005261976,0.00007758157],"genre_scores_gemma":[0.99649423,0.00083401595,0.000404353,0.0000705015,0.00010598956,0.0017177108,0.000032600954,0.000054944157,0.0002856661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649745,0.0009017353,0.00040022703,0.00078599824,0.0005853516,0.00082925864],"domain_scores_gemma":[0.9979285,0.00044477434,0.00011330985,0.00029433076,0.0006577621,0.0005612954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016161966,0.00024217828,0.00038091064,0.00015001024,0.00034568313,0.00011266461,0.000105854495,0.00014959344,0.000607806],"category_scores_gemma":[0.0005367295,0.0002058695,0.0000339582,0.00030292178,0.00083217345,0.00022747468,0.00046910945,0.00062456954,0.000010734984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012755164,0.000119539036,0.061764218,0.00076631893,0.000052033873,0.00009226435,0.0023623824,0.000004199404,0.90737844,0.000004701635,0.0019010846,0.0127996765],"study_design_scores_gemma":[0.009495204,0.0039806734,0.15353246,0.00539828,0.00012591053,0.00012084441,0.01763776,0.0027611896,0.80256695,0.00019639406,0.0030729137,0.0011113988],"about_ca_topic_score_codex":0.0017447021,"about_ca_topic_score_gemma":0.00027798538,"teacher_disagreement_score":0.104811445,"about_ca_system_score_codex":0.00047558866,"about_ca_system_score_gemma":0.00049821776,"threshold_uncertainty_score":0.83951145},"labels":[],"label_agreement":null},{"id":"W2129480424","doi":"10.1158/0008-5472.can-10-2711","title":"Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets<i>Cyr61</i>and<i>CTGF</i>","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":414,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"CTGF; CYR61; Hippo signaling pathway; Cancer research; Gene knockdown; Breast cancer; Biology; Oncogene; Transcription factor; Signal transduction; Cancer; Cell biology; Cell cycle; Gene; Genetics; Growth factor; Receptor","score_opus":0.039289336534808504,"score_gpt":0.2891670504287984,"score_spread":0.2498777138939899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129480424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95803905,0.03679502,0.000016114594,0.0020237518,0.00012049762,0.0004145054,0.0019659637,0.0000123799255,0.00061271485],"genre_scores_gemma":[0.9877417,0.009665262,0.000034964312,0.0005456752,0.00016520973,0.000368698,0.00008393796,0.000033970704,0.0013605844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781466,0.0002824516,0.00026421982,0.0006075057,0.00043090605,0.00060025416],"domain_scores_gemma":[0.99916697,0.000050132003,0.000058075428,0.00028681036,0.00021870555,0.0002193293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007410918,0.00021879452,0.00020877545,0.00007642345,0.00023983956,0.00003991833,0.00032418835,0.00019409093,0.00031212688],"category_scores_gemma":[0.000019245688,0.00016895648,0.00005388116,0.00022093246,0.00035891295,0.0000111986665,0.00010365293,0.00043292134,0.000012629082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038364582,0.00008287481,0.0010938194,0.00006595794,0.000045225523,0.000009168245,0.00094294763,0.0000023273744,0.9912469,0.00007637446,0.0049695047,0.0010812624],"study_design_scores_gemma":[0.0011297099,0.00009433578,0.00302937,0.00012170175,0.000011141675,0.000008583349,0.00019066376,0.00003888154,0.90641975,0.00011570802,0.088545755,0.00029439514],"about_ca_topic_score_codex":0.0013892468,"about_ca_topic_score_gemma":0.0011359245,"teacher_disagreement_score":0.08482714,"about_ca_system_score_codex":0.000063197105,"about_ca_system_score_gemma":0.00029216794,"threshold_uncertainty_score":0.6889845},"labels":[],"label_agreement":null},{"id":"W2129842013","doi":"10.1158/0008-5472.can-11-2967","title":"PGC-1α Promotes the Growth of ErbB2/Neu–Induced Mammary Tumors by Regulating Nutrient Supply","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Cancer Research UK","keywords":"Coactivator; Downregulation and upregulation; Biology; Endocrinology; Regulator; Mitochondrion; Cancer cell; Receptor; Glycolysis; Peroxisome proliferator-activated receptor; Cancer research; Internal medicine; Cell biology; Cancer; Metabolism; Transcription factor; Biochemistry; Medicine","score_opus":0.07534840771767871,"score_gpt":0.3894688967571994,"score_spread":0.3141204890395207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129842013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778412,0.01356315,0.000020547153,0.0051891576,0.00016382735,0.0008923696,0.000016275637,0.000029394112,0.0022840842],"genre_scores_gemma":[0.9939558,0.00040671538,0.00013676641,0.00013916043,0.00072450744,0.00018677165,0.00001528991,0.000035592933,0.004399399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976634,0.0002155111,0.00027653773,0.00023500744,0.00086461025,0.0007449713],"domain_scores_gemma":[0.9985673,0.00019672766,0.0000765181,0.00050513167,0.0003713478,0.00028300387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014588645,0.00013307118,0.00030150914,0.00013123274,0.00017295443,0.000017708158,0.0002813357,0.000086056054,0.00025001398],"category_scores_gemma":[0.00038722335,0.00008681973,0.00007316546,0.0005826949,0.00020549553,0.00016478116,0.00017348606,0.0005619129,0.000030293635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020201078,0.00029761143,0.018309034,0.00038342053,0.0001132708,0.000013557043,0.003817414,1.2433743e-7,0.91876125,0.00797864,0.034589488,0.015534176],"study_design_scores_gemma":[0.0011018128,0.0002461026,0.038986675,0.00033399987,0.00005613215,0.000035080713,0.0004767112,0.00001610731,0.9328573,0.0006303835,0.025117863,0.0001418725],"about_ca_topic_score_codex":0.0008827934,"about_ca_topic_score_gemma":0.000006777608,"teacher_disagreement_score":0.020677641,"about_ca_system_score_codex":0.00010316775,"about_ca_system_score_gemma":0.00031326388,"threshold_uncertainty_score":0.3540406},"labels":[],"label_agreement":null},{"id":"W2129884859","doi":"10.1158/0008-5472.can-04-4109","title":"Dietary Genistein Reduces Metastasis in a Postsurgical Orthotopic Breast Cancer Model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Genistein; Breast cancer; Metastasis; Adjuvant; Primary tumor; Cancer; Oncology; Adjuvant therapy; In vivo; Metastatic breast cancer; Internal medicine; Mammary gland; Mammary tumor; Cancer research; Pathology; Biology; Biotechnology","score_opus":0.1310869041713019,"score_gpt":0.47315430778745043,"score_spread":0.3420674036161485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129884859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734004,0.0074632135,0.000003030198,0.015885534,0.000053409032,0.00080507755,0.00012424402,0.000033669523,0.0022313902],"genre_scores_gemma":[0.99109226,0.0033504537,0.00021120209,0.00023395615,0.00066460326,0.00071772037,0.000013917256,0.000043324115,0.0036725379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965447,0.00028170072,0.00030454237,0.0005675501,0.0012247767,0.0010766839],"domain_scores_gemma":[0.9986251,0.00011904011,0.000028889597,0.000411527,0.0003478893,0.0004675457],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012239795,0.0001900564,0.00043269075,0.0004668415,0.0001657672,0.000048950216,0.00028126748,0.00013884727,0.0012726701],"category_scores_gemma":[0.000055143253,0.00014005997,0.00014486458,0.0009180127,0.00033611152,0.00015380573,0.00019006952,0.001151147,0.0000686601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027518054,0.0011008934,0.025341585,0.00050061557,0.0003272759,0.00073096354,0.00069827936,0.0031209071,0.581139,0.00019616124,0.006589207,0.3775033],"study_design_scores_gemma":[0.018155547,0.0019192739,0.31181034,0.0034437547,0.0003274468,0.0008919503,0.0009971693,0.12714908,0.48016804,0.0007503641,0.05242525,0.0019617677],"about_ca_topic_score_codex":0.002151044,"about_ca_topic_score_gemma":0.0010331149,"teacher_disagreement_score":0.37554154,"about_ca_system_score_codex":0.00071878865,"about_ca_system_score_gemma":0.0013917478,"threshold_uncertainty_score":0.9996403},"labels":[],"label_agreement":null},{"id":"W2129961545","doi":"10.1158/0008-5472.can-05-4230","title":"Transgenic Mice Expressing the p75 CCAAT-Displacement Protein/Cut Homeobox Isoform Develop a Myeloproliferative Disease–Like Myeloid Leukemia","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Université de Montréal; Immunovaccine (Canada); McGill University","funders":"Canadian Breast Cancer Research Alliance; Genome Canada; U.S. Department of Defense","keywords":"Biology; Genetically modified mouse; Myeloid; Haematopoiesis; Transgene; Myeloproliferative neoplasm; Cancer research; Bone marrow; Leukemia; Myeloproliferative Disorders; Molecular biology; Immunology; Pathology; Stem cell; Cell biology; Myelofibrosis; Medicine; Genetics; Gene","score_opus":0.03405168369609882,"score_gpt":0.34772411565660705,"score_spread":0.3136724319605082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129961545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721504,0.0067961193,0.0004318676,0.0020412721,0.000102514714,0.0020490033,0.0001025443,0.000031710613,0.0012299143],"genre_scores_gemma":[0.98352957,0.000737227,0.00013513495,0.00026426435,0.0010994836,0.002782203,0.00017475929,0.000099817546,0.011177538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954242,0.0006441748,0.00039829855,0.00090535666,0.0012676452,0.0013602856],"domain_scores_gemma":[0.99791056,0.00006284669,0.00008042477,0.00089403597,0.00074403285,0.00030809036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015947953,0.00035740514,0.00024604157,0.00017135346,0.00094300427,0.00022279886,0.0010281306,0.000187132,0.00025416273],"category_scores_gemma":[0.000094974115,0.0002721736,0.00014845275,0.0007573871,0.00066725176,0.00002110529,0.00034072998,0.0006983281,0.00006913993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049503827,0.00009278352,0.0002820916,0.000103956656,0.00011937685,0.00000943224,0.00027832057,0.00042151284,0.97748566,0.000072297466,0.010213654,0.005970534],"study_design_scores_gemma":[0.0014033224,0.00073417573,0.0009894808,0.0001254829,0.000014240827,0.000003283079,0.00026818848,0.00012372239,0.91037863,0.0002703144,0.08526919,0.0004199733],"about_ca_topic_score_codex":0.00047049273,"about_ca_topic_score_gemma":0.002205807,"teacher_disagreement_score":0.07505553,"about_ca_system_score_codex":0.00061473285,"about_ca_system_score_gemma":0.003569499,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W2130198367","doi":"10.1158/1538-7445.am2015-2515","title":"Abstract 2515: Tumor presenting cells: a new strategy for cancer immunotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axela (Canada)","funders":"","keywords":"Cytotoxic T cell; MHC class I; Antigen presentation; Immunotherapy; Cancer research; Cancer immunotherapy; MHC class II; Major histocompatibility complex; Immunology; T cell; Immune system; Antigen-presenting cell; Cytokine; Cancer; Biology; Medicine; Internal medicine; In vitro; Biochemistry","score_opus":0.15678600146051622,"score_gpt":0.42518744620251664,"score_spread":0.26840144474200045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130198367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8503734,0.14356259,0.00011685085,0.0012199351,0.0018530721,0.0013886896,0.000111738045,0.0001939089,0.001179804],"genre_scores_gemma":[0.93755335,0.0047527617,0.000089153786,0.00027023398,0.00048312955,0.0010978661,0.00003870406,0.00016001682,0.055554792],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973186,0.0003773326,0.00042404883,0.0005020863,0.00017569013,0.0012022064],"domain_scores_gemma":[0.99818796,0.0005114242,0.00013392569,0.0005262053,0.0005496759,0.0000908156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015741141,0.00026760422,0.00039173564,0.0002668859,0.00037355107,0.00012050043,0.00071723433,0.00023736189,0.0018952049],"category_scores_gemma":[0.00015576486,0.00023412847,0.00017061712,0.0003808341,0.00037105966,0.00024668203,0.00010108512,0.00077239407,0.00025842673],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033211687,0.00010794334,0.00017638573,0.000046152105,0.00032347284,0.000005702532,0.0012894708,0.000103741964,0.85456425,0.0001559797,0.0888878,0.05101793],"study_design_scores_gemma":[0.0028589745,0.0002363827,0.0008148169,0.00007439183,0.000008492229,0.0000075459498,0.000718401,0.0000046608848,0.47981077,0.00039976524,0.51485527,0.00021052636],"about_ca_topic_score_codex":0.008801023,"about_ca_topic_score_gemma":0.00025453992,"teacher_disagreement_score":0.42596745,"about_ca_system_score_codex":0.0003009744,"about_ca_system_score_gemma":0.002460192,"threshold_uncertainty_score":0.9990172},"labels":[],"label_agreement":null},{"id":"W2130552536","doi":"10.1158/0008-5472.can-09-2503","title":"Preclinical Evaluation of Radiation and Perifosine in a Genetically and Histologically Accurate Model of Brainstem Glioma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"National Cancer Institute","keywords":"Brainstem; Glioma; Medicine; Pathology; Nuclear medicine; Cancer research; Internal medicine","score_opus":0.2386984628107603,"score_gpt":0.4938904615033807,"score_spread":0.2551919986926204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130552536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560606,0.0022333823,0.000008217113,0.0013009333,0.000019990714,0.00058439875,0.0000090778485,0.000002964366,0.00023499897],"genre_scores_gemma":[0.99884456,0.00059298286,0.00035837258,0.000015351323,0.000021375685,0.0001483293,0.0000040189925,0.000005766278,0.000009235614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881274,0.00012657429,0.00024980571,0.00019885472,0.0004777915,0.00013425201],"domain_scores_gemma":[0.9990793,0.00020819821,0.00004967894,0.00015032256,0.0004225527,0.000089987334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015310006,0.000055625675,0.00020081655,0.00016414488,0.000021169679,0.0000064447245,0.00003852337,0.00009301155,0.000060829287],"category_scores_gemma":[0.00078564,0.000042150987,0.000019974168,0.00017237694,0.00024051088,0.00003115191,0.000041423067,0.00018043318,4.3526458e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050473365,0.00045201185,0.13219321,0.0001396223,0.0000367824,0.000008873604,0.00042475175,0.00023128996,0.70929646,0.0009964801,0.00007890889,0.15563688],"study_design_scores_gemma":[0.0056606964,0.0006643553,0.7421709,0.0001241775,0.00007628252,0.00001327908,0.000044395656,0.17276658,0.07751483,0.00085479184,0.000045680026,0.00006405816],"about_ca_topic_score_codex":0.00010672974,"about_ca_topic_score_gemma":0.00019954953,"teacher_disagreement_score":0.63178164,"about_ca_system_score_codex":0.00006006735,"about_ca_system_score_gemma":0.00031309322,"threshold_uncertainty_score":0.17188673},"labels":[],"label_agreement":null},{"id":"W2130573961","doi":"10.1158/1538-7445.am2014-4486","title":"Abstract 4486: Stromal depletion by a docetaxel nanoparticle for enhanced therapy of breast and pancreatic cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Docetaxel; Stromal cell; Stroma; Pancreatic cancer; Medicine; Cancer research; Paclitaxel; Tumor microenvironment; Breast cancer; Drug delivery; Pathology; Cancer; Chemistry; Internal medicine; Immunohistochemistry","score_opus":0.060366058058998785,"score_gpt":0.39957709144603865,"score_spread":0.33921103338703984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130573961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902149,0.0070262467,0.00021760259,0.0011650291,0.00007262981,0.00077297766,0.00019871238,0.000016504317,0.00031539265],"genre_scores_gemma":[0.9928798,0.005423095,0.00015507522,0.000109479864,0.00022916966,0.0006658715,0.000014335384,0.000030843003,0.00049233146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985251,0.00005808104,0.00023276976,0.00032007307,0.00042157152,0.00044241032],"domain_scores_gemma":[0.9989548,0.00016843357,0.00007156616,0.00024621925,0.0003612121,0.00019777521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067432394,0.00012111076,0.00033483424,0.000087981345,0.00010055414,0.00002460676,0.000085090884,0.00006094176,0.00054792245],"category_scores_gemma":[0.00005974987,0.000097865806,0.00006946811,0.0002237318,0.0001944698,0.00007029853,0.00002609303,0.0001685126,0.0000030860099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012969328,0.00010635914,0.002677319,0.00028416503,0.00007768312,4.7732016e-7,0.00016934543,0.0000040083137,0.876754,0.000050157938,0.003057984,0.1155216],"study_design_scores_gemma":[0.004420225,0.0006027927,0.028908527,0.00027345982,0.000045246594,0.000005320212,0.0001355304,0.00007509288,0.9473709,0.000106210355,0.01792967,0.00012701923],"about_ca_topic_score_codex":0.0029266966,"about_ca_topic_score_gemma":0.00032107395,"teacher_disagreement_score":0.115394585,"about_ca_system_score_codex":0.00012279798,"about_ca_system_score_gemma":0.0002387507,"threshold_uncertainty_score":0.59993666},"labels":[],"label_agreement":null},{"id":"W2131310342","doi":"10.1158/0008-5472.can-04-4480","title":"Reduced Expression of Hypoxia-Inducible Factor-1α in Perinecrotic Regions of Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hypoxia (environmental); Tumor hypoxia; Cancer research; Biology; Hypoxia-inducible factors; Transcription factor; Gene expression; G alpha subunit; HIF1A; Pathology; Internal medicine; Medicine; Chemistry; Gene; Radiation therapy; Protein subunit; Angiogenesis; Oxygen; Biochemistry","score_opus":0.066375667660505,"score_gpt":0.3874455807646014,"score_spread":0.3210699131040964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131310342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929861,0.0055429647,0.000030020317,0.00022543727,0.00019274447,0.00028815004,0.000060506234,0.000004645369,0.0006694279],"genre_scores_gemma":[0.9947219,0.0025584025,0.00015977523,0.0000222229,0.0007472573,0.000101420155,0.000014213602,0.000025246258,0.0016495776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984321,0.00012573983,0.0003213511,0.0003653311,0.00034292633,0.00041254173],"domain_scores_gemma":[0.99899054,0.000023048638,0.000087652494,0.00052468764,0.0002591118,0.000114968345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036048208,0.000119154865,0.0002682868,0.00020299427,0.000050868162,0.000006624031,0.0003154507,0.0001333753,0.00013217611],"category_scores_gemma":[0.00017337163,0.00011215244,0.00008905596,0.000323426,0.00021408616,0.000008366147,0.00017591899,0.00023638387,0.0000036300348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014829096,0.00008892039,0.00027005613,0.000065852284,0.000010793061,6.4517286e-7,0.00027436897,0.00018612017,0.9911053,0.000036184145,0.0035858904,0.0042275866],"study_design_scores_gemma":[0.0006090702,0.00011238814,0.0045162425,0.00012026351,0.000003349276,0.0000026413325,0.00018870858,0.00001037147,0.95206404,0.00003626591,0.04222931,0.00010734466],"about_ca_topic_score_codex":0.00042414016,"about_ca_topic_score_gemma":0.00029689813,"teacher_disagreement_score":0.039041247,"about_ca_system_score_codex":0.000055428038,"about_ca_system_score_gemma":0.00052668364,"threshold_uncertainty_score":0.45734438},"labels":[],"label_agreement":null},{"id":"W2131395507","doi":"10.1158/0008-5472.can-03-2399","title":"<b><i>Helicobacter pylori</i></b>Induces Plasminogen Activator Inhibitor 2 in Gastric Epithelial Cells through Nuclear Factor-κB and RhoA","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Helicobacter pylori; Gastrin; Paracrine signalling; Plasminogen activator inhibitor-1; Plasminogen activator; Cancer research; Autocrine signalling; Biology; Interleukin 8; Internal medicine; Endocrinology; Medicine; Cytokine; Immunology; Receptor; Secretion","score_opus":0.05997769623088915,"score_gpt":0.3437803518842757,"score_spread":0.2838026556533865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131395507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916818,0.0005380646,0.0000063329776,0.005853535,0.0004652906,0.0008197336,0.00012321568,0.00008469072,0.00042733396],"genre_scores_gemma":[0.9957291,0.0020681708,0.00027489135,0.00072416896,0.0007247206,0.00014682571,0.000008622614,0.00009292411,0.00023058396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964323,0.00020159347,0.0004713189,0.00081763964,0.00077660667,0.0013005551],"domain_scores_gemma":[0.99861854,0.0001677615,0.00008655289,0.00044117443,0.00032592984,0.00036006534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004066257,0.00036269342,0.00060418283,0.00046561324,0.00025571755,0.000071095834,0.00026003455,0.0003232626,0.00021883727],"category_scores_gemma":[0.00019659616,0.0003143596,0.000086256165,0.0008501354,0.0006662414,0.00037336376,0.0003681695,0.0016517728,0.00021129475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015685785,0.00036429527,0.041499406,0.00016629157,0.00032985845,0.0002979275,0.006053722,0.000011595632,0.9449068,0.000053634933,0.0016146328,0.0031332702],"study_design_scores_gemma":[0.015220427,0.00282056,0.25314268,0.0009344517,0.00010934711,0.00016572622,0.0023600832,0.0000051742236,0.6831423,0.00030792336,0.04112624,0.00066511123],"about_ca_topic_score_codex":0.0013812592,"about_ca_topic_score_gemma":0.00024472023,"teacher_disagreement_score":0.2617645,"about_ca_system_score_codex":0.0008870604,"about_ca_system_score_gemma":0.00047051255,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W2131456094","doi":"10.1158/0008-5472.can-08-3667","title":"Characterization of <i>ERG</i> , <i>AR</i> and <i>PTEN</i> Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":532,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"TMPRSS2; Prostate cancer; Erg; Abiraterone acetate; Cancer research; PTEN; LNCaP; Androgen receptor; Docetaxel; Prostate; Androgen deprivation therapy; Medicine; Cancer; Biology; Oncology; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.02910325348655226,"score_gpt":0.3281111560618453,"score_spread":0.2990079025752931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131456094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950446,0.0016597703,0.0000037480931,0.00060162763,0.000052937998,0.001555829,0.00087119004,0.000018653394,0.00019162605],"genre_scores_gemma":[0.9965342,0.0021425593,0.0001089723,0.00015809816,0.00009680259,0.00023797221,0.0004506567,0.000032664193,0.00023806193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973675,0.00011922169,0.0003744507,0.00049638416,0.00094105455,0.00070140464],"domain_scores_gemma":[0.99861383,0.00007047787,0.00012463308,0.00027317356,0.0006556634,0.00026219274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028288708,0.00019412197,0.00037504584,0.00026092888,0.00012737198,0.000055683475,0.00009062673,0.000064325424,0.00009888022],"category_scores_gemma":[0.00002532772,0.0001488188,0.000030670504,0.0007597456,0.00020846467,0.0002206582,0.00004234458,0.0003817241,0.0000024016108],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025266793,0.00022942816,0.17804554,0.00013076008,0.000044304354,0.000068229325,0.0009558019,0.000021898684,0.80949146,0.00000791452,0.000058511443,0.008419459],"study_design_scores_gemma":[0.005841815,0.000688378,0.5497575,0.0006790209,0.00003170984,0.000001056944,0.00014135549,0.000082413666,0.44195658,0.00004330831,0.0006087952,0.0001680793],"about_ca_topic_score_codex":0.003666734,"about_ca_topic_score_gemma":0.00069893274,"teacher_disagreement_score":0.37171194,"about_ca_system_score_codex":0.00046604415,"about_ca_system_score_gemma":0.0009216341,"threshold_uncertainty_score":0.60686547},"labels":[],"label_agreement":null},{"id":"W2131530904","doi":"10.1158/0008-5472.can-05-2103","title":"A Novel RING-Type Ubiquitin Ligase <i>Breast Cancer-Associated Gene 2</i> Correlates with Outcome in Invasive Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Canadian Institutes of Health Research","funders":"","keywords":"Ubiquitin ligase; Breast cancer; Cancer research; DNA ligase; Cancer; Ubiquitin; Estrogen receptor; RING finger domain; Biology; Chemistry; Molecular biology; Gene; Genetics; Transcription factor; Zinc finger","score_opus":0.04781845951193837,"score_gpt":0.34517379583891866,"score_spread":0.2973553363269803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131530904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990803,0.0036231377,0.0000103038365,0.0027994188,0.00015495069,0.00066696847,0.0014103914,0.000030736537,0.0005010696],"genre_scores_gemma":[0.9929739,0.0027352527,0.00008403906,0.0007188839,0.00076700066,0.0008115111,0.00011192712,0.00008449774,0.0017129388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970817,0.00016680703,0.00037638014,0.00075973064,0.0005478858,0.0010675229],"domain_scores_gemma":[0.9983322,0.000059441227,0.0001347766,0.00044191763,0.00073429506,0.000297343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007087017,0.00031914585,0.00035252768,0.0001813099,0.00021390754,0.0000768243,0.00049876305,0.00030080636,0.0004974467],"category_scores_gemma":[0.000105025225,0.00028150185,0.0000786686,0.0007552805,0.00027299873,0.000020724037,0.00029680599,0.0007076238,0.000035444933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009986596,0.0002689714,0.1837345,0.000079744124,0.00013609382,0.000028450553,0.00023995934,0.0010340549,0.807415,0.000025814097,0.0016829594,0.0043557608],"study_design_scores_gemma":[0.0040187053,0.00037304356,0.06693765,0.00059099053,0.00003726899,0.00012985809,0.00020007539,0.00016926687,0.922431,0.000018187633,0.0043771546,0.000716827],"about_ca_topic_score_codex":0.007535478,"about_ca_topic_score_gemma":0.035703648,"teacher_disagreement_score":0.11679685,"about_ca_system_score_codex":0.00053815625,"about_ca_system_score_gemma":0.0014831936,"threshold_uncertainty_score":0.9999637},"labels":[],"label_agreement":null},{"id":"W2131611002","doi":"10.1158/0008-5472.can-07-5817","title":"Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Cancer research; Transcription factor; Biology; Repressor; Lymphoma; Psychological repression; Diffuse large B-cell lymphoma; Suppressor; Gene; B cell; Gene expression; Immunology; Genetics; Germinal center","score_opus":0.135465683375778,"score_gpt":0.40252433179571423,"score_spread":0.2670586484199362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131611002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934849,0.0030936198,0.0001348549,0.00087022624,0.00021393501,0.0009980152,0.0002091714,0.000051061663,0.0009441967],"genre_scores_gemma":[0.9929852,0.0018009386,0.0002210986,0.00014218717,0.0004966694,0.0008424293,0.00009888984,0.000035266316,0.0033773028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982603,0.00006504009,0.00018882252,0.00033787615,0.0005243872,0.0006235306],"domain_scores_gemma":[0.9991584,0.00010470108,0.000028233868,0.00020871821,0.00027581205,0.00022412304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024049096,0.00012898627,0.00022435296,0.00013133792,0.00038443008,0.000022621347,0.00008660224,0.0000924157,0.00047581285],"category_scores_gemma":[0.000055701497,0.00010306758,0.00015898344,0.00019346333,0.00008761096,0.00008097102,0.000026472095,0.00012318535,0.00006433072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022627905,0.010878071,0.10631707,0.000905445,0.00034902836,0.0005523051,0.005150182,0.0000040357345,0.7784211,0.00082097814,0.08401868,0.010320292],"study_design_scores_gemma":[0.044037033,0.000952935,0.033698216,0.00015281141,0.00008839709,0.00003977156,0.00034224195,0.00023364322,0.67383826,0.00008626295,0.24624562,0.00028480357],"about_ca_topic_score_codex":0.00038516452,"about_ca_topic_score_gemma":0.000035347453,"teacher_disagreement_score":0.16222695,"about_ca_system_score_codex":0.00071841973,"about_ca_system_score_gemma":0.0004921047,"threshold_uncertainty_score":0.5209817},"labels":[],"label_agreement":null},{"id":"W2131690391","doi":"10.1158/0008-5472.can-15-0423","title":"WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; Ontario Institute for Cancer Research","funders":"Cancer Council NSW; Medical Research Council; Ministero dello Sviluppo Economico; University of New South Wales; Ontario Ministry of Economic Development and Innovation; Ontario Genomics Institute; Ontario Genomics; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"Neuroblastoma; Biology; Cancer research; Promoter; Histone; Molecular biology; Carcinogenesis; RNA interference; Mdm2; Gene expression; Regulation of gene expression; Gene; Cell culture; Genetics; RNA","score_opus":0.19753647558300041,"score_gpt":0.43740358643601873,"score_spread":0.23986711085301832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131690391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951381,0.00053909805,0.000017694434,0.0014606053,0.00011828763,0.0017972037,0.00006596988,0.00007121349,0.00079184514],"genre_scores_gemma":[0.9965607,0.00014052168,0.00032399295,0.00014620199,0.00026672124,0.0008234709,0.00013591957,0.00006172046,0.0015407332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955767,0.00052249694,0.00024834607,0.00070986117,0.0019379355,0.0010047056],"domain_scores_gemma":[0.99788094,0.000076721706,0.00003844516,0.00051431754,0.00041476698,0.0010748305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065012975,0.00023255541,0.00033753886,0.0005837337,0.00014956422,0.00006904799,0.00029621532,0.00012829347,0.0008571067],"category_scores_gemma":[0.00010182406,0.00018615952,0.00008764766,0.00067384774,0.00027932457,0.00033362783,0.00011557755,0.0010484784,0.00008443721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002979132,0.0009018908,0.016166374,0.00010777162,0.000032469943,0.0025670954,0.00073892326,0.000033481592,0.9687475,0.00004363191,0.0059911013,0.0016906271],"study_design_scores_gemma":[0.011365638,0.0050528804,0.2040082,0.00046863395,0.000024320247,0.00042981966,0.0006308011,0.000342542,0.76296216,0.0008879889,0.013418614,0.00040840285],"about_ca_topic_score_codex":0.00023486417,"about_ca_topic_score_gemma":0.0002637817,"teacher_disagreement_score":0.20578535,"about_ca_system_score_codex":0.00046199278,"about_ca_system_score_gemma":0.0012811257,"threshold_uncertainty_score":0.93847173},"labels":[],"label_agreement":null},{"id":"W2131738082","doi":"10.1158/0008-5472.can-10-1436","title":"A Randomized Trial of Dietary Intervention for Breast Cancer Prevention","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Calorie; Randomized controlled trial; Cancer; Randomization; Incidence (geometry); Internal medicine; Hazard ratio; Weight change; Physiology; Weight loss; Obesity; Confidence interval","score_opus":0.23107953490264474,"score_gpt":0.48679825467157434,"score_spread":0.25571871976892957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131738082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181486,0.005953752,0.0002577139,0.002617366,0.00053122826,0.005574565,0.00029544922,0.000021290221,0.0029337949],"genre_scores_gemma":[0.9901088,0.0029889995,0.00021634604,0.00002797036,0.0005772878,0.00392541,0.000022409831,0.000013433336,0.0021193307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989215,0.00012929841,0.00027027813,0.00015948057,0.00032015573,0.00019929426],"domain_scores_gemma":[0.9990538,0.00013538635,0.000065794724,0.00010783087,0.0005760296,0.000061196195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012167072,0.00006181554,0.00036009864,0.000096260876,0.00007023046,0.0000039579245,0.000058554968,0.00004476412,0.0011649722],"category_scores_gemma":[0.00013229069,0.000046440837,0.00031207784,0.00014503655,0.00018366461,0.000042945983,0.000042655563,0.000112522874,0.0000030568694],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97206014,0.0006707656,0.0001852571,0.00048510596,0.00028126608,0.0000011909991,0.0001269637,1.4910468e-7,0.00086848554,0.0005121803,0.0053605502,0.019447967],"study_design_scores_gemma":[0.9848184,0.0011633872,0.004238043,0.00072077423,0.00014280956,0.0000021993328,0.00017476217,0.000022696719,0.0018783825,0.0056508644,0.001129336,0.000058344427],"about_ca_topic_score_codex":0.0020557658,"about_ca_topic_score_gemma":0.00017234996,"teacher_disagreement_score":0.019389624,"about_ca_system_score_codex":0.00009990898,"about_ca_system_score_gemma":0.000107966705,"threshold_uncertainty_score":0.9997481},"labels":[],"label_agreement":null},{"id":"W2132051411","doi":"10.1158/0008-5472.can-06-3552","title":"The Androgen Receptor Negatively Regulates the Expression of c-Met: Implications for a Novel Mechanism of Prostate Cancer Progression","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Androgen receptor; Cancer research; Transcription factor; Biology; Androgen; Cancer; Angiogenesis; Sp1 transcription factor; Internal medicine; Endocrinology; Gene expression; Medicine; Promoter; Gene; Hormone; Genetics","score_opus":0.10025272154611951,"score_gpt":0.45553688022424876,"score_spread":0.35528415867812924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132051411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047244,0.0026760297,0.00023406846,0.004311442,0.00010294731,0.0019061542,0.00016539854,0.000010076981,0.00012147447],"genre_scores_gemma":[0.9964898,0.0008665667,0.00070076337,0.000048377326,0.00013627988,0.0010435035,0.000014992645,0.000015730282,0.0006839509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890804,0.00010924219,0.00024007192,0.00020474695,0.00020655166,0.00033133724],"domain_scores_gemma":[0.9978846,0.00079809705,0.00014396178,0.00033571897,0.0007781922,0.000059447873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015585241,0.00007724639,0.00017954982,0.00006766282,0.00036185153,0.0000043545756,0.00021704564,0.00009640759,0.00003462492],"category_scores_gemma":[0.00019177349,0.000037569396,0.000060736915,0.0003066085,0.0006382916,0.000034743185,0.00009677204,0.00023511426,0.0000011043805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015789098,0.000075557604,0.0029164641,0.00010079424,0.000042113294,2.006956e-7,0.0013827386,0.0000019467902,0.9723358,0.006415084,0.001103708,0.014046644],"study_design_scores_gemma":[0.0008376375,0.000484695,0.017846853,0.00024843382,0.000021368403,0.0000022829042,0.00044851366,0.000008147198,0.9710915,0.005168957,0.0037997568,0.00004182141],"about_ca_topic_score_codex":0.0000886168,"about_ca_topic_score_gemma":0.000038492388,"teacher_disagreement_score":0.014930389,"about_ca_system_score_codex":0.000057937013,"about_ca_system_score_gemma":0.00032879674,"threshold_uncertainty_score":0.2783106},"labels":[],"label_agreement":null},{"id":"W2132212967","doi":"10.1158/0008-5472.can-10-4610","title":"Targeting Hyaluronidase for Cancer Therapy: Antitumor Activity of Sulfated Hyaluronic Acid in Prostate Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"LNCaP; Protein kinase B; Cancer research; Tumor progression; DU145; Prostate cancer; PI3K/AKT/mTOR pathway; Hyaluronic acid; Angiogenesis; Metastasis; Cancer; Downregulation and upregulation; Biology; Chemistry; Signal transduction; Medicine; Internal medicine; Cell biology; Biochemistry","score_opus":0.08190990194604485,"score_gpt":0.3870912419041421,"score_spread":0.30518133995809726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132212967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851302,0.011827584,0.00007599908,0.0002512968,0.00016465966,0.0018433672,0.0005024447,0.0000112913995,0.00019318072],"genre_scores_gemma":[0.981382,0.013665957,0.00016421708,0.00003953174,0.0001939399,0.003112174,0.000036282996,0.000069475835,0.0013363886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969626,0.0003044101,0.00033574944,0.00074789,0.00048824993,0.0011610697],"domain_scores_gemma":[0.99847734,0.000037822516,0.00012144822,0.00048559994,0.00069613766,0.00018164876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001243113,0.00024943595,0.00034113182,0.00025005202,0.00017021423,0.0000311298,0.0005865997,0.00016711617,0.00033238294],"category_scores_gemma":[0.0001051458,0.0002230745,0.00011404339,0.0005856075,0.00039897088,0.000020708907,0.0002499461,0.0004714396,0.000003846713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026454418,0.0002192074,0.0072579365,0.00022311654,0.00008431416,0.000010902539,0.00029911957,0.00012698838,0.96137595,0.000015909656,0.0010876141,0.02665347],"study_design_scores_gemma":[0.0018704104,0.00074587413,0.0028084943,0.00010599008,0.000005867064,7.1609594e-7,0.000083691935,0.00029356938,0.9834003,0.000053924316,0.01037218,0.0002590157],"about_ca_topic_score_codex":0.01432362,"about_ca_topic_score_gemma":0.003259441,"teacher_disagreement_score":0.026394455,"about_ca_system_score_codex":0.0002069571,"about_ca_system_score_gemma":0.0016180413,"threshold_uncertainty_score":0.9922401},"labels":[],"label_agreement":null},{"id":"W2132445818","doi":"10.1158/0008-5472.can-08-0987","title":"The Role of Tumor Cell–Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"CTGF; Pancreatic cancer; Pancreatic tumor; Stromal cell; Growth factor; Cancer research; Pathology; Connective tissue; Biology; Tumor progression; Medicine; Cancer; Internal medicine","score_opus":0.026236088593357628,"score_gpt":0.34642297652815734,"score_spread":0.3201868879347997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132445818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834086,0.012253951,0.000023398872,0.0006474162,0.000059689162,0.001032307,0.00008156868,0.000014089755,0.002479013],"genre_scores_gemma":[0.99772084,0.0010694019,0.000028423927,0.000089868314,0.00020326609,0.00026240572,0.000016904924,0.000043948665,0.00056495256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99643826,0.0006871453,0.00037484147,0.00069765944,0.00076429656,0.0010377944],"domain_scores_gemma":[0.99765944,0.00039884358,0.0001071716,0.00061012217,0.0009974523,0.00022695046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008705519,0.0002608538,0.00035371436,0.0002499504,0.00026985194,0.00007347765,0.0008902002,0.000116521034,0.00019316601],"category_scores_gemma":[0.0013530859,0.00021134585,0.00009745559,0.0007329905,0.00048201423,0.000015888261,0.0002953469,0.0005979931,0.00003128012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056459085,0.00012234748,0.012745053,0.000050320807,0.000037738013,0.00002559135,0.00029525592,0.000002381401,0.9825727,0.0004643949,0.00066860137,0.0024510506],"study_design_scores_gemma":[0.00083587255,0.0009297694,0.04910874,0.00004932875,0.000005839476,0.0000059345207,0.0007002699,0.000017686718,0.94065696,0.0017715347,0.005692186,0.00022590635],"about_ca_topic_score_codex":0.0017299617,"about_ca_topic_score_gemma":0.00052924,"teacher_disagreement_score":0.041915745,"about_ca_system_score_codex":0.00023697075,"about_ca_system_score_gemma":0.0006266018,"threshold_uncertainty_score":0.86184335},"labels":[],"label_agreement":null},{"id":"W2132468839","doi":"10.1158/0008-5472.sabcs12-s1-5","title":"Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; HRAS; KRAS; Medicine; Internal medicine; Oncology; Exemestane; Hazard ratio; Mutation; Breast cancer; Tamoxifen; Cancer; Cancer research; Genetics; Gene; Biology; Colorectal cancer; Confidence interval","score_opus":0.11909862924820123,"score_gpt":0.469012708659068,"score_spread":0.3499140794108668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132468839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990308,0.002247305,0.00031739855,0.0035684917,0.00038577217,0.0020746137,0.00010787042,0.00011605818,0.0008745307],"genre_scores_gemma":[0.99173224,0.00005584472,0.002127659,0.0004151234,0.0012060202,0.0021983106,0.000058731068,0.000074273106,0.0021317902],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965765,0.00021875893,0.00039964396,0.00054264633,0.001248987,0.0010134461],"domain_scores_gemma":[0.99725115,0.00035435447,0.00011357714,0.00061551447,0.00102111,0.00064429524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009554866,0.00024024815,0.00042741257,0.00044032946,0.00034840556,0.000031184747,0.00028465217,0.00013119057,0.0024747564],"category_scores_gemma":[0.0005966826,0.00020599423,0.00007927822,0.00072043657,0.00024898496,0.00028774247,0.00020860917,0.0008282575,0.0005006551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003770897,0.004066219,0.21434584,0.00036180313,0.00027098693,0.00062246795,0.031362507,0.00045307534,0.6329301,0.00019046827,0.009909281,0.10171636],"study_design_scores_gemma":[0.0039675236,0.00047901904,0.93378586,0.00042348108,0.000035562938,0.0000945669,0.0091568725,0.000019140743,0.009848176,0.00018727948,0.041683044,0.00031948148],"about_ca_topic_score_codex":0.00014092086,"about_ca_topic_score_gemma":0.00010244731,"teacher_disagreement_score":0.71944,"about_ca_system_score_codex":0.0007042219,"about_ca_system_score_gemma":0.00044234868,"threshold_uncertainty_score":0.9984371},"labels":[],"label_agreement":null},{"id":"W2132926900","doi":"10.1158/0008-5472.can-06-4338","title":"PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; Cancer research; Src family kinase; Phosphorylation; FYN; Small interfering RNA; Tyrosine phosphorylation; Dephosphorylation; Cancer cell; Cancer; Biology; Chemistry; Cell culture; Cell biology; Internal medicine; Phosphatase; Medicine; Transfection","score_opus":0.07668065833149285,"score_gpt":0.3987175737992973,"score_spread":0.32203691546780444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132926900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958593,0.036775324,0.00093866704,0.002367916,0.0001501038,0.00093709724,0.0000936719,0.0000067438177,0.00013747138],"genre_scores_gemma":[0.99690115,0.0012407138,0.00007758695,0.00041679427,0.00028142444,0.00038544572,0.00001687532,0.000018105935,0.00066188094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987726,0.000089362286,0.00017685156,0.00025828058,0.00031238224,0.00039048822],"domain_scores_gemma":[0.9989893,0.000038292783,0.00005281425,0.0003524136,0.0005162784,0.00005090867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079876586,0.00009334653,0.00011590731,0.000042308908,0.0001443304,0.000022626386,0.0003574117,0.00008878135,0.000033229924],"category_scores_gemma":[0.00021601633,0.0000648373,0.00004135224,0.00033307896,0.00020636342,0.0000065655813,0.00021631746,0.00015264032,0.000009317168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005888088,0.00002873765,0.00020627334,0.000040334544,0.000049003265,5.315953e-7,0.000102789345,0.00009891942,0.9753159,0.00026140717,0.018916227,0.004391058],"study_design_scores_gemma":[0.0002561328,0.00014745432,0.00034605744,0.00007686074,0.000005694992,2.6050648e-7,0.00010337225,0.0000023478726,0.87191546,0.00004677605,0.12703024,0.00006935202],"about_ca_topic_score_codex":0.0028434799,"about_ca_topic_score_gemma":0.0010511122,"teacher_disagreement_score":0.10811402,"about_ca_system_score_codex":0.00012339851,"about_ca_system_score_gemma":0.0003853405,"threshold_uncertainty_score":0.429851},"labels":[],"label_agreement":null},{"id":"W2132997840","doi":"10.1158/0008-5472.can-12-3783","title":"Sequential Application of a Cytotoxic Nanoparticle and a PI3K Inhibitor Enhances Antitumor Efficacy","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fields Institute for Research in Mathematical Sciences; University of Waterloo","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Cytotoxic T cell; Cancer research; Discovery and development of mTOR inhibitors; Pharmacology; Chemistry; Medicine; PI3K/AKT/mTOR pathway; Biochemistry; Apoptosis; In vitro","score_opus":0.04031615193506187,"score_gpt":0.35537632270755637,"score_spread":0.3150601707724945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132997840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781334,0.000604461,0.0001430899,0.0004161545,0.00011155728,0.00080829975,0.000011890057,0.00004421011,0.000047012854],"genre_scores_gemma":[0.99876595,0.000054101907,0.00029993994,0.00003372029,0.00014240712,0.00058702857,0.000001145257,0.000015889013,0.00009982628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814224,0.0001910365,0.0002713333,0.00037302825,0.0005548674,0.00046748927],"domain_scores_gemma":[0.99890196,0.0002050578,0.0000725074,0.00032540766,0.0003372154,0.00015782645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006838757,0.00009666559,0.00017660392,0.000114924354,0.00015076349,0.00010872374,0.0002476642,0.000044685792,0.0004298074],"category_scores_gemma":[0.00013440616,0.000085465064,0.00002641926,0.000430797,0.0005129531,0.0003542244,0.00017315861,0.00012330349,0.00049181713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007598697,0.000116421616,0.0006157686,0.000093784314,0.0000043083996,0.0000023202008,0.0002487353,0.000014012487,0.9953499,0.00025834134,0.00039290285,0.0028275086],"study_design_scores_gemma":[0.00056109246,0.000161373,0.0018119785,0.000052752224,0.0000057802463,0.0000018166473,0.00008466761,0.00044357395,0.99630773,0.00030461152,0.0001699242,0.000094721465],"about_ca_topic_score_codex":0.001589971,"about_ca_topic_score_gemma":0.000058496495,"teacher_disagreement_score":0.002732787,"about_ca_system_score_codex":0.00008934926,"about_ca_system_score_gemma":0.00018259902,"threshold_uncertainty_score":0.63214785},"labels":[],"label_agreement":null},{"id":"W2133024109","doi":"10.1158/0008-5472.can-10-3040","title":"Cell Cycle Regulator ING4 Is a Suppressor of Melanoma Angiogenesis That Is Regulated by the Metastasis Suppressor BRMS1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Matrigel; Gene knockdown; Cancer research; Melanoma; Biology; CD31; HIF1A; Cell migration; Cell growth; Cell cycle; Cell biology; Metastasis; Human umbilical vein endothelial cell; Cell; Apoptosis; Umbilical vein; Cancer; In vitro","score_opus":0.03381329294549038,"score_gpt":0.33395916594034264,"score_spread":0.30014587299485224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133024109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872419,0.0070709214,0.00008074106,0.0025054628,0.0002690506,0.00065755687,0.001502457,0.000018389846,0.0006534868],"genre_scores_gemma":[0.99357986,0.000656827,0.00061114243,0.000436841,0.00023307912,0.00032327275,0.00007859277,0.00009510522,0.0039852783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965135,0.00035373718,0.0003877423,0.00084268535,0.0010653937,0.00083692867],"domain_scores_gemma":[0.9970304,0.000106805994,0.00019914942,0.001805777,0.00059690204,0.00026100563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012898508,0.00031084951,0.00039540263,0.00015664611,0.00027761338,0.00008530181,0.0013482086,0.00033590524,0.0024611608],"category_scores_gemma":[0.00014206233,0.0002419741,0.00030017103,0.0004938078,0.00052452856,0.00001851588,0.0005668467,0.00044364884,0.000023539953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022942551,0.00006937098,0.00018301948,0.000065838605,0.0002346005,0.0000019175338,0.00016994355,0.0000046884024,0.8089583,0.000033499582,0.18734816,0.0027012227],"study_design_scores_gemma":[0.00069190754,0.00017363793,0.00022527965,0.000017621222,0.000090544796,0.000006814741,0.00013894681,0.000028227449,0.8780166,0.00019247741,0.12018213,0.00023580673],"about_ca_topic_score_codex":0.0006683028,"about_ca_topic_score_gemma":0.00010074532,"teacher_disagreement_score":0.06905829,"about_ca_system_score_codex":0.000044391425,"about_ca_system_score_gemma":0.0003510299,"threshold_uncertainty_score":0.9984507},"labels":[],"label_agreement":null},{"id":"W2133164153","doi":"10.1158/0008-5472.can-05-2560","title":"Characterization of a von Hippel Lindau Pathway Involved in Extracellular Matrix Remodeling, Cell Invasion, and Angiogenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Angiogenesis; Extracellular matrix; Hypoxia-inducible factors; Vascular endothelial growth factor; Cancer research; Cell biology; Biology; Matrix metalloproteinase; Growth factor; Pathology; Chemistry; Medicine; Gene; Biochemistry; Receptor","score_opus":0.029262576975375213,"score_gpt":0.3039757927964357,"score_spread":0.2747132158210605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133164153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96425784,0.034813777,0.0002365455,0.000079974394,0.00015477378,0.00029705232,0.000060849317,0.000005127586,0.00009406995],"genre_scores_gemma":[0.9874749,0.00906939,0.00011502469,0.000015239414,0.00072361075,0.00007038465,0.00019141764,0.000028300263,0.0023117259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865496,0.00012752463,0.000270171,0.00037228028,0.0002537542,0.00032130498],"domain_scores_gemma":[0.9993176,0.000011270331,0.000074642034,0.0002788993,0.00024698421,0.00007060722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005646107,0.00011625579,0.0001761291,0.00018150218,0.00005897362,0.000021735805,0.00014683153,0.00017570965,0.000028883136],"category_scores_gemma":[0.000031761847,0.00011786938,0.000053785185,0.00027858897,0.00010047374,0.000008119417,0.00011171452,0.00012443587,0.000002046576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012323198,0.00006119153,0.0035582893,0.000099773664,0.0000053622034,0.0000011956097,0.00009272944,0.000049763756,0.99161315,0.000056769015,0.00024871682,0.004089828],"study_design_scores_gemma":[0.000698521,0.00006367971,0.006654198,0.000038129572,0.000006380946,0.0000010719366,0.000064135485,0.0001538478,0.9377288,0.00008243432,0.05437748,0.00013127369],"about_ca_topic_score_codex":0.0012650187,"about_ca_topic_score_gemma":0.00092302635,"teacher_disagreement_score":0.054128766,"about_ca_system_score_codex":0.0000344967,"about_ca_system_score_gemma":0.00028670306,"threshold_uncertainty_score":0.4806574},"labels":[],"label_agreement":null},{"id":"W2133288737","doi":"10.1158/0008-5472.1018.65.3","title":"Photodynamic Therapy–Induced Cell Surface Expression and Release of Heat Shock Proteins: Relevance for Tumor Response","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hsp70; Photodynamic therapy; Tumor necrosis factor alpha; Heat shock protein; Immune system; Inflammation; Biology; Cancer research; Immunology; Umbilical vein; Chemistry; In vitro; Biochemistry","score_opus":0.039488105967813596,"score_gpt":0.37577730534903886,"score_spread":0.33628919938122526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133288737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942244,0.0069174133,0.00020642494,0.00070338394,0.000026283396,0.0025247633,0.000080881146,0.000010697736,0.00010770515],"genre_scores_gemma":[0.99291843,0.0020869428,0.0015443291,0.00005885419,0.00017065502,0.0009717875,0.000015980573,0.000064357315,0.0021686344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720097,0.0006162997,0.0002859683,0.00065341697,0.00055390026,0.00068945275],"domain_scores_gemma":[0.9983122,0.0001999277,0.000043331747,0.00068819267,0.00052339735,0.00023295586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019348607,0.00018381893,0.00022540535,0.00011912565,0.00021717722,0.000033255634,0.00039167932,0.00017561615,0.000055800985],"category_scores_gemma":[0.00070640666,0.00016392086,0.0000743475,0.00024926683,0.0002202956,0.000014101876,0.0002539029,0.00035951025,0.0000063890716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00829939,0.00012248654,0.000082850784,0.00015528561,0.000013053008,0.0000032472467,0.00009690177,0.00020407465,0.9877892,0.000002484433,0.0010003644,0.0022306598],"study_design_scores_gemma":[0.0017219342,0.0012401578,0.00015136095,0.00010464294,0.0000016439327,0.0000034367097,0.00008009644,0.00039185578,0.9726492,0.000018112747,0.023466116,0.00017140125],"about_ca_topic_score_codex":0.00021788826,"about_ca_topic_score_gemma":0.00007038906,"teacher_disagreement_score":0.02246575,"about_ca_system_score_codex":0.00013224284,"about_ca_system_score_gemma":0.0007874253,"threshold_uncertainty_score":0.6684499},"labels":[],"label_agreement":null},{"id":"W2133318825","doi":"10.1158/0008-5472.can-03-1242","title":"Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Urokinase receptor; Tissue microarray; Plasminogen activator inhibitor-1; Protein kinase B; Plasminogen activator; Growth factor; Insulin-like growth factor; Signal transduction; Internal medicine; Endocrinology; Medicine; Receptor; Biology; Cell biology","score_opus":0.0261978555791697,"score_gpt":0.3030374014706229,"score_spread":0.2768395458914532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133318825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752134,0.00068537646,0.0000073609244,0.0007758587,0.00010987564,0.0003510524,0.0005038573,0.000004358349,0.000040904004],"genre_scores_gemma":[0.99874395,0.0006646771,0.000017662553,0.00012808105,0.000117636315,0.00014072061,0.000013363667,0.000024353347,0.0001495656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986488,0.00016273101,0.00013828286,0.00033683042,0.00039036904,0.00032297638],"domain_scores_gemma":[0.99935615,0.000019848045,0.00006928947,0.00022053972,0.00023531503,0.00009888416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024008237,0.00012631444,0.00014874754,0.000055423894,0.00010329253,0.000016770446,0.00022426761,0.0001548831,0.000072733805],"category_scores_gemma":[0.000076983226,0.000084239204,0.000035944544,0.0002620347,0.00015465624,0.000010884097,0.0002003182,0.0002540789,0.0000010242712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049043656,0.00008205279,0.007550382,0.000026549593,0.000027791344,0.000002052806,0.00015359414,0.0000044456892,0.9908114,0.0000150928045,0.00059511606,0.00024109763],"study_design_scores_gemma":[0.0013758049,0.00014628418,0.009015507,0.00026678943,0.000003954959,0.0000015575127,0.00008337192,0.0000013247169,0.9884863,0.000058225014,0.00044616338,0.000114730145],"about_ca_topic_score_codex":0.0012145903,"about_ca_topic_score_gemma":0.00031760434,"teacher_disagreement_score":0.002325102,"about_ca_system_score_codex":0.00013915668,"about_ca_system_score_gemma":0.0005338286,"threshold_uncertainty_score":0.3435175},"labels":[],"label_agreement":null},{"id":"W2133386306","doi":"10.1158/0008-5472.can-07-5472","title":"Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and Radioresistance","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"RAD51; Homologous recombination; Radioresistance; DNA repair; Biology; Molecular biology; Cell cycle; DNA damage; Radiosensitivity; Cancer research; Cell biology; Chemistry; Cell; Cell culture; DNA; Radiation therapy; Biochemistry; Genetics; Internal medicine; Medicine","score_opus":0.03081393139601044,"score_gpt":0.32007165228691414,"score_spread":0.2892577208909037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133386306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928212,0.005400691,0.00020823503,0.00035242958,0.000042351458,0.00054770993,0.00004474214,0.000013416121,0.000569185],"genre_scores_gemma":[0.9942236,0.0022076906,0.001348634,0.000026685362,0.00012632179,0.00061433826,0.000012140371,0.000026227566,0.001414347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855727,0.0001477716,0.0001789027,0.00043705935,0.00033539266,0.00034359194],"domain_scores_gemma":[0.9990124,0.0000556048,0.000055127548,0.00043157922,0.00029880757,0.00014644046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044195954,0.00011709179,0.00017975597,0.00011117205,0.00015288079,0.000010614664,0.00025845587,0.00010749269,0.000034007848],"category_scores_gemma":[0.00060368126,0.00011821274,0.000043992226,0.0002708669,0.000267922,0.00000564527,0.00013741986,0.000108351924,0.0000056336357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022208513,0.000047587906,0.00040721308,0.0001049702,0.00002779268,0.000013711329,0.000041252086,0.000008274894,0.9867083,0.00017649424,0.003077259,0.009165085],"study_design_scores_gemma":[0.00027501502,0.0003444534,0.005244975,0.000089784735,0.000005568321,0.000018194869,0.000025247362,0.000010691515,0.98936397,0.00018690812,0.004305353,0.00012983684],"about_ca_topic_score_codex":0.00016062344,"about_ca_topic_score_gemma":0.00030811908,"teacher_disagreement_score":0.009035247,"about_ca_system_score_codex":0.00013961633,"about_ca_system_score_gemma":0.00041030522,"threshold_uncertainty_score":0.48205757},"labels":[],"label_agreement":null},{"id":"W2133433434","doi":"10.1158/0008-5472.can-04-0690","title":"Antioxidants Block Prostate Cancer in <b> <i>Lady</i> </b> Transgenic Mice","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Sunnybrook Hospital; Women's College Hospital","funders":"","keywords":"Prostate cancer; Cancer; Prostate; Medicine; Tramp; Genetically modified mouse; Adenocarcinoma; Micronutrient; Internal medicine; Cancer research; Pathology; Transgene; Endocrinology; Biology","score_opus":0.06930789148496402,"score_gpt":0.41660304659498903,"score_spread":0.347295155110025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133433434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685104,0.0034568005,0.000020672886,0.0065069785,0.0001838664,0.00094664533,0.00010763139,0.000050892442,0.0018754989],"genre_scores_gemma":[0.98899513,0.0077206623,0.000061131905,0.00022732718,0.0003071921,0.00030636342,0.000006788127,0.0000442997,0.002331094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737734,0.0001397327,0.00028001657,0.00054046465,0.0007826714,0.000879782],"domain_scores_gemma":[0.99902606,0.00008334825,0.000045860437,0.00029501377,0.00031820757,0.00023148414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000591881,0.00019520799,0.00037175854,0.00038589782,0.00016426011,0.00003544643,0.00021173421,0.00013497526,0.000351663],"category_scores_gemma":[0.000071509414,0.00017519233,0.00009583694,0.0012583284,0.00038899473,0.00023287823,0.00006199914,0.0010151436,0.000078467856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013815658,0.0005350467,0.05665284,0.00050086126,0.00008381305,0.00018497607,0.0022509284,0.00039489346,0.927771,0.0002831075,0.0008047927,0.009156234],"study_design_scores_gemma":[0.007211037,0.00036914757,0.20794441,0.0019895295,0.000040660252,0.000029991563,0.0006998052,0.000020513615,0.7720364,0.00045420454,0.0088433055,0.00036100944],"about_ca_topic_score_codex":0.0045535318,"about_ca_topic_score_gemma":0.006103565,"teacher_disagreement_score":0.15573455,"about_ca_system_score_codex":0.00055241067,"about_ca_system_score_gemma":0.0011177394,"threshold_uncertainty_score":0.7144136},"labels":[],"label_agreement":null},{"id":"W2133575187","doi":"10.1158/0008-5472.can-04-0289","title":"Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow Cytometry","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Hypoxia (environmental); Flow cytometry; Tumor hypoxia; Medicine; Pathology; Cancer research; Internal medicine; Immunology; Chemistry; Radiation therapy","score_opus":0.06469110279816502,"score_gpt":0.39306825495679726,"score_spread":0.3283771521586322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133575187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97842103,0.019349927,0.00025436102,0.00030106027,0.000613963,0.00035187296,0.00007651395,0.000014970149,0.0006162939],"genre_scores_gemma":[0.99478847,0.0026165457,0.0001785617,0.00019775165,0.0013169656,0.00020999307,0.00008016584,0.00004534152,0.00056619575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978368,0.00011252547,0.00025212442,0.0005693644,0.0004701392,0.00075901876],"domain_scores_gemma":[0.99919623,0.000011739555,0.000033963912,0.00041439198,0.00014817461,0.0001955112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006844064,0.00017306487,0.00022020956,0.00025317015,0.0001886482,0.000054656244,0.00036584624,0.00013565397,0.000083655075],"category_scores_gemma":[0.000059641203,0.00017553572,0.000099823665,0.0006206967,0.000207258,0.000008096428,0.000105420644,0.00040831504,0.000016097705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009796827,0.00011083623,0.00043734862,0.000050205093,0.000023371127,0.000007370783,0.0001762918,0.00024677423,0.98491544,0.00004807791,0.010008229,0.0038781143],"study_design_scores_gemma":[0.0021259058,0.0001931261,0.0036501356,0.00007853895,0.0000075920643,0.000008673015,0.00018665152,0.000007027506,0.6534886,0.0000672215,0.33990777,0.0002787893],"about_ca_topic_score_codex":0.0012280402,"about_ca_topic_score_gemma":0.0019174201,"teacher_disagreement_score":0.33142686,"about_ca_system_score_codex":0.00014726006,"about_ca_system_score_gemma":0.0003671966,"threshold_uncertainty_score":0.71581393},"labels":[],"label_agreement":null},{"id":"W2133850696","doi":"10.1158/0008-5472.can-04-2126","title":"Phosphorylation of Estrogen Receptor α Blocks Its Acetylation and Regulates Estrogen Sensitivity","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Phosphorylation; Estrogen receptor; Estrogen receptor alpha; Biology; Protein kinase A; Acetylation; Signal transduction; Estrogen receptor beta; Cancer research; Chemistry; Biochemistry; Cell biology; Molecular biology; Cancer; Breast cancer; Genetics; Gene","score_opus":0.02053605689466307,"score_gpt":0.32606230088126437,"score_spread":0.3055262439866013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133850696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895344,0.0095947115,0.000056510187,0.00025800397,0.000069921196,0.00031545205,0.000020924732,0.000010532394,0.00013957542],"genre_scores_gemma":[0.997308,0.0019395492,0.00024795294,0.00001092993,0.00016860313,0.0000308723,0.000060850758,0.000020135167,0.00021309625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889266,0.00012932929,0.00014685726,0.00030683796,0.00024765808,0.00027663683],"domain_scores_gemma":[0.9993466,0.000027252632,0.000056686404,0.00020422609,0.0002588097,0.000106414256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056434964,0.00010942187,0.00012679322,0.000067579,0.00011993971,0.000016933218,0.0000715938,0.00021635128,0.000016789745],"category_scores_gemma":[0.000108568034,0.000102878585,0.000050204166,0.00019586475,0.00016962289,0.000008032428,0.00010021258,0.00019351809,0.000007758892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018224076,0.00003423389,0.0017381114,0.000029089324,0.00006335108,0.000002430184,0.0000864315,0.0007095703,0.9932988,0.00037044947,0.00020573645,0.003279509],"study_design_scores_gemma":[0.000615385,0.0002667932,0.0010049471,0.000048213653,0.000012115729,0.000010355094,0.000041025756,0.000068354006,0.99655294,0.00011792544,0.0011587841,0.000103156264],"about_ca_topic_score_codex":0.00012418318,"about_ca_topic_score_gemma":0.000010095724,"teacher_disagreement_score":0.0077736415,"about_ca_system_score_codex":0.000053194537,"about_ca_system_score_gemma":0.00019556396,"threshold_uncertainty_score":0.4195267},"labels":[],"label_agreement":null},{"id":"W2133899403","doi":"10.1158/0008-5472.can-08-4475","title":"Human Schwannomas Express Activated Platelet-Derived Growth Factor Receptors and c-kit and Are Growth Inhibited by Gleevec (Imatinib Mesylate)","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children","funders":"","keywords":"Imatinib mesylate; Platelet-derived growth factor receptor; Cancer research; Imatinib; Growth factor receptor; Chronic myelogenous leukemia; Neurofibromatosis type 2; Growth factor; Medicine; Platelet-derived growth factor; Leukemia; Receptor; Internal medicine; Schwannoma; Pathology","score_opus":0.05656369293570782,"score_gpt":0.3505539044540589,"score_spread":0.29399021151835103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133899403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361837,0.0017229606,0.0000026615296,0.0030512125,0.00006029877,0.0008266917,0.0001195986,0.0001409118,0.00045731053],"genre_scores_gemma":[0.9981583,0.0005216178,0.00009889171,0.00024884535,0.00013798583,0.00007760861,0.000056291727,0.00006129796,0.0006391691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701536,0.00025745016,0.00040950425,0.00077302364,0.0007737041,0.00077098235],"domain_scores_gemma":[0.99830407,0.00016389994,0.00013015879,0.0003449488,0.00048201438,0.00057488447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031643736,0.0003397258,0.00059933367,0.00037734755,0.00049436407,0.00019794414,0.00017380517,0.00021961943,0.0003380448],"category_scores_gemma":[0.00030893917,0.00028848049,0.00006407839,0.0006204122,0.00038423625,0.00032554584,0.00014986892,0.00082326116,0.000010017427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041461145,0.00013105788,0.0068796305,0.00022801288,0.000056862467,0.00018890818,0.0004901275,5.4836043e-8,0.9707634,0.0001175595,0.018689217,0.0020405846],"study_design_scores_gemma":[0.0027756912,0.0009927828,0.058513943,0.0005596131,0.000019148802,0.00009719234,0.00035586397,0.000009678588,0.9334539,0.0002172522,0.0026603874,0.00034453796],"about_ca_topic_score_codex":0.00038219432,"about_ca_topic_score_gemma":0.0000090051935,"teacher_disagreement_score":0.05163431,"about_ca_system_score_codex":0.0001406355,"about_ca_system_score_gemma":0.00011549052,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W2134029343","doi":"10.1158/0008-5472.can-12-4136","title":"Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Cancer Institute","keywords":"Gefitinib; Cancer research; Cancer stem cell; Stem cell; Biology; T790M; Downregulation and upregulation; Population; Cancer; Epidermal growth factor receptor; Medicine; Cell biology; Genetics","score_opus":0.060552013784821807,"score_gpt":0.3762643656085135,"score_spread":0.31571235182369173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134029343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916427,0.0017073819,0.0000034252323,0.0028325266,0.00008758616,0.0018761454,0.000056883655,0.000021891407,0.0017714292],"genre_scores_gemma":[0.9679845,0.0002736203,0.00006990002,0.0002475444,0.000048969756,0.00204254,0.000009306223,0.000035188496,0.02928842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981925,0.00009446584,0.0002695939,0.0003302755,0.0006873431,0.00042585586],"domain_scores_gemma":[0.998625,0.000059234673,0.00007906327,0.00024707153,0.0008262402,0.00016342808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021155275,0.00013293495,0.00026593136,0.00027733453,0.00008746984,0.00003317611,0.00010339627,0.00006915616,0.00032553973],"category_scores_gemma":[0.0000117383,0.0000960026,0.00003214689,0.0009022759,0.00011548406,0.0001544415,0.000035958386,0.00014657913,0.000031212658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019861849,0.001556296,0.07633768,0.0019129736,0.00060422684,0.00012329574,0.04820098,0.00047859698,0.7499489,0.000057414232,0.10119912,0.017594308],"study_design_scores_gemma":[0.0052587753,0.00097312196,0.08076063,0.0042864415,0.00013076243,0.0000011782449,0.006150911,0.00009618848,0.89662945,0.000050051305,0.005318618,0.00034385786],"about_ca_topic_score_codex":0.008590577,"about_ca_topic_score_gemma":0.005171582,"teacher_disagreement_score":0.14668055,"about_ca_system_score_codex":0.0013325219,"about_ca_system_score_gemma":0.00093151873,"threshold_uncertainty_score":0.9980113},"labels":[],"label_agreement":null},{"id":"W2134045444","doi":"10.1158/0008-5472.can-05-1201","title":"Myxoma Virus Is a Novel Oncolytic Virus with Significant Antitumor Activity against Experimental Human Gliomas","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Western University; Robarts Clinical Trials; University of Calgary","funders":"National Cancer Institute","keywords":"Myxoma virus; Oncolytic virus; Myxoma; Virus; In vivo; Glioma; Virology; Biology; Viral replication; Pathology; Medicine; Cancer research; Internal medicine","score_opus":0.07548925556738698,"score_gpt":0.42087111305172326,"score_spread":0.34538185748433625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134045444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951531,0.0015834504,0.000045909404,0.0006160506,0.00004321045,0.00080018106,0.00015032063,0.000030405843,0.0015773493],"genre_scores_gemma":[0.9956141,0.0003460883,0.00008728943,0.00037260793,0.0007332646,0.00051467353,0.0000351424,0.00009853682,0.0021982857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964668,0.00022238695,0.00022838567,0.0009213735,0.0010849342,0.0010760893],"domain_scores_gemma":[0.9983119,0.000029161696,0.0000704629,0.0009037026,0.00031998765,0.00036483436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007699702,0.00030525308,0.00027717266,0.00025145197,0.0005026844,0.00013113633,0.00069971924,0.0001769665,0.00047067253],"category_scores_gemma":[0.000027694714,0.00027182436,0.000112479705,0.0005430438,0.00062940194,0.000020974974,0.00032633892,0.00054034573,0.00010491659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042127464,0.00073385617,0.00022022065,0.000024516414,0.00013257432,0.000026209676,0.00019707598,0.00008630078,0.98692167,0.000011902951,0.0035414344,0.0038915004],"study_design_scores_gemma":[0.002034689,0.0035157762,0.00037867518,0.00003763941,0.000006329379,0.000007819806,0.000113338414,0.00008924563,0.9682937,0.0000026385537,0.025168506,0.00035163102],"about_ca_topic_score_codex":0.0007928997,"about_ca_topic_score_gemma":0.002634885,"teacher_disagreement_score":0.021627072,"about_ca_system_score_codex":0.00044806965,"about_ca_system_score_gemma":0.0009020504,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2134171575","doi":"10.1158/0008-5472.can-04-2231","title":"Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); IONICS Mass Spectrometry (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Vanderbilt-Ingram Cancer Center; Vanderbilt University","keywords":"Cancer research; Chemistry; Apoptosis; ErbB; Receptor; Pharmacology; Biology; Biochemistry","score_opus":0.03143229849120987,"score_gpt":0.3567136593811664,"score_spread":0.3252813608899565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134171575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918029,0.00045005447,0.0014188859,0.003858319,0.000008104711,0.0007305372,0.0001004889,0.00013552983,0.0014952127],"genre_scores_gemma":[0.99255675,0.000077033896,0.0032522038,0.00007180856,0.000077307224,0.0029187629,0.000008768386,0.000056982353,0.0009803788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977058,0.00011263565,0.0002064898,0.00053309626,0.0007317093,0.0007102446],"domain_scores_gemma":[0.9988676,0.000075462645,0.000046610803,0.00067207654,0.00013526715,0.00020303513],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063274754,0.00017801314,0.00018381179,0.00045342094,0.00012271362,0.00008075249,0.0005880333,0.0001377014,0.0018960235],"category_scores_gemma":[0.00011090569,0.00017291568,0.00004065934,0.001597673,0.000086429056,0.000048653812,0.00015268715,0.00075658754,0.000029094426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050932023,0.00009670845,0.00028335777,0.000042975345,0.000009672799,0.00003365077,0.000105888714,0.0000060803222,0.9979938,0.00020022597,0.00015084252,0.00056742155],"study_design_scores_gemma":[0.0005297815,0.00021100431,0.00051475276,0.00023735818,0.0000028239401,0.0000016417756,0.000075375865,0.000006293872,0.9898193,0.0026384508,0.0057773944,0.0001858589],"about_ca_topic_score_codex":0.00046222445,"about_ca_topic_score_gemma":0.00005616449,"teacher_disagreement_score":0.008174592,"about_ca_system_score_codex":0.00090303126,"about_ca_system_score_gemma":0.0001956678,"threshold_uncertainty_score":0.9990164},"labels":[],"label_agreement":null},{"id":"W2134299232","doi":"10.1158/0008-5472.can-10-0266","title":"Distinct Biological Roles for the Akt Family in Mammary Tumor Progression","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Manitoba; Occupational Cancer Research Centre","funders":"U.S. Public Health Service; National Cancer Institute; National Institutes of Health; Terry Fox Foundation; Canadian Breast Cancer Research Alliance; Fondation du cancer du sein du Québec; Canadian Institutes of Health Research; Cancer Research Society","keywords":"AKT1; AKT2; Protein kinase B; Metastasis; Cancer research; Biology; AKT3; Tumor progression; Cancer; PI3K/AKT/mTOR pathway; Genetically modified mouse; Phenotype; Mammary tumor; Kinase; Breast cancer; Transgene; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.1813491112632949,"score_gpt":0.49741870898950663,"score_spread":0.31606959772621174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134299232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011239359,0.99553674,0.0001214824,0.00014658281,0.00047164378,0.002143157,0.0002296903,0.000015518694,0.0002112638],"genre_scores_gemma":[0.0009975572,0.98973167,0.00019162145,0.000063666266,0.0016091433,0.006643283,0.00026471622,0.00007656296,0.00042177885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970223,0.00044773347,0.00044100956,0.00089691544,0.0004036988,0.0007883495],"domain_scores_gemma":[0.9981575,0.00041195704,0.00016023779,0.00090017094,0.0002457948,0.00012434053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018526799,0.00036294278,0.00068125455,0.00013142749,0.0002203616,0.0000932387,0.0015027889,0.0006693116,0.00003266899],"category_scores_gemma":[0.000579067,0.00020950731,0.00034533936,0.00035225315,0.00046552936,0.0000037212412,0.0006516549,0.0012883302,0.00001320226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009941581,0.000049854505,0.00006488695,0.0018708734,0.00006413613,0.000014096643,0.00000801835,7.1889326e-7,0.007497743,0.000052517396,0.0070502358,0.9832275],"study_design_scores_gemma":[0.00024679734,0.0002570554,0.000040598687,0.0024552287,0.000030489582,0.000010461344,0.000009700188,0.000005522239,0.001263482,0.000071783856,0.9953314,0.0002774876],"about_ca_topic_score_codex":0.00005587176,"about_ca_topic_score_gemma":0.00015079953,"teacher_disagreement_score":0.98828113,"about_ca_system_score_codex":0.00015940225,"about_ca_system_score_gemma":0.001507019,"threshold_uncertainty_score":0.85434604},"labels":[],"label_agreement":null},{"id":"W2134499341","doi":"10.1158/0008-5472.can-09-1510","title":"Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; McGill University; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Myxoma virus; Oncolytic virus; Glioma; Virotherapy; Microglia; In vivo; Immune system; Biology; Viral replication; Cancer research; Virus; Medicine; Immunology; Inflammation","score_opus":0.04579266854613521,"score_gpt":0.37200922831314187,"score_spread":0.32621655976700664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134499341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958132,0.0022408653,0.0003227815,0.0005760832,0.000034350665,0.00081539055,0.00003836323,0.000010563035,0.00014841107],"genre_scores_gemma":[0.99629074,0.0011549208,0.00096821866,0.00005380604,0.00021364389,0.0010401822,0.000040241597,0.000055900324,0.00018233496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823445,0.00014222042,0.00019056832,0.0005231223,0.00034014464,0.0005694938],"domain_scores_gemma":[0.9991356,0.000056973444,0.00003765297,0.00038799268,0.00025170128,0.00013004203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091126416,0.00016739017,0.00016781315,0.00019871496,0.00017838218,0.00010408209,0.00029587667,0.00016038476,0.00003914757],"category_scores_gemma":[0.000032367778,0.00014713316,0.00004314458,0.00024987888,0.0002713057,0.000017723936,0.00008411148,0.00036249927,0.0000012532245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012970676,0.00008934988,0.00016801141,0.000026217038,0.00005062294,0.000009512895,0.0000953607,0.00037708553,0.97993255,0.00021952772,0.000083554405,0.005977552],"study_design_scores_gemma":[0.0020932977,0.0059428615,0.00025987445,0.000028282673,0.0000030673816,0.00001700163,0.00011736823,0.0024909955,0.9864898,0.00019058712,0.002162931,0.00020393477],"about_ca_topic_score_codex":0.0003246919,"about_ca_topic_score_gemma":0.0071444483,"teacher_disagreement_score":0.010877378,"about_ca_system_score_codex":0.000047474736,"about_ca_system_score_gemma":0.0004993497,"threshold_uncertainty_score":0.5999916},"labels":[],"label_agreement":null},{"id":"W2134589440","doi":"10.1158/0008-5472.372.65.1","title":"Glypican-3 as a Serum Marker for Hepatocellular Carcinoma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":433,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glypican 3; Hepatocellular carcinoma; Oncology; Medicine; Internal medicine; Cancer research; Pathology","score_opus":0.05166019831599096,"score_gpt":0.3841471475783414,"score_spread":0.33248694926235045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134589440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877991,0.0037518442,0.00043660484,0.0034165059,0.00008561705,0.0011805018,0.00015484018,0.000015673906,0.0031593232],"genre_scores_gemma":[0.9732947,0.00057111034,0.00052516814,0.00031819416,0.0012466096,0.0015405167,0.00007205949,0.0000608119,0.02237088],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973084,0.00016494808,0.00021918095,0.0006725539,0.0005784214,0.0010565403],"domain_scores_gemma":[0.9983902,0.00004533339,0.000032300188,0.0006661744,0.0005499687,0.0003160362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010397321,0.000187199,0.00018206677,0.00015841424,0.0003173605,0.00008253737,0.00060792157,0.00021466706,0.0005452577],"category_scores_gemma":[0.00022324857,0.00017572644,0.00014140563,0.00029535394,0.0002620702,0.000008886821,0.00030651918,0.00033578745,0.00010508485],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012835899,0.00011974871,0.02377369,0.00011639121,0.00008914936,0.00001856539,0.00007610473,0.000025976728,0.89200777,0.0005743924,0.03512841,0.046786185],"study_design_scores_gemma":[0.00085641904,0.0004207688,0.0021329003,0.000014927713,0.0000046714267,0.000010130767,0.000056220717,0.00049013697,0.45614314,0.00014944295,0.539541,0.00018025382],"about_ca_topic_score_codex":0.0005638537,"about_ca_topic_score_gemma":0.00035942672,"teacher_disagreement_score":0.5044126,"about_ca_system_score_codex":0.00014795565,"about_ca_system_score_gemma":0.00085092895,"threshold_uncertainty_score":0.71659166},"labels":[],"label_agreement":null},{"id":"W2134693307","doi":"10.1158/0008-5472.can-03-2502","title":"<b> <i>NBS1</i> </b> Is a Prostate Cancer Susceptibility Gene","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Prostate cancer; Loss of heterozygosity; Nijmegen breakage syndrome; Prostate; Allele; Medicine; Cancer; Mutation; Heterozygote advantage; Internal medicine; Oncology; Biology; Genetics; Gene; DNA damage; DNA","score_opus":0.04082948727779253,"score_gpt":0.38065902203454877,"score_spread":0.33982953475675626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134693307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275714,0.0037423954,0.0001315424,0.0017538706,0.00020108192,0.00056471623,0.00014763512,0.00003005767,0.0006715788],"genre_scores_gemma":[0.99064493,0.0026149077,0.00045172794,0.0006848993,0.00043582564,0.0005553284,0.000032389256,0.000049064285,0.004530954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978344,0.00010366269,0.00018128876,0.00070301245,0.0004912924,0.0006863589],"domain_scores_gemma":[0.9986387,0.000008116976,0.00003704217,0.0007060325,0.00040957448,0.00020054227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006639463,0.00015786462,0.00014662501,0.000062742394,0.00017073759,0.000046427544,0.00037986712,0.00015746042,0.000300622],"category_scores_gemma":[0.00006491701,0.0001486852,0.0000926982,0.00029256544,0.00022343936,0.0000059835656,0.00030453404,0.0002766038,0.00007356739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015914759,0.00006528503,0.0012774265,0.000042631546,0.000034694636,0.00000882369,0.00021489878,0.00013692827,0.9889898,0.00007600823,0.0054685296,0.0035258753],"study_design_scores_gemma":[0.00075298175,0.00023538564,0.00024175335,0.000029652774,0.0000058126857,0.000004033497,0.000067615445,0.000005878412,0.96277046,0.001090173,0.03462024,0.00017601883],"about_ca_topic_score_codex":0.0016614263,"about_ca_topic_score_gemma":0.0011430196,"teacher_disagreement_score":0.029151712,"about_ca_system_score_codex":0.00024325402,"about_ca_system_score_gemma":0.0009127148,"threshold_uncertainty_score":0.6063207},"labels":[],"label_agreement":null},{"id":"W2134816104","doi":"10.1158/0008-5472.can-08-4710","title":"The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog–Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog–Treated Cerebellar Neural Precursors","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; National Institute of Neurological Disorders and Stroke; Pediatric Brain Tumor Foundation","keywords":"Medulloblastoma; Sonic hedgehog; GLI1; Biology; Cancer research; PTCH1; Hedgehog signaling pathway; Ectopic expression; microRNA; Cell biology; Signal transduction; Genetics; Cell culture; Gene","score_opus":0.03663524622639638,"score_gpt":0.3541138992377684,"score_spread":0.31747865301137207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134816104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981451,0.0147152515,0.0000022800677,0.0026747086,0.00011812331,0.00073523476,0.00005388677,0.000025017453,0.00022454318],"genre_scores_gemma":[0.99528015,0.002184297,0.000010138144,0.00017269109,0.00012967402,0.00014920691,0.000052865827,0.000050254177,0.0019707428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962744,0.0005204092,0.00046340367,0.00091162557,0.0005128081,0.001317342],"domain_scores_gemma":[0.9987229,0.0001096946,0.000095886004,0.00062564155,0.00022207882,0.00022375985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008889787,0.0003668436,0.00038357533,0.00021144086,0.00037544055,0.00010698608,0.0005952216,0.00036164644,0.000027019196],"category_scores_gemma":[0.00023246527,0.00030700624,0.000090222056,0.00079205236,0.00043931667,0.0000138383075,0.00029375957,0.00075568387,0.0000103205875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005288897,0.000099472076,0.008531402,0.000030179302,0.00008273843,0.000012992361,0.0008835146,0.000089683774,0.97373503,0.000011928682,0.007803474,0.0081906635],"study_design_scores_gemma":[0.0041923495,0.0018304161,0.04565441,0.00028658094,0.000028508257,0.000016807806,0.0012192568,0.001029023,0.9218739,0.00015807782,0.022847667,0.0008629555],"about_ca_topic_score_codex":0.0008177616,"about_ca_topic_score_gemma":0.0026169282,"teacher_disagreement_score":0.051861115,"about_ca_system_score_codex":0.00028168628,"about_ca_system_score_gemma":0.00036067533,"threshold_uncertainty_score":0.9999382},"labels":[],"label_agreement":null},{"id":"W2135055026","doi":"10.1158/0008-5472.can-09-0511","title":"Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 <i>In vitro</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Mayo Foundation for Medical Education and Research; General Mills; Mayo Clinic","keywords":"Insulin receptor; CD135; Insulin-like growth factor 1 receptor; Gene isoform; Receptor; In vitro; Chemistry; Endocrinology; Cancer research; Insulin; Internal medicine; Pharmacology; Medicine; Growth factor; Insulin resistance; Biochemistry; Tyrosine kinase; Gene","score_opus":0.02345310161037838,"score_gpt":0.32318859162499214,"score_spread":0.29973549001461375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135055026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205834,0.0036813782,0.0000017192638,0.00091372494,0.0004151162,0.0023091657,0.00024182614,0.00004391053,0.0003348243],"genre_scores_gemma":[0.99525046,0.0035324872,0.00012958462,0.00016589725,0.00028584138,0.00022000812,0.00007602362,0.00007900424,0.00026068656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99443877,0.0007592183,0.0012629636,0.0008707066,0.0015104755,0.001157892],"domain_scores_gemma":[0.9975259,0.00041990445,0.00034214254,0.0008200238,0.00050020154,0.00039188075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017010702,0.0005356562,0.0013192312,0.00078136113,0.0002293607,0.00003574838,0.00053739065,0.00061908824,0.0001719197],"category_scores_gemma":[0.00060091796,0.000375222,0.00025841637,0.0021288523,0.0006376161,0.00031976812,0.00036662884,0.0021805463,0.000020683214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046384647,0.00035149546,0.017325643,0.0005202348,0.00005705184,0.00001656521,0.0031112626,0.0000017563905,0.9615911,0.000023102131,0.0030090336,0.009354292],"study_design_scores_gemma":[0.00707227,0.002847031,0.043501113,0.0012105004,0.000039220293,0.000008057186,0.0002817293,0.000011145013,0.9430871,0.00005584171,0.001558651,0.00032735404],"about_ca_topic_score_codex":0.0013471688,"about_ca_topic_score_gemma":0.000059039543,"teacher_disagreement_score":0.026175467,"about_ca_system_score_codex":0.0012079532,"about_ca_system_score_gemma":0.0007489981,"threshold_uncertainty_score":0.99986994},"labels":[],"label_agreement":null},{"id":"W2135462324","doi":"10.1158/1538-7445.am2013-5029","title":"Abstract 5029: The role of estrogen receptor signaling in rhabdomyosarcoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Rhabdomyosarcoma; Tamoxifen; Estrogen receptor; Cancer research; Estrogen; Medicine; Estrogen receptor alpha; Internal medicine; Vincristine; Viability assay; Biology; Cancer; Sarcoma; Oncology; Chemotherapy; Apoptosis; Breast cancer; Pathology; Cyclophosphamide","score_opus":0.06446796171217592,"score_gpt":0.38923221172602845,"score_spread":0.32476425001385256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135462324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98124933,0.012547814,1.55484e-7,0.0032180166,0.00003755016,0.00076234015,0.000007182712,0.000009236549,0.0021683744],"genre_scores_gemma":[0.9982176,0.00056270044,0.00010174797,0.000059924307,0.00014490345,0.0007830481,0.0000053726444,0.000017205484,0.000107485845],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986668,0.00007791754,0.00021393124,0.00019016204,0.00048708823,0.00036408874],"domain_scores_gemma":[0.9989663,0.00036914722,0.000035924044,0.0003102986,0.00021271041,0.00010564419],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004958683,0.000083946914,0.00019148042,0.00013417905,0.00006222151,0.000022159693,0.00015980138,0.00005256945,0.002646185],"category_scores_gemma":[0.000091045804,0.000051546984,0.000068764966,0.0003412219,0.00013903357,0.000053678523,0.000057867433,0.00032018172,0.00021852329],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009836295,0.0004692684,0.5277226,0.000057492347,0.000093792696,0.000019303066,0.00053384906,0.000014135736,0.3562395,0.0004968914,0.002665043,0.11158978],"study_design_scores_gemma":[0.0014613023,0.00018043554,0.39776793,0.0004203229,0.000019941826,0.0000054239654,0.0019461456,0.000037647867,0.58226895,0.0013031737,0.0144866025,0.000102123304],"about_ca_topic_score_codex":0.0068415855,"about_ca_topic_score_gemma":0.00006448838,"teacher_disagreement_score":0.22602947,"about_ca_system_score_codex":0.00019331765,"about_ca_system_score_gemma":0.00021480232,"threshold_uncertainty_score":0.99977195},"labels":[],"label_agreement":null},{"id":"W2135497148","doi":"10.1158/1538-7445.am2013-lb-289","title":"Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Medicine; PLK1; Pharmacokinetics; Chills; Adverse effect; Pharmacodynamics; Kinase; Pharmacology; Neutropenia; Cmax; Nausea; Cell cycle; Internal medicine; Toxicity; Oncology; Cancer research; Cancer; Chemistry","score_opus":0.024989796433512027,"score_gpt":0.36146043904671965,"score_spread":0.33647064261320764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135497148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974486,0.00070682913,0.000008035873,0.00004410077,0.00005551002,0.0014421646,0.00005884992,0.000008613634,0.0002272771],"genre_scores_gemma":[0.9987105,0.00045307752,0.000034200635,0.000051409843,0.00007145601,0.00048278505,0.00011987912,0.000035393597,0.00004126666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.000082035185,0.0003097883,0.00040231823,0.0003712907,0.00040165038],"domain_scores_gemma":[0.9988024,0.000053703745,0.00010844946,0.0004053173,0.0005174368,0.00011265029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021420608,0.00015550228,0.00022591377,0.00013782727,0.00007130365,0.000039502305,0.00022272147,0.00007914454,0.000076750395],"category_scores_gemma":[0.00009613572,0.00013448995,0.00003355069,0.00033056855,0.000085130014,0.000012597329,0.00010447377,0.00020963572,0.00000798518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030739326,0.004880928,0.15473102,0.00009489808,0.00017114053,0.000009283582,0.000883649,0.0023172388,0.71596867,0.000007778676,0.00069984834,0.11716163],"study_design_scores_gemma":[0.0139644295,0.0046797525,0.90838414,0.00015409566,0.000015914393,2.9989303e-7,0.00060325867,0.0002644963,0.07053393,0.00005873085,0.0009558094,0.00038512563],"about_ca_topic_score_codex":0.00087145995,"about_ca_topic_score_gemma":0.0007771806,"teacher_disagreement_score":0.7536531,"about_ca_system_score_codex":0.00010614072,"about_ca_system_score_gemma":0.0002766814,"threshold_uncertainty_score":0.54843414},"labels":[],"label_agreement":null},{"id":"W2135521451","doi":"10.1158/0008-5472.can-04-3726","title":"Selective Identification of Secreted and Transmembrane Breast Cancer Markers using <i>Escherichia coli</i> Ampicillin Secretion Trap","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Congressionally Directed Medical Research Programs; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Complementary DNA; Biology; Gene; Breast cancer; Escherichia coli; Plasmid; cDNA library; Cancer; Signal peptide; Secretion; Molecular biology; Cancer research; Genetics; Peptide sequence; Biochemistry","score_opus":0.030433264867247622,"score_gpt":0.3390680779725948,"score_spread":0.3086348131053472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135521451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977965,0.00019828996,0.0002705203,0.00082371425,0.000072876974,0.00034320616,0.00016230532,0.00001336306,0.00031923086],"genre_scores_gemma":[0.99829406,0.00081978424,0.00013602493,0.000064984975,0.000080032914,0.000063245105,0.000008137156,0.000017016933,0.0005167412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881035,0.00013452457,0.00023088996,0.00029439174,0.00024803806,0.00028182968],"domain_scores_gemma":[0.99959064,0.00003698227,0.00007496942,0.0001293928,0.00007533382,0.00009268312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038687637,0.00009558252,0.00012651194,0.00006623945,0.00018935051,0.00004054039,0.000120269026,0.000071894974,0.002551224],"category_scores_gemma":[0.0000075467547,0.00009495082,0.000038680235,0.00051463407,0.0003050709,0.0003300462,0.00003912203,0.00026578654,0.000014745742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714657,0.000035820394,0.0009603854,0.000031216947,0.000021737354,3.3951287e-7,0.00062580407,0.00091128936,0.9831768,0.0000030681686,0.0002886619,0.013773392],"study_design_scores_gemma":[0.0005816927,0.00005136109,0.312516,0.00011157385,0.000034775392,0.000010628134,0.00031109474,0.006621464,0.675505,0.000020651094,0.0040310696,0.00020470483],"about_ca_topic_score_codex":0.008936304,"about_ca_topic_score_gemma":0.0026649134,"teacher_disagreement_score":0.31155562,"about_ca_system_score_codex":0.0005154164,"about_ca_system_score_gemma":0.00006297829,"threshold_uncertainty_score":0.9983606},"labels":[],"label_agreement":null},{"id":"W2135546199","doi":"10.1158/0008-5472.can-09-0128","title":"Identification of a Protein, G0S2, That Lacks Bcl-2 Homology Domains and Interacts with and Antagonizes Bcl-2","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Howard Hughes Medical Institute","keywords":"Apoptosis; Cell biology; Biology; Ectopic expression; Gene; Regulator; Homology (biology); Mitochondrion; Tumor necrosis factor alpha; Molecular biology; Genetics; Immunology","score_opus":0.026802258276763236,"score_gpt":0.35021485880088316,"score_spread":0.3234126005241199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135546199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951591,0.0033305099,0.00052376813,0.0005217056,0.00002128287,0.00032318718,0.0000074758573,0.0000036613492,0.00010931881],"genre_scores_gemma":[0.9965629,0.0022033192,0.00011091246,0.000022249116,0.00006365161,0.00003882039,0.000018357647,0.0000080199325,0.0009717866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999268,0.00006872563,0.000108014974,0.000247986,0.00014257281,0.00016473468],"domain_scores_gemma":[0.9995719,0.000008188458,0.000053698615,0.0001745743,0.00013872542,0.000052891017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002919311,0.00006963402,0.000094389,0.0000680485,0.00007651452,0.000027478072,0.00006844569,0.000086859036,0.000008214559],"category_scores_gemma":[0.000016642422,0.000053407643,0.0000132535115,0.00008008004,0.00015987545,0.000006879373,0.000048464564,0.000085317566,5.4416626e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020440303,0.000027566726,0.00046572147,0.000039735416,0.000015495092,0.000002207546,0.00009736259,0.000003418512,0.98240626,0.00041034637,0.00007328566,0.016254192],"study_design_scores_gemma":[0.00060326915,0.00060622534,0.018076938,0.000055575976,0.0000073694073,0.000021768994,0.00015199101,0.000037740356,0.9776312,0.00075191463,0.0019691926,0.000086786706],"about_ca_topic_score_codex":0.00005203196,"about_ca_topic_score_gemma":0.00008847126,"teacher_disagreement_score":0.017611217,"about_ca_system_score_codex":0.00001279838,"about_ca_system_score_gemma":0.00005642367,"threshold_uncertainty_score":0.21779005},"labels":[],"label_agreement":null},{"id":"W2135655765","doi":"10.1158/0008-5472.can-10-2229","title":"Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Immune system; Cancer research; Biology; Tumor progression; Signal transduction; Syk; Breast cancer; Carcinogenesis; Acquired immune system; Receptor tyrosine kinase; Mammary tumor; Tyrosine kinase; Cancer; Immunology; Cell biology","score_opus":0.05529221576837432,"score_gpt":0.4000468603426212,"score_spread":0.34475464457424687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135655765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773043,0.00323562,0.000014724249,0.0147805335,0.00042865652,0.0033802143,0.00058655656,0.00007092853,0.00019846136],"genre_scores_gemma":[0.98913157,0.0012098148,0.00013868802,0.0002501149,0.0006570749,0.0037139202,0.000016511516,0.00015836043,0.004723931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99266744,0.0014586817,0.0007318266,0.0009579157,0.0022214826,0.0019626643],"domain_scores_gemma":[0.99607944,0.0010816875,0.00014913299,0.00088795606,0.0012400023,0.0005617541],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009559749,0.00037019415,0.00056284503,0.00060664164,0.00050888065,0.00017485408,0.0007686718,0.00021321354,0.0031942057],"category_scores_gemma":[0.00065402203,0.00027640696,0.00014408618,0.002576892,0.0010798124,0.00020347782,0.0004334941,0.0049461834,0.00018603734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009419537,0.00018747798,0.0025702568,0.00019482033,0.00005785451,0.000132832,0.0021040014,0.000053769003,0.9628593,0.000018751052,0.010482581,0.011918846],"study_design_scores_gemma":[0.0025999183,0.00044040434,0.0048590824,0.0013804112,0.000016484644,0.000032755288,0.0013142831,0.0003055213,0.9750402,0.00008740732,0.013557595,0.00036591664],"about_ca_topic_score_codex":0.024011534,"about_ca_topic_score_gemma":0.0017974421,"teacher_disagreement_score":0.02221409,"about_ca_system_score_codex":0.0019466603,"about_ca_system_score_gemma":0.004595891,"threshold_uncertainty_score":0.9999688},"labels":[],"label_agreement":null},{"id":"W2135757364","doi":"10.1158/0008-5472.can-10-1128","title":"Keratinocyte-Specific Stat3 Heterozygosity Impairs Development of Skin Tumors in Human Papillomavirus 8 Transgenic Mice","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Torino; York University","keywords":"STAT3; Carcinogenesis; Cancer research; Biology; STAT protein; Transgene; Angiogenesis; Cancer; Epidermis (zoology); Genetically modified mouse; Pathology; Gene; Medicine; Genetics","score_opus":0.10962613377395565,"score_gpt":0.42359346397971853,"score_spread":0.3139673302057629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135757364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779034,0.00024192891,0.00005250342,0.00017521605,0.0001863599,0.00045715072,0.00002434776,0.00002286613,0.0010492965],"genre_scores_gemma":[0.9985138,0.00006223696,0.0006460317,0.00002709583,0.00019749122,0.00013903456,0.000022812364,0.000027675775,0.00036380315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981155,0.000085700296,0.0004753642,0.00033156297,0.00054335437,0.0004485511],"domain_scores_gemma":[0.9990749,0.00008295951,0.000055784472,0.00031479305,0.00029571386,0.00017587347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080052536,0.00013297047,0.00029942716,0.0003833412,0.00019569977,0.000025131194,0.00017993321,0.0000826186,0.0016268111],"category_scores_gemma":[0.00003526262,0.00011999559,0.00008815091,0.0004537674,0.00017834592,0.000076790784,0.00005019735,0.001106914,0.000027410964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022957537,0.00024203048,0.004275733,0.00009474589,0.000026092288,0.00001613769,0.0025663371,0.000009441374,0.9852837,0.000090365655,0.0007740141,0.0063918335],"study_design_scores_gemma":[0.0011775716,0.00019909005,0.05341286,0.0002185761,0.000004760721,0.000009601645,0.00037052974,0.000020070598,0.92494273,0.000030160145,0.019497788,0.00011626505],"about_ca_topic_score_codex":0.0011588138,"about_ca_topic_score_gemma":0.004089169,"teacher_disagreement_score":0.060340963,"about_ca_system_score_codex":0.00026334877,"about_ca_system_score_gemma":0.0005766502,"threshold_uncertainty_score":0.9992858},"labels":[],"label_agreement":null},{"id":"W2136027279","doi":"10.1158/0008-5472.can-13-2845","title":"Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"Autocrine signalling; Cell biology; Cytokine; Biology; Bone morphogenetic protein; Effector; Immunology; Receptor","score_opus":0.02450043488564107,"score_gpt":0.3414542810229115,"score_spread":0.3169538461372704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136027279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963521,0.002282352,0.00019827273,0.00008944065,0.00025365394,0.000662183,0.000013474203,0.000027261234,0.00012130197],"genre_scores_gemma":[0.99336696,0.000011949459,0.00035395965,0.000035095738,0.0005601253,0.0006454617,0.00011898741,0.000053951455,0.004853496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976622,0.00046795412,0.00025603658,0.00057407585,0.0004150585,0.0006246846],"domain_scores_gemma":[0.9990612,0.000055304146,0.000048791542,0.00046646333,0.00020299376,0.00016520217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080500194,0.00018462587,0.0001839927,0.00018790823,0.00026267214,0.000058458198,0.00031178715,0.00012911357,0.00023703079],"category_scores_gemma":[0.00022646642,0.00018036229,0.00008602465,0.0002753576,0.00014982569,0.0000055413566,0.0002182681,0.00048547896,0.00007626153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019502093,0.00008832425,0.00048797036,0.00008713501,0.000026226238,0.000009899812,0.000028919621,0.006402136,0.9893326,0.000008689687,0.0027533758,0.00057967147],"study_design_scores_gemma":[0.0008628147,0.00036365882,0.0016106017,0.00013242428,0.000008464601,0.0000023753098,0.000026246535,0.000407086,0.97183216,0.000012401462,0.02450048,0.00024131035],"about_ca_topic_score_codex":0.00023932112,"about_ca_topic_score_gemma":0.00015941664,"teacher_disagreement_score":0.021747103,"about_ca_system_score_codex":0.00010639033,"about_ca_system_score_gemma":0.00020692883,"threshold_uncertainty_score":0.73549604},"labels":[],"label_agreement":null},{"id":"W2136090166","doi":"10.1158/0008-5472.can-05-0516","title":"Lysophosphatidic Acid Acyltransferase-β Is a Prognostic Marker and Therapeutic Target in Gynecologic Malignancies","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Lysophosphatidic acid; Ovarian cancer; Cancer research; Autocrine signalling; Chemistry; Cancer; Internal medicine; Endocrinology; Biology; Medicine; Receptor","score_opus":0.03571514133970627,"score_gpt":0.33820562696031425,"score_spread":0.302490485620608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136090166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415836,0.056643456,0.00006903191,0.0010498704,0.00006725866,0.0003525587,0.000017994713,0.000008853939,0.0002073912],"genre_scores_gemma":[0.99210745,0.0057937335,0.0002681517,0.00085908134,0.00029943092,0.00019064709,0.000009861568,0.000023252705,0.00044836666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984566,0.00015778295,0.00018374044,0.0004202444,0.00024767098,0.0005339464],"domain_scores_gemma":[0.999482,0.00005338717,0.00002033296,0.00022675957,0.00011398258,0.000103534454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000783088,0.00014007762,0.00016819756,0.00010804385,0.00011762546,0.000047927617,0.00020730551,0.00013617358,0.00035061335],"category_scores_gemma":[0.00013308667,0.00012180862,0.0000430206,0.00025177072,0.00017869883,0.0000072175576,0.000088133114,0.00021940861,0.000013635197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013329404,0.000055582357,0.051313967,0.000045571614,0.00003058208,0.0000064060832,0.00040571947,0.00003361663,0.9373993,0.000094342395,0.0006035438,0.009878041],"study_design_scores_gemma":[0.0011005215,0.00016836285,0.054894786,0.000049488477,0.000011761214,0.000006660477,0.00021728959,0.0001396408,0.8952748,0.00033979592,0.047554046,0.00024282119],"about_ca_topic_score_codex":0.00006822668,"about_ca_topic_score_gemma":0.00009781495,"teacher_disagreement_score":0.050849725,"about_ca_system_score_codex":0.00003395052,"about_ca_system_score_gemma":0.00020383923,"threshold_uncertainty_score":0.49672112},"labels":[],"label_agreement":null},{"id":"W2136244657","doi":"10.1158/0008-5472.can-10-0749","title":"Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Small interfering RNA; Cancer research; Hepatocellular carcinoma; Ubiquitin; Biology; Cell growth; Growth inhibition; Blockade; Cell culture; Chemistry; Transfection; Receptor; Gene; Biochemistry; Genetics","score_opus":0.07538696647647183,"score_gpt":0.35911137041695324,"score_spread":0.2837244039404814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136244657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952269,0.00048382007,0.00015934352,0.00011423847,0.00007230846,0.00038982695,0.00004302735,0.000005891919,0.0035046032],"genre_scores_gemma":[0.9988038,0.000040998137,0.00041285076,0.00005841792,0.0001768153,0.00023064467,0.000105417224,0.00002368858,0.00014736912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988216,0.00009812261,0.00018928476,0.000288918,0.00029604556,0.00030603932],"domain_scores_gemma":[0.9992844,0.000017935856,0.000052019055,0.00029887856,0.00027513035,0.0000716595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074544636,0.00009683922,0.000119327604,0.0001370032,0.000087905064,0.000017530343,0.00021667409,0.0001780881,0.00021786656],"category_scores_gemma":[0.00008397935,0.000099015866,0.000048380338,0.00019907198,0.00016099378,0.000005374721,0.000089988476,0.00034241562,0.000008936105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062806685,0.00009030819,0.022110377,0.00005504181,0.000009008282,0.0000023607108,0.000109024324,0.000002369495,0.96809804,0.009109484,0.00004236201,0.00030878934],"study_design_scores_gemma":[0.0006328591,0.00024350264,0.0073276283,0.000021027407,0.000002399799,0.0000039827396,0.00005988774,0.00010773095,0.9840745,0.0057501527,0.0016676624,0.000108680295],"about_ca_topic_score_codex":0.00056227064,"about_ca_topic_score_gemma":0.00017770739,"teacher_disagreement_score":0.015976418,"about_ca_system_score_codex":0.000031672,"about_ca_system_score_gemma":0.00025351517,"threshold_uncertainty_score":0.40377498},"labels":[],"label_agreement":null},{"id":"W2136357864","doi":"10.1158/0008-5472.can-06-3191","title":"Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Taiwan University; National Health Research Institutes","keywords":"Sulfasalazine; Cancer research; Receptor tyrosine kinase; Metastasis; Gefitinib; Lung cancer; Cancer; Medicine; Epidermal growth factor receptor; Biology; Pharmacology; Internal medicine; Receptor","score_opus":0.04174750058290603,"score_gpt":0.3497060818952645,"score_spread":0.3079585813123584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136357864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92226756,0.07635595,0.00013031827,0.00019583793,0.00023099495,0.00023601443,0.000021460242,0.000016421303,0.00054546446],"genre_scores_gemma":[0.9945486,0.0011204369,0.000041335436,0.000012493126,0.000044675275,0.000024971601,0.000020870992,0.000018938354,0.004167633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985257,0.00026584702,0.00030062,0.0003038117,0.00011348158,0.000490581],"domain_scores_gemma":[0.9987856,0.00047618087,0.000095466814,0.00030570434,0.0003029543,0.00003405978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012174918,0.00011748385,0.00025284893,0.00021825249,0.00024992725,0.000022783635,0.00023674838,0.00012895124,0.00023682474],"category_scores_gemma":[0.000078119934,0.00010725604,0.000039704424,0.00029365186,0.0004650211,0.00016266361,0.00017339391,0.00031664644,0.000011150297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038889082,0.000040842362,0.009632456,0.00021237915,0.00004769266,0.0000044606318,0.0007261504,0.0000045827665,0.98138,0.000340535,0.0058959965,0.0013260345],"study_design_scores_gemma":[0.00073876366,0.000022258346,0.058055613,0.00025160264,0.000011977566,0.0000036193217,0.00027328078,0.0000019885724,0.931592,0.000115924406,0.00882994,0.00010304014],"about_ca_topic_score_codex":0.00027747086,"about_ca_topic_score_gemma":0.00018265388,"teacher_disagreement_score":0.07523551,"about_ca_system_score_codex":0.00008905071,"about_ca_system_score_gemma":0.00013304909,"threshold_uncertainty_score":0.43737742},"labels":[],"label_agreement":null},{"id":"W2136415416","doi":"10.1158/0008-5472.can-09-1089","title":"Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; RIKEN; Howard Hughes Medical Institute","keywords":"Wnt signaling pathway; Hepatocellular carcinoma; Transcriptome; Cancer research; Biology; Gene; Cancer; Computational biology; Liver cancer; Gene expression; Genetics","score_opus":0.13899146074986196,"score_gpt":0.4005337659510201,"score_spread":0.2615423052011581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136415416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868346,0.005784167,0.00008713109,0.0012377223,0.000028746912,0.00092384825,0.000041293784,0.000040365598,0.0031732637],"genre_scores_gemma":[0.9980592,0.0002138106,0.0001081252,0.0001138253,0.000078432095,0.00014351714,0.0001438408,0.000027675516,0.0011115515],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705297,0.00043020846,0.00047739924,0.00049227494,0.0009587789,0.0005883881],"domain_scores_gemma":[0.9981915,0.00009339073,0.00008774165,0.0006539158,0.00066452386,0.00030894965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007797436,0.0002542013,0.0008984603,0.0010007834,0.00016067982,0.00003355741,0.00026361636,0.00016272935,0.00052388717],"category_scores_gemma":[0.00004556787,0.00020490956,0.0005472847,0.0026168157,0.00025999921,0.00008632356,0.000030715768,0.00052399054,0.000013882352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013562122,0.00020879266,0.54697216,0.00007185372,0.0005001502,0.00032802715,0.0006018191,6.0157845e-7,0.44944417,0.0006680542,0.0003157301,0.0007530277],"study_design_scores_gemma":[0.0014171323,0.0019401518,0.20136015,0.00018137228,0.0014258005,0.0000067280107,0.0003943032,0.00050277705,0.7910655,0.0010354128,0.00044171247,0.00022894442],"about_ca_topic_score_codex":0.0013525197,"about_ca_topic_score_gemma":0.00008301808,"teacher_disagreement_score":0.345612,"about_ca_system_score_codex":0.00029993287,"about_ca_system_score_gemma":0.0002254748,"threshold_uncertainty_score":0.835597},"labels":[],"label_agreement":null},{"id":"W2136436270","doi":"10.1158/0008-5472.can-10-4222","title":"Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Antibody-dependent cell-mediated cytotoxicity; Monoclonal antibody; Immunotherapy; In vivo; Antibody; Biology; Immune system; Fc receptor; Antigen; Cytotoxicity; Immunology; Cancer research; Molecular biology; In vitro; Biochemistry","score_opus":0.0855082650429859,"score_gpt":0.3982245960752643,"score_spread":0.31271633103227836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136436270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97195536,0.006913881,0.000020425432,0.00033985355,0.00014306203,0.0010119069,0.000052066025,0.000054246404,0.019509178],"genre_scores_gemma":[0.9785191,0.014097887,0.00016848386,0.00011054409,0.00037525778,0.00016512448,0.000049000515,0.000071009716,0.0064435927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954064,0.0002501528,0.00051996903,0.00073055644,0.0014678302,0.0016251112],"domain_scores_gemma":[0.9983856,0.00017065843,0.00007340437,0.00056287955,0.00040077648,0.00040666672],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013648142,0.00030306165,0.0005462741,0.0007512867,0.0003422159,0.000061384875,0.00059816515,0.00014941955,0.0033472327],"category_scores_gemma":[0.000049276558,0.00025100796,0.0001713834,0.00093600963,0.00047506287,0.00021534997,0.0003285642,0.0015036073,0.00037903312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00328835,0.00056697807,0.1192289,0.0004449673,0.000055084714,0.0011357508,0.001567446,0.0000011040364,0.87277794,0.00017992241,0.0001912886,0.0005622664],"study_design_scores_gemma":[0.0023025502,0.00046609223,0.3182529,0.00035000988,0.000005239605,0.00010823952,0.00055833266,0.000022466164,0.67389876,0.00024830078,0.0035076053,0.00027953374],"about_ca_topic_score_codex":0.006360968,"about_ca_topic_score_gemma":0.00031226448,"teacher_disagreement_score":0.199024,"about_ca_system_score_codex":0.0005674295,"about_ca_system_score_gemma":0.0005010137,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W2136443348","doi":"10.1158/0008-5472.can-07-0080","title":"Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; Pretargeting; CD20; Lymphoma; Raji cell; Medicine; Cancer research; Biodistribution; Antigen; Ibritumomab tiuxetan; CD22; Antibody; Immunology; Monoclonal antibody; Chemistry","score_opus":0.13587631984553242,"score_gpt":0.46846264311062596,"score_spread":0.3325863232650935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136443348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97230136,0.024452941,0.00004435754,0.00027146935,0.000058294623,0.0010056875,0.000017991484,0.0000055139435,0.0018423825],"genre_scores_gemma":[0.99692535,0.0019272713,0.0005476409,0.000025290177,0.00009420715,0.0001850695,0.0000121905105,0.000016475358,0.00026647828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834526,0.00008383534,0.00025061125,0.00018123646,0.00087795814,0.00026109032],"domain_scores_gemma":[0.9982195,0.0003448246,0.00007448682,0.00018080197,0.0011075294,0.00007287231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004698478,0.000073362775,0.00022034267,0.00016066546,0.000061881154,0.000006121604,0.00004967827,0.000057034405,0.00014571921],"category_scores_gemma":[0.00018787285,0.000058349022,0.00005953214,0.00020637675,0.00012429153,0.000032602962,0.000019762472,0.00004905104,0.0000012962441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013460818,0.0009226813,0.05082442,0.00052825967,0.00028863022,0.0000055902237,0.0013485798,0.000014019777,0.6585395,0.0003859918,0.0030784179,0.28271788],"study_design_scores_gemma":[0.012115597,0.0006860111,0.052670572,0.00018847134,0.00013414209,0.000002945929,0.0003948009,0.00035634075,0.92795235,0.00027761894,0.0051584626,0.00006269994],"about_ca_topic_score_codex":0.00058375526,"about_ca_topic_score_gemma":0.000023656035,"teacher_disagreement_score":0.28265518,"about_ca_system_score_codex":0.00045551782,"about_ca_system_score_gemma":0.0005658998,"threshold_uncertainty_score":0.23794042},"labels":[],"label_agreement":null},{"id":"W2136489225","doi":"10.1158/0008-5472.can-12-3931","title":"The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research","funders":"","keywords":"Metastasis; Biology; Tumor microenvironment; Cancer research; Medicine; Cancer; Internal medicine; Tumor cells","score_opus":0.2776940276123176,"score_gpt":0.5428467811171697,"score_spread":0.26515275350485207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136489225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008539746,0.9890195,2.971807e-7,0.0006708442,0.00007073103,0.0015295205,0.00007065855,0.0000027132044,0.00009594916],"genre_scores_gemma":[0.002532252,0.9962163,0.000025881533,0.000041904772,0.000088773675,0.0007409085,0.000015945503,0.00001384209,0.00032418835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969897,0.0018494424,0.00044249443,0.00032984838,0.00008615041,0.0003023296],"domain_scores_gemma":[0.9977916,0.0013018256,0.00013510212,0.00063913903,0.00006890189,0.000063422434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011388251,0.00012548712,0.0007358967,0.00007899186,0.00013343342,0.000004323566,0.0003481795,0.00030464,0.00009500737],"category_scores_gemma":[0.00019123773,0.00005692619,0.00017885164,0.00020496512,0.0016337758,0.000011116188,0.0004027057,0.0011583575,0.00005058909],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019861956,0.00007101206,0.0024307151,0.0007071449,0.00020977974,0.0000010344561,0.000055754943,3.730892e-8,0.00054161076,0.00032629436,0.00040231674,0.99523443],"study_design_scores_gemma":[0.00030580745,0.00013488915,0.023220997,0.0009798827,0.00027249934,0.000016160351,0.000047175243,0.0000018176288,0.00004639241,0.00034565417,0.97456414,0.00006461188],"about_ca_topic_score_codex":0.00026824832,"about_ca_topic_score_gemma":0.00006866864,"teacher_disagreement_score":0.9951698,"about_ca_system_score_codex":0.00009091007,"about_ca_system_score_gemma":0.00035878256,"threshold_uncertainty_score":0.6019715},"labels":[],"label_agreement":null},{"id":"W2136544650","doi":"10.1158/0008-5472.can-08-3363","title":"Cell Type–Specific Targeted Mutations of <i>Kras</i> and <i>Pten</i> Document Proliferation Arrest in Granulosa Cells versus Oncogenic Insult to Ovarian Surface Epithelial Cells","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute","keywords":"PTEN; Biology; Cancer research; Cell growth; Granulosa cell; Cell biology; Endocrinology; Signal transduction; PI3K/AKT/mTOR pathway; Ovary; Genetics","score_opus":0.04896954379738093,"score_gpt":0.3654261816708621,"score_spread":0.31645663787348116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136544650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943581,0.0014928103,0.00002875831,0.0017010656,0.00043879522,0.0013018732,0.00005506402,0.000015644027,0.0006078437],"genre_scores_gemma":[0.9981995,0.0006828983,0.00033564,0.00009518889,0.00018869333,0.000039497307,0.000036853195,0.000011114229,0.0004106082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981704,0.00027633962,0.00032102392,0.00051474036,0.0003483113,0.0003692055],"domain_scores_gemma":[0.9987655,0.00012579538,0.000049652335,0.00038222634,0.0004999252,0.00017688077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009637726,0.00013177517,0.0002733662,0.00015476604,0.0001036648,0.00001711607,0.00011093774,0.00012771651,0.00008515433],"category_scores_gemma":[0.00010580537,0.00011577472,0.000036503516,0.00072145177,0.0001998332,0.00008039474,0.000039444578,0.00041676074,0.000042979806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011024129,0.00025995768,0.0013505523,0.000050523635,0.000017438437,0.0000124377975,0.0010428048,0.00017079234,0.9833557,0.00004073438,0.0013378519,0.0013370865],"study_design_scores_gemma":[0.0026260656,0.0010363291,0.048133668,0.000037799695,0.000015104484,9.677082e-7,0.00017394814,0.000018507422,0.9433465,0.00022527124,0.0042754593,0.00011039268],"about_ca_topic_score_codex":0.00027280746,"about_ca_topic_score_gemma":0.000074801355,"teacher_disagreement_score":0.046783116,"about_ca_system_score_codex":0.0002227994,"about_ca_system_score_gemma":0.00036334503,"threshold_uncertainty_score":0.47211558},"labels":[],"label_agreement":null},{"id":"W2136549416","doi":"10.1158/0008-5472.can-12-3950","title":"Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Carcinogenesis; Mutation; Fibroblast growth factor receptor; Tyrosine kinase; Biology; Lung cancer; Fibroblast growth factor receptor 1; Tyrosine-kinase inhibitor; Receptor tyrosine kinase; Squamous-cell carcinoma of the lung; Fibroblast growth factor; Cancer; Carcinoma; Kinase; Internal medicine; Receptor; Medicine; Gene; Genetics","score_opus":0.023639438675803225,"score_gpt":0.33434830020687,"score_spread":0.3107088615310668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136549416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957347,0.0012573553,0.000019070741,0.0004159836,0.00004685801,0.00065648666,0.000026042608,0.0000073517817,0.0018361633],"genre_scores_gemma":[0.99732363,0.00008343043,0.000052042153,0.000041319207,0.00018770601,0.00034335605,0.0000426637,0.000034642955,0.0018911986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804974,0.00027484616,0.00016934497,0.00048144837,0.00037998584,0.00064461905],"domain_scores_gemma":[0.998986,0.00010093696,0.000023192893,0.00029531075,0.0003905537,0.00020401346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003744255,0.00013201822,0.00012587017,0.0002315228,0.00013882323,0.00008219824,0.00018293087,0.00015325489,0.00014171588],"category_scores_gemma":[0.00018464975,0.0001305449,0.000033727232,0.0003504878,0.00032536002,0.0000138767355,0.00032801155,0.00043720202,0.00006524615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005323618,0.00004190938,0.03849167,0.00009175848,0.0000050013764,0.000014308956,0.00025553652,0.00002336111,0.9552513,0.0000178819,0.0052679083,0.0004861613],"study_design_scores_gemma":[0.0009074572,0.0002803182,0.14127745,0.000021259295,0.0000024236363,0.0000062609333,0.0006409817,0.00026945726,0.85533965,0.00006476615,0.0009997651,0.0001902279],"about_ca_topic_score_codex":0.0025713355,"about_ca_topic_score_gemma":0.00038374303,"teacher_disagreement_score":0.10278577,"about_ca_system_score_codex":0.000120218414,"about_ca_system_score_gemma":0.00030707745,"threshold_uncertainty_score":0.5323466},"labels":[],"label_agreement":null},{"id":"W2136580161","doi":"","title":"Oviduct-specific glycoprotein (OVGP1), a new serum biomarker for the detection of ovarian cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Immunohistochemistry; Oviduct; Biology; Cystadenocarcinoma; Ovarian cancer; Glycoprotein; Clear cell; Polyclonal antibodies; Antibody; Monoclonal antibody; Pathology; Serous carcinoma; Monoclonal; Cancer; Ovary; Endometrium; Cancer research; Medicine; Immunology; Molecular biology; Endocrinology","score_opus":0.1933657799724145,"score_gpt":0.4175337521712154,"score_spread":0.2241679721988009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136580161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.788223,0.12562172,0.003707474,0.067786776,0.0021408396,0.010158261,0.0004233993,0.00012594985,0.0018125786],"genre_scores_gemma":[0.9794584,0.0122434255,0.00024582713,0.00014403508,0.0010619021,0.0025082338,0.000005737469,0.000048079914,0.0042843516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979948,0.000076355216,0.00028103663,0.0004367449,0.0006774905,0.00053361856],"domain_scores_gemma":[0.9983553,0.00028289188,0.000078353034,0.0005882452,0.0004784668,0.00021669315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005032442,0.00016371494,0.00030627224,0.00019094998,0.00038148585,0.000023462913,0.00019039056,0.00010903436,0.0014118261],"category_scores_gemma":[0.00007046487,0.000108805005,0.00016481735,0.0007929867,0.00026823021,0.00007099324,0.00005901012,0.00028308737,0.00002205632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044488558,0.000451121,0.017879955,0.00037831676,0.0010651895,0.00006683434,0.0013983853,0.000039215425,0.14179085,0.0006081835,0.095905475,0.73596764],"study_design_scores_gemma":[0.0060841297,0.000678452,0.20147856,0.00034635075,0.00011664015,0.000039319402,0.00016738253,0.00011330579,0.25302598,0.0002573449,0.5375171,0.0001754351],"about_ca_topic_score_codex":0.010022827,"about_ca_topic_score_gemma":0.0013607938,"teacher_disagreement_score":0.73579216,"about_ca_system_score_codex":0.000701522,"about_ca_system_score_gemma":0.0013015838,"threshold_uncertainty_score":0.999501},"labels":[],"label_agreement":null},{"id":"W2136675669","doi":"10.1158/0008-5472.can-05-2839","title":"Telomerase- and Alternative Telomere Lengthening–Independent Telomere Stabilization in a Metastasis-Derived Human Non–Small Cell Lung Cancer Cell Line: Effect of Ectopic hTERT","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Telomerase; Telomere; Telomerase reverse transcriptase; Cancer research; Biology; Cancer; Cell culture; Cancer cell; Metastasis; Molecular biology; Genetics; DNA","score_opus":0.03565672414768492,"score_gpt":0.3711631989922156,"score_spread":0.33550647484453067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136675669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827407,0.01262599,0.000043190004,0.00020486969,0.0001750371,0.0023150255,0.00008559538,0.000051489515,0.0017580916],"genre_scores_gemma":[0.9942098,0.0029728855,0.00014773486,0.000048552676,0.000365986,0.0006623205,0.00005475119,0.000102111844,0.0014358031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99530804,0.0005874405,0.00084030326,0.0010323314,0.0011823012,0.001049553],"domain_scores_gemma":[0.99778134,0.00048260868,0.0002622877,0.0006269652,0.00053790974,0.00030887334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013257752,0.0005009397,0.001043411,0.00076422666,0.00025206295,0.000072128234,0.00038016154,0.0002448303,0.0006250851],"category_scores_gemma":[0.00009945648,0.00042757977,0.00015896042,0.0010890649,0.0003944782,0.00020835751,0.00023197815,0.0009650026,0.000007692428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071067055,0.00042760812,0.274821,0.003255171,0.00010350438,0.00014555074,0.0019007077,0.0002992891,0.7113072,0.000049061433,0.00027030692,0.0067099086],"study_design_scores_gemma":[0.0064494843,0.0009795061,0.080704704,0.0009365918,0.0001750876,0.000009953021,0.00064890506,0.0008842816,0.9083652,0.00005461651,0.00033847117,0.0004531958],"about_ca_topic_score_codex":0.029746868,"about_ca_topic_score_gemma":0.0072434,"teacher_disagreement_score":0.19705799,"about_ca_system_score_codex":0.00087289145,"about_ca_system_score_gemma":0.00056121097,"threshold_uncertainty_score":0.9998176},"labels":[],"label_agreement":null},{"id":"W2136715524","doi":"10.1158/0008-5472.can-09-3421","title":"Impaired SHP2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Growth Factor Receptor–Activating Mutations","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Howard Hughes Medical Institute","keywords":"Gefitinib; Epidermal growth factor receptor; Cancer research; Lung cancer; Extracellular; Epidermal growth factor; Kinase; Cancer; Signal transduction; Biology; Receptor; Medicine; Internal medicine; Cell biology","score_opus":0.032393143749651854,"score_gpt":0.37646347192751584,"score_spread":0.344070328177864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136715524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101806,0.00029966971,0.001094273,0.004288466,0.00018876494,0.0021563426,0.00076462986,0.00008483341,0.00010495245],"genre_scores_gemma":[0.99724364,0.000051757874,0.0006303127,0.000109503315,0.00023783291,0.00074187585,0.0003505177,0.0000658985,0.00056863856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973388,0.00027306683,0.00041425016,0.0005333027,0.00077137735,0.000669244],"domain_scores_gemma":[0.9957318,0.0011300592,0.00018958843,0.00034231995,0.002221915,0.00038434612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065896113,0.0002588083,0.0004657213,0.0004535976,0.0003582857,0.000053757165,0.000101774946,0.00017762388,0.00090488256],"category_scores_gemma":[0.0005652724,0.0002098086,0.0000868056,0.0013772681,0.00027132503,0.00025993443,0.000052656815,0.0007147028,0.000014119258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007014063,0.00027109563,0.024831036,0.00020980887,0.00047518234,0.00003120216,0.0011900316,0.0003132436,0.9665714,0.00008031938,0.0013156282,0.0040096594],"study_design_scores_gemma":[0.0027121522,0.00024529026,0.06108764,0.0005834906,0.00013038993,0.000003986556,0.00032046696,0.001572171,0.9322783,0.000018608416,0.00083259324,0.00021494964],"about_ca_topic_score_codex":0.007863824,"about_ca_topic_score_gemma":0.00090526365,"teacher_disagreement_score":0.036256604,"about_ca_system_score_codex":0.0007203757,"about_ca_system_score_gemma":0.0016114603,"threshold_uncertainty_score":0.9987429},"labels":[],"label_agreement":null},{"id":"W2136950738","doi":"10.1158/0008-5472.can-03-2517","title":"Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Autocrine signalling; Apoptosis; Signal transduction; Biology; Cancer research; Translation (biology); Cell biology; Cytokine; EIF4E; Initiation factor; Messenger RNA; Immunology; Cell culture; Gene; Biochemistry; Genetics","score_opus":0.036652434498755354,"score_gpt":0.34824676347203776,"score_spread":0.31159432897328243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136950738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998001,0.0006129435,0.0005302342,0.00029834444,0.000034507073,0.00021290762,0.000054645698,0.000002117654,0.00025330068],"genre_scores_gemma":[0.99901986,0.00009562711,0.00017189338,0.000010855813,0.00009458361,0.000059838792,0.0000733185,0.000008662723,0.00046533527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999214,0.000045270408,0.00018484589,0.00017179205,0.0002455896,0.00013848729],"domain_scores_gemma":[0.9994225,0.000006031828,0.000047988593,0.00016047969,0.0003291443,0.000033845045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020904913,0.000057582063,0.000089179295,0.00006397185,0.000027012937,0.0000051598745,0.00014189373,0.00009003436,0.000070141105],"category_scores_gemma":[0.00002904529,0.000054800166,0.000052057978,0.00012667412,0.00014431655,0.0000046995583,0.00003374008,0.000084370855,0.0000029770094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021036527,0.000048441005,0.00019478082,0.0000418209,0.000025591235,5.8328766e-8,0.00009119045,0.00011743551,0.9959953,0.00011654627,0.0011470104,0.0020114742],"study_design_scores_gemma":[0.0004452578,0.00031646236,0.0005630385,0.00008961424,0.0000025859442,2.522405e-7,0.00005030626,0.000005101328,0.9967605,0.00046971053,0.0012444207,0.00005276905],"about_ca_topic_score_codex":0.00020680223,"about_ca_topic_score_gemma":0.000043422642,"teacher_disagreement_score":0.0019587053,"about_ca_system_score_codex":0.000022762335,"about_ca_system_score_gemma":0.00019396872,"threshold_uncertainty_score":0.22346859},"labels":[],"label_agreement":null},{"id":"W2136961532","doi":"10.1158/0008-5472.can-12-4258","title":"Targeting Sonic Hedgehog-Associated Medulloblastoma through Inhibition of Aurora and Polo-like Kinases","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medulloblastoma; Sonic hedgehog; Cancer research; Cell cycle; Biology; Cell cycle checkpoint; Aurora inhibitor; Patched; Hedgehog signaling pathway; Apoptosis; Cell biology; Signal transduction; Genetics","score_opus":0.04969056883732557,"score_gpt":0.3584216203576166,"score_spread":0.308731051520291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136961532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928009,0.005993816,0.000038573886,0.00043329128,0.00008140146,0.0003055519,0.000031327163,0.000014763597,0.000300398],"genre_scores_gemma":[0.9977262,0.001291725,0.00010837245,0.00009687746,0.00014603454,0.00015795037,0.000040161565,0.000026255122,0.00040641337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984931,0.00019419058,0.00021496708,0.00035310505,0.00029072378,0.00045395797],"domain_scores_gemma":[0.9990555,0.00006364269,0.000073482865,0.00019150742,0.00054202194,0.000073843476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004437708,0.00012729483,0.00018213439,0.000062686406,0.00019330451,0.000029212995,0.00012234563,0.00013660028,0.00007760233],"category_scores_gemma":[0.00049653894,0.00011831645,0.00004500006,0.00022910518,0.0004045939,0.0000101685855,0.00027070704,0.0001841541,0.00001495507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003089483,0.000042666816,0.0023606198,0.00006347684,0.00006451089,0.0000023838465,0.0003327796,0.000019149771,0.9860236,0.00003057357,0.010298673,0.00073069375],"study_design_scores_gemma":[0.00064297824,0.00045844878,0.004418984,0.0001443556,0.000010868602,0.0000018999555,0.001054256,0.000039625364,0.987687,0.0003379546,0.0050057247,0.0001979072],"about_ca_topic_score_codex":0.00094086665,"about_ca_topic_score_gemma":0.00012819971,"teacher_disagreement_score":0.005292949,"about_ca_system_score_codex":0.000056111534,"about_ca_system_score_gemma":0.00016265194,"threshold_uncertainty_score":0.48248047},"labels":[],"label_agreement":null},{"id":"W2136989123","doi":"10.1158/1538-7445.am2015-sy43-02","title":"Abstract SY43-02: Mismatch repair, gut microbiota, and the etiology of colon cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gut flora; Colorectal cancer; Phenocopy; DNA mismatch repair; MLH1; Butyrate; Cancer; MSH2; Cancer research; DNA repair; Medicine; Biology; Immunology; Internal medicine; Genetics; DNA; Gene; Biochemistry; Phenotype","score_opus":0.13538131165910125,"score_gpt":0.44210652765088515,"score_spread":0.30672521599178393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136989123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730221,0.016666036,0.0000018586865,0.005257323,0.00048146115,0.00091854454,0.000040826562,0.000031419877,0.0035804035],"genre_scores_gemma":[0.9938029,0.0026798453,0.00017529687,0.00032048507,0.00029406324,0.00038075034,0.000004751044,0.000030266914,0.0023116241],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99801093,0.00024275159,0.0003143311,0.00037904785,0.000563142,0.00048981427],"domain_scores_gemma":[0.9979313,0.00044141867,0.0000865662,0.00047479037,0.0008337721,0.00023215738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001841852,0.00014582556,0.00042502093,0.00012858653,0.00009217659,0.000015236072,0.00022385409,0.00018731796,0.00081949716],"category_scores_gemma":[0.0004672282,0.00009534069,0.00008723483,0.00036202872,0.0015442586,0.00002928589,0.00018561618,0.0006447022,0.000023617491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009014985,0.00015358336,0.03969232,0.000886875,0.00041525334,0.0000467897,0.0042149145,0.000082446284,0.67030406,0.00036021855,0.26464072,0.010187827],"study_design_scores_gemma":[0.031001564,0.0031082013,0.3384415,0.0017853098,0.00041092513,0.00023491922,0.0044619795,0.00045402354,0.32268998,0.0025223105,0.2939912,0.0008980963],"about_ca_topic_score_codex":0.0075245593,"about_ca_topic_score_gemma":0.001440926,"teacher_disagreement_score":0.3476141,"about_ca_system_score_codex":0.00044241524,"about_ca_system_score_gemma":0.0013285406,"threshold_uncertainty_score":0.9990844},"labels":[],"label_agreement":null},{"id":"W2137267184","doi":"10.1158/0008-5472.can-11-3132","title":"<i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":483,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"PTEN; Cancer research; Prostate cancer; Metastasis; PI3K/AKT/mTOR pathway; Progenitor cell; MAPK/ERK pathway; Protein kinase B; Cancer; Cancer stem cell; Medicine; Prostate; Stem cell; Biology; Signal transduction; Internal medicine; Cell biology","score_opus":0.08197185588993593,"score_gpt":0.388698260547377,"score_spread":0.30672640465744105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137267184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877082,0.009729804,0.00008203246,0.0005925235,0.00031158864,0.0008952778,0.0006123174,0.00001905332,0.00004917997],"genre_scores_gemma":[0.9944875,0.0026676087,0.000217916,0.00036611705,0.0007505081,0.0007846866,0.00007780501,0.00006437192,0.00058344327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997823,0.00023847353,0.00023068053,0.0006008365,0.00039113674,0.00071588275],"domain_scores_gemma":[0.9986557,0.000043730874,0.00006890214,0.00034707307,0.0004956096,0.00038898666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065183255,0.00023026756,0.00023244722,0.0000976991,0.0002195037,0.00011698825,0.00020411331,0.00016767623,0.000098478646],"category_scores_gemma":[0.000057146262,0.00021088553,0.000032964053,0.000342016,0.00022616508,0.000033444467,0.00029305066,0.00028196376,0.000015567315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047098895,0.00004337885,0.0056145717,0.000071347145,0.0001630539,0.0000029811536,0.00055787485,0.000039292074,0.9738874,0.0000046364053,0.0036134473,0.01553106],"study_design_scores_gemma":[0.0006984391,0.00018132788,0.000967567,0.000104714425,0.000029343608,0.0000021199496,0.00011123742,0.000022602446,0.94407195,0.000013397745,0.0535388,0.00025849696],"about_ca_topic_score_codex":0.0011667927,"about_ca_topic_score_gemma":0.00014374842,"teacher_disagreement_score":0.049925353,"about_ca_system_score_codex":0.00012890963,"about_ca_system_score_gemma":0.00033059018,"threshold_uncertainty_score":0.8599662},"labels":[],"label_agreement":null},{"id":"W2137349242","doi":"10.1158/0008-5472.can-14-0108","title":"Emergence, Involution, and Progression to Carcinoma of Mutant Clones in Normal Endometrial Tissues","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"PTEN; Carcinogenesis; Endometrial cancer; Biology; Carcinoma; Cancer research; Pathology; Oncology; Cancer; Internal medicine; Medicine; Genetics","score_opus":0.07596648738764479,"score_gpt":0.4356516464816572,"score_spread":0.35968515909401244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137349242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279594,0.0034300284,0.000013022997,0.0021882446,0.00015208796,0.000698046,0.0000116808205,0.0000072902303,0.0007036355],"genre_scores_gemma":[0.99793303,0.000996937,0.00028841014,0.00003072739,0.0002916537,0.00035058052,0.0000045014303,0.000011553997,0.000092630304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986074,0.00011320235,0.0002250894,0.00026667342,0.0004801949,0.00030744507],"domain_scores_gemma":[0.99925107,0.0001160098,0.00003134047,0.00019791858,0.00022078892,0.00018286583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000704957,0.00008222479,0.00025288798,0.00045636776,0.00005544317,0.000010278544,0.00006915703,0.000052037332,0.00026690034],"category_scores_gemma":[0.0002458969,0.00006326658,0.000026344684,0.00083450216,0.000107299056,0.00004546237,0.00008903384,0.00014188782,0.000009440538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085834536,0.00024996532,0.89226234,0.00020165967,0.000027785443,0.000026472217,0.00078982033,0.000005421228,0.015103754,0.0006226966,0.00222186,0.08762985],"study_design_scores_gemma":[0.004800455,0.0024093748,0.80232245,0.00066087814,0.00002661191,0.0000076086094,0.00026484253,0.00009972479,0.17446487,0.00015541313,0.014665898,0.00012186547],"about_ca_topic_score_codex":0.0023109883,"about_ca_topic_score_gemma":0.0005618883,"teacher_disagreement_score":0.15936111,"about_ca_system_score_codex":0.00011805657,"about_ca_system_score_gemma":0.00018089516,"threshold_uncertainty_score":0.34935385},"labels":[],"label_agreement":null},{"id":"W2137429553","doi":"10.1158/0008-5472.can-15-0236","title":"Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canadian Institutes of Health Research; Rosetrees Trust; Cancer Research UK; Wellcome Trust","keywords":"Bromodomain; Cancer research; Cancer; Leukemia; Small molecule; Cancer therapy; Medicine; Chemistry; Pharmacology; Internal medicine; Biochemistry; Epigenetics; Gene","score_opus":0.1686787036596094,"score_gpt":0.38876082950339147,"score_spread":0.22008212584378206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137429553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634546,0.0014192582,0.00076844683,0.00027969514,0.00011272422,0.000664272,0.000034563298,0.000002601356,0.00037299024],"genre_scores_gemma":[0.9980805,0.00012725843,0.00026353417,0.000060165705,0.00034440568,0.0002493636,0.000026955415,0.000014922876,0.0008329087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999075,0.00017491374,0.00015605545,0.00018784992,0.00023843333,0.00016778057],"domain_scores_gemma":[0.99888945,0.000015124312,0.00007137324,0.00025025365,0.000721202,0.00005260485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005835435,0.000067348024,0.00009367893,0.000045642006,0.000058855752,0.00000922798,0.00020395282,0.000094454175,0.000005860394],"category_scores_gemma":[0.00024922122,0.0000491831,0.00006756457,0.00020646397,0.00014441769,0.0000033545505,0.0000712728,0.000091603244,5.883186e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021012696,0.000027206279,0.00018214891,0.000014073583,0.000025066192,5.510381e-8,0.00011477391,0.00005835821,0.9821406,0.00014267827,0.01547063,0.0016142769],"study_design_scores_gemma":[0.00089041435,0.0003976555,0.00011771173,0.000014774827,0.000002347047,5.0002984e-7,0.000056904715,0.00013812286,0.99006116,0.00014835795,0.008117444,0.00005458632],"about_ca_topic_score_codex":0.00018506941,"about_ca_topic_score_gemma":0.0001275995,"teacher_disagreement_score":0.007920574,"about_ca_system_score_codex":0.00009421686,"about_ca_system_score_gemma":0.0008891005,"threshold_uncertainty_score":0.20056286},"labels":[],"label_agreement":null},{"id":"W2137644376","doi":"10.1158/0008-5472.can-10-1108","title":"Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of β-Catenin, KRAS, and the Oncogenic Transcription Factor ITF2","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"KRAS; Small hairpin RNA; Cancer research; Oncogene; Gene silencing; Apoptosis; Blockade; In vivo; Colorectal cancer; Biology; Catenin; Medicine; Cell cycle; Cancer; Gene knockdown; Internal medicine; Wnt signaling pathway; Receptor; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.018724358124570163,"score_gpt":0.3050197034798051,"score_spread":0.28629534535523493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137644376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972124,0.0012681792,0.000047027494,0.0006124465,0.00014660957,0.00052059616,0.00009400849,0.000010216177,0.0000885162],"genre_scores_gemma":[0.9985668,0.00046692908,0.000016085198,0.000055772507,0.00010877406,0.00030213333,0.00009857172,0.000022396245,0.00036251507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986984,0.00020840886,0.0001939298,0.000314624,0.0003069047,0.000277738],"domain_scores_gemma":[0.999328,0.00005858949,0.00008677213,0.0001443428,0.00030749032,0.00007476669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064013083,0.00012929147,0.00018052153,0.00006198865,0.00017004526,0.00003057104,0.0001757071,0.00016136725,0.000083636165],"category_scores_gemma":[0.00008629261,0.000094934396,0.00006213411,0.0002134162,0.00074849644,0.000007279117,0.00006150265,0.00037935504,0.0000035954122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001269012,0.000037066264,0.003576373,0.000036341746,0.000072744544,8.529775e-7,0.0001974224,0.0000011736823,0.9906126,0.000039170285,0.0032933818,0.00086384825],"study_design_scores_gemma":[0.0023528032,0.00020715776,0.01155233,0.000036113717,0.000013506413,0.0000030916474,0.00006733354,0.000014961686,0.983396,0.00011162808,0.002123585,0.00012148666],"about_ca_topic_score_codex":0.0001994075,"about_ca_topic_score_gemma":0.00011411496,"teacher_disagreement_score":0.007975956,"about_ca_system_score_codex":0.00003526518,"about_ca_system_score_gemma":0.00018082357,"threshold_uncertainty_score":0.38713124},"labels":[],"label_agreement":null},{"id":"W2137792649","doi":"10.1158/0008-5472.can-09-0024","title":"Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells <i>In vivo</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"MAPK/ERK pathway; KRAS; PTEN; Cancer research; PI3K/AKT/mTOR pathway; Kinase; Biology; Signal transduction; Thyroid cancer; Follicular thyroid cancer; Cell biology; Thyroid; Cancer; Papillary thyroid cancer; Endocrinology; Genetics","score_opus":0.04119421789582388,"score_gpt":0.36156725231838893,"score_spread":0.32037303442256504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137792649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057597,0.0010967517,0.0004054188,0.004288726,0.000111365574,0.0013881049,0.000040620125,0.00005306721,0.0020399818],"genre_scores_gemma":[0.9969409,0.0007198161,0.00017938747,0.000871274,0.00035675088,0.000094268835,0.000006239359,0.000043260745,0.0007880706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974873,0.00011637543,0.00032366763,0.0005419712,0.0008264129,0.0007042796],"domain_scores_gemma":[0.99878806,0.00025924784,0.00003847233,0.00032058396,0.00025034565,0.00034331027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007155177,0.0001917957,0.0003145837,0.00043732187,0.00013832004,0.000048376805,0.00015922601,0.00020414872,0.00015491356],"category_scores_gemma":[0.00024468068,0.00018653536,0.00006712028,0.0009593039,0.000095379095,0.00011030895,0.000035603425,0.0008524508,0.0000387768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012276598,0.00008716575,0.00001148356,0.0000533203,0.000023666329,0.00015427441,0.0012810453,0.0013286583,0.9536901,0.0000390638,0.0008649914,0.041238543],"study_design_scores_gemma":[0.0019217953,0.0012365242,0.00007155317,0.00040158528,0.00002061801,0.000019048513,0.00019448547,0.00024783605,0.9824492,0.00026482652,0.01298185,0.00019070593],"about_ca_topic_score_codex":0.00078174827,"about_ca_topic_score_gemma":0.00019816877,"teacher_disagreement_score":0.041047838,"about_ca_system_score_codex":0.0008885676,"about_ca_system_score_gemma":0.0006652945,"threshold_uncertainty_score":0.7606691},"labels":[],"label_agreement":null},{"id":"W2137906640","doi":"10.1158/0008-5472.can-12-3956","title":"A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Human Genome Research Institute; Canadian Institutes of Health Research","keywords":"Computational biology; Synthetic lethality; Biology; Cancer; Cancer cell; Gene; Genetics; DNA repair","score_opus":0.21273917867520045,"score_gpt":0.48421272584541986,"score_spread":0.27147354717021943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137906640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359375,0.0018678928,0.0021248155,0.00013137043,0.00010354065,0.0007124252,0.000027955302,0.000008160976,0.0014300937],"genre_scores_gemma":[0.9934845,0.00014361847,0.0005488319,0.00003808724,0.0003301407,0.0033021313,0.000048490947,0.00002384975,0.0020803276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987683,0.000101039936,0.00018853367,0.00039667025,0.00015710591,0.00038829754],"domain_scores_gemma":[0.99938333,0.000028630571,0.000039544946,0.00024496525,0.00023214503,0.000071376184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003068863,0.00010777797,0.00016006244,0.00010763695,0.00018936717,0.000069765956,0.00023278185,0.00006005387,0.00023267175],"category_scores_gemma":[0.000022745891,0.000104132574,0.0000677381,0.00013835683,0.00012240534,0.000008451734,0.000105566025,0.00024150393,0.00001048807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031488245,0.000052698288,0.00033080028,0.000074499454,0.00003945603,2.6640177e-7,0.00049510447,0.002765767,0.9894759,0.000030363697,0.005450846,0.0012528121],"study_design_scores_gemma":[0.002329548,0.00023313411,0.0051689404,0.0003415386,0.000029400542,0.000012199824,0.0044025644,0.025915299,0.94771016,0.0008685737,0.012295248,0.0006934103],"about_ca_topic_score_codex":0.003827162,"about_ca_topic_score_gemma":0.0012467481,"teacher_disagreement_score":0.041765753,"about_ca_system_score_codex":0.00020679433,"about_ca_system_score_gemma":0.00019288991,"threshold_uncertainty_score":0.578555},"labels":[],"label_agreement":null},{"id":"W2137918402","doi":"10.1158/0008-5472.can-05-3077","title":"The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Penetration (warfare); Doxorubicin; Cell culture; Cancer research; Medicine; Biology; Chemotherapy; Internal medicine","score_opus":0.04052590192923124,"score_gpt":0.36240008697084447,"score_spread":0.32187418504161325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137918402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904764,0.007165291,0.00016724964,0.00024129062,0.0001341538,0.0005077433,0.000019737727,0.0000059197714,0.0012821624],"genre_scores_gemma":[0.9976528,0.0014805696,0.00014015645,0.000033459768,0.00017174534,0.000027334483,0.000006351125,0.000016803697,0.00047074194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827236,0.000118004486,0.00034947006,0.00023040875,0.00077398523,0.00025577244],"domain_scores_gemma":[0.9986936,0.00019231158,0.00017525263,0.00029168365,0.00059357035,0.000053599484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008918804,0.00009580157,0.00030223114,0.000087652414,0.000116967865,0.000012303683,0.00007779519,0.000038393897,0.00014428889],"category_scores_gemma":[0.00005564346,0.00006952142,0.000059002043,0.0003989025,0.00039887638,0.000070785536,0.000058061985,0.00019312635,0.0000027637175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007675961,0.00007152658,0.0025027061,0.0006024114,0.000029897898,0.0000062972704,0.00031870583,0.000010401835,0.9867073,0.00069359405,0.0009465668,0.0073429714],"study_design_scores_gemma":[0.0007379818,0.00045907823,0.008397291,0.00029582717,0.00007757956,0.000002988995,0.00058673957,0.000018706764,0.9820308,0.0006208406,0.0067144185,0.000057722318],"about_ca_topic_score_codex":0.009216525,"about_ca_topic_score_gemma":0.00042195714,"teacher_disagreement_score":0.008794568,"about_ca_system_score_codex":0.000100201156,"about_ca_system_score_gemma":0.00037380488,"threshold_uncertainty_score":0.9973812},"labels":[],"label_agreement":null},{"id":"W2137996608","doi":"10.1158/0008-5472.can-06-3332","title":"Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":524,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Cancer Institute; Prostate Cancer Foundation; National Institutes of Health; Michael Smith Health Research BC; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Oregon National Primate Research Center; National Institute of Child Health and Human Development; U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Androgen; Androgen deprivation therapy; Medicine; Androgen receptor; Internal medicine; Endocrinology; Testosterone (patch); Prostate; TMPRSS2; LNCaP; Cancer research; Cancer; Hormone","score_opus":0.0799958214474921,"score_gpt":0.4127913581025604,"score_spread":0.33279553665506834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137996608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95934457,0.030138696,0.00012380106,0.0060376166,0.00010405792,0.0035035405,0.0005928628,0.000059357644,0.00009551703],"genre_scores_gemma":[0.98973036,0.003133027,0.0006369299,0.00016410946,0.00023555532,0.0034251004,0.00018498169,0.00007516532,0.0024147672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707663,0.000097724784,0.0004084793,0.0007288626,0.0006162548,0.001072056],"domain_scores_gemma":[0.9976617,0.00028843785,0.000078727215,0.0004915328,0.00093813246,0.00054147985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008929936,0.00027558792,0.00036210116,0.00036219973,0.0006242426,0.000121848854,0.0001466719,0.00016627653,0.00027309856],"category_scores_gemma":[0.00005306472,0.00020573346,0.00009229756,0.00064910663,0.00054926483,0.00018005604,0.00010325682,0.00039305177,0.000005248777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067349975,0.00020730648,0.041844636,0.00044391345,0.00018488054,0.00005018919,0.0013654247,0.0000044249095,0.9264232,0.00004356344,0.0012761023,0.021421375],"study_design_scores_gemma":[0.0065150848,0.0011809078,0.17943394,0.0006704216,0.0001810549,0.0000646585,0.00077032734,0.00006402531,0.80411,0.00051243725,0.00612768,0.00036946393],"about_ca_topic_score_codex":0.00018610718,"about_ca_topic_score_gemma":0.0003067793,"teacher_disagreement_score":0.1375893,"about_ca_system_score_codex":0.00054489385,"about_ca_system_score_gemma":0.00077946397,"threshold_uncertainty_score":0.8389567},"labels":[],"label_agreement":null},{"id":"W2138197862","doi":"10.1158/0008-5472.can-05-1913","title":"Isolation of a Natural Inhibitor of Human Malignant Glial Cell Invasion: Inter α-Trypsin Inhibitor Heavy Chain 2","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glioma; Cancer research; U87; Protein kinase B; Biology; Cell; Brain tumor; Cancer; Cell culture; Pathology; Signal transduction; Medicine; Cell biology; Biochemistry","score_opus":0.046077811682729626,"score_gpt":0.3723791321181197,"score_spread":0.32630132043539006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138197862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430585,0.0014509974,0.000040120893,0.0010037445,0.00020639025,0.00092089706,0.000026307996,0.000022470475,0.00202322],"genre_scores_gemma":[0.99124986,0.00006890545,0.00027888783,0.000035075605,0.0008651748,0.0000864534,0.00005292967,0.000050090606,0.0073126415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996198,0.00032345465,0.00067365024,0.00047415434,0.0016985436,0.0006321732],"domain_scores_gemma":[0.99781483,0.00017060146,0.0001390401,0.00053796126,0.0011469568,0.00019058514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107401,0.00018477975,0.00045474913,0.0005541626,0.00012676409,0.00002662836,0.00027014682,0.00018377852,0.0007841325],"category_scores_gemma":[0.00016651179,0.00015542068,0.00016910519,0.0009571323,0.00050669065,0.00009453246,0.00033731363,0.0008727895,0.00004074339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011853159,0.0003768205,0.004926084,0.00071138114,0.000016975453,0.000053756354,0.00024137886,0.000004481733,0.9764989,0.00012634131,0.014565345,0.0012932004],"study_design_scores_gemma":[0.0021855002,0.0009266187,0.004786876,0.0006408374,0.0000130364815,0.000007326827,0.00024638648,0.00020116818,0.98872024,0.00012237001,0.0020171255,0.00013253442],"about_ca_topic_score_codex":0.0021659175,"about_ca_topic_score_gemma":0.0004021002,"teacher_disagreement_score":0.012548219,"about_ca_system_score_codex":0.00043222946,"about_ca_system_score_gemma":0.00052148243,"threshold_uncertainty_score":0.85857016},"labels":[],"label_agreement":null},{"id":"W2138239169","doi":"10.1158/0008-5472.can-15-0024","title":"Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Prostate cancer; Cancer research; Tumor microenvironment; Androgen receptor; Extracellular matrix; Metastasis; Tumor progression; Prostate; Biology; Cancer; Chemistry; Cell biology; Internal medicine; Medicine","score_opus":0.1806620059592841,"score_gpt":0.44799361783142977,"score_spread":0.26733161187214566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138239169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97857785,0.0146629065,0.0000022830425,0.0044736415,0.000035883502,0.001170903,0.000004030717,0.000012190416,0.0010603121],"genre_scores_gemma":[0.99808013,0.00025750734,0.000113457674,0.00032702772,0.00007137323,0.0004823735,0.0000060922966,0.000013810618,0.0006482216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981588,0.0002241101,0.0001694953,0.00022061141,0.0008545891,0.00037240787],"domain_scores_gemma":[0.99947053,0.000047378533,0.000025635507,0.00024959035,0.00008175839,0.00012510252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013167467,0.000090869646,0.00018458086,0.0001089448,0.00009040916,0.000023629509,0.000110857,0.000022327302,0.00006492803],"category_scores_gemma":[0.00009065115,0.00005228521,0.000030958447,0.00042355727,0.0002549257,0.000047779096,0.00014584826,0.0003537403,0.00011532938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070124543,0.003956477,0.17428343,0.0014932943,0.00054864923,0.0055769235,0.024346119,0.00006871363,0.4501875,0.0005513686,0.22203277,0.109942295],"study_design_scores_gemma":[0.01631507,0.0036139798,0.11433805,0.0025687658,0.00015012191,0.00063281396,0.019031234,0.0002204102,0.6870419,0.0026928964,0.15278995,0.00060485094],"about_ca_topic_score_codex":0.0003094311,"about_ca_topic_score_gemma":0.00010205694,"teacher_disagreement_score":0.23685436,"about_ca_system_score_codex":0.00021837304,"about_ca_system_score_gemma":0.00015355236,"threshold_uncertainty_score":0.2132129},"labels":[],"label_agreement":null},{"id":"W2138277779","doi":"10.1158/0008-5472.can-05-1186","title":"Efficient Deletion of Normal <i>Brca2</i>-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Poly ADP ribose polymerase; Intestinal epithelium; Polymerase; Epithelium; Cancer research; Molecular biology; Biology; Ribose; Medicine; Pathology; Biochemistry; Enzyme","score_opus":0.05584133082506588,"score_gpt":0.3705531389634022,"score_spread":0.3147118081383363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138277779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97286445,0.010879797,0.0066489554,0.0069178888,0.0002520217,0.0012876054,0.00015137473,0.000094697025,0.0009031936],"genre_scores_gemma":[0.9959933,0.0006645379,0.0004681187,0.00056751154,0.0010639435,0.00047068953,0.000077416655,0.00007555181,0.0006188942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955403,0.00033051436,0.00066516147,0.0006511313,0.0019125419,0.00090032036],"domain_scores_gemma":[0.9977073,0.00010026871,0.0002117119,0.0005571766,0.0010696832,0.00035383765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011709031,0.00029766394,0.00041422795,0.0005341679,0.00034197725,0.00006595967,0.00020337017,0.00017369083,0.00096175144],"category_scores_gemma":[0.000054355678,0.00026656027,0.00018511733,0.00094113016,0.0007170985,0.00017275664,0.00008595447,0.000848746,0.00007335953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038965112,0.0012219971,0.00008797848,0.00015044515,0.000066891684,0.000024984,0.00071400346,0.008701081,0.95226145,0.00021445096,0.0037270738,0.028933108],"study_design_scores_gemma":[0.0057147294,0.0013911914,0.00020730238,0.00039697046,0.000036149377,0.000116783405,0.00019442648,0.018789427,0.96956193,0.00014812537,0.0031404162,0.00030251898],"about_ca_topic_score_codex":0.0007924867,"about_ca_topic_score_gemma":0.000011055845,"teacher_disagreement_score":0.02863059,"about_ca_system_score_codex":0.0010033471,"about_ca_system_score_gemma":0.0010295591,"threshold_uncertainty_score":0.99997866},"labels":[],"label_agreement":null},{"id":"W2138516395","doi":"10.1158/1538-7445.am10-581","title":"Abstract 581: Development of RNA interference-based therapeutics for bladder cancer and hepatocellular carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Survivin; Cancer research; Cancer; Small interfering RNA; Medicine; Apoptosis; RNA interference; Bladder cancer; Cancer cell; Liver cancer; Hepatocellular carcinoma; Cell culture; Transfection; Biology; Internal medicine; RNA; Biochemistry","score_opus":0.11163472146474182,"score_gpt":0.3891323330309027,"score_spread":0.27749761156616093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138516395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952733,0.002642821,0.0010129742,0.00030201767,0.000120556295,0.00035434955,0.00006059385,0.0000035632395,0.00022985216],"genre_scores_gemma":[0.9974223,0.00041570427,0.00085334893,0.00006294516,0.00015549568,0.00064902316,0.000030713498,0.000021532265,0.0003889765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907696,0.000017824315,0.00018199401,0.00028897705,0.00016842697,0.0002658388],"domain_scores_gemma":[0.99913126,0.000023725564,0.000053328084,0.0002854888,0.00042879116,0.000077376804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003451145,0.00010021522,0.000107003776,0.00006355602,0.00013357292,0.000025426822,0.00021213066,0.00012029422,0.00013729281],"category_scores_gemma":[0.000017483964,0.00008799318,0.000038447357,0.00008731446,0.00017448585,0.0000033434512,0.00005351394,0.00018541183,0.000001155512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114065835,0.000037483303,0.0076942835,0.0000743333,0.000046099827,2.2357143e-7,0.000120653465,0.000006244094,0.9397245,0.000059595124,0.00038423447,0.051738285],"study_design_scores_gemma":[0.0004635379,0.00006750234,0.015710842,0.000018373617,0.000008251688,2.5528317e-7,0.00006819714,0.00023021353,0.93439496,0.0000425839,0.048881777,0.000113530055],"about_ca_topic_score_codex":0.00017457335,"about_ca_topic_score_gemma":0.0004960697,"teacher_disagreement_score":0.051624756,"about_ca_system_score_codex":0.000030456353,"about_ca_system_score_gemma":0.0009090565,"threshold_uncertainty_score":0.35882577},"labels":[],"label_agreement":null},{"id":"W2138706637","doi":"10.1158/0008-5472.can-10-2227","title":"Telomerase Inhibition Potentiates the Effects of Genotoxic Agents in Breast and Colorectal Cancer Cells in a Cell Cycle–Specific Manner","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomerase; DNA damage; Telomere; Cancer research; Etoposide; Cell cycle; Biology; Topoisomerase inhibitor; Topoisomerase; DNA repair; Cancer cell; Cancer; Molecular biology; DNA; Chemotherapy; Biochemistry; Genetics","score_opus":0.021764033919762883,"score_gpt":0.32845444200158996,"score_spread":0.30669040808182707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138706637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470586,0.0029042312,6.419951e-7,0.0007640809,0.00029573854,0.0011237537,0.000046946385,0.0000135602,0.00014521454],"genre_scores_gemma":[0.99371415,0.0054021734,0.000021735072,0.00009415573,0.00017036044,0.00033980806,0.000008873606,0.000032403415,0.0002163512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790484,0.00019562965,0.000307602,0.0004251207,0.0005809423,0.0005858872],"domain_scores_gemma":[0.99902135,0.00027722993,0.00006369175,0.0002830643,0.00017578626,0.00017886421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006579247,0.00017150314,0.00031367168,0.00047466537,0.00010390105,0.00003312441,0.00015584816,0.00014738351,0.00028398924],"category_scores_gemma":[0.00005051831,0.0001268372,0.000049567676,0.0008985593,0.0004728195,0.000099915174,0.0001116339,0.0010027812,0.00001587718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042714976,0.0002609493,0.066937335,0.0005435944,0.000012089021,0.0001833989,0.0012913919,0.000008662321,0.921132,0.000014147245,0.0007956351,0.008393645],"study_design_scores_gemma":[0.0017751342,0.00009635296,0.4055911,0.00036429783,0.00000910119,0.00001785611,0.00022003026,0.000086091626,0.5913805,0.000047822694,0.00030383686,0.000107911255],"about_ca_topic_score_codex":0.0045477687,"about_ca_topic_score_gemma":0.002641419,"teacher_disagreement_score":0.33865377,"about_ca_system_score_codex":0.00017487993,"about_ca_system_score_gemma":0.00025184025,"threshold_uncertainty_score":0.68748957},"labels":[],"label_agreement":null},{"id":"W2138784667","doi":"10.1158/0008-5472.can-08-0364","title":"Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; National Health Research Institutes","keywords":"CD117; Cancer stem cell; CD44; Ovarian cancer; Homeobox protein NANOG; Biology; Cancer research; Stem cell; SOX2; Stem cell marker; Cancer cell; Cancer; Pathology; Cell; Medicine; Embryonic stem cell; Cell biology; CD34; Induced pluripotent stem cell","score_opus":0.10646043403161018,"score_gpt":0.3875269241879351,"score_spread":0.2810664901563249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138784667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973487,0.000862033,0.00007345415,0.00043447554,0.00012156388,0.0004010272,0.00020515603,0.00001752886,0.0005360431],"genre_scores_gemma":[0.9945922,0.0034701691,0.00008153547,0.00009307547,0.00038138556,0.00012971336,0.00014563535,0.000024522078,0.001081774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985905,0.00008458855,0.00030329623,0.00029633506,0.00048819615,0.00023703255],"domain_scores_gemma":[0.999139,0.0000485651,0.00012248817,0.0002454642,0.00032032948,0.00012412242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036346965,0.00008790802,0.00025409233,0.0001703795,0.0002071812,0.000018228931,0.00008098996,0.000052990046,0.00050067116],"category_scores_gemma":[0.00002186329,0.000085751155,0.000037817037,0.00033946085,0.00020077475,0.00011119265,0.00005737946,0.00022931042,0.0000056695017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008945674,0.000046055302,0.010458182,0.00021768264,0.000036081143,0.000013289041,0.0008374412,0.0000010000182,0.97489136,0.000028227585,0.00026652226,0.013114697],"study_design_scores_gemma":[0.00072968233,0.00005553283,0.27914274,0.0002347506,0.00003107087,0.0000035044172,0.00007556151,0.00001554857,0.71798253,0.000029205929,0.0016266074,0.000073253716],"about_ca_topic_score_codex":0.005186851,"about_ca_topic_score_gemma":0.0001207051,"teacher_disagreement_score":0.26868454,"about_ca_system_score_codex":0.00021170496,"about_ca_system_score_gemma":0.00041049536,"threshold_uncertainty_score":0.7841002},"labels":[],"label_agreement":null},{"id":"W2138822815","doi":"10.1158/0008-5472.can-06-2146","title":"Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"Bone marrow; Stromal cell; Pathology; Biology; Cancer research; Carcinogenesis; Cancer; Immunology; Medicine","score_opus":0.051137356154817924,"score_gpt":0.3654506486540249,"score_spread":0.314313292499207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138822815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97714293,0.00090660015,0.000066322,0.00092478306,0.000057957834,0.0011157171,0.00005973863,0.000039954473,0.019686013],"genre_scores_gemma":[0.9776443,0.0003154327,0.00026382724,0.000019014893,0.00022691372,0.00010911485,0.000060761715,0.00003473117,0.02132587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652517,0.0002229604,0.0004237078,0.0003116517,0.0017803744,0.00073614536],"domain_scores_gemma":[0.998444,0.00012712817,0.000056053428,0.00038634634,0.00074225897,0.00024420393],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009947078,0.00014724425,0.00035955364,0.00033177406,0.0001281657,0.00003298899,0.00020629949,0.00015461363,0.0017410483],"category_scores_gemma":[0.00006986561,0.00012281668,0.00011149142,0.00061146554,0.00027549284,0.00010544423,0.000054174732,0.00060465786,0.00011585074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010798188,0.0001677703,0.00021566449,0.00048611072,0.000026738111,0.0005679819,0.00037597524,0.00005810733,0.99046564,0.00023505167,0.004723974,0.0015971673],"study_design_scores_gemma":[0.0017188673,0.00046497458,0.0015437009,0.0001257889,0.000016497286,0.00018118614,0.0003752914,0.00021467383,0.9877605,0.00006290495,0.0074174367,0.00011820561],"about_ca_topic_score_codex":0.0030649058,"about_ca_topic_score_gemma":0.00045913877,"teacher_disagreement_score":0.0027051675,"about_ca_system_score_codex":0.0004236217,"about_ca_system_score_gemma":0.00045182163,"threshold_uncertainty_score":0.9991715},"labels":[],"label_agreement":null},{"id":"W2139072646","doi":"10.1158/0008-5472.can-12-2681","title":"Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"Neuroblastoma; Bone marrow; Cancer research; Metastasis; Pediatric cancer; Biology; Pathology; Cancer; Medicine; Internal medicine; Cell culture","score_opus":0.04506932406081283,"score_gpt":0.3551775424288442,"score_spread":0.3101082183680314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139072646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856485,0.0008829129,0.000062763094,0.0035916134,0.000037700705,0.0020484559,0.000033042277,0.00010846437,0.0046701757],"genre_scores_gemma":[0.9888851,0.00034696126,0.0022734401,0.00029314405,0.00006873157,0.0015729101,0.000018687719,0.00011149704,0.0064295083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99511033,0.0002568591,0.00027024618,0.0008670246,0.0019599546,0.00153558],"domain_scores_gemma":[0.9964292,0.0002763562,0.00007059418,0.00071028346,0.0016616292,0.00085191097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003733514,0.00034384016,0.00046049137,0.0005292634,0.00038528745,0.00012872217,0.00030295498,0.00007334079,0.0013598787],"category_scores_gemma":[0.00017098876,0.00021904353,0.000058524238,0.0022574158,0.0005704693,0.00037139098,0.00017695621,0.00092236383,0.00073656254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016719526,0.0026150055,0.023368271,0.0017607781,0.0010480261,0.012884437,0.00093034666,0.00016632101,0.7502271,0.00030707888,0.02850768,0.1614654],"study_design_scores_gemma":[0.028705744,0.026107855,0.14119127,0.001916562,0.00037857474,0.0039805956,0.0020670795,0.0002974349,0.7655239,0.0002219501,0.02795588,0.0016531496],"about_ca_topic_score_codex":0.0013415058,"about_ca_topic_score_gemma":0.00062893686,"teacher_disagreement_score":0.15981226,"about_ca_system_score_codex":0.0004103981,"about_ca_system_score_gemma":0.0016290834,"threshold_uncertainty_score":0.999553},"labels":[],"label_agreement":null},{"id":"W2139214771","doi":"10.1158/0008-5472.can-06-4442","title":"DNA Double-Strand Breaks Form in Bystander Cells after Microbeam Irradiation of Three-dimensional Human Tissue Models","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"National Cancer Institute; National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering; U.S. Department of Energy","keywords":"Bystander effect; Genome instability; Apoptosis; DNA damage; DNA; Biology; Molecular biology; Cell biology; Cancer research; Chemistry; Immunology; Genetics","score_opus":0.057254400818324266,"score_gpt":0.3956075018542927,"score_spread":0.33835310103596844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139214771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953239,0.0013843615,0.00024735965,0.0004923419,0.00009072889,0.0010031499,0.000026397092,0.000017483528,0.0014142643],"genre_scores_gemma":[0.9986191,0.000031561467,0.00020301173,0.00007800775,0.00018977108,0.000081691534,0.000027752689,0.000032298274,0.0007368322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797666,0.000045460347,0.00036711112,0.0003005183,0.0008132498,0.00049702503],"domain_scores_gemma":[0.99888027,0.00015380586,0.00006200035,0.00030304512,0.00042210688,0.0001788004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016318602,0.00012750583,0.00026905042,0.00049514836,0.00006473536,0.000015204891,0.00011532361,0.00017895065,0.0003889691],"category_scores_gemma":[0.000017412478,0.0001170543,0.00005125818,0.00044951573,0.00014555547,0.00018494828,0.00003932151,0.0004579943,0.000017248109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028727385,0.00025340248,0.012502887,0.0004459351,0.000055555476,0.00009507196,0.0009208389,0.001391626,0.97300184,0.00039070228,0.0028075702,0.0052618473],"study_design_scores_gemma":[0.01158676,0.00095623784,0.13764943,0.0005442366,0.000036431462,0.00001898769,0.00008893734,0.0008764192,0.84415686,0.0017587686,0.0020376968,0.00028925057],"about_ca_topic_score_codex":0.0012977837,"about_ca_topic_score_gemma":0.004929348,"teacher_disagreement_score":0.12884498,"about_ca_system_score_codex":0.0004421975,"about_ca_system_score_gemma":0.00027680103,"threshold_uncertainty_score":0.47733358},"labels":[],"label_agreement":null},{"id":"W2139230560","doi":"10.1158/0008-5472.can-05-2159","title":"Mutually Exclusive Cyclin-Dependent Kinase 4/Cyclin D1 and Cyclin-Dependent Kinase 6/Cyclin D2 Pairing Inactivates Retinoblastoma Protein and Promotes Cell Cycle Dysregulation in Multiple Myeloma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Cyclin D; Cyclin-dependent kinase; Cyclin-dependent kinase 6; Cyclin D1; Cancer research; Cyclin D3; Retinoblastoma protein; Cyclin B; Cyclin A2; Cyclin A; Cyclin E; Cyclin D2; Biology; Cyclin; Cell biology; Cell cycle; Cancer; Genetics","score_opus":0.042170720834725055,"score_gpt":0.3512264233061662,"score_spread":0.30905570247144115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139230560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880922,0.0027601258,0.000038993207,0.0028332032,0.00008440491,0.005318023,0.00009847931,0.00013445418,0.00064014265],"genre_scores_gemma":[0.99256295,0.000946043,0.0015032724,0.000077200006,0.0005365005,0.0015343098,0.00009087474,0.00014943862,0.0025993863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99269915,0.0008655685,0.0009908959,0.0016546987,0.0019668383,0.0018228423],"domain_scores_gemma":[0.99643004,0.0009276573,0.00024532038,0.0008700699,0.00043602305,0.0010909127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020085583,0.0006403465,0.0008666306,0.001083992,0.00062226295,0.00024186863,0.00036362335,0.00042831793,0.0002844601],"category_scores_gemma":[0.001313162,0.0005801384,0.00013090494,0.0007729559,0.000628662,0.00057765393,0.0007890378,0.0016588166,0.00008957657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063934065,0.002001098,0.17013863,0.001140983,0.0001933654,0.0015673776,0.0024160738,0.0002069492,0.6661579,0.000036324207,0.00009967652,0.14964822],"study_design_scores_gemma":[0.01665301,0.0015218362,0.268994,0.0014423158,0.00005587369,0.00006874804,0.0016944658,0.009029572,0.6989202,0.0004469688,0.0004848184,0.00068821915],"about_ca_topic_score_codex":0.0023742765,"about_ca_topic_score_gemma":0.0037354226,"teacher_disagreement_score":0.14896,"about_ca_system_score_codex":0.0012183441,"about_ca_system_score_gemma":0.0005823777,"threshold_uncertainty_score":0.999665},"labels":[],"label_agreement":null},{"id":"W2139248766","doi":"10.1158/0008-5472.can-07-5727","title":"Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"PTEN; Tensin; Cancer research; Carcinogenesis; Biology; ErbB; Mammary gland; Genetically modified mouse; Mammary tumor; Tumor suppressor gene; Mouse mammary tumor virus; Transgene; Cancer; Breast cancer; PI3K/AKT/mTOR pathway; Gene; Genetics; Signal transduction","score_opus":0.08771960693232289,"score_gpt":0.3445811752914882,"score_spread":0.2568615683591653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139248766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358135,0.0056536254,0.00006402352,0.00010857674,0.000050439197,0.0002786585,0.00014808135,0.0000106494335,0.00010457452],"genre_scores_gemma":[0.9963117,0.002377145,0.00024323989,0.00009335385,0.000100145524,0.0001241242,0.000058777157,0.00003112867,0.00066038605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982864,0.00012729505,0.000254267,0.0005387911,0.00034792686,0.0004452682],"domain_scores_gemma":[0.99904364,0.00003341705,0.000068046465,0.0004220746,0.00032736166,0.00010545583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041088383,0.00016247151,0.0002116785,0.00021357388,0.00013127727,0.000016658027,0.0002891697,0.00013947334,0.000031077438],"category_scores_gemma":[0.00016065779,0.00015767131,0.000040845243,0.00038031169,0.00035848466,0.000014344783,0.00016695294,0.00026503572,0.000004675724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003734342,0.00012268034,0.0012748935,0.000055201723,0.0000152203,0.000039888455,0.00009361713,0.0024389946,0.99260366,0.000036852387,0.0021380987,0.00080747146],"study_design_scores_gemma":[0.0006267424,0.00044535217,0.001091632,0.000040794286,0.0000033982176,0.000022255686,0.000036090827,0.0012392293,0.9960108,0.000053256685,0.0002562677,0.00017419482],"about_ca_topic_score_codex":0.0005516025,"about_ca_topic_score_gemma":0.00009691408,"teacher_disagreement_score":0.0034071386,"about_ca_system_score_codex":0.00013494084,"about_ca_system_score_gemma":0.0006394122,"threshold_uncertainty_score":0.6429649},"labels":[],"label_agreement":null},{"id":"W2139462186","doi":"10.1158/0008-5472.can-10-3025","title":"IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Vesicular stomatitis virus; Interferon; Interferon type I; Biology; Immunology; Interleukin 12; Immunotherapy; Dendritic cell; Cancer research; Immune system; Virus; Cytotoxic T cell; In vitro","score_opus":0.07077929348208974,"score_gpt":0.33224750101636225,"score_spread":0.2614682075342725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139462186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954552,0.0010025136,0.0002427256,0.00005671976,0.001971373,0.0004185846,0.00003842751,0.000027880198,0.00078654516],"genre_scores_gemma":[0.98891604,0.0004229369,0.000015021205,0.000045879748,0.000034257144,0.00007669061,0.00006157344,0.000019235766,0.010408367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901026,0.00018684803,0.00021686332,0.00023781865,0.00004978552,0.00029843938],"domain_scores_gemma":[0.99909043,0.00016553726,0.00009718384,0.00017023337,0.00045363317,0.000022977518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027082916,0.00010271933,0.00017888361,0.00016737505,0.00013786563,0.000011869874,0.00011602285,0.0001556971,0.0017861394],"category_scores_gemma":[0.000090127265,0.00009629258,0.000038614555,0.0001863678,0.00018661573,0.00014248442,0.00005739635,0.0003100048,0.00012256089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016092317,0.00009762211,0.000146658,0.00007713814,0.000055447494,3.0304852e-7,0.00044176765,3.4282286e-7,0.9288016,0.00004245355,0.067875504,0.0008519036],"study_design_scores_gemma":[0.00071446685,0.00078631524,0.0005271184,0.0000845534,0.000012755659,0.0000017640295,0.00047414764,0.0000058037117,0.9604553,0.000037187918,0.036810685,0.000089925445],"about_ca_topic_score_codex":0.00076586055,"about_ca_topic_score_gemma":0.000039434995,"teacher_disagreement_score":0.03165365,"about_ca_system_score_codex":0.00011207068,"about_ca_system_score_gemma":0.000066699635,"threshold_uncertainty_score":0.9991264},"labels":[],"label_agreement":null},{"id":"W2139508757","doi":"10.1158/0008-5472.can-07-0219","title":"A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Acromegaly; Growth hormone receptor; Endocrinology; Internal medicine; Biology; Cancer research; Pegvisomant; Hormone; Medicine; Growth hormone","score_opus":0.04030347779811645,"score_gpt":0.3596578994731386,"score_spread":0.31935442167502215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139508757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478705,0.008851359,0.00008695648,0.0014931313,0.00007984376,0.00090202066,0.000028240704,0.00007291709,0.0036984903],"genre_scores_gemma":[0.9971087,0.0012508207,0.00037147192,0.00016751187,0.00025087295,0.00015995493,0.00013992294,0.00004871773,0.00050203694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997079,0.00011278334,0.0004211031,0.0005012175,0.0008948209,0.0009910696],"domain_scores_gemma":[0.99871624,0.00020938064,0.000056995796,0.0002455864,0.0003793815,0.0003924004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014207147,0.00022374089,0.00037342572,0.0006939301,0.00018675062,0.00002999522,0.00016198693,0.00013940345,0.00020945533],"category_scores_gemma":[0.00023343333,0.00019103702,0.00009773977,0.001283118,0.00017043055,0.0002261727,0.00007303031,0.0006153922,0.00014519528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01886983,0.004445947,0.4735649,0.00091264263,0.00085041224,0.00794555,0.010819219,0.000075583244,0.39878455,0.0021643376,0.04850165,0.033065394],"study_design_scores_gemma":[0.018878916,0.0036724622,0.9308996,0.0005658885,0.000089036905,0.000097538694,0.004352283,0.00019264696,0.03364907,0.0064094425,0.0005327596,0.00066035695],"about_ca_topic_score_codex":0.0063702497,"about_ca_topic_score_gemma":0.00035163766,"teacher_disagreement_score":0.4573347,"about_ca_system_score_codex":0.0007271549,"about_ca_system_score_gemma":0.0004293541,"threshold_uncertainty_score":0.9629954},"labels":[],"label_agreement":null},{"id":"W2139591061","doi":"10.1158/0008-5472.can-11-1620","title":"Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1645,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Immune system; Cancer; Cancer research; Receptor; Antibody; Immunology; Ipilimumab; Biology; Inhibitory postsynaptic potential; CD8; Blockade; Cancer cell; Immune tolerance; Knockout mouse; Immunotherapy; Neuroscience; Biochemistry","score_opus":0.05320576067752921,"score_gpt":0.33173856694882153,"score_spread":0.27853280627129234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139591061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98162043,0.009819899,0.00011532317,0.001041398,0.000321171,0.00088737987,0.000012639349,0.00007015327,0.0061116205],"genre_scores_gemma":[0.9909682,0.0009364513,0.0004917078,0.00022893744,0.00024271014,0.00021052358,0.000012440577,0.0000565451,0.0068524815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780554,0.00013133853,0.00036701112,0.00048564887,0.0005900924,0.0006203992],"domain_scores_gemma":[0.99876815,0.000037952934,0.000054711873,0.0005038261,0.0003521006,0.0002832433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010205683,0.0001965667,0.0003184398,0.00029814508,0.0002067191,0.00004644561,0.00016990265,0.00012844893,0.0009115214],"category_scores_gemma":[0.00006944034,0.00016821732,0.00009830853,0.0005510032,0.00038521533,0.000092278075,0.00016290466,0.00047013938,0.00007827401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008841645,0.00016816387,0.0003424487,0.00022015224,0.00009766652,0.000077862394,0.00068321853,9.30288e-7,0.95604295,0.00015845317,0.0018309557,0.031535555],"study_design_scores_gemma":[0.0046554804,0.0032723881,0.12128033,0.00093041296,0.00009991222,0.000055706358,0.0004875717,0.00008472286,0.83171123,0.0004161405,0.036540482,0.000465609],"about_ca_topic_score_codex":0.0015720703,"about_ca_topic_score_gemma":0.000055880246,"teacher_disagreement_score":0.124331705,"about_ca_system_score_codex":0.0002548077,"about_ca_system_score_gemma":0.00035436658,"threshold_uncertainty_score":0.998052},"labels":[],"label_agreement":null},{"id":"W2139708381","doi":"10.1158/0008-5472.can-08-2871","title":"The EGF/CSF-1 Paracrine Invasion Loop Can Be Triggered by Heregulin β1 and CXCL12","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Terry Fox Foundation; Canadian Breast Cancer Research Alliance","keywords":"Paracrine signalling; Neuregulin; Epidermal growth factor; Biology; ERBB3; Cell biology; Cancer research; Autocrine signalling; Stromal cell; ERBB4; Receptor; Cancer cell; Signal transduction; Cancer; Receptor tyrosine kinase","score_opus":0.08850055017116402,"score_gpt":0.41114239903952216,"score_spread":0.3226418488683581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139708381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942769,0.01408149,0.000004520768,0.041484896,0.000065416316,0.00043171615,0.000013995792,0.000026170128,0.001122795],"genre_scores_gemma":[0.9786222,0.0077790027,0.000026420086,0.000588399,0.00040510294,0.000046208563,0.000024195733,0.000020468242,0.012487983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822617,0.00010685103,0.00021235851,0.00030475057,0.0006330758,0.00051678694],"domain_scores_gemma":[0.9989013,0.00023574951,0.00003427605,0.00030895395,0.00024406292,0.000275665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009597417,0.00012348736,0.00024053508,0.00007305731,0.00035648458,0.00008343522,0.00014451107,0.000083437124,0.0003358877],"category_scores_gemma":[0.00024262257,0.00007891325,0.000051012994,0.00037798722,0.00018692066,0.000044252392,0.00006134473,0.00054680015,0.000007917129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087299163,0.00014001592,0.002346173,0.00009990795,0.00006450757,0.000043565065,0.0006260837,0.0000022862046,0.52669525,0.00015760753,0.22547565,0.24347597],"study_design_scores_gemma":[0.004255477,0.00091645087,0.002250194,0.00042170283,0.00005005992,0.000050061055,0.0011411485,0.00025842007,0.53079885,0.0006704906,0.45889765,0.00028953524],"about_ca_topic_score_codex":0.00069750607,"about_ca_topic_score_gemma":0.00018510627,"teacher_disagreement_score":0.24318644,"about_ca_system_score_codex":0.00017424178,"about_ca_system_score_gemma":0.00028564926,"threshold_uncertainty_score":0.36777347},"labels":[],"label_agreement":null},{"id":"W2139934419","doi":"10.1158/0008-5472.can-13-1051","title":"Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with <i>IL1A</i> and <i>TNFSF10</i>","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Center for Research Resources; Cancer Research UK; Wellcome Trust","keywords":"Ovarian cancer; Single-nucleotide polymorphism; SNP; Genotype; Serous fluid; Case-control study; Genome-wide association study; Cancer","score_opus":0.01632619631271562,"score_gpt":0.2892135973588634,"score_spread":0.2728874010461477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139934419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910918,0.006652605,0.00008643448,0.0010073348,0.000048682192,0.0005265325,0.000062643645,0.000006005359,0.00051794533],"genre_scores_gemma":[0.9933018,0.0047980743,0.00018097267,0.00016070307,0.00020936645,0.00040931924,0.000007624253,0.000026351243,0.0009058088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847925,0.00030061987,0.00016160193,0.0003337381,0.000380649,0.00034411615],"domain_scores_gemma":[0.99892867,0.000117948766,0.00012220144,0.0003043749,0.000432441,0.00009434128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093030964,0.00011858885,0.0001686512,0.00004003738,0.00017615895,0.00006206213,0.00017120822,0.00012752437,0.0000502425],"category_scores_gemma":[0.00016201542,0.000077817414,0.000030153195,0.00016201564,0.00038030153,0.000006268519,0.0001544984,0.0002535569,0.0000043064565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030335522,0.000026856656,0.1281155,0.000070034395,0.00021995176,0.0000016255681,0.0004242165,0.000061963045,0.8524524,0.0001256087,0.0037898861,0.014408598],"study_design_scores_gemma":[0.004044398,0.00039915837,0.04569682,0.00009713573,0.00006956877,0.0000073616766,0.00023018391,0.0001747561,0.9305143,0.00087451807,0.017605852,0.00028597808],"about_ca_topic_score_codex":0.0055851596,"about_ca_topic_score_gemma":0.0009115761,"teacher_disagreement_score":0.08241868,"about_ca_system_score_codex":0.00005069281,"about_ca_system_score_gemma":0.00026067218,"threshold_uncertainty_score":0.8443128},"labels":[],"label_agreement":null},{"id":"W2140058220","doi":"10.1158/0008-5472.can-06-2449","title":"Mammalian Target of Rapamycin Inhibitors as Possible Adjuvant Therapy for Microscopic Residual Disease in Head and Neck Squamous Cell Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"PTEN; Cancer research; PI3K/AKT/mTOR pathway; Tensin; Head and neck squamous-cell carcinoma; Medicine; Adjuvant therapy; Cancer; Protein kinase B; Pathology; Head and neck cancer; Biology; Internal medicine; Phosphorylation; Signal transduction","score_opus":0.033120374171358574,"score_gpt":0.3880264414847514,"score_spread":0.3549060673133928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140058220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95285857,0.04538552,0.000034326386,0.00033213044,0.00022579098,0.0008030463,0.0002127272,0.0000067890737,0.00014109629],"genre_scores_gemma":[0.99531573,0.0018647839,0.00028883383,0.00017367804,0.0005465009,0.00032693843,0.000049138944,0.00005410782,0.0013803152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979086,0.00010617605,0.00033483445,0.000575882,0.00035559162,0.00071891653],"domain_scores_gemma":[0.9989412,0.000076958946,0.000082539606,0.0003659343,0.0002780227,0.00025536274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093552703,0.0001901665,0.00023651322,0.00019010452,0.00010797308,0.000030046212,0.00028198017,0.00017645305,0.00009703791],"category_scores_gemma":[0.00009768624,0.00018183656,0.00006821836,0.0002866287,0.0002874554,0.0000087509425,0.00011403705,0.00024193579,0.0000017488497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027134726,0.00011888816,0.14401889,0.00021708522,0.000016131118,0.000011817188,0.00020431975,0.00014424494,0.84602755,0.000008547137,0.0041539636,0.0023650837],"study_design_scores_gemma":[0.0028247652,0.00076321437,0.030578436,0.0001151019,0.0000057380967,6.7407996e-7,0.000091719856,0.000008771626,0.9501558,0.00015726908,0.015093653,0.00020484382],"about_ca_topic_score_codex":0.0023066218,"about_ca_topic_score_gemma":0.0017155713,"teacher_disagreement_score":0.11344045,"about_ca_system_score_codex":0.0001463183,"about_ca_system_score_gemma":0.0010056834,"threshold_uncertainty_score":0.74150795},"labels":[],"label_agreement":null},{"id":"W2140207058","doi":"10.1158/0008-5472.can-08-0006","title":"Ultrasound Imaging of Apoptosis in Tumor Response: Novel Preclinical Monitoring of Photodynamic Therapy Effects","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; University of Toronto; Sunnybrook Health Science Centre","funders":"Canada Research Chairs; University of Toronto; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Ontario Innovation Trust","keywords":"Photodynamic therapy; Apoptosis; Ultrasound; Medicine; Programmed cell death; Cancer; In vivo; Cancer research; Cell; Pathology; Internal medicine; Radiology; Chemistry; Biology","score_opus":0.049620887963575874,"score_gpt":0.3706639185623797,"score_spread":0.3210430305988038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140207058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958478,0.002739091,0.00050392,0.000019001798,0.00027710194,0.00034184198,0.000019554398,0.00004747695,0.00020420334],"genre_scores_gemma":[0.99767935,0.0015859343,0.0004415116,0.0000055395967,0.00007341341,0.00013113012,0.0000010147722,0.000045731897,0.000036342197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823135,0.00014097098,0.00038233167,0.00023333596,0.00049215095,0.00051988487],"domain_scores_gemma":[0.99700564,0.002433801,0.000041866526,0.00030323828,0.00013409548,0.000081334154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012343909,0.00014157352,0.00032680455,0.00033628085,0.000059793452,0.000009496776,0.00030924246,0.00004848723,0.000028149407],"category_scores_gemma":[0.0006050786,0.0001417655,0.00007090995,0.0006589857,0.00029078222,0.000113418486,0.000035833356,0.00056448893,0.0000021997628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003275449,0.00007107927,0.050163846,0.00019330447,0.000028560751,0.0000097571465,0.00076519087,0.0031833372,0.9443038,0.0000029384114,0.00007082787,0.0008798128],"study_design_scores_gemma":[0.0011239531,0.000043313405,0.13329382,0.00043606316,0.0000036431188,0.000016810209,0.0001835806,0.003492101,0.86121416,0.000017478358,0.000045820667,0.00012927395],"about_ca_topic_score_codex":0.00047179978,"about_ca_topic_score_gemma":0.0000041503076,"teacher_disagreement_score":0.08312998,"about_ca_system_score_codex":0.00027982736,"about_ca_system_score_gemma":0.0002274154,"threshold_uncertainty_score":0.57810295},"labels":[],"label_agreement":null},{"id":"W2140341406","doi":"10.1158/0008-5472.can-12-4331","title":"Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Medulloblastoma; PLK1; Cancer research; Medicine; Oncology; Internal medicine; Cancer; Biology; Cell cycle","score_opus":0.023846180280928112,"score_gpt":0.3301628875389191,"score_spread":0.306316707257991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140341406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018575,0.018516941,0.000014577966,0.00042424223,0.0000653389,0.0006328886,0.000047495432,0.0000064726487,0.00010627275],"genre_scores_gemma":[0.9934292,0.005213864,0.00009586703,0.00005435671,0.00030687792,0.00055425277,0.000022864693,0.000028240156,0.00029448658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982406,0.00032459883,0.00019824205,0.00039042367,0.0003584178,0.00048775124],"domain_scores_gemma":[0.99917865,0.000058558067,0.00006200787,0.00038938847,0.0002210297,0.000090363625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003703906,0.0001601331,0.00019126065,0.00013240629,0.00014425148,0.00002261806,0.00029119887,0.00010205098,0.0000976376],"category_scores_gemma":[0.000135338,0.00011265482,0.00009514517,0.00036449643,0.000221557,0.0000036262018,0.00012402692,0.00016852634,0.000038006514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015871943,0.0004615814,0.2614391,0.0000418897,0.00037146907,0.000026702815,0.0018966433,0.0004758949,0.7273384,0.00008293453,0.0036210008,0.00408572],"study_design_scores_gemma":[0.0024855111,0.0024542748,0.11815912,0.000031628035,0.00006569914,0.000006875877,0.0011033968,0.000042035354,0.87008524,0.0004375542,0.004733679,0.0003949584],"about_ca_topic_score_codex":0.01001362,"about_ca_topic_score_gemma":0.00027600353,"teacher_disagreement_score":0.14327998,"about_ca_system_score_codex":0.000104568884,"about_ca_system_score_gemma":0.0002621491,"threshold_uncertainty_score":0.9965788},"labels":[],"label_agreement":null},{"id":"W2140511126","doi":"10.1158/0008-5472.can-06-4317","title":"Improvement of Antitumor Activity by Gene Amplification with a Replicating but Nondisseminating Adenovirus","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut National de la Recherche Scientifique; Montreal Neurological Institute and Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Cytosine deaminase; Genetic enhancement; Suicide gene; In vivo; Bystander effect; Vector (molecular biology); Viral vector; Biology; Transgene; Cancer research; Virology; Molecular biology; Virus; Viral replication; Adenoviridae; Gene; Immunology; Recombinant DNA","score_opus":0.04093101733635616,"score_gpt":0.4064647640434927,"score_spread":0.3655337467071365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140511126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568397,0.001087529,0.0020088055,0.00013932251,0.000016685264,0.00053634774,0.000058245645,0.000009820452,0.00045926304],"genre_scores_gemma":[0.9982055,0.00029734074,0.00031217077,0.000030272857,0.00013700186,0.00017612905,0.000047489553,0.000038128095,0.000755959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794567,0.000085188556,0.00021813322,0.00052912516,0.00064185256,0.0005800345],"domain_scores_gemma":[0.99848497,0.000057858982,0.000121931655,0.0006798852,0.0005195918,0.0001357876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022912116,0.00012551084,0.00014230961,0.00012102837,0.0001797855,0.000027018494,0.0003698941,0.00009252083,0.000036243884],"category_scores_gemma":[0.00013292559,0.00011354655,0.000038500242,0.00041925602,0.0002485625,0.0000069159983,0.00014908377,0.00027924989,0.000004413143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020861493,0.00010537399,0.0016004062,0.00005404284,0.00004366535,0.000002537618,0.00005039477,0.000008591076,0.9327228,0.000005191226,0.00033666342,0.0629842],"study_design_scores_gemma":[0.00046134263,0.0018478077,0.0010219378,0.000030502684,0.0000038071812,0.00000293745,0.00014686072,0.000017509648,0.99552816,0.000006677693,0.00080609403,0.00012635639],"about_ca_topic_score_codex":0.00050790544,"about_ca_topic_score_gemma":0.0003182686,"teacher_disagreement_score":0.062857844,"about_ca_system_score_codex":0.00012642132,"about_ca_system_score_gemma":0.00030714105,"threshold_uncertainty_score":0.4630294},"labels":[],"label_agreement":null},{"id":"W2140725200","doi":"10.1158/0008-5472.can-13-1462","title":"Androgen Glucuronidation: An Unexpected Target for Androgen Deprivation Therapy, with Prognosis and Diagnostic Implications","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Androgen deprivation therapy; Androgen; Medicine; Glucuronidation; Oncology; Internal medicine; Endocrinology; Prostate cancer; Physiology; Biology; Hormone; Cancer; Biochemistry","score_opus":0.09685667553276887,"score_gpt":0.41098529621588004,"score_spread":0.31412862068311115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140725200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052895,0.0047653136,0.00016638535,0.009288993,0.000016597156,0.0048839166,0.000058433692,0.000081852835,0.00020955129],"genre_scores_gemma":[0.9811055,0.0032776182,0.0012867246,0.00008516531,0.00018445041,0.013113924,0.00039309257,0.00004414475,0.00050937943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984417,0.000086730484,0.00015988736,0.00043976668,0.00038252515,0.00048940437],"domain_scores_gemma":[0.9979311,0.00031971667,0.000037102487,0.00032046545,0.0010910472,0.00030055593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748904,0.00013496264,0.00018526275,0.00020033446,0.00036924816,0.00012517508,0.00011923448,0.00007531108,0.0003238107],"category_scores_gemma":[0.00013484324,0.00009312002,0.000028498962,0.0005754107,0.0002427051,0.00029142408,0.000041111267,0.00018272425,0.000014059912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013080311,0.00073302374,0.78832287,0.00025176283,0.0004102975,0.00000903068,0.0011272709,0.000010122127,0.06963275,0.00054501503,0.007354271,0.13029553],"study_design_scores_gemma":[0.014822679,0.008404777,0.6745184,0.00032145056,0.000107614906,0.000054308286,0.0010103034,0.0009407187,0.26337352,0.004233339,0.031659883,0.00055300613],"about_ca_topic_score_codex":0.00045849624,"about_ca_topic_score_gemma":0.00006658516,"teacher_disagreement_score":0.19374076,"about_ca_system_score_codex":0.00019884558,"about_ca_system_score_gemma":0.00049512275,"threshold_uncertainty_score":0.37973243},"labels":[],"label_agreement":null},{"id":"W2140741923","doi":"10.1158/0008-5472.can-13-0992","title":"A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":768,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Hypoxia (environmental); Mechanism (biology); Immunity; Acquired immune system; Cancer; Immune escape; Cancer cell; Biology; Immunology; Immune system; Cancer research; Chemistry; Oxygen; Genetics; Physics","score_opus":0.058333819865556504,"score_gpt":0.330047577685109,"score_spread":0.2717137578195525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140741923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909907,0.004022036,0.00003644598,0.00037241844,0.0019820724,0.00048599282,0.00004693923,0.000025041614,0.0020383478],"genre_scores_gemma":[0.9902043,0.0014063077,0.000013109753,0.00009201789,0.00003497691,0.00043000132,0.00006269543,0.00001764542,0.0077389646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983416,0.00059624965,0.0002951366,0.00025394864,0.000089149355,0.0004238952],"domain_scores_gemma":[0.9988152,0.00036857123,0.00008634598,0.00028439914,0.00041888122,0.000026605507],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003698577,0.00012136924,0.00024689652,0.0002882094,0.0001100448,0.000013824259,0.00026774025,0.00023114988,0.032267835],"category_scores_gemma":[0.00007903332,0.000109349756,0.000057870966,0.0003825761,0.00020093806,0.00017445738,0.0001295711,0.00094346923,0.0019637146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000300193,0.0001644532,0.00016082889,0.000009402812,0.00008646917,8.732645e-7,0.0007516434,0.000007940929,0.97831357,0.00014477887,0.017428957,0.002630912],"study_design_scores_gemma":[0.0011010452,0.00023193785,0.0053783343,0.00010667627,0.000007203031,6.5184986e-7,0.0019028271,0.000074409305,0.98027164,0.0004294874,0.010373231,0.00012254293],"about_ca_topic_score_codex":0.11588672,"about_ca_topic_score_gemma":0.0012986154,"teacher_disagreement_score":0.1145881,"about_ca_system_score_codex":0.0002629768,"about_ca_system_score_gemma":0.0002085723,"threshold_uncertainty_score":0.9988134},"labels":[],"label_agreement":null},{"id":"W2140804399","doi":"10.1158/0008-5472.can-03-3715","title":"Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-Chloroethyl)Ureas","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université Laval; Hôpital Saint-François d'Assise","funders":"University of Texas MD Anderson Cancer Center","keywords":"Angiogenesis; Glutathione; In vitro; Cytotoxicity; In vivo; Cancer research; Chemistry; Chorioallantoic membrane; Buthionine sulfoximine; In vitro toxicology; Cell biology; Biochemistry; Pharmacology; Biology; Enzyme","score_opus":0.04360934939060658,"score_gpt":0.37204519736518155,"score_spread":0.328435847974575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140804399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038995,0.017980287,0.00011313008,0.00028740754,0.0004394382,0.0001934602,0.000049214475,0.000006530039,0.0005405752],"genre_scores_gemma":[0.98961663,0.0085435165,0.00011149416,0.00004095827,0.0009962195,0.00003660458,0.00001063695,0.000020567295,0.0006233773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882394,0.00006770628,0.00011384161,0.0003453057,0.00027431652,0.00037487593],"domain_scores_gemma":[0.9993104,0.000007841381,0.000040414867,0.0003234463,0.00018717715,0.00013073355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003714081,0.00010867435,0.00017724148,0.000086183885,0.000096258096,0.000019107842,0.0001775483,0.00010762099,0.00003734008],"category_scores_gemma":[0.00006288217,0.00010423243,0.00007951014,0.00020831866,0.0003673341,0.0000071712134,0.00016607183,0.0001623664,0.000004247397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018744242,0.000053165717,0.0008787387,0.000049855294,0.000048430655,0.0000016573159,0.000068403046,0.00001593654,0.9874169,0.00023415139,0.0014751273,0.009570166],"study_design_scores_gemma":[0.0010153586,0.00015758809,0.01181502,0.000030102023,0.000014343699,0.000010679042,0.000039916693,0.0000016492063,0.92135614,0.00027862398,0.0651502,0.00013036218],"about_ca_topic_score_codex":0.0012964408,"about_ca_topic_score_gemma":0.00046707146,"teacher_disagreement_score":0.06606077,"about_ca_system_score_codex":0.00003013961,"about_ca_system_score_gemma":0.0004173213,"threshold_uncertainty_score":0.42504752},"labels":[],"label_agreement":null},{"id":"W2140821112","doi":"10.1158/0008-5472.can-15-0840","title":"<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced NMR Techniques and Applications","field":"Chemistry","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute","keywords":"Pyruvate dehydrogenase complex; Isocitrate dehydrogenase; Pyruvate dehydrogenase kinase; IDH1; Clonogenic assay; Biology; Reprogramming; Biochemistry; Mutant; Glutamate dehydrogenase; Glutamate receptor; Chemistry; Molecular biology; Cell; Enzyme","score_opus":0.157945186169426,"score_gpt":0.4644908237887913,"score_spread":0.3065456376193653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140821112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440915,0.0016756009,0.0007845848,0.00039918497,0.000015452313,0.00014247865,0.000023242776,0.00010985619,0.012440456],"genre_scores_gemma":[0.9949698,0.00021569782,0.0030535974,0.000015357939,0.0001617042,0.00052063435,0.000015748687,0.000020168087,0.0010273047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989101,0.00002095238,0.00017843282,0.00023184561,0.0004094599,0.0002491884],"domain_scores_gemma":[0.99892527,0.00005310877,0.0000696472,0.00035917645,0.00048370834,0.00010907111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045192792,0.00006648176,0.0001197752,0.000066667235,0.00007401039,0.000020314823,0.00023656989,0.0000687695,0.00011739029],"category_scores_gemma":[0.00012934701,0.000062448096,0.00003168675,0.00041323356,0.0001495195,0.00010010105,0.00009018498,0.0002755226,0.000010847394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030349664,0.000047560723,0.000116860014,0.000063637846,0.000013830322,0.00000306821,0.00043555352,0.00009519482,0.90346175,0.0044775843,0.00158731,0.089667276],"study_design_scores_gemma":[0.0001862928,0.000009694073,0.00001742639,0.00003589865,0.0000050655776,0.0000011764729,0.00053809263,0.00004374982,0.8807497,0.008256055,0.11008941,0.000067468034],"about_ca_topic_score_codex":0.00048998994,"about_ca_topic_score_gemma":0.00001489459,"teacher_disagreement_score":0.1085021,"about_ca_system_score_codex":0.00008793365,"about_ca_system_score_gemma":0.00014825053,"threshold_uncertainty_score":0.25465596},"labels":[],"label_agreement":null},{"id":"W2140841327","doi":"10.1158/0008-5472.can-08-4766","title":"Src Stimulates Fibroblast Growth Factor Receptor-2 Shedding by an ADAM15 Splice Variant Linked to Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Biotechnology and Biological Sciences Research Council; University of California, San Francisco; Wellcome Trust","keywords":"Proto-oncogene tyrosine-protein kinase Src; Cancer research; Biology; Breast cancer; Cancer; Src family kinase; splice; Cell biology; Kinase; Biochemistry; Gene; Genetics","score_opus":0.08792739972269824,"score_gpt":0.4507606643172731,"score_spread":0.3628332645945748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140841327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95577323,0.0024359182,0.0002173973,0.034341037,0.00037726268,0.0028805528,0.0015286836,0.00031976722,0.0021261412],"genre_scores_gemma":[0.9883355,0.0017451158,0.00066154025,0.0015552142,0.0020557789,0.00059812283,0.00009069163,0.00016866821,0.0047893925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9923473,0.00046563253,0.0006007027,0.0014570607,0.0028366616,0.0022926705],"domain_scores_gemma":[0.99449944,0.00029100655,0.000079279416,0.0011415028,0.001901242,0.0020875253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015199705,0.00048257058,0.00073197315,0.00070598756,0.00051258015,0.00023906968,0.0010184789,0.0003637274,0.010887058],"category_scores_gemma":[0.0004465073,0.00043327708,0.00014268754,0.0023327419,0.0002799784,0.00043088984,0.00030057796,0.0020237386,0.0004985155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002012728,0.00044694805,0.005149509,0.00039487626,0.0001328702,0.00012732475,0.0016789355,0.00018667078,0.73122686,0.000110767534,0.19565706,0.06287546],"study_design_scores_gemma":[0.015746633,0.013804531,0.31826082,0.013098741,0.00019375682,0.00038400062,0.0026595378,0.0063500446,0.35583714,0.0008601232,0.26834053,0.0044641793],"about_ca_topic_score_codex":0.009836718,"about_ca_topic_score_gemma":0.00052365754,"teacher_disagreement_score":0.37538972,"about_ca_system_score_codex":0.0028477858,"about_ca_system_score_gemma":0.0021467984,"threshold_uncertainty_score":0.9998119},"labels":[],"label_agreement":null},{"id":"W2140897623","doi":"10.1158/0008-5472.can-05-2737","title":"Aromatase Inhibitors in Human Lung Cancer Therapy","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Aromatase; Anastrozole; Lung cancer; Cancer research; Aromatase inhibitor; Medicine; Internal medicine; Estrogen; Cancer; Breast cancer; Biology; Endocrinology","score_opus":0.02874407903790465,"score_gpt":0.4118088203535915,"score_spread":0.38306474131568685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140897623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587957,0.03917702,0.0000014708687,0.0006370895,0.00007742695,0.00030843978,0.000014999336,0.000009249532,0.0009785979],"genre_scores_gemma":[0.9897926,0.007625127,0.000014358204,0.00012060561,0.00072609464,0.00029330517,0.00004220704,0.000026432854,0.0013592594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987552,0.0001368416,0.00013695698,0.00031442542,0.0002257786,0.00043079193],"domain_scores_gemma":[0.9995392,0.00001108149,0.000022151668,0.0002564503,0.000066547414,0.00010458033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039785737,0.00010655345,0.000100144855,0.000110580564,0.00012056266,0.000025308622,0.00020176149,0.00017313128,0.00013111252],"category_scores_gemma":[0.000015757834,0.000091449525,0.000048032554,0.00023470819,0.000114631235,0.0000049698097,0.00008615719,0.00035471653,0.000012883285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000942705,0.00006682829,0.0069460305,0.000013459346,0.000034516597,0.000009242414,0.00008803768,0.00019823787,0.95150614,0.00002882979,0.028731411,0.012283025],"study_design_scores_gemma":[0.00093533937,0.00012646594,0.001338217,0.000053917007,0.00000225785,0.0000019627946,0.000025301508,0.0000519149,0.92929345,0.000013936564,0.06802227,0.00013494388],"about_ca_topic_score_codex":0.0006320134,"about_ca_topic_score_gemma":0.0003289065,"teacher_disagreement_score":0.03929086,"about_ca_system_score_codex":0.00010920242,"about_ca_system_score_gemma":0.00018117466,"threshold_uncertainty_score":0.37292033},"labels":[],"label_agreement":null},{"id":"W2140949230","doi":"10.1158/0008-5472.can-05-0217","title":"Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Prostate cancer; Cancer research; Biology; Chromoplexy; Gene knockdown; Cancer; Cell growth; Metastasis; Prostate; Alternative splicing; Tumor suppressor gene; Tumor progression; Carcinogenesis; Gene isoform; Cell culture; Genetics; Gene; PCA3","score_opus":0.02265521298183107,"score_gpt":0.3375404844316563,"score_spread":0.31488527144982525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140949230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665345,0.008737137,0.000015441266,0.0017389816,0.000088663066,0.00067204185,0.00033103273,0.000009012367,0.0017542655],"genre_scores_gemma":[0.9872431,0.009995227,0.00006376009,0.00009171875,0.00034294618,0.0002520568,0.00004409334,0.000040272163,0.0019268047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977148,0.00030368895,0.00023002997,0.00050648843,0.00062032125,0.00062463543],"domain_scores_gemma":[0.99865836,0.00005708944,0.00007288052,0.0004990405,0.00055510266,0.0001575086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000491804,0.00016649574,0.00016790455,0.0000755878,0.00017906164,0.000044575707,0.00037978607,0.0001708635,0.00029184567],"category_scores_gemma":[0.00017281916,0.00012648835,0.00006317149,0.00034918895,0.000452742,0.00002173096,0.0005646029,0.00037726434,0.0000074793375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002075337,0.00007748541,0.007093733,0.00019720389,0.00003471192,0.000002598372,0.00024086959,0.00002857572,0.98052806,0.00003785743,0.010092532,0.0014588679],"study_design_scores_gemma":[0.0006340511,0.00014756186,0.0053901104,0.00006509059,0.000008939608,0.0000035897622,0.00013959894,0.000028110315,0.9767831,0.000053379914,0.016602164,0.00014431275],"about_ca_topic_score_codex":0.0048791063,"about_ca_topic_score_gemma":0.0024792214,"teacher_disagreement_score":0.0065096314,"about_ca_system_score_codex":0.000109233544,"about_ca_system_score_gemma":0.0005940563,"threshold_uncertainty_score":0.73757815},"labels":[],"label_agreement":null},{"id":"W2140966153","doi":"10.1158/0008-5472.can-11-2502","title":"Vav3-Rac1 Signaling Regulates Prostate Cancer Metastasis with Elevated Vav3 Expression Correlating with Prostate Cancer Progression and Posttreatment Recurrence","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Chi Mei Medical Center; National Health Research Institutes","keywords":"Prostate cancer; Metastasis; Medicine; Cancer; Prostate; Cancer research; Internal medicine; RAC1; Oncology; Bone metastasis; Signal transduction; Biology","score_opus":0.10264542145177849,"score_gpt":0.40345635400143637,"score_spread":0.30081093254965785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140966153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828323,0.013925926,0.000023959179,0.0006822695,0.00017386458,0.0020243118,0.00012304679,0.00012654581,0.0000877898],"genre_scores_gemma":[0.99024653,0.0054867384,0.0005114294,0.00014823698,0.00020930027,0.0025656908,0.000010402779,0.00011385454,0.000707838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942538,0.0006579554,0.00045779912,0.0012027344,0.0017074167,0.0017202777],"domain_scores_gemma":[0.997661,0.0005479093,0.00036113395,0.000422269,0.0004803052,0.00052738824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010236852,0.0004979713,0.0004635065,0.00026612962,0.0012160991,0.00023871592,0.00034996786,0.00011293706,0.00022827646],"category_scores_gemma":[0.00017458844,0.0003183678,0.000049174258,0.0014047225,0.00060783915,0.001079852,0.00027743733,0.00093692023,0.000012247026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002832105,0.0001711485,0.055465795,0.00022992944,0.000042670785,0.000066866625,0.0029365844,0.001105128,0.90103817,0.00003323021,0.00017386134,0.035904527],"study_design_scores_gemma":[0.0013683691,0.0007090861,0.0027187557,0.003462159,0.00006380361,0.000032902775,0.0004299086,0.00040933624,0.98879147,0.000037732516,0.0014883538,0.00048812403],"about_ca_topic_score_codex":0.00070121314,"about_ca_topic_score_gemma":0.00007953162,"teacher_disagreement_score":0.08775331,"about_ca_system_score_codex":0.00042647417,"about_ca_system_score_gemma":0.000580538,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2141004462","doi":"10.1158/1538-7445.sabcs14-p4-11-11","title":"Abstract P4-11-11: CADER prognostic gene signature for disease free survival in hormone receptor positive breast cancer: NCIC CTG MA.12 phase III placebo-controlled tamoxifen trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Tamoxifen; Hormone receptor; Clinical endpoint; Cancer; Proportional hazards model; Gynecology; Placebo; Gene signature; Randomized controlled trial; Pathology; Biology; Gene expression; Gene","score_opus":0.04520311746771554,"score_gpt":0.3722970663252771,"score_spread":0.32709394885756155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141004462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96410394,0.017214304,0.000049270915,0.0053978777,0.0006348988,0.0055020484,0.0069304383,0.000029460118,0.00013775071],"genre_scores_gemma":[0.98409253,0.0011863791,0.00006322475,0.000118996504,0.002581128,0.009957333,0.00089787616,0.00009897761,0.0010035431],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99611515,0.00034521558,0.00049058313,0.0010475984,0.0008641924,0.0011372331],"domain_scores_gemma":[0.99741894,0.00027273517,0.00017075411,0.00063725596,0.00088015944,0.0006201308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011680224,0.0004581832,0.000700496,0.00018890871,0.00024644096,0.00008244004,0.0005528017,0.00032649675,0.00011449113],"category_scores_gemma":[0.0006276333,0.00039668576,0.00023916198,0.0003294781,0.00035067287,0.000026623504,0.00032508577,0.0004193673,0.000008443495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7890088,0.0015901601,0.00630574,0.000111323956,0.00095686666,0.000080601734,0.00046213984,0.00022133173,0.13272381,0.000023934497,0.06453182,0.003983448],"study_design_scores_gemma":[0.89258915,0.002053751,0.03762897,0.0003321672,0.00048549808,0.0000108638915,0.0007556901,0.000111374786,0.053018752,0.00024826697,0.01135268,0.0014128158],"about_ca_topic_score_codex":0.0047032116,"about_ca_topic_score_gemma":0.0076549877,"teacher_disagreement_score":0.10358035,"about_ca_system_score_codex":0.00076968886,"about_ca_system_score_gemma":0.0022726685,"threshold_uncertainty_score":0.9998485},"labels":[],"label_agreement":null},{"id":"W2141156902","doi":"10.1158/0008-5472.can-07-1388","title":"Tobacco Smoke Induces Urokinase-Type Plasminogen Activator and Cell Invasiveness: Evidence for an Epidermal Growth Factor Receptor–Dependent Mechanism","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"MAPK/ERK pathway; Urokinase receptor; Cancer research; Extracellular matrix; Cell migration; Plasminogen activator; Kinase; Epidermal growth factor; Cell biology; Epidermal growth factor receptor; Plasmin; Protein kinase A; Biology; Chemistry; Cell; Receptor; Biochemistry; Endocrinology","score_opus":0.1491285347053122,"score_gpt":0.39555313436181533,"score_spread":0.24642459965650312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141156902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582237,0.002165015,0.000550628,0.00014422386,0.00028861218,0.00087162346,0.0000678557,0.000015980206,0.00007367367],"genre_scores_gemma":[0.996846,0.0012974092,0.0003586477,0.00022851316,0.00077667914,0.00016526152,0.00004412189,0.00003923892,0.0002441149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788535,0.0001715711,0.00022433921,0.00068257534,0.00036784072,0.0006683549],"domain_scores_gemma":[0.9985999,0.0001297925,0.00007736822,0.00037033166,0.00049439,0.00032820468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011994526,0.0002042756,0.00018517599,0.00012051684,0.00027037773,0.00007800331,0.00038059574,0.00028847271,0.000054180127],"category_scores_gemma":[0.00046330635,0.00019311723,0.000056825083,0.00015861515,0.000084435036,0.000045588033,0.00021638857,0.00026461348,0.0000062373806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085173966,0.00007061405,0.00046228906,0.00006774911,0.000023467446,0.0000055673345,0.00008449601,5.737319e-7,0.9945036,0.00029372185,0.00057623954,0.0030599385],"study_design_scores_gemma":[0.0005787623,0.001583261,0.0004353851,0.00007309457,0.000008624184,0.000004054498,0.00019828526,0.000002189206,0.9945748,0.0008611233,0.0014354212,0.00024502445],"about_ca_topic_score_codex":0.00029370398,"about_ca_topic_score_gemma":0.000119925964,"teacher_disagreement_score":0.002814914,"about_ca_system_score_codex":0.00009659938,"about_ca_system_score_gemma":0.00042997327,"threshold_uncertainty_score":0.7875092},"labels":[],"label_agreement":null},{"id":"W2141163897","doi":"10.1158/0008-5472.can-09-4417","title":"Colorectal Cancer Incidence Trends in the United States and United Kingdom: Evidence of Right- to Left-Sided Biological Gradients with Implications for Screening","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Colorectal cancer; Medicine; Incidence (geometry); Adenoma; Epidemiology; Cancer; Cohort; Differential effects; Internal medicine; Demography; Oncology","score_opus":0.2046976164578152,"score_gpt":0.4637715285585951,"score_spread":0.2590739121007799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141163897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237365,0.00021780237,0.00041377285,0.0060304073,0.000046710684,0.00081657455,0.00004542574,0.000027736287,0.000027923614],"genre_scores_gemma":[0.99782777,0.00019450692,0.0005995444,0.00022758043,0.00009122184,0.000960707,0.000041862215,0.000014741643,0.00004205571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848306,0.00015399046,0.00022161448,0.00038126807,0.0003512166,0.00040886074],"domain_scores_gemma":[0.99774194,0.0011488235,0.00006611808,0.00025078803,0.0006304516,0.00016189243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011584988,0.00012663344,0.00022789936,0.00091698114,0.00024226932,0.000039021284,0.00023167476,0.00009295784,0.00004986739],"category_scores_gemma":[0.00064411625,0.000077793426,0.00003489696,0.002869964,0.00036571996,0.00008454758,0.0000778255,0.0005971028,3.9349246e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023871545,0.00015367418,0.6525691,0.00015191511,0.00010177196,0.000012044413,0.0039168918,0.00054315827,0.2817514,0.00063474954,0.001299488,0.03499424],"study_design_scores_gemma":[0.0014706304,0.0051265922,0.9545653,0.00082096015,0.000038484573,0.00005000777,0.00046314875,0.0017030061,0.032949436,0.00021504237,0.0024218378,0.00017556219],"about_ca_topic_score_codex":0.022395916,"about_ca_topic_score_gemma":0.026297167,"teacher_disagreement_score":0.30199617,"about_ca_system_score_codex":0.00012428508,"about_ca_system_score_gemma":0.00016918308,"threshold_uncertainty_score":0.9914704},"labels":[],"label_agreement":null},{"id":"W2141425188","doi":"10.1158/0008-5472.can-09-0820","title":"3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology; Amgen; Breast Cancer Research Foundation; Avon Foundation for Women","keywords":"PTEN; Pleckstrin homology domain; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; Biology; Phosphatidylinositol; Phosphoinositide 3-kinase; Kinase; Signal transduction; Proto-Oncogene Proteins c-akt; AKT2; AKT1; Cell biology","score_opus":0.03578427460942647,"score_gpt":0.33494127257067224,"score_spread":0.2991569979612458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141425188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988888,0.0048236405,0.000019696674,0.004047517,0.0002164772,0.0005755994,0.00018508003,0.00002013601,0.001223826],"genre_scores_gemma":[0.9968576,0.00054719124,0.000025355297,0.0008434534,0.00044009782,0.00026667942,0.00005882037,0.000040961266,0.0009198683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704665,0.00033660416,0.0003075434,0.0007430802,0.0007105526,0.0008555656],"domain_scores_gemma":[0.99842346,0.00010864678,0.00007362165,0.00089963875,0.00028480438,0.00020980387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008485197,0.00027562722,0.00021447263,0.00014630395,0.00034258005,0.00010201961,0.0007573036,0.00021285095,0.00028295844],"category_scores_gemma":[0.00011697496,0.0002132087,0.00013102831,0.00043656008,0.00021752788,0.000009780757,0.00018556176,0.0006363052,0.000058160935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007663088,0.00041605844,0.015735712,0.0000249407,0.000043619104,0.00018705435,0.00016636263,0.0005963916,0.94879806,0.0009545783,0.012628649,0.019682275],"study_design_scores_gemma":[0.0007882455,0.0005099701,0.023843704,0.00014929727,0.0000069874654,0.000019387406,0.00020149365,0.00004569279,0.9701224,0.00040958295,0.0036241899,0.00027906484],"about_ca_topic_score_codex":0.0012069242,"about_ca_topic_score_gemma":0.00022917338,"teacher_disagreement_score":0.021324333,"about_ca_system_score_codex":0.00027866228,"about_ca_system_score_gemma":0.00060014636,"threshold_uncertainty_score":0.86943984},"labels":[],"label_agreement":null},{"id":"W2141497573","doi":"10.1158/0008-5472.can-05-4302","title":"Connexins Act as Tumor Suppressors in Three-dimensional Mammary Cell Organoids by Regulating Differentiation and Angiogenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Canadian Breast Cancer Research Alliance; McGill University","keywords":"Organoid; Angiogenesis; Suppressor; Cell biology; Biology; Cancer research; Cancer; Genetics","score_opus":0.015888014641981293,"score_gpt":0.2952684068952381,"score_spread":0.2793803922532568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141497573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464947,0.004186012,0.00003660936,0.00039630773,0.000046407262,0.00018211259,0.000038531532,0.0000073553374,0.00045717217],"genre_scores_gemma":[0.9983381,0.00012691673,0.00005896509,0.00008032003,0.00015034332,0.000054132837,0.00019479862,0.000019581057,0.0009768511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998749,0.00014149085,0.0001649754,0.00041132345,0.00016531159,0.00036788438],"domain_scores_gemma":[0.9995281,0.00004588384,0.000038168106,0.00022176675,0.00010417304,0.00006188715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027695962,0.00011782967,0.0001286136,0.00009804023,0.00011144685,0.000031022406,0.0001442763,0.00013167603,0.00014358849],"category_scores_gemma":[0.000038788185,0.00010981789,0.000036494886,0.0001532642,0.00011921115,0.0000058443447,0.00020702221,0.0001316423,0.000004213069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107180334,0.000048776885,0.041563034,0.000019302292,0.000010121128,0.000005932576,0.000011954428,0.000022616528,0.95405173,0.00011508363,0.0027419028,0.0013023644],"study_design_scores_gemma":[0.00090256176,0.00019651729,0.088516265,0.000015226392,0.0000050813746,0.000008728971,0.000025198942,0.000250045,0.9038892,0.0004158328,0.005582907,0.0001924482],"about_ca_topic_score_codex":0.0019171562,"about_ca_topic_score_gemma":0.0017098929,"teacher_disagreement_score":0.050162546,"about_ca_system_score_codex":0.000038468486,"about_ca_system_score_gemma":0.00012594246,"threshold_uncertainty_score":0.44782436},"labels":[],"label_agreement":null},{"id":"W2141569270","doi":"10.1158/0008-5472.can-08-0249","title":"Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1412,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; Oregon National Primate Research Center; National Cancer Institute; Prostate Cancer Foundation; National Institutes of Health; University of Washington; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Defense","keywords":"Prostate cancer; Castration; Androgen; Medicine; Prostate; Orchiectomy; Testosterone (patch); Internal medicine; Androgen deprivation therapy; Androgen receptor; CYP17A1; Cancer research; Cancer; Intracrine; Endocrinology; Oncology; Biology; Hormone; Gene; Receptor","score_opus":0.10793038384495086,"score_gpt":0.4065856309627567,"score_spread":0.29865524711780583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141569270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972195,0.0031306539,0.00003170719,0.0032304986,0.00010181567,0.0029995318,0.00047381085,0.00002437014,0.0002856589],"genre_scores_gemma":[0.98797184,0.0049991207,0.00069632847,0.00009103821,0.000100457066,0.0034373156,0.000043675052,0.00004959819,0.0026106508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701065,0.00013700032,0.0004776806,0.00050484977,0.00088317815,0.0009866196],"domain_scores_gemma":[0.99762136,0.00017479372,0.00009840602,0.0002974856,0.0015396357,0.00026831194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007726069,0.00020595944,0.00054478366,0.00048459152,0.00020449112,0.000020944499,0.00019532676,0.000051054976,0.00013108984],"category_scores_gemma":[0.00025611272,0.00016044964,0.00011841631,0.0010917446,0.0005051822,0.00013855654,0.00006182165,0.0004509552,0.0000055853093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02488648,0.0014533201,0.06115043,0.0051089623,0.00070388603,0.0037137961,0.0062308856,0.000054736687,0.85851556,0.023166476,0.011615035,0.0034004494],"study_design_scores_gemma":[0.022322217,0.0040782243,0.02060137,0.0020024534,0.00013801723,0.00023234647,0.0023885195,0.00093337795,0.9349138,0.010520954,0.0013023973,0.0005663025],"about_ca_topic_score_codex":0.0038658807,"about_ca_topic_score_gemma":0.0015611964,"teacher_disagreement_score":0.07639828,"about_ca_system_score_codex":0.0007972522,"about_ca_system_score_gemma":0.0030807313,"threshold_uncertainty_score":0.6542946},"labels":[],"label_agreement":null},{"id":"W2141596026","doi":"10.1158/0008-5472.can-09-1199","title":"Development and Cancer: At the Crossroads of Nodal and Notch Signaling","year":2009,"lang":"en","type":"review","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Notch signaling pathway; NODAL; Biology; Embryonic stem cell; Phenotype; Hes3 signaling axis; Signal transduction; Cell biology; Stem cell; Cancer research; Tumor progression; Nodal signaling; Cancer; Neuroscience; Embryogenesis; Genetics; Embryo; Gastrulation; Gene","score_opus":0.09868246044520355,"score_gpt":0.43938470548897546,"score_spread":0.3407022450437719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141596026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07688587,0.92247367,0.0000036108804,0.000036672387,0.000031935233,0.00045629664,0.00005619747,0.0000021739386,0.0000535724],"genre_scores_gemma":[0.0015241461,0.9969757,0.000073982825,0.000013886269,0.00020045009,0.00020742966,0.00008437808,0.000025787236,0.0008941947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865216,0.00013996186,0.00026785707,0.00039376563,0.00026832908,0.00027794458],"domain_scores_gemma":[0.99932873,0.00003830411,0.00011411009,0.00027645638,0.00015621197,0.00008616266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055502035,0.00017203967,0.000356296,0.00006208648,0.00019797788,0.00003601944,0.00019931914,0.00019968246,0.000046070352],"category_scores_gemma":[0.000036174115,0.00012011236,0.000067165434,0.00014218572,0.00029236573,0.0000018573188,0.0003409943,0.00019091021,0.0000018343194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002627155,0.000009340198,0.000025748985,0.0033673195,0.00010299233,0.0000013506105,0.000063238,0.000003243693,0.033610135,0.00000621914,0.0009725077,0.9618116],"study_design_scores_gemma":[0.000117840405,0.000022555843,0.00006237203,0.0017614317,0.000051286064,0.00000620669,0.00000867073,8.703278e-7,0.028213738,0.000004192632,0.9696193,0.00013156031],"about_ca_topic_score_codex":0.00007407456,"about_ca_topic_score_gemma":0.00012831061,"teacher_disagreement_score":0.96864676,"about_ca_system_score_codex":0.00014864405,"about_ca_system_score_gemma":0.0009642649,"threshold_uncertainty_score":0.489804},"labels":[],"label_agreement":null},{"id":"W2141659194","doi":"10.1158/0008-5472.can-07-1525","title":"Egr-1 Mediates Hypoxia-Inducible Transcription of the <i>NDRG1</i> Gene through an Overlapping Egr-1/Sp1 Binding Site in the Promoter","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Molecular biology; Transactivation; Gene knockdown; Transcription factor; Promoter; Biology; Electrophoretic mobility shift assay; Gene expression; Transcription (linguistics); Gene; Binding site; Transfection; Response element; Messenger RNA; Chemistry; Biochemistry","score_opus":0.08997272842241157,"score_gpt":0.38554649681184294,"score_spread":0.2955737683894314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141659194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939553,0.003117067,0.00054920546,0.0007798076,0.00028162505,0.00062136643,0.0000701699,0.000006229462,0.00061924424],"genre_scores_gemma":[0.9970773,0.0012283406,0.000559487,0.00028031398,0.000489251,0.00015867171,0.000040315295,0.00003148164,0.00013484801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974618,0.00041348804,0.00031818193,0.00045814787,0.00075223943,0.0005961456],"domain_scores_gemma":[0.9988467,0.00005202542,0.00008904843,0.00075595296,0.00018917385,0.00006707155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035127385,0.00015359752,0.000174656,0.00009923011,0.00018179299,0.00004314618,0.0007483266,0.00016293912,0.00007184225],"category_scores_gemma":[0.000111203364,0.00010144436,0.0001018086,0.0005985126,0.00019473447,0.000029651605,0.00012529583,0.0004020494,0.0000054938846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012082688,0.00006284399,0.0008790166,0.00004648532,0.00002575483,0.0000037851194,0.0011129845,0.000021364693,0.99304307,0.00013341702,0.00049058866,0.004059848],"study_design_scores_gemma":[0.00049432134,0.00019755782,0.0020174817,0.000059705984,0.000012704351,0.0000056091403,0.0005698078,0.0000073861643,0.9783157,0.00027101612,0.01792668,0.00012199102],"about_ca_topic_score_codex":0.0005546645,"about_ca_topic_score_gemma":0.0012738018,"teacher_disagreement_score":0.017436093,"about_ca_system_score_codex":0.00008891908,"about_ca_system_score_gemma":0.00023675054,"threshold_uncertainty_score":0.4136781},"labels":[],"label_agreement":null},{"id":"W2141669181","doi":"10.1158/0008-5472.can-12-1993","title":"Preventing Postoperative Metastatic Disease by Inhibiting Surgery-Induced Dysfunction in Natural Killer Cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Natural killer cell; Medicine; Cell; Cancer; Cancer research; Surgical stress; Lymphokine-activated killer cell; In vivo; Perioperative; Immunology; Cancer cell; Myeloid-derived Suppressor Cell; Cytotoxicity; Biology; T cell; Internal medicine; Interleukin 21; In vitro; Immune system; Surgery; Suppressor","score_opus":0.05653864915091346,"score_gpt":0.3511605343646519,"score_spread":0.29462188521373844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141669181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98421365,0.0069083152,0.000014676475,0.0004654748,0.00762935,0.00033980803,0.0000033189967,0.000030936077,0.0003944451],"genre_scores_gemma":[0.9693639,0.00013958779,0.0000036779961,0.00016247078,0.000067107445,0.0001619955,0.00012844421,0.000020077614,0.029952692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778295,0.0008978794,0.0002926834,0.00025116705,0.00009938565,0.0006759335],"domain_scores_gemma":[0.99913937,0.00042537152,0.00007255137,0.00013271526,0.0001776806,0.000052290558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012914201,0.00013323325,0.00019215287,0.00029125952,0.0002883249,0.000034037737,0.0000819654,0.0000636929,0.0023950874],"category_scores_gemma":[0.00033122374,0.00011849195,0.00007727183,0.00036435903,0.00007814795,0.00048812234,0.000072175055,0.0008651876,0.0006388954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030694093,0.00013335735,0.002045111,0.000026358832,0.000046045934,0.000002090015,0.00051078305,0.0000034795037,0.9252009,0.000025629188,0.06780424,0.0038950772],"study_design_scores_gemma":[0.0007974073,0.000049358852,0.0049016546,0.00017369087,0.000016719401,0.000007903946,0.0016253772,0.000022872804,0.9264878,0.000007814828,0.0656912,0.0002181933],"about_ca_topic_score_codex":0.00066448696,"about_ca_topic_score_gemma":0.00003705405,"teacher_disagreement_score":0.029558247,"about_ca_system_score_codex":0.00031601294,"about_ca_system_score_gemma":0.00012922614,"threshold_uncertainty_score":0.99851686},"labels":[],"label_agreement":null},{"id":"W2141833679","doi":"10.1158/0008-5472.can-03-2735","title":"Tid-1 Interacts with the von Hippel-Lindau Protein and Modulates Angiogenesis by Destabilization of HIF-1α","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"College of Medicine, Seoul National University","keywords":"Angiogenesis; Cancer research; Neuroscience; Chemistry; Medicine; Biology","score_opus":0.021726168817508912,"score_gpt":0.32487431793299215,"score_spread":0.30314814911548327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141833679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133063,0.016872589,0.00015384177,0.0010149018,0.0000432742,0.0004146116,0.00003385241,0.0000044289145,0.00013187602],"genre_scores_gemma":[0.995714,0.0021132783,0.00011538662,0.00006639548,0.00049691094,0.00014342241,0.000030162368,0.000021598238,0.0012988255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990503,0.00010050737,0.0001121015,0.0002609092,0.00022803165,0.0002481165],"domain_scores_gemma":[0.9993616,0.000017902581,0.000045898858,0.00025788488,0.000246535,0.00007023016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033391712,0.00009420995,0.000107890606,0.00004667788,0.000099451856,0.00002626311,0.00015531099,0.00007318604,0.000042777032],"category_scores_gemma":[0.000049689774,0.0000642597,0.000030058543,0.00018464586,0.00022819843,0.000008128715,0.00008589551,0.000095790325,0.0000017310662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019373465,0.00002962868,0.000394362,0.00003481726,0.000026659298,1.249737e-7,0.00018709782,0.00006573384,0.9751041,0.000028780223,0.0057260217,0.018208958],"study_design_scores_gemma":[0.00036758324,0.00013468869,0.000583518,0.00003062924,0.000009961185,0.000001996013,0.0001276248,0.000056524794,0.8643801,0.00001448317,0.13421172,0.000081122314],"about_ca_topic_score_codex":0.00024643447,"about_ca_topic_score_gemma":0.00073043554,"teacher_disagreement_score":0.1284857,"about_ca_system_score_codex":0.00002540749,"about_ca_system_score_gemma":0.00015932006,"threshold_uncertainty_score":0.26204345},"labels":[],"label_agreement":null},{"id":"W2141873881","doi":"10.1158/0008-5472.can-08-3380","title":"LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Center for Research Resources; U.S. Department of Defense","keywords":"LNCaP; Androgen receptor; Prostate cancer; Cancer research; Androgen; Gene knockdown; Biology; Cancer; Prostate; Internal medicine; Endocrinology; Medicine; Cell culture; Hormone","score_opus":0.05182841548603007,"score_gpt":0.3796057018448488,"score_spread":0.32777728635881875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141873881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617363,0.028378874,0.0000011719845,0.006537806,0.00012586152,0.0026419265,0.00015879516,0.000040638377,0.0003785938],"genre_scores_gemma":[0.92293745,0.072589256,0.00007956129,0.000089918634,0.000186497,0.0009927319,0.000077058125,0.000046224937,0.0030013116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959761,0.00027737254,0.00056382787,0.0008199428,0.0013984448,0.0009643426],"domain_scores_gemma":[0.99810404,0.00009697541,0.00014912199,0.00042522035,0.000796953,0.00042768085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009976056,0.00029363856,0.000577087,0.0006915286,0.0002315731,0.000060637452,0.00020945774,0.00021230386,0.00043011562],"category_scores_gemma":[0.00011170571,0.0002283693,0.00007843651,0.0012084004,0.00036753324,0.00034038688,0.00015724785,0.00071452913,0.0000073621886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049361764,0.00030727612,0.28207022,0.0006966194,0.00007498911,0.000059707385,0.0029271843,0.00003434583,0.641896,0.000056851826,0.0037395833,0.06320101],"study_design_scores_gemma":[0.007194551,0.00093342486,0.10528703,0.0024069655,0.000036825062,0.000012308781,0.0005163563,0.00008241708,0.87962466,0.00069716614,0.0029182918,0.00029001868],"about_ca_topic_score_codex":0.0032377206,"about_ca_topic_score_gemma":0.0004974807,"teacher_disagreement_score":0.23772863,"about_ca_system_score_codex":0.00082563097,"about_ca_system_score_gemma":0.0016462087,"threshold_uncertainty_score":0.931263},"labels":[],"label_agreement":null},{"id":"W2141955227","doi":"10.1158/0008-5472.can-06-2552","title":"Small Molecules, Big Players: the National Cancer Institute's Initiative for Chemical Genetics","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial Natural Products and Biosynthesis","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; University of California, Irvine; University of California, Los Angeles; Harvard University","keywords":"Chemical genetics; Data science; Computer science; Computational biology; Library science; Chemistry; Nanotechnology; World Wide Web; Small molecule; Biology; Biochemistry","score_opus":0.22054698270819514,"score_gpt":0.4083654363822265,"score_spread":0.18781845367403135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141955227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460155,0.008680557,0.00014043317,0.03915389,0.0004622777,0.0016665164,0.00040640988,0.000034434757,0.00343999],"genre_scores_gemma":[0.99184585,0.00061953923,0.0005872613,0.0013209891,0.0036832942,0.00012140311,0.00005221258,0.000021411279,0.0017480548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986763,0.000042047817,0.00015732922,0.00029070277,0.00044484006,0.00038880395],"domain_scores_gemma":[0.99863964,0.00015406014,0.000033864675,0.00013033189,0.00097220077,0.000069884925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000480191,0.00010180238,0.00013968316,0.00008807141,0.00017626297,0.000037841986,0.00018212976,0.00009529679,0.00011000268],"category_scores_gemma":[0.00032334612,0.00006292147,0.00006263183,0.00033522863,0.0003351836,0.00002793502,0.00006931143,0.00035716823,0.000009050099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036858112,0.000082396175,0.0001482117,0.000116917836,0.000076319666,0.0000048265333,0.00009577992,0.000050141934,0.88347393,0.0014672326,0.09658848,0.01752718],"study_design_scores_gemma":[0.00067321677,0.000055053733,0.0006046301,0.000095467556,0.000025724003,0.000005375506,0.00003460388,0.00016206184,0.70466065,0.0005823402,0.2930001,0.00010074802],"about_ca_topic_score_codex":0.000900754,"about_ca_topic_score_gemma":0.0005857595,"teacher_disagreement_score":0.19641164,"about_ca_system_score_codex":0.00038505797,"about_ca_system_score_gemma":0.00091414247,"threshold_uncertainty_score":0.2565863},"labels":[],"label_agreement":null},{"id":"W2141976382","doi":"10.1158/0008-5472.can-08-3506","title":"Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Michael Smith Health Research BC","keywords":"Prostate cancer; Gene signature; Osteoblast; Cancer research; Biology; Metastasis; Cancer; Gene expression; Phenotype; Prostate; Tumor progression; Gene; In vitro; Genetics","score_opus":0.11172701462873631,"score_gpt":0.4458255886357266,"score_spread":0.3340985740069903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141976382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672079,0.026552761,0.0000027460915,0.003875761,0.00013719084,0.0017706375,0.0001423285,0.0000977384,0.00021295727],"genre_scores_gemma":[0.98627484,0.010174618,0.0001057234,0.00010435097,0.00025398386,0.0005302548,0.0001605285,0.00005132957,0.0023443555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99577737,0.0003270367,0.000259642,0.0008538907,0.0017277726,0.0010542643],"domain_scores_gemma":[0.9980273,0.00011109219,0.00008777833,0.00046575148,0.0006016606,0.0007064222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070281053,0.00034324685,0.00046036096,0.0004774704,0.0006101604,0.0002455438,0.00025923573,0.0002496024,0.00038331054],"category_scores_gemma":[0.000081299324,0.0002230942,0.00008990361,0.00067016535,0.0004534538,0.000634761,0.00018903722,0.0011953377,0.00000720173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022087968,0.00024793466,0.022954985,0.00019537057,0.000100736026,0.00012392829,0.0030097135,0.0000031409334,0.89104706,0.000010107486,0.0021818157,0.0779164],"study_design_scores_gemma":[0.0023142071,0.0014561289,0.102761775,0.0008042973,0.000060308157,0.00001031457,0.0020182815,0.000025812245,0.887758,0.00024556636,0.002283542,0.00026173147],"about_ca_topic_score_codex":0.00033024725,"about_ca_topic_score_gemma":0.00007443032,"teacher_disagreement_score":0.07980679,"about_ca_system_score_codex":0.00043619072,"about_ca_system_score_gemma":0.00072243856,"threshold_uncertainty_score":0.9097518},"labels":[],"label_agreement":null},{"id":"W2142316694","doi":"10.1158/0008-5472.can-06-4746","title":"Regulation of <i>Helicobacter pylori cagA</i> Expression in Response to Salt","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"CagA; Helicobacter pylori; Secretion; Tyrosine phosphorylation; Biology; Gastric mucosa; Tyrosine; Microbiology; Stomach; Gene; Endocrinology; Biochemistry","score_opus":0.059421393633979525,"score_gpt":0.39829518168788364,"score_spread":0.3388737880539041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142316694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912609,0.0002932372,0.00014733372,0.006844044,0.00018275893,0.0006846085,0.000010757444,0.000030056903,0.00054629095],"genre_scores_gemma":[0.9974697,0.00010285636,0.00040068247,0.00043136443,0.00018777019,0.00009620602,0.000006669779,0.000031077412,0.0012736651],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99735683,0.00032874205,0.00048278616,0.00039187446,0.0006933584,0.00074641005],"domain_scores_gemma":[0.9981826,0.00038484187,0.000059360304,0.00046435755,0.0006528703,0.00025600198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003706157,0.00013830412,0.00033910907,0.00090622273,0.000071979455,0.0000077234545,0.00015765762,0.00016693844,0.00012653322],"category_scores_gemma":[0.0008731945,0.00012131331,0.00004826191,0.0011330715,0.00020331664,0.000087417895,0.00018711443,0.00063382456,0.00006139611],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013354439,0.00009188124,0.17293228,0.00004690121,0.000029770714,0.000045059758,0.001498027,0.000013325789,0.8055001,0.0000065333456,0.0035996148,0.0028820876],"study_design_scores_gemma":[0.0015224568,0.00055857823,0.72236997,0.00042288247,0.000008107298,0.000007418782,0.00021865746,0.000003225458,0.26396218,0.000018328214,0.010844504,0.000063672305],"about_ca_topic_score_codex":0.0002565879,"about_ca_topic_score_gemma":0.0004659049,"teacher_disagreement_score":0.5494377,"about_ca_system_score_codex":0.00055478245,"about_ca_system_score_gemma":0.00019426647,"threshold_uncertainty_score":0.49470133},"labels":[],"label_agreement":null},{"id":"W2142399962","doi":"10.1158/0008-5472.can-14-1997","title":"Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants <i>In Vivo</i> with Magnetic Resonance Elastography","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Engineering and Physical Sciences Research Council; CHILDREN with CANCER UK; Cancer Research UK; Wellcome Trust","keywords":"Magnetic resonance elastography; In vivo; Magnetic resonance imaging; Elastography; Medicine; Nuclear magnetic resonance; Pathology; Radiology; Biology; Physics; Ultrasound","score_opus":0.14078368495146798,"score_gpt":0.3182322293678668,"score_spread":0.17744854441639885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142399962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904735,0.010246661,0.000050715214,0.00032353183,0.000058407775,0.00020271492,0.000013390378,0.0000030993635,0.00005415209],"genre_scores_gemma":[0.99742717,0.0019351965,0.00003290832,0.00006047153,0.000043837434,0.00025866408,7.329326e-7,0.0000129002165,0.00022810603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990965,0.00013614548,0.00012450325,0.0002395223,0.0001548694,0.00024844237],"domain_scores_gemma":[0.99948716,0.000020549312,0.000025781008,0.00024903336,0.00016112467,0.000056340174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058631774,0.00008839235,0.00010653326,0.00008163311,0.00006755215,0.000021610527,0.00017835524,0.00004003242,0.000004724179],"category_scores_gemma":[0.000083928295,0.000049611444,0.000026778669,0.0002585982,0.00022004155,0.000008684518,0.0001605981,0.00013852923,6.1258254e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017423363,0.000027649461,0.0006724362,0.000017626777,0.000003750055,0.0000043217265,0.00031555918,0.0000024120552,0.99400973,0.000049371658,0.00018878636,0.0045341407],"study_design_scores_gemma":[0.0002952732,0.0007734223,0.00026232257,0.000118205004,0.0000017889198,0.000028821776,0.0012555156,0.000059393602,0.9744022,0.00007360473,0.022648761,0.00008071284],"about_ca_topic_score_codex":0.00014356646,"about_ca_topic_score_gemma":0.0004930623,"teacher_disagreement_score":0.022459975,"about_ca_system_score_codex":0.000013971605,"about_ca_system_score_gemma":0.00009831776,"threshold_uncertainty_score":0.20230961},"labels":[],"label_agreement":null},{"id":"W2142483688","doi":"10.1158/0008-5472.can-07-0622","title":"Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD8; Immunotherapy; Cancer research; Cancer; MHC class I; Biology; T cell; Immunology; Oncogene; Immune system; Antigen; Tumor microenvironment; Cancer immunotherapy; Medicine; Internal medicine; Cell cycle","score_opus":0.04918820138997393,"score_gpt":0.3337704090664264,"score_spread":0.2845822076764525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142483688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153656,0.0050852974,0.0007565014,0.0007491995,0.00042128126,0.000798537,0.000059313683,0.000053990127,0.00053934264],"genre_scores_gemma":[0.99376374,0.00064017874,0.00002960514,0.00030747865,0.000037290716,0.00009035912,0.000015492325,0.000037062786,0.005078812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966846,0.0011584366,0.0003844324,0.00047473877,0.00012879878,0.0011689954],"domain_scores_gemma":[0.9983331,0.00095936307,0.00003120166,0.00043515596,0.00017738577,0.00006382521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002652283,0.0002492354,0.00039794165,0.00055401574,0.00022859263,0.000032533593,0.00037234233,0.00025758325,0.00040419135],"category_scores_gemma":[0.000088187066,0.00021214073,0.00010797363,0.00065493095,0.00029788664,0.0001073213,0.0001341691,0.001030495,0.0002948168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006056057,0.0001959151,0.00023461471,0.000020255167,0.000076671415,0.0010668308,0.002883394,0.000015796606,0.9402916,0.00010803281,0.0008316106,0.048219237],"study_design_scores_gemma":[0.0012968268,0.00043163935,0.044039845,0.00016091455,0.0000031994452,0.00036145412,0.0007663417,0.0000019806928,0.91949344,0.00004706605,0.03312463,0.00027267766],"about_ca_topic_score_codex":0.0015643148,"about_ca_topic_score_gemma":0.001685199,"teacher_disagreement_score":0.04794656,"about_ca_system_score_codex":0.00045873536,"about_ca_system_score_gemma":0.00035243185,"threshold_uncertainty_score":0.86508477},"labels":[],"label_agreement":null},{"id":"W2142646959","doi":"10.1158/0008-5472.can-08-0067","title":"Twist Is Required for Thrombin-Induced Tumor Angiogenesis and Growth","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Matrigel; Angiogenesis; Thrombin; CD31; Endothelial stem cell; Chorioallantoic membrane; Cancer research; Biology; Cell biology; Chemistry; Metastasis; Internal medicine; Immunology; Medicine; Cancer; Biochemistry; Platelet; In vitro","score_opus":0.11242348136705062,"score_gpt":0.3906257391563328,"score_spread":0.2782022577892822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142646959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904144,0.007674764,0.00014673616,0.0007306251,0.00012098467,0.00039160543,0.00009526158,0.000010682563,0.00041493677],"genre_scores_gemma":[0.99283355,0.0034921635,0.00021065844,0.00053756166,0.0006271112,0.00045731678,0.000026678938,0.000045409026,0.0017695549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853545,0.00005917791,0.00015578196,0.0005163005,0.00025275094,0.00048053806],"domain_scores_gemma":[0.9990513,0.00003102063,0.000037765334,0.00031989973,0.00041156614,0.0001484992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003296825,0.00014103494,0.0001689368,0.00007418686,0.00036217514,0.000024598143,0.00022035568,0.000113996764,0.000069399786],"category_scores_gemma":[0.00007914851,0.00013058669,0.00012297326,0.00019121871,0.00025209718,0.000005771716,0.0001426876,0.00006778371,0.000008722032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017206173,0.000031135856,0.007885775,0.00005011659,0.0000741871,0.0000055259848,0.0001029901,4.4117394e-7,0.9339459,0.00013044264,0.056366153,0.0012353052],"study_design_scores_gemma":[0.00069134636,0.00035455,0.0073506203,0.000019541634,0.000012527717,0.000027144037,0.0000613917,0.000012046931,0.9513264,0.00015864371,0.039779987,0.00020584755],"about_ca_topic_score_codex":0.0003389887,"about_ca_topic_score_gemma":0.00004507641,"teacher_disagreement_score":0.017380483,"about_ca_system_score_codex":0.000049325165,"about_ca_system_score_gemma":0.00031024942,"threshold_uncertainty_score":0.532517},"labels":[],"label_agreement":null},{"id":"W2142828058","doi":"10.1158/0008-5472.can-11-3732","title":"Loss of Cell-Surface Laminin Anchoring Promotes Tumor Growth and Is Associated with Poor Clinical Outcomes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Laminin; Cancer; Anchoring; Extracellular matrix; Cancer cell; Tumor progression; Biology; Cancer research; Dystroglycan; Cell biology; Genetics; Psychology","score_opus":0.11376341387553883,"score_gpt":0.4432179273249995,"score_spread":0.32945451344946064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142828058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953304,0.0011213596,0.0000067286906,0.0014160099,0.00005017972,0.0007053283,0.000024075911,0.000026420039,0.0013195012],"genre_scores_gemma":[0.9957429,0.00046060377,0.0004702718,0.00013589025,0.00013498457,0.00004721874,0.0000057825278,0.000051798474,0.0029505198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655956,0.0003889959,0.00038531417,0.00038885654,0.0013946316,0.0008826189],"domain_scores_gemma":[0.9973515,0.0010327927,0.000095134405,0.0003485605,0.0006276127,0.00054440193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025186953,0.00016250896,0.0005309384,0.00012696523,0.00010826586,0.00002702534,0.00019802777,0.00011854415,0.00032980382],"category_scores_gemma":[0.0013898679,0.000116337455,0.00007937737,0.00065544934,0.00060273,0.00011116413,0.00026637703,0.0009192738,0.000028585375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003357055,0.00041548235,0.91500026,0.00029713358,0.0001200783,0.00006860635,0.00038571388,1.7123155e-7,0.08154131,0.00001739916,0.0013209815,0.00049716624],"study_design_scores_gemma":[0.0026421628,0.00091306365,0.63541454,0.0003188009,0.00004374042,0.000010850695,0.0002894585,0.000035692818,0.359734,0.000015451318,0.00042585144,0.0001563652],"about_ca_topic_score_codex":0.0003321071,"about_ca_topic_score_gemma":0.000023150513,"teacher_disagreement_score":0.2795857,"about_ca_system_score_codex":0.00014333255,"about_ca_system_score_gemma":0.00039840024,"threshold_uncertainty_score":0.47441036},"labels":[],"label_agreement":null},{"id":"W2143010317","doi":"10.1158/0008-5472.can-03-2594","title":"Selective Usage of D-Type Cyclins by Ewing’s Tumors and Rhabdomyosarcomas","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"National Cancer Institute","keywords":"Cyclin D1; Cyclin D; Cyclin D3; Cancer research; Cyclin A; Biology; Cyclin; Cyclin A2; Cyclin B; Cyclin D2; Cyclin-dependent kinase; Cyclin E; Cyclin-dependent kinase complex; Cell cycle; Molecular biology; Cancer; Genetics","score_opus":0.05302374837557954,"score_gpt":0.39072643800595797,"score_spread":0.3377026896303784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143010317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685724,0.007187563,0.000100609366,0.0011270591,0.00009467674,0.000599336,0.000030971005,0.00003514553,0.0039673764],"genre_scores_gemma":[0.9976536,0.0010342629,0.00019666435,0.00010715084,0.00009558807,0.000054266962,0.000012243259,0.000041385156,0.0008048167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817127,0.00008752459,0.00022449151,0.00038505712,0.0006562577,0.00047540193],"domain_scores_gemma":[0.99884725,0.00007682886,0.00004898561,0.0003260396,0.00046022644,0.00024069384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005203182,0.00012709312,0.0003025347,0.00024030833,0.00010490547,0.000014821982,0.000121948695,0.00011845324,0.00010332365],"category_scores_gemma":[0.00032490768,0.000119513694,0.000053769636,0.0009285055,0.00040102747,0.000055886267,0.000099159966,0.0007186836,0.0000189278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056925043,0.00015486676,0.0034127964,0.0001995301,0.00012713834,0.0000882412,0.0011431075,0.000058835292,0.98485553,0.00029400468,0.004954174,0.004142526],"study_design_scores_gemma":[0.0044916635,0.0014391631,0.0074580973,0.0007677161,0.00005404767,0.00007001009,0.00030130174,0.00004295779,0.9729931,0.0009038143,0.0112634925,0.00021465904],"about_ca_topic_score_codex":0.0024519602,"about_ca_topic_score_gemma":0.0001606144,"teacher_disagreement_score":0.011862452,"about_ca_system_score_codex":0.00058427587,"about_ca_system_score_gemma":0.0010924566,"threshold_uncertainty_score":0.48736268},"labels":[],"label_agreement":null},{"id":"W2143202717","doi":"10.1158/0008-5472.can-07-0307","title":"Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood properties and coagulation","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"University of California, San Francisco","keywords":"Ovarian cancer; Fibronectin; Gene knockdown; Extracellular matrix; Cancer research; Integrin; Ovarian tumor; Biology; Metastasis; Tissue transglutaminase; Cell; Pathology; Cell biology; Cancer; Cell culture; Medicine; Enzyme","score_opus":0.04183587451315267,"score_gpt":0.41707521301127526,"score_spread":0.3752393384981226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143202717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890106,0.0016769132,0.0020365766,0.0023512873,0.0001093186,0.0005084264,0.000013032976,0.0000400857,0.00425378],"genre_scores_gemma":[0.9901312,0.00009674201,0.00010959127,0.00010664454,0.00035664474,0.00008921361,0.000039312643,0.000024736672,0.009045921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985172,0.000047383015,0.00018014752,0.00025068954,0.0005792586,0.00042529614],"domain_scores_gemma":[0.9992544,0.00006237384,0.000021632024,0.00019984234,0.00027501944,0.00018671197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081069226,0.000087074965,0.00014365907,0.00011639606,0.0001626678,0.000029159219,0.00008519528,0.00006982668,0.0008325909],"category_scores_gemma":[0.00006351114,0.00007415578,0.000030224704,0.00037643948,0.00010943968,0.00008538869,0.000019101615,0.00031264857,0.00004286152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048734352,0.000088565896,0.00018835168,0.000089831774,0.000013355415,0.00002582557,0.0008251776,8.176495e-7,0.8409792,0.00007329832,0.00367503,0.15355316],"study_design_scores_gemma":[0.000665138,0.00035500564,0.009701733,0.00014364951,0.000017328288,0.000011769196,0.0006111803,0.000051815918,0.9628253,0.000031222426,0.025489867,0.00009601376],"about_ca_topic_score_codex":0.00051851285,"about_ca_topic_score_gemma":0.000113525384,"teacher_disagreement_score":0.15345715,"about_ca_system_score_codex":0.00018498632,"about_ca_system_score_gemma":0.00012111589,"threshold_uncertainty_score":0.91162866},"labels":[],"label_agreement":null},{"id":"W2143498161","doi":"10.1158/0008-5472.sabcs10-p2-16-06","title":"Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Taxane; Docetaxel; Internal medicine; Regimen; Chemotherapy; Clinical endpoint; Metastatic breast cancer; Oncology; Population; Chemotherapy regimen; Surgery; Progression-free survival; Anthracycline; Cancer; Breast cancer; Randomized controlled trial","score_opus":0.1836768031969175,"score_gpt":0.47802080924116985,"score_spread":0.29434400604425237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143498161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910782,0.001029957,0.000015403662,0.00093786337,0.0001730324,0.0030409372,0.0036945245,0.000014546892,0.000015523305],"genre_scores_gemma":[0.9974461,0.0005442898,0.00007985608,0.00007349433,0.0003255844,0.0009264414,0.0004704365,0.00003680066,0.00009697137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718976,0.00032961907,0.00046986484,0.00059070234,0.0009538016,0.00046628146],"domain_scores_gemma":[0.9960307,0.0023096136,0.00026826488,0.00037322167,0.00078673527,0.00023149958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016703943,0.0002398243,0.0006052822,0.00025705682,0.0003713598,0.00005322762,0.00021329137,0.000048771308,0.0005485648],"category_scores_gemma":[0.000393342,0.00015605988,0.00013131213,0.0007247451,0.00026615863,0.0001139738,0.000098245444,0.00065217767,8.037823e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1018384,0.0018811913,0.81926864,0.00008827846,0.006953315,0.000021842474,0.009408155,0.00028922845,0.0013255266,0.0000062482736,0.0006919367,0.05822721],"study_design_scores_gemma":[0.030424777,0.002338269,0.9630094,0.00018095026,0.0019291886,2.1770555e-7,0.00071554043,0.00096246763,0.000087889355,0.000094870935,0.000096956515,0.00015947875],"about_ca_topic_score_codex":0.0106453225,"about_ca_topic_score_gemma":0.029568871,"teacher_disagreement_score":0.14374073,"about_ca_system_score_codex":0.00035774955,"about_ca_system_score_gemma":0.00081376923,"threshold_uncertainty_score":0.9959429},"labels":[],"label_agreement":null},{"id":"W2143584784","doi":"10.1158/0008-5472.can-05-2292","title":"Defining the Role of Prolactin as an Invasion Suppressor Hormone in Breast Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Autocrine signalling; Cancer research; Biology; Signal transduction; Cancer cell; Metastasis; Cancer; Cell biology; Receptor","score_opus":0.027077182352869197,"score_gpt":0.341255769989642,"score_spread":0.3141785876367728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143584784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855382,0.0079481695,5.919158e-7,0.0017803729,0.000057743673,0.00065504026,0.00006432637,0.00002317056,0.0039324006],"genre_scores_gemma":[0.99794376,0.000995401,0.000023408988,0.00010518197,0.00024265924,0.00028080537,0.000021183301,0.000041355324,0.00034625313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975516,0.00021337284,0.00037209326,0.00037249335,0.0008557995,0.00063460914],"domain_scores_gemma":[0.99881184,0.00013022707,0.00008211869,0.00045249716,0.00036643507,0.00015685539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089352997,0.00015906252,0.00030812225,0.0003102372,0.00014128438,0.00003363026,0.00028993745,0.00014387874,0.00028915273],"category_scores_gemma":[0.00005240473,0.00010941411,0.00006484395,0.0008489638,0.0002368279,0.00020241622,0.00011702711,0.0008069199,0.000040175706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018786917,0.00029360526,0.100077614,0.00007326868,0.000023479828,0.000021944572,0.0008179522,0.000031694897,0.8852547,0.0007187747,0.0034639768,0.007344297],"study_design_scores_gemma":[0.0013644161,0.00029880498,0.46566942,0.00016380547,0.000021482374,0.000013902327,0.00094388257,0.00014959343,0.52732766,0.00063610566,0.0032829926,0.00012792688],"about_ca_topic_score_codex":0.039282393,"about_ca_topic_score_gemma":0.0011879283,"teacher_disagreement_score":0.3655918,"about_ca_system_score_codex":0.00025754538,"about_ca_system_score_gemma":0.0006790248,"threshold_uncertainty_score":0.9671151},"labels":[],"label_agreement":null},{"id":"W2143813439","doi":"10.1158/0008-5472.can-04-4449","title":"A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro","keywords":"Stromal cell; Biology; Matrigel; Integrin; Disintegrin; Laminin; Cancer research; Extracellular matrix; Metalloproteinase; Matrix metalloproteinase; Cell; Cell biology; Angiogenesis","score_opus":0.12243064554014828,"score_gpt":0.4351790889075675,"score_spread":0.31274844336741925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143813439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871631,0.0007783271,0.000042401414,0.004421535,0.000046738383,0.0009936228,0.00002644739,0.000040066923,0.006487729],"genre_scores_gemma":[0.9935727,0.00015914203,0.001173195,0.00013645727,0.00034673416,0.00025149793,0.000025805664,0.00004672494,0.004287725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969057,0.00017746205,0.00037800538,0.00043374725,0.0013934952,0.00071160117],"domain_scores_gemma":[0.99809474,0.00026122978,0.000066807224,0.00050880306,0.0007833459,0.00028510176],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006150707,0.00015281391,0.00032562914,0.0002951211,0.00017348134,0.00003085813,0.00029298305,0.00007710515,0.0034042383],"category_scores_gemma":[0.0004708472,0.00012953956,0.0001314113,0.00095224124,0.00033819064,0.00022428151,0.0003190664,0.0010202592,0.00018009692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087849336,0.0003016199,0.010453081,0.0003773236,0.00005480534,0.00008997371,0.0012594548,0.0000034235388,0.9642991,0.00018690723,0.0074621267,0.014633706],"study_design_scores_gemma":[0.0017558096,0.00083966233,0.018487034,0.000400979,0.000022504802,0.00010568627,0.0006080763,0.0007649406,0.93432873,0.00020632865,0.0423369,0.00014335179],"about_ca_topic_score_codex":0.001370625,"about_ca_topic_score_gemma":0.0004356429,"teacher_disagreement_score":0.034874775,"about_ca_system_score_codex":0.00067424524,"about_ca_system_score_gemma":0.00077508023,"threshold_uncertainty_score":0.9975068},"labels":[],"label_agreement":null},{"id":"W2143923333","doi":"10.1158/0008-5472.can-13-1897","title":"YEATS4 Is a Novel Oncogene Amplified in Non–Small Cell Lung Cancer That Regulates the p53 Pathway","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Oncogene; Cancer research; Cancer; Lung cancer; Medicine; Cell; Biology; Oncology; Internal medicine; Genetics; Cell cycle","score_opus":0.046522174837176654,"score_gpt":0.34193594503668606,"score_spread":0.29541377019950943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143923333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985469,0.009679793,0.00014423244,0.0022582058,0.00023717355,0.0012045886,0.00005937465,0.00001131078,0.00093635585],"genre_scores_gemma":[0.98565435,0.0023748842,0.0000780736,0.00028599837,0.00056066684,0.0013741575,0.000045809287,0.000058586545,0.0095674405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979158,0.000114106784,0.0002418803,0.0006139507,0.0004223645,0.00069190154],"domain_scores_gemma":[0.99869937,0.00004468965,0.00008181608,0.00070907123,0.00033492022,0.00013013343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500051,0.00020659772,0.0001844533,0.00012997366,0.0001758076,0.00009623203,0.00049436407,0.00028482973,0.00049694406],"category_scores_gemma":[0.0000277789,0.00016348815,0.00009610687,0.00046491786,0.0001893388,0.000011162828,0.00027546517,0.00039221425,0.000038319093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007188451,0.000046235742,0.004355973,0.000057132038,0.000049155697,9.1440006e-7,0.00039382628,0.0010882062,0.968203,0.000008899405,0.018236103,0.007488656],"study_design_scores_gemma":[0.0009877016,0.00007214498,0.017483365,0.00009705403,0.000012655639,0.000002465401,0.00020326885,0.001354373,0.9513439,0.000060965005,0.028130451,0.00025164534],"about_ca_topic_score_codex":0.0073999865,"about_ca_topic_score_gemma":0.0033191592,"teacher_disagreement_score":0.016859103,"about_ca_system_score_codex":0.00031424253,"about_ca_system_score_gemma":0.00062742736,"threshold_uncertainty_score":0.9992098},"labels":[],"label_agreement":null},{"id":"W2143949606","doi":"10.1158/0008-5472.can-08-0896","title":"Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute on Drug Abuse","keywords":"Cannabinoid receptor; Endocannabinoid system; Survivin; Cannabinoid; Cancer research; Colorectal cancer; Biology; Receptor; Signal transduction; Cancer; Internal medicine; Medicine; Cell biology; Antagonist","score_opus":0.08386908584760935,"score_gpt":0.39247711354427633,"score_spread":0.30860802769666695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143949606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792164,0.002113744,0.0000055999494,0.01361211,0.00014758419,0.0006852347,0.000048709768,0.000047952253,0.004122675],"genre_scores_gemma":[0.964757,0.0011324295,0.00016547632,0.00019509757,0.00058059144,0.0004482754,0.000020312034,0.000059495418,0.032641273],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962184,0.0001881181,0.00040947084,0.00051047275,0.0016995721,0.0009740073],"domain_scores_gemma":[0.9958678,0.00005460738,0.000070675625,0.0005068433,0.0029556255,0.000544472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010162592,0.00019662139,0.0004573502,0.0005384536,0.00030087773,0.000027193528,0.00041240206,0.000096709875,0.0033706329],"category_scores_gemma":[0.00097132265,0.00016267892,0.00015255081,0.001517491,0.0013936805,0.00011924311,0.00024403294,0.0010872902,0.00013851632],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010519277,0.0003830445,0.07125034,0.00072835543,0.00006863885,0.0004896192,0.0006773189,0.0000017965481,0.31429183,0.000613254,0.60739124,0.0030526186],"study_design_scores_gemma":[0.0026183273,0.0017068811,0.14421703,0.0005082477,0.00002586122,0.0005704733,0.0006008949,0.000039234288,0.701076,0.00023597864,0.14803429,0.000366799],"about_ca_topic_score_codex":0.004086798,"about_ca_topic_score_gemma":0.00007359719,"teacher_disagreement_score":0.459357,"about_ca_system_score_codex":0.00048085535,"about_ca_system_score_gemma":0.0029396021,"threshold_uncertainty_score":0.9975404},"labels":[],"label_agreement":null},{"id":"W2144009448","doi":"10.1158/0008-5472.can-04-4249","title":"A Germline DNA Polymorphism Enhances Alternative Splicing of the <i>KLF6</i> Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Prostate cancer; Biology; Transactivation; Tumor suppressor gene; Cancer research; Chromoplexy; Cancer; Alternative splicing; LNCaP; Germline; Genetics; Carcinogenesis; Exon; Gene; PCA3; Transcription factor","score_opus":0.020091256568164635,"score_gpt":0.3355413915992305,"score_spread":0.3154501350310659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144009448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938506,0.0031417932,0.000008525845,0.0011649985,0.0000447459,0.0007039499,0.0009491699,0.000007930283,0.00012831771],"genre_scores_gemma":[0.99503064,0.0026052454,0.000042472362,0.00019196118,0.0002958977,0.0003012556,0.00002862437,0.000047136287,0.001456757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972363,0.00044748856,0.00025150742,0.0005657468,0.00082512177,0.000673797],"domain_scores_gemma":[0.9983688,0.000104235456,0.00018620423,0.0004905605,0.00067623536,0.00017394694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081626506,0.00020296128,0.0002580857,0.00010364857,0.00023491871,0.000050809726,0.0005000447,0.00009963913,0.0001364857],"category_scores_gemma":[0.00030400296,0.00013642729,0.00006427602,0.00041619092,0.0006639474,0.000015294556,0.0004255533,0.0004781893,0.000002789751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046900767,0.000073421754,0.04000436,0.000032047676,0.00021338195,0.000004608312,0.0004877532,0.00006071007,0.9560803,0.0000021301473,0.0015003339,0.0010719543],"study_design_scores_gemma":[0.0012519202,0.00024483027,0.020640183,0.00013848823,0.000023390443,0.000004444796,0.00007954742,0.00019535016,0.97505814,0.000017935577,0.0021766215,0.00016915538],"about_ca_topic_score_codex":0.009767475,"about_ca_topic_score_gemma":0.00487382,"teacher_disagreement_score":0.019364176,"about_ca_system_score_codex":0.00016724147,"about_ca_system_score_gemma":0.00069769286,"threshold_uncertainty_score":0.9968266},"labels":[],"label_agreement":null},{"id":"W2144040380","doi":"10.1158/0008-5472.can-08-1769","title":"Identification of Alternative Splicing Markers for Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Alternative splicing; RNA splicing; Breast cancer; Cancer; Biology; Disease; Gene; Cancer research; Transcriptome; Computational biology; Bioinformatics; Gene expression; Medicine; Genetics; Pathology; Exon; RNA","score_opus":0.05537725039381674,"score_gpt":0.41101553838237503,"score_spread":0.3556382879885583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144040380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969693,0.0008192214,0.00095633836,0.0004035362,0.0000742542,0.0004108618,0.00022051336,0.0000035926396,0.00014237064],"genre_scores_gemma":[0.9913671,0.002267234,0.000046981986,0.000026770707,0.00032300942,0.00038255667,0.000017039834,0.000019629868,0.005549646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987547,0.00007761517,0.00017790547,0.00028701936,0.00034050283,0.00036229938],"domain_scores_gemma":[0.99890083,0.000038520982,0.000056727917,0.0002485948,0.0006626362,0.000092705246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006347192,0.00007129521,0.0001036192,0.00010159491,0.00018339885,0.000012512774,0.00025919735,0.000059385053,0.000063667285],"category_scores_gemma":[0.00011103649,0.00006640802,0.00006228921,0.00018552858,0.00022089473,0.0000061805417,0.000088616216,0.00011803846,0.0000030102217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043775907,0.000022110322,0.0041472507,0.000060086975,0.0000557873,0.0000013565885,0.000059640366,0.00014779641,0.98289365,0.000047247857,0.005311254,0.0068160687],"study_design_scores_gemma":[0.00054133596,0.00011874756,0.01527192,0.000044575456,0.0000037597608,0.000007775572,0.00011571998,0.00064887945,0.98132086,0.00005122833,0.001784955,0.000090247806],"about_ca_topic_score_codex":0.0012154861,"about_ca_topic_score_gemma":0.00019192329,"teacher_disagreement_score":0.011124669,"about_ca_system_score_codex":0.000074868956,"about_ca_system_score_gemma":0.00032207248,"threshold_uncertainty_score":0.27080405},"labels":[],"label_agreement":null},{"id":"W2144123665","doi":"10.1158/0008-5472.can-05-4076","title":"HER-2/neu Status Is a Determinant of Mammary Aromatase Activity <i>In vivo</i>: Evidence for a Cyclooxygenase-2-Dependent Mechanism","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; Medical College of Wisconsin; National Institutes of Health; Botwinick-Wolfensohn Foundation; Breast Cancer Alliance; Breast Cancer Research Foundation","keywords":"Aromatase; Endocrinology; Internal medicine; Estrogen; Cyclooxygenase; In vivo; Prostaglandin; Chemistry; Prostaglandin E; Biology; Cancer research; Cancer; Enzyme; Breast cancer; Biochemistry; Medicine","score_opus":0.04374078491200886,"score_gpt":0.37943877629881273,"score_spread":0.3356979913868039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144123665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151003,0.0066871913,0.00047017372,0.0001618928,0.000077555356,0.00075865636,0.00021212897,0.0000073071396,0.000115088646],"genre_scores_gemma":[0.9955318,0.0028390468,0.0002306875,0.00003701869,0.00010852494,0.00043148504,0.000017599848,0.00002689588,0.00077694963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820024,0.00017276853,0.00020130315,0.00047462262,0.0003349408,0.0006161229],"domain_scores_gemma":[0.9991298,0.000093107825,0.00006960508,0.00045383716,0.00014132707,0.00011237712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064008025,0.00014675745,0.00019385776,0.000115383795,0.00008181481,0.000023827335,0.0002784784,0.00020980145,0.000016435537],"category_scores_gemma":[0.0000840922,0.00013225233,0.00010609264,0.00019458075,0.00009529671,0.0000123424725,0.00018822993,0.00022117546,0.000003075821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063606276,0.00013912047,0.00053012604,0.00016673098,0.000027816386,0.000038718055,0.0000311321,0.000020207026,0.9929177,0.0000961613,0.0026397759,0.0027564566],"study_design_scores_gemma":[0.0008608261,0.0005286303,0.00063078635,0.00013951641,0.000009974481,0.00000852087,0.000018333776,0.0001931321,0.9953926,0.00043098108,0.0016390724,0.00014759942],"about_ca_topic_score_codex":0.0018210656,"about_ca_topic_score_gemma":0.0003303327,"teacher_disagreement_score":0.004021786,"about_ca_system_score_codex":0.00008712852,"about_ca_system_score_gemma":0.00041279107,"threshold_uncertainty_score":0.5393093},"labels":[],"label_agreement":null},{"id":"W2144489030","doi":"10.1158/0008-5472.can-10-3096","title":"ETV6-NTRK3–Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Jewish General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Insulin-like growth factor 1 receptor; Matrigel; Cancer research; PI3K/AKT/mTOR pathway; Tyrosine kinase; Fibroblast growth factor; Receptor tyrosine kinase; Biology; Protein kinase B; Signal transduction; Growth factor; Internal medicine; Medicine; Receptor; Cell biology; Angiogenesis","score_opus":0.02591915286761758,"score_gpt":0.31380527997831775,"score_spread":0.28788612711070016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144489030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739415,0.0007089034,0.000051965035,0.007991816,0.0003440641,0.00080424704,0.00032730037,0.000077748286,0.0022997754],"genre_scores_gemma":[0.9971516,0.00029236497,0.000040124523,0.0006461091,0.0007561373,0.0001467084,0.0001568991,0.000054088887,0.0007559337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970397,0.00017125632,0.00044420376,0.00037088396,0.0011299392,0.00084402267],"domain_scores_gemma":[0.9983643,0.00024596098,0.000082063525,0.00037591415,0.00058580155,0.00034594227],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001649647,0.00021817062,0.0002791075,0.00019432853,0.0005339777,0.00009027627,0.0003365099,0.00025188457,0.0012563764],"category_scores_gemma":[0.00016329702,0.00014731257,0.00012864673,0.0007268155,0.00028999193,0.00021083116,0.00005371362,0.0019687328,0.00020430493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025199112,0.00009377971,0.0011637475,0.00009733495,0.00003324884,0.000008028466,0.0037963584,0.0000012646351,0.9722914,0.000024247349,0.01691618,0.0053223874],"study_design_scores_gemma":[0.0018426621,0.0001813519,0.0009624849,0.00005982137,0.00003113369,0.000014912752,0.0011395845,0.0004156413,0.89908326,0.00006863586,0.09599355,0.000206952],"about_ca_topic_score_codex":0.0008826556,"about_ca_topic_score_gemma":0.0000288637,"teacher_disagreement_score":0.07907736,"about_ca_system_score_codex":0.00011455138,"about_ca_system_score_gemma":0.00052749563,"threshold_uncertainty_score":0.9996566},"labels":[],"label_agreement":null},{"id":"W2144502394","doi":"10.1158/0008-5472.can-05-2598","title":"Low-Dose Metronomic Daily Cyclophosphamide and Weekly Tirapazamine: A Well-Tolerated Combination Regimen with Enhanced Efficacy That Exploits Tumor Hypoxia","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Tirapazamine; Cyclophosphamide; Medicine; Hypoxia (environmental); Chemotherapy; Tumor hypoxia; Pharmacology; Cancer; Cancer research; Oncology; Internal medicine; Cytotoxicity; Radiation therapy; Biology; Chemistry; Oxygen","score_opus":0.01844842676887849,"score_gpt":0.2936771452451152,"score_spread":0.2752287184762367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144502394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878102,0.008901041,0.00015660247,0.0002878297,0.0003153118,0.00069711276,0.000027098069,0.000030374087,0.0017744104],"genre_scores_gemma":[0.9891901,0.002471744,0.00013376484,0.000102739825,0.00083677575,0.00034864777,0.0001492838,0.00006783628,0.0066990885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977574,0.00016162686,0.00024027048,0.00074753474,0.00042491077,0.0006682999],"domain_scores_gemma":[0.99885744,0.00004759418,0.000108269734,0.0004975061,0.00030648705,0.00018269505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044423825,0.000266037,0.000302653,0.00017453945,0.00022997167,0.000111906804,0.0002849615,0.00013000604,0.00005926819],"category_scores_gemma":[0.00004426183,0.00024253229,0.0000605183,0.00039252182,0.0003303407,0.000023015984,0.00014829046,0.00028469003,0.000022417684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010563878,0.00019287928,0.0005002579,0.00005572308,0.00007502594,0.0000054419334,0.000086799046,0.00011476356,0.9794019,0.000091780326,0.012394899,0.006024164],"study_design_scores_gemma":[0.0049150353,0.000444753,0.032584533,0.00008660459,0.000031114112,0.000011215029,0.00021269718,0.00003695619,0.8996256,0.00006044072,0.06160796,0.0003830858],"about_ca_topic_score_codex":0.00086725765,"about_ca_topic_score_gemma":0.00045407884,"teacher_disagreement_score":0.07977627,"about_ca_system_score_codex":0.00011032226,"about_ca_system_score_gemma":0.0004111455,"threshold_uncertainty_score":0.98901796},"labels":[],"label_agreement":null},{"id":"W2144611693","doi":"10.1158/0008-5472.can-08-2760","title":"PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A–Mediated Inactivation in Human Malignant Glioma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"MAPK/ERK pathway; Kinase; Signal transduction; Phosphatase; Protein kinase A; Cell biology; Protein phosphatase 1; c-Raf; Cancer research; Biology; Protein phosphatase 2; Mitogen-activated protein kinase kinase; Phosphorylation; Chemistry","score_opus":0.03230272462130947,"score_gpt":0.3367391847315715,"score_spread":0.30443646011026204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144611693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422735,0.0024709073,0.00011051736,0.0004902016,0.00003507312,0.002312861,0.00019000824,0.000036641515,0.00012645233],"genre_scores_gemma":[0.99722373,0.000040131075,0.00006002214,0.000021252663,0.00027790567,0.00087521767,0.00061153463,0.000054364373,0.000835822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957589,0.0008349062,0.00037134427,0.0010087173,0.0010310056,0.0009951409],"domain_scores_gemma":[0.998353,0.000046373814,0.00011374678,0.00078676885,0.0003923795,0.00030771838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013584999,0.00029757785,0.000298747,0.00042389394,0.00031090414,0.00009090953,0.0004937933,0.00042748006,0.00026697517],"category_scores_gemma":[0.00039015492,0.00030030461,0.0000872274,0.0011318518,0.00026783318,0.0000316972,0.0001851548,0.00088064524,0.00004311609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010297969,0.00049016933,0.00006887339,0.00004176018,0.000024885716,0.00034150883,0.00010531347,0.00004875871,0.98898494,0.00004234479,0.0007991153,0.008022524],"study_design_scores_gemma":[0.0016026786,0.0007325249,0.0015873075,0.00021617068,0.0000024648093,0.0000026643224,0.00004240455,0.00016781497,0.9915153,0.00017206921,0.003624654,0.0003339605],"about_ca_topic_score_codex":0.0037655488,"about_ca_topic_score_gemma":0.0005954805,"teacher_disagreement_score":0.007688564,"about_ca_system_score_codex":0.00057912956,"about_ca_system_score_gemma":0.0007499166,"threshold_uncertainty_score":0.9999449},"labels":[],"label_agreement":null},{"id":"W2144648281","doi":"10.1158/0008-5472.can-14-2012","title":"Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Capital District Health Authority; Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; University of Toronto; Centre hospitalier universitaire de Québec; Izaak Walton Killam Health Centre","funders":"National Human Genome Research Institute; National Institute for Health and Care Research; Canadian Institutes of Health Research; Medical Research Council; National Cancer Institute; Cancer Research UK; Francis Crick Institute","keywords":"MAMMOGRAPHIC DENSITY; Breast cancer; Medicine; Oncology; Cancer; Mammography; Internal medicine","score_opus":0.1234562792647765,"score_gpt":0.39711998215436817,"score_spread":0.2736637028895917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144648281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369204,0.00094941095,0.00012106627,0.002060037,0.00012436588,0.0004220338,0.0013552386,0.000090702735,0.0011851242],"genre_scores_gemma":[0.9987608,0.0003525422,0.00009878283,0.000053151423,0.0005330083,0.000052409203,0.00003710031,0.000027594164,0.00008460264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972612,0.00023318156,0.00028505965,0.00047539652,0.0011051372,0.0006399984],"domain_scores_gemma":[0.99754703,0.0002918138,0.0001041377,0.00036833843,0.0010494741,0.0006392211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030092702,0.000167451,0.00039611908,0.00038368508,0.00038835738,0.00014027294,0.00016768942,0.00011941568,0.00002381651],"category_scores_gemma":[0.00048641427,0.00014845764,0.0001042634,0.0012382566,0.00045941258,0.00030722038,0.00016119427,0.0008890705,0.0000044770472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001416286,0.000120263816,0.9522809,0.0000423784,0.00027504726,0.000008355193,0.00033729963,0.0000039733122,0.0013292414,0.00002793212,0.00079482916,0.044638187],"study_design_scores_gemma":[0.0013395456,0.00008517369,0.9966489,0.000186666,0.00015724187,0.000041168274,0.00029923304,0.000076802404,0.00032705738,0.0005323979,0.0001658927,0.0001399092],"about_ca_topic_score_codex":0.031406954,"about_ca_topic_score_gemma":0.005390947,"teacher_disagreement_score":0.04449828,"about_ca_system_score_codex":0.00038789728,"about_ca_system_score_gemma":0.0005344311,"threshold_uncertainty_score":0.975043},"labels":[],"label_agreement":null},{"id":"W2144720355","doi":"10.1158/0008-5472.can-03-3380","title":"A Genetically Defined Model for Human Ovarian Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Ovarian cancer; Telomerase reverse transcriptase; Cancer research; Biology; HRAS; Cancer; Ovarian tumor; KRAS; Pancreatic cancer; Ovarian carcinoma; Cancer cell; Telomerase; Colorectal cancer; Gene","score_opus":0.19323200475697336,"score_gpt":0.46933147553962123,"score_spread":0.27609947078264785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144720355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789766,0.0020297281,0.00713596,0.006597218,0.0002642279,0.0020208152,0.00010168798,0.000080081576,0.0027936797],"genre_scores_gemma":[0.9839307,0.00030017455,0.0076857605,0.0006432431,0.00055643194,0.0031913032,0.000015434038,0.00008390685,0.0035930476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973816,0.00003899545,0.00028031526,0.00057411875,0.0008322647,0.0008926639],"domain_scores_gemma":[0.9981916,0.000084536405,0.000035948713,0.0005007221,0.0008076218,0.00037958802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051225896,0.00018825862,0.00031694313,0.00021503378,0.00028419765,0.000042934706,0.00028391214,0.00018331858,0.000837179],"category_scores_gemma":[0.0002032022,0.00016916444,0.00012567308,0.00043953393,0.00031489859,0.00003550781,0.0001224191,0.0004955147,0.000027942748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015970813,0.00030596077,0.0029213703,0.0005747006,0.0002224732,0.000026433256,0.0012762409,0.017431326,0.9382597,0.010792304,0.011097494,0.015494891],"study_design_scores_gemma":[0.037466384,0.0058479393,0.037231855,0.0019767333,0.0005297516,0.000062188,0.00033613676,0.029921364,0.6816244,0.1631832,0.039837167,0.001982861],"about_ca_topic_score_codex":0.0015311434,"about_ca_topic_score_gemma":0.002297083,"teacher_disagreement_score":0.2566353,"about_ca_system_score_codex":0.001317671,"about_ca_system_score_gemma":0.0025302272,"threshold_uncertainty_score":0.9166523},"labels":[],"label_agreement":null},{"id":"W2144820933","doi":"10.1158/0008-5472.can-06-0143","title":"Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway × ACI Intercross","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Cancer; Breast cancer; Biology; Carcinogenesis; Mammary tumor; Mammary gland; Estrogen; Phenotype; Population; Internal medicine; Endocrinology; Genetics; Gene; Medicine","score_opus":0.029911687075874552,"score_gpt":0.3451890731251003,"score_spread":0.3152773860492257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144820933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112153,0.00757205,0.000095818905,0.00028755708,0.000077661556,0.00069878553,0.000030486011,0.0000027875951,0.00011330384],"genre_scores_gemma":[0.9987203,0.0006078973,0.00009449432,0.00004290799,0.0001495215,0.0002791908,0.0000092507635,0.000017984403,0.000078491255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793994,0.00043342324,0.0004177618,0.00040393905,0.00032122305,0.0004836901],"domain_scores_gemma":[0.99911296,0.00009380277,0.00007130318,0.00044386365,0.00021717035,0.00006091036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010256191,0.00014759344,0.00027814173,0.00019408615,0.000055846845,0.000020724356,0.00046633967,0.00015760155,0.000021690183],"category_scores_gemma":[0.00010605264,0.00011546032,0.00010026006,0.0006816086,0.00015082532,0.0000059763656,0.00015748474,0.00029433478,0.0000020655173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031628614,0.000111058376,0.058073673,0.00010491128,0.000026297188,0.000018313724,0.00027303465,0.0016494691,0.9362627,0.000021060601,0.00018267178,0.002960518],"study_design_scores_gemma":[0.0010103177,0.0003064798,0.053717725,0.00015476631,0.000007315583,0.000003669229,0.00032430337,0.00013844138,0.94373745,0.00003833883,0.00042226547,0.00013894141],"about_ca_topic_score_codex":0.0067795217,"about_ca_topic_score_gemma":0.0040412825,"teacher_disagreement_score":0.0075987126,"about_ca_system_score_codex":0.000108098924,"about_ca_system_score_gemma":0.0004118244,"threshold_uncertainty_score":0.9998344},"labels":[],"label_agreement":null},{"id":"W2145003990","doi":"10.1158/0008-5472.can-11-0994","title":"Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Association pour la Recherche sur le Cancer; Pfizer","keywords":"Clusterin; Hsp90 inhibitor; Heat shock protein; Hsp27; Hsp90; Cancer research; In vivo; Hsp70; Apoptosis; Prostate cancer; Heat shock; Cancer; Pharmacology; Chemistry; Biology; Internal medicine; Medicine; Biochemistry","score_opus":0.12602686059849,"score_gpt":0.4191705581578721,"score_spread":0.2931436975593821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145003990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945418,0.0014105055,0.00010323022,0.0016382103,0.00030021588,0.0013180895,0.00025736337,0.000048752365,0.00038183018],"genre_scores_gemma":[0.9977479,0.00026223197,0.00015795279,0.00016329692,0.00023921824,0.0007805515,0.0000112005555,0.00006982731,0.00056780595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953853,0.0014611223,0.00047773737,0.00075582287,0.0008487764,0.0010712532],"domain_scores_gemma":[0.9981135,0.00046324095,0.00008610837,0.0006213449,0.00038946277,0.000326327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020995229,0.00028967098,0.00044128695,0.0003182777,0.00034909672,0.000091843634,0.00023721199,0.00019910478,0.00082875276],"category_scores_gemma":[0.0005539701,0.00022411282,0.00008478376,0.00072870665,0.001061862,0.00023471922,0.0003821625,0.0010261636,0.000016298947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03384809,0.00026939434,0.0018725655,0.0003152107,0.0000313883,0.00063465553,0.002055924,0.00007835799,0.9586482,0.00000709914,0.0011020269,0.0011370723],"study_design_scores_gemma":[0.002785725,0.0008357311,0.055774886,0.0020083603,0.00007610479,0.000098357785,0.0011545144,0.0020179374,0.9338682,0.00013029546,0.0008219916,0.00042784167],"about_ca_topic_score_codex":0.0064639067,"about_ca_topic_score_gemma":0.0024079732,"teacher_disagreement_score":0.05390232,"about_ca_system_score_codex":0.0013480431,"about_ca_system_score_gemma":0.0014349443,"threshold_uncertainty_score":0.9771536},"labels":[],"label_agreement":null},{"id":"W2145167393","doi":"10.1158/0008-5472.850.65.3","title":"Receptor for Hyaluronan-Mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic Integrity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Centrosome; Motility; Multiple myeloma; Mitosis; Biology; Cell biology; Cancer research; Cancer; Immunology; Genetics; Cell cycle","score_opus":0.07405062333954149,"score_gpt":0.3745876947268252,"score_spread":0.3005370713872837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145167393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251854,0.0015873192,0.000036176774,0.0030993803,0.000049862963,0.0021848879,0.00028965485,0.00004722025,0.00018692584],"genre_scores_gemma":[0.995245,0.00056654273,0.001148917,0.00007654358,0.00019382384,0.0009070594,0.00017386499,0.00004019897,0.0016480404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971392,0.00022757586,0.00029396178,0.0005333003,0.0007053413,0.0011006031],"domain_scores_gemma":[0.9975532,0.0011207702,0.00003949441,0.00033402533,0.0004585829,0.00049390295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009354803,0.00021442826,0.00039271355,0.00034163563,0.00021445223,0.000057278445,0.00014801952,0.00014303498,0.00032164488],"category_scores_gemma":[0.0012373524,0.00015789075,0.000056916928,0.00043470497,0.00057109375,0.00019140774,0.00010380777,0.0008638913,0.00005113122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00563872,0.00055946625,0.95514804,0.00046332192,0.0001539725,0.00006855671,0.0008916763,0.000018819472,0.0043466534,0.00017022666,0.0008900459,0.031650525],"study_design_scores_gemma":[0.018857712,0.0023103268,0.9442228,0.000643169,0.000032939675,0.000031170337,0.0019314677,0.009786437,0.010595295,0.00014859825,0.011151638,0.00028843124],"about_ca_topic_score_codex":0.0018102285,"about_ca_topic_score_gemma":0.0043589766,"teacher_disagreement_score":0.03136209,"about_ca_system_score_codex":0.0009452497,"about_ca_system_score_gemma":0.00059074117,"threshold_uncertainty_score":0.6438598},"labels":[],"label_agreement":null},{"id":"W2145231631","doi":"10.1158/0008-5472.can-10-1316","title":"Chemotherapy-Induced Genotoxic Stress Promotes Sensitivity to Natural Killer Cell Cytotoxicity by Enabling Missing-Self Recognition","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Natural Sciences and Engineering Research Council of Canada; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"NKG2D; Downregulation and upregulation; MHC class I; Major histocompatibility complex; Biology; Cytotoxicity; Receptor; Cytotoxic T cell; Cell; Natural killer cell; Interleukin 12; Immunology; Cell biology; Cancer research; Immune system; In vitro; Gene; Genetics","score_opus":0.03544514701153032,"score_gpt":0.32740222137923874,"score_spread":0.2919570743677084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145231631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927437,0.00040561086,0.000049277896,0.0011549231,0.0040318514,0.0006564337,0.000019835965,0.000122606,0.00081580656],"genre_scores_gemma":[0.9884484,0.00008764001,0.000060872986,0.00038595928,0.00018762265,0.00010904578,0.00015361827,0.000036402198,0.010530476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806106,0.0004657481,0.00022703505,0.00048722787,0.0001259784,0.0006329618],"domain_scores_gemma":[0.998908,0.00022537021,0.00007132635,0.00031752524,0.00040896106,0.00006882819],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00090503116,0.00018968408,0.00020805579,0.00023118351,0.0005364363,0.00008720586,0.00016602338,0.00032451,0.002872247],"category_scores_gemma":[0.00019055353,0.00017549453,0.00007739593,0.00032848908,0.000099753786,0.00019424583,0.00008282511,0.0017986425,0.0010051101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033039917,0.00022576455,0.00009189371,0.00003127166,0.00004771776,0.0000025678419,0.00083716464,3.9721425e-7,0.9646832,0.0000017274676,0.0202935,0.013454419],"study_design_scores_gemma":[0.0007208,0.00015767758,0.00047219289,0.00004630626,0.0000069968487,0.000015150402,0.0002168812,0.000019486943,0.95299584,0.00001206668,0.04512913,0.00020744806],"about_ca_topic_score_codex":0.0008020601,"about_ca_topic_score_gemma":0.00018137772,"teacher_disagreement_score":0.024835631,"about_ca_system_score_codex":0.00019158465,"about_ca_system_score_gemma":0.0001534134,"threshold_uncertainty_score":0.9997727},"labels":[],"label_agreement":null},{"id":"W2145278311","doi":"10.1158/0008-5472.can-08-0676","title":"The Hypoxia-Activated ProDrug AQ4N Penetrates Deeply in Tumor Tissues and Complements the Limited Distribution of Mitoxantrone","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"University Health Network","keywords":"Mitoxantrone; Prodrug; Cancer research; In vivo; Tumor hypoxia; Hypoxia (environmental); Chemistry; Drug; Pharmacology; Topoisomerase; Tumor microenvironment; Distribution (mathematics); Chemotherapy; Biology; Medicine; In vitro; Tumor cells; Biochemistry; Oxygen; Internal medicine; Radiation therapy","score_opus":0.03786739809377082,"score_gpt":0.3631058923036818,"score_spread":0.32523849420991097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145278311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773612,0.020035416,0.0000081373655,0.001824871,0.0001246465,0.00046532613,0.00007574008,0.000004137858,0.000100539466],"genre_scores_gemma":[0.9916725,0.007443871,0.000011870694,0.00006326873,0.00035664177,0.00008468791,0.000092013026,0.0000088801835,0.0002662515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987241,0.00020226515,0.0001928488,0.0002488644,0.00026136584,0.0003705808],"domain_scores_gemma":[0.99933594,0.000053831063,0.000056950837,0.00029151008,0.00020618709,0.000055573604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065563445,0.00009971156,0.00013113812,0.00003326957,0.00021126188,0.000050355782,0.0002515888,0.000044872897,0.000009063362],"category_scores_gemma":[0.00014393633,0.0000628571,0.000029485358,0.0002677609,0.0002907882,0.000006466634,0.00008610693,0.00018798036,9.655255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031668658,0.00005340635,0.00093583466,0.0000124580965,0.000026177637,6.0457995e-7,0.000092910464,0.000011518995,0.9734784,0.0001749913,0.006444133,0.018452907],"study_design_scores_gemma":[0.0007669077,0.00026260034,0.11679568,0.000032036394,0.000007210318,0.0000031688157,0.00028835947,0.000030362438,0.6145014,0.00022643509,0.2669857,0.00010011495],"about_ca_topic_score_codex":0.0004984209,"about_ca_topic_score_gemma":0.0008368828,"teacher_disagreement_score":0.35897696,"about_ca_system_score_codex":0.00003432548,"about_ca_system_score_gemma":0.00014777685,"threshold_uncertainty_score":0.2563238},"labels":[],"label_agreement":null},{"id":"W2145284843","doi":"10.1158/0008-5472.can-14-3283","title":"Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK","keywords":"Biology; Cancer research","score_opus":0.15296459169601045,"score_gpt":0.4465292280537598,"score_spread":0.2935646363577493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145284843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941078,0.0007580106,0.0016480841,0.00082201423,0.00005486025,0.0018902831,0.0000031680904,0.000012543607,0.0007032627],"genre_scores_gemma":[0.996886,0.000216249,0.00030124112,0.000041779178,0.00008639628,0.00041108695,0.000001539316,0.000019856569,0.0020358285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980994,0.00024020177,0.00025556827,0.00023862922,0.0008551437,0.0003110646],"domain_scores_gemma":[0.99875706,0.000109581604,0.000038324855,0.00030095328,0.00058765855,0.00020639965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015149416,0.000077399665,0.00017703901,0.00058348116,0.000049267976,0.000022209824,0.000096147254,0.000054668744,0.00018015564],"category_scores_gemma":[0.00021447275,0.00006853264,0.000022899905,0.000932438,0.00010219264,0.000109223765,0.00007116415,0.00030587107,0.000031583008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008895826,0.000040270428,0.00043443963,0.00006272942,0.0000069895054,0.00000384417,0.0011073863,0.00028547217,0.8679772,0.000011013289,0.00016577495,0.12901528],"study_design_scores_gemma":[0.0010230913,0.0006703397,0.03338205,0.0002804179,0.000005622236,0.000013558298,0.00057981996,0.0016114914,0.9593772,0.0013551544,0.0016203742,0.00008086868],"about_ca_topic_score_codex":0.000996281,"about_ca_topic_score_gemma":0.00041757931,"teacher_disagreement_score":0.12893441,"about_ca_system_score_codex":0.0005888966,"about_ca_system_score_gemma":0.00037033376,"threshold_uncertainty_score":0.27946797},"labels":[],"label_agreement":null},{"id":"W2145329513","doi":"10.1158/0008-5472.can-07-0402","title":"The Role of Platelet/Endothelial Cell Adhesion Molecule–1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"CD31; CD38; Bone marrow; Leukemia; Chemistry; Cell adhesion molecule; Cell adhesion; Endothelial stem cell; Stromal cell; Immunology; Cancer research; Cell; Cell biology; Biology; CD34; In vitro; Stem cell; Biochemistry","score_opus":0.013962014534455605,"score_gpt":0.27598084983327503,"score_spread":0.2620188352988194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145329513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929384,0.0050651967,0.000011859481,0.000030502018,0.0005128324,0.0002751589,0.000020833144,0.000005504697,0.0011397211],"genre_scores_gemma":[0.99048555,0.0050771385,0.00001068062,0.0000111446525,0.000015389689,0.000011000175,0.000024886955,0.000013504074,0.0043506986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987946,0.00021358152,0.00032219655,0.0002078249,0.000087254295,0.00037455096],"domain_scores_gemma":[0.999481,0.00013194066,0.000113099144,0.00018937637,0.00006609331,0.000018491715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736641,0.00009586144,0.00015713728,0.0001702779,0.00017845456,0.00000796969,0.00015114158,0.0001566935,0.00029891654],"category_scores_gemma":[0.0000108561135,0.0000770992,0.000058654034,0.0001402965,0.00038503154,0.000055820376,0.00009650649,0.00043704617,0.000056221965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014034265,0.000056232308,0.0012857355,0.000018304698,0.000051121795,0.0000045675674,0.00037686655,0.000003609175,0.9902881,0.000019563542,0.0005464862,0.0059459866],"study_design_scores_gemma":[0.0008535396,0.00028170578,0.0040845,0.000030806972,0.000010674161,0.000013692183,0.0009425667,0.0000060788943,0.97626925,0.000023559012,0.01741849,0.00006512893],"about_ca_topic_score_codex":0.0010476842,"about_ca_topic_score_gemma":0.00010725057,"teacher_disagreement_score":0.016872004,"about_ca_system_score_codex":0.00022030181,"about_ca_system_score_gemma":0.00006214996,"threshold_uncertainty_score":0.32729262},"labels":[],"label_agreement":null},{"id":"W2145413275","doi":"10.1158/0008-5472.can-05-1353","title":"Genetic Ablation of Protein Tyrosine Phosphatase 1B Accelerates Lymphomagenesis of p53-Null Mice through the Regulation of B-Cell Development","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Cancer Research Society; Cancer Research Institute","keywords":"Biology; Protein tyrosine phosphatase; Cancer research; Carcinogenesis; Receptor tyrosine kinase; Bone marrow; Endocrinology; Signal transduction; Internal medicine; Immunology; Cancer; Cell biology; Medicine; Genetics","score_opus":0.03759192734981452,"score_gpt":0.32856972443058297,"score_spread":0.29097779708076843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145413275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418665,0.056369893,0.0005236596,0.00017173072,0.000022431735,0.00081029424,0.000120373,0.0000041980074,0.000110887086],"genre_scores_gemma":[0.9910201,0.00075402815,0.0073329373,0.00002192009,0.000101903206,0.00023367592,0.00013443638,0.000023877188,0.00037713096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984029,0.0001423841,0.00044617514,0.0002911798,0.0004511526,0.00026622618],"domain_scores_gemma":[0.99859506,0.000035333727,0.00024050163,0.00046543012,0.0006230834,0.000040568422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046535043,0.00013106813,0.00017685042,0.00005798086,0.00009400014,0.0000120386985,0.00037910393,0.000097668955,0.00009470485],"category_scores_gemma":[0.00011048847,0.00010649019,0.000050937797,0.00034793472,0.00028130575,0.000015042616,0.0001975262,0.00007105897,0.0000045658608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029858827,0.00016063172,0.00041517292,0.000207825,0.000033981287,2.252401e-7,0.00015566836,0.0006898031,0.984026,0.00020456484,0.00087521184,0.01293231],"study_design_scores_gemma":[0.00074380817,0.000145886,0.008176106,0.00008479363,0.0000113996475,8.1693685e-7,0.00004292409,0.00005349144,0.9833103,0.00006999577,0.0072576287,0.00010288158],"about_ca_topic_score_codex":0.0005997579,"about_ca_topic_score_gemma":0.000107241714,"teacher_disagreement_score":0.055615865,"about_ca_system_score_codex":0.00007298313,"about_ca_system_score_gemma":0.0004595511,"threshold_uncertainty_score":0.43425438},"labels":[],"label_agreement":null},{"id":"W2145539398","doi":"10.1158/0008-5472.can-03-2970","title":"The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of <b> <i>BRCA1</i> </b>-Related Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; McGill University Health Centre; Sunnybrook Health Science Centre; Jewish General Hospital; McGill University; Immunovaccine (Canada)","funders":"","keywords":"Breast cancer; Cancer research; Biology; Cancer; Cyclin D1; Estrogen receptor; Cyclin E; Lymph node; Basal (medicine); Cytokeratin; Oncology; Internal medicine; Pathology; Immunohistochemistry; Cell cycle; Medicine; Endocrinology","score_opus":0.019375750377365508,"score_gpt":0.336762416802405,"score_spread":0.3173866664250395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145539398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296714,0.00945763,0.00020565392,0.005225534,0.00050924305,0.0011297947,0.00017827132,0.000012057735,0.00031470455],"genre_scores_gemma":[0.99534243,0.002797629,0.00009605271,0.00015561911,0.00025829286,0.0007147902,0.000041371502,0.00004707643,0.00054673594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977205,0.00025883917,0.00047896057,0.00046627142,0.0006295384,0.0004459023],"domain_scores_gemma":[0.9973494,0.00008116266,0.00021569448,0.0010181238,0.0012588574,0.000076766446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088355364,0.00017456851,0.00018785545,0.000071950686,0.00042178752,0.00004004377,0.00078016747,0.00019369437,0.00006881365],"category_scores_gemma":[0.00017992916,0.00011873508,0.00016542789,0.0008300922,0.0007659748,0.00001119411,0.0002697981,0.00035251808,0.000009595731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017544116,0.00010014805,0.011363453,0.000091920825,0.00026110772,3.25731e-7,0.00026876718,0.0054708095,0.97208166,0.0007714318,0.002807314,0.006607629],"study_design_scores_gemma":[0.0012139307,0.000098430995,0.057217438,0.00012729081,0.00006172141,0.0000079560505,0.00014948343,0.00004327301,0.929769,0.0013946296,0.009724658,0.00019221421],"about_ca_topic_score_codex":0.0011469388,"about_ca_topic_score_gemma":0.0014399032,"teacher_disagreement_score":0.045853984,"about_ca_system_score_codex":0.00035946834,"about_ca_system_score_gemma":0.00220976,"threshold_uncertainty_score":0.4841876},"labels":[],"label_agreement":null},{"id":"W2145623483","doi":"10.1158/0008-5472.can-10-1202","title":"MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Cystectomy; Medicine; Radiation therapy; Bladder cancer; Cohort; Oncology; Immunohistochemistry; Cancer; Internal medicine; Predictive marker; Survival analysis; Urology; Pathology","score_opus":0.10061902072895273,"score_gpt":0.42862922649996565,"score_spread":0.3280102057710129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145623483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827162,0.00788942,0.00055515283,0.0022639807,0.002282553,0.0026410674,0.00072735304,0.00006639466,0.00085785676],"genre_scores_gemma":[0.9876093,0.004926185,0.0007240985,0.00027763945,0.0022200088,0.0021349322,0.000038977694,0.00013001461,0.001938824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996861,0.0001268433,0.00036745958,0.0006884931,0.0011905326,0.0007656741],"domain_scores_gemma":[0.99782526,0.00048528795,0.00008853915,0.00062060734,0.00058778253,0.00039253407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000596221,0.00026518825,0.00059310114,0.00025153396,0.00026110077,0.000032932123,0.00029382945,0.00027447788,0.0028624577],"category_scores_gemma":[0.00012410711,0.00021235638,0.0003193169,0.0004493528,0.00042252927,0.00013939537,0.00006854367,0.0007920867,0.000008127211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024982868,0.00034327875,0.016398512,0.00019871918,0.0008648174,0.000041451465,0.002952927,0.0000058209584,0.92677885,0.000084437204,0.037390653,0.012442246],"study_design_scores_gemma":[0.014112531,0.00170748,0.019892868,0.0008304663,0.0002653295,0.000006758438,0.0008489347,0.00008712556,0.8027147,0.00036268623,0.15875162,0.0004195208],"about_ca_topic_score_codex":0.00074178743,"about_ca_topic_score_gemma":0.00038403794,"teacher_disagreement_score":0.12406418,"about_ca_system_score_codex":0.00040369158,"about_ca_system_score_gemma":0.0014552759,"threshold_uncertainty_score":0.9980491},"labels":[],"label_agreement":null},{"id":"W2145719260","doi":"10.1158/0008-5472.can-12-2395","title":"eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"EIF4E; PI3K/AKT/mTOR pathway; mTORC1; Cancer research; Cancer; Initiation factor; Translation (biology); Targeted therapy; Eukaryotic initiation factor; Mechanistic target of rapamycin; Phosphorylation; Medicine; Biology; Signal transduction; Internal medicine; Messenger RNA; Cell biology; Gene; Biochemistry","score_opus":0.06194265840891831,"score_gpt":0.38877262337911844,"score_spread":0.3268299649702001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145719260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715784,0.025925567,0.00019193211,0.0006867812,0.00044052213,0.00039341612,0.000047412603,0.000012527536,0.0007234139],"genre_scores_gemma":[0.995564,0.0009298276,0.00008474844,0.00016984018,0.0015732297,0.0001986947,0.000028287124,0.00003273135,0.0014186852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823445,0.0002861847,0.00019264038,0.00024946744,0.0004924751,0.0005447858],"domain_scores_gemma":[0.99880123,0.00012979991,0.00006268599,0.0005642659,0.00032220135,0.000119817385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010689831,0.0001235727,0.00013588819,0.000052000727,0.00016041136,0.000025090281,0.0004943845,0.00013551278,0.00033628216],"category_scores_gemma":[0.00029538525,0.000085853084,0.00008037039,0.00024305996,0.00042131566,0.000007657409,0.00017151094,0.00026641457,0.000020138472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002379164,0.00007351355,0.0057241227,0.000031174113,0.00012535191,4.2025619e-7,0.0006483395,0.00007540766,0.96166253,0.0001769019,0.028780703,0.0024636462],"study_design_scores_gemma":[0.0005658014,0.00019612249,0.008424048,0.000031035273,0.00001100204,0.0000014630385,0.00013373002,0.000018657309,0.83273774,0.000045163164,0.15772158,0.000113654954],"about_ca_topic_score_codex":0.00014344558,"about_ca_topic_score_gemma":0.000027082766,"teacher_disagreement_score":0.12894088,"about_ca_system_score_codex":0.00006107937,"about_ca_system_score_gemma":0.00034366548,"threshold_uncertainty_score":0.3682054},"labels":[],"label_agreement":null},{"id":"W2145979349","doi":"10.1158/0008-5472.can-11-2348","title":"p53 Inhibits Angiogenesis by Inducing the Production of Arresten","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; California Dental Association Foundation","keywords":"Angiogenesis; Downregulation and upregulation; Extracellular matrix; Cell biology; Enhancer; Matrix metalloproteinase; Chemistry; Cancer research; In vivo; Biology; Molecular biology; Gene expression; Gene; Biochemistry; Genetics","score_opus":0.11413417923275145,"score_gpt":0.42644776496262965,"score_spread":0.3123135857298782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145979349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843218,0.008077738,0.000005907424,0.0052697295,0.00018521876,0.0007106198,0.0000059925846,0.000016976433,0.0014060528],"genre_scores_gemma":[0.99200124,0.0007265067,0.000040513794,0.00006420905,0.0005789182,0.00018638984,0.000007836037,0.00003168369,0.006362717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732137,0.00029562574,0.00020265534,0.00024839395,0.001289839,0.00064209],"domain_scores_gemma":[0.9984526,0.00019450397,0.000041287665,0.00053806993,0.00054130395,0.00023223377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022250048,0.000090182955,0.00017080319,0.00016959623,0.00016877304,0.000015820728,0.00019777795,0.000080175254,0.00043181799],"category_scores_gemma":[0.0009596064,0.000059169986,0.00006893479,0.0010970389,0.00031266134,0.000097470525,0.0001843273,0.0004959919,0.00008816847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013972499,0.000121135345,0.02288613,0.0001375877,0.000039685125,0.0000018163647,0.00058961543,0.0000023752648,0.90338093,0.00002532394,0.052890494,0.019785166],"study_design_scores_gemma":[0.00022171588,0.000094738316,0.015714044,0.00014666223,0.000015935573,0.000012342296,0.00045024807,0.0000056573754,0.94869363,0.0000086563305,0.034575857,0.00006050394],"about_ca_topic_score_codex":0.0006565889,"about_ca_topic_score_gemma":0.000024612009,"teacher_disagreement_score":0.04531269,"about_ca_system_score_codex":0.00023369753,"about_ca_system_score_gemma":0.00025076748,"threshold_uncertainty_score":0.47281042},"labels":[],"label_agreement":null},{"id":"W2146124745","doi":"10.1158/0008-5472.can-03-3764","title":"Soluble Interleukin-13Rα2 Decoy Receptor Inhibits Hodgkin’s Lymphoma Growth<b><i>in Vitro</i></b>and<b><i>in Vivo</i></b>","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital","funders":"","keywords":"Decoy; In vivo; Lymphoma; In vitro; Cancer research; Interleukin 2; Receptor; Medicine; Immunology; Chemistry; Internal medicine; Biology; Biochemistry; Genetics","score_opus":0.035841142600185845,"score_gpt":0.31576079289983516,"score_spread":0.2799196502996493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146124745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869567,0.005771369,0.000016596938,0.0009846406,0.0011926536,0.0005987266,0.00046450086,0.0000839741,0.0039308444],"genre_scores_gemma":[0.991773,0.003479898,0.00010123103,0.00033238294,0.00014967954,0.00039787448,0.000054285963,0.00006638066,0.0036452315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962848,0.0004925926,0.00054200727,0.00088142336,0.00019474147,0.0016044602],"domain_scores_gemma":[0.9988385,0.00026645348,0.000080396865,0.00042647953,0.0002730045,0.000115158626],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013764353,0.00034036333,0.0005425627,0.00076731306,0.0003085955,0.00006500597,0.0005734413,0.00051055005,0.00056400156],"category_scores_gemma":[0.0003310193,0.00033337783,0.00009446718,0.0010105354,0.0007134122,0.00029110073,0.00041833936,0.0009725523,0.0008365593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012324771,0.0002803884,0.0011350985,0.000114160735,0.00004262211,0.00004454828,0.0022245196,0.000007315629,0.98275244,0.00086132804,0.0063982266,0.004906885],"study_design_scores_gemma":[0.005362682,0.00022264838,0.00075361173,0.00029962446,0.000006097797,0.00003778428,0.00054999744,0.0000011376019,0.8942254,0.0011442426,0.097045995,0.00035074571],"about_ca_topic_score_codex":0.006075837,"about_ca_topic_score_gemma":0.0039776983,"teacher_disagreement_score":0.090647765,"about_ca_system_score_codex":0.0010035901,"about_ca_system_score_gemma":0.0009787851,"threshold_uncertainty_score":0.9999414},"labels":[],"label_agreement":null},{"id":"W2146129028","doi":"10.1158/0008-5472.can-05-0440","title":"Three-dimensional High-Frequency Ultrasound Imaging for Longitudinal Evaluation of Liver Metastases in Preclinical Models","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Ontario Innovation Trust; Pfizer","keywords":"Medicine; Metastasis; Ultrasound; Melanoma; Colorectal cancer; Liver tumor; Cancer; Pathology; Liver cancer; Oncology; Radiology; Cancer research; Internal medicine; Hepatocellular carcinoma","score_opus":0.20434715197559045,"score_gpt":0.42783478066785635,"score_spread":0.2234876286922659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146129028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98487157,0.0072236615,0.0064096055,0.00023002256,0.000050371913,0.0007514965,0.00014506571,0.000037604168,0.00028059338],"genre_scores_gemma":[0.9943193,0.00019282903,0.0043663057,0.000010020826,0.00018100317,0.00085783645,0.000035699482,0.00002463672,0.000012330674],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99857575,0.000059649963,0.00026686932,0.00023068461,0.00056687853,0.0003001988],"domain_scores_gemma":[0.99855316,0.0006923092,0.000021699643,0.00022880347,0.00044528648,0.000058714653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016970922,0.000090166395,0.00015681269,0.00015532634,0.000069458336,0.000020515085,0.00017033082,0.00004624619,0.0003316493],"category_scores_gemma":[0.00014435513,0.000087139706,0.00005156479,0.00027026082,0.00010642696,0.00021659516,0.000018285493,0.0002164076,0.000011505073],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006902236,0.00025800336,0.007955709,0.00014938333,0.00011863359,0.0000011317188,0.00030094958,0.7568504,0.1463109,0.008783511,0.0026306082,0.07657173],"study_design_scores_gemma":[0.0024305834,0.000051610914,0.037331033,0.00017500036,0.00012509384,0.000008907826,0.000049378457,0.8890157,0.02342827,0.046090983,0.0009337938,0.0003596661],"about_ca_topic_score_codex":0.0007305175,"about_ca_topic_score_gemma":0.0037314661,"teacher_disagreement_score":0.13216525,"about_ca_system_score_codex":0.00026737794,"about_ca_system_score_gemma":0.00019139424,"threshold_uncertainty_score":0.36313272},"labels":[],"label_agreement":null},{"id":"W2146135854","doi":"10.1158/0008-5472.can-04-1216","title":"Protein Profiling of Microdissected Prostate Tissue Links Growth Differentiation Factor 15 to Prostate Carcinogenesis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Kelowna General Hospital; University of British Columbia; BC Cancer Agency","funders":"University of Victoria","keywords":"Laser capture microdissection; Prostate cancer; Prostate; Carcinogenesis; Intraepithelial neoplasia; High-grade prostatic intraepithelial neoplasia; Microdissection; Pathology; Biology; Cancer; Cancer research; Medicine; Gene expression; Internal medicine; Gene","score_opus":0.04093504716683209,"score_gpt":0.362721072094208,"score_spread":0.3217860249273759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146135854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206495,0.00079575274,0.000065568776,0.0027466405,0.00009215956,0.0039617433,0.000080436206,0.000056462275,0.00013625527],"genre_scores_gemma":[0.99700123,0.00014497619,0.00061395596,0.00003277169,0.00009349637,0.0004953508,0.0000688951,0.000048275408,0.001501044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978044,0.00010640132,0.0003489532,0.00043888707,0.00071205065,0.0005892885],"domain_scores_gemma":[0.9982684,0.000024533269,0.000074753574,0.0002897675,0.0010445105,0.00029798545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032237853,0.00017285896,0.00029661553,0.00043553824,0.00013283742,0.000028835606,0.00014574185,0.00024751681,0.00008740698],"category_scores_gemma":[0.00019617402,0.000132076,0.00006287757,0.0010763172,0.00013232746,0.00006312475,0.00008651297,0.0006161831,0.000041188596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009862413,0.00013892897,0.02333593,0.000853364,0.00009713271,0.00003209342,0.0015504368,0.0000131676225,0.97036517,0.000038457863,0.00007282725,0.0025162473],"study_design_scores_gemma":[0.0015769647,0.00063154247,0.08067689,0.0007186779,0.00002713528,0.000005572389,0.00016780422,0.000008172218,0.91583115,0.00009203094,0.00013116856,0.00013291114],"about_ca_topic_score_codex":0.0015583923,"about_ca_topic_score_gemma":0.00010434483,"teacher_disagreement_score":0.057340957,"about_ca_system_score_codex":0.00038051006,"about_ca_system_score_gemma":0.0006955221,"threshold_uncertainty_score":0.5385903},"labels":[],"label_agreement":null},{"id":"W2146191341","doi":"10.1158/0008-5472.can-05-0414","title":"A New Three-Dimensional Ultrasound Microimaging Technology for Preclinical Studies Using a Transgenic Prostate Cancer Mouse Model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Ontario Innovation Trust","keywords":"Prostate cancer; Ultrasound; Prostate; Medicine; Cancer; In vivo; Pathology; Biomedical engineering; Nuclear medicine; Radiology; Internal medicine; Biology","score_opus":0.19992726506713515,"score_gpt":0.48254109278365254,"score_spread":0.2826138277165174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146191341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608881,0.021581618,0.011218863,0.00442774,0.00018572317,0.0012283385,0.00010646963,0.00032562893,0.00003752815],"genre_scores_gemma":[0.9134716,0.0051193396,0.075116254,0.00010574277,0.00097652804,0.0015563976,0.0000077902905,0.00022044784,0.003425921],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967625,0.0000526538,0.00045147573,0.0005648361,0.0008294242,0.0013391047],"domain_scores_gemma":[0.99791414,0.00080123474,0.000029254239,0.00039780198,0.0005566049,0.00030097668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014568769,0.00023278061,0.00037564323,0.0005048476,0.00027606415,0.00006850047,0.0005737295,0.00021476556,0.00012469407],"category_scores_gemma":[0.0006674874,0.00021741263,0.00010905761,0.00083856337,0.0005722383,0.0001622813,0.00019460409,0.0011784725,0.000021815673],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017307977,0.000044783803,0.00093690155,0.00045730517,0.00033865988,0.0000025580157,0.00054904143,0.21203987,0.6999597,0.00011342731,0.009164991,0.07621969],"study_design_scores_gemma":[0.0023167946,0.00010224969,0.00006667359,0.0005959665,0.00004789907,0.000009130334,0.00012966497,0.61890626,0.3591657,0.0047005,0.013394816,0.0005643542],"about_ca_topic_score_codex":0.0002403943,"about_ca_topic_score_gemma":0.00079716824,"teacher_disagreement_score":0.40686637,"about_ca_system_score_codex":0.0010065674,"about_ca_system_score_gemma":0.0010609281,"threshold_uncertainty_score":0.886583},"labels":[],"label_agreement":null},{"id":"W2146284460","doi":"10.1158/0008-5472.can-11-3594","title":"HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Epithelium; Cancer research; Breast cancer; Medicine; Internal medicine; Oncology; Pathology; Cancer","score_opus":0.19696368002746906,"score_gpt":0.46742808663521285,"score_spread":0.2704644066077438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146284460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8966153,0.0027556294,0.00023889233,0.09477616,0.00042873615,0.004119286,0.0002472588,0.000057174577,0.00076154113],"genre_scores_gemma":[0.99009186,0.0003568323,0.0001533236,0.001569102,0.0019228642,0.0033943073,0.000013048036,0.0000643675,0.0024343242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996945,0.00020372603,0.00021692408,0.00034623037,0.0010750653,0.0012130127],"domain_scores_gemma":[0.9977029,0.00044973617,0.000042223663,0.0005430387,0.000665696,0.0005964377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025857186,0.00016547913,0.00025941085,0.00027647163,0.00036388217,0.000092257156,0.00027992102,0.00008857776,0.0003982941],"category_scores_gemma":[0.000485256,0.00011346033,0.000049927152,0.0006528566,0.00015068804,0.00019336857,0.0002232709,0.00045903164,0.00016759404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048440234,0.0003467087,0.011068905,0.0038558773,0.00023056523,0.000017894336,0.020821873,0.0000066513808,0.3081239,0.0005884674,0.34046894,0.3096262],"study_design_scores_gemma":[0.0035095555,0.0027365503,0.02952114,0.0014982793,0.00009306205,0.00045404723,0.0033616666,0.0008977903,0.27323624,0.00022900527,0.6839375,0.0005251704],"about_ca_topic_score_codex":0.00079597626,"about_ca_topic_score_gemma":0.00072228507,"teacher_disagreement_score":0.34346852,"about_ca_system_score_codex":0.0005678446,"about_ca_system_score_gemma":0.00043785735,"threshold_uncertainty_score":0.46267778},"labels":[],"label_agreement":null},{"id":"W2146363635","doi":"10.1158/0008-5472.can-04-2667","title":"EphB4 Expression and Biological Significance in Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Cancer Council NSW; National Health and Medical Research Council; Prostate Cancer Foundation of Australia; Medical Research Council; National Cancer Institute; Prostate Cancer Foundation","keywords":"Prostate cancer; Cancer research; PTEN; Cancer; Gene knockdown; Prostate; Biology; Epidermal growth factor; Small interfering RNA; Growth factor; Epidermal growth factor receptor; Medicine; Cell culture; Pathology; Internal medicine; PI3K/AKT/mTOR pathway; Receptor; Signal transduction; Transfection; Cell biology","score_opus":0.23104636727804725,"score_gpt":0.4468261120502619,"score_spread":0.21577974477221465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146363635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944789,0.0024632367,0.000005078739,0.0018912101,0.000063023086,0.0004115257,0.000018192984,0.00003383033,0.0006350064],"genre_scores_gemma":[0.99083716,0.0069804923,0.000038455713,0.00063834497,0.00021036675,0.00051606994,3.9593058e-7,0.000016115675,0.00076261064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977706,0.0003268228,0.00020175372,0.00062604644,0.00045386545,0.0006209045],"domain_scores_gemma":[0.9992211,0.00038538116,0.000038051436,0.00016397487,0.00005262692,0.00013889206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054579444,0.00011749259,0.00015208518,0.0001391506,0.00020645776,0.000054827862,0.00026824285,0.000058774156,0.00042190065],"category_scores_gemma":[0.00027247018,0.000091338494,0.000021429767,0.0005198289,0.0003558399,0.00021101364,0.000174473,0.00054642995,0.00004091912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016506248,0.000036621597,0.0076727,0.00001589097,5.075687e-7,0.00003231201,0.00023597924,0.000198158,0.9706786,0.00019998844,0.0006408434,0.020123297],"study_design_scores_gemma":[0.00044091363,0.00007273459,0.004779017,0.00013486641,5.424727e-7,0.0000031609682,0.00005613593,0.0002167748,0.96828264,0.00037764863,0.025499374,0.00013617928],"about_ca_topic_score_codex":0.0002452291,"about_ca_topic_score_gemma":0.00014131851,"teacher_disagreement_score":0.02485853,"about_ca_system_score_codex":0.00015489916,"about_ca_system_score_gemma":0.00014714524,"threshold_uncertainty_score":0.4619516},"labels":[],"label_agreement":null},{"id":"W2146369144","doi":"10.1158/0008-5472.can-09-0167","title":"Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":372,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Angiogenesis; Vasculogenesis; Stromal cell; Vascular endothelial growth factor; Cancer research; Endothelial stem cell; Bone marrow; Progenitor cell; Stem cell; Biology; Pathology; Medicine; Immunology; Cell biology; In vitro","score_opus":0.04610302731924862,"score_gpt":0.3254478754342846,"score_spread":0.279344848115036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146369144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858333,0.011311209,0.00008568337,0.00047263384,0.00020257136,0.0014833811,0.0004645255,0.00007765416,0.00006906831],"genre_scores_gemma":[0.9948372,0.0032529696,0.00048226782,0.00024813542,0.00045707825,0.00016969982,0.000011034288,0.00008030449,0.00046128378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99623126,0.0002430552,0.00039866628,0.00097230345,0.0011210247,0.0010337181],"domain_scores_gemma":[0.99792767,0.00013448029,0.00009587891,0.0005768399,0.00047989617,0.0007852503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046612258,0.00040905667,0.0007596869,0.00047569055,0.00030578146,0.00012574045,0.00022397944,0.000114696464,0.0005309583],"category_scores_gemma":[0.00005837182,0.00034209416,0.0002620319,0.0006691418,0.00030602206,0.00016281843,0.00014760776,0.0003600277,0.000022666472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046139563,0.00014885355,0.0027210503,0.00039629146,0.00028182953,0.00027402551,0.00042573322,7.021775e-7,0.95617944,0.0000071970585,0.00030738793,0.03879607],"study_design_scores_gemma":[0.0032488995,0.0010315834,0.05215797,0.00016430633,0.00020941105,0.00009405707,0.00017932129,0.0000232162,0.93527,0.00003289804,0.0071878713,0.00040042706],"about_ca_topic_score_codex":0.001228761,"about_ca_topic_score_gemma":0.000088731365,"teacher_disagreement_score":0.04943692,"about_ca_system_score_codex":0.00029597254,"about_ca_system_score_gemma":0.00043359367,"threshold_uncertainty_score":0.9999031},"labels":[],"label_agreement":null},{"id":"W2146475510","doi":"10.1158/0008-5472.can-06-3505","title":"Estrogen Receptor β2 Negatively Regulates the Transactivation of Estrogen Receptor α in Human Breast Cancer Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Toronto","funders":"","keywords":"Transactivation; Estrogen receptor; Estrogen receptor alpha; Estrogen receptor beta; Cancer research; Chromatin immunoprecipitation; Estrogen; Biology; Cancer cell; Hormone response element; Breast cancer; Endocrinology; Internal medicine; Chemistry; Cancer; Transcription factor; Gene expression; Promoter; Medicine; Gene; Biochemistry","score_opus":0.021726262786754682,"score_gpt":0.350967964667404,"score_spread":0.32924170188064933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146475510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940328,0.0042938977,0.00003408818,0.0005815569,0.00014816337,0.0005667993,0.00009080265,0.000009104742,0.00024278364],"genre_scores_gemma":[0.99703544,0.0016543284,0.000087685374,0.000030992644,0.0003633495,0.00012938546,0.00004869739,0.000039961535,0.00061014155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980536,0.00026316495,0.00031855277,0.00039836226,0.0003973456,0.0005689388],"domain_scores_gemma":[0.9990785,0.00007430806,0.0001023111,0.00033686045,0.00028783223,0.00012019123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012111443,0.00017400825,0.00019092317,0.00011588674,0.00018208892,0.000021796643,0.00037822305,0.00027406286,0.00018206514],"category_scores_gemma":[0.000027273492,0.00013128105,0.000105428335,0.0005431168,0.00038573556,0.000011218364,0.00006590482,0.00047313794,0.000008745594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005163008,0.0000832028,0.0030811727,0.00003767561,0.00010139987,0.0000017860699,0.00029119864,0.00017311977,0.98670745,0.00015032395,0.0015887416,0.00726764],"study_design_scores_gemma":[0.00064678106,0.00020394337,0.0031627165,0.000092743605,0.0000107228725,0.0000027834762,0.0002526724,0.000010238653,0.9915955,0.00004096351,0.0038367321,0.00014421546],"about_ca_topic_score_codex":0.0012167542,"about_ca_topic_score_gemma":0.00012282314,"teacher_disagreement_score":0.0071234247,"about_ca_system_score_codex":0.00014913926,"about_ca_system_score_gemma":0.0002845818,"threshold_uncertainty_score":0.5353486},"labels":[],"label_agreement":null},{"id":"W2146487117","doi":"10.1158/0008-5472.can-09-3281","title":"The Tumor-Suppressive Function of Connexin43 in Keratinocytes Is Mediated in Part via Interaction with Caveolin-1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University","funders":"Canadian Institutes of Health Research","keywords":"Keratinocyte; Cell biology; Cell culture; Epidermal growth factor; Connexin; Cancer research; Gap junction; Biology; Chemistry; Intracellular","score_opus":0.02626387188357759,"score_gpt":0.34953336776403326,"score_spread":0.32326949588045567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146487117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980123,0.00052012276,0.000012389095,0.0005909462,0.00018347436,0.00021676988,0.000015901396,0.0000023118416,0.0004457881],"genre_scores_gemma":[0.9990513,0.00028071026,0.000008317878,0.00010286554,0.00014640931,0.00015083497,0.000032664222,0.000009736093,0.00021719483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990306,0.00016289877,0.00017818308,0.00024237738,0.0001259148,0.00026001935],"domain_scores_gemma":[0.99933153,0.000103067876,0.00005649458,0.0002475743,0.00022317664,0.000038156457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051603094,0.00007828064,0.0001048044,0.000079966,0.00006507389,0.000014484326,0.00014613578,0.00010175442,0.00013997218],"category_scores_gemma":[0.00014518082,0.000051956737,0.00002142372,0.00018009619,0.00026239577,0.0000046840837,0.000071063405,0.0004267556,0.0000046717773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011099499,0.000036103662,0.018623384,0.000010038789,0.000016522163,0.0000046769164,0.00014102814,0.00001560371,0.9737053,0.00009712773,0.000953103,0.0052871737],"study_design_scores_gemma":[0.0013719647,0.00074263033,0.02142372,0.000049953145,0.000004240245,0.000013032193,0.0006640998,0.00029649882,0.8731551,0.00017840927,0.10194784,0.00015248494],"about_ca_topic_score_codex":0.0010616854,"about_ca_topic_score_gemma":0.023325067,"teacher_disagreement_score":0.100994736,"about_ca_system_score_codex":0.00002223261,"about_ca_system_score_gemma":0.00017364624,"threshold_uncertainty_score":0.9944967},"labels":[],"label_agreement":null},{"id":"W2146601467","doi":"10.1158/0008-5472.can-08-1079","title":"Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":422,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Glioma; Cancer stem cell; Cancer research; Neurosphere; Small hairpin RNA; Stem cell; L1; Cancer cell; Gene knockdown; Biology; Cancer; Cell culture; Cell biology; Endothelial stem cell; Adult stem cell; In vitro","score_opus":0.14844212865165865,"score_gpt":0.4151330782550606,"score_spread":0.2666909496034019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146601467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548498,0.034235757,0.00008834963,0.003231171,0.0008555503,0.0008682097,0.00015529107,0.00010790866,0.0056079635],"genre_scores_gemma":[0.94950724,0.0382663,0.00038851443,0.00039312156,0.0015277057,0.000550583,0.0000125981505,0.0000881597,0.0092657935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99656,0.00015946999,0.0003492232,0.0006379149,0.0012464983,0.0010469113],"domain_scores_gemma":[0.9981048,0.00016331745,0.00007164527,0.0004611056,0.0008605704,0.00033856518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005028732,0.00023538095,0.00047995592,0.00021454027,0.0004566474,0.000041685347,0.0002932848,0.00012640982,0.0032321878],"category_scores_gemma":[0.000050009858,0.00019817022,0.00014949676,0.0011130568,0.00053936656,0.00020783642,0.00018777243,0.0007119412,0.00014845748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005782587,0.00019409863,0.0054192045,0.0008025025,0.00020620922,0.0006811693,0.0020603691,0.00006734386,0.67608684,0.00017590873,0.30829865,0.0054294444],"study_design_scores_gemma":[0.0013345301,0.00016032206,0.00041994493,0.00023216863,0.000049734852,0.000048359616,0.00047387613,0.000013753048,0.7817475,0.000056544617,0.21525109,0.00021218076],"about_ca_topic_score_codex":0.009461722,"about_ca_topic_score_gemma":0.00014940333,"teacher_disagreement_score":0.10566065,"about_ca_system_score_codex":0.0005463017,"about_ca_system_score_gemma":0.001209322,"threshold_uncertainty_score":0.997679},"labels":[],"label_agreement":null},{"id":"W2146777763","doi":"10.1158/0008-5472.can-12-0939","title":"Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"DNA damage; Cancer research; DNA repair; Tensin; Biology; Phosphatase; Apoptosis; Kinase; DNA; Molecular biology; Cell biology; Biochemistry; Phosphorylation; PTEN","score_opus":0.05405427981362192,"score_gpt":0.3834887238705363,"score_spread":0.32943444405691436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146777763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537917,0.012766957,0.030564558,0.00019192447,0.00047956812,0.0014934626,0.0006079432,0.000024100886,0.00007979907],"genre_scores_gemma":[0.98418593,0.0001493346,0.013324552,0.000060985974,0.00079934293,0.0009376297,0.00017209395,0.000084072555,0.00028605358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997626,0.00013159496,0.00031247854,0.00046933282,0.00038809257,0.0010725197],"domain_scores_gemma":[0.9987647,0.00008760999,0.000112893,0.00041162578,0.00037651762,0.0002466563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012286045,0.0001857523,0.00023292545,0.00010282489,0.00022697698,0.000025324873,0.00036709383,0.00016496377,0.00006645943],"category_scores_gemma":[0.00045104415,0.00019130312,0.00019550197,0.00016998642,0.00020694747,0.000010748732,0.0001797964,0.0001472464,0.000002460442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006407963,0.000040816543,0.0004889374,0.00019268384,0.0001212538,0.0000017527994,0.00006550752,0.0007436821,0.9826749,0.00025139697,0.0074588805,0.0073193912],"study_design_scores_gemma":[0.0009982394,0.00039423705,0.00024791056,0.000060416107,0.000045558376,0.0000042311744,0.0002741318,0.0012024809,0.97099197,0.000080654165,0.025462344,0.00023779875],"about_ca_topic_score_codex":0.00036486666,"about_ca_topic_score_gemma":0.000036286212,"teacher_disagreement_score":0.030394247,"about_ca_system_score_codex":0.00010845908,"about_ca_system_score_gemma":0.0003328405,"threshold_uncertainty_score":0.7801115},"labels":[],"label_agreement":null},{"id":"W2146808831","doi":"10.1158/0008-5472.can-14-3370","title":"VR23: A Quinoline–Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E–Mediated Centrosome Amplification","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Sudbury; University of Ottawa","funders":"","keywords":"Proteasome; Bortezomib; Proteasome inhibitor; Cancer cell; Cancer research; Chemistry; Lactacystin; Biology; Pharmacology; Biochemistry; Molecular biology; Cancer; Multiple myeloma; Immunology","score_opus":0.09920634340745745,"score_gpt":0.375373421682756,"score_spread":0.27616707827529857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146808831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772144,0.0071435203,0.00053271145,0.0014781154,0.00040663153,0.0017321735,0.00037555554,0.000062847976,0.000547001],"genre_scores_gemma":[0.99170434,0.0016862706,0.00013995267,0.00029737834,0.0017419318,0.0022445188,0.0003417073,0.0000772425,0.0017666722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668604,0.00042667048,0.00030294925,0.0008237906,0.00080933905,0.00095121464],"domain_scores_gemma":[0.99775654,0.000043809756,0.0001345525,0.0005531504,0.0010112937,0.00050063385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010805416,0.00027310898,0.00026723667,0.00017695199,0.00020892355,0.00009782371,0.00049399136,0.00023325373,0.00013586924],"category_scores_gemma":[0.00048186906,0.0002569925,0.00009573812,0.00046808028,0.00027276954,0.000020924488,0.00025546114,0.0005387569,0.00016297826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005618921,0.00013018912,0.0042192815,0.000064823245,0.00006983466,0.0000073913798,0.0002534831,0.00003194397,0.9749786,0.000030157278,0.013543298,0.0061090793],"study_design_scores_gemma":[0.0012837714,0.00032971168,0.0012967401,0.00007372378,0.000009553921,0.000009827213,0.00010099171,0.000085932894,0.8845751,0.00030396305,0.1116128,0.0003178424],"about_ca_topic_score_codex":0.0007283698,"about_ca_topic_score_gemma":0.00019433051,"teacher_disagreement_score":0.098069504,"about_ca_system_score_codex":0.000371792,"about_ca_system_score_gemma":0.0013171412,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W2146833615","doi":"10.1158/0008-5472.can-05-1512","title":"Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin αvβ3 in Angiogenesis <i>In vitro</i> : Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and αvβ3 Are Critical","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemopexin; Integrin; Matrix metalloproteinase; Angiogenesis; Disintegrin; Extracellular matrix; Matrix metalloproteinase inhibitor; Collagen receptor; Cell biology; Chemistry; Cell adhesion; Type IV collagen; Vitronectin; Biology; Metalloproteinase; Molecular biology; Biochemistry; Cell; Cancer research; Enzyme; Laminin","score_opus":0.02258339668651514,"score_gpt":0.3459173249340055,"score_spread":0.32333392824749035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146833615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98495036,0.0141143985,0.000018076731,0.0004119253,0.000030611052,0.00033432455,0.00003982928,0.0000028768704,0.00009760113],"genre_scores_gemma":[0.99848616,0.0008357206,0.0003501206,0.000020808879,0.00014060002,0.00008626778,0.0000043310174,0.000015871927,0.00006014426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986492,0.00021060483,0.00022394973,0.00033869522,0.00025195285,0.00032562856],"domain_scores_gemma":[0.9993444,0.00011504578,0.00005399844,0.00024871615,0.00016462615,0.000073205665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090311555,0.00012194671,0.00022024925,0.00011519419,0.00006698992,0.0000200337,0.00018786218,0.00012108183,0.0000143200805],"category_scores_gemma":[0.00038422606,0.00009570658,0.0000443546,0.00027577856,0.00031753388,0.000015698344,0.0002664323,0.00021548616,5.4441296e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037974791,0.00007282922,0.0018032511,0.00010023301,0.00001654734,0.000006020759,0.000080232676,0.000011285664,0.9948823,0.00021693046,0.000011059333,0.0024195684],"study_design_scores_gemma":[0.0003003746,0.00013366347,0.00047239565,0.00011075618,0.00000530957,0.000007577346,0.0010656947,0.000070804184,0.99669236,0.0005896739,0.00045021324,0.00010120191],"about_ca_topic_score_codex":0.0014030517,"about_ca_topic_score_gemma":0.0007605566,"teacher_disagreement_score":0.013535778,"about_ca_system_score_codex":0.000032441963,"about_ca_system_score_gemma":0.00009964533,"threshold_uncertainty_score":0.3902801},"labels":[],"label_agreement":null},{"id":"W2146845803","doi":"10.1158/0008-5472.can-12-2609","title":"Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Cancer research; Medicine; Antigen; Immunotherapy; Flow cytometry; Immune system; Pathology; Immunology","score_opus":0.03340807651879335,"score_gpt":0.3086964074338523,"score_spread":0.27528833091505894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146845803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327147,0.0008691568,0.0011429427,0.00097024586,0.00010229125,0.00091584027,0.000053957112,0.00020255413,0.0024715313],"genre_scores_gemma":[0.99509937,0.00013963712,0.0011984146,0.00013780857,0.000082744,0.0011816621,0.000014062184,0.000059949234,0.0020863654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860954,0.00006140838,0.00018925083,0.00022434806,0.00033713854,0.0005783282],"domain_scores_gemma":[0.9987834,0.000425705,0.000011101989,0.00035623967,0.00018083141,0.00024271499],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027222408,0.00013272412,0.00016892535,0.00019514555,0.0001644504,0.00011698792,0.00036040138,0.000038648628,0.0027440733],"category_scores_gemma":[0.00007222817,0.00012635504,0.00005117467,0.0007260358,0.00007811508,0.00013156662,0.000032386313,0.00031566143,0.002224648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032997316,0.000016905067,0.00003975868,0.00003335887,0.00004687085,0.000001622409,0.000589404,0.0033788392,0.96328926,0.00014290282,0.028560704,0.0038970932],"study_design_scores_gemma":[0.00095232425,0.00013343652,0.0065808706,0.00010376246,0.000026724776,0.0000076289557,0.0015462837,0.0021776974,0.831042,0.0014974602,0.15517424,0.00075757114],"about_ca_topic_score_codex":0.0015647457,"about_ca_topic_score_gemma":0.00012601409,"teacher_disagreement_score":0.13224724,"about_ca_system_score_codex":0.00020499706,"about_ca_system_score_gemma":0.00007373403,"threshold_uncertainty_score":0.99855226},"labels":[],"label_agreement":null},{"id":"W2146868090","doi":"10.1158/0008-5472.can-06-1456","title":"Spontaneous Fusion with, and Transformation of Mouse Stroma by, Malignant Human Breast Cancer Epithelium","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Stroma; Biology; Pathology; Cancer; Adenocarcinoma; Cytokeratin; Cancer research; Cancer cell; Epithelium; Mitosis; Malignant transformation; Mycoplasma; Immunology; Medicine; Cell biology; Immunohistochemistry","score_opus":0.029482591298035297,"score_gpt":0.34415747082803266,"score_spread":0.31467487952999734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146868090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352556,0.0029319068,0.000037183643,0.0013482117,0.000028971066,0.0005289623,0.00055948336,0.000017896042,0.001021814],"genre_scores_gemma":[0.99350715,0.002544364,0.000043923457,0.000036008496,0.00014033585,0.000113109876,0.000048033773,0.000028765662,0.0035382907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848545,0.00005529487,0.0002320224,0.0002471345,0.0006162613,0.000363812],"domain_scores_gemma":[0.9992867,0.00002197783,0.000053625336,0.00020298928,0.00030110218,0.00013357695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030701468,0.00012246409,0.0002649359,0.00015703622,0.0001305288,0.000021025871,0.00007275036,0.00006118495,0.00059365993],"category_scores_gemma":[0.0000022164177,0.00009027441,0.000040239767,0.00026142044,0.00021633894,0.000078478595,0.000023732839,0.00022100909,0.0000026200619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011133284,0.00013289334,0.002908503,0.00048348622,0.000044247103,0.00008077097,0.00028763092,0.000019749159,0.968312,0.00016322905,0.0030035095,0.023450617],"study_design_scores_gemma":[0.0055673113,0.0011261256,0.01876044,0.0010126824,0.00017490744,0.0010489217,0.0007166599,0.00005109113,0.95211107,0.00007537283,0.019035254,0.0003201878],"about_ca_topic_score_codex":0.027845897,"about_ca_topic_score_gemma":0.0046399897,"teacher_disagreement_score":0.023205906,"about_ca_system_score_codex":0.00022663047,"about_ca_system_score_gemma":0.00022357106,"threshold_uncertainty_score":0.97862774},"labels":[],"label_agreement":null},{"id":"W2146893766","doi":"10.1158/0008-5472.can-04-3494","title":"Nuclear Factor-κB Induced by Doxorubicin Is Deficient in Phosphorylation and Acetylation and Represses Nuclear Factor-κB–Dependent Transcription in Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research","keywords":"Doxorubicin; Transcription factor; NF-κB; IκBα; Acetylation; Cancer research; IκB kinase; Biology; Anthracycline; Cancer cell; Histone deacetylase; Histone deacetylase inhibitor; Signal transduction; Phosphorylation; Cancer; Histone; Cell biology; Biochemistry; Gene; Breast cancer; Chemotherapy; Genetics","score_opus":0.059764238038616996,"score_gpt":0.34963993182522324,"score_spread":0.28987569378660627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146893766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947941,0.0039799847,0.000013043271,0.00048369737,0.000068944384,0.0004470769,0.00009294255,0.000012123779,0.000108120475],"genre_scores_gemma":[0.99552333,0.003957788,0.00003572068,0.00013215894,0.00008338289,0.000049577597,0.000022731174,0.0000420856,0.00015322224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816066,0.00015715887,0.00026886954,0.00062473974,0.0003797194,0.00040887546],"domain_scores_gemma":[0.99945015,0.000022941147,0.00006152855,0.0002464451,0.00011065104,0.000108311804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003677815,0.00016915028,0.0001725699,0.00015865403,0.00011025228,0.00007958689,0.0001412227,0.00025395915,0.00027107832],"category_scores_gemma":[0.000032668915,0.00017643797,0.000028369519,0.00021706375,0.00009288018,0.000029399658,0.00008868973,0.00036169848,0.000009306607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018849158,0.000064012005,0.0027444493,0.000044342945,0.000011516373,0.0000011864039,0.002223736,0.00022570573,0.9836793,0.00001190074,0.0004290474,0.010376328],"study_design_scores_gemma":[0.00092687184,0.00014641052,0.009523192,0.00007560971,0.0000041754884,8.8630605e-7,0.00034578092,0.00039852108,0.9806586,0.000012436658,0.0077085253,0.00019898723],"about_ca_topic_score_codex":0.0029594803,"about_ca_topic_score_gemma":0.0015561536,"teacher_disagreement_score":0.01017734,"about_ca_system_score_codex":0.00026645974,"about_ca_system_score_gemma":0.00009894537,"threshold_uncertainty_score":0.71949315},"labels":[],"label_agreement":null},{"id":"W2146913091","doi":"10.1158/0008-5472.can-05-1024","title":"Misregulated Wnt/β-Catenin Signaling Leads to Ovarian Granulosa Cell Tumor Development","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Inha University","keywords":"Wnt signaling pathway; Biology; Granulosa cell; Carcinogenesis; Internal medicine; Endocrinology; Ovarian cancer; Cancer research; Ovary; Signal transduction; Cancer; Cell biology; Medicine; Genetics","score_opus":0.04022363763526633,"score_gpt":0.33994367088130584,"score_spread":0.2997200332460395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146913091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411285,0.0018718756,0.00038407076,0.0011421297,0.00019501097,0.0004936246,0.000011045947,0.000043414842,0.0017459863],"genre_scores_gemma":[0.979315,0.00009519691,0.004629289,0.0006327938,0.00088757975,0.000450531,0.00009559262,0.00007535662,0.013818688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968835,0.00014727612,0.00041849245,0.0008052398,0.00072443584,0.0010210171],"domain_scores_gemma":[0.9986821,0.000026877658,0.00006814537,0.00033858363,0.00051448797,0.00036985194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011421954,0.0002915111,0.00023991078,0.00023720603,0.000393295,0.00010601911,0.0006713473,0.00017671614,0.0006876974],"category_scores_gemma":[0.000058695576,0.0002853267,0.00008470677,0.00058749964,0.00013219942,0.0000106436155,0.00032616584,0.00034338655,0.00040185888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025679538,0.00006619915,0.0010098612,0.00004131447,0.000048514947,0.000009529219,0.00042470594,0.0009459242,0.97051233,0.000018213866,0.021061914,0.005604677],"study_design_scores_gemma":[0.0006146379,0.000089009096,0.0005620726,0.000063210515,0.0000068378713,0.0000041094167,0.000063879575,0.000012947103,0.8249817,0.000018094346,0.17322867,0.0003548223],"about_ca_topic_score_codex":0.0000771387,"about_ca_topic_score_gemma":0.00013293867,"teacher_disagreement_score":0.15216675,"about_ca_system_score_codex":0.0002727891,"about_ca_system_score_gemma":0.0010238499,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2146922701","doi":"10.1158/0008-5472.can-06-1820","title":"Synuclein-γ Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule Drugs","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Queen's University","funders":"","keywords":"Synuclein; Cancer research; Biology; Chemistry; Medicine; Alpha-synuclein; Pathology; Parkinson's disease","score_opus":0.018086141168554115,"score_gpt":0.33081358350248685,"score_spread":0.31272744233393274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146922701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657017,0.00088932,0.0007132142,0.00037594527,0.00027370988,0.0004061822,0.00026854192,0.000011464165,0.00049145106],"genre_scores_gemma":[0.9959766,0.0013665424,0.00041753752,0.00023104232,0.0006959081,0.000042393076,0.000026149866,0.000044546116,0.0011992605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786025,0.0001664084,0.0002665358,0.0005398638,0.00041244194,0.0007544849],"domain_scores_gemma":[0.99876016,0.00006942389,0.00008617144,0.00036606553,0.0005032744,0.0002148898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019797503,0.00018462537,0.00023876532,0.00014448471,0.0001650027,0.000034434215,0.00025594278,0.00017049584,0.000121168094],"category_scores_gemma":[0.00004986518,0.00017950361,0.00010615996,0.0003177375,0.00020767466,0.000009476087,0.00034826397,0.0002695179,0.000026570855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002581704,0.00006272791,0.002284323,0.00009299465,0.000049230763,0.000007696561,0.0002634021,0.000058736223,0.9767917,0.000005958892,0.017116332,0.0030087272],"study_design_scores_gemma":[0.00023387723,0.00007169102,0.0018531025,0.000119101016,0.000008651751,0.0000048341954,0.00042331417,0.000014063951,0.9814144,0.0000035254411,0.015645508,0.0002079558],"about_ca_topic_score_codex":0.0020376889,"about_ca_topic_score_gemma":0.0013032206,"teacher_disagreement_score":0.004622677,"about_ca_system_score_codex":0.000108317625,"about_ca_system_score_gemma":0.00027220964,"threshold_uncertainty_score":0.73199445},"labels":[],"label_agreement":null},{"id":"W2146940336","doi":"10.1158/0008-5472.can-06-3436","title":"p53-Independent Abrogation of a Postmitotic Checkpoint Contributes to Human Papillomavirus <i>E6</i> -Induced Polyploidy","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Carcinogenesis; Mitosis; Biology; Cell biology; Cancer research; Cell cycle checkpoint; Aneuploidy; Mutation; Cell cycle; Genetics; Cancer; Chromosome; Gene","score_opus":0.07806482042190938,"score_gpt":0.4285574770758191,"score_spread":0.3504926566539097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146940336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068266,0.0019730132,0.0005937614,0.0016308702,0.00030992416,0.0017224421,0.000027721164,0.00007262519,0.002986972],"genre_scores_gemma":[0.9981294,0.000087156695,0.00009891711,0.00038675842,0.00028031075,0.000149474,0.000024836356,0.000065907465,0.00077722874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99636,0.00012387581,0.0006080819,0.0005328419,0.0014614024,0.0009138236],"domain_scores_gemma":[0.9974493,0.00014491819,0.00011499798,0.0006749477,0.001146645,0.00046922933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022113032,0.00020613745,0.0004610954,0.0007682137,0.00018702204,0.00003190581,0.00026593168,0.00023769824,0.00021895044],"category_scores_gemma":[0.0004752974,0.00020017725,0.00015652769,0.0014231028,0.0001515957,0.00006307387,0.00018229411,0.00084723823,0.00011233647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008315276,0.00020047592,0.001566242,0.00013228782,0.0001416171,0.00012699395,0.00045176296,0.00001616201,0.98800135,0.0007418452,0.0010312969,0.006758464],"study_design_scores_gemma":[0.002940872,0.000975482,0.03199124,0.00049655634,0.000061548475,0.000020918253,0.00033956303,0.00001230783,0.9597044,0.00021427096,0.0030740034,0.00016883164],"about_ca_topic_score_codex":0.003266733,"about_ca_topic_score_gemma":0.0012630371,"teacher_disagreement_score":0.030424997,"about_ca_system_score_codex":0.001476365,"about_ca_system_score_gemma":0.0006962472,"threshold_uncertainty_score":0.81629914},"labels":[],"label_agreement":null},{"id":"W2147025483","doi":"10.1158/0008-5472.can-05-0650","title":"CaSm-Mediated Cellular Transformation Is Associated with Altered Gene Expression and Messenger RNA Stability","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Biology; DU145; Cancer research; Antisense RNA; Gene expression; Cell growth; Cancer cell; Molecular biology; Cancer; Gene; Cell biology; Genetics; LNCaP","score_opus":0.04153764609790749,"score_gpt":0.3385311350651063,"score_spread":0.2969934889671988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147025483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966184,0.0015637324,0.00021053794,0.0008348434,0.000015855716,0.00036693393,0.000067418936,0.000011339837,0.00031094247],"genre_scores_gemma":[0.997682,0.0009981927,0.00007794129,0.000078128076,0.00015403569,0.0000974976,0.00014475666,0.000020791678,0.0007466981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982809,0.00022730001,0.00015879486,0.0003481829,0.00049885735,0.0004859608],"domain_scores_gemma":[0.9991177,0.00004225142,0.000032250027,0.00027085404,0.00033128433,0.00020570843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008685041,0.00011438625,0.00012954522,0.000072656134,0.00020493107,0.00005090732,0.00014691765,0.00013459251,0.00021407209],"category_scores_gemma":[0.00012758333,0.000090205496,0.00002975692,0.00018926869,0.00016446733,0.00001794296,0.00006761262,0.00027549808,0.000007280474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026513936,0.000043610205,0.00070066785,0.000026833817,0.000033555818,0.0000029922194,0.0003583073,0.000010871941,0.9955924,0.0000020902362,0.0013416734,0.001621844],"study_design_scores_gemma":[0.0009809246,0.00020190631,0.0011019795,0.000038659568,0.000003967389,0.0000016566762,0.00014314447,0.0003970058,0.99323577,0.0000058529868,0.003772098,0.00011706637],"about_ca_topic_score_codex":0.00014923768,"about_ca_topic_score_gemma":0.00029859878,"teacher_disagreement_score":0.0024304248,"about_ca_system_score_codex":0.000095736155,"about_ca_system_score_gemma":0.00020004889,"threshold_uncertainty_score":0.36784732},"labels":[],"label_agreement":null},{"id":"W2147138391","doi":"10.1158/0008-5472.can-10-2379","title":"Effect of Maternal and Postweaning Folic Acid Supplementation on Mammary Tumor Risk in the Offspring","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Offspring; Folic acid; Pregnancy; Physiology; Biology; Medicine; Internal medicine; Genetics","score_opus":0.039200168608787146,"score_gpt":0.42475197466135084,"score_spread":0.3855518060525637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147138391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722266,0.0001339944,0.0000043779605,0.0009767306,0.00007028782,0.00049986615,0.0000069091125,0.000005607033,0.0010795661],"genre_scores_gemma":[0.9951356,0.004395511,0.00011216077,0.000141705,0.00010378573,0.00008505769,0.0000037851673,0.000008663291,0.0000137243715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988852,0.00021166539,0.00013681348,0.00013992786,0.00037897198,0.00024743492],"domain_scores_gemma":[0.999531,0.00017178494,0.00003740552,0.0001500552,0.000047922404,0.00006185639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024812852,0.00005727543,0.00012171018,0.00016557497,0.00009129973,0.000018314255,0.00009476552,0.000028731836,0.00007804528],"category_scores_gemma":[0.000098335935,0.000036879843,0.000013942969,0.00015859542,0.000055987,0.000040147974,0.000040428633,0.00062351004,0.0000052818027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007132095,0.000023562428,0.84682786,0.000633272,0.000015839758,0.000036317175,0.0017419388,3.1483458e-7,0.106373906,0.0032957557,0.00030997788,0.040028058],"study_design_scores_gemma":[0.0014640202,0.00059848645,0.77584976,0.00019311291,0.0000059291683,0.000015614096,0.0001092814,0.000034503333,0.22113444,0.00039301574,0.0001676503,0.000034168566],"about_ca_topic_score_codex":0.0016642475,"about_ca_topic_score_gemma":0.00073996745,"teacher_disagreement_score":0.114760526,"about_ca_system_score_codex":0.000060722963,"about_ca_system_score_gemma":0.00017398682,"threshold_uncertainty_score":0.27088755},"labels":[],"label_agreement":null},{"id":"W2147467790","doi":"10.1158/0008-5472.can-10-3973","title":"A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Foundation; Terry Fox Foundation","keywords":"Endocrinology; Internal medicine; Cancer; Biology; Immune system; Medicine; Immunology","score_opus":0.08934013441595273,"score_gpt":0.37332424812558934,"score_spread":0.2839841137096366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147467790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925346,0.003327444,0.0000024046706,0.0005341071,0.00021730467,0.0011212598,0.000031036994,0.000034700603,0.0054782736],"genre_scores_gemma":[0.99386597,0.0022782208,0.00010322296,0.0001314482,0.00039486465,0.0019654287,0.000005862629,0.000029302815,0.0012256713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984911,0.00009946582,0.00017149553,0.00031430158,0.0004682905,0.00045533077],"domain_scores_gemma":[0.9992417,0.000024883906,0.00004303168,0.00018464505,0.00032336303,0.00018238148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035100256,0.00013002449,0.00027206243,0.0001734316,0.00014729628,0.00001963777,0.000093351235,0.000051599876,0.00029859337],"category_scores_gemma":[0.00014969008,0.00010323102,0.000034303826,0.00038159807,0.00019837762,0.00012868166,0.00012960067,0.0003112881,0.000015403366],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048924778,0.0008655553,0.07465116,0.0032006926,0.00063779,0.00026392937,0.012879057,5.1696503e-7,0.87373203,0.0036552553,0.008843904,0.016377611],"study_design_scores_gemma":[0.0037198795,0.0010891076,0.76537144,0.0014028868,0.00014801897,0.000001149473,0.0005866713,0.0000135110795,0.22102256,0.0025778594,0.0036942319,0.00037266893],"about_ca_topic_score_codex":0.0049625514,"about_ca_topic_score_gemma":0.00033090706,"teacher_disagreement_score":0.6907203,"about_ca_system_score_codex":0.00008957578,"about_ca_system_score_gemma":0.00031821357,"threshold_uncertainty_score":0.7501926},"labels":[],"label_agreement":null},{"id":"W2147517893","doi":"10.1158/0008-5472.can-05-2664","title":"DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Scheme for Promotion of Academic and Research Collaboration","keywords":"Pancreatic cancer; Pancreatitis; Pancreatic juice; Methylation; DNA methylation; Gastroenterology; Medicine; Pancreatic disease; Internal medicine; KRAS; Pancreatic Intraepithelial Neoplasia; Pancreas; Adenocarcinoma; Cancer research; Cancer; Pathology; Biology; Gene; Pancreatic ductal adenocarcinoma; Colorectal cancer; Gene expression; Biochemistry","score_opus":0.04919570516489161,"score_gpt":0.39751134732806037,"score_spread":0.3483156421631688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147517893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908772,0.0006273668,0.00008767532,0.00175618,0.000018286462,0.0016748704,0.000041349875,0.000015556856,0.004901513],"genre_scores_gemma":[0.9973933,0.000112927824,0.00017259059,0.00006466016,0.00013320635,0.0006634188,0.00016052603,0.000020659847,0.0012786754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969872,0.0006637076,0.00036546937,0.00028972304,0.0012059124,0.000487972],"domain_scores_gemma":[0.9975448,0.0009973581,0.000073432864,0.0004982069,0.0007515621,0.00013460942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011633735,0.00012988753,0.0003897751,0.00037191145,0.00017756449,0.000028321743,0.00019894342,0.00006478237,0.00039202522],"category_scores_gemma":[0.0004976756,0.00007887582,0.000047192676,0.0012883007,0.00041420566,0.00010228297,0.000037994796,0.00044091904,0.000016834334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015998901,0.00066911353,0.99263793,0.00021916427,0.00006219897,0.000035952737,0.0004789012,0.0000319299,0.0011870093,0.0015757795,0.001160792,0.0003413601],"study_design_scores_gemma":[0.0025028784,0.00040594573,0.99442166,0.0002306419,0.00015023994,0.000001307375,0.00025645812,0.00035932614,0.00040007324,0.00088350795,0.00030744914,0.00008048414],"about_ca_topic_score_codex":0.0027110942,"about_ca_topic_score_gemma":0.000908083,"teacher_disagreement_score":0.0065161334,"about_ca_system_score_codex":0.00032259416,"about_ca_system_score_gemma":0.000972895,"threshold_uncertainty_score":0.42924014},"labels":[],"label_agreement":null},{"id":"W2147520687","doi":"10.1158/0008-5472.can-06-0149","title":"<i>p27Kip1</i> Repression of ErbB2-Induced Mammary Tumor Growth in Transgenic Mice Involves Skp2 and Wnt/β-Catenin Signaling","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute on Aging","keywords":"Biology; Wnt signaling pathway; Cancer research; Haploinsufficiency; Carcinogenesis; SKP2; Tumor suppressor gene; Oncogene; Mammary tumor; Loss of heterozygosity; Ubiquitin ligase; Signal transduction; Cell cycle; Cancer; Cell biology; Ubiquitin; Breast cancer; Genetics; Gene; Phenotype","score_opus":0.054697625134720526,"score_gpt":0.34903586479098037,"score_spread":0.2943382396562598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147520687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692155,0.009965617,0.00007338158,0.00096330344,0.00010494738,0.00074156193,0.00001413818,0.000040761297,0.0011747436],"genre_scores_gemma":[0.9981181,0.0008391,0.00028076285,0.0000868701,0.00019139607,0.00015849883,0.000018804538,0.00005229248,0.00025416957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997354,0.00024012485,0.00047054683,0.0005888143,0.00076654577,0.0005799893],"domain_scores_gemma":[0.9989534,0.00014830608,0.00008491441,0.00030269157,0.00033793054,0.00017275037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009862802,0.00018571212,0.00041873855,0.0005203814,0.00008414813,0.000025199439,0.00021468262,0.00016590624,0.00005273971],"category_scores_gemma":[0.00013283604,0.00017541007,0.00009112143,0.0010079478,0.00019245454,0.00012611691,0.00011671178,0.0008539953,0.0000054452416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232258,0.000117711854,0.002823883,0.0004916976,0.000031422012,0.00012547297,0.00038303237,0.000042089716,0.99313366,0.00021940793,0.0007190262,0.0013893811],"study_design_scores_gemma":[0.0027064742,0.00024809464,0.00600053,0.0011966598,0.000031386055,0.000032199292,0.00014070787,0.00014073953,0.98839617,0.0007271959,0.00021093892,0.0001688852],"about_ca_topic_score_codex":0.0064224,"about_ca_topic_score_gemma":0.0004594833,"teacher_disagreement_score":0.01119656,"about_ca_system_score_codex":0.00030035595,"about_ca_system_score_gemma":0.00065037096,"threshold_uncertainty_score":0.9708791},"labels":[],"label_agreement":null},{"id":"W2147583733","doi":"10.1158/0008-5472.can-09-2141","title":"Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; McGill University","keywords":"Endocrinology; Internal medicine; Insulin receptor; Protein kinase B; Type 2 diabetes; Breast cancer; Biology; Insulin; Carcinogenesis; Insulin-like growth factor; Cancer; Cancer research; Diabetes mellitus; Phosphorylation; Medicine; Growth factor; Receptor; Insulin resistance; Cell biology","score_opus":0.04235556865629729,"score_gpt":0.36965099461093737,"score_spread":0.32729542595464006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147583733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95633227,0.04321894,0.0000037467812,0.000040207728,0.00008901163,0.00021148374,0.000051238247,0.0000023146774,0.000050777275],"genre_scores_gemma":[0.9757387,0.023598678,0.00026882847,0.000026059995,0.00009687453,0.0001818965,0.000033597367,0.000014036841,0.000041303614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901605,0.000048823153,0.0002094751,0.00023403812,0.0002408173,0.00025077967],"domain_scores_gemma":[0.99924856,0.00001373833,0.000062021165,0.00017253745,0.00043017408,0.000072937975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004537681,0.000085377294,0.00015726202,0.00010603961,0.000035643432,0.000010019456,0.00013842274,0.00013119889,0.00005702983],"category_scores_gemma":[0.0000694742,0.00007295905,0.000016056596,0.0002277206,0.00015473843,0.000007999455,0.00010944529,0.00019183915,7.464112e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120616554,0.00005912607,0.021610469,0.0001046478,0.000016637483,1.177684e-7,0.00019242885,0.0000788207,0.8311734,0.000014268254,0.00014010683,0.14648934],"study_design_scores_gemma":[0.0006544929,0.00005649068,0.02073386,0.00009614719,0.000004118804,1.4409467e-7,0.00003203103,0.001432879,0.9718312,0.000037383707,0.0050156475,0.00010563001],"about_ca_topic_score_codex":0.00010052356,"about_ca_topic_score_gemma":0.00071193505,"teacher_disagreement_score":0.1463837,"about_ca_system_score_codex":0.000020827343,"about_ca_system_score_gemma":0.0007091146,"threshold_uncertainty_score":0.29751837},"labels":[],"label_agreement":null},{"id":"W2147651272","doi":"10.1158/0008-5472.can-03-3880","title":"A Mouse Mammary Tumor Virus-Like Long Terminal Repeat Superantigen in Human Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Mouse mammary tumor virus; Long terminal repeat; Biology; Superantigen; Gene; Carcinogenesis; Retrovirus; Molecular biology; Cancer research; Virology; T cell; Immune system; Immunology; Genetics; Gene expression","score_opus":0.06369984540883535,"score_gpt":0.4163930012827816,"score_spread":0.3526931558739463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147651272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702514,0.0030247478,0.0000069407165,0.007108749,0.00010323417,0.0007743518,0.00017578987,0.000052139363,0.001728883],"genre_scores_gemma":[0.9764902,0.0026451582,0.00008355844,0.00069977413,0.00075254345,0.00050166366,0.000046309942,0.00006483934,0.01871594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958497,0.0001816602,0.00041643187,0.00071834296,0.0015090059,0.0013248498],"domain_scores_gemma":[0.9983293,0.00007137255,0.00003591807,0.0005864204,0.00044073412,0.00053628837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008859761,0.00026246105,0.00047128668,0.0006486235,0.00035252635,0.00009505194,0.0005171304,0.00012381103,0.0021665373],"category_scores_gemma":[0.00003708303,0.00021694141,0.00014996616,0.0009167883,0.00049727777,0.00023759234,0.00037478723,0.0014063836,0.00013043835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031960746,0.00089961966,0.27405056,0.0011653056,0.00019311596,0.0111989565,0.0012901464,0.00007702719,0.683141,0.0008467137,0.0074869534,0.016454555],"study_design_scores_gemma":[0.008432396,0.0009103666,0.7504828,0.0023937358,0.00004138943,0.0018486625,0.00037003797,0.00008346205,0.2103813,0.00073924253,0.023431418,0.00088521815],"about_ca_topic_score_codex":0.05381077,"about_ca_topic_score_gemma":0.013282101,"teacher_disagreement_score":0.4764322,"about_ca_system_score_codex":0.0009867691,"about_ca_system_score_gemma":0.0014865343,"threshold_uncertainty_score":0.9987456},"labels":[],"label_agreement":null},{"id":"W2148231922","doi":"10.1158/1538-7445.sabcs14-p3-02-02","title":"Abstract P3-02-02: Impact of breast density notification laws on radiology practices: A survey of 110 radiology facilities","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast density; Medicine; Breast imaging; Breast cancer; Mandate; Modalities; Risk assessment; Family medicine; Exact test; Test (biology); Mammography; Radiology; Law; Surgery; Cancer; Internal medicine; Political science; Management","score_opus":0.2649883974362561,"score_gpt":0.47487390541557206,"score_spread":0.209885507979316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148231922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930849,0.000718717,0.000019383044,0.0005234819,0.00011367946,0.000387255,0.0005832478,0.000021245807,0.0045481063],"genre_scores_gemma":[0.99920774,0.00015070656,0.000026741487,0.000021152324,0.00011011898,0.000029248738,0.00013382592,0.00001711569,0.0003033786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766034,0.0005229151,0.00039953436,0.00036403295,0.0005697829,0.000483413],"domain_scores_gemma":[0.99624234,0.0010424341,0.0003221788,0.00052948145,0.0015767289,0.00028681898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033058922,0.00015756868,0.0005391136,0.0004911058,0.00005026412,0.000021313577,0.00022986486,0.00013963648,0.00013325161],"category_scores_gemma":[0.0021290656,0.00012242622,0.00015511224,0.00070013694,0.0008845054,0.00023404419,0.00005039928,0.00053208706,0.000024401052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013204016,0.0008247514,0.89875346,0.00052475283,0.0006483001,0.00006019312,0.001458047,0.00012934672,0.04041409,0.0004244963,0.0109032085,0.03265535],"study_design_scores_gemma":[0.001147044,0.0012041068,0.99207455,0.00013612714,0.000021689975,0.00037860547,0.00043487764,0.000060204464,0.004012958,0.0001927514,0.0002305756,0.00010648882],"about_ca_topic_score_codex":0.031015446,"about_ca_topic_score_gemma":0.00059788977,"teacher_disagreement_score":0.09332113,"about_ca_system_score_codex":0.00030797592,"about_ca_system_score_gemma":0.0013034563,"threshold_uncertainty_score":0.9754371},"labels":[],"label_agreement":null},{"id":"W2148232451","doi":"10.1158/0008-5472.can-11-3985","title":"FGFR2 Isoforms Support Epithelial–Stromal Interactions in Thyroid Cancer Progression","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Fibroblast growth factor receptor 2; Cancer research; Tumor progression; Fibroblast growth factor receptor; Fibroblast growth factor; Thyroid cancer; Cancer cell; Metastasis; Cancer; Biology; Endocrinology; Internal medicine; Receptor; Thyroid; Medicine","score_opus":0.06512220998217905,"score_gpt":0.45561863772796646,"score_spread":0.3904964277457874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148232451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943795,0.00180888,0.000019184388,0.0006851184,0.00035355196,0.00052653276,0.00008716643,0.000016204132,0.002123867],"genre_scores_gemma":[0.99317515,0.00086958497,0.000104072715,0.000054473745,0.000993748,0.00075556943,0.000075270196,0.00005302744,0.003919087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971385,0.00023236191,0.0002532197,0.00042862992,0.00065268186,0.00129461],"domain_scores_gemma":[0.99889076,0.000041928404,0.0000473066,0.00044002698,0.00025311776,0.0003268702],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010256923,0.00017476069,0.00016630598,0.00027305726,0.0001793379,0.000053716118,0.00042845786,0.00013489471,0.0011397141],"category_scores_gemma":[0.00016896534,0.0001471841,0.00007842784,0.00046351738,0.00025196516,0.000037236325,0.0004694312,0.00072742405,0.00015859315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030613324,0.00014580043,0.11902751,0.000051603736,0.000026856795,0.000004300688,0.0002340516,0.000009474255,0.8641677,0.000035237263,0.0076927287,0.008298629],"study_design_scores_gemma":[0.000714576,0.00035588775,0.073676966,0.000111884874,0.00000371793,0.0000116678075,0.0002369539,0.000014543261,0.82701397,0.000027688187,0.09759976,0.00023237547],"about_ca_topic_score_codex":0.0009667332,"about_ca_topic_score_gemma":0.0007886536,"teacher_disagreement_score":0.08990703,"about_ca_system_score_codex":0.00029373667,"about_ca_system_score_gemma":0.00054212566,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W2148351004","doi":"10.1158/0008-5472.can-04-1117","title":"α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β <b> <i>In vivo</i> </b>, Inhibits Intestinal Tumor Progression","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Endocrinology; In vivo; Internal medicine; Transforming growth factor; Tumor progression; Immune system; Transforming growth factor beta; Carcinogenesis; Cancer research; Biology; Receptor; Chemistry; Cancer; Immunology; Medicine","score_opus":0.037399479811842794,"score_gpt":0.3797336251132898,"score_spread":0.342334145301447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148351004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744594,0.0014387579,0.00018392365,0.000093087576,0.00004524218,0.0005071002,0.000065659224,0.000016252783,0.00020400807],"genre_scores_gemma":[0.99888605,0.00006753126,0.0005185333,0.00003391315,0.00017741615,0.00020348185,0.000028052134,0.00003686674,0.000048177037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982293,0.000106361396,0.0002790498,0.00043792138,0.00046651188,0.0004808596],"domain_scores_gemma":[0.9991532,0.000017121016,0.00005928496,0.00028332823,0.00030786585,0.00017922181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036077644,0.00015167953,0.00016573408,0.00013449008,0.00011639784,0.000032203483,0.00035067825,0.000093066665,0.00005471308],"category_scores_gemma":[0.00017676168,0.00013919466,0.00005727534,0.00029580455,0.0002908897,0.000014878699,0.00009705047,0.00026057684,0.000003186698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043506734,0.00023296318,0.005947328,0.00019304449,0.00000886162,0.00002478634,0.00017017235,0.000057303067,0.9905862,0.00005445157,0.000043441443,0.002246339],"study_design_scores_gemma":[0.00095371477,0.00059968274,0.0009068914,0.00044997965,0.000003385492,0.00000997947,0.000102056074,0.000004359949,0.99584824,0.00012971967,0.000833606,0.00015839151],"about_ca_topic_score_codex":0.00044272438,"about_ca_topic_score_gemma":0.00034773987,"teacher_disagreement_score":0.0052619916,"about_ca_system_score_codex":0.000096631884,"about_ca_system_score_gemma":0.0008217515,"threshold_uncertainty_score":0.5676194},"labels":[],"label_agreement":null},{"id":"W2148435735","doi":"10.1158/0008-5472.can-11-1446","title":"SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor α in Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Christie (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Estrogen receptor; Cancer research; Breast cancer; Cancer; Fulvestrant; Cancer cell; Tamoxifen; Estrogen receptor alpha; Estrogen; Biology; Sirtuin 1; Metastasis; Internal medicine; Medicine; Endocrinology; Downregulation and upregulation; Gene; Biochemistry","score_opus":0.09521057831256746,"score_gpt":0.42397164788901276,"score_spread":0.3287610695764453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148435735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349285,0.010715546,0.000028598408,0.0036252073,0.0004047712,0.0011680212,0.00021976852,0.0000232753,0.00032194142],"genre_scores_gemma":[0.99167675,0.003206672,0.0003026472,0.00058341044,0.001271725,0.0012133667,0.000040774106,0.000074499825,0.0016301431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972466,0.00010938721,0.00042236212,0.0005598336,0.0007129385,0.0009488494],"domain_scores_gemma":[0.9988033,0.00011452543,0.000057715173,0.00033482473,0.0003628672,0.0003267441],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010342684,0.00019977381,0.00045203706,0.00037268945,0.00010003291,0.000018356925,0.00025920934,0.00019821608,0.0048089754],"category_scores_gemma":[0.0000690416,0.00016390237,0.00012864762,0.0007334238,0.00024752846,0.000081648584,0.00006937572,0.00072873436,0.00002837432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004018322,0.0005402878,0.12759167,0.0003906675,0.00021646963,0.00011313115,0.0022429836,0.0000128763595,0.78243047,0.00012503765,0.06249479,0.0198233],"study_design_scores_gemma":[0.020140808,0.0014290657,0.010529901,0.002619409,0.00019480656,0.00007397713,0.0030354906,0.0008668095,0.8963348,0.00032342973,0.0636678,0.0007837016],"about_ca_topic_score_codex":0.006750208,"about_ca_topic_score_gemma":0.0002080156,"teacher_disagreement_score":0.117061764,"about_ca_system_score_codex":0.0006083213,"about_ca_system_score_gemma":0.00095663976,"threshold_uncertainty_score":0.9998639},"labels":[],"label_agreement":null},{"id":"W2148601288","doi":"10.1158/0008-5472.can-05-2057","title":"SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)–Dependent Tyrosine Phosphorylation of β-Catenin and Its Nuclear Signaling","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase; Cancer research; Tyrosine phosphorylation; Cell biology; Kinase; Biology; Chemistry; Molecular biology; Signal transduction","score_opus":0.017646534354995018,"score_gpt":0.29646378428094766,"score_spread":0.27881724992595264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148601288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133117,0.01800285,0.000023399816,0.000054477452,0.000059110138,0.00028656496,0.00009662988,0.0000068410145,0.00013894311],"genre_scores_gemma":[0.9965339,0.0027336497,0.0001523129,0.000010470764,0.000091337846,0.00006157813,0.000047463003,0.000027468028,0.00034184838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984887,0.000110003566,0.00031669313,0.00040650554,0.00036273812,0.00031535217],"domain_scores_gemma":[0.99926144,0.000045872777,0.0001411235,0.00009845438,0.00037242493,0.00008066632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005435198,0.0001458077,0.00021444606,0.000066603,0.00012210953,0.000029918567,0.00015193512,0.00013469192,0.000103930506],"category_scores_gemma":[0.00005676285,0.00014333043,0.000041555148,0.00017758239,0.00021593648,0.000013169326,0.00017269219,0.00014846948,5.5737013e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002567317,0.000062521656,0.01728851,0.00021003067,0.000050718874,7.448919e-7,0.000086890635,0.00007816265,0.9803968,0.000033191573,0.00092133984,0.00061435014],"study_design_scores_gemma":[0.0005591796,0.00011795553,0.0060395594,0.0001163663,0.000021457203,0.0000011238452,0.000066439236,0.00011437251,0.9925347,0.00008107755,0.00021560854,0.00013215067],"about_ca_topic_score_codex":0.0018225181,"about_ca_topic_score_gemma":0.00008068894,"teacher_disagreement_score":0.015269198,"about_ca_system_score_codex":0.000044384793,"about_ca_system_score_gemma":0.00018606297,"threshold_uncertainty_score":0.5844845},"labels":[],"label_agreement":null},{"id":"W2148733940","doi":"10.1158/0008-5472.can-03-0675","title":"A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); University of Calgary","funders":"","keywords":"Cell growth; Wortmannin; Cancer research; Breast cancer; Biology; CD36; Cancer cell; Cancer; Endocrinology; Internal medicine; Scavenger receptor; Receptor; Protein kinase B; Signal transduction; Lipoprotein; Cell biology; Cholesterol; Medicine; Biochemistry","score_opus":0.025266298820654332,"score_gpt":0.3348107858434775,"score_spread":0.30954448702282317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148733940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949179,0.0015357245,0.000057856105,0.0007373848,0.0017217163,0.00063869386,0.00026785722,0.000012656656,0.00011017636],"genre_scores_gemma":[0.9859184,0.0019684213,0.00008261599,0.00009055923,0.010662901,0.00036169676,0.00005667615,0.000035708643,0.00082299346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822056,0.000117303476,0.00026264417,0.00047286932,0.00047527332,0.00045134308],"domain_scores_gemma":[0.99870044,0.0000055778623,0.000087438726,0.00040649602,0.00064523495,0.00015482091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047505583,0.00015719724,0.00023258766,0.000104686165,0.00018922552,0.00003191637,0.00023038943,0.00018196192,0.00019878306],"category_scores_gemma":[0.000029053235,0.00014824346,0.0000803946,0.00027412042,0.0002453698,0.000009831761,0.00014936159,0.0002641442,0.000013807994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027410474,0.00009405409,0.0001455306,0.000087666864,0.000040837112,1.651107e-7,0.00017751851,0.000115653434,0.9866652,0.0002452443,0.0065145,0.0056395414],"study_design_scores_gemma":[0.0011399363,0.0001742122,0.002048798,0.00010518527,0.000010810673,0.0000034023888,0.000056895744,9.703363e-7,0.9737785,0.00016177964,0.022352964,0.00016653845],"about_ca_topic_score_codex":0.013982858,"about_ca_topic_score_gemma":0.0061090435,"teacher_disagreement_score":0.015838465,"about_ca_system_score_codex":0.00017144295,"about_ca_system_score_gemma":0.00083514105,"threshold_uncertainty_score":0.9925831},"labels":[],"label_agreement":null},{"id":"W2148790437","doi":"10.1158/0008-5472.can-06-1787","title":"Repression of Prostaglandin Dehydrogenase by Epidermal Growth Factor and Snail Increases Prostaglandin E2 and Promotes Cancer Progression","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Public Health Service; Universität Hamburg; Universitat Pompeu Fabra; National Cancer Institute; National Institutes of Health; Vanderbilt University","keywords":"Cancer research; Snail; Biology; Colorectal cancer; Prostaglandin E; Transcription factor; Cancer; Epidermal growth factor; Epidermal growth factor receptor; Angiogenesis; Prostaglandin E2; Endocrinology; Receptor; Biochemistry","score_opus":0.02939243687553913,"score_gpt":0.3692024232116017,"score_spread":0.3398099863360626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148790437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803251,0.016958758,0.0000029892944,0.0005368825,0.000052210355,0.001804296,0.00018740115,0.000041447696,0.000090920104],"genre_scores_gemma":[0.9968649,0.0015160409,0.000052597326,0.000026185478,0.0003052307,0.00065180706,0.000061717066,0.000041885585,0.0004796124],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756587,0.00026069273,0.0003441629,0.00051726046,0.0007393762,0.0005726319],"domain_scores_gemma":[0.99874234,0.00023475024,0.00012937016,0.0002441955,0.00031954638,0.00032976654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007777527,0.00021949325,0.00043165174,0.00021699513,0.00021849871,0.00004021363,0.00007990665,0.00016925356,0.00012673349],"category_scores_gemma":[0.00034420213,0.00015234383,0.00005055042,0.0002954253,0.00045654216,0.00015338091,0.00014498914,0.00039343646,0.0000018430434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009970895,0.00017822355,0.6014388,0.0016316244,0.000035110137,0.000074322175,0.00024836717,3.2057034e-7,0.3845306,0.000028707134,0.005348938,0.005487881],"study_design_scores_gemma":[0.0030962771,0.00067552255,0.11065375,0.0017875339,0.00004629493,0.000036506204,0.00005081069,0.00017157594,0.8814774,0.00011551814,0.001669613,0.00021915241],"about_ca_topic_score_codex":0.004408377,"about_ca_topic_score_gemma":0.00017304346,"teacher_disagreement_score":0.49694684,"about_ca_system_score_codex":0.00013050764,"about_ca_system_score_gemma":0.00034477861,"threshold_uncertainty_score":0.6664177},"labels":[],"label_agreement":null},{"id":"W2148894060","doi":"10.1158/0008-5472.can-08-3232","title":"Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Wnt signaling pathway; Colorectal cancer; Cancer research; Tumor progression; Mouse model of colorectal and intestinal cancer; Tumor M2-PK; Cancer; Biology; Receptor tyrosine kinase; Medicine; Signal transduction; Internal medicine; Cell biology","score_opus":0.16528780703437215,"score_gpt":0.47515695539825975,"score_spread":0.30986914836388757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148894060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979018,0.00077484915,0.0000032247176,0.0005457268,0.0000809864,0.00044419616,0.000011184832,0.000014865265,0.00022314837],"genre_scores_gemma":[0.9981939,0.0014063272,0.0000039547726,0.00005288411,0.00012453977,0.00015439911,0.0000010300831,0.0000086419595,0.000054298736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984774,0.00016969582,0.00018815449,0.00037018923,0.0004894623,0.0003051244],"domain_scores_gemma":[0.9996024,0.00008461082,0.00006730435,0.00008462813,0.000094287396,0.000066779154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002955456,0.00007911615,0.00011850841,0.00017820353,0.00010936799,0.00002372073,0.0001493626,0.00007171721,0.000113659844],"category_scores_gemma":[0.00013233107,0.00006959573,0.000018534525,0.00056815776,0.00008902761,0.00023152136,0.00005920131,0.00033223195,0.0000034846769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026412305,0.00005649215,0.0016584715,0.000022951981,8.8782554e-7,0.0000016399482,0.00019260691,0.000025540225,0.9678878,0.0005306634,0.000093068855,0.02926571],"study_design_scores_gemma":[0.00035784242,0.00018096612,0.07740822,0.00011528931,0.0000016808523,0.0000018801813,0.00001253818,0.00023330686,0.9209676,0.0004235548,0.00023311238,0.00006401274],"about_ca_topic_score_codex":0.00013219495,"about_ca_topic_score_gemma":0.000050379498,"teacher_disagreement_score":0.07574975,"about_ca_system_score_codex":0.00011930827,"about_ca_system_score_gemma":0.00014366419,"threshold_uncertainty_score":0.28380314},"labels":[],"label_agreement":null},{"id":"W2148998706","doi":"10.1158/0008-5472.can-09-0786","title":"The <i>CHRNA5-CHRNA3-CHRNB4</i> Nicotinic Receptor Subunit Gene Cluster Affects Risk for Nicotine Dependence in African-Americans and in European-Americans","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Institute on Drug Abuse; U.S. Public Health Service; National Institute on Alcohol Abuse and Alcoholism; Johns Hopkins University; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Single-nucleotide polymorphism; Nicotine; Odds ratio; Genetics; SNP; Medicine; Oncology; Genotype; Internal medicine; Biology; Gene","score_opus":0.03408506273957453,"score_gpt":0.3644837447542646,"score_spread":0.3303986820146901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148998706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869287,0.0073262705,0.00036128706,0.002435704,0.00017887178,0.0014858051,0.00007935448,0.000020425343,0.0011835794],"genre_scores_gemma":[0.97924674,0.017643396,0.0006286176,0.00037734603,0.00048885774,0.0003250858,0.0000310803,0.00007281784,0.0011860522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955988,0.001303206,0.00048078815,0.0009400009,0.00047153202,0.0012056562],"domain_scores_gemma":[0.9980509,0.0005419634,0.00019421545,0.0007533177,0.00022873619,0.0002308551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031021438,0.00031774165,0.0003746416,0.00018468256,0.00033637462,0.00009106962,0.0008444298,0.00013790609,0.000020705029],"category_scores_gemma":[0.0011745873,0.00025960195,0.00010734298,0.00087854784,0.0005030592,0.000014965561,0.00039683524,0.0008534667,0.000017378548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018541286,0.00044199073,0.04309834,0.00004846529,0.00009694132,0.0000039439883,0.00066748855,0.0004719113,0.8368223,0.000030317382,0.020044016,0.096420184],"study_design_scores_gemma":[0.01010218,0.0044774623,0.040759932,0.00027720124,0.00005837848,0.00003170245,0.0022199238,0.0005801212,0.52225155,0.00020050963,0.4174776,0.0015634033],"about_ca_topic_score_codex":0.0006340295,"about_ca_topic_score_gemma":0.0032382568,"teacher_disagreement_score":0.39743358,"about_ca_system_score_codex":0.00018619957,"about_ca_system_score_gemma":0.0003249803,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W2149011125","doi":"10.1158/0008-5472.can-10-4049","title":"Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":273,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Metastasis; Hypoxia (environmental); Cancer research; Medicine; Cancer; Primary tumor; Oncology; Internal medicine; Pathology; Chemistry; Oxygen","score_opus":0.0446552823228403,"score_gpt":0.31675264046180157,"score_spread":0.2720973581389613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149011125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720564,0.025460128,0.00006539107,0.000046520396,0.00028963122,0.00045601183,0.0003185395,0.00001219761,0.0012951904],"genre_scores_gemma":[0.9740844,0.023648653,0.00035645836,0.00011714755,0.0009878166,0.00033232875,0.00015311109,0.000032386466,0.00028771858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982161,0.00019200769,0.00031569746,0.00043031957,0.00041991484,0.00042594524],"domain_scores_gemma":[0.99886495,0.000043111293,0.00017600034,0.0003760076,0.00035095654,0.0001889971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027503297,0.00018084931,0.00032164945,0.00012672221,0.00015555075,0.000024368741,0.00027982608,0.0001618192,0.00026273774],"category_scores_gemma":[0.00013915158,0.00016255175,0.00008523785,0.00018699754,0.00032655633,0.000025312449,0.0002130963,0.0002165811,0.0000021397395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053813204,0.00007901662,0.0021355553,0.00022634542,0.00022109658,0.00003296305,0.0010397385,9.904846e-7,0.9787403,0.00011195598,0.0029224774,0.013951473],"study_design_scores_gemma":[0.0019497311,0.0006607628,0.071522236,0.00030628208,0.00022837424,0.00007645257,0.00028068607,0.0000060512925,0.90488076,0.00079473667,0.018877985,0.00041592127],"about_ca_topic_score_codex":0.0050991895,"about_ca_topic_score_gemma":0.001993276,"teacher_disagreement_score":0.073859476,"about_ca_system_score_codex":0.000047635724,"about_ca_system_score_gemma":0.00027300956,"threshold_uncertainty_score":0.77084833},"labels":[],"label_agreement":null},{"id":"W2149140088","doi":"10.1158/0008-5472.can-07-1214","title":"Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"National Cancer Institute","keywords":"Oncolytic virus; Myxoma virus; Medulloblastoma; Cancer research; Biology; Virotherapy; Myxoma; Virus; PI3K/AKT/mTOR pathway; Glioma; Virology; Internal medicine; Apoptosis; Medicine","score_opus":0.02900722365161133,"score_gpt":0.39745081902794255,"score_spread":0.3684435953763312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149140088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922088,0.0037755547,0.000860498,0.00046390394,0.000055560195,0.0008100288,0.000051955765,0.000032923876,0.0017408009],"genre_scores_gemma":[0.9907453,0.0012613612,0.0000977772,0.00059756247,0.0005919501,0.000294702,0.000070027185,0.00012689429,0.006214397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960415,0.00028100805,0.0003324146,0.000859645,0.0011227198,0.001362735],"domain_scores_gemma":[0.99832344,0.000067537236,0.00007973564,0.0007142298,0.0004839287,0.0003311431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023226726,0.0002913586,0.0002646423,0.00022261764,0.00050153345,0.000082902654,0.0007100014,0.0002426726,0.0007019934],"category_scores_gemma":[0.0000521555,0.00025659578,0.000087368484,0.0006471871,0.00053291034,0.00001084697,0.00015682515,0.0006163629,0.00007393196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048857015,0.00014322413,0.00023176662,0.000027576705,0.00013064653,0.0000121814855,0.00023613876,0.00001890688,0.96188045,0.000006485294,0.024703678,0.0077232504],"study_design_scores_gemma":[0.0018357795,0.0047081523,0.00009353771,0.00003859001,0.000004876293,0.0000026766738,0.00020059616,0.000007981223,0.94869554,0.000030817322,0.04406692,0.0003145454],"about_ca_topic_score_codex":0.00042827998,"about_ca_topic_score_gemma":0.0017823786,"teacher_disagreement_score":0.019363245,"about_ca_system_score_codex":0.00025855994,"about_ca_system_score_gemma":0.00048755092,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W2149173705","doi":"10.1158/0008-5472.664.65.2","title":"Levels of Cyclooxygenase-2 Are Increased in the Oral Mucosa of Smokers: Evidence for the Role of Epidermal Growth Factor Receptor and Its Ligands","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Amphiregulin; Epidermal growth factor receptor; Cyclooxygenase; TGF alpha; Epidermal growth factor; Tyrosine kinase; Internal medicine; Oral mucosa; Cancer research; Medicine; Endocrinology; Receptor; Chemistry; Pathology; Enzyme; Biochemistry","score_opus":0.15044704431532746,"score_gpt":0.42135061726720036,"score_spread":0.2709035729518729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149173705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860018,0.011091074,0.0000029876387,0.0015988589,0.000036776375,0.0011175704,0.00012454085,0.0000038809003,0.000022505817],"genre_scores_gemma":[0.99848413,0.0009245895,0.000032788612,0.000077950055,0.00023622972,0.00020178595,0.0000018198809,0.0000142972185,0.00002638305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983559,0.00023397122,0.00032445052,0.00017751273,0.00059389474,0.00031425714],"domain_scores_gemma":[0.9966165,0.0024214617,0.00012984178,0.00025764617,0.0004864136,0.00008816791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025022705,0.00010336822,0.00033869463,0.00014603313,0.00006862825,0.0000065291097,0.00023418941,0.000083347455,0.00009340488],"category_scores_gemma":[0.00232613,0.000057612662,0.00007337913,0.00034111188,0.00023558082,0.000104684805,0.000055539225,0.0002853205,0.000001480278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028974416,0.00018329351,0.193445,0.0021211496,0.00012590562,0.00000737955,0.005271247,0.000011747106,0.77442646,0.00042224932,0.0013197869,0.01976836],"study_design_scores_gemma":[0.0013569436,0.0003277877,0.22644801,0.0008225828,0.0000272095,0.0000024049234,0.0009391945,0.00053431373,0.7687612,0.0000390531,0.0006825538,0.000058758837],"about_ca_topic_score_codex":0.0006452562,"about_ca_topic_score_gemma":0.00022470746,"teacher_disagreement_score":0.033003017,"about_ca_system_score_codex":0.00007198394,"about_ca_system_score_gemma":0.00036468322,"threshold_uncertainty_score":0.2784763},"labels":[],"label_agreement":null},{"id":"W2149247636","doi":"10.1158/0008-5472.can-07-5270","title":"Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trichostatin A; Cancer research; Histone deacetylase; Immune system; Epigenetics; Biology; Antigen; MHC class I; Antigen presentation; Immunogenicity; Immunotherapy; Immunology; Major histocompatibility complex; Histone; T cell; Genetics","score_opus":0.06469056655122991,"score_gpt":0.3834948850328331,"score_spread":0.3188043184816032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149247636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141294,0.007593345,0.0001488775,0.000050409675,0.000018630568,0.000414507,0.000016620477,0.000002751141,0.00034189483],"genre_scores_gemma":[0.9960021,0.0030378678,0.00031556314,0.0000022127142,0.00007088397,0.00011376856,0.000048312468,0.000016377147,0.00039291693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986378,0.00015470696,0.000259295,0.00025965893,0.00043795313,0.0002506188],"domain_scores_gemma":[0.99903643,0.000019899857,0.00008454514,0.00018526184,0.0006126674,0.00006119893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004912658,0.00007568801,0.00013846773,0.00013743814,0.000118465,0.0000065208205,0.00012242384,0.00006713282,0.00004390523],"category_scores_gemma":[0.00016230339,0.00007528067,0.000031021176,0.00024703593,0.0005080731,0.000007022593,0.000111436515,0.00011948188,0.0000028440418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012782305,0.0000756706,0.002147002,0.00021046567,0.000016274771,0.0000020373786,0.00037139846,0.0000031642,0.9778687,9.98514e-7,0.00011208487,0.019064384],"study_design_scores_gemma":[0.00030935337,0.00038291604,0.0035871754,0.00013876751,0.00000247115,0.0000067251704,0.000116428746,0.000034324654,0.9950338,0.000036554473,0.00028005033,0.00007141046],"about_ca_topic_score_codex":0.0003225426,"about_ca_topic_score_gemma":0.000023891958,"teacher_disagreement_score":0.018992973,"about_ca_system_score_codex":0.00003111449,"about_ca_system_score_gemma":0.00037787732,"threshold_uncertainty_score":0.30698568},"labels":[],"label_agreement":null},{"id":"W2149307998","doi":"10.1158/0008-5472.can-09-3108","title":"Genetic Screen Identifies Insulin-like Growth Factor Binding Protein 5 as a Modulator of Tamoxifen Resistance in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; Cancer research; Insulin-like growth factor-binding protein; Cancer; Insulin resistance; Biology; Growth factor; Insulin-like growth factor; Oncology; Internal medicine; Medicine; Bioinformatics; Insulin; Endocrinology; Receptor","score_opus":0.0389957551018218,"score_gpt":0.3469398326980147,"score_spread":0.3079440775961929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149307998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339163,0.0018025015,0.000004407635,0.0016246691,0.0003341106,0.0015913921,0.00035254942,0.000055040582,0.00084367796],"genre_scores_gemma":[0.9941184,0.00080059667,0.00028524725,0.00008249341,0.00040728395,0.0006151008,0.00001533403,0.00009394722,0.0035815996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99572456,0.00018674797,0.0007398036,0.000773482,0.0015343982,0.0010409858],"domain_scores_gemma":[0.9974475,0.000103417675,0.00017931347,0.00074576883,0.0010572113,0.00046677768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075896335,0.00032965804,0.0006515582,0.0010183514,0.00018381578,0.000071368195,0.00055745,0.0003378253,0.0010811357],"category_scores_gemma":[0.0003811521,0.00029518237,0.00014598787,0.0018325082,0.00056511303,0.00030890247,0.00023233274,0.0016675956,0.00008002168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010384489,0.00018137085,0.17447773,0.00056083436,0.00008712601,0.00008021001,0.00085733685,9.670662e-7,0.81952053,0.00028041104,0.0018011348,0.0011138801],"study_design_scores_gemma":[0.0024236508,0.00015657551,0.7650745,0.00093063025,0.000029950023,0.000015322024,0.00019913707,0.000025334035,0.22864822,0.00073749205,0.0013957319,0.00036348283],"about_ca_topic_score_codex":0.011668343,"about_ca_topic_score_gemma":0.004768152,"teacher_disagreement_score":0.59087235,"about_ca_system_score_codex":0.0004048209,"about_ca_system_score_gemma":0.0013758809,"threshold_uncertainty_score":0.99995005},"labels":[],"label_agreement":null},{"id":"W2149331300","doi":"10.1158/0008-5472.can-06-0284","title":"AAL881, a Novel Small Molecule Inhibitor of RAF and Vascular Endothelial Growth Factor Receptor Activities, Blocks the Growth of Malignant Glioma","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Glioma; Cancer research; Vascular endothelial growth factor; Kinase insert domain receptor; Vascular endothelial growth inhibitor; Receptor; Biology; Basic fibroblast growth factor; Growth factor; Medicine; Vascular endothelial growth factor A; Internal medicine; VEGF receptors","score_opus":0.03852794546987647,"score_gpt":0.31070117884556786,"score_spread":0.2721732333756914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149331300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507016,0.002241128,0.00024784994,0.0007845555,0.00015311601,0.00080546876,0.0003092557,0.000016696471,0.0003717789],"genre_scores_gemma":[0.99736625,0.00092766783,0.00020557955,0.00005726576,0.00054781395,0.00011572235,0.000008665305,0.000046859244,0.0007241622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979789,0.00009925384,0.00031876564,0.00034660913,0.0008009931,0.00045548083],"domain_scores_gemma":[0.9987591,0.00020456825,0.000109001885,0.00035448052,0.00045322176,0.00011960984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575371,0.00017550876,0.00041072452,0.00024292585,0.00009410292,0.000022810627,0.00020168963,0.00011506772,0.00035479467],"category_scores_gemma":[0.00008096974,0.00012014434,0.00014140138,0.00049206376,0.00037913807,0.000050361825,0.00011066508,0.00034315587,0.0000016308347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000696343,0.00020516892,0.0007886219,0.00028623902,0.00012846441,0.000007640151,0.00042681256,6.4128307e-7,0.9931057,0.002966144,0.0007613985,0.0006267949],"study_design_scores_gemma":[0.0030472411,0.00055520044,0.0015003481,0.00026384825,0.000033669567,0.000009968472,0.00020440253,0.000018978786,0.9915612,0.00031350317,0.0023708036,0.000120856945],"about_ca_topic_score_codex":0.008254087,"about_ca_topic_score_gemma":0.0002680074,"teacher_disagreement_score":0.00798608,"about_ca_system_score_codex":0.00016111838,"about_ca_system_score_gemma":0.0004971524,"threshold_uncertainty_score":0.99835},"labels":[],"label_agreement":null},{"id":"W2149369425","doi":"10.1158/0008-5472.can-08-1551","title":"<i>Enterococcus faecalis</i> Induces Aneuploidy and Tetraploidy in Colonic Epithelial Cells through a Bystander Effect","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center; National Cancer Institute; National Institutes of Health; University of Oklahoma; U.S. Department of Veterans Affairs","keywords":"Enterococcus faecalis; Bystander effect; Biology; Carcinogenesis; Genome instability; DNA damage; Microbiology; Superoxide dismutase; Cancer research; Immunology; Cancer; Oxidative stress; Genetics; Gene; Escherichia coli; DNA; Biochemistry","score_opus":0.04087461707508931,"score_gpt":0.35007658311808565,"score_spread":0.3092019660429963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149369425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608004,0.0025776606,0.000030592197,0.00012091847,0.00015142326,0.00058742234,0.000041300573,0.000016708307,0.00039392838],"genre_scores_gemma":[0.995665,0.003006806,0.000053262735,0.00014062205,0.00017763702,0.0002852036,0.000013815886,0.00003634231,0.00062127004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979921,0.0003308507,0.00018330073,0.0005531637,0.00037086636,0.00056973606],"domain_scores_gemma":[0.99937433,0.00005811287,0.000032332347,0.0003306173,0.00009260831,0.00011199432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057143613,0.00017176381,0.0002114519,0.0000913604,0.0001506618,0.000026805948,0.00026036,0.00020609099,0.00003985985],"category_scores_gemma":[0.00006745421,0.00015317429,0.000054516404,0.00026155857,0.00029787107,0.000010315267,0.00023402103,0.00035859345,0.000016975946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027213406,0.00006982236,0.0026243285,0.000054104734,0.000025704874,0.0000639073,0.00028482615,0.000008491651,0.99474347,0.000021417234,0.0014258096,0.00040597233],"study_design_scores_gemma":[0.0012970418,0.0009967397,0.0009342296,0.00003022421,0.00000436726,0.000027062304,0.00006720268,0.0000070404567,0.98389566,0.00009274649,0.012484205,0.00016346287],"about_ca_topic_score_codex":0.0004228616,"about_ca_topic_score_gemma":0.00025543763,"teacher_disagreement_score":0.011058395,"about_ca_system_score_codex":0.000079631245,"about_ca_system_score_gemma":0.00019888296,"threshold_uncertainty_score":0.62462664},"labels":[],"label_agreement":null},{"id":"W2149400959","doi":"10.1158/0008-5472.can-08-2657","title":"Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Medical Research Council; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; National Cancer Institute; Institut National Du Cancer; Cancer Research UK; Association pour la Recherche sur le Cancer; Ohio State University","keywords":"Transgene; Cancer; Cancer research; Biology; Medicine; Internal medicine; Gene; Genetics","score_opus":0.045049256993053656,"score_gpt":0.3570249915789128,"score_spread":0.31197573458585914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149400959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97805357,0.02115944,0.000099797064,0.00019741092,0.00010947303,0.00017342661,0.0000644781,0.000008369976,0.00013403445],"genre_scores_gemma":[0.98835355,0.010879265,0.000010314241,0.0000430322,0.00015807744,0.000074222444,0.0000455195,0.000010480688,0.00042551963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988488,0.0001196453,0.0001945987,0.00028505464,0.0002721162,0.00027978583],"domain_scores_gemma":[0.9993727,0.000012581186,0.000044579974,0.0002357104,0.00025716933,0.00007722561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550342,0.00009035425,0.00012468014,0.00006665679,0.00007457632,0.000015140196,0.00021107846,0.0001171833,0.00009066945],"category_scores_gemma":[0.000018832961,0.000079622325,0.000046200053,0.00020318179,0.000082374594,0.0000060999264,0.000026386351,0.00012101789,0.000008506088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002557123,0.000044157998,0.00049996615,0.000021942375,0.000013566935,8.657838e-7,0.000101681864,0.00008879882,0.967553,0.000003183237,0.024819836,0.00659729],"study_design_scores_gemma":[0.00032182763,0.0004730448,0.00045985702,0.00011527538,0.0000029562707,0.0000033189,0.00014372884,0.000011529576,0.9934628,0.000017912233,0.0049003935,0.00008735008],"about_ca_topic_score_codex":0.00013331327,"about_ca_topic_score_gemma":0.000040458617,"teacher_disagreement_score":0.025909808,"about_ca_system_score_codex":0.00004501279,"about_ca_system_score_gemma":0.00011518917,"threshold_uncertainty_score":0.3246904},"labels":[],"label_agreement":null},{"id":"W2149444011","doi":"10.1158/1538-7445.am2013-265","title":"Abstract 265: Mechanisms of Met-dependent tumorigenesis in models of triple negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Biology; Carcinogenesis; Hepatocyte growth factor; Triple-negative breast cancer; Receptor tyrosine kinase; Receptor; Signal transduction; Cell biology; Genetics","score_opus":0.09742724917533191,"score_gpt":0.3938476532019956,"score_spread":0.2964204040266637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149444011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173516,0.0026372983,0.00018773065,0.0008629297,0.00023347311,0.001445651,0.00043747853,0.000013343392,0.0024469153],"genre_scores_gemma":[0.99429613,0.0031741885,0.00038437417,0.000044320885,0.00010104624,0.00071175786,0.0000051777374,0.000036569563,0.0012464318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997412,0.000100675905,0.00051398936,0.00037885553,0.0010504163,0.0005440104],"domain_scores_gemma":[0.99816746,0.00011711648,0.000148229,0.00040883882,0.00092555565,0.00023282689],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008659527,0.00016101441,0.0006122643,0.0004443414,0.0000428937,0.000013400817,0.00023578228,0.00009121325,0.0054971767],"category_scores_gemma":[0.000048774076,0.00013405325,0.00012938725,0.000832777,0.00018119634,0.00017943046,0.00010443867,0.00038862054,0.000015928741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012458146,0.00051171257,0.0017813643,0.0011648042,0.00026042946,0.000029672343,0.0011951494,0.00085118576,0.9022914,0.0012025359,0.002579847,0.08688607],"study_design_scores_gemma":[0.0032767232,0.00028787839,0.030428082,0.0006856476,0.00006299964,0.00000860798,0.0018828048,0.00027690068,0.9558582,0.0069487905,0.0001001155,0.00018326812],"about_ca_topic_score_codex":0.13496973,"about_ca_topic_score_gemma":0.0038648252,"teacher_disagreement_score":0.1311049,"about_ca_system_score_codex":0.00055129087,"about_ca_system_score_gemma":0.0011244661,"threshold_uncertainty_score":0.99541193},"labels":[],"label_agreement":null},{"id":"W2149516653","doi":"10.1158/0008-5472.can-08-1963","title":"Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"DMBA; Carcinogenesis; Biology; Endocrinology; MAPK/ERK pathway; Cancer; Kinase; Knockout mouse; Internal medicine; Cancer research; Protein kinase A; Medicine; Cell biology; Receptor","score_opus":0.04779065869297002,"score_gpt":0.3893778175211927,"score_spread":0.3415871588282227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149516653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036276,0.0062587853,0.0001598955,0.0020611086,0.00003892688,0.00074663607,0.00008950607,0.0000033690972,0.00027902296],"genre_scores_gemma":[0.99878675,0.0002025996,0.00015346572,0.00018686424,0.00021632628,0.0003019405,0.000043175853,0.0000075810703,0.00010127105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990377,0.00014165674,0.0001264848,0.00021626442,0.00020455572,0.00027335266],"domain_scores_gemma":[0.9994535,0.000048376092,0.000035447647,0.00022559473,0.00020874543,0.000028352446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000711922,0.00006655666,0.00009084929,0.00005702194,0.00006956108,0.000012619368,0.00024553936,0.0000813779,0.0000072113276],"category_scores_gemma":[0.0003386437,0.000052165346,0.00003827367,0.00021257096,0.00008536252,0.00000528199,0.000038569862,0.0001581017,0.000001304433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004508729,0.000047004087,0.00023652018,0.000015740463,0.000011635257,7.548607e-7,0.000108567234,0.000052952277,0.98023105,0.0011537966,0.0043003173,0.01339077],"study_design_scores_gemma":[0.00039638282,0.00044372663,0.0073831296,0.000013544382,0.0000028862473,0.0000029171058,0.00015875477,0.000016773869,0.985384,0.0010411557,0.0051008123,0.000055914938],"about_ca_topic_score_codex":0.00041301426,"about_ca_topic_score_gemma":0.00017454442,"teacher_disagreement_score":0.013334855,"about_ca_system_score_codex":0.000037889076,"about_ca_system_score_gemma":0.0002076617,"threshold_uncertainty_score":0.2127241},"labels":[],"label_agreement":null},{"id":"W2149688672","doi":"10.1158/0008-5472.can-09-3414","title":"Preventing the Activation or Cycling of the Rap1 GTPase Alters Adhesion and Cytoskeletal Dynamics and Blocks Metastatic Melanoma Cell Extravasation into the Lungs","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Rap1; Pseudopodia; Extravasation; Cell biology; Melanoma; Cytoskeleton; Focal adhesion; Cancer research; Biology; Cell migration; Cell adhesion; Chemistry; Actin; Cell; Immunology; Phosphorylation; Signal transduction","score_opus":0.02291672719436255,"score_gpt":0.3413416238406851,"score_spread":0.31842489664632256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149688672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976482,0.00028993157,0.00064612634,0.0009146187,0.00010234529,0.00031230907,0.0000054048414,0.0000015649198,0.0000795256],"genre_scores_gemma":[0.998711,0.000404834,0.00008318596,0.000036651505,0.00007553036,0.00004761394,0.000012315682,0.000010120005,0.0006187639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928117,0.00013369063,0.00012457509,0.00016657631,0.00016415305,0.0001298298],"domain_scores_gemma":[0.99944717,0.00009889628,0.00007631762,0.00024220718,0.0001068134,0.000028585044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069196225,0.000064512016,0.00005621212,0.000028173708,0.00034287988,0.000044258297,0.00015428299,0.000045832472,0.000024201652],"category_scores_gemma":[0.00016328161,0.000032610875,0.000034635836,0.00010588883,0.00013103476,0.000008279362,0.0001638493,0.00028809166,2.27989e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004408065,0.000014601302,0.00026550182,0.000028125067,0.000018926616,1.4669064e-7,0.00036449844,0.000009288388,0.99129313,0.00015144964,0.00006631139,0.0077439197],"study_design_scores_gemma":[0.00020626873,0.00009103754,0.0006070411,0.000027332706,0.000020665324,0.000004789349,0.0009826692,0.0064583896,0.9898083,0.00022371222,0.0015176585,0.00005208983],"about_ca_topic_score_codex":0.00032394793,"about_ca_topic_score_gemma":0.00097053073,"teacher_disagreement_score":0.00769183,"about_ca_system_score_codex":0.000016719678,"about_ca_system_score_gemma":0.000088172645,"threshold_uncertainty_score":0.26371893},"labels":[],"label_agreement":null},{"id":"W2149703329","doi":"10.1158/0008-5472.can-03-3465","title":"Activation of Akt-1 (PKB-α) Can Accelerate ErbB-2-Mediated Mammary Tumorigenesis but Suppresses Tumor Invasion","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McMaster University","funders":"National Cancer Institute","keywords":"Protein kinase B; Cancer research; Mammary tumor; ErbB; Biology; Carcinogenesis; Tumor progression; Mammary gland; Genetically modified mouse; Transgene; Cancer; Breast cancer; Signal transduction; Cell biology","score_opus":0.06499140865525947,"score_gpt":0.35895702911600946,"score_spread":0.29396562046075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149703329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960205,0.0016611627,0.00026079957,0.00095686706,0.0002253759,0.00039582152,0.00013892318,0.000024732608,0.00031581416],"genre_scores_gemma":[0.9970761,0.0011790107,0.0002068783,0.00022961515,0.00047220677,0.00018929545,0.00019634471,0.00005349574,0.00039705957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773884,0.00017073711,0.00031584373,0.00057588,0.0006271341,0.0005715522],"domain_scores_gemma":[0.9983071,0.000070108625,0.00012532863,0.000614343,0.0007100179,0.00017310739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005217325,0.00020213952,0.00023453825,0.00018943213,0.00016447979,0.00005236991,0.0006054334,0.0001704265,0.00012468411],"category_scores_gemma":[0.0003690153,0.00019684788,0.000082729384,0.00052191433,0.00024825588,0.000019410749,0.00029067736,0.00029978898,0.000011887657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002866922,0.000076065,0.0014621436,0.00012868183,0.000060496564,0.000013995523,0.000086873464,0.000757034,0.993498,0.000043396063,0.002673027,0.0009135949],"study_design_scores_gemma":[0.00088074617,0.0003139664,0.0019280796,0.00013448019,0.000008170946,0.000005218108,0.000087798886,0.000011129132,0.99086213,0.00019975987,0.005357684,0.00021086358],"about_ca_topic_score_codex":0.0023349656,"about_ca_topic_score_gemma":0.00035351847,"teacher_disagreement_score":0.0026846568,"about_ca_system_score_codex":0.00027654946,"about_ca_system_score_gemma":0.0016405799,"threshold_uncertainty_score":0.80272233},"labels":[],"label_agreement":null},{"id":"W2149775431","doi":"10.1158/0008-5472.can-05-3561","title":"Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Chromatin immunoprecipitation; Epidermal growth factor receptor; Biology; Receptor; Estrogen receptor; Molecular biology; Cancer research; Epidermal growth factor; Promoter; Breast cancer; Cancer; Gene expression; Gene; Genetics","score_opus":0.09333588458577985,"score_gpt":0.4254608625046686,"score_spread":0.33212497791888873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149775431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890113,0.0005497462,0.0000021090332,0.0074246074,0.0001289119,0.0017398875,0.00016700928,0.000008413708,0.00096800225],"genre_scores_gemma":[0.99614036,0.00019343842,0.00006874706,0.0000122636875,0.00014989733,0.00020498356,0.0000061231854,0.000027400338,0.0031968139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99650455,0.0006860081,0.0004757016,0.00035166164,0.0014596971,0.0005224137],"domain_scores_gemma":[0.99850124,0.0002936382,0.00012820598,0.00057029474,0.00041514676,0.00009149294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017148359,0.00012136828,0.00027431388,0.00022923602,0.00014872482,0.00001957181,0.00037971223,0.00013511282,0.00016274702],"category_scores_gemma":[0.0011687115,0.00006756938,0.000078213736,0.0011260414,0.0006859703,0.0000870324,0.00038348834,0.00089971157,0.0000046160135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078821776,0.00009815172,0.14195554,0.00063640345,0.000010803812,0.0000028544482,0.0004623898,0.0000058863557,0.8503636,0.00015748653,0.0030444649,0.0024741928],"study_design_scores_gemma":[0.0015189761,0.00014501247,0.21756718,0.0019387734,0.0000047287144,0.0000027894614,0.00019058773,0.00002879203,0.7763329,0.00014998352,0.0020517106,0.000068572],"about_ca_topic_score_codex":0.0062232073,"about_ca_topic_score_gemma":0.0006305558,"teacher_disagreement_score":0.075611636,"about_ca_system_score_codex":0.00045400453,"about_ca_system_score_gemma":0.0006588938,"threshold_uncertainty_score":0.94076693},"labels":[],"label_agreement":null},{"id":"W2149870009","doi":"10.1158/0008-5472.can-11-3148","title":"A Zebrafish Model to Study and Therapeutically Manipulate Hypoxia Signaling in Tumorigenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK; Wellcome Trust","keywords":"Zebrafish; Carcinogenesis; Biology; Transgene; Cancer research; Hypoxia-inducible factors; Transcription factor; Cell biology; Signal transduction; Cancer; Genetics; Gene","score_opus":0.1050404974690253,"score_gpt":0.39966711007783445,"score_spread":0.2946266126088092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149870009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904018,0.008209345,0.00021847842,0.00017677495,0.0002126276,0.000560899,0.000009556163,0.0000074010504,0.00020308964],"genre_scores_gemma":[0.9967252,0.0009228689,0.0002302411,0.00029916066,0.0009762591,0.0003155732,0.0000034612326,0.00003424899,0.0004929981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833304,0.00015912729,0.00017582715,0.00037727665,0.00030367266,0.00065104244],"domain_scores_gemma":[0.99928343,0.000019034544,0.000018072229,0.00030136952,0.00011952683,0.00025857068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010432325,0.00013173524,0.00017283615,0.00013083902,0.000104776525,0.00003991025,0.00020454856,0.00008273879,0.000032805776],"category_scores_gemma":[0.000048776135,0.00012379533,0.000034572717,0.0002587257,0.00005938159,0.000008370228,0.00022174537,0.00018283079,0.000007688631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023706614,0.0001983538,0.0099096475,0.000015822896,0.00004439627,0.0000014131684,0.00097958,0.0004021426,0.9757152,0.000057131645,0.0002812992,0.012157924],"study_design_scores_gemma":[0.005682431,0.0012916079,0.28145823,0.00010729978,0.0001055671,0.000022413487,0.0031150286,0.001163609,0.61747473,0.0008147556,0.08728746,0.0014768208],"about_ca_topic_score_codex":0.00028598626,"about_ca_topic_score_gemma":0.00033004876,"teacher_disagreement_score":0.35824046,"about_ca_system_score_codex":0.000041868632,"about_ca_system_score_gemma":0.00013823125,"threshold_uncertainty_score":0.5048227},"labels":[],"label_agreement":null},{"id":"W2150160398","doi":"10.1158/0008-5472.can-05-3466","title":"Discovering Clinical Biomarkers of Ionizing Radiation Exposure with Serum Proteomic Analysis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Proteomics; Ionizing radiation; Blood proteins; Biomarker; Surface-enhanced laser desorption/ionization; Biomarker discovery; Cancer; Chemistry; Medicine; Mass spectrometry; Chromatography; Tandem mass spectrometry; Internal medicine; Irradiation; Biochemistry; Protein mass spectrometry","score_opus":0.0483729673986435,"score_gpt":0.41514205389060205,"score_spread":0.36676908649195855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150160398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880587,0.00023755082,0.00976916,0.00025167727,0.000005844874,0.00026058208,0.00005934189,0.000045680696,0.0013114581],"genre_scores_gemma":[0.99175483,0.00020379658,0.0069636893,0.000003525548,0.00012674209,0.00048847066,0.00003299564,0.000019639057,0.00040628167],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987962,0.00003549231,0.00031205558,0.00030559776,0.00029680037,0.00025385665],"domain_scores_gemma":[0.9992005,0.00007710346,0.00012966616,0.00038995047,0.0001516487,0.00005109897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045380674,0.00008463582,0.00018978828,0.0001412373,0.00013045837,0.000028949235,0.00020848526,0.00008699559,0.00015807146],"category_scores_gemma":[0.000023758203,0.000073203024,0.00008985424,0.00087674876,0.00017525622,0.00008986571,0.00006350015,0.00029234038,0.0000017289258],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016317103,0.00009053399,0.5574755,0.00012363849,0.00030301342,0.0000024704068,0.000037001868,0.0027526615,0.42887378,0.00080772466,0.00021485961,0.009155638],"study_design_scores_gemma":[0.00047430396,0.000048087815,0.026511062,0.00008683558,0.00008432824,7.992993e-7,0.000091315094,0.00093112304,0.9695193,0.001057639,0.0010336107,0.00016157803],"about_ca_topic_score_codex":0.000712659,"about_ca_topic_score_gemma":0.00015554934,"teacher_disagreement_score":0.54064554,"about_ca_system_score_codex":0.0001528221,"about_ca_system_score_gemma":0.00013047374,"threshold_uncertainty_score":0.2985133},"labels":[],"label_agreement":null},{"id":"W2150429839","doi":"10.1158/0008-5472.can-09-1496","title":"Three-Dimensional Imaging and Quantification of Both Solitary Cells and Metastases in Whole Mouse Liver by Magnetic Resonance Imaging","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Magnetic resonance imaging; Population; Metastasis; Pathology; Medicine; Cell; Cancer; Nuclear medicine; Biology; Radiology; Internal medicine","score_opus":0.0498547918904327,"score_gpt":0.36608908240485505,"score_spread":0.31623429051442237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150429839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78252894,0.20761807,0.000042932497,0.00900096,0.00003344041,0.00051907194,0.00015214829,0.000016148486,0.00008827589],"genre_scores_gemma":[0.98784155,0.010410787,0.0009223713,0.0004000699,0.00005613633,0.00007674741,0.00001949503,0.000022713324,0.00025013642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983426,0.00009937763,0.0002494326,0.00043091553,0.0005037283,0.0003739888],"domain_scores_gemma":[0.99910516,0.0002508632,0.000042178828,0.00028932132,0.00017937618,0.00013309921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079476443,0.000119042976,0.00024583808,0.00028395676,0.00007178114,0.00002578475,0.00009261577,0.0000312751,0.0001194387],"category_scores_gemma":[0.00005492126,0.00011447941,0.000022916262,0.00035250428,0.0003614851,0.00015495729,0.0000687236,0.00029886243,0.0000040964765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003741542,0.0002280928,0.101092964,0.00025442868,0.000008344467,0.0000752792,0.00033491678,0.000020690219,0.6108961,0.00009650716,0.12296597,0.16365252],"study_design_scores_gemma":[0.0050421515,0.0005683529,0.45736814,0.0018667855,0.00008996615,0.00005117304,0.0004398302,0.016376244,0.46507597,0.00088721496,0.05172306,0.0005111048],"about_ca_topic_score_codex":0.0051736347,"about_ca_topic_score_gemma":0.00044205209,"teacher_disagreement_score":0.35627517,"about_ca_system_score_codex":0.00014960114,"about_ca_system_score_gemma":0.00016483442,"threshold_uncertainty_score":0.7821023},"labels":[],"label_agreement":null},{"id":"W2150626960","doi":"10.1158/1538-7445.am2014-3450","title":"Abstract 3450: Internalization and recycling of RET receptor tyrosine kinase isoforms","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Cell biology; Receptor tyrosine kinase; Internalization; Tyrosine kinase; Endosome; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Gene isoform; Clathrin; Signal transduction; Receptor; Intracellular; Endocytosis; Genetics; Gene","score_opus":0.046504628850118176,"score_gpt":0.38222013016149864,"score_spread":0.33571550131138045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150626960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473923,0.0017951336,0.0016613255,0.00026979164,0.000079915255,0.00010670655,0.000016924068,0.000003792046,0.0013271864],"genre_scores_gemma":[0.9954674,0.0031418006,0.00015361521,0.000040368654,0.00022464679,0.000044117656,0.000041536747,0.000013058849,0.0008734238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930376,0.000041936055,0.00014219385,0.00020481943,0.000150246,0.00015704549],"domain_scores_gemma":[0.9994174,0.00001442468,0.00004992468,0.00023339913,0.00022820305,0.00005662667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005193878,0.000056613128,0.000075862474,0.00005313978,0.00006936135,0.000021256783,0.00012200442,0.00007103382,0.00013262902],"category_scores_gemma":[0.00013146979,0.000049095695,0.000022822698,0.00010625713,0.00012088034,0.0000051086386,0.00006251256,0.00009566815,0.000004497149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007677643,0.000017518363,0.0024263689,0.000047647314,0.000011015371,8.707104e-8,0.000040535648,0.000027818623,0.96067524,0.00034909678,0.0024842846,0.03384362],"study_design_scores_gemma":[0.00037193252,0.00016199441,0.010620462,0.00009864139,0.0000034971856,7.8242596e-7,0.000060447026,0.00011282881,0.89545155,0.00022678725,0.092792325,0.0000987553],"about_ca_topic_score_codex":0.0002267174,"about_ca_topic_score_gemma":0.000055249242,"teacher_disagreement_score":0.09030803,"about_ca_system_score_codex":0.000023285736,"about_ca_system_score_gemma":0.000058399986,"threshold_uncertainty_score":0.20020644},"labels":[],"label_agreement":null},{"id":"W2150775704","doi":"10.1158/0008-5472.can-06-0028","title":"Short Hairpin RNA Knockdown of the Androgen Receptor Attenuates Ligand-Independent Activation and Delays Tumor Progression","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Small hairpin RNA; Androgen receptor; LNCaP; Prostate cancer; Cancer research; Bicalutamide; Gene knockdown; Endocrinology; Internal medicine; Transactivation; MAPK/ERK pathway; Androgen; Tumor progression; Biology; Medicine; Chemistry; Signal transduction; Cancer; Transcription factor; Apoptosis; Cell biology; Hormone","score_opus":0.05021880836211736,"score_gpt":0.39125638510971195,"score_spread":0.3410375767475946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150775704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892804,0.0036543107,0.00000663925,0.004224025,0.000073754614,0.0012762023,0.000022447679,0.000022529164,0.0014396984],"genre_scores_gemma":[0.99595505,0.000777865,0.000041454994,0.000024694513,0.00024038852,0.0003345576,0.000029694898,0.00002649096,0.0025698324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977898,0.00013076572,0.00023517356,0.00033940354,0.0010489366,0.0004558922],"domain_scores_gemma":[0.99895453,0.00008609792,0.000051336112,0.00031687575,0.000462448,0.00012868058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065345294,0.00013158662,0.00023335536,0.00016773665,0.00027175082,0.000040049472,0.0001629609,0.00008361351,0.00008308714],"category_scores_gemma":[0.00007288177,0.00007654366,0.00006521496,0.00051827927,0.00037104983,0.00010170621,0.00018640226,0.00043606324,0.0000081106255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010841818,0.00016590385,0.22374284,0.00026598942,0.000076930395,0.000015497291,0.00019268916,0.0000065549348,0.73759717,0.00007588984,0.009506407,0.027269935],"study_design_scores_gemma":[0.0013018035,0.00026241154,0.06480746,0.0006043385,0.000021409647,0.000009907313,0.00013944434,0.00006480153,0.9281827,0.00014072293,0.0043823086,0.00008268834],"about_ca_topic_score_codex":0.00056147453,"about_ca_topic_score_gemma":0.000076747536,"teacher_disagreement_score":0.19058552,"about_ca_system_score_codex":0.0003559027,"about_ca_system_score_gemma":0.00045119217,"threshold_uncertainty_score":0.312136},"labels":[],"label_agreement":null},{"id":"W2150852429","doi":"10.1158/0008-5472.can-07-6042","title":"Suppression of Colorectal Oncogenesis by Selenium-Enriched Milk Proteins: Apoptosis and <i>K-ras</i> Mutations","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Health and Medical Research Council; Medical Research Council; Gardiner Foundation","keywords":"Azoxymethane; Selenium; Aberrant crypt foci; Carcinogenesis; Carcinogen; Casein; Bioavailability; Apoptosis; Chemistry; Endocrinology; Biology; Internal medicine; Biochemistry; Colorectal cancer; Cancer; Pharmacology; Medicine","score_opus":0.07281018999040093,"score_gpt":0.37037291523036303,"score_spread":0.2975627252399621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150852429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426335,0.0030468754,0.000020133495,0.00078006624,0.00024403134,0.0010838981,0.00009495443,0.000062619016,0.00040405217],"genre_scores_gemma":[0.9981532,0.00040262743,0.0002927594,0.000040624767,0.00012874835,0.00069100934,0.00003155084,0.000029753432,0.0002297301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973728,0.00061086554,0.0003427953,0.00045506455,0.0006881759,0.00053026376],"domain_scores_gemma":[0.99850905,0.0005554773,0.0000962914,0.0002390307,0.0004188738,0.00018128159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059538597,0.00015480933,0.00031466098,0.00014604437,0.00042723233,0.000023998993,0.00027851693,0.00022231216,0.00013191416],"category_scores_gemma":[0.00039270538,0.000124193,0.000059381942,0.00075863773,0.0006124356,0.000110191075,0.00011494092,0.00034664795,0.000017280534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043879513,0.00011138718,0.017984986,0.00010663996,0.00002320886,8.781729e-7,0.00072709064,0.000005758255,0.96197295,0.000007447224,0.01774653,0.00087429496],"study_design_scores_gemma":[0.0006684712,0.00038769835,0.007573923,0.00007464972,0.000011191065,0.000010350809,0.00028718045,0.000052954936,0.98644507,0.000058801055,0.004275894,0.00015382405],"about_ca_topic_score_codex":0.0021649508,"about_ca_topic_score_gemma":0.000030003337,"teacher_disagreement_score":0.02447208,"about_ca_system_score_codex":0.00023548363,"about_ca_system_score_gemma":0.00009260835,"threshold_uncertainty_score":0.50644433},"labels":[],"label_agreement":null},{"id":"W2150866896","doi":"10.1158/0008-5472.can-07-1147","title":"RIN1 Is a Breast Tumor Suppressor Gene","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Gene silencing; Cancer research; Gene knockdown; Carcinogenesis; Biology; Tumor suppressor gene; Medicine; Cancer; Internal medicine; Cell culture; Gene","score_opus":0.051027967185931784,"score_gpt":0.40319876305091906,"score_spread":0.3521707958649873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150866896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191266,0.0025139465,0.00061177684,0.00083214586,0.00010850212,0.00019256641,0.00012224754,0.0000090591975,0.0036970917],"genre_scores_gemma":[0.99201804,0.0003879965,0.00016334478,0.00033214618,0.00067066646,0.00012043251,0.000029171024,0.00002388985,0.006254318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871194,0.00004106242,0.0001329898,0.00035162427,0.00029349077,0.00046891547],"domain_scores_gemma":[0.9990345,0.00001150129,0.000025231531,0.00047243224,0.00031225497,0.00014403793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062234554,0.0000856438,0.00007709563,0.00007322767,0.00015586408,0.000035637044,0.00029351847,0.000071487724,0.00050028105],"category_scores_gemma":[0.000022987053,0.00007917489,0.0000524333,0.00021602215,0.00015087593,0.0000032187065,0.00011940097,0.00016276544,0.00006489408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012721968,0.000036829693,0.0011099344,0.000011419126,0.000023953395,0.0000061034875,0.000045801145,0.0000050488347,0.9637463,0.0000966992,0.029007733,0.0057829786],"study_design_scores_gemma":[0.00026705468,0.00005266651,0.0084497435,0.000008121124,0.0000029739049,0.00002192448,0.000062356696,0.0000060532216,0.78387755,0.00004982023,0.20710321,0.00009854949],"about_ca_topic_score_codex":0.00027772252,"about_ca_topic_score_gemma":0.00011092081,"teacher_disagreement_score":0.17986876,"about_ca_system_score_codex":0.000059601447,"about_ca_system_score_gemma":0.00020963396,"threshold_uncertainty_score":0.54777265},"labels":[],"label_agreement":null},{"id":"W2150930870","doi":"10.1158/0008-5472.can-08-1833","title":"IκB Kinase-α Regulates Endothelial Cell Motility and Tumor Angiogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Angiogenesis; Cancer research; Endothelial stem cell; Metastasis; Vascular endothelial growth inhibitor; Vascular endothelial growth factor B; Biology; Motility; Vascular endothelial growth factor A; Cell growth; Cell biology; Vascular endothelial growth factor; Medicine; Internal medicine; Cancer; In vitro; Biochemistry","score_opus":0.057810483501009625,"score_gpt":0.3305616058780622,"score_spread":0.27275112237705257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150930870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426115,0.00452264,0.00001877221,0.00009782923,0.00006917197,0.00019883005,0.00007052128,0.0000145055765,0.0007465828],"genre_scores_gemma":[0.9967199,0.00057965686,0.000172387,0.000067395704,0.000365248,0.00007203595,0.000018622124,0.00002891337,0.0019758441],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985532,0.00015060882,0.0001289384,0.00045690898,0.00028730524,0.00042302857],"domain_scores_gemma":[0.99920106,0.000030990803,0.000027181144,0.0003968918,0.00019424959,0.00014964702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004236227,0.00011931431,0.00012406109,0.00006661448,0.00023418265,0.000018856776,0.00021333565,0.00008916615,0.00010963903],"category_scores_gemma":[0.00008783614,0.00011406157,0.00006094957,0.00014719526,0.0003753286,0.0000022942893,0.00019184424,0.00013091874,0.000024316176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009147544,0.000038591126,0.013263937,0.000036630005,0.0000146948505,0.000029608227,0.00006461304,0.000016499329,0.9833006,0.000006843885,0.0024212194,0.00071524497],"study_design_scores_gemma":[0.00039137938,0.00014441383,0.008183015,0.000010657499,0.0000042001843,0.000019283223,0.00002704255,0.00001677085,0.9793309,0.000054452546,0.011709158,0.000108736305],"about_ca_topic_score_codex":0.00033882522,"about_ca_topic_score_gemma":0.000044982473,"teacher_disagreement_score":0.009287939,"about_ca_system_score_codex":0.000036487298,"about_ca_system_score_gemma":0.00024749554,"threshold_uncertainty_score":0.4651296},"labels":[],"label_agreement":null},{"id":"W2151001058","doi":"10.1158/0008-5472.can-09-4120","title":"FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Susan G. Komen; Susan G. Komen for the Cure","keywords":"Breast cancer; Medicine; Oncology; Biomarker; Gene knockdown; Internal medicine; Lymph node; Cancer; Metastasis; Ectopic expression; Cancer research; CA15-3; Immunohistochemistry; Biology; Gene","score_opus":0.031176912803069723,"score_gpt":0.33654549059199623,"score_spread":0.3053685777889265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151001058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927303,0.0012905765,0.00008688435,0.0040862532,0.0004426949,0.0005628965,0.00038480008,0.000016837621,0.00039873327],"genre_scores_gemma":[0.99566436,0.00038155922,0.00008516181,0.0003289047,0.0006206229,0.0017684221,0.00006061456,0.000048564638,0.0010417714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997792,0.00008684663,0.00017382004,0.0007288495,0.0005454582,0.0006729966],"domain_scores_gemma":[0.9988957,0.000033767534,0.000048738333,0.00039948616,0.0004768153,0.00014546316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002841712,0.00022534397,0.00018526717,0.00014372137,0.00020092362,0.000049370632,0.00024382117,0.00015329775,0.0008881362],"category_scores_gemma":[0.000026288233,0.00018259989,0.000060348593,0.00047833705,0.00049584714,0.000011827975,0.00017125331,0.0004202288,0.000023935489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002510889,0.00030252858,0.3667407,0.000072635645,0.00032537518,0.00004620391,0.00013229594,0.000089187095,0.58682275,0.000027338505,0.031594418,0.01133566],"study_design_scores_gemma":[0.0021982992,0.00012931661,0.9525446,0.00009032672,0.000033454675,0.00004604312,0.00012390252,0.000055998153,0.03053538,0.00007037948,0.013820513,0.0003517308],"about_ca_topic_score_codex":0.0035926327,"about_ca_topic_score_gemma":0.010418788,"teacher_disagreement_score":0.585804,"about_ca_system_score_codex":0.00012661422,"about_ca_system_score_gemma":0.00077190105,"threshold_uncertainty_score":0.97244686},"labels":[],"label_agreement":null},{"id":"W2151127655","doi":"10.1158/0008-5472.can-10-2833","title":"LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases β1 Integrin-Mediated Cell Adhesion and Liver Metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; TLR4; Medicine; Cancer research; Colorectal cancer; Cancer; Immunology; Receptor; Internal medicine","score_opus":0.08350852750680367,"score_gpt":0.34026465619218565,"score_spread":0.256756128685382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151127655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908167,0.007933843,0.0000014414582,0.000037994083,0.0001573843,0.00043515553,0.000022537804,0.000032100776,0.0005628526],"genre_scores_gemma":[0.9969401,0.002181705,0.000013962736,0.000027083126,0.000036756916,0.00024284153,0.000041557494,0.000024269346,0.0004917343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976216,0.0010202746,0.00031733664,0.00036567185,0.00010245333,0.0005726918],"domain_scores_gemma":[0.9991027,0.00037315756,0.00008408945,0.00017976078,0.00021263024,0.00004764578],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010710591,0.00017470033,0.0002862333,0.000471636,0.00027877052,0.000024149054,0.0002416635,0.00026783918,0.0029400548],"category_scores_gemma":[0.00010682063,0.00015271346,0.00005176126,0.00037994896,0.0002478827,0.00018327875,0.00018665507,0.0007400283,0.00019891946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009292309,0.000119779594,0.0019274876,0.00005721846,0.00006085764,0.0000254397,0.0026228556,0.0000012479817,0.9902023,0.000035131972,0.0004433573,0.003575086],"study_design_scores_gemma":[0.0011284258,0.00031158142,0.007933819,0.00013604679,0.000021586578,0.0000038368935,0.0009322442,0.0000056990248,0.9882937,0.000028576993,0.0010319585,0.000172498],"about_ca_topic_score_codex":0.02813316,"about_ca_topic_score_gemma":0.0016035906,"teacher_disagreement_score":0.02652957,"about_ca_system_score_codex":0.00022241959,"about_ca_system_score_gemma":0.00023556947,"threshold_uncertainty_score":0.9979714},"labels":[],"label_agreement":null},{"id":"W2151278366","doi":"10.1158/0008-5472.can-07-2057","title":"Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"LNCaP; Androgen receptor; Prostate cancer; Hsp27; Enzalutamide; Transactivation; Cancer research; Gene knockdown; Biology; Heat shock protein; Chemistry; Cell biology; Endocrinology; Internal medicine; Cancer; Hsp70; Medicine; Apoptosis; Transcription factor; Biochemistry","score_opus":0.09593777713391984,"score_gpt":0.4080646734768817,"score_spread":0.31212689634296187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151278366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915291,0.0013614049,0.0028609305,0.0014454153,0.000065623026,0.0012511731,0.00036612403,0.00001357804,0.0011066431],"genre_scores_gemma":[0.9894916,0.00050928554,0.00023451255,0.000026817652,0.00045730695,0.00039304438,0.00009826148,0.000032438897,0.008756757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736595,0.00044002954,0.00021989793,0.0006228172,0.0005885783,0.00076272374],"domain_scores_gemma":[0.99862957,0.00008856671,0.000017501376,0.00033716077,0.00055748085,0.00036969484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001727624,0.00017942389,0.00019791651,0.00018949086,0.00039221623,0.000072462986,0.00024663057,0.00017937423,0.00038027036],"category_scores_gemma":[0.00026642077,0.00017039523,0.00006577531,0.00035544523,0.00044027288,0.000024866631,0.00018778951,0.00074351096,0.00006202352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005524121,0.00006469099,0.0019516844,0.00005332231,0.00009302968,0.0000050630583,0.00020272504,0.000007800647,0.98798865,0.00003694805,0.0018483337,0.0071953456],"study_design_scores_gemma":[0.000518266,0.0004175703,0.0027960485,0.0000404667,0.0000034445989,0.0000042781753,0.00014885486,0.000009749806,0.8339153,0.000030540818,0.16195193,0.00016357403],"about_ca_topic_score_codex":0.00081087876,"about_ca_topic_score_gemma":0.0008141506,"teacher_disagreement_score":0.16010359,"about_ca_system_score_codex":0.00021487783,"about_ca_system_score_gemma":0.0005311122,"threshold_uncertainty_score":0.6948516},"labels":[],"label_agreement":null},{"id":"W2151558996","doi":"10.1158/0008-5472.can-04-3578","title":"Effects of DNA Methylation on Galectin-3 Expression in Pituitary Tumors","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Cancer Institute","keywords":"DNA methylation; Biology; Pituitary tumors; Methylation; Cancer research; Prolactin; Molecular biology; Null cell; Gene expression; Gene; Hormone; Endocrinology; Genetics","score_opus":0.03270018215322294,"score_gpt":0.3650823574676268,"score_spread":0.33238217531440384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151558996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899553,0.007396582,0.0000115063085,0.0003406645,0.00025106195,0.0003497831,0.000005085066,0.000017677428,0.0016723563],"genre_scores_gemma":[0.9979645,0.0004475686,0.000020480476,0.000067194866,0.00008786675,0.0001870018,0.00001000364,0.000012722012,0.0012026576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840236,0.00057622744,0.00021487709,0.00029838033,0.00007625204,0.00043189232],"domain_scores_gemma":[0.9991948,0.00044487498,0.00005381686,0.00018868236,0.0000964912,0.000021305466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005924151,0.000101678015,0.00021907155,0.00033967636,0.00009733498,0.0000037265538,0.00019551207,0.00018739702,0.00056240626],"category_scores_gemma":[0.00015370203,0.00008502828,0.000044160806,0.00036657965,0.00018831997,0.000050458813,0.00006962794,0.00057426555,0.00011489899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004027273,0.00012490303,0.0020879237,0.000054074673,0.000015933292,0.0000030473689,0.00038197855,0.000041684798,0.96457356,0.00012371353,0.00251929,0.029671174],"study_design_scores_gemma":[0.0010496359,0.00037568543,0.042829804,0.00015930626,0.0000028682002,0.0000025343222,0.000065694076,0.0000014714678,0.9450848,0.00014988302,0.010199371,0.00007891002],"about_ca_topic_score_codex":0.00035703316,"about_ca_topic_score_gemma":0.00030162692,"teacher_disagreement_score":0.04074188,"about_ca_system_score_codex":0.00019437453,"about_ca_system_score_gemma":0.0001356226,"threshold_uncertainty_score":0.6157954},"labels":[],"label_agreement":null},{"id":"W2151856174","doi":"10.1158/0008-5472.can-05-0169","title":"Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2–Driven <i>VHL</i> −/− Renal Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":462,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Cancer Research Society","keywords":"Gene silencing; Carcinogenesis; Epidermal growth factor receptor; Cancer research; Biology; Small hairpin RNA; Hypoxia-inducible factors; Growth factor receptor; Cell culture; Cancer; Cell biology; Gene knockdown; Signal transduction; Gene; Genetics","score_opus":0.05687807371830175,"score_gpt":0.35866045416939574,"score_spread":0.30178238045109396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151856174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740989,0.021955647,0.00011861156,0.000756777,0.0010153824,0.00044148194,0.00084208685,0.000024054923,0.000747026],"genre_scores_gemma":[0.97397465,0.01615131,0.00029116805,0.00020909039,0.0062346677,0.00028482295,0.00006299321,0.00007302694,0.0027182826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968295,0.00023895777,0.000439848,0.0007810802,0.0007522482,0.0009583655],"domain_scores_gemma":[0.9980377,0.00008122097,0.00014852751,0.00062888884,0.0007873714,0.00031632022],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003656264,0.00029182885,0.00041985628,0.00019151263,0.00023003602,0.000055489567,0.00063432055,0.0002857908,0.0016570514],"category_scores_gemma":[0.0002712769,0.00027465756,0.00019663534,0.00042032223,0.0003284311,0.000037084163,0.00031814014,0.00048979756,0.000029741112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020128068,0.00007049144,0.0014589601,0.00010613347,0.000109147644,8.0237766e-7,0.00030445989,0.00022914374,0.9342463,0.000032245483,0.047932554,0.015308487],"study_design_scores_gemma":[0.0006329789,0.00010441575,0.0019334059,0.000074273295,0.000013789464,0.0000024556489,0.00007554907,0.000014269271,0.7269799,0.000013553552,0.2699201,0.00023526662],"about_ca_topic_score_codex":0.0020444707,"about_ca_topic_score_gemma":0.0011905286,"teacher_disagreement_score":0.22198755,"about_ca_system_score_codex":0.00016602351,"about_ca_system_score_gemma":0.0010992329,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2151918137","doi":"10.1158/0008-5472.can-06-0018","title":"IMC-EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces Nonobese Diabetic/Severe Combined Immunodeficient Engraftment of Some Acute Lymphoblastic Leukemia Cell Lines and Primary Leukemic Samples","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Center for Research Resources; Wellcome Trust; Leukemia and Lymphoma Society","keywords":"Monoclonal antibody; Cancer research; Nod; Leukemia; Antibody; In vivo; Cell sorting; Cell culture; Acute lymphocytic leukemia; Immunotherapy; Medicine; Immunology; Biology; Immune system; Flow cytometry","score_opus":0.026051094371597607,"score_gpt":0.3313813454030475,"score_spread":0.3053302510314499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151918137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892819,0.007366221,0.00003358802,0.0006556165,0.00018925566,0.0016901322,0.00030720385,0.00008186435,0.0003942115],"genre_scores_gemma":[0.99134034,0.0054274593,0.0008178774,0.000059714384,0.00039690384,0.00026278003,0.00039891186,0.0001227806,0.0011732168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940628,0.00043648324,0.0008865198,0.0012291995,0.0018519876,0.0015330279],"domain_scores_gemma":[0.9965648,0.00090292294,0.00021721498,0.0008219408,0.0009396999,0.0005534081],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016446305,0.0005449312,0.0011428772,0.0007337811,0.00041918742,0.00016794012,0.00054011174,0.0003318199,0.000098253455],"category_scores_gemma":[0.00017823707,0.00046221042,0.00013008463,0.00081398856,0.0018518686,0.00040727278,0.00082195713,0.0008166301,0.000014832377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026265113,0.00067990855,0.017811859,0.0012630094,0.00025295618,0.00016410873,0.00041609726,0.00020212537,0.973146,0.0002951679,0.0010343054,0.002107941],"study_design_scores_gemma":[0.023721702,0.0046461215,0.3213242,0.0012347656,0.0004940712,0.0003240182,0.0009599019,0.008662898,0.63584375,0.0007589409,0.0008854824,0.0011441112],"about_ca_topic_score_codex":0.004650872,"about_ca_topic_score_gemma":0.0000411617,"teacher_disagreement_score":0.33730224,"about_ca_system_score_codex":0.0028878911,"about_ca_system_score_gemma":0.0049801846,"threshold_uncertainty_score":0.999783},"labels":[],"label_agreement":null},{"id":"W2152037292","doi":"10.1158/0008-5472.can-07-6052","title":"A Novel RET Kinase–β-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Beta-catenin; Carcinogenesis; Tyrosine kinase; Biology; Receptor tyrosine kinase; Catenin; GSK-3; Signal transduction; Wnt signaling pathway; Thyroid carcinoma; Endocrinology; Thyroid cancer; Proto-oncogene tyrosine-protein kinase Src; Internal medicine; Cancer; Cell biology; Medicine; Thyroid","score_opus":0.05252819685056034,"score_gpt":0.33191096969754846,"score_spread":0.27938277284698815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152037292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991632,0.0059975735,0.0006308127,0.00080444873,0.00015704604,0.0005258292,0.00006214383,0.000012641769,0.00017753497],"genre_scores_gemma":[0.9973246,0.00032354725,0.00016210282,0.0001030088,0.00040458722,0.0003540424,0.00007302215,0.000039947194,0.0012151627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806714,0.00012289647,0.00026570293,0.0005623423,0.00037222222,0.00060968427],"domain_scores_gemma":[0.9990058,0.000037854745,0.000041146905,0.00037204727,0.00039261958,0.00015053697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061068503,0.00015480981,0.00019496337,0.0002719087,0.00018224625,0.000026901333,0.00028593693,0.0001843566,0.000038576134],"category_scores_gemma":[0.00018219493,0.0001615848,0.00006787361,0.00078338664,0.00013783098,0.000006193651,0.0001761376,0.00023493415,0.000021715568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031881657,0.000044771255,0.008463434,0.000015826652,0.00002283256,0.000017032398,0.0001338252,0.0022876887,0.9845219,0.00003525059,0.0030820956,0.0010564877],"study_design_scores_gemma":[0.00095645513,0.00020549692,0.0205133,0.00004970448,0.0000036196684,0.000013370046,0.00006688289,0.00008744344,0.96552867,0.000031270858,0.01235501,0.00018879722],"about_ca_topic_score_codex":0.0015752699,"about_ca_topic_score_gemma":0.0009921675,"teacher_disagreement_score":0.018993288,"about_ca_system_score_codex":0.00034069997,"about_ca_system_score_gemma":0.00074125506,"threshold_uncertainty_score":0.6589237},"labels":[],"label_agreement":null},{"id":"W2152353081","doi":"10.1158/0008-5472.can-03-2756","title":"Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Loss of heterozygosity; Biology; Locus (genetics); Genetics; Allele; CDKN2A; Chromosome; Carcinogenesis; Gene","score_opus":0.08548270174099934,"score_gpt":0.42682545038658,"score_spread":0.3413427486455807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152353081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756087,0.005481976,0.0006916302,0.0017571988,0.00003295169,0.001231,0.0000678818,0.000023960762,0.0031525565],"genre_scores_gemma":[0.98894775,0.0016728211,0.008099368,0.000065148524,0.00006783072,0.00028242118,0.000032970518,0.0000400555,0.0007916527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970458,0.0002130022,0.0005455268,0.000421674,0.0009919158,0.0007820746],"domain_scores_gemma":[0.996698,0.0010604621,0.00012560091,0.0005698971,0.0012642874,0.00028175244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016562977,0.00018250171,0.00090158504,0.00039241128,0.00013584344,0.000009373615,0.00031588797,0.00016660812,0.0006043513],"category_scores_gemma":[0.0013299972,0.00014711032,0.00012851841,0.00068502454,0.0012158616,0.000091323425,0.000203404,0.0005344999,0.00005541699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021414466,0.00090364,0.92517,0.0018183448,0.0004033505,0.00014328235,0.006120628,0.00009204583,0.059520822,0.0030575912,0.00038574144,0.0002430742],"study_design_scores_gemma":[0.0064384528,0.00404844,0.90826684,0.00086141773,0.00023257874,0.00003488015,0.005438196,0.0005163486,0.06539728,0.007660478,0.0008521008,0.00025301726],"about_ca_topic_score_codex":0.0020690397,"about_ca_topic_score_gemma":0.000370577,"teacher_disagreement_score":0.016903216,"about_ca_system_score_codex":0.00039045897,"about_ca_system_score_gemma":0.0024694481,"threshold_uncertainty_score":0.66172224},"labels":[],"label_agreement":null},{"id":"W2152453694","doi":"10.1158/0008-5472.can-13-2278","title":"Cancer Cells Exploit eIF4E2-Directed Synthesis of Hypoxia Response Proteins to Drive Tumor Progression","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cancer cell; EIF4E; Cancer; Protein biosynthesis; Cancer research; Cell biology; Phenotype; Translation (biology); Hypoxia (environmental); Chemistry; Genetics; Messenger RNA; Gene","score_opus":0.02953992234865828,"score_gpt":0.3569907752408222,"score_spread":0.3274508528921639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152453694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334514,0.003438808,0.00013182539,0.0006685977,0.00063924416,0.0011784873,0.0001454712,0.00003618197,0.00041622875],"genre_scores_gemma":[0.9895785,0.0015711426,0.0010084475,0.00017543981,0.0018142969,0.0033887704,0.000009967293,0.0000793342,0.002374093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968353,0.000741159,0.00031880333,0.0007039408,0.00067764014,0.0007231932],"domain_scores_gemma":[0.99792856,0.00013602662,0.000113057635,0.00075258315,0.0007270336,0.0003427125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015177935,0.00022651422,0.00036030266,0.00024011913,0.00017356379,0.00003724517,0.0005290968,0.00016199135,0.00019250427],"category_scores_gemma":[0.0010467554,0.00020236483,0.00012319075,0.0005454482,0.00024957905,0.000008509053,0.00031644793,0.00026154687,0.000030257374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027311614,0.000088130066,0.0001221347,0.000090300244,0.000051210885,0.0000014809069,0.00017883597,0.000048624435,0.93329865,0.000012902757,0.017924642,0.045451935],"study_design_scores_gemma":[0.00037947137,0.0002933742,0.0016976806,0.00019575706,0.000015548027,0.0000011557637,0.00007008056,0.000020782853,0.7323279,0.000015162814,0.2647965,0.00018661196],"about_ca_topic_score_codex":0.0007261178,"about_ca_topic_score_gemma":0.00042919742,"teacher_disagreement_score":0.24687186,"about_ca_system_score_codex":0.00011166431,"about_ca_system_score_gemma":0.0007989219,"threshold_uncertainty_score":0.8252198},"labels":[],"label_agreement":null},{"id":"W2152643523","doi":"10.1158/0008-5472.can-05-2321","title":"Ubiquitin-Proteasome System Stress Sensitizes Ovarian Cancer to Proteasome Inhibitor–Induced Apoptosis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Proteasome; Apoptosis; Cancer research; Proteasome inhibitor; Ovarian cancer; Ovarian carcinoma; Ubiquitin; Cell growth; Biology; Cancer; Cell biology; Chemistry; Endocrinology; Internal medicine; Medicine; Biochemistry; Gene","score_opus":0.04267547276804309,"score_gpt":0.34092791819319795,"score_spread":0.29825244542515483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152643523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970467,0.0012041114,0.00010722388,0.0013801898,0.0004824045,0.0025807729,0.00049137196,0.00010230117,0.0039469437],"genre_scores_gemma":[0.9879862,0.00008140811,0.00027031646,0.00017979211,0.003930856,0.0041746427,0.00011107984,0.00011349523,0.0031521984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956893,0.00051851396,0.0004455866,0.0010941419,0.0009385895,0.0013138907],"domain_scores_gemma":[0.9977691,0.00003837292,0.00011018585,0.00085659535,0.00079422875,0.00043151376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010766698,0.0003869001,0.00038678016,0.0002749721,0.00049802935,0.00020334788,0.000588136,0.00037597975,0.00014918437],"category_scores_gemma":[0.00012447377,0.00037545283,0.00015537806,0.00068287435,0.00015363173,0.000015233583,0.00050058373,0.0005393575,0.00012776919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031522452,0.00007928339,0.0010053784,0.0003774734,0.00006479248,0.000016670014,0.00010292893,0.00011687162,0.98773175,0.0006740119,0.005971295,0.0035443022],"study_design_scores_gemma":[0.0007877799,0.00032781498,0.00097322627,0.00048480634,0.000015043336,0.000009879685,0.00033464527,0.000023016015,0.97757345,0.00005160659,0.018940032,0.00047872233],"about_ca_topic_score_codex":0.006780563,"about_ca_topic_score_gemma":0.0009108451,"teacher_disagreement_score":0.012968736,"about_ca_system_score_codex":0.00038586475,"about_ca_system_score_gemma":0.00070511556,"threshold_uncertainty_score":0.99986976},"labels":[],"label_agreement":null},{"id":"W2152654745","doi":"10.1158/0008-5472-can-04-3913","title":"<i>PIK3CA</i> Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":886,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"PTEN; Cancer research; P110α; PI3K/AKT/mTOR pathway; Metastasis; Mutation; Cowden syndrome; Biology; Carcinogenesis; Cancer; Internal medicine; Medicine; Signal transduction; Gene; Genetics","score_opus":0.022334606909791364,"score_gpt":0.3242153701023652,"score_spread":0.3018807631925738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152654745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827696,0.009664492,0.00011271842,0.0010349415,0.000024703471,0.00037419368,0.00014155576,0.000011128857,0.00035929916],"genre_scores_gemma":[0.99733955,0.0009971402,0.00040167893,0.00013573683,0.00022458976,0.00021306412,0.00008471332,0.000051210147,0.0005522993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982011,0.00014530445,0.00018719393,0.00060792133,0.0003560467,0.0005024708],"domain_scores_gemma":[0.9991052,0.00003552461,0.00007937486,0.00032817989,0.00026278532,0.00018892673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033435313,0.00020751743,0.00022268454,0.00013818793,0.0002393849,0.00006550705,0.00019736367,0.00013044162,0.000036431353],"category_scores_gemma":[0.000018663417,0.00017231367,0.000021784543,0.0003062783,0.00061527983,0.000019433572,0.00017381065,0.0003905227,0.0000023221596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027628287,0.00023748592,0.2109687,0.00018007364,0.00040538158,0.00019313232,0.0017357516,0.0024354744,0.7639721,0.00014467121,0.005862228,0.011102178],"study_design_scores_gemma":[0.02592944,0.005715749,0.42254922,0.0014010424,0.00037765232,0.0016134161,0.0056848405,0.0008258478,0.44942614,0.0002721459,0.0828315,0.0033730052],"about_ca_topic_score_codex":0.00053994084,"about_ca_topic_score_gemma":0.0020673545,"teacher_disagreement_score":0.31454593,"about_ca_system_score_codex":0.000111162386,"about_ca_system_score_gemma":0.00032521592,"threshold_uncertainty_score":0.70267475},"labels":[],"label_agreement":null},{"id":"W2152713204","doi":"10.1158/0008-5472.can-06-1199","title":"<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Chronic myelogenous leukemia; ABL; Cancer research; Imatinib mesylate; In vivo; Leukemia; Biology; breakpoint cluster region; Pharmacology; Receptor; Immunology; Tyrosine kinase; Genetics","score_opus":0.02715129866584341,"score_gpt":0.33191717612750676,"score_spread":0.30476587746166334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152713204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245864,0.0013944455,0.000016273334,0.00055679237,0.00015503442,0.0010753793,0.00022329437,0.000023027647,0.004097114],"genre_scores_gemma":[0.9963371,0.0004123765,0.00035818384,0.00010705501,0.00024344532,0.00024736286,0.000013113379,0.000058296275,0.002223073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99670047,0.00016243377,0.00052276294,0.0006714004,0.0009914949,0.00095145445],"domain_scores_gemma":[0.99832946,0.0006167807,0.00012104048,0.00052394706,0.00018912414,0.00021963444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080344774,0.00028820598,0.0006810852,0.0005020916,0.000082568695,0.0000384256,0.00017529452,0.00018688677,0.00014240363],"category_scores_gemma":[0.00014397164,0.00026551858,0.00008533669,0.0009940566,0.0003711502,0.00017608429,0.00018308153,0.00077241386,0.000017917213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002560541,0.00081011665,0.0018452841,0.0006495215,0.000034521174,0.00024202261,0.00018305516,0.00012264958,0.9893593,0.000027158516,0.0030588862,0.0011069303],"study_design_scores_gemma":[0.010387181,0.00024179672,0.0050624595,0.0007959876,0.00002847448,0.000012741739,0.00008274164,0.00074449804,0.97777104,0.000051325504,0.004600184,0.00022158811],"about_ca_topic_score_codex":0.00994586,"about_ca_topic_score_gemma":0.0023801406,"teacher_disagreement_score":0.011588291,"about_ca_system_score_codex":0.0025573403,"about_ca_system_score_gemma":0.0015700947,"threshold_uncertainty_score":0.9999797},"labels":[],"label_agreement":null},{"id":"W2152755366","doi":"10.1158/0008-5472.can-03-3334","title":"Menin Inactivation Leads to Loss of Transforming Growth Factor β Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"MEN1; Parathyroid chief cell; Endocrinology; Autocrine signalling; Hyperparathyroidism; Parathyroid hormone; Internal medicine; Paracrine signalling; Primary hyperparathyroidism; Secondary hyperparathyroidism; Transforming growth factor; Cancer research; Parathyroid gland; Secretion; Biology; Endocrine system; Medicine; Hormone; Receptor; Calcium","score_opus":0.04501069485944239,"score_gpt":0.3616503374366834,"score_spread":0.31663964257724103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152755366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157745,0.0047553736,0.0013368656,0.0006643368,0.000011788404,0.0012090968,0.000048071568,0.000014378498,0.00038264663],"genre_scores_gemma":[0.99730426,0.0020082116,0.00019605452,0.000027484124,0.000048878046,0.00022713788,0.00006780307,0.000019517096,0.00010067249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849266,0.00006294638,0.00031636743,0.00028296164,0.00056813285,0.0002769421],"domain_scores_gemma":[0.99912757,0.000034461693,0.00008167538,0.00014590858,0.00046150104,0.00014890051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026291594,0.0001364044,0.00027586106,0.00033156291,0.00009872007,0.000014676645,0.000041103314,0.00010691197,0.0000057641278],"category_scores_gemma":[0.000051477717,0.00012143121,0.000045287245,0.0005767492,0.0001155741,0.00023889789,0.00001986512,0.00019631897,0.0000063209413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011333113,0.00032789388,0.0035357324,0.00007163707,0.00002251315,0.000006883493,0.0025375602,0.000045100063,0.9913804,0.00037393987,0.00030954462,0.0002554832],"study_design_scores_gemma":[0.004508927,0.0018349322,0.03176202,0.00006428077,0.00002497312,0.00000604186,0.0002910146,0.000017811946,0.96071553,0.0006382842,0.0000387426,0.00009742112],"about_ca_topic_score_codex":0.00048097383,"about_ca_topic_score_gemma":0.000062562045,"teacher_disagreement_score":0.030664848,"about_ca_system_score_codex":0.0002910146,"about_ca_system_score_gemma":0.0002952346,"threshold_uncertainty_score":0.4951821},"labels":[],"label_agreement":null},{"id":"W2153074282","doi":"10.1158/0008-5472.can-05-2879","title":"Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non–Small Cell Lung Cancer Both <i>In vitro</i> and <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Cancer research; Transfection; Translation (biology); Biology; Cancer; Lung cancer; Cell culture; Cell; Molecular biology; Internal medicine; Medicine; Messenger RNA; Genetics; Gene","score_opus":0.02177370343206645,"score_gpt":0.30994262923217336,"score_spread":0.2881689258001069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153074282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848027,0.012778961,0.00021936801,0.00057991047,0.00004091388,0.0006660947,0.000041631665,0.000002045501,0.00086832885],"genre_scores_gemma":[0.9952444,0.0038574734,0.00006483489,0.000033293814,0.00007728279,0.00026743804,0.000006112916,0.000018612958,0.00043059356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986618,0.00020266604,0.00024867317,0.00033050263,0.00022234715,0.0003340176],"domain_scores_gemma":[0.9996134,0.00006080947,0.000041822186,0.00020632391,0.00004595659,0.000031678046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080369494,0.00010692161,0.00015340984,0.000093251285,0.000043287953,0.000013242408,0.00017287231,0.000129951,0.000031375173],"category_scores_gemma":[0.000010353375,0.00007671022,0.00003348246,0.00017947923,0.000074448915,0.00000690494,0.000030674953,0.0001545086,3.2956655e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004935888,0.000040889583,0.0043759556,0.00009813218,0.000004125527,0.0000032402168,0.00021438366,0.00029962536,0.9862536,0.000004979662,0.00007516955,0.008136272],"study_design_scores_gemma":[0.0009843067,0.00003326424,0.0018177337,0.0001442147,0.000004287514,4.1572747e-7,0.00008680066,0.0001482054,0.9959588,0.00013450666,0.0005909807,0.00009648633],"about_ca_topic_score_codex":0.0052037193,"about_ca_topic_score_gemma":0.008461418,"teacher_disagreement_score":0.0104416115,"about_ca_system_score_codex":0.00004871575,"about_ca_system_score_gemma":0.00013109409,"threshold_uncertainty_score":0.7866502},"labels":[],"label_agreement":null},{"id":"W2153448114","doi":"10.1158/0008-5472.can-12-4031","title":"Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intracellular pH; Homeostasis; Cell biology; Metastasis; Gene isoform; Chemistry; Cytoplasm; Cancer cell; Sodium–hydrogen antiporter; Cytosol; Cancer; Intracellular; Biology; Biochemistry; Enzyme; Sodium; Gene","score_opus":0.11188681907078199,"score_gpt":0.41550743662967843,"score_spread":0.30362061755889647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153448114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004328537,0.99394715,0.00000767132,0.00020233377,0.0002446111,0.00091815053,0.00023788199,0.0000031125014,0.00011056435],"genre_scores_gemma":[0.010636149,0.9848969,0.0000073081856,0.000011227696,0.00042910816,0.0009846748,0.00018709138,0.00004464467,0.0028029198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981733,0.00029711667,0.00037213837,0.0003859614,0.00043481085,0.00033668152],"domain_scores_gemma":[0.9989561,0.000016542763,0.00016823446,0.0004906492,0.00031471715,0.000053749514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005069518,0.00020099121,0.0004797986,0.00017749664,0.00006894417,0.000016944046,0.0004065551,0.00034219542,0.0005271901],"category_scores_gemma":[0.000012074105,0.00013263227,0.00026334036,0.00060129305,0.00017236601,0.0000056163417,0.000111202135,0.00031040574,0.000008227822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002875721,0.00003933473,0.00016972913,0.00524564,0.00013291666,5.766723e-7,0.000052362113,0.00003090691,0.008766167,0.00004156178,0.004420439,0.9810716],"study_design_scores_gemma":[0.00019219024,0.000020729953,0.0016426943,0.0035655878,0.00009333258,0.000004635984,0.000021013713,0.000005741382,0.0050924444,0.000031615105,0.98912823,0.00020180158],"about_ca_topic_score_codex":0.0007748379,"about_ca_topic_score_gemma":0.00037485504,"teacher_disagreement_score":0.9847078,"about_ca_system_score_codex":0.00013772794,"about_ca_system_score_gemma":0.0005869873,"threshold_uncertainty_score":0.57723624},"labels":[],"label_agreement":null},{"id":"W2153599990","doi":"10.1158/0008-5472.can-10-0944","title":"Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Ku70; RAD51; DNA repair protein XRCC4; DNA repair; Biology; Molecular biology; Cancer research; DNA damage; Chromatin immunoprecipitation; Gene knockdown; Cell biology; Gene expression; Promoter; Cell culture; Gene; DNA; Nucleotide excision repair; Genetics","score_opus":0.015855777099364757,"score_gpt":0.299008811501634,"score_spread":0.28315303440226924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153599990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340516,0.0038565346,0.000054188,0.00016104055,0.00021394316,0.00057718914,0.00016913809,0.00004481153,0.0015179918],"genre_scores_gemma":[0.99596524,0.0002574568,0.00017550099,0.000073356736,0.0002701156,0.00019428307,0.00009671423,0.00005218114,0.0029151398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979556,0.00013468189,0.00024770584,0.0005750907,0.00052203215,0.0005648802],"domain_scores_gemma":[0.99848217,0.00003154871,0.000089719055,0.0007644062,0.00041920203,0.00021293278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007314075,0.00019084102,0.00024244988,0.00008125663,0.00012805179,0.00003352154,0.0004316638,0.00025307,0.00037768565],"category_scores_gemma":[0.000032429616,0.00017772573,0.00016095083,0.00017738611,0.0002651392,0.000008305394,0.00013940732,0.00034641984,0.000019087083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000657198,0.00009477806,0.0016348924,0.00005708272,0.00006514173,0.0000060504535,0.00002928513,0.000014382817,0.9904914,0.000058267324,0.00611346,0.00077808916],"study_design_scores_gemma":[0.002154973,0.0002442827,0.00034814188,0.000015636797,0.000017462004,0.000012532892,0.00006681274,0.00009836051,0.9095794,0.00006927403,0.08721725,0.00017589048],"about_ca_topic_score_codex":0.00048746978,"about_ca_topic_score_gemma":0.00033406945,"teacher_disagreement_score":0.08110379,"about_ca_system_score_codex":0.00003077052,"about_ca_system_score_gemma":0.0003030822,"threshold_uncertainty_score":0.72474444},"labels":[],"label_agreement":null},{"id":"W2153725546","doi":"10.1158/0008-5472.can-13-3596","title":"Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1–PD-L1 Axis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; American Cancer Society","keywords":"Chemoimmunotherapy; Cyclophosphamide; Cancer research; Medicine; Myeloid-derived Suppressor Cell; Immune system; Immunotherapy; Immunology; Myeloid; Cancer; Chemotherapy; Pharmacology; Internal medicine; Suppressor","score_opus":0.03998289898138229,"score_gpt":0.3433612938903187,"score_spread":0.3033783949089364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153725546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974356,0.005773635,0.00011126166,0.0048567047,0.003900067,0.0006533766,0.000035017103,0.000086403066,0.010227528],"genre_scores_gemma":[0.89080256,0.0019942806,0.000008225937,0.0013460306,0.00015168826,0.00020139645,0.00006984444,0.000048091242,0.10537787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664336,0.0015208287,0.00035882182,0.0005182163,0.00017368293,0.0007851029],"domain_scores_gemma":[0.9979137,0.00074495526,0.00015345604,0.00076651893,0.00038881638,0.000032533204],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010455687,0.00025389873,0.00030356486,0.00013637268,0.00090214453,0.000099895886,0.00067824393,0.00028349715,0.005689338],"category_scores_gemma":[0.00016846301,0.00018182132,0.00013615146,0.0003689658,0.0005265261,0.00024126541,0.00016666943,0.0013902646,0.0029658482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014065257,0.00009166473,0.000036904836,0.000015965625,0.00007865785,9.2880816e-7,0.000901555,0.000002233349,0.7373971,0.00004955484,0.2580037,0.0020152107],"study_design_scores_gemma":[0.00093936006,0.00023120882,0.00037020605,0.000030088318,0.000007516481,0.0000050733356,0.00053563365,0.0000030410863,0.55218005,0.000033360746,0.44553947,0.00012498836],"about_ca_topic_score_codex":0.0020706134,"about_ca_topic_score_gemma":0.00002338241,"teacher_disagreement_score":0.18753576,"about_ca_system_score_codex":0.00018240565,"about_ca_system_score_gemma":0.00018803249,"threshold_uncertainty_score":0.9978105},"labels":[],"label_agreement":null},{"id":"W2154101400","doi":"10.1158/0008-5472.can-03-2270","title":"Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation in <b> <i>p53</i> </b>+/− Mutant Mice","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Prevent Cancer Foundation","keywords":"Mammary gland; Biology; Mammary tumor; Carcinogenesis; BRCA2 Protein; Cancer research; Involution (esoterism); Adenocarcinoma; Tumor suppressor gene; Epithelium; Genetically modified mouse; Breast cancer; Internal medicine; Cancer; Transgene; Mutation; Germline mutation; Gene; Medicine; Genetics","score_opus":0.04022672030561803,"score_gpt":0.3208763635096949,"score_spread":0.28064964320407687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154101400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042077,0.0060117613,0.00300275,0.007251611,0.00023890864,0.0019336519,0.00003392923,0.00015472074,0.0009518961],"genre_scores_gemma":[0.99444604,0.0010881592,0.0026041623,0.00049240625,0.00015693552,0.0006739068,0.00004853073,0.0000659254,0.0004239527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959518,0.00016875543,0.0006521347,0.0007157688,0.0013537577,0.0011577925],"domain_scores_gemma":[0.99828994,0.00007821395,0.00010647163,0.0007026412,0.00047704106,0.00034567597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001236505,0.0003006568,0.00039951366,0.0007674306,0.00023800234,0.0000905578,0.0005109775,0.0002519637,0.000054426317],"category_scores_gemma":[0.00021434228,0.0002460334,0.00010434958,0.0012306293,0.00017469568,0.00045110544,0.00035906694,0.0010990258,0.00012102235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055369735,0.00041198524,0.0013991953,0.000986998,0.000048304286,0.0014462211,0.004367573,0.00012887354,0.96812016,0.0006595646,0.00028682622,0.021590598],"study_design_scores_gemma":[0.0035474566,0.00037832314,0.0129461,0.0009290978,0.000019012316,0.00039629385,0.00041312026,0.00014918673,0.9786037,0.00060389313,0.0016600817,0.00035369425],"about_ca_topic_score_codex":0.0011768364,"about_ca_topic_score_gemma":0.0008308496,"teacher_disagreement_score":0.021236904,"about_ca_system_score_codex":0.0031312709,"about_ca_system_score_gemma":0.0032227493,"threshold_uncertainty_score":0.99999917},"labels":[],"label_agreement":null},{"id":"W2154213970","doi":"10.1158/0008-5472.can-04-4369","title":"Ceratamines, Structurally Simple Microtubule-Stabilizing Antimitotic Agents with Unusual Cellular Effects","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microtubule; Mitosis; Tubulin; Cell biology; Interphase; Paclitaxel; Microtubule nucleation; Microtubule polymerization; In vitro; Biology; Centrosome; Cell cycle; Chemistry; Cell; Biochemistry; Genetics; Cancer","score_opus":0.02360421169502985,"score_gpt":0.3322270268055038,"score_spread":0.30862281511047396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154213970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961163,0.0021618395,0.00050738774,0.00019373409,0.00009270967,0.0005701922,0.000040985396,0.00001870658,0.00029816182],"genre_scores_gemma":[0.99641824,0.00057412405,0.00067962025,0.00023167563,0.000717019,0.0001009135,0.00020479802,0.000062759806,0.0010108518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979442,0.00015952495,0.00019682676,0.00059907854,0.00036723854,0.0007331806],"domain_scores_gemma":[0.9989249,0.000033999662,0.000048245336,0.0005410059,0.0002728979,0.00017892121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028119658,0.00022609653,0.00019709198,0.000106375235,0.00020444434,0.000088216686,0.00040676704,0.0001629864,0.00009609405],"category_scores_gemma":[0.000052822794,0.00019106227,0.00006797245,0.00026111148,0.00020063437,0.000012002377,0.00023690631,0.0003111203,0.000027289407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014139622,0.000049088067,0.0028616781,0.00012965754,0.000070953785,0.000017030336,0.000086868655,0.0003774859,0.9855477,0.00002171744,0.0057450263,0.0049514],"study_design_scores_gemma":[0.0009247067,0.000322126,0.0017359958,0.000051601284,0.000017318234,0.00001283381,0.000056592402,0.00021985956,0.94132227,0.000013852219,0.0550544,0.0002684466],"about_ca_topic_score_codex":0.00014409295,"about_ca_topic_score_gemma":0.00050160853,"teacher_disagreement_score":0.049309373,"about_ca_system_score_codex":0.00011142887,"about_ca_system_score_gemma":0.0002793347,"threshold_uncertainty_score":0.7791293},"labels":[],"label_agreement":null},{"id":"W2154267969","doi":"10.1158/0008-5472.can-05-2304","title":"Preferential Dependence of Breast Cancer Cells versus Normal Cells on Integrin-Linked Kinase for Protein Kinase B/Akt Activation and Cell Survival","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children’s Health Research Institute; BC Cancer Agency","funders":"","keywords":"Integrin-linked kinase; Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Kinase; Cancer; Breast cancer; Phosphorylation; Cancer cell; Biology; Cell biology; Protein kinase A; Signal transduction; Chemistry; Internal medicine; Medicine; Cyclin-dependent kinase 2","score_opus":0.070167984886412,"score_gpt":0.3783176704807769,"score_spread":0.3081496855943649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154267969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436206,0.0001948768,0.00022611591,0.0005522852,0.00023738663,0.0027082968,0.0002772004,0.000027484853,0.0014143144],"genre_scores_gemma":[0.9937114,0.00019627198,0.0002225366,0.00001502269,0.00049438264,0.0008756917,0.000051386298,0.000065468405,0.0043677986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962496,0.0002597081,0.00039506739,0.0006790868,0.0015850564,0.00083146925],"domain_scores_gemma":[0.997558,0.00039058446,0.000117350646,0.00048187465,0.001143696,0.00030851437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080529304,0.00025116425,0.00038402606,0.00034806426,0.00018531813,0.000060891143,0.00029590537,0.0002136022,0.0007950916],"category_scores_gemma":[0.00009780796,0.00022222199,0.000110958834,0.00054773374,0.0003320341,0.00012700296,0.00021700528,0.0008978381,0.00002451616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014329267,0.0005392275,0.00029136665,0.0009659582,0.000034557375,0.000017774615,0.00007022892,0.00013011393,0.97423863,0.00010551862,0.0015115648,0.0077657667],"study_design_scores_gemma":[0.006001991,0.0011764984,0.0034763224,0.00039831252,0.00002893676,0.0000011219818,0.00013430366,0.0004164412,0.9865153,0.000035782534,0.0016207217,0.00019430622],"about_ca_topic_score_codex":0.008079396,"about_ca_topic_score_gemma":0.00091139437,"teacher_disagreement_score":0.012276606,"about_ca_system_score_codex":0.00058016955,"about_ca_system_score_gemma":0.0008510344,"threshold_uncertainty_score":0.9985259},"labels":[],"label_agreement":null},{"id":"W2154284454","doi":"10.1158/0008-5472.can-04-2630","title":"One-Carbon Metabolism,<i>MTHFR</i>Polymorphisms, and Risk of Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Environmental Health Sciences; Health Canada","keywords":"Methylenetetrahydrofolate reductase; Breast cancer; Multivitamin; Odds ratio; Medicine; Internal medicine; Oncology; Cancer; Population; Genotype; Allele; Physiology; Gynecology; Endocrinology; Gastroenterology; Vitamin; Genetics; Biology; Environmental health; Gene","score_opus":0.06223820339988635,"score_gpt":0.39183588945379816,"score_spread":0.3295976860539118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154284454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638631,0.026859283,0.0000016063879,0.005119627,0.000063604675,0.00050028827,0.0001871932,0.000027729919,0.0033775836],"genre_scores_gemma":[0.9496147,0.044719037,0.000110645495,0.000101066296,0.0008871153,0.0001713457,0.0000057211214,0.00004529405,0.0043450613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99698365,0.00022236815,0.00029775078,0.0004456541,0.0012947025,0.00075588166],"domain_scores_gemma":[0.9982185,0.00014532433,0.00006264441,0.00049067836,0.0006816507,0.0004012483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011662578,0.000156429,0.00044767375,0.0004625308,0.0001364437,0.000030826344,0.00021613312,0.00014477452,0.0014527895],"category_scores_gemma":[0.00010697138,0.00013261738,0.0000807469,0.0008268539,0.0005552724,0.00012225423,0.00020670456,0.00092010526,0.000029618923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020856548,0.0005508231,0.16886175,0.0004678248,0.00089760014,0.000029772293,0.0010251033,0.000018403967,0.4389056,0.00030668,0.0066995975,0.38015118],"study_design_scores_gemma":[0.004173061,0.00030735464,0.77075154,0.0004987637,0.00030361928,0.000047364374,0.00022122764,0.0007524614,0.17822757,0.00012331123,0.044281743,0.00031195272],"about_ca_topic_score_codex":0.01584179,"about_ca_topic_score_gemma":0.0015667366,"teacher_disagreement_score":0.6018898,"about_ca_system_score_codex":0.00022254173,"about_ca_system_score_gemma":0.0006781776,"threshold_uncertainty_score":0.99946004},"labels":[],"label_agreement":null},{"id":"W2154481619","doi":"10.1158/0008-5472.can-05-0239","title":"Caspase-1α Is Down-regulated in Human Ovarian Cancer Cells and the Overexpression of Caspase-1α Induces Apoptosis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Apoptosis; Caspase 10; Caspase 3; Caspase 8; Caspase; Biology; Molecular biology; Caspase-9; Cell culture; Ovarian cancer; Western blot; XIAP; Cancer research; Caspase 2; Cell biology; Programmed cell death; Cancer; Gene; Biochemistry; Genetics","score_opus":0.03503610504854773,"score_gpt":0.3558045035064654,"score_spread":0.3207683984579177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154481619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492276,0.003002524,0.000015437388,0.0011567618,0.00006503453,0.00042728905,0.00005203513,0.000004591079,0.0003535637],"genre_scores_gemma":[0.995137,0.0025159142,0.000054420263,0.00010777845,0.00030935594,0.0001312617,0.00002804525,0.00002243878,0.0016938194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984754,0.00020175264,0.000252513,0.00038891786,0.00033543925,0.0003460209],"domain_scores_gemma":[0.9992676,0.000030221096,0.00008480272,0.00036146806,0.00017084727,0.00008506936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006241182,0.00014060886,0.00019433825,0.00011823917,0.00019085343,0.000035348374,0.00021106227,0.0002214367,0.0002956412],"category_scores_gemma":[0.000018068095,0.00009832662,0.00005794165,0.00024228718,0.0002819116,0.000009622311,0.00019784222,0.00022986105,0.0000017426372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022934908,0.000040953648,0.000095136595,0.00004365855,0.000031997846,6.409738e-7,0.00046013057,0.00033579586,0.98929524,0.00023081586,0.0021319697,0.0071043367],"study_design_scores_gemma":[0.0016525933,0.000072844006,0.0011498389,0.00011957273,0.0000110646415,0.0000012528014,0.00013437789,0.00026468915,0.9904179,0.00018100496,0.0058687213,0.00012616963],"about_ca_topic_score_codex":0.005594361,"about_ca_topic_score_gemma":0.001127292,"teacher_disagreement_score":0.006978167,"about_ca_system_score_codex":0.00006664598,"about_ca_system_score_gemma":0.00013423988,"threshold_uncertainty_score":0.8457038},"labels":[],"label_agreement":null},{"id":"W2154544186","doi":"10.1158/0008-5472.can-05-1435","title":"Regulation of Prostaglandin Metabolism by Calcitriol Attenuates Growth Stimulation in Prostate Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Calcitriol; Calcitriol receptor; Prostate cancer; Endocrinology; Internal medicine; Prostaglandin E2; Cell growth; Cancer research; Prostate; Vitamin D and neurology; Prostaglandin; Cancer; Chemistry; Pharmacology; Medicine; Biochemistry","score_opus":0.02992517046008704,"score_gpt":0.3707475122924515,"score_spread":0.3408223418323645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154544186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940266,0.0030727666,0.0000075256776,0.0011727402,0.000117568256,0.0013840667,0.000059160004,0.000019981982,0.00013960926],"genre_scores_gemma":[0.99669886,0.0009357166,0.000054240518,0.00005668224,0.0003886605,0.00042380713,0.000042077627,0.00002978273,0.0013701613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980818,0.00017581254,0.00033558288,0.0002817777,0.0006836059,0.00044144742],"domain_scores_gemma":[0.9989949,0.00013399459,0.00008537913,0.00018901029,0.0004574635,0.00013925608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010396858,0.00012681608,0.00031142568,0.0003418935,0.00006080685,0.000014068431,0.000079635494,0.00009614842,0.00025240064],"category_scores_gemma":[0.00012119116,0.0001050356,0.000043931814,0.0006267615,0.0001247092,0.00015580526,0.000033830907,0.00035633403,0.000020332756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082656124,0.00009342048,0.09164074,0.00041351147,0.00002614553,0.000006584228,0.0013063815,0.0004887664,0.8883869,0.00006709942,0.007543365,0.009200488],"study_design_scores_gemma":[0.0026560174,0.00009940366,0.14653873,0.0003148776,0.000022326743,9.694633e-7,0.00003657473,0.0024443923,0.8421345,0.00007587899,0.005559034,0.00011731755],"about_ca_topic_score_codex":0.001855859,"about_ca_topic_score_gemma":0.00028786148,"teacher_disagreement_score":0.05489799,"about_ca_system_score_codex":0.0003792027,"about_ca_system_score_gemma":0.00036200412,"threshold_uncertainty_score":0.42832273},"labels":[],"label_agreement":null},{"id":"W2154562194","doi":"10.1158/0008-5472.can-12-4038","title":"Endothelial-Specific Notch Blockade Inhibits Vascular Function and Tumor Growth through an eNOS-Dependent Mechanism","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada","keywords":"Nitric oxide; Notch signaling pathway; Enos; Cell biology; Angiogenesis; Endothelial stem cell; Vascular endothelial growth factor B; Vascular endothelial growth factor A; Vascular endothelial growth factor; Biology; Nitric Oxide Synthase Type III; Soluble guanylyl cyclase; Sprouting angiogenesis; Vascular endothelial growth inhibitor; Cancer research; Endothelium; Vascular endothelial growth factor C; Signal transduction; Nitric oxide synthase; Chemistry; Endocrinology; Neovascularization; Biochemistry","score_opus":0.0414148594490239,"score_gpt":0.3245796845804184,"score_spread":0.2831648251313945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154562194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859938,0.0059990156,0.006069829,0.00026029753,0.0002988095,0.00033415447,0.00003832391,0.000021836498,0.0009839019],"genre_scores_gemma":[0.9903526,0.006788079,0.00021505018,0.00029421365,0.0015290569,0.0002072473,0.000034852193,0.0000531688,0.00052577775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793035,0.00024715866,0.00018043048,0.00067945075,0.000471994,0.00049061014],"domain_scores_gemma":[0.9990203,0.00002156984,0.000045070767,0.0004558452,0.00029830588,0.0001589109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007907734,0.00017844774,0.00017257567,0.00006673802,0.00027552454,0.00007490525,0.00023252428,0.00015071267,0.0001541312],"category_scores_gemma":[0.000041334966,0.0001620661,0.000080184094,0.00014541716,0.00014818473,0.000016866734,0.00018962933,0.00019727656,0.000026098385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013885136,0.00005160958,0.00041720117,0.00003409282,0.00004861795,0.000001783698,0.00007194907,0.000010258,0.9898833,0.0055649457,0.0011195412,0.0026578237],"study_design_scores_gemma":[0.00078712957,0.0005222076,0.0006680915,0.000024734816,0.0000148953595,0.000007070686,0.000109643064,0.00002464605,0.87786454,0.0028612965,0.11689278,0.00022294192],"about_ca_topic_score_codex":0.00032196095,"about_ca_topic_score_gemma":0.000116323885,"teacher_disagreement_score":0.11577324,"about_ca_system_score_codex":0.000057268113,"about_ca_system_score_gemma":0.000113168564,"threshold_uncertainty_score":0.6608864},"labels":[],"label_agreement":null},{"id":"W2154575661","doi":"10.1158/0008-5472.can-05-3003","title":"The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"FOXM1; Cancer research; Biology; Cell cycle; Cyclin B1; Cell growth; Carcinogenesis; Lung cancer; Cancer; Pathology; Cyclin-dependent kinase 1; Medicine","score_opus":0.03202361172419579,"score_gpt":0.34090243086175326,"score_spread":0.3088788191375575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154575661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959579,0.0025946314,0.00041722675,0.0002152444,0.00012796473,0.00059176824,0.00005251796,0.0000056542535,0.000037078265],"genre_scores_gemma":[0.9988017,0.00017789766,0.0000697556,0.000005943409,0.00013481261,0.00020384116,0.00003506144,0.000016541378,0.00055445347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987174,0.000114512965,0.0003098496,0.00019708138,0.00040607507,0.00025507418],"domain_scores_gemma":[0.9992807,0.00002405868,0.00008563159,0.00021930762,0.00036192592,0.000028405717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034476529,0.00009654683,0.00009626157,0.000048327798,0.00029995517,0.000027989101,0.00019797229,0.000063094,0.000039880044],"category_scores_gemma":[0.000013612182,0.00006291185,0.000057016092,0.00015559806,0.00017397039,0.00000977966,0.000024442174,0.000119363205,8.0072704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020056118,0.000026739963,0.006056458,0.00011334084,0.000035092202,9.9154974e-8,0.00029376417,0.0018897309,0.99013996,0.000039852996,0.0003040576,0.00090035883],"study_design_scores_gemma":[0.0003461016,0.000033312022,0.06414015,0.00004290206,0.000006882501,2.9515675e-7,0.000052093696,0.00026374776,0.93115234,0.000018326695,0.0038775704,0.00006630454],"about_ca_topic_score_codex":0.0002793121,"about_ca_topic_score_gemma":0.0014338433,"teacher_disagreement_score":0.05898763,"about_ca_system_score_codex":0.000096546806,"about_ca_system_score_gemma":0.00028628312,"threshold_uncertainty_score":0.2565471},"labels":[],"label_agreement":null},{"id":"W2154695733","doi":"10.1158/0008-5472.can-07-6778","title":"Down-regulation of Na+/H+ Exchanger Regulatory Factor 1 Increases Expression and Function of Multidrug Resistance Protein 4","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Internalization; Efflux; Cell biology; Transport protein; Transporter; Transmembrane protein; Small interfering RNA; ATP-binding cassette transporter; Biology; Chemistry; Biochemistry; Cell; RNA; Receptor; Gene","score_opus":0.059146342925525654,"score_gpt":0.32889674949283665,"score_spread":0.269750406567311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154695733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496496,0.0034861658,0.00019322538,0.00010576348,0.000048150818,0.000787917,0.000041147363,0.00002447251,0.00034818382],"genre_scores_gemma":[0.9928394,0.00044609123,0.0004464611,0.000007685166,0.00009873609,0.00012804332,0.000020298434,0.000023832476,0.005989477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982373,0.000087624256,0.00029551057,0.00028896626,0.00084300194,0.00024756574],"domain_scores_gemma":[0.9989081,0.000054296932,0.00011201122,0.00032886432,0.0004632863,0.00013342661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037317976,0.00011715569,0.00030277585,0.00024868775,0.00013600364,0.0000034177697,0.00007277699,0.00011828272,0.00028950578],"category_scores_gemma":[0.000059485606,0.00009278165,0.000059687958,0.0003187318,0.0003965121,0.000117704825,0.000028810247,0.00020367675,0.0000018010654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020257875,0.000116994655,0.006618898,0.00090368156,0.000023622375,0.000008133541,0.0005452477,0.0000019001717,0.98764527,0.00013066512,0.00039967737,0.0015801364],"study_design_scores_gemma":[0.0010829291,0.00011959014,0.23584267,0.0010093779,0.000013571834,0.000001689993,0.00012571429,0.000008565738,0.7605356,0.00013332706,0.0010532931,0.00007367888],"about_ca_topic_score_codex":0.0002535404,"about_ca_topic_score_gemma":0.000105572195,"teacher_disagreement_score":0.22922377,"about_ca_system_score_codex":0.00008492635,"about_ca_system_score_gemma":0.00023616904,"threshold_uncertainty_score":0.37835258},"labels":[],"label_agreement":null},{"id":"W2154750559","doi":"10.1158/0008-5472.can-12-1160","title":"Molecular Signature of Smoking in Human Lung Tissues","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval","keywords":"Gene; Lung cancer; Gene expression; Gene expression profiling; Smoking cessation; Medicine; Cancer; Lung; Biology; Genetics; Oncology; Bioinformatics; Internal medicine; Pathology","score_opus":0.03559240175348493,"score_gpt":0.3940959791792365,"score_spread":0.35850357742575156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154750559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749809,0.02378867,0.000090204776,0.00011582815,0.00006141525,0.00013303905,0.0000128157035,0.000002986359,0.00081417017],"genre_scores_gemma":[0.99912494,0.0003700928,0.000023684279,0.00004379501,0.00016020545,0.0000400949,0.000024873016,0.000017246373,0.0001950528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903464,0.000104400715,0.000120776196,0.00015243363,0.00021553399,0.00037222577],"domain_scores_gemma":[0.999628,0.000009745319,0.000015212952,0.00019855163,0.00007310474,0.00007538766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040790573,0.000072834686,0.00009750061,0.00008544519,0.000045295536,0.0000073043852,0.00015827734,0.00012177925,0.00010463428],"category_scores_gemma":[0.000018394894,0.000069709866,0.000042686355,0.00016702541,0.00008435899,0.0000038729563,0.000058835023,0.00021772459,0.0000013077279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029884792,0.000042211792,0.015332967,0.000042602096,0.000018680617,0.0000042168203,0.0002099325,0.00006172836,0.9820425,0.0011100039,0.00056653935,0.00053876464],"study_design_scores_gemma":[0.00029583453,0.000073788586,0.0038121527,0.00004496534,0.0000045014835,0.0000015229438,0.00006869823,0.000004016164,0.9894354,0.00007122124,0.006101957,0.000085956715],"about_ca_topic_score_codex":0.00038703583,"about_ca_topic_score_gemma":0.000048634593,"teacher_disagreement_score":0.024144085,"about_ca_system_score_codex":0.000024540763,"about_ca_system_score_gemma":0.00005032475,"threshold_uncertainty_score":0.2842686},"labels":[],"label_agreement":null},{"id":"W2154852632","doi":"10.1158/0008-5472.can-04-2223","title":"Ectopic Expression of Interferon Regulatory Factor-1 Promotes Human Breast Cancer Cell Death and Results in Reduced Expression of Survivin","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Survivin; Ectopic expression; Interferon regulatory factors; Cancer research; Human breast; Interferon; Cancer; Breast cancer; Biology; Medicine; Internal medicine; Transcription factor; Immunology; Gene; Genetics","score_opus":0.05519449552755367,"score_gpt":0.3628891065268729,"score_spread":0.3076946109993192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154852632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249184,0.006286732,0.0000022569354,0.00012855284,0.0001662953,0.00036072027,0.0001650606,0.00001441782,0.00038414536],"genre_scores_gemma":[0.99765617,0.0007734668,0.000013100474,0.0000046102464,0.000022732585,0.00006722272,0.000018402898,0.000021371492,0.0014229321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978927,0.00062333426,0.0005344158,0.0003931432,0.0001248612,0.00043157963],"domain_scores_gemma":[0.99901503,0.00015125825,0.00016838906,0.00040499796,0.00022542622,0.000034895198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006501297,0.00016834194,0.00037166043,0.0002726063,0.00011357494,0.000009730414,0.00030521693,0.00025537508,0.00049217755],"category_scores_gemma":[0.00007356879,0.00013571138,0.000053169715,0.00016166766,0.0003948039,0.00012772785,0.0002694419,0.0004842338,0.000004792039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028292283,0.00020029403,0.0028473847,0.0001761521,0.000014740606,0.0000017372556,0.0022137496,0.000005811075,0.9905996,0.000044641714,0.00019862744,0.0008680517],"study_design_scores_gemma":[0.0024646476,0.0004479689,0.07614365,0.0015438055,0.00000382976,0.00000518062,0.0004905146,2.5043005e-7,0.9186154,0.00005896002,0.00010993183,0.000115874995],"about_ca_topic_score_codex":0.008121512,"about_ca_topic_score_gemma":0.0008801863,"teacher_disagreement_score":0.073296264,"about_ca_system_score_codex":0.00027921994,"about_ca_system_score_gemma":0.0002897123,"threshold_uncertainty_score":0.9984835},"labels":[],"label_agreement":null},{"id":"W2155051272","doi":"10.1158/0008-5472.can-05-4627","title":"Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; Cancer research; Tumor suppressor gene; Bladder cancer; Urothelium; Pathology; Protein kinase B; Cancer; Hyperplasia; Carcinoma; Urinary bladder; Biology; PI3K/AKT/mTOR pathway; Medicine; Carcinogenesis; Internal medicine; Signal transduction","score_opus":0.02958327603748246,"score_gpt":0.34747009804866896,"score_spread":0.3178868220111865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155051272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917903,0.006502939,0.0000011602004,0.00023263531,0.000066335895,0.00066436763,0.000044738026,0.000006076012,0.00069145265],"genre_scores_gemma":[0.99798113,0.00022491773,0.000029188326,0.000048558555,0.00019023637,0.00062890444,0.000035026642,0.000035569792,0.0008264881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980356,0.00015567354,0.0002566605,0.0006433486,0.00033707294,0.0005716607],"domain_scores_gemma":[0.99941456,0.000016812091,0.000048799393,0.00024222818,0.00018430466,0.000093318624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042884686,0.00016998775,0.00018462227,0.0001964658,0.00011007669,0.000047497804,0.00019299441,0.00017356347,0.00003782239],"category_scores_gemma":[0.00004752529,0.00016906497,0.000023870487,0.00029018527,0.00026044712,0.0000085709,0.00020809434,0.00032373032,0.000001513665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116636205,0.00008593094,0.14974493,0.000054337157,0.000010716177,0.00000724581,0.00012023302,0.000060577087,0.8476277,0.000029914396,0.00089436234,0.0012474284],"study_design_scores_gemma":[0.0028937922,0.00036305454,0.32454368,0.00024669108,0.000009063549,0.000003951073,0.00013643388,0.00008749857,0.6635127,0.00017911154,0.0075877523,0.00043623126],"about_ca_topic_score_codex":0.009369578,"about_ca_topic_score_gemma":0.0071451403,"teacher_disagreement_score":0.18411496,"about_ca_system_score_codex":0.00022902094,"about_ca_system_score_gemma":0.00025014722,"threshold_uncertainty_score":0.99722713},"labels":[],"label_agreement":null},{"id":"W2155157530","doi":"10.1158/0008-5472.can-09-4676","title":"Oncogenic Ras Promotes Reovirus Spread by Suppressing IFN-β Production through Negative Regulation of <i>RIG-I</i> Signaling","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Transfection; Interferon; Viral replication; RIG-I; Virology; Virus; Signal transduction; Cell culture; RNA; Cell biology; Gene; Genetics","score_opus":0.05293381893738741,"score_gpt":0.37646630844169765,"score_spread":0.32353248950431024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155157530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330086,0.0034045205,0.00004840275,0.00067804364,0.0009629004,0.0005063677,0.000038615424,0.000041920182,0.0010183656],"genre_scores_gemma":[0.99012965,0.00017085165,0.0001391026,0.000024463401,0.00011391472,0.0000920311,0.000044686054,0.000026255817,0.009259051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802935,0.0006512895,0.00032634535,0.00038964863,0.00013356545,0.00046982532],"domain_scores_gemma":[0.9985949,0.00034898918,0.00013279887,0.0003853454,0.00051787595,0.000020117786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009597876,0.00014572954,0.00024737386,0.00013931694,0.0003484433,0.000029343912,0.00027472997,0.0002532575,0.0015989526],"category_scores_gemma":[0.00073367124,0.00012675396,0.00007397676,0.00032005928,0.00080382026,0.000279567,0.000107249856,0.0009655591,0.00016001805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010826264,0.00009512868,0.00013750541,0.00004496334,0.00008919811,5.684842e-7,0.0015050465,0.000003868737,0.9752479,0.00012567815,0.016314901,0.005352604],"study_design_scores_gemma":[0.0005549943,0.00022996918,0.00036295783,0.00013913005,0.000015453395,0.000015703663,0.00037213613,0.000002311698,0.9720066,0.00048102203,0.02569397,0.00012570458],"about_ca_topic_score_codex":0.000984032,"about_ca_topic_score_gemma":0.000073764924,"teacher_disagreement_score":0.009379067,"about_ca_system_score_codex":0.00008888908,"about_ca_system_score_gemma":0.00032447235,"threshold_uncertainty_score":0.9993137},"labels":[],"label_agreement":null},{"id":"W2155265055","doi":"10.1158/0008-5472.can-12-3425","title":"Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; University of California, San Francisco; U.S. Food and Drug Administration","keywords":"Juvenile myelomonocytic leukemia; Cancer research; Leukemia; Immunology; Myeloid; Dasatinib; Haematopoiesis; Medicine; Myeloid leukemia; Biology; Internal medicine; Stem cell; Cell biology","score_opus":0.09768547454312058,"score_gpt":0.37555996042031553,"score_spread":0.27787448587719493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155265055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96626073,0.00064768596,0.00007601841,0.0028287088,0.00016942462,0.0014503319,0.000025708438,0.000082019505,0.028459378],"genre_scores_gemma":[0.99008596,0.0007760206,0.0002217109,0.00038080564,0.00031385335,0.0003745426,0.00003976523,0.00006935001,0.007737977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959967,0.0004071802,0.00035335103,0.0005757643,0.0016177335,0.001049268],"domain_scores_gemma":[0.99662834,0.00067789474,0.00009462853,0.00074453943,0.0014110993,0.00044350408],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013322666,0.00023359101,0.000576773,0.00061576103,0.00022984859,0.00007826634,0.00021467637,0.00024890306,0.0011323635],"category_scores_gemma":[0.0006273382,0.00020397187,0.0001442176,0.0010299984,0.0009399039,0.00036921687,0.0003302992,0.0013409638,0.00081221864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625882,0.00017554268,0.0040629613,0.00095929415,0.00018352049,0.0002493255,0.001471651,0.00005394641,0.8292059,0.00036299595,0.097402535,0.0652098],"study_design_scores_gemma":[0.004527754,0.00087975775,0.03456324,0.0010359281,0.00006885017,0.00013597055,0.0059564663,0.0031139979,0.9412687,0.0013702802,0.006630966,0.00044812742],"about_ca_topic_score_codex":0.0075334334,"about_ca_topic_score_gemma":0.0002552854,"teacher_disagreement_score":0.11206282,"about_ca_system_score_codex":0.004113828,"about_ca_system_score_gemma":0.0034033605,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W2155273887","doi":"10.1158/0008-5472.can-09-1504","title":"Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Docetaxel; Prostate cancer; Paclitaxel; Androgen receptor; Cancer research; Gene knockdown; Chemistry; Maspin; FOXO1; PTEN; Small interfering RNA; LY294002; Cancer; Cell culture; PI3K/AKT/mTOR pathway; Biology; Apoptosis; Medicine; Internal medicine; Transfection; Protein kinase B; Metastasis; Biochemistry","score_opus":0.06360354436155137,"score_gpt":0.4047751119384639,"score_spread":0.3411715675769125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155273887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854807,0.00251964,0.000003846351,0.008771773,0.00006589093,0.0017949293,0.000092696246,0.000010406193,0.0012601112],"genre_scores_gemma":[0.990889,0.0051872814,0.00005581497,0.00020606114,0.00008395087,0.00036858037,0.000010444278,0.000021035308,0.0031778456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997955,0.000095934854,0.00029044994,0.00028489344,0.000913941,0.00045974358],"domain_scores_gemma":[0.9989167,0.000044888155,0.00008590661,0.00033558058,0.00050454756,0.00011236314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068152027,0.00012214996,0.00030189232,0.00026644918,0.000068782465,0.000010035116,0.00015979385,0.00008811325,0.00060582056],"category_scores_gemma":[0.00006693671,0.00007847951,0.00008830122,0.0011395178,0.00025454143,0.00007278466,0.000054312408,0.0004405416,0.00000573061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002293931,0.00042835166,0.005335215,0.00021534725,0.000059063528,0.000008921714,0.0016979418,0.00000719359,0.9730645,0.0007957804,0.0011193969,0.014974389],"study_design_scores_gemma":[0.0050549204,0.00068508653,0.0064460956,0.0009557071,0.000011150126,0.0000038572043,0.00031219167,0.000031060088,0.9834716,0.0014212091,0.001528669,0.00007850776],"about_ca_topic_score_codex":0.0018803996,"about_ca_topic_score_gemma":0.00018240343,"teacher_disagreement_score":0.0148958815,"about_ca_system_score_codex":0.00051374675,"about_ca_system_score_gemma":0.0012362938,"threshold_uncertainty_score":0.66333103},"labels":[],"label_agreement":null},{"id":"W2155388118","doi":"10.1158/0008-5472.can-07-6381","title":"Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Daunorubicin; Biology; International HapMap Project; Cytotoxicity; Genotype; Gene; Genetics; Gene expression; Single-nucleotide polymorphism; Molecular biology; In vitro; Leukemia","score_opus":0.1930223636851178,"score_gpt":0.4814117945314891,"score_spread":0.28838943084637125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155388118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126333,0.00065425783,0.00003922511,0.0031982928,0.00024116598,0.0010138836,0.000025072295,0.000049840462,0.0035149115],"genre_scores_gemma":[0.99365944,0.00038216743,0.00012725081,0.0009979276,0.0008330495,0.00032801705,0.000006068371,0.00002694081,0.0036391644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780244,0.00014004411,0.00019759638,0.00038732833,0.0005121653,0.0009604225],"domain_scores_gemma":[0.99871325,0.00016137998,0.00002593201,0.00029184858,0.0003760442,0.00043155235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047048053,0.00012890826,0.00029644452,0.00022067047,0.00041794273,0.000012254829,0.00014709115,0.000089486704,0.0015984875],"category_scores_gemma":[0.0001523587,0.000113784954,0.000060942377,0.0006643804,0.00009956952,0.00003535002,0.0001412884,0.00043460447,0.00033094015],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095865404,0.00023801252,0.10250665,0.000041069594,0.000132963,0.00078107085,0.0006669508,0.000012100276,0.87380713,0.00003277357,0.016953198,0.0038693997],"study_design_scores_gemma":[0.0043952074,0.0012575899,0.64713055,0.00009381739,0.00005253396,0.0001830939,0.0000626942,0.000052718315,0.33497426,0.000039200404,0.011574906,0.00018342688],"about_ca_topic_score_codex":0.0019272483,"about_ca_topic_score_gemma":0.00016444095,"teacher_disagreement_score":0.5446239,"about_ca_system_score_codex":0.0006617847,"about_ca_system_score_gemma":0.00077802164,"threshold_uncertainty_score":0.9993142},"labels":[],"label_agreement":null},{"id":"W2155480439","doi":"10.1158/0008-5472.can-04-1601","title":"Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"U.S. Army; U.S. Department of Defense","keywords":"DNA repair; Biology; DNA repair protein XRCC4; RAD51; DNA damage; Cancer research; LNCaP; XRCC1; Genome instability; Prostate cancer; Chromoplexy; Nucleotide excision repair; Molecular biology; DNA; Cancer; Gene; Genetics; PCA3","score_opus":0.018754503619369357,"score_gpt":0.3384371741422549,"score_spread":0.3196826705228855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155480439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957495,0.0019803254,0.000019139765,0.00022925629,0.000158565,0.0007418245,0.00012568226,0.00003037174,0.00096537615],"genre_scores_gemma":[0.9951627,0.0010151754,0.00015511381,0.00013991931,0.00020176226,0.0010720644,0.000020057247,0.00005227994,0.0021809281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785084,0.00017418213,0.0002000133,0.0006797839,0.00038948926,0.0007056747],"domain_scores_gemma":[0.99905866,0.000015898264,0.00003450065,0.0005014291,0.0002260112,0.00016352514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006173765,0.00018253578,0.00017435006,0.00013390362,0.00008016549,0.0000398757,0.00024795355,0.00015711451,0.00019454306],"category_scores_gemma":[0.00004232112,0.00017556401,0.00010686441,0.00033850595,0.00018856784,0.000011015199,0.00021455056,0.00035253126,0.000032090313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005801276,0.00008944659,0.002024378,0.00007588297,0.00004897102,0.00010078854,0.00039160388,0.0003199848,0.9948634,0.00003894843,0.0008188802,0.00064758305],"study_design_scores_gemma":[0.0013554547,0.00028159708,0.005538013,0.00011132733,0.000007672497,0.000003559726,0.00016479606,0.0000078364865,0.98456573,0.00047990194,0.007262519,0.00022160665],"about_ca_topic_score_codex":0.001769828,"about_ca_topic_score_gemma":0.007837884,"teacher_disagreement_score":0.01029769,"about_ca_system_score_codex":0.00032289934,"about_ca_system_score_gemma":0.0006842808,"threshold_uncertainty_score":0.71592927},"labels":[],"label_agreement":null},{"id":"W2155509846","doi":"10.1158/0008-5472.can-12-3678","title":"Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Cancer Research UK","keywords":"Biology; Neoplastic transformation; Stem cell; Somatic cell; Cancer; Cancer stem cell; Somatic evolution in cancer; Genome; Cancer research; Genetics; Malignant transformation; Carcinogenesis; Computational biology; Gene","score_opus":0.1926037494874433,"score_gpt":0.47324451713097804,"score_spread":0.28064076764353474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155509846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048235836,0.9934253,0.00016459524,0.00005632211,0.00026211195,0.000695301,0.0004296913,0.000003823649,0.00013925921],"genre_scores_gemma":[0.0018556169,0.99671793,0.000059779548,0.000026794054,0.0005491853,0.00045417037,0.00009543065,0.000045307796,0.0001958044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809825,0.00028400865,0.00053052255,0.00057812536,0.00019066046,0.00031840356],"domain_scores_gemma":[0.99808776,0.00056132715,0.00015258254,0.0006277772,0.00036262276,0.00020790412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058906706,0.00020153797,0.0006127403,0.00008796146,0.00010079199,0.00004691818,0.0003076474,0.00038068806,0.00009350548],"category_scores_gemma":[0.00013228471,0.00016732221,0.00025506318,0.00016388514,0.00086370326,0.0000018241977,0.00045230472,0.00038449094,0.00003183828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033898777,0.00014057338,0.00014479843,0.0042171874,0.00042403588,0.0000011042389,0.000004281123,0.0000051992324,0.001461792,0.005197897,0.025936006,0.9624332],"study_design_scores_gemma":[0.00016386226,0.0002329934,0.000030306797,0.0005751341,0.00016807526,0.000006980469,0.000006114438,0.0000030040733,0.0008122765,0.00019843597,0.99761915,0.00018366543],"about_ca_topic_score_codex":0.00003737787,"about_ca_topic_score_gemma":0.000035880512,"teacher_disagreement_score":0.97168314,"about_ca_system_score_codex":0.000055688346,"about_ca_system_score_gemma":0.0010067782,"threshold_uncertainty_score":0.6823202},"labels":[],"label_agreement":null},{"id":"W2155530557","doi":"10.1158/1538-7445.am10-4560","title":"Abstract 4560: Integrative proteomic profiling of pancreatic cancer cell line supernatants, pancreatic juice and ascites fluid for the identification of novel pancreatic cancer biomarkers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Pancreatic cancer; Proteome; Cell culture; Cancer; Pancreatic juice; Cancer research; Biology; Cell; Pancreas; Chemistry; Bioinformatics; Biochemistry; Genetics","score_opus":0.08191285008818511,"score_gpt":0.4307452967806777,"score_spread":0.3488324466924926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155530557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754339,0.015884604,0.00044131736,0.0014524793,0.0002652664,0.005522279,0.00062729826,0.00002606828,0.0003468008],"genre_scores_gemma":[0.96792203,0.022467734,0.0020890443,0.00003949516,0.00035915474,0.005540738,0.000047856967,0.00007320716,0.0014607166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609876,0.00017982448,0.0011158623,0.00069970044,0.0010730095,0.0008328564],"domain_scores_gemma":[0.9935324,0.0028764487,0.00044632825,0.0008240126,0.0020431571,0.0002776171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036507542,0.00035181665,0.001097558,0.00033487764,0.00036788319,0.000055830627,0.0005391036,0.00028310064,0.00053637737],"category_scores_gemma":[0.0021148317,0.00022895448,0.00016845635,0.0007740586,0.0016019111,0.00022591578,0.00015202441,0.0009575885,0.000004109828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017557299,0.0003345399,0.123080865,0.002626013,0.0008921185,0.0000031150958,0.0011300406,0.000013320301,0.86556166,0.0002033292,0.0003305531,0.0040687225],"study_design_scores_gemma":[0.004554193,0.0006310691,0.1558905,0.0016547628,0.001273745,0.000010997762,0.002915716,0.014093781,0.8182271,0.00017529221,0.00027201357,0.00030083413],"about_ca_topic_score_codex":0.02271947,"about_ca_topic_score_gemma":0.0027635125,"teacher_disagreement_score":0.047334548,"about_ca_system_score_codex":0.00041045004,"about_ca_system_score_gemma":0.0025875736,"threshold_uncertainty_score":0.9837883},"labels":[],"label_agreement":null},{"id":"W2155606755","doi":"10.1158/0008-5472.can-04-4223","title":"Ckap2 Regulates Aneuploidy, Cell Cycling, and Cell Death in a p53-Dependent Manner","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cytokinesis; Cell biology; Mitosis; Cell cycle checkpoint; Cell cycle; Centrosome; Aneuploidy; DNA damage; G2-M DNA damage checkpoint; Cell; Cancer research; Molecular biology; Cell division; Gene; Genetics; DNA; Chromosome","score_opus":0.04924754989058793,"score_gpt":0.3661724141576663,"score_spread":0.3169248642670784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155606755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97158414,0.0134151345,0.000014855293,0.0018812298,0.00009583678,0.0007598022,0.000014344648,0.00005341377,0.012181267],"genre_scores_gemma":[0.9842694,0.0031746249,0.0004059831,0.00023020334,0.0003557741,0.00017533418,0.000011932559,0.00007338867,0.011303389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973201,0.00013133386,0.00031295346,0.00062889257,0.0008008817,0.00080583594],"domain_scores_gemma":[0.99881524,0.000084811465,0.000047651192,0.0005190434,0.00018978417,0.00034344636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008030702,0.00019882995,0.00031356566,0.00037288864,0.000115387134,0.000047195936,0.00018374909,0.00021559834,0.00049143494],"category_scores_gemma":[0.000058134236,0.00018736313,0.0000646847,0.00046085566,0.00015497749,0.00009033615,0.00019210897,0.0010742904,0.00014154526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070675835,0.0004963628,0.015700273,0.00057912397,0.000041779473,0.0007011988,0.0016413686,0.00079180003,0.9568502,0.00013052132,0.008520664,0.013839969],"study_design_scores_gemma":[0.0059485664,0.0004649075,0.013606283,0.00046842295,0.00004813072,0.00008475357,0.000281472,0.0015075885,0.93385386,0.00021708629,0.04314589,0.0003730425],"about_ca_topic_score_codex":0.0015009721,"about_ca_topic_score_gemma":0.000949529,"teacher_disagreement_score":0.034625225,"about_ca_system_score_codex":0.0007760817,"about_ca_system_score_gemma":0.0004603471,"threshold_uncertainty_score":0.76404464},"labels":[],"label_agreement":null},{"id":"W2155632812","doi":"10.1158/0008-5472.can-07-0177","title":"Increased Glioma Growth in Mice Depleted of Macrophages","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Glioma; Cancer research; Macrophage; Tumor necrosis factor alpha; Phagocytosis; In vivo; Integrin alpha M; Ganciclovir; Biology; Immunology; Apoptosis; Medicine; Immune system; Virus; In vitro","score_opus":0.037781535240349266,"score_gpt":0.3655714358487241,"score_spread":0.3277899006083748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155632812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767091,0.018544585,0.000026342443,0.0001397662,0.000425749,0.00028564883,0.000024741094,0.000023079127,0.0038209488],"genre_scores_gemma":[0.99846697,0.00033380042,0.00004579426,0.00004730882,0.00004107935,0.000051895015,0.00001657823,0.000024584506,0.0009720039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981177,0.00036327945,0.000350204,0.00029777532,0.00011793999,0.00075309095],"domain_scores_gemma":[0.9986892,0.00060213206,0.000065291635,0.00026563928,0.00035048908,0.000027251188],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002126492,0.00011743518,0.00025068177,0.00057066523,0.00009242121,0.0000067808487,0.00047604082,0.0002372393,0.0012638542],"category_scores_gemma":[0.00029918164,0.0001126881,0.000050271894,0.0010240186,0.0006282451,0.000057904024,0.00017953264,0.00069811306,0.00017940575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074299256,0.00008561395,0.008666181,0.00007911716,0.000051182527,0.0000514619,0.00039085676,7.7310716e-7,0.98390883,0.0003493203,0.003082549,0.0025910973],"study_design_scores_gemma":[0.0015265415,0.000092474525,0.027262202,0.000086882,0.0000049675605,0.000014849318,0.00024693512,4.4819814e-7,0.966217,0.00022952615,0.0042117927,0.000106402484],"about_ca_topic_score_codex":0.007816146,"about_ca_topic_score_gemma":0.0006982645,"teacher_disagreement_score":0.021757815,"about_ca_system_score_codex":0.00028468954,"about_ca_system_score_gemma":0.00026462149,"threshold_uncertainty_score":0.9996491},"labels":[],"label_agreement":null},{"id":"W2155736495","doi":"10.1158/0008-5472.can-06-4628","title":"Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non–Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Nicotine; Nicotinic acetylcholine receptor; Cancer research; Lung cancer; Gene expression; Protein subunit; Carcinogenesis; Biology; Phenotype; Microarray analysis techniques; Gene expression profiling; Gene; Acetylcholine receptor; Molecular biology; Receptor; Pathology; Medicine; Genetics","score_opus":0.04830710782290697,"score_gpt":0.3864623818175627,"score_spread":0.3381552739946557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155736495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856339,0.012653445,0.00011564164,0.0002019948,0.00016961449,0.00082430016,0.000085796244,0.000009668008,0.00030564278],"genre_scores_gemma":[0.98438555,0.013117541,0.0003913467,0.00003606588,0.0005142778,0.00016485348,0.00004529448,0.00005292533,0.0012921698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99700165,0.00030032598,0.00060833344,0.0007325396,0.00049962103,0.0008575497],"domain_scores_gemma":[0.9984821,0.00021961595,0.00019206053,0.00050735293,0.00034023635,0.00025864254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022310803,0.0002719459,0.00046100767,0.00028403205,0.00013644324,0.000025639934,0.0005521884,0.00033637363,0.00014730917],"category_scores_gemma":[0.0001791413,0.00024434068,0.00008668186,0.0005680459,0.00035776463,0.000011643451,0.00056104775,0.00058105984,0.0000033035767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000136286,0.00005929337,0.46888313,0.00012179177,0.000029945772,2.9694118e-7,0.00020086726,0.0000067528326,0.52638763,8.432536e-7,0.0011948842,0.0029782762],"study_design_scores_gemma":[0.001606023,0.00022011161,0.07518712,0.00029921046,0.000024566538,6.251488e-7,0.00073506497,0.000009305328,0.91965014,0.000004781945,0.0019811727,0.00028190427],"about_ca_topic_score_codex":0.0012833708,"about_ca_topic_score_gemma":0.0011662869,"teacher_disagreement_score":0.393696,"about_ca_system_score_codex":0.00012841336,"about_ca_system_score_gemma":0.00033695655,"threshold_uncertainty_score":0.99639237},"labels":[],"label_agreement":null},{"id":"W2155879201","doi":"10.1158/0008-5472.can-08-3255","title":"Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"School of Medicine, Vanderbilt University; Vanderbilt University","keywords":"Angiogenesis; Matrix metalloproteinase; Neovascularization; Matrix metalloproteinase inhibitor; Cancer research; In vivo; Metalloproteinase; Angiogenesis inhibitor; Chemistry; Proteolytic enzymes; Cell biology; Biology; Biochemistry; Enzyme","score_opus":0.023545734489275855,"score_gpt":0.32424753513500576,"score_spread":0.30070180064572993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155879201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412423,0.004422555,0.00013108585,0.00032918123,0.000027292646,0.00043392094,0.000026247748,0.000008261591,0.000497246],"genre_scores_gemma":[0.9983879,0.0005738532,0.00025270812,0.00011224498,0.00019170096,0.000111149675,0.000020902027,0.000012979299,0.00033658047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988416,0.00011673323,0.00015486489,0.00033113273,0.000277244,0.0002784425],"domain_scores_gemma":[0.9991824,0.000009857712,0.000048526166,0.00019362752,0.00046537502,0.00010021011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004717109,0.00010499008,0.00013748124,0.00011913574,0.000108082204,0.00001677846,0.00009861773,0.00010112161,0.000037200833],"category_scores_gemma":[0.00013932056,0.00009674499,0.000059668997,0.00027081723,0.00009365389,0.000007636265,0.000087244305,0.00012148068,0.0000027236265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001613718,0.000046168556,0.00007139648,0.00003174801,0.000024325067,0.0000056100735,0.000029787416,0.0000013373055,0.99604887,0.0004262699,0.0020355685,0.001117551],"study_design_scores_gemma":[0.00038783124,0.00070277276,0.00028769457,0.00003982002,0.000009973747,0.000007945268,0.000034058037,0.000004499562,0.99491644,0.0027927232,0.0007088625,0.00010738904],"about_ca_topic_score_codex":0.00013807075,"about_ca_topic_score_gemma":0.000021287708,"teacher_disagreement_score":0.0042636725,"about_ca_system_score_codex":0.000029733385,"about_ca_system_score_gemma":0.00016756124,"threshold_uncertainty_score":0.39451462},"labels":[],"label_agreement":null},{"id":"W2155886123","doi":"10.1158/0008-5472.can-07-1687","title":"A Chemical Screen Identifies Anisomycin as an Anoikis Sensitizer That Functions by Decreasing FLIP Protein Synthesis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"","keywords":"Anoikis; Anisomycin; Chemistry; Apoptosis; Cell biology; Cancer cell; Cancer research; Programmed cell death; Kinase; Biology; Biochemistry; Cancer","score_opus":0.03970559114106361,"score_gpt":0.35405909441926964,"score_spread":0.31435350327820605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155886123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522936,0.0007717391,0.0022291944,0.0002161093,0.00006727501,0.00035764716,0.00003293178,0.000021297228,0.0010744133],"genre_scores_gemma":[0.9932391,0.00010943909,0.00038494464,0.00004932035,0.00043173347,0.000083432315,0.0001473023,0.00003503325,0.005519679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984005,0.00012315248,0.00014669259,0.00045428946,0.0004095029,0.00046584333],"domain_scores_gemma":[0.99914896,0.000032554108,0.00003616958,0.0003566763,0.00022050831,0.00020515488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093406247,0.00012814607,0.00011655869,0.00009125606,0.00026226512,0.00008917421,0.00015360242,0.00021679122,0.0001915772],"category_scores_gemma":[0.0001217323,0.00011959797,0.00006496269,0.00018303074,0.00015151389,0.000012248498,0.00008897315,0.00017034222,0.000024031264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022691512,0.000048849244,0.00011577549,0.000013633584,0.000029296833,0.000007513875,0.000040686547,0.0000017926808,0.9816744,0.00007280235,0.0020961284,0.015672205],"study_design_scores_gemma":[0.00020160952,0.00007650769,0.0004083683,0.00004159814,0.000010785133,0.000014646301,0.00042312074,0.000024512487,0.9849736,0.00013895727,0.0135333715,0.00015293187],"about_ca_topic_score_codex":0.0011180103,"about_ca_topic_score_gemma":0.00031967476,"teacher_disagreement_score":0.015519273,"about_ca_system_score_codex":0.00007213002,"about_ca_system_score_gemma":0.00013184533,"threshold_uncertainty_score":0.48770636},"labels":[],"label_agreement":null},{"id":"W2156221266","doi":"10.1158/0008-5472.can-08-4428","title":"Bone Morphogenetic Proteins 2 and 5 Are Down-regulated in Adrenocortical Carcinoma and Modulate Adrenal Cell Proliferation and Steroidogenesis","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health","keywords":"Adrenocortical carcinoma; Bone morphogenetic protein; Endocrinology; Biology; Internal medicine; Bone morphogenetic protein 2; Cancer research; Cell growth; Carcinogenesis; Chemistry; Cancer; Medicine; In vitro; Biochemistry","score_opus":0.04071749808066934,"score_gpt":0.327523904055883,"score_spread":0.2868064059752137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156221266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902804,0.007752381,0.000013029496,0.0020292168,0.000012148683,0.0010778873,0.000012058671,0.000016186412,0.000059061626],"genre_scores_gemma":[0.9987667,0.00023122504,0.00010982884,0.00010175408,0.00010787915,0.00010525781,0.000009575359,0.000015446176,0.00055229414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984386,0.0001373293,0.00023265678,0.0004159154,0.00036147112,0.00041401922],"domain_scores_gemma":[0.99934685,0.000036289195,0.000036423273,0.00017023241,0.00011468703,0.0002954919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035935218,0.00014542032,0.00027563618,0.00026699237,0.00012737789,0.00004461931,0.000041631603,0.000102840655,0.00005318464],"category_scores_gemma":[0.00004212763,0.00011887965,0.000017996908,0.0003580675,0.00019317081,0.000065755936,0.000056601148,0.00036314173,0.0000030401648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051079453,0.00059235026,0.4833817,0.001132155,0.00005562008,0.005478176,0.0029365076,0.00013505432,0.43209746,0.00018355604,0.0004057543,0.06849374],"study_design_scores_gemma":[0.0025033967,0.00067506253,0.94141895,0.00020767523,0.00002447859,0.0006523041,0.000091676564,0.0019104428,0.052068755,0.00027367266,0.000030478166,0.00014313926],"about_ca_topic_score_codex":0.0002597388,"about_ca_topic_score_gemma":0.00014830656,"teacher_disagreement_score":0.45803723,"about_ca_system_score_codex":0.00007461524,"about_ca_system_score_gemma":0.00014264982,"threshold_uncertainty_score":0.48477715},"labels":[],"label_agreement":null},{"id":"W2156323098","doi":"10.1158/1538-7445.am2014-4308","title":"Abstract 4308: 3D nuclear telomeric signatures define circulating tumor cells (CTCs) and characterize CTC subpopulations in intermediate risk prostate cancer patients","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Circulating tumor cell; Prostate cancer; Medicine; Cancer; Prostate; Biomarker; Oncology; Disease; Internal medicine; Pathology; Cancer research; Metastasis; Biology","score_opus":0.03332727917225034,"score_gpt":0.3379939088779058,"score_spread":0.3046666297056555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156323098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964572,0.0013276251,0.0000017977753,0.00029565598,0.00031705663,0.0009005687,0.00030541528,0.00003687523,0.0003577786],"genre_scores_gemma":[0.9952591,0.0035421653,0.00012606574,0.0002216083,0.0003151135,0.00024314102,0.00006984884,0.000074969495,0.00014797799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740547,0.00016753003,0.0004856783,0.00057222426,0.00064016494,0.000728907],"domain_scores_gemma":[0.99865544,0.00020926507,0.00020190702,0.0003184837,0.0003051765,0.00030972512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000860475,0.00022977368,0.00045262338,0.00041398022,0.00021332216,0.00008475347,0.00014273479,0.00009078419,0.00063945644],"category_scores_gemma":[0.00033328187,0.0002015585,0.00007315522,0.00063273706,0.00021878551,0.00016364292,0.0001393461,0.00097369787,0.000027136268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094991276,0.00039781543,0.48583525,0.0011064459,0.00012011888,0.000056240922,0.0027399403,0.00026886523,0.23751555,0.000025528678,0.0015663869,0.2694179],"study_design_scores_gemma":[0.0026201853,0.00023191137,0.97435236,0.0006122715,0.00005313192,0.0000021720055,0.00012940443,0.0005031042,0.003703984,0.00004651421,0.017481506,0.00026348373],"about_ca_topic_score_codex":0.008430642,"about_ca_topic_score_gemma":0.0013713575,"teacher_disagreement_score":0.48851708,"about_ca_system_score_codex":0.00039175985,"about_ca_system_score_gemma":0.00022126689,"threshold_uncertainty_score":0.9981723},"labels":[],"label_agreement":null},{"id":"W2156569777","doi":"10.1158/0008-5472.can-05-3928","title":"Androgen-Dependent Regulation of Her-2/neu in Prostate Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"LNCaP; Prostate cancer; Androgen receptor; Cancer research; Androgen; Endocrinology; Gene knockdown; Internal medicine; Prostate; Tramp; Dihydrotestosterone; Cancer cell; Biology; Cancer; Medicine; Chemistry; Hormone; Cell culture","score_opus":0.05746381969102102,"score_gpt":0.4072790718170662,"score_spread":0.34981525212604514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156569777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829696,0.010132797,0.0000023926282,0.0019253033,0.000118824944,0.0013554472,0.000079622376,0.00002318191,0.003392868],"genre_scores_gemma":[0.9745603,0.004035388,0.00003919085,0.000021943713,0.0002135091,0.000619902,0.000039227318,0.00003649539,0.020433998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972889,0.00014582848,0.0003548556,0.00041432373,0.0011056755,0.0006904172],"domain_scores_gemma":[0.99885505,0.000075420874,0.000062648905,0.0003407448,0.00052715285,0.00013895819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077095133,0.00014330546,0.00031777844,0.00048446006,0.0000859696,0.000025471189,0.00014094744,0.00009186494,0.00079036714],"category_scores_gemma":[0.000018991348,0.00011518194,0.00006575943,0.0009520996,0.00027712955,0.000108156746,0.00008728928,0.00044187167,0.000028069751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002012608,0.00044448095,0.1655192,0.00059689797,0.00006550089,0.00015053732,0.0004465574,0.000586893,0.81178415,0.00018711643,0.006022217,0.012183816],"study_design_scores_gemma":[0.0042746663,0.00029982557,0.088432446,0.0004917128,0.000019564732,0.0000054014135,0.0001756967,0.00015957531,0.90016586,0.0006509744,0.005185191,0.0001390931],"about_ca_topic_score_codex":0.012207561,"about_ca_topic_score_gemma":0.0020918474,"teacher_disagreement_score":0.08838168,"about_ca_system_score_codex":0.00092163135,"about_ca_system_score_gemma":0.0009772079,"threshold_uncertainty_score":0.9943702},"labels":[],"label_agreement":null},{"id":"W2156636441","doi":"10.1158/0008-5472.can-06-1227","title":"Therapeutic Expression of an Anti-Death Receptor 5 Single-Chain Fixed-Variable Region Prevents Tumor Growth in Mice","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Monoclonal antibody; Recombinant DNA; Single-chain variable fragment; Molecular biology; Transduction (biophysics); Antibody; Biology; Apoptosis; Genetic enhancement; In vivo; Cancer research; In vitro; Cell culture; Virology; Gene; Immunology; Biochemistry","score_opus":0.05178687222365997,"score_gpt":0.35642602248954075,"score_spread":0.3046391502658808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156636441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958564,0.0025711006,0.000106481624,0.00013461334,0.000063627536,0.0005446861,0.000027843686,0.00001119106,0.0006840421],"genre_scores_gemma":[0.9975103,0.0003719685,0.0002573475,0.000055447366,0.00028772134,0.00017385554,0.00009159152,0.00005495377,0.001196807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970979,0.0007830069,0.00030099918,0.00058303034,0.0005783716,0.00065669516],"domain_scores_gemma":[0.9989352,0.000048754675,0.00007963927,0.00049884926,0.00032615618,0.000111382324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011884179,0.00016880635,0.00021801467,0.00023641725,0.00010755399,0.000033530567,0.0005430514,0.00016312377,0.000098316625],"category_scores_gemma":[0.00008048562,0.00015910239,0.000056552406,0.0005057395,0.0001758472,0.000016038639,0.00016927715,0.00032202317,0.0000064523365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001889051,0.00039963875,0.0042269686,0.00007846789,0.000013385557,0.000007784828,0.000044449658,0.00016869509,0.99092495,0.000050649018,0.0008746913,0.0013212853],"study_design_scores_gemma":[0.0010023603,0.0016947084,0.0007333821,0.00013968203,0.0000026288933,0.0000035466944,0.000056978406,0.000047557776,0.99364936,0.0005012452,0.0020015382,0.00016699394],"about_ca_topic_score_codex":0.0012253536,"about_ca_topic_score_gemma":0.00031285055,"teacher_disagreement_score":0.0034935863,"about_ca_system_score_codex":0.00014113945,"about_ca_system_score_gemma":0.0003853124,"threshold_uncertainty_score":0.64880073},"labels":[],"label_agreement":null},{"id":"W2156828789","doi":"10.1158/0008-5472.can-08-4924","title":"Positive Feedback Activation of Estrogen Receptors by the CXCL12-CXCR4 Pathway","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Estrogen receptor; Cancer research; Biology; Tamoxifen; Autocrine signalling; Gene silencing; Antiestrogen; Chemokine receptor; Cell biology; Receptor; Breast cancer; Chemokine; Cancer; Gene; Biochemistry; Genetics","score_opus":0.0528404646527703,"score_gpt":0.3810950979160664,"score_spread":0.32825463326329607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156828789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98642445,0.0011131387,0.000049597398,0.007875019,0.00007834416,0.00044733862,0.00001706753,0.000016051124,0.0039789984],"genre_scores_gemma":[0.99662644,0.00026794008,0.000050538954,0.00021804534,0.00037438903,0.00002879963,0.00003575602,0.000014950202,0.0023831537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857575,0.00010133276,0.00018096149,0.00020442416,0.0006277061,0.00030985393],"domain_scores_gemma":[0.99904406,0.0001677655,0.00005297974,0.0002260923,0.00040391902,0.000105182495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058469415,0.00009187636,0.00018570393,0.000081367776,0.0001256625,0.000018668252,0.00013725471,0.00007812914,0.00056261313],"category_scores_gemma":[0.00014748983,0.000060904917,0.00007535145,0.0005008841,0.00013272601,0.000059965634,0.000029488521,0.00042117707,0.000013539325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004835324,0.00011523549,0.0010479108,0.00003101929,0.000051210474,0.0000017252281,0.000782827,0.000006603877,0.8461821,0.00024798478,0.042060874,0.108988956],"study_design_scores_gemma":[0.0005773399,0.00033946216,0.0010524861,0.00020143678,0.000010325767,0.0000033803722,0.00042472794,0.000035761524,0.9719618,0.00017049235,0.02515792,0.00006485319],"about_ca_topic_score_codex":0.0003249162,"about_ca_topic_score_gemma":0.0000025858856,"teacher_disagreement_score":0.1257797,"about_ca_system_score_codex":0.0002473773,"about_ca_system_score_gemma":0.00027093862,"threshold_uncertainty_score":0.61602193},"labels":[],"label_agreement":null},{"id":"W2157083916","doi":"10.1158/0008-5472.can-11-0773","title":"Modification of<i>BRCA1</i>-Associated Breast and Ovarian Cancer Risk by<i>BRCA1</i>-Interacting Genes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Royal Marsden NHS Foundation Trust; University of California, Irvine; Universität Wien; University of California, Los Angeles; Georgetown University; Cancer Research UK; Jonsson Comprehensive Cancer Center; Women's College Hospital; NorthShore University HealthSystem; Creighton University; City of Hope; University of Pennsylvania","keywords":"Breast cancer; PALB2; BRCA2 Protein; Cancer; Oncology; CHEK2; Ovarian cancer; Haplotype; Internal medicine; Genetics; RAD51; Medicine; Biology; Gene; Cancer research; Mutation; DNA repair; Genotype; Germline mutation","score_opus":0.06530137019086849,"score_gpt":0.37487880875442486,"score_spread":0.30957743856355635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157083916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804903,0.008932472,0.0003405127,0.00026824718,0.0002555569,0.00031660756,0.00053615763,0.000015493319,0.0012859207],"genre_scores_gemma":[0.99143505,0.0067202942,0.00033653135,0.00004397787,0.0002130055,0.0003392269,0.00007804944,0.00004472679,0.0007891098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817175,0.0002749138,0.00028559787,0.0005311435,0.00031932004,0.0004172654],"domain_scores_gemma":[0.99857247,0.000052491607,0.00019222549,0.00042279417,0.00064057496,0.00011946499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007710122,0.00015684059,0.00017660057,0.000107886175,0.00022661708,0.000033481265,0.0003080263,0.00018055506,0.00022488767],"category_scores_gemma":[0.00016897284,0.00015883103,0.000057052628,0.00032720578,0.00028358513,0.00001505632,0.00018012509,0.00029028955,0.0000053103445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024324936,0.00010783406,0.039317273,0.00004542614,0.00026760652,0.0000011089174,0.0009738243,0.0000741894,0.90881413,0.000056990524,0.007814222,0.042284127],"study_design_scores_gemma":[0.0011108485,0.00016995339,0.038627688,0.00010728948,0.00006085249,0.000010769297,0.0006710596,0.0003082787,0.94551283,0.0002196548,0.012859811,0.00034097693],"about_ca_topic_score_codex":0.0067900955,"about_ca_topic_score_gemma":0.0009691913,"teacher_disagreement_score":0.04194315,"about_ca_system_score_codex":0.00022444942,"about_ca_system_score_gemma":0.0004662253,"threshold_uncertainty_score":0.99982375},"labels":[],"label_agreement":null},{"id":"W2157384800","doi":"10.1158/0008-5472.can-06-4206","title":"AS1411 Alters the Localization of a Complex Containing Protein Arginine Methyltransferase 5 and Nucleolin","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"DOD Prostate Cancer Research Program; U.S. Department of Defense","keywords":"Protein arginine methyltransferase 5; Nucleolin; Biology; Methylation; Arginine; Molecular biology; Derepression; Nuclear localization sequence; Cancer research; Cell biology; Nucleolus; Cytoplasm; Methyltransferase; Gene; Gene expression; Biochemistry; Psychological repression","score_opus":0.05508116087377711,"score_gpt":0.38650622780704275,"score_spread":0.3314250669332656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157384800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791918,0.0019004697,0.017425926,0.0006105817,0.00003438899,0.0005293852,0.000012149986,0.000005517072,0.00028978783],"genre_scores_gemma":[0.9991319,0.000256696,0.00013156516,0.00006173721,0.00016282935,0.000044210617,0.00003629347,0.000017075985,0.00015767428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.00012425879,0.00017868253,0.0002115219,0.00024487003,0.0002428099],"domain_scores_gemma":[0.999423,0.000035177156,0.00003959694,0.0002040995,0.00023677335,0.00006132017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011604927,0.000073279574,0.000093823044,0.00007192071,0.00011534242,0.000014018358,0.00011269124,0.000084353494,0.000040387935],"category_scores_gemma":[0.000074152944,0.000059556227,0.000028275927,0.00024099018,0.00028674744,0.0000034751029,0.00005132502,0.00013328277,9.113511e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004680553,0.000013183059,0.00058576895,0.000034402827,0.000037993745,8.279905e-7,0.0002349978,0.00095249736,0.98114604,0.00023671259,0.00035872858,0.015930803],"study_design_scores_gemma":[0.00081128447,0.0003208602,0.0026850055,0.000056568704,0.000009579247,0.0000034308036,0.00031787215,0.0012370046,0.97250193,0.000111680565,0.021848446,0.00009632423],"about_ca_topic_score_codex":0.00038676383,"about_ca_topic_score_gemma":0.0005161101,"teacher_disagreement_score":0.021489717,"about_ca_system_score_codex":0.000043044773,"about_ca_system_score_gemma":0.00012019445,"threshold_uncertainty_score":0.24286325},"labels":[],"label_agreement":null},{"id":"W2157688061","doi":"10.1158/0008-5472.can-05-0628","title":"Tobacco Smoke Stimulates the Transcription of Amphiregulin in Human Oral Epithelial Cells: Evidence of a Cyclic AMP-Responsive Element Binding Protein–Dependent Mechanism","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Amphiregulin; Aryl hydrocarbon receptor; Transcription factor; Chemistry; Kinase; Cancer research; Protein kinase A; Epidermal growth factor receptor; Signal transduction; Transcription (linguistics); Molecular biology; Receptor; Biology; Biochemistry; Gene","score_opus":0.094806780013852,"score_gpt":0.4100557403312039,"score_spread":0.3152489603173519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157688061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997387,0.0008663617,0.0001555492,0.0004215818,0.000043973705,0.0010446213,0.00006395625,0.0000028701993,0.000014091041],"genre_scores_gemma":[0.99853796,0.00045481572,0.00014879178,0.000021870628,0.00011151564,0.00026408245,0.000012076894,0.000015823261,0.00043305146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813694,0.0003366277,0.00035472,0.00033069466,0.00048310676,0.00035790162],"domain_scores_gemma":[0.9991871,0.0000385186,0.00009825173,0.00037727313,0.00024290034,0.000055951965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014407512,0.0001244136,0.00018707885,0.00015018163,0.00010652193,0.00002098286,0.00034444494,0.0001029215,0.00010803084],"category_scores_gemma":[0.00004862071,0.00009987594,0.00009598994,0.0002238043,0.0001575049,0.0000089610985,0.00014869461,0.000209303,0.0000024622634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047816942,0.00011160847,0.0004251568,0.000054188942,0.000042409345,0.0000012470363,0.00039039977,0.0008804209,0.9946117,0.00022288067,0.00003189262,0.0027499576],"study_design_scores_gemma":[0.00052329316,0.00047024837,0.0008463434,0.00014484159,0.000012168413,7.809383e-7,0.0003516259,0.000042056574,0.99682873,0.00013748658,0.00053973665,0.00010267147],"about_ca_topic_score_codex":0.0015396698,"about_ca_topic_score_gemma":0.0054677944,"teacher_disagreement_score":0.003928125,"about_ca_system_score_codex":0.00015132905,"about_ca_system_score_gemma":0.0002235891,"threshold_uncertainty_score":0.4072823},"labels":[],"label_agreement":null},{"id":"W2157783262","doi":"10.1158/0008-5472.can-07-6494","title":"Recruitment and Activation of Natural Killer Cells <i>In vitro</i> by a Human Dendritic Cell Vaccine","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Chemokine; CXCL10; Tumor necrosis factor alpha; CXCR3; Biology; Immunology; Interleukin 12; T cell; Immune system; Cell biology; Chemistry; Cancer research; Cytotoxic T cell; In vitro; Chemokine receptor","score_opus":0.059049486250766954,"score_gpt":0.3534801301637865,"score_spread":0.29443064391301954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157783262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659694,0.03295036,0.000002624525,0.00020195724,0.00024665284,0.00043416795,0.00000970361,0.000009608962,0.00017555071],"genre_scores_gemma":[0.97941417,0.0039574173,0.000008867838,0.0000626497,0.000011027103,0.00013877978,0.000033813318,0.000014467759,0.016358783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868673,0.00043594744,0.00022302361,0.00021566695,0.00007014664,0.00036851125],"domain_scores_gemma":[0.99942726,0.00022539195,0.000047517304,0.00018953037,0.00009697144,0.000013359631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036515645,0.000104560226,0.00021375995,0.0002003693,0.00022023173,0.000005927969,0.0001524885,0.00012271466,0.00030562934],"category_scores_gemma":[0.000020726291,0.00009237685,0.00003462138,0.00022051917,0.00022364297,0.00008279222,0.00006227858,0.00046736372,0.000021851021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012851357,0.00014059755,0.0002079876,0.00003237629,0.000033306333,0.0000028985755,0.0007358314,5.9645186e-7,0.98428744,0.000010321037,0.011107971,0.0021555147],"study_design_scores_gemma":[0.0020874704,0.00017625511,0.0018772138,0.000047768957,0.0000027143851,0.000008357139,0.00016372991,5.8308024e-7,0.94607645,0.000012609426,0.04945913,0.00008771722],"about_ca_topic_score_codex":0.0009153565,"about_ca_topic_score_gemma":0.000013493445,"teacher_disagreement_score":0.03835116,"about_ca_system_score_codex":0.000104458806,"about_ca_system_score_gemma":0.00009093073,"threshold_uncertainty_score":0.37670186},"labels":[],"label_agreement":null},{"id":"W2157885410","doi":"10.1158/0008-5472.can-07-3239","title":"Variants on 9p24 and 8q24 Are Associated with Risk of Colorectal Cancer: Results from the Colon Cancer Family Registry","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Odds ratio; Population; Microsatellite instability; Colorectal cancer; Medicine; Oncology; Cancer registry; Single-nucleotide polymorphism; Confidence interval; Family history; Internal medicine; Cancer; Genotype; Genetics; Biology; Microsatellite; Allele","score_opus":0.07073985074393246,"score_gpt":0.3810666271786735,"score_spread":0.31032677643474105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157885410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370934,0.006274235,0.000005038663,0.0022349053,0.00045558388,0.0011431703,0.0027713652,0.000039761253,0.0033665942],"genre_scores_gemma":[0.99247015,0.005536209,0.000045588065,0.00036147266,0.0003870461,0.00029913257,0.000036485384,0.00006326782,0.0008006432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960933,0.00033505395,0.0004551003,0.0007446468,0.0015634731,0.00080844236],"domain_scores_gemma":[0.9953876,0.0023066932,0.0003797585,0.00059241627,0.0010428187,0.00029071464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002069342,0.00027530434,0.0005353736,0.0001462848,0.00032231715,0.000040376006,0.00036361895,0.000296169,0.000158828],"category_scores_gemma":[0.0019216285,0.00018111087,0.000067650035,0.00097427407,0.000952511,0.000045306308,0.00015139845,0.0013793687,0.000004454674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044214025,0.00040995475,0.7841667,0.00014946851,0.0015521474,0.00022305433,0.003423546,0.00046256636,0.098118596,0.00006180307,0.050551087,0.016667042],"study_design_scores_gemma":[0.004785613,0.0013094866,0.95261604,0.0016254508,0.00018030933,0.000003187222,0.0012344704,0.00010132843,0.035659038,0.00012551156,0.0021391727,0.00022040999],"about_ca_topic_score_codex":0.052677628,"about_ca_topic_score_gemma":0.049184024,"teacher_disagreement_score":0.16844931,"about_ca_system_score_codex":0.0012378541,"about_ca_system_score_gemma":0.0017143796,"threshold_uncertainty_score":0.9681659},"labels":[],"label_agreement":null},{"id":"W2157912415","doi":"10.1158/0008-5472.can-13-0409","title":"Cyclin D1-Dependent Induction of Luminal Inflammatory Breast Tumors by Activated Notch3","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Cyclin D1; Cancer research; Progenitor cell; Breast cancer; Cyclin; Cancer; Inflammatory breast cancer; CD24; Medicine; Pathology; Biology; Stem cell; Internal medicine; Cell biology; Cell cycle","score_opus":0.047648533258616024,"score_gpt":0.37180547492660293,"score_spread":0.3241569416679869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157912415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955675,0.0007211349,0.000008034031,0.0015768535,0.00026767186,0.00066769146,0.00005678558,0.000026544158,0.0011078104],"genre_scores_gemma":[0.9936958,0.00047501666,0.000030576713,0.000055574783,0.00044450408,0.00027568897,0.000024006178,0.00003278866,0.0049660527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793214,0.00011288904,0.0003044439,0.0003150319,0.00088050147,0.0004550145],"domain_scores_gemma":[0.9986204,0.000051794494,0.00008686409,0.0003463801,0.0006211781,0.0002733948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005429994,0.0001262794,0.000287863,0.00024129331,0.00008081806,0.000024140296,0.0001410041,0.000099384415,0.003204514],"category_scores_gemma":[0.000055882647,0.000108122455,0.00007367997,0.00044713955,0.00025210253,0.00015836916,0.00008458915,0.0005964774,0.0001297166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003097129,0.00012481163,0.0044853706,0.00022173455,0.00006803215,0.000010029868,0.00020031109,0.0000045179404,0.91608596,0.000007806456,0.032066848,0.04641488],"study_design_scores_gemma":[0.001601978,0.00021333562,0.033667695,0.0003076589,0.000033982054,0.00005788652,0.0008766462,0.000007330405,0.9491468,0.000042549764,0.013899442,0.00014468364],"about_ca_topic_score_codex":0.0070055444,"about_ca_topic_score_gemma":0.00009747545,"teacher_disagreement_score":0.04627019,"about_ca_system_score_codex":0.00041486355,"about_ca_system_score_gemma":0.0005510391,"threshold_uncertainty_score":0.9996069},"labels":[],"label_agreement":null},{"id":"W2157917711","doi":"10.1158/0008-5472.can-06-0402","title":"Restoration of Tamoxifen Sensitivity in Estrogen Receptor–Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Breast Cancer Research Foundation","keywords":"Trichostatin A; Corepressor; Tamoxifen; Cancer research; Estrogen receptor; Histone deacetylase; Chromatin immunoprecipitation; Breast cancer; Estrogen receptor alpha; Biology; Antiestrogen; Cancer; Chemistry; Histone; Nuclear receptor; Promoter; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.042521618632506274,"score_gpt":0.36494312473919327,"score_spread":0.322421506106687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157917711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577135,0.00058052666,0.00004917042,0.00040108475,0.00015690488,0.0010091938,0.0011886439,0.000018578603,0.0008245604],"genre_scores_gemma":[0.99684674,0.00024863382,0.00011270859,0.00001602785,0.00058011466,0.000495484,0.0003154673,0.00006539717,0.0013194513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99584895,0.0010813657,0.0004846188,0.00087871676,0.00092334993,0.00078301935],"domain_scores_gemma":[0.9973878,0.00021499413,0.00020395988,0.00060840655,0.0014203356,0.00016446014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001396371,0.00027563906,0.00038618187,0.0002992671,0.0002286375,0.00005266776,0.00030002627,0.00029742063,0.00016003006],"category_scores_gemma":[0.00031490353,0.00027972207,0.000100567995,0.0008938252,0.0009778722,0.00003223305,0.00029462748,0.00066334225,0.000021184715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014836034,0.00025964726,0.007951131,0.000070373535,0.0000574259,0.00002016542,0.00027338174,0.0007264774,0.9764591,0.000058660746,0.011721695,0.0009183629],"study_design_scores_gemma":[0.00097196375,0.00015451366,0.0259431,0.00016639662,0.000008240666,0.0000072592447,0.00014547497,0.00013273352,0.96958447,0.00012383534,0.0024895517,0.00027247722],"about_ca_topic_score_codex":0.04102963,"about_ca_topic_score_gemma":0.015963284,"teacher_disagreement_score":0.025066344,"about_ca_system_score_codex":0.0007928699,"about_ca_system_score_gemma":0.000944581,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W2158003079","doi":"10.1158/0008-5472.can-06-4511","title":"High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":356,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Susan G. Komen for the Cure","keywords":"Breast cancer; Tissue microarray; Cancer; Heat shock protein; Cancer research; Estrogen receptor; Hsp90; Medicine; Oncology; Lymph node; Biology; Internal medicine; Pathology","score_opus":0.03827477800412672,"score_gpt":0.38451284954416576,"score_spread":0.34623807154003905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158003079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666065,0.0007963952,0.00011887261,0.00092788343,0.000068120506,0.0005461264,0.00015724976,0.000012212728,0.0007124929],"genre_scores_gemma":[0.9965869,0.0005018267,0.00006121806,0.00012558192,0.00032277644,0.00032144168,0.000067256944,0.00005618122,0.0019568196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965812,0.00037469738,0.0002367616,0.00062465004,0.0010457095,0.0011369697],"domain_scores_gemma":[0.9983867,0.00009261331,0.000038901544,0.00049319287,0.00064469734,0.00034393297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024151534,0.00017888326,0.00021730945,0.00024960755,0.00017309337,0.00004637129,0.00044139943,0.000278502,0.0006077078],"category_scores_gemma":[0.00022752897,0.00014886893,0.000044618362,0.00081425416,0.00024354564,0.000009355175,0.00026580947,0.00060322386,0.000015729143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012954263,0.00013453043,0.047507763,0.000026396861,0.000053060237,0.00006763858,0.000068489186,0.000032317308,0.9430291,0.000009203062,0.0045986916,0.0031773488],"study_design_scores_gemma":[0.0016346043,0.00016841873,0.07441075,0.00022377326,0.0000033020922,0.000004317655,0.00010662409,0.00000873968,0.9202808,0.000023160932,0.0029220642,0.00021342855],"about_ca_topic_score_codex":0.007965581,"about_ca_topic_score_gemma":0.007713473,"teacher_disagreement_score":0.02690299,"about_ca_system_score_codex":0.00042183336,"about_ca_system_score_gemma":0.001247985,"threshold_uncertainty_score":0.9986405},"labels":[],"label_agreement":null},{"id":"W2158008340","doi":"10.1158/0008-5472.can-08-0103","title":"Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cell biology; Receptor; Transfection; Histone; Transcription factor; Endocrinology; Molecular biology; Biochemistry; Gene","score_opus":0.05334643843936412,"score_gpt":0.33631964740781806,"score_spread":0.28297320896845396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158008340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984044,0.0006121789,0.00026604385,0.00038729762,0.00006393385,0.00018721852,0.00002022374,0.000009593749,0.000049107704],"genre_scores_gemma":[0.9974326,0.00057869253,0.000023815539,0.000021454694,0.00078578887,0.00005658248,0.00022090088,0.000016818685,0.00086333085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909973,0.00004873902,0.0001244214,0.00026497763,0.00023226654,0.00022984456],"domain_scores_gemma":[0.9995862,0.00000770063,0.000027041524,0.00016632336,0.00012647666,0.00008620899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014089595,0.00008431787,0.000091344125,0.00006115257,0.00020134234,0.000018161458,0.00008327948,0.000098332894,0.00003107844],"category_scores_gemma":[0.000013681202,0.00007412732,0.000030495403,0.00008473387,0.00011267482,0.0000070031283,0.0000458362,0.00013025802,0.000004349574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007434595,0.000013432539,0.0883803,0.00003844222,0.000021008209,0.0000027269944,0.0001795793,0.00003219371,0.90264595,0.0000071664317,0.0006675257,0.007937353],"study_design_scores_gemma":[0.00043265533,0.000088250184,0.52364457,0.00002629008,0.0000048996785,0.0000036679082,0.000017243885,0.00009403162,0.47018355,0.00006434515,0.005357099,0.00008336119],"about_ca_topic_score_codex":0.000046809095,"about_ca_topic_score_gemma":0.000017099412,"teacher_disagreement_score":0.4352643,"about_ca_system_score_codex":0.000015710095,"about_ca_system_score_gemma":0.00005187478,"threshold_uncertainty_score":0.30228242},"labels":[],"label_agreement":null},{"id":"W2158110937","doi":"10.1158/0008-5472.can-06-4145","title":"HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80HER4","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Ubiquitin ligase; Mitosis; Biology; Nuclear export signal; Cell biology; Ubiquitin; Molecular biology; Biochemistry; Cell nucleus; Cytoplasm","score_opus":0.08267448019521528,"score_gpt":0.43567567780294325,"score_spread":0.35300119760772797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158110937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820817,0.004266478,0.0000043338537,0.0091875335,0.00012404208,0.0008376462,0.000008192396,0.000021360942,0.0034686832],"genre_scores_gemma":[0.98881495,0.00070462964,0.0003242083,0.000073215175,0.00035643112,0.00002153466,0.0000041872217,0.00002721352,0.009673633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722433,0.0002095967,0.00028658038,0.0003772104,0.0013293801,0.0005729108],"domain_scores_gemma":[0.9987649,0.00015384953,0.00007322701,0.00039128427,0.00040748608,0.0002092609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018998532,0.00012929972,0.00023006999,0.00017481543,0.00033364558,0.000036048677,0.00026075612,0.00008366305,0.00016954247],"category_scores_gemma":[0.0002354527,0.00007605859,0.0000707448,0.00073947996,0.0011908069,0.00009919996,0.00023876676,0.0006158843,0.000018109084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002143509,0.00020802562,0.07827998,0.0011727997,0.00010492304,0.00008072059,0.0007357757,0.000003229869,0.72041327,0.003068524,0.005574013,0.18821523],"study_design_scores_gemma":[0.0010627107,0.0007708335,0.41482636,0.0014320904,0.00003738389,0.00011424739,0.0006678973,0.00010911971,0.54317665,0.0014912304,0.036090743,0.00022072108],"about_ca_topic_score_codex":0.0009304166,"about_ca_topic_score_gemma":0.00019199996,"teacher_disagreement_score":0.33654636,"about_ca_system_score_codex":0.00016067957,"about_ca_system_score_gemma":0.00031081034,"threshold_uncertainty_score":0.43875775},"labels":[],"label_agreement":null},{"id":"W2158183808","doi":"10.1158/0008-5472.can-13-0920","title":"β-Catenin Inhibitor ICAT Modulates the Invasive Motility of Melanoma Cells","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; Canadian Institute for Theoretical Astrophysics","keywords":"Cancer research; Melanoma; Motility; Ectopic expression; Catenin; Mesenchymal stem cell; Matrigel; Biology; Cell migration; Cell; Cell biology; Chemistry; Cell culture; Wnt signaling pathway; Signal transduction; Angiogenesis","score_opus":0.03782276081039113,"score_gpt":0.3265294765183976,"score_spread":0.28870671570800643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158183808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964621,0.0013893854,0.00009699946,0.0005873979,0.00020062135,0.00024328327,0.000019308665,0.000007147212,0.0009937236],"genre_scores_gemma":[0.9967791,0.00053742476,0.00009905231,0.00009084684,0.00040897052,0.0001354202,0.00002750064,0.000021282274,0.0019004244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844015,0.00024328439,0.0002147163,0.00035768648,0.00037959628,0.0003645481],"domain_scores_gemma":[0.9989279,0.00009766532,0.00006533139,0.0004277314,0.00040307397,0.00007832951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010981499,0.00012176434,0.00014791975,0.000050520575,0.00014832494,0.00002633118,0.0005209221,0.00012512089,0.0001454131],"category_scores_gemma":[0.00016869146,0.000085665655,0.000073058116,0.0002133836,0.00041719328,0.0000039755823,0.00026639164,0.00022580345,0.000024028875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008164701,0.000024776442,0.003907027,0.000043748118,0.00004591046,3.9909003e-7,0.00014506286,0.00009902692,0.9806642,0.000060542538,0.012801613,0.0021260786],"study_design_scores_gemma":[0.00026677718,0.00012506293,0.0031208626,0.000031708936,0.0000060903653,6.8482206e-7,0.00007320518,0.000029795514,0.9777035,0.00036489067,0.018181996,0.00009540388],"about_ca_topic_score_codex":0.00023289389,"about_ca_topic_score_gemma":0.00010257465,"teacher_disagreement_score":0.0053803846,"about_ca_system_score_codex":0.000039159087,"about_ca_system_score_gemma":0.0003035335,"threshold_uncertainty_score":0.34933442},"labels":[],"label_agreement":null},{"id":"W2158353647","doi":"10.1158/0008-5472.can-08-1753","title":"Translymphatic Chemotherapy by Intrapleural Placement of Gelatin Sponge Containing Biodegradable Paclitaxel Colloids Controls Lymphatic Metastasis in Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Paclitaxel; PLGA; Lymphatic system; Pharmacokinetics; Lymph; Medicine; Lymph node; Lung cancer; Metastasis; Chemotherapy; Pharmacology; Cancer; Urology; Pathology; Surgery; Internal medicine; Chemistry; In vitro","score_opus":0.05950563420338142,"score_gpt":0.4371428807677152,"score_spread":0.3776372465643338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158353647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95049304,0.039596062,0.000042694985,0.006634148,0.00011327946,0.0019955002,0.00018949145,0.000028329992,0.00090744003],"genre_scores_gemma":[0.9907983,0.0054839244,0.00011225543,0.00090648537,0.000113766924,0.0008275951,0.000045368437,0.00003327749,0.0016790187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715173,0.00030416736,0.0005662256,0.00044215153,0.0006941139,0.0008416014],"domain_scores_gemma":[0.9988169,0.00035259308,0.00011587024,0.0002585935,0.00021721039,0.00023883909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010412006,0.00026148214,0.00082233554,0.00040115937,0.00009978165,0.000025385156,0.0001850513,0.00011686278,0.0024975638],"category_scores_gemma":[0.000038913422,0.00022454384,0.00013545158,0.0009288204,0.00020802832,0.00012314977,0.000015856589,0.0002643791,0.0000032161074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021989614,0.002381305,0.08762919,0.0009007844,0.0017590856,0.000142077,0.006041404,0.00022807125,0.7154335,0.0003170779,0.026341077,0.13683683],"study_design_scores_gemma":[0.16363563,0.013572961,0.06252761,0.0030373754,0.0016339096,0.00004613481,0.0038649219,0.011366252,0.71351194,0.0005451427,0.02475295,0.0015052051],"about_ca_topic_score_codex":0.004730635,"about_ca_topic_score_gemma":0.0008188253,"teacher_disagreement_score":0.14164601,"about_ca_system_score_codex":0.0016941078,"about_ca_system_score_gemma":0.0010011295,"threshold_uncertainty_score":0.9984143},"labels":[],"label_agreement":null},{"id":"W2158440938","doi":"10.1158/1538-7445.am2011-117","title":"Abstract 117: The role of microRNAs in mammary tumorigenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"microRNA; Mammary tumor; Carcinogenesis; Biology; Cancer research; Metastasis; Genetically modified mouse; Suppressor; Transgene; Mammary gland; Breast cancer; Cancer; Gene; Genetics","score_opus":0.045626867812919664,"score_gpt":0.33651288373815735,"score_spread":0.29088601592523766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158440938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933476,0.0071694814,0.000009941688,0.00006165122,0.000033299642,0.00018318968,0.000012270883,0.0000025867896,0.0031928294],"genre_scores_gemma":[0.9990324,0.00056248636,0.0000688475,0.000015845773,0.00008222417,0.00007043456,0.000010324307,0.000012323042,0.00014512158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992052,0.00008142234,0.00013884601,0.00018964327,0.00016228145,0.00022260874],"domain_scores_gemma":[0.9993938,0.0000128832335,0.000037067097,0.00037949224,0.00013318103,0.000043569074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004439676,0.00006074383,0.000067120985,0.00006507195,0.00003969342,0.000007706706,0.00034471138,0.00006597871,0.0001293664],"category_scores_gemma":[0.0000399234,0.00004775519,0.000042319174,0.00016644066,0.00012950735,0.000003468768,0.000132961,0.00010281178,0.000009210548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008509241,0.000042520653,0.010344357,0.000021227599,0.000015550566,0.0000025295328,0.00011349697,0.0000048174375,0.9838252,0.0001455081,0.00047173348,0.004927973],"study_design_scores_gemma":[0.000112730384,0.000022811868,0.17966196,0.000016057189,0.0000016913656,0.0000010816275,0.000086116896,0.0000034361008,0.8132189,0.00050085457,0.006327904,0.000046433197],"about_ca_topic_score_codex":0.0007994901,"about_ca_topic_score_gemma":0.00022028151,"teacher_disagreement_score":0.17060627,"about_ca_system_score_codex":0.000033394503,"about_ca_system_score_gemma":0.00022324143,"threshold_uncertainty_score":0.19474001},"labels":[],"label_agreement":null},{"id":"W2158637523","doi":"10.1158/0008-5472.can-06-1634","title":"Population-Based Study of Natural Variation in the <i>Melanocortin-1 Receptor</i> Gene and Melanoma","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; BC Cancer Agency; Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Melanocortin 1 receptor; Melanoma; Penetrance; Odds ratio; Population; Locus (genetics); Biology; Genetics; Genotype; Confidence interval; Skin cancer; Melanin; Gene; Medicine; Internal medicine; Cancer; Phenotype","score_opus":0.02462836607566998,"score_gpt":0.35143964380335985,"score_spread":0.32681127772768986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158637523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988657,0.000443049,0.000023855418,0.000113897484,0.000058209742,0.00036189007,0.0000062660233,0.0000015829205,0.0001255121],"genre_scores_gemma":[0.9994473,0.000019987598,0.00005740847,0.000031302414,0.0001311794,0.0000930639,0.000107407395,0.000005624626,0.000106762185],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909526,0.00024888586,0.00014439161,0.00016315765,0.00023237738,0.00011592601],"domain_scores_gemma":[0.9996892,0.00003532922,0.000040665927,0.00014726185,0.000075778546,0.000011739116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345857,0.000047464353,0.000060637583,0.000055613567,0.00005978364,0.000016589982,0.000095748605,0.00003961635,0.000013203049],"category_scores_gemma":[0.000034019617,0.00003577852,0.000011596979,0.00015336761,0.00001964204,0.0000026937332,0.00002118484,0.00008053264,6.734459e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009203094,0.00010828094,0.28276807,0.000010641694,0.0000061219966,8.1451293e-7,0.00020350942,0.00016810306,0.715748,0.00006322982,0.00041947662,0.00041169446],"study_design_scores_gemma":[0.0009818675,0.00028301767,0.9091692,0.000007530139,0.00000413529,6.230256e-7,0.0002940907,0.000097914286,0.088743776,0.00009166658,0.00026501765,0.00006115621],"about_ca_topic_score_codex":0.0032072128,"about_ca_topic_score_gemma":0.0016965435,"teacher_disagreement_score":0.6270042,"about_ca_system_score_codex":0.000022029446,"about_ca_system_score_gemma":0.000041056395,"threshold_uncertainty_score":0.4848368},"labels":[],"label_agreement":null},{"id":"W2158648304","doi":"10.1158/0008-5472.can-11-2602","title":"PTP1B Is an Androgen Receptor–Regulated Phosphatase That Promotes the Progression of Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen receptor; Androgen; Cancer research; Biology; Prostate; Cancer; Internal medicine; Endocrinology; Medicine; Hormone; Genetics","score_opus":0.05937314214097161,"score_gpt":0.39515766097424926,"score_spread":0.33578451883327765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158648304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82339084,0.17381346,0.0000041040284,0.0007475591,0.0001362175,0.0011339391,0.00071786635,0.000014197817,0.00004179196],"genre_scores_gemma":[0.9939475,0.003554464,0.00014345917,0.00010970395,0.00032889933,0.0009898662,0.00035493853,0.000045360157,0.00052581687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979101,0.00025629788,0.00019508683,0.0003864914,0.00054939854,0.00070262916],"domain_scores_gemma":[0.9985746,0.00002095475,0.00011280779,0.0007183006,0.0003589364,0.00021438579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010029132,0.00017561282,0.0001622425,0.000049839473,0.00022663671,0.0000419078,0.0005015236,0.0001343397,0.00044057582],"category_scores_gemma":[0.0000962389,0.000117457006,0.000056828103,0.00032177632,0.00045447296,0.000030450186,0.00033868558,0.00022189332,0.000011927172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093433954,0.00030301392,0.062344003,0.00018978704,0.00013860302,0.0000019195907,0.0009037029,0.000007982348,0.8104942,0.00031556177,0.048006132,0.076360784],"study_design_scores_gemma":[0.00039734432,0.00027863565,0.0017532632,0.000104003026,0.00001230198,0.0000023569291,0.00010051507,0.000008579828,0.91641736,0.00003793487,0.08074309,0.00014458588],"about_ca_topic_score_codex":0.00072012295,"about_ca_topic_score_gemma":0.000071409944,"teacher_disagreement_score":0.17055663,"about_ca_system_score_codex":0.000043129417,"about_ca_system_score_gemma":0.000330332,"threshold_uncertainty_score":0.4823996},"labels":[],"label_agreement":null},{"id":"W2158735191","doi":"10.1158/0008-5472.can-04-2030","title":"Cytoplasmic Domain of proEGF Affects Distribution and Post-Translational Modification of Microtubuli and Increases Microtubule-Associated Proteins 1b and 2 Production in Human Thyroid Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Deutsche Krebshilfe","keywords":"Biology; Cytoplasm; Thyroid carcinoma; Exon; Thyroid; Gene isoform; Cell biology; Molecular biology; Cancer research; Endocrinology; Gene; Genetics","score_opus":0.021881138266503744,"score_gpt":0.3048845350204242,"score_spread":0.28300339675392044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158735191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956698,0.0026248326,0.0000104501605,0.0003518505,0.00000653407,0.0010330275,0.00027440191,0.0000032966163,0.000025828867],"genre_scores_gemma":[0.99888676,0.00038321054,0.00013941978,0.0000050253866,0.000057112815,0.00016423968,0.0002806219,0.000010275002,0.00007334207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989907,0.00020526884,0.0001700017,0.00029594803,0.00015470789,0.00018335257],"domain_scores_gemma":[0.9995324,0.000019755418,0.00007752062,0.00012098435,0.00019817274,0.0000511838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059889146,0.00009077377,0.00012831695,0.000083173,0.000089885914,0.000012890191,0.000057908615,0.0001117305,0.0000051244906],"category_scores_gemma":[0.00007057643,0.000091686816,0.000017004793,0.00012704985,0.00027165655,0.000011473668,0.00005334999,0.00012327638,2.614932e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019562677,0.00023738031,0.01088489,0.00019158867,0.00001292595,3.4949616e-7,0.00019937404,0.000005516912,0.986343,0.000048219692,0.000054166416,0.0018269361],"study_design_scores_gemma":[0.0013036509,0.00034238576,0.05072262,0.000075803095,0.000005405695,0.000004904825,0.000060185354,0.000016058988,0.9470751,0.00010160599,0.00020945213,0.00008280799],"about_ca_topic_score_codex":0.0005076856,"about_ca_topic_score_gemma":0.0004353369,"teacher_disagreement_score":0.03983773,"about_ca_system_score_codex":0.000038135426,"about_ca_system_score_gemma":0.00011456635,"threshold_uncertainty_score":0.373888},"labels":[],"label_agreement":null},{"id":"W2158943500","doi":"10.1158/0008-5472.can-05-2902","title":"LKB1/STK11 Suppresses Cyclooxygenase-2 Induction and Cellular Invasion through PEA3 in Lung Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"STK11; Cancer; Lung cancer; Cyclooxygenase; Cancer research; Lung; Medicine; Biology; Pathology; Internal medicine; KRAS; Enzyme; Colorectal cancer; Biochemistry","score_opus":0.04902940744749609,"score_gpt":0.37819862926157405,"score_spread":0.32916922181407793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158943500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816141,0.0150525,0.00001121022,0.00096346927,0.00036250567,0.0007710156,0.00001126465,0.000035231653,0.0011787064],"genre_scores_gemma":[0.99481744,0.0023550116,0.00003858824,0.00007390308,0.001254972,0.00038435424,0.00002535106,0.000038291313,0.0010120892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979572,0.00019099354,0.00024456324,0.00040934814,0.0006284653,0.0005694281],"domain_scores_gemma":[0.9992444,0.00012176183,0.000042504653,0.0002657064,0.00019503558,0.00013061936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006956521,0.00015682784,0.0002889347,0.00025885238,0.00015934408,0.000036597266,0.00009058809,0.00017125248,0.00044180706],"category_scores_gemma":[0.000097909004,0.0001330341,0.00003924517,0.0005361279,0.00019427201,0.00020947606,0.00008320901,0.00064193766,0.000013709413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005288521,0.00018085405,0.18021873,0.0015582904,0.000037108664,0.0003851337,0.0011510797,0.0000925092,0.7748092,0.00038291235,0.037342526,0.0033128425],"study_design_scores_gemma":[0.003281748,0.00023211329,0.09806901,0.0011365942,0.00004776921,0.000019626299,0.00033497668,0.00037925053,0.8672212,0.00047581844,0.028493414,0.00030849333],"about_ca_topic_score_codex":0.014856925,"about_ca_topic_score_gemma":0.0024940895,"teacher_disagreement_score":0.092412025,"about_ca_system_score_codex":0.00042609568,"about_ca_system_score_gemma":0.00041594182,"threshold_uncertainty_score":0.9917032},"labels":[],"label_agreement":null},{"id":"W2159234812","doi":"10.1158/0008-5472.can-09-0727","title":"Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":527,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; HRAS; Medicine; Cancer research; AKT1; Thyroid cancer; Oncology; Thyroid; Internal medicine; Cancer; Biology; PI3K/AKT/mTOR pathway; Colorectal cancer","score_opus":0.035583434624319565,"score_gpt":0.36702180438824383,"score_spread":0.33143836976392427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159234812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93465286,0.059945397,0.000039444378,0.0014254034,0.000044554185,0.0021422575,0.00086700916,0.000020859328,0.0008622132],"genre_scores_gemma":[0.9873295,0.00851979,0.0017402091,0.0003388585,0.00012869466,0.0014116004,0.00012897955,0.00003200074,0.00037039706],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998037,0.000112113,0.0003312493,0.0005244416,0.0005449367,0.0004502684],"domain_scores_gemma":[0.99858606,0.00046889987,0.00011811248,0.0002486315,0.00032004018,0.00025824297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000394139,0.00021377063,0.00052287825,0.00016282192,0.00016151396,0.00002568298,0.00008736427,0.000054687054,0.00006908523],"category_scores_gemma":[0.000092146685,0.00017656802,0.00007843752,0.00025475677,0.0003192354,0.000121511475,0.000031475214,0.00021156331,0.0000014526714],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007593359,0.00087193004,0.007359152,0.0015825224,0.0006166134,0.00009680989,0.0019868577,0.00014671849,0.4394411,0.0005486216,0.008083164,0.53167313],"study_design_scores_gemma":[0.04199941,0.01955381,0.65945786,0.0028524038,0.0013887773,0.00020461115,0.002352269,0.0003353507,0.24184793,0.006035628,0.022645144,0.0013267791],"about_ca_topic_score_codex":0.00012466268,"about_ca_topic_score_gemma":0.000064179265,"teacher_disagreement_score":0.6520987,"about_ca_system_score_codex":0.00051070104,"about_ca_system_score_gemma":0.0007250341,"threshold_uncertainty_score":0.72002345},"labels":[],"label_agreement":null},{"id":"W2159349532","doi":"10.1158/1538-7445.am10-2313","title":"Abstract 2313: Role of ferritin dysregulation in human breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"","keywords":"Ferritin; Breast cancer; Cancer; Cancer cell; Ectopic expression; Transferrin; Cancer research; Transferrin receptor; Phenotype; Biology; Chemistry; Biochemistry; Gene; Genetics","score_opus":0.02978674630115526,"score_gpt":0.38492583525170865,"score_spread":0.3551390889505534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159349532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668264,0.0007712081,0.000004161042,0.00032307362,0.00008703458,0.00018379396,0.000116884105,0.0000037460236,0.0018274672],"genre_scores_gemma":[0.9983842,0.00037705194,0.000026755482,0.000016331269,0.00032152826,0.00020193231,0.000034549234,0.000018410168,0.0006192366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900186,0.000038516017,0.0001854785,0.0002745977,0.00022965358,0.00026989006],"domain_scores_gemma":[0.99930656,0.00000859273,0.00005071557,0.0003489152,0.00021851408,0.000066702865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003717571,0.000079231664,0.000097289725,0.00009985232,0.000082029226,0.000020685773,0.00023308981,0.00013638039,0.0006584892],"category_scores_gemma":[0.000009105841,0.00007862301,0.00003926768,0.0001920425,0.00016152658,0.000006335887,0.00005936228,0.00028058898,0.0000051273714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004211,0.000058041056,0.008219096,0.000022362276,0.000009186619,4.2307317e-7,0.000041640644,0.00014196048,0.9800156,0.00037299166,0.0007612049,0.010315404],"study_design_scores_gemma":[0.00026303765,0.000020483372,0.20462804,0.000024710525,0.0000018610536,8.222514e-7,0.000065042645,0.000023612227,0.7869277,0.00020029345,0.0077619213,0.000082508406],"about_ca_topic_score_codex":0.0037596005,"about_ca_topic_score_gemma":0.005254932,"teacher_disagreement_score":0.19640894,"about_ca_system_score_codex":0.000045084456,"about_ca_system_score_gemma":0.00023769088,"threshold_uncertainty_score":0.7209994},"labels":[],"label_agreement":null},{"id":"W2159375511","doi":"10.1158/0008-5472.can-08-1229","title":"Mechanisms by which E-Selectin Regulates Diapedesis of Colon Cancer Cells under Flow Conditions","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Cancer Research Society","keywords":"Paracellular transport; Transcellular; Extravasation; Cell biology; Endothelium; Cancer cell; Extracellular; Leukocyte extravasation; Biology; Selectin; Cell adhesion molecule; Chemistry; Cancer; Immunology; Biochemistry; Endocrinology","score_opus":0.07628565547481456,"score_gpt":0.40685460760041514,"score_spread":0.33056895212560056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159375511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049807,0.0023618394,0.00035543204,0.0038358485,0.00013287716,0.0011283153,0.00023975762,0.000057288573,0.0013905708],"genre_scores_gemma":[0.97435755,0.005282689,0.0005723541,0.0002232688,0.00010090461,0.0006385803,0.000060410326,0.000077514705,0.018686727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961459,0.00032290636,0.00035837948,0.00055853097,0.0017303332,0.0008839483],"domain_scores_gemma":[0.9967916,0.0004504072,0.000069605194,0.0005581904,0.0016980451,0.0004321733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068297127,0.00019325862,0.0004376901,0.00033349489,0.00039022966,0.000021983918,0.00031489972,0.00021535817,0.007904833],"category_scores_gemma":[0.0001980658,0.00017739474,0.000108785745,0.001929398,0.00048966776,0.00009467178,0.00016883021,0.0008286642,0.00015301589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000291304,0.00021713786,0.0003175565,0.00016102116,0.00010416035,0.000035767884,0.00013632006,0.0002446565,0.88349336,0.000109946,0.11402688,0.0008618894],"study_design_scores_gemma":[0.0012246019,0.00042280531,0.0023824607,0.00016733383,0.000032439955,0.00001899663,0.00017856243,0.0009330777,0.98855865,0.00029600246,0.0056174886,0.00016758594],"about_ca_topic_score_codex":0.0025374321,"about_ca_topic_score_gemma":0.00046230457,"teacher_disagreement_score":0.10840939,"about_ca_system_score_codex":0.000682229,"about_ca_system_score_gemma":0.001493496,"threshold_uncertainty_score":0.99300206},"labels":[],"label_agreement":null},{"id":"W2159415114","doi":"10.1158/0008-5472.can-08-1404","title":"Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Cancer research; Cancer","score_opus":0.04325530047083126,"score_gpt":0.35616420859934095,"score_spread":0.3129089081285097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159415114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952326,0.0027248529,0.000074828306,0.0008418201,0.000052935146,0.00050319755,0.00015736968,0.000008196217,0.0004042465],"genre_scores_gemma":[0.9977633,0.00035736238,0.0009347695,0.0000871821,0.000050111033,0.0003509127,0.000039798993,0.000025817957,0.00039078807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824136,0.00014562976,0.00039281195,0.00031800382,0.0005178128,0.00038435898],"domain_scores_gemma":[0.9987066,0.000048102524,0.00010780341,0.00035123763,0.00070963765,0.00007662573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192058,0.0001438626,0.00025000368,0.000062680876,0.00021474768,0.000005506395,0.00037028393,0.00007199884,0.000041651198],"category_scores_gemma":[0.00012120529,0.000098490586,0.000091111775,0.0004539156,0.000415461,0.0000035205721,0.000114547205,0.00014296258,0.0000045412526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001665404,0.00028182694,0.013766064,0.0000701238,0.0006457643,0.000008552978,0.0036504036,0.000012972588,0.9742421,0.000028923763,0.0028918092,0.0027360502],"study_design_scores_gemma":[0.00082040235,0.00018049138,0.12154665,0.000099706136,0.00001412724,0.0000036191323,0.00052604824,5.5150684e-7,0.87105954,0.00001864712,0.0055780523,0.0001521716],"about_ca_topic_score_codex":0.00010558827,"about_ca_topic_score_gemma":0.0005557894,"teacher_disagreement_score":0.10778058,"about_ca_system_score_codex":0.000079254554,"about_ca_system_score_gemma":0.0007638129,"threshold_uncertainty_score":0.40163293},"labels":[],"label_agreement":null},{"id":"W2159428875","doi":"10.1158/0008-5472.can-12-1390","title":"Soluble CD200 Is Critical to Engraft Chronic Lymphocytic Leukemia Cells in Immunocompromised Mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Chronic lymphocytic leukemia; Monoclonal antibody; Medicine; Immunology; Splenocyte; Spleen; Rituximab; Leukemia; Cancer research; CD20; Cancer; Antibody; Internal medicine","score_opus":0.07371061650272423,"score_gpt":0.43253032998626684,"score_spread":0.3588197134835426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159428875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97365534,0.0146685885,0.00004372438,0.0018619107,0.00082786375,0.0023884606,0.000027783668,0.00010840959,0.0064178896],"genre_scores_gemma":[0.9804667,0.0012564324,0.0004127906,0.0007960186,0.0013631589,0.0011188065,0.0000108679915,0.0001267679,0.0144484565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99275225,0.00037308614,0.00059881614,0.00082528125,0.0020713946,0.0033791729],"domain_scores_gemma":[0.99574363,0.0010060865,0.000031979045,0.0011830444,0.000609721,0.0014255099],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028098244,0.00034352695,0.0006505494,0.0008635995,0.000250525,0.00010955937,0.000718317,0.00033312847,0.003941939],"category_scores_gemma":[0.00075273425,0.00032582422,0.00016352185,0.0019856184,0.00058052276,0.00030509187,0.0006561658,0.0013881878,0.0036180129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0024304828,0.00031339464,0.00052766793,0.0020383114,0.00015444202,0.00036067137,0.0036754182,0.00037330066,0.8759737,0.0005142774,0.1033365,0.010301805],"study_design_scores_gemma":[0.028759891,0.000819014,0.0008622618,0.0014056017,0.000055205193,0.00016656662,0.0006976188,0.013273792,0.7503366,0.00010499534,0.20282061,0.0006978743],"about_ca_topic_score_codex":0.017774612,"about_ca_topic_score_gemma":0.00033370891,"teacher_disagreement_score":0.20911564,"about_ca_system_score_codex":0.28104743,"about_ca_system_score_gemma":0.0719318,"threshold_uncertainty_score":0.99991935},"labels":[],"label_agreement":null},{"id":"W2159476762","doi":"10.1158/0008-5472.can-05-4588","title":"Nuclear Factor-κB Contributes to Hedgehog Signaling Pathway Activation through Sonic Hedgehog Induction in Pancreatic Cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Sonic hedgehog; GLI1; Pancreatic cancer; Hedgehog signaling pathway; Cancer research; Hedgehog; Biology; Tumor necrosis factor alpha; Signal transduction; Cyclopamine; Endocrinology; Internal medicine; Cancer; Cell biology; Chemistry; Medicine","score_opus":0.07461206094835297,"score_gpt":0.37276750107721895,"score_spread":0.29815544012886597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159476762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932973,0.0037142537,0.00056981645,0.0009247113,0.00023948324,0.000733548,0.00006394891,0.00003714963,0.00041983929],"genre_scores_gemma":[0.9970907,0.00041953594,0.00011108182,0.000249738,0.0008215484,0.00050403026,0.00005626727,0.00007073329,0.00067633844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727863,0.00028938326,0.0003943524,0.0007346355,0.00045952635,0.0008434924],"domain_scores_gemma":[0.99884415,0.00008873234,0.00008376688,0.00038999834,0.0005003972,0.00009295277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059498235,0.0002608598,0.0003313663,0.00023525735,0.0003401872,0.000093673676,0.0003196007,0.00026553278,0.00012663526],"category_scores_gemma":[0.00030930655,0.00025758677,0.000084699175,0.0008233574,0.00018308616,0.000023672463,0.00022370473,0.0004406377,0.000036049794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019561278,0.00007323925,0.009733344,0.00007275477,0.00006748579,0.0000041095313,0.00048304044,0.0021932102,0.982301,0.00021146977,0.0028479986,0.0018167172],"study_design_scores_gemma":[0.00075626187,0.00017534826,0.011689081,0.000301022,0.000008083623,9.777593e-7,0.00057842676,0.000028794704,0.9525071,0.00034047567,0.03330785,0.00030659608],"about_ca_topic_score_codex":0.0047588567,"about_ca_topic_score_gemma":0.0015914461,"teacher_disagreement_score":0.030459853,"about_ca_system_score_codex":0.0005861021,"about_ca_system_score_gemma":0.00045164066,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W2159566378","doi":"10.1158/0008-5472.can-08-3873","title":"Human Bone Marrow–Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Δ24-RGD to Human Gliomas","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Massachusetts General Hospital","keywords":"Bioluminescence imaging; Oncolytic virus; Glioma; Oncolytic adenovirus; Mesenchymal stem cell; Cancer research; Medicine; Pathology; Bone marrow; Luciferase; Biology; Cell culture; Transfection; Tumor cells","score_opus":0.060778230079623796,"score_gpt":0.39198305928210975,"score_spread":0.33120482920248595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159566378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416405,0.0031810286,0.00006387559,0.0004673792,0.00006817858,0.0015613692,0.000093205854,0.000018349832,0.00038256752],"genre_scores_gemma":[0.99629116,0.00024360884,0.00014981107,0.00022398327,0.00042447,0.0003385373,0.000042690688,0.00006598712,0.0022197517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964477,0.00034747767,0.00044597985,0.0007845166,0.0009232599,0.0010511052],"domain_scores_gemma":[0.9976764,0.000039919876,0.00008210006,0.0009603106,0.0008525757,0.00038871163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00159362,0.0002634959,0.00040164567,0.00041220005,0.0003682905,0.00006492562,0.0008398448,0.00025762207,0.000171912],"category_scores_gemma":[0.000037535126,0.00027007578,0.00022878135,0.0005550421,0.0002800881,0.000009910797,0.00024402693,0.00035159246,0.000026146656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019243134,0.00018056085,0.000040635274,0.00009383124,0.00012824973,0.000015814012,0.00014435555,0.0001686205,0.977984,0.00005746378,0.0056170044,0.013645134],"study_design_scores_gemma":[0.0016253564,0.008842806,0.00023794897,0.000060666054,0.000017645403,0.0000033749568,0.00015264271,0.00002024788,0.9814562,0.00011220049,0.007182951,0.00028796497],"about_ca_topic_score_codex":0.00026827332,"about_ca_topic_score_gemma":0.000665988,"teacher_disagreement_score":0.013357169,"about_ca_system_score_codex":0.00022891726,"about_ca_system_score_gemma":0.00058163406,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2159606069","doi":"10.1158/0008-5472.can-04-2312","title":"Inactivation of Anthracyclines by Cellular Peroxidase","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Doxorubicin; Chemistry; Clonogenic assay; Daunorubicin; Anthracycline; Biochemistry; Cytotoxic T cell; Cancer cell; Cardiotoxicity; Pharmacology; K562 cells; Myeloperoxidase; Leukemia; In vitro; Cancer; Biology; Internal medicine; Chemotherapy; Medicine; Toxicity; Immunology","score_opus":0.06947277325698539,"score_gpt":0.426184454000998,"score_spread":0.3567116807440126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159606069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934604,0.0009606133,0.0002968177,0.0033258917,0.00002920362,0.00027593505,0.000006985733,0.000017154847,0.0016269695],"genre_scores_gemma":[0.9970656,0.0005993455,0.00012269767,0.00014824966,0.0004172273,0.000042123702,0.000016556909,0.000014154069,0.0015740575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907154,0.00004930564,0.0001474139,0.00015110016,0.00040120276,0.00017943414],"domain_scores_gemma":[0.99935734,0.00005352513,0.000032715918,0.00018369767,0.000295654,0.00007703827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285513,0.000056867022,0.00014283873,0.00010443773,0.000058937203,0.000007642696,0.000054591423,0.00007430275,0.00021730998],"category_scores_gemma":[0.000097623466,0.00005162916,0.000049465718,0.00027940315,0.000115411574,0.000098334654,0.000014554248,0.0002301638,0.000012872505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118887205,0.00009121101,0.0003383078,0.000067468325,0.00002178295,0.000002132216,0.00021354666,0.0000047879357,0.94972295,0.000056638044,0.0055571618,0.0438051],"study_design_scores_gemma":[0.0007712659,0.000087617205,0.00076965644,0.00008939646,0.0000072054245,0.0000021078013,0.0001022333,0.00006026666,0.9746364,0.000044634267,0.023385145,0.000044090542],"about_ca_topic_score_codex":0.0001444739,"about_ca_topic_score_gemma":0.0000065253125,"teacher_disagreement_score":0.04376101,"about_ca_system_score_codex":0.00020234985,"about_ca_system_score_gemma":0.00014414379,"threshold_uncertainty_score":0.23793918},"labels":[],"label_agreement":null},{"id":"W2159794260","doi":"10.1158/0008-5472.can-06-4221","title":"Hypoxia Enhances Metastatic Efficiency in HT1080 Fibrosarcoma Cells by Increasing Cell Survival in Lungs, Not Cell Adhesion and Invasion","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"HT1080; Fibrosarcoma; Extravasation; Hypoxia (environmental); Apoptosis; Metastasis; Cancer research; Biology; Cell; Tirapazamine; Cell culture; Pathology; Immunology; Chemistry; Medicine; In vitro; Cytotoxicity; Cancer; Biochemistry","score_opus":0.029919437131697778,"score_gpt":0.3328820491839109,"score_spread":0.30296261205221314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159794260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97064584,0.027553717,0.00008691083,0.000058258327,0.0003916339,0.00043017085,0.000038451017,0.0000066276752,0.0007884029],"genre_scores_gemma":[0.9855587,0.0128566995,0.00025995538,0.00006686826,0.00030567287,0.000044372784,0.0000358871,0.000033721222,0.0008381145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719316,0.00042240386,0.0003780701,0.00067393587,0.000508867,0.0008235787],"domain_scores_gemma":[0.9990826,0.00020928803,0.000075545,0.0003195778,0.00011245365,0.00020054019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028816268,0.00020897317,0.0002915349,0.0002842656,0.00011453841,0.00004972705,0.00029845405,0.00016058517,0.000033354372],"category_scores_gemma":[0.000120843186,0.00020357686,0.00005197435,0.00052499835,0.00020987542,0.000016580212,0.00025034812,0.0004020219,0.000007835022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005266308,0.000154301,0.0014433182,0.00014470531,0.000004061118,0.0000081771,0.00022667475,0.000012361319,0.9915133,0.0000049768046,0.001047565,0.0049139294],"study_design_scores_gemma":[0.0014122446,0.00019929998,0.005650252,0.00007051936,0.0000064627584,0.0000025107233,0.00040611412,0.000023501854,0.97733635,0.000025142928,0.01463724,0.00023037822],"about_ca_topic_score_codex":0.003388006,"about_ca_topic_score_gemma":0.0025637911,"teacher_disagreement_score":0.014912882,"about_ca_system_score_codex":0.00010097703,"about_ca_system_score_gemma":0.00025601304,"threshold_uncertainty_score":0.83016235},"labels":[],"label_agreement":null},{"id":"W2159794319","doi":"10.1158/0008-5472.can-05-0471","title":"Amplification and Overexpression of the <i>KIT</i> Gene Is Associated with Progression in the Seminoma Subtype of Testicular Germ Cell Tumors of Adolescents and Adults","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Seminoma; Biology; Cancer research; Gene duplication; Exon; PDGFRA; Gene; Tumor progression; Proto-Oncogene Proteins c-kit; Germ cell; Carcinogenesis; Germ cell tumors; Molecular biology; Genetics; Stem cell factor; Stem cell","score_opus":0.02661734444610617,"score_gpt":0.34392206147279436,"score_spread":0.31730471702668817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159794319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529546,0.0037823168,5.426689e-7,0.00015676647,0.0000034783682,0.00068047835,0.000040097864,0.000002323729,0.000038559174],"genre_scores_gemma":[0.9996449,0.00020103224,0.00004218404,0.000021862783,0.000011230931,0.00003765215,0.000008614612,0.0000085908605,0.00002398323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892783,0.00011365298,0.00015889319,0.00015582019,0.00050917926,0.0001346187],"domain_scores_gemma":[0.9992701,0.00008148281,0.00014475768,0.0002298288,0.00022259037,0.00005125717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023709406,0.000068841175,0.00014620926,0.00004902461,0.000040397266,0.0000047576873,0.00007725634,0.00003879969,0.000007730425],"category_scores_gemma":[0.0001421647,0.000033777254,0.000021810234,0.00026601163,0.00019106932,0.000027277274,0.000048040016,0.00011710974,1.9388568e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004649612,0.00058564334,0.91286176,0.00037616468,0.000018029852,0.000005824005,0.00064004667,0.0000030654815,0.08032776,0.0000029109508,0.00007102471,0.0046428326],"study_design_scores_gemma":[0.0017309419,0.00023398,0.83549106,0.0032140648,0.000040716182,0.0000044157573,0.00009121067,0.00014282124,0.1590049,0.000008634389,0.000008668083,0.000028604856],"about_ca_topic_score_codex":0.0002118084,"about_ca_topic_score_gemma":0.000016094713,"teacher_disagreement_score":0.07867714,"about_ca_system_score_codex":0.00004721218,"about_ca_system_score_gemma":0.00013987086,"threshold_uncertainty_score":0.13773964},"labels":[],"label_agreement":null},{"id":"W2159845695","doi":"10.1158/0008-5472.can-04-0297","title":"Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Lewis lung carcinoma; Matrix metalloproteinase; Metastasis; Cancer research; Tumor microenvironment; Angiostatin; Tumor progression; Medicine; Macrophage; Stromal cell; Angiogenesis; Lung cancer; Cancer; Lung; Pathology; Immunology; Biology; Internal medicine; In vitro; Tumor cells","score_opus":0.021332975638556472,"score_gpt":0.34477246432717323,"score_spread":0.32343948868861677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159845695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821487,0.014729733,0.0006823776,0.00012798337,0.00011098034,0.00060327933,0.00048789562,0.000016244354,0.0010927827],"genre_scores_gemma":[0.99601,0.00043449714,0.0005107521,0.000025253146,0.00043808954,0.0002804041,0.00017120282,0.000035625853,0.002094178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998119,0.00024224575,0.0002554066,0.00040926834,0.00048228735,0.0004918046],"domain_scores_gemma":[0.9990016,0.000026499387,0.00007046785,0.000424801,0.00036809256,0.00010853612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063357997,0.0001602769,0.00020420464,0.00012978728,0.00012981528,0.000034125816,0.00033838814,0.00012269497,0.00032928068],"category_scores_gemma":[0.00014398774,0.00014354703,0.00012462807,0.00023390939,0.00019317304,0.00001079054,0.00025275984,0.00019682891,0.0000119546285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018222124,0.00010467657,0.00017095366,0.00015423709,0.000060565722,0.000025345695,0.000006255294,0.00001677057,0.9790956,0.0013738655,0.018635428,0.0001741287],"study_design_scores_gemma":[0.00053327717,0.00024160137,0.000048278263,0.000035405432,0.000023791912,0.000005309981,0.000019274925,0.000011904628,0.98587716,0.00077994214,0.012275037,0.00014904725],"about_ca_topic_score_codex":0.0014657457,"about_ca_topic_score_gemma":0.00013049197,"teacher_disagreement_score":0.014295236,"about_ca_system_score_codex":0.0000343712,"about_ca_system_score_gemma":0.00024230877,"threshold_uncertainty_score":0.5853678},"labels":[],"label_agreement":null},{"id":"W2160001764","doi":"10.1158/0008-5472.can-04-2910","title":"The G-Quadruplex-Interactive Molecule BRACO-19 Inhibits Tumor Growth, Consistent with Telomere Targeting and Interference with Telomerase Function","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":566,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Albert-Ludwigs-Universität Freiburg","keywords":"Telomerase; Telomere; Biology; Telomerase reverse transcriptase; Molecular biology; DNA damage; Cancer research; Cell biology; DNA; Biochemistry","score_opus":0.017999937904881965,"score_gpt":0.3310384391677136,"score_spread":0.3130385012628316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160001764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935701,0.0026849275,0.0010286318,0.0017803404,0.000017853135,0.00030740505,0.00001708369,0.00003202172,0.00056166697],"genre_scores_gemma":[0.9967312,0.0011247351,0.0009569998,0.00042939375,0.0001702948,0.00008546864,0.000018409344,0.000025638994,0.00045785325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848473,0.00015414626,0.00017007074,0.0005027689,0.00029254073,0.00039573567],"domain_scores_gemma":[0.99886006,0.00007132874,0.00008912756,0.0002681999,0.00058296876,0.00012831266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043134493,0.00017477883,0.000142391,0.00007989301,0.0004437178,0.000105056664,0.00014941762,0.0000600918,0.000005589796],"category_scores_gemma":[0.00015272394,0.000101461876,0.00003492794,0.00027863402,0.0005467901,0.000015656684,0.00014946569,0.00033966382,0.000002384878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017384678,0.000049377188,0.0014796323,0.00002693585,0.00015252267,0.000012707527,0.000073038726,0.00001285064,0.9785107,0.00006689919,0.0031484356,0.014728456],"study_design_scores_gemma":[0.00041703385,0.0008134862,0.00036757666,0.00009873345,0.000025816187,0.000042331314,0.0005862476,0.00005623386,0.98349226,0.000042455293,0.013851592,0.0002062419],"about_ca_topic_score_codex":0.000075885684,"about_ca_topic_score_gemma":0.00051411457,"teacher_disagreement_score":0.0145222135,"about_ca_system_score_codex":0.00007322455,"about_ca_system_score_gemma":0.00017239538,"threshold_uncertainty_score":0.41374952},"labels":[],"label_agreement":null},{"id":"W2160092994","doi":"10.1158/0008-5472.can-14-1531","title":"The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; National Institute on Aging; Instituto de Salud Carlos III; Stavros Niarchos Foundation; World Cancer Research Fund; Medical Research Council; U.S. Public Health Service; National Institutes of Health; Deutsche Krebshilfe; Hellenic Health Foundation; Institut National de la Santé et de la Recherche Médicale; Fondation de France; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; Purdue University; World Health Organization; Wellcome Trust; Cancer Research UK; British Heart Foundation; European Commission; Association pour la Recherche sur le Cancer; Cancerfonden","keywords":"Genome-wide association study; Bladder cancer; Cyclin E; Single-nucleotide polymorphism; Biology; Allele; Cancer research; Cancer; Cyclin D1; Oncology; Genetic association; Cell cycle; Genetics; Medicine; Gene; Genotype","score_opus":0.037376963235006215,"score_gpt":0.3738532822423926,"score_spread":0.3364763190073864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160092994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96475816,0.016775312,0.00011557435,0.014651335,0.0002958258,0.0011358985,0.00007626111,0.00006256128,0.0021290751],"genre_scores_gemma":[0.98744583,0.0039374316,0.000008990509,0.00052250864,0.00079879415,0.0008799404,0.000012472545,0.000036007063,0.0063580424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798787,0.00020915401,0.00013471376,0.00033392836,0.0008683323,0.00046601257],"domain_scores_gemma":[0.9985449,0.00033334567,0.00010171769,0.00025548914,0.00045987323,0.00030468107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055384554,0.0001359902,0.00017327265,0.000073753705,0.00048555332,0.00008695696,0.00008153313,0.00007030556,0.0002931897],"category_scores_gemma":[0.00017649797,0.00007904585,0.000040571816,0.00027816094,0.00017682026,0.00008634519,0.0000419507,0.000382815,0.000025194884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008114355,0.00023528888,0.7329662,0.00019324823,0.0014465745,0.000037163612,0.0005656711,0.00006974642,0.0026931386,0.0007316728,0.03943162,0.21351533],"study_design_scores_gemma":[0.008938376,0.0025960018,0.8041847,0.0007951089,0.0007923958,0.000008478842,0.0003503927,0.00045290717,0.0043728435,0.0030379947,0.17408149,0.00038936024],"about_ca_topic_score_codex":0.00087774574,"about_ca_topic_score_gemma":0.0008569622,"teacher_disagreement_score":0.21312596,"about_ca_system_score_codex":0.0005287329,"about_ca_system_score_gemma":0.00052316365,"threshold_uncertainty_score":0.37345326},"labels":[],"label_agreement":null},{"id":"W2160267143","doi":"10.1158/0008-5472.can-03-3255","title":"Transforming Growth Factor β Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Vanderbilt University Medical Center; Vanderbilt-Ingram Cancer Center","keywords":"Azoxymethane; Colorectal cancer; Cancer research; In vivo; Biology; Transforming growth factor; Cancer; Signal transduction; Receptor; Epithelium; Endocrinology; Cell biology; Genetics","score_opus":0.043777434766443094,"score_gpt":0.3877959196425993,"score_spread":0.3440184848761562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160267143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947559,0.0040059546,0.00003500474,0.0005652263,0.00006620154,0.0004904327,0.000028749468,0.000006235037,0.000046292564],"genre_scores_gemma":[0.9985948,0.0008232234,0.00009641728,0.000018964609,0.00012791967,0.00021362797,0.000022379741,0.000014227433,0.000088401874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991481,0.00005920899,0.00011254498,0.00020725187,0.00027094147,0.0002019912],"domain_scores_gemma":[0.9994271,0.000019500618,0.00004237144,0.00013577238,0.0003191531,0.000056113156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021294766,0.00007537243,0.00007580397,0.00004086335,0.00020684367,0.000020901953,0.00014243246,0.00007152548,0.000055450928],"category_scores_gemma":[0.00012062777,0.000052162923,0.000019829846,0.00017983063,0.00017320814,0.000009133823,0.00008241072,0.00011978379,5.2739296e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025642884,0.000066766115,0.0020060393,0.000096608295,0.000025534979,2.7124258e-7,0.0005037706,0.000018862096,0.98276734,0.000038124774,0.000278603,0.013941624],"study_design_scores_gemma":[0.00034427378,0.00042738928,0.0013497695,0.00015895789,0.0000050930057,3.6742983e-7,0.00010371694,0.0000019587383,0.99208987,0.00005672076,0.005397031,0.00006485836],"about_ca_topic_score_codex":0.00030411428,"about_ca_topic_score_gemma":0.00010386502,"teacher_disagreement_score":0.013876766,"about_ca_system_score_codex":0.00008543333,"about_ca_system_score_gemma":0.00046846486,"threshold_uncertainty_score":0.21271423},"labels":[],"label_agreement":null},{"id":"W2160517382","doi":"10.1158/1538-7445.am2012-3496","title":"Abstract 3496: Self-renewal as a therapeutic target in human colorectal cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Cancer research; Internal medicine; Oncology; Regulator; Cancer therapy; Gene; Biology","score_opus":0.10236030780937677,"score_gpt":0.4564178227727789,"score_spread":0.35405751496340215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160517382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629975,0.023272788,0.0000011812735,0.0016813431,0.00037724516,0.00071734487,0.000030855474,0.00005268361,0.010869045],"genre_scores_gemma":[0.99293053,0.0027719778,0.00007000658,0.0005500495,0.0011691068,0.0007417343,0.000014761834,0.000055035485,0.0016967957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731016,0.00011395172,0.00027342432,0.000355097,0.000817355,0.0011300137],"domain_scores_gemma":[0.99893874,0.00009565183,0.000048681417,0.00028308734,0.00019993335,0.00043390138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011431639,0.00018460443,0.00036082353,0.00032309754,0.00015630589,0.00003517424,0.00018472149,0.00013287796,0.008858308],"category_scores_gemma":[0.000029528279,0.00015734899,0.0001067271,0.0006803803,0.00015568027,0.00013666284,0.00008419868,0.00079281186,0.00012962874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010364931,0.0011176307,0.16652365,0.0005263006,0.0003804199,0.00010229361,0.004183756,0.000021883381,0.7805486,0.0006897107,0.017579727,0.027289545],"study_design_scores_gemma":[0.004458256,0.00050636055,0.16994096,0.00040623313,0.000108112064,0.000030240248,0.00078976917,0.000009052291,0.42476785,0.00045144404,0.3980562,0.00047552213],"about_ca_topic_score_codex":0.01742515,"about_ca_topic_score_gemma":0.00271353,"teacher_disagreement_score":0.38047647,"about_ca_system_score_codex":0.0011310169,"about_ca_system_score_gemma":0.0009889588,"threshold_uncertainty_score":0.9920477},"labels":[],"label_agreement":null},{"id":"W2160543963","doi":"10.1158/0008-5472.can-05-0713","title":"Ischemia-Induced K- <i>ras</i> Mutations in Human Colorectal Cancer Cells: Role of Microenvironmental Regulation of MSH2 Expression","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Guelph","funders":"","keywords":"Microsatellite instability; Colorectal cancer; Biology; Cancer research; MSH2; DNA mismatch repair; Mouse model of colorectal and intestinal cancer; Genome instability; Cancer; Genetics; Allele; Gene; DNA damage; Microsatellite","score_opus":0.04057859283183344,"score_gpt":0.37709946808466,"score_spread":0.33652087525282653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160543963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599874,0.0013143794,0.0000023675918,0.00022435667,0.000077855344,0.00073614804,0.00005489351,0.000011416084,0.0015798409],"genre_scores_gemma":[0.9984546,0.00020676538,0.00039017887,0.000021316939,0.00016915234,0.0003465409,0.000026113325,0.000035070563,0.00035028986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979602,0.000112791706,0.00043947253,0.00034951145,0.00075962977,0.0003783712],"domain_scores_gemma":[0.999208,0.00009662264,0.00013010018,0.00026904544,0.00017742238,0.000118809745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003546054,0.00013872366,0.00030849688,0.0002863199,0.00007450297,0.000006395257,0.00017262851,0.00015477034,0.0019155979],"category_scores_gemma":[0.000040873612,0.00013542976,0.000071954695,0.00045850457,0.00030030016,0.00008433777,0.00011690346,0.0004273157,0.000009679423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003490684,0.00021445955,0.020214567,0.000105309744,0.00002018867,0.0000012380092,0.0011600917,0.0006185988,0.9730795,0.0000062523413,0.00081966684,0.0034110367],"study_design_scores_gemma":[0.0012965432,0.00026964606,0.041302193,0.00031541096,0.000017418268,0.0000018339034,0.000530905,0.00015361577,0.95515764,0.000047013807,0.00080674764,0.00010101531],"about_ca_topic_score_codex":0.0013281527,"about_ca_topic_score_gemma":0.0007285757,"teacher_disagreement_score":0.021087628,"about_ca_system_score_codex":0.00093017076,"about_ca_system_score_gemma":0.00035477197,"threshold_uncertainty_score":0.9989968},"labels":[],"label_agreement":null},{"id":"W2160615924","doi":"10.1158/0008-5472.can-13-1791","title":"Tumor–Stroma Interaction: Revealing Fibroblast-Secreted Exosomes as Potent Regulators of Wnt-Planar Cell Polarity Signaling in Cancer Metastasis","year":2013,"lang":"en","type":"review","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Microvesicles; Wnt signaling pathway; Metastasis; Autocrine signalling; Biology; Cancer research; Cell biology; Stroma; Cancer cell; Cell polarity; Cell signaling; Exosome; Cell migration; Tumor microenvironment; Cancer; Signal transduction; Cell; microRNA; Immunology; Cell culture; Tumor cells; Genetics","score_opus":0.09926399825180503,"score_gpt":0.42984879029283335,"score_spread":0.3305847920410283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160615924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10429497,0.89377934,0.000013723487,0.000044883396,0.00018792148,0.0011621088,0.00036459314,0.000012218907,0.00014025182],"genre_scores_gemma":[0.04335975,0.9536615,0.00029048987,0.000027728476,0.0004395249,0.0007807743,0.000429067,0.00014171404,0.0008694671],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952643,0.0010890206,0.0009978935,0.0010487001,0.0007610406,0.0008390456],"domain_scores_gemma":[0.99762326,0.00013441563,0.00051856745,0.0009267861,0.00046112487,0.00033583737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010456943,0.0005145045,0.0011903194,0.0004880983,0.00012729641,0.000079388636,0.0009134098,0.00044943087,0.00043901906],"category_scores_gemma":[0.0002420949,0.000484391,0.0005323673,0.00073611795,0.00027813812,0.000020018098,0.00041913273,0.0011191142,0.000033955046],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341028,0.0004077371,0.000311804,0.043048117,0.0010274573,0.0002046802,0.00013865496,0.0003345742,0.74096686,0.00006440489,0.003315887,0.20983878],"study_design_scores_gemma":[0.0007462338,0.00039661615,0.000032790773,0.018551802,0.0004060723,0.00004471763,0.00033038334,0.00001767682,0.48846492,0.00010668284,0.48986796,0.0010341385],"about_ca_topic_score_codex":0.002699164,"about_ca_topic_score_gemma":0.00013090386,"teacher_disagreement_score":0.4865521,"about_ca_system_score_codex":0.00050934113,"about_ca_system_score_gemma":0.0017826315,"threshold_uncertainty_score":0.99976075},"labels":[],"label_agreement":null},{"id":"W2160699786","doi":"10.1158/0008-5472.can-04-1776","title":"Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Granulocyte macrophage colony-stimulating factor; Immune system; Immunotherapy; Cytokine; Biology; Immunology; Melanoma; Fusion protein; Cancer research; Cancer immunotherapy; Gene; Recombinant DNA; Genetics","score_opus":0.05899636004179159,"score_gpt":0.39163224559429183,"score_spread":0.33263588555250023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160699786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91017336,0.086460285,0.00044505092,0.00079678034,0.0007358285,0.001070152,0.00019846832,0.0000648277,0.000055247663],"genre_scores_gemma":[0.98225456,0.01165478,0.00015391628,0.00023676339,0.00010737855,0.0008136962,0.000044189896,0.00006800943,0.004666712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777365,0.00034042366,0.00036447283,0.00051631033,0.00011539928,0.0008897614],"domain_scores_gemma":[0.9986697,0.00049500196,0.00009673066,0.0003845034,0.00031275005,0.00004134897],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070753443,0.00026535042,0.0004034478,0.00027042135,0.00094506145,0.000074737414,0.00038337358,0.00031447306,0.0011250289],"category_scores_gemma":[0.00012303308,0.00022907791,0.00012691513,0.0002925911,0.000585579,0.00015486595,0.0001375828,0.0006491766,0.00005853097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003711396,0.00007813124,0.00076613954,0.00005203942,0.00021611736,0.000004427234,0.0018630554,0.00005075453,0.9213505,0.00013349809,0.00027838335,0.0714956],"study_design_scores_gemma":[0.006360065,0.0007803535,0.008175426,0.00019759175,0.000012332228,0.000021285105,0.00021183472,0.000006541639,0.90748,0.00029201468,0.076165654,0.0002969305],"about_ca_topic_score_codex":0.0030776584,"about_ca_topic_score_gemma":0.00023048511,"teacher_disagreement_score":0.07588727,"about_ca_system_score_codex":0.00044553826,"about_ca_system_score_gemma":0.00043516108,"threshold_uncertainty_score":0.9997881},"labels":[],"label_agreement":null},{"id":"W2160755225","doi":"10.1158/0008-5472.can-09-3166","title":"Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Azoxymethane; Cancer research; Carcinogenesis; Wnt signaling pathway; Notch signaling pathway; Matrix metalloproteinase; Colorectal cancer; Biology; Apoptosis; Cancer; Proinflammatory cytokine; Chemistry; Immunology; Signal transduction; Inflammation; Medicine; Internal medicine; Cell biology; Biochemistry","score_opus":0.03271457878011269,"score_gpt":0.37802903197592835,"score_spread":0.34531445319581566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160755225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443537,0.0016480052,0.0000066503344,0.0006540236,0.0005663361,0.0005201611,0.00010040798,0.000022934984,0.00204613],"genre_scores_gemma":[0.9733721,0.00024541773,0.00006771341,0.00015437143,0.0004347887,0.0021415697,0.00009736114,0.000046079986,0.023440579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978637,0.00015817705,0.00024903895,0.000524363,0.00048029478,0.0007244015],"domain_scores_gemma":[0.99895155,0.000035602676,0.00005991571,0.00035357015,0.00043436594,0.00016497479],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008998601,0.00017493019,0.00019710141,0.00016926734,0.00021214758,0.00007185625,0.00041944187,0.00020910129,0.0030066755],"category_scores_gemma":[0.0003028314,0.00017121035,0.00007968672,0.00052309834,0.00023131107,0.000009975588,0.00020548774,0.0006838405,0.00008826418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025729727,0.00007946189,0.005340704,0.000026498365,0.00008268272,0.000019123083,0.00008131156,0.000039343817,0.971656,0.00009798914,0.021805927,0.00051365007],"study_design_scores_gemma":[0.0012888318,0.0001440603,0.012486558,0.00007834285,0.000015975547,0.000007029836,0.00015101345,0.000021724607,0.81480163,0.000305724,0.17035313,0.00034597766],"about_ca_topic_score_codex":0.0037421354,"about_ca_topic_score_gemma":0.013110468,"teacher_disagreement_score":0.15685438,"about_ca_system_score_codex":0.00014674985,"about_ca_system_score_gemma":0.00114524,"threshold_uncertainty_score":0.9979047},"labels":[],"label_agreement":null},{"id":"W2160970614","doi":"10.1158/1538-7445.cansusc14-ia03","title":"Abstract IA03: DICER1: From ontogenesis to oncogenesis","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Germline; Cancer research; Biology; Gene silencing; Genetics; Rhabdomyosarcoma; Medicine; Gene; Pathology; Sarcoma","score_opus":0.12593171775688566,"score_gpt":0.4449256361479586,"score_spread":0.31899391839107294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160970614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97029114,0.0016414413,0.00005607172,0.0061569815,0.00017573284,0.0005760526,0.000057844674,0.000069815236,0.020974927],"genre_scores_gemma":[0.99450886,0.0002589977,0.0003374347,0.0007178999,0.0008121238,0.00043712894,0.000010021224,0.00004918057,0.002868341],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99751973,0.00011000341,0.0002684735,0.0004641842,0.0010216855,0.00061593816],"domain_scores_gemma":[0.99774235,0.00066967774,0.000028137694,0.00060047145,0.0004616137,0.0004977581],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008339294,0.00016329934,0.00038657407,0.00023848105,0.00017985736,0.000044644148,0.0002426596,0.00008889355,0.002545789],"category_scores_gemma":[0.0010995459,0.0001390459,0.0001009668,0.00051328336,0.00012066499,0.000049065588,0.00021576621,0.0002672593,0.0020142542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005173829,0.00018486366,0.06296019,0.00023560331,0.0004224911,0.00006427483,0.0019276507,0.000009471528,0.299959,0.00007374275,0.030175721,0.6034696],"study_design_scores_gemma":[0.0010794025,0.00022711902,0.7785478,0.00031232703,0.00007820322,0.000002309109,0.00046296822,0.00003553854,0.038403444,0.0002141828,0.18038471,0.0002519717],"about_ca_topic_score_codex":0.00784933,"about_ca_topic_score_gemma":0.0034046134,"teacher_disagreement_score":0.7155876,"about_ca_system_score_codex":0.0004016333,"about_ca_system_score_gemma":0.00028726595,"threshold_uncertainty_score":0.9987628},"labels":[],"label_agreement":null},{"id":"W2161074122","doi":"10.1158/1538-7445.sabcs14-p2-09-03","title":"Abstract P2-09-03: Got patient advocates? The value of patient advocate participation in a large research study to develop personalized risk-based breast cancer screening strategies","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Family medicine; Breast cancer screening; Focus group; Mammography; Cancer; Internal medicine","score_opus":0.2709379542052931,"score_gpt":0.5074012783658793,"score_spread":0.23646332416058624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161074122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130005,0.0019228952,0.000081718375,0.0028077278,0.00013176772,0.0030547765,0.00012811327,0.00003340263,0.0005395462],"genre_scores_gemma":[0.99701357,0.00010425218,0.00022250427,0.00021644699,0.00015513341,0.0021744177,0.000020419291,0.000048542483,0.000044688208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99160564,0.0014798818,0.000835626,0.00075425295,0.0038663368,0.0014582819],"domain_scores_gemma":[0.99316293,0.00053258723,0.00021620547,0.0006982504,0.0047974144,0.0005926222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00857773,0.00027857578,0.00052684086,0.00065164117,0.00041747862,0.00013670772,0.0004422612,0.00010867649,0.00028049288],"category_scores_gemma":[0.0015934813,0.00020311699,0.000082340826,0.0037926636,0.00036066858,0.00028585317,0.0003454197,0.0014255953,0.000040528263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01251134,0.0023108658,0.8197147,0.00030177293,0.0002697119,0.00031780452,0.07542706,0.032411315,0.002522573,0.00024301586,0.005402029,0.048567805],"study_design_scores_gemma":[0.004201939,0.0028129087,0.82984775,0.0016431719,0.00006478356,0.000008184997,0.15278935,0.0018037532,0.0041296603,0.00017825997,0.0021732578,0.000347009],"about_ca_topic_score_codex":0.07100285,"about_ca_topic_score_gemma":0.015532717,"teacher_disagreement_score":0.077362284,"about_ca_system_score_codex":0.0014797923,"about_ca_system_score_gemma":0.0059446087,"threshold_uncertainty_score":0.9996908},"labels":[],"label_agreement":null},{"id":"W2161214210","doi":"10.1158/0008-5472.can-08-0943","title":"Carcinoma-Associated Fibroblast–Like Differentiation of Human Mesenchymal Stem Cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":903,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Rutgers Cancer Institute of New Jersey","keywords":"Mesenchymal stem cell; Myofibroblast; Stromal cell; Metastasis; Cancer research; Angiogenesis; Pathology; Biology; Stroma; Tumor progression; Cancer; Cell biology; Immunology; Medicine; Fibrosis; Immunohistochemistry","score_opus":0.13144150902662466,"score_gpt":0.3820011400307257,"score_spread":0.25055963100410106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161214210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963147,0.0011064381,0.000012460383,0.00018617226,0.00015033905,0.00044457518,0.000059429247,0.000026842168,0.0016990383],"genre_scores_gemma":[0.9871401,0.00042499433,0.00002079352,0.000032361782,0.00016876454,0.000067784575,0.000026298983,0.00003146408,0.012087437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777687,0.00015787104,0.00031183782,0.00031862108,0.00094838,0.00048639916],"domain_scores_gemma":[0.9987043,0.00007804761,0.00009531016,0.00035827278,0.0005561637,0.00020788239],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039614024,0.00012990361,0.0003826048,0.00026443243,0.00021661761,0.00001058711,0.00014258703,0.00010192035,0.0009464332],"category_scores_gemma":[0.00001678822,0.00011470353,0.00014126116,0.00058034837,0.00023742436,0.000058975762,0.00009007783,0.00038003223,0.000026012756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019809522,0.00024613275,0.02838243,0.00028889492,0.00013244798,0.00004517653,0.0010228152,0.000008834332,0.9509971,0.00005139619,0.016771095,0.001855562],"study_design_scores_gemma":[0.002339806,0.0006398792,0.08778684,0.00023666139,0.000074248084,0.000008548501,0.0002755742,0.000032707012,0.9055284,0.00002171344,0.0029091174,0.00014645958],"about_ca_topic_score_codex":0.0022613462,"about_ca_topic_score_gemma":0.00027355284,"teacher_disagreement_score":0.05940441,"about_ca_system_score_codex":0.00037456842,"about_ca_system_score_gemma":0.00046298798,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W2161225883","doi":"10.1158/0008-5472.can-03-3911","title":"Adenovirus Vector-Mediated<b><i>in Vivo</i></b>Gene Transfer of OX40 Ligand to Tumor Cells Enhances Antitumor Immunity of Tumor-Bearing Hosts","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Cytotoxic T cell; Lewis lung carcinoma; Cancer research; In vivo; Immunotherapy; CD8; Biology; Immune system; Immunology; Melanoma; Ex vivo; Genetic enhancement; Cancer immunotherapy; Cancer; T cell; In vitro; Metastasis; Gene","score_opus":0.03136247271252012,"score_gpt":0.32400460187453667,"score_spread":0.29264212916201654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161225883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97695404,0.021340607,0.000026682479,0.00016942159,0.0004319572,0.00062586716,0.00020798943,0.000025238978,0.00021821064],"genre_scores_gemma":[0.99690974,0.0022409922,0.000032619333,0.00007946344,0.0000295194,0.00011636593,0.0000112314065,0.000041276853,0.00053878303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997306,0.0005543556,0.00066851935,0.00040147363,0.0002085207,0.00086114375],"domain_scores_gemma":[0.99857146,0.0004386603,0.00008767501,0.0005495712,0.00030162506,0.000050986968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013488751,0.00024807404,0.0006579096,0.00065272226,0.00019528532,0.000018015087,0.0007372433,0.00015630272,0.0006877771],"category_scores_gemma":[0.00018096868,0.00023159302,0.00013659844,0.0010469278,0.0007120848,0.00014760128,0.00014410456,0.0008044681,0.00013810731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032729486,0.00034697895,0.00046680242,0.00015439461,0.00012512557,0.000028129714,0.0024638004,0.00007592938,0.9924281,0.000099448036,0.00010850183,0.00042981535],"study_design_scores_gemma":[0.0024014874,0.000810265,0.0071734833,0.00052363524,0.000010460323,0.000017190689,0.0005714373,1.8233133e-7,0.9842421,0.000031602416,0.0039932835,0.00022490924],"about_ca_topic_score_codex":0.0077138627,"about_ca_topic_score_gemma":0.0005019419,"teacher_disagreement_score":0.019955723,"about_ca_system_score_codex":0.00019982512,"about_ca_system_score_gemma":0.0007777925,"threshold_uncertainty_score":0.99889386},"labels":[],"label_agreement":null},{"id":"W2161245944","doi":"10.1158/0008-5472.can-07-6055","title":"Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Prostate cancer; MAPK/ERK pathway; Cancer research; PTEN; Cancer; Transcription factor; Prostate; Biology; Activator (genetics); Signal transduction; Kinase; Medicine; Internal medicine; PI3K/AKT/mTOR pathway; Gene; Cell biology; Genetics","score_opus":0.11784495281120548,"score_gpt":0.4152820933890138,"score_spread":0.2974371405778083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161245944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907342,0.005593304,0.000001657255,0.0010384526,0.000038311744,0.0022629024,0.00012708026,0.00003913078,0.00016494961],"genre_scores_gemma":[0.99155366,0.004230892,0.000027946544,0.00000887363,0.000051720875,0.0011232257,0.000037423746,0.000035002584,0.0029312314],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974955,0.00016774966,0.00020039822,0.00042275377,0.0011396442,0.00057400926],"domain_scores_gemma":[0.99847674,0.00007117808,0.00011037811,0.00021481192,0.00085661525,0.00027026737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035904435,0.00017786134,0.00035584005,0.00024061347,0.0002998246,0.000018257533,0.0001008894,0.000112746646,0.00014526625],"category_scores_gemma":[0.00012493749,0.00011096656,0.000043131815,0.0008020785,0.0008061183,0.00018645922,0.0000416788,0.00058863393,0.0000013910903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042549814,0.0004351634,0.7068067,0.000702451,0.00023007201,0.00011288598,0.0034087636,0.0000019074907,0.27300897,0.000012039646,0.0007448264,0.010281189],"study_design_scores_gemma":[0.0039704507,0.0016094231,0.42876598,0.0040989323,0.000037079575,0.000008338183,0.0006233058,0.000017226192,0.5596915,0.000027753902,0.00096800714,0.00018201604],"about_ca_topic_score_codex":0.0004831829,"about_ca_topic_score_gemma":0.00015921655,"teacher_disagreement_score":0.28668252,"about_ca_system_score_codex":0.0004747341,"about_ca_system_score_gemma":0.0010953487,"threshold_uncertainty_score":0.45250848},"labels":[],"label_agreement":null},{"id":"W2161246322","doi":"10.1158/0008-5472.can-14-0708","title":"Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Melanoma Research Alliance","keywords":"Cancer research; Cell; Immunology; Biology; Genetics","score_opus":0.03973813749334912,"score_gpt":0.37794927804162426,"score_spread":0.33821114054827517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161246322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061364,0.0017712896,0.00002720279,0.0049858605,0.00014543772,0.0006772272,0.000050449347,0.000031536085,0.0016973622],"genre_scores_gemma":[0.9946936,0.00018278719,0.0000333038,0.00025388674,0.00024862544,0.00012025715,0.000002347184,0.000025462125,0.00443974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977841,0.00048159622,0.00026313396,0.00028989723,0.000697746,0.00048353904],"domain_scores_gemma":[0.9975248,0.0010316102,0.000036939815,0.000661643,0.00038133241,0.00036368045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019915036,0.00012444404,0.00028146766,0.00021266632,0.000112223825,0.000016306272,0.00024288811,0.00008644779,0.0005316327],"category_scores_gemma":[0.0009422323,0.00007421686,0.00011596237,0.00076199893,0.00024706745,0.000025754454,0.00010147219,0.00044330035,0.000119094904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00623719,0.00027800567,0.0004217688,0.00015723055,0.000036092202,0.00001515008,0.00046089143,0.000098318815,0.97106385,0.00004549714,0.019145811,0.0020401895],"study_design_scores_gemma":[0.0023647104,0.0011240707,0.048316844,0.00020210948,0.00007718844,0.0000057299094,0.00021695576,0.0002735993,0.82673746,0.00006284087,0.120457575,0.00016091057],"about_ca_topic_score_codex":0.0006105961,"about_ca_topic_score_gemma":0.000010087957,"teacher_disagreement_score":0.14432639,"about_ca_system_score_codex":0.0001417774,"about_ca_system_score_gemma":0.00051686325,"threshold_uncertainty_score":0.5821005},"labels":[],"label_agreement":null},{"id":"W2161287613","doi":"10.1158/0008-5472.can-11-4199","title":"Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Temozolomide; Integrin; Glioma; Cancer research; Integrin alpha M; Medicine; Biology; Internal medicine; Receptor","score_opus":0.04808890190628758,"score_gpt":0.3906281873462974,"score_spread":0.34253928544000983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161287613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603506,0.00283593,0.00007368714,0.01797769,0.00004969215,0.0009814749,0.000019466286,0.00002557461,0.0020014376],"genre_scores_gemma":[0.9960703,0.00007596149,0.0002286784,0.0002932441,0.0001750967,0.0009465186,0.0000059021368,0.00006209686,0.002142161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957782,0.0005334251,0.00032574902,0.0005122001,0.0013315969,0.0015188332],"domain_scores_gemma":[0.9976444,0.00089428166,0.000020609401,0.00064185075,0.00023769822,0.0005611425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023628687,0.00020151766,0.00035867578,0.00051333813,0.00011312819,0.0000714217,0.0005202463,0.00012950899,0.0003568487],"category_scores_gemma":[0.0011004801,0.00013464397,0.000042010623,0.0019637707,0.00040007822,0.00014185833,0.0004154555,0.0018882577,0.00014115543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036405176,0.0004882524,0.036826212,0.00026345634,0.00002449374,0.00048039717,0.0028435148,0.000013779273,0.9346353,0.0010462909,0.015820855,0.0039169737],"study_design_scores_gemma":[0.003297246,0.00084491534,0.057771433,0.001747722,0.000007948525,0.00004560746,0.0051468518,0.00008347412,0.86794704,0.00016233421,0.06252409,0.00042130298],"about_ca_topic_score_codex":0.0024417827,"about_ca_topic_score_gemma":0.00679233,"teacher_disagreement_score":0.06668819,"about_ca_system_score_codex":0.0012121935,"about_ca_system_score_gemma":0.0003527004,"threshold_uncertainty_score":0.82036453},"labels":[],"label_agreement":null},{"id":"W2161546085","doi":"10.1158/0008-5472.can-12-0420","title":"CD73-Deficient Mice Are Resistant to Carcinogenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Carcinogenesis; Immune system; Cancer research; Cancer cell; Antibody; Cancer; Monoclonal antibody; CD8; Biology; Prostate cancer; Cytotoxic T cell; Immunology; Chemistry; Biochemistry","score_opus":0.0807088229543634,"score_gpt":0.39311867363908665,"score_spread":0.31240985068472327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161546085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735607,0.02378523,0.0001226014,0.0007395536,0.00015016613,0.00017902262,0.000027828713,0.00000794354,0.0014269873],"genre_scores_gemma":[0.9951345,0.0002700058,0.00011992635,0.00031034774,0.0010811161,0.00012472004,0.000013728492,0.000025376274,0.0029203168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985451,0.000111042,0.00011976659,0.00027728776,0.00033212767,0.0006146927],"domain_scores_gemma":[0.9991465,0.000020786916,0.000023932118,0.00032398748,0.00022759767,0.00025720167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005943765,0.00009786587,0.000098322824,0.0000872354,0.0001609039,0.000023141089,0.00024001567,0.00008217853,0.00012583632],"category_scores_gemma":[0.00008113517,0.00008853185,0.000048661674,0.00028358222,0.000051219693,0.0000029316077,0.00021968958,0.00011892499,0.0000782182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014839254,0.000040957108,0.01012193,0.000024923771,0.00002409086,0.000003442349,0.00013121679,0.00008828988,0.91212714,0.00007723535,0.07690008,0.00031229528],"study_design_scores_gemma":[0.00015807583,0.000103834645,0.008964398,0.000028234144,0.000008325119,0.0000033632218,0.0003615996,0.0000017340466,0.69256544,0.0000072479493,0.2976501,0.00014764963],"about_ca_topic_score_codex":0.00035076667,"about_ca_topic_score_gemma":0.00003226497,"teacher_disagreement_score":0.22075002,"about_ca_system_score_codex":0.00006259567,"about_ca_system_score_gemma":0.000112315414,"threshold_uncertainty_score":0.3610224},"labels":[],"label_agreement":null},{"id":"W2161751938","doi":"10.1158/0008-5472.can-05-0436","title":"Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Antigen; Chimeric antigen receptor; Cancer research; In vivo; Prostate cancer; Cancer; Glutamate carboxypeptidase II; Adoptive cell transfer; Immunology; T cell; Prostate; Biology; Medicine; Immune system; Internal medicine","score_opus":0.05288526224692186,"score_gpt":0.4252216114787874,"score_spread":0.37233634923186554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161751938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800742,0.010942259,0.000004387203,0.0041378816,0.00004818512,0.0011388568,0.000093066934,0.0000799649,0.0034811553],"genre_scores_gemma":[0.95156443,0.0061426503,0.00018718845,0.00011528373,0.00039188605,0.00065664196,0.00008157237,0.000068035355,0.040792294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99667037,0.00023869498,0.00036135773,0.00043960894,0.0015332672,0.0007566966],"domain_scores_gemma":[0.9975996,0.0001495791,0.000059774953,0.0004355965,0.0014603671,0.00029508476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009295838,0.0001568522,0.000329856,0.0003682481,0.00015984497,0.000034660414,0.00025496478,0.00012929233,0.01414193],"category_scores_gemma":[0.00017997676,0.00014018417,0.00007938414,0.0009486527,0.00046826288,0.00008217887,0.00011010025,0.00047071555,0.000042721254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071820617,0.00018461618,0.005530967,0.00015711777,0.00009192626,0.0000063904135,0.00043216906,0.00002188229,0.85644275,0.000042007254,0.021658743,0.114713214],"study_design_scores_gemma":[0.0025119986,0.0004325329,0.018340725,0.00017084404,0.000021508724,0.0000030324504,0.00006645699,0.0005580608,0.89964986,0.00004180929,0.07806366,0.00013951157],"about_ca_topic_score_codex":0.002656107,"about_ca_topic_score_gemma":0.00050973543,"teacher_disagreement_score":0.1145737,"about_ca_system_score_codex":0.0012460662,"about_ca_system_score_gemma":0.00096163276,"threshold_uncertainty_score":0.9867593},"labels":[],"label_agreement":null},{"id":"W2161815207","doi":"10.1158/0008-5472.can-05-1470","title":"γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Cell growth; Kinase; Protein kinase A; In vivo; Biology; Extracellular; Endocrinology; Internal medicine; Chemistry; Cancer research; Cell biology; Biochemistry; Medicine","score_opus":0.024907287901189675,"score_gpt":0.26331480079973074,"score_spread":0.23840751289854106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161815207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552936,0.011393552,0.0006483032,0.00025831032,0.00016180279,0.0013591599,0.00016811717,0.00014859239,0.00033280827],"genre_scores_gemma":[0.9968401,0.00013605872,0.00012815685,0.00001522946,0.00025148925,0.00033946507,0.000047077607,0.00011926373,0.0021231307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996842,0.00014047066,0.00052526145,0.0004096547,0.0012628642,0.000819713],"domain_scores_gemma":[0.9985094,0.000069914444,0.0001035385,0.00074326544,0.00037267574,0.0002011761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075355906,0.0003104849,0.00030553254,0.0002837282,0.0002167447,0.00007231653,0.0006472763,0.00024225921,0.000373775],"category_scores_gemma":[0.00007460331,0.00025646182,0.00014150492,0.0012154959,0.00022263094,0.00033836626,0.00014816665,0.00076213025,0.000075786724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007129937,0.00006512871,0.00041170965,0.0002100007,0.000058732283,0.0000042593156,0.00031385236,0.003703013,0.9844878,0.00020166213,0.0013902086,0.009082371],"study_design_scores_gemma":[0.0009238619,0.00006328898,0.0012338202,0.0002291832,0.00001708647,0.0000037647108,0.000027805441,0.0020566059,0.9888741,0.00033889772,0.0059452043,0.00028640102],"about_ca_topic_score_codex":0.00026197336,"about_ca_topic_score_gemma":0.00017138227,"teacher_disagreement_score":0.011310775,"about_ca_system_score_codex":0.0009746506,"about_ca_system_score_gemma":0.00018935141,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W2161886933","doi":"10.1158/0008-5472.can-08-4591","title":"Gonadotropin-Releasing Hormone Type II Induces Apoptosis of Human Endometrial Cancer Cells by Activating GADD45α","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"MAPK/ERK pathway; Gene knockdown; Small interfering RNA; Apoptosis; Gonadotropin-releasing hormone receptor; Cell biology; Cell growth; Receptor; Biology; Chemistry; Cancer research; Kinase; Endocrinology; Gonadotropin-releasing hormone; Internal medicine; Cell culture; Transfection; Hormone; Luteinizing hormone; Medicine; Biochemistry","score_opus":0.04214995765799479,"score_gpt":0.3843504112227433,"score_spread":0.34220045356474854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161886933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97942424,0.019118015,0.000005911405,0.00019488976,0.00016434042,0.0002865087,0.000027208702,0.000011184043,0.00076772954],"genre_scores_gemma":[0.99029726,0.008398971,0.000049005794,0.000043388667,0.00049781625,0.000034214096,0.000037012247,0.000026499441,0.0006158291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983165,0.00017131612,0.00023325818,0.000377604,0.00039743047,0.0005038554],"domain_scores_gemma":[0.9991822,0.000039399645,0.00010223162,0.0002678917,0.00027466987,0.00013360278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002820404,0.00015834207,0.0002242038,0.00015723983,0.00033300006,0.000027862412,0.0002905945,0.0002614662,0.00006181817],"category_scores_gemma":[0.000121954006,0.00014302373,0.000083793806,0.0006083083,0.00015013404,0.00000832111,0.00013079059,0.00045092026,0.0000035346839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032443833,0.00009142538,0.000048674156,0.000016580594,0.00008846579,8.731817e-7,0.00007309789,0.000021682075,0.97095513,0.000017785982,0.011220808,0.01714105],"study_design_scores_gemma":[0.00092013204,0.001542989,0.00032811455,0.00007032181,0.000012648617,6.506321e-7,0.00004700135,0.000003936257,0.9937968,0.00001893297,0.003101517,0.00015690165],"about_ca_topic_score_codex":0.00058925594,"about_ca_topic_score_gemma":0.0000034357085,"teacher_disagreement_score":0.022841735,"about_ca_system_score_codex":0.000091990325,"about_ca_system_score_gemma":0.00023680997,"threshold_uncertainty_score":0.5832339},"labels":[],"label_agreement":null},{"id":"W2162003888","doi":"10.1158/0008-5472.can-08-4450","title":"<i>PIK3CA</i> and <i>PIK3CB</i> Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Pfizer","keywords":"Cancer research; P110α; Estrogen receptor; Breast cancer; Estrogen; Cancer; RNA interference; Synthetic lethality; PI3K/AKT/mTOR pathway; Biology; Estrogen receptor alpha; Mutant; Chemistry; Internal medicine; Apoptosis; Medicine; Endocrinology; Gene; Genetics; RNA","score_opus":0.02220956555352251,"score_gpt":0.32143217733045665,"score_spread":0.29922261177693416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162003888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910431,0.0034390204,0.000102296086,0.0040374417,0.000074658106,0.000836394,0.00020182953,0.00002442233,0.00024087202],"genre_scores_gemma":[0.9974115,0.00083960424,0.00027984532,0.0004293712,0.00031104905,0.00043542494,0.00013047017,0.00004292417,0.00011980363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732786,0.00032255764,0.00028134463,0.0008922524,0.00054007437,0.00063589436],"domain_scores_gemma":[0.9987099,0.000038933897,0.0001011308,0.0004852584,0.00048930285,0.00017545452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084166834,0.00025540637,0.00025280847,0.00012663321,0.0001727028,0.00007887156,0.00023524948,0.0002033178,0.00006553352],"category_scores_gemma":[0.00007594526,0.00023893888,0.000046387526,0.00040387895,0.0003273525,0.000029861769,0.0001160483,0.00042953304,0.000005398349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018989092,0.00015094977,0.027285114,0.00005200759,0.000066080254,0.000010703883,0.00024491575,0.00018403481,0.9551813,0.00016768365,0.0018435454,0.012914758],"study_design_scores_gemma":[0.001640436,0.00086883846,0.015122346,0.0003411684,0.000027784215,0.000034575532,0.000080996506,0.000029243309,0.97877395,0.00045322673,0.0022375963,0.0003898318],"about_ca_topic_score_codex":0.0011234621,"about_ca_topic_score_gemma":0.00043939182,"teacher_disagreement_score":0.023592658,"about_ca_system_score_codex":0.00031782503,"about_ca_system_score_gemma":0.00056134845,"threshold_uncertainty_score":0.9743645},"labels":[],"label_agreement":null},{"id":"W2162047243","doi":"10.1158/0008-5472.can-05-1524","title":"HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Breast Cancer Research Foundation","keywords":"Mammary gland; Carcinogenesis; Angiogenesis; Genetically modified mouse; Knockout mouse; Mammary tumor; Biology; Internal medicine; Cyclooxygenase; Endocrinology; Cancer research; Prostaglandin; Breast cancer; Cancer; Transgene; Medicine; Receptor; Gene; Enzyme","score_opus":0.054286328399993304,"score_gpt":0.3750889146088052,"score_spread":0.3208025862088119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162047243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884257,0.0063573318,0.000001669153,0.0034372513,0.0001877141,0.000774647,0.000010344746,0.000059718597,0.0007456256],"genre_scores_gemma":[0.9952294,0.0015884564,0.0001285146,0.0003155981,0.0010789785,0.00038557884,0.0000072750604,0.000057237725,0.0012089589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737006,0.0002828903,0.00031396767,0.0005628276,0.0006613465,0.00080890354],"domain_scores_gemma":[0.9986068,0.0001890846,0.000058839978,0.0004650181,0.00023950315,0.00044073665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011668297,0.00021846195,0.00042990976,0.0005618634,0.00015849814,0.000036559555,0.00019680864,0.00018653825,0.00018392396],"category_scores_gemma":[0.00023188308,0.00019845128,0.00008585286,0.0007931159,0.0001275047,0.00015608664,0.00013150524,0.0004724687,0.00009066853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064386555,0.00020365788,0.035521198,0.0006724688,0.000083634346,0.0008586025,0.0010966596,0.000009710754,0.8699553,0.000053960164,0.0060313507,0.08486956],"study_design_scores_gemma":[0.002368974,0.00023027459,0.36036775,0.0004258228,0.000032851367,0.00007250222,0.00041902086,0.00018059474,0.62472296,0.0000273234,0.01082686,0.00032510163],"about_ca_topic_score_codex":0.00083591527,"about_ca_topic_score_gemma":0.0007689303,"teacher_disagreement_score":0.32484654,"about_ca_system_score_codex":0.0005019089,"about_ca_system_score_gemma":0.00054721173,"threshold_uncertainty_score":0.80926085},"labels":[],"label_agreement":null},{"id":"W2162074485","doi":"10.1158/0008-5472.can-13-1175","title":"Casein Kinase 1ϵ Promotes Cell Proliferation by Regulating mRNA Translation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; University of Leicester","keywords":"EIF4E; Translation (biology); Initiation factor; Casein kinase 1; Translational regulation; EIF4A1; Eukaryotic translation; Biology; Messenger RNA; Cell biology; Eukaryotic initiation factor; Cancer research; Eukaryotic translation initiation factor 4 gamma; Phosphorylation; Protein kinase A; Genetics; Gene","score_opus":0.05159236650077313,"score_gpt":0.36219734390934955,"score_spread":0.3106049774085764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162074485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156946,0.0048194565,0.0004979684,0.0011381918,0.000130506,0.00079617015,0.000031471245,0.00002012462,0.0009966642],"genre_scores_gemma":[0.9952317,0.00020079207,0.0005040087,0.000083576706,0.0008378616,0.0006637047,0.00014493789,0.000039755996,0.0022936692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983542,0.00018965395,0.00020222583,0.0004289604,0.00039650692,0.00042844698],"domain_scores_gemma":[0.9991014,0.000026841048,0.00005371257,0.00032429135,0.0003743418,0.00011938796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014353,0.00013069932,0.000103112834,0.00006585568,0.00019338499,0.00009913201,0.0001988886,0.00016631222,0.00031408176],"category_scores_gemma":[0.000055190234,0.000127134,0.00004539214,0.00021034984,0.00010077889,0.000016378488,0.000048720176,0.00023162508,0.00004033294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041810945,0.000034969285,0.0007086355,0.00005877531,0.0000119982715,9.917146e-7,0.00013283348,0.00006903464,0.9551363,0.0000054998777,0.021275753,0.022523409],"study_design_scores_gemma":[0.00044192825,0.00022086648,0.00012182719,0.00003110635,0.000004412169,0.0000019588451,0.00006445333,0.00073453033,0.97526157,0.00009611756,0.022863349,0.00015790621],"about_ca_topic_score_codex":0.0005419083,"about_ca_topic_score_gemma":0.000087780834,"teacher_disagreement_score":0.022365503,"about_ca_system_score_codex":0.000093670824,"about_ca_system_score_gemma":0.00024604268,"threshold_uncertainty_score":0.5184374},"labels":[],"label_agreement":null},{"id":"W2162184748","doi":"10.1158/0008-5472.can-04-1446","title":"<b> <i>Notch1</i> </b> and <b> <i>Notch2</i> </b> Have Opposite Effects on Embryonal Brain Tumor Growth","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"HES1; Biology; Notch signaling pathway; Carcinogenesis; Medulloblastoma; Cancer research; Progenitor cell; Cell growth; Oncogene; Cell; Signal transduction; Cell cycle; Cell biology; Gene; Stem cell; Genetics","score_opus":0.016766538787811466,"score_gpt":0.3286821687583751,"score_spread":0.3119156299705636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162184748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918118,0.0014625096,0.000102304526,0.0042438526,0.00015263884,0.00034771694,0.000020666255,0.000014755962,0.0018437253],"genre_scores_gemma":[0.9950052,0.00033958402,0.00016175742,0.002377938,0.00036252526,0.00013373519,0.00009077572,0.000025033578,0.0015034658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985145,0.00014797553,0.00013563996,0.00050695083,0.00025909086,0.00043586327],"domain_scores_gemma":[0.99942183,0.000060996113,0.00003190005,0.00020866998,0.00012101972,0.00015556514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045238595,0.00016112189,0.00013464336,0.00008940533,0.00024469887,0.000034646033,0.00017393079,0.00015194538,0.000012206974],"category_scores_gemma":[0.00010207981,0.00014569146,0.00004564912,0.00013543415,0.00024220036,0.000006248491,0.00017400685,0.00023499025,0.000037245452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003272288,0.000044374927,0.004115008,0.000057272366,0.00003236955,0.000019206174,0.000050606526,0.00002234479,0.9810903,0.00054168917,0.007643025,0.006056549],"study_design_scores_gemma":[0.001164867,0.0005481552,0.011846837,0.0000716695,0.0000044328303,0.000024872219,0.000019247944,0.0000015068431,0.9662042,0.0013466888,0.018576896,0.00019060692],"about_ca_topic_score_codex":0.00008377468,"about_ca_topic_score_gemma":0.000100433084,"teacher_disagreement_score":0.014886105,"about_ca_system_score_codex":0.00007279785,"about_ca_system_score_gemma":0.00022344668,"threshold_uncertainty_score":0.5941126},"labels":[],"label_agreement":null},{"id":"W2162713910","doi":"10.1158/0008-5472.can-05-3016","title":"Loss of Phosphatase and Tensin Homologue Increases Transforming Growth Factor β–Mediated Invasion with Enhanced SMAD3 Transcriptional Activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"PTEN; Tensin; Biology; Cancer research; Transforming growth factor; Protein kinase B; Tumor suppressor gene; PI3K/AKT/mTOR pathway; Cell biology; Carcinogenesis; Signal transduction; Cancer; Genetics","score_opus":0.035081505569922136,"score_gpt":0.3232368391590593,"score_spread":0.2881553335891372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162713910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947895,0.0038856103,0.00038350784,0.00015196948,0.000014608186,0.00026835626,0.00047063516,0.000011021403,0.000024832209],"genre_scores_gemma":[0.99857867,0.00078024535,0.00016176103,0.000043678712,0.000116734685,0.000075216405,0.00017307811,0.000021967382,0.000048659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987347,0.000115196875,0.00014176164,0.00035322353,0.00034102894,0.0003140696],"domain_scores_gemma":[0.999226,0.00009416859,0.000040813502,0.00018214875,0.00029508825,0.0001617872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001997911,0.00013460833,0.00016029962,0.000084728956,0.00011654143,0.000016573134,0.00014995172,0.00010899633,0.00007337763],"category_scores_gemma":[0.00016265227,0.000112829555,0.00003973068,0.00015854703,0.0004315881,0.000017418024,0.000038978607,0.00016812215,0.0000021365481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013938403,0.00018227055,0.004139766,0.00010451471,0.00005510453,0.000008180665,0.00010679927,0.000020640651,0.9884338,0.000016627551,0.000099910954,0.005438551],"study_design_scores_gemma":[0.0010421408,0.0002926137,0.019098323,0.00008408802,0.000012333429,0.0000064577866,0.00003860704,0.000009553184,0.97817904,0.000009459568,0.0010900468,0.00013733537],"about_ca_topic_score_codex":0.00050899014,"about_ca_topic_score_gemma":0.00061690604,"teacher_disagreement_score":0.014958557,"about_ca_system_score_codex":0.000041839183,"about_ca_system_score_gemma":0.0004244256,"threshold_uncertainty_score":0.46010557},"labels":[],"label_agreement":null},{"id":"W2162808671","doi":"10.1158/0008-5472.can-09-3669","title":"The Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre National de la Recherche Scientifique; Institute of Genetics; Wellcome Trust","keywords":"Carcinogenesis; Protein kinase A; MAPK/ERK pathway; Kinase; Cancer; Cancer research; Biology; Cell biology; Mitogen-activated protein kinase; Signal transduction; Cancer cell; Genetics","score_opus":0.043867190907508596,"score_gpt":0.35013322029543975,"score_spread":0.3062660293879311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162808671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934621,0.0035769397,0.0000043540645,0.00086595205,0.0003392658,0.0010429245,0.000047981233,0.000012282149,0.00064819696],"genre_scores_gemma":[0.99231595,0.00030548318,0.00003404824,0.00005021487,0.0006815143,0.002710493,0.00002734935,0.00004031748,0.0038346243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795794,0.00022074029,0.0002094345,0.000506947,0.00036886404,0.000736061],"domain_scores_gemma":[0.99883157,0.0000306583,0.000052043004,0.000647559,0.00026089948,0.0001772778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007846203,0.00016924823,0.00014034174,0.00008663845,0.00036753775,0.00010627968,0.00053444196,0.00022604998,0.00016666365],"category_scores_gemma":[0.0002398289,0.00012585818,0.00007416009,0.00035539622,0.00036087644,0.000006658768,0.00024899805,0.0007060727,0.00002763507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003699279,0.000057621055,0.0010898283,0.000024685838,0.000027002829,0.000015001009,0.0001650336,0.0000039260817,0.9754074,0.000106765474,0.0026775517,0.020055223],"study_design_scores_gemma":[0.0005408225,0.00011902327,0.00070972566,0.000024300896,0.0000023980056,0.0000023963273,0.000093104165,0.000015753141,0.7414635,0.00011582134,0.2567839,0.00012924336],"about_ca_topic_score_codex":0.003231585,"about_ca_topic_score_gemma":0.017508723,"teacher_disagreement_score":0.25410634,"about_ca_system_score_codex":0.000086608285,"about_ca_system_score_gemma":0.0011813275,"threshold_uncertainty_score":0.9770279},"labels":[],"label_agreement":null},{"id":"W2162815046","doi":"10.1158/0008-5472.can-07-1441","title":"Suppression of Proximal T Cell Receptor Signaling and Lytic Function in CD8+ Tumor-Infiltrating T Cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Oklahoma Health Sciences Center; National Cancer Institute; National Institutes of Health; School of Medicine, New York University; York University; University of Oklahoma","keywords":"Lytic cycle; Cell biology; Biology; T-cell receptor; Cytolysis; Cytotoxic T cell; Cancer research; In vitro; T cell; Immunology; Biochemistry; Immune system","score_opus":0.03354219923372063,"score_gpt":0.33035343676964896,"score_spread":0.2968112375359283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162815046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986941,0.011883931,0.00006078968,0.00004448838,0.0002856305,0.00032501732,0.00000771519,0.000014603781,0.00043684017],"genre_scores_gemma":[0.99777126,0.0003474634,0.000058630227,0.000023601517,0.000032109117,0.00002812747,0.000008379175,0.000017077515,0.0017133772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984092,0.00042326294,0.00033375405,0.00024128133,0.00008661347,0.0005058911],"domain_scores_gemma":[0.9990323,0.0005681235,0.00008192404,0.00017141516,0.00012744052,0.000018803408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002158921,0.000108651235,0.00020198361,0.00031105228,0.00017458227,0.00001412923,0.00014220989,0.00014659243,0.00077384035],"category_scores_gemma":[0.00008161336,0.00009551936,0.00003535488,0.00032621503,0.00028533445,0.000106085456,0.00006843038,0.000577985,0.00003578883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002987981,0.00007972645,0.002403662,0.000098302975,0.000019197561,0.0000028731656,0.0008502103,0.0000069415582,0.9886126,0.00003134053,0.00033910255,0.004568078],"study_design_scores_gemma":[0.0011956356,0.0003919554,0.0027300601,0.00020847116,0.000004221636,0.0000042807787,0.0011190051,0.0000034603518,0.99000084,0.000027218028,0.0042166,0.00009823503],"about_ca_topic_score_codex":0.0004550073,"about_ca_topic_score_gemma":0.000023474217,"teacher_disagreement_score":0.011536468,"about_ca_system_score_codex":0.00008337647,"about_ca_system_score_gemma":0.00015993425,"threshold_uncertainty_score":0.84730095},"labels":[],"label_agreement":null},{"id":"W2162925433","doi":"10.1158/0008-5472.can-10-0135","title":"Transforming Growth Factor-β Regulator SnoN Modulates Mammary Gland Branching Morphogenesis, Postlactational Involution, and Mammary Tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Involution (esoterism); Biology; Carcinogenesis; Mammary gland; Internal medicine; Endocrinology; Thymic involution; Oncogene; Cell biology; Morphogenesis; Cell growth; Transforming growth factor; Cancer research; Cell cycle; Cell; Cancer; Immunology; Gene; Medicine","score_opus":0.02114431554435314,"score_gpt":0.31231864602597564,"score_spread":0.2911743304816225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162925433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926983,0.0051954924,0.0011581903,0.00031688766,0.00017446246,0.00028135147,0.00008934557,0.00003038112,0.00005555052],"genre_scores_gemma":[0.9973037,0.0006909891,0.00086350646,0.00007062616,0.0004935132,0.00011543411,0.0001580915,0.0000413125,0.00026279932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821293,0.000111982714,0.00022777739,0.00055117236,0.0004335105,0.000462605],"domain_scores_gemma":[0.99891585,0.00005319135,0.000047461665,0.00036491544,0.00037362555,0.0002449463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036865636,0.00019027271,0.00015468469,0.00015683683,0.0003716953,0.000113134956,0.0003716641,0.00018785374,0.000045072804],"category_scores_gemma":[0.00015110962,0.00018896011,0.00006874091,0.00019460855,0.00019011888,0.000038091915,0.00015397802,0.00026669138,0.0000034791647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112671,0.000037001584,0.025293833,0.000108437234,0.00005772492,0.00000760266,0.000097126074,0.000020319865,0.97078496,0.00035403055,0.00038736194,0.0027389512],"study_design_scores_gemma":[0.000513714,0.000067693014,0.09699773,0.00003741476,0.000009869633,0.000023149816,0.000023860897,0.00011698966,0.89834654,0.0005163006,0.0030827879,0.00026392777],"about_ca_topic_score_codex":0.00023622769,"about_ca_topic_score_gemma":0.00019461317,"teacher_disagreement_score":0.07243838,"about_ca_system_score_codex":0.000042304593,"about_ca_system_score_gemma":0.00056287175,"threshold_uncertainty_score":0.7705569},"labels":[],"label_agreement":null},{"id":"W2163017229","doi":"10.1158/0008-5472.can-06-2393","title":"Targeting Cancer Cells by Novel Engineered Modular Transporters","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Curtin University of Technology; Petroleum Technology Alliance Canada; Russian Foundation for Basic Research; Russian Foundation for Fundamental Investigations; CRDF Global","keywords":"Photosensitizer; Transporter; Cancer cell; Chemistry; Biochemistry; Receptor; Endosome; ATP-binding cassette transporter; Cell biology; Biophysics; Biology; Cancer","score_opus":0.03506997526086674,"score_gpt":0.37181369850804874,"score_spread":0.336743723247182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163017229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802381,0.014301855,0.00064874854,0.0025452857,0.0001812735,0.00096738135,0.00042909163,0.00009875065,0.0005895576],"genre_scores_gemma":[0.9874916,0.003640035,0.00016701684,0.00012289458,0.00047584268,0.000683678,0.00007984536,0.000074080286,0.0072649973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681926,0.00006122834,0.00028864894,0.0004954438,0.0012287699,0.0011066524],"domain_scores_gemma":[0.99886006,0.00011926151,0.00003327147,0.00032893507,0.00042445713,0.00023400692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007685544,0.0002066336,0.0003682133,0.00024497748,0.00021976155,0.00003356258,0.00025830715,0.00010404604,0.0006724644],"category_scores_gemma":[0.000039929244,0.00017944645,0.000101102494,0.0006760114,0.00031394436,0.00008765808,0.000051534378,0.00078365457,0.00002039244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024360816,0.00015104738,0.0005234374,0.00017728,0.0001380832,0.0000356286,0.0002703125,0.00090053194,0.9570416,0.000021221782,0.03962754,0.00086968596],"study_design_scores_gemma":[0.0035674633,0.00021215521,0.0038988057,0.00029194498,0.00003873086,0.0000032089697,0.00031647412,0.0030632585,0.9005753,0.00005637174,0.0876239,0.0003523848],"about_ca_topic_score_codex":0.0074249995,"about_ca_topic_score_gemma":0.00019762233,"teacher_disagreement_score":0.05646632,"about_ca_system_score_codex":0.0007369403,"about_ca_system_score_gemma":0.00039313617,"threshold_uncertainty_score":0.99918467},"labels":[],"label_agreement":null},{"id":"W2163175652","doi":"10.1158/0008-5472.can-07-2192","title":"Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Immunovaccine (Canada); Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"Canadian Breast Cancer Research Alliance","keywords":"Bone marrow; Homing (biology); Haematopoiesis; Myeloid leukemia; Leukemia; Stem cell; Cancer research; Radiation therapy; Medicine; Pathology; Immunology; Biology; Internal medicine; Cell biology","score_opus":0.07910947506448765,"score_gpt":0.3959061314747365,"score_spread":0.3167966564102489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163175652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98021126,0.0134397475,0.0012040407,0.0031992067,0.00026667467,0.00077653094,0.000016724882,0.00001914567,0.0008666883],"genre_scores_gemma":[0.9942866,0.0016547723,0.00019103561,0.00045868318,0.00030430596,0.00006251132,0.0000014398687,0.000037033948,0.0030036282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997874,0.000100553465,0.00031111363,0.00028849565,0.00082646945,0.0005993691],"domain_scores_gemma":[0.99869394,0.00021101027,0.000053748223,0.00046301834,0.00027614296,0.0003021343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022927022,0.00012185488,0.00034273884,0.00027553257,0.0001114856,0.00002146184,0.00021404312,0.00007837853,0.00054395583],"category_scores_gemma":[0.000016942051,0.00008279562,0.00009290649,0.001043137,0.00024531904,0.00003298802,0.000060586703,0.0004299357,0.000040100076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084797625,0.00008941578,0.00031207313,0.00021919543,0.0000988592,0.00006086299,0.0024958656,0.000078824654,0.8230197,0.00007778064,0.01690032,0.15579917],"study_design_scores_gemma":[0.0010876709,0.00031758755,0.0010854063,0.00023938541,0.000027263408,0.000019676925,0.0020036707,0.000017320313,0.8745631,0.000010292017,0.12052381,0.00010484348],"about_ca_topic_score_codex":0.0013618524,"about_ca_topic_score_gemma":0.00045103708,"teacher_disagreement_score":0.15569432,"about_ca_system_score_codex":0.0004056259,"about_ca_system_score_gemma":0.00041663347,"threshold_uncertainty_score":0.59559345},"labels":[],"label_agreement":null},{"id":"W2163205674","doi":"10.1158/0008-5472.can-04-4133","title":"Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Epigenetics; Multiple drug resistance; Sarcoma; Biology; Cell culture; Genetics; Cancer research; Gene; Medicine; Drug resistance; Pathology","score_opus":0.046421196414274266,"score_gpt":0.3637124439429463,"score_spread":0.317291247528672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163205674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895332,0.009637375,0.0002696304,0.00006795884,0.000026180825,0.00025648947,0.000022862318,0.0000011881311,0.00018510841],"genre_scores_gemma":[0.9964088,0.0026618543,0.00065131683,0.000007918001,0.00009606938,0.000024353174,0.000003413761,0.000016905386,0.00012937165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883145,0.00014949184,0.0002911068,0.0002445553,0.00024619655,0.00023717606],"domain_scores_gemma":[0.99935097,0.000021613274,0.00006322847,0.0003411536,0.00017062886,0.000052398034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004236888,0.000086667635,0.00012989731,0.000087669454,0.00006226206,0.000007790649,0.00021741082,0.00008972501,0.000009856708],"category_scores_gemma":[0.000026358162,0.000070389506,0.000044343073,0.00018200265,0.00015165843,0.0000018719196,0.00016288173,0.00013875231,4.6709454e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043558033,0.00006460201,0.0040531266,0.000059571783,0.0000069470466,3.118729e-7,0.00012423629,0.03096911,0.9631453,0.000020566045,0.0000054408147,0.0015071997],"study_design_scores_gemma":[0.00049371365,0.00016881958,0.0040489426,0.000035492,0.0000056593008,1.08366706e-7,0.000040167728,0.009373875,0.9846843,0.00011481073,0.0009597318,0.000074384174],"about_ca_topic_score_codex":0.0011165545,"about_ca_topic_score_gemma":0.0013389573,"teacher_disagreement_score":0.021595232,"about_ca_system_score_codex":0.000050965293,"about_ca_system_score_gemma":0.00013588114,"threshold_uncertainty_score":0.28704008},"labels":[],"label_agreement":null},{"id":"W2163208661","doi":"10.1158/0008-5472.can-08-4899","title":"Mouse Mammary Tumor Virus p75 and p110 CUX1 Transgenic Mice Develop Mammary Tumors of Various Histologic Types","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Immunovaccine (Canada)","funders":"Canadian Breast Cancer Research Alliance; U.S. Department of Defense","keywords":"Mouse mammary tumor virus; Mammary tumor; Genetically modified mouse; Transgene; Biology; Pathology; Virus; Mammary gland; Cancer research; Cancer; Virology; Medicine; Gene; Breast cancer; Genetics","score_opus":0.036203716315201646,"score_gpt":0.34633510838241244,"score_spread":0.3101313920672108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163208661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97818506,0.01922715,0.00022763613,0.0009812535,0.00004952062,0.0004214683,0.000044045802,0.000023434959,0.0008404323],"genre_scores_gemma":[0.990616,0.0062960135,0.0005490624,0.0004136105,0.00013467988,0.00008472855,0.00003672036,0.000034472232,0.0018346843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975396,0.00036040726,0.00029553007,0.0006128944,0.0004949543,0.00069662736],"domain_scores_gemma":[0.9986212,0.00004653805,0.00006062092,0.0006138408,0.0004414097,0.00021636262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091290765,0.00021161007,0.00028476835,0.00022707788,0.0001567527,0.00004109049,0.00075866695,0.0001685515,0.00006561286],"category_scores_gemma":[0.00012356525,0.00020130552,0.000073645744,0.0005012195,0.00033643676,0.0000137153775,0.00018991566,0.00042629658,0.000012849513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016584758,0.00010244067,0.00022983308,0.00006822228,0.00006612511,0.00003481212,0.00010637195,0.000020126528,0.9737952,0.00011946578,0.0021046614,0.0216943],"study_design_scores_gemma":[0.00082473987,0.0022266456,0.001337849,0.000026528229,0.00000779075,0.00003206844,0.000027508026,0.000029528443,0.98542786,0.00047469977,0.009325601,0.0002591776],"about_ca_topic_score_codex":0.00021629763,"about_ca_topic_score_gemma":0.0004581503,"teacher_disagreement_score":0.021435123,"about_ca_system_score_codex":0.00010404855,"about_ca_system_score_gemma":0.0010768016,"threshold_uncertainty_score":0.8209001},"labels":[],"label_agreement":null},{"id":"W2163357887","doi":"10.1158/0008-5472.can-08-2110","title":"ADP-Ribosylation Factor 6 Regulates Glioma Cell Invasion through the IQ-Domain GTPase-Activating Protein 1-Rac1–Mediated Pathway","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"IQGAP1; RAC1; Glioma; Cell migration; Small interfering RNA; Cancer research; Small GTPase; Biology; ADP ribosylation factor; Gene knockdown; Cell biology; GTPase-activating protein; Scaffold protein; Signal transduction; Cell; Chemistry; Transfection; Cell culture; G protein; Biochemistry","score_opus":0.059963167735313905,"score_gpt":0.34951963870754127,"score_spread":0.28955647097222736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163357887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994981,0.0019446368,0.0002115976,0.0010605169,0.00007834786,0.00091414806,0.00008780652,0.00003751284,0.0006844492],"genre_scores_gemma":[0.99812967,0.000055551543,0.00030181478,0.0001711215,0.00046078133,0.0002347791,0.0001652206,0.00003905304,0.0004420076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752945,0.00045600685,0.00026271798,0.0005498113,0.0006270601,0.000574956],"domain_scores_gemma":[0.99866396,0.00009887656,0.00011675715,0.0006601329,0.00032886025,0.00013141177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006153692,0.00020216272,0.00014540387,0.000061248116,0.0004152633,0.00009175442,0.00047937297,0.00020576827,0.00013264967],"category_scores_gemma":[0.0005916856,0.00015399135,0.00009061783,0.0004875751,0.00018787754,0.00001769875,0.00016106326,0.00037730142,0.00002802752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023724746,0.000085084044,0.00019208514,0.000032893986,0.000015155865,0.000012844289,0.00035793884,0.00007924407,0.9947949,0.000064872336,0.0014676745,0.002660041],"study_design_scores_gemma":[0.0005769556,0.00030667885,0.0009464018,0.00008973402,0.000002770261,0.0000019874037,0.00022974228,0.000036345293,0.9855845,0.0011602511,0.010868704,0.0001959287],"about_ca_topic_score_codex":0.000115861905,"about_ca_topic_score_gemma":0.00002013618,"teacher_disagreement_score":0.00940103,"about_ca_system_score_codex":0.00011605679,"about_ca_system_score_gemma":0.00042879826,"threshold_uncertainty_score":0.6279585},"labels":[],"label_agreement":null},{"id":"W2163385235","doi":"10.1158/0008-5472.can-08-1128","title":"Interstitial Doppler Optical Coherence Tomography as a Local Tumor Necrosis Predictor in Photodynamic Therapy of Prostatic Carcinoma: An<i>In vivo</i>Study","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto Metropolitan University; University Health Network; University of Toronto","funders":"","keywords":"Photodynamic therapy; Medicine; Necrosis; In vivo; Prostate; Nuclear medicine; Optical coherence tomography; Ultrasound; Pathology; Radiology; Cancer; Internal medicine; Chemistry","score_opus":0.03733472883451232,"score_gpt":0.3306947472537813,"score_spread":0.29336001841926895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163385235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960794,0.00031162682,0.00017012734,0.000031789874,0.000060077786,0.0020969757,0.000064356,0.000084410625,0.0011012767],"genre_scores_gemma":[0.9963734,0.00012671745,0.00018488917,0.000014206657,0.000031880594,0.003203691,0.000004912839,0.000046760746,0.000013554968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751353,0.0001533061,0.0004749445,0.00047176352,0.0006846065,0.00070184056],"domain_scores_gemma":[0.9988538,0.00021261556,0.000026751113,0.0004962397,0.00018222323,0.00022835733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044559635,0.0002199257,0.00035687652,0.00071485544,0.00007285942,0.000031652948,0.00053894415,0.00008931885,0.00037064473],"category_scores_gemma":[0.000035313828,0.00021645344,0.00007481913,0.0024014043,0.0008416153,0.00019904244,0.00007367943,0.0007546467,0.000012653586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015513146,0.0043879463,0.5685498,0.0003909379,0.00015134575,0.0004768042,0.01195944,0.008190436,0.39962396,0.001169471,0.00068381144,0.0028647308],"study_design_scores_gemma":[0.00969264,0.0055985604,0.73257315,0.0005050539,0.000025906225,0.0000642189,0.005402425,0.055977896,0.18686004,0.0017754633,0.0001815626,0.0013430706],"about_ca_topic_score_codex":0.0034972474,"about_ca_topic_score_gemma":0.0028941785,"teacher_disagreement_score":0.21276392,"about_ca_system_score_codex":0.00025586796,"about_ca_system_score_gemma":0.00025815214,"threshold_uncertainty_score":0.88267154},"labels":[],"label_agreement":null},{"id":"W2163654664","doi":"10.1158/0008-5472.can-11-3317","title":"Hepatocyte–Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; National Cancer Institute; National Institutes of Health; Institut National de la Santé et de la Recherche Médicale; Association pour la Recherche sur le Cancer","keywords":"Hepatic stellate cell; Cancer research; Biology; Angiogenesis; Hepatocyte; Metastasis; Hepatocyte growth factor; Hepatocellular carcinoma; Trichostatin A; Tumor microenvironment; Tumor progression; Histone deacetylase; Cancer; Histone; Gene; Genetics","score_opus":0.09515258412988559,"score_gpt":0.3810045256691691,"score_spread":0.2858519415392835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163654664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97864956,0.018892258,0.0000010286385,0.00028609656,0.00011501214,0.0012501951,0.0000057055063,0.000010990556,0.0007891617],"genre_scores_gemma":[0.9966111,0.0021004274,0.000023770019,0.00019808389,0.00022911979,0.0004174349,0.000015510892,0.000026607764,0.0003779492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710035,0.0009061219,0.00023186966,0.00038761157,0.00046482933,0.00090923836],"domain_scores_gemma":[0.9990604,0.00020257366,0.000060367223,0.00045580356,0.000044862252,0.00017601394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001359158,0.00018714869,0.0002721042,0.00024376632,0.0001601126,0.000017193586,0.00028638047,0.00023574654,0.00038856818],"category_scores_gemma":[0.000027234812,0.00012984102,0.000077799414,0.00023729095,0.0007031144,0.00015009238,0.00019670832,0.0010973372,0.00011015528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045413972,0.00025726433,0.88282526,0.00022172206,0.000012221138,0.0009156138,0.016086595,0.0000068760896,0.09818442,0.00001816299,0.00016685843,0.0008508696],"study_design_scores_gemma":[0.0015070876,0.00020198704,0.88506216,0.0001307589,0.000013510461,0.000061159306,0.0020190326,0.0001227593,0.10785661,0.000036685033,0.0028462396,0.00014204225],"about_ca_topic_score_codex":0.0002572783,"about_ca_topic_score_gemma":0.0000357686,"teacher_disagreement_score":0.017961545,"about_ca_system_score_codex":0.00035510477,"about_ca_system_score_gemma":0.00020987881,"threshold_uncertainty_score":0.5294763},"labels":[],"label_agreement":null},{"id":"W2163894821","doi":"10.1158/0008-5472.can-03-3038","title":"Hypoxia Enhances Metastatic Efficiency by Up-Regulating Mdm2 in KHT Cells and Increasing Resistance to Apoptosis","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Institute on Aging","keywords":"Mdm2; Hypoxia (environmental); Apoptosis; Cancer research; Transactivation; Transfection; Biology; Programmed cell death; Tumor hypoxia; Metastasis; Gene; Chemistry; Transcription factor; Internal medicine; Medicine; Cancer; Genetics; Oxygen","score_opus":0.025439675240510207,"score_gpt":0.3424657106104671,"score_spread":0.3170260353699569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163894821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743612,0.02368603,0.00033044966,0.00038693624,0.00035977823,0.00040798687,0.000052222407,0.000009252448,0.0004061852],"genre_scores_gemma":[0.9925866,0.003988396,0.0011551656,0.00016226777,0.00039147693,0.0001887699,0.000014417852,0.000032283922,0.0014806254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978401,0.00020406359,0.0002656205,0.0006211306,0.00040994407,0.00065913575],"domain_scores_gemma":[0.9991975,0.000060573995,0.00005187815,0.0003273988,0.00015193658,0.00021075273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108477,0.0001732281,0.00023954728,0.00016442798,0.00018538865,0.00006954084,0.00026860475,0.00008281912,0.000020937638],"category_scores_gemma":[0.0002606627,0.00017285564,0.00004447318,0.00061417837,0.00019786881,0.000012088947,0.00018271296,0.00022058828,0.0000067376573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020331377,0.00003814806,0.00006601402,0.0000650428,0.000015966325,3.8826565e-7,0.0003519208,0.00014340875,0.9911929,0.000052525513,0.002244469,0.005625945],"study_design_scores_gemma":[0.00086361036,0.000085928725,0.00043924857,0.0001254888,0.000008804316,0.0000017693775,0.00029832867,0.0000038789894,0.95663434,0.0001619864,0.041166704,0.00020989416],"about_ca_topic_score_codex":0.0015015458,"about_ca_topic_score_gemma":0.0016865182,"teacher_disagreement_score":0.038922235,"about_ca_system_score_codex":0.000116811985,"about_ca_system_score_gemma":0.00032556106,"threshold_uncertainty_score":0.7048848},"labels":[],"label_agreement":null},{"id":"W2164320457","doi":"10.1158/1538-7445.sabcs14-s2-04","title":"Abstract S2-04: Comprehensive molecular characterization of invasive lobular breast tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CDH1; PTEN; Invasive lobular carcinoma; Cancer research; Carcinogenesis; Breast cancer; FOXA1; Biology; Epigenetics; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer; Phosphorylation; Gene; Genetics; Cadherin; Invasive ductal carcinoma; Signal transduction","score_opus":0.05105709866870405,"score_gpt":0.3411490428161809,"score_spread":0.29009194414747685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164320457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703914,0.0012330099,0.0001337611,0.0003117919,0.0001365538,0.00029090885,0.00029986713,0.0000052248533,0.00054974004],"genre_scores_gemma":[0.9980842,0.00089583657,0.000050181377,0.00016283899,0.00026896872,0.00006359102,0.00032823093,0.000031096628,0.00011507693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870354,0.00006658205,0.00021580585,0.00032353433,0.00036840088,0.0003221554],"domain_scores_gemma":[0.99823785,0.000029711779,0.00008906221,0.00038166912,0.001058278,0.00020342504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024407545,0.00012408977,0.00017166875,0.00009355505,0.000048595557,0.000031251177,0.00026596678,0.00010977589,0.000046255856],"category_scores_gemma":[0.00014454545,0.00012968642,0.000060792856,0.00019901135,0.00019680444,0.0000056352146,0.00020788205,0.00015436464,0.000019349576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017090644,0.000051341252,0.0014120569,0.000058171012,0.00004344459,0.000019841907,0.00009191015,0.000255192,0.9952034,0.00014069033,0.0012623682,0.0012906785],"study_design_scores_gemma":[0.00068403495,0.00021275545,0.015277997,0.00007115626,0.000008578338,0.000014395762,0.0001479231,0.000013444618,0.9698877,0.00016242864,0.01334669,0.00017294176],"about_ca_topic_score_codex":0.00038912555,"about_ca_topic_score_gemma":0.000058779297,"teacher_disagreement_score":0.025315745,"about_ca_system_score_codex":0.000084116626,"about_ca_system_score_gemma":0.0008890181,"threshold_uncertainty_score":0.5288459},"labels":[],"label_agreement":null},{"id":"W2164479838","doi":"10.1158/0008-5472.can-08-1319","title":"Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Medical Research Council; North West Cancer Research; Strong","keywords":"DNA methylation; Methylation; Biology; Cancer; Epigenetics; Stromal cell; Carcinogenesis; Cancer research; Pathology; Immunohistochemistry; Malignant transformation; Molecular biology; Medicine; DNA; Genetics; Immunology; Gene; Gene expression","score_opus":0.07069110492109085,"score_gpt":0.3916869680687425,"score_spread":0.3209958631476516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164479838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921333,0.006625844,0.00006683715,0.00009185153,0.00008375014,0.00019462843,0.00006328205,0.0000041008893,0.0007364024],"genre_scores_gemma":[0.9941295,0.005248216,0.000064655214,0.00001076252,0.000114062794,0.000060964547,0.000046175173,0.000013416718,0.00031225116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872893,0.00017623161,0.00022160955,0.00026985424,0.00029163648,0.00031173142],"domain_scores_gemma":[0.9993648,0.000023514318,0.00006917601,0.00020145297,0.00027407962,0.000067000554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047592886,0.00008497856,0.00013313633,0.00010134233,0.00007231008,0.0000066875446,0.00016550055,0.00014746388,0.000048791062],"category_scores_gemma":[0.00013671139,0.000089745445,0.000044986427,0.0004449525,0.00013743844,0.000003701364,0.00009638974,0.00009876381,0.0000042041343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007118806,0.00005204179,0.1417523,0.000012381315,0.000021381973,0.0000016495239,0.00006343564,0.0014707465,0.8537858,0.000018603407,0.00022372854,0.0025267191],"study_design_scores_gemma":[0.00055532623,0.00018805427,0.47669074,0.000022704719,0.0000028021793,4.2547828e-7,0.000016638367,0.000077132376,0.52045244,0.00026344587,0.0016306527,0.000099676676],"about_ca_topic_score_codex":0.0022620175,"about_ca_topic_score_gemma":0.0028066854,"teacher_disagreement_score":0.3349384,"about_ca_system_score_codex":0.00022059305,"about_ca_system_score_gemma":0.00043458003,"threshold_uncertainty_score":0.3659713},"labels":[],"label_agreement":null},{"id":"W2164484108","doi":"10.1158/0008-5472.can-07-2707","title":"Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":494,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Tamoxifen; Gefitinib; Estrogen receptor; Breast cancer; Epidermal growth factor receptor; Cancer research; Internal medicine; Growth factor receptor; Endocrinology; ERBB3; Protein kinase B; Estrogen; Epidermal growth factor; Biology; Cancer; Medicine; Signal transduction; Receptor; Cell biology","score_opus":0.017669061798178957,"score_gpt":0.2823640995906942,"score_spread":0.26469503779251524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164484108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930586,0.0058672116,0.00003808925,0.00025287352,0.000058241167,0.0003783416,0.00013265565,0.000011905221,0.00020205807],"genre_scores_gemma":[0.99593556,0.0021242064,0.00021399553,0.000031767384,0.00014623755,0.00010701036,0.0001161114,0.00004755475,0.001277528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980528,0.00024641177,0.00026820166,0.00056467974,0.00041195014,0.00045601022],"domain_scores_gemma":[0.9990989,0.00003194334,0.00011790948,0.0003455866,0.0002563731,0.00014930137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002487149,0.00017979938,0.00023492464,0.00012463902,0.00015825054,0.00001340239,0.0002587243,0.00023896553,0.00012540269],"category_scores_gemma":[0.00003361126,0.00014899846,0.00007066479,0.00038603548,0.00029165938,0.000012891961,0.00009948329,0.00042911695,0.000017405611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017382002,0.000068740505,0.032939393,0.000055765202,0.00006676662,0.000006286231,0.00021135778,0.000029079643,0.9511609,0.000008621823,0.0134331575,0.00028173806],"study_design_scores_gemma":[0.0010187469,0.00044010213,0.0053034616,0.00024746679,0.000008078101,0.000009957109,0.00006688506,0.000010367569,0.9897605,0.0000166601,0.002907008,0.00021072914],"about_ca_topic_score_codex":0.00016596203,"about_ca_topic_score_gemma":0.000016214175,"teacher_disagreement_score":0.038599644,"about_ca_system_score_codex":0.00014502344,"about_ca_system_score_gemma":0.00037680694,"threshold_uncertainty_score":0.60759807},"labels":[],"label_agreement":null},{"id":"W2164566492","doi":"10.1158/0008-5472.can_10-3398","title":"Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity","year":2011,"lang":"en","type":"review","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Medical Research and Materiel Command; Canadian Institutes of Health Research","keywords":"Androgen receptor; Prostate cancer; Medicine; Transactivation; Cancer; Androgen; Androgen Receptor Antagonists; Cancer research; Androgen deprivation therapy; Pharmacology; Internal medicine; Hormone; Chemistry; Biochemistry","score_opus":0.2289123433616003,"score_gpt":0.4516203472506589,"score_spread":0.22270800388905862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164566492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034349775,0.9896374,0.0000011578273,0.00031484108,0.00024070567,0.0032210052,0.00016345968,0.000034006316,0.002952468],"genre_scores_gemma":[0.00055003917,0.99254924,0.000027595574,0.000011888261,0.00070045475,0.0013330522,0.000111885725,0.00012680537,0.0045890445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584174,0.000965621,0.0005337715,0.00070973416,0.0009367885,0.0010123539],"domain_scores_gemma":[0.99754,0.00037845457,0.00024831155,0.0008763478,0.0006150255,0.00034187612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002095735,0.0004214686,0.0015277298,0.00046856227,0.00031499838,0.000039701175,0.0006364045,0.00039561462,0.00089838676],"category_scores_gemma":[0.00020229425,0.00023274777,0.00061752304,0.0012883631,0.0007580658,0.000055282177,0.00051055505,0.002163919,0.00012887348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025001465,0.00019291352,0.000081765385,0.016560124,0.00074155,0.000041741077,0.0003551642,5.8019683e-8,0.00043963332,0.00004054566,0.015198392,0.96609807],"study_design_scores_gemma":[0.0006201563,0.0003474503,0.000005697195,0.008772374,0.00030493413,0.000011769437,0.00012975863,5.584612e-7,0.010932561,0.000011038567,0.9786497,0.00021400153],"about_ca_topic_score_codex":0.0014720933,"about_ca_topic_score_gemma":0.000048704616,"teacher_disagreement_score":0.9658841,"about_ca_system_score_codex":0.00081994507,"about_ca_system_score_gemma":0.0043214904,"threshold_uncertainty_score":0.98367053},"labels":[],"label_agreement":null},{"id":"W2164576175","doi":"10.1158/0008-5472.can-03-3295","title":"The Functional <b> <i>UGT1A1</i> </b> Promoter Polymorphism Decreases Endometrial Cancer Risk","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Endometrial cancer; Odds ratio; Genotype; Allele; Internal medicine; Confidence interval; Case-control study; Carcinogenesis; Medicine; Endocrinology; Metabolite; Biology; Gastroenterology; Oncology; Cancer; Gene; Genetics","score_opus":0.26724815707206856,"score_gpt":0.5216540665629215,"score_spread":0.2544059094908529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164576175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93037176,0.052036688,0.000102612226,0.007277726,0.0056984313,0.00113833,0.00043236167,0.00008589264,0.002856212],"genre_scores_gemma":[0.9400011,0.049109124,0.00004194447,0.0013245803,0.004694511,0.0016524545,0.000015340122,0.00006019171,0.003100781],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567324,0.001197879,0.00040680994,0.0005538171,0.0009073293,0.0012608969],"domain_scores_gemma":[0.99709207,0.0012703394,0.00013655942,0.0003740125,0.00051957247,0.00060747017],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032487013,0.00027298572,0.0002727208,0.00027388762,0.0020417683,0.00012184667,0.00070502044,0.00026394238,0.003931453],"category_scores_gemma":[0.00051851326,0.00019553196,0.00018675593,0.0010122625,0.00089841225,0.00011941819,0.0002845915,0.0021605175,0.00036626455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006473952,0.0010293546,0.01961111,0.000066140026,0.0012693896,0.00012214851,0.001052628,0.007488405,0.5125889,0.0074821617,0.07755587,0.36525992],"study_design_scores_gemma":[0.0054422244,0.00008121351,0.0032814115,0.000018820618,0.0001360759,0.000011393292,0.000053255964,0.000081661965,0.27334568,0.0051130084,0.7121855,0.00024976343],"about_ca_topic_score_codex":0.0020404034,"about_ca_topic_score_gemma":0.00039232793,"teacher_disagreement_score":0.6346296,"about_ca_system_score_codex":0.00037862093,"about_ca_system_score_gemma":0.001396771,"threshold_uncertainty_score":0.99925745},"labels":[],"label_agreement":null},{"id":"W2164600784","doi":"10.1158/0008-5472.can-14-3475","title":"The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; University of Calgary; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Tamoxifen; Cancer research; Breast cancer; Estrogen receptor; Fulvestrant; Nuclear receptor; Biomarker; Biology; Estrogen receptor alpha; Cancer; Medicine; Transcription factor; Internal medicine; Gene","score_opus":0.025946984710687588,"score_gpt":0.34078797173533526,"score_spread":0.3148409870246477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164600784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982049,0.016139254,0.0000021091007,0.0006638883,0.00017445635,0.0004920505,0.00017516145,0.0000060109737,0.000298105],"genre_scores_gemma":[0.9957334,0.002174272,0.000008486609,0.000018539375,0.00008784764,0.00021472834,0.00003963003,0.000028261476,0.0016948604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810535,0.0004726285,0.0002094374,0.0003641057,0.00038732478,0.0004611503],"domain_scores_gemma":[0.99891007,0.00009332838,0.00006550727,0.0003690537,0.00031544553,0.00024662024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011612372,0.00014240874,0.00016645392,0.000110155626,0.00016423638,0.0000475209,0.00028185404,0.00010937041,0.00002037018],"category_scores_gemma":[0.00020065585,0.00010299671,0.000047615136,0.00028394177,0.00041781284,0.000009696922,0.00024631352,0.00029471322,0.000016213224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005100274,0.000040003455,0.005622259,0.000022583148,0.00014429593,0.00002141175,0.00026420574,0.000055548066,0.9754518,0.000039208608,0.011654373,0.0015840009],"study_design_scores_gemma":[0.0039698267,0.0008143582,0.009644927,0.00012755301,0.000038396425,0.00012659584,0.0032152892,0.000074094874,0.92910224,0.00009223065,0.052402493,0.00039200584],"about_ca_topic_score_codex":0.005820485,"about_ca_topic_score_gemma":0.0008637378,"teacher_disagreement_score":0.046349604,"about_ca_system_score_codex":0.0001940371,"about_ca_system_score_gemma":0.0012576885,"threshold_uncertainty_score":0.8798871},"labels":[],"label_agreement":null},{"id":"W2164606502","doi":"10.1158/0008-5472.can-04-4108","title":"Alteration of <i>SMRT</i> Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Lymphoma; Biology; Suppressor; Tumor suppressor gene; Gene; Genetics; Carcinogenesis; Immunology","score_opus":0.049118236942208834,"score_gpt":0.38808283325512605,"score_spread":0.3389645963129172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164606502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915955,0.0008524885,0.000025743419,0.0034099757,0.000080224774,0.0007457357,0.000021812699,0.000013746749,0.0032547414],"genre_scores_gemma":[0.9980324,0.0003941694,0.00008797109,0.00019889946,0.00023219683,0.00060456264,0.000029460793,0.000017303395,0.0004030604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985397,0.00006565542,0.0002742843,0.00024795017,0.0005267403,0.00034565636],"domain_scores_gemma":[0.99936134,0.00009321148,0.000031828044,0.00022035291,0.00018099816,0.00011224897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040237652,0.000100496065,0.00023815081,0.0002524977,0.000048858765,0.000015997119,0.00006714604,0.000056001867,0.00052601326],"category_scores_gemma":[0.000032189408,0.00008112441,0.0000662619,0.00038838136,0.00007764851,0.00013349735,0.000016700973,0.00012329257,0.000045878693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054258374,0.003426551,0.18287763,0.0007526862,0.00023311048,0.00015386703,0.0034975633,0.00042794968,0.5905935,0.0008115657,0.017582063,0.19421765],"study_design_scores_gemma":[0.008556245,0.00076080754,0.23487519,0.0003412244,0.000038986134,0.000013267288,0.00014789127,0.000574548,0.7391496,0.000066634006,0.0153759,0.00009975058],"about_ca_topic_score_codex":0.0013071012,"about_ca_topic_score_gemma":0.00092546805,"teacher_disagreement_score":0.1941179,"about_ca_system_score_codex":0.00072322576,"about_ca_system_score_gemma":0.00045087968,"threshold_uncertainty_score":0.57594764},"labels":[],"label_agreement":null},{"id":"W2164789880","doi":"10.1158/0008-5472.can-06-0712","title":"High-Grade Glioma Formation Results from Postnatal Pten Loss or Mutant Epidermal Growth Factor Receptor Expression in a Transgenic Mouse Glioma Model","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Cleveland Clinic","keywords":"PTEN; Glioma; Epidermal growth factor receptor; Cancer research; Biology; Mutant; Genetically modified mouse; Transgene; Cancer; PI3K/AKT/mTOR pathway; Signal transduction; Gene; Genetics","score_opus":0.043441049966162916,"score_gpt":0.3393354872042447,"score_spread":0.2958944372380818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164789880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995537,0.00043649334,0.0010016734,0.0007222803,0.000052384672,0.00054514693,0.0016438668,0.000022044132,0.000039150727],"genre_scores_gemma":[0.9965105,0.00047551442,0.000571614,0.000025478117,0.00035883547,0.00018544223,0.0009527619,0.000045978537,0.0008738901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968702,0.0003126715,0.00049248734,0.0006458502,0.00077335024,0.0009054223],"domain_scores_gemma":[0.9988781,0.000089305395,0.00007557658,0.00046355123,0.00027183656,0.00022161071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056299305,0.00022059029,0.0002395076,0.0003223295,0.0001957153,0.00009095609,0.0004973829,0.00027455125,0.00007285947],"category_scores_gemma":[0.0002533269,0.00017798576,0.00009547529,0.00047264187,0.00015182028,0.0000509347,0.00018934107,0.00044303763,0.000020189305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004124885,0.000116395386,0.00009931211,0.000041073257,0.000017140015,0.00008308904,0.00016129043,0.0007628186,0.9914839,0.000016831364,0.0026339141,0.00045934072],"study_design_scores_gemma":[0.0033117202,0.0002081373,0.0006200363,0.0000823949,0.0000025486438,0.000009431734,0.000102085316,0.003239056,0.9918616,0.00010285754,0.00023101244,0.00022911833],"about_ca_topic_score_codex":0.0064708823,"about_ca_topic_score_gemma":0.0023739643,"teacher_disagreement_score":0.0040969183,"about_ca_system_score_codex":0.00021171813,"about_ca_system_score_gemma":0.0003607732,"threshold_uncertainty_score":0.9782082},"labels":[],"label_agreement":null},{"id":"W2164896016","doi":"10.1158/0008-5472.can-09-2322","title":"The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent <i>Ex vivo</i> Natural Killer Cell Activation and Maturation","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cytokine; Cell biology; Ex vivo; Natural killer cell; Interleukin 15; Granulocyte macrophage colony-stimulating factor; STAT5; Cancer research; Immunology; Interleukin; Signal transduction; In vivo; Cytotoxic T cell; In vitro; Biochemistry","score_opus":0.029510173459776055,"score_gpt":0.33138736128244584,"score_spread":0.30187718782266976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164896016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962836,0.0015381747,0.000018339573,0.0005617104,0.0005676212,0.0005472619,0.0000021745993,0.000019620584,0.00046153224],"genre_scores_gemma":[0.9896877,0.000214692,0.000009350796,0.000057618763,0.00003343703,0.000031595668,0.00002575487,0.000008373912,0.009931519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888104,0.00031178657,0.00024117573,0.00022943474,0.00008803204,0.0002485406],"domain_scores_gemma":[0.99939054,0.00012597899,0.00012780781,0.00014112647,0.00019737899,0.00001713888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003634324,0.00011242472,0.00013850641,0.00011985896,0.000657942,0.000056378183,0.00009625454,0.00014720192,0.00015104195],"category_scores_gemma":[0.000072496536,0.00007826762,0.00002970566,0.00013416143,0.00021847148,0.0001837244,0.000071060145,0.00063542527,0.0000091593465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048792147,0.000030512267,0.00021186874,0.000022684919,0.000014508869,7.0774917e-7,0.0005643831,0.0000025057439,0.9849888,0.000098619945,0.00085510785,0.012722393],"study_design_scores_gemma":[0.00072693627,0.00041211388,0.02712652,0.00008287286,0.000004975908,0.0000061652477,0.00035047828,0.000023191798,0.9659345,0.000064624925,0.005185094,0.00008250707],"about_ca_topic_score_codex":0.00022529568,"about_ca_topic_score_gemma":0.000026979926,"teacher_disagreement_score":0.02691465,"about_ca_system_score_codex":0.000088759225,"about_ca_system_score_gemma":0.00003318184,"threshold_uncertainty_score":0.5060424},"labels":[],"label_agreement":null},{"id":"W2164924162","doi":"10.1158/0008-5472.can-05-1634","title":"Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; SickKids Foundation; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"Agence Nationale pour la Gestion des Déchets Radioactifs","keywords":"Genetically modified mouse; Biology; Transgene; Receptor tyrosine kinase; Cancer research; Gene isoform; Oncogene; Lung cancer; Transcription factor; Malignancy; Adenocarcinoma; Gene; Kinase; Cancer; Cell biology; Internal medicine; Cell cycle; Genetics; Medicine","score_opus":0.056015909261265734,"score_gpt":0.38005635577608576,"score_spread":0.32404044651482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164924162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902346,0.005839851,0.0004513162,0.0004171097,0.00005772441,0.0002865588,0.000016157019,0.000007831229,0.0026888235],"genre_scores_gemma":[0.979123,0.0048857406,0.00013025984,0.000031845455,0.000500842,0.00012380091,0.00003746179,0.000031715677,0.015135355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985346,0.0000705154,0.00016692332,0.0005188294,0.00028453718,0.0004245956],"domain_scores_gemma":[0.99938965,0.0000044720296,0.000021410153,0.00035275202,0.00015843268,0.00007330431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038513105,0.00010956421,0.00010455166,0.00010815216,0.00008793512,0.000028599978,0.00019855898,0.00014509237,0.00004743824],"category_scores_gemma":[0.000013891122,0.000104270955,0.000060069386,0.00023496023,0.00011577989,0.0000030580668,0.00007034914,0.0002078011,0.00002103611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020751814,0.00008590094,0.00026786712,0.00001707526,0.000010148572,0.0000020376692,0.000043392098,0.0063346834,0.9875725,0.00025220183,0.0042949584,0.00091173715],"study_design_scores_gemma":[0.00048284754,0.00015258261,0.00045675444,0.000010724031,0.0000027154647,0.00000234781,0.000032421747,0.00044994653,0.94795674,0.00033741712,0.04997019,0.00014532614],"about_ca_topic_score_codex":0.0003880329,"about_ca_topic_score_gemma":0.0005512142,"teacher_disagreement_score":0.045675233,"about_ca_system_score_codex":0.000083551626,"about_ca_system_score_gemma":0.00027917232,"threshold_uncertainty_score":0.42520463},"labels":[],"label_agreement":null},{"id":"W2165179743","doi":"10.1158/0008-5472.can-07-0392","title":"Phenethyl Isothiocyanate, a Cancer Chemopreventive Constituent of Cruciferous Vegetables, Inhibits Cap-Dependent Translation by Regulating the Level and Phosphorylation of 4E-BP1","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"National Cancer Institute; U.S. Public Health Service; Hillman Foundation","keywords":"Phenethyl isothiocyanate; EIF4E; Cancer research; Phosphorylation; Apoptosis; Biology; Chemistry; Translation (biology); Cell biology; Biochemistry; Messenger RNA","score_opus":0.05684307266558901,"score_gpt":0.35402609739372826,"score_spread":0.29718302472813923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165179743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696311,0.027435658,0.0016478441,0.00012537211,0.000061185165,0.00044632124,0.00018237223,0.0000026566881,0.0004675291],"genre_scores_gemma":[0.99706244,0.0021533926,0.00021402982,0.000026762778,0.0001036902,0.000051046623,0.000049655835,0.00001728356,0.0003217221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861264,0.00009412435,0.000340142,0.0003318341,0.0003175216,0.0003037073],"domain_scores_gemma":[0.99904513,0.000073396666,0.00016062484,0.00022440146,0.00042604064,0.00007038836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008856643,0.00012640638,0.0001887191,0.00005113638,0.00010908597,0.000012482161,0.00016825754,0.00013759507,0.000025918955],"category_scores_gemma":[0.00007556062,0.00010775497,0.000050547435,0.0001556093,0.00047528557,0.000008083025,0.000092775364,0.00019220918,3.0101148e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002594792,0.000040857394,0.0022514607,0.00010365113,0.00007394489,3.6934415e-7,0.00052615465,0.00011999846,0.9825128,0.000051801533,0.00034331687,0.013716219],"study_design_scores_gemma":[0.00071985903,0.00006746073,0.0019656087,0.000102653416,0.000016940628,0.0000016493611,0.0003699871,0.000041870986,0.99558854,0.00020127787,0.00081451674,0.00010960584],"about_ca_topic_score_codex":0.001358891,"about_ca_topic_score_gemma":0.0010468318,"teacher_disagreement_score":0.027431356,"about_ca_system_score_codex":0.00006497396,"about_ca_system_score_gemma":0.00020437721,"threshold_uncertainty_score":0.43941203},"labels":[],"label_agreement":null},{"id":"W2165733309","doi":"10.1158/0008-5472.can-13-0842","title":"Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and <i>Hox</i> Gene Expression in Hematopoietic Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Biology; Haematopoiesis; Cancer research; Bone marrow; Myeloid; Progenitor cell; Myelopoiesis; Erythropoiesis; Mammary tumor; Cancer; Immunology; Stem cell; Breast cancer; Cell biology; Medicine; Internal medicine; Genetics; Anemia","score_opus":0.02450840687318352,"score_gpt":0.30892573651088534,"score_spread":0.28441732963770183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165733309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724529,0.025444722,0.0001574977,0.0011161108,0.000050179508,0.00061412866,0.000058133723,0.000012761787,0.000093601164],"genre_scores_gemma":[0.9839304,0.013014318,0.0001433099,0.0001835245,0.00006626756,0.0006911354,0.00007943351,0.00005322561,0.0018383792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793744,0.00023071372,0.00022202198,0.00060428417,0.00042095868,0.0005845659],"domain_scores_gemma":[0.99895006,0.00005193955,0.00008592289,0.00040782278,0.00031720707,0.00018705214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039188197,0.00021510643,0.00024783917,0.00013218827,0.00013752241,0.00008896488,0.00023253977,0.0002675766,0.00016945612],"category_scores_gemma":[0.000037628317,0.00018619731,0.000028139442,0.00037911398,0.00017177555,0.00001163845,0.00019536194,0.00021470666,0.000006038419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002628079,0.000054765467,0.0036494029,0.000047831938,0.000044556582,0.0000043482974,0.00023024209,0.00003536326,0.9899703,0.0000013675643,0.0042290855,0.0017064301],"study_design_scores_gemma":[0.0007582831,0.0001768523,0.004367113,0.00013779898,0.000009454615,6.9780856e-7,0.00007130731,0.00009340899,0.99238664,0.00012747328,0.0016230703,0.00024788507],"about_ca_topic_score_codex":0.0007740326,"about_ca_topic_score_gemma":0.0008155876,"teacher_disagreement_score":0.012430403,"about_ca_system_score_codex":0.00008517927,"about_ca_system_score_gemma":0.00015776194,"threshold_uncertainty_score":0.75929064},"labels":[],"label_agreement":null},{"id":"W2165734992","doi":"10.1158/0008-5472.can-06-4431","title":"Mapping Genes that Contribute to Daunorubicin-Induced Cytotoxicity","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Daunorubicin; Biology; Single-nucleotide polymorphism; Genetics; Candidate gene; Gene; Leukemia; Genotype","score_opus":0.14574911575984628,"score_gpt":0.4265439107057257,"score_spread":0.28079479494587944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165734992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781127,0.0005759985,0.0022869785,0.003937418,0.00021266344,0.0012862233,0.000016329439,0.000090216425,0.0037829278],"genre_scores_gemma":[0.99530965,0.00024872296,0.00020977107,0.0016345909,0.0010054598,0.000108677326,0.000014473792,0.00003914341,0.0014295037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972775,0.00009727198,0.00024824386,0.00045281378,0.0010285312,0.00089565193],"domain_scores_gemma":[0.998248,0.00021300698,0.00004127639,0.00046348237,0.0005252523,0.0005090305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026706776,0.00016364279,0.00035189654,0.0004556339,0.00026589152,0.00004869692,0.00018674321,0.00019112574,0.00021016492],"category_scores_gemma":[0.00022143492,0.0001532208,0.00012410614,0.0009983042,0.0000881011,0.00009476459,0.000092529066,0.00062388286,0.00010890129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003367329,0.000045463843,0.0041998946,0.00007169411,0.00007742006,0.000066324465,0.0007449467,0.0000030865626,0.95953876,0.00009780559,0.0014715382,0.03334635],"study_design_scores_gemma":[0.0012945621,0.00017629583,0.033735953,0.0002245444,0.000009363009,0.000026878111,0.0007663123,0.000008421087,0.9442606,0.00007815184,0.019264285,0.00015465912],"about_ca_topic_score_codex":0.00065577775,"about_ca_topic_score_gemma":0.00026595258,"teacher_disagreement_score":0.033191692,"about_ca_system_score_codex":0.0008507596,"about_ca_system_score_gemma":0.00034940927,"threshold_uncertainty_score":0.6248163},"labels":[],"label_agreement":null},{"id":"W2165891408","doi":"10.1158/0008-5472.can-13-2016","title":"14-3-3ζ Orchestrates Mammary Tumor Onset and Progression via miR-221–Mediated Cell Proliferation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Carcinogenesis; Cancer research; Genetically modified mouse; Transgene; Biology; Cell growth; Metastasis; Breast cancer; Cancer; Mammary tumor; Gene; Genetics","score_opus":0.02968683795875156,"score_gpt":0.37119674840237654,"score_spread":0.341509910443625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165891408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947602,0.0016837207,0.00022695289,0.0014808975,0.000093086404,0.0010583038,0.000021511392,0.00002279499,0.00065253745],"genre_scores_gemma":[0.99441165,0.00041483794,0.0005717077,0.00011812929,0.00018114726,0.001709613,0.0001591813,0.000027813765,0.0024059394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985396,0.00020907425,0.00016959704,0.00041411942,0.0002769297,0.0003906234],"domain_scores_gemma":[0.9989531,0.00004193686,0.00005075081,0.00032455198,0.00046084812,0.00016880596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031727122,0.00013085324,0.000100815334,0.00009875027,0.00019095658,0.00014342758,0.00019954442,0.00013316027,0.00021720878],"category_scores_gemma":[0.0001625375,0.000114053866,0.000029669238,0.00017941177,0.00015679303,0.000024994335,0.00018759452,0.0003299039,0.000104925115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006849747,0.000076304364,0.006136392,0.00006774747,0.00001596598,0.0000054929023,0.000054305034,0.000001895659,0.9692194,0.0000042638153,0.02022248,0.0041272407],"study_design_scores_gemma":[0.00044543573,0.0003735145,0.0085699875,0.000057303376,0.0000041846574,0.000024808298,0.000070677524,0.00030029032,0.9757018,0.00021298962,0.014060142,0.00017887115],"about_ca_topic_score_codex":0.00028260588,"about_ca_topic_score_gemma":0.00008385827,"teacher_disagreement_score":0.00648238,"about_ca_system_score_codex":0.000051358955,"about_ca_system_score_gemma":0.00028520162,"threshold_uncertainty_score":0.46509817},"labels":[],"label_agreement":null},{"id":"W2166065433","doi":"10.1158/0008-5472.can-04-3451","title":"Deficiency in the Catalytic Subunit of DNA-Dependent Protein Kinase Causes Down-Regulation of ATM","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"DNA-PKcs; Transfection; Chinese hamster ovary cell; Molecular biology; Protein subunit; Small interfering RNA; Biology; DNA; Gene knockdown; Protein kinase A; Cell biology; Kinase; Cell culture; Gene; Biochemistry; Genetics","score_opus":0.04365688477496965,"score_gpt":0.35274171759897127,"score_spread":0.3090848328240016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166065433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758375,0.0009641472,0.000035105735,0.00022678233,0.000016457701,0.0004944389,0.000019170293,0.0000026831542,0.0006574464],"genre_scores_gemma":[0.9989473,0.00005803383,0.00007131406,0.000014697056,0.00006206808,0.00014410281,0.000017948349,0.000010156228,0.00067435676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987783,0.00016955101,0.00018982885,0.00020311898,0.00042602356,0.00023319805],"domain_scores_gemma":[0.999287,0.000019823143,0.000053741976,0.00041872996,0.00019075575,0.000029932819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000939017,0.00006807378,0.000091322276,0.00008880895,0.00003743987,0.000008356284,0.00032213615,0.000073169074,0.000052635078],"category_scores_gemma":[0.00011215265,0.000052046802,0.00003688936,0.00025326828,0.00013506008,0.00000490546,0.00010388788,0.00011324587,0.00000563039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006330511,0.00009314273,0.0003952939,0.00005662615,0.0000059224026,0.0000013160144,0.00020505363,0.0002215257,0.99619114,0.00046430834,0.00010376704,0.0021985946],"study_design_scores_gemma":[0.00027659078,0.00017862822,0.0022706029,0.00003407633,0.0000034747243,0.0000018846235,0.00019938781,0.000045145956,0.9956983,0.0001619216,0.0010757436,0.00005425787],"about_ca_topic_score_codex":0.00057635875,"about_ca_topic_score_gemma":0.0015957243,"teacher_disagreement_score":0.0021443367,"about_ca_system_score_codex":0.00005412181,"about_ca_system_score_gemma":0.00022755245,"threshold_uncertainty_score":0.2122407},"labels":[],"label_agreement":null},{"id":"W2166095967","doi":"10.1158/0008-5472.can-08-1911","title":"Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Biology; Gene; DNA repair; Replication (statistics); DNA damage; DNA; Gene expression; DNA replication; Molecular biology; Genetics; Cancer research; Virology","score_opus":0.05046098711140317,"score_gpt":0.3736847999006557,"score_spread":0.3232238127892525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166095967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972012,0.0017847824,0.000059488924,0.000050939372,0.000051213414,0.0004290304,0.00012119731,0.000014203306,0.0002879221],"genre_scores_gemma":[0.9975746,0.0014047901,0.000107093234,0.000017740043,0.00028464344,0.00020465026,0.0002132611,0.000028428703,0.00016478133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978069,0.00043033157,0.0003004228,0.00055417215,0.00061387895,0.00029430987],"domain_scores_gemma":[0.9982593,0.0000844503,0.00013562795,0.0008815069,0.000545094,0.00009398971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067873485,0.00011805381,0.00018984718,0.00016965003,0.00015621776,0.0000063096604,0.00025443718,0.00016011177,0.00013142954],"category_scores_gemma":[0.00032776574,0.000115186645,0.0001103373,0.00040508193,0.00030492424,0.000013241758,0.00013724832,0.0002145375,0.0000074829136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014203556,0.00009933208,0.004267366,0.000024181076,0.00005926797,0.0000024570923,0.00037498664,0.000037049685,0.99156785,0.000003581569,0.000813221,0.0013303264],"study_design_scores_gemma":[0.00059231155,0.0013169801,0.010433803,0.000042247513,0.0000043569057,7.0730897e-7,0.00009429175,0.000013616381,0.987104,0.00006641536,0.00022627633,0.00010501384],"about_ca_topic_score_codex":0.00061500235,"about_ca_topic_score_gemma":0.00015111902,"teacher_disagreement_score":0.006166437,"about_ca_system_score_codex":0.00009010587,"about_ca_system_score_gemma":0.00054258434,"threshold_uncertainty_score":0.4697175},"labels":[],"label_agreement":null},{"id":"W2166144086","doi":"10.1158/0008-5472.can-09-1684","title":"Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); McGill University","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Terry Fox Foundation; McGill University","keywords":"STAT3; Cancer research; Malignancy; Breast cancer; Tumor progression; Medicine; Cancer; Metastasis; Biology; Pathology; Oncology; Internal medicine; Signal transduction","score_opus":0.11749199480688864,"score_gpt":0.44725385699317927,"score_spread":0.3297618621862906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166144086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585754,0.0017419704,0.0003160999,0.0010938684,0.00011726002,0.00062775065,0.000009006502,0.000019941454,0.00021659516],"genre_scores_gemma":[0.99895114,0.0002608736,0.00012973396,0.000043761007,0.000117939,0.000103727114,0.000019800462,0.000010256848,0.00036278646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842,0.00015172517,0.00038264878,0.00020934278,0.00057874096,0.00025754375],"domain_scores_gemma":[0.99925935,0.0000429318,0.000075893164,0.00023486052,0.00030987916,0.00007707028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012340866,0.00006883451,0.00018285542,0.00026604367,0.000061352504,0.000016830232,0.0000731204,0.000039269675,0.00018988362],"category_scores_gemma":[0.000073195355,0.000059573984,0.000053670494,0.0005505925,0.00006277577,0.00010912325,0.0000092484415,0.00034062692,0.000008605749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045862407,0.0002469515,0.0012778894,0.00009888461,0.000017165603,0.000010850757,0.00049290503,0.0003930433,0.9778917,0.00043428555,0.0014027231,0.017275017],"study_design_scores_gemma":[0.0020428465,0.00092156307,0.09458776,0.0015162269,0.000048479586,0.000007784956,0.0006713675,0.0020331342,0.8938404,0.0022587315,0.0019431608,0.00012854625],"about_ca_topic_score_codex":0.00012907902,"about_ca_topic_score_gemma":0.00013081981,"teacher_disagreement_score":0.09330987,"about_ca_system_score_codex":0.00024128243,"about_ca_system_score_gemma":0.0002444892,"threshold_uncertainty_score":0.24293566},"labels":[],"label_agreement":null},{"id":"W2166186123","doi":"10.1158/0008-5472.can-05-2046","title":"Effects of the Vascular Disrupting Agent ZD6126 on Interstitial Fluid Pressure and Cell Survival in Tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Terry Fox Foundation; AstraZeneca","keywords":"Medicine; Pathology","score_opus":0.017788046628639604,"score_gpt":0.3199407007373477,"score_spread":0.3021526541087081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166186123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98792,0.010879117,0.000025596579,0.000066349545,0.00013160014,0.0002504048,0.0000113986835,0.0000018611809,0.0007136661],"genre_scores_gemma":[0.99840695,0.00057323556,0.0000075810003,0.00002699944,0.00027472002,0.00006652401,0.000004210162,0.000015035836,0.0006247664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895257,0.00017745719,0.000121566154,0.00025197113,0.00025266624,0.0002437513],"domain_scores_gemma":[0.99962884,0.000039533435,0.000029959852,0.00020656576,0.00006226992,0.000032828775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003433839,0.000084710984,0.000108871,0.000039635655,0.00006713377,0.00001356419,0.0001811645,0.0000709998,0.000012453044],"category_scores_gemma":[0.00003896297,0.00006129977,0.00007073008,0.00011931731,0.00014869162,0.0000019096872,0.00018206188,0.00012038967,9.186349e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010621163,0.0000637395,0.013081175,0.00022269339,0.000024711257,0.00000403911,0.000053746713,0.00051677215,0.9838378,0.00009114187,0.0011418536,0.0008561338],"study_design_scores_gemma":[0.00056118995,0.00014797498,0.046762247,0.00013006935,0.000012466186,4.4724905e-7,0.0000480932,0.000044117747,0.9398844,0.000023190027,0.012295913,0.00008984957],"about_ca_topic_score_codex":0.0009273762,"about_ca_topic_score_gemma":0.0002668303,"teacher_disagreement_score":0.043953337,"about_ca_system_score_codex":0.000024919504,"about_ca_system_score_gemma":0.00008175966,"threshold_uncertainty_score":0.2499732},"labels":[],"label_agreement":null},{"id":"W2166209724","doi":"10.1158/0008-5472.can-07-5949","title":"Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Melphalan; Melanoma; Cancer research; Cytotoxic T cell; Chemotherapy; Pharmacology; Apoptosis; Medicine; Dacarbazine; Cancer; Biology; Internal medicine; In vitro","score_opus":0.06756760915100839,"score_gpt":0.3673069495021007,"score_spread":0.2997393403510923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166209724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939719,0.005190673,0.00002938211,0.00008946165,0.00007806044,0.00021306716,0.000009070158,0.0000057142615,0.000412658],"genre_scores_gemma":[0.98941994,0.008494856,0.00014495719,0.0000104478195,0.00015968186,0.00021468983,0.00001045301,0.00001641925,0.0015285704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988449,0.00012465878,0.00015743588,0.0002970553,0.00024129386,0.00033465648],"domain_scores_gemma":[0.9995975,0.000025598232,0.000049038856,0.00017201537,0.0001118501,0.000044017823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033126617,0.000114758455,0.00017193762,0.000087966124,0.00010322661,0.000008356237,0.00018844345,0.00008010405,0.00014229484],"category_scores_gemma":[0.000030751027,0.00009643141,0.00004767616,0.00022132036,0.00022881803,0.0000061891164,0.0000692686,0.00010638744,0.000006491899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021419527,0.000075217176,0.029015554,0.000020951818,0.00004507933,0.000010244159,0.00042482474,0.000046646852,0.9675152,0.0000051543584,0.00048432974,0.0021426254],"study_design_scores_gemma":[0.0004746308,0.0002792235,0.0130729545,0.000029999273,0.0000016162122,0.000002083655,0.00010161148,0.000007377317,0.98023784,0.00001607677,0.005665964,0.00011064672],"about_ca_topic_score_codex":0.00051771355,"about_ca_topic_score_gemma":0.00016465399,"teacher_disagreement_score":0.0159426,"about_ca_system_score_codex":0.00009940668,"about_ca_system_score_gemma":0.00038776564,"threshold_uncertainty_score":0.39323586},"labels":[],"label_agreement":null},{"id":"W2166244290","doi":"10.1158/0008-5472.can-08-1209","title":"Dietary Induction of Colonic Tumors in a Mouse Model of Sporadic Colon Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Colorectal cancer; Cancer; Carcinogenesis; Biology; Choline; Internal medicine; Endocrinology; Vitamin; Physiology; Cancer research; Medicine","score_opus":0.2092324122173848,"score_gpt":0.4218930235532453,"score_spread":0.2126606113358605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166244290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955205,0.002769736,0.0000027570673,0.00038499202,0.000121393634,0.0007530287,0.000065868146,0.000013397616,0.00036833854],"genre_scores_gemma":[0.99457943,0.0031514638,0.00016730578,0.000039461036,0.00008027368,0.0003739553,0.0000056990234,0.000032457596,0.0015699501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978929,0.00010013881,0.00040098565,0.0003194088,0.00085862755,0.0004279434],"domain_scores_gemma":[0.99886125,0.000076211196,0.00010400186,0.00034291393,0.00048340674,0.00013224193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048657728,0.00012479456,0.00044376793,0.0004624698,0.00005205899,0.0000019691274,0.00018365435,0.00014188408,0.00033309858],"category_scores_gemma":[0.00013854937,0.000117995216,0.00006932793,0.0008815744,0.0006481506,0.000055996155,0.00008682356,0.0006088302,0.000003308297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001871801,0.00024228873,0.08807856,0.00045415928,0.000047609035,0.000022379601,0.0021104536,0.0085126525,0.89482635,0.00001242173,0.0018021275,0.0020192116],"study_design_scores_gemma":[0.0021956575,0.0010928389,0.07076454,0.00046526775,0.000022519625,0.000014255304,0.0002769758,0.0041128634,0.920605,0.00015281951,0.00013876913,0.00015847723],"about_ca_topic_score_codex":0.008466588,"about_ca_topic_score_gemma":0.002209099,"teacher_disagreement_score":0.025778677,"about_ca_system_score_codex":0.000922143,"about_ca_system_score_gemma":0.002497034,"threshold_uncertainty_score":0.9981361},"labels":[],"label_agreement":null},{"id":"W2166355659","doi":"10.1158/0008-5472.can-06-3610","title":"The Ability of Versican to Simultaneously Cause Apoptotic Resistance and Sensitivity","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Versican; Apoptosis; Cytotoxic T cell; Stromal cell; Transfection; Cell biology; Cancer cell; Extracellular matrix; Cancer research; Biology; Programmed cell death; Chemistry; Cell culture; In vitro; Proteoglycan; Cancer; Biochemistry; Genetics","score_opus":0.03399817512941171,"score_gpt":0.3870186411875158,"score_spread":0.35302046605810405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166355659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611264,0.0011093582,0.00037348527,0.0011069205,0.000045373064,0.0005010897,0.000044129447,0.000004679748,0.000702296],"genre_scores_gemma":[0.9977468,0.0004733854,0.00012555179,0.000048041507,0.000129397,0.000034921897,0.000004248193,0.0000148737,0.0014227623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980519,0.00024634012,0.00017954444,0.00039869815,0.0005029622,0.00062055845],"domain_scores_gemma":[0.9982042,0.0004148845,0.00002932332,0.00056177756,0.00054965867,0.00024020577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034465748,0.00010086109,0.00012572951,0.000070464754,0.0003222002,0.00003515383,0.00020142793,0.0000884764,0.000007985337],"category_scores_gemma":[0.0011063119,0.00007748948,0.000037810663,0.00035522832,0.00068075745,0.000003286079,0.00030688327,0.0002618641,0.0000034494974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012424646,0.000029976934,0.001246896,0.000053570246,0.000036457983,0.000031294032,0.00011462184,0.000029069777,0.9851756,0.00017973786,0.0015444331,0.010315875],"study_design_scores_gemma":[0.00044736892,0.0004035271,0.018354695,0.000041458683,0.000006098108,0.000009664136,0.00037329074,0.000030242685,0.89287895,0.0001327441,0.08714982,0.00017213258],"about_ca_topic_score_codex":0.00074137753,"about_ca_topic_score_gemma":0.010199584,"teacher_disagreement_score":0.092296645,"about_ca_system_score_codex":0.00008786992,"about_ca_system_score_gemma":0.00026954745,"threshold_uncertainty_score":0.56916076},"labels":[],"label_agreement":null},{"id":"W2166508172","doi":"10.1158/0008-5472.can-03-2876","title":"Genetics and Cytogenetics of Multiple Myeloma","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":686,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"National Cancer Institute","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Biology; Chromosomal translocation; Cytogenetics; Genetics; Immunology; Cancer research; Chromosome; Monoclonal; Gene; Antibody; Monoclonal antibody","score_opus":0.12736509049962977,"score_gpt":0.4379651948271182,"score_spread":0.3106001043274884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166508172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256986,0.005278893,0.00004936747,0.0006897859,0.000027596898,0.0005605203,0.000037369082,0.0000140874245,0.00077254],"genre_scores_gemma":[0.9934749,0.003989311,0.0018836848,0.000027661667,0.00009405545,0.00008530555,0.0000103374105,0.000023731314,0.00041101978],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835575,0.000053023752,0.00016868697,0.00025423706,0.000707662,0.00046066026],"domain_scores_gemma":[0.9988071,0.0001121145,0.000023317805,0.0003192566,0.0004005172,0.00033772035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026981859,0.000096024414,0.00020459574,0.00020630636,0.00009561707,0.000014933502,0.00010145552,0.00007314138,0.000098435776],"category_scores_gemma":[0.00021959309,0.00007900144,0.00004123311,0.00033279863,0.0003911027,0.000024630575,0.00013253483,0.0002485394,0.000025201498],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008794961,0.0003846095,0.568272,0.00043127986,0.00021688077,0.00021254724,0.0005141473,0.00007097453,0.34571078,0.0002789676,0.00024852864,0.08277982],"study_design_scores_gemma":[0.006378264,0.0009021883,0.37557715,0.00019475538,0.0000238427,0.00003582412,0.00015765584,0.00010278707,0.61314934,0.00051116693,0.0028684852,0.00009851956],"about_ca_topic_score_codex":0.0005929182,"about_ca_topic_score_gemma":0.00018140975,"teacher_disagreement_score":0.26743856,"about_ca_system_score_codex":0.00017443292,"about_ca_system_score_gemma":0.00048996124,"threshold_uncertainty_score":0.32215852},"labels":[],"label_agreement":null},{"id":"W2166568854","doi":"10.1158/0008-5472.can-05-0047","title":"Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":417,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Thyroglobulin; Thyroid; Sodium-iodide symporter; Thyroid carcinoma; Internal medicine; Endocrinology; Thyroid peroxidase; Goiter; Genetically modified mouse; Triiodothyronine; Thyroid cancer; Medicine; Cancer research; Biology; Transgene; Symporter; Gene","score_opus":0.05701681975358119,"score_gpt":0.35947211314940253,"score_spread":0.30245529339582133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166568854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97745585,0.019042647,0.000008806969,0.0017141267,0.0001283367,0.000942854,0.00013252918,0.000014731572,0.0005601307],"genre_scores_gemma":[0.97742116,0.021647867,0.00013515782,0.000056962883,0.00014405977,0.00026696632,0.000059195732,0.0000348521,0.00023379653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710786,0.00026663858,0.00064696075,0.0005006011,0.0009154923,0.00056244596],"domain_scores_gemma":[0.99874985,0.00028483215,0.00016904029,0.0004373303,0.00020310366,0.00015582146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068126875,0.00020122097,0.0005287037,0.00059301284,0.00004341672,0.000009531331,0.00021076808,0.000171281,0.00018042086],"category_scores_gemma":[0.00005352903,0.00017126992,0.0001197072,0.000853861,0.00015729392,0.00014948992,0.000057846035,0.00046346555,0.0000063346547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028528026,0.0006149764,0.022153273,0.0003775327,0.00006029482,0.00001331464,0.0029874677,0.0015133828,0.960721,0.000023161987,0.0040370827,0.004645713],"study_design_scores_gemma":[0.0075214454,0.00053590233,0.0966438,0.0010546203,0.00002676811,9.871205e-7,0.0006333895,0.000102203056,0.8926278,0.000049829563,0.0006738312,0.00012945647],"about_ca_topic_score_codex":0.0059282263,"about_ca_topic_score_gemma":0.010244855,"teacher_disagreement_score":0.074490525,"about_ca_system_score_codex":0.0015781564,"about_ca_system_score_gemma":0.00084837,"threshold_uncertainty_score":0.89617443},"labels":[],"label_agreement":null},{"id":"W2166676058","doi":"10.1158/0008-5472.can-05-0160","title":"Inhibition of Rho-Kinase Affects Astrocytoma Morphology, Motility, and Invasion through Activation of Rac1","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Membrane ruffling; Motility; RAC1; Rho-associated protein kinase; Cell migration; Focal adhesion; Cell biology; Biology; Rho kinase inhibitor; Rac GTP-Binding Proteins; Gentamicin protection assay; Cell; Astrocytoma; ROCK1; Kinase; Chemistry; Cytoskeleton; Cancer research; Protein kinase A; Glioma; Signal transduction; Biochemistry; Western blot","score_opus":0.041629344138634394,"score_gpt":0.35909004746189377,"score_spread":0.3174607033232594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166676058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983187,0.0006673541,0.00031837696,0.00019792763,0.000018423769,0.00023247446,0.000026280683,0.0000029291793,0.00021754658],"genre_scores_gemma":[0.99841285,0.00085441215,0.00041284197,0.000044638808,0.00010096343,0.000030144849,0.000053464184,0.000010176662,0.00008048731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921566,0.000106668354,0.0001308477,0.00022427802,0.00014964772,0.00017290119],"domain_scores_gemma":[0.99949396,0.000023686995,0.00006081946,0.0002071029,0.0001788795,0.00003557744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002976265,0.0000701804,0.000113445996,0.00005878735,0.000045526547,0.0000053562844,0.000074948046,0.00012873004,0.000025231402],"category_scores_gemma":[0.000078525816,0.00006801121,0.000031904336,0.0001151187,0.00021000634,0.000007596257,0.00015248627,0.00011912606,0.0000010603077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019930837,0.000069290705,0.00194591,0.00009318681,0.000014503435,5.3772015e-7,0.00008827138,0.00004740557,0.99114925,0.000051283056,0.00077272375,0.0055683525],"study_design_scores_gemma":[0.0005388463,0.00034812657,0.0032905077,0.000060835413,0.000004314557,0.000002966479,0.00006944456,0.000043489115,0.99470866,0.00007390487,0.0008111449,0.000047787875],"about_ca_topic_score_codex":0.00013528319,"about_ca_topic_score_gemma":0.00013197504,"teacher_disagreement_score":0.0055205645,"about_ca_system_score_codex":0.000032967964,"about_ca_system_score_gemma":0.000092235976,"threshold_uncertainty_score":0.2773417},"labels":[],"label_agreement":null},{"id":"W2166690788","doi":"10.1158/0008-5472.can-03-2729","title":"A Genome-Wide Screen in <b> <i>Saccharomyces cerevisiae</i> </b> Reveals Altered Transport As a Mechanism of Resistance to the Anticancer Drug Bleomycin","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"U.S. Bureau of Land Management","keywords":"Saccharomyces cerevisiae; Biology; Mutant; Bleomycin; Mutation; Gene; Genetics; Cell biology","score_opus":0.025589613471820604,"score_gpt":0.34178135888371713,"score_spread":0.31619174541189654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166690788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819726,0.007002225,0.0007288164,0.00797532,0.000040480143,0.0009647796,0.00020079067,0.000007136824,0.001107884],"genre_scores_gemma":[0.99313486,0.0029038035,0.00032584433,0.0006593325,0.00026360588,0.0005980144,0.0000354335,0.000027772985,0.0020513518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982261,0.000111434594,0.00031952737,0.00046824396,0.00039437626,0.00048033163],"domain_scores_gemma":[0.9988462,0.000031815285,0.000062503284,0.0006886959,0.0002348822,0.00013590243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009083948,0.00014125543,0.00023214599,0.00010976964,0.00011495796,0.000017236238,0.0006863461,0.00006850131,0.000045675588],"category_scores_gemma":[0.000102218204,0.0001126111,0.00007316994,0.00066036946,0.00014350464,0.000006873514,0.00011765978,0.00021012922,0.000021669854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018276137,0.000064231164,0.001270778,0.00006219627,0.000025789956,0.000003493536,0.00042597696,0.00013301776,0.9935959,0.0026705198,0.0012065882,0.00035875457],"study_design_scores_gemma":[0.0010750805,0.00008584097,0.021920083,0.00017506318,0.000017921748,0.000002177318,0.0003409397,8.46929e-7,0.8765379,0.004505797,0.09509126,0.00024705997],"about_ca_topic_score_codex":0.0013455412,"about_ca_topic_score_gemma":0.0035733264,"teacher_disagreement_score":0.117057964,"about_ca_system_score_codex":0.000051962703,"about_ca_system_score_gemma":0.00041956914,"threshold_uncertainty_score":0.45921475},"labels":[],"label_agreement":null},{"id":"W2166705808","doi":"10.1158/0008-5472.can-09-3231","title":"Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary Tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Kræftens Bekæmpelse","keywords":"Protein kinase B; Mdm2; Mammary gland; Carcinogenesis; Involution (esoterism); Mammary tumor; Cancer research; Biology; Apoptosis; Transgene; Genetically modified mouse; Phosphorylation; In vivo; Internal medicine; Endocrinology; Cancer; Cell biology; Medicine; Breast cancer; Gene; Genetics","score_opus":0.0464094833112316,"score_gpt":0.345887762250708,"score_spread":0.2994782789394764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166705808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950696,0.0040901992,0.000737173,0.0034233923,0.00021775946,0.0009061431,0.000031095948,0.000051337058,0.0010359193],"genre_scores_gemma":[0.9931189,0.0036855862,0.0009716168,0.00012195859,0.00017348671,0.00035851958,0.00009652449,0.000049407663,0.0014240041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774104,0.0001154048,0.00039350585,0.0005422481,0.0006573797,0.000550395],"domain_scores_gemma":[0.99845505,0.00010379629,0.000095485215,0.000655685,0.0004589017,0.00023110419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008527335,0.00019959852,0.00035580512,0.0006147939,0.00009747275,0.00004765883,0.000299509,0.00027147093,0.000094395364],"category_scores_gemma":[0.00010767844,0.00019956863,0.00006043859,0.0010275062,0.00019964614,0.0004327205,0.00029446042,0.0010091797,0.0000070710553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070134056,0.00015413896,0.0054262015,0.0003764975,0.0000550842,0.00006289635,0.00020248079,0.000009237954,0.9731998,0.0006574188,0.005085929,0.014069019],"study_design_scores_gemma":[0.0034904475,0.000272022,0.021692872,0.00027100008,0.00001710756,0.000050642753,0.000049927483,0.00050110207,0.9652023,0.00049024046,0.007748843,0.00021352977],"about_ca_topic_score_codex":0.0031717536,"about_ca_topic_score_gemma":0.000521518,"teacher_disagreement_score":0.01626667,"about_ca_system_score_codex":0.00036890552,"about_ca_system_score_gemma":0.0008777093,"threshold_uncertainty_score":0.81381726},"labels":[],"label_agreement":null},{"id":"W2166751199","doi":"10.1158/0008-5472.can-10-0296","title":"Mesenchymal Stromal Cells Expressing ErbB-2/<i>neu</i> Elicit Protective Antibreast Tumor Immunity <i>In vivo</i>, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Jewish General Hospital; McGill University; University Health Network","funders":"","keywords":"Immune system; Immunology; Priming (agriculture); Antigen; Tumor necrosis factor alpha; Biology; CD8; Immunoediting; Cancer research; Immunotherapy; Medicine","score_opus":0.04317737126982137,"score_gpt":0.36332065703806043,"score_spread":0.3201432857682391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166751199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906659,0.00054656307,0.000039806335,0.0018893193,0.0001733277,0.0031293218,0.00039335128,0.00008613979,0.003076265],"genre_scores_gemma":[0.99664384,0.0001511561,0.00046328656,0.00021033555,0.00029962024,0.00049754465,0.000015867743,0.00013953038,0.0015788227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918933,0.0008436298,0.00078174326,0.0014416628,0.002692557,0.002347086],"domain_scores_gemma":[0.9953167,0.00092787493,0.00017562596,0.0012064142,0.0012071395,0.0011662756],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024666134,0.00056977535,0.000982508,0.000612467,0.0007274664,0.00045532433,0.0008414993,0.0003396281,0.0023326774],"category_scores_gemma":[0.0009235107,0.00050888374,0.00014401073,0.0016346964,0.0009195632,0.0004992239,0.00086997927,0.0050374796,0.000047485668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012996842,0.0004158883,0.014116857,0.00066328014,0.000062332416,0.00019393889,0.0014878039,0.0000015379761,0.9761085,0.000014664791,0.0037055218,0.0019299801],"study_design_scores_gemma":[0.0028025096,0.0006151613,0.022204213,0.0007024377,0.000024718614,0.000098896875,0.0006860173,0.0007385345,0.9678836,0.00006574815,0.0036940177,0.00048417336],"about_ca_topic_score_codex":0.009589187,"about_ca_topic_score_gemma":0.0011592353,"teacher_disagreement_score":0.008429952,"about_ca_system_score_codex":0.00044229475,"about_ca_system_score_gemma":0.0014758683,"threshold_uncertainty_score":0.99973625},"labels":[],"label_agreement":null},{"id":"W2167076800","doi":"10.1158/0008-5472.can-13-0310","title":"Formalizing an Integrative, Multidisciplinary Cancer Therapy Discovery Workflow","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; American Association for Cancer Research","keywords":"Multidisciplinary approach; Workflow; Cancer; Medicine; Medical physics; Intensive care medicine; Computer science; Internal medicine; Sociology; Database","score_opus":0.045645269698194185,"score_gpt":0.4229781039246168,"score_spread":0.3773328342264226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167076800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908051,0.005731664,0.00094289624,0.00029653963,0.00003157251,0.00046381954,0.000008108809,0.00002757722,0.0016927518],"genre_scores_gemma":[0.9773803,0.013066509,0.00067357294,0.00014342199,0.00040588705,0.0013805717,0.000076326316,0.000041516156,0.006831927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838805,0.00018838419,0.00017237948,0.0004746023,0.00029652595,0.00048006763],"domain_scores_gemma":[0.9988564,0.00002041215,0.000042827687,0.000580243,0.0003763799,0.00012368447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038982567,0.0001617987,0.00015761453,0.0001251179,0.00021048362,0.00018751297,0.00045417136,0.0001214758,0.0003972318],"category_scores_gemma":[0.000033960543,0.00012278259,0.000098883065,0.00030299491,0.00022670522,0.00006365723,0.00028038918,0.0002950839,0.00001645147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007115521,0.00007134752,0.0065304646,0.000008719663,0.000061829654,0.0000021933524,0.00018628653,0.00002038572,0.9206067,0.000014322583,0.015160463,0.05726613],"study_design_scores_gemma":[0.0002746105,0.00024498938,0.003462392,0.00005499787,0.0000050082276,0.0000011128582,0.0004342872,0.00025703743,0.9802612,0.00033876827,0.014454037,0.00021157549],"about_ca_topic_score_codex":0.0034461454,"about_ca_topic_score_gemma":0.0013414772,"teacher_disagreement_score":0.059654485,"about_ca_system_score_codex":0.00008608114,"about_ca_system_score_gemma":0.00019651525,"threshold_uncertainty_score":0.5209564},"labels":[],"label_agreement":null},{"id":"W2167369508","doi":"10.1158/0008-5472.can-08-3360","title":"Metastasis Research Society–American Association for Cancer Research Joint Conference on Metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Peter MacCallum Cancer Centre; National Cancer Institute; Cancer Research UK; McGill University Health Centre; Weill Cornell Medical College; Eli Lilly and Company","keywords":"Metastasis; Cancer; Cancer metastasis; Medicine; Oncology; Internal medicine","score_opus":0.5248666791214895,"score_gpt":0.5381087899586683,"score_spread":0.013242110837178744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167369508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8921223,0.0101943575,0.00018520998,0.07194223,0.00085984205,0.007023803,0.0018044665,0.00020655707,0.0156612],"genre_scores_gemma":[0.8933524,0.05131451,0.0019708532,0.0007055608,0.002063397,0.008161234,0.000100106954,0.00021679293,0.04211517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848301,0.0020919393,0.0007886562,0.0016702855,0.0072013293,0.0034176884],"domain_scores_gemma":[0.9848195,0.002559555,0.00022978499,0.0013114983,0.010079573,0.0010001184],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019830087,0.0004390339,0.001266748,0.0014586311,0.0023315118,0.00021412905,0.0007097829,0.00028778586,0.0020849854],"category_scores_gemma":[0.0024884692,0.00038651028,0.0007082909,0.0054072454,0.001986199,0.00022628652,0.00044576873,0.003786993,0.0002729399],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002906348,0.0010231104,0.0022663183,0.00086567213,0.0019286161,0.00012749848,0.004018986,0.00006389349,0.14322124,0.0026088043,0.73690504,0.10406444],"study_design_scores_gemma":[0.004092657,0.0029521766,0.0033516232,0.0006376688,0.00023804551,0.00002063296,0.00517251,0.00016963665,0.24589482,0.00090443733,0.73596656,0.0005992362],"about_ca_topic_score_codex":0.019124594,"about_ca_topic_score_gemma":0.0020543442,"teacher_disagreement_score":0.10346521,"about_ca_system_score_codex":0.007062892,"about_ca_system_score_gemma":0.0059047122,"threshold_uncertainty_score":0.9998587},"labels":[],"label_agreement":null},{"id":"W2167390668","doi":"10.1158/0008-5472.can-04-1738","title":"The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Loss of heterozygosity; Barrett's esophagus; Esophagus; Adenocarcinoma; CDKN2A; Biology; Esophageal cancer; Cancer; Field cancerization; Internal medicine; Pathology; Oncology; Medicine; Genetics; Allele; Gene","score_opus":0.06818777688215522,"score_gpt":0.43763319829494124,"score_spread":0.369445421412786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167390668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926884,0.004009291,0.00009206812,0.0047934474,0.00005196738,0.0013430301,0.0000066971706,0.00001282521,0.0004218114],"genre_scores_gemma":[0.99780947,0.0007799328,0.000708016,0.000042670552,0.00009149229,0.0003235737,0.0000040703926,0.000011378046,0.00022936867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979153,0.00021654642,0.00024866595,0.0002709609,0.0009537935,0.0003947275],"domain_scores_gemma":[0.9984965,0.0003158782,0.000034886343,0.00031411974,0.00056901254,0.0002696201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014825801,0.00007985483,0.00022478102,0.00013649219,0.00030623158,0.00001812867,0.00014232063,0.000093028895,0.000045052642],"category_scores_gemma":[0.00058791664,0.00005079781,0.000027645523,0.00039613762,0.0006678346,0.000040019895,0.00017920193,0.00037500294,0.0000095820105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015894205,0.00031583282,0.9301547,0.00028461512,0.000042254196,0.00004306108,0.0013984018,0.000008203952,0.019896407,0.0011493146,0.00040388055,0.04471392],"study_design_scores_gemma":[0.0020626625,0.0018184112,0.98381746,0.00022845119,0.00001873258,0.000018458293,0.0002178203,0.0001078003,0.009848899,0.0015808468,0.00023813259,0.000042329382],"about_ca_topic_score_codex":0.00033478843,"about_ca_topic_score_gemma":0.00008518856,"teacher_disagreement_score":0.053662766,"about_ca_system_score_codex":0.00031952103,"about_ca_system_score_gemma":0.0011128071,"threshold_uncertainty_score":0.24606645},"labels":[],"label_agreement":null},{"id":"W2167505689","doi":"10.1158/0008-5472.can-05-0108","title":"Using a Xenograft Model of Human Breast Cancer Metastasis to Find Genes Associated with Clinically Aggressive Disease","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Breast cancer; Metastasis; Cancer research; Biology; Tissue microarray; Cancer; Microarray analysis techniques; Microarray; Pathology; Gene expression; Gene; Medicine; Genetics","score_opus":0.3637211878877031,"score_gpt":0.5562513565462694,"score_spread":0.19253016865856637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167505689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871787,0.0032156357,0.00015077197,0.00619621,0.000042815027,0.0015287739,0.0012858341,0.00005018244,0.00035112276],"genre_scores_gemma":[0.9931503,0.0012091325,0.0013024338,0.00044140324,0.00053919636,0.0007640959,0.000027932601,0.00013043993,0.0024350847],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99393827,0.00042742628,0.00069660984,0.00084806,0.0027595342,0.0013300999],"domain_scores_gemma":[0.9944718,0.00027938394,0.00025490415,0.0008979907,0.002730689,0.001365271],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020496757,0.000306028,0.0007557029,0.0006601549,0.00034604722,0.00006947558,0.0005713066,0.00015942095,0.0014375461],"category_scores_gemma":[0.0006278557,0.0002470455,0.00018678368,0.0017122293,0.0007284232,0.00016049886,0.00036244374,0.0010195798,0.000023437959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016813505,0.0027680385,0.29038852,0.0015043356,0.0026535601,0.00057013624,0.0035905608,0.083224125,0.4046409,0.00017638742,0.016893715,0.17677619],"study_design_scores_gemma":[0.044790734,0.011454763,0.45997894,0.049761962,0.00434926,0.00013552724,0.0031225085,0.23359762,0.17465019,0.0010735005,0.011289239,0.005795754],"about_ca_topic_score_codex":0.0026666862,"about_ca_topic_score_gemma":0.0014512164,"teacher_disagreement_score":0.22999072,"about_ca_system_score_codex":0.0017885951,"about_ca_system_score_gemma":0.0052489145,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W2167510443","doi":"10.1158/1538-7445.tumimm2012-a88","title":"Abstract A88: Identification of factors modulating sensitivity to T cell infiltration in the breast cancer setting via next-generation sequencing.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Immune system; Infiltration (HVAC); CD8; Immunohistochemistry; Medicine; Immunotherapy; Pathology; Transcriptome; Cancer; Cancer research; Biology; Immunology; Internal medicine; Gene; Gene expression","score_opus":0.1369984323469261,"score_gpt":0.3841539225332614,"score_spread":0.2471554901863353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167510443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953507,0.00021982146,0.00017908862,0.0028433453,0.00011514038,0.0011136206,0.000033290922,0.000013270605,0.0001317188],"genre_scores_gemma":[0.9989984,0.0001027065,0.0000448842,0.00018802313,0.0002822649,0.00025447365,0.000036502046,0.00001728894,0.000075431424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998149,0.00022146715,0.000412587,0.00027400258,0.00063099485,0.00031199804],"domain_scores_gemma":[0.9988703,0.00016707118,0.0001305677,0.00029048155,0.00047747305,0.000064089196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019041145,0.000112102665,0.0001603548,0.00022521077,0.00015628811,0.00009684744,0.00009988221,0.00008182755,0.00025258015],"category_scores_gemma":[0.00007180126,0.00008339339,0.00005377143,0.0007137549,0.000077447345,0.00031812277,0.000021905624,0.000327501,0.000010498731],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009512969,0.000036273996,0.022493817,0.000109755936,0.000015271065,0.0000016527698,0.002888549,0.0008402648,0.9407255,0.0000023826362,0.00047696102,0.03231446],"study_design_scores_gemma":[0.00033833165,0.00003638518,0.55118465,0.00013064929,0.00000740886,0.0000050694034,0.0016178407,0.006273366,0.4402795,0.000012523908,0.000032593594,0.00008167058],"about_ca_topic_score_codex":0.043252826,"about_ca_topic_score_gemma":0.0028792624,"teacher_disagreement_score":0.5286908,"about_ca_system_score_codex":0.00069651287,"about_ca_system_score_gemma":0.00036521023,"threshold_uncertainty_score":0.96311826},"labels":[],"label_agreement":null},{"id":"W2167661193","doi":"10.1158/0008-5472.can-08-0041","title":"Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Melanoma; Medicine; Brain metastasis; Metastasis; Pathology; Primary tumor; Cancer; Central nervous system; Cancer research; Parenchyma; Internal medicine","score_opus":0.2827505677954827,"score_gpt":0.44757281579890984,"score_spread":0.16482224800342715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167661193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702454,0.0010423493,0.00017285722,0.000107064945,0.0000390289,0.0005958208,0.0000747265,0.000019806375,0.00092380476],"genre_scores_gemma":[0.9895144,0.00010479016,0.009472929,0.000010906401,0.000055240504,0.000115393574,0.00002310011,0.000023852312,0.0006793957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761033,0.00015273731,0.00057604525,0.000295754,0.0008952687,0.00046985497],"domain_scores_gemma":[0.99880207,0.00011326785,0.000099923134,0.000396413,0.0003372867,0.00025101512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075224496,0.00012962916,0.0005453963,0.00016308513,0.00014949232,0.0000036522254,0.00015351518,0.000072083,0.00014265305],"category_scores_gemma":[0.00005639318,0.00009941,0.00014435458,0.00024096678,0.00024023632,0.000023797458,0.00009471618,0.00024200481,0.000007928838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017307369,0.013075432,0.058517743,0.018705806,0.01278738,0.024056895,0.0362319,0.0056436113,0.50878483,0.018993082,0.009337642,0.2765583],"study_design_scores_gemma":[0.024697488,0.0070841783,0.16862358,0.0048482106,0.0016343251,0.0058955527,0.0057543223,0.011462346,0.7574923,0.00022675937,0.010950284,0.0013306561],"about_ca_topic_score_codex":0.00035325694,"about_ca_topic_score_gemma":0.000115256444,"teacher_disagreement_score":0.27522764,"about_ca_system_score_codex":0.00043731547,"about_ca_system_score_gemma":0.0012035966,"threshold_uncertainty_score":0.40538222},"labels":[],"label_agreement":null},{"id":"W2167690894","doi":"10.1158/0008-5472.can-06-3964","title":"Mcl-1 Down-regulation Potentiates ABT-737 Lethality by Cooperatively Inducing Bak Activation and Bax Translocation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Apoptosis; Cell biology; Ectopic expression; Cyclin-dependent kinase; Bcl-2-associated X protein; Biology; Bcl-xL; Knockout mouse; Small hairpin RNA; Chemistry; Cancer research; Molecular biology; Programmed cell death; Cell culture; Cell cycle; Caspase 3; Biochemistry; Genetics; Receptor; Gene knockdown; Gene","score_opus":0.06750929746893732,"score_gpt":0.4013572958215663,"score_spread":0.333847998352629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167690894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97457266,0.0021546825,0.018323155,0.0028220222,0.00010874639,0.00090140227,0.00002294842,0.00007640052,0.0010179672],"genre_scores_gemma":[0.99828744,0.0004594833,0.00020515604,0.00015084301,0.0001983511,0.000075953416,0.00014155425,0.000035573263,0.00044566888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785745,0.00016710933,0.00030048066,0.00046686438,0.0007501515,0.00045794132],"domain_scores_gemma":[0.9986676,0.0001339715,0.00006257837,0.0002655773,0.0006632713,0.0002069955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018267257,0.00014764686,0.00020810151,0.00027593208,0.00028048415,0.00005738322,0.00007793522,0.00021149052,0.00018416771],"category_scores_gemma":[0.00021750214,0.00014354389,0.00003976033,0.0007449257,0.00020788179,0.00023842788,0.00003183348,0.0006418008,0.0000137718935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037271113,0.000063769934,0.0009154634,0.00009216618,0.000052191725,0.000003976302,0.00094176276,0.000085837215,0.95006084,0.00022074096,0.0023469268,0.044843618],"study_design_scores_gemma":[0.0016951957,0.00017721497,0.040618576,0.00032381387,0.000025139048,0.000009305797,0.000341907,0.00060337153,0.95197433,0.00009778936,0.00397764,0.00015572668],"about_ca_topic_score_codex":0.0019084238,"about_ca_topic_score_gemma":0.0002600344,"teacher_disagreement_score":0.044687893,"about_ca_system_score_codex":0.0006656357,"about_ca_system_score_gemma":0.00038613426,"threshold_uncertainty_score":0.585355},"labels":[],"label_agreement":null},{"id":"W2167749314","doi":"10.1158/0008-5472.can-07-5997","title":"Androgen Levels Increase by Intratumoral <i>De novo</i> Steroidogenesis during Progression of Castration-Resistant Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":739,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Dihydrotestosterone; Androgen; Androgen receptor; LNCaP; Androgen deprivation therapy; Tumor progression; Internal medicine; Endocrinology; Cancer research; Cancer; Prostate; Medicine; Biology; Hormone","score_opus":0.08711475349095844,"score_gpt":0.4118222421841693,"score_spread":0.32470748869321087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167749314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807967,0.015427844,0.0000016382683,0.0013397593,0.000058755362,0.0013917179,0.0005796956,0.000043857355,0.00036006086],"genre_scores_gemma":[0.98666203,0.006402055,0.00010712439,0.000042636635,0.00019991308,0.001080367,0.00006646533,0.000058109053,0.0053813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965648,0.00022796165,0.0004050769,0.0005176776,0.0012944875,0.0009899861],"domain_scores_gemma":[0.9981347,0.00007195588,0.00009889453,0.0003983988,0.00078414514,0.0005119398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006011658,0.00022979021,0.00041770606,0.00027564316,0.00046761462,0.000036279118,0.00021460654,0.00012144468,0.0004927691],"category_scores_gemma":[0.000071008115,0.00017948565,0.00009464131,0.0008509376,0.0006791263,0.00018056628,0.00012935311,0.0004983478,0.000010512868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048760413,0.00032802433,0.10281358,0.00068630936,0.00014589666,0.00068357115,0.0010358549,0.000009480846,0.88183224,0.0000065278186,0.0039800736,0.0036023683],"study_design_scores_gemma":[0.0045829667,0.0006654491,0.04135608,0.00065899926,0.000041757543,0.00012586077,0.00022178177,0.000019552315,0.9504408,0.000017744042,0.001676506,0.00019245833],"about_ca_topic_score_codex":0.0021826404,"about_ca_topic_score_gemma":0.00020619556,"teacher_disagreement_score":0.068608575,"about_ca_system_score_codex":0.0009241637,"about_ca_system_score_gemma":0.002689094,"threshold_uncertainty_score":0.73192126},"labels":[],"label_agreement":null},{"id":"W2167767113","doi":"10.1158/0008-5472.can-05-1663","title":"HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Dana-Farber Cancer Institute; Brigham and Women's Hospital; U.S. Department of Defense","keywords":"Protein kinase B; Phosphorylation; Retinoblastoma protein; Cell growth; Cell biology; Cancer research; Signal transduction; Cell cycle; PI3K/AKT/mTOR pathway; Biology; Chemistry; Apoptosis; Molecular biology; Biochemistry","score_opus":0.0655541043594134,"score_gpt":0.3741319057708692,"score_spread":0.3085778014114558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167767113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932862,0.0009995175,0.000057643614,0.0020920795,0.000055753066,0.00042791126,0.000008389014,0.000024207216,0.0030483203],"genre_scores_gemma":[0.997638,0.0005924792,0.00036122566,0.0001473462,0.0004064269,0.00004462927,0.000014186316,0.000029165165,0.0007665722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986057,0.00009033188,0.00018164006,0.00027885026,0.0005721315,0.0002712952],"domain_scores_gemma":[0.998932,0.00005715525,0.00004391363,0.0002828412,0.00048238924,0.0002017131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045226066,0.00008573084,0.00016863637,0.00024994888,0.000066213826,0.000014462747,0.00008305946,0.000113785805,0.0002217944],"category_scores_gemma":[0.000147782,0.000079514204,0.000029951985,0.0004049341,0.00015952525,0.00014840771,0.00006985939,0.00041894199,0.000019394549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002667409,0.000114591916,0.00062061107,0.00016547403,0.000012873271,0.000005632178,0.000636342,0.000009642415,0.9831011,0.00014093114,0.0044062017,0.010519846],"study_design_scores_gemma":[0.0013713383,0.00037728433,0.0019177765,0.00018885966,0.000012430397,0.000006499677,0.00014610992,0.00007634844,0.9873626,0.00010256388,0.008364033,0.000074107644],"about_ca_topic_score_codex":0.00051816826,"about_ca_topic_score_gemma":0.000107387146,"teacher_disagreement_score":0.010445739,"about_ca_system_score_codex":0.00029767054,"about_ca_system_score_gemma":0.00046359835,"threshold_uncertainty_score":0.3242495},"labels":[],"label_agreement":null},{"id":"W2168035069","doi":"10.1158/0008-5472.can-06-2287","title":"Inhibition of Epidermal Growth Factor Receptor Signaling Elevates 15-Hydroxyprostaglandin Dehydrogenase in Non–Small-Cell Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Erlotinib; Cancer research; Epidermal growth factor receptor; Biology; MAPK/ERK pathway; Kinase; Sp1 transcription factor; Epidermal growth factor; Molecular biology; Cell biology; Promoter; Receptor; Gene expression; Biochemistry","score_opus":0.03494680091892666,"score_gpt":0.35595471174346816,"score_spread":0.3210079108245415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168035069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950838,0.002654365,0.0000769327,0.00017241924,0.0002406263,0.0013685783,0.00005960944,0.00003010504,0.0003135271],"genre_scores_gemma":[0.9979638,0.00052305596,0.00009439206,0.000098396784,0.0006786197,0.00026717613,0.000035496407,0.000058156966,0.0002809336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970345,0.00018638704,0.00056923367,0.00043653316,0.00078886084,0.000984468],"domain_scores_gemma":[0.9983028,0.00045717962,0.00013078765,0.00025383447,0.0004759098,0.00037944244],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024348379,0.00022316437,0.0004665013,0.000685296,0.00011288174,0.000018117795,0.00012548255,0.00022301142,0.0009598386],"category_scores_gemma":[0.0002731493,0.0001972729,0.000108278444,0.00090276386,0.0001657038,0.0001228894,0.00010073416,0.00080373604,0.000027266626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006824865,0.00011472033,0.23905364,0.0014429569,0.000031229247,0.00017002031,0.0012012636,0.000027034093,0.75567317,0.00001248153,0.0007277113,0.000863308],"study_design_scores_gemma":[0.0028039787,0.00021742789,0.01336682,0.0011174333,0.000024536837,0.0000033569454,0.00022122759,0.0004283601,0.9814413,0.000024620833,0.00015537947,0.0001955443],"about_ca_topic_score_codex":0.0026459936,"about_ca_topic_score_gemma":0.00090758444,"teacher_disagreement_score":0.22576816,"about_ca_system_score_codex":0.0007472526,"about_ca_system_score_gemma":0.0006498761,"threshold_uncertainty_score":0.99995345},"labels":[],"label_agreement":null},{"id":"W2168108949","doi":"10.1158/0008-5472.can-12-4178","title":"The ShcA PTB Domain Functions as a Biological Sensor of Phosphotyrosine Signaling during Breast Cancer Progression","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Proto-oncogene tyrosine-protein kinase Src; Phosphotyrosine-binding domain; Receptor tyrosine kinase; Carcinogenesis; Breast cancer; Biology; Tyrosine kinase; Angiogenesis; Growth factor receptor; Cancer; Signal transduction; SH2 domain; Medicine; Cell biology; Internal medicine","score_opus":0.061020368180146764,"score_gpt":0.4113303422574947,"score_spread":0.35030997407734793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168108949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849102,0.003991504,0.0000109587845,0.0085856095,0.00009160138,0.001497221,0.000034082306,0.000046760393,0.00083205133],"genre_scores_gemma":[0.9900995,0.0023355368,0.00014505628,0.000058312984,0.0003261847,0.0014506624,0.000009429814,0.000042384945,0.0055329544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964459,0.0003548996,0.00037209268,0.00048037645,0.0014166505,0.00093010516],"domain_scores_gemma":[0.9972602,0.00041885255,0.00007688936,0.00053649436,0.0013111919,0.00039635808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010018483,0.00017270185,0.00029610522,0.00016428356,0.0006711602,0.00008903446,0.00031565514,0.00015406436,0.00937924],"category_scores_gemma":[0.00029460425,0.00009893958,0.00012841614,0.0010233751,0.0008250853,0.000068820336,0.00034622263,0.00096979266,0.00037949928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009809376,0.00014627013,0.019413406,0.00014026008,0.00007026133,0.00004215629,0.00015018073,0.000012190961,0.9569768,0.000044453718,0.0024412784,0.01958184],"study_design_scores_gemma":[0.0024688602,0.00062208343,0.120316155,0.0010030866,0.00002311242,0.00014485943,0.0022661714,0.00015177061,0.86097074,0.0002636848,0.011517643,0.000251831],"about_ca_topic_score_codex":0.0031497409,"about_ca_topic_score_gemma":0.00005887251,"teacher_disagreement_score":0.10090275,"about_ca_system_score_codex":0.00045237853,"about_ca_system_score_gemma":0.00055193924,"threshold_uncertainty_score":0.9915263},"labels":[],"label_agreement":null},{"id":"W2168189152","doi":"10.1158/0008-5472.can-05-3261","title":"Oncogenic Function of a Novel WD-Domain Protein, STRAP, in Human Carcinogenesis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"SMAD; Cancer research; Biology; Kinase; Carcinogenesis; Small interfering RNA; Cell biology; MAPK/ERK pathway; Cell growth; Ectopic expression; Signal transduction; Transforming growth factor beta; Gene knockdown; Protein kinase A; Chemistry; Molecular biology; Cell culture; Transfection; Cancer","score_opus":0.05235035122766665,"score_gpt":0.37040716739815843,"score_spread":0.31805681617049175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168189152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618304,0.0026848193,0.00018658927,0.000032560412,0.000026913463,0.00038154933,0.000039657403,0.0000067362394,0.00045812677],"genre_scores_gemma":[0.99858993,0.000011742158,0.0001043642,0.000010003393,0.0002594373,0.0002907995,0.00006585712,0.000024318708,0.00064353104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868643,0.00010148546,0.00022222952,0.00032508542,0.00033266106,0.0003320973],"domain_scores_gemma":[0.99936813,0.000010445679,0.00004755695,0.00031574658,0.0002018369,0.000056286637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041156833,0.00009678241,0.00011770625,0.0001419656,0.00007924727,0.000013451625,0.00021271245,0.00011045227,0.0000990467],"category_scores_gemma":[0.000033044827,0.000099861,0.000063234154,0.0002693303,0.00015942511,0.0000031053967,0.00009140882,0.0001227832,0.0000035991468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001851882,0.00020418207,0.009707187,0.00007362699,0.000019935374,0.0000025242628,0.000013571958,0.00026879337,0.9882911,0.00017556285,0.00056740944,0.0004909559],"study_design_scores_gemma":[0.00085306895,0.00020716741,0.03153902,0.000053235584,0.0000053880394,6.205639e-7,0.00005715335,0.0000056319986,0.96362305,0.00022363175,0.0033222584,0.000109788554],"about_ca_topic_score_codex":0.0015721304,"about_ca_topic_score_gemma":0.00094870053,"teacher_disagreement_score":0.024668027,"about_ca_system_score_codex":0.00007733886,"about_ca_system_score_gemma":0.00036233038,"threshold_uncertainty_score":0.40722135},"labels":[],"label_agreement":null},{"id":"W2168245581","doi":"10.1158/0008-5472.can-05-1948","title":"Loss-of-Function of <i>Nkx3.1</i> Promotes Increased Oxidative Damage in Prostate Carcinogenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Carcinogenesis; Oxidative stress; DNA damage; Prostate cancer; Cancer research; Oxidative phosphorylation; Superoxide dismutase; Biology; Chemistry; Cancer; Endocrinology; Biochemistry; Genetics","score_opus":0.033766237016328304,"score_gpt":0.3581623204297581,"score_spread":0.3243960834134298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168245581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660635,0.0017557058,0.000026016878,0.00014956742,0.00002855454,0.00034635508,0.00009339956,0.0000029069488,0.0009911633],"genre_scores_gemma":[0.99853384,0.00068682065,0.00008311016,0.00002207121,0.00010026259,0.000104914674,0.00008690634,0.000012065984,0.00036999275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871314,0.00031788842,0.00022162752,0.00029828545,0.00017529886,0.0002737643],"domain_scores_gemma":[0.9992156,0.000042422074,0.00007820565,0.0002656301,0.00034669338,0.000051444673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059862115,0.000098504446,0.00016846956,0.00012886382,0.000043907105,0.0000043007058,0.00019849329,0.00011256538,0.00006619156],"category_scores_gemma":[0.00014850461,0.00008600183,0.000045481465,0.00030028695,0.00045532998,0.0000075924686,0.00012333521,0.00015729488,0.000003395779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006796754,0.00008565598,0.13832465,0.000056624485,0.00003714471,0.0000019414283,0.00011108132,0.00003862023,0.8574255,0.000065346314,0.00026330966,0.0029104594],"study_design_scores_gemma":[0.0005694256,0.00036814236,0.09683622,0.000043304095,0.0000051439038,6.547064e-7,0.00010411106,0.0000095509085,0.8996579,0.0000976738,0.0022310908,0.0000767939],"about_ca_topic_score_codex":0.0005699485,"about_ca_topic_score_gemma":0.00077948294,"teacher_disagreement_score":0.04223239,"about_ca_system_score_codex":0.000031709023,"about_ca_system_score_gemma":0.00023173865,"threshold_uncertainty_score":0.3507053},"labels":[],"label_agreement":null},{"id":"W2168250718","doi":"10.1158/0008-5472.can-07-3217","title":"Vascular Endothelial Growth Factor–Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Toyota Research Institute, North America","keywords":"Angiogenesis; Vascular endothelial growth factor; Cancer research; Biomarker; In vivo; Receptor tyrosine kinase; Kinase insert domain receptor; Medicine; Cancer; Growth factor; Tumor progression; Vascular endothelial growth factor A; Receptor; Internal medicine; Biology; VEGF receptors; Biochemistry","score_opus":0.07211428138570343,"score_gpt":0.3388667513158498,"score_spread":0.2667524699301464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168250718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919964,0.003144852,0.00025222416,0.00024286303,0.0005871721,0.0014671648,0.0019948513,0.000047680216,0.0002667688],"genre_scores_gemma":[0.9890684,0.0065459246,0.00025595963,0.00028282334,0.0009833768,0.0013946977,0.00032673945,0.00018608964,0.0009560126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948456,0.0005084441,0.0006173075,0.0013447346,0.0010600669,0.0016238049],"domain_scores_gemma":[0.9970297,0.00035509825,0.00015362156,0.0006697009,0.0011240933,0.0006677552],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090743846,0.0005587844,0.0006217562,0.0004081181,0.0004765443,0.00008395359,0.0008531717,0.00044177775,0.0009616144],"category_scores_gemma":[0.0023741692,0.00052169454,0.0006253646,0.0006640195,0.0005308481,0.0000411743,0.0003333267,0.00041783144,0.00010442719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014996681,0.0002975277,0.038436394,0.00019799935,0.00051662064,0.00006701425,0.0002943098,0.0000065033223,0.9514731,0.00015330495,0.0064675612,0.00058996695],"study_design_scores_gemma":[0.006559971,0.00059012626,0.014866714,0.00010639329,0.000034234898,0.00002435134,0.00009872728,0.00008862946,0.9139587,0.00016182898,0.062657334,0.00085295393],"about_ca_topic_score_codex":0.003934642,"about_ca_topic_score_gemma":0.00053305057,"teacher_disagreement_score":0.05618977,"about_ca_system_score_codex":0.0003697934,"about_ca_system_score_gemma":0.0019582196,"threshold_uncertainty_score":0.99995166},"labels":[],"label_agreement":null},{"id":"W2168414172","doi":"10.1158/0008-5472.can-06-1010","title":"Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1338,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Angiogenesis; Glioma; Cancer research; Vascular endothelial growth factor; Endothelial stem cell; Biology; Cancer stem cell; Pathology; Stem cell; Bevacizumab; Population; Immunology; Medicine; In vitro; Cell biology; Chemotherapy; VEGF receptors","score_opus":0.0560186523997923,"score_gpt":0.34201605973707416,"score_spread":0.28599740733728185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168414172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825469,0.010626285,0.00013576906,0.0004384317,0.00052982586,0.0012917779,0.0003878803,0.00009669332,0.003946425],"genre_scores_gemma":[0.98756784,0.0015171353,0.0005795302,0.00017790985,0.001453917,0.0003813803,0.000024133506,0.00012362168,0.008174552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99616265,0.00018340838,0.00037907713,0.00073721,0.0014581189,0.001079517],"domain_scores_gemma":[0.998281,0.00010782685,0.000079961836,0.0006815773,0.00056056364,0.00028903913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004655558,0.00029382287,0.0005181053,0.0002917756,0.0002454347,0.00008438786,0.00030912046,0.00011452269,0.0014577684],"category_scores_gemma":[0.000010301215,0.00024731914,0.0003796903,0.0010542014,0.00023006725,0.00013823464,0.00014660189,0.00041531067,0.00024978202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031346944,0.00028634237,0.00088359305,0.0005984369,0.000117883974,0.0003695669,0.00031040353,0.000008540944,0.9740746,0.00007524707,0.018016793,0.004945098],"study_design_scores_gemma":[0.0018747699,0.0002047113,0.0007785451,0.000089181216,0.0000871613,0.000017750435,0.00012387842,0.0000055095315,0.8020689,0.00007081024,0.1944642,0.00021459897],"about_ca_topic_score_codex":0.009297975,"about_ca_topic_score_gemma":0.00020918837,"teacher_disagreement_score":0.1764474,"about_ca_system_score_codex":0.00055146095,"about_ca_system_score_gemma":0.0007521765,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W2168591146","doi":"10.1158/0008-5472.can-14-2999-t","title":"RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway–Dependent Tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Army Research Office; National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; Autism Speaks; U.S. Public Health Service; Emerald Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Cancer research; Metastasis; MAPK/ERK pathway; Resistance (ecology); Medicine; Biology; Internal medicine; Cancer; Cell biology; Signal transduction; Ecology","score_opus":0.06794504538849389,"score_gpt":0.36390020145457863,"score_spread":0.29595515606608475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168591146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948195,0.0027928741,0.00055492774,0.00089573,0.000069241876,0.00042809744,0.000043040724,0.000012612686,0.00038395333],"genre_scores_gemma":[0.9983606,0.000109313296,0.00021684247,0.00011240714,0.00018896598,0.00032244285,0.000028294879,0.000022505581,0.00063868123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814934,0.00027133612,0.00021904096,0.00049843313,0.00045581875,0.00040600987],"domain_scores_gemma":[0.99900675,0.00003515673,0.000045025048,0.00025745147,0.00047106954,0.00018454646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012395156,0.00013393405,0.00016382759,0.00020930257,0.00012947053,0.000041013132,0.00012859533,0.00006627873,0.000006234264],"category_scores_gemma":[0.0008283804,0.00013273029,0.000024526325,0.0004005382,0.00014435363,0.000013350486,0.00022362784,0.00019690534,0.000010207687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003055811,0.00004623471,0.00526543,0.000049725695,0.000022492548,0.000014413732,0.00061453576,0.00016017469,0.9887184,0.00028803173,0.0040658815,0.00044908535],"study_design_scores_gemma":[0.0007505936,0.00020713861,0.011098741,0.00018234731,0.0000034748446,0.0000025451445,0.0013987675,0.0000073408823,0.97572124,0.0006553228,0.009774809,0.00019767124],"about_ca_topic_score_codex":0.00031969708,"about_ca_topic_score_gemma":0.0015332979,"teacher_disagreement_score":0.012997165,"about_ca_system_score_codex":0.00030149048,"about_ca_system_score_gemma":0.0004580396,"threshold_uncertainty_score":0.5412584},"labels":[],"label_agreement":null},{"id":"W2168634761","doi":"10.1158/0008-5472.can-09-1778","title":"Loss of Collapsin Response Mediator Protein1, as Detected by iTRAQ Analysis, Promotes Invasion of Human Gliomas Expressing Mutant EGFRvIII","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Toronto Western Hospital; York University; University of Toronto","funders":"","keywords":"Gene knockdown; Mutant; Western blot; Cancer research; Cell culture; Biology; Phenotype; Molecular biology; Gene; Genetics","score_opus":0.08872576312473403,"score_gpt":0.40456287464486507,"score_spread":0.31583711152013105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168634761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978473,0.0006642517,0.000015749409,0.00043869624,0.00002813653,0.0007835032,0.00006902623,0.000036938345,0.000116352916],"genre_scores_gemma":[0.9993401,0.00010930066,0.00002625834,0.00006208103,0.000044384957,0.00008728654,0.0000036520196,0.000023966782,0.00030292876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99515474,0.0012913249,0.0005827647,0.0006745588,0.0016815894,0.0006150363],"domain_scores_gemma":[0.9978635,0.0007675641,0.00028839102,0.00051617983,0.00035508937,0.0002093191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016938489,0.00018752167,0.00043890794,0.00069291505,0.00042748245,0.00004390332,0.0006367596,0.00012340173,0.00033088002],"category_scores_gemma":[0.0020811446,0.00016701422,0.0001374162,0.0033633932,0.00054004433,0.00017747247,0.00017936667,0.00038054868,0.000009230752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002346329,0.00015898666,0.0007726211,0.000060074697,0.00002096021,0.000067876186,0.000469555,0.000022580773,0.9954388,0.00003971755,0.00018255612,0.00041993015],"study_design_scores_gemma":[0.00061270734,0.0009367124,0.001674661,0.00021231394,0.00003160123,0.000005763438,0.000058240043,0.00007939633,0.9957727,0.00025274992,0.00020810255,0.00015502228],"about_ca_topic_score_codex":0.00017929845,"about_ca_topic_score_gemma":0.000060475024,"teacher_disagreement_score":0.0027087305,"about_ca_system_score_codex":0.00021858438,"about_ca_system_score_gemma":0.00042709877,"threshold_uncertainty_score":0.68106425},"labels":[],"label_agreement":null},{"id":"W2168659791","doi":"10.1158/0008-5472.can-07-0718","title":"Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Neuroblastoma; Bone marrow; Neural crest; Pathology; Cancer research; Primary tumor; Minimal residual disease; Biology; Cancer; Medicine; Metastasis; Internal medicine; Cell culture; Cell biology; Embryo","score_opus":0.043060655872622956,"score_gpt":0.37027397285567126,"score_spread":0.3272133169830483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168659791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929094,0.0018315895,0.00008831021,0.0005997642,0.00018814403,0.0011688828,0.000172818,0.00014147173,0.0028996647],"genre_scores_gemma":[0.9956946,0.0001938556,0.00053577666,0.0006382745,0.00031942668,0.00011887224,0.000081788035,0.000099234174,0.0023182032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949184,0.0004711221,0.0005026926,0.0008135706,0.0016430536,0.0016511488],"domain_scores_gemma":[0.99632967,0.0013165663,0.0001149423,0.0006120112,0.0007146552,0.0009121845],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012893311,0.00033039702,0.0005371202,0.00062420534,0.00032928237,0.000115995186,0.00030913463,0.00011575155,0.0013322204],"category_scores_gemma":[0.00041411127,0.00028093604,0.00017568552,0.0011798929,0.00026014462,0.00018608602,0.00026573992,0.0015445006,0.00045190717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036666784,0.00044725774,0.0011654089,0.00012098466,0.00016176405,0.00963635,0.00016399281,0.000004254212,0.9770721,0.000018813593,0.0041927802,0.0033495685],"study_design_scores_gemma":[0.006678887,0.0022354675,0.0114715155,0.00020984214,0.00008563369,0.00009998294,0.0004182442,0.000266438,0.97422844,0.0001288444,0.0038636376,0.00031303917],"about_ca_topic_score_codex":0.0020708987,"about_ca_topic_score_gemma":0.00049101835,"teacher_disagreement_score":0.010306107,"about_ca_system_score_codex":0.0004799657,"about_ca_system_score_gemma":0.0006869204,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W2168786562","doi":"10.1158/0008-5472.can-10-4246","title":"CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":393,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Cancer research; Metastasis; Melanoma; CD8; Adoptive cell transfer; Immunology; Cytotoxic T cell; Biology; Cancer immunotherapy; Immunotherapy; Cancer; T cell; In vitro","score_opus":0.1085437339786479,"score_gpt":0.3827667634199589,"score_spread":0.274223029441311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168786562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98569036,0.012804133,0.00003397205,0.00009320388,0.000036417405,0.00020745632,0.000048515645,0.000006597357,0.0010793781],"genre_scores_gemma":[0.99864703,0.00021425058,0.00030165896,0.00013890983,0.00010925305,0.000097277116,0.0000134073125,0.000018806213,0.00045940347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988168,0.00016809785,0.0001279769,0.0003270456,0.00022537113,0.00033469906],"domain_scores_gemma":[0.99931806,0.00001603902,0.00003065421,0.00029580994,0.00016436697,0.00017506174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048253048,0.000108571025,0.00012272235,0.000087706474,0.00020210356,0.000029523164,0.00021165278,0.000056155666,0.0001739365],"category_scores_gemma":[0.00006254064,0.00009850044,0.000036921618,0.00013542119,0.00012537531,0.000003897363,0.00032186665,0.00014269589,0.000009424675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005367108,0.00009115614,0.0019956678,0.000019871002,0.00004515644,0.000021614802,0.00039531605,0.0000034545692,0.9905567,0.00003821519,0.0061928644,0.00010322691],"study_design_scores_gemma":[0.00033779905,0.00032193828,0.0040126015,0.00003390262,0.000009890738,0.0000063494394,0.0022503312,0.0000039249007,0.9829151,0.000009559632,0.009961331,0.00013728948],"about_ca_topic_score_codex":0.0033980177,"about_ca_topic_score_gemma":0.00010496201,"teacher_disagreement_score":0.012956708,"about_ca_system_score_codex":0.00003794744,"about_ca_system_score_gemma":0.00009834329,"threshold_uncertainty_score":0.51368093},"labels":[],"label_agreement":null},{"id":"W2168805216","doi":"10.1158/0008-5472.can-07-0752","title":"Eukaryotic Translation Initiation Factor 4E–Induced Progression of Primary Human Mammary Epithelial Cells along the Cancer Pathway Is Associated with Targeted Translational Deregulation of Oncogenic Drivers and Inhibitors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"EIF4E; Translational regulation; Biology; Initiation factor; Translational efficiency; Carcinogenesis; Cell biology; Translation (biology); Cancer research; Eukaryotic translation; Polysome; Cancer; Eukaryotic initiation factor; Genetics; Messenger RNA; Gene; RNA; Ribosome","score_opus":0.04903204303092206,"score_gpt":0.3298446536682882,"score_spread":0.2808126106373661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168805216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967092,0.0010882735,0.0011393862,0.00018807333,0.000051966777,0.0006472152,0.000100435645,0.0000059427575,0.00006946818],"genre_scores_gemma":[0.9992492,0.0001874507,0.00023342115,0.000020686542,0.000093384,0.000050708542,0.000115614705,0.000019752219,0.000029790632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847275,0.0002180739,0.0002890976,0.00026676944,0.0005285182,0.00022478632],"domain_scores_gemma":[0.9991955,0.00008132327,0.0001836582,0.00016361603,0.0003211758,0.000054734825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000835012,0.00011678205,0.00015290243,0.00010445039,0.00016390867,0.000014027861,0.00013599246,0.00018500388,0.00004068519],"category_scores_gemma":[0.00002134524,0.00008724011,0.000053845015,0.00023402677,0.00013571663,0.000021952977,0.000025033838,0.00013366528,1.7592865e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025669928,0.000038929033,0.004468734,0.000057046964,0.00007346662,9.307794e-7,0.00064369506,0.00002497896,0.9507339,0.0000222573,0.000012335679,0.043667037],"study_design_scores_gemma":[0.00068592816,0.00029367526,0.06764284,0.00012240605,0.000017123522,5.4584643e-7,0.000047487625,0.000027504278,0.9309122,0.00010296957,0.000050012608,0.00009731978],"about_ca_topic_score_codex":0.0001499453,"about_ca_topic_score_gemma":0.00030224794,"teacher_disagreement_score":0.0631741,"about_ca_system_score_codex":0.000055593435,"about_ca_system_score_gemma":0.00034292482,"threshold_uncertainty_score":0.35575485},"labels":[],"label_agreement":null},{"id":"W2168880860","doi":"","title":"Effect of post-initiation induction of NQO1 by oltipraz on AOM induced colon tumor formation in Sprague-Dawley rats","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Azoxymethane; Carcinogen; Chemistry; Aberrant crypt foci; Enzyme; Carcinogenesis; Glutathione; Anticarcinogen; Enzyme inducer; Pharmacology; Colorectal cancer; Internal medicine; Endocrinology; Biochemistry; Cancer; Biology; Medicine; Gene; Colonic disease","score_opus":0.030029886752793684,"score_gpt":0.36976605923408606,"score_spread":0.3397361724812924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168880860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849933,0.00033908535,0.00001564412,0.00019316752,0.00006416938,0.0004742385,0.000070236885,0.0000031101197,0.00034101564],"genre_scores_gemma":[0.99923724,0.0001672335,0.000020087416,0.0000423731,0.000171061,0.00010791354,0.00020750127,0.000013804138,0.00003278731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873513,0.00029629972,0.00026300582,0.00023234429,0.0002442663,0.00022896066],"domain_scores_gemma":[0.9992642,0.00006231489,0.00012884886,0.00020430912,0.00029189757,0.000048431808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064367434,0.000102862796,0.00016861803,0.00014058955,0.000035313522,0.000008705607,0.00014860673,0.00012769457,0.000022104923],"category_scores_gemma":[0.00029654955,0.0000987059,0.000043237433,0.0001784241,0.000084572945,0.000015942482,0.0000569082,0.00021438698,0.0000057657353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091050344,0.000072817056,0.00065881293,0.000106125386,0.000011895079,3.6907207e-7,0.00013837943,0.000052794938,0.99038786,0.000009289108,0.00092785707,0.006723273],"study_design_scores_gemma":[0.0009103921,0.001326748,0.0015473458,0.000065229666,0.000004092381,9.69315e-7,0.000077222445,0.00003382269,0.9953311,0.0000139599815,0.0006059583,0.00008314339],"about_ca_topic_score_codex":0.00017109083,"about_ca_topic_score_gemma":0.00017551082,"teacher_disagreement_score":0.0066401297,"about_ca_system_score_codex":0.00011852618,"about_ca_system_score_gemma":0.000091317575,"threshold_uncertainty_score":0.402511},"labels":[],"label_agreement":null},{"id":"W2168985289","doi":"10.1158/1538-7445.am2015-4624","title":"Abstract 4624: Clinical impact of telomere shortening in normal and leukemia cells in chronic lymphocytic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Telomere; Buccal swab; Leukemia; Medicine; Cancer; Oncology; Immunology; Internal medicine; Senescence; Biology; Genetics; Gene","score_opus":0.15255905789859608,"score_gpt":0.4704692906714003,"score_spread":0.3179102327728042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168985289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933942,0.004686322,0.0000019363606,0.00004277367,0.00012472503,0.0004889685,0.000017419856,0.000021230939,0.0012224083],"genre_scores_gemma":[0.99646497,0.0027424055,0.00006820829,0.000031583233,0.00032397255,0.00004312116,0.000008596622,0.000037432288,0.00027968793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967433,0.00020045208,0.00080250204,0.0005323658,0.0008094757,0.00091188506],"domain_scores_gemma":[0.9981686,0.00040666864,0.00009888962,0.0004496846,0.0002877444,0.0005884417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027825588,0.0002163771,0.0007037619,0.00064357696,0.000044331617,0.000030303843,0.0002513762,0.00026526573,0.00019089897],"category_scores_gemma":[0.00035552582,0.00018292452,0.00012115586,0.0009806016,0.0005489238,0.000197956,0.00015304633,0.0011994661,0.00003351383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0029711474,0.00010603085,0.7870094,0.00079305324,0.000107598054,0.0010773432,0.0018553935,0.0042237914,0.117503025,0.000020072726,0.0035776603,0.08075549],"study_design_scores_gemma":[0.008255125,0.0011490938,0.9630638,0.001184248,0.000019826954,0.000050802162,0.00079560466,0.0065539563,0.01804381,0.000050119404,0.0005305191,0.0003031399],"about_ca_topic_score_codex":0.027858313,"about_ca_topic_score_gemma":0.0026040587,"teacher_disagreement_score":0.17605436,"about_ca_system_score_codex":0.020306377,"about_ca_system_score_gemma":0.027013091,"threshold_uncertainty_score":0.98345447},"labels":[],"label_agreement":null},{"id":"W2169055265","doi":"10.1158/0008-5472.can-12-3979","title":"Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hsp27; Prostate cancer; Epithelial–mesenchymal transition; Cancer research; Metastasis; Cancer; Prostate; Medicine; Twist transcription factor; Cancer cell; Oncology; Internal medicine; Biology; Heat shock protein; Hsp70","score_opus":0.029565058773532243,"score_gpt":0.3503490141689637,"score_spread":0.3207839553954315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169055265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929804,0.0038002,0.000020608204,0.0015370607,0.00004923908,0.0012886727,0.00013026307,0.000008754741,0.00018476303],"genre_scores_gemma":[0.9957755,0.0013220464,0.00021459883,0.0000919524,0.00024455565,0.0015874217,0.0000297683,0.000043144406,0.00069099345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972623,0.00043561004,0.00028530828,0.00060997944,0.00054172735,0.00086508284],"domain_scores_gemma":[0.998906,0.000044989643,0.00003138499,0.0003438658,0.00043647643,0.00023728628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011234552,0.000171617,0.0002122723,0.00020935037,0.00019353695,0.00011352069,0.00024637143,0.000100840465,0.00053834723],"category_scores_gemma":[0.00012998907,0.0001570137,0.000049269045,0.0004261985,0.00031610834,0.000021656278,0.00020381734,0.00043943388,0.000028622237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007815836,0.000034224533,0.0015116795,0.00013392976,0.00003435285,0.000015850026,0.00035979098,0.0002371341,0.99016774,0.000012285325,0.0011188019,0.0062960493],"study_design_scores_gemma":[0.00072018395,0.0001447347,0.002855233,0.000095040916,0.0000041798758,0.000010089081,0.0003187537,0.00043626677,0.99104226,0.00022313192,0.003948495,0.00020162742],"about_ca_topic_score_codex":0.0075948187,"about_ca_topic_score_gemma":0.00089817954,"teacher_disagreement_score":0.006696639,"about_ca_system_score_codex":0.00011871733,"about_ca_system_score_gemma":0.0005133309,"threshold_uncertainty_score":0.9990137},"labels":[],"label_agreement":null},{"id":"W2169101810","doi":"10.1158/0008-5472.can-09-2377","title":"Oncolysis of Prostate Cancers Induced by Vesicular Stomatitis Virus in PTEN Knockout Mice","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Southern California","keywords":"Oncolytic virus; PTEN; Vesicular stomatitis virus; Prostate cancer; Virus; Prostate; Cancer research; Biology; Terminal deoxynucleotidyl transferase; Apoptosis; Cancer; Virology; Pathology; Medicine; TUNEL assay; PI3K/AKT/mTOR pathway","score_opus":0.030030008949219464,"score_gpt":0.3840278062552367,"score_spread":0.3539977973060172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169101810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963392,0.0018013886,0.0000019434444,0.00032352383,0.000121405865,0.000551111,0.0001583437,0.000008404732,0.0006946875],"genre_scores_gemma":[0.9970217,0.001493861,0.000038861144,0.000072772214,0.00015490953,0.00046917266,0.00006294341,0.0000492301,0.0006365512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975041,0.00031722337,0.00029065294,0.00052195636,0.0006774421,0.00068859383],"domain_scores_gemma":[0.99865717,0.000058041533,0.000073619274,0.0006167294,0.00040683174,0.00018758407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012296175,0.00016400462,0.00024328599,0.00024793769,0.000097012235,0.000030721283,0.00059929164,0.00022957701,0.00024758241],"category_scores_gemma":[0.00018731356,0.00016370256,0.00007693716,0.00068705785,0.00037180254,0.000008270011,0.00020476483,0.0007093971,0.000020063173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010325655,0.0000765415,0.00080498285,0.000046009256,0.00006722618,0.0000066714288,0.00020152914,0.00004135142,0.9820327,0.0000060067428,0.0022485317,0.013435856],"study_design_scores_gemma":[0.000966481,0.0009648919,0.00047456552,0.000031765016,0.0000045147563,0.0000011927085,0.00014803254,0.00005837529,0.98836,0.000043136464,0.008772065,0.00017496647],"about_ca_topic_score_codex":0.007932072,"about_ca_topic_score_gemma":0.032101806,"teacher_disagreement_score":0.024169734,"about_ca_system_score_codex":0.00019602882,"about_ca_system_score_gemma":0.0012771442,"threshold_uncertainty_score":0.9986742},"labels":[],"label_agreement":null},{"id":"W2169448460","doi":"10.1158/0008-5472.can-04-3872","title":"Genetic Polymorphism in Cytochrome <i>P</i>450 7A1 and Risk of Colorectal Cancer: The Fukuoka Colorectal Cancer Study","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Colorectal cancer; Cholesterol 7 alpha-hydroxylase; Genotype; Odds ratio; Internal medicine; Gastroenterology; Bile acid; Medicine; Cancer; Oncology; Biology; Genetics; Gene","score_opus":0.030186407730386496,"score_gpt":0.3558420840774106,"score_spread":0.3256556763470241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169448460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97442794,0.020910764,0.0000051109696,0.0017735232,0.00017740446,0.0021581743,0.00013597809,0.00002718695,0.00038394378],"genre_scores_gemma":[0.9803412,0.016718943,0.000074948985,0.000067044566,0.00045647312,0.0014459365,0.0000036242227,0.0000519875,0.00083983113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968851,0.0002647128,0.0004671781,0.0005587123,0.0010506652,0.00077362737],"domain_scores_gemma":[0.9988704,0.00017111075,0.0001128654,0.00032614643,0.00028501474,0.00023448587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010716612,0.0002444532,0.0005600502,0.0003017745,0.00024860457,0.000027242635,0.00032444278,0.00013909701,0.00068037014],"category_scores_gemma":[0.000041431216,0.00016755445,0.0000918334,0.00093309674,0.0005865569,0.00007454171,0.000099068646,0.0009173744,0.000008703286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028516403,0.00070740253,0.7332771,0.00020945043,0.00040441222,0.00015757966,0.007632386,0.000337431,0.22824703,0.000050897008,0.0006707555,0.025453936],"study_design_scores_gemma":[0.004365986,0.00082324044,0.9301973,0.00031427917,0.00020390337,0.000013681035,0.0020366514,0.00026421144,0.05983039,0.000069503796,0.001649344,0.00023152745],"about_ca_topic_score_codex":0.019791648,"about_ca_topic_score_gemma":0.08168052,"teacher_disagreement_score":0.19692022,"about_ca_system_score_codex":0.00051642006,"about_ca_system_score_gemma":0.0009999459,"threshold_uncertainty_score":0.98673564},"labels":[],"label_agreement":null},{"id":"W2169519275","doi":"10.1158/0008-5472.can-13-1055","title":"Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Neuregulin; Breast cancer; Autocrine signalling; Neuregulin 1; Medicine; Cancer research; Trastuzumab; Lapatinib; Cancer; In vivo; Oncology; Internal medicine; Receptor; Biology","score_opus":0.06370755747525297,"score_gpt":0.39784602243945827,"score_spread":0.3341384649642053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169519275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919647,0.0005063039,0.00006119656,0.0032408403,0.00011429739,0.002137975,0.000048770125,0.0001538291,0.0017721007],"genre_scores_gemma":[0.99612164,0.0001374637,0.00076963985,0.00010190979,0.0006302878,0.0009109425,0.000026823443,0.00011556262,0.0011857426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950828,0.00042960915,0.0006369744,0.00066271087,0.0019982785,0.0011896187],"domain_scores_gemma":[0.99673593,0.0005516911,0.0001643198,0.00058237906,0.001502117,0.00046355117],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016844873,0.00026917408,0.00052855967,0.00045053213,0.00024470664,0.00012684197,0.00042667103,0.00013865418,0.0033550526],"category_scores_gemma":[0.00035998353,0.00024658686,0.000118313415,0.001304582,0.00025967084,0.0003077307,0.0002441862,0.001252898,0.00012481926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017289394,0.0002534669,0.0023625006,0.0011948999,0.000100895966,0.000023486105,0.00059723656,0.00005166893,0.970618,0.000015280402,0.007718505,0.016891183],"study_design_scores_gemma":[0.001477038,0.000498958,0.0020068884,0.0011112257,0.000021489901,0.000034037672,0.00044683818,0.0016119771,0.99031574,0.00013800035,0.0021025124,0.00023529712],"about_ca_topic_score_codex":0.007115683,"about_ca_topic_score_gemma":0.000030778145,"teacher_disagreement_score":0.019697756,"about_ca_system_score_codex":0.0008650608,"about_ca_system_score_gemma":0.0013686807,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W2169943027","doi":"10.1158/0008-5472.can-05-0669","title":"Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer Detection","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Antibody; Ovarian cancer; Medicine; Antigen; Oncology; Confidence interval; Receiver operating characteristic; Internal medicine; Multiplex; Immunology; Cancer; Gastroenterology; Biology; Bioinformatics","score_opus":0.052336635409493355,"score_gpt":0.41953983346319235,"score_spread":0.367203198053699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169943027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991214,0.0009976812,0.003997798,0.0014772255,0.000067637986,0.0008545681,0.00015931147,0.000036938913,0.0011948469],"genre_scores_gemma":[0.99768317,0.0004303613,0.00021993803,0.00006932801,0.00022364262,0.00019344667,0.00005215659,0.000033854354,0.0010940869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715245,0.00025487135,0.0004958623,0.0004078023,0.0010744584,0.0006145817],"domain_scores_gemma":[0.99789983,0.00018705432,0.000109235654,0.00034317706,0.0012712552,0.0001894628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011165021,0.00015170104,0.00043832193,0.00062848284,0.00019701303,0.000014903099,0.00022078684,0.000121550984,0.00008036161],"category_scores_gemma":[0.00025360586,0.00013470948,0.00011258384,0.0013299219,0.00021709892,0.000055378485,0.00011475699,0.00044204472,0.000011601498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021011531,0.00021340235,0.051630452,0.00028237695,0.00008298672,0.000024275581,0.00015591497,0.0037718916,0.92865396,0.00018270392,0.00021072583,0.01269016],"study_design_scores_gemma":[0.0015293696,0.0008539617,0.22611234,0.00076487625,0.000053687305,0.0000151317545,0.0002219311,0.15046053,0.6163308,0.0005365444,0.0028013957,0.0003194223],"about_ca_topic_score_codex":0.039547175,"about_ca_topic_score_gemma":0.0027598974,"teacher_disagreement_score":0.31232312,"about_ca_system_score_codex":0.0003423319,"about_ca_system_score_gemma":0.0006845018,"threshold_uncertainty_score":0.96684855},"labels":[],"label_agreement":null},{"id":"W2170193835","doi":"10.1158/0008-5472.can-06-4238","title":"Anticancer Therapies Combining Antiangiogenic and Tumor Cell Cytotoxic Effects Reduce the Tumor Stem-Like Cell Fraction in Glioma Xenograft Tumors","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cytotoxic T cell; Cancer research; Medicine; Chemotherapy; Glioma; Chemosensitizer; Stem cell; Tumor microenvironment; Cancer stem cell; Pharmacology; Immunology; Cancer; Biology; Internal medicine; Cytotoxicity; Tumor cells; In vitro","score_opus":0.03744233668470328,"score_gpt":0.3618694293855893,"score_spread":0.32442709270088604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170193835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736007,0.019540742,0.000006282847,0.0008057916,0.0001854752,0.0015720917,0.000006909789,0.00003892866,0.00048373695],"genre_scores_gemma":[0.99810094,0.00081744575,0.00005524942,0.00021579619,0.00017903293,0.00040831283,0.0000049036644,0.000056315217,0.00016198741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972358,0.0002499148,0.0003326655,0.0005258315,0.00077409914,0.0008816899],"domain_scores_gemma":[0.9982426,0.0007888463,0.000099124125,0.0004483576,0.00017601754,0.0002450635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015246712,0.0002440151,0.0004051237,0.0005652016,0.00031525956,0.000090533635,0.0001781459,0.0000681208,0.00008654928],"category_scores_gemma":[0.000038334525,0.00016811873,0.000106649386,0.001232415,0.00032720537,0.00011451561,0.0001032401,0.0005805341,0.000039120605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007574204,0.0008146877,0.13649546,0.0005119448,0.00010476748,0.002528469,0.0017132398,0.00000773154,0.8506186,0.00003805934,0.0013293021,0.005080342],"study_design_scores_gemma":[0.0038039556,0.0006641002,0.19030608,0.0005389722,0.00006159431,0.00010698648,0.0024629356,0.000050656967,0.800521,0.000048005142,0.0012500162,0.00018567483],"about_ca_topic_score_codex":0.0014100972,"about_ca_topic_score_gemma":0.0002510666,"teacher_disagreement_score":0.05381062,"about_ca_system_score_codex":0.00042892614,"about_ca_system_score_gemma":0.00025701334,"threshold_uncertainty_score":0.6855683},"labels":[],"label_agreement":null},{"id":"W2170437481","doi":"10.1158/0008-5472.can-04-3612","title":"Tumor Necrosis Factor Reduces Brain Tumor Growth by Enhancing Macrophage Recruitment and Microcyst Formation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tumor necrosis factor alpha; Glioma; Macrophage; Cancer research; Population; Medicine; Brain tumor; Pathology; Necrosis; Cancer; Tumor progression; Immunology; Biology; Internal medicine; In vitro","score_opus":0.05951164370443768,"score_gpt":0.36328571268267,"score_spread":0.30377406897823234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170437481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649452,0.029875625,0.000051797902,0.0029516171,0.0004731085,0.0009106146,0.00018862452,0.000061371335,0.0005420386],"genre_scores_gemma":[0.9867341,0.0014668165,0.000104561484,0.00065668876,0.00012623743,0.0006633707,0.00006525766,0.000042011216,0.010140941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976976,0.00041532924,0.0003897109,0.00047932175,0.00013964383,0.00087837526],"domain_scores_gemma":[0.9989969,0.0003062047,0.000114841154,0.00028809972,0.00023209758,0.00006186279],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008054851,0.00022162836,0.00028565776,0.00020226359,0.0005365778,0.00009049395,0.00036653032,0.00014194414,0.0019264856],"category_scores_gemma":[0.00015592018,0.00020506007,0.000057204463,0.00028074568,0.00044856788,0.00034049829,0.0002476217,0.0007485499,0.000481816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015899604,0.000045969064,0.00006869162,0.00008385424,0.00004753169,0.0000037752457,0.0014038567,5.649712e-7,0.893738,0.000023466808,0.08439135,0.020034],"study_design_scores_gemma":[0.0008751175,0.00011274765,0.00026117163,0.00010738974,0.0000068679697,0.000034359964,0.000347125,0.000002753441,0.81337297,0.000028455814,0.18467033,0.00018072914],"about_ca_topic_score_codex":0.00069391576,"about_ca_topic_score_gemma":0.00019055804,"teacher_disagreement_score":0.10027899,"about_ca_system_score_codex":0.00076522166,"about_ca_system_score_gemma":0.00019942083,"threshold_uncertainty_score":0.9989859},"labels":[],"label_agreement":null},{"id":"W2170461821","doi":"10.1158/0008-5472.can-13-3629","title":"Foretinib Is Effective Therapy for Metastatic Sonic Hedgehog Medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Medicine; Oncology; Targeted therapy; Immunohistochemistry; Cancer research; Primary tumor; Cancer; Internal medicine; Pathology; Metastasis; Biology; Signal transduction","score_opus":0.06939624105679291,"score_gpt":0.42704883906035934,"score_spread":0.3576525980035664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170461821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888506,0.005295308,0.0028130545,0.0007728773,0.00018120317,0.0013194103,0.00007113974,0.000019277913,0.0006771217],"genre_scores_gemma":[0.9943565,0.00061848824,0.00035202154,0.00047319173,0.0005551969,0.0022573473,0.000025214382,0.000054199427,0.0013078218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809456,0.00029837913,0.0001640013,0.0005233809,0.00030731753,0.00061235984],"domain_scores_gemma":[0.9986988,0.00025855054,0.000043263575,0.00039679225,0.00048736174,0.000115278686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014066106,0.0001706784,0.00022483611,0.00008585711,0.00027390805,0.00003646158,0.00031405268,0.00009034766,0.00006533644],"category_scores_gemma":[0.00054590974,0.00014361202,0.00017180567,0.00018171355,0.00027878574,0.0000029742023,0.00012925339,0.00017049444,0.000034135155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007228652,0.0000864161,0.0007365465,0.0001475463,0.0004711748,0.0000012550784,0.0007116136,0.000054739732,0.89429116,0.00027360162,0.03382334,0.06867971],"study_design_scores_gemma":[0.0014454306,0.0014542443,0.0004233954,0.000038055514,0.000012789386,0.0000016314578,0.00014949025,0.00016103023,0.78342885,0.00078745664,0.21191317,0.0001844561],"about_ca_topic_score_codex":0.000040037765,"about_ca_topic_score_gemma":0.000054056407,"teacher_disagreement_score":0.17808983,"about_ca_system_score_codex":0.000052902236,"about_ca_system_score_gemma":0.00017505235,"threshold_uncertainty_score":0.58563286},"labels":[],"label_agreement":null},{"id":"W2170501509","doi":"10.1158/0008-5472.can-04-2938","title":"Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Prostate; Androgen receptor; Androgen; Cancer research; Biology; Internal medicine; Endocrinology; Cancer; Medicine; Hormone","score_opus":0.08228398841353438,"score_gpt":0.4110044743045733,"score_spread":0.32872048589103897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170501509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686545,0.00092153705,0.0000050254584,0.0007200023,0.00007114011,0.00095610955,0.000054416934,0.00002176439,0.00038454463],"genre_scores_gemma":[0.99744576,0.0011607372,0.000027172817,0.000015225208,0.00014238672,0.00014640445,0.000025643323,0.000023483042,0.0010132114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823374,0.00008131564,0.00021207864,0.0003183124,0.00069281406,0.0004617561],"domain_scores_gemma":[0.99905825,0.00003530837,0.0000461921,0.00024395934,0.00039507612,0.00022122805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044494777,0.00011748443,0.00025903445,0.00023914501,0.0002071918,0.000027194672,0.000092985734,0.00007323423,0.00011950915],"category_scores_gemma":[0.00002684009,0.00008905922,0.000054200165,0.00036748862,0.00026932947,0.00007698697,0.00009450741,0.0003619378,0.000012301643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005070795,0.00018703713,0.0077629113,0.0002704242,0.0000735178,0.00003511176,0.00084816647,0.000002142122,0.98706275,0.00031890193,0.000060077055,0.002871867],"study_design_scores_gemma":[0.004113409,0.00091251166,0.025373362,0.00015307068,0.000025878477,0.000005048174,0.00014513159,0.000004880017,0.96781,0.0012295789,0.00014588791,0.00008126523],"about_ca_topic_score_codex":0.0012995878,"about_ca_topic_score_gemma":0.000117862786,"teacher_disagreement_score":0.019252788,"about_ca_system_score_codex":0.00035359806,"about_ca_system_score_gemma":0.00051138556,"threshold_uncertainty_score":0.36317298},"labels":[],"label_agreement":null},{"id":"W2170563954","doi":"10.1158/0008-5472.can-07-0035","title":"Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Ovarian cancer; Biology; Cancer research; Trichostatin A; Motility; Cancer; Transforming growth factor; Cancer cell; Histone deacetylase inhibitor; Gene silencing; Endocrinology; Internal medicine; Histone deacetylase; Medicine; Cell biology; Histone","score_opus":0.04055740327725963,"score_gpt":0.38520914663941513,"score_spread":0.3446517433621555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170563954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927971,0.0067213955,0.000024136112,0.000060530227,0.00003035136,0.00019390143,0.000021037664,0.0000024336398,0.00014914013],"genre_scores_gemma":[0.9992102,0.00047766938,0.00007177244,0.000016560854,0.00008047798,0.000049345093,0.00001228658,0.000011885679,0.000069821726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879205,0.00012125877,0.00020472067,0.00031975663,0.00023874172,0.0003234597],"domain_scores_gemma":[0.99947774,0.000040063627,0.000034495562,0.00025051652,0.000098044984,0.00009913917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010006325,0.0000768389,0.00012004676,0.00014264551,0.0000373929,0.00000811514,0.0001768286,0.000115423645,0.00004434878],"category_scores_gemma":[0.00014319365,0.00007440351,0.000019993266,0.00022567701,0.00017565323,0.0000036030378,0.00019306815,0.00017790354,5.573904e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025470287,0.000053121916,0.3486005,0.000052606807,0.0000031641675,0.000005426442,0.00012641013,0.00006776686,0.6472721,0.0000033297406,0.000049644503,0.003511223],"study_design_scores_gemma":[0.00045422267,0.000042514148,0.2775423,0.000121977406,9.387102e-7,3.5597031e-7,0.00011510012,0.000010054646,0.72087747,0.00006938416,0.00071565283,0.0000500331],"about_ca_topic_score_codex":0.0024115327,"about_ca_topic_score_gemma":0.006161694,"teacher_disagreement_score":0.07360539,"about_ca_system_score_codex":0.00007352982,"about_ca_system_score_gemma":0.0002676302,"threshold_uncertainty_score":0.3645532},"labels":[],"label_agreement":null},{"id":"W2170776802","doi":"10.1158/0008-5472.can-08-3065","title":"Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Minnesota Ovarian Cancer Alliance","keywords":"Ovarian cancer; Small hairpin RNA; Biology; Cancer research; Cisplatin; Chromatin immunoprecipitation; Molecular biology; Paclitaxel; Transcription factor; Gene silencing; Gene expression; Cell culture; Cancer; Promoter; Gene; Genetics; Chemotherapy; Gene knockdown","score_opus":0.032111109177466735,"score_gpt":0.3485218902514525,"score_spread":0.3164107810739858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170776802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970457,0.0014884883,0.00012602042,0.00038187756,0.000059083904,0.00026302406,0.00011374581,0.0000041171966,0.00051794533],"genre_scores_gemma":[0.9982574,0.00085079984,0.00016091771,0.00007639461,0.00015939683,0.000039231305,0.00005779847,0.00001745253,0.00038061274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987303,0.00012960841,0.00022093096,0.000354102,0.00024314031,0.00032194398],"domain_scores_gemma":[0.9993469,0.000016806014,0.000068939975,0.00031296592,0.00016851805,0.00008586078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021219217,0.00010957158,0.00016098082,0.00007655214,0.000058213656,0.000016345586,0.00024483935,0.00014658956,0.0002867655],"category_scores_gemma":[0.00008075007,0.000104216095,0.00004379407,0.00016344503,0.000098468096,0.0000070642795,0.000079117766,0.00018238138,0.0000035642972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019273638,0.00007203327,0.0016296642,0.000027667253,0.000010393098,9.421026e-7,0.0001846124,0.00004529842,0.99030936,0.000042296437,0.0051329453,0.002352051],"study_design_scores_gemma":[0.00054444006,0.00013043618,0.024694163,0.00008605324,0.000002484749,4.3747548e-7,0.000054648986,0.000046646557,0.96918714,0.0003615969,0.0047738845,0.00011808791],"about_ca_topic_score_codex":0.00043458526,"about_ca_topic_score_gemma":0.00009185942,"teacher_disagreement_score":0.0230645,"about_ca_system_score_codex":0.00008719043,"about_ca_system_score_gemma":0.00012905309,"threshold_uncertainty_score":0.4249809},"labels":[],"label_agreement":null},{"id":"W2171217566","doi":"10.1158/0008-5472.can-05-1633","title":"Transforming Acidic Coiled Coil 1 Promotes Transformation and Mammary Tumorigenesis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Biology; PTEN; Mammary tumor; Cancer research; Carcinogenesis; Protein kinase B; PI3K/AKT/mTOR pathway; Oncogene; Genetically modified mouse; Kinase; Mammary gland; Transgene; Ectopic expression; Phosphoinositide 3-kinase; Signal transduction; Apoptosis; Cell biology; Molecular biology; Cancer; Breast cancer; Cell culture; Cell cycle; Genetics; Gene","score_opus":0.04015463037297322,"score_gpt":0.3423297028681136,"score_spread":0.30217507249514036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171217566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093926,0.0025811668,0.003055136,0.0022813622,0.000046849756,0.0003960434,0.000021429034,0.00002175745,0.0006569899],"genre_scores_gemma":[0.99706113,0.0017981889,0.00019759979,0.00005234012,0.0001753874,0.00013666123,0.000076080774,0.000017724256,0.00048490692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989435,0.00008516073,0.00016403581,0.00025057033,0.0002746961,0.00028201521],"domain_scores_gemma":[0.9995634,0.000009799262,0.000018634253,0.00016848209,0.00014347394,0.00009622636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039604,0.00009980974,0.000090818445,0.00009719289,0.00015956008,0.0000483643,0.00012643026,0.00010533145,0.000052949206],"category_scores_gemma":[0.000015452528,0.000097597986,0.000040083174,0.00015266443,0.00015422904,0.000031394276,0.000015297686,0.00012207859,0.0000088179195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080954575,0.000020973654,0.0002670774,0.00006217739,0.000018189214,5.666733e-7,0.00039775122,0.000029221019,0.9429182,0.00030172797,0.00022314682,0.05568004],"study_design_scores_gemma":[0.00063164794,0.00012703064,0.002188237,0.000025844269,0.0000066873386,0.000009195012,0.0001006143,0.00019943382,0.939286,0.000063516985,0.05723058,0.00013121353],"about_ca_topic_score_codex":0.00006275882,"about_ca_topic_score_gemma":0.000282747,"teacher_disagreement_score":0.057007432,"about_ca_system_score_codex":0.000052554373,"about_ca_system_score_gemma":0.00012490335,"threshold_uncertainty_score":0.39799306},"labels":[],"label_agreement":null},{"id":"W2171342019","doi":"10.1158/0008-5472.can-06-1193","title":"ROS Fusion Tyrosine Kinase Activates a SH2 Domain–Containing Phosphatase-2/Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Signaling Axis to Form Glioblastoma in Mice","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cancer research; Receptor tyrosine kinase; Biology; Protein kinase B; Ectopic expression; PI3K/AKT/mTOR pathway; Glioma; Protein tyrosine phosphatase; Tyrosine kinase; Kinase; PTEN; Signal transduction; Cell biology; Cell culture; Genetics","score_opus":0.017271988285079518,"score_gpt":0.31452896795620844,"score_spread":0.2972569796711289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171342019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96695304,0.030000085,0.00047569262,0.00049502455,0.00011213418,0.0012837098,0.00056720973,0.000025089957,0.000088020344],"genre_scores_gemma":[0.99517465,0.00016323157,0.0028868376,0.00014090791,0.0003633042,0.00062397774,0.00040130032,0.00008198849,0.00016381848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996441,0.00021091069,0.0006400895,0.00089546066,0.0007089931,0.001103547],"domain_scores_gemma":[0.99836206,0.00010920356,0.00017807873,0.00063140824,0.0004617625,0.000257465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001125675,0.00036610634,0.00044107842,0.0003749757,0.00023828127,0.00007695164,0.00067255815,0.0002460814,0.00014888181],"category_scores_gemma":[0.0003106464,0.00037354988,0.00012861841,0.0010984762,0.0002265613,0.0000367024,0.0005495935,0.00038173082,0.00001502095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003175555,0.00022268787,0.006728612,0.0001632916,0.00003152758,0.00006561038,0.0001608012,0.00076929375,0.9823975,0.00058509066,0.0032448599,0.0024551519],"study_design_scores_gemma":[0.0017945856,0.0012466213,0.0022413097,0.00037227012,0.000009761779,0.0000048994393,0.00027398282,0.000037005426,0.98355323,0.00043400712,0.009637369,0.00039495766],"about_ca_topic_score_codex":0.005782048,"about_ca_topic_score_gemma":0.0015576106,"teacher_disagreement_score":0.029836854,"about_ca_system_score_codex":0.0002706325,"about_ca_system_score_gemma":0.00041765638,"threshold_uncertainty_score":0.9998717},"labels":[],"label_agreement":null},{"id":"W2171387445","doi":"10.1158/0008-5472.can-09-1770","title":"Suppression of Hypoxia-Inducible Factor 2α Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Clear cell renal cell carcinoma; Cancer research; Downregulation and upregulation; Biology; Small hairpin RNA; Suppressor; Programmed cell death; Tumor suppressor gene; Chemotherapy; Hypoxia-inducible factors; Apoptosis; Cancer; Renal cell carcinoma; Pathology; Gene; Medicine; Gene knockdown; Carcinogenesis; Genetics","score_opus":0.04195429450530473,"score_gpt":0.343005181221167,"score_spread":0.3010508867158623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171387445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892377,0.0094631,0.00006349384,0.00013406953,0.00026486628,0.00025967276,0.00013005106,0.000005109671,0.00044190956],"genre_scores_gemma":[0.99445844,0.003516438,0.00014813722,0.000024834731,0.0005697031,0.000021746697,0.000010329738,0.000017543565,0.0012328093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983563,0.00014492948,0.00021218933,0.00046738744,0.00043079417,0.0003883984],"domain_scores_gemma":[0.9988413,0.00003773958,0.00011924558,0.0005409585,0.00031447568,0.00014628438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033988454,0.00015405126,0.00029847043,0.0001128698,0.00009274161,0.000013588913,0.00025966286,0.00017709918,0.00004250673],"category_scores_gemma":[0.0001011899,0.00014057982,0.00008351758,0.00021459426,0.00031332884,0.0000133264675,0.00012951676,0.00022716398,8.6368124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007124237,0.00014398366,0.0005664008,0.00011096,0.000021104393,0.0000013386297,0.000107989035,0.0000050635867,0.97800326,0.000013386735,0.008641232,0.011672825],"study_design_scores_gemma":[0.0010738677,0.00027065497,0.034079496,0.00006243358,0.0000118570215,0.0000020653206,0.00003508414,0.0000062794165,0.93973416,0.00006526711,0.024526166,0.00013265788],"about_ca_topic_score_codex":0.0005648248,"about_ca_topic_score_gemma":0.00013192215,"teacher_disagreement_score":0.03826912,"about_ca_system_score_codex":0.000039134182,"about_ca_system_score_gemma":0.00031818176,"threshold_uncertainty_score":0.57326794},"labels":[],"label_agreement":null},{"id":"W2171506563","doi":"10.1158/0008-5472.can-11-2531","title":"Hedgehog and Notch Signaling Regulate Self-Renewal of Undifferentiated Pleomorphic Sarcomas","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; University of Toronto; SickKids Foundation; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Hedgehog; Sarcoma; Cancer research; Biology; Hedgehog signaling pathway; Population; Rhabdomyosarcoma; Pathology; Notch signaling pathway; Cancer; Cancer stem cell; Stem cell; Medicine; Signal transduction; Cell biology; Genetics","score_opus":0.08035227192172416,"score_gpt":0.37615524316394094,"score_spread":0.2958029712422168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171506563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865925,0.012620441,0.0000638094,0.00011413591,0.00012632067,0.0002057037,0.000026476164,0.000017336082,0.00023330332],"genre_scores_gemma":[0.99799377,0.00089027116,0.00018819625,0.00002167904,0.00038880567,0.00004981731,0.000028412973,0.000032491578,0.0004065413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983081,0.00022797441,0.00022056498,0.00030467522,0.00033642218,0.00060221215],"domain_scores_gemma":[0.9991073,0.000060672708,0.00006111693,0.0003037319,0.00029441126,0.0001727781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008533041,0.00014824232,0.00021227988,0.0001121898,0.00017106583,0.000019079072,0.00019406507,0.00014199065,0.00004572019],"category_scores_gemma":[0.000118751035,0.00013605926,0.000053517204,0.00023186141,0.00027331768,0.000005454918,0.00030837255,0.00019132398,0.000006520004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074923024,0.000069029375,0.026854958,0.00011035033,0.00015813237,0.0000014154166,0.0005242483,0.000011707886,0.97114974,0.00008463475,0.00045413588,0.0005067335],"study_design_scores_gemma":[0.0005351392,0.000161554,0.008723248,0.00006609578,0.000025179326,0.000005124989,0.00016498826,0.000014780776,0.98634374,0.000093307106,0.0036948582,0.00017200453],"about_ca_topic_score_codex":0.00014405811,"about_ca_topic_score_gemma":0.00004432401,"teacher_disagreement_score":0.01813171,"about_ca_system_score_codex":0.00003814371,"about_ca_system_score_gemma":0.00013382376,"threshold_uncertainty_score":0.55483353},"labels":[],"label_agreement":null},{"id":"W2171516947","doi":"","title":"Importin-β mediates Cdc7 nuclear import by binding to Kinase Insert II, which can be antagonized by importin-α","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Importin; Cell biology; Nuclear transport; Biology; Nuclear localization sequence; Cell nucleus; Molecular biology; Nucleus","score_opus":0.03306352115289781,"score_gpt":0.35713494744551205,"score_spread":0.32407142629261426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171516947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677672,0.0039919014,0.0000056839385,0.022417495,0.00040409484,0.0016906884,0.00069363666,0.0002513898,0.0027779257],"genre_scores_gemma":[0.9885566,0.0007114052,0.00014040661,0.0016448332,0.00057093444,0.00046843968,0.00090316194,0.00026914905,0.0067350357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934771,0.00016537565,0.0010631906,0.0012048259,0.002095097,0.0019944198],"domain_scores_gemma":[0.99670875,0.00008887421,0.00026366257,0.0010368924,0.00079637824,0.0011054177],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001796061,0.00047511264,0.0008026269,0.0006541873,0.00062997773,0.00011977696,0.0005267649,0.00039887775,0.0017800402],"category_scores_gemma":[0.00066817994,0.00046440458,0.0001899758,0.0025297673,0.0002572295,0.0001347105,0.0004880935,0.0015189322,0.00010601522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042852532,0.00018331007,0.005484336,0.00007356902,0.00007336647,0.00021117012,0.00026171588,0.00000467664,0.5940975,0.000025475201,0.3981515,0.0010049003],"study_design_scores_gemma":[0.0038486656,0.0009214293,0.0016694124,0.000317947,0.00009221778,0.00007772211,0.00043664325,0.000072293726,0.5591011,0.00003075069,0.4328113,0.00062052807],"about_ca_topic_score_codex":0.017611276,"about_ca_topic_score_gemma":0.0027689869,"teacher_disagreement_score":0.034996375,"about_ca_system_score_codex":0.0017512782,"about_ca_system_score_gemma":0.0018408286,"threshold_uncertainty_score":0.9997808},"labels":[],"label_agreement":null},{"id":"W2171698012","doi":"10.1158/0008-5472.can-14-1891","title":"The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Neurofibromatosis; Cyclase; Adenylate kinase; Glioma; Neurofibromatosis type I; Cancer research; Biology; Internal medicine; Endocrinology; Medicine; Genetics","score_opus":0.06957043517227356,"score_gpt":0.35220530335422934,"score_spread":0.28263486818195577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171698012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964544,0.0011266833,0.0000029025007,0.0005189434,0.00019362391,0.0005038052,0.00004400319,0.000021264063,0.0011343501],"genre_scores_gemma":[0.99782115,0.0012249447,0.000027014372,0.00007912334,0.000107683416,0.00009070819,0.0000071635604,0.000042312953,0.0005998867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714875,0.0005300096,0.0004092125,0.00041372192,0.0009513079,0.0005470131],"domain_scores_gemma":[0.9978975,0.0006172226,0.00009916977,0.00081549684,0.00039505574,0.00017552901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009143521,0.00015215273,0.00032891735,0.00027890113,0.00021990492,0.000050428716,0.00028568477,0.000088987144,0.00014802095],"category_scores_gemma":[0.00041539158,0.000103111764,0.00009735173,0.0010610418,0.0002843538,0.00006565254,0.0001542358,0.00050271826,0.00009905757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001994051,0.00062008004,0.64714843,0.00030955966,0.00007916977,0.000059106478,0.0016159324,0.000012984431,0.24464111,0.0007791072,0.03546635,0.06727411],"study_design_scores_gemma":[0.003443388,0.0016078737,0.55194205,0.00036882062,0.000019448942,0.000021347028,0.00022315868,0.00026010672,0.26557156,0.000648727,0.17560919,0.000284371],"about_ca_topic_score_codex":0.00060094445,"about_ca_topic_score_gemma":0.00004500375,"teacher_disagreement_score":0.14014283,"about_ca_system_score_codex":0.00008396042,"about_ca_system_score_gemma":0.00013906637,"threshold_uncertainty_score":0.42047757},"labels":[],"label_agreement":null},{"id":"W2171828042","doi":"10.1158/0008-5472.can-12-4367","title":"Integration of High-Resolution Methylome and Transcriptome Analyses to Dissect Epigenomic Changes in Childhood Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval; McGill University and Génome Québec Innovation Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"McGill University","keywords":"DNA methylation; Biology; Epigenetics; Epigenomics; CpG site; Methylation; Genetics; Transcriptome; Differentially methylated regions; Gene; Gene expression","score_opus":0.04827228430854968,"score_gpt":0.3793679656628081,"score_spread":0.33109568135425843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171828042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417955,0.0033035872,0.0016693263,0.000294298,0.000052786407,0.00042099282,0.000029323857,0.0000035235319,0.00004659998],"genre_scores_gemma":[0.99632317,0.0027759576,0.00038508588,0.00002283333,0.00009241665,0.00021107084,0.00005500907,0.000016529151,0.000117957265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888426,0.00015153697,0.00019122104,0.0003105756,0.00019130195,0.00027111717],"domain_scores_gemma":[0.9994474,0.000033603472,0.000037880225,0.00020043812,0.00018303632,0.00009763895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038411486,0.000104484774,0.00016433194,0.00028250366,0.000053850188,0.00002871356,0.00012968256,0.000104789164,0.000040886105],"category_scores_gemma":[0.00009445406,0.00009339269,0.00002978488,0.00034566343,0.00007753931,0.0000072883677,0.000061936975,0.00010121515,0.0000050141643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005040329,0.000020516132,0.0005317974,0.000015749933,0.000039253504,3.9415215e-7,0.0003054486,0.00045931397,0.9869853,0.000027942971,0.000035894707,0.0115279555],"study_design_scores_gemma":[0.0003235086,0.0003375889,0.16186206,0.0000310136,0.000012900426,3.6613852e-7,0.00010639977,0.00014204431,0.83662623,0.00033966365,0.00012555013,0.000092670154],"about_ca_topic_score_codex":0.0032389034,"about_ca_topic_score_gemma":0.0023687368,"teacher_disagreement_score":0.16133027,"about_ca_system_score_codex":0.00012278206,"about_ca_system_score_gemma":0.00013677658,"threshold_uncertainty_score":0.48962745},"labels":[],"label_agreement":null},{"id":"W2171943253","doi":"10.1158/0008-5472.can-07-2222","title":"Dietary Feeding of Silibinin Inhibits Prostate Tumor Growth and Progression in Transgenic Adenocarcinoma of the Mouse Prostate Model","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Silymarin and Mushroom Poisoning","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Silibinin; Tramp; Endocrinology; Prostate; Internal medicine; Prostate cancer; Cyclin-dependent kinase; Adenocarcinoma; Proliferating cell nuclear antigen; Medicine; Genetically modified mouse; Cancer research; Biology; Cancer; Transgene; Cell cycle; Biochemistry; Immunohistochemistry","score_opus":0.074247854662248,"score_gpt":0.3948371824294836,"score_spread":0.32058932776723564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171943253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526316,0.0024489285,0.0000031372497,0.00057260506,0.000027465563,0.001209177,0.000011803708,0.000013020882,0.00045070116],"genre_scores_gemma":[0.99886584,0.00034674807,0.00017817841,0.00003711448,0.000032627282,0.000074187745,0.0000028949828,0.000029708212,0.0004326767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981149,0.00007499822,0.00038614852,0.00028938142,0.0006423045,0.0004923062],"domain_scores_gemma":[0.99926174,0.00009783922,0.00008250012,0.00021638177,0.0002104581,0.0001310872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013505038,0.00011868638,0.00027846434,0.0002836633,0.00007398096,0.000008502641,0.00013291024,0.00006267445,0.000008430113],"category_scores_gemma":[0.00016681936,0.00008013645,0.000053260042,0.00067688257,0.0003795449,0.00009507981,0.00014018049,0.0005393345,3.3793722e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012370787,0.000091192735,0.27849427,0.0008923333,0.0000156313,0.0000131292545,0.004838096,0.000029157913,0.7083357,0.000044190925,0.000043145257,0.005966076],"study_design_scores_gemma":[0.0018081049,0.0002970846,0.18990122,0.0010905305,0.000014015533,0.000008490517,0.00071264466,0.0009120425,0.8050796,0.00009824333,0.0000047209846,0.00007331138],"about_ca_topic_score_codex":0.00044264592,"about_ca_topic_score_gemma":0.00018226166,"teacher_disagreement_score":0.09674391,"about_ca_system_score_codex":0.00009995911,"about_ca_system_score_gemma":0.0003792964,"threshold_uncertainty_score":0.32678697},"labels":[],"label_agreement":null},{"id":"W2171975491","doi":"10.1158/0008-5472.can-05-0500","title":"Identification of a Novel c-Myc Protein Interactor, JPO2, with Transforming Activity in Medulloblastoma Cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Gene knockdown; Oncogene; RNA interference; Neoplastic transformation; Phenotype; Malignant transformation; Cell culture; Carcinogenesis; Cancer; Genetics; Cell cycle; Gene","score_opus":0.02199951625043125,"score_gpt":0.3330921519943288,"score_spread":0.31109263574389756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171975491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975442,0.00009912698,0.0016067533,0.00018313777,0.000019344632,0.00038239904,0.000030533545,0.0000024810456,0.00013201984],"genre_scores_gemma":[0.99894816,0.000069419715,0.00034248663,0.0000069317935,0.000058642167,0.00013616182,0.0000077561335,0.000016409582,0.00041401407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914813,0.000039074333,0.00016504861,0.00022830229,0.00019475917,0.00022468923],"domain_scores_gemma":[0.9995398,0.000009221225,0.000056054763,0.00021964873,0.0001319141,0.000043390373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003730319,0.000076081364,0.00009567297,0.00008421564,0.000034942164,0.000017473916,0.0001852687,0.00007260272,0.000013746832],"category_scores_gemma":[0.000015702579,0.00006938781,0.000027949987,0.00015813572,0.00008599826,0.0000075440316,0.000044922635,0.00015852567,0.0000019519584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018653086,0.0001381827,0.00020158847,0.00005868042,0.000013948335,5.0072833e-7,0.00019171042,0.00053600874,0.9928798,0.000027992597,0.000016973447,0.005748081],"study_design_scores_gemma":[0.00054448145,0.00014070871,0.00074488483,0.000057565518,0.0000019884287,0.0000014384323,0.00009240605,0.0017706555,0.995454,0.000006635945,0.0011058645,0.000079346035],"about_ca_topic_score_codex":0.0001671932,"about_ca_topic_score_gemma":0.0019267738,"teacher_disagreement_score":0.0056687347,"about_ca_system_score_codex":0.00008629482,"about_ca_system_score_gemma":0.0001956251,"threshold_uncertainty_score":0.2829553},"labels":[],"label_agreement":null},{"id":"W2172088918","doi":"10.1158/0008-5472.can-05-4251","title":"Chromatin Modification of the <i>Trefoil Factor 1</i> Gene in Human Breast Cancer Cells by the Ras/Mitogen-Activated Protein Kinase Pathway","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Molecular biology; Protein kinase A; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Biology; Histone H3; Kinase; c-Raf; MAP kinase kinase kinase; Cyclin-dependent kinase 2; Mitogen-activated protein kinase; Cancer research; Cyclin-dependent kinase 9; Histone; Cell biology; Biochemistry; Gene","score_opus":0.019682331430754,"score_gpt":0.31315643754767825,"score_spread":0.29347410611692426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172088918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951793,0.0030671346,0.0000058943738,0.00043255932,0.00007142901,0.0007940916,0.00027640068,0.000006359294,0.00016684642],"genre_scores_gemma":[0.99728626,0.0001761346,0.000003914976,0.000020663017,0.00015206505,0.0004571965,0.000056819983,0.000027211488,0.001819757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844354,0.00035766605,0.00021403933,0.00030380944,0.00032971008,0.00035121848],"domain_scores_gemma":[0.99923533,0.000014914364,0.000095887626,0.0004510999,0.00015648888,0.000046260324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028839742,0.00013431975,0.000121289304,0.00004139916,0.00019155248,0.000023373112,0.00039791805,0.00017973804,0.000038563747],"category_scores_gemma":[0.000011861348,0.000079758145,0.00006880402,0.00035650228,0.0002659171,0.0000050404524,0.00011676187,0.0003440134,0.0000027698632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082249484,0.00009032145,0.0005738888,0.00003199728,0.000023596784,9.450989e-7,0.000061368395,0.00014401232,0.99542433,0.00001715353,0.0021285051,0.0014216423],"study_design_scores_gemma":[0.0005383781,0.00005551355,0.0030972133,0.000054570315,0.0000036727902,0.0000015751117,0.000024808747,0.000023038427,0.9944961,0.000020939611,0.0015843463,0.00009983731],"about_ca_topic_score_codex":0.00510445,"about_ca_topic_score_gemma":0.0002643203,"teacher_disagreement_score":0.00484013,"about_ca_system_score_codex":0.00011604036,"about_ca_system_score_gemma":0.00025764253,"threshold_uncertainty_score":0.7716436},"labels":[],"label_agreement":null},{"id":"W2172170762","doi":"10.1158/0008-5472.can-05-1479","title":"Oncogenes and Angiogenesis: Down-regulation of Thrombospondin-1 in Normal Fibroblasts Exposed to Factors from Cancer Cells Harboring Mutant Ras","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Angiogenesis; Thrombospondin 1; Cancer cell; Stromal cell; Biology; Paracrine signalling; Cell culture; Cancer research; Cell biology; Cancer; Receptor; Biochemistry; Genetics","score_opus":0.04979805484174815,"score_gpt":0.35437807785560627,"score_spread":0.3045800230138581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172170762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090284,0.008135122,0.000061284016,0.0001743658,0.00012184075,0.0003169454,0.0002166053,0.000006458985,0.00006456203],"genre_scores_gemma":[0.99644935,0.0023581472,0.00022831427,0.00004845585,0.00050722284,0.0001407428,0.000032541553,0.00003485723,0.00020038671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983269,0.00010062547,0.00028916303,0.00049721677,0.00033864897,0.00044746764],"domain_scores_gemma":[0.99926287,0.00004080006,0.000065544715,0.00029563523,0.00017892483,0.00015624825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002829951,0.00017738753,0.00023949977,0.00018773295,0.000085696396,0.000027052012,0.00022153014,0.00015941892,0.00033604304],"category_scores_gemma":[0.000021245223,0.00016401938,0.00008071099,0.00034001406,0.00011051286,0.000015434589,0.00018780571,0.0000865872,0.0000048100624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100902,0.000041374034,0.03701621,0.000026458123,0.000056973397,7.3138e-7,0.00037970967,0.0022476292,0.9515591,0.00000672848,0.00038207896,0.00807292],"study_design_scores_gemma":[0.0004229211,0.000121069635,0.1260637,0.00007878386,0.000010642842,2.2905594e-7,0.00016927217,0.00004246251,0.8677589,0.000005984822,0.005156444,0.00016956028],"about_ca_topic_score_codex":0.002533248,"about_ca_topic_score_gemma":0.00367424,"teacher_disagreement_score":0.0890475,"about_ca_system_score_codex":0.00014183969,"about_ca_system_score_gemma":0.00024096233,"threshold_uncertainty_score":0.6688516},"labels":[],"label_agreement":null},{"id":"W2173198068","doi":"","title":"Inhibition of STAT3 using shRNA inhibits Thymidine Kinase (TK) mediated glioma cell death in vitro and abrogates Flt3L and TK dependent tumor regression in vivo.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Small hairpin RNA; Cancer research; Immune system; Biology; Immunotherapy; Glioma; STAT3; In vivo; Immunology; Signal transduction; Cell culture; Cell biology; Gene knockdown","score_opus":0.04974931770559396,"score_gpt":0.34278760509905043,"score_spread":0.2930382873934565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173198068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493265,0.004653781,0.0000060760917,0.000038699043,0.000025552004,0.00021711997,0.000057054047,0.000002800528,0.000066254215],"genre_scores_gemma":[0.99585426,0.0038760928,0.0000695272,0.000023559438,0.000047171314,0.000028776316,0.000032251763,0.000014310315,0.0000540419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987265,0.00013595608,0.00023413994,0.0003516012,0.00024244086,0.00030940276],"domain_scores_gemma":[0.9995174,0.00002935225,0.000058277285,0.00014880276,0.00015470119,0.0000914913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003421204,0.00012178753,0.0001728571,0.00026557464,0.00006596562,0.000014100793,0.00007811759,0.0001051847,0.000019334771],"category_scores_gemma":[0.000069099005,0.000108266846,0.000020357831,0.00023609075,0.00015346806,0.000014556865,0.00019624726,0.00018726608,8.0988315e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061049813,0.00006835436,0.017563762,0.00007470027,0.0000051081897,0.00013182758,0.00020785825,0.000030149171,0.9809981,9.269612e-7,0.00007781721,0.00023089518],"study_design_scores_gemma":[0.0011272987,0.00022210584,0.0030640494,0.00022259833,0.0000025608513,0.00002583257,0.00022648864,0.00026038426,0.9946877,0.000025330432,0.000025777235,0.000109870845],"about_ca_topic_score_codex":0.0013710816,"about_ca_topic_score_gemma":0.00041124347,"teacher_disagreement_score":0.014499713,"about_ca_system_score_codex":0.0000587925,"about_ca_system_score_gemma":0.00015712669,"threshold_uncertainty_score":0.44149938},"labels":[],"label_agreement":null},{"id":"W2173695568","doi":"10.1158/1538-7445.am2015-4934","title":"Abstract 4934: Mosaic RNase IIIb domain <i>DICER1</i> mutations in children with multiple primary tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Sanger sequencing; Missense mutation; Molecular biology; Nonsense mutation; Cancer research; Germline; Mutation; Germline mutation; Biology; Medicine; Genetics; Gene","score_opus":0.06101314830557921,"score_gpt":0.369203597339705,"score_spread":0.3081904490341258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173695568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859497,0.0019468303,0.000008055387,0.0017052362,0.00003369605,0.0013091568,0.00009224533,0.000054243053,0.008900819],"genre_scores_gemma":[0.9977307,0.00010053833,0.00037977527,0.00019737346,0.0001563614,0.0006439275,0.000090777066,0.000045719516,0.00065482885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975288,0.00011055792,0.0003027661,0.00037372648,0.0010666111,0.0006175393],"domain_scores_gemma":[0.9985055,0.00025557773,0.000048077894,0.00038198842,0.0004015681,0.00040731236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010052779,0.0001711129,0.00035009102,0.00032580193,0.00011895077,0.000036401227,0.00017602213,0.000063194704,0.0001499807],"category_scores_gemma":[0.00039710588,0.00013580656,0.00004386043,0.00083379,0.00037090757,0.00013606137,0.00012756903,0.0006534393,0.0001771725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072846096,0.00041557782,0.9681268,0.0001933719,0.00024131818,0.00034634504,0.0035616152,0.000097082564,0.005561791,0.000035168232,0.009135912,0.011556555],"study_design_scores_gemma":[0.006183703,0.00025919813,0.9871325,0.0003655622,0.000030156954,0.00006420864,0.0018595436,0.000031662727,0.0012659247,0.00022125621,0.002370401,0.0002159156],"about_ca_topic_score_codex":0.003618482,"about_ca_topic_score_gemma":0.003035808,"teacher_disagreement_score":0.019005666,"about_ca_system_score_codex":0.00083605264,"about_ca_system_score_gemma":0.0014483104,"threshold_uncertainty_score":0.5538031},"labels":[],"label_agreement":null},{"id":"W2174381910","doi":"10.1158/0008-5472.can-15-0885","title":"SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer; Biology; Signal transduction; Medicine; Cell biology; Genetics; KRAS","score_opus":0.2255534121920662,"score_gpt":0.46030897323501113,"score_spread":0.23475556104294493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174381910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862538,0.0045598047,0.000914207,0.0060080057,0.00017368882,0.0004976064,0.00013209808,0.000010342871,0.0014504693],"genre_scores_gemma":[0.9983558,0.0003415037,0.000114759,0.0003224819,0.00040392773,0.00013136437,0.00011193695,0.000024328792,0.00019387504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977212,0.00076963095,0.00036105065,0.0002939225,0.00054179516,0.0003124206],"domain_scores_gemma":[0.9980303,0.0005205941,0.00014569717,0.00038369332,0.0008384546,0.000081273094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029326025,0.00011204057,0.00013553117,0.00003891324,0.00019090321,0.00004079011,0.0005091936,0.00012352118,0.000038733077],"category_scores_gemma":[0.0010447693,0.00007183646,0.00007320516,0.0002792693,0.00048533746,0.000008353609,0.000114833834,0.00030397368,0.000009184656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000874627,0.000042221196,0.009456081,0.00003107954,0.00009946838,0.0000012932283,0.0010662748,0.00017723131,0.95500875,0.00016535507,0.027801987,0.005275641],"study_design_scores_gemma":[0.002549526,0.0015883293,0.0061453525,0.00012759939,0.000069982314,0.000011490285,0.0021393297,0.0010548191,0.8797961,0.0019301447,0.10414033,0.00044703318],"about_ca_topic_score_codex":0.00028710274,"about_ca_topic_score_gemma":0.000105270046,"teacher_disagreement_score":0.07633834,"about_ca_system_score_codex":0.00006436406,"about_ca_system_score_gemma":0.00045818114,"threshold_uncertainty_score":0.2929406},"labels":[],"label_agreement":null},{"id":"W2174841492","doi":"10.1158/1538-7445.am2015-lb-297","title":"Abstract LB-297: Integrative analysis identifies driver lncRNAs in prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Prostate cancer; Epigenetics; Gene; Biology; Genome-wide association study; Genetics; Cancer; Genome; MALAT1; Germline; Computational biology; Cancer research; Long non-coding RNA; Single-nucleotide polymorphism; RNA; Genotype","score_opus":0.052107093550969444,"score_gpt":0.41435591867187155,"score_spread":0.3622488251209021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174841492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706913,0.008313403,0.00044621306,0.0006492355,0.00027083923,0.0007884903,0.00013710743,0.000019542329,0.0023060653],"genre_scores_gemma":[0.98807436,0.003156087,0.000058017602,0.00008412382,0.00025226074,0.0008645883,0.0001273962,0.00005367142,0.007329502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996397,0.00034780274,0.000349438,0.00086574693,0.0011119371,0.0009280772],"domain_scores_gemma":[0.99765605,0.00003734924,0.00007967332,0.0006598635,0.0012013074,0.0003657748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001579591,0.00025156903,0.0003411326,0.00079671096,0.00012646677,0.00014878564,0.00061435206,0.00022874564,0.000497509],"category_scores_gemma":[0.00037789904,0.00022869886,0.00018049878,0.0021412834,0.00035448043,0.000021643307,0.00044487242,0.0008516495,0.00006489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084070343,0.00012710087,0.0041474127,0.000057011926,0.00091372384,0.000118956435,0.0013197715,0.0060230964,0.9593912,0.0000998052,0.021949595,0.0050116475],"study_design_scores_gemma":[0.0018833099,0.00028923035,0.008376742,0.00014254301,0.000084715044,0.0000037603218,0.0020841497,0.00039340107,0.95418155,0.0004789229,0.03157481,0.0005068842],"about_ca_topic_score_codex":0.009258974,"about_ca_topic_score_gemma":0.02869819,"teacher_disagreement_score":0.019439215,"about_ca_system_score_codex":0.00062932086,"about_ca_system_score_gemma":0.0015872397,"threshold_uncertainty_score":0.9973385},"labels":[],"label_agreement":null},{"id":"W2175306372","doi":"10.1158/1538-7445.am2015-lb-302","title":"Abstract LB-302: PTP1B regulates the Moyamoya disease-associated E3 ligase, RNF213 and cellular dioxygenase activity to allow breast tumor survival in hypoxia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Programmed cell death; Apoptosis; Hypoxia (environmental); Biology; Ubiquitin ligase; Chemistry; Biochemistry; Ubiquitin; Gene","score_opus":0.058987583390966374,"score_gpt":0.34270564066659026,"score_spread":0.2837180572756239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175306372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426645,0.0023244068,0.0000086979735,0.002194566,0.000091478396,0.0004582752,0.00025070366,0.0000106238085,0.00039482344],"genre_scores_gemma":[0.9977527,0.00027331072,0.000009471232,0.000091051035,0.00022982233,0.00030952765,0.00005935126,0.000032473432,0.0012422876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809,0.00024111656,0.00017057522,0.00051749084,0.00045269722,0.00052811997],"domain_scores_gemma":[0.9985471,0.00004789829,0.00005032577,0.0005752401,0.00032879272,0.00045066688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001210396,0.00016492681,0.00016622548,0.00008422346,0.00017388405,0.00010331924,0.00036245334,0.0000915534,0.000048492064],"category_scores_gemma":[0.00025442376,0.00013059439,0.000055660148,0.00032348983,0.00020093516,0.000012737341,0.00022003318,0.00027620097,0.000019856707],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006472619,0.00018804945,0.006778165,0.000027373015,0.000054321295,0.000030133342,0.0001356754,0.00032416562,0.98056346,0.00005152681,0.0072546448,0.0039452016],"study_design_scores_gemma":[0.0012345117,0.00015783701,0.6687072,0.00008437882,0.000015534273,0.0000041243047,0.00032786274,0.00020133246,0.31583548,0.00033810476,0.012694631,0.00039900374],"about_ca_topic_score_codex":0.0019900699,"about_ca_topic_score_gemma":0.0014939068,"teacher_disagreement_score":0.664728,"about_ca_system_score_codex":0.00018033186,"about_ca_system_score_gemma":0.0005618663,"threshold_uncertainty_score":0.5325485},"labels":[],"label_agreement":null},{"id":"W2175533780","doi":"10.1158/1538-7445.am2015-2429","title":"Abstract 2429: Nestin expression in tumor cells is associated with BRCA1 positive genotype and a basal-like phenotype in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Breast cancer; Nestin; Metastasis; Cancer; Immunohistochemistry; Triple-negative breast cancer; Pathology; Medicine; Cancer stem cell; Cancer research; CA15-3; Metastatic breast cancer; Internal medicine; Biology; Oncology; Stem cell; Neural stem cell; Genetics","score_opus":0.03051820449334208,"score_gpt":0.3513402822029995,"score_spread":0.3208220777096574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175533780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996705,0.0012180957,0.000050768078,0.00091497635,0.000021302763,0.0004166508,0.00019999396,0.000008394438,0.00046484286],"genre_scores_gemma":[0.9982393,0.0003716792,0.00017701794,0.00045601444,0.00006131752,0.00037014126,0.000069521906,0.000025986537,0.00022906571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985929,0.00014738673,0.00017109122,0.00048491094,0.00022944609,0.0003742524],"domain_scores_gemma":[0.9992023,0.000028383769,0.00006090048,0.00027449918,0.00029541223,0.00013850503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059541845,0.00013319931,0.0001606971,0.00010897174,0.000056342593,0.000027662429,0.0002045223,0.00016297217,0.00005063873],"category_scores_gemma":[0.000040213898,0.000111224836,0.00001997914,0.00032293022,0.00017052385,0.0000059273007,0.00016202756,0.00030749876,0.0000036709075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027569782,0.00009237073,0.027567696,0.000009633962,0.000012564632,0.000025781268,0.00011260339,0.000035871526,0.9632498,0.0000114832665,0.007804009,0.00080251216],"study_design_scores_gemma":[0.0015042404,0.00023330975,0.28401914,0.00026522216,0.0000073689225,0.000009199304,0.00019396696,0.000076711556,0.7087999,0.00034128755,0.004217196,0.00033242785],"about_ca_topic_score_codex":0.0024263265,"about_ca_topic_score_gemma":0.0021176143,"teacher_disagreement_score":0.25645146,"about_ca_system_score_codex":0.00016345928,"about_ca_system_score_gemma":0.00039693562,"threshold_uncertainty_score":0.4535617},"labels":[],"label_agreement":null},{"id":"W2180785957","doi":"10.1158/1538-7445.am2015-1529","title":"Abstract 1529: MYC and HIF-2alpha cooperates in oral squamous carcinoma cell self-renewal during hypoxia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Oncogene; Biology; Metastasis; Cancer; Population; Cell; Hypoxia (environmental); Cell culture; Carcinogenesis; Medicine; Cell cycle; Chemistry; Genetics","score_opus":0.05663235848603611,"score_gpt":0.35261994681017506,"score_spread":0.29598758832413896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180785957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884154,0.009046063,0.0000020472746,0.00021760647,0.0000741321,0.00020893262,0.000021275137,0.000009789157,0.0020047561],"genre_scores_gemma":[0.9970403,0.0010190136,0.0000636136,0.000030052388,0.0002138903,0.00013969782,0.000023819499,0.000024661007,0.0014449726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872017,0.0000789265,0.00015976978,0.00039587542,0.0002313864,0.00041389398],"domain_scores_gemma":[0.9992175,0.000013682579,0.000026855056,0.00029983884,0.00024554884,0.00019659194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004130262,0.0001185072,0.00012005742,0.00009435078,0.00011295485,0.00006601244,0.00020139525,0.000119574885,0.000048654998],"category_scores_gemma":[0.000043548043,0.000111921065,0.000024082168,0.00022046399,0.00010952664,0.000008783358,0.0001340387,0.00021199348,0.000016369066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018460935,0.00010153814,0.02894539,0.000063957166,0.000011559353,0.000021009218,0.00030074106,0.00016547828,0.9660691,0.000022635913,0.0029882386,0.0011257421],"study_design_scores_gemma":[0.0028080717,0.00027582,0.12376458,0.000022718497,0.000008102048,0.000012395475,0.0006726014,0.000079704376,0.85383666,0.00007846518,0.018088648,0.00035221665],"about_ca_topic_score_codex":0.0016324956,"about_ca_topic_score_gemma":0.00080814766,"teacher_disagreement_score":0.112232424,"about_ca_system_score_codex":0.00012893115,"about_ca_system_score_gemma":0.00047385614,"threshold_uncertainty_score":0.45640084},"labels":[],"label_agreement":null},{"id":"W2186648481","doi":"","title":"Kinetics of chromatin activation and active DNA demethylation in vertebrate cells: Histone acetylation sets the stage for demethylase interactions with DNA resulting in demethylation","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Epigenomics; Trichostatin A; DNA demethylation; DNA methylation; Epigenome; Molecular biology; Histone methylation; Biology; Histone methyltransferase; Chromatin; Histone; Histone code; Demethylase; Chemistry; Histone deacetylase; Biochemistry; DNA; Gene expression; Nucleosome; Gene","score_opus":0.053230075220118946,"score_gpt":0.39765743222014305,"score_spread":0.3444273570000241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186648481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848105,0.00048307716,0.01317,0.00043308915,0.000057988855,0.000934675,0.00003485846,0.000004854974,0.00007097177],"genre_scores_gemma":[0.99698305,0.0003915361,0.0020899454,0.000014985803,0.00007082168,0.0002469433,0.00012540727,0.000026353275,0.00005098512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844974,0.00027728325,0.00036427798,0.0003571244,0.00028582825,0.00026577132],"domain_scores_gemma":[0.9988205,0.0002450274,0.00020781904,0.00022969668,0.0004515153,0.000045457295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010107943,0.00013258249,0.0001497479,0.0002668614,0.00011660578,0.00002656467,0.000109017434,0.0001293593,0.000006202859],"category_scores_gemma":[0.0005404421,0.00011350298,0.000028416733,0.0005121996,0.00013416051,0.00003670414,0.000057968304,0.00023596517,4.0179688e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048153874,0.00007112228,0.0013197149,0.00005945364,0.000020773829,2.2144425e-7,0.0008414265,0.020885602,0.96471363,0.00006733454,0.0000049149453,0.01153424],"study_design_scores_gemma":[0.0015951684,0.0003187552,0.03114996,0.000096098636,0.000009241512,1.8024615e-7,0.00049989193,0.0020875332,0.9631515,0.0005572444,0.0004149889,0.000119396725],"about_ca_topic_score_codex":0.00053581723,"about_ca_topic_score_gemma":0.0039212313,"teacher_disagreement_score":0.029830243,"about_ca_system_score_codex":0.0002551201,"about_ca_system_score_gemma":0.00014712468,"threshold_uncertainty_score":0.4628517},"labels":[],"label_agreement":null},{"id":"W2199343997","doi":"10.1158/0008-5472.can-15-0216","title":"PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreatic cancer; Biology; Cancer research; Cell cycle; Cyclin D1; Cancer; Autophagy; Cell biology; Tumor progression; Cancer cell; Apoptosis; Genetics","score_opus":0.042922699034900424,"score_gpt":0.3614243553721852,"score_spread":0.3185016563372848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199343997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845594,0.01225143,0.000025966307,0.0018577902,0.00009948283,0.00067874533,0.00018276142,0.000010693125,0.0003337083],"genre_scores_gemma":[0.99585587,0.002915533,0.00016976756,0.00010150389,0.00022542682,0.00022692964,0.000019956273,0.00004893916,0.00043607265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719214,0.00042372188,0.00024738087,0.000623927,0.0008499765,0.0006628646],"domain_scores_gemma":[0.99794143,0.00017989399,0.000044475175,0.0005546731,0.00054458366,0.0007349678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071698346,0.00021052631,0.0002470241,0.0000885502,0.00018553637,0.000077737255,0.00037462323,0.00016172913,0.00003899908],"category_scores_gemma":[0.0005225485,0.00014750402,0.00004535817,0.00029221727,0.00095721055,0.000020043828,0.00067484175,0.00030450322,0.0000061743654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012341236,0.000115359835,0.0036029872,0.0006621183,0.000027029078,0.000012798314,0.00058132515,0.00011028952,0.98333764,0.00010763471,0.009535302,0.0006734154],"study_design_scores_gemma":[0.00080131216,0.0003928031,0.0011713076,0.00015581808,0.000022862565,0.0000019990541,0.00044022332,0.0002265735,0.99231744,0.00037619012,0.003896288,0.00019719612],"about_ca_topic_score_codex":0.0006232075,"about_ca_topic_score_gemma":0.00007992727,"teacher_disagreement_score":0.011296448,"about_ca_system_score_codex":0.00006957567,"about_ca_system_score_gemma":0.0008405884,"threshold_uncertainty_score":0.6015039},"labels":[],"label_agreement":null},{"id":"W2200338017","doi":"10.1158/1538-7445.sabcs14-p4-07-10","title":"Abstract P4-07-10: MiRNAs are important regulators of Pax-5 expression and function during breast cancer progression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Université de Moncton","funders":"","keywords":"microRNA; Biology; Cancer; Cancer research; Breast cancer; Untranslated region; Regulation of gene expression; Cancer cell; Gene; Genetics; Messenger RNA","score_opus":0.037640675093471576,"score_gpt":0.3629690682264356,"score_spread":0.325328393132964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200338017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120426,0.008024199,0.000005191511,0.00016433625,0.00010464163,0.00030862534,0.000080566766,0.000011319435,0.0000968727],"genre_scores_gemma":[0.9983156,0.0007834849,0.000028128896,0.000006144753,0.00034508965,0.00013091022,0.000042674834,0.000029078283,0.00031893526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984918,0.000083295796,0.0002486252,0.00039799098,0.00047500822,0.00030322792],"domain_scores_gemma":[0.9987403,0.000007729412,0.00017487237,0.000335143,0.0005093681,0.00023257219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045054947,0.00012997602,0.00013914087,0.000091697024,0.000108949804,0.000027832037,0.00012717447,0.0001615407,0.00018457447],"category_scores_gemma":[0.000057495738,0.000110190995,0.000044384215,0.00014127599,0.00016641132,0.000016008393,0.0001772308,0.00013490651,0.0000039293413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009981538,0.000048676677,0.04223145,0.00018535761,0.000027872466,0.00000376102,0.000038628084,0.000050108196,0.950704,0.0000030604833,0.003329774,0.0023791972],"study_design_scores_gemma":[0.0006089454,0.000055665616,0.34398508,0.00031573966,0.0000087623375,0.0000060186453,0.000079660516,0.000013473183,0.6530007,0.000043189164,0.001775919,0.000106856205],"about_ca_topic_score_codex":0.0001649719,"about_ca_topic_score_gemma":0.000064416854,"teacher_disagreement_score":0.30175364,"about_ca_system_score_codex":0.000112413254,"about_ca_system_score_gemma":0.0003035052,"threshold_uncertainty_score":0.44934583},"labels":[],"label_agreement":null},{"id":"W2201154982","doi":"10.1158/1538-7445.sabcs14-p6-10-17","title":"Abstract P6-10-17: Psychosocial adjustment, cancer worry and perceived risk in 6-13 year old girls from breast cancer families","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Worry; Anxiety; Daughter; Psychosocial; Breast cancer; Somatization; Psychology; Medicine; Clinical psychology; Psychiatry; Cancer; Internal medicine","score_opus":0.05133445611431508,"score_gpt":0.3884549112484147,"score_spread":0.3371204551340996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201154982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776012,0.016699217,0.000004393016,0.0012390604,0.00058828236,0.00043152948,0.0020720698,0.000016306327,0.0013479543],"genre_scores_gemma":[0.964542,0.02829262,0.000102102706,0.00024948517,0.0020493914,0.0009790678,0.000113136564,0.00006289332,0.00360933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975839,0.00018986528,0.0002833799,0.0007799523,0.000532578,0.00063028326],"domain_scores_gemma":[0.99868524,0.00004790992,0.000094578594,0.00046135427,0.00044780446,0.00026309775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049682916,0.00023907234,0.00025308083,0.00016404617,0.00014650355,0.000074521326,0.00037296946,0.00028716348,0.0014007455],"category_scores_gemma":[0.000082858234,0.00023732596,0.00006536635,0.000365309,0.00039793865,0.000020381513,0.00021211036,0.0005082005,0.000034339988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016955993,0.00020410604,0.3847849,0.00007568891,0.00040228563,0.000013015026,0.004374158,0.001523149,0.19034383,0.000011990826,0.35726455,0.05930672],"study_design_scores_gemma":[0.0027271272,0.00009032608,0.9359383,0.00014692279,0.00003452698,0.0000019066381,0.0018897926,0.00003781716,0.0064752707,0.0002029561,0.052035887,0.00041916157],"about_ca_topic_score_codex":0.04900055,"about_ca_topic_score_gemma":0.04343693,"teacher_disagreement_score":0.5511534,"about_ca_system_score_codex":0.0008347622,"about_ca_system_score_gemma":0.0015325567,"threshold_uncertainty_score":0.99951214},"labels":[],"label_agreement":null},{"id":"W2202272068","doi":"10.1158/1538-7445.sabcs14-p3-09-08","title":"Abstract P3-09-08: Patterns of oncotype DX testing and adjuvant chemotherapy use in a tertiary care centre","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cohort; Breast cancer; Internal medicine; Oncology; Cancer; Retrospective cohort study; Adjuvant chemotherapy; Stage (stratigraphy)","score_opus":0.07648407887525321,"score_gpt":0.37437022367450995,"score_spread":0.29788614479925674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202272068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934108,0.0057542664,0.0000021272567,0.00033111326,0.00004367177,0.00020867234,0.00007501376,0.0000053714034,0.00016893567],"genre_scores_gemma":[0.99878234,0.0007353773,0.00013069692,0.000056309975,0.00012077251,0.00004579885,0.000025229672,0.000021745607,0.000081721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896675,0.000056173405,0.00014171591,0.00030826477,0.00021888355,0.00030818346],"domain_scores_gemma":[0.99925834,0.000053096308,0.000039359624,0.000227163,0.00032444854,0.00009759671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016808548,0.00011459091,0.00014598516,0.00006406848,0.00003851601,0.000017093833,0.0001139045,0.000077913974,0.00001447337],"category_scores_gemma":[0.00013533866,0.000100328434,0.000023770966,0.000111110116,0.000109386594,0.0000070951896,0.0001400752,0.0001351186,0.000002285497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019537048,0.000050263967,0.9217154,0.00007683386,0.00004175671,0.000014429418,0.00089779217,0.0000148649515,0.04972204,0.0000011512518,0.00048120526,0.026788943],"study_design_scores_gemma":[0.0016894493,0.000115684066,0.92038417,0.00019825621,0.0000062892764,0.000003514624,0.0014906654,0.000005106497,0.07445315,0.00001666016,0.001511745,0.00012530525],"about_ca_topic_score_codex":0.0066458015,"about_ca_topic_score_gemma":0.0045245104,"teacher_disagreement_score":0.026663639,"about_ca_system_score_codex":0.00012221727,"about_ca_system_score_gemma":0.00024626084,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W2204391919","doi":"","title":"Anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in pancreatic and breast cancer models and recognizes CD9 on CD34+CD38- leukemic cancer stem cells.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pancreatic cancer; Cancer research; Cancer; Antibody; Monoclonal antibody; Cancer stem cell; Biology; Immunology; Medicine; Internal medicine","score_opus":0.08873852709799437,"score_gpt":0.3819003029346531,"score_spread":0.2931617758366587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204391919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784127,0.015690178,0.000007728352,0.0027199683,0.00012017083,0.0016364256,0.00021396502,0.000059145026,0.0011397072],"genre_scores_gemma":[0.8964875,0.09847623,0.000046416775,0.00039698565,0.0002885764,0.00062001485,0.000014691189,0.00012804275,0.003541553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941601,0.0004631304,0.0006118244,0.0013712978,0.0018386841,0.0015549302],"domain_scores_gemma":[0.9973103,0.00041017338,0.000110351364,0.0005752098,0.0007814399,0.0008125365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010083809,0.00047786205,0.0010144004,0.0009044156,0.00039514725,0.00009535227,0.00033135104,0.00023706707,0.0005136643],"category_scores_gemma":[0.000068407746,0.00041335117,0.00009628357,0.0015522838,0.0011432407,0.0002996152,0.00044320337,0.0017513819,0.000053057393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029844367,0.00046197604,0.22623602,0.002283561,0.0002010542,0.0018372964,0.001633847,0.00030497028,0.7341458,0.00010198734,0.005348688,0.024460336],"study_design_scores_gemma":[0.014804649,0.0012297234,0.3305857,0.008570951,0.00015754039,0.0011550047,0.0010148764,0.01332452,0.62565225,0.0006558469,0.001242116,0.0016068526],"about_ca_topic_score_codex":0.01848047,"about_ca_topic_score_gemma":0.001266016,"teacher_disagreement_score":0.10849359,"about_ca_system_score_codex":0.0013199631,"about_ca_system_score_gemma":0.0018110899,"threshold_uncertainty_score":0.99983186},"labels":[],"label_agreement":null},{"id":"W2211448663","doi":"","title":"The p15ink4B tumor suppressor is a direct target for the ZNF217 oncoprotein","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Chromatin immunoprecipitation; Molecular biology; Repressor; Gene silencing; Chromatin; Histone deacetylase; Biology; Histone deacetylase inhibitor; Histone; Chemistry; Cancer research; Gene expression; Promoter; Gene; Biochemistry","score_opus":0.07660762807839201,"score_gpt":0.39861873446373564,"score_spread":0.32201110638534364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211448663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449826,0.044713113,0.0008779824,0.005124344,0.0002956166,0.0013945972,0.00013145816,0.000010460235,0.0024698577],"genre_scores_gemma":[0.9828938,0.00576266,0.00022084576,0.00015405526,0.0007725034,0.0012016108,0.000019632369,0.000030303236,0.008944589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986846,0.00014043067,0.00014144371,0.0002885055,0.00031941623,0.00042564844],"domain_scores_gemma":[0.99884367,0.00021573476,0.000039198214,0.0005092957,0.0003219762,0.00007014863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010212128,0.00009433277,0.00008631629,0.000023245937,0.0010131814,0.000051078743,0.00041183812,0.00007012283,0.00004595676],"category_scores_gemma":[0.00037908636,0.00005455113,0.000088984474,0.00013291114,0.0003072798,0.0000023178375,0.00012920158,0.00016691067,0.000010476175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026881535,0.000027298836,0.00060902804,0.000017857858,0.00007738506,0.0000022159013,0.0002146193,0.000092792674,0.9532893,0.00010366935,0.03975873,0.0055382974],"study_design_scores_gemma":[0.00017986649,0.00013191401,0.00045091938,0.0000037092436,0.0000027403735,6.9169823e-7,0.000029802293,0.00009544328,0.541714,0.00023168307,0.45710835,0.000050869607],"about_ca_topic_score_codex":0.0002337951,"about_ca_topic_score_gemma":0.000131888,"teacher_disagreement_score":0.4173496,"about_ca_system_score_codex":0.0000318343,"about_ca_system_score_gemma":0.00030373287,"threshold_uncertainty_score":0.7792675},"labels":[],"label_agreement":null},{"id":"W2212036227","doi":"","title":"Regulation of ubiquitous expression of the human growth hormone receptor (hGHR) gene","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Exon; Biology; Alternative splicing; Gene; Untranslated region; Growth hormone receptor; CpG site; Promoter; Genetics; Cancer; Cancer research; Molecular biology; Gene expression; Messenger RNA; DNA methylation; Endocrinology; Growth hormone; Hormone","score_opus":0.06568906903801716,"score_gpt":0.378826845907905,"score_spread":0.31313777686988786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212036227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940302,0.0014538462,0.00006104872,0.00041256662,0.00014678422,0.0005760331,0.000016108166,0.00002000189,0.0032834527],"genre_scores_gemma":[0.9975638,0.000335897,0.00018362846,0.000037555965,0.00034858627,0.000026339394,0.000017414417,0.000031554493,0.0014552282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748427,0.00012620156,0.00050524826,0.00026766982,0.0011759447,0.00044065673],"domain_scores_gemma":[0.99812096,0.00010034496,0.00016756915,0.0005545663,0.00089679885,0.0001597489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014012282,0.0001265488,0.00030027918,0.00029731216,0.00017734214,0.000006899727,0.00028723374,0.00017123282,0.00016063599],"category_scores_gemma":[0.00025072607,0.000085558604,0.00012344154,0.00090155355,0.00038734073,0.00009248251,0.00016173591,0.00047143365,0.00000895301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040761338,0.000116595926,0.01736232,0.00013068708,0.000022146389,0.0000017699127,0.0004781903,9.235125e-7,0.9688221,0.00041330443,0.011243501,0.0010008526],"study_design_scores_gemma":[0.0007260426,0.00028137438,0.26259774,0.00015431615,0.000014558012,0.0000019042579,0.00013947036,0.0000019920517,0.7348949,0.00016263379,0.00096602296,0.00005910112],"about_ca_topic_score_codex":0.0005042168,"about_ca_topic_score_gemma":0.00001151708,"teacher_disagreement_score":0.2452354,"about_ca_system_score_codex":0.00019833296,"about_ca_system_score_gemma":0.00021799782,"threshold_uncertainty_score":0.34889784},"labels":[],"label_agreement":null},{"id":"W2214296283","doi":"10.1158/1538-7445.sabcs14-p1-06-02","title":"Abstract P1-06-02: Identifying hypermethylated tumor suppressor genes in breast cancer with an in vivo total genome knockdown screen","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Small hairpin RNA; Gene knockdown; Cancer research; Breast cancer; Decitabine; DNA methylation; Cancer; Biology; Methylation; Gene; Molecular biology; Gene expression; Genetics","score_opus":0.0771920434747722,"score_gpt":0.3813666969590166,"score_spread":0.3041746534842444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214296283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278355,0.0056373496,0.000014390053,0.00036532138,0.000059029768,0.0003942911,0.0002915129,0.000010856914,0.00044371583],"genre_scores_gemma":[0.997312,0.0008478015,0.00008337238,0.000047353824,0.00032629378,0.0005284349,0.00009072155,0.000047601792,0.00071641366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978955,0.0001509252,0.00026356996,0.0006178401,0.00044092047,0.00063123624],"domain_scores_gemma":[0.99880564,0.000012369188,0.00005937455,0.0005022253,0.00037020302,0.00025016288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071023,0.00018023244,0.00020458596,0.00023088991,0.0000943649,0.00009766273,0.00039767017,0.0001283222,0.00029742086],"category_scores_gemma":[0.000020177038,0.00015938931,0.00003596325,0.0005086752,0.00016438149,0.00003400856,0.00013536052,0.000336912,0.00001086324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005478003,0.000113108574,0.016900975,0.000033926644,0.000031248062,0.00003354751,0.00018108237,0.0032298919,0.976488,0.000008881562,0.0004492049,0.0019823117],"study_design_scores_gemma":[0.0039617084,0.00038171007,0.45301014,0.00023758756,0.000017768922,0.000069596426,0.001585806,0.00048623743,0.5254037,0.000061678744,0.013967365,0.0008167252],"about_ca_topic_score_codex":0.010066945,"about_ca_topic_score_gemma":0.009371051,"teacher_disagreement_score":0.45108435,"about_ca_system_score_codex":0.00027257678,"about_ca_system_score_gemma":0.0008712965,"threshold_uncertainty_score":0.9965251},"labels":[],"label_agreement":null},{"id":"W2214871002","doi":"10.1158/1538-7445.sabcs14-p4-11-03","title":"Abstract P4-11-03: Androgen receptor expression is an independent marker of lower residual risk in the TACT2 trial (CRUK/05/019)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Androgen receptor; Capecitabine; Epirubicin; Medicine; Breast cancer; Internal medicine; Oncology; Biomarker; Proportional hazards model; Cancer; Urology; Prostate cancer; Colorectal cancer; Biology","score_opus":0.09137023052310644,"score_gpt":0.3986497914847439,"score_spread":0.30727956096163744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214871002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952605,0.0022196567,0.000001829341,0.00065820524,0.000268202,0.00062784227,0.00024520772,0.0000056865238,0.0007128996],"genre_scores_gemma":[0.99744105,0.0010800036,0.00004936386,0.00007770655,0.00066681387,0.00035531636,0.00006662026,0.000027748123,0.00023535233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974239,0.00051737094,0.00028486055,0.0005045859,0.0008217008,0.00044759596],"domain_scores_gemma":[0.9987096,0.000071576316,0.000110906,0.0006622035,0.000308985,0.00013669142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017137747,0.00017674152,0.00021835086,0.00009510568,0.00012011453,0.00003709746,0.00047871814,0.00019631143,0.00020930593],"category_scores_gemma":[0.00021402615,0.00012189419,0.00007534986,0.00021127019,0.00021899946,0.000015335925,0.0002467151,0.00032502887,0.00001762961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12944715,0.002350826,0.13763234,0.00011372396,0.00046924388,0.000084907304,0.006490398,0.00008665198,0.3581936,0.00002268931,0.35227025,0.012838216],"study_design_scores_gemma":[0.041515943,0.0024858478,0.10838879,0.00019193636,0.00005545679,0.00001173582,0.004480091,0.000004439267,0.73967856,0.00026174652,0.10237713,0.0005483374],"about_ca_topic_score_codex":0.003039059,"about_ca_topic_score_gemma":0.0015273601,"teacher_disagreement_score":0.38148493,"about_ca_system_score_codex":0.000109893306,"about_ca_system_score_gemma":0.0004536376,"threshold_uncertainty_score":0.49707007},"labels":[],"label_agreement":null},{"id":"W2216093506","doi":"10.1158/1538-7445.am2015-ct329","title":"Abstract CT329: Phase I study of the PI3Kβ/δ inhibitor AZD8186 in patients with advanced castration resistant prostate cancer, triple negative breast cancer, squamous non-small cell lung cancer or PTEN deficient solid tumors: update from dose-finding","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; PTEN; Prostate cancer; Cancer; Breast cancer; PI3K/AKT/mTOR pathway; Tolerability; Internal medicine; Triple-negative breast cancer; Oncology; Adverse effect; Apoptosis; Biology","score_opus":0.03604909238887559,"score_gpt":0.36495426943045833,"score_spread":0.32890517704158273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216093506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903701,0.0026840062,0.000006618433,0.00016145948,0.00064250734,0.0034861628,0.002582684,0.000015577054,0.00005088624],"genre_scores_gemma":[0.9961766,0.0003941163,0.0000512403,0.000056262772,0.00038902674,0.0025143498,0.00010233876,0.0001035694,0.00021246742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99551105,0.00033559836,0.0007776495,0.0011211175,0.0012629697,0.0009915829],"domain_scores_gemma":[0.9968684,0.000078521174,0.000569081,0.00078472256,0.0014021512,0.0002971765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073242886,0.00045615475,0.0005442714,0.0002080611,0.00027906682,0.00010044511,0.00075069844,0.00018016284,0.00010630836],"category_scores_gemma":[0.00011607321,0.0003272941,0.00008263345,0.0009934618,0.00027780057,0.00005147624,0.0003192029,0.00068900245,0.0000017027929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03651564,0.0033151647,0.22442302,0.00041338292,0.00031468645,0.000047703677,0.007567257,0.035285704,0.68167657,0.0000010308635,0.0028362675,0.0076036025],"study_design_scores_gemma":[0.04345488,0.0043890197,0.22269806,0.0020145916,0.00016856247,0.0000016882141,0.00643622,0.00060707686,0.71867865,0.000015748612,0.00042131616,0.0011141971],"about_ca_topic_score_codex":0.035432555,"about_ca_topic_score_gemma":0.053668845,"teacher_disagreement_score":0.03700209,"about_ca_system_score_codex":0.0014711004,"about_ca_system_score_gemma":0.004094258,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W2216110120","doi":"","title":"Dasatinib sensitizes chronic lymphocytic leukemia lymphocytes to chemotherapeutic agents","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Chlorambucil; Chronic lymphocytic leukemia; Fludarabine; Dasatinib; Cancer research; Medicine; Leukemia; Imatinib; Immunology; Pharmacology; Chemotherapy; Internal medicine","score_opus":0.10185933044397279,"score_gpt":0.45616625495048213,"score_spread":0.35430692450650936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216110120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185664,0.0029765936,0.00020307668,0.0008957809,0.00051978306,0.0020545693,0.00001746776,0.00024992824,0.0112261465],"genre_scores_gemma":[0.9717647,0.0010105913,0.00036335262,0.0017704624,0.0018581359,0.00025609252,0.000025366951,0.00018239318,0.022768915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921622,0.00020938517,0.00068686093,0.0011555424,0.0029951194,0.0027908455],"domain_scores_gemma":[0.99511063,0.0009241739,0.00007644511,0.0014496521,0.001015227,0.0014238871],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003889912,0.00042860472,0.0006856964,0.0010481791,0.00042085646,0.00013580464,0.000666013,0.00033693764,0.0019118432],"category_scores_gemma":[0.0006800433,0.00039017614,0.00021042573,0.0025499912,0.0006509676,0.00014206249,0.000512123,0.00081459526,0.0023065072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0098739695,0.00024666017,0.00162358,0.0031418258,0.001256818,0.0043652817,0.006196458,0.002308558,0.69146633,0.0009770172,0.09927015,0.17927335],"study_design_scores_gemma":[0.041887853,0.0016244455,0.0055725505,0.0016005026,0.00011966534,0.0010090985,0.0010578911,0.016883919,0.7741118,0.00025142444,0.1549017,0.000979119],"about_ca_topic_score_codex":0.006627491,"about_ca_topic_score_gemma":0.000803735,"teacher_disagreement_score":0.28463563,"about_ca_system_score_codex":0.37927598,"about_ca_system_score_gemma":0.09464033,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2216596139","doi":"10.1158/1538-7445.sabcs14-p3-06-43","title":"Abstract P3-06-43: A genetic deletion in the uridine diphosphate glucuronosyltransferase 2B17 affects the pharmacokinetics of exemestane","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exemestane; Glucuronidation; Glucuronosyltransferase; Internal medicine; Uridine diphosphate; Pharmacokinetics; Chemistry; Uridine; Endocrinology; Medicine; Aromatase; Pharmacology; Cancer; Enzyme; Breast cancer; Biochemistry; Microsome; Gene","score_opus":0.2807887475047311,"score_gpt":0.5201519390325852,"score_spread":0.23936319152785407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216596139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654328,0.02544579,0.000043577587,0.0046290285,0.0008731366,0.0014419869,0.000115753035,0.000024974643,0.0019929314],"genre_scores_gemma":[0.98246795,0.014885615,0.00004635213,0.0012238862,0.0006152443,0.00050161267,0.000020932286,0.000044217744,0.00019420625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952721,0.0018775179,0.00050187897,0.00043847712,0.0009331561,0.0009768936],"domain_scores_gemma":[0.99752945,0.0010688602,0.000120213845,0.0004816175,0.00043565014,0.00036420286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005672392,0.00028962127,0.00034309048,0.00022877674,0.0002674082,0.000052279207,0.0012021195,0.00020190823,0.0006147209],"category_scores_gemma":[0.00018550582,0.00018955459,0.000120157405,0.0010530703,0.0006908594,0.000089692214,0.00014875278,0.0018574899,0.000086969725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026959076,0.0013647518,0.013469043,0.000372729,0.00031526975,0.0004056777,0.008193283,0.018170305,0.8008501,0.0008935145,0.04607033,0.10719912],"study_design_scores_gemma":[0.0069821193,0.00033914362,0.027139805,0.000069402464,0.00024491447,0.000034792138,0.0006893763,0.0047139516,0.49169558,0.001263355,0.46637776,0.00044980823],"about_ca_topic_score_codex":0.00033220463,"about_ca_topic_score_gemma":0.000107944325,"teacher_disagreement_score":0.42030743,"about_ca_system_score_codex":0.00013056103,"about_ca_system_score_gemma":0.00054761354,"threshold_uncertainty_score":0.80699724},"labels":[],"label_agreement":null},{"id":"W2218191974","doi":"10.1158/1538-7445.am2015-1652","title":"Abstract 1652: Therapeutic targeting of ETS factor ERG for the treatment of prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"TMPRSS2; Prostate cancer; Erg; ETS transcription factor family; Cancer research; Prostate; Transcription factor; Cancer; Fusion gene; Chromoplexy; Medicine; Biology; Internal medicine; Disease; Gene; PCA3; Genetics; Neuroscience","score_opus":0.25598791353889366,"score_gpt":0.4918970224277504,"score_spread":0.23590910888885674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218191974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9109202,0.08060437,0.00001019066,0.0043173595,0.00023667936,0.0030997668,0.00037627234,0.000018805504,0.0004163335],"genre_scores_gemma":[0.9748223,0.018564343,0.000052922755,0.000029872323,0.00032281555,0.0018839809,0.000027997115,0.0000435149,0.004252289],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769336,0.00008007994,0.00033478218,0.0003092558,0.0009340758,0.0006484481],"domain_scores_gemma":[0.99735266,0.00056305877,0.00010894658,0.0003828824,0.0013553757,0.00023708642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006903124,0.00017174531,0.00039806112,0.00017369802,0.00014245656,0.00002042913,0.00020218294,0.00008267816,0.00035960102],"category_scores_gemma":[0.00010496586,0.00009165195,0.00015639773,0.00042969442,0.00042612807,0.00006869997,0.00003789706,0.00021489996,0.0000064492397],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018706854,0.0022723216,0.13940094,0.002079653,0.0027718493,0.000045405828,0.022902869,0.00027063445,0.34567684,0.00018494995,0.01896131,0.44672638],"study_design_scores_gemma":[0.012589502,0.0050609973,0.047076553,0.0004940265,0.00018386867,0.000002338483,0.0034347007,0.00028774975,0.7954086,0.00040966272,0.13481778,0.00023419227],"about_ca_topic_score_codex":0.003406842,"about_ca_topic_score_gemma":0.00021453614,"teacher_disagreement_score":0.4497318,"about_ca_system_score_codex":0.0008703167,"about_ca_system_score_gemma":0.0020118735,"threshold_uncertainty_score":0.5150148},"labels":[],"label_agreement":null},{"id":"W2218432009","doi":"","title":"Effect of active smoking on the bronchial epithelium transcriptome","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transcriptome; Lung cancer; Medicine; Cancer; Smoking cessation; Gene; Lung; Tobacco smoke; Cohort; Lung cancer screening; Internal medicine; Pathology; Oncology; Gene expression; Biology; Genetics; Environmental health","score_opus":0.0403290505373414,"score_gpt":0.4015465566719849,"score_spread":0.36121750613464354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218432009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940081,0.0009666119,0.00019024627,0.00039819645,0.00011800646,0.00027105334,0.000024192781,0.0000031024224,0.0040204483],"genre_scores_gemma":[0.99859923,0.00026035748,0.0000030802623,0.00006564689,0.00024985542,0.000099447934,0.0000068872964,0.000013431638,0.0007020336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989715,0.00018238387,0.00010261031,0.00019713384,0.00027716195,0.00026917376],"domain_scores_gemma":[0.99938494,0.00011293515,0.000028079181,0.00031384573,0.00012278986,0.00003740492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015287811,0.00007112259,0.00007896644,0.000053656746,0.0001279953,0.00001063994,0.00024469683,0.00007292754,0.00009260269],"category_scores_gemma":[0.00007733912,0.000045354693,0.00006417669,0.00017295618,0.00018917714,0.0000018044931,0.00003072002,0.00020779284,0.00000473787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007068036,0.000018595727,0.00022568663,0.000017584187,0.00003667278,5.789638e-7,0.000101636266,0.000016237387,0.9329532,0.00035275632,0.0009445698,0.06462572],"study_design_scores_gemma":[0.00031056,0.00054110057,0.0033679868,0.000020361775,0.0000055607625,5.6929844e-7,0.00007489033,0.0000025394208,0.96400654,0.0000256474,0.03159359,0.000050662562],"about_ca_topic_score_codex":0.00014266463,"about_ca_topic_score_gemma":0.000041065727,"teacher_disagreement_score":0.064575054,"about_ca_system_score_codex":0.00004859392,"about_ca_system_score_gemma":0.00008880405,"threshold_uncertainty_score":0.18495107},"labels":[],"label_agreement":null},{"id":"W2219921700","doi":"","title":"Abberations in bilateral breast cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; CHEK2; Cancer; Concordance; PTEN; Disease; Chromosome instability; Biology; Medicine; Oncology; Genetics; Cancer research; Germline mutation; Mutation; Gene; Pathology; Chromosome; PI3K/AKT/mTOR pathway","score_opus":0.04899584717431175,"score_gpt":0.4303502968049053,"score_spread":0.3813544496305935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219921700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328065,0.0019204188,0.00022796074,0.0018224277,0.00028501803,0.00023845368,0.000086477135,0.000008555082,0.002130015],"genre_scores_gemma":[0.99518454,0.0006184123,0.00016826639,0.00023784731,0.0007416194,0.00026939606,0.000029685543,0.00002499958,0.0027252452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866426,0.000064764565,0.00017871593,0.00034259955,0.0002633748,0.00048628292],"domain_scores_gemma":[0.99928975,0.00002147691,0.000021799116,0.0002929356,0.0002827825,0.00009128302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077265984,0.000089072484,0.00007974047,0.00018622664,0.00012073733,0.000034615987,0.0002189119,0.000116664894,0.0005280929],"category_scores_gemma":[0.000030179692,0.0000884466,0.000033771194,0.00049880805,0.00015414893,0.0000059575323,0.00010322419,0.00024312935,0.000022978993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019068674,0.00006378886,0.054068852,0.000020637963,0.000036019293,0.000012170298,0.00032214512,0.0010071807,0.8991243,0.00018958481,0.02256257,0.02240203],"study_design_scores_gemma":[0.0012560637,0.0000984784,0.2619924,0.00007636176,0.000007051788,0.000030336922,0.00037651142,0.00007883056,0.5871562,0.00034686216,0.1481978,0.00038314261],"about_ca_topic_score_codex":0.0013728503,"about_ca_topic_score_gemma":0.013385518,"teacher_disagreement_score":0.31196815,"about_ca_system_score_codex":0.00043521056,"about_ca_system_score_gemma":0.0007306292,"threshold_uncertainty_score":0.74694335},"labels":[],"label_agreement":null},{"id":"W2220630609","doi":"10.1158/1538-7445.brain15-pr03","title":"Abstract PR03: Myxopapillary spinal ependymomas demonstrate a Warburg phenotype","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Filum terminale; Conus medullaris; Ependymoma; Gene expression profiling; Biology; Pathology; PKM2; Gene expression; Cancer research; Medicine; Spinal cord; Gene; Neuroscience; Genetics; Pyruvate kinase","score_opus":0.20196712409917913,"score_gpt":0.45133806725389664,"score_spread":0.2493709431547175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220630609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670599,0.009714635,0.0000018450686,0.003898684,0.00017851347,0.00056284224,0.000013211903,0.00005263998,0.018517692],"genre_scores_gemma":[0.99777025,0.00054035865,0.00013867518,0.00013162808,0.0004398754,0.00026851104,0.000015318188,0.000033106913,0.00066225254],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977722,0.00006616335,0.00020875948,0.00037501001,0.0009514683,0.0006263872],"domain_scores_gemma":[0.9983353,0.000061000363,0.000037737813,0.00040568746,0.0005221434,0.0006381172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007243409,0.00015401085,0.00026163756,0.00021015744,0.00011963295,0.000054625652,0.00014406114,0.000095603915,0.00058127375],"category_scores_gemma":[0.00015553446,0.00011875334,0.00007935206,0.00044608922,0.000175533,0.00008949688,0.00008367547,0.00043125622,0.0006650932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006914011,0.0038066234,0.23390467,0.0008416659,0.0011072257,0.018333692,0.0012564687,0.00007364691,0.1678909,0.002491454,0.18343282,0.37994683],"study_design_scores_gemma":[0.014123452,0.00449822,0.62019795,0.001546952,0.00024160251,0.00046438817,0.0013516039,0.00011809955,0.19413322,0.003113111,0.15946361,0.00074779114],"about_ca_topic_score_codex":0.0010808877,"about_ca_topic_score_gemma":0.00008213394,"teacher_disagreement_score":0.38629326,"about_ca_system_score_codex":0.00045655784,"about_ca_system_score_gemma":0.0010858244,"threshold_uncertainty_score":0.8548649},"labels":[],"label_agreement":null},{"id":"W2220722402","doi":"10.1158/1538-7445.brain15-ia18","title":"Abstract IA18: Epigenetic addiction in pediatric high-grade gliomas","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Epigenome; Epigenetics; Biology; Carcinogenesis; Chromatin; Histone; DNA methylation; Cancer research; Genetics; Epigenetic therapy; Chromatin remodeling; Cancer; Gene; Gene expression","score_opus":0.08269978511778345,"score_gpt":0.3944988315611928,"score_spread":0.3117990464434094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220722402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763835,0.02157277,0.00009117232,0.00023607904,0.000277625,0.00022235018,0.0000146546745,0.000008581063,0.0011932886],"genre_scores_gemma":[0.9916587,0.006743354,0.00011955194,0.00001581814,0.00089905947,0.000110156485,0.000069534864,0.000025751937,0.0003581095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984532,0.00014292168,0.00020873357,0.00036885482,0.00042401056,0.00040229518],"domain_scores_gemma":[0.9991824,0.00002603818,0.000042886826,0.00030917083,0.00025201714,0.00018750648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009921583,0.00010590715,0.00010363023,0.00024084176,0.00006129835,0.000036081437,0.00020114121,0.00017414252,0.00004968776],"category_scores_gemma":[0.00018649876,0.00010681778,0.000035931465,0.00047959597,0.000063622836,0.0000049292826,0.000100509584,0.00022846238,0.00004507055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019505754,0.00019262242,0.06098288,0.00004223225,0.000029036957,0.000020974894,0.00015880683,0.0028157318,0.91218644,0.00008253201,0.0051296223,0.01816407],"study_design_scores_gemma":[0.0015710352,0.0004381498,0.30574048,0.000017932005,0.000012513794,0.0000011273158,0.000083652405,0.000058183843,0.6524774,0.0014807489,0.037820127,0.0002986953],"about_ca_topic_score_codex":0.00074620853,"about_ca_topic_score_gemma":0.00071008306,"teacher_disagreement_score":0.25970906,"about_ca_system_score_codex":0.000103286235,"about_ca_system_score_gemma":0.00036968678,"threshold_uncertainty_score":0.43559027},"labels":[],"label_agreement":null},{"id":"W2220844073","doi":"","title":"Chemoprevention of colon cancer by diosgenin, a steroidal saponin constituent of fenugreek","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Azoxymethane; Diosgenin; Aberrant crypt foci; Colorectal cancer; Carcinogen; Apoptosis; Medicine; Internal medicine; Cancer; Crypt; Carcinogenesis; Endocrinology; Cancer research; Gastroenterology; Pharmacology; Biology; Biochemistry","score_opus":0.03739806597422525,"score_gpt":0.3849837133887948,"score_spread":0.34758564741456954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220844073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865909,0.011959047,0.000030673098,0.00035398183,0.000046092897,0.00019798057,0.00020496368,0.0000024603885,0.0006138748],"genre_scores_gemma":[0.99514824,0.0033381789,0.00005048723,0.00003255909,0.00017858075,0.00012969061,0.000025321995,0.000008833427,0.0010881237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903417,0.000060788687,0.00017590912,0.00021308412,0.0002617661,0.00025430718],"domain_scores_gemma":[0.9994868,0.00002069155,0.00007225301,0.00015396376,0.00021166929,0.00005460944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002231011,0.00008488984,0.00016449543,0.000026480418,0.000061512386,0.0000055980713,0.00015783853,0.00008442165,0.00009764891],"category_scores_gemma":[0.00003531892,0.00007519239,0.0000702264,0.00011172172,0.0004029395,0.000003917146,0.00015452637,0.0001281912,0.0000012085749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002457424,0.0001133937,0.0013669796,0.0000708368,0.000085389234,2.64809e-7,0.000045608966,0.000009926712,0.97164327,0.000010634029,0.016283905,0.010124021],"study_design_scores_gemma":[0.0004453801,0.00020137864,0.00024401817,0.000051566803,0.000008305117,7.2366606e-7,0.000091531714,0.000009469037,0.9575569,0.000013774745,0.04130102,0.000075904514],"about_ca_topic_score_codex":0.00048385662,"about_ca_topic_score_gemma":0.0003553039,"teacher_disagreement_score":0.025017112,"about_ca_system_score_codex":0.00006693003,"about_ca_system_score_gemma":0.00013064468,"threshold_uncertainty_score":0.30662563},"labels":[],"label_agreement":null},{"id":"W2220899579","doi":"10.1158/1538-7445.sabcs14-p3-07-31","title":"Abstract P3-07-31: Case series of 21 patients with metastastic lobular breast carcinoma to the gastrointestinal tract","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Lobular carcinoma; Invasive lobular carcinoma; Cancer; Metastasis; Gastrointestinal tract; Gastrointestinal cancer; Metastatic breast cancer; Oncology; Internal medicine; Breast carcinoma; Pathology; Ductal carcinoma; Colorectal cancer; Invasive ductal carcinoma","score_opus":0.1067622570855049,"score_gpt":0.36009594521869426,"score_spread":0.25333368813318935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220899579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945551,0.0010562562,0.000041158124,0.0017827019,0.000073852905,0.0009298138,0.0004990328,0.000015543568,0.0010465265],"genre_scores_gemma":[0.99858516,0.000011565188,0.00048661957,0.00006531974,0.00021958731,0.00016472656,0.000020576628,0.00003654268,0.00040987894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970879,0.00015554385,0.00034817716,0.00039788993,0.0013661495,0.0006443382],"domain_scores_gemma":[0.9965949,0.00015016722,0.00009097779,0.0005965477,0.0020371287,0.0005302558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013197706,0.00022935739,0.00046787338,0.00019478003,0.00021053279,0.000043747874,0.00019598468,0.000028205568,0.0003215323],"category_scores_gemma":[0.00039254458,0.00013151686,0.00009235301,0.00058162096,0.0004052881,0.00012524589,0.0001638972,0.00048329475,0.000072820214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008883159,0.0010917139,0.9192401,0.0007952723,0.00027829187,0.013367369,0.0026227313,0.00018074692,0.0017970334,0.00018119684,0.038162936,0.013399425],"study_design_scores_gemma":[0.003525908,0.004590474,0.95807534,0.00056816265,0.00028344328,0.01790386,0.0075728013,0.00001700988,0.001553638,0.000024153795,0.005603336,0.00028185584],"about_ca_topic_score_codex":0.0012748002,"about_ca_topic_score_gemma":0.00054072205,"teacher_disagreement_score":0.03883523,"about_ca_system_score_codex":0.0002366899,"about_ca_system_score_gemma":0.00082324015,"threshold_uncertainty_score":0.5363102},"labels":[],"label_agreement":null},{"id":"W2221578897","doi":"","title":"Genomic alterations in primary breast cancers and their sentinel lymph node metastases detected by array CGH","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Breast cancer; Sentinel lymph node; Comparative genomic hybridization; Lymph node; Metastasis; Sentinel node; Breast carcinoma; Axillary lymph nodes; Lymph; Cancer; Oncology; Pathology; Internal medicine; Biology; Chromosome; Gene","score_opus":0.02305934069300029,"score_gpt":0.2798152489717454,"score_spread":0.2567559082787451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221578897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500847,0.0034198586,0.00010473095,0.00026552018,0.00003575583,0.00013909665,0.00046430892,0.0000066790594,0.00055557245],"genre_scores_gemma":[0.996397,0.0019538426,0.00008775146,0.0001204549,0.00013442175,0.00015735476,0.00023311976,0.000018246898,0.0008978169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989785,0.00012324894,0.00016086022,0.00029617987,0.00011004896,0.00033114926],"domain_scores_gemma":[0.9995465,0.000020259862,0.000029656005,0.00020894133,0.000112721,0.00008192282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018489902,0.00011430038,0.00012206386,0.000079414625,0.00023692552,0.00003164229,0.00013757116,0.00006532353,0.00005411629],"category_scores_gemma":[0.000014224866,0.00010276378,0.000032325195,0.00014628084,0.00018270146,0.000007834952,0.00009039247,0.00011372104,0.0000037750065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006593806,0.000027480875,0.03487171,0.000021247746,0.000041811523,0.0000026494831,0.00025920605,0.00013228194,0.9631368,0.000014251255,0.0011117869,0.00031483098],"study_design_scores_gemma":[0.0020699026,0.0000682206,0.2992063,0.000047605165,0.000013582531,0.0002351081,0.0010482833,0.00008304835,0.68545276,0.000082247294,0.011208424,0.00048452555],"about_ca_topic_score_codex":0.0015115042,"about_ca_topic_score_gemma":0.00020209754,"teacher_disagreement_score":0.27768406,"about_ca_system_score_codex":0.00017268573,"about_ca_system_score_gemma":0.0005534414,"threshold_uncertainty_score":0.41905853},"labels":[],"label_agreement":null},{"id":"W2221764180","doi":"","title":"VB6-845: recombinant engineering of an Ep-CAM-specific Fab antibody for optimal delivery of de-immunized bouganin (de-bouganin)","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Molecular biology; Recombinant DNA; Antibody; Pseudomonas exotoxin; Fusion protein; Chemistry; Expression vector; Linker; Biology; Biochemistry; Gene; Monoclonal antibody; Immunology","score_opus":0.03932579909087205,"score_gpt":0.3552397642918294,"score_spread":0.3159139652009574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221764180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831577,0.012530886,0.002959988,0.00011242603,0.00043766494,0.0005635559,0.00011154884,0.000039487215,0.00008672263],"genre_scores_gemma":[0.99016005,0.00210324,0.005660851,0.000014101459,0.000084414474,0.00013886382,0.00008173795,0.00006009038,0.0016966667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788964,0.00026818548,0.00046975026,0.00034941468,0.0000983729,0.00092462584],"domain_scores_gemma":[0.99864584,0.00026427794,0.00012270243,0.0005404705,0.00036627578,0.000060416423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015525661,0.00019753606,0.0004618084,0.00024885562,0.00023925686,0.000026828471,0.00066442136,0.0003267566,0.001014549],"category_scores_gemma":[0.00010759677,0.00019568845,0.0001507374,0.00030964223,0.00031425172,0.00018652837,0.00014567703,0.0006123478,0.000035023586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007022999,0.00021999804,0.00009565934,0.00009580348,0.00012751493,0.0000025519776,0.0013279939,0.00032612841,0.9829984,0.0023832845,0.0007745324,0.010945862],"study_design_scores_gemma":[0.002362829,0.0008408458,0.0012506967,0.00016363869,0.00001690217,0.000018969027,0.00056976086,0.0003159138,0.9476868,0.00009908202,0.04647573,0.0001988152],"about_ca_topic_score_codex":0.00032267446,"about_ca_topic_score_gemma":0.000021010244,"teacher_disagreement_score":0.0457012,"about_ca_system_score_codex":0.00023165086,"about_ca_system_score_gemma":0.0005458527,"threshold_uncertainty_score":0.9998987},"labels":[],"label_agreement":null},{"id":"W2223384622","doi":"10.1158/1538-7445.sabcs14-p1-13-07","title":"Abstract P1-13-07: A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit for the","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Hazard ratio; Breast cancer; Tolerability; Antiestrogen; Aromatase inhibitor; Oncology; Clinical endpoint; Cancer; Population; Adverse effect; Randomized controlled trial; Tamoxifen; Gynecology; Confidence interval","score_opus":0.08213161146119569,"score_gpt":0.47809687708098275,"score_spread":0.39596526561978707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223384622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873041,0.0036963117,0.0000027408107,0.00207198,0.00025434513,0.006018468,0.00059673394,0.000051960815,0.000003345516],"genre_scores_gemma":[0.99458784,0.0003800688,0.00016697857,0.00007388946,0.0004945265,0.004114616,0.00003545408,0.00011636139,0.000030284551],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995692,0.00014508041,0.00085773424,0.00091270916,0.0013163512,0.0010761075],"domain_scores_gemma":[0.9969039,0.000731577,0.0002950662,0.00071782764,0.00044733647,0.0009043195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017568299,0.00045517745,0.0009144425,0.00024941994,0.00029642772,0.00007262754,0.00033347597,0.000113491755,0.000099331315],"category_scores_gemma":[0.0003744051,0.00025247876,0.00009256327,0.000671712,0.00044058866,0.00038830264,0.0001312173,0.00075971545,0.0000012161013],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5363599,0.0040834467,0.12478325,0.00035280298,0.0007998056,0.00057216734,0.009517965,0.00021875768,0.014419053,0.0000044461135,0.000043213753,0.30884516],"study_design_scores_gemma":[0.3575541,0.05573043,0.4885982,0.0043665767,0.0003822289,0.000084284875,0.08806805,0.0003313418,0.0022354804,0.00011869487,0.0013329486,0.0011976486],"about_ca_topic_score_codex":0.00062523736,"about_ca_topic_score_gemma":0.00098721,"teacher_disagreement_score":0.36381495,"about_ca_system_score_codex":0.00059443683,"about_ca_system_score_gemma":0.0023514952,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2224634642","doi":"10.1158/1538-7445.am2015-lb-159","title":"Abstract LB-159: Methylation of BRCA1 gene in blood is not inherited via maternal germ line and may predispose to triple-negative or medullary breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylation; Breast cancer; Germline; Germline mutation; High Resolution Melt; MLH1; Cancer; DNA methylation; Medicine; Cancer research; Oncology; Mutation; Internal medicine; Genetics; Biology; Gene; Genotype; Colorectal cancer; Gene expression; DNA mismatch repair","score_opus":0.06352670668756678,"score_gpt":0.3927140456033079,"score_spread":0.32918733891574115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224634642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940576,0.0033031828,0.00003032961,0.0008720246,0.000099470264,0.00048633292,0.0010915018,0.000005341871,0.000054236076],"genre_scores_gemma":[0.9957575,0.0026694813,0.00024994533,0.00019831445,0.00042255342,0.0001859732,0.000068010624,0.000027344207,0.0004208479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844384,0.00012181811,0.0002905581,0.0004146083,0.0003973209,0.0003318468],"domain_scores_gemma":[0.9986624,0.000025202287,0.00006972633,0.0002573763,0.00063800655,0.00034726685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046978125,0.00014330767,0.00019361044,0.00017137232,0.000045425164,0.000028265926,0.0001760537,0.00014484097,0.00018199945],"category_scores_gemma":[0.000124361,0.0001297999,0.000037710586,0.00028898305,0.0001495141,0.000010662507,0.00014006805,0.00014215018,0.0000028172713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004185817,0.00020280649,0.023858003,0.00015578775,0.00007732541,0.000017839662,0.00045960475,0.00009014435,0.9634212,0.0000017584698,0.0011402577,0.006389412],"study_design_scores_gemma":[0.0024105862,0.00025019498,0.1993833,0.00007723282,0.000019101248,0.000008740021,0.0001090282,0.000038818398,0.79696774,0.00010259136,0.00049174496,0.00014093434],"about_ca_topic_score_codex":0.0029982713,"about_ca_topic_score_gemma":0.0013648792,"teacher_disagreement_score":0.17552531,"about_ca_system_score_codex":0.00006815647,"about_ca_system_score_gemma":0.0005605203,"threshold_uncertainty_score":0.5293086},"labels":[],"label_agreement":null},{"id":"W2226239069","doi":"10.1158/1538-7445.sabcs14-p3-05-15","title":"Abstract P3-05-15: Divergent activation of AKT1 and AKT2 isoforms downstream of PI3K mutation impacts response of breast cancer cells to estradiol and PI3K inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PI3K/AKT/mTOR pathway; AKT2; Protein kinase B; AKT1; Cancer research; Estrogen receptor; Breast cancer; Fulvestrant; Biology; Endocrinology; Estrogen; Phosphorylation; Internal medicine; Medicine; Cancer; Signal transduction; Cell biology","score_opus":0.05796178867786553,"score_gpt":0.3945458219769818,"score_spread":0.33658403329911624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226239069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962287,0.0012082248,0.000045807938,0.0012202789,0.00011056605,0.00082932034,0.0002980253,0.000013654887,0.000045403583],"genre_scores_gemma":[0.9988598,0.00049530383,0.00024876976,0.000037300786,0.0001365753,0.00009191274,0.000009502519,0.000032436077,0.00008836497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978489,0.00009741598,0.00044803,0.00033378994,0.0008845746,0.0003872721],"domain_scores_gemma":[0.9977922,0.00021238155,0.00023563358,0.00029915065,0.001029982,0.0004306888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009720987,0.00018260533,0.0004370212,0.0004564749,0.000054344982,0.000011956182,0.00010723638,0.000109077424,0.00010325773],"category_scores_gemma":[0.0002141585,0.00014981009,0.00004660472,0.0006094206,0.00042642388,0.00029057864,0.00008857596,0.0002599903,0.0000015947247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017348597,0.00014068547,0.012143855,0.0006371396,0.00011536814,0.000008485433,0.00481878,0.0004224265,0.90343183,0.000010186249,0.00047243517,0.060450185],"study_design_scores_gemma":[0.0023804305,0.0008272827,0.31738988,0.00096691045,0.00002712505,0.000024363562,0.0018560229,0.000026399288,0.6760754,0.00009140156,0.00021722697,0.000117551375],"about_ca_topic_score_codex":0.005131324,"about_ca_topic_score_gemma":0.00013142318,"teacher_disagreement_score":0.30524603,"about_ca_system_score_codex":0.0005341642,"about_ca_system_score_gemma":0.0009880378,"threshold_uncertainty_score":0.7757061},"labels":[],"label_agreement":null},{"id":"W2226431206","doi":"10.1158/1538-7445.sabcs14-p6-09-04","title":"Abstract P6-09-04: Volumetric breast density improves breast cancer risk prediction","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Logistic regression; Population; Matching (statistics); Conditional logistic regression; Case-control study; Statistics; Cancer; Internal medicine; Mathematics; Pathology; Environmental health","score_opus":0.07949661242317152,"score_gpt":0.39830681880307206,"score_spread":0.31881020637990054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226431206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900003,0.0036817978,0.000031171105,0.0018120183,0.0009238529,0.00076139515,0.0014427452,0.00013282291,0.0012138712],"genre_scores_gemma":[0.9915555,0.0036614086,0.000025437785,0.000078178484,0.0023232491,0.00024641003,0.000041489744,0.00006582321,0.0020024893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635947,0.00011650376,0.00037784548,0.0006740997,0.0015696356,0.0009024545],"domain_scores_gemma":[0.99667907,0.000100382254,0.00013319118,0.00062285515,0.0015222118,0.0009423129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013665588,0.00025240425,0.00042871523,0.00058656296,0.000284961,0.000104793704,0.0002461841,0.00022941489,0.0009385459],"category_scores_gemma":[0.00020524733,0.00021141302,0.00014973078,0.0015466509,0.00033211533,0.0002815238,0.0001556943,0.0013431062,0.00018188872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001606973,0.00027514776,0.70523185,0.0001789805,0.00020756006,0.00004961504,0.00058723637,0.000039281436,0.011224395,0.000007471776,0.060742974,0.2198485],"study_design_scores_gemma":[0.0024377343,0.00020495609,0.98265094,0.00018686902,0.00009621762,0.00011951028,0.00037925452,0.00026941675,0.0018556193,0.000073787036,0.011520872,0.00020479853],"about_ca_topic_score_codex":0.112753436,"about_ca_topic_score_gemma":0.0041062287,"teacher_disagreement_score":0.2774191,"about_ca_system_score_codex":0.0020721776,"about_ca_system_score_gemma":0.0019256524,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W2226446856","doi":"","title":"Xenografts of human hepatocellular carcinoma: A tool for screening drugs used in treatment of this disease","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Growth inhibition; Docetaxel; Cancer research; Oncology; Biology; Endocrinology; Cancer; Cell culture","score_opus":0.08618972893966557,"score_gpt":0.3989945629769559,"score_spread":0.3128048340372903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226446856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187195,0.006849027,0.00013596221,0.00017446803,0.000035637437,0.0007009531,0.00014561095,0.0000043628365,0.000082045066],"genre_scores_gemma":[0.9976975,0.00021682665,0.00033530194,0.000019101486,0.00035513687,0.00058977184,0.000072680275,0.000031429245,0.0006822908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985386,0.000104794126,0.00028705795,0.0003603526,0.00032105882,0.00038814577],"domain_scores_gemma":[0.9990966,0.00004638285,0.00007339618,0.00043685638,0.00024189007,0.00010492968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042861418,0.00012937485,0.00022532872,0.00014409001,0.00006689087,0.000009626272,0.00023502203,0.00009237569,0.000091823305],"category_scores_gemma":[0.000050267743,0.00012408735,0.00013770552,0.00019152496,0.00018127028,0.0000061802752,0.00006861282,0.000076552256,0.000001086167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005951092,0.0002064702,0.11740768,0.0001319495,0.00005408409,0.0000036392557,0.0004121601,0.00018268387,0.87562513,0.000044772136,0.00075688236,0.0045794286],"study_design_scores_gemma":[0.0023139939,0.00077578577,0.0040487438,0.000083766965,0.00001997906,2.4525426e-7,0.00006535455,0.00037431915,0.9765012,0.000036558493,0.015635185,0.00014483952],"about_ca_topic_score_codex":0.00085284375,"about_ca_topic_score_gemma":0.00018485401,"teacher_disagreement_score":0.11335894,"about_ca_system_score_codex":0.00016932891,"about_ca_system_score_gemma":0.0003708689,"threshold_uncertainty_score":0.5060136},"labels":[],"label_agreement":null},{"id":"W2226486849","doi":"10.1158/1538-7445.sabcs14-p3-06-01","title":"Abstract P3-06-01: Nuclear β-catenin negativity predicts for late relapse in ER+, tamoxifen-treated breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Oncology; Internal medicine; Catenin; Cancer; Context (archaeology); Wnt signaling pathway; Biology; Signal transduction","score_opus":0.09719641289210473,"score_gpt":0.38548066374591866,"score_spread":0.28828425085381393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226486849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859541,0.0023833888,0.000013173471,0.005766813,0.0003647849,0.0022921076,0.0006519058,0.00017698166,0.0023967351],"genre_scores_gemma":[0.9943392,0.0008384157,0.00012982106,0.00023971238,0.0005414976,0.0010317698,0.000102156526,0.00018186425,0.0025955173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958574,0.0002000683,0.0005162268,0.0008846148,0.0012447471,0.0012969113],"domain_scores_gemma":[0.9971108,0.00017345388,0.0001306403,0.0007045511,0.0010235984,0.00085695466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016640978,0.00034378897,0.0006076708,0.00055416184,0.00018316775,0.00007744251,0.0003597875,0.0004190815,0.0006431748],"category_scores_gemma":[0.00047626795,0.0003221046,0.00016212839,0.0013539934,0.00039124332,0.0002520461,0.00018745213,0.0015147951,0.00021155537],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018959468,0.0013651802,0.033321355,0.0013596577,0.0007076871,0.0012834292,0.0044996217,0.0026208214,0.6267549,0.00027580874,0.27467987,0.034172248],"study_design_scores_gemma":[0.07523775,0.0038311996,0.5105487,0.009673252,0.00062361924,0.00043356343,0.001489523,0.015121807,0.15655252,0.002621903,0.22085547,0.0030106548],"about_ca_topic_score_codex":0.012893597,"about_ca_topic_score_gemma":0.0036310712,"teacher_disagreement_score":0.47722736,"about_ca_system_score_codex":0.002684907,"about_ca_system_score_gemma":0.002247454,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W2226743944","doi":"10.1158/1538-7445.sabcs14-p3-12-02","title":"Abstract P3-12-02: Lifestyle interventions combined with acupuncture-like transcutaneous electrical nerve stimulation in managing vasomotor symptoms induced by breast cancer treatment: Results of a phase 2 randomized controlled trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Music Therapy and Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Transcutaneous electrical nerve stimulation; Acupuncture; Breast cancer; Hot flash; Vasomotor; Randomized controlled trial; Physical therapy; Clinical trial; Cancer; Internal medicine; Alternative medicine","score_opus":0.09780550014161123,"score_gpt":0.45606072097282574,"score_spread":0.3582552208312145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226743944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98481256,0.0017813473,0.000072129085,0.0023058532,0.00056634506,0.009067218,0.0003395303,0.000048642974,0.0010063786],"genre_scores_gemma":[0.99315727,0.00023623805,0.000011737178,0.00006216621,0.00030752615,0.004426848,0.0001033896,0.000048031583,0.001646789],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948885,0.001890791,0.0011694739,0.00059066183,0.00070355076,0.0007570622],"domain_scores_gemma":[0.99680203,0.0015973181,0.00037213592,0.00053981185,0.00034664734,0.00034203855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031887046,0.00033978614,0.001699599,0.0005421989,0.00012473906,0.000051104507,0.00033568282,0.00024031693,0.00090866577],"category_scores_gemma":[0.00015682208,0.00020614246,0.00040939817,0.00063544966,0.00020128202,0.00011046309,0.000020458843,0.0006552944,0.000008826642],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97119707,0.0030237033,0.00005404609,0.000055740893,0.000974623,0.00006437748,0.0041910345,0.00015677337,0.0014467633,0.00014412274,0.0013135237,0.017378211],"study_design_scores_gemma":[0.99103916,0.0065801484,0.00018879703,0.00028044553,0.00019506465,0.00001224824,0.00016570135,0.00079152454,0.00011339057,0.00018862778,0.0002454741,0.00019942973],"about_ca_topic_score_codex":0.019479832,"about_ca_topic_score_gemma":0.0048914226,"teacher_disagreement_score":0.019842068,"about_ca_system_score_codex":0.00085899816,"about_ca_system_score_gemma":0.0008566259,"threshold_uncertainty_score":0.99492526},"labels":[],"label_agreement":null},{"id":"W2227412280","doi":"10.1158/1538-7445.sabcs14-p3-05-01","title":"Abstract P3-05-01: Development for clinical utility of a validated predictive test of clinical response to aromatase inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Anastrozole; Aromatase; Internal medicine; Estrogen receptor; Housekeeping gene; Cancer; Immunohistochemistry; Exemestane; Microarray; Cancer research; Gene expression; Biology; Gene","score_opus":0.2765460441546886,"score_gpt":0.5271743756780837,"score_spread":0.2506283315233951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227412280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965334,0.0005905173,0.00009651399,0.0006029372,0.0002518852,0.0008149996,0.0009940444,0.000008458703,0.000107246444],"genre_scores_gemma":[0.99779934,0.00013542193,0.0011318771,0.000043710927,0.00028410568,0.00038429128,0.000113330294,0.000021544076,0.00008636817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973034,0.00039191777,0.0009087405,0.0005553721,0.0004748802,0.0003656439],"domain_scores_gemma":[0.9969962,0.0008861655,0.0001807675,0.00049420027,0.0011177365,0.0003248806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006046747,0.00014817734,0.00042616492,0.000083173756,0.0000662961,0.000007607946,0.0002834002,0.0002009466,0.000017048951],"category_scores_gemma":[0.0067740735,0.00012770908,0.00013877134,0.00022985203,0.00047984513,0.0000050943004,0.0003524905,0.000195016,0.0000064323367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09734949,0.0030940857,0.51351,0.00028147045,0.0010819116,0.000016030215,0.0009900628,0.000022773615,0.09888118,0.000003503293,0.24686356,0.037905958],"study_design_scores_gemma":[0.0033857166,0.002223803,0.5567741,0.00012910944,0.0000276762,0.0000012800297,0.0004054977,0.0000074944032,0.38721278,0.000026392905,0.04965679,0.00014935905],"about_ca_topic_score_codex":0.000176033,"about_ca_topic_score_gemma":0.00012888876,"teacher_disagreement_score":0.2883316,"about_ca_system_score_codex":0.00007896602,"about_ca_system_score_gemma":0.0022436883,"threshold_uncertainty_score":0.8109688},"labels":[],"label_agreement":null},{"id":"W2227961447","doi":"","title":"Investigating androgen receptor antagonism by structural analyses, molecular dynamics simulations and support vector machines","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Androgen receptor; Agonist; Chemistry; Antagonist; Prostate cancer; Antiandrogen; Receptor; Androgen; Pharmacology; Internal medicine; Biology; Hormone; Cancer; Medicine; Biochemistry","score_opus":0.07754643704947568,"score_gpt":0.4658515299322195,"score_spread":0.38830509288274384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227961447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093753,0.0050557675,0.000094033145,0.0022049427,0.00008398938,0.0006206439,0.00038640408,0.0000433856,0.0005732781],"genre_scores_gemma":[0.9956263,0.00034534943,0.00042957996,0.00012285564,0.00016460057,0.00003528879,0.000813343,0.000041615236,0.0024210776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977267,0.0000976242,0.0002591095,0.0004160215,0.00078633503,0.0007142223],"domain_scores_gemma":[0.9986442,0.00017316185,0.000044292166,0.00026880353,0.0003730343,0.0004965171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062928506,0.00017102588,0.0002623217,0.00029168013,0.00035521033,0.00007663603,0.00012488123,0.00011320189,0.00040522497],"category_scores_gemma":[0.00017049508,0.0001347384,0.00005455033,0.00072236324,0.00046613472,0.00011462404,0.000119446675,0.0005455347,0.000009222593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024876447,0.000042842872,0.12162702,0.00018780802,0.00025871384,0.00010312476,0.0005557626,0.000030991872,0.8517134,0.00022747401,0.0016481223,0.023355959],"study_design_scores_gemma":[0.0069416487,0.0012570906,0.037272427,0.0002692496,0.00020431622,0.00008606609,0.00082426297,0.020817801,0.9227038,0.0011181678,0.007794572,0.0007106096],"about_ca_topic_score_codex":0.000947265,"about_ca_topic_score_gemma":0.00018571208,"teacher_disagreement_score":0.08435459,"about_ca_system_score_codex":0.00074524607,"about_ca_system_score_gemma":0.0006395515,"threshold_uncertainty_score":0.54944724},"labels":[],"label_agreement":null},{"id":"W2232619420","doi":"","title":"Two adhesion molecules: New serological diagnostic breast cancer biomarkers","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"ALCAM; Breast cancer; Medicine; Cancer; Oncology; Pathology; Serology; Internal medicine; CA 15-3; Biomarker; CA15-3; Cell adhesion molecule; Immunology; Biology; Antibody","score_opus":0.06667120135394183,"score_gpt":0.39361808557713046,"score_spread":0.3269468842231886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232619420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895716,0.0047605336,0.00021145763,0.0032462135,0.00012529315,0.00056641543,0.00007397398,0.00002705737,0.0014174875],"genre_scores_gemma":[0.98533916,0.0076601696,0.00016902226,0.00031615118,0.000708968,0.00034431144,0.000057725534,0.000038255155,0.0053662597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732596,0.00030751922,0.00020643951,0.00062389433,0.0007624829,0.0007736983],"domain_scores_gemma":[0.9985179,0.000096781005,0.000036613514,0.00046636036,0.00042874503,0.0004536396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046044486,0.00018061773,0.00016617289,0.00016505395,0.00036228503,0.000041498093,0.00046019984,0.00019195718,0.0015565506],"category_scores_gemma":[0.0004333805,0.00015426561,0.00009902971,0.00052304147,0.00040039985,0.000008831375,0.00032262274,0.00039187606,0.00016522176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085295935,0.00011971475,0.032366868,0.000034005687,0.00010145564,0.00011865468,0.00007240317,0.00023478108,0.86096275,0.00007435724,0.08712701,0.017935066],"study_design_scores_gemma":[0.005049298,0.0009341849,0.14660099,0.00017210354,0.000019182713,0.00028697183,0.00017505168,0.00031831267,0.67595637,0.00027110893,0.16938785,0.0008285571],"about_ca_topic_score_codex":0.00325232,"about_ca_topic_score_gemma":0.00056072965,"teacher_disagreement_score":0.18500635,"about_ca_system_score_codex":0.00011627049,"about_ca_system_score_gemma":0.0010236577,"threshold_uncertainty_score":0.99935615},"labels":[],"label_agreement":null},{"id":"W2234586702","doi":"10.1158/1538-7445.sabcs14-p3-08-06","title":"Abstract P3-08-06: Demographics of breast cancer in a cohort of Afro-Caribbean women","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Afro-Caribbean; Cohort; Population; Incidence (geometry); Cancer; Etiology; Demography; Ovarian cancer; Gynecology; Obstetrics; Internal medicine; Environmental health","score_opus":0.050030242450716474,"score_gpt":0.3854634268714998,"score_spread":0.33543318442078335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234586702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939992,0.003586285,0.000021766424,0.00039589693,0.00012716033,0.00032751125,0.00047543578,0.0000044356416,0.0010623038],"genre_scores_gemma":[0.99664736,0.0023269036,0.00008344376,0.000032491003,0.00018402834,0.00044550357,0.000031275627,0.000029999543,0.00021901548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981689,0.00011031917,0.00032927736,0.000368171,0.0005561798,0.00046714154],"domain_scores_gemma":[0.99836385,0.000029064227,0.0001017781,0.00047514512,0.0008646199,0.00016552149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013130151,0.00012328784,0.00022870902,0.0002507013,0.000033429867,0.000011593137,0.00039671853,0.00017821327,0.00018393742],"category_scores_gemma":[0.0000967862,0.00012371612,0.000058232014,0.00071294344,0.00043361,0.00000731446,0.0001752867,0.0002758109,0.0000041797875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006496155,0.00017861059,0.47405493,0.00023678625,0.00023307667,0.000005666513,0.0012055626,0.0015781105,0.503532,0.00007433133,0.010121158,0.008130144],"study_design_scores_gemma":[0.0029229817,0.00041402061,0.63772213,0.000259493,0.000027760934,0.000011719006,0.0031576878,0.00009408586,0.3318897,0.0008416566,0.022165919,0.0004928349],"about_ca_topic_score_codex":0.0019917393,"about_ca_topic_score_gemma":0.001915197,"teacher_disagreement_score":0.1716423,"about_ca_system_score_codex":0.00046507595,"about_ca_system_score_gemma":0.0021564153,"threshold_uncertainty_score":0.5044997},"labels":[],"label_agreement":null},{"id":"W2239073428","doi":"10.1158/1538-7445.am2015-4493","title":"Abstract 4493: Ironing out breast cancer: investigation of a novel iron chelator","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Breast cancer; Cancer; Cancer cell; Cancer research; Transferrin receptor; Apoptosis; Medicine; Cell growth; Transferrin; Pharmacology; Chemistry; Internal medicine; Biochemistry","score_opus":0.16041744913845013,"score_gpt":0.4282522650823843,"score_spread":0.26783481594393416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239073428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887503,0.0044203945,0.000020646623,0.003154933,0.0002541061,0.00034531468,0.00007984005,0.000026390688,0.0028233393],"genre_scores_gemma":[0.99753326,0.00045471752,0.00016432194,0.00016652787,0.0004404101,0.000101430654,0.00001917895,0.00003036719,0.0010897832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815416,0.000042135518,0.00023917595,0.0002658219,0.000883449,0.00041527423],"domain_scores_gemma":[0.9986731,0.000042943757,0.000073908755,0.0002924218,0.00052757177,0.00039004962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008675057,0.000113488684,0.00024738957,0.00020318881,0.00006543949,0.00001835404,0.00014232175,0.000107948115,0.00035136097],"category_scores_gemma":[0.00015310053,0.000098533295,0.000048726644,0.00033628708,0.00030500113,0.00013992771,0.00006430479,0.00042723893,0.000040288927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014532037,0.00034646035,0.22772464,0.0016674444,0.000060796443,0.000016430038,0.009319103,0.00039694857,0.7012725,0.0009694645,0.03071001,0.026062984],"study_design_scores_gemma":[0.011776418,0.00024662304,0.9059515,0.0010238319,0.00012594025,0.000021152067,0.004111616,0.000351103,0.0637792,0.0003114627,0.011871378,0.00042976707],"about_ca_topic_score_codex":0.004615437,"about_ca_topic_score_gemma":0.00025842455,"teacher_disagreement_score":0.6782269,"about_ca_system_score_codex":0.00026053863,"about_ca_system_score_gemma":0.0016173731,"threshold_uncertainty_score":0.69771904},"labels":[],"label_agreement":null},{"id":"W2243255469","doi":"10.1158/1538-7445.am2015-854","title":"Abstract 854: Ovarian cancer risk factors by histologic subtypes: evidence for etiologic heterogeneity","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Toronto","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Clear cell; Oncology; Endometrial cancer; Cancer; Internal medicine; Cohort; Risk factor; Gynecology; Serous carcinoma; Clear cell carcinoma; Carcinoma","score_opus":0.3916433470307197,"score_gpt":0.49597247247097176,"score_spread":0.10432912544025208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243255469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95228297,0.03963677,0.0000672191,0.0048940214,0.00055513345,0.001582692,0.00049992895,0.00007414058,0.0004071205],"genre_scores_gemma":[0.98532605,0.010767611,0.0001760636,0.00022940036,0.0004096899,0.0023022394,0.00006214228,0.000041258158,0.0006855199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971588,0.00019759874,0.00032874607,0.0007867167,0.00070896314,0.0008191695],"domain_scores_gemma":[0.99723136,0.00075115904,0.00013956697,0.00058017165,0.0007140411,0.0005836725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013703271,0.00026213942,0.0004859997,0.00014760587,0.00026279906,0.000059204107,0.00028519737,0.00022520308,0.0007141247],"category_scores_gemma":[0.0010070897,0.00018835625,0.0001764386,0.00036395612,0.00028155962,0.00014221978,0.00008377995,0.0005300724,0.00006422539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012454872,0.00040032036,0.8397304,0.00020468075,0.0003434033,0.00003530721,0.00036957048,0.000084402505,0.0028576837,0.00007341058,0.14515789,0.009497484],"study_design_scores_gemma":[0.006653279,0.0028306185,0.7654347,0.000831221,0.0004059192,0.0000113646975,0.0004872656,0.00009659709,0.050798588,0.000962368,0.17085753,0.0006305597],"about_ca_topic_score_codex":0.017544331,"about_ca_topic_score_gemma":0.0012824069,"teacher_disagreement_score":0.07429568,"about_ca_system_score_codex":0.0024767483,"about_ca_system_score_gemma":0.0013382981,"threshold_uncertainty_score":0.98899794},"labels":[],"label_agreement":null},{"id":"W2244438265","doi":"10.1158/1538-7445.am2015-615","title":"Abstract 615: Noninvasive diagnosis of actionable mutations by deep sequencing of circulating tumor DNA in multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Liquid biopsy; Circulating tumor DNA; DNA sequencing; Deep sequencing; Medicine; Multiple myeloma; Cancer; Whole genome sequencing; Genome; Cancer research; Gene; Biology; Genetics; Internal medicine; Colorectal cancer","score_opus":0.07634253989996632,"score_gpt":0.3572720474437637,"score_spread":0.28092950754379736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244438265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671227,0.0020588078,0.00007008935,0.00007509362,0.000071670285,0.00023485254,0.00015720016,0.00000247811,0.0006175558],"genre_scores_gemma":[0.99892944,0.00039334228,0.00021812941,0.000024171199,0.00009383484,0.00020380424,0.000082153936,0.000019005107,0.00003610027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890906,0.000047349993,0.00026572496,0.00024176386,0.00026314927,0.00027294687],"domain_scores_gemma":[0.99888784,0.00020115069,0.00010499046,0.00021551887,0.0004864801,0.000104009116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042929887,0.00008307578,0.00014968791,0.000106306,0.000051318475,0.00001342906,0.00016307653,0.000071682334,0.00003513025],"category_scores_gemma":[0.001043664,0.00009221993,0.000046002122,0.0002530443,0.00014353495,0.0000075667795,0.00009688292,0.0001394219,0.0000025187571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007844253,0.00006894756,0.05307146,0.00008356448,0.000030422798,0.00000986419,0.00043006096,0.006957942,0.93606937,0.00002984541,0.0014555551,0.0017145092],"study_design_scores_gemma":[0.00072835264,0.00014219344,0.006688563,0.00007675289,0.000005531512,0.0000032621288,0.0015066013,0.00029649743,0.98883796,0.00016553051,0.0014385605,0.00011019371],"about_ca_topic_score_codex":0.003992873,"about_ca_topic_score_gemma":0.0023187657,"teacher_disagreement_score":0.052768573,"about_ca_system_score_codex":0.00024289374,"about_ca_system_score_gemma":0.00093473424,"threshold_uncertainty_score":0.60360557},"labels":[],"label_agreement":null},{"id":"W2248082960","doi":"10.1158/1538-7445.am2015-709","title":"Abstract 709: Resistance to paclitaxel in triple negative breast cancer cells is associated with ABCB1 gene rearrangement","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Paclitaxel; Cancer research; Taxane; Cancer; Medicine; Metastatic breast cancer; Oncology; Biology; Internal medicine","score_opus":0.05216335135473303,"score_gpt":0.3575752842922519,"score_spread":0.30541193293751884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248082960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985726,0.0027663794,0.000027402975,0.002825244,0.00020294702,0.0007391739,0.0014690434,0.000008592411,0.0021039867],"genre_scores_gemma":[0.99305457,0.002037088,0.00013201774,0.00069459225,0.00035417124,0.00056106946,0.000053028238,0.000049310678,0.0030641605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786246,0.00009472955,0.00024281291,0.00059508963,0.0005443252,0.00066060014],"domain_scores_gemma":[0.99835896,0.00005885424,0.00007464372,0.00043986103,0.00070487644,0.00036282794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007998187,0.00018760203,0.00022912136,0.00013032957,0.000089937705,0.00006980401,0.0003230871,0.00013647594,0.00011506219],"category_scores_gemma":[0.00018071047,0.00017432653,0.000045041234,0.0004991603,0.00012887016,0.000007682947,0.00016542742,0.000264517,0.000023292774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032350207,0.0002861963,0.009533425,0.000053755568,0.00020786324,0.00006907369,0.0014483024,0.0013262222,0.70034575,0.000033680004,0.28108132,0.0023793846],"study_design_scores_gemma":[0.005486352,0.0006069135,0.07737517,0.00042810533,0.00002644182,0.0000026114171,0.001005958,0.000022877803,0.82295763,0.000252373,0.091077365,0.00075816445],"about_ca_topic_score_codex":0.0052405866,"about_ca_topic_score_gemma":0.032703828,"teacher_disagreement_score":0.19000396,"about_ca_system_score_codex":0.00071698247,"about_ca_system_score_gemma":0.0013591524,"threshold_uncertainty_score":0.9849468},"labels":[],"label_agreement":null},{"id":"W2251738513","doi":"10.1158/1538-7445.sabcs14-p1-12-14","title":"Abstract P1-12-14: Retinoic acid sensitizes triple-negative breast cancer cells to tamoxifen treatment","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Tamoxifen; Estrogen receptor; Triple-negative breast cancer; Breast cancer; Internal medicine; Estrogen; Cancer research; Endocrinology; Medicine; Retinoic acid; Cell growth; Cancer; Biology; Cell culture","score_opus":0.06173556195886221,"score_gpt":0.37462043878805057,"score_spread":0.31288487682918836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2251738513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989222,0.002862404,0.00004232795,0.0011424152,0.0004476169,0.0006684656,0.00031435766,0.00002682157,0.005273593],"genre_scores_gemma":[0.9858964,0.0023396045,0.0001799869,0.00021385186,0.0012671103,0.0005259169,0.000055489305,0.000059155413,0.009462485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974174,0.0001912124,0.00026230435,0.0007448869,0.0006158751,0.00076835416],"domain_scores_gemma":[0.99805933,0.000041368272,0.00007192597,0.000554398,0.0007448697,0.00052810815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049287,0.0002819546,0.00027653947,0.000115004346,0.00018367679,0.000093617324,0.0003880209,0.00023527157,0.00025318295],"category_scores_gemma":[0.00014533655,0.00023592146,0.00010646145,0.00030659532,0.00025537654,0.000010657705,0.00020306285,0.00027723127,0.00012568782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083906774,0.000086531356,0.00060301373,0.000054867178,0.0001070176,0.00003852012,0.000598573,0.00018774325,0.94885385,0.00000714002,0.039376494,0.009247191],"study_design_scores_gemma":[0.0012503691,0.00043373136,0.00079014705,0.000065022745,0.000017423266,0.00001356002,0.00045061746,0.000007755052,0.956469,0.00007483844,0.04014211,0.00028541565],"about_ca_topic_score_codex":0.0018422768,"about_ca_topic_score_gemma":0.0006608572,"teacher_disagreement_score":0.008961776,"about_ca_system_score_codex":0.0005663916,"about_ca_system_score_gemma":0.0015569825,"threshold_uncertainty_score":0.9620598},"labels":[],"label_agreement":null},{"id":"W2258534149","doi":"10.1158/0008-5472.sabcs12-p2-13-02","title":"Abstract P2-13-02: Effect of aspirin (ASP) or celecoxib (CC) use on outcomes in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of British Columbia Hospital","funders":"","keywords":"Medicine; Anastrozole; Randomization; Internal medicine; Clinical endpoint; Breast cancer; Exemestane; Oncology; Placebo; Randomized controlled trial; Cancer; Gynecology; Surgery; Tamoxifen","score_opus":0.02584340846951045,"score_gpt":0.37316784924947527,"score_spread":0.3473244407799648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258534149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568397,0.0012170656,0.0000021945407,0.00019352823,0.00039655613,0.0020670781,0.00027795002,0.0000129900955,0.00014867443],"genre_scores_gemma":[0.9964508,0.00095591747,0.000026927846,0.00013001078,0.00017931974,0.0006390679,0.00010007997,0.00006932555,0.0014485982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657553,0.0006765948,0.0004967726,0.0005204038,0.000653119,0.0010775708],"domain_scores_gemma":[0.99828875,0.00043065593,0.00013296993,0.0004764756,0.0002520893,0.0004190604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014074574,0.00036418086,0.0007873414,0.00029076825,0.00008577804,0.00003759182,0.0003546338,0.0003076618,0.00022133037],"category_scores_gemma":[0.0004910952,0.00022253388,0.00015469229,0.00044404334,0.00019532013,0.000025364378,0.00021087493,0.0005477868,0.000045406938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32748622,0.0021378219,0.1689905,0.00039624213,0.00061340956,0.000073581636,0.00022320807,0.00014567036,0.47795933,0.000009676343,0.0040318873,0.017932475],"study_design_scores_gemma":[0.1436836,0.006004622,0.23539555,0.0006137698,0.00011290157,0.000015478125,0.00004790285,0.00001754206,0.61178195,0.0000021823173,0.0016553354,0.0006691454],"about_ca_topic_score_codex":0.0019945828,"about_ca_topic_score_gemma":0.0005082032,"teacher_disagreement_score":0.18380262,"about_ca_system_score_codex":0.00023233269,"about_ca_system_score_gemma":0.0003475128,"threshold_uncertainty_score":0.9074668},"labels":[],"label_agreement":null},{"id":"W2261541794","doi":"10.1158/0008-5472.can-15-2743","title":"An Integrated Analysis of Heterogeneous Drug Responses in Acute Myeloid Leukemia That Enables the Discovery of Predictive Biomarkers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University Health Network; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Myeloid leukemia; Drug; Medicine; Leukemia; Drug discovery; Oncology; Computational biology; Pharmacology; Internal medicine; Bioinformatics; Biology","score_opus":0.04404891370566785,"score_gpt":0.3766089575067579,"score_spread":0.33256004380109006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261541794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949871,0.0012028369,0.00021996908,0.0017145325,0.000042953852,0.00087379734,0.0007488066,0.000023282337,0.00018672783],"genre_scores_gemma":[0.9930011,0.003850628,0.00006755699,0.000045458833,0.000048726237,0.00026165857,0.00004458838,0.00004345746,0.0026368415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950457,0.0014656842,0.0005294415,0.0006117573,0.0015505408,0.00079686404],"domain_scores_gemma":[0.99566346,0.0019035871,0.00015387074,0.0012276679,0.0008391348,0.00021226476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033670382,0.00022458288,0.0007437902,0.0021935145,0.00010491823,0.000038114755,0.00082361203,0.00015557138,0.00026146066],"category_scores_gemma":[0.0007651394,0.00011559552,0.00024861985,0.0043703094,0.0017554924,0.0003445111,0.00027896097,0.00059133064,0.00000511343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020549988,0.0001880805,0.16522485,0.0001273542,0.0059127943,0.00021395765,0.002045597,0.0002615607,0.78956175,0.00004959666,0.0020256867,0.013838788],"study_design_scores_gemma":[0.0028680554,0.00087434263,0.17081669,0.000662795,0.00074006343,0.000017188151,0.0035848748,0.002116204,0.81722444,0.00008678047,0.00080317806,0.00020535737],"about_ca_topic_score_codex":0.009210336,"about_ca_topic_score_gemma":0.0025023867,"teacher_disagreement_score":0.027662713,"about_ca_system_score_codex":0.0027361384,"about_ca_system_score_gemma":0.0036064452,"threshold_uncertainty_score":0.9973874},"labels":[],"label_agreement":null},{"id":"W2262172886","doi":"","title":"Flaxseed oil is the major component of flaxseed that increases the effectiveness of tamoxifen in reducing established MCF-7 tumor growth in ovariectomized nude mice","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovariectomized rat; Tamoxifen; MCF-7; Chemistry; Endocrinology; Internal medicine; Corn oil; Pharmacology; Estrogen; Medicine; Cancer; Breast cancer; Human breast","score_opus":0.039552031104342425,"score_gpt":0.37520994452294076,"score_spread":0.33565791341859835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262172886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934751,0.0025748382,0.000010544208,0.0010428252,0.000110974666,0.0016720508,0.00003177958,0.000013947874,0.0010679862],"genre_scores_gemma":[0.9989144,0.0002877886,0.000045601813,0.00007719077,0.00012985586,0.0003468324,0.000011993891,0.000045830016,0.00014050823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936108,0.0026565925,0.0005881016,0.00050501607,0.0016276177,0.0010119018],"domain_scores_gemma":[0.9904222,0.00793018,0.0001433321,0.00067551224,0.0006319167,0.00019689066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019089224,0.00023206769,0.0008031645,0.0007633429,0.00016550688,0.000038140028,0.0007093633,0.00012051559,0.000098017124],"category_scores_gemma":[0.0022520537,0.0001288606,0.00016995595,0.0023675698,0.0009863586,0.000120639386,0.0003556662,0.001317435,0.0000047192007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022244956,0.000721657,0.11244469,0.0021156808,0.00018111074,0.00018426555,0.0013079273,0.000029959288,0.85919493,0.0001868197,0.0003207148,0.0010673034],"study_design_scores_gemma":[0.0060971053,0.00024478458,0.40161633,0.0017661069,0.000029104845,0.000019000978,0.0006410519,0.00021055098,0.5890681,0.00015027262,0.000056281773,0.00010129399],"about_ca_topic_score_codex":0.06945585,"about_ca_topic_score_gemma":0.0013916638,"teacher_disagreement_score":0.28917164,"about_ca_system_score_codex":0.0006046859,"about_ca_system_score_gemma":0.0009671094,"threshold_uncertainty_score":0.9367407},"labels":[],"label_agreement":null},{"id":"W2264651442","doi":"","title":"Systemic administration of mutant vesicular stomatitis virus (VSV) completely eradicates nasopharyngeal carcinoma (NPC) models","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Vesicular stomatitis virus; Nasopharyngeal carcinoma; Cytotoxic T cell; Virology; Biology; Apoptosis; Multiplicity of infection; In vivo; Cancer research; In vitro; Molecular biology; Virus; Medicine; Radiation therapy; Internal medicine","score_opus":0.05633128785846851,"score_gpt":0.35415620380871454,"score_spread":0.297824915950246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264651442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874241,0.010417849,0.00020736744,0.00020542205,0.00006868968,0.00064990105,0.00025085587,0.000018387986,0.0007574795],"genre_scores_gemma":[0.99786824,0.0007601601,0.00006759,0.0000360921,0.00039349333,0.00028325795,0.0002453796,0.000054148048,0.0002916098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706125,0.0004412459,0.00041496058,0.0005456365,0.0008872158,0.00064966374],"domain_scores_gemma":[0.99850935,0.00004939671,0.000103100385,0.00064612954,0.0005378021,0.00015420027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086800696,0.0002001539,0.00028442638,0.00019694025,0.00019385158,0.00005378561,0.0005487198,0.00017847652,0.00010132635],"category_scores_gemma":[0.000031599546,0.00019849313,0.000116540665,0.00036683443,0.00039418344,0.000013668487,0.00014408477,0.00028135438,0.00002104102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015847887,0.000110451525,0.00046682588,0.00015611332,0.000060940594,0.00004019396,0.000050303715,0.0010249846,0.9932903,0.00023924872,0.0017078333,0.0012680079],"study_design_scores_gemma":[0.0008352424,0.0020897696,0.00081391033,0.000064423315,0.00001020743,0.000041450938,0.000066265005,0.001341962,0.99343616,0.00038395278,0.0007179219,0.00019876169],"about_ca_topic_score_codex":0.0017113346,"about_ca_topic_score_gemma":0.0015383193,"teacher_disagreement_score":0.010444222,"about_ca_system_score_codex":0.00015324756,"about_ca_system_score_gemma":0.0008752571,"threshold_uncertainty_score":0.8094315},"labels":[],"label_agreement":null},{"id":"W2265030930","doi":"10.1158/0008-5472.can-15-2770","title":"STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Immunoediting; Immunosurveillance; Immune system; Tumor microenvironment; Cancer research; Biology; Carcinogenesis; Metastasis; STAT3; Breast cancer; Tumor progression; Mammary tumor; Tumor initiation; Cancer; Immunotherapy; Immunology; Pathology; Medicine; Signal transduction","score_opus":0.039013514009550415,"score_gpt":0.3383662543991735,"score_spread":0.2993527403896231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265030930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995689,0.0006954947,0.000015921765,0.002462504,0.00003698664,0.0005520149,0.0004911129,0.000011814435,0.000045154367],"genre_scores_gemma":[0.9988353,0.0003652026,0.00010417869,0.000030764226,0.00010183469,0.00018392112,0.0000025287607,0.000027867121,0.00034836342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985322,0.00013624069,0.00020232644,0.00031134326,0.00045695066,0.0003609561],"domain_scores_gemma":[0.99902683,0.00010906151,0.000052048035,0.0003883793,0.00022792506,0.00019572445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034536474,0.00011518717,0.000207687,0.00017895039,0.00019543602,0.00004588421,0.0001662239,0.000021739625,0.0003862939],"category_scores_gemma":[0.00009313306,0.00006229711,0.000050383172,0.00021468468,0.00023748247,0.00017577173,0.00017228055,0.00016740656,0.000006695559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004357805,0.000078359124,0.03822013,0.00010195151,0.000090714224,0.000020660398,0.00105549,0.0000014968499,0.9557617,0.000018653542,0.00012693473,0.0040881513],"study_design_scores_gemma":[0.000443918,0.000341204,0.3012347,0.00024180868,0.000029598808,0.00004288074,0.00040264687,5.7171326e-7,0.696619,0.000011500727,0.0005742565,0.000057963913],"about_ca_topic_score_codex":0.0028900488,"about_ca_topic_score_gemma":0.00007002698,"teacher_disagreement_score":0.26301455,"about_ca_system_score_codex":0.00014195679,"about_ca_system_score_gemma":0.00011649036,"threshold_uncertainty_score":0.43689084},"labels":[],"label_agreement":null},{"id":"W2271201097","doi":"10.1158/1538-7445.am2015-5081","title":"Abstract 5081: The IGF axis regulates hepatic stellate cell recruitment and activation during colorectal carcinoma liver metastasis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Hepatic stellate cell; Metastasis; Medicine; Tamoxifen; Stromal cell; Colorectal cancer; Cancer research; Internal medicine; Pathology; Endocrinology; Cancer; Breast cancer","score_opus":0.20861338059462173,"score_gpt":0.3944604311554381,"score_spread":0.18584705056081638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271201097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509966,0.0020522506,6.0561746e-7,0.0008056768,0.00008475581,0.0008230932,0.000009056942,0.000017679498,0.0011072013],"genre_scores_gemma":[0.99817175,0.00046763988,0.000026676784,0.0000605974,0.00017212446,0.00018824324,0.000011234269,0.000015603628,0.0008861072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986549,0.00028760065,0.00014275633,0.00028329078,0.00028969752,0.00034173636],"domain_scores_gemma":[0.9990492,0.00027885256,0.000046370125,0.00024669504,0.00022637178,0.0001525505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007869764,0.00010751522,0.00019834604,0.00010480012,0.00020534638,0.000017362812,0.00010133498,0.00009710144,0.00022274158],"category_scores_gemma":[0.00007961216,0.000070769536,0.00003638517,0.00019037914,0.00031793106,0.0000809316,0.00011852899,0.0004364406,0.000049851245],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003217315,0.00018961728,0.08381224,0.0005359979,0.00020181328,0.00023604128,0.007120503,0.00005267617,0.89357305,0.00005358069,0.002790027,0.008217143],"study_design_scores_gemma":[0.001014947,0.00037729272,0.57739437,0.00004802376,0.000038798193,0.000025099462,0.00044196183,0.00006125642,0.4197554,0.00018574412,0.00058238674,0.00007472692],"about_ca_topic_score_codex":0.0010183344,"about_ca_topic_score_gemma":0.000073495765,"teacher_disagreement_score":0.49358213,"about_ca_system_score_codex":0.0002260987,"about_ca_system_score_gemma":0.00024881776,"threshold_uncertainty_score":0.28858978},"labels":[],"label_agreement":null},{"id":"W2274299408","doi":"10.1158/0008-5472.can-15-1551","title":"A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk","year":2016,"lang":"en","type":"review","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute on Aging; Niilo Helanderin Säätiö; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Prostate cancer; Prospective cohort study; Oncology; Medicine; Internal medicine; Cancer; Meta-analysis; Confidence interval; Prostate; Logistic regression","score_opus":0.7311588476992905,"score_gpt":0.5504153431900828,"score_spread":0.18074350450920773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274299408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042979177,0.92540616,0.000004260144,0.000102902064,0.00003229601,0.0013926439,0.030036204,0.000012873231,0.00003351308],"genre_scores_gemma":[0.090713836,0.9075612,0.000048554655,0.000010590806,0.00020817987,0.0003793804,0.0007240922,0.00006034581,0.0002938379],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99295264,0.001681411,0.0016871418,0.00092090445,0.0020195558,0.0007383494],"domain_scores_gemma":[0.9940992,0.0014287605,0.001719952,0.0014387171,0.00096657244,0.00034677333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0094125,0.00036916343,0.0056092893,0.001142304,0.00012702988,0.00004564337,0.0006801098,0.0004076217,0.00043616825],"category_scores_gemma":[0.0017192096,0.00023397781,0.00078026816,0.002194469,0.000211048,0.0002768479,0.0005791,0.00094173837,0.0000041027265],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031012325,0.00007692417,0.049715288,0.010608102,0.45845014,0.000006865191,0.00118905,0.0000010840641,0.000096598225,0.000011578745,0.00048352501,0.47932982],"study_design_scores_gemma":[0.0005526905,0.0002486332,0.05045477,0.0031566424,0.9075405,8.6226953e-7,0.00009544359,0.000010998511,0.00006984788,0.000052068113,0.03746742,0.00035014687],"about_ca_topic_score_codex":0.0024438698,"about_ca_topic_score_gemma":0.00018421272,"teacher_disagreement_score":0.47897968,"about_ca_system_score_codex":0.00032778803,"about_ca_system_score_gemma":0.0016843373,"threshold_uncertainty_score":0.95413387},"labels":[],"label_agreement":null},{"id":"W2281277401","doi":"10.1158/0008-5472.can-15-2406","title":"Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health","keywords":"Medicine; Adiponectin; Overweight; Multiple myeloma; Internal medicine; Quartile; Body mass index; Obesity; Population; Confidence interval; Cancer; Insulin resistance; Environmental health","score_opus":0.0788986461537108,"score_gpt":0.3767806936737487,"score_spread":0.29788204752003794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281277401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722826,0.0007967857,0.000015352645,0.0003834614,0.000015848109,0.00086339074,0.00040697824,0.000021633414,0.00026830836],"genre_scores_gemma":[0.9987087,0.0003322784,0.0001052504,0.0000122840565,0.000048531743,0.00019541831,0.000008775834,0.000036785852,0.00055192143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969784,0.00044813257,0.00028574403,0.00044448403,0.0010929095,0.0007503272],"domain_scores_gemma":[0.99717104,0.0015655834,0.00014032444,0.0003352009,0.000471857,0.00031599827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013483096,0.00016336663,0.00042369493,0.00046129923,0.00013294333,0.000022339007,0.00012339285,0.00012362325,0.0002902834],"category_scores_gemma":[0.0042322595,0.0000987172,0.00004352734,0.0007402912,0.00033016197,0.00013398784,0.00012958334,0.0004391316,0.000012170179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047870135,0.00026507457,0.9301427,0.00012603057,0.00025580142,0.00020286739,0.00037712738,0.0000025120903,0.035785966,0.000008208332,0.0000722906,0.032282747],"study_design_scores_gemma":[0.008527398,0.0004199507,0.9418162,0.0023609747,0.00002108598,0.000010922151,0.00017928376,0.000108685526,0.04632967,0.00007639157,0.000039714345,0.00010971793],"about_ca_topic_score_codex":0.0014297117,"about_ca_topic_score_gemma":0.0025885364,"teacher_disagreement_score":0.03217303,"about_ca_system_score_codex":0.00051992765,"about_ca_system_score_gemma":0.000410117,"threshold_uncertainty_score":0.50667155},"labels":[],"label_agreement":null},{"id":"W2281699589","doi":"10.1158/1538-7445.transcagen-a2-07","title":"Abstract A2-07: Integrative functional genomics of breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Synthetic lethality; Druggability; Breast cancer; Cancer; Small hairpin RNA; Biology; Epigenetics; Cancer research; Somatic cell; Computational biology; Gene; Genomics; Functional genomics; Copy-number variation; Drug discovery; Genetics; Bioinformatics; Genome; Gene knockdown; DNA repair","score_opus":0.11183959317875541,"score_gpt":0.40342195205910875,"score_spread":0.29158235888035333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281699589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032784,0.0032433781,0.0003360568,0.0011325703,0.0004052332,0.0002051057,0.00017923756,0.000007392433,0.0041631768],"genre_scores_gemma":[0.9953269,0.0009739324,0.000045600376,0.000078381025,0.00056008203,0.00019542404,0.000056035868,0.000017880575,0.002745791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886954,0.00007158239,0.00016491904,0.00029913752,0.00036575587,0.00022906708],"domain_scores_gemma":[0.99860597,0.000011547308,0.000068378955,0.000278802,0.00087872206,0.00015659216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040486176,0.00009546118,0.000106611085,0.00008385915,0.00006201206,0.000018111392,0.00020951127,0.0001098014,0.0005833905],"category_scores_gemma":[0.000049441554,0.00007875194,0.000051288676,0.00018499463,0.00018210686,0.0000058197456,0.000097531345,0.00019119066,0.000027797318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003790481,0.000045110868,0.0019548456,0.000016530752,0.000035285557,4.22882e-7,0.00013394623,0.00022835728,0.8899603,0.000119746255,0.099626414,0.007500027],"study_design_scores_gemma":[0.00082051364,0.000107427746,0.047466613,0.000059994414,0.00000717913,0.0000043686164,0.0013036429,0.00003467635,0.78087574,0.0002540868,0.16889657,0.00016920704],"about_ca_topic_score_codex":0.00039712273,"about_ca_topic_score_gemma":0.00019093149,"teacher_disagreement_score":0.10908454,"about_ca_system_score_codex":0.00016641444,"about_ca_system_score_gemma":0.0012589047,"threshold_uncertainty_score":0.63877165},"labels":[],"label_agreement":null},{"id":"W2282228815","doi":"10.1158/0008-5472.can-14-2391","title":"Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Epigenetics; Suppressor; Cancer; Cancer research; Gene; Tumor suppressor gene; Biology; Calcium signaling; Signal transduction; Medicine; Carcinogenesis; Genetics","score_opus":0.07136098863494002,"score_gpt":0.37333210771239994,"score_spread":0.30197111907745994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282228815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577075,0.0033957039,0.00008172139,0.00030501824,0.00009931511,0.00022811847,0.000028792647,0.000003152838,0.00008739965],"genre_scores_gemma":[0.99740344,0.0019597048,0.000094991374,0.00003889239,0.000062855164,0.00019311067,0.000010263074,0.000024435263,0.00021228693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866426,0.00012132262,0.00023117899,0.0003489403,0.00026997147,0.00036430042],"domain_scores_gemma":[0.9994832,0.000037746446,0.00006314061,0.00016501013,0.0001915319,0.00005933926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003548661,0.00010282269,0.000119659446,0.00012120926,0.000058436643,0.000010636269,0.00021221573,0.00006958958,0.00010885229],"category_scores_gemma":[0.000118841504,0.00008084889,0.000030854197,0.00021148907,0.00011924334,0.000005048542,0.00014043908,0.00009391552,0.000002672307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007545912,0.000035536814,0.01134295,0.000035941972,0.000013985861,0.0000013951733,0.000068468624,0.00019968805,0.9824637,0.0000053145304,0.00029678244,0.0054607745],"study_design_scores_gemma":[0.0003869926,0.00008114009,0.025545329,0.0000864625,0.0000020361283,3.475532e-7,0.00010502076,0.0000068936383,0.9714026,0.000054750675,0.002214843,0.00011358053],"about_ca_topic_score_codex":0.0005288391,"about_ca_topic_score_gemma":0.00016126591,"teacher_disagreement_score":0.014202379,"about_ca_system_score_codex":0.000051428036,"about_ca_system_score_gemma":0.00027550786,"threshold_uncertainty_score":0.3296922},"labels":[],"label_agreement":null},{"id":"W2287398531","doi":"10.1158/0008-5472.can-15-1898","title":"Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Guelph; McMaster University; McMaster Children's Hospital; University of Calgary; Calgary Laboratory Services","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"DU145; Prostate cancer; Cancer research; Metastasis; Medicine; Cancer; Tramp; Prostate; Tumor progression; LNCaP; Oncology; Internal medicine","score_opus":0.09897801585726965,"score_gpt":0.43253324657944603,"score_spread":0.3335552307221764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287398531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97544795,0.009642882,0.000009111414,0.010820728,0.00013179956,0.0032682572,0.00008899085,0.00003041388,0.0005598442],"genre_scores_gemma":[0.983364,0.001737371,0.00024154245,0.00006407569,0.00020080995,0.0021930907,0.0000036673143,0.000047718222,0.012147721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971673,0.00030661884,0.00034047122,0.0004168842,0.0011295965,0.00063913676],"domain_scores_gemma":[0.99832815,0.00016554448,0.00014083667,0.00053006795,0.0006282822,0.00020710359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001058784,0.00017578031,0.0003439166,0.00016223128,0.00017282549,0.000025989515,0.00024689644,0.00004943837,0.0012655428],"category_scores_gemma":[0.00014181227,0.000077841905,0.000117860516,0.00062086305,0.0004810626,0.00011328572,0.00015944518,0.0003555858,0.000025779833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084120926,0.00015141683,0.002096647,0.0007588486,0.000043590157,0.000019627116,0.00037161316,0.0000013139665,0.7821947,0.00002777991,0.003295609,0.21019767],"study_design_scores_gemma":[0.0018775191,0.0007928061,0.0012533359,0.0015072223,0.000069288,0.000005351233,0.00016506141,0.000017520932,0.96903276,0.0001189098,0.025045605,0.00011461129],"about_ca_topic_score_codex":0.0008502412,"about_ca_topic_score_gemma":0.00021571592,"teacher_disagreement_score":0.21008305,"about_ca_system_score_codex":0.0002395493,"about_ca_system_score_gemma":0.0007144803,"threshold_uncertainty_score":0.99964744},"labels":[],"label_agreement":null},{"id":"W2290707026","doi":"10.1158/0008-5472.can-15-2782","title":"Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"National Cancer Institute; National Institutes of Health; Chesapeake Research Consortium; Cancer Research UK; Susan G. Komen for the Cure","keywords":"Cancer; Cancer research; Breast cancer; Oncogene; Carcinogenesis; Mammary tumor; Biology; Tumor progression; CDH1; Mouse mammary tumor virus; Cre recombinase; Suppressor; Immunology; Cell cycle; Cell; Genetically modified mouse; Transgene; Gene; Genetics","score_opus":0.12419411833151517,"score_gpt":0.5201761263797922,"score_spread":0.395982008048277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290707026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8129648,0.0056630247,0.000115307215,0.1656199,0.00042390247,0.0038370097,0.0002980244,0.00024780977,0.010830205],"genre_scores_gemma":[0.9883528,0.0012669928,0.0006267648,0.00090435793,0.0006717106,0.0019702397,0.000010143289,0.000107634725,0.0060893963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933889,0.00071415934,0.0005170747,0.0009833528,0.0026604247,0.0017361131],"domain_scores_gemma":[0.99503094,0.0017842174,0.00004739979,0.000997302,0.0012352238,0.0009049429],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025834853,0.00026720876,0.0005346646,0.00081213564,0.00017907404,0.00007956004,0.00058439985,0.00024040327,0.004251716],"category_scores_gemma":[0.005729342,0.00017708434,0.00011070683,0.0018752582,0.0012441451,0.00030466128,0.00049753673,0.0013526792,0.0008300897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005155063,0.0009330945,0.074042216,0.0016786561,0.00013224706,0.003852444,0.0017998264,3.2970462e-7,0.4454882,0.0028090437,0.28696138,0.17714751],"study_design_scores_gemma":[0.018321328,0.003439227,0.116332375,0.01788149,0.00004433492,0.00025031678,0.0011112684,0.00051511225,0.5751643,0.008636852,0.25701118,0.0012922239],"about_ca_topic_score_codex":0.0006262638,"about_ca_topic_score_gemma":0.00016052193,"teacher_disagreement_score":0.17585528,"about_ca_system_score_codex":0.0020252888,"about_ca_system_score_gemma":0.003372114,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2296551054","doi":"10.1158/1538-7445.brain15-b35","title":"Abstract B35: BMP regulation of cancer stem cell quiescence is responsible for chemotherapeutic resistance in glioblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"SOX2; Cancer stem cell; Cancer research; Temozolomide; Stem cell; Stem cell marker; Biology; Homeobox protein NANOG; Population; Cancer; Immunostaining; KLF4; Glioma; Pathology; Immunology; Medicine; Immunohistochemistry; Embryonic stem cell; Cell biology; Induced pluripotent stem cell; Genetics","score_opus":0.14138195317453311,"score_gpt":0.43325797185858156,"score_spread":0.29187601868404844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296551054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674709,0.023348501,0.0000481749,0.0046103126,0.00021497114,0.0013878308,0.00013879045,0.00002366034,0.002756848],"genre_scores_gemma":[0.98032707,0.0017226445,0.00048159919,0.00018646083,0.00019968442,0.0004549758,0.0000032758599,0.000047704525,0.016576594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764824,0.00007982793,0.00040978965,0.0004452292,0.00086469034,0.00055222143],"domain_scores_gemma":[0.99804217,0.00017559313,0.00013102894,0.000491589,0.0009338843,0.00022572845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015148469,0.00015196274,0.0003942933,0.00038599668,0.00005928859,0.000022138885,0.00019369739,0.00011820389,0.00034901843],"category_scores_gemma":[0.000051276176,0.00014185281,0.00009199321,0.0010268606,0.00023962805,0.00011494919,0.000044899993,0.00030991118,0.000011616596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021454958,0.00031635098,0.0052612564,0.0029672536,0.00008283687,0.000012272941,0.0044854293,0.000112238355,0.8806615,0.00034696487,0.04290323,0.04139574],"study_design_scores_gemma":[0.0035923028,0.0003025057,0.008481276,0.00085633405,0.000030961957,8.781572e-7,0.0007028551,0.000052874773,0.8984349,0.0005323258,0.08686109,0.00015171635],"about_ca_topic_score_codex":0.0019847169,"about_ca_topic_score_gemma":0.0055673984,"teacher_disagreement_score":0.043957863,"about_ca_system_score_codex":0.0009314068,"about_ca_system_score_gemma":0.0025016686,"threshold_uncertainty_score":0.57845896},"labels":[],"label_agreement":null},{"id":"W2308714960","doi":"10.1158/0008-5472.can-15-2128","title":"Ovarian Cancers Harboring Inactivating Mutations in <i>CDK12</i> Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genome instability; Cancer research; Biology; Genetics; Tandem repeat; BRCA2 Protein; Mutation; DNA damage; DNA; Germline mutation; Gene; Genome","score_opus":0.024800116455846087,"score_gpt":0.3177420023494144,"score_spread":0.29294188589356834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308714960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938703,0.00022979142,0.0035870848,0.0007552678,0.00006878202,0.00043330065,0.000719211,0.000012417189,0.00032384114],"genre_scores_gemma":[0.9974159,0.00020922953,0.00004011483,0.00006200169,0.00020945002,0.0012325498,0.00016339966,0.00002611652,0.00064121827],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99840474,0.00017138266,0.00028649557,0.00044414846,0.00017819103,0.00051504275],"domain_scores_gemma":[0.9992279,0.00006705735,0.000077674384,0.00036903706,0.00015417597,0.0001041667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005557114,0.00013301251,0.00014597598,0.00007627288,0.0002912372,0.00004965691,0.0002562799,0.00009616269,0.00016758981],"category_scores_gemma":[0.00010239248,0.00011082013,0.000047856345,0.0002228649,0.000121497986,0.000019926147,0.00018111449,0.00017256885,0.000011875016],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033089877,0.000055915436,0.18366747,0.00002466766,0.000024410534,0.0000010377919,0.00020284679,0.000005039268,0.81131774,0.00013274844,0.00011098991,0.0044240667],"study_design_scores_gemma":[0.003677809,0.00017246447,0.6358876,0.00019233898,0.000018553428,0.0000061839223,0.00083859876,0.00008007294,0.2533751,0.0002933659,0.10478524,0.0006726338],"about_ca_topic_score_codex":0.0016909346,"about_ca_topic_score_gemma":0.0026818377,"teacher_disagreement_score":0.5579426,"about_ca_system_score_codex":0.0005660998,"about_ca_system_score_gemma":0.00048747766,"threshold_uncertainty_score":0.4519114},"labels":[],"label_agreement":null},{"id":"W2310066925","doi":"10.1158/0008-5472.can-15-2194","title":"JPO2/CDCA7L and LEDGF/p75 Are Novel Mediators of PI3K/AKT Signaling and Aggressive Phenotypes in Medulloblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; University of Pennsylvania","keywords":"Medulloblastoma; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Phenotype; Malignancy; Metastasis; Biology; Signal transduction; Cancer; Cell biology; Genetics; Gene","score_opus":0.053607264515759694,"score_gpt":0.37890524573581613,"score_spread":0.32529798122005643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310066925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874294,0.009461441,0.000004910198,0.0025196595,0.00005049486,0.00035477604,0.00004108021,0.000009231659,0.00012900963],"genre_scores_gemma":[0.99785584,0.001661459,0.000088190216,0.00003936083,0.00010315212,0.00014559437,0.0000015793115,0.000019871572,0.000084937135],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986188,0.000058135807,0.00020019159,0.00031636364,0.00046007073,0.0003464526],"domain_scores_gemma":[0.99879545,0.00047761152,0.00009494431,0.00018167551,0.00023937946,0.00021096639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035308476,0.00011929779,0.00031613914,0.00030527875,0.00005736565,0.000012910604,0.00006814918,0.00007894199,0.00015653847],"category_scores_gemma":[0.00043505817,0.0000738745,0.000028511062,0.00028783633,0.0003440617,0.00006320212,0.00010017149,0.00014976124,0.000006116875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053159986,0.0003284049,0.57067204,0.0002965533,0.00014220102,0.00031053167,0.0009641052,0.000002069686,0.38149074,0.00032627137,0.00066073774,0.044274747],"study_design_scores_gemma":[0.01075222,0.00072148215,0.2743112,0.0048260405,0.00006866541,0.000048456917,0.0011505202,0.000023776349,0.7062539,0.00041143043,0.0012136345,0.0002187026],"about_ca_topic_score_codex":0.0004678741,"about_ca_topic_score_gemma":0.0004581538,"teacher_disagreement_score":0.32476312,"about_ca_system_score_codex":0.00014959848,"about_ca_system_score_gemma":0.00017492543,"threshold_uncertainty_score":0.30125147},"labels":[],"label_agreement":null},{"id":"W2312038691","doi":"10.1158/1538-7445.sabcs15-p6-06-03","title":"Abstract P6-06-03: Novel hereditary breast cancer gene mutations: Should there be greater concern regarding ovarian cancer risk?","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PALB2; Ovarian cancer; Breast cancer; Proband; Medicine; Cancer; Oncology; Germline mutation; Internal medicine; Mutation; Genetics; Cancer research; Gynecology; Biology; Gene","score_opus":0.10374267629318808,"score_gpt":0.39480265988806623,"score_spread":0.29105998359487817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312038691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963599,0.013611886,0.00070425647,0.011711292,0.0010796358,0.000846246,0.0072205993,0.000057799665,0.0011692533],"genre_scores_gemma":[0.9798925,0.007626389,0.0003463546,0.0005138874,0.0033112916,0.0020003505,0.00015191584,0.00015432392,0.006002993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99629545,0.0001915675,0.0004596335,0.0011586543,0.0008475486,0.0010471315],"domain_scores_gemma":[0.9973523,0.00011364097,0.00019363583,0.0009567118,0.0010826987,0.0003009993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000823236,0.00039001566,0.00032027156,0.00019650794,0.0005359552,0.000114255316,0.000745902,0.0004126692,0.0027792004],"category_scores_gemma":[0.00013900804,0.00029802995,0.00015998851,0.00046238114,0.00066389964,0.00004624832,0.0003273311,0.0005544649,0.00008456753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045951904,0.00008003233,0.0355899,0.00008083792,0.00067207206,0.000029037226,0.00043422988,0.0010384924,0.87727374,0.000030906464,0.057456147,0.0268551],"study_design_scores_gemma":[0.0054418356,0.000177391,0.1291253,0.00064220926,0.00016553898,0.000093833936,0.0007103524,0.00007627873,0.6890906,0.0003104296,0.17291257,0.0012536227],"about_ca_topic_score_codex":0.008500499,"about_ca_topic_score_gemma":0.0058051343,"teacher_disagreement_score":0.18818308,"about_ca_system_score_codex":0.0012473994,"about_ca_system_score_gemma":0.0021578246,"threshold_uncertainty_score":0.9999472},"labels":[],"label_agreement":null},{"id":"W2312242410","doi":"10.1158/1538-7445.am2013-4940","title":"Abstract 4940: Prognostic significance of Fbw7 in human melanoma and its role in cell migration.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Melanoma; Gene knockdown; Ubiquitin ligase; Cancer research; Tissue microarray; Cell migration; Cancer; MAPK/ERK pathway; Cell growth; Biology; Medicine; Cell; Ubiquitin; Cell culture; Internal medicine; Kinase; Cell biology; Gene; Genetics","score_opus":0.03850026839509161,"score_gpt":0.3321735292689539,"score_spread":0.29367326087386225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312242410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930522,0.0043374,9.555099e-7,0.00013359996,0.00001118214,0.0006224562,0.000019901678,0.00000223838,0.0018200935],"genre_scores_gemma":[0.9986953,0.00037675726,0.00002279761,0.000014392438,0.000046185683,0.0005024542,0.000021335554,0.000008968782,0.00031179425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999095,0.00008781095,0.00016669054,0.00024120792,0.00014996715,0.00025931443],"domain_scores_gemma":[0.9996131,0.000031529362,0.000033793935,0.00013783306,0.0001243548,0.000059374157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003625459,0.00007175866,0.00009848466,0.000092802584,0.000034371762,0.000018995464,0.00013713875,0.00009325453,0.0001488855],"category_scores_gemma":[0.0000679506,0.00006932383,0.000016232909,0.00014614008,0.000073324554,0.000006560094,0.00006682135,0.00018015942,0.000012836947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019162995,0.000054833523,0.037889767,0.00010469632,0.0000027864571,0.0000020870568,0.00016221224,0.00001620765,0.9606092,0.000027370996,0.00023306246,0.0008785992],"study_design_scores_gemma":[0.0003234864,0.00014370958,0.083028115,0.000044577722,6.993351e-7,4.1608186e-7,0.00013952068,0.00002443827,0.9153144,0.0002009153,0.00070463045,0.000075108575],"about_ca_topic_score_codex":0.00162615,"about_ca_topic_score_gemma":0.0013758782,"teacher_disagreement_score":0.045294832,"about_ca_system_score_codex":0.000021666496,"about_ca_system_score_gemma":0.00012345768,"threshold_uncertainty_score":0.28269437},"labels":[],"label_agreement":null},{"id":"W2312250478","doi":"10.1158/1538-7445.am2013-5456","title":"Abstract 5456: The E3 ubiquitin ligase Siah2 regulates the androgen receptor activity and contributes to castration-resistant prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ubiquitin ligase; Prostate cancer; Androgen receptor; Cancer research; Biology; Carcinogenesis; Cancer; Ubiquitin; Gene; Genetics","score_opus":0.0575119219321257,"score_gpt":0.3926918297648122,"score_spread":0.33517990783268653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312250478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8944379,0.010265967,7.077736e-7,0.09058651,0.00009431893,0.0038956269,0.00018026035,0.00003693877,0.00050177524],"genre_scores_gemma":[0.9836783,0.0045579476,0.000015203148,0.00036062705,0.00032593534,0.00403068,0.000022297201,0.000040355393,0.006968658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715215,0.00023024181,0.000266309,0.0005254915,0.00087139173,0.0009544337],"domain_scores_gemma":[0.99743354,0.0006163981,0.00006733967,0.0005678435,0.00092352054,0.00039138194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013069016,0.00023296164,0.00031738015,0.00015174155,0.0009025069,0.0003789075,0.0003012859,0.0001041887,0.0010555225],"category_scores_gemma":[0.0002565382,0.0001182826,0.00007278252,0.0007453895,0.00076261774,0.00020491058,0.00020456711,0.0007455766,0.00010973102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023010918,0.00012919932,0.00694096,0.00024480536,0.00031628623,0.000032857726,0.0014708505,0.000015453174,0.86474913,0.0001359475,0.065002024,0.058661386],"study_design_scores_gemma":[0.0024440296,0.0005229978,0.21435812,0.0005410817,0.000058229016,0.000008682339,0.001584215,0.00006851918,0.74564236,0.0004965221,0.03404993,0.0002252896],"about_ca_topic_score_codex":0.012588443,"about_ca_topic_score_gemma":0.0021338216,"teacher_disagreement_score":0.20741716,"about_ca_system_score_codex":0.00059025746,"about_ca_system_score_gemma":0.0011642838,"threshold_uncertainty_score":0.99985766},"labels":[],"label_agreement":null},{"id":"W2312265193","doi":"10.1158/1538-7445.am2013-5289","title":"Abstract 5289: Identification of basal-like subtype-specific MicroRNAs in lymph node negative breast cancer .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Breast cancer; Subtyping; Lymph node; Oncology; Medicine; microRNA; Internal medicine; Cancer; Cytokeratin; Cancer research; Pathology; Biology; Immunohistochemistry; Gene","score_opus":0.029671405019686795,"score_gpt":0.3422177502677492,"score_spread":0.3125463452480624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312265193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232423,0.004095882,0.00040261628,0.0010547265,0.0002840112,0.0009733067,0.00023924066,0.000011042418,0.00061493804],"genre_scores_gemma":[0.9920821,0.005199874,0.00006862465,0.000087982335,0.00024424295,0.0008860429,0.00006534442,0.000067283225,0.0012985112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706125,0.00022594462,0.00048251974,0.0007239486,0.00074488006,0.000761463],"domain_scores_gemma":[0.9977661,0.000049809947,0.00014112858,0.00072343124,0.0011328434,0.00018670714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085287786,0.0002058714,0.00023964971,0.00035880905,0.00011170222,0.00008461561,0.0006177434,0.00028855578,0.0015777163],"category_scores_gemma":[0.00008863395,0.00021103691,0.00010406049,0.0007879672,0.00034798,0.00002295218,0.00026749496,0.0004921493,0.00013795152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002537843,0.000099676705,0.0009070167,0.00008920069,0.000059084807,0.00000559487,0.000106638756,0.00041193306,0.9827294,0.000039937684,0.008007169,0.007290574],"study_design_scores_gemma":[0.00092575495,0.00003799136,0.089908004,0.00012043343,0.000004161928,0.0000044426183,0.00020408967,0.00009641866,0.9059229,0.00023460384,0.0023253215,0.00021586553],"about_ca_topic_score_codex":0.009716886,"about_ca_topic_score_gemma":0.000990859,"teacher_disagreement_score":0.089000985,"about_ca_system_score_codex":0.00044023912,"about_ca_system_score_gemma":0.0008349078,"threshold_uncertainty_score":0.999335},"labels":[],"label_agreement":null},{"id":"W2312291368","doi":"10.1158/1538-7445.am2011-4071","title":"Abstract 4071: Sestrins modulate the expression of the metabolic stress sensor AMPK in breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"AMPK; Protein kinase A; Immunoprecipitation; Chemistry; Cell biology; Gene knockdown; AMP-activated protein kinase; Chromatin immunoprecipitation; Protein subunit; Cancer cell; Molecular biology; Cancer research; Phosphorylation; Biology; Gene expression; Cancer; Biochemistry; Apoptosis; Gene","score_opus":0.05406978999846279,"score_gpt":0.33619141100869177,"score_spread":0.282121621010229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312291368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958045,0.0023129098,0.0000048025345,0.0002506263,0.00016375435,0.00037119508,0.0004526286,0.0000032910605,0.0006363297],"genre_scores_gemma":[0.99588716,0.0032745954,0.000026544718,0.000052835425,0.00024801795,0.00013684113,0.000008642091,0.000024918047,0.00034042902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847174,0.00018120313,0.00023793643,0.0003764183,0.0002962014,0.00043653013],"domain_scores_gemma":[0.99888605,0.000030211922,0.000103123944,0.0006640339,0.0002366981,0.00007987556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003266552,0.00015068882,0.0001769104,0.000051250456,0.00011468745,0.000016435099,0.00070216693,0.00012860571,0.00017951877],"category_scores_gemma":[0.000028997121,0.00009116054,0.00010025285,0.00021476425,0.00041957316,0.0000062993654,0.0003565251,0.0003696576,0.0000043829796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001527085,0.00007968387,0.0172821,0.000037648548,0.000028528644,0.000001181419,0.00037009714,0.00023304194,0.9802089,0.000013247165,0.0006212828,0.0009716298],"study_design_scores_gemma":[0.00027960484,0.000013527046,0.15570301,0.00007529769,0.00000623217,8.5488705e-7,0.00027777188,0.0000039371803,0.8422681,0.00007780109,0.001199526,0.00009433343],"about_ca_topic_score_codex":0.0028660148,"about_ca_topic_score_gemma":0.00063098146,"teacher_disagreement_score":0.13842091,"about_ca_system_score_codex":0.000036506186,"about_ca_system_score_gemma":0.00022852792,"threshold_uncertainty_score":0.4332576},"labels":[],"label_agreement":null},{"id":"W2312366560","doi":"10.1158/1538-7445.am2012-4872","title":"Abstract 4872: ICGC PedBrain Tumor - Next-generation sequencing identifies novel subgroup-specific mutations and copy number aberrations in medulloblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Biology; Copy-number variation; Genetics; Exome sequencing; Gene; Indel; ATRX; Transcriptome; Cancer; DNA sequencing; Exome; Genome; Somatic evolution in cancer; Somatic cell; Wnt signaling pathway; Mutation; Genotype; Single-nucleotide polymorphism","score_opus":0.13372805579033695,"score_gpt":0.3778872657351249,"score_spread":0.24415920994478793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312366560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492776,0.002923931,0.0003241678,0.00032082113,0.00030461414,0.0002916072,0.00011813425,0.0000071283002,0.0007818102],"genre_scores_gemma":[0.9965744,0.0013155082,0.00032495896,0.00010261251,0.000942903,0.00024438,0.00020069558,0.000028390428,0.0002661395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869144,0.000053398653,0.00024157604,0.00032047252,0.00023753903,0.0004555973],"domain_scores_gemma":[0.999272,0.00008409607,0.000050878636,0.0002430334,0.0001950969,0.00015489601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119645,0.00012485997,0.00011625037,0.00010984854,0.00023708068,0.00016641914,0.00012696239,0.000094013194,0.00016397286],"category_scores_gemma":[0.00018234574,0.00013650685,0.000035239293,0.00023135409,0.00017571934,0.000035573477,0.00010096493,0.000217999,0.000025308615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027090035,0.000058328067,0.008867108,0.000022520053,0.00001491026,0.0000026640607,0.00051969994,0.00026504317,0.98232657,0.0007886624,0.0064980243,0.00060937606],"study_design_scores_gemma":[0.0016394241,0.000121976685,0.07419554,0.00009531888,0.000018533936,0.000051288407,0.0027330501,0.00054744363,0.8683065,0.0003742387,0.05127151,0.0006451279],"about_ca_topic_score_codex":0.0010976503,"about_ca_topic_score_gemma":0.0056067705,"teacher_disagreement_score":0.11402003,"about_ca_system_score_codex":0.00020069053,"about_ca_system_score_gemma":0.00032668555,"threshold_uncertainty_score":0.55665874},"labels":[],"label_agreement":null},{"id":"W2312375518","doi":"10.1158/0008-5472.can-15-1501","title":"PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cegep de Saint Hyacinthe; Université du Québec à Trois-Rivières; McGill University; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Prostate Cancer Canada; U.S. Department of Defense","keywords":"PTEN; Prostate; Character (mathematics); Cancer research; Prostate cancer; Internal medicine; Medicine; Biology; Endocrinology; Oncology; Cancer; Apoptosis; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.03077824690191469,"score_gpt":0.33180894359621205,"score_spread":0.3010306966942974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312375518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882681,0.0059861406,0.00007798935,0.0036711649,0.00009370912,0.0011402532,0.0006617205,0.000003726716,0.00009721614],"genre_scores_gemma":[0.9975811,0.0011272021,0.000029169789,0.00014242,0.000097364835,0.0006916209,0.000013019015,0.000016368811,0.00030172843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981731,0.00023298946,0.0002531472,0.0004041326,0.00047736987,0.00045924945],"domain_scores_gemma":[0.99809086,0.00018208497,0.000111459565,0.00085895916,0.0006774379,0.000079223115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009092203,0.00012569204,0.00016609041,0.000046982583,0.0001485036,0.000016558324,0.0007073787,0.000058843143,0.00008615123],"category_scores_gemma":[0.00087017455,0.000058469628,0.00006913006,0.00032121982,0.00090825855,0.00000695979,0.00053126266,0.000121292105,0.000010527001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061581336,0.000040710893,0.0018707174,0.0000682856,0.000027938191,8.198599e-7,0.0003295075,0.000040349783,0.98774654,0.0009636135,0.0044506392,0.003845073],"study_design_scores_gemma":[0.00029926954,0.000553523,0.012668818,0.00010448157,0.00000758962,6.3592546e-7,0.0002023437,8.0777795e-7,0.9788635,0.00037884113,0.0068330914,0.00008709145],"about_ca_topic_score_codex":0.002658864,"about_ca_topic_score_gemma":0.00085775903,"teacher_disagreement_score":0.010798101,"about_ca_system_score_codex":0.00013944048,"about_ca_system_score_gemma":0.000689963,"threshold_uncertainty_score":0.4019425},"labels":[],"label_agreement":null},{"id":"W2312422559","doi":"10.1158/1538-7445.am2011-5235","title":"Abstract 5235: Surgical stress promotes the development of cancer metastases by coagulation dependent inhibition of natural-killer cell mediated tumor cell clearance","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Surgical stress; Fibrin; Cancer; Platelet; Metastasis; Perioperative; Coagulation; Cell; Pathology; Fibrinogen; Natural killer cell; Cancer cell; Cancer research; Immunology; Surgery; Internal medicine; Cytotoxicity; Chemistry","score_opus":0.066093754265381,"score_gpt":0.35934950363566365,"score_spread":0.29325574937028265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312422559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914682,0.00521814,0.000005703418,0.0002788406,0.00014417736,0.001107203,0.00008220281,0.000016363776,0.001679185],"genre_scores_gemma":[0.997453,0.0015900851,0.0001232412,0.00003029517,0.00005398262,0.00034797576,0.000073368676,0.000025922194,0.00030215774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763614,0.00012668916,0.00049918983,0.0003106957,0.0010384033,0.00038889432],"domain_scores_gemma":[0.99880487,0.00015120767,0.00021611642,0.00027300091,0.00044657345,0.00010825783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091068796,0.00015420106,0.00039085915,0.00014446417,0.00012950586,0.000013129161,0.00017247345,0.000058069345,0.0012983767],"category_scores_gemma":[0.000036114714,0.000102924365,0.00006957832,0.00033891317,0.00021025707,0.00008694642,0.00011734439,0.00033722332,0.000014386476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003934784,0.010186964,0.029065823,0.008626269,0.001074117,0.00017431293,0.019864514,0.00022643269,0.8548774,0.0002830303,0.031997338,0.039689004],"study_design_scores_gemma":[0.0012026116,0.00014683079,0.107771866,0.0004199929,0.00006246124,5.9385593e-7,0.00063447346,0.000028348564,0.88685167,0.0000148331565,0.002754283,0.000112043206],"about_ca_topic_score_codex":0.0028454685,"about_ca_topic_score_gemma":0.00092022,"teacher_disagreement_score":0.07870604,"about_ca_system_score_codex":0.00019355743,"about_ca_system_score_gemma":0.00036945308,"threshold_uncertainty_score":0.9996146},"labels":[],"label_agreement":null},{"id":"W2312452780","doi":"10.1158/1538-7445.am2011-918","title":"Abstract 918: A key role for Crk adaptor proteins in basal breast cancer tumor growth <i>in vivo</i>","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Armand Frappier Museum; Institut National de la Recherche Scientifique; McGill University","funders":"","keywords":"Adapter molecule crk; Cancer research; Biology; Gene knockdown; Carcinogenesis; Breast cancer; Cell growth; Signal transducing adaptor protein; Cancer; Cell biology; Signal transduction; Cell culture; Biochemistry","score_opus":0.07848586488403189,"score_gpt":0.3778106964855508,"score_spread":0.2993248316015189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312452780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830365,0.0011737078,0.000013640238,0.0027751685,0.00009128332,0.0041515636,0.0003537395,0.000042425207,0.008361935],"genre_scores_gemma":[0.989848,0.00046580035,0.0004450015,0.00028843046,0.0003885119,0.0059091626,0.0000085919955,0.00011205443,0.0025344475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957149,0.0001720456,0.00047378847,0.0007932034,0.0013573115,0.0014887387],"domain_scores_gemma":[0.9979127,0.0002124941,0.00006127069,0.00051263074,0.00078133505,0.0005195771],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016783731,0.00024965106,0.00048358462,0.0006391396,0.00011437871,0.00004445728,0.00050200016,0.00016020259,0.004605781],"category_scores_gemma":[0.00035762606,0.00022184166,0.0001279222,0.0012016642,0.00028460988,0.00016101704,0.00021999548,0.0012454364,0.00008396193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010282783,0.0014019522,0.095267944,0.0015557337,0.000070923634,0.00081640866,0.0017566329,0.000007081263,0.86432856,0.00030418215,0.015363175,0.008844606],"study_design_scores_gemma":[0.007260843,0.00072777504,0.3396254,0.0015591489,0.000016580607,0.000032175212,0.0008800165,0.00043920844,0.6388589,0.0007785664,0.009326446,0.00049492595],"about_ca_topic_score_codex":0.036521427,"about_ca_topic_score_gemma":0.008911978,"teacher_disagreement_score":0.24435744,"about_ca_system_score_codex":0.0011914147,"about_ca_system_score_gemma":0.0019234865,"threshold_uncertainty_score":0.99630415},"labels":[],"label_agreement":null},{"id":"W2312496231","doi":"10.1158/1538-7445.am2012-1222","title":"Abstract 1222: Met-dependent positive and negative signaling cascades in gastric cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Signal transduction; Autocrine signalling; Phosphorylation; Cancer research; Cell signaling; Receptor tyrosine kinase; Hepatocyte growth factor; C-Met; Cell biology; Biology; Cancer; Cancer cell; Cell growth; Receptor; Genetics","score_opus":0.0871102064614003,"score_gpt":0.42366493552085477,"score_spread":0.3365547290594545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312496231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981951,0.015553201,0.000030106667,0.0006022827,0.00022223276,0.0006680565,0.00006525252,0.000016654358,0.0008912273],"genre_scores_gemma":[0.99364233,0.0044757756,0.0001609226,0.00021921286,0.0006159713,0.00029960249,0.0000031555855,0.000036953294,0.00054605334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979479,0.000109227214,0.00021297554,0.00032299248,0.00061797525,0.00078894006],"domain_scores_gemma":[0.99897903,0.00024796175,0.00005146918,0.00016831241,0.00021166427,0.0003415435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009917242,0.00015946386,0.00030677245,0.0003516583,0.00011937324,0.000040127103,0.0000922943,0.000103974584,0.0014499092],"category_scores_gemma":[0.000034902452,0.00013496527,0.00004869504,0.00051248935,0.00012233401,0.00018290532,0.00006804462,0.000709382,0.00001916978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074059184,0.00015400261,0.008382647,0.0001278114,0.00012054636,0.00006830019,0.0041139433,0.0000380926,0.9408953,0.0002764158,0.00032816178,0.04475416],"study_design_scores_gemma":[0.0023697584,0.0002918772,0.05731718,0.00055966934,0.000033081353,0.000018273447,0.0021896637,0.00002330905,0.93566775,0.00035229058,0.0009712443,0.00020589444],"about_ca_topic_score_codex":0.013537469,"about_ca_topic_score_gemma":0.00084647135,"teacher_disagreement_score":0.04893453,"about_ca_system_score_codex":0.0007694646,"about_ca_system_score_gemma":0.00036630942,"threshold_uncertainty_score":0.9994629},"labels":[],"label_agreement":null},{"id":"W2312504486","doi":"10.1158/1538-7445.am2011-752","title":"Abstract 752: A CCR4 antagonist combined with protein-or DNA-based vaccines efficiently breaks tolerance and elicits CD8+T cells directed against self and viral associated tumor antigens","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Antigen; Immunology; Cytotoxic T cell; DNA vaccination; CCR4; CD8; Biology; Immune system; Chemokine; Chemokine receptor; Immunization","score_opus":0.02664362101442815,"score_gpt":0.28727886797029867,"score_spread":0.26063524695587054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312504486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926772,0.005156873,0.0000033799306,0.0001373774,0.00014796911,0.0012847569,0.00012150848,0.00018954375,0.00028140013],"genre_scores_gemma":[0.99702394,0.00054643856,0.000051100913,0.00015077213,0.000020244925,0.00024368925,0.000042425076,0.00005576485,0.0018656334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974054,0.0006091666,0.00035826705,0.0005765841,0.00014593436,0.00090461446],"domain_scores_gemma":[0.998682,0.00031612915,0.00016009857,0.0003767812,0.00039865906,0.00006630681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007839015,0.00033342044,0.0005014613,0.00025973824,0.0007748067,0.000086392865,0.0003071994,0.0002288192,0.00029514346],"category_scores_gemma":[0.00009070577,0.00024229039,0.000053626947,0.0004785789,0.00062242785,0.00013184857,0.00008981802,0.0006871734,0.000035769095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015174202,0.00059055927,0.0028047338,0.00011137184,0.00028586847,0.00006750616,0.0013087769,0.0000018649164,0.9778248,0.000013699331,0.00036315003,0.0014534798],"study_design_scores_gemma":[0.00660647,0.0016707875,0.112462536,0.00041352422,0.000024021194,0.000018440243,0.00019479077,0.000022462318,0.87529963,0.000007113439,0.0029133747,0.00036683015],"about_ca_topic_score_codex":0.0009515796,"about_ca_topic_score_gemma":0.0002630782,"teacher_disagreement_score":0.1096578,"about_ca_system_score_codex":0.00010694162,"about_ca_system_score_gemma":0.0005346334,"threshold_uncertainty_score":0.98803157},"labels":[],"label_agreement":null},{"id":"W2312510953","doi":"10.1158/0008-5472.sabcs11-p5-20-06","title":"P5-20-06: Survival in Women with Breast Cancer Who Used or Did Not Use Scalp Cooling in the Neoadjuvant/Adjuvant Setting.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal; Hôpital du Saint-Sacrement","funders":"","keywords":"Scalp; Medicine; Breast cancer; Hazard ratio; Population; Proportional hazards model; Internal medicine; Cancer; Surgery; Confidence interval","score_opus":0.11749577109362605,"score_gpt":0.3801999796861297,"score_spread":0.26270420859250365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312510953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329156,0.00041765612,0.000010524173,0.003927907,0.00008178613,0.0010421503,0.000106874075,0.000033983975,0.0010875323],"genre_scores_gemma":[0.9961441,0.0005335892,0.000039158767,0.0011211743,0.00020722965,0.000843428,0.000010413335,0.00006122317,0.0010396875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611205,0.00042967542,0.00037320587,0.00055709406,0.0011404955,0.0013874798],"domain_scores_gemma":[0.9983212,0.00042176683,0.000059047594,0.0005596671,0.0002927602,0.0003455676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002137125,0.00024519436,0.00051031733,0.00044077585,0.00015609441,0.0000779356,0.00042119707,0.00013418535,0.0008342437],"category_scores_gemma":[0.00026836427,0.00014436914,0.000042031534,0.0015282319,0.00038969397,0.00026146087,0.00011492557,0.0011318396,0.000033716464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02461709,0.0005031013,0.90303886,0.0003820805,0.000089159854,0.0009255743,0.040203344,0.00008294399,0.002477439,0.00008145532,0.0027720637,0.024826916],"study_design_scores_gemma":[0.0074095344,0.0005014223,0.9721634,0.0011433573,0.000019029436,0.000042517546,0.012865704,0.00032292094,0.00085632096,0.000038512364,0.004311816,0.00032550396],"about_ca_topic_score_codex":0.023843303,"about_ca_topic_score_gemma":0.03747472,"teacher_disagreement_score":0.06912453,"about_ca_system_score_codex":0.0006062329,"about_ca_system_score_gemma":0.0016084355,"threshold_uncertainty_score":0.982657},"labels":[],"label_agreement":null},{"id":"W2312520979","doi":"10.1158/1538-7445.am10-535a","title":"Abstract 535A: The tyrosine kinase Src co-operates with the ERM family member ezrin to promote Met activation and ECM degradation in a breast epithelial cell model","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ezrin; Proto-oncogene tyrosine-protein kinase Src; Invadopodia; Filopodia; Phosphorylation; Src family kinase; Cortactin; Cell biology; Moesin; Cancer research; Chemistry; Tyrosine phosphorylation; Cell migration; Biology; Cell; Cancer cell; Cytoskeleton; Cancer; Actin; Biochemistry","score_opus":0.0869883775831335,"score_gpt":0.4163157521679209,"score_spread":0.3293273745847874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312520979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710065,0.00016542891,0.00005328356,0.024627296,0.000042186402,0.002160759,0.00009626829,0.00002360101,0.0018246355],"genre_scores_gemma":[0.9961038,0.00020360664,0.00031294482,0.0004301709,0.000296761,0.00093507837,0.00002398923,0.00005954932,0.0016340894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970116,0.00018067943,0.00024181115,0.0005226863,0.0013435349,0.000699683],"domain_scores_gemma":[0.9981015,0.00028311243,0.000047570335,0.000664086,0.00062807935,0.00027569177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002672041,0.00020461078,0.00024300393,0.00027205163,0.00033228466,0.0001898865,0.00037230342,0.00012862429,0.00026262534],"category_scores_gemma":[0.00016693803,0.00010951828,0.00003177078,0.00088093936,0.00042347165,0.00020053521,0.00014416158,0.0018245203,0.000044920762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013434773,0.00014130505,0.0028627913,0.0001455991,0.000023538832,0.00001985007,0.0014020156,0.0004311911,0.9679034,0.00008539754,0.0041012014,0.021540262],"study_design_scores_gemma":[0.0035180892,0.0005850397,0.1367925,0.00050913496,0.000031030224,0.000043658754,0.0013704353,0.006958789,0.8359803,0.0001571495,0.013694314,0.00035955448],"about_ca_topic_score_codex":0.0049493224,"about_ca_topic_score_gemma":0.0030088217,"teacher_disagreement_score":0.1339297,"about_ca_system_score_codex":0.00036698676,"about_ca_system_score_gemma":0.0013354943,"threshold_uncertainty_score":0.79267347},"labels":[],"label_agreement":null},{"id":"W2312533745","doi":"10.1158/0008-5472.sabcs-3048","title":"Insulin like growth factor in breast cancer subtypes.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Cancer; Tissue microarray; Immunohistochemistry; Internal medicine; Insulin-like growth factor; Staining; Oncology; Stage (stratigraphy); Growth factor; Pathology; Receptor; Biology","score_opus":0.05790251149650323,"score_gpt":0.3749869839144363,"score_spread":0.3170844724179331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312533745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766495,0.0049114623,0.000003919717,0.014038866,0.00026948596,0.0006470115,0.0001112827,0.000083698564,0.0032847475],"genre_scores_gemma":[0.9894946,0.006675221,0.000029136549,0.0016359354,0.00059277826,0.00013628697,0.000019859415,0.000046109966,0.0013700388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966853,0.00015004793,0.00042242598,0.0006113513,0.0010424521,0.00108839],"domain_scores_gemma":[0.998286,0.00007904915,0.000054736793,0.00045857375,0.0006331927,0.0004884653],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052333,0.0002625005,0.00047560903,0.0007340759,0.00013730305,0.00005399901,0.00032806132,0.00025156097,0.0014266882],"category_scores_gemma":[0.000118267526,0.00022219251,0.00011329205,0.0017471685,0.00017858556,0.00025343205,0.00007990402,0.0013282222,0.00019733963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026803727,0.00089902326,0.76065177,0.00029404002,0.00011624739,0.00041936364,0.0020630553,0.000005760055,0.10945291,0.00074642967,0.050722472,0.07194854],"study_design_scores_gemma":[0.0023618746,0.00031804913,0.97709423,0.00027532259,0.000015748234,0.00002481474,0.00012015828,0.000034735516,0.01036892,0.0004012654,0.008715173,0.00026968395],"about_ca_topic_score_codex":0.004427561,"about_ca_topic_score_gemma":0.00025023025,"teacher_disagreement_score":0.21644247,"about_ca_system_score_codex":0.0008957118,"about_ca_system_score_gemma":0.0010001204,"threshold_uncertainty_score":0.99948615},"labels":[],"label_agreement":null},{"id":"W2312617417","doi":"10.1158/0008-5472.sabcs12-p4-02-05","title":"Abstract P4-02-05: A novel 64Cu-liposomal PET agent (MM-DX-929) predicts response to liposomal chemotherapeutics in preclinical breast cancer models","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Liposome; Doxorubicin; Cancer; Breast cancer; Irinotecan; Chemotherapy; Nuclear medicine; Pharmacology; Internal medicine; Colorectal cancer; Chemistry","score_opus":0.2516333324958117,"score_gpt":0.5070442895247834,"score_spread":0.2554109570289717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312617417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391187,0.00074079196,0.0008384332,0.05598464,0.0001918983,0.0018325505,0.0004321347,0.00020982607,0.00065105036],"genre_scores_gemma":[0.98911,0.0007746368,0.0033641737,0.0023820577,0.0011708481,0.0018482512,0.000021205895,0.000089259156,0.0012395679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958674,0.0001679431,0.00063297275,0.0006423607,0.0013566406,0.0013327232],"domain_scores_gemma":[0.9968923,0.0004921575,0.00007797619,0.0008636383,0.00040946863,0.0012644964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028394712,0.0002713603,0.00046992974,0.00035364882,0.00014900632,0.00005422981,0.0004979867,0.00021356455,0.0008935251],"category_scores_gemma":[0.00033416116,0.0002353931,0.00012647599,0.00086234626,0.00035767953,0.00020744215,0.0002948178,0.0014934287,0.00007059743],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014503387,0.0058733276,0.03317395,0.00078962493,0.000311821,0.0001726561,0.003355736,0.00024145316,0.7714469,0.0011548911,0.0933211,0.07565518],"study_design_scores_gemma":[0.011652798,0.0012885708,0.66328835,0.004951376,0.00024973243,0.00073107483,0.0004637526,0.027725333,0.058062278,0.0007947398,0.22925596,0.0015360316],"about_ca_topic_score_codex":0.0016743969,"about_ca_topic_score_gemma":0.00013657058,"teacher_disagreement_score":0.71338457,"about_ca_system_score_codex":0.00085215893,"about_ca_system_score_gemma":0.0011924483,"threshold_uncertainty_score":0.9783473},"labels":[],"label_agreement":null},{"id":"W2312621489","doi":"10.1158/0008-5472.sabcs-2103","title":"Assessment of barriers to patient participation in clinical trials among oncology outpatients at a community teaching hospital in Toronto.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto East General Hospital","funders":"","keywords":"Medicine; Clinical trial; Family medicine; Thematic analysis; Curiosity; Alternative medicine; Likert scale; Descriptive statistics; Test (biology); Internal medicine; Psychology; Qualitative research; Pathology; Social psychology","score_opus":0.7051530168662777,"score_gpt":0.7587013821568019,"score_spread":0.0535483652905242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312621489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850762,0.000093975505,0.00001280812,0.0037623215,0.00023813019,0.0021856907,0.000016379996,0.000010890033,0.008603586],"genre_scores_gemma":[0.99814904,0.0002883193,0.00038855636,0.00047330442,0.000096995915,0.0004138475,0.000015395995,0.000016789963,0.00015774455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9774922,0.016598798,0.0024587824,0.00047964737,0.002156154,0.00081442646],"domain_scores_gemma":[0.97231233,0.024738235,0.00027856496,0.00085173803,0.0008279127,0.0009912474],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.10062061,0.00013116297,0.0009843992,0.00029088985,0.00018019966,0.000018155379,0.00040776443,0.0005023705,0.00045734827],"category_scores_gemma":[0.18756813,0.0001136684,0.00015237878,0.00040534858,0.00042918418,0.00011989355,0.0005000026,0.006579817,0.0000068103486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014384097,0.0024167877,0.918701,0.000094097544,0.000032574302,0.000032515076,0.0067943656,0.000054354532,0.0009810011,0.0007140394,0.00048762604,0.068253264],"study_design_scores_gemma":[0.0032913783,0.01138929,0.9784635,0.00075764186,0.00001102141,1.7422772e-7,0.00400421,0.00028872173,0.0004933852,0.0008909388,0.0003098889,0.00009987083],"about_ca_topic_score_codex":0.026281465,"about_ca_topic_score_gemma":0.08528172,"teacher_disagreement_score":0.086947516,"about_ca_system_score_codex":0.006681875,"about_ca_system_score_gemma":0.0024918169,"threshold_uncertainty_score":0.9971313},"labels":[],"label_agreement":null},{"id":"W2312649718","doi":"10.1158/0008-5472.sabcs12-p3-04-11","title":"Abstract P3-04-11: Systemic treatment decision making for patients with stage I and II, hormone receptor positive, her2/neu negative breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Stage (stratigraphy); Adjuvant chemotherapy; Oncology; Demographics; Gynecology; HER2 negative; Cancer; Metastatic breast cancer","score_opus":0.027486734206954758,"score_gpt":0.35767271546776064,"score_spread":0.3301859812608059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312649718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897004,0.006770337,0.000046847632,0.00020476432,0.00013935607,0.0012565192,0.0025029164,0.000012348486,0.00009686677],"genre_scores_gemma":[0.9947407,0.0022903297,0.00033320306,0.000038624425,0.00043932276,0.0016433297,0.000113433605,0.00005613376,0.00034486954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812907,0.00006873461,0.00019297666,0.00053108943,0.00036703024,0.0007111219],"domain_scores_gemma":[0.998802,0.00012989265,0.00010135266,0.00028530153,0.00050634873,0.00017508033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020236392,0.00028038956,0.00027423483,0.0000834048,0.0004943915,0.000041735362,0.00013103955,0.00010209485,0.000058829064],"category_scores_gemma":[0.000032015763,0.00020271799,0.00006144018,0.00015728151,0.00020385114,0.00002646782,0.00017046113,0.000103139566,0.0000038464955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016196074,0.0014335214,0.78286934,0.00025393194,0.0015590938,0.000004970305,0.0026678194,0.000060845337,0.061778057,0.000041560426,0.0073281187,0.12580667],"study_design_scores_gemma":[0.006243001,0.0014595723,0.96373963,0.0006345394,0.00009295334,0.000009702306,0.0008043492,0.0000045078123,0.021228103,0.000010973898,0.0053033624,0.00046932054],"about_ca_topic_score_codex":0.0017255875,"about_ca_topic_score_gemma":0.0010444224,"teacher_disagreement_score":0.18087028,"about_ca_system_score_codex":0.00066143635,"about_ca_system_score_gemma":0.00020632721,"threshold_uncertainty_score":0.82666},"labels":[],"label_agreement":null},{"id":"W2312809053","doi":"10.1158/0008-5472.sabcs12-p1-05-06","title":"Abstract P1-05-06: A novel mutation in the tyrosine kinase domain of ErbB2: molecular and proteomic investigation of its role in breast cancer invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Transfection; Molecular biology; Stable isotope labeling by amino acids in cell culture; Mutant; Receptor tyrosine kinase; Cancer research; Cancer cell; Mutation; Cancer; Cell culture; Gene; Proteomics; Cell biology; Kinase; Genetics","score_opus":0.08177840667425737,"score_gpt":0.41042282887034487,"score_spread":0.32864442219608747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312809053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369174,0.0020267284,0.000008544978,0.0033816688,0.000006254794,0.0007362818,0.000043202817,0.0000030627755,0.00010249018],"genre_scores_gemma":[0.99905264,0.00022410789,0.00009560869,0.000064537904,0.000059744194,0.00047240857,0.0000144318155,0.000008606876,0.0000079079455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904263,0.00005781086,0.00022549031,0.00013782077,0.00032809036,0.00020814672],"domain_scores_gemma":[0.9994901,0.00009523294,0.000056723835,0.00014359922,0.00011860708,0.000095761294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086694845,0.000066095374,0.00013425857,0.00010417244,0.000028652701,0.000006023259,0.00008321665,0.00006430067,0.000039952924],"category_scores_gemma":[0.000076469034,0.00005083306,0.000017896187,0.0005419173,0.00018281073,0.00008897712,0.000024744617,0.00032012846,0.0000010730423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015308184,0.00014056731,0.026906356,0.00045071403,0.0000056650233,0.000003015412,0.0010295149,0.000042014926,0.97010356,0.0003027432,0.00003335149,0.0008294153],"study_design_scores_gemma":[0.00083943695,0.000012250761,0.3365592,0.00032560047,0.0000070428973,0.000010165268,0.00024441327,0.00008088263,0.6616687,0.00017968538,0.000038303875,0.000034269295],"about_ca_topic_score_codex":0.00058213325,"about_ca_topic_score_gemma":0.000026013251,"teacher_disagreement_score":0.30965284,"about_ca_system_score_codex":0.0001256708,"about_ca_system_score_gemma":0.00017964815,"threshold_uncertainty_score":0.2072912},"labels":[],"label_agreement":null},{"id":"W2312840436","doi":"10.1158/1538-7445.am10-2975","title":"Abstract 2975: Two putative founder MSH6 mutations associated with inherited cancer susceptibility in Ashkenazi Jewish population","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"MSH6; Lynch syndrome; MLH1; MSH2; Genetics; Population; Gene duplication; Colorectal cancer; Cancer; Medicine; Exon; Mutation; Biology; DNA mismatch repair; Gene","score_opus":0.10225983594255436,"score_gpt":0.456214629453218,"score_spread":0.3539547935106636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312840436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953432,0.00024080552,0.000014429287,0.0012460811,0.00039821066,0.0014322066,0.00014505156,0.00007451374,0.0011055066],"genre_scores_gemma":[0.99773514,0.000042913816,0.000264761,0.00011666563,0.00022945816,0.0008971194,0.0001873353,0.00006597141,0.00046060927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967451,0.00021929291,0.00040701186,0.0006712257,0.0011852891,0.00077206513],"domain_scores_gemma":[0.9973773,0.0005383861,0.00012350062,0.0004302609,0.0012609604,0.00026963576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012583915,0.00023288316,0.00038784603,0.0003884611,0.00020273912,0.00007376039,0.00019829963,0.0002328843,0.0030042252],"category_scores_gemma":[0.0011886823,0.00020153123,0.000064081665,0.0016118233,0.0004294729,0.00018672185,0.00007244153,0.0018798966,0.00002257741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048011224,0.0002897297,0.8402584,0.00008911348,0.00012106917,0.00004043881,0.0011780971,0.0010229175,0.14509274,0.000039601204,0.00037432794,0.011013414],"study_design_scores_gemma":[0.0026449682,0.0002526684,0.9858017,0.00023381061,0.00003281402,0.0000042179563,0.00036357375,0.00038156268,0.0085898265,0.0012684786,0.00019984882,0.00022653695],"about_ca_topic_score_codex":0.021008167,"about_ca_topic_score_gemma":0.26721907,"teacher_disagreement_score":0.2462109,"about_ca_system_score_codex":0.001999888,"about_ca_system_score_gemma":0.0013478218,"threshold_uncertainty_score":0.99790716},"labels":[],"label_agreement":null},{"id":"W2312886965","doi":"10.1158/1538-7445.am10-4586","title":"Abstract 4586: MRM-based targeted analysis of potential cancer markers in blood","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Selected reaction monitoring; Cancer; Multiplex; Biology; Triple quadrupole mass spectrometer; Molecular biology; Chemistry; Computational biology; Cancer research; Chromatography; Mass spectrometry; Bioinformatics; Tandem mass spectrometry; Genetics","score_opus":0.04398898652512963,"score_gpt":0.42308762502329084,"score_spread":0.3790986384981612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312886965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642926,0.0007129635,0.000007951544,0.0012328512,0.00025114574,0.00042615682,0.00019467522,0.000020715077,0.00072426314],"genre_scores_gemma":[0.99878246,0.00017159861,0.00014352996,0.00011141617,0.00015575397,0.00028214115,0.00005847491,0.000027818185,0.00026682805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781847,0.00012313081,0.00035939756,0.00042230706,0.00072646246,0.00055021007],"domain_scores_gemma":[0.9984645,0.00017244223,0.000076849145,0.0005932628,0.00044312098,0.00024981043],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009522824,0.00012900202,0.00045305712,0.0013462576,0.000048723043,0.000012813312,0.00024806423,0.00017682425,0.01106245],"category_scores_gemma":[0.00035663592,0.000121416124,0.00018942993,0.0020248794,0.00042030303,0.000038666425,0.000092554124,0.0008838471,0.000012220877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014863948,0.00036146858,0.29536292,0.00026331202,0.000655214,0.0003642691,0.0000946687,0.0011647866,0.69623005,0.0000067025817,0.0008792873,0.0031308995],"study_design_scores_gemma":[0.002354408,0.00009032554,0.95174646,0.00009726859,0.00062795513,0.0000025710315,0.00007159827,0.0019276574,0.04258174,0.000012940263,0.00037071787,0.000116352276],"about_ca_topic_score_codex":0.007514034,"about_ca_topic_score_gemma":0.008062112,"teacher_disagreement_score":0.6563835,"about_ca_system_score_codex":0.00015138935,"about_ca_system_score_gemma":0.0010334512,"threshold_uncertainty_score":0.999095},"labels":[],"label_agreement":null},{"id":"W2312914698","doi":"10.1158/0008-5472.sabcs10-p2-09-16","title":"Abstract P2-09-16: Effect of Continuous Statistically Standardized qPCR and IHC ER and PR on Disease-Free Survival in NCIC CTG MA.12","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Breast cancer; Immunohistochemistry; Oncology; Proportional hazards model; Placebo; Randomization; Cancer; Gynecology; Clinical trial; Pathology","score_opus":0.028941889105593206,"score_gpt":0.39891292314582,"score_spread":0.3699710340402268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312914698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994116,0.0018569281,0.00007555682,0.0011279514,0.00016379387,0.0010627535,0.00046016392,0.000026906304,0.0011099395],"genre_scores_gemma":[0.9985125,0.00035235367,0.00024076289,0.00004527329,0.00018803056,0.00019523218,0.000013863917,0.00005133365,0.00040066394],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974802,0.00020335156,0.00029219931,0.00046879266,0.0009942553,0.00056121557],"domain_scores_gemma":[0.99736863,0.0013286985,0.00006636365,0.0005479031,0.00027066318,0.00041776063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016091948,0.00020840508,0.0005795188,0.00022983883,0.000076485696,0.000034956985,0.00016803147,0.00010092599,0.00048532832],"category_scores_gemma":[0.0015012689,0.00016372158,0.0000424993,0.00020699587,0.00083466043,0.00008986857,0.00012711875,0.00094590895,0.000005101724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.082772836,0.00033173562,0.28402892,0.0031620373,0.00029035308,0.00064012886,0.0006911215,0.000010983704,0.19512062,0.0021831251,0.001250858,0.4295173],"study_design_scores_gemma":[0.0151948,0.0014399237,0.9580163,0.0008301335,0.000057614656,0.000015342493,0.00012549765,0.000022945445,0.015081018,0.0023645796,0.0065870923,0.000264804],"about_ca_topic_score_codex":0.0006675443,"about_ca_topic_score_gemma":0.001259118,"teacher_disagreement_score":0.6739873,"about_ca_system_score_codex":0.00021823712,"about_ca_system_score_gemma":0.0004354784,"threshold_uncertainty_score":0.6676372},"labels":[],"label_agreement":null},{"id":"W2313020383","doi":"10.1158/0008-5472.sabcs10-p5-15-02","title":"Abstract P5-15-02: Characteristics and Prognosis of Patients Presenting with Isolated Axillary Nodal Metastases from Occult Breast Primary Carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Axillary lymph nodes; Cancer; Oncology; Internal medicine; Mastectomy; Cohort; Lymph node; Primary tumor; Occult; Radiation therapy; Metastatic breast cancer; Metastasis; Pathology","score_opus":0.03197314740239057,"score_gpt":0.3251910432313187,"score_spread":0.2932178958289281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313020383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959309,0.00070262194,8.541697e-7,0.0004513326,0.000097566895,0.0009054591,0.0016739811,0.000021325493,0.00021593191],"genre_scores_gemma":[0.99837387,0.0003819167,0.00016418031,0.000047022553,0.0002040566,0.00026474366,0.00047868676,0.000039644434,0.00004588027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980384,0.00004757921,0.00030951021,0.00044383577,0.00073333643,0.00042731132],"domain_scores_gemma":[0.9983387,0.00019742911,0.00013377254,0.00034586256,0.0007245841,0.00025965547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002152041,0.00019217022,0.00043174202,0.0001523388,0.00013132796,0.00005642635,0.00011204878,0.000094824194,0.00048259308],"category_scores_gemma":[0.00005733281,0.00014019043,0.000060986113,0.0002693978,0.00029146404,0.00012467818,0.0001326632,0.00051249535,0.0000060479147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010053965,0.00075633486,0.96507996,0.00034413725,0.0003028433,0.00009059805,0.00025984287,1.9284866e-7,0.014868938,0.000003887913,0.0006564054,0.01663146],"study_design_scores_gemma":[0.002236896,0.00037895693,0.98185605,0.00020223626,0.00017023523,0.00001316414,0.00005776442,0.000016888092,0.014074766,0.0000045500624,0.0008590665,0.00012942453],"about_ca_topic_score_codex":0.0046831938,"about_ca_topic_score_gemma":0.00041563463,"teacher_disagreement_score":0.016776089,"about_ca_system_score_codex":0.00012572271,"about_ca_system_score_gemma":0.00038295216,"threshold_uncertainty_score":0.7079619},"labels":[],"label_agreement":null},{"id":"W2313073532","doi":"10.1158/0008-5472.sabcs10-p4-04-06","title":"Abstract P4-04-06: Histone H2A Inhibits Breast Cancer Stem Cell Growth","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Histone deacetylase; HDAC11; Histone deacetylase 5; Histone; Cancer research; Biology; Acetylation; Histone H2A; Cancer epigenetics; Epigenetics; Histone deacetylase 2; Cell biology; Histone methyltransferase; Genetics; Gene","score_opus":0.027554949101061633,"score_gpt":0.367503215345437,"score_spread":0.33994826624437535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313073532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802984,0.0027749473,0.0000075319717,0.0018878748,0.0005285166,0.0005548927,0.00041904853,0.00003787167,0.0057595074],"genre_scores_gemma":[0.9785972,0.0012738077,0.00004265218,0.00011839865,0.0018425077,0.0005173812,0.0000900561,0.000118424876,0.017399542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99589986,0.00018433633,0.00038460657,0.0010117771,0.0012227398,0.0012967003],"domain_scores_gemma":[0.9970869,0.000055835848,0.00009411237,0.0009388647,0.0012416908,0.0005826226],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012418474,0.00031848004,0.00029010858,0.00030199572,0.00043810153,0.00010828732,0.00084997586,0.00046940887,0.0013489118],"category_scores_gemma":[0.00007327771,0.00031043947,0.0001547784,0.00058440777,0.00091033726,0.00002016204,0.0004938878,0.001755579,0.00048064362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020528816,0.00016391561,0.0011216885,0.00015543653,0.000033759334,0.000029687411,0.00010882652,0.000009127094,0.9246361,0.000046323414,0.06849805,0.0049917456],"study_design_scores_gemma":[0.000791556,0.00009332641,0.0035280082,0.000055563865,0.0000067404567,0.000025885754,0.000058964222,0.000008256968,0.91436285,0.000020412715,0.080703676,0.00034475862],"about_ca_topic_score_codex":0.0035103676,"about_ca_topic_score_gemma":0.002659982,"teacher_disagreement_score":0.012205623,"about_ca_system_score_codex":0.00035597515,"about_ca_system_score_gemma":0.0015597219,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W2313087451","doi":"10.1158/1538-7445.am10-3740","title":"Abstract 3740: Circulating endothelial progenitor cells as a predictive biomarker of acute skin toxicity in early breast cancer patients undergoing radiation therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; CD31; Progenitor cell; Toxicity; Biomarker; Internal medicine; Cancer; Pathology; Oncology; Angiogenesis; Stem cell; Biology","score_opus":0.022974855956434035,"score_gpt":0.34536244197859267,"score_spread":0.3223875860221586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313087451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977372,0.0005392537,0.000009549831,0.00007562463,0.0003312953,0.00056006084,0.0005230372,0.0000061127603,0.00021782625],"genre_scores_gemma":[0.99728054,0.0015838642,0.000024946296,0.000040197545,0.00062797684,0.00030118346,0.00003492919,0.000036969286,0.00006938464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983699,0.000098911085,0.00026951573,0.0004199532,0.00042299269,0.0004187478],"domain_scores_gemma":[0.99910766,0.00004156958,0.0001264064,0.0002466111,0.00037798774,0.000099754376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040549223,0.0001517451,0.00016391641,0.00012360666,0.00010336596,0.00003256109,0.0002362002,0.00021405988,0.00017276901],"category_scores_gemma":[0.000031822437,0.00013870669,0.00010728582,0.00025898797,0.00017840511,0.000016874052,0.00008294494,0.00024894325,0.00000454439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066376064,0.00012550486,0.14625727,0.000024158111,0.00014254282,0.0000018332778,0.0001739509,0.000024486431,0.82722163,0.000004666531,0.00016897109,0.025191234],"study_design_scores_gemma":[0.0011018319,0.00017434802,0.3590033,0.00003804321,0.00000671855,0.0000011008176,0.00002425826,0.000027502047,0.63906366,0.000016869397,0.00042980816,0.00011259286],"about_ca_topic_score_codex":0.0020506377,"about_ca_topic_score_gemma":0.00062403374,"teacher_disagreement_score":0.21274602,"about_ca_system_score_codex":0.000116495015,"about_ca_system_score_gemma":0.00063972134,"threshold_uncertainty_score":0.5656295},"labels":[],"label_agreement":null},{"id":"W2313103021","doi":"10.1158/1538-7445.am2012-4210","title":"Abstract 4210: Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Lung cancer; Locus (genetics); Genome-wide association study; Adenocarcinoma; Lung cancer susceptibility; Biology; Oncology; Genotype; Gene; Cancer; Lung; Bioinformatics; Genetics; Medicine; Internal medicine; Single-nucleotide polymorphism","score_opus":0.032630074491453595,"score_gpt":0.37985976978603925,"score_spread":0.34722969529458564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313103021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903989,0.008193061,0.00005033445,0.00060439296,0.00007468686,0.0003593439,0.000044581593,0.0000027204787,0.00027197503],"genre_scores_gemma":[0.99695975,0.0014532285,0.00006214117,0.000029973118,0.00019242891,0.00027586543,0.000009832172,0.000013580831,0.0010032201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887437,0.00013015135,0.00014844636,0.00023545352,0.00029047517,0.00032109828],"domain_scores_gemma":[0.99922854,0.000028663677,0.00009280121,0.00036044398,0.00021713138,0.00007243085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054234,0.000080442216,0.000101658465,0.000041240484,0.0001235535,0.00001595135,0.00016310075,0.00008691605,0.00007194715],"category_scores_gemma":[0.000076067576,0.00005571166,0.000023519811,0.00021195166,0.00011648975,0.000012964153,0.00009669155,0.00020205087,5.193197e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004346278,0.00003715809,0.31704378,0.000048568592,0.0000124908765,1.5761202e-7,0.0001367318,0.00004250933,0.6791383,0.000012721605,0.0030339712,0.000450172],"study_design_scores_gemma":[0.00028914903,0.000017898688,0.43013835,0.00007574737,0.0000072286075,6.2586304e-7,0.00009480079,0.000014884401,0.5655638,0.000008437659,0.0037193892,0.000069662885],"about_ca_topic_score_codex":0.0009923227,"about_ca_topic_score_gemma":0.001441911,"teacher_disagreement_score":0.113574475,"about_ca_system_score_codex":0.00023708392,"about_ca_system_score_gemma":0.00026441037,"threshold_uncertainty_score":0.22718555},"labels":[],"label_agreement":null},{"id":"W2313163324","doi":"10.1158/1538-7445.am2012-2484","title":"Abstract 2484: Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; Université de Montréal","funders":"","keywords":"Sibling; Exome sequencing; Genetics; Germline; Exome; Gene; Biology; Allele; Cancer; Childhood leukemia; Lymphoblastic Leukemia; Leukemia; Medicine; Mutation","score_opus":0.05355953661122302,"score_gpt":0.3739228559020745,"score_spread":0.3203633192908515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313163324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935919,0.0016409097,0.000079937774,0.00023279023,0.00023316093,0.0009812019,0.00034859029,0.00004784116,0.0028436643],"genre_scores_gemma":[0.9971814,0.00034973765,0.0003624919,0.000064936474,0.000789046,0.00017188644,0.000039268856,0.0000986416,0.00094256556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948814,0.00020648644,0.0007988306,0.00052130484,0.001954858,0.0016371183],"domain_scores_gemma":[0.9959523,0.00086863554,0.00020011446,0.000964419,0.0011689321,0.00084560225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018679616,0.0003170466,0.0008141756,0.0008006074,0.000191281,0.000023836697,0.0004653901,0.00032000794,0.0008260289],"category_scores_gemma":[0.0010272347,0.00026990398,0.0002335941,0.0014041992,0.0009024977,0.00033416552,0.00042315127,0.0010332086,0.00014756146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0021930097,0.00059919606,0.010703725,0.002546062,0.0011109716,0.0055231345,0.006963479,0.0001466279,0.94586045,0.00029747043,0.008967769,0.015088116],"study_design_scores_gemma":[0.027473934,0.0027617055,0.14284886,0.00506816,0.0009081717,0.017666588,0.010915003,0.0024498734,0.7846313,0.0002974483,0.0036560658,0.0013228602],"about_ca_topic_score_codex":0.004858975,"about_ca_topic_score_gemma":0.00008253124,"teacher_disagreement_score":0.16122912,"about_ca_system_score_codex":0.006372938,"about_ca_system_score_gemma":0.009322965,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2313183516","doi":"10.1158/1538-7445.am2011-804","title":"Abstract 804: Class II transactivator (CIITA) transcription is reduced by the ER-E2 signaling pathway in breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Memorial University of Newfoundland","funders":"","keywords":"CIITA; Transactivation; Estrogen receptor; Cancer research; Biology; Cell biology; Molecular biology; Immune system; MHC class II; Chemistry; Transcription factor; Breast cancer; T cell; Cancer; Immunology; Gene; Genetics","score_opus":0.06389841596775539,"score_gpt":0.3202971772009466,"score_spread":0.25639876123319116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313183516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725958,0.022486918,0.000013254223,0.0026160588,0.0006558508,0.00058225694,0.00042949463,0.000039651713,0.0005807331],"genre_scores_gemma":[0.9913209,0.0028332835,0.0000035404655,0.00032886592,0.00005131,0.00044142237,0.000017525492,0.00004939322,0.0049537285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728125,0.00072930445,0.00041664895,0.00047622583,0.00016393476,0.0009326559],"domain_scores_gemma":[0.9990363,0.00021078785,0.000085016654,0.00044905726,0.0001806569,0.00003816344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012363053,0.00025663868,0.0003199095,0.0002183435,0.0006869212,0.000034551278,0.00064720196,0.00037651847,0.011611172],"category_scores_gemma":[0.000011002752,0.00019050305,0.00015369712,0.00047900222,0.0005807883,0.0002458385,0.00003490213,0.0014071135,0.0001378808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037022508,0.00026640185,0.0000652975,0.000034860783,0.00018524828,0.00000439158,0.010320213,0.000003668617,0.9546277,0.000026796077,0.007320402,0.023442773],"study_design_scores_gemma":[0.0015258053,0.00015090051,0.003026963,0.00017108867,0.000009998675,0.000011244462,0.0012244674,0.0000010717587,0.94485414,0.0000522509,0.048744716,0.00022732998],"about_ca_topic_score_codex":0.0091640875,"about_ca_topic_score_gemma":0.00017049735,"teacher_disagreement_score":0.041424315,"about_ca_system_score_codex":0.00029654024,"about_ca_system_score_gemma":0.0005134174,"threshold_uncertainty_score":0.99743396},"labels":[],"label_agreement":null},{"id":"W2313186082","doi":"10.1158/0008-5472.sabcs-09-606","title":"Benefits of Adding Paclitaxel to Adjuvant Doxorubicin/Cyclophosphamide Depending on HER2 &amp; ER Status: Analysis of Tumor Tissue Microarrays and Immunohistochemistry in CALGB 9344 (Intergroup 0148).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tissue microarray; Immunohistochemistry; Breast cancer; Paclitaxel; Medicine; Concordance; Internal medicine; Doxorubicin; Cyclophosphamide; Oncology; Adjuvant; Cancer; Proportional hazards model; Chemotherapy","score_opus":0.05532989185998875,"score_gpt":0.42910622241684604,"score_spread":0.3737763305568573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313186082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848782,0.010420532,0.000027001888,0.0008203055,0.00006677919,0.0009333794,0.00027412252,0.000021463557,0.002558262],"genre_scores_gemma":[0.9957756,0.0017311253,0.0007777651,0.00019167077,0.00009551586,0.00016182785,0.0000578476,0.00005281048,0.0011558632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951181,0.00020537009,0.0008845812,0.0008721663,0.0016308457,0.0012889369],"domain_scores_gemma":[0.9972282,0.00041279534,0.00015554504,0.0009770241,0.00063312054,0.00059331127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019436729,0.00030868212,0.0011425258,0.0017687381,0.00010808162,0.000037648304,0.00043551036,0.00016832321,0.0008592721],"category_scores_gemma":[0.0009618477,0.00029523275,0.00015795339,0.003419624,0.0003090987,0.000084821324,0.00023282178,0.0011134255,0.000019000334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020052865,0.0002850219,0.038039558,0.0006371441,0.00033579807,0.00007049726,0.002371925,0.0006537963,0.92240095,0.00010437968,0.0018428905,0.031252746],"study_design_scores_gemma":[0.0023701862,0.0014303762,0.20956548,0.0039640097,0.00021405921,0.000014253255,0.0012807774,0.000090517526,0.77399373,0.000040303807,0.006618724,0.0004175529],"about_ca_topic_score_codex":0.009500942,"about_ca_topic_score_gemma":0.0016392904,"teacher_disagreement_score":0.17152593,"about_ca_system_score_codex":0.0014671821,"about_ca_system_score_gemma":0.0006206789,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W2313242882","doi":"10.1158/1538-7445.am2012-sy25-02","title":"Abstract SY25-02: Recent advances in the genomics and genetics of the medulloblastomas: The impact of intertumoral and intratumoral heterogeneity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Oncology; Population; Genetic heterogeneity; Medicine; Internal medicine; Biology; Bioinformatics; Pathology; Genetics; Phenotype; Gene","score_opus":0.07605160293291087,"score_gpt":0.43162130969026874,"score_spread":0.3555697067573579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313242882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401476,0.058006965,1.7854777e-7,0.0011385756,0.000049720387,0.0005228715,0.0000270442,0.0000015251616,0.00010551962],"genre_scores_gemma":[0.9771274,0.022672992,0.000011486825,0.00003627224,0.000068781635,0.00007071276,0.0000013788276,0.000008869855,0.0000021319634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890167,0.00015937026,0.00019765952,0.0001240739,0.00031475312,0.000302486],"domain_scores_gemma":[0.9992212,0.00021241736,0.00007014684,0.0003059474,0.00010875175,0.000081559665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079134956,0.00009749764,0.000188313,0.00005774879,0.00006994283,0.0000168048,0.00016819271,0.000034281788,0.000027031738],"category_scores_gemma":[0.000079500875,0.000039630304,0.000055956196,0.00023605656,0.00046979994,0.000055689885,0.00011967469,0.0002612031,5.2445677e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002760977,0.0003641506,0.9375545,0.000109142384,0.00008348429,0.0000064971896,0.002190691,0.00003698245,0.020548416,0.00007316457,0.00027994966,0.03847696],"study_design_scores_gemma":[0.0006334715,0.00029340028,0.94671255,0.00011981703,0.000024013812,0.00003274249,0.0007589933,0.000031454947,0.05046449,0.00008086854,0.0008085312,0.000039673894],"about_ca_topic_score_codex":0.0004045433,"about_ca_topic_score_gemma":0.0004826734,"teacher_disagreement_score":0.038437285,"about_ca_system_score_codex":0.00014415909,"about_ca_system_score_gemma":0.00014111566,"threshold_uncertainty_score":0.17309976},"labels":[],"label_agreement":null},{"id":"W2313305420","doi":"10.1158/1538-7445.am2011-924","title":"Abstract 924: Identification of somatic mutations of the PPP2R1A gene in subtypes of endometrial and ovarian carcinomas","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Somatic cell; Ovarian cancer; Cancer research; Gene; Endometrial cancer; Exon; Genetics; Cancer","score_opus":0.06788833377129615,"score_gpt":0.3457021095478775,"score_spread":0.27781377577658134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313305420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976148,0.0017219938,0.000027312002,0.000030493427,0.00008579555,0.00021113514,0.0000761683,4.690541e-7,0.00023181952],"genre_scores_gemma":[0.9991777,0.0006269794,0.000077781406,0.000002711959,0.000040452436,0.000028290084,0.000009699599,0.000006417472,0.000029984165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933255,0.00004719191,0.0002569722,0.00012236706,0.00013754424,0.00010336039],"domain_scores_gemma":[0.9993838,0.000066733926,0.00011622538,0.0002421626,0.00016714194,0.000023923161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043715147,0.00004155811,0.000098044926,0.00010457392,0.00002429503,0.000004064683,0.00015303037,0.000050608036,0.000024082892],"category_scores_gemma":[0.0003136439,0.00003512934,0.000032897948,0.00020189102,0.00020486952,0.0000024900335,0.000080272686,0.000060686365,3.421753e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092035596,0.000049189286,0.048087336,0.0000769258,0.000020644213,2.9941188e-7,0.00036454175,0.000032859352,0.95016575,0.00026431907,0.000030491849,0.0008155993],"study_design_scores_gemma":[0.00031840365,0.0000436779,0.34182888,0.00001326583,0.000006133222,3.7036605e-7,0.00008880023,0.000008265049,0.65724987,0.00038560093,0.000033796045,0.000022917535],"about_ca_topic_score_codex":0.0020916972,"about_ca_topic_score_gemma":0.00065815984,"teacher_disagreement_score":0.29374155,"about_ca_system_score_codex":0.000017775665,"about_ca_system_score_gemma":0.000244964,"threshold_uncertainty_score":0.31620345},"labels":[],"label_agreement":null},{"id":"W2313367740","doi":"10.1158/1538-7445.am10-3191","title":"Abstract 3191: Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating hedgehog signaling","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hedgehog; Patched; Glypican 3; Hedgehog signaling pathway; Cell biology; Cancer research; Smoothened; Chemistry; Cancer; Signal transduction; Biology; Medicine; Internal medicine","score_opus":0.031804412842215336,"score_gpt":0.3685976262604346,"score_spread":0.3367932134182192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313367740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953083,0.0009825017,0.00029663547,0.00056465814,0.00014432918,0.00070846826,0.00007796153,0.000024863091,0.0018922894],"genre_scores_gemma":[0.99565053,0.00018875796,0.00045654556,0.00007713803,0.0007939593,0.00039282162,0.00015718614,0.00005985395,0.0022232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721986,0.00014238391,0.000290861,0.0006866551,0.0007414512,0.0009188092],"domain_scores_gemma":[0.9984175,0.00009957541,0.00007266042,0.0005702056,0.0005406481,0.000299395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011714739,0.00022187438,0.00018651827,0.00015813044,0.0004932902,0.0002069209,0.00059529755,0.00030511458,0.00046835156],"category_scores_gemma":[0.00032656448,0.0002070807,0.00008512775,0.0003564261,0.00028721994,0.000021128328,0.00025850738,0.0011834049,0.000037172333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024659114,0.00010900445,0.0024209055,0.0000826769,0.000025697867,0.0000063366024,0.000067774,0.00006943844,0.9745299,0.000019956658,0.0070689507,0.015352734],"study_design_scores_gemma":[0.00069504324,0.00022656603,0.000892575,0.000028196415,0.0000026737243,0.000003641051,0.00009029931,0.00019167038,0.9560481,0.00007731818,0.04150207,0.00024187432],"about_ca_topic_score_codex":0.00064041384,"about_ca_topic_score_gemma":0.00025466265,"teacher_disagreement_score":0.03443312,"about_ca_system_score_codex":0.000066067165,"about_ca_system_score_gemma":0.00061432907,"threshold_uncertainty_score":0.84445053},"labels":[],"label_agreement":null},{"id":"W2313398017","doi":"10.1158/1538-7445.am2013-3454","title":"Abstract 3454: Bcl-xL anti-apoptotic network is dispensable for emergence and maintenance of CML but required for disease progression, and represents an alternative target for halting survival of blast crisis CML progenitors.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bcl-xL; Progenitor cell; Cancer research; Chronic myelogenous leukemia; Biology; Bone marrow; Stem cell; Haematopoiesis; Stromal cell; Leukemia; Immunology; Apoptosis; Programmed cell death; Cell biology; Genetics","score_opus":0.08764253185837266,"score_gpt":0.4240263148210392,"score_spread":0.3363837829626665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313398017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883295,0.0021330612,0.00048030866,0.00079753756,0.00020478437,0.0068591796,0.0006529295,0.000017614395,0.000021657517],"genre_scores_gemma":[0.9903538,0.0007182715,0.00460983,0.000019215295,0.00046653656,0.0032373078,0.00009842111,0.00006759781,0.0004290216],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709916,0.0000797873,0.00056831026,0.000769268,0.0006035408,0.00087994285],"domain_scores_gemma":[0.9967248,0.00048538257,0.00029744324,0.0005138411,0.0015102898,0.00046823852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095746055,0.00023847351,0.0006073455,0.000112630965,0.000246436,0.000039470437,0.00021782948,0.00009237734,0.00010358264],"category_scores_gemma":[0.0007906078,0.00019188372,0.00011762852,0.00024297007,0.0003866023,0.00028909452,0.00015295595,0.00016457467,0.0000011106937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015484187,0.0021527738,0.72242475,0.019675065,0.002041794,0.000039049366,0.003590562,0.00047836345,0.11099234,0.00037234867,0.07174884,0.050999954],"study_design_scores_gemma":[0.050718635,0.008897665,0.36508873,0.0109572755,0.0010592456,0.00002088288,0.0073336987,0.11215629,0.42330065,0.014051495,0.0046355263,0.0017798857],"about_ca_topic_score_codex":0.0011160829,"about_ca_topic_score_gemma":0.000046789242,"teacher_disagreement_score":0.35733598,"about_ca_system_score_codex":0.00025254017,"about_ca_system_score_gemma":0.0005652736,"threshold_uncertainty_score":0.7824791},"labels":[],"label_agreement":null},{"id":"W2313417670","doi":"10.1158/1538-7445.am2013-787","title":"Abstract 787: Tumor suppressor p53 inhibits expression of the pro-metastasis protein Toca-1.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Gene silencing; Invadopodia; Metastasis; Ectopic expression; Cancer; Biology; Breast cancer; Molecular biology; Cell culture; Gene","score_opus":0.04016572794647205,"score_gpt":0.36951070006824405,"score_spread":0.329344972121772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313417670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954377,0.0005292173,0.0001051541,0.0009916178,0.000020641332,0.0016943391,0.00005180512,0.000011211177,0.0011583202],"genre_scores_gemma":[0.9952977,0.000056136512,0.0005723682,0.00009127115,0.00008533723,0.0030427522,0.000023779074,0.000020830248,0.0008098438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987642,0.00012993361,0.00019818619,0.00033849213,0.00025094248,0.000318203],"domain_scores_gemma":[0.9988509,0.000011548222,0.00008141449,0.00066666916,0.00031614144,0.000073364485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003284453,0.000109037726,0.00011170054,0.00004237738,0.0001497363,0.000022947557,0.00049978483,0.00012083615,0.00027501877],"category_scores_gemma":[0.00010162355,0.00007228827,0.0000857798,0.00018917608,0.00028058502,0.000004681808,0.00038730397,0.00024910417,0.000016988095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042269705,0.000054915676,0.0001648555,0.00004055673,0.000010586884,3.2132982e-7,0.000012188454,0.0000028961301,0.98576516,0.0001258959,0.012359971,0.0014203847],"study_design_scores_gemma":[0.00014209827,0.00015716226,0.0015327354,0.000069487185,0.0000027010965,0.0000017884867,0.000026095953,0.0000025685927,0.97386646,0.0003234399,0.023791034,0.00008443483],"about_ca_topic_score_codex":0.0001939119,"about_ca_topic_score_gemma":0.00003717153,"teacher_disagreement_score":0.011898703,"about_ca_system_score_codex":0.0000194385,"about_ca_system_score_gemma":0.00015348691,"threshold_uncertainty_score":0.30112627},"labels":[],"label_agreement":null},{"id":"W2313429800","doi":"10.1158/1538-7445.am2011-3967","title":"Abstract 3967: Identification of metadherin as a novel target of miR-375 in head and neck cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; microRNA; Head and neck squamous-cell carcinoma; Cell; Cancer; Chemistry; Ectopic expression; Nasopharyngeal carcinoma; Clonogenic assay; Cell culture; Biology; Head and neck cancer; Medicine; Internal medicine; Radiation therapy; Biochemistry; Gene","score_opus":0.18019340697661396,"score_gpt":0.4503245698780054,"score_spread":0.27013116290139144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313429800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255,0.0054484927,0.000038808736,0.00027672967,0.00010326761,0.00048076993,0.00005840746,0.0000067642363,0.0010367597],"genre_scores_gemma":[0.9966701,0.0019297955,0.0003285579,0.000041330964,0.000059331953,0.00020580646,0.0000049582172,0.000021275659,0.00073884265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986796,0.000027824683,0.00035035223,0.00025384602,0.00042816528,0.00026023138],"domain_scores_gemma":[0.9991859,0.00003297343,0.00010260117,0.00027484947,0.00030286162,0.00010077695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007273972,0.00008902599,0.00030008543,0.00024261585,0.000026005328,0.000006926828,0.00011291396,0.000074753974,0.0015894468],"category_scores_gemma":[0.000043503613,0.00007919143,0.000046723686,0.00041457082,0.00014797373,0.0000833686,0.00003774613,0.00024733547,0.000005763807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010665277,0.00025511044,0.00895788,0.00039069168,0.000076139695,0.000007148323,0.0018949488,0.0000035726391,0.9794056,0.0012463181,0.00020615169,0.0064899195],"study_design_scores_gemma":[0.002180866,0.00030805529,0.28857568,0.00037514314,0.000015014475,0.0000030421743,0.00033476023,0.00003954871,0.7044247,0.0012037774,0.0024549381,0.00008446057],"about_ca_topic_score_codex":0.02824767,"about_ca_topic_score_gemma":0.0024624602,"teacher_disagreement_score":0.27961782,"about_ca_system_score_codex":0.00013426025,"about_ca_system_score_gemma":0.00043737804,"threshold_uncertainty_score":0.99932325},"labels":[],"label_agreement":null},{"id":"W2313437566","doi":"10.1158/0008-5472.sabcs10-p5-10-24","title":"Abstract P5-10-24: A Pragmatic Review of Adjuvant Chemotherapy Regimens in Early-Stage Breast Cancer — Hematologic Toxicities Experienced in a Single Institution","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Docetaxel; Epirubicin; Carboplatin; Internal medicine; Febrile neutropenia; Neutropenia; Chemotherapy; Regimen; Mucositis; Oncology; Breast cancer; Cyclophosphamide; Cancer; Gastroenterology; Surgery; Cisplatin","score_opus":0.14155633216674618,"score_gpt":0.47177489216211693,"score_spread":0.33021855999537075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313437566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02061638,0.9725205,9.045212e-7,0.0005977979,0.0002715026,0.0036558376,0.00017539237,0.00003386058,0.0021278472],"genre_scores_gemma":[0.004886113,0.9875153,0.000022435808,0.00014856186,0.00017814361,0.005776365,0.000036899026,0.00006848486,0.0013677422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961657,0.00031488572,0.0012246261,0.0006920137,0.00085005455,0.000752734],"domain_scores_gemma":[0.99795246,0.00020112927,0.00045267818,0.00079254195,0.0004081433,0.00019305488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011835378,0.00044246644,0.0025791742,0.00084322627,0.00009127234,0.000036687306,0.00040330336,0.0004279361,0.0036493524],"category_scores_gemma":[0.0001972145,0.00033893457,0.00033995116,0.00197599,0.0005948113,0.00019400961,0.000101539204,0.0019993978,0.00003776528],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002993758,0.0010733324,0.0009864989,0.4693387,0.00017403907,0.00032252385,0.0014539543,0.0000028557863,0.0020912713,0.0003145023,0.002974852,0.52096814],"study_design_scores_gemma":[0.0010667454,0.00017428797,0.0008554693,0.35245794,0.00010098552,0.0001386277,0.00014913394,6.094181e-7,0.0004780489,0.000011610608,0.6442318,0.00033476172],"about_ca_topic_score_codex":0.0032824518,"about_ca_topic_score_gemma":0.002266555,"teacher_disagreement_score":0.6412569,"about_ca_system_score_codex":0.0017649868,"about_ca_system_score_gemma":0.003641113,"threshold_uncertainty_score":0.99990624},"labels":[],"label_agreement":null},{"id":"W2313487475","doi":"10.1158/0008-5472.sabcs-3045","title":"Deletion of STAT5 prevents HER2/Neu/ErbB2-induced mammary tumor development.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"STAT5; Cancer research; Biology; Oncogene; HER2/neu; Genetically modified mouse; Mammary tumor; Cytokine; Mouse mammary tumor virus; Cancer; Breast cancer; Transgene; Signal transduction; Immunology; Cell cycle; Cell biology; Gene; Virus","score_opus":0.16704424792469927,"score_gpt":0.488980963841901,"score_spread":0.32193671591720174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313487475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984861,0.0013931753,0.00012296572,0.0032956176,0.0001484804,0.0014551779,0.0000142471545,0.000076150165,0.008633155],"genre_scores_gemma":[0.9917886,0.00061540626,0.0014445889,0.00036087728,0.0002803543,0.0003111397,0.000027438447,0.000050275372,0.005121278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948817,0.00035061466,0.000565384,0.0006148066,0.002467772,0.0011197451],"domain_scores_gemma":[0.997518,0.00013747178,0.000092551665,0.0007802386,0.0009692591,0.0005024623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002258201,0.00021544805,0.00045956383,0.00059670774,0.0001860404,0.000047503974,0.0005658074,0.00014329399,0.0009267965],"category_scores_gemma":[0.0003805262,0.00020066997,0.000095101306,0.0013048075,0.00016006776,0.00018068288,0.00019664533,0.0010800628,0.00014256238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012990304,0.00081486825,0.009339807,0.0011906946,0.000168704,0.00042692805,0.001327507,0.000008121199,0.6055256,0.0006649023,0.031146565,0.34808728],"study_design_scores_gemma":[0.0032039876,0.0019003807,0.092529364,0.0016188741,0.000023348673,0.00006011581,0.00026556457,0.00009378754,0.8234989,0.0010788756,0.0753263,0.0004004728],"about_ca_topic_score_codex":0.0004954233,"about_ca_topic_score_gemma":0.000077419994,"teacher_disagreement_score":0.34768683,"about_ca_system_score_codex":0.0012703507,"about_ca_system_score_gemma":0.004053047,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W2313507970","doi":"10.1158/1538-7445.am10-12","title":"Abstract 12: Metastatic neuroblastoma cancer stem cells display a mixed phenotype of tumor and niche origin required for survival","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children","funders":"","keywords":"Biology; Cancer research; Pathology; Metastasis; Cancer stem cell; Neural crest; Cancer; Lineage markers; Haematopoiesis; Bone marrow; Stem cell; Neuroblastoma; Nestin; Progenitor cell; Neural stem cell; Immunology; Medicine; Cell culture; Gene; Cell biology; Genetics","score_opus":0.11240286320650116,"score_gpt":0.41977297398420393,"score_spread":0.30737011077770277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313507970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960056,0.00039085644,0.000010338478,0.00076075055,0.00044829954,0.0016795147,0.00038705886,0.00003033495,0.00028725015],"genre_scores_gemma":[0.996422,0.00029101135,0.00022479401,0.000043709806,0.00018931778,0.0007570043,0.00000990317,0.000074289295,0.0019879567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970753,0.00014746419,0.00035411792,0.0005803418,0.00097389705,0.00086886476],"domain_scores_gemma":[0.9974851,0.0008204722,0.00010380019,0.00050078495,0.00054620026,0.0005436366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008132842,0.00023056513,0.0005116133,0.00028390807,0.0001668127,0.00005070866,0.00023754741,0.000062573316,0.00033365417],"category_scores_gemma":[0.00018389139,0.00017902769,0.00011171385,0.0003958404,0.00054642075,0.0001238395,0.0001276159,0.0007299241,0.000024497405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003243176,0.00034278468,0.0033016603,0.0010624102,0.00024288846,0.00018606031,0.00010892168,0.000004863238,0.9780303,0.00024188068,0.0021810073,0.011053998],"study_design_scores_gemma":[0.007887333,0.0019803543,0.057535894,0.00035301977,0.00016151444,0.000027427774,0.00015847452,0.0003512212,0.9211976,0.00022858419,0.009844369,0.00027418806],"about_ca_topic_score_codex":0.0012355606,"about_ca_topic_score_gemma":0.0025599569,"teacher_disagreement_score":0.05683273,"about_ca_system_score_codex":0.000118257434,"about_ca_system_score_gemma":0.0010813692,"threshold_uncertainty_score":0.7300537},"labels":[],"label_agreement":null},{"id":"W2313550396","doi":"10.1158/1538-7445.am10-3742","title":"Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene knockdown; Breast cancer; Cancer research; Estrogen receptor; Metastasis; Ubiquitin ligase; Biology; Tissue microarray; Immunohistochemistry; Epithelial–mesenchymal transition; Ubiquitin; Cancer; Internal medicine; Medicine; Apoptosis; Immunology; Gene","score_opus":0.026382055048191834,"score_gpt":0.3165726648039387,"score_spread":0.29019060975574684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313550396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967639,0.00028828255,0.00016518042,0.0014230465,0.00036635052,0.00048916374,0.00020520856,0.000013152236,0.0002857475],"genre_scores_gemma":[0.9972637,0.000109946675,0.00006677887,0.00015480221,0.00046693036,0.0004856231,0.00008913885,0.000038596463,0.0013244416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817556,0.00006329349,0.00018244007,0.00054124027,0.0005658948,0.00047156046],"domain_scores_gemma":[0.99906313,0.000018508295,0.000045144414,0.00031830766,0.00041870694,0.0001362048],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000365529,0.00015865939,0.00011865126,0.00013096335,0.00011520826,0.00006123742,0.00019632828,0.00018362603,0.0024421702],"category_scores_gemma":[0.000020111773,0.00014055503,0.00005274791,0.0002998006,0.00028242622,0.000018283165,0.000041225467,0.0005235895,0.000026417129],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009016335,0.00008523486,0.08054846,0.00004732663,0.000040289637,0.000008018185,0.000033396882,0.00030465765,0.90883046,0.000015953989,0.006721365,0.002463229],"study_design_scores_gemma":[0.0009561831,0.00007588038,0.9342318,0.000052183157,0.000008391597,0.000012279996,0.000033815624,0.00011769897,0.0533023,0.000041062456,0.010957707,0.00021067058],"about_ca_topic_score_codex":0.0011754753,"about_ca_topic_score_gemma":0.004929652,"teacher_disagreement_score":0.8555281,"about_ca_system_score_codex":0.00007785142,"about_ca_system_score_gemma":0.00062591565,"threshold_uncertainty_score":0.9984697},"labels":[],"label_agreement":null},{"id":"W2313563487","doi":"10.1158/0008-5472.sabcs10-p5-10-23","title":"Abstract P5-10-23: Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Canadian Population Sample of Women with Estrogen and/or Progesterone Receptor Positive Early Stage Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Population; Logistic regression; Chemotherapy; Cancer; Emergency department; Adverse effect; Internal medicine; Stage (stratigraphy); Estrogen receptor; Gynecology; Obstetrics","score_opus":0.017582450444357717,"score_gpt":0.3605277780415742,"score_spread":0.3429453275972165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313563487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966159,0.00035955547,1.4297011e-7,0.00056591455,0.000044398428,0.0016979007,0.00064624316,0.0000076112033,0.00006232933],"genre_scores_gemma":[0.99865067,0.0003050432,0.00007298596,0.000035044206,0.00004112998,0.0005196455,0.00005644523,0.000027287708,0.00029176215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987579,0.000060704755,0.00019204973,0.00025865843,0.0002253884,0.0005052706],"domain_scores_gemma":[0.99906695,0.00012711035,0.00008159769,0.00013421285,0.00020483293,0.0003852837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031583977,0.00013167954,0.00032670755,0.00026535604,0.000051793126,0.000008123311,0.000056271914,0.0001184295,0.0015415864],"category_scores_gemma":[0.000026888974,0.00010279346,0.000015091554,0.0003634994,0.000241869,0.00010010998,0.000015491723,0.00035010718,0.0000013206792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067137657,0.00014844832,0.870843,0.0003873234,0.00023024266,0.00004878888,0.0031742258,0.0000036038205,0.09899436,0.00003023019,0.000042409145,0.019383596],"study_design_scores_gemma":[0.005380863,0.0011364362,0.9824457,0.0002959126,0.000029576535,0.0000134922575,0.0001258217,0.000009764735,0.010249488,0.000015174405,0.0002020243,0.00009570881],"about_ca_topic_score_codex":0.8084673,"about_ca_topic_score_gemma":0.6464693,"teacher_disagreement_score":0.161998,"about_ca_system_score_codex":0.00094223616,"about_ca_system_score_gemma":0.001208522,"threshold_uncertainty_score":0.9993711},"labels":[],"label_agreement":null},{"id":"W2313564723","doi":"10.1158/1538-7445.am10-2521","title":"Abstract 2521: The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; MEK inhibitor; Cancer research; Kinase; V600E; Mutant; Phosphorylation; Cell growth; Signal transduction; Protein kinase A; Biology; Chemistry; Cell biology; Biochemistry; Gene","score_opus":0.02505307162938562,"score_gpt":0.31663698929806644,"score_spread":0.2915839176686808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313564723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971799,0.00062318926,0.000011447074,0.0003214402,0.00015728273,0.00060242694,0.000025100391,0.000008486977,0.0010706777],"genre_scores_gemma":[0.9982147,0.00007741609,0.000045097906,0.00012288717,0.0007724364,0.00028844734,0.00002299515,0.000026910313,0.00042909116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985086,0.00011995469,0.00019900425,0.00043840747,0.0002888279,0.00044524748],"domain_scores_gemma":[0.9993275,0.000047991027,0.000051200463,0.0002631791,0.0002090016,0.00010115081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008543306,0.00014172542,0.00012319052,0.0000989046,0.00020795014,0.0000899675,0.00018914962,0.00015884977,0.00004655406],"category_scores_gemma":[0.00015479462,0.00010614401,0.00003525267,0.00021588283,0.0001705471,0.0000113626675,0.0001358642,0.00069723447,0.000013298692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013795808,0.00005328114,0.0028998973,0.000051845873,0.000008243986,0.000014330132,0.0003517018,0.000008388701,0.9941742,0.00006335834,0.00076558796,0.0014711984],"study_design_scores_gemma":[0.00064056215,0.00016999186,0.0063620135,0.00002778836,0.0000035004648,0.000011827536,0.00019067373,0.000042263848,0.98862517,0.00014287046,0.003641051,0.00014230458],"about_ca_topic_score_codex":0.00026785253,"about_ca_topic_score_gemma":0.001808548,"teacher_disagreement_score":0.005549056,"about_ca_system_score_codex":0.00003232824,"about_ca_system_score_gemma":0.0003792113,"threshold_uncertainty_score":0.43284273},"labels":[],"label_agreement":null},{"id":"W2313590912","doi":"10.1158/1538-7445.am2011-4677","title":"Abstract 4677: The differences among various age groups of oral cancers in British Columbia","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Age groups; Cancer registry; Cancer; Incidence (geometry); Basal cell; Internal medicine; Population; Demography; Tongue; Longitudinal study; Pathology","score_opus":0.14851407512534673,"score_gpt":0.387129191078013,"score_spread":0.2386151159526663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313590912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857543,0.002587455,6.083565e-7,0.00018524764,0.0001701941,0.00051684293,0.000025157651,0.000017432401,0.010742757],"genre_scores_gemma":[0.99497277,0.0029242432,0.000018848583,0.00007327005,0.00008659746,0.00020775059,0.0000021308633,0.000019247407,0.0016951757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981754,0.00009749541,0.00028405988,0.00029330494,0.0005952621,0.0005544913],"domain_scores_gemma":[0.9992084,0.00012557022,0.000050681396,0.00028250102,0.00020475908,0.00012811851],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007785828,0.000085986896,0.0004114206,0.000076406424,0.00017216713,0.00005292717,0.00026630377,0.000081769314,0.0016807273],"category_scores_gemma":[0.00012238687,0.000084907035,0.00006378045,0.00043806172,0.0009228779,0.0000714924,0.00010928124,0.0006283676,0.000006247605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105461564,0.00009861666,0.96810955,0.00018699028,0.000079679645,0.0002949579,0.004545156,4.997507e-7,0.0008202454,0.000012021187,0.0071195452,0.018627275],"study_design_scores_gemma":[0.00077367685,0.00025343642,0.99526954,0.0005929199,0.000013612594,0.000005965912,0.001582317,0.0000060570724,0.00032131904,0.0002652266,0.000827889,0.00008806719],"about_ca_topic_score_codex":0.7341418,"about_ca_topic_score_gemma":0.8965242,"teacher_disagreement_score":0.16238235,"about_ca_system_score_codex":0.00036635215,"about_ca_system_score_gemma":0.00058616913,"threshold_uncertainty_score":0.9992319},"labels":[],"label_agreement":null},{"id":"W2313602753","doi":"10.1158/0008-5472.sabcs11-p4-11-14","title":"P4-11-14: Number Needed To Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Advanced Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Denosumab; Medicine; Number needed to treat; Zoledronic acid; Breast cancer; Randomized controlled trial; Oncology; Urology; Internal medicine; Surgery; Relative risk; Cancer; Osteoporosis; Confidence interval","score_opus":0.05851396126191138,"score_gpt":0.4121546398440055,"score_spread":0.35364067858209414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313602753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920911,0.0022491298,0.0000050290587,0.0013432411,0.00012833596,0.0034069554,0.00018416652,0.000016881517,0.0005751678],"genre_scores_gemma":[0.9949614,0.00070782384,0.00008611989,0.00007685592,0.00003616373,0.0017371696,0.000033151773,0.000048530233,0.0023127922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973484,0.00015601696,0.0005638774,0.00039923753,0.00083794026,0.00069450063],"domain_scores_gemma":[0.99847263,0.00010177366,0.00015983696,0.00044236967,0.0005461985,0.0002771659],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008343663,0.00020237446,0.00047581518,0.0002238497,0.00014017355,0.0000050089293,0.00023768972,0.00012727626,0.0009206061],"category_scores_gemma":[0.00009632492,0.00014981398,0.00015363662,0.00073929364,0.000120723395,0.00013183284,0.00009755687,0.00034623462,0.000027591417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0544401,0.0043801498,0.67572343,0.0031748863,0.0012559699,0.000055515942,0.011715273,0.00009486249,0.053218037,0.00077053055,0.003734755,0.19143647],"study_design_scores_gemma":[0.0376777,0.0026100571,0.7031586,0.0040692803,0.00048143862,0.00008086593,0.0020619233,0.000112628506,0.24749675,0.0013216316,0.0005194089,0.00040967696],"about_ca_topic_score_codex":0.05455683,"about_ca_topic_score_gemma":0.021849373,"teacher_disagreement_score":0.19427872,"about_ca_system_score_codex":0.0010396211,"about_ca_system_score_gemma":0.0010615904,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2313634730","doi":"10.1158/1538-7445.am2011-4870","title":"Abstract 4870: High-throughput proteomics using stable isotope labelling with amino acids in cell culture (SILAC) reveals potential modulators of androgen-independent prostate cancers","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"LNCaP; Stable isotope labeling by amino acids in cell culture; Prostate cancer; Androgen; Androgen receptor; Cancer research; Biology; Androgen deprivation therapy; Internal medicine; Proteomics; Endocrinology; Chemistry; Cancer; Biochemistry; Medicine; Hormone; Genetics","score_opus":0.051014096698436706,"score_gpt":0.33634538264546493,"score_spread":0.2853312859470282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313634730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941502,0.00044703833,0.002852475,0.000019733481,0.00002086237,0.0012009843,0.00019795558,0.000050939387,0.0010597673],"genre_scores_gemma":[0.95850754,0.0008197268,0.03892615,0.000007588245,0.00007188221,0.0007948998,0.00002241934,0.00007044621,0.0007793259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762523,0.000031950272,0.00045689024,0.0006103421,0.0005520052,0.00072355533],"domain_scores_gemma":[0.99859935,0.000015716812,0.00025096087,0.00057621574,0.0004097358,0.0001480322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004221205,0.00024431513,0.00033776948,0.0001291121,0.00020449386,0.00004037852,0.00045351608,0.00022163767,0.00027222795],"category_scores_gemma":[0.0000101996075,0.00021953085,0.00005286164,0.0005121767,0.00023094712,0.00024416487,0.0001636654,0.0008804553,0.000002890927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040057933,0.00013428919,0.010494053,0.0005308478,0.00003170105,0.000026569423,0.0010645506,0.006472277,0.9801917,0.00019831875,0.000043169814,0.00041195462],"study_design_scores_gemma":[0.000792493,0.000065992186,0.00029286163,0.0003483794,0.000013812012,0.000004252955,0.00047337302,0.00058586395,0.994966,0.0019678718,0.00021606674,0.00027307993],"about_ca_topic_score_codex":0.0077991164,"about_ca_topic_score_gemma":0.00027251113,"teacher_disagreement_score":0.036073674,"about_ca_system_score_codex":0.0009099503,"about_ca_system_score_gemma":0.0006526197,"threshold_uncertainty_score":0.998808},"labels":[],"label_agreement":null},{"id":"W2313644315","doi":"10.1158/1538-7445.am2012-867","title":"Abstract 867: Therapeutic potential of small molecule SYK inhibitors for treatment of primary B cell acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Syk; Cancer research; Flow cytometry; Leukemia; Medicine; breakpoint cluster region; PI3K/AKT/mTOR pathway; Phosphorylation; Immunology; Tyrosine kinase; Signal transduction; Receptor; Biology; Internal medicine; Cell biology","score_opus":0.05417884030168962,"score_gpt":0.3543860928901216,"score_spread":0.30020725258843195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313644315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894513,0.0052453307,0.00074158213,0.00020098076,0.00025567092,0.0019493201,0.0001667739,0.000029666968,0.0019594019],"genre_scores_gemma":[0.9947289,0.0015146008,0.0006031961,0.00004858335,0.0006365922,0.0005537362,0.000069829235,0.0000976379,0.0017468904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963461,0.0001241031,0.00059421186,0.00042980266,0.0012408402,0.0012648972],"domain_scores_gemma":[0.9972194,0.000669802,0.0001718245,0.00064054603,0.00081016816,0.00048826254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076130126,0.00028678752,0.00073164987,0.00047631288,0.0001179469,0.00001778419,0.00031043193,0.00024783178,0.00023815365],"category_scores_gemma":[0.0000868746,0.00022496606,0.00031181026,0.0005604245,0.00053279806,0.00011110576,0.0001325852,0.00021154505,0.00003586252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037524821,0.0010891042,0.0019486116,0.0015130932,0.00059697486,0.00004554926,0.00062583963,0.000076087716,0.97449994,0.000058669943,0.0019047997,0.013888833],"study_design_scores_gemma":[0.010879715,0.002669993,0.013810486,0.0002857289,0.0004065427,0.000038370617,0.00025648632,0.0006047881,0.9688147,0.00005168886,0.001945304,0.00023621376],"about_ca_topic_score_codex":0.0009989702,"about_ca_topic_score_gemma":0.000011752869,"teacher_disagreement_score":0.013652619,"about_ca_system_score_codex":0.005910296,"about_ca_system_score_gemma":0.0052178167,"threshold_uncertainty_score":0.99790585},"labels":[],"label_agreement":null},{"id":"W2313674717","doi":"10.1158/0008-5472.sabcs11-p5-08-04","title":"P5-08-04: Mammographic Microcalcifications and Breast Cancer Tumorigenesis: A Radiologic-Pathologic Analysis.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Malignancy; Cancer; Oncology; Lymphovascular invasion; Invasive lobular carcinoma; Histology; Internal medicine; Radiology; Pathology; Gynecology; Metastasis; Invasive ductal carcinoma","score_opus":0.08161479655242239,"score_gpt":0.36714129273908647,"score_spread":0.2855264961866641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313674717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97233725,0.025337435,0.0001256818,0.00080461847,0.0000914586,0.0003206713,0.0004023667,0.0000314275,0.0005491048],"genre_scores_gemma":[0.97986525,0.017831726,0.00028546408,0.00014713853,0.00022899582,0.0012479639,0.000061153114,0.000024849945,0.00030747836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979285,0.00023097268,0.00021678183,0.00079263176,0.0002240489,0.0006070678],"domain_scores_gemma":[0.99882245,0.000028658618,0.00007136892,0.0005448467,0.00036634045,0.00016633944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041631897,0.00022780486,0.00030639386,0.0003169587,0.00037927835,0.000031033265,0.00034004095,0.00015565369,0.00023916176],"category_scores_gemma":[0.00002890658,0.00018422575,0.00014981731,0.0010842741,0.00070539815,0.00000736553,0.00024989713,0.00019444022,0.000014274602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047427329,0.00023931878,0.83599114,0.000045751898,0.0019781347,0.000040007384,0.00057340885,0.000017857734,0.15054333,0.00025597506,0.0023995899,0.007441196],"study_design_scores_gemma":[0.00053205364,0.00011273975,0.9734649,0.000019092156,0.00032662484,0.000049872207,0.00044051156,0.0000044278936,0.022386514,0.00021789297,0.002174868,0.00027051987],"about_ca_topic_score_codex":0.0019485478,"about_ca_topic_score_gemma":0.0013657168,"teacher_disagreement_score":0.13747373,"about_ca_system_score_codex":0.00008444249,"about_ca_system_score_gemma":0.00017045169,"threshold_uncertainty_score":0.7512508},"labels":[],"label_agreement":null},{"id":"W2313850657","doi":"10.1158/0008-5472.sabcs11-p5-15-03","title":"P5-15-03: Development of a Patient Decision Aid for Women 70 Years and Older with Stage I, Hormonally Sensitive, Breast Cancer Considering Adjuvant Treatment Post-Lumpectomy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lumpectomy; Medicine; Breast cancer; Stage (stratigraphy); Cancer; Distress; Decision aids; Test (biology); Adjuvant; Patient satisfaction; Gynecology; Oncology; Internal medicine; Mastectomy; Surgery; Alternative medicine; Clinical psychology; Pathology","score_opus":0.03708323250710277,"score_gpt":0.3327802974229299,"score_spread":0.29569706491582715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313850657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961663,0.0022429335,0.00020757985,0.00008117056,0.00005612609,0.00075010245,0.00039899987,0.0000066058205,0.000090199195],"genre_scores_gemma":[0.98891866,0.0009479047,0.008244463,0.000057093326,0.000058833022,0.0012687165,0.000027883765,0.000041820233,0.0004346259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985052,0.000052289895,0.00022967713,0.0004651283,0.00031048327,0.000437274],"domain_scores_gemma":[0.99887115,0.000036560694,0.00007788103,0.00026513718,0.00060817605,0.00014111213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023757535,0.00016420457,0.00020279374,0.00010006838,0.00012468397,0.000019488247,0.00010426228,0.0000845515,0.00010984308],"category_scores_gemma":[0.00002133476,0.00013628125,0.000034229335,0.0001168873,0.00021097538,0.000008485407,0.00013742612,0.00008332986,0.0000020940552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058957073,0.00030685303,0.013172994,0.00017998675,0.0007601778,0.00003302041,0.022855205,0.00017459404,0.69855124,0.000023453198,0.0007912549,0.2572555],"study_design_scores_gemma":[0.003650797,0.0015506811,0.084126405,0.00020827865,0.00002370832,0.000028783608,0.0041445014,0.000025923166,0.8626214,0.000034643985,0.043207515,0.00037732476],"about_ca_topic_score_codex":0.0005925519,"about_ca_topic_score_gemma":0.0019589611,"teacher_disagreement_score":0.25687817,"about_ca_system_score_codex":0.0005865403,"about_ca_system_score_gemma":0.001727713,"threshold_uncertainty_score":0.5557388},"labels":[],"label_agreement":null},{"id":"W2313872863","doi":"10.1158/0008-5472.sabcs11-p1-17-01","title":"P1-17-01: Figitumumab Plus Exemestane Versus Exemestane as First-Line Treatment of Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer: A Randomized, Open-Label Phase II Trial.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Exemestane; Medicine; Clinical endpoint; Internal medicine; Interim analysis; Breast cancer; Oncology; Metastatic breast cancer; Randomized controlled trial; Clinical trial; Cancer; Tamoxifen","score_opus":0.1443047070812785,"score_gpt":0.4505939564901019,"score_spread":0.3062892494088234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313872863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91146314,0.04158066,0.00014615146,0.0043604043,0.0013444329,0.020482209,0.015529741,0.00022672761,0.0048665465],"genre_scores_gemma":[0.8965335,0.06375357,0.0029996193,0.00032519663,0.0014575713,0.020794507,0.0024233034,0.0004153291,0.011297439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993668,0.0005348014,0.0012564684,0.0013737628,0.0015927162,0.0015742523],"domain_scores_gemma":[0.9947658,0.00085708493,0.00056862977,0.0013738623,0.0015999184,0.00083470065],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011121929,0.0008243,0.0026291416,0.00052868965,0.0006287951,0.00006499673,0.0008681673,0.00028113852,0.004550249],"category_scores_gemma":[0.00030092915,0.0006638293,0.0002640783,0.0013738746,0.0015464043,0.00064375123,0.0004725359,0.00066211255,0.000047704933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82549864,0.0065992908,0.0000031201864,0.00010624369,0.0015891193,0.0002679716,0.0027266059,0.000022225835,0.024238614,0.00024323646,0.0015746265,0.13713028],"study_design_scores_gemma":[0.89646,0.050178137,0.000033286477,0.0007528122,0.0005796412,0.00010741664,0.0006550519,0.0000618339,0.031880222,0.00030706832,0.018368952,0.000615602],"about_ca_topic_score_codex":0.013951934,"about_ca_topic_score_gemma":0.00085507234,"teacher_disagreement_score":0.13651468,"about_ca_system_score_codex":0.004329725,"about_ca_system_score_gemma":0.0031267053,"threshold_uncertainty_score":0.9995813},"labels":[],"label_agreement":null},{"id":"W2313887414","doi":"10.1158/1538-7445.am2012-115","title":"Abstract 115: KIR haplotype polymorphism determines innate susceptibility/resistance to childhood leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Gene; Genetics; Haplotype; Major histocompatibility complex; Receptor; Leukemia; MHC class I; Gene family; Genome; Genotype","score_opus":0.045525426343140475,"score_gpt":0.3437498573860631,"score_spread":0.2982244310429226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313887414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97900784,0.008102247,0.000014414352,0.00081148854,0.004327025,0.00040498507,0.000013475421,0.00009767712,0.007220863],"genre_scores_gemma":[0.9444934,0.000261693,0.000016324073,0.0003722217,0.00030308444,0.00014059908,0.000037515816,0.000033916793,0.054341253],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805325,0.0002241576,0.0003043152,0.00037028687,0.0001225256,0.0009254443],"domain_scores_gemma":[0.9988955,0.00017044414,0.000063165775,0.00048655603,0.0002844993,0.00009980517],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008200666,0.00018325094,0.00022083496,0.0002923468,0.0003890059,0.00003950727,0.00032393556,0.00021876118,0.0073990943],"category_scores_gemma":[0.000268298,0.00016555612,0.00008734892,0.00039278742,0.00019865712,0.00030717312,0.00014959136,0.00081998267,0.0064510517],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047761167,0.00013499688,0.0042988095,0.000031139276,0.00006526438,0.0000018528094,0.0009971414,0.0000027725484,0.87220573,0.00015298065,0.11513242,0.00649927],"study_design_scores_gemma":[0.0005124375,0.000088795256,0.1331867,0.000074202086,0.000007872435,0.000009874139,0.00023563566,2.471105e-7,0.36229426,0.000029215807,0.5033692,0.0001915397],"about_ca_topic_score_codex":0.0007609195,"about_ca_topic_score_gemma":0.00037207,"teacher_disagreement_score":0.5099115,"about_ca_system_score_codex":0.00058043073,"about_ca_system_score_gemma":0.00023100259,"threshold_uncertainty_score":0.99432254},"labels":[],"label_agreement":null},{"id":"W2313936515","doi":"10.1158/1538-7445.am2011-lb-33","title":"Abstract LB-33: Pre-clinical evaluation of AB-16B5, a monoclonal antibody specific for tumor-associated sCLU, demonstrates therapeutic potential as an inhibitor of EMT in prostate, pancreatic and lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada)","funders":"","keywords":"DU145; Cancer research; Pancreatic cancer; Prostate cancer; Medicine; Cancer; Vimentin; In vivo; Gemcitabine; Monoclonal antibody; Prostate; Clusterin; Docetaxel; Apoptosis; Epithelial–mesenchymal transition; Immunohistochemistry; Cancer cell; Antibody; Pathology; Internal medicine; Immunology; Metastasis; Chemistry; Biology","score_opus":0.1963807648930076,"score_gpt":0.5188798082866372,"score_spread":0.32249904339362956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313936515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100703,0.0054377667,0.000006410439,0.000076237644,0.00014930803,0.002870568,0.00023705397,0.000014342317,0.00020126098],"genre_scores_gemma":[0.9977538,0.0010117728,0.00012943738,0.000024173127,0.00015724532,0.00074466155,0.00007595502,0.0000389731,0.00006398322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968912,0.00052134803,0.00077917875,0.0005031633,0.0008295253,0.00047558028],"domain_scores_gemma":[0.9977836,0.00033460578,0.0002502323,0.00031906168,0.0011134761,0.00019899475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036648372,0.00016745496,0.0005757599,0.00029516488,0.000062787076,0.000015189791,0.00015357765,0.00014504175,0.0007785875],"category_scores_gemma":[0.00040398305,0.00015164798,0.00009254117,0.0003491977,0.000618909,0.00012599514,0.000075220545,0.00040301782,0.0000014582024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007491686,0.0012878015,0.75609374,0.00083291635,0.00026483473,0.000057144556,0.0014576825,0.000047304435,0.22287059,0.00002000182,0.00030464117,0.009271683],"study_design_scores_gemma":[0.005163958,0.0010806334,0.97068477,0.0008059467,0.0002434478,0.000013104354,0.00039250427,0.00553376,0.01515852,0.00078280555,0.000007179943,0.00013334662],"about_ca_topic_score_codex":0.0019510946,"about_ca_topic_score_gemma":0.0006151947,"teacher_disagreement_score":0.21459109,"about_ca_system_score_codex":0.00028798857,"about_ca_system_score_gemma":0.0016228635,"threshold_uncertainty_score":0.85249865},"labels":[],"label_agreement":null},{"id":"W2314002099","doi":"10.1158/1538-7445.am10-3684","title":"Abstract 3684: Developing STAT3 protein inhibitors as adjuvant therapeutics: Promising synergistic effects in human cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"STAT3; Cancer research; STAT protein; Venetoclax; Cyclin D1; Cancer; Leukemia; Cancer cell; Medicine; Survivin; Cell cycle; Biology; Signal transduction; Immunology; Cell biology; Internal medicine; Chronic lymphocytic leukemia","score_opus":0.06123415778194602,"score_gpt":0.4353586659263953,"score_spread":0.3741245081444493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314002099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992719,0.0017650228,0.00008893061,0.0014731773,0.0003717966,0.0023877511,0.0000074100913,0.00010493192,0.0010819632],"genre_scores_gemma":[0.99589443,0.00007967112,0.00092765206,0.00022738417,0.00066498155,0.001411446,0.00001092985,0.000117355594,0.00066616916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965129,0.00013100456,0.00045753643,0.0006918602,0.0010529216,0.0011537964],"domain_scores_gemma":[0.99837595,0.00023084892,0.00011763825,0.0005591457,0.0004355209,0.0002808985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010438063,0.00031697267,0.00049666467,0.0005362011,0.0003129387,0.00008039488,0.0003106985,0.00020352572,0.0003148997],"category_scores_gemma":[0.00024709076,0.00028281676,0.00007403581,0.00083594257,0.00055539864,0.00022044974,0.000112134505,0.0021197658,0.00004918758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005146994,0.000065097185,0.002944631,0.00084103685,0.0000795805,0.0002239787,0.0010937535,0.000044902747,0.920098,0.0009714138,0.000027967579,0.07309496],"study_design_scores_gemma":[0.003781154,0.00035535303,0.035822958,0.004226575,0.000025108147,0.0000176585,0.0005669883,0.00003801056,0.9400726,0.0045667696,0.0100266235,0.0005001867],"about_ca_topic_score_codex":0.006858867,"about_ca_topic_score_gemma":0.0039556087,"teacher_disagreement_score":0.07259477,"about_ca_system_score_codex":0.002241527,"about_ca_system_score_gemma":0.0028864734,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2314211455","doi":"10.1158/1538-7445.am2011-2179","title":"Abstract 2179: Bile acids downregulate the squamous differentiation program of esophageal cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Esophagus; Stratified squamous epithelium; Epithelium; Biology; Bile acid; Transcription factor; Gene; Gene expression; Downregulation and upregulation; Cancer research; Cell; Western blot; Internal medicine; Endocrinology; Biochemistry; Medicine; Genetics; Anatomy","score_opus":0.09737043471741834,"score_gpt":0.40642186069322817,"score_spread":0.3090514259758098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314211455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870634,0.00582814,0.000008017432,0.00041043918,0.00011859247,0.0021212085,0.00004828298,0.00006587621,0.004336034],"genre_scores_gemma":[0.99662304,0.0005668598,0.00013443704,0.000027590813,0.00019952151,0.0010006287,0.000023814031,0.000035311306,0.0013888071],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972698,0.00014914421,0.00029820498,0.00036209106,0.0011978878,0.0007228654],"domain_scores_gemma":[0.9983334,0.00015439306,0.0000771276,0.00062749273,0.0005051708,0.0003024092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074139796,0.00016634012,0.00027606977,0.00021598894,0.00020045678,0.00003502605,0.00031518925,0.00009979154,0.0028560357],"category_scores_gemma":[0.00006476881,0.00009979549,0.00014907822,0.00057602377,0.00049317174,0.0000943709,0.0001280852,0.0005929977,0.00011301251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094318185,0.008918312,0.26798508,0.0030378338,0.001400477,0.0016562017,0.008886122,0.000031371066,0.17315224,0.0023849846,0.013123166,0.5099924],"study_design_scores_gemma":[0.0017389251,0.0014976269,0.5577854,0.00009580644,0.000047935446,0.000008618395,0.00017904365,0.000042721535,0.4376297,0.000409968,0.00047466627,0.00008962208],"about_ca_topic_score_codex":0.0021656358,"about_ca_topic_score_gemma":0.00015905712,"teacher_disagreement_score":0.5099028,"about_ca_system_score_codex":0.00029666166,"about_ca_system_score_gemma":0.00049608387,"threshold_uncertainty_score":0.9980555},"labels":[],"label_agreement":null},{"id":"W2314263435","doi":"10.1158/0008-5472.sabcs12-p3-06-03","title":"Abstract P3-06-03: Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemcitabine; Docetaxel; Medicine; Oncology; Internal medicine; Breast cancer; Clinical endpoint; Chemotherapy; Proportional hazards model; Cancer; Metastatic breast cancer; Clinical trial","score_opus":0.014685694215985324,"score_gpt":0.3414404570234122,"score_spread":0.3267547628074269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314263435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952234,0.0074467836,4.3401872e-7,0.0007026954,0.00018723533,0.0005202153,0.0014871655,0.000010061913,0.00012305407],"genre_scores_gemma":[0.99375135,0.0046422887,0.000007101139,0.00002941715,0.00066569523,0.0006229073,0.00012898693,0.00004182868,0.00011042331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977477,0.00020189057,0.0003023225,0.000450964,0.0005110606,0.0007860555],"domain_scores_gemma":[0.9988119,0.00015803345,0.00017362078,0.0002511223,0.00043850444,0.00016681517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068973855,0.00025652253,0.0004139482,0.00015385053,0.00011961065,0.00001970328,0.00018081568,0.00019821424,0.000100371064],"category_scores_gemma":[0.00009090297,0.00021912731,0.00006825047,0.00036873543,0.00015515517,0.000035862122,0.00022964127,0.00029351746,0.000008656915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007243522,0.00011465394,0.9409768,0.00018320439,0.0002806242,5.747506e-7,0.00013055268,0.000011576841,0.015429944,0.0000024178194,0.00075963803,0.041385677],"study_design_scores_gemma":[0.0023882182,0.00012140181,0.9675647,0.00018398979,0.0000560878,0.0000011186397,0.000031792784,5.693711e-7,0.028613515,0.0000055718383,0.0008353828,0.00019762218],"about_ca_topic_score_codex":0.005837986,"about_ca_topic_score_gemma":0.0017711588,"teacher_disagreement_score":0.041188058,"about_ca_system_score_codex":0.0007361537,"about_ca_system_score_gemma":0.00020795161,"threshold_uncertainty_score":0.8935752},"labels":[],"label_agreement":null},{"id":"W2314369639","doi":"10.1158/0008-5472.sabcs-6083","title":"Breast cancer mortality reduction in the western world: therapeutic versus diagnostic interventions. Implications for cancer care organization processes.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; BC Cancer Agency; McGill University","funders":"","keywords":"Medicine; Breast cancer; Cancer; Demography; Epidemiology; Mammography; Population; Gerontology; Environmental health; Internal medicine","score_opus":0.31296667317668175,"score_gpt":0.5406637457360698,"score_spread":0.22769707255938804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314369639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91098136,0.027955513,0.00044312936,0.056216262,0.00045748826,0.003165085,0.0003491588,0.000076862234,0.0003551616],"genre_scores_gemma":[0.9928503,0.0034299437,0.000017562645,0.00047991032,0.0006530193,0.0022072922,0.00009398357,0.000022605796,0.00024538938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826306,0.000109690554,0.00030120084,0.00040001294,0.00047294394,0.00045308832],"domain_scores_gemma":[0.9974586,0.00022423634,0.0000829792,0.00037547498,0.0017636048,0.00009515571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047980362,0.00014125122,0.00020603438,0.00023863607,0.00031438307,0.00009586942,0.0003064875,0.00007148121,0.00014638834],"category_scores_gemma":[0.00025240093,0.000109469605,0.000075330805,0.0025446806,0.00011694629,0.0002291035,0.00002868068,0.00037534817,0.0000048944985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012006337,0.00035673898,0.77140695,0.0015156214,0.00018539437,0.000008300581,0.005642977,0.00092133833,0.0025908093,0.000794052,0.008619477,0.20675771],"study_design_scores_gemma":[0.0016075193,0.00022541471,0.9906581,0.0013369569,0.00018454301,0.000019149671,0.0019141835,0.000009678599,0.0010763787,0.00032910422,0.0024799455,0.00015903983],"about_ca_topic_score_codex":0.0048601665,"about_ca_topic_score_gemma":0.020633623,"teacher_disagreement_score":0.21925114,"about_ca_system_score_codex":0.0011967553,"about_ca_system_score_gemma":0.0011452449,"threshold_uncertainty_score":0.99723727},"labels":[],"label_agreement":null},{"id":"W2314400253","doi":"10.1158/1538-7445.am2012-4119","title":"Abstract 4119: High-throughput proteomics reveals that enzymes of the ketogenic pathway are upregulated during prostate cancer progression","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"LNCaP; Prostate cancer; Stable isotope labeling by amino acids in cell culture; Cancer research; DU145; Androgen; Androgen deprivation therapy; Cancer; Biology; Clonogenic assay; Cancer cell; Internal medicine; Endocrinology; Proteomics; Medicine; Cell; Biochemistry; Hormone","score_opus":0.04068437089014193,"score_gpt":0.35390517957880524,"score_spread":0.3132208086886633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314400253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614827,0.033747688,0.0000025534034,0.00038064245,0.0027467725,0.0012758378,0.0002572808,0.000014762284,0.000091764276],"genre_scores_gemma":[0.9840782,0.006351034,0.00006337696,0.0000417656,0.0061781723,0.0008807027,0.000029220257,0.000058434507,0.0023190542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758947,0.00020603549,0.0003011216,0.0004434564,0.0006126814,0.00084722845],"domain_scores_gemma":[0.9984771,0.000017867342,0.00024544785,0.0007154834,0.00036067388,0.00018339965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075529923,0.00021944742,0.0002817854,0.000067206354,0.00027287766,0.000035826142,0.0004617798,0.00022693923,0.00013153139],"category_scores_gemma":[0.00009268275,0.00015453013,0.00014378471,0.00029649984,0.00033795508,0.000023444956,0.00039323594,0.00038143582,0.0000046124765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031052358,0.000076316304,0.070398785,0.00028956035,0.000075761374,1.40358e-7,0.0003121433,0.000047883535,0.9202082,0.000032250908,0.005951841,0.0022966089],"study_design_scores_gemma":[0.0005910508,0.000029760471,0.20302045,0.00028184717,0.000013032261,0.000002722408,0.00009808611,7.153667e-7,0.76097214,0.000029963456,0.034802064,0.00015815327],"about_ca_topic_score_codex":0.00071303744,"about_ca_topic_score_gemma":0.0002862688,"teacher_disagreement_score":0.15923603,"about_ca_system_score_codex":0.00013639574,"about_ca_system_score_gemma":0.0005107083,"threshold_uncertainty_score":0.63015556},"labels":[],"label_agreement":null},{"id":"W2314400904","doi":"10.1158/0008-5472.sabcs10-p3-11-11","title":"Abstract P3-11-11: A Comparison of Breast Cancer Treatment Rates in British Columbia, Scotland, and Western Australia, and a Comparison with Models of “Optimal” Therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Radiation therapy; Medicine; Breast cancer; Population; Chemotherapy; Hormonal therapy; Stage (stratigraphy); Cancer; Epidemiology; Cancer registry; Hormone therapy; Surgery; Oncology; Internal medicine; Environmental health","score_opus":0.48554989281672983,"score_gpt":0.5256536323746558,"score_spread":0.040103739557925955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314400904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920219,0.004168756,0.000015938349,0.0018947967,0.000073154144,0.000944533,0.00083272357,0.0000071816016,0.00004101621],"genre_scores_gemma":[0.9975293,0.0014336313,0.00022051462,0.000054276767,0.00007748773,0.00034840443,0.000011938236,0.00002644162,0.00029800663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702007,0.00014620136,0.0017336956,0.0005011183,0.00016309942,0.00043582378],"domain_scores_gemma":[0.9981471,0.00043082726,0.0007675384,0.00029858795,0.0001738268,0.00018215673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036440413,0.00013464967,0.0011284685,0.00021964918,0.000110574154,0.00017756832,0.00017636019,0.0001434503,0.00037623243],"category_scores_gemma":[0.000053149182,0.00018354904,0.000038348127,0.00021981032,0.00038748275,0.00032148173,0.000038439743,0.00028451925,0.000005610023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008516265,0.0002882539,0.9939546,0.00031794532,0.000059066493,0.0000011281138,0.0022143852,0.00070760347,0.00011693354,0.00014492196,0.00068174576,0.0014282713],"study_design_scores_gemma":[0.0027011097,0.0002711491,0.98942834,0.00037008492,0.000004542106,0.0000062795834,0.0013205642,0.004124421,0.00011369181,0.00032175294,0.0011329141,0.00020515274],"about_ca_topic_score_codex":0.69553816,"about_ca_topic_score_gemma":0.86798656,"teacher_disagreement_score":0.17244838,"about_ca_system_score_codex":0.0002850051,"about_ca_system_score_gemma":0.00030587288,"threshold_uncertainty_score":0.7484912},"labels":[],"label_agreement":null},{"id":"W2314410937","doi":"10.1158/0008-5472.sabcs12-p2-10-23","title":"Abstract P2-10-23: Lymphovascular Invasion (LVI) and Overall Survival in Node-negative and Node-positive Breast Cancer Patients: A Meta-analysis.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Breast cancer; Meta-analysis; Lymph node; Hazard ratio; Internal medicine; Subgroup analysis; Oncology; Confidence interval; Proportional hazards model; Cancer; Metastasis","score_opus":0.06301517663574838,"score_gpt":0.35702697381723764,"score_spread":0.2940117971814893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314410937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753837,0.022145009,0.00000739244,0.0008286558,0.000061132756,0.00040512113,0.00074896286,0.0000067019837,0.00041329899],"genre_scores_gemma":[0.9946828,0.0040736985,0.000046300655,0.00016809111,0.00016330706,0.00051050534,0.00012976099,0.000031806714,0.00019372947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758536,0.00029464962,0.00025583786,0.0006704364,0.00052097696,0.00067274814],"domain_scores_gemma":[0.9987962,0.00012265335,0.00008574141,0.00033674247,0.00044693289,0.00021171752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067884766,0.0002905899,0.00061819557,0.00021080836,0.00019488043,0.000052366355,0.0001517604,0.00015037469,0.0003079125],"category_scores_gemma":[0.00007762007,0.0002322679,0.00024139995,0.00042776714,0.0003313707,0.00003661704,0.00037627958,0.00020058005,0.0000073351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014864065,0.0008055482,0.9116253,0.00014642288,0.064295776,0.000012222062,0.0017206904,0.00015757779,0.014467071,0.00006518962,0.0016058695,0.0036119001],"study_design_scores_gemma":[0.0018504293,0.00005245088,0.9833939,0.000021027428,0.004270142,0.0000025038678,0.00019774877,0.000007311418,0.009439279,0.000028997474,0.00045562632,0.00028058168],"about_ca_topic_score_codex":0.010766428,"about_ca_topic_score_gemma":0.0040986054,"teacher_disagreement_score":0.071768574,"about_ca_system_score_codex":0.0002813049,"about_ca_system_score_gemma":0.00015256985,"threshold_uncertainty_score":0.99582094},"labels":[],"label_agreement":null},{"id":"W2314474958","doi":"10.1158/0008-5472.sabcs-09-2049","title":"Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Paroxetine; Fluoxetine; Internal medicine; Sertraline; Venlafaxine; Antidepressant; Oncology; Population; Citalopram; CYP2D6; Cancer; Serotonin","score_opus":0.01086209334396202,"score_gpt":0.31608987663596005,"score_spread":0.305227783291998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314474958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967285,0.0021284472,0.0000042259594,0.00017380172,0.000013160009,0.00058524316,0.00011769181,0.0000068918057,0.00024203333],"genre_scores_gemma":[0.9970728,0.0022865853,0.000034587953,0.000040835203,0.00008038902,0.00022500945,0.000005597965,0.000019972042,0.00023423677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854064,0.00019346045,0.00014239695,0.00041477042,0.0002249569,0.00048380485],"domain_scores_gemma":[0.9993116,0.00001890605,0.00004580509,0.00021673765,0.00022266823,0.00018427879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003697783,0.00014121167,0.00021582456,0.00014552094,0.00007535068,0.000017459586,0.00013123074,0.00015951971,0.000013408266],"category_scores_gemma":[0.000035252364,0.000108739456,0.00002161595,0.00047848324,0.00009428885,0.000006617368,0.00006340746,0.0003157226,0.0000013835687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031974632,0.00010656469,0.15263906,0.000025730984,0.000120031895,0.00004136994,0.00043692108,0.00027160216,0.8287184,0.000005943459,0.00046599287,0.0139708705],"study_design_scores_gemma":[0.0010984378,0.0010106189,0.4138181,0.00014112312,0.00000904919,0.000020653508,0.00007311011,0.000020381985,0.5835158,0.000020175545,0.0001425636,0.00012996983],"about_ca_topic_score_codex":0.0012686622,"about_ca_topic_score_gemma":0.00022846572,"teacher_disagreement_score":0.26117903,"about_ca_system_score_codex":0.0001142029,"about_ca_system_score_gemma":0.0002275454,"threshold_uncertainty_score":0.44342664},"labels":[],"label_agreement":null},{"id":"W2314505601","doi":"10.1158/1538-7445.am2011-289","title":"Abstract 289: Associations between germline genotype and efficacy and safety outcomes in a phase III study of sunitinib (SU) and FOLFIRI in metastatic colorectal cancer (mCRC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"FOLFIRI; Single-nucleotide polymorphism; Internal medicine; Genotype; Medicine; Oncology; Genotyping; Colorectal cancer; Gastroenterology; Cancer; Biology; Irinotecan; Genetics; Gene","score_opus":0.18736922359245417,"score_gpt":0.47272447136859763,"score_spread":0.28535524777614346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314505601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932731,0.00423345,3.426661e-7,0.00033064297,0.000025031746,0.001596014,0.0002263879,0.000008581467,0.00030647469],"genre_scores_gemma":[0.99713445,0.002361269,0.000028774097,0.00001458182,0.000028861024,0.0003172676,0.000012451441,0.000017066457,0.00008526211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984243,0.00012579537,0.00042733454,0.0003310058,0.00034372453,0.0003478603],"domain_scores_gemma":[0.9988978,0.00058853213,0.00008954034,0.00011550483,0.000176845,0.0001317907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007170547,0.00015663994,0.0007166417,0.00032619954,0.00012442458,0.000015520158,0.00005613378,0.000049476912,0.00011265118],"category_scores_gemma":[0.00020901996,0.0001231176,0.00002345964,0.00042545504,0.00021478342,0.00007316305,0.00012272105,0.00032974736,4.3208877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023380849,0.0013600725,0.95103735,0.00007885815,0.00052781973,0.00006573838,0.015996354,7.1128926e-7,0.00075883255,0.000012277641,0.000017622335,0.02780631],"study_design_scores_gemma":[0.0200399,0.0017234938,0.9752557,0.00010259236,0.00014261383,0.0000010779484,0.0022156453,0.000005599136,0.00032130847,0.00004170513,0.000051293413,0.000099061726],"about_ca_topic_score_codex":0.030571338,"about_ca_topic_score_gemma":0.045327842,"teacher_disagreement_score":0.027707247,"about_ca_system_score_codex":0.00028842423,"about_ca_system_score_gemma":0.00023210318,"threshold_uncertainty_score":0.9758842},"labels":[],"label_agreement":null},{"id":"W2314583760","doi":"10.1158/1538-7445.am2012-3561","title":"Abstract 3561: Effects of metformin on markers of insulin resistance and on breast cancer proliferation: The putative role of IGFBP-1 as a predictive biomarker","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Metformin; Medicine; Insulin resistance; Internal medicine; Breast cancer; Endocrinology; Oncology; Cancer; Adiponectin; Biomarker; Insulin; Biology","score_opus":0.01859572880791431,"score_gpt":0.3403176090643982,"score_spread":0.32172188025648385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314583760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8442991,0.15322927,0.0000036145989,0.00007278936,0.00009141317,0.00056403846,0.00030771244,0.0000020870773,0.00143],"genre_scores_gemma":[0.9728289,0.02628499,0.000015161037,0.00006125855,0.0001954537,0.00041127027,0.000013459458,0.000019444962,0.0001700385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984598,0.00023520284,0.00024190031,0.00025870185,0.00047783405,0.00032653293],"domain_scores_gemma":[0.9988335,0.0001790046,0.00016661629,0.0003034361,0.00041782128,0.00009965637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083644263,0.00013958172,0.00023775746,0.00009048729,0.00007199752,0.000008637335,0.00018569366,0.00011462568,0.000063922584],"category_scores_gemma":[0.00019974659,0.00009750454,0.000063896754,0.0002413881,0.00044261958,0.000014169707,0.000056624227,0.00018070567,0.0000013250955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011068754,0.00036559367,0.005298922,0.0008890011,0.00061229616,0.0000010464595,0.0014495521,0.000051997682,0.797702,0.00075191364,0.0029699244,0.17883901],"study_design_scores_gemma":[0.0007617016,0.0004136594,0.07537001,0.00025774084,0.000029694349,6.9280674e-7,0.0003485125,0.000008541464,0.91396266,0.00017353283,0.00857521,0.00009803688],"about_ca_topic_score_codex":0.00027828076,"about_ca_topic_score_gemma":0.00008201347,"teacher_disagreement_score":0.17874098,"about_ca_system_score_codex":0.00005126805,"about_ca_system_score_gemma":0.00032148557,"threshold_uncertainty_score":0.39761198},"labels":[],"label_agreement":null},{"id":"W2314631958","doi":"10.1158/1538-7445.am2013-3186","title":"Abstract 3186: Characterizing the antitumor effects of inhibiting translation initiation in glioblastoma multiforme.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"EIF4E; Cancer research; Carcinogenesis; PTEN; Translation (biology); Biology; Oncogene; Eukaryotic translation; Cancer; Gene; Cell cycle; Messenger RNA; PI3K/AKT/mTOR pathway; Genetics; Apoptosis","score_opus":0.03303099448931571,"score_gpt":0.3383848920148175,"score_spread":0.3053538975255018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314631958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958237,0.0027935945,0.000026186748,0.00026571983,0.00026608232,0.0005722879,0.000008119872,0.0000046787354,0.00023967396],"genre_scores_gemma":[0.9973511,0.0014971271,0.000029689038,0.000061390776,0.00073185464,0.00025679296,0.000015127026,0.000015881627,0.000041046314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897814,0.00009038225,0.00020659971,0.00020070773,0.00023120426,0.00029295761],"domain_scores_gemma":[0.99947834,0.00006985623,0.00006884564,0.00016779998,0.00017155566,0.00004357876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046836914,0.00008383194,0.00011480241,0.000107106534,0.00008178885,0.00003249929,0.00013569377,0.00008321992,0.000036060366],"category_scores_gemma":[0.00013333141,0.00006723626,0.000047026697,0.00022061015,0.00009637247,0.000020460042,0.000041600244,0.0002066319,0.000009134361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055611916,0.000023926536,0.00067091646,0.0001338577,0.000008536751,4.8077914e-7,0.00027464438,0.000013198333,0.9568905,0.000011282759,0.0002083965,0.04170863],"study_design_scores_gemma":[0.0005973823,0.0000675181,0.07770534,0.00012634952,0.0000031566296,0.0000012561999,0.00009352036,0.00005337463,0.9155321,0.000024744913,0.0057181185,0.00007715496],"about_ca_topic_score_codex":0.00075173,"about_ca_topic_score_gemma":0.0004203851,"teacher_disagreement_score":0.07703442,"about_ca_system_score_codex":0.000027098617,"about_ca_system_score_gemma":0.00013086008,"threshold_uncertainty_score":0.27418151},"labels":[],"label_agreement":null},{"id":"W2314657015","doi":"10.1158/1538-7445.am2011-sy02-02","title":"Abstract SY02-02: Interaction of MMPs with oncogenic signaling: Disruption of dynamic reciprocity and tissue polarity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"MMP9; Cancer research; Cell biology; MAPK/ERK pathway; Cancer; Biology; Signal transduction; Downregulation and upregulation; Biochemistry; Genetics","score_opus":0.07766793069941999,"score_gpt":0.39890791986222457,"score_spread":0.3212399891628046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314657015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818397,0.0008685279,0.00019477369,0.000025732415,0.000025579217,0.00018964327,0.000028270895,0.0000030058338,0.0004804758],"genre_scores_gemma":[0.9990937,0.00041534886,0.0002699694,0.0000051914813,0.000041263796,0.000026640228,0.00001976135,0.000011432838,0.00011666397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927604,0.000051205865,0.0001391874,0.00021188857,0.00016363872,0.00015801452],"domain_scores_gemma":[0.99943966,0.000011309381,0.000076267206,0.0001807363,0.00023865081,0.000053398868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034671364,0.00006969169,0.00010770394,0.000058344336,0.00004824557,0.0000068128497,0.000100034835,0.000090371635,0.00010511522],"category_scores_gemma":[0.000038451184,0.000057940408,0.000025740976,0.00010030993,0.00018123566,0.000008317218,0.00006366913,0.0001616996,0.0000011404215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047204594,0.00007149555,0.0032551158,0.00010392587,0.000035462785,0.0000015292053,0.0001544558,0.000001769242,0.9833541,0.000024869447,0.000014515169,0.012510734],"study_design_scores_gemma":[0.0002505615,0.00063605356,0.023791943,0.00007957321,0.000007464194,0.0000039259053,0.00020573502,0.000010320991,0.9743313,0.000091821654,0.00052261417,0.00006865021],"about_ca_topic_score_codex":0.0015598283,"about_ca_topic_score_gemma":0.0007576338,"teacher_disagreement_score":0.020536827,"about_ca_system_score_codex":0.000030447673,"about_ca_system_score_gemma":0.000110667504,"threshold_uncertainty_score":0.23627412},"labels":[],"label_agreement":null},{"id":"W2314662733","doi":"10.1158/1538-7445.am10-5010","title":"Abstract 5010: Nucleophosmin (NPM) is univerally deregulated in acute promyelocytic leukemia","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Nucleophosmin; Ribosome biogenesis; Biology; Acute promyelocytic leukemia; Cancer research; Cell biology; Cell culture; Molecular biology; Retinoic acid; Myeloid leukemia; Ribosome; Genetics; RNA","score_opus":0.02073165205111431,"score_gpt":0.3435020645604866,"score_spread":0.3227704125093723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314662733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945954,0.00042055757,0.000010156419,0.00038105235,0.00017069039,0.00030157014,0.00001537192,0.000016224501,0.004088967],"genre_scores_gemma":[0.99511623,0.0007698704,0.000132755,0.00016948133,0.00032159855,0.00008656152,0.0000434106,0.00004394112,0.0033161486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818623,0.000047039062,0.00022186372,0.00055742904,0.00037743527,0.00060997583],"domain_scores_gemma":[0.9990071,0.000020842988,0.000050378865,0.0005360326,0.00025675967,0.00012890028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000484887,0.00017623414,0.00016348911,0.00014937045,0.00013106111,0.000072797695,0.0005908227,0.00035544595,0.00045284288],"category_scores_gemma":[0.00008098363,0.00016890855,0.00006586572,0.0004036628,0.0003153073,0.000011918011,0.00020409326,0.0008486896,0.000060177896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015461906,0.00003046398,0.0021261238,0.00007164177,0.000038402224,0.00005654081,0.00011922183,0.000026136157,0.987868,0.00011118785,0.0035978851,0.005799782],"study_design_scores_gemma":[0.0008228217,0.000092997165,0.012930705,0.00004792729,0.0000075944176,0.000015921454,0.000069602815,0.00008335641,0.9596012,0.00048420244,0.025598573,0.00024508772],"about_ca_topic_score_codex":0.00073098636,"about_ca_topic_score_gemma":0.0005964276,"teacher_disagreement_score":0.028266786,"about_ca_system_score_codex":0.00018676418,"about_ca_system_score_gemma":0.0018302406,"threshold_uncertainty_score":0.68878907},"labels":[],"label_agreement":null},{"id":"W2314746754","doi":"10.1158/1538-7445.am2011-1984","title":"Abstract 1984: Activated BMP signalling modulates multicellular spheroid formation and reattachment of ascites-derived human epithelial ovarian cancer cells in an in vitro model of metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Spheroid; Cancer research; Biology; Cell biology; Metastasis; Paracrine signalling; Ovarian cancer; Cell culture; Cancer; Receptor; Genetics","score_opus":0.11483413943933052,"score_gpt":0.3814279681689726,"score_spread":0.2665938287296421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314746754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984621,0.00048072782,0.00021636988,0.000017904524,0.000017323053,0.00055766833,0.00018146209,0.0000039787633,0.00006247452],"genre_scores_gemma":[0.99842936,0.00046119373,0.00081164314,0.000004452196,0.000028349525,0.00012392498,0.00007709771,0.000030940344,0.000033057007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795395,0.00025790173,0.00043863268,0.00041333484,0.0004453966,0.00049076154],"domain_scores_gemma":[0.99902904,0.00003172627,0.00012395818,0.00033539068,0.00034851755,0.00013135989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010272325,0.00016579064,0.00028927997,0.00030889563,0.000054933662,0.000019990524,0.00031136215,0.00017719324,0.00011583836],"category_scores_gemma":[0.00004565944,0.00016021582,0.00005158228,0.00028334119,0.00020812456,0.00004301133,0.00016975318,0.00034187376,9.205857e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009547823,0.00022661945,0.0020013237,0.00018385347,0.000047491358,0.0000037127325,0.0010773774,0.004947279,0.98770785,0.0000040606487,0.0000047963886,0.00284085],"study_design_scores_gemma":[0.0011197161,0.00018748104,0.0037746427,0.000083907056,0.0000072270245,2.193318e-7,0.00033660448,0.009459949,0.9848121,0.00006824344,0.0000065301497,0.00014342014],"about_ca_topic_score_codex":0.010658342,"about_ca_topic_score_gemma":0.0018828494,"teacher_disagreement_score":0.008775492,"about_ca_system_score_codex":0.00015377211,"about_ca_system_score_gemma":0.00023654738,"threshold_uncertainty_score":0.9959298},"labels":[],"label_agreement":null},{"id":"W2314820863","doi":"10.1158/1538-7445.am10-lb-81","title":"Abstract LB-81: Purification and characterization of a human urinary compound with potent anticancer activity","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; Université de Montréal","funders":"","keywords":"Cancer; Medicine; In vivo; Urine; Urinary system; In vitro; Pharmacology; Cancer research; Internal medicine; Chemistry; Biology; Biochemistry; Biotechnology","score_opus":0.0365938719441296,"score_gpt":0.35794613011734244,"score_spread":0.32135225817321283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314820863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820065,0.00028593838,0.000046570935,0.00023749794,0.000531092,0.00027839333,0.000046630197,0.0000056977156,0.00036749546],"genre_scores_gemma":[0.99579775,0.0010721094,0.000034700213,0.00001935897,0.0025865412,0.00008858638,0.000062169485,0.000018096021,0.00032067977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907625,0.00004292025,0.000113948816,0.00030144813,0.0002449689,0.00022045354],"domain_scores_gemma":[0.9992617,0.000009037842,0.00007246694,0.0003121353,0.0002573703,0.0000873077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031091526,0.00009228041,0.00012995099,0.00007013715,0.00013102914,0.000029201865,0.00012448675,0.00009887592,0.000046574336],"category_scores_gemma":[0.000015352975,0.000081063554,0.000024687137,0.00011282916,0.000318481,0.00001210775,0.00006202646,0.00024274187,0.0000011838838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025054088,0.00009881411,0.0031342097,0.00007033264,0.000023780798,1.6816205e-7,0.0000641164,7.177404e-7,0.98841596,0.00010374906,0.0003162375,0.007521404],"study_design_scores_gemma":[0.00042211785,0.00017794556,0.39514324,0.00002234617,0.000007810078,0.0000057126445,0.000020725589,0.000004232035,0.5608702,0.000017540568,0.043214146,0.00009402235],"about_ca_topic_score_codex":0.00035135486,"about_ca_topic_score_gemma":0.00027278313,"teacher_disagreement_score":0.42754576,"about_ca_system_score_codex":0.000017475091,"about_ca_system_score_gemma":0.00019453111,"threshold_uncertainty_score":0.3305676},"labels":[],"label_agreement":null},{"id":"W2314860898","doi":"10.1158/1538-7445.am2013-617","title":"Abstract 617: High-throughput screens identify PARP inhibition as being synthetically lethal with ERCC1 deficiency in non-small cell lung cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"ERCC1; Synthetic lethality; Biology; PARP inhibitor; Cancer research; DNA repair; In vivo; DNA damage; Cell culture; Poly ADP ribose polymerase; Nucleotide excision repair; DNA; Genetics","score_opus":0.04290597672587172,"score_gpt":0.3883638873514839,"score_spread":0.3454579106256122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314860898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96384823,0.003936264,0.000291335,0.003544145,0.00029033943,0.0023390497,0.00005128462,0.00009275395,0.025606586],"genre_scores_gemma":[0.9903257,0.0033076222,0.0006680945,0.0005940896,0.0007786758,0.002351196,0.000041555373,0.00013832422,0.0017947356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948908,0.00019643124,0.0007235032,0.0010737103,0.0016457345,0.0014698228],"domain_scores_gemma":[0.9970569,0.00034263794,0.00017171675,0.00076348154,0.0011639562,0.0005013197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001176807,0.00041973966,0.00058463536,0.00045109444,0.00029441982,0.00019323618,0.00034563063,0.00033697372,0.0061261365],"category_scores_gemma":[0.00006934405,0.00036574836,0.0001229215,0.0011031531,0.0005417248,0.0005122248,0.0001503353,0.0016230396,0.00043111594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00131354,0.0012561907,0.03340572,0.0029745668,0.00009151106,0.0007169585,0.0029956584,0.0012503302,0.93519115,0.00033038342,0.015564459,0.004909499],"study_design_scores_gemma":[0.011390401,0.0010911673,0.16231832,0.006353081,0.00013616693,0.00007196076,0.0019009588,0.0008006876,0.8117675,0.0012048424,0.0017243184,0.0012405769],"about_ca_topic_score_codex":0.04322935,"about_ca_topic_score_gemma":0.0033509505,"teacher_disagreement_score":0.1289126,"about_ca_system_score_codex":0.0019725722,"about_ca_system_score_gemma":0.0016496547,"threshold_uncertainty_score":0.9998794},"labels":[],"label_agreement":null},{"id":"W2314925876","doi":"10.1158/0008-5472.sabcs-09-2130","title":"Validation of FOXA1 as a Prognostic Marker in Breast Cancer in a Large Population-Based Tissue Microarray.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"FOXA1; Breast cancer; Population; Immunohistochemistry; Tissue microarray; Internal medicine; Estrogen receptor; Oncology; Cancer; Medicine; Cancer research; Endocrinology; Biology","score_opus":0.023210954400436197,"score_gpt":0.36672667430625605,"score_spread":0.34351571990581986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314925876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741656,0.00056784047,0.00006495598,0.0012159918,0.00004661114,0.0004959783,0.00010279663,0.0000053117224,0.00008397868],"genre_scores_gemma":[0.9992459,0.00008642038,0.00004347603,0.00006589872,0.000058526133,0.00012262311,0.00020064673,0.000013581981,0.00016293112],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99870944,0.00017912283,0.00023515587,0.00029070434,0.00028457388,0.00030097712],"domain_scores_gemma":[0.9994945,0.000017222561,0.00004648597,0.0001975791,0.00019404062,0.000050197425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004578736,0.000092659044,0.000120718374,0.00024237954,0.00003192457,0.00001609443,0.00012487434,0.00012613785,0.00028135086],"category_scores_gemma":[0.00006180194,0.00009741965,0.00003116172,0.00045001914,0.000035191068,0.000010196572,0.000013863202,0.00014106519,0.0000044617577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002453248,0.00009300773,0.3153799,0.000033691853,0.000004307326,0.0000014705446,0.000050991574,0.0010042972,0.6806463,0.000024181287,0.00009107723,0.00242547],"study_design_scores_gemma":[0.00071014935,0.000079503436,0.73831654,0.00010573686,0.0000025932025,0.0000010204583,0.000019286212,0.0001612428,0.2600236,0.00007735104,0.00041700658,0.00008597954],"about_ca_topic_score_codex":0.0021048025,"about_ca_topic_score_gemma":0.0017438425,"teacher_disagreement_score":0.42293665,"about_ca_system_score_codex":0.00015404874,"about_ca_system_score_gemma":0.00026887446,"threshold_uncertainty_score":0.39726582},"labels":[],"label_agreement":null},{"id":"W2314954211","doi":"10.1158/0008-5472.sabcs10-p5-11-15","title":"Abstract P5-11-15: Modeling for Response Predictive Factors in Adjuvant Endocrine Therapy: Impact on Preferential Benefits of Tamoxifen and Aromatase Inhibitors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Aromatase; Cohort; Aromatase inhibitor; Adjuvant therapy; Adjuvant; Cohort study; Endocrine system; Gynecology; Cancer; Hormone","score_opus":0.0382956972413924,"score_gpt":0.37339838894152266,"score_spread":0.33510269170013024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314954211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997167,0.0015391177,0.0000059304957,0.000048709448,0.00010496205,0.00068586174,0.00041993044,0.000006158186,0.000022359103],"genre_scores_gemma":[0.998718,0.00081270514,0.000015582784,0.0000045869333,0.00015043482,0.0001250759,0.00012285831,0.000029150155,0.000021577973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987421,0.000107300395,0.00019556364,0.00034935126,0.00022685197,0.00037883033],"domain_scores_gemma":[0.99930084,0.0001264319,0.000048466612,0.00025085546,0.00013718827,0.00013622621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058263505,0.0001588317,0.00018181991,0.00017085973,0.000073004834,0.000019096435,0.00014650139,0.00020017853,0.00001585011],"category_scores_gemma":[0.0001914687,0.00011501321,0.00008057977,0.00011161077,0.00011300331,0.000008332811,0.0000757852,0.0004054172,5.5784255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008742801,0.00011869597,0.0060480307,0.000025020328,0.00006151896,0.0000021452304,0.00015082545,0.0024165881,0.98027676,0.00000556921,0.00017722472,0.0019747932],"study_design_scores_gemma":[0.0016393984,0.001422891,0.020698477,0.00007588153,0.00000566386,0.0000020738078,0.000044959663,0.00066787825,0.9751954,0.000032534354,0.00009482489,0.00012000142],"about_ca_topic_score_codex":0.00044752602,"about_ca_topic_score_gemma":0.000099673765,"teacher_disagreement_score":0.014650445,"about_ca_system_score_codex":0.00003183054,"about_ca_system_score_gemma":0.00022300147,"threshold_uncertainty_score":0.46901026},"labels":[],"label_agreement":null},{"id":"W2314955265","doi":"10.1158/1538-7445.am10-5448","title":"Abstract 5448: The tricyclic anti-depressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cyclin D1; Cyclin D; Viability assay; Apoptosis; Transactivation; Cyclin A; Cell cycle; Cyclin; Cyclin D2; Cancer research; Biology; Cyclin D3; Molecular biology; Pharmacology; Biochemistry; Gene expression","score_opus":0.039848124554297024,"score_gpt":0.35759307970467863,"score_spread":0.3177449551503816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314955265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890347,0.004788204,0.000102585625,0.0034469108,0.00024860678,0.0011014104,0.000070555834,0.00008308111,0.0011239193],"genre_scores_gemma":[0.99634814,0.002121446,0.000077098484,0.00020536857,0.00044735102,0.00025906187,0.000045609515,0.000085185704,0.00041073828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694717,0.00015413239,0.00048794723,0.0006609661,0.0010353826,0.00071440684],"domain_scores_gemma":[0.99813557,0.00057302974,0.00016312976,0.00045711105,0.00036559344,0.00030554313],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012358394,0.00027256904,0.00039571233,0.00035496408,0.00046930776,0.00010077804,0.00022629737,0.00033600148,0.00022194743],"category_scores_gemma":[0.00054772705,0.00021172644,0.00011000874,0.0009406457,0.000512748,0.00019063303,0.00008174168,0.002547823,0.000018074266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021665206,0.00017886252,0.0002475969,0.0001445037,0.00004615086,0.000011885749,0.00046395,0.000016770393,0.96119916,0.00001280533,0.0032474173,0.034214232],"study_design_scores_gemma":[0.0022504549,0.00014476816,0.002605767,0.00025479018,0.00006037722,0.000015840424,0.0003763483,0.00009843886,0.99012387,0.000023028992,0.003824968,0.00022136664],"about_ca_topic_score_codex":0.0017811172,"about_ca_topic_score_gemma":0.00022240668,"teacher_disagreement_score":0.033992864,"about_ca_system_score_codex":0.000252946,"about_ca_system_score_gemma":0.00047291475,"threshold_uncertainty_score":0.99975336},"labels":[],"label_agreement":null},{"id":"W2314961315","doi":"10.1158/1538-7445.am10-lb-388","title":"Abstract LB-388: Macrophage migration inhibitory factor (MIF) plays a role in proliferation, differentiation, and survival of Ewing tumor cells through the activation of several kinases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Macrophage migration inhibitory factor; Cancer research; Cancer; Signal transduction; Cell growth; Chemokine; Kinase; Tumor-associated macrophage; Tyrosine kinase; Cytokine; Cancer cell; Biology; Medicine; Immunology; Cell biology; Tumor microenvironment; Internal medicine; Immune system; Tumor cells","score_opus":0.030173079971802016,"score_gpt":0.31275753359752084,"score_spread":0.2825844536257188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314961315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979541,0.00038163562,0.000068372545,0.00020391426,0.00046199234,0.0006712433,0.0001701833,0.00001574934,0.00007285793],"genre_scores_gemma":[0.9993539,0.00004874921,0.000023787437,0.000020003863,0.00012703588,0.0001370975,0.00007315866,0.000018856323,0.00019742225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982838,0.00038660536,0.00050730625,0.000307528,0.00020609229,0.0003086381],"domain_scores_gemma":[0.9985483,0.00047307598,0.00023817,0.0002753857,0.00044106832,0.000023942968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052411214,0.00015870354,0.0002551065,0.00018992175,0.00023401987,0.000038426148,0.00019870033,0.00018865168,0.0007646041],"category_scores_gemma":[0.00025112685,0.00012366341,0.00005042021,0.00029249376,0.00040704902,0.00034005434,0.000078113306,0.0007592618,0.00001130983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020831241,0.00011563299,0.018414559,0.000100867444,0.000029986897,7.6494604e-7,0.005643998,0.00006713798,0.9744497,0.00019782984,0.00046463637,0.0003065632],"study_design_scores_gemma":[0.0007135993,0.00006339755,0.11523495,0.00005818839,0.000005295952,0.0000013772374,0.0009446629,0.000039501072,0.8820899,0.00010634933,0.000645645,0.00009714011],"about_ca_topic_score_codex":0.0019866412,"about_ca_topic_score_gemma":0.002830963,"teacher_disagreement_score":0.096820384,"about_ca_system_score_codex":0.00007645174,"about_ca_system_score_gemma":0.00025694232,"threshold_uncertainty_score":0.8371878},"labels":[],"label_agreement":null},{"id":"W2314966483","doi":"10.1158/1538-7445.am10-382","title":"Abstract 382: Platelets are implicated in the rapid host responses induced by cytotoxic chemotherapy which limit its anti-tumor efficacy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Platelet; Cytotoxic T cell; Chemokine; Immunology; Paclitaxel; Cancer research; Bone marrow; Cytokine; Homing (biology); Biology; Pharmacology; Immune system; Medicine; Cancer; Internal medicine; In vitro","score_opus":0.05089688966703706,"score_gpt":0.37092437506258447,"score_spread":0.32002748539554743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314966483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909339,0.0045053908,9.541964e-7,0.0026817254,0.00043024536,0.0008522606,0.00014644818,0.000018563016,0.00043049364],"genre_scores_gemma":[0.9919963,0.0052231704,0.0000072039975,0.000697187,0.0013419779,0.00035415412,0.00005788698,0.00005867752,0.0002634328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975084,0.0002459402,0.00029060993,0.0006644916,0.00049359247,0.00079698407],"domain_scores_gemma":[0.9983768,0.00014422138,0.000104623796,0.0008326826,0.00037124808,0.00017045125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014057008,0.00024469607,0.0002779295,0.00015450706,0.00022462753,0.00011728602,0.00086326513,0.0003071166,0.00026531954],"category_scores_gemma":[0.00054833904,0.00019209179,0.00008911937,0.00068293273,0.00016082865,0.000011828076,0.00011829396,0.0011289305,0.000037197202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007532819,0.00016991008,0.0003107913,0.000024842568,0.00003463301,0.000005649792,0.00014671737,0.0000010809616,0.9772998,0.0000080931095,0.0151367085,0.00610851],"study_design_scores_gemma":[0.0012977755,0.00012218225,0.11215342,0.000023848497,0.000003908014,0.0000132182,0.00008962871,0.0000019879728,0.6894183,0.000004271814,0.19667841,0.0001930543],"about_ca_topic_score_codex":0.0002605536,"about_ca_topic_score_gemma":0.0006453512,"teacher_disagreement_score":0.2878815,"about_ca_system_score_codex":0.000038651066,"about_ca_system_score_gemma":0.00056612,"threshold_uncertainty_score":0.7833276},"labels":[],"label_agreement":null},{"id":"W2314980109","doi":"10.1158/1538-7445.am2011-554","title":"Abstract 554: The impact of matrigel on the evaluation of nanomedicines in a mouse model of human breast adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Matrigel; Medicine; Indocyanine green; Breast cancer; Pathology; Cancer; Perfusion; Cancer research; Biomedical engineering; Internal medicine; Angiogenesis","score_opus":0.23869765456382122,"score_gpt":0.4690193150761833,"score_spread":0.23032166051236205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314980109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970772,0.0010785449,0.0000012494631,0.00006675355,0.000006957544,0.0005201217,0.00018903034,8.5750094e-7,0.0010592829],"genre_scores_gemma":[0.9994239,0.00024271502,0.0000025675931,0.0000032808477,0.00003347985,0.00015353443,0.00001486832,0.000011603216,0.00011402947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855095,0.00018523577,0.0002059671,0.00017087303,0.0006476644,0.00023928998],"domain_scores_gemma":[0.998871,0.000034778215,0.00008470478,0.0004552732,0.0005078463,0.00004634862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015179046,0.00008242446,0.0001326358,0.00011441653,0.00004969587,0.0000039379106,0.0003334545,0.00005499688,0.00018909687],"category_scores_gemma":[0.00008040991,0.00004307802,0.00008771159,0.00018145172,0.0003496874,0.000003884948,0.00008282596,0.0001506418,0.0000012970196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075007667,0.00024576532,0.021882774,0.00004067405,0.00012484989,5.7268267e-7,0.0005791634,0.00076582644,0.97362125,0.00009085982,0.00035905355,0.0015391499],"study_design_scores_gemma":[0.0012014906,0.0008236135,0.24059002,0.00007049178,0.00001323521,9.426905e-7,0.0003047635,0.0006935354,0.7557596,0.00048734015,0.0000015058406,0.00005345143],"about_ca_topic_score_codex":0.017184263,"about_ca_topic_score_gemma":0.0011912341,"teacher_disagreement_score":0.21870725,"about_ca_system_score_codex":0.000105759515,"about_ca_system_score_gemma":0.0006513288,"threshold_uncertainty_score":0.9893604},"labels":[],"label_agreement":null},{"id":"W2315021292","doi":"10.1158/1538-7445.am10-4739","title":"Abstract 4739: Interactions between variants of angiogenesis pathway genes and reflux symptom, BMI, and smoking in esophageal adenocarcinoma susceptibility","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Body mass index; Gastroenterology; Odds ratio; Oncology; PDGFRA; Single-nucleotide polymorphism; Genotype; Gene; Biology; Genetics","score_opus":0.07858014942965524,"score_gpt":0.4136830231507217,"score_spread":0.33510287372106645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315021292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872089,0.0109390365,0.0000029159248,0.0005579931,0.00007720753,0.000680581,0.00012711178,0.000018669654,0.00038759757],"genre_scores_gemma":[0.998416,0.00077176065,0.000115299044,0.000014858023,0.00027470052,0.00016249334,0.000022126822,0.000029873534,0.00019287692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976849,0.00013900292,0.00035810733,0.00056470814,0.000652993,0.00060030096],"domain_scores_gemma":[0.99827504,0.0004642657,0.000062025654,0.00045743753,0.00031140164,0.00042981654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012607543,0.00017591016,0.00040849356,0.00049562455,0.00015781171,0.00004599019,0.00014414205,0.00013361203,0.0004891595],"category_scores_gemma":[0.00021655713,0.00015089786,0.00006655027,0.0004967288,0.0004635938,0.00017549374,0.00019498312,0.000852742,0.000005627545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027826097,0.00014229536,0.90341,0.00028982596,0.000111934314,0.0001905827,0.00032469246,3.8160127e-7,0.057573717,0.00010524541,0.000042211388,0.037530836],"study_design_scores_gemma":[0.0015207623,0.00030595038,0.9376514,0.00015165062,0.000028901366,0.000023460098,0.0001437422,0.000009634781,0.059751835,0.00024408709,0.00008080322,0.000087786284],"about_ca_topic_score_codex":0.0055274083,"about_ca_topic_score_gemma":0.0033032116,"teacher_disagreement_score":0.03744305,"about_ca_system_score_codex":0.0002636087,"about_ca_system_score_gemma":0.000546969,"threshold_uncertainty_score":0.83558244},"labels":[],"label_agreement":null},{"id":"W2315053004","doi":"10.1158/1538-7445.am10-3434","title":"Abstract 3434: Lipopoylsaccharide promotes human esophageal cancer cell metastatic potential via the selectin/sialyl Lewis X axis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Selectin; Sialyl-Lewis X; Cancer; Cancer cell; Flow cytometry; Esophageal cancer; Cell adhesion molecule; In vivo; Cell adhesion; Cancer research; Pathology; Metastasis; Cell; Medicine; Chemistry; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.03453008601893137,"score_gpt":0.38940546290105493,"score_spread":0.35487537688212356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315053004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913799,0.005282055,0.00006306374,0.00076492166,0.00028573605,0.0009526875,0.00015000466,0.000022889828,0.0010987092],"genre_scores_gemma":[0.99298203,0.0012932888,0.0000905813,0.00007723001,0.0011568543,0.0010553098,0.00010070374,0.00006750712,0.0031765217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968504,0.00018617047,0.00027741483,0.00073066365,0.0008663644,0.0010890084],"domain_scores_gemma":[0.99832296,0.00004878967,0.00008750936,0.00073809014,0.00047821758,0.0003244301],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008868268,0.00027306442,0.00022695454,0.00009521381,0.0008273143,0.00020280803,0.0007821835,0.00015455874,0.002214761],"category_scores_gemma":[0.00006852799,0.00020040195,0.0001708518,0.00033438927,0.00044903546,0.000021110976,0.00032374615,0.0009716511,0.00007122261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001830053,0.00021050868,0.0010543402,0.000068881294,0.00022605945,0.000045189252,0.00010951173,0.000022086513,0.9760472,0.000018419953,0.00610934,0.015905468],"study_design_scores_gemma":[0.0011417451,0.00041051282,0.0041878084,0.00001765238,0.000042188458,0.00001725436,0.00006530401,0.000038665225,0.97953165,0.00037782622,0.013916906,0.00025251688],"about_ca_topic_score_codex":0.036499403,"about_ca_topic_score_gemma":0.03305479,"teacher_disagreement_score":0.01565295,"about_ca_system_score_codex":0.00016200604,"about_ca_system_score_gemma":0.0008572298,"threshold_uncertainty_score":0.99869734},"labels":[],"label_agreement":null},{"id":"W2315089601","doi":"10.1158/1538-7445.am2013-1906","title":"Abstract 1906: Differential downstream effects of nicotinamide adenine dinucleotide (NAD) salvage pathway-inhibition in chronic lymphocytic leukemia (CLL) and multiple myeloma (MM).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; NAD+ kinase; Chronic lymphocytic leukemia; Nicotinamide adenine dinucleotide; Cancer research; Nicotinamide mononucleotide; CD38; Biology; Leukemia; Chemistry; Biochemistry; Enzyme; Cell biology; Immunology; CD34; Stem cell","score_opus":0.02653195952976865,"score_gpt":0.33112868026877845,"score_spread":0.3045967207390098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315089601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941038,0.0029605767,0.00003132844,0.00025747067,0.00019030973,0.0018373397,0.000042704763,0.00007218049,0.0005043113],"genre_scores_gemma":[0.99691457,0.0013112581,0.00005707875,0.00007430653,0.0004922654,0.00063908787,0.00005277317,0.00007335636,0.00038531102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996811,0.00019645663,0.00059139915,0.0006328113,0.0009083923,0.0008599594],"domain_scores_gemma":[0.99801934,0.0006440908,0.00015508533,0.00052447274,0.00031003638,0.00034700663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039264595,0.00029819226,0.0005865448,0.0005387772,0.00012617685,0.0000596126,0.00014321515,0.00021823184,0.0012591658],"category_scores_gemma":[0.00025111914,0.00027459528,0.000113250826,0.0005798596,0.00056289794,0.00026496744,0.00013702048,0.0007546842,0.0000961592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005582444,0.00007940223,0.005241553,0.0016864947,0.00006280274,0.00013049394,0.00029096822,0.00014566313,0.96945333,0.000053563726,0.0014881075,0.020809354],"study_design_scores_gemma":[0.011426303,0.0006015954,0.18446833,0.0026712914,0.000020855368,0.000036160513,0.00008528595,0.0018883944,0.79801923,0.00026221346,0.00027179855,0.0002485686],"about_ca_topic_score_codex":0.009185573,"about_ca_topic_score_gemma":0.0010239368,"teacher_disagreement_score":0.17922677,"about_ca_system_score_codex":0.009999056,"about_ca_system_score_gemma":0.0025112259,"threshold_uncertainty_score":0.9999706},"labels":[],"label_agreement":null},{"id":"W2315103005","doi":"10.1158/1538-7445.am10-942","title":"Abstract 942: Effects of maternal and postnatal folic acid supplementation on genomic DNA methylation in the mammary glands in a chemical rat model of mammary tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"DNA methylation; Offspring; DMBA; Endocrinology; Internal medicine; Biology; Mammary gland; Carcinogenesis; Lactation; Weaning; Methylation; Epigenetics; Cancer; Breast cancer; Pregnancy; Medicine; Genetics; Gene expression; DNA; Gene","score_opus":0.022864664713110796,"score_gpt":0.3448026717428242,"score_spread":0.3219380070297134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315103005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984756,0.0008272569,0.00013976455,0.00012597014,0.000042416097,0.00029387453,0.000020374964,0.0000011028454,0.00007361866],"genre_scores_gemma":[0.9983114,0.0011226488,0.0003423323,0.0000129864875,0.000054546046,0.000074700285,0.00006269168,0.000009343967,0.000009379719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910736,0.00009199209,0.00020619805,0.00020201232,0.00022430727,0.00016815656],"domain_scores_gemma":[0.9995717,0.00006108037,0.000058204572,0.00021139639,0.00006677144,0.000030842733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067984284,0.00007746482,0.00010515015,0.00013470017,0.000021433627,0.000015268974,0.00018854578,0.000100001474,0.0000042562356],"category_scores_gemma":[0.000057773355,0.00006437203,0.000027251524,0.00011498076,0.00005767831,0.00000877626,0.000077745615,0.0001779614,2.5673242e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015796137,0.000037669342,0.00793911,0.000093887895,0.0000074533978,0.0000031846605,0.00015570664,0.00009532936,0.9850893,0.00015009491,0.000008779987,0.0062615443],"study_design_scores_gemma":[0.0005874906,0.00010331582,0.11473002,0.000017960483,0.0000026377163,8.457795e-7,0.000013291221,0.00039607252,0.88355917,0.00052638503,0.000012064889,0.000050719842],"about_ca_topic_score_codex":0.00019039612,"about_ca_topic_score_gemma":0.00024262493,"teacher_disagreement_score":0.106790915,"about_ca_system_score_codex":0.00002191846,"about_ca_system_score_gemma":0.00012590045,"threshold_uncertainty_score":0.2625015},"labels":[],"label_agreement":null},{"id":"W2315115823","doi":"10.1158/1538-7445.am2013-3801a","title":"Abstract 3801A: Reoxygenation and repopulation of hypoxic cells in a solid tumor after chemotherapy: a cause of treatment failure.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Hypoxia (environmental); Chemotherapy; Bone marrow; Medicine; Doxorubicin; Cancer research; Radiation therapy; Pathology; Biology; Internal medicine; Chemistry; Oxygen","score_opus":0.028875435763154822,"score_gpt":0.34245946894266305,"score_spread":0.3135840331795082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315115823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962637,0.002937375,0.0000068281515,0.00014119672,0.000082834275,0.0004680743,0.000025037374,0.000002164595,0.00007278141],"genre_scores_gemma":[0.99564886,0.0033309388,0.00010792844,0.000024055817,0.00022989923,0.00030092176,0.000013727906,0.00001603278,0.00032763215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990816,0.000052471547,0.00024028144,0.00025082077,0.00016532131,0.00020951963],"domain_scores_gemma":[0.9993955,0.000013376431,0.000083461215,0.00024419982,0.00020563652,0.00005781472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022296872,0.0000922734,0.0001712746,0.00012447953,0.000020105817,0.000012356054,0.000065974,0.000079822465,0.000094569776],"category_scores_gemma":[0.000028946177,0.00008090303,0.00004275859,0.00013971841,0.00009825341,0.000009337355,0.00003212478,0.00007027332,0.000002106004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015513274,0.000061089675,0.0030713594,0.00006203726,0.0000305936,7.6286796e-7,0.0002274055,0.00003167954,0.98878074,0.00000410078,0.00057513145,0.006999987],"study_design_scores_gemma":[0.00092739274,0.00020104159,0.12530494,0.000046203182,0.000006987711,0.000002124578,0.00009954532,0.000027680639,0.8668005,0.0000781086,0.006419174,0.00008629499],"about_ca_topic_score_codex":0.0022783868,"about_ca_topic_score_gemma":0.0019332188,"teacher_disagreement_score":0.12223357,"about_ca_system_score_codex":0.00007166547,"about_ca_system_score_gemma":0.00018645894,"threshold_uncertainty_score":0.34442547},"labels":[],"label_agreement":null},{"id":"W2315123780","doi":"10.1158/1538-7445.am10-2136","title":"Abstract 2136: Combined 8q gain and 10q loss predicts for relapse following radical radiotherapy in intermediate risk prostate cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; University of British Columbia; University Health Network","funders":"","keywords":"PTEN; Prostate cancer; Prostate; Radiation therapy; Medicine; Oncology; Biochemical recurrence; Cancer; Cancer research; Internal medicine; Erg; Urology; Biology; Prostatectomy; PI3K/AKT/mTOR pathway; Genetics; Apoptosis","score_opus":0.016847874803537995,"score_gpt":0.36159420867145964,"score_spread":0.34474633386792164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315123780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026847,0.005561981,0.0005591607,0.0006713067,0.00076401746,0.001801421,0.00025721602,0.000021645918,0.000094780306],"genre_scores_gemma":[0.98409235,0.011974088,0.0003270508,0.000111738234,0.00068204006,0.0018677214,0.00010190901,0.0001106285,0.0007324929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968313,0.00022564191,0.00039047524,0.0008705523,0.0006151932,0.0010668199],"domain_scores_gemma":[0.9985124,0.00015968154,0.000091394904,0.0005481371,0.0003183722,0.0003700352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022836828,0.00025855794,0.00031073162,0.00028205293,0.0002298679,0.00010821065,0.0004713178,0.00044483188,0.00012810045],"category_scores_gemma":[0.0011601922,0.00025243626,0.00014340482,0.00036495156,0.00047010783,0.000017231383,0.00023399656,0.001453862,0.0000036604436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020411394,0.00009988902,0.0031373128,0.00012469388,0.00017198411,0.00004893936,0.00034657214,0.00015774243,0.96849364,0.0000489885,0.003755972,0.02157312],"study_design_scores_gemma":[0.014971852,0.0015893136,0.007248738,0.0003819637,0.000038733106,0.000011242391,0.00017195594,0.0019769429,0.85579425,0.0009075675,0.11611199,0.00079548475],"about_ca_topic_score_codex":0.001086753,"about_ca_topic_score_gemma":0.0035382658,"teacher_disagreement_score":0.11269943,"about_ca_system_score_codex":0.00019814346,"about_ca_system_score_gemma":0.000937925,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W2315182050","doi":"10.1158/0008-5472.fbcr09-b29","title":"Abstract B29: Inactivation of suppressor of fused alone is not sufficient to cause medulloblastoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Patched; Nestin; Suppressor; Biology; Cerebellum; Cancer research; PTCH1; Tumor suppressor gene; Progenitor cell; Neural stem cell; Hedgehog signaling pathway; Sonic hedgehog; Cell biology; Carcinogenesis; Endocrinology; Signal transduction; Stem cell; Genetics; Cancer","score_opus":0.08678451362095586,"score_gpt":0.40947947546763586,"score_spread":0.32269496184668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315182050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977469,0.00035678837,0.000059895396,0.0011072644,0.000049466642,0.00027870797,0.0000921295,0.000005108458,0.00030377012],"genre_scores_gemma":[0.99931127,0.00011300563,0.00007625279,0.00014943932,0.00009805105,0.000035753514,0.000011861046,0.0000125229235,0.00019182882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986441,0.000056643166,0.00024309618,0.00029209573,0.00045815672,0.00030586682],"domain_scores_gemma":[0.9988462,0.00004091285,0.00005170653,0.00035461242,0.0006175135,0.00008910473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004612745,0.00009829728,0.00018401968,0.00013743067,0.00005907273,0.000008045992,0.00023019702,0.000091223694,0.000052612693],"category_scores_gemma":[0.0003168461,0.000092531154,0.000053586537,0.00028844705,0.00011876156,0.0000032162454,0.0000973029,0.00012480853,0.0000065802665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038384635,0.00012729122,0.00029024505,0.000048610615,0.000047584694,0.0000020320788,0.00069165137,0.00017046812,0.99257576,0.000019287725,0.0043508336,0.0012923754],"study_design_scores_gemma":[0.00034817544,0.00058681663,0.020778086,0.00005988216,0.0000052139417,4.484847e-7,0.00019439068,0.000005888864,0.97530967,0.000008960516,0.0026171822,0.00008530604],"about_ca_topic_score_codex":0.00021137964,"about_ca_topic_score_gemma":0.000060358227,"teacher_disagreement_score":0.020487841,"about_ca_system_score_codex":0.00005251885,"about_ca_system_score_gemma":0.00019153647,"threshold_uncertainty_score":0.37733108},"labels":[],"label_agreement":null},{"id":"W2315267901","doi":"10.1158/1538-7445.am10-636","title":"Abstract 636: Role of Prostaglandin E2 in breast-cancer associated lymphangiogenesis in an in vitro system","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Lymphangiogenesis; Matrigel; Cancer research; Angiogenesis; Vascular endothelial growth factor C; Metastasis; Lymphatic Endothelium; Lymphatic system; Cancer cell; Medicine; Cancer; Biology; Immunology; Vascular endothelial growth factor; Internal medicine; Vascular endothelial growth factor A","score_opus":0.025191138771528305,"score_gpt":0.35672082685045453,"score_spread":0.33152968807892624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315267901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767566,0.0006708614,4.7107203e-8,0.00018830938,0.00018878399,0.00090165104,0.00009232784,0.00002121848,0.00026116834],"genre_scores_gemma":[0.99892575,0.000087178705,0.0000066586413,0.000017172233,0.00023999857,0.00062198745,0.000021524102,0.00003704568,0.000042698128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976963,0.0002232976,0.0004060133,0.0003392583,0.0006592876,0.0006758582],"domain_scores_gemma":[0.999012,0.0001534509,0.0000827476,0.00030810377,0.00024399777,0.00019968726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025172415,0.000145786,0.00045872497,0.00082236377,0.000033400443,0.000015974229,0.00017922377,0.00025384876,0.0001731861],"category_scores_gemma":[0.00012711958,0.0001282479,0.000055487126,0.0010410644,0.0001027347,0.00012282013,0.000047752306,0.00046071142,0.000012811926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008662608,0.00015336533,0.45909297,0.0003055352,0.000010575006,0.00010081537,0.0005061818,0.000008720807,0.53489435,0.000010213747,0.000024647063,0.0040263534],"study_design_scores_gemma":[0.0025804949,0.000055499793,0.7654014,0.00072682224,0.0000060746866,0.000005062064,0.00038345423,0.00047276306,0.23019405,0.000008239832,0.000060849085,0.00010528446],"about_ca_topic_score_codex":0.011354367,"about_ca_topic_score_gemma":0.011746396,"teacher_disagreement_score":0.30630842,"about_ca_system_score_codex":0.0009810224,"about_ca_system_score_gemma":0.0008495312,"threshold_uncertainty_score":0.9952291},"labels":[],"label_agreement":null},{"id":"W2315295647","doi":"10.1158/1538-7445.am2012-3330","title":"Abstract 3330: Functional characterization of microRNAs identified in human acute myeloid leukemia stem cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Myeloid leukemia; microRNA; Stem cell; Biology; Leukemia; Population; Cancer stem cell; Cancer research; Haematopoiesis; Myeloid; Computational biology; Immunology; Gene; Medicine; Genetics","score_opus":0.04688141928060411,"score_gpt":0.34245867942017394,"score_spread":0.2955772601395698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315295647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877256,0.00044449564,0.0000744785,0.000026752148,0.00018827857,0.00025548393,0.00007840683,0.000004596081,0.0001549371],"genre_scores_gemma":[0.9977767,0.0001677565,0.000009856412,0.000015430996,0.000360136,0.000066924455,0.00034752925,0.0000218083,0.0012338959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882734,0.000085618325,0.00024213061,0.00023148282,0.00027529837,0.0003381262],"domain_scores_gemma":[0.9993518,0.000009351693,0.000088430614,0.0002609569,0.00019812079,0.00009132141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234921,0.000093024326,0.00010696051,0.0001365639,0.000071610404,0.000021453503,0.00015277267,0.00013270626,0.00022733206],"category_scores_gemma":[0.0000069747593,0.00009879712,0.000051990944,0.00018818001,0.000102095146,0.00001729791,0.00009863089,0.00014534534,0.000021845439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111327,0.000052651303,0.0048759943,0.000066725195,0.000039209946,8.78866e-7,0.00006545971,0.000026004842,0.9931879,0.000028699245,0.000760134,0.0007850073],"study_design_scores_gemma":[0.00027465782,0.000015773652,0.24009627,0.000027208325,0.0000051470633,8.861598e-7,0.00002110061,0.000002915417,0.75733966,0.000006783108,0.002138213,0.00007137489],"about_ca_topic_score_codex":0.0000816649,"about_ca_topic_score_gemma":0.0000292911,"teacher_disagreement_score":0.23584823,"about_ca_system_score_codex":0.00020123331,"about_ca_system_score_gemma":0.00022360157,"threshold_uncertainty_score":0.40288296},"labels":[],"label_agreement":null},{"id":"W2315416109","doi":"10.1158/1538-7445.am10-994","title":"Abstract 994: Role of Akt isoforms in regulating intermediate filaments expression in cancer progression","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Protein kinase B; Vimentin; PI3K/AKT/mTOR pathway; Cell biology; Biology; Epithelial–mesenchymal transition; Keratin; Intermediate filament; Cancer cell; Gene isoform; Cancer research; Keratin 8; Metastasis; Signal transduction; Cancer; Cytoskeleton; Cell; Immunology; Biochemistry; Gene; Genetics","score_opus":0.03496094410865343,"score_gpt":0.4222033861857417,"score_spread":0.3872424420770883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315416109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966498,0.0019758884,0.000004495779,0.00007689678,0.0002882275,0.00038297242,0.000031899017,0.000006914303,0.00058292487],"genre_scores_gemma":[0.99835056,0.0004238244,0.00017652137,0.000020854792,0.00032303884,0.00045887457,0.000029413588,0.000035665646,0.00018124531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980146,0.00007923996,0.0003790192,0.00047043146,0.00048971834,0.0005669715],"domain_scores_gemma":[0.9991284,0.00003976903,0.00013171163,0.00041644176,0.00018011998,0.00010357647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009043227,0.00015265541,0.0001991069,0.00020883649,0.000058600854,0.000024211613,0.00043226828,0.0002684621,0.0002993313],"category_scores_gemma":[0.00018817524,0.000131312,0.00005109087,0.0002937305,0.0002098462,0.000016832037,0.00030361165,0.00062846375,0.0000033339763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027821885,0.00009141969,0.06495622,0.000082744235,0.0000078264775,0.0000033959661,0.00024575286,0.00015052753,0.8933265,0.0000035870999,0.00036403726,0.040489767],"study_design_scores_gemma":[0.0007619363,0.00011714157,0.046255745,0.00069845206,0.0000013768092,5.586415e-7,0.00013426888,0.00010133422,0.9483322,0.00013522443,0.0033169386,0.00014480553],"about_ca_topic_score_codex":0.0008084868,"about_ca_topic_score_gemma":0.0025719278,"teacher_disagreement_score":0.055005714,"about_ca_system_score_codex":0.00013602476,"about_ca_system_score_gemma":0.00039657616,"threshold_uncertainty_score":0.5354748},"labels":[],"label_agreement":null},{"id":"W2315481411","doi":"10.1158/1538-7445.am2012-1696","title":"Abstract 1696: Targeting EVI1-overexpressing AML with darinaparsin","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Arsenic trioxide; Medicine; Internal medicine; Cancer research; Bone marrow; Oncology; Biology; Apoptosis","score_opus":0.10227864170550705,"score_gpt":0.4302239543152163,"score_spread":0.32794531260970927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315481411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607218,0.0045546014,0.00006262739,0.002191164,0.000119447104,0.00074637646,0.000014482289,0.00009086285,0.03149867],"genre_scores_gemma":[0.992327,0.00037880568,0.0014870274,0.00017389511,0.0015712491,0.00020412674,0.00002666015,0.00009528002,0.0037360045],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954322,0.00018061815,0.00027921793,0.00046123215,0.0017658689,0.0018808577],"domain_scores_gemma":[0.9975428,0.00035801192,0.000061827806,0.0006267001,0.0006197826,0.00079086126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026455105,0.0002172107,0.00035461638,0.00036116253,0.00042764813,0.000112949674,0.0003307046,0.00016070747,0.0023701529],"category_scores_gemma":[0.0004902252,0.00016337374,0.00006923377,0.0008687544,0.0004915675,0.00047553427,0.00027214587,0.0019139872,0.00043013663],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025759374,0.00045565708,0.13297045,0.0011008424,0.0002741669,0.00033035595,0.0023138602,0.000032032338,0.6669228,0.00049040245,0.15053232,0.042001154],"study_design_scores_gemma":[0.00676522,0.000802641,0.21760431,0.0027593558,0.00009357141,0.00025154947,0.003835309,0.0002555632,0.36812082,0.00012148344,0.39846054,0.0009296324],"about_ca_topic_score_codex":0.0012481041,"about_ca_topic_score_gemma":0.00002364242,"teacher_disagreement_score":0.29880202,"about_ca_system_score_codex":0.0016015376,"about_ca_system_score_gemma":0.0014319234,"threshold_uncertainty_score":0.99854183},"labels":[],"label_agreement":null},{"id":"W2315561973","doi":"10.1158/1538-7445.am10-5530","title":"Abstract 5530: A novel bacterial anticancer treatment modality targeting hypoxic solid tumors as an enzyme-prodrug using non-pathogenic <i>Bifidobacterium longum</i> expressing cytosine deaminase","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Cytosine deaminase; Bifidobacterium longum; Cancer research; In vivo; Biology; Prodrug; Genetic enhancement; Pharmacology; Bifidobacterium; Microbiology; Biochemistry; Gene; Fermentation","score_opus":0.05036104859902534,"score_gpt":0.3986358523742511,"score_spread":0.34827480377522574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315561973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969271,0.000505009,0.0001476518,0.00014015469,0.00047980406,0.0009779462,0.0005565834,0.000028519315,0.00023724987],"genre_scores_gemma":[0.99463415,0.00035642323,0.0012420759,0.00005144445,0.0023727498,0.0004381102,0.0005019805,0.00012594638,0.00027710956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955248,0.00018836143,0.00051118137,0.0013539325,0.00081942626,0.0016022547],"domain_scores_gemma":[0.9973657,0.000048208727,0.00016535338,0.0011098521,0.0005504793,0.00076039165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010092382,0.00049602345,0.00047534454,0.00019725831,0.00069460686,0.00037596008,0.0005940786,0.00029491837,0.0004398644],"category_scores_gemma":[0.00021149979,0.00045024155,0.00021563965,0.00035462985,0.00050985935,0.00007295366,0.00037188284,0.00063897594,0.000030869436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014019099,0.0007190074,0.0014794284,0.00007245194,0.00015225932,0.000101214,0.00019017323,0.000052702497,0.99071246,0.0000053863737,0.00013462098,0.0049783937],"study_design_scores_gemma":[0.0027327957,0.00081563025,0.0041340715,0.000091949776,0.000034472352,0.000049609884,0.00012259735,0.00030210055,0.988472,0.000037541155,0.0027414435,0.0004658077],"about_ca_topic_score_codex":0.010341159,"about_ca_topic_score_gemma":0.0029708862,"teacher_disagreement_score":0.0073702727,"about_ca_system_score_codex":0.00050673436,"about_ca_system_score_gemma":0.002189799,"threshold_uncertainty_score":0.99979496},"labels":[],"label_agreement":null},{"id":"W2315582552","doi":"10.1158/1538-7445.am2012-5084","title":"Abstract 5084: Functional genomic classification of breast cancer using pooled lentivirus shRNA screens","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Synthetic lethality; Small hairpin RNA; Biology; KRAS; Cancer; Breast cancer; Cancer research; Oncogene; Gene; Somatic cell; CDKN2A; Genetics; Genomics; Computational biology; Genome; Gene knockdown; Mutation; Cell cycle; DNA repair","score_opus":0.12120754586582667,"score_gpt":0.3895261595092365,"score_spread":0.26831861364340986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315582552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909266,0.006790812,0.00025382984,0.00023157672,0.00039285753,0.00021384083,0.0005324445,0.0000048051625,0.0006531946],"genre_scores_gemma":[0.995781,0.0021355455,0.00007921836,0.0000660531,0.0015547815,0.00007423925,0.000077730576,0.000033405602,0.0001980328],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863166,0.00005299709,0.00022872572,0.000286413,0.00031518622,0.00048503184],"domain_scores_gemma":[0.99898714,0.000036716046,0.00010131875,0.00032564183,0.0003911498,0.00015803103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050400716,0.00012302793,0.00013917111,0.00010669767,0.00014171166,0.000027018337,0.00018799883,0.0001327289,0.0004719323],"category_scores_gemma":[0.00004237626,0.00012637214,0.00008339402,0.000169415,0.00018598071,0.000011101326,0.00014777438,0.00018895573,0.00001772589],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022213509,0.000086736974,0.04553805,0.0000356401,0.00008422633,3.746621e-7,0.00002763678,0.00043266633,0.9454602,0.00016889637,0.0030760018,0.0048674364],"study_design_scores_gemma":[0.0005657334,0.000038574937,0.77295816,0.00004484143,0.000035951452,0.0000071714603,0.00009523316,0.00013710464,0.2147449,0.000041987547,0.011130248,0.00020012866],"about_ca_topic_score_codex":0.0019120158,"about_ca_topic_score_gemma":0.00034869128,"teacher_disagreement_score":0.73071533,"about_ca_system_score_codex":0.0002328821,"about_ca_system_score_gemma":0.00062441564,"threshold_uncertainty_score":0.51673275},"labels":[],"label_agreement":null},{"id":"W2315607170","doi":"10.1158/1538-7445.am2011-2530","title":"Abstract 2530: The anticancer kinase inhibitor dovitinib (TKI258/CHIR258) may have multiple modes of action because it also binds DNA and inhibits topoisomerase I and topoisomerase IIα","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Topoisomerase; Tyrosine kinase; Biology; Biochemistry; Kinase; Molecular biology; Tyrosine-kinase inhibitor; Fibroblast growth factor receptor; DNA; Receptor; Fibroblast growth factor; Chemistry; Cancer","score_opus":0.1557381596321504,"score_gpt":0.44102447292447355,"score_spread":0.2852863132923231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315607170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913959,0.0023339207,0.0000056875333,0.002963499,0.0001269119,0.0010918992,0.00020229502,0.000029082028,0.0018508382],"genre_scores_gemma":[0.9951496,0.0026094583,0.000118298536,0.00024080276,0.00028857513,0.00037760753,0.00003208903,0.000043153963,0.0011403947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793226,0.000105251595,0.00037705962,0.0004980125,0.000582589,0.0005048509],"domain_scores_gemma":[0.99841374,0.00030611196,0.00011610551,0.0004401444,0.00040368817,0.00032019962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049883325,0.0002344634,0.0003521927,0.00027509747,0.00036854844,0.00005989291,0.00011162896,0.00012754569,0.0004619126],"category_scores_gemma":[0.00018297065,0.00016035842,0.00007309097,0.00032880413,0.0006859362,0.00028522505,0.00011818495,0.00045977897,0.000009718395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037194774,0.0016030509,0.18638204,0.0014794325,0.0009967762,0.00023800331,0.02030551,0.000016638667,0.6765704,0.00086905377,0.0067230626,0.10109653],"study_design_scores_gemma":[0.007085554,0.00081420114,0.14136851,0.000769355,0.00031690716,0.000041312203,0.007993183,0.00023359316,0.8343968,0.00036204734,0.0062522143,0.00036634784],"about_ca_topic_score_codex":0.007727906,"about_ca_topic_score_gemma":0.0025494548,"teacher_disagreement_score":0.15782636,"about_ca_system_score_codex":0.0002284986,"about_ca_system_score_gemma":0.00043625166,"threshold_uncertainty_score":0.99887973},"labels":[],"label_agreement":null},{"id":"W2315628315","doi":"10.1158/0008-5472.sabcs11-p4-18-04","title":"P4-18-04: Hypofractionated Radiotherapy for Breast Ductal Carcinoma In Situ.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Radiation therapy; Ductal carcinoma; Breast cancer; Regimen; Radiation oncologist; Breast-conserving surgery; Stage (stratigraphy); Lumpectomy; Radiology; Cancer; Mastectomy; Surgery; Internal medicine","score_opus":0.09500053291713596,"score_gpt":0.3862847713689658,"score_spread":0.2912842384518298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315628315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923308,0.0043927743,0.00006495858,0.0006888478,0.00017738606,0.00047316452,0.00015182744,0.000011441002,0.0017087831],"genre_scores_gemma":[0.99708116,0.0007091852,0.0002843336,0.00010745183,0.0004337577,0.0007619825,0.00005173221,0.00003561353,0.0005347978],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987063,0.00007826457,0.00013793677,0.00042652743,0.00018685422,0.00046410866],"domain_scores_gemma":[0.99933416,0.000029898194,0.000030621803,0.00027436245,0.00025205853,0.00007893176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002416421,0.00013716816,0.0001495626,0.000116434545,0.00012643138,0.000013207728,0.00019555558,0.00010777045,0.00024897963],"category_scores_gemma":[0.000029790384,0.00012819751,0.0000664535,0.00020955318,0.00017507402,0.000009001825,0.000074651165,0.00014189594,0.00000779119],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033767787,0.00038330254,0.11340014,0.00006272478,0.00033302256,0.000030006573,0.0007544131,0.00001277613,0.84514433,0.00020214194,0.013143613,0.023156771],"study_design_scores_gemma":[0.0033487836,0.0003278734,0.6517551,0.000027781834,0.000013434986,0.00006454424,0.00030810572,0.000012979929,0.32607806,0.00024677528,0.017537162,0.00027941843],"about_ca_topic_score_codex":0.0021026535,"about_ca_topic_score_gemma":0.0010549701,"teacher_disagreement_score":0.53835493,"about_ca_system_score_codex":0.00021604155,"about_ca_system_score_gemma":0.00023847353,"threshold_uncertainty_score":0.5227743},"labels":[],"label_agreement":null},{"id":"W2315676405","doi":"10.1158/1538-7445.am10-1865","title":"Abstract 1865: <i>ERCC2</i> polymorphisms, smoking, and risk of breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"ERCC2; Breast cancer; Medicine; Odds ratio; Single-nucleotide polymorphism; Oncology; Population; Nucleotide excision repair; Cancer; Internal medicine; DNA repair; Genetics; Genotype; Gynecology; Biology; Environmental health; Gene","score_opus":0.020512869214105434,"score_gpt":0.33625957444627885,"score_spread":0.3157467052321734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315676405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584466,0.0021917194,0.00000839071,0.00022176931,0.00025741023,0.0001820973,0.00036504035,0.000010632854,0.0009182958],"genre_scores_gemma":[0.99489456,0.003611528,0.00010614992,0.000047404443,0.0004072731,0.000096738186,0.00001283652,0.000033292694,0.00079023436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986244,0.00006548152,0.00016309739,0.000396233,0.00035512671,0.00039569163],"domain_scores_gemma":[0.9990133,0.000025638581,0.000075097785,0.0004573586,0.00026907862,0.0001594954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072539045,0.0001229635,0.00014086596,0.0000778429,0.00011394348,0.000026149477,0.00027964194,0.00019909689,0.0005218343],"category_scores_gemma":[0.000074648284,0.00011242293,0.000056638906,0.0001372303,0.0003047843,0.000005674513,0.0002222752,0.0004991238,0.0000059775784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000998632,0.000033185584,0.029737927,0.00003297295,0.00007690043,0.0000029459814,0.000035865218,0.0000034395694,0.9524711,0.00008054752,0.0032259088,0.014199357],"study_design_scores_gemma":[0.00043271057,0.00007275507,0.08384005,0.000032562395,0.00001854495,0.000014698326,0.00003512447,0.000008242734,0.8967756,0.00016955301,0.018455096,0.00014505745],"about_ca_topic_score_codex":0.003949989,"about_ca_topic_score_gemma":0.002190857,"teacher_disagreement_score":0.05569548,"about_ca_system_score_codex":0.000021912107,"about_ca_system_score_gemma":0.00029143348,"threshold_uncertainty_score":0.59712285},"labels":[],"label_agreement":null},{"id":"W2315799576","doi":"10.1158/1538-7445.am2011-lb-58","title":"Abstract LB-58: Spontaneous Epstein Barr virus-associated lymphomagenesis in primary human solid tumor xenografts","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Pathology; Biology; CD20; Transplantation; Immunohistochemistry; Epstein–Barr virus; Lymphoma; HCCS; Xenotransplantation; Cancer research; Cancer; Antigen; Nuclear atypia; Hepatocellular carcinoma; Virus; Medicine; Virology; Immunology","score_opus":0.06862987168005778,"score_gpt":0.36322841329545424,"score_spread":0.29459854161539645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315799576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450893,0.002481734,5.45295e-7,0.00024688794,0.00019389844,0.0007962021,0.00006724348,0.00011542034,0.051008772],"genre_scores_gemma":[0.9947544,0.0008359853,0.000024653737,0.0006461239,0.00019313382,0.0003305065,0.00006830904,0.00010262197,0.003044293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960299,0.00023202872,0.0005654593,0.00065562077,0.0011455953,0.0013714001],"domain_scores_gemma":[0.99840736,0.000099280085,0.00014428052,0.00054430735,0.0003875402,0.00041725545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013954696,0.00030526673,0.00065307936,0.00058021175,0.0003339737,0.000052609557,0.00040344277,0.00026329467,0.0035285745],"category_scores_gemma":[0.00022854947,0.00029724525,0.00018894211,0.0011136282,0.0003066565,0.00015881179,0.0001457909,0.0008260708,0.00019604359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007035547,0.004474041,0.1588037,0.0011197702,0.00092987233,0.022554213,0.009028009,0.000034677374,0.7075595,0.00018918737,0.059990358,0.028281078],"study_design_scores_gemma":[0.010470136,0.0011880334,0.9454378,0.0009749715,0.00009915118,0.000080408936,0.0015783819,0.000024846755,0.03511771,0.0005404954,0.0037571823,0.00073088333],"about_ca_topic_score_codex":0.021934506,"about_ca_topic_score_gemma":0.011752848,"teacher_disagreement_score":0.7866341,"about_ca_system_score_codex":0.0030915563,"about_ca_system_score_gemma":0.0013932199,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W2315806036","doi":"10.1158/1538-7445.am2011-2996","title":"Abstract 2996: DNA-damaging agents disrupt telomere structure","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Telomere; Shelterin; Telomerase; Telomere-binding protein; DNA; Biology; DNA repair; Molecular biology; DNA damage; Gene; Cell biology; Genetics; DNA-binding protein; Transcription factor","score_opus":0.1835115424267239,"score_gpt":0.4284177526737415,"score_spread":0.2449062102470176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315806036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982657,0.0014409502,0.000005376176,0.00066246506,0.00037377301,0.00052859436,0.00006365787,0.0001028614,0.01416532],"genre_scores_gemma":[0.9953269,0.00051081146,0.00020259149,0.00034545953,0.0005352063,0.00005529473,0.000025759733,0.000065154454,0.002932832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969252,0.000089108355,0.00031731374,0.00059540244,0.0010719033,0.001001089],"domain_scores_gemma":[0.9981755,0.00008311718,0.000063726766,0.000738674,0.00040598746,0.0005329846],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046426707,0.00024140572,0.0003580268,0.0003895299,0.0002974111,0.000054557822,0.00041804506,0.00016202197,0.0090634655],"category_scores_gemma":[0.00018055945,0.00019932307,0.0001043444,0.0007632616,0.00038876763,0.00020216634,0.00015586219,0.0010745756,0.0002552719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013451292,0.00051898503,0.384015,0.0014038394,0.00035616691,0.0022859275,0.012152035,0.0000039932897,0.3904339,0.0008037845,0.04104905,0.16563219],"study_design_scores_gemma":[0.0013134552,0.00016016158,0.8594475,0.00045957023,0.000037582973,0.00006972246,0.0013807759,0.000023011762,0.11245223,0.0006264833,0.023677928,0.0003515737],"about_ca_topic_score_codex":0.0017015748,"about_ca_topic_score_gemma":0.00024518647,"teacher_disagreement_score":0.47543252,"about_ca_system_score_codex":0.0002871597,"about_ca_system_score_gemma":0.00048409216,"threshold_uncertainty_score":0.9918424},"labels":[],"label_agreement":null},{"id":"W2315862261","doi":"10.1158/0008-5472.sabcs12-p6-08-03","title":"Abstract P6-08-03: Informational needs and psychosocial assessment of patients in their first year after metastatic breast cancer diagnosis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Anxiety; Population; Distress; Metastatic breast cancer; Hospital Anxiety and Depression Scale; Cancer; Physical therapy; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.05169698646489583,"score_gpt":0.40496987038884197,"score_spread":0.3532728839239461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315862261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994918,0.0012361761,0.0000017512024,0.0012921522,0.00028037763,0.00043829996,0.0007874104,0.000006989286,0.0010388778],"genre_scores_gemma":[0.9960555,0.0019347518,0.000016979537,0.00012653971,0.0002517003,0.0015028714,0.00003939928,0.000018092147,0.00005420599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842554,0.00005496539,0.00027011242,0.00012870922,0.00069992285,0.00042075754],"domain_scores_gemma":[0.99913037,0.00014256213,0.000061231316,0.00015992773,0.00031503825,0.00019084962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005316194,0.00011697698,0.00024171954,0.00031105685,0.00005822043,0.000022644193,0.000086520704,0.0000624147,0.0027457017],"category_scores_gemma":[0.000022092903,0.00009511019,0.000055782166,0.0005093945,0.00013882862,0.0002679084,0.00006774023,0.0003534783,0.000011495415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002991843,0.00022717446,0.98153025,0.00037932192,0.000069828384,8.2468483e-7,0.006392919,0.000002920938,0.000015592288,0.000056560955,0.002528089,0.008497361],"study_design_scores_gemma":[0.0013160801,0.000054348056,0.98945045,0.00030344824,0.000021481397,6.591852e-7,0.0016223534,0.000008445714,0.000106482905,0.000025161862,0.0069995113,0.00009155623],"about_ca_topic_score_codex":0.005335914,"about_ca_topic_score_gemma":0.0070715016,"teacher_disagreement_score":0.008405806,"about_ca_system_score_codex":0.0004391177,"about_ca_system_score_gemma":0.00032499662,"threshold_uncertainty_score":0.9981659},"labels":[],"label_agreement":null},{"id":"W2315891240","doi":"10.1158/0008-5472.sabcs10-p5-10-08","title":"Abstract P5-10-08: Evaluating the Efficacy of Current Clinical Practice of Adjuvant Chemotherapy in Post-Menopausal Women with One to Three Positive Auxiliary Nodes and Estrogen and/or Progesterone Positive Early Stage Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Cancer; Gynecology; Adjuvant therapy; Internal medicine; Hormonal therapy; Adjuvant; Cancer registry; Clinical Practice; Hormone therapy; Adjuvant chemotherapy; Stage (stratigraphy); Oncology; Family medicine","score_opus":0.06778704996750386,"score_gpt":0.4608297119368812,"score_spread":0.39304266196937737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315891240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937816,0.002647181,0.000004949838,0.0018401471,0.00004076335,0.0010933117,0.0005483051,0.0000038408025,0.000039874263],"genre_scores_gemma":[0.99796575,0.00090890285,0.00033222904,0.00008423364,0.00016118285,0.00047319444,0.0000135661085,0.000031079573,0.000029843051],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99802405,0.00020317148,0.0003402479,0.000524304,0.0004744348,0.00043376704],"domain_scores_gemma":[0.99811506,0.0003947981,0.00018085766,0.0003238763,0.0008422431,0.00014315153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012578329,0.00019551838,0.00033812798,0.00006800982,0.000107002714,0.000028522156,0.0002011625,0.00009245351,0.000060043956],"category_scores_gemma":[0.00025143684,0.00012786825,0.00002011049,0.0002025389,0.00065781135,0.000022613147,0.00025010304,0.00042958267,8.7372683e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040428933,0.0011017502,0.13793573,0.00014402797,0.0009666997,0.000011363144,0.0032790727,0.000015053343,0.54844004,0.000027940145,0.000024902249,0.2676245],"study_design_scores_gemma":[0.0030257767,0.0035475139,0.9610159,0.00026593084,0.000051918774,0.000013237202,0.00060489425,0.00000420814,0.031236086,0.0000063911293,0.00008016915,0.00014801853],"about_ca_topic_score_codex":0.002293264,"about_ca_topic_score_gemma":0.0019562847,"teacher_disagreement_score":0.8230801,"about_ca_system_score_codex":0.000094867806,"about_ca_system_score_gemma":0.0007304506,"threshold_uncertainty_score":0.52143157},"labels":[],"label_agreement":null},{"id":"W2315892755","doi":"10.1158/1538-7445.am2013-lb-266","title":"Abstract LB-266: SIRT1 governs GnRH neuron migration and The Kallmann syndrome phenotype.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Endocrinology; Internal medicine; Biology; Forebrain; Sirtuin 1; Hypothalamus; Kallmann syndrome; Anterior pituitary; Cell biology; Medicine; Central nervous system; Downregulation and upregulation; Hormone; Gene","score_opus":0.05047868861271645,"score_gpt":0.34752250037808247,"score_spread":0.29704381176536604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315892755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400322,0.001337112,0.000015028722,0.035204332,0.00018708345,0.00081288256,0.000004824784,0.0000361533,0.022370413],"genre_scores_gemma":[0.9861377,0.0006911381,0.000010914552,0.001065363,0.00014169741,0.00017396818,0.000008536568,0.00001871487,0.011752002],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99876654,0.00008397684,0.0001360897,0.00022816818,0.0004977089,0.000287515],"domain_scores_gemma":[0.999187,0.00017299608,0.000028872626,0.00027360625,0.00018822576,0.00014929137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000443468,0.000086777276,0.00014030994,0.00007669837,0.00016348058,0.00008369749,0.00008842378,0.00006255703,0.003328576],"category_scores_gemma":[0.00023356943,0.000055553577,0.000040724815,0.00022881129,0.0002941484,0.00012852215,0.000046942598,0.00041809384,0.0006163857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055378694,0.00079191744,0.07407877,0.0012770767,0.00054011017,0.00019383406,0.0052774814,0.000110830755,0.05743483,0.017500065,0.6962954,0.14096183],"study_design_scores_gemma":[0.0047324495,0.00026258468,0.8997439,0.00008077832,0.000032078908,0.000032984943,0.0010041012,0.0005273576,0.0002001492,0.0011199462,0.0921329,0.0001307678],"about_ca_topic_score_codex":0.005847993,"about_ca_topic_score_gemma":0.00050146476,"teacher_disagreement_score":0.8256651,"about_ca_system_score_codex":0.000079857484,"about_ca_system_score_gemma":0.00015165344,"threshold_uncertainty_score":0.9975825},"labels":[],"label_agreement":null},{"id":"W2315915756","doi":"10.1158/0008-5472.sabcs11-p4-12-05","title":"P4-12-05: Impact of the Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (LISA) Weight Loss Intervention upon Physical Activity.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight loss; Medicine; Randomized controlled trial; Breast cancer; Observational study; Obesity; Physical therapy; Psychological intervention; Cancer; Physical activity; Weight change; Clinical trial; Internal medicine","score_opus":0.10210930234437911,"score_gpt":0.44617326885567543,"score_spread":0.34406396651129634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315915756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730223,0.0006174928,0.0000054513225,0.00014564901,0.00031987045,0.0012300008,0.00016495082,0.000012028183,0.00020232768],"genre_scores_gemma":[0.9983775,0.00022506886,7.507557e-7,0.0000023676985,0.00022738331,0.00051662454,0.000004337327,0.00003084157,0.00061514386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976688,0.0005461641,0.00030989855,0.00035800715,0.00072128867,0.0003958589],"domain_scores_gemma":[0.9987491,0.0000636988,0.00016460287,0.00054172106,0.0003538003,0.00012708228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005072346,0.00018956549,0.00050545804,0.00026607024,0.00005025434,0.000011682738,0.00023077792,0.00007668202,0.00069134246],"category_scores_gemma":[0.000021892833,0.00012010938,0.0005236157,0.00064825895,0.00019187946,0.00015183724,0.0001279404,0.00034218162,0.0000045214006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004822612,0.006808776,0.84994435,0.00023764078,0.0003513992,0.000024738738,0.016379086,0.000004914709,0.0056766737,0.000012566557,0.00006843078,0.11566881],"study_design_scores_gemma":[0.003852112,0.0043832697,0.9622516,0.0008462206,0.00010799405,0.000006304484,0.0011119304,0.000053432606,0.027228318,0.000029266279,0.000032502845,0.00009705692],"about_ca_topic_score_codex":0.28117013,"about_ca_topic_score_gemma":0.07467122,"teacher_disagreement_score":0.20649892,"about_ca_system_score_codex":0.0013856082,"about_ca_system_score_gemma":0.0003748936,"threshold_uncertainty_score":0.9422136},"labels":[],"label_agreement":null},{"id":"W2315916493","doi":"10.1158/1538-7445.am2011-777","title":"Abstract 777: Antitumor role of early infiltrating interferon-gamma producing NKT cells in murine malignant mesothelioma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"","keywords":"Tumor microenvironment; Cytokine; Natural killer T cell; Immune system; Pathology; Cancer research; Medicine; Interferon gamma; Immunology; T cell","score_opus":0.07475780805771882,"score_gpt":0.35363231473482953,"score_spread":0.2788745066771107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315916493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429274,0.0007639462,7.9856994e-7,0.00006915354,0.000040867984,0.00038111146,0.000042621916,0.000012575416,0.004396202],"genre_scores_gemma":[0.99903446,0.00013538775,0.00016059713,0.00002331601,0.000112679634,0.000073583105,0.00000881208,0.000021495633,0.00042966995],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985947,0.00004236222,0.0002843208,0.00028236464,0.00046575879,0.00033050007],"domain_scores_gemma":[0.99941945,0.000052217056,0.00005554263,0.00024488624,0.00007344677,0.00015443788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039651166,0.000100989375,0.00019163574,0.00023206297,0.000042276162,0.000009232416,0.00013062175,0.000038926057,0.0015390263],"category_scores_gemma":[0.00007632793,0.000083630635,0.000043609754,0.000282693,0.00016290968,0.000114667695,0.00008822801,0.00024105464,0.00006111312],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007993921,0.00030060363,0.33751956,0.0002734668,0.000022116925,0.000053524273,0.0010389492,0.000008937702,0.6567025,0.00003696944,0.0000992472,0.0031447238],"study_design_scores_gemma":[0.00032160495,0.0002666624,0.5620268,0.00040660996,0.0000060000943,0.0000025453846,0.0002743629,0.00001149051,0.4364891,0.00006420998,0.00007610741,0.000054533968],"about_ca_topic_score_codex":0.0050259875,"about_ca_topic_score_gemma":0.0001260908,"teacher_disagreement_score":0.22450723,"about_ca_system_score_codex":0.00014568694,"about_ca_system_score_gemma":0.00021127432,"threshold_uncertainty_score":0.9993737},"labels":[],"label_agreement":null},{"id":"W2315933221","doi":"10.1158/1538-7445.am10-1714","title":"Abstract 1714: Transcriptional networks downstream of the AR identify clinically relevant prostate cancer targets","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Prostate cancer; Cancer research; Kinase; Biology; Chromatin immunoprecipitation; Androgen receptor; Gene; Androgen; Cancer; Gene expression; Computational biology; Cell biology; Genetics; Endocrinology; Promoter; Hormone","score_opus":0.06759293460744974,"score_gpt":0.4438031511632234,"score_spread":0.37621021655577364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315933221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97754514,0.005628145,0.000005587265,0.01096016,0.0012093015,0.0016987356,0.0002205603,0.000037958667,0.0026944214],"genre_scores_gemma":[0.9806705,0.010668689,0.000060667866,0.00015071286,0.00083291804,0.0006762913,0.00004065141,0.000052090076,0.0068474836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960433,0.00015215037,0.00062462443,0.0005665451,0.0016581068,0.0009552506],"domain_scores_gemma":[0.99725467,0.00029814086,0.00013824468,0.00074641634,0.0011802193,0.00038233332],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018874597,0.00022201256,0.00041079745,0.00018395728,0.00034663704,0.000060623828,0.00051852386,0.00026400606,0.0026534568],"category_scores_gemma":[0.00024931997,0.0001343051,0.00028121262,0.0007398422,0.0012722417,0.00013512782,0.0001496306,0.002687865,0.00003750233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041245134,0.0007176611,0.20396686,0.0006102866,0.00047636314,0.000095492185,0.0007719404,0.00016375541,0.7273595,0.00042534864,0.0150947645,0.046193562],"study_design_scores_gemma":[0.00485883,0.00042026612,0.9009545,0.0008370595,0.00010194816,0.00001689375,0.00015419193,0.00022676907,0.04935465,0.00088812,0.041915867,0.00027091923],"about_ca_topic_score_codex":0.0013806054,"about_ca_topic_score_gemma":0.0009845558,"teacher_disagreement_score":0.6969876,"about_ca_system_score_codex":0.0002635717,"about_ca_system_score_gemma":0.0021915573,"threshold_uncertainty_score":0.999613},"labels":[],"label_agreement":null},{"id":"W2315938045","doi":"10.1158/1538-7445.am10-991","title":"Abstract 991: Cadherin-cadherin engagement promotes cell survival via Rac/Cdc42 and Stat3","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"CDC42; STAT3; Cadherin; Cell biology; RAC1; STAT protein; Cell; Biology; Chemistry; Cell growth; Signal transduction; Cancer research; Biochemistry","score_opus":0.09489989248745666,"score_gpt":0.4210733563370583,"score_spread":0.3261734638496016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315938045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001884,0.0012354339,0.00007039183,0.0014558138,0.0006484957,0.00092989835,0.00003068146,0.000055326007,0.005555107],"genre_scores_gemma":[0.99272543,0.0012710099,0.0004225579,0.000119201046,0.000707808,0.00025240125,0.0000103056,0.00006335186,0.0044279443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775255,0.00008930187,0.00023417544,0.0004861226,0.0007717805,0.0006660851],"domain_scores_gemma":[0.9986855,0.00013904621,0.00004966301,0.0004722567,0.00027226956,0.00038128367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017061462,0.00018980775,0.0002997249,0.00014932235,0.00023191558,0.00008294623,0.00017633499,0.00013388152,0.0054751616],"category_scores_gemma":[0.00004721629,0.00016192462,0.00006139141,0.00026048528,0.00019591337,0.00009326884,0.00012850465,0.0014737622,0.00008674294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003707973,0.00016357769,0.0012697275,0.00027075523,0.000051408206,0.00007469116,0.000749807,9.303034e-7,0.94171274,0.00033807458,0.0010400906,0.053957388],"study_design_scores_gemma":[0.0043594604,0.0010049328,0.036867525,0.00014234007,0.00003149072,0.00001850663,0.0006319945,0.0000897879,0.73337644,0.001416116,0.2216513,0.00041012964],"about_ca_topic_score_codex":0.002772995,"about_ca_topic_score_gemma":0.0011537212,"teacher_disagreement_score":0.22061121,"about_ca_system_score_codex":0.00014456631,"about_ca_system_score_gemma":0.00042865926,"threshold_uncertainty_score":0.995434},"labels":[],"label_agreement":null},{"id":"W2315945850","doi":"10.1158/1538-7445.am2013-3114","title":"Abstract 3114: Constitutively active signal transducer and activator of transcription-3: an oncogene that increases gap junctional intercellular communication.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell biology; Proto-oncogene tyrosine-protein kinase Src; STAT protein; Biology; Lucifer yellow; STAT3; Signal transduction; MAPK/ERK pathway; Intracellular; Chemistry; Gap junction","score_opus":0.09319254674425263,"score_gpt":0.3606867153840491,"score_spread":0.26749416863979647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315945850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963481,0.0019007127,0.000112158355,0.00034238634,0.000032297627,0.00030705938,0.00015111972,0.00000573775,0.0008004554],"genre_scores_gemma":[0.99810284,0.0011675505,0.000078591875,0.00007270711,0.000101218655,0.0001509567,0.00015672328,0.0000129588325,0.00015642321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989342,0.00021461322,0.00015488952,0.0003006768,0.00016518398,0.00023044168],"domain_scores_gemma":[0.99914825,0.00006747157,0.000047475063,0.00026854975,0.00034158345,0.00012669826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027903818,0.00011568722,0.00015075383,0.000082612525,0.00014859834,0.000025170584,0.00021582977,0.00014761582,0.0013529513],"category_scores_gemma":[0.000026869408,0.00010186136,0.00005538793,0.00007542166,0.0007903352,0.000023579592,0.000059631773,0.00022705585,0.0000060785055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003537178,0.00013288623,0.0012280731,0.000025208668,0.00009319281,7.45363e-7,0.00017655597,0.0000049268906,0.9856501,0.00023683757,0.0003901454,0.011707606],"study_design_scores_gemma":[0.0007067353,0.0003511776,0.028709855,0.000042058822,0.000012652113,0.000008637524,0.0008697896,0.000016271726,0.95697606,0.00024022764,0.011912554,0.00015398007],"about_ca_topic_score_codex":0.002886107,"about_ca_topic_score_gemma":0.00033137653,"teacher_disagreement_score":0.028674044,"about_ca_system_score_codex":0.00003500251,"about_ca_system_score_gemma":0.00027208668,"threshold_uncertainty_score":0.99955994},"labels":[],"label_agreement":null},{"id":"W2315948620","doi":"10.1158/1538-7445.am10-4349","title":"Abstract 4349: The chromosome 17q oncogene LASP1 promotes metastatic dissemination of medulloblastoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Isochromosome; Oncogene; Biology; Cancer research; Cancer; Metastasis; Primary tumor; Oncology; Pathology; Internal medicine; Medicine; Chromosome; Cell cycle; Genetics; Gene","score_opus":0.038399598915633076,"score_gpt":0.4046976303034819,"score_spread":0.3662980313878488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315948620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996134,0.0011744449,0.000046504476,0.0010077083,0.00013459088,0.0003161195,0.000067207104,0.0000050507774,0.0011143957],"genre_scores_gemma":[0.99751097,0.0004518872,0.00010984316,0.000019734716,0.00024896127,0.0002990095,0.00003675469,0.000018879333,0.0013039762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989087,0.000067235684,0.00017681609,0.00024880303,0.0003498414,0.0002485783],"domain_scores_gemma":[0.99889773,0.00007214438,0.00007161048,0.0004990592,0.00039077847,0.00006866859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007442382,0.000087977416,0.000097501776,0.000055825512,0.00014854789,0.000031201227,0.00037324047,0.00007160976,0.0003937688],"category_scores_gemma":[0.00025686534,0.00006131183,0.00005773373,0.00023052173,0.00031782576,0.0000060726297,0.00007901211,0.00026251705,0.0000145281665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003241343,0.000060692037,0.0001810653,0.000035784095,0.00003762336,7.9601085e-7,0.00009114559,0.000010219455,0.98147374,0.00023603818,0.0027827837,0.015057721],"study_design_scores_gemma":[0.00012781563,0.000101838166,0.0064952443,0.000028768149,0.00000927381,0.0000040215327,0.00012088571,0.000024640169,0.96786845,0.00013621182,0.02500315,0.0000797037],"about_ca_topic_score_codex":0.00013689695,"about_ca_topic_score_gemma":0.00045047016,"teacher_disagreement_score":0.022220366,"about_ca_system_score_codex":0.0000222195,"about_ca_system_score_gemma":0.00028686904,"threshold_uncertainty_score":0.4311492},"labels":[],"label_agreement":null},{"id":"W2315975479","doi":"10.1158/1538-7445.am2012-1253","title":"Abstract 1253: Fer is required for mammary tumorigenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Endocytosis; Endocytic cycle; Lapatinib; MAPK/ERK pathway; Internalization; Cell biology; Signal transduction; Cancer research; Receptor tyrosine kinase; Chemistry; Epidermal growth factor receptor; Tyrosine kinase; Biology; Receptor; Cancer; Biochemistry; Breast cancer","score_opus":0.21633626982451604,"score_gpt":0.4823561918370528,"score_spread":0.26601992201253677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315975479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495199,0.011824699,0.000060936913,0.019439636,0.00039128,0.001196328,0.00014031772,0.00005522912,0.017371701],"genre_scores_gemma":[0.93845296,0.0025394624,0.00061437505,0.00087073236,0.0023522812,0.00067209365,0.000043333606,0.000051902065,0.054402877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694437,0.00006360909,0.0002514112,0.00034126654,0.00107846,0.0013208624],"domain_scores_gemma":[0.9979565,0.0003542921,0.00003057907,0.00043739073,0.0005765297,0.0006447124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014035953,0.0001591578,0.00029606433,0.00025839737,0.00030714888,0.000047596153,0.00029368294,0.00012287227,0.0024314004],"category_scores_gemma":[0.00017747619,0.00012342559,0.00017925535,0.00041834844,0.0002063955,0.00022313447,0.00017370484,0.00046011707,0.00045895306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034900391,0.000635886,0.07364263,0.0020650139,0.00039185924,0.00009480148,0.001083649,7.110799e-7,0.31623983,0.0047457614,0.49914315,0.09846667],"study_design_scores_gemma":[0.0011087109,0.00027649637,0.15327682,0.00017371337,0.000022452277,0.000032595137,0.00012537235,0.00003332154,0.13804959,0.00065113895,0.7060239,0.0002258998],"about_ca_topic_score_codex":0.0007196124,"about_ca_topic_score_gemma":0.000016929209,"teacher_disagreement_score":0.20688073,"about_ca_system_score_codex":0.00024767863,"about_ca_system_score_gemma":0.00052281335,"threshold_uncertainty_score":0.9984805},"labels":[],"label_agreement":null},{"id":"W2316009074","doi":"10.1158/1538-7445.am2012-5311","title":"Abstract 5311: Transducer of Cdc42-dependent actin assembly-1 (Toca-1) promotes breast cancer invasion and metastasis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Invadopodia; CDC42; Cancer research; Cell migration; Metastasis; Cell culture; Biology; Extracellular matrix; Cell; Cell biology; Cancer; Chemistry; Actin; Biochemistry","score_opus":0.07236806506294129,"score_gpt":0.38957496424405696,"score_spread":0.31720689918111566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316009074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253553,0.0053794067,0.0000626836,0.00067699025,0.00020789531,0.00029802017,0.00020021181,0.000005474349,0.0006338046],"genre_scores_gemma":[0.9950184,0.0038727599,0.000046377732,0.000030502471,0.00032958278,0.00015162723,0.000029921937,0.000029405464,0.00049138704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864376,0.00009517238,0.00019700325,0.00029977743,0.0003378537,0.00042642985],"domain_scores_gemma":[0.99918306,0.000028290959,0.00006519848,0.0002848154,0.00026049776,0.00017816511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007183043,0.00013065666,0.0001596154,0.000098609315,0.000117963114,0.000031371263,0.00016358061,0.00012414214,0.0008560593],"category_scores_gemma":[0.000041641055,0.000113885704,0.000077156066,0.00013857872,0.00007288889,0.000021409825,0.00012354559,0.00026854247,0.000007528896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002511691,0.00014162445,0.00068574044,0.00008428464,0.00010458196,9.4308854e-7,0.00012787995,0.0000033794283,0.9790785,0.000064358705,0.0008833675,0.018574195],"study_design_scores_gemma":[0.0003126972,0.00016411825,0.004654409,0.00005986397,0.00002511318,0.000016673337,0.00020340276,0.00001080918,0.98272926,0.000020215197,0.011673034,0.00013041327],"about_ca_topic_score_codex":0.00083490665,"about_ca_topic_score_gemma":0.00050948927,"teacher_disagreement_score":0.018443782,"about_ca_system_score_codex":0.000056097135,"about_ca_system_score_gemma":0.00017048663,"threshold_uncertainty_score":0.93732494},"labels":[],"label_agreement":null},{"id":"W2316013746","doi":"10.1158/1538-7445.am10-2370","title":"Abstract 2370: A novel Src/Ezrin pathway regulates local invasion and metastasis of breast","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ezrin; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Metastasis; Breast cancer; Breast carcinoma; Intravasation; Extravasation; Biology; Cancer; Medicine; Pathology; Phosphorylation; Cell; Cell biology; Internal medicine; Cytoskeleton","score_opus":0.07847915574800435,"score_gpt":0.39122190144162733,"score_spread":0.312742745693623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316013746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521536,0.000649338,0.000047786183,0.001885444,0.00005842436,0.00054766197,0.00007856122,0.000022308248,0.0014951266],"genre_scores_gemma":[0.9977979,0.00034555836,0.0005336709,0.00003767422,0.00013107409,0.00007175164,0.000016049773,0.00004290478,0.00102339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971356,0.00007527755,0.00031479026,0.00048052162,0.0013892106,0.0006046277],"domain_scores_gemma":[0.99770755,0.00033432027,0.000054074215,0.00061580376,0.00079932064,0.00048894633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016532374,0.00015483568,0.0003491387,0.00033237613,0.00011977695,0.00004006321,0.00024745328,0.00017048296,0.001993885],"category_scores_gemma":[0.00036936256,0.000123197,0.000087616296,0.0006473256,0.00093206664,0.000088430505,0.0003512248,0.0013007718,0.000052888896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004950049,0.00020589044,0.0020514454,0.0003784438,0.000047241352,0.00005670832,0.00012228786,0.000002540606,0.8795117,0.00021743806,0.0007370414,0.116174266],"study_design_scores_gemma":[0.0017057909,0.00024802398,0.12001898,0.0002555354,0.000016900012,0.00016723888,0.0003001658,0.00017505049,0.86900526,0.00012115976,0.007850239,0.00013564862],"about_ca_topic_score_codex":0.0019971519,"about_ca_topic_score_gemma":0.0005440395,"teacher_disagreement_score":0.11796754,"about_ca_system_score_codex":0.00010789242,"about_ca_system_score_gemma":0.00063341466,"threshold_uncertainty_score":0.9989184},"labels":[],"label_agreement":null},{"id":"W2316080597","doi":"10.1158/1538-7445.am2012-sy16-01","title":"Abstract SY16-01: Clinical trial design to match patients to treatment based on molecular profiling of tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Druggability; Crizotinib; Personalized medicine; Precision medicine; Medicine; Clinical trial; Lung cancer; Cancer; Vemurafenib; Bioinformatics; Computational biology; Cancer research; Biology; Oncology; Genetics; Internal medicine; Gene; Pathology","score_opus":0.15431377973213967,"score_gpt":0.4588853082531105,"score_spread":0.30457152852097086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316080597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959759,0.00021145759,0.0011741824,0.00019750065,0.00034806516,0.0016403969,0.00009998763,0.000004319825,0.00034817448],"genre_scores_gemma":[0.9967806,0.0000936252,0.0016046965,0.00034085172,0.00054474483,0.0005031663,0.000047535403,0.000034601304,0.00005020974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823797,0.00015633022,0.00034930426,0.00037149046,0.0003693049,0.0005155731],"domain_scores_gemma":[0.9987023,0.00016258837,0.00005836267,0.00046828052,0.00020799247,0.00040051367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009973723,0.00014301435,0.00021918892,0.00010582902,0.000057847938,0.000021186583,0.00022178506,0.00011556082,0.00004762671],"category_scores_gemma":[0.00054567115,0.0001280618,0.000113377704,0.00015669083,0.000052125324,0.0000023482883,0.0001002462,0.00012205508,0.00004177027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09738019,0.004409899,0.034035817,0.0000989779,0.0002094827,0.000015615864,0.0001988199,0.0143284025,0.7791818,0.00013994674,0.0127385715,0.057262518],"study_design_scores_gemma":[0.009101069,0.007840621,0.0072070207,0.000053190353,0.000014251111,1.2837869e-7,0.000027323482,0.000031076404,0.966973,0.000011756128,0.008538442,0.0002021194],"about_ca_topic_score_codex":0.0001739955,"about_ca_topic_score_gemma":0.000017372084,"teacher_disagreement_score":0.18779124,"about_ca_system_score_codex":0.00017785732,"about_ca_system_score_gemma":0.0005063779,"threshold_uncertainty_score":0.52222085},"labels":[],"label_agreement":null},{"id":"W2316086785","doi":"10.1158/0008-5472.sabcs12-p1-04-05","title":"Abstract P1-04-05: Role of the Rb and p53 Tumor Suppressor Pathways in Mammary Tumorigenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Cancer research; Carcinogenesis; Biology; Cre recombinase; Mammary tumor; Retinoblastoma; Mammary gland; Tumor suppressor gene; Cancer; Breast cancer; Molecular biology; Gene; Transgene; Genetically modified mouse; Genetics","score_opus":0.05076359784337019,"score_gpt":0.34156357649093255,"score_spread":0.29079997864756235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316086785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97608256,0.018530646,0.0000028407078,0.0007122012,0.00024767907,0.0007597324,0.000057434783,0.000022415506,0.003584481],"genre_scores_gemma":[0.9984065,0.0006897513,0.000056848177,0.000106552754,0.00024681192,0.0002166037,0.0000053014023,0.00004542827,0.00022615925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976538,0.00015639082,0.00031318152,0.00031480665,0.0008082906,0.0007535362],"domain_scores_gemma":[0.99865705,0.00014420481,0.00007465615,0.0006758678,0.0001790591,0.00026915598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010463684,0.00015763528,0.00031373042,0.00024779304,0.000097608485,0.000019634721,0.0002946488,0.00011454983,0.0002645268],"category_scores_gemma":[0.0002471155,0.00011896269,0.00009219024,0.0006387159,0.00027938225,0.00013523942,0.00028920465,0.00075490604,0.000017622295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002863617,0.00020617392,0.026892986,0.0003201702,0.00004865551,0.00006439954,0.0011105624,0.0000118474845,0.9590528,0.0004833396,0.0019634888,0.009559201],"study_design_scores_gemma":[0.0012562338,0.00010271188,0.33665013,0.00043600635,0.000024248317,0.000058441106,0.00041346194,0.000040600888,0.64921767,0.0002211598,0.011437947,0.00014139274],"about_ca_topic_score_codex":0.0014423872,"about_ca_topic_score_gemma":0.0002050416,"teacher_disagreement_score":0.30983514,"about_ca_system_score_codex":0.0003535932,"about_ca_system_score_gemma":0.00065037434,"threshold_uncertainty_score":0.4851158},"labels":[],"label_agreement":null},{"id":"W2316216944","doi":"10.1158/1538-7445.am2013-2776","title":"Abstract 2776: Establishment of patient non-small cell lung cancer derived models for test of anticancer drugs.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Docetaxel; Medicine; Gemcitabine; Carboplatin; Pemetrexed; Primary tumor; Cancer; Crizotinib; Lung cancer; Gefitinib; Cisplatin; Erlotinib; Transplantation; Paclitaxel; Cancer research; Oncology; Internal medicine; Pathology; Chemotherapy; Metastasis; Epidermal growth factor receptor","score_opus":0.02928240231228324,"score_gpt":0.35105410416437943,"score_spread":0.3217717018520962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316216944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883057,0.007536396,0.00017476054,0.00019653785,0.000084302155,0.002002001,0.0005344934,0.0000045978895,0.0011612189],"genre_scores_gemma":[0.990265,0.0055626296,0.00034473446,0.000039092978,0.00012395112,0.0031151224,0.00007001912,0.000043223237,0.0004361881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978154,0.00004336013,0.00035999378,0.00048947934,0.0005778043,0.00071401015],"domain_scores_gemma":[0.9978862,0.00010547579,0.00014055942,0.00048724713,0.0011512138,0.00022929862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028091806,0.00018880253,0.00028754483,0.00012886758,0.000098541794,0.000036514542,0.00036858808,0.000120767094,0.0002801505],"category_scores_gemma":[0.00006396215,0.0001644407,0.0001442144,0.00022855971,0.00023276592,0.000019122066,0.00022325649,0.00016961737,0.0000036223373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002908347,0.0004290514,0.007186592,0.00074759626,0.00017199926,0.0000013820821,0.00036608588,0.00093202246,0.96744776,0.00001107363,0.009947694,0.012467922],"study_design_scores_gemma":[0.0015748907,0.00058557076,0.0024473253,0.00016634534,0.00002233032,2.3328543e-7,0.00026248684,0.00062025717,0.99258596,0.00013352925,0.0014304185,0.00017064401],"about_ca_topic_score_codex":0.0146430135,"about_ca_topic_score_gemma":0.0008232763,"teacher_disagreement_score":0.025138222,"about_ca_system_score_codex":0.00019263379,"about_ca_system_score_gemma":0.000994754,"threshold_uncertainty_score":0.99191856},"labels":[],"label_agreement":null},{"id":"W2316218283","doi":"10.1158/1538-7445.am10-1829","title":"Abstract 1829: Measures of body size and the risk of microsatellite stable and unstable molecular subtypes of sporadic endometrial cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia; Alberta Health Services","funders":"","keywords":"Endometrial cancer; Microsatellite instability; Odds ratio; Body mass index; Cancer; Medicine; Internal medicine; Oncology; Overweight; Population; Risk factor; Gynecology; Waist–hip ratio; Waist; Microsatellite; Biology; Genetics","score_opus":0.04695229149978782,"score_gpt":0.365232289643757,"score_spread":0.3182799981439692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316218283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95767576,0.04007446,0.000002607757,0.00024967076,0.00013344247,0.00070474995,0.000289012,0.000005366206,0.0008649223],"genre_scores_gemma":[0.97777677,0.021693652,0.000083910425,0.000016629729,0.00011674578,0.00007240539,0.0000043217674,0.000019748539,0.00021581649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980313,0.00015517283,0.0004044183,0.0002738508,0.00079881336,0.00033642096],"domain_scores_gemma":[0.99727964,0.0014169867,0.00020409576,0.00034130015,0.0005936054,0.0001643696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019146688,0.00013758104,0.0006335841,0.00024534247,0.000077748606,0.000016308864,0.00015204071,0.000105621264,0.0005523118],"category_scores_gemma":[0.0014317584,0.00008372412,0.000101889185,0.00094854773,0.0011678829,0.00005830425,0.0000858565,0.00051119766,6.9664094e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008094925,0.00017435377,0.12807772,0.0006272468,0.00056522235,0.0000100232,0.00029973616,0.000005861511,0.8393748,0.00034719057,0.00009289391,0.02233003],"study_design_scores_gemma":[0.01417431,0.00036760504,0.12059986,0.00018945723,0.00027375168,0.0000035230469,0.00013145136,0.000004580837,0.8605095,0.00083299744,0.0028238902,0.00008904847],"about_ca_topic_score_codex":0.031402983,"about_ca_topic_score_gemma":0.0008324211,"teacher_disagreement_score":0.03057056,"about_ca_system_score_codex":0.00005210454,"about_ca_system_score_gemma":0.00044415006,"threshold_uncertainty_score":0.975047},"labels":[],"label_agreement":null},{"id":"W2316226082","doi":"10.1158/1538-7445.am2015-ct302","title":"Abstract CT302: Pharmacokinetics (PK) and safety of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Abiraterone acetate; Medicine; Enzalutamide; Docetaxel; Internal medicine; Androgen receptor; Pharmacokinetics; Prednisone; Pharmacology; Gastroenterology; Urology; Cancer; Androgen deprivation therapy","score_opus":0.08136193661629539,"score_gpt":0.39515731123476694,"score_spread":0.31379537461847157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316226082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902128,0.005546233,0.0000031947316,0.0012245191,0.000033075496,0.0022509813,0.00027648365,0.000016772177,0.0004359167],"genre_scores_gemma":[0.99249643,0.0055102576,0.0002903036,0.000031057236,0.00004100518,0.0004940143,0.00006349253,0.000054516357,0.0010189153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969541,0.00014236197,0.0004018462,0.0005413777,0.0012494987,0.0007108229],"domain_scores_gemma":[0.9979975,0.000096703254,0.00012644804,0.00027701614,0.0010098325,0.00049249065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007883616,0.0002674321,0.0005116901,0.0003367021,0.00010944536,0.000064339096,0.000111086534,0.00005785395,0.000080051934],"category_scores_gemma":[0.000039008184,0.0001742761,0.000019872437,0.00067725824,0.0007580011,0.00024410198,0.000088749606,0.00052103493,0.000002810049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12083193,0.0017887517,0.74222726,0.0044541564,0.001358087,0.0006990492,0.01114642,0.0010169145,0.061317705,0.000055156594,0.0013706619,0.05373393],"study_design_scores_gemma":[0.06437061,0.007288677,0.8556485,0.0024852115,0.0002849104,0.00002175242,0.0021688684,0.00026545057,0.0649541,0.000084964464,0.0018975827,0.00052934955],"about_ca_topic_score_codex":0.0027655736,"about_ca_topic_score_gemma":0.0018670033,"teacher_disagreement_score":0.11342128,"about_ca_system_score_codex":0.00051644567,"about_ca_system_score_gemma":0.0013552312,"threshold_uncertainty_score":0.7106773},"labels":[],"label_agreement":null},{"id":"W2316259484","doi":"10.1158/1538-7445.am10-lb-271","title":"Abstract LB-271: The biological role of the transcription factor Kaiso in breast tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Carcinogenesis; Cancer research; Biology; Cell biology; Epithelial–mesenchymal transition; Transcription factor; Signal transduction; Cancer; Metastasis","score_opus":0.04449819277496224,"score_gpt":0.3384674615025985,"score_spread":0.29396926872763623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316259484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725115,0.0010169083,0.0000025826523,0.0007675689,0.0002417589,0.00021669216,0.000040983807,0.0000039348697,0.00045841638],"genre_scores_gemma":[0.9988108,0.00047001586,0.000012199424,0.000051303745,0.00025590678,0.00012096157,0.000009850285,0.000011528808,0.00025743287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892676,0.00009449463,0.00017144484,0.00024047463,0.0002731829,0.0002936478],"domain_scores_gemma":[0.9994437,0.000029687375,0.000040099152,0.00029557277,0.0001498584,0.000041045685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054730556,0.00009294402,0.00009419259,0.000037522732,0.000120794626,0.000020275054,0.00053256407,0.00014652996,0.0003741873],"category_scores_gemma":[0.00004390111,0.0000505066,0.000074671974,0.0002244955,0.00033144775,0.0000036377535,0.000088005116,0.00038463462,0.0000063006146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087189284,0.000029262375,0.05633485,0.000008478269,0.000013123074,3.379924e-7,0.00013840797,0.00000906238,0.9384829,0.000041114356,0.00048254215,0.004372728],"study_design_scores_gemma":[0.00015421359,0.000019791238,0.35506007,0.000013760899,0.0000014220686,0.0000020363523,0.000120434706,0.0000019122676,0.6325358,0.00012741164,0.011901502,0.000061619285],"about_ca_topic_score_codex":0.0004148285,"about_ca_topic_score_gemma":0.00055154774,"teacher_disagreement_score":0.30594707,"about_ca_system_score_codex":0.000026304246,"about_ca_system_score_gemma":0.000255511,"threshold_uncertainty_score":0.4097089},"labels":[],"label_agreement":null},{"id":"W2316261099","doi":"10.1158/1538-7445.am2013-247","title":"Abstract 247: ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Reprogramming; Myeloid leukemia; Biology; Progenitor cell; Cancer research; Small hairpin RNA; Stem cell; Myeloid; Leukemia; Gene knockdown; Immunology; Cell biology; Genetics; Cell; Gene","score_opus":0.040730923984520724,"score_gpt":0.3625602808864312,"score_spread":0.3218293569019105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316261099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942094,0.003798494,0.00000965011,0.00038073515,0.000058429894,0.0007827735,0.000006863328,0.000015158684,0.00073850167],"genre_scores_gemma":[0.99635404,0.00027856676,0.000104903986,0.000036879777,0.00045097823,0.0008578278,0.000042503023,0.000025517014,0.0018488052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984624,0.000075816846,0.00019870113,0.00043878943,0.0003090793,0.00051526306],"domain_scores_gemma":[0.99914485,0.000012627814,0.000037946535,0.00039613646,0.00021864387,0.00018981665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039657007,0.000112278576,0.00010117288,0.00009397041,0.00009256217,0.00008919004,0.00022849366,0.00012178628,0.00044503875],"category_scores_gemma":[0.0001164669,0.00009971225,0.00005719542,0.00022423074,0.00013745052,0.0000107873175,0.00011973153,0.00018368184,0.00010904086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005101458,0.000040111212,0.0068559106,0.00008263907,0.000014950245,0.0000101192545,0.000032382002,0.000056109035,0.94703555,0.000027226184,0.0028113471,0.042982668],"study_design_scores_gemma":[0.001274075,0.00026812725,0.124161705,0.00014799308,0.0000049016585,0.0000058662154,0.0002022489,0.00029149247,0.81717,0.00022815136,0.05588975,0.00035568146],"about_ca_topic_score_codex":0.001013428,"about_ca_topic_score_gemma":0.00026428432,"teacher_disagreement_score":0.12986553,"about_ca_system_score_codex":0.00034216203,"about_ca_system_score_gemma":0.0012153613,"threshold_uncertainty_score":0.4872862},"labels":[],"label_agreement":null},{"id":"W2316376858","doi":"10.1158/1538-7445.am2012-5408","title":"Abstract 5408: CD73 as a target in cancer immunotherapy","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Adenosine; Tumor microenvironment; 5'-nucleotidase; Cancer research; Cancer immunotherapy; Immunotherapy; FOXP3; Extracellular; Cancer; Nucleotidase; Biology; Immunology; Immune system; Medicine; Cell biology; Internal medicine; Biochemistry","score_opus":0.06362887726275455,"score_gpt":0.4293431032109684,"score_spread":0.36571422594821384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316376858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274962,0.06933541,0.000017292601,0.0004561633,0.00015950644,0.00015814372,0.000010473416,0.000009453573,0.0023573488],"genre_scores_gemma":[0.9914962,0.004876719,0.00005186646,0.00026802212,0.0011122512,0.000231504,0.00001734063,0.000040134568,0.0019059512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871016,0.00007438551,0.00014417621,0.00022479269,0.0002481547,0.0005983198],"domain_scores_gemma":[0.9994992,0.000022605956,0.000027558553,0.00024123718,0.00009879523,0.000110608795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006038631,0.00010473647,0.00010902446,0.00008661622,0.00006288097,0.000021179325,0.00022254456,0.00012474693,0.0010805763],"category_scores_gemma":[0.00003155719,0.000095224874,0.00004675051,0.00020668838,0.00007756566,0.00000819132,0.00007800666,0.0002736898,0.00003733775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020450357,0.00009521695,0.034756165,0.000024952684,0.000051428156,0.000006069818,0.00025965535,0.0001449088,0.9339949,0.000078810845,0.027727414,0.0026559902],"study_design_scores_gemma":[0.0006928327,0.00009171472,0.021100888,0.000051871088,0.0000025067623,0.000004147366,0.00015623521,0.00000516852,0.5626982,0.00012985492,0.41485786,0.00020873889],"about_ca_topic_score_codex":0.003053781,"about_ca_topic_score_gemma":0.00007156649,"teacher_disagreement_score":0.38713044,"about_ca_system_score_codex":0.00007190468,"about_ca_system_score_gemma":0.0002723707,"threshold_uncertainty_score":0.9998326},"labels":[],"label_agreement":null},{"id":"W2316383768","doi":"10.1158/1538-7445.fbcr11-c39","title":"Abstract C39: Catalytic inhibition of human DNA topoisomerase II α by salicylate and related nonsteroidal anti-inflammatory drugs","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Topoisomerase; Chemistry; Pharmacology; Doxorubicin; Aspirin; Etoposide; Metabolite; In vivo; Salicylic acid; Cancer cell; Cancer; Biochemistry; Cancer research; Enzyme; Biology; Medicine; Chemotherapy; Internal medicine","score_opus":0.034778146738714454,"score_gpt":0.328102163870177,"score_spread":0.29332401713146256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316383768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595344,0.0017760375,0.0000048267775,0.00007886596,0.00008202555,0.00022623703,0.00006843018,0.000008573866,0.0018015564],"genre_scores_gemma":[0.99802494,0.0009024528,0.000008649108,0.000044650624,0.00006374705,0.000042259155,0.00008002116,0.000028093458,0.00080517103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988659,0.000045643646,0.00023424826,0.00032593054,0.00021603737,0.00031223622],"domain_scores_gemma":[0.99936336,0.000006602033,0.00007720402,0.00029093467,0.0001431504,0.00011876666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041802478,0.00012154059,0.00014447741,0.00008980633,0.00017639334,0.000014935166,0.00012710459,0.00015158899,0.0001377278],"category_scores_gemma":[0.000007850463,0.00012140099,0.000049790528,0.000106872736,0.000246866,0.000008691434,0.0001598414,0.00019189557,0.0000043768323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007584518,0.00005715344,0.0001825302,0.00005926545,0.000055037617,0.0000048477214,0.0006173195,4.415329e-7,0.9957307,0.00023988036,0.00059227523,0.0023847166],"study_design_scores_gemma":[0.00071795896,0.00029061612,0.0011953148,0.000052071813,0.000011238533,0.0000038676203,0.0001620806,0.0000024329877,0.9947417,0.00047055652,0.0022131372,0.00013903803],"about_ca_topic_score_codex":0.00045922495,"about_ca_topic_score_gemma":0.00006995649,"teacher_disagreement_score":0.0022456786,"about_ca_system_score_codex":0.000032732474,"about_ca_system_score_gemma":0.00012075893,"threshold_uncertainty_score":0.49505886},"labels":[],"label_agreement":null},{"id":"W2316413853","doi":"10.1158/1538-7445.am2011-sy07-02","title":"Abstract SY07-02: Polarity proteins in morphogenesis and metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cell polarity; Metastasis; Cancer research; Biology; Context (archaeology); Metastasis suppressor; Cancer; Suppressor; Primary tumor; Morphogenesis; Cell biology; Cell; Gene; Genetics","score_opus":0.14152129895077312,"score_gpt":0.375841641422165,"score_spread":0.23432034247139186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316413853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946874,0.0037493175,0.000027558388,0.00008829523,0.000034502038,0.00025287157,0.000052598258,0.0000073712117,0.0011000964],"genre_scores_gemma":[0.99840075,0.00067008974,0.00031279432,0.00004185005,0.00009933107,0.00014871977,0.00001308524,0.000019653087,0.00029375567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987659,0.00012510554,0.00014139077,0.0003668766,0.00021329257,0.0003874255],"domain_scores_gemma":[0.9994255,0.000013345562,0.000024276147,0.00028394177,0.00012451842,0.00012843058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091665034,0.000102858125,0.00012233159,0.00011282321,0.00009709082,0.000023351438,0.00018918338,0.00017648061,0.00019380522],"category_scores_gemma":[0.000102771985,0.00009535747,0.00003882209,0.00018099217,0.00015081168,0.0000047162775,0.00012419483,0.00031311833,0.000017073115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010688682,0.00006233597,0.009104463,0.000044148474,0.000027774802,0.000018444971,0.00020837317,0.0000017504734,0.98366094,0.000033766337,0.00006456082,0.006666573],"study_design_scores_gemma":[0.00030216164,0.0001406986,0.037758432,0.00003245914,0.0000049659097,0.000004224983,0.00009671818,0.0000030006127,0.957183,0.00016484367,0.004175231,0.00013428059],"about_ca_topic_score_codex":0.0042437054,"about_ca_topic_score_gemma":0.0009781804,"teacher_disagreement_score":0.028653968,"about_ca_system_score_codex":0.000029815352,"about_ca_system_score_gemma":0.00020196127,"threshold_uncertainty_score":0.6415242},"labels":[],"label_agreement":null},{"id":"W2316489042","doi":"10.1158/1538-7445.am2013-751","title":"Abstract 751: Identification of variant claudin 1 transcripts in human breast tumors.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Claudin; Biology; Tight junction; Cancer; Breast cancer; Cancer research; Exon; Gene; Molecular biology; Genetics","score_opus":0.03618722484366739,"score_gpt":0.3651549867865888,"score_spread":0.32896776194292143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316489042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956909,0.0009888709,0.00075231626,0.0005107075,0.00007992873,0.00082764163,0.000064807355,0.00000867469,0.0010761416],"genre_scores_gemma":[0.99804175,0.00031989207,0.000026071353,0.000024496005,0.000134343,0.00049700483,0.00007579525,0.000040582538,0.0008400869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765056,0.00018758651,0.0004378583,0.0005157985,0.00063118205,0.000577038],"domain_scores_gemma":[0.99865365,0.00001620553,0.000077162484,0.0005754016,0.00053351437,0.00014408852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010943732,0.00013592452,0.00018117318,0.00030893527,0.00009918895,0.000059529422,0.00049420295,0.0002044894,0.0006826251],"category_scores_gemma":[0.00007665639,0.00014104327,0.00008266533,0.0005006293,0.0002137622,0.000013573755,0.00012239201,0.00047402494,0.00004634495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007017289,0.0001069779,0.00008928842,0.00009106803,0.000030214733,0.0000110016,0.00007757041,0.0001454428,0.993409,0.00029501857,0.001805943,0.003868312],"study_design_scores_gemma":[0.00066252524,0.00011748689,0.019661747,0.00009063939,0.0000033325591,0.000013440483,0.00011849855,0.00006908308,0.9777367,0.00050498336,0.0008729106,0.00014863862],"about_ca_topic_score_codex":0.0038523213,"about_ca_topic_score_gemma":0.0005782237,"teacher_disagreement_score":0.01957246,"about_ca_system_score_codex":0.00014808442,"about_ca_system_score_gemma":0.00037590205,"threshold_uncertainty_score":0.7474266},"labels":[],"label_agreement":null},{"id":"W2316564286","doi":"10.1158/1538-7445.am2013-3191","title":"Abstract 3191: The Akt-mTOR axis determines cell fate through the regulation of eIF2α phosphorylation pathway.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; eIF2; Phosphorylation; Cell biology; Biology; Cancer research; Signal transduction; Programmed cell death; Translation (biology); Apoptosis; Biochemistry; Gene; Messenger RNA","score_opus":0.03179789244354278,"score_gpt":0.3263549287465309,"score_spread":0.29455703630298813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316564286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918097,0.0033924638,0.000042064243,0.0007327124,0.00009550362,0.00047074567,0.000034332166,0.000005061831,0.0034173846],"genre_scores_gemma":[0.99713576,0.00085274497,0.000028597695,0.00007281068,0.00022226345,0.00025918704,0.000037126705,0.000015890715,0.0013756375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988925,0.0001011677,0.000188357,0.00023427271,0.00032360994,0.00026011406],"domain_scores_gemma":[0.9989797,0.0000695408,0.000084497566,0.00048458512,0.00032788113,0.00005381495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023689836,0.00009932178,0.00008461342,0.00001864408,0.00019508759,0.000051052546,0.00029856412,0.000079732956,0.0003037207],"category_scores_gemma":[0.00008799247,0.000055949968,0.0000771323,0.00012332392,0.00027213828,0.000011714443,0.00010774684,0.00013409556,0.000027922355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007098462,0.000039422695,0.0014464945,0.000060184608,0.000018411214,5.627987e-7,0.00019849812,0.00028116355,0.9799364,0.0000887108,0.011445953,0.006413166],"study_design_scores_gemma":[0.00029949695,0.00007441281,0.036367264,0.000025366282,0.000007486589,7.2424405e-7,0.0002960047,0.00014303929,0.94531494,0.000692654,0.016686505,0.00009212474],"about_ca_topic_score_codex":0.001258009,"about_ca_topic_score_gemma":0.00007711318,"teacher_disagreement_score":0.034920767,"about_ca_system_score_codex":0.000020760077,"about_ca_system_score_gemma":0.00013899709,"threshold_uncertainty_score":0.33255288},"labels":[],"label_agreement":null},{"id":"W2316579798","doi":"10.1158/1538-7445.am2013-550","title":"Abstract 550: Akt2 regulates mitophagy in breast cancer cell lines.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"AKT2; PINK1; Protein kinase B; Mitophagy; mTORC2; PI3K/AKT/mTOR pathway; Cancer research; Biology; Phosphorylation; Autophagy; AKT1; Cell biology; Kinase; mTORC1; Signal transduction; Biochemistry; Apoptosis","score_opus":0.0326500834107956,"score_gpt":0.3630787979736418,"score_spread":0.33042871456284617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316579798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97988874,0.015800817,0.0000040176465,0.0013614338,0.00037002683,0.00044036558,0.00009450323,0.000017797842,0.0020223102],"genre_scores_gemma":[0.9895069,0.00433647,0.00006324598,0.00024300984,0.0013148014,0.0008260058,0.000034557863,0.00006533321,0.0036097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976145,0.00010394388,0.000305242,0.0006656995,0.00047208503,0.0008385495],"domain_scores_gemma":[0.99857,0.000047470992,0.00006914357,0.0005897623,0.0005151435,0.00020843183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044940793,0.00022018208,0.00021449817,0.00011034539,0.00010641417,0.00008781483,0.0005751761,0.00028329884,0.0033796446],"category_scores_gemma":[0.00003834958,0.00020690825,0.000086714965,0.00032853585,0.00023630491,0.000019518833,0.00022283949,0.00043170623,0.00013403388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100783785,0.000072724244,0.0077155908,0.000088212066,0.000028013026,0.000007655122,0.00005631008,0.00033068893,0.94025683,0.000004905926,0.045173656,0.0061646323],"study_design_scores_gemma":[0.0008632388,0.00006522752,0.08177252,0.00013433781,0.0000044998924,0.0000056655895,0.000106411004,0.00006278063,0.89912856,0.00012288138,0.017403416,0.00033047827],"about_ca_topic_score_codex":0.01570218,"about_ca_topic_score_gemma":0.001982113,"teacher_disagreement_score":0.07405693,"about_ca_system_score_codex":0.00032358392,"about_ca_system_score_gemma":0.000621036,"threshold_uncertainty_score":0.9975314},"labels":[],"label_agreement":null},{"id":"W2316601565","doi":"10.1158/1538-7445.am2012-1430","title":"Abstract 1430: Characterization of the medulloblastoma splice-ome reveals subgroup-specific changes in alternative splicing and isoform expression patterns","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Alternative splicing; RNA splicing; Biology; Exon; Genetics; Gene; Spliceosome; Gene isoform; Cancer research; RNA","score_opus":0.05366363925201599,"score_gpt":0.3518407704727522,"score_spread":0.2981771312207362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316601565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977295,0.0013063698,0.00006266405,0.000301473,0.00011665908,0.0003038318,0.000058859743,0.0000023589378,0.00011829194],"genre_scores_gemma":[0.9938329,0.0053325933,0.000009788359,0.00003973302,0.00034812634,0.00018115017,0.000026752374,0.000015814052,0.00021318557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990284,0.00007515669,0.00015254402,0.00021380719,0.0002313413,0.00029876566],"domain_scores_gemma":[0.99941957,0.000017079208,0.00009001341,0.00029791996,0.00011337165,0.000062050654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004878932,0.00008577521,0.000099955454,0.00007719104,0.00009147644,0.000014998141,0.00019659246,0.00008038215,0.000064428474],"category_scores_gemma":[0.000020027028,0.000063511674,0.000024084675,0.00016109127,0.00009685244,0.000015128717,0.00014771553,0.00015101179,0.0000018007818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004623056,0.00003300963,0.04353716,0.000044631804,0.0000061632277,1.9986558e-7,0.0004585767,0.0000027088179,0.94975626,0.000040030933,0.000071005525,0.006004039],"study_design_scores_gemma":[0.00013997481,0.000022904278,0.43959707,0.000103639126,9.871803e-7,0.0000010388817,0.00013576575,0.0000034338052,0.557619,0.000010054828,0.0023162789,0.000049872848],"about_ca_topic_score_codex":0.0002028643,"about_ca_topic_score_gemma":0.0002204276,"teacher_disagreement_score":0.3960599,"about_ca_system_score_codex":0.000058947313,"about_ca_system_score_gemma":0.000033440632,"threshold_uncertainty_score":0.2589931},"labels":[],"label_agreement":null},{"id":"W2316693109","doi":"10.1158/1538-7445.am2013-1688","title":"Abstract 1688: Autophagy inhibition enhances the antitumor effects of combretastatin A4 phosphate (CA4P).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Autophagy; Programmed cell death; Necrosis; Cancer research; Senescence; Biology; Cancer cell; Cell; Cancer; Cell culture; Cell biology; Apoptosis; Biochemistry","score_opus":0.01939345152267611,"score_gpt":0.33654313424152293,"score_spread":0.3171496827188468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316693109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834102,0.012656883,0.000058226757,0.00035757976,0.0020220177,0.00065715186,0.0000276583,0.000009319682,0.0008009626],"genre_scores_gemma":[0.990086,0.0049969424,0.00004242458,0.0001509533,0.0030771352,0.0004457233,0.000030188323,0.000022535263,0.001148106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855024,0.00013234653,0.00021755316,0.000311095,0.0003691196,0.0004196466],"domain_scores_gemma":[0.999026,0.00008085881,0.00008740897,0.00036978806,0.00034104777,0.00009489822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047547565,0.00012978926,0.00018008,0.00005668069,0.00014851379,0.00004977381,0.00025312102,0.00008454188,0.00031200904],"category_scores_gemma":[0.00012969658,0.00009426033,0.000082296036,0.00019390193,0.0003773725,0.0000127673065,0.00012147383,0.00022972189,0.00005596127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054112228,0.000045128403,0.00007760596,0.00017846079,0.00003345728,2.7416314e-7,0.00010693839,0.000011468517,0.93709993,0.00015539228,0.050736263,0.0115009835],"study_design_scores_gemma":[0.000531084,0.00012346216,0.012732396,0.00007191873,0.0000079196125,0.0000015593921,0.00008760028,0.000007910734,0.8995733,0.00019065717,0.08656938,0.00010277278],"about_ca_topic_score_codex":0.0017278758,"about_ca_topic_score_gemma":0.00018158436,"teacher_disagreement_score":0.037526574,"about_ca_system_score_codex":0.00002637351,"about_ca_system_score_gemma":0.0002578039,"threshold_uncertainty_score":0.38438246},"labels":[],"label_agreement":null},{"id":"W2316751273","doi":"10.1158/1538-7445.am2012-1362","title":"Abstract 1362: Developing genetically flexible mouse models of sarcoma - a novel functional genomics platform","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Biology; Germline; Sarcoma; Skeletal muscle; Cancer research; Transgene; Genetically modified mouse; Desmin; Green fluorescent protein; Pathology; Immunohistochemistry; Immunology; Medicine; Genetics; Gene; Vimentin; Endocrinology","score_opus":0.27542484255819566,"score_gpt":0.42082019952221933,"score_spread":0.14539535696402367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316751273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930167,0.0008119751,0.0015591944,0.00039894963,0.00007394552,0.00054679584,0.000060899038,0.00003204099,0.003499487],"genre_scores_gemma":[0.9944267,0.00046679308,0.0028356707,0.0000902754,0.00025770738,0.0001440216,0.000027240983,0.00004474649,0.0017067912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732393,0.00002264413,0.0002731588,0.00026387238,0.0010803548,0.0010360382],"domain_scores_gemma":[0.9984973,0.00016681544,0.00004106498,0.000326846,0.0004715706,0.00049642223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060116063,0.00014141235,0.00024173643,0.00031930176,0.00015732054,0.000023513267,0.00015720016,0.00009146873,0.00049765763],"category_scores_gemma":[0.000088083405,0.00011930517,0.00008055693,0.00036853904,0.00022048075,0.0002293314,0.00019447523,0.000476379,0.00011103572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017922712,0.0008068538,0.004402742,0.0003376707,0.00027404111,0.000025596046,0.00020660996,0.0002268649,0.97683835,0.005277533,0.0013499615,0.008461515],"study_design_scores_gemma":[0.0041423654,0.00046965107,0.092473306,0.00018527459,0.00002864759,0.000070797694,0.000121537334,0.0006469015,0.89553577,0.0009259643,0.005176538,0.00022326321],"about_ca_topic_score_codex":0.0002399498,"about_ca_topic_score_gemma":0.000022567734,"teacher_disagreement_score":0.088070564,"about_ca_system_score_codex":0.00062097766,"about_ca_system_score_gemma":0.0013283712,"threshold_uncertainty_score":0.5449002},"labels":[],"label_agreement":null},{"id":"W2316856547","doi":"10.1158/1538-7445.am10-946","title":"Abstract 946: Effects of maternal and postweaning folic acid supplementation on gene-specific DNA methylation in the offspring","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Offspring; DNA methylation; Methylation; Biology; Weaning; Endocrinology; Internal medicine; Pregnancy; Exon; Lactation; Andrology; Gene expression; Genetics; Gene; Medicine","score_opus":0.06364410690724366,"score_gpt":0.41922291408293855,"score_spread":0.3555788071756949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316856547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975904,0.0004256112,0.0000047803564,0.0006852303,0.00007501195,0.00061233784,0.000005331657,0.000005786904,0.00059550814],"genre_scores_gemma":[0.9988357,0.0007154303,0.000073712516,0.000030424158,0.00017765429,0.00008261141,0.000010535912,0.000014322329,0.000059623908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845684,0.000111413836,0.00017534224,0.00019870633,0.0007488287,0.00030888084],"domain_scores_gemma":[0.9992154,0.0003358819,0.000031975334,0.00022075938,0.0001304243,0.000065546286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00141362,0.000074623196,0.00012837691,0.00034961992,0.00008957001,0.000044965742,0.00012927095,0.0000625761,0.00016625872],"category_scores_gemma":[0.000114360744,0.000051928208,0.000026213986,0.00032500416,0.00010131775,0.0000860231,0.000045696732,0.00069199275,0.000014009686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024828484,0.000041885047,0.020653443,0.00018928296,0.000014978636,0.000036207333,0.00078346353,0.0000014221604,0.9333905,0.00018968976,0.00015159526,0.044299237],"study_design_scores_gemma":[0.0006557404,0.0001689792,0.4394122,0.000083798055,0.0000028748118,0.000004193232,0.00009942852,0.000020917902,0.55912596,0.00004988484,0.0003495822,0.000026442458],"about_ca_topic_score_codex":0.0006426289,"about_ca_topic_score_gemma":0.00027299765,"teacher_disagreement_score":0.41875878,"about_ca_system_score_codex":0.000073006544,"about_ca_system_score_gemma":0.00008467574,"threshold_uncertainty_score":0.30064026},"labels":[],"label_agreement":null},{"id":"W2316895357","doi":"10.1158/0008-5472.sabcs12-p1-05-22","title":"Abstract P1-05-22: Breast cancer cells that undergo an Epithelial-to-Mesenchymal transition co-opt LPP, a regulator of mesenchymal cell migration and invasion.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Epithelial–mesenchymal transition; Cell migration; Cancer research; Metastasis; Focal adhesion; Breast cancer; Mesenchymal stem cell; Cancer cell; Biology; Transforming growth factor; Cancer; Cell; Cell biology; Signal transduction","score_opus":0.07278941176959579,"score_gpt":0.37982955876396524,"score_spread":0.30704014699436943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316895357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904124,0.0025554602,0.000014509222,0.0046057818,0.00025346503,0.0011814717,0.00055150734,0.00002811084,0.0003972822],"genre_scores_gemma":[0.9937727,0.004276499,0.00012066056,0.00020546216,0.000706564,0.00047533767,0.00005179522,0.00005145034,0.00033952206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971567,0.00015046491,0.00034546925,0.00050934183,0.0011110068,0.00072701194],"domain_scores_gemma":[0.99816823,0.0001684678,0.000103834245,0.00045690313,0.00034611762,0.00075645465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008542883,0.00025242445,0.00045032168,0.00034169984,0.00019157569,0.000051868272,0.00012137994,0.00016944273,0.0014578514],"category_scores_gemma":[0.000015078009,0.00020887141,0.00011495337,0.0003906909,0.00022415031,0.00038537863,0.000043845903,0.000366495,0.000028671637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018968203,0.0017855669,0.08251851,0.0009858104,0.00020180967,0.000037535305,0.0066725696,0.00015433595,0.8660629,0.000089358415,0.017531468,0.022063356],"study_design_scores_gemma":[0.0018023975,0.00043547375,0.43446863,0.00043400854,0.000097488155,0.000023549408,0.0008527852,0.00003270428,0.5596176,0.000024688123,0.0020209518,0.00018975977],"about_ca_topic_score_codex":0.01532843,"about_ca_topic_score_gemma":0.002006704,"teacher_disagreement_score":0.3519501,"about_ca_system_score_codex":0.00063906214,"about_ca_system_score_gemma":0.0006378076,"threshold_uncertainty_score":0.999455},"labels":[],"label_agreement":null},{"id":"W2316932644","doi":"10.1158/1538-7445.am2012-377","title":"Abstract 377: Organic Anion Transporting Polypeptides (OATPs): A potential new molecular target for imaging/therapy of hormone dependent breast cancers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Organic anion-transporting polypeptide; Cancer research; Solute carrier family; Cancer; Gene isoform; Organic anion transporter 1; Medicine; Transporter; Internal medicine; Pharmacology; Chemistry; Biology; Biochemistry; Gene","score_opus":0.03414248089179244,"score_gpt":0.3536497533227544,"score_spread":0.31950727243096194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316932644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629832,0.026236046,0.007977174,0.0010829015,0.0002772072,0.001090099,0.00012296163,0.00005236558,0.00017807791],"genre_scores_gemma":[0.99518675,0.0020536543,0.0014024134,0.00008305354,0.00065531867,0.00010921329,0.00006268917,0.00009274133,0.00035419376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972084,0.000031617845,0.00045473015,0.00036443933,0.0009363765,0.0010044085],"domain_scores_gemma":[0.9986428,0.000033775377,0.00012996109,0.00032446507,0.00037717327,0.0004918416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093158946,0.0002212927,0.00041522854,0.00023418726,0.00014177397,0.000020892463,0.00021683682,0.00011221868,0.0006580004],"category_scores_gemma":[0.000017215529,0.00019115351,0.00021498052,0.00039203893,0.00013552755,0.00017733141,0.0000147584415,0.00039601908,0.0000073337824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022520479,0.00016098842,0.0058720796,0.0001841235,0.00014993615,0.000044911525,0.0005646068,0.000034448243,0.9736608,0.0001047003,0.0008610306,0.016110292],"study_design_scores_gemma":[0.0053392933,0.00031641958,0.0692939,0.00035904994,0.00009084975,0.00005138617,0.0008441531,0.00004523877,0.9204429,0.00041717404,0.0024493001,0.000350331],"about_ca_topic_score_codex":0.0019178402,"about_ca_topic_score_gemma":0.00015363345,"teacher_disagreement_score":0.06342182,"about_ca_system_score_codex":0.00036937257,"about_ca_system_score_gemma":0.0011419272,"threshold_uncertainty_score":0.7795014},"labels":[],"label_agreement":null},{"id":"W2317017811","doi":"10.1158/1538-7445.am2012-4453","title":"Abstract 4453: Smoking characteristics, intention to quit, and nicotine dependence in patients with head and neck cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Medicine; Smoking cessation; Head and neck cancer; Nicotine; Cohort; Nicotine dependence; Internal medicine; Nicotine replacement therapy; Cancer; Prospective cohort study; Physical therapy","score_opus":0.08187745413101608,"score_gpt":0.41303065994191795,"score_spread":0.3311532058109019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317017811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471486,0.003341161,0.0000023078774,0.00096287316,0.00014688932,0.0005121855,0.000030580537,0.000012770574,0.00027640062],"genre_scores_gemma":[0.9976124,0.0015801525,0.00003775906,0.00018624736,0.00017412138,0.0001831356,0.0000073077667,0.000021096514,0.00019776453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984687,0.00003278377,0.00018511162,0.00028148582,0.00045950292,0.00057243096],"domain_scores_gemma":[0.999194,0.000053852473,0.000034151195,0.0001456149,0.00027758512,0.0002947817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046998955,0.00012210928,0.00028262718,0.00018268808,0.00012312221,0.000027976084,0.000053733173,0.000054079643,0.00013280784],"category_scores_gemma":[0.0001241971,0.00009431154,0.000012135583,0.00027606974,0.0001165147,0.00016399387,0.00011983244,0.00039055911,0.0000063688676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006536643,0.00009543604,0.94845,0.00023287465,0.000028089062,0.0000034819623,0.001070471,1.7266413e-7,0.0012003134,0.000009433492,0.00035056812,0.04790548],"study_design_scores_gemma":[0.0016056511,0.00034925496,0.99298376,0.0013446002,0.000013149867,0.0000014308672,0.00018902004,0.0000028558673,0.0006636362,0.000002719237,0.0027364078,0.00010749331],"about_ca_topic_score_codex":0.0041754423,"about_ca_topic_score_gemma":0.0038960967,"teacher_disagreement_score":0.047797985,"about_ca_system_score_codex":0.00030143175,"about_ca_system_score_gemma":0.00012760764,"threshold_uncertainty_score":0.6312048},"labels":[],"label_agreement":null},{"id":"W2317045207","doi":"10.1158/1538-7445.am2011-5073","title":"Abstract 5073: Proteomic profiling of head and neck squamous cell carcinoma cell lines","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Head and neck squamous-cell carcinoma; Biomarker discovery; Proteomics; Transcriptome; Gene expression profiling; Cancer research; Biomarker; Immunohistochemistry; Human Protein Atlas; Microarray; Tissue microarray; Cancer; Biology; Pathology; Gene expression; Medicine; Head and neck cancer; Gene; Protein expression; Genetics","score_opus":0.12547924971072597,"score_gpt":0.37584248751637594,"score_spread":0.25036323780564995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317045207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812507,0.007251951,0.0000021994608,0.00019991258,0.00007929635,0.0011408154,0.00002061339,0.000022867393,0.010031658],"genre_scores_gemma":[0.99735075,0.0005677373,0.00074571354,0.000041902593,0.00021904429,0.0004139892,0.000004983295,0.00004217535,0.0006137016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982678,0.0000520841,0.0003022903,0.00039472163,0.0004871245,0.000495936],"domain_scores_gemma":[0.99887717,0.0000460683,0.00007765276,0.00035282274,0.00041921792,0.00022706599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805693,0.00015015407,0.00031531128,0.0001895968,0.000097531985,0.00001710965,0.00015978681,0.000117827796,0.00047458525],"category_scores_gemma":[0.000039896666,0.00012321326,0.00007200645,0.0002976555,0.0002288061,0.00007486119,0.00010193483,0.00048724358,0.000020325439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000978141,0.0004548136,0.39413643,0.0030201678,0.000015863732,0.00003103932,0.0013492652,0.0000015097858,0.5946219,0.000025151852,0.0009718994,0.004393832],"study_design_scores_gemma":[0.0014011529,0.0007099403,0.21001582,0.00013581793,0.000025308795,0.0000023021983,0.00027373637,0.00002504174,0.7869896,0.0000274155,0.00029166555,0.00010218851],"about_ca_topic_score_codex":0.0032691436,"about_ca_topic_score_gemma":0.000059696755,"teacher_disagreement_score":0.19236772,"about_ca_system_score_codex":0.000109620036,"about_ca_system_score_gemma":0.000493672,"threshold_uncertainty_score":0.5196376},"labels":[],"label_agreement":null},{"id":"W2317058388","doi":"10.1158/1538-7445.am10-3586","title":"Abstract 3586: Reactive oxygen species and antioxidant pathway in resistance to doxorubicin and paclitaxel in cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Toronto; Sunnybrook Health Science Centre; Sudbury Regional Hospital; Mount Sinai Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Single-nucleotide polymorphism; Cancer research; Biology; Cancer; Drug resistance; Breast cancer; Gene; Genetics; Chemotherapy","score_opus":0.03445943634778214,"score_gpt":0.3796414414777006,"score_spread":0.3451820051299185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317058388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945029,0.0018159632,0.000025202853,0.0016716782,0.0000247052,0.0004460322,0.00007419149,0.000005836963,0.0014334919],"genre_scores_gemma":[0.99607164,0.002025295,0.00039418993,0.00014712871,0.00008505459,0.0005650534,0.000013030605,0.000014989032,0.00068362977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988891,0.000052941698,0.00015367755,0.00046462714,0.0001134816,0.00032618424],"domain_scores_gemma":[0.999469,0.00002564601,0.000028007353,0.00028513398,0.00009200855,0.00010024116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053577765,0.00010512512,0.00012905507,0.00012607157,0.0000736921,0.000025150053,0.00015210317,0.00016159199,0.000028332332],"category_scores_gemma":[0.000084081694,0.00009787202,0.000016848006,0.00022319167,0.0002213427,0.0000046040286,0.00015955005,0.0003805162,0.0000012294574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008419118,0.00003120469,0.008999383,0.000019063835,0.000007030182,0.000006821418,0.00008643361,9.2758825e-7,0.9867619,0.0008876229,0.00095667335,0.0021587124],"study_design_scores_gemma":[0.00023329414,0.00005200937,0.26240197,0.000049990944,8.8712596e-7,0.0000016903143,0.00009693282,0.0000012359693,0.66051716,0.0004496962,0.07606992,0.00012519424],"about_ca_topic_score_codex":0.0011593569,"about_ca_topic_score_gemma":0.028738754,"teacher_disagreement_score":0.32624477,"about_ca_system_score_codex":0.000036789344,"about_ca_system_score_gemma":0.00012526487,"threshold_uncertainty_score":0.9889842},"labels":[],"label_agreement":null},{"id":"W2317080695","doi":"10.1158/0008-5472.sabcs12-p1-07-17","title":"Abstract P1-07-17: V Array: A novel tool for constructing virtual tissue microarrays (TMAs), an evaluation of its use in optimizing TMA construction for Ductal Carcinoma in Situ (DCIS).","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Tissue microarray; Ductal carcinoma; Medicine; Magnification; Pathology; Biomarker; Oncology; Internal medicine; Cancer; Breast cancer; Biology; Computer science; Artificial intelligence","score_opus":0.1370029878654418,"score_gpt":0.44158593964772436,"score_spread":0.30458295178228256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317080695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933239,0.00057062233,0.0029610768,0.00040068635,0.00039312395,0.0020969543,0.0000434152,0.000015663265,0.00019453543],"genre_scores_gemma":[0.97535145,0.000037592585,0.023517858,0.000043623437,0.0005875013,0.000315477,0.00006719776,0.00004449963,0.00003478364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974595,0.00014638292,0.00056175,0.00039338865,0.0007243284,0.0007146906],"domain_scores_gemma":[0.99805236,0.00061289425,0.00015847139,0.00023478769,0.0007452161,0.0001962708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057041557,0.00016270972,0.00040835544,0.00052015163,0.00011362524,0.00005326107,0.00013175744,0.00015132526,0.00009627137],"category_scores_gemma":[0.0032471523,0.00016405608,0.00006860236,0.00033445962,0.00026815082,0.0005670487,0.0000370431,0.00068972417,0.0000016746894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005795442,0.00016980521,0.047160957,0.00032844106,0.000030307256,0.0000034370385,0.001605712,0.0015915653,0.90700865,0.0005159923,0.000088791516,0.040916823],"study_design_scores_gemma":[0.031094937,0.0012108403,0.15581648,0.002390527,0.00025626054,0.00038812615,0.011695872,0.07953716,0.7138151,0.00021287319,0.0026880787,0.0008937426],"about_ca_topic_score_codex":0.0005477905,"about_ca_topic_score_gemma":0.00013775428,"teacher_disagreement_score":0.19319353,"about_ca_system_score_codex":0.0004931595,"about_ca_system_score_gemma":0.0007222102,"threshold_uncertainty_score":0.6690013},"labels":[],"label_agreement":null},{"id":"W2317106443","doi":"10.1158/1538-7445.am2011-1505","title":"Abstract 1505: The role of cathepsin B in colorectal tumorigenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cathepsin B; Molecular biology; Cathepsin H; Cathepsin L1; Small hairpin RNA; Biology; Western blot; Alternative splicing; Cathepsin L; Cathepsin S; Cathepsin E; Exon; Cancer research; Cell culture; Cathepsin; Gene knockdown; Cathepsin O; Gene; Enzyme; Biochemistry; Genetics","score_opus":0.1236612823674716,"score_gpt":0.4000838748001707,"score_spread":0.2764225924326991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317106443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642778,0.006195914,1.7558109e-7,0.00020278843,0.000035328725,0.00037154512,0.0000049698397,0.0000069235484,0.028904554],"genre_scores_gemma":[0.9988587,0.0005195703,0.000018872724,0.00002188533,0.00006495396,0.00017599603,5.898825e-7,0.000009809596,0.00032963447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991104,0.00004207329,0.00014192631,0.00013004904,0.00033319413,0.00024235886],"domain_scores_gemma":[0.9995734,0.00007086248,0.000023065078,0.00015736072,0.0001296228,0.000045660312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571837,0.000054604196,0.00015168739,0.00009114639,0.00006258476,0.0000036356255,0.00011019172,0.000035416986,0.00041686365],"category_scores_gemma":[0.00006994677,0.00003382716,0.000039281644,0.00031085964,0.0002768993,0.000027369424,0.00008228941,0.00025625352,0.000046279696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018656616,0.00046436212,0.45080733,0.00018796201,0.00010599438,0.00011557494,0.010273452,6.6635516e-7,0.49528593,0.00078063144,0.0015389043,0.03857351],"study_design_scores_gemma":[0.00029181223,0.00013112155,0.55675286,0.00007350401,0.000005324446,0.0000036512597,0.0024706828,0.0000020768086,0.43849513,0.0007369564,0.0010033365,0.000033563803],"about_ca_topic_score_codex":0.013670151,"about_ca_topic_score_gemma":0.0012669318,"teacher_disagreement_score":0.10594549,"about_ca_system_score_codex":0.000082079394,"about_ca_system_score_gemma":0.00015504182,"threshold_uncertainty_score":0.9928979},"labels":[],"label_agreement":null},{"id":"W2317222179","doi":"10.1158/1538-7445.am2012-4844","title":"Abstract 4844: A novel mechanism of immune escape in cancer and its regulation by nitric oxide","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DU145; Hypoxia (environmental); Immune system; Cancer cell; Cancer research; Gene knockdown; Biology; Cell biology; MHC class I; Immunology; Chemistry; Cancer; Cell culture; Major histocompatibility complex","score_opus":0.04627545876435238,"score_gpt":0.35917220266630345,"score_spread":0.3128967439019511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317222179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91745734,0.081550054,0.000043398388,0.00010376957,0.00021905292,0.00027154648,0.000083701016,0.0000036596875,0.00026746935],"genre_scores_gemma":[0.9826138,0.015375626,0.000051165396,0.00003305077,0.0005701814,0.00017660382,0.000030755593,0.000024249895,0.0011245734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871457,0.000044471897,0.00023411468,0.00026017005,0.00028582956,0.00046084236],"domain_scores_gemma":[0.9993851,0.000020307994,0.000074404736,0.00021561427,0.0001832669,0.00012129051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007363559,0.000114596405,0.00018047733,0.00013885736,0.000055955552,0.000012495003,0.00014878469,0.00015750284,0.000097650845],"category_scores_gemma":[0.00007454735,0.000113047354,0.000043968,0.00028020036,0.00006903252,0.000015423371,0.00011461281,0.00019799122,0.0000028316995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115406445,0.000078167075,0.0005250696,0.00007314132,0.000024059931,9.8823115e-8,0.00007259287,0.000012122684,0.9925607,0.0003508822,0.0013667941,0.0048209783],"study_design_scores_gemma":[0.00093397393,0.000030184854,0.05193581,0.00005232966,0.000009448308,0.0000021337971,0.000072030474,0.000026675669,0.91209215,0.00006342441,0.034638394,0.00014345295],"about_ca_topic_score_codex":0.0019163444,"about_ca_topic_score_gemma":0.00020196736,"teacher_disagreement_score":0.08046854,"about_ca_system_score_codex":0.00006184278,"about_ca_system_score_gemma":0.00019915838,"threshold_uncertainty_score":0.46099374},"labels":[],"label_agreement":null},{"id":"W2317230602","doi":"10.1158/1538-7445.am2013-3804","title":"Abstract 3804: Rare DNA variants are enriched at the BARD1 locus and likely influence neuroblastoma susceptibility.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Genetics; Exome; Nonsense mutation; Genome-wide association study; Sanger sequencing; Locus (genetics); Exome sequencing; Single-nucleotide polymorphism; Gene; DNA sequencing; Mutation; Genotype; Missense mutation","score_opus":0.0436693732719615,"score_gpt":0.36048109567097014,"score_spread":0.3168117223990086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317230602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934597,0.00089663564,6.072785e-7,0.0066801347,0.000062438616,0.0017467914,0.000041151015,0.000059708724,0.0011665921],"genre_scores_gemma":[0.99334204,0.00061401475,0.0000106278885,0.0004991547,0.00013466371,0.0005528982,0.000008093907,0.000052643474,0.0047858898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99622744,0.00030463605,0.0002879929,0.00076612,0.0013167898,0.0010970038],"domain_scores_gemma":[0.9968606,0.00063705706,0.00006984227,0.0009462371,0.0007559225,0.0007303044],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00058671914,0.00025670032,0.0003294693,0.00021249443,0.0005260215,0.00018551781,0.00035305714,0.00011743521,0.0031331712],"category_scores_gemma":[0.0007759724,0.00016480713,0.00008440787,0.0006281365,0.0007906307,0.00028317276,0.00053426885,0.0009686219,0.0013612247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012894464,0.0004115829,0.08880213,0.0005055943,0.0002028929,0.0012076336,0.00043780237,0.00001683299,0.85991794,0.000022132699,0.032801308,0.014384733],"study_design_scores_gemma":[0.0018879137,0.00059641624,0.96882284,0.00014906994,0.000018612252,0.00010189373,0.00017100362,0.000029887484,0.025755974,0.00016241237,0.0021545992,0.00014940114],"about_ca_topic_score_codex":0.001988279,"about_ca_topic_score_gemma":0.0008403228,"teacher_disagreement_score":0.8800207,"about_ca_system_score_codex":0.00039198177,"about_ca_system_score_gemma":0.0003913422,"threshold_uncertainty_score":0.99941635},"labels":[],"label_agreement":null},{"id":"W2317259184","doi":"10.1158/0008-5472.sabcs10-p5-05-15","title":"Abstract P5-05-15: Transgenic Mice Expressing Either p200, p110 or p75 CUX1 Isoform Develop Mammary Tumors of Various Histological Types","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene isoform; Biology; Cancer research; Genetically modified mouse; Transgenesis; Transgene; Molecular biology; Gene; Genetics; Embryogenesis","score_opus":0.045219025093149505,"score_gpt":0.378887389972231,"score_spread":0.33366836487908147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317259184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908188,0.0013580308,0.003504284,0.00054848223,0.00009253255,0.00038922677,0.00004499411,0.000031673062,0.0032120026],"genre_scores_gemma":[0.991785,0.0005653895,0.0054613203,0.00016363006,0.00015744817,0.00025553233,0.000060791193,0.000029203404,0.0015216683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986016,0.000064821485,0.00026539326,0.0004475158,0.00019438312,0.000426285],"domain_scores_gemma":[0.99898034,0.00003546112,0.00007858613,0.00050239306,0.00029118024,0.00011201832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046280384,0.0001540326,0.00018841782,0.00007791508,0.00015612027,0.000021296115,0.0005774607,0.00036289886,0.00040033663],"category_scores_gemma":[0.00011075139,0.0001200809,0.00007857458,0.00023816625,0.00038256473,0.000005791651,0.00016529148,0.00051085453,0.000010579672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001315913,0.00007763433,0.00023782559,0.000036787416,0.000037954775,0.000007951062,0.000041351675,0.0000016979931,0.9848849,0.000449261,0.004948376,0.009144655],"study_design_scores_gemma":[0.00026646655,0.00018127031,0.0033654727,0.00003024183,0.000008889421,0.000032633066,0.000021259835,0.000009136868,0.85813963,0.0003605414,0.13739029,0.00019414801],"about_ca_topic_score_codex":0.00017223295,"about_ca_topic_score_gemma":0.00029101028,"teacher_disagreement_score":0.13244191,"about_ca_system_score_codex":0.00002814323,"about_ca_system_score_gemma":0.0005511547,"threshold_uncertainty_score":0.4896757},"labels":[],"label_agreement":null},{"id":"W2317266930","doi":"10.1158/1538-7445.am10-4553","title":"Abstract 4553: Novel bispecific 111In-labeled immunoconjugates (bsICs) for imaging HER2/HER3 heterodimerization in breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Chemistry; Avidity; Immunoglobulin Fab Fragments; Antibody; Molecular biology; Biochemistry; Stereochemistry; Peptide sequence; Medicine; Biology","score_opus":0.08696278918616107,"score_gpt":0.4584273060321324,"score_spread":0.3714645168459713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317266930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98514986,0.0007229917,0.000107636115,0.011678898,0.00018829777,0.0010223326,0.00023087604,0.000048677248,0.0008504142],"genre_scores_gemma":[0.99618596,0.00041903244,0.0002545274,0.00020601723,0.00065750984,0.001583569,0.000072475144,0.000044764,0.0005761385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983778,0.000015462443,0.00028993396,0.00042893903,0.00033205515,0.00055583386],"domain_scores_gemma":[0.99878883,0.00017698447,0.000049939885,0.00036306452,0.0004083624,0.00021281162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005141622,0.00014739623,0.00021728288,0.000119917015,0.00018749735,0.00006846296,0.00021661776,0.00007904445,0.0015581338],"category_scores_gemma":[0.000070888884,0.0001372503,0.00006204504,0.00053514715,0.00026898572,0.00012714924,0.000041876545,0.00094233657,0.000022601193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029628072,0.0002212904,0.009411229,0.00020050674,0.000025461179,0.0000050116687,0.000053776726,0.000031120788,0.97805125,0.00017592582,0.0011100421,0.010418089],"study_design_scores_gemma":[0.00419872,0.000024008696,0.07836278,0.0003036848,0.00003252162,0.000046949866,0.00013197903,0.002554248,0.86862725,0.00018338389,0.04523351,0.00030095753],"about_ca_topic_score_codex":0.00073901034,"about_ca_topic_score_gemma":0.0001295357,"teacher_disagreement_score":0.10942401,"about_ca_system_score_codex":0.00022312575,"about_ca_system_score_gemma":0.00034455257,"threshold_uncertainty_score":0.9993546},"labels":[],"label_agreement":null},{"id":"W2317269400","doi":"10.1158/1538-7445.am2011-4405","title":"Abstract 4405: The novel allosteric Akt inhibitor, MK-2206, synergizes with gefitinib against human glioma cells via promoting the switch from autophagy to apoptosis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Quinazolinone synthesis and applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Gefitinib; Protein kinase B; Apoptosis; Cancer research; Glioma; Epidermal growth factor receptor; Autophagy; Cancer cell; Tyrosine-kinase inhibitor; Biology; Pharmacology; Cancer; Medicine; Internal medicine; Biochemistry","score_opus":0.08596835986222348,"score_gpt":0.33473207182719555,"score_spread":0.24876371196497207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317269400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860202,0.00019931635,0.00003472273,0.0011951404,0.000051297244,0.0005198351,0.00013236697,0.000082441045,0.011764673],"genre_scores_gemma":[0.9967764,0.00004056863,0.00021607104,0.00012343288,0.00069332734,0.0014497008,0.000018005827,0.00008198262,0.00060052733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972485,0.000060500115,0.00039934268,0.0006677932,0.0008237733,0.000800148],"domain_scores_gemma":[0.9977877,0.00039470114,0.00015416155,0.0011394013,0.0002997933,0.00022422113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000705207,0.00027811216,0.0002592204,0.00008211184,0.0010221445,0.00021253238,0.0012460402,0.0001351628,0.0018267658],"category_scores_gemma":[0.000047934012,0.00016205582,0.00009976802,0.00055180554,0.00031832818,0.00010719057,0.00035997215,0.0007351163,0.00017812251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059060036,0.00021712638,0.00011253657,0.00005375745,0.00008570217,0.000005561701,0.0024214939,0.000011372287,0.98637146,0.00009641622,0.0009239765,0.009641554],"study_design_scores_gemma":[0.0003205805,0.000041285228,0.0017099918,0.00021970326,0.000020289754,0.000002009169,0.0010185734,0.00004390491,0.9908854,0.00011612052,0.005380564,0.00024162211],"about_ca_topic_score_codex":0.0044078943,"about_ca_topic_score_gemma":0.00043896097,"teacher_disagreement_score":0.011164146,"about_ca_system_score_codex":0.00018273415,"about_ca_system_score_gemma":0.00018436767,"threshold_uncertainty_score":0.9990857},"labels":[],"label_agreement":null},{"id":"W2317303901","doi":"10.1158/0008-5472.sabcs11-p4-19-05","title":"P4-19-05: A Population-Based Study of Guideline-Based BRCA Screening in Male Breast Carcinoma.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Referral; BRCA mutation; Genetic testing; Family history; Male breast cancer; Context (archaeology); Breast cancer; Gynecology; Genetic counseling; Guideline; Population; Cancer; Internal medicine; Oncology; Family medicine; Pathology; Genetics","score_opus":0.10927773336233614,"score_gpt":0.40474323145993285,"score_spread":0.2954654980975967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317303901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973639,0.00055749645,0.00084205065,0.00016184588,0.00008066907,0.00059039984,0.00007437659,0.000007621563,0.00032159637],"genre_scores_gemma":[0.9973639,0.000005506718,0.0017305076,0.00012236023,0.00013880126,0.00034216876,0.000100737045,0.000035504625,0.00016048545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804175,0.00026716103,0.00041108954,0.00046619875,0.00044075897,0.0003730697],"domain_scores_gemma":[0.99867326,0.000034736237,0.00008560033,0.00059230655,0.00051241333,0.000101675185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086638925,0.00013292376,0.00016970329,0.00029968447,0.000098074044,0.000013968504,0.00037418358,0.0001149154,0.000409158],"category_scores_gemma":[0.00011642844,0.00013857233,0.000055296663,0.00055324816,0.000087031636,0.0000052976147,0.0001084602,0.00020361983,0.0000033299075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052682124,0.00033406136,0.94718707,0.00004559646,0.000027227816,0.000014660099,0.00034153461,0.0066810586,0.040517002,0.000008875445,0.0019900808,0.0023260303],"study_design_scores_gemma":[0.0038800798,0.0007029689,0.90306187,0.000064191474,0.000019457779,0.000006172578,0.0013110081,0.0019437578,0.08734134,0.000028325781,0.0013352409,0.00030556472],"about_ca_topic_score_codex":0.020764405,"about_ca_topic_score_gemma":0.008047883,"teacher_disagreement_score":0.04682434,"about_ca_system_score_codex":0.0001935617,"about_ca_system_score_gemma":0.0011413244,"threshold_uncertainty_score":0.9857564},"labels":[],"label_agreement":null},{"id":"W2317334390","doi":"10.1158/0008-5472.sabcs10-p5-15-05","title":"Abstract P5-15-05: Applicability of Breast Cancer Guidelines and Knowledge Translation in a Community Oncology Setting","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Guideline; Breast cancer; Cancer; Stage (stratigraphy); Cohort; Internal medicine; Disease; Oncology; Pathology","score_opus":0.2538775380861942,"score_gpt":0.45125239392823474,"score_spread":0.19737485584204056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317334390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776332,0.004725129,0.00003282156,0.0033652484,0.0002879363,0.00039578712,0.00056198216,0.000012962103,0.012984949],"genre_scores_gemma":[0.99729913,0.0017812139,0.00024287548,0.00008690446,0.00027792525,0.0001953449,0.0000061134406,0.000022593258,0.00008791932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99826396,0.00007168914,0.0008309052,0.0003399884,0.00004980234,0.00044364922],"domain_scores_gemma":[0.9984849,0.0004858213,0.00023620816,0.00038144484,0.00028042385,0.00013120048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045767385,0.00013627335,0.00048864377,0.0003110041,0.0001725726,0.000036446585,0.0003258608,0.00024335705,0.0006497848],"category_scores_gemma":[0.00037630883,0.00015376453,0.00006145408,0.0003521758,0.00044293771,0.00027667673,0.000106820546,0.001262634,0.000024216744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003756158,0.00050666835,0.34673974,0.0006437375,0.000058050697,0.0000022874078,0.0070650023,0.0001177977,0.01590702,0.013798126,0.0032825817,0.61150336],"study_design_scores_gemma":[0.0016919087,0.00010048436,0.89723426,0.00013074886,0.0000046029904,0.0000051516618,0.0007238258,0.0008883468,0.0011064669,0.020255825,0.07752294,0.00033544813],"about_ca_topic_score_codex":0.027785074,"about_ca_topic_score_gemma":0.041697368,"teacher_disagreement_score":0.6111679,"about_ca_system_score_codex":0.00032440817,"about_ca_system_score_gemma":0.00041758694,"threshold_uncertainty_score":0.978689},"labels":[],"label_agreement":null},{"id":"W2317406779","doi":"10.1158/0008-5472.fbcr09-b33","title":"Abstract B33: Dissecting the role of Nrf3 (NF-E2-related factor 3) in chemical carcinogenesis using knock-out mice","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Benzo(a)pyrene; Carcinogenesis; Carcinogen; Pathology; Cancer research; Lung cancer; Transcription factor; In vivo; Neutrophilia; Medicine; Chemistry; Cancer; Biology; Internal medicine; Biochemistry; Genetics","score_opus":0.051435348979201,"score_gpt":0.3764457132956183,"score_spread":0.32501036431641733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317406779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939288,0.0046381177,0.000008263488,0.00012668523,0.00006867879,0.0002554938,0.000046958543,0.0000049572554,0.0009220447],"genre_scores_gemma":[0.99929047,0.00023613388,0.000056792727,0.000027498136,0.00025231874,0.00001870299,0.00002582284,0.00002149438,0.000070746966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842477,0.00009896442,0.00030748604,0.00041345332,0.00026354738,0.0004917778],"domain_scores_gemma":[0.9991056,0.00006250903,0.000088584355,0.000365297,0.00028440944,0.000093651026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034435964,0.00015404951,0.00020085003,0.00007364689,0.00009488766,0.000023599448,0.0004410686,0.00018494493,0.00005296958],"category_scores_gemma":[0.00025780575,0.00012777647,0.00009553998,0.00021032598,0.00019890681,0.000005961001,0.0001415289,0.00037613872,0.0000030502113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107374646,0.00005754578,0.011585898,0.000020123687,0.000029460738,0.0000015699594,0.0003800873,0.00007529023,0.9825313,0.00000998295,0.00005055847,0.0051508294],"study_design_scores_gemma":[0.0003047791,0.000043195905,0.019432595,0.000050218816,0.0000060257144,0.0000016927872,0.000567368,0.000058336616,0.9786985,0.0002684475,0.00042931482,0.00013956129],"about_ca_topic_score_codex":0.00063545647,"about_ca_topic_score_gemma":0.00014668533,"teacher_disagreement_score":0.007846697,"about_ca_system_score_codex":0.00010181452,"about_ca_system_score_gemma":0.0002015961,"threshold_uncertainty_score":0.5210573},"labels":[],"label_agreement":null},{"id":"W2317425283","doi":"10.1158/1538-7445.am2013-4795","title":"Abstract 4795: N-hydroxylation of 4-aminobiphenyl (ABP) and associated oxidative stress may influence ABP carcinogenicity in the mouse liver.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oxidative stress; Carcinogenesis; Carcinogen; Liver cancer; Internal medicine; Cancer; Endocrinology; DNA damage; Liver cell; Biology; Cancer research; Medicine; Biochemistry; DNA","score_opus":0.046899822565606694,"score_gpt":0.3631914682301755,"score_spread":0.3162916456645688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317425283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975937,0.0013403748,0.0000019375987,0.00033160206,0.000016357277,0.00046267736,0.00006911403,0.0000030938527,0.00018112527],"genre_scores_gemma":[0.997899,0.0014796675,0.000011368325,0.0002001255,0.000046065354,0.00013854369,0.00005480357,0.00001018334,0.00016023898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987277,0.0002824969,0.0001864036,0.0002644693,0.00024733102,0.00029159113],"domain_scores_gemma":[0.99916875,0.00009400815,0.0000709813,0.0002064656,0.00040039053,0.000059398575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059169467,0.000095586634,0.00013833566,0.000070121474,0.00009274942,0.000025111936,0.00024814624,0.00014139332,0.00011875727],"category_scores_gemma":[0.00016270793,0.00007157016,0.000030598232,0.00017012235,0.0002666675,0.00001341169,0.00013679356,0.00028715713,0.0000058301384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005983189,0.00008652757,0.03557614,0.000030395704,0.000029544344,0.000004170256,0.00029276707,0.0000857376,0.9610185,0.000022756783,0.002011184,0.000782461],"study_design_scores_gemma":[0.0004951446,0.00013987241,0.46074072,0.000016413427,0.000006462933,0.0000013729906,0.00027390066,0.00010837418,0.5377083,0.000047086945,0.00037989588,0.00008248289],"about_ca_topic_score_codex":0.003415252,"about_ca_topic_score_gemma":0.0009138232,"teacher_disagreement_score":0.42516455,"about_ca_system_score_codex":0.000035171644,"about_ca_system_score_gemma":0.00010836303,"threshold_uncertainty_score":0.5162862},"labels":[],"label_agreement":null},{"id":"W2317491385","doi":"10.1158/1538-7445.am10-2374","title":"Abstract 2374: Integrin-linked kinase (ILK) promotes melanoma angiogenesis by activating IL-6 signaling pathway","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Integrin-linked kinase; Cancer research; Angiogenesis; Small hairpin RNA; Gene knockdown; Biology; Kinase; Signal transduction; Downregulation and upregulation; Cell biology; Chemistry; Molecular biology; Protein kinase A; Cell culture; Cyclin-dependent kinase 2","score_opus":0.04495735664613726,"score_gpt":0.351530291816323,"score_spread":0.30657293517018575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317491385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994244,0.0034907502,0.0000964521,0.00034604638,0.00029227222,0.0003536904,0.00016718687,0.000027460937,0.0009821868],"genre_scores_gemma":[0.99653345,0.0003482339,0.00033864248,0.00010493931,0.0011776547,0.0003210938,0.00012600678,0.000076592565,0.0009733819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977001,0.0001008362,0.000292269,0.0006938143,0.0004719089,0.0007410913],"domain_scores_gemma":[0.9985886,0.000085941225,0.00009938119,0.0005520322,0.00043590768,0.00023813861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009581375,0.00024838708,0.0002166623,0.00010933723,0.00034059453,0.000103425664,0.00052083377,0.00034382113,0.00060574966],"category_scores_gemma":[0.00025493614,0.00022093944,0.00018799689,0.00029431237,0.00023224439,0.000013068207,0.00023181282,0.00052087125,0.000033757497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010007608,0.000074703596,0.0027294059,0.000047972135,0.00007988103,0.000008114011,0.00007189791,0.000008986338,0.9551027,0.000036507394,0.0055783945,0.03616137],"study_design_scores_gemma":[0.00031158866,0.00013482796,0.0013923132,0.000047142516,0.0000061350547,0.000003824132,0.0001397757,0.000013933071,0.90513474,0.000038630384,0.09251139,0.0002657075],"about_ca_topic_score_codex":0.00058098324,"about_ca_topic_score_gemma":0.00025373095,"teacher_disagreement_score":0.086933,"about_ca_system_score_codex":0.00006731777,"about_ca_system_score_gemma":0.00043863646,"threshold_uncertainty_score":0.9009649},"labels":[],"label_agreement":null},{"id":"W2317503011","doi":"10.1158/1538-7445.am10-4355","title":"Abstract 4355: The C19MC miRNA polycistron are frequent targets of gene amplification in aggressive primitive neuroectodermal brain tumors and encode oncogenic miRNAs that inhibit normal neural stem cell differentiation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; microRNA; Cancer research; Gene; Primitive neuroectodermal tumor; Stem cell; Neural stem cell; Pathology; Genetics; Immunohistochemistry; Immunology; Medicine","score_opus":0.028655891162400113,"score_gpt":0.31186154896019946,"score_spread":0.2832056577977993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317503011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677366,0.0018628504,0.000062676125,0.0004618691,0.000089247755,0.00058369304,0.00012158954,0.0000053293766,0.00003908484],"genre_scores_gemma":[0.9992675,0.00016096774,0.000027769593,0.000039892624,0.00014200048,0.00012289533,0.00015230445,0.000025574742,0.00006106996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837524,0.00021127178,0.00026506136,0.0004203527,0.00037020046,0.00035786527],"domain_scores_gemma":[0.99893546,0.000065963206,0.00032148036,0.00036357544,0.00020969394,0.0001038353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035390086,0.00015574759,0.00014395891,0.00011085368,0.00012492626,0.000044878296,0.00024828254,0.00013094432,0.000028437089],"category_scores_gemma":[0.000068794194,0.00013127143,0.000064110514,0.00013274889,0.00025013508,0.000018886363,0.00012456175,0.00041005705,0.0000017775964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020224927,0.00007045598,0.022404527,0.00006653256,0.000013063701,0.0000074589384,0.00019901032,0.00013812885,0.9753244,0.0000086391565,0.0001252704,0.0014402779],"study_design_scores_gemma":[0.0003441377,0.000040070827,0.40912193,0.000024699491,0.0000051124293,0.0000052671935,0.00010138742,0.0001383383,0.5900872,0.000008754338,0.000048617112,0.000074494295],"about_ca_topic_score_codex":0.00023411348,"about_ca_topic_score_gemma":0.0006069465,"teacher_disagreement_score":0.3867174,"about_ca_system_score_codex":0.000070260045,"about_ca_system_score_gemma":0.0001958052,"threshold_uncertainty_score":0.5353093},"labels":[],"label_agreement":null},{"id":"W2317544705","doi":"10.1158/1538-7445.am2011-4688","title":"Abstract 4688: Met receptor tyrosine kinase cross-talk in tumorigenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Receptor tyrosine kinase; Hepatocyte Growth Factor Receptor; Cancer research; Signal transduction; Phosphorylation; Biology; Tyrosine phosphorylation; Carcinogenesis; Cell biology; Gefitinib; Tyrosine kinase; Hepatocyte growth factor; Growth factor receptor; Receptor; Cell surface receptor; Receptor Protein-Tyrosine Kinases; Epidermal growth factor receptor; Cancer; C-Met; Biochemistry; Genetics","score_opus":0.19401767819495228,"score_gpt":0.4509157697842561,"score_spread":0.2568980915893039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317544705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990933,0.0013369774,0.0000011316978,0.00021367497,0.00027876406,0.00030507063,0.000028349585,0.000027460206,0.006875551],"genre_scores_gemma":[0.99636006,0.00045470946,0.00016842948,0.00016885014,0.00032123228,0.00017744132,0.000022152597,0.000022756696,0.0023043682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849075,0.0001462964,0.00020845002,0.0003674041,0.00024411567,0.00054298586],"domain_scores_gemma":[0.99908996,0.000114697534,0.00003184929,0.00036692747,0.00023239458,0.0001641466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008790042,0.0001112524,0.0002626707,0.0002427551,0.00009788147,0.000008347431,0.00019081688,0.00016536945,0.00827262],"category_scores_gemma":[0.00015603473,0.00009294714,0.000055416054,0.0004229271,0.0004737074,0.00008487752,0.00008581585,0.00062594673,0.0005606585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022539673,0.00039988424,0.25155586,0.00020409207,0.000045892364,0.0007980999,0.0012995809,0.0000019060595,0.73514557,0.0004970518,0.003216554,0.004581554],"study_design_scores_gemma":[0.0009912327,0.0003403707,0.75778484,0.00008326789,0.0000071793743,0.000011074704,0.000096667514,0.0000011864578,0.2369992,0.00047769738,0.0031141967,0.00009307199],"about_ca_topic_score_codex":0.0022683127,"about_ca_topic_score_gemma":0.00016824031,"teacher_disagreement_score":0.506229,"about_ca_system_score_codex":0.00015357934,"about_ca_system_score_gemma":0.00031361432,"threshold_uncertainty_score":0.99263394},"labels":[],"label_agreement":null},{"id":"W2317566112","doi":"10.1158/1538-7445.am2011-2642","title":"Abstract 2642: Small molecule inhibitor borrelidin induces apoptosis in acute lymphoblastic leukemia cell lines in association with GCN2 kinase pathway activation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Propidium iodide; Jurkat cells; Apoptosis; Chemistry; Asparaginase; Kinase; Programmed cell death; Flow cytometry; Cell growth; Cancer research; Leukemia; Molecular biology; Cell biology; Biochemistry; Biology; Lymphoblastic Leukemia; T cell; Immunology","score_opus":0.04511339892192966,"score_gpt":0.3036514443490458,"score_spread":0.2585380454271161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317566112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980574,0.0002876305,0.000056069643,0.00011885376,0.00007216479,0.000349888,0.000024372037,0.000008034945,0.001025564],"genre_scores_gemma":[0.99782175,0.0006431068,0.00010642174,0.000048978418,0.00014561042,0.00058113976,0.000059152175,0.00002957724,0.00056426233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985167,0.00010768895,0.00023918704,0.00042571645,0.0002938826,0.00041687046],"domain_scores_gemma":[0.9992225,0.000032955286,0.00011081269,0.00027084598,0.00028348336,0.000079415186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005047009,0.00014259474,0.000137819,0.000215203,0.00007735935,0.000041881394,0.00021425635,0.00023117867,0.000042062835],"category_scores_gemma":[0.00009007136,0.00013083192,0.000034162178,0.0005058806,0.000051289953,0.000018381628,0.00006544111,0.00029358867,0.000010104144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003109631,0.00013477873,0.010705046,0.000032539414,0.000020707059,0.000004004935,0.00027358212,0.00014737499,0.98632705,0.000010753413,0.00044648495,0.0015867396],"study_design_scores_gemma":[0.0008500493,0.00017030626,0.041567508,0.00008671872,0.000005004289,2.9011875e-7,0.00022511602,0.000030253737,0.9563562,0.000017186525,0.0005304771,0.00016085198],"about_ca_topic_score_codex":0.002389035,"about_ca_topic_score_gemma":0.0012207947,"teacher_disagreement_score":0.030862462,"about_ca_system_score_codex":0.00081498164,"about_ca_system_score_gemma":0.00087763334,"threshold_uncertainty_score":0.53351706},"labels":[],"label_agreement":null},{"id":"W2317668246","doi":"10.1158/1538-7445.am2012-1508","title":"Abstract 1508: TNF-receptor 2 plays a critical role in liver metastasis by regulating sinusoidal endothelial VCAM-1 expression, LY6G+ leukocyte recruitment and transendothelial migration","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Chemokine; VCAM-1; Tumor necrosis factor alpha; CXCL1; Cytokine; Downregulation and upregulation; Cancer research; Tumor microenvironment; CCL2; Receptor; CXC chemokine receptors; Chemokine receptor; Biology; Immunology; Medicine; Pathology; Inflammation; ICAM-1; Cancer; Immune system; Cell adhesion molecule; Internal medicine","score_opus":0.10481815895777397,"score_gpt":0.3995173601921563,"score_spread":0.2946992012343823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317668246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068284,0.006030197,0.00006412417,0.0016436551,0.00013425438,0.00083754584,0.00018629056,0.00003313558,0.0003879468],"genre_scores_gemma":[0.9967373,0.0008839804,0.0006037479,0.00009603983,0.0009661205,0.00039710358,0.000053382122,0.000042897074,0.0002194531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971475,0.00023032176,0.00043258272,0.00044173832,0.00086931087,0.0008785261],"domain_scores_gemma":[0.9985866,0.00051686866,0.00005088599,0.00021837342,0.00017903751,0.00044825245],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001388044,0.00022799938,0.00039754598,0.00023399765,0.00020494832,0.00006848861,0.00010407241,0.000178584,0.0017494552],"category_scores_gemma":[0.00033976577,0.00019375593,0.00009936743,0.00026733338,0.00020909766,0.00028392795,0.000059743466,0.0006927469,0.00002948941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082826486,0.00026419613,0.0051620374,0.00020655074,0.000033079017,0.000008226984,0.0026971803,0.000005715217,0.9605893,0.000028214045,0.006301778,0.023875458],"study_design_scores_gemma":[0.00216519,0.0001543929,0.0025590204,0.00054698664,0.000032674885,0.000022173424,0.0009083846,0.00018353088,0.9717557,0.00002458969,0.021430524,0.00021683812],"about_ca_topic_score_codex":0.0013123865,"about_ca_topic_score_gemma":0.00017810406,"teacher_disagreement_score":0.02365862,"about_ca_system_score_codex":0.00043687498,"about_ca_system_score_gemma":0.00017568142,"threshold_uncertainty_score":0.9991631},"labels":[],"label_agreement":null},{"id":"W2317684280","doi":"10.1158/1538-7445.am2012-5232","title":"Abstract 5232: Tyrosine kinase inhibitor, gefitinib targets ZAP-70 over expressing chronic lymphocytic leukemia cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Gefitinib; Tyrosine kinase; Cancer research; LYN; Syk; Cytotoxic T cell; Medicine; Chronic lymphocytic leukemia; Tyrosine-kinase inhibitor; Kinase; Epidermal growth factor receptor; Cancer; Internal medicine; Chemistry; Leukemia; Biology; Receptor; Cell biology; Biochemistry; In vitro","score_opus":0.06487174804501919,"score_gpt":0.3910950851984509,"score_spread":0.32622333715343166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317684280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504995,0.037039135,0.00002337634,0.00028597043,0.0010273671,0.0013827417,0.00005693145,0.00021066911,0.009474327],"genre_scores_gemma":[0.9826953,0.0033418234,0.000121853314,0.0003276894,0.005802845,0.0004726012,0.00006074769,0.00022806227,0.0069491016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9899003,0.0002982611,0.00080880703,0.0010217932,0.0043502054,0.0036206231],"domain_scores_gemma":[0.99478626,0.0008034372,0.00015252568,0.0015333954,0.00073865603,0.0019856975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003297106,0.0005459342,0.00078528386,0.0006985222,0.00055824243,0.00021778473,0.0007685321,0.0005963944,0.011095322],"category_scores_gemma":[0.00080870977,0.00048696063,0.00028313434,0.0012890686,0.0008967911,0.00069715676,0.00080193975,0.0019535602,0.0018488603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014200376,0.00030567124,0.0009357761,0.0027845872,0.00023638114,0.0012648565,0.001049127,0.00041952828,0.86642563,0.00020572018,0.101361,0.023591679],"study_design_scores_gemma":[0.025056787,0.00036568186,0.0032993588,0.0027380406,0.000068025874,0.00027191834,0.00021597685,0.0054685394,0.86331165,0.000049369395,0.09840183,0.00075281155],"about_ca_topic_score_codex":0.0082562715,"about_ca_topic_score_gemma":0.00016731709,"teacher_disagreement_score":0.1317512,"about_ca_system_score_codex":0.21994789,"about_ca_system_score_gemma":0.0881967,"threshold_uncertainty_score":0.9997582},"labels":[],"label_agreement":null},{"id":"W2317767830","doi":"10.1158/0008-5472.sabcs-77","title":"BCIRG 005 main efficacy analysis: a phase III randomized trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (AC→T) in women with Her-2/neu negative axillary lymph node positive early breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; William Osler Health System","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Anthracycline; Febrile neutropenia; Breast cancer; Neutropenia; Cyclophosphamide; Regimen; Mucositis; Clinical endpoint; Metastatic breast cancer; Chemotherapy; Gastroenterology; Doxorubicin; Cancer; Oncology; Surgery; Randomized controlled trial","score_opus":0.02207255447226454,"score_gpt":0.36669337262837537,"score_spread":0.34462081815611084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317767830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483133,0.0065525784,0.000025436333,0.0027328143,0.00011686135,0.0050255046,0.0001566245,0.00005277513,0.0005060655],"genre_scores_gemma":[0.9924546,0.004728531,0.000070301525,0.00036031078,0.00012805329,0.0017585957,0.00009508703,0.000058919308,0.0003456333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947554,0.0008696524,0.0008431103,0.0011919423,0.0010038336,0.0013360461],"domain_scores_gemma":[0.9972172,0.0012259234,0.0003160422,0.00037412767,0.00029398466,0.0005727443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017244436,0.00062194664,0.0023938245,0.001102807,0.00027433687,0.00014423906,0.00022617615,0.00021931717,0.00014743525],"category_scores_gemma":[0.00009162109,0.00048895774,0.00013294516,0.0031474158,0.0008136116,0.00039930988,0.00009702091,0.0009286814,0.0000018810075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9477932,0.0020973096,0.028423654,0.00007467206,0.0024107762,0.0006006403,0.005596985,0.00038874394,0.006526337,0.000038755028,0.00019984409,0.0058490695],"study_design_scores_gemma":[0.8515703,0.003497784,0.13725959,0.0006032494,0.0011351231,0.000030751027,0.0009652709,0.0008638806,0.0034986474,0.00006353911,0.000028195484,0.00048363715],"about_ca_topic_score_codex":0.027839495,"about_ca_topic_score_gemma":0.0046625324,"teacher_disagreement_score":0.108835936,"about_ca_system_score_codex":0.0028031932,"about_ca_system_score_gemma":0.0009070759,"threshold_uncertainty_score":0.9997562},"labels":[],"label_agreement":null},{"id":"W2317774139","doi":"10.1158/1538-7445.am2012-3952","title":"Abstract 3952: New advances in regulation of senescence by PML and the PML nuclear bodies","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Promyelocytic leukemia protein; Senescence; Cancer research; Biology; DNA damage; Cell biology; Cyclin-dependent kinase; Kinase; Nuclear protein; Cancer; Cell cycle; Gene; DNA; Transcription factor; Genetics","score_opus":0.021297578656705972,"score_gpt":0.3445803529797177,"score_spread":0.3232827743230117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317774139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279233,0.068693906,0.000048416932,0.00034932484,0.000046626836,0.00013935177,0.000005506659,0.0000023671048,0.0027911796],"genre_scores_gemma":[0.9807522,0.01797018,0.00004975991,0.000029258801,0.00017384195,0.000015745356,0.000008806166,0.0000099882345,0.0009902079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991469,0.00009282838,0.00014868556,0.00016076257,0.00021545375,0.00023541157],"domain_scores_gemma":[0.9995748,0.00004618758,0.000051281808,0.0001900995,0.00008352547,0.000054140855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077237096,0.000066775865,0.00010162625,0.000027485055,0.000066103516,0.00001725769,0.00016326188,0.00007449572,0.000059041453],"category_scores_gemma":[0.00015909469,0.00004612344,0.000023428081,0.000086441025,0.00037385183,0.00001573448,0.000086242435,0.000135244,0.0000036454123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002443508,0.000017945666,0.009745214,0.00010034052,0.000008350668,1.9252666e-7,0.00037650432,0.000012356388,0.96830964,0.00033519295,0.0059784786,0.014871418],"study_design_scores_gemma":[0.0009250743,0.00006752563,0.012908381,0.00007636472,0.0000046137247,0.0000029619093,0.00049730047,0.000020003856,0.82349604,0.0005601657,0.16132079,0.00012077675],"about_ca_topic_score_codex":0.00020336817,"about_ca_topic_score_gemma":0.000037921225,"teacher_disagreement_score":0.15534233,"about_ca_system_score_codex":0.00002006738,"about_ca_system_score_gemma":0.0000914068,"threshold_uncertainty_score":0.18808594},"labels":[],"label_agreement":null},{"id":"W2317785746","doi":"10.1158/1538-7445.am2011-1973","title":"Abstract 1973: Caveolin-1 promotes cell proliferation, EGFR activation and tumor growth in kidney cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Epidermal growth factor receptor; Caveolin 1; Cell growth; Carcinogenesis; Biology; Clear cell renal cell carcinoma; Gene knockdown; Tumor progression; Signal transduction; Epidermal growth factor; Cancer; Cell biology; Receptor; Medicine; Cell culture; Internal medicine; Renal cell carcinoma","score_opus":0.04473558560640465,"score_gpt":0.32911953435688013,"score_spread":0.28438394875047546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317785746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465126,0.0017868964,0.000045054076,0.0002789751,0.000060888317,0.00041652014,0.000028477783,0.000009165718,0.002722794],"genre_scores_gemma":[0.9967116,0.0012297619,0.000053775926,0.00020330666,0.00030415368,0.0003885238,0.000048640188,0.000026747955,0.0010335079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872833,0.00005605335,0.00018584622,0.00041933826,0.00023802267,0.0003724183],"domain_scores_gemma":[0.99921983,0.000012389441,0.00005285325,0.00017770898,0.00037576418,0.00016145282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004115716,0.00013187129,0.000118751384,0.00012166835,0.000113556845,0.000042329924,0.00016819403,0.00011403436,0.00023170588],"category_scores_gemma":[0.00016162425,0.0001230319,0.000025999572,0.00023028294,0.0001339533,0.000016829626,0.00009759518,0.00025309506,0.0000069376188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021535346,0.000120500525,0.030170118,0.0003990596,0.000015415913,0.000007327397,0.00056760316,0.000002432769,0.96523577,0.000049229533,0.0020397196,0.0011774442],"study_design_scores_gemma":[0.00052339386,0.000099971236,0.010476099,0.0000899409,0.0000038811145,0.0000025284905,0.000112810674,0.000012734289,0.9856299,0.00030488806,0.0025894882,0.00015435966],"about_ca_topic_score_codex":0.002861039,"about_ca_topic_score_gemma":0.0008418441,"teacher_disagreement_score":0.02039411,"about_ca_system_score_codex":0.00005854843,"about_ca_system_score_gemma":0.0007260349,"threshold_uncertainty_score":0.5017095},"labels":[],"label_agreement":null},{"id":"W2317815042","doi":"10.1158/1538-7445.am2012-4335","title":"Abstract 4335: The genomic landscape of childhood pre-B acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; Université de Montréal","funders":"","keywords":"Exome sequencing; Pediatric cancer; Deep sequencing; Cancer; DNA sequencing; Exome; Genotyping; Biology; Leukemia; Genetics; Genome; Copy-number variation; Computational biology; Mutation; Genotype; Gene","score_opus":0.033009623766281596,"score_gpt":0.35742267118321513,"score_spread":0.32441304741693355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317815042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838747,0.004009439,0.000044650442,0.0010379598,0.00024535414,0.0010917954,0.00007289565,0.00004994115,0.009573267],"genre_scores_gemma":[0.9946656,0.0010781925,0.000097119744,0.00017527817,0.0012587663,0.00029491607,0.000024153313,0.000085337466,0.0023206393],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956133,0.00018414308,0.000467428,0.0004073479,0.001796187,0.0015315893],"domain_scores_gemma":[0.99680954,0.0009730315,0.00011094986,0.0010130351,0.00052367535,0.0005697508],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020040139,0.0002477312,0.0004584118,0.0003528601,0.00027590973,0.00004550786,0.0007227575,0.00020912051,0.001971837],"category_scores_gemma":[0.0005026157,0.00015870699,0.00017073742,0.0009437317,0.00068013126,0.00018905908,0.00045281198,0.0010209075,0.00047837142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005952751,0.0015653053,0.115601145,0.0016799436,0.0032478382,0.0002477751,0.012657231,0.00037939078,0.650704,0.0019284973,0.16314515,0.042890944],"study_design_scores_gemma":[0.0054187756,0.0004441335,0.9350275,0.0004113255,0.0002231376,0.0002758259,0.00066287175,0.0004662039,0.044577193,0.0001590633,0.012030803,0.0003031718],"about_ca_topic_score_codex":0.0007572966,"about_ca_topic_score_gemma":0.00002338329,"teacher_disagreement_score":0.81942636,"about_ca_system_score_codex":0.002517706,"about_ca_system_score_gemma":0.0048066336,"threshold_uncertainty_score":0.99894047},"labels":[],"label_agreement":null},{"id":"W2317892040","doi":"10.1158/1538-7445.am10-2658","title":"Abstract 2658: Anti-GD3 antibodies are targeting molecules for delivery of RNAi to melanoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Monoclonal antibody; Antibody; Melanoma; In vivo; Liposome; In vitro; Flow cytometry; Chemistry; Small interfering RNA; Cancer research; Cell; Molecular biology; Transfection; Biochemistry; Medicine; Biology; Immunology","score_opus":0.04371020346881559,"score_gpt":0.37744918362872065,"score_spread":0.33373898015990505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317892040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724704,0.001221085,0.00015772355,0.0003018697,0.00022788774,0.00029365547,0.0001423239,0.0000061720634,0.00040222105],"genre_scores_gemma":[0.9977907,0.0005950204,0.00058329245,0.000097400196,0.00040744842,0.000093314055,0.000045414563,0.000023589557,0.00036381307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987898,0.000028923292,0.0002017425,0.0003567692,0.00021733371,0.0004054391],"domain_scores_gemma":[0.99884385,0.00003899295,0.00006298189,0.0003060058,0.000641371,0.000106770975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004340507,0.00011836949,0.00017042633,0.00011092434,0.000120354576,0.00003261159,0.00037069485,0.00013805112,0.00007390739],"category_scores_gemma":[0.0002249759,0.00010917742,0.00009685654,0.000110719746,0.00013125964,0.0000061905375,0.00016976362,0.00020502518,0.00001664039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014309959,0.000033520148,0.0065398067,0.00007970881,0.00004536799,0.0000034365237,0.000058316953,0.000041485837,0.9743941,0.00002428868,0.015304971,0.0033319273],"study_design_scores_gemma":[0.00020616589,0.00020617804,0.013357423,0.000054348715,0.000004850802,0.000001241853,0.00025778858,0.000013928444,0.9678004,0.000043245043,0.017920833,0.00013360442],"about_ca_topic_score_codex":0.0002679744,"about_ca_topic_score_gemma":0.00034811435,"teacher_disagreement_score":0.0068176165,"about_ca_system_score_codex":0.000011703546,"about_ca_system_score_gemma":0.00014441466,"threshold_uncertainty_score":0.4452126},"labels":[],"label_agreement":null},{"id":"W2317894924","doi":"10.1158/1538-7445.am10-1679","title":"Abstract 1679: Identification of pharmacogenomic markers associated with paclitaxel and carboplatin response in cancer: The cross-talk between agents","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Carboplatin; Pharmacogenomics; Single-nucleotide polymorphism; SNP genotyping; Paclitaxel; Biology; Computational biology; Cancer research; Gene; Bioinformatics; Cancer; Genetics; Genotype; Cisplatin; Chemotherapy","score_opus":0.07394549340349145,"score_gpt":0.4373206914529119,"score_spread":0.3633751980494205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317894924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619085,0.0010667648,0.0000022170548,0.0010995272,0.00014502135,0.0010234665,0.0002500705,0.000018554874,0.00020354484],"genre_scores_gemma":[0.9987326,0.00038137104,0.0000068166173,0.000034760273,0.000098765326,0.00026552912,0.000027573813,0.00004611535,0.0004064695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977143,0.00027947154,0.00041740632,0.00039255596,0.00074096175,0.00045529983],"domain_scores_gemma":[0.99829394,0.00053096743,0.00018617367,0.00042983697,0.0003919608,0.00016715325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036636258,0.00014584455,0.00027164223,0.00028473343,0.00014244001,0.000050844847,0.0002180936,0.0001632824,0.00025184077],"category_scores_gemma":[0.00072522095,0.00011269897,0.000048624905,0.0007155459,0.00062017934,0.00008213522,0.00007464553,0.0012494555,0.000004918945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034885656,0.000055829805,0.14467265,0.0000781043,0.0001727971,0.000043983073,0.0006137085,0.00006060324,0.84556985,0.0000028646457,0.0003210441,0.0049200053],"study_design_scores_gemma":[0.0025073723,0.00014072898,0.8577813,0.0002288297,0.000052469313,0.000004546464,0.00012430025,0.00012302154,0.1384178,0.000017978731,0.0005000891,0.000101596124],"about_ca_topic_score_codex":0.004183543,"about_ca_topic_score_gemma":0.0018549485,"teacher_disagreement_score":0.7131086,"about_ca_system_score_codex":0.00057622336,"about_ca_system_score_gemma":0.0010389744,"threshold_uncertainty_score":0.6324293},"labels":[],"label_agreement":null},{"id":"W2317915251","doi":"10.1158/1538-7445.am2012-1278","title":"Abstract 1278: Determining the proteomic changes that define progressor and non-progressor clear cell renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Medicine; Kidney cancer; Cancer; Renal cell carcinoma; Clear cell; Asymptomatic; Cancer research; Oncology; Pathology; Internal medicine","score_opus":0.11574277233982827,"score_gpt":0.37027574418444736,"score_spread":0.2545329718446191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317915251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145807,0.01030903,9.575014e-7,0.0016966892,0.00012709825,0.0028374144,0.000021490365,0.000040303283,0.0035089345],"genre_scores_gemma":[0.995185,0.00042298916,0.00031558602,0.00009929035,0.0008214994,0.0015955729,0.00002015118,0.00009634513,0.0014435432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966161,0.0001667571,0.00024802136,0.0005399609,0.0010742242,0.0013548883],"domain_scores_gemma":[0.99817187,0.00020862506,0.00013116049,0.0006779671,0.00026691667,0.0005434587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012755834,0.00032695438,0.00039377928,0.00022836294,0.00041230992,0.00011727723,0.0002917666,0.00016419642,0.00024571695],"category_scores_gemma":[0.00004836159,0.00020595401,0.00009771627,0.0003039371,0.00046007574,0.00015564857,0.00029530848,0.00088706106,0.00012023479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015774431,0.0006638414,0.7070374,0.0014879853,0.00007764958,0.00021975805,0.0028762904,9.280582e-7,0.25765553,0.0000060234584,0.0035370581,0.024860078],"study_design_scores_gemma":[0.0018003633,0.00084948924,0.51714844,0.00015020808,0.00006987388,0.000028752534,0.00026035236,0.000015734711,0.47728282,0.000004473012,0.002222155,0.00016733377],"about_ca_topic_score_codex":0.00032273773,"about_ca_topic_score_gemma":0.00005142221,"teacher_disagreement_score":0.21962729,"about_ca_system_score_codex":0.00039687188,"about_ca_system_score_gemma":0.00027274806,"threshold_uncertainty_score":0.8398561},"labels":[],"label_agreement":null},{"id":"W2317997914","doi":"10.1158/0008-5472.sabcs-3063","title":"Synthetic lethality when combining phosphoinositide 3-kinase alpha and beta catalytic subunit-directed RNAi and estrogen deprivation for estrogen receptor positive breast cancer: implications for clinical trial design with pharmacological inhibitors.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Gene knockdown; RNA interference; Estrogen receptor; Biology; Estrogen receptor alpha; Phosphoinositide 3-kinase; P110α; PI3K/AKT/mTOR pathway; Synthetic lethality; Cell culture; Signal transduction; Cell biology; Cancer; Breast cancer; Mutant; Gene; Biochemistry; Genetics","score_opus":0.12865491326818448,"score_gpt":0.445071612604939,"score_spread":0.31641669933675454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317997914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98341805,0.0047360216,0.003312087,0.0042092646,0.0001356395,0.0031446128,0.0009947092,0.000039084513,0.00001055076],"genre_scores_gemma":[0.9917293,0.001445133,0.003215181,0.00029241014,0.0007249964,0.002214944,0.00030135224,0.000043945205,0.000032713448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974876,0.00039238154,0.0004246478,0.0008822227,0.00023015398,0.00058297085],"domain_scores_gemma":[0.99786913,0.00061450776,0.00016995531,0.00031291254,0.00073779875,0.00029568878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015614305,0.0002449828,0.00034982068,0.000073530835,0.00042011042,0.00009583247,0.00026736624,0.00030691296,0.000014267459],"category_scores_gemma":[0.00028817583,0.00022194909,0.00009579074,0.00018455985,0.0004762803,0.000022123262,0.000097820965,0.0003696554,5.297276e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06117182,0.00047051578,0.012401783,0.00007382664,0.00062980497,0.0000032309526,0.00015359277,0.00007301797,0.8387062,0.00029468132,0.009812646,0.07620889],"study_design_scores_gemma":[0.02607375,0.006542966,0.009738767,0.00020220652,0.00041907636,0.000037390255,0.00006694165,0.000344558,0.95243347,0.00072513934,0.002805891,0.00060987374],"about_ca_topic_score_codex":0.00024266941,"about_ca_topic_score_gemma":0.000024857514,"teacher_disagreement_score":0.11372725,"about_ca_system_score_codex":0.00018725096,"about_ca_system_score_gemma":0.0007748994,"threshold_uncertainty_score":0.9050821},"labels":[],"label_agreement":null},{"id":"W2318021381","doi":"10.1158/1538-7445.am2011-lb-51","title":"Abstract LB-51: Pten null prostate tumorigenesis and prostate stem cell activity are inhibited by targeted knockout of the Survivin gene","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PTEN; Survivin; Tramp; Prostate cancer; Prostate; Conditional gene knockout; Cancer research; Carcinogenesis; Cancer; Intraepithelial neoplasia; Biology; Knockout mouse; Hyperplasia; Pathology; Medicine; Internal medicine; Apoptosis; Gene; PI3K/AKT/mTOR pathway; Genetics; Phenotype","score_opus":0.03717007571421451,"score_gpt":0.29619717719277866,"score_spread":0.25902710147856417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318021381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875463,0.0084585305,0.000005944465,0.00010192444,0.0008413943,0.00073427055,0.0006550889,0.00001073507,0.00043745927],"genre_scores_gemma":[0.9906749,0.00445239,0.00001795234,0.000036720965,0.00075172365,0.00019371568,0.000028454731,0.000045643872,0.0037984615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804896,0.00023656536,0.00024151629,0.00053255336,0.00039389488,0.0005464853],"domain_scores_gemma":[0.9987039,0.000019860965,0.0001715344,0.00054482045,0.00039378385,0.00016612976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006775045,0.00020169969,0.00026388245,0.00006982053,0.0001777591,0.000029778488,0.00031967062,0.00014606636,0.000047170714],"category_scores_gemma":[0.00003343115,0.00015397588,0.0000886388,0.00028783063,0.0003596696,0.000012553657,0.00029307228,0.00028623652,0.000003819231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046696948,0.00011004789,0.0077432254,0.00016136191,0.00004318719,3.0678652e-7,0.0005446071,0.0000026179362,0.9716537,0.0000015342472,0.013245695,0.0060267397],"study_design_scores_gemma":[0.00063543435,0.00008797451,0.06946545,0.000036625137,0.000013697266,0.000001453969,0.00022546003,0.0000031521688,0.8834766,0.000012478754,0.045871194,0.00017045913],"about_ca_topic_score_codex":0.002628145,"about_ca_topic_score_gemma":0.0008153894,"teacher_disagreement_score":0.08817709,"about_ca_system_score_codex":0.000049839975,"about_ca_system_score_gemma":0.00039010993,"threshold_uncertainty_score":0.6278954},"labels":[],"label_agreement":null},{"id":"W2318102135","doi":"10.1158/1538-7445.am2012-3018","title":"Abstract 3018: Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through GnRH-I receptor and mitogen-activated protein kinases (MAPKs)-dependent activation of matrix metalloproteinase (MMP)-2","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Agonist; Endometrial cancer; Motility; Internal medicine; Cancer research; Angiogenesis; Metastasis; Endocrinology; Gonadotropin-releasing hormone; Receptor; Kinase; MAPK/ERK pathway; Medicine; Cancer; Biology; Chemistry; Luteinizing hormone; Hormone; Cell biology","score_opus":0.041512019020211295,"score_gpt":0.3480371772451675,"score_spread":0.3065251582249562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318102135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689956,0.028904758,0.000008814875,0.00022040175,0.00029235016,0.0013987554,0.00009702044,0.000011144377,0.00007119525],"genre_scores_gemma":[0.9916638,0.006835951,0.00012452871,0.000010177451,0.00047024034,0.00026179626,0.000077079196,0.000052264953,0.0005041689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976563,0.00034520088,0.00040746454,0.00041642028,0.000586029,0.00058862695],"domain_scores_gemma":[0.99844795,0.000114851864,0.00031046724,0.00044703958,0.00054103293,0.00013864327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006270423,0.00026165645,0.00036433895,0.00013845392,0.00047078458,0.00003316052,0.00032147818,0.0003254788,0.000101543665],"category_scores_gemma":[0.0003446342,0.00019355473,0.00011918464,0.00062649895,0.00050409767,0.000046081987,0.00036821872,0.00044458307,0.0000030269764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026875238,0.00020614074,0.00011559155,0.0002072106,0.0003551643,0.0000014048242,0.00030493576,0.000063846,0.9926275,0.00006323794,0.00050248095,0.0028649797],"study_design_scores_gemma":[0.0013880131,0.00074226514,0.000990483,0.00020441707,0.0000468247,0.0000029001517,0.00018314295,0.0000026658606,0.99253,0.00002490823,0.0036735055,0.00021085776],"about_ca_topic_score_codex":0.0030154372,"about_ca_topic_score_gemma":0.000018724948,"teacher_disagreement_score":0.022668235,"about_ca_system_score_codex":0.00012803577,"about_ca_system_score_gemma":0.0004502723,"threshold_uncertainty_score":0.7892933},"labels":[],"label_agreement":null},{"id":"W2318183721","doi":"10.1158/1538-7445.am10-lb-21","title":"Abstract LB-21: Emergence of castration resistant prostate cancer class defined by recurrent <i>ERG</i> fusion","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prostate cancer; Erg; Cancer research; Fusion gene; Cancer; Transcriptome; Chromatin immunoprecipitation; Medicine; Gene; Gene expression; TMPRSS2; Biology; Internal medicine; Promoter; Genetics","score_opus":0.0689584488285101,"score_gpt":0.42352315334370466,"score_spread":0.35456470451519456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318183721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97924083,0.008133908,0.00000210898,0.0065290923,0.0006441222,0.0014494606,0.00045863524,0.000044028628,0.0034978276],"genre_scores_gemma":[0.9773152,0.015751954,0.00009203679,0.00004515129,0.00030597506,0.0008155709,0.00016770486,0.000051172163,0.0054552197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962342,0.000106777814,0.0005120612,0.0006276522,0.0016132718,0.0009060853],"domain_scores_gemma":[0.99745584,0.00014026705,0.0001439353,0.0005832303,0.0012444403,0.0004322939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011006183,0.00024086327,0.0003843191,0.00028639642,0.00028652928,0.00004790624,0.00027990885,0.00019048054,0.0026801152],"category_scores_gemma":[0.00018157283,0.00018601723,0.00011404049,0.00092645333,0.00051322905,0.00017274125,0.00012495165,0.0013280604,0.0000405483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030877977,0.0003577287,0.0059250738,0.0005269444,0.00007357098,0.000040531493,0.00039508138,0.000004188297,0.8919179,0.00010395501,0.069218986,0.028348275],"study_design_scores_gemma":[0.004211003,0.0012994376,0.031083483,0.0009025857,0.00006654519,0.000007670436,0.00057801255,0.0000957633,0.87020355,0.00028943457,0.09089829,0.00036422553],"about_ca_topic_score_codex":0.0040787766,"about_ca_topic_score_gemma":0.0030979782,"teacher_disagreement_score":0.02798405,"about_ca_system_score_codex":0.00030965812,"about_ca_system_score_gemma":0.0020175595,"threshold_uncertainty_score":0.9982316},"labels":[],"label_agreement":null},{"id":"W2318200996","doi":"10.1158/1538-7445.am2013-3108","title":"Abstract 3108: A novel role for hPygo2 in ribosomal RNA transcription.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Biology; Chromatin immunoprecipitation; Chromatin remodeling; Chromatin; Cell biology; Transcription (linguistics); Histone; Ribosomal protein; Molecular biology; Ribosome; Gene expression; RNA; Promoter; Gene; Genetics","score_opus":0.05063447982310735,"score_gpt":0.3637318388711296,"score_spread":0.3130973590480222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318200996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992827,0.004133823,0.00025758796,0.00082124176,0.00009697671,0.0007028858,0.00019285975,0.0000070971046,0.0009605167],"genre_scores_gemma":[0.9961924,0.000675527,0.00032095288,0.00017962865,0.00052181556,0.0011087421,0.00013751056,0.000024226125,0.0008391812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988141,0.000028922546,0.0001800607,0.0003387076,0.0001988411,0.0004393353],"domain_scores_gemma":[0.99925905,0.000017502083,0.00002115799,0.00023975785,0.00029501691,0.00016748116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024359772,0.00009832277,0.000095958545,0.00009023574,0.000090718364,0.000051603914,0.00020673458,0.00012032337,0.0002532218],"category_scores_gemma":[0.00007072497,0.000100568934,0.00007817282,0.0001081111,0.0001116744,0.0000075309918,0.00003392771,0.00012234916,0.000030735046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015388115,0.00018558891,0.0012214163,0.000071032,0.000013645078,6.475465e-7,0.00005198939,0.000032231066,0.9845443,0.000052845728,0.010933073,0.0027393536],"study_design_scores_gemma":[0.004120868,0.00035168006,0.07204409,0.00006640369,0.000009136264,0.0000018409124,0.00047317738,0.00012401928,0.78820664,0.0021303499,0.13212961,0.00034218334],"about_ca_topic_score_codex":0.0005647641,"about_ca_topic_score_gemma":0.00032995178,"teacher_disagreement_score":0.19633766,"about_ca_system_score_codex":0.00004379896,"about_ca_system_score_gemma":0.0002355086,"threshold_uncertainty_score":0.4101082},"labels":[],"label_agreement":null},{"id":"W2318204998","doi":"10.1158/1538-7445.am10-1091","title":"Abstract 1091: The role for retinoblastoma-like p130 (RBL2) and DNA damage response in human pancreatic cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; University Health Network","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Cancer research; KRAS; Carcinogenesis; Pancreatic cancer; Oncogene; Biology; Cancer; Pancreatic duct; DNA damage; Pancreas; Cell cycle; Colorectal cancer; Endocrinology","score_opus":0.03660713899545802,"score_gpt":0.38133742725429837,"score_spread":0.34473028825884033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318204998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905168,0.0023299924,0.000005442091,0.0034291716,0.00036425347,0.0019265302,0.00010021248,0.00004337854,0.0012842513],"genre_scores_gemma":[0.9951303,0.00040879435,0.000074428805,0.00024316124,0.00037431996,0.0014129789,0.000012154236,0.0000889368,0.0022549417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973155,0.00022863834,0.00034606052,0.00059013034,0.0006782281,0.0008414008],"domain_scores_gemma":[0.9978102,0.0006739985,0.000080738355,0.0008201898,0.00032930888,0.0002855584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026459594,0.00022241219,0.00035407871,0.0003379415,0.00034062448,0.000078745245,0.0003206426,0.0002509142,0.0006314941],"category_scores_gemma":[0.00041004503,0.00017390514,0.00009408258,0.00053158746,0.00056839513,0.00007814708,0.00014572404,0.0017056554,0.00002226876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033370564,0.00007187743,0.0010250681,0.00016172118,0.00004964076,0.000065146305,0.000866602,0.000021988088,0.98536956,0.0000697295,0.0060253763,0.0029362596],"study_design_scores_gemma":[0.004504418,0.0007224134,0.091782436,0.0007025329,0.000084076266,0.000022603988,0.0007353448,0.00036223172,0.7774517,0.00045967996,0.12281865,0.0003539105],"about_ca_topic_score_codex":0.0045787045,"about_ca_topic_score_gemma":0.0075514633,"teacher_disagreement_score":0.20791784,"about_ca_system_score_codex":0.000417156,"about_ca_system_score_gemma":0.0010350269,"threshold_uncertainty_score":0.7410318},"labels":[],"label_agreement":null},{"id":"W2318214478","doi":"10.1158/0008-5472.sabcs-09-910","title":"p16 Expression and Breast Cancer Risk in Women with Atypical Hyperplasia.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Immunohistochemistry; Cancer; Atypia; Atypical hyperplasia; Population; Biopsy; Oncology; Hyperplasia; Incidence (geometry); Pathology; Risk factor; Internal medicine; Gynecology","score_opus":0.02527874662020073,"score_gpt":0.3574687078443599,"score_spread":0.33218996122415917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318214478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915683,0.003733069,0.00002065986,0.003182677,0.000047810336,0.0005498597,0.000047739126,0.00003717863,0.00081266183],"genre_scores_gemma":[0.9946956,0.0040085125,0.00010485184,0.00026677927,0.00020797501,0.00031072999,0.0000028790605,0.000031510426,0.00037113417],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978327,0.00014041264,0.00017243193,0.00047941573,0.0006719055,0.00070311234],"domain_scores_gemma":[0.99900526,0.00005496362,0.00003634744,0.0003446093,0.00018448572,0.00037433518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045323026,0.00015201076,0.00028339992,0.0002703954,0.00011280746,0.00003004612,0.000111310495,0.00014747678,0.00045518787],"category_scores_gemma":[0.00005722029,0.00011456201,0.000021582066,0.00064155046,0.00020582297,0.000081607934,0.000061534345,0.0010502723,0.000014538251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029125983,0.00044830504,0.09583369,0.0001901935,0.000099282326,0.0006894486,0.003144623,0.00022659499,0.54265434,0.00007258996,0.008492237,0.3190227],"study_design_scores_gemma":[0.009070859,0.0013979888,0.9399382,0.002283428,0.000034752164,0.0003118115,0.0006506448,0.0001952898,0.03382898,0.00026535764,0.011663398,0.0003593201],"about_ca_topic_score_codex":0.00076739874,"about_ca_topic_score_gemma":0.00030219782,"teacher_disagreement_score":0.84410447,"about_ca_system_score_codex":0.0009672173,"about_ca_system_score_gemma":0.00064450083,"threshold_uncertainty_score":0.4983988},"labels":[],"label_agreement":null},{"id":"W2318217547","doi":"10.1158/1538-7445.am2012-2479","title":"Abstract 2479: TP53 status as a marker of recurrence and survival in choroid plexus carcinomas","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Choroid plexus; Cancer; Choroid plexus papilloma; Internal medicine; Choroid; Radiation therapy; Tumor progression; Oncology; Carcinoma; Neurosurgery; Pathology; Surgery; Central nervous system; Biology","score_opus":0.11112448286092491,"score_gpt":0.43116792161646417,"score_spread":0.32004343875553926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318217547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97426635,0.018600266,1.0209175e-7,0.00039723836,0.000114749826,0.00043212963,0.00003255419,0.0000060297416,0.006150588],"genre_scores_gemma":[0.9964003,0.0031051212,0.00003015733,0.00001746151,0.000104108425,0.00017460079,0.000009474708,0.000014952333,0.00014384321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983488,0.000088190805,0.00018932056,0.00021955727,0.00052397215,0.00063018966],"domain_scores_gemma":[0.9989906,0.00024692182,0.000033844935,0.000244752,0.0001559285,0.00032795675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008061436,0.000100553945,0.00024830527,0.00022365846,0.000040159044,0.000012786733,0.000060911017,0.000062540006,0.0006445393],"category_scores_gemma":[0.0002117615,0.000080558166,0.00003364306,0.00034509687,0.00015818446,0.00008725341,0.000072314135,0.00029431327,0.000029518333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031013307,0.00037147396,0.9701478,0.00016165845,0.000036597383,0.00006341089,0.0006086525,5.5698246e-7,0.009294822,0.0001989385,0.00076740497,0.01803857],"study_design_scores_gemma":[0.0015110469,0.00016833506,0.98077124,0.0002124099,0.000013171652,0.000008295863,0.00032449252,0.0000036776084,0.012360172,0.000051452625,0.0045095417,0.00006616022],"about_ca_topic_score_codex":0.009522381,"about_ca_topic_score_gemma":0.00062728615,"teacher_disagreement_score":0.022133939,"about_ca_system_score_codex":0.0002522814,"about_ca_system_score_gemma":0.00028500287,"threshold_uncertainty_score":0.9970733},"labels":[],"label_agreement":null},{"id":"W2318220596","doi":"10.1158/1538-7445.am2012-1449","title":"Abstract 1449: Spicing up radiation treatment for prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Capsaicin; Medicine; LNCaP; Prostate cancer; Cancer; Carcinogen; In vivo; Ionizing radiation; Apoptosis; Pharmacology; In vitro; Adverse effect; Cancer research; Toxicity; Radiation therapy; Internal medicine; Receptor; Irradiation; Chemistry; Biology; Biochemistry","score_opus":0.15521020305066918,"score_gpt":0.5003177089441364,"score_spread":0.3451075058934672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318220596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96997565,0.021523843,0.000025873152,0.004250473,0.0013209063,0.0016935328,0.000039970768,0.00003589435,0.0011338725],"genre_scores_gemma":[0.9762832,0.0072485576,0.00006557698,0.00024517815,0.0041010315,0.0015112637,0.000037060345,0.000039089897,0.010469075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830395,0.0000343283,0.0002034779,0.00023193315,0.00048772807,0.0007385756],"domain_scores_gemma":[0.99894965,0.00014691715,0.000044877335,0.00024065324,0.00028175098,0.00033616956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073424424,0.00013121901,0.00025355327,0.00017672878,0.00020166217,0.000021257942,0.000063748936,0.00008561119,0.0007962763],"category_scores_gemma":[0.000110673886,0.00008712263,0.000079429876,0.00024229604,0.0000994636,0.00010277844,0.000017310265,0.00024646876,0.000030115354],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017015472,0.00031344482,0.08222729,0.00052460143,0.0002951543,0.000014556697,0.003779,0.00005108075,0.21065733,0.0001485956,0.03563274,0.6646547],"study_design_scores_gemma":[0.009734408,0.0013867544,0.24107969,0.0007112365,0.00017091364,0.000010364096,0.0011699618,0.00024301057,0.15835549,0.000053255822,0.586829,0.00025588437],"about_ca_topic_score_codex":0.0020611822,"about_ca_topic_score_gemma":0.000086131615,"teacher_disagreement_score":0.6643988,"about_ca_system_score_codex":0.0009297135,"about_ca_system_score_gemma":0.00046091282,"threshold_uncertainty_score":0.8718667},"labels":[],"label_agreement":null},{"id":"W2318268630","doi":"10.1158/0008-5472.sabcs10-p5-05-01","title":"Abstract P5-05-01: IGFBP-7 Reduces Growth of Xenografted Breast Tumors in Mice and Inhibits Breast Cancer Cell Proliferation and Migration through the MEK-ERK Pathway","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Breast cancer; Ectopic expression; Cyclin-dependent kinase 6; Cell growth; Biology; Metastasis; Cancer; Carcinogenesis; Cyclin D1; Cell culture; Cell cycle; Genetics","score_opus":0.018004067151367143,"score_gpt":0.30717204314148594,"score_spread":0.2891679759901188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318268630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911995,0.008069663,0.0000037729071,0.001521903,0.00025989237,0.00049936835,0.0002577308,0.000005818836,0.00026190025],"genre_scores_gemma":[0.99016297,0.008294245,0.000040702173,0.00008974781,0.00095449877,0.00023113345,0.000044733006,0.000023952556,0.00015802524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856055,0.000109096865,0.00025982727,0.00041969118,0.0003041531,0.00034669955],"domain_scores_gemma":[0.9991946,0.000029669509,0.00009970009,0.00021498898,0.0003682038,0.000092839175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054960477,0.00015907023,0.00018204957,0.00006771214,0.00015034148,0.00006479803,0.00017004798,0.00016631761,0.000040064566],"category_scores_gemma":[0.000041412644,0.00012206367,0.00003643228,0.00026361356,0.00035320895,0.000035478268,0.00010524385,0.0003688229,6.338394e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027339766,0.000061019364,0.002477081,0.00010074019,0.00001698518,6.686456e-7,0.0008973629,0.000005607174,0.98676854,0.00006360446,0.0014112466,0.007923758],"study_design_scores_gemma":[0.00079350756,0.00006422129,0.070040695,0.000082015715,0.00001139356,0.00003535207,0.0004963045,0.000018580984,0.9232393,0.000096600015,0.0049538007,0.0001682188],"about_ca_topic_score_codex":0.010841121,"about_ca_topic_score_gemma":0.02910753,"teacher_disagreement_score":0.06756361,"about_ca_system_score_codex":0.0000308752,"about_ca_system_score_gemma":0.00044192368,"threshold_uncertainty_score":0.9957458},"labels":[],"label_agreement":null},{"id":"W2318293625","doi":"10.1158/1538-7445.am10-915","title":"Abstract 915: Xenobiotic metabolizing gene variants, occupational chemical exposures, and renal cell cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Microsomal epoxide hydrolase; Cancer; Odds ratio; Genotype; Medicine; Kidney cancer; Biology; Internal medicine; Oncology; Genetics; Gene; Microsome; Epoxide hydrolase","score_opus":0.03676297860533656,"score_gpt":0.3500112700905961,"score_spread":0.31324829148525957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318293625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192756,0.0067402287,0.000065823966,0.00028981848,0.00024273733,0.0001712203,0.00020150786,0.000008714544,0.00035235638],"genre_scores_gemma":[0.9961235,0.00184618,0.00044149216,0.00012613425,0.0008957909,0.00008925807,0.000091796705,0.00002891063,0.00035695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985742,0.000046801964,0.00017910064,0.00043415066,0.00031980462,0.000445949],"domain_scores_gemma":[0.9992893,0.000031909294,0.000028573751,0.00026934585,0.00017457265,0.00020632242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038459798,0.00014578852,0.0001373223,0.00006496592,0.00016666914,0.000057950754,0.00021484877,0.00019698784,0.0006235654],"category_scores_gemma":[0.000034332454,0.00013339617,0.000057697736,0.00011754465,0.00020689575,0.000007675842,0.000090500755,0.00048823276,0.0000110442525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001747126,0.000045926376,0.0018634083,0.000030516416,0.000036009125,0.000007908963,0.000042081818,0.000013684604,0.9928133,0.0001224549,0.0021309394,0.0027190698],"study_design_scores_gemma":[0.0006034335,0.00004969113,0.020659717,0.000013615563,0.000015201343,0.000011228728,0.000012073513,0.000012483991,0.9584697,0.000050126084,0.019931044,0.0001717125],"about_ca_topic_score_codex":0.00095763133,"about_ca_topic_score_gemma":0.00038314724,"teacher_disagreement_score":0.034343615,"about_ca_system_score_codex":0.000017766431,"about_ca_system_score_gemma":0.00042297563,"threshold_uncertainty_score":0.68276036},"labels":[],"label_agreement":null},{"id":"W2318305503","doi":"10.1158/1538-7445.am2013-681","title":"Abstract 681: SGI-110, a novel 5-aza-2’-deoxycytidine- containing dinucleotide, induces Cancer Germline (CG) antigen expression in Acute Myeloid Leukemia (AML) cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Demethylating agent; DNA methylation; Cancer research; Molecular biology; HL60; Bisulfite sequencing; Myeloid leukemia; Biology; Decitabine; CpG site; Cancer; Viability assay; Leukemia; Cell culture; Gene expression; Immunology; Gene; Genetics","score_opus":0.050061849312547944,"score_gpt":0.35783621994875126,"score_spread":0.30777437063620333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318305503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947428,0.0030870046,0.000049702732,0.00032797485,0.00031104143,0.00055413914,0.00010510627,0.00001866811,0.0008035441],"genre_scores_gemma":[0.98779035,0.009176108,0.00015183186,0.00025497578,0.00060064223,0.00044503706,0.000079703765,0.000057804104,0.0014435297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972428,0.000090382484,0.0004445306,0.0008051441,0.00048698098,0.00093013694],"domain_scores_gemma":[0.9985687,0.000049020757,0.00012595174,0.0005349264,0.00048092665,0.00024044901],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052656705,0.00029759662,0.00032592448,0.00024238614,0.00017850101,0.00014455624,0.00069046987,0.00032445378,0.00079957355],"category_scores_gemma":[0.0000668006,0.0002658142,0.000113656504,0.0003349493,0.00020597548,0.00004860562,0.0004369792,0.00068501045,0.0001247106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025949837,0.00006126822,0.0042583,0.00003978123,0.000073986346,0.000018861445,0.00020239723,0.0002161425,0.97826606,0.000003535662,0.011043366,0.005556824],"study_design_scores_gemma":[0.00093092996,0.00022639547,0.03909221,0.00029687965,0.000007141565,0.0000036011133,0.00033629258,0.00008321557,0.95279264,0.000028127512,0.0058681127,0.00033444437],"about_ca_topic_score_codex":0.0077190325,"about_ca_topic_score_gemma":0.0014088919,"teacher_disagreement_score":0.034833908,"about_ca_system_score_codex":0.00029012386,"about_ca_system_score_gemma":0.00080151344,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W2318349396","doi":"10.1158/0008-5472.sabcs-2027","title":"Validation of a custom 512-gene breast cancer panel on the illumina-based DASL mRNA expression platform: focus on triple negative breast tumors using RNA from stored formalin-fixed, paraffin blocks.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Breast cancer; Concordance; Multiplex; Gene expression; Molecular biology; Immunohistochemistry; Biology; Gene; Cancer research; Cancer; Pathology; Medicine; Bioinformatics; Genetics","score_opus":0.06444748407447187,"score_gpt":0.35877462274636834,"score_spread":0.29432713867189647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318349396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940796,0.00023965054,0.0017017244,0.00186695,0.000045536275,0.0008461112,0.0010368017,0.000020525616,0.00016309622],"genre_scores_gemma":[0.9980167,0.00018119905,0.0005204108,0.0002952116,0.00024237111,0.00039592478,0.00023400938,0.000028594588,0.00008554168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809754,0.00021021983,0.0003064871,0.0005335561,0.0004138815,0.00043832642],"domain_scores_gemma":[0.99861205,0.00006521821,0.00020065857,0.00067339605,0.0003318425,0.000116818446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043656066,0.00022887935,0.00022893756,0.00011487113,0.00032405363,0.000030418825,0.00047267904,0.0002372358,0.00011035513],"category_scores_gemma":[0.000044682693,0.00016702795,0.00012346369,0.00032108702,0.00024897905,0.000009323397,0.00009349398,0.00035602634,0.0000035692012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010324769,0.00015985065,0.00013297173,0.0000065240183,0.000032688484,0.0000026619498,0.00006591222,0.0008946066,0.98898053,0.0001369458,0.0012697148,0.00728511],"study_design_scores_gemma":[0.00076890003,0.00034557423,0.001385654,0.00017141551,0.000017388315,0.000004786151,0.00008787054,0.0006187077,0.9956058,0.0004516313,0.00034800952,0.00019422309],"about_ca_topic_score_codex":0.0018681008,"about_ca_topic_score_gemma":0.000060398972,"teacher_disagreement_score":0.007090887,"about_ca_system_score_codex":0.00014661998,"about_ca_system_score_gemma":0.00036619237,"threshold_uncertainty_score":0.6811202},"labels":[],"label_agreement":null},{"id":"W2318350339","doi":"10.1158/0008-5472.sabcs11-p4-07-02","title":"P4-07-02: Detection, Enrichment, Characterization and Propagation of Circulating Tumour Cells from Patients with Advanced Metastatic Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Circulating tumor cell; Ficoll; Peripheral blood mononuclear cell; Flow cytometry; Cancer; Cytokeratin; Breast cancer; Medicine; Metastatic breast cancer; Cancer research; Pathology; Cancer cell; In vitro; Immunology; Internal medicine; Biology; Metastasis; Immunohistochemistry","score_opus":0.046376626662909724,"score_gpt":0.32291087966650417,"score_spread":0.27653425300359447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318350339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677986,0.00037050922,0.0012130802,0.000062129046,0.00012359311,0.0009891569,0.00034606952,0.00002071886,0.00009489517],"genre_scores_gemma":[0.998337,0.00062583835,0.00038422053,0.00003242351,0.00009395591,0.0002851363,0.00007665462,0.000036579764,0.00012823191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832,0.000092852366,0.00029399802,0.00038222547,0.00059768994,0.00031325745],"domain_scores_gemma":[0.99857044,0.000039887167,0.0001961003,0.00021778759,0.00081253756,0.00016322355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026099282,0.0001462568,0.00030145064,0.00018132273,0.00012355298,0.000019410354,0.000070561255,0.00003814219,0.00070950575],"category_scores_gemma":[0.000025496685,0.00011752521,0.00003366131,0.00047439558,0.000132188,0.00022186413,0.00004491828,0.00021760099,0.000005546933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008506496,0.00015036172,0.04293481,0.0002877128,0.00010796835,0.000004090663,0.0007926683,0.000007140655,0.80477077,0.000003865836,0.000010008984,0.15007995],"study_design_scores_gemma":[0.0020497749,0.00030358683,0.45513415,0.00036580046,0.00012582644,0.0000027736023,0.00014660305,0.000055647943,0.5415455,0.000018841924,0.00013448331,0.00011698318],"about_ca_topic_score_codex":0.003635047,"about_ca_topic_score_gemma":0.00031722325,"teacher_disagreement_score":0.41219935,"about_ca_system_score_codex":0.00024861892,"about_ca_system_score_gemma":0.00026651824,"threshold_uncertainty_score":0.77685905},"labels":[],"label_agreement":null},{"id":"W2318403202","doi":"10.1158/1538-7445.am10-43","title":"Abstract 43: Role of Ets-1 in the regulation of energy metabolism in cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; McMaster University","funders":"","keywords":"Glycolysis; Citric acid cycle; Oxidative phosphorylation; Biology; Mitochondrion; Cell biology; Reactive oxygen species; Biochemistry; Cancer cell; Metabolism; Chemistry; Cancer; Genetics","score_opus":0.025273885416988454,"score_gpt":0.34657207502172427,"score_spread":0.32129818960473583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318403202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846338,0.012909504,0.0000031086922,0.00019931408,0.00043597506,0.00017246002,0.000048908194,0.0000014966508,0.0015954586],"genre_scores_gemma":[0.99227995,0.0063613625,0.000030340367,0.000055854984,0.0008155165,0.00015964307,0.000015178986,0.000015340489,0.0002668342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869025,0.00011989132,0.00026678745,0.0002526248,0.00036677875,0.00030369803],"domain_scores_gemma":[0.99921066,0.000037319613,0.00008393967,0.00041142665,0.00021265115,0.000044019875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009129683,0.00009461411,0.00018867552,0.00016059916,0.00002892109,0.00001003223,0.00036304857,0.000164135,0.00016302825],"category_scores_gemma":[0.000055207987,0.000075444215,0.00006387058,0.00036393566,0.00019441036,0.0000070841684,0.00007321777,0.0003133302,8.6424126e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001134275,0.00006761114,0.00068422145,0.00002669755,0.000012023185,2.1773562e-7,0.0002683546,0.00018229996,0.97897124,0.0006599306,0.001328912,0.017685058],"study_design_scores_gemma":[0.00039806278,0.000018143968,0.07371167,0.000017839455,0.0000043423615,4.2932982e-7,0.00012940548,0.000013280557,0.7571156,0.0003426767,0.1681841,0.000064438565],"about_ca_topic_score_codex":0.01197218,"about_ca_topic_score_gemma":0.022052554,"teacher_disagreement_score":0.22185564,"about_ca_system_score_codex":0.000018650868,"about_ca_system_score_gemma":0.0004057461,"threshold_uncertainty_score":0.99579245},"labels":[],"label_agreement":null},{"id":"W2318424614","doi":"10.1158/1538-7445.am2012-5505","title":"Abstract 5505: Risk of second malignancies in patients with Chronic Lymphocytic Leukemia: A population based Canadian study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Cancer; Cancer registry; Internal medicine; Standardized mortality ratio; Population; Relative survival; Incidence (geometry); Relative risk; Malignancy; Epidemiology; Oncology; Leukemia; Confidence interval","score_opus":0.0350687143105119,"score_gpt":0.3436964862447262,"score_spread":0.3086277719342143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318424614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996059,0.0008248075,9.1684956e-7,0.000025002417,0.000082064464,0.002237029,0.00008968929,0.000018566443,0.0006629428],"genre_scores_gemma":[0.99899703,0.0000344279,0.00002507289,0.000027591628,0.00016047424,0.0003236153,0.00006093259,0.00005926438,0.00031161678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958111,0.00026428,0.00043893812,0.0004136197,0.0016450053,0.0014270277],"domain_scores_gemma":[0.9976489,0.0002948951,0.000108312204,0.00070893014,0.0005689569,0.0006700224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001973025,0.00021163792,0.0004478951,0.0010224275,0.00015258475,0.000027875356,0.0002584266,0.00016309046,0.0014679723],"category_scores_gemma":[0.00035230353,0.00017090022,0.00005811861,0.0012496798,0.00019290313,0.0002361174,0.00007188888,0.0007122211,0.000052896645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008809497,0.00020433454,0.9949199,0.00050700916,0.0000918675,0.00004286967,0.00062161154,0.0008430406,0.00016930987,0.000008757105,0.0003150491,0.0013953256],"study_design_scores_gemma":[0.023160623,0.00080586364,0.97302437,0.0004043488,0.000036944395,0.0000025473141,0.00026771336,0.0008441856,0.0010165689,0.0000053462895,0.00026814092,0.00016337135],"about_ca_topic_score_codex":0.77399063,"about_ca_topic_score_gemma":0.65320975,"teacher_disagreement_score":0.16342218,"about_ca_system_score_codex":0.2398167,"about_ca_system_score_gemma":0.07639451,"threshold_uncertainty_score":0.99944484},"labels":[],"label_agreement":null},{"id":"W2318444703","doi":"10.1158/1538-7445.am10-4104","title":"Abstract 4104: Protease-activated receptor 2, a KLK14 target in colon cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Mount Sinai Hospital","funders":"","keywords":"Biology; Receptor; Protease-activated receptor; Cancer; Cancer research; Immunohistochemistry; Autocrine signalling; Pathology; Molecular biology; Immunology; Medicine; Thrombin; Biochemistry; Platelet","score_opus":0.06517268182179635,"score_gpt":0.4025122531418805,"score_spread":0.33733957132008413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318444703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910714,0.0012975531,0.0000016676312,0.0035296755,0.00062223495,0.001466989,0.00007372871,0.00006987546,0.0018668901],"genre_scores_gemma":[0.9906735,0.0004293202,0.00019320918,0.00018112744,0.0008299008,0.0009248763,0.000040139425,0.000058362708,0.006669574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756926,0.00008238873,0.00033991298,0.0004967965,0.0007352919,0.00077631924],"domain_scores_gemma":[0.99857265,0.00016845902,0.000079626465,0.00040855352,0.00041804515,0.00035264003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087533187,0.0001924442,0.00034761115,0.00032733902,0.00016369115,0.000053351778,0.00020922063,0.00023887794,0.012884832],"category_scores_gemma":[0.00023210699,0.00017221601,0.00008426173,0.0008226691,0.00024787345,0.00016121414,0.00006787097,0.0012438511,0.00018506178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064876705,0.00021211673,0.02880425,0.00017761838,0.000035046396,0.00003762801,0.00055145856,0.00001896357,0.94208145,0.000055079858,0.017744357,0.009633276],"study_design_scores_gemma":[0.0017020253,0.00012955832,0.08358735,0.000332361,0.000008563698,0.00000293338,0.00010834385,0.00010654917,0.8079522,0.00012423428,0.10574605,0.00019979985],"about_ca_topic_score_codex":0.011514848,"about_ca_topic_score_gemma":0.0022351614,"teacher_disagreement_score":0.13412921,"about_ca_system_score_codex":0.0003742598,"about_ca_system_score_gemma":0.0013100568,"threshold_uncertainty_score":0.99506754},"labels":[],"label_agreement":null},{"id":"W2318521937","doi":"10.1158/1538-7445.am2011-4729","title":"Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Cancer Care Ontario; Coalition for Research in Women's Health","funders":"","keywords":"Genome-wide association study; International HapMap Project; Single-nucleotide polymorphism; Biology; Genetics; SNP; Genetic association; Tag SNP; Minor allele frequency; Allele frequency; Imputation (statistics); Population; Multiple comparisons problem; Allele; Genotype; Gene; Medicine; Missing data","score_opus":0.13243948472147024,"score_gpt":0.4194913509958866,"score_spread":0.28705186627441637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318521937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148774,0.0036358126,0.0013700693,0.00031004386,0.00023053582,0.0018351908,0.0006498313,0.000021371266,0.00045939887],"genre_scores_gemma":[0.9926963,0.0024158102,0.00024387495,0.000147763,0.0006258409,0.0016214111,0.00013415572,0.000082364226,0.0020324688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968292,0.00029219946,0.00033096413,0.0008539833,0.0007786306,0.0009150145],"domain_scores_gemma":[0.9980664,0.00011183414,0.00012853665,0.0005534837,0.0008652545,0.0002744596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019197344,0.00024304516,0.0002888592,0.0002441822,0.00035307175,0.00009807256,0.0004358039,0.00031562615,0.0003701949],"category_scores_gemma":[0.0005882593,0.00023806212,0.00012903847,0.00037731504,0.00010678154,0.0000143221805,0.00031898025,0.00046007615,0.000014340902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006963311,0.00018017115,0.0045813187,0.000058081863,0.00057546934,0.000017826833,0.0005758942,0.000091387636,0.9882495,0.000012878435,0.0017785915,0.0031825968],"study_design_scores_gemma":[0.0023292745,0.00089457125,0.036200292,0.000026523901,0.00006571798,0.0000015485198,0.0005408835,0.000036152574,0.9408916,0.0001869252,0.018453239,0.00037327124],"about_ca_topic_score_codex":0.0044293352,"about_ca_topic_score_gemma":0.0027859742,"teacher_disagreement_score":0.04735785,"about_ca_system_score_codex":0.00043129106,"about_ca_system_score_gemma":0.0008463521,"threshold_uncertainty_score":0.97078913},"labels":[],"label_agreement":null},{"id":"W2318534181","doi":"10.1158/0008-5472.sabcs12-p1-07-13","title":"Abstract P1-07-13: Prognostic relevance of statistically standardized estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in tamoxifen(TAM)-treated NCIC CTG MA.14 patients","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Proportional hazards model; Biomarker; Estrogen receptor; Progesterone receptor; Tamoxifen; Gynecology; Cancer; Confidence interval; Biology","score_opus":0.04751012845281061,"score_gpt":0.37770389612705385,"score_spread":0.33019376767424324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318534181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900925,0.0037368382,0.00008242001,0.0005762109,0.00028728376,0.0033420816,0.001573471,0.000115525465,0.00019367602],"genre_scores_gemma":[0.9916876,0.0009234361,0.0047772904,0.00006738453,0.0004269704,0.0011115931,0.0003528294,0.00019833572,0.00045454837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99355465,0.0005393471,0.0011863498,0.0009713023,0.0018710238,0.0018773461],"domain_scores_gemma":[0.9956277,0.000903177,0.00039607112,0.00068596087,0.0014954333,0.00089167483],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013170983,0.00059203064,0.0011857533,0.00048151313,0.00024315395,0.00006252625,0.00038505232,0.000331614,0.0030706252],"category_scores_gemma":[0.0020968292,0.00053337275,0.00012139324,0.0007235067,0.0010496883,0.0006552989,0.00022539537,0.0012864032,0.0001299805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061198897,0.0011762339,0.80445814,0.0015140163,0.0002879155,0.000017025524,0.0014640853,0.0000030740932,0.1312839,0.00026677284,0.0014720298,0.05193694],"study_design_scores_gemma":[0.011159769,0.001976431,0.86259604,0.0022961367,0.00008718792,0.000010632097,0.00033136443,0.0000053753747,0.10785937,0.00023520124,0.0126484735,0.0007940043],"about_ca_topic_score_codex":0.0010450097,"about_ca_topic_score_gemma":0.00015523225,"teacher_disagreement_score":0.05813792,"about_ca_system_score_codex":0.0015478232,"about_ca_system_score_gemma":0.0006308351,"threshold_uncertainty_score":0.9997118},"labels":[],"label_agreement":null},{"id":"W2318574019","doi":"10.1158/1538-7445.am10-1052","title":"Abstract 1052: RNAi-mediated mutual regulation of FGF-2 and its antisense gene, NUDT6, in C6 glioma cells.","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Gene knockdown; RNA interference; Biology; Cell cycle; Molecular biology; Cell growth; Fibroblast growth factor; Flow cytometry; Cell biology; Cell; Chemistry; Cell culture; Gene; RNA; Genetics; Receptor","score_opus":0.03636283233964837,"score_gpt":0.3598332615450555,"score_spread":0.32347042920540714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318574019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974062,0.0015948222,0.00000753951,0.00017344193,0.000116999065,0.00020999086,0.00006433555,0.000003956972,0.00042273826],"genre_scores_gemma":[0.99776286,0.0014775192,0.000061168015,0.000013147713,0.0001780676,0.000052944153,0.000051319726,0.00001662314,0.00038633042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998987,0.000052172727,0.00018955742,0.00029674487,0.00022476137,0.00024971992],"domain_scores_gemma":[0.99928457,0.000027118902,0.000055200097,0.00027613677,0.00027186747,0.000085134285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045578476,0.00008243014,0.00010553428,0.00013294868,0.00006191984,0.000019917248,0.00014303028,0.00016539023,0.00015020354],"category_scores_gemma":[0.00008638506,0.000080367456,0.000026340209,0.0002620732,0.00015595662,0.0000074386853,0.00006503808,0.00023058915,0.000010410247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009022799,0.000039665454,0.0013292116,0.000030096751,0.000010503706,0.00000339797,0.00005514158,0.000019133486,0.99357444,0.00006090595,0.0010655599,0.0037217198],"study_design_scores_gemma":[0.00043565666,0.000053671818,0.09040583,0.0000143712505,0.0000021200863,0.0000031966488,0.00003055218,0.00014155066,0.90392876,0.000027564804,0.004873797,0.00008292159],"about_ca_topic_score_codex":0.0002770276,"about_ca_topic_score_gemma":0.0005139042,"teacher_disagreement_score":0.08964567,"about_ca_system_score_codex":0.000020601867,"about_ca_system_score_gemma":0.00021304976,"threshold_uncertainty_score":0.327729},"labels":[],"label_agreement":null},{"id":"W2318577602","doi":"10.1158/1538-7445.am2011-4249","title":"Abstract 4249: NGR-TNF, a novel direct-acting vascular targeting agent, does not induce “cytokine-rebound” recruitment of pro-angiogenic bone-marrow derived cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Bone marrow; Cancer research; Angiogenesis; Lewis lung carcinoma; Homing (biology); Tumor necrosis factor alpha; Cytokine; Immunology; Medicine; Biology; Internal medicine; Cancer; Metastasis","score_opus":0.22329175877403332,"score_gpt":0.3981785280428668,"score_spread":0.17488676926883348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318577602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910877,0.0005921517,0.00007551649,0.00048078303,0.00010132206,0.0011188759,0.00009751575,0.00007094813,0.0063752136],"genre_scores_gemma":[0.99645716,0.000364015,0.00088611955,0.00020714376,0.00030734634,0.00044380513,0.000039091203,0.000060253795,0.0012350822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965514,0.00016646791,0.0006633757,0.00063681713,0.0011832953,0.00079865527],"domain_scores_gemma":[0.9979398,0.00015538407,0.00025763566,0.00056687417,0.0007012758,0.00037901304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019604203,0.0002588792,0.00058692996,0.00051335373,0.00026394217,0.000046804944,0.00022957784,0.00016573296,0.002119051],"category_scores_gemma":[0.00039496366,0.00020075234,0.00046135834,0.0007945128,0.00025421238,0.00015763912,0.00016221272,0.00064477243,0.000077149394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024788768,0.00038102487,0.0007015422,0.00038733875,0.00043531932,0.00008365128,0.0018966318,0.00000878083,0.99113137,0.000019716957,0.00067215523,0.004034565],"study_design_scores_gemma":[0.0013442971,0.00011656217,0.002193081,0.000958683,0.000113268645,0.0000031059865,0.0012768256,0.00006487093,0.9848411,0.000013061888,0.008845134,0.00022997719],"about_ca_topic_score_codex":0.0020551456,"about_ca_topic_score_gemma":0.00017601337,"teacher_disagreement_score":0.008172978,"about_ca_system_score_codex":0.00043603466,"about_ca_system_score_gemma":0.000492724,"threshold_uncertainty_score":0.9987931},"labels":[],"label_agreement":null},{"id":"W2318594458","doi":"10.1158/1538-7445.am2011-2874","title":"Abstract 2874: Treatment with the autophagy inhibitor 3-Methyladenine sensitizes pancreatic cancer cells to GSK3 inhibition-induced apoptosis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Autophagy; GSK-3; Programmed cell death; Pancreatic cancer; Cancer research; Apoptosis; Cancer cell; Cancer; Medicine; Growth inhibition; Biology; Kinase; Internal medicine; Cell biology; Biochemistry","score_opus":0.06588763755066196,"score_gpt":0.33379008777984115,"score_spread":0.2679024502291792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318594458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529874,0.0012628218,0.000029194136,0.0010757692,0.00023259407,0.000728945,0.00004889775,0.000027042004,0.0012959857],"genre_scores_gemma":[0.99251485,0.0010075785,0.00026960205,0.00035896944,0.00075458037,0.0015310152,0.000029798464,0.00006194166,0.0034716702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780804,0.00013409836,0.00023572127,0.0006250508,0.0005114993,0.0006856094],"domain_scores_gemma":[0.99870366,0.000050849256,0.00007347087,0.00047035152,0.00043092348,0.00027076426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042367727,0.00028748537,0.00024717947,0.000119652825,0.00035415211,0.000069452,0.00026597388,0.00015759552,0.0008277925],"category_scores_gemma":[0.000023574157,0.00018503387,0.00008654551,0.0004174687,0.00019093552,0.000010281191,0.00013269443,0.00023637821,0.000073315685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052423356,0.000073585186,0.00037565883,0.000028611526,0.00020969701,0.000012058909,0.0010728422,0.00003356269,0.98241097,0.0000076218494,0.010316504,0.00493468],"study_design_scores_gemma":[0.00072534033,0.00066907384,0.0017403136,0.00010647023,0.00003708022,0.0000027897815,0.00041196967,0.0000019512852,0.98499787,0.000012920043,0.011013731,0.0002805138],"about_ca_topic_score_codex":0.0023638783,"about_ca_topic_score_gemma":0.00076864596,"teacher_disagreement_score":0.0046541663,"about_ca_system_score_codex":0.0002629851,"about_ca_system_score_gemma":0.0007873166,"threshold_uncertainty_score":0.90637475},"labels":[],"label_agreement":null},{"id":"W2318660654","doi":"10.1158/1538-7445.am2012-3410","title":"Abstract 3410: Identification of frequently gained genomic regions in breast circulating tumor cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Genomics; Centre for Social Innovation; University of Toronto","funders":"","keywords":"Circulating tumor cell; Breast cancer; Microdissection; Biology; Primary tumor; Cancer; Intravasation; Laser capture microdissection; Cancer research; Pathology; Immunomagnetic separation; Cancer cell; Metastasis; Medicine; Molecular biology; Gene; Genetics","score_opus":0.04654958247084903,"score_gpt":0.3560264982462235,"score_spread":0.3094769157753745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318660654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965256,0.002152911,0.000064156135,0.00018997985,0.00017124967,0.00023374248,0.00014194209,0.0000032419211,0.00051721284],"genre_scores_gemma":[0.99856156,0.00069912756,0.000052064104,0.000043407465,0.00039486395,0.00007711676,0.000058529156,0.000023393284,0.00008991735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882126,0.0000544854,0.00029779988,0.00023180632,0.00018556463,0.0004091098],"domain_scores_gemma":[0.9992264,0.000045513203,0.000099753604,0.000351607,0.00016866675,0.000108074855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076046644,0.0000857443,0.00011415341,0.00011637446,0.00006306433,0.0000225481,0.00020833148,0.00007172487,0.000051364575],"category_scores_gemma":[0.000081346116,0.00009417138,0.000052714546,0.00018851459,0.000108762455,0.0000069303633,0.00010338129,0.00015678488,0.000016230959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039361217,0.000069529844,0.013886834,0.000046560963,0.00001317517,0.000001945287,0.00011730485,0.00034176587,0.98337084,0.00023468194,0.0011687555,0.0007092393],"study_design_scores_gemma":[0.00050137786,0.000033189634,0.20909944,0.000053613676,0.000007215211,0.000010502683,0.00024299821,0.000054427626,0.7860601,0.00019932864,0.0035626418,0.00017516145],"about_ca_topic_score_codex":0.00092943344,"about_ca_topic_score_gemma":0.000166862,"teacher_disagreement_score":0.19731075,"about_ca_system_score_codex":0.00014289733,"about_ca_system_score_gemma":0.00025970017,"threshold_uncertainty_score":0.38401976},"labels":[],"label_agreement":null},{"id":"W2318717008","doi":"10.1158/1538-7445.am2011-746","title":"Abstract 746: Acquired bortezomib resistance in non-small cell lung cancer is associated with overexpression of the mutated β5 proteasome subunit","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bortezomib; Proteasome inhibitor; Proteasome; Cancer research; Apoptosis; Lung cancer; Chemistry; Multiple myeloma; A549 cell; Pharmacology; Biology; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.04598820071831536,"score_gpt":0.3167967232750064,"score_spread":0.2708085225566911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318717008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901513,0.002093567,0.000004690964,0.000100990146,0.00004684603,0.0012304897,0.00019372604,0.000008586323,0.0061698384],"genre_scores_gemma":[0.9955373,0.00037366705,0.000053965865,0.00007439582,0.000065598746,0.0006830238,0.000024917084,0.00004451493,0.0031426451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980017,0.00022547488,0.0002776239,0.00046476806,0.00045111054,0.0005793028],"domain_scores_gemma":[0.9986701,0.000031317122,0.00018810126,0.0005687319,0.00043269704,0.000109062625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006862513,0.00019048051,0.00021962801,0.00008671484,0.00014237082,0.000020698017,0.000588341,0.00023514166,0.00036583978],"category_scores_gemma":[0.00009213879,0.00013564326,0.00007160739,0.0004971072,0.00024528586,0.000010417125,0.00021411854,0.0003546066,0.0000026165062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068605004,0.00014496046,0.036719833,0.00022588408,0.000053599644,0.000008453347,0.0011965497,0.000009761287,0.95885897,0.0000069867815,0.0019398843,0.00014907286],"study_design_scores_gemma":[0.001113506,0.00009094644,0.09785668,0.0009014888,0.000009255654,3.8360466e-7,0.000113760245,0.000015783075,0.89905554,0.000053612486,0.00061306136,0.00017595886],"about_ca_topic_score_codex":0.001898284,"about_ca_topic_score_gemma":0.0024918593,"teacher_disagreement_score":0.06113685,"about_ca_system_score_codex":0.00013481441,"about_ca_system_score_gemma":0.0007274917,"threshold_uncertainty_score":0.5531372},"labels":[],"label_agreement":null},{"id":"W2318718623","doi":"10.1158/1538-7445.am10-lb-252","title":"Abstract LB-252: Expression of FGF-2 is essential for the maintenance of cancer stem cell characteristics in human colorectal tumor cell lines","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"CD44; Wnt signaling pathway; Cancer stem cell; Cancer research; Biology; Colorectal cancer; Stem cell; Epithelial–mesenchymal transition; Fibroblast growth factor; Cancer; Catenin; Cell; Cell biology; Pathology; Medicine; Metastasis; Signal transduction; Genetics","score_opus":0.05187073307786202,"score_gpt":0.4017861198436555,"score_spread":0.3499153867657935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318718623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502456,0.0018135217,0.000018632527,0.00053293956,0.0005182083,0.0011297008,0.0005375264,0.0000077783725,0.00041711133],"genre_scores_gemma":[0.99538046,0.001502437,0.000094243944,0.000053180032,0.00058666774,0.0004991154,0.000013047758,0.00004207182,0.0018287845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798787,0.00004127461,0.0005231061,0.0003496338,0.000592935,0.00050515996],"domain_scores_gemma":[0.9981821,0.00027525122,0.00026229743,0.00042632959,0.00072314375,0.00013088924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008386972,0.00016212052,0.00047443283,0.00017206665,0.00011582012,0.00001873826,0.00031738653,0.000104444094,0.00096844113],"category_scores_gemma":[0.000045829536,0.00011134114,0.00015034327,0.00032687042,0.0004499779,0.000052742856,0.000110550405,0.00071084726,0.0000026751716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010595412,0.00024094294,0.005782708,0.0014833608,0.000019355266,0.000009657435,0.00072382507,0.0000058164346,0.98007125,0.000017382423,0.004720701,0.005865448],"study_design_scores_gemma":[0.001802927,0.00018299301,0.023539348,0.00043276764,0.000044910936,0.0000011765052,0.00044676167,0.00005156786,0.9623942,0.000015687965,0.010982539,0.00010514616],"about_ca_topic_score_codex":0.0039795637,"about_ca_topic_score_gemma":0.0016654022,"teacher_disagreement_score":0.017756639,"about_ca_system_score_codex":0.00011657778,"about_ca_system_score_gemma":0.00070456037,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W2318768390","doi":"10.1158/1538-7445.am10-1590","title":"Abstract 1590: BRM and BRM polymorphisms applications for target therapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario HIV Treatment Network","funders":"","keywords":"Biology; Chromatin; Cancer research; Cell cycle checkpoint; Cell cycle; Suppressor; Chromatin remodeling; Cell growth; Genetics; Cancer; DNA","score_opus":0.049368389559963526,"score_gpt":0.4038188956679614,"score_spread":0.3544505061079979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318768390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906611,0.005255359,0.0011059042,0.00070005475,0.00011679032,0.0005900418,0.000094117655,0.000013258799,0.0014634156],"genre_scores_gemma":[0.9942114,0.0016440961,0.0010445075,0.00014825695,0.00083178125,0.0008897395,0.000060946546,0.000020038678,0.0011492455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912864,0.000012972426,0.00010236507,0.00030520916,0.00017507681,0.00027572725],"domain_scores_gemma":[0.999312,0.000025824142,0.000024974774,0.00030584805,0.00023311636,0.00009823405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036448654,0.00008222286,0.000078714154,0.000036451398,0.00018428336,0.00003980542,0.00017550042,0.00014763027,0.00011546764],"category_scores_gemma":[0.000027555136,0.00007371676,0.000042325726,0.00007107212,0.00014640507,0.0000028415566,0.00004664395,0.00023799141,0.0000057727466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006093578,0.000025735528,0.00029045803,0.000019427533,0.000017378703,1.5211945e-7,0.000028369304,0.000011246933,0.947837,0.0001840689,0.003628429,0.047896814],"study_design_scores_gemma":[0.00054888683,0.00008002019,0.0012816772,0.000006916898,0.0000019778663,0.0000028213783,0.000026321773,0.00006988818,0.5417183,0.0010562177,0.45508745,0.00011948628],"about_ca_topic_score_codex":0.00022161684,"about_ca_topic_score_gemma":0.0001587533,"teacher_disagreement_score":0.45145902,"about_ca_system_score_codex":0.000015593852,"about_ca_system_score_gemma":0.00022359096,"threshold_uncertainty_score":0.30060822},"labels":[],"label_agreement":null},{"id":"W2318785266","doi":"10.1158/1538-7445.am2012-2550","title":"Abstract 2550: Expanded simple tandem repeat (ESTR) mutations in offspring of benzo(a)pyrene exposed DNA repair deficient male mice","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Offspring; Benzo(a)pyrene; Biology; Genetics; Molecular biology; Mutation; Germline; Mutant; Andrology; Carcinogen; Pregnancy; Medicine; Gene","score_opus":0.060435671322869026,"score_gpt":0.36502023371897674,"score_spread":0.3045845623961077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318785266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958549,0.0018039857,0.00005808216,0.000050433224,0.000114483475,0.00037404665,0.000030275512,0.00002276887,0.0016910238],"genre_scores_gemma":[0.99822867,0.00015295534,0.00046638263,0.000024361561,0.00015660517,0.0001851191,0.00006627965,0.000033126413,0.00068647444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980239,0.00013272869,0.00035290507,0.0003994444,0.00042729147,0.00066373096],"domain_scores_gemma":[0.9989391,0.00004873778,0.000085372325,0.0005448507,0.00021773214,0.00016419616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196965,0.0001392778,0.00018562876,0.00016347085,0.00009886454,0.000016084043,0.00026185144,0.00015935807,0.00019625484],"category_scores_gemma":[0.0002622635,0.00014353663,0.00011089311,0.00031819433,0.00011854752,0.000014181784,0.00021213361,0.00022631015,0.000013567725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006999821,0.00015682734,0.017943857,0.00005935896,0.000027762811,0.0000066646053,0.00024811167,0.0001549776,0.9794631,0.00008579808,0.0007612561,0.0010222621],"study_design_scores_gemma":[0.00052946794,0.00013446712,0.022823133,0.000049685743,0.0000073821834,0.000008098855,0.00058446516,0.00004639626,0.97278637,0.00006910941,0.0028101956,0.00015120745],"about_ca_topic_score_codex":0.00046343388,"about_ca_topic_score_gemma":0.00046160555,"teacher_disagreement_score":0.0066767335,"about_ca_system_score_codex":0.00013943756,"about_ca_system_score_gemma":0.00022725461,"threshold_uncertainty_score":0.58532536},"labels":[],"label_agreement":null},{"id":"W2318822787","doi":"10.1158/0008-5472.sabcs11-p1-12-12","title":"P1-12-12: Evaluation of Ile655Val HER2 Polymorphism Associated with Cardiac Toxicity Following the Administration of Trastuzumab in Women with Non-Metastatic Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Trastuzumab; Breast cancer; Medicine; Metastatic breast cancer; Ejection fraction; Population; Toxicity; Oncology; Internal medicine; Genotype; Cardiac toxicity; Genotyping; Cancer; Biology; Heart failure; Genetics","score_opus":0.15211811148307627,"score_gpt":0.4311966634983403,"score_spread":0.279078552015264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318822787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393594,0.00060851057,0.000018962786,0.00058740797,0.00009618976,0.0024147357,0.00020418972,0.000015945152,0.002118097],"genre_scores_gemma":[0.9973144,0.00016566645,0.000054108234,0.000032950145,0.00009636705,0.002034976,0.000017040593,0.00006283914,0.00022164205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99282676,0.0011388273,0.000555319,0.0005067911,0.004047769,0.0009245157],"domain_scores_gemma":[0.9972576,0.0003600299,0.00022375598,0.0006318966,0.0012722756,0.00025443154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00782504,0.00023895303,0.0007009243,0.00040515565,0.00014749767,0.000025825362,0.00037829884,0.00011589918,0.0010065302],"category_scores_gemma":[0.00035727958,0.00016000871,0.00009392579,0.0015336478,0.00062888797,0.00018675893,0.00007641227,0.00084652635,0.0000029639536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05495494,0.0044224695,0.57668304,0.0020771276,0.005228163,0.00038672902,0.06571884,0.00088233425,0.13630223,0.00007689363,0.002161315,0.15110591],"study_design_scores_gemma":[0.00677982,0.0039368584,0.9163274,0.0027084085,0.00033895206,0.000018410872,0.006481116,0.00093866757,0.06205719,0.00009896237,0.000035486002,0.00027871024],"about_ca_topic_score_codex":0.013411167,"about_ca_topic_score_gemma":0.011007113,"teacher_disagreement_score":0.33964437,"about_ca_system_score_codex":0.0032883806,"about_ca_system_score_gemma":0.008514645,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2318867117","doi":"10.1158/0008-5472.sabcs-6082","title":"Breast cancer mortality trends in the WEST compared to the EAST: lives gained, lives lost.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Demography; China; Westernization; Breast cancer; Population; Mortality rate; Epidemiology; Psychological intervention; Cancer; Environmental health; Geography; Surgery; Internal medicine; Economic growth","score_opus":0.2884822385971949,"score_gpt":0.5007452950412025,"score_spread":0.21226305644400756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318867117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90649754,0.004520072,0.000007979914,0.075448126,0.000116723844,0.0006151565,0.0001153126,0.00002639575,0.012652694],"genre_scores_gemma":[0.99232036,0.00050921185,0.000020704223,0.0043725744,0.0009445476,0.00023348551,0.000012872317,0.000014771249,0.001571485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966846,0.0003398921,0.00029523103,0.00045750174,0.0013920497,0.0008307034],"domain_scores_gemma":[0.99850464,0.00012443974,0.00004616657,0.00072032755,0.00035780075,0.00024665263],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015983973,0.00019328408,0.00032043178,0.00025578402,0.00028904056,0.00012105436,0.00074117276,0.000055614895,0.0016241218],"category_scores_gemma":[0.000074619405,0.00010922883,0.000107651045,0.001919841,0.00025457906,0.00013671075,0.00010211642,0.00083425594,0.00011369718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004461252,0.00068552536,0.44377685,0.00014753341,0.00025843555,0.000873976,0.044415012,0.0018999263,0.005515043,0.0012536395,0.20901729,0.28769553],"study_design_scores_gemma":[0.00075614214,0.00026002168,0.9814353,0.00046673894,0.000034778353,0.0000938649,0.007969652,0.00020671877,0.0002132506,0.00012706246,0.008274664,0.00016178153],"about_ca_topic_score_codex":0.017737702,"about_ca_topic_score_gemma":0.018984014,"teacher_disagreement_score":0.53765845,"about_ca_system_score_codex":0.00043870136,"about_ca_system_score_gemma":0.00040488187,"threshold_uncertainty_score":0.9992885},"labels":[],"label_agreement":null},{"id":"W2318903285","doi":"10.1158/1538-7445.am2013-2715","title":"Abstract 2715: Establishment of patient primary colorectal tumor xenograft models for test of anticancer agents.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Irinotecan; Medicine; Primary tumor; Oxaliplatin; Colorectal cancer; Transplantation; Histopathology; Cancer; Cancer research; Oncology; Pathology; Metastasis; Internal medicine","score_opus":0.040138490582337774,"score_gpt":0.35987126205750447,"score_spread":0.3197327714751667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318903285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941768,0.0020891728,0.000039398554,0.00012883969,0.000059083504,0.0015522066,0.0005241592,0.0000048090224,0.0014255513],"genre_scores_gemma":[0.99670106,0.0009479265,0.00026691586,0.000043154705,0.00008426515,0.0015938209,0.00013194844,0.00003076073,0.00020017043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805653,0.00004386922,0.0003127769,0.00038597328,0.0006248742,0.00057599746],"domain_scores_gemma":[0.99842536,0.00009675639,0.00010655216,0.00035321258,0.0008318715,0.00018626823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028500194,0.00014228513,0.00023950398,0.00012339982,0.000080425045,0.0000285715,0.00029137652,0.00007285037,0.00023716388],"category_scores_gemma":[0.00012503655,0.0001234365,0.00012572735,0.0002135436,0.00031263148,0.000018456982,0.00021065577,0.00013233392,0.0000058681194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067821477,0.00070694555,0.0078030177,0.0004177261,0.00020253187,0.00000389282,0.00012496788,0.0002481674,0.95503575,0.0000359364,0.018141115,0.016601766],"study_design_scores_gemma":[0.0015106353,0.0018526801,0.012503167,0.00009512035,0.0000129741275,0.000001549526,0.00013618391,0.00013900625,0.97807515,0.0003973611,0.005119701,0.00015646797],"about_ca_topic_score_codex":0.0031380127,"about_ca_topic_score_gemma":0.00023355697,"teacher_disagreement_score":0.023039436,"about_ca_system_score_codex":0.00015476199,"about_ca_system_score_gemma":0.00065245555,"threshold_uncertainty_score":0.5033595},"labels":[],"label_agreement":null},{"id":"W2318906201","doi":"10.1158/1538-7445.am2012-5069","title":"Abstract 5069: Genomic profiles of primary non-small cell lung cancer (NSCLC) xenograft tumors identify distinct gene signatures associated with histological subtypes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children; University Health Network","funders":"","keywords":"Cancer research; Adenocarcinoma; Somatic cell; Cancer; Lung cancer; Biology; SOX2; Primary tumor; Histology; Copy-number variation; Gene; Medicine; Pathology; Genetics; Metastasis; Genome","score_opus":0.027471401686618675,"score_gpt":0.31913446404163054,"score_spread":0.2916630623550119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318906201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96164787,0.035633128,0.000054532546,0.00006452854,0.00020995383,0.00060996524,0.00040902867,0.000012526422,0.0013584787],"genre_scores_gemma":[0.995788,0.0022148136,0.00013919617,0.00006918003,0.00058094884,0.0003317641,0.0003160334,0.00006315275,0.0004969117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977952,0.00010496557,0.00033517572,0.00049781316,0.00040762607,0.00085921475],"domain_scores_gemma":[0.99855894,0.00013637655,0.0002161563,0.00041610977,0.0004192568,0.00025318257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067301065,0.0002580452,0.00035889627,0.000116447154,0.00017958575,0.000044173314,0.00046765886,0.00027110122,0.00015782619],"category_scores_gemma":[0.00013782004,0.00021739639,0.000117932184,0.00023809598,0.00036788196,0.000009868487,0.00029298212,0.00044820574,0.0000052570217],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003583812,0.00023646577,0.19037528,0.00020485277,0.0001432357,0.000011975928,0.000121215526,0.0001742703,0.80246305,0.000010722633,0.0053196712,0.0005808754],"study_design_scores_gemma":[0.0007233728,0.00019778225,0.5847521,0.00011826364,0.00005869369,0.000002071042,0.00006597478,0.0000125780025,0.41197655,0.000009269141,0.0017842992,0.00029905283],"about_ca_topic_score_codex":0.0014359909,"about_ca_topic_score_gemma":0.00090593554,"teacher_disagreement_score":0.3943768,"about_ca_system_score_codex":0.00051922246,"about_ca_system_score_gemma":0.0009866928,"threshold_uncertainty_score":0.88651675},"labels":[],"label_agreement":null},{"id":"W2318910691","doi":"10.1158/1538-7445.am2011-lb-38","title":"Abstract LB-38: Selective Smoothened antagonists for anti-tumor therapy","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Casa","funders":"","keywords":"Smoothened; Patched; Hedgehog signaling pathway; Hedgehog; GLI1; Cancer research; PTCH1; Sonic hedgehog; Chemistry; Biology; Cell biology; Signal transduction","score_opus":0.17135991753827154,"score_gpt":0.4167625486713849,"score_spread":0.24540263113311336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318910691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931818,0.0028809558,0.00017057228,0.00012082315,0.00015168641,0.00070401846,0.00008037003,0.000019566136,0.0026901923],"genre_scores_gemma":[0.9970179,0.0009814898,0.00024579262,0.00012049827,0.0004215871,0.0006430864,0.000019454472,0.000046650388,0.0005035114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853295,0.00007402028,0.00015707818,0.00045861592,0.00021769355,0.00055965385],"domain_scores_gemma":[0.99898726,0.00004320981,0.00004599546,0.00031439395,0.00051517115,0.000093951734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063054974,0.00014787776,0.0001684587,0.00007572109,0.00027308217,0.000025650495,0.00031010207,0.00009605846,0.000083342704],"category_scores_gemma":[0.00013703784,0.00012867413,0.00009040219,0.00016312127,0.00023756434,0.000003850831,0.00008521344,0.00017272335,0.00001683085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039938473,0.0000877811,0.0026555918,0.00003267249,0.00012951254,0.0000059533504,0.00048734387,0.000002610972,0.9875119,0.000052649284,0.00559677,0.003037875],"study_design_scores_gemma":[0.00068807387,0.0004241653,0.012243388,0.000018464058,0.0000030065357,0.0000017696108,0.00016214783,0.0000024455096,0.9445022,0.00024435908,0.04154705,0.00016295532],"about_ca_topic_score_codex":0.00020003779,"about_ca_topic_score_gemma":0.00007452953,"teacher_disagreement_score":0.04300968,"about_ca_system_score_codex":0.00004989074,"about_ca_system_score_gemma":0.00034534113,"threshold_uncertainty_score":0.52471787},"labels":[],"label_agreement":null},{"id":"W2318954959","doi":"10.1158/0008-5472.sabcs10-p2-11-01","title":"Abstract P2-11-01: Molecular Profiling Identifies Differentially Expressed Genes between Normal Breast Tissue from <i>BRCA</i> Carriers and Women at Population Risk","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Microarray; Gene expression; Population; Gene; Gene expression profiling; Microarray analysis techniques; Biology; Reduction Mammoplasty; Oncology; Genetics; Cancer; Bioinformatics; Pathology; Medicine","score_opus":0.020816747098856014,"score_gpt":0.3273912466761906,"score_spread":0.30657449957733457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318954959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976243,0.00093316316,0.00015369579,0.00015342885,0.00026495347,0.00032280365,0.0004399621,0.000018890994,0.00008879423],"genre_scores_gemma":[0.99732906,0.00053337915,0.00009676047,0.00002042425,0.0006696113,0.00026389802,0.000599748,0.0000396873,0.00044744852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805504,0.00014853524,0.000250433,0.0006312916,0.0004550881,0.00045960746],"domain_scores_gemma":[0.9988937,0.00003104675,0.00011880502,0.0005122373,0.0001857873,0.00025844484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041683146,0.00018031686,0.00017643045,0.00009935714,0.0003455387,0.0001320175,0.00029592545,0.0002527727,0.00024196957],"category_scores_gemma":[0.00006572151,0.0001731764,0.000045028606,0.0001275993,0.00017105631,0.000018171206,0.0002813344,0.00033384378,0.000007695497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103561964,0.000014747563,0.08514943,0.00003071773,0.00004427121,0.0000016577034,0.00014513677,0.000016289427,0.904145,0.0000066614366,0.00044749674,0.009895006],"study_design_scores_gemma":[0.00039983727,0.000026698262,0.22735901,0.000015317855,0.0000120558325,8.850977e-7,0.00016138711,0.000007937286,0.76662695,0.00011855084,0.0051088175,0.00016252237],"about_ca_topic_score_codex":0.0014370407,"about_ca_topic_score_gemma":0.0008117492,"teacher_disagreement_score":0.14220959,"about_ca_system_score_codex":0.000075168406,"about_ca_system_score_gemma":0.00012465614,"threshold_uncertainty_score":0.7061929},"labels":[],"label_agreement":null},{"id":"W2318991709","doi":"10.1158/1538-7445.am2012-sy15-01","title":"Abstract SY15-01: Cellular context-specific tumor suppression by <i>PTPN11</i>","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTPN11; Biology; Cancer research; Population; Pathology; Mutation; Genetics; Medicine; Gene; KRAS","score_opus":0.06171657700198393,"score_gpt":0.3535917091381917,"score_spread":0.2918751321362078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318991709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8502389,0.14082845,0.000014342831,0.00054856174,0.001722974,0.00033011526,0.00011056061,0.00006210897,0.0061439867],"genre_scores_gemma":[0.9757987,0.0013340496,0.0000027169099,0.00020719568,0.00015974556,0.00013173578,0.00008708352,0.000039093335,0.022239674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974975,0.00053721823,0.0002945295,0.00032425448,0.00014280184,0.0012036699],"domain_scores_gemma":[0.9988473,0.00035234238,0.00006072043,0.00046594764,0.00018264812,0.00009104609],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010637916,0.0001986297,0.00027668357,0.00016633072,0.00043826716,0.000045575496,0.00048409696,0.0002201582,0.015596268],"category_scores_gemma":[0.00009627349,0.0001623291,0.00010188296,0.00019236444,0.00053323363,0.00022052083,0.00020550047,0.001041861,0.005330656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061908667,0.0001239649,0.0002787433,0.000019135456,0.000037410526,0.0000049026507,0.00027878856,6.837934e-8,0.64444506,0.0002426455,0.34944534,0.0045048674],"study_design_scores_gemma":[0.00046842775,0.00006229418,0.0005687902,0.00005248238,0.0000027269582,0.000012143622,0.00039240118,7.208514e-8,0.51615256,0.0000073637716,0.48217803,0.000102684695],"about_ca_topic_score_codex":0.00046682285,"about_ca_topic_score_gemma":0.000008026928,"teacher_disagreement_score":0.13949439,"about_ca_system_score_codex":0.00017204361,"about_ca_system_score_gemma":0.00015326936,"threshold_uncertainty_score":0.9954438},"labels":[],"label_agreement":null},{"id":"W2319060123","doi":"10.1158/1538-7445.am2011-3742","title":"Abstract 3742: Gene-environment Interactions in esophageal adenocarcinoma risk: A case-only analysis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"GERD; Single-nucleotide polymorphism; Internal medicine; Medicine; Esophageal cancer; Gastroenterology; Logistic regression; Incidence (geometry); Etiology; Cancer; Oncology; Disease; Reflux; Biology; Gene; Genetics; Genotype","score_opus":0.13003310230730436,"score_gpt":0.4162698483340639,"score_spread":0.2862367460267595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319060123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98382974,0.011274135,0.00003946056,0.00029556258,0.000059059195,0.00089770235,0.00013833432,0.000035178367,0.003430853],"genre_scores_gemma":[0.9947234,0.0020169828,0.00040269172,0.000039679882,0.0001888426,0.00070233823,0.000039462564,0.00004140786,0.0018452251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996644,0.00026649056,0.0004095032,0.0007210163,0.0009728326,0.0009861479],"domain_scores_gemma":[0.9981676,0.00018536222,0.00007850815,0.00077131885,0.0001613108,0.00063592196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009991847,0.00022997882,0.00045260132,0.0013341723,0.00026643215,0.00004166511,0.0002213751,0.0000834882,0.009539927],"category_scores_gemma":[0.00008631844,0.0001977384,0.00026394968,0.0015094305,0.00027813076,0.00017259651,0.00016585787,0.0013292474,0.00044385338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009520966,0.00076226436,0.9516018,0.00006881644,0.0012417908,0.030665677,0.0016001835,0.000052286843,0.00033139702,0.00004649983,0.00040554898,0.012271639],"study_design_scores_gemma":[0.0017097307,0.0004258085,0.98956984,0.000045748995,0.00034408813,0.00053186,0.00052862224,0.00012436607,0.0062106154,0.00011698083,0.00024529998,0.00014704597],"about_ca_topic_score_codex":0.040856324,"about_ca_topic_score_gemma":0.0114138415,"teacher_disagreement_score":0.037968036,"about_ca_system_score_codex":0.0017311444,"about_ca_system_score_gemma":0.00062194205,"threshold_uncertainty_score":0.9913655},"labels":[],"label_agreement":null},{"id":"W2319080733","doi":"10.1158/1538-7445.am2012-4455","title":"Abstract 4455: Mild and moderate early-life stressors differentially affect stress reactivity and mammary tumorigenesis in BALB/c mice: A new look at the stress and breast cancer relationship","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Endocrinology; Internal medicine; Breast cancer; Carcinogenesis; Stressor; DMBA; Endocrine system; Offspring; Mammary gland; Estrogen; Hormone; Cancer; Estrogen receptor; Medicine; 7,12-Dimethylbenz[a]anthracene; Psychology; Physiology; Biology; Pregnancy; Clinical psychology","score_opus":0.0961856715642044,"score_gpt":0.39226291402147906,"score_spread":0.2960772424572746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319080733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780304,0.015549422,0.000006475748,0.0049228426,0.000102806254,0.00087156164,0.00021548565,0.000022231843,0.00027882034],"genre_scores_gemma":[0.93570673,0.063108794,0.000026447731,0.00012195601,0.00032750834,0.00016243049,0.000018651579,0.000036717065,0.0004907461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749655,0.00029669394,0.00028369337,0.00049664703,0.0005983438,0.00082807086],"domain_scores_gemma":[0.9982041,0.00048798483,0.000092986695,0.00031767163,0.00012455617,0.0007726937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009107471,0.00024129656,0.00039133482,0.00022708974,0.00045719772,0.00010975528,0.00012407544,0.0001782818,0.00014147702],"category_scores_gemma":[0.000086912754,0.00017726947,0.000030433552,0.00029117498,0.00030821405,0.0003334548,0.00023549335,0.0008686978,0.000003948829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009557438,0.00011563181,0.98632884,0.0008300634,0.00006695294,0.000017166953,0.00217147,0.0000042348843,0.0024316534,0.0003754685,0.0006361765,0.0060665887],"study_design_scores_gemma":[0.0016896604,0.000043790697,0.99464077,0.00072692195,0.00003422548,0.000019227477,0.00029395387,0.000050071667,0.0020303703,0.00025237657,0.000039328846,0.0001793255],"about_ca_topic_score_codex":0.018690243,"about_ca_topic_score_gemma":0.024625009,"teacher_disagreement_score":0.047559373,"about_ca_system_score_codex":0.00034274356,"about_ca_system_score_gemma":0.0010310796,"threshold_uncertainty_score":0.99317306},"labels":[],"label_agreement":null},{"id":"W2319101391","doi":"10.1158/1538-7445.am10-1452","title":"Abstract 1452: Examination of mechanisms involved in spontaneous melanoma metastasis to CNS","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; Health Sciences Centre; National Institute for Nanotechnology; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Melanoma; Medicine; Metastasis; Brain metastasis; Cancer research; Cancer; Pathology; Parenchyma; Internal medicine","score_opus":0.04421985935714208,"score_gpt":0.32230843550544863,"score_spread":0.27808857614830657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319101391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966489,0.00018668229,0.00054638245,0.000049818038,0.0004531975,0.00043089775,0.00006552711,0.000060100196,0.0015584728],"genre_scores_gemma":[0.99827087,0.00010090291,0.0012438608,0.0000108133545,0.00007157934,0.00015088069,0.000008001834,0.00005227407,0.000090825044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985036,0.000023381217,0.00027157573,0.00020051003,0.0005456399,0.0004552579],"domain_scores_gemma":[0.99914813,0.0001735722,0.000022583967,0.0003412134,0.0001779222,0.00013659112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009862947,0.0001298829,0.00021360276,0.0005251113,0.00003676349,0.00002793661,0.0003415434,0.000121448815,0.00053316366],"category_scores_gemma":[0.0001237289,0.00013168778,0.000039546856,0.0007193477,0.00004802972,0.00013134569,0.00005476227,0.0005987676,0.000052786978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041441708,0.000022479797,0.00006353767,0.00011269415,0.000026492355,0.000076431206,0.00055339583,0.0016107938,0.96447587,0.0008378042,0.000112321395,0.032066755],"study_design_scores_gemma":[0.0004978353,0.0001087174,0.009201776,0.00008931702,0.000007741011,0.000008976272,0.00026824226,0.00078942266,0.9847896,0.0017369284,0.0022830013,0.00021841237],"about_ca_topic_score_codex":0.00054390525,"about_ca_topic_score_gemma":0.008623222,"teacher_disagreement_score":0.03184834,"about_ca_system_score_codex":0.00032755383,"about_ca_system_score_gemma":0.00010140092,"threshold_uncertainty_score":0.58377683},"labels":[],"label_agreement":null},{"id":"W2319127466","doi":"10.1158/0008-5472.sabcs-09-5086","title":"Outcomes of Women with Early Stage HER2 Overexpressing Breast Cancer Receiving Adjuvant Trastuzumab: A Population Based Analysis.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Internal medicine; Stage (stratigraphy); Population; Cancer; Adjuvant; Gynecology","score_opus":0.07056468673399381,"score_gpt":0.4438137434065366,"score_spread":0.3732490566725428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319127466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947467,0.0006569996,0.0001375605,0.0026856293,0.000045942128,0.0009054902,0.00022405213,0.000068502304,0.0005291373],"genre_scores_gemma":[0.99712336,0.00030794714,0.00028263486,0.00022987094,0.00016991433,0.00038165622,0.00002633098,0.0000637975,0.0014145134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396795,0.00041562333,0.0005605155,0.00075020397,0.0028226282,0.0014831041],"domain_scores_gemma":[0.9970336,0.00027076062,0.00018133015,0.0008926855,0.001001526,0.0006201041],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021295464,0.00029401353,0.001031268,0.0012217191,0.00023542599,0.00011101717,0.0003794894,0.0001570393,0.002807306],"category_scores_gemma":[0.00018488451,0.00022682901,0.00016527316,0.0033823268,0.000234639,0.00026097536,0.000068594025,0.000977741,0.000007218421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023646706,0.0002477504,0.9496927,0.00032660583,0.0006248703,0.00005517209,0.0012757836,0.0013374693,0.011423022,0.000026239819,0.00025372347,0.032371994],"study_design_scores_gemma":[0.0019633349,0.00069437077,0.9920695,0.0007510816,0.00014439113,0.0000032153712,0.0003755698,0.0008164831,0.0025227924,0.000027604881,0.000400238,0.00023142737],"about_ca_topic_score_codex":0.037152678,"about_ca_topic_score_gemma":0.0024439334,"teacher_disagreement_score":0.04237679,"about_ca_system_score_codex":0.0044565676,"about_ca_system_score_gemma":0.0020288578,"threshold_uncertainty_score":0.99936515},"labels":[],"label_agreement":null},{"id":"W2319160127","doi":"10.1158/1538-7445.am10-4507","title":"Abstract 4507: Discovery of a novel single chain ribosome inactivating protein that selectively kills human melanoma cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Melanoma; Dacarbazine; Cytotoxic T cell; Cancer research; Medicine; Biology; Pharmacology; In vitro; Biochemistry","score_opus":0.058642406093763685,"score_gpt":0.33416853526980883,"score_spread":0.27552612917604513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319160127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961194,0.00027409111,0.00010141919,0.00012481715,0.00045864529,0.00083304674,0.00014729977,0.000039305272,0.0019020172],"genre_scores_gemma":[0.99447,0.000013960789,0.00020947336,0.000019817115,0.00009818206,0.00024468717,0.000024943052,0.000046956062,0.0048720078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806243,0.00015657498,0.00032990804,0.00047500708,0.00017803007,0.000798042],"domain_scores_gemma":[0.99885577,0.0001960279,0.00019706415,0.0004624796,0.000249817,0.00003882885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010270247,0.00021729544,0.00036005548,0.000289058,0.0004448468,0.000065334345,0.0005385496,0.0003705096,0.00080230716],"category_scores_gemma":[0.00016611302,0.0001917854,0.00010604585,0.00035870858,0.0004826823,0.00032690982,0.00024033239,0.0016632528,0.000056572684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013660155,0.00051949715,0.00021292732,0.00006900249,0.00010211478,0.0000033487856,0.0005107836,0.0000013914959,0.99156564,0.0051648817,0.000179388,0.0015344372],"study_design_scores_gemma":[0.0011554436,0.0003980913,0.0054630786,0.00017172184,0.000005776559,0.0000062604117,0.00045034025,8.85405e-7,0.98943394,0.00030418456,0.0023984043,0.00021185006],"about_ca_topic_score_codex":0.0020931163,"about_ca_topic_score_gemma":0.00036723135,"teacher_disagreement_score":0.0052501513,"about_ca_system_score_codex":0.00016852065,"about_ca_system_score_gemma":0.00028705853,"threshold_uncertainty_score":0.8784701},"labels":[],"label_agreement":null},{"id":"W2319200733","doi":"10.1158/1538-7445.am2012-3019","title":"Abstract 3019: TGFβ3 is a less potent inducer of TGFβ signaling than TGFβ1 in non-small cell lung cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Transforming growth factor; SMAD; R-SMAD; Cancer research; ACVRL1; Cell biology; Smad2 Protein; Cytokine; Biology; Transforming growth factor beta; Endoglin; Receptor; Medicine; Internal medicine; TGF alpha; Growth factor; Immunology; Stem cell","score_opus":0.05818725952778235,"score_gpt":0.37411008226101916,"score_spread":0.3159228227332368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319200733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827993,0.015409521,0.00003661043,0.000087492124,0.00026080935,0.00051402947,0.00012203524,0.000008379654,0.00076182187],"genre_scores_gemma":[0.9973754,0.0007346334,0.000097032615,0.00011354408,0.0006652847,0.0003130554,0.000027646314,0.000068875306,0.0006045161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973669,0.00014247968,0.00040495576,0.00052512245,0.00055608054,0.001004483],"domain_scores_gemma":[0.9986118,0.0000644935,0.00013468458,0.00054398656,0.00032961933,0.0003154003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008819664,0.00024493222,0.00028165363,0.00021241987,0.000105184634,0.000037330585,0.0005685393,0.00027592384,0.00035126414],"category_scores_gemma":[0.000041083676,0.00024037444,0.0001368542,0.00034115856,0.00016550435,0.000014608569,0.00030332137,0.00047301612,0.000015537942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015245519,0.00029633072,0.07201221,0.00043893658,0.000062206724,0.0000057534257,0.0007245738,0.00069982174,0.9219919,0.0000017771866,0.0023997542,0.0012143248],"study_design_scores_gemma":[0.000640685,0.000054099142,0.029976962,0.00027456635,0.000020433676,5.4221766e-7,0.00040288572,0.000043985016,0.9665843,0.0000046635705,0.0017271141,0.000269726],"about_ca_topic_score_codex":0.0027858214,"about_ca_topic_score_gemma":0.00031724066,"teacher_disagreement_score":0.044592477,"about_ca_system_score_codex":0.00018524079,"about_ca_system_score_gemma":0.0007788946,"threshold_uncertainty_score":0.9802185},"labels":[],"label_agreement":null},{"id":"W2319222851","doi":"10.1158/1538-7445.am2013-2777","title":"Abstract 2777: Advantages of patient primary tumor models versus tumor cell lines derived models for testing anticancer therapeutics.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Primary tumor; Pemetrexed; Irinotecan; Gemcitabine; Cancer; Docetaxel; Cancer research; Carboplatin; Cisplatin; Stromal tumor; Pancreatic cancer; Oncology; Internal medicine; Colorectal cancer; Chemotherapy; Metastasis; Stromal cell","score_opus":0.10820620486425346,"score_gpt":0.3891859528945111,"score_spread":0.2809797480302576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319222851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891656,0.0074947574,0.00029099322,0.00010433355,0.00010813342,0.0014101341,0.0002201378,0.000013385727,0.0011925141],"genre_scores_gemma":[0.99508363,0.0013204628,0.001529322,0.000107137006,0.00018824902,0.001496188,0.00007602898,0.000059071135,0.00013990606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978094,0.00006711025,0.0003057149,0.00052498316,0.0005348298,0.0007579501],"domain_scores_gemma":[0.99805105,0.0001751684,0.00011216154,0.0004471236,0.0010231134,0.0001914124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023339682,0.00021140932,0.00025776692,0.00010783817,0.00016370026,0.00006206935,0.00034482032,0.000071491166,0.00005514402],"category_scores_gemma":[0.00006856781,0.00018139266,0.0001177418,0.00020100326,0.0002108362,0.000034177105,0.00021588382,0.00020129509,0.000007969002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013205132,0.0002563489,0.00033624037,0.0003394111,0.0001560769,0.000006336542,0.00012705357,0.0030928906,0.9730697,0.000017051863,0.000887481,0.020390868],"study_design_scores_gemma":[0.003181395,0.001447312,0.00084343966,0.000116034535,0.000027276388,0.0000020323155,0.0003670533,0.0032361217,0.9881357,0.0012363697,0.0011167311,0.0002905206],"about_ca_topic_score_codex":0.0015509871,"about_ca_topic_score_gemma":0.00018882906,"teacher_disagreement_score":0.020100348,"about_ca_system_score_codex":0.00014844844,"about_ca_system_score_gemma":0.00074101397,"threshold_uncertainty_score":0.7396978},"labels":[],"label_agreement":null},{"id":"W2319234722","doi":"10.1158/0008-5472.fbcr09-b59","title":"Abstract B59: Role of Nf1 signaling in regulating pigmentation in the mouse","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurofibromin 1; Microphthalmia-associated transcription factor; Melanocyte; Dermis; Biology; Melanocortin 1 receptor; Knockout mouse; Gene knockin; Allele; Neurofibromatosis; Cancer research; Genetics; Cell biology; Gene; Anatomy; Melanoma; Transcription factor","score_opus":0.05199039787244116,"score_gpt":0.37962530007676654,"score_spread":0.3276349022043254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319234722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971757,0.00067409594,0.0000061139067,0.00014718156,0.000009235805,0.00015459722,0.000003799036,0.0000013698856,0.001827889],"genre_scores_gemma":[0.99961233,0.00008715516,0.00004969543,0.000045056626,0.00008102939,0.00002732022,0.000020397916,0.0000044019735,0.0000726409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992729,0.00009003309,0.00013935428,0.00013768085,0.00017630302,0.00018376812],"domain_scores_gemma":[0.9997336,0.000022244209,0.000028634167,0.00015118539,0.0000457234,0.000018565976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007531216,0.000043758235,0.000059176622,0.00006630068,0.000030294656,0.000011388296,0.00014593355,0.000052334493,0.000018702682],"category_scores_gemma":[0.000053138298,0.00003510628,0.000019491685,0.00014830168,0.000028971566,0.0000033070773,0.000020028028,0.00012839268,0.000001342662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049630813,0.000032326978,0.0027900438,0.000010707706,0.0000018042326,0.000001783078,0.00040765657,0.00033410566,0.9880476,0.00010929542,0.00012402887,0.008091001],"study_design_scores_gemma":[0.0002701925,0.00010594877,0.028599136,0.000026433061,5.979743e-7,5.6568354e-7,0.0009135678,0.00003352933,0.9691215,0.00039414858,0.0004917103,0.000042674146],"about_ca_topic_score_codex":0.00031691758,"about_ca_topic_score_gemma":0.00019403851,"teacher_disagreement_score":0.025809092,"about_ca_system_score_codex":0.000023500063,"about_ca_system_score_gemma":0.00008407952,"threshold_uncertainty_score":0.14315926},"labels":[],"label_agreement":null},{"id":"W2319401511","doi":"10.1158/0008-5472.sabcs-09-1115","title":"Non-Infectious Pneumonitis (NIP) in Breast Cancer (BC) Patients (Pts) Treated with Everolimus (Afinitor™) Containing Therapy: Analysis of Five Studies.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Discontinuation; Everolimus; Pneumonitis; Internal medicine; Breast cancer; Cancer; Adverse effect; NIP; Combination therapy; Oncology; Gastroenterology; Surgery; Lung","score_opus":0.03646062814678887,"score_gpt":0.3788572968589696,"score_spread":0.3423966687121808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319401511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959039,0.0029164238,0.000010287886,0.00017507482,0.00008674552,0.00042306914,0.0002035986,0.0000121169105,0.00026880068],"genre_scores_gemma":[0.99288785,0.006176698,0.000010648943,0.00016062234,0.00018749457,0.0003200757,0.00006520096,0.000033469325,0.00015795641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997721,0.00017969232,0.00033326307,0.0006195572,0.0005436283,0.0006028664],"domain_scores_gemma":[0.9980277,0.00006476568,0.0001485193,0.00044138706,0.0012015188,0.00011610238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040075835,0.00024403165,0.00051331765,0.00045942064,0.0001217927,0.000023919962,0.0002863255,0.00014162941,0.00007584261],"category_scores_gemma":[0.00004256815,0.00020682799,0.00012176414,0.0016294603,0.00024616683,0.000012391581,0.00007407065,0.0003102634,0.0000019183583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024089199,0.0003138226,0.85791224,0.00003393566,0.0025557752,0.000023292601,0.0008085396,0.0072058113,0.10675205,0.000002506506,0.00068966986,0.021293424],"study_design_scores_gemma":[0.0058380626,0.0028290309,0.8560685,0.00033395254,0.00025873928,0.0000031855031,0.00049444346,0.00032482363,0.13223371,0.000017959374,0.0010510127,0.00054657564],"about_ca_topic_score_codex":0.009942517,"about_ca_topic_score_gemma":0.00393464,"teacher_disagreement_score":0.02548165,"about_ca_system_score_codex":0.0004811132,"about_ca_system_score_gemma":0.00041161219,"threshold_uncertainty_score":0.99665034},"labels":[],"label_agreement":null},{"id":"W2319453476","doi":"10.1158/1538-7445.am10-1998","title":"Abstract 1998: A <i>sparse</i> prognostic gene signature for stage IB and II patients with completely resected non-small cell lung cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Gene signature; Overfitting; Gene; Microarray analysis techniques; Normalization (sociology); Gene expression; Univariate; Proportional hazards model; Computational biology; False discovery rate; Microarray; Gene expression profiling; Significance analysis of microarrays; Biology; Computer science; Multivariate statistics; Medicine; Genetics; Mathematics; Artificial intelligence; Statistics; Internal medicine","score_opus":0.030777911858563396,"score_gpt":0.3285075593139065,"score_spread":0.29772964745534314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319453476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558693,0.0017290895,0.0001616792,0.0002017625,0.00018131976,0.001422651,0.00044058645,0.0000119377555,0.00026402797],"genre_scores_gemma":[0.9947764,0.00036761587,0.000407648,0.00012346965,0.00030422068,0.0014425144,0.00033648984,0.000050006678,0.002191603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983311,0.00004243216,0.0001720727,0.0006198248,0.00034050253,0.00049401284],"domain_scores_gemma":[0.9986939,0.0000393945,0.00009319387,0.0004098444,0.00056105165,0.00020265044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026571748,0.00018148078,0.00015109265,0.00008603869,0.00035227378,0.00006492066,0.00027113818,0.000224959,0.00009438526],"category_scores_gemma":[0.00005427177,0.00014652987,0.000039674433,0.00020602198,0.00016887166,0.000008247293,0.00015639803,0.00047748364,0.000001497669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054032216,0.00011342521,0.024788791,0.00019200511,0.000031974087,9.750592e-7,0.000091445356,0.00003572355,0.9567286,0.0000044202875,0.015470268,0.0020020898],"study_design_scores_gemma":[0.002505156,0.00050965376,0.07767512,0.000083385,0.00002095593,4.579605e-7,0.000058913804,0.000113055714,0.82685316,0.0000080536165,0.09188394,0.0002881673],"about_ca_topic_score_codex":0.00019347882,"about_ca_topic_score_gemma":0.0012993072,"teacher_disagreement_score":0.12987542,"about_ca_system_score_codex":0.00004005742,"about_ca_system_score_gemma":0.0005002881,"threshold_uncertainty_score":0.59753144},"labels":[],"label_agreement":null},{"id":"W2319511967","doi":"10.1158/1538-7445.am2013-997","title":"Abstract 997: Potential targets for siRNA-mediated combinational therapy of breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Survivin; Apoptosis; Gene silencing; Cancer research; Cancer cell; Small interfering RNA; Doxorubicin; MCL1; Cancer; Biology; Cell culture; Programmed cell death; Transfection; Chemotherapy; Downregulation and upregulation; Gene","score_opus":0.04585132737012457,"score_gpt":0.3691751931021335,"score_spread":0.3233238657320089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319511967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804639,0.006852921,0.00014419299,0.0071484414,0.0007132098,0.0028422633,0.00093376235,0.000055747376,0.00084554317],"genre_scores_gemma":[0.99375236,0.003270154,0.000097888034,0.00021655975,0.00041461203,0.0013739489,0.00013816252,0.000068576606,0.0006677103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975444,0.00005956491,0.00034520208,0.00039160828,0.0010352405,0.00062397757],"domain_scores_gemma":[0.99712217,0.00014891445,0.00010989539,0.00033186635,0.0020177097,0.00026945554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044782757,0.00017364192,0.00032535667,0.00029237467,0.00012907932,0.000032512962,0.00022940298,0.00018927055,0.0061802417],"category_scores_gemma":[0.00006417711,0.00015288041,0.00016340408,0.0004484303,0.00028862536,0.000114937124,0.000054527107,0.00053114054,0.00008900312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005317056,0.00030697367,0.00035151423,0.00017021576,0.00021084955,0.00001167079,0.00013002698,0.0001687003,0.93851364,0.00006968845,0.039820235,0.01971481],"study_design_scores_gemma":[0.01375541,0.0006913202,0.21096303,0.00052393595,0.000047038622,0.000027007802,0.00016496626,0.0018026897,0.74691707,0.0007260723,0.023937045,0.00044443444],"about_ca_topic_score_codex":0.003665074,"about_ca_topic_score_gemma":0.0000701106,"teacher_disagreement_score":0.2106115,"about_ca_system_score_codex":0.0004619351,"about_ca_system_score_gemma":0.0013264848,"threshold_uncertainty_score":0.99472827},"labels":[],"label_agreement":null},{"id":"W2319533240","doi":"10.1158/0008-5472.sabcs-09-6015","title":"Advancing Breast Cancer HER2 FISH Quality by Image Analysis.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Pathology; Stage (stratigraphy); Cancer; Biology; Internal medicine","score_opus":0.02988549941776134,"score_gpt":0.474985907764336,"score_spread":0.44510040834657466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319533240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8675783,0.001991038,0.0012367478,0.124303795,0.00013438676,0.0003372569,0.00012452982,0.000102494676,0.004191442],"genre_scores_gemma":[0.98767805,0.0018105748,0.0004938974,0.005353575,0.00061739964,0.00006168793,0.00005711374,0.000029145993,0.0038985347],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970837,0.00025525605,0.00032677603,0.0005028074,0.001029996,0.00080141355],"domain_scores_gemma":[0.9984064,0.00015389344,0.000068730704,0.000443733,0.00041987354,0.0005073713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021707073,0.00015210305,0.0004787412,0.0003056456,0.00022670736,0.000082020655,0.00024089705,0.000082571714,0.0018916697],"category_scores_gemma":[0.000407936,0.000128413,0.00017108826,0.0014692094,0.00022806376,0.00013394553,0.000057369198,0.0012400631,0.000019357307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044591867,0.0003390127,0.10265484,0.00021185697,0.0007071146,0.00012727236,0.0004847089,0.00023314884,0.3076444,0.00014970463,0.36367178,0.22333026],"study_design_scores_gemma":[0.0032258907,0.00024270073,0.84858286,0.0004597754,0.0005543523,0.000043923836,0.0004104964,0.0083075315,0.00796376,0.000411976,0.12922734,0.0005693827],"about_ca_topic_score_codex":0.006032068,"about_ca_topic_score_gemma":0.00024543374,"teacher_disagreement_score":0.74592805,"about_ca_system_score_codex":0.00052135077,"about_ca_system_score_gemma":0.00037537058,"threshold_uncertainty_score":0.99902076},"labels":[],"label_agreement":null},{"id":"W2319573465","doi":"10.1158/1538-7445.am10-2835","title":"Abstract 2835: Mitochondrial genetic variants influence ovarian cancer risk","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Mitochondrial DNA; Single-nucleotide polymorphism; Minor allele frequency; Biology; Genetics; Heteroplasmy; Haplotype; Odds ratio; Allele frequency; Ovarian cancer; Genotype; Allele; Cancer; Oncology; Internal medicine; Gene; Medicine","score_opus":0.02060943937678766,"score_gpt":0.35930198040204964,"score_spread":0.338692541025262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319573465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922112,0.0018804254,0.0015000337,0.00050502305,0.0014588214,0.0009704229,0.00026976713,0.00003736107,0.0011669315],"genre_scores_gemma":[0.9890137,0.004156339,0.0012509489,0.0001518379,0.002708011,0.0010087537,0.000044620585,0.00012661821,0.0015392132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566036,0.000277559,0.00038837627,0.0011528617,0.001189375,0.0013314708],"domain_scores_gemma":[0.9970151,0.0000651739,0.0001222547,0.0013131452,0.00096192246,0.00052240025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008966747,0.00031762684,0.0002584541,0.00027778264,0.0004933864,0.00019911288,0.0011386168,0.00061611953,0.0018359909],"category_scores_gemma":[0.0008385683,0.0003207971,0.0001555526,0.0006668116,0.0004653599,0.000017009856,0.0005446857,0.0021459744,0.00018203384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038221286,0.00007162404,0.0005231439,0.000040273007,0.0001321674,0.00003908405,0.000064347034,0.0009805512,0.97540367,0.00007697791,0.0055527748,0.016733183],"study_design_scores_gemma":[0.0019375553,0.00026243593,0.03171659,0.0000739139,0.000031586056,0.000024300489,0.00004003915,0.00015662592,0.8500249,0.00051167636,0.11466199,0.0005584042],"about_ca_topic_score_codex":0.0063031465,"about_ca_topic_score_gemma":0.00648158,"teacher_disagreement_score":0.12537877,"about_ca_system_score_codex":0.00015041686,"about_ca_system_score_gemma":0.0019148458,"threshold_uncertainty_score":0.9999244},"labels":[],"label_agreement":null},{"id":"W2319592243","doi":"10.1158/1538-7445.am2013-lb-28","title":"Abstract LB-28: The IGF/insulin signaling axis TMPRSS2:ERG and prostate cancer survival.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"TMPRSS2; Prostate cancer; IGFBP3; Medicine; Erg; Internal medicine; Hazard ratio; Prostate; Tissue microarray; Cancer; Oncology; Proportional hazards model; Endocrinology; Cancer research; Receptor; Disease; Confidence interval; Growth factor","score_opus":0.054107141743436823,"score_gpt":0.3653199210769442,"score_spread":0.3112127793335074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319592243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9333842,0.061858237,0.000008199767,0.0020569798,0.0008081567,0.0007094449,0.00008420693,0.000014409502,0.0010761633],"genre_scores_gemma":[0.9569366,0.033821233,0.000035047015,0.00026009828,0.0028466983,0.00096782396,0.00002313592,0.0000495108,0.005059886],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978825,0.00015337212,0.00023811596,0.0005544313,0.0004589273,0.0007126698],"domain_scores_gemma":[0.9986776,0.00007028249,0.00006657327,0.00048309375,0.00048699693,0.00021546028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008673962,0.00019951566,0.00020832368,0.00006818318,0.00034768207,0.00015835773,0.00037790654,0.00015276806,0.0006274262],"category_scores_gemma":[0.00012363351,0.0001451217,0.00007853819,0.00023858085,0.00038126943,0.000011526367,0.00024408213,0.00043975687,0.000045811452],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012233958,0.000030046764,0.0011561019,0.000078023746,0.00010100909,0.0000012604096,0.0003357087,0.000141174,0.911522,0.000040727788,0.028081913,0.058389693],"study_design_scores_gemma":[0.0011904428,0.0001221661,0.023513308,0.00008744931,0.000028108452,0.0000043621394,0.0006406569,0.000052516203,0.27843955,0.00029636116,0.69521666,0.0004084219],"about_ca_topic_score_codex":0.008308857,"about_ca_topic_score_gemma":0.0015076266,"teacher_disagreement_score":0.66713476,"about_ca_system_score_codex":0.000057686062,"about_ca_system_score_gemma":0.0005386152,"threshold_uncertainty_score":0.9982949},"labels":[],"label_agreement":null},{"id":"W2319756919","doi":"10.1158/1538-7445.am2011-3123","title":"Abstract 3123: Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Gap junction; Cell biology; Kinase; Biology; MAPK/ERK pathway; Phosphatidylinositol; Protein kinase B; Intracellular; Tyrosine kinase; Signal transduction; Molecular biology","score_opus":0.10490107151401981,"score_gpt":0.35121398595948866,"score_spread":0.24631291444546885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319756919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951544,0.0032381122,0.000072197465,0.000034178127,0.00020115898,0.00024493306,0.000030014127,0.00000749162,0.0010175373],"genre_scores_gemma":[0.99787813,0.0014786698,0.000044168344,0.000032770167,0.00014920474,0.000065550856,0.00007489431,0.000019920468,0.00025670842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988319,0.00019017667,0.00020260976,0.00029049013,0.00017452701,0.00031024724],"domain_scores_gemma":[0.9990676,0.000043509113,0.00007372598,0.00052639394,0.00020883173,0.00007996289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024144,0.00011658644,0.00015806197,0.000098386925,0.00011033631,0.000011254414,0.00038590227,0.00013015536,0.0005951612],"category_scores_gemma":[0.00007001437,0.00010426573,0.00008294289,0.00010625443,0.00023677855,0.000004562503,0.0002553885,0.00022168306,0.000024101619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040186645,0.00015174084,0.002049903,0.000079739046,0.000072627656,0.0000070563583,0.00017673554,4.3345227e-7,0.99380964,0.0001154295,0.00050294504,0.002631887],"study_design_scores_gemma":[0.00046313374,0.00033914746,0.035493452,0.00007258831,0.000007789196,0.000004621061,0.00008458512,0.000009911427,0.95839626,0.00011479455,0.0049000485,0.00011369466],"about_ca_topic_score_codex":0.0016972378,"about_ca_topic_score_gemma":0.00053259433,"teacher_disagreement_score":0.035413403,"about_ca_system_score_codex":0.0000300452,"about_ca_system_score_gemma":0.00012164613,"threshold_uncertainty_score":0.6516598},"labels":[],"label_agreement":null},{"id":"W2319796016","doi":"10.1158/1538-7445.am10-4291","title":"Abstract 4291: Imetelstat, a telomerase inhibitor in phase I trials in solid tumor and hematological malignancies, has broad activity against multiple types of cancer stem cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Telomerase; Cancer research; Telomere; Cancer; Cancer stem cell; Clonogenic assay; Metastasis; Cancer cell; Immunology; Biology; Stem cell; Medicine; Cell; Internal medicine; Genetics","score_opus":0.10384400668954352,"score_gpt":0.4360111154237619,"score_spread":0.3321671087342184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319796016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429035,0.0039667278,0.000002125914,0.00018174518,0.00011228005,0.0008816138,0.0005019773,0.000005584847,0.00005758384],"genre_scores_gemma":[0.9967942,0.002271143,0.00004025635,0.000023661869,0.00013433478,0.0005899448,0.00002000887,0.000024048406,0.00010240345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975689,0.00034345224,0.0004610883,0.0005642783,0.0003986543,0.00066362304],"domain_scores_gemma":[0.9988652,0.00025874918,0.00013351257,0.0003305704,0.00018196642,0.00023004023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017803748,0.00019611669,0.00058227126,0.0002482287,0.00008689956,0.000060585768,0.00022185921,0.00017461456,0.000101767095],"category_scores_gemma":[0.00046461276,0.00016119605,0.00009376402,0.00034269807,0.0005334589,0.000016941212,0.00020140845,0.00055599865,0.0000041797525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021736766,0.0005899991,0.015642324,0.00015471595,0.000060211245,0.00011317948,0.00007960652,0.000019420524,0.95065844,0.000002911294,0.00052730594,0.029978212],"study_design_scores_gemma":[0.0048257625,0.00030400415,0.0062304265,0.0001188447,0.0000056802123,0.0000029457635,0.000065576074,0.00004960215,0.9855972,0.000018728617,0.0026244374,0.00015679772],"about_ca_topic_score_codex":0.009770842,"about_ca_topic_score_gemma":0.034160692,"teacher_disagreement_score":0.034938756,"about_ca_system_score_codex":0.00011471648,"about_ca_system_score_gemma":0.001058698,"threshold_uncertainty_score":0.9968232},"labels":[],"label_agreement":null},{"id":"W2319847690","doi":"10.1158/1538-7445.am2012-sy32-03","title":"Abstract SY32-03: Promoting tissue-specific antitumor immunity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Immunology; Adoptive cell transfer; CD8; Antigen; Biology; Immunity; Immune system; T cell; Autoimmunity; Cytotoxic T cell; Acquired immune system; Cancer research; In vitro","score_opus":0.1527286173809832,"score_gpt":0.44578536235398164,"score_spread":0.29305674497299844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319847690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609866,0.02488677,0.0000047951653,0.0014275301,0.00046205206,0.0006561767,0.000014141092,0.00006731274,0.011494625],"genre_scores_gemma":[0.9931254,0.0031926036,0.00009417923,0.00010962534,0.001075864,0.00012809629,0.00001639781,0.000041891562,0.0022159698],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997759,0.000112634974,0.00026645503,0.00024378943,0.0007114785,0.0009066588],"domain_scores_gemma":[0.9987897,0.000115782714,0.000054545464,0.00051431597,0.00025251723,0.0002730904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002159318,0.00014401121,0.00024157827,0.00020690852,0.0003231358,0.00005752787,0.0002177942,0.00010090246,0.0046412344],"category_scores_gemma":[0.00007772162,0.00011977427,0.00008299346,0.00060891424,0.00029843877,0.00021343978,0.00008759427,0.0007757982,0.0004266242],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009621449,0.00027374594,0.012614733,0.00028011698,0.00008654768,0.000030159645,0.0013197137,1.6880665e-7,0.8787653,0.0000725461,0.01383976,0.0917551],"study_design_scores_gemma":[0.0013867391,0.00019876425,0.25041014,0.0004422214,0.000011520562,0.000045659133,0.00050620874,0.0000020298073,0.34998477,0.00002011247,0.39681068,0.00018114653],"about_ca_topic_score_codex":0.0010495922,"about_ca_topic_score_gemma":0.000028543645,"teacher_disagreement_score":0.5287805,"about_ca_system_score_codex":0.00047306815,"about_ca_system_score_gemma":0.00028536512,"threshold_uncertainty_score":0.99626863},"labels":[],"label_agreement":null},{"id":"W2319867709","doi":"10.1158/1538-7445.am2013-5341","title":"Abstract 5341: Clinical relevance of metastasis-related miRNAs in early breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Breast cancer; Metastasis; Medicine; microRNA; Clinical significance; Immunohistochemistry; Oncology; Cancer; Monoclonal antibody; Internal medicine; Stage (stratigraphy); Pathology; Cancer research; Antibody; Biology; Immunology; Gene","score_opus":0.05629495172716769,"score_gpt":0.4157676922698805,"score_spread":0.3594727405427128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319867709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937593,0.004715069,0.000004906697,0.0005359493,0.00011437729,0.00044671263,0.000097130745,0.0000063271964,0.00032027956],"genre_scores_gemma":[0.99708366,0.0020049512,0.00006227945,0.000028695682,0.00015667935,0.00020548068,0.0000272026,0.000027264818,0.00040378026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981466,0.00021554924,0.0004782641,0.00042000867,0.00033635154,0.00040323622],"domain_scores_gemma":[0.99875104,0.00006262532,0.0001182221,0.00043851655,0.00048091408,0.0001486593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082430954,0.00011664147,0.00020598939,0.00010509528,0.00004223883,0.000023155244,0.0003146226,0.00019928243,0.00081740523],"category_scores_gemma":[0.0001652119,0.00011034118,0.00010198012,0.00033288173,0.0003001469,0.000013364919,0.00012963623,0.00033566597,0.000055398905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020508363,0.00013829076,0.070539035,0.00008203856,0.000101496946,0.0000039162446,0.00003684261,0.00015116,0.8982834,0.000031957898,0.006733637,0.023693118],"study_design_scores_gemma":[0.00077850546,0.00007169678,0.8855911,0.00011832992,0.000008653826,0.0000022848562,0.000025568766,0.000037102975,0.110355966,0.00018361516,0.0026916014,0.00013556267],"about_ca_topic_score_codex":0.0037130448,"about_ca_topic_score_gemma":0.00055084354,"teacher_disagreement_score":0.8150521,"about_ca_system_score_codex":0.00008358697,"about_ca_system_score_gemma":0.00040676747,"threshold_uncertainty_score":0.8950014},"labels":[],"label_agreement":null},{"id":"W2319894149","doi":"10.1158/1538-7445.am2011-4093","title":"Abstract 4093: Prostate apoptosis response-4 (Par-4): A novel substrate of caspase-3 during apoptosis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Apoptosis; Cleavage (geology); Caspase; Caspase 3; Poly ADP ribose polymerase; Molecular biology; Caspase 8; Caspase-9; Cell culture; Biology; Cell biology; In vitro; Programmed cell death; Chemistry; Biochemistry; Enzyme","score_opus":0.08501195258354367,"score_gpt":0.35751436112076024,"score_spread":0.2725024085372166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319894149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714136,0.0010853461,0.000011871944,0.00008178053,0.00010089238,0.0004488554,0.0002705589,0.000018825413,0.0008405181],"genre_scores_gemma":[0.9983681,0.0005085554,0.00016462312,0.000020797108,0.00012703805,0.00029628313,0.000030739036,0.00005950723,0.00042437654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977785,0.00015267474,0.00033883972,0.00057561195,0.0004923895,0.00066198537],"domain_scores_gemma":[0.9983611,0.000043740427,0.00011060673,0.0007869808,0.00046045118,0.00023708148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083629874,0.0001975487,0.00021186718,0.00019357902,0.0001801847,0.0000321183,0.0005193897,0.00016089859,0.00032703098],"category_scores_gemma":[0.00035560507,0.00020036688,0.00015421753,0.00036401494,0.00043114647,0.000011593487,0.0002635472,0.00026879576,0.000021301803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029497505,0.00023065464,0.008070419,0.00018047905,0.00013113694,0.000006106345,0.0002530309,0.000017238872,0.9872348,0.000018342522,0.00055116205,0.00035691602],"study_design_scores_gemma":[0.0007038557,0.00015412945,0.112442315,0.00008391167,0.000016621027,0.0000040766913,0.00020473234,0.0000015516432,0.88558924,0.000028785631,0.0005742919,0.00019650138],"about_ca_topic_score_codex":0.0007579817,"about_ca_topic_score_gemma":0.00009069198,"teacher_disagreement_score":0.10437189,"about_ca_system_score_codex":0.0000860124,"about_ca_system_score_gemma":0.0005054092,"threshold_uncertainty_score":0.81707245},"labels":[],"label_agreement":null},{"id":"W2319913994","doi":"10.1158/1538-7445.am2011-4949","title":"Abstract 4949: microRNA (miR) analysis as a tool for discovering platinum resistance mechanisms in non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"microRNA; Cisplatin; Biology; Cancer research; Gene expression; Gene; Lung cancer; Cancer; Oncology; Genetics; Medicine; Chemotherapy","score_opus":0.030212956730332627,"score_gpt":0.3350182202636202,"score_spread":0.3048052635332876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319913994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053943,0.0028412943,0.004379958,0.00006312246,0.000086705266,0.0009236294,0.00021008079,0.00000923794,0.00094652176],"genre_scores_gemma":[0.9950792,0.0003720738,0.0014445588,0.00004348584,0.00015252449,0.0010040688,0.00012107137,0.000050095747,0.0017329174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980493,0.000066114735,0.00031772797,0.0006677366,0.00027185812,0.00062725384],"domain_scores_gemma":[0.99896604,0.000034181085,0.000113379,0.000521357,0.0002416119,0.00012340675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060010137,0.00019469376,0.0002351535,0.00025028424,0.00013003136,0.00005329235,0.00039611678,0.00018359309,0.00024762045],"category_scores_gemma":[0.00006153537,0.00020168886,0.00018507024,0.0005342539,0.000075205906,0.000013988138,0.00015855659,0.00020347683,0.000007793591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062823266,0.00007013207,0.004702059,0.00027206328,0.00020834658,0.000008524036,0.0003273831,0.00034192915,0.9921454,0.00006153339,0.0009388587,0.00029552705],"study_design_scores_gemma":[0.00091571716,0.000051638628,0.042233504,0.00014181498,0.00009759456,3.3979597e-7,0.0001294438,0.00022422243,0.9544485,0.00026582443,0.0011845442,0.00030685225],"about_ca_topic_score_codex":0.0015076817,"about_ca_topic_score_gemma":0.006093654,"teacher_disagreement_score":0.037696905,"about_ca_system_score_codex":0.0002511745,"about_ca_system_score_gemma":0.00049050635,"threshold_uncertainty_score":0.8224633},"labels":[],"label_agreement":null},{"id":"W2319917655","doi":"10.1158/1538-7445.am2013-1596","title":"Abstract 1596: Evaluation of radiosensitizing effects of KSP inhibition in cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Radiosensitizer; Cancer research; Cancer; Mitosis; Cancer cell; Radiation therapy; Medicine; Chemistry; Biology; Internal medicine; Cell biology","score_opus":0.04055584536922644,"score_gpt":0.3765966169436868,"score_spread":0.33604077157446033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319917655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552625,0.0034298606,0.000017388256,0.000059047605,0.000090972266,0.0005814758,0.000011433744,0.0000016361969,0.0002819155],"genre_scores_gemma":[0.99760497,0.001926802,0.000034510154,0.000021114625,0.000096545074,0.0002267853,0.000023282279,0.000013143993,0.000052862164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890316,0.00014555942,0.00018987145,0.00020062308,0.0003443751,0.00021642233],"domain_scores_gemma":[0.99908763,0.000032553664,0.00006526864,0.0001937593,0.00058148365,0.000039283335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007160134,0.00007020506,0.00012172499,0.00011342154,0.000023522085,0.000007996796,0.00006632382,0.000111056965,0.0000826612],"category_scores_gemma":[0.00008095325,0.000069386806,0.00004016491,0.00016623878,0.00008935834,0.000006455851,0.00005465186,0.00013266128,0.0000042512384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023866907,0.00005016574,0.0005609332,0.00023553791,0.00001789176,8.8880324e-7,0.00009550969,0.00050124055,0.9862825,0.000006576119,0.0010591677,0.011165679],"study_design_scores_gemma":[0.00060650683,0.00006815343,0.011708123,0.00019246792,0.0000088332,5.103867e-7,0.000054992564,0.00031915065,0.98679173,0.000063879816,0.00012012376,0.0000655516],"about_ca_topic_score_codex":0.0030715135,"about_ca_topic_score_gemma":0.000662608,"teacher_disagreement_score":0.01114719,"about_ca_system_score_codex":0.00009655579,"about_ca_system_score_gemma":0.00028052967,"threshold_uncertainty_score":0.46432298},"labels":[],"label_agreement":null},{"id":"W2319941534","doi":"10.1158/1538-7445.am2012-sy07-03","title":"Abstract SY07-03: The ubiquitin-based response to DNA double-strand breaks","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA damage; Ubiquitin; Chromatin; DNA; Biology; DNA repair; Cell biology; Cancer research; Genetics; Gene","score_opus":0.06395292885263947,"score_gpt":0.3911257360107771,"score_spread":0.3271728071581376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319941534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928984,0.00086905266,0.00008477359,0.0027312855,0.0002335972,0.0005712633,0.00003814321,0.00002120309,0.0025522516],"genre_scores_gemma":[0.99593085,0.0000339878,0.00009153338,0.0006198012,0.000651232,0.00038118754,0.000017915972,0.000041737978,0.002231732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997883,0.0002765462,0.00016591854,0.00034803906,0.00051154726,0.000814929],"domain_scores_gemma":[0.99856204,0.0001255188,0.00003109845,0.0007319849,0.00022951896,0.00031986294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003165179,0.00014519808,0.00011541492,0.00008652396,0.00022596808,0.000081214595,0.0005086391,0.00020793549,0.00035804076],"category_scores_gemma":[0.00019890479,0.000109040426,0.00008642278,0.00023391737,0.0001454954,0.0000073949427,0.00017504777,0.0003906941,0.00022477275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035867514,0.00005658615,0.00019573886,0.000022472606,0.000025804105,0.0000043333457,0.00012479388,0.00004978239,0.98577464,0.00007884263,0.008208561,0.0018717133],"study_design_scores_gemma":[0.0006951756,0.00017759022,0.00358927,0.000025689713,0.000005286021,0.0000040867276,0.00013183239,0.0000036004242,0.8700197,0.000020522124,0.12519301,0.0001342731],"about_ca_topic_score_codex":0.00017924976,"about_ca_topic_score_gemma":0.000112022135,"teacher_disagreement_score":0.11698445,"about_ca_system_score_codex":0.00008741664,"about_ca_system_score_gemma":0.0004178552,"threshold_uncertainty_score":0.44465393},"labels":[],"label_agreement":null},{"id":"W2319958126","doi":"10.1158/1538-7445.am10-4194","title":"Abstract 4194: Interrogation of glioma ontogeny using mouse models","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children","funders":"","keywords":"Biology; Glioma; Neural stem cell; Progenitor cell; Phenotype; Stem cell; Cancer stem cell; Neurogenesis; Cancer research; Cell type; Neuroscience; Pathology; Cell; Medicine; Cell biology; Genetics; Gene","score_opus":0.11462505650744786,"score_gpt":0.4446614664780347,"score_spread":0.3300364099705868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319958126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792,0.0005328632,0.00009676552,0.000047783127,0.00008362639,0.00023226344,0.00007925019,0.000005479141,0.0010019636],"genre_scores_gemma":[0.998971,0.00015576594,0.00021307316,0.0000082319,0.0001983453,0.00006621103,0.000043457352,0.000022630125,0.00032128405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987559,0.000043522738,0.00014954022,0.00028287878,0.00039744194,0.0003707686],"domain_scores_gemma":[0.9990596,0.0000135052105,0.000041915435,0.0003852888,0.00035970533,0.00013998682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036244825,0.0000911715,0.00010301698,0.00013074333,0.000091077716,0.000028982015,0.00025319358,0.00011377877,0.0001888057],"category_scores_gemma":[0.000041322004,0.000084561965,0.00006604396,0.00017384118,0.00019240125,0.0000114972245,0.00015280685,0.00026438673,0.00000794471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024045799,0.00007842608,0.0004674316,0.000029998722,0.000057682497,0.000005543031,0.00007441521,0.00016598824,0.9952985,0.000083062776,0.00035396157,0.0031445166],"study_design_scores_gemma":[0.0005596545,0.00012836701,0.0004996259,0.000018547813,0.000003866489,0.0000045674738,0.000099484474,0.00026421077,0.99720806,0.000199752,0.0009357292,0.00007813496],"about_ca_topic_score_codex":0.0055797645,"about_ca_topic_score_gemma":0.0067174076,"teacher_disagreement_score":0.0030663817,"about_ca_system_score_codex":0.00008462486,"about_ca_system_score_gemma":0.0005745568,"threshold_uncertainty_score":0.8434972},"labels":[],"label_agreement":null},{"id":"W2319995089","doi":"10.1158/1538-7445.am10-2779","title":"Abstract 2779: Relationship of mammographic density with breast cancer subtypes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Estrogen receptor; Cytokeratin; Medicine; Immunohistochemistry; Oncology; Internal medicine; Population; Tissue microarray; Pathology; Cancer","score_opus":0.03364040354559575,"score_gpt":0.3543028843306331,"score_spread":0.32066248078503734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319995089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965326,0.0012822831,0.000006326011,0.0011104957,0.00011248038,0.00018981034,0.00015224189,0.000010014503,0.0006037182],"genre_scores_gemma":[0.9985474,0.0006097551,0.00008570443,0.000028805527,0.0002834354,0.00018594122,0.000024202922,0.000024896388,0.00020987513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880785,0.000045157776,0.00013246149,0.00034793976,0.00033176263,0.00033483852],"domain_scores_gemma":[0.99881613,0.000051317715,0.00006147047,0.0004028866,0.00057274534,0.00009545264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029014022,0.00012947012,0.00014859649,0.00010141858,0.00018187317,0.0000158617,0.00019591676,0.00012040905,0.00016854735],"category_scores_gemma":[0.000044321252,0.00010090188,0.000054441985,0.00032907136,0.00051871466,0.0000067540773,0.00009377372,0.00035451888,0.000006687126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042681742,0.0000636924,0.7889616,0.00005066866,0.00012877563,0.0000034968741,0.000056716428,0.000010935202,0.2065744,0.00017216885,0.0010345784,0.002516163],"study_design_scores_gemma":[0.0004524866,0.000044986926,0.9123186,0.000045396053,0.00001996504,0.000012798705,0.00005608975,4.808185e-7,0.0856396,0.0000906503,0.0012091659,0.000109766814],"about_ca_topic_score_codex":0.003099518,"about_ca_topic_score_gemma":0.014044907,"teacher_disagreement_score":0.12335702,"about_ca_system_score_codex":0.000033434506,"about_ca_system_score_gemma":0.00035235233,"threshold_uncertainty_score":0.7837388},"labels":[],"label_agreement":null},{"id":"W2320002232","doi":"10.1158/0008-5472.sabcs-09-5161","title":"CYP11A1 Is a Predictor of Mammographic Breast Density.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Single-nucleotide polymorphism; Minor allele frequency; Biology; Allele frequency; Population; Oncology; Genotyping; Genetics; Medicine; Internal medicine; Allele; Cancer; Bioinformatics; Genotype; Gene","score_opus":0.028907824561613848,"score_gpt":0.356373286136668,"score_spread":0.3274654615750542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320002232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927841,0.0036730363,0.00002307545,0.0021833533,0.000059254577,0.00018621482,0.00015848968,0.000010587171,0.0009219171],"genre_scores_gemma":[0.9975887,0.0013529288,0.00005507703,0.00020884632,0.0002752099,0.000054458684,0.000021411342,0.000013167533,0.0004301988],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987504,0.00006355876,0.0001345797,0.00033940194,0.00034937033,0.00036267232],"domain_scores_gemma":[0.9991063,0.000013202489,0.000036278114,0.00038242262,0.00036906012,0.00009276225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019056899,0.000115571755,0.00015429701,0.00010644789,0.00010171816,0.000011782697,0.00021391561,0.00009037622,0.000079044796],"category_scores_gemma":[0.000023730514,0.00010255241,0.000086807515,0.00031841276,0.00023595376,0.000003115234,0.00010403319,0.00012364137,0.000008065761],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011645675,0.00037340412,0.17602791,0.000080998296,0.00044554155,0.000016491851,0.00046447417,0.000006479511,0.74184096,0.00032483655,0.04659645,0.032657865],"study_design_scores_gemma":[0.0013062172,0.0004893978,0.58567274,0.00009589688,0.000034566558,0.000037219957,0.0001361529,0.000003208793,0.401727,0.00063517643,0.009651942,0.000210503],"about_ca_topic_score_codex":0.00031024843,"about_ca_topic_score_gemma":0.00011037883,"teacher_disagreement_score":0.4096448,"about_ca_system_score_codex":0.000040814448,"about_ca_system_score_gemma":0.0001590794,"threshold_uncertainty_score":0.41819662},"labels":[],"label_agreement":null},{"id":"W2320020197","doi":"10.1158/1538-7445.am2013-907","title":"Abstract 907: Efficacy of SAR302503, a JAK2 inhibitor, in primary human acute myeloid leukemia xenografts.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Myeloid leukemia; Ruxolitinib; Transplantation; Leukemia; Myeloid; Stem cell; Bone marrow; Cancer research; Janus kinase 2; Myeloproliferative Disorders; Internal medicine; Pharmacology; Myelofibrosis; Biology; Receptor","score_opus":0.05848348975548139,"score_gpt":0.3956894276361967,"score_spread":0.3372059378807153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320020197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98572016,0.0011782577,5.1680667e-7,0.0013811988,0.00009468749,0.0017558732,0.000025669486,0.000028575201,0.009815036],"genre_scores_gemma":[0.99560606,0.0012616497,0.00013522743,0.00018436289,0.00033577043,0.0011514144,0.00006511539,0.00004292361,0.0012174677],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972899,0.00010908594,0.0005063091,0.0004942065,0.0009177563,0.0006827557],"domain_scores_gemma":[0.99836475,0.00030236263,0.000086961336,0.00049498025,0.00046193998,0.0002889847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005228962,0.00022583033,0.0005643991,0.00046813238,0.0001306745,0.000045945537,0.00019679968,0.00015740597,0.0018914059],"category_scores_gemma":[0.00009001403,0.00017799053,0.0001290242,0.00062875036,0.00029379985,0.0001493603,0.00014070161,0.0007409264,0.00024665208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086634094,0.0022061446,0.3130502,0.0008611245,0.0006474607,0.0003928878,0.0022993751,0.000023944063,0.56874526,0.0003984992,0.04973404,0.060774744],"study_design_scores_gemma":[0.0048186714,0.000755142,0.8524267,0.0006913157,0.000035960056,0.000007474574,0.00011255717,0.0000057199613,0.13814636,0.0000984526,0.002747348,0.00015427568],"about_ca_topic_score_codex":0.0050269878,"about_ca_topic_score_gemma":0.00035337504,"teacher_disagreement_score":0.53937656,"about_ca_system_score_codex":0.0014781716,"about_ca_system_score_gemma":0.0011181151,"threshold_uncertainty_score":0.999021},"labels":[],"label_agreement":null},{"id":"W2320090071","doi":"10.1158/1538-7445.am10-2123","title":"Abstract 2123: Novel integration sites for Friend murine leukemia virus","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Murine leukemia virus; Retrovirus; Biology; Southern blot; Virology; Restriction enzyme; Provirus; Molecular biology; Leukemia; Gene; Restriction site; Genome; Long terminal repeat; DNA; Virus; Genetics","score_opus":0.07149169665984312,"score_gpt":0.4219889877578079,"score_spread":0.3504972910979648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320090071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635965,0.0005529814,0.0003840173,0.00044231006,0.00018083888,0.0006218924,0.0001905428,0.000016068347,0.0012517036],"genre_scores_gemma":[0.9947588,0.00036230963,0.00046713682,0.00009259063,0.0011115121,0.00059195556,0.00025551827,0.000053793152,0.0023064134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982125,0.00004379516,0.00018924732,0.0005024983,0.00043341893,0.00061851786],"domain_scores_gemma":[0.9985188,0.00007686247,0.000039813924,0.0005684214,0.0006150467,0.0001810374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011793006,0.00015295073,0.000131145,0.00014419113,0.00024394007,0.000087356224,0.0004765358,0.00022314371,0.0004845019],"category_scores_gemma":[0.0003831739,0.00013871472,0.000091588445,0.0002194682,0.00025931132,0.000009401618,0.000137463,0.0006138614,0.000045133733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017187069,0.0000631919,0.00010188154,0.000030301147,0.000035715428,0.0000012537292,0.000049055543,0.000029547122,0.9722926,0.000110016066,0.0072210343,0.018346706],"study_design_scores_gemma":[0.0008221061,0.0008305893,0.0005591285,0.000011086356,0.0000028883642,0.0000020475657,0.00004964438,0.00011551515,0.92453146,0.00015105175,0.072773255,0.00015125176],"about_ca_topic_score_codex":0.0003521411,"about_ca_topic_score_gemma":0.008486528,"teacher_disagreement_score":0.06555222,"about_ca_system_score_codex":0.0001050939,"about_ca_system_score_gemma":0.0007463169,"threshold_uncertainty_score":0.5656622},"labels":[],"label_agreement":null},{"id":"W2320142960","doi":"10.1158/1538-7445.am2011-2396","title":"Abstract 2396: Function of HLTF in the development of colon cancer and in the maintenance of genomic stability","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Carcinogenesis; Knockout mouse; Genome instability; Biology; Transcription factor; Cancer research; Cell biology; Chemistry; Genetics; DNA damage; Cancer; Gene; DNA","score_opus":0.13010313776954627,"score_gpt":0.3769031639490793,"score_spread":0.24680002617953303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320142960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627864,0.002877507,0.000038615188,0.000039832477,0.000020249177,0.0002408849,0.000010343205,2.6187345e-7,0.0004936856],"genre_scores_gemma":[0.998796,0.0010156562,0.00007717964,0.0000073316005,0.000013740231,0.00007280516,0.000003765172,0.0000035642818,0.000009947274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992643,0.00011757723,0.00021382868,0.00012601,0.00015633303,0.00012197097],"domain_scores_gemma":[0.9995817,0.000039062175,0.00006651306,0.00017528687,0.00012620672,0.000011233523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017653968,0.00004232268,0.00007772044,0.000039359067,0.000021996324,0.0000023851526,0.00015082976,0.00005007265,0.00002449433],"category_scores_gemma":[0.0000414949,0.000027021706,0.000014809853,0.00011307353,0.00014744495,0.0000020069726,0.000042363758,0.00009634523,1.4800358e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025460485,0.000059634658,0.062417828,0.00007264657,0.0000087015005,1.5515363e-7,0.0023987156,0.000017216727,0.9265128,0.000031711035,0.000010850208,0.008215172],"study_design_scores_gemma":[0.00014244729,0.000059572838,0.5500584,0.000014759945,0.0000013537144,3.223675e-8,0.00056974584,0.0000030696158,0.44863412,0.00013960863,0.00035714105,0.000019731895],"about_ca_topic_score_codex":0.0010243573,"about_ca_topic_score_gemma":0.006570777,"teacher_disagreement_score":0.4876406,"about_ca_system_score_codex":0.000027158005,"about_ca_system_score_gemma":0.0002145696,"threshold_uncertainty_score":0.36666477},"labels":[],"label_agreement":null},{"id":"W2320144877","doi":"10.1158/1538-7445.am2011-3832","title":"Abstract 3832: Defining molecular mechanisms controlling FES activation and microtubule binding as a potential strategy to limit mast cell recruitment to tumors via the SCF/KIT axis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Mast cell; Stem cell factor; Cell biology; Microtubule; Cancer research; Biology; Chemistry; Haematopoiesis; Stem cell; Immunology","score_opus":0.12018728886312333,"score_gpt":0.3661923436479236,"score_spread":0.24600505478480025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320144877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106354,0.00014323354,0.0012555232,0.00067825726,0.00001778638,0.00060043513,0.00004713172,0.000036010875,0.006158057],"genre_scores_gemma":[0.99715227,0.00003240516,0.00046332154,0.00009801824,0.00008396047,0.0013595861,0.000022150407,0.000035401717,0.0007529159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983199,0.000029049063,0.00024561796,0.0004885934,0.00039941064,0.0005174065],"domain_scores_gemma":[0.99901444,0.00012139089,0.00007239664,0.00037979335,0.00015884108,0.00025311238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045220339,0.00017204051,0.00016087173,0.00007704918,0.00047878423,0.00014915828,0.00036105528,0.00010343141,0.0010673695],"category_scores_gemma":[0.00006272714,0.00015275719,0.000054602082,0.00029176957,0.00006254423,0.00008352152,0.00018026948,0.000457647,0.000106721825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001451336,0.000067959605,0.000017113525,0.00007366802,0.000027493592,0.000012761964,0.00053581677,0.00016703644,0.9907392,0.00041715265,0.000084040425,0.0077126175],"study_design_scores_gemma":[0.00036744596,0.00006340134,0.000067286106,0.00014210847,0.000013350917,0.000006128179,0.0014818449,0.000048248774,0.99580514,0.0011931972,0.0006423678,0.00016946699],"about_ca_topic_score_codex":0.0008067855,"about_ca_topic_score_gemma":0.000024604722,"teacher_disagreement_score":0.007543151,"about_ca_system_score_codex":0.00020584629,"about_ca_system_score_gemma":0.00014427397,"threshold_uncertainty_score":0.9998458},"labels":[],"label_agreement":null},{"id":"W2320222853","doi":"10.1158/1538-7445.am2013-769","title":"Abstract 769: Integrin-Linked Kinase (ILK) breaks Merlin's spell to inhibit the Hippo tumor suppressor pathway and activate the YAP oncogene.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Hippo signaling pathway; Cancer research; Integrin-linked kinase; Phosphorylation; Kinase; Biology; Cell biology; Merlin (protein); Focal adhesion; Chemistry; Protein kinase A; Cancer; Suppressor; Cyclin-dependent kinase 2","score_opus":0.045355175053309986,"score_gpt":0.3366461958908603,"score_spread":0.2912910208375503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320222853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900188,0.0016050325,0.00001899273,0.0042706938,0.00016041228,0.00094647694,0.00007874941,0.000015000156,0.0028858692],"genre_scores_gemma":[0.9943137,0.0002686617,0.00003881817,0.0007724524,0.0007297964,0.00028934036,0.000030437179,0.00005020398,0.0035065871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975944,0.00030045034,0.00026937277,0.00061331445,0.00047911072,0.0007433419],"domain_scores_gemma":[0.99825996,0.00017326856,0.000068276386,0.00080012734,0.00039188348,0.00030647835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012350117,0.00024735893,0.00020037494,0.00007685739,0.00034438932,0.00021959562,0.0006971977,0.000160078,0.0007413976],"category_scores_gemma":[0.0002745885,0.00014346937,0.00010014182,0.00024645386,0.00038567153,0.0000116918445,0.00044723295,0.0007303851,0.00035230783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013476642,0.000045348028,0.0001171235,0.000030471469,0.000049319966,0.000012674269,0.0003880469,0.000043498196,0.9806657,0.000036857487,0.006457862,0.0120183695],"study_design_scores_gemma":[0.00034970551,0.00019875118,0.001323875,0.00006229995,0.0000075039334,0.000010996893,0.0004293082,0.000028035152,0.8707071,0.00013454464,0.12654924,0.0001986264],"about_ca_topic_score_codex":0.0017451197,"about_ca_topic_score_gemma":0.00030163242,"teacher_disagreement_score":0.120091386,"about_ca_system_score_codex":0.000058189627,"about_ca_system_score_gemma":0.00036081567,"threshold_uncertainty_score":0.8117784},"labels":[],"label_agreement":null},{"id":"W2320231577","doi":"10.1158/0008-5472.sabcs10-p4-03-02","title":"Abstract P4-03-02: Establishing a Relationship between Breast Cancer, Prolactin and Altered Fat Metabolism","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Endocrinology; Internal medicine; AMPK; Lipogenesis; Breast cancer; Fatty acid synthase; Carnitine; Biology; Cancer; Lipid metabolism; Protein kinase A; Medicine; Kinase; Biochemistry","score_opus":0.06237004471513645,"score_gpt":0.3816550430415014,"score_spread":0.3192849983263649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320231577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630524,0.006268149,0.00001585331,0.0012769086,0.0040792474,0.000575502,0.0004409847,0.000026590598,0.0010115479],"genre_scores_gemma":[0.96064466,0.0016711671,0.000115334304,0.00008169045,0.035276726,0.0005274837,0.000079641315,0.000058772173,0.0015445411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99766976,0.00011456148,0.00029893185,0.0006972957,0.0004880523,0.0007313937],"domain_scores_gemma":[0.99842596,0.00014189305,0.000102975384,0.00057262066,0.00038927188,0.0003672513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010531973,0.00023146004,0.0002908768,0.00018696165,0.00039496456,0.00023214518,0.0004074243,0.0003208636,0.00019242495],"category_scores_gemma":[0.00038007367,0.00021902392,0.000088346926,0.00033528713,0.0003253095,0.000045232304,0.00024593493,0.0011457038,0.00001439157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000343531,0.000041608342,0.11489841,0.000115977746,0.000087415356,3.464887e-7,0.00022300956,0.00001266397,0.840153,0.00051480404,0.02117279,0.022436487],"study_design_scores_gemma":[0.0008656706,0.00002373284,0.6203736,0.000039524686,0.00003453149,0.000009406011,0.00009525263,0.000005030197,0.0281842,0.00036192418,0.3497377,0.00026938427],"about_ca_topic_score_codex":0.003791792,"about_ca_topic_score_gemma":0.0031945372,"teacher_disagreement_score":0.81196874,"about_ca_system_score_codex":0.000048665337,"about_ca_system_score_gemma":0.00048936513,"threshold_uncertainty_score":0.8931536},"labels":[],"label_agreement":null},{"id":"W2320270113","doi":"10.1158/0008-5472.sabcs13-p6-06-56","title":"Abstract P6-06-56: Emergency room visits and hospital admission rates after curative chemotherapy for breast cancer. A retrospective single center experience","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Internal medicine; Dyslipidemia; Retrospective cohort study; Chemotherapy; Disease","score_opus":0.03919516578843649,"score_gpt":0.41009885235317134,"score_spread":0.3709036865647348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320270113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775703,0.0066043767,0.000008201913,0.012941068,0.00021872604,0.0021090452,0.00031907012,0.00002653524,0.00020269126],"genre_scores_gemma":[0.98559654,0.005751456,0.00005628092,0.00017664148,0.00052415096,0.0067242538,0.000017930322,0.00004707809,0.0011056738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804634,0.000029187831,0.00024143913,0.0006216789,0.00047409243,0.0005872817],"domain_scores_gemma":[0.9984459,0.000057954876,0.00007181541,0.00026280477,0.00079738616,0.0003641009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000114089926,0.0002284407,0.0003224873,0.0001062198,0.00019536613,0.00008020089,0.00009863694,0.000090312824,0.00665755],"category_scores_gemma":[0.00003943484,0.0001707525,0.00012151065,0.0002657505,0.000089617875,0.00030349888,0.00006148443,0.00023873075,0.00002697751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014734378,0.001450164,0.8513453,0.00025355967,0.00034209352,0.00002832326,0.009937618,8.652536e-7,0.030178796,0.00002349677,0.045034904,0.059931412],"study_design_scores_gemma":[0.0027439434,0.0008106364,0.96589565,0.0005698061,0.00002177839,0.0000068586196,0.000871409,0.000025700001,0.024946528,0.0001853111,0.00370249,0.00021989911],"about_ca_topic_score_codex":0.0024788664,"about_ca_topic_score_gemma":0.0003712551,"teacher_disagreement_score":0.114550315,"about_ca_system_score_codex":0.0008969541,"about_ca_system_score_gemma":0.00021116274,"threshold_uncertainty_score":0.9942505},"labels":[],"label_agreement":null},{"id":"W2320271319","doi":"10.1158/1538-7445.am2012-4139","title":"Abstract 4139: Clinical evaluation of microRNA expression profiling in non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"microRNA; TaqMan; Carcinogenesis; Lung cancer; Oncogene; Biology; Gene expression profiling; Cancer research; Real-time polymerase chain reaction; Gene expression; Cancer; Computational biology; Gene; Oncology; Medicine; Genetics; Cell cycle","score_opus":0.10748713684376258,"score_gpt":0.4668122417109173,"score_spread":0.3593251048671547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320271319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457855,0.013845178,0.00004430776,0.00003273193,0.00020906041,0.0007467255,0.00002484644,0.0000030638566,0.00051555113],"genre_scores_gemma":[0.9981201,0.0005819192,0.00024045796,0.000013338951,0.0005656992,0.0003132344,0.000057281777,0.00002397714,0.00008397706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981164,0.00033266668,0.00036472167,0.00031030158,0.00046771448,0.00040822243],"domain_scores_gemma":[0.9988587,0.000039712784,0.00012232829,0.00033502394,0.00051436585,0.0001298585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036845296,0.00010106761,0.0001403756,0.00010057177,0.000047579768,0.000011267568,0.00019853696,0.00020132338,0.00022594695],"category_scores_gemma":[0.00017104132,0.00009675509,0.00007122579,0.00016843423,0.00008941414,0.000010619979,0.0001363704,0.00024709795,0.0000059358827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115657196,0.00012481878,0.1675884,0.00015624636,0.00001217534,2.5247144e-7,0.00006791767,0.0003165753,0.82687867,9.49457e-7,0.0012656226,0.0034727103],"study_design_scores_gemma":[0.0007567763,0.000020180738,0.2006839,0.00014082553,0.000014976383,1.8225185e-7,0.00005097024,0.00038092624,0.7974829,0.0000064979267,0.00037475472,0.0000871019],"about_ca_topic_score_codex":0.00019167466,"about_ca_topic_score_gemma":0.00009085729,"teacher_disagreement_score":0.033095505,"about_ca_system_score_codex":0.0001643801,"about_ca_system_score_gemma":0.0006513111,"threshold_uncertainty_score":0.3945558},"labels":[],"label_agreement":null},{"id":"W2320277167","doi":"10.1158/0008-5472.sabcs12-p4-16-01","title":"Abstract P4-16-01: Accelerated hypofractionated whole breast radiotherapy for localized breast cancer: the effect of a boost on patient reported long-term cosmetic outcome","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Radiation therapy; Cancer; Surgery; Internal medicine","score_opus":0.06262046302619645,"score_gpt":0.4096422884184601,"score_spread":0.34702182539226367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320277167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821306,0.006496376,0.000041348154,0.002098081,0.0004108762,0.0017028741,0.00091745995,0.00002455683,0.000095353374],"genre_scores_gemma":[0.9956727,0.00088690966,0.000010480365,0.00019676932,0.00051571295,0.0022092806,0.00023905015,0.00007444238,0.00019462683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973684,0.00027729146,0.00047357817,0.00051865104,0.0005679766,0.000794103],"domain_scores_gemma":[0.9981466,0.00027387295,0.0002689581,0.00064955803,0.00048056056,0.00018044126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007407951,0.000335206,0.00044709857,0.00012080677,0.00034460667,0.00004263061,0.00030404664,0.00018040402,0.00023923298],"category_scores_gemma":[0.00008739534,0.00022175955,0.00021166718,0.00035155955,0.0003584901,0.000021345959,0.00010147689,0.00030452153,0.0000072716675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013743767,0.00055672554,0.5599862,0.00029629134,0.002018628,0.000008495013,0.00014743819,0.00016896597,0.32421526,0.000008180985,0.008585522,0.09026456],"study_design_scores_gemma":[0.0048144497,0.0007387294,0.7571488,0.00015582574,0.000117592856,0.000084075364,0.000044446628,0.000009573163,0.2301139,0.000003658495,0.0064750994,0.00029382642],"about_ca_topic_score_codex":0.0018469789,"about_ca_topic_score_gemma":0.00021261504,"teacher_disagreement_score":0.19716266,"about_ca_system_score_codex":0.0005923842,"about_ca_system_score_gemma":0.00022657578,"threshold_uncertainty_score":0.9043092},"labels":[],"label_agreement":null},{"id":"W2320336139","doi":"10.1158/1538-7445.am10-1099","title":"Abstract 1099: <i>In vitro</i> and <i>in cellulo</i> measurement of p53-binding activities reveals involvement of chromatin in p53-binding pattern formation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chromatin; In vitro; Binding site; Biology; Effector; Cell biology; DNA; Gene; DNA damage; Molecular biology; Computational biology; Genetics","score_opus":0.07068231857733422,"score_gpt":0.3436695941371033,"score_spread":0.2729872755597691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320336139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682224,0.0008709612,0.000021069784,0.0003044321,0.00013396007,0.0011573458,0.000044736127,0.000010191797,0.00063505897],"genre_scores_gemma":[0.9990777,0.0004192371,0.000094393516,0.000028439725,0.00005167285,0.00023263205,0.000021784228,0.000033146713,0.00004100234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969363,0.00013816994,0.00074904476,0.0003408124,0.0012721345,0.0005635168],"domain_scores_gemma":[0.99899286,0.00012721175,0.00021907596,0.00034920074,0.00019440592,0.000117246054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034358602,0.00017609195,0.00049050304,0.000962205,0.000043069776,0.000020541182,0.00015648351,0.00017113992,0.00008126922],"category_scores_gemma":[0.00017283211,0.00017926905,0.000059964175,0.0006626607,0.00016447455,0.00021557866,0.00011186872,0.0010407777,0.0000035249723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002784197,0.00017700896,0.015407586,0.001532904,0.000021031285,0.000034265093,0.0017094014,0.000031093623,0.97147995,0.0000067759074,0.0001022586,0.0092193335],"study_design_scores_gemma":[0.0028338043,0.00012098938,0.021732219,0.0024671422,0.000010679081,0.000005106057,0.0009684028,0.00015515371,0.97139907,0.000026279997,0.00014617493,0.0001349822],"about_ca_topic_score_codex":0.002372601,"about_ca_topic_score_gemma":0.0052623986,"teacher_disagreement_score":0.009084351,"about_ca_system_score_codex":0.00094160787,"about_ca_system_score_gemma":0.00042804744,"threshold_uncertainty_score":0.731038},"labels":[],"label_agreement":null},{"id":"W2320387648","doi":"10.1158/1538-7445.am2012-175","title":"Abstract 175: Atypical PKC knockdown alters TGFβ signaling potential","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Epithelial–mesenchymal transition; SMAD; Phosphorylation; Signal transduction; Smad2 Protein; Gene knockdown; Cell biology; Transfection; Biology; Cancer research; Cell migration; MAPK/ERK pathway; Metastasis; Cell; Apoptosis; Cell culture; Cancer","score_opus":0.05729910217019066,"score_gpt":0.39671600669420837,"score_spread":0.33941690452401774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320387648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165046,0.0067526815,0.00022848375,0.00015760773,0.00032777066,0.00019241766,0.000030101963,0.000022629836,0.0006378546],"genre_scores_gemma":[0.9964088,0.00012249868,0.00018766051,0.00011196879,0.0023071521,0.00009921427,0.00007179268,0.000041758212,0.0006491296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997984,0.00012802766,0.00019701628,0.00036055324,0.00049188297,0.0008385063],"domain_scores_gemma":[0.99897647,0.000038544724,0.00004012114,0.00038570067,0.0001885639,0.00037062334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063611165,0.00014709512,0.00012579514,0.000082899336,0.00021919276,0.000056698325,0.0003727447,0.00016523681,0.00085076736],"category_scores_gemma":[0.00015714134,0.00014084182,0.00010638837,0.00013664589,0.00021206928,0.000010289457,0.000220804,0.00031591364,0.00016854692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032490387,0.00011802527,0.004030885,0.000047396825,0.0000641118,0.000007478946,0.00006291142,0.00026950208,0.97968805,0.000020074667,0.011520539,0.0038461445],"study_design_scores_gemma":[0.00045184462,0.00008220871,0.019171737,0.000051005325,0.000014594836,0.0000056516296,0.00010620504,0.000012137492,0.91228664,0.00003360129,0.06753718,0.00024718753],"about_ca_topic_score_codex":0.00005676214,"about_ca_topic_score_gemma":0.000009875461,"teacher_disagreement_score":0.06740139,"about_ca_system_score_codex":0.000070386945,"about_ca_system_score_gemma":0.0002930774,"threshold_uncertainty_score":0.9315306},"labels":[],"label_agreement":null},{"id":"W2320416298","doi":"10.1158/1538-7445.am2011-1668","title":"Abstract 1668: Effect of folate and γ-glutamyl hydrolase modulation on in vivo chemosensitivity of colon cancer cells to 5-fluorouracil","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Social Innovation; University of Toronto","funders":"","keywords":"Thymidylate synthase; In vivo; Apoptosis; Colorectal cancer; In vitro; Chemistry; Fluorouracil; Homocysteine; Cancer cell; Pharmacology; Cancer; Endocrinology; Biochemistry; Internal medicine; Cancer research; Biology; Medicine","score_opus":0.042189902168153125,"score_gpt":0.369976007459745,"score_spread":0.3277861052915919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320416298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981554,0.0005005032,0.000004480178,0.00006405749,0.00003629819,0.000600144,0.00015603236,0.0000027247922,0.00048035174],"genre_scores_gemma":[0.9989042,0.00070739177,0.00001930187,0.000016019841,0.00004182894,0.00017727533,0.000007482096,0.000017875438,0.00010861409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986463,0.00014808471,0.00017210613,0.0003518913,0.00032820867,0.00035340336],"domain_scores_gemma":[0.9993262,0.000059493846,0.000053258198,0.00026735038,0.00014680196,0.00014683687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061308633,0.00012489925,0.00021943836,0.00015164123,0.000040287712,0.0000076002775,0.00011316643,0.000100349105,0.000075073316],"category_scores_gemma":[0.00006300247,0.00011017991,0.000047695874,0.00022343289,0.00012097578,0.000007647851,0.0001103201,0.00015865585,0.000002984204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033238484,0.00011189324,0.008309478,0.00014155824,0.000054096512,0.000014209547,0.00015206696,0.00016311678,0.966303,0.0000035010464,0.00028533372,0.021137932],"study_design_scores_gemma":[0.0011359359,0.0016490903,0.026847376,0.000107358,0.000005691616,6.746243e-7,0.000009842393,0.00006745382,0.96988064,0.000022226812,0.00018928494,0.00008444523],"about_ca_topic_score_codex":0.0099691525,"about_ca_topic_score_gemma":0.0036664174,"teacher_disagreement_score":0.021053487,"about_ca_system_score_codex":0.0001147156,"about_ca_system_score_gemma":0.00012973354,"threshold_uncertainty_score":0.9966236},"labels":[],"label_agreement":null},{"id":"W2320420041","doi":"10.1158/1538-7445.am2011-2244","title":"Abstract 2244: The M-SKIP Project: an international pooled-analysis on melanocortin-1 receptor (MC1 R) variants and skin carcinogenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Melanocortin 1 receptor; Skin cancer; Carcinogenesis; Melanoma; Medicine; Cancer; Oncology; Meta-analysis; Dermatology; Internal medicine; Phenotype; Biology; Cancer research; Genetics; Gene","score_opus":0.09544905132341396,"score_gpt":0.3978049648103783,"score_spread":0.30235591348696433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320420041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925099,0.00020089604,0.000039782157,0.00014607981,0.00014253691,0.00026219117,0.000060810456,0.0000055787814,0.006632195],"genre_scores_gemma":[0.99762625,0.0006393934,0.00009705139,0.00010745315,0.0003122532,0.00015292964,0.00014220328,0.000015058858,0.0009073986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986938,0.00017118841,0.00016062078,0.00038733156,0.00035174566,0.00023529225],"domain_scores_gemma":[0.9993092,0.00002466718,0.000055711298,0.00035987762,0.00017541971,0.000075135344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069270696,0.00009934117,0.00009973399,0.00014740019,0.00015187972,0.00005444062,0.00033414623,0.000089702386,0.000657992],"category_scores_gemma":[0.00006857773,0.000071545684,0.000059360653,0.00023391888,0.00010106204,0.00000938659,0.000094182615,0.00013676171,0.00001698367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074986776,0.00023398279,0.06667136,0.000024698958,0.0015058931,0.000007955363,0.001856354,0.000030438514,0.8986882,0.00077299273,0.0047164704,0.024741787],"study_design_scores_gemma":[0.00047889428,0.00032233854,0.4493291,0.000012991508,0.00012506818,0.0000029012083,0.0006457748,0.00007491295,0.5427412,0.00007713391,0.006003584,0.00018613903],"about_ca_topic_score_codex":0.0014454118,"about_ca_topic_score_gemma":0.00043436367,"teacher_disagreement_score":0.38265774,"about_ca_system_score_codex":0.000036592435,"about_ca_system_score_gemma":0.0001124286,"threshold_uncertainty_score":0.72045505},"labels":[],"label_agreement":null},{"id":"W2320428533","doi":"10.1158/1538-7445.am10-4126","title":"Abstract 4126: Identifying novel tumor modifier genes involved in gliomagenesis using retroviral gene-trapping mutagenesis screens","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; PTEN; Glioma; Gene; Cancer research; Transgene; Tumor progression; Genetics; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.14066982436398145,"score_gpt":0.41303729037106834,"score_spread":0.2723674660070869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320428533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920514,0.005053396,0.001893066,0.000060755963,0.00034068353,0.0003468183,0.000038787064,0.000013991904,0.00020107822],"genre_scores_gemma":[0.9949097,0.0008261791,0.0031938816,0.00003376033,0.00070642104,0.00008330269,0.00004887278,0.00006770908,0.00013016722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975113,0.0001057121,0.0003992743,0.00070532033,0.0005457809,0.0007325822],"domain_scores_gemma":[0.99871194,0.000042913787,0.000103071405,0.00058547367,0.00037267234,0.00018395363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014824618,0.00022146336,0.00021820112,0.00034396094,0.00028055,0.00013859042,0.00042088295,0.00026079814,0.00007865105],"category_scores_gemma":[0.00020441542,0.0002377739,0.00011693774,0.00059441605,0.00020084775,0.00001985189,0.00025559354,0.0004462237,0.000008230616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007076883,0.000057565474,0.019446684,0.00004596992,0.000035802263,0.000017691613,0.000050579103,0.000986067,0.9758345,0.00001829776,0.000020885935,0.003415182],"study_design_scores_gemma":[0.0005348671,0.000043184824,0.046001427,0.000031608266,0.000010565706,0.0000026585274,0.00011262021,0.001105679,0.95055443,0.00006174232,0.00126796,0.0002732581],"about_ca_topic_score_codex":0.001813745,"about_ca_topic_score_gemma":0.002524885,"teacher_disagreement_score":0.026554741,"about_ca_system_score_codex":0.00008672657,"about_ca_system_score_gemma":0.00039193017,"threshold_uncertainty_score":0.96961385},"labels":[],"label_agreement":null},{"id":"W2320592393","doi":"10.1158/0008-5472.sabcs-2014","title":"Role of radiation induced ß1 – integrin expression in trastuzumab resistance in Her-2 positive breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Trastuzumab; Breast cancer; Integrin; Protein kinase B; Cancer research; Transactivation; Cancer; Phosphorylation; Radiation therapy; Medicine; Cell; Chemistry; Biology; Internal medicine; Cell biology; Gene expression; Biochemistry","score_opus":0.057727053875883415,"score_gpt":0.4423883504464646,"score_spread":0.3846612965705812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320592393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800238,0.007624816,0.0000049545274,0.005211013,0.000072087925,0.0013658961,0.00010465916,0.000024795874,0.0055679707],"genre_scores_gemma":[0.9961724,0.0022532383,0.000083776584,0.00010943508,0.0002507978,0.000484748,0.00001783988,0.000040204683,0.0005875447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956082,0.0005837093,0.0005872952,0.0006595795,0.0015923168,0.00096889003],"domain_scores_gemma":[0.9982985,0.00023788157,0.00009859357,0.0005321508,0.0005531478,0.00027968094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017855236,0.0002154677,0.0005465526,0.001057694,0.00007752873,0.00003206725,0.00040107113,0.00025420755,0.00059573015],"category_scores_gemma":[0.0002903756,0.00020117675,0.000074168034,0.0023859837,0.00018779805,0.00021960828,0.00009051869,0.0017523034,0.000014293466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036646316,0.00044078808,0.033886015,0.00020421675,0.000016964768,0.000084014006,0.0036147314,0.00003700043,0.7716927,0.00017551993,0.0018707832,0.18431264],"study_design_scores_gemma":[0.002574437,0.00037121752,0.6305181,0.003296442,0.000005020793,0.0000063490443,0.001014807,0.00008508584,0.36054343,0.0006172627,0.00080018595,0.00016766619],"about_ca_topic_score_codex":0.00834134,"about_ca_topic_score_gemma":0.010287219,"teacher_disagreement_score":0.59663206,"about_ca_system_score_codex":0.003863541,"about_ca_system_score_gemma":0.0022490714,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W2320668194","doi":"10.1158/0008-5472.sabcs10-p2-13-02","title":"Abstract P2-13-02: Phase II Study of Glucosamine with Chondroitin on Joint Symptoms Induced by Aromatase Inhibitors in Breast Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Internal medicine; Breast cancer; Chondroitin sulfate; Rheumatoid arthritis; Aromatase inhibitor; Clinical endpoint; Joint pain; Quality of life (healthcare); Cancer; Physical therapy; Clinical trial; Aromatase; Pathology","score_opus":0.04500327653697841,"score_gpt":0.4034036155030255,"score_spread":0.3584003389660471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320668194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572235,0.000097306205,2.179951e-8,0.00089495676,0.0002072731,0.002250689,0.00059138413,0.000021325077,0.00021468036],"genre_scores_gemma":[0.9985413,0.000051723673,0.0000029367377,0.00010263049,0.00010706268,0.00085357716,0.00015906576,0.00004775454,0.00013395528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970655,0.000078884535,0.0004782002,0.00051851536,0.0011714324,0.0006874931],"domain_scores_gemma":[0.9984349,0.000068540336,0.00014108425,0.00049107627,0.00035730752,0.0005070698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004159407,0.00023110064,0.00046244488,0.00042502256,0.00015511489,0.000015026215,0.00012884685,0.00013073543,0.00039309368],"category_scores_gemma":[0.000062702966,0.00016879546,0.000035199915,0.0006842504,0.00012528969,0.00010391249,0.00007046221,0.0011722939,0.000017507833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0125051,0.042521052,0.6825496,0.00048002115,0.0002674842,0.0002565667,0.002549877,0.000003500883,0.14702928,0.000006148848,0.0055559543,0.10627545],"study_design_scores_gemma":[0.041596532,0.013499591,0.88966763,0.0008320603,0.000042330743,0.0000069127123,0.00039224513,0.000008826899,0.053449873,0.0000061098935,0.00028194592,0.00021591569],"about_ca_topic_score_codex":0.033064496,"about_ca_topic_score_gemma":0.011813851,"teacher_disagreement_score":0.20711808,"about_ca_system_score_codex":0.0004412443,"about_ca_system_score_gemma":0.00080028566,"threshold_uncertainty_score":0.9733744},"labels":[],"label_agreement":null},{"id":"W2320690382","doi":"10.1158/1538-7445.am2013-1706","title":"Abstract 1706: Estrogen induces stearoyl-CoA desaturase expression in human MCF-7 breast carcinoma cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Atlantic Cancer Research Institute; Université de Moncton","funders":"","keywords":"Estrogen; Endocrinology; Internal medicine; Cell growth; Lipogenesis; Chemistry; Angiogenesis; Fatty acid synthesis; Carcinogenesis; Biology; Lipid metabolism; Fatty acid; Cancer research; Cancer; Biochemistry; Medicine","score_opus":0.03681368800357458,"score_gpt":0.34436422852922594,"score_spread":0.30755054052565134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320690382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277043,0.0043054475,0.0000024298947,0.00016802546,0.0011333324,0.0004992133,0.000060093353,0.000011891145,0.0010491337],"genre_scores_gemma":[0.99130446,0.0006826513,0.00005306715,0.00006650061,0.0059736706,0.00039640488,0.000065120286,0.00004241127,0.0014157227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997886,0.00014533002,0.0002621615,0.00057438307,0.00041425184,0.0007178619],"domain_scores_gemma":[0.99890363,0.000021224465,0.00005953287,0.00053246337,0.00022455875,0.0002585692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041889242,0.00019786632,0.00021121107,0.00017285197,0.00018000403,0.000097957,0.00044125796,0.00024125262,0.00039302712],"category_scores_gemma":[0.000026802283,0.00017895139,0.00008658374,0.00022255223,0.00020238574,0.000020420468,0.0002522412,0.00048991805,0.000056030483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066558045,0.00014888778,0.002604196,0.000046816065,0.000011976301,0.0000010299865,0.00012908991,0.000010552627,0.94895875,0.000012723208,0.04153894,0.006470466],"study_design_scores_gemma":[0.0016601068,0.000071888986,0.047744654,0.000068213696,0.000004460611,0.0000065067757,0.00034922094,0.000002840657,0.87758225,0.00006324876,0.07220103,0.0002455902],"about_ca_topic_score_codex":0.005815903,"about_ca_topic_score_gemma":0.00053618854,"teacher_disagreement_score":0.071376525,"about_ca_system_score_codex":0.00009652376,"about_ca_system_score_gemma":0.00034791598,"threshold_uncertainty_score":0.87919444},"labels":[],"label_agreement":null},{"id":"W2320704335","doi":"10.1158/1538-7445.am10-4035","title":"Abstract 4035: MicroRNA-221 levels correlate with aggressive and clinically recurrent prostate cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Prostate cancer; microRNA; Medicine; Prostatectomy; Biomarker; Oncology; Metastasis; Prostate; Cancer; Disease; Internal medicine; Cancer research; Biology; Gene","score_opus":0.038191804311427685,"score_gpt":0.3924703679389102,"score_spread":0.35427856362748256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320704335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924096,0.0033076026,0.00021004582,0.0008445527,0.0005055627,0.001063632,0.00022411908,0.000023221757,0.0014116538],"genre_scores_gemma":[0.99235326,0.0045012366,0.00046518014,0.00014666325,0.00042817552,0.0004358396,0.000069678885,0.00009447355,0.001505498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966813,0.00016016109,0.00036645934,0.000998488,0.0007840355,0.0010095859],"domain_scores_gemma":[0.9976473,0.000076238626,0.00019270177,0.00072843285,0.000877871,0.0004774824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012476632,0.00028316333,0.00026448493,0.00017531798,0.00033742,0.00014577496,0.00049955474,0.00038336404,0.00035617288],"category_scores_gemma":[0.00042766845,0.00024299984,0.000080502294,0.00037493606,0.0008794295,0.000013301994,0.00040900166,0.0019057153,0.000033056105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001464029,0.000052833922,0.00029454342,0.000078715995,0.00014296547,0.00009621019,0.00014516598,0.000075109616,0.94950205,0.00006085163,0.003457262,0.04463025],"study_design_scores_gemma":[0.0043196823,0.002518757,0.0087029785,0.0005424701,0.000042541546,0.00016007452,0.00027483358,0.00012565669,0.86496437,0.00035367566,0.11708037,0.00091459503],"about_ca_topic_score_codex":0.00062253466,"about_ca_topic_score_gemma":0.0021839733,"teacher_disagreement_score":0.113623105,"about_ca_system_score_codex":0.00015087165,"about_ca_system_score_gemma":0.002008155,"threshold_uncertainty_score":0.9909246},"labels":[],"label_agreement":null},{"id":"W2320714136","doi":"10.1158/0008-5472.sabcs12-p2-05-12","title":"Abstract P2-05-12: Effects of de-escalated bisphosphonate therapy on bone turnover or metastasis markers and their correlation with risk of skeletal related events – A biomarker analysis in conjunction with the REFORM study.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; N-terminal telopeptide; Bone remodeling; Internal medicine; Bone metastasis; Biomarker; Odds ratio; Oncology; Urology; Gastroenterology; Cancer; Breast cancer; Osteocalcin; Alkaline phosphatase","score_opus":0.03311082297379142,"score_gpt":0.3578931135751562,"score_spread":0.32478229060136476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320714136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647117,0.0014402716,0.000009307721,0.00015647782,0.000033117103,0.0017542171,0.000021546786,0.000009680296,0.00010420644],"genre_scores_gemma":[0.99858123,0.00095788157,0.000014623171,0.000018916378,0.0000042611255,0.00018256035,0.000020560057,0.00002394903,0.00019601689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981612,0.00036992916,0.00029227193,0.0002366435,0.0005409889,0.0003989539],"domain_scores_gemma":[0.9986947,0.00043074126,0.0002230011,0.00030384935,0.00018710033,0.00016058935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017221691,0.00016987823,0.00043862264,0.00045202146,0.000097548575,0.000005620585,0.000051065486,0.00009348366,0.00009768998],"category_scores_gemma":[0.00006163016,0.00007335697,0.00006220336,0.0015546317,0.00016896919,0.00010528882,0.000018015084,0.0004331403,0.000001734639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030646427,0.0012352277,0.9148413,0.000149898,0.0042986083,0.000024082517,0.0020589277,0.00003548387,0.00085609726,0.000001797123,0.000035170073,0.045817006],"study_design_scores_gemma":[0.00831627,0.0029111695,0.9844811,0.00022072317,0.00052115956,0.000008041347,0.00056253135,0.00019762624,0.002668986,0.000005033677,0.000036170855,0.0000711834],"about_ca_topic_score_codex":0.019299047,"about_ca_topic_score_gemma":0.004736042,"teacher_disagreement_score":0.06963983,"about_ca_system_score_codex":0.00039802486,"about_ca_system_score_gemma":0.00022608391,"threshold_uncertainty_score":0.98723155},"labels":[],"label_agreement":null},{"id":"W2320739989","doi":"10.1158/1538-7445.am2011-5351","title":"Abstract 5351: Prevalence and function of p53 mutations among children with adrenocortical carcinoma (ADCC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Missense mutation; Adrenocortical carcinoma; Germline; Germline mutation; Genetics; Mutation; Biology; Pedigree chart; Cancer research; Medicine; Gene; Internal medicine","score_opus":0.040688657181545365,"score_gpt":0.3159400473496891,"score_spread":0.27525139016814376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320739989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307275,0.005439945,0.00010783259,0.00001678982,0.00009573367,0.00030497703,0.000040178198,0.000005662552,0.00091614824],"genre_scores_gemma":[0.9975903,0.0012680667,0.000087630324,0.00001007332,0.00048346946,0.00011637363,0.000024444518,0.000017058235,0.0004026062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990283,0.000044259235,0.00013642824,0.00030571863,0.00022386642,0.0002614166],"domain_scores_gemma":[0.9993654,0.000010287798,0.000045012006,0.00024869444,0.00022751463,0.00010308027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019948081,0.00009064243,0.000107451604,0.00006734195,0.00008456104,0.000012832251,0.00011954001,0.00008639006,0.00017938844],"category_scores_gemma":[0.000029381374,0.000077340585,0.000031053205,0.00013032096,0.00046043948,0.000009189003,0.000065500324,0.00015424655,0.000002514001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006904442,0.00012132658,0.6311301,0.00014429001,0.00011847181,0.0000014692064,0.00024319004,0.000008677567,0.3568982,0.00045852037,0.000912047,0.009273277],"study_design_scores_gemma":[0.0004392805,0.00023293542,0.8909001,0.000023762426,0.000032161523,0.000004785985,0.000038258273,0.0000020393634,0.10736814,0.00009161626,0.000779561,0.000087355686],"about_ca_topic_score_codex":0.0011318296,"about_ca_topic_score_gemma":0.0005687269,"teacher_disagreement_score":0.25976998,"about_ca_system_score_codex":0.000013564721,"about_ca_system_score_gemma":0.00021156677,"threshold_uncertainty_score":0.31538573},"labels":[],"label_agreement":null},{"id":"W2320753189","doi":"10.1158/1538-7445.am2012-1394","title":"Abstract 1394: Acute bacterial infection increases lung cancer metastasis via toll-like receptors 2 and 4","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Immunology; In vivo; Lipoteichoic acid; Biology; Receptor; Pneumonia; A549 cell; Cancer research; Antigen; Microbiology; Bacterial pneumonia; Cancer; Medicine; Lung cancer; Pathology; Staphylococcus aureus; Bacteria; Internal medicine","score_opus":0.03537056131473632,"score_gpt":0.40441420320214033,"score_spread":0.369043641887404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320753189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875684,0.010748377,0.000019610143,0.0001578224,0.00057112385,0.000437161,0.00018391301,0.000015155075,0.00029843056],"genre_scores_gemma":[0.97912765,0.017917518,0.00003751087,0.000046899353,0.0011855736,0.0006789674,0.00019283003,0.000038280894,0.00077475305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803084,0.0001672686,0.00016487058,0.00040455197,0.00041928695,0.0008131977],"domain_scores_gemma":[0.9990077,0.000032640637,0.00004689727,0.00029719938,0.00018960323,0.00042596014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005041302,0.00018586995,0.00018367752,0.00014049785,0.00026965613,0.00008645592,0.00014060838,0.0001382064,0.0011491664],"category_scores_gemma":[0.00005524072,0.00016412883,0.00007847786,0.00022593276,0.00019543256,0.00003570943,0.00024262027,0.00024579823,0.000019516416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014373965,0.00028714913,0.15786564,0.0001408391,0.001209308,0.000011532711,0.00010662706,0.0000051000115,0.73525685,0.000010815302,0.046103634,0.057565086],"study_design_scores_gemma":[0.002638917,0.0004865599,0.107126735,0.00009775324,0.00016925359,0.000035175144,0.000043773776,0.0000103251805,0.57779807,0.000026316531,0.3110478,0.0005193125],"about_ca_topic_score_codex":0.020736668,"about_ca_topic_score_gemma":0.0038580194,"teacher_disagreement_score":0.26494417,"about_ca_system_score_codex":0.00023978042,"about_ca_system_score_gemma":0.00030739626,"threshold_uncertainty_score":0.9997639},"labels":[],"label_agreement":null},{"id":"W2320760176","doi":"10.1158/1538-7445.am2012-5246","title":"Abstract 5246: Use of γH2aX and other biomarkers to quantify distribution of drug activity in solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Doxorubicin; Distribution (mathematics); Monoclonal antibody; Immunohistochemistry; Pathology; Cancer research; Antibody; Medicine; Drug; Mitoxantrone; Chemistry; Pharmacology; Chemotherapy; Internal medicine; Immunology","score_opus":0.07798272342995227,"score_gpt":0.40374979822727775,"score_spread":0.3257670747973255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320760176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965755,0.0025416913,0.000037579866,0.00011156853,0.00017383133,0.00023077447,0.00025587404,0.0000020028745,0.0000712134],"genre_scores_gemma":[0.9987605,0.0007350809,0.000030411284,0.000024154193,0.00024823577,0.000040187093,0.00001618456,0.000013128532,0.00013212445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989917,0.000096176314,0.00016042299,0.00019931627,0.00020599592,0.000346339],"domain_scores_gemma":[0.9994281,0.000035125977,0.000055023367,0.00023341626,0.000120433084,0.0001278879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076235656,0.00008290813,0.0001699389,0.00008703721,0.000029576197,0.00001001787,0.000100611134,0.00007672369,0.000023122206],"category_scores_gemma":[0.00016119558,0.00007850695,0.000040638573,0.00021241257,0.00016997893,0.000012036615,0.00010425085,0.000115530296,0.0000014540823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040161566,0.000089425725,0.028447583,0.000077500634,0.000027387261,1.8480226e-7,0.00015146936,0.000013570201,0.96036255,0.00004069027,0.003411228,0.006976788],"study_design_scores_gemma":[0.00028421733,0.000034263026,0.27641746,0.00004479092,0.000003801694,6.674349e-7,0.00007278211,0.0000033006058,0.67093796,0.0000062158592,0.052121956,0.00007258772],"about_ca_topic_score_codex":0.00472056,"about_ca_topic_score_gemma":0.00096400385,"teacher_disagreement_score":0.2894246,"about_ca_system_score_codex":0.000037174545,"about_ca_system_score_gemma":0.00013648419,"threshold_uncertainty_score":0.7136106},"labels":[],"label_agreement":null},{"id":"W2320834114","doi":"10.1158/1538-7445.am2013-4378","title":"Abstract 4378: Poly(ADP-ribose)glycohydrolase (PARG) is a novel therapeutic target in breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Synthetic lethality; Poly ADP ribose polymerase; Cancer research; DNA repair; DNA damage; Olaparib; Cancer; PARP inhibitor; Biology; Breast cancer; Polymerase; DNA; Genetics","score_opus":0.10282170091736256,"score_gpt":0.4296681558549162,"score_spread":0.3268464549375536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320834114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91582733,0.012138171,0.00006847507,0.064499386,0.0005239581,0.0021130461,0.0006247947,0.00012911888,0.0040757293],"genre_scores_gemma":[0.9857507,0.0022577452,0.00015967031,0.0048786253,0.0013841563,0.0028641664,0.000027238922,0.00011700339,0.002560735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956515,0.000120327364,0.000573163,0.0008228813,0.0014281927,0.0014039228],"domain_scores_gemma":[0.99759173,0.000202758,0.00011714376,0.00082226057,0.00070998166,0.00055612536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008590238,0.00035322874,0.0005593384,0.0006704821,0.00020441091,0.00012068576,0.00044224254,0.00026407957,0.033934098],"category_scores_gemma":[0.000032404383,0.00031496456,0.00015892569,0.0014462633,0.00047467012,0.0003875419,0.00010361198,0.0014413047,0.0008661152],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014900798,0.00085150904,0.06300498,0.00039303198,0.00028472467,0.0000735475,0.0012375588,0.00006468486,0.81806266,0.00014887487,0.08905166,0.025336713],"study_design_scores_gemma":[0.018535135,0.00046622852,0.63047266,0.002571267,0.000061296276,0.00019677305,0.00078117347,0.0018332436,0.20630695,0.0025091881,0.13498788,0.0012782246],"about_ca_topic_score_codex":0.01845172,"about_ca_topic_score_gemma":0.00029297662,"teacher_disagreement_score":0.61175567,"about_ca_system_score_codex":0.0017183982,"about_ca_system_score_gemma":0.0016272959,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null},{"id":"W2320851050","doi":"10.1158/1538-7445.am2013-4819","title":"Abstract 4819: Assessing the environmental factors in two Ontario communities with diverging colorectal cancer incidence rates .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lakeridge Health; Ontario Tech University","funders":"","keywords":"Colorectal cancer; Medicine; Incidence (geometry); Environmental health; Cancer; Population; Causes of cancer; Internal medicine","score_opus":0.09216711962361972,"score_gpt":0.4175105959300436,"score_spread":0.32534347630642385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320851050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552137,0.0014635772,5.221904e-7,0.001351604,0.00004738097,0.0004724683,0.00001511512,0.000008996017,0.0011189694],"genre_scores_gemma":[0.99826854,0.0007888181,0.00002288764,0.000117486685,0.000088292094,0.00043082118,0.000020804258,0.000013669845,0.0002486973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871314,0.00007066787,0.00013141533,0.0001425354,0.000549739,0.0003925059],"domain_scores_gemma":[0.99928045,0.0003962624,0.000033022952,0.00012961257,0.0000783527,0.00008230186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027576223,0.000111349706,0.00017330582,0.00007085853,0.0005138809,0.000098890196,0.00015349934,0.000025747815,0.002387816],"category_scores_gemma":[0.000014924177,0.00006606945,0.00002892225,0.00014766246,0.0005094408,0.0002166647,0.00016819271,0.0007213192,0.000014144119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075915996,0.00007291788,0.98737466,0.000027585169,0.00004232613,0.000015151263,0.0031537367,0.000048707916,0.007967148,0.000014469769,0.00073762354,0.00046975008],"study_design_scores_gemma":[0.0007180551,0.000076527605,0.97643816,0.0003624843,0.000007868283,0.000003286078,0.018201731,0.000019293277,0.0032616074,0.00006762054,0.0007587712,0.00008460452],"about_ca_topic_score_codex":0.6204803,"about_ca_topic_score_gemma":0.3854559,"teacher_disagreement_score":0.23502442,"about_ca_system_score_codex":0.0012502924,"about_ca_system_score_gemma":0.0003122771,"threshold_uncertainty_score":0.9985241},"labels":[],"label_agreement":null},{"id":"W2320855096","doi":"10.1158/1538-7445.am2012-5075","title":"Abstract 5075: Genome-wide analysis of DNA copy number variations in osteosarcoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"SNP array; Genotyping; Copy-number variation; Amplicon; Biology; Gene duplication; Genome; Genetics; Chromosome; SNP; Copy number analysis; SNP genotyping; Gene; Single-nucleotide polymorphism; Genotype; Polymerase chain reaction","score_opus":0.0944610359366958,"score_gpt":0.43357152173938096,"score_spread":0.33911048580268516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320855096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900154,0.0023331298,0.000004868127,0.0011274432,0.000045237262,0.00036341665,0.000052357314,0.000010242069,0.006047925],"genre_scores_gemma":[0.99855185,0.00054315664,0.00012725811,0.000070437585,0.000099761004,0.00029630648,0.00008375112,0.000016068581,0.0002114368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839234,0.00008911199,0.0002815614,0.00019564986,0.00055510993,0.00048624983],"domain_scores_gemma":[0.99864125,0.00050888705,0.000050431845,0.000374392,0.00021900256,0.00020603465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075896055,0.000094191055,0.00035792324,0.0005630657,0.000056362554,0.000012127562,0.00009982054,0.0000700718,0.0041487585],"category_scores_gemma":[0.00014544615,0.00007858048,0.00013768244,0.00183498,0.00008236149,0.00010161004,0.000051974108,0.00023300332,0.00012392714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070743234,0.0008362701,0.99335104,0.00003842896,0.000750909,0.000018955912,0.0005928699,0.000018994957,0.0017032581,0.0003510402,0.00042713998,0.0018403303],"study_design_scores_gemma":[0.00079359295,0.000031685842,0.990685,0.00004305642,0.00031044672,0.0000011537743,0.0001543297,0.000016785974,0.0044596777,0.000028781003,0.0034134819,0.000062005114],"about_ca_topic_score_codex":0.0024993154,"about_ca_topic_score_gemma":0.0006280824,"teacher_disagreement_score":0.008536443,"about_ca_system_score_codex":0.00044885252,"about_ca_system_score_gemma":0.00019216431,"threshold_uncertainty_score":0.99676156},"labels":[],"label_agreement":null},{"id":"W2320909538","doi":"10.1158/0008-5472.sabcs-3100","title":"Preference for breast cancer risk reduction hormonal therapy in women age 50-69 years attending screening mammography.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Mammography; Logistic regression; Gynecology; Raloxifene; Cancer; Obstetrics; Demography; Family medicine; Oncology; Internal medicine","score_opus":0.13418352558155597,"score_gpt":0.42351996082602894,"score_spread":0.28933643524447294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320909538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378455,0.0031572795,0.0000873605,0.0013654121,0.00015378991,0.0009869243,0.00022791045,0.00004230338,0.00019449055],"genre_scores_gemma":[0.9827096,0.014924525,0.00018718936,0.00011212687,0.0007326559,0.00075882935,0.0000146641,0.000032983724,0.0005274558],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977111,0.00008804043,0.0002476213,0.00048793317,0.0006186359,0.0008466255],"domain_scores_gemma":[0.9991652,0.000059883325,0.000071533585,0.00027508228,0.00018318153,0.0002451528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086284126,0.0001623671,0.00030522706,0.0005549214,0.0001690522,0.0000632523,0.00017792261,0.000117667856,0.0004527451],"category_scores_gemma":[0.000025210202,0.00014623324,0.000105813546,0.00087470014,0.00014995823,0.00015310815,0.00002898465,0.00072582543,0.0000032828298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047217663,0.000117048054,0.07159155,0.00004495415,0.000089370646,0.000019252668,0.00203252,0.000084836196,0.036287025,0.000036573096,0.0033467866,0.88162833],"study_design_scores_gemma":[0.002534181,0.0005757939,0.98351175,0.00037523665,0.000011253063,0.0000102996455,0.0006625909,0.000059924874,0.0011163241,0.00040742473,0.0105551835,0.00018001243],"about_ca_topic_score_codex":0.0066948435,"about_ca_topic_score_gemma":0.00030782956,"teacher_disagreement_score":0.91192025,"about_ca_system_score_codex":0.0007902086,"about_ca_system_score_gemma":0.00032032994,"threshold_uncertainty_score":0.99991965},"labels":[],"label_agreement":null},{"id":"W2320946924","doi":"10.1158/0008-5472.sabcs10-pd10-05","title":"Abstract PD10-05: Do the Results of Metastatic Breast Tumour Biopsies Affect Patient Survival Outcomes? Results from a Large Prospective Trial","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Prospective cohort study; Biopsy; Proportional hazards model; Metastatic breast cancer; Internal medicine; Breast cancer; Cancer; Disease; Survival analysis; Oncology; Surgery","score_opus":0.041752878248600175,"score_gpt":0.37764214058119344,"score_spread":0.33588926233259325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320946924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857756,0.00050625455,0.0000025492427,0.0018070266,0.00078664767,0.0011972983,0.009015529,0.000014493333,0.0008946156],"genre_scores_gemma":[0.9983068,0.00015255145,0.000058526657,0.000030279756,0.0005270662,0.000494504,0.00023606698,0.000036139932,0.00015802761],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99705654,0.0003206436,0.00049369974,0.00073077355,0.0007800955,0.00061825087],"domain_scores_gemma":[0.99765456,0.0005577411,0.00024031941,0.0008537356,0.00057698676,0.000116646086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014363336,0.0002749142,0.0004145049,0.000087321125,0.00029456062,0.000061424056,0.00045640528,0.00011862679,0.000050314145],"category_scores_gemma":[0.0011552563,0.00017294454,0.00019692845,0.00029464645,0.000477899,0.000010526755,0.00039692485,0.00052857463,0.000015717833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27048126,0.0029085625,0.037785016,0.00011859539,0.0037339597,0.000088619185,0.0061789327,0.00004598817,0.6409003,0.00035625574,0.025009327,0.012393137],"study_design_scores_gemma":[0.076061495,0.0012653418,0.6763055,0.000110725465,0.0001347898,0.00001139995,0.0024270455,0.0000045355782,0.23621272,0.00036499483,0.006618652,0.00048285018],"about_ca_topic_score_codex":0.0053612078,"about_ca_topic_score_gemma":0.0053796475,"teacher_disagreement_score":0.6385204,"about_ca_system_score_codex":0.00008747037,"about_ca_system_score_gemma":0.00038484583,"threshold_uncertainty_score":0.8104578},"labels":[],"label_agreement":null},{"id":"W2320971620","doi":"10.1158/0008-5472.sabcs11-ms3-3","title":"MS3-3: Energy Metabolism in Breast Cancer: Translational Science Insights Relevant to Effects of Diet, Exercise, and Metformin on Risk and Prognosis.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Metformin; Breast cancer; Insulin; Medicine; Internal medicine; Endocrinology; Cancer; Carcinogenesis; Hormone; Diabetes mellitus; Oncology; Cancer research","score_opus":0.022918963055368866,"score_gpt":0.31134813128236827,"score_spread":0.2884291682269994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320971620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75717497,0.24221681,0.000013936338,0.00002809346,0.00009589651,0.00027852497,0.00005300832,0.000002871034,0.00013586864],"genre_scores_gemma":[0.75304234,0.24620005,0.000116304276,0.000062083585,0.00009425269,0.00043643924,0.000002734993,0.000014059749,0.000031711712],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983082,0.00011221895,0.00019264643,0.000533155,0.000438548,0.00041525927],"domain_scores_gemma":[0.9992179,0.000037391772,0.00004720378,0.00022939597,0.00025314576,0.00021492127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056940503,0.00014299066,0.00024837523,0.0002977216,0.00012243254,0.000021187188,0.00023097075,0.000088603905,0.000022771135],"category_scores_gemma":[0.00006015494,0.00011754912,0.000032062257,0.00053709233,0.00047546654,0.000018344754,0.00012148672,0.0001527977,6.230188e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012128877,0.00014119362,0.0077995877,0.0001869526,0.000044864428,0.0000034909147,0.0012696127,0.000012642091,0.2443575,0.0011990989,0.0003067176,0.7434654],"study_design_scores_gemma":[0.00092090445,0.00025582488,0.08685158,0.00026540225,0.000029126562,0.0000011773421,0.00004913972,0.000028696702,0.88878137,0.0007145183,0.02190617,0.00019608175],"about_ca_topic_score_codex":0.0023226417,"about_ca_topic_score_gemma":0.00085502525,"teacher_disagreement_score":0.7432694,"about_ca_system_score_codex":0.000026885155,"about_ca_system_score_gemma":0.00036244385,"threshold_uncertainty_score":0.4793514},"labels":[],"label_agreement":null},{"id":"W2320971985","doi":"10.1158/0008-5472.sabcs-6138","title":"Interpreting the results of clinical trials of cancer chemotherapy: the importance of reporting concurrent supportive care.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Nausea; Clinical trial; Randomized controlled trial; Internal medicine; Cancer; Vomiting; Neutropenia; myalgia; Metastatic breast cancer; Mucositis; Febrile neutropenia; Chemotherapy","score_opus":0.7398557373018874,"score_gpt":0.7338130369648956,"score_spread":0.006042700336991724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320971985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552249,0.0037152746,0.00005491348,0.038325097,0.00034321108,0.0015291526,0.00012605781,0.000008278476,0.00067312905],"genre_scores_gemma":[0.99563086,0.002657229,0.000110547124,0.00090391457,0.00052569294,0.00006375789,0.000019397816,0.000014515623,0.00007409112],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9858807,0.0024256578,0.009789118,0.00037954136,0.0011945604,0.00033043715],"domain_scores_gemma":[0.9688335,0.01750541,0.009819279,0.00079523376,0.0029423218,0.00010422219],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07151951,0.000115241746,0.0010336055,0.00007480289,0.00008064669,0.000009233891,0.00030458282,0.00009541581,0.00028135342],"category_scores_gemma":[0.18540931,0.00006128762,0.00038020298,0.00048736436,0.00057881424,0.00006559334,0.00009130896,0.0009991253,6.677119e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008188425,0.0002762277,0.27030647,0.00037635156,0.000434317,0.0000109064895,0.0074789734,0.000028284732,0.035320375,0.00016779626,0.01762759,0.65978426],"study_design_scores_gemma":[0.018694006,0.0045076944,0.54810655,0.004686823,0.00083910685,0.000014130169,0.047380604,0.0009163656,0.34564704,0.0008033821,0.02807446,0.00032984084],"about_ca_topic_score_codex":0.0023309146,"about_ca_topic_score_gemma":0.00072705845,"teacher_disagreement_score":0.6594544,"about_ca_system_score_codex":0.00012891582,"about_ca_system_score_gemma":0.0018442867,"threshold_uncertainty_score":0.9560661},"labels":[],"label_agreement":null},{"id":"W2320974423","doi":"10.1158/1538-7445.am2012-716","title":"Abstract 716: High viral load is associated with poor postoperative survival in hepatitis B virus-related hepatocellular carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Viral load; Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis B virus; Gastroenterology; Prospective cohort study; Cohort; Viral hepatitis; Hepatitis B; Virus; Oncology; Virology","score_opus":0.06410195988520202,"score_gpt":0.35192960935577144,"score_spread":0.28782764947056944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320974423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98844504,0.0030729598,0.000001574882,0.0020715946,0.0002688575,0.001121382,0.00025110474,0.00006258563,0.0047049024],"genre_scores_gemma":[0.99471575,0.0010872822,0.00002481139,0.00039119308,0.0002007253,0.00035076684,0.000068410765,0.000083121005,0.0030779324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953649,0.00040410922,0.0004892796,0.00053384405,0.0017470333,0.0014608518],"domain_scores_gemma":[0.9976943,0.00030599182,0.00009786984,0.00040645956,0.0010808223,0.00041453054],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017590675,0.00033088535,0.0007236078,0.00033977817,0.00029307316,0.00004678602,0.00020988518,0.0002587207,0.001678807],"category_scores_gemma":[0.00064601237,0.00027447788,0.00008863474,0.0010731542,0.00047318367,0.00033505564,0.00016634494,0.0013350158,0.0003787446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042963988,0.0003663881,0.9680637,0.00005593406,0.00028358743,0.00051884324,0.004222043,0.0000021527821,0.021357508,0.0001422816,0.0039544227,0.0006034725],"study_design_scores_gemma":[0.0028211644,0.0005236898,0.9585761,0.00040586267,0.000044468296,0.000009219652,0.00016839358,0.000094914125,0.035427757,0.000038077393,0.0015719761,0.0003183952],"about_ca_topic_score_codex":0.23499252,"about_ca_topic_score_gemma":0.076263145,"teacher_disagreement_score":0.15872937,"about_ca_system_score_codex":0.0026373575,"about_ca_system_score_gemma":0.0010807571,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W2320996995","doi":"10.1158/1538-7445.am2013-1817","title":"Abstract 1817: Expression of the Kaiso-binding partner Znf131 negatively correlates with cell proliferation in murine intestinal and human breast tumor tissues.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Biology; Cell growth; Carcinogenesis; Hyperplasia; Cancer research; Transcription factor; Proliferation Marker; Progenitor cell; Cell; Cell biology; Signal transduction; Stem cell; Endocrinology; Cancer; Genetics; Gene","score_opus":0.039750041184811305,"score_gpt":0.34555289798000566,"score_spread":0.30580285679519437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320996995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960674,0.00042692313,0.000010093499,0.0005731957,0.00003500871,0.0012841686,0.000008957684,0.000016951686,0.0015773216],"genre_scores_gemma":[0.99858475,0.000028752938,0.00009438,0.000021972477,0.00007585699,0.00032318544,0.000009346274,0.00003326463,0.00082848396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838823,0.00010336671,0.0002639788,0.00031457742,0.0005771865,0.00035268572],"domain_scores_gemma":[0.9990239,0.00008094855,0.000110423476,0.00027357388,0.00038281028,0.00012831716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003698193,0.00013965108,0.00021885452,0.0001988102,0.00014184862,0.00004076883,0.0001290747,0.00006906999,0.00043145148],"category_scores_gemma":[0.00008235133,0.00008957209,0.000027290358,0.00045595778,0.0003391228,0.000139264,0.00011980791,0.00080090266,0.000015527037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019402566,0.00012884224,0.10159427,0.00026203485,0.000010245976,0.00003267969,0.00079849135,0.00006249094,0.8949678,0.000031453466,0.000955395,0.0009623017],"study_design_scores_gemma":[0.00217931,0.00034330523,0.2599007,0.002497738,0.000015171873,0.0000949885,0.00040400392,0.0001719421,0.7340452,0.00007068723,0.0001529398,0.00012399576],"about_ca_topic_score_codex":0.0018985975,"about_ca_topic_score_gemma":0.00028697556,"teacher_disagreement_score":0.16092254,"about_ca_system_score_codex":0.00022084024,"about_ca_system_score_gemma":0.0003198963,"threshold_uncertainty_score":0.4724091},"labels":[],"label_agreement":null},{"id":"W2321105108","doi":"10.1158/1538-7445.am2011-241","title":"Abstract 241: Transcription factor RBP-J-mediated signaling regulates basal cell carcinoma growth","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Notch signaling pathway; Biology; Transcription factor; Cyclin-dependent kinase 8; JAG1; Cancer research; Carcinogenesis; Signal transduction; Basal cell carcinoma; Cell biology; Notch proteins; NUMB; Gene; Internal medicine; Genetics; Medicine","score_opus":0.08997708007172178,"score_gpt":0.3354405489608005,"score_spread":0.24546346888907872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321105108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950731,0.0014113706,0.00004924238,0.00013098758,0.00018666226,0.0004638485,0.00017588686,0.000026677699,0.0024822461],"genre_scores_gemma":[0.9974885,0.0004099607,0.00009163131,0.000048439742,0.00039120502,0.00013041515,0.00018440023,0.000078994606,0.001176427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968842,0.00025279666,0.00030651834,0.0007115008,0.0008057825,0.0010391717],"domain_scores_gemma":[0.9982629,0.00006300179,0.00005781654,0.00052010425,0.0007256864,0.0003705082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006894032,0.00024709266,0.00021088397,0.00025746654,0.00019828044,0.0000710082,0.0006433513,0.00034271277,0.001818785],"category_scores_gemma":[0.00017390592,0.00023233893,0.0001377047,0.00038547962,0.0003156826,0.000020703723,0.00016002195,0.0006497995,0.00015818646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038301674,0.00011415599,0.0203522,0.0001270712,0.00003244496,0.000020635256,0.00041050478,0.0000022788558,0.97519624,0.000009791985,0.002880942,0.00047071613],"study_design_scores_gemma":[0.0006465695,0.00032158988,0.07283612,0.000022234984,0.000005041842,0.0000014549984,0.00020920057,0.000013390142,0.9238666,0.000087427165,0.0017428076,0.00024754246],"about_ca_topic_score_codex":0.0022535208,"about_ca_topic_score_gemma":0.00019289185,"teacher_disagreement_score":0.052483927,"about_ca_system_score_codex":0.00015678706,"about_ca_system_score_gemma":0.00055861974,"threshold_uncertainty_score":0.9990937},"labels":[],"label_agreement":null},{"id":"W2321190300","doi":"10.1158/1538-7445.am2013-3564","title":"Abstract 3564: ARID1A promotes endocrine resistance in ER+ breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"ARID1A; Cancer research; Gene silencing; Estrogen; Biology; Estrogen receptor; Cancer cell; Estrogen receptor alpha; Breast cancer; Cell growth; Chromatin; Cancer; Internal medicine; Endocrinology; Medicine; Gene; Mutation; Genetics","score_opus":0.05636248359988951,"score_gpt":0.3898862271509738,"score_spread":0.33352374355108433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321190300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93708366,0.010180115,0.0000011019152,0.039403778,0.0003064002,0.0021374954,0.00018576103,0.00006132651,0.0106403725],"genre_scores_gemma":[0.98525,0.0053897393,0.00015595414,0.00027690118,0.0005479027,0.0037558023,0.000014029447,0.000058408423,0.004551285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970603,0.00007749787,0.00036766665,0.0006721203,0.0008331013,0.0009892967],"domain_scores_gemma":[0.998298,0.00016468165,0.000065300876,0.0005918547,0.00051352254,0.0003666472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036823325,0.00024027823,0.000420803,0.00031136937,0.0001280725,0.00010117696,0.00022863,0.00009564699,0.010228465],"category_scores_gemma":[0.000035421763,0.00019351346,0.00009208285,0.00075751846,0.0002079335,0.00020335277,0.00009591068,0.00071102177,0.0004458083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015312964,0.003260749,0.41284156,0.0024666858,0.00062425755,0.0015319512,0.001550623,0.000059641578,0.17757563,0.0011289938,0.2778431,0.11958551],"study_design_scores_gemma":[0.0034073663,0.00012790973,0.9008234,0.0014686841,0.000033899276,0.000013487939,0.00013349432,0.000017533692,0.067198336,0.00050478627,0.025995566,0.00027550707],"about_ca_topic_score_codex":0.02266924,"about_ca_topic_score_gemma":0.009182715,"teacher_disagreement_score":0.48798186,"about_ca_system_score_codex":0.0013777971,"about_ca_system_score_gemma":0.0008782383,"threshold_uncertainty_score":0.99067634},"labels":[],"label_agreement":null},{"id":"W2321199954","doi":"10.1158/1538-7445.am10-1607","title":"Abstract 1607: Effect of folate and GGH modulation on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Social Innovation; University of Toronto","funders":"","keywords":"Thymidylate synthase; Dihydrofolate reductase; Intracellular; Antifolate; Antimetabolite; Biochemistry; Pharmacology; Methotrexate; Chemistry; Cytotoxicity; Cancer research; In vitro; Biology; Enzyme; Cancer; Fluorouracil; Immunology","score_opus":0.021197128213164915,"score_gpt":0.38537697768721485,"score_spread":0.3641798494740499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321199954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831253,0.0006016885,0.0000056317645,0.00018998088,0.000039688577,0.00044663483,0.0002704932,0.0000025180473,0.00013086056],"genre_scores_gemma":[0.9983496,0.0013300414,0.000052624448,0.000012652655,0.00006769928,0.00007701775,0.00001007824,0.000015252821,0.00008500248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890083,0.00011063843,0.000117423726,0.00034625802,0.00025833742,0.0002665143],"domain_scores_gemma":[0.99927527,0.00010263763,0.0000470182,0.00020592228,0.00018778504,0.00018137122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006606729,0.00011795943,0.00019974791,0.00008597832,0.00007161998,0.00002089247,0.00006287745,0.00010127713,0.000024762503],"category_scores_gemma":[0.00004852533,0.000097685544,0.000026989328,0.000116915035,0.00021246386,0.000007943765,0.00013377615,0.00020045674,9.259213e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014175655,0.000030203884,0.007583163,0.00015096512,0.00006337001,0.0000035178684,0.000046584297,0.000014175799,0.89580864,0.000006658886,0.00012645575,0.09474871],"study_design_scores_gemma":[0.0008687824,0.00069374515,0.125478,0.000051799427,0.000010041647,0.0000050731187,0.000006441025,0.000038568945,0.87251717,0.000021035563,0.00023583931,0.00007352506],"about_ca_topic_score_codex":0.0042851446,"about_ca_topic_score_gemma":0.0019060725,"teacher_disagreement_score":0.117894836,"about_ca_system_score_codex":0.000027882306,"about_ca_system_score_gemma":0.000095245974,"threshold_uncertainty_score":0.6477885},"labels":[],"label_agreement":null},{"id":"W2321212865","doi":"10.1158/1538-7445.am10-4724","title":"Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibility","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Linkage disequilibrium; Ovarian cancer; Genome-wide association study; Single-nucleotide polymorphism; Haplotype; Odds ratio; Oncology; Internal medicine; Serous fluid; Breast cancer; Cancer; Genetic association; Biology; Genotype; Medicine; Genetics; Gene","score_opus":0.07972038708556338,"score_gpt":0.39022850028136535,"score_spread":0.31050811319580196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321212865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376994,0.00024209851,0.00008139554,0.00236701,0.00018277916,0.00035998833,0.00014058179,0.000016386799,0.0028397876],"genre_scores_gemma":[0.99397707,0.00039968514,0.000040478444,0.0003412041,0.00045415363,0.00040512352,0.000059159804,0.00003837049,0.0042847595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982099,0.000051931806,0.00016767815,0.00063484185,0.00044355541,0.0004920708],"domain_scores_gemma":[0.9983393,0.00003256256,0.00007732422,0.000782225,0.0006044475,0.00016413619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056786,0.00015885632,0.00014404525,0.0000754395,0.00025651947,0.00006873351,0.00034825306,0.00024771257,0.00055483775],"category_scores_gemma":[0.00013912155,0.00012997925,0.00006435835,0.00031212368,0.00029190362,0.000007744192,0.00006740767,0.00063901074,0.000017479202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032641913,0.00020314145,0.006778641,0.000017236878,0.000083667626,0.0000038240837,0.00008929623,0.00003836518,0.9710482,0.0001921464,0.015383708,0.0058353785],"study_design_scores_gemma":[0.002352842,0.0005628208,0.24500145,0.0001645107,0.000025563604,0.000006537508,0.00015349401,0.00006494984,0.59995466,0.00014480151,0.15099582,0.000572577],"about_ca_topic_score_codex":0.0019485647,"about_ca_topic_score_gemma":0.0067879166,"teacher_disagreement_score":0.37109354,"about_ca_system_score_codex":0.00014304211,"about_ca_system_score_gemma":0.00072825945,"threshold_uncertainty_score":0.6075084},"labels":[],"label_agreement":null},{"id":"W2321215824","doi":"10.1158/1538-7445.am10-194","title":"Abstract 194: Loss of imprinting and abnormal expression of insulin-like growth factor II in gastric cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Cancer; Gastric mucosa; Genomic imprinting; Carcinogenesis; Internal medicine; Immunohistochemistry; Imprinting (psychology); Gastroenterology; Pathology; Oncology; Stomach; Biology; DNA methylation; Gene expression; Gene; Genetics","score_opus":0.023342648088211,"score_gpt":0.34582656522960825,"score_spread":0.32248391714139724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321215824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969083,0.0021133267,0.000096083175,0.000078964076,0.00016232958,0.00035943277,0.00007036118,0.0000046886375,0.00020650713],"genre_scores_gemma":[0.99636525,0.0029811538,0.0002008745,0.00001281773,0.00015239377,0.0001198303,0.000013369299,0.000035171182,0.00011912732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979282,0.00009833426,0.00035055046,0.00046742402,0.00058537134,0.0005701187],"domain_scores_gemma":[0.9987478,0.000045458917,0.000115958035,0.00039169475,0.0005354499,0.00016363102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074133667,0.00015451977,0.00023131719,0.0003297144,0.00010001087,0.000017072898,0.0003866367,0.00028919516,0.000259476],"category_scores_gemma":[0.0002719346,0.00014871234,0.0000641979,0.00045865908,0.00032422668,0.000012564759,0.0006486073,0.0008746533,0.0000011353237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028639945,0.00007842648,0.0060753427,0.00019660708,0.00002210861,0.0000063594525,0.00013915866,0.000041246916,0.9856578,0.00003100156,0.0001322814,0.0073332335],"study_design_scores_gemma":[0.00091926084,0.00019803715,0.028485943,0.00012788866,0.000003113757,0.0000050372855,0.000056216668,0.000029807263,0.9691006,0.000044237997,0.000899574,0.00013026744],"about_ca_topic_score_codex":0.0027572901,"about_ca_topic_score_gemma":0.0012439423,"teacher_disagreement_score":0.0224106,"about_ca_system_score_codex":0.000058849022,"about_ca_system_score_gemma":0.0006075721,"threshold_uncertainty_score":0.6064313},"labels":[],"label_agreement":null},{"id":"W2321244133","doi":"10.1158/1538-7445.am2011-171","title":"Abstract 171: Pre-miR-518b and pre-miR-598, novel serum biomarkers of de novo chemoresistance in advanced or unresectable NSCLC","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of Alberta; University of British Columbia","funders":"","keywords":"Gemcitabine; Carboplatin; MiRBase; microRNA; Oncology; Internal medicine; Medicine; Chemotherapy; Biomarker; Cancer; Cisplatin; Cancer research; Biology; Gene","score_opus":0.04783602059862037,"score_gpt":0.3623610012442993,"score_spread":0.31452498064567896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321244133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945544,0.0034721084,0.0001314347,0.000054698758,0.00004347705,0.000564843,0.00011232811,0.000008887661,0.0010578173],"genre_scores_gemma":[0.99747837,0.0006114842,0.0008249213,0.000020713005,0.000061062994,0.00018387256,0.000027665421,0.000037218433,0.00075471017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827933,0.00007105267,0.00028479434,0.00050252036,0.00029243706,0.0005698725],"domain_scores_gemma":[0.998982,0.000041517098,0.00009531122,0.00047967775,0.00023632922,0.00016517358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063306675,0.00016280185,0.00018948177,0.00013548096,0.00006959208,0.00001978887,0.000318743,0.00018698539,0.00020138586],"category_scores_gemma":[0.00023708114,0.00015333753,0.000047862373,0.0003532769,0.0003003013,0.000018986188,0.00018608518,0.00018489582,0.0000018786814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003387692,0.00014699083,0.012880727,0.00034609903,0.00006078579,0.000008444537,0.0002161485,0.00004650904,0.98008394,0.000020013671,0.00044189813,0.0023607202],"study_design_scores_gemma":[0.0011623614,0.000117894466,0.32371512,0.00016092451,0.000006018509,0.0000044738795,0.000081637234,0.000037840025,0.6732932,0.00005676299,0.0012201251,0.00014365501],"about_ca_topic_score_codex":0.00069688464,"about_ca_topic_score_gemma":0.00209429,"teacher_disagreement_score":0.31083438,"about_ca_system_score_codex":0.00013887593,"about_ca_system_score_gemma":0.0005929087,"threshold_uncertainty_score":0.6252923},"labels":[],"label_agreement":null},{"id":"W2321282271","doi":"10.1158/0008-5472.sabcs12-p4-09-07","title":"Abstract P4-09-07: ING1 Expression Measured by AQUA can be an Independent Prognostic Marker in Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Tissue microarray; Cancer; Medicine; Immunohistochemistry; Oncology; Cancer research; Internal medicine; Pathology","score_opus":0.062358365378764526,"score_gpt":0.38597018785325315,"score_spread":0.3236118224744886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321282271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878372,0.010455526,0.000025691956,0.00047505155,0.00018805746,0.00040429085,0.00017232276,0.000008738282,0.0004331199],"genre_scores_gemma":[0.9967903,0.0017917347,0.000039819664,0.00006447745,0.00047673995,0.0003673608,0.00014344067,0.000044129843,0.0002820351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976705,0.0002775383,0.00024478068,0.00044274222,0.00063476793,0.0007297029],"domain_scores_gemma":[0.99893963,0.00003116451,0.0000647041,0.00038692367,0.00025850968,0.00031908927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013915377,0.00017021957,0.00014907666,0.00011010988,0.00012738798,0.000056402412,0.000273189,0.00025523387,0.00037334007],"category_scores_gemma":[0.0000994967,0.00015700962,0.000042380798,0.00019510167,0.000095677824,0.000018490196,0.00014711161,0.00038443855,0.0000095961495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013199412,0.00013636608,0.2368991,0.000028072769,0.000015323389,0.0000014934152,0.00018175587,0.00005018659,0.75508434,0.0000021389867,0.0012677282,0.0062014973],"study_design_scores_gemma":[0.00046198486,0.00005600697,0.40687796,0.00006520032,0.0000053498434,0.0000011414493,0.00009775685,0.000017039529,0.58507645,0.000022734648,0.007124851,0.00019352409],"about_ca_topic_score_codex":0.0041366066,"about_ca_topic_score_gemma":0.0026156292,"teacher_disagreement_score":0.1700079,"about_ca_system_score_codex":0.00017021567,"about_ca_system_score_gemma":0.00031550735,"threshold_uncertainty_score":0.64026666},"labels":[],"label_agreement":null},{"id":"W2321291599","doi":"10.1158/1538-7445.am2011-2724","title":"Abstract 2724: Intravesical treatment with Vesicular Stomatitis virus decreases the size of bladder tumors without adversely affecting the health and well-being of immune-competent mice","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; Vesicular Stomatitis; Bladder cancer; Bioluminescence imaging; Immune system; Medicine; Virus; Wild type; Cancer; Vesicular stomatitis Indiana virus; Urinary bladder; Virology; Biology; Cancer research; Immunology; Pathology; Internal medicine; Luciferase; Cell culture; Mutant","score_opus":0.03272237393293088,"score_gpt":0.33765644854700577,"score_spread":0.3049340746140749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321291599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923994,0.005905878,0.000011417889,0.00024105201,0.00001764022,0.00074904156,0.0000114349195,0.0000057515167,0.00065840443],"genre_scores_gemma":[0.9961455,0.0033738452,0.000106460095,0.0000657297,0.00007141869,0.00012334205,0.000006473739,0.00003326255,0.00007399405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794835,0.0004799081,0.00028625634,0.00032981345,0.0004767687,0.0004789241],"domain_scores_gemma":[0.9987333,0.00022914093,0.00014624682,0.0005195388,0.0002155387,0.0001562308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364261,0.00017219376,0.0002611387,0.000056356806,0.00028013086,0.000020622401,0.0003518672,0.00005856322,0.00011001649],"category_scores_gemma":[0.00009403741,0.00009463747,0.00008261975,0.00019976583,0.0007968556,0.000006946091,0.00012403207,0.00024159391,0.000002817639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004985261,0.00026140103,0.0058529256,0.00016621592,0.0005143861,0.000013595702,0.0036312472,0.000030942905,0.9699548,0.00004383527,0.00007532999,0.014470061],"study_design_scores_gemma":[0.0009771715,0.006675133,0.017836055,0.00014210925,0.000019715775,0.000018399704,0.0020570415,0.000022408616,0.97181314,0.000040283805,0.0002812551,0.000117277166],"about_ca_topic_score_codex":0.0052578244,"about_ca_topic_score_gemma":0.0015978903,"teacher_disagreement_score":0.0143527845,"about_ca_system_score_codex":0.00007833787,"about_ca_system_score_gemma":0.00076636707,"threshold_uncertainty_score":0.79482925},"labels":[],"label_agreement":null},{"id":"W2321326542","doi":"10.1158/1538-7445.am2013-2919","title":"Abstract 2919: Different ROS control mechanisms and mutagenic consequences in primitive subsets of normal human mammary cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Reactive oxygen species; Glutathione peroxidase; Superoxide dismutase; Progenitor cell; Cell biology; Glutathione; Mitochondrial ROS; Carcinogenesis; DNA damage; Oxidative stress; Biology; Chemistry; Biochemistry; Stem cell; Enzyme; DNA","score_opus":0.027771153049768148,"score_gpt":0.3403964277015402,"score_spread":0.3126252746517721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321326542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997311,0.0012978335,0.000074463685,0.00017436582,0.00004469566,0.0004328159,0.000058324786,0.0000030771628,0.0006034269],"genre_scores_gemma":[0.99865043,0.0007678764,0.000028401577,0.000043376363,0.000039747123,0.00019121566,0.00003337615,0.000008345217,0.00023724265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883896,0.00019231248,0.0001848073,0.0003100398,0.00014148267,0.0003323713],"domain_scores_gemma":[0.99946284,0.000049602284,0.000056951423,0.00018758317,0.00016017168,0.0000828689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002705176,0.00011474758,0.00017716581,0.000078246056,0.000078404686,0.000019789148,0.00022108784,0.0001632079,0.00015706438],"category_scores_gemma":[0.000031786712,0.00009204228,0.00003755018,0.00006330782,0.00058116746,0.000009099371,0.00012017428,0.00022660561,0.00000434597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073589545,0.000041052393,0.0067919404,0.000038935315,0.000041562536,0.000007591588,0.00005650068,0.0000040955197,0.99151874,0.00041050877,0.00016268021,0.00085279124],"study_design_scores_gemma":[0.00064692803,0.000206624,0.17916559,0.000026533282,0.0000027219844,0.0000017104679,0.00011369289,0.0000052189885,0.8189796,0.00071586395,0.000048490383,0.00008699825],"about_ca_topic_score_codex":0.00062931166,"about_ca_topic_score_gemma":0.00040352717,"teacher_disagreement_score":0.17253913,"about_ca_system_score_codex":0.000021556565,"about_ca_system_score_gemma":0.00009728658,"threshold_uncertainty_score":0.37533754},"labels":[],"label_agreement":null},{"id":"W2321330838","doi":"10.1158/1538-7445.am2012-736","title":"Abstract 736: RTOG 0320:A phase III trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Ottawa Hospital; McGill University","funders":"","keywords":"Medicine; Erlotinib; Radiosurgery; Lung cancer; Temozolomide; Internal medicine; Oncology; Clinical endpoint; Concomitant; Radiation therapy; Hazard ratio; Cancer; Randomized controlled trial; Confidence interval; Epidermal growth factor receptor","score_opus":0.13884500343603418,"score_gpt":0.43219836310624077,"score_spread":0.2933533596702066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321330838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97141933,0.019712502,0.00010095353,0.003202977,0.0004100234,0.0047191223,0.00027565713,0.000036990285,0.00012244972],"genre_scores_gemma":[0.99328977,0.002134185,0.00041880386,0.00034336874,0.0010778337,0.0016706157,0.00022097345,0.00009561347,0.00074883417],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968462,0.00030057423,0.0004986097,0.0006525315,0.0006243561,0.0010777414],"domain_scores_gemma":[0.9954258,0.0030777664,0.0002265074,0.00043036306,0.0002070752,0.00063249085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002584157,0.0003983178,0.00089288317,0.0003464585,0.00039486546,0.00015097359,0.00012507798,0.00012144718,0.00031898293],"category_scores_gemma":[0.00024716405,0.00028035723,0.0001252801,0.0004229508,0.00023702331,0.00036261813,0.000063212836,0.00047562624,0.0000035860826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66811943,0.00370399,0.038707104,0.0018384415,0.003755123,0.00025226636,0.0044784066,0.000050854793,0.029296316,0.000041494477,0.05930931,0.19044727],"study_design_scores_gemma":[0.8475818,0.010224457,0.023161612,0.00094458956,0.0012674647,0.00010662321,0.0019302937,0.001216377,0.034797896,0.000010002249,0.077651285,0.0011076236],"about_ca_topic_score_codex":0.0019983137,"about_ca_topic_score_gemma":0.00052999094,"teacher_disagreement_score":0.18933964,"about_ca_system_score_codex":0.00043988536,"about_ca_system_score_gemma":0.00083701307,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2321350289","doi":"10.1158/1538-7445.am10-2680","title":"Abstract 2680: Nonautoinhibitory properties of the C-terminal helix of the mitogen- and stress-activated protein kinase 1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada)","funders":"","keywords":"Autophosphorylation; Mitogen-activated protein kinase kinase; MAP2K7; Cyclin-dependent kinase 9; c-Raf; MAP kinase kinase kinase; Protein kinase A; Cyclin-dependent kinase 2; MAPK14; Protein kinase domain; Protein kinase R; Chemistry; Kinase; Cell biology; Biochemistry; Molecular biology; Biology; Mutant; Gene","score_opus":0.0380924380102597,"score_gpt":0.30561936430842024,"score_spread":0.26752692629816055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321350289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980301,0.0007911616,3.969962e-7,0.00017194514,0.00020255365,0.00043735196,0.00007002476,0.0000020871207,0.00029435498],"genre_scores_gemma":[0.99864006,0.000034211036,0.000007922896,0.000010342114,0.00017187132,0.00006699877,0.0000026160185,0.000011803164,0.0010541953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999123,0.000089328394,0.0001382633,0.00018768552,0.00026714688,0.00019460314],"domain_scores_gemma":[0.99923784,0.000008355651,0.000069531685,0.00042985953,0.00020979902,0.00004463032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026390655,0.00008054788,0.000090654314,0.000023456012,0.00011489918,0.000011461202,0.0003132587,0.000105906525,0.000031826057],"category_scores_gemma":[0.00012916136,0.00004363383,0.000053037013,0.00008987035,0.0005585711,0.0000035056692,0.00026385506,0.00029510685,7.6233357e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111257126,0.00003680581,0.00210257,0.00017176133,0.000014891213,0.00000106615,0.000100428544,0.0000010805343,0.995846,0.000027315846,0.00023241978,0.0013544328],"study_design_scores_gemma":[0.00021706581,0.00006883633,0.011958498,0.00013891468,0.0000031503557,0.0000035135524,0.000073897056,0.0000019329436,0.9836957,0.0000141227865,0.0037697048,0.000054650296],"about_ca_topic_score_codex":0.00028080287,"about_ca_topic_score_gemma":0.00027915233,"teacher_disagreement_score":0.012150258,"about_ca_system_score_codex":0.0000078729045,"about_ca_system_score_gemma":0.000361739,"threshold_uncertainty_score":0.20580785},"labels":[],"label_agreement":null},{"id":"W2321351135","doi":"10.1158/1538-7445.am2013-5613","title":"Abstract 5613: Enhanced treatment of lung metastasis of triple negative breast cancer by doxorubicin-mitomycin C co-loaded polymer lipid nanoparticles.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biodistribution; Doxorubicin; In vivo; Medicine; Triple-negative breast cancer; Metastatic breast cancer; Bioluminescence imaging; Metastasis; Cancer research; Breast cancer; Cancer; Pathology; Lung cancer; Ex vivo; Lymph node; Toxicity; Chemotherapy; Internal medicine; Biology; Luciferase; Cell culture; Transfection","score_opus":0.030894777382844123,"score_gpt":0.3340445003919046,"score_spread":0.30314972300906046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321351135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652273,0.009575782,0.000056031156,0.00017796029,0.00038532255,0.0011729051,0.0014050113,0.00008183894,0.00062241114],"genre_scores_gemma":[0.9943754,0.0035907233,0.00004806496,0.00001356972,0.00017855052,0.0009895873,0.000020410664,0.00010035053,0.0006833474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972057,0.0000621986,0.00065290544,0.000379095,0.0007970257,0.00090307556],"domain_scores_gemma":[0.998347,0.00025823817,0.00013911753,0.00052856357,0.00045296896,0.00027411952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022473562,0.00034678038,0.0006769022,0.00028886367,0.00009784611,0.000043901506,0.00036948445,0.00014579885,0.0035180994],"category_scores_gemma":[0.00002286547,0.00029401822,0.00016947593,0.00085135363,0.00033251263,0.00036953654,0.000038796104,0.00027886557,0.00005499662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002196088,0.00015851283,0.0005249576,0.00025956496,0.00055322016,0.0000018078387,0.0010451643,0.00043423517,0.95746857,0.000012154449,0.0075137033,0.031808488],"study_design_scores_gemma":[0.002217878,0.00017288188,0.0024474044,0.00016769298,0.000064638894,0.0000013021172,0.00030161132,0.00031413848,0.99336886,0.000039336388,0.0006333853,0.0002708757],"about_ca_topic_score_codex":0.015165406,"about_ca_topic_score_gemma":0.00036802128,"teacher_disagreement_score":0.035900272,"about_ca_system_score_codex":0.0011217577,"about_ca_system_score_gemma":0.000307091,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W2321351886","doi":"10.1158/1538-7445.am10-4361","title":"Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children; Queen's University","funders":"","keywords":"Retinoblastoma; Biology; Tissue microarray; Cancer research; Comparative genomic hybridization; Malignancy; Tumor progression; Gene duplication; Fluorescence in situ hybridization; Gene; Genetics; DNA microarray; Tumor suppressor gene; Chromosome; Cancer; Carcinogenesis; Gene expression","score_opus":0.05849809269733512,"score_gpt":0.44272938447434085,"score_spread":0.3842312917770057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321351886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632007,0.00089953875,0.000025576368,0.0004652634,0.00022288594,0.0007421128,0.00001902648,0.000042747542,0.0012628048],"genre_scores_gemma":[0.99701965,0.000051361083,0.0022893318,0.00005524906,0.000232299,0.00006634678,0.000047561953,0.000039746104,0.00019843668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767244,0.00014455087,0.00033228585,0.00053772016,0.0006437758,0.00066921674],"domain_scores_gemma":[0.9985643,0.00010053175,0.00012523467,0.00054535735,0.00035051763,0.00031403732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006192941,0.00019290441,0.0004410253,0.00054010644,0.00044704028,0.000048994698,0.00017067196,0.0002243327,0.0012099858],"category_scores_gemma":[0.00008718541,0.00016051071,0.00014361415,0.00084114773,0.0003657667,0.00007668828,0.00014248489,0.0010822335,0.00013475666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595728,0.00039192298,0.13379115,0.00009207187,0.0006059956,0.00067779893,0.00058439455,0.000063826956,0.82889783,0.000009101349,0.00028637485,0.034039944],"study_design_scores_gemma":[0.0025422717,0.0009174339,0.3841346,0.00045805055,0.0007702999,0.000122038335,0.00041722102,0.00072366424,0.599415,0.000046680798,0.010094887,0.00035785357],"about_ca_topic_score_codex":0.00064123276,"about_ca_topic_score_gemma":0.00032643523,"teacher_disagreement_score":0.25034347,"about_ca_system_score_codex":0.0004050547,"about_ca_system_score_gemma":0.0005452821,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W2321374733","doi":"10.1158/1538-7445.am2011-4042","title":"Abstract 4042: Activation of ErbB2 results in decreased Par6-associated aPKC kinase activity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cell polarity; Polarity (international relations); Cell biology; In vitro; Oncogene; Kinase; Cancer; Cell; Cell growth; Cancer research; Chemistry; Biology; Cell cycle; Medicine; Internal medicine; Biochemistry","score_opus":0.15542936033293317,"score_gpt":0.4010698695027303,"score_spread":0.24564050916979716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321374733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761725,0.0001982137,0.00001790774,0.00039509326,0.00008383278,0.00080502126,0.00006815197,0.000041957348,0.010772584],"genre_scores_gemma":[0.99916404,0.00020456199,0.000052786632,0.000035863213,0.000059608363,0.00015649652,0.000043564458,0.000039565413,0.00024348503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975578,0.00022218647,0.00036794555,0.0004353082,0.00085778744,0.00055896555],"domain_scores_gemma":[0.9983148,0.00022245644,0.00016040844,0.00053224544,0.00053633016,0.00023374702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015014148,0.00015069413,0.0003414417,0.00048460768,0.00006269345,0.000009929387,0.00017183216,0.00025088887,0.0003608887],"category_scores_gemma":[0.0018795059,0.00014877878,0.00009198112,0.0011579266,0.00018551732,0.00012832053,0.0000703009,0.0009483623,0.000026195949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007854014,0.0010001631,0.004427198,0.00017111521,0.00010893731,0.00014989101,0.0012277856,0.00002180652,0.9640069,0.000045552773,0.001555912,0.01943075],"study_design_scores_gemma":[0.0039542904,0.0002828069,0.34112203,0.00066693313,0.000015683407,0.0000014740175,0.000089928384,0.00007421126,0.6531511,0.00010677088,0.00042540414,0.00010937645],"about_ca_topic_score_codex":0.017965948,"about_ca_topic_score_gemma":0.0017325248,"teacher_disagreement_score":0.33669484,"about_ca_system_score_codex":0.0011684027,"about_ca_system_score_gemma":0.0012243375,"threshold_uncertainty_score":0.9885735},"labels":[],"label_agreement":null},{"id":"W2321436014","doi":"10.1158/1538-7445.am10-1762","title":"Abstract 1762: Clinical relevance of plasma IL-6 and IL-6 levels in chronic lymphocytic leukemia (CLL)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Clinical significance; Gastroenterology; Endocrinology; Leukemia; Cytokine; Plasma levels; Immunology","score_opus":0.11935197722133122,"score_gpt":0.4593718489228082,"score_spread":0.34001987170147696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321436014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932231,0.0017963649,0.0000034418815,0.00037028076,0.00034810352,0.0010469824,0.00006870171,0.000045544894,0.0030975284],"genre_scores_gemma":[0.99214387,0.0043990104,0.00023126206,0.00006221501,0.00078621635,0.00018705722,0.000008969474,0.000081649705,0.0020997766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99467057,0.00022711881,0.0010508198,0.00096057437,0.0017118247,0.0013790834],"domain_scores_gemma":[0.99493074,0.0024707788,0.00014624484,0.0011847069,0.00061882637,0.0006487237],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004579138,0.00028443823,0.000829526,0.00056029024,0.0001257135,0.00005089801,0.000579818,0.00053471606,0.0009316927],"category_scores_gemma":[0.00327912,0.00025328272,0.0001465921,0.0010484683,0.0020071142,0.00020083768,0.00045347775,0.0028708733,0.00017010499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0042194314,0.00027381873,0.012202409,0.0047051534,0.00032307042,0.0017178473,0.0009623067,0.000518596,0.7447691,0.0016488478,0.008275357,0.22038408],"study_design_scores_gemma":[0.13291062,0.0032441837,0.31392628,0.0048445174,0.00012567577,0.0009320755,0.00063841324,0.081077434,0.35389462,0.0019118729,0.104991,0.0015033036],"about_ca_topic_score_codex":0.008258977,"about_ca_topic_score_gemma":0.0046063825,"teacher_disagreement_score":0.39087445,"about_ca_system_score_codex":0.061632607,"about_ca_system_score_gemma":0.10549724,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W2321445992","doi":"10.1158/1538-7445.am2011-3716","title":"Abstract 3716: The Mayo Mammography Health Study (MMHS): A prospective cohort study on mammographic breast density and breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Mammography; Quartile; Prospective cohort study; Cohort; Breast imaging; Gynecology; Breast density; Cohort study; Internal medicine; Cancer; Confidence interval; Demography; Oncology; Obstetrics","score_opus":0.05998314873409074,"score_gpt":0.38135612912609756,"score_spread":0.32137298039200685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321445992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875398,0.0009057361,0.0000016494771,0.0018040664,0.00015527436,0.0060750153,0.00017508866,0.0001048896,0.003238425],"genre_scores_gemma":[0.9974997,0.0003019897,0.000006479135,0.0002888806,0.00025185436,0.0014494272,0.0000049141368,0.00006268857,0.00013409149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559826,0.00033596033,0.0004146886,0.0010343088,0.0015638466,0.0010529305],"domain_scores_gemma":[0.99765575,0.00012545403,0.00012827806,0.0008760587,0.00063933077,0.000575136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025092794,0.00037580694,0.0006080737,0.00090745743,0.0007354045,0.00017311597,0.0003690885,0.00006784022,0.00024062663],"category_scores_gemma":[0.00002140886,0.00024970673,0.00019208269,0.0024541176,0.0008605816,0.00025321366,0.00018735322,0.0012894432,0.000014273246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020729823,0.0036512145,0.96208954,0.00009506478,0.0009279406,0.00018356115,0.004112056,2.8601792e-7,0.00005524298,0.00006875589,0.000817689,0.025925657],"study_design_scores_gemma":[0.002150732,0.0016183854,0.98601574,0.00028664575,0.0001230747,0.00030184208,0.009001378,0.0000016044787,0.00005145788,0.00017047189,0.000046053152,0.00023262028],"about_ca_topic_score_codex":0.021171963,"about_ca_topic_score_gemma":0.0037808244,"teacher_disagreement_score":0.025693037,"about_ca_system_score_codex":0.00026429576,"about_ca_system_score_gemma":0.00046276723,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2321453487","doi":"10.1158/0008-5472.sabcs11-p5-11-11","title":"P5-11-11: Automated Quantification Methods Improve the Accuracy of PR as an Independent Prognostic Factor in Tamoxifen Treated Breast Cancer Patients.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Tissue microarray; Oncology; Internal medicine; Progesterone receptor; Cancer; Estrogen receptor; Adjuvant therapy; Pathology","score_opus":0.06002058216854171,"score_gpt":0.42495176989840316,"score_spread":0.36493118772986144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321453487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976716,0.00072057627,0.000017771166,0.00008539178,0.0001241852,0.0011329292,0.000124919,0.000028310356,0.0000943283],"genre_scores_gemma":[0.99860287,0.00041957168,0.00008555729,0.000017463592,0.000058031095,0.00052135537,0.00011175337,0.000034518765,0.00014889162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770236,0.0007897421,0.00029652772,0.0004562963,0.00032330345,0.0004317814],"domain_scores_gemma":[0.99867225,0.000083206905,0.00014296004,0.00046770807,0.0005073599,0.00012651847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071594934,0.00016605316,0.0001784006,0.00012450009,0.00010528688,0.000027782298,0.00042594402,0.00027542387,0.00009481232],"category_scores_gemma":[0.00028256615,0.000112756636,0.000060622824,0.00041737195,0.00019925434,0.000017469705,0.00013805083,0.00030534618,0.0000067530655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003498158,0.00036603824,0.18493411,0.000049374466,0.00007723907,0.0000027836813,0.00062067626,0.00001101743,0.80188066,0.000036760437,0.00016522114,0.011506321],"study_design_scores_gemma":[0.0006589595,0.00037573153,0.31075573,0.000045457982,0.000018541414,0.0000023321793,0.00009814767,0.0003570016,0.6873394,0.000025462386,0.0001968978,0.00012628028],"about_ca_topic_score_codex":0.00864459,"about_ca_topic_score_gemma":0.0008418039,"teacher_disagreement_score":0.12582164,"about_ca_system_score_codex":0.00009828246,"about_ca_system_score_gemma":0.00042663893,"threshold_uncertainty_score":0.99795693},"labels":[],"label_agreement":null},{"id":"W2321529004","doi":"10.1158/1538-7445.am2012-3004","title":"Abstract 3004: Biomarker identification through integrative bioinformatics analysis of serous epithelial ovarian cancer tumor samples","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ovarian cancer; Serous fluid; Cancer research; Biology; Gene expression profiling; Cancer; Biomarker; Gene signature; Oncology; Medicine; Bioinformatics; Gene expression; Internal medicine; Gene; Genetics","score_opus":0.07670747037085987,"score_gpt":0.40342068944872594,"score_spread":0.3267132190778661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321529004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190075,0.009882969,0.0022954799,0.0002249148,0.0030627102,0.00042899506,0.001336846,0.000013244977,0.00085410604],"genre_scores_gemma":[0.989508,0.0047297054,0.00047968663,0.000098266435,0.0040387884,0.00025579773,0.00029589428,0.000026567051,0.0005673281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981219,0.0001222643,0.00045563013,0.00029395666,0.00046129807,0.0005449442],"domain_scores_gemma":[0.9984752,0.00005155216,0.00020858827,0.0005214784,0.0006038493,0.00013934002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009619328,0.0001775631,0.00033405714,0.00027226738,0.00014358226,0.000046074878,0.0003351474,0.00013231742,0.0003706983],"category_scores_gemma":[0.00019096874,0.00014757205,0.000206239,0.0009788522,0.00031161253,0.000039209874,0.00012364161,0.00020296314,0.000013282999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002677574,0.00011882542,0.0076599293,0.00011135738,0.0013163321,6.7316094e-8,0.0023264375,0.000120533026,0.9503097,0.0003667308,0.017870825,0.019531539],"study_design_scores_gemma":[0.00070208084,0.00005625837,0.20137149,0.000064555934,0.00043825278,0.0000017767442,0.0019606075,0.00015663325,0.4606251,0.000088485656,0.33418655,0.00034819284],"about_ca_topic_score_codex":0.0059719277,"about_ca_topic_score_gemma":0.0021305778,"teacher_disagreement_score":0.48968455,"about_ca_system_score_codex":0.00011236313,"about_ca_system_score_gemma":0.00041216877,"threshold_uncertainty_score":0.90278083},"labels":[],"label_agreement":null},{"id":"W2321546038","doi":"10.1158/1538-7445.am2013-sy03-01","title":"Abstract SY03-01: Genotypic and phenotypic features of de novo and acquired resistance to cancer therapies.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Drug resistance; Cancer; Cellular adaptation; Epigenetics; Drug; Biology; Medicine; Acquired resistance; Bioinformatics; Genetics; Pharmacology; Gene","score_opus":0.025636302632083406,"score_gpt":0.3387904739837322,"score_spread":0.3131541713516488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321546038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90850943,0.08856063,0.000022130735,0.0012049392,0.00050968165,0.00042656387,0.000056347064,0.0000069151115,0.0007033831],"genre_scores_gemma":[0.9728122,0.019313285,0.00026679668,0.0003543391,0.0029409633,0.00039118523,0.000006897982,0.00003241502,0.0038819409],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863636,0.00006819129,0.00016474159,0.00041296746,0.00024085231,0.00047687776],"domain_scores_gemma":[0.9991118,0.00003256438,0.000044951154,0.0003323849,0.0002622185,0.00021611789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033632733,0.00014490422,0.00020609032,0.0000888617,0.00012238027,0.000054207972,0.00021369409,0.00013716475,0.00019868082],"category_scores_gemma":[0.00007150505,0.00012933083,0.00003605896,0.0001682318,0.0002869602,0.000010249866,0.00014301832,0.00013895788,0.000003576531],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002906157,0.000018522749,0.002007832,0.00013389908,0.00006330221,1.4241564e-7,0.00055533275,0.000007180151,0.92312926,0.0001361268,0.046460044,0.027197747],"study_design_scores_gemma":[0.00095265114,0.00010091278,0.38704124,0.00012341427,0.000016877968,0.0000032611467,0.0003575812,0.0000013168383,0.19977868,0.000493878,0.41085643,0.0002737528],"about_ca_topic_score_codex":0.0025497228,"about_ca_topic_score_gemma":0.0038546994,"teacher_disagreement_score":0.7233506,"about_ca_system_score_codex":0.000052751755,"about_ca_system_score_gemma":0.00031098782,"threshold_uncertainty_score":0.5273958},"labels":[],"label_agreement":null},{"id":"W2321587245","doi":"10.1158/1538-7445.am2011-5103","title":"Abstract 5103: Mining the pancreatic cancer ascites fluid proteome with mass spectrometry","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Ascites; Pancreatic cancer; Tandem mass spectrometry; Cancer; Chromatography; Chemistry; Proteome; Orbitrap; Mass spectrometry; Medicine; Internal medicine; Biochemistry","score_opus":0.08228712580276014,"score_gpt":0.38020059389988886,"score_spread":0.2979134680971287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321587245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96428347,0.0014227411,0.0015006227,0.0007160467,0.00001654802,0.00072254316,0.00008672519,0.00015990519,0.031091416],"genre_scores_gemma":[0.9667562,0.0011240804,0.0222996,0.000046607896,0.000300892,0.0066139093,0.0000082807155,0.00006808269,0.0027823069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821025,0.000023073862,0.00020683344,0.00043416393,0.00049314834,0.0006325522],"domain_scores_gemma":[0.9986975,0.00014042099,0.000090379486,0.0007164648,0.00022817201,0.00012701757],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040334204,0.0001788269,0.00018483041,0.00009373352,0.00041015408,0.00006846323,0.00067137944,0.000095730014,0.004666072],"category_scores_gemma":[0.00004456629,0.00011770153,0.000049579627,0.0005903103,0.00036069952,0.00012270024,0.000106296895,0.0007036965,0.000029174807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013802634,0.00005372427,0.0055527147,0.00016356268,0.000070512746,0.000011172387,0.0004906903,0.000012805129,0.9885594,0.0009345147,0.0007875289,0.0032253382],"study_design_scores_gemma":[0.0002345481,0.00006149512,0.0015891017,0.0002620292,0.000016862696,0.000004780202,0.0005463276,0.00003474644,0.9887702,0.0037795207,0.004481126,0.0002192706],"about_ca_topic_score_codex":0.0013550872,"about_ca_topic_score_gemma":0.00011895761,"teacher_disagreement_score":0.02830911,"about_ca_system_score_codex":0.0003225806,"about_ca_system_score_gemma":0.00029207068,"threshold_uncertainty_score":0.9962438},"labels":[],"label_agreement":null},{"id":"W2321625187","doi":"10.1158/0008-5472.sabcs12-p6-05-09","title":"Abstract P6-05-09: Unravelling the global effect of estrogen on breast cancer cell proteome using quantitative proteomics.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Stable isotope labeling by amino acids in cell culture; Estrogen receptor; Estrogen; Proteome; Biology; Proteomics; Breast cancer; Estrogen receptor alpha; Estrogen receptor beta; Quantitative proteomics; Cell growth; Cancer research; Cancer; Cell biology; Bioinformatics; Endocrinology; Biochemistry; Gene; Genetics","score_opus":0.07675593350037878,"score_gpt":0.4409968428916955,"score_spread":0.3642409093913167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321625187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242675,0.0014294519,0.0014768727,0.00026930057,0.000049818835,0.0015610945,0.00063738687,0.000054108525,0.0020952204],"genre_scores_gemma":[0.9917114,0.00038992087,0.0048915828,0.000014151289,0.00037141834,0.002465855,0.000009251503,0.000049014772,0.00009744608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800044,0.00008318075,0.00029960406,0.00035383934,0.0005315591,0.0007313999],"domain_scores_gemma":[0.9985803,0.00023549389,0.00020522697,0.0005543488,0.00026208546,0.0001625419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008782788,0.0002263203,0.000260988,0.000037444137,0.00034550249,0.000041101794,0.0005342607,0.00014853601,0.00040766678],"category_scores_gemma":[0.00004223676,0.00016266391,0.00011019318,0.00037837718,0.000303751,0.00016507188,0.00015246111,0.00066906353,0.000016315556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004855854,0.000119542325,0.0064094122,0.00049689895,0.000053159903,0.000001356892,0.00023765268,0.0010230612,0.98639244,0.002253357,0.000087999004,0.002439548],"study_design_scores_gemma":[0.00032952498,0.000061545965,0.00041524804,0.00029943456,0.000020406933,0.0000056382823,0.00012937128,0.00031593328,0.9969771,0.0006876829,0.0005786937,0.00017941593],"about_ca_topic_score_codex":0.0043632463,"about_ca_topic_score_gemma":0.000040850282,"teacher_disagreement_score":0.010584678,"about_ca_system_score_codex":0.0010545311,"about_ca_system_score_gemma":0.0002633337,"threshold_uncertainty_score":0.6633242},"labels":[],"label_agreement":null},{"id":"W2321650420","doi":"10.1158/0008-5472.sabcs10-p5-03-05","title":"Abstract P5-03-05: Triple Negative Breast Cancer: Prognosis Dependent on Presenting Stage Rather Than Receptor Status","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Family history","score_opus":0.04111115009983929,"score_gpt":0.3748358202482378,"score_spread":0.3337246701483985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321650420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177015,0.00088001246,0.0000020893367,0.001840739,0.000696592,0.00090524164,0.0015799666,0.000034111854,0.0022911027],"genre_scores_gemma":[0.9906461,0.0020561772,0.0000828424,0.00008809457,0.0011838602,0.001714744,0.000079983576,0.0000790713,0.004069098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969772,0.00014796628,0.00025348915,0.00085661904,0.00071021856,0.0010545263],"domain_scores_gemma":[0.99845487,0.00008924686,0.000121899415,0.00055213,0.0005128507,0.0002689901],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046525343,0.00030658985,0.00025996758,0.00012335843,0.00042972437,0.000109605324,0.00039366927,0.00019894591,0.001227358],"category_scores_gemma":[0.00014989037,0.0002598144,0.00011995835,0.00028772262,0.00034118383,0.000017096441,0.0003099264,0.0007079301,0.000074714284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018725286,0.00058057584,0.20271158,0.00012891849,0.00071630214,0.000021470587,0.0009316082,0.00005257555,0.7400245,0.00007545616,0.023699718,0.029184751],"study_design_scores_gemma":[0.0022753722,0.00020454919,0.26945627,0.00010211734,0.000028864604,0.00000486496,0.00084857806,0.0000062433173,0.68695,0.000036576705,0.03965269,0.00043383447],"about_ca_topic_score_codex":0.008098359,"about_ca_topic_score_gemma":0.008802735,"teacher_disagreement_score":0.06674469,"about_ca_system_score_codex":0.0002471276,"about_ca_system_score_gemma":0.0006155502,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W2321676231","doi":"10.1158/1538-7445.am2011-lb-109","title":"Abstract LB-109: BCR-ABL1 kinase activity but not its expression is dispensable for Ph+ quiescent stem cell survival which depends on the PP2A-controlled Jak2 activation and is sensitive to FTY720 treatment","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Protein phosphatase 2; Progenitor cell; Stem cell; Cancer research; CD38; Haematopoiesis; Biology; Tyrosine kinase; CD34; Cell biology; Signal transduction; Phosphatase; Phosphorylation","score_opus":0.17323417840581218,"score_gpt":0.3960053296568782,"score_spread":0.222771151251066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321676231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857934,0.00009974975,0.00006719237,0.0039246795,0.00015853248,0.005532971,0.00018429999,0.000037786634,0.004201364],"genre_scores_gemma":[0.986548,0.0004380066,0.000034030894,0.0003608234,0.00033824664,0.001770218,0.000013288515,0.00008108868,0.010416276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544203,0.0004012104,0.00035356867,0.000987085,0.0016412938,0.0011748337],"domain_scores_gemma":[0.9954176,0.0020243954,0.00012391148,0.00088381954,0.0009691707,0.00058110134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018286174,0.00038848424,0.0007010709,0.00028139778,0.0005585219,0.000116713796,0.0002653635,0.00023021088,0.0006907936],"category_scores_gemma":[0.00035641596,0.00024656477,0.00016547323,0.0004991255,0.00014834931,0.00021023011,0.00023209104,0.00060980354,0.000115350005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053872265,0.0010154606,0.000113670256,0.00047067308,0.0002893314,0.00008102231,0.0068242257,0.000017425507,0.91493917,0.00008429307,0.005542108,0.016750332],"study_design_scores_gemma":[0.026161972,0.0015460588,0.0022173512,0.00045749452,0.000057184203,0.0000047667763,0.0016296281,0.0018275509,0.9644901,0.000010929593,0.0013636699,0.00023326692],"about_ca_topic_score_codex":0.0066638174,"about_ca_topic_score_gemma":0.0005225519,"teacher_disagreement_score":0.049550932,"about_ca_system_score_codex":0.012958988,"about_ca_system_score_gemma":0.004442737,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W2321735989","doi":"10.1158/1538-7445.am2012-lb-297","title":"Abstract LB-297: The EMT inhibitor AB-16B5 interacts with specific isoforms of secreted clusterin","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada)","funders":"","keywords":"Clusterin; In vivo; Cancer research; Gene isoform; Cancer; Epithelial–mesenchymal transition; Antibody; Chemistry; Apoptosis; Molecular biology; Biology; Medicine; Immunology; Metastasis; Internal medicine; Biochemistry; Gene","score_opus":0.12083219739844314,"score_gpt":0.4306148425278938,"score_spread":0.30978264512945064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321735989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892172,0.0017478672,0.000024935267,0.0017658665,0.000416083,0.0008804099,0.00004835417,0.000034036962,0.005865225],"genre_scores_gemma":[0.9968953,0.00028870092,0.00009928233,0.00022097622,0.0010485101,0.00022533805,0.000023200088,0.000054856297,0.0011437994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997575,0.00013042065,0.00034612013,0.00030156478,0.0008212006,0.0008256794],"domain_scores_gemma":[0.99790204,0.0004214533,0.00010318961,0.00080270076,0.00041011925,0.00036052777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010865672,0.0001776348,0.00032515105,0.00022732635,0.00012283778,0.000028765906,0.00031361936,0.000113464324,0.0024845768],"category_scores_gemma":[0.00023295393,0.00010409484,0.000080850084,0.00048951525,0.0006490809,0.00016898515,0.0003072363,0.00081073534,0.00019420461],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0221554,0.0014262821,0.13353623,0.0029096308,0.0005224666,0.00041968163,0.013761309,0.000046765585,0.6693951,0.00036013318,0.11715534,0.038311675],"study_design_scores_gemma":[0.004491889,0.0012645199,0.7618312,0.0014315698,0.00006698284,0.00030783028,0.003598664,0.00005110166,0.1402671,0.000060496575,0.08624983,0.00037877003],"about_ca_topic_score_codex":0.00020541667,"about_ca_topic_score_gemma":0.000072764204,"teacher_disagreement_score":0.628295,"about_ca_system_score_codex":0.00031426616,"about_ca_system_score_gemma":0.0003111773,"threshold_uncertainty_score":0.9984273},"labels":[],"label_agreement":null},{"id":"W2321839215","doi":"10.1158/1538-7445.am2013-2712","title":"Abstract 2712: Identification of tumor initiating genes RPL39 and MLF2 that mediate lung metastasis through nitric oxide signaling and mesenchymal to epithelial transition.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene knockdown; Cancer research; Breast cancer; Metastasis; Lung cancer; Cancer; Biology; Epithelial–mesenchymal transition; Small hairpin RNA; Triple-negative breast cancer; Medicine; Oncology; Internal medicine; Gene; Genetics","score_opus":0.04528164730434831,"score_gpt":0.35813021529986633,"score_spread":0.312848567995518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321839215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649865,0.0067828405,0.0052135303,0.00044372256,0.000046021236,0.00081427523,0.000121723635,0.000009818152,0.000069396214],"genre_scores_gemma":[0.99604803,0.0024744682,0.0008002786,0.000099654186,0.00015735188,0.00028381936,0.000043724776,0.000041859046,0.000050815644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977025,0.00022178219,0.00034936785,0.00056775723,0.00064806995,0.00051055534],"domain_scores_gemma":[0.9987755,0.00008885355,0.00009712908,0.00031065982,0.00052576757,0.0002021128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011001413,0.00016969422,0.00021948435,0.00024084213,0.00021241883,0.00011725354,0.00022695037,0.00012758953,0.00012624724],"category_scores_gemma":[0.00024037222,0.00016735695,0.00006204472,0.00040024452,0.00019732099,0.000036406134,0.00019496013,0.00029560173,0.000009043563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086824104,0.000023064642,0.000073385956,0.00017146193,0.00009802888,0.0000062246218,0.00026991972,0.00038429568,0.9930926,0.000031484662,0.00019350137,0.0055691977],"study_design_scores_gemma":[0.00047040527,0.00008765985,0.0018833372,0.00007241528,0.000025577761,0.000010624352,0.0006434453,0.00028812359,0.9957984,0.0002579701,0.0002895273,0.0001725159],"about_ca_topic_score_codex":0.0012494008,"about_ca_topic_score_gemma":0.000048692567,"teacher_disagreement_score":0.009549356,"about_ca_system_score_codex":0.00006457507,"about_ca_system_score_gemma":0.00022851619,"threshold_uncertainty_score":0.6824618},"labels":[],"label_agreement":null},{"id":"W2321914729","doi":"10.1158/0008-5472.sabcs-6110","title":"Adjuvant chemotherapy in breast cancer: is TC a cost-effective regimen compared to AC?.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Regimen; Breast cancer; Internal medicine; Oncology; Marginal cost; Adverse effect; Cost effectiveness; Quality-adjusted life year; Chemotherapy; Adjuvant; Cancer; Chemotherapy regimen; Cost–benefit analysis; Gynecology","score_opus":0.43865748679176164,"score_gpt":0.5561309391135602,"score_spread":0.11747345232179851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321914729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6244492,0.0058557168,0.00010437269,0.36039507,0.00032498088,0.0050941,0.0008925896,0.00004974333,0.002834246],"genre_scores_gemma":[0.95402455,0.0020423515,0.00019677117,0.037090145,0.0006916967,0.004177685,0.000014481504,0.000052327665,0.0017099907],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9955573,0.00048162896,0.0018083765,0.0009127167,0.00022640242,0.0010135848],"domain_scores_gemma":[0.99767274,0.00055180694,0.0004490081,0.0006782349,0.00022855158,0.00041966664],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.012055226,0.00022295724,0.0010456354,0.00082959206,0.0002127244,0.00012298478,0.00058101537,0.00015561264,0.0019407597],"category_scores_gemma":[0.00040000776,0.00027696975,0.000094220355,0.0011266414,0.00009686496,0.0003283605,0.00006739477,0.0005180884,0.0015357563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009558624,0.00054839026,0.15918854,0.0004072458,0.00018279605,0.0000094094485,0.02275243,0.001286358,0.00042604312,0.013966215,0.75331,0.046966664],"study_design_scores_gemma":[0.0038968062,0.00025482493,0.5426894,0.0006720039,0.000003770002,0.000006662543,0.0016373133,0.002876859,0.0004200896,0.009919613,0.43684906,0.0007736368],"about_ca_topic_score_codex":0.012990109,"about_ca_topic_score_gemma":0.0013999844,"teacher_disagreement_score":0.38350084,"about_ca_system_score_codex":0.0040511712,"about_ca_system_score_gemma":0.00049783563,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W2322118450","doi":"10.1158/1538-7445.am2011-2727","title":"Abstract 2727: The three-dimensional nuclear organization of telomeres during endometrial carcinoma development","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"PTEN; Telomere; Biology; Pathology; In situ hybridization; Fluorescence in situ hybridization; Hyperplasia; Carcinoma; Cancer research; Microsatellite instability; Medicine; Gene expression; Genetics; Chromosome; Gene; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.11440107676266742,"score_gpt":0.3371192958075745,"score_spread":0.22271821904490707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322118450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760926,0.00063794607,0.0000034709876,0.00020612971,0.00019561175,0.00048407883,0.000007673053,0.000038243328,0.0008175964],"genre_scores_gemma":[0.99894863,0.00008939269,0.00032152858,0.000040948187,0.00026213317,0.000024645657,0.000008823536,0.000044735545,0.0002591516],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977602,0.000066214205,0.0003731452,0.00031919763,0.001018677,0.00046257544],"domain_scores_gemma":[0.9984266,0.00016722028,0.00009009213,0.00039763446,0.00074716605,0.00017126376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006743345,0.00014167954,0.00026171675,0.00038346465,0.00035899263,0.000019079445,0.0002980212,0.000093710034,0.0034026466],"category_scores_gemma":[0.0004815782,0.00009815996,0.00005229459,0.0012042973,0.00032518696,0.000091042064,0.00017271623,0.0004422574,0.0001130178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002300899,0.0005884373,0.43028048,0.00072247704,0.00030044126,0.00032059962,0.009157777,0.000009533859,0.52700156,0.00052617246,0.002184239,0.026607372],"study_design_scores_gemma":[0.001099293,0.00007468632,0.7221308,0.000114288254,0.000012948067,0.0000264186,0.0002994293,0.000005153813,0.2752928,0.00001860168,0.000831664,0.00009393812],"about_ca_topic_score_codex":0.0012162667,"about_ca_topic_score_gemma":0.00013313568,"teacher_disagreement_score":0.2918503,"about_ca_system_score_codex":0.00022168404,"about_ca_system_score_gemma":0.00073710835,"threshold_uncertainty_score":0.9975084},"labels":[],"label_agreement":null},{"id":"W2322175913","doi":"10.1158/1538-7445.am10-937","title":"Abstract 937: Nicotinic acetylcholine receptor polymorphisms, secondhand smoke and lung cancer risk","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Lung cancer; Single-nucleotide polymorphism; Medicine; Population; Minor allele frequency; Oncology; Internal medicine; Genetics; Environmental health; Biology; Genotype","score_opus":0.0815248220110526,"score_gpt":0.44033669077783666,"score_spread":0.35881186876678406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322175913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993376,0.0025467565,0.0000025644197,0.0017869448,0.00084261154,0.00047690928,0.0001361196,0.000052005315,0.0007800707],"genre_scores_gemma":[0.99201035,0.0039176107,0.000032641663,0.00012568108,0.0010553026,0.0002450755,0.00003815328,0.00004557685,0.0025295743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808306,0.00006294746,0.00023424625,0.00044119035,0.0006617538,0.000516834],"domain_scores_gemma":[0.9987045,0.00014252006,0.000079734215,0.00042015285,0.00033591763,0.00031719435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010847369,0.00015349593,0.0002416969,0.00021996687,0.0002749158,0.00007597822,0.00014446444,0.0002314009,0.0107249],"category_scores_gemma":[0.0002064755,0.00013192433,0.000056402416,0.0003359524,0.0002742403,0.00013359607,0.00007674329,0.0018253394,0.000014153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019336572,0.0000676038,0.7194012,0.00009770364,0.00005447697,0.000006189953,0.00035705182,0.000001143151,0.23737976,0.000023412993,0.010065218,0.0323529],"study_design_scores_gemma":[0.001982942,0.00007793191,0.9025429,0.00017507201,0.000092939874,0.000010452053,0.000110828194,0.000029553014,0.08302641,0.000022349115,0.011761366,0.00016728435],"about_ca_topic_score_codex":0.005470484,"about_ca_topic_score_gemma":0.0012087368,"teacher_disagreement_score":0.1831417,"about_ca_system_score_codex":0.00018997575,"about_ca_system_score_gemma":0.0005039576,"threshold_uncertainty_score":0.9901794},"labels":[],"label_agreement":null},{"id":"W2322276682","doi":"10.1158/1538-7445.am2012-1238","title":"Abstract 1238: Gab1 regulates epithelial cell polarity and scattering by acting as a platform for PAR proteins","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cell polarity; Signal transducing adaptor protein; Cell biology; Scaffold protein; Polarity (international relations); Tight junction; Phosphorylation; Chemistry; Cell; Signal transduction; Biology; Biochemistry","score_opus":0.05341881043409228,"score_gpt":0.38764889821983406,"score_spread":0.33423008778574176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322276682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960528,0.0016999944,0.00010283279,0.00039544314,0.0001192651,0.0007765481,0.000119502656,0.000011824002,0.0007218117],"genre_scores_gemma":[0.9968325,0.0001597788,0.00050742016,0.000042781485,0.00064124353,0.0006328335,0.00004388386,0.000035660105,0.0011039176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873006,0.000033175293,0.00014843138,0.00029935868,0.0001854672,0.00060352037],"domain_scores_gemma":[0.9993143,0.000055590543,0.000056646375,0.00025457097,0.00014317855,0.00017572427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006277365,0.00012290364,0.00010617841,0.000054304648,0.00033067437,0.00007636281,0.00016568159,0.00012744238,0.000095379306],"category_scores_gemma":[0.00019474796,0.00011916732,0.00005203339,0.00006719705,0.00012671693,0.000027461501,0.0001707123,0.00030013215,0.000017131557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016625799,0.000054008036,0.001829296,0.000106757376,0.000026781963,3.8287925e-7,0.00013100737,9.493371e-7,0.99187344,0.0000104406445,0.0013890256,0.0044116713],"study_design_scores_gemma":[0.00033992316,0.00011900284,0.002627445,0.000041948046,0.0000050446906,0.0000058243504,0.00015591893,0.0000051240713,0.94818914,0.00008431466,0.048290636,0.00013569281],"about_ca_topic_score_codex":0.001111531,"about_ca_topic_score_gemma":0.00009788748,"teacher_disagreement_score":0.046901613,"about_ca_system_score_codex":0.00007155263,"about_ca_system_score_gemma":0.00011539544,"threshold_uncertainty_score":0.48595023},"labels":[],"label_agreement":null},{"id":"W2322315532","doi":"10.1158/1538-7445.am2011-920","title":"Abstract 920: Mislocalization of the polarity protein Scribble promotes tumorigenesis in the mouse mammary gland","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carcinogenesis; Biology; Cancer; Cancer research; Mammary gland; Genetically modified mouse; Pathology; Transgene; Breast cancer; Medicine; Gene; Genetics","score_opus":0.05655191183300011,"score_gpt":0.3268488687173266,"score_spread":0.2702969568843265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322315532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968769,0.0012342373,0.000101877944,0.0004114669,0.000041327552,0.00076260796,0.000017110933,0.0000041140843,0.000550338],"genre_scores_gemma":[0.9990497,0.0001516419,0.000056113036,0.000022070237,0.00009658809,0.00016063583,0.000022002438,0.000013650441,0.00042758568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988107,0.00022618014,0.00017354595,0.0002272387,0.0003292985,0.00023304977],"domain_scores_gemma":[0.99921715,0.000010234799,0.000061844315,0.0004890575,0.00019281777,0.000028869516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008130673,0.00008019177,0.000078128294,0.000055369976,0.00010133902,0.000018947509,0.00043592474,0.000120410004,0.000038219765],"category_scores_gemma":[0.00009969926,0.00005242143,0.000046681427,0.00036457973,0.00015019362,0.000007978034,0.00011251109,0.00018452719,0.0000018408639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011775061,0.00007715269,0.008014257,0.00006666496,0.000016927992,8.9819093e-7,0.0003398846,0.00003946358,0.98889524,0.00014214077,0.0004946473,0.001794981],"study_design_scores_gemma":[0.00025238428,0.000068974645,0.07056826,0.00003958183,0.0000034768198,0.0000018299675,0.00006484579,0.00004016345,0.9269527,0.0003273468,0.0016137995,0.000066624714],"about_ca_topic_score_codex":0.0029908244,"about_ca_topic_score_gemma":0.0019071528,"teacher_disagreement_score":0.062554,"about_ca_system_score_codex":0.000056957935,"about_ca_system_score_gemma":0.00031434323,"threshold_uncertainty_score":0.4521252},"labels":[],"label_agreement":null},{"id":"W2322332016","doi":"10.1158/0008-5472.sabcs12-p2-11-10","title":"Abstract P2-11-10: Prospective memory impairment in early breast cancer survivors: Finally homing in on the real deficit?","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Depression (economics); Memory impairment; Neuropsychology; Cancer; Physical therapy; Psychology; Internal medicine; Psychiatry; Cognition","score_opus":0.06623225768492863,"score_gpt":0.39264941273863185,"score_spread":0.3264171550537032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322332016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807072,0.0016182779,4.797212e-7,0.0063209636,0.0002801791,0.002397338,0.0000993176,0.000043637585,0.008532557],"genre_scores_gemma":[0.9930263,0.0016256123,0.000004438054,0.00019506935,0.0007121268,0.0025256546,0.0000053182403,0.000063462176,0.0018419784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597853,0.00030392528,0.00044860085,0.0005522831,0.0012494746,0.0014671973],"domain_scores_gemma":[0.9980558,0.0007188074,0.00010079917,0.0004035181,0.00048526278,0.00023580417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026808209,0.00030974118,0.00046851928,0.00057026505,0.0002422899,0.000048150745,0.00024145999,0.00015099469,0.0014942796],"category_scores_gemma":[0.00024322531,0.00022463205,0.00010301349,0.0012848706,0.00039130735,0.00023542701,0.00019654294,0.0014463047,0.00014109326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029948694,0.0008017951,0.9791546,0.00016912965,0.0001421493,0.00007740005,0.0068780375,0.000053488468,0.0017586269,0.00013210111,0.0025534874,0.0052843336],"study_design_scores_gemma":[0.0024413108,0.00036071302,0.989493,0.0015382397,0.000026514936,0.000009011204,0.0038319887,0.0000133831145,0.001713048,0.000050966406,0.00029231064,0.00022950182],"about_ca_topic_score_codex":0.07535094,"about_ca_topic_score_gemma":0.04243751,"teacher_disagreement_score":0.03291343,"about_ca_system_score_codex":0.004184752,"about_ca_system_score_gemma":0.00080531987,"threshold_uncertainty_score":0.999638},"labels":[],"label_agreement":null},{"id":"W2322390058","doi":"10.1158/0008-5472.sabcs-09-6041","title":"Assessing the Differential Expression of Molecular Biomarkers in Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Breast cancer; Oncology; Medicine; Lymphovascular invasion; Cytokeratin; Internal medicine; Biomarker; Estrogen receptor; Progesterone receptor; Tissue microarray; Pathology; Epidermal growth factor receptor; Cancer; Immunohistochemistry; Biology; Metastasis","score_opus":0.0366809456142753,"score_gpt":0.4082537629406092,"score_spread":0.3715728173263339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322390058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916188,0.0046497355,0.000057667687,0.0029856656,0.00008345089,0.00020410688,0.000039479262,0.000004871576,0.00035623726],"genre_scores_gemma":[0.99849296,0.0010634037,0.000031570617,0.00008260466,0.00014886641,0.00012745186,0.000013037356,0.000013513831,0.00002657512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861157,0.00019454885,0.00016501851,0.00032121362,0.0003430674,0.00036458528],"domain_scores_gemma":[0.9993821,0.00002621722,0.000051750714,0.00032926624,0.00016040189,0.00005026761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024383518,0.00012358424,0.00014760693,0.0000829788,0.00012055081,0.000034300676,0.0002811797,0.000080893,0.00006665978],"category_scores_gemma":[0.000024677947,0.000085442894,0.000062713996,0.0002953942,0.00022271715,0.000007828476,0.00014102596,0.0001585078,8.903143e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018697938,0.000081355734,0.017661333,0.000016143817,0.000055183096,0.0000049174305,0.000082702994,0.00004295115,0.96436775,0.000018888948,0.0011822656,0.016299522],"study_design_scores_gemma":[0.00065914827,0.000040952782,0.28645864,0.0001503252,0.0000104433175,0.0000035580636,0.00023776738,0.0000091722,0.71197873,0.00008725363,0.00026873683,0.00009523987],"about_ca_topic_score_codex":0.000796556,"about_ca_topic_score_gemma":0.000118823365,"teacher_disagreement_score":0.2687973,"about_ca_system_score_codex":0.000101018166,"about_ca_system_score_gemma":0.00020044766,"threshold_uncertainty_score":0.348426},"labels":[],"label_agreement":null},{"id":"W2322412916","doi":"10.1158/1538-7445.am2011-2651","title":"Abstract 2651: Cucurbitacin I (JSI-124) activates the JNK signaling pathway leading to transcriptional up-regulation of vascular endothelial growth factor in B leukemia cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Cucurbitaceae Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Signal transduction; Apoptosis; Gene knockdown; Cancer research; Kinase; Phosphorylation; Cell biology; STAT3; Leukemia; Chemistry; Biology; Immunology; Biochemistry","score_opus":0.08284840650176123,"score_gpt":0.3608431087446723,"score_spread":0.27799470224291106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322412916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996297,0.00097424234,0.0008620953,0.00008133232,0.00019508894,0.0006445143,0.000116743526,0.0000089345995,0.0008200378],"genre_scores_gemma":[0.9983391,0.00034007378,0.00030666054,0.000027314854,0.00030556292,0.00020077398,0.000022685175,0.000047165195,0.0004106568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730134,0.00026817797,0.00036128232,0.0005407052,0.0008400705,0.0006884041],"domain_scores_gemma":[0.99870515,0.00018879725,0.000072662995,0.00044322736,0.00044210628,0.00014805673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011845516,0.00019562065,0.00022544891,0.0002442636,0.0001642636,0.00003219112,0.0006511477,0.00017963843,0.00044169225],"category_scores_gemma":[0.00025011654,0.00015949158,0.00011357876,0.00046748458,0.00030014938,0.000032188538,0.00016565787,0.00055963686,0.00002560955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003459071,0.000050063158,0.002097229,0.000096393305,0.0000515626,0.000002884561,0.0011539011,0.00065410393,0.9930284,0.00032429196,0.00015616103,0.002039114],"study_design_scores_gemma":[0.0005082391,0.0001981916,0.00656312,0.000094957715,0.0000034237376,0.0000010671042,0.0003495907,0.000031527616,0.9889264,0.00048848457,0.0026595818,0.00017537663],"about_ca_topic_score_codex":0.00075481215,"about_ca_topic_score_gemma":0.00026806077,"teacher_disagreement_score":0.004465891,"about_ca_system_score_codex":0.00030778677,"about_ca_system_score_gemma":0.00059562153,"threshold_uncertainty_score":0.6503878},"labels":[],"label_agreement":null},{"id":"W2322513139","doi":"10.1158/0008-5472.sabcs10-p4-09-09","title":"Abstract P4-09-09: Serum SDF-1: Biomarker of Bone Relapse in the NCIC MA.14 Adjuvant Breast Cancer Trial","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Osteopontin; Stromal cell-derived factor 1; Oncology; Bone metastasis; Bone remodeling; Cancer; Endocrinology; CXCR4; Receptor; Chemokine","score_opus":0.06299466351041254,"score_gpt":0.40977418813343436,"score_spread":0.3467795246230218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322513139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179256,0.0022316556,0.00000248918,0.0027512466,0.0004272184,0.0011797881,0.00042450812,0.000008361232,0.0011821988],"genre_scores_gemma":[0.99687207,0.0007757027,0.000011001759,0.000045104298,0.0006793176,0.00061976834,0.00003291454,0.00004928717,0.00091486523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99649906,0.00044815562,0.00042347112,0.0006690311,0.0010468722,0.00091343164],"domain_scores_gemma":[0.99790573,0.00021103352,0.000102012375,0.0009712688,0.00062110665,0.00018881776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032302097,0.00022477681,0.00031451348,0.0002882969,0.00015929445,0.0000643499,0.0008533973,0.00031971087,0.0015465508],"category_scores_gemma":[0.00060857786,0.00016998939,0.00015041785,0.00071790576,0.0005927655,0.0000150809165,0.00038221618,0.0012624273,0.00004279901],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008824981,0.00021055923,0.012335364,0.00009521574,0.00006758116,0.000039899976,0.00017690098,0.0000034333473,0.94660693,0.00006138213,0.003983763,0.027593989],"study_design_scores_gemma":[0.015856152,0.0005229386,0.6043594,0.00013219322,0.000018575034,0.000043373017,0.000364711,0.00002250676,0.34162402,0.00020437608,0.036408104,0.00044362125],"about_ca_topic_score_codex":0.005303342,"about_ca_topic_score_gemma":0.01036006,"teacher_disagreement_score":0.6049829,"about_ca_system_score_codex":0.000117507065,"about_ca_system_score_gemma":0.000969136,"threshold_uncertainty_score":0.99936616},"labels":[],"label_agreement":null},{"id":"W2322535563","doi":"10.1158/1538-7445.am10-2375","title":"Abstract 2375: Nodal regulates the angiogenic switch in breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"NODAL; Angiogenesis; Breast cancer; Embryonic stem cell; Cancer; Nodal signaling; Cancer research; Metastasis; Phenotype; Biology; Stem cell; Pathology; Medicine; Cell biology; Genetics; Gene","score_opus":0.04240718374453202,"score_gpt":0.3920412732483817,"score_spread":0.3496340895038497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322535563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610583,0.010810183,0.0000027709207,0.026735652,0.00063137006,0.00034831165,0.000021546955,0.000035013414,0.0003568475],"genre_scores_gemma":[0.9888684,0.0006122691,0.000029087189,0.000061789404,0.0019440878,0.00020901271,0.0000062169734,0.000033410794,0.00823572],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984526,0.000038342114,0.00017742974,0.00027127517,0.0005463204,0.0005140583],"domain_scores_gemma":[0.99906534,0.000117304866,0.000021613678,0.00038780743,0.0002267478,0.00018117118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083849364,0.00012813855,0.00021182836,0.00020545181,0.0001222956,0.000021262513,0.00019454872,0.00010768846,0.0020892448],"category_scores_gemma":[0.000080657155,0.00007378122,0.000058096037,0.0006336349,0.0003086228,0.000040497613,0.00004951616,0.0013154274,0.000044918655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013892751,0.00006686979,0.033383742,0.0001011707,0.0000618879,0.00008383484,0.000599257,0.00015395979,0.9299436,0.0002438972,0.016842114,0.018380739],"study_design_scores_gemma":[0.0014185264,0.000060453116,0.89362466,0.00038670038,0.000021393384,0.00011771402,0.00023146266,0.00028202796,0.058083463,0.000042732558,0.045578644,0.00015220964],"about_ca_topic_score_codex":0.0033333378,"about_ca_topic_score_gemma":0.0017386188,"teacher_disagreement_score":0.87186015,"about_ca_system_score_codex":0.00014495527,"about_ca_system_score_gemma":0.0003693033,"threshold_uncertainty_score":0.998823},"labels":[],"label_agreement":null},{"id":"W2322536257","doi":"10.1158/1538-7445.am2013-5559","title":"Abstract 5559: Molecular mechanisms of elesclomol cytotoxicity.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chemistry; Topoisomerase; Oxidative stress; Cytotoxicity; Apoptosis; K562 cells; Biochemistry; Cancer research; Pharmacology; Biology; In vitro","score_opus":0.13561936674631156,"score_gpt":0.39374755742882206,"score_spread":0.25812819068251047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322536257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837337,0.0012314804,0.00018624989,0.0009858457,0.000037989787,0.0006246624,0.0000062679064,0.000019014344,0.013174805],"genre_scores_gemma":[0.99722004,0.0001458303,0.0005410685,0.00011967695,0.000060247505,0.00022435226,0.0000024371109,0.000024827503,0.0016615336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839157,0.000091785994,0.00022574433,0.00021300276,0.00071625446,0.00036166492],"domain_scores_gemma":[0.99888813,0.000083362625,0.000038927446,0.0003761985,0.00045614937,0.00015721428],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006076498,0.00009485576,0.00027087206,0.00014848325,0.000061467,0.000025333313,0.0001786556,0.0000664239,0.0068460805],"category_scores_gemma":[0.00017622153,0.00006843524,0.00009133575,0.00022131934,0.00014599242,0.00006394201,0.00008535637,0.00029840835,0.0003321568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063244064,0.000069273345,0.00012588964,0.00024328803,0.000043521697,0.000010062426,0.00005548497,0.0000019761303,0.9917195,0.0021790706,0.0013519155,0.004136765],"study_design_scores_gemma":[0.00023339949,0.00018573085,0.00808733,0.0001880909,0.000009222878,0.000004768416,0.00011327722,0.000036554105,0.9861699,0.003857284,0.0010418418,0.00007263297],"about_ca_topic_score_codex":0.0015962996,"about_ca_topic_score_gemma":0.000010870386,"teacher_disagreement_score":0.013486342,"about_ca_system_score_codex":0.00006741798,"about_ca_system_score_gemma":0.00017458978,"threshold_uncertainty_score":0.99406177},"labels":[],"label_agreement":null},{"id":"W2322606226","doi":"10.1158/1538-7445.am2013-1580","title":"Abstract 1580: A novel C. elegans animal model for human RET receptor function.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photosynthetic Processes and Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Caenorhabditis elegans; Gene isoform; Phenotype; Receptor tyrosine kinase; Proto-Oncogene Proteins c-ret; Cell biology; Tyrosine kinase; Signal transduction; Receptor; Genetics; Cancer research; Gene","score_opus":0.08366987028984255,"score_gpt":0.38408957636908375,"score_spread":0.3004197060792412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322606226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97904104,0.00028323464,0.01775931,0.0006487404,0.00010261149,0.0007301683,0.00014556927,0.000018141998,0.0012711671],"genre_scores_gemma":[0.9922738,0.00013352376,0.0006002816,0.00018014859,0.00038457476,0.0012147258,0.00008263692,0.000038947248,0.0050913817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986993,0.000013262766,0.0001517255,0.0004114883,0.00023138251,0.000492857],"domain_scores_gemma":[0.99903256,0.000014792146,0.00003761232,0.0003031583,0.0004664893,0.00014537974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036524975,0.00011929187,0.00011077867,0.00005272077,0.00023031197,0.000062411535,0.0002764352,0.00015504677,0.00038123125],"category_scores_gemma":[0.000078967125,0.00010904653,0.00007257661,0.00009317658,0.00008161207,0.000009331054,0.00010075113,0.00017584633,0.00003643115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013619657,0.000065768676,0.0000058593846,0.000058185244,0.000026446545,1.0785634e-7,0.000031247757,0.000038334463,0.9873185,0.001348492,0.010189101,0.0007817486],"study_design_scores_gemma":[0.0005230179,0.00040349917,0.000052041505,0.000024579937,0.0000061703163,0.0000011353588,0.00009278532,0.0013650913,0.96539444,0.0026097435,0.029365934,0.00016153965],"about_ca_topic_score_codex":0.00029236847,"about_ca_topic_score_gemma":0.00012184859,"teacher_disagreement_score":0.02192405,"about_ca_system_score_codex":0.000043178283,"about_ca_system_score_gemma":0.00036762582,"threshold_uncertainty_score":0.44467884},"labels":[],"label_agreement":null},{"id":"W2322721767","doi":"10.1158/0008-5472.sabcs-1134","title":"NCIC CTG MA.17: hormone receptor expression of in-breast recurrences and contralateral primary breast cancers arising on aromatase inhibitors.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Breast cancer; Exemestane; Oncology; Internal medicine; Aromatase; Estrogen receptor; Raloxifene; Selective estrogen receptor modulator; Placebo; Gynecology; Cancer; Pathology","score_opus":0.013513336343342527,"score_gpt":0.3127578137323552,"score_spread":0.2992444773890127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322721767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890114,0.009737582,0.0000014962724,0.0004708323,0.00009020182,0.0002952669,0.00012751378,0.000007517491,0.0003684534],"genre_scores_gemma":[0.9954369,0.0039766314,0.00004421667,0.00006803009,0.00020674121,0.00003247902,0.000120129494,0.000014043569,0.00010080085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843097,0.00018070063,0.00023001604,0.00041411503,0.0003134568,0.00043073893],"domain_scores_gemma":[0.9994186,0.000028661167,0.00007006855,0.00023482408,0.00009345647,0.0001543957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004311336,0.00015858129,0.00021423683,0.00014433207,0.0000972788,0.000029657862,0.00015974471,0.00021535375,0.000015161321],"category_scores_gemma":[0.000021113003,0.00013039923,0.000047155158,0.0002272465,0.00021592194,0.000012754943,0.000073201256,0.00039972924,0.000002674969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00160866,0.00007897639,0.002005428,0.000033651413,0.000015523909,0.000011073108,0.00009681305,0.000036530968,0.9732357,0.00000849666,0.00839835,0.014470779],"study_design_scores_gemma":[0.002075976,0.0013072012,0.04848633,0.00086169917,0.000010300516,0.0000570993,0.000127837,0.000024146024,0.94530094,0.00007277233,0.0013593184,0.00031637447],"about_ca_topic_score_codex":0.00021886139,"about_ca_topic_score_gemma":0.00001060331,"teacher_disagreement_score":0.0464809,"about_ca_system_score_codex":0.00012675337,"about_ca_system_score_gemma":0.00025799428,"threshold_uncertainty_score":0.53175265},"labels":[],"label_agreement":null},{"id":"W2322731366","doi":"10.1158/1538-7445.am2011-lb-93","title":"Abstract LB-93: The role of GSK-3 in mammary gland development and oncogenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Myoepithelial cell; Biology; Carcinogenesis; Cancer research; Mammary gland; Breast cancer; GSK-3; Internal medicine; Cancer; Endocrinology; Signal transduction; Cell biology; Genetics; Medicine; Immunology; Immunohistochemistry","score_opus":0.06305650891537744,"score_gpt":0.33044335160299054,"score_spread":0.2673868426876131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322731366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859622,0.009410772,0.00001113869,0.000060142153,0.000041785264,0.00014654532,0.000003175058,0.0000030071337,0.004361204],"genre_scores_gemma":[0.9973463,0.0015753236,0.00035949473,0.00003140104,0.00006073245,0.00013218171,0.000007845785,0.000012161132,0.00047458283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906516,0.000050246024,0.00017336382,0.00023262367,0.00021634607,0.00026227624],"domain_scores_gemma":[0.99958533,0.000019458957,0.00003601873,0.00019366933,0.00011385752,0.000051676005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000660283,0.00008529036,0.000095447656,0.000066619345,0.00007457056,0.000012989291,0.00028541376,0.00008609714,0.00007696989],"category_scores_gemma":[0.000019112002,0.00006302077,0.000020544265,0.00014698421,0.00013726085,0.0000043615687,0.00019086424,0.00012210428,0.0000038184185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026954577,0.00006273535,0.107412234,0.000060800787,0.00008303648,0.000007299031,0.0021564953,0.0000037997706,0.79408926,0.00012525011,0.0008893534,0.094840184],"study_design_scores_gemma":[0.00025292923,0.00003430106,0.10262969,0.0000352723,0.0000020272614,0.0000016132631,0.0003118294,0.0000015419382,0.86020905,0.00019760858,0.036231074,0.000093068404],"about_ca_topic_score_codex":0.0004142009,"about_ca_topic_score_gemma":0.0003963166,"teacher_disagreement_score":0.09474712,"about_ca_system_score_codex":0.000033679906,"about_ca_system_score_gemma":0.0004092083,"threshold_uncertainty_score":0.25699124},"labels":[],"label_agreement":null},{"id":"W2322798756","doi":"10.1158/0008-5472.sabcs10-p2-12-02","title":"Abstract P2-12-02: How Common Is Sexual Dysfunction among Women with Early Stage Breast Cancer?","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Sexual function; Sexual dysfunction; Distress; Cancer; Anxiety; Quality of life (healthcare); Hypoactive sexual desire disorder; Gynecology; Internal medicine; Clinical psychology; Obstetrics; Sexual desire; Human sexuality; Psychiatry","score_opus":0.04462945169785858,"score_gpt":0.35400715699563473,"score_spread":0.30937770529777614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322798756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190515,0.00020204975,0.0000072169696,0.0037032692,0.0006718995,0.0006234163,0.00041995576,0.00009854552,0.00236852],"genre_scores_gemma":[0.9721597,0.00013804004,0.0000045797096,0.00027335266,0.0012381274,0.00080717675,0.000021482883,0.00008281985,0.025274709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966824,0.000074530566,0.0001929742,0.00063163834,0.0013982939,0.0010201456],"domain_scores_gemma":[0.99787205,0.0000886723,0.00008522807,0.00075916597,0.0006218942,0.00057299266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007713296,0.00025675364,0.0003865734,0.00027064187,0.00028812495,0.00025929543,0.00028275687,0.00022577398,0.004856645],"category_scores_gemma":[0.00001907046,0.00020613281,0.000050318828,0.00062663987,0.00050868257,0.000440392,0.00009759374,0.0020082435,0.00003975955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043307007,0.00017081869,0.8244481,0.0006639593,0.00026874754,0.00017849304,0.01111542,0.0000058960563,0.07331363,0.000038877464,0.014172861,0.07129246],"study_design_scores_gemma":[0.0018184414,0.00062823656,0.95576143,0.00019742965,0.000030141313,0.00002152228,0.005196245,0.000016039223,0.0077245906,0.000014043065,0.028296562,0.00029532],"about_ca_topic_score_codex":0.08479315,"about_ca_topic_score_gemma":0.14954841,"teacher_disagreement_score":0.1313133,"about_ca_system_score_codex":0.000830847,"about_ca_system_score_gemma":0.0009206252,"threshold_uncertainty_score":0.99605304},"labels":[],"label_agreement":null},{"id":"W2322833847","doi":"10.1158/0008-5472.sabcs10-pd03-04","title":"Abstract PD03-04: Effects of Diabetes (DM), Hypertension (HTN) and Coronary Artery Disease (CAD) on Prognosis after 5 Years of Adjuvant Tamoxifen (TAM) and on Treatment Outcomes with the Use of Extended Letrozole (LET): NCIC CTG MA.17","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Coronary artery disease; Proportional hazards model; Oncology; Comorbidity; Diabetes mellitus; Tamoxifen; Placebo; Stage (stratigraphy); Cancer; Gynecology; Endocrinology","score_opus":0.05104227832135881,"score_gpt":0.3313739612836153,"score_spread":0.28033168296225647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322833847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965131,0.0012653603,2.0133487e-7,0.0008812005,0.000059198377,0.0011348631,0.0001255644,0.000008602186,0.000011886437],"genre_scores_gemma":[0.9985845,0.00069695787,0.000017674909,0.00013987462,0.000044609056,0.00028613216,0.000009036817,0.000030397043,0.00019081653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850374,0.000064122956,0.0002038903,0.00032645994,0.0005979705,0.00030383773],"domain_scores_gemma":[0.9984265,0.0006798053,0.00009100482,0.00043692597,0.00014608458,0.00021968175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017580841,0.00018209152,0.00047216192,0.00017217518,0.0000485095,0.000016473203,0.00007306655,0.000068823334,0.00006387356],"category_scores_gemma":[0.0000916518,0.00009901995,0.00008175573,0.00013294429,0.0005476236,0.00006784672,0.000052567735,0.00030569744,0.000001599856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044788355,0.000841709,0.8650183,0.00066339277,0.00028472292,0.00016450758,0.00050316076,0.0000073287215,0.059822273,0.000006124854,0.00074829033,0.06746136],"study_design_scores_gemma":[0.0021802518,0.0022201363,0.9712091,0.0006058399,0.00014221694,0.0000020243644,0.000051292493,0.000031146992,0.022820571,0.0000084683825,0.00063475204,0.00009418318],"about_ca_topic_score_codex":0.00065619603,"about_ca_topic_score_gemma":0.00030124953,"teacher_disagreement_score":0.106190816,"about_ca_system_score_codex":0.000074390824,"about_ca_system_score_gemma":0.00015465163,"threshold_uncertainty_score":0.4037916},"labels":[],"label_agreement":null},{"id":"W2322851380","doi":"10.1158/1538-7445.am2011-4676","title":"Abstract 4676: Survival of gastric cancer differs by ethnicity: A population-based experience from British Columbia, Canada","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ethnic group; Cancer; Internal medicine; Disease; Proportional hazards model; Multivariate analysis; Population; Cancer registry; Stage (stratigraphy); Oncology; Demography; Environmental health; Biology","score_opus":0.09012195006694326,"score_gpt":0.3591739704908276,"score_spread":0.2690520204238843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322851380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593896,0.0014188103,0.000027667938,0.00035300688,0.00041031677,0.0005104592,0.00036677063,0.000026115522,0.00094787223],"genre_scores_gemma":[0.9959201,0.00040751722,0.00005279539,0.00030207878,0.00014669364,0.0002645882,0.000085873035,0.000032325966,0.002788034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972672,0.000070853,0.00035936284,0.0004371548,0.0012801517,0.0005852657],"domain_scores_gemma":[0.99876493,0.00017027937,0.00011274056,0.00037009103,0.00031106363,0.0002708958],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002554345,0.00012533026,0.0004013398,0.00009307166,0.00014055145,0.000057293622,0.0002957461,0.00007513906,0.0077904724],"category_scores_gemma":[0.00012465676,0.00016630709,0.000077077,0.0006957157,0.0001608094,0.000080201105,0.00007576641,0.0003848023,0.0000020219572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012457503,0.00007917272,0.9464506,0.000115393996,0.00007619034,0.00005653431,0.00016457924,0.0000071146555,0.0011451027,0.0000011059423,0.040294044,0.011485575],"study_design_scores_gemma":[0.0012516406,0.000067161374,0.9940154,0.00019363005,0.000037351412,5.563244e-7,0.00037377744,0.000031168154,0.00081679894,0.000016949447,0.0030549292,0.00014062197],"about_ca_topic_score_codex":0.9988965,"about_ca_topic_score_gemma":0.9921309,"teacher_disagreement_score":0.0475648,"about_ca_system_score_codex":0.0010192599,"about_ca_system_score_gemma":0.0014560223,"threshold_uncertainty_score":0.99311656},"labels":[],"label_agreement":null},{"id":"W2322860265","doi":"10.1158/1538-7445.am2011-1620","title":"Abstract 1620: Effects of γ-glutamyl hydrolase and folylpolyglutamyl synthase modulation on gene-specific promoter CpG island methylation","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"DNA methylation; CpG site; Epigenetics; Biology; Methylation; DNA methyltransferase; Molecular biology; Cancer research; Transfection; Carcinogenesis; Promoter; Gene expression; Gene; Biochemistry","score_opus":0.05670350053057115,"score_gpt":0.33948229515415085,"score_spread":0.2827787946235797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322860265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274206,0.0039895284,0.0017907993,0.00003273975,0.00012741564,0.00047195615,0.00002708252,0.0000069220623,0.00081147096],"genre_scores_gemma":[0.99747694,0.0017746489,0.00023149661,0.000009910201,0.00018913773,0.00011596361,0.000044017866,0.000030591043,0.00012731517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985928,0.00014264771,0.00022979669,0.00042334004,0.00032744525,0.00028398854],"domain_scores_gemma":[0.9991735,0.00006847882,0.000090084424,0.00036584516,0.00018710115,0.00011498067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005929897,0.0001431537,0.00014953272,0.00016203162,0.000106679596,0.000022842836,0.000122465,0.00017793216,0.00007121245],"category_scores_gemma":[0.00010831347,0.00013225658,0.000052901145,0.0001497415,0.0001322331,0.0000100055095,0.00006798876,0.00017097642,0.000007681474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028916087,0.00009299806,0.0014241644,0.00008335851,0.00003732915,0.000004432326,0.00021341836,0.00012664156,0.9718257,0.00006063671,0.00006929535,0.025772847],"study_design_scores_gemma":[0.00057082437,0.00051398156,0.037103023,0.000048086058,0.000008886729,6.479475e-7,0.000011186832,0.0002257269,0.9595961,0.0007877316,0.000998317,0.00013550482],"about_ca_topic_score_codex":0.00013111606,"about_ca_topic_score_gemma":0.000042952997,"teacher_disagreement_score":0.03567886,"about_ca_system_score_codex":0.00003234352,"about_ca_system_score_gemma":0.00006548807,"threshold_uncertainty_score":0.5393267},"labels":[],"label_agreement":null},{"id":"W2322931245","doi":"10.1158/1538-7445.am2013-5013","title":"Abstract 5013: Loss of Igfbp7 leads to the expansion of luminal progenitors by altering the stromal fibroblasts’ ability to support luminal cell differentiation.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre; University of Manitoba","funders":"","keywords":"Biology; Stromal cell; Progenitor cell; Internal medicine; Endocrinology; Insulin-like growth factor-binding protein; Morphogenesis; Mammary gland; Stem cell; Transcriptome; Cancer research; Cell biology; Growth factor; Breast cancer; Cancer; Gene expression; Insulin-like growth factor; Receptor; Medicine; Gene; Genetics","score_opus":0.048091902662702184,"score_gpt":0.36533227358992443,"score_spread":0.31724037092722224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322931245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951311,0.00034552137,0.000050426046,0.002309024,0.00021610352,0.0015980941,0.000105754814,0.000008882097,0.00023510543],"genre_scores_gemma":[0.9979421,0.00008079497,0.00009767095,0.000058451744,0.00041590194,0.00044314493,0.000015335048,0.000025049387,0.00092154957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754155,0.00011228709,0.0004255844,0.00035103425,0.0010536112,0.0005159163],"domain_scores_gemma":[0.99827325,0.00014823713,0.000095566575,0.0006239748,0.00058507035,0.00027392234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085926324,0.00015107014,0.00029964835,0.00009736211,0.0001349625,0.000035127974,0.00036544155,0.00005698793,0.0016939947],"category_scores_gemma":[0.00008289306,0.00008972429,0.00012597196,0.00044084372,0.0002584804,0.000079483994,0.00020819013,0.00037082264,0.000058909394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040386192,0.00015756725,0.018313086,0.00063158077,0.000029766816,0.0000023549794,0.0012031551,0.000054644912,0.93907547,0.0000021688488,0.025645994,0.014480328],"study_design_scores_gemma":[0.0005245891,0.0009770227,0.13541728,0.0001634691,0.00003841609,0.0000041227404,0.0010152603,0.000010277668,0.85538876,0.0000060801126,0.006353615,0.00010111194],"about_ca_topic_score_codex":0.0030525685,"about_ca_topic_score_gemma":0.0001944921,"teacher_disagreement_score":0.1171042,"about_ca_system_score_codex":0.0002101882,"about_ca_system_score_gemma":0.00043853253,"threshold_uncertainty_score":0.9992186},"labels":[],"label_agreement":null},{"id":"W2322949740","doi":"10.1158/1538-7445.am10-5213","title":"Abstract 5213: KiSS1R signaling in breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Transactivation; Metastasis; Breast cancer; Biology; Kisspeptin; Cancer; Epidermal growth factor receptor; Receptor; Medicine; Internal medicine; Transcription factor","score_opus":0.12980495660672808,"score_gpt":0.43095444787137466,"score_spread":0.3011494912646466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322949740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957439,0.000046534296,8.530729e-8,0.0010443117,0.00031429503,0.00016812321,0.000048742295,0.00003009324,0.002603964],"genre_scores_gemma":[0.99813354,0.0002555161,0.0000053611025,0.00050222647,0.0005138935,0.00010642619,4.1511612e-7,0.000028645485,0.00045398058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981633,0.00009902289,0.00017050697,0.00051375484,0.0003828196,0.00067064044],"domain_scores_gemma":[0.9992172,0.00027365214,0.000033382486,0.00024355932,0.00008846371,0.00014370079],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032405197,0.00010917242,0.00014348389,0.00016171382,0.00016768997,0.00007139626,0.00047893453,0.00006770996,0.003513703],"category_scores_gemma":[0.00013201998,0.00009327072,0.00004040305,0.00054908794,0.000307683,0.00015831078,0.0001577169,0.0013059932,0.00022313005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008986593,0.000049023,0.0020076458,0.000023184746,9.869533e-7,0.000067350855,0.000056734574,0.00006746026,0.9899803,0.00075799134,0.0011210381,0.00577845],"study_design_scores_gemma":[0.0003134606,0.00003686867,0.0829213,0.00006270114,8.95866e-7,0.000011652143,0.000028577324,0.000039896968,0.9040291,0.0007758604,0.011622309,0.00015740936],"about_ca_topic_score_codex":0.0024075694,"about_ca_topic_score_gemma":0.0007285595,"teacher_disagreement_score":0.085951194,"about_ca_system_score_codex":0.00005997108,"about_ca_system_score_gemma":0.00021736187,"threshold_uncertainty_score":0.99739724},"labels":[],"label_agreement":null},{"id":"W2323055234","doi":"10.1158/1538-7445.am10-5405","title":"Abstract 5405: PPARγ-agonist can render bladder tumor sensitive to EGFR inhibition","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Epidermal growth factor receptor; Cancer research; MTT assay; Bladder cancer; Viability assay; Cell growth; In vivo; Agonist; Cell culture; Medicine; Receptor; Cancer; Chemistry; Biology; Internal medicine","score_opus":0.03244563278343503,"score_gpt":0.3612612782052362,"score_spread":0.32881564542180114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323055234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942104,0.00007066205,0.000020665764,0.0019339425,0.00038202706,0.00040690112,0.00014285921,0.000025010268,0.0028075299],"genre_scores_gemma":[0.99669284,0.000060574024,0.00012810757,0.0006124651,0.0010514123,0.00022350115,0.00011952013,0.0000551431,0.0010564111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979579,0.000105340274,0.00019137796,0.00062074786,0.00045023378,0.000674419],"domain_scores_gemma":[0.9985586,0.000026854159,0.000044611592,0.0004604135,0.00054455537,0.0003649572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052619627,0.00019082762,0.00015475057,0.00014937363,0.0002699702,0.00009336327,0.00020370222,0.00021837965,0.00041895307],"category_scores_gemma":[0.0002621331,0.00018307814,0.000066217355,0.00032641395,0.00026217225,0.000008446833,0.00021192274,0.0008159922,0.00012348786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000177865,0.000052380714,0.00038357743,0.000016240356,0.000049515318,0.00001983672,0.00013399108,0.000014555926,0.9761231,0.000033305645,0.021531658,0.001463976],"study_design_scores_gemma":[0.0003196328,0.0001238355,0.0017971543,0.000021318692,0.0000039726633,0.000015272864,0.00020101471,0.0000026807768,0.9447494,0.000026788734,0.05251706,0.00022184539],"about_ca_topic_score_codex":0.0006368511,"about_ca_topic_score_gemma":0.0016640237,"teacher_disagreement_score":0.031373672,"about_ca_system_score_codex":0.00012908192,"about_ca_system_score_gemma":0.0006132934,"threshold_uncertainty_score":0.746571},"labels":[],"label_agreement":null},{"id":"W2323112071","doi":"10.1158/0008-5472.sabcs10-p1-13-08","title":"Abstract P1-13-08: A Cross-Sectional Study Evaluating Bone Quantity and Quality in Women with Bone Metastases from Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Regional Municipality of Durham; Ottawa Hospital; University of Toronto","funders":"","keywords":"Medicine; Bone mineral; Osteoporosis; Breast cancer; Bisphosphonate; Quantitative computed tomography; Internal medicine; Population; Bone remodeling; Pathologic fracture; Oncology; Bone density; Cancer; Radiology; Surgery","score_opus":0.22887833081818343,"score_gpt":0.5491793845357205,"score_spread":0.32030105371753703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323112071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630326,0.001125006,4.9121536e-7,0.00039004616,0.00012668948,0.0011959624,0.0007590044,0.00002628801,0.000073280076],"genre_scores_gemma":[0.9980922,0.00012122327,0.000101285994,0.00009010252,0.00018290973,0.0011768175,0.000028009477,0.000027545912,0.00017995838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967032,0.00024980147,0.00045229908,0.0006129429,0.0012681492,0.0007135745],"domain_scores_gemma":[0.99826044,0.00035221962,0.00010498287,0.0003735003,0.00044555645,0.0004633253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003581031,0.00017592669,0.00044937897,0.00021002334,0.00030122133,0.00009298115,0.000077403325,0.00009919814,0.0020544664],"category_scores_gemma":[0.00019471617,0.00013286511,0.000025514726,0.00044221076,0.00029898965,0.0001778627,0.00008095567,0.0011214656,0.000019298403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065962155,0.0009685939,0.97011006,0.00014548085,0.00014746387,0.000103886094,0.00076789485,0.0000045873094,0.009633268,0.000005860537,0.000038844788,0.011477874],"study_design_scores_gemma":[0.007566942,0.0005674637,0.99071336,0.00010290898,0.000022390486,0.00001969789,0.00055840635,0.000016097929,0.0002101234,0.000047361107,0.000055669807,0.000119579236],"about_ca_topic_score_codex":0.3099955,"about_ca_topic_score_gemma":0.20369251,"teacher_disagreement_score":0.10630299,"about_ca_system_score_codex":0.00056644477,"about_ca_system_score_gemma":0.0014402536,"threshold_uncertainty_score":0.9988578},"labels":[],"label_agreement":null},{"id":"W2323125978","doi":"10.1158/1538-7445.am2011-4645","title":"Abstract 4645: Decreased CD4+ naive and effector memory T cell counts, and CD8+ naive T cell counts, are associated with trichloroethylene exposure","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"CD8; Immunology; Lymphocyte; Carcinogen; Trichloroethylene; Cytotoxic T cell; Biology; Chemistry; Internal medicine; Medicine; Physiology; Toxicology; Immune system; In vitro; Biochemistry; Environmental chemistry","score_opus":0.03340410650468923,"score_gpt":0.2990674641442945,"score_spread":0.2656633576396053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323125978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832721,0.006713264,0.0000075100256,0.000018601933,0.000052012983,0.00025433715,0.00015218656,0.0000065558693,0.009523459],"genre_scores_gemma":[0.99610317,0.0014778248,0.000029489367,0.000055952136,0.00008553906,0.000047677047,0.00004690159,0.000020443056,0.002133015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991159,0.00006245303,0.00008086398,0.0002783341,0.00021871754,0.00024374046],"domain_scores_gemma":[0.9994479,0.00003364873,0.00004671314,0.000168934,0.00018251651,0.000120325494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027475707,0.000108925866,0.00012204908,0.00004400815,0.00009183746,0.000024889445,0.000086214946,0.00012430616,0.00030612928],"category_scores_gemma":[0.00002448495,0.000091479575,0.000024341272,0.00008351004,0.00012401144,0.0000035995574,0.000059858565,0.00016843317,0.00001809932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005435782,0.00024809423,0.025101949,0.00026405032,0.0001635863,0.000081542785,0.00034802908,0.000002213294,0.9443337,0.000010713823,0.02550407,0.0033984736],"study_design_scores_gemma":[0.0019917171,0.0007652593,0.12874223,0.000092601294,0.000047935322,0.0000056165118,0.00044913124,0.000009386903,0.8466226,0.00002304954,0.020892816,0.00035765933],"about_ca_topic_score_codex":0.00020556123,"about_ca_topic_score_gemma":0.00011278634,"teacher_disagreement_score":0.10364028,"about_ca_system_score_codex":0.00004900889,"about_ca_system_score_gemma":0.0001762474,"threshold_uncertainty_score":0.37304288},"labels":[],"label_agreement":null},{"id":"W2323138189","doi":"10.1158/0008-5472.sabcs11-p4-16-08","title":"P4-16-08: Pilot Randomized Trial of De-Escalated (q12 Weekly) Versus Standard (q3-4 Weekly) Intravenous Bisphosphonates in Women with Low-Risk Bone Metastases from Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Randomization; N-terminal telopeptide; Breast cancer; Randomized controlled trial; Bone pain; Internal medicine; Surgery; Brief Pain Inventory; Cancer; Physical therapy; Alkaline phosphatase; Chronic pain","score_opus":0.05347406223543602,"score_gpt":0.36284068652752544,"score_spread":0.3093666242920894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323138189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886627,0.0044926256,0.000020686633,0.000708794,0.00031729494,0.0034148956,0.0018323148,0.00005526543,0.0004954218],"genre_scores_gemma":[0.989501,0.0070491033,0.00032641273,0.00006367291,0.00012212891,0.0024104826,0.000068497415,0.000080215104,0.0003785059],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99508697,0.00091263314,0.00080992695,0.0006434099,0.0011716023,0.0013754431],"domain_scores_gemma":[0.9968801,0.0008979109,0.00028168294,0.00057258096,0.0006008394,0.00076689036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024004334,0.0003593463,0.0016838607,0.0004727083,0.00016488171,0.000027073562,0.00022708462,0.00017033485,0.0033529976],"category_scores_gemma":[0.00041172316,0.000259145,0.00011956908,0.0011067782,0.0007065168,0.00012753165,0.00009013866,0.0009368605,0.000024321065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95085037,0.0014427694,0.0044535804,0.0001925473,0.0011511067,0.00025224607,0.0016990862,0.0000071113036,0.0004719403,0.000021848402,0.0005525942,0.0389048],"study_design_scores_gemma":[0.9573375,0.010270922,0.01868931,0.0008448251,0.00039894495,0.00001119675,0.0006649287,0.000028292676,0.010776642,0.00040493763,0.00030252078,0.00027000735],"about_ca_topic_score_codex":0.27071184,"about_ca_topic_score_gemma":0.015740497,"teacher_disagreement_score":0.25497136,"about_ca_system_score_codex":0.0024016306,"about_ca_system_score_gemma":0.0034962292,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W2323146919","doi":"10.1158/1538-7445.am2013-lb-133","title":"Abstract LB-133: A novel tumor suppressor role for sirt1 inhibiting mitophagy in prostate mouse tissue.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Mitophagy; Sirtuin 1; Carcinogenesis; Prostate cancer; Cancer research; Sirtuin; Autophagy; Biology; Prostate; Cancer; Oncogene; Gene knockdown; Genetically modified mouse; Cell biology; Transgene; NAD+ kinase; Downregulation and upregulation; Cell culture; Apoptosis; Cell cycle; Biochemistry; Genetics","score_opus":0.033077757529955266,"score_gpt":0.3538932821527919,"score_spread":0.32081552462283663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323146919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931809,0.003345459,0.00006439554,0.00040325773,0.0007111745,0.0014513612,0.00023017019,0.000014455112,0.0005988385],"genre_scores_gemma":[0.98329884,0.00046020793,0.0005704419,0.00020960582,0.005893348,0.0027715173,0.00009184593,0.00007131757,0.0066328975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801147,0.000039774688,0.0002893062,0.0005444731,0.00029355177,0.00082142215],"domain_scores_gemma":[0.9989974,0.000043542655,0.000063975975,0.00034319577,0.0003716628,0.00018023183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005187481,0.00017399629,0.00022094841,0.00013225836,0.00012202465,0.000094652474,0.00029170542,0.00010945767,0.00011584754],"category_scores_gemma":[0.00025704538,0.00016881908,0.00007375842,0.00016938645,0.00013975233,0.000018228933,0.00017117706,0.00028744998,0.000025572606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016317079,0.000079460406,0.00017144652,0.0001141786,0.000015391799,2.62531e-7,0.00019481753,0.00016933972,0.96092665,0.000032325424,0.033622216,0.004510768],"study_design_scores_gemma":[0.0013415173,0.00009538952,0.0009985446,0.000041693016,0.0000030320662,0.0000024371766,0.00025329448,0.00014222831,0.78830063,0.00010330648,0.20853189,0.00018605441],"about_ca_topic_score_codex":0.0018722453,"about_ca_topic_score_gemma":0.0008713593,"teacher_disagreement_score":0.17490968,"about_ca_system_score_codex":0.00007456303,"about_ca_system_score_gemma":0.00042788827,"threshold_uncertainty_score":0.6884242},"labels":[],"label_agreement":null},{"id":"W2323152328","doi":"10.1158/1538-7445.am2011-4309","title":"Abstract 4309: Establishment of the chick chorioallantoic membrane (CAM) as an ex vivo model system to study mechanisms underlying epithelial ovarian tumour growth and metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Western University","funders":"","keywords":"Biology; Angiogenesis; Chorioallantoic membrane; Metastasis; Cancer research; Ovarian cancer; Cell culture; Matrigel; Cancer; Pathology; Medicine; Genetics","score_opus":0.07677224817262326,"score_gpt":0.35599022969065686,"score_spread":0.27921798151803356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323152328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911008,0.00031145508,0.004637699,0.00015897902,0.00017662883,0.0020480515,0.00013798091,0.000022788448,0.0014056332],"genre_scores_gemma":[0.99819475,0.00019717723,0.0008055567,0.00006332334,0.000080419675,0.00038852013,0.00000906227,0.00008478701,0.00017641268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961366,0.0005230762,0.00040192905,0.0009171403,0.0012374511,0.0007837741],"domain_scores_gemma":[0.99803925,0.000025685149,0.000108016335,0.0009184778,0.0004888928,0.00041966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019791424,0.00028646202,0.0003381773,0.00026264013,0.00037070518,0.00010341225,0.0009982546,0.00020132211,0.00011486061],"category_scores_gemma":[0.00015267184,0.00023127967,0.00011198313,0.0005467517,0.00014105695,0.000020796595,0.0008040305,0.00052067987,0.0000075756884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005996239,0.0002454687,0.00002091329,0.00015060052,0.00023622873,0.000018417917,0.0010218389,0.00036217624,0.9942566,0.002055497,0.00003547994,0.0009971275],"study_design_scores_gemma":[0.001152598,0.0010937365,0.0005109086,0.000082737795,0.000054900593,0.000022739634,0.0023900082,0.00039143587,0.9933136,0.0006841367,0.00004485278,0.0002583077],"about_ca_topic_score_codex":0.0059417244,"about_ca_topic_score_gemma":0.0011149208,"teacher_disagreement_score":0.007093957,"about_ca_system_score_codex":0.00016261624,"about_ca_system_score_gemma":0.00066603866,"threshold_uncertainty_score":0.9431311},"labels":[],"label_agreement":null},{"id":"W2323192953","doi":"10.1158/1538-7445.am2011-2799","title":"Abstract 2799: Unexpected sustained hypoxic glutamine metabolism and therapeutic opportunities","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Research Council (Canada)","funders":"","keywords":"Glutaminolysis; Glutamine; Glutaminase; Glycolysis; Citric acid cycle; Anabolism; Hypoxia (environmental); Catabolism; Biochemistry; Biology; Metabolism; Glutamine amidotransferase; Glucose transporter; Metabolic pathway; Chemistry; Amino acid; Endocrinology","score_opus":0.1282179259729351,"score_gpt":0.3560585674883824,"score_spread":0.22784064151544728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323192953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9353718,0.058315616,0.000024976542,0.00026955205,0.0005291058,0.0003331876,0.000051930823,0.000026560623,0.005077248],"genre_scores_gemma":[0.97196436,0.020743689,0.000071683266,0.00021850743,0.0014811712,0.00019507532,0.00003615409,0.000050839877,0.0052385414],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981822,0.0001334785,0.00022169437,0.0004740757,0.00034073708,0.00064785057],"domain_scores_gemma":[0.9987998,0.000025823554,0.000057286896,0.00046605483,0.0003993414,0.00025169266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054206775,0.00020572584,0.00024325511,0.00017953353,0.00019729254,0.000048771068,0.00029967478,0.00017421447,0.00042209585],"category_scores_gemma":[0.000075621814,0.0001849413,0.000076887976,0.00021495386,0.00044526206,0.000009601743,0.00018568734,0.0002747092,0.000008144648],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004232341,0.00008362004,0.00023057843,0.00006714874,0.00016926855,0.000010454854,0.0006704569,0.0000010484747,0.9434991,0.0013416073,0.0043519326,0.049151555],"study_design_scores_gemma":[0.0015731764,0.00019250327,0.03363914,0.000027637845,0.000055392367,0.000019526551,0.0027333756,0.0000064692385,0.38115123,0.0008710127,0.5792915,0.00043902965],"about_ca_topic_score_codex":0.0007223321,"about_ca_topic_score_gemma":0.00019587956,"teacher_disagreement_score":0.57493955,"about_ca_system_score_codex":0.000031204847,"about_ca_system_score_gemma":0.00046557066,"threshold_uncertainty_score":0.7541687},"labels":[],"label_agreement":null},{"id":"W2323196829","doi":"10.1158/1538-7445.am2013-3047a","title":"Abstract 3047A: Differential subcellular localization and trafficking of RET isoforms.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell biology; Endosome; Gene isoform; Biology; Subcellular localization; Receptor tyrosine kinase; Proximity ligation assay; Signal transduction; Alternative splicing; Endocytosis; Signal transducing adaptor protein; Receptor; Cytoplasm; Intracellular; Gene; Biochemistry","score_opus":0.026699762186225152,"score_gpt":0.325712576312731,"score_spread":0.2990128141265058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323196829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958245,0.0021892854,0.0012405321,0.00013866294,0.000087893764,0.00028716936,0.000007084782,0.0000063993534,0.00021846153],"genre_scores_gemma":[0.9981866,0.001095416,0.000022786995,0.000008706848,0.00022003018,0.000052239368,0.000073533505,0.000018919562,0.0003217776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999069,0.00004097972,0.00016854148,0.00024166991,0.0002459353,0.00023388349],"domain_scores_gemma":[0.99942285,0.000011280772,0.000050216204,0.00019973895,0.00024839593,0.00006749112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017977924,0.00007996752,0.00009746029,0.00007382878,0.00008244143,0.000029803636,0.00009885576,0.0001459727,0.0002380367],"category_scores_gemma":[0.00003564428,0.000074852374,0.000033301956,0.00014073128,0.0001555803,0.000008232899,0.00007270038,0.00011937594,0.0000060737907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004847564,0.000019274317,0.0013776044,0.0000738883,0.000027738215,2.7256635e-7,0.00007456786,0.0007656177,0.97700846,0.000032254353,0.0024040435,0.018167783],"study_design_scores_gemma":[0.0005973625,0.0001503899,0.028300835,0.000073227806,0.000009414745,0.0000023448736,0.00009212387,0.0022700424,0.96295214,0.00014345616,0.005260341,0.00014831377],"about_ca_topic_score_codex":0.00045814528,"about_ca_topic_score_gemma":0.00011283711,"teacher_disagreement_score":0.02692323,"about_ca_system_score_codex":0.000042621316,"about_ca_system_score_gemma":0.00009695679,"threshold_uncertainty_score":0.30523914},"labels":[],"label_agreement":null},{"id":"W2323213552","doi":"10.1158/1538-7445.am2012-4542","title":"Abstract 4542: Early detection of clinically significant prostate cancer at diagnosis: A prospective study using a novel panel of TMPRSS2:ETS fusion gene markers","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"TMPRSS2; Prostate cancer; Biopsy; Medicine; Prostate biopsy; Cancer; Fusion gene; PCA3; Prospective cohort study; Internal medicine; Oncology; Pathology; Biology; Gene; Disease; Genetics","score_opus":0.19294162332719006,"score_gpt":0.4576746504209172,"score_spread":0.26473302709372715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323213552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990089,0.0041118674,0.000011078278,0.00014650924,0.00023664701,0.004998222,0.00021789953,0.000030217423,0.00015854416],"genre_scores_gemma":[0.99291855,0.0036199696,0.00012518691,0.000011797336,0.00032146464,0.0023770952,0.000010233319,0.00007456623,0.00054113363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953593,0.00023464319,0.00089006894,0.0006339459,0.0017866924,0.0010953395],"domain_scores_gemma":[0.9967614,0.00038391136,0.00035060622,0.0005564916,0.0014693436,0.00047829002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026930296,0.0002827733,0.00068466517,0.00048707612,0.0002867061,0.000025297879,0.00023040388,0.00017937178,0.0004098547],"category_scores_gemma":[0.00031325495,0.00021743323,0.00018228289,0.0011041297,0.00059894274,0.0002381896,0.00031284493,0.0007581558,0.000011122323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007335588,0.0017281111,0.5026095,0.00032790747,0.00035048282,0.000016538554,0.0030830286,0.000014029582,0.4773597,8.369681e-7,0.00002895572,0.007145288],"study_design_scores_gemma":[0.0045227516,0.0020730305,0.6502944,0.00053395465,0.00014542189,0.000004092812,0.0013291073,0.000035633606,0.34081498,0.000008672799,0.00008095281,0.00015696851],"about_ca_topic_score_codex":0.010515728,"about_ca_topic_score_gemma":0.00029527076,"teacher_disagreement_score":0.14768492,"about_ca_system_score_codex":0.0018600493,"about_ca_system_score_gemma":0.0011111042,"threshold_uncertainty_score":0.9960733},"labels":[],"label_agreement":null},{"id":"W2323289001","doi":"10.1158/1538-7445.am2012-4501","title":"Abstract 4501: Energetic risk and prostate cancer-specific and all-cause mortality in two large cohorts of men with localized prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Prostate cancer; Medicine; Hazard ratio; Quartile; Proportional hazards model; Body mass index; Confidence interval; Population; Internal medicine; Cancer; Prostate-specific antigen; Relative risk; Oncology; Demography; Environmental health","score_opus":0.06457050515790969,"score_gpt":0.4243236490776437,"score_spread":0.359753143919734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323289001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91733253,0.080057934,0.0000031847565,0.00025594162,0.00009519783,0.0017309433,0.0002930078,0.000019542776,0.00021171059],"genre_scores_gemma":[0.81531554,0.1835778,0.000021861648,0.000034178116,0.00016731133,0.0006335236,0.000020895206,0.00004212575,0.00018676592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967094,0.00026983055,0.000423349,0.00050077756,0.0009579813,0.0011386741],"domain_scores_gemma":[0.9983022,0.00010527569,0.00012707362,0.00045118987,0.0003086421,0.000705582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024604634,0.00023336888,0.00067652174,0.00024796103,0.0001351217,0.000026534031,0.000077869816,0.00009371456,0.00020389754],"category_scores_gemma":[0.00005115458,0.00016653049,0.00006367902,0.0005059666,0.0004318175,0.00016959879,0.00009075358,0.0007532646,0.0000020159628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001588629,0.00014353942,0.9797807,0.0009486276,0.0006409916,0.00006364654,0.0026620608,0.00006563038,0.001633484,0.000021370353,0.00081928907,0.011632081],"study_design_scores_gemma":[0.006228617,0.00012315225,0.9624352,0.00057377445,0.0002556862,0.000012977473,0.00061841635,0.000059178343,0.0048915646,0.000021072032,0.024566432,0.00021394521],"about_ca_topic_score_codex":0.069409415,"about_ca_topic_score_gemma":0.018821616,"teacher_disagreement_score":0.10351987,"about_ca_system_score_codex":0.00043187337,"about_ca_system_score_gemma":0.00076843414,"threshold_uncertainty_score":0.9990823},"labels":[],"label_agreement":null},{"id":"W2323347260","doi":"10.1158/0008-5472.sabcs11-p3-08-04","title":"P3-08-04: “How Important Is This for Me?” – The Role of Necessity Beliefs as Determinants of Breast Cancer Prevention Intentions among High-Risk Women.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Worry; Psychological intervention; Risk perception; Medicine; Champion; Breast cancer; Intervention (counseling); Psychology; Social psychology; Cancer; Gynecology; Family medicine; Nursing; Psychiatry; Perception; Anxiety","score_opus":0.03483047881026752,"score_gpt":0.3609181236377688,"score_spread":0.3260876448275013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323347260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995194,0.0024356043,0.00012144009,0.00022932419,0.00017529044,0.00067249406,0.00091255555,0.0000054737216,0.00025381992],"genre_scores_gemma":[0.9935073,0.0025783745,0.00020974677,0.0000268398,0.00016909458,0.0015390767,0.00002009484,0.000031258514,0.0019181898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982692,0.00016444495,0.00033323208,0.00039641582,0.0004149854,0.00042170592],"domain_scores_gemma":[0.9980002,0.000034424615,0.00031279708,0.00058557553,0.0009779686,0.00008902662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009833975,0.00013912612,0.00021019504,0.00009828982,0.00023363094,0.000019419045,0.0005004512,0.00015608197,0.00059406663],"category_scores_gemma":[0.00012540954,0.000109329885,0.00013905263,0.00028976944,0.0005032046,0.000017038785,0.0002244991,0.00019488484,0.0000018187216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009320696,0.00032076405,0.3945451,0.00024005077,0.00057993707,0.000001172574,0.0044577066,0.000013937711,0.5379784,0.00015603099,0.0055483724,0.055226427],"study_design_scores_gemma":[0.00062429666,0.00045520774,0.08429981,0.00010819976,0.000059832004,0.0000036113322,0.0017784061,0.00013408254,0.9063586,0.0031369743,0.002884132,0.00015683049],"about_ca_topic_score_codex":0.006004614,"about_ca_topic_score_gemma":0.0043515936,"teacher_disagreement_score":0.36838022,"about_ca_system_score_codex":0.00021297824,"about_ca_system_score_gemma":0.00095873047,"threshold_uncertainty_score":0.907722},"labels":[],"label_agreement":null},{"id":"W2323432289","doi":"10.1158/0008-5472.sabcs-1027","title":"Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Bevacizumab; Docetaxel; Internal medicine; Population; Gastroenterology; Breast cancer; Oncology; Cancer; Chemotherapy","score_opus":0.12369791208952845,"score_gpt":0.4383749559649993,"score_spread":0.31467704387547085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323432289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228966,0.0004267146,0.000004904687,0.0023566002,0.00014516116,0.004569771,0.00015025174,0.000018938801,0.00003800496],"genre_scores_gemma":[0.9966642,0.00092193065,0.000040368188,0.00054736243,0.00009215647,0.000710552,0.000038320464,0.000039412233,0.0009456799],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99617517,0.00053216546,0.0005633831,0.0006653137,0.0013069054,0.00075708784],"domain_scores_gemma":[0.9978874,0.0005454806,0.0001681666,0.0005250385,0.000663621,0.00021029195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007190439,0.00034533054,0.0008306694,0.00048120497,0.00013147607,0.000045581644,0.00030868425,0.00007392861,0.00066247286],"category_scores_gemma":[0.00008989768,0.00014859367,0.000057982455,0.0014842529,0.00033630495,0.00021079178,0.00006555235,0.0008916621,0.000007398918],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71465886,0.029146872,0.06575398,0.00035950507,0.0008600483,0.0034019356,0.011966728,0.0007340816,0.0015809619,0.000009803022,0.002867677,0.16865954],"study_design_scores_gemma":[0.3418845,0.044179343,0.603152,0.0026641774,0.0011161038,0.000163252,0.0030513841,0.0008915673,0.0014165313,0.000009894596,0.00090301223,0.00056824356],"about_ca_topic_score_codex":0.008332103,"about_ca_topic_score_gemma":0.027064841,"teacher_disagreement_score":0.53739804,"about_ca_system_score_codex":0.001136238,"about_ca_system_score_gemma":0.0016760031,"threshold_uncertainty_score":0.9982715},"labels":[],"label_agreement":null},{"id":"W2323452145","doi":"10.1158/1538-7445.am2013-64","title":"Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Quebec - Clinical Research Organization in Cancer; Simon Fraser University; McGill University Health Centre","funders":"","keywords":"Medicine; Biopsy; Oncology; Sentinel lymph node; Lymph node; Pathology; Cancer; Internal medicine; Breast cancer","score_opus":0.29533983724513796,"score_gpt":0.5105911388387749,"score_spread":0.21525130159363698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323452145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418287,0.00027028238,0.0022598691,0.00012662243,0.000033520362,0.053153582,0.0023175348,0.0000019974952,0.000007887649],"genre_scores_gemma":[0.93413216,0.00007008327,0.0031796244,0.000023632041,0.000113318325,0.06228647,0.00014577321,0.000017838172,0.000031100946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881816,0.000056274628,0.00047532973,0.0003273085,0.00010010975,0.00022280432],"domain_scores_gemma":[0.9980633,0.0009007791,0.00018091364,0.00020977971,0.000578376,0.00006684158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009539683,0.000105263825,0.00032217358,0.000053041007,0.0000480448,0.000023948518,0.00009794635,0.00014419931,0.000012727292],"category_scores_gemma":[0.002337307,0.0000950103,0.00005946796,0.000051106206,0.00014688873,0.000006641292,0.00006731189,0.000047366466,1.1931338e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038854715,0.0003066576,0.010586796,0.0007374597,0.00003886109,1.1129439e-7,0.00016754794,0.0000660686,0.97362727,0.000020221503,0.00035703476,0.010206496],"study_design_scores_gemma":[0.02938647,0.0009883805,0.060970712,0.00021704586,0.000023187325,4.447356e-7,0.0004242862,0.010136565,0.89171827,0.0013083199,0.0045281597,0.00029818312],"about_ca_topic_score_codex":0.0030031255,"about_ca_topic_score_gemma":0.0010109287,"teacher_disagreement_score":0.08190902,"about_ca_system_score_codex":0.000051454874,"about_ca_system_score_gemma":0.00020061347,"threshold_uncertainty_score":0.45398477},"labels":[],"label_agreement":null},{"id":"W2323455392","doi":"10.1158/0008-5472.sabcs11-p1-06-13","title":"P1-06-13: An Amplicon-Driven Aromatase Inhibitor Response (ADAIR) Signature Provides an Orthogonal Risk Classifier for ER+ Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Tamoxifen; Aromatase; Oncology; Biology; Amplicon; Estrogen receptor; Gene signature; Microarray analysis techniques; Cancer research; Microarray; Copy-number variation; Aromatase inhibitor; Internal medicine; Gene expression; Cancer; Gene; Bioinformatics; Medicine; Genetics; Genome; Polymerase chain reaction","score_opus":0.07168039927021055,"score_gpt":0.37593867125371927,"score_spread":0.30425827198350874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323455392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835135,0.002441389,0.00007725397,0.0005482576,0.00022473748,0.0011339472,0.007066332,0.000048294816,0.00010846145],"genre_scores_gemma":[0.99284154,0.00075260544,0.0005487449,0.00019463045,0.0013748026,0.0030077894,0.00060892315,0.00010307749,0.00056791335],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965186,0.0006131034,0.00029954492,0.0011445761,0.00047955613,0.00094462367],"domain_scores_gemma":[0.9977713,0.0001038339,0.00013809359,0.00088718877,0.0006701476,0.00042942213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008373273,0.00037433844,0.00032742406,0.00014920015,0.00061262364,0.000077524,0.00056576944,0.00034467454,0.00021846907],"category_scores_gemma":[0.00014376064,0.00032414641,0.00014809478,0.0002937951,0.00057403033,0.000045693727,0.0002770621,0.00045749542,0.000011360289],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03910109,0.0012211482,0.107316196,0.000212353,0.0009001859,0.000059163824,0.0019443405,0.00007692034,0.7735079,0.00020219578,0.04501446,0.030444056],"study_design_scores_gemma":[0.007541854,0.0037366375,0.60911703,0.00033386657,0.0002755064,0.00012895462,0.0023040324,0.000178272,0.2998909,0.0007794137,0.07405472,0.0016587977],"about_ca_topic_score_codex":0.0021405828,"about_ca_topic_score_gemma":0.0061470536,"teacher_disagreement_score":0.50180084,"about_ca_system_score_codex":0.00027060878,"about_ca_system_score_gemma":0.0011515477,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W2323506228","doi":"10.1158/0008-5472.sabcs12-p2-13-08","title":"Abstract P2-13-08: Comparison of Compliance to Anti Estrogen Therapy in Patients with Early Breast Cancer followed at Tertiary Centers versus Through Family Physicians and Primary Surgeons: A Practice Review","year":2012,"lang":"en","type":"review","venue":"Cancer Research","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; Western University","funders":"","keywords":"Medicine; Cohort; Breast cancer; Cancer; Internal medicine; Adjuvant therapy; Retrospective cohort study; Cohort study; Estrogen","score_opus":0.26569097199666186,"score_gpt":0.49445164118797047,"score_spread":0.2287606691913086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323506228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037303656,0.9563843,0.0000028042607,0.00082545116,0.00020942163,0.004387997,0.0002849009,0.000019293599,0.0005821595],"genre_scores_gemma":[0.008187633,0.9886752,0.0000838641,0.00097283634,0.00011062582,0.0014702106,0.00016765758,0.000077522396,0.0002544735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956702,0.0004000857,0.00089041627,0.0007517456,0.0014839248,0.0008036325],"domain_scores_gemma":[0.99695915,0.0004790669,0.00065754366,0.0008296417,0.00076120684,0.00031337023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007169898,0.00045987754,0.002221924,0.00018726464,0.00011268097,0.00003115276,0.00046357862,0.00017044031,0.0002764657],"category_scores_gemma":[0.00007738838,0.00034695704,0.00018156304,0.001127859,0.00031378004,0.00038929502,0.00016895683,0.0010033154,0.00015739028],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020460566,0.0010690198,0.13777104,0.048104096,0.0006251055,0.000016286811,0.00028269392,4.3483564e-7,0.000025020812,0.0000043325576,0.009397543,0.80065835],"study_design_scores_gemma":[0.0026127163,0.0003722556,0.31650224,0.1868933,0.00040523073,0.0000052261175,0.00007080164,2.8376772e-7,0.0000059446597,4.322442e-7,0.4927848,0.00034677848],"about_ca_topic_score_codex":0.0027822184,"about_ca_topic_score_gemma":0.000069272464,"teacher_disagreement_score":0.80031157,"about_ca_system_score_codex":0.00086400483,"about_ca_system_score_gemma":0.0011888378,"threshold_uncertainty_score":0.99989825},"labels":[],"label_agreement":null},{"id":"W2323506779","doi":"10.1158/0008-5472.sabcs12-p3-02-10","title":"Abstract P3-02-10: Implementation and uptake of a provincial, population-based, organized breast screening program for high risk women in Ontario: The Ontario breast screening program (OBSP) high risk program.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; North York General Hospital; Cancer Care Ontario; Health Sciences Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Referral; Population; Family history; Breast cancer screening; Family medicine; Risk assessment; Breast MRI; Gynecology; Cancer; Gerontology; Internal medicine; Environmental health","score_opus":0.03437459890678407,"score_gpt":0.36940839629688343,"score_spread":0.33503379739009936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323506779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993227,0.0002521678,0.00023652092,0.00017949232,0.000097696095,0.005404539,0.00052945886,0.00004443854,0.000028688903],"genre_scores_gemma":[0.97065586,0.000029702354,0.018997978,0.000018030727,0.00031505298,0.008808386,0.0009141949,0.00007266986,0.00018814759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968201,0.00022421073,0.00059471175,0.00061673915,0.0005854167,0.0011588564],"domain_scores_gemma":[0.99820393,0.00009125228,0.00036868537,0.00049843197,0.00061374326,0.00022396307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023425468,0.0002874337,0.00031061485,0.00018788679,0.00047365608,0.00016794661,0.00035048713,0.00021745743,0.0004099959],"category_scores_gemma":[0.00010521128,0.0002473475,0.000091184666,0.00047698186,0.00024090357,0.000046325677,0.00017680292,0.00058346096,0.0000016116871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009790661,0.0003092835,0.5475599,0.00006216438,0.00014759375,5.6909056e-7,0.00092723494,0.00021138796,0.001322809,0.000010425076,0.00020323042,0.4482663],"study_design_scores_gemma":[0.003058915,0.00090497476,0.9827226,0.00006436912,0.00006175975,0.000008498263,0.001081657,0.00008712224,0.003851168,0.000063479376,0.007812819,0.000282671],"about_ca_topic_score_codex":0.69479126,"about_ca_topic_score_gemma":0.84779286,"teacher_disagreement_score":0.44798362,"about_ca_system_score_codex":0.0014351966,"about_ca_system_score_gemma":0.0019588878,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W2323529144","doi":"10.1158/1538-7445.am10-1946","title":"Abstract 1946: Identification of miRNAs that contribute to melanoma brain metastasis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Brain metastasis; Melanoma; Metastasis; microRNA; Cancer research; Cancer; Biology; Medicine; Pathology; Gene; Internal medicine","score_opus":0.04355940917262042,"score_gpt":0.3881198745832255,"score_spread":0.3445604654106051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323529144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694026,0.00050110975,0.00027787025,0.0014032325,0.00014326713,0.00036426255,0.00020858757,0.000005513197,0.00015587242],"genre_scores_gemma":[0.9987281,0.00004875352,0.000099109835,0.00005136813,0.00017468743,0.00011076571,0.000119180615,0.000017055723,0.0006509556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988625,0.000072588795,0.00019029705,0.00029078487,0.0003291373,0.00025468526],"domain_scores_gemma":[0.99887556,0.000037383514,0.000073169336,0.00047799578,0.0004017679,0.00013411052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010100881,0.00007818673,0.0001018285,0.00010631404,0.00006799163,0.000033674412,0.00027731215,0.000103766484,0.00018969856],"category_scores_gemma":[0.00037632926,0.00007692659,0.00006208417,0.00017884125,0.00010816942,0.000005635112,0.000104611725,0.0001482346,0.000035111545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009522817,0.00003092688,0.0012640017,0.000034640525,0.000036914505,0.0000010308373,0.000026855061,0.00001655966,0.98233706,0.00010086519,0.012043398,0.0040125316],"study_design_scores_gemma":[0.00020850835,0.0000338663,0.06555631,0.000010469948,0.0000063164275,0.0000011793084,0.000019685634,0.000004678476,0.8926319,0.000098927405,0.041356448,0.00007170947],"about_ca_topic_score_codex":0.00016165701,"about_ca_topic_score_gemma":0.0004016324,"teacher_disagreement_score":0.08970515,"about_ca_system_score_codex":0.00003028967,"about_ca_system_score_gemma":0.00017781316,"threshold_uncertainty_score":0.31369755},"labels":[],"label_agreement":null},{"id":"W2323536404","doi":"10.1158/1538-7445.am2015-5142","title":"Abstract 5142: A naturally occurring model for gastric cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Pathology; Carcinogenesis; Medicine; Carcinoma; Disease; Cancer cell; Submucosa; Biology; Cancer research; Internal medicine","score_opus":0.15641591995106638,"score_gpt":0.46765695005935515,"score_spread":0.31124103010828874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323536404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833412,0.012881142,0.00071282516,0.0004510758,0.00017862217,0.0008857171,0.00042458877,0.000019512601,0.0011053103],"genre_scores_gemma":[0.9934426,0.0009953995,0.00035120608,0.00013638269,0.000559289,0.0016330231,0.00008157284,0.000041614738,0.002758937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979595,0.000040281884,0.00015227639,0.0004896282,0.00054842734,0.0008099095],"domain_scores_gemma":[0.9984842,0.000025086003,0.00003608778,0.0003494489,0.0006968512,0.00040834068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005352441,0.00015155529,0.00014350828,0.00012691326,0.00015912652,0.000076045224,0.00037589512,0.00011856572,0.000050898878],"category_scores_gemma":[0.00019090643,0.00013433774,0.0000940327,0.00023471528,0.00011775242,0.000011446557,0.00019601415,0.00026523846,0.000017044118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041860025,0.00034239242,0.009829664,0.0002983621,0.0005599783,0.000042919473,0.00040890023,0.011493179,0.63700914,0.00014969289,0.27297834,0.06270144],"study_design_scores_gemma":[0.019890262,0.002733476,0.005241129,0.00047862466,0.00009359514,0.000040609983,0.0006836209,0.027082274,0.5450178,0.0035264883,0.3933839,0.0018282232],"about_ca_topic_score_codex":0.0020004928,"about_ca_topic_score_gemma":0.00306519,"teacher_disagreement_score":0.12040555,"about_ca_system_score_codex":0.00032563318,"about_ca_system_score_gemma":0.0017223764,"threshold_uncertainty_score":0.5478134},"labels":[],"label_agreement":null},{"id":"W2323596778","doi":"10.1158/0008-5472.sabcs12-p3-04-10","title":"Abstract P3-04-10: Comparison between RNA-Seq and Affymetrix gene expression data","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Transcriptome; Ensembl; RNA-Seq; Gene; Biology; Gene expression; Microarray; Computational biology; DNA microarray; Gene expression profiling; Genetics; Genome; Genomics","score_opus":0.25566729178286857,"score_gpt":0.4765735822689985,"score_spread":0.22090629048612992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323596778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791017,0.017763842,0.00058801356,0.00041880764,0.00018906762,0.00025129537,0.00014101302,0.000015452939,0.0015307788],"genre_scores_gemma":[0.99409133,0.0018155806,0.0004581688,0.00004088603,0.001272537,0.00007618278,0.0005507538,0.00002854583,0.0016660189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812907,0.00014766231,0.00022802509,0.0005258854,0.00045549023,0.0005138968],"domain_scores_gemma":[0.998414,0.000045538436,0.00007897093,0.0010079234,0.00014715435,0.00030642457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010563051,0.000137505,0.00016438885,0.00012793507,0.00020999605,0.00006332009,0.00057952735,0.00019195762,0.00034084843],"category_scores_gemma":[0.00014540508,0.00012077057,0.000028440178,0.00023585786,0.00014574139,0.000023939827,0.0006852723,0.00027604724,0.000043829958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008014432,0.000047092915,0.018194823,0.000028600623,0.000018635274,2.759587e-7,0.00005271258,0.0000027348137,0.8795505,0.0000074394743,0.0758097,0.026207313],"study_design_scores_gemma":[0.0003095483,0.000051044724,0.027769314,0.000028490398,0.000006706669,7.43497e-7,0.00011990735,0.000009464128,0.7091969,0.00001523109,0.26236323,0.00012941007],"about_ca_topic_score_codex":0.00009211804,"about_ca_topic_score_gemma":0.000012949335,"teacher_disagreement_score":0.18655354,"about_ca_system_score_codex":0.000043582968,"about_ca_system_score_gemma":0.0001477955,"threshold_uncertainty_score":0.49248812},"labels":[],"label_agreement":null},{"id":"W2323619027","doi":"10.1158/0008-5472.sabcs-2106","title":"A 24-month subgroup analysis of the effect of denosumab on bone mineral density in women with breast cancer undergoing aromatase inhibitor therapy.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada)","funders":"","keywords":"Medicine; Denosumab; Placebo; Breast cancer; Bone mineral; Femoral neck; Internal medicine; Aromatase inhibitor; Osteoporosis; Urology; Bone remodeling; Subgroup analysis; Adjuvant therapy; Oncology; Endocrinology; Cancer; Aromatase; Meta-analysis; Pathology","score_opus":0.02713392056206128,"score_gpt":0.3672846134906532,"score_spread":0.34015069292859196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323619027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639493,0.0012320156,3.6056954e-7,0.0013981371,0.000029266117,0.0007795697,0.000090632406,0.0000074776317,0.00006763657],"genre_scores_gemma":[0.99896246,0.0004283029,0.0000067784313,0.00016519784,0.00003571427,0.00023574769,0.000009199446,0.000013116766,0.00014349469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979674,0.00028436395,0.0002497188,0.00027998764,0.0007245785,0.00049394416],"domain_scores_gemma":[0.99894035,0.00021737568,0.00009540667,0.0004327651,0.0001381499,0.00017597916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006044913,0.00014211253,0.0005657887,0.00043313656,0.000077889,0.000007403489,0.00009705883,0.00006692958,0.00007672032],"category_scores_gemma":[0.000044368047,0.00007749683,0.00007817866,0.0018798491,0.00013968292,0.000042501768,0.000024368766,0.0003315555,0.0000011392466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03198261,0.0005557473,0.9268547,0.00026435286,0.00077669695,0.00010067332,0.000834689,0.00015505125,0.011904841,0.000008243736,0.0004520759,0.026110278],"study_design_scores_gemma":[0.006524133,0.0028508594,0.97293186,0.0005453636,0.00014038976,0.0000076006386,0.000053875105,0.000054431835,0.01679702,0.000009435039,0.000019741532,0.00006529623],"about_ca_topic_score_codex":0.009867531,"about_ca_topic_score_gemma":0.010555644,"teacher_disagreement_score":0.046077114,"about_ca_system_score_codex":0.00083674386,"about_ca_system_score_gemma":0.0005659927,"threshold_uncertainty_score":0.99672586},"labels":[],"label_agreement":null},{"id":"W2323760660","doi":"10.1158/1538-7445.am2011-4857","title":"Abstract 4857: Improved technology for ribosomal RNA (rRNA) removal from formalin-fixed paraffin-embedded (FFPE) total RNA","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"RNA; Ribosomal RNA; Biology; DNA; Molecular biology; Computational biology; RNA editing; Intron; Genetics; Gene","score_opus":0.056986589868752255,"score_gpt":0.37385684498978217,"score_spread":0.3168702551210299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323760660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805222,0.0015463692,0.013125539,0.0007920985,0.00013861891,0.0012044491,0.00027865847,0.00009540942,0.0022966343],"genre_scores_gemma":[0.9787655,0.0004934113,0.017255008,0.00013493035,0.00043802187,0.0017986533,0.00032758655,0.000058561716,0.00072831573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979043,0.000055382177,0.0003501034,0.00074416614,0.00017852613,0.0007675034],"domain_scores_gemma":[0.9984731,0.000029086828,0.00012152054,0.0008344202,0.0003817001,0.00016014162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045258785,0.00023351764,0.00025388369,0.00014805539,0.00027408262,0.000028407616,0.00068423303,0.0006128039,0.00013358182],"category_scores_gemma":[0.00012662297,0.00022210157,0.00016689455,0.00025147907,0.00039573916,0.000007798607,0.00034750893,0.0004254478,0.000020535528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033063715,0.0000801544,0.00011437963,0.000016351107,0.00009352595,0.000010772571,0.000027643027,0.0000015478245,0.98009616,0.0019664767,0.0031687391,0.014093639],"study_design_scores_gemma":[0.0007393553,0.000394684,0.0006367492,0.000018650278,0.000016528531,0.00001535891,0.000068590605,0.00007121642,0.95899284,0.003057246,0.035719786,0.00026899466],"about_ca_topic_score_codex":0.00038917246,"about_ca_topic_score_gemma":0.000121833895,"teacher_disagreement_score":0.032551046,"about_ca_system_score_codex":0.000055739652,"about_ca_system_score_gemma":0.0002839355,"threshold_uncertainty_score":0.90570396},"labels":[],"label_agreement":null},{"id":"W2323761746","doi":"10.1158/1538-7445.am10-913","title":"Abstract 913: 5,10-Methylenetetrahydrofolate reductase C677T allele frequency and childhood leukemia incidence in predominantly European ancestry countries","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylenetetrahydrofolate reductase; Leukemia; Incidence (geometry); Poisson regression; Medicine; Allele; Allele frequency; Rate ratio; Childhood leukemia; Demography; Genetics; Minor allele frequency; Internal medicine; Oncology; Confidence interval; Biology; Population; Lymphoblastic Leukemia; Environmental health","score_opus":0.04453553931578134,"score_gpt":0.388981771066525,"score_spread":0.3444462317507436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323761746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98326546,0.0049732574,5.945123e-7,0.0013005497,0.00012656223,0.00072411733,0.00005032483,0.000045893674,0.009513256],"genre_scores_gemma":[0.9913597,0.005095601,0.00026658946,0.00007884676,0.00048150663,0.00009993577,0.000031136915,0.00006516051,0.0025215368],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963068,0.00023796479,0.0004530308,0.00076676987,0.0011298261,0.0011056212],"domain_scores_gemma":[0.99799865,0.00027328727,0.000069380694,0.00071903435,0.00044933127,0.0004902855],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00308464,0.00025566077,0.00039405204,0.00053762086,0.00027503373,0.00014649467,0.00046514726,0.00021507322,0.0015241189],"category_scores_gemma":[0.0008305337,0.00022057472,0.00006077179,0.0007951264,0.00090917066,0.0003900288,0.00026049925,0.0026722297,0.00026355663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064039015,0.00024318541,0.07529494,0.0005648452,0.00008217378,0.0018002649,0.0015145028,0.000007407483,0.8886349,0.00014904421,0.0077819647,0.02328633],"study_design_scores_gemma":[0.0030573714,0.0005778398,0.91007304,0.0006232524,0.00002081317,0.0001751845,0.00037106845,0.00007771564,0.072354384,0.0004584649,0.011815397,0.00039544568],"about_ca_topic_score_codex":0.003564332,"about_ca_topic_score_gemma":0.0015261323,"teacher_disagreement_score":0.83477813,"about_ca_system_score_codex":0.0003526095,"about_ca_system_score_gemma":0.0017616969,"threshold_uncertainty_score":0.99962866},"labels":[],"label_agreement":null},{"id":"W2323775746","doi":"10.1158/0008-5472.fbcr09-c40","title":"Abstract C40: Salicylic acid-based small molecule inhibitors of Stat3 show potent and selective activity in a variety of human cancer cell lines","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"STAT3; STAT protein; Cancer cell; In vivo; Cancer; Activator (genetics); In vitro; Biology; Transcription factor; Cell culture; Cancer research; Chemistry; Apoptosis; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.08224226386161616,"score_gpt":0.3700550843048668,"score_spread":0.2878128204432506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323775746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970157,0.00089181296,0.0000031038767,0.00026612007,0.00001093943,0.00016618635,0.00013374856,0.000013816925,0.0014985614],"genre_scores_gemma":[0.999445,0.00030667745,0.000021829952,0.0000212321,0.00007721559,0.00007135668,0.000004091518,0.000011586845,0.00004099479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984806,0.000106796426,0.00024199254,0.0004077353,0.00035303534,0.00040979462],"domain_scores_gemma":[0.9990745,0.00021519598,0.00013462639,0.0002210172,0.0002469888,0.000107624815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103674,0.00016210739,0.00036899204,0.00007657858,0.00007244846,0.000018121049,0.00019380117,0.00019437665,0.00031215348],"category_scores_gemma":[0.00008334181,0.00012790666,0.00008183752,0.0002985091,0.00022471952,0.000062884865,0.00006608457,0.0004725807,2.9247033e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028027067,0.00056946435,0.013985823,0.00023789257,0.000018113467,0.0000046604055,0.00012378805,0.000021760174,0.96114826,0.0000061669675,0.00005426353,0.023549551],"study_design_scores_gemma":[0.00045155748,0.00014932432,0.123744726,0.00011597473,0.0000062354698,1.4264994e-7,0.00010960725,0.00004335154,0.8751524,0.00008305473,0.0000253842,0.00011821983],"about_ca_topic_score_codex":0.016804213,"about_ca_topic_score_gemma":0.004136152,"teacher_disagreement_score":0.109758906,"about_ca_system_score_codex":0.00032581517,"about_ca_system_score_gemma":0.00030205873,"threshold_uncertainty_score":0.989743},"labels":[],"label_agreement":null},{"id":"W2323777391","doi":"10.1158/1538-7445.am2011-2386","title":"Abstract 2386: Overexpression of 14-3-3ζ in mouse mammary gland promotes mammary tumor development and progression by enhancing multiple tumor-associated properties","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Mammary tumor; Cancer research; Carcinogenesis; Angiogenesis; Biology; Mammary gland; DMBA; Genetically modified mouse; Mouse mammary tumor virus; Transgene; Metastasis; Cancer; Breast cancer; Immunology; Gene; Genetics","score_opus":0.05022869352322584,"score_gpt":0.3278741668603003,"score_spread":0.27764547333707446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323777391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654657,0.0023696555,0.000036366233,0.000042428834,0.000031888874,0.0006864078,0.000023569251,0.000015805204,0.0002473142],"genre_scores_gemma":[0.9974394,0.00018607547,0.0010602728,0.0000163868,0.000028136072,0.0005373573,0.000042086576,0.000028442766,0.00066188327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834394,0.0001456038,0.00033311464,0.00042891962,0.00033305833,0.00041537054],"domain_scores_gemma":[0.99919385,0.000029414592,0.00012617995,0.0002856411,0.00025944452,0.0001054733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005960795,0.00015973694,0.00017948647,0.00012615968,0.00013031883,0.000036181347,0.0002724296,0.00011771925,0.000027672495],"category_scores_gemma":[0.00040301896,0.00013289513,0.000029725696,0.00013710986,0.000117227006,0.000034075925,0.00040075075,0.00032065983,0.0000024298304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002978342,0.00025473587,0.013974593,0.00019783153,0.00003109908,0.000010768319,0.00059666357,8.5059344e-7,0.9815896,0.0000018812501,0.00058820937,0.0024559193],"study_design_scores_gemma":[0.000632475,0.00017233734,0.012457291,0.000742703,0.0000015494363,0.0000046727846,0.00013035357,0.00002250849,0.9847771,0.000015748594,0.0008820411,0.00016125532],"about_ca_topic_score_codex":0.00062154856,"about_ca_topic_score_gemma":0.00049282453,"teacher_disagreement_score":0.003187451,"about_ca_system_score_codex":0.00011200316,"about_ca_system_score_gemma":0.00038582116,"threshold_uncertainty_score":0.5419306},"labels":[],"label_agreement":null},{"id":"W2323822196","doi":"10.1158/0008-5472.sabcs-09-2150","title":"Cyclin D1 Is a Direct Target of JAG-Mediated Notch Signaling in Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D1; JAG1; Cancer research; Cyclin D; Notch signaling pathway; Tissue microarray; Breast cancer; Biology; Cyclin A2; Cyclin B; Cell cycle; Cancer; Cyclin E; Cyclin; Cyclin A; Signal transduction; Cell biology; Genetics","score_opus":0.026277238781418064,"score_gpt":0.37206208458227924,"score_spread":0.34578484580086116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323822196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98285574,0.009624012,0.0003186356,0.0037610738,0.00021795953,0.00087778416,0.0005883228,0.000024116276,0.0017323747],"genre_scores_gemma":[0.99359393,0.004343231,0.00014717154,0.00040314067,0.0003172972,0.00021662036,0.00008145983,0.00005139554,0.0008457548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99658716,0.00033261042,0.00041787373,0.00075302547,0.00093272794,0.0009766152],"domain_scores_gemma":[0.99839264,0.000056565692,0.00008761726,0.0005918018,0.00062998687,0.00024139848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011858927,0.00022825532,0.0003526623,0.00039877967,0.000104873965,0.000038051207,0.0005990077,0.00034312558,0.0008056513],"category_scores_gemma":[0.00017985785,0.0002335477,0.00013583378,0.0011988877,0.00019252577,0.000009715254,0.00020242168,0.00069479516,0.000020213594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006244477,0.00013045395,0.00056259957,0.00005560596,0.00006422286,0.000024765834,0.00014554088,0.0009820956,0.98612624,0.000013728334,0.0061772643,0.005093029],"study_design_scores_gemma":[0.0012118128,0.0002887784,0.0016103865,0.00020328912,0.0000075143043,0.000006356831,0.00008343254,0.0003791294,0.9872762,0.00014891337,0.008526188,0.00025798788],"about_ca_topic_score_codex":0.0022301434,"about_ca_topic_score_gemma":0.00037594212,"teacher_disagreement_score":0.010738208,"about_ca_system_score_codex":0.00028432603,"about_ca_system_score_gemma":0.0011241478,"threshold_uncertainty_score":0.9523799},"labels":[],"label_agreement":null},{"id":"W2323851209","doi":"10.1158/1538-7445.am2012-847","title":"Abstract 847: Foretinib, a multi-kinase inhibitor of cMET and PDGFRα, in the treatment of disseminated medulloblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cancer research; Hepatocyte growth factor; Medulloblastoma; Platelet-derived growth factor receptor; Metastasis; Receptor tyrosine kinase; Medicine; Cancer; Cell cycle; Flow cytometry; Growth factor receptor; Cell growth; Internal medicine; Biology; Growth factor; Receptor; Immunology","score_opus":0.08751522856555478,"score_gpt":0.42108128001480155,"score_spread":0.3335660514492468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323851209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990163,0.00923342,0.0000025560528,0.000089569985,0.00003861885,0.00029762264,0.00006243766,0.0000017842883,0.000110935995],"genre_scores_gemma":[0.99813217,0.0014343369,0.000058080077,0.0000062176127,0.00010631025,0.0001540386,0.0000117749905,0.0000112417665,0.000085841864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904794,0.00011659302,0.00017743753,0.00016230276,0.00019523206,0.00030051047],"domain_scores_gemma":[0.99945956,0.000098424585,0.00004574016,0.00021561516,0.00012493058,0.00005574214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006166691,0.00009341682,0.00015186287,0.00007131022,0.00004892808,0.0000052772975,0.00012069361,0.00007376207,0.00001472258],"category_scores_gemma":[0.00015320833,0.00006179615,0.000041909345,0.00015457826,0.0003019503,0.0000028987683,0.000052449468,0.00007676872,0.0000010115997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016448816,0.00042943616,0.038961355,0.000080264464,0.000046171102,0.0000031233308,0.002954456,0.0000016629696,0.9505568,0.000012104424,0.00035009865,0.0064400085],"study_design_scores_gemma":[0.00067338673,0.00055987685,0.061380874,0.000060597653,0.00000738286,0.000001362721,0.001392047,0.0000054793595,0.931949,0.0000049280693,0.0038996257,0.00006540733],"about_ca_topic_score_codex":0.00027103082,"about_ca_topic_score_gemma":0.00023355504,"teacher_disagreement_score":0.02241952,"about_ca_system_score_codex":0.000031644962,"about_ca_system_score_gemma":0.00006522204,"threshold_uncertainty_score":0.25199738},"labels":[],"label_agreement":null},{"id":"W2323921495","doi":"10.1158/0008-5472.can-15-2961","title":"REG3β Plays a Key Role in IL17RA Protumoral Effect—Letter","year":2016,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Key (lock); Biology; Ecology","score_opus":0.05239105051715435,"score_gpt":0.3781204500728383,"score_spread":0.3257293995556839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323921495","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10054782,0.0017991666,0.0000022105412,0.85838264,0.00048030756,0.002701802,0.000073403455,0.00009411608,0.035918534],"genre_scores_gemma":[0.015906991,0.0002747834,0.000052456806,0.7963181,0.02983471,0.007607408,0.00023984679,0.00025570992,0.14950997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958029,0.0005413381,0.0003356734,0.0007240647,0.001325183,0.0012708616],"domain_scores_gemma":[0.99805677,0.0006617261,0.00006716271,0.0007711644,0.00025299675,0.00019018272],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011926917,0.0003287224,0.0007960698,0.00079329626,0.000084574975,0.00005757688,0.00028236877,0.0007059199,0.0036352389],"category_scores_gemma":[0.0005310431,0.00021980902,0.00015114633,0.0005048656,0.0003030316,0.000076093835,0.00013635113,0.0037000112,0.0015712274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043649034,0.000020094689,0.0065043024,0.00095321634,0.000064618645,0.0012817573,0.000093670336,1.2181992e-7,0.0114275245,0.0000067764045,0.9763154,0.0028960428],"study_design_scores_gemma":[0.0027906224,0.00046373732,0.0007322458,0.0023510926,0.00003369554,0.000022775486,0.000008677332,0.000007781703,0.012372106,0.00012431579,0.98084974,0.00024322403],"about_ca_topic_score_codex":0.00047475888,"about_ca_topic_score_gemma":0.000015488293,"teacher_disagreement_score":0.11359143,"about_ca_system_score_codex":0.0008748008,"about_ca_system_score_gemma":0.00068530446,"threshold_uncertainty_score":0.9992062},"labels":[],"label_agreement":null},{"id":"W2323951299","doi":"10.1158/0008-5472.sabcs12-p4-17-08","title":"Abstract P4-17-08: Tissue Expander/Implant Breast Reconstruction with and without Postmastectomy Radiation: Predictive Factors for Complications","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast reconstruction; Implant; Surgery; Capsular contracture; Mastectomy; Complication; Radiation therapy; Breast cancer; Wound dehiscence; Incidence (geometry); Cancer; Internal medicine","score_opus":0.06859993020559971,"score_gpt":0.3798482124777625,"score_spread":0.31124828227216284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323951299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516886,0.00064460083,0.0005656261,0.00079505314,0.00028956638,0.0012886731,0.00039509815,0.00006059838,0.00079189485],"genre_scores_gemma":[0.99806774,0.00008771124,0.00033029748,0.000014713777,0.0006940508,0.0003269627,0.00015036286,0.000027312308,0.00030083815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871415,0.000036275807,0.00019335668,0.00027787927,0.000306645,0.0004716907],"domain_scores_gemma":[0.9989043,0.00014968778,0.0000830101,0.00018677028,0.0003457861,0.00033048156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029621384,0.00014934545,0.00023174059,0.00023663921,0.0003482804,0.00004144639,0.000056553323,0.000124015,0.00016533321],"category_scores_gemma":[0.00001516924,0.00010900627,0.000030897358,0.00022048081,0.00025936987,0.00031908686,0.000020278136,0.00033239077,0.00000873084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015477428,0.00008661428,0.49661994,0.00023724508,0.0002333414,0.0000013618487,0.0010399059,0.0000036915237,0.014809881,0.00013214917,0.0011777476,0.4841104],"study_design_scores_gemma":[0.0025945068,0.00032815852,0.9456039,0.0003088264,0.00009330865,0.034489043,0.0014964427,0.000048249207,0.012355089,0.00005642945,0.0024280977,0.00019792635],"about_ca_topic_score_codex":0.00025270056,"about_ca_topic_score_gemma":0.00006885744,"teacher_disagreement_score":0.48391247,"about_ca_system_score_codex":0.00019997786,"about_ca_system_score_gemma":0.0002365661,"threshold_uncertainty_score":0.4445147},"labels":[],"label_agreement":null},{"id":"W2323991864","doi":"10.1158/1538-7445.am2011-2223","title":"Abstract 2223: ELISA coupled anion exchange methodology for separation of KLK6 glycoprotein subpopulations in biological fluids","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Ovarian cancer; Chemistry; Glycoprotein; Glycosylation; Ascites; Ovary; Cancer; Chromatography; Biochemistry; Biology; Endocrinology; Internal medicine; Medicine","score_opus":0.618035173054968,"score_gpt":0.5530142226925199,"score_spread":0.06502095036244815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323991864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939914,0.0016736393,0.00047596026,0.0008307673,0.00008202225,0.0013981431,0.000064109496,0.000014883547,0.0014690987],"genre_scores_gemma":[0.99225134,0.0011707139,0.003933683,0.000049037222,0.00023068157,0.00071171456,0.00009209962,0.000016396525,0.0015443135],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980708,0.00028753973,0.00036833942,0.0003244469,0.00043741244,0.00051150616],"domain_scores_gemma":[0.9985294,0.00055804674,0.000052570813,0.0002205286,0.00049797754,0.0001415255],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025004512,0.00011274007,0.0003549979,0.0003734502,0.00010061294,0.000006972815,0.00016314842,0.00019145139,0.002656168],"category_scores_gemma":[0.0005634008,0.00008574582,0.00009525887,0.0004770987,0.000298074,0.00006641676,0.000082552535,0.00039878977,0.000029055229],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008046001,0.00037975068,0.054357354,0.0005979825,0.00006216447,0.000027717977,0.0011770918,0.00000585829,0.91733515,0.004051169,0.0013583169,0.012601459],"study_design_scores_gemma":[0.0028221419,0.0027754083,0.7817565,0.00026804418,0.000017192193,0.000014740745,0.00036222194,0.0013015111,0.19843894,0.00467431,0.0073442976,0.00022466433],"about_ca_topic_score_codex":0.007265708,"about_ca_topic_score_gemma":0.0009336465,"teacher_disagreement_score":0.7273992,"about_ca_system_score_codex":0.00014017317,"about_ca_system_score_gemma":0.00025420415,"threshold_uncertainty_score":0.999345},"labels":[],"label_agreement":null},{"id":"W2324015074","doi":"10.1158/1538-7445.am2012-4251","title":"Abstract 4251: Evaluating novel targeted therapeutic agents in T-cell acute lymphoblastic leukemia using a zebrafish xenotransplantation model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Xenotransplantation; Cancer research; PTEN; PI3K/AKT/mTOR pathway; Zebrafish; Medicine; Leukemia; Cancer; T cell; Protein kinase B; Notch signaling pathway; Immunology; Biology; Transplantation; Signal transduction; Internal medicine; Receptor; Immune system","score_opus":0.1478994786034071,"score_gpt":0.45035742376238685,"score_spread":0.3024579451589797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324015074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873062,0.00094210444,0.0103687085,0.00011887917,0.000057727197,0.00063708535,0.000121511,0.000013186834,0.0004346336],"genre_scores_gemma":[0.9969536,0.0004399582,0.0013836824,0.00016809291,0.0002250012,0.00038992512,0.00019587304,0.000050044422,0.00019379996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713194,0.00013650102,0.00030869286,0.00044974714,0.0009224135,0.0010507177],"domain_scores_gemma":[0.9988521,0.00009334554,0.00006446705,0.00038113643,0.00026678768,0.00034221433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015732409,0.00017036754,0.00015519845,0.00021410844,0.00019498802,0.00005314632,0.00043289873,0.00021780137,0.00011599696],"category_scores_gemma":[0.00016845476,0.0001683896,0.00006325266,0.0005736808,0.00021116159,0.000026309346,0.00014411133,0.00041796415,0.000032769974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016208398,0.00016501259,0.00092595414,0.000069530244,0.00004677763,0.0000017394361,0.0001539966,0.0038347314,0.9926073,0.000026414187,0.00029613046,0.0017103108],"study_design_scores_gemma":[0.0030552994,0.00017561215,0.023277732,0.00013146953,0.000044193774,0.0000074031655,0.00012913682,0.13228439,0.83954173,0.00023002799,0.0006935428,0.00042946465],"about_ca_topic_score_codex":0.00043545748,"about_ca_topic_score_gemma":0.000084421954,"teacher_disagreement_score":0.15306559,"about_ca_system_score_codex":0.00061463716,"about_ca_system_score_gemma":0.0014033758,"threshold_uncertainty_score":0.6866728},"labels":[],"label_agreement":null},{"id":"W2324019217","doi":"10.1158/1538-7445.am10-5279","title":"Abstract 5279: LPS-TLR4 binding increases metastatic potential of colorectal cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Fibronectin; Medicine; Colorectal cancer; TLR4; Cancer cell; Receptor; Cancer research; Lipopolysaccharide; Cancer; Flow cytometry; Extracellular matrix; Pathology; Immunology; Internal medicine; Biology; Cell biology","score_opus":0.033355040908143556,"score_gpt":0.36010976596776656,"score_spread":0.326754725059623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324019217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961694,0.0018383354,0.0000055220175,0.00017934405,0.00091099855,0.00032131354,0.000107231885,0.000024535197,0.00044334235],"genre_scores_gemma":[0.997691,0.0007058319,0.00003151304,0.000011067066,0.000072591676,0.00014866692,0.000065331675,0.000020260213,0.0012537445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984874,0.00029252825,0.00031735975,0.00024679027,0.00013919604,0.00051673735],"domain_scores_gemma":[0.99895453,0.0003405611,0.000121300305,0.00023420357,0.0003134726,0.000035925077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010969442,0.00012881553,0.0002545612,0.00032821554,0.0002595316,0.000026600504,0.00032418582,0.00017192193,0.007726995],"category_scores_gemma":[0.0001871272,0.00011207281,0.00008862302,0.00029789278,0.00048027778,0.00017007822,0.00011949089,0.00082201953,0.00043695894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007174582,0.00008779504,0.00041208856,0.0000662367,0.00016456432,0.000009745148,0.00017719316,0.000018723775,0.9890968,0.000115519535,0.0029237564,0.006210108],"study_design_scores_gemma":[0.00075427664,0.00009156514,0.009754364,0.000059612437,0.000028206692,0.000011201268,0.00022074448,0.0000067218452,0.98181725,0.000037393023,0.0071028206,0.00011585327],"about_ca_topic_score_codex":0.006708756,"about_ca_topic_score_gemma":0.0006493628,"teacher_disagreement_score":0.0093422765,"about_ca_system_score_codex":0.0000744468,"about_ca_system_score_gemma":0.0005875101,"threshold_uncertainty_score":0.99990565},"labels":[],"label_agreement":null},{"id":"W2324105121","doi":"10.1158/1538-7445.am2011-lb-177","title":"Abstract LB-177: HPV16 CpG and de novo-cytosine methylation is differentially associated with low-grade versus high-grade anal intraepithelial neoplasia in HIV-infected men","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CpG site; Anal cancer; DNA methylation; Methylation; Men who have sex with men; Epigenetics; Biology; Cancer; Bisulfite sequencing; Medicine; Genetics; Human immunodeficiency virus (HIV); Gene; Virology; Gene expression","score_opus":0.0839306034603427,"score_gpt":0.38012026252968106,"score_spread":0.29618965906933836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324105121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219763,0.00035469723,0.00006685501,0.0015855603,0.00008857849,0.0008084347,0.00011087015,0.00006377472,0.0047235703],"genre_scores_gemma":[0.9980791,0.00064037286,0.000093142524,0.00007365302,0.00033034614,0.00023708136,0.00010062133,0.00006350846,0.00038214933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99624515,0.00028191545,0.0003798998,0.0006228094,0.0013425908,0.0011276504],"domain_scores_gemma":[0.9980092,0.00044294362,0.00007804797,0.00036164137,0.0005579694,0.00055020896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010398536,0.0002719595,0.0005196328,0.00063597807,0.00018227611,0.00008681844,0.00024675805,0.00028039,0.006911022],"category_scores_gemma":[0.00039226245,0.00021986113,0.00007052773,0.001288722,0.00041834224,0.00017315331,0.0001392055,0.0014655596,0.000028605584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07000917,0.0039374125,0.59082234,0.0015369849,0.0020613493,0.0014980771,0.010603665,0.000036702146,0.22193618,0.0014680969,0.006606373,0.08948363],"study_design_scores_gemma":[0.012902914,0.0010145808,0.93291384,0.00018565168,0.00007589343,0.0000071220675,0.0001755686,0.0003133896,0.05165699,0.00033892112,0.00017359853,0.00024154804],"about_ca_topic_score_codex":0.008449426,"about_ca_topic_score_gemma":0.0074510067,"teacher_disagreement_score":0.34209147,"about_ca_system_score_codex":0.0011568723,"about_ca_system_score_gemma":0.0011104415,"threshold_uncertainty_score":0.9981534},"labels":[],"label_agreement":null},{"id":"W2324167279","doi":"10.1158/1538-7445.am2011-4023","title":"Abstract 4023: ARID1A is a candidate tumor suppressor gene in breast cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Biology; ARID1A; Cancer research; Tumor suppressor gene; Gene; Nonsense mutation; Cancer; Genetics; Synthetic lethality; Exon; Mutation; Carcinogenesis; Missense mutation; DNA repair","score_opus":0.06074729445696998,"score_gpt":0.3706897005498797,"score_spread":0.30994240609290974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324167279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363285,0.003310451,0.000011328085,0.0004191002,0.00017479375,0.00023770552,0.00041177962,0.000012767581,0.0017892448],"genre_scores_gemma":[0.9958666,0.0019499438,0.00008108655,0.0003698304,0.00042598034,0.00036361028,0.000028524686,0.00004455952,0.000869881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998112,0.00006683144,0.00024539352,0.0005541781,0.0003557365,0.00066582795],"domain_scores_gemma":[0.9990323,0.00001030562,0.000053013722,0.0004922126,0.0002440348,0.00016812036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043885663,0.00017100648,0.00018208023,0.00011384603,0.00010494615,0.000034239452,0.0004021209,0.00012912056,0.0021466722],"category_scores_gemma":[0.000019714325,0.00015811139,0.00007428645,0.00024238421,0.00016105814,0.000007984793,0.00017232985,0.00034508077,0.000036772504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047501002,0.0000962669,0.0097349025,0.00008885363,0.000058779355,0.00003297448,0.0004935045,0.00010670383,0.96496296,0.000007724845,0.020289201,0.0036531365],"study_design_scores_gemma":[0.0010353747,0.00006614909,0.049735975,0.00014802582,0.0000092871605,0.000023601895,0.00013430444,0.00018842984,0.93970937,0.00012875862,0.008498157,0.0003225583],"about_ca_topic_score_codex":0.018568018,"about_ca_topic_score_gemma":0.0032065592,"teacher_disagreement_score":0.040001072,"about_ca_system_score_codex":0.00016454468,"about_ca_system_score_gemma":0.0006535503,"threshold_uncertainty_score":0.9987655},"labels":[],"label_agreement":null},{"id":"W2324179234","doi":"10.1158/1538-7445.am2011-537","title":"Abstract 537: Mechanisms by which pantoprazole, a proton pump inhibitor, enhances the activity of doxorubicin in solid tumors","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto and Region Conservation Authority; ITS Electronics (Canada)","funders":"","keywords":"Doxorubicin; Autophagy; Chemistry; Cancer research; Cancer cell; Cytotoxicity; Pharmacology; Flow cytometry; Apoptosis; Cancer; Biology; Molecular biology; In vitro; Biochemistry; Medicine; Chemotherapy; Internal medicine","score_opus":0.06064096412827226,"score_gpt":0.3873755191493012,"score_spread":0.32673455502102894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324179234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614924,0.0005764833,0.00008516591,0.00024840655,0.00004822902,0.0009545646,0.00005510693,0.0000061834503,0.0018766456],"genre_scores_gemma":[0.99759215,0.0010196869,0.000023631836,0.000025822244,0.00011863995,0.00078259996,0.000014428452,0.00002749888,0.000395515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772006,0.0002603896,0.0002576171,0.0004567601,0.00063287176,0.00067232776],"domain_scores_gemma":[0.9989194,0.000057149984,0.000083934814,0.0005028646,0.00031693123,0.00011966918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014927511,0.00015724299,0.00021510547,0.00010853003,0.00013768199,0.000026902648,0.00057878543,0.00016418955,0.0002756611],"category_scores_gemma":[0.00020398288,0.00011337928,0.000063880245,0.00046263312,0.00029553118,0.000014914335,0.00030085345,0.0005415021,0.000014664308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004721804,0.00020240669,0.0006199742,0.00010332953,0.000029851119,0.000008371603,0.00021031042,0.000003300983,0.9942265,0.000039046,0.0007120382,0.0033726501],"study_design_scores_gemma":[0.00034652872,0.00034594766,0.0022418133,0.00009601448,0.0000025073912,0.0000010181988,0.0003311772,0.000018272123,0.9949185,0.0002227092,0.001345759,0.00012973021],"about_ca_topic_score_codex":0.0043242956,"about_ca_topic_score_gemma":0.0018551467,"teacher_disagreement_score":0.00324292,"about_ca_system_score_codex":0.00005443886,"about_ca_system_score_gemma":0.0005368422,"threshold_uncertainty_score":0.653707},"labels":[],"label_agreement":null},{"id":"W2324209658","doi":"10.1158/0008-5472.sabcs12-ot1-2-02","title":"Abstract OT1-2-02: SHARE. A French multiceter phase III trial comparing accelerated partial irradiation (APBI) versus standard or hypofractionated whole breast irradiation in low risk of local recurrence breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Clinical endpoint; Ductal carcinoma; Brachytherapy; Lymphovascular invasion; Mastectomy; Wide local excision; Cancer; Surgery; Randomized controlled trial; Radiology; Internal medicine; Metastasis","score_opus":0.10193189730430631,"score_gpt":0.42072297521371216,"score_spread":0.31879107790940586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324209658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406344,0.0014985314,0.00009425422,0.00023568154,0.00082594046,0.00083088677,0.0023705456,0.000018570629,0.000062155865],"genre_scores_gemma":[0.99670696,0.00090358383,0.000026211575,0.000015467762,0.0010153074,0.00080200995,0.00046562403,0.00003547701,0.000029367922],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972643,0.00028941614,0.00051330274,0.00054342416,0.00062732486,0.0007621801],"domain_scores_gemma":[0.9984384,0.00015237872,0.00027952716,0.00033596216,0.00058528595,0.00020841922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073674694,0.00027226566,0.0003997227,0.00020667468,0.00020329814,0.000052358013,0.00023730857,0.0002166105,0.00054501346],"category_scores_gemma":[0.00012985634,0.00024359243,0.00009179457,0.0005556053,0.00024608662,0.000096788535,0.00012260236,0.00046913858,0.000014042365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6056713,0.0031350702,0.09822648,0.0003027347,0.0014561273,0.000015137016,0.001824525,0.0067106453,0.08125999,0.0000107032865,0.0054130824,0.19597425],"study_design_scores_gemma":[0.15231964,0.0009434445,0.79649085,0.00038095843,0.00015017718,0.000012578501,0.000639119,0.0022527867,0.043644045,0.0000051529933,0.0025470213,0.0006141932],"about_ca_topic_score_codex":0.010800358,"about_ca_topic_score_gemma":0.0057947114,"teacher_disagreement_score":0.6982644,"about_ca_system_score_codex":0.0008483638,"about_ca_system_score_gemma":0.0007393943,"threshold_uncertainty_score":0.9957868},"labels":[],"label_agreement":null},{"id":"W2324247129","doi":"10.1158/0008-5472.sabcs-101","title":"Identifying stromal-epithelial interactions in the mammary gland through genome-wide siRNA screening.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Stromal cell; Biology; Telomerase; Telomerase reverse transcriptase; Myoepithelial cell; Mammary gland; Cell culture; Cancer research; Fibroblast; Progenitor cell; Cell biology; Cell; Cancer; Molecular biology; Immunology; Stem cell; Breast cancer; Genetics; Gene","score_opus":0.17789079845798192,"score_gpt":0.4550125657698554,"score_spread":0.27712176731187343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324247129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455958,0.006668354,0.0028803158,0.025552249,0.000300498,0.0009768024,0.000046225385,0.00004275888,0.017937018],"genre_scores_gemma":[0.99155974,0.002652004,0.0010449968,0.0015160535,0.0006992393,0.00010983818,0.000021621352,0.000017045795,0.00237945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979957,0.00018603887,0.00024179035,0.00032546208,0.000700922,0.0005501099],"domain_scores_gemma":[0.999038,0.00019924567,0.00004025233,0.00046297003,0.00015316739,0.000106381085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009418376,0.00012145082,0.00022349444,0.00021908457,0.00020757207,0.00012107513,0.0003150357,0.00003939041,0.00042105073],"category_scores_gemma":[0.00010858618,0.00008726715,0.000104073246,0.00074833684,0.00009400321,0.00023714463,0.00007365014,0.00086993235,0.000034043576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004192037,0.0014695129,0.05940505,0.0006729695,0.000549582,0.0025660584,0.02536921,0.00023358212,0.39254603,0.0031871228,0.07244683,0.43736202],"study_design_scores_gemma":[0.003914553,0.0005378051,0.36100858,0.00058513467,0.000085056025,0.00013616394,0.0033552204,0.000047378253,0.014749019,0.0020202908,0.6132531,0.00030766285],"about_ca_topic_score_codex":0.0022294894,"about_ca_topic_score_gemma":0.0009329922,"teacher_disagreement_score":0.5408063,"about_ca_system_score_codex":0.0002586456,"about_ca_system_score_gemma":0.00026462984,"threshold_uncertainty_score":0.46102104},"labels":[],"label_agreement":null},{"id":"W2324289595","doi":"10.1158/1538-7445.am2013-1352","title":"Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Serous fluid; Ovarian cancer; Population; SNP; Biology; Oncology; Genotype; Cancer; Ancestry-informative marker; Case-control study; Internal medicine; Genetics; Medicine; Gene","score_opus":0.04161216823740239,"score_gpt":0.3453912623959014,"score_spread":0.303779094158499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324289595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889697,0.0015021106,0.000010297438,0.0048213834,0.00013198303,0.0012424253,0.00046335856,0.00002676656,0.0029046822],"genre_scores_gemma":[0.98936355,0.008436232,0.00023140422,0.00018371738,0.000437474,0.0011500382,0.000011450527,0.00005708919,0.00012903212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99669355,0.00036098668,0.0005701641,0.0007069726,0.0007515586,0.0009167685],"domain_scores_gemma":[0.9982359,0.00015692708,0.00017667456,0.0005094541,0.00044243856,0.00047859756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012227728,0.0002761415,0.0005477732,0.0003956771,0.00015929055,0.00007626692,0.00022599475,0.00012978897,0.0016798213],"category_scores_gemma":[0.00013443484,0.00023593607,0.00007251894,0.00078782695,0.0004055056,0.0003107791,0.000080067795,0.0006941612,0.00006431502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027880238,0.0017954145,0.18328837,0.0012041965,0.00083079323,0.00079245894,0.02176764,0.00093098363,0.311931,0.00021509465,0.001147841,0.47330818],"study_design_scores_gemma":[0.0040044705,0.00045561726,0.9798731,0.0006483386,0.000045859702,0.000011948457,0.0007254891,0.000063802814,0.012406055,0.00033435994,0.0012125109,0.00021842092],"about_ca_topic_score_codex":0.029592171,"about_ca_topic_score_gemma":0.00073058193,"teacher_disagreement_score":0.7965848,"about_ca_system_score_codex":0.0008050235,"about_ca_system_score_gemma":0.000776239,"threshold_uncertainty_score":0.99923277},"labels":[],"label_agreement":null},{"id":"W2324299864","doi":"10.1158/1538-7445.am10-3303","title":"Abstract 3303: Investigation of SPAG5 gene expression as a molecular marker for breast cancer prognosis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Breast cancer; Cancer; Cancer research; Estrogen receptor; Biomarker; Medicine; Oncology; Tissue microarray; Internal medicine; Biology","score_opus":0.03248595315310264,"score_gpt":0.39334810230608647,"score_spread":0.3608621491529838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324299864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956837,0.0004316749,0.001062545,0.001285047,0.000056997054,0.00087127707,0.00029640176,0.000014486174,0.0002978289],"genre_scores_gemma":[0.9925561,0.00035420083,0.0037328,0.00014543234,0.00019232226,0.0026385523,0.00017001003,0.000033203927,0.00017740688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881375,0.000051361025,0.00019580264,0.00042491037,0.00020262932,0.0003115584],"domain_scores_gemma":[0.99884033,0.000016803904,0.0000861455,0.00042297455,0.0005116842,0.00012207421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004617671,0.00012225,0.0001232441,0.000075267395,0.000117169206,0.000017900991,0.00030368383,0.00026605435,0.0002090081],"category_scores_gemma":[0.00005076275,0.00011068851,0.00009091612,0.00016188883,0.0002814121,0.0000043905575,0.00013104409,0.00024425393,0.0000027465485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011294087,0.000035508117,0.0050409874,0.000045647255,0.000028953822,7.624912e-7,0.000012270336,0.0000048029497,0.98691326,0.00031448106,0.0032098396,0.0042805136],"study_design_scores_gemma":[0.00023916842,0.00007773806,0.014585892,0.00003344922,0.000008923552,0.0000054090983,0.000009290071,0.000010195389,0.9746479,0.000684683,0.009575803,0.00012156309],"about_ca_topic_score_codex":0.00028297983,"about_ca_topic_score_gemma":0.000081002254,"teacher_disagreement_score":0.012265407,"about_ca_system_score_codex":0.000018630824,"about_ca_system_score_gemma":0.00030809984,"threshold_uncertainty_score":0.45137465},"labels":[],"label_agreement":null},{"id":"W2324417768","doi":"10.1158/0008-5472.sabcs-43","title":"Differential Wnt pathway activation in triple negative breast cancers comparative to HER2 and hormone positive breast cancers identified from formalin-fixed, paraffin-embedded tissues.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Immunohistochemistry; Wnt signaling pathway; Breast cancer; Concordance; Tissue microarray; Gene expression; RNA; Cancer research; Messenger RNA; Biology; Pathology; Molecular biology; Cancer; Medicine; Oncology; Gene; Internal medicine; Genetics","score_opus":0.03900763815884474,"score_gpt":0.362794552662616,"score_spread":0.3237869145037713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324417768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949486,0.0010609374,0.0008013795,0.0011554821,0.00012022777,0.0009575302,0.0006303982,0.000013125131,0.000312289],"genre_scores_gemma":[0.99727947,0.00071283075,0.00009986213,0.00018622706,0.0003566707,0.00046610628,0.00031818997,0.000022692466,0.00055795343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977343,0.00022062796,0.00031453327,0.0007280431,0.00042865914,0.0005738268],"domain_scores_gemma":[0.9988496,0.000040575946,0.000102982536,0.000343285,0.00041424297,0.0002493291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021105053,0.00025071602,0.00032037188,0.00018349075,0.00024292112,0.00012518007,0.0002837993,0.00016568738,0.00009349319],"category_scores_gemma":[0.000023770786,0.0002447957,0.000058597052,0.0004971756,0.00019094674,0.000041225358,0.000107519096,0.00033180654,0.000009190547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024877053,0.00008848167,0.00019005433,0.000007917581,0.00010092273,0.0000035036555,0.0024946986,0.00054185383,0.97138774,0.00019410021,0.0030847134,0.01941828],"study_design_scores_gemma":[0.0029717633,0.00052834855,0.11531504,0.00015361515,0.000017724467,0.000006450724,0.0022628033,0.00037231387,0.876748,0.0003633922,0.0007720711,0.00048842997],"about_ca_topic_score_codex":0.020765228,"about_ca_topic_score_gemma":0.007850079,"teacher_disagreement_score":0.115124986,"about_ca_system_score_codex":0.0008028109,"about_ca_system_score_gemma":0.00067403394,"threshold_uncertainty_score":0.9982479},"labels":[],"label_agreement":null},{"id":"W2324428487","doi":"10.1158/0008-5472.sabcs11-p1-11-11","title":"P1-11-11: Wait Times for Breast Cancer Care in Manitoba 2009–2010. Time To Face the Challenge.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Breast cancer; Cancer; Population; Radiation therapy; Disease; Presentation (obstetrics); Pediatrics; Surgery; General surgery; Internal medicine","score_opus":0.1310404865449883,"score_gpt":0.325506558369262,"score_spread":0.19446607182427372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324428487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7987692,0.051706806,0.00019939318,0.030951524,0.0021276965,0.0052613886,0.010645684,0.00011475077,0.100223556],"genre_scores_gemma":[0.9751346,0.002880697,0.00008802101,0.00072417146,0.0009429419,0.0020279745,0.000013250059,0.000102886755,0.018085457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974265,0.00003798907,0.0005704026,0.000748346,0.00010501628,0.0011117209],"domain_scores_gemma":[0.9985893,0.000113407856,0.00015760683,0.00065929146,0.00023272177,0.0002476728],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011480312,0.00025396043,0.0005240868,0.0004114335,0.00028960156,0.00011359864,0.00095319346,0.00019828274,0.008438271],"category_scores_gemma":[0.00010093427,0.00023598732,0.00014243489,0.00048400718,0.00020149506,0.0003482178,0.0002183329,0.0003906138,0.0019145994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001974844,0.00058470125,0.124094844,0.00071007985,0.00034905676,0.000030488005,0.037307836,0.00079736713,0.00024352038,0.14848693,0.4997104,0.18570994],"study_design_scores_gemma":[0.0017842117,0.00031330885,0.17162776,0.00021114321,0.000012266765,0.0000036990002,0.002336918,0.00046010522,0.00067442405,0.011072818,0.81063676,0.0008665791],"about_ca_topic_score_codex":0.025591366,"about_ca_topic_score_gemma":0.03333891,"teacher_disagreement_score":0.31092638,"about_ca_system_score_codex":0.0010721476,"about_ca_system_score_gemma":0.00030915323,"threshold_uncertainty_score":0.9988625},"labels":[],"label_agreement":null},{"id":"W2324431387","doi":"10.1158/0008-5472.sabcs-09-908","title":"Protective Effect of Estrogen (E2) and Increased Risk of E2 Plus Progestin (Prog) on Breast Cancer (BrCa). The 2009 Review of the Women's Health Initiative (WHI) Hormone Replacement Therapy (HRT) Published Trials.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Medicine; Hormone replacement therapy (female-to-male); Breast cancer; Hazard ratio; Hormone therapy; Women's Health Initiative; Gynecology; Estrogen; Progestin; Randomized controlled trial; Internal medicine; Placebo; Cancer; Oncology; Observational study; Pathology; Alternative medicine; Confidence interval","score_opus":0.030409189164644242,"score_gpt":0.37801234536728945,"score_spread":0.3476031562026452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324431387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8436993,0.14790843,0.0000028426125,0.0023715296,0.0000394047,0.0055943234,0.00028490112,0.0000057257384,0.0000935869],"genre_scores_gemma":[0.90524006,0.09269944,0.000008868664,0.000278332,0.000119601806,0.0015846788,0.000019037796,0.00002208651,0.000027896891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99339086,0.0044095367,0.00060534256,0.0004569524,0.00066483027,0.0004724842],"domain_scores_gemma":[0.9975494,0.00033447394,0.0007438116,0.00067641767,0.0005515472,0.00014432221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0084082745,0.00024576508,0.0007492307,0.000084682455,0.00018874557,0.000019412128,0.00041431328,0.00016223856,0.000029727038],"category_scores_gemma":[0.0013345182,0.0001232523,0.00018903225,0.00060297747,0.00043021629,0.000010435949,0.00012423689,0.000620275,4.253208e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058976557,0.001027775,0.0067506204,0.0048927306,0.0030816651,0.0000052516302,0.002098857,0.00009869665,0.6677756,0.0001769477,0.018221626,0.23689371],"study_design_scores_gemma":[0.009312585,0.01910416,0.022092676,0.004189903,0.00012199776,0.000015142113,0.00017772932,0.000026099513,0.9433101,0.00017294254,0.0011988702,0.00027780797],"about_ca_topic_score_codex":0.0010483337,"about_ca_topic_score_gemma":0.000014416243,"teacher_disagreement_score":0.27553454,"about_ca_system_score_codex":0.00022974891,"about_ca_system_score_gemma":0.0014050419,"threshold_uncertainty_score":0.5026083},"labels":[],"label_agreement":null},{"id":"W2324431971","doi":"10.1158/1538-7445.am10-326","title":"Abstract 326: Prognostic value of KIF14 and MDM4 in Ewing's sarcoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Biology; Aneuploidy; Chromosome instability; Fluorescence in situ hybridization; Chromosome; Chromothripsis; Cell cycle; Cancer research; Genetics; Cancer; Molecular biology; Gene; Genome instability; DNA damage; DNA","score_opus":0.07669411411160588,"score_gpt":0.4248553011695527,"score_spread":0.34816118705794685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324431971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298495,0.0027164717,2.2071718e-7,0.0018278146,0.00007040497,0.00054476666,0.000009335003,0.000010129937,0.0018359225],"genre_scores_gemma":[0.99889416,0.0004868752,0.00014120775,0.00004597998,0.00010671316,0.00021964105,0.0000043133455,0.000016785023,0.000084310144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880743,0.000037926962,0.00018030622,0.00023615026,0.0004097432,0.00032844607],"domain_scores_gemma":[0.9990352,0.00039619053,0.000026559095,0.00025328036,0.00013920236,0.00014961505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053511,0.000084842664,0.00021647017,0.00022178404,0.00004262037,0.000016137712,0.00008048877,0.00007633612,0.00030827426],"category_scores_gemma":[0.00033323083,0.00006637125,0.00003526164,0.0002780528,0.00019891743,0.000041311396,0.00006157109,0.00049558486,0.00001698917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010029038,0.0004761894,0.8936257,0.00017996761,0.000033594093,0.00017833267,0.00024003007,8.340101e-7,0.06664662,0.0007122397,0.0004682406,0.03733796],"study_design_scores_gemma":[0.001381091,0.00015261181,0.95469886,0.00027116554,0.000014833476,0.000015555008,0.00007712949,0.000021744845,0.041291457,0.00032874188,0.0016923335,0.000054497683],"about_ca_topic_score_codex":0.0020801453,"about_ca_topic_score_gemma":0.0005310555,"teacher_disagreement_score":0.06107314,"about_ca_system_score_codex":0.000072306975,"about_ca_system_score_gemma":0.00023857727,"threshold_uncertainty_score":0.3375387},"labels":[],"label_agreement":null},{"id":"W2324535812","doi":"10.1158/1538-7445.am2012-2706","title":"Abstract 2706: Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Vinorelbine; Capecitabine; Sorafenib; Internal medicine; Pharmacokinetics; Metastatic breast cancer; Oncology; Cancer; Breast cancer; Docetaxel; Chemotherapy; Concomitant; Pharmacology; Gastroenterology; Colorectal cancer; Hepatocellular carcinoma","score_opus":0.1254380671873317,"score_gpt":0.5228773848304897,"score_spread":0.39743931764315804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324535812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188316,0.0059631243,0.0000024196663,0.00055861863,0.000066800756,0.0009978582,0.00028408007,0.000011188669,0.00023276443],"genre_scores_gemma":[0.99708354,0.0017987716,0.000025346031,0.00006712269,0.00015954563,0.00043319052,0.00003009793,0.000025391542,0.00037701277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998145,0.0001393444,0.00030857814,0.00029487585,0.0005532464,0.0005589832],"domain_scores_gemma":[0.9989633,0.00016831867,0.00008390638,0.00021704235,0.00027565967,0.00029177676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053444767,0.0001713089,0.00060852664,0.0008749285,0.000052274117,0.000011937326,0.000094552175,0.000034851317,0.0030890983],"category_scores_gemma":[0.000010535161,0.0001255012,0.00005816467,0.0020134537,0.0002315114,0.00011327407,0.000054536467,0.00038441722,0.0000034643274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069802976,0.00676078,0.9107214,0.0002394389,0.0051629697,0.00012146579,0.0022006796,0.00021494545,0.0501299,0.0000071290547,0.0014036235,0.016057352],"study_design_scores_gemma":[0.019640625,0.0014246189,0.96121997,0.0000930875,0.005127502,0.00001627541,0.000991628,0.00023502883,0.010119295,0.0000033734993,0.0009472486,0.0001813394],"about_ca_topic_score_codex":0.0079798745,"about_ca_topic_score_gemma":0.0039761993,"teacher_disagreement_score":0.05049856,"about_ca_system_score_codex":0.00030553262,"about_ca_system_score_gemma":0.00030129708,"threshold_uncertainty_score":0.99862605},"labels":[],"label_agreement":null},{"id":"W2324598201","doi":"10.1158/1538-7445.am2013-1968","title":"Abstract 1968: Inactivation of the tumor suppressor Lgl via PTEN loss promotes the invasiveness of glioblastoma multiforme.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"PTEN; Cancer research; Biology; Glioma; Cancer; U87; Cell migration; Pathology; Cell; Medicine; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology","score_opus":0.023766736970314343,"score_gpt":0.31454566623240043,"score_spread":0.2907789292620861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324598201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794006,0.00072603684,0.000038320894,0.00046098017,0.000058633428,0.0005339392,0.000028504037,0.0000027336444,0.00021080274],"genre_scores_gemma":[0.9992159,0.0001165176,0.00000812497,0.00002904124,0.00012111315,0.0002067016,0.000010700296,0.000016004338,0.00027586918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989272,0.00008020119,0.00019902029,0.00020267794,0.0003437594,0.00024716993],"domain_scores_gemma":[0.9986867,0.00006360763,0.0001204205,0.00041924434,0.0006702619,0.000039788178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035881533,0.000093486386,0.00011681711,0.00003886495,0.00011857348,0.00002141994,0.0004928559,0.00007577308,0.00013871187],"category_scores_gemma":[0.00022856177,0.000053985448,0.00007240263,0.00022975235,0.00040231456,0.000010821414,0.00022970288,0.00018505912,0.000006783932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001117365,0.00006352855,0.0015492396,0.00022203456,0.000033076587,5.839254e-7,0.0001396719,0.00002830537,0.9949023,0.000014349224,0.00042620208,0.0025089544],"study_design_scores_gemma":[0.0002540271,0.000100059355,0.012214311,0.00007758371,0.000005259351,0.0000042424,0.00020953933,0.00003222429,0.98542744,0.00020834096,0.0014011709,0.000065829416],"about_ca_topic_score_codex":0.0010654803,"about_ca_topic_score_gemma":0.00026815294,"teacher_disagreement_score":0.010665072,"about_ca_system_score_codex":0.000023894538,"about_ca_system_score_gemma":0.00027938496,"threshold_uncertainty_score":0.22014627},"labels":[],"label_agreement":null},{"id":"W2324625725","doi":"10.1158/1538-7445.am2012-1976","title":"Abstract 1976: Monocytic/macrophagic differentiation status of human promyelocytic leukemia cells dictates targeting efficacy of NF-kappaB downstream gene productes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Cell biology; Matrix metalloproteinase; Gene expression; Chemistry; Cancer research; Biology; Cellular differentiation; Gene; Molecular biology; Biochemistry","score_opus":0.0690896344212632,"score_gpt":0.3836215413417031,"score_spread":0.3145319069204399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324625725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689914,0.010969863,0.000004708604,0.00009275062,0.00016789093,0.0011800434,0.000056587185,0.000037511985,0.00059152883],"genre_scores_gemma":[0.995755,0.0028180752,0.00024501875,0.000009227712,0.0005512773,0.000250373,0.00009191548,0.000057256057,0.00022183816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664074,0.00012909409,0.00066490495,0.00043353508,0.0010121218,0.0011196305],"domain_scores_gemma":[0.9979923,0.00016977145,0.00027721553,0.00049588137,0.00068979623,0.00037503653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080745434,0.00023520004,0.0005623016,0.00032157745,0.000164094,0.00002841022,0.00021862949,0.00011803281,0.00066046964],"category_scores_gemma":[0.00022656198,0.00019142918,0.00014732782,0.0006333629,0.00036529722,0.00017765541,0.00013061125,0.0005085825,0.000019769754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033416064,0.0005265426,0.08024459,0.0017843293,0.00017334602,0.0000023015625,0.00139656,0.000058892732,0.9038439,0.000028475677,0.0011493195,0.010457621],"study_design_scores_gemma":[0.001485725,0.00032929867,0.20895214,0.0003616929,0.00009235987,9.395913e-7,0.0002993129,0.000055694916,0.7878136,0.000015969179,0.00045594107,0.00013733494],"about_ca_topic_score_codex":0.0022005134,"about_ca_topic_score_gemma":0.000015318754,"teacher_disagreement_score":0.12870754,"about_ca_system_score_codex":0.001028901,"about_ca_system_score_gemma":0.00079020596,"threshold_uncertainty_score":0.7806255},"labels":[],"label_agreement":null},{"id":"W2324731084","doi":"10.1158/1538-7445.am2012-4131","title":"Abstract 4131: Serum miRNA profiles of patients with oral cancer and pre-cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"microRNA; Cancer; Medicine; Internal medicine; Oncology; Carcinoma; Basal cell; Stage (stratigraphy); Gastroenterology; Biology; Gene","score_opus":0.033952960339698295,"score_gpt":0.3708586794293491,"score_spread":0.3369057190896508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324731084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855081,0.012410122,0.00007131687,0.00021024147,0.00016447325,0.00089171354,0.00039898796,0.0000103859875,0.00033468366],"genre_scores_gemma":[0.99407613,0.003399175,0.00012415864,0.00005881348,0.00032513664,0.0007744823,0.00006112083,0.00007242615,0.0011085804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997316,0.00012216023,0.00023560607,0.0004983314,0.0008722098,0.0009556755],"domain_scores_gemma":[0.9983856,0.000024950907,0.00009666044,0.00045352473,0.000716539,0.00032274096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005715844,0.00021970437,0.0002425832,0.00015620171,0.0001478947,0.000038216687,0.00032490556,0.00022944242,0.0007177701],"category_scores_gemma":[0.00006470442,0.00018298834,0.000056462774,0.00036169004,0.00037652784,0.000023748513,0.00032362842,0.00045966028,0.0000058780847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018658079,0.00031944996,0.13121562,0.00048499904,0.00040164718,0.000002621193,0.00028240215,0.0001671202,0.8190807,0.00007836616,0.006757281,0.039343968],"study_design_scores_gemma":[0.0016307896,0.00040024534,0.24179766,0.00018220002,0.000027404454,0.000001078032,0.000063709595,0.000014173386,0.7303672,0.00001864264,0.025204789,0.00029211908],"about_ca_topic_score_codex":0.0014927973,"about_ca_topic_score_gemma":0.0007840711,"teacher_disagreement_score":0.11058204,"about_ca_system_score_codex":0.00014784864,"about_ca_system_score_gemma":0.0005888587,"threshold_uncertainty_score":0.7859079},"labels":[],"label_agreement":null},{"id":"W2324740323","doi":"10.1158/1538-7445.am10-4064","title":"Abstract 4064: Development of ALN-VSP: An RNAi therapeutic for solid tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Cancer research; Small interfering RNA; Hepatocellular carcinoma; Liver tumor; Pathology; Liver cancer; Medicine; Biology; Cell culture; Transfection","score_opus":0.09064843143201033,"score_gpt":0.43882286597822556,"score_spread":0.3481744345462152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324740323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998507,0.0003620976,0.00018143172,0.00008821958,0.0001501573,0.00023234052,0.000020946916,0.0000042600773,0.00045352953],"genre_scores_gemma":[0.99825567,0.00009481562,0.0004713993,0.00006849221,0.0002629265,0.00015836608,0.00004679447,0.000018657489,0.00062290084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989987,0.000022853834,0.00018923532,0.00027076763,0.00019353788,0.00032490393],"domain_scores_gemma":[0.9991639,0.000016682603,0.000043249063,0.00030925026,0.00037502378,0.00009185777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052045146,0.00008903456,0.00011162716,0.00006215879,0.00010856092,0.000022077504,0.00034542615,0.00010935394,0.0001415599],"category_scores_gemma":[0.000036928774,0.000077949044,0.000049606835,0.00006377893,0.00012274814,0.000005169885,0.00006972979,0.00018782928,0.00001143461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014737812,0.00005560897,0.000449046,0.000034505392,0.000037995505,6.260357e-7,0.0001562781,0.0000063619386,0.96261585,0.000030922587,0.00084772793,0.035617683],"study_design_scores_gemma":[0.00023576226,0.0002262222,0.007089415,0.0000186604,0.0000025584839,0.0000012204197,0.00013900203,0.000014021089,0.9682753,0.00012512645,0.023772102,0.000100626086],"about_ca_topic_score_codex":0.0000653358,"about_ca_topic_score_gemma":0.00058018795,"teacher_disagreement_score":0.035517056,"about_ca_system_score_codex":0.000015118587,"about_ca_system_score_gemma":0.0005574627,"threshold_uncertainty_score":0.31786698},"labels":[],"label_agreement":null},{"id":"W2324756289","doi":"10.1158/1538-7445.am10-5287","title":"Abstract 5287: Role of Wnt-beta-catenin pathway in the control of tumor cell invasion in the triple negative subset of breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wnt signaling pathway; Downregulation and upregulation; Cancer research; Extracellular matrix; Biology; Metastasis; Cancer; Signal transduction; Integrin; Cell; Pathology; Medicine; Cell biology; Gene; Genetics","score_opus":0.05194170739611255,"score_gpt":0.3658599155739682,"score_spread":0.31391820817785565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324756289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903072,0.002843549,2.817299e-7,0.0028273158,0.000060324717,0.0018125321,0.00050188735,0.0000036151284,0.0016432744],"genre_scores_gemma":[0.9982453,0.0007144308,0.0000071395284,0.0000625879,0.00010522286,0.00066429947,0.000018526638,0.000020715614,0.00016175282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694926,0.0004369231,0.0005027005,0.00029855783,0.0012590095,0.0005535474],"domain_scores_gemma":[0.99780494,0.0008338488,0.00017536514,0.00048891676,0.00060623983,0.00009071383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030761336,0.00015925425,0.0004879349,0.00037151953,0.00006615326,0.000015392965,0.0005915431,0.00010456531,0.00058979815],"category_scores_gemma":[0.00013659321,0.00008226227,0.000116106654,0.0011306226,0.0006995062,0.00009568558,0.00006418678,0.0012646255,0.0000053109575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034253183,0.0007785369,0.08991013,0.0004321712,0.00005571476,0.000055069304,0.0072500193,0.00001753605,0.8922738,0.00014811833,0.00061775243,0.005035841],"study_design_scores_gemma":[0.005883686,0.00033661016,0.3639453,0.00030529953,0.000019546094,0.000007070772,0.0056769084,0.000050943487,0.6231238,0.00028224173,0.0002907041,0.00007787093],"about_ca_topic_score_codex":0.019834775,"about_ca_topic_score_gemma":0.008513527,"teacher_disagreement_score":0.2740352,"about_ca_system_score_codex":0.00016997769,"about_ca_system_score_gemma":0.0016165392,"threshold_uncertainty_score":0.98669225},"labels":[],"label_agreement":null},{"id":"W2324771589","doi":"10.1158/1538-7445.am10-1075","title":"Abstract 1075: Cul1 Expression Is Increased in Early Stages of Human Melanoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Skp1; Cancer research; Melanoma; SKP2; Ubiquitin ligase; Gene knockdown; Medicine; Cell cycle; Cell growth; Ubiquitin; Cancer; Biology; Internal medicine; Cell culture; Genetics","score_opus":0.04962360634367383,"score_gpt":0.38293882567440163,"score_spread":0.3333152193307278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324771589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576086,0.00040665703,9.853064e-7,0.00007155664,0.000045760695,0.00022313348,0.00006577627,0.0000047530034,0.003420527],"genre_scores_gemma":[0.9989822,0.00010414752,0.000057509424,0.000028274057,0.00018352288,0.00009865526,0.000027548107,0.00001793545,0.0005002345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889195,0.00008270778,0.00016765845,0.00027748826,0.00027593342,0.00030428046],"domain_scores_gemma":[0.9993103,0.000022224473,0.000044756493,0.0003718833,0.00015239143,0.000098453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064445945,0.00008805788,0.000116039024,0.0001040164,0.00007427556,0.000020025816,0.000292344,0.00017648007,0.00062467123],"category_scores_gemma":[0.0000836624,0.00007995325,0.000044044802,0.00012292425,0.00015965836,0.000004852128,0.00014688863,0.00040161543,0.000012790157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008045635,0.00004968933,0.05027059,0.000051269293,0.0000066409098,0.0000044917483,0.00017161832,3.014787e-7,0.9472316,0.000045890396,0.0011172371,0.0009702545],"study_design_scores_gemma":[0.00041624482,0.00015884236,0.06575093,0.000049263963,9.3392663e-7,5.5695165e-7,0.00004592642,4.770465e-7,0.92876637,0.00013486252,0.0045904107,0.00008520462],"about_ca_topic_score_codex":0.0018103143,"about_ca_topic_score_gemma":0.0005337517,"teacher_disagreement_score":0.01846521,"about_ca_system_score_codex":0.000013843323,"about_ca_system_score_gemma":0.0001594608,"threshold_uncertainty_score":0.6839712},"labels":[],"label_agreement":null},{"id":"W2324854014","doi":"10.1158/1538-7445.am10-2867","title":"Abstract 2867: Anthocyanin and carotenoid rich fresh vs. processed colored potatoes suppress human colon cancer cell proliferation and elevate apoptosis via suppression of inducible nitric oxide synthase (iNOS) pathway","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Potato Plant Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apoptosis; Anthocyanin; Carotenoid; Chemoprotective; Chemistry; Cancer cell; Biochemistry; Biology; Cancer; Food science; Antioxidant","score_opus":0.03769853373060381,"score_gpt":0.3181855145048417,"score_spread":0.2804869807742379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324854014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966724,0.00083327305,2.5559973e-7,0.0004568243,0.00005755645,0.0012983702,0.00044641097,0.000041860923,0.00019308625],"genre_scores_gemma":[0.997834,0.001014727,0.000029338933,0.0000227209,0.00016729019,0.00064547604,0.00010346154,0.0000073836186,0.00017555992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664265,0.00029062346,0.00040283022,0.0007665468,0.0010306857,0.0008666553],"domain_scores_gemma":[0.9980062,0.00056634156,0.00017212224,0.0001702552,0.00070555386,0.00037950225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013786738,0.00026049727,0.00039624365,0.00011968559,0.0007194028,0.00026982086,0.00049820845,0.00032239314,0.00078811974],"category_scores_gemma":[0.00021890865,0.0001273972,0.000042302374,0.0007881518,0.00045753116,0.0004926796,0.0003082675,0.0009591811,0.000004322216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039143526,0.00019336684,0.028956218,0.0003207861,0.000017608825,0.000008601893,0.00028228643,0.000003112664,0.9655989,0.000014137655,0.00070457446,0.0035089895],"study_design_scores_gemma":[0.0004461032,0.00025909548,0.163775,0.000103883795,0.000009834614,0.000003984752,0.00036065138,0.00008208146,0.83430994,0.000103832,0.0003355173,0.0002100684],"about_ca_topic_score_codex":0.020661542,"about_ca_topic_score_gemma":0.012613617,"teacher_disagreement_score":0.13481878,"about_ca_system_score_codex":0.00010344476,"about_ca_system_score_gemma":0.00019784484,"threshold_uncertainty_score":0.98585993},"labels":[],"label_agreement":null},{"id":"W2324860478","doi":"10.1158/1538-7445.am2012-689","title":"Abstract 689: Validation of antibodies to Estrogen Receptor ≤ and quantitative assessment of ERα1 and ERα5 expression in breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Breast cancer; Estrogen receptor; Fulvestrant; Gene knockdown; Medicine; Cancer research; Cancer; Estrogen receptor alpha; Oncology; Antibody; Internal medicine; Biology; Immunology; Cell culture; Genetics","score_opus":0.11994855885367893,"score_gpt":0.4977432605650237,"score_spread":0.37779470171134477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324860478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923702,0.004365443,0.000007032122,0.0021025178,0.000047333207,0.00047251818,0.00020936354,0.000004061213,0.00042155036],"genre_scores_gemma":[0.9935409,0.004809362,0.0011655516,0.000022325134,0.000098865414,0.000093930495,0.000014944149,0.0000137375855,0.00024038195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828607,0.00013068711,0.0002753959,0.00021964152,0.0006818019,0.00040641316],"domain_scores_gemma":[0.99889886,0.00026298978,0.0000630318,0.00013508483,0.00038777041,0.00025226304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010004584,0.000107103406,0.0003178369,0.00033111076,0.00006368708,0.000011911897,0.0000793662,0.00006322027,0.00050775777],"category_scores_gemma":[0.00007632299,0.00008130397,0.000030287327,0.00033485785,0.00034018478,0.00016070223,0.00016387079,0.00029616008,0.000003117124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000518164,0.00009566828,0.5047797,0.00046695594,0.000027228712,0.0000014987688,0.00074080896,0.00000581633,0.48925483,0.00023048463,0.0005662181,0.0033126562],"study_design_scores_gemma":[0.00044799823,0.00015921642,0.7679033,0.0007783762,0.0000070579654,0.0000037360508,0.00059684104,0.00001990563,0.22937076,0.00002921989,0.000617039,0.00006653468],"about_ca_topic_score_codex":0.0025109116,"about_ca_topic_score_gemma":0.00005565022,"teacher_disagreement_score":0.26312366,"about_ca_system_score_codex":0.00010947541,"about_ca_system_score_gemma":0.00024515993,"threshold_uncertainty_score":0.55595917},"labels":[],"label_agreement":null},{"id":"W2324866384","doi":"10.1158/1538-7445.am10-2795","title":"Abstract 2795: Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Gastroenterology; Pancreatic cancer; Insulin-like growth factor; Cancer; Adenocarcinoma; Oncology; Confidence interval; Risk factor; Endocrinology; Growth factor; Receptor","score_opus":0.037921472185127814,"score_gpt":0.3654091282335859,"score_spread":0.3274876560484581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324866384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836297,0.010308573,0.000004264824,0.0020550615,0.00026247095,0.0028643874,0.00037552122,0.000028971423,0.00047103566],"genre_scores_gemma":[0.9803105,0.017580118,0.00008775705,0.00015808009,0.00052795565,0.0009462009,0.000017898241,0.00006192025,0.0003095484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964414,0.00032371806,0.0006721345,0.0007367053,0.0009374735,0.0008885213],"domain_scores_gemma":[0.9978201,0.00057403836,0.00023608032,0.00047832655,0.00051257916,0.0003789109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025240474,0.00036967822,0.0007433907,0.0004246902,0.00057018554,0.00014437114,0.00026492513,0.00032432206,0.00036025496],"category_scores_gemma":[0.00078017777,0.0002641259,0.00007743565,0.0008134878,0.00084558356,0.00037481883,0.00022140486,0.0021168808,0.0000015072886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027205367,0.00032674882,0.83185506,0.00090877427,0.00057497073,0.000088356275,0.011067948,0.00001601499,0.096296534,0.00013989444,0.004563777,0.026956549],"study_design_scores_gemma":[0.024742518,0.0013114159,0.9552187,0.00054146803,0.00029357636,0.0000247837,0.0015823428,0.0007741529,0.012397783,0.00016380836,0.0025655897,0.00038391136],"about_ca_topic_score_codex":0.03053503,"about_ca_topic_score_gemma":0.012498615,"teacher_disagreement_score":0.123363584,"about_ca_system_score_codex":0.00015348778,"about_ca_system_score_gemma":0.001108008,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W2324916450","doi":"10.1158/1538-7445.am2012-5247","title":"Abstract 5247: Use of two markers of hypoxia to study migration, re-oxygenation and repopulation of originally hypoxic cells in MCF-7 tumor xenografts following chemotherapy","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Hypoxia (environmental); Bone marrow; Biology; Pathology; Radiation therapy; Tumor hypoxia; Cancer research; Chemotherapy; Medicine; Internal medicine; Chemistry; Oxygen","score_opus":0.052985445261849264,"score_gpt":0.37921460712570443,"score_spread":0.32622916186385514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324916450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971183,0.0017226936,0.00004234043,0.000054632976,0.00029750017,0.0006965942,0.000022425744,0.0000027170584,0.000042824136],"genre_scores_gemma":[0.9982828,0.0005791219,0.0006204285,0.000024667022,0.00026918628,0.00007087512,0.000015208144,0.000021235974,0.00011651664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984778,0.00014380502,0.00042542405,0.0002652453,0.00040686713,0.00028081515],"domain_scores_gemma":[0.99909884,0.000044413693,0.00016202647,0.00031268146,0.00028484818,0.00009721528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012640572,0.00011332163,0.00024292381,0.00024448617,0.000037998052,0.000012833541,0.00012199336,0.00006219855,0.000021022199],"category_scores_gemma":[0.00014306068,0.00011289498,0.000063511776,0.00040844985,0.000061232226,0.000027787997,0.000052696618,0.00010098897,4.2623643e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004659415,0.0002014588,0.07813354,0.000056436165,0.000056783785,4.7636414e-7,0.00067529525,0.00013983175,0.9154451,0.000007645402,0.0005431145,0.004274368],"study_design_scores_gemma":[0.0010331995,0.00022565456,0.38895053,0.00004700525,0.000014858208,5.951693e-7,0.0003347303,0.000010455512,0.60406995,0.000012027118,0.00520337,0.000097669086],"about_ca_topic_score_codex":0.0026417312,"about_ca_topic_score_gemma":0.0016206235,"teacher_disagreement_score":0.3113752,"about_ca_system_score_codex":0.000043263513,"about_ca_system_score_gemma":0.00014958152,"threshold_uncertainty_score":0.4603724},"labels":[],"label_agreement":null},{"id":"W2324941573","doi":"10.1158/0008-5472.sabcs11-p4-19-02","title":"P4-19-02: A Population-Based Study of Contemporary Systemic Therapy for Male Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Tamoxifen; Trastuzumab; Breast cancer; Internal medicine; Oncology; Population; Adjuvant therapy; Male breast cancer; Tolerability; Cancer; Gynecology; Adverse effect","score_opus":0.2992207059602504,"score_gpt":0.4883676172575377,"score_spread":0.18914691129728728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324941573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852269,0.007404641,0.000016213547,0.0010696974,0.00016662861,0.0051810397,0.0002340386,0.000040257433,0.0006605585],"genre_scores_gemma":[0.994282,0.0002311588,0.000046267665,0.00018868144,0.0002927789,0.004070227,0.000014244144,0.00004437708,0.00083026715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768984,0.0002373235,0.00047653096,0.00040117788,0.0007138287,0.00048126918],"domain_scores_gemma":[0.99779207,0.00026159294,0.00015067766,0.00047278302,0.0010867164,0.00023613995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011171971,0.00015868494,0.0005329034,0.00029546203,0.00021488189,0.000007435335,0.00019670486,0.0000783266,0.0007506958],"category_scores_gemma":[0.00008681171,0.00012652365,0.00007590669,0.00045695703,0.00009989795,0.000053333322,0.00004679772,0.000262607,0.000005419205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057252706,0.00074808224,0.9801862,0.0019497422,0.0001550686,0.00001733725,0.0024440468,0.000007191129,0.0010373644,0.00003766939,0.004013379,0.0036786417],"study_design_scores_gemma":[0.0074602207,0.001457111,0.98644274,0.0007748271,0.000027827311,0.000021126658,0.0026917146,0.00008890565,0.00049513124,0.000023356248,0.00038663423,0.00013039037],"about_ca_topic_score_codex":0.068769254,"about_ca_topic_score_gemma":0.0017393313,"teacher_disagreement_score":0.06702992,"about_ca_system_score_codex":0.00044860714,"about_ca_system_score_gemma":0.0017699394,"threshold_uncertainty_score":0.9374319},"labels":[],"label_agreement":null},{"id":"W2324989373","doi":"10.1158/1538-7445.am2012-1979","title":"Abstract 1979: Sweet wormwood-derived artesunate causes cell cycle arrest in ovarian cancer cell lines","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Artesunate; Artemisinin; Artemisia annua; Pharmacology; Traditional medicine; Cytotoxic T cell; Propidium iodide; Biology; Cancer research; Medicine; Immunology; Apoptosis; Programmed cell death; Biochemistry; In vitro; Plasmodium falciparum","score_opus":0.05856531040454207,"score_gpt":0.37717352369382134,"score_spread":0.3186082132892793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324989373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648715,0.027770966,0.0000027326892,0.00065529,0.0007119907,0.0002764078,0.00006605955,0.000012163143,0.005632888],"genre_scores_gemma":[0.9890646,0.0075409003,0.000034827743,0.00025577354,0.00115895,0.0004063971,0.000038253977,0.000030576535,0.0014697306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980209,0.00017934715,0.0002364531,0.00043955754,0.000164931,0.0009588195],"domain_scores_gemma":[0.999197,0.00007475916,0.00006656767,0.00033914016,0.00014988742,0.00017261785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006107595,0.00020721709,0.00022983296,0.000080377096,0.00022858244,0.000018122897,0.0003052665,0.00036996516,0.00033619843],"category_scores_gemma":[0.000069889174,0.00018505273,0.00006564293,0.0001889772,0.00039997057,0.000015003115,0.0002527736,0.00044986646,0.00006828519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001819317,0.00022296779,0.051292382,0.000056466823,0.000055914687,0.000008918293,0.00021439568,0.000040440016,0.9407327,0.000017413558,0.0067839017,0.00039256772],"study_design_scores_gemma":[0.0007626456,0.000094581184,0.21943268,0.000026458556,0.00001047301,0.000001166087,0.00025784655,0.0000019362508,0.7646811,0.0000383009,0.014460178,0.00023265518],"about_ca_topic_score_codex":0.0019571616,"about_ca_topic_score_gemma":0.008792547,"teacher_disagreement_score":0.17605162,"about_ca_system_score_codex":0.00009564202,"about_ca_system_score_gemma":0.00024810727,"threshold_uncertainty_score":0.7546232},"labels":[],"label_agreement":null},{"id":"W2325054384","doi":"10.1158/0008-5472.sabcs-09-1083","title":"Change in Receptor Status in Locally Advanced Breast Cancer Patients after Treatment with Neoadjuvant Therapy (NAT).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Neoadjuvant therapy; Oncology; Internal medicine; Cancer; Progesterone receptor; Stage (stratigraphy); Biopsy; Hormonal therapy; Metastatic breast cancer; Breast-conserving surgery; Adjuvant therapy; Prospective cohort study; Estrogen receptor","score_opus":0.028128852343142562,"score_gpt":0.3574429687119552,"score_spread":0.32931411636881264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325054384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819799,0.014759989,0.0000010800491,0.0017112218,0.00008255657,0.001017406,0.00032128708,0.000009616799,0.00011695486],"genre_scores_gemma":[0.9617133,0.03391006,0.00004379783,0.0003815573,0.00020450672,0.0035026486,0.00007910795,0.0000342218,0.0001307591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978011,0.0001237007,0.0001967713,0.0006601624,0.00036037358,0.00085789623],"domain_scores_gemma":[0.9992232,0.000014643762,0.00004417475,0.00033357582,0.00024650345,0.00013795865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011260734,0.00027017324,0.00026815865,0.00016879002,0.00006436123,0.00002252475,0.00014115726,0.000106559455,0.00014104063],"category_scores_gemma":[0.000006050826,0.00019825202,0.000044680637,0.00042024394,0.00013022688,0.000017076565,0.000054943986,0.0001683942,0.000007713496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006887305,0.0007270698,0.56055164,0.000009754837,0.00006185866,0.000020075484,0.0008511843,0.00003192897,0.0061813686,0.0000021872127,0.00014085512,0.42453477],"study_design_scores_gemma":[0.00795281,0.0019769522,0.9667015,0.00021568617,0.0000047888857,0.0000011682175,0.000121559395,0.0000033866534,0.012659329,0.000009792713,0.010082329,0.00027069796],"about_ca_topic_score_codex":0.0060436376,"about_ca_topic_score_gemma":0.016679898,"teacher_disagreement_score":0.42426407,"about_ca_system_score_codex":0.00093900925,"about_ca_system_score_gemma":0.0003508328,"threshold_uncertainty_score":0.93077743},"labels":[],"label_agreement":null},{"id":"W2325065247","doi":"10.1158/0008-5472.sabcs12-p1-13-01","title":"Abstract P1-13-01: A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Ottawa Regional Cancer Foundation; Health Sciences Centre; Saint John Regional Hospital; McMaster University; Queen's University; University of Calgary; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Epirubicin; Internal medicine; Paclitaxel; Randomized controlled trial; Taxane; Cyclophosphamide; Gastroenterology; Chemotherapy; Cancer","score_opus":0.05582360208603607,"score_gpt":0.3945439117137432,"score_spread":0.33872030962770716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325065247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97954243,0.0019175486,0.0000038570283,0.0027930152,0.0012398458,0.003639109,0.010054679,0.000024964756,0.00078453333],"genre_scores_gemma":[0.9929801,0.0026725056,0.000062123596,0.000063334905,0.000428519,0.001964314,0.00017576003,0.00007196489,0.0015813321],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924531,0.002278302,0.0011625699,0.00082502625,0.0018018045,0.0014792086],"domain_scores_gemma":[0.98996484,0.0069772624,0.00082938356,0.0010376557,0.0006479957,0.00054283073],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043024886,0.0005487011,0.0022298337,0.0005400588,0.0002415553,0.000028144192,0.00057754223,0.00033069885,0.00091755524],"category_scores_gemma":[0.0017755056,0.00034714368,0.00054506055,0.0026789631,0.001250365,0.00025568213,0.00023878628,0.0013039343,0.000006282328],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9553699,0.0018359208,0.005902926,0.00009639119,0.00783151,0.000053586245,0.004160038,0.00008419362,0.0053943056,0.0000097114225,0.018496681,0.0007648184],"study_design_scores_gemma":[0.93699753,0.003020354,0.04692568,0.00027775674,0.0035391832,0.0000024891092,0.0015905399,0.00003862223,0.006911995,0.00002185249,0.0003037066,0.00037027424],"about_ca_topic_score_codex":0.1246769,"about_ca_topic_score_gemma":0.027202347,"teacher_disagreement_score":0.097474545,"about_ca_system_score_codex":0.0026205082,"about_ca_system_score_gemma":0.0020671648,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2325141145","doi":"10.1158/1538-7445.am2012-5127","title":"Abstract 5127: Characterization of lung cancers by integrated genomic and proteomic analysis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Proteome; Adenocarcinoma; Lung cancer; Cancer; Biology; Computational biology; Primary tumor; Carcinoma; Transcriptome; Cancer research; Oncology; Pathology; Bioinformatics; Medicine; Internal medicine; Gene; Metastasis; Gene expression; Genetics","score_opus":0.02878373130064258,"score_gpt":0.3554071777896726,"score_spread":0.32662344648903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325141145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630284,0.0026116779,0.00037944995,0.000088632754,0.000040260686,0.0002451235,0.00018275664,0.0000033874123,0.00014585367],"genre_scores_gemma":[0.99589247,0.0027855057,0.000026654503,0.000020366768,0.000112124195,0.00020186398,0.00033274322,0.000013171222,0.00061509706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920446,0.00005397154,0.000147171,0.00020049911,0.00013900579,0.00025488358],"domain_scores_gemma":[0.999447,0.0000052110004,0.00006507594,0.00022127923,0.00017109237,0.000090325506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003576094,0.0000751415,0.0001157661,0.00011422095,0.000073868185,0.000019146772,0.00011859993,0.000080258294,0.00015413573],"category_scores_gemma":[0.00001661735,0.00006859572,0.00003982827,0.00036136722,0.00012144061,0.000008957054,0.000043969852,0.00010749,0.0000019375723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051738763,0.00001851552,0.030619394,0.0000257946,0.0001619028,4.6446512e-8,0.00006738526,0.000015344785,0.9657088,0.000011237127,0.00082333165,0.0024965347],"study_design_scores_gemma":[0.00017940957,0.000029128845,0.28183112,0.000011370328,0.000044350276,3.1673054e-7,0.000049589413,0.00009626033,0.7075114,0.0000018232381,0.010147727,0.000097495744],"about_ca_topic_score_codex":0.000888847,"about_ca_topic_score_gemma":0.000055487137,"teacher_disagreement_score":0.25819737,"about_ca_system_score_codex":0.00012026316,"about_ca_system_score_gemma":0.00019605998,"threshold_uncertainty_score":0.27972522},"labels":[],"label_agreement":null},{"id":"W2325171307","doi":"10.1158/1538-7445.am2011-4285","title":"Abstract 4285: Development of a combined photoacoustic micro-ultrasound system for non-invasive detection of mouse lymph nodes and intra-tumoral oxygen saturation measurements","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; FujiFilm VisualSonics (Canada); Illumisonics (Canada)","funders":"","keywords":"Saturation (graph theory); Transducer; Materials science; Detection limit; Laser; Absorbance; Serial dilution; Ultrasound; Photoacoustic imaging in biomedicine; Biomedical engineering; Optical fiber; Optics; Oxygen saturation; SIGNAL (programming language); Analytical Chemistry (journal); Oxygen; Chemistry; Acoustics; Chromatography; Computer science; Medicine; Physics; Pathology","score_opus":0.06775854826591508,"score_gpt":0.2906969522555466,"score_spread":0.2229384039896315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325171307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693466,0.00026383426,0.011719971,0.0000013742007,0.00016364381,0.00064445555,0.000063438034,0.000041414336,0.0001672133],"genre_scores_gemma":[0.99758434,0.00005388952,0.002006786,0.0000019805625,0.0000292687,0.00026209213,0.000011066627,0.00003344123,0.000017135386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873024,0.000025417603,0.00036123223,0.00019655569,0.00033937732,0.00034718378],"domain_scores_gemma":[0.99912316,0.00017153447,0.00007484377,0.00014901119,0.0004007622,0.00008069902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006320242,0.00014095189,0.00023569615,0.00018305556,0.00011727221,0.000021078416,0.00013690011,0.00007036487,0.000011726663],"category_scores_gemma":[0.00011554586,0.00013969933,0.000034549787,0.00018128668,0.00010070038,0.00011672857,0.000020714831,0.00013599283,0.0000013890019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018265062,0.000031582407,0.0006797541,0.002307836,0.0001110342,9.4716887e-7,0.0021876714,0.0002831817,0.9927633,0.0000022761649,0.00001695046,0.001432847],"study_design_scores_gemma":[0.0009362059,0.000033269596,0.0138672255,0.000383586,0.000025203864,0.0000044509793,0.00145104,0.0020498934,0.981104,0.000011580787,0.000003035461,0.00013050501],"about_ca_topic_score_codex":0.00034384805,"about_ca_topic_score_gemma":0.00008948325,"teacher_disagreement_score":0.013187472,"about_ca_system_score_codex":0.0004868138,"about_ca_system_score_gemma":0.00026043833,"threshold_uncertainty_score":0.56967735},"labels":[],"label_agreement":null},{"id":"W2325178024","doi":"10.1158/1538-7445.am2012-1853","title":"Abstract 1853: Identification and characterization of genes in regions of recurrent genomic gain as putative therapeutic targets in pancreatic ductal adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Gene; Biology; Pancreatic cancer; Candidate gene; Cancer; Copy-number variation; Computational biology; SNP array; Genome; Human genome; Cancer research; Genetics; Bioinformatics; Single-nucleotide polymorphism; Genotype","score_opus":0.04879879933680131,"score_gpt":0.3598498728694744,"score_spread":0.3110510735326731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325178024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97853637,0.020808885,0.00005611195,0.000097206525,0.0000730481,0.00032189602,0.00006919465,0.000001011211,0.000036300236],"genre_scores_gemma":[0.9874472,0.012153333,0.000018580675,0.000011894981,0.00008881554,0.00009815376,0.00013839883,0.000013546142,0.000030093772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908847,0.000093365634,0.00026751112,0.0001935674,0.00012749633,0.00022962048],"domain_scores_gemma":[0.9995098,0.000047140893,0.000105337334,0.00016703387,0.000117486445,0.000053216383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004836239,0.00007676946,0.00013776106,0.00015780123,0.000026139156,0.000009874706,0.00009828873,0.0000713889,0.0000149217385],"category_scores_gemma":[0.00007268941,0.000080648344,0.000024027553,0.00017048624,0.00013448829,0.000009849573,0.00006502105,0.00009914436,0.0000016515764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001292668,0.000079099715,0.1199808,0.00006989328,0.000017032355,8.108383e-7,0.0007485154,0.000020378757,0.87612575,0.00020662982,0.000009547645,0.0026122956],"study_design_scores_gemma":[0.00026635051,0.00007757359,0.66844,0.0000347355,0.0000057442494,0.0000017190796,0.00023543058,0.00002624586,0.3305104,0.00018848064,0.00015047252,0.00006285704],"about_ca_topic_score_codex":0.0004479471,"about_ca_topic_score_gemma":0.0002031749,"teacher_disagreement_score":0.5484592,"about_ca_system_score_codex":0.00007750177,"about_ca_system_score_gemma":0.00018145113,"threshold_uncertainty_score":0.3288744},"labels":[],"label_agreement":null},{"id":"W2325263157","doi":"10.1158/0008-5472.sabcs-09-2046","title":"Outcome of Invasive Lobular Carcinoma Compared to Infiltrating Ductal Carcinoma: A Population Based Study from British Columbia.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Invasive lobular carcinoma; Lobular carcinoma; Breast cancer; Cohort; Ductal carcinoma; Population; Carcinoma; Oncology; Cancer; Internal medicine; Cancer registry; Retrospective cohort study; Invasive ductal carcinoma","score_opus":0.058357295565276975,"score_gpt":0.3614069462086491,"score_spread":0.30304965064337214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325263157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976637,0.0007196673,0.0000151180675,0.00025787746,0.00008409232,0.00085628306,0.00030595454,0.000011370553,0.00008593561],"genre_scores_gemma":[0.9988564,0.0000066345765,0.00020856394,0.0001664572,0.00024595705,0.00019820672,0.0002114601,0.000021443066,0.000084871004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980553,0.00019634588,0.000335248,0.00055054645,0.00047465457,0.0003879329],"domain_scores_gemma":[0.9988983,0.000053375457,0.00007433836,0.0004260114,0.00041739002,0.00013058465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023584368,0.00013344563,0.00031700011,0.00006538338,0.00021764466,0.000092230126,0.00025921882,0.00007645355,0.0000749918],"category_scores_gemma":[0.00020113421,0.0001873843,0.00007365284,0.00031779782,0.000057091816,0.0000075086496,0.00013395722,0.0001466885,0.0000032258074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014434087,0.00024524954,0.9485427,0.000016800506,0.000060402548,0.00003566839,0.00023508642,0.00010641634,0.04853522,5.396513e-7,0.0013938365,0.0006837403],"study_design_scores_gemma":[0.0016037325,0.000538079,0.98456335,0.000035150177,0.000027970727,0.000002531453,0.0006302559,0.000008580943,0.012339728,0.000024289164,0.000058540983,0.00016776152],"about_ca_topic_score_codex":0.24698175,"about_ca_topic_score_gemma":0.20878378,"teacher_disagreement_score":0.038197983,"about_ca_system_score_codex":0.0002105848,"about_ca_system_score_gemma":0.00022994289,"threshold_uncertainty_score":0.80565387},"labels":[],"label_agreement":null},{"id":"W2325289331","doi":"10.1158/1538-7445.am2012-lb-293","title":"Abstract LB-293: High-throughput proteomic analysis identifies protein s as a modulator of high grade and castrate-resistant prostate cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"DU145; LNCaP; Prostate cancer; Prostate; Cancer research; Androgen; Cancer; Androgen deprivation therapy; Internal medicine; Medicine; Oncology; Biology; Hormone","score_opus":0.04305049356946446,"score_gpt":0.38898561716855434,"score_spread":0.3459351235990899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325289331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557215,0.0016159489,0.00017001935,0.0005070779,0.000020351954,0.001268626,0.0005664125,0.0000788915,0.00020051749],"genre_scores_gemma":[0.98787916,0.00074702443,0.0027243393,0.000008445045,0.00017441783,0.0063007134,0.00004239667,0.000054458967,0.0020690388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753386,0.00004350977,0.0004735729,0.00055757904,0.00061845087,0.0007730412],"domain_scores_gemma":[0.99842334,0.000052886604,0.00024542902,0.0006791386,0.00034827495,0.00025095805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051835045,0.00024457026,0.0004285228,0.00022487596,0.0002824028,0.000088172834,0.0003539055,0.00016914462,0.0009975213],"category_scores_gemma":[0.00004625351,0.00022582481,0.000104646,0.00084272405,0.00043136498,0.0003130616,0.00020419732,0.0005953481,0.00001035689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001812174,0.00012436455,0.0024729476,0.0005314281,0.0002682484,0.0000036793488,0.0002947676,0.00014942473,0.9921729,0.002675598,0.00013501919,0.0009904354],"study_design_scores_gemma":[0.00036815857,0.000027970073,0.0060304683,0.00017918088,0.00009162751,0.000001395848,0.00015831663,0.000034148718,0.98499256,0.007324455,0.00054264616,0.0002490736],"about_ca_topic_score_codex":0.023692418,"about_ca_topic_score_gemma":0.000613184,"teacher_disagreement_score":0.023079235,"about_ca_system_score_codex":0.00035060607,"about_ca_system_score_gemma":0.00028209898,"threshold_uncertainty_score":0.9999157},"labels":[],"label_agreement":null},{"id":"W2325389636","doi":"10.1158/1538-7445.am2012-2999","title":"Abstract 2999: Gene expression signature of differential response to chemotherapy in sporadic pediatric osteosarcoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Osteosarcoma; Cancer research; Chemotherapy; Cancer; Malignancy; Pathology; Bone cancer; Gene expression; Medicine; Gene; Biology; Oncology; Internal medicine","score_opus":0.026036551403902652,"score_gpt":0.3787507307203466,"score_spread":0.35271417931644394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325389636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589384,0.0025933282,0.0005248987,0.00039433356,0.00004124977,0.0004313756,0.000042539483,0.000007890021,0.0000705541],"genre_scores_gemma":[0.99761134,0.0007005568,0.00075308414,0.00008727854,0.0003328559,0.00025707905,0.00004734719,0.000022599339,0.00018783967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881357,0.00014672092,0.00018436882,0.0002740026,0.00019167329,0.0003896919],"domain_scores_gemma":[0.9992947,0.00002567207,0.000045778957,0.00039864608,0.000097737975,0.00013744997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065619993,0.00010489943,0.00012665492,0.00016848031,0.00005021486,0.000006703592,0.00028851975,0.00023420258,0.00012595109],"category_scores_gemma":[0.000059324662,0.00009337926,0.00005463084,0.0002935637,0.00006737141,0.0000030997571,0.00013671833,0.00024232564,0.0000056526246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008330034,0.00012525833,0.01020761,0.000018255398,0.000006677834,9.593177e-7,0.00006317826,0.0000051608768,0.98556924,0.000018757122,0.0020036276,0.0011483007],"study_design_scores_gemma":[0.00033271877,0.00013113173,0.0756054,0.000012354242,0.0000026989073,0.0000013689006,0.000016118296,9.349409e-7,0.9112941,0.000022160924,0.012485812,0.00009517744],"about_ca_topic_score_codex":0.000043859836,"about_ca_topic_score_gemma":0.000006509546,"teacher_disagreement_score":0.074275084,"about_ca_system_score_codex":0.000026822432,"about_ca_system_score_gemma":0.000105595595,"threshold_uncertainty_score":0.38078958},"labels":[],"label_agreement":null},{"id":"W2325404207","doi":"10.1158/1538-7445.am2013-1070","title":"Abstract 1070: New potent inhibitors of the androgen receptor that target its BF3 surface binding site.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transactivation; Androgen receptor; Bicalutamide; Prostate cancer; LNCaP; Antiandrogens; Chemistry; Cancer research; Binding site; In silico; Dihydrotestosterone; Pharmacology; Cancer; Androgen; Biochemistry; Biology; Internal medicine; Medicine; Transcription factor; Hormone","score_opus":0.10403281234376517,"score_gpt":0.38424054420310266,"score_spread":0.2802077318593375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325404207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974904,0.010142254,8.6849855e-7,0.0105823185,0.0003269102,0.0018101457,0.00008702992,0.000029515808,0.0021169845],"genre_scores_gemma":[0.9639544,0.003260387,0.000086973574,0.00005545147,0.00035754195,0.00011844461,0.000037235863,0.000048146605,0.032081425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968391,0.00013265655,0.00027352342,0.00040757185,0.0015033209,0.0008438103],"domain_scores_gemma":[0.9982286,0.00015541147,0.000084748,0.0005081747,0.0005657109,0.00045735814],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00071435195,0.00018708808,0.00031709694,0.00018369066,0.00025518608,0.00007130053,0.0003423866,0.00014467558,0.0053127157],"category_scores_gemma":[0.00013595005,0.00011194927,0.0001573636,0.00085487287,0.0002783101,0.00020405636,0.0002629426,0.0007531807,0.0008383333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033032152,0.00014470887,0.10097462,0.0003439574,0.0001783005,0.000016495876,0.00088986056,0.000040221163,0.70677894,0.000011137662,0.18338744,0.006904],"study_design_scores_gemma":[0.0018678622,0.00020259555,0.03298532,0.00061450247,0.000019153904,0.000004676164,0.0004653482,0.000030045638,0.9312486,0.0000611096,0.032353826,0.00014698131],"about_ca_topic_score_codex":0.0029972438,"about_ca_topic_score_gemma":0.00004316275,"teacher_disagreement_score":0.22446965,"about_ca_system_score_codex":0.0006396404,"about_ca_system_score_gemma":0.0013714624,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W2325469591","doi":"10.1158/1538-7445.am2012-1295","title":"Abstract 1295: Regulation of PAX2 activity by estradiol in breast cancer cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Breast cancer; Cancer research; Estrogen receptor; Biology; Cancer; Oncogene; Estrogen; Progesterone receptor; Transcription factor; Estrogen receptor alpha; Cancer cell; Internal medicine; Endocrinology; Medicine; Cell cycle; Gene; Biochemistry","score_opus":0.047296920987505854,"score_gpt":0.38304623950136363,"score_spread":0.33574931851385775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325469591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524224,0.003127248,0.00004033799,0.0004128357,0.000106555664,0.00019627255,0.00021773901,0.0000032349726,0.0006535412],"genre_scores_gemma":[0.9961782,0.0026994227,0.000017003158,0.00001854103,0.00027649396,0.00019761454,0.000025519152,0.000016903448,0.00057032047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989403,0.00007708371,0.00014352577,0.00022429004,0.00024453155,0.00037029007],"domain_scores_gemma":[0.9993837,0.000015148404,0.000059205482,0.00029970595,0.00014427633,0.00009798731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047218456,0.00008622064,0.00010831083,0.00006626467,0.000053339387,0.000012088492,0.00016409336,0.00012202267,0.00032726768],"category_scores_gemma":[0.000009179754,0.00008249525,0.000039386607,0.00021297419,0.00012547184,0.000014952689,0.000041852356,0.00017566948,0.0000059814247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010190411,0.000108423636,0.018618643,0.000035785804,0.000014735236,1.13016625e-7,0.000045561887,0.00009938301,0.9561508,0.000021432134,0.009645558,0.0151576325],"study_design_scores_gemma":[0.00020448372,0.000013578608,0.3010924,0.000023141927,0.0000023617,6.941654e-7,0.000027820066,0.000014089421,0.69163,0.00000972778,0.006905816,0.00007589408],"about_ca_topic_score_codex":0.0021293967,"about_ca_topic_score_gemma":0.00015210906,"teacher_disagreement_score":0.28247374,"about_ca_system_score_codex":0.00011984742,"about_ca_system_score_gemma":0.00021475858,"threshold_uncertainty_score":0.35833517},"labels":[],"label_agreement":null},{"id":"W2325505501","doi":"10.1158/1538-7445.am10-40","title":"Abstract 40: Developmental profile and regulation of the glycolytic enzyme hexokinase 2 and its association with aerobic glycolysis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Anaerobic glycolysis; Glycolysis; Hexokinase; Biology; Carbohydrate metabolism; Internal medicine; Biochemistry; Endocrinology; Enzyme; Medicine","score_opus":0.0174804193311265,"score_gpt":0.29825912895773077,"score_spread":0.2807787096266043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325505501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745035,0.0014456096,0.0000018604039,0.00018509194,0.00016146767,0.00034407058,0.000024359877,0.0000031009893,0.00038408063],"genre_scores_gemma":[0.99670595,0.0005399329,0.00007853326,0.000024430869,0.00031955465,0.00009537846,0.000013918278,0.000012282811,0.0022100222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991185,0.000043244887,0.00011175851,0.00022759388,0.00029362843,0.0002052703],"domain_scores_gemma":[0.9994651,0.00002342376,0.00007475414,0.0001395734,0.00023437178,0.0000627405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042952897,0.000077694014,0.00009837335,0.00004256017,0.00014079224,0.000027356238,0.00009656571,0.000113737704,0.00006961098],"category_scores_gemma":[0.00012062746,0.000056804387,0.000021481257,0.00015275984,0.000086796,0.000008822823,0.00009240854,0.00019820833,0.0000013494265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014793071,0.000016587665,0.005118183,0.00003829287,0.00003511502,1.42423e-7,0.00007657081,0.0000035235103,0.9909883,0.00004773782,0.0010930374,0.0024345394],"study_design_scores_gemma":[0.00053269183,0.000043053384,0.19868237,0.000021823244,0.000013928334,0.0000051224556,0.000047472276,0.000013459391,0.77918345,0.000016681337,0.02136342,0.000076513425],"about_ca_topic_score_codex":0.00015355441,"about_ca_topic_score_gemma":0.00086632767,"teacher_disagreement_score":0.21180487,"about_ca_system_score_codex":0.000043035103,"about_ca_system_score_gemma":0.00037224498,"threshold_uncertainty_score":0.23164156},"labels":[],"label_agreement":null},{"id":"W2325513691","doi":"10.1158/0008-5472.sabcs11-p5-12-03","title":"P5-12-03: An Innovative Quantification Method for Tamoxifen and Three Metabolites in Formalin-Fixed Paraffin-Embedded Tissues by Liquid Chromatography and Tandem Mass Spectrometry.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tamoxifen; Breast cancer; Chemistry; Liquid chromatography–mass spectrometry; Desmethyl; Chromatography; Tandem mass spectrometry; Estrogen receptor; Pharmacology; Cancer; Mass spectrometry; Medicine; Metabolite; Internal medicine; Biochemistry","score_opus":0.05615189304754959,"score_gpt":0.38634861978520035,"score_spread":0.33019672673765077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325513691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765126,0.016040139,0.006252584,0.000102655074,0.000041672924,0.00076082937,0.000048139536,0.000014821666,0.00022656069],"genre_scores_gemma":[0.97874284,0.0029510807,0.017565446,0.00003249589,0.000081554484,0.00037928417,0.00014294083,0.000033283253,0.00007108182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842787,0.00022505225,0.00022785015,0.0005019282,0.00017571267,0.0004416186],"domain_scores_gemma":[0.9992484,0.00006185659,0.00007246124,0.00026208718,0.00022837818,0.00012684734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238364,0.00016791948,0.00023640106,0.00025891565,0.00013332773,0.00004594455,0.00017812688,0.00024288095,0.00001297256],"category_scores_gemma":[0.00009509373,0.00014578739,0.000035962887,0.00055484637,0.00022058473,0.000023965129,0.00007689778,0.00023643405,0.0000011369752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006101846,0.000068367386,0.0038821453,0.00004853988,0.0001098899,0.0000017859498,0.0005142714,6.4564756e-7,0.99133056,0.001145659,0.00025725662,0.002030664],"study_design_scores_gemma":[0.000927406,0.0012359822,0.0031858901,0.00002301483,0.00001707972,0.0000044377853,0.00015607268,0.00016171897,0.9917972,0.00099149,0.0013100277,0.00018965939],"about_ca_topic_score_codex":0.00020538532,"about_ca_topic_score_gemma":0.00008342439,"teacher_disagreement_score":0.013089058,"about_ca_system_score_codex":0.000018259925,"about_ca_system_score_gemma":0.000085663756,"threshold_uncertainty_score":0.59450376},"labels":[],"label_agreement":null},{"id":"W2325563775","doi":"10.1158/1538-7445.am2011-3536","title":"Abstract 3536: Caulobacter crescentus as new intravesical treatment for bladder cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Caulobacter crescentus; Bladder cancer; In vivo; Microbiology; Bioluminescence imaging; Biology; Cancer research; Cell culture; Cancer; Medicine; Internal medicine; Luciferase; Cell cycle; Biotechnology","score_opus":0.14935544667496986,"score_gpt":0.4455246096128715,"score_spread":0.29616916293790163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325563775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98614365,0.005802407,0.000057257526,0.0008637963,0.0002597785,0.001405806,0.000310143,0.000021225489,0.0051359623],"genre_scores_gemma":[0.9753744,0.0065338095,0.00017492558,0.00019914348,0.0013815166,0.0017311466,0.00014197522,0.000069762165,0.014393324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997676,0.00005955643,0.00019981142,0.00065474445,0.00040869522,0.0010011976],"domain_scores_gemma":[0.99842775,0.000030125884,0.000040724797,0.0004949706,0.00027968996,0.00072673924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001917896,0.00023716815,0.00020656815,0.000104880106,0.00020112008,0.000064335945,0.00032586453,0.00017535087,0.0026497592],"category_scores_gemma":[0.0000949696,0.00019162262,0.00016770202,0.00015851637,0.00019335453,0.00001081927,0.00012033565,0.00018942452,0.0001144266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073753223,0.0011263143,0.0086516095,0.00010785717,0.0017363812,0.000102687416,0.00090351974,0.000008760808,0.5251721,0.00036044302,0.2216068,0.23284818],"study_design_scores_gemma":[0.003139664,0.0017511029,0.007877478,0.00004272136,0.0000358893,0.000006449287,0.0000815693,0.000003258108,0.6709955,0.0004821449,0.31531268,0.00027158283],"about_ca_topic_score_codex":0.028929934,"about_ca_topic_score_gemma":0.009331223,"teacher_disagreement_score":0.2325766,"about_ca_system_score_codex":0.00039737724,"about_ca_system_score_gemma":0.0022019804,"threshold_uncertainty_score":0.9982619},"labels":[],"label_agreement":null},{"id":"W2325598043","doi":"10.1158/1538-7445.am2011-1875","title":"Abstract 1875: Lung cancer risk among hairdressers in SYNERGY – pooled analysis from case-control studies in Europe and Canada with detailed smoking data","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Odds ratio; International agency; Demography; Confidence interval; Population; Cohort; Cancer registry; Logistic regression; Cancer; Cohort study; Tobacco control; Environmental health; Internal medicine; Public health; Pathology","score_opus":0.08873832529331468,"score_gpt":0.38631010322978815,"score_spread":0.2975717779364735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325598043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95421255,0.044508614,0.000009545039,0.00010593705,0.000095891824,0.0005831346,0.00037187318,0.000013456726,0.00009902115],"genre_scores_gemma":[0.9822434,0.017340496,0.000021297728,0.000047344205,0.000089881345,0.00016224963,0.000030737156,0.00003460171,0.000029946557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693805,0.0004874365,0.00038152369,0.0007218115,0.00075127,0.000719926],"domain_scores_gemma":[0.9978304,0.00046714308,0.00009962534,0.00086226675,0.00038700184,0.0003535767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018228453,0.00020284351,0.0007991,0.0005782928,0.00016744663,0.000023410154,0.00021360363,0.000088102315,0.00014740316],"category_scores_gemma":[0.00070454535,0.00014815437,0.000051306764,0.0016323156,0.0002501577,0.00015220905,0.00012572536,0.0009302186,3.2358122e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005626736,0.000026482567,0.98241603,0.00018917391,0.004967561,0.007821078,0.0011279696,0.0006639275,0.00002134224,0.0000014416676,0.00021913747,0.0019832023],"study_design_scores_gemma":[0.00288599,0.000027901662,0.99106807,0.0004397548,0.0017417935,0.000014866222,0.0024685098,0.00085874065,0.00011885876,0.0000018775274,0.00020469238,0.00016896988],"about_ca_topic_score_codex":0.9955026,"about_ca_topic_score_gemma":0.999071,"teacher_disagreement_score":0.02803092,"about_ca_system_score_codex":0.0008532698,"about_ca_system_score_gemma":0.0024797092,"threshold_uncertainty_score":0.60415596},"labels":[],"label_agreement":null},{"id":"W2325653118","doi":"10.1158/0008-5472.sabcs11-p5-19-08","title":"P5-19-08: Pooled Analysis of Individual Patient Data from Capecitabine Monotherapy Clinical Trials in Anthracycline-/Taxane-Pretreated Locally Advanced or Metastatic Breast Cancer (LA/MBC).","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Taxane; Metastatic breast cancer; Refractory (planetary science); Clinical trial; Anthracycline; Regimen; Oncology; Breast cancer; Cancer","score_opus":0.4927062928935304,"score_gpt":0.5873651864627961,"score_spread":0.09465889356926571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325653118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005396,0.0076107546,0.0000787259,0.001195101,0.00030784053,0.0019492208,0.008578294,0.000037695198,0.00018842239],"genre_scores_gemma":[0.97755224,0.018383514,0.0008388876,0.0004810668,0.00026219594,0.0007596044,0.0013343294,0.000063930325,0.00032425363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99125487,0.003644691,0.0021441248,0.001120205,0.0010923464,0.0007437548],"domain_scores_gemma":[0.9927913,0.004281795,0.00062508276,0.0012517625,0.0005542407,0.00049583457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006512677,0.0003669559,0.0025602751,0.0011755008,0.0000833492,0.000029260587,0.0007947711,0.00022710148,0.022893796],"category_scores_gemma":[0.0013343896,0.00026098115,0.0003619636,0.0029893627,0.00059984426,0.00022211317,0.00033573597,0.00085746474,0.00001824738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0868983,0.006520402,0.34093723,0.00018589575,0.033973873,0.00088370073,0.0041858573,0.00023667223,0.018942444,0.0000107041915,0.0088653285,0.49835962],"study_design_scores_gemma":[0.07299449,0.0050938176,0.8571241,0.001022974,0.025710367,0.000022726226,0.0026729624,0.0055844765,0.021983583,0.00014974392,0.006669563,0.0009712078],"about_ca_topic_score_codex":0.027851414,"about_ca_topic_score_gemma":0.020019034,"teacher_disagreement_score":0.5161869,"about_ca_system_score_codex":0.00045339603,"about_ca_system_score_gemma":0.0022068198,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W2325708367","doi":"10.1158/1538-7445.am2012-3324","title":"Abstract 3324: Cyclooxygenase-2 mediated breast cancer progression by induction of stem like cells and micro RNA","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mediprobe Research (Canada); Western University","funders":"","keywords":"Cancer research; SKBR3; Cancer; Metastasis; Small interfering RNA; Breast cancer; Downregulation and upregulation; Epithelial–mesenchymal transition; Vimentin; Transfection; Biology; Cancer cell; Medicine; Cell culture; Immunology; Internal medicine","score_opus":0.039117668746341365,"score_gpt":0.3739082872604947,"score_spread":0.3347906185141533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325708367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856305,0.012224437,8.568489e-7,0.00045855244,0.00060348696,0.00072018546,0.00016371976,0.00003011015,0.00016815249],"genre_scores_gemma":[0.9954819,0.0029962757,0.00001789799,0.000053281507,0.00077925745,0.00021479742,0.000023667439,0.000040772535,0.0003921656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979672,0.00013116836,0.0002662129,0.00026374136,0.0007317369,0.0006399362],"domain_scores_gemma":[0.9987243,0.0001288191,0.000108782355,0.00023941771,0.0003241337,0.0004745854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011293055,0.00016051374,0.00030665027,0.00019483519,0.000119009135,0.000015678479,0.000090472306,0.00019822594,0.00041024334],"category_scores_gemma":[0.00002038867,0.00012232443,0.000045108223,0.0003439025,0.00024969867,0.0001806963,0.0000649124,0.00056659087,0.00003225126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046081783,0.00014100192,0.03192787,0.000725064,0.000054051205,0.000009693843,0.0005070485,4.2894763e-7,0.90262747,0.0000019307079,0.022897964,0.04064669],"study_design_scores_gemma":[0.0013117408,0.00011681227,0.11208588,0.0006756652,0.000032183623,0.00001795666,0.00021497978,0.000009918484,0.8744444,0.0000015779717,0.010947084,0.00014179372],"about_ca_topic_score_codex":0.0006918331,"about_ca_topic_score_gemma":0.000023722554,"teacher_disagreement_score":0.08015801,"about_ca_system_score_codex":0.0002490905,"about_ca_system_score_gemma":0.00032990676,"threshold_uncertainty_score":0.49882454},"labels":[],"label_agreement":null},{"id":"W2325719154","doi":"10.1158/1538-7445.fbcr11-b32","title":"Abstract B32: Telomerase activity confers growth and DNA damage survival advantages in telomerase-negative transformed human cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomerase; Telomere; Telomerase reverse transcriptase; Biology; Carcinogenesis; Cell growth; Oncogene; Cell cycle; Cancer research; Telomerase RNA component; Cell biology; Cell; Molecular biology; Cancer; DNA; Genetics; Gene","score_opus":0.12956091230975833,"score_gpt":0.40233335387714775,"score_spread":0.27277244156738945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325719154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873493,0.00031297072,0.000006267668,0.00048036186,0.00017504256,0.0012205606,0.000120698256,0.00008126593,0.010253576],"genre_scores_gemma":[0.9968356,0.002010365,0.00010317706,0.00010608753,0.00015954186,0.00018709447,0.000018395216,0.00007473561,0.00050499884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99611866,0.00033856614,0.00046071742,0.00087613385,0.0010064206,0.0011995194],"domain_scores_gemma":[0.99789536,0.0005393931,0.000092028306,0.0004992512,0.00032096624,0.0006529962],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012687935,0.000400487,0.0007360865,0.00080896966,0.00035036262,0.00006247805,0.0003235114,0.00023418514,0.0012045393],"category_scores_gemma":[0.0002380193,0.00036004127,0.00011042376,0.0009210783,0.0011228214,0.00047659507,0.000097826065,0.0014945719,0.00003824688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016072993,0.000592423,0.05220344,0.0008339855,0.000097627424,0.0006777959,0.005848272,3.9450077e-7,0.930369,0.00022210549,0.00022859468,0.00731904],"study_design_scores_gemma":[0.002590765,0.00031377625,0.42097393,0.00025328164,0.000022373075,0.0000069625276,0.00221072,0.000005166979,0.5729153,0.00019525019,0.00021365212,0.00029877533],"about_ca_topic_score_codex":0.011164788,"about_ca_topic_score_gemma":0.0021183104,"teacher_disagreement_score":0.3687705,"about_ca_system_score_codex":0.00030726587,"about_ca_system_score_gemma":0.0006131859,"threshold_uncertainty_score":0.99988514},"labels":[],"label_agreement":null},{"id":"W2325719561","doi":"10.1158/1538-7445.am2012-2717","title":"Abstract 2717: Reolysin: A novel reovirus-based agent that induces endoplasmic reticular stress in RAS-activated pancreatic cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"KRAS; Pancreatic cancer; Cancer research; Apoptosis; Biology; Unfolded protein response; Oncogene; Tunicamycin; Endoplasmic reticulum; Cancer; Immunology; Cell biology; Cell cycle; Colorectal cancer","score_opus":0.09911899268141466,"score_gpt":0.39784408791376485,"score_spread":0.2987250952323502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325719561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698676,0.010450025,0.000018489884,0.000531522,0.00022112178,0.00096464815,0.00019158323,0.000026659487,0.00060922356],"genre_scores_gemma":[0.99439204,0.0027856561,0.000057497873,0.00022829307,0.00056938,0.0012468902,0.00014106624,0.00011114383,0.0004680621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953675,0.00048673587,0.00039713603,0.0008165543,0.0012076056,0.0017244578],"domain_scores_gemma":[0.997948,0.00014695479,0.000125057,0.0009840475,0.0003368172,0.000459112],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019387406,0.00037582978,0.00039882882,0.00044931824,0.00023616916,0.00009742739,0.00073882483,0.00036147615,0.00097343355],"category_scores_gemma":[0.00023833288,0.0003515768,0.00014769568,0.00087125896,0.00041055435,0.000032485754,0.00024155565,0.0009499241,0.000052126048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031903796,0.00041082702,0.020672414,0.00014428636,0.00015190811,0.000019249977,0.00017338771,0.0007140929,0.9694541,0.000005791302,0.001032521,0.0040310533],"study_design_scores_gemma":[0.0018744534,0.0004920516,0.010353322,0.0002614697,0.000015212285,0.0000029637667,0.0002148784,0.000050623403,0.9801538,0.000008603686,0.00617932,0.00039327727],"about_ca_topic_score_codex":0.0029044815,"about_ca_topic_score_gemma":0.0029276584,"teacher_disagreement_score":0.010699735,"about_ca_system_score_codex":0.0005838374,"about_ca_system_score_gemma":0.0012088678,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W2325724207","doi":"10.1158/1538-7445.am10-5190","title":"Abstract 5190: GnRH promotes peritoneal adhesion and dissemination of ovarian cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Mesothelium; Metastasis; Cancer research; Medicine; Endocrinology; Cancer; Internal medicine; Biology; Pathology; Peritoneum","score_opus":0.04657831388753839,"score_gpt":0.42053473651446877,"score_spread":0.37395642262693035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325724207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141073,0.0015098482,0.000001178243,0.0045228065,0.0002801394,0.0006628728,0.00008152501,0.000016919255,0.0015139761],"genre_scores_gemma":[0.9964581,0.0019481444,0.00020917656,0.000024033638,0.0003859562,0.00038326255,0.000010787959,0.000026168778,0.00055436854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985691,0.000031766096,0.00020383294,0.00034390576,0.0005320562,0.0003193415],"domain_scores_gemma":[0.99885553,0.00022633991,0.00006079797,0.00029063728,0.00035944476,0.00020723796],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045201118,0.00012116741,0.0002399034,0.00015380574,0.000117504045,0.00003536061,0.00008520846,0.00012081367,0.0019270112],"category_scores_gemma":[0.000105083374,0.00009554621,0.000048588845,0.0002462745,0.00021587244,0.000087136155,0.000054182914,0.00044908904,0.00001126467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020881374,0.00032935818,0.040057804,0.00041276083,0.00006962126,0.000028951254,0.00067286013,6.479972e-7,0.87695354,0.00024207727,0.0032970686,0.0777265],"study_design_scores_gemma":[0.0006223389,0.00021996134,0.3866243,0.00062508613,0.000039863186,0.0000045176957,0.00009785054,0.000027002836,0.60879165,0.00006079139,0.0028025613,0.00008406656],"about_ca_topic_score_codex":0.0029743423,"about_ca_topic_score_gemma":0.00073705864,"teacher_disagreement_score":0.3465665,"about_ca_system_score_codex":0.00014847085,"about_ca_system_score_gemma":0.00039079555,"threshold_uncertainty_score":0.99898535},"labels":[],"label_agreement":null},{"id":"W2325760039","doi":"10.1158/1538-7445.am2012-lb-269","title":"Abstract LB-269: A new role for the gain-of-function activity of p53 in breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Myoepithelial cell; Breast cancer; Galectin-3; Cancer research; Estrogen receptor; Biology; Cancer; Gene expression profiling; Internal medicine; Immunohistochemistry; Oncology; Gene expression; Gene; Medicine; Genetics","score_opus":0.07338308171961247,"score_gpt":0.3916061913139236,"score_spread":0.3182231095943111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325760039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976301,0.0207274,0.00006543935,0.0010950417,0.0007296091,0.00047239187,0.00014345361,0.000007935555,0.00045772918],"genre_scores_gemma":[0.99737144,0.0010265158,0.000003903944,0.000038220744,0.00021742769,0.0003140355,0.000006393159,0.000012598022,0.0010094777],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886936,0.00014547058,0.00018419378,0.00018577582,0.00006066645,0.00055450655],"domain_scores_gemma":[0.9990568,0.0004002347,0.00009566342,0.00023938439,0.00017706734,0.000030806572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008830358,0.00009591824,0.00022414734,0.000119016804,0.00011024342,0.0000040922405,0.00023329111,0.00019238607,0.001646382],"category_scores_gemma":[0.000047022466,0.000066527035,0.00007667623,0.00028392137,0.00028279456,0.00007780407,0.00007032571,0.0004401929,0.000014727231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016414355,0.00012187417,0.04261119,0.000056838715,0.00012328276,7.669826e-8,0.00045953278,0.000026998578,0.81890184,0.00028810353,0.0067956704,0.12897317],"study_design_scores_gemma":[0.0013578202,0.00016478561,0.65068346,0.00006881318,0.000025534637,0.0000053077756,0.00042051898,0.000004377524,0.3035354,0.00023770865,0.043391574,0.000104708444],"about_ca_topic_score_codex":0.023151757,"about_ca_topic_score_gemma":0.0034195564,"teacher_disagreement_score":0.6080723,"about_ca_system_score_codex":0.00015055551,"about_ca_system_score_gemma":0.00048750962,"threshold_uncertainty_score":0.99926627},"labels":[],"label_agreement":null},{"id":"W2325789207","doi":"10.1158/0008-5472.sabcs11-pd04-04","title":"PD04-04: Sexual Dysfunction in Women with Early Stage Breast Cancer on Endocrine Therapy: Encouraging Results from a Prospective Study.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Prospective cohort study; Sexual function; Cancer; Endocrine system; Gynecology; Distress; Sexual dysfunction; Internal medicine; Aromatase inhibitor; Orgasm; Oncology; Hormone; Clinical psychology","score_opus":0.07959762572107734,"score_gpt":0.3647713660859682,"score_spread":0.28517374036489085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325789207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934544,0.0004647939,0.0000052363525,0.00059965043,0.0002557731,0.0017312384,0.00035286372,0.00007031385,0.0030657426],"genre_scores_gemma":[0.9933764,0.00033130724,0.000005878856,0.00016831346,0.00051782094,0.0024485504,0.000011225041,0.00006548247,0.003075035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653816,0.0002625024,0.00029430332,0.0008699908,0.0011912159,0.00084383844],"domain_scores_gemma":[0.99841684,0.00012302586,0.00007723162,0.0006147498,0.00050011213,0.00026800987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077730505,0.00025542435,0.00040101464,0.00040318104,0.0001453129,0.000053967786,0.00021150905,0.000069437585,0.0015627038],"category_scores_gemma":[0.000034325152,0.00019135425,0.000027834312,0.0010374982,0.00016502611,0.00018419781,0.0000795677,0.0010502639,0.000025897236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100165635,0.0011733266,0.6669425,0.000058220165,0.00039767186,0.00060339924,0.15798646,0.00003075996,0.0029665714,0.00001806653,0.00027000022,0.069387436],"study_design_scores_gemma":[0.011046024,0.004059086,0.9353263,0.0002919385,0.000016207758,0.000005284744,0.045543443,0.000015495007,0.0025665555,0.000044683522,0.0008437928,0.00024122218],"about_ca_topic_score_codex":0.27173328,"about_ca_topic_score_gemma":0.086609446,"teacher_disagreement_score":0.2683838,"about_ca_system_score_codex":0.002031755,"about_ca_system_score_gemma":0.00069218926,"threshold_uncertainty_score":0.99935},"labels":[],"label_agreement":null},{"id":"W2325806172","doi":"10.1158/1538-7445.am2011-2431","title":"Abstract 2431: Inhibition of metastasis through therapeutic targeting of focal adhesion kinase (FAK) in pancreatic cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Focal adhesion; Cancer research; Pancreatic cancer; PTK2; Metastasis; Angiogenesis; Cancer; Cell migration; Medicine; Integrin; Signal transduction; Kinase; Biology; Pathology; Cell; Cell biology; Receptor; Internal medicine; Protein kinase A","score_opus":0.17839633456376447,"score_gpt":0.4275976473868944,"score_spread":0.2492013128231299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325806172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881514,0.008167368,0.000039640086,0.00028668018,0.00004792809,0.00087456586,0.00003241549,0.000015423857,0.002384585],"genre_scores_gemma":[0.9949202,0.0038765562,0.0005540501,0.000050458963,0.0000697949,0.000284083,0.000015306161,0.000048996437,0.00018056935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996485,0.00034981233,0.0006429664,0.00043704791,0.0014088313,0.00067637215],"domain_scores_gemma":[0.9981843,0.00031140062,0.00014383369,0.00044925144,0.00074114307,0.00017006611],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016977814,0.00017675871,0.0005451178,0.00040404208,0.000068044406,0.00000902337,0.00020643247,0.0001479904,0.004566803],"category_scores_gemma":[0.00035020598,0.00014721675,0.00014105925,0.0012309334,0.00044134754,0.00014503182,0.00015729398,0.000771671,0.000025839605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015947907,0.00049847754,0.027128214,0.001344797,0.00009314337,0.000115746145,0.0017477415,0.000013847518,0.9448334,0.00014247691,0.0005019831,0.021985365],"study_design_scores_gemma":[0.0014939824,0.0004847804,0.07961494,0.0011224472,0.000045060573,0.0000024296828,0.0009715406,0.000077915305,0.9151341,0.0005322703,0.00039790085,0.00012268593],"about_ca_topic_score_codex":0.015800767,"about_ca_topic_score_gemma":0.0005961129,"teacher_disagreement_score":0.05248672,"about_ca_system_score_codex":0.00042731946,"about_ca_system_score_gemma":0.00065827684,"threshold_uncertainty_score":0.99634314},"labels":[],"label_agreement":null},{"id":"W2325825979","doi":"10.1158/1538-7445.am10-5096","title":"Abstract 5096: Alterations in cholesterol regulation contribute to the production of intratumoral androgens in castration-resistant prostate cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Internal medicine; Endocrinology; Androgen; Castration; Androgen receptor; Cancer research; Cholesterol; Biology; Cancer; Medicine; Hormone","score_opus":0.0276629694421662,"score_gpt":0.35635328546886236,"score_spread":0.3286903160266962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325825979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933537,0.00066149776,0.000005332955,0.0027651605,0.0021450263,0.000890063,0.00011172541,0.0000032482533,0.00006421012],"genre_scores_gemma":[0.9949068,0.00041087298,0.000028160779,0.000050659302,0.0033515047,0.00066411356,0.00005205559,0.000013380759,0.00052244455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987464,0.00008720992,0.0002821941,0.00032055966,0.0002551352,0.0003085024],"domain_scores_gemma":[0.99917775,0.000015096333,0.00006113098,0.00032019868,0.00035823675,0.00006756411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008465586,0.00009368036,0.0001286608,0.0001371785,0.000089951456,0.000041983483,0.0001506953,0.00008296996,0.000042202995],"category_scores_gemma":[0.00019268216,0.000077254015,0.00002972153,0.00039014203,0.00011615446,0.000016404138,0.000041607145,0.00031953084,0.0000021184208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034462102,0.000044005134,0.0046481146,0.000026653246,0.000008940291,1.2926226e-7,0.00048386783,0.0016490852,0.9833326,0.00008781826,0.0058438075,0.00353039],"study_design_scores_gemma":[0.0006959169,0.00008915989,0.36763102,0.00009006597,0.0000056065915,0.0000025252793,0.00019962981,0.00003111398,0.5476814,0.00006427577,0.08337535,0.00013392344],"about_ca_topic_score_codex":0.0035352458,"about_ca_topic_score_gemma":0.17399457,"teacher_disagreement_score":0.43565115,"about_ca_system_score_codex":0.00006433759,"about_ca_system_score_gemma":0.00051267474,"threshold_uncertainty_score":0.84107786},"labels":[],"label_agreement":null},{"id":"W2325867938","doi":"10.1158/0008-5472.sabcs10-p6-07-01","title":"Abstract P6-07-01: CCN3 Impairs Osteoblasts and Stimulates Osteoclast Differentiation To Favor Breast Cancer Metastasis to Bone","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Ottawa Hospital","funders":"","keywords":"Osteoclast; RANKL; Bone metastasis; Cancer research; Breast cancer; Osteoblast; Medicine; Metastasis; Internal medicine; Pathology; Cancer; Oncology; Chemistry; In vitro; Activator (genetics); Receptor","score_opus":0.034755453280035785,"score_gpt":0.38228858653109693,"score_spread":0.34753313325106117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325867938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387443,0.000574424,0.000051079205,0.0034417794,0.00021996269,0.0010525,0.0006373457,0.000022746864,0.00012575784],"genre_scores_gemma":[0.9976404,0.0001756131,0.000085500105,0.00009698646,0.00055837404,0.0005767541,0.00005032865,0.00006905591,0.000747023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970125,0.00014840438,0.00026945132,0.0008924459,0.0007303701,0.0009468512],"domain_scores_gemma":[0.9977996,0.000100510704,0.000049137525,0.00059127214,0.0007289522,0.0007305462],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008154734,0.0002697231,0.00028727818,0.00037054476,0.00027618295,0.00019280522,0.00037973048,0.0001912581,0.0012338893],"category_scores_gemma":[0.00043289535,0.0002515972,0.00008137128,0.0004887154,0.00018112603,0.00002083321,0.0007002203,0.0006244797,0.00015172294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048943306,0.00006091612,0.012468394,0.00007879289,0.000090045556,0.000008030328,0.00024004918,0.000043436456,0.94589216,0.000012315104,0.002829742,0.037786692],"study_design_scores_gemma":[0.0007295373,0.00033297282,0.456142,0.0000623585,0.000014711173,0.000013493971,0.0001520386,0.000022087672,0.5347381,0.000027147255,0.0074447426,0.0003207897],"about_ca_topic_score_codex":0.0029421856,"about_ca_topic_score_gemma":0.009326614,"teacher_disagreement_score":0.4436736,"about_ca_system_score_codex":0.00014524194,"about_ca_system_score_gemma":0.00034904465,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W2325873006","doi":"10.1158/1538-7445.am2011-4696","title":"Abstract 4696: TRAF2 plays a critical role in maintaining lymphocyte homeostasis by regulating the basal activities of IKK and caspase-8","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"TRAF2; Tumor necrosis factor alpha; Cell biology; Biology; Apoptosis; Basal (medicine); Internal medicine; Endocrinology; Medicine; Biochemistry; Tumor necrosis factor receptor","score_opus":0.06647141624584162,"score_gpt":0.35819456548081186,"score_spread":0.2917231492349702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325873006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830736,0.014211868,0.000004779884,0.0003159951,0.00008605585,0.00014995971,0.00005924226,0.00001109117,0.0020874045],"genre_scores_gemma":[0.99882615,0.00052849296,0.000013827526,0.000049850103,0.000015232499,0.00007019615,0.000005095638,0.000016679838,0.00047449328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984245,0.0004968441,0.00024016463,0.00022344026,0.00007772651,0.00053738203],"domain_scores_gemma":[0.99855995,0.0010935476,0.00003958721,0.00020841739,0.00007358964,0.000024897181],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010641981,0.0001145485,0.00022194322,0.00017339217,0.0002147121,0.000019841646,0.00022299871,0.00015082673,0.0011190292],"category_scores_gemma":[0.00032530894,0.00008613745,0.0000416415,0.00014930475,0.0010384977,0.000106245,0.00013846035,0.00053379993,0.00001532336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029138804,0.000094888004,0.001167265,0.000057652018,0.000080735605,0.000013595266,0.010255805,0.0000011245924,0.957569,0.0011666064,0.001454815,0.025224604],"study_design_scores_gemma":[0.00088116794,0.00026836366,0.014549054,0.00018602911,0.0000076112883,0.000028606912,0.01772416,0.000009245185,0.9645285,0.00023870177,0.0014596602,0.00011887573],"about_ca_topic_score_codex":0.004544336,"about_ca_topic_score_gemma":0.00026824305,"teacher_disagreement_score":0.025105728,"about_ca_system_score_codex":0.00012728751,"about_ca_system_score_gemma":0.00022016601,"threshold_uncertainty_score":0.99979407},"labels":[],"label_agreement":null},{"id":"W2325916270","doi":"10.1158/1538-7445.am2012-1488","title":"Abstract 1488: Role of niche requirements in transient leukemia of Down syndrome","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Haematopoiesis; GATA1; Bone marrow; Stromal cell; Leukemia; Trisomy; Fetus; Extramedullary hematopoiesis; Stem cell; Cancer research; CD34; Myeloid leukemia; Myeloid; Biology; Pathology; Medicine; Immunology; Cell biology; Genetics; Pregnancy","score_opus":0.090553124337799,"score_gpt":0.42018626079575644,"score_spread":0.32963313645795744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325916270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851915,0.0036270437,0.0000024978415,0.00037100582,0.00006526034,0.0008440439,0.000033886394,0.000012552868,0.009852165],"genre_scores_gemma":[0.9979551,0.0007955858,0.00010538345,0.000026100677,0.00010048498,0.00017001342,0.0000135898,0.000039555383,0.0007942035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962127,0.00016259175,0.0005700437,0.0003024354,0.0016783699,0.0010738608],"domain_scores_gemma":[0.99828583,0.00021995805,0.00008398629,0.0006099299,0.00043224805,0.00036802038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027425617,0.00014949018,0.00049640617,0.0006739324,0.00004308357,0.0000071443897,0.00037537888,0.00017855714,0.0014360112],"category_scores_gemma":[0.00026458295,0.00012956608,0.00010524952,0.0011141975,0.00041197435,0.00019378186,0.00014870644,0.0010298823,0.00006983344],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010099197,0.0005201112,0.09893095,0.0010184414,0.00012972117,0.00007213518,0.0020442365,0.000028507526,0.8820254,0.00019349802,0.0026912307,0.011335817],"study_design_scores_gemma":[0.0030694627,0.000478667,0.68189627,0.00075407047,0.000023865497,0.000036200247,0.0011068663,0.00006285794,0.30651864,0.00009385941,0.005808788,0.00015046561],"about_ca_topic_score_codex":0.0037833676,"about_ca_topic_score_gemma":0.00013544176,"teacher_disagreement_score":0.5829653,"about_ca_system_score_codex":0.0022271767,"about_ca_system_score_gemma":0.0017954966,"threshold_uncertainty_score":0.9994768},"labels":[],"label_agreement":null},{"id":"W2325939998","doi":"10.1158/1538-7445.am2013-3157","title":"Abstract 3157: Loss of heterozygosity as a molecular ‘second hit’ In familial pancreatic cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Loss of heterozygosity; Copy number analysis; Pancreatic cancer; Biology; Genetics; CDKN2A; Comparative genomic hybridization; Microdissection; SNP array; Molecular Inversion Probe; Copy-number variation; Carcinogenesis; Laser capture microdissection; Locus (genetics); Allele; Molecular biology; Cancer research; Gene; Cancer; Genome; Single-nucleotide polymorphism; Genotype","score_opus":0.06847872152337109,"score_gpt":0.43778679587972996,"score_spread":0.3693080743563589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325939998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813068,0.0023699405,0.0000056010877,0.001576465,0.00007949312,0.0015388285,0.00003215076,0.000018828425,0.013071882],"genre_scores_gemma":[0.9929903,0.0015532483,0.00010917835,0.00021893789,0.00014679205,0.0011953741,0.000009826078,0.000034412147,0.0037419393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967333,0.0002553,0.0005005044,0.00047297365,0.0010870042,0.0009509099],"domain_scores_gemma":[0.99788636,0.00041076483,0.00008037216,0.00056461064,0.00065993116,0.00039797425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010911791,0.00018927999,0.00078157656,0.0004446934,0.000089708454,0.000025950527,0.00034072768,0.0002342936,0.014534502],"category_scores_gemma":[0.00043207922,0.00016175068,0.00011193247,0.00069064886,0.000727615,0.00012508959,0.0001677534,0.00089992816,0.0002763107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007186509,0.00040105646,0.660418,0.00096228597,0.00021047491,0.0004330525,0.00060893164,0.0000108758795,0.3272081,0.00014841981,0.0034289213,0.0054512415],"study_design_scores_gemma":[0.0035512445,0.0007378123,0.94081956,0.0007630171,0.000051627274,0.000027727912,0.0004033169,0.00017456195,0.051307656,0.00094191625,0.001022776,0.0001987891],"about_ca_topic_score_codex":0.036672268,"about_ca_topic_score_gemma":0.0023548307,"teacher_disagreement_score":0.28040156,"about_ca_system_score_codex":0.0007012507,"about_ca_system_score_gemma":0.0018632847,"threshold_uncertainty_score":0.98636633},"labels":[],"label_agreement":null},{"id":"W2325985016","doi":"10.1158/1538-7445.am2011-5075","title":"Abstract 5075: An integrated <i>in silico</i> and proteomic approach towards the identification of novel cancer biomarkers based on tissue specificity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate cancer; Cancer; In silico; Cancer biomarkers; Computational biology; Biology; Biomarker discovery; Human proteome project; Human Protein Atlas; Proteomics; Proteome; UniGene; Bioinformatics; Cancer research; Gene; Transcriptome; Gene expression; Genetics; Protein expression","score_opus":0.1384541497044062,"score_gpt":0.39791125999257626,"score_spread":0.2594571102881701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325985016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702615,0.00014633182,0.006042128,0.00027451164,0.000015332856,0.0010741742,0.00030707108,0.000049881502,0.0050644083],"genre_scores_gemma":[0.99211115,0.00025006064,0.004863779,0.000017188693,0.00004452577,0.0024866743,0.00004059872,0.000029217346,0.00015679376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985772,0.00003820569,0.00034400576,0.00044210276,0.00031389427,0.00028463078],"domain_scores_gemma":[0.99892473,0.00004788933,0.00013775693,0.00060265,0.0002102595,0.0000767296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084022136,0.00013649545,0.00015478987,0.00011726776,0.00012932028,0.000032733027,0.00045074415,0.00012271498,0.00024348823],"category_scores_gemma":[0.000046650537,0.0001041868,0.000027545504,0.00044124873,0.00036289162,0.0001085673,0.000054142223,0.000508866,0.0000013113802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023611914,0.00031351967,0.0005661997,0.00013052998,0.000009748736,5.7249116e-7,0.0002467355,0.00017832432,0.98120564,0.00050410157,0.00006448481,0.016544014],"study_design_scores_gemma":[0.00033455776,0.000028115628,0.0045035416,0.00009029656,0.000004290622,6.2087173e-7,0.0002775353,0.0044452893,0.9891229,0.00030910506,0.00076183473,0.00012188697],"about_ca_topic_score_codex":0.0055772597,"about_ca_topic_score_gemma":0.00018108309,"teacher_disagreement_score":0.016422128,"about_ca_system_score_codex":0.00024571648,"about_ca_system_score_gemma":0.00023205868,"threshold_uncertainty_score":0.84311855},"labels":[],"label_agreement":null},{"id":"W2326011502","doi":"10.1158/0008-5472.sabcs11-p5-17-06","title":"P5-17-06: Pilot Study of a Questionnaire To Assess Impact of a Breast Cancer Diagnosis in Young Women on Their Relationship with Their Mothers.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Daughter; CLARITY; Family medicine; Cancer; Gynecology; Clinical psychology; Internal medicine","score_opus":0.25277567447345817,"score_gpt":0.447036579323206,"score_spread":0.19426090484974784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326011502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452597,0.000081277096,0.0000045967618,0.0002978551,0.00006720904,0.0013145285,0.00016169414,0.000023096078,0.003523798],"genre_scores_gemma":[0.9960265,0.00008880471,0.000008177833,0.00001943288,0.00007067977,0.0034601656,9.80868e-7,0.00003230328,0.0002929569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680614,0.0009624606,0.0002963432,0.00036847487,0.0009157632,0.00065081584],"domain_scores_gemma":[0.99816096,0.00047715136,0.000118968324,0.00042379502,0.00059354183,0.00022560747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026441356,0.00015860479,0.0003227196,0.00047376868,0.0002523229,0.00003423967,0.00059552706,0.00006663145,0.0007627323],"category_scores_gemma":[0.00027139307,0.000112377464,0.000037401038,0.0020362695,0.00042329283,0.00023769998,0.00008731283,0.000403779,0.0000050885596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067709544,0.0010121276,0.82206184,0.000023541195,0.000063402345,0.0000037212324,0.1741959,0.00022897078,0.0000964403,0.00024809502,0.00042106968,0.0009678323],"study_design_scores_gemma":[0.0005605918,0.001827329,0.9330137,0.00040051775,0.000004392339,3.6215928e-7,0.06348355,0.0000049774385,0.00017396134,0.00038099784,0.000019659967,0.00012998175],"about_ca_topic_score_codex":0.3558531,"about_ca_topic_score_gemma":0.23765463,"teacher_disagreement_score":0.11819848,"about_ca_system_score_codex":0.0019082768,"about_ca_system_score_gemma":0.0015280414,"threshold_uncertainty_score":0.8351384},"labels":[],"label_agreement":null},{"id":"W2326016276","doi":"10.1158/1538-7445.am2013-3552","title":"Abstract 3552: Subgroup-specific pattern of recurrence in medulloblastoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; McGill University; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Cohort; Chemotherapy; Radiation therapy; Retrospective cohort study; Oncology; Surgery; Internal medicine; Primary tumor; Metastasis; Cancer; Pathology","score_opus":0.09700874969514389,"score_gpt":0.40254265694367164,"score_spread":0.30553390724852775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326016276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241966,0.0033231701,0.0000016119926,0.0017804396,0.00008985897,0.00065703585,0.00001234522,0.000010095704,0.001705797],"genre_scores_gemma":[0.9973894,0.0017670926,0.00002817007,0.000032628956,0.000084637184,0.00059235597,0.000007942584,0.000015621052,0.00008218294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984476,0.00004960473,0.00024528257,0.00027345875,0.00057581044,0.0004082413],"domain_scores_gemma":[0.9989998,0.00017120824,0.000038594484,0.00033594004,0.0002954476,0.00015903515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003410233,0.00009622709,0.00023277916,0.00029189215,0.00003191089,0.000020492518,0.00013450548,0.00006299769,0.003335599],"category_scores_gemma":[0.00004589053,0.00007520649,0.000052274325,0.00048345583,0.00014229851,0.00007594802,0.0000544493,0.0003153431,0.00038116687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010448862,0.000980803,0.5857449,0.00026722846,0.000051338324,0.00016968264,0.000651524,0.0000058806804,0.09695339,0.00009000979,0.022246314,0.2927344],"study_design_scores_gemma":[0.0013095123,0.00019819253,0.9299692,0.00057374383,0.000003991556,0.0000050136327,0.00022176738,0.000016424208,0.06399487,0.000119192475,0.0035150081,0.00007308821],"about_ca_topic_score_codex":0.0060182237,"about_ca_topic_score_gemma":0.0005178292,"teacher_disagreement_score":0.34422427,"about_ca_system_score_codex":0.00024174707,"about_ca_system_score_gemma":0.0001274655,"threshold_uncertainty_score":0.99757546},"labels":[],"label_agreement":null},{"id":"W2326043584","doi":"10.1158/1538-7445.am2012-297","title":"Abstract 297: Effect of hypoxia on the expression of the T cell co-inhibitory ligands B7-H3 and B7-H1 in cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DU145; Hypoxia (environmental); Cancer cell; Immune system; Cancer research; Gene knockdown; Prostate cancer; Cancer; Apoptosis; Transcription factor; Immunology; HIF1A; Biology; Medicine; Internal medicine; Chemistry; Angiogenesis; LNCaP; Gene; Biochemistry","score_opus":0.031354932844839305,"score_gpt":0.3585510823473695,"score_spread":0.3271961495025302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326043584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729255,0.02442826,5.3416295e-7,0.0001313406,0.0005337273,0.0004156234,0.000056914712,0.0000021436917,0.0015059906],"genre_scores_gemma":[0.99285805,0.005252534,0.000002125334,0.00005728675,0.0010323997,0.00017952207,0.00000418629,0.00002151924,0.00059236964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985464,0.00021306456,0.00019815342,0.00024089681,0.00039546174,0.00040597797],"domain_scores_gemma":[0.9991158,0.00015053064,0.00009343968,0.00045752755,0.00009194064,0.00009074062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012001939,0.00013643967,0.00020512889,0.00006354066,0.00009875956,0.000010681226,0.00029350418,0.0001499978,0.00008374277],"category_scores_gemma":[0.00010981388,0.000077158875,0.00008446875,0.00016609966,0.00032489598,0.000007183051,0.00016505146,0.00031511232,0.0000017577775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030977634,0.000056035366,0.01389807,0.00014468991,0.000011685799,1.5625403e-7,0.00021555687,0.000015927782,0.96969193,0.000010261797,0.012642567,0.0030033216],"study_design_scores_gemma":[0.0006265942,0.0001238101,0.039472017,0.0001520563,0.000008547523,5.2165063e-7,0.00008214662,0.0000010527008,0.92643124,0.000007114284,0.033014536,0.000080345555],"about_ca_topic_score_codex":0.00069670746,"about_ca_topic_score_gemma":0.00021158106,"teacher_disagreement_score":0.043260694,"about_ca_system_score_codex":0.000041034433,"about_ca_system_score_gemma":0.00016810221,"threshold_uncertainty_score":0.31464475},"labels":[],"label_agreement":null},{"id":"W2326080921","doi":"10.1158/1538-7445.am2012-3559","title":"Abstract 3559: Gene-expression changes in adipose tissue with diet- and/or exercise-induced weight loss: a randomized controlled trial","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Weight loss; Endocrinology; Internal medicine; Overweight; Adipose tissue; Obesity; Medicine","score_opus":0.06693322951767758,"score_gpt":0.40265533449056784,"score_spread":0.33572210497289023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326080921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573279,0.03199074,0.0000040599225,0.0012457392,0.00031170552,0.008378636,0.000008130749,0.000037055794,0.0006960243],"genre_scores_gemma":[0.9767878,0.012798258,0.0001491792,0.00008002289,0.0018296476,0.0048976233,0.000014028065,0.00004091013,0.00340252],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99702364,0.000406927,0.00042887518,0.0003941127,0.0008511935,0.00089522183],"domain_scores_gemma":[0.99798584,0.00079517707,0.00012296584,0.00034263273,0.00022391981,0.00052946736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031257954,0.00026054957,0.0017597075,0.0003382862,0.0001257117,0.000031592484,0.00013631278,0.00021516213,0.0010878689],"category_scores_gemma":[0.00049956463,0.00013113042,0.000092347735,0.00037762776,0.0002093671,0.00017376234,0.00008429025,0.00064462435,0.00003652461],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8297246,0.00028506937,0.00020197988,0.00011691076,0.00012824252,0.00013506551,0.0011605626,1.6850957e-7,0.15619811,0.000013773317,0.00032479444,0.0117106885],"study_design_scores_gemma":[0.8260599,0.00069471437,0.0010951003,0.00081652944,0.00025008747,0.000018604444,0.0000943265,0.0000053559456,0.16307992,0.000015736552,0.007684159,0.00018556995],"about_ca_topic_score_codex":0.0005258864,"about_ca_topic_score_gemma":0.0002898129,"teacher_disagreement_score":0.019459901,"about_ca_system_score_codex":0.000108502005,"about_ca_system_score_gemma":0.0003402482,"threshold_uncertainty_score":0.9998253},"labels":[],"label_agreement":null},{"id":"W2326098356","doi":"10.1158/1538-7445.am2011-lb-101","title":"Abstract LB-101: Y-box binding protein-1 (YB-1) inhibition triggers differentiation of normal and cancer stem cells from the brain","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Pacific Centre for Reproductive Medicine; University of British Columbia","funders":"","keywords":"Neurosphere; Nestin; Neural stem cell; Subventricular zone; Gene silencing; Cancer research; Stem cell; Biology; Cancer stem cell; Cellular differentiation; Molecular biology; Cell biology; Chemistry; Adult stem cell; Genetics","score_opus":0.055378763672849454,"score_gpt":0.3311425522988569,"score_spread":0.2757637886260075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326098356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975384,0.0012396964,0.000050486673,0.00030952104,0.00004954814,0.00048563932,0.00012544106,0.0000046809355,0.00019662455],"genre_scores_gemma":[0.9974599,0.00087192375,0.000025920846,0.000026195172,0.00017488914,0.00018674383,0.00003014066,0.000018075174,0.0012062219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986147,0.00016102532,0.0001830769,0.00029397215,0.00037504733,0.000372154],"domain_scores_gemma":[0.9993532,0.00005159522,0.000072832125,0.00024122561,0.00017602669,0.0001051224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006349685,0.00010075345,0.00011520008,0.00006915273,0.00017950947,0.000040074076,0.00018202918,0.000109173605,0.0001834979],"category_scores_gemma":[0.000038099875,0.00007405348,0.000046842193,0.00015024739,0.00022898278,0.00001332491,0.0001410145,0.0002678645,0.000005157578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027945172,0.000026973925,0.0026684797,0.00005144854,0.000045081662,0.0000020925377,0.00026171125,0.0000027563115,0.98420787,0.000022362023,0.0008786561,0.01155314],"study_design_scores_gemma":[0.0005046405,0.0001266985,0.007177613,0.000109933455,0.0000047546228,3.1695023e-7,0.00034716964,0.000016799342,0.99107754,0.00003236973,0.00051650143,0.000085680214],"about_ca_topic_score_codex":0.0041282615,"about_ca_topic_score_gemma":0.00070165185,"teacher_disagreement_score":0.01146746,"about_ca_system_score_codex":0.000051602987,"about_ca_system_score_gemma":0.00019352033,"threshold_uncertainty_score":0.62407243},"labels":[],"label_agreement":null},{"id":"W2326134291","doi":"10.1158/0008-5472.sabcs11-p4-09-26","title":"P4-09-26: Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Medicine; Tissue inhibitor of metalloproteinase; Tissue microarray; Immunohistochemistry; Oncology; Internal medicine; Hazard ratio; Stage (stratigraphy); Cancer; Clinical significance; Proportional hazards model; Matrix metalloproteinase; Pathology; Biology; Confidence interval","score_opus":0.05205147679210336,"score_gpt":0.34299414804741885,"score_spread":0.2909426712553155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326134291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397445,0.0037200614,0.00009976723,0.00011504333,0.00012943658,0.0011015896,0.00017380346,0.000009726018,0.00067614386],"genre_scores_gemma":[0.9975714,0.00056821515,0.00031500967,0.000020081257,0.00023161061,0.00090951286,0.000009977942,0.000040933555,0.0003332246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981129,0.00019409442,0.0003644716,0.00043946077,0.00041608122,0.00047298791],"domain_scores_gemma":[0.9988404,0.000018794626,0.00012210604,0.00043421824,0.000460468,0.00012401963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006715947,0.00015828612,0.00027623575,0.00015637356,0.000043719774,0.0000071645345,0.00039020667,0.00017345542,0.0003947169],"category_scores_gemma":[0.00010464467,0.00014732203,0.00006944861,0.00042040553,0.0002944766,0.000011249789,0.00020093698,0.00024452768,0.000009389635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004182647,0.00018717376,0.0024891517,0.00023014273,0.000040910752,0.000010149117,0.00013380295,0.000005367944,0.991346,0.00014123048,0.0005432467,0.004454535],"study_design_scores_gemma":[0.00050470926,0.0004870408,0.002100411,0.000221268,0.000010877956,0.0000036548188,0.000079990394,0.0000056443414,0.9951338,0.0003097622,0.0009894846,0.00015332483],"about_ca_topic_score_codex":0.0044710366,"about_ca_topic_score_gemma":0.0005225479,"teacher_disagreement_score":0.0043012104,"about_ca_system_score_codex":0.00005957603,"about_ca_system_score_gemma":0.00059678254,"threshold_uncertainty_score":0.67588997},"labels":[],"label_agreement":null},{"id":"W2326156776","doi":"10.1158/1538-7445.am2011-64","title":"Abstract 64: Development of homogeneous non-radioactive assays for studying histone 3 methyltransferases and demethylases","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal","funders":"","keywords":"Histone methyltransferase; Histone; Epigenetics; Histone H3; Methyltransferase; Histone methylation; Biology; Histone code; EZH2; Histone H2A; Biochemistry; Cancer epigenetics; Methylation; Chromatin; Molecular biology; DNA methylation; DNA; Gene expression; Gene; Nucleosome","score_opus":0.16528942038780917,"score_gpt":0.41735630851739863,"score_spread":0.25206688812958944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326156776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097193,0.010385546,0.007612442,0.000013104658,0.000060914645,0.00044607808,0.000037796366,0.0000036007912,0.00046858846],"genre_scores_gemma":[0.98930556,0.0016465854,0.00858243,0.0000066170983,0.00007895363,0.00023777378,0.00002429986,0.000023755898,0.000094031704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989021,0.000059751826,0.00022782721,0.0003218826,0.00021163089,0.00027680988],"domain_scores_gemma":[0.99920064,0.000113992646,0.000051336887,0.00018290951,0.00035912349,0.000091977294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008334186,0.00011129301,0.00015892812,0.00010373144,0.0001688286,0.000010427853,0.00013710644,0.000098414894,0.000029493633],"category_scores_gemma":[0.00013761056,0.00010624417,0.00004543951,0.0000967241,0.00014645442,0.0000042562665,0.000060899878,0.00009597607,7.3041343e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019614871,0.00008466004,0.0018741712,0.0000818641,0.00012017112,0.00000117743,0.000943932,0.00001098141,0.95479363,0.000012301094,0.000043751123,0.041837227],"study_design_scores_gemma":[0.0004028512,0.0002913872,0.018017886,0.000021622665,0.000015257874,4.2745387e-7,0.00026328056,0.00000584114,0.9783552,0.00013280654,0.0023703477,0.00012305068],"about_ca_topic_score_codex":0.0001825782,"about_ca_topic_score_gemma":0.00021045437,"teacher_disagreement_score":0.041714177,"about_ca_system_score_codex":0.000043205386,"about_ca_system_score_gemma":0.00029652216,"threshold_uncertainty_score":0.43325117},"labels":[],"label_agreement":null},{"id":"W2326222495","doi":"10.1158/1538-7445.am10-4538","title":"Abstract 4538: Inhibition of mitochondrial protein synthesis with antimicrobial tigecycline preferentially induces cell death in leukemia cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Tigecycline; Leukemia; Myeloid leukemia; Cytotoxic T cell; Daunorubicin; Clonogenic assay; Medicine; Pharmacology; Apoptosis; Biology; Cancer research; Immunology; Microbiology; Antibiotics; In vitro; Biochemistry","score_opus":0.032891086493183806,"score_gpt":0.31617779017506825,"score_spread":0.28328670368188447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326222495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983673,0.0000624997,0.00006840224,0.00006622332,0.00018371303,0.00056650676,0.00007440683,0.00000506176,0.0006058585],"genre_scores_gemma":[0.9980499,0.00019766815,0.00074020756,0.00002007323,0.00041430516,0.00020941155,0.000030721178,0.00003324782,0.0003044782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868524,0.000059885566,0.00022427046,0.00038201423,0.00028872277,0.0003598863],"domain_scores_gemma":[0.999286,0.000018052202,0.00008757437,0.0003144764,0.00021359853,0.00008029808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030699137,0.00013907734,0.00017072694,0.00013088598,0.000058568265,0.0000334243,0.000207834,0.00022920755,0.00013711529],"category_scores_gemma":[0.000018825564,0.00012201448,0.00005055177,0.0001571436,0.000121157274,0.0000073834103,0.00008689335,0.00044386057,0.000004452232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073987717,0.00011591031,0.00005940072,0.00009457711,0.00002047125,0.0000034926557,0.000045134908,0.000032970136,0.9970699,0.000038362752,0.00013680068,0.0016431343],"study_design_scores_gemma":[0.00088449917,0.00021792972,0.00036616964,0.00011350138,0.000008043735,8.075544e-7,0.000022532919,0.0000034147006,0.9961957,0.000051898598,0.0019887276,0.0001468284],"about_ca_topic_score_codex":0.0009605631,"about_ca_topic_score_gemma":0.002662004,"teacher_disagreement_score":0.0018519269,"about_ca_system_score_codex":0.000058213205,"about_ca_system_score_gemma":0.00080065755,"threshold_uncertainty_score":0.4975606},"labels":[],"label_agreement":null},{"id":"W2326230364","doi":"10.1158/1538-7445.am2011-3460","title":"Abstract 3460: Genome-wide copy number analysis reveals novel somatic mutations associated with choroid plexus tumorigenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Copy-number variation; Biology; Carcinogenesis; Context (archaeology); Single-nucleotide polymorphism; Copy number analysis; Transcriptome; Pathology; Microarray; DNA microarray; Tissue microarray; Gene; Genetics; Cancer research; Cancer; Gene expression; Medicine; Genome; Endocrinology; Central nervous system","score_opus":0.12305230544107046,"score_gpt":0.3925928490247506,"score_spread":0.2695405435836802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326230364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930834,0.00041732859,0.00003541664,0.00036481937,0.000030642666,0.00075465115,0.00013277332,0.0000539984,0.005126936],"genre_scores_gemma":[0.997353,0.00016349295,0.0004193887,0.00008922112,0.000064230575,0.00086202775,0.00018082914,0.00004579469,0.0008220072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975828,0.0000828304,0.0003456664,0.00044624522,0.00090374995,0.0006386995],"domain_scores_gemma":[0.9979607,0.00040485695,0.00012446854,0.0005091813,0.000649413,0.00035141615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063343946,0.00019684233,0.00051315664,0.00045210877,0.00026393944,0.0000494089,0.00016612631,0.00009028944,0.005309403],"category_scores_gemma":[0.00026708047,0.00014726352,0.00017021164,0.0019183374,0.00017187741,0.00009381756,0.000041607313,0.0002735534,0.00029665694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012765804,0.0012123362,0.9849094,0.000065450804,0.0033890249,0.00028576507,0.0009150246,0.000059699832,0.008163456,0.000047475132,0.0006044734,0.0002201927],"study_design_scores_gemma":[0.0017154897,0.0001593703,0.985497,0.00013874598,0.0010574263,0.0000072292532,0.0002927802,0.000025515896,0.0107278,0.00010489483,0.000119531665,0.00015424506],"about_ca_topic_score_codex":0.0035582073,"about_ca_topic_score_gemma":0.0015589589,"teacher_disagreement_score":0.005012746,"about_ca_system_score_codex":0.0007358006,"about_ca_system_score_gemma":0.00039504768,"threshold_uncertainty_score":0.99559987},"labels":[],"label_agreement":null},{"id":"W2326270405","doi":"10.1158/1538-7445.am2012-lb-517","title":"Abstract LB-517: EIF5A2, A downstream target of PI3K/Akt pathway, Is an adverse prognostic marker of melanoma patient survival by increasing cell invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Protein kinase B; Cancer research; Medicine; Tissue microarray; Metastasis; PTEN; PI3K/AKT/mTOR pathway; Immunohistochemistry; Cancer; Pathology; Oncology; Internal medicine; Biology; Signal transduction; Cell biology","score_opus":0.03944835908933938,"score_gpt":0.3089208844004857,"score_spread":0.26947252531114635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326270405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923684,0.002347251,0.000018649507,0.000024449413,0.0001759509,0.00045551677,0.0004951821,0.000007481416,0.004107146],"genre_scores_gemma":[0.99869615,0.00025162665,0.00025955486,0.000028544468,0.00018584046,0.00007735417,0.00030237596,0.000037141923,0.00016140664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976654,0.0003482001,0.00038556923,0.0003925522,0.00057413656,0.00063414336],"domain_scores_gemma":[0.9985373,0.00008333252,0.00017310196,0.0005370012,0.00036079736,0.00030843873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011139056,0.00019480246,0.00026702855,0.00010373291,0.000093010814,0.0000115583525,0.00029621794,0.00022000053,0.00037089575],"category_scores_gemma":[0.00018475954,0.00017413207,0.0001029761,0.0001889303,0.0002119933,0.000021959266,0.00024308989,0.00022790574,0.000013142008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004459892,0.00048097863,0.10834043,0.00020931261,0.000035881378,0.0000040737286,0.00034776615,0.0000030889257,0.8847197,0.000011573469,0.0022222234,0.0031789502],"study_design_scores_gemma":[0.0005863582,0.000838851,0.026177634,0.00007835791,0.000011757946,0.0000040423797,0.0004939701,0.0000071244335,0.9604671,0.00001626789,0.011128813,0.00018971006],"about_ca_topic_score_codex":0.0013255663,"about_ca_topic_score_gemma":0.000056517783,"teacher_disagreement_score":0.0821628,"about_ca_system_score_codex":0.000048529717,"about_ca_system_score_gemma":0.00036837673,"threshold_uncertainty_score":0.71009},"labels":[],"label_agreement":null},{"id":"W2326276681","doi":"10.1158/1538-7445.am2012-83","title":"Abstract 83: Differential regulation of PTEN in ERα positive and negative ovarian cancer cells during cisplatin induced apoptosis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"PTEN; Tensin; Cisplatin; Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Apoptosis; Proteasome inhibitor; Biology; Phosphatase; Chemistry; Molecular biology; Phosphorylation; Cell biology; Biochemistry; Chemotherapy","score_opus":0.04462280743708124,"score_gpt":0.36601257173332674,"score_spread":0.3213897642962455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326276681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807733,0.0008325693,0.000018457375,0.00010645336,0.00019802741,0.00032861004,0.00008598734,0.000004564193,0.00034799916],"genre_scores_gemma":[0.9987506,0.00034953555,0.000053309595,0.000014260769,0.00048017254,0.00015787398,0.000020949527,0.000029183473,0.00014409718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984477,0.00015111828,0.00024214556,0.00033981723,0.00033554027,0.00048366608],"domain_scores_gemma":[0.99926746,0.000063511965,0.000102624785,0.0002252969,0.00021621397,0.0001249138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037407328,0.00014468812,0.00019118605,0.00015040651,0.00009231492,0.000022756583,0.0001555073,0.00019742124,0.00023546859],"category_scores_gemma":[0.00006521171,0.00014382291,0.000042644926,0.00023535566,0.00015062357,0.000019417657,0.00015495058,0.0002985596,0.0000021019086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039819986,0.00004956871,0.0113133965,0.00007546769,0.00006284001,4.4942306e-7,0.00064809184,0.00007524436,0.9839828,0.00001765177,0.00009799157,0.0032783255],"study_design_scores_gemma":[0.00061001314,0.00004932187,0.28183454,0.00011394867,0.000007598268,4.283937e-7,0.00008326339,0.000016523616,0.717114,0.000024792602,0.000034901674,0.00011067192],"about_ca_topic_score_codex":0.0027829274,"about_ca_topic_score_gemma":0.0003589149,"teacher_disagreement_score":0.27052113,"about_ca_system_score_codex":0.00018324953,"about_ca_system_score_gemma":0.00017559997,"threshold_uncertainty_score":0.5864928},"labels":[],"label_agreement":null},{"id":"W2326286020","doi":"10.1158/1538-7445.am2012-4505","title":"Abstract 4505: Polymorphisms in <i>vascular endothelial growth factor</i> (<i>VEGF</i>) and associated receptors as prognostic and predictive factors in advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bevacizumab; Angiogenesis; Vascular endothelial growth factor; Medicine; Oncology; Internal medicine; Vascular endothelial growth factor A; Cancer research; Cancer; VEGF receptors; Chemotherapy","score_opus":0.02617175290195912,"score_gpt":0.3281332820886371,"score_spread":0.301961529186678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326286020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908204,0.009769287,0.000004365375,0.00006435969,0.00016667745,0.0005261573,0.00014182019,0.000009909195,0.00023538241],"genre_scores_gemma":[0.9942556,0.005024012,0.000011793633,0.000056889014,0.00019775555,0.00022718559,0.000061971965,0.000046552923,0.00011823867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781775,0.00018350228,0.00028469905,0.0005049007,0.00038459522,0.000824539],"domain_scores_gemma":[0.9992308,0.00011556933,0.00007813377,0.00018933113,0.00013583056,0.0002503542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060322694,0.0002337742,0.00029044427,0.00018673074,0.00010656573,0.000035450244,0.00016749691,0.00023776115,0.00007031207],"category_scores_gemma":[0.0005690537,0.00021243794,0.000066019056,0.00030422967,0.00025987093,0.000032123695,0.00017280281,0.0003392254,0.0000033159235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016595202,0.00010564949,0.6776357,0.000028670718,0.000050983348,0.0000058460555,0.00055557373,0.000010276743,0.32030088,0.000012638052,0.00011867202,0.0010091378],"study_design_scores_gemma":[0.0010326502,0.0002691355,0.78734016,0.00013675542,0.000008583776,0.000002492361,0.0004098127,0.0000053096664,0.2093298,0.00004901787,0.0011498741,0.0002664231],"about_ca_topic_score_codex":0.0010362774,"about_ca_topic_score_gemma":0.00042883612,"teacher_disagreement_score":0.110971086,"about_ca_system_score_codex":0.00017461395,"about_ca_system_score_gemma":0.00022477622,"threshold_uncertainty_score":0.86629677},"labels":[],"label_agreement":null},{"id":"W2326312986","doi":"10.1158/1538-7445.am10-1346","title":"Abstract 1346: Neutrophils facilitate metastasis by increasing cancer cell recruitment to liver sinusoids","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Umbilical vein; Metastasis; Lipopolysaccharide; Inflammation; In vivo; Medicine; Cancer; Cancer cell; Intravital microscopy; Pathology; Immunology; Cell adhesion; In vitro; Andrology; Cell; Cancer research; Chemistry; Biology; Internal medicine; Microcirculation","score_opus":0.14223266151736472,"score_gpt":0.39560718962112434,"score_spread":0.2533745281037596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326312986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393913,0.048713833,0.000011642548,0.001244625,0.002522495,0.0014214574,0.00068938447,0.00008549181,0.005919772],"genre_scores_gemma":[0.9772305,0.005350428,0.00015363592,0.00041078476,0.00017857013,0.0017778429,0.00007109258,0.00007644776,0.014750688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963802,0.0005565069,0.00045231753,0.0008690299,0.00027005916,0.0014718988],"domain_scores_gemma":[0.99780303,0.00053968735,0.0000985423,0.0008914747,0.0005030837,0.00016418142],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019081957,0.00035474947,0.0004493051,0.00022055162,0.0005658673,0.00008856166,0.0009000735,0.00039018792,0.021386446],"category_scores_gemma":[0.00014334526,0.00032798614,0.00014331893,0.00047708038,0.00058750674,0.00022615606,0.00044591312,0.0019619926,0.0023524135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045384417,0.00013279718,0.00019759884,0.000077391676,0.00014887426,0.000013545086,0.0010511832,0.000019445506,0.8656028,0.000034379813,0.08820538,0.044062775],"study_design_scores_gemma":[0.0006055028,0.00010028742,0.0016390667,0.000046381865,0.000022740038,0.000005449053,0.00016854644,5.991921e-7,0.53002167,0.000020854994,0.4671255,0.00024340379],"about_ca_topic_score_codex":0.039633516,"about_ca_topic_score_gemma":0.0032786173,"teacher_disagreement_score":0.3789201,"about_ca_system_score_codex":0.00085199217,"about_ca_system_score_gemma":0.0005948836,"threshold_uncertainty_score":0.9999172},"labels":[],"label_agreement":null},{"id":"W2326316618","doi":"10.1158/1538-7445.am2012-2492","title":"Abstract 2492: Integrated genomics on molecular subgroups in medulloblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Oncology; Biology; Sonic hedgehog; Medicine; Internal medicine; Bioinformatics; Cancer research; Genetics; Gene","score_opus":0.037188617034654536,"score_gpt":0.36841039773316686,"score_spread":0.3312217806985123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326316618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038106,0.00405716,0.0006945703,0.0003774326,0.00029547373,0.0006588433,0.000046104273,0.00002106124,0.0034682911],"genre_scores_gemma":[0.9970367,0.0010605456,0.0001370767,0.00024070672,0.00038299416,0.00037895257,0.00010037132,0.00010030013,0.0005623435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965169,0.0003127873,0.00030603356,0.0006203539,0.00082196324,0.0014219644],"domain_scores_gemma":[0.9984637,0.00004624152,0.000050562176,0.00073840126,0.0002986485,0.00040246345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001624404,0.0002591416,0.00022436096,0.00044323222,0.000118929864,0.00006239538,0.00059873523,0.00038872767,0.00038699977],"category_scores_gemma":[0.00031261728,0.00026140586,0.00011668992,0.0007469757,0.00020625195,0.000011753127,0.000311537,0.0010907695,0.00019984249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004227569,0.00018838166,0.00022734288,0.000032859243,0.0000579825,0.000038152313,0.00009496602,0.00056173786,0.98772615,0.0005102272,0.0025534416,0.0075859763],"study_design_scores_gemma":[0.0007968849,0.0002903537,0.0013386226,0.00007531131,0.0000042980487,0.000009973017,0.00017288474,0.0000481709,0.9252837,0.00009201189,0.07160573,0.0002821218],"about_ca_topic_score_codex":0.0005944152,"about_ca_topic_score_gemma":0.00041139848,"teacher_disagreement_score":0.06905229,"about_ca_system_score_codex":0.000632722,"about_ca_system_score_gemma":0.0006623146,"threshold_uncertainty_score":0.9999838},"labels":[],"label_agreement":null},{"id":"W2326347011","doi":"10.1158/1538-7445.am2011-1877","title":"Abstract 1877: Lung cancer risk in painters: Results from the SYNERGY pooled analysis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"International agency; Lung cancer; Asbestos; Medicine; Odds ratio; Carcinogen; Cancer; Environmental health; Logistic regression; Mesothelioma; Internal medicine; Demography; Pathology; Biology","score_opus":0.06429581318220559,"score_gpt":0.3803663247194418,"score_spread":0.3160705115372362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326347011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912754,0.0037414993,0.000005144554,0.0011280514,0.000058249258,0.00024547204,0.0008324334,0.000014819955,0.0026988995],"genre_scores_gemma":[0.9962368,0.0022327304,0.000022945442,0.00022325397,0.00021009134,0.00018112309,0.000136088,0.000014176063,0.0007428115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983533,0.00015270506,0.00024287464,0.0003497331,0.00057093863,0.000330463],"domain_scores_gemma":[0.9989866,0.00035658272,0.000057066896,0.00038631872,0.000059280123,0.00015415669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058538385,0.000102780505,0.00019139826,0.00016919369,0.00010805322,0.000018198914,0.00019966929,0.000056293444,0.0041641854],"category_scores_gemma":[0.0002122662,0.000066337605,0.00012389409,0.000650268,0.00018792652,0.000067935114,0.00008402276,0.00039415888,0.000050297265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026365859,0.00020385257,0.98034537,0.000019976485,0.0011033824,0.00006470133,0.0011464875,0.00030391704,0.00094379473,0.000015586485,0.0064959875,0.0067203646],"study_design_scores_gemma":[0.0008971602,0.000035280114,0.99548525,0.00014483568,0.0004354105,1.6034984e-7,0.00046644325,0.0005600023,0.0008801495,0.00009539077,0.0009225927,0.0000773204],"about_ca_topic_score_codex":0.14657529,"about_ca_topic_score_gemma":0.013716684,"teacher_disagreement_score":0.1328586,"about_ca_system_score_codex":0.00042486307,"about_ca_system_score_gemma":0.00015764788,"threshold_uncertainty_score":0.9967461},"labels":[],"label_agreement":null},{"id":"W2326407947","doi":"10.1158/0008-5472.sabcs12-p2-07-01","title":"Abstract P2-07-01: BRCA1 regulates RHAMM function in breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transfection; Cancer research; Biology; Molecular biology; Cell culture; Cell biology; Genetics","score_opus":0.04600575787871723,"score_gpt":0.3864252156584965,"score_spread":0.3404194577797793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326407947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512465,0.011068134,0.0000036520792,0.0007464895,0.0002726101,0.00039486453,0.000067253,0.000014505719,0.002307819],"genre_scores_gemma":[0.9931126,0.0015959922,0.000008459132,0.000075119104,0.0011722216,0.00037623575,0.00003815029,0.00004675484,0.0035744533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99744767,0.00017747402,0.00020757872,0.00044319645,0.0005992478,0.0011248157],"domain_scores_gemma":[0.9988486,0.000054311102,0.000027821663,0.00047120993,0.00029678558,0.00030124342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011714572,0.00016095069,0.00015907738,0.00021543678,0.0001505661,0.0000593458,0.00027693954,0.0002205201,0.0025721],"category_scores_gemma":[0.000078823476,0.00015297867,0.00007643988,0.0004702546,0.00020712054,0.000025267864,0.00028410793,0.00053754076,0.00028491413],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006066613,0.00013050437,0.087495066,0.00011109431,0.000052826614,0.0000066283933,0.0000782768,0.000028061024,0.85284317,0.00003222846,0.014423215,0.04419225],"study_design_scores_gemma":[0.000777251,0.00012176673,0.72736573,0.0000941417,0.0000069577027,0.000020632586,0.00013430096,0.000022912474,0.19791462,0.00007353726,0.07317563,0.00029254603],"about_ca_topic_score_codex":0.0025911187,"about_ca_topic_score_gemma":0.0021278535,"teacher_disagreement_score":0.65492857,"about_ca_system_score_codex":0.00025386567,"about_ca_system_score_gemma":0.00042728992,"threshold_uncertainty_score":0.9983397},"labels":[],"label_agreement":null},{"id":"W2326476055","doi":"10.1158/1538-7445.am10-4350","title":"Abstract 4350: Clonal selection and parallel evolution during leptomeningeal dissemination of human and mouse medulloblastoma result in bicompartmental disease","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Primary tumor; Metastasis; Somatic evolution in cancer; Cancer research; Biology; Cancer; Pathology; Medicine; Genetics","score_opus":0.015576494537321928,"score_gpt":0.35620338331927653,"score_spread":0.34062688878195463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326476055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990663,0.0005181259,0.000005520472,0.00008403324,0.000038132235,0.0001747145,0.00006326191,0.0000031873337,0.00004672543],"genre_scores_gemma":[0.9992339,0.00035597512,0.00004385229,0.0000028300938,0.00014319066,0.000064825836,0.000052316023,0.000010968323,0.00009215027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99923676,0.000024723902,0.00014162833,0.00024608665,0.00015915972,0.0001916318],"domain_scores_gemma":[0.99963313,0.000027309226,0.00004041795,0.00009923053,0.000089710724,0.00011021225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023145103,0.00007219354,0.0000777551,0.00011121576,0.00010826279,0.000024605246,0.000058725764,0.00006674401,0.000015714333],"category_scores_gemma":[0.00009288229,0.00007696897,0.000016365619,0.000088345325,0.000138025,0.00000772582,0.00008453746,0.00018087323,3.608123e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032597658,0.000055095094,0.084378235,0.00004750076,0.000008021944,0.0000014165225,0.000058462927,0.000053951786,0.9144003,0.00016835856,0.00013153013,0.00037118178],"study_design_scores_gemma":[0.0005861061,0.00011363243,0.7156943,0.00003249893,0.0000037202708,0.0000022008014,0.00006299917,0.00011140801,0.28308988,0.00009012801,0.00012733084,0.00008579177],"about_ca_topic_score_codex":0.00037954186,"about_ca_topic_score_gemma":0.0029713314,"teacher_disagreement_score":0.63131607,"about_ca_system_score_codex":0.000064607055,"about_ca_system_score_gemma":0.000093825096,"threshold_uncertainty_score":0.31387037},"labels":[],"label_agreement":null},{"id":"W2326481417","doi":"10.1158/1538-7445.am2013-3516","title":"Abstract 3516: AZD1208 PIM kinase inhibitor - Preliminary evidence of target pathway inhibition in Phase I clinical trials of AML.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Kinase; Medicine; Cancer research; Pharmacology; Biomarker; Oncology; Chemistry; Biology; Cell biology; Biochemistry","score_opus":0.3546090096755345,"score_gpt":0.5537047291426573,"score_spread":0.19909571946712284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326481417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883803,0.007159693,0.00006339854,0.0018042991,0.00030552727,0.0020275202,0.00007604105,0.000015643722,0.0001675873],"genre_scores_gemma":[0.99488705,0.0033127237,0.00027159997,0.00010579792,0.0006662092,0.00053560553,0.000014699403,0.000032070442,0.00017422713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99574584,0.0007607752,0.0016868914,0.0004353785,0.0009296295,0.00044149498],"domain_scores_gemma":[0.9965071,0.0015510207,0.00039624315,0.00050387275,0.00077293837,0.00026881273],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010554258,0.00015972494,0.0009954873,0.00041190718,0.000042271164,0.000018131941,0.0001347293,0.00021885341,0.0038528454],"category_scores_gemma":[0.0025026884,0.00012977557,0.00026282217,0.00059512304,0.00032685965,0.00026770003,0.0000882482,0.00074861624,0.000032671625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007450607,0.0013838469,0.00096517423,0.0008267623,0.0000525419,0.00008749292,0.000413337,0.000010404745,0.88431126,0.00017060402,0.00489139,0.09943655],"study_design_scores_gemma":[0.0094517395,0.0060595106,0.011461175,0.0048579425,0.000022857552,0.000005245858,0.00041544193,0.00013067872,0.9639282,0.0019044032,0.0015991398,0.00016366478],"about_ca_topic_score_codex":0.00248013,"about_ca_topic_score_gemma":0.00007237828,"teacher_disagreement_score":0.09927289,"about_ca_system_score_codex":0.00022193283,"about_ca_system_score_gemma":0.0011521302,"threshold_uncertainty_score":0.9970578},"labels":[],"label_agreement":null},{"id":"W2326559171","doi":"10.1158/1538-7445.am2011-2331","title":"Abstract 2331: Role of MMP expression in the effect of Plk4 on cell migration and invasion","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Motility; Cell biology; Biology; Matrigel; Cell migration; Molecular biology; Cell; Genetics","score_opus":0.04935563414269255,"score_gpt":0.3488146881379556,"score_spread":0.299459053995263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326559171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958326,0.001830037,0.0000044386966,0.000029424165,0.000012197205,0.00019538822,0.000006979738,6.914273e-7,0.002088214],"genre_scores_gemma":[0.9986632,0.0011366842,0.000014441048,0.0000068255827,0.000027186135,0.00008914368,0.000008340447,0.000005019266,0.00004916904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993972,0.000121607416,0.00009807042,0.00013551906,0.00015217817,0.0000954138],"domain_scores_gemma":[0.999636,0.000033136483,0.00003842291,0.00022194088,0.000051876057,0.000018636165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052059477,0.000045289107,0.00006155853,0.000049251965,0.000031648196,0.000004329472,0.00012882482,0.000059288934,0.00002708779],"category_scores_gemma":[0.000027520948,0.000028705219,0.000019940238,0.000082553874,0.00007455408,0.0000029862379,0.000030325466,0.00009272438,0.0000010830681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024700342,0.000035277513,0.010778216,0.00004464856,0.0000020965824,2.1482091e-7,0.00032802203,0.000009643667,0.9837694,0.000013069892,0.00028531443,0.004487076],"study_design_scores_gemma":[0.000238227,0.00043387353,0.059601568,0.000044069464,0.0000014972259,1.381988e-7,0.00017887368,0.0000054271227,0.9385183,0.00003563463,0.0009150928,0.000027295668],"about_ca_topic_score_codex":0.00053308567,"about_ca_topic_score_gemma":0.00015660448,"teacher_disagreement_score":0.04882335,"about_ca_system_score_codex":0.000008949349,"about_ca_system_score_gemma":0.000035191257,"threshold_uncertainty_score":0.11705649},"labels":[],"label_agreement":null},{"id":"W2326597807","doi":"10.1158/1538-7445.am10-5204","title":"Abstract 5204: Nodal regulates invasive phenotypes in extravillous and choriocarcinoma trophoblast cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Nodal signaling; NODAL; Gene knockdown; Biology; Small hairpin RNA; Cell growth; Cancer research; Cell migration; Cell biology; Cell; Cell culture; Embryogenesis; Embryo; Anatomy; Genetics","score_opus":0.05156515005522635,"score_gpt":0.36929153104323625,"score_spread":0.3177263809880099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326597807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871235,0.0016410894,5.879716e-7,0.0011532372,0.00020425029,0.0010099341,0.00001526055,0.000027265647,0.008824878],"genre_scores_gemma":[0.99432147,0.00094988645,0.00014345524,0.000047301994,0.00049190596,0.00017122232,0.0000074082454,0.0000551891,0.0038121787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966302,0.00012100781,0.0003352707,0.0006664005,0.0011974822,0.0010496172],"domain_scores_gemma":[0.9977251,0.00063525006,0.000043497697,0.00057272107,0.00044538325,0.00057800853],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014475432,0.00020892521,0.0003879199,0.0005454259,0.00016782561,0.000100843354,0.00030213533,0.0002446449,0.0025351648],"category_scores_gemma":[0.0005297925,0.00017708766,0.00005916438,0.00071528286,0.00067002885,0.00012097551,0.00022869329,0.0021169134,0.00021583927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005255916,0.00011729082,0.03705267,0.00039300087,0.000022997707,0.0004446734,0.0005146655,0.000002579097,0.9471221,0.00013073868,0.001291012,0.012382684],"study_design_scores_gemma":[0.0017698875,0.00033248294,0.4669499,0.00024975295,0.00000808561,0.00004141434,0.0003579415,0.00005159929,0.5249882,0.00028476142,0.0047677406,0.00019825005],"about_ca_topic_score_codex":0.004290738,"about_ca_topic_score_gemma":0.0043165083,"teacher_disagreement_score":0.42989725,"about_ca_system_score_codex":0.00023689594,"about_ca_system_score_gemma":0.0009270634,"threshold_uncertainty_score":0.99837667},"labels":[],"label_agreement":null},{"id":"W2326621994","doi":"10.1158/0008-5472.sabcs12-p2-05-11","title":"Abstract P2-05-11: Proteomic identification and in-silico verification of subtype-specific signatures in breast cancer.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Proteome; Breast cancer; Proteomics; In silico; Computational biology; Biology; Cancer; Transcriptome; Cancer research; Identification (biology); Disease; Tandem mass spectrometry; Bioinformatics; Gene; Mass spectrometry; Genetics; Medicine; Chemistry; Gene expression; Pathology","score_opus":0.04736532092677527,"score_gpt":0.3804393904858434,"score_spread":0.33307406955906815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326621994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565244,0.0024454007,0.00008747052,0.0007344303,0.000024887224,0.00053236063,0.000113370486,0.000027309634,0.00038231927],"genre_scores_gemma":[0.99413,0.0032308407,0.0003462734,0.000007503939,0.00012425022,0.0019317808,0.00002029467,0.000025096133,0.00018397016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986774,0.00002866967,0.00033819917,0.00031424096,0.00026490356,0.00037660295],"domain_scores_gemma":[0.99916404,0.000061333245,0.0001288611,0.0003930858,0.00015338662,0.000099304685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058444793,0.00010973372,0.00015479924,0.00018825955,0.00007425869,0.000026812353,0.00025218417,0.00015433224,0.00041258457],"category_scores_gemma":[0.000030316414,0.000114605566,0.000023454684,0.00045098393,0.00017401266,0.0002263402,0.00006287008,0.00049018173,0.0000045823217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089921596,0.00010184627,0.04584479,0.00017522444,0.0000031717868,4.0440398e-7,0.00019270662,0.00007374554,0.9454271,0.0011717705,0.0005684237,0.006350901],"study_design_scores_gemma":[0.0002578249,0.0000029700996,0.2268722,0.00016327953,0.0000018235329,0.0000012771849,0.00011615202,0.000051996954,0.76922923,0.0010820737,0.0020964963,0.00012464385],"about_ca_topic_score_codex":0.0011620218,"about_ca_topic_score_gemma":0.00025507924,"teacher_disagreement_score":0.18102741,"about_ca_system_score_codex":0.00039092865,"about_ca_system_score_gemma":0.00013135186,"threshold_uncertainty_score":0.46734795},"labels":[],"label_agreement":null},{"id":"W2326634654","doi":"10.1158/1538-7445.am2012-2155","title":"Abstract 2155: Inhibition of the ERK1/2 pathway by RanBPM","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell biology; Gene knockdown; Signal transduction; Phosphorylation; Biology; Apoptosis; Chemistry; Biochemistry","score_opus":0.037339819724964876,"score_gpt":0.343932463334253,"score_spread":0.3065926436092881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326634654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269813,0.0053003933,0.00007317439,0.00019986184,0.00016591807,0.00017398357,0.0000322902,0.0000025729278,0.0013536956],"genre_scores_gemma":[0.9967631,0.00069718366,0.000015176681,0.00003154501,0.0002991901,0.000033807977,0.000036660276,0.000010688915,0.0021126429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926436,0.00005635222,0.000097384764,0.00011712741,0.00023682199,0.00022792838],"domain_scores_gemma":[0.9995783,0.000008498457,0.00003527581,0.00021919432,0.000106317806,0.00005243911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046967703,0.000052112086,0.000052542127,0.000020890968,0.00008897718,0.000007887062,0.00009354999,0.00009633369,0.00014425284],"category_scores_gemma":[0.000027402664,0.000035418027,0.00004840386,0.00009988335,0.00008389512,0.0000039310103,0.0000786025,0.000107744265,0.0000069587823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002455924,0.000033995562,0.00037692062,0.000020648826,0.000007716462,7.650744e-8,0.00003363335,0.000007582018,0.98239326,0.00017035323,0.007498927,0.009432334],"study_design_scores_gemma":[0.00016836046,0.000027192522,0.0043907897,0.00001747398,0.0000017929274,6.757375e-7,0.000024811332,0.0000023832192,0.89181364,0.00008080164,0.103429504,0.000042593816],"about_ca_topic_score_codex":0.00009966771,"about_ca_topic_score_gemma":0.000022133145,"teacher_disagreement_score":0.09593058,"about_ca_system_score_codex":0.00002003374,"about_ca_system_score_gemma":0.00006769572,"threshold_uncertainty_score":0.15794675},"labels":[],"label_agreement":null},{"id":"W2326653174","doi":"10.1158/0008-5472.sabcs-6143","title":"Effect of glutamine on doxorubicin-induced cardiotoxicity: an echocardiographic assessment.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Ventricle; Medicine; Ejection fraction; Diastole; Doxorubicin; Cardiology; Internal medicine; Glutamine; Heart failure; Toxicity; Blood pressure; Chemotherapy; Chemistry","score_opus":0.05529388478333776,"score_gpt":0.46304658677646054,"score_spread":0.4077527019931228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326653174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868406,0.00023725042,0.0000863868,0.0008118703,0.00013990988,0.001392316,0.000016773576,0.000086883956,0.008544525],"genre_scores_gemma":[0.9982523,0.00038331884,0.000045803154,0.00034817876,0.0006352133,0.000113490125,0.00003187152,0.000039351744,0.0001504986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963375,0.0007430919,0.00030678086,0.00054894143,0.0014755327,0.00058820867],"domain_scores_gemma":[0.99810565,0.00026616524,0.00007202447,0.00085432024,0.00037497815,0.00032689006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027588839,0.0002447377,0.000749696,0.000696515,0.00016486745,0.00003562127,0.00021819377,0.00025424306,0.00006950435],"category_scores_gemma":[0.00012512483,0.00020451611,0.00036409448,0.0013077137,0.00015319843,0.0001383409,0.000026224678,0.0009942345,0.00000928668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010786394,0.00014887993,0.0017872097,0.00013525404,0.00017037507,0.000041878688,0.00010470013,0.000032887398,0.8937919,0.0001732798,0.00024755037,0.102287404],"study_design_scores_gemma":[0.0029992335,0.011748306,0.024896396,0.0003478449,0.000087701614,0.000022466027,0.00005362891,0.00011044286,0.9590369,0.00012847871,0.00040259352,0.00016599146],"about_ca_topic_score_codex":0.00017648427,"about_ca_topic_score_gemma":0.000009328549,"teacher_disagreement_score":0.10212141,"about_ca_system_score_codex":0.00042824633,"about_ca_system_score_gemma":0.00031829072,"threshold_uncertainty_score":0.8339925},"labels":[],"label_agreement":null},{"id":"W2326658876","doi":"10.1158/1538-7445.am10-1821","title":"Abstract 1821: International Study of Embryonal Tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Hepatoblastoma; Medicine; Family history; Population; Rhabdomyosarcoma; Etiology; Embryonal rhabdomyosarcoma; Cancer; Pediatrics; Demography; Environmental health; Pathology; Internal medicine; Sarcoma","score_opus":0.03256349936288058,"score_gpt":0.39730174514324873,"score_spread":0.3647382457803682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326658876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225193,0.00016254306,0.0000015618278,0.0001687836,0.00042593505,0.00014481688,0.000013886907,0.0000034276447,0.0068271183],"genre_scores_gemma":[0.9976966,0.00015351847,0.000012179447,0.000019004005,0.00042161578,0.000048766993,0.000014487516,0.000010721753,0.0016231035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990699,0.000026600504,0.0001360453,0.00021485674,0.00036679753,0.00018576438],"domain_scores_gemma":[0.999427,0.000011107338,0.000036551748,0.0001988024,0.00025716072,0.0000693865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002977112,0.00006150949,0.00007226423,0.00007097145,0.000056941448,0.000014367938,0.00032102063,0.000084738174,0.00036202744],"category_scores_gemma":[0.00005149365,0.000049815775,0.00003811715,0.000109182285,0.00013759999,0.0000026706673,0.00010990461,0.00039465478,0.000011611957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014762428,0.00015067079,0.0061815954,0.0000103355615,0.000079566315,0.000006685892,0.00008650704,0.00008051017,0.9863634,0.000039359747,0.0033263534,0.003527401],"study_design_scores_gemma":[0.0016205548,0.00065683696,0.091714755,0.000042229552,0.000008269882,0.0000107047545,0.00087948376,0.000018136398,0.85922277,0.00011557537,0.045509383,0.00020128755],"about_ca_topic_score_codex":0.00044267694,"about_ca_topic_score_gemma":0.00035264288,"teacher_disagreement_score":0.1271406,"about_ca_system_score_codex":0.000015919386,"about_ca_system_score_gemma":0.00020962466,"threshold_uncertainty_score":0.39639467},"labels":[],"label_agreement":null},{"id":"W2326673102","doi":"10.1158/1538-7445.am2012-5071","title":"Abstract 5071: The genomic landscape of pancreatic cancer: from discovery to patient care","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatic cancer; Cancer; Medicine; Oncology; Adenocarcinoma; Carcinogenesis; Cohort; Internal medicine; Precision medicine; Bioinformatics; Pathology; Biology","score_opus":0.02785817583568014,"score_gpt":0.3367896783700227,"score_spread":0.3089315025343426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326673102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546085,0.042907342,0.000016899887,0.00025663062,0.00033836233,0.0003604864,0.000826995,0.0000028939996,0.00068187073],"genre_scores_gemma":[0.9929734,0.0052939635,0.000038085323,0.00021273842,0.0009729381,0.0002867248,0.00009006557,0.000028438088,0.00010367213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878955,0.00005226592,0.00018777509,0.00025471018,0.00026322762,0.00045245045],"domain_scores_gemma":[0.9990118,0.000097404285,0.00005576694,0.00049643696,0.00018450279,0.00015409588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018275234,0.0001183307,0.00015026829,0.000046763736,0.00011356967,0.000042556767,0.00031934612,0.00007757117,0.00014228329],"category_scores_gemma":[0.00008630349,0.00008839866,0.00007266559,0.00013270872,0.00009306713,0.000006167865,0.00028612366,0.00015242833,0.000017198148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032094863,0.000066495384,0.087218076,0.00006790262,0.00013152818,0.0000013479862,0.0024781416,0.0008449772,0.87142056,0.000060809507,0.01646914,0.020920051],"study_design_scores_gemma":[0.000575402,0.00038644494,0.1849247,0.00012166308,0.000052505846,8.927401e-7,0.0041066175,0.0000055743653,0.6371745,0.00004814351,0.1722763,0.00032724804],"about_ca_topic_score_codex":0.0062511708,"about_ca_topic_score_gemma":0.0016583889,"teacher_disagreement_score":0.23424609,"about_ca_system_score_codex":0.00012162054,"about_ca_system_score_gemma":0.00036770903,"threshold_uncertainty_score":0.9449942},"labels":[],"label_agreement":null},{"id":"W2326687951","doi":"10.1158/1538-7445.am2012-1185","title":"Abstract 1185: Plakoglobin (β-catenin) interacts with the transcription factor p53 and regulates the expression of genes involved in tumorigenesis and metastasis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Plakoglobin; Catenin; Biology; Cell biology; Chromatin immunoprecipitation; Transcription factor; Cancer research; Carcinogenesis; Gene expression; Molecular biology; Signal transduction; Gene; Genetics; Promoter; Wnt signaling pathway","score_opus":0.05786208460153013,"score_gpt":0.3320063910420057,"score_spread":0.27414430644047555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326687951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97956306,0.019624352,0.000010841022,0.0004413225,0.00005285143,0.00025412304,0.000016253416,0.00000307248,0.000034149514],"genre_scores_gemma":[0.9962783,0.0031975333,0.00006278727,0.000035482582,0.00010376283,0.00014303485,0.000013572987,0.000015953625,0.000149561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896485,0.00012954183,0.00015097985,0.0002142041,0.00024180282,0.00029863496],"domain_scores_gemma":[0.9995338,0.00006218279,0.000055917684,0.00017091555,0.000114420196,0.000062770254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065055036,0.00011858075,0.00012498698,0.00005876948,0.00012743287,0.000034185017,0.00017602205,0.000067939705,0.00004239498],"category_scores_gemma":[0.00002192319,0.000062101244,0.000024052428,0.00015206431,0.00029725287,0.000019555511,0.00008182363,0.00014875014,6.5665523e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030928064,0.000021665848,0.019757489,0.000049885333,0.00003584981,5.285001e-7,0.000909581,0.000013467964,0.97352844,0.0000068568797,0.0005098324,0.0048571387],"study_design_scores_gemma":[0.00031034474,0.000055887787,0.082353994,0.00007330845,0.000009262699,0.0000019705644,0.00084204867,0.0000024058515,0.9126813,0.000013282242,0.0035694244,0.00008676974],"about_ca_topic_score_codex":0.00026024733,"about_ca_topic_score_gemma":0.000346058,"teacher_disagreement_score":0.06259651,"about_ca_system_score_codex":0.000025466972,"about_ca_system_score_gemma":0.000087193446,"threshold_uncertainty_score":0.25324154},"labels":[],"label_agreement":null},{"id":"W2326784079","doi":"10.1158/1538-7445.am10-2830","title":"Abstract 2830: Energy balance and breast cancer risk among sisters pairs in the Breast Cancer Family Registry Study","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Breast cancer; Medicine; Quartile; Body mass index; Odds ratio; Cancer; Confidence interval; Cohort; Logistic regression; Internal medicine; Cohort study; Demography; Oncology","score_opus":0.041077621727675755,"score_gpt":0.378180421736615,"score_spread":0.3371028000089392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326784079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016213,0.0027115284,0.0000013634237,0.003873508,0.0005121354,0.00085182604,0.0007947929,0.000040726612,0.0010520115],"genre_scores_gemma":[0.98846483,0.008176603,0.0000039172896,0.00038415348,0.0010207648,0.0012369154,0.000009447948,0.000065338514,0.0006380341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963346,0.0002234755,0.00042367246,0.0008304305,0.0012370626,0.0009507587],"domain_scores_gemma":[0.9979283,0.00024781068,0.00016035554,0.0009272757,0.00036289816,0.0003733321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014598599,0.00033002597,0.00049572584,0.00026553587,0.00036316537,0.00017178257,0.0005171333,0.00020727084,0.00067163754],"category_scores_gemma":[0.000054630906,0.00022817249,0.00010689097,0.0008649616,0.00081058784,0.00020840089,0.00015291119,0.0022267827,0.000005205589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071624777,0.00029031807,0.94157207,0.00010364454,0.00011930799,0.00012486469,0.0016000444,0.000027045353,0.004898821,0.000015217353,0.009774514,0.040757935],"study_design_scores_gemma":[0.002094408,0.00009407332,0.98754215,0.0002859139,0.00006303499,0.000044421864,0.0044476846,0.000071669485,0.00009567248,0.000029855886,0.0049740155,0.000257083],"about_ca_topic_score_codex":0.39445245,"about_ca_topic_score_gemma":0.17921355,"teacher_disagreement_score":0.2152389,"about_ca_system_score_codex":0.00049951876,"about_ca_system_score_gemma":0.0009043288,"threshold_uncertainty_score":0.96743864},"labels":[],"label_agreement":null},{"id":"W2326789931","doi":"10.1158/0008-5472.sabcs12-p1-14-13","title":"Abstract P1-14-13: Increased Pathologic Complete Response Rate and Reduced Tumour RNA Levels Upon Treatment of Locally Advanced Breast Cancer with Neoadjuvant Concurrent Chemotherapy and Radiation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; London Health Sciences Centre; University of Sudbury","funders":"","keywords":"Medicine; Breast cancer; Docetaxel; Regimen; Oncology; Epirubicin; Internal medicine; Neoadjuvant therapy; Radiation therapy; Cyclophosphamide; Chemotherapy; Cancer; Clinical endpoint; Surgery; Clinical trial","score_opus":0.05001374754842886,"score_gpt":0.3636864300718455,"score_spread":0.3136726825234166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326789931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97669625,0.020721596,0.00001731654,0.0010867009,0.00008330238,0.000645912,0.0007112775,0.00001187163,0.000025741843],"genre_scores_gemma":[0.9859511,0.013100616,0.000066707915,0.00006689228,0.00020371786,0.00047649315,0.000049746697,0.000036854603,0.00004781745],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809456,0.00036915828,0.00023382336,0.0004965623,0.0002586994,0.00054716977],"domain_scores_gemma":[0.9989589,0.00013923556,0.0001428835,0.00027532096,0.00026777232,0.00021589191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064826536,0.00027785788,0.00035863448,0.00009373438,0.00017712326,0.00002433092,0.0000992154,0.000099875855,0.00004765781],"category_scores_gemma":[0.000043979122,0.00020545334,0.00004434634,0.00015608297,0.00037904587,0.000020402002,0.00006460493,0.00011261432,0.0000013205497],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010260327,0.00022012847,0.013827024,0.00005373559,0.00020556,0.000009528032,0.0005073992,0.000032672826,0.88358617,0.0000065304603,0.00009419905,0.09119671],"study_design_scores_gemma":[0.004762881,0.00070993666,0.6918344,0.00010186636,0.00003272453,0.000030854186,0.0001745444,0.000009514998,0.3010962,0.0000057970765,0.001052375,0.00018888638],"about_ca_topic_score_codex":0.0010874063,"about_ca_topic_score_gemma":0.00027127008,"teacher_disagreement_score":0.67800736,"about_ca_system_score_codex":0.00026600654,"about_ca_system_score_gemma":0.00033935197,"threshold_uncertainty_score":0.83781445},"labels":[],"label_agreement":null},{"id":"W2326796800","doi":"10.1158/1538-7445.am2013-447","title":"Abstract 447: Hypoxia induces tumor cell escape from T cell-mediated immunity via up-regulation of B7-H1.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cytotoxic T cell; Jurkat cells; Hypoxia (environmental); Biology; Cancer research; Apoptosis; Cancer cell; DU145; Cancer immunotherapy; Immune system; T cell; Cell; Immunotherapy; Immunology; Cell biology; Chemistry; Cancer; In vitro; Biochemistry","score_opus":0.029717642704872357,"score_gpt":0.3108755765863674,"score_spread":0.281157933881495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326796800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866513,0.009353149,0.000020438632,0.000109406166,0.0009552578,0.00047335803,0.00014446276,0.000013412394,0.0022792048],"genre_scores_gemma":[0.99469984,0.0017787687,0.00007595679,0.00006567934,0.0015020912,0.00018217783,0.00033626947,0.00004151639,0.0013177339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980372,0.00017924338,0.0003390606,0.00043776634,0.00048820884,0.00051847287],"domain_scores_gemma":[0.9983564,0.00007670359,0.00015143801,0.0006316322,0.0005851674,0.00019863993],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004542363,0.00019273175,0.00025894554,0.00012749378,0.00014526003,0.000050095518,0.0004645787,0.00021729637,0.0013807213],"category_scores_gemma":[0.00008694909,0.00018396537,0.00010901157,0.00027688054,0.00023954183,0.000019786155,0.00021220263,0.00041657581,0.00013402439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013080741,0.00009678106,0.00031413796,0.000058616584,0.00003193407,3.5702882e-7,0.00014693665,0.000027535196,0.97812694,0.00000170191,0.015993617,0.0050706076],"study_design_scores_gemma":[0.00080637104,0.00008424462,0.07215001,0.000022404603,0.000012600702,5.515172e-7,0.0002092072,0.000031088908,0.893685,0.00018231277,0.032626126,0.0001900765],"about_ca_topic_score_codex":0.015283077,"about_ca_topic_score_gemma":0.00043042502,"teacher_disagreement_score":0.08444196,"about_ca_system_score_codex":0.0000538907,"about_ca_system_score_gemma":0.00038823384,"threshold_uncertainty_score":0.99953216},"labels":[],"label_agreement":null},{"id":"W2326818380","doi":"10.1158/1538-7445.am2011-479","title":"Abstract 479: Targeting tumor initiating cells inhibits tumor growth and serial transplantation ability in soft-tissue sarcomas","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Queen's University; Centre for Social Innovation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cancer research; Biology; Cancer stem cell; Hedgehog signaling pathway; Side population; Hedgehog; Population; Notch signaling pathway; Stem cell; Gene expression profiling; Signal transduction; Pathology; Gene expression; Gene; Cell biology; Medicine; Genetics","score_opus":0.08672879455309908,"score_gpt":0.3690190757816343,"score_spread":0.2822902812285352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326818380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467933,0.0020635708,0.000038246806,0.00019017726,0.00017867862,0.0007169809,0.000057751124,0.000030548366,0.0020447439],"genre_scores_gemma":[0.99741614,0.0009988963,0.0009786334,0.00010390838,0.00032302827,0.000099790916,0.0000195414,0.000033807843,0.0000262386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795437,0.00013595248,0.00037552568,0.00047330765,0.00047902108,0.00058180484],"domain_scores_gemma":[0.99915755,0.0001641622,0.00007308819,0.00017347989,0.00019172918,0.00023999531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014613623,0.00015546345,0.00031936567,0.00018470347,0.00014686484,0.000035619214,0.000098890865,0.000060558268,0.0011228117],"category_scores_gemma":[0.00017131068,0.00014954736,0.000043342276,0.0003510413,0.00020078199,0.00018043652,0.000050477578,0.0006095592,0.000021432013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012367446,0.00016451666,0.01996986,0.0020384896,0.000021517164,0.00037715223,0.0070458823,0.0000054938114,0.9535265,0.000020435937,0.00022382398,0.0153696155],"study_design_scores_gemma":[0.002442608,0.0002268119,0.069487974,0.00049258734,0.000030027873,0.000029215307,0.0010647458,0.00001804156,0.92527753,0.0002231758,0.0005110756,0.00019619074],"about_ca_topic_score_codex":0.009970919,"about_ca_topic_score_gemma":0.0014511393,"teacher_disagreement_score":0.049518116,"about_ca_system_score_codex":0.0001579207,"about_ca_system_score_gemma":0.00040609678,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W2326879037","doi":"10.1158/1538-7445.am2012-sy35-02","title":"Abstract SY35-02: Phenotypic heterogeneity and instability of human serous ovarian cancer tumor-initiating cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Ovarian cancer; Cancer stem cell; Serous fluid; Cancer research; Malignancy; Population; Taxane; Cancer; Carcinogenesis; Medicine; Cancer cell; Oncology; Biology; Internal medicine; Breast cancer","score_opus":0.0652030638450817,"score_gpt":0.380090959189142,"score_spread":0.31488789534406025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326879037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162674,0.0068095988,0.000016677694,0.00006326993,0.00020685606,0.00028233323,0.00022704918,0.000006101213,0.0007613485],"genre_scores_gemma":[0.99788743,0.0011167077,0.0000839307,0.000100738405,0.00061411323,0.00011127659,0.0000248064,0.000030301004,0.000030722735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847716,0.00009308122,0.00026809965,0.00035449874,0.00024535824,0.00056179654],"domain_scores_gemma":[0.9989596,0.000066891786,0.00009593736,0.00040625615,0.00025093363,0.0002204079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007967509,0.00014628326,0.00019954225,0.000058013,0.00019662181,0.0000339361,0.00020631717,0.00011055127,0.00011177041],"category_scores_gemma":[0.000106181025,0.00014866675,0.000057597448,0.00012796142,0.00026166133,0.00001013582,0.00028339305,0.00023905422,0.0000032825078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007237165,0.000093422044,0.09360996,0.00017414776,0.00004700587,0.0000013455217,0.00016367447,0.00005334224,0.9021986,0.00011401482,0.00037581596,0.0030962734],"study_design_scores_gemma":[0.00047530243,0.00012073448,0.15228054,0.000044118704,0.00001375047,0.0000018257832,0.00011661062,0.000008755711,0.8436082,0.000081190876,0.0030702434,0.00017873419],"about_ca_topic_score_codex":0.0032479067,"about_ca_topic_score_gemma":0.0021023895,"teacher_disagreement_score":0.058670588,"about_ca_system_score_codex":0.00010998094,"about_ca_system_score_gemma":0.0002850568,"threshold_uncertainty_score":0.6062454},"labels":[],"label_agreement":null},{"id":"W2326881112","doi":"10.1158/1538-7445.am10-743","title":"Abstract 743: Assessment of novel tyrosine-chlorambucil hybrid molecules on a panel of breast, ovarian, and uterine cancer cell lines","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Chlorambucil; Ovarian cancer; Cancer research; Aromatase; Tyrosine; Cytotoxic T cell; Chemistry; Pharmacology; Biology; Internal medicine; Biochemistry; Breast cancer; In vitro; Cancer; Medicine; Chemotherapy","score_opus":0.11540307718313274,"score_gpt":0.45070938756866985,"score_spread":0.3353063103855371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326881112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901651,0.0010503083,0.000025432084,0.0031637654,0.00014219765,0.0004600882,0.0008357765,0.000012063959,0.0041452786],"genre_scores_gemma":[0.9920511,0.0031145634,0.0008513426,0.000091401795,0.0004317243,0.00011390773,0.000027898868,0.00003474781,0.003283281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974853,0.000041131017,0.00037928708,0.0004053103,0.0011745122,0.0005144612],"domain_scores_gemma":[0.9980309,0.00025456236,0.000102048354,0.0004048838,0.0009022643,0.000305333],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006957264,0.00019170865,0.00044394098,0.00021074829,0.00009420926,0.000026986403,0.00023995338,0.00009350505,0.0014237836],"category_scores_gemma":[0.000060549028,0.00014425609,0.000094138755,0.0002631077,0.0005458935,0.00007319959,0.00021855584,0.00087915384,0.000004275496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011379558,0.0007045368,0.011967352,0.0014451442,0.000078427656,0.00004934562,0.00006785739,0.000026802116,0.9716434,0.00076287595,0.0012589017,0.010857401],"study_design_scores_gemma":[0.0026392767,0.00065853173,0.5570636,0.000609308,0.000029073872,0.000074863994,0.000069953894,0.0016351546,0.42885956,0.000068814334,0.0080846,0.00020729589],"about_ca_topic_score_codex":0.012431142,"about_ca_topic_score_gemma":0.00065653404,"teacher_disagreement_score":0.5450962,"about_ca_system_score_codex":0.00008348802,"about_ca_system_score_gemma":0.000840283,"threshold_uncertainty_score":0.99948907},"labels":[],"label_agreement":null},{"id":"W2326917709","doi":"10.1158/1538-7445.am2012-1249","title":"Abstract 1249: Modulation of epidermal growth factor induction of migration by integrin-linked kinase","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"RAC1; Cell biology; Cell migration; Motility; Integrin; Integrin-linked kinase; Epidermal growth factor; Cancer research; Tyrosine kinase; Signal transduction; Epidermal growth factor receptor; Biology; Kinase; Chemistry; Cell; Protein kinase A; Receptor; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.19814498477933895,"score_gpt":0.46903170139245454,"score_spread":0.2708867166131156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326917709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946708,0.0015997983,0.00012224371,0.0015992095,0.00025468765,0.00080001954,0.00009723985,0.000023974992,0.00083199376],"genre_scores_gemma":[0.9977999,0.0007891769,0.00013115251,0.000022070833,0.0005247649,0.00015326256,0.000076682765,0.000038939295,0.0004640647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968014,0.00023577968,0.0005197389,0.00028396118,0.0015232132,0.00063595054],"domain_scores_gemma":[0.9975911,0.00024203633,0.00014911633,0.00040126554,0.0012983753,0.00031810725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016787595,0.00014422205,0.00034582053,0.00046953827,0.00007585432,0.000014094263,0.00018196592,0.00021518754,0.0012602989],"category_scores_gemma":[0.0008816779,0.00012722667,0.00009336416,0.0007761407,0.00032501871,0.00035520951,0.00007557504,0.0008809742,0.000034365028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042791944,0.000289415,0.088897295,0.00075735326,0.000052827025,0.0000018720742,0.0009482758,0.000011537182,0.87433046,0.00013902353,0.007849234,0.02629479],"study_design_scores_gemma":[0.00079544616,0.00025980474,0.40759706,0.0003090503,0.000012548065,0.0000035614705,0.00028862944,0.00015514278,0.58767843,0.00008412906,0.0027145199,0.00010165174],"about_ca_topic_score_codex":0.0063284896,"about_ca_topic_score_gemma":0.00012107226,"teacher_disagreement_score":0.31869978,"about_ca_system_score_codex":0.0006804164,"about_ca_system_score_gemma":0.0005596756,"threshold_uncertainty_score":0.9996527},"labels":[],"label_agreement":null},{"id":"W2326935077","doi":"10.1158/1538-7445.am10-1234","title":"Abstract 1234: Erk-dependent phosphorylation of Notch intracellular domain (NIC) correlates with increased NIC-dependent transcription","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"MAPK/ERK pathway; HES1; MEK inhibitor; Transfection; Molecular biology; Luciferase; Transcription factor; Chemistry; Transcription (linguistics); KRAS; Notch signaling pathway; Cell biology; Phosphorylation; Biology; Cancer research; Signal transduction; Biochemistry; Gene; Mutation","score_opus":0.029803973083233234,"score_gpt":0.3301650427497804,"score_spread":0.3003610696665472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326935077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941147,0.0015840968,0.00073171325,0.00091757166,0.00040482148,0.0010786953,0.000046761474,0.000049012586,0.0010726494],"genre_scores_gemma":[0.99711895,0.0008175701,0.00041086166,0.000060614097,0.00031319648,0.00021040806,0.000044104174,0.000062025676,0.0009622616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971899,0.00008723444,0.00039476072,0.00046870016,0.0013424038,0.0005170509],"domain_scores_gemma":[0.99838793,0.000102399,0.00012763216,0.0005494304,0.00055426493,0.00027833765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017065307,0.00020744193,0.000379556,0.0002569375,0.00015019742,0.000043372216,0.00020849281,0.00023686724,0.0042296946],"category_scores_gemma":[0.000035199904,0.00016776742,0.00010016013,0.00037702496,0.00021145388,0.0001685173,0.000027820583,0.0012966216,0.000048698494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031094267,0.00029278934,0.0017756827,0.00017010067,0.00012365157,0.000062877036,0.00079634174,0.00003728177,0.98193747,0.0012574333,0.00026103278,0.010175922],"study_design_scores_gemma":[0.005460584,0.00084350334,0.012437698,0.00032824377,0.000065577864,0.00003680306,0.0006562312,0.00015022162,0.97486436,0.0015708135,0.0033498742,0.00023610017],"about_ca_topic_score_codex":0.0038798426,"about_ca_topic_score_gemma":0.0022792749,"teacher_disagreement_score":0.0106620155,"about_ca_system_score_codex":0.00028172266,"about_ca_system_score_gemma":0.0006708094,"threshold_uncertainty_score":0.99668056},"labels":[],"label_agreement":null},{"id":"W2326960069","doi":"10.1158/1538-7445.am10-2243","title":"Abstract 2243: Prognostic significance of nuclear Sox4 expression in cutaneous melanoma and its role in cell migration","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SOX4; Tissue microarray; Cancer research; Melanoma; Gene silencing; Biology; Cancer; Immunohistochemistry; Pathology; Medicine; Gene expression; Oncology; Internal medicine; Immunology; Gene; Promoter; Genetics","score_opus":0.03627270018192275,"score_gpt":0.3460081347575535,"score_spread":0.30973543457563074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326960069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511456,0.0021611098,4.734063e-7,0.00039159524,0.000069347014,0.00070898916,0.000020064226,0.000008601601,0.0015252728],"genre_scores_gemma":[0.99813753,0.0012957084,0.00013383578,0.000019981606,0.00007506941,0.00010070883,0.000006328343,0.000018406654,0.00021245307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987016,0.000052242773,0.00024207369,0.00029319368,0.00039272435,0.00031816695],"domain_scores_gemma":[0.9993472,0.00014164623,0.000052879936,0.00019135934,0.00013897016,0.000127963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004489161,0.0000931397,0.00022394776,0.0002569212,0.0000348809,0.00001622453,0.00009328819,0.00010233447,0.00050386327],"category_scores_gemma":[0.00013492742,0.000081964194,0.000026895988,0.00027745956,0.00009012395,0.00007263658,0.00004714094,0.0006432713,0.0000149080615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004019915,0.00016466518,0.020094771,0.00037514587,0.0000031700283,0.00007146548,0.0009034653,0.000012747792,0.96821046,0.00001108472,0.00031848787,0.009432556],"study_design_scores_gemma":[0.0014662378,0.00029055373,0.06557897,0.00046048206,0.000010665132,0.000015370972,0.00057821366,0.00021071997,0.9229261,0.00007179714,0.008261239,0.00012961098],"about_ca_topic_score_codex":0.0016517597,"about_ca_topic_score_gemma":0.003398386,"teacher_disagreement_score":0.045484196,"about_ca_system_score_codex":0.000083803156,"about_ca_system_score_gemma":0.00025831987,"threshold_uncertainty_score":0.5516949},"labels":[],"label_agreement":null},{"id":"W2326961607","doi":"10.1158/1538-7445.am2012-lb-445","title":"Abstract LB-445: Human papillomavirus (HPV) status is a long-term survival indicator for patients with oropharyngeal cancers in British Columbia","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; CISH; Chromogenic in situ hybridization; Internal medicine; Oncology; Incidence (geometry); Human papillomavirus; Disease; Stage (stratigraphy); In situ hybridization","score_opus":0.07339184029220533,"score_gpt":0.4086902951710332,"score_spread":0.3352984548788279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326961607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915883,0.004561728,7.8698554e-7,0.00015824118,0.00027963586,0.0017827209,0.00054937135,0.000035958794,0.0010432343],"genre_scores_gemma":[0.9947913,0.001652543,0.000033002634,0.00020861281,0.00053343823,0.0012956214,0.00008546203,0.0000789653,0.0013210459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637604,0.00007516748,0.000359578,0.00051493204,0.0010292238,0.0016450721],"domain_scores_gemma":[0.9984134,0.00015233993,0.000085273205,0.0003260261,0.00040774758,0.00061525445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060564943,0.00017957982,0.0006163918,0.0001604374,0.00039926433,0.00011238454,0.00018359718,0.00013122351,0.0022684135],"category_scores_gemma":[0.00008141614,0.00021360439,0.00007895128,0.00046052385,0.00036360347,0.00022141347,0.000102881495,0.00061152154,0.000026384645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000528237,0.00042785672,0.9531509,0.00052301533,0.00014522477,0.000041974705,0.000988329,1.6808579e-7,0.0005060748,0.0000015853313,0.0131859165,0.030500686],"study_design_scores_gemma":[0.006662548,0.0008135475,0.98517627,0.00057035475,0.00003413157,0.0000017443517,0.00023477159,4.7881855e-7,0.00033946472,0.0000069151906,0.00591761,0.00024217785],"about_ca_topic_score_codex":0.1033627,"about_ca_topic_score_gemma":0.2678548,"teacher_disagreement_score":0.1644921,"about_ca_system_score_codex":0.0018853976,"about_ca_system_score_gemma":0.0012803384,"threshold_uncertainty_score":0.99864364},"labels":[],"label_agreement":null},{"id":"W2326971524","doi":"10.1158/1538-7445.am2012-5420","title":"Abstract 5420: The effect of folate deficiency on chemosensitivity of colon cancer cells to 5-Fluorouracil","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thymidylate synthase; Colorectal cancer; Cell growth; Cell culture; Intracellular; Cancer cell; Biology; Biochemistry; Cancer research; Molecular biology; Cancer; Fluorouracil; Chemistry; Genetics","score_opus":0.07494627721796471,"score_gpt":0.43988071926169336,"score_spread":0.36493444204372866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326971524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913858,0.0017562878,0.0000015044451,0.001041937,0.00015552122,0.0011700529,0.00005323911,0.000011565315,0.0044240924],"genre_scores_gemma":[0.9978271,0.0004942495,0.000010152129,0.000063252766,0.00022217592,0.00017137907,0.0000027251929,0.000027908167,0.0011810157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969139,0.00028688853,0.00026291003,0.00026688524,0.0014105443,0.0008588509],"domain_scores_gemma":[0.99761504,0.0009894446,0.00006587216,0.0005551746,0.00047689915,0.0002975609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003526288,0.0001543836,0.00040706227,0.00024198325,0.00013713546,0.000013371023,0.00025849734,0.00011582422,0.0004837661],"category_scores_gemma":[0.00034301842,0.00009234873,0.00012364819,0.00091823953,0.00029889523,0.00008044583,0.00015570987,0.0007346367,0.00012674383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018013421,0.00018822588,0.011712976,0.00059488637,0.000061027873,0.00001148302,0.0005703082,0.0000295002,0.91262335,0.000023548637,0.0051079374,0.06727539],"study_design_scores_gemma":[0.000741134,0.0019333535,0.06969568,0.00029787046,0.00002821947,0.0000028063355,0.000075009506,0.000021919364,0.92494327,0.0000039681627,0.0021759325,0.000080836944],"about_ca_topic_score_codex":0.003609899,"about_ca_topic_score_gemma":0.0001539331,"teacher_disagreement_score":0.06719456,"about_ca_system_score_codex":0.0003377538,"about_ca_system_score_gemma":0.00034279237,"threshold_uncertainty_score":0.54571116},"labels":[],"label_agreement":null},{"id":"W2327031434","doi":"10.1158/1538-7445.am10-3578","title":"Abstract 3578: New Angiochem-modified doxorubicin with increased brain penetration and efficacy against brain tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Angiochem (Canada)","funders":"","keywords":"Doxorubicin; Blood–brain barrier; Paclitaxel; Medicine; Pharmacology; Drug; Peptide; Cancer research; Efflux; Chemotherapy; Chemistry; Internal medicine; Biochemistry; Central nervous system","score_opus":0.029447611282972963,"score_gpt":0.3161238917802913,"score_spread":0.28667628049731836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327031434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952731,0.0005075977,0.00025535072,0.0006770337,0.00015964903,0.0005690404,0.00002602943,0.00018799493,0.0023442036],"genre_scores_gemma":[0.99855,0.0000936502,0.00026086622,0.00013848646,0.00043920852,0.00006624743,0.00003755839,0.000094135394,0.00031985977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820375,0.000024053315,0.00023751525,0.0003382331,0.0005650229,0.0006313959],"domain_scores_gemma":[0.9985852,0.0004648023,0.000034004748,0.00041534385,0.0001223107,0.00037830163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006398913,0.00023068111,0.00022760908,0.00020785826,0.00015061835,0.00015899545,0.0002787287,0.00015712714,0.00014660864],"category_scores_gemma":[0.00020014841,0.00020523409,0.000038388225,0.0005266195,0.00017323339,0.0002561649,0.000041517334,0.0009557362,0.000026758084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001551668,0.000020499654,0.0005470664,0.00010407669,0.0000491337,0.0000247588,0.0003678889,0.0013765243,0.97191393,0.00017793408,0.0076703224,0.017592706],"study_design_scores_gemma":[0.0059401547,0.00027935885,0.062429003,0.00040441734,0.000020661011,0.000020027228,0.00017802263,0.003429717,0.9109513,0.00060959114,0.014857605,0.0008801193],"about_ca_topic_score_codex":0.0011144935,"about_ca_topic_score_gemma":0.0020896532,"teacher_disagreement_score":0.061881937,"about_ca_system_score_codex":0.00018561803,"about_ca_system_score_gemma":0.0004078417,"threshold_uncertainty_score":0.8369203},"labels":[],"label_agreement":null},{"id":"W2327045091","doi":"10.1158/1538-7445.am2013-2310","title":"Abstract 2310: Targeting EP4 receptor on cancer cells and macrophages to abrogate stem-like functions, lymphangiogenesis and lymphatic metastasis in a breast cancer model.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Lymphangiogenesis; Cancer research; Metastasis; Cancer; Medicine; Angiogenesis; Cancer cell; Cancer stem cell; Breast cancer; Immunology; Internal medicine","score_opus":0.035800629497505884,"score_gpt":0.34243554509315927,"score_spread":0.30663491559565337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327045091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848873,0.010353619,0.0000068329387,0.0025448238,0.00035484563,0.001472476,0.0002694363,0.000037726248,0.00007292081],"genre_scores_gemma":[0.98603934,0.008436336,0.00011960216,0.000581854,0.00040796786,0.0028431776,0.000008674766,0.000079731435,0.0014833146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972017,0.00017943526,0.0003631598,0.0006714516,0.00070241484,0.00088182866],"domain_scores_gemma":[0.9984148,0.00023110604,0.00007333457,0.00029556634,0.0003599828,0.0006252249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00097361725,0.00029747438,0.00049564295,0.00056103664,0.000243703,0.00010096258,0.00012571209,0.00013984198,0.0014055993],"category_scores_gemma":[0.000037775775,0.0002448793,0.00006733958,0.00064236694,0.00015337113,0.00020390032,0.000119408025,0.0001985392,0.00014382269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011245917,0.00016171775,0.036118288,0.0017303729,0.00027645033,0.000073934585,0.001458861,0.002132457,0.7633704,0.000010010202,0.04213898,0.15140395],"study_design_scores_gemma":[0.013319563,0.0008937149,0.30973753,0.0072109164,0.0004908,0.00005175248,0.003934286,0.0152786225,0.6345445,0.000071645525,0.012253057,0.0022136199],"about_ca_topic_score_codex":0.011434153,"about_ca_topic_score_gemma":0.0004932432,"teacher_disagreement_score":0.27361923,"about_ca_system_score_codex":0.00083523564,"about_ca_system_score_gemma":0.00054540165,"threshold_uncertainty_score":0.99950725},"labels":[],"label_agreement":null},{"id":"W2327069088","doi":"10.1158/0008-5472.sabcs11-p4-15-01","title":"P4-15-01: High Prevalence of Prospective Memory (PM) Impairment in Early Breast Cancer (EBC) Survivors within 1 Year of Adjuvant Chemotherapy Completion: Novel Findings Concerning Post Chemotherapy Cognitive Effects.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Ottawa Hospital","funders":"","keywords":"Medicine; Forgetting; Anxiety; Depression (economics); Prospective cohort study; Breast cancer; Cancer; Internal medicine; Physical therapy; Psychiatry; Psychology","score_opus":0.059677906388633475,"score_gpt":0.3628870221197432,"score_spread":0.30320911573110976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327069088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322754,0.0008752325,0.00016142167,0.00014941809,0.00059239403,0.0021321625,0.00091056526,0.000034691562,0.0019166012],"genre_scores_gemma":[0.99677026,0.000371922,0.00007054147,0.00013114886,0.0001906094,0.0010833953,0.000012660325,0.00007576788,0.0012937131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687964,0.0003825884,0.0005463912,0.00076771335,0.00072636973,0.0006972869],"domain_scores_gemma":[0.9973223,0.0004521628,0.0002678751,0.00037536878,0.0014269017,0.00015535584],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013627793,0.00030256348,0.00062076625,0.0004812218,0.00012915263,0.000016404867,0.00036542883,0.00018123101,0.0068597067],"category_scores_gemma":[0.00007381336,0.0002854285,0.00012863723,0.00094395113,0.00096847455,0.00015773167,0.000102968595,0.00074209424,0.000039638457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014287423,0.0024092058,0.77794176,0.0011731336,0.0008269397,0.000037155678,0.081474096,0.0000081829785,0.1069917,0.001114605,0.0003562717,0.013379506],"study_design_scores_gemma":[0.006681126,0.0012522923,0.92737097,0.0012397512,0.00004045955,0.0000100416455,0.003925463,0.0000072240164,0.059067182,0.000110954235,0.00002148671,0.0002730559],"about_ca_topic_score_codex":0.0471124,"about_ca_topic_score_gemma":0.0017819501,"teacher_disagreement_score":0.14942919,"about_ca_system_score_codex":0.0004620292,"about_ca_system_score_gemma":0.00048459222,"threshold_uncertainty_score":0.99995977},"labels":[],"label_agreement":null},{"id":"W2327071570","doi":"10.1158/1538-7445.am2011-4406","title":"Abstract 4406: Multiple organic anion transporting polypeptides (OATPs) contribute to the in vitro and in vivo disposition of docetaxel","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Docetaxel; Pharmacology; Organic anion-transporting polypeptide; Organic cation transport proteins; Taxane; Chemistry; In vivo; Transporter; Organic anion transporter 1; Pharmacokinetics; Biochemistry; Medicine; Biology; Cancer; Internal medicine; Breast cancer","score_opus":0.05322698373965835,"score_gpt":0.3364809103132771,"score_spread":0.28325392657361875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327071570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974473,0.00077469763,0.00009989951,0.00063670153,0.000048366026,0.000708023,0.000055691635,0.000011378915,0.00021792868],"genre_scores_gemma":[0.99920285,0.00036103732,0.00013291166,0.000047509635,0.000051775434,0.00008121307,0.000008644245,0.00001937209,0.00009468613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861723,0.000044442215,0.00033279747,0.00024583036,0.00036424675,0.00039546413],"domain_scores_gemma":[0.99944144,0.000084699146,0.000047541507,0.0001921314,0.000120866294,0.00011330632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011003853,0.00009867215,0.00025708094,0.00022740972,0.000060863596,0.0000080350765,0.00011569908,0.000073338495,0.0002050358],"category_scores_gemma":[0.000060663362,0.00006913234,0.000035504865,0.00052109745,0.000092138485,0.0000748694,0.000015061092,0.00035312228,0.0000034595812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023047691,0.00011580217,0.072429284,0.00018597596,0.000012731298,0.00006012493,0.0026307236,0.0000037030572,0.9203019,0.00003375597,0.000020117415,0.0019011045],"study_design_scores_gemma":[0.0010064603,0.0000583266,0.42528516,0.00040042205,0.000008420912,0.0000016921883,0.0006350383,0.000017903369,0.5723954,0.00006744417,0.000068778616,0.000054984073],"about_ca_topic_score_codex":0.0022150811,"about_ca_topic_score_gemma":0.012163229,"teacher_disagreement_score":0.35285586,"about_ca_system_score_codex":0.000111720656,"about_ca_system_score_gemma":0.00012294244,"threshold_uncertainty_score":0.67873675},"labels":[],"label_agreement":null},{"id":"W2327096311","doi":"10.1158/1538-7445.am10-1778","title":"Abstract 1778: Nimotuzumab, a humanized antiepidermal growth factor receptor antibody, interacts with EGFRvIII","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada); National Research Council Canada","funders":"","keywords":"Flow cytometry; Epidermal growth factor receptor; Antibody; Cancer research; Chemistry; Apoptosis; Cell culture; Molecular biology; Receptor; Medicine; Biology; Biochemistry; Immunology; Genetics","score_opus":0.038613453671496045,"score_gpt":0.4083546466587963,"score_spread":0.36974119298730024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327096311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544513,0.00044479803,0.000022452501,0.00062822725,0.00025072275,0.00057508517,0.00018986974,0.000026527052,0.002417215],"genre_scores_gemma":[0.99570495,0.0009006255,0.00017682687,0.00008094293,0.00074111175,0.00021923853,0.0002905062,0.00006944895,0.0018163706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972405,0.00010600172,0.00022455938,0.00071807037,0.0007269888,0.0009838785],"domain_scores_gemma":[0.9981873,0.000056170833,0.00006923822,0.00061792776,0.00065758027,0.00041179833],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037006743,0.0002590409,0.00024580787,0.0001892888,0.00032060544,0.00016974601,0.0005446017,0.00018846562,0.0017440404],"category_scores_gemma":[0.00021566203,0.00018322558,0.00010235772,0.0003075424,0.00041858648,0.000025930067,0.0002778383,0.0008836054,0.00017124985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011997899,0.00017782854,0.011765322,0.0000666265,0.00018373465,0.000049654984,0.00008261215,6.582267e-7,0.9732233,0.000049038124,0.0075576883,0.005643721],"study_design_scores_gemma":[0.0026347353,0.0007936442,0.032356158,0.00008210757,0.000008452845,0.000021030408,0.00006813175,0.0000036167562,0.9007064,0.00004608495,0.06294188,0.00033775548],"about_ca_topic_score_codex":0.0031916793,"about_ca_topic_score_gemma":0.0037649083,"teacher_disagreement_score":0.072516926,"about_ca_system_score_codex":0.00010232689,"about_ca_system_score_gemma":0.0007843385,"threshold_uncertainty_score":0.9991685},"labels":[],"label_agreement":null},{"id":"W2327106913","doi":"10.1158/0008-5472.sabcs11-p1-12-25","title":"P1-12-25: Evaluation of PTEN, EGFR and Ki67 Expression as Predictors of Response to a Trastuzumab-Containing Neoadjuvant Chemotherapy Regimen in a HER-2 Over-Expressing Locally Advanced Breast Cancer (LABC) Trial.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; PTEN; Breast cancer; Oncology; Docetaxel; Regimen; Epirubicin; Internal medicine; Chemotherapy; Tissue microarray; Carboplatin; Neoadjuvant therapy; Immunohistochemistry; Cancer; Cisplatin; Biology; PI3K/AKT/mTOR pathway","score_opus":0.06200430170921554,"score_gpt":0.3939882848043629,"score_spread":0.3319839830951473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327106913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931979,0.0045061535,0.00003474461,0.0003209241,0.0001164433,0.0013730775,0.000096184944,0.000008969844,0.00034560164],"genre_scores_gemma":[0.99709564,0.0011803088,0.00020161085,0.00005717236,0.00013392385,0.0011724577,0.000009750324,0.000045286655,0.00010384746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969706,0.00065171305,0.00044612333,0.00064559054,0.0008105169,0.00047546288],"domain_scores_gemma":[0.99851316,0.00009463686,0.00019237067,0.00045754545,0.00059312745,0.00014914044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019539704,0.0002366661,0.00041520398,0.00024435323,0.00009924488,0.0000144336955,0.00025192223,0.0001609334,0.00011982268],"category_scores_gemma":[0.0002733127,0.0002113963,0.00006875583,0.0003205029,0.00027212861,0.000025724252,0.00021061751,0.00018141347,5.8950775e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14746621,0.00024834657,0.012664162,0.000058986923,0.00014241069,0.0000035898877,0.0045732753,0.0001135769,0.7800787,0.0000036613076,0.00020421483,0.054442838],"study_design_scores_gemma":[0.04160734,0.0021851875,0.19752055,0.0015274244,0.00006208336,0.0000066592265,0.0022007062,0.00007076877,0.7538302,0.00007975136,0.00059885025,0.00031047754],"about_ca_topic_score_codex":0.0032625813,"about_ca_topic_score_gemma":0.00091793603,"teacher_disagreement_score":0.1848564,"about_ca_system_score_codex":0.00040317868,"about_ca_system_score_gemma":0.0010450501,"threshold_uncertainty_score":0.86204904},"labels":[],"label_agreement":null},{"id":"W2327116862","doi":"10.1158/1538-7445.am2012-3887","title":"Abstract 3887: A screen for new cancer specific drugs that target centrosome clustering","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Centrosome; Mitosis; Cancer cell; Cell biology; Spindle apparatus; Cancer; Biology; Microtubule; Integrin-linked kinase; Cancer research; Spindle pole body; Cell cycle; Cell division; Chemistry; Cell; Genetics","score_opus":0.07441681385294438,"score_gpt":0.37692260766683217,"score_spread":0.30250579381388776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327116862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561062,0.034339964,0.004640326,0.0010525606,0.0008142579,0.0010545269,0.00040181054,0.000021916096,0.001568449],"genre_scores_gemma":[0.9805645,0.007772235,0.0010380119,0.00023479556,0.0038577772,0.00029346198,0.00018553366,0.000069265734,0.005984472],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823624,0.000037762136,0.00015634373,0.00036583358,0.00026934885,0.0009345007],"domain_scores_gemma":[0.99911886,0.00002566329,0.000048389593,0.00037168546,0.00013445936,0.0003009404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045290237,0.00015927343,0.00015790499,0.00007149827,0.00016695356,0.00006161336,0.0003342245,0.00016458897,0.00038166175],"category_scores_gemma":[0.000022205164,0.00015183515,0.000110458874,0.000110453286,0.00008333015,0.000014103728,0.00020539551,0.00021796545,0.000027110198],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026229845,0.000048647977,0.004873153,0.00007588612,0.00006907274,6.00213e-7,0.0002146683,0.000083170184,0.89418924,0.00006646533,0.08949899,0.010617787],"study_design_scores_gemma":[0.00068444334,0.00004701915,0.0028670584,0.00004571709,0.0000061918918,0.0000014013679,0.0001329169,0.00003103425,0.37699813,0.00003815111,0.61895084,0.00019711272],"about_ca_topic_score_codex":0.0008380982,"about_ca_topic_score_gemma":0.00028722428,"teacher_disagreement_score":0.52945185,"about_ca_system_score_codex":0.00013352624,"about_ca_system_score_gemma":0.00028607494,"threshold_uncertainty_score":0.6191658},"labels":[],"label_agreement":null},{"id":"W2327126234","doi":"10.1158/0008-5472.sabcs11-p4-11-12","title":"P4-11-12: Molecular Phenotype of Breast Cancers in a Large Cohort of Young Women According to Time Interval Since Pregnancy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Pregnancy; Oncology; Biomarker; Population; Cohort; Cancer; Obstetrics; Internal medicine; Gynecology; Biology","score_opus":0.05227754892027271,"score_gpt":0.3731857082450899,"score_spread":0.3209081593248172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327126234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947537,0.00096447277,0.00006024327,0.00010308128,0.00011074008,0.0008533423,0.0001377621,0.00001557917,0.003001073],"genre_scores_gemma":[0.9987806,0.00023110569,0.000079943486,0.000043163036,0.0000530419,0.0002856524,0.0000059989857,0.00004163534,0.0004788235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977013,0.00009075608,0.00039430472,0.00039301603,0.0006841923,0.0007364595],"domain_scores_gemma":[0.9987734,0.000037906542,0.00008773495,0.00046213003,0.00037202457,0.00026678896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073295436,0.00015479118,0.00053751154,0.00042195307,0.000034672034,0.000008336768,0.00029409587,0.000090055175,0.0010345894],"category_scores_gemma":[0.000093822724,0.0001437131,0.000082407736,0.000828292,0.00016415601,0.00009232864,0.00021796903,0.00035377822,0.000016282565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018296713,0.00022062904,0.8386868,0.00046788645,0.0001620377,0.000088978464,0.008786783,0.000019917386,0.1430626,0.00017276403,0.00027243124,0.0062294537],"study_design_scores_gemma":[0.0035352395,0.0011362224,0.89679384,0.0050489223,0.00005937784,0.000019635405,0.003037086,0.00020512502,0.088786796,0.00011010582,0.000880296,0.00038737315],"about_ca_topic_score_codex":0.03539485,"about_ca_topic_score_gemma":0.003741694,"teacher_disagreement_score":0.058106974,"about_ca_system_score_codex":0.0014266022,"about_ca_system_score_gemma":0.00091010955,"threshold_uncertainty_score":0.9998786},"labels":[],"label_agreement":null},{"id":"W2327132015","doi":"10.1158/0008-5472.sabcs11-ot1-01-02","title":"OT1-01-02: A Multicentre Study Assessing 12-Weekly Intravenous Bisphosphonate Therapy in Women with Low Risk Bone Metastases from Breast Cancer – The TRIUMPH Trial.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Adverse effect; Internal medicine; Cancer; Bisphosphonate; Quality of life (healthcare); Disease; Surgery; Oncology; Osteoporosis","score_opus":0.09831010759620584,"score_gpt":0.4044968693748321,"score_spread":0.30618676177862625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327132015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876351,0.0057793274,0.0000030522838,0.00092939066,0.00020101295,0.0049129305,0.0003766936,0.000045724242,0.00011680751],"genre_scores_gemma":[0.98980176,0.0056668324,0.00008840974,0.00029500958,0.00013763306,0.0035032248,0.000015407848,0.000075622724,0.0004160798],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955591,0.0009820684,0.0004764984,0.0006907911,0.0010622651,0.0012292631],"domain_scores_gemma":[0.99788654,0.00043153192,0.00018589328,0.0007059497,0.0003122659,0.00047782937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017035962,0.00031792835,0.0006991982,0.000264533,0.00035446655,0.000091202055,0.0002561115,0.00010528193,0.0016551875],"category_scores_gemma":[0.00009203085,0.0001797412,0.000060782266,0.0008724204,0.00025404972,0.00017857963,0.00007583665,0.00108082,0.000031924224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30691382,0.009093933,0.2485574,0.000094391886,0.0015002599,0.0011545672,0.0369644,0.0000103026305,0.0005072752,0.000001875238,0.0004981758,0.3947036],"study_design_scores_gemma":[0.12418394,0.0044120504,0.8569057,0.00043018468,0.00018063124,0.000016243574,0.011175785,0.00004681848,0.0014406776,0.000065364286,0.00088387285,0.0002587049],"about_ca_topic_score_codex":0.3277375,"about_ca_topic_score_gemma":0.031517453,"teacher_disagreement_score":0.6083483,"about_ca_system_score_codex":0.0011712768,"about_ca_system_score_gemma":0.0019685535,"threshold_uncertainty_score":0.99925745},"labels":[],"label_agreement":null},{"id":"W2327283214","doi":"10.1158/0008-5472.sabcs-09-706","title":"Biomarker Profiles in Trastuzumab (T) Refractory HER2+ Inflammatory Breast Cancer (IBC) That Predict for Survival Benefit from Lapatinib (L) Monotherapy.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Lapatinib; Internal medicine; Oncology; Trastuzumab; Cohort; Biomarker; Breast cancer; Cancer; Immunohistochemistry; Progression-free survival; Overall survival; Proportional hazards model; Gastroenterology","score_opus":0.13191626037152934,"score_gpt":0.4425371703677506,"score_spread":0.3106209099962213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327283214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97491544,0.008550799,0.000032592154,0.008629634,0.00049683044,0.0039510657,0.0017599564,0.00014930483,0.001514347],"genre_scores_gemma":[0.98464197,0.0063662482,0.00017673527,0.00041693947,0.0015989206,0.003920872,0.00016147138,0.00017620133,0.0025406443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934158,0.00042054034,0.0007125156,0.0012325977,0.002413421,0.0018051314],"domain_scores_gemma":[0.99650687,0.00076239393,0.00013939447,0.0010521661,0.00090133626,0.00063781627],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024598807,0.00046233402,0.0008457208,0.00080267136,0.00026351423,0.00013365941,0.0007446172,0.000453437,0.0029794269],"category_scores_gemma":[0.00020764302,0.00041351415,0.00022523731,0.0010695976,0.00045173385,0.00032077622,0.00012412072,0.001531601,0.000046708545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012978066,0.0009151389,0.3749737,0.0006877226,0.0003691074,0.00018158997,0.0020133099,0.000055699627,0.09365408,0.00014864022,0.02691693,0.487106],"study_design_scores_gemma":[0.00829262,0.00094263256,0.9067018,0.0018714675,0.00004019336,0.00001131814,0.0007150385,0.0006989052,0.018265035,0.00085759145,0.061034247,0.00056916935],"about_ca_topic_score_codex":0.009313239,"about_ca_topic_score_gemma":0.005217304,"teacher_disagreement_score":0.5317281,"about_ca_system_score_codex":0.0030253918,"about_ca_system_score_gemma":0.0030955926,"threshold_uncertainty_score":0.9998317},"labels":[],"label_agreement":null},{"id":"W2327292235","doi":"10.1158/0008-5472.fbcr09-a6","title":"Abstract A6: Dissecting mechanisms of RANKL dependency in osteosarcoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"RANKL; Osteosarcoma; Cancer research; Carcinogenesis; Biology; Metastasis; Cancer; Pathology; Medicine; Receptor; Activator (genetics); Genetics","score_opus":0.10528585332707384,"score_gpt":0.44895601305706084,"score_spread":0.343670159729987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327292235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989816,0.00040855346,0.00010912256,0.0011219687,0.00013229757,0.0002992927,0.000007985289,0.000019813548,0.008084967],"genre_scores_gemma":[0.9992342,0.00007423555,0.00015934082,0.000057120924,0.0001517478,0.000027449743,0.0000052127634,0.000011912625,0.00027876883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986868,0.000042289492,0.0002652143,0.00020482781,0.00047427008,0.0003266291],"domain_scores_gemma":[0.99917394,0.00012936995,0.000042450985,0.00021854413,0.00033770996,0.00009798375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006689045,0.0000763834,0.0002011118,0.00032354714,0.00006549343,0.000014365367,0.00010986254,0.00006144017,0.0010891511],"category_scores_gemma":[0.00034449776,0.000066621906,0.000069827634,0.00045335985,0.000034310677,0.000077790406,0.000025028516,0.00060192996,0.000019491927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002297806,0.00016883542,0.0014949071,0.00006355229,0.000011525459,0.000063730564,0.0003012601,0.0000145566055,0.97500247,0.0011008953,0.00026426572,0.021284249],"study_design_scores_gemma":[0.0011306142,0.0005520459,0.07019698,0.00074091187,0.000008676924,0.000023169892,0.0006254664,0.00007698447,0.9215343,0.0046280846,0.0003942708,0.000088521396],"about_ca_topic_score_codex":0.001098773,"about_ca_topic_score_gemma":0.00028409561,"teacher_disagreement_score":0.06870207,"about_ca_system_score_codex":0.00015803114,"about_ca_system_score_gemma":0.00022832821,"threshold_uncertainty_score":0.999824},"labels":[],"label_agreement":null},{"id":"W2327382056","doi":"10.1158/1538-7445.am2013-930","title":"Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Angiogenesis; Medicine; Tyrosine-kinase inhibitor; Targeted therapy; Erythropoietin-producing hepatocellular (Eph) receptor; Cancer; Pharmacology; Receptor; Internal medicine","score_opus":0.07335841076048638,"score_gpt":0.3595713153221302,"score_spread":0.28621290456164383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327382056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951341,0.0028715173,0.00001910585,0.00087978534,0.00022077435,0.00070496177,0.00010391207,0.000011409879,0.000054425636],"genre_scores_gemma":[0.998189,0.0003888712,0.00006266009,0.000032394153,0.000043808337,0.00023942841,0.00015174565,0.000016649152,0.0008754659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985666,0.00018103921,0.0005595831,0.0002629501,0.000114574366,0.0003152506],"domain_scores_gemma":[0.9988012,0.00019765312,0.00016491754,0.000282999,0.0005254586,0.00002782076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065200304,0.00010638897,0.00032268462,0.0002568164,0.000055025186,0.000011929686,0.00022618027,0.0001905707,0.0012510445],"category_scores_gemma":[0.00029364342,0.00009345406,0.000053214728,0.000541214,0.0002560089,0.00018172602,0.000081445476,0.00028170962,0.00006538189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057751895,0.00027985586,0.005864742,0.00008423028,0.000038047525,8.2376914e-8,0.0005338309,0.000002713611,0.98824596,0.00007924777,0.0013920646,0.0029016752],"study_design_scores_gemma":[0.0006787483,0.00009429613,0.3630971,0.00024578627,0.0000017668885,6.300932e-8,0.000060832466,0.000001308842,0.63227206,0.000018689489,0.0034694597,0.000059894584],"about_ca_topic_score_codex":0.00077371835,"about_ca_topic_score_gemma":0.00022134931,"teacher_disagreement_score":0.35723236,"about_ca_system_score_codex":0.00011658206,"about_ca_system_score_gemma":0.00019745583,"threshold_uncertainty_score":0.9996619},"labels":[],"label_agreement":null},{"id":"W2327393509","doi":"10.1158/0008-5472.sabcs-1162","title":"Local control with conventional and hypofractionated adjuvant radiotherapy for ductal carcinoma in-situ: is there a difference in outcome?.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Ductal carcinoma; Radiation therapy; Dose fractionation; Adjuvant; Mastectomy; Retrospective cohort study; Cancer; Oncology; Radiology; Surgery; Internal medicine","score_opus":0.03475527254297508,"score_gpt":0.36161778104217,"score_spread":0.32686250849919496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327393509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705506,0.008369442,0.00056889595,0.0033816001,0.000026022444,0.00046166297,0.00006142933,0.000003555707,0.000072325376],"genre_scores_gemma":[0.99844086,0.00055442,0.00006561359,0.00034656582,0.00007221325,0.00031706903,0.000021376203,0.000011528083,0.00017034929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900633,0.000058098514,0.00012870357,0.00033796014,0.00017156858,0.00029731583],"domain_scores_gemma":[0.99962914,0.00004316572,0.000026497197,0.0001250849,0.00012572791,0.000050413564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014855598,0.00011552567,0.00017860584,0.00007860655,0.000065386106,0.000014650901,0.0000843665,0.0000697518,0.000019622626],"category_scores_gemma":[0.000014051735,0.00009050101,0.00002947519,0.00011762561,0.00018269986,0.000005892853,0.000017196235,0.00013142191,5.1203915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047724578,0.00024645714,0.8615512,0.00004059297,0.00013808072,0.000031914245,0.00020905414,0.000053870433,0.11150101,0.00022754475,0.00047423563,0.020753557],"study_design_scores_gemma":[0.0068235975,0.00047623864,0.97724587,0.000033128676,0.0000064674196,0.000014189031,0.00015501377,0.000103978644,0.013862159,0.00014570165,0.0010155705,0.00011807954],"about_ca_topic_score_codex":0.00042501086,"about_ca_topic_score_gemma":0.0011365494,"teacher_disagreement_score":0.11569464,"about_ca_system_score_codex":0.00015495483,"about_ca_system_score_gemma":0.00015505611,"threshold_uncertainty_score":0.3690524},"labels":[],"label_agreement":null},{"id":"W2327534410","doi":"10.1158/1538-7445.am2012-1305","title":"Abstract 1305: Alternative splicing of the metabolic regulator Estrogen-Related Receptor alpha (ERRα) in colon carcinogenesis","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Gene silencing; Cancer research; Carcinogenesis; Regulator; Coactivator; Colorectal cancer; Nuclear receptor; Small hairpin RNA; Chemistry; Cancer; Biology; Gene knockdown; Internal medicine; Medicine; Apoptosis; Transcription factor; Biochemistry","score_opus":0.03147012143233341,"score_gpt":0.3529531447265167,"score_spread":0.32148302329418327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327534410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96454066,0.033788353,0.0000011153703,0.00019122503,0.00032717257,0.00046479097,0.000023293924,0.000005903587,0.00065747165],"genre_scores_gemma":[0.9962181,0.0028081078,0.000023944041,0.000024064337,0.00024737185,0.000108934815,0.000015239885,0.000035918547,0.0005183227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810535,0.00031108566,0.0002790136,0.0003004757,0.0003876367,0.0006164622],"domain_scores_gemma":[0.9990884,0.00004893914,0.00010782472,0.00044593058,0.00016253856,0.0001463864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009852487,0.00015667464,0.00021464829,0.00011719187,0.00011659722,0.000011436739,0.0003956157,0.0002559973,0.00008340576],"category_scores_gemma":[0.000113769784,0.0001148504,0.00013283372,0.000502755,0.00024946022,0.0000102440235,0.00022225102,0.0004265861,0.000018985642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013499633,0.00008572555,0.039177164,0.000024771913,0.00013459488,0.0000014106241,0.00030418995,0.0001553189,0.957046,0.00055049977,0.00048121647,0.0019041293],"study_design_scores_gemma":[0.0005630076,0.00007251551,0.045515016,0.00006530854,0.000017817034,0.000004258851,0.00010051977,0.000016119733,0.94661784,0.000022909257,0.006884146,0.00012056226],"about_ca_topic_score_codex":0.0009679793,"about_ca_topic_score_gemma":0.000047004512,"teacher_disagreement_score":0.03167742,"about_ca_system_score_codex":0.00008646023,"about_ca_system_score_gemma":0.0002325927,"threshold_uncertainty_score":0.46834633},"labels":[],"label_agreement":null},{"id":"W2327586678","doi":"10.1158/1538-7445.am2015-4701","title":"Abstract 4701: NY-ESO T cells administered post ASCT for MM exhibit extended functionality without exhaustion in a natural pattern of effector and memory programming","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Computer Research Institute of Montréal","funders":"","keywords":"Medicine; CD28; Immunology; Antigen; Immunotherapy; Immune system; Multiple myeloma; Oncology; Cancer; Internal medicine; Leukapheresis; T cell; Stem cell; CD34; Biology","score_opus":0.11997577695296056,"score_gpt":0.43846624403139967,"score_spread":0.3184904670784391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327586678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386984,0.0018786398,0.000031551957,0.0006648443,0.00022731267,0.0029439616,0.000068848414,0.00002868791,0.00028629243],"genre_scores_gemma":[0.9955804,0.000061336475,0.00014862313,0.000053069463,0.00035837188,0.0007282892,0.000078184574,0.00004890015,0.002942838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693614,0.00024217916,0.00038558643,0.00053323025,0.0012338453,0.0006689917],"domain_scores_gemma":[0.99756265,0.000477115,0.00008449683,0.00040062884,0.001105727,0.0003693996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003389169,0.00018575846,0.00043881842,0.0003970415,0.000075834265,0.00005797374,0.00015960778,0.00015114756,0.0004832565],"category_scores_gemma":[0.00045666323,0.00015940881,0.00010052298,0.00040725447,0.00034073458,0.00013354483,0.00011378421,0.0007774771,0.000012073499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009808698,0.00036316636,0.017907241,0.001701575,0.0000996762,0.000042510103,0.0009646885,0.000004458774,0.72528034,0.00000268966,0.0008037301,0.24302125],"study_design_scores_gemma":[0.026070813,0.0062103895,0.46208873,0.0019230215,0.00008983618,0.000076829834,0.0038867465,0.0011140285,0.48472154,0.00011137841,0.013065984,0.0006406977],"about_ca_topic_score_codex":0.0027840612,"about_ca_topic_score_gemma":0.0011381499,"teacher_disagreement_score":0.4441815,"about_ca_system_score_codex":0.00062235136,"about_ca_system_score_gemma":0.00088386255,"threshold_uncertainty_score":0.6500503},"labels":[],"label_agreement":null},{"id":"W2327657083","doi":"10.1158/1538-7445.am10-2145","title":"Abstract 2145: Identification of genomic alterations and integrated gene expression profiles for MSS colon tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Loss of heterozygosity; SNP array; Genetics; Colorectal cancer; Cancer; Copy number analysis; Epigenetics; Comparative genomic hybridization; Copy-number variation; Cancer research; Gene; Single-nucleotide polymorphism; Genome; Allele; Genotype","score_opus":0.07379097639336156,"score_gpt":0.42017739936312976,"score_spread":0.3463864229697682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327657083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971946,0.00037397456,0.0001338093,0.00039332247,0.00026448278,0.0013747922,0.00014874473,0.00001678218,0.00009948625],"genre_scores_gemma":[0.99676794,0.00011695967,0.0015358219,0.000014966977,0.00017941752,0.0008394015,0.000069991256,0.000024274827,0.00045121898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988567,0.000034808818,0.00028643582,0.00028369328,0.00030487546,0.00023344201],"domain_scores_gemma":[0.9986844,0.00016198576,0.00008369791,0.00027115454,0.0006870353,0.00011172405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006342848,0.00008733609,0.0001689479,0.00017655284,0.00013195997,0.00003141696,0.000115321316,0.00010053478,0.00030634308],"category_scores_gemma":[0.00034789264,0.00007325757,0.000033825563,0.0001672519,0.00024915178,0.000052148815,0.00004790616,0.0003694185,0.000006206974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033403363,0.000047009464,0.004166033,0.00019659725,0.00001346182,9.562146e-7,0.00030392632,0.000011208127,0.9901798,0.000040190604,0.0014044911,0.0033022899],"study_design_scores_gemma":[0.00051404117,0.00017048567,0.09487179,0.00008325066,0.000010929938,0.000004080791,0.00012376555,0.00018634167,0.9028108,0.00015672564,0.0010081877,0.000059583297],"about_ca_topic_score_codex":0.00020067247,"about_ca_topic_score_gemma":0.00017657815,"teacher_disagreement_score":0.09070576,"about_ca_system_score_codex":0.00012357456,"about_ca_system_score_gemma":0.0005280418,"threshold_uncertainty_score":0.3354242},"labels":[],"label_agreement":null},{"id":"W2327705112","doi":"10.1158/1538-7445.am10-4087","title":"Abstract 4087: Large intergenic noncoding RNAs associated with Ewing sarcoma family of tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Sarcoma; Genetics; Intergenic region; Gene; DNA microarray; Genomics; Pediatric cancer; RNA; Gene expression profiling; Computational biology; Cancer; Genome; Gene expression; Medicine; Pathology","score_opus":0.03546548399805304,"score_gpt":0.3627908448324721,"score_spread":0.32732536083441904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327705112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945529,0.0008235139,0.00094790926,0.000123771,0.00021572156,0.00043448096,0.00008530128,0.000020315394,0.0027960702],"genre_scores_gemma":[0.99832886,0.00024642993,0.00011787524,0.000057012403,0.00024034565,0.00013066805,0.000079367324,0.00008177725,0.0007176651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970126,0.00016029282,0.0003227743,0.0005892124,0.0009418324,0.00097329775],"domain_scores_gemma":[0.9981256,0.000068738234,0.000116204625,0.0006572903,0.00079357816,0.00023857855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017220575,0.00020821957,0.00026525525,0.00026545112,0.00021110318,0.000055744767,0.00066013145,0.00030391949,0.0003043519],"category_scores_gemma":[0.0005623226,0.00019238959,0.00012870143,0.00061665935,0.000274682,0.000011304194,0.00041184938,0.0012814202,0.000017087863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027299495,0.00011155946,0.00040283092,0.000046420308,0.00016277365,0.00003296424,0.0000837227,0.00004023202,0.99508697,0.00014026115,0.0012778154,0.0023414292],"study_design_scores_gemma":[0.0012511654,0.00041008863,0.00399772,0.00019818734,0.000011544981,0.000007952867,0.00022013324,0.00008903144,0.9856067,0.000051855197,0.007918455,0.00023721527],"about_ca_topic_score_codex":0.00040045858,"about_ca_topic_score_gemma":0.0017682054,"teacher_disagreement_score":0.009480345,"about_ca_system_score_codex":0.00013727132,"about_ca_system_score_gemma":0.0009548938,"threshold_uncertainty_score":0.78454196},"labels":[],"label_agreement":null},{"id":"W2327814134","doi":"10.1158/0008-5472.sabcs10-p1-10-05","title":"Abstract P1-10-05: The Impact of Resource Setting and Guidelines on Global Early Breast Cancer Practice","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Family medicine; Guideline; Tamoxifen; Internal medicine; Gynecology; Cancer; Pathology","score_opus":0.18439742322501293,"score_gpt":0.5401066128028843,"score_spread":0.35570918957787134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327814134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97053975,0.0019317681,0.0000014926408,0.01879556,0.00010227999,0.00041277314,0.00021792065,0.000024654852,0.00797379],"genre_scores_gemma":[0.9972179,0.0004084301,0.00014857897,0.00070887693,0.0010183549,0.000064956,0.000004265935,0.000021934953,0.00040670598],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99736947,0.000112798436,0.00035401204,0.0003849487,0.0011767885,0.00060195493],"domain_scores_gemma":[0.99707544,0.00045973505,0.00015549074,0.0005168832,0.0015107164,0.0002817518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024154359,0.00017779671,0.0002674471,0.00008318344,0.00026518176,0.0000916997,0.0003049949,0.00013477712,0.0007646836],"category_scores_gemma":[0.0016412126,0.00010869881,0.00011111488,0.0005847949,0.00040250312,0.00021863624,0.00014166794,0.0010636003,0.000015454936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009229859,0.0001849166,0.23241259,0.00021533335,0.00050137454,0.00021574718,0.0012107756,0.0004958228,0.06588766,0.00048344862,0.38193682,0.30722564],"study_design_scores_gemma":[0.0013501267,0.0006515862,0.9603024,0.0011126581,0.000076933204,0.00035136117,0.0015056297,0.00017091705,0.0020555605,0.00013540065,0.032074623,0.00021277719],"about_ca_topic_score_codex":0.0545001,"about_ca_topic_score_gemma":0.0011231067,"teacher_disagreement_score":0.72788984,"about_ca_system_score_codex":0.0003524613,"about_ca_system_score_gemma":0.001094252,"threshold_uncertainty_score":0.95179605},"labels":[],"label_agreement":null},{"id":"W2327823306","doi":"10.1158/1538-7445.am2013-4284","title":"Abstract 4284: Cadherin-11 function is required for full neoplastic transformation of mouse fibroblasts by v-Src.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University","funders":"","keywords":"STAT3; STAT protein; Gene knockdown; Biology; Cancer research; Transcription factor; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Small hairpin RNA; Signal transduction; E2F; STAT4; Cell growth; Cell cycle; Apoptosis; stat; Gene; Genetics","score_opus":0.04065285842004938,"score_gpt":0.3522282267261798,"score_spread":0.3115753683061304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327823306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540114,0.0004293614,0.0017698734,0.0005388858,0.000098138036,0.0010748081,0.0003462771,0.0000124916205,0.00032902093],"genre_scores_gemma":[0.99470925,0.0003017834,0.000062665815,0.00004028211,0.00015187038,0.00059982116,0.00029681856,0.000043921696,0.0037935653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805933,0.000078731566,0.00031577676,0.00038573853,0.0005417198,0.0006187062],"domain_scores_gemma":[0.9984969,0.000076018805,0.00006723741,0.0003775866,0.00080077775,0.000181502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042666178,0.00015490546,0.00017271066,0.00012676483,0.000115447445,0.000060802016,0.00030406957,0.00023465644,0.0008873945],"category_scores_gemma":[0.00014899182,0.00014651482,0.000102705024,0.00021474,0.00017701824,0.000033236298,0.000071790346,0.00020746607,0.000084138184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004365767,0.000055611443,0.00020448794,0.0002629782,0.000043823693,1.43279e-7,0.00010173345,0.000040804185,0.9021557,0.0000117692,0.09341524,0.003271154],"study_design_scores_gemma":[0.0007367951,0.00080742314,0.0008610461,0.000035787903,0.0000057885277,0.0000010530175,0.00018435971,0.00021556449,0.9598992,0.000059676575,0.037039492,0.00015380263],"about_ca_topic_score_codex":0.0013947627,"about_ca_topic_score_gemma":0.0003377855,"teacher_disagreement_score":0.057743527,"about_ca_system_score_codex":0.000106980966,"about_ca_system_score_gemma":0.00030512424,"threshold_uncertainty_score":0.97163475},"labels":[],"label_agreement":null},{"id":"W2327835887","doi":"10.1158/1538-7445.am2013-2376","title":"Abstract 2376: Improved progression-free survival (PFS) in patients with short tumor telomere length: Subgroup analysis from a randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced NSCLC .","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Telomerase; Telomere; Medicine; Internal medicine; Oncology; Biology; Cancer research; Genetics","score_opus":0.02880326899768943,"score_gpt":0.3675628717224027,"score_spread":0.3387596027247133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327835887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825232,0.0010834524,0.000017095985,0.000507787,0.00022240695,0.0152681675,0.00027075576,0.000047967445,0.000059160884],"genre_scores_gemma":[0.9933984,0.00024735302,0.00037088734,0.00009993655,0.00015372904,0.005353161,0.000086386215,0.00009462349,0.00019547436],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939033,0.00060242735,0.0011576987,0.0011294025,0.0020821912,0.0011249743],"domain_scores_gemma":[0.9943702,0.0014113068,0.00036748807,0.0016768062,0.0017798156,0.0003943356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001968932,0.00051719625,0.00190304,0.00074717,0.00039537245,0.000080474136,0.00087589654,0.00013759945,0.0004384791],"category_scores_gemma":[0.001521744,0.0002926961,0.00040948796,0.0027236044,0.0007011887,0.00037050553,0.00028631042,0.00090442476,0.0000046134173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43533632,0.01409608,0.32078484,0.00024350004,0.0031030034,0.000046727375,0.004658552,0.000028638742,0.083853565,0.000009831383,0.00052441703,0.13731453],"study_design_scores_gemma":[0.5169617,0.007923621,0.42493507,0.00086966425,0.00055287225,9.933981e-7,0.004617416,0.0003990163,0.042756073,0.00013391997,0.00016715574,0.00068250473],"about_ca_topic_score_codex":0.008021127,"about_ca_topic_score_gemma":0.0024762196,"teacher_disagreement_score":0.13663203,"about_ca_system_score_codex":0.00029432727,"about_ca_system_score_gemma":0.00070448685,"threshold_uncertainty_score":0.9999525},"labels":[],"label_agreement":null},{"id":"W2327847401","doi":"10.1158/1538-7445.am2012-lb-52","title":"Abstract LB-52: Relentless in the fight against blood cancer: the Leukemia &amp; Lymphoma Society","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Leukemia; Lymphoma; Disease; Multiple myeloma; Quality of life (healthcare); Family medicine; Internal medicine; Oncology; Nursing","score_opus":0.10722723644145146,"score_gpt":0.4226506969041498,"score_spread":0.3154234604626983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327847401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589156,0.019987265,0.0000019659033,0.008712212,0.00029340637,0.0017699839,0.000045628887,0.000047294347,0.010226637],"genre_scores_gemma":[0.9735454,0.0154717015,0.00002988612,0.002583909,0.0020484778,0.0022489177,0.000035819594,0.00008035613,0.003955555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935552,0.00046746578,0.00047882888,0.0005599622,0.0027720914,0.0021664554],"domain_scores_gemma":[0.99616295,0.001410222,0.00008857585,0.0015205173,0.00041570066,0.000402025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053452323,0.00029980156,0.00040676448,0.00016626192,0.00058465084,0.00014346513,0.0012486419,0.00029105227,0.0010666798],"category_scores_gemma":[0.00042062148,0.0001675143,0.00027223415,0.0015918965,0.0008325138,0.00023003524,0.00039745582,0.0016755288,0.0003498077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013182287,0.0016273524,0.02332006,0.002193197,0.001021124,0.00038845767,0.03372794,0.00030490512,0.043775856,0.0010928074,0.76669556,0.1245345],"study_design_scores_gemma":[0.023556804,0.00012908212,0.054771163,0.0012601606,0.00014355019,0.00022011671,0.0051133935,0.0007436343,0.020522965,0.00012785823,0.89283305,0.0005782469],"about_ca_topic_score_codex":0.014302544,"about_ca_topic_score_gemma":0.0021136934,"teacher_disagreement_score":0.12613747,"about_ca_system_score_codex":0.026804388,"about_ca_system_score_gemma":0.01876508,"threshold_uncertainty_score":0.99984646},"labels":[],"label_agreement":null},{"id":"W2327857135","doi":"10.1158/1538-7445.am2012-809","title":"Abstract 809: Prenatal and postnatal management of infants at 100%-risk for developing retinoblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Retinoblastoma; Pediatrics; Surgery; Chemotherapy; Cisplatin","score_opus":0.07575314139567006,"score_gpt":0.4391288783285041,"score_spread":0.36337573693283404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327857135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993771,0.0035568594,0.000012714135,0.00023132125,0.000089542176,0.0007424699,0.000058498892,0.00001064861,0.0015269058],"genre_scores_gemma":[0.9964369,0.0010040513,0.0013003378,0.000018661272,0.000078063924,0.00016073372,0.000026197966,0.000015035046,0.00096001575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989857,0.00003362613,0.00014217955,0.00017575583,0.0002686616,0.0003940897],"domain_scores_gemma":[0.9994375,0.000112067435,0.00004761951,0.0001648009,0.000118846016,0.00011914342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055232254,0.00008047176,0.0001588213,0.00010091567,0.00013966559,0.0000045287,0.000059252503,0.00008090079,0.00010848967],"category_scores_gemma":[0.000048336657,0.000066138404,0.000035721296,0.000112698624,0.00014296215,0.00007643972,0.00015324236,0.00015529992,0.000021830825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062047658,0.00042060754,0.89014035,0.0030879101,0.0016689938,0.00025091151,0.0013718323,0.000001071884,0.0051560705,0.0008998587,0.0022051698,0.08859246],"study_design_scores_gemma":[0.002806113,0.00030248155,0.9169724,0.00046800842,0.00008510893,0.00003715686,0.00016626652,0.0000049919654,0.07564183,0.000046636214,0.0033914393,0.00007757169],"about_ca_topic_score_codex":0.00008288443,"about_ca_topic_score_gemma":0.00002433875,"teacher_disagreement_score":0.08851489,"about_ca_system_score_codex":0.00024144651,"about_ca_system_score_gemma":0.0000868814,"threshold_uncertainty_score":0.26970458},"labels":[],"label_agreement":null},{"id":"W2327927685","doi":"10.1158/1538-7445.am2013-1527","title":"Abstract 1527: Investigation the role of prostate cancer derived exosomes on their tumor microenvironment.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microvesicles; Microvesicle; Paracrine signalling; Prostate cancer; Cancer research; Cancer; Secretion; Cancer cell; Medicine; Tumor microenvironment; Exosome; Cell biology; Biology; Pathology; microRNA; Internal medicine; Biochemistry","score_opus":0.02311242860110729,"score_gpt":0.30307488396515797,"score_spread":0.2799624553640507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327927685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886587,0.009357467,0.0000010436133,0.0008790677,0.000041680312,0.0006336192,0.00006402724,0.0000054187385,0.0003589509],"genre_scores_gemma":[0.9969204,0.00143864,0.000025321735,0.00020102801,0.00015462606,0.0006897961,0.00003191199,0.000029331293,0.0005089502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987833,0.00013094174,0.00016838248,0.00030428555,0.00028067082,0.00033244304],"domain_scores_gemma":[0.9991836,0.00003585462,0.0000770537,0.00046684002,0.00012170532,0.00011495121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027109243,0.000120062374,0.00009302443,0.000040049657,0.00012083756,0.000034694764,0.00035790828,0.000056134202,0.00034103284],"category_scores_gemma":[0.000058715614,0.00008343449,0.000056327546,0.00009934175,0.00048812883,0.000007996626,0.00014474354,0.0002037603,0.00004497032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006649768,0.000041744846,0.012085001,0.000032439802,0.00003551004,9.3216204e-7,0.00019009816,0.00010785716,0.9782934,0.000020945574,0.0017033047,0.0074222204],"study_design_scores_gemma":[0.00020659377,0.00006968477,0.057257652,0.00004495426,0.0000041330495,5.295733e-7,0.0004065266,0.000023130558,0.93405735,0.0007090111,0.0071312296,0.00008922718],"about_ca_topic_score_codex":0.0006736661,"about_ca_topic_score_gemma":0.00007634015,"teacher_disagreement_score":0.04517265,"about_ca_system_score_codex":0.000059929112,"about_ca_system_score_gemma":0.00019951139,"threshold_uncertainty_score":0.37340704},"labels":[],"label_agreement":null},{"id":"W2327928092","doi":"10.1158/1538-7445.am2012-1435","title":"Abstract 1435: Phenotype:Genotype correlations of p53 mutation carriers: The 20-year Toronto experience","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Missense mutation; Genetics; Sanger sequencing; Multiplex ligation-dependent probe amplification; Biology; Germline mutation; Genotype; Mutation; Exon; Cancer research; Gene","score_opus":0.07705810494226542,"score_gpt":0.41097316756103724,"score_spread":0.3339150626187718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327928092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589401,0.01590834,0.00025283702,0.0005849102,0.00071801577,0.00090926513,0.000047087084,0.00004154924,0.022597903],"genre_scores_gemma":[0.99793655,0.00037994364,0.00012062818,0.00006786305,0.0004403944,0.00020510769,0.000024451681,0.00003387791,0.0007911929],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981267,0.00009306923,0.00024811015,0.0002133944,0.0008192718,0.0004994889],"domain_scores_gemma":[0.9985162,0.00014985599,0.00007658514,0.0005251708,0.0005118374,0.00022033184],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006594817,0.00011042494,0.00017258919,0.00007296019,0.00019651298,0.000017563834,0.00018727312,0.00012030195,0.002471109],"category_scores_gemma":[0.00032993616,0.00008535416,0.00007458749,0.00040627044,0.00031844885,0.00021421105,0.000064957676,0.00045368576,0.000106865446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016498172,0.00052392937,0.023422189,0.00041330053,0.00044377678,0.0000378345,0.06456383,0.0010539447,0.8316935,0.005630293,0.028250206,0.042317435],"study_design_scores_gemma":[0.0066902917,0.0011715825,0.37112537,0.0011866284,0.0003933654,0.000086268985,0.04617722,0.0008309956,0.3392479,0.00050591596,0.23159212,0.000992349],"about_ca_topic_score_codex":0.004361924,"about_ca_topic_score_gemma":0.0011881317,"teacher_disagreement_score":0.49244553,"about_ca_system_score_codex":0.00071722944,"about_ca_system_score_gemma":0.00056118227,"threshold_uncertainty_score":0.99844074},"labels":[],"label_agreement":null},{"id":"W2328001740","doi":"10.1158/1538-7445.am2013-3929","title":"Abstract 3929: Estrone-3-sulphate, a potential novel ligand for targeting breast cancers.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Estrone; Breast cancer; In vivo; Cancer research; Organic anion-transporting polypeptide; Estrogen; Internal medicine; Hormone; In vitro; Cancer; Chemistry; Medicine; Ligand (biochemistry); Pharmacology; Endocrinology; Receptor; Biology; Transporter; Biochemistry","score_opus":0.020828160240086453,"score_gpt":0.3381797867642869,"score_spread":0.31735162652420046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328001740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924817,0.0049567446,0.00032913554,0.0006259177,0.00026075504,0.00082944735,0.000098518656,0.000017574948,0.00040018422],"genre_scores_gemma":[0.9957127,0.0007293552,0.0002893977,0.000060046183,0.0009806465,0.00064506504,0.00015171707,0.00004964442,0.0013814234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983165,0.000033623706,0.00018968334,0.00045468565,0.00027242873,0.0007330658],"domain_scores_gemma":[0.9990485,0.00002788776,0.000053829302,0.00025122886,0.0004064203,0.00021216599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040522538,0.00016446372,0.00014889975,0.000070704315,0.00027407455,0.00010044507,0.00027688826,0.00024344331,0.00010025682],"category_scores_gemma":[0.00005956672,0.00014345377,0.000113331196,0.00014539629,0.00016285796,0.000012500927,0.00012510364,0.00033232872,0.000049569644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010345284,0.000046005516,0.00025308662,0.000049401635,0.000098537465,0.000002868253,0.00002509926,0.00029434962,0.97096264,0.000017128095,0.024362814,0.0037846235],"study_design_scores_gemma":[0.0019828083,0.00037382214,0.0033108606,0.00008092755,0.000020444373,0.000031514064,0.00018154773,0.00033358918,0.97162783,0.00007157389,0.021622589,0.00036251955],"about_ca_topic_score_codex":0.00090745324,"about_ca_topic_score_gemma":0.000025466776,"teacher_disagreement_score":0.004227389,"about_ca_system_score_codex":0.00009795935,"about_ca_system_score_gemma":0.00044618148,"threshold_uncertainty_score":0.5849875},"labels":[],"label_agreement":null},{"id":"W2328019051","doi":"10.1158/1538-7445.am10-5099","title":"Abstract 5099: Adiponectin inhibits oxidative stress in prostate cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"DU145; Adiponectin; Oxidative stress; Endocrinology; Internal medicine; Catalase; Chemistry; Adiponectin receptor 1; Reactive oxygen species; Biology; LNCaP; Prostate cancer; Cancer; Medicine; Biochemistry; Insulin resistance; Obesity","score_opus":0.04246996727520016,"score_gpt":0.38967929712703175,"score_spread":0.3472093298518316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328019051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910669,0.0018607924,8.025434e-7,0.001134731,0.000443135,0.0010628978,0.00020148457,0.000044665085,0.004184631],"genre_scores_gemma":[0.9918185,0.0017837875,0.00004823446,0.00010894635,0.0008476211,0.0007397876,0.000040961542,0.000041144398,0.004571046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977577,0.000079854704,0.00032779798,0.00042906206,0.0007378386,0.0006677798],"domain_scores_gemma":[0.99836975,0.00015373516,0.00007849728,0.00037573455,0.0006461565,0.00037614658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007120727,0.00017506439,0.00030282547,0.00039832442,0.00012463884,0.000049016777,0.0001765667,0.00010430723,0.0024903314],"category_scores_gemma":[0.00034366184,0.0001481336,0.000060281476,0.00069105433,0.00026992298,0.00021649517,0.00006748811,0.0010141095,0.00011194317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006177667,0.00029367727,0.04665824,0.0004308835,0.00006543352,0.00009342929,0.0020402283,0.00007833342,0.9153815,0.00019259464,0.004421411,0.029726518],"study_design_scores_gemma":[0.0017344685,0.00005488802,0.21121566,0.00044687782,0.00002904451,0.0000030546462,0.00044228515,0.000025975329,0.7495163,0.000119702076,0.03622832,0.00018342219],"about_ca_topic_score_codex":0.005972783,"about_ca_topic_score_gemma":0.008723787,"teacher_disagreement_score":0.16586518,"about_ca_system_score_codex":0.00016389182,"about_ca_system_score_gemma":0.0013844556,"threshold_uncertainty_score":0.99842155},"labels":[],"label_agreement":null},{"id":"W2328029782","doi":"10.1158/1538-7445.am10-938","title":"Abstract 938: Inflammation and immune response pathway analysis of lung cancer using hierarchal modeling based on GWAS data","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Genome-wide association study; KEGG; Inflammation; Immune system; Biology; Carcinogenesis; Cancer; Computational biology; Immunology; Gene; Genetics; Transcriptome; Single-nucleotide polymorphism; Genotype; Gene expression","score_opus":0.15732386264180453,"score_gpt":0.4532557209861567,"score_spread":0.29593185834435215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328029782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567163,0.0016150537,0.00020615211,0.001567941,0.00011139992,0.00045077028,0.00023493463,0.000018886141,0.00012325871],"genre_scores_gemma":[0.9987425,0.0003976101,0.00031688012,0.000039911665,0.0002285846,0.00011439557,0.00008860603,0.000031736163,0.000039767823],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975523,0.00017143654,0.00040844295,0.000520809,0.0009427238,0.00040431158],"domain_scores_gemma":[0.9978366,0.00028904507,0.0001057593,0.0010376123,0.00054869795,0.00018228649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029530972,0.00015064026,0.00042518196,0.0009573723,0.00018403452,0.000049659433,0.0002951851,0.00014079339,0.0006549646],"category_scores_gemma":[0.00038770217,0.00013042227,0.00009062334,0.0012946763,0.00019387767,0.00018613414,0.00017733559,0.00079518405,9.883687e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004776489,0.00009236638,0.018246198,0.0003197058,0.0005314707,0.000011788165,0.00040950387,0.025733966,0.9298823,0.000057476173,0.00004189849,0.019896828],"study_design_scores_gemma":[0.0010656646,0.00010528209,0.047120772,0.00042101162,0.00039376426,6.9072615e-7,0.00009413966,0.8829127,0.06746664,0.000010251875,0.00027045258,0.00013866571],"about_ca_topic_score_codex":0.0050269444,"about_ca_topic_score_gemma":0.0007703043,"teacher_disagreement_score":0.8624157,"about_ca_system_score_codex":0.00023746908,"about_ca_system_score_gemma":0.0011828922,"threshold_uncertainty_score":0.759927},"labels":[],"label_agreement":null},{"id":"W2328059020","doi":"10.1158/1538-7445.am2013-2468","title":"Abstract 2468: Novel 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates highly selective against breast cancer cells: Design, synthesis and biological evaluation.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières; Université de Sherbrooke; Université Laval","funders":"","keywords":"Breast cancer; Tamoxifen; Cancer; Medicine; Cancer research; Aromatase; Context (archaeology); Internal medicine; Pharmacology; Oncology; Biology","score_opus":0.17327878012666842,"score_gpt":0.3688527899313554,"score_spread":0.19557400980468698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328059020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167407,0.0020346486,0.000016602355,0.0016011347,0.000084964515,0.0005751785,0.00045944907,0.00009492539,0.0034590398],"genre_scores_gemma":[0.9927089,0.0036154573,0.00016257512,0.000103219936,0.00050286297,0.0027280382,0.000010561538,0.00003789998,0.00013045085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996422,0.00029869942,0.00037770518,0.0010130986,0.00088967744,0.0009988532],"domain_scores_gemma":[0.9950794,0.002978239,0.00014337653,0.0003775015,0.00107804,0.00034341874],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001849915,0.0003693229,0.0004805523,0.00012734566,0.0004657731,0.0002309194,0.0005141574,0.00045503603,0.009022205],"category_scores_gemma":[0.00077503704,0.00024982134,0.00011854328,0.00041852222,0.0005093931,0.00025244526,0.00025353473,0.00073448656,0.00010538493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016766517,0.0002702995,0.003948389,0.00006813413,0.00011330382,0.0000028913962,0.000045653753,0.000093430805,0.8773638,0.000018313945,0.0016244394,0.116283655],"study_design_scores_gemma":[0.00042507128,0.000032518004,0.09726891,0.00018052974,0.000027804526,0.000005203726,0.00023323424,0.00085668685,0.8994666,0.0004343164,0.00066060893,0.0004085176],"about_ca_topic_score_codex":0.0031920075,"about_ca_topic_score_gemma":0.000069413836,"teacher_disagreement_score":0.11587513,"about_ca_system_score_codex":0.00068621786,"about_ca_system_score_gemma":0.00042726536,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2328061424","doi":"10.1158/0008-5472.fbcr09-b48","title":"Abstract B48: Germline mutations in BRCA1 and BRCA2 as predictive biomarkers of therapy response","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Lakehead University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer research; Ovarian cancer; Germline mutation; Cancer; Doxorubicin; Internal medicine; Chemosensitivity assay; Paclitaxel; Chemotherapy; Germline; Mutation; Biology; Gene; Genetics","score_opus":0.04245410394157669,"score_gpt":0.41391531731173653,"score_spread":0.37146121337015986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328061424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910478,0.0058914996,0.000033369222,0.0018454007,0.00004624472,0.0003494941,0.00006244919,0.000005569313,0.000718156],"genre_scores_gemma":[0.9967122,0.0025346167,0.00015354884,0.000119319295,0.00008306409,0.00010435771,0.000028419508,0.000014190519,0.0002502568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987755,0.00017976656,0.00020448735,0.00033081486,0.00025233146,0.00025711092],"domain_scores_gemma":[0.99923295,0.00009586043,0.000048079146,0.00028420682,0.00026709036,0.00007182939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009256219,0.00009330283,0.00011058942,0.00021807327,0.000069439586,0.00001814727,0.00016941247,0.00011845123,0.000087303306],"category_scores_gemma":[0.00026991905,0.000092277194,0.000034118264,0.0003831547,0.00029500198,0.0000071775003,0.00004094258,0.00017000678,0.0000031943875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003337237,0.00007960316,0.0015855186,0.0000098374985,0.000058647205,0.00000656243,0.00055478956,0.0002629188,0.9681686,0.000024187333,0.0014056367,0.024506442],"study_design_scores_gemma":[0.0014538816,0.0009239009,0.33837652,0.000050817853,0.0000040127334,0.00000687305,0.0005950077,0.00005056475,0.649573,0.0008392121,0.007986821,0.000139378],"about_ca_topic_score_codex":0.0002567701,"about_ca_topic_score_gemma":0.00009810294,"teacher_disagreement_score":0.336791,"about_ca_system_score_codex":0.00014888767,"about_ca_system_score_gemma":0.0008210255,"threshold_uncertainty_score":0.37629548},"labels":[],"label_agreement":null},{"id":"W2328069724","doi":"10.1158/1538-7445.am10-1832","title":"Abstract 1832: Associations between ovarian cancer and other malignant neoplasms in an international population-based study","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Germ cell tumors; Serous fluid; Population; Oncology; Internal medicine; Stomach cancer; Incidence (geometry); Ovary; Epidemiology; Cancer registry; Cumulative incidence; Gynecology; Pathology; Cohort","score_opus":0.1115620759545287,"score_gpt":0.4590718012458812,"score_spread":0.3475097252913525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328069724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934477,0.000069669426,9.840941e-7,0.00442659,0.00027806425,0.0008729092,0.00036071806,0.000021839904,0.0005214843],"genre_scores_gemma":[0.99821365,0.000026579588,0.00010756192,0.00016652718,0.0005768238,0.0006541893,0.00009373792,0.000030653322,0.0001302707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983124,0.000068711044,0.0002662382,0.0004123959,0.00061556324,0.0003247066],"domain_scores_gemma":[0.99901354,0.0002088041,0.00006473855,0.00029431086,0.00021936077,0.00019921572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073186785,0.00012299916,0.00023989324,0.0003092078,0.00013514383,0.00009918534,0.00013388181,0.00010032234,0.0013047551],"category_scores_gemma":[0.0000862233,0.00010552789,0.000033893713,0.00029943383,0.000042489857,0.00013355217,0.00003453739,0.00051179534,0.0000112226035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006865245,0.0005982075,0.9880814,0.000012416276,0.00011305265,0.000025168592,0.00038764486,0.000024547291,0.00064775633,0.00021480893,0.00010015982,0.009726216],"study_design_scores_gemma":[0.002793768,0.00016192703,0.99484384,0.00008226841,0.00003699437,4.0024494e-7,0.000106668085,0.00005271054,0.00039259056,0.00009902039,0.0013299646,0.00009985585],"about_ca_topic_score_codex":0.04340789,"about_ca_topic_score_gemma":0.056787964,"teacher_disagreement_score":0.013380073,"about_ca_system_score_codex":0.0005674965,"about_ca_system_score_gemma":0.00045788477,"threshold_uncertainty_score":0.99960816},"labels":[],"label_agreement":null},{"id":"W2328077432","doi":"10.1158/1538-7445.am2012-lb-146","title":"Abstract LB-146: A study of p16 inactivation in lung cancer cell lines and tumor samples with a meta-analysis of the literature","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"KRAS; Methylation; Adenocarcinoma; Lung cancer; Mutation; Cancer research; Biology; Cancer; Meta-analysis; Oncology; Genetics; Medicine; Internal medicine; Gene","score_opus":0.09758618536715338,"score_gpt":0.41563396797147356,"score_spread":0.3180477826043202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328077432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614599,0.03804794,0.000009105202,0.000051970947,0.0000136173785,0.0003047571,0.00004832109,6.386578e-7,0.00006375876],"genre_scores_gemma":[0.99873143,0.0009469738,0.00003448564,0.000007604443,0.000045719404,0.00012934531,0.000011783236,0.000008141424,0.000084493215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991129,0.00014696515,0.00016842363,0.00017003367,0.00024869447,0.0001529758],"domain_scores_gemma":[0.99929297,0.000046518395,0.00010321014,0.00024348758,0.0002804268,0.000033387227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055133476,0.00007477262,0.00022475739,0.00010677342,0.000038357826,0.000012883432,0.0001031257,0.00004812058,0.00004011498],"category_scores_gemma":[0.000045115605,0.00004412096,0.00007085103,0.00060613576,0.000054903732,0.000008160597,0.00006702786,0.00010968117,2.1495644e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107692336,0.00019410693,0.24973366,0.00008656018,0.0033330608,2.1228367e-7,0.0015273831,0.00077446393,0.74403757,0.0000054256225,0.000015425576,0.00018441834],"study_design_scores_gemma":[0.0002685195,0.00010617018,0.4259786,0.000012875051,0.0021350044,5.6614553e-8,0.000633358,0.00002902977,0.57064676,0.000005048356,0.00012496159,0.000059614515],"about_ca_topic_score_codex":0.0035129844,"about_ca_topic_score_gemma":0.006574749,"teacher_disagreement_score":0.17624494,"about_ca_system_score_codex":0.00002549764,"about_ca_system_score_gemma":0.000079345955,"threshold_uncertainty_score":0.5310605},"labels":[],"label_agreement":null},{"id":"W2328183592","doi":"10.1158/1538-7445.am2012-lb-140","title":"Abstract LB-140: Targeting brain tumour initiating cells using a dual-pronged approach of oncolytic virotherapy and chemotherapeutics","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Cancer research; Synthetic lethality; Virotherapy; Biology; Medicine; DNA repair; Gene","score_opus":0.10872101150744787,"score_gpt":0.4156410586176868,"score_spread":0.3069200471102389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328183592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080443,0.0074135023,0.00019059193,0.00015843815,0.000058177524,0.00062048604,0.00002843331,0.000010963156,0.00071495585],"genre_scores_gemma":[0.99647874,0.0009750115,0.0013393355,0.00018135898,0.00068598805,0.00008742231,0.000020076848,0.00009082887,0.00014125048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972929,0.00037545752,0.00034082762,0.00042754365,0.000613082,0.0009502248],"domain_scores_gemma":[0.9988745,0.00012472009,0.000121708224,0.00037078536,0.00027107712,0.00023723683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030331705,0.00021385976,0.0002661661,0.00017135333,0.00023400228,0.000051886385,0.00027076894,0.00020303573,0.00010340481],"category_scores_gemma":[0.000120282864,0.00020843577,0.00007882919,0.0003450628,0.00036660963,0.000018879253,0.00018098271,0.00048849615,0.0000043543023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007544629,0.00015171875,0.001123478,0.00018120155,0.00010039648,0.0000014478693,0.0005994267,0.00015034057,0.9899195,0.0000087890685,0.0002618441,0.006747394],"study_design_scores_gemma":[0.0009891036,0.00053919567,0.0006614132,0.000049831087,0.00000757431,0.0000055728365,0.0005797832,0.0005596601,0.99491066,0.000021404781,0.0014466506,0.00022915936],"about_ca_topic_score_codex":0.00016257177,"about_ca_topic_score_gemma":0.000026097661,"teacher_disagreement_score":0.0065182345,"about_ca_system_score_codex":0.00012306144,"about_ca_system_score_gemma":0.00043911528,"threshold_uncertainty_score":0.8499764},"labels":[],"label_agreement":null},{"id":"W2328220145","doi":"10.1158/1538-7445.am2011-4673","title":"Abstract 4673: Host genetic polymorphisms at TIMP3 are associated with survival of patients with adenocarcinoma of esophagus and gastoeophageal junction","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Esophagus; Medicine; Cancer; Oncology; Adenocarcinoma; Internal medicine; Proportional hazards model; Single-nucleotide polymorphism; Esophageal cancer; Biology; Genotype; Gene; Genetics","score_opus":0.05991871349280589,"score_gpt":0.31395894301889055,"score_spread":0.2540402295260846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328220145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850487,0.013524068,0.0000031381287,0.000051623156,0.000048640006,0.0008840541,0.00015685479,0.000016811473,0.0002660823],"genre_scores_gemma":[0.99889874,0.00020270873,0.00007358229,0.000010767755,0.000045897752,0.00011703871,0.000044917782,0.000048223665,0.00055813725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716485,0.00012449524,0.00027588452,0.00042061458,0.0014271892,0.0005869742],"domain_scores_gemma":[0.9980393,0.00010943346,0.00018962484,0.00037101167,0.00091628433,0.0003743235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033257218,0.0002019303,0.00045843903,0.00028348307,0.00012723093,0.000009662252,0.00012918479,0.00009543474,0.0007592806],"category_scores_gemma":[0.00007349028,0.00013897994,0.000049495677,0.00051347195,0.0006292413,0.00008524368,0.000100474965,0.00034724394,0.000008985417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075020734,0.0005833259,0.989279,0.00023121317,0.0003544886,0.00026833906,0.00034313538,0.0000015517268,0.00041736665,0.000005607941,0.00012302933,0.00089087506],"study_design_scores_gemma":[0.0054734005,0.004779616,0.9723313,0.00033925267,0.000089449735,0.000006882138,0.00009521973,0.0000034577229,0.01676896,0.000009865667,0.0000019104102,0.00010070404],"about_ca_topic_score_codex":0.002995983,"about_ca_topic_score_gemma":0.0011416872,"teacher_disagreement_score":0.01694771,"about_ca_system_score_codex":0.0005158042,"about_ca_system_score_gemma":0.0004479229,"threshold_uncertainty_score":0.83135897},"labels":[],"label_agreement":null},{"id":"W2328236393","doi":"10.1158/0008-5472.fbcr09-c31","title":"Abstract C31: Identification of causal genetic events in oral cancer progression","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Comparative genomic hybridization; Carcinogenesis; Disease; Biology; Tumor progression; Dysplasia; Gene dosage; Gene; Cancer research; Pathology; Genetics; Genome; Medicine; Gene expression","score_opus":0.13794684842910523,"score_gpt":0.5196212780544118,"score_spread":0.3816744296253066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328236393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886729,0.007359082,0.0000031235415,0.0026939523,0.00013285075,0.0005763047,0.000011525763,0.000014429339,0.00053583144],"genre_scores_gemma":[0.995298,0.0036512993,0.00004179826,0.000059612074,0.00015545869,0.00022574984,0.000004880423,0.000012217336,0.0005509798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982156,0.000064143875,0.00034983258,0.0002769761,0.0006985635,0.000394849],"domain_scores_gemma":[0.99924266,0.000036218797,0.000064977736,0.00023331094,0.00031634368,0.00010646877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006080266,0.000093082526,0.00027429877,0.0002344397,0.000068777794,0.000006117803,0.00011514769,0.0000726771,0.00020100406],"category_scores_gemma":[0.000089082285,0.000076131226,0.000039484723,0.00055290957,0.000096767006,0.00006209674,0.000032923333,0.00033028427,0.00001490029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007377421,0.00041926804,0.2302859,0.0003986653,0.00004138923,0.000041106592,0.0010235487,0.00003733118,0.45404708,0.000029691644,0.0036025885,0.30933568],"study_design_scores_gemma":[0.0009697589,0.00024263484,0.9459979,0.0007621737,0.000009778424,0.0000015119689,0.00008022248,0.000038981005,0.0506911,0.00014504117,0.0009927826,0.000068101144],"about_ca_topic_score_codex":0.001231184,"about_ca_topic_score_gemma":0.0005699944,"teacher_disagreement_score":0.715712,"about_ca_system_score_codex":0.00037552396,"about_ca_system_score_gemma":0.0004942549,"threshold_uncertainty_score":0.31045413},"labels":[],"label_agreement":null},{"id":"W2328293316","doi":"10.1158/1538-7445.am2013-4564","title":"Abstract 4564: Assessment of genetic alterations using next-generation sequencing in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the BOLERO-2 phase III trial.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Exemestane; Everolimus; Oncology; Breast cancer; Internal medicine; Medicine; Hormone receptor; Cancer; Estrogen receptor; Biology; Cancer research; Aromatase","score_opus":0.06466511953825303,"score_gpt":0.37316007876773644,"score_spread":0.3084949592294834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328293316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994781,0.001142019,0.00021456846,0.0005464569,0.00012804048,0.0014959122,0.0015881535,0.000004331623,0.000099474666],"genre_scores_gemma":[0.99323636,0.0034437256,0.0012455886,0.00011912937,0.0006434917,0.0009661851,0.00027591953,0.00003466892,0.000034934797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794495,0.00019811529,0.0004796191,0.00052707363,0.00038097982,0.0004692885],"domain_scores_gemma":[0.9984226,0.00018943117,0.00021125533,0.00042476246,0.00062102434,0.00013090474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045992626,0.00019221239,0.00024569902,0.00007885068,0.00022481059,0.00013510337,0.0002518377,0.0001049203,0.000108952925],"category_scores_gemma":[0.00008910338,0.00015319117,0.000030633113,0.00030519016,0.00020675255,0.000032732863,0.00011048954,0.00029219405,0.0000017053144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007068283,0.00012289484,0.00019354145,0.0000066997327,0.00009262451,0.0000027166589,0.00061875646,0.017872086,0.96590084,0.000009170818,0.00051587145,0.0075965296],"study_design_scores_gemma":[0.14298749,0.0076871677,0.118137226,0.0006884304,0.00009619725,0.000010859002,0.006747536,0.015141222,0.7058687,0.0002907761,0.0009817751,0.0013626084],"about_ca_topic_score_codex":0.03589591,"about_ca_topic_score_gemma":0.0043882504,"teacher_disagreement_score":0.26003212,"about_ca_system_score_codex":0.0010148922,"about_ca_system_score_gemma":0.0019588226,"threshold_uncertainty_score":0.97052413},"labels":[],"label_agreement":null},{"id":"W2328418052","doi":"10.1158/1538-7445.am2013-4769","title":"Abstract 4769: Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Motility; Growth hormone–releasing hormone; Endocrinology; Internal medicine; Antagonist; Receptor; Biology; Hormone; Cancer research; Medicine; Cell biology","score_opus":0.04957333621110425,"score_gpt":0.35870079444383696,"score_spread":0.3091274582327327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328418052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632744,0.032727763,0.000027302221,0.00080286583,0.00014891164,0.0014878573,0.00021917191,0.0000688696,0.0012428636],"genre_scores_gemma":[0.9936,0.0046590427,0.0001750232,0.00004088987,0.00042402107,0.00041779436,0.000062889936,0.00010286411,0.0005174851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99580663,0.00021676389,0.0007667684,0.00085993425,0.0013537697,0.0009961347],"domain_scores_gemma":[0.99735594,0.0003059967,0.00028699767,0.00065259344,0.0008578888,0.0005405805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008317738,0.0003680597,0.000728358,0.0004187834,0.00046894644,0.0001370856,0.0003167308,0.00030745534,0.0006663845],"category_scores_gemma":[0.0003484288,0.0003347164,0.00016054651,0.0008912694,0.00085754745,0.00026571474,0.00030288304,0.0013557501,0.0000251784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050813105,0.0001949349,0.0036098259,0.00040772776,0.000085057676,0.000016782855,0.0003878896,0.000012083123,0.97170717,0.0000079580495,0.017932862,0.0051295822],"study_design_scores_gemma":[0.0062295278,0.00058100093,0.07196285,0.0005291741,0.000067065375,0.000009159756,0.0004331714,0.00013212567,0.91870457,0.00011375748,0.0009065695,0.00033100764],"about_ca_topic_score_codex":0.04328562,"about_ca_topic_score_gemma":0.00013335672,"teacher_disagreement_score":0.06835302,"about_ca_system_score_codex":0.0006828134,"about_ca_system_score_gemma":0.00046617325,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W2328459544","doi":"10.1158/1538-7445.am2013-1591","title":"Abstract 1591: Capsaicin enhances the effect of radiation in prostate cancer through NFκB suppression.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"LNCaP; DU145; Capsaicin; In vivo; Clonogenic assay; Prostate cancer; Medicine; Pharmacology; Ionizing radiation; Cancer; In vitro; Cancer research; Chemistry; Internal medicine; Biology; Receptor; Irradiation; Biochemistry","score_opus":0.05918232114173686,"score_gpt":0.41084392267427716,"score_spread":0.3516616015325403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328459544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934848,0.0014757905,0.0000010939617,0.0022420345,0.000716478,0.001202715,0.000023532022,0.000014997657,0.0008385379],"genre_scores_gemma":[0.99294746,0.0044196504,0.0000017219468,0.00006673113,0.00020998222,0.0011508563,0.0000015439155,0.00001872404,0.0011833273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976946,0.00049491244,0.00024799275,0.000357108,0.00069090695,0.0005144708],"domain_scores_gemma":[0.9987191,0.0008368168,0.000090614856,0.00020262158,0.00009022116,0.00006064256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075657223,0.0001248638,0.00019091455,0.000111912515,0.00021199847,0.00006468257,0.00041193268,0.000064964726,0.0016481138],"category_scores_gemma":[0.0003601738,0.000067486115,0.000049399045,0.0006760685,0.00039871802,0.0003408402,0.00009276281,0.0004994933,0.000092737246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081300816,0.000021403113,0.0010891643,0.00012231075,0.000003180632,0.0000024359797,0.00183237,0.00056834286,0.9669209,0.000027046215,0.010020512,0.019311013],"study_design_scores_gemma":[0.00042554038,0.0001240798,0.0037883974,0.00017763744,0.0000016711035,4.928137e-7,0.00016147802,0.00015039451,0.991867,0.00019471628,0.003026438,0.00008216978],"about_ca_topic_score_codex":0.012031179,"about_ca_topic_score_gemma":0.00019513372,"teacher_disagreement_score":0.024946066,"about_ca_system_score_codex":0.0001399504,"about_ca_system_score_gemma":0.00014697944,"threshold_uncertainty_score":0.99926454},"labels":[],"label_agreement":null},{"id":"W2328468386","doi":"10.1158/1538-7445.am10-993","title":"Abstract 993: A novel cadherin-dependent Rac/Stat3 pathway in invasive breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"STAT3; RAC1; Cancer research; STAT protein; Cadherin; Downregulation and upregulation; Biology; Signal transduction; Catenin; Cell biology; Cell; Wnt signaling pathway; Gene","score_opus":0.04949056709399372,"score_gpt":0.38719478906533433,"score_spread":0.3377042219713406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328468386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950299,0.0006590791,0.000010140846,0.0010361796,0.00039505056,0.0006338996,0.0007138631,0.000014684649,0.0015071994],"genre_scores_gemma":[0.9949706,0.00095984014,0.000043453667,0.00010424332,0.00072250795,0.0006638445,0.0000659338,0.00007666285,0.002392881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964859,0.00012099586,0.00032454764,0.0008531212,0.0009903642,0.0012250767],"domain_scores_gemma":[0.99794877,0.000096989555,0.00006570193,0.0007912679,0.0007060181,0.00039128534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011816825,0.00025533617,0.00024725383,0.00028131204,0.00014358156,0.00011923901,0.0008684282,0.00037793088,0.00204717],"category_scores_gemma":[0.00035815002,0.0002396508,0.000095306284,0.0004692037,0.0003918655,0.000018847937,0.0005853608,0.0016650014,0.000111666974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031551416,0.00018594919,0.026793515,0.00008143035,0.000045616856,0.000049029364,0.00014006418,0.000040338444,0.96272665,0.000038622242,0.0025469575,0.007036325],"study_design_scores_gemma":[0.0013705734,0.00010710793,0.10993879,0.000074499156,0.0000022235624,0.000027976825,0.00025666028,0.000010055227,0.8652532,0.00004211194,0.022577394,0.0003394221],"about_ca_topic_score_codex":0.014974701,"about_ca_topic_score_gemma":0.0727253,"teacher_disagreement_score":0.09747345,"about_ca_system_score_codex":0.00029326353,"about_ca_system_score_gemma":0.0027879565,"threshold_uncertainty_score":0.99886507},"labels":[],"label_agreement":null},{"id":"W2328502373","doi":"10.1158/0008-5472.sabcs11-p3-09-02","title":"P3-09-02: Intermittent Dietary Carbohydrate Restriction Enables Weight Loss and Reduces Breast Cancer Risk Biomarkers.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Overweight; Weight loss; Intermittent fasting; Internal medicine; Dieting; Adiponectin; Leptin; Endocrinology; Breast cancer; Body mass index; Insulin resistance; Physiology; Obesity; Cancer","score_opus":0.041491586276693804,"score_gpt":0.32512122597985577,"score_spread":0.28362963970316196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328502373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774586,0.02045177,0.000012405756,0.00042243107,0.00033978213,0.00027245635,0.00048037243,0.000015309864,0.0005468889],"genre_scores_gemma":[0.9135231,0.08493668,0.000057952253,0.00004929226,0.00071529136,0.00023275224,0.000063021434,0.000030043693,0.00039188447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998244,0.00023337979,0.00020148265,0.00057979254,0.00026559955,0.00047573098],"domain_scores_gemma":[0.998927,0.000014183671,0.000066890796,0.00036409308,0.00033838602,0.0002894413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031343734,0.00017511682,0.00014148276,0.00015082455,0.00026515723,0.000045683955,0.00023241848,0.00014607233,0.00015531208],"category_scores_gemma":[0.00003731754,0.0001603423,0.00007223812,0.00021907342,0.00047090615,0.00001231313,0.00020371069,0.00018583567,0.0000063257326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024856792,0.0003166724,0.13340826,0.00017993299,0.0003939709,0.000044644123,0.00035266107,0.0000067291076,0.8027102,0.000023269082,0.021765096,0.038312882],"study_design_scores_gemma":[0.0018176045,0.00054850284,0.32508427,0.0001993658,0.00013015929,0.000023137587,0.00059358985,0.00005663619,0.65849143,0.0012676326,0.011197117,0.0005905381],"about_ca_topic_score_codex":0.003729691,"about_ca_topic_score_gemma":0.0003632852,"teacher_disagreement_score":0.19167599,"about_ca_system_score_codex":0.00007060222,"about_ca_system_score_gemma":0.00026586495,"threshold_uncertainty_score":0.65385693},"labels":[],"label_agreement":null},{"id":"W2328517593","doi":"10.1158/1538-7445.am2011-5347","title":"Abstract 5347: Inhibition of Notch3 signaling reduces tumorigenic properties of human rhabdomyosarcoma cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Rhabdomyosarcoma; HES1; Notch signaling pathway; Cancer research; Alveolar rhabdomyosarcoma; Myogenesis; Progenitor cell; Biology; Myogenin; Embryonal rhabdomyosarcoma; Cell biology; Signal transduction; Stem cell; Myocyte; Medicine; Sarcoma; Pathology","score_opus":0.10295056927875053,"score_gpt":0.35294275301374733,"score_spread":0.24999218373499682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328517593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534786,0.0026407863,0.00010820979,0.0000294475,0.00009332919,0.00048809085,0.000030751486,0.000009183744,0.0012523247],"genre_scores_gemma":[0.9986337,0.00046288053,0.00014178012,0.00001000023,0.00016511489,0.00013698109,0.000020071313,0.000047823734,0.0003816791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977154,0.00018300678,0.00041834827,0.00044746898,0.0007109093,0.00052482996],"domain_scores_gemma":[0.9984461,0.000012423205,0.00013967828,0.00048297097,0.00079143053,0.00012739612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096247933,0.00015977818,0.00023817827,0.00025717195,0.00013353939,0.000016186403,0.00040198572,0.00019676723,0.0003386673],"category_scores_gemma":[0.00007435651,0.00015086902,0.00013662736,0.00035234285,0.0004810355,0.000010483994,0.00026259807,0.00038462726,0.000010208868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035005037,0.00013953859,0.000017782933,0.0002508819,0.00007999221,0.000008574033,0.00040586133,0.000034292436,0.99733245,0.000084488696,0.00031524617,0.0009808292],"study_design_scores_gemma":[0.0004558549,0.0005419095,0.000116925374,0.0002761374,0.000010344583,0.0000023823202,0.00035745453,0.000005105197,0.9976868,0.00016060882,0.0002324406,0.00015405887],"about_ca_topic_score_codex":0.0011381186,"about_ca_topic_score_gemma":0.00009776879,"teacher_disagreement_score":0.0032857927,"about_ca_system_score_codex":0.000076891265,"about_ca_system_score_gemma":0.00053752924,"threshold_uncertainty_score":0.61522603},"labels":[],"label_agreement":null},{"id":"W2328546953","doi":"10.1158/1538-7445.am2011-1107","title":"Abstract 1107: Transforming growth factor-beta (TGF-β) increases Par-4 expression via activation of Smad and NF-κB in endometrial cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"SMAD; Apoptosis; Transforming growth factor; Cancer research; Biology; Gene isoform; Transforming growth factor beta; Signal transduction; Cancer cell; Molecular biology; Endometrial cancer; Chemistry; Endocrinology; Internal medicine; Cancer; Cell biology; Medicine; Gene; Biochemistry","score_opus":0.07783131428443509,"score_gpt":0.358021400557896,"score_spread":0.2801900862734609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328546953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970342,0.0020821565,0.00011341725,0.000013289832,0.00007496101,0.0003653894,0.00008958301,0.000007872051,0.00021912527],"genre_scores_gemma":[0.9983573,0.0010812843,0.00009501387,0.0000120284485,0.00020505128,0.00016561648,0.00002824001,0.000027485718,0.000028010903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984717,0.00013030185,0.00028473226,0.00038753866,0.00035806192,0.00036769136],"domain_scores_gemma":[0.99924713,0.00010147858,0.000086664506,0.00022461038,0.00020091487,0.00013921224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003606758,0.00014896045,0.00019744529,0.00024707834,0.00008605415,0.000017907274,0.00023631802,0.00016305294,0.00027195225],"category_scores_gemma":[0.0001557388,0.00013631658,0.000056892044,0.00026064768,0.00018534473,0.00002178532,0.000095011674,0.0002107824,0.0000015044395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091272703,0.0001396995,0.022534844,0.00016473792,0.000030585474,0.0000028259253,0.00028921655,0.00001033328,0.96994716,0.000004505438,0.000112518006,0.0058508744],"study_design_scores_gemma":[0.0010312519,0.00011664513,0.031715807,0.00019360996,0.000006697899,3.7984745e-7,0.0000782471,0.0000035066596,0.9663673,0.00003944196,0.00030481996,0.0001423037],"about_ca_topic_score_codex":0.0055393977,"about_ca_topic_score_gemma":0.0003109509,"teacher_disagreement_score":0.00918096,"about_ca_system_score_codex":0.00006203501,"about_ca_system_score_gemma":0.0003130213,"threshold_uncertainty_score":0.83739495},"labels":[],"label_agreement":null},{"id":"W2328566020","doi":"10.1158/1538-7445.am2015-3316","title":"Abstract 3316: The role of high mobility group box 1 in the combination therapy of gemcitabine and radiation in muscle invasive bladder cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Gemcitabine; Bladder cancer; Medicine; Cancer research; Clonogenic assay; Cancer; Radiation therapy; HMGB1; Urology; Viability assay; Oncology; Internal medicine; Pathology; In vivo; Inflammation; Cell; Biology","score_opus":0.07257318120202744,"score_gpt":0.3844806850768114,"score_spread":0.31190750387478394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328566020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420745,0.011903051,7.4253063e-7,0.002031409,0.00005127285,0.0011631575,0.000035474655,0.00000367047,0.0006037773],"genre_scores_gemma":[0.9940406,0.005185644,0.0000052163487,0.0001075668,0.00006933657,0.00053982716,0.000012917103,0.000011449839,0.000027421771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853766,0.00023786534,0.00024320142,0.00019543523,0.0005741171,0.00021174319],"domain_scores_gemma":[0.9990531,0.0002799295,0.00007042058,0.0002764422,0.00026679656,0.000053310716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013277965,0.00008882063,0.00020721085,0.00013800479,0.00003793195,0.000011526933,0.00014507835,0.0000631707,0.000120913064],"category_scores_gemma":[0.00011476158,0.00005150915,0.00002810398,0.00049893244,0.00025007396,0.00010089911,0.00003041311,0.0002863944,0.0000010883035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028018188,0.00215346,0.6399572,0.0002473317,0.00019115738,0.00001292448,0.027552476,0.00015471279,0.057943363,0.0014767443,0.0012056465,0.26630315],"study_design_scores_gemma":[0.004365127,0.0004482392,0.96406454,0.00009325818,0.000010128823,8.192092e-7,0.0027096902,0.000031922875,0.023963373,0.003595266,0.0006690136,0.000048615802],"about_ca_topic_score_codex":0.048995297,"about_ca_topic_score_gemma":0.007493262,"teacher_disagreement_score":0.32410735,"about_ca_system_score_codex":0.00026864457,"about_ca_system_score_gemma":0.00047231372,"threshold_uncertainty_score":0.9573375},"labels":[],"label_agreement":null},{"id":"W2328568124","doi":"10.1158/1538-7445.am10-1489","title":"Abstract 1489: Basal cell carcinomas express functional indoleamine 2,3-dioxygenase (IDO) which may confer immunoprotection","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Basal cell carcinoma; Indoleamine 2,3-dioxygenase; Biology; Immune system; Cancer research; Hair follicle; Kynurenine; Keratinocyte; Carcinogenesis; FOXP3; Immunology; Downregulation and upregulation; Cancer; Cell biology; Medicine; Pathology; Cell culture; Basal cell; Gene","score_opus":0.08472240354582905,"score_gpt":0.3436644546561708,"score_spread":0.25894205111034174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328568124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558336,0.00015582336,0.00005245139,0.0008791044,0.0010509021,0.0006146373,0.000060378352,0.00009312571,0.011510187],"genre_scores_gemma":[0.99352986,0.00007328752,0.000026407235,0.00022714442,0.0006274151,0.00039360026,0.000010877268,0.000051753723,0.0050596735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968947,0.00020335872,0.00025940718,0.0007570275,0.0010825329,0.0008029763],"domain_scores_gemma":[0.9983996,0.00033714177,0.000067746696,0.0005792551,0.0003759009,0.00024033722],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072530843,0.00021535979,0.00017989893,0.00032092573,0.00054282794,0.00019868213,0.0005238553,0.00021386478,0.0054234318],"category_scores_gemma":[0.00056156114,0.00019969966,0.00007892465,0.000815048,0.0003945901,0.00031530598,0.00018487913,0.0018827571,0.0005379472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003091287,0.00016451976,0.0002396286,0.00007017008,0.0000043113187,0.000018225863,0.00015165382,0.000044706798,0.9906466,0.00027727132,0.005986232,0.0020875637],"study_design_scores_gemma":[0.0011008274,0.00008020773,0.048842467,0.00001764318,0.0000010740713,0.0000063430416,0.0001329423,0.00007357928,0.927527,0.0002167394,0.021781664,0.00021952474],"about_ca_topic_score_codex":0.0010061995,"about_ca_topic_score_gemma":0.0004829052,"teacher_disagreement_score":0.063119605,"about_ca_system_score_codex":0.00011482711,"about_ca_system_score_gemma":0.00054634747,"threshold_uncertainty_score":0.9954857},"labels":[],"label_agreement":null},{"id":"W2328620161","doi":"10.1158/1538-7445.am2012-961","title":"Abstract 961: Pathways of tumorigenesis promoted by the growth factor progranulin in SW-13 adrenocortical carcinoma cells","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cancer research; Aphidicolin; Cell growth; Adrenocortical carcinoma; Cell cycle; Endocrinology; Internal medicine; Cancer; Medicine","score_opus":0.05045086809940137,"score_gpt":0.3342858579595428,"score_spread":0.28383498986014144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328620161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851124,0.013086535,0.000012554805,0.00013491252,0.0003996386,0.00073215924,0.00021655767,0.00000707538,0.00029811627],"genre_scores_gemma":[0.996465,0.0015810111,0.000027337152,0.0000348046,0.0011398272,0.00037593622,0.00003961417,0.000034152803,0.00030227442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979631,0.0001741218,0.0002988446,0.0003376947,0.00044813682,0.0007781114],"domain_scores_gemma":[0.99902314,0.000042326454,0.00006570879,0.0004137378,0.00024707732,0.00020799741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006651368,0.00016359331,0.00022244532,0.00008019977,0.00008674157,0.000023383847,0.00039594775,0.00016510797,0.000118001284],"category_scores_gemma":[0.00010393323,0.00012061433,0.00009919069,0.00031329208,0.00028132982,0.000009692772,0.00013980232,0.00032985865,0.000012332138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016000966,0.00041888424,0.010797045,0.00008869647,0.000024220742,8.101112e-7,0.00033918137,6.76268e-7,0.9745199,0.000022689339,0.003922452,0.009705436],"study_design_scores_gemma":[0.0009946608,0.00011003683,0.06677051,0.000018018329,0.00000872543,0.0000018105467,0.00013039153,0.0000027810265,0.9073365,0.000018668174,0.024464464,0.00014343744],"about_ca_topic_score_codex":0.0016547021,"about_ca_topic_score_gemma":0.00027247774,"teacher_disagreement_score":0.067183405,"about_ca_system_score_codex":0.000058987738,"about_ca_system_score_gemma":0.00038231825,"threshold_uncertainty_score":0.49185097},"labels":[],"label_agreement":null},{"id":"W2328622815","doi":"10.1158/1538-7445.am2011-3138","title":"Abstract 3138: FOXC1 represses estrogen receptor-α expression via increasing NF-κB activity in breast cancer: A novel mechanism to explain antiestrogen resistance","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Estrogen receptor; Antiestrogen; Tamoxifen; Breast cancer; Cancer research; Biology; Cancer; Estrogen receptor alpha; Transcription factor; Endocrinology; Internal medicine; Medicine; Gene","score_opus":0.06853743656291751,"score_gpt":0.34504309753881945,"score_spread":0.27650566097590196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328622815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611634,0.00075692433,0.0013288477,0.00036149155,0.00018414379,0.0006279604,0.00029513738,0.00003143614,0.00029771263],"genre_scores_gemma":[0.99701136,0.00048595536,0.001485243,0.00004248257,0.00021553476,0.00045172332,0.000047857662,0.000059672522,0.00020017623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973506,0.00025002312,0.00030431617,0.00084648206,0.0005625792,0.00068603765],"domain_scores_gemma":[0.9986389,0.0000345653,0.0001025919,0.0006487495,0.00032399074,0.00025115607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009256939,0.00024861193,0.00024255564,0.00023299106,0.00019924845,0.000053187017,0.00044710055,0.0002544103,0.00027156228],"category_scores_gemma":[0.00009010083,0.00025826565,0.00008553455,0.0004299007,0.00013127229,0.000047655503,0.00018577825,0.00035021882,0.000015994881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002258167,0.00015022191,0.010971714,0.0000748084,0.00003114612,0.000004911857,0.00030592742,0.00004207995,0.9835525,0.00007590839,0.00071344053,0.0018191624],"study_design_scores_gemma":[0.0006086739,0.00006157923,0.05426211,0.00026479128,0.0000051807824,0.0000053332647,0.000095264535,0.000008400167,0.9422265,0.00010143423,0.002096412,0.00026430507],"about_ca_topic_score_codex":0.0057678744,"about_ca_topic_score_gemma":0.0014894005,"teacher_disagreement_score":0.043290395,"about_ca_system_score_codex":0.00029579742,"about_ca_system_score_gemma":0.0003416288,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W2328635215","doi":"10.1158/1538-7445.am2012-3418","title":"Abstract 3418: Regulation of Dicer expression by Sox4 and its role in melanoma cell invasion and patient survival","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dicer; Gene knockdown; SOX4; Cancer research; Biology; microRNA; Melanoma; Molecular biology; Gene expression; Cell culture; Small interfering RNA; Transfection; Gene; Genetics; Promoter","score_opus":0.06434605987294245,"score_gpt":0.35977791177078133,"score_spread":0.2954318518978389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328635215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698242,0.02746637,0.0000012531286,0.0001976522,0.000068466914,0.0003335935,0.00002523368,0.0000043461914,0.002078875],"genre_scores_gemma":[0.99635255,0.0031833,0.000032250984,0.000018034541,0.000072168186,0.000041926272,0.000012355218,0.000014414824,0.00027300758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988293,0.00007602961,0.00018356548,0.00018624266,0.0004386796,0.00028619965],"domain_scores_gemma":[0.99944055,0.000086199645,0.000051184365,0.0001328171,0.0001032551,0.0001859729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053873693,0.00007803225,0.0001830978,0.00013161228,0.000044588818,0.000009084758,0.000033758115,0.00007129321,0.00030919455],"category_scores_gemma":[0.000037001642,0.00006314475,0.000018433197,0.00016033216,0.000057878173,0.00012996978,0.00008242689,0.00020546927,0.000003234055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033262788,0.00012541116,0.028713102,0.00026983127,0.0000052940413,0.000001283614,0.0010951209,0.0000017830281,0.9308158,0.0000119987935,0.0014843359,0.037143383],"study_design_scores_gemma":[0.0010942495,0.00014003144,0.13992587,0.00024924448,0.000009066269,0.0000013942055,0.0005815036,0.00001377269,0.84625757,0.0000238959,0.011635297,0.00006812218],"about_ca_topic_score_codex":0.0010624162,"about_ca_topic_score_gemma":0.000092205526,"teacher_disagreement_score":0.11121277,"about_ca_system_score_codex":0.00009339688,"about_ca_system_score_gemma":0.000075003285,"threshold_uncertainty_score":0.33854637},"labels":[],"label_agreement":null},{"id":"W2328668828","doi":"10.1158/1538-7445.am2013-1973","title":"Abstract 1973: Tumor suppressor p15Ink4b determines cell fate of hematopoietic progenitors: Implications for development of human blood disorders.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Haematopoiesis; Progenitor cell; Erythropoiesis; Erythropoietin receptor; Biology; Myeloid; Cell biology; Cancer research; Immunology; MAPK/ERK pathway; Stem cell; Signal transduction; Medicine; Anemia; Internal medicine","score_opus":0.08610635134883951,"score_gpt":0.4000613374010568,"score_spread":0.3139549860522173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328668828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697006,0.0004219085,0.000027626445,0.00046899455,0.00006454064,0.0014727447,0.000031951917,0.000018197115,0.00052395137],"genre_scores_gemma":[0.99640286,0.000052056177,0.00091239734,0.000026484018,0.00011889337,0.0018741518,0.0000396756,0.000024835557,0.0005486697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987788,0.00003301205,0.00039819896,0.00024801685,0.00020926661,0.00033269648],"domain_scores_gemma":[0.99866724,0.00014338436,0.0001163576,0.00031993949,0.0006332038,0.00011987112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020374384,0.00010733006,0.00028636566,0.0001681693,0.00013982865,0.000008123061,0.00015539391,0.00006623408,0.0005424377],"category_scores_gemma":[0.000059565577,0.00008878505,0.00008481899,0.00019733327,0.00020579698,0.000048273734,0.000059207097,0.00016111153,0.000020351945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006833206,0.0003843011,0.0044767447,0.0014761623,0.000045811383,4.1936588e-7,0.00044430757,9.4161965e-7,0.98959184,0.000053686763,0.0018108719,0.0016465792],"study_design_scores_gemma":[0.0013634046,0.0004113787,0.0804141,0.00014483799,0.000031895477,0.0000035302942,0.0002008749,0.000004461832,0.9142856,0.0005471512,0.0024957934,0.00009698391],"about_ca_topic_score_codex":0.00016058407,"about_ca_topic_score_gemma":0.00007303032,"teacher_disagreement_score":0.07593735,"about_ca_system_score_codex":0.000038336886,"about_ca_system_score_gemma":0.00036831357,"threshold_uncertainty_score":0.59393126},"labels":[],"label_agreement":null},{"id":"W2328780038","doi":"10.1158/1538-7445.am10-819","title":"Abstract 819: Ambient temperature storage of RNA for use in a RT-qPCR test for the detection of GCC mRNA","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"DiagnoCure (Canada)","funders":"","keywords":"RNA; Molecular biology; TaqMan; Messenger RNA; RNase P; Complementary DNA; RNA extraction; Ribonuclease; Chemistry; Real-time polymerase chain reaction; Biology; Biochemistry; Gene","score_opus":0.03808600792283298,"score_gpt":0.38277100871172653,"score_spread":0.3446850007888935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328780038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957895,0.0003671942,0.00220135,0.00029485777,0.00004847228,0.0010523545,0.0002181401,0.0000035991543,0.000024484676],"genre_scores_gemma":[0.99747086,0.00026015588,0.0006157269,0.00003191877,0.00009823823,0.0013119954,0.000037054204,0.000013809668,0.00016022648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993448,0.000020057598,0.00015452404,0.00020935948,0.00008777044,0.00018347346],"domain_scores_gemma":[0.9991192,0.0001246175,0.00005945647,0.00035593283,0.0003105338,0.000030235475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000516914,0.000065600616,0.00008995664,0.000052172523,0.00008538597,0.000010538916,0.0002169292,0.00018273867,0.0000075273338],"category_scores_gemma":[0.0002879696,0.000048726622,0.00007193307,0.00012662745,0.00018297443,0.0000024741628,0.000053267708,0.00022344319,1.7466654e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010492317,0.000060871436,0.00037474514,0.000039610328,0.000012768514,1.2394683e-7,0.000012846637,0.000011116715,0.9949343,0.00010423825,0.0007996366,0.0035448165],"study_design_scores_gemma":[0.00027430055,0.00022042816,0.005459957,0.000013291522,0.0000045352563,7.774782e-7,0.00002378391,0.0000626089,0.96570873,0.00009232077,0.028088657,0.000050611292],"about_ca_topic_score_codex":0.0002601792,"about_ca_topic_score_gemma":0.0014926952,"teacher_disagreement_score":0.029225575,"about_ca_system_score_codex":0.00001358284,"about_ca_system_score_gemma":0.00010674577,"threshold_uncertainty_score":0.1987014},"labels":[],"label_agreement":null},{"id":"W2328783775","doi":"10.1158/1538-7445.am2013-1887","title":"Abstract 1887: Bone marrow-derived stromal cells and hypoxia promote glutamine dependency in leukemias.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Stromal cell; Glutamine; Tumor microenvironment; Cancer cell; Biology; Bone marrow; Cancer research; Cell biology; Oxidative phosphorylation; Biochemistry; Cancer; Immunology; Amino acid; Genetics","score_opus":0.02597807060559799,"score_gpt":0.3119020446613028,"score_spread":0.2859239740557048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328783775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410517,0.013633098,0.000009326238,0.00029967885,0.00035105334,0.0006431212,0.000043952103,0.000011108164,0.00090348424],"genre_scores_gemma":[0.98748094,0.008478025,0.00023047089,0.00007537369,0.0010516312,0.00032593618,0.00003131167,0.000041570394,0.0022847704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794364,0.00009262539,0.000267757,0.0005937324,0.00037370136,0.0007285445],"domain_scores_gemma":[0.9990627,0.000022391938,0.00005404547,0.0004104675,0.00020662262,0.000243749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004788408,0.00019617875,0.00024318545,0.0001457894,0.00010385553,0.00008343461,0.00026360754,0.00022017845,0.00041728647],"category_scores_gemma":[0.000075815806,0.00018802083,0.00005830085,0.00020148043,0.00022687603,0.000018288383,0.00024213271,0.0004308604,0.000047199243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000874123,0.000049149676,0.00036588416,0.00006677436,0.000020375279,0.000007860662,0.00007762934,0.000011308724,0.9652448,0.000007785594,0.006377797,0.02768321],"study_design_scores_gemma":[0.0018450331,0.00020085745,0.06568542,0.000062070416,0.000008985451,0.00001703188,0.00015723324,0.000031615607,0.8542936,0.0002012771,0.0771523,0.0003445868],"about_ca_topic_score_codex":0.002817313,"about_ca_topic_score_gemma":0.0012875943,"teacher_disagreement_score":0.11095122,"about_ca_system_score_codex":0.000091990965,"about_ca_system_score_gemma":0.00044823412,"threshold_uncertainty_score":0.7667267},"labels":[],"label_agreement":null},{"id":"W2328845034","doi":"10.1158/0008-5472.sabcs11-p2-15-07","title":"P2-15-07: The Need for Additional Surgeries to Adequately Excise Early Breast Cancers May Have a Negative Impact on Local Recurrence.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Mastectomy; Breast cancer; Cancer; Stage (stratigraphy); Surgery; Oncology; Internal medicine","score_opus":0.09755257558407014,"score_gpt":0.3906222425251624,"score_spread":0.29306966694109227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328845034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620875,0.0016597923,0.00056293746,0.004921754,0.00055022544,0.0026110867,0.023744678,0.000039750106,0.003822245],"genre_scores_gemma":[0.99401975,0.00021430828,0.00009052499,0.0002761695,0.00055658084,0.0038209339,0.00025505797,0.00004284231,0.00072385365],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978452,0.0001701828,0.00019275767,0.00059020077,0.0004499644,0.0007516951],"domain_scores_gemma":[0.99836797,0.0002706885,0.00006418856,0.00042835818,0.0006395435,0.0002292754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036355222,0.00026882137,0.00023476388,0.00010845333,0.00042340026,0.000047996862,0.0003740787,0.00011164934,0.0016251324],"category_scores_gemma":[0.0001725083,0.00018046211,0.00017478399,0.0002629935,0.0007055293,0.000011874756,0.00017652572,0.00024151783,0.000069667476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030414762,0.00039957717,0.015429362,0.00008885853,0.0017913335,0.000029983164,0.0071504535,0.0003556479,0.004558999,0.00075041904,0.8422145,0.09681606],"study_design_scores_gemma":[0.0062563526,0.007331188,0.6382655,0.0009032365,0.00016414527,0.00007750988,0.010324071,0.00007650831,0.20928808,0.0030865006,0.122280106,0.00194681],"about_ca_topic_score_codex":0.00751234,"about_ca_topic_score_gemma":0.0022661085,"teacher_disagreement_score":0.71993446,"about_ca_system_score_codex":0.00056836975,"about_ca_system_score_gemma":0.0009808686,"threshold_uncertainty_score":0.99928755},"labels":[],"label_agreement":null},{"id":"W2328908718","doi":"10.1158/1538-7445.am2013-lb-31","title":"Abstract LB-31: Maternal supplementation with folic acid and other vitamins before and during pregnancy and risk of leukemia in the offspring: A childhood leukemia international consortium (CLIC) study.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Odds ratio; Childhood leukemia; Offspring; Leukemia; Pediatrics; Physiology; Internal medicine; Biology; Genetics; Lymphoblastic Leukemia","score_opus":0.02980764645904346,"score_gpt":0.35422742914845184,"score_spread":0.3244197826894084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328908718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721533,0.0005191174,9.451465e-7,0.00029359438,0.000014542139,0.0014592082,0.000041151678,0.0000072014154,0.00044889582],"genre_scores_gemma":[0.9979033,0.0013027187,0.00003453851,0.000017230843,0.000067674206,0.0003441765,0.00000570322,0.00002141659,0.00030327326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998302,0.000104540966,0.00025095363,0.00031393336,0.0006819414,0.0003466722],"domain_scores_gemma":[0.9993718,0.00008189338,0.00006941973,0.00021161027,0.00015905977,0.00010621271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050404225,0.0001264494,0.00019701393,0.00029484837,0.00012970733,0.000102458725,0.00015107186,0.000054132008,0.0001956417],"category_scores_gemma":[0.00005620906,0.0000800091,0.000017311258,0.00020966279,0.00029603735,0.0001950651,0.00013859748,0.00051376375,0.0000034663044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023069234,0.00009441804,0.9671926,0.00020230045,0.00016773072,0.00004357469,0.0054693925,0.0000020609502,0.017276097,0.000020895068,0.000042596064,0.009257648],"study_design_scores_gemma":[0.0040159523,0.0005696676,0.98175806,0.00046316287,0.000025325235,0.00005202083,0.003742736,0.00007410841,0.009140194,0.000037609254,0.0000495847,0.00007159821],"about_ca_topic_score_codex":0.016046848,"about_ca_topic_score_gemma":0.0049164137,"teacher_disagreement_score":0.014565446,"about_ca_system_score_codex":0.00030773776,"about_ca_system_score_gemma":0.0002807349,"threshold_uncertainty_score":0.9905054},"labels":[],"label_agreement":null},{"id":"W2328918404","doi":"10.1158/1538-7445.am2012-30","title":"Abstract 30: The integrin α6A splice variant regulates colon cancer cell proliferation and the Wnt/β-catenin pathway","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Wnt signaling pathway; Gene knockdown; Integrin; Colorectal cancer; Cancer research; Cancer; Biology; Catenin; Cell growth; Population; Alternative splicing; Cancer cell; Cell culture; Cell; Cell biology; Gene isoform; Medicine; Signal transduction; Genetics; Gene","score_opus":0.06728316391407299,"score_gpt":0.38737614258101855,"score_spread":0.3200929786669455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328918404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95902795,0.019339344,0.000010621716,0.013617421,0.00015682883,0.0022121598,0.000016542926,0.0000314471,0.005587662],"genre_scores_gemma":[0.98387754,0.006124468,0.000026724621,0.00033326348,0.00077415374,0.001312865,0.000010185607,0.000047519905,0.0074932547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663633,0.00052697357,0.00030169933,0.00037751975,0.0012586098,0.00089888915],"domain_scores_gemma":[0.9977065,0.0008072219,0.000072828974,0.00050436804,0.00058291137,0.00032620996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042960774,0.00018508194,0.00027095483,0.000081303464,0.0005135565,0.00011969083,0.00035899563,0.00014884339,0.0024877193],"category_scores_gemma":[0.00037090114,0.00009298422,0.00007313693,0.00047438094,0.00077733205,0.00015766342,0.00030720184,0.0012814787,0.00016378543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039819027,0.00042141508,0.0049956334,0.00068728364,0.00017786259,0.00006468166,0.0095558455,0.000032313743,0.89691,0.0025123956,0.026537437,0.054123197],"study_design_scores_gemma":[0.0052037984,0.0002948499,0.0466799,0.00036075836,0.00007560918,0.000067927525,0.0029867375,0.0011156031,0.88174874,0.00035713287,0.060788486,0.0003204878],"about_ca_topic_score_codex":0.007853861,"about_ca_topic_score_gemma":0.0008300178,"teacher_disagreement_score":0.05380271,"about_ca_system_score_codex":0.0005004465,"about_ca_system_score_gemma":0.00062335585,"threshold_uncertainty_score":0.99875295},"labels":[],"label_agreement":null},{"id":"W2328991709","doi":"10.1158/1538-7445.am2012-4884","title":"Abstract 4884: The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cisplatin; Ovarian cancer; Cancer research; Cancer; Kinase; CHEK1; Biology; Cancer cell; Dephosphorylation; Phosphatase; DNA damage; Apoptosis; Ovarian carcinoma; Medicine; Internal medicine; Cell cycle; Cell cycle checkpoint; Chemotherapy; Phosphorylation; Cell biology; Biochemistry; DNA","score_opus":0.05974899658051212,"score_gpt":0.3567264207579343,"score_spread":0.2969774241774222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328991709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996235,0.01356917,0.00005395699,0.002864303,0.00015224678,0.0011042298,0.000098286546,0.000020726266,0.0021747146],"genre_scores_gemma":[0.998047,0.0004513794,0.00014388742,0.00024272139,0.00022204722,0.00026100085,0.00006430085,0.00005145372,0.0005162187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747604,0.00018503278,0.00036468243,0.00041513582,0.0007500173,0.0008091199],"domain_scores_gemma":[0.99856305,0.00029693748,0.00011606078,0.0005152085,0.00020171853,0.00030705222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019250904,0.00019191601,0.00025925186,0.0001678823,0.00022054644,0.00005396223,0.00016603197,0.000160521,0.00023182556],"category_scores_gemma":[0.0003521532,0.00015985663,0.00005897517,0.00061052147,0.00026377273,0.00018427063,0.00010346897,0.001127129,0.000040096525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007809137,0.00023965826,0.0039773877,0.00023001665,0.00004679432,0.000053930995,0.0018434292,0.000007987751,0.9729856,0.00027613007,0.014418258,0.0051398715],"study_design_scores_gemma":[0.0049667037,0.00008618301,0.04103759,0.000517798,0.00003214838,0.000008452684,0.00076712086,0.000082188766,0.93463767,0.00005356763,0.017588366,0.00022220342],"about_ca_topic_score_codex":0.002797521,"about_ca_topic_score_gemma":0.00048636217,"teacher_disagreement_score":0.03834794,"about_ca_system_score_codex":0.0009890809,"about_ca_system_score_gemma":0.0005729282,"threshold_uncertainty_score":0.65187645},"labels":[],"label_agreement":null},{"id":"W2329053913","doi":"10.1158/1538-7445.am10-4551","title":"Abstract 4551: 111In-NLS-Nimotuzumab: A potent auger electron-emitting radiotherapeutic agent for EGFR-overexpressing breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Aptose Biosciences (Canada); University of Toronto","funders":"","keywords":"NLS; Chemistry; Nuclear localization sequence; Internalization; Cytotoxicity; Cancer research; Molecular biology; Clonogenic assay; Monoclonal antibody; Cell; Biophysics; Biochemistry; Antibody; Biology; In vitro; Immunology; Cytoplasm","score_opus":0.0979358228536435,"score_gpt":0.4826516208273503,"score_spread":0.3847157979737068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329053913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838712,0.0025442042,0.00017564533,0.009399425,0.00019959912,0.0012483438,0.00016138601,0.00009553408,0.0023046623],"genre_scores_gemma":[0.993369,0.00043832924,0.0004322946,0.0006104212,0.001623344,0.0015066577,0.00002471873,0.00007455354,0.0019206686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737436,0.00003350422,0.00034038787,0.00059952645,0.0006415228,0.0010107267],"domain_scores_gemma":[0.99827224,0.00025065345,0.00008166457,0.00049918186,0.00046626903,0.0004300044],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007276054,0.00022172379,0.0003173854,0.000099694604,0.0004718294,0.00010243283,0.00030411629,0.00015208399,0.001860888],"category_scores_gemma":[0.00009693431,0.00019460396,0.0001518221,0.00041349724,0.00029421697,0.00010064943,0.000053660144,0.0015427805,0.000028462986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041424303,0.00016093077,0.0010683188,0.0004452996,0.0001227315,0.000012561655,0.00008269666,0.000022974345,0.95633453,0.00027504328,0.0051808273,0.035879865],"study_design_scores_gemma":[0.0028643345,0.00007230464,0.035454124,0.0004942239,0.00012829476,0.00014751067,0.00007093556,0.0021417942,0.8339536,0.00025145142,0.12402621,0.000395218],"about_ca_topic_score_codex":0.00045048908,"about_ca_topic_score_gemma":0.000041008014,"teacher_disagreement_score":0.12238091,"about_ca_system_score_codex":0.0006979498,"about_ca_system_score_gemma":0.00096331787,"threshold_uncertainty_score":0.9990516},"labels":[],"label_agreement":null},{"id":"W2329129089","doi":"10.1158/0008-5472.sabcs10-p5-12-03","title":"Abstract P5-12-03: Concurrent vs. Sequential Administration of Adjuvant Trastuzumab in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis","year":2010,"lang":"en","type":"review","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Breast cancer; Meta-analysis; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Adjuvant; Clinical trial; Inclusion and exclusion criteria; Cancer; Pathology; Alternative medicine","score_opus":0.3509230911295733,"score_gpt":0.5485707472303206,"score_spread":0.1976476561007473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329129089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022511037,0.98285025,0.0000031694772,0.0008358435,0.00012035019,0.011115829,0.0046241134,0.000027320544,0.00019800354],"genre_scores_gemma":[0.0075155078,0.98034614,0.000014771368,0.000055485205,0.00018089596,0.009974383,0.00023570251,0.00013605342,0.0015410526],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9890407,0.0018416868,0.0030154944,0.0014617087,0.0033961437,0.0012442934],"domain_scores_gemma":[0.994372,0.0007668011,0.0010797143,0.0017133822,0.0013288045,0.00073928],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007257372,0.000836053,0.012936709,0.0018520589,0.00012675703,0.00015913983,0.0009186392,0.00066049787,0.0057239705],"category_scores_gemma":[0.00053421344,0.0005888528,0.0022544384,0.003179655,0.0007231221,0.00017982285,0.0002856504,0.0042250673,0.000054282275],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008921843,0.00020645189,0.0000435481,0.9435706,0.034979776,0.00021053874,0.00013167935,6.540326e-7,0.000013146613,0.000030685165,0.00037083964,0.02035285],"study_design_scores_gemma":[0.0010595587,0.0006024236,0.00044638079,0.279312,0.62217706,0.00018895703,0.00006826094,0.000011524258,0.00004661404,0.000005123945,0.09518799,0.0008941054],"about_ca_topic_score_codex":0.007898045,"about_ca_topic_score_gemma":0.0077727144,"teacher_disagreement_score":0.6642586,"about_ca_system_score_codex":0.0019493222,"about_ca_system_score_gemma":0.00926013,"threshold_uncertainty_score":0.99965626},"labels":[],"label_agreement":null},{"id":"W2329207647","doi":"10.1158/1538-7445.am2013-1684","title":"Abstract 1684: Autophagy inhibition as an effective strategy for sensitizing triple-negative breast cancer cells to chemotherapy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Autophagy; Triple-negative breast cancer; Cancer research; Breast cancer; Chemotherapy; In vivo; Cancer; Medicine; Cell culture; Biology; Pharmacology; Oncology; Internal medicine; Apoptosis","score_opus":0.047524475868695445,"score_gpt":0.423418160117536,"score_spread":0.37589368424884056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329207647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041986,0.00040270537,0.00006642936,0.002371026,0.0001912419,0.005175164,0.00025539592,0.00009161496,0.0010265845],"genre_scores_gemma":[0.99142444,0.0002401598,0.00011074977,0.0016169613,0.0010710363,0.0039818417,0.00003380486,0.00008601236,0.0014349865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758947,0.00014644695,0.00026327392,0.0006197097,0.00060123764,0.0007798843],"domain_scores_gemma":[0.99757594,0.0002798335,0.00006971694,0.00037218424,0.0010861994,0.0006161086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005330774,0.00025169778,0.00038491507,0.00027505832,0.00027280068,0.00011823646,0.00012333374,0.00016834897,0.003845379],"category_scores_gemma":[0.00004963108,0.00021810255,0.00013164949,0.00048392444,0.00016344707,0.00033795464,0.000032279393,0.0004646519,0.00028181495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026685363,0.0003188435,0.00009356262,0.00023707411,0.00023656583,0.000058381775,0.0014920036,0.00010665157,0.8359041,0.00016437995,0.0071286852,0.1515912],"study_design_scores_gemma":[0.0043975203,0.0009868859,0.09378626,0.00038863055,0.000032221644,0.000017713104,0.00087222666,0.00034199975,0.8959726,0.0024031976,0.00052775716,0.0002729646],"about_ca_topic_score_codex":0.007764905,"about_ca_topic_score_gemma":0.0001687455,"teacher_disagreement_score":0.15131824,"about_ca_system_score_codex":0.0006840535,"about_ca_system_score_gemma":0.0006589271,"threshold_uncertainty_score":0.9988425},"labels":[],"label_agreement":null},{"id":"W2329268420","doi":"10.1158/1538-7445.am10-4347","title":"Abstract 4347: Medulloblastoma comprises four distinct diseases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Biology; Isochromosome; CDKN2B; Genetics; Oncology; PTCH1; Cancer; Cancer research; Internal medicine; Chromosome; Gene; CDKN2A; Medicine; Sonic hedgehog; Karyotype","score_opus":0.054766817711909103,"score_gpt":0.3901079709490914,"score_spread":0.3353411532371823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329268420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421996,0.0011986864,0.000064459135,0.00059400336,0.00028746665,0.00018851132,0.000121526835,0.000016870856,0.0033085349],"genre_scores_gemma":[0.99629647,0.00035796288,0.00006190803,0.000058879727,0.0008571883,0.0002704048,0.000060299128,0.000026007674,0.002010879],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987612,0.000042180287,0.00013417266,0.00036949507,0.00031935543,0.00037364662],"domain_scores_gemma":[0.9988998,0.000031642678,0.000035171517,0.0005415542,0.00029205982,0.00019974679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022794359,0.0001087085,0.000097116754,0.00005910268,0.00024056804,0.00006834957,0.00038188166,0.0001003728,0.00074456463],"category_scores_gemma":[0.00014932523,0.00009570441,0.000069370195,0.00015276528,0.0003018417,0.0000050756594,0.00012651859,0.00031476968,0.00006911477],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008625789,0.00007180576,0.011483032,0.000025611474,0.000028416483,0.000004952631,0.000013055519,0.0000118177995,0.9400105,0.0001933442,0.0323098,0.015761392],"study_design_scores_gemma":[0.00048856175,0.00011145391,0.31804225,0.000023753497,0.000011299773,0.0000068406516,0.00006891661,0.000022401291,0.16805886,0.0003100989,0.5125858,0.00026973302],"about_ca_topic_score_codex":0.00019584855,"about_ca_topic_score_gemma":0.000650537,"teacher_disagreement_score":0.7719517,"about_ca_system_score_codex":0.000025206404,"about_ca_system_score_gemma":0.00032983153,"threshold_uncertainty_score":0.81524605},"labels":[],"label_agreement":null},{"id":"W2329281304","doi":"10.1158/0008-5472.sabcs-09-3077","title":"The Influence of Older Age on Physician and Patient Decision-Making Regarding Enrollment to Breast Cancer Clinical Trials.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Breast cancer; Reimbursement; Population; Family medicine; Cancer; Randomized controlled trial; Geriatric oncology; Internal medicine; Health care","score_opus":0.5017087855504949,"score_gpt":0.6808921183530636,"score_spread":0.1791833328025687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329281304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715668,0.0011119925,0.000019555619,0.024555398,0.00018547128,0.0013926326,0.0000294017,0.000014631042,0.0011241206],"genre_scores_gemma":[0.9884987,0.006426603,0.00016942997,0.0039894027,0.00047662598,0.00018561086,4.636156e-7,0.00002327739,0.00022989768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9931135,0.001253434,0.001211075,0.0006636878,0.0030446842,0.0007135869],"domain_scores_gemma":[0.9511441,0.04578203,0.00018386586,0.0008794937,0.0015430979,0.00046740225],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02592426,0.00015729661,0.000684889,0.00020802213,0.00037223456,0.00009731978,0.00045852555,0.00024421627,0.000060202456],"category_scores_gemma":[0.04676718,0.00009546735,0.00018691561,0.0007235552,0.0006502326,0.000059887538,0.0003533902,0.002845601,0.000017559645],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005536113,0.00026076878,0.004769244,0.000075481505,0.00009245997,0.000056351102,0.0005850064,0.0003660771,0.002946686,0.0022447845,0.004020648,0.9790464],"study_design_scores_gemma":[0.0051994747,0.0049139117,0.91302115,0.018728634,0.00007404473,0.000008295592,0.0009848302,0.00016650306,0.0031773616,0.038115747,0.015228534,0.0003815027],"about_ca_topic_score_codex":0.0001874047,"about_ca_topic_score_gemma":0.0002118692,"teacher_disagreement_score":0.9786649,"about_ca_system_score_codex":0.00040058926,"about_ca_system_score_gemma":0.000999114,"threshold_uncertainty_score":0.99945486},"labels":[],"label_agreement":null},{"id":"W2329291046","doi":"10.1158/1538-7445.am10-1869","title":"Abstract 1869: Genetic variants of DNA repair genes and lung cancer among nonsmokers: A pooled analysis in the International Lung Cancer Consortium","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Lung cancer; Medicine; Single-nucleotide polymorphism; Odds ratio; Genotyping; Internal medicine; Cancer; Oncology; Logistic regression; Confidence interval; Epidemiology; Genotype; Genetics; Gene; Biology","score_opus":0.02499179321895451,"score_gpt":0.373891520488988,"score_spread":0.3488997272700335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329291046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858538,0.012051595,0.00004732007,0.0007596779,0.00021147385,0.00037769324,0.00016311687,0.0000062238664,0.00052913313],"genre_scores_gemma":[0.98998976,0.008226463,0.00008473396,0.000100954596,0.000318303,0.0008129098,0.000030787356,0.000018754414,0.0004173133],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982882,0.00010608904,0.00032159753,0.00049401226,0.00044098438,0.0003491067],"domain_scores_gemma":[0.9988003,0.000051186216,0.000118406024,0.00054225867,0.00040069336,0.00008716855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007851876,0.00014045885,0.00019584857,0.00024404551,0.00012566864,0.00006688841,0.0005110999,0.00015304454,0.00052209874],"category_scores_gemma":[0.00007620444,0.00011129688,0.00011931942,0.0005784268,0.00036450845,0.000013917078,0.00012863861,0.00035153553,5.6469287e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007341771,0.000051963467,0.4288082,0.0000475807,0.0007476851,0.000004714564,0.00022646917,0.00056927686,0.5652953,0.00004462394,0.0016324011,0.0024983622],"study_design_scores_gemma":[0.00051879475,0.000022495202,0.94703746,0.00004741028,0.00024456633,0.0000019348622,0.0001999146,0.0038435669,0.044901393,0.000012819293,0.0029940854,0.00017553785],"about_ca_topic_score_codex":0.010446252,"about_ca_topic_score_gemma":0.022723913,"teacher_disagreement_score":0.5203939,"about_ca_system_score_codex":0.00007373291,"about_ca_system_score_gemma":0.00053231535,"threshold_uncertainty_score":0.9961433},"labels":[],"label_agreement":null},{"id":"W2329318802","doi":"10.1158/0008-5472.sabcs11-p5-18-02","title":"P5-18-02: A Population Level Assessment of Emergency Room Visits and Hospitalizations for Women Undergoing Adjuvant Chemotherapy for Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Credit Valley Hospital; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Population; Internal medicine; Chemotherapy; Regimen; Cancer; Cancer registry; Chemotherapy regimen; Oncology","score_opus":0.2011688486938001,"score_gpt":0.4988959855576793,"score_spread":0.2977271368638792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329318802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931743,0.0012899296,0.0011685592,0.0011563818,0.00027395424,0.0019992567,0.00055489765,0.000019266801,0.0003634383],"genre_scores_gemma":[0.9906551,0.0026454998,0.0006066827,0.000054828026,0.00026261748,0.0026854754,0.00005423609,0.00003928152,0.0029962775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877197,0.00003854954,0.00024657045,0.00029298707,0.00023740511,0.00041253265],"domain_scores_gemma":[0.9990472,0.00008274874,0.00008899245,0.0001481098,0.00048016428,0.00015279118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031031788,0.00012176219,0.00027988918,0.00017144413,0.00016265445,0.000009574238,0.000079178426,0.00007234163,0.001647948],"category_scores_gemma":[0.00001731332,0.000110170375,0.00006390101,0.0002709261,0.000029841425,0.00010299074,0.000027780496,0.00009930226,4.9099475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023845078,0.00063486566,0.91882885,0.0013049694,0.00071856217,0.0000023340892,0.0056823674,0.000017647888,0.015538977,0.0013313543,0.0078416765,0.045713887],"study_design_scores_gemma":[0.005286678,0.0013469179,0.9871985,0.00015009158,0.00008489647,0.0000021468206,0.00029969122,0.00051441864,0.002270911,0.0017315949,0.0009824198,0.00013176857],"about_ca_topic_score_codex":0.0025096857,"about_ca_topic_score_gemma":0.0015065469,"teacher_disagreement_score":0.06836962,"about_ca_system_score_codex":0.00061519665,"about_ca_system_score_gemma":0.0005038346,"threshold_uncertainty_score":0.99926466},"labels":[],"label_agreement":null},{"id":"W2329426514","doi":"10.1158/1538-7445.am2012-5432","title":"Abstract 5432: The effect of folic acid supplementation on chemosensitivity of colon cancer cells to 5-fluorouracil in a xenograft model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Colorectal cancer; Fluorouracil; Medicine; Cancer; Metastasis; Chemotherapy; Internal medicine; Pharmacology; Cancer research","score_opus":0.09019218686043283,"score_gpt":0.46761919086265186,"score_spread":0.377427004002219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329426514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955546,0.00048181438,0.0000066103057,0.0013711975,0.000051655785,0.0014954966,0.00010240756,0.0000065932945,0.00092959695],"genre_scores_gemma":[0.99855906,0.00037374205,0.000030318834,0.0000712509,0.00012184392,0.00042816892,0.000012780747,0.000023461636,0.00037936887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745643,0.00025401756,0.00027116298,0.00022283533,0.0011142374,0.0006813448],"domain_scores_gemma":[0.9986609,0.00044753565,0.000055018725,0.0003655986,0.0002797841,0.00019116257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027417445,0.00013021752,0.00034222525,0.00034077387,0.00006804361,0.000010678537,0.0001689231,0.00009015899,0.000294025],"category_scores_gemma":[0.0001466744,0.00008613637,0.000079958416,0.00080872275,0.00015740913,0.00010091371,0.00010537055,0.00056265586,0.00002971841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025165256,0.00019802,0.016269717,0.00047502836,0.000054459408,0.0000060783345,0.0015103767,0.00041353155,0.94842577,0.000013165383,0.003819378,0.026297975],"study_design_scores_gemma":[0.0014712024,0.0009844755,0.045666866,0.00026462472,0.000018253279,9.742492e-7,0.00015330614,0.0006014791,0.95044464,0.0000054271554,0.0003193682,0.000069392714],"about_ca_topic_score_codex":0.0061822953,"about_ca_topic_score_gemma":0.0012282892,"teacher_disagreement_score":0.029397147,"about_ca_system_score_codex":0.0004580322,"about_ca_system_score_gemma":0.0003133467,"threshold_uncertainty_score":0.93458223},"labels":[],"label_agreement":null},{"id":"W2329448006","doi":"10.1158/1538-7445.am10-4303","title":"Abstract 4303: Definitive identification and characterization of ovarian cancer-initiating cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"CD117; CD44; Ovarian cancer; Serous fluid; Medicine; Cancer research; Cancer; Population; Flow cytometry; Pathology; Internal medicine; Cell; Oncology; Biology; Stem cell; Immunology; CD34; Cell biology","score_opus":0.09257352590738756,"score_gpt":0.4056602370994662,"score_spread":0.31308671119207865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329448006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615735,0.00025873695,0.00004740568,0.0009129116,0.00036554463,0.0004316285,0.00021108633,0.000015099024,0.0016002515],"genre_scores_gemma":[0.9965682,0.0022071432,0.00012439924,0.000071167306,0.00035796783,0.00015912365,0.000052188505,0.00002334479,0.0004364901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987219,0.000041100917,0.00027600332,0.00027887244,0.00041540537,0.00026671658],"domain_scores_gemma":[0.99883085,0.00009608476,0.0001291754,0.00023040969,0.0005715506,0.00014192557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007471976,0.00008952278,0.00020365776,0.00019169341,0.000118311145,0.000040459476,0.00007569941,0.00008396784,0.00093117665],"category_scores_gemma":[0.000090904854,0.00008452032,0.00003896938,0.0003425792,0.0001871073,0.00012290174,0.00004339364,0.00046965716,0.000012218127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011017882,0.000044245597,0.0029545396,0.00028791843,0.000031644067,0.0000043210266,0.00045240115,4.2158615e-7,0.929476,0.00024922623,0.00008597051,0.066303104],"study_design_scores_gemma":[0.0005836041,0.00004062942,0.18797699,0.00015419703,0.000033777276,0.00000294175,0.00013841865,0.000017338827,0.80750656,0.000055155433,0.0034185518,0.00007184997],"about_ca_topic_score_codex":0.0018944002,"about_ca_topic_score_gemma":0.00037657123,"teacher_disagreement_score":0.18502244,"about_ca_system_score_codex":0.00007557392,"about_ca_system_score_gemma":0.00042476627,"threshold_uncertainty_score":0.9999821},"labels":[],"label_agreement":null},{"id":"W2329465541","doi":"10.1158/0008-5472.sabcs-5118","title":"Phase II trial of neoadjuvant chemotherapy of sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): a multi-centre study from British Columbia.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kelowna General Hospital; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Docetaxel; Carboplatin; Breast cancer; Internal medicine; Epirubicin; Oncology; Chemotherapy; Cancer; Surgery; Cisplatin","score_opus":0.05717163578144839,"score_gpt":0.44103397805998534,"score_spread":0.38386234227853694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329465541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812282,0.0062288097,0.00011625272,0.001095372,0.00025009323,0.0075187306,0.003452749,0.000048776186,0.000061034396],"genre_scores_gemma":[0.99470556,0.0016851427,0.00047570426,0.00012411595,0.0005157079,0.000779135,0.00009013362,0.00011671535,0.0015077676],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99423283,0.0004103656,0.0010161437,0.0011242774,0.002047611,0.0011687949],"domain_scores_gemma":[0.99696654,0.000308517,0.00030416145,0.0006961217,0.0011896794,0.0005349533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013152523,0.00033438485,0.0013311502,0.00018367748,0.0003710197,0.00019473684,0.00046251167,0.0002596883,0.0012628689],"category_scores_gemma":[0.00024730936,0.00041489195,0.00023439399,0.0007160511,0.00054045604,0.00022165645,0.00015736156,0.0008315374,7.5085904e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06630576,0.010244778,0.0038708483,0.0003556664,0.00046746686,0.000078466284,0.0019160592,0.000016503189,0.5128939,6.3253873e-7,0.01535869,0.3884912],"study_design_scores_gemma":[0.85972327,0.029239232,0.012155369,0.0043109586,0.00039235456,0.000027501086,0.0025910602,0.0019902594,0.082040265,0.000074357944,0.0064816396,0.00097372907],"about_ca_topic_score_codex":0.10799347,"about_ca_topic_score_gemma":0.030328602,"teacher_disagreement_score":0.7934175,"about_ca_system_score_codex":0.0010240098,"about_ca_system_score_gemma":0.0023097987,"threshold_uncertainty_score":0.9998303},"labels":[],"label_agreement":null},{"id":"W2329477774","doi":"10.1158/1538-7445.am2011-lb-332","title":"Abstract LB-332: High-throughput proteomic analysis identifies protein S as a potential modulator of androgen-independent prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"LNCaP; Prostate cancer; Androgen; Cancer research; Androgen receptor; Biology; Androgen deprivation therapy; Prostate; Cancer; Internal medicine; Endocrinology; Medicine; Hormone","score_opus":0.039098206664685595,"score_gpt":0.3315087777018385,"score_spread":0.2924105710371529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329477774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197274,0.0044249957,0.00006106551,0.00012965675,0.00051140366,0.0020934676,0.0004942275,0.00006370767,0.00024870242],"genre_scores_gemma":[0.99318093,0.00030756232,0.00011729547,0.000017366729,0.000055661276,0.00204809,0.000071124734,0.000047648202,0.0041543217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968939,0.00043539985,0.0005555666,0.0008212968,0.00037023483,0.0009236063],"domain_scores_gemma":[0.99821424,0.00002853966,0.00025492164,0.0007906758,0.0006061798,0.0001054553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010924177,0.00028233803,0.00054218376,0.00064538815,0.00031101741,0.000043305023,0.0007349145,0.0003851198,0.011865803],"category_scores_gemma":[0.00007202133,0.00025321761,0.0002791544,0.0009740117,0.0007577361,0.00020451375,0.00039552277,0.00066370505,0.0003153809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019299334,0.00030328849,0.0022352203,0.0002157963,0.0031886587,0.000057774494,0.0008486451,0.000022827442,0.98623335,0.00037899203,0.00088796543,0.0036975427],"study_design_scores_gemma":[0.001317496,0.00016650121,0.025678966,0.00012415915,0.0003148901,0.000005938379,0.00034527847,0.00000846898,0.9689047,0.0026810507,0.00018481637,0.00026776543],"about_ca_topic_score_codex":0.019969888,"about_ca_topic_score_gemma":0.00080774084,"teacher_disagreement_score":0.023443747,"about_ca_system_score_codex":0.00028743228,"about_ca_system_score_gemma":0.0008753178,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W2329477786","doi":"10.1158/1538-7445.am2012-1352","title":"Abstract 1352: Shp2 is required for CML initiation and maintenance","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Dasatinib; Cancer research; Tyrosine kinase; Imatinib; Bosutinib; Stem cell; Myeloid leukemia; Bone marrow; Imatinib mesylate; Haematopoiesis; Medicine; Biology; Immunology; Signal transduction; Cell biology","score_opus":0.1621364712561549,"score_gpt":0.4530184521059848,"score_spread":0.29088198084982986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329477786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591745,0.0039926535,0.00003594645,0.0034297244,0.00014939718,0.000987056,0.00006214866,0.000027924509,0.0053976714],"genre_scores_gemma":[0.9934638,0.0010343494,0.00028908622,0.00034646882,0.00057874335,0.00048292248,0.000028777253,0.000028279472,0.0037475831],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986224,0.000025411257,0.00015057155,0.00022625792,0.00036805388,0.0006072601],"domain_scores_gemma":[0.9990271,0.00020005532,0.000036115536,0.00025378668,0.00024952105,0.00023344815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006431833,0.00009377083,0.00016377721,0.00010395797,0.00011842347,0.000019698831,0.0000632829,0.00008519339,0.0005580611],"category_scores_gemma":[0.00028448238,0.000077820674,0.000038843944,0.0001615287,0.00011919748,0.0001809306,0.00004507192,0.0002143281,0.00007481891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003984281,0.00080160465,0.1530384,0.0031589663,0.00066593266,0.00007965185,0.010637809,0.0000025481195,0.21210572,0.0037599895,0.36476028,0.24700482],"study_design_scores_gemma":[0.017580407,0.00077073433,0.54209185,0.0012425308,0.00013759687,0.00007845602,0.0010198161,0.00023524328,0.14076196,0.0015844356,0.2940429,0.00045410648],"about_ca_topic_score_codex":0.0003103036,"about_ca_topic_score_gemma":0.000021203638,"teacher_disagreement_score":0.38905343,"about_ca_system_score_codex":0.0012674191,"about_ca_system_score_gemma":0.00046302867,"threshold_uncertainty_score":0.6110378},"labels":[],"label_agreement":null},{"id":"W2329522542","doi":"10.1158/0008-5472.sabcs-2025","title":"The pattern of metastatic spread among breast cancer sub-types.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Metastasis; Cancer; Oncology; Internal medicine; Basal (medicine); Stage (stratigraphy); CA15-3; Pathology; Biology","score_opus":0.03497753622710331,"score_gpt":0.37420826532862506,"score_spread":0.33923072910152174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329522542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800008,0.015689619,0.000029597382,0.003251944,0.00014762294,0.00028962237,0.00019720248,0.000008422271,0.0003851628],"genre_scores_gemma":[0.9932028,0.005799157,0.0000065466857,0.00009678808,0.000202862,0.00019946192,0.000018266684,0.0000182226,0.0004558626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986024,0.00012824693,0.0001739209,0.00031275832,0.00032591738,0.00045674288],"domain_scores_gemma":[0.9990406,0.00005141156,0.0000632801,0.00041873116,0.00035917858,0.00006680294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033018153,0.00013833855,0.00016468135,0.000045140398,0.00023069915,0.000027741013,0.00032336463,0.00004970691,0.000052033505],"category_scores_gemma":[0.000030819083,0.00009382632,0.00007749332,0.00021772992,0.0004001536,0.0000050933854,0.00011757242,0.0001562165,0.000008817048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063509797,0.0002443013,0.13528228,0.00008122784,0.00090632786,0.000011383035,0.000419613,0.00012861197,0.34514788,0.00007775465,0.029365718,0.48769984],"study_design_scores_gemma":[0.0010026069,0.0001840934,0.57132196,0.00011179316,0.000062883024,0.0000094980305,0.00023279648,0.000010256969,0.4191653,0.00016019544,0.007530708,0.00020788176],"about_ca_topic_score_codex":0.0028919617,"about_ca_topic_score_gemma":0.0023347356,"teacher_disagreement_score":0.48749194,"about_ca_system_score_codex":0.000087513596,"about_ca_system_score_gemma":0.00021810902,"threshold_uncertainty_score":0.43718004},"labels":[],"label_agreement":null},{"id":"W2329568405","doi":"10.1158/1538-7445.am2013-591","title":"Abstract 591: Reovirus is oncolytic towards organ specific and highly metastatic lung cancer cells: Possible mechanisms of action.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Bone and Joint Health Institute","funders":"","keywords":"Oncolytic virus; Metastasis; Medicine; Cancer research; Pathology; Adenocarcinoma; Cancer; Apoptosis; Cancer cell; Flow cytometry; Biology; Immunology; Internal medicine","score_opus":0.07448583445682606,"score_gpt":0.40540681086698355,"score_spread":0.3309209764101575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329568405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870581,0.009984037,0.00011030728,0.000976772,0.00017027384,0.0008741736,0.0001300497,0.000013328267,0.00068293826],"genre_scores_gemma":[0.98182994,0.014184372,0.00026828703,0.00016033622,0.00023460113,0.0004704211,0.000017528753,0.000069126894,0.0027653691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973279,0.00019982648,0.00032181016,0.0006236692,0.0008051013,0.0007216537],"domain_scores_gemma":[0.9982527,0.000051576928,0.000094121686,0.00062715774,0.0006881239,0.00028635908],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000849617,0.00021900766,0.00028452132,0.00023692161,0.00019995192,0.0001112352,0.00046329113,0.00015063382,0.003354118],"category_scores_gemma":[0.00003663454,0.00019797529,0.00008451848,0.00047877347,0.00031541227,0.000023020028,0.00022935671,0.0004170755,0.000064293585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057572155,0.00007313457,0.00007937987,0.00020552186,0.00016707534,0.0000051620354,0.00013598688,0.000031012332,0.96405625,0.000026675847,0.015386444,0.019257635],"study_design_scores_gemma":[0.00077230134,0.0008055902,0.0007308194,0.00006045032,0.000015182956,0.0000025284232,0.00025137924,0.000078981386,0.9923947,0.00048582288,0.0041949996,0.00020725289],"about_ca_topic_score_codex":0.0033462464,"about_ca_topic_score_gemma":0.0006283264,"teacher_disagreement_score":0.02833844,"about_ca_system_score_codex":0.00022140164,"about_ca_system_score_gemma":0.0010055976,"threshold_uncertainty_score":0.9975569},"labels":[],"label_agreement":null},{"id":"W2329597870","doi":"10.1158/1538-7445.am2013-3860","title":"Abstract 3860: Furin is required for processing KISS1 to kisspeptins.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Furin; Proprotein Convertases; Proprotein convertase; Gene knockdown; Proteases; Biology; Kexin; Enzyme; Cell biology; Biochemistry; Cancer research; Apoptosis; LDL receptor","score_opus":0.15968653386189566,"score_gpt":0.4775090537806028,"score_spread":0.31782251991870714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329597870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491484,0.0003133212,0.00020270901,0.03876148,0.00002262544,0.001243955,0.00003549258,0.000074308606,0.01019767],"genre_scores_gemma":[0.9748701,0.00003386356,0.0006737629,0.0023540326,0.00051938946,0.00097388256,0.000021222664,0.000032990978,0.020520749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820346,0.000023399258,0.00024252791,0.0003760783,0.00059176184,0.00056278886],"domain_scores_gemma":[0.9982756,0.000060608043,0.000036214096,0.00029185548,0.0008966713,0.00043909842],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046071273,0.000112194546,0.0002273003,0.00033627034,0.0002079168,0.00011540457,0.00013288336,0.00007896024,0.007411349],"category_scores_gemma":[0.00019777965,0.00009359868,0.00011328269,0.0006298124,0.000075718635,0.00015737863,0.00005127954,0.00026211762,0.0010522186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015975154,0.00013728117,0.0005276192,0.0005278688,0.000048967737,0.000014614826,0.00075205625,0.0000034671443,0.6300259,0.000052058458,0.28821576,0.079534665],"study_design_scores_gemma":[0.0039470387,0.0006458598,0.031310286,0.0043247268,0.000065876084,0.000015794189,0.002362224,0.0010979674,0.6657492,0.0012761265,0.2885828,0.000622113],"about_ca_topic_score_codex":0.0006006375,"about_ca_topic_score_gemma":0.00004312408,"teacher_disagreement_score":0.07891255,"about_ca_system_score_codex":0.00022389942,"about_ca_system_score_gemma":0.000339589,"threshold_uncertainty_score":0.9997256},"labels":[],"label_agreement":null},{"id":"W2329632577","doi":"10.1158/1538-7445.am2012-1375","title":"Abstract 1375: Contrasting effects of VEGF pathway inhibitors in primary and metastatic disease using perioperative neoadjuvant mouse models","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Primary tumor; Oncology; Melanoma; Bevacizumab; Internal medicine; Metastasis; Neoadjuvant therapy; Perioperative; Chemotherapy; Disease; Cancer research; Cancer; Breast cancer; Surgery","score_opus":0.06049617489743127,"score_gpt":0.36077129357579896,"score_spread":0.3002751186783677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329632577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621988,0.03703907,0.00018627854,0.000019867613,0.00006696712,0.0003379003,0.00003801486,0.0000028234874,0.00011025844],"genre_scores_gemma":[0.9981514,0.0012459282,0.00016429949,0.000041512783,0.00018186525,0.000105982384,0.000014290997,0.000025847645,0.0000688284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878055,0.00013039031,0.00019420411,0.00024745133,0.00023249292,0.0004149095],"domain_scores_gemma":[0.9994155,0.00006270436,0.000051045114,0.00016383833,0.00012331556,0.00018360859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004963296,0.00012324852,0.00019015142,0.00008073474,0.000079444726,0.000018160388,0.00008849748,0.00004827303,0.000008811823],"category_scores_gemma":[0.0000916312,0.00010701186,0.000051287167,0.00011847992,0.00017542821,0.000021277392,0.000121908066,0.00013117037,5.181356e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015644555,0.00008436036,0.0068358253,0.00035733392,0.00003885817,0.000009660774,0.0003106706,0.00070344063,0.98692256,0.000046076504,0.000030077641,0.0045047128],"study_design_scores_gemma":[0.0011188226,0.00011955153,0.020964958,0.00035263586,0.000022636546,0.0000029411815,0.0003153794,0.000905147,0.9755203,0.000024868948,0.00040799758,0.00024476775],"about_ca_topic_score_codex":0.0002339277,"about_ca_topic_score_gemma":0.000025559904,"teacher_disagreement_score":0.035952628,"about_ca_system_score_codex":0.00008961571,"about_ca_system_score_gemma":0.00031647572,"threshold_uncertainty_score":0.4363817},"labels":[],"label_agreement":null},{"id":"W2329709737","doi":"10.1158/1538-7445.am2011-5360","title":"Abstract 5360: Differential induction of the anti-oxidant response by arsenic trioxide and darinaparsin in leukemic cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Thioredoxin; Oxidative stress; Western blot; Apoptosis; Molecular biology; Thioredoxin reductase; Superoxide dismutase; Chemistry; Reactive oxygen species; Biochemistry; Biology; Gene","score_opus":0.04251407120576066,"score_gpt":0.31674472938763054,"score_spread":0.27423065818186987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329709737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975101,0.0018034548,0.000013441246,0.00006583413,0.00012461653,0.00019639768,0.000015754618,0.000002800116,0.00026761397],"genre_scores_gemma":[0.99761146,0.001584727,0.000015656646,0.0000133320145,0.00004888187,0.00003366623,0.0000049802165,0.00001556934,0.00067169836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987441,0.00023985167,0.00020117052,0.00030354894,0.00023099325,0.0002803866],"domain_scores_gemma":[0.9994469,0.000030255374,0.0000643983,0.0003156249,0.00009028749,0.00005249641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006359034,0.000100565216,0.00012587021,0.00007070654,0.000073899515,0.000014480636,0.00028090386,0.00015718571,0.00004490361],"category_scores_gemma":[0.000102044905,0.00007641317,0.000042553304,0.00018981098,0.00037161016,0.000005881289,0.00017074437,0.000320462,0.0000017721648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070451724,0.00005299449,0.0029458676,0.000050348586,0.000013165046,0.0000028470854,0.00017378843,0.000002703592,0.9940758,0.000008139916,0.00088911975,0.0010807243],"study_design_scores_gemma":[0.00049822364,0.00010209565,0.047666617,0.000049170656,0.000004193376,0.0000057169996,0.00015277453,0.0000031029806,0.9498592,0.00006199001,0.0015137634,0.000083152125],"about_ca_topic_score_codex":0.0005365473,"about_ca_topic_score_gemma":0.000037261543,"teacher_disagreement_score":0.044720747,"about_ca_system_score_codex":0.00006801302,"about_ca_system_score_gemma":0.00037556686,"threshold_uncertainty_score":0.31160387},"labels":[],"label_agreement":null},{"id":"W2329752051","doi":"10.1158/1538-7445.am10-5064","title":"Abstract 5064: The non-receptor tyrosine kinase Fer is required for activated ErbB2-mediated tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Carcinogenesis; Cell biology; Focal adhesion; Endocytosis; Biology; Internalization; Receptor tyrosine kinase; Tyrosine kinase; Cancer research; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Signal transducing adaptor protein; Cell; Cancer; Biochemistry","score_opus":0.12733841121686232,"score_gpt":0.4613987581692534,"score_spread":0.33406034695239106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329752051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96152717,0.0007602231,0.000017940949,0.030029217,0.0010823308,0.0037192532,0.00050980045,0.000121930985,0.0022321285],"genre_scores_gemma":[0.98195976,0.0008113761,0.00025886565,0.0008785967,0.0024371068,0.003399317,0.00014948566,0.00019738171,0.009908099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99438846,0.00015487846,0.00054350734,0.00093624217,0.0021754305,0.0018015011],"domain_scores_gemma":[0.9940986,0.0013110982,0.000109382505,0.0015324553,0.0021621743,0.00078626414],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0033952508,0.00036012733,0.000550909,0.00046040124,0.00071072526,0.00018955377,0.0009630845,0.0003820157,0.009527017],"category_scores_gemma":[0.002133878,0.0002504728,0.00023712254,0.0017584251,0.00094574393,0.00019147304,0.00025748333,0.0024250047,0.000923327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014388778,0.00019003027,0.0016472663,0.00036271024,0.00011296973,0.000029401153,0.0004199712,0.0000012610457,0.78762853,0.000037893988,0.19619235,0.011938748],"study_design_scores_gemma":[0.002329226,0.00036227592,0.016563158,0.00023976475,0.000027859889,0.0000075423036,0.00023438172,0.0001113701,0.6724078,0.0000762296,0.30738932,0.00025104402],"about_ca_topic_score_codex":0.0028860932,"about_ca_topic_score_gemma":0.000493767,"teacher_disagreement_score":0.115220696,"about_ca_system_score_codex":0.00076821423,"about_ca_system_score_gemma":0.003025282,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W2329854883","doi":"10.1158/0008-5472.sabcs11-p5-14-17","title":"P5-14-17: Stage IV at Presentation – Are HER2 Positive Tumors Overrepresented?","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Oncology; Cohort; Internal medicine; Disease; Gynecology","score_opus":0.0761799214803195,"score_gpt":0.3866336401301781,"score_spread":0.3104537186498586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329854883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807614,0.0022916861,0.00003459892,0.00048490957,0.00015485441,0.0005075109,0.00031790428,0.000023134193,0.015424008],"genre_scores_gemma":[0.9788869,0.0006353992,0.000055074794,0.00012463421,0.0003199735,0.00044744316,0.00013284483,0.00004033422,0.019357383],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980521,0.00018508149,0.00016378635,0.00060132495,0.00044983858,0.0005478234],"domain_scores_gemma":[0.9988675,0.00003349138,0.00007797461,0.00047832212,0.00040047473,0.0001422548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021203887,0.0001828185,0.00017178548,0.00008493523,0.00028986603,0.000023388362,0.0002631334,0.00010365614,0.0006203726],"category_scores_gemma":[0.00008128846,0.00016852835,0.00008369493,0.00021621562,0.00031813153,0.00001091239,0.0005174604,0.0001805969,0.00006272913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038775313,0.0005880592,0.6075348,0.00014494461,0.00096716225,0.00020889731,0.0031905905,0.000070410715,0.22128023,0.00024169548,0.1589231,0.0029725786],"study_design_scores_gemma":[0.0012322731,0.00023739623,0.46007153,0.000079527694,0.000022474633,0.000010476847,0.0012114537,0.000007393291,0.52142525,0.00008385339,0.015352397,0.00026596262],"about_ca_topic_score_codex":0.0035132796,"about_ca_topic_score_gemma":0.002105817,"teacher_disagreement_score":0.30014503,"about_ca_system_score_codex":0.0002611804,"about_ca_system_score_gemma":0.00014153648,"threshold_uncertainty_score":0.68723863},"labels":[],"label_agreement":null},{"id":"W2329892342","doi":"10.1158/1538-7445.am2012-1445","title":"Abstract 1445: Integrative genomics identifies actionable targets for therapy in medulloblastoma subgroups","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PDGFRA; Medulloblastoma; PTEN; Biology; Cancer research; Copy-number variation; Wnt signaling pathway; Genomics; Genetics; Computational biology; PI3K/AKT/mTOR pathway; Gene; Genome; Signal transduction","score_opus":0.10421881247815223,"score_gpt":0.42321690628142766,"score_spread":0.31899809380327543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329892342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855131,0.009499876,0.000040350864,0.0018476322,0.00040422165,0.0011539999,0.00003638773,0.000025715053,0.0014787278],"genre_scores_gemma":[0.98994136,0.0052280137,0.00016485079,0.00017417005,0.0006900552,0.0020907046,0.000023771705,0.00004129182,0.001645811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818486,0.00005977469,0.00024101204,0.00028432804,0.00045227015,0.0007777538],"domain_scores_gemma":[0.99890524,0.00019347509,0.000047806876,0.00022911208,0.00041860298,0.0002057345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001202014,0.00014612742,0.00027859033,0.00027328997,0.00015495722,0.000047709993,0.00015311774,0.000113949114,0.0010852457],"category_scores_gemma":[0.0001252178,0.00011364404,0.00010547551,0.0003942545,0.00015426002,0.00027759143,0.000043451862,0.00047455204,0.000045089128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052057346,0.0013755937,0.102789775,0.0005909879,0.00041095773,0.0000104489245,0.009961141,0.00002784526,0.6952442,0.001149428,0.076206155,0.10702772],"study_design_scores_gemma":[0.0025247594,0.00052266975,0.20938577,0.00026690948,0.000015323378,0.0000049580535,0.004367433,0.00004568116,0.62566054,0.00046981985,0.15649572,0.0002404005],"about_ca_topic_score_codex":0.0010244717,"about_ca_topic_score_gemma":0.0005477828,"teacher_disagreement_score":0.10678732,"about_ca_system_score_codex":0.0008691791,"about_ca_system_score_gemma":0.00040404956,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W2329911270","doi":"10.1158/1538-7445.am2011-1484","title":"Abstract 1484: Inhibition of the glycosylation enzyme Mgat1 blocks migration, invasion and metastasis of malignant cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Occupational Cancer Research Centre; University of Waterloo; Ontario Institute for Cancer Research","funders":"","keywords":"Gene knockdown; Small hairpin RNA; Cell biology; HeLa; Cell migration; Cell; Cell growth; Chemistry; Biology; Cell culture; Biochemistry","score_opus":0.0694220781593474,"score_gpt":0.32940071267584137,"score_spread":0.25997863451649394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329911270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976052,0.00079047837,0.00009786,0.00020606538,0.000042575983,0.00043616936,0.000051801042,0.0000027963354,0.0007670698],"genre_scores_gemma":[0.99838257,0.00099014,0.00013185738,0.000016156866,0.00004601922,0.000056270095,0.000021423957,0.000012142158,0.00034341836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998637,0.00016164525,0.000263049,0.00024889596,0.00047510548,0.00021428049],"domain_scores_gemma":[0.9988865,0.000025155898,0.00010855905,0.00034155836,0.00056877814,0.00006942634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083512143,0.00008710375,0.000115372364,0.00012199911,0.000108255204,0.000012601023,0.0001608258,0.00011332647,0.0002811983],"category_scores_gemma":[0.0001294838,0.00006368996,0.00006079538,0.00029532248,0.00026915266,0.000010545113,0.00016714203,0.00016002335,0.000003237062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001735052,0.000059595404,0.0020399042,0.000080441285,0.000022851013,6.9523566e-7,0.00023469217,0.000018262599,0.9933888,0.0001120053,0.00089047523,0.0029788236],"study_design_scores_gemma":[0.00031815466,0.0001513723,0.018242838,0.0000628719,0.000006394809,0.0000013480503,0.000103350496,0.000026643993,0.9784046,0.00020274422,0.0024162813,0.000063425185],"about_ca_topic_score_codex":0.0014816804,"about_ca_topic_score_gemma":0.00085596606,"teacher_disagreement_score":0.016202932,"about_ca_system_score_codex":0.000022483508,"about_ca_system_score_gemma":0.00019600565,"threshold_uncertainty_score":0.3078924},"labels":[],"label_agreement":null},{"id":"W2329927582","doi":"10.1158/0008-5472.sabcs12-p2-12-01","title":"Abstract P2-12-01: Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brief Pain Inventory; Breast cancer; Discontinuation; Internal medicine; Physical therapy; Joint pain; Cancer; Stage (stratigraphy); Osteoarthritis; Quality of life (healthcare); Prospective cohort study; Chronic pain; Alternative medicine","score_opus":0.12432054850348384,"score_gpt":0.4420153711132128,"score_spread":0.317694822609729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329927582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921248,0.0023741978,7.935825e-7,0.0005030212,0.00020333244,0.0031884199,0.0010699831,0.000017859114,0.0005175717],"genre_scores_gemma":[0.9896224,0.00024887235,0.000024394125,0.000044907443,0.0005861698,0.009302072,0.000054355074,0.000045931793,0.000070886665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969657,0.00012179951,0.0004389641,0.00037122672,0.0012559253,0.0008463699],"domain_scores_gemma":[0.9983552,0.00018751009,0.00015565143,0.00029509267,0.0007190071,0.00028752617],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026425358,0.00018396079,0.00039882894,0.0003511659,0.000103706414,0.000030518077,0.00007990617,0.00009482774,0.0011799401],"category_scores_gemma":[0.0001670919,0.00015688916,0.000065757726,0.00041132394,0.00012842442,0.00027977038,0.000066098895,0.00033139513,0.0000102138365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018002097,0.0016884467,0.9213714,0.00072690484,0.00041135433,0.000012679987,0.00829011,0.00008915448,0.030892953,0.00014971297,0.0009789382,0.033588108],"study_design_scores_gemma":[0.005537806,0.0007001082,0.95267284,0.000791046,0.00007964649,0.0000038994067,0.0011698469,0.000041255462,0.03860194,0.0001011083,0.00015646606,0.0001440384],"about_ca_topic_score_codex":0.009485053,"about_ca_topic_score_gemma":0.0011507348,"teacher_disagreement_score":0.03344407,"about_ca_system_score_codex":0.005052632,"about_ca_system_score_gemma":0.0012033532,"threshold_uncertainty_score":0.9997331},"labels":[],"label_agreement":null},{"id":"W2329976634","doi":"10.1158/1538-7445.am2011-4108","title":"Abstract 4108: BH3 only Bcl-2 family member BNIP3 repressed expression of death receptor 5 (DR5) in glioblastoma cells: Implications for regulation of the tumor necrosis factor related apoptosis inducing ligand (TRAIL) cell death pathway","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Apoptosis; Programmed cell death; Cancer research; Tumor necrosis factor alpha; Temozolomide; Glioma; Biology; Small hairpin RNA; Receptor; Chemistry; Immunology; Genetics","score_opus":0.0864611690604593,"score_gpt":0.3317901583564123,"score_spread":0.24532898929595298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329976634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962153,0.0010578944,0.000016229813,0.00008986002,0.00031733248,0.0010684202,0.00031420734,0.000025185394,0.00089558994],"genre_scores_gemma":[0.9972331,0.00021965169,0.00008145983,0.00001635128,0.000014319209,0.00028419873,0.000020903284,0.000041817922,0.0020881975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764353,0.0004759777,0.0007416436,0.00047844474,0.00012243817,0.0005379452],"domain_scores_gemma":[0.9977878,0.0005501502,0.0003740816,0.00074841926,0.00049998064,0.000039614373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078054314,0.0002111747,0.00039710663,0.00034229917,0.00025121114,0.000015516065,0.00056880567,0.0003504639,0.00061775866],"category_scores_gemma":[0.00024739778,0.00015866425,0.00018446184,0.00044338452,0.0002775508,0.00016132173,0.00018862297,0.00060721795,0.000023521998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018642814,0.0002777395,0.0036899953,0.00012849744,0.00004753206,1.4462498e-7,0.0025393285,0.0000073813267,0.9889315,0.00014763093,0.0011687595,0.0011972336],"study_design_scores_gemma":[0.0011184781,0.00027410008,0.13774735,0.00045277728,0.000012688277,0.0000014661836,0.00040997186,0.000001848074,0.8588773,0.00012467643,0.00084278116,0.00013659343],"about_ca_topic_score_codex":0.0015258646,"about_ca_topic_score_gemma":0.00007541596,"teacher_disagreement_score":0.13405734,"about_ca_system_score_codex":0.00019050376,"about_ca_system_score_gemma":0.00049717387,"threshold_uncertainty_score":0.6764024},"labels":[],"label_agreement":null},{"id":"W2329988052","doi":"10.1158/0008-5472.sabcs12-p2-10-34","title":"Abstract P2-10-34: Development and validation of ClinicoMolecular Triad Classification (CMTC), a platform for breast cancer (BC) prognostic and predictive gene signature portfolios.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Breast cancer; Medicine; Bioinformatics; Cancer; Microarray; Gene signature; Computational biology; Oncology; Internal medicine; Gene; Biology; Gene expression; Genetics","score_opus":0.0713729637347451,"score_gpt":0.37755944657413426,"score_spread":0.30618648283938915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329988052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889035,0.008706261,0.00047485996,0.00017887635,0.00012922742,0.00088480645,0.0006296761,0.000004662244,0.00010128496],"genre_scores_gemma":[0.99401015,0.004037791,0.00041736575,0.000036556066,0.00041602107,0.00064393616,0.0003069753,0.000028725224,0.00010247858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998729,0.000029013569,0.00029430533,0.00034163802,0.00023522787,0.000370829],"domain_scores_gemma":[0.99893993,0.000107012966,0.00013487748,0.0001943694,0.00045181697,0.00017198478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007015957,0.00013963848,0.00017400832,0.000091771384,0.00012786927,0.000033549477,0.00011195573,0.00020106541,0.000036547248],"category_scores_gemma":[0.00018256869,0.00013279005,0.000040397277,0.0001182347,0.00014386991,0.00001547692,0.000103783605,0.00014671829,9.208968e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00229949,0.00030777723,0.05085857,0.00049505493,0.00035611607,0.0000016273851,0.0005901085,0.00010777941,0.86602265,0.000248589,0.0042107687,0.07450149],"study_design_scores_gemma":[0.0016851882,0.00029199306,0.27675524,0.00011838919,0.000070403235,0.000007992121,0.00023561633,0.00011915172,0.70232475,0.000106266416,0.018017432,0.00026761097],"about_ca_topic_score_codex":0.00010750274,"about_ca_topic_score_gemma":0.000053430413,"teacher_disagreement_score":0.22589667,"about_ca_system_score_codex":0.000105894076,"about_ca_system_score_gemma":0.0005314224,"threshold_uncertainty_score":0.5415021},"labels":[],"label_agreement":null},{"id":"W2330103196","doi":"10.1158/0008-5472.sabcs11-p5-08-03","title":"P5-08-03: How Reader's Training, Software, and Image Formats Impact Percent Dense Area Measures.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Digital mammography; Medicine; Quartile; Reproducibility; Mammography; Consistency (knowledge bases); Breast cancer; Confusion; Nuclear medicine; Medical physics; Computer science; Artificial intelligence; Statistics; Mathematics; Psychology; Cancer; Confidence interval","score_opus":0.4584710725101177,"score_gpt":0.45720067800995456,"score_spread":0.0012703945001631411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330103196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850305,0.0054208343,0.00043294783,0.0015566164,0.000116526484,0.0006738603,0.000052471107,0.00010544205,0.0066108406],"genre_scores_gemma":[0.99514955,0.0016452151,0.0015228264,0.00035543894,0.0002594583,0.00013253101,0.000012494662,0.00004333118,0.0008791379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99687713,0.0001273009,0.00022007142,0.00047007174,0.0012276972,0.0010777358],"domain_scores_gemma":[0.9979577,0.00008325087,0.000057664187,0.00048128268,0.0007114269,0.00070868485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013636312,0.00023397444,0.0003977479,0.00025797196,0.0002782788,0.00011581296,0.00024718198,0.00015106397,0.0009878926],"category_scores_gemma":[0.00061246526,0.00018152347,0.00012870527,0.00040769373,0.00045400482,0.0004113135,0.00014128505,0.0007869255,0.00006197031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007155804,0.00030430316,0.27439442,0.0009618893,0.00081513135,0.0026215706,0.0635318,0.000005363927,0.053511396,0.00026384814,0.20706461,0.38936985],"study_design_scores_gemma":[0.008844414,0.004656383,0.8518304,0.0032972465,0.00035018433,0.0019272283,0.030614935,0.00031701563,0.03465447,0.0019741335,0.060025238,0.0015083334],"about_ca_topic_score_codex":0.0038057903,"about_ca_topic_score_gemma":0.0005449476,"teacher_disagreement_score":0.577436,"about_ca_system_score_codex":0.00058446964,"about_ca_system_score_gemma":0.0008890049,"threshold_uncertainty_score":0.9999253},"labels":[],"label_agreement":null},{"id":"W2330161326","doi":"10.1158/1538-7445.am2011-333","title":"Abstract 333: The role of the retinoblastoma pathway (Rb) in high grade serous ovarian varcinoma (HGSC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Retinoblastoma; Biology; Cancer research; Loss of heterozygosity; Cyclin D1; Immunohistochemistry; Retinoblastoma protein; Ovarian cancer; Tissue microarray; Gene expression profiling; Cancer; Cell cycle; Gene expression; Gene; Genetics; Immunology","score_opus":0.06367800575832928,"score_gpt":0.31943294082583107,"score_spread":0.2557549350675018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330161326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168486,0.002127142,0.000004769492,0.0019826875,0.0002625556,0.001129122,0.00003853494,0.00003261753,0.012737683],"genre_scores_gemma":[0.99863756,0.00017435073,0.00004412271,0.0001719185,0.00019510747,0.0002444051,0.0000041981516,0.00006155293,0.00046679328],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970404,0.00031685474,0.00041247287,0.00043939723,0.001060774,0.00073012576],"domain_scores_gemma":[0.9980487,0.00014585529,0.000120970406,0.0012139353,0.00030301156,0.00016750868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012769687,0.00019200234,0.0003117877,0.00022556001,0.00016822225,0.000018629113,0.0006825055,0.00020581894,0.0008127028],"category_scores_gemma":[0.00022853902,0.00011882103,0.00014672749,0.0011345578,0.00052224833,0.00005904291,0.00027902675,0.0015460306,0.000060514285],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020324497,0.0008474466,0.06125006,0.00035490174,0.000268503,0.0005514103,0.010946285,0.00006451547,0.8763836,0.008891475,0.003260336,0.035149023],"study_design_scores_gemma":[0.0016669782,0.00029000093,0.51836807,0.0004541457,0.00002774744,0.000054100354,0.00067678525,0.000052127,0.4681718,0.0022819045,0.0078031025,0.00015326278],"about_ca_topic_score_codex":0.01350338,"about_ca_topic_score_gemma":0.0020819057,"teacher_disagreement_score":0.45711797,"about_ca_system_score_codex":0.00046671095,"about_ca_system_score_gemma":0.0011081655,"threshold_uncertainty_score":0.9930658},"labels":[],"label_agreement":null},{"id":"W2330170442","doi":"10.1158/1538-7445.am2012-139","title":"Abstract 139: The role of miRNAs in cyclooxygenase-2-mediated breast cancer progression","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Transfection; Metastasis; microRNA; Cancer; Angiogenesis; HIF1A; Biology; Tumor progression; Cancer cell; Breast cancer; Cell culture; Medicine; Gene; Internal medicine","score_opus":0.03538650232599142,"score_gpt":0.40646515839102526,"score_spread":0.3710786560650338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330170442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318154,0.013193951,1.333821e-7,0.0011278229,0.00024573866,0.00082816725,0.000043852408,0.000020069465,0.0013587313],"genre_scores_gemma":[0.9973023,0.0010397166,0.000006822122,0.00006415672,0.0008730597,0.00054889236,0.000010431771,0.000032098826,0.00012250758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977268,0.00017312849,0.0002723722,0.00019220343,0.0008679319,0.0007675434],"domain_scores_gemma":[0.9987791,0.0002583881,0.000077204,0.0003388247,0.00025627334,0.0002902011],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018497644,0.00013242234,0.00026180985,0.0002128594,0.00009663094,0.00001082453,0.00018320499,0.00013308063,0.0009711263],"category_scores_gemma":[0.00015146534,0.000079478916,0.00006396956,0.00059503864,0.0002503971,0.00011802112,0.00007633435,0.00071921834,0.0000752091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008099676,0.0002739399,0.62291425,0.00036005076,0.00004580111,0.000026981388,0.0014392504,0.0000047502604,0.32139686,0.000065237626,0.002335054,0.050327834],"study_design_scores_gemma":[0.001046311,0.00005924681,0.85920817,0.00070398644,0.000013675828,0.0000123670225,0.00040176936,0.000055959732,0.12480798,0.000024363904,0.013567017,0.000099161305],"about_ca_topic_score_codex":0.0020353368,"about_ca_topic_score_gemma":0.00027680947,"teacher_disagreement_score":0.23629388,"about_ca_system_score_codex":0.0002859302,"about_ca_system_score_gemma":0.0005349339,"threshold_uncertainty_score":0.9999421},"labels":[],"label_agreement":null},{"id":"W2330184794","doi":"10.1158/1538-7445.am10-5449","title":"Abstract 5449: Histone deacetylase inhibitor treatment in B-cell non-Hodgkin's lymphoma - effect of <i>ex vivo</i> treatment on primary patient samples","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Panobinostat; Mantle cell lymphoma; Medicine; Cancer research; Lymphoma; Chronic lymphocytic leukemia; Propidium iodide; Vorinostat; Pathology; Immunology; Leukemia; Histone deacetylase; Chemistry; Programmed cell death; Apoptosis; Histone","score_opus":0.03162514763190731,"score_gpt":0.3815259222822599,"score_spread":0.3499007746503526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330184794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640645,0.0011615143,7.253169e-7,0.00045766323,0.00020135143,0.0040119216,0.00018407627,0.000033428416,0.00754286],"genre_scores_gemma":[0.9944642,0.0012382371,0.00006930621,0.00007503545,0.00023244429,0.0016911561,0.0000844182,0.00009745828,0.0020477278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99563384,0.0003274453,0.0005664021,0.0008580081,0.0015304093,0.0010838917],"domain_scores_gemma":[0.99688774,0.0011909573,0.00011549042,0.00093953166,0.00037263086,0.000493647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007041505,0.00047045705,0.0009299448,0.000800387,0.00016905493,0.00003988712,0.00023058643,0.00024992813,0.0008564067],"category_scores_gemma":[0.00024199125,0.0003417171,0.0002668839,0.0006687028,0.00052776915,0.00007446213,0.00010812492,0.0004965869,0.0001392991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010530836,0.005001242,0.018256128,0.0005647302,0.0001318911,0.0007186214,0.0015613857,0.000029690078,0.8133114,0.00000767363,0.0019159535,0.14797045],"study_design_scores_gemma":[0.013597222,0.017177597,0.010855333,0.0002967101,0.000039546354,0.000050802424,0.0001681863,0.000042242176,0.9457585,0.000009233646,0.011750091,0.0002544981],"about_ca_topic_score_codex":0.011576795,"about_ca_topic_score_gemma":0.0031914087,"teacher_disagreement_score":0.14771596,"about_ca_system_score_codex":0.005271929,"about_ca_system_score_gemma":0.002280798,"threshold_uncertainty_score":0.9999035},"labels":[],"label_agreement":null},{"id":"W2330186804","doi":"10.1158/1538-7445.am2011-1118","title":"Abstract 1118: Role of the type I insulin-like growth factor receptor in lung tumorigenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Carcinogenesis; Lung cancer; Cancer research; A549 cell; Apoptosis; Cell growth; Insulin-Like Growth Factor Receptor; Insulin-like growth factor; Cell culture; Receptor; Cancer; Biology; Medicine; Growth factor; Endocrinology; Internal medicine","score_opus":0.045739687113534,"score_gpt":0.33167764441257225,"score_spread":0.28593795729903826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330186804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821173,0.014616154,0.0000010912722,0.000045820212,0.0009861471,0.0002626647,0.000055328517,0.0000043782975,0.0019111453],"genre_scores_gemma":[0.99224454,0.0061458885,0.000037406542,0.000044865625,0.00066865544,0.00006729374,0.000007967294,0.000025166813,0.0007582115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987416,0.00010738299,0.00019609791,0.00029721617,0.00029092006,0.00036676446],"domain_scores_gemma":[0.9991205,0.000016538055,0.00005740256,0.00040470192,0.00031603355,0.00008485732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034857087,0.00010923296,0.00015020347,0.00008139157,0.00006605578,0.000009411962,0.0004490455,0.00012237662,0.00039996358],"category_scores_gemma":[0.00013693988,0.000083898754,0.00007533292,0.00036853904,0.00016346705,0.0000042608053,0.00017783273,0.0002372733,0.00001322713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025348036,0.00006767485,0.017638223,0.000049362854,0.000028418855,3.7775106e-7,0.00041962092,0.0000023467671,0.974148,0.00006589282,0.0033899955,0.0039366204],"study_design_scores_gemma":[0.00034141217,0.00005643102,0.17094392,0.00003122669,0.000004686405,6.491578e-7,0.00015682753,0.0000016232741,0.7614777,0.00009122884,0.06678463,0.00010965657],"about_ca_topic_score_codex":0.0026113358,"about_ca_topic_score_gemma":0.00073653914,"teacher_disagreement_score":0.21267028,"about_ca_system_score_codex":0.00005682411,"about_ca_system_score_gemma":0.00050097145,"threshold_uncertainty_score":0.43793207},"labels":[],"label_agreement":null},{"id":"W2330189505","doi":"10.1158/0008-5472.sabcs12-p2-06-03","title":"Abstract P2-06-03: Specific Transcriptional Response of Four Blockers of Estrogen Receptors on Estrogen-Modulated Genes in ZR-75-1 Breast Cancer Xenografts","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Theratechnologies (Canada)","funders":"","keywords":"Toremifene; Fulvestrant; Antiestrogen; Tamoxifen; Estrogen receptor; Estrogen; Breast cancer; Selective estrogen receptor modulator; Raloxifene; Ovariectomized rat; Cancer; Medicine; Internal medicine; Pharmacology; Endocrinology; Cancer research","score_opus":0.04294972960875102,"score_gpt":0.34581769885379415,"score_spread":0.3028679692450431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330189505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744252,0.024143962,0.0000023126504,0.0003069836,0.0003477144,0.00043895878,0.000243256,0.000009523403,0.00008211266],"genre_scores_gemma":[0.99401444,0.0049799145,0.00008544081,0.000015022232,0.00042495676,0.00012702741,0.000079478064,0.000052101823,0.00022160792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973718,0.00039919722,0.00042934695,0.000426553,0.0006086511,0.0007644369],"domain_scores_gemma":[0.998841,0.00008068679,0.00012241735,0.0004128618,0.00028931967,0.00025375106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012333955,0.00024281575,0.00030704262,0.0003302771,0.00008557907,0.000010001833,0.00033378197,0.00037403812,0.00023028707],"category_scores_gemma":[0.000041586238,0.00022181639,0.00019285367,0.00055247365,0.00036689846,0.000014717968,0.00006486603,0.0004661471,0.000023523666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005087002,0.00030969162,0.053876117,0.00007009207,0.00018950221,0.0000084045305,0.0001677698,0.00049218495,0.9356095,0.000057386256,0.0014238012,0.0027085005],"study_design_scores_gemma":[0.0013047358,0.00035973574,0.10456102,0.00019160798,0.000017850392,0.00001997879,0.00013378102,0.000011807906,0.8821758,0.0000083511595,0.010980038,0.00023530253],"about_ca_topic_score_codex":0.0004546675,"about_ca_topic_score_gemma":0.000024771602,"teacher_disagreement_score":0.05343376,"about_ca_system_score_codex":0.00015661979,"about_ca_system_score_gemma":0.00039626705,"threshold_uncertainty_score":0.90454096},"labels":[],"label_agreement":null},{"id":"W2330240530","doi":"10.1158/1538-7445.am2012-31","title":"Abstract 31: Activated phosphatidylinositol-3 kinase: An oncogene that increases gap junctional, intercellular communication","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Phosphatidylinositol; Cell biology; Gap junction; Kinase; Biology; Protein kinase B; Anti-apoptotic Ras signalling cascade; Signal transduction; PI3K/AKT/mTOR pathway; Tyrosine kinase; MAPK/ERK pathway; Intracellular","score_opus":0.12507931868197533,"score_gpt":0.40586770747159234,"score_spread":0.280788388789617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330240530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867265,0.0110698715,0.000025000818,0.00033089877,0.00014596773,0.00022039263,0.00003907123,0.000017393604,0.0014249104],"genre_scores_gemma":[0.99490404,0.0027555453,0.000081104416,0.00016469651,0.00055595755,0.00012957085,0.00065648876,0.000025821195,0.0007267622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985792,0.0002673488,0.00015534526,0.00030141202,0.00021743705,0.00047926023],"domain_scores_gemma":[0.9987657,0.000060753024,0.00005861911,0.0006576689,0.00024595292,0.00021128039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076170615,0.00013933156,0.00013224309,0.00008420066,0.00025042673,0.000038152997,0.00038091838,0.00020489866,0.0005628849],"category_scores_gemma":[0.00009146448,0.00012664347,0.000061469575,0.00014300217,0.00023225436,0.000020920117,0.00024243505,0.0002963202,0.000040323626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002894654,0.00025009288,0.0100653125,0.000017262226,0.000056419463,0.000001455882,0.00006509085,0.000005835682,0.9739059,0.00012986375,0.0060948874,0.0091183875],"study_design_scores_gemma":[0.00034555153,0.0001592078,0.024157329,0.000026756932,0.000007660784,0.0000063984007,0.00025469367,0.0000061764313,0.7873363,0.00003173493,0.18751313,0.0001550753],"about_ca_topic_score_codex":0.0017509207,"about_ca_topic_score_gemma":0.00037787156,"teacher_disagreement_score":0.18656965,"about_ca_system_score_codex":0.000096953474,"about_ca_system_score_gemma":0.00019351336,"threshold_uncertainty_score":0.6163195},"labels":[],"label_agreement":null},{"id":"W2330244165","doi":"10.1158/1538-7445.am2013-3063","title":"Abstract 3063: MicroRNA-605: A novel genetic modifier in Li-Fraumeni Syndrome.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Penetrance; microRNA; Genetics; Biology; Single-nucleotide polymorphism; Cancer; Cancer research; SNP; Li–Fraumeni syndrome; Mutation; Germline mutation; Gene; Genotype; Phenotype","score_opus":0.08181127741397909,"score_gpt":0.3782222790053685,"score_spread":0.2964110015913894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330244165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868384,0.0045715617,0.000098412274,0.0025547158,0.0002281707,0.0016094528,0.000026510012,0.000053219293,0.0040195687],"genre_scores_gemma":[0.994473,0.0006554796,0.0005273305,0.00029628584,0.00017322876,0.0009788589,0.00001321981,0.00009028818,0.0027923363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99689287,0.00006438858,0.00041112152,0.00063040346,0.0009562352,0.0010449917],"domain_scores_gemma":[0.9982835,0.000093672905,0.00005504738,0.00074766926,0.00040731733,0.0004127617],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005118361,0.00022287683,0.00037909817,0.00059378875,0.00009260926,0.0000754326,0.00032397785,0.00026712447,0.0042297957],"category_scores_gemma":[0.00015714894,0.00021245888,0.00011514517,0.00096570083,0.0002437579,0.00011355294,0.00016712723,0.0013700753,0.0013764412],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015433268,0.00031571396,0.0018498512,0.00027035148,0.00010032546,0.00062429544,0.00042147565,0.00029396382,0.9634645,0.00003259134,0.011111044,0.021361545],"study_design_scores_gemma":[0.011405375,0.0009210002,0.80908155,0.0022765,0.00007243596,0.00091535813,0.0005292125,0.001746272,0.12553778,0.00062106166,0.045919973,0.0009734686],"about_ca_topic_score_codex":0.0102098165,"about_ca_topic_score_gemma":0.00049079466,"teacher_disagreement_score":0.83792675,"about_ca_system_score_codex":0.0010481802,"about_ca_system_score_gemma":0.0009569267,"threshold_uncertainty_score":0.9994011},"labels":[],"label_agreement":null},{"id":"W2330293929","doi":"10.1158/1538-7445.am2013-4123","title":"Abstract 4123: Investigation of growth factor signaling through macrophage colony stimulating factor (CSF-1) and its receptor (FMS) in the bone marrow stromal microenvironment in acute myeloid leukemia (AML).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Stromal cell; Cancer research; Macrophage colony-stimulating factor; Growth factor; Bone marrow; Biology; Myeloid leukemia; Cell biology; Immunology; Macrophage; Receptor","score_opus":0.04747560597264398,"score_gpt":0.31606786992310004,"score_spread":0.26859226395045604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330293929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966295,0.008068142,0.0000040730574,0.0005546059,0.0002329539,0.0012186506,0.00013547184,0.000012917225,0.00011021361],"genre_scores_gemma":[0.9974719,0.001459182,0.00011532156,0.00010555182,0.000044847104,0.00034087212,0.00005072318,0.00003544107,0.00037616093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732834,0.0006315235,0.0005793625,0.00048525646,0.00022035028,0.00075514754],"domain_scores_gemma":[0.99870324,0.0006441047,0.00018646683,0.00029583002,0.00013529406,0.00003508408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007649903,0.000240299,0.00038437627,0.00019655701,0.00018995546,0.000049716098,0.00044178346,0.000318373,0.002912233],"category_scores_gemma":[0.00014026348,0.00019724232,0.000052918942,0.00035398413,0.00055113615,0.0003563825,0.00022502773,0.0013112223,0.00014044117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016532218,0.00003336478,0.025310656,0.0001358094,0.00006140453,0.000008171563,0.004292164,0.00006859392,0.968365,0.000026120568,0.00050213747,0.0010312458],"study_design_scores_gemma":[0.0013662687,0.00016850265,0.22011119,0.00021135171,0.0000078715075,0.000005002135,0.00069898606,0.000019159179,0.7768291,0.00010473745,0.00029553907,0.00018228874],"about_ca_topic_score_codex":0.0035466626,"about_ca_topic_score_gemma":0.00013689132,"teacher_disagreement_score":0.19480054,"about_ca_system_score_codex":0.0008757534,"about_ca_system_score_gemma":0.00026539547,"threshold_uncertainty_score":0.99799925},"labels":[],"label_agreement":null},{"id":"W2330432678","doi":"10.1158/1538-7445.am10-5672","title":"Abstract 5672: A novel anti-cancer effect of hesperidin: reversion of epithelial mesenchymal transition in human prostate cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatography in Natural Products","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Prostate cancer; LNCaP; Hesperidin; Epithelial–mesenchymal transition; Cancer research; Cancer; Metastasis; Cancer cell; Medicine; DU145; Prostate; Viability assay; Cell; Internal medicine; Pathology; Biology; Biochemistry","score_opus":0.025760061976020075,"score_gpt":0.36335014139604804,"score_spread":0.33759007942002794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330432678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666417,0.0010131656,2.0597544e-7,0.00036032696,0.0003112016,0.00051984657,0.0006766811,0.000026278325,0.00042811976],"genre_scores_gemma":[0.9981843,0.0009194302,0.000029590254,0.0000066105627,0.00036872734,0.00018944862,0.00002340744,0.00004419002,0.0002342624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729085,0.000072475654,0.00048423992,0.0005810038,0.0009614144,0.00060999807],"domain_scores_gemma":[0.99854183,0.00020478651,0.00018876127,0.0005167979,0.00042444342,0.00012339714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011411237,0.0002418039,0.0004955777,0.00035729588,0.00011747455,0.000024949877,0.0004593643,0.00027521595,0.002256225],"category_scores_gemma":[0.000083370025,0.00021183852,0.00016785224,0.00084404036,0.00056004035,0.00021368547,0.00008888762,0.0014648827,0.0000037481518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005863099,0.0001514514,0.004502094,0.0027971885,0.000053007265,0.00000939757,0.0007670063,0.00015140651,0.9883885,0.000012780057,0.00049762323,0.0020832792],"study_design_scores_gemma":[0.0018222348,0.000082870276,0.004158803,0.00080712937,0.000018542585,0.0000015082042,0.00006096531,0.000029767845,0.99225503,0.000022207169,0.00053495093,0.00020598662],"about_ca_topic_score_codex":0.0095714675,"about_ca_topic_score_gemma":0.0008942926,"teacher_disagreement_score":0.008677175,"about_ca_system_score_codex":0.00020555542,"about_ca_system_score_gemma":0.00031942278,"threshold_uncertainty_score":0.99865586},"labels":[],"label_agreement":null},{"id":"W2330447886","doi":"10.1158/1538-7445.am2012-1432","title":"Abstract 1432: The heterogeneous genomic landscape of posterior fossa ependymoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Immunohistochemistry; Proportional hazards model; Biology; Pathology; Brain tumor; Disease; Tissue microarray; Oncology; Hazard ratio; Medicine; Internal medicine; Bioinformatics; Confidence interval","score_opus":0.059588018835714775,"score_gpt":0.39264065235830403,"score_spread":0.33305263352258924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330447886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868369,0.0107678585,0.0000075485,0.0002906689,0.0000968002,0.00026897847,0.00007015364,0.000004718963,0.0016563367],"genre_scores_gemma":[0.99754494,0.00065456354,0.000015715188,0.000059900776,0.0006965662,0.00009936051,0.000027844386,0.00002891141,0.0008721958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983696,0.00014345812,0.00017820475,0.00023118846,0.00040702464,0.00067056407],"domain_scores_gemma":[0.99903697,0.000052643478,0.000043699605,0.00052601093,0.00017839656,0.00016225589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008447398,0.00010981833,0.00012649204,0.00006347243,0.00016855898,0.000030432686,0.00048099036,0.00010940058,0.00072371366],"category_scores_gemma":[0.00008325865,0.000076376295,0.00009943148,0.00014117223,0.00026396094,0.000006110449,0.00036026412,0.00024126223,0.000093171504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018916519,0.000059931313,0.0056481846,0.00004207358,0.00006501449,0.000008914553,0.00008318845,0.000015755772,0.9810669,0.000012128184,0.0024059708,0.010402804],"study_design_scores_gemma":[0.00032040253,0.00017068948,0.024457019,0.000021204607,0.0000067249957,0.000025448244,0.00017380637,0.000007922591,0.94298273,0.000013605505,0.03169568,0.00012474223],"about_ca_topic_score_codex":0.00021003655,"about_ca_topic_score_gemma":0.00005571436,"teacher_disagreement_score":0.038084112,"about_ca_system_score_codex":0.00002816749,"about_ca_system_score_gemma":0.00020011731,"threshold_uncertainty_score":0.7924157},"labels":[],"label_agreement":null},{"id":"W2330496296","doi":"10.1158/1538-7445.am2012-811","title":"Abstract 811: VAL083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Neurosphere; Cancer research; Cancer stem cell; Cancer; Cancer cell; Medicine; Brain tumor; Stem cell; Pharmacology; Glioblastoma; In vitro; Biology; Internal medicine; Pathology; Biochemistry; Cell biology; Adult stem cell","score_opus":0.08243690836174092,"score_gpt":0.3835010885560616,"score_spread":0.3010641801943207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330496296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943497,0.0023179038,0.0015837966,0.00017066929,0.0001788356,0.0012044472,0.00016292908,0.000016114815,0.000015589518],"genre_scores_gemma":[0.9970642,0.0005005831,0.00042067494,0.000010904797,0.000792108,0.00048309617,0.000028177667,0.000043771004,0.0006565201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984523,0.000058011403,0.00018917782,0.0004314727,0.00025013398,0.0006188961],"domain_scores_gemma":[0.9991684,0.000044035685,0.0001188031,0.00021851753,0.00018044295,0.00026981524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039287077,0.00019323714,0.0001635687,0.00009505266,0.00024540542,0.00008016844,0.000097060816,0.00016147202,0.000020417123],"category_scores_gemma":[0.000033208755,0.0001784737,0.00009078838,0.00011604004,0.00008368647,0.00004116659,0.00011230987,0.00010735387,0.0000032243643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005938578,0.0001320475,0.0016215879,0.00015370252,0.00009578962,5.307215e-7,0.00012995831,0.0004137943,0.9527104,0.0000056851795,0.00042037253,0.043722313],"study_design_scores_gemma":[0.0014075842,0.00021049815,0.0099449,0.0000843851,0.000033901546,0.000004172727,0.00007788116,0.00066886214,0.98327255,0.0000054079906,0.004098588,0.00019123948],"about_ca_topic_score_codex":0.0012904459,"about_ca_topic_score_gemma":0.00064049434,"teacher_disagreement_score":0.04353107,"about_ca_system_score_codex":0.00040835206,"about_ca_system_score_gemma":0.00046243187,"threshold_uncertainty_score":0.7277946},"labels":[],"label_agreement":null},{"id":"W2330510000","doi":"10.1158/1538-7445.am2011-lb-460","title":"Abstract LB-460: Effects of folic acid supplementation on mammary tumor progression","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; DMBA; Folic acid; Folic acid supplementation; Internal medicine; Physiology; Vitamin; Mammary tumor; Endocrinology; Carcinogenesis","score_opus":0.11076086531803621,"score_gpt":0.46527530386501126,"score_spread":0.35451443854697506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330510000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677355,0.0009324829,0.000009005577,0.00046155715,0.000097685515,0.0012447338,0.0000111284835,0.000029367427,0.010440462],"genre_scores_gemma":[0.9975746,0.0005738172,0.00021824015,0.00007230191,0.00014489659,0.00038347795,0.000027835365,0.000028456461,0.0009763322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997627,0.00012161074,0.000226939,0.0003121952,0.0011645278,0.0005476948],"domain_scores_gemma":[0.9988103,0.00013878918,0.000050277587,0.00042007756,0.00036063616,0.0002199035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071496505,0.00011740397,0.00021902382,0.00043782254,0.000098947945,0.000017622098,0.00022461536,0.00007418164,0.0011303279],"category_scores_gemma":[0.00017933412,0.00008851833,0.000070944116,0.0005046148,0.00015886231,0.00013055997,0.00011641951,0.00053412124,0.00014159892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310706,0.000940025,0.014902825,0.0026788912,0.00012985546,0.00061425066,0.0011446261,2.3063963e-7,0.8435241,0.00049004646,0.012965701,0.12027836],"study_design_scores_gemma":[0.0016003045,0.0019163799,0.16112727,0.00079489744,0.000011588099,0.0000064947158,0.00008544993,0.000012023116,0.8330414,0.00013096475,0.0011979544,0.00007524356],"about_ca_topic_score_codex":0.00055369287,"about_ca_topic_score_gemma":0.000033388158,"teacher_disagreement_score":0.14622444,"about_ca_system_score_codex":0.00018736723,"about_ca_system_score_gemma":0.00040025057,"threshold_uncertainty_score":0.9997828},"labels":[],"label_agreement":null},{"id":"W2330598133","doi":"10.1158/1538-7445.am2012-1243","title":"Abstract 1243: RET and integrin crosstalk provides functional plasticity","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell biology; Integrin; Glial cell line-derived neurotrophic factor; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Receptor tyrosine kinase; Biology; Cell adhesion; Chemistry; Neurotrophic factors; Signal transduction; Cell; Receptor; Genetics","score_opus":0.25617715126673013,"score_gpt":0.49153109932044164,"score_spread":0.23535394805371151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330598133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859061,0.0037579567,0.000047800077,0.0026322226,0.00030489083,0.0007659857,0.000047951457,0.000096167634,0.0064408835],"genre_scores_gemma":[0.99299204,0.0006483327,0.00014937318,0.00015008432,0.0015618028,0.00042188397,0.000010272645,0.000064825115,0.004001393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638987,0.00012912262,0.00026725998,0.00043172613,0.0015780737,0.0012039747],"domain_scores_gemma":[0.9978111,0.0004594274,0.000035878194,0.000322223,0.00059212407,0.0007792448],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020864736,0.00017381634,0.00027532346,0.00030126492,0.00030322853,0.000112924805,0.00016488977,0.00017089253,0.0029754434],"category_scores_gemma":[0.0012343157,0.0001412961,0.00005904439,0.0004995582,0.0008212359,0.00027245758,0.0002529693,0.0016139784,0.00026204987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038402642,0.0007359263,0.42944354,0.0025661716,0.00020436457,0.00014443332,0.0018755371,0.000022173861,0.30041036,0.0021967255,0.17727935,0.08128114],"study_design_scores_gemma":[0.0017098188,0.0004127914,0.74094903,0.0005634756,0.00002258317,0.00009301519,0.00062252604,0.00006749904,0.044911407,0.00029022733,0.21008879,0.00026883782],"about_ca_topic_score_codex":0.0015173595,"about_ca_topic_score_gemma":0.0001651272,"teacher_disagreement_score":0.31150547,"about_ca_system_score_codex":0.0008128432,"about_ca_system_score_gemma":0.0011914974,"threshold_uncertainty_score":0.99793595},"labels":[],"label_agreement":null},{"id":"W2330660730","doi":"10.1158/1538-7445.am10-1596","title":"Abstract 1596: Effects of folylpolyglutamyl synthase and γ-glutamyl hydrolase modulation on DNA methylation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Social Innovation; University of Toronto","funders":"","keywords":"DNA methylation; Biology; Transfection; Methylation; Epigenetics; Methyltransferase; DNA methyltransferase; Molecular biology; DNMT1; Intracellular; Cancer research; Carcinogenesis; DNA; Biochemistry; Gene expression; Gene","score_opus":0.024276221147788414,"score_gpt":0.35987481748998185,"score_spread":0.3355985963421934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330660730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727225,0.0012283052,0.0002850328,0.00011575815,0.00020346517,0.00033361788,0.000016478101,0.0000067281,0.0005383537],"genre_scores_gemma":[0.99883753,0.0005319242,0.00012418194,0.00001426581,0.00025842723,0.000061075,0.00003736435,0.000023958934,0.0001112659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988099,0.00009178886,0.0001855982,0.0003417369,0.00032783454,0.00024315665],"domain_scores_gemma":[0.9991357,0.00014312757,0.00007429925,0.0003429449,0.00018378992,0.00012013871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006826019,0.000114473674,0.00012272225,0.00014375012,0.000109802975,0.000031202588,0.00011267308,0.00019349981,0.00003163303],"category_scores_gemma":[0.0004324211,0.00010910616,0.0000455053,0.00014595776,0.00015073999,0.0000074839973,0.00006205866,0.00027111024,0.0000051411002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011371147,0.00005376321,0.00077837,0.00007222215,0.000022731923,0.0000015583845,0.00004518074,0.00022970121,0.9584672,0.00015161357,0.000039100098,0.040024873],"study_design_scores_gemma":[0.0004495451,0.00027523437,0.037655372,0.000028799204,0.000007811244,3.7455877e-7,0.000006486877,0.00041783915,0.95876646,0.00061851926,0.0016669278,0.00010662461],"about_ca_topic_score_codex":0.00010990215,"about_ca_topic_score_gemma":0.0000729394,"teacher_disagreement_score":0.039918248,"about_ca_system_score_codex":0.000016487942,"about_ca_system_score_gemma":0.00009180893,"threshold_uncertainty_score":0.444922},"labels":[],"label_agreement":null},{"id":"W2330666378","doi":"10.1158/1538-7445.am2013-5387","title":"Abstract 5387: Integrative analysis of transcriptomic and metabolomic data reveals a critical role for aminosugar metabolism in prostate cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada)","funders":"","keywords":"Prostate cancer; Aminosugar; Cancer; Metabolomics; Prostate; Biology; Transcriptome; Cancer research; Medicine; Bioinformatics; Biochemistry; Internal medicine; Glucosamine; Gene; Gene expression","score_opus":0.06163445214200589,"score_gpt":0.43790400428748544,"score_spread":0.3762695521454795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330666378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96381575,0.031671282,0.000029320609,0.00052531494,0.000036575722,0.0010588694,0.0027654727,0.0000036548133,0.0000937314],"genre_scores_gemma":[0.9895223,0.007780063,0.00019008314,0.000035043326,0.000072335104,0.0017274878,0.0004011596,0.000022868071,0.0002487024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796575,0.00015142528,0.00031124364,0.00067054085,0.00031130528,0.000589714],"domain_scores_gemma":[0.99861634,0.00012689897,0.000047881753,0.0005786848,0.00044622173,0.00018397106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006736707,0.00016607843,0.00044188817,0.00037059136,0.00007979987,0.000060816285,0.0004523107,0.00009043181,0.00020858027],"category_scores_gemma":[0.00031062713,0.00013425013,0.00009829224,0.0005920362,0.00038764617,0.000033154436,0.0001994629,0.00022723082,0.0000023537918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008594871,0.00015864668,0.013162868,0.00014112948,0.0014576591,0.0000030846497,0.00038077842,0.000022389077,0.9650046,0.00014068781,0.002747596,0.015921067],"study_design_scores_gemma":[0.0048377314,0.00056082744,0.4274693,0.00019372317,0.0008576686,0.0000022700365,0.0017234557,0.0015142757,0.5494504,0.0019659596,0.010845612,0.00057878194],"about_ca_topic_score_codex":0.02102562,"about_ca_topic_score_gemma":0.017518904,"teacher_disagreement_score":0.41555423,"about_ca_system_score_codex":0.000076805496,"about_ca_system_score_gemma":0.00040493047,"threshold_uncertainty_score":0.9854935},"labels":[],"label_agreement":null},{"id":"W2330701311","doi":"10.1158/1538-7445.am2013-292","title":"Abstract 292: Breast cancer malignancy is regulated by PAX5 through the disruption of FAK1 signaling.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Breast cancer; PAX5; Cancer research; Cancer; Malignancy; Metastasis; Carcinogenesis; Medicine; Biology; Immunology; Pathology; Internal medicine; B cell; Antibody","score_opus":0.06425326405663322,"score_gpt":0.4103897158042302,"score_spread":0.346136451747597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330701311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96589303,0.0065423725,0.000022076694,0.022858007,0.0000846274,0.0015943226,0.00022075755,0.000037890386,0.0027469173],"genre_scores_gemma":[0.98623204,0.0040762513,0.00003841871,0.0004199917,0.00023655493,0.0006908876,0.000036881975,0.000067498244,0.008201447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958818,0.00022010664,0.00046483727,0.0005389648,0.0020045468,0.0008897599],"domain_scores_gemma":[0.99699116,0.00026492536,0.00011485195,0.00081860274,0.0015447708,0.0002656906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007309427,0.00021095615,0.0003552529,0.000121974634,0.0002426258,0.000082089064,0.0004813102,0.00018881811,0.023440458],"category_scores_gemma":[0.000102935875,0.00013823826,0.00014773924,0.0010662655,0.0006474424,0.00019639249,0.00020915999,0.00095821876,0.00038873244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027628397,0.00017256186,0.0029477165,0.00032755613,0.00012864312,0.000017427117,0.000736745,0.000012887956,0.8215223,0.000032135093,0.12591793,0.04790782],"study_design_scores_gemma":[0.0025956603,0.00030181624,0.16656889,0.0012616832,0.00006142749,0.000038543614,0.0012325475,0.00032564855,0.8011448,0.000721897,0.025387054,0.00036004794],"about_ca_topic_score_codex":0.023184784,"about_ca_topic_score_gemma":0.00008706002,"teacher_disagreement_score":0.16362117,"about_ca_system_score_codex":0.00043665376,"about_ca_system_score_gemma":0.00054276595,"threshold_uncertainty_score":0.98331994},"labels":[],"label_agreement":null},{"id":"W2330777353","doi":"10.1158/1538-7445.am10-2256","title":"Abstract 2256: Identifying the molecular signature of melanoma metastasis via a personalized quantitative proteomics approach","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Stable isotope labeling by amino acids in cell culture; Quantitative proteomics; Proteomics; Melanoma; Metastasis; Proteome; Cancer research; Cancer; Biology; Epithelial–mesenchymal transition; Computational biology; Bioinformatics; Genetics; Gene","score_opus":0.07848430003314107,"score_gpt":0.4206133860303326,"score_spread":0.34212908599719155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330777353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9172199,0.0016178382,0.074253015,0.0005839273,0.000023576224,0.0010205399,0.00017383437,0.000067673136,0.0050397203],"genre_scores_gemma":[0.90365183,0.00014832603,0.09375885,0.000018695102,0.000058501155,0.002018984,0.000025552528,0.00004078221,0.00027847444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984436,0.000045784174,0.0002474745,0.0003728749,0.00052883127,0.0003614092],"domain_scores_gemma":[0.99856544,0.00017763588,0.0001470156,0.00061002944,0.00041835403,0.0000815301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007975294,0.00014750662,0.00020531224,0.00007856515,0.00026889486,0.00005589065,0.0007110092,0.00016888723,0.00054271566],"category_scores_gemma":[0.00013390183,0.00011078964,0.00012641834,0.00040274073,0.0005182864,0.00009057746,0.00016399709,0.0015939262,0.0000065355352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006990588,0.000060023693,0.00003690952,0.00018332528,0.00006518135,0.000002530417,0.0004273366,0.000031339856,0.96850055,0.029096067,0.00012631729,0.0014004802],"study_design_scores_gemma":[0.00022106928,0.000012535032,0.000031521296,0.000038078582,0.000017245105,0.0000042933,0.00060012576,0.0003490105,0.9845872,0.01150536,0.0025038735,0.0001296693],"about_ca_topic_score_codex":0.0002683686,"about_ca_topic_score_gemma":0.000014504543,"teacher_disagreement_score":0.019505836,"about_ca_system_score_codex":0.00007113883,"about_ca_system_score_gemma":0.00016239296,"threshold_uncertainty_score":0.69249046},"labels":[],"label_agreement":null},{"id":"W2330794137","doi":"10.1158/1538-7445.am2011-5146","title":"Abstract 5146: EGFL7 is a potent endogenous inhibitor of tumor angiogenesis","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FPInnovations; Prostate Cancer Canada","funders":"","keywords":"HT1080; Angiogenesis; Metastasis; Chorioallantoic membrane; Fibrosarcoma; Biology; Cancer research; Cancer; Endothelial stem cell; Tumor progression; Pathology; Medicine; In vitro; Tumor cells; Biochemistry","score_opus":0.10136482044655824,"score_gpt":0.34017364037306785,"score_spread":0.2388088199265096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330794137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765058,0.015651753,0.000017170903,0.00007617495,0.001969961,0.00033683883,0.00018110815,0.0000099622775,0.0052511916],"genre_scores_gemma":[0.9900349,0.0030308613,0.00013358876,0.00014747427,0.00549481,0.00015574238,0.000016012498,0.00003843981,0.0009481851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836683,0.000064954314,0.00024792916,0.00041440796,0.00039061814,0.0005152584],"domain_scores_gemma":[0.9988264,0.0000120891345,0.00007191475,0.0005180128,0.00039297945,0.00017862173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039981602,0.00014461133,0.00020970682,0.00012628047,0.000096707176,0.000013160099,0.00034023522,0.00011179605,0.0005212573],"category_scores_gemma":[0.000057429934,0.00013453834,0.00017346673,0.00021468778,0.00022511037,0.0000049155256,0.00017001716,0.00014438662,0.000031810898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002833205,0.000109798544,0.0011457026,0.00007401958,0.00007930276,0.0000013630579,0.00042642496,0.0000013828598,0.95839226,0.000029842075,0.03160703,0.00784952],"study_design_scores_gemma":[0.0004056552,0.00015168368,0.005763435,0.00002483836,0.0000135740565,0.000008758978,0.00016168776,4.912687e-7,0.7799292,0.000039004106,0.21337378,0.00012784702],"about_ca_topic_score_codex":0.0029254341,"about_ca_topic_score_gemma":0.00021837554,"teacher_disagreement_score":0.18176675,"about_ca_system_score_codex":0.000044252625,"about_ca_system_score_gemma":0.0004050715,"threshold_uncertainty_score":0.57074016},"labels":[],"label_agreement":null},{"id":"W2330797109","doi":"10.1158/1538-7445.am10-1290","title":"Abstract 1290: O6-methylguanine-methyltransferase modulates glioblastoma angiogenesis and invasion","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Temozolomide; Angiogenesis; Cancer research; Sunitinib; Biology; Methyltransferase; DNA methyltransferase; Tumor progression; U87; Glioma; Cancer; DNA methylation; Gene expression; Gene; Methylation","score_opus":0.05001310973409637,"score_gpt":0.38059480033771814,"score_spread":0.33058169060362175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330797109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247974,0.003024777,0.0000021271785,0.0032623503,0.00014568484,0.0005555889,0.00003493659,0.000048236125,0.00044657337],"genre_scores_gemma":[0.99730533,0.0016494717,0.00023508906,0.00011140855,0.0002602903,0.00025551376,0.000011503567,0.000040987787,0.00013040638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821055,0.000051612635,0.00019629319,0.00045915597,0.00058206345,0.0005003283],"domain_scores_gemma":[0.99855995,0.0002877235,0.000022388493,0.00041440935,0.00029795992,0.0004175715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005960831,0.00017472096,0.0002742248,0.00038077775,0.00020880431,0.00006430468,0.0001089897,0.00015243246,0.0010564144],"category_scores_gemma":[0.00016616455,0.00013471254,0.00009782836,0.0004852551,0.00022409618,0.00009363026,0.00006656836,0.00048152526,0.00008383305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027645723,0.00028029617,0.043492734,0.000106408035,0.0000981213,0.00027953382,0.00015737844,0.000003426288,0.91124505,0.00011856103,0.0013868097,0.042555198],"study_design_scores_gemma":[0.0016841493,0.00037235132,0.22446735,0.000116027244,0.00004812345,0.00004643091,0.00007654127,0.000030070833,0.7688027,0.0001780887,0.0040486,0.00012954074],"about_ca_topic_score_codex":0.0012829526,"about_ca_topic_score_gemma":0.0007957515,"teacher_disagreement_score":0.18097462,"about_ca_system_score_codex":0.00007834888,"about_ca_system_score_gemma":0.00017355567,"threshold_uncertainty_score":0.99985677},"labels":[],"label_agreement":null},{"id":"W2330836741","doi":"10.1158/1538-7445.am2011-3476","title":"Abstract 3476: Blockade of endothelial Notch diminishes tumor growth and perfusion","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Lewis lung carcinoma; Mural cell; Biology; Vascular endothelial growth factor A; Pericyte; Genetically modified mouse; Cancer research; Cell biology; Receptor; Transgene; Chemistry; Endocrinology; Vascular endothelial growth factor; Endothelial stem cell; Signal transduction; Vascular smooth muscle; Cancer; Biochemistry; Genetics","score_opus":0.0695638755343887,"score_gpt":0.34892897755354124,"score_spread":0.27936510201915254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330836741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260205,0.0030401996,0.000011819689,0.00007064355,0.00008437625,0.00013337683,0.00005825558,0.000004113543,0.0039951634],"genre_scores_gemma":[0.996171,0.002929238,0.00012841432,0.000043787102,0.0003486698,0.000057524932,0.000006532683,0.000020957777,0.00029386595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990155,0.000042473566,0.00014734991,0.0002919509,0.00022396295,0.00027873673],"domain_scores_gemma":[0.9994653,0.000019440226,0.000043057782,0.00021269738,0.00016725328,0.0000922615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027898976,0.0000954126,0.00012070046,0.000054676304,0.000088919354,0.00001057675,0.00019058539,0.00008222422,0.00029124704],"category_scores_gemma":[0.000057696467,0.000080836064,0.000058266374,0.00008583986,0.000263966,0.0000036910842,0.00016294063,0.00010497273,0.0000045843462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022926663,0.00004652565,0.011921086,0.00006142519,0.00002122468,0.0000043377454,0.00017910977,3.6252104e-7,0.98320854,0.00007504306,0.0009243384,0.0033287676],"study_design_scores_gemma":[0.0002933428,0.00020193048,0.026442159,0.00003082982,0.0000063844363,0.000003960508,0.00013595802,0.0000019005095,0.9673381,0.00006566156,0.0053821285,0.000097659766],"about_ca_topic_score_codex":0.0007737953,"about_ca_topic_score_gemma":0.000066160406,"teacher_disagreement_score":0.015870428,"about_ca_system_score_codex":0.000011428786,"about_ca_system_score_gemma":0.00015437555,"threshold_uncertainty_score":0.32963988},"labels":[],"label_agreement":null},{"id":"W2330839320","doi":"10.1158/0008-5472.sabcs10-p6-05-05","title":"Abstract P6-05-05: Signaling Pathways Activated in Her 2 and ER Negative Breast Cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Cancer research; Breast cancer; Cancer; PTEN; Cyclin D1; Cyclin-dependent kinase 6; Metastasis; Signal transduction; Biology; Triple-negative breast cancer; Oncogene; Medicine; Angiogenesis; PI3K/AKT/mTOR pathway; Cell cycle; Internal medicine; Cell biology","score_opus":0.05404393219268049,"score_gpt":0.3646271039288277,"score_spread":0.3105831717361472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330839320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353236,0.00066632085,0.0000065229406,0.0016837678,0.00038675644,0.0009042175,0.0000938094,0.0000643705,0.0026618945],"genre_scores_gemma":[0.9982292,0.00033501285,0.00012019827,0.0002565466,0.00037555132,0.00025703298,0.000018623763,0.0000835326,0.00032430145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972133,0.00010623735,0.00031966713,0.00066042086,0.0008264472,0.0008739003],"domain_scores_gemma":[0.99834174,0.000224887,0.00007602059,0.0004576638,0.0004665512,0.00043311116],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086953543,0.00024594835,0.00038089123,0.0004704034,0.00016449591,0.00006484303,0.00018785831,0.00030884866,0.0014554647],"category_scores_gemma":[0.00027769883,0.00022844206,0.00007249026,0.0009867795,0.00046374186,0.00021532545,0.00012347547,0.0026867434,0.000036845067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007763407,0.000072178336,0.001269247,0.00012598002,0.00008377333,0.00037399112,0.0012898943,0.00009072606,0.9758313,0.000081823935,0.0021662845,0.01783851],"study_design_scores_gemma":[0.0060756244,0.0003149145,0.080678225,0.001208298,0.000039743707,0.0002461575,0.0011900802,0.00026019462,0.9025015,0.00043024708,0.0065445974,0.0005104122],"about_ca_topic_score_codex":0.014305765,"about_ca_topic_score_gemma":0.005106713,"teacher_disagreement_score":0.07940898,"about_ca_system_score_codex":0.0010262573,"about_ca_system_score_gemma":0.0018405159,"threshold_uncertainty_score":0.9996141},"labels":[],"label_agreement":null},{"id":"W2330883993","doi":"10.1158/1538-7445.am10-lb-386","title":"Abstract LB-386: The role of neuronal connexins in the differentiation of neuroblastoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Retinoic acid; Neuroblastoma; Cellular differentiation; Transfection; Tretinoin; Biology; Messenger RNA; Gap junction; SH-SY5Y; Gap-43 protein; Cell biology; Molecular biology; Chemistry; Cell culture; Intracellular; Biochemistry; Immunology; Immunohistochemistry; Gene; Genetics","score_opus":0.026619792223169302,"score_gpt":0.3432541210632909,"score_spread":0.3166343288401216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330883993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776274,0.00025575445,0.0000026874159,0.00064318936,0.00007889664,0.00016497723,0.000024215466,0.0000011673965,0.001066353],"genre_scores_gemma":[0.99955297,0.00013623404,0.0000028483341,0.00006599194,0.00014770633,0.000037933933,0.000012945402,0.0000068718373,0.000036523877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917823,0.00015675496,0.00015078008,0.00015947514,0.00016809464,0.00018667939],"domain_scores_gemma":[0.9993571,0.00011035192,0.0000526589,0.00033337355,0.00012642988,0.000020081878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005302228,0.000059098493,0.00007966241,0.00004654917,0.000050728482,0.000008403689,0.00038545148,0.00008160605,0.00010798444],"category_scores_gemma":[0.00012858759,0.00003434529,0.000047232552,0.00011929111,0.00028809393,0.0000018293047,0.000095489464,0.0003419461,0.0000016929646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009907814,0.00005085565,0.007714951,0.000009123843,0.000008145679,4.404044e-7,0.000121840945,0.00000749336,0.9852533,0.0011868076,0.0001447977,0.005403175],"study_design_scores_gemma":[0.0002580224,0.00021965928,0.42412436,0.000006161701,0.0000029218056,0.000002661547,0.00024824476,0.000038430422,0.5540867,0.000373326,0.02059122,0.00004831847],"about_ca_topic_score_codex":0.0003560501,"about_ca_topic_score_gemma":0.001981611,"teacher_disagreement_score":0.43116662,"about_ca_system_score_codex":0.000003401167,"about_ca_system_score_gemma":0.00009538162,"threshold_uncertainty_score":0.14856048},"labels":[],"label_agreement":null},{"id":"W2330923983","doi":"10.1158/1538-7445.am10-5097","title":"Abstract 5097: ITCH E3 ubiquitin ligase regulates LATS1 tumor suppressor stability","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ubiquitin ligase; Downregulation and upregulation; Ubiquitin; Gene knockdown; Cancer research; Biology; Regulator; Suppressor; Cancer; Ectopic expression; Proteasome; Cell biology; Apoptosis; Biochemistry; Cell culture; Genetics","score_opus":0.055249266262709165,"score_gpt":0.3721173061737131,"score_spread":0.31686803991100393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330923983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959418,0.0006149923,0.0000054837215,0.0005358402,0.00024774688,0.00030700682,0.00017150039,0.000031775395,0.0021438478],"genre_scores_gemma":[0.99753,0.00006995222,0.00009261332,0.000092866074,0.00088317064,0.00015830019,0.000082996936,0.000043516935,0.0010466177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977808,0.00013640823,0.00025777903,0.0006439927,0.00045436426,0.0007266486],"domain_scores_gemma":[0.99827826,0.00008577224,0.000054098145,0.0008359851,0.00045466798,0.00029123228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015633609,0.00018251555,0.00018608106,0.00007434612,0.0002542361,0.000090576636,0.00049215124,0.00022458746,0.001250678],"category_scores_gemma":[0.00051686564,0.00016652237,0.00010852001,0.00018108293,0.0003854817,0.0000074944546,0.0002167013,0.000788812,0.000095297364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016597018,0.00008918503,0.0015002842,0.00007310725,0.00002388479,0.000017654102,0.00010081712,0.000009411121,0.9948652,0.00005427891,0.0018754306,0.0012248111],"study_design_scores_gemma":[0.0003575542,0.00009733716,0.0035992917,0.000028359764,0.0000047749036,0.0000066478055,0.00009004294,0.000015853175,0.95603675,0.00024099583,0.039327003,0.00019538568],"about_ca_topic_score_codex":0.00047638794,"about_ca_topic_score_gemma":0.00060232735,"teacher_disagreement_score":0.03882841,"about_ca_system_score_codex":0.000034248627,"about_ca_system_score_gemma":0.00050440093,"threshold_uncertainty_score":0.99966234},"labels":[],"label_agreement":null},{"id":"W2330960312","doi":"10.1158/0008-5472.sabcs-1069","title":"Combination of low plasma stromal cell-derived factor-1 and phosphorylated-CXCR4: independent prognostic marker for breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Stromal cell; CXCR4; Breast cancer; Tissue microarray; Metastasis; Cancer; Medicine; Cancer research; Oncology; Internal medicine; Immunohistochemistry; Pathology; Plasma cell; Stromal cell-derived factor 1; Predictive marker; CA15-3; Receptor; Chemokine; Bone marrow","score_opus":0.0352685208785246,"score_gpt":0.3536392298383591,"score_spread":0.3183707089598345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330960312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648774,0.0011533924,0.000036059293,0.0008846095,0.00008332366,0.0010110481,0.00015577093,0.000019450199,0.00016858295],"genre_scores_gemma":[0.9985646,0.0005297314,0.000062922176,0.000026649717,0.000134324,0.00012101759,0.000023961617,0.000021754084,0.00051504414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984922,0.00004262587,0.00023073776,0.00029315523,0.0005557348,0.00038558754],"domain_scores_gemma":[0.9988548,0.00015437882,0.000071881885,0.00013835035,0.0006030946,0.00017750465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031234074,0.00012805637,0.00027509805,0.00013470987,0.000105026695,0.000029131095,0.00008795186,0.00011654289,0.00054859085],"category_scores_gemma":[0.000066262364,0.000110642366,0.000059351016,0.00022416419,0.000097526936,0.00006751927,0.000034383876,0.00032270356,0.0000014664483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018194017,0.00036789814,0.07306504,0.0007322076,0.00007384362,0.0000097052,0.00050698407,0.000022464003,0.85657007,0.000038224534,0.0010395176,0.065754645],"study_design_scores_gemma":[0.004551762,0.00071574375,0.36721057,0.0006149889,0.000041703584,0.000014161849,0.00023073256,0.001958678,0.62422913,0.00007706187,0.00020255618,0.00015294284],"about_ca_topic_score_codex":0.0002412409,"about_ca_topic_score_gemma":0.00002899842,"teacher_disagreement_score":0.29414552,"about_ca_system_score_codex":0.00024306572,"about_ca_system_score_gemma":0.00036774922,"threshold_uncertainty_score":0.6006685},"labels":[],"label_agreement":null},{"id":"W2330965451","doi":"10.1158/0008-5472.sabcs12-p2-12-07","title":"Abstract P2-12-07: A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials","year":2012,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Quality of life (healthcare); Metastatic breast cancer; Breast cancer; Internal medicine; Cancer; Disease; Oncology; Phases of clinical research; Intensive care medicine; Nursing","score_opus":0.8964209041648008,"score_gpt":0.7636633541804825,"score_spread":0.13275754998431832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330965451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010768729,0.98054194,6.159894e-7,0.00071390317,0.0006600493,0.004723556,0.0024958444,0.000007806367,0.00008754964],"genre_scores_gemma":[0.0019062478,0.9954867,0.000058845242,0.00028329718,0.0006007717,0.0010021814,0.00012559984,0.00006479615,0.0004715689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97877437,0.0092189675,0.009461239,0.0007416852,0.0011374658,0.00066625816],"domain_scores_gemma":[0.9728591,0.021551015,0.0034476472,0.000797505,0.0006571382,0.00068758393],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04112133,0.00048976607,0.014938033,0.00053897337,0.00003115634,0.000009498316,0.0003384876,0.00044491855,0.0060065305],"category_scores_gemma":[0.008486421,0.0003225365,0.0018954391,0.0006235338,0.0010159602,0.0001322828,0.00022216911,0.001856568,0.000014806378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030488942,0.002907475,0.0148717435,0.22911713,0.0032199544,0.000025514495,0.000045099274,3.7348258e-8,0.000007304159,0.000026991787,0.0034080546,0.7433218],"study_design_scores_gemma":[0.026916245,0.00091632985,0.016809504,0.1791247,0.009986272,0.000019520665,0.000026016467,7.6487294e-7,0.0000120884115,0.000015595344,0.7657498,0.00042314988],"about_ca_topic_score_codex":0.004792968,"about_ca_topic_score_gemma":0.0005623414,"teacher_disagreement_score":0.76234174,"about_ca_system_score_codex":0.00028039076,"about_ca_system_score_gemma":0.0062302654,"threshold_uncertainty_score":0.9999227},"labels":[],"label_agreement":null},{"id":"W2331000207","doi":"10.1158/0008-5472.sabcs10-p3-02-08","title":"Abstract P3-02-08: Detection of Circulating Tumor Cells Prior to Autologous Stem Cell Transplantation Is Predictive of Shorter Progression Free Survival in Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apheresis; Medicine; Oncology; Stem cell; CD34; Circulating tumor cell; Cancer stem cell; Autologous stem-cell transplantation; Progenitor cell; Internal medicine; Transplantation; Haematopoiesis; Bone marrow; Cancer; Hematopoietic stem cell transplantation; Cancer research; Immunology; Metastasis; Biology","score_opus":0.0470067050307222,"score_gpt":0.37940888202779366,"score_spread":0.3324021769970715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331000207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959504,0.00042438586,0.00023362748,0.00025037903,0.00040919596,0.0014795322,0.0009305992,0.000019444127,0.00030243924],"genre_scores_gemma":[0.9986639,0.0002394,0.0004332699,0.000027681648,0.0001340928,0.0003749543,0.000009834972,0.000040974,0.000075868964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972484,0.00013169395,0.000582397,0.00046965628,0.0010735806,0.00049427326],"domain_scores_gemma":[0.9984092,0.00017547743,0.00019526649,0.00041353,0.000585217,0.0002212769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011603547,0.00018565121,0.00051702774,0.00046980692,0.00007058844,0.000016300377,0.00020006012,0.000095964424,0.0005677813],"category_scores_gemma":[0.000022445356,0.0001594082,0.00011203327,0.0007569449,0.00016035397,0.00012092594,0.000054323944,0.0007199963,0.0000048711777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017868268,0.00020608885,0.007503372,0.0017223152,0.000058472986,0.00004650972,0.0025322698,0.00014951408,0.846406,0.0000016252312,0.000061696264,0.1395253],"study_design_scores_gemma":[0.0017036538,0.00034667779,0.15502815,0.0007064306,0.00011246286,0.000020749538,0.00068423536,0.00021144502,0.8409359,0.000012328883,0.00011075135,0.00012723685],"about_ca_topic_score_codex":0.0058936197,"about_ca_topic_score_gemma":0.005245718,"teacher_disagreement_score":0.14752479,"about_ca_system_score_codex":0.000275945,"about_ca_system_score_gemma":0.0007111047,"threshold_uncertainty_score":0.89094293},"labels":[],"label_agreement":null},{"id":"W2331030151","doi":"10.1158/1538-7445.am2013-610","title":"Abstract 610: Short peptides for targeted apoptosis in cancer cells: development &amp; evaluation of therapeutic applications.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Cancer cell; Carcinogenesis; Biology; Cancer; Cancer research; Cell biology; Genetics","score_opus":0.14003492347442834,"score_gpt":0.4329326069525933,"score_spread":0.2928976834781649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331030151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938755,0.0029926505,0.0005639623,0.0002549575,0.00005040589,0.0019637248,0.000017834222,0.000004524458,0.0002764192],"genre_scores_gemma":[0.9871302,0.00049699424,0.0007029592,0.000051223014,0.00010079808,0.011064422,0.00011178536,0.00001538008,0.00032623616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988227,0.000072042356,0.00022880614,0.0002557327,0.00038959342,0.00023116586],"domain_scores_gemma":[0.998852,0.00002183201,0.000042165837,0.00021401845,0.00081960723,0.000050378996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000991793,0.00008000716,0.00009164479,0.00010433135,0.00007059295,0.000019814524,0.000170414,0.000077806835,0.0003044976],"category_scores_gemma":[0.00004526714,0.00007396315,0.00003406127,0.0001894853,0.00006977618,0.000007953241,0.00004001856,0.00009071228,0.0000132443865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022124072,0.000051102306,0.00064017245,0.00004896813,0.000024126348,4.3853126e-9,0.00005350277,0.00013355455,0.90634674,0.000009143227,0.0031254445,0.08954512],"study_design_scores_gemma":[0.00026774805,0.00002258064,0.0055951253,0.000025538939,0.000004566048,3.8615198e-8,0.00007102751,0.00005657086,0.9487526,0.00010683674,0.04501237,0.000085038235],"about_ca_topic_score_codex":0.00044482056,"about_ca_topic_score_gemma":0.00048038468,"teacher_disagreement_score":0.08946008,"about_ca_system_score_codex":0.00014571099,"about_ca_system_score_gemma":0.0005877837,"threshold_uncertainty_score":0.33340353},"labels":[],"label_agreement":null},{"id":"W2331050473","doi":"10.1158/0008-5472.sabcs-6105","title":"Docetaxel plus cyclophosphamide is cost-effective compared to doxorubicin plus cyclophosphamide, based on an economic analysis of US oncology trial 9735: additional rationale to avoid anthracyclines in the adjuvant treatment of operable breast cancer?.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Population; Breast cancer; Oncology; Life expectancy; Cyclophosphamide; Quality-adjusted life year; Clinical trial; Cancer; Chemotherapy; Surgery; Cost effectiveness","score_opus":0.32068076796273676,"score_gpt":0.5291640050859733,"score_spread":0.20848323712323652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331050473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93070084,0.0011080983,0.00010547663,0.038013816,0.00037776356,0.0075173755,0.021370314,0.000014128668,0.00079216965],"genre_scores_gemma":[0.98368216,0.00050314964,0.00031814084,0.00668754,0.0004995423,0.0074866344,0.0005826538,0.000028390385,0.00021181269],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99367696,0.0011951565,0.0030643044,0.0009936049,0.00037117492,0.0006987922],"domain_scores_gemma":[0.993877,0.0036128224,0.001028166,0.000839361,0.00030233752,0.0003403427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008467835,0.0003118987,0.002110532,0.0016641225,0.00027389973,0.000069436246,0.00064131327,0.00017307358,0.0046146787],"category_scores_gemma":[0.0006752485,0.00030326023,0.00027630947,0.0015257844,0.00017049976,0.00028658123,0.00003870306,0.0002703564,0.00018841118],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021959925,0.0021585529,0.017904302,0.00011588962,0.0007822454,0.00000798901,0.008425906,0.90737104,0.00007390972,0.003261249,0.032746818,0.0051921615],"study_design_scores_gemma":[0.050178368,0.007482395,0.6830678,0.00047940537,0.0001923352,0.0000037993018,0.0034393854,0.16839123,0.0009025143,0.0013778859,0.08343072,0.0010541767],"about_ca_topic_score_codex":0.044533126,"about_ca_topic_score_gemma":0.02752904,"teacher_disagreement_score":0.7389798,"about_ca_system_score_codex":0.008583279,"about_ca_system_score_gemma":0.002457801,"threshold_uncertainty_score":0.99994195},"labels":[],"label_agreement":null},{"id":"W2331058833","doi":"10.1158/1538-7445.am2012-2150","title":"Abstract 2150: The role of SHP2 in HER2+ breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"PTPN11; Cancer research; Breast cancer; Cancer; Juvenile myelomonocytic leukemia; Carcinogenesis; Medicine; Metastatic breast cancer; Biology; Internal medicine; Haematopoiesis; Genetics; Stem cell; Colorectal cancer; KRAS","score_opus":0.031714111337918564,"score_gpt":0.37747422889353405,"score_spread":0.3457601175556155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331058833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90090805,0.09714221,0.0000013465412,0.0005515616,0.000074304306,0.0002640284,0.00023469496,0.0000031728325,0.00082063634],"genre_scores_gemma":[0.99729395,0.0017411684,0.000012454886,0.00005780867,0.0004105652,0.00029233663,0.000017936762,0.000017427694,0.00015637954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988975,0.00007786194,0.00013561516,0.00017337127,0.00026077998,0.00045485896],"domain_scores_gemma":[0.9993778,0.000021194623,0.000037643866,0.00035501903,0.00012908576,0.000079254234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064652023,0.000081101156,0.0000922095,0.00004204726,0.000055772623,0.000011248313,0.0003430652,0.000076534554,0.00039043603],"category_scores_gemma":[0.00005862971,0.00005921852,0.00003676044,0.00019572908,0.00019714072,0.000007359732,0.00018965742,0.00021048317,0.00001266465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017511626,0.000087035565,0.089553006,0.000037737434,0.00002778114,8.499284e-7,0.00008262894,0.00003194172,0.87517637,0.00056517054,0.0038619505,0.03040043],"study_design_scores_gemma":[0.00017329502,0.00002062463,0.14076865,0.000036003516,0.0000021449678,0.0000022874242,0.00010413831,0.0000019649956,0.82691586,0.00009640436,0.031812113,0.000066505134],"about_ca_topic_score_codex":0.0060704467,"about_ca_topic_score_gemma":0.0010342813,"teacher_disagreement_score":0.09638588,"about_ca_system_score_codex":0.000056062465,"about_ca_system_score_gemma":0.00023037208,"threshold_uncertainty_score":0.917674},"labels":[],"label_agreement":null},{"id":"W2331081899","doi":"10.1158/1538-7445.am10-2023","title":"Abstract 2023: Potential importance of micro-RNA-193b in human head and neck squamous cell carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Head and neck squamous-cell carcinoma; microRNA; Cancer research; Clonogenic assay; Luciferase; Biology; Cell culture; Transfection; Cancer; Medicine; Head and neck cancer; Gene; Genetics","score_opus":0.020860095429059332,"score_gpt":0.34611765430805125,"score_spread":0.32525755887899194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331081899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434674,0.00313312,0.0000353372,0.00016761164,0.00014424944,0.00047418274,0.00006187659,0.0000052823743,0.0016316314],"genre_scores_gemma":[0.99829274,0.00026600453,0.00012397641,0.000035488276,0.0002319032,0.00010902849,0.000054810313,0.0000487417,0.0008372888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771553,0.00009249014,0.00032631762,0.0006320354,0.00052023574,0.0007133634],"domain_scores_gemma":[0.99875015,0.000019833671,0.00007660372,0.0006206787,0.00031812367,0.0002146271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075001596,0.00017637871,0.00021404299,0.0002478857,0.0001295238,0.000044385022,0.00044437015,0.00034054095,0.00032475265],"category_scores_gemma":[0.00009396822,0.000189186,0.00007936513,0.00032910178,0.00033965206,0.00000827988,0.00035780846,0.0010197598,0.000007085846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019967697,0.00010282315,0.0037813524,0.00013478287,0.000009733525,0.00006181821,0.000041281437,0.00003830419,0.99352807,0.000039407765,0.0011107252,0.0009520219],"study_design_scores_gemma":[0.0015596008,0.00031129798,0.022459192,0.000020834445,0.000004283277,0.000010894779,0.0000571136,0.000023850802,0.97308344,0.00011152517,0.0021719136,0.00018605651],"about_ca_topic_score_codex":0.0027194503,"about_ca_topic_score_gemma":0.0044408496,"teacher_disagreement_score":0.020444635,"about_ca_system_score_codex":0.00006843236,"about_ca_system_score_gemma":0.00050703995,"threshold_uncertainty_score":0.7714781},"labels":[],"label_agreement":null},{"id":"W2331120883","doi":"10.1158/0008-5472.sabcs12-p1-05-05","title":"Abstract P1-05-05: Podocalyxin is a key regulator of breast cancer progression and metastasis.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Cancer research; Metastasis; Cancer cell; Cancer; Biology; Small hairpin RNA; Breast cancer; Medicine; Immunology; Pathology; Cell culture; Gene knockdown; Internal medicine","score_opus":0.053828536614385004,"score_gpt":0.42128283804892613,"score_spread":0.3674543014345411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331120883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834716,0.01313616,0.000013122296,0.0019721906,0.00009343238,0.00050015363,0.00021707837,0.0000081123135,0.00058815157],"genre_scores_gemma":[0.9955808,0.002183436,0.00015394128,0.00008317612,0.00035327932,0.00023617865,0.000022161976,0.000031779888,0.0013552677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784964,0.00015175986,0.0002417317,0.00037031603,0.0007160658,0.0006705019],"domain_scores_gemma":[0.99868226,0.000025298546,0.00007453233,0.0004103429,0.00046594834,0.00034160636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001086103,0.00014908575,0.00020104382,0.00016167422,0.00015266835,0.000039182487,0.00023879591,0.00017118966,0.00093715166],"category_scores_gemma":[0.000087111875,0.0001214808,0.00007304133,0.00032174468,0.00034429747,0.000019388777,0.00028068654,0.00029092134,0.000012698691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004971001,0.00014734376,0.01740028,0.00022483325,0.00010056512,0.0000031419431,0.00019295179,0.0000040199784,0.8780067,0.00010002208,0.026243903,0.07707916],"study_design_scores_gemma":[0.00072583917,0.00014197384,0.106899954,0.00011839887,0.000010796409,0.000017135002,0.000111256224,0.000014007223,0.761071,0.000031869,0.13067901,0.00017871085],"about_ca_topic_score_codex":0.0007841902,"about_ca_topic_score_gemma":0.00010267445,"teacher_disagreement_score":0.11693563,"about_ca_system_score_codex":0.000060334805,"about_ca_system_score_gemma":0.00031450414,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W2331134921","doi":"10.1158/1538-7445.am2013-962","title":"Abstract 962: Prolonged antiangiogenic therapy with oral metronomic topotecan and pazopanib in pediatric solid tumor mouse model.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pazopanib; Topotecan; Medicine; Combination therapy; Pharmacology; Angiogenesis; Internal medicine; CD31; Cancer; Oncology; Chemotherapy","score_opus":0.06292327511891385,"score_gpt":0.3795756891656592,"score_spread":0.3166524140467454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331134921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958627,0.0012876386,0.0000028560278,0.0007906591,0.000012213616,0.001714713,0.00001573751,0.000033146764,0.0002803189],"genre_scores_gemma":[0.99602044,0.001990688,0.00014381419,0.00007160431,0.000096274176,0.00079233723,0.0000070907263,0.000052960713,0.00082481885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977829,0.00009992075,0.00019381488,0.00047724706,0.0005834151,0.0008627114],"domain_scores_gemma":[0.9989438,0.00007696079,0.00003560021,0.00033925145,0.00020324574,0.0004011285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038465924,0.0001783947,0.00030205492,0.0005630314,0.000105877196,0.00008095236,0.00015963987,0.00005548412,0.0003303265],"category_scores_gemma":[0.00003993625,0.00012814526,0.00004716037,0.0005084915,0.00017113904,0.00020040965,0.000077047014,0.0005808245,0.00008682044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008184438,0.0021870078,0.5172208,0.00058326987,0.0005270639,0.001041787,0.00075078075,0.00045646515,0.42408216,0.000035517107,0.0040145237,0.04091619],"study_design_scores_gemma":[0.0138100395,0.0034530414,0.82377684,0.00009889397,0.00003942945,0.000051323612,0.00016050384,0.0026963647,0.15518051,0.00022491794,0.000105859275,0.00040228845],"about_ca_topic_score_codex":0.001909374,"about_ca_topic_score_gemma":0.0006043436,"teacher_disagreement_score":0.30655605,"about_ca_system_score_codex":0.00026948028,"about_ca_system_score_gemma":0.00071377394,"threshold_uncertainty_score":0.5225612},"labels":[],"label_agreement":null},{"id":"W2331147898","doi":"10.1158/1538-7445.am2011-3421","title":"Abstract 3421: Twist1 and clusterin regulate epithelial-mesenchymal transition","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; Gene knockdown; Epithelial–mesenchymal transition; Chromatin immunoprecipitation; Transcription factor; Cancer research; Downregulation and upregulation; Biology; Chemistry; Molecular biology; Gene expression; Promoter; Apoptosis; Gene","score_opus":0.16549775030196812,"score_gpt":0.41919908240054077,"score_spread":0.25370133209857265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331147898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887181,0.0007726926,0.000039653674,0.0017960616,0.00015983003,0.0005066009,0.000047497233,0.000053128857,0.007906438],"genre_scores_gemma":[0.99748826,0.000425065,0.0002727696,0.0002064173,0.0002847961,0.00014806441,0.00001237044,0.00003446516,0.0011277625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984024,0.00011113412,0.00021491873,0.00039495,0.00039115158,0.00048542855],"domain_scores_gemma":[0.99900967,0.000063215324,0.000029825687,0.00039003778,0.00019882518,0.00030845497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006514784,0.00012531699,0.0002213678,0.00021373814,0.00010887256,0.000018213532,0.000112560556,0.00012806174,0.0022939285],"category_scores_gemma":[0.00007828984,0.000114046605,0.00005574966,0.00020411603,0.00048370115,0.00008283043,0.00010216746,0.00041504749,0.0001124536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008480077,0.0005918409,0.008181674,0.0020962104,0.00019791107,0.0027077454,0.012821441,0.000011522743,0.883443,0.00077798386,0.005764893,0.07492568],"study_design_scores_gemma":[0.003827552,0.00072582177,0.9323755,0.00045036126,0.0000780236,0.000426031,0.0007034474,0.00021505215,0.05235604,0.0021183454,0.0063780732,0.00034579143],"about_ca_topic_score_codex":0.0005898293,"about_ca_topic_score_gemma":0.00008683088,"teacher_disagreement_score":0.9241938,"about_ca_system_score_codex":0.00012757845,"about_ca_system_score_gemma":0.00017614046,"threshold_uncertainty_score":0.9986181},"labels":[],"label_agreement":null},{"id":"W2331153369","doi":"10.1158/1538-7445.am2013-5050","title":"Abstract 5050: KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Gene knockdown; Wnt signaling pathway; Cancer research; Biology; Internal medicine; Oncology; Medicine; Cell culture; Genetics; Signal transduction","score_opus":0.04218573571108931,"score_gpt":0.3604627611684143,"score_spread":0.318277025457325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331153369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708713,0.008031207,0.000002216677,0.002438715,0.00006393178,0.000702542,0.00003646873,0.000016390388,0.0016213896],"genre_scores_gemma":[0.9969598,0.0020134812,0.00023536438,0.00007708187,0.000068674286,0.0004221439,0.0000061429064,0.0000169597,0.00020037431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987238,0.00006353325,0.00018073992,0.00024797325,0.0004426111,0.00034131954],"domain_scores_gemma":[0.99884087,0.00029309897,0.00004935179,0.00026434244,0.00035580475,0.00019650988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032894203,0.000111960675,0.00026304804,0.00016765014,0.00008919395,0.000028982757,0.00007443164,0.00006873812,0.0032136901],"category_scores_gemma":[0.00009877427,0.0000780102,0.00004828806,0.00020906927,0.00042326123,0.000054480428,0.000052998726,0.00024295675,0.00010460708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039460455,0.00083752465,0.7863008,0.00042776874,0.00090042414,0.00012587637,0.0004149193,0.000015605663,0.088769704,0.0018685911,0.014705907,0.105238326],"study_design_scores_gemma":[0.0021630847,0.0003179419,0.92291975,0.00021948127,0.000058625803,0.000013842144,0.0001736904,0.000042820317,0.06718826,0.0017516178,0.005056282,0.000094590476],"about_ca_topic_score_codex":0.0077473433,"about_ca_topic_score_gemma":0.00011165961,"teacher_disagreement_score":0.13661902,"about_ca_system_score_codex":0.00009804034,"about_ca_system_score_gemma":0.00022077755,"threshold_uncertainty_score":0.9988602},"labels":[],"label_agreement":null},{"id":"W2331260218","doi":"10.1158/1538-7445.am2011-1967","title":"Abstract 1967: Ligand-dependent TGFβ signalling potential","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"R-SMAD; Transforming growth factor; Cell biology; SMAD; Biology; Signal transduction; Receptor; Cancer research; Chemistry; TGF alpha; Growth factor; Biochemistry","score_opus":0.08150474636532268,"score_gpt":0.3672447415203057,"score_spread":0.285739995154983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331260218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304765,0.003472614,0.00030148576,0.00003503784,0.00019101216,0.00019008652,0.000026243679,0.000022286586,0.0027135676],"genre_scores_gemma":[0.9974745,0.00028258568,0.00013700122,0.00005448936,0.00070965453,0.00009907396,0.00003158853,0.0000385046,0.0011725881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983162,0.00007149188,0.00018745087,0.0004411744,0.0004647009,0.0005189399],"domain_scores_gemma":[0.9991263,0.000015081222,0.000042484164,0.00035943152,0.00025599354,0.00020066732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005005438,0.00013054705,0.00010782513,0.00008398152,0.00018688948,0.0000478438,0.00045396172,0.00014009897,0.00071448734],"category_scores_gemma":[0.000079320314,0.00012635952,0.0000832397,0.000101943944,0.00015770367,0.0000052258533,0.00020834738,0.00026031648,0.00013076059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002509547,0.00010317456,0.0010455857,0.000040377672,0.000064123524,0.000040631418,0.000106473046,0.00012928614,0.99401695,0.00001856891,0.0020166112,0.0021672938],"study_design_scores_gemma":[0.0003366783,0.00010582304,0.004075127,0.00004100188,0.0000093066665,0.0000034510354,0.00008690256,0.000007808224,0.9904207,0.00013350527,0.0046111047,0.0001685944],"about_ca_topic_score_codex":0.00024804808,"about_ca_topic_score_gemma":0.00006800493,"teacher_disagreement_score":0.004426848,"about_ca_system_score_codex":0.000041667812,"about_ca_system_score_gemma":0.0003932949,"threshold_uncertainty_score":0.7823135},"labels":[],"label_agreement":null},{"id":"W2331287588","doi":"10.1158/1538-7445.am2012-2899","title":"Abstract 2899: Doxorubicin-mitomycin co-loaded polymer lipid nanoparticle enhanced efficacy against breast tumor and decreased toxicity as compared to Doxil","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Heart and Stroke Foundation; University Health Network; University of Toronto","funders":"","keywords":"Toxicity; Medicine; Doxorubicin; Cancer; In vivo; Chemotherapy; Breast cancer; Mitomycin C; Pharmacology; Internal medicine; Surgery; Biology","score_opus":0.031756828953077826,"score_gpt":0.36171808061908084,"score_spread":0.329961251666003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331287588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155766,0.00410138,0.000020151307,0.00047667787,0.0014863908,0.0006445682,0.00013160783,0.000031713957,0.0015498257],"genre_scores_gemma":[0.98799294,0.00041245497,0.000035075256,0.0009246088,0.009530168,0.00022167119,0.000055862045,0.000054145967,0.0007730729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970986,0.00019125386,0.00033348228,0.00063604617,0.00053867267,0.0012019448],"domain_scores_gemma":[0.9979718,0.000074991025,0.00007368788,0.00060657447,0.00024901357,0.0010239433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074524264,0.00028171475,0.0003570462,0.00014070485,0.0002851996,0.000093493545,0.0003514997,0.0001411347,0.0002993531],"category_scores_gemma":[0.00019159554,0.0002666736,0.00010196587,0.00033856355,0.00028423438,0.00002391808,0.00021544476,0.00030874877,0.00013995692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097644073,0.00024928595,0.0016199141,0.00004108839,0.000057992114,4.4775928e-7,0.00032077354,0.000012207476,0.9722118,0.0000255006,0.01861267,0.0058718747],"study_design_scores_gemma":[0.0017067771,0.000099050674,0.039524816,0.00005530641,0.000014248969,0.000011757946,0.00022488715,0.0000024691449,0.8677447,0.0000028255295,0.090311974,0.0003011947],"about_ca_topic_score_codex":0.0012040574,"about_ca_topic_score_gemma":0.00027035992,"teacher_disagreement_score":0.10446711,"about_ca_system_score_codex":0.0001057556,"about_ca_system_score_gemma":0.00044657927,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W2331300233","doi":"10.1158/1538-7445.am2011-1719","title":"Abstract 1719: Integrative genomic analysis of ovarian cancer cell lines points to EMT involvement in the development of cisplatin resistance","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ovarian cancer; Drug resistance; Cisplatin; Cancer; Oncology; Cancer research; Medicine; Population; Disease; microRNA; Bioinformatics; Chemotherapy; Internal medicine; Biology; Gene; Genetics","score_opus":0.07201922914301698,"score_gpt":0.3751705525118984,"score_spread":0.3031513233688814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331300233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223757,0.0023080448,0.0018724418,0.00015852471,0.000055784923,0.0007777373,0.00010636236,0.000002846778,0.0024806634],"genre_scores_gemma":[0.99597436,0.0007146366,0.0021308819,0.00007362477,0.000044592736,0.00056204374,0.000046899342,0.000026090866,0.00042684277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974374,0.00026333082,0.00055949314,0.0005182869,0.0007249072,0.0004965626],"domain_scores_gemma":[0.9984047,0.000051010462,0.0001433639,0.0006371675,0.0006486666,0.00011510813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018727058,0.00017952654,0.00031865938,0.0004512821,0.00008901547,0.000016479005,0.0008117703,0.00014535354,0.00047954838],"category_scores_gemma":[0.000108807966,0.00014038479,0.00012422385,0.0014640603,0.0001447858,0.000006884473,0.00029769284,0.00032606954,0.0000047082494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064662774,0.0001663297,0.00059841597,0.00010095239,0.00043943684,0.0000044030025,0.008012755,0.00027329082,0.98702675,0.00008844224,0.0005894813,0.0020531002],"study_design_scores_gemma":[0.00042465652,0.00012598076,0.027452774,0.00011244047,0.000045915236,9.48774e-8,0.0023301006,0.000021652215,0.9673762,0.000053434494,0.0019067621,0.00015004285],"about_ca_topic_score_codex":0.0045304345,"about_ca_topic_score_gemma":0.09505693,"teacher_disagreement_score":0.0905265,"about_ca_system_score_codex":0.0003271494,"about_ca_system_score_gemma":0.0011497398,"threshold_uncertainty_score":0.9214559},"labels":[],"label_agreement":null},{"id":"W2331519235","doi":"10.1158/1538-7445.am2012-2927","title":"Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Single-nucleotide polymorphism; microRNA; Biology; Minor allele frequency; Ovarian cancer; SNP; Carcinogenesis; Odds ratio; Serous fluid; Cancer; Genotype; Genetics; Oncology; Gene; Bioinformatics; Internal medicine; Medicine","score_opus":0.039361330961368124,"score_gpt":0.3758516539203667,"score_spread":0.33649032295899856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331519235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898226,0.00768826,0.00010049103,0.0005920121,0.00015866205,0.0018925698,0.00025164764,0.000009616591,0.00032450486],"genre_scores_gemma":[0.9914382,0.00559893,0.000095319214,0.00018072304,0.000510407,0.0018207774,0.000045464516,0.000048345508,0.00026184812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953297,0.001205934,0.00035956356,0.00071823,0.0011122109,0.0012743652],"domain_scores_gemma":[0.9985153,0.000117950614,0.00012362204,0.0007667715,0.00020856145,0.00026781583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034136644,0.00027459612,0.0002516648,0.00022613328,0.00044365684,0.000113437505,0.00080547703,0.00029600572,0.00041750347],"category_scores_gemma":[0.00023891199,0.0002123948,0.000084402425,0.000878472,0.00033015248,0.00002368033,0.0005190683,0.0012462507,0.00014488657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041091244,0.000535828,0.024365613,0.000011501766,0.00012015658,0.000050103365,0.0016452722,0.0013799756,0.9675668,0.000013088611,0.0013643038,0.002536458],"study_design_scores_gemma":[0.0031052474,0.0012866616,0.2840369,0.00007210039,0.00005379305,0.000017889197,0.003404966,0.00002790211,0.6575811,0.00003256412,0.04972959,0.0006513091],"about_ca_topic_score_codex":0.0032643827,"about_ca_topic_score_gemma":0.001309746,"teacher_disagreement_score":0.3099857,"about_ca_system_score_codex":0.00067100977,"about_ca_system_score_gemma":0.0006585923,"threshold_uncertainty_score":0.8661209},"labels":[],"label_agreement":null},{"id":"W2331519665","doi":"10.1158/0008-5472.can-15-2347","title":"A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Senescence; Cyclin-dependent kinase; Biology; Epigenetics; Cancer research; Cell biology; DNA methylation; Kinase; Retinoblastoma protein; Cancer; Cell cycle; Gene expression; Genetics; Gene","score_opus":0.04748211863294191,"score_gpt":0.3543597841666069,"score_spread":0.306877665533665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331519665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914016,0.003818694,0.002627,0.0005667338,0.00041081483,0.0006244955,0.00009060223,0.000025972951,0.0004340487],"genre_scores_gemma":[0.98771113,0.005985904,0.0001361803,0.00011122889,0.0008536512,0.0010016167,0.000009523872,0.000060683757,0.004130096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972355,0.00026495222,0.00023266957,0.0008585134,0.0006636159,0.0007447773],"domain_scores_gemma":[0.99856186,0.000051299154,0.00007504698,0.0006808181,0.00040708506,0.00022387964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048413154,0.0002267146,0.00019763221,0.0000770093,0.00020007697,0.00005838925,0.0006746176,0.00028264642,0.0005017298],"category_scores_gemma":[0.0001266266,0.00016501985,0.00007944423,0.00020457689,0.00017309141,0.0000082825145,0.0003503155,0.00027044173,0.00011792341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001126892,0.000034363686,0.0002015299,0.000051910876,0.00005001647,0.000018132027,0.00006394906,0.0000050450244,0.9850664,0.00004393687,0.00060231646,0.013749722],"study_design_scores_gemma":[0.00066197105,0.00019790155,0.00010608426,0.0001773005,0.0000100331345,0.0000022952966,0.000059995553,0.0000057921393,0.99159783,0.00097318314,0.005937929,0.0002696664],"about_ca_topic_score_codex":0.0012132565,"about_ca_topic_score_gemma":0.0003486999,"teacher_disagreement_score":0.013480056,"about_ca_system_score_codex":0.00019680931,"about_ca_system_score_gemma":0.0009981182,"threshold_uncertainty_score":0.67293143},"labels":[],"label_agreement":null},{"id":"W2331590218","doi":"10.1158/0008-5472.sabcs10-p1-13-01","title":"Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Denosumab; Brief Pain Inventory; Breast cancer; Internal medicine; Zoledronic acid; Bone pain; Clinical endpoint; Randomized controlled trial; Oncology; Cancer; Physical therapy; Osteoporosis; Chronic pain","score_opus":0.034659930866046525,"score_gpt":0.3834066668880435,"score_spread":0.34874673602199696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331590218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585116,0.0018205721,0.000008895631,0.00024466985,0.000097114935,0.0018732394,0.000035145084,0.0000057372654,0.00006347042],"genre_scores_gemma":[0.99867344,0.0005056398,0.00001190667,0.000034211866,0.00006954802,0.0006549315,0.000011173388,0.000014726733,0.000024401024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99863577,0.00029127966,0.00024436932,0.00024077701,0.00033868416,0.00024914643],"domain_scores_gemma":[0.9982133,0.0012469757,0.00012905062,0.00016445424,0.00015839435,0.000087826294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012345685,0.00013680596,0.0006229806,0.00019452881,0.00007298966,0.000015883397,0.00006504411,0.00004126914,0.0001264969],"category_scores_gemma":[0.00014203954,0.00007343349,0.000033435077,0.00023653434,0.0006082158,0.00006667757,0.00003872426,0.0005048329,2.3048793e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88915557,0.0008629116,0.061591323,0.00049138395,0.00041279232,0.000015548887,0.00062796735,0.000008472939,0.017884556,0.000011373269,0.00008760887,0.028850516],"study_design_scores_gemma":[0.87934476,0.004892451,0.098950095,0.001113297,0.0003355771,0.0000053965396,0.00009185952,0.00012270111,0.014985522,0.000010858642,0.000045041714,0.00010245706],"about_ca_topic_score_codex":0.0029527936,"about_ca_topic_score_gemma":0.005063256,"teacher_disagreement_score":0.037358772,"about_ca_system_score_codex":0.00008324334,"about_ca_system_score_gemma":0.00031220465,"threshold_uncertainty_score":0.44637606},"labels":[],"label_agreement":null},{"id":"W2331592886","doi":"10.1158/1538-7445.am2013-811","title":"Abstract 811: Identifying genomic signatures within circulating breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Ontario Genomics","funders":"","keywords":"Circulating tumor cell; Breast cancer; Metastasis; Copy number analysis; Primary tumor; Metastatic breast cancer; Cancer; Biology; Amplicon; Cancer research; Oncology; Copy-number variation; Medicine; Gene; Genome; Genetics","score_opus":0.0413540625713226,"score_gpt":0.35488356431104207,"score_spread":0.3135295017397195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331592886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909089,0.0066828183,0.000040746196,0.00040679128,0.0005710636,0.0004561198,0.00018907554,0.00001558191,0.0007289094],"genre_scores_gemma":[0.9946107,0.0024371748,0.00013184456,0.00029522527,0.0013095458,0.00039306722,0.000037278514,0.000065562446,0.00071958394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804544,0.000058086127,0.00028542744,0.00057888357,0.00036952048,0.0006626087],"domain_scores_gemma":[0.998731,0.000056202516,0.000097598764,0.00045233933,0.00044023947,0.00022258611],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004275817,0.0001943261,0.00017304794,0.00011219654,0.00028856596,0.00024541726,0.0004364644,0.00019940738,0.0010978446],"category_scores_gemma":[0.000055843022,0.00019250643,0.00009554185,0.00020142247,0.00017049848,0.000012746765,0.00031197458,0.00045529293,0.00010768091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033933346,0.000027180262,0.0030982427,0.000081546066,0.00006119275,0.000006952303,0.00011502946,0.003241804,0.9743217,0.000037364938,0.013571421,0.0054036165],"study_design_scores_gemma":[0.0010098894,0.00008730652,0.14978747,0.00020241826,0.000024400422,0.000016570986,0.0005101207,0.00039583023,0.83384717,0.00045794004,0.012911671,0.000749234],"about_ca_topic_score_codex":0.0073069795,"about_ca_topic_score_gemma":0.0010473819,"teacher_disagreement_score":0.14668922,"about_ca_system_score_codex":0.00023319406,"about_ca_system_score_gemma":0.00055186794,"threshold_uncertainty_score":0.9998153},"labels":[],"label_agreement":null},{"id":"W2331619903","doi":"10.1158/1538-7445.am10-459","title":"Abstract 459: Caveolin-1 mediated signaling and proliferation is regulated through the oxygen sensing pathway","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Caveolin 1; Cell growth; Cancer research; MAPK/ERK pathway; Carcinogenesis; Clear cell renal cell carcinoma; Gene knockdown; Oncogene; Biology; Receptor tyrosine kinase; Cell biology; Downregulation and upregulation; Cell; Signal transduction; Cell cycle; Cancer; Cell culture; Medicine; Internal medicine; Renal cell carcinoma","score_opus":0.03478809496893316,"score_gpt":0.33660128922918403,"score_spread":0.3018131942602509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331619903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951688,0.0021147488,0.000091846465,0.0014572558,0.00012686514,0.0002940786,0.00002627684,0.000014197396,0.00070590404],"genre_scores_gemma":[0.997423,0.00059948023,0.00008027249,0.00033528285,0.0006786045,0.000026971102,0.0000820705,0.000028217844,0.00074613123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986915,0.000066283115,0.00018008523,0.00037726059,0.00032141758,0.00036346162],"domain_scores_gemma":[0.9990579,0.000053492244,0.00005234197,0.00032745235,0.00042379444,0.00008501039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066351925,0.00012726821,0.00010724252,0.000036342695,0.0003602075,0.00011334208,0.00016856666,0.000204908,0.00009897774],"category_scores_gemma":[0.00019708187,0.0000937592,0.00003910266,0.00018520551,0.00026197638,0.000009765622,0.00011516641,0.00046546658,0.00001167815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066175555,0.000012893542,0.0001588947,0.00004097019,0.000031018677,0.000005355963,0.00052375457,0.000014731225,0.99507,0.000037163176,0.0010935329,0.0029455263],"study_design_scores_gemma":[0.00027739807,0.00004285274,0.00041716665,0.000022839053,0.000006067423,0.00001570483,0.00020412845,0.00013000998,0.9612114,0.00039185194,0.037152328,0.0001282552],"about_ca_topic_score_codex":0.0003260211,"about_ca_topic_score_gemma":0.0004186563,"teacher_disagreement_score":0.036058795,"about_ca_system_score_codex":0.00001456356,"about_ca_system_score_gemma":0.00033720548,"threshold_uncertainty_score":0.3823389},"labels":[],"label_agreement":null},{"id":"W2331647858","doi":"10.1158/1538-7445.am2011-3469","title":"Abstract 3469: EphrinB2 promotes endothelial cell survival and vascular integrity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cell biology; Gene silencing; Endothelial stem cell; Programmed cell death; Signal transduction; Apoptosis; Cancer research; Cell; In vitro; Gene; Genetics","score_opus":0.0993076410124867,"score_gpt":0.34201856443290063,"score_spread":0.24271092342041395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331647858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844356,0.00395001,0.000033230666,0.00008911423,0.00071056467,0.00043395726,0.00012266698,0.000060405906,0.010164452],"genre_scores_gemma":[0.997995,0.0004631298,0.00013932852,0.00002035388,0.00004535581,0.00013498381,0.000014861441,0.000025176725,0.0011617834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983201,0.0003755768,0.00016970914,0.00042247726,0.00011990273,0.0005922224],"domain_scores_gemma":[0.9991638,0.00015733404,0.000036998717,0.00039740343,0.0001697671,0.00007467122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012499227,0.00015451251,0.00021275351,0.00013404209,0.00023054595,0.000022518278,0.0003786929,0.00027844743,0.0048494115],"category_scores_gemma":[0.00011989013,0.00012785416,0.00007611376,0.00014134454,0.00059085584,0.00007840086,0.0002656454,0.0008767337,0.00042696658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002994426,0.0002633596,0.007981474,0.00010990756,0.00020475996,0.000018331533,0.00068333355,2.1019522e-8,0.9794996,0.0016088327,0.0015212124,0.0078097717],"study_design_scores_gemma":[0.0014990729,0.00015783533,0.083964966,0.000050658615,0.000026040305,0.0000043505197,0.0005440779,5.664285e-7,0.900831,0.0031319002,0.009561708,0.00022784964],"about_ca_topic_score_codex":0.0017466052,"about_ca_topic_score_gemma":0.00014775454,"teacher_disagreement_score":0.07866858,"about_ca_system_score_codex":0.00006798185,"about_ca_system_score_gemma":0.0002085601,"threshold_uncertainty_score":0.9960603},"labels":[],"label_agreement":null},{"id":"W2331667785","doi":"10.1158/1538-7445.am2012-3879","title":"Abstract 3879: High-throughput, homogeneous <i>in cyto</i> assays to monitor histone H3 post-translational modifications","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal","funders":"","keywords":"Sodium butyrate; Histone; EZH2; Histone methyltransferase; Trichostatin A; Histone H2A; Molecular biology; Histone H3; Histone deacetylase; Biology; Acetylation; Chromatin; H3K4me3; Chemistry; Cell biology; Cell culture; Biochemistry; Gene expression; Genetics; DNA; Promoter; Gene","score_opus":0.05693045895738565,"score_gpt":0.4082989389494398,"score_spread":0.3513684799920542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331667785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841053,0.007576532,0.0007288663,0.0013700618,0.0002553881,0.00038739466,0.00019933056,0.00000905728,0.0010628348],"genre_scores_gemma":[0.9961413,0.00078900484,0.00086394197,0.000088476634,0.0008351142,0.00025768738,0.00021103115,0.000033828535,0.0007795771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983299,0.00010801199,0.00023955034,0.00035426154,0.00041725844,0.0005510539],"domain_scores_gemma":[0.99893147,0.000052983818,0.000037284048,0.00039507478,0.0003599013,0.00022331552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000737394,0.00012789553,0.00011805939,0.00015439249,0.00016125284,0.00003088736,0.00023545146,0.0001642471,0.00014208592],"category_scores_gemma":[0.000112508234,0.0001350102,0.000046281577,0.00029294132,0.000084128595,0.000010830505,0.000073989955,0.00021924396,0.00008529393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071350565,0.00013390648,0.0021381502,0.000014387747,0.000018465298,0.0000014594416,0.00016881558,0.0012788405,0.98906446,0.0002387703,0.0008782013,0.005993193],"study_design_scores_gemma":[0.00032850474,0.00010216428,0.11078047,0.0000146699,0.0000058675478,0.0000011557278,0.00005245166,0.000009424796,0.85735214,0.00016071433,0.03098782,0.00020462151],"about_ca_topic_score_codex":0.0011718702,"about_ca_topic_score_gemma":0.0004955086,"teacher_disagreement_score":0.13171233,"about_ca_system_score_codex":0.00012082993,"about_ca_system_score_gemma":0.00018819324,"threshold_uncertainty_score":0.5505556},"labels":[],"label_agreement":null},{"id":"W2331679660","doi":"10.1158/1538-7445.am2013-lb-92","title":"Abstract LB-92: RVX-2135 is a novel, orally bioavailable epigenetic BET inhibitor that synergizes with cytarabine and idarubicin to inhibit proliferation of acute myeloid leukemia cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Bromodomain; Cytarabine; BRD4; Idarubicin; BET inhibitor; Cancer research; Biology; Molecular biology; Acetylation; Chemistry; Myeloid leukemia; Biochemistry; Gene","score_opus":0.026507293168157583,"score_gpt":0.30100085482814265,"score_spread":0.27449356165998506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331679660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578696,0.0009298874,0.0001689203,0.0014252452,0.00006722376,0.0012139222,0.000107833665,0.000013559429,0.00028644374],"genre_scores_gemma":[0.99420637,0.0009546012,0.0010125246,0.00035112514,0.00024000311,0.0004629557,0.00007485401,0.000044065906,0.0026534977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980462,0.0000590577,0.00030212168,0.0005836849,0.0005273053,0.00048158516],"domain_scores_gemma":[0.9986088,0.000018753926,0.000103705686,0.00042439043,0.000592033,0.00025228178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003728548,0.0002241074,0.00024154328,0.00018936966,0.00014878163,0.00012370534,0.00023414691,0.00018700743,0.0002566916],"category_scores_gemma":[0.000039852024,0.00018156147,0.0000447455,0.00035573577,0.00025883605,0.000034954406,0.00019644409,0.00023641132,0.00004884341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025091183,0.00005008394,0.0013063998,0.00009123397,0.000071138515,0.0000015619781,0.000120706056,0.000034621775,0.975772,0.00000977738,0.020619297,0.0016722662],"study_design_scores_gemma":[0.0008666938,0.00080084836,0.0029845221,0.00013481281,0.000014146383,0.000003466901,0.00007849275,0.000034007662,0.9836358,0.000017515016,0.011200984,0.00022875427],"about_ca_topic_score_codex":0.0009954595,"about_ca_topic_score_gemma":0.00020593994,"teacher_disagreement_score":0.009418313,"about_ca_system_score_codex":0.00010541054,"about_ca_system_score_gemma":0.0005653332,"threshold_uncertainty_score":0.7403862},"labels":[],"label_agreement":null},{"id":"W2331729803","doi":"10.1158/1538-7445.am2012-4970","title":"Abstract 4970: Convergence of protein kinase and caspase signaling: A mechanism for pathological rewiring of survival pathways by protein kinase CK2","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Phosphorylation; Cell biology; Kinase; Caspase; Biology; Protein phosphorylation; Protein kinase A; Phosphorylation cascade; Caspase 3; Cancer research; Apoptosis; Programmed cell death; Biochemistry","score_opus":0.12368615745410062,"score_gpt":0.37628665831790103,"score_spread":0.2526005008638004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331729803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997754,0.004364537,0.001108368,0.00027340828,0.000113135946,0.0035919652,0.00034882862,0.000036413323,0.00018580396],"genre_scores_gemma":[0.99697644,0.00014492025,0.0009977845,0.00002445958,0.00015721032,0.0014349973,0.000029182818,0.00006046803,0.00017453398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696237,0.00020316368,0.0005398246,0.0005006624,0.00092569296,0.0008682745],"domain_scores_gemma":[0.9978585,0.00016636257,0.00020482381,0.0004866416,0.00081358827,0.0004700419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002296073,0.00023979286,0.00056749844,0.00021164693,0.00012112217,0.00001472385,0.00019821215,0.00027599133,0.00021785646],"category_scores_gemma":[0.0010818592,0.00021447302,0.00013660887,0.00040680496,0.00040810718,0.00010965673,0.00016378114,0.00066108565,0.000005195007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001157239,0.0003548278,0.00037269952,0.0014684208,0.000056750658,0.000089912646,0.00047750387,0.0000032071307,0.9903288,0.0034184724,0.00018292111,0.0020892778],"study_design_scores_gemma":[0.0022324778,0.0009635652,0.00042644725,0.00089568197,0.000040449988,0.000014573173,0.00034187158,0.00006626608,0.993699,0.00068373914,0.00043314236,0.00020278664],"about_ca_topic_score_codex":0.00061708834,"about_ca_topic_score_gemma":0.000026932841,"teacher_disagreement_score":0.006998904,"about_ca_system_score_codex":0.00024298156,"about_ca_system_score_gemma":0.00052693,"threshold_uncertainty_score":0.87459564},"labels":[],"label_agreement":null},{"id":"W2331850616","doi":"10.1158/1538-7445.am2011-lb-130","title":"Abstract LB-130: Abnormal expression of SWI/SNF chromatin remodeling complex genes in lung cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"SMARCA4; Chromatin remodeling; SWI/SNF; ARID1A; Biology; Chromatin; SMARCB1; Cancer research; Molecular biology; Gene; Genetics; Mutation","score_opus":0.11904661731480352,"score_gpt":0.4049754372037306,"score_spread":0.28592881988892704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331850616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864569,0.010798073,0.00022755418,0.000043269956,0.000124337,0.00027697385,0.000046100085,0.000013047482,0.0020137515],"genre_scores_gemma":[0.99494004,0.0033339078,0.00092974096,0.00003767587,0.00030663,0.00016487089,0.000034545676,0.000039985687,0.00021258481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803436,0.00010571838,0.00042195528,0.00046110884,0.00043633,0.0005405289],"domain_scores_gemma":[0.99898255,0.00002133803,0.00011008009,0.00045641328,0.000315024,0.00011458629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006895754,0.00017233833,0.00024100982,0.00013673009,0.0001135349,0.000017764825,0.00041009774,0.00018915531,0.0007952892],"category_scores_gemma":[0.00004562296,0.00016021772,0.00008606433,0.00022951313,0.00016185822,0.000012027735,0.00021736586,0.00028997276,0.0000043084183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022173993,0.00006536546,0.0058730654,0.00027453864,0.000019755164,0.0000045622496,0.00040102727,0.0024997878,0.9806239,0.000007320531,0.0018310639,0.0081779],"study_design_scores_gemma":[0.00073760084,0.00007188027,0.0143561615,0.00039766115,0.00000680884,0.0000026277082,0.0002573384,0.004512498,0.97842586,0.000058615075,0.0009471853,0.0002257438],"about_ca_topic_score_codex":0.0046224794,"about_ca_topic_score_gemma":0.0010883005,"teacher_disagreement_score":0.008483165,"about_ca_system_score_codex":0.00011801609,"about_ca_system_score_gemma":0.00044109276,"threshold_uncertainty_score":0.87078583},"labels":[],"label_agreement":null},{"id":"W2331850977","doi":"10.1158/1538-7445.am2011-2260","title":"Abstract 2260: CD151 immunoreactivity at diagnosis predicts early biochemical failure and metastasis in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Metastasis; Medicine; Prostate cancer; Immunohistochemistry; Cancer; Pathological; Pathology; Oncology; Prostate; Prostatectomy; Monoclonal antibody; Internal medicine; Antibody; Immunology","score_opus":0.09510264232693,"score_gpt":0.38934285839940513,"score_spread":0.29424021607247514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331850977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892223,0.0065734307,4.6345315e-7,0.0012420601,0.0000412683,0.0013187175,0.00012410757,0.000038672064,0.0014389782],"genre_scores_gemma":[0.9890042,0.0076853544,0.00011133971,0.000052856234,0.00009017746,0.0019763221,0.000019950898,0.00006494518,0.0009948489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626976,0.00020930514,0.00034306562,0.0007809585,0.0013171018,0.0010798156],"domain_scores_gemma":[0.9980472,0.0003171226,0.000059929047,0.0005822921,0.00042798647,0.0005655218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011837226,0.00024381098,0.00043972163,0.0004153381,0.00015916921,0.00005306011,0.0002786994,0.00018066843,0.0037188407],"category_scores_gemma":[0.00041154027,0.000207347,0.00009084998,0.00094211305,0.0006361536,0.00018479644,0.0005784056,0.0013884106,0.00009557769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002203801,0.0004918452,0.48051223,0.00054142997,0.00016005292,0.000707238,0.001721247,6.281931e-7,0.47777176,0.000012270752,0.007748459,0.02812903],"study_design_scores_gemma":[0.0015239706,0.00023178528,0.5864655,0.00033559112,0.000024539513,0.000015604966,0.00015375773,0.00000862189,0.40608484,0.000049118767,0.0049419226,0.000164762],"about_ca_topic_score_codex":0.01789037,"about_ca_topic_score_gemma":0.002528871,"teacher_disagreement_score":0.10595327,"about_ca_system_score_codex":0.0009500333,"about_ca_system_score_gemma":0.0004989404,"threshold_uncertainty_score":0.9971919},"labels":[],"label_agreement":null},{"id":"W2331962380","doi":"10.1158/1538-7445.am2013-4952","title":"Abstract 4952: A novel smoothened antagonist, TAK-441, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Smoothened; LNCaP; Cyclopamine; Paracrine signalling; GLI1; Prostate cancer; Cancer research; Hedgehog signaling pathway; Internal medicine; Biology; Endocrinology; Androgen receptor; Hedgehog; Sonic hedgehog; Medicine; Cancer; Signal transduction; Cell biology; Receptor","score_opus":0.07902332384076281,"score_gpt":0.4364564706676511,"score_spread":0.35743314682688826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331962380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772725,0.0100389365,0.000011228457,0.0072503895,0.00013109682,0.0039927084,0.00026658812,0.000080367776,0.0009561622],"genre_scores_gemma":[0.9880692,0.0029476087,0.00027040203,0.00011304089,0.00029325846,0.003945299,0.00022115748,0.000104289276,0.0040357425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99499404,0.00013789006,0.0006971627,0.0009178204,0.0016034361,0.0016496716],"domain_scores_gemma":[0.99761,0.00022640023,0.00015665457,0.0005122367,0.0009093361,0.00058541045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011276193,0.00038772213,0.00054282346,0.00044433583,0.00046193274,0.0002877983,0.0003196992,0.00017246821,0.0016348922],"category_scores_gemma":[0.00013902092,0.00029099453,0.00011269773,0.0011698769,0.0004873525,0.0004042376,0.00016365222,0.0012198304,0.00008893819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020672036,0.00072536094,0.048841942,0.0007651686,0.00012207389,0.00026725803,0.0011451747,0.00007196972,0.90364707,0.000028048262,0.0045043733,0.03781436],"study_design_scores_gemma":[0.026281338,0.0025145488,0.16514917,0.008259165,0.00012625588,0.00006772632,0.004483498,0.0027479604,0.7660771,0.00042608817,0.022169314,0.0016978575],"about_ca_topic_score_codex":0.012636098,"about_ca_topic_score_gemma":0.00086439634,"teacher_disagreement_score":0.13756998,"about_ca_system_score_codex":0.0014321073,"about_ca_system_score_gemma":0.0016841191,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W2331978332","doi":"10.1158/1538-7445.am2013-3265","title":"Abstract 3265: PI3Kδ inhibitor, GS-1101, impacts transcription and translation in mantle cell lymphoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Mantle cell lymphoma; Cancer research; Cell cycle; Cyclin D1; Biology; Cell biology; Apoptosis; Chemistry; Molecular biology; Signal transduction; Lymphoma; Immunology; Biochemistry","score_opus":0.07073239549172139,"score_gpt":0.36971030736419175,"score_spread":0.29897791187247036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331978332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853556,0.0064020036,0.0000016486315,0.0025684524,0.00007390564,0.0009261798,0.000012670393,0.000021637852,0.0046378635],"genre_scores_gemma":[0.9954515,0.0035294164,0.00007524593,0.00008726879,0.0001340394,0.00040236392,0.000023672494,0.000021991422,0.00027450477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985518,0.000054935215,0.00021724777,0.00030156868,0.00044059032,0.0004338636],"domain_scores_gemma":[0.9993367,0.00010665512,0.00002474565,0.00018122779,0.00011782934,0.0002328357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031244868,0.00012882549,0.0002014049,0.00024533985,0.000086755725,0.00006707863,0.000050201208,0.00011198328,0.00060980994],"category_scores_gemma":[0.000016518126,0.00010368356,0.00004880884,0.00027557855,0.00008547144,0.00023155127,0.000011606585,0.00013877478,0.00014483814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046245268,0.0016625143,0.09138484,0.00070297316,0.000057187088,0.0001408002,0.003320766,0.000005366552,0.6056468,0.000073490664,0.0063550407,0.29018775],"study_design_scores_gemma":[0.007607954,0.00028413426,0.8574586,0.00032982515,0.000020993952,0.0000102760705,0.0003790741,0.000060806637,0.13048288,0.00022558283,0.0030130707,0.0001267751],"about_ca_topic_score_codex":0.0075538415,"about_ca_topic_score_gemma":0.0006216695,"teacher_disagreement_score":0.76607376,"about_ca_system_score_codex":0.00050634966,"about_ca_system_score_gemma":0.00023838178,"threshold_uncertainty_score":0.99905497},"labels":[],"label_agreement":null},{"id":"W2332048425","doi":"10.1158/1538-7445.am2011-1914","title":"Abstract 1914: Consumption of Lake Ontario sport fish and prostate cancer incidence in the New York State Angler Cohort Study (NYSACS)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Poisson regression; Cohort; Prostate cancer; Cancer registry; Prospective cohort study; Demography; Environmental health; Confounding; Incidence (geometry); Cohort study; Confidence interval; Cancer; Gerontology; Internal medicine; Population","score_opus":0.14834458470735076,"score_gpt":0.39664932723145235,"score_spread":0.2483047425241016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332048425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952305,0.0012214674,1.70107e-7,0.0006759289,0.00006626787,0.0015924916,0.000052434367,0.000007243403,0.0011535061],"genre_scores_gemma":[0.9948346,0.0028986405,0.000017479659,0.00016536334,0.00007688886,0.00039536116,0.000010595864,0.0000109847615,0.0015901102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984253,0.00003817249,0.00025699867,0.00027376297,0.0006923254,0.00031342724],"domain_scores_gemma":[0.9993257,0.0000680459,0.00005938184,0.00020683605,0.00023435535,0.00010569005],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010446046,0.00010101153,0.00025207593,0.00009285601,0.00009478693,0.00001615576,0.000115743685,0.000034440567,0.0009703571],"category_scores_gemma":[0.000026442145,0.00007017259,0.00002694217,0.00022890657,0.00021866256,0.000069826885,0.0000714352,0.00041911573,0.000006291033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009491118,0.0003077778,0.9752456,0.00012959553,0.00006802069,0.000067228204,0.008143544,0.0000012746643,0.00013797419,0.00001123377,0.013813858,0.0011247688],"study_design_scores_gemma":[0.0013510421,0.00030725886,0.9887823,0.00026982705,0.000025564514,0.0000043307596,0.0011551962,4.4630286e-7,0.0001767625,0.00015046957,0.0077062855,0.00007054717],"about_ca_topic_score_codex":0.31156284,"about_ca_topic_score_gemma":0.8042925,"teacher_disagreement_score":0.4927297,"about_ca_system_score_codex":0.0002040441,"about_ca_system_score_gemma":0.00052694685,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W2332124480","doi":"10.1158/1538-7445.am2012-3567","title":"Abstract 3567: Loss of heterozygosity (LOH) profiles predict oral cancer recurrence in the Oral Cancer Recurrence Prediction Cohort","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia","funders":"","keywords":"Medicine; Cancer; Dysplasia; Internal medicine; Biopsy; Cohort; Retrospective cohort study; Loss of heterozygosity; Stage (stratigraphy); Carcinoma; Oncology; Gastroenterology; Pathology; Biology","score_opus":0.08941435267103046,"score_gpt":0.41290594559328275,"score_spread":0.32349159292225227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332124480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826999,0.014077413,0.00006051202,0.00045858714,0.0005727388,0.00087842776,0.0007397893,0.000010425643,0.00050224067],"genre_scores_gemma":[0.9809807,0.015589119,0.000035662735,0.00006713744,0.00064394483,0.0022459093,0.000113062655,0.000023873206,0.00030056815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973013,0.00033334916,0.00039018664,0.00051444134,0.00072306924,0.0007376822],"domain_scores_gemma":[0.9985374,0.00004391313,0.00014681758,0.0006419783,0.0004858745,0.00014401949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018674659,0.00020229844,0.0002326969,0.000111650705,0.00020288068,0.00004459177,0.0006693209,0.00020342416,0.00028895336],"category_scores_gemma":[0.000110301095,0.00015592674,0.000085090345,0.00055616495,0.0004929439,0.00004461913,0.00014496713,0.0005545765,0.0000070952856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002457148,0.00023756243,0.8719482,0.00014682412,0.000072822884,0.0000013212716,0.00040614934,0.00018016233,0.09367557,0.00006246029,0.018001402,0.015021831],"study_design_scores_gemma":[0.0005151915,0.00015475713,0.892197,0.00026552367,0.000028545617,0.000005923018,0.00022049776,0.00008887935,0.086132966,0.00004029758,0.020116152,0.00023424692],"about_ca_topic_score_codex":0.0068255933,"about_ca_topic_score_gemma":0.00237139,"teacher_disagreement_score":0.02024884,"about_ca_system_score_codex":0.00022949933,"about_ca_system_score_gemma":0.0006355069,"threshold_uncertainty_score":0.99978805},"labels":[],"label_agreement":null},{"id":"W2332184346","doi":"10.1158/1538-7445.am2011-5105","title":"Abstract 5105: Towards a multiparametric biomarker panel for pancreatic cancer detection","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Pancreatic cancer; Cancer; Biomarker; Proteome; Proteomics; Biomarker discovery; Cancer research; Medicine; Biology; Computational biology; Pathology; Oncology; Internal medicine; Bioinformatics; Biochemistry","score_opus":0.4043216270569312,"score_gpt":0.4921914597424319,"score_spread":0.08786983268550069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332184346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476106,0.0032196685,0.0005721072,0.0005480549,0.00027539465,0.0024164168,0.000060680126,0.00007785537,0.008068734],"genre_scores_gemma":[0.9863071,0.002637241,0.0011014267,0.00012057636,0.00038347385,0.0046244273,0.00001258306,0.000060985472,0.0047521736],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969035,0.00014902536,0.00039830996,0.0005827625,0.00086227094,0.0011041372],"domain_scores_gemma":[0.99749315,0.000494296,0.00008082906,0.0005102224,0.0010276835,0.0003938133],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019877888,0.00021324416,0.00060089113,0.0008153072,0.0003210431,0.00003144798,0.00026490775,0.00028898608,0.0029218365],"category_scores_gemma":[0.0012700774,0.00017005295,0.00017128533,0.0012927048,0.00044907685,0.00011360233,0.0000939578,0.0006709671,0.00013892916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008719381,0.0009567441,0.18120912,0.0018890962,0.0011822996,0.00014872302,0.0019584484,0.0000023788223,0.12514715,0.0000922925,0.009460091,0.6692343],"study_design_scores_gemma":[0.0042913808,0.0010096275,0.9439301,0.00035892715,0.0002692538,0.00002960745,0.0005357651,0.0017997149,0.037066378,0.00044072626,0.009989993,0.00027851074],"about_ca_topic_score_codex":0.014094897,"about_ca_topic_score_gemma":0.00064488134,"teacher_disagreement_score":0.762721,"about_ca_system_score_codex":0.0008641728,"about_ca_system_score_gemma":0.0012616984,"threshold_uncertainty_score":0.99798965},"labels":[],"label_agreement":null},{"id":"W2332301743","doi":"10.1158/1538-7445.am10-315","title":"Abstract 315: RasGRP1 is a critical link to Ras activation by phorbol esters in mouse epidermal keratinocytes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Guanine nucleotide exchange factor; Carcinogenesis; Diacylglycerol kinase; GTP'; Tetradecanoylphorbol Acetate; Guanine; Cancer research; Chemistry; Biology; Cell biology; Biochemistry; Signal transduction; Nucleotide; Enzyme; Protein kinase C; Gene","score_opus":0.04976794505406687,"score_gpt":0.42634509260937303,"score_spread":0.37657714755530614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332301743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990628,0.00038101053,0.00020316911,0.007538549,0.00018400136,0.0003761781,0.000087459965,0.000014985209,0.00058663957],"genre_scores_gemma":[0.99622625,0.00010566571,0.00034524113,0.0012195084,0.00078545656,0.0003684664,0.000044457676,0.000045939203,0.00085898535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794114,0.00010453747,0.00026238317,0.0005971668,0.00044389238,0.0006509124],"domain_scores_gemma":[0.9987884,0.0001607912,0.00003194516,0.0004673144,0.0003029045,0.00024861586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074796146,0.00017083976,0.00016768252,0.0001342128,0.00012318301,0.0001007319,0.00038453387,0.00028853098,0.00046819117],"category_scores_gemma":[0.00093238236,0.00017574916,0.000057160927,0.00023593206,0.00021683647,0.00001646711,0.00015683098,0.0007817241,0.000049862658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020656594,0.000051403436,0.0017298649,0.000035661422,0.000016113327,0.0000044174353,0.00012660348,0.000039791907,0.9508009,0.00002159118,0.04062888,0.0063381987],"study_design_scores_gemma":[0.0004408843,0.00013212166,0.0015961921,0.000040298677,0.0000021382762,0.0000017541682,0.000051544033,0.000050577535,0.959357,0.00003927533,0.038088117,0.00020006906],"about_ca_topic_score_codex":0.00080266315,"about_ca_topic_score_gemma":0.000328489,"teacher_disagreement_score":0.008556121,"about_ca_system_score_codex":0.00011987696,"about_ca_system_score_gemma":0.0004040221,"threshold_uncertainty_score":0.7166843},"labels":[],"label_agreement":null},{"id":"W2332461257","doi":"10.1158/0008-5472.sabcs-1035","title":"Effect of anticoagulation therapy on bleeding and thromboembolic events (TEs) in the AVADO phase III study of docetaxel (D) ± bevacizumab (BV) in inoperable locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Metastatic breast cancer; Concomitant; Docetaxel; Internal medicine; Surgery; Placebo; Phases of clinical research; Gastroenterology; Cancer; Clinical trial; Chemotherapy; Breast cancer","score_opus":0.11909703441275973,"score_gpt":0.5104941023681366,"score_spread":0.3913970679553769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332461257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924575,0.003463993,0.0000010427925,0.0008727762,0.000083083185,0.0030108348,0.000022135355,0.000006149357,0.0000824869],"genre_scores_gemma":[0.9948338,0.0044929506,0.0000030240153,0.00010273463,0.0000763688,0.0004241131,0.0000075597377,0.00001467506,0.000044722303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745107,0.00076235563,0.00041332302,0.00033384908,0.00065266766,0.00038675382],"domain_scores_gemma":[0.9990642,0.00037673608,0.00010111334,0.00023009325,0.00015391692,0.00007396078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016621987,0.00018568596,0.0006420494,0.00045129322,0.00007287028,0.000012684335,0.00015972172,0.000049484275,0.00028410737],"category_scores_gemma":[0.000037074267,0.00010874373,0.00004221359,0.0009737493,0.00011077606,0.00009564257,0.000028148734,0.00043784242,0.0000011147207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093640655,0.01894765,0.12797089,0.0007006476,0.0005740784,0.00015913624,0.022254571,0.0006650921,0.123333424,0.000050371396,0.00056296063,0.61114055],"study_design_scores_gemma":[0.19048138,0.07869168,0.67827475,0.0019227877,0.00051153946,0.00004648608,0.0021176657,0.0019953835,0.0452957,0.00014948394,0.00015304048,0.00036011782],"about_ca_topic_score_codex":0.004354134,"about_ca_topic_score_gemma":0.0014619417,"teacher_disagreement_score":0.6107804,"about_ca_system_score_codex":0.00036086328,"about_ca_system_score_gemma":0.00031425687,"threshold_uncertainty_score":0.6582178},"labels":[],"label_agreement":null},{"id":"W2332484719","doi":"10.1158/1538-7445.am2013-1814","title":"Abstract 1814: Characterization of the MSI2 gene on 17q22-24.2 and its role in Breast Cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; SKBR3; Breast cancer; Cancer research; Tissue microarray; Cancer stem cell; Stem cell marker; Stem cell; Cancer; Pathology; Metastasis; Immunohistochemistry; Immunology; Cell biology; Medicine; Genetics","score_opus":0.057576480311660086,"score_gpt":0.3677579047077884,"score_spread":0.31018142439612834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332484719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114645,0.0015443062,3.3028456e-7,0.0054784445,0.00015683458,0.0006995647,0.00014488326,0.000006840993,0.00082234526],"genre_scores_gemma":[0.9931509,0.004809362,0.000003720381,0.0002344171,0.0002522776,0.0002938187,0.000008966957,0.000020843418,0.0012256748],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987171,0.000057305315,0.0001945699,0.0002417966,0.0004734188,0.00031577077],"domain_scores_gemma":[0.99925965,0.000038258717,0.000058668546,0.0002484885,0.0002739609,0.00012099557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003055738,0.00009471238,0.00020921505,0.00014153715,0.000064058375,0.00002257446,0.00011833327,0.00006191868,0.0018343235],"category_scores_gemma":[0.000024416184,0.00006476204,0.000039387265,0.0004163156,0.000090706315,0.00008803166,0.00006914095,0.0003540955,0.000024748797],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017030902,0.00007676226,0.015915541,0.00017182853,0.000022102822,0.0000024741694,0.00025091472,0.000008141441,0.93588555,0.000032093085,0.0007348913,0.04672942],"study_design_scores_gemma":[0.000712452,0.000042560674,0.7040308,0.00032954282,0.0000098096525,0.000004744111,0.000068864865,0.000046147492,0.29138532,0.000022316211,0.0032874853,0.000059918242],"about_ca_topic_score_codex":0.0053810105,"about_ca_topic_score_gemma":0.0003879847,"teacher_disagreement_score":0.6881153,"about_ca_system_score_codex":0.0002251258,"about_ca_system_score_gemma":0.0003535312,"threshold_uncertainty_score":0.99907815},"labels":[],"label_agreement":null},{"id":"W2332559074","doi":"10.1158/1538-7445.am10-1092","title":"Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Point mutation; Retinoblastoma; Exon; Breast cancer; Cancer; Cancer research; Gene; Germline mutation; Mutation; Genetics; Medicine; Biology","score_opus":0.040337720499346266,"score_gpt":0.37711306888295815,"score_spread":0.3367753483836119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332559074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911434,0.0003935539,0.00001020523,0.0022128923,0.00042133333,0.00075525674,0.00015166731,0.000018678093,0.0048929965],"genre_scores_gemma":[0.9977181,0.0001711467,0.00006523548,0.0000941421,0.00024249306,0.00018499469,0.000009520975,0.000034825833,0.0014795606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803966,0.0000768593,0.00030893512,0.00031949312,0.0007849412,0.00047008612],"domain_scores_gemma":[0.9985479,0.00007718401,0.00007660232,0.0007376099,0.00039961786,0.00016108947],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072628545,0.00011818325,0.0002163103,0.0002392896,0.00012494679,0.000020497164,0.00028657066,0.00014442926,0.0014585597],"category_scores_gemma":[0.0001519722,0.000092117065,0.000091879316,0.00087857235,0.00041418194,0.000058195943,0.00012162274,0.0015441665,0.000019581674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002857025,0.00006231992,0.0035898748,0.00008117069,0.000033595403,0.000033895467,0.0004852238,0.00036397637,0.9894602,0.0002487182,0.002091846,0.003263496],"study_design_scores_gemma":[0.0030897728,0.00013093564,0.17578451,0.00049806514,0.000022286684,0.00007267498,0.00025817155,0.0003508609,0.8059359,0.00005717068,0.01361893,0.00018071607],"about_ca_topic_score_codex":0.009248208,"about_ca_topic_score_gemma":0.019753793,"teacher_disagreement_score":0.18352428,"about_ca_system_score_codex":0.0006173293,"about_ca_system_score_gemma":0.0024333727,"threshold_uncertainty_score":0.99945426},"labels":[],"label_agreement":null},{"id":"W2332561578","doi":"10.1158/1538-7445.am2011-2242","title":"Abstract 2242: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor Dinaciclib (SCH 727965) in patients with non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Erlotinib; Internal medicine; Oncology; Lung cancer; Cancer; Epidermal growth factor receptor","score_opus":0.04515505282875971,"score_gpt":0.3741909476857539,"score_spread":0.3290358948569942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332561578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896937,0.0015586358,0.000019708077,0.00013839925,0.00029474805,0.0071945307,0.00006661883,0.000029469822,0.0010042123],"genre_scores_gemma":[0.9963182,0.00017072723,0.000083332285,0.00006837576,0.0001986277,0.0025120268,0.0000058135724,0.0001002537,0.0005426005],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957128,0.00041839245,0.0007529001,0.00072010315,0.001532054,0.000863754],"domain_scores_gemma":[0.9973046,0.0002813141,0.00032484691,0.0009751073,0.0008431598,0.00027097933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013544043,0.0003677038,0.0010042749,0.00039000052,0.00016481352,0.000024385528,0.000546972,0.00012595845,0.0007231013],"category_scores_gemma":[0.00013369603,0.00022637355,0.00015478942,0.00091703725,0.00050669664,0.00019142877,0.00024941692,0.0011673183,0.000007696131],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.368388,0.010353391,0.5767279,0.00077573577,0.0005284897,0.00011625047,0.016966974,0.00010069866,0.014000589,0.000008655019,0.00011761735,0.0119156595],"study_design_scores_gemma":[0.5985436,0.0017895614,0.3217152,0.001882352,0.00027872087,0.000001623766,0.0036080899,0.000052359548,0.071558565,0.0000422303,0.00009373029,0.00043397435],"about_ca_topic_score_codex":0.008110246,"about_ca_topic_score_gemma":0.0019371451,"teacher_disagreement_score":0.25501275,"about_ca_system_score_codex":0.0007798997,"about_ca_system_score_gemma":0.0009624697,"threshold_uncertainty_score":0.99849486},"labels":[],"label_agreement":null},{"id":"W2332711774","doi":"10.1158/1538-7445.am2011-4732","title":"Abstract 4732: Cis-expression QTL analysis of established risk variants for colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Colorectal cancer; Genetics; Expression quantitative trait loci; Gene; SNP array; DNA methylation; Single-nucleotide polymorphism; DNA microarray; Quantitative trait locus; SNP; Cancer; Genotype; Gene expression","score_opus":0.1232615787091346,"score_gpt":0.4207944470165268,"score_spread":0.29753286830739223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332711774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165565,0.0015073827,0.00022829178,0.0000809645,0.00047011627,0.0013106801,0.00065548054,0.000039566028,0.00405189],"genre_scores_gemma":[0.99509966,0.0010833069,0.0016884337,0.00003557883,0.00023112084,0.0012647008,0.000039692015,0.00005678081,0.0005006989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99688464,0.000117638556,0.0005022067,0.00066984387,0.0010568359,0.00076880713],"domain_scores_gemma":[0.99699694,0.00050660584,0.0002256794,0.00058596337,0.0013506379,0.0003341544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013681131,0.00022291385,0.0007113428,0.0008918959,0.00018061929,0.000024984725,0.00039685806,0.00024969582,0.009893088],"category_scores_gemma":[0.00079747493,0.00018459027,0.00030964063,0.0021107732,0.000351866,0.00011127122,0.00015089072,0.00061300053,0.000010282313],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007471687,0.00041328467,0.1953438,0.00041536603,0.0021162475,0.000016730663,0.0023584326,0.00020991969,0.76150423,0.000030279556,0.0120731145,0.018046917],"study_design_scores_gemma":[0.0013692298,0.00062197715,0.50761026,0.00019620881,0.00080197805,9.260333e-7,0.0002200163,0.00050875166,0.4872372,0.0001410632,0.001114844,0.00017758705],"about_ca_topic_score_codex":0.008872604,"about_ca_topic_score_gemma":0.0024350751,"teacher_disagreement_score":0.31226644,"about_ca_system_score_codex":0.00054013776,"about_ca_system_score_gemma":0.001038419,"threshold_uncertainty_score":0.9977274},"labels":[],"label_agreement":null},{"id":"W2332829719","doi":"10.1158/1538-7445.am10-lb-130","title":"Abstract LB-130: The NCI-Nature Pathway Interaction Database: A cell signaling resource","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Database; World Wide Web; Computer science; Biological pathway; Upload; Computational biology; Bioinformatics; Biology; Genetics; Gene","score_opus":0.02654499007857366,"score_gpt":0.34403983325124865,"score_spread":0.317494843172675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332829719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98810816,0.0015909524,0.0001381036,0.000799763,0.00044530377,0.00026918066,0.000070608236,0.000009264534,0.008568653],"genre_scores_gemma":[0.9967212,0.00019822849,0.00013370055,0.0003923057,0.0012728426,0.00005565354,0.00015252705,0.000021658225,0.0010518703],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988614,0.000053902502,0.00017146059,0.00025376695,0.00027660528,0.000382921],"domain_scores_gemma":[0.9990375,0.00006175765,0.00006323576,0.0005824021,0.00015621899,0.00009887129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011205508,0.000110479006,0.000078218945,0.00004169509,0.00027825753,0.00010838506,0.00045278433,0.00027138894,0.00026592077],"category_scores_gemma":[0.00006284712,0.000078307756,0.000059662103,0.00012921586,0.0001386596,0.000007747048,0.0002474107,0.0016946184,0.000037975155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007993179,0.00002079431,0.00005499937,0.000032728687,0.000015973505,0.0000029115936,0.0001126889,0.00011008937,0.9611442,0.00010505484,0.028231557,0.010089089],"study_design_scores_gemma":[0.00019117071,0.000040874835,0.00015710312,0.000022781285,0.0000031479349,0.0000052471337,0.00026956416,0.00022436549,0.44201598,0.000060585066,0.55690205,0.00010714114],"about_ca_topic_score_codex":0.00010928332,"about_ca_topic_score_gemma":0.00031350646,"teacher_disagreement_score":0.5286705,"about_ca_system_score_codex":0.000023563132,"about_ca_system_score_gemma":0.00019452549,"threshold_uncertainty_score":0.73623675},"labels":[],"label_agreement":null},{"id":"W2332893390","doi":"10.1158/1538-7445.am2011-3455","title":"Abstract 3455: Comparison of expression profiles of pediatric high and low grade brainstem gliomas to pediatric supratentorial high grade astrocytomas","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Brainstem; Glioma; Medicine; Astrocytoma; Anaplastic astrocytoma; Oncology; Pathology; Cancer research; Internal medicine","score_opus":0.11760419490454407,"score_gpt":0.3924129466987669,"score_spread":0.2748087517942228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332893390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958436,0.0021741395,0.0000028866039,0.00021690778,0.00040227096,0.0011541304,0.00010009772,0.000027050219,0.000078914934],"genre_scores_gemma":[0.9973322,0.00058314076,0.0005037497,0.000005726653,0.0011741222,0.00030063625,0.000026137259,0.000037595764,0.0000366583],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99717796,0.00012255898,0.00056239025,0.0004804531,0.0011049559,0.0005516769],"domain_scores_gemma":[0.9982953,0.00023214296,0.00020149874,0.00040701,0.00043813293,0.00042589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042330832,0.00022291878,0.0006149727,0.0007917749,0.00010621056,0.000018886265,0.00020444187,0.00015666289,0.00023028703],"category_scores_gemma":[0.0001268536,0.00017201269,0.00009342074,0.0009903216,0.00011994231,0.00010362835,0.00017181641,0.00032118164,0.000016443224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014631518,0.0029475489,0.7744453,0.0014052729,0.00010329906,0.00012031272,0.0016357342,0.000013274896,0.20844336,0.00029956838,0.0080646835,0.0010585232],"study_design_scores_gemma":[0.0027937735,0.0012918755,0.4540746,0.00013188213,0.00010502669,0.0000032693317,0.00024389476,0.000004650059,0.5411242,0.00005266803,0.00006030945,0.00011385863],"about_ca_topic_score_codex":0.0022426608,"about_ca_topic_score_gemma":0.000060325052,"teacher_disagreement_score":0.33268085,"about_ca_system_score_codex":0.00015246186,"about_ca_system_score_gemma":0.0003040698,"threshold_uncertainty_score":0.70144737},"labels":[],"label_agreement":null},{"id":"W2332981905","doi":"10.1158/1538-7445.am10-5534","title":"Abstract 5534: Liposome accumulation within leukemia engrafted bone marrow is significantly enhanced when the formulation contains cytarabine plus daunorubicin","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Leukemia; Cytarabine; Bone marrow; Liposome; Biodistribution; Medicine; Pharmacology; Cancer research; Chemistry; Immunology; In vitro; Biochemistry","score_opus":0.06661424841608132,"score_gpt":0.3614347039803098,"score_spread":0.2948204555642285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332981905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952196,0.00017167904,0.00025729975,0.0019195256,0.0006810053,0.001295789,0.00009176015,0.00013561203,0.0002277661],"genre_scores_gemma":[0.99750656,0.000028070883,0.00031959554,0.0003087005,0.0005317853,0.00037383163,0.000032839587,0.000054839784,0.00084376737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960355,0.00028999968,0.0006363385,0.00068938837,0.0014268927,0.0009218769],"domain_scores_gemma":[0.9970539,0.0006822794,0.00023440723,0.00095518347,0.00082559173,0.00024861316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035212054,0.00025964752,0.0003161812,0.00024128711,0.00063599093,0.00036158226,0.0007083339,0.00020894805,0.002736429],"category_scores_gemma":[0.0005295471,0.00019704428,0.00008334781,0.00062248344,0.00035897852,0.0007767185,0.00017995483,0.0009925679,0.00057889166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068074645,0.000043077758,0.00020075914,0.000044375294,0.000013473115,0.000011230748,0.002638824,0.0026710504,0.9896624,0.0004904521,0.0021614053,0.0013821719],"study_design_scores_gemma":[0.0013770093,0.00010851013,0.004760681,0.00006356752,0.000016823804,0.0000026219711,0.00029834843,0.0063453023,0.98470175,0.0013524609,0.0007168539,0.0002560817],"about_ca_topic_score_codex":0.005319473,"about_ca_topic_score_gemma":0.004129395,"teacher_disagreement_score":0.004960695,"about_ca_system_score_codex":0.0009784055,"about_ca_system_score_gemma":0.0012982679,"threshold_uncertainty_score":0.9981752},"labels":[],"label_agreement":null},{"id":"W2332983285","doi":"10.1158/1538-7445.am10-3817","title":"Abstract 3817: Initial characterization of the prolactin-inducible protein (PIP) null mouse suggests an immunomodulatory role for mPIP","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Biology; Germinal center; Immune system; Submandibular gland; Knockout mouse; Lymphatic system; Microarray analysis techniques; Immunology; Endocrinology; Internal medicine; Receptor; B cell; Antibody; Gene expression; Gene; Medicine; Genetics","score_opus":0.058943291863018,"score_gpt":0.37882751281527377,"score_spread":0.31988422095225577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332983285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556,0.000056826077,0.000006078017,0.0006406779,0.00029293814,0.0027933454,0.000106801526,0.00004145302,0.0005018768],"genre_scores_gemma":[0.9973896,0.000020159947,0.000052235726,0.000071083705,0.00065930403,0.0007711846,0.00008823008,0.00006485136,0.0008833617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789864,0.000091152935,0.000383365,0.00039298637,0.0006907813,0.00054308545],"domain_scores_gemma":[0.9979779,0.000048446804,0.00015275426,0.0007936163,0.0008219929,0.00020527546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010502727,0.0001718045,0.0002798202,0.00021532172,0.00025803607,0.000048902213,0.00037126534,0.00024558746,0.00021771829],"category_scores_gemma":[0.00033737544,0.00012536261,0.00011325783,0.00039767238,0.00024872576,0.0003548195,0.000088264074,0.0011021376,0.000016961205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010915416,0.0002744606,0.006250451,0.00020606357,0.000033869,0.0000017072783,0.00054403354,3.7953214e-7,0.98453975,0.00012756194,0.000102373444,0.006827815],"study_design_scores_gemma":[0.0010009211,0.00035184386,0.24771415,0.00007140265,0.000013154389,0.0000027158342,0.00009322525,0.000037632068,0.7457468,0.00008225157,0.0047808834,0.00010503713],"about_ca_topic_score_codex":0.00040628284,"about_ca_topic_score_gemma":0.000106375,"teacher_disagreement_score":0.24146369,"about_ca_system_score_codex":0.000113933325,"about_ca_system_score_gemma":0.001017248,"threshold_uncertainty_score":0.5112139},"labels":[],"label_agreement":null},{"id":"W2333205177","doi":"10.1158/1538-7445.am2011-3701","title":"Abstract 3701: Dimethylbenzanthracene (DMBA) and DMBA dihydrodiol mutagenicity in rat epithelial and fibroblast cell lines, and its inhibition by combinations of nutraceuticals","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"DMBA; Chemistry; Carcinogen; Metabolite; Chinese hamster ovary cell; Biochemistry; Cell culture; In vitro; Molecular biology; Pharmacology; Carcinogenesis; Biology; Genetics","score_opus":0.05102307050223089,"score_gpt":0.3391139740507888,"score_spread":0.28809090354855793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333205177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916865,0.007307981,0.000025116258,0.000118447,0.000023789236,0.00032243185,0.00022547416,0.0000030074577,0.00028720693],"genre_scores_gemma":[0.9930699,0.0065335818,0.00007686411,0.000019544521,0.00005127711,0.00003897224,0.000051967632,0.000015625104,0.00014227911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887806,0.00010160528,0.00022452085,0.00038228734,0.00013649718,0.00027703794],"domain_scores_gemma":[0.999432,0.00006676579,0.00006115825,0.00015058732,0.00015958781,0.00012989747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037722208,0.00012685354,0.00018173206,0.00007519384,0.0000751427,0.000018024,0.00008600641,0.00016228735,0.00003323334],"category_scores_gemma":[0.000120733865,0.0001252103,0.000023705812,0.00009409777,0.00039682112,0.000012412445,0.00017525983,0.00022407097,0.0000012349581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001523848,0.00019492806,0.0014610576,0.00015193706,0.000012367247,0.0000016558577,0.00028172982,0.0000015411199,0.99684155,0.000040533418,0.00024303088,0.0006173075],"study_design_scores_gemma":[0.0011999855,0.00017081681,0.00782756,0.000064214684,0.000006062623,0.0000016363605,0.00012447315,0.000029469013,0.9896058,0.0002409863,0.000600573,0.00012846608],"about_ca_topic_score_codex":0.00016137472,"about_ca_topic_score_gemma":0.00008918033,"teacher_disagreement_score":0.007235771,"about_ca_system_score_codex":0.000019636074,"about_ca_system_score_gemma":0.00006121222,"threshold_uncertainty_score":0.5105928},"labels":[],"label_agreement":null},{"id":"W2333249679","doi":"10.1158/1538-7445.am10-1296","title":"Abstract 1296: Metronomic chemotherapy and DC101 induce unique changes in tumor vascular function and metabolic activity in pancreatic cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Medicine; Erlotinib; Pancreatic cancer; Bevacizumab; Cancer; Pancreatic tumor; Chemotherapy; Internal medicine; Cancer research; Oncology; Pathology; Epidermal growth factor receptor","score_opus":0.027984737953732446,"score_gpt":0.33526923643789386,"score_spread":0.3072844984841614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333249679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97828215,0.020404201,0.000007039479,0.00037602385,0.00034106366,0.00045161037,0.000022332622,0.0000065236386,0.00010902952],"genre_scores_gemma":[0.9641703,0.03409467,0.0000307637,0.00013696741,0.0008795025,0.0005088183,0.0000072412895,0.000032738728,0.00013901567],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985685,0.00012515564,0.00013886477,0.00052457635,0.0001834633,0.0004594657],"domain_scores_gemma":[0.9993976,0.00003255358,0.000050202514,0.00030822502,0.00007855973,0.00013287981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095121696,0.00017390483,0.00029093042,0.00025676878,0.00007087778,0.000045789177,0.0001367573,0.00017930997,0.0001055738],"category_scores_gemma":[0.000051521067,0.00016808572,0.00003589472,0.00028134027,0.00019324114,0.000017403474,0.00009347533,0.0005900283,0.0000011763716],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023837738,0.000048320035,0.019135928,0.00005424724,0.000046369387,8.230438e-7,0.000096980984,0.0000074983423,0.9288789,0.00004431985,0.00011190161,0.05133631],"study_design_scores_gemma":[0.0013687788,0.000057451132,0.5972399,0.0000312286,0.000014063553,0.0000019881088,0.000070077986,0.000017633021,0.34565794,0.00007549906,0.0552844,0.00018101795],"about_ca_topic_score_codex":0.009377651,"about_ca_topic_score_gemma":0.052561898,"teacher_disagreement_score":0.58322096,"about_ca_system_score_codex":0.000055322762,"about_ca_system_score_gemma":0.00033543285,"threshold_uncertainty_score":0.99721897},"labels":[],"label_agreement":null},{"id":"W2333316760","doi":"10.1158/0008-5472.sabcs-1144","title":"A global perspective on the use of aromatase inhibitors in early-stage breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Aromatase; Cancer; Internal medicine; Stage (stratigraphy); Gynecology; Adjuvant; Adjuvant therapy; Oncology; Family medicine","score_opus":0.04356782286706691,"score_gpt":0.3785842791166106,"score_spread":0.3350164562495437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333316760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952988,0.0017506538,0.0000013622348,0.0018075273,0.00004668118,0.00031988992,0.00026628614,0.0000044131734,0.00050436356],"genre_scores_gemma":[0.9985735,0.0008478437,0.0000062435574,0.00013294828,0.0001240496,0.000051203067,0.000008861424,0.000008233889,0.0002471586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988292,0.0001952113,0.000114548995,0.00027311558,0.00026752483,0.00032038373],"domain_scores_gemma":[0.9994131,0.00003215123,0.000033762928,0.00029308008,0.00015208729,0.00007585791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025549997,0.000099730605,0.000103369704,0.000055001325,0.00007084576,0.000025354826,0.00019287775,0.00012722393,0.000027309938],"category_scores_gemma":[0.000075850345,0.0000683994,0.000058321715,0.00040009804,0.00017684903,0.0000052147943,0.00006348806,0.00026478912,0.0000051494912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036032447,0.0006289139,0.04567958,0.000039746665,0.00021298017,0.000116780386,0.0007619988,0.0024808508,0.879976,0.0073370864,0.04940212,0.00976072],"study_design_scores_gemma":[0.0024095294,0.002337537,0.23639098,0.0004989095,0.000023184435,0.000023785315,0.0010769904,0.00015353294,0.7442189,0.00054123567,0.011813345,0.0005120571],"about_ca_topic_score_codex":0.00475269,"about_ca_topic_score_gemma":0.0004136861,"teacher_disagreement_score":0.19071141,"about_ca_system_score_codex":0.00023040627,"about_ca_system_score_gemma":0.00023892646,"threshold_uncertainty_score":0.7184677},"labels":[],"label_agreement":null},{"id":"W2333400794","doi":"10.1158/1538-7445.am2013-156","title":"Abstract 156: Prognostic significance of distance travelled to the cancer center in women treated with adjuvant trastuzumab.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Trastuzumab; Cohort; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Stage (stratigraphy); Adjuvant therapy; Oncology; Retrospective cohort study; Chemotherapy; Gynecology; Surgery; Confidence interval","score_opus":0.02598272796691956,"score_gpt":0.32575181863789,"score_spread":0.2997690906709704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333400794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937373,0.002083991,0.000036969937,0.001903312,0.000041948893,0.0015003715,0.00018828732,0.00000773346,0.0005001],"genre_scores_gemma":[0.9911991,0.00086188375,0.000033562068,0.00012672514,0.00012927128,0.0070946338,0.000017402588,0.00003601496,0.00050144567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979738,0.0001064373,0.00025144627,0.0005496662,0.00040135696,0.0007172908],"domain_scores_gemma":[0.9989247,0.0000681286,0.0000669102,0.0004479351,0.00035383482,0.00013849208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027031553,0.00020973649,0.0002721704,0.00008376162,0.00010793695,0.00003120836,0.0004120909,0.0000682484,0.00025232835],"category_scores_gemma":[0.00005353964,0.00013064001,0.000041188498,0.00049639115,0.00029991276,0.000008814283,0.00010298298,0.00020517372,0.000019909348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005034034,0.0010339181,0.465907,0.00036612106,0.0007363112,0.000027998614,0.0058752,0.0010008217,0.42427453,0.00002611723,0.017611098,0.078106835],"study_design_scores_gemma":[0.0020026655,0.00047551357,0.8808576,0.00031212546,0.000012799414,0.0000019789336,0.0015725831,0.000007880649,0.10507918,0.000019463238,0.009392678,0.0002655672],"about_ca_topic_score_codex":0.0056129834,"about_ca_topic_score_gemma":0.0056755207,"teacher_disagreement_score":0.41495058,"about_ca_system_score_codex":0.00034946142,"about_ca_system_score_gemma":0.00032508047,"threshold_uncertainty_score":0.8485189},"labels":[],"label_agreement":null},{"id":"W2333431835","doi":"10.1158/0008-5472.sabcs-09-904","title":"Breast Cancer Events Associated with Germline Mutations of the CDH1 Gene (Hereditary Diffuse Gastric Cancer).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Breast cancer; CDH1; Cancer; Prophylactic Surgery; Prophylactic Mastectomy; Genetic counseling; Germline mutation; Oncology; Internal medicine; Genetic testing; Mastectomy; Mutation; Gene; Genetics","score_opus":0.029914737675164775,"score_gpt":0.35637896320370327,"score_spread":0.3264642255285385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333431835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076575,0.003932563,0.000077211414,0.003044067,0.0002698394,0.00049625366,0.0012379044,0.000013426325,0.00016296466],"genre_scores_gemma":[0.99560636,0.0014344788,0.0000864434,0.00023240499,0.00056305184,0.00044228273,0.00011198523,0.000038699298,0.0014843004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997848,0.00022001888,0.0002699937,0.00045389705,0.0006823569,0.00052575977],"domain_scores_gemma":[0.99820626,0.000039415947,0.00015229678,0.0005655313,0.0009174336,0.00011905145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033824716,0.00018452154,0.00019298056,0.000115904855,0.0002706234,0.00001932481,0.0005609654,0.00014806305,0.0002794625],"category_scores_gemma":[0.00008077704,0.00013700109,0.00009215725,0.0010324111,0.00029851345,0.000010679074,0.00012550305,0.00034423097,0.0000027973933],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030871,0.0007508847,0.06176729,0.000058728026,0.0007206875,0.000011954903,0.0004565815,0.012431779,0.86077636,0.000029058894,0.032680508,0.02971309],"study_design_scores_gemma":[0.0034143503,0.00040318456,0.6746689,0.00036431412,0.00014105183,0.000049484075,0.00019760932,0.0002156885,0.31729203,0.00028390766,0.0025178674,0.00045158743],"about_ca_topic_score_codex":0.0010935201,"about_ca_topic_score_gemma":0.0025656102,"teacher_disagreement_score":0.6129016,"about_ca_system_score_codex":0.00060942257,"about_ca_system_score_gemma":0.0020693543,"threshold_uncertainty_score":0.5586742},"labels":[],"label_agreement":null},{"id":"W2333456116","doi":"10.1158/1538-7445.am10-474","title":"Abstract 474: Cx43 mutant mice show delayed formation of palpable mammary gland tumors but are more susceptible to lung lesions","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"DMBA; Mammary gland; Mammary tumor; Gap junction; Cancer; Breast cancer; Pathology; Connexin; Cancer research; Medicine; Internal medicine; Endocrinology; Biology; Carcinogenesis; Intracellular; Cell biology","score_opus":0.03197740462480785,"score_gpt":0.3533595729906475,"score_spread":0.32138216836583966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333456116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970634,0.00044770126,0.00022345493,0.0011156532,0.00012056053,0.0003290082,0.00015999677,0.000008852847,0.0005313921],"genre_scores_gemma":[0.9983443,0.00026557583,0.00017242038,0.00011005639,0.00023252411,0.000085936445,0.00013515547,0.00001741192,0.0006365968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878794,0.00005181645,0.00021488345,0.00031418024,0.00020005126,0.00043115576],"domain_scores_gemma":[0.9989471,0.000030739346,0.000067265784,0.00042226963,0.00037427078,0.0001583885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045254157,0.00011799453,0.0001590112,0.0001238771,0.00014208884,0.0000275092,0.00033987287,0.00018680721,0.00019082725],"category_scores_gemma":[0.00010464986,0.00010327361,0.00006273662,0.00019584101,0.00011578206,0.000010059337,0.00021768016,0.00033057237,0.000010668151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020298395,0.000037265654,0.002173318,0.00005848378,0.00002054245,0.000010400399,0.00008864935,0.00003597861,0.9892466,0.000057103665,0.005773116,0.0022955367],"study_design_scores_gemma":[0.0004469453,0.00028536128,0.014246278,0.000042685464,0.000006404864,0.000017840395,0.00048315938,0.00017283426,0.9599002,0.000033600067,0.02418889,0.00017577513],"about_ca_topic_score_codex":0.0009826473,"about_ca_topic_score_gemma":0.003785875,"teacher_disagreement_score":0.029346395,"about_ca_system_score_codex":0.00003259667,"about_ca_system_score_gemma":0.00024239233,"threshold_uncertainty_score":0.42113757},"labels":[],"label_agreement":null},{"id":"W2333503313","doi":"10.1158/1538-7445.am10-4200","title":"Abstract 4200: Transgenic mice overexpressing a Claudin-6 tail deletion mutant are resistant to tumor formation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Claudin; Carcinogenesis; Tight junction; Involucrin; Epidermis (zoology); Cell biology; Biology; Genetically modified mouse; Barrier function; Mutant; Occludin; Transmembrane protein; Wild type; Transgene; Molecular biology; Genetics; Keratinocyte; Cell culture; Anatomy; Cancer; Receptor; Gene","score_opus":0.09903276252549738,"score_gpt":0.3802168249058621,"score_spread":0.28118406238036475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333503313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404687,0.00012618152,0.00026775803,0.0020195483,0.000745199,0.00044245986,0.00008948768,0.00007261041,0.0021899068],"genre_scores_gemma":[0.998265,0.00007634253,0.00007740297,0.00062724575,0.00044592388,0.00019078219,0.000001689411,0.000024023522,0.00029157734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997741,0.00010811218,0.00027445008,0.0004804429,0.0008172158,0.00057881296],"domain_scores_gemma":[0.99891716,0.00019874652,0.00008683907,0.00032197323,0.00027471106,0.00020058392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005285964,0.00015049426,0.00017491612,0.00023845462,0.0007875509,0.00018599392,0.00029786248,0.000078127756,0.0004567286],"category_scores_gemma":[0.00058228074,0.00012890012,0.00006421941,0.0007044469,0.00018165012,0.0003806643,0.00007912966,0.0008288274,0.000114386814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032019,0.000015718997,0.00009615069,0.000064245396,0.0000039622964,0.000010618362,0.00079877005,0.000015003927,0.9901997,0.00020850451,0.0053090304,0.002958136],"study_design_scores_gemma":[0.000359466,0.000063926214,0.008386453,0.00009572584,0.0000049538135,0.000010140148,0.0005137188,0.00003195293,0.90064454,0.00041278062,0.089295805,0.00018056859],"about_ca_topic_score_codex":0.00014771652,"about_ca_topic_score_gemma":0.0011074303,"teacher_disagreement_score":0.08955516,"about_ca_system_score_codex":0.00015397825,"about_ca_system_score_gemma":0.00014228624,"threshold_uncertainty_score":0.6057284},"labels":[],"label_agreement":null},{"id":"W2333523858","doi":"10.1158/1538-7445.am2011-lb-41","title":"Abstract LB-41: Regulation of adhesion, motility, and invasion by insulin-like growth factor-2 binding protein 3 in pancreatic cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gene knockdown; Pancreatic cancer; Transfection; Small interfering RNA; Growth factor; Cancer research; Extracellular matrix; Molecular biology; Cancer; Biology; Cell culture; Chemistry; Medicine; Cell biology; Internal medicine","score_opus":0.08166422631337995,"score_gpt":0.3387370588745813,"score_spread":0.25707283256120134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333523858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963822,0.0026291856,0.000014637718,0.000060314134,0.0000460904,0.00050582096,0.00008990791,0.000004709549,0.0002671309],"genre_scores_gemma":[0.99582344,0.003141357,0.00007968276,0.000010946089,0.00004481136,0.00028912487,0.000029125225,0.000020307229,0.00056117494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869204,0.00011455762,0.00026005693,0.00039070065,0.00026527824,0.0002773715],"domain_scores_gemma":[0.9992583,0.000017764616,0.000089973924,0.00029135906,0.0002542852,0.0000883126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044583494,0.000114861825,0.00014929922,0.00012711731,0.000083721454,0.000016843755,0.00018348728,0.00015007582,0.00020969883],"category_scores_gemma":[0.00005401393,0.00010563344,0.000030405386,0.0002603093,0.000165651,0.000011997095,0.000100205856,0.00017949034,0.0000033700455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012392289,0.0000681753,0.023832353,0.00013727027,0.000014443593,4.911961e-7,0.0001857945,0.0000025126722,0.97222733,0.000018750641,0.00058093545,0.0028080293],"study_design_scores_gemma":[0.00035273336,0.00008680145,0.13509673,0.00012391225,0.0000033386702,2.2561015e-7,0.00008005924,0.000012149382,0.86360514,0.00011489744,0.0004336284,0.000090411755],"about_ca_topic_score_codex":0.0039532264,"about_ca_topic_score_gemma":0.00048639227,"teacher_disagreement_score":0.11126438,"about_ca_system_score_codex":0.00009597388,"about_ca_system_score_gemma":0.00021951307,"threshold_uncertainty_score":0.59761226},"labels":[],"label_agreement":null},{"id":"W2333527753","doi":"10.1158/1538-7445.am2013-3094","title":"Abstract 3094: MiRNAs 484 and 210 control Pax-5 expression and function in breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"microRNA; Biology; Cancer; Cancer research; Untranslated region; Breast cancer; Cancer cell; Regulation of gene expression; Gene silencing; Context (archaeology); Gene expression; Gene; Messenger RNA; Genetics","score_opus":0.018939903241039214,"score_gpt":0.33232792605871575,"score_spread":0.3133880228176765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333527753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98602545,0.0104626315,0.00037196538,0.0017035056,0.00012921529,0.00086278934,0.00006962581,0.000012210379,0.00036259534],"genre_scores_gemma":[0.99144405,0.00661016,0.000025451069,0.00017303257,0.0002718705,0.000871468,0.000019421805,0.00004180796,0.0005427538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789447,0.00017534397,0.0002066858,0.00062416604,0.0004572837,0.00064202835],"domain_scores_gemma":[0.9989932,0.000038948787,0.000043770797,0.0003343224,0.0003268118,0.0002629209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056361407,0.0001743141,0.00018264147,0.00018988857,0.00015994765,0.00011763946,0.00018439301,0.0002722983,0.0006617742],"category_scores_gemma":[0.000058902217,0.00016108915,0.00003685899,0.00023015823,0.00022403846,0.000021080097,0.0002229728,0.0005526235,0.00001578106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042629358,0.000035360077,0.0018553099,0.00007057646,0.000032601973,0.0000066559314,0.000035438763,0.000049864688,0.9649659,0.000018333381,0.005212953,0.027290724],"study_design_scores_gemma":[0.006074551,0.00047942332,0.16145779,0.00043684957,0.000019027817,0.000043172407,0.00039533057,0.00062345446,0.807552,0.00059574796,0.021724084,0.00059859175],"about_ca_topic_score_codex":0.005207119,"about_ca_topic_score_gemma":0.0009713051,"teacher_disagreement_score":0.1596025,"about_ca_system_score_codex":0.00012510273,"about_ca_system_score_gemma":0.00028921475,"threshold_uncertainty_score":0.7871641},"labels":[],"label_agreement":null},{"id":"W2333542667","doi":"10.1158/1538-7445.am2012-4338","title":"Abstract 4338: Monitoring radiation response in tumor vasculature using intravital photoacoustic imaging in a murine window chamber model <i>in vivo</i>","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; FujiFilm VisualSonics (Canada); University Health Network; Illumisonics (Canada)","funders":"","keywords":"In vivo; Biomedical engineering; Preclinical imaging; Vascularity; Tumor hypoxia; Materials science; Intravital microscopy; Ultrasound; Ex vivo; Oxygen saturation; Imaging phantom; Nuclear medicine; Chemistry; Pathology; Radiation therapy; Medicine; Oxygen; Surgery; Radiology; Biology","score_opus":0.032833443347447575,"score_gpt":0.3372059033124722,"score_spread":0.3043724599650246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333542667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439317,0.0037671754,0.00060356193,0.000034178523,0.00037642472,0.0004551477,0.000027135227,0.00006401695,0.00027919104],"genre_scores_gemma":[0.99887955,0.0001945362,0.00032364012,0.000017861581,0.00031809657,0.00015556444,0.0000023661362,0.000082187275,0.00002622244],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99730265,0.00012358189,0.00038407353,0.00031653565,0.00053066417,0.0013425042],"domain_scores_gemma":[0.9991569,0.00030084176,0.000030525494,0.00027627,0.000060036054,0.00017542175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023319293,0.00023800907,0.00028030583,0.0008410524,0.00007381671,0.0000719203,0.00017384937,0.00009275616,0.000055016244],"category_scores_gemma":[0.00022406984,0.00026791528,0.000049660437,0.0009529269,0.00007172208,0.0007264723,0.00006124915,0.0012833022,0.0000056740932],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016525007,0.000044044828,0.027625946,0.00010648247,0.0000057582483,0.00009894586,0.0015388305,0.4679396,0.50169337,0.0000019300442,0.000028761016,0.0007511119],"study_design_scores_gemma":[0.0015026375,0.000006678022,0.124613,0.00076764193,0.00000765981,0.000036447753,0.0007898005,0.80969906,0.062105365,0.00004127214,0.00004525525,0.0003851848],"about_ca_topic_score_codex":0.001311528,"about_ca_topic_score_gemma":0.000072215706,"teacher_disagreement_score":0.43958798,"about_ca_system_score_codex":0.0021002102,"about_ca_system_score_gemma":0.00024097442,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W2333559932","doi":"10.1158/1538-7445.am2011-2506","title":"Abstract 2506: Preclinical evaluation of sorafenib in combination with ionizing radiation in metastatic breast cancer model","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Sorafenib; Clonogenic assay; Medicine; Cancer research; Breast cancer; Cancer; Vascular endothelial growth factor; Platelet-derived growth factor receptor; Radiation therapy; Internal medicine; Oncology; Growth factor; Hepatocellular carcinoma; Cell; Receptor; Biology; VEGF receptors","score_opus":0.20379812027040614,"score_gpt":0.43821650323644507,"score_spread":0.23441838296603892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333559932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974854,0.0014253923,0.00022013868,0.00019419681,0.000031627314,0.00043686506,0.000044849417,0.000002268163,0.00015924282],"genre_scores_gemma":[0.9986794,0.000807092,0.00012154179,0.000015670543,0.000025219393,0.00027957492,0.00003971343,0.0000145099375,0.000017259597],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99864864,0.00020212994,0.00025092514,0.000245558,0.0004326179,0.00022011463],"domain_scores_gemma":[0.99939835,0.000023774808,0.00005111344,0.00016010425,0.00032048143,0.000046151647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016361169,0.00007988245,0.00012493094,0.00014786063,0.000029716723,0.000007864504,0.00011098668,0.00007282589,0.00011642234],"category_scores_gemma":[0.000039619477,0.000071324874,0.000027620355,0.00024130597,0.00009086005,0.000014294538,0.00001847272,0.00018376349,0.0000013805641],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003163264,0.0011536181,0.07624592,0.00021887106,0.00011372877,0.0000072888165,0.0024097012,0.084559,0.7381274,0.00056301575,0.00013217966,0.09330601],"study_design_scores_gemma":[0.008652438,0.0005196371,0.60861135,0.00035793922,0.00006521407,0.000005497651,0.00034599562,0.059058473,0.32024387,0.0017810594,0.000027082036,0.0003314692],"about_ca_topic_score_codex":0.0027882466,"about_ca_topic_score_gemma":0.003855483,"teacher_disagreement_score":0.5323654,"about_ca_system_score_codex":0.000103074504,"about_ca_system_score_gemma":0.0006396798,"threshold_uncertainty_score":0.42150134},"labels":[],"label_agreement":null},{"id":"W2333579202","doi":"10.1158/1538-7445.am10-2979","title":"Abstract 2979: Tumor suppressor ING1b maintains genomic stability through PCNA monoubiquitination and histone H4 acetylation","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proliferating cell nuclear antigen; Biology; Histone H4; Genome instability; Histone; DNA replication; Cancer research; Molecular biology; Cell biology; DNA damage; Genetics; Cell growth; DNA","score_opus":0.057083773703591044,"score_gpt":0.40156603264093027,"score_spread":0.34448225893733925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333579202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568534,0.0015391639,0.00032869226,0.00046544895,0.00016506216,0.00037859127,0.00005454851,0.000010610312,0.0013725181],"genre_scores_gemma":[0.9980237,0.0006728887,0.0005128268,0.00003440267,0.00036058127,0.00009724472,0.00012438478,0.000025731208,0.00014823233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986605,0.00010027124,0.00020922298,0.00043323645,0.00026326702,0.0003335196],"domain_scores_gemma":[0.9990942,0.00005049919,0.000071009665,0.00036373804,0.00032226325,0.000098329336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010348188,0.00011644675,0.00011056108,0.0000572041,0.00021991479,0.00006355677,0.00015709859,0.00014930186,0.00022792626],"category_scores_gemma":[0.00026613218,0.00011887899,0.000036901572,0.00010283727,0.00023464067,0.000015100146,0.00014663252,0.00036099445,0.0000068853046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007754915,0.00003900378,0.003398809,0.000038265945,0.00001219735,0.0000010051957,0.00020612255,0.000027083212,0.99263793,0.0002460898,0.00013307114,0.0031828964],"study_design_scores_gemma":[0.00035761725,0.00010074973,0.080009654,0.0000069820144,0.000005100591,0.0000010442866,0.000100611745,0.000076576805,0.90025175,0.0012909105,0.017664734,0.00013427195],"about_ca_topic_score_codex":0.00059350784,"about_ca_topic_score_gemma":0.000971497,"teacher_disagreement_score":0.092386164,"about_ca_system_score_codex":0.0000868954,"about_ca_system_score_gemma":0.00020011932,"threshold_uncertainty_score":0.48477447},"labels":[],"label_agreement":null},{"id":"W2333644254","doi":"10.1158/0008-5472.sabcs11-p4-01-04","title":"P4-01-04: Effects of CYP2D6 Phenotype and Drug Adherence on Tamoxifen Metabolite Levels.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"CYP2D6; Tamoxifen; Metabolite; Medicine; Genotype; Pharmacology; Internal medicine; Active metabolite; Oncology; Pharmacogenetics; Confounding; Breast cancer; Cancer; Biology; Cytochrome P450; Genetics","score_opus":0.1758046066839674,"score_gpt":0.4552985116812434,"score_spread":0.279493904997276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333644254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764974,0.011202983,0.0000042116485,0.00036438927,0.00028159507,0.00075232715,0.000028898015,0.000021962604,0.010846233],"genre_scores_gemma":[0.99209803,0.0018602941,0.00008980878,0.00020679133,0.00021713169,0.00023380062,0.000004848906,0.000022376003,0.0052668992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986123,0.00016382514,0.00015237989,0.00031081235,0.0003725297,0.00038819623],"domain_scores_gemma":[0.9990167,0.0002805445,0.000043725966,0.00025480866,0.00019781818,0.0002064265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035140695,0.0001301682,0.00032431446,0.00018075298,0.00006866653,0.000006821038,0.00012007477,0.000064274165,0.0013719068],"category_scores_gemma":[0.00007454908,0.00010163249,0.000049922728,0.00031126168,0.00029580318,0.00005173234,0.00007982076,0.0003512238,0.000059942395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012427573,0.002144488,0.08499625,0.003548209,0.0015445063,0.00052696664,0.022922114,0.000001952315,0.6088427,0.0072323545,0.03560954,0.22020338],"study_design_scores_gemma":[0.0053386902,0.0021348812,0.20645809,0.0003377431,0.00022892095,0.0000059989497,0.00008552361,0.000009804713,0.7671163,0.0011952067,0.016915299,0.0001735124],"about_ca_topic_score_codex":0.0028513987,"about_ca_topic_score_gemma":0.00015040557,"teacher_disagreement_score":0.22002988,"about_ca_system_score_codex":0.00011250171,"about_ca_system_score_gemma":0.00027512628,"threshold_uncertainty_score":0.999541},"labels":[],"label_agreement":null},{"id":"W2333651255","doi":"10.1158/1538-7445.am2011-4398","title":"Abstract 4398: MEK inhibitors prevent rebound reactivation of ERK signaling by the RAF inhibitor PLX4032 and enhance its antitumor activity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; Melanoma; MEK inhibitor; Cancer research; Kinase; Phosphorylation; Therapeutic index; Medicine; V600E; Signal transduction; Mutant; Pharmacology; Chemistry; Biology; Drug; Cell biology; Biochemistry","score_opus":0.06595565880279666,"score_gpt":0.3472648796411768,"score_spread":0.28130922083838017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333651255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967115,0.0017574886,0.000026107036,0.00008765576,0.00009357779,0.00036048086,0.000029723582,0.0000035167525,0.00092994905],"genre_scores_gemma":[0.9988281,0.00052775996,0.000026638176,0.000012455553,0.00016569691,0.00009108575,0.000009689345,0.000014394897,0.00032417418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988661,0.00013176733,0.0001765967,0.00030995684,0.0002488959,0.00026673067],"domain_scores_gemma":[0.9994379,0.000047531383,0.00008880242,0.0002294646,0.00013543971,0.00006081353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000856465,0.0000987749,0.000121231344,0.00005443465,0.00009418487,0.000016729737,0.00015308613,0.00010166499,0.00003374737],"category_scores_gemma":[0.00013433004,0.00007721208,0.00003256527,0.00013979289,0.00015005587,0.000014107318,0.00010655448,0.00023478849,0.0000017989723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022105638,0.00008894409,0.0009886642,0.00007662112,0.000015899175,0.0000024143737,0.0002497359,0.0000011376826,0.9936797,0.000028178847,0.0009160816,0.003731557],"study_design_scores_gemma":[0.00022136078,0.00015387182,0.0068313223,0.00008554788,0.000003053204,0.0000014905271,0.00010532026,0.0000029717098,0.9905939,0.00006424596,0.0018511986,0.000085680724],"about_ca_topic_score_codex":0.000500542,"about_ca_topic_score_gemma":0.00015725681,"teacher_disagreement_score":0.005842658,"about_ca_system_score_codex":0.00003617763,"about_ca_system_score_gemma":0.00017247525,"threshold_uncertainty_score":0.3148617},"labels":[],"label_agreement":null},{"id":"W2333780672","doi":"10.1158/1538-7445.am10-lb-374","title":"Abstract LB-374: The Hh inhibitor IPI-926 enhances tumor perfusion and nab-paclitaxel activity in a pancreatic xenograft model","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FujiFilm VisualSonics (Canada); Illumisonics (Canada)","funders":"","keywords":"Paclitaxel; Gemcitabine; Pancreatic cancer; Cancer research; Medicine; Cancer; Stroma; Hedgehog; Pancreas; Internal medicine; Chemistry; Immunohistochemistry; Signal transduction","score_opus":0.04810510645222769,"score_gpt":0.3744452486785315,"score_spread":0.3263401422263038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333780672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963476,0.0018623268,0.000022071703,0.0007106947,0.00011489249,0.00039461584,0.000031671905,0.000010055057,0.0005060766],"genre_scores_gemma":[0.9977605,0.00096818776,0.00008426938,0.00006644093,0.00037201014,0.00028746822,0.000004881152,0.000025198877,0.0004310428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983537,0.00012949837,0.00016975327,0.0004791679,0.00035352894,0.0005143187],"domain_scores_gemma":[0.9991453,0.000116234856,0.000047952173,0.00040130815,0.0001825015,0.00010668156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012396924,0.00016648213,0.00018765988,0.00008826057,0.0003151959,0.00006626742,0.00027498743,0.00012953205,0.000026424514],"category_scores_gemma":[0.0004010577,0.0001192456,0.000051404248,0.00019812348,0.00050716096,0.000010334971,0.00031903342,0.00069491076,0.000007971853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014223749,0.000058143134,0.0032543316,0.000059898346,0.000016661319,0.0000055980213,0.00046040083,0.000032917633,0.99228776,0.0000117334075,0.0006231967,0.003047098],"study_design_scores_gemma":[0.00048312225,0.00015108805,0.019921059,0.00008425919,0.000007169679,0.000004092541,0.00040881155,0.000590193,0.9752811,0.00016892442,0.0026981912,0.00020195826],"about_ca_topic_score_codex":0.00064866553,"about_ca_topic_score_gemma":0.0026252244,"teacher_disagreement_score":0.017006652,"about_ca_system_score_codex":0.000037539663,"about_ca_system_score_gemma":0.00032202015,"threshold_uncertainty_score":0.48626944},"labels":[],"label_agreement":null},{"id":"W2333880554","doi":"10.1158/1538-7445.am2012-1409","title":"Abstract 1409: Real-time <i>in vivo</i> imaging for sensitive detection of primary and metastatic disease in a human breast-to-lung orthotopic model","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; In vivo; Breast cancer; mCherry; Circulating tumor cell; Cancer; Primary tumor; Nod; Metastasis; Medicine; Pathology; Biology; Green fluorescent protein; Internal medicine","score_opus":0.028247159163938534,"score_gpt":0.37708547086468513,"score_spread":0.3488383117007466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333880554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752146,0.0009053525,0.00016188757,0.000080833124,0.000011850815,0.00082595425,0.00026689732,0.0000031777524,0.00022260967],"genre_scores_gemma":[0.99877024,0.00029465623,0.000098724144,0.000023534905,0.000057015426,0.0004963385,0.00003932078,0.000020653066,0.00019950229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987751,0.000078650504,0.0001566484,0.0002810804,0.00021632574,0.00049216853],"domain_scores_gemma":[0.99939907,0.000037278798,0.000028673781,0.00018070998,0.00012250523,0.00023176355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005360686,0.00009945146,0.0001532859,0.0001899162,0.00006243314,0.000015402284,0.00007139276,0.000024767196,0.000008071628],"category_scores_gemma":[0.000041240914,0.00009749777,0.000040872103,0.00016392459,0.00008262557,0.00001660175,0.000098656594,0.0001030568,7.952295e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079286733,0.000121499994,0.018883828,0.00018684757,0.000028500745,0.000009919491,0.00010540143,0.0001741879,0.9765326,0.000009551561,0.000096470416,0.0030583632],"study_design_scores_gemma":[0.0033528004,0.00019634579,0.1862884,0.00023377624,0.00002973663,0.000009245821,0.00010261286,0.0030019039,0.806095,0.00018728722,0.00020955845,0.00029334312],"about_ca_topic_score_codex":0.0028166056,"about_ca_topic_score_gemma":0.0012446684,"teacher_disagreement_score":0.17043757,"about_ca_system_score_codex":0.00019357087,"about_ca_system_score_gemma":0.00022670612,"threshold_uncertainty_score":0.4257884},"labels":[],"label_agreement":null},{"id":"W2333891044","doi":"10.1158/0008-5472.sabcs12-p2-05-13","title":"Abstract P2-05-13: Correlation of conventional versus experimental biomarkers of bone turnover and metastasis behaviour with skeletal related events – A biomarker analysis in conjunction with the TRIUMPH study.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Ottawa Hospital","funders":"","keywords":"Medicine; N-terminal telopeptide; Biomarker; Bone metastasis; Internal medicine; Bone remodeling; Bone resorption; Oncology; Cohort; Procollagen peptidase; Odds ratio; Cancer; Urology; Gastroenterology; Endocrinology; Osteocalcin; Metastasis; Alkaline phosphatase","score_opus":0.07358907543647779,"score_gpt":0.4144171717759693,"score_spread":0.3408280963394915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333891044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967859,0.0018013517,0.000006239794,0.00017230971,0.0000675808,0.0010269693,0.000029823952,0.0000052536107,0.00010456778],"genre_scores_gemma":[0.99958324,0.000028565646,0.000024875797,0.0000041443336,0.000007843861,0.00015198218,0.00006678267,0.0000139121,0.00011864272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982345,0.00018623524,0.00031975427,0.00021240232,0.00075821945,0.0002888536],"domain_scores_gemma":[0.99914795,0.00014304937,0.00017434769,0.00019024666,0.00020096151,0.00014342977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010009692,0.00011916407,0.00033027577,0.00048736233,0.00007778215,0.000004988428,0.000036204063,0.000063576306,0.00029491758],"category_scores_gemma":[0.000024638253,0.00007221241,0.00006632296,0.0012289013,0.00024414342,0.00013976078,0.000025016856,0.00020786701,0.0000019974862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013295911,0.0016660107,0.9787025,0.000051817595,0.002651063,0.000016736923,0.00069599674,0.000009776942,0.0020401636,0.000008164335,0.0000543698,0.0008075144],"study_design_scores_gemma":[0.013676543,0.0013106605,0.98052377,0.00006973005,0.00089326577,0.000009978022,0.0022012028,0.000064294436,0.0011766013,7.625327e-7,0.000012267262,0.00006090909],"about_ca_topic_score_codex":0.0063951435,"about_ca_topic_score_gemma":0.0011919625,"teacher_disagreement_score":0.005203181,"about_ca_system_score_codex":0.00024033242,"about_ca_system_score_gemma":0.00019371625,"threshold_uncertainty_score":0.96675867},"labels":[],"label_agreement":null},{"id":"W2333962656","doi":"10.1158/0008-5472.sabcs-09-5160","title":"Cytochrome P450 (CYP) 2A6 Genetic Variation Predicts Letrozole Plasma Concentrations in Postmenopausal Women with Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Letrozole; Breast cancer; Medicine; Aromatase inhibitor; Internal medicine; CYP2A6; Pharmacokinetics; Oncology; Endocrinology; Pharmacogenomics; Pharmacogenetics; Cancer; Pharmacology; Aromatase; Genotype; Biology; Cytochrome P450; CYP3A4; Metabolism","score_opus":0.0114824063487222,"score_gpt":0.3075003710194956,"score_spread":0.2960179646707734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333962656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963537,0.0016287162,0.00005060233,0.0007371712,0.00004756893,0.0005489503,0.00008998735,0.000016556407,0.00052675215],"genre_scores_gemma":[0.9975064,0.0012208541,0.00007468422,0.00012386647,0.00030935093,0.00034008594,0.0000523218,0.0000232353,0.0003491935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982017,0.00016597156,0.0001784262,0.00042042724,0.00036181894,0.0006716504],"domain_scores_gemma":[0.99927074,0.000018891724,0.000046372395,0.00026902204,0.00019520913,0.00019975672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025078282,0.00015553445,0.00015027625,0.000112784735,0.00015111383,0.00005164394,0.0002111142,0.00019305584,0.00009978047],"category_scores_gemma":[0.000020689604,0.00013264059,0.000019393408,0.00041800734,0.00013123726,0.000012407549,0.00004593351,0.0003531209,0.000012872304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079795637,0.00012668235,0.0029845152,0.000017321841,0.00006586314,0.00003290596,0.00028216763,0.0015965562,0.98978657,0.000058998827,0.0007357705,0.0035147096],"study_design_scores_gemma":[0.0045881285,0.0045923237,0.7834185,0.00018738135,0.00002960677,0.00012291412,0.00020142223,0.0008221482,0.20335081,0.00011170466,0.0020639354,0.00051117555],"about_ca_topic_score_codex":0.00030343086,"about_ca_topic_score_gemma":0.00015524268,"teacher_disagreement_score":0.7864357,"about_ca_system_score_codex":0.00031487088,"about_ca_system_score_gemma":0.00071216957,"threshold_uncertainty_score":0.54089266},"labels":[],"label_agreement":null},{"id":"W2333989249","doi":"10.1158/1538-7445.am2011-3677","title":"Abstract 3677: Prediction of oral cancer recurrence at post-surgery follow-up using fluorescence visualization","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Cancer recurrence; Cancer; Biopsy; Dysplasia; Surgery; Lesion; Disease; Internal medicine","score_opus":0.31716001921805603,"score_gpt":0.4618599701558512,"score_spread":0.14469995093779514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333989249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993026,0.004166551,0.000027150694,0.00019389184,0.00094124407,0.0004723105,0.00013870613,0.000043210595,0.000990901],"genre_scores_gemma":[0.9929019,0.005979759,0.00010326138,0.00005918175,0.0002227386,0.00015363938,0.000023664474,0.00003331554,0.00052250683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976601,0.000102059355,0.0004124924,0.00040922107,0.000869065,0.00054703635],"domain_scores_gemma":[0.99798197,0.00012376814,0.00012091601,0.00030338776,0.001276108,0.00019383267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088737183,0.00015700769,0.00043231726,0.00030439923,0.00024729545,0.000010602451,0.00012553057,0.00011734377,0.0012860385],"category_scores_gemma":[0.00036538247,0.0001372897,0.000107222775,0.0007676478,0.00033279066,0.00019362799,0.00012045119,0.00030497267,0.000017086297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002960355,0.00025944773,0.47531226,0.0013362602,0.00021718338,0.000039642415,0.0052921236,0.0000069934727,0.44795808,0.00007442334,0.018331168,0.048212074],"study_design_scores_gemma":[0.0015756337,0.0005185341,0.67178935,0.003661729,0.00011424722,0.000017551096,0.0006051838,0.0005843444,0.3171936,0.00004987153,0.003609197,0.00028077813],"about_ca_topic_score_codex":0.011109627,"about_ca_topic_score_gemma":0.0010513671,"teacher_disagreement_score":0.19647707,"about_ca_system_score_codex":0.00070841075,"about_ca_system_score_gemma":0.0010888499,"threshold_uncertainty_score":0.99962693},"labels":[],"label_agreement":null},{"id":"W2334037247","doi":"10.1158/1538-7445.am10-4599","title":"Abstract 4599: The RING E3 ligase BCA2 is regulated by estrogen and co-expressed with estrogen receptor in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Ubiquitin ligase; Estrogen receptor; Estrogen; Ubiquitin; Chemistry; Zinc finger; Ring finger; Cancer; Cell biology; Cancer research; Breast cancer; Biology; Gene; Transcription factor; Biochemistry; Endocrinology; Genetics","score_opus":0.020178889100551687,"score_gpt":0.3237067545668562,"score_spread":0.3035278654663045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334037247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994703,0.00206829,0.0000013968242,0.0016020364,0.00005360645,0.00047845932,0.00061712007,0.000010775942,0.0004653209],"genre_scores_gemma":[0.99701667,0.0015247683,0.000053389533,0.00016491488,0.00027123446,0.0003591048,0.00005274594,0.000042175554,0.00051500066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983778,0.00009177557,0.0001676014,0.0004924434,0.00031845362,0.0005519235],"domain_scores_gemma":[0.99909526,0.000034818906,0.000057407997,0.00045424182,0.00016721801,0.00019102372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056747283,0.00017679812,0.00014793781,0.0000547643,0.00018884747,0.00009024475,0.000356879,0.00019499847,0.0004728373],"category_scores_gemma":[0.000019168881,0.00012734605,0.00003599662,0.0001899032,0.00035387924,0.000009752603,0.00012706046,0.00061862945,0.000014129418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033661324,0.000044708187,0.005003675,0.000039960734,0.000042404718,0.000004765851,0.00015611286,0.000008005317,0.98113495,0.000011834459,0.008916844,0.0043001357],"study_design_scores_gemma":[0.00076095207,0.000069433816,0.0018763975,0.000060058253,0.000005246456,0.000008058002,0.000087770146,0.000016703014,0.9597526,0.000015331401,0.03718229,0.00016515242],"about_ca_topic_score_codex":0.001868991,"about_ca_topic_score_gemma":0.00023551272,"teacher_disagreement_score":0.028265445,"about_ca_system_score_codex":0.00003705269,"about_ca_system_score_gemma":0.0003455713,"threshold_uncertainty_score":0.5193021},"labels":[],"label_agreement":null},{"id":"W2334046975","doi":"10.1158/1538-7445.am2012-1452","title":"Abstract 1452: mTOR inhibition radiosensitizes bladder cancer tumor cells <i>in vitro</i> and <i>in vivo</i>: A novel strategy for treatment","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Clonogenic assay; PI3K/AKT/mTOR pathway; In vivo; Cancer research; Bladder cancer; Protein kinase B; Cancer; Radiation therapy; Medicine; Cell cycle; Chemistry; Pharmacology; Internal medicine; Biology; Signal transduction; Biochemistry","score_opus":0.04906192858329264,"score_gpt":0.35222960633809464,"score_spread":0.303167677754802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334046975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069847,0.015361562,0.000019598694,0.00020866224,0.0015026934,0.0009832178,0.0008543842,0.0000073921924,0.0003640481],"genre_scores_gemma":[0.9813212,0.007890172,0.00011610316,0.00019400379,0.008129147,0.0013465949,0.00005401932,0.0000450775,0.000903666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981584,0.000065604916,0.00027190679,0.00046321278,0.00022072744,0.0008201657],"domain_scores_gemma":[0.9993186,0.00005742186,0.000058445024,0.000234736,0.00012574489,0.00020505064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000565181,0.00021494314,0.00033548192,0.00015032427,0.00008614232,0.000044507422,0.000081938015,0.00014017388,0.000055547822],"category_scores_gemma":[0.000026794924,0.00019359899,0.00009279651,0.00016615534,0.00014723078,0.000019801162,0.00004854175,0.00013950144,0.0000024176754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011587057,0.00019394174,0.0002932341,0.00007185311,0.000039996277,5.578109e-7,0.00016854682,0.00009401809,0.9847181,0.000021866957,0.009627677,0.0036115341],"study_design_scores_gemma":[0.003040357,0.000095692136,0.0019152014,0.00004159696,0.000014552004,0.0000040480213,0.00019217122,0.000016218224,0.79012567,0.000011170285,0.20435189,0.00019143653],"about_ca_topic_score_codex":0.0024921698,"about_ca_topic_score_gemma":0.0028267882,"teacher_disagreement_score":0.1947242,"about_ca_system_score_codex":0.00020882995,"about_ca_system_score_gemma":0.00043874205,"threshold_uncertainty_score":0.7894737},"labels":[],"label_agreement":null},{"id":"W2334104746","doi":"10.1158/1538-7445.am10-1991","title":"Abstract 1991: Integrated analysis of copy number alteration and RNA expression profile in pediatric diffuse intrinsic pontine glioma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Copy number analysis; Computational biology; Gene; Glioma; Genomics; Biology; Human genome; DNA microarray; Genome; Copy-number variation; Gene expression; Genetics; Bioinformatics","score_opus":0.023422388696455073,"score_gpt":0.3635472799818566,"score_spread":0.3401248912854015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334104746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882257,0.00042707488,0.000044698238,0.00008099671,0.000056029774,0.00018458776,0.00005023948,0.0000035760474,0.00033024192],"genre_scores_gemma":[0.9980345,0.0010646182,0.00016590224,0.0000076015717,0.00014326264,0.00014131484,0.00020983537,0.000010514156,0.00022247373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990798,0.000057089528,0.00020370778,0.00028374014,0.00018896791,0.00018665458],"domain_scores_gemma":[0.99930227,0.00002100978,0.000063393476,0.00028591667,0.00026263716,0.000064784894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037433227,0.000079141544,0.00013363079,0.00028564033,0.00005591057,0.000030558258,0.00013069481,0.00011632896,0.0002678975],"category_scores_gemma":[0.000084550775,0.00006688204,0.000038645423,0.0008909804,0.000085903026,0.0000090331405,0.00006434496,0.0002469341,0.0000032702214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117206575,0.000085616244,0.04846451,0.000021716809,0.000032281387,0.000001831857,0.000054108437,0.000025345249,0.94641024,0.000025280768,0.000695502,0.0040663728],"study_design_scores_gemma":[0.0005876133,0.000047995854,0.25387433,0.000011968777,0.000032900964,9.60876e-7,0.00005003025,0.00018374367,0.7438114,0.000017967168,0.0012803122,0.00010070835],"about_ca_topic_score_codex":0.0007989224,"about_ca_topic_score_gemma":0.0010582008,"teacher_disagreement_score":0.20540984,"about_ca_system_score_codex":0.000020760615,"about_ca_system_score_gemma":0.00012385251,"threshold_uncertainty_score":0.29332897},"labels":[],"label_agreement":null},{"id":"W2334170299","doi":"10.1158/1538-7445.am2012-5581","title":"Abstract 5581: A non-coding RNA panel is prognostically superior to standard pathologic criteria and coding transcripts in rhabdomyosarcoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Rhabdomyosarcoma; Cog; Proportional hazards model; Oncology; Microarray analysis techniques; Cohort; Medicine; Internal medicine; Pathology; Gene; Sarcoma; Biology; Gene expression; Computer science; Artificial intelligence; Genetics","score_opus":0.08338142897473394,"score_gpt":0.3971842908276759,"score_spread":0.313802861852942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334170299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900995,0.0028871049,0.0035188983,0.0012646279,0.00019046412,0.001147838,0.00013480536,0.000016215388,0.00074058154],"genre_scores_gemma":[0.99628997,0.0016007116,0.0006844515,0.0003505267,0.00030693063,0.0005271567,0.000021456632,0.00006429268,0.000154504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99666584,0.00020716175,0.00032889674,0.0006946309,0.000696258,0.0014072236],"domain_scores_gemma":[0.99863875,0.00006218032,0.00002880826,0.00043231295,0.00030387763,0.00053408166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001861401,0.00024765375,0.0003019313,0.00031845536,0.00020430818,0.0001482228,0.00038469376,0.00030071824,0.00028451532],"category_scores_gemma":[0.00043489606,0.00024401974,0.00007835953,0.00048616272,0.0002207196,0.000023421815,0.0003534752,0.00066995807,0.000023121833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067502813,0.000069827125,0.0007144604,0.00015586163,0.000029232628,0.00008206415,0.0008560798,0.000004602773,0.9850521,0.00006345881,0.0012578461,0.011039419],"study_design_scores_gemma":[0.0012362616,0.0006143253,0.008928509,0.00026309706,0.000009677431,0.000038101327,0.0004232301,0.000044741402,0.9794707,0.000058048074,0.00855513,0.00035818806],"about_ca_topic_score_codex":0.00023085513,"about_ca_topic_score_gemma":0.00013765422,"teacher_disagreement_score":0.010681231,"about_ca_system_score_codex":0.00021585714,"about_ca_system_score_gemma":0.00037033402,"threshold_uncertainty_score":0.99508363},"labels":[],"label_agreement":null},{"id":"W2334199519","doi":"10.1158/0008-5472.sabcs11-p1-06-08","title":"P1-06-08: Effect of Treatment Emergent Symptoms on Relapse Free Survival: NCIC CTG MA.12 a Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women in Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Vasomotor; Breast cancer; Tamoxifen; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Joint pain; Cancer","score_opus":0.013170594489831329,"score_gpt":0.3123101809287036,"score_spread":0.2991395864388723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334199519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990425,0.003198974,0.0000013370014,0.000055174376,0.00024218332,0.0056339605,0.00007549592,0.000008172267,0.00035972314],"genre_scores_gemma":[0.98541015,0.004210706,0.0000057014668,0.000010277853,0.00015297726,0.009179529,0.000016934424,0.000057827165,0.0009558915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955596,0.0019097643,0.00067582174,0.0005661615,0.0004903874,0.00079831056],"domain_scores_gemma":[0.99859273,0.00026342904,0.0001993893,0.00064007146,0.00010552986,0.00019882781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030702173,0.00034425742,0.0013114262,0.00029998014,0.000034608714,0.000009887116,0.00036850217,0.0003536923,0.00019391524],"category_scores_gemma":[0.000166488,0.00023782188,0.00022340455,0.0002917045,0.00029048,0.000008578536,0.000112099944,0.00035634657,0.0000040979294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8635851,0.000611687,0.0043753623,0.0000838654,0.0007024751,0.000021225987,0.0015728476,0.000057610636,0.12712042,0.000006417748,0.00006897868,0.0017939693],"study_design_scores_gemma":[0.8148304,0.012554116,0.005688669,0.0002171465,0.000067404515,0.0000017015388,0.000030818854,0.000040940995,0.16627045,0.000032409134,0.000043285923,0.00022266431],"about_ca_topic_score_codex":0.004353006,"about_ca_topic_score_gemma":0.0006706391,"teacher_disagreement_score":0.04875474,"about_ca_system_score_codex":0.0005257985,"about_ca_system_score_gemma":0.0004885507,"threshold_uncertainty_score":0.9698095},"labels":[],"label_agreement":null},{"id":"W2334224680","doi":"10.1158/0008-5472.sabcs11-p5-19-14","title":"P5-19-14: Platinum-Based Chemotherapy in Triple-Negative Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vinorelbine; Internal medicine; Triple-negative breast cancer; Oncology; Gemcitabine; Capecitabine; Regimen; Chemotherapy; Breast cancer; Metastatic breast cancer; Cancer; Retrospective cohort study; Cisplatin; Chemotherapy regimen; Surgery; Colorectal cancer","score_opus":0.16560893439651836,"score_gpt":0.4741263035522565,"score_spread":0.30851736915573813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334224680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766263,0.0017317877,0.000008300264,0.007097638,0.00037088327,0.0015402908,0.0001792697,0.00006257749,0.0123829935],"genre_scores_gemma":[0.9889985,0.0012391252,0.00013234324,0.0013794858,0.00045717155,0.001389152,0.000016286791,0.000048170554,0.006339778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795634,0.000180522,0.00024708538,0.000447802,0.00047706554,0.0006911725],"domain_scores_gemma":[0.99888146,0.00019168263,0.000055556477,0.0002787122,0.00029154445,0.00030101894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004857348,0.0001896441,0.0003739732,0.00039322028,0.00010986801,0.000012859964,0.00018678933,0.00013530093,0.018694565],"category_scores_gemma":[0.000038937287,0.0001613385,0.00008636645,0.00090375356,0.00032132876,0.00007665951,0.000036099766,0.0006497756,0.00006859569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042951684,0.0030162204,0.6097325,0.0006043202,0.0007309668,0.00077047385,0.013116759,0.00004457508,0.05669332,0.0003126623,0.15169644,0.120330065],"study_design_scores_gemma":[0.05534431,0.0018153342,0.69893324,0.0006708166,0.00012310428,0.00004390049,0.00066659844,0.00047031837,0.2139943,0.000914301,0.026416782,0.00060697156],"about_ca_topic_score_codex":0.02369532,"about_ca_topic_score_gemma":0.005720858,"teacher_disagreement_score":0.15730098,"about_ca_system_score_codex":0.0013139014,"about_ca_system_score_gemma":0.0017364504,"threshold_uncertainty_score":0.98280597},"labels":[],"label_agreement":null},{"id":"W2334238127","doi":"10.1158/1538-7445.am2011-566","title":"Abstract 566: Role of bone marrow derived cells in response to ionizing radiation in normal brain","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Pathology; Bone marrow; Glioma; In vivo; mCherry; Medicine; Cancer research; Green fluorescent protein; Biology","score_opus":0.036140975767871834,"score_gpt":0.32968252820666477,"score_spread":0.29354155243879293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334238127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944401,0.004325491,0.000009443658,0.00019854646,0.0001730658,0.00028618745,0.000025379268,0.0000028618488,0.0005389242],"genre_scores_gemma":[0.9980852,0.0009351178,0.00014208486,0.00007708715,0.0002717853,0.0001072479,0.000009846712,0.000017699243,0.00035391864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986869,0.00020268363,0.00023484018,0.00027850212,0.00021338472,0.00038368365],"domain_scores_gemma":[0.9994522,0.00003894827,0.00004281258,0.00025556874,0.000106271465,0.000104227904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014367016,0.00008625795,0.00015030321,0.00028777312,0.000031601805,0.000009940373,0.00016903083,0.00011823208,0.000113483315],"category_scores_gemma":[0.00021035025,0.0000935885,0.0000405636,0.0003268734,0.00006957532,0.000008117489,0.000097721546,0.00018977953,0.000010034972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021847347,0.000053186646,0.0014797249,0.000020583402,0.000006290948,0.0000033342458,0.0011102644,0.00007403201,0.9813427,0.000008360112,0.000987296,0.012729495],"study_design_scores_gemma":[0.0006694965,0.00009853836,0.13191631,0.000033176795,0.0000011844993,7.982959e-7,0.00027477014,0.0000063441908,0.83723813,0.00003073482,0.029639134,0.00009136188],"about_ca_topic_score_codex":0.0023258438,"about_ca_topic_score_gemma":0.00266499,"teacher_disagreement_score":0.14410454,"about_ca_system_score_codex":0.000075087235,"about_ca_system_score_gemma":0.00037241683,"threshold_uncertainty_score":0.38164282},"labels":[],"label_agreement":null},{"id":"W2334242376","doi":"10.1158/0008-5472.sabcs-2089","title":"Molecular differences in triple negative breast cancer between race/ethnicities.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Breast cancer; Significance analysis of microarrays; Cohort; RNA extraction; Gene expression; Downregulation and upregulation; Oncology; Cancer; Gene; Tissue microarray; Microarray; Biology; Fold change; Medicine; Cancer research; Molecular biology; Internal medicine; Genetics","score_opus":0.05205228374028015,"score_gpt":0.4104365190040248,"score_spread":0.35838423526374463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334242376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129164,0.0020390633,0.00078254263,0.004171141,0.000027547436,0.00052559323,0.00016540474,0.000019852487,0.0009772314],"genre_scores_gemma":[0.9957651,0.0023001502,0.00016347191,0.00037073696,0.0002011601,0.0005534411,0.00005392335,0.000016974547,0.0005750603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838233,0.00020526683,0.000204708,0.00048978283,0.00022735853,0.0004905526],"domain_scores_gemma":[0.9992512,0.000021882266,0.000047030146,0.00038044533,0.00018817517,0.00011128658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003609723,0.00015246123,0.00020801969,0.00012568448,0.000113503105,0.000027369526,0.00042018076,0.00021924735,0.000090543595],"category_scores_gemma":[0.000040885272,0.00013797879,0.00006927851,0.00041055106,0.00024391802,0.00000424798,0.00011859683,0.00036073933,0.0000050601548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010296892,0.000076073935,0.019801212,0.0000118336375,0.00004411763,0.000008262376,0.00008157948,0.000015005967,0.94821,0.00081093464,0.0037288317,0.027109195],"study_design_scores_gemma":[0.00081406336,0.00032234518,0.18842025,0.000079414436,0.00001273007,0.000005143792,0.00011331657,0.000025192985,0.8004634,0.0030616983,0.0063202986,0.00036215852],"about_ca_topic_score_codex":0.0008848706,"about_ca_topic_score_gemma":0.00022293902,"teacher_disagreement_score":0.16861904,"about_ca_system_score_codex":0.00007787486,"about_ca_system_score_gemma":0.00022352848,"threshold_uncertainty_score":0.5626612},"labels":[],"label_agreement":null},{"id":"W2334266283","doi":"10.1158/1538-7445.fbcr11-b49","title":"Abstract B49: Using ionizing radiation and primary human esophageal adenocarcinoma xenograft models to interrogate tumor cell characteristics associated with tumor-initiating cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Radioresistance; Cancer research; Adenocarcinoma; Cancer; In vivo; Metastasis; Cell culture; Radiation therapy; Medicine; Primary tumor; Ionizing radiation; Population; Pathology; Biology; Irradiation; Internal medicine","score_opus":0.1856645347332694,"score_gpt":0.35882233095031935,"score_spread":0.17315779621704994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334266283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959046,0.0011238188,0.00012110422,0.000044859706,0.00010943333,0.0007763641,0.00009150165,0.000048939986,0.0017793449],"genre_scores_gemma":[0.9979834,0.00010234726,0.0009625604,0.00029926634,0.0002622094,0.000079150275,0.000045351197,0.000082127975,0.00018356556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975738,0.00011681711,0.00040626733,0.00052278716,0.00064962346,0.0007307064],"domain_scores_gemma":[0.9985687,0.000086911816,0.00019186968,0.00029566634,0.0004172189,0.0004396053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000904152,0.00023695278,0.0004525958,0.00037355107,0.00035369844,0.0000975552,0.00015026251,0.00006717455,0.00021995968],"category_scores_gemma":[0.000036532354,0.00021768008,0.000062060346,0.00047206008,0.00014799084,0.00023535319,0.00014534545,0.0006421313,0.000009687719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015988882,0.00061320415,0.051220518,0.0016253964,0.00034461948,0.0016518363,0.017310273,0.00015064412,0.9139861,0.000055323133,0.00049556076,0.0109476205],"study_design_scores_gemma":[0.0060326103,0.0019405021,0.44878855,0.0029904898,0.00047110245,0.0000851707,0.0027826196,0.0019910603,0.5335568,0.00011650747,0.00027439205,0.00097016606],"about_ca_topic_score_codex":0.0021606067,"about_ca_topic_score_gemma":0.0001258784,"teacher_disagreement_score":0.39756802,"about_ca_system_score_codex":0.0007682628,"about_ca_system_score_gemma":0.0005039817,"threshold_uncertainty_score":0.88767356},"labels":[],"label_agreement":null},{"id":"W2334272293","doi":"10.1158/1538-7445.am2011-623","title":"Abstract 623: CLU inhibition using OGX-011 is a new adjuvant therapeutic strategy for HSP90 inhibition in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clusterin; LNCaP; Cancer research; Prostate cancer; Hsp90 inhibitor; Apoptosis; Cell growth; Biology; In vivo; Hsp90; Cancer; Heat shock protein; Medicine; Internal medicine; Biochemistry","score_opus":0.3489976194467707,"score_gpt":0.4827314625150633,"score_spread":0.1337338430682926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334272293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158084,0.0038726712,0.00012242203,0.0010235871,0.00017991265,0.00227125,0.00016988756,0.000044392025,0.00073501735],"genre_scores_gemma":[0.9962995,0.0008362808,0.0002151147,0.0005491956,0.0003743311,0.0009728433,0.00004458698,0.00007250986,0.0006356325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757445,0.000113369584,0.0004319031,0.0005783441,0.00048753605,0.0008143747],"domain_scores_gemma":[0.9987536,0.00008049213,0.00010042977,0.00035987768,0.00041310472,0.00029251783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069365953,0.0002085592,0.00034898144,0.00036914487,0.000121768404,0.00003501499,0.00008112654,0.00016514887,0.002536907],"category_scores_gemma":[0.000064034415,0.00019627775,0.000097906785,0.0005230904,0.00023594558,0.000201505,0.00008860517,0.00056688517,0.00003500579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010189987,0.00080950366,0.023813669,0.002271251,0.00015714692,0.00090353563,0.011362302,0.0002650711,0.82949483,0.00027658333,0.0068188547,0.11363728],"study_design_scores_gemma":[0.020613613,0.002306069,0.4145237,0.0058619734,0.00028232118,0.00022161867,0.0033698627,0.0027451534,0.5252684,0.019763837,0.0038583977,0.0011851111],"about_ca_topic_score_codex":0.007517961,"about_ca_topic_score_gemma":0.0020081068,"teacher_disagreement_score":0.39071003,"about_ca_system_score_codex":0.00089695153,"about_ca_system_score_gemma":0.0017163021,"threshold_uncertainty_score":0.9990911},"labels":[],"label_agreement":null},{"id":"W2334358529","doi":"10.1158/1538-7445.am10-5452","title":"Abstract 5452: Cancer-associated metabolite 2-hydroxyglutarate accumulates in AML with IDH1/2 mutations","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"IDH1; Isocitrate dehydrogenase; IDH2; Metabolite; Mutant; Chemistry; Glioma; Cancer research; Carcinogenesis; Leukemia; Wild type; Mutation; Enzyme; Molecular biology; Biology; Biochemistry; Genetics; Gene","score_opus":0.03985265360046397,"score_gpt":0.3860882106559195,"score_spread":0.3462355570554555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334358529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901866,0.006823617,0.000005639052,0.0004787998,0.0007805538,0.0004494298,0.00023600567,0.000022011038,0.0010173521],"genre_scores_gemma":[0.9917012,0.0043032644,0.000062711224,0.00012897249,0.0012821043,0.0005681986,0.00016237253,0.000057398942,0.001733813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977412,0.00011134028,0.00027580024,0.00059463765,0.0004566042,0.0008203775],"domain_scores_gemma":[0.9986546,0.00005079142,0.00011904576,0.00047884005,0.00047369755,0.00022299154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074193353,0.00022388676,0.00028581155,0.00022372331,0.00020117898,0.00009258362,0.00039841273,0.00025312483,0.00041851721],"category_scores_gemma":[0.00023357147,0.00019745968,0.000080482656,0.0006770175,0.00032425747,0.0000205349,0.00011261397,0.0008172114,0.000028387627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017802986,0.00009994947,0.0060004666,0.00002468938,0.00010166479,0.0000051752418,0.00020371778,0.00078861,0.98535615,0.00006827189,0.0016404012,0.005532899],"study_design_scores_gemma":[0.0021843987,0.00011129514,0.11283646,0.00006553854,0.00003852531,0.000005182632,0.00015016686,0.00009196997,0.6740321,0.00021955099,0.20980534,0.0004595017],"about_ca_topic_score_codex":0.006090299,"about_ca_topic_score_gemma":0.030497119,"teacher_disagreement_score":0.31132406,"about_ca_system_score_codex":0.00007584056,"about_ca_system_score_gemma":0.0010196037,"threshold_uncertainty_score":0.98719376},"labels":[],"label_agreement":null},{"id":"W2334376408","doi":"10.1158/0008-5472.sabcs11-p1-01-09","title":"P1-01-09: A Focused Immune Response Targeting the Homotypic Binding Domain of the Carcinoembryonic Antigen Blocks the Establishment of Tumor Foci In Vivo.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Carcinoembryonic antigen; Metastasis; ELISPOT; Cancer research; Immune system; Antigen; Cancer; Medicine; Immunology; T cell; Internal medicine","score_opus":0.06880871459884243,"score_gpt":0.35403032836106185,"score_spread":0.28522161376221944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334376408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854913,0.0056698355,0.0000021294252,0.005280248,0.00012850671,0.0013852095,0.00005726436,0.0000087370845,0.0019767997],"genre_scores_gemma":[0.99561334,0.000662326,0.00008124968,0.00006281003,0.00012143362,0.00020432439,0.0000020439652,0.00003274921,0.0032197174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950381,0.0015257058,0.00061876024,0.00035014047,0.0015600757,0.0009072475],"domain_scores_gemma":[0.9971593,0.0012712894,0.00017410405,0.00088655745,0.00038415904,0.00012456901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0076839672,0.0001914083,0.0004348309,0.00032385098,0.00046644674,0.000026605589,0.0011440368,0.000083012,0.0009462424],"category_scores_gemma":[0.0007548947,0.00008929681,0.00023171752,0.0015961836,0.0012897612,0.00006312338,0.0007354894,0.0012422616,0.000010000356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009998137,0.00029513636,0.13021933,0.00033842918,0.00018108475,0.00008664048,0.013059942,0.000010326727,0.839789,0.00054891524,0.003488333,0.0019847425],"study_design_scores_gemma":[0.001769828,0.00056496146,0.38312793,0.0007698709,0.000028757493,0.000023817578,0.0059906514,0.00008912444,0.59546226,0.0005468249,0.011467615,0.00015835343],"about_ca_topic_score_codex":0.010951376,"about_ca_topic_score_gemma":0.0005555817,"teacher_disagreement_score":0.2529086,"about_ca_system_score_codex":0.0002645773,"about_ca_system_score_gemma":0.0011879081,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W2334400532","doi":"10.1158/1538-7445.am2012-1444","title":"Abstract 1444: Stathmin suppression influences ROCK signaling and reduces cell invasion and metastasis in neuroblastoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Stathmin; Cofilin; Neuroblastoma; Biology; ROCK2; Metastasis; Cancer research; Transfection; Cell migration; Small hairpin RNA; Cell biology; Kinase; Cytoskeleton; Molecular biology; Microtubule; Actin cytoskeleton; Cell; Cancer; Cell culture; Rho-associated protein kinase; Gene knockdown","score_opus":0.09930939092711356,"score_gpt":0.4134523697647558,"score_spread":0.31414297883764225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334400532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937558,0.0047594486,7.728213e-7,0.000491704,0.00004518589,0.00051995396,0.000018424547,0.00001879664,0.00038987823],"genre_scores_gemma":[0.9968973,0.0024951594,0.0000925683,0.0000470919,0.000090051326,0.0001106043,0.000005829284,0.000026956905,0.00023443237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976171,0.00022086679,0.0002233206,0.00038929444,0.00075025763,0.00079913554],"domain_scores_gemma":[0.9986815,0.00039898042,0.000041763215,0.00018845477,0.00011906503,0.0005702551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007637467,0.00016154049,0.00025243717,0.00046426023,0.00017669343,0.000071002265,0.00009465901,0.00007096853,0.00020349014],"category_scores_gemma":[0.00018774501,0.00012284928,0.000028482546,0.0004182006,0.00015170607,0.00039743236,0.00021278558,0.00060120784,0.000027285865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007227957,0.00028932607,0.041997924,0.00032975132,0.000024876284,0.00020439482,0.00067044166,0.0000129707605,0.9413687,0.0000050787994,0.00051379297,0.013859959],"study_design_scores_gemma":[0.0016654137,0.0005337063,0.19680266,0.0003806572,0.000016829545,0.00003720268,0.0004802541,0.0000324931,0.79913133,0.00004684335,0.0007574688,0.00011511606],"about_ca_topic_score_codex":0.00047948092,"about_ca_topic_score_gemma":0.00003835214,"teacher_disagreement_score":0.15480474,"about_ca_system_score_codex":0.000098197816,"about_ca_system_score_gemma":0.00018387925,"threshold_uncertainty_score":0.5009648},"labels":[],"label_agreement":null},{"id":"W2334434334","doi":"10.1158/1538-7445.am2013-5515","title":"Abstract 5515: <i>In vivo</i> efficacy of the PARG inhibitor Gallotannin against triple negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Cancer; Breast cancer; Cell growth; Cyclin D1; In vivo; Cell cycle checkpoint; Cancer cell; Biology; Cell cycle; Medicine; Internal medicine; Oncology; Chemistry; Biochemistry; Genetics","score_opus":0.059339270538116884,"score_gpt":0.4147771849554307,"score_spread":0.3554379144173138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334434334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98149055,0.0017037849,1.1264769e-7,0.008427714,0.00044451054,0.001869963,0.00016866965,0.000019292944,0.0058754073],"genre_scores_gemma":[0.9917183,0.0014556213,0.000008022762,0.00044518244,0.00060009625,0.0010521113,0.0000041873172,0.000033037642,0.004683441],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99792314,0.00015947115,0.00034117603,0.00035728342,0.0006065446,0.0006124177],"domain_scores_gemma":[0.9986194,0.00032469223,0.000097092496,0.00034291513,0.00041639208,0.00019953916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003633072,0.00017472844,0.00037269318,0.00017035066,0.00011850011,0.000021471078,0.0002619847,0.00011086614,0.006303783],"category_scores_gemma":[0.00007134492,0.00011713717,0.00013284896,0.000884555,0.00042635863,0.00010890024,0.000111859845,0.000681835,0.000054291642],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001916302,0.0009525237,0.08600299,0.00024982146,0.00022280515,0.000035875662,0.0014085984,0.000081490274,0.6551069,0.00002650474,0.23227972,0.02171649],"study_design_scores_gemma":[0.009082481,0.00020044463,0.69125223,0.00065704994,0.000045731464,0.000006461529,0.0003148701,0.000047954458,0.28790513,0.00006307086,0.010256226,0.00016836324],"about_ca_topic_score_codex":0.01597976,"about_ca_topic_score_gemma":0.0020817323,"teacher_disagreement_score":0.6052492,"about_ca_system_score_codex":0.00078118633,"about_ca_system_score_gemma":0.0010638062,"threshold_uncertainty_score":0.9946046},"labels":[],"label_agreement":null},{"id":"W2334495433","doi":"10.1158/0008-5472.sabcs-09-4078","title":"High Frequency of BRCA1 Founder Mutations in the Bahamas.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Founder effect; Breast cancer; Ovarian cancer; Mutation; Population; Genetics; Family history; Cancer; Demography; Medicine; Biology; Internal medicine; Genotype; Haplotype; Gene","score_opus":0.06036859716792139,"score_gpt":0.40929091534993434,"score_spread":0.34892231818201297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334495433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894965,0.0020357035,0.00019487362,0.004218925,0.000095212206,0.0002757073,0.000023274506,0.0000034560944,0.003656301],"genre_scores_gemma":[0.9981782,0.00028518465,0.00045605548,0.00035312155,0.0002012179,0.00014102252,0.00003595956,0.000008783622,0.0003404578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998893,0.00016877262,0.00016319833,0.0002209051,0.00030707484,0.00024703037],"domain_scores_gemma":[0.9992639,0.00004434381,0.000030774154,0.00039442643,0.0002383814,0.000028182516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005943059,0.00006623432,0.00007646239,0.00009841779,0.000083909494,0.000020497682,0.00036817478,0.00007858621,0.00013152587],"category_scores_gemma":[0.00011977278,0.000052976553,0.00003671966,0.00045883135,0.00018352129,0.0000042783972,0.00003186666,0.0001903422,0.0000079234305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004619796,0.00014024728,0.0030514323,0.000022822478,0.00003785214,0.0000070213737,0.0012274443,0.0015571724,0.9595803,0.007146698,0.012253728,0.014929094],"study_design_scores_gemma":[0.002099752,0.00074529904,0.17660077,0.00008675281,0.000024236637,0.000019910665,0.0026078715,0.000056939032,0.7451248,0.043693505,0.02850001,0.00044011246],"about_ca_topic_score_codex":0.00047966468,"about_ca_topic_score_gemma":0.0007182846,"teacher_disagreement_score":0.21445546,"about_ca_system_score_codex":0.00011962761,"about_ca_system_score_gemma":0.00054056646,"threshold_uncertainty_score":0.2160321},"labels":[],"label_agreement":null},{"id":"W2334501021","doi":"10.1158/1538-7445.am2013-2989","title":"Abstract 2989: Loss of methylation in a regulatory region of BCL2 in MDS/AML.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelodysplastic syndromes; DNA methylation; Myeloid leukemia; Bone marrow; Cancer research; Methylation; Biology; International Prognostic Scoring System; Leukemia; Azacitidine; Oncology; Internal medicine; Medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.08747754957051372,"score_gpt":0.4177919529338563,"score_spread":0.33031440336334256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334501021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248034,0.0010625905,0.000007782741,0.00200416,0.0000311296,0.0010982531,0.0000039341185,0.000009119848,0.0033027176],"genre_scores_gemma":[0.9976254,0.0007934158,0.000100902245,0.000024567287,0.00008545674,0.0002442304,0.000008032724,0.000028989873,0.0010890086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972654,0.00024595586,0.0005326802,0.00032605638,0.0010855049,0.0005444011],"domain_scores_gemma":[0.9980718,0.000379825,0.00009682461,0.00055431935,0.000746703,0.00015053403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020951144,0.00010922979,0.0004035008,0.001164111,0.000023004843,0.000008935569,0.0002532773,0.00019344392,0.0006602432],"category_scores_gemma":[0.0006410984,0.00009776925,0.0000614782,0.0014689704,0.00043921944,0.00019494588,0.00012554218,0.0009608185,0.000045868313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014275651,0.0004360116,0.32759255,0.0019546768,0.000066671164,0.00024083312,0.002265053,0.00017732881,0.5949247,0.0006590553,0.0106471535,0.05960841],"study_design_scores_gemma":[0.002563733,0.00020095194,0.82624346,0.00082896405,0.0000043683553,0.000008661253,0.0005441376,0.00035690493,0.16759332,0.0009568975,0.00060245773,0.000096152144],"about_ca_topic_score_codex":0.01613294,"about_ca_topic_score_gemma":0.0006155645,"teacher_disagreement_score":0.4986509,"about_ca_system_score_codex":0.0012375718,"about_ca_system_score_gemma":0.0012774448,"threshold_uncertainty_score":0.99041873},"labels":[],"label_agreement":null},{"id":"W2334518515","doi":"10.1158/1538-7445.am2013-3163","title":"Abstract 3163: ZMAT3, a signature gene for sporadic osteosarcoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Copy-number variation; Osteosarcoma; Genotyping; Biology; Genetics; SNP array; Cancer; Copy number analysis; Malignancy; Candidate gene; Genotype; Gene; Genome; Single-nucleotide polymorphism; Cancer research","score_opus":0.05946497809437931,"score_gpt":0.37528748004417756,"score_spread":0.3158225019497982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334518515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693593,0.024706488,0.00002497757,0.0020420845,0.0006870715,0.0011284165,0.00009155853,0.00006360602,0.0018965327],"genre_scores_gemma":[0.9695463,0.0003461506,0.000048052974,0.00020792893,0.00011147616,0.00083316443,0.000083549654,0.00003370297,0.028789673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983672,0.00018461919,0.0002291247,0.0003306441,0.0000797493,0.000808657],"domain_scores_gemma":[0.99872595,0.00039945892,0.000046432873,0.00036612063,0.00041627017,0.000045786324],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005704929,0.00015431672,0.00023466362,0.00022734172,0.00031428842,0.00005664666,0.0004555926,0.00030976383,0.00942615],"category_scores_gemma":[0.0001603957,0.000123951,0.000117658106,0.00018677433,0.00034480327,0.00012853133,0.00010554519,0.0007454539,0.003077763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048104094,0.000058349386,0.000068582114,0.00004367709,0.00008737953,0.0000034277205,0.00020199858,7.3418795e-7,0.85327905,0.00028659872,0.13271834,0.012770802],"study_design_scores_gemma":[0.0010949379,0.00026604722,0.0046535293,0.00005938165,0.0000065199497,0.000018947429,0.00029137777,0.0000018421522,0.7309007,0.00036730818,0.26218712,0.00015227418],"about_ca_topic_score_codex":0.00090093695,"about_ca_topic_score_gemma":0.000036694964,"teacher_disagreement_score":0.1294688,"about_ca_system_score_codex":0.00013317156,"about_ca_system_score_gemma":0.00026701269,"threshold_uncertainty_score":0.9976985},"labels":[],"label_agreement":null},{"id":"W2334529426","doi":"10.1158/0008-5472.sabcs-2072","title":"Prognosis in BRCA1, BRCA2 associated breast cancer (BC): a prospective Breast Cancer Family Registry (BCFR) international population-based cohort study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Population; Cohort; Cancer registry; Cancer; Family history; Gynecology; Proportional hazards model; Univariate analysis; Multivariate analysis","score_opus":0.026749296295449126,"score_gpt":0.3800485041168038,"score_spread":0.35329920782135465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334529426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886466,0.0009672583,0.00001645081,0.0054891375,0.0005008152,0.0020245311,0.0013350805,0.00004488739,0.0007572009],"genre_scores_gemma":[0.9927558,0.0005523391,0.000049148497,0.00040768163,0.0007633389,0.0039655715,0.0003438252,0.00006456939,0.0010977351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959991,0.00033131172,0.00050586753,0.0012013075,0.0011776089,0.00078480697],"domain_scores_gemma":[0.9975362,0.000045204382,0.00020154711,0.0005619016,0.0014809571,0.00017422647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009769591,0.0003320062,0.00035575687,0.0003434614,0.00026187836,0.0001517794,0.0007430465,0.00029967917,0.00039647988],"category_scores_gemma":[0.0001434312,0.0003438366,0.000119972916,0.0011287403,0.00017747498,0.000031035226,0.00014877401,0.0006331592,0.0000088978395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005391043,0.00071107276,0.9652663,0.000018154862,0.0003079789,0.00001672278,0.00017661114,0.0028451364,0.015794173,0.000013703255,0.007832266,0.006478802],"study_design_scores_gemma":[0.002040926,0.00016452727,0.99282235,0.00017735134,0.000036300855,0.000007290455,0.00028073072,0.00030607436,0.0031449122,0.00008640576,0.0005482387,0.0003849065],"about_ca_topic_score_codex":0.030797787,"about_ca_topic_score_gemma":0.020101102,"teacher_disagreement_score":0.027556062,"about_ca_system_score_codex":0.0039922665,"about_ca_system_score_gemma":0.0022699127,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W2334537782","doi":"10.1158/0008-5472.sabcs11-p4-11-08","title":"P4-11-08: Changes in the Distribution of Loco-Regional and Distant Breast Cancer Recurrences over the Last 20 Years: Implications for Patient Care and Future Research.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Randomized controlled trial; Cancer; Clinical trial; Axillary lymph nodes; Surgery; Internal medicine","score_opus":0.07523518069478691,"score_gpt":0.38928901987269,"score_spread":0.3140538391779031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334537782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672655,0.023134254,0.0000032379362,0.006136681,0.00005062314,0.0006917234,0.0026781515,0.0000019280276,0.000037903617],"genre_scores_gemma":[0.9844046,0.013335152,0.000008527621,0.00004497507,0.00028632217,0.001751067,0.00015484607,0.000008413677,0.000006061637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893236,0.00016722099,0.000098005075,0.00028376034,0.00022984519,0.00028883462],"domain_scores_gemma":[0.999204,0.000081625956,0.000037221133,0.00023685666,0.000399428,0.000040892824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035468597,0.000086834836,0.0000929034,0.000038942322,0.0002493805,0.000021596334,0.00018848841,0.00006080498,0.000011508327],"category_scores_gemma":[0.000020328238,0.00005207972,0.000024205385,0.0002260096,0.00067633827,0.0000056200574,0.00015380005,0.00013598976,1.8643374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017793406,0.00038983236,0.5009337,0.00044341126,0.0003354011,0.0000029766286,0.03155912,0.0000037438085,0.012612828,0.005339725,0.055697862,0.39090204],"study_design_scores_gemma":[0.000500668,0.0002816597,0.89720005,0.00007111509,0.000015715634,0.0000056002605,0.007776398,0.0000012610673,0.0023102725,0.00031937368,0.09143134,0.000086557135],"about_ca_topic_score_codex":0.002386129,"about_ca_topic_score_gemma":0.020212725,"teacher_disagreement_score":0.3962663,"about_ca_system_score_codex":0.00007754511,"about_ca_system_score_gemma":0.00015490681,"threshold_uncertainty_score":0.9976658},"labels":[],"label_agreement":null},{"id":"W2334552479","doi":"10.1158/0008-5472.sabcs10-p4-09-17","title":"Abstract P4-09-17: Case-Matching Study Comparing Outcome of Unilateral and Synchronous Bilateral Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cohort; Lymphovascular invasion; Internal medicine; Retrospective cohort study; Oncology; Cancer; Lymph node; Metastasis","score_opus":0.053037435986509694,"score_gpt":0.40277024799267624,"score_spread":0.34973281200616657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334552479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800533,0.00067992485,0.0000025336813,0.0002715281,0.00023933702,0.0004037476,0.00014251433,0.00001365887,0.0002414288],"genre_scores_gemma":[0.99907076,0.00012304449,0.00003950963,0.000024473347,0.00036226443,0.00019351223,0.000011976923,0.000035446028,0.00013898767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833935,0.00006932112,0.00029886342,0.00050251617,0.0002922935,0.0004976526],"domain_scores_gemma":[0.99908996,0.000039309332,0.000081094,0.0004008859,0.0002514051,0.00013733674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041550785,0.00021444785,0.00032425788,0.000107117616,0.00027801708,0.000054316257,0.00021368104,0.00010433135,0.00013286041],"category_scores_gemma":[0.000014618964,0.00018116474,0.00005767123,0.00014456808,0.00030747353,0.000013266792,0.0003811874,0.00043721872,0.0000028453248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023198429,0.00018959983,0.81367594,0.000083710096,0.00025298676,0.00014439179,0.00075439713,0.00008449059,0.18059017,0.000008875622,0.00014877143,0.003834667],"study_design_scores_gemma":[0.0015903875,0.00013200523,0.9817505,0.000055793596,0.00004314757,0.00036656286,0.0006905705,0.00001477856,0.014803438,0.00002429147,0.00028012492,0.00024841478],"about_ca_topic_score_codex":0.02615577,"about_ca_topic_score_gemma":0.027753882,"teacher_disagreement_score":0.16807452,"about_ca_system_score_codex":0.000081588485,"about_ca_system_score_gemma":0.00014032521,"threshold_uncertainty_score":0.9899871},"labels":[],"label_agreement":null},{"id":"W2334571725","doi":"10.1158/1538-7445.am2012-4235","title":"Abstract 4235: Functional assessment of mouse tumor microenvironment following sunitinib treatment using an integrated micro-ultrasound and photoacoustic system","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; FujiFilm VisualSonics (Canada); Health Sciences Centre; Illumisonics (Canada)","funders":"","keywords":"Medicine; Sunitinib; Ultrasound; Microbubbles; Perfusion; Photoacoustic imaging in biomedicine; Nuclear medicine; Blood volume; Oxygen saturation; Urology; Biomedical engineering; Cancer; Pathology; Radiology; Internal medicine; Chemistry; Oxygen","score_opus":0.06719274181476696,"score_gpt":0.34439964202801343,"score_spread":0.27720690021324645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334571725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935717,0.0014622892,0.0036959203,0.000002905252,0.00032628034,0.00041304037,0.00019169638,0.000079360005,0.00025682684],"genre_scores_gemma":[0.9979964,0.00015679735,0.0014012681,0.0000066320954,0.00014196968,0.00011542019,0.000043888995,0.00006243384,0.000075202224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982143,0.000086480584,0.00030660324,0.0002494379,0.00042701024,0.00071615004],"domain_scores_gemma":[0.9991362,0.00024763367,0.00004491026,0.0002526937,0.000062004605,0.00025654567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006622152,0.00023138386,0.00029552387,0.00019569759,0.00019726183,0.000062384,0.00011452671,0.000059913255,0.00015246109],"category_scores_gemma":[0.00002033739,0.00021085143,0.00006859828,0.00019393554,0.00012877694,0.00026284138,0.000030022427,0.00032959683,0.000003979417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001795937,0.00014156105,0.0073770843,0.0002682251,0.00015441838,0.0000127777685,0.00033318912,0.013640621,0.9775746,0.000009595339,0.000046783265,0.0004231853],"study_design_scores_gemma":[0.0029359886,0.00022472873,0.07297462,0.0009897471,0.00032586115,0.00022563656,0.016649798,0.073873445,0.8297125,0.00000515094,0.001179073,0.00090341695],"about_ca_topic_score_codex":0.00097162795,"about_ca_topic_score_gemma":0.000019078023,"teacher_disagreement_score":0.14786208,"about_ca_system_score_codex":0.0019745652,"about_ca_system_score_gemma":0.00018747052,"threshold_uncertainty_score":0.85982716},"labels":[],"label_agreement":null},{"id":"W2334630106","doi":"10.1158/0008-5472.sabcs10-p1-10-09","title":"Abstract P1-10-09: Access to HER2 Testing in Early Stage Breast Cancer (ESBC) in a Single Payor, Public Healthcare System — Ontario (ON), Canada","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cohort; Cancer registry; Stage (stratigraphy); Cancer; Population; Odds ratio; Retrospective cohort study; Reimbursement; Internal medicine; Health care; Environmental health","score_opus":0.1089550689407006,"score_gpt":0.3825424676874781,"score_spread":0.2735873987467775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334630106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908169,0.0004106388,4.5750758e-7,0.005876436,0.0003556509,0.00067238405,0.00047670119,0.000015865133,0.0013750029],"genre_scores_gemma":[0.9972057,0.000030163426,0.000023373721,0.00029071237,0.00034151197,0.0011926633,0.000030479803,0.00005138796,0.00083403883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969797,0.0001181167,0.00035003765,0.00081172475,0.0006287176,0.0011116876],"domain_scores_gemma":[0.9984241,0.00008995116,0.00008199878,0.0005605678,0.00049224397,0.0003511029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005152773,0.00027349376,0.0003174509,0.00023336995,0.00020868656,0.0001653589,0.0006164425,0.00016543308,0.00017972424],"category_scores_gemma":[0.00013630533,0.0002578236,0.00003932354,0.00074574247,0.00009968281,0.000023874658,0.00036970517,0.0007826148,0.000008828514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046124263,0.00017298784,0.9575568,0.00024563342,0.00006847373,0.00013174582,0.00042317653,0.00016854896,0.025040945,0.00002742019,0.0032670614,0.012435951],"study_design_scores_gemma":[0.00085577817,0.000117310265,0.9757583,0.00034221163,0.0000033779431,0.000008270573,0.00031964324,0.000003067989,0.008328461,0.0000029252374,0.013973511,0.00028714625],"about_ca_topic_score_codex":0.9932651,"about_ca_topic_score_gemma":0.99970293,"teacher_disagreement_score":0.018201483,"about_ca_system_score_codex":0.0034136712,"about_ca_system_score_gemma":0.0061262096,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W2334648771","doi":"10.1158/1538-7445.am10-3985","title":"Abstract 3985: New quantification tools for perfusion and VEGFR2 Expression in tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Microbubbles; Perfusion; Contrast-enhanced ultrasound; Ultrasound; Biomedical engineering; Medicine; In vivo; Receptor expression; Contrast (vision); Pathology; Nuclear medicine; Radiology; Receptor; Computer science; Biology; Internal medicine","score_opus":0.08810608128866101,"score_gpt":0.37622413415067435,"score_spread":0.2881180528620133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334648771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997715,0.00037025532,0.0004307339,0.000306336,0.00007635201,0.00037587824,0.000013261882,0.000045202123,0.0006670089],"genre_scores_gemma":[0.99837595,0.00032499566,0.00055843487,0.0000062317613,0.00017475324,0.00032639483,0.000015275713,0.000020245227,0.00019774152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939996,0.0000072012645,0.000107914035,0.00015509743,0.00012546623,0.00020436983],"domain_scores_gemma":[0.9994762,0.00021236057,0.000008834073,0.00017283179,0.00004857031,0.00008120567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026462274,0.00005815797,0.00007006949,0.0000957027,0.00009492314,0.00008263828,0.0001110953,0.000068324174,0.00013932251],"category_scores_gemma":[0.00008116227,0.00005390935,0.000014201334,0.00014502794,0.000037367638,0.00014616882,0.000014332367,0.00031053525,0.000016731798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008925089,0.000009685205,0.0003647764,0.00003809305,9.130317e-7,1.8479506e-7,0.00024407197,0.00013067004,0.94423026,0.00034583753,0.0012797661,0.053346816],"study_design_scores_gemma":[0.0008564134,0.000029810479,0.12936975,0.00019149008,0.0000034896611,0.0000028758575,0.00040016195,0.003328975,0.71830887,0.0021551747,0.14506681,0.00028617156],"about_ca_topic_score_codex":0.00013805433,"about_ca_topic_score_gemma":0.000411853,"teacher_disagreement_score":0.22592138,"about_ca_system_score_codex":0.00003434949,"about_ca_system_score_gemma":0.00006154308,"threshold_uncertainty_score":0.21983594},"labels":[],"label_agreement":null},{"id":"W2334682430","doi":"10.1158/1538-7445.am2011-926","title":"Abstract 926: Whole genome and transcriptome sequencing defines the spectrum of somatic changes in high-risk neuroblastoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Indel; Genome; DNA sequencing; Computational biology; Genetics; Transcriptome; Cancer genome sequencing; Reference genome; Somatic cell; Whole genome sequencing; Shotgun sequencing; Germline; Deep sequencing; Gene; Single-nucleotide polymorphism; Gene expression","score_opus":0.09756184651413846,"score_gpt":0.3426425791228778,"score_spread":0.24508073260873936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334682430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957412,0.0010584242,0.0000017049725,0.0017074691,0.000040272847,0.00073550316,0.000058803493,0.000020528407,0.0006361227],"genre_scores_gemma":[0.99779963,0.0015915628,0.000044553493,0.000049665527,0.000066997294,0.00016758003,0.000003970696,0.000033619275,0.00024241845],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980067,0.00018314854,0.00022477629,0.0003290911,0.00061518844,0.0006410786],"domain_scores_gemma":[0.99906456,0.00019580922,0.000055808297,0.00038108166,0.000102865015,0.00019989375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062205264,0.00014857415,0.0002908341,0.00042631413,0.00012676774,0.000022291419,0.00020171111,0.000054835607,0.00030434644],"category_scores_gemma":[0.000110172965,0.000098124896,0.000045288198,0.0005777857,0.0003891702,0.000085515916,0.00008110175,0.00061104377,0.0000326205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011249186,0.0003173665,0.061934784,0.00077360444,0.00016132997,0.00075774465,0.003918755,0.0000068366426,0.9243247,0.00017189395,0.0000818021,0.006426292],"study_design_scores_gemma":[0.0020589114,0.0012826542,0.8822237,0.00030779492,0.0000320598,0.00005007111,0.0005212681,0.00003287121,0.11226041,0.0009887518,0.00013796709,0.00010351931],"about_ca_topic_score_codex":0.0058584996,"about_ca_topic_score_gemma":0.0035270567,"teacher_disagreement_score":0.82028896,"about_ca_system_score_codex":0.00016506585,"about_ca_system_score_gemma":0.00026250203,"threshold_uncertainty_score":0.88563377},"labels":[],"label_agreement":null},{"id":"W2334715558","doi":"10.1158/0008-5472.sabcs11-p5-20-04","title":"P5-20-04: Is Primary Prophylaxis with G-CSF Indicated for Adjuvant TC or FEC-D Chemotherapy? A Systematic Review and Meta-Analyses.","year":2011,"lang":"en","type":"review","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Epirubicin; Docetaxel; Febrile neutropenia; Internal medicine; Cyclophosphamide; Neutropenia; Clinical trial; Odds ratio; Meta-analysis; Adjuvant; Chemotherapy; Oncology; Gastroenterology; Surgery","score_opus":0.4746517407575063,"score_gpt":0.5364379344937045,"score_spread":0.06178619373619815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334715558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034440548,0.9765824,0.000023514825,0.000696103,0.000043534263,0.021432156,0.0003929413,0.000060291797,0.0007656121],"genre_scores_gemma":[0.0000074708055,0.94229347,0.00013424184,0.0014252657,0.00014874936,0.03473466,0.000112316404,0.0002010698,0.020942736],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952557,0.0006878954,0.0011997424,0.0011323303,0.0009324553,0.00079185603],"domain_scores_gemma":[0.99599075,0.00039402832,0.00064450887,0.0014441985,0.00108182,0.00044466992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018871586,0.00073424407,0.008402627,0.0006489568,0.00027586112,0.00009623928,0.00050101,0.00034200036,0.0029831072],"category_scores_gemma":[0.0002227372,0.00034928854,0.001067383,0.0020253337,0.00038052892,0.00011908558,0.00013646875,0.001302781,0.00008567385],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017713981,0.000119734825,0.0000016989352,0.93895173,0.017319985,0.00003304638,0.00007976938,8.543706e-9,0.0000070032143,0.000010751034,0.012913396,0.030385707],"study_design_scores_gemma":[0.0008304429,0.0012848245,0.0000018035141,0.18897945,0.14074337,0.00028412556,0.000012769732,1.3564018e-7,0.000035600493,0.000009120788,0.6674308,0.00038750932],"about_ca_topic_score_codex":0.00025903923,"about_ca_topic_score_gemma":0.00008036978,"teacher_disagreement_score":0.7499723,"about_ca_system_score_codex":0.0008522532,"about_ca_system_score_gemma":0.0038941507,"threshold_uncertainty_score":0.99989593},"labels":[],"label_agreement":null},{"id":"W2334751259","doi":"10.1158/1538-7445.am2012-2930","title":"Abstract 2930: Novel colorectal cancer loci in multiplex-proficient mismatch repair families","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Memorial University of Newfoundland","funders":"","keywords":"Microsatellite instability; Genetic linkage; Genetics; Colorectal cancer; Medicine; Single-nucleotide polymorphism; Cancer; Family history; Linkage (software); Microsatellite; Oncology; Biology; Internal medicine; Genotype; Gene; Allele","score_opus":0.12238120398074033,"score_gpt":0.42732146708830626,"score_spread":0.30494026310756595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334751259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842148,0.007933181,0.000007327732,0.0009593126,0.001028564,0.0015227646,0.00009079656,0.00012662925,0.0041166474],"genre_scores_gemma":[0.99426895,0.0012155183,0.00042697374,0.00022305839,0.00082744675,0.0016577475,0.000019008834,0.00008373019,0.0012775562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561465,0.00010136864,0.0004995178,0.0006417545,0.0014793217,0.0016633753],"domain_scores_gemma":[0.9980394,0.0003218644,0.00007794294,0.0005102446,0.0005309343,0.00051956286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016015186,0.00030277064,0.00049327855,0.0004834584,0.00017610478,0.0000339486,0.00031115438,0.00028624604,0.0023160302],"category_scores_gemma":[0.00047585473,0.0002667007,0.0001685726,0.0011735446,0.0005287495,0.00014530259,0.00024492986,0.0012578149,0.00014387399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010222137,0.00056129793,0.4996784,0.00044158965,0.000089777706,0.000024272618,0.0033188395,0.0002441509,0.4791001,0.000037336653,0.010033203,0.0054488205],"study_design_scores_gemma":[0.0021741032,0.00023370792,0.77109855,0.00034210915,0.000023875793,0.00001474468,0.0016638826,0.00032981645,0.20222037,0.000012129768,0.021563556,0.00032313977],"about_ca_topic_score_codex":0.011869031,"about_ca_topic_score_gemma":0.00394855,"teacher_disagreement_score":0.27687973,"about_ca_system_score_codex":0.0023509588,"about_ca_system_score_gemma":0.0011559284,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W2334770269","doi":"10.1158/1538-7445.am2011-3475","title":"Abstract 3475: Tumor stage dependent contribution of bone marrow derived cells to tumor neo-vascularization","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; University of Toronto","funders":"","keywords":"Pathology; Bone marrow; In vivo; Neovascularization; Cancer research; Medicine; Angiogenesis; Glioma; Immunohistochemistry; Biology","score_opus":0.037118523892719156,"score_gpt":0.32301322923455306,"score_spread":0.2858947053418339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334770269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933254,0.0034896194,0.001146238,0.000050185987,0.0005815728,0.00065396936,0.00015647519,0.00001083544,0.00058570947],"genre_scores_gemma":[0.9967987,0.000919097,0.00022905308,0.00012692847,0.0006064128,0.00018676452,0.00007244337,0.000031644147,0.0010289797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981962,0.00011741121,0.00029342427,0.00043228507,0.000463017,0.0004976569],"domain_scores_gemma":[0.9985569,0.000012916115,0.00010065915,0.00045257938,0.0006586146,0.00021830958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007812062,0.00014525697,0.00023463432,0.00013359399,0.00010023375,0.00002362539,0.00024564014,0.00009581447,0.00041561332],"category_scores_gemma":[0.00016072391,0.00014501516,0.000104867155,0.0002286507,0.00011761914,0.000009370226,0.00016179963,0.00018838757,0.000035215486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044346324,0.00008247784,0.0003717997,0.000060131002,0.000047543836,0.0000069744247,0.00013184287,0.00006074475,0.9949785,0.00007761245,0.001868973,0.0018699754],"study_design_scores_gemma":[0.0007988135,0.00015156168,0.009739886,0.00003284696,0.000014869261,0.0000030665865,0.000100316625,0.0000064603178,0.9406825,0.00003001251,0.04828371,0.00015596439],"about_ca_topic_score_codex":0.0011567468,"about_ca_topic_score_gemma":0.00069273403,"teacher_disagreement_score":0.05429597,"about_ca_system_score_codex":0.00007688428,"about_ca_system_score_gemma":0.00041280876,"threshold_uncertainty_score":0.59135467},"labels":[],"label_agreement":null},{"id":"W2334792830","doi":"10.1158/1538-7445.am2013-720","title":"Abstract 720: A validation study on photoacoustics imaging of fluorescent pyroporphysome <i>in vivo</i>.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; FujiFilm VisualSonics (Canada)","funders":"","keywords":"In vivo; Fluorescence; Absorbance; Ultrasound; Photoacoustic imaging in biomedicine; Materials science; Biomedical engineering; Preclinical imaging; Bolus (digestion); Nuclear medicine; Optics; Medicine; Radiology; Surgery","score_opus":0.03976861469455958,"score_gpt":0.3330419897837399,"score_spread":0.29327337508918033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334792830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662274,0.0003092894,0.00007930959,0.000038700884,0.00027393625,0.0011277028,0.000039099177,0.00007459513,0.0014346038],"genre_scores_gemma":[0.99923193,0.00017556884,0.00004021555,0.000012156861,0.00009272192,0.00032520536,0.000003434925,0.00006656296,0.00005217037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812376,0.00002805756,0.00035036076,0.00023033464,0.00074590987,0.00052155985],"domain_scores_gemma":[0.9991111,0.00014265942,0.000036205663,0.00038784067,0.00022306685,0.00009912135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004476079,0.00016124255,0.00021895689,0.00039469157,0.000049242866,0.00005779255,0.00028886113,0.00005007829,0.0006175983],"category_scores_gemma":[0.000046156492,0.00015489546,0.000041288306,0.00057287904,0.00007617771,0.0002087749,0.000047662408,0.0004769337,0.00008886359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039765993,0.00020721635,0.00861463,0.00018366807,0.000036530808,0.000016622365,0.0007410299,0.016079245,0.9684765,0.000023426604,0.0023043838,0.0032769882],"study_design_scores_gemma":[0.0014193654,0.00016068046,0.02995869,0.00028596542,0.0000107516735,7.1649475e-7,0.00139471,0.0056323376,0.9599128,0.0004942932,0.00044072405,0.00028901023],"about_ca_topic_score_codex":0.0012237063,"about_ca_topic_score_gemma":0.00006215306,"teacher_disagreement_score":0.02134406,"about_ca_system_score_codex":0.0005823936,"about_ca_system_score_gemma":0.0000852367,"threshold_uncertainty_score":0.6762268},"labels":[],"label_agreement":null},{"id":"W2334892627","doi":"10.1158/1538-7445.am2013-597","title":"Abstract 597: The combination of valproic acid and fludarabine treatment induces a synergistic apoptotic response in chronic lymphocytic leukemia (CLL) patients involving the lysosomal protease cathepsin B.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Fludarabine; XIAP; Chronic lymphocytic leukemia; Cathepsin B; Cancer research; Cathepsin; Apoptosis; Vorinostat; Caspase; Chemistry; Pharmacology; Histone deacetylase; Leukemia; Programmed cell death; Medicine; Immunology; Biochemistry; Internal medicine; Histone; Chemotherapy; Enzyme","score_opus":0.05297574096075227,"score_gpt":0.35615709543771934,"score_spread":0.3031813544769671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334892627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006337,0.0039495006,0.0000014113442,0.0010345802,0.000066767665,0.0047103693,0.000014226577,0.00002513623,0.00013465926],"genre_scores_gemma":[0.99594426,0.0007340155,0.00001130637,0.00004496972,0.000119702694,0.0025423442,0.000017074344,0.00005357769,0.00053274055],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995596,0.0008518624,0.0005933006,0.000561098,0.0014674647,0.0009302673],"domain_scores_gemma":[0.99639106,0.0016098614,0.00015369106,0.0009032055,0.00068620406,0.00025600207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002356226,0.00028672055,0.00044862585,0.0004599146,0.00033499394,0.00011749395,0.00046161388,0.000164549,0.00022258703],"category_scores_gemma":[0.0019542002,0.00016170775,0.000089475885,0.0010670847,0.0010862715,0.00020904992,0.0002672539,0.00066482177,0.000063489],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015744876,0.001124882,0.006699067,0.0033764124,0.00059295725,0.0002546571,0.012453982,0.0017382309,0.90661764,0.0005607277,0.0012012745,0.049635284],"study_design_scores_gemma":[0.078308806,0.009594628,0.4859477,0.0037205487,0.00021317879,0.00008587735,0.0029127577,0.07274621,0.34406036,0.0013106553,0.00035225233,0.00074701634],"about_ca_topic_score_codex":0.032249678,"about_ca_topic_score_gemma":0.00061299064,"teacher_disagreement_score":0.5625573,"about_ca_system_score_codex":0.12759374,"about_ca_system_score_gemma":0.041580927,"threshold_uncertainty_score":0.97419465},"labels":[],"label_agreement":null},{"id":"W2334934464","doi":"10.1158/1538-7445.am2011-1400","title":"Abstract 1400: Inhibition of cell migration by the synthetic triterpenoid acetylenic tricyclic bis-(cyano enone)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical compounds biological activities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"IQGAP1; Chemistry; Cell migration; Immunofluorescence; Cell polarity; Cell; Cell biology; Enone; Cell growth; Stereochemistry; Cytoskeleton; Biochemistry; Biology; Antibody; Immunology","score_opus":0.07433732642103076,"score_gpt":0.3303990498663205,"score_spread":0.25606172344528977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334934464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927137,0.0023172935,0.000047422516,0.00021288589,0.00003963883,0.00031214394,0.000066637505,0.000009152922,0.004281113],"genre_scores_gemma":[0.9979831,0.0009706538,0.00003196751,0.00005905284,0.000112589136,0.0001761661,0.00005966531,0.000015720361,0.00059106894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865574,0.00019003016,0.00022036447,0.00032952375,0.00026918334,0.00033517342],"domain_scores_gemma":[0.999237,0.00009797254,0.000086867214,0.00035223868,0.00015497852,0.00007095861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004971547,0.00012493735,0.00014477967,0.000053194373,0.00010871214,0.000019567908,0.00031362954,0.0001681073,0.00018016687],"category_scores_gemma":[0.00012339244,0.000085113206,0.000093885625,0.00020969396,0.00038730534,0.000008336734,0.00014582791,0.00029043795,0.000015056584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024681696,0.0001635862,0.00011715949,0.000037099824,0.000015263844,6.5972847e-7,0.0000809939,5.01228e-7,0.99468964,0.0000082446395,0.003724861,0.00091514026],"study_design_scores_gemma":[0.0002849773,0.00029823673,0.0008279494,0.000021444275,0.000006077542,0.0000016026892,0.000089308596,0.000002457531,0.99165565,0.0003178166,0.0063886186,0.00010585524],"about_ca_topic_score_codex":0.00033688365,"about_ca_topic_score_gemma":0.000047497007,"teacher_disagreement_score":0.0052694045,"about_ca_system_score_codex":0.00004644255,"about_ca_system_score_gemma":0.00009900493,"threshold_uncertainty_score":0.34708157},"labels":[],"label_agreement":null},{"id":"W2334940009","doi":"10.1158/0008-5472.sabcs-104","title":"ALDH1 is a useful marker of basalness in human breast cancer and its stem/progenitor cells.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"","keywords":"Breast cancer; Cancer stem cell; Tissue microarray; Stem cell marker; Progenitor cell; Stem cell; Pathology; Immunohistochemistry; Cancer; Biology; Cancer research; Cancer cell; Triple-negative breast cancer; Internal medicine; Medicine; Cell biology","score_opus":0.09145120072848562,"score_gpt":0.41542396650113944,"score_spread":0.3239727657726538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334940009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98300034,0.011802219,8.9793014e-7,0.0033459219,0.000118722935,0.0006849753,0.00023350971,0.000013288949,0.0008001379],"genre_scores_gemma":[0.9907688,0.003980002,0.000016932521,0.00033692108,0.00030040744,0.00016062616,0.000003554059,0.000030231371,0.0044025513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978737,0.000093659044,0.00031644822,0.0004508726,0.00069659145,0.00056870404],"domain_scores_gemma":[0.9988573,0.000045386714,0.000059965005,0.00033273976,0.0004324462,0.00027215912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066070387,0.00016448066,0.00043542925,0.00034443417,0.00008459406,0.000025313042,0.00015932186,0.00010550233,0.0016009491],"category_scores_gemma":[0.000008461803,0.00014313024,0.00007462994,0.00074402906,0.00012491916,0.0000933419,0.000078574,0.00043468832,0.000008339113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015197677,0.00040659308,0.04026529,0.0011671127,0.00013481094,0.000110165274,0.0012865238,0.0000052222417,0.82488257,0.000106856314,0.015501645,0.114613436],"study_design_scores_gemma":[0.0040642107,0.00033749745,0.16429617,0.0010444905,0.000083646075,0.000028739603,0.00043151202,0.00004176041,0.80319124,0.00006366708,0.02613346,0.00028362084],"about_ca_topic_score_codex":0.002968715,"about_ca_topic_score_gemma":0.0005744153,"teacher_disagreement_score":0.12403088,"about_ca_system_score_codex":0.00032464453,"about_ca_system_score_gemma":0.00050131255,"threshold_uncertainty_score":0.99931175},"labels":[],"label_agreement":null},{"id":"W2334961640","doi":"10.1158/1538-7445.am10-1708","title":"Abstract 1708: Telomerase as an important target of androgen-signaling blockade for prostate cancer treatment","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"","keywords":"Prostate cancer; Telomerase; Bicalutamide; Telomerase reverse transcriptase; Androgen receptor; Androgen deprivation therapy; Androgen; Cancer research; Downregulation and upregulation; Medicine; Cancer; Internal medicine; Biology; Hormone","score_opus":0.07610324182538035,"score_gpt":0.44646624196154944,"score_spread":0.3703630001361691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334961640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782176,0.0056939586,0.0000016253161,0.0019780847,0.00024721376,0.0030763913,0.00064461236,0.00004910968,0.00048724026],"genre_scores_gemma":[0.9854027,0.0053962367,0.0004881384,0.000048969414,0.00068391534,0.0032930695,0.00020199317,0.00009041098,0.004394541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671847,0.000060589657,0.0005092094,0.00068253215,0.00092762377,0.0011015608],"domain_scores_gemma":[0.99737716,0.00018760134,0.00013146404,0.0006065109,0.0010106454,0.000686609],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001034802,0.00028897365,0.0005399125,0.00039733807,0.00033467237,0.00005954555,0.00023568276,0.00018217658,0.0017658733],"category_scores_gemma":[0.00011449822,0.00020559892,0.00018748557,0.00052157935,0.000465557,0.00016314666,0.0000561881,0.00062835455,0.000016713664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004808316,0.0009475901,0.05899696,0.0005211419,0.00046275023,0.00019781187,0.0014093786,0.000019102381,0.89983016,0.00008775287,0.0007642926,0.031954743],"study_design_scores_gemma":[0.005857523,0.0022583622,0.004085013,0.00020591449,0.00008268497,0.000016552596,0.00044263943,0.00010458105,0.95277554,0.00064498174,0.033300966,0.00022525426],"about_ca_topic_score_codex":0.00514636,"about_ca_topic_score_gemma":0.00074321765,"teacher_disagreement_score":0.05491195,"about_ca_system_score_codex":0.0005250676,"about_ca_system_score_gemma":0.00382243,"threshold_uncertainty_score":0.99914664},"labels":[],"label_agreement":null},{"id":"W2334998682","doi":"10.1158/1538-7445.am2011-lb-179","title":"Abstract LB-179: The effects of hypoxia and reactive oxygen species on the methylation status of the polo-like kinases","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Polo-like kinase; Biology; PLK1; DNA methylation; Epigenetics; Methylation; Cytokinesis; Kinase; Mitosis; Carcinogenesis; Cell biology; Cancer research; Molecular biology; Cell cycle; Cell division; Genetics; Cell; Cancer; Gene expression; DNA; Gene","score_opus":0.05002435981951321,"score_gpt":0.3270801038388398,"score_spread":0.2770557440193266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334998682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948563,0.002148632,0.0000047982007,0.00018375138,0.000081083206,0.00038570253,0.000034692013,0.0000013242499,0.0023036997],"genre_scores_gemma":[0.9964883,0.002917491,0.00000778725,0.00006455986,0.00005921064,0.0000463675,0.0000052744276,0.000009692208,0.00040131755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991548,0.00017724656,0.00010455862,0.00015594662,0.00019301113,0.00021440658],"domain_scores_gemma":[0.99915737,0.00020995295,0.000073751035,0.00038021518,0.00014837776,0.000030357223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034441822,0.0000737849,0.00008311363,0.000026484542,0.00012304442,0.000008749208,0.00024269949,0.00006558252,0.000024902612],"category_scores_gemma":[0.00028045115,0.000035549703,0.000050274542,0.000105745974,0.00041972438,0.0000029728164,0.00014689295,0.00017316193,8.3350454e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013194612,0.000033137974,0.001226879,0.000044275585,0.000057695772,3.130182e-7,0.0005198836,0.0000016442152,0.994751,0.00054325286,0.0010491175,0.0016409031],"study_design_scores_gemma":[0.00012312463,0.00015777608,0.14534508,0.000035482426,0.0000099258,4.0718075e-7,0.00035070183,0.00000160067,0.84881413,0.00020293532,0.004921695,0.00003712344],"about_ca_topic_score_codex":0.0010176804,"about_ca_topic_score_gemma":0.00028133564,"teacher_disagreement_score":0.1459368,"about_ca_system_score_codex":0.000023079088,"about_ca_system_score_gemma":0.00012113072,"threshold_uncertainty_score":0.1546492},"labels":[],"label_agreement":null},{"id":"W2335017796","doi":"10.1158/1538-7445.am2011-lb-380","title":"Abstract LB-380: Direct targeting of the Hedgehog pathway in primary chondrosarcoma xenografts with the Smoothened inhibitor IPI-926","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Smoothened; GLI1; PTCH1; Hedgehog; Hedgehog signaling pathway; Cancer research; Chondrosarcoma; Patched; Medicine; Cyclopamine; Biology; Pathology; Signal transduction; Cell biology","score_opus":0.05204589060826312,"score_gpt":0.3050321828572872,"score_spread":0.25298629224902414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335017796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891514,0.004001486,0.0000045353545,0.00030029242,0.00014279185,0.00055695436,0.000041485804,0.000009105441,0.005791957],"genre_scores_gemma":[0.9983696,0.0002160062,0.00007125411,0.000106744585,0.00030276575,0.00025033025,0.000010080821,0.000042508418,0.00063073816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979594,0.00029506072,0.00026978605,0.00042415594,0.00048613045,0.0005654766],"domain_scores_gemma":[0.9988596,0.00008809253,0.00010857155,0.0006000769,0.00027707726,0.00006661108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013136404,0.00018594376,0.00022481263,0.00007784737,0.00025240795,0.000021136482,0.0006602166,0.00012044862,0.000035404664],"category_scores_gemma":[0.0001693475,0.000102884806,0.000094084324,0.00045688308,0.00067508937,0.0000067281608,0.0004033516,0.00043021337,0.000004868882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030497773,0.00009761011,0.017839637,0.00009774779,0.00006615182,0.000008782747,0.0015323752,0.000021859263,0.9764961,0.000011544151,0.0022532807,0.0012699346],"study_design_scores_gemma":[0.0005331457,0.00018940537,0.075634934,0.00015463674,0.0000050949693,0.0000016535674,0.00047202708,0.0000014768586,0.9118848,0.00002206819,0.010941433,0.00015935018],"about_ca_topic_score_codex":0.0004534278,"about_ca_topic_score_gemma":0.00054527645,"teacher_disagreement_score":0.06461132,"about_ca_system_score_codex":0.000078152676,"about_ca_system_score_gemma":0.0004600255,"threshold_uncertainty_score":0.41955206},"labels":[],"label_agreement":null},{"id":"W2335066513","doi":"10.1158/0008-5472.can-14-3457","title":"Emmanuel Farber: In Memoriam (1918–2014)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Context (archaeology); Darwinism; Classics; Medicine; Gerontology; Pathology; Philosophy; History; Epistemology","score_opus":0.04466565914627454,"score_gpt":0.3839001036250216,"score_spread":0.33923444447874707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335066513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97390574,0.0014680016,0.0005296843,0.0020895728,0.0009220728,0.000516522,0.000028645114,0.000016787146,0.020522967],"genre_scores_gemma":[0.98998624,0.0026151836,0.00031517915,0.00027206563,0.0017482921,0.00014171955,0.000065132146,0.000029256491,0.0048269383],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973618,0.0002471662,0.00030222588,0.0004077496,0.0008148455,0.00086624245],"domain_scores_gemma":[0.9987114,0.00006890776,0.000035356043,0.00057564647,0.00030915794,0.0002994986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022868284,0.00014367295,0.00018114893,0.0002337011,0.000119120756,0.00006872275,0.0006344038,0.00024055847,0.0001998507],"category_scores_gemma":[0.00078723166,0.00012463577,0.000067462264,0.00030465238,0.00042669466,0.0000054790903,0.0004275067,0.00045066874,0.00026404043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058481446,0.0002844787,0.010499975,0.0004175667,0.000080946375,0.000017190163,0.00046315265,0.000075355776,0.56469476,0.00055785873,0.2880684,0.13425544],"study_design_scores_gemma":[0.0012331168,0.00059041945,0.0068336525,0.000055845758,0.0000035766434,0.0000050298613,0.00021801573,0.0004951127,0.12973903,0.000885978,0.85965514,0.000285044],"about_ca_topic_score_codex":0.0003323319,"about_ca_topic_score_gemma":0.0005951604,"teacher_disagreement_score":0.5715867,"about_ca_system_score_codex":0.00007214738,"about_ca_system_score_gemma":0.00030794673,"threshold_uncertainty_score":0.50824994},"labels":[],"label_agreement":null},{"id":"W2335084072","doi":"10.1158/1538-7445.am2011-lb-64","title":"Abstract LB-64: Hitting Testicular Cancer Where It Hurts: Through Public Awareness and Post-Treatment Support","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Medical Association","funders":"","keywords":"Testicular cancer; Notice; Disease; Medicine; Cancer; Population; Suspect; Family medicine; Gerontology; Psychology; Internal medicine; Environmental health; Political science","score_opus":0.22757633804455984,"score_gpt":0.448777379466841,"score_spread":0.22120104142228114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335084072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730719,0.017939745,0.000007808771,0.0040955967,0.00014125789,0.0009384663,0.0002013794,0.00008541278,0.003518444],"genre_scores_gemma":[0.9911239,0.0058459216,0.00027116673,0.00025028648,0.00022622928,0.0007798228,0.00007696008,0.00006277507,0.0013629327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.00006667109,0.00026976687,0.00061873096,0.0006589936,0.00081942324],"domain_scores_gemma":[0.9980721,0.00012255387,0.00007631187,0.0005119692,0.0006837388,0.00053336145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022238985,0.00026966823,0.00036364494,0.00012900897,0.00034646486,0.00008540951,0.00014030689,0.00011700854,0.004191518],"category_scores_gemma":[0.0001793601,0.00020085686,0.00011105851,0.00031502455,0.00025942436,0.00023976532,0.00011651171,0.00025703624,0.00009113631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029893793,0.0012044127,0.9397031,0.000539782,0.0007798798,0.0018164894,0.0018906929,0.0000021828419,0.0034932413,0.00018429547,0.0023557444,0.047731243],"study_design_scores_gemma":[0.004002621,0.0012519606,0.9538512,0.0007765706,0.00045365028,0.00010603154,0.0015840706,0.000022938153,0.0054513114,0.00025397123,0.03186696,0.00037869997],"about_ca_topic_score_codex":0.02400627,"about_ca_topic_score_gemma":0.001226895,"teacher_disagreement_score":0.047352545,"about_ca_system_score_codex":0.0006571008,"about_ca_system_score_gemma":0.0016983035,"threshold_uncertainty_score":0.99671876},"labels":[],"label_agreement":null},{"id":"W2335100749","doi":"10.1158/1538-7445.am2013-298","title":"Abstract 298: Breast cancer malignancy and drug sensitivity are regulated by mammaglobin 1.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"La Cité Collégiale; Université de Moncton","funders":"","keywords":"Breast cancer; Metastasis; Cancer; Cancer research; Malignancy; Cancer cell; CA15-3; Medicine; Biology; Oncology; Internal medicine","score_opus":0.03657704042365566,"score_gpt":0.3526800034162622,"score_spread":0.31610296299260654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335100749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97236633,0.0093887085,0.0000028372847,0.015455813,0.00016680261,0.00087257754,0.0005126626,0.000055638906,0.0011786104],"genre_scores_gemma":[0.98099494,0.0060934178,0.000033173088,0.00037807456,0.0003674478,0.00034321976,0.00002503097,0.000053511536,0.01171118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99753386,0.00013820847,0.0002483685,0.0005822751,0.0007157118,0.0007815972],"domain_scores_gemma":[0.998185,0.00010555291,0.00007947362,0.0004323224,0.0006852582,0.0005124187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007150489,0.00021621841,0.00041260917,0.00015649258,0.00019235969,0.00010178572,0.00009283322,0.00011194259,0.005048497],"category_scores_gemma":[0.00003678285,0.00018124077,0.00007735854,0.00048476685,0.00032610883,0.00018894715,0.000121906,0.0005972246,0.00013371304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022959479,0.00013127227,0.03339781,0.0005255402,0.000131392,0.000101480284,0.00020189522,0.000004053985,0.46851066,0.000014071361,0.38632476,0.11042747],"study_design_scores_gemma":[0.0022546996,0.000053500302,0.83510303,0.0011765469,0.00007569025,0.00010841766,0.0005574693,0.0000318973,0.11640615,0.00007449234,0.04377023,0.00038786972],"about_ca_topic_score_codex":0.042629637,"about_ca_topic_score_gemma":0.0019073528,"teacher_disagreement_score":0.80170524,"about_ca_system_score_codex":0.0004388296,"about_ca_system_score_gemma":0.0003892993,"threshold_uncertainty_score":0.995861},"labels":[],"label_agreement":null},{"id":"W2335111169","doi":"10.1158/1538-7445.am2011-320","title":"Abstract 320: Association of higher Gleason grade with presence of PTEN deletion in prostatic adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Robarts Clinical Trials; University Health Network; Queen's University","funders":"","keywords":"PTEN; TMPRSS2; Prostate cancer; Cancer research; Fluorescence in situ hybridization; Prostate; Tissue microarray; Adenocarcinoma; Fusion gene; Grading (engineering); Cancer; Pathology; Biology; Medicine; Immunohistochemistry; Oncology; Gene; Chromosome; Internal medicine; Genetics; Disease; PI3K/AKT/mTOR pathway","score_opus":0.11401701115516859,"score_gpt":0.39439451656392255,"score_spread":0.28037750540875395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335111169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903945,0.0041387435,0.0000032519522,0.00074993377,0.00004012593,0.0010676389,0.00002355661,0.000011777887,0.0035705196],"genre_scores_gemma":[0.99545527,0.0010252538,0.00020216871,0.000009201107,0.00003818091,0.00027986447,0.000016611066,0.000022746242,0.0029507244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772125,0.00013085669,0.0002917705,0.0002729338,0.0011069102,0.00047625197],"domain_scores_gemma":[0.9986411,0.00016896747,0.0001384234,0.00027145323,0.0006609555,0.000119106444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008701392,0.000107043394,0.00029566558,0.00033943425,0.00003835386,0.0000076528995,0.00014543654,0.00010375735,0.0005144304],"category_scores_gemma":[0.00011557676,0.00007718959,0.000042259344,0.00077348517,0.00021782078,0.00012949595,0.000046306533,0.00043184162,0.000010029436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035373499,0.00050926063,0.9483446,0.00097150035,0.00012662627,0.000073622636,0.0023085466,0.0000048521183,0.03904847,0.00014206623,0.0012980924,0.0036350489],"study_design_scores_gemma":[0.0026875872,0.00092255214,0.8753325,0.00076032133,0.000026304415,0.000001803395,0.00030596057,0.000030403362,0.11939742,0.00022137792,0.00023824802,0.00007555962],"about_ca_topic_score_codex":0.0039621894,"about_ca_topic_score_gemma":0.00033546286,"teacher_disagreement_score":0.080348946,"about_ca_system_score_codex":0.00064713985,"about_ca_system_score_gemma":0.0006190761,"threshold_uncertainty_score":0.59896713},"labels":[],"label_agreement":null},{"id":"W2335118418","doi":"10.1158/1538-7445.am2013-1091","title":"Abstract 1091: Procoagulant receptor tissue factor provokes the escape from brain tumor dormancy.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Montreal Children's Hospital","funders":"","keywords":"Tissue factor; Angiogenesis; Micrometastasis; Glioma; Cancer research; Medicine; Tumor progression; Pathology; Cancer; Tumor microenvironment; Inflammation; Biology; Immunology; Breast cancer; Coagulation; Internal medicine","score_opus":0.04703786160841261,"score_gpt":0.365824601757543,"score_spread":0.3187867401491304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335118418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720443,0.0070017334,0.000026789408,0.0030983374,0.00022802422,0.000978185,0.00016180062,0.000017648117,0.0012830327],"genre_scores_gemma":[0.9910745,0.0007048797,0.0000942579,0.0005232626,0.0012921721,0.0013200175,0.00008812769,0.000048027603,0.0048547457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820113,0.00011117907,0.00021290172,0.0004911155,0.00042125498,0.0005623876],"domain_scores_gemma":[0.9988629,0.0000685943,0.00006456787,0.00054388365,0.00031307156,0.00014696621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030534968,0.00017890696,0.00015888458,0.000045936446,0.00024815698,0.00012885114,0.00056403206,0.00012704263,0.0033384599],"category_scores_gemma":[0.00009977069,0.00011572407,0.00008390848,0.00016463018,0.00022382787,0.000012111743,0.0002038624,0.00025093218,0.0005207661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004778777,0.000030120622,0.0015724583,0.00002488461,0.00004973662,0.0000011385304,0.00009939392,0.0000041361923,0.8225955,0.000009296297,0.15592745,0.019638091],"study_design_scores_gemma":[0.00019594595,0.00009918623,0.021854362,0.00003345927,0.0000030155866,8.472756e-7,0.00013876606,0.0000063142465,0.5558973,0.000047895763,0.42157167,0.00015127125],"about_ca_topic_score_codex":0.0029317148,"about_ca_topic_score_gemma":0.00042759886,"teacher_disagreement_score":0.26669824,"about_ca_system_score_codex":0.000064535845,"about_ca_system_score_gemma":0.00032288177,"threshold_uncertainty_score":0.9975726},"labels":[],"label_agreement":null},{"id":"W2335153152","doi":"10.1158/1538-7445.am10-596","title":"Abstract 596: Oncolytic vesicular stomatitis virus selectively kills bladder cancer cells which have a low level of type I interferon receptor","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; Interferon; Bladder cancer; Cancer; Cancer research; Virology; Virus; Biology; Medicine; Immunology; Internal medicine","score_opus":0.07099336078365931,"score_gpt":0.3982835697999831,"score_spread":0.3272902090163238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335153152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959267,0.0013737745,0.000024943109,0.00035720447,0.00041880994,0.00072674896,0.00040546016,0.000015140706,0.0007512143],"genre_scores_gemma":[0.9941623,0.0022031725,0.00012608398,0.00009793893,0.00060878857,0.0003244079,0.00005333969,0.000096291194,0.002327679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692625,0.0002552789,0.00035788256,0.0007191919,0.0008661738,0.0008752472],"domain_scores_gemma":[0.99685055,0.00009094687,0.00011564092,0.00076481554,0.0018957064,0.00028233533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011247299,0.00027029985,0.00032565466,0.00023511473,0.0001717427,0.000067181914,0.00076018303,0.00037546238,0.0025561335],"category_scores_gemma":[0.00025816186,0.00025882653,0.0001090419,0.0006281477,0.00040326727,0.000015531697,0.00025748517,0.0010540546,0.00013308207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022605401,0.00019280333,0.0003048672,0.00010897736,0.00024076861,0.000004950839,0.00020249019,0.00013762226,0.96770394,0.000004088136,0.014918363,0.0139206],"study_design_scores_gemma":[0.0008171395,0.0020277968,0.0014200672,0.00009814479,0.000011369316,0.0000016478542,0.00006878926,0.000071587565,0.9839202,0.000027709651,0.011258612,0.00027691427],"about_ca_topic_score_codex":0.0031276827,"about_ca_topic_score_gemma":0.024572866,"teacher_disagreement_score":0.021445183,"about_ca_system_score_codex":0.00023576549,"about_ca_system_score_gemma":0.0022578405,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W2335163657","doi":"10.1158/1538-7445.am10-990","title":"Abstract 990: Fundamental causes of colorectal cancer outcomes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Colorectal cancer; Inequality; Demography; Health care; Census; Cancer; Gerontology; Family medicine; Population; Internal medicine; Environmental health; Law; Sociology","score_opus":0.0944445290029357,"score_gpt":0.44877066578795066,"score_spread":0.35432613678501496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335163657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210775,0.0005551496,0.0000016796223,0.0009743643,0.0008062673,0.0004211329,0.000058340862,0.000060994367,0.005014309],"genre_scores_gemma":[0.9979199,0.00019890325,0.00008200624,0.00006366027,0.00032775095,0.00030810953,0.000005959002,0.000024729074,0.001068947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982036,0.00003307199,0.00023908471,0.00031093,0.0007823758,0.00043097578],"domain_scores_gemma":[0.9988796,0.00017850756,0.00006594769,0.0002447852,0.00041972805,0.00021144458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004916593,0.00013125945,0.00030910678,0.00025440255,0.00014430807,0.00002703783,0.00014094343,0.00013570389,0.002764161],"category_scores_gemma":[0.00019288699,0.00010765358,0.000117423326,0.00046167456,0.0003532762,0.00008685018,0.00008082003,0.0009578894,0.000030545954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024773886,0.00011052025,0.301068,0.00013415521,0.000106763466,0.000017080649,0.00026365262,0.0000058388146,0.67852575,0.000060238282,0.0017442147,0.015486378],"study_design_scores_gemma":[0.0009292472,0.000623753,0.63902646,0.00008769395,0.000022179922,0.000012240924,0.00017222582,0.00002069587,0.35359094,0.000037089358,0.005378349,0.00009910787],"about_ca_topic_score_codex":0.012019308,"about_ca_topic_score_gemma":0.009936822,"teacher_disagreement_score":0.33795848,"about_ca_system_score_codex":0.0002564221,"about_ca_system_score_gemma":0.0006727265,"threshold_uncertainty_score":0.9981474},"labels":[],"label_agreement":null},{"id":"W2335233297","doi":"10.1158/1538-7445.am10-1467","title":"Abstract 1467: AB-16B5, a therapeutic monoclonal antibody against human clusterin that blocks the epithelial-to-mesenchymal transition","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; Alethia Biotherapeutics (Canada)","funders":"","keywords":"DU145; Clusterin; Cancer research; Monoclonal antibody; In vivo; Epithelial–mesenchymal transition; Antibody; Cancer; Metastasis; Prostate cancer; In vitro; Cancer cell; Chemistry; Biology; Molecular biology; Immunology; Medicine; Apoptosis; Internal medicine; Biochemistry; LNCaP","score_opus":0.10142479553278994,"score_gpt":0.4556428528162041,"score_spread":0.35421805728341416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335233297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816243,0.00030905753,0.000102968195,0.012232781,0.00053750054,0.0014717161,0.00012390451,0.000084285326,0.0035134628],"genre_scores_gemma":[0.99517703,0.00018469908,0.00008026329,0.0017999215,0.0011911475,0.00048491464,0.000073915646,0.00007254332,0.00093558006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99687946,0.00021917609,0.0003314484,0.00062630704,0.0010252063,0.00091839675],"domain_scores_gemma":[0.99793655,0.00026227126,0.00005977483,0.0009706971,0.00033169184,0.00043900966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001488862,0.00025914123,0.0003476496,0.00033052,0.00051872,0.00009876251,0.0005326727,0.00023445231,0.002323461],"category_scores_gemma":[0.000097571785,0.0001885366,0.00017547737,0.0004423465,0.0006705784,0.00008808882,0.00020044945,0.0017452155,0.00023817149],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069409906,0.00019975286,0.002669938,0.000112951995,0.00006616777,0.0002469539,0.0014730192,0.000053021835,0.98226136,0.0000788109,0.0014244583,0.010719496],"study_design_scores_gemma":[0.005751483,0.0010270706,0.79834205,0.00061417016,0.00014094937,0.0004148743,0.0015325025,0.0009652521,0.13496745,0.0009160951,0.054475203,0.0008529213],"about_ca_topic_score_codex":0.0004781846,"about_ca_topic_score_gemma":0.0004794191,"teacher_disagreement_score":0.84729385,"about_ca_system_score_codex":0.00017642585,"about_ca_system_score_gemma":0.00044754098,"threshold_uncertainty_score":0.99858856},"labels":[],"label_agreement":null},{"id":"W2335233539","doi":"10.1158/1538-7445.am2013-293","title":"Abstract 293: TGF-b regulates Par-4 expression through XIAP in ovarian and endometrial cancers.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"XIAP; Inhibitor of apoptosis; Cancer research; Apoptosis; Transfection; Ovarian cancer; Gene silencing; Endometrial cancer; Biology; Cancer cell; Cancer; Programmed cell death; Caspase; Cell culture; Gene; Genetics","score_opus":0.05445243332467893,"score_gpt":0.38108756872295935,"score_spread":0.32663513539828043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335233539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100393,0.0073977793,0.000014845872,0.00021604086,0.00013479403,0.00044344054,0.000020549356,0.000010175801,0.0007584732],"genre_scores_gemma":[0.9974706,0.00085963856,0.00023632264,0.000059889833,0.0005538013,0.00038968632,0.00003502605,0.00002901097,0.000365997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983217,0.00012775585,0.00022012615,0.00048909255,0.00033916856,0.0005021217],"domain_scores_gemma":[0.9991618,0.00009413543,0.000048289377,0.00037281457,0.00017648649,0.000146511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003892828,0.00014026968,0.000160116,0.000121344834,0.00013545409,0.000097308584,0.00027487357,0.00017117844,0.00056742644],"category_scores_gemma":[0.00038600204,0.00012584645,0.000041132673,0.00025686438,0.00024581264,0.000019696567,0.0002243866,0.00024824077,0.000023818327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021709743,0.000037708698,0.005154581,0.00005148783,0.000020100937,0.0000043417613,0.00012841307,0.00007405568,0.98254,0.000011604162,0.009522337,0.0022382801],"study_design_scores_gemma":[0.0011315334,0.00008489281,0.02890416,0.00011633383,0.0000028806471,0.0000012722603,0.0001053296,0.000007125644,0.95656306,0.00037088938,0.01255116,0.00016134993],"about_ca_topic_score_codex":0.0033309378,"about_ca_topic_score_gemma":0.00021650443,"teacher_disagreement_score":0.02597692,"about_ca_system_score_codex":0.00009895536,"about_ca_system_score_gemma":0.0003772626,"threshold_uncertainty_score":0.6212922},"labels":[],"label_agreement":null},{"id":"W2335238283","doi":"10.1158/1538-7445.am2013-63","title":"Abstract 63: Incorporation of flanking probes reduces truncation losses for fluorescence in situ hybridization analysis of recurrent genomic deletions in tumor sections.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Children's Hospital of Eastern Ontario; Queen's University","funders":"","keywords":"PTEN; Fluorescence in situ hybridization; Biology; Computational biology; Comparative genomic hybridization; DNA microarray; Molecular biology; Chromosome; Genetics; Cancer research; Gene; Gene expression","score_opus":0.04076552018770001,"score_gpt":0.3778758470408284,"score_spread":0.33711032685312836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335238283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980387,0.00027151368,0.0010623224,0.00009365981,0.000016386526,0.00046051896,0.000025289668,0.0000049733385,0.000026641475],"genre_scores_gemma":[0.99703693,0.0005187681,0.0019048282,0.0000040898503,0.000038801732,0.0002054524,0.00027082415,0.0000071434524,0.000013181852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902976,0.00007297807,0.00034472832,0.0002519707,0.00015147444,0.00014906631],"domain_scores_gemma":[0.9990425,0.000034344444,0.00016737593,0.00016627832,0.00056822906,0.000021234968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048232469,0.00007035256,0.0001674614,0.0006040711,0.00004609108,0.000015075246,0.00010381133,0.00005774579,0.0000030849344],"category_scores_gemma":[0.000188342,0.00006669721,0.0000648172,0.0010705973,0.000104283485,0.0000150235255,0.000031355346,0.00008378711,2.1907496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053727974,0.000078800906,0.0074435975,0.00004714779,0.000046886875,1.2426365e-7,0.000047895184,0.0012470883,0.98442346,0.000018613056,0.0000593254,0.006533311],"study_design_scores_gemma":[0.000114255046,0.00008466869,0.059131827,0.0000691806,0.000027197006,2.1651287e-7,0.00012272867,0.0010727234,0.9390724,0.00020694592,0.000032021333,0.00006589145],"about_ca_topic_score_codex":0.0006876178,"about_ca_topic_score_gemma":0.0033621432,"teacher_disagreement_score":0.05168823,"about_ca_system_score_codex":0.00009565867,"about_ca_system_score_gemma":0.00014950191,"threshold_uncertainty_score":0.27198333},"labels":[],"label_agreement":null},{"id":"W2335379987","doi":"10.1158/1538-7445.am10-lb-333","title":"Abstract LB-333: A CREBZF/Zhangfei isoform activates CHOP and promotes apoptosis during prolonged endoplasmic reticulum stress","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Unfolded protein response; CHOP; Endoplasmic reticulum; Transcription factor; Gene isoform; Apoptosis; Activating transcription factor; Cell biology; RNA splicing; Ccaat-enhancer-binding proteins; Biology; ATF4; Leucine zipper; Activator (genetics); Integrated stress response; Messenger RNA; Translation (biology); Nuclear protein; Gene; RNA; Biochemistry","score_opus":0.03924868891839584,"score_gpt":0.38207962929573025,"score_spread":0.3428309403773344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335379987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942215,0.00022413893,4.155376e-7,0.0009394355,0.00014102331,0.0010248366,0.000047229667,0.000079714315,0.0033216996],"genre_scores_gemma":[0.9970553,0.00043609607,0.00008910283,0.000015851296,0.00029036996,0.0007070484,0.000011297199,0.000042887616,0.0013520254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982434,0.000039288792,0.00019509144,0.00043357772,0.00044984146,0.00063880155],"domain_scores_gemma":[0.998891,0.00012453237,0.000048322963,0.00038320306,0.00025185064,0.00030111545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033958303,0.00018251926,0.0002531756,0.00027149907,0.00042985668,0.00009739926,0.000101054684,0.00017057048,0.00093719177],"category_scores_gemma":[0.00023869032,0.00014219614,0.0000584112,0.00034747977,0.0002709222,0.00017249833,0.000101288526,0.0010456466,0.00006165338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046141492,0.0006869973,0.13585861,0.000704215,0.00032868647,0.00008227706,0.0008803596,8.82646e-7,0.82457936,0.000043503125,0.00024663057,0.036127068],"study_design_scores_gemma":[0.0016910533,0.00019153357,0.16273779,0.00027366672,0.00003606762,0.000041407617,0.00017189725,0.000017336019,0.83198905,0.000048858314,0.002670472,0.00013089694],"about_ca_topic_score_codex":0.0016451685,"about_ca_topic_score_gemma":0.0008441582,"teacher_disagreement_score":0.035996173,"about_ca_system_score_codex":0.00014794809,"about_ca_system_score_gemma":0.00023932797,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W2335384118","doi":"10.1158/1538-7445.am2012-1029","title":"Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Public Health Ontario; University of Toronto","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Odds ratio; Body mass index; Internal medicine; Cancer; Menarche; Gynecology","score_opus":0.0490245761147269,"score_gpt":0.39819503647410837,"score_spread":0.3491704603593815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335384118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927884,0.004105811,0.000013362157,0.00044176052,0.00012368067,0.0006224096,0.00013995075,0.000007483667,0.0017571826],"genre_scores_gemma":[0.9963884,0.002399768,0.000018498236,0.000022468563,0.0003860606,0.0002339296,0.000014855705,0.000017112245,0.00051895453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997046,0.00031204175,0.00041276307,0.00022124843,0.0014736952,0.0005342705],"domain_scores_gemma":[0.99734074,0.0012921566,0.00031413615,0.00033154065,0.0005650702,0.00015637049],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002695008,0.00012726318,0.0006017204,0.00097481254,0.000059992366,0.000011568371,0.00017725019,0.00012737031,0.0013300761],"category_scores_gemma":[0.0010041296,0.000073458374,0.00017902712,0.0060296045,0.00011962108,0.000100212084,0.000040734107,0.0005568047,0.0000069694584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036603257,0.00028586935,0.98444,0.000091482565,0.0030140686,0.0000028675117,0.00023846453,0.00015311158,0.004552874,0.000023663815,0.00010040863,0.0034368143],"study_design_scores_gemma":[0.006071564,0.00025698618,0.97416586,0.000087792345,0.0012633459,1.813457e-7,0.00021682575,0.000023000486,0.017308755,0.000036833342,0.0004973011,0.0000715674],"about_ca_topic_score_codex":0.03516123,"about_ca_topic_score_gemma":0.0045198463,"teacher_disagreement_score":0.030641384,"about_ca_system_score_codex":0.0010759236,"about_ca_system_score_gemma":0.000441025,"threshold_uncertainty_score":0.9995828},"labels":[],"label_agreement":null},{"id":"W2335451838","doi":"10.1158/1538-7445.am2013-2562","title":"Abstract 2562: Polymorphisms in microRNA (miRNA) pathways and survival in esophageal cancer (EC) patients.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Memorial University of Newfoundland; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; microRNA; Biology; Hazard ratio; SNP; Oncology; Genetics; Proportional hazards model; Gene; Cancer; Internal medicine; Cancer research; Bioinformatics; Medicine; Genotype","score_opus":0.031065457827592714,"score_gpt":0.32817991092185317,"score_spread":0.29711445309426043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335451838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124575,0.005972902,0.000020437908,0.0006412098,0.00022781914,0.00095645094,0.00008453057,0.000009750605,0.0008411351],"genre_scores_gemma":[0.9942899,0.0036822583,0.000040104536,0.0001280407,0.00021178089,0.0009266411,0.00006594285,0.00006822518,0.0005871223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967849,0.0002522245,0.00035690193,0.00081919256,0.00069672515,0.0010900315],"domain_scores_gemma":[0.998793,0.00004901053,0.00005916965,0.00046520817,0.00035121563,0.00028241068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079756236,0.00024427575,0.00027250592,0.0004003303,0.0001074988,0.0001036294,0.00045838414,0.0003418417,0.0006273362],"category_scores_gemma":[0.00015849723,0.00024985755,0.00006421064,0.00057445845,0.00025805697,0.000021199708,0.00045614803,0.0008641128,0.000049999824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002076973,0.00015108338,0.01799967,0.000056026507,0.000033720593,0.00003685162,0.00015998495,0.00008451319,0.958497,0.00006382925,0.0018953212,0.020814303],"study_design_scores_gemma":[0.0039433716,0.0003731281,0.36512905,0.00020208837,0.0000049778578,0.0000035609937,0.00017413682,0.000108503424,0.622969,0.00034164035,0.0062098047,0.000540777],"about_ca_topic_score_codex":0.014730318,"about_ca_topic_score_gemma":0.00648258,"teacher_disagreement_score":0.34712937,"about_ca_system_score_codex":0.00035131408,"about_ca_system_score_gemma":0.0006370896,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2335473974","doi":"10.1158/1538-7445.am10-4637","title":"Abstract 4637: Mini-chromosome maintenance protein 7 as a potential theranostic biomarker in epithelial ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Tissue microarray; Immunohistochemistry; Pathology; Biology; Biomarker; Concordance; Ovarian cancer; Ovarian tumor; Cancer; Cancer research; Oncology; Medicine; Bioinformatics; Genetics","score_opus":0.024071626199429173,"score_gpt":0.34232616724772796,"score_spread":0.3182545410482988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335473974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301636,0.0015429413,0.000026147925,0.0016634469,0.0007547421,0.0008211912,0.00029346196,0.000011054172,0.0018706734],"genre_scores_gemma":[0.99503195,0.0010250178,0.00011512954,0.0002457336,0.0009179247,0.0008429078,0.000046916324,0.00006430635,0.0017101006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976537,0.00008271686,0.00031173756,0.00068788533,0.00041487635,0.0008490664],"domain_scores_gemma":[0.9987369,0.000051741543,0.00007560129,0.00059436786,0.0003149079,0.00022645487],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070560916,0.00022889148,0.00021656162,0.00016220249,0.0001544842,0.0001063574,0.00052795664,0.00030857357,0.0011663078],"category_scores_gemma":[0.0004164547,0.0002167474,0.0001025574,0.0003095217,0.00035784228,0.000009299551,0.0002360621,0.0006702198,0.00007024568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005962117,0.00011281954,0.0007339843,0.00004353732,0.000045945122,0.000081060694,0.00006717121,0.00005914794,0.9833031,0.00020132461,0.0040948982,0.010660787],"study_design_scores_gemma":[0.0037516186,0.0003424412,0.054305475,0.000236628,0.000017235161,0.000029200502,0.00012544151,0.0000878262,0.810323,0.0020609729,0.12799528,0.00072489004],"about_ca_topic_score_codex":0.007487979,"about_ca_topic_score_gemma":0.010509398,"teacher_disagreement_score":0.17298011,"about_ca_system_score_codex":0.000122022124,"about_ca_system_score_gemma":0.0013217822,"threshold_uncertainty_score":0.99974674},"labels":[],"label_agreement":null},{"id":"W2335579892","doi":"10.1158/1538-7445.am2011-5092","title":"Abstract 5092: Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Genome-wide association study; Locus (genetics); Radiation therapy; Biology; Haplotype; Single-nucleotide polymorphism; Oncology; Allele; Lymphoma; Genetics; Cancer research; Internal medicine; Medicine; Gene; Genotype","score_opus":0.19379448531167243,"score_gpt":0.3958448695147185,"score_spread":0.20205038420304605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335579892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771028,0.0018778576,7.022435e-7,0.00076559116,0.00013794866,0.0008413044,0.00006104407,0.000012416684,0.01920034],"genre_scores_gemma":[0.9956157,0.00120438,0.0000318066,0.0012724533,0.000166781,0.00064267544,0.000012127491,0.00002922752,0.0010248004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978931,0.0002462825,0.0003691655,0.00041357343,0.00043826492,0.0006396005],"domain_scores_gemma":[0.9986899,0.00021829885,0.00008454613,0.0006758959,0.00021496534,0.00011641495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012563377,0.00016845172,0.0003673738,0.00023693437,0.00008915396,0.000012467673,0.0003920364,0.00017250709,0.014751966],"category_scores_gemma":[0.000050300732,0.00011227738,0.0001015092,0.00037328084,0.00033354148,0.00010585892,0.000112318216,0.00037989402,0.00008664198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008634038,0.0004320592,0.07359806,0.00042651765,0.00021738569,0.0004036147,0.014096371,6.064852e-7,0.81653404,0.00015426455,0.009237832,0.0762652],"study_design_scores_gemma":[0.002417873,0.00041624834,0.8905873,0.00008013571,0.000007765405,0.000034685745,0.00042772465,0.0000025714173,0.08681067,0.00015157509,0.018945944,0.00011755263],"about_ca_topic_score_codex":0.0018469149,"about_ca_topic_score_gemma":0.0011579231,"teacher_disagreement_score":0.8169892,"about_ca_system_score_codex":0.00035957267,"about_ca_system_score_gemma":0.00072852,"threshold_uncertainty_score":0.98614866},"labels":[],"label_agreement":null},{"id":"W2335637981","doi":"10.1158/1538-7445.am2011-4344","title":"Abstract 4344: Membrane-type 1 matrix metalloproteinase-mediated pro-invasive properties of neuroblastoma initiating cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Neuroblastoma; Cancer research; Metastasis; Bone marrow; Transplantation; Biology; Neurosphere; Pathology; Primary tumor; Cell culture; Medicine; Cancer; Internal medicine; In vitro; Endothelial stem cell","score_opus":0.19445905117001355,"score_gpt":0.3836362204244624,"score_spread":0.18917716925444883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335637981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271625,0.0007616201,5.644969e-7,0.0001773265,0.00010453897,0.0019602599,0.000037431404,0.00007998963,0.0041620415],"genre_scores_gemma":[0.99725515,0.0006731057,0.00018304944,0.000050031846,0.00010156556,0.00038484007,0.000011814504,0.00007985492,0.0012605933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644643,0.00025047967,0.000453639,0.0005345778,0.0013755556,0.00093930855],"domain_scores_gemma":[0.9973937,0.00021535202,0.00013090388,0.0005483201,0.0012434222,0.00046826995],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006242647,0.00025334972,0.00047492792,0.0005312363,0.00017241332,0.000031343534,0.00032332056,0.00011885933,0.0013888598],"category_scores_gemma":[0.0009321732,0.00019080263,0.000129079,0.0009885196,0.000479486,0.00021868461,0.00020289035,0.0008195684,0.00039980118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002699568,0.000545957,0.0007752649,0.0013952834,0.00024600656,0.000858547,0.0006200033,0.000002559661,0.9919571,0.00002000178,0.0002798763,0.00059980695],"study_design_scores_gemma":[0.0017488857,0.0017604437,0.004410519,0.0006692673,0.000041038864,0.000026944863,0.00025229904,0.000019315938,0.9906985,0.000026598003,0.00020423385,0.0001419469],"about_ca_topic_score_codex":0.0011701195,"about_ca_topic_score_gemma":0.00010204193,"teacher_disagreement_score":0.004538917,"about_ca_system_score_codex":0.00016538301,"about_ca_system_score_gemma":0.0014127145,"threshold_uncertainty_score":0.999524},"labels":[],"label_agreement":null},{"id":"W2335652956","doi":"10.1158/1538-7445.am2011-2493","title":"Abstract 2493: Capsaicin, a novel radiosensitizer, acts via a TRPV6 mediated mechanism","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Capsaicin; TRPV; TRPV1; DU145; Chemistry; Pharmacology; Clonogenic assay; LNCaP; Transient receptor potential channel; Apoptosis; Radiosensitizer; Cancer research; Internal medicine; Receptor; Medicine; Biochemistry; Cancer; Cancer cell; Radiation therapy","score_opus":0.26064360971945333,"score_gpt":0.3859515881717053,"score_spread":0.12530797845225194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335652956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846557,0.0001609103,0.0002719573,0.00082567835,0.0018169448,0.0006707392,0.000078866644,0.00015720347,0.011362023],"genre_scores_gemma":[0.99651086,0.0005280713,0.00007385842,0.0004365986,0.00039116378,0.000083668114,0.00000366798,0.000055824697,0.0019163035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968481,0.00016367488,0.00026389785,0.00066123425,0.001073801,0.0009892794],"domain_scores_gemma":[0.99863917,0.00032867267,0.00007391543,0.00032370383,0.00024013741,0.00039440216],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00088639965,0.00020255492,0.00024510818,0.00033217508,0.00033759812,0.00005662791,0.0005360149,0.00018320268,0.0025482848],"category_scores_gemma":[0.00059576944,0.00016352415,0.00009114478,0.00082398683,0.00033584939,0.00019439509,0.00016581571,0.00076874916,0.00084366347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011032642,0.00014017323,0.0000024019134,0.000031023796,0.000008439419,0.000094415846,0.0016337368,0.0000034933157,0.99233884,0.0018257697,0.0024495523,0.0013618413],"study_design_scores_gemma":[0.00071684597,0.000109606546,0.00018467159,0.00005779195,0.0000037809946,0.000026192705,0.00016904193,0.00031353478,0.9928525,0.0011107448,0.0042423937,0.00021286006],"about_ca_topic_score_codex":0.0018196215,"about_ca_topic_score_gemma":0.00011671387,"teacher_disagreement_score":0.011855166,"about_ca_system_score_codex":0.00019818927,"about_ca_system_score_gemma":0.00031304458,"threshold_uncertainty_score":0.9999343},"labels":[],"label_agreement":null},{"id":"W2335702324","doi":"10.1158/1538-7445.am2013-4069","title":"Abstract 4069: FGFR2 expression and mutation are rare in papillary renal cell carcinoma.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Papillary renal cell carcinomas; Renal cell carcinoma; Immunohistochemistry; Medicine; Cancer research; Fibroblast growth factor receptor 2; Cancer; Mutation; Pathology; Internal medicine; Receptor; Biology; Fibroblast growth factor; Gene; Genetics","score_opus":0.06817045516972807,"score_gpt":0.3551371496249612,"score_spread":0.2869666944552331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335702324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666644,0.0076902458,0.0000013935846,0.0009260496,0.000042464697,0.00096990145,0.00000827748,0.000019501156,0.00367575],"genre_scores_gemma":[0.99727917,0.00043033343,0.000101117424,0.00006160686,0.00015524658,0.0004562528,0.000031977102,0.000031090196,0.0014532381],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981336,0.00011988522,0.00023114086,0.00041494108,0.00063776766,0.00046263565],"domain_scores_gemma":[0.99893904,0.00013795587,0.00005592846,0.0003197178,0.00026979082,0.00027758145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032060163,0.00014894048,0.00023576857,0.0002959043,0.000100779944,0.00005031964,0.000088877336,0.00011922176,0.0009907049],"category_scores_gemma":[0.000056970708,0.000116150055,0.000041427287,0.0002821243,0.00011341422,0.00016217447,0.000091447444,0.0005084505,0.00012606314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028530508,0.00015573144,0.17191108,0.00062589726,0.0000109947805,0.0010930476,0.0008699969,0.000021052445,0.8057602,0.0000030843507,0.00991789,0.009345724],"study_design_scores_gemma":[0.0013592634,0.00018678213,0.6932744,0.00030496778,0.000007103627,0.000020435275,0.0006899169,0.000033102435,0.30358663,0.00007485737,0.00037245775,0.00009013817],"about_ca_topic_score_codex":0.0024374377,"about_ca_topic_score_gemma":0.00009539435,"teacher_disagreement_score":0.52136326,"about_ca_system_score_codex":0.00044548127,"about_ca_system_score_gemma":0.00022051699,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2335708793","doi":"10.1158/1538-7445.am2011-5074","title":"Abstract 5074: Evaluation of PTEN and TMPRSS2-ERG abnormalities in prostate cancer by FISH and immunohistochemistry to address intra- and inter- tissue heterogeneity and disease progression","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; Queen's University; University Health Network","funders":"","keywords":"PTEN; Prostate cancer; TMPRSS2; Prostate; Erg; Immunohistochemistry; Tissue microarray; Prostatectomy; Pathology; Cancer; Biology; Fusion gene; Cancer research; Carcinoma; Medicine; Internal medicine; Disease; Gene; Genetics","score_opus":0.09877131346931951,"score_gpt":0.4575403250542027,"score_spread":0.3587690115848832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335708793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624642,0.034256194,4.412443e-7,0.0012043684,0.000029718754,0.0015503317,0.00025664832,0.0000100684565,0.00022801508],"genre_scores_gemma":[0.9869981,0.011359662,0.000023786053,0.000042812775,0.000036337482,0.0011339984,0.00004076835,0.000021769965,0.0003428124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981189,0.00012494116,0.00024978525,0.00045569454,0.00063484773,0.00041582552],"domain_scores_gemma":[0.9987612,0.000057795147,0.00005406318,0.00021339611,0.00042120685,0.0004923444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010860284,0.0001647377,0.00027156202,0.00018054016,0.00010974749,0.00004495603,0.00007680911,0.00006749341,0.00010958689],"category_scores_gemma":[0.00014456619,0.00013163462,0.00001444261,0.00018276222,0.0005973156,0.0001663468,0.00021055609,0.00030822642,4.429433e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076057413,0.00031590243,0.37582397,0.0036789859,0.00016312058,0.000087866516,0.0077762865,0.0000013267767,0.30464303,0.0000063012594,0.002843785,0.29705366],"study_design_scores_gemma":[0.0055645765,0.00065081567,0.6351867,0.0027465934,0.00010634533,0.000015372025,0.0011417357,0.00014492364,0.35313183,0.0001641769,0.00085059187,0.00029638677],"about_ca_topic_score_codex":0.0026209168,"about_ca_topic_score_gemma":0.00038932066,"teacher_disagreement_score":0.29675728,"about_ca_system_score_codex":0.00026978162,"about_ca_system_score_gemma":0.00046286124,"threshold_uncertainty_score":0.53679043},"labels":[],"label_agreement":null},{"id":"W2336130565","doi":"10.1158/0008-5472.can-15-2980","title":"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; Memorial University of Newfoundland; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Cancer Research UK; National Institutes of Health; Francis Crick Institute; World Health Organization","keywords":"Colorectal cancer; Cancer; Prostate; Ovary; Oncology; Medicine; Breast cancer; Lung; Internal medicine; Biology","score_opus":0.02575789161895091,"score_gpt":0.3718098753734756,"score_spread":0.3460519837545247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336130565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98344314,0.0074441587,0.00021077652,0.0011793714,0.0001269145,0.00041135415,0.00702946,0.000007254802,0.00014755181],"genre_scores_gemma":[0.9802019,0.016855853,0.00005115354,0.00012435265,0.00033821916,0.0005121199,0.0001196754,0.00003502207,0.0017616745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811435,0.00006961106,0.0003417996,0.0005649952,0.00036173858,0.00054751977],"domain_scores_gemma":[0.9983981,0.00018236406,0.000163438,0.00034007247,0.00073656975,0.00017942814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044968099,0.00017104375,0.00034415006,0.00024376824,0.00018094205,0.000064355,0.0002755138,0.00016802711,0.00035858274],"category_scores_gemma":[0.00023369765,0.00013920544,0.00013409292,0.00069691346,0.000393324,0.000011873708,0.00029443597,0.00013998749,0.000001926224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013950432,0.0000445776,0.51784366,0.00002758008,0.00075456616,7.9264225e-7,0.00006174574,0.00020109574,0.478332,0.000065703134,0.0013573287,0.0011714193],"study_design_scores_gemma":[0.0010275417,0.00011163568,0.940837,0.00004191643,0.00021314736,0.0000010611161,0.000013877695,0.000050768394,0.049704842,0.00006638919,0.007710943,0.00022085517],"about_ca_topic_score_codex":0.0027395508,"about_ca_topic_score_gemma":0.0036634132,"teacher_disagreement_score":0.4286272,"about_ca_system_score_codex":0.00035023195,"about_ca_system_score_gemma":0.0007126971,"threshold_uncertainty_score":0.5676633},"labels":[],"label_agreement":null},{"id":"W2336149985","doi":"10.1158/1538-7445.compsysbio-b2-15","title":"Abstract B2-15: Functional enrichment and pathway analysis of the transcriptome related to lymphovascular invasion and recurrence in axillary-node negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Lymphovascular invasion; KEGG; Transcriptome; Breast cancer; Biology; Gene expression profiling; Carcinogenesis; Gene; Cancer; Gene expression; Computational biology; Cancer research; Genetics; Metastasis","score_opus":0.04708744531671564,"score_gpt":0.3354277810110661,"score_spread":0.2883403356943504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336149985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878788,0.009895414,0.000007763589,0.0014809642,0.000090616544,0.00029563752,0.00023687044,0.0000030746494,0.00011083617],"genre_scores_gemma":[0.9973374,0.0022037113,0.000017465367,0.00008222782,0.000031721178,0.00022337017,0.000020564677,0.00001086649,0.00007267514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985104,0.000137955,0.00019593025,0.0004402412,0.00042850868,0.00028695844],"domain_scores_gemma":[0.9991986,0.000035001107,0.000047926344,0.00026148383,0.00032701038,0.00012993404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054101786,0.00013518875,0.00022226975,0.00018594168,0.0001009724,0.000016156211,0.00013289302,0.00008759641,0.000041172658],"category_scores_gemma":[0.00006606226,0.000098479344,0.00006739543,0.0009883691,0.00024457814,0.00000942995,0.00019879937,0.00013589903,8.5705915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012268071,0.0001999712,0.7691553,0.00008762895,0.0021172585,0.000007850816,0.0036221393,0.0026907944,0.19748744,0.000068509646,0.0013183766,0.022017868],"study_design_scores_gemma":[0.0011694311,0.000051824583,0.9772687,0.00008767566,0.00009077669,0.0000046509726,0.0005438396,0.000025509884,0.020064795,0.00007005627,0.0005067342,0.00011602628],"about_ca_topic_score_codex":0.0052019265,"about_ca_topic_score_gemma":0.0038211874,"teacher_disagreement_score":0.20811333,"about_ca_system_score_codex":0.00022492096,"about_ca_system_score_gemma":0.0003600354,"threshold_uncertainty_score":0.78637916},"labels":[],"label_agreement":null},{"id":"W2336618894","doi":"","title":"Higher levels of the anti-inflammatory protein CC10 are associated with improvement in sputum atypia in individuals at high risk for lung cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sputum; Atypia; Medicine; Lung cancer; Bronchoalveolar lavage; Context (archaeology); Gastroenterology; Lung; Internal medicine; Pathology; Biology","score_opus":0.04521146183515928,"score_gpt":0.380177541792952,"score_spread":0.3349660799577927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336618894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088645,0.0018984699,0.0000027205117,0.0019607504,0.0001510542,0.004602586,0.0003847689,0.000010918002,0.000102260055],"genre_scores_gemma":[0.9946071,0.00023253512,0.00003264421,0.00008280566,0.00014055484,0.003058138,0.000010537373,0.000046564146,0.0017891406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726284,0.00014143539,0.0004392039,0.00045099313,0.00093490904,0.0007706453],"domain_scores_gemma":[0.99855006,0.00025964133,0.00026428627,0.00041748717,0.00038415336,0.00012439874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019592028,0.00019638626,0.00045581817,0.00025811768,0.00012760317,0.000015594753,0.00020762475,0.00015096292,0.000364737],"category_scores_gemma":[0.0001222828,0.00012429034,0.00008120588,0.00077582954,0.00017939389,0.000061421626,0.0001419811,0.0004831546,0.0000014906286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043040342,0.00035140762,0.98802674,0.0003805947,0.0003128984,0.000025997382,0.00039928296,0.00007360675,0.005896506,0.00008579071,0.0011240927,0.002892683],"study_design_scores_gemma":[0.0065241,0.00029820405,0.8817481,0.0026593993,0.000071599876,2.5616006e-7,0.00008151012,0.000016398168,0.107864626,0.000052811232,0.00055957853,0.00012340896],"about_ca_topic_score_codex":0.0068799453,"about_ca_topic_score_gemma":0.042674117,"teacher_disagreement_score":0.10627863,"about_ca_system_score_codex":0.0049839835,"about_ca_system_score_gemma":0.0007983792,"threshold_uncertainty_score":0.9997333},"labels":[],"label_agreement":null},{"id":"W2336787713","doi":"","title":"Cell growth and topoisomerase IIα inhibitory activity of the bacterial metabolites kinamycin C and kinamycin A","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Waterloo","funders":"","keywords":"Topoisomerase; Dithiothreitol; Molecular biology; Growth inhibition; Apoptosis; Cell growth; Biochemistry; Flow cytometry; Chemistry; Annexin; K562 cells; Biology; DNA; Enzyme","score_opus":0.024517298209760563,"score_gpt":0.32027158905213216,"score_spread":0.2957542908423716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336787713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925228,0.0059888703,0.000016395365,0.0007405272,0.00012917168,0.00022279978,0.00004696377,0.0000028100033,0.00032970906],"genre_scores_gemma":[0.99544644,0.0033849115,0.000065840395,0.00010209321,0.00045998459,0.00005023077,0.000003117532,0.000016120928,0.00047124043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990448,0.00013262982,0.00010283,0.0002759261,0.0001925632,0.00025129548],"domain_scores_gemma":[0.9995089,0.000021958995,0.00004365034,0.00024258975,0.00010020291,0.00008268165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030447205,0.00010124292,0.00012841968,0.000045153516,0.00011692577,0.000028702561,0.00014207877,0.00009086387,0.000031247186],"category_scores_gemma":[0.000025648254,0.00007685393,0.00004152472,0.000107604836,0.00022027074,0.000006896004,0.0002520872,0.00016170033,5.309431e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018840216,0.000040550356,0.00033204217,0.000050823157,0.00001927901,3.2904916e-7,0.00011197484,9.079376e-7,0.9890908,0.00022780722,0.0002560501,0.00968102],"study_design_scores_gemma":[0.0006354405,0.00012687966,0.0019976394,0.000015249446,0.000012122285,0.0000022547388,0.000038720373,0.00000776437,0.9642942,0.00013403676,0.032649968,0.000085714986],"about_ca_topic_score_codex":0.00033410895,"about_ca_topic_score_gemma":0.00019084236,"teacher_disagreement_score":0.032393917,"about_ca_system_score_codex":0.00002236061,"about_ca_system_score_gemma":0.00015877046,"threshold_uncertainty_score":0.31340125},"labels":[],"label_agreement":null},{"id":"W2337050790","doi":"10.1158/0008-5472.can-15-3114","title":"Carcinoma Cell Hyaluronan as a “Portable” Cancerized Prometastatic Microenvironment","year":2016,"lang":"en","type":"review","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Cancer research; Medicine; Tumor cells","score_opus":0.07620806799136455,"score_gpt":0.4173416214822363,"score_spread":0.34113355349087177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337050790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024939934,0.9905835,0.000024785551,0.0000822798,0.0001929655,0.0031657894,0.00084508123,0.000015163466,0.0025964673],"genre_scores_gemma":[0.00071568263,0.93414265,0.00008229973,0.000037760623,0.0006793217,0.0058632456,0.0003909595,0.00022121306,0.057866838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937101,0.0007916301,0.0007287888,0.0016785738,0.0012319396,0.0018589437],"domain_scores_gemma":[0.9973072,0.00008525724,0.00024675432,0.0015225706,0.00024832928,0.00058992347],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013212409,0.0006569069,0.0013204027,0.00039092396,0.00037168546,0.00018095253,0.0015097884,0.00055474316,0.0019372714],"category_scores_gemma":[0.00013354252,0.00051982986,0.0005346573,0.00058434415,0.00062462006,0.000008731522,0.0010038028,0.0010277003,0.0006558521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010927864,0.00013058471,0.00001311258,0.009392187,0.00026159085,0.00016743787,0.00001858077,5.131398e-7,0.0127556315,0.0000078095545,0.00808612,0.96905714],"study_design_scores_gemma":[0.00074668374,0.0007638231,0.0000044899125,0.0034393026,0.000115475676,0.00006242005,0.00001909544,4.167179e-7,0.0052294303,0.000025680012,0.98898613,0.0006070541],"about_ca_topic_score_codex":0.0026348177,"about_ca_topic_score_gemma":0.00044387922,"teacher_disagreement_score":0.9809,"about_ca_system_score_codex":0.0006578816,"about_ca_system_score_gemma":0.005139375,"threshold_uncertainty_score":0.99972534},"labels":[],"label_agreement":null},{"id":"W2337185978","doi":"10.1158/1538-7445.sabcs14-p5-09-01","title":"Abstract P5-09-01: Nottingham prognostic index plus (NPI+): Validation of the modern clinical decision making tool in breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Nottingham Prognostic Index; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Breast cancer; Adjuvant therapy; Cytokeratin; Prognostic variable; Mitotic index; Cancer; Estrogen receptor; Gynecology; Immunohistochemistry; Biology","score_opus":0.1070458704760939,"score_gpt":0.45444520533529664,"score_spread":0.3473993348592027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337185978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962815,0.0016165026,0.0001228606,0.0007870668,0.00031866526,0.0005075026,0.00009057418,0.00000769149,0.0002676552],"genre_scores_gemma":[0.9986038,0.00040755805,0.00007435018,0.0000664194,0.0004281842,0.0003075322,0.000011235802,0.000028881608,0.000071994626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978023,0.00020297326,0.00042834197,0.00047834468,0.0006669878,0.00042105082],"domain_scores_gemma":[0.99864036,0.00016904742,0.00014101478,0.00047019185,0.0005128124,0.000066554225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012147848,0.00015678687,0.0002360868,0.0000826664,0.000101013924,0.000031794094,0.00039501517,0.00017712898,0.000037322887],"category_scores_gemma":[0.00051361934,0.00011540167,0.000094245675,0.00034429462,0.0002744829,0.000012341629,0.00044831377,0.000351285,0.000005594366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001523376,0.0001751243,0.8948001,0.000059978713,0.00010188924,0.0000056231506,0.00034639423,0.0037091826,0.006602268,0.000010906096,0.002867479,0.08979765],"study_design_scores_gemma":[0.0022017416,0.00007092522,0.98548794,0.00052873214,0.000021332773,0.0000073473916,0.00015690313,0.00037698814,0.009633675,0.0007815659,0.000551657,0.00018119172],"about_ca_topic_score_codex":0.0011903761,"about_ca_topic_score_gemma":0.0013317455,"teacher_disagreement_score":0.09068781,"about_ca_system_score_codex":0.000369566,"about_ca_system_score_gemma":0.0011810758,"threshold_uncertainty_score":0.47059435},"labels":[],"label_agreement":null},{"id":"W2337584090","doi":"10.1158/1538-7445.am2015-4346","title":"Abstract 4346: Prognostic gene signature for intermediate risk prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Gene signature; Medicine; Prostate cancer; Oncology; Cohort; Internal medicine; Cancer; Watchful waiting; Gene expression; Framingham Risk Score; Disease; Gene; Pathology; Biology; Genetics","score_opus":0.11562471563761231,"score_gpt":0.4515401193544227,"score_spread":0.3359154037168104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337584090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622401,0.028113538,0.000017076809,0.00295781,0.00055553555,0.0042451303,0.00088642474,0.000097072945,0.00088728644],"genre_scores_gemma":[0.9692792,0.008586479,0.00016616876,0.00010817921,0.0012747628,0.006200078,0.00020929385,0.000106101914,0.014069729],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961955,0.00013002685,0.00035954107,0.00071152585,0.0012797053,0.0013237011],"domain_scores_gemma":[0.99623513,0.00039594094,0.00010643583,0.000475139,0.0018949889,0.00089233747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016953535,0.000272755,0.00041960145,0.00036393446,0.00026192472,0.000108194174,0.00029076613,0.00021189109,0.00045978953],"category_scores_gemma":[0.00096685474,0.00019742742,0.00014604034,0.00069448317,0.00046661866,0.00017220328,0.00016305812,0.0012221335,0.00012449252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0210846,0.000982184,0.37452212,0.0020911815,0.0013511493,0.00067239004,0.0059702923,0.00021411732,0.078800194,0.00005884653,0.2689451,0.24530782],"study_design_scores_gemma":[0.040948328,0.007320394,0.28590462,0.0028860266,0.00061272085,0.000034929806,0.0019866938,0.00055933354,0.40408793,0.004472149,0.24971879,0.0014680774],"about_ca_topic_score_codex":0.0016262205,"about_ca_topic_score_gemma":0.0004163302,"teacher_disagreement_score":0.32528773,"about_ca_system_score_codex":0.00115931,"about_ca_system_score_gemma":0.0032175037,"threshold_uncertainty_score":0.80508566},"labels":[],"label_agreement":null},{"id":"W2338145786","doi":"","title":"Telomere dysfunction in prostatic carcinogenesis: The crognostic importance of telomere length in HPIN (high-grade prostatic intraepithelial neoplasia)","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Telomere; Chromosome instability; Carcinogenesis; Biology; Genome instability; Cancer research; Cancer; Intraepithelial neoplasia; Prostate; Prostate cancer; Chromosome; Telomerase; Pathology; Genetics; Medicine; DNA damage; Gene; DNA","score_opus":0.04021225650331403,"score_gpt":0.3419026734960489,"score_spread":0.3016904169927349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338145786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885423,0.005231212,0.00001095735,0.0029805866,0.00022330058,0.0026285888,0.00006705147,0.000046193512,0.0002697781],"genre_scores_gemma":[0.99700725,0.0008670013,0.00014426917,0.00013927021,0.00030939365,0.00093033083,0.000042454834,0.00007466017,0.00048536455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952096,0.0004748582,0.0010189124,0.0007539069,0.001376974,0.0011657962],"domain_scores_gemma":[0.99778676,0.00069725997,0.00020188038,0.00072711625,0.00041215497,0.00017483674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015316717,0.00034331856,0.0007135068,0.00086871354,0.0001788066,0.000051810708,0.0003850569,0.00019222022,0.0001707701],"category_scores_gemma":[0.00067779684,0.000258094,0.00010069685,0.0028815856,0.0007237018,0.00019181633,0.00010011258,0.0011261383,0.000030024912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011090412,0.0006703819,0.9113008,0.0014091429,0.000047657748,0.00036052056,0.0019057712,0.00031838665,0.0690301,0.000991773,0.0010961114,0.0117603615],"study_design_scores_gemma":[0.0037236197,0.0005057932,0.941621,0.0010384427,0.000049529084,0.000051187424,0.0022833338,0.0003414498,0.04823977,0.0014222668,0.0004157831,0.00030782644],"about_ca_topic_score_codex":0.014631283,"about_ca_topic_score_gemma":0.017011637,"teacher_disagreement_score":0.030320242,"about_ca_system_score_codex":0.00066499936,"about_ca_system_score_gemma":0.0013599917,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2338704926","doi":"10.1158/1538-7445.am2015-2755","title":"Abstract 2755: Germline copy number variations in melanoma families with/without CDKN2A/CDK4 mutations","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Copy-number variation; Germline; Germline mutation; Melanoma; Genetics; Biology; Cancer; CDKN2B; Cancer research; Medicine; Mutation; Oncology; Gene; Genome","score_opus":0.05593121471719413,"score_gpt":0.3955761730507264,"score_spread":0.33964495833353225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338704926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890691,0.0007532275,0.00032755962,0.00070991623,0.00014074193,0.00031657304,0.00016234911,0.000009758532,0.00851079],"genre_scores_gemma":[0.9966058,0.00074810896,0.0006652888,0.00011964045,0.00038428133,0.00028583608,0.00019949232,0.00003197614,0.00095955277],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870306,0.000058426183,0.00019985953,0.00034427183,0.0003081734,0.00038622302],"domain_scores_gemma":[0.99888796,0.00006890932,0.00004403351,0.00034461566,0.00047119756,0.00018326717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045565784,0.00012270102,0.0001405859,0.00010480561,0.000099041885,0.00006499389,0.00021089884,0.00011312149,0.00012461726],"category_scores_gemma":[0.00024368586,0.00011431704,0.00003274824,0.00030814437,0.00017176328,0.00000782942,0.00010631238,0.0002313078,0.00007096997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014796505,0.00067181565,0.7186575,0.000120887875,0.00026122705,0.00010558382,0.0021449036,0.008491854,0.19648467,0.0032570856,0.057720672,0.010604132],"study_design_scores_gemma":[0.011025884,0.0013383507,0.27483112,0.00026370908,0.00007435067,0.00006886844,0.0039298306,0.0007004295,0.19732828,0.004229945,0.5046044,0.00160479],"about_ca_topic_score_codex":0.002556706,"about_ca_topic_score_gemma":0.007412644,"teacher_disagreement_score":0.44688377,"about_ca_system_score_codex":0.00015582854,"about_ca_system_score_gemma":0.0011187122,"threshold_uncertainty_score":0.46617132},"labels":[],"label_agreement":null},{"id":"W2338839436","doi":"10.1158/1538-7445.pedca15-a50","title":"Abstract A50: Mutational analysis of a mouse model of second malignant neoplasms","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Exome sequencing; Carcinogenesis; Biology; Germline; Germline mutation; Genetics; Exome; Deep sequencing; Cancer research; Somatic cell; Context (archaeology); Cancer; Mutation; Gene; Genome","score_opus":0.059205723071039655,"score_gpt":0.39275554788598604,"score_spread":0.3335498248149464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338839436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996991,0.00046917744,0.00022145314,0.000098780736,0.000010845019,0.00014690425,0.0015228319,0.000002117722,0.0005369154],"genre_scores_gemma":[0.99451625,0.0005137563,0.000087162625,0.000009459845,0.000028247638,0.00009393745,0.000072021365,0.0000124044,0.0046667503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869627,0.000046229874,0.00020002139,0.00027961924,0.00047215482,0.00030569689],"domain_scores_gemma":[0.9990256,0.0000494647,0.00006321293,0.00032243357,0.0004246311,0.00011466454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031087283,0.00008120915,0.00017939671,0.00026674537,0.000039524813,0.000007563911,0.00020660437,0.00006897668,0.00070203026],"category_scores_gemma":[0.000067581335,0.000056128018,0.00013805872,0.00033332655,0.00022687932,0.0000058145947,0.00009937813,0.00006293356,0.000006161723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037032884,0.00009282414,0.004254488,0.000037849906,0.0009393003,0.0000022861298,0.000038445247,0.0008167818,0.9900372,0.00008419298,0.00080972776,0.0025165584],"study_design_scores_gemma":[0.00073037547,0.0001539162,0.004963866,0.000020188381,0.000040679726,3.7665697e-7,0.000022584132,0.00019071063,0.9932993,0.00012981432,0.00037940915,0.0000687596],"about_ca_topic_score_codex":0.000649,"about_ca_topic_score_gemma":0.0024446454,"teacher_disagreement_score":0.004129835,"about_ca_system_score_codex":0.000064779495,"about_ca_system_score_gemma":0.00054432754,"threshold_uncertainty_score":0.7686739},"labels":[],"label_agreement":null},{"id":"W2339720302","doi":"10.1158/1538-7445.pedca15-a37","title":"Abstract A37: De novo and transmitted germline TP53 variation in pediatric osteosarcoma: A report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exon; Germline; Genotyping; Biology; Indel; Genetics; Osteosarcoma; Medicine; Oncology; Cancer research; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.034570607819341445,"score_gpt":0.36257171449493125,"score_spread":0.3280011066755898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339720302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824503,0.0040015136,0.00028592124,0.011643381,0.00013083931,0.00088508014,0.00006127401,0.00003711551,0.00050458807],"genre_scores_gemma":[0.99519664,0.0031815604,0.00016997752,0.00019780631,0.0008328901,0.00023188535,0.000035645273,0.00003855073,0.0001150528],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977989,0.0002409446,0.00038099548,0.0004929725,0.0005442242,0.0005419509],"domain_scores_gemma":[0.9984345,0.0006535222,0.00009030844,0.00046021657,0.00017458832,0.00018687951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001624537,0.00013913297,0.0002664166,0.0002330696,0.00009557277,0.000020722617,0.00016662065,0.00024239966,0.00034501683],"category_scores_gemma":[0.0005353311,0.00008840707,0.00006061804,0.0005930057,0.0001704224,0.000073213414,0.00006607617,0.000776643,0.000019989096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018180673,0.0004644059,0.4075227,0.00009157444,0.00019115188,0.0031436766,0.0018252856,0.0000070769406,0.48252806,0.00016216948,0.0030800176,0.09916578],"study_design_scores_gemma":[0.004588789,0.00022578482,0.98889357,0.00013693784,0.00006835426,0.0003159108,0.000024544666,0.000013504156,0.0023005067,0.00046449705,0.00285434,0.000113248425],"about_ca_topic_score_codex":0.005199405,"about_ca_topic_score_gemma":0.0023968522,"teacher_disagreement_score":0.58137083,"about_ca_system_score_codex":0.0008714339,"about_ca_system_score_gemma":0.0011680848,"threshold_uncertainty_score":0.785998},"labels":[],"label_agreement":null},{"id":"W2339738484","doi":"10.1158/1538-7445.sabcs15-p4-10-16","title":"Abstract P4-10-16: Long term effects of trastuzumab on cardiopulmonary and left ventricular function in women with HER2 overexpressing breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Heart failure; Internal medicine; Cardiology; Cardiac function curve; Cancer; Aerobic exercise","score_opus":0.0191100171575789,"score_gpt":0.31736607288973445,"score_spread":0.2982560557321555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339738484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731517,0.0013089592,0.000026733811,0.0003400592,0.000053586227,0.0005752217,0.000020310117,0.000015930551,0.00034402477],"genre_scores_gemma":[0.99864703,0.00067494035,0.000002411454,0.00005910529,0.00021713915,0.00014065662,0.0000031673,0.000029390825,0.00022615206],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845356,0.000089652334,0.00015546725,0.0003256652,0.0005904118,0.0003852624],"domain_scores_gemma":[0.9993056,0.00014121551,0.000052554416,0.00022076938,0.00013808688,0.00014179006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036974705,0.00013203429,0.00030065628,0.00021700663,0.00006754295,0.000016974725,0.000055129814,0.00010826728,0.00023374846],"category_scores_gemma":[0.000024783718,0.00008833388,0.000042278647,0.00022629765,0.00015311394,0.00013765562,0.00002194864,0.00027016556,0.0000025163733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036587268,0.000110814966,0.06076486,0.0007397897,0.0001360432,0.00014028362,0.000279099,0.000010424646,0.7745819,0.0000024480994,0.0001280917,0.15944754],"study_design_scores_gemma":[0.002295294,0.00033940954,0.6685056,0.0032663264,0.000016129163,0.00003699571,0.00005904498,0.0000010048857,0.32528353,0.000018640598,0.000097185904,0.00008082759],"about_ca_topic_score_codex":0.0005732355,"about_ca_topic_score_gemma":0.00008265101,"teacher_disagreement_score":0.60774076,"about_ca_system_score_codex":0.0012877999,"about_ca_system_score_gemma":0.00027109202,"threshold_uncertainty_score":0.3602151},"labels":[],"label_agreement":null},{"id":"W2340096214","doi":"","title":"Hyperacute rejection mimicry for cancer gene therapy","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Xenotransplantation; Antibody; Complement system; Epitope; Biology; Immunology; Genetically modified mouse; Molecular biology; Transplantation; Cancer research; Transgene; Medicine; Gene; Biochemistry; Internal medicine","score_opus":0.16125401452308044,"score_gpt":0.48281116818777176,"score_spread":0.3215571536646913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340096214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799097,0.0076098796,0.00051802717,0.010369087,0.00026471468,0.00090974255,0.00005373652,0.000044969183,0.00032011446],"genre_scores_gemma":[0.9414464,0.04587667,0.0007485026,0.0015149858,0.00066115434,0.0013601045,0.0000527649,0.00005502113,0.008284355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891114,0.000060615475,0.00013926528,0.0002254071,0.0003205354,0.00034302787],"domain_scores_gemma":[0.9992245,0.00007894687,0.000020214535,0.00019344286,0.00037650028,0.00010643666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042847736,0.000084137064,0.00014948918,0.00018375454,0.00018162029,0.000021648264,0.00007919146,0.0000736619,0.00035811216],"category_scores_gemma":[0.00003992382,0.000069294976,0.000074648124,0.0003226398,0.00008419164,0.00006621013,0.000008133673,0.00025150724,0.000035255158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005076411,0.0000879441,0.0003398916,0.000074000236,0.000083231986,0.000013085752,0.00062415615,0.00005437855,0.96700954,0.000089537694,0.0021420994,0.024405694],"study_design_scores_gemma":[0.0055012302,0.00045151662,0.009524915,0.00014875433,0.000018759625,0.000033358378,0.000098471115,0.000018402943,0.8442953,0.0001460868,0.13966414,0.000099036944],"about_ca_topic_score_codex":0.0011201848,"about_ca_topic_score_gemma":0.00008689159,"teacher_disagreement_score":0.13752204,"about_ca_system_score_codex":0.0003905313,"about_ca_system_score_gemma":0.0008883624,"threshold_uncertainty_score":0.3921077},"labels":[],"label_agreement":null},{"id":"W2340356624","doi":"10.1158/1538-7445.sabcs15-p5-09-06","title":"Abstract P5-09-06: Patient education for targeted therapies with apps","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Tamoxifen; Patient education; Breast cancer; Health professionals; Schedule; Oncology; Family medicine; Health care; Medical education; Cancer; Internal medicine; Computer science","score_opus":0.05530587403857739,"score_gpt":0.4068275192339474,"score_spread":0.35152164519537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340356624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731025,0.008939403,0.0011043295,0.013336385,0.00021015796,0.002009247,0.000084391395,0.000095654264,0.00111795],"genre_scores_gemma":[0.9910591,0.00046059184,0.0013394193,0.00027818122,0.0005450501,0.0024024749,0.000019378005,0.0000660629,0.0038297197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983068,0.000038923452,0.00017947354,0.00037578444,0.00056897773,0.0005300041],"domain_scores_gemma":[0.9982583,0.00020377467,0.00006566134,0.00040260112,0.0008881315,0.00018154678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025758325,0.00015102042,0.00021050304,0.000185156,0.00015466646,0.000022323231,0.00013402048,0.00006594976,0.00061769667],"category_scores_gemma":[0.000082499304,0.00008546077,0.000051971794,0.0002842049,0.00028857013,0.00016670156,0.000026579399,0.00019105093,0.00005647418],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022560384,0.00017625377,0.0022243594,0.00014678153,0.00012305501,0.0000028930917,0.00088216213,0.000002878098,0.23534313,0.00035841862,0.0039310176,0.754553],"study_design_scores_gemma":[0.0040383684,0.0014806074,0.031317867,0.0017083086,0.000032085514,0.000023369304,0.0028471472,0.0000026299567,0.26942933,0.0035747425,0.685175,0.0003705636],"about_ca_topic_score_codex":0.00013601665,"about_ca_topic_score_gemma":0.00005046166,"teacher_disagreement_score":0.75418246,"about_ca_system_score_codex":0.00057306624,"about_ca_system_score_gemma":0.0012471644,"threshold_uncertainty_score":0.6763345},"labels":[],"label_agreement":null},{"id":"W2340502172","doi":"10.1158/1538-7445.pedca15-pr14","title":"Abstract PR14: Harnessing the power of big data to advance pediatric cancer care","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Clinical trial; Genomics; Context (archaeology); Medicine; Cancer; Pediatric cancer; Precision medicine; Genome; Oncology; Bioinformatics; Computational biology; Internal medicine; Biology; Gene; Genetics; Pathology","score_opus":0.08503690714583517,"score_gpt":0.4049094259908754,"score_spread":0.31987251884504025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340502172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660037,0.028963301,0.00018341106,0.002063869,0.0006480163,0.00036086683,0.0011219389,0.0000049647388,0.00064993],"genre_scores_gemma":[0.98531663,0.012464657,0.000058037036,0.0001733689,0.0013919797,0.00013134208,0.000026723992,0.000030803116,0.00040647876],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985433,0.00004458579,0.00018946733,0.00048111824,0.00032975373,0.00041176242],"domain_scores_gemma":[0.9980404,0.000114679715,0.0000650657,0.0011795954,0.00047678433,0.0001234886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038614776,0.00011414838,0.00012385247,0.00006927336,0.00013395812,0.000034037508,0.00092931505,0.00007884215,0.00009836431],"category_scores_gemma":[0.00039098624,0.00007123138,0.00003905094,0.00025460508,0.00014546509,0.000006811656,0.0007495928,0.00012876485,0.00001533225],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023599037,0.00003710237,0.01642385,0.000117637785,0.000040054518,0.0000040727,0.0003261101,0.00012162775,0.8080968,0.000048697624,0.043721057,0.13082696],"study_design_scores_gemma":[0.0007856618,0.00020072253,0.0368433,0.00016435751,0.000024649133,0.0000014008737,0.00050508155,0.000001647002,0.29189545,0.000061626226,0.669202,0.00031405245],"about_ca_topic_score_codex":0.0006061389,"about_ca_topic_score_gemma":0.0014485442,"teacher_disagreement_score":0.625481,"about_ca_system_score_codex":0.00009358316,"about_ca_system_score_gemma":0.00091556605,"threshold_uncertainty_score":0.2904731},"labels":[],"label_agreement":null},{"id":"W2340583087","doi":"10.1158/1538-7445.sabcs15-p3-07-32","title":"Abstract P3-07-32: Tumour infiltrating lymphocyte (TIL) and chemokine gene signature predicts for benefit of anthracycline-containing chemotherapy in breast cancer patients","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Anthracycline; Gene signature; Tumor-infiltrating lymphocytes; Oncology; Cancer research; Cancer; Internal medicine; Medicine; CTL*; Chemokine; Immunology; Biology; Immune system; Immunotherapy; Gene expression; Gene; CD8","score_opus":0.03309062105273057,"score_gpt":0.3593285938650032,"score_spread":0.3262379728122726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340583087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98862743,0.0058786348,0.000012616786,0.0035488268,0.0001429817,0.0011125688,0.0005060564,0.000023244853,0.00014761595],"genre_scores_gemma":[0.988646,0.009860875,0.00011780806,0.0003086555,0.00039515525,0.00036127563,0.000024176768,0.000060611816,0.00022547261],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977145,0.000032909084,0.00052979344,0.0004887223,0.0005916124,0.0006424254],"domain_scores_gemma":[0.998475,0.0003047498,0.00018682754,0.0002592866,0.000609018,0.0001650854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008089856,0.00022942496,0.00046748598,0.0002725825,0.000106707404,0.000025014911,0.00018243822,0.00020057797,0.0004409579],"category_scores_gemma":[0.00009950597,0.00016237925,0.000100072524,0.00038955774,0.00028103433,0.0001893801,0.000051020765,0.00028104242,0.0000011718336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013191019,0.0001653076,0.11165563,0.00029793722,0.00011495496,0.0000051886714,0.0004232459,0.000004462619,0.6459595,0.0000061103106,0.00039143345,0.22778524],"study_design_scores_gemma":[0.021064186,0.00062184857,0.59868497,0.0026704266,0.000021864877,0.000010371404,0.00014760635,0.00009540101,0.37490362,0.000064889326,0.0014814122,0.00023338845],"about_ca_topic_score_codex":0.0017260546,"about_ca_topic_score_gemma":0.00030164674,"teacher_disagreement_score":0.48702934,"about_ca_system_score_codex":0.0007360899,"about_ca_system_score_gemma":0.00064234406,"threshold_uncertainty_score":0.6621634},"labels":[],"label_agreement":null},{"id":"W2340631460","doi":"","title":"Genomic profiling of mammary duct carcinoma in situ (DCIS) using array comparative genomic hybridization","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Comparative genomic hybridization; Breast cancer; Ductal carcinoma; Lumpectomy; Fluorescence in situ hybridization; Population; Mastectomy; Medicine; Cancer; Carcinoma in situ; Biology; Microdissection; Oncology; Pathology; Internal medicine; Genome; Chromosome; Genetics; Gene","score_opus":0.060748034199244315,"score_gpt":0.34330235663608094,"score_spread":0.28255432243683665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340631460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953802,0.0020016497,0.0008954292,0.000037534577,0.00006341273,0.00028812938,0.000036782643,0.0000037580169,0.0012930622],"genre_scores_gemma":[0.9980732,0.000101018544,0.0011769427,0.000009076187,0.00024824007,0.00004353614,0.000115945906,0.000015514674,0.00021650137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883515,0.00014527162,0.0002797656,0.00028556856,0.0001492239,0.00030500957],"domain_scores_gemma":[0.99943256,0.000013817176,0.00007536116,0.00024288637,0.00020082855,0.00003455089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003290884,0.00010321586,0.00016123825,0.00014297113,0.00009524254,0.000026115094,0.00020438075,0.000072697694,0.000017004264],"category_scores_gemma":[0.000009876835,0.000109403445,0.000043579665,0.00019807306,0.000101251986,0.000009302497,0.000110228386,0.00012442752,0.000003303813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051371953,0.00003500671,0.043465942,0.000041319625,0.000013800299,0.000002509601,0.00015589544,0.006259721,0.9493878,0.00048006023,0.00006662746,0.000039955787],"study_design_scores_gemma":[0.00037606698,0.000060959268,0.045510408,0.0000157301,0.000004634763,0.0000069365888,0.0003153263,0.00028766927,0.95270723,0.00023276283,0.00036358048,0.0001186919],"about_ca_topic_score_codex":0.0013700752,"about_ca_topic_score_gemma":0.00043936324,"teacher_disagreement_score":0.0059720515,"about_ca_system_score_codex":0.0001708807,"about_ca_system_score_gemma":0.00047798528,"threshold_uncertainty_score":0.4461343},"labels":[],"label_agreement":null},{"id":"W2341144619","doi":"10.1158/1538-7445.pedca15-a41","title":"Abstract A41: TRICEPS: A feasibility study of personalized targeted therapy in relapsed/refractory childhood cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Context (archaeology); Cancer; Targeted therapy; Clinical trial; Internal medicine; Oncology; Disease; Pediatric cancer","score_opus":0.0581793800070386,"score_gpt":0.37946591972376126,"score_spread":0.32128653971672266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341144619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198693,0.0067396746,0.0000011061946,0.00011179812,0.00008145819,0.00078642723,0.00011492667,0.0000052436967,0.00017245054],"genre_scores_gemma":[0.99573416,0.003613692,0.00000533277,0.000031466116,0.00011871721,0.0002029878,0.000012306867,0.000024526727,0.00025679317],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830455,0.00021554592,0.00026000896,0.0004912607,0.0003458741,0.00038274145],"domain_scores_gemma":[0.99902946,0.000052293944,0.00007564319,0.00046068904,0.00025788837,0.00012404125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063163467,0.0001344214,0.00020286406,0.00013401994,0.00007186524,0.000011867386,0.00032191572,0.00010610432,0.00029246166],"category_scores_gemma":[0.00017012538,0.000092790666,0.00008734831,0.00024721332,0.00018148009,0.0000044564617,0.000086354376,0.00016114413,0.000004302968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024332304,0.0015869593,0.07079044,0.00002470069,0.00012149449,0.00001507586,0.0009405019,0.000019842922,0.911144,0.0000050908857,0.0009356493,0.011982975],"study_design_scores_gemma":[0.008923548,0.0018000691,0.9256297,0.00006160787,0.0000066736334,0.0000010815953,0.0021034433,9.5272196e-7,0.057223186,0.00007742606,0.003935665,0.00023666413],"about_ca_topic_score_codex":0.0015383052,"about_ca_topic_score_gemma":0.0010328598,"teacher_disagreement_score":0.85483927,"about_ca_system_score_codex":0.00021535809,"about_ca_system_score_gemma":0.0009241042,"threshold_uncertainty_score":0.37838936},"labels":[],"label_agreement":null},{"id":"W2341298585","doi":"10.1158/1538-7445.sabcs15-pd5-03","title":"Abstract PD5-03: Prophylactic beta blockade preserves left ventricular ejection fraction in HER2-overexpresssing breast cancer patients receiving trastuzumab: Primary results of the MANTICORE randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Alberta","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology; Trastuzumab; Breast cancer; Ventricular remodeling; Asymptomatic; Bisoprolol; Perindopril; Cancer","score_opus":0.026839385082364817,"score_gpt":0.3282862190332369,"score_spread":0.3014468339508721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341298585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894359,0.00043974386,0.000014973848,0.0019527018,0.00044993506,0.0068603656,0.000049268692,0.00002412874,0.00077294826],"genre_scores_gemma":[0.99742424,0.00069121487,0.000009589013,0.000027118653,0.00060852047,0.0007143187,0.000011596718,0.000036945217,0.0004764302],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99595654,0.00094814826,0.00084604893,0.0004589297,0.001343272,0.00044704368],"domain_scores_gemma":[0.9975312,0.0008895763,0.000464374,0.00041285268,0.000599912,0.00010209098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025631578,0.00020607059,0.0010290826,0.00028828715,0.00017592752,0.000047339992,0.00018562771,0.00022317826,0.00013193444],"category_scores_gemma":[0.0012357933,0.00011556666,0.0003988963,0.0004302061,0.0002698579,0.0003134142,0.000059881037,0.00063401775,0.0000028195072],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60802543,0.0004318424,0.0075666,0.0002662142,0.00022566113,0.000005075973,0.00020021085,0.000028447366,0.37521866,0.0000019550403,0.00011067076,0.007919211],"study_design_scores_gemma":[0.6450538,0.00014645404,0.148963,0.0019144639,0.000117080315,0.000005012149,0.000055195964,0.000032536154,0.20347025,0.000054417782,0.00006951042,0.000118297074],"about_ca_topic_score_codex":0.0014686506,"about_ca_topic_score_gemma":0.00015100832,"teacher_disagreement_score":0.17174843,"about_ca_system_score_codex":0.001366895,"about_ca_system_score_gemma":0.00069830264,"threshold_uncertainty_score":0.47126716},"labels":[],"label_agreement":null},{"id":"W2342089507","doi":"10.1158/1538-7445.am2015-1369","title":"Abstract 1369: Inhibition of Notch- and EGFR signaling reduces cell viability and angiogenesis in glioblastoma multiforme","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Notch signaling pathway; Angiogenesis; Cancer research; Cyclin-dependent kinase 8; Hes3 signaling axis; Signal transduction; EGFR inhibitors; Glioma; Medicine; Biology; Epidermal growth factor receptor; Cancer; Cell biology; Internal medicine","score_opus":0.08217140774517982,"score_gpt":0.3865409631042658,"score_spread":0.30436955535908594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342089507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958743,0.0030380255,0.000008725994,0.00039333568,0.000041650263,0.00039531587,0.00001904801,0.000009716899,0.00021988225],"genre_scores_gemma":[0.99910444,0.0004544747,0.00018746746,0.000022828814,0.00009641412,0.000057814246,0.0000020625387,0.000014651668,0.000059819693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988746,0.000048434187,0.00020123397,0.00025425063,0.00037520952,0.00024629207],"domain_scores_gemma":[0.999292,0.000084673964,0.00004110047,0.00013699099,0.0002590875,0.00018610733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011133845,0.00008447035,0.0002133991,0.0002217703,0.00003907092,0.000016440812,0.000035609322,0.00007686343,0.00010676167],"category_scores_gemma":[0.0000561952,0.00007397633,0.000028033888,0.00030399003,0.00016051698,0.00009081115,0.000043846605,0.00017694217,0.0000017803235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010790499,0.00010028399,0.0032027974,0.0002626925,0.000010503355,0.000014528138,0.001363934,0.000015124956,0.9734938,0.00002188042,0.00008441302,0.02035099],"study_design_scores_gemma":[0.0020595137,0.00047186625,0.013985571,0.00018962371,0.000007296435,0.0000039300567,0.001178005,0.00008706617,0.9810025,0.00058364205,0.00035476466,0.000076183285],"about_ca_topic_score_codex":0.0020916427,"about_ca_topic_score_gemma":0.00045171194,"teacher_disagreement_score":0.020274809,"about_ca_system_score_codex":0.00019557562,"about_ca_system_score_gemma":0.00026750346,"threshold_uncertainty_score":0.3161952},"labels":[],"label_agreement":null},{"id":"W2342299882","doi":"10.1158/1538-7445.am2015-4445","title":"Abstract 4445: Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nuclear export signal; Leukemia; Cancer research; Myeloid leukemia; Haematopoiesis; Biology; Cancer; Medicine; Immunology; Stem cell; Cell nucleus; Cell biology; Gene; Genetics","score_opus":0.045502194131582116,"score_gpt":0.30868017597697306,"score_spread":0.26317798184539093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342299882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867059,0.00026089727,0.000043492564,0.00006252596,0.00044712395,0.0003645283,0.00004314198,0.000026663776,0.012045699],"genre_scores_gemma":[0.9976406,0.00018300419,0.0003210643,0.00010925785,0.0009818907,0.000034001696,0.000029871348,0.00007881278,0.00062148174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761295,0.0001544436,0.00035304867,0.00061518885,0.00059520046,0.0006691886],"domain_scores_gemma":[0.9982909,0.000044478005,0.00019049567,0.00049089006,0.000707683,0.00027553158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087350345,0.00024341738,0.0003057208,0.00013621683,0.00020622938,0.00007163875,0.0002851758,0.00030788122,0.00015328296],"category_scores_gemma":[0.00011351791,0.00023961952,0.000119079035,0.0003220167,0.0001792051,0.00004140431,0.00029641856,0.0006172005,0.000061505176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047354307,0.00006251773,0.00023692052,0.00014479042,0.00006148967,0.000011179868,0.00037586,0.0006118907,0.966905,0.0000059291624,0.02931161,0.0017992862],"study_design_scores_gemma":[0.0007816529,0.00034236172,0.00052279717,0.00010297867,0.000014562983,0.000006790262,0.00059277995,0.00026904218,0.9829737,0.000020387903,0.014104232,0.00026869864],"about_ca_topic_score_codex":0.00043130008,"about_ca_topic_score_gemma":0.000114271235,"teacher_disagreement_score":0.016068734,"about_ca_system_score_codex":0.00036059762,"about_ca_system_score_gemma":0.000671053,"threshold_uncertainty_score":0.97714007},"labels":[],"label_agreement":null},{"id":"W2342447202","doi":"10.1158/1538-7445.sabcs15-p2-05-14","title":"Abstract P2-05-14: The long noncoding RNA BHLHE40-AS1 as a functional biomarker of invasive breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Biomarker; Medicine; Ductal carcinoma; Cancer; Disease; Carcinogenesis; Epigenetics; Oncology; Long non-coding RNA; Bioinformatics; Internal medicine; Biology; RNA; Gene","score_opus":0.054599283376673614,"score_gpt":0.36955707943979843,"score_spread":0.3149577960631248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342447202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978278,0.0061985906,0.0019221073,0.007233077,0.0007418116,0.00107148,0.0005015903,0.000023796629,0.004029588],"genre_scores_gemma":[0.9892562,0.00489707,0.000015449266,0.00020004943,0.0006254263,0.0005093276,0.000026388514,0.00006994124,0.004400135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965965,0.00026007797,0.00034005343,0.0007068238,0.0012258018,0.00087072956],"domain_scores_gemma":[0.9974422,0.00019828715,0.00012492188,0.0007767071,0.0012133953,0.000244478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012548575,0.00023707694,0.0002229318,0.00022376617,0.00030393913,0.00006104002,0.0007093708,0.00028524347,0.0032844024],"category_scores_gemma":[0.0003846276,0.0001530176,0.0001944041,0.00054973154,0.0006435751,0.00001838321,0.000548231,0.00046669424,0.00009808417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008740825,0.000054867673,0.00030235486,0.00006951434,0.00027126822,0.00002558251,0.000040786043,0.000053985812,0.9416325,0.00012979275,0.023793532,0.032751705],"study_design_scores_gemma":[0.0012931762,0.00016454597,0.01052719,0.00033564807,0.000019585626,0.000053728345,0.000097148404,0.000009510097,0.9733654,0.00019376291,0.013698459,0.0002418259],"about_ca_topic_score_codex":0.0019859464,"about_ca_topic_score_gemma":0.001842472,"teacher_disagreement_score":0.032509882,"about_ca_system_score_codex":0.0003655382,"about_ca_system_score_gemma":0.002199917,"threshold_uncertainty_score":0.9976267},"labels":[],"label_agreement":null},{"id":"W2342715069","doi":"10.1158/0008-5472.can-15-3393","title":"Rictor/mTORC2 Drives Progression and Therapeutic Resistance of <i>HER2</i> -Amplified Breast Cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Congressionally Directed Medical Research Programs; National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; Israel National Road Safety Authority; Susan G. Komen for the Cure","keywords":"mTORC2; mTORC1; Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Biology; Phosphorylation; Signal transduction; Cell biology","score_opus":0.03870614404945852,"score_gpt":0.382807893281617,"score_spread":0.3441017492321585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342715069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758286,0.021101495,0.00025535922,0.001016999,0.0002179878,0.00038819984,0.00014266511,0.000019401275,0.0010292744],"genre_scores_gemma":[0.99341387,0.003362122,0.00012547194,0.00007391676,0.0003537714,0.00021404099,0.0000054813295,0.000043440115,0.0024079145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980626,0.0001927191,0.00022060616,0.00054269313,0.0004831176,0.00049827015],"domain_scores_gemma":[0.9987813,0.000078448065,0.000098568125,0.0004987202,0.0003935981,0.00014936138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053277245,0.00016440522,0.00019204417,0.00008021968,0.00012915215,0.000023690012,0.00035494743,0.0001573362,0.00009953679],"category_scores_gemma":[0.00006335904,0.00011527352,0.000055917462,0.00022506107,0.00069288304,0.0000073820916,0.00016573162,0.00015100653,0.0000042230035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005715354,0.000023159648,0.0067613046,0.00008211648,0.00006910096,0.000001970753,0.00008159179,0.0000032232322,0.9699367,0.00018349012,0.0040484103,0.018237386],"study_design_scores_gemma":[0.0009834139,0.00026715256,0.0061571687,0.0004709964,0.000012359259,0.000005394176,0.000058798756,0.0000022800505,0.9038264,0.0003568834,0.08762498,0.00023412348],"about_ca_topic_score_codex":0.00012091535,"about_ca_topic_score_gemma":0.00026626894,"teacher_disagreement_score":0.083576575,"about_ca_system_score_codex":0.00017218417,"about_ca_system_score_gemma":0.00055350584,"threshold_uncertainty_score":0.47007176},"labels":[],"label_agreement":null},{"id":"W2343663030","doi":"10.1158/0008-5472.can-15-3174","title":"Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Susan G. Komen for the Cure","keywords":"PI3K/AKT/mTOR pathway; AKT1; Breast cancer; Cancer research; Protein kinase B; Cancer; Estrogen receptor; Mutant; Medicine; P110α; Signal transduction; Phosphorylation; Mutation; Gene isoform; Kinase; Biology; Internal medicine; Gene; Genetics","score_opus":0.05241272442000865,"score_gpt":0.38585109915506255,"score_spread":0.3334383747350539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343663030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925976,0.0049892697,0.00015492551,0.00072651764,0.00015453869,0.00023724469,0.00062847184,0.000010716756,0.0005007247],"genre_scores_gemma":[0.998171,0.00088140764,0.00009505002,0.00008497887,0.00035049446,0.0002356003,0.00004618685,0.00004153374,0.00009376526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795395,0.00028714773,0.00033318394,0.00051586854,0.00045396085,0.00045589078],"domain_scores_gemma":[0.9987202,0.00012475318,0.00009946663,0.00052947825,0.00040882188,0.00011723885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939487,0.00015153419,0.0002114695,0.00015725766,0.00008357533,0.000019340334,0.0004310713,0.00014326448,0.00017350573],"category_scores_gemma":[0.00011365209,0.00012144932,0.00007068308,0.0003692694,0.00030451204,0.000010495183,0.00021530938,0.00023044112,0.000009157931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022754203,0.000037233454,0.012441092,0.000019482533,0.00005140556,0.000018801764,0.00020597018,0.00059580134,0.9743956,0.00012241033,0.00054849806,0.011336186],"study_design_scores_gemma":[0.0015730591,0.0000763513,0.008145861,0.00040114415,0.0000090797585,0.0000022892757,0.000091030575,0.00007652068,0.9858763,0.0009242253,0.002626339,0.00019780025],"about_ca_topic_score_codex":0.006207016,"about_ca_topic_score_gemma":0.003255506,"teacher_disagreement_score":0.011480723,"about_ca_system_score_codex":0.00022868495,"about_ca_system_score_gemma":0.0005973704,"threshold_uncertainty_score":0.93831927},"labels":[],"label_agreement":null},{"id":"W2343780951","doi":"10.1158/1538-7445.am2015-1122","title":"Abstract 1122: Personalized oncogenomics in advanced stage breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Breast cancer; PTEN; Cancer; ARID1A; Oncology; Genomics; Personalized medicine; Biology; Internal medicine; Medicine; Cancer research; Bioinformatics; Gene; Genetics; Genome; Mutation; PI3K/AKT/mTOR pathway","score_opus":0.0689288528796059,"score_gpt":0.40338348261803947,"score_spread":0.33445462973843354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343780951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863627,0.009217014,0.000018183713,0.00081484305,0.0003209207,0.00035556,0.000657312,0.000008657465,0.0022447922],"genre_scores_gemma":[0.98865604,0.0073700435,0.000112173446,0.0002900293,0.00066521735,0.00032548257,0.000075673306,0.00005308254,0.0024522487],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998178,0.000067518224,0.00023564512,0.0005138544,0.0003766846,0.00062829396],"domain_scores_gemma":[0.99875426,0.0000414635,0.000058523496,0.0004039253,0.00042947335,0.00031234734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006942857,0.00016998702,0.00020077544,0.00012387283,0.000076379394,0.000059644924,0.0003673872,0.00015289275,0.0003061704],"category_scores_gemma":[0.00014259684,0.00017542938,0.00006746326,0.0002673501,0.00020397978,0.000008197497,0.00022609674,0.00032510117,0.000030280407],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002678421,0.00026563506,0.04212245,0.00011548814,0.00010234483,0.000075230855,0.00069489004,0.0067775417,0.88360494,0.00051929895,0.030750949,0.03229283],"study_design_scores_gemma":[0.007942735,0.00037911214,0.04749477,0.00017673672,0.00001641229,0.000017528831,0.0020609922,0.0001568935,0.11454062,0.00037681079,0.82592976,0.00090763834],"about_ca_topic_score_codex":0.0034749047,"about_ca_topic_score_gemma":0.006365611,"teacher_disagreement_score":0.7951788,"about_ca_system_score_codex":0.0005382571,"about_ca_system_score_gemma":0.0017995457,"threshold_uncertainty_score":0.7153802},"labels":[],"label_agreement":null},{"id":"W2343957336","doi":"10.1158/1538-7445.sabcs15-p5-01-01","title":"Abstract P5-01-01: Real-time imaging of lymph node metastasis in response to systemic ezrin inhibitor treatment in breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ezrin; Medicine; Cancer research; Cancer; Breast cancer; Metastasis; Lymph node; Lymphovascular invasion; Lymphatic system; Oncology; Internal medicine; Pathology; Cell; Biology","score_opus":0.05278140084795379,"score_gpt":0.40470289368837725,"score_spread":0.35192149284042346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343957336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759815,0.0019312146,0.0000011293454,0.019350098,0.000077659075,0.0010033663,0.00074803067,0.000021697988,0.00088535534],"genre_scores_gemma":[0.9876479,0.0046179597,0.000055319033,0.00007331059,0.00026719322,0.0007748053,0.000007919123,0.000052924424,0.006502696],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99564475,0.0006235524,0.00068196113,0.0006534301,0.0012673434,0.0011289527],"domain_scores_gemma":[0.99751216,0.0010227265,0.00008051711,0.000532383,0.0003686901,0.00048349416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026170798,0.00026995083,0.00074881245,0.0012427297,0.000076207114,0.000026910224,0.00030253406,0.0000966321,0.0021705087],"category_scores_gemma":[0.000217348,0.00017315369,0.00014206133,0.0011118323,0.00027353954,0.00013146557,0.00020592095,0.0002904175,0.00025713362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017010834,0.00027564395,0.20581739,0.0003694488,0.00007808339,0.00043369248,0.00047768565,0.000026422425,0.7375441,0.0000134097245,0.0015592141,0.036394026],"study_design_scores_gemma":[0.005271908,0.0002445548,0.88652647,0.0063939006,0.000022893175,0.00008912941,0.00039298844,0.000051372383,0.09793835,0.000025277284,0.0027517017,0.00029143807],"about_ca_topic_score_codex":0.06427052,"about_ca_topic_score_gemma":0.0016659887,"teacher_disagreement_score":0.6807091,"about_ca_system_score_codex":0.003293295,"about_ca_system_score_gemma":0.0018917602,"threshold_uncertainty_score":0.9987416},"labels":[],"label_agreement":null},{"id":"W2344058987","doi":"10.1158/1538-7445.sabcs15-p3-06-03","title":"Abstract P3-06-03: Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Anthracycline; Breast cancer; Medicine; Oncology; Internal medicine; SKBR3; Cancer research; Biomarker; Adjuvant; Cancer; Histone deacetylase; Histone; Biology; Gene; Genetics","score_opus":0.03604001392386179,"score_gpt":0.36914708154051296,"score_spread":0.33310706761665115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344058987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944101,0.0016581024,0.000012983985,0.002760025,0.000024757928,0.0002079993,0.00079585967,0.0000074347377,0.00012274209],"genre_scores_gemma":[0.9971841,0.0022834192,0.00001691239,0.000047976286,0.000112486996,0.000099980985,0.000037995724,0.000022742084,0.00019439752],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986433,0.00009367593,0.00018062144,0.000416546,0.00031156203,0.00035430424],"domain_scores_gemma":[0.9991301,0.00008117141,0.00009642225,0.00023845951,0.00038076393,0.00007313404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044598526,0.00014862539,0.0002344356,0.00009179649,0.00008636992,0.0000087060935,0.00006821348,0.000114457085,0.0000900428],"category_scores_gemma":[0.000049518487,0.0001015648,0.000031632957,0.00020815211,0.0004459847,0.000012580777,0.00010369515,0.000108837005,0.0000024627616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006845305,0.00014048065,0.19136152,0.00003593111,0.00013965632,0.000013829326,0.0001615618,0.000012414554,0.7909848,0.000008553189,0.001205554,0.015251167],"study_design_scores_gemma":[0.0016541033,0.000072665236,0.85101545,0.00029389994,0.00001325409,0.0000068510294,0.00005035054,0.000006852219,0.14648397,0.000031396892,0.00024381214,0.00012741447],"about_ca_topic_score_codex":0.0031383971,"about_ca_topic_score_gemma":0.007945865,"teacher_disagreement_score":0.6596539,"about_ca_system_score_codex":0.0002860067,"about_ca_system_score_gemma":0.0002460367,"threshold_uncertainty_score":0.47443384},"labels":[],"label_agreement":null},{"id":"W2345165131","doi":"10.1158/1538-7445.sabcs15-p2-09-10","title":"Abstract P2-09-10: Double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Frameshift mutation; Loss of heterozygosity; Sanger sequencing; Breast cancer; BRCA2 Protein; Genetic testing; Biology; Genetics; Cancer; Ovarian cancer; Germline; Family history; Exon; DNA sequencing; Germline mutation; Medicine; Mutation; Gene; Internal medicine; Allele","score_opus":0.05589724787719344,"score_gpt":0.37790613967692926,"score_spread":0.3220088917997358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345165131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103683,0.0048985695,0.00021007146,0.0015510821,0.0002070272,0.00084318646,0.0010861981,0.000008913178,0.00015810365],"genre_scores_gemma":[0.99521327,0.0015570981,0.00026963203,0.00009003617,0.00021181029,0.001815302,0.00003032562,0.000041804316,0.0007706975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997966,0.000099211575,0.00028831974,0.0006932085,0.0003252416,0.00062804733],"domain_scores_gemma":[0.9988635,0.000070360154,0.00007524547,0.00044230156,0.00039199716,0.00015656246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000595082,0.00018244892,0.00020391302,0.00014343704,0.00014751534,0.000052445674,0.00026705858,0.00012524641,0.00052110857],"category_scores_gemma":[0.000053308297,0.0001433325,0.00006888428,0.00023519178,0.00025990477,0.00001738581,0.0002012783,0.00014753597,0.0000141273995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068055885,0.0001323401,0.0058693336,0.00012906366,0.00014688869,0.000010168108,0.0002546353,0.000071219714,0.8820041,0.00003276801,0.009497882,0.10117107],"study_design_scores_gemma":[0.013711709,0.0009202562,0.3389396,0.0006168303,0.00008214901,0.00008172603,0.00031577706,0.00009632686,0.572763,0.0015107399,0.06975994,0.0012019069],"about_ca_topic_score_codex":0.0018012581,"about_ca_topic_score_gemma":0.0033167868,"teacher_disagreement_score":0.33307025,"about_ca_system_score_codex":0.00049092557,"about_ca_system_score_gemma":0.00086627924,"threshold_uncertainty_score":0.584493},"labels":[],"label_agreement":null},{"id":"W2345186885","doi":"10.1158/1538-7445.sabcs15-p6-12-01","title":"Abstract P6-12-01: Attitudes and practice of breast surgeons towards referring young women with breast cancer (YWBC) for fertility preservation (FP)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CReATe Fertility Centre; University of Toronto; University of Calgary; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Referral; Oncofertility; Family medicine; Breast cancer; Gynecology; Fertility preservation; Fertility; General surgery; Cancer; Population; Internal medicine","score_opus":0.1268254320234521,"score_gpt":0.43058657676170414,"score_spread":0.30376114473825205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345186885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719555,0.00069303415,0.000058484286,0.009780991,0.00008102674,0.0009543685,0.00036782998,0.000027061578,0.000841655],"genre_scores_gemma":[0.9976146,0.00052722736,0.000080669255,0.000038829334,0.00017000838,0.0007518286,0.0000075245002,0.000021711554,0.00078754994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978752,0.00020610356,0.0002844826,0.00062964746,0.00045956683,0.00054501125],"domain_scores_gemma":[0.9970237,0.00056802516,0.000117037845,0.00053793547,0.0015561671,0.00019710882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032901384,0.00015053757,0.00034387427,0.000107613545,0.00017122482,0.000017702254,0.00013699727,0.00013072159,0.00034463612],"category_scores_gemma":[0.0011878347,0.000089919406,0.000036290567,0.00021443635,0.00064417475,0.00049950543,0.00009952564,0.00028752533,0.0000018450561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076165624,0.00032258144,0.7416204,0.0009210464,0.00033949863,0.000006148746,0.0007934754,0.0000012415463,0.14360061,0.000033911907,0.00036891532,0.035826508],"study_design_scores_gemma":[0.0013397661,0.0002640898,0.98992324,0.00038548507,0.000031701406,0.000050713443,0.00021269686,0.000002660478,0.006259946,0.00011055846,0.0013132266,0.00010591458],"about_ca_topic_score_codex":0.006757675,"about_ca_topic_score_gemma":0.0013773066,"teacher_disagreement_score":0.24830282,"about_ca_system_score_codex":0.00055611506,"about_ca_system_score_gemma":0.0007293717,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W2345630854","doi":"10.1158/1538-7445.am2015-5327","title":"Abstract 5327: Simultaneous inhibition of ATR and PARP greatly sensitizes colon cancer cell lines to irinotecan","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Irinotecan; DNA damage; DNA repair; Poly ADP ribose polymerase; Cancer research; Olaparib; Chemistry; IC50; Topoisomerase inhibitor; Pharmacology; Cancer cell; Kinase; Cancer; Colorectal cancer; Polymerase; Topoisomerase; Medicine; DNA; Biochemistry; In vitro","score_opus":0.07756187985646132,"score_gpt":0.38992968480331447,"score_spread":0.3123678049468531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345630854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993358,0.0049012173,0.00006156362,0.0005727874,0.00015774318,0.00032172658,0.000130378,0.000007767723,0.0004888238],"genre_scores_gemma":[0.99498373,0.003190131,0.000105653104,0.00021198114,0.0004282514,0.00008724079,0.000024619088,0.000027862063,0.0009405264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988167,0.000051565305,0.0001648854,0.00033980294,0.00029790725,0.00032909893],"domain_scores_gemma":[0.99887645,0.00003761283,0.000049124126,0.0002363716,0.00056413334,0.00023632364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003547512,0.00012315516,0.00015789228,0.000055050208,0.000065842854,0.000027426076,0.000098223754,0.00012863186,0.000035194527],"category_scores_gemma":[0.000056852365,0.000117843774,0.00003634248,0.000128982,0.00010390975,0.0000043098216,0.00013526321,0.00012402449,0.000004019738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046379343,0.000041864507,0.0000822662,0.00006514324,0.000024829242,0.000011030491,0.00023149565,0.0005700008,0.98378277,0.000020189042,0.001958934,0.012747673],"study_design_scores_gemma":[0.0006185183,0.0006338234,0.000108830565,0.000053442793,0.000010639549,0.0000032776734,0.00025509193,0.000056233417,0.9568959,0.00008939797,0.041131403,0.00014346016],"about_ca_topic_score_codex":0.00457544,"about_ca_topic_score_gemma":0.004420854,"teacher_disagreement_score":0.03917247,"about_ca_system_score_codex":0.00010745414,"about_ca_system_score_gemma":0.00037543388,"threshold_uncertainty_score":0.6916728},"labels":[],"label_agreement":null},{"id":"W2346657233","doi":"10.1158/1538-7445.am2015-2947","title":"Abstract 2947: Pharmacodynamic (PD) and pharmacokinetic (PK) results of the second-generation hypomethylating agent, SGI-110, in patients with hepatocellular carcinoma (HCC) after progression on sorafenib","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Decitabine; Sorafenib; Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Hypomethylating agent; Cancer; Pharmacodynamics; Progressive disease; Gastroenterology; Pharmacology; Pharmacokinetics; DNA methylation; Disease; Biology","score_opus":0.06035489821808602,"score_gpt":0.35721767707048907,"score_spread":0.29686277885240303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346657233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708307,0.0014934916,0.0000056701065,0.00017564239,0.00010252223,0.0006561157,0.000106297055,0.0000032164178,0.0003739637],"genre_scores_gemma":[0.9988983,0.00010604514,0.00003558145,0.000043876316,0.00013377906,0.0002672442,0.00007316038,0.0000238352,0.00041817751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984711,0.00017763668,0.00024675505,0.0003888922,0.00043980638,0.00027583982],"domain_scores_gemma":[0.99912363,0.000014348501,0.000109041015,0.0003309579,0.00031930022,0.00010274114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056097336,0.00013019734,0.00011819893,0.00009954353,0.00008225059,0.00002907607,0.00018267197,0.0000780396,0.000031206284],"category_scores_gemma":[0.000042590604,0.000090115005,0.000029428731,0.00026636387,0.000148997,0.00001211776,0.000102289814,0.00024090284,0.0000018362591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020233477,0.00019015056,0.1568987,0.00007737349,0.000027868635,0.000004898278,0.00024557507,0.00037606314,0.826612,0.0000027809401,0.0013008788,0.012240347],"study_design_scores_gemma":[0.0055493233,0.00056121004,0.35172668,0.00013169443,0.0000132760015,0.0000011184649,0.0000635546,0.0012483888,0.63472253,0.000013204854,0.0057430896,0.00022593868],"about_ca_topic_score_codex":0.000111526744,"about_ca_topic_score_gemma":0.00016738736,"teacher_disagreement_score":0.19482797,"about_ca_system_score_codex":0.00009745969,"about_ca_system_score_gemma":0.00022496813,"threshold_uncertainty_score":0.36747834},"labels":[],"label_agreement":null},{"id":"W2394531238","doi":"10.1158/1538-7445.pedca15-a51","title":"Abstract A51: Dianhydrogalactitol (VAL-083) offers potential therapeutic alternatives in the treatment of pediatric brain tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Medulloblastoma; Clinical trial; Oncology; Internal medicine; Brain tumor; Methyltransferase; Glioma; Cancer research; In vivo; Cancer; Pathology; Biology; Methylation; DNA","score_opus":0.08668547766704972,"score_gpt":0.419772125077255,"score_spread":0.33308664741020527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394531238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830858,0.003431189,0.0000022287315,0.011917709,0.00008952159,0.0008560727,0.00003070794,0.000010469584,0.0005762873],"genre_scores_gemma":[0.9928023,0.005970633,0.0000049409973,0.00006159933,0.0003774478,0.00049931754,0.0000037594355,0.000020775647,0.00025922596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812573,0.00018380184,0.00023520361,0.00029478307,0.000719717,0.00044074625],"domain_scores_gemma":[0.9987123,0.0006448306,0.00006372845,0.00036360204,0.000109319175,0.000106217325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004163582,0.00014848358,0.00026295887,0.00034657374,0.00007101131,0.000020241116,0.00017065278,0.00005189868,0.0004086636],"category_scores_gemma":[0.000051213417,0.000068958834,0.0001334581,0.00040837572,0.00017097672,0.00006743596,0.000017975763,0.00012245949,0.000053664113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012302273,0.0060131536,0.651103,0.00016377792,0.00056375057,0.0015667465,0.0045682117,0.000024326237,0.1332198,0.00035578187,0.002224681,0.19896653],"study_design_scores_gemma":[0.006139241,0.0016165747,0.91727775,0.00013193313,0.00008351302,0.000014481667,0.0005029225,0.000008212875,0.07143715,0.0002716454,0.002401738,0.00011484132],"about_ca_topic_score_codex":0.0013703904,"about_ca_topic_score_gemma":0.00016390518,"teacher_disagreement_score":0.26617473,"about_ca_system_score_codex":0.00047072253,"about_ca_system_score_gemma":0.00025665038,"threshold_uncertainty_score":0.44745797},"labels":[],"label_agreement":null},{"id":"W2394540622","doi":"10.1158/1538-7445.sabcs15-p2-12-13","title":"Abstract P2-12-13: Modified pectoral nerves block for postoperative analgesia after modified radical mastectomy: A comparative study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Modified Radical Mastectomy; Intercostal nerves; Anesthesia; Surgery; Radical mastectomy; Mastectomy; Nerve block; Breast cancer; Cancer; Internal medicine","score_opus":0.16279360198035775,"score_gpt":0.42749111154602076,"score_spread":0.264697509565663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394540622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871964,0.00047084977,0.00027884697,0.0064643663,0.00004749538,0.0037986776,0.000019405355,0.00005746672,0.0016664971],"genre_scores_gemma":[0.985995,0.00004028019,0.00008643396,0.00036156917,0.0003257528,0.002464316,0.000009273888,0.000041125393,0.010676267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970129,0.00036934705,0.00034963328,0.0006477445,0.0008742316,0.0007461124],"domain_scores_gemma":[0.9981799,0.0004919435,0.00005828312,0.00048634212,0.00045064726,0.00033290024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011760851,0.00026484643,0.00055090897,0.00030383197,0.00023018938,0.000071235634,0.00026171777,0.00010627778,0.00057992124],"category_scores_gemma":[0.00008672327,0.00016310194,0.00014914798,0.0003026056,0.00038430552,0.00012877377,0.0000787517,0.0003750348,0.00007309131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10683425,0.010178896,0.56396496,0.001729369,0.005446242,0.0038357787,0.042132743,0.00082226214,0.10295237,0.0053018276,0.124413244,0.032388087],"study_design_scores_gemma":[0.01431421,0.004317142,0.9567454,0.0006095106,0.0001793303,0.0000140313305,0.0040001227,0.00076899707,0.0038892908,0.00024971538,0.014352662,0.0005596022],"about_ca_topic_score_codex":0.00044385382,"about_ca_topic_score_gemma":0.00051387394,"teacher_disagreement_score":0.39278045,"about_ca_system_score_codex":0.000389034,"about_ca_system_score_gemma":0.00033089463,"threshold_uncertainty_score":0.6651104},"labels":[],"label_agreement":null},{"id":"W2394789034","doi":"10.1158/1538-7445.nonrna15-b07","title":"Abstract B07: Long noncoding RNAs underlying genetic predispositions to prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Cancer; Biology; Single-nucleotide polymorphism; Transcriptome; Enhancer; Gene; Genetics; Long non-coding RNA; Epigenetics; microRNA; SNP; Cancer research; Computational biology; Bioinformatics; Downregulation and upregulation; Gene expression; Genotype","score_opus":0.06944224454658175,"score_gpt":0.4178872573687018,"score_spread":0.34844501282212004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394789034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656463,0.0045263944,0.022280365,0.0038648706,0.00045979617,0.0016744194,0.00027153714,0.000051075738,0.0012252235],"genre_scores_gemma":[0.98810214,0.0037851844,0.00031893275,0.00019770503,0.000605264,0.0015665086,0.000021638885,0.00010498542,0.0052976217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965287,0.00016996084,0.0003036552,0.0008968084,0.00088957866,0.0012113318],"domain_scores_gemma":[0.9980127,0.000061924344,0.000055992732,0.00071057404,0.0006573399,0.0005014347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066467916,0.00023770508,0.00019490292,0.00030838387,0.00039969076,0.00012696136,0.0005935645,0.00022268566,0.0007369587],"category_scores_gemma":[0.00019993805,0.0001974701,0.00011447497,0.0005868387,0.00020015024,0.00001546825,0.00047573342,0.00039694764,0.00014898878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002486034,0.000039243027,0.00035645952,0.000059807906,0.00009552706,0.000037289767,0.00009466857,0.000930844,0.9454848,0.000043227014,0.005509005,0.047100525],"study_design_scores_gemma":[0.0012179933,0.00042299935,0.012073319,0.0006337941,0.000018671642,0.000016330996,0.00009880801,0.000031212076,0.9488774,0.00018111564,0.03595529,0.00047308466],"about_ca_topic_score_codex":0.0007854518,"about_ca_topic_score_gemma":0.0017743314,"teacher_disagreement_score":0.04662744,"about_ca_system_score_codex":0.00055637816,"about_ca_system_score_gemma":0.0010555453,"threshold_uncertainty_score":0.8069181},"labels":[],"label_agreement":null},{"id":"W2394805951","doi":"10.1158/1538-7445.sabcs15-p5-14-01","title":"Abstract P5-14-01: A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Oncology; Anastrozole; Odds ratio; Breast cancer; Clinical trial; Cancer; Confidence interval; Randomized controlled trial; Progression-free survival; Gynecology; Estrogen receptor; Tamoxifen; Overall survival","score_opus":0.2738566685408791,"score_gpt":0.534350758404024,"score_spread":0.26049408986314493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394805951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442551,0.027037663,0.0005728326,0.0053980686,0.00034464546,0.0038925335,0.018403275,0.00003683792,0.000059027414],"genre_scores_gemma":[0.98325574,0.0072755287,0.0026692846,0.000057302106,0.00046343284,0.0052857366,0.00012848001,0.000105632695,0.0007588284],"study_design_codex":"meta_analysis","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996097,0.00016165077,0.0011327158,0.00093037286,0.00085012085,0.0008281221],"domain_scores_gemma":[0.99207854,0.0035910707,0.0006366216,0.0007112103,0.0026769456,0.00030559071],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009126856,0.00044667692,0.0025651339,0.00049578625,0.00014285021,0.000017324079,0.00033635256,0.00017477525,0.0016110118],"category_scores_gemma":[0.00017287896,0.00026916072,0.001597936,0.00074785255,0.0008505039,0.00024205347,0.000046013516,0.00014997646,0.0000037309167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10227852,0.0012856807,0.0029602519,0.00025030418,0.30127695,0.00000771251,0.0014290803,0.000445911,0.29836082,0.0009883859,0.000089907466,0.29062647],"study_design_scores_gemma":[0.05322834,0.01984051,0.060616586,0.0005605598,0.10456747,0.000007826504,0.0020153238,0.00011273202,0.7456618,0.0017695387,0.010613474,0.0010058418],"about_ca_topic_score_codex":0.0013850823,"about_ca_topic_score_gemma":0.0006964381,"teacher_disagreement_score":0.44730097,"about_ca_system_score_codex":0.00083180965,"about_ca_system_score_gemma":0.0008885935,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W2395259318","doi":"10.1158/1538-7445.sabcs15-p5-07-07","title":"Abstract P5-07-07: Fluorescence quantitative image analysis of HER2 evaluation against current clinical HER2 assays in breast cancer testing","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Immunohistochemistry; Tissue microarray; Breast cancer; Trastuzumab; Fluorescence in situ hybridization; Pathology; Medicine; Cancer; In situ hybridization; Pathological; Oncology; Internal medicine; Biology; Gene expression; Gene; Chromosome","score_opus":0.18462813053676827,"score_gpt":0.5342390260089249,"score_spread":0.3496108954721566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395259318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474746,0.00094829255,0.0022574672,0.0008906426,0.00005863706,0.000468825,0.00033021998,0.000015432373,0.00028301566],"genre_scores_gemma":[0.993185,0.0031305724,0.003212124,0.000022894776,0.00012838621,0.00022257047,0.00004831532,0.00001814292,0.000031980573],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800557,0.00024390998,0.00043870925,0.00053391804,0.00043874976,0.00033912723],"domain_scores_gemma":[0.9978913,0.00016003496,0.00017676978,0.0004363839,0.0012459408,0.00008956857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020048292,0.00012393718,0.00023540312,0.00017030601,0.000082202234,0.00001725851,0.00026114107,0.000115480965,0.00007775178],"category_scores_gemma":[0.00055448245,0.00009506974,0.00010937654,0.00080970174,0.00038783514,0.000013115124,0.00014106913,0.00024424292,0.000010462279],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007719351,0.00011331683,0.02422085,0.000019359904,0.000077588615,9.261505e-7,0.000015748063,0.00010225125,0.75304794,0.000037996975,0.00054657174,0.22174025],"study_design_scores_gemma":[0.0012377383,0.00022042722,0.69600576,0.00088091096,0.00018185726,0.0000013464806,0.00015377557,0.006299206,0.2907921,0.0006726345,0.0030419126,0.00051231537],"about_ca_topic_score_codex":0.0005528429,"about_ca_topic_score_gemma":0.000502831,"teacher_disagreement_score":0.6717849,"about_ca_system_score_codex":0.00016980864,"about_ca_system_score_gemma":0.00046750292,"threshold_uncertainty_score":0.38768318},"labels":[],"label_agreement":null},{"id":"W2395439453","doi":"10.1158/1538-7445.sabcs15-s1-08","title":"Abstract S1-08: High risk premenopausal luminal A breast cancer patients derive no benefit from adjuvant chemotherapy: Results from DBCG77B randomized trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of Ottawa; University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cyclophosphamide; Chemotherapy; Randomized controlled trial; Axillary lymph nodes; Cancer; Radiation therapy; Tissue microarray","score_opus":0.019404971663996684,"score_gpt":0.3175649996941471,"score_spread":0.2981600280301504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395439453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682002,0.0019017799,0.000015272482,0.0016383711,0.0009832017,0.0015938024,0.025395269,0.000030105446,0.00024201212],"genre_scores_gemma":[0.9845118,0.007945423,0.00009605424,0.00012183173,0.0038391524,0.0017405722,0.0009774783,0.000085284744,0.000682426],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960189,0.00035518245,0.0006316209,0.0012477118,0.0008872319,0.00085936324],"domain_scores_gemma":[0.9971544,0.0005174995,0.0003463673,0.0007535758,0.00096982135,0.00025835063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005791879,0.00044290768,0.00076709327,0.00008870524,0.00031304074,0.00006732555,0.0005148896,0.00027607556,0.001418312],"category_scores_gemma":[0.0004168344,0.0002977424,0.00021101967,0.00015687442,0.0006289245,0.000021959182,0.00030420406,0.00030400587,0.00020773234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87614423,0.00045123431,0.0059578507,0.000011697486,0.0016536019,0.000007191133,0.00027645382,0.000006009555,0.06406666,0.0000030479962,0.015615798,0.035806205],"study_design_scores_gemma":[0.790331,0.0004871964,0.13145612,0.00031145627,0.00019142721,5.6674435e-7,0.000042183197,0.0000028055692,0.069892906,0.00033204633,0.0064427736,0.00050954026],"about_ca_topic_score_codex":0.058714643,"about_ca_topic_score_gemma":0.0037654554,"teacher_disagreement_score":0.12549827,"about_ca_system_score_codex":0.00046966085,"about_ca_system_score_gemma":0.00048356145,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W2395879256","doi":"10.1158/1538-7445.sabcs15-p1-01-11","title":"Abstract P1-01-11: Nuclear immunohistochemical IKK-ϵexpression in flat epithelial atypia (FEA) of the breast: A predictor of ipsilateral ADH, in-situ or invasive malignancy?","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pathology; Ductal carcinoma; Immunohistochemistry; Breast cancer; Carcinoma in situ; Nuclear atypia; Biopsy; Atypia; Malignancy; Lobular carcinoma; Medicine; Prostate cancer; Cancer; Hyperplasia; Carcinoma; Biology; Internal medicine","score_opus":0.04258063469602266,"score_gpt":0.3381571850960804,"score_spread":0.2955765504000577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395879256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996504,0.00044184964,5.5105966e-7,0.0015439687,0.0001421081,0.00062889466,0.00012569412,0.000010135367,0.00060279795],"genre_scores_gemma":[0.99863136,0.00024940012,0.000022726781,0.000032817232,0.00016700635,0.0000767402,0.0000035802707,0.000036402544,0.0007799612],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772745,0.0001590303,0.0004980499,0.00035626264,0.00075297256,0.00050624966],"domain_scores_gemma":[0.998613,0.00026797407,0.00011814776,0.0006210486,0.00023294428,0.00014685615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005474484,0.0001605307,0.00040999756,0.00024964052,0.00005463323,0.0000073875917,0.00040865736,0.00021126364,0.001252875],"category_scores_gemma":[0.00023522398,0.00008322762,0.00013132629,0.00048496385,0.00053564744,0.0001082442,0.0003050445,0.00048334122,0.000016991882],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031377473,0.00016412912,0.06159128,0.00029026685,0.000019273593,0.00005807131,0.00066484674,6.203312e-7,0.9298809,0.000057911417,0.0013361189,0.0027988397],"study_design_scores_gemma":[0.0029713984,0.00014212332,0.7037766,0.0052450886,0.00001135029,0.00005673394,0.00017301594,0.0000030986048,0.28709707,0.00006799765,0.00036496375,0.00009055225],"about_ca_topic_score_codex":0.0011942027,"about_ca_topic_score_gemma":0.0006555654,"teacher_disagreement_score":0.6427838,"about_ca_system_score_codex":0.00043857636,"about_ca_system_score_gemma":0.0010202323,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W2396097888","doi":"10.1158/1538-7445.fbcr15-ia20","title":"Abstract IA20: Chromatin looping factors and breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chromatin; Breast cancer; Estrogen receptor; Cancer research; Cancer; Estrogen receptor alpha; Promoter; Biology; Bivalent chromatin; ChIA-PET; Chromatin remodeling; Gene; Genetics; Gene expression","score_opus":0.03122379233933099,"score_gpt":0.34521755569678725,"score_spread":0.31399376335745627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396097888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970381,0.0013619536,0.000038006896,0.0007765478,0.00009526804,0.00012781986,0.00020865352,0.0000078618505,0.0003457529],"genre_scores_gemma":[0.99576074,0.0031178966,0.00003528964,0.00003833386,0.0002672276,0.000055466935,0.0000116310275,0.00002687095,0.00068655296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989439,0.000033670818,0.00013062243,0.000327308,0.00018465726,0.00037979527],"domain_scores_gemma":[0.99942225,0.000026838494,0.000038866066,0.00024964756,0.0001358328,0.00012655677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022414264,0.000117710755,0.00010790609,0.00004940324,0.00013329618,0.00004241774,0.00019070944,0.00010637922,0.00034440393],"category_scores_gemma":[0.00003048292,0.00007868418,0.000036567468,0.00007420115,0.00017284835,0.0000049695827,0.00017659937,0.00010319288,0.000009726528],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023424749,0.000013220493,0.034411237,0.000044329063,0.00003353183,0.0000014674093,0.00004131124,0.000005142538,0.9509831,0.000045749035,0.0016642918,0.012733174],"study_design_scores_gemma":[0.0010153967,0.00010748671,0.60288996,0.00029573342,0.000009804709,0.000015305513,0.0002079304,0.000037158832,0.38118887,0.00026584667,0.013541976,0.00042452852],"about_ca_topic_score_codex":0.00048581423,"about_ca_topic_score_gemma":0.00054127316,"teacher_disagreement_score":0.56979424,"about_ca_system_score_codex":0.000079072706,"about_ca_system_score_gemma":0.00019862018,"threshold_uncertainty_score":0.37709814},"labels":[],"label_agreement":null},{"id":"W2396118549","doi":"10.1158/1538-7445.fbcr15-ia13","title":"Abstract IA13: Clonal dynamics of normal and malignant human mammary cell growth in xenografts","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Carcinogenesis; Transcriptome; In vivo; Cancer; Cancer research; Transplantation; Mammary tumor; Oncogene; Cell; Malignant transformation; Breast cancer; Genetics; Cell cycle; Gene; Medicine; Gene expression; Internal medicine","score_opus":0.06276660409646706,"score_gpt":0.40419639746707103,"score_spread":0.341429793370604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396118549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556226,0.0010779285,0.000025046484,0.003889915,0.00007621289,0.0003731981,0.000023495179,0.000011643994,0.008960287],"genre_scores_gemma":[0.99411106,0.0024909566,0.00006303876,0.00006595365,0.0001953677,0.000049330483,0.0000073015617,0.000015252786,0.003001747],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973694,0.00007250524,0.0002863556,0.0003619749,0.0011987009,0.0007110439],"domain_scores_gemma":[0.99867773,0.00020197385,0.00004183847,0.00028674238,0.00040177285,0.00038995603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002032478,0.000108584754,0.00026647502,0.00061032135,0.00008873316,0.000014232157,0.00027179363,0.00009214529,0.00033534007],"category_scores_gemma":[0.00017179674,0.000067276866,0.00004020001,0.0006103599,0.00084413274,0.0001502527,0.000181294,0.00041576158,0.000011257242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050556974,0.00029279248,0.3423791,0.0008869706,0.00002179958,0.0004668334,0.0005843374,2.8033958e-7,0.6203648,0.002723992,0.0025872448,0.029186308],"study_design_scores_gemma":[0.004770558,0.0008904945,0.8780673,0.0011815815,0.000009478977,0.000037331993,0.00052093074,0.000054302458,0.112457804,0.00086209265,0.0009854282,0.00016265937],"about_ca_topic_score_codex":0.0019847525,"about_ca_topic_score_gemma":0.0006953656,"teacher_disagreement_score":0.5356882,"about_ca_system_score_codex":0.00027131726,"about_ca_system_score_gemma":0.00065670535,"threshold_uncertainty_score":0.36717385},"labels":[],"label_agreement":null},{"id":"W2396128270","doi":"10.1158/1538-7445.sabcs15-p1-05-01","title":"Abstract P1-05-01: The epithelial to mesenchymal transition: Identifying a signature of recurrence in ductal carcinoma in situ","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Sunnybrook Health Science Centre","funders":"","keywords":"Ductal carcinoma; Epithelial–mesenchymal transition; Breast cancer; Gene signature; Cancer research; Tumor progression; In situ; Pathology; Biology; Oncology; Cancer; Gene expression; Medicine; Internal medicine; Gene; Metastasis; Chemistry","score_opus":0.04227573891008681,"score_gpt":0.3673524528648054,"score_spread":0.3250767139547186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396128270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927789,0.002260339,0.00064743217,0.0029216146,0.00018530006,0.000726636,0.00007030663,0.0000043651553,0.00040507969],"genre_scores_gemma":[0.9985149,0.0006191857,0.00004381525,0.000060833692,0.00024660895,0.00027248007,0.000008600663,0.000028883487,0.00020470882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973481,0.00030144752,0.00032564916,0.000589039,0.00074436615,0.0006913896],"domain_scores_gemma":[0.99896073,0.00008253832,0.000044435186,0.0005197575,0.00025359247,0.0001389561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014670413,0.00015607849,0.0001954719,0.00033388328,0.00008108441,0.00003041114,0.00062174205,0.00023783509,0.00014490158],"category_scores_gemma":[0.00030071664,0.00011088031,0.000092792485,0.00081175554,0.00023605344,0.000013517583,0.00023800075,0.0006047481,0.000013755641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057385606,0.000051080162,0.00013279692,0.000055865825,0.000016389964,0.00007677507,0.00051195023,0.00015735274,0.98995924,0.000086155975,0.0007516034,0.0076269573],"study_design_scores_gemma":[0.0010000375,0.00023549382,0.009403037,0.00030337,0.0000028278937,0.000012214696,0.00027662973,0.000008460369,0.9864427,0.0002092793,0.0019478253,0.00015812305],"about_ca_topic_score_codex":0.0010165323,"about_ca_topic_score_gemma":0.0036236069,"teacher_disagreement_score":0.00927024,"about_ca_system_score_codex":0.00023436997,"about_ca_system_score_gemma":0.000685154,"threshold_uncertainty_score":0.4521568},"labels":[],"label_agreement":null},{"id":"W2396137434","doi":"10.1158/1538-7445.sabcs15-p5-02-07","title":"Abstract P5-02-07: Effect of multidisciplinary case conferences on physician decision making: Breast diagnostic rounds","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multidisciplinary approach; Family medicine","score_opus":0.15091774622842621,"score_gpt":0.49022981125434156,"score_spread":0.3393120650259154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396137434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935264,0.00074239797,0.000061057166,0.0008040501,0.00018351816,0.0005809877,0.00009861011,0.000029698836,0.003973271],"genre_scores_gemma":[0.99889827,0.00025543966,0.000038701895,0.000057307858,0.00043119185,0.00014403043,0.0000039028473,0.00002532632,0.00014583964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99730265,0.00015840607,0.00030871373,0.00046970288,0.001169782,0.0005907698],"domain_scores_gemma":[0.99442464,0.004319098,0.00009449344,0.0004886603,0.0004488239,0.00022427572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012133023,0.00019881625,0.00041975421,0.00022855114,0.00020813041,0.00003554786,0.00024370031,0.000115366594,0.00059248816],"category_scores_gemma":[0.000993537,0.000116353134,0.00012721244,0.00038620684,0.00036995567,0.00016611775,0.0001491286,0.00039410513,0.00019131937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006525037,0.00018879733,0.14041002,0.0004011013,0.00010580498,0.005087199,0.00026294158,0.000038838687,0.025923964,0.00029279746,0.00390169,0.8168618],"study_design_scores_gemma":[0.00759789,0.008180084,0.87861645,0.028364265,0.00015438457,0.0015107438,0.0010801716,0.00013714688,0.07114777,0.0013262642,0.0012608037,0.00062399876],"about_ca_topic_score_codex":0.0012678036,"about_ca_topic_score_gemma":0.00032277848,"teacher_disagreement_score":0.8162378,"about_ca_system_score_codex":0.00042163068,"about_ca_system_score_gemma":0.00047089782,"threshold_uncertainty_score":0.64873296},"labels":[],"label_agreement":null},{"id":"W2396181567","doi":"10.1158/1538-7445.sabcs15-p3-07-16","title":"Abstract P3-07-16: Comparing surrogates of oncotype Dx recurrence scores in invasive ductal carcinoma: How complicated does it have to be?","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Surrogate endpoint; Internal medicine; Breast cancer; Oncology; Urology; Nuclear medicine; Gastroenterology; Cancer","score_opus":0.11224042664940287,"score_gpt":0.38424886797946695,"score_spread":0.2720084413300641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396181567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914719,0.0011941165,0.000008258878,0.0062407944,0.00009764222,0.00039017524,0.00013155295,0.0000074939703,0.00045806167],"genre_scores_gemma":[0.99857557,0.0007303858,0.000045045457,0.000052101874,0.000123433,0.00024703794,0.00003394301,0.00002255615,0.00016991298],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982864,0.00009818396,0.00021159514,0.0005549322,0.0003316249,0.00051722507],"domain_scores_gemma":[0.99876267,0.0001584634,0.000074866715,0.00040972984,0.00046321,0.0001310429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029088368,0.00018333888,0.0002925394,0.00014799545,0.00009485795,0.000029748304,0.00038889807,0.000091347,0.000059569415],"category_scores_gemma":[0.00028164152,0.00012308042,0.000058244535,0.00022515564,0.00041267514,0.000014130041,0.00039379616,0.00015187291,0.000012954868],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004590713,0.00008470758,0.52163786,0.00006901194,0.00006476093,0.000008965554,0.0004174694,0.000006141912,0.4738834,0.0000121683415,0.0019970695,0.0013593822],"study_design_scores_gemma":[0.0008044852,0.0001581983,0.45614612,0.00024717068,0.0000061000883,0.000002660125,0.0008112748,7.349654e-7,0.54111767,0.00003296633,0.0005284175,0.00014420888],"about_ca_topic_score_codex":0.0048185154,"about_ca_topic_score_gemma":0.05253859,"teacher_disagreement_score":0.06723428,"about_ca_system_score_codex":0.00027109234,"about_ca_system_score_gemma":0.00032158184,"threshold_uncertainty_score":0.9647501},"labels":[],"label_agreement":null},{"id":"W2396440731","doi":"10.1158/1538-7445.chromepi15-b24","title":"Abstract B24: High-dimensional genomic data integration and bias correction using MANCIE","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenomics; Computational biology; Identification (biology); Principal component analysis; Normalization (sociology); Genome; Genomics; genomic DNA; Biology; Computer science; Genetics; Artificial intelligence; DNA methylation; DNA; Gene","score_opus":0.22096931055535696,"score_gpt":0.4234801726731524,"score_spread":0.20251086211779545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396440731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959844,0.0009655753,0.0016503626,0.00062044704,0.0004654296,0.00014007444,0.000045325458,0.000007580259,0.00012080028],"genre_scores_gemma":[0.99708194,0.0008643487,0.00017405239,0.000058574118,0.00040924046,0.000028094704,0.000098672615,0.000015339774,0.001269749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998939,0.00007802751,0.00012678729,0.0004385595,0.00021928118,0.00019837517],"domain_scores_gemma":[0.9992048,0.00002466609,0.000048619066,0.0004726809,0.00016998277,0.000079252844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051399384,0.00007807014,0.00006580577,0.0000818189,0.00014287088,0.00003505074,0.00019888509,0.00009371286,0.00013412457],"category_scores_gemma":[0.000117768315,0.000055250774,0.0000144174655,0.000098955046,0.000112635775,0.000014000425,0.00023496225,0.00009976918,0.000014355387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000910795,0.000012334878,0.00058163126,0.0000053436092,0.000008689101,4.5828725e-7,0.0000078683315,0.000017184664,0.9191736,0.00002277518,0.016038848,0.06404019],"study_design_scores_gemma":[0.00059178873,0.000076819364,0.037921276,0.000113888695,0.000006822039,0.000008166506,0.00006793018,0.0006673757,0.92246044,0.00012299964,0.03780297,0.0001595284],"about_ca_topic_score_codex":0.00025960008,"about_ca_topic_score_gemma":0.0001256625,"teacher_disagreement_score":0.06388066,"about_ca_system_score_codex":0.00008578873,"about_ca_system_score_gemma":0.0002556033,"threshold_uncertainty_score":0.22530612},"labels":[],"label_agreement":null},{"id":"W2396656778","doi":"10.1158/1538-7445.fbcr15-a39","title":"Abstract A39: Sall2 tumor suppressor protein is a novel Casein Kinase 2 target","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Casein kinase 2; Kinase; Phosphorylation; Biology; Immunoprecipitation; Cell biology; Subcellular localization; Protein kinase A; Arabidopsis; Biochemistry; Cyclin-dependent kinase 2; Cytoplasm; Gene","score_opus":0.036862390408808704,"score_gpt":0.3508441170997955,"score_spread":0.3139817266909868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396656778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904261,0.0028041864,0.00008352222,0.0041506705,0.00016949401,0.00047131805,0.00027549345,0.0000150479555,0.0016041489],"genre_scores_gemma":[0.9882692,0.0006089828,0.00012010857,0.00024291067,0.0008301495,0.0003942241,0.000018344106,0.00004190294,0.009474149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818164,0.000054888027,0.0001893244,0.0005238487,0.00041610486,0.00063417],"domain_scores_gemma":[0.9989855,0.000017306364,0.000050477902,0.00043807505,0.0002817937,0.00022679925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036760484,0.00016154998,0.00014064334,0.00008024366,0.0001382827,0.00003796099,0.00035778733,0.00017087204,0.00074219605],"category_scores_gemma":[0.00008598509,0.00010299895,0.00009886709,0.00017327588,0.0002562352,0.000008496089,0.00015646956,0.00026702424,0.00012345191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003178438,0.000058700618,0.00010833243,0.000055447927,0.000062113526,0.000037791804,0.000029560966,0.000006840301,0.969281,0.000042277643,0.027391193,0.0026088664],"study_design_scores_gemma":[0.00076049403,0.00014481721,0.00038622433,0.00011826854,0.0000030431133,0.000007981551,0.000027108723,0.0000024784833,0.76852655,0.000069909845,0.2298007,0.00015238454],"about_ca_topic_score_codex":0.00042138566,"about_ca_topic_score_gemma":0.000045936114,"teacher_disagreement_score":0.20240952,"about_ca_system_score_codex":0.00010948551,"about_ca_system_score_gemma":0.00050996407,"threshold_uncertainty_score":0.81265265},"labels":[],"label_agreement":null},{"id":"W2396834739","doi":"10.1158/1538-7445.am2015-934","title":"Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ontario Institute for Cancer Research; Jewish General Hospital","funders":"","keywords":"Medicine; Adiponectin; Internal medicine; Multiple myeloma; Cohort; Prospective cohort study; Odds ratio; Prostate cancer; Confidence interval; Cancer; Cohort study; Oncology; Body mass index; Logistic regression; Obesity; Insulin resistance","score_opus":0.09717574872119188,"score_gpt":0.36689783792661496,"score_spread":0.26972208920542307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396834739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933366,0.0056180367,0.000040580882,0.00004450177,0.00044958357,0.0001939731,0.00007687397,0.000003870348,0.000235978],"genre_scores_gemma":[0.9976419,0.00042385017,0.00022034756,0.0000114432005,0.0015324906,0.000034953802,0.000015075941,0.000015175597,0.00010475184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998942,0.00011627817,0.00021447832,0.00023525333,0.00028032696,0.00021163849],"domain_scores_gemma":[0.99898547,0.000055323362,0.00011877962,0.00022947385,0.00046938148,0.00014159383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010467584,0.00007931651,0.00016158336,0.00008459981,0.000050044324,0.000010069505,0.00011018614,0.000100404184,0.00001359675],"category_scores_gemma":[0.0008351127,0.00007671752,0.00004870322,0.0001623019,0.00022875408,0.0000064269784,0.000090126996,0.00015059917,0.000001042925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113852126,0.000010774437,0.072073594,0.000071988565,0.00007172069,6.545168e-8,0.00045104767,0.00008408522,0.9182247,0.000016916722,0.0015834314,0.007297821],"study_design_scores_gemma":[0.0011948313,0.0001157933,0.348514,0.00006446384,0.000027934242,0.0000025059865,0.00041185413,0.00007357211,0.6402955,0.0002146942,0.008975621,0.00010924634],"about_ca_topic_score_codex":0.0026716022,"about_ca_topic_score_gemma":0.00063306844,"teacher_disagreement_score":0.27792922,"about_ca_system_score_codex":0.000026869604,"about_ca_system_score_gemma":0.00043066865,"threshold_uncertainty_score":0.4038681},"labels":[],"label_agreement":null},{"id":"W2396850485","doi":"10.1158/1538-7445.nonrna15-b37","title":"Abstract B37: Small nucleolar RNAs – New players in breast cancer prognosis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Alberta","funders":"","keywords":"Small nucleolar RNA; Biology; Biogenesis; Long non-coding RNA; Breast cancer; Carcinogenesis; Computational biology; Transcriptome; Methylation; Cancer research; Genetics; Cancer; RNA; Gene; Bioinformatics; Gene expression","score_opus":0.07206232815696877,"score_gpt":0.3754215845595633,"score_spread":0.30335925640259453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396850485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98723537,0.003733253,0.000092888906,0.0072701066,0.00013774584,0.00032617402,0.00013431042,0.000011853879,0.001058327],"genre_scores_gemma":[0.9851826,0.00846701,0.000058795984,0.00014596806,0.00058836956,0.0004579197,0.00000919956,0.000036704223,0.005053459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984336,0.00005969441,0.00019339148,0.00049480255,0.0002694743,0.00054905936],"domain_scores_gemma":[0.999123,0.000021485554,0.000044949506,0.00039765573,0.00021147638,0.00020147159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037469098,0.000133635,0.00012407123,0.00011730505,0.000097451375,0.000044153385,0.00039157606,0.00015272552,0.0009040135],"category_scores_gemma":[0.00003380817,0.00009918169,0.00006224797,0.0002709043,0.00014891921,0.000009987472,0.00010756249,0.00019078866,0.000055114673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001836155,0.000055356348,0.032781433,0.000021391119,0.000036162946,0.0000042214906,0.00004367613,0.000027950671,0.8177046,0.00010926813,0.022949986,0.12608235],"study_design_scores_gemma":[0.0016898782,0.00009157956,0.30915916,0.00028182677,0.000008761346,0.0000062358336,0.000109924935,0.000007462001,0.38823596,0.00014979656,0.2998747,0.0003847254],"about_ca_topic_score_codex":0.0039625205,"about_ca_topic_score_gemma":0.0026906272,"teacher_disagreement_score":0.42946863,"about_ca_system_score_codex":0.00020480552,"about_ca_system_score_gemma":0.0008646431,"threshold_uncertainty_score":0.9898314},"labels":[],"label_agreement":null},{"id":"W2397000609","doi":"10.1158/1538-7445.sabcs15-p2-02-09","title":"Abstract P2-02-09: Obesity associated factors are inversely associated with circulating tumor cells in metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Statistics Canada; Western University; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine; Cancer; Breast cancer; Metastatic breast cancer; Adiponectin; Obesity; Oncology; Circulating tumor cell; Metastasis; Insulin resistance","score_opus":0.1075769733433825,"score_gpt":0.3809120954141881,"score_spread":0.27333512207080557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397000609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581265,0.00029678535,0.0000034940772,0.0010094631,0.00019005511,0.00084249186,0.0014276555,0.000087961074,0.00032941208],"genre_scores_gemma":[0.9983977,0.00023761312,0.00000552909,0.00012404143,0.00012167796,0.00018454778,0.00003302051,0.000087538836,0.00080832565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588126,0.00026555095,0.0004794113,0.0006960583,0.001449876,0.0012278584],"domain_scores_gemma":[0.99744576,0.0006249181,0.00031739,0.00039709694,0.0007485805,0.0004662588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011910386,0.00034352616,0.00075994036,0.00044602592,0.00022218462,0.000067523186,0.0002495026,0.00014696358,0.0024787486],"category_scores_gemma":[0.0005063082,0.00022142187,0.00013896315,0.0013375103,0.00032299312,0.0002679161,0.0000907046,0.0009497082,0.0000398977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031797925,0.00036531477,0.9539474,0.00013544082,0.00034958601,0.0003258576,0.0006984959,0.000052270014,0.039785035,0.0000057427146,0.002084598,0.0019322276],"study_design_scores_gemma":[0.0034982723,0.00012036947,0.9838538,0.0026122024,0.00007921018,0.0000053186745,0.00085723173,0.00004515488,0.008326394,0.000032908745,0.00024862084,0.00032049176],"about_ca_topic_score_codex":0.0318236,"about_ca_topic_score_gemma":0.03485482,"teacher_disagreement_score":0.031458642,"about_ca_system_score_codex":0.0044691893,"about_ca_system_score_gemma":0.0015450022,"threshold_uncertainty_score":0.99935246},"labels":[],"label_agreement":null},{"id":"W2397017190","doi":"10.1158/1538-7445.sabcs15-ss1-1","title":"Abstract SS1-1: Breast cancer early detection strategies in absence of screening mammography","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mammography; Breast cancer; Randomized controlled trial; Incidence (geometry); Cancer; Breast cancer screening; Clinical trial; Gold standard (test); Gynecology; Surgery; Internal medicine","score_opus":0.13539395898854634,"score_gpt":0.434516035130753,"score_spread":0.29912207614220665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397017190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476236,0.0016811055,0.00034618215,0.00107439,0.00009875831,0.00032789382,0.0000614481,0.000031733045,0.0016161266],"genre_scores_gemma":[0.99796784,0.0013386951,0.000091319605,0.000039570263,0.0002341022,0.00016058207,8.962994e-7,0.000021811156,0.0001451616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758613,0.00006775243,0.00033661723,0.0003891217,0.0009834468,0.0006369351],"domain_scores_gemma":[0.9987435,0.0001326293,0.000086940694,0.00030739908,0.0005453891,0.00018417774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008594589,0.00014223064,0.00028332608,0.0005066011,0.000088977984,0.000038903312,0.00021925218,0.000120274846,0.00061990233],"category_scores_gemma":[0.00006062792,0.0001019918,0.000095170464,0.0011486664,0.00035744745,0.00045947128,0.00006500121,0.00044261542,0.000013962946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011564187,0.000033499393,0.44622794,0.00014914521,0.000043649085,0.00005471231,0.00021833736,0.00004098259,0.3794355,0.00011800385,0.00017793797,0.17234385],"study_design_scores_gemma":[0.0009873046,0.00015343905,0.9598766,0.0024831546,0.000008084015,0.00001630428,0.00073411147,0.000011327825,0.03503391,0.00027496685,0.0002985552,0.00012226078],"about_ca_topic_score_codex":0.032000054,"about_ca_topic_score_gemma":0.0062171454,"teacher_disagreement_score":0.5136486,"about_ca_system_score_codex":0.000305269,"about_ca_system_score_gemma":0.0005366616,"threshold_uncertainty_score":0.97444594},"labels":[],"label_agreement":null},{"id":"W2397271455","doi":"10.1158/1538-7445.sabcs15-p6-01-01","title":"Abstract P6-01-01: Impact of imaging surveillance on the risk of radiation induced malignancies in breast cancer survivors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Mammography; Context (archaeology); Cancer; Medical physics; Radiology; Nuclear medicine; Internal medicine","score_opus":0.051644629176754574,"score_gpt":0.39748700514647756,"score_spread":0.345842375969723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397271455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190974,0.0009984467,0.0000045226616,0.0058780415,0.000088613066,0.00036830176,0.00021817832,0.000010705547,0.0005234242],"genre_scores_gemma":[0.9959586,0.0036603294,0.0000015779889,0.000047589307,0.00016025193,0.00006952883,0.0000033388249,0.000023123923,0.000075638716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809086,0.00027054714,0.00034692886,0.00024214412,0.00064587867,0.00040362187],"domain_scores_gemma":[0.99828255,0.00076612097,0.00019650903,0.00038661517,0.00027846682,0.00008976587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020205332,0.00012273384,0.00028205098,0.0003641227,0.00006760704,0.000016192784,0.00018755553,0.000046495872,0.00082133804],"category_scores_gemma":[0.00048660763,0.00006637838,0.00010421242,0.0006998862,0.00018383717,0.00016781804,0.0000331647,0.0003257383,0.000012056333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027543763,0.000040668037,0.73952705,0.000039522183,0.00005043613,0.0000030237863,0.00040771975,0.00007148645,0.19725096,0.000018859362,0.0009319269,0.061382912],"study_design_scores_gemma":[0.0008547401,0.000045760153,0.92112166,0.00045933056,0.000005483993,0.0000020319183,0.00014625746,0.00011919374,0.07704748,0.000043920278,0.00008405254,0.000070061586],"about_ca_topic_score_codex":0.039533373,"about_ca_topic_score_gemma":0.0013935886,"teacher_disagreement_score":0.18159464,"about_ca_system_score_codex":0.0005877193,"about_ca_system_score_gemma":0.0007329944,"threshold_uncertainty_score":0.96686244},"labels":[],"label_agreement":null},{"id":"W2397293125","doi":"10.1158/0008-5472.can-15-3179","title":"Toward Value-Based Pricing to Boost Cancer Research and Innovation","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Business; Sustainability; Drug development; Value (mathematics); Health care; Intervention (counseling); Drug; Risk analysis (engineering); Medicine; Pharmacology; Economics; Computer science; Economic growth","score_opus":0.29857279194704067,"score_gpt":0.42109510655226945,"score_spread":0.12252231460522878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397293125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946374,0.0043577757,0.002170346,0.030809702,0.0004948643,0.00076891785,0.00030771358,0.000042016873,0.014674665],"genre_scores_gemma":[0.98824686,0.0016636465,0.00020845549,0.000866866,0.00067765615,0.00061134173,0.0000030741235,0.000058314155,0.007663771],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971823,0.000061604274,0.0006165526,0.0008103462,0.000211835,0.0011173267],"domain_scores_gemma":[0.99807537,0.00034689682,0.00013419091,0.0004707209,0.0007002169,0.0002726256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041222963,0.00017580476,0.00039703527,0.0019400304,0.00037857643,0.00020379707,0.00045215187,0.00016626848,0.001000641],"category_scores_gemma":[0.0009736628,0.00015983706,0.000041081148,0.002313612,0.0003947056,0.00043949205,0.0002373134,0.00046160587,0.0006210778],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005517325,0.00011881732,0.09018324,0.00020378735,0.000078178775,0.000010883063,0.0011783312,0.00012491876,0.019926848,0.76170963,0.044107955,0.08180569],"study_design_scores_gemma":[0.0028584623,0.0007721692,0.07283265,0.0007445375,0.0000042601823,0.000001939304,0.00019835673,0.00018009449,0.03370246,0.12127432,0.7665687,0.000862048],"about_ca_topic_score_codex":0.004302664,"about_ca_topic_score_gemma":0.0002828913,"teacher_disagreement_score":0.72246075,"about_ca_system_score_codex":0.0014907778,"about_ca_system_score_gemma":0.000521262,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W2397327796","doi":"10.1158/1538-7445.sabcs15-p1-11-07","title":"Abstract P1-11-07: The relationship between breast cancer progression and workplace productivity in the US","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Productivity; Cancer; Cohort; Quarter (Canadian coin); Demography; Gerontology; Selection bias; Residence; Disease; Internal medicine; Oncology; Pathology","score_opus":0.15396075813967167,"score_gpt":0.3849355600207593,"score_spread":0.23097480188108763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397327796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94405305,0.005755606,0.000017221444,0.044835664,0.00019401753,0.00062652776,0.0003077815,0.000013392294,0.0041967193],"genre_scores_gemma":[0.9956972,0.0012089034,0.000007371712,0.00011048491,0.00083344546,0.00046000484,0.0000018104121,0.000024447218,0.0016563564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983187,0.00007860626,0.0003968873,0.00050048257,0.000119681274,0.0005856423],"domain_scores_gemma":[0.9982392,0.00092256366,0.00018626427,0.00049232045,0.00006713261,0.00009247475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035437904,0.00014649676,0.00026504585,0.00017734716,0.0003917784,0.00015431698,0.00048753314,0.0001275137,0.00035268738],"category_scores_gemma":[0.00044220663,0.000083616666,0.00004919054,0.00043958053,0.00048297082,0.0005070349,0.00011312745,0.00052248465,0.00013930352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054642733,0.00002598417,0.9559793,0.000027877575,0.000010775372,0.0000014702532,0.00041518526,0.00000675645,0.00002070303,0.022631053,0.0024138321,0.018412456],"study_design_scores_gemma":[0.00040098585,0.00001928696,0.9409856,0.00014770843,0.0000023899747,0.0000021698397,0.000053744676,0.000003050349,0.000042679767,0.020466035,0.03774026,0.00013607414],"about_ca_topic_score_codex":0.0030974373,"about_ca_topic_score_gemma":0.0022174125,"teacher_disagreement_score":0.051644105,"about_ca_system_score_codex":0.0004271997,"about_ca_system_score_gemma":0.00015929175,"threshold_uncertainty_score":0.46824193},"labels":[],"label_agreement":null},{"id":"W2397391873","doi":"10.1158/1538-7445.brain15-a32","title":"Abstract A32: Cell autonomous and cell non-autonomous roles of p75 neurotrophin receptor (p75NTR) in glioma invasion","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; University of Calgary","funders":"","keywords":"Glioma; Low-affinity nerve growth factor receptor; Biology; Cancer research; Population; Neurotrophin; Receptor; Medicine; Genetics","score_opus":0.04440389964121128,"score_gpt":0.29876987323996584,"score_spread":0.25436597359875457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397391873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921499,0.003815963,0.000049015878,0.00006265708,0.00038307888,0.0005085325,0.000056123496,0.00007650564,0.0028982214],"genre_scores_gemma":[0.99809307,0.0010967742,0.00028422213,0.000011085922,0.00014897289,0.00009857047,0.000008871318,0.000091505775,0.00016694062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980297,0.000036915117,0.00041945302,0.0003364162,0.00052655785,0.00065096834],"domain_scores_gemma":[0.9989367,0.00014012567,0.00005725937,0.00040240868,0.00017895825,0.0002845456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407688,0.00022626611,0.0003371693,0.0004856857,0.00005088053,0.000060336904,0.00038468515,0.00017552119,0.0001275363],"category_scores_gemma":[0.000048783946,0.00022679272,0.000043441447,0.0006038373,0.00014845155,0.00024885885,0.0001413763,0.0006640326,0.00007091049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016156616,0.0000685163,0.0009874323,0.00044816954,0.000011508763,0.000051621486,0.0012625526,0.012113298,0.9747212,0.000009682845,0.0018521074,0.0083123455],"study_design_scores_gemma":[0.0021484834,0.0002747051,0.0019109083,0.00014046741,0.000007200493,0.000004212237,0.0003331649,0.0031059408,0.98356473,0.00025825633,0.007922406,0.00032954075],"about_ca_topic_score_codex":0.000814288,"about_ca_topic_score_gemma":0.00030981927,"teacher_disagreement_score":0.009007357,"about_ca_system_score_codex":0.0006229353,"about_ca_system_score_gemma":0.00041883087,"threshold_uncertainty_score":0.9248339},"labels":[],"label_agreement":null},{"id":"W2397554324","doi":"10.1158/1538-7445.sabcs15-p1-01-04","title":"Abstract P1-01-04: Early stage breast cancer prognostication using whole tumor or Ki67 heterogeneity-based digital imaging","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Stage (stratigraphy); Cohort; Oncology; Cancer; Internal medicine; Adjuvant therapy; Pathology; Radiology; Biology","score_opus":0.06494183270319297,"score_gpt":0.42374048315077917,"score_spread":0.3587986504475862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397554324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824871,0.00044021438,0.0021818208,0.01333484,0.00019545316,0.00063346734,0.0002911949,0.0001009078,0.00033501495],"genre_scores_gemma":[0.9971923,0.00007247858,0.00034099637,0.00046214962,0.0007141219,0.00016265684,0.00001954666,0.00008585772,0.0009498779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971344,0.00008476606,0.00034006184,0.00057662884,0.001008363,0.0008558162],"domain_scores_gemma":[0.99822366,0.00032904028,0.000109020875,0.0004368324,0.00041360795,0.00048785872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008154303,0.00021073048,0.00029976416,0.00029451848,0.00026824282,0.00024359152,0.00026683352,0.000057302528,0.00079878856],"category_scores_gemma":[0.00060119084,0.00013486439,0.00009552403,0.0004234404,0.0005024143,0.00037532655,0.00010420914,0.000662676,0.00007448028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009893429,0.00023072866,0.53611016,0.00045680784,0.00009728559,0.00044991632,0.00013084248,0.00016385688,0.27845967,0.000034613644,0.0018511781,0.18102558],"study_design_scores_gemma":[0.010140056,0.00037380922,0.8267361,0.007887195,0.00016308384,0.00029885405,0.00026530825,0.024984356,0.0477236,0.0001355302,0.08016015,0.0011319671],"about_ca_topic_score_codex":0.0016598178,"about_ca_topic_score_gemma":0.000046053716,"teacher_disagreement_score":0.29062593,"about_ca_system_score_codex":0.00068831106,"about_ca_system_score_gemma":0.0013098151,"threshold_uncertainty_score":0.87461746},"labels":[],"label_agreement":null},{"id":"W2397621937","doi":"10.1158/1538-7445.compsysbio-b1-32","title":"Abstract B1-32: Genome-wide integrative analysis correlating locus-specific DNA methylation and hydroxymethylation to gene expression in normal prostate cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Occupational Cancer Research Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"DNA methylation; Biology; Epigenetics; Epigenomics; Gene; CpG site; Gene expression; Genetics; Regulation of gene expression; Enhancer; Carcinogenesis; Methylation; Promoter","score_opus":0.048299162521257384,"score_gpt":0.35654527247666323,"score_spread":0.30824610995540586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397621937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834142,0.0067630108,0.008549195,0.00011934256,0.00008697872,0.00052016706,0.000029656983,0.000007689697,0.00050981325],"genre_scores_gemma":[0.995954,0.0015259995,0.0017018537,0.000019638257,0.00015084598,0.0001147814,0.00021339356,0.000025767027,0.00029374455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997914,0.00029870938,0.00036734255,0.0005745588,0.00045235915,0.00039301527],"domain_scores_gemma":[0.9987539,0.000118878525,0.000108468244,0.0003077662,0.000465491,0.000245516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018824138,0.00017123163,0.00021712742,0.00050639675,0.00012344764,0.00008554347,0.00015027093,0.00016888622,0.000028695029],"category_scores_gemma":[0.00029986157,0.00015780953,0.000056902078,0.00096254,0.00007975675,0.0000234269,0.00017229623,0.0002899269,0.000009663507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018799717,0.000027811295,0.015316373,0.000009593475,0.000051209696,0.00000271423,0.0012312712,0.028759096,0.94803613,0.0000030027168,0.000062524174,0.006312254],"study_design_scores_gemma":[0.0004629801,0.00018456565,0.03968971,0.000023095448,0.000021250975,1.2071719e-7,0.00042966343,0.00060826656,0.95435864,0.00016371708,0.0038638639,0.00019411785],"about_ca_topic_score_codex":0.00022575396,"about_ca_topic_score_gemma":0.00043986234,"teacher_disagreement_score":0.028150829,"about_ca_system_score_codex":0.00013444923,"about_ca_system_score_gemma":0.00015198647,"threshold_uncertainty_score":0.6435285},"labels":[],"label_agreement":null},{"id":"W2397649199","doi":"10.1158/1538-7445.sabcs15-p2-08-29","title":"Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Exemestane; Gene signature; Framingham Risk Score; Cohort; Internal medicine; Risk assessment; Cancer; Tamoxifen; Bioinformatics; Computer science; Gene; Biology; Disease; Gene expression; Genetics","score_opus":0.024945406813875557,"score_gpt":0.36231779323453317,"score_spread":0.3373723864206576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397649199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024594,0.008116891,0.0000047439107,0.00046980532,0.0000587831,0.0005251551,0.00005403587,0.00000340924,0.00052125263],"genre_scores_gemma":[0.99601316,0.0032394968,0.00007086373,0.000011499937,0.00019916664,0.00017388668,0.000027332626,0.000013577832,0.00025098582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863625,0.00027269323,0.00018029289,0.00027725176,0.00032706122,0.0003064569],"domain_scores_gemma":[0.9993437,0.00027333942,0.000058147343,0.0001993422,0.00006981938,0.00005567512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081016717,0.00011151428,0.00014456685,0.000097205295,0.000100651785,0.00001534571,0.00015217689,0.0001262693,0.000012398769],"category_scores_gemma":[0.00040330732,0.000059254635,0.00007208483,0.0001447511,0.000120920085,0.000005743336,0.0000690031,0.00022493774,0.0000025796319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005632764,0.00016406884,0.0036847936,0.000017498693,0.00013149022,0.000056160374,0.00035755913,0.000019167188,0.95222217,0.00009709074,0.0005609317,0.037056327],"study_design_scores_gemma":[0.05371693,0.0034201946,0.02161641,0.0002644971,0.000054719076,0.00002164798,0.00035991622,0.000021002512,0.9136038,0.00048042988,0.0061395764,0.00030089985],"about_ca_topic_score_codex":0.00034891133,"about_ca_topic_score_gemma":0.00007023827,"teacher_disagreement_score":0.04808417,"about_ca_system_score_codex":0.0000661935,"about_ca_system_score_gemma":0.0003122477,"threshold_uncertainty_score":0.2416334},"labels":[],"label_agreement":null},{"id":"W2397731054","doi":"10.1158/1538-7445.sabcs15-p5-12-02","title":"Abstract P5-12-02: Effect of 5 vs 2.5 mg/day letrozole on residual estrogen levels in post-menopausal women with high BMI - A prospective crossover study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Statistics Canada; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Medicine; Breast cancer; Aromatase inhibitor; Tamoxifen; Internal medicine; Estrone; Gynecology; Population; Adverse effect; Estrogen; Cancer; Oncology","score_opus":0.014734006003170945,"score_gpt":0.33656103098804596,"score_spread":0.32182702498487503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397731054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742025,0.00039700535,0.0000013182514,0.00014330374,0.000062240804,0.0014060173,0.00011457592,0.000012280438,0.0004430085],"genre_scores_gemma":[0.9982738,0.000061220984,0.0000065137683,0.000018330338,0.00017563182,0.0006260947,0.00001001091,0.00005331367,0.00077509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972328,0.0004457114,0.00024858618,0.00065467914,0.0006348665,0.00078334304],"domain_scores_gemma":[0.99883276,0.00018808515,0.00008442142,0.000503947,0.00022139148,0.00016937204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013772516,0.00025753182,0.0003421458,0.00017694154,0.00011189175,0.00003401404,0.00033413147,0.00021422465,0.00009976434],"category_scores_gemma":[0.00019445884,0.00015360749,0.000031493833,0.00025561237,0.00032635542,0.0000139320355,0.00017638296,0.00044178843,0.000031529722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014549566,0.00037532262,0.039098445,0.00004629104,0.0003337995,0.00010012244,0.00032417252,0.000032997457,0.94287753,0.000029068626,0.00025696735,0.001975729],"study_design_scores_gemma":[0.0054258816,0.027510805,0.24949552,0.00011701531,0.0000130695535,0.000004055855,0.00010249927,2.0685167e-7,0.7170123,0.000017194534,0.000118057236,0.00018339942],"about_ca_topic_score_codex":0.0004336819,"about_ca_topic_score_gemma":0.0001877512,"teacher_disagreement_score":0.22586522,"about_ca_system_score_codex":0.00032185676,"about_ca_system_score_gemma":0.00043819682,"threshold_uncertainty_score":0.62639314},"labels":[],"label_agreement":null},{"id":"W2397731920","doi":"10.1158/1538-7445.compsysbio-ia19","title":"Abstract IA19: Regulation of signaling interactomes in cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Computational biology; Biology; Context (archaeology); Cancer; Protein–protein interaction; Phenotype; Bioinformatics; Genetics; Gene","score_opus":0.10566311300259158,"score_gpt":0.43441017339254057,"score_spread":0.328747060389949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397731920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954105,0.0019718364,0.00005538967,0.0004373378,0.00015496154,0.00022517549,0.000026044125,0.0000038114606,0.0017149437],"genre_scores_gemma":[0.9975192,0.0011490356,0.00015398255,0.00004066418,0.00027598525,0.000063525935,0.000041272386,0.000013599363,0.00074276625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982323,0.000083947496,0.00032590886,0.0002199968,0.00071783504,0.000420014],"domain_scores_gemma":[0.9988137,0.00004428416,0.0000624337,0.00025320164,0.00061459263,0.00021182711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014281123,0.00009195365,0.00014661762,0.00022487578,0.00003301111,0.000027181088,0.00031342226,0.0001494838,0.00020338518],"category_scores_gemma":[0.0005164349,0.00007954427,0.00004494903,0.00031470685,0.00026633564,0.0000087924345,0.00018882584,0.00026222362,0.000015294128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025769207,0.00007471054,0.008880557,0.00015086141,0.00002680583,0.0000019795673,0.00045795555,0.00034947405,0.9538815,0.00001854295,0.00807682,0.027823089],"study_design_scores_gemma":[0.0009669922,0.00031623576,0.02486086,0.00020319811,0.0000031510888,0.0000010456077,0.000891073,0.00034075638,0.94434184,0.00037563615,0.027536258,0.00016295377],"about_ca_topic_score_codex":0.001059678,"about_ca_topic_score_gemma":0.00075389293,"teacher_disagreement_score":0.027660135,"about_ca_system_score_codex":0.00011325139,"about_ca_system_score_gemma":0.0007353204,"threshold_uncertainty_score":0.3243721},"labels":[],"label_agreement":null},{"id":"W2397893479","doi":"10.1158/1538-7445.sabcs15-ot3-01-01","title":"Abstract OT3-01-01: HERMIONE: A phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician's choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and ado-trastuzumab emtansine (T-DM1)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Anthracycline; Vinorelbine; Internal medicine; Oncology; Clinical endpoint; Metastatic breast cancer; Capecitabine; Hazard ratio; Breast cancer; Interim analysis; Docetaxel; Chemotherapy; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.057093002480880145,"score_gpt":0.42629622262914296,"score_spread":0.3692032201482628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397893479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819883,0.0030879197,0.00009112773,0.0016382576,0.00011563387,0.011895458,0.0006463411,0.000059010283,0.00047793926],"genre_scores_gemma":[0.98794866,0.0067320624,0.00019561185,0.0002872179,0.0002901131,0.0034245919,0.0001617918,0.00018636498,0.0007735715],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940676,0.00063916587,0.0012013856,0.0013971943,0.0012998807,0.001394756],"domain_scores_gemma":[0.995873,0.0013983592,0.0006198629,0.0005603026,0.0009938137,0.0005546983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008968589,0.0008568705,0.003018285,0.0005353165,0.00028625765,0.00010266095,0.00042995706,0.0001749845,0.00066464284],"category_scores_gemma":[0.00009548844,0.00053590414,0.00016353313,0.0011976685,0.0015580618,0.0007078854,0.0001543991,0.00081142,0.0000068079644],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8823967,0.008499456,0.003934438,0.00062271726,0.001881621,0.00037951223,0.0019288873,0.00013259186,0.0098648835,0.000008145176,0.00043278662,0.08991824],"study_design_scores_gemma":[0.95128596,0.012528283,0.020656265,0.005883683,0.00076455576,0.00007698766,0.0003508273,0.00048065156,0.007029038,0.0000206683,0.00023408365,0.000689018],"about_ca_topic_score_codex":0.010769524,"about_ca_topic_score_gemma":0.007242533,"teacher_disagreement_score":0.08922922,"about_ca_system_score_codex":0.0037998185,"about_ca_system_score_gemma":0.003392949,"threshold_uncertainty_score":0.99970925},"labels":[],"label_agreement":null},{"id":"W2398008608","doi":"10.1158/1538-7445.compsysbio-b1-12","title":"Abstract B1-12: RNA Architect: High performance tools to exhaustively detect cancer-specific structural events in RNA sequencing data","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Computer science; Computational biology; Pipeline (software); Exon; RNA splicing; Polyadenylation; Software; Breakpoint; Frame (networking); RNA; Algorithm; Biology; Gene; Genetics","score_opus":0.20335144051109127,"score_gpt":0.3915066017141225,"score_spread":0.18815516120303122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398008608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587846,0.002060455,0.00014381717,0.00023648275,0.0003207428,0.0006697489,0.00021727392,0.000013619517,0.00045939835],"genre_scores_gemma":[0.99667436,0.0010858722,0.0006685441,0.00006453072,0.0006443284,0.00031964306,0.00007846648,0.000046790487,0.00041744908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972177,0.00017603677,0.0003038372,0.0008211282,0.0006779497,0.0008033082],"domain_scores_gemma":[0.9983776,0.000046010133,0.00007083712,0.000982157,0.00020736134,0.000316002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014808337,0.00022452358,0.00023656744,0.00018125672,0.00015260806,0.00006578378,0.0012522903,0.00015871196,0.000127898],"category_scores_gemma":[0.00025488067,0.00020749477,0.00003468999,0.0003275589,0.000087756314,0.000034942128,0.0006861142,0.0004218837,0.00003201153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045392482,0.0000072890593,0.00073543057,0.00003624252,0.000021909771,0.000010769631,0.00012209376,0.0008740201,0.8386245,0.0000091668935,0.00053524814,0.15856944],"study_design_scores_gemma":[0.00063721236,0.0003151918,0.016913978,0.00020603552,0.0000038116682,0.000005678591,0.00014449685,0.00005767229,0.9741062,0.00024421446,0.0070501114,0.00031539056],"about_ca_topic_score_codex":0.0023424528,"about_ca_topic_score_gemma":0.0010698241,"teacher_disagreement_score":0.15825406,"about_ca_system_score_codex":0.00040440913,"about_ca_system_score_gemma":0.000853718,"threshold_uncertainty_score":0.8461391},"labels":[],"label_agreement":null},{"id":"W2398308686","doi":"10.1158/1538-7445.sabcs15-p4-08-03","title":"Abstract P4-08-03: DEAD-box RNA helicase DP103 as a novel regulator of Wnt/β-catenin signaling pathway and promotes cancer stem cell-like behavior in triple negative breast cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Wnt signaling pathway; Cancer research; LRP6; Breast cancer; Biology; LRP5; Cancer stem cell; Cancer; Triple-negative breast cancer; Beta-catenin; Stem cell; Signal transduction; Cell biology; Genetics","score_opus":0.04951274232268202,"score_gpt":0.3456790319530031,"score_spread":0.2961662896303211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398308686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324137,0.004480951,0.000038694227,0.00042352005,0.000103600614,0.00078733533,0.0007612533,0.000009036381,0.00015421129],"genre_scores_gemma":[0.99470013,0.0018019988,0.00007895639,0.000033666496,0.00017566544,0.0014225688,0.000016325814,0.00004934812,0.0017213073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780715,0.000099760546,0.00039384543,0.0006981965,0.0004181001,0.00058296823],"domain_scores_gemma":[0.9986636,0.000055994355,0.00016923423,0.0003844266,0.0005054663,0.00022130397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000541707,0.00022693705,0.00028001197,0.00017186921,0.00014016441,0.000040994633,0.00031621335,0.00020526312,0.00021051822],"category_scores_gemma":[0.000030930976,0.00017709984,0.00008158818,0.00036076843,0.0004582733,0.000023845436,0.00013700873,0.0002386001,0.000008079506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042830096,0.00012031834,0.0015201318,0.00008926973,0.000039779763,0.00000774608,0.00021693905,0.000032288724,0.9706878,0.000035969195,0.0002484959,0.026572945],"study_design_scores_gemma":[0.0017851476,0.00019576335,0.0074092434,0.00025147575,0.000015858777,0.000009455105,0.00033651976,0.000010444681,0.9889064,0.000032415184,0.0007980885,0.00024918563],"about_ca_topic_score_codex":0.007892028,"about_ca_topic_score_gemma":0.0021789838,"teacher_disagreement_score":0.02632376,"about_ca_system_score_codex":0.00037267015,"about_ca_system_score_gemma":0.0014700001,"threshold_uncertainty_score":0.9987145},"labels":[],"label_agreement":null},{"id":"W2398393048","doi":"10.1158/1538-7445.sabcs15-p1-07-10","title":"Abstract P1-07-10: Increasing population rates of in-situ breast cancer [DCIS] are associated with reduced breast cancer (BrCa) mortality. A case for screening mammography and \"overdiagnosis\" linked to outcome benefits","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of Toronto; University of British Columbia; Centre for Advancing Health Outcomes; St. Michael's Hospital; Providence Health Care; BC Cancer Agency; University of British Columbia Hospital","funders":"","keywords":"Overdiagnosis; Medicine; Cancer registry; Demography; Breast cancer; Population; Mammography; Cancer; Gynecology; Cohort; Incidence (geometry); Internal medicine; Environmental health","score_opus":0.1345046378724988,"score_gpt":0.43522975227186234,"score_spread":0.30072511439936356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398393048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968774,0.0013573774,0.0000089954365,0.0036787805,0.000105856605,0.0016480364,0.003442353,0.00003860919,0.00003224791],"genre_scores_gemma":[0.99736935,0.00081441127,0.00004793239,0.000111864516,0.00032388096,0.0011091474,0.000042548898,0.00008197904,0.00009891217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968487,0.0001262848,0.00062359474,0.0007256061,0.00083786726,0.00083795894],"domain_scores_gemma":[0.9972357,0.0005769561,0.00031210037,0.0003779366,0.0010257339,0.00047154177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011407065,0.00032378826,0.00079302426,0.0006872746,0.00022250308,0.00006949092,0.00014726132,0.00021251617,0.00031727637],"category_scores_gemma":[0.00027879153,0.0002326143,0.00013859436,0.0010931076,0.00019954683,0.00030127275,0.000082277315,0.000377203,0.000001200362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003197216,0.00012865674,0.9448388,0.00030951443,0.00031345309,0.000088409724,0.00023933851,0.00009129926,0.017931119,0.000009553089,0.0003100708,0.03254257],"study_design_scores_gemma":[0.0038559732,0.00015439437,0.98800427,0.005201994,0.00014725463,0.00008695844,0.0003164894,0.000017908034,0.0018378367,0.0000126967625,0.00005344042,0.00031080324],"about_ca_topic_score_codex":0.14061381,"about_ca_topic_score_gemma":0.12637615,"teacher_disagreement_score":0.043165457,"about_ca_system_score_codex":0.0010242843,"about_ca_system_score_gemma":0.00039717436,"threshold_uncertainty_score":0.9485736},"labels":[],"label_agreement":null},{"id":"W2398400369","doi":"10.1158/1538-7445.am2015-4320","title":"Abstract 4320: Genomic change in residual triple-negative breast cancers after neoadjuvant chemotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital; Hôpital du Sacré-Cœur de Montréal; Concordia University; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Chemotherapy; Exome sequencing; Comparative genomic hybridization; Medicine; Cancer; Oncology; Copy-number variation; Cancer research; Exome; Chromosome instability; Internal medicine; Gene; Biology; Phenotype; Genetics; Chromosome; Genome","score_opus":0.15560729100561188,"score_gpt":0.4399093889895884,"score_spread":0.28430209798397654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398400369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97412646,0.009840133,3.227672e-7,0.012285724,0.00025348112,0.0015717475,0.0001864563,0.000029102976,0.0017065519],"genre_scores_gemma":[0.9893272,0.0045267353,0.000047076635,0.00080501963,0.0011069309,0.0033345341,0.000019516614,0.00005769618,0.0007752823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997531,0.000087097214,0.00028618265,0.0005356704,0.0008013538,0.00075867854],"domain_scores_gemma":[0.9986392,0.00009810507,0.000054379627,0.00041485485,0.0003298303,0.00046360987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006984528,0.00021587152,0.00041602424,0.00036021505,0.000056716603,0.00004504403,0.00015174923,0.000117606236,0.0017134706],"category_scores_gemma":[0.000041310388,0.00017903696,0.00008187772,0.0005589545,0.00021148886,0.00013660858,0.00007058108,0.0005362861,0.00014086338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021206845,0.0013251336,0.5678512,0.00038731718,0.0005838542,0.0020992784,0.023289088,0.000060272385,0.004031036,0.00007589013,0.06803805,0.31105208],"study_design_scores_gemma":[0.009954381,0.00047360174,0.97215027,0.0005516732,0.000023432784,0.000029464167,0.00070631737,0.000023709783,0.0044356054,0.00011189969,0.011325509,0.00021416058],"about_ca_topic_score_codex":0.06914262,"about_ca_topic_score_gemma":0.018595902,"teacher_disagreement_score":0.40429908,"about_ca_system_score_codex":0.005066564,"about_ca_system_score_gemma":0.0017459772,"threshold_uncertainty_score":0.99931216},"labels":[],"label_agreement":null},{"id":"W2398731035","doi":"10.1158/1538-7445.brain15-a34","title":"Abstract A34: Id-1 mediates glioma stem cell chemoresistance to temozolomide","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Temozolomide; Glioma; Context (archaeology); Stem cell; Immunohistochemistry; Cancer research; Biology; Tissue microarray; Dacarbazine; Chemotherapy; Cancer; Cancer stem cell; Oncology; Medicine; Internal medicine; Pathology; Melanoma; Genetics","score_opus":0.05686932312273453,"score_gpt":0.37386627858580535,"score_spread":0.31699695546307083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398731035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794938,0.008721512,0.0006908012,0.0017875244,0.0004174666,0.0010421982,0.0001490385,0.00004751498,0.007650159],"genre_scores_gemma":[0.99192905,0.0005586469,0.00027929858,0.00031233442,0.00074637186,0.0005595975,0.000067613684,0.00010727564,0.0054397816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960128,0.00020065377,0.0003212381,0.000916754,0.0013731581,0.0011754005],"domain_scores_gemma":[0.99706316,0.000052213643,0.00006275945,0.0009611134,0.0009150381,0.0009457033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016575449,0.0002657392,0.00025954423,0.00030063617,0.00017564933,0.00012428193,0.0009503346,0.00031750143,0.00017279705],"category_scores_gemma":[0.00022674727,0.0002665755,0.00009792936,0.0008189092,0.00020022823,0.000010565521,0.000615223,0.0005891047,0.00045575012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000562312,0.00006255151,0.00002225809,0.000067691355,0.000037465245,0.00006779461,0.000116074465,0.00034285325,0.88525796,0.000040997376,0.1105346,0.002887455],"study_design_scores_gemma":[0.0008749648,0.00032805072,0.000109007786,0.00003962718,0.000005405435,0.0000070525025,0.00028259092,0.000016267091,0.8633229,0.00009248895,0.13464741,0.0002742412],"about_ca_topic_score_codex":0.00071277673,"about_ca_topic_score_gemma":0.0005774185,"teacher_disagreement_score":0.024112811,"about_ca_system_score_codex":0.00042905984,"about_ca_system_score_gemma":0.0015167403,"threshold_uncertainty_score":0.99997866},"labels":[],"label_agreement":null},{"id":"W2399066128","doi":"10.1158/1538-7445.sabcs15-p4-13-14","title":"Abstract P4-13-14: Time on treatment of everolimus, fulvestrant, and capecitabine for the treatment of HR+/HER2- metastatic breast cancer: A retrospective claims study in the US","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Capecitabine; Discontinuation; Fulvestrant; Everolimus; Internal medicine; Metastatic breast cancer; Regimen; Oncology; Aromatase inhibitor; Cancer; Hazard ratio; Tolerability; Breast cancer; Anastrozole; Aromatase; Adverse effect; Tamoxifen; Confidence interval","score_opus":0.07351609551178608,"score_gpt":0.41901837090530686,"score_spread":0.3455022753935208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399066128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840651,0.005530533,0.000011958121,0.0048422795,0.00006142753,0.0044937516,0.000918534,0.00001185286,0.00006456495],"genre_scores_gemma":[0.9895163,0.006521015,0.000034835444,0.000033356162,0.00021405978,0.0030595066,0.0000042926513,0.00004432877,0.00057226216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976305,0.000190139,0.00040354917,0.00048270065,0.000761807,0.0005313302],"domain_scores_gemma":[0.9975001,0.001202,0.00015003297,0.00066015153,0.00038459265,0.000103102204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056554575,0.0002892784,0.0006976743,0.00019735092,0.00013280539,0.000014463444,0.00020432725,0.00004934951,0.00033096963],"category_scores_gemma":[0.000031291707,0.00012074196,0.00013590856,0.0004173517,0.00054764736,0.00007895393,0.000016717026,0.00013358127,0.000004474236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030290961,0.011059548,0.18172954,0.00029776862,0.0032752855,0.000111132715,0.02266437,0.0001687297,0.07572103,0.00013212588,0.0001575703,0.6743919],"study_design_scores_gemma":[0.018416638,0.013342535,0.95265764,0.00038717926,0.00029789747,0.000029413603,0.0020133792,0.000021133781,0.010616567,0.00042428882,0.0016391416,0.00015415814],"about_ca_topic_score_codex":0.0074629453,"about_ca_topic_score_gemma":0.00413925,"teacher_disagreement_score":0.77092814,"about_ca_system_score_codex":0.0017564174,"about_ca_system_score_gemma":0.00042499293,"threshold_uncertainty_score":0.99914646},"labels":[],"label_agreement":null},{"id":"W2399265223","doi":"10.1158/1538-7445.sabcs15-s5-08","title":"Abstract S5-08: Late side-effects of breast cancer radiotherapy: Second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Cancer; Lung cancer; Internal medicine; Incidence (geometry); Relative risk; Clinical trial; Oncology; Surgery; Confidence interval","score_opus":0.03321324001033287,"score_gpt":0.3829674535385039,"score_spread":0.34975421352817104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399265223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97621363,0.018472124,0.000009471922,0.0014077706,0.0003809212,0.0010669807,0.0023000624,0.000015302789,0.00013372672],"genre_scores_gemma":[0.9512415,0.042956386,0.000010558061,0.00014426759,0.00073237665,0.0039408803,0.00000807726,0.000074230426,0.0008917221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597013,0.00043501385,0.00063797325,0.0010593509,0.00063881755,0.0012587361],"domain_scores_gemma":[0.997846,0.0003457554,0.00034090786,0.00064982736,0.00047061138,0.000346885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018748756,0.00045173566,0.0010238327,0.00022896347,0.00016323882,0.000050433377,0.00044856136,0.00029522512,0.0013846982],"category_scores_gemma":[0.0001379011,0.00032677854,0.00015028815,0.0004542551,0.0009009364,0.000056854915,0.00029258494,0.00032305066,0.000003018771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014556069,0.00011163238,0.50767773,0.00043978938,0.0008016338,0.000019911213,0.0005383233,0.000046080884,0.44360724,0.0000020386522,0.0011124286,0.044187568],"study_design_scores_gemma":[0.0035893256,0.00008660635,0.8817985,0.0009052359,0.000044886456,0.000004808634,0.000079422534,0.000007405674,0.11250298,0.000059840833,0.00056554074,0.00035541528],"about_ca_topic_score_codex":0.025960343,"about_ca_topic_score_gemma":0.017372603,"teacher_disagreement_score":0.37412077,"about_ca_system_score_codex":0.0011469234,"about_ca_system_score_gemma":0.00096614624,"threshold_uncertainty_score":0.9999184},"labels":[],"label_agreement":null},{"id":"W2399308995","doi":"10.1158/1538-7445.brain15-a46","title":"Abstract A46: Transcriptome analysis on tumor and its normal cerebellar counterpart from mouse models reveals molecular mechanisms underlying evolution of SHH and Group3 medulloblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Transcriptome; Sonic hedgehog; PTCH1; Biology; Tumor initiation; Cancer research; Gene expression profiling; Gene; Genetics; Molecular biology; Gene expression; Carcinogenesis","score_opus":0.07997437637273833,"score_gpt":0.35572346166204966,"score_spread":0.2757490852893113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399308995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850062,0.006244859,0.007868264,0.00012935829,0.000033639237,0.00024200551,0.00023024667,0.0000070271926,0.00023841213],"genre_scores_gemma":[0.9987906,0.0006443855,0.00014813173,0.00005163012,0.000034199747,0.00009122146,0.000053733747,0.000022757738,0.00016332502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843204,0.0001104445,0.00023194645,0.000464881,0.00046316674,0.0002975225],"domain_scores_gemma":[0.99901944,0.000018154824,0.00007233001,0.00033183018,0.0003578459,0.00020039012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005742275,0.00014049563,0.0002227764,0.00018891557,0.000096249416,0.000041947413,0.00018163223,0.000116131974,0.000026957428],"category_scores_gemma":[0.000030156645,0.00013644206,0.00006666631,0.00030080843,0.00010924006,0.000019980038,0.000063406595,0.000160935,0.0000019993854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023738292,0.000049223312,0.00016763169,0.000033386237,0.00023472152,0.0000031754541,0.00013804073,0.0028359473,0.99456716,0.0013615715,0.00013027915,0.00024147097],"study_design_scores_gemma":[0.0017289608,0.0006827199,0.006237527,0.00009454813,0.00022746022,0.000004324236,0.0010768379,0.0102520045,0.97397196,0.0048313686,0.00045866636,0.00043359678],"about_ca_topic_score_codex":0.00086718344,"about_ca_topic_score_gemma":0.00023118182,"teacher_disagreement_score":0.020595184,"about_ca_system_score_codex":0.00011624272,"about_ca_system_score_gemma":0.00018445558,"threshold_uncertainty_score":0.5563946},"labels":[],"label_agreement":null},{"id":"W2399514156","doi":"10.1158/1538-7445.compsysbio-b2-06","title":"Abstract B2-06: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Serous fluid; Oncology; Ovarian cancer; Ovarian carcinoma; Internal medicine; Serous carcinoma; Stage (stratigraphy); Cancer; Adjuvant; Surgery; Biology","score_opus":0.2731987781954914,"score_gpt":0.45766126075695973,"score_spread":0.18446248256146835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399514156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665028,0.0047668577,0.015108238,0.011507083,0.00004007731,0.0011084647,0.00025866562,0.00001946079,0.0006883479],"genre_scores_gemma":[0.994231,0.00031636326,0.004597931,0.00007522875,0.00014196365,0.0004461595,0.000116379226,0.00002205527,0.000052925257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990526,0.000023112809,0.00018427841,0.0002452952,0.00026219033,0.00023251201],"domain_scores_gemma":[0.9986826,0.00015829367,0.000039018712,0.0001879551,0.0007452123,0.00018687271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043416405,0.0000821634,0.00018448663,0.00012831503,0.00010762045,0.000025244566,0.00006794807,0.000050576953,0.00001834065],"category_scores_gemma":[0.00003683565,0.000071124465,0.000044021377,0.00016839038,0.00007604036,0.000056743334,0.000028941826,0.0001277456,0.0000014453335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019295115,0.00084592536,0.6185726,0.00046794472,0.0007428874,0.00001549177,0.0021028302,0.06519177,0.0012560835,0.017723924,0.004889409,0.28626162],"study_design_scores_gemma":[0.013718175,0.0010271211,0.61187595,0.00035113547,0.0000802414,0.000029091661,0.00096201425,0.355209,0.00058690493,0.014344466,0.0015597091,0.00025622846],"about_ca_topic_score_codex":0.0015688976,"about_ca_topic_score_gemma":0.000093728086,"teacher_disagreement_score":0.29001722,"about_ca_system_score_codex":0.0002589216,"about_ca_system_score_gemma":0.00057391485,"threshold_uncertainty_score":0.29003716},"labels":[],"label_agreement":null},{"id":"W2399581150","doi":"10.1158/1538-7445.nonrna15-a17","title":"Abstract A17: A lincRNA orchestrates glioma stem cell-mediated angiogenesis in glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"Angiogenesis; Glioma; Biology; Cancer research; Pericyte; Stem cell; Cancer; Cancer stem cell; Progenitor cell; Endothelial stem cell; Cell biology; Genetics; In vitro","score_opus":0.03231638854946168,"score_gpt":0.33808120606776154,"score_spread":0.30576481751829987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399581150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992423,0.004728298,0.0003740492,0.0007152239,0.00013557477,0.0006172291,0.000105942665,0.0000316558,0.00086904276],"genre_scores_gemma":[0.9950682,0.0023302732,0.000029543253,0.00004723712,0.00026773772,0.0004964515,0.000018804816,0.00009289632,0.0016488641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630105,0.00030022027,0.00037712787,0.0009001191,0.0008852695,0.0012361989],"domain_scores_gemma":[0.9981905,0.00014936854,0.00007172887,0.00075265067,0.000474464,0.00036128974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012213312,0.00027217876,0.00025136556,0.0005759221,0.00013396857,0.00007312107,0.00071739254,0.00043775092,0.0004615522],"category_scores_gemma":[0.00015986615,0.0002198624,0.00014674483,0.0011198763,0.00028370586,0.000014428934,0.000382377,0.00040429737,0.00021642154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006849548,0.000106341344,0.00022367017,0.000056603316,0.000051605435,0.00016345117,0.000042296564,0.00004333921,0.9808384,0.000026567603,0.002853812,0.014908945],"study_design_scores_gemma":[0.001577929,0.00043120087,0.0010902933,0.00012591202,0.0000049860128,0.000013298068,0.00011221188,0.000021871827,0.9848277,0.00006712801,0.0114295315,0.00029793687],"about_ca_topic_score_codex":0.0005395888,"about_ca_topic_score_gemma":0.0009956004,"teacher_disagreement_score":0.014611008,"about_ca_system_score_codex":0.00035894426,"about_ca_system_score_gemma":0.0011389294,"threshold_uncertainty_score":0.8965728},"labels":[],"label_agreement":null},{"id":"W2400161350","doi":"10.1158/1538-7445.fbcr15-ia16","title":"Abstract IA16: Clonal evolution in breast cancer patients and patient derived xenografts","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Somatic evolution in cancer; Cancer; Breast cancer; Biology; Population; Clonal selection; Oncology; Medicine; Cancer research; Genetics; Immunology","score_opus":0.018526780326012127,"score_gpt":0.3194277002063467,"score_spread":0.30090091988033457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400161350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536884,0.0023562387,0.00001303726,0.0012750877,0.0002062784,0.00023755297,0.00041697532,0.0000037169523,0.00012230294],"genre_scores_gemma":[0.9950714,0.0042777536,0.000014600965,0.00012281626,0.000241374,0.00019331936,0.000018131297,0.000019816152,0.000040793457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99877673,0.000042994838,0.00016687781,0.00036648844,0.00024381596,0.00040307577],"domain_scores_gemma":[0.99935573,0.000031851217,0.000040722607,0.00016945312,0.00026885088,0.00013340656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014589664,0.000108502645,0.000099563804,0.00009132158,0.00008001725,0.000025463067,0.00012090627,0.000104209896,0.00009892713],"category_scores_gemma":[0.00006231071,0.00008522385,0.000030513911,0.00011918762,0.0001602716,0.0000068982167,0.00017640009,0.000110584566,0.000007535136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034251186,0.00010682907,0.1944048,0.000021379772,0.000021121246,0.0000030606236,0.00007143803,0.00001798321,0.7558977,0.000041428288,0.0051518413,0.043919895],"study_design_scores_gemma":[0.0013890436,0.00016926463,0.9113027,0.000112204245,0.0000035816004,0.0000018347346,0.000053532738,0.0000030313458,0.07613875,0.0001378999,0.010495882,0.00019228071],"about_ca_topic_score_codex":0.0012754174,"about_ca_topic_score_gemma":0.0014877947,"teacher_disagreement_score":0.7168979,"about_ca_system_score_codex":0.0002544235,"about_ca_system_score_gemma":0.00031325713,"threshold_uncertainty_score":0.34753278},"labels":[],"label_agreement":null},{"id":"W2401046652","doi":"10.1158/1538-7445.sabcs15-p3-12-02","title":"Abstract P3-12-02: Patient prognostic score and survival benefit offered by radiotherapy for ductal carcinoma in situ","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ductal carcinoma; Breast-conserving surgery; Proportional hazards model; Breast cancer; Cohort; Radiation therapy; Cumulative incidence; Internal medicine; Oncology; Epidemiology; Cancer; Retrospective cohort study; Hazard ratio; Incidence (geometry); Surveillance, Epidemiology, and End Results; Stage (stratigraphy); Cancer registry; Mastectomy; Confidence interval","score_opus":0.04348501139073019,"score_gpt":0.3376913524789167,"score_spread":0.2942063410881865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401046652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881066,0.009474058,0.000020745132,0.0012095921,0.000106463725,0.0006693794,0.0002852845,0.000006259634,0.00012159399],"genre_scores_gemma":[0.9969071,0.0017856347,0.00004153739,0.000035622274,0.00019937969,0.0007545998,0.000045876084,0.000032167074,0.00019807101],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99864614,0.00004208874,0.00015195909,0.00047057495,0.00021672876,0.00047251128],"domain_scores_gemma":[0.9994041,0.000103482365,0.00003456414,0.00021960477,0.00014255286,0.000095699856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017665746,0.00015361303,0.00017617397,0.000060214083,0.00010087427,0.000021704702,0.00012858555,0.00009231779,0.000026052207],"category_scores_gemma":[0.00006796768,0.000110515284,0.000043021075,0.00007269097,0.0002044011,0.0000063218545,0.00008959725,0.0000770401,0.0000014303791],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010028272,0.00010542076,0.2563213,0.000053073738,0.00009819502,0.000007016577,0.00015827244,0.0000012806223,0.69864994,0.000022755585,0.0028515183,0.040728357],"study_design_scores_gemma":[0.0043442543,0.00089161494,0.6551899,0.00012832662,0.000011598202,0.0000066268153,0.00014726231,0.000002380301,0.33180043,0.00013372733,0.007053249,0.00029066717],"about_ca_topic_score_codex":0.00047688687,"about_ca_topic_score_gemma":0.0016202,"teacher_disagreement_score":0.39886853,"about_ca_system_score_codex":0.00016629779,"about_ca_system_score_gemma":0.00013093729,"threshold_uncertainty_score":0.45066825},"labels":[],"label_agreement":null},{"id":"W2401514086","doi":"10.1158/1538-7445.sabcs15-p2-02-12","title":"Abstract P2-02-12: Association of inflammatory and tumor markers with circulating tumor cells in metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University Health Network; University of Toronto; Statistics Canada; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Circulating tumor cell; Metastatic breast cancer; Breast cancer; Internal medicine; Cancer; Oncology; CA15-3; Lung cancer; Metastasis","score_opus":0.03560014408594866,"score_gpt":0.351782605026157,"score_spread":0.31618246094020835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401514086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956896,0.00087630184,9.151388e-7,0.0021686764,0.000049853523,0.0006276964,0.00018415472,0.000010758216,0.00039209716],"genre_scores_gemma":[0.9982567,0.0007716478,0.000033821034,0.000057955825,0.00008467695,0.00050217466,0.0000024075503,0.000028090908,0.00026253154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821043,0.00008759125,0.00028517825,0.00030704367,0.00068858155,0.00042118147],"domain_scores_gemma":[0.9987931,0.00043540756,0.00015637244,0.00019051963,0.0002721455,0.0001524057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008091408,0.00012923703,0.00032978898,0.0002151313,0.000051417053,0.000019125397,0.000059335383,0.000029682056,0.0007179159],"category_scores_gemma":[0.00006880272,0.00008260033,0.00004118649,0.00025140287,0.00012135,0.00011346613,0.00003664052,0.0001980655,0.0000067964247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006359982,0.00014707308,0.91615975,0.0005278334,0.00022975443,0.00018243838,0.00023289084,0.000022582244,0.064325206,0.000016203787,0.000998734,0.016521558],"study_design_scores_gemma":[0.0036703034,0.00013689253,0.97240585,0.002021882,0.00006250268,0.00001690288,0.00020775404,0.00001818895,0.020891394,0.000022676153,0.00043985047,0.000105773564],"about_ca_topic_score_codex":0.005078084,"about_ca_topic_score_gemma":0.0051914062,"teacher_disagreement_score":0.05624615,"about_ca_system_score_codex":0.0017681192,"about_ca_system_score_gemma":0.0007605542,"threshold_uncertainty_score":0.78606755},"labels":[],"label_agreement":null},{"id":"W2401571708","doi":"10.1158/0008-5472.can-16-0544","title":"Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer cell; Metastasis; Cancer; Cancer research; Adenosine; Cancer metastasis; Adenosine receptor; Cell biology; Biology; Receptor; Chemistry; Internal medicine; Medicine; Endocrinology; Agonist","score_opus":0.06624438584411894,"score_gpt":0.3876530948703673,"score_spread":0.32140870902624835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401571708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541486,0.0100684,0.0002172755,0.00295428,0.00027133513,0.0003119021,0.00014162678,0.000018689341,0.0006016266],"genre_scores_gemma":[0.9816442,0.004619501,0.00017731298,0.00016321296,0.001329952,0.00034741816,0.00001921399,0.000045637516,0.011653515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826795,0.00019239199,0.00015806254,0.00049419067,0.00040652743,0.00048087607],"domain_scores_gemma":[0.99909997,0.000065203836,0.00004605418,0.00039015937,0.0002482137,0.00015040496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040903498,0.00015099008,0.00014103414,0.00008960021,0.00015403575,0.00002763021,0.0003072869,0.00013040272,0.0017680255],"category_scores_gemma":[0.00008057336,0.00009495425,0.000068110465,0.00018023269,0.00012890731,0.0000065377217,0.00017416828,0.00016242354,0.00010126705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019671087,0.000041408068,0.00020651703,0.000019341947,0.00003828389,0.0000026619,0.000025859605,0.000013539265,0.8108947,0.000017922062,0.18234853,0.0061944905],"study_design_scores_gemma":[0.00040478297,0.00022724236,0.000047527028,0.0001786995,0.0000067747674,6.411064e-7,0.000020800715,9.899782e-7,0.83016944,0.000028515464,0.16878372,0.00013088227],"about_ca_topic_score_codex":0.00013981128,"about_ca_topic_score_gemma":0.0000114567265,"teacher_disagreement_score":0.0192747,"about_ca_system_score_codex":0.000070008275,"about_ca_system_score_gemma":0.00020215455,"threshold_uncertainty_score":0.9991445},"labels":[],"label_agreement":null},{"id":"W2401702538","doi":"10.1158/1538-7445.sabcs15-p5-10-04","title":"Abstract P5-10-04: Care guidelines for young women diagnosed with breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Psychosocial; Medicine; Family medicine; Cancer; Psychological intervention; Health care; Feeling; Gynecology; Nursing; Gerontology; Psychiatry; Internal medicine; Psychology","score_opus":0.14157117572817093,"score_gpt":0.4727140248797155,"score_spread":0.33114284915154457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401702538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98226786,0.0040362054,0.00003754686,0.009614485,0.00028898005,0.0013254134,0.0013740116,0.00007140698,0.0009841233],"genre_scores_gemma":[0.98179513,0.003130208,0.000066970606,0.00029459255,0.0017788758,0.0035241141,0.000019525902,0.00008582872,0.009304731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973455,0.000026516509,0.000296166,0.0005382037,0.00082403567,0.0009695945],"domain_scores_gemma":[0.9958733,0.00020047267,0.00006933243,0.00047741097,0.002949224,0.00043028404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004426803,0.00021549032,0.00037649737,0.0001977171,0.000198012,0.000049862738,0.00022080205,0.000115354305,0.006000114],"category_scores_gemma":[0.00018561001,0.00011972555,0.00009193083,0.0003473594,0.00025565215,0.00014631085,0.000060993723,0.0002428966,0.000044624525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067714406,0.0001279278,0.17978181,0.0009857967,0.00035986066,0.00010942771,0.0036429802,0.000017532499,0.03652409,0.000042649717,0.34925473,0.42238176],"study_design_scores_gemma":[0.010760971,0.00091928756,0.4655575,0.0026282773,0.00007565594,0.000033194407,0.005460467,0.0000091750035,0.009860083,0.00006092462,0.5040609,0.00057355367],"about_ca_topic_score_codex":0.010531454,"about_ca_topic_score_gemma":0.0072616204,"teacher_disagreement_score":0.4218082,"about_ca_system_score_codex":0.0018252112,"about_ca_system_score_gemma":0.0015683748,"threshold_uncertainty_score":0.9960575},"labels":[],"label_agreement":null},{"id":"W2401769792","doi":"10.1158/1538-7445.sabcs15-p1-01-01","title":"Abstract P1-01-01: Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"External quality assessment; Intraclass correlation; Medicine; Breast cancer; Protocol (science); Nuclear proliferation; Nuclear medicine; Pathology; Medical physics; Reproducibility; Statistics; Cancer; Internal medicine; Mathematics","score_opus":0.11483865516037185,"score_gpt":0.5499462012080074,"score_spread":0.4351075460476356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401769792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95800877,0.0000065083723,0.006470197,0.0033690818,0.00012730724,0.031178238,0.000112699905,0.000018844163,0.00070834404],"genre_scores_gemma":[0.9759905,0.000011307668,0.0020877442,0.000024859093,0.00033568905,0.021312471,0.000026192507,0.00002130051,0.00018993995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840826,0.00007312875,0.00035776658,0.00021541925,0.0007377431,0.00020766439],"domain_scores_gemma":[0.99842376,0.00024438323,0.000120754805,0.00019311758,0.000886562,0.00013140697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015235387,0.00007079338,0.0002123889,0.00022286558,0.000049118615,0.000024844703,0.0001365061,0.000050720704,0.00053108414],"category_scores_gemma":[0.001527002,0.00004819945,0.000055347053,0.00019783936,0.00018586408,0.00020399441,0.000031260173,0.00017409674,0.0000014700863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009409908,0.00074011035,0.011388186,0.00070376234,0.0001685745,0.000007898872,0.0004079246,0.00008387929,0.87657267,0.00059247896,0.001750927,0.098173685],"study_design_scores_gemma":[0.043457624,0.0016126684,0.009554869,0.0026295632,0.00006242964,0.0000036987642,0.00029664012,0.027176755,0.86961627,0.0003053243,0.045100573,0.00018360997],"about_ca_topic_score_codex":0.00006876061,"about_ca_topic_score_gemma":0.0000062826225,"teacher_disagreement_score":0.09799008,"about_ca_system_score_codex":0.00023127823,"about_ca_system_score_gemma":0.0004394699,"threshold_uncertainty_score":0.58149993},"labels":[],"label_agreement":null},{"id":"W2402043385","doi":"10.1158/1538-7445.sabcs15-p4-14-19","title":"Abstract P4-14-19: ONT-380 in the treatment of HER2+ breast cancer central nervous system (CNS) metastases (mets)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; London Health Sciences Centre","funders":"","keywords":"Lapatinib; Medicine; Capecitabine; Internal medicine; Oncology; Trastuzumab; Metastatic breast cancer; Breast cancer; Cancer; Trastuzumab emtansine; Response Evaluation Criteria in Solid Tumors; Taxane; Progressive disease; Disease; Colorectal cancer","score_opus":0.08869328547876004,"score_gpt":0.40876859892697875,"score_spread":0.3200753134482187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402043385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97665274,0.01074553,0.000010013942,0.00850492,0.00021154185,0.0016015433,0.0015445478,0.000031785352,0.0006973555],"genre_scores_gemma":[0.99244535,0.005216409,0.000047206202,0.00009251643,0.00038941347,0.000999483,0.000022854807,0.00003907818,0.0007476618],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99668247,0.00041899472,0.00043790857,0.00048946915,0.0010354627,0.0009356919],"domain_scores_gemma":[0.99805033,0.0005300432,0.00010556839,0.0007340587,0.00024341399,0.00033658824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009198002,0.0002664959,0.0005802101,0.00024016316,0.00013147267,0.000033707885,0.00025467365,0.00008432778,0.0013291471],"category_scores_gemma":[0.00004750185,0.00012311188,0.00023429954,0.0005205414,0.00027377091,0.00008730301,0.00003606275,0.00019508688,0.000042578053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050163455,0.0058253556,0.13070787,0.001643561,0.0024264038,0.0031124642,0.0036103537,0.00014982081,0.019689607,0.0020324045,0.015221436,0.8105644],"study_design_scores_gemma":[0.014567625,0.0023916182,0.88141316,0.0024466107,0.00059411896,0.00033748138,0.0037298992,0.000025740392,0.02406215,0.000073561736,0.06994224,0.00041579257],"about_ca_topic_score_codex":0.046611577,"about_ca_topic_score_gemma":0.0054816725,"teacher_disagreement_score":0.8101486,"about_ca_system_score_codex":0.0021835559,"about_ca_system_score_gemma":0.0008797293,"threshold_uncertainty_score":0.9995838},"labels":[],"label_agreement":null},{"id":"W2402099603","doi":"10.1158/1538-7445.fbcr15-a09","title":"Abstract A09: ACSL4 is a target of the 17beta-estradiol/estrogen-receptor alpha pathway in mammary carcinoma cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Atlantic Cancer Research Institute; Université de Moncton","funders":"","keywords":"Estrogen receptor alpha; Arachidonic acid; Estrogen receptor; Estrogen; Endocrinology; Internal medicine; Biology; Eicosapentaenoic acid; Cell culture; Estrogen receptor beta; Mammary tumor; Polyunsaturated fatty acid; Fatty acid; Cancer; Biochemistry; Breast cancer; Medicine","score_opus":0.04629900437330034,"score_gpt":0.3343173334814081,"score_spread":0.28801832910810776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402099603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915178,0.0035388237,0.0000033216957,0.002611016,0.00040135832,0.0007951119,0.00009371588,0.00001978426,0.0010190747],"genre_scores_gemma":[0.9962664,0.0004097919,0.00006953048,0.0001403092,0.00063385075,0.00020621099,0.0000043666437,0.00004088616,0.0022286419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746454,0.00019998317,0.00039620965,0.00039199681,0.00085325737,0.0006939949],"domain_scores_gemma":[0.9983192,0.0003130644,0.00010022463,0.0007152735,0.0002984893,0.0002537204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011795784,0.00019878548,0.00039798414,0.00023410586,0.000081369406,0.000014766382,0.0004413942,0.00018339223,0.0009017371],"category_scores_gemma":[0.0002166438,0.000108093845,0.00017597436,0.0004968974,0.0002931484,0.000122015765,0.00014023104,0.00053517846,0.00010571511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030869167,0.0001418035,0.15554364,0.0005664399,0.000033279226,0.00010993346,0.0006147306,0.0000012314805,0.8221974,0.000076371805,0.012499953,0.007906581],"study_design_scores_gemma":[0.0017724064,0.00018012655,0.13961418,0.00043807842,0.000007254733,0.000006814135,0.000058245118,0.000011996569,0.8414304,0.00007743971,0.016275143,0.0001278818],"about_ca_topic_score_codex":0.00047177108,"about_ca_topic_score_gemma":0.00003573557,"teacher_disagreement_score":0.019233089,"about_ca_system_score_codex":0.00029159492,"about_ca_system_score_gemma":0.0014170446,"threshold_uncertainty_score":0.98733884},"labels":[],"label_agreement":null},{"id":"W2402103677","doi":"10.1158/1538-7445.nonrna15-a21","title":"Abstract A21: MiR-106a and miR-106b affect growth and metastasis of lung adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"microRNA; Cancer research; Epithelial–mesenchymal transition; Adenocarcinoma; Metastasis; Biology; Cell growth; Transfection; Lung cancer; Cell; Cell culture; Downregulation and upregulation; Pathology; Cancer; Medicine; Internal medicine; Gene","score_opus":0.034574713316133335,"score_gpt":0.36213871985366153,"score_spread":0.3275640065375282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402103677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754052,0.021598779,0.0005896478,0.0008547302,0.00007331198,0.00057925953,0.0001479211,0.000009323583,0.0007417961],"genre_scores_gemma":[0.9913334,0.0075871903,0.00013635236,0.000036996105,0.00014323779,0.00016214115,0.0000138842215,0.000054381737,0.0005323681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975442,0.00024078747,0.00024594401,0.0006996104,0.000595957,0.0006734635],"domain_scores_gemma":[0.99870694,0.00011701954,0.00006706665,0.00049094623,0.0003268974,0.00029112046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089031254,0.00020419848,0.00027152404,0.00024410505,0.00013853637,0.000044866647,0.00031585904,0.0002333545,0.00022707661],"category_scores_gemma":[0.0003001015,0.00015822506,0.0000848853,0.00028699168,0.000536692,0.00001342659,0.00047945636,0.00028841276,0.0000071540526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033633327,0.000032604366,0.0014755776,0.00024065883,0.00017144973,0.000015335087,0.000043953252,7.5574724e-7,0.9876239,0.0002128327,0.0025200357,0.0073266192],"study_design_scores_gemma":[0.0012241646,0.00039633748,0.009366997,0.00014010789,0.00002556906,0.000020804444,0.000049952047,0.0000071622685,0.9856786,0.00013717629,0.002748164,0.00020494443],"about_ca_topic_score_codex":0.00050210184,"about_ca_topic_score_gemma":0.00013362784,"teacher_disagreement_score":0.015928218,"about_ca_system_score_codex":0.000072749535,"about_ca_system_score_gemma":0.00031862344,"threshold_uncertainty_score":0.645223},"labels":[],"label_agreement":null},{"id":"W2402380592","doi":"10.1158/1538-7445.sabcs15-p4-02-15","title":"Abstract P4-02-15: Preoperative MRI of the breast and ipsilateral breast tumor recurrence: Long-term follow up","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Breast MRI; Lumpectomy; Breast-conserving surgery; Univariate analysis; Mastectomy; Cohort; Radiation therapy; Breast surgery; Radiology; Surgery; Oncology; Cancer; Internal medicine; Multivariate analysis; Mammography","score_opus":0.032093147892825295,"score_gpt":0.3519618041006736,"score_spread":0.3198686562078483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402380592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939817,0.002234948,0.0000078442135,0.0022051123,0.00022929617,0.00037770218,0.0006508324,0.0000063539774,0.00030621092],"genre_scores_gemma":[0.997354,0.0010080122,0.000010825074,0.000040667932,0.00026287787,0.00019892427,0.000011625964,0.000022833425,0.0010902571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841416,0.00012428738,0.00018883075,0.0004799047,0.00035186135,0.0004409536],"domain_scores_gemma":[0.9989411,0.000046303176,0.00007348951,0.00044275908,0.00039179574,0.000104519044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025444894,0.00018699032,0.00019426872,0.00004581274,0.00021315205,0.000030799376,0.00032509194,0.00007887622,0.00017618216],"category_scores_gemma":[0.00003903244,0.000102788865,0.00008363587,0.00015144183,0.0006923708,0.000013807734,0.00039198223,0.00015536978,0.000009531781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008323042,0.00009147776,0.69934785,0.00008699002,0.00025998888,0.000007817644,0.0003120109,0.0000011972793,0.27245778,0.00003271502,0.003111966,0.023457903],"study_design_scores_gemma":[0.0011487745,0.00008299484,0.85244876,0.00028756165,0.000016293185,0.00009066413,0.000046632947,3.2318295e-7,0.14548586,0.000035897523,0.00022358331,0.0001326487],"about_ca_topic_score_codex":0.0003466801,"about_ca_topic_score_gemma":0.00064594386,"teacher_disagreement_score":0.15310092,"about_ca_system_score_codex":0.00009625369,"about_ca_system_score_gemma":0.0003054499,"threshold_uncertainty_score":0.41916084},"labels":[],"label_agreement":null},{"id":"W2402428003","doi":"10.1158/1538-7445.sabcs15-p2-09-09","title":"Abstract P2-09-09: Risk-reducing surgery and cancer-related distress among female <i>BRCA1</i> and <i>BRCA2</i> mutation carriers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"","keywords":"Medicine; BRCA mutation; Breast cancer; Distress; Cancer; Psychosocial; Internal medicine; Oncology; Prophylactic Surgery; Interim analysis; Demography; Clinical trial; Clinical psychology; Psychiatry","score_opus":0.0304684074092054,"score_gpt":0.3426844739001515,"score_spread":0.3122160664909461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402428003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825086,0.015283749,0.000082506915,0.0006890994,0.00041138183,0.0003749025,0.00030998242,0.000031502994,0.0003082937],"genre_scores_gemma":[0.98463166,0.013734918,0.000106902226,0.00003365313,0.00032349944,0.0004199274,0.000050301842,0.00006009222,0.0006390733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761903,0.00024865204,0.0003439097,0.0008167248,0.00035849336,0.00061321206],"domain_scores_gemma":[0.99850947,0.0002682965,0.00016566581,0.0004523337,0.00033517525,0.00026905912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010981462,0.00022580716,0.0002359848,0.00015289865,0.00040452485,0.000099118275,0.00019704831,0.00025012772,0.000117184005],"category_scores_gemma":[0.00035895893,0.00018857309,0.00007071403,0.00030522048,0.0007205679,0.000031639804,0.0001857511,0.00030581772,0.0000066513776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016344557,0.000042857617,0.11601721,0.00018015558,0.0003356201,0.000019812109,0.0009474306,0.00021178935,0.4787609,0.000014965712,0.0072526573,0.39605317],"study_design_scores_gemma":[0.0019686758,0.00016923518,0.2083993,0.0005831275,0.000097486685,0.000025990199,0.0010325799,0.00008626573,0.7561496,0.0002639878,0.030383382,0.00084040844],"about_ca_topic_score_codex":0.002640259,"about_ca_topic_score_gemma":0.0009392924,"teacher_disagreement_score":0.39521277,"about_ca_system_score_codex":0.00036979836,"about_ca_system_score_gemma":0.00070296985,"threshold_uncertainty_score":0.7689787},"labels":[],"label_agreement":null},{"id":"W2402551987","doi":"10.1158/1538-7445.fbcr15-a25","title":"Abstract A25: Evolving functional heterogeneity in B-acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Somatic evolution in cancer; clone (Java method); Biology; SNP array; Leukemia; Acute lymphocytic leukemia; Immunophenotyping; Minimal residual disease; Disease; Oncology; Immunology; Cancer research; Cancer; Genetics; Medicine; Internal medicine; Lymphoblastic Leukemia; Flow cytometry; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.06708123661942589,"score_gpt":0.37756181528005045,"score_spread":0.31048057866062456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402551987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922509,0.00068224414,0.00046698877,0.0022359826,0.0002705632,0.00064375636,0.000055991204,0.00008206626,0.0033114625],"genre_scores_gemma":[0.99388534,0.00067826733,0.00013278582,0.00017649293,0.00059148774,0.0004167803,0.000012775943,0.00007572245,0.0040303697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99502647,0.00017180825,0.00047214303,0.0008178845,0.0020514482,0.0014602501],"domain_scores_gemma":[0.9968125,0.0011116649,0.000058016332,0.0006934039,0.0007456369,0.000578764],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001513803,0.00025704582,0.00042154032,0.0007703842,0.0001943841,0.00006380736,0.00036985643,0.00024746722,0.004136248],"category_scores_gemma":[0.0010723653,0.00017636968,0.00013495304,0.0010457587,0.000591788,0.00029902288,0.00033531123,0.00069108116,0.001143859],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0030028601,0.00021790058,0.077044204,0.00029780212,0.00030691942,0.0013824723,0.00013365879,0.000058531554,0.85272235,0.00022509214,0.036301617,0.02830662],"study_design_scores_gemma":[0.013980888,0.00050823594,0.86602587,0.0018143991,0.000050364888,0.00031049422,0.00010682226,0.0010751584,0.10713755,0.0004903245,0.007992572,0.0005073504],"about_ca_topic_score_codex":0.0010689391,"about_ca_topic_score_gemma":0.00034133394,"teacher_disagreement_score":0.7889816,"about_ca_system_score_codex":0.013884092,"about_ca_system_score_gemma":0.0065311575,"threshold_uncertainty_score":0.99963385},"labels":[],"label_agreement":null},{"id":"W2402869410","doi":"10.1158/1538-7445.sabcs15-p5-07-06","title":"Abstract P5-07-06: A competing risks analysis of the association between prediagnostic serum glucose and lipids and breast cancer survival","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Proportional hazards model; Medicine; Hazard ratio; Breast cancer; Internal medicine; Cause of death; Cancer; Relative risk; Survival analysis; Oncology; Disease; Confidence interval","score_opus":0.048811087938605564,"score_gpt":0.36883627637729327,"score_spread":0.3200251884386877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402869410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922092,0.0043072854,0.000012310295,0.0011065685,0.0007073936,0.00020322239,0.0013251418,0.00000505942,0.00012382088],"genre_scores_gemma":[0.9827233,0.012266805,0.0000050196813,0.000027628816,0.0044347104,0.000065257176,0.000015562238,0.000016448344,0.00044529664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841386,0.00021986729,0.00021940358,0.00036197787,0.00041198314,0.00037290202],"domain_scores_gemma":[0.9988049,0.00031238922,0.00013861207,0.00028548785,0.00034047483,0.00011809643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011128817,0.00011983778,0.0002777931,0.0001052843,0.0001546924,0.0000355946,0.00019340124,0.00015077292,0.00008121649],"category_scores_gemma":[0.00037165763,0.00007924565,0.000091151254,0.00035497683,0.00021596064,0.000009643365,0.00023297075,0.0001712235,0.0000015413935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004732491,0.000014958153,0.83889663,0.000040604085,0.0005895964,3.348088e-8,0.00009648323,0.000011764018,0.14546025,0.000013637324,0.001332556,0.013496139],"study_design_scores_gemma":[0.00059682317,0.00002302591,0.96493345,0.00007750856,0.00027688665,3.6980327e-7,0.000076106204,0.000007501218,0.015625093,0.000017103925,0.01826004,0.00010611324],"about_ca_topic_score_codex":0.002626457,"about_ca_topic_score_gemma":0.0030317337,"teacher_disagreement_score":0.12983516,"about_ca_system_score_codex":0.0001081205,"about_ca_system_score_gemma":0.00025273915,"threshold_uncertainty_score":0.39704347},"labels":[],"label_agreement":null},{"id":"W2403099611","doi":"10.1158/1538-7445.sabcs15-p2-05-26","title":"Abstract P2-05-26: Focal adhesion kinase is required for efficient tumor-induced osteoclastogenesis via control of macrophage colony stimulating factor expression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Osteolysis; Denosumab; Medicine; Cancer research; Focal adhesion; Breast cancer; RANKL; Bone metastasis; Metastatic breast cancer; Cancer; Osteoclast; Metastasis; Internal medicine; Oncology; Signal transduction; Biology; Osteoporosis; Cell biology; Receptor; Surgery","score_opus":0.10631994119448478,"score_gpt":0.42513797525488867,"score_spread":0.3188180340604039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403099611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470586,0.00058200915,0.00049440534,0.0010973897,0.00019149712,0.0025443363,0.00029520973,0.000045404377,0.000043867847],"genre_scores_gemma":[0.99848884,0.000029699651,0.00017974737,0.00013114324,0.0001268372,0.00059830496,0.0000063005737,0.00006462464,0.00037449299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972032,0.00013211546,0.00048628097,0.0005108984,0.0008587044,0.0008088521],"domain_scores_gemma":[0.99743503,0.0008500952,0.00016872845,0.00044164428,0.0005955958,0.00050891226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005981785,0.00019952396,0.00048735994,0.00021118752,0.00025481734,0.000011989077,0.00013021837,0.00015627181,0.00042757727],"category_scores_gemma":[0.00045853178,0.00012864312,0.00014486119,0.0002254804,0.000119218304,0.000060782462,0.00006233982,0.00019809426,0.000054090782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005185993,0.00026870205,0.01115606,0.0004702614,0.00004124416,0.00006758931,0.00014098235,0.00000809167,0.9307143,0.0000022732156,0.00046714695,0.05147736],"study_design_scores_gemma":[0.012334791,0.0019074349,0.06037155,0.0011617162,0.000038807113,0.0000056932663,0.000037314578,0.0005961055,0.92295814,0.000017003436,0.0004380931,0.00013338037],"about_ca_topic_score_codex":0.000660568,"about_ca_topic_score_gemma":0.00003041545,"teacher_disagreement_score":0.05134398,"about_ca_system_score_codex":0.0006249808,"about_ca_system_score_gemma":0.00062823395,"threshold_uncertainty_score":0.52459145},"labels":[],"label_agreement":null},{"id":"W2403162184","doi":"10.1158/1538-7445.nonrna15-b36","title":"Abstract B36: Developing circRNA signatures as a biomarker for the early diagnosis of pancreatic carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Microvesicles; Biology; Cancer research; Pancreatic cancer; Biomarker; CD81; CD63; microRNA; Transcriptome; Gene; Computational biology; Cancer; Gene expression; Immunology; Genetics","score_opus":0.0622963729671413,"score_gpt":0.38027538790557086,"score_spread":0.31797901493842956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403162184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98125225,0.01594493,0.00050077704,0.0013204453,0.00008671024,0.000572837,0.00008756867,0.0000058549713,0.00022862249],"genre_scores_gemma":[0.99656606,0.0015315177,0.00014639292,0.00007073261,0.00019988824,0.0008735619,0.000008176638,0.000033201966,0.00057050004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986731,0.0000907464,0.00019150038,0.00033131932,0.00031004375,0.00040329964],"domain_scores_gemma":[0.99854153,0.0004572483,0.00006167881,0.0004938905,0.000350664,0.00009498117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006441024,0.000114682254,0.0001189526,0.00006285444,0.00014591007,0.00002579698,0.00048588397,0.000121260695,0.0001283219],"category_scores_gemma":[0.0007452495,0.000069308066,0.00011145203,0.0001493824,0.0003303245,0.0000058126384,0.00015773744,0.00009521656,0.000011106035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029733605,0.000030590945,0.024934253,0.00010204371,0.0001166264,0.000005242673,0.000048988353,0.0000015206158,0.9458248,0.00020213953,0.0069069588,0.021529475],"study_design_scores_gemma":[0.0005488864,0.00011065429,0.15192245,0.00012054908,0.000020845755,0.0000010344905,0.000050503033,0.0000037522,0.8329374,0.00057514437,0.013582714,0.00012606023],"about_ca_topic_score_codex":0.00028282797,"about_ca_topic_score_gemma":0.000053754287,"teacher_disagreement_score":0.1269882,"about_ca_system_score_codex":0.000060428465,"about_ca_system_score_gemma":0.00045272982,"threshold_uncertainty_score":0.2826301},"labels":[],"label_agreement":null},{"id":"W2403219295","doi":"10.1158/1538-7445.sabcs15-s6-01","title":"Abstract S6-01: <i>PIK3CA</i> status in circulating tumor DNA (ctDNA) predicts efficacy of buparlisib (BUP) plus fulvestrant (FULV) in postmenopausal women with endocrine-resistant HR+/HER2– advanced breast cancer (BC): First results from the randomized, phase III BELLE-2 trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Clinical endpoint; Internal medicine; Oncology; Population; Breast cancer; Cancer; Metastatic breast cancer; Everolimus; Clinical trial; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Estrogen receptor","score_opus":0.020835317724902172,"score_gpt":0.321575235329682,"score_spread":0.30073991760477986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403219295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874603,0.0028444913,0.00001835049,0.0013101731,0.0002644189,0.0027585349,0.005132455,0.000012400941,0.00019887573],"genre_scores_gemma":[0.99219704,0.005335468,0.000041808606,0.00009766818,0.0006693087,0.0013554672,0.00016157712,0.00007555774,0.000066106746],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954115,0.00033186594,0.001114157,0.0010168628,0.0007781493,0.0013474721],"domain_scores_gemma":[0.9962989,0.0017843978,0.00040316823,0.00086709124,0.00032049697,0.0003259127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00152362,0.00040707903,0.00085748633,0.00016238978,0.00023513043,0.00006308277,0.000614036,0.00014412987,0.00012747092],"category_scores_gemma":[0.0009845011,0.00026256763,0.00011533147,0.00046383304,0.00068795873,0.00003274833,0.0003370946,0.00046038744,0.0000024279875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70800775,0.00043377638,0.0004689102,0.000054123197,0.00018711637,0.00012225246,0.0008871435,0.0020378928,0.28272069,0.000022494374,0.00033999805,0.0047178823],"study_design_scores_gemma":[0.93186504,0.001791872,0.011007396,0.0010998647,0.000055854834,0.000009800485,0.0007167295,0.000079358855,0.04840799,0.00007380711,0.004309613,0.0005826716],"about_ca_topic_score_codex":0.03491305,"about_ca_topic_score_gemma":0.02740828,"teacher_disagreement_score":0.23431268,"about_ca_system_score_codex":0.0008272932,"about_ca_system_score_gemma":0.0023419613,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W2403333208","doi":"10.1158/1538-7445.sabcs15-p6-14-03","title":"Abstract P6-14-03: Genome wide association study (GWAS) to identify variants conferring ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology","funders":"","keywords":"Minor allele frequency; Single-nucleotide polymorphism; Genome-wide association study; Breast cancer; SNP; Oncology; Internal medicine; Candidate gene; Medicine; Genotype; Genotyping; Cancer; Genetics; Biology; Gene","score_opus":0.06423979927546755,"score_gpt":0.3854510703608519,"score_spread":0.3212112710853844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403333208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917151,0.00059643906,0.000014104689,0.0048245816,0.0006371195,0.0016014499,0.0003994895,0.000011551827,0.00020020589],"genre_scores_gemma":[0.99530935,0.0017533192,0.000003332431,0.000762836,0.0009097299,0.0006500724,0.00003515157,0.00004601075,0.00053017563],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99689984,0.0003865237,0.00043009163,0.0006515041,0.0008200107,0.0008120378],"domain_scores_gemma":[0.9979748,0.0005251293,0.00015281868,0.0005088517,0.00067018095,0.00016820186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002548354,0.00021078186,0.00029594608,0.00016670654,0.00025026276,0.00018094853,0.00058816,0.0002424077,0.00017005205],"category_scores_gemma":[0.0019715196,0.00015105178,0.0000972329,0.00042803382,0.000053687974,0.000016741496,0.0002944396,0.00035004964,0.00006412534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00784351,0.0010572983,0.1409709,0.000023259418,0.00033596836,0.00006940938,0.00088607904,0.00025817179,0.8179296,0.000013216519,0.024356613,0.006255933],"study_design_scores_gemma":[0.017769258,0.0004888097,0.96772224,0.00010313506,0.000036290603,0.0000020461805,0.00035554654,0.0000045973243,0.004904438,0.000073708106,0.008223037,0.00031688326],"about_ca_topic_score_codex":0.004150609,"about_ca_topic_score_gemma":0.010945641,"teacher_disagreement_score":0.82675135,"about_ca_system_score_codex":0.0010646629,"about_ca_system_score_gemma":0.00071406155,"threshold_uncertainty_score":0.62745064},"labels":[],"label_agreement":null},{"id":"W2403393996","doi":"10.1158/1538-7445.sabcs15-s5-07","title":"Abstract S5-07: Preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer enrolled in KEYNOTE-028","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Breast cancer; Oncology; Cancer; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Progressive disease; Immunotherapy; Clinical trial; Disease","score_opus":0.01529012457989496,"score_gpt":0.32621919828278506,"score_spread":0.3109290737028901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403393996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992351,0.0017090277,0.00000419056,0.001857566,0.000088234716,0.0025243359,0.0007707496,0.000020494143,0.00067440816],"genre_scores_gemma":[0.99541974,0.0033837631,0.000082401435,0.00008712957,0.00008313731,0.00045829517,0.000035915917,0.000067999994,0.00038162665],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996532,0.0003123483,0.00061410025,0.0007729049,0.00093512563,0.0008335018],"domain_scores_gemma":[0.99769706,0.0007326727,0.00021220896,0.00041732096,0.00070368295,0.00023706972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064668834,0.0003536935,0.00072485616,0.00048784984,0.000121726735,0.00002044994,0.0002351656,0.00020416088,0.00097059936],"category_scores_gemma":[0.00012153652,0.00024227177,0.00008975551,0.00089392555,0.0008504353,0.00029999999,0.0001233924,0.0006045493,0.000011030717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47658446,0.00102526,0.27218983,0.00026386883,0.0004743553,0.000053038733,0.00213472,0.000030212655,0.044852473,0.000017242546,0.00027246145,0.2021021],"study_design_scores_gemma":[0.04390439,0.0023442816,0.9221922,0.0047376817,0.000029945168,0.0000064976807,0.00029477556,0.0000041351473,0.02601561,0.00001527993,0.00017088426,0.00028432137],"about_ca_topic_score_codex":0.0045379763,"about_ca_topic_score_gemma":0.0006534737,"teacher_disagreement_score":0.65000236,"about_ca_system_score_codex":0.0017142456,"about_ca_system_score_gemma":0.0010350513,"threshold_uncertainty_score":0.99994266},"labels":[],"label_agreement":null},{"id":"W2403464392","doi":"10.1158/1538-7445.sabcs15-p2-08-05","title":"Abstract P2-08-05: Association between the neutrophil-to-lymphocyte ratio (NLR) and the 21-gene recurrence score","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Estrogen receptor; Lymph node; Oncology; Neutrophil to lymphocyte ratio; Progesterone receptor; Cancer; Stage (stratigraphy); Gastroenterology; Pathology; Lymphocyte; Biology","score_opus":0.09691555961791676,"score_gpt":0.39960723345656407,"score_spread":0.3026916738386473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403464392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89895576,0.0051686093,0.000011019178,0.09360831,0.00019528031,0.0012335065,0.00010886355,0.000019449632,0.0006991657],"genre_scores_gemma":[0.98842496,0.007843725,0.000009666484,0.00046098843,0.0009533641,0.000791476,0.000007944631,0.000020268653,0.001487593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801,0.00016826476,0.00021817288,0.00035170105,0.0007997733,0.00045209314],"domain_scores_gemma":[0.9976912,0.0012465297,0.0000806956,0.0004459457,0.00035224922,0.00018333747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014865437,0.00013014185,0.0002509925,0.00007931952,0.00033873413,0.00008610423,0.00019291618,0.00007031961,0.00022557186],"category_scores_gemma":[0.00039195592,0.000056031167,0.00007218936,0.00034322988,0.00023814796,0.00007407786,0.000117450414,0.0002594625,0.00013807749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022332757,0.00018232627,0.45339647,0.00016202731,0.00071271183,0.000046101573,0.0018609709,0.000011121173,0.020597706,0.0012786002,0.08916012,0.43035856],"study_design_scores_gemma":[0.005855615,0.0002626081,0.9145388,0.0003722616,0.00012465923,0.0000047162507,0.00005816692,0.0000040621508,0.030321395,0.00043081059,0.04790279,0.00012414294],"about_ca_topic_score_codex":0.0014706885,"about_ca_topic_score_gemma":0.00027844412,"teacher_disagreement_score":0.4611423,"about_ca_system_score_codex":0.0014271749,"about_ca_system_score_gemma":0.0005210359,"threshold_uncertainty_score":0.37320128},"labels":[],"label_agreement":null},{"id":"W2403657692","doi":"10.1158/1538-7445.sabcs15-p5-05-01","title":"Abstract P5-05-01: Prevalance of crown-like structures of the breast, a histologic biomarker linked to obesity: A retrospective study of 99 cases","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Statistics Canada; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Fat necrosis; Adipose tissue; Cohort; CLs upper limits; Obesity; Pathology; Cancer; Biomarker; Oncology; Gastroenterology; Biology","score_opus":0.06487620239432522,"score_gpt":0.3787360167594077,"score_spread":0.3138598143650825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403657692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483013,0.0029753197,0.000005242938,0.00036671557,0.00010690416,0.0013079236,0.00021695318,0.000010933368,0.00017985023],"genre_scores_gemma":[0.9992664,0.0001291195,0.000010308435,0.000023954452,0.00007682843,0.0000680651,0.000001096665,0.000015361014,0.00040885815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977724,0.00025098806,0.000301729,0.00035776987,0.0010280841,0.00028902426],"domain_scores_gemma":[0.9980846,0.00016615553,0.0001205905,0.00085795176,0.0006247122,0.00014601194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006422033,0.00012611014,0.00051809876,0.00017159415,0.0000748259,0.0000053637987,0.00029559582,0.00007745232,0.00021514737],"category_scores_gemma":[0.00039163427,0.0000683262,0.00026131386,0.00058060256,0.00036682186,0.000041757063,0.00022278959,0.00021149834,0.0000020350788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036869308,0.0010947795,0.6059186,0.0006366862,0.0013824217,0.00014053546,0.0009743595,0.000006528581,0.37301993,0.000036892543,0.0030417945,0.010060548],"study_design_scores_gemma":[0.0017236662,0.0004440095,0.9804156,0.0005069277,0.00019837143,0.00004603649,0.00020185916,7.8874206e-7,0.016181383,0.000081359314,0.00012751552,0.00007248493],"about_ca_topic_score_codex":0.0016906951,"about_ca_topic_score_gemma":0.00029531497,"teacher_disagreement_score":0.37449703,"about_ca_system_score_codex":0.00021696948,"about_ca_system_score_gemma":0.00036809465,"threshold_uncertainty_score":0.27862614},"labels":[],"label_agreement":null},{"id":"W2403959377","doi":"10.1158/1538-7445.am2015-sy33-04","title":"Abstract SY33-04: Integrated omic analysis of lung cancer reveals metabolism-proteome signatures with prognostic impact","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Proteome; Biology; Transcriptome; Lung cancer; Cancer research; Adenocarcinoma; Gene; Cancer; Genetics; Computational biology; Gene expression; Pathology; Medicine","score_opus":0.05028286988918127,"score_gpt":0.42120291223175826,"score_spread":0.37092004234257697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403959377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96986157,0.02878179,0.00023045529,0.00011869656,0.00005632481,0.0005018757,0.00022258505,0.000007670287,0.00021904326],"genre_scores_gemma":[0.9973736,0.001576242,0.00014179823,0.000016838156,0.00015735428,0.00023046292,0.00020673376,0.000030754323,0.00026624178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812806,0.00019432722,0.00027203135,0.0004217813,0.00055747246,0.00042632033],"domain_scores_gemma":[0.9979379,0.00005114471,0.00013639152,0.0004208224,0.0012260335,0.00022769706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010345865,0.00017786052,0.00035035945,0.00037682327,0.0000644713,0.00004661669,0.0002873392,0.00018235452,0.00013887875],"category_scores_gemma":[0.00031226836,0.00012619823,0.00013332014,0.0012770415,0.0001674467,0.000008399265,0.000080795384,0.00029649428,0.0000015815432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045011815,0.00005210916,0.074723385,0.000046696943,0.0015549415,0.000003586456,0.00012413712,0.015807912,0.90494776,0.000010794642,0.0010331857,0.0012454034],"study_design_scores_gemma":[0.00076436496,0.00034264656,0.35179517,0.0000863622,0.00054908096,3.32964e-7,0.000096969845,0.00092739734,0.643498,0.00008372063,0.0015712443,0.0002846959],"about_ca_topic_score_codex":0.003308802,"about_ca_topic_score_gemma":0.00096521975,"teacher_disagreement_score":0.27707177,"about_ca_system_score_codex":0.00012534793,"about_ca_system_score_gemma":0.00092573464,"threshold_uncertainty_score":0.51462144},"labels":[],"label_agreement":null},{"id":"W2403998717","doi":"10.1158/1538-7445.compsysbio-b2-57","title":"Abstract B2-57: Genomic analysis of metachronous pancreatic ductal adenocarcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Adenocarcinoma; Pancreas; Copy number analysis; Pathology; DNA sequencing; Genome; Copy-number variation; Cancer; Medicine; Genetics; DNA; Gene","score_opus":0.198877548468724,"score_gpt":0.4682988950253972,"score_spread":0.26942134655667316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403998717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767048,0.009998073,0.00003512369,0.0007423232,0.0000710525,0.000629444,0.00004707173,0.000026933218,0.011745215],"genre_scores_gemma":[0.9951686,0.0008130737,0.00040014042,0.00005013157,0.00026936107,0.00018982567,0.000049363873,0.000031966578,0.003027482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665344,0.00027366713,0.0004897103,0.00046550328,0.0013308462,0.00078685826],"domain_scores_gemma":[0.99702525,0.0004597807,0.00010011042,0.00074451393,0.0010156013,0.0006547368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025591666,0.00017176931,0.0011280606,0.0011952542,0.00010805347,0.000023523773,0.000336957,0.00016780477,0.0021848187],"category_scores_gemma":[0.00063613214,0.00014000539,0.00024223774,0.002037938,0.0006742904,0.00008190903,0.00016794368,0.00066592,0.00020464213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009835005,0.0002976156,0.955511,0.00021112066,0.0049009826,0.00028329456,0.0011754467,0.000059358943,0.031792946,0.00020426243,0.0036752212,0.00090525206],"study_design_scores_gemma":[0.0018015957,0.00065008056,0.9899342,0.00006306896,0.0026072443,0.000028378978,0.0010264114,0.0009962261,0.0017852869,0.00015433779,0.0008195405,0.00013359581],"about_ca_topic_score_codex":0.0048689693,"about_ca_topic_score_gemma":0.00028436782,"teacher_disagreement_score":0.034423232,"about_ca_system_score_codex":0.0009094727,"about_ca_system_score_gemma":0.0029127882,"threshold_uncertainty_score":0.9987273},"labels":[],"label_agreement":null},{"id":"W2404037937","doi":"10.1158/1538-7445.compsysbio-b1-17","title":"Abstract B1-17: Airway gene-coexpression network rewiring in the presence of bronchial dysplasia and lung cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Carcinogenesis; Cancer; Context (archaeology); Biomarker; Lung; Disease; Pathology; Dysplasia; Medicine; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.03828297522039039,"score_gpt":0.35735540958124884,"score_spread":0.31907243436085847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404037937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802215,0.016808795,0.00012306214,0.0002913243,0.00017624396,0.00035261293,0.000018444287,0.0000027125172,0.0020052923],"genre_scores_gemma":[0.99655455,0.0021471397,0.00014960821,0.00008284314,0.00068064185,0.00010398214,0.000013761322,0.000012340161,0.00025512883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874103,0.00009899329,0.00022388753,0.0002182476,0.00031133747,0.0004065182],"domain_scores_gemma":[0.999345,0.000049501956,0.000068860754,0.00031220936,0.00012565817,0.000098775956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013095958,0.000100505764,0.00012483863,0.000037791007,0.00009131909,0.000037717953,0.0003448535,0.00013110331,0.000022824104],"category_scores_gemma":[0.000049466795,0.0000728362,0.000027419812,0.00016591701,0.00017326717,0.00000888138,0.00024705665,0.0003122416,6.725206e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00109157,0.00009517404,0.03755885,0.00036415475,0.00012392878,0.000013794551,0.0037248966,0.034960464,0.4912141,0.00022312676,0.3962194,0.03441052],"study_design_scores_gemma":[0.011733952,0.0017303621,0.11000969,0.003355974,0.000120437064,0.00007462743,0.004840451,0.04050104,0.48383662,0.0033838055,0.33804193,0.0023711228],"about_ca_topic_score_codex":0.00054699305,"about_ca_topic_score_gemma":0.0006948521,"teacher_disagreement_score":0.07245085,"about_ca_system_score_codex":0.00003944467,"about_ca_system_score_gemma":0.0002786021,"threshold_uncertainty_score":0.29701743},"labels":[],"label_agreement":null},{"id":"W2404061100","doi":"10.1158/1538-7445.sabcs15-p6-12-02","title":"Abstract P6-12-02: Association between a dedicated program for young breast cancer patients and discussion about fertility preservation","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fertility; Documentation; Breast cancer; Cancer; Prospective cohort study; Cohort; Demography; Gynecology; Family medicine; Population; Internal medicine; Environmental health","score_opus":0.07641847057745677,"score_gpt":0.4305632699830962,"score_spread":0.3541447994056394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404061100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871373,0.00023424148,0.00003173161,0.009028183,0.00016294126,0.002267443,0.000963143,0.00007006851,0.00010493194],"genre_scores_gemma":[0.99531484,0.0006345406,0.000021522685,0.000033758977,0.00042581037,0.0016546886,0.00012217663,0.000034085693,0.0017585834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768597,0.00006961671,0.0003170591,0.0004484002,0.0008912571,0.0005876872],"domain_scores_gemma":[0.99827623,0.00018802327,0.00014393343,0.00021622532,0.0008875979,0.00028801555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008321705,0.0001471048,0.00027605623,0.00013184636,0.00022745976,0.00006322095,0.000114423594,0.00018933059,0.0002694671],"category_scores_gemma":[0.00035837188,0.0000794529,0.00007176176,0.00025744273,0.00011548466,0.0003208693,0.00007660543,0.00027898097,0.0000055884116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006157526,0.00012850903,0.72939724,0.00016741778,0.000077866825,3.1551966e-7,0.00020033037,1.02786075e-7,0.003363315,0.0000016360656,0.004432539,0.26161495],"study_design_scores_gemma":[0.0027522312,0.00023838624,0.9854411,0.00050019164,0.000058881127,1.7845905e-7,0.0000246815,0.000020796591,0.001997583,0.00009671429,0.008750297,0.00011894313],"about_ca_topic_score_codex":0.0050023803,"about_ca_topic_score_gemma":0.0017911897,"teacher_disagreement_score":0.261496,"about_ca_system_score_codex":0.001587312,"about_ca_system_score_gemma":0.00038722032,"threshold_uncertainty_score":0.7562136},"labels":[],"label_agreement":null},{"id":"W2404115445","doi":"10.1158/1538-7445.sabcs15-s1-01","title":"Abstract S1-01: Analysis of molecular prognostic factors associated with tumor immune and stromal microenvironment in BEATRICE, an open-label phase 3 trial in early triple-negative breast cancer (eTNBC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene signature; Breast cancer; Population; Oncology; Immune system; Biomarker; Stromal cell; Medicine; Cancer research; Proportional hazards model; Internal medicine; Triple-negative breast cancer; CD8; Cancer; Immunology; Biology; Gene expression; Gene; Genetics","score_opus":0.07188113592461359,"score_gpt":0.3979305673090321,"score_spread":0.3260494313844185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404115445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951899,0.0011140283,0.000002631709,0.00037880475,0.00003563721,0.0024090358,0.0008334331,0.000008225998,0.000028311542],"genre_scores_gemma":[0.9987113,0.00052001356,0.000016215048,0.00002214961,0.000025256884,0.0005147878,0.000053177548,0.00003558183,0.00010151329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972473,0.0003051422,0.0005660647,0.00056813064,0.00071893726,0.0005944728],"domain_scores_gemma":[0.99877375,0.00032258718,0.00022545004,0.00034335154,0.00015053769,0.00018432458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010048117,0.0002334421,0.00076420465,0.00089755206,0.00006694235,0.000051859457,0.00029650223,0.0001031074,0.0006867415],"category_scores_gemma":[0.0001406311,0.00015416631,0.00006608579,0.002070389,0.00044859597,0.00025753284,0.00009740397,0.00036510846,8.831368e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14977024,0.0027377622,0.25378606,0.000043825938,0.0018552842,0.00012802574,0.00074604474,0.000007296638,0.58140904,0.0000018015876,0.000015779366,0.009498811],"study_design_scores_gemma":[0.1430954,0.0029350019,0.820534,0.00061147125,0.0003004906,0.0000010831329,0.00028689989,0.000022579936,0.03201649,0.0000046881455,0.000010774818,0.00018115739],"about_ca_topic_score_codex":0.023531439,"about_ca_topic_score_gemma":0.0062272563,"teacher_disagreement_score":0.5667479,"about_ca_system_score_codex":0.0012168677,"about_ca_system_score_gemma":0.0006579929,"threshold_uncertainty_score":0.98297095},"labels":[],"label_agreement":null},{"id":"W2404127287","doi":"10.1158/1538-7445.sabcs15-s4-06","title":"Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tamoxifen; Oncology; Biomarker; Meta-analysis; Clinical trial; Internal medicine; Breast cancer; Cancer","score_opus":0.045027838102963895,"score_gpt":0.37718226040927016,"score_spread":0.33215442230630626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404127287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912287,0.0012375225,0.0012205269,0.0035460268,0.00005887599,0.0010980637,0.001226234,0.000026058418,0.000357993],"genre_scores_gemma":[0.99651,0.00076456764,0.0005666109,0.00034353705,0.00013008015,0.0002913016,0.0001569442,0.00005760901,0.0011793239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969091,0.000105923056,0.0004523499,0.0006528712,0.0011178837,0.0007618953],"domain_scores_gemma":[0.9973177,0.000839186,0.00014782498,0.00045762776,0.0006931188,0.0005445686],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008733814,0.00024540292,0.0010700953,0.0004162291,0.00012368972,0.000047021964,0.00020662333,0.00011724908,0.00091781176],"category_scores_gemma":[0.00052525033,0.00014153907,0.00036864678,0.00052146724,0.00041997855,0.00013569115,0.00005507728,0.00049002544,0.0000036984425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015033597,0.0009091903,0.7109515,0.00057633355,0.10411014,0.00008393594,0.0024475732,0.0001925161,0.01670888,0.00004762613,0.004712232,0.14422649],"study_design_scores_gemma":[0.009843737,0.0022543778,0.9256735,0.00036918788,0.03779277,0.0000031027635,0.00021337552,0.0032880947,0.003368931,0.0003053869,0.016494866,0.00039271294],"about_ca_topic_score_codex":0.0041436106,"about_ca_topic_score_gemma":0.00056365645,"teacher_disagreement_score":0.21472198,"about_ca_system_score_codex":0.00020746813,"about_ca_system_score_gemma":0.00041059853,"threshold_uncertainty_score":0.99999547},"labels":[],"label_agreement":null},{"id":"W2404135395","doi":"10.1158/1538-7445.sabcs15-pl2","title":"Abstract PL2: Clonal Dynamics and Breast Cancer Subtypes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Somatic evolution in cancer; Breast cancer; Context (archaeology); Biology; Cancer; Clonal selection; Population; Copy-number variation; Precision medicine; Computational biology; Bioinformatics; Genetics; Medicine; Genome; Gene; Immunology","score_opus":0.023827475917529248,"score_gpt":0.34916226930873856,"score_spread":0.3253347933912093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404135395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893849,0.0043525235,0.00006810334,0.004025878,0.00019778572,0.00014176992,0.0009784367,0.0000067901087,0.0008438249],"genre_scores_gemma":[0.9791267,0.018145533,0.000026098884,0.0001487746,0.0007324574,0.000101880876,0.000021873338,0.000027968803,0.0016687475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988608,0.000026776586,0.00012226221,0.00037421283,0.00021344845,0.00040253892],"domain_scores_gemma":[0.99924546,0.000065499444,0.000031059404,0.00025685353,0.0002381618,0.00016293275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002601862,0.00011120212,0.00010378813,0.000055256816,0.00011706116,0.000043991677,0.00018653602,0.00011489076,0.0003265389],"category_scores_gemma":[0.000061929,0.000082875384,0.000037442092,0.00008660916,0.0002657829,0.000004782254,0.00019504732,0.0001212569,0.000016187138],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042538907,0.000050474595,0.063275725,0.00005489485,0.00008482303,0.000010518707,0.000029017472,0.000017246453,0.7646544,0.0015992641,0.021546118,0.14825214],"study_design_scores_gemma":[0.0028982048,0.0003301027,0.58704066,0.0003178291,0.000031635645,0.0000560352,0.00014503021,0.000087946966,0.23369533,0.001440052,0.17308868,0.00086847984],"about_ca_topic_score_codex":0.0009319481,"about_ca_topic_score_gemma":0.0031417424,"teacher_disagreement_score":0.53095907,"about_ca_system_score_codex":0.00014751221,"about_ca_system_score_gemma":0.0004184041,"threshold_uncertainty_score":0.35753718},"labels":[],"label_agreement":null},{"id":"W2404348945","doi":"10.1158/1538-7445.brain15-b09","title":"Abstract B09: DNA polymerase mutations trigger rapid onset of ultra-hypermutant malignant brain tumors in children with biallelic mismatch repair deficiency","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Mount Sinai Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Cancer research; PMS2; Mutation; DNA mismatch repair; Germline mutation; Biology; MLH1; Microsatellite instability; MSH2; MSH6; Malignant transformation; Cancer; Carcinogenesis; ATRX; Exome sequencing; Genetics; DNA repair; Gene; Allele; Microsatellite","score_opus":0.07000380422191921,"score_gpt":0.37015952683775083,"score_spread":0.3001557226158316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404348945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916711,0.0031486563,0.000004283338,0.0020627372,0.00008741512,0.0013540946,0.00013203752,0.00005686612,0.0014828298],"genre_scores_gemma":[0.9984442,0.0001665071,0.00018431593,0.00016557543,0.000100549914,0.00030764187,0.000043745888,0.000057288595,0.000530147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996466,0.00022197518,0.00055292103,0.0005849522,0.001408404,0.0007657857],"domain_scores_gemma":[0.99801004,0.000291899,0.000113822025,0.0006175422,0.00052946585,0.00043723517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015415888,0.0002327574,0.00048134828,0.000609082,0.000088093584,0.000022304675,0.0002831357,0.00013211281,0.0005378117],"category_scores_gemma":[0.0007002956,0.00017983407,0.00010406848,0.0014804971,0.0005618143,0.00007677747,0.000051735704,0.00062107365,0.000030280706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004320565,0.0015298781,0.6073134,0.0005229235,0.00030432493,0.0005565847,0.008469955,0.00066282577,0.35440382,0.00006799364,0.013322333,0.008525407],"study_design_scores_gemma":[0.0065423474,0.00247538,0.6520937,0.0008502036,0.00006364465,0.00042931046,0.0019914168,0.000062864565,0.3342106,0.00014256415,0.0006810497,0.00045690613],"about_ca_topic_score_codex":0.005197163,"about_ca_topic_score_gemma":0.0007900042,"teacher_disagreement_score":0.044780325,"about_ca_system_score_codex":0.00076123857,"about_ca_system_score_gemma":0.004730193,"threshold_uncertainty_score":0.839116},"labels":[],"label_agreement":null},{"id":"W2404395307","doi":"10.1158/1538-7445.sabcs15-p4-09-19","title":"Abstract P4-09-19: Comprehensive multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PDGFRA; KRAS; Phyllodes tumor; Cancer research; CDH1; Sanger sequencing; Breast cancer; Gene expression profiling; CDKN2A; PDGFRB; Medicine; Biology; Cancer; Gene; Pathology; Mutation; Gene expression; Internal medicine; Stromal cell; GiST; Genetics; Cell","score_opus":0.052469013024894075,"score_gpt":0.3483863285425749,"score_spread":0.2959173155176808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404395307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471647,0.0018938738,0.00003832494,0.0018723151,0.000114197406,0.0007839508,0.00006759622,0.000016152142,0.00049715134],"genre_scores_gemma":[0.9991168,0.00013796934,0.00012794622,0.000047325393,0.000057758247,0.00010451058,0.0000052300015,0.00003064416,0.0003718523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977588,0.00009303629,0.0003649162,0.00036619382,0.0008283299,0.0005887126],"domain_scores_gemma":[0.99855334,0.00011670587,0.00009207733,0.00051074504,0.00055032916,0.00017679826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066206674,0.00015428473,0.00030369873,0.00027990344,0.00013385207,0.00002635008,0.00030728208,0.000090080364,0.00027112802],"category_scores_gemma":[0.00010401401,0.00008452869,0.00015145865,0.0005834168,0.00048600527,0.00012952372,0.00021557481,0.000298293,0.000018885024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041156515,0.000095297175,0.054186273,0.0002695931,0.00009489571,0.000121887075,0.000094106144,0.000020122632,0.9383281,0.0001768688,0.0001791478,0.006022155],"study_design_scores_gemma":[0.0013906236,0.00003488201,0.5204946,0.001203679,0.000016952295,0.00007295181,0.0006064261,0.00003184121,0.47571018,0.0002023933,0.00013400667,0.000101464786],"about_ca_topic_score_codex":0.0030339467,"about_ca_topic_score_gemma":0.00017065495,"teacher_disagreement_score":0.46630833,"about_ca_system_score_codex":0.00025299558,"about_ca_system_score_gemma":0.0007411534,"threshold_uncertainty_score":0.458644},"labels":[],"label_agreement":null},{"id":"W2404451320","doi":"10.1158/1538-7445.fbcr15-pr03","title":"Abstract PR03: High-resolution detection of fitness genes and genotype-specific cancer vulnerabilities with CRISPR-Cas9 screens","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Biology; CRISPR; Gene; Genetics; Gene knockout; Context (archaeology); Computational biology; RNA interference; RNA","score_opus":0.033244287744331774,"score_gpt":0.3577820944463337,"score_spread":0.32453780670200194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404451320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715674,0.019503802,0.008329444,0.00018674287,0.000092831564,0.00019484357,0.00006484397,0.000008930552,0.00005114188],"genre_scores_gemma":[0.98620915,0.012804425,0.00012475491,0.000004606715,0.00031567345,0.00013424044,0.000005916966,0.000023593688,0.00037765907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989821,0.000043278087,0.00013474551,0.0003163362,0.0002282139,0.00029536808],"domain_scores_gemma":[0.9992904,0.00003387873,0.000031799642,0.00025632337,0.0003128953,0.00007468752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026890181,0.000109715664,0.00011675187,0.00008354692,0.00009948467,0.000017144104,0.00010434803,0.00009702929,0.000062997824],"category_scores_gemma":[0.00002809655,0.00007620027,0.000025382797,0.0001308279,0.0002452651,0.000007266874,0.00006604418,0.00009796287,0.0000016471763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023924845,0.0000123620275,0.0012856249,0.00009464429,0.000031743213,0.0000012225744,0.000049645805,0.000500407,0.9529501,0.000029865041,0.00014451066,0.044660613],"study_design_scores_gemma":[0.00046784582,0.00019442946,0.034640532,0.000110271256,0.000005976509,0.0000035843138,0.00009033555,0.000015110086,0.95724255,0.00003307279,0.007073594,0.00012269216],"about_ca_topic_score_codex":0.00092236005,"about_ca_topic_score_gemma":0.0012643085,"teacher_disagreement_score":0.04453792,"about_ca_system_score_codex":0.000051362204,"about_ca_system_score_gemma":0.000089269975,"threshold_uncertainty_score":0.31073567},"labels":[],"label_agreement":null},{"id":"W2404670179","doi":"10.1158/1538-7445.sabcs15-p4-09-08","title":"Abstract P4-09-08: miR-135a is associated with a metastatic phenotype in invasive lobular carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Invasive lobular carcinoma; Metastasis; Medicine; Cancer research; Cancer; microRNA; Pathology; Oncology; Breast cancer; Internal medicine; Invasive ductal carcinoma; Biology; Gene","score_opus":0.047625802154444806,"score_gpt":0.34062595315043825,"score_spread":0.29300015099599347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404670179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966661,0.0018562465,0.00003586992,0.00056410336,0.000030427314,0.0004046063,0.00011383568,0.0000073141914,0.00032154657],"genre_scores_gemma":[0.99876547,0.00017237202,0.000039406517,0.00007805987,0.00008082174,0.00015341277,0.000058457328,0.00003545044,0.0006165542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833477,0.00016528525,0.00018182654,0.00044273812,0.00039312203,0.00048223746],"domain_scores_gemma":[0.99894637,0.00007931342,0.00006946234,0.00039198078,0.0003805509,0.00013230648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046474492,0.00014056142,0.00015934149,0.00012468253,0.000066141445,0.000027346588,0.00024027382,0.00010400406,0.00044015146],"category_scores_gemma":[0.00035795904,0.00010097957,0.000047533777,0.00030032318,0.00018967333,0.000009789102,0.0001022778,0.0001376085,0.00006120126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021853176,0.00007282486,0.017723367,0.000045410958,0.00010082595,0.000046323905,0.00009331197,0.000013956879,0.9771684,0.000014492594,0.003137933,0.0013646306],"study_design_scores_gemma":[0.0018844139,0.00017714045,0.20704149,0.00024007798,0.000018535648,0.000002830468,0.00006099021,0.0000065955505,0.787966,0.00022054081,0.0021550674,0.00022633154],"about_ca_topic_score_codex":0.0003857366,"about_ca_topic_score_gemma":0.0011647316,"teacher_disagreement_score":0.18931812,"about_ca_system_score_codex":0.0002597825,"about_ca_system_score_gemma":0.00074497086,"threshold_uncertainty_score":0.48193496},"labels":[],"label_agreement":null},{"id":"W2405105446","doi":"10.1158/1538-7445.chromepi15-b12","title":"Abstract B12: H3-K27M is a negative prognostic marker in high- and low-grade pediatric thalamic glioma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Brainstem; Cohort; Histone H3; Internal medicine; Astrocytoma; Oncology; Gastroenterology; Cancer; Pathology; Histone; Biology; Cancer research","score_opus":0.04648877038296236,"score_gpt":0.3732369780520338,"score_spread":0.3267482076690715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405105446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877528,0.0029248574,4.4963045e-7,0.0077730324,0.00007419142,0.000994725,0.000056450954,0.000023129762,0.00040035552],"genre_scores_gemma":[0.995625,0.0030131298,0.000033402703,0.00006979325,0.0002375299,0.00068275945,0.0000038060828,0.00003251055,0.00030207835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793667,0.000095194344,0.00022938802,0.0005031167,0.0006124003,0.0006232465],"domain_scores_gemma":[0.998355,0.000818499,0.000044967972,0.0003053983,0.00022832467,0.0002478626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045557634,0.00017092146,0.00028299642,0.00053822075,0.00007983148,0.000038176844,0.00010728688,0.00010508283,0.0008531805],"category_scores_gemma":[0.00039249533,0.000104929415,0.00004698544,0.00091630046,0.00017931024,0.00010986532,0.00009426405,0.00026882236,0.00015637561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002904436,0.0005669293,0.95318705,0.00024528135,0.000083710765,0.0011974663,0.00039917807,3.0706778e-7,0.022476438,0.00009774949,0.0056122723,0.015843173],"study_design_scores_gemma":[0.0042970837,0.00024159194,0.972309,0.00044830286,0.00003771452,0.000022456832,0.000076344826,0.0000063161297,0.021599771,0.0005849378,0.00025384472,0.00012262183],"about_ca_topic_score_codex":0.0014031455,"about_ca_topic_score_gemma":0.00023653811,"teacher_disagreement_score":0.019121964,"about_ca_system_score_codex":0.0003725118,"about_ca_system_score_gemma":0.00032651858,"threshold_uncertainty_score":0.9341728},"labels":[],"label_agreement":null},{"id":"W2405392601","doi":"10.1158/1538-7445.nonrna15-a29","title":"Abstract A29: Hypoxia regulated long noncoding RNAs and antisense transcripts in breast cancer: Novel insights of noncoding transcriptional regulation in hypoxic microenvironment","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Downregulation and upregulation; Cancer research; Epigenetics; Long non-coding RNA; Hypoxia (environmental); microRNA; Tumor hypoxia; Cell biology; Gene; Genetics; Chemistry; Medicine; Internal medicine","score_opus":0.03395549839718154,"score_gpt":0.31483680559447724,"score_spread":0.2808813071972957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405392601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917998,0.0045349477,0.0015255598,0.0011502194,0.000114665476,0.0006303576,0.00015815884,0.000007545097,0.000078767756],"genre_scores_gemma":[0.9891851,0.010116,0.00010233817,0.000029001709,0.00012604421,0.00014805887,0.000024756,0.000055479493,0.00021324969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971381,0.00017731848,0.0005138975,0.0007687326,0.0007053135,0.0006966394],"domain_scores_gemma":[0.99912363,0.00005181983,0.000094336865,0.00037301963,0.00017970115,0.00017751762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078197254,0.00023813821,0.00030556062,0.00054526195,0.00009916673,0.000030906587,0.000267992,0.00030997672,0.00014227898],"category_scores_gemma":[0.000037620233,0.00021404025,0.00008560475,0.00051885913,0.00036830132,0.000035724326,0.00010504906,0.00038269378,0.0000026812452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008499842,0.00013988443,0.0014595021,0.00011833173,0.00004980019,0.000027187469,0.00016441729,0.00050900626,0.98642915,0.00007259153,0.0000561088,0.0101240575],"study_design_scores_gemma":[0.0028134403,0.00008782504,0.26454973,0.0007068259,0.000007268751,0.000021991185,0.000046419405,0.00014220795,0.73075116,0.00005227805,0.000608824,0.00021202078],"about_ca_topic_score_codex":0.0012479795,"about_ca_topic_score_gemma":0.0027055435,"teacher_disagreement_score":0.26309022,"about_ca_system_score_codex":0.00055893033,"about_ca_system_score_gemma":0.00040946572,"threshold_uncertainty_score":0.8728308},"labels":[],"label_agreement":null},{"id":"W2405407273","doi":"10.1158/1538-7445.sabcs15-p5-14-02","title":"Abstract P5-14-02: Clinical predictors of benefit from fulvestrant in advanced breast cancer: A meta-analysis of randomized controlled trials","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Oncology; Breast cancer; Metastatic breast cancer; Tamoxifen; Clinical endpoint; Hazard ratio; Randomized controlled trial; Meta-analysis; Cancer; Adverse effect; Confidence interval; Gynecology","score_opus":0.19746940196252744,"score_gpt":0.49732033457268743,"score_spread":0.29985093261016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405407273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486453,0.03771289,0.00018525074,0.004776219,0.00030667218,0.00442687,0.0037448222,0.000035995345,0.00016597785],"genre_scores_gemma":[0.9844963,0.011126313,0.00026187027,0.00007446046,0.00036735655,0.0030258682,0.00002686592,0.00005914889,0.0005618436],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98902816,0.002356594,0.0048936964,0.0009216172,0.002022556,0.00077738165],"domain_scores_gemma":[0.9755142,0.019490063,0.0017775646,0.0010729535,0.001763991,0.00038127528],"candidate_categories":["metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019523356,0.00043606918,0.017366115,0.0013710931,0.00004903723,0.00001562535,0.00048968795,0.00029247082,0.009162274],"category_scores_gemma":[0.005670966,0.0002237051,0.0060977195,0.0016695827,0.0013450616,0.00022194251,0.00009475815,0.0006367394,0.0000059296035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5967882,0.00049844646,0.016715383,0.00011683766,0.2916876,0.000022484222,0.00031006872,0.0005932182,0.06052848,0.00011948838,0.000043203447,0.032576557],"study_design_scores_gemma":[0.6626693,0.00030034635,0.13636768,0.0008242782,0.18075898,0.000002603073,0.0002527504,0.000092087284,0.016724952,0.0013252645,0.00029174722,0.00038997878],"about_ca_topic_score_codex":0.0056343065,"about_ca_topic_score_gemma":0.0020495523,"teacher_disagreement_score":0.1196523,"about_ca_system_score_codex":0.0004325837,"about_ca_system_score_gemma":0.0012313935,"threshold_uncertainty_score":0.9972221},"labels":[],"label_agreement":null},{"id":"W2405420781","doi":"10.1158/1538-7445.sabcs15-p4-03-05","title":"Abstract P4-03-05: Wide-field optical coherence tomography (WF-OCT) for near real-time, point-of-care assessment of margin status in breast-conserving surgery specimens: Results of a feasibility study at a high-volume single-centre","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Lumpectomy; Optical coherence tomography; Breast-conserving surgery; Medicine; Breast cancer; Margin (machine learning); Surgical margin; Nuclear medicine; Radiology; Mastectomy; Cancer; Surgery; Computer science; Resection","score_opus":0.050904463931646805,"score_gpt":0.3468311960753269,"score_spread":0.2959267321436801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405420781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942089,0.00017289347,0.00008413693,0.00044881777,0.000065456334,0.0026159075,0.0010598749,0.00006389545,0.0012801718],"genre_scores_gemma":[0.9970322,0.00008781348,0.0022435137,0.00000358218,0.000026887767,0.00050077436,0.000021916052,0.000045580735,0.000037732098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963322,0.00020364032,0.0010980619,0.00063058885,0.0008554922,0.0008799946],"domain_scores_gemma":[0.99283755,0.004821595,0.00017359483,0.0009842211,0.00092175585,0.00026126424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016725654,0.00025614313,0.0006972628,0.00047691245,0.00007725135,0.000035045505,0.0004444475,0.00016446206,0.00043149717],"category_scores_gemma":[0.0005441598,0.00022612985,0.0002170647,0.0014309742,0.0004753767,0.00019081363,0.00020229565,0.00034019575,0.0000069668417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00226576,0.0016397764,0.69672287,0.0015946946,0.00023028978,0.000015987633,0.00082128006,0.00042951922,0.2851222,0.0002210438,0.0028442752,0.008092344],"study_design_scores_gemma":[0.0026047216,0.0007002923,0.95831263,0.0011930804,0.00004019051,9.4933995e-7,0.00093908526,0.00041685256,0.035070762,0.00028532476,0.00009053528,0.0003455642],"about_ca_topic_score_codex":0.0020166023,"about_ca_topic_score_gemma":0.001909254,"teacher_disagreement_score":0.2615898,"about_ca_system_score_codex":0.0006654802,"about_ca_system_score_gemma":0.000461088,"threshold_uncertainty_score":0.92213076},"labels":[],"label_agreement":null},{"id":"W2405478812","doi":"10.1158/1538-7445.fbcr15-ia10","title":"Abstract IA10: The role of stem cells in the origin of relapse in acute leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Somatic evolution in cancer; Cancer stem cell; Stem cell; Epigenetics; Biology; Genetic heterogeneity; Cancer; Leukemia; Cancer research; Genetics; Gene; Phenotype","score_opus":0.030538058026344985,"score_gpt":0.34145385151061824,"score_spread":0.3109157934842733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405478812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952274,0.0028916083,0.0000040771515,0.00041387344,0.000055045726,0.00022892446,0.00009539685,6.917366e-7,0.0010829582],"genre_scores_gemma":[0.99345416,0.006107276,0.0000073895285,0.00004051257,0.00007995791,0.0000707547,0.0000023272332,0.000010084592,0.00022751099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906605,0.00009143659,0.0002042925,0.00017775774,0.00021697098,0.00024347755],"domain_scores_gemma":[0.9992046,0.00019550908,0.00005490192,0.00041973792,0.0000983871,0.000026915433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008550009,0.00006647581,0.000105383515,0.000056959834,0.000024902576,0.000008732018,0.00045952154,0.00007902153,0.000026441372],"category_scores_gemma":[0.00003293912,0.000034727676,0.000043477197,0.00018876998,0.00019459295,0.0000025547963,0.00011390251,0.00015634389,0.000004558327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015716384,0.000028733431,0.0059732697,0.000014773227,0.000016495034,0.0000037972281,0.00021887322,0.00007223875,0.9780394,0.0004377687,0.0017705121,0.013267018],"study_design_scores_gemma":[0.0005390225,0.00010790655,0.009552062,0.000061344464,0.0000039496854,9.342703e-7,0.00040174584,0.0000057072452,0.9444578,0.0004295301,0.044379376,0.000060621005],"about_ca_topic_score_codex":0.0014025191,"about_ca_topic_score_gemma":0.0014931204,"teacher_disagreement_score":0.042608865,"about_ca_system_score_codex":0.000103540784,"about_ca_system_score_gemma":0.0005013198,"threshold_uncertainty_score":0.21201986},"labels":[],"label_agreement":null},{"id":"W2406237143","doi":"10.1158/1538-7445.brain15-b28","title":"Abstract B28: Dianhydrogalactitol inhibits the growth of glioblastoma multiforme stem and non-stem cultures, in vitro and in vivo","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Delmar (Canada)","funders":"","keywords":"Temozolomide; Methyltransferase; Cancer research; In vivo; Medicine; Cancer; Cancer stem cell; DNA repair; Glioblastoma; O-6-methylguanine-DNA methyltransferase; Guanine; Dacarbazine; Brain tumor; Oncology; Internal medicine; Pathology; Biology; Methylation; Melanoma; DNA; Genetics","score_opus":0.053146189998684076,"score_gpt":0.3635211368292786,"score_spread":0.3103749468305945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406237143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994297,0.003045851,9.095842e-8,0.0013841769,0.00003308496,0.0007276245,0.000024261779,0.0000056608105,0.00048223144],"genre_scores_gemma":[0.9989771,0.0006211446,0.0000101454625,0.000026337477,0.000050418068,0.00023466266,0.0000014421867,0.0000144957685,0.00006423912],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986709,0.000064134205,0.00021854369,0.00025088264,0.00046285838,0.00033272745],"domain_scores_gemma":[0.9992247,0.00017803261,0.000043091703,0.00018269675,0.00017148718,0.00019996021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006311937,0.000116534386,0.00026512594,0.0002566016,0.000042581472,0.000028657034,0.00007562073,0.000083502404,0.000010736355],"category_scores_gemma":[0.000048364713,0.00007167928,0.000024797748,0.00041993376,0.00015074162,0.0001005228,0.00008779022,0.00032355875,0.0000047244184],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003738212,0.0008832197,0.57826614,0.0007618401,0.000114460105,0.00065602217,0.0073032635,0.000019489738,0.39117235,0.00006629364,0.0029691192,0.014049592],"study_design_scores_gemma":[0.005637691,0.0003186822,0.1703163,0.00055262755,0.000014022985,0.00002942637,0.0022190695,0.00014366885,0.82001835,0.000033486074,0.0006179651,0.00009871373],"about_ca_topic_score_codex":0.0036498469,"about_ca_topic_score_gemma":0.0035475271,"teacher_disagreement_score":0.428846,"about_ca_system_score_codex":0.00026204265,"about_ca_system_score_gemma":0.00017718709,"threshold_uncertainty_score":0.5517501},"labels":[],"label_agreement":null},{"id":"W2406374454","doi":"10.1158/1538-7445.sabcs15-p5-04-03","title":"Abstract P5-04-03: Targeting glycoprotein non-metastatic B (GPNMB) to overcome EGFR-mediated resistance to Mek inhibition in triple negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triple-negative breast cancer; Medicine; MAPK/ERK pathway; Breast cancer; Cancer research; Targeted therapy; Melanoma; Cancer; Oncology; Internal medicine; Signal transduction; Biology","score_opus":0.051021202333936394,"score_gpt":0.39655701719486974,"score_spread":0.3455358148609333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406374454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94987583,0.00080233766,0.000057767662,0.043548632,0.00016982772,0.0025872907,0.0010981831,0.000042866188,0.0018172835],"genre_scores_gemma":[0.97869015,0.00086826173,0.0006053863,0.00085648446,0.0006239564,0.0018787339,0.00003819185,0.00007667324,0.016362164],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9946132,0.0002779997,0.0006659454,0.0008955857,0.0019731803,0.0015741308],"domain_scores_gemma":[0.9966574,0.0008241206,0.00009066509,0.00042450338,0.0010299397,0.0009733737],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019494795,0.00033025682,0.00062354724,0.0009184409,0.00026129547,0.00007290032,0.000290717,0.00012369719,0.004376913],"category_scores_gemma":[0.0012082178,0.00023156566,0.000118083466,0.0022949579,0.00028175965,0.0002756758,0.00028717352,0.0008743974,0.0011640781],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011890836,0.00030176388,0.01033523,0.00080474647,0.00011883627,0.0007770769,0.0014118328,0.000035494442,0.8782136,0.000098883116,0.08107058,0.014941154],"study_design_scores_gemma":[0.010605881,0.0009842078,0.59287024,0.010797352,0.000031254007,0.000035347435,0.0011081127,0.00007541714,0.32753775,0.0008672495,0.053976893,0.0011103017],"about_ca_topic_score_codex":0.017847626,"about_ca_topic_score_gemma":0.011382048,"teacher_disagreement_score":0.582535,"about_ca_system_score_codex":0.0018229394,"about_ca_system_score_gemma":0.0012092096,"threshold_uncertainty_score":0.99961364},"labels":[],"label_agreement":null},{"id":"W2406500056","doi":"10.1158/1538-7445.sabcs15-pd5-04","title":"Abstract PD5-04: NSABP FB-7: A phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N+T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neratinib; Trastuzumab; Medicine; Pertuzumab; Internal medicine; Breast cancer; Regimen; Docetaxel; Oncology; Neoadjuvant therapy; Lapatinib; Metastatic breast cancer; Chemotherapy; Cancer","score_opus":0.050687440653441856,"score_gpt":0.424429407720223,"score_spread":0.3737419670667811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406500056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692052,0.0040569007,0.00021996329,0.010445783,0.00010082717,0.014758277,0.00081829197,0.00009225184,0.00030249124],"genre_scores_gemma":[0.97172004,0.00634518,0.00090510206,0.0006969451,0.00036370553,0.015834976,0.00003438325,0.00028075682,0.0038189287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98929596,0.0016975146,0.0013050303,0.002134354,0.0031131394,0.0024540294],"domain_scores_gemma":[0.9928724,0.0029391649,0.00039160726,0.0008108276,0.001741447,0.0012445118],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005031714,0.0010848541,0.002719004,0.00055048167,0.0008542574,0.00034113086,0.00044442515,0.00032568295,0.0020394498],"category_scores_gemma":[0.00069981924,0.00051723426,0.000101611884,0.0016536147,0.0026385407,0.00078096526,0.00017898672,0.0018447425,0.000005467684],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.72927874,0.0010141702,0.00025361028,0.00016916957,0.0006774916,0.00068880914,0.008854296,0.000063856016,0.06474862,0.000008347954,0.000824506,0.1934184],"study_design_scores_gemma":[0.89578104,0.07384039,0.0015622346,0.0058542755,0.000114822345,0.00032128528,0.005978601,0.00040422534,0.014503202,0.000015846463,0.0006523374,0.00097173575],"about_ca_topic_score_codex":0.0058281776,"about_ca_topic_score_gemma":0.008493086,"teacher_disagreement_score":0.19244666,"about_ca_system_score_codex":0.0039610057,"about_ca_system_score_gemma":0.013026555,"threshold_uncertainty_score":0.9998626},"labels":[],"label_agreement":null},{"id":"W2406500772","doi":"10.1158/1538-7445.am2019-568","title":"Abstract 568: Decoding shared antigenic epitopes and their cognate TCR genes in melanoma TILs using a library of paired human cell-based pHLA multimers and artificial APCs","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Wellcome Trust","keywords":"Antigen; Epitope; Human leukocyte antigen; Melanoma; T-cell receptor; Immunology; T cell; Biology; Adoptive cell transfer; Cancer research; Immunotherapy; Immune system","score_opus":0.1312969369451226,"score_gpt":0.40013439014120517,"score_spread":0.26883745319608254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406500772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246037,0.0054472885,0.0000019664296,0.00045476898,0.00004169895,0.00069377624,0.00013390265,0.000015389456,0.0007508518],"genre_scores_gemma":[0.9977699,0.0012242267,0.00021846735,0.000046986203,0.00013096082,0.00002494471,0.00005242179,0.00003637409,0.00049571384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980564,0.00015850985,0.00034723713,0.00042321524,0.00044461986,0.00057002454],"domain_scores_gemma":[0.99897766,0.000406027,0.00006721109,0.00020990547,0.000118654745,0.00022052602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064652605,0.000176812,0.0004219828,0.00046746604,0.00015464718,0.00006397163,0.00015669367,0.00011801358,0.00089809165],"category_scores_gemma":[0.000035433997,0.00013853084,0.000070847105,0.0003744153,0.00034697598,0.00016650351,0.00017569325,0.00045481196,0.000009842057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092663313,0.00009724188,0.25573155,0.00090966653,0.00004431616,0.000056049845,0.0004793858,0.00003366085,0.7230626,0.00001478237,0.00009260918,0.018551555],"study_design_scores_gemma":[0.0021595417,0.000390539,0.23182741,0.00100657,0.000014785842,0.000009223701,0.00067138573,0.010736414,0.75125813,0.00013978354,0.0015275425,0.0002586532],"about_ca_topic_score_codex":0.0017678962,"about_ca_topic_score_gemma":0.00027411757,"teacher_disagreement_score":0.028195612,"about_ca_system_score_codex":0.000044805623,"about_ca_system_score_gemma":0.0003808344,"threshold_uncertainty_score":0.98334736},"labels":[],"label_agreement":null},{"id":"W2406732508","doi":"10.1158/1538-7445.sabcs15-p6-03-03","title":"Abstract P6-03-03: The Q-CROC-3 project reveals novel genomic alterations in triple negative breast cancers in residual tumors after neoadjuvant chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; McGill University and Génome Québec Innovation Centre; Jewish General Hospital; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"","keywords":"Breast cancer; Chemotherapy; Cancer research; Taxane; Exome sequencing; Gene expression profiling; Triple-negative breast cancer; Primary tumor; KRAS; Anthracycline; Medicine; Minimal residual disease; Cancer; Oncology; Biology; Pathology; Gene; Internal medicine; Gene expression; Metastasis; Mutation; Genetics","score_opus":0.03998469035001432,"score_gpt":0.3630671993466522,"score_spread":0.3230825089966379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406732508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915637,0.0020499881,0.000008848465,0.0064417054,0.00009851262,0.0010939507,0.0005701358,0.000008940865,0.00057153695],"genre_scores_gemma":[0.99438405,0.0017112885,0.000060119703,0.00032270493,0.00040361393,0.0022512951,0.000020763517,0.000045390872,0.000800798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99779624,0.00016598108,0.00034167498,0.00064430234,0.0003323431,0.00071943627],"domain_scores_gemma":[0.99906486,0.00011805309,0.00007974334,0.00047789855,0.0001886301,0.000070807175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006326996,0.00024214892,0.00025288918,0.00018814481,0.00016218428,0.000047747963,0.00035860675,0.00011072709,0.00010742998],"category_scores_gemma":[0.00008780299,0.00015107436,0.000071067494,0.00040871723,0.00041269415,0.00001904332,0.00016442135,0.00027405188,0.000022021235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056112823,0.00033278452,0.058472425,0.00006552869,0.00028388246,0.00004984015,0.004675488,0.00014535883,0.89339656,0.000047853395,0.012255858,0.024663115],"study_design_scores_gemma":[0.004743111,0.00013512815,0.9327423,0.00034897547,0.0000075729995,0.000018848406,0.00078227156,0.000004696093,0.057721417,0.00013143377,0.003056422,0.0003078358],"about_ca_topic_score_codex":0.014801117,"about_ca_topic_score_gemma":0.03241243,"teacher_disagreement_score":0.87426984,"about_ca_system_score_codex":0.00096710864,"about_ca_system_score_gemma":0.0011360947,"threshold_uncertainty_score":0.9917594},"labels":[],"label_agreement":null},{"id":"W2407120253","doi":"10.1158/1538-7445.sabcs15-p4-11-10","title":"Abstract P4-11-10: Breast cancer patients' preferences for adjuvant radiotherapy post-lumpectomy: Whole breast irradiation versus partial breast irradiation-single institutional study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lumpectomy; Medicine; Breast cancer; Radiation therapy; Breast-conserving surgery; Oncology; Cancer; Stage (stratigraphy); Ductal carcinoma; Regimen; Mastectomy; Internal medicine; Radiology","score_opus":0.04576931726297678,"score_gpt":0.3584225689176218,"score_spread":0.312653251654645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407120253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416567,0.0014550857,0.000042266573,0.003609395,0.00079023984,0.0013840965,0.0084341355,0.000037553524,0.0000815638],"genre_scores_gemma":[0.9946572,0.00046328083,0.000032102856,0.000060602135,0.0018055927,0.0022239569,0.00046524437,0.000058737707,0.00023325454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970007,0.00015957042,0.00038634567,0.0009219932,0.00073727214,0.000794107],"domain_scores_gemma":[0.9977423,0.00013777934,0.00017081079,0.00044032192,0.0012813632,0.00022744235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003502183,0.00035743238,0.00032990487,0.00017060956,0.00057024934,0.00010293311,0.000398491,0.00017373828,0.00065981544],"category_scores_gemma":[0.0000746817,0.0002696928,0.0001414638,0.00027842209,0.00048030054,0.00006742076,0.00012357056,0.0001373139,0.000025980868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018209126,0.0041669896,0.5488549,0.00013053871,0.0018814969,0.0000068912595,0.0009302395,0.00025334556,0.18412714,0.00010469429,0.013656011,0.22767867],"study_design_scores_gemma":[0.010326088,0.0008588201,0.97639936,0.00010279031,0.00006229675,0.0000073756673,0.00028523803,0.000010054744,0.003245867,0.000017062206,0.008284699,0.0004003172],"about_ca_topic_score_codex":0.0039691264,"about_ca_topic_score_gemma":0.0068824156,"teacher_disagreement_score":0.42754453,"about_ca_system_score_codex":0.0009878511,"about_ca_system_score_gemma":0.0010655321,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W2407536151","doi":"10.1158/1538-7445.sabcs15-p3-08-04","title":"Abstract P3-08-04: Improving sleep to reduce breast cancer risk in shift workers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"School Health and Nursing Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Pittsburgh Sleep Quality Index; Breast cancer; Sleep hygiene; Psychological intervention; Physical therapy; Sleep (system call); Cancer; Gerontology; Internal medicine; Sleep quality; Psychiatry; Insomnia","score_opus":0.13470187122819918,"score_gpt":0.545382115519282,"score_spread":0.41068024429108274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407536151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93373585,0.00089778646,0.000023645425,0.05985756,0.0027291547,0.0013605055,0.00015923576,0.00006336577,0.001172911],"genre_scores_gemma":[0.99173087,0.00051801273,0.00009344351,0.00055839244,0.001999148,0.0023684865,0.0000035987644,0.000053034346,0.0026750169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957271,0.00077692553,0.00051983143,0.0006093328,0.0006428598,0.0017239021],"domain_scores_gemma":[0.9970212,0.0010637853,0.00014656158,0.00055795244,0.00043221677,0.0007782882],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0035196226,0.00016387152,0.00024043607,0.0005254321,0.0009056061,0.000024466979,0.00040594474,0.00025430907,0.003347183],"category_scores_gemma":[0.00072267005,0.00012086739,0.000039952705,0.0010529449,0.000105141226,0.00023705121,0.00010777197,0.0016431034,0.001356706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013472585,0.00007194411,0.53648144,0.00030121722,0.00000998154,0.000004429041,0.0037944189,0.000012039796,0.0045719347,0.000027690001,0.07731916,0.3760585],"study_design_scores_gemma":[0.000982495,0.00004440181,0.98639166,0.0020892587,0.000004555965,5.7094803e-7,0.001887267,0.0000071386744,0.00029692397,0.00034670913,0.0077830553,0.00016593719],"about_ca_topic_score_codex":0.08961453,"about_ca_topic_score_gemma":0.020928496,"teacher_disagreement_score":0.44991025,"about_ca_system_score_codex":0.003697797,"about_ca_system_score_gemma":0.0039534774,"threshold_uncertainty_score":0.9994209},"labels":[],"label_agreement":null},{"id":"W2407612119","doi":"10.1158/1538-7445.sabcs15-p6-10-17","title":"Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; BRCA mutation; Ovarian cancer; Breast cancer; Prophylactic Surgery; Gynecology; Incidence (geometry); Prophylactic Mastectomy; Obstetrics; Cancer; Prophylactic treatment; Internal medicine; Mastectomy","score_opus":0.08902855466320109,"score_gpt":0.40639246938863116,"score_spread":0.3173639147254301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407612119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997518,0.0007640971,0.0002749725,0.00021844856,0.00017984274,0.00030723933,0.000046093788,0.000010753218,0.0006805679],"genre_scores_gemma":[0.99610484,0.00021476792,0.00010969081,0.000015538248,0.00019733977,0.00041995957,0.000018348695,0.00002053694,0.0028989876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860847,0.00008912277,0.00024044431,0.0003740444,0.0003654845,0.00032246107],"domain_scores_gemma":[0.99877656,0.000059552385,0.00010252404,0.0003506627,0.00062707067,0.00008361009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035995798,0.00011440484,0.00012485648,0.00011591632,0.00014652123,0.00003751787,0.0002110794,0.00012169632,0.00069284526],"category_scores_gemma":[0.0006860607,0.0000806384,0.000046639223,0.00032975586,0.0009011311,0.000034217363,0.00008383676,0.00008652942,0.000009982853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038373674,0.00004616511,0.0035028714,0.000073559095,0.000031176907,0.000006787912,0.00077718,0.00007197734,0.97780424,0.000013410802,0.00209473,0.01519414],"study_design_scores_gemma":[0.0003957116,0.0002552632,0.01444237,0.00009470059,0.0000048301554,0.0000043101104,0.00071495975,0.0000040831933,0.9730381,0.000045654127,0.01086706,0.00013299703],"about_ca_topic_score_codex":0.00044534385,"about_ca_topic_score_gemma":0.0006501942,"teacher_disagreement_score":0.015061144,"about_ca_system_score_codex":0.0003079479,"about_ca_system_score_gemma":0.0012178265,"threshold_uncertainty_score":0.7586169},"labels":[],"label_agreement":null},{"id":"W2408016393","doi":"10.1158/1538-7445.sabcs15-ot3-02-12","title":"Abstract OT3-02-12: OPTIMA (optimal personalised treatment of early breast cancer usIng multi-parameter analysis), a prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Population; Randomized controlled trial; Stage (stratigraphy); Cancer; Gynecology; Biology","score_opus":0.11154309882993041,"score_gpt":0.4249607962156463,"score_spread":0.3134176973857159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408016393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923935,0.0011755374,0.0011246632,0.00013449958,0.0000518252,0.0025293315,0.0025655334,0.000011138694,0.000013981345],"genre_scores_gemma":[0.9959935,0.0010273014,0.0008741736,0.000006248661,0.00012034165,0.0018924883,0.000017812701,0.000030474252,0.000037646478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977019,0.00038381823,0.00030254293,0.00074386643,0.00044769922,0.00042021731],"domain_scores_gemma":[0.9976001,0.00078654656,0.00015511313,0.0005127404,0.00079901126,0.00014653626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005335072,0.00027156406,0.00052680954,0.00016757523,0.00020542828,0.000024350593,0.00021240677,0.0001279404,0.00006819633],"category_scores_gemma":[0.00022392147,0.0001529569,0.00021911293,0.00049613207,0.0005318911,0.000017384635,0.00012382818,0.0000872443,5.048254e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060121834,0.00075113476,0.16787206,0.000018799778,0.0019689589,0.000002121217,0.0007262322,0.00023434604,0.76076126,3.7990742e-7,0.0000147197825,0.0075281807],"study_design_scores_gemma":[0.013052816,0.0007375052,0.5251057,0.00012678902,0.00020566146,0.0000016243645,0.00008929521,0.000111904075,0.46043664,0.000003772705,0.000016572407,0.00011168701],"about_ca_topic_score_codex":0.0027836151,"about_ca_topic_score_gemma":0.00029864613,"teacher_disagreement_score":0.35723367,"about_ca_system_score_codex":0.0004146439,"about_ca_system_score_gemma":0.00036949335,"threshold_uncertainty_score":0.62374014},"labels":[],"label_agreement":null},{"id":"W2408477660","doi":"10.1158/1538-7445.sabcs15-p1-10-20","title":"Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Asymptomatic; Stage (stratigraphy); Internal medicine; Cancer; Disease; Oncology; Physical therapy","score_opus":0.09652163825045382,"score_gpt":0.3756239939993864,"score_spread":0.2791023557489326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408477660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856483,0.009470956,0.0000053248214,0.0032938102,0.000119886245,0.0010453211,0.00008021266,0.000017581733,0.0003186135],"genre_scores_gemma":[0.99490213,0.0016037262,0.000034607543,0.00011007924,0.00010699059,0.0014062646,8.4288433e-7,0.000036478123,0.0017988859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969477,0.00012133796,0.00044641463,0.00049379107,0.0013496015,0.00064114475],"domain_scores_gemma":[0.99840915,0.00018593365,0.00019122889,0.0005762297,0.0004822783,0.0001551726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068824855,0.00023588623,0.00031772157,0.00009902368,0.00025917724,0.000024012294,0.00030599293,0.00005400627,0.00065272994],"category_scores_gemma":[0.00006587286,0.00011077306,0.00005950497,0.00043026675,0.0007736049,0.00015976498,0.00012875919,0.0002773053,0.000007660431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016630117,0.00025461824,0.56747407,0.00018430752,0.0001913361,0.000029565985,0.032181915,0.00004673826,0.12547891,0.00005340795,0.00020713916,0.27223498],"study_design_scores_gemma":[0.0027290997,0.00011742568,0.74620557,0.001896329,0.000015486276,0.000011364972,0.0027704267,0.0000035331695,0.15764268,0.000030462674,0.088369444,0.00020819549],"about_ca_topic_score_codex":0.0033860991,"about_ca_topic_score_gemma":0.0063227587,"teacher_disagreement_score":0.2720268,"about_ca_system_score_codex":0.0023689263,"about_ca_system_score_gemma":0.0011390131,"threshold_uncertainty_score":0.7146935},"labels":[],"label_agreement":null},{"id":"W2408503479","doi":"10.1158/1538-7445.sabcs15-p4-14-01","title":"Abstract P4-14-01: Trastuzumab emtansine improves overall survival versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer: Final results from the phase 3 EMILIA study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Lapatinib; Trastuzumab emtansine; Medicine; Taxane; Trastuzumab; Interim analysis; Internal medicine; Metastatic breast cancer; Gastroenterology; Confidence interval; Hazard ratio; Breast cancer; Cancer; Oncology; Randomized controlled trial","score_opus":0.07246694683704773,"score_gpt":0.4110668480894483,"score_spread":0.3385999012524006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408503479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823774,0.0007490593,0.0000028397146,0.0042712423,0.00038161592,0.0058267512,0.005695973,0.00008283571,0.00061225134],"genre_scores_gemma":[0.995156,0.0010546073,0.000028655733,0.00006543592,0.00065305654,0.001555479,0.00029117384,0.00015422858,0.0010413904],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9914957,0.00079990964,0.00096798287,0.0016007071,0.003275925,0.0018597665],"domain_scores_gemma":[0.9935454,0.0023498351,0.00024096295,0.001413643,0.001832861,0.00061728933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018169577,0.00060992874,0.0010020387,0.0003320386,0.00035596648,0.00011732257,0.00081993925,0.0002088823,0.0011416655],"category_scores_gemma":[0.0009904696,0.00034982467,0.0001247121,0.0013577219,0.000734516,0.00038422283,0.00026667517,0.0015733773,0.000053239437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45121086,0.0063637663,0.23645912,0.00022007742,0.0011481588,0.00082162215,0.006681642,0.000080374586,0.02005894,0.000006554071,0.0054202457,0.27152866],"study_design_scores_gemma":[0.1354842,0.007533088,0.85030806,0.0020592224,0.00010080898,0.0000025970228,0.00092645345,0.00003115796,0.002359649,0.00000817607,0.0007403882,0.00044618556],"about_ca_topic_score_codex":0.063254856,"about_ca_topic_score_gemma":0.05291028,"teacher_disagreement_score":0.6138489,"about_ca_system_score_codex":0.005190004,"about_ca_system_score_gemma":0.0036915678,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2408683543","doi":"10.1158/1538-7445.am2015-4865","title":"Abstract 4865: PhyloSpan: using multi-mutation reads to resolve subclonal architectures from heterogeneous tumor samples","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Indel; Genetics; Biology; Germline mutation; Germline; Mutation; Population; Computational biology; Single-nucleotide polymorphism; Genotype; Gene","score_opus":0.13897743501851847,"score_gpt":0.4060364666579114,"score_spread":0.26705903163939293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408683543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365,0.003372369,0.0014748668,0.00023551806,0.00025886224,0.00034396534,0.000574732,0.000011191382,0.00007846628],"genre_scores_gemma":[0.9919226,0.00010455363,0.006088394,0.00035015194,0.0011276715,0.0000916748,0.00020056366,0.000049208615,0.000065177504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998236,0.00008193047,0.00021605143,0.0005424965,0.00042351577,0.0004999993],"domain_scores_gemma":[0.99867254,0.000084521365,0.000054051317,0.00041916658,0.0003925626,0.0003771604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037798498,0.0001685472,0.00016619613,0.00011273119,0.00013155467,0.00009605783,0.00031656885,0.00010381171,0.000047386675],"category_scores_gemma":[0.0004559663,0.00016856125,0.000071786926,0.00016200275,0.0001266118,0.0000027463523,0.00025584098,0.00021724754,0.000025367886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006423216,0.00007535452,0.00354768,0.000018392555,0.00006694333,0.000062664134,0.00036968215,0.027958825,0.9603546,0.000009230238,0.0033047297,0.0035895654],"study_design_scores_gemma":[0.0013533538,0.0004622203,0.015562402,0.000072516064,0.000019482477,0.000025050213,0.0002623997,0.00047206946,0.9507994,0.00048108053,0.030037861,0.00045217405],"about_ca_topic_score_codex":0.007700859,"about_ca_topic_score_gemma":0.0036587864,"teacher_disagreement_score":0.027486755,"about_ca_system_score_codex":0.00020405756,"about_ca_system_score_gemma":0.0006917019,"threshold_uncertainty_score":0.99890697},"labels":[],"label_agreement":null},{"id":"W2412466530","doi":"10.1158/1538-7445.am2015-4303","title":"Abstract 4303: Programmed death ligand 1 (PD-L1) expression in paired melanoma tumor samples","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Concordance; Immunohistochemistry; Medicine; Melanoma; Internal medicine; Confidence interval; Gastroenterology; Pathology; Oncology; Cancer research","score_opus":0.22448888422165203,"score_gpt":0.4316842909616055,"score_spread":0.20719540673995346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412466530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875373,0.0073652347,0.000005108532,0.0019296573,0.00017676018,0.0009927333,0.000018558194,0.000060021597,0.0019145746],"genre_scores_gemma":[0.99720526,0.0005097766,0.00025484603,0.0002013022,0.0003230322,0.0005205694,0.00002832699,0.000039261533,0.0009176408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975406,0.00012327904,0.00032685374,0.00041598937,0.00089247944,0.0007008086],"domain_scores_gemma":[0.99875355,0.00013860696,0.00005744951,0.00041550785,0.00028554496,0.00034933956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016961145,0.00016449702,0.00031204504,0.00030124796,0.00009217571,0.0000652385,0.00021796394,0.00011260264,0.00030116382],"category_scores_gemma":[0.0002551291,0.00012639342,0.00008305019,0.00058528874,0.00019676733,0.0001142901,0.00008011277,0.0005027542,0.00003636794],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018086959,0.00059030455,0.1814936,0.00039631338,0.0001100275,0.0005437972,0.002322625,0.0000044500252,0.6668038,0.000024664727,0.029362136,0.100261375],"study_design_scores_gemma":[0.009898647,0.0009928093,0.42592108,0.0015289646,0.000015814683,0.000046346886,0.0017334127,0.000025644455,0.41252515,0.00029272787,0.14669143,0.00032797465],"about_ca_topic_score_codex":0.0042011943,"about_ca_topic_score_gemma":0.0007965812,"teacher_disagreement_score":0.2542786,"about_ca_system_score_codex":0.0006910398,"about_ca_system_score_gemma":0.001142187,"threshold_uncertainty_score":0.6350977},"labels":[],"label_agreement":null},{"id":"W2412646424","doi":"10.1158/0008-5472.can-15-3455","title":"Design and Reporting of Targeted Anticancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy","year":2016,"lang":"en","type":"review","venue":"Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Sorafenib; Medicine; Meta-analysis; Oncology; Internal medicine; Publication bias; Hepatocellular carcinoma; Cancer; Renal cell carcinoma; External validity; Subgroup analysis; Clinical study design; Clinical trial","score_opus":0.9843123348499394,"score_gpt":0.7927409852617976,"score_spread":0.19157134958814181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412646424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041134507,0.9934565,0.0025766566,0.00014480844,0.00017410763,0.0028396833,0.00033582546,0.000038503633,0.000022577577],"genre_scores_gemma":[0.00012348185,0.748342,0.2504084,0.000009071564,0.00018275563,0.0007674347,0.0000015275558,0.000084039915,0.00008128856],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9710098,0.013227165,0.011426131,0.0015253135,0.0019497733,0.0008618039],"domain_scores_gemma":[0.49154842,0.48890984,0.01337842,0.0017972367,0.0039991625,0.00036692226],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.074327886,0.00067267625,0.021626612,0.0009260205,0.00018648492,0.000036247242,0.00077716855,0.00045873973,0.00035757077],"category_scores_gemma":[0.7308551,0.00038627285,0.0028153255,0.0032597214,0.0039222427,0.00007959031,0.0011027664,0.0013110719,0.0000035091414],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029281026,0.0003066819,0.000027897597,0.09007347,0.6868017,0.000068466776,0.0008063582,0.0000040756313,0.00021857386,0.0052045244,0.001096219,0.21509923],"study_design_scores_gemma":[0.0012479243,0.0015329367,0.000018424837,0.03678455,0.8155025,0.0000076718425,0.00044894178,0.00006807827,0.0010772165,0.13628586,0.0058744554,0.0011514267],"about_ca_topic_score_codex":0.000026946123,"about_ca_topic_score_gemma":0.0000063321836,"teacher_disagreement_score":0.6565272,"about_ca_system_score_codex":0.0002584045,"about_ca_system_score_gemma":0.00137552,"threshold_uncertainty_score":0.9998589},"labels":[],"label_agreement":null},{"id":"W2414504306","doi":"10.1158/1538-7445.am2015-3888","title":"Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048).","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Hôpital Maisonneuve-Rosemont; Dr. Georges-L.-Dumont University Hospital Centre; Hôpital du Saint-Sacrement; Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; St Mary's Hospital Centre; McGill University; Hôpital du Sacré-Cœur de Montréal; Simon Fraser University; Hôtel-Dieu de Québec; Centre de Santé et de Services Sociaux de Chicoutimi; Hôpital Charles-Le Moyne; University of British Columbia; Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Colorectal cancer; Medicine; Bevacizumab; FOLFOX; Oxaliplatin; Oncology; Internal medicine; Somatic evolution in cancer; Liquid biopsy; Biopsy; KRAS; Cancer; Chemotherapy","score_opus":0.15417217814356649,"score_gpt":0.4673843036645816,"score_spread":0.31321212552101513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414504306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894659,0.0048565757,0.00012652125,0.00038002367,0.00007088787,0.0048883366,0.00015398145,0.000015402946,0.000042399868],"genre_scores_gemma":[0.996667,0.00055823673,0.00033690536,0.00002593722,0.000025260442,0.0022902912,0.00001609824,0.00004180892,0.000038428338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727875,0.000187655,0.0006604086,0.000623153,0.00086106034,0.00038896484],"domain_scores_gemma":[0.9979121,0.00013748893,0.00023503855,0.00033572037,0.0012131842,0.00016644121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083365064,0.00024488184,0.00071461423,0.00033736316,0.00016208267,0.000052789306,0.00016598564,0.000054942917,0.000022729588],"category_scores_gemma":[0.00012225303,0.0001886056,0.00008412041,0.00054504874,0.00030901536,0.00013516928,0.00014175252,0.00032384807,8.4955826e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011528815,0.0022448546,0.8819074,0.00032637105,0.0017324061,0.00005137698,0.0064774784,0.0003439215,0.09460985,0.00013970377,0.0000114811255,0.0006263655],"study_design_scores_gemma":[0.0064688493,0.0019182562,0.860227,0.00027580067,0.00014481577,0.0000010120189,0.0027236522,0.000015334574,0.12737837,0.00069101807,0.0000029135517,0.00015296607],"about_ca_topic_score_codex":0.0014372849,"about_ca_topic_score_gemma":0.00568156,"teacher_disagreement_score":0.032768525,"about_ca_system_score_codex":0.0005339332,"about_ca_system_score_gemma":0.0006035752,"threshold_uncertainty_score":0.7691113},"labels":[],"label_agreement":null},{"id":"W2415132460","doi":"10.1158/1538-7445.am2015-1360","title":"Abstract 1360: Combination therapy of reovirus and PD-1 blockade effectively establishes tumor control via innate and adaptive immune responses","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; Innate immune system; Immune checkpoint; Acquired immune system; Cancer research; Immunology; Immunotherapy; Antigen; Combination therapy; Blockade; Antibody; Medicine; Biology; Receptor; Pharmacology; Internal medicine","score_opus":0.05461094865813924,"score_gpt":0.3711110305139404,"score_spread":0.31650008185580114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415132460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781783,0.020347498,0.000041799158,0.00037225167,0.00004115221,0.0007285118,0.000060473598,0.00000878752,0.00022119163],"genre_scores_gemma":[0.99644023,0.002941039,0.000025711237,0.00005276005,0.000087374836,0.00020169943,0.000011133578,0.000034082612,0.0002059642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772406,0.00071403885,0.00021749451,0.00041933358,0.0005146471,0.0004104069],"domain_scores_gemma":[0.99834514,0.00023350207,0.0000849745,0.00032353404,0.00082186935,0.00019097155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026496476,0.00016148128,0.0002461258,0.00021464504,0.00012916149,0.00005815344,0.00022984877,0.00011757678,0.000018319866],"category_scores_gemma":[0.00042017654,0.00014347487,0.00003894614,0.0002577165,0.0006341025,0.00001895945,0.0001309244,0.00034399182,0.000003007889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027957132,0.000098734796,0.0020928532,0.000027409105,0.00011654333,0.000009165971,0.00018232757,0.000017448405,0.95202035,0.000019638936,0.00021588043,0.017242534],"study_design_scores_gemma":[0.0046439557,0.005941072,0.021748869,0.000038559996,0.000004540838,0.0000073622737,0.00014532845,0.000082485196,0.96533346,0.00040128257,0.0014945911,0.00015846617],"about_ca_topic_score_codex":0.0010696065,"about_ca_topic_score_gemma":0.00021185436,"teacher_disagreement_score":0.023313176,"about_ca_system_score_codex":0.00007140359,"about_ca_system_score_gemma":0.0005247164,"threshold_uncertainty_score":0.58507353},"labels":[],"label_agreement":null},{"id":"W2416409425","doi":"10.1158/1538-7445.am2015-4271","title":"Abstract 4271: Lack of CD47 membrane mobility contributes to the poor erythrocyte binding of SIRPαFc, a novel CD47-blocking cancer immunotherapeutic","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Antibody; Biology; Plasma protein binding; Phagocytosis; Cell biology; Immunology","score_opus":0.27090874226839706,"score_gpt":0.4587590791183107,"score_spread":0.18785033684991365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416409425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314786,0.008385725,0.00015454584,0.0058145076,0.00062571984,0.0011582127,0.0002125925,0.000030350142,0.00047050352],"genre_scores_gemma":[0.99616355,0.0013063807,0.00006201927,0.0006776716,0.00031554603,0.00028172552,0.000014144057,0.000036155965,0.0011428394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762785,0.00012979799,0.0005158854,0.0003979313,0.00075228646,0.0005762455],"domain_scores_gemma":[0.9968874,0.0007234089,0.00016248522,0.00062045816,0.0013986329,0.00020764382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019369991,0.00018396156,0.00060542754,0.0002802722,0.00014432798,0.000017888691,0.00033103453,0.00015817194,0.0006612969],"category_scores_gemma":[0.0005321415,0.00012782498,0.00014317156,0.000960407,0.0004712727,0.00006864891,0.00015136284,0.00062508084,0.00004215355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034246435,0.00025396154,0.0034868293,0.00045712697,0.00035302652,0.0000044775347,0.0010656219,0.0006699144,0.9834543,0.00009371935,0.0028035936,0.0039327694],"study_design_scores_gemma":[0.0066924556,0.0009125306,0.045205686,0.001198797,0.0001608457,0.0000134390975,0.0026954857,0.00046965232,0.8626313,0.000085177046,0.079666376,0.00026820798],"about_ca_topic_score_codex":0.004702697,"about_ca_topic_score_gemma":0.00078543654,"teacher_disagreement_score":0.12082297,"about_ca_system_score_codex":0.00051075034,"about_ca_system_score_gemma":0.0012476943,"threshold_uncertainty_score":0.7240737},"labels":[],"label_agreement":null},{"id":"W2419535014","doi":"10.1158/1538-7445.am2015-2187","title":"Abstract 2187: Pan-cancer identification and prioritization of cancer-associated differentially expressed genes: A biomarker discovery application","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; BC Cancer Agency","funders":"","keywords":"Cancer; Biology; Gene; Computational biology; Transcriptome; Gene expression; Biomarker discovery; Pancreatic cancer; Gene expression profiling; Cancer research; Genetics; Proteomics","score_opus":0.11378319654232416,"score_gpt":0.43592837176322297,"score_spread":0.3221451752208988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419535014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397714,0.0115855625,0.00029291335,0.002446964,0.00013876027,0.0009511272,0.00029378213,0.000028041157,0.0002857107],"genre_scores_gemma":[0.981083,0.014006326,0.000022248347,0.000033906646,0.00025453526,0.00080258946,0.00018865433,0.000033014585,0.0035757504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972449,0.00014650376,0.000429175,0.0004641565,0.0012727495,0.00044252223],"domain_scores_gemma":[0.99781924,0.00015506768,0.00016487321,0.0003081037,0.0012935181,0.00025918288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008635912,0.00015914884,0.00032471842,0.00027507657,0.00014519533,0.00009408368,0.00019684675,0.00014523663,0.00012797413],"category_scores_gemma":[0.00019941175,0.00013299506,0.00006628512,0.00063839834,0.00034160912,0.00025328112,0.00013602932,0.00030877313,0.000011481539],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000971511,0.00024295477,0.08837293,0.0005191612,0.0001693984,0.000004330938,0.00035489307,0.000013928528,0.8282754,0.00015088114,0.0018720834,0.07905254],"study_design_scores_gemma":[0.0018483222,0.00012683685,0.7847256,0.00053670263,0.00006979595,0.0000016113034,0.00027338008,0.0012325896,0.20565799,0.0005418129,0.0047864188,0.00019895525],"about_ca_topic_score_codex":0.011080526,"about_ca_topic_score_gemma":0.001186404,"teacher_disagreement_score":0.69635266,"about_ca_system_score_codex":0.00037522567,"about_ca_system_score_gemma":0.0008737266,"threshold_uncertainty_score":0.9955048},"labels":[],"label_agreement":null},{"id":"W2431963657","doi":"10.1158/0008-5472.can-16-0902","title":"Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Cancer Institute; Urology Foundation; Urology Care Foundation","keywords":"Prostate cancer; Cancer; Oncology; Prostate; Medicine; Internal medicine; Outcome (game theory); Biology","score_opus":0.17242886122125436,"score_gpt":0.4514678559211168,"score_spread":0.2790389946998625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431963657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98279244,0.0017661847,0.000058704056,0.01248187,0.00010139326,0.0014593109,0.0002722347,0.000042016876,0.001025869],"genre_scores_gemma":[0.9630644,0.0019131459,0.00016146307,0.00005828575,0.00018613451,0.0010753362,0.00002840383,0.000049686707,0.033463184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997183,0.000114884606,0.0003716803,0.00049287954,0.0011181191,0.0007194098],"domain_scores_gemma":[0.99714696,0.0001695264,0.00011576076,0.00044917729,0.0018274605,0.00029113438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008755831,0.00018635209,0.0004019297,0.00039221474,0.00011939734,0.000024258436,0.00021629003,0.00010706446,0.0006821106],"category_scores_gemma":[0.00018807958,0.00009339143,0.00006632118,0.0010858254,0.0007340562,0.00014620349,0.00007014097,0.00040606468,0.00004605528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044008214,0.00020219173,0.36939746,0.0003099159,0.00015306276,0.000026420903,0.00023258428,5.141633e-7,0.60218674,0.00018309156,0.0027102744,0.02019694],"study_design_scores_gemma":[0.015042712,0.002656539,0.6152831,0.0039648637,0.0001491032,0.000033259916,0.0009102265,0.00004969204,0.33206165,0.00014995602,0.029284887,0.00041406712],"about_ca_topic_score_codex":0.001656079,"about_ca_topic_score_gemma":0.0003822515,"teacher_disagreement_score":0.2701251,"about_ca_system_score_codex":0.0010093687,"about_ca_system_score_gemma":0.0019570969,"threshold_uncertainty_score":0.74686325},"labels":[],"label_agreement":null},{"id":"W2441019106","doi":"10.1158/1538-7445.am2015-4670","title":"Abstract 4670: A novel companion diagnostic predicts response to the PARP inhibitor rucaparib in ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germline; Loss of heterozygosity; Ovarian cancer; Indel; Biology; Genetics; PARP inhibitor; Cancer research; Cancer; Computational biology; Single-nucleotide polymorphism; Gene; Allele; Genotype","score_opus":0.18959289508511318,"score_gpt":0.4556190603433872,"score_spread":0.26602616525827405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441019106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379356,0.0031010956,0.00011075336,0.053995848,0.001040191,0.0022846828,0.00023678597,0.00008778748,0.0012072591],"genre_scores_gemma":[0.9916289,0.00047107012,0.000109521745,0.001924379,0.0017620096,0.0031370253,0.00001846107,0.0000687377,0.0008798915],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9958015,0.00043283956,0.0004984054,0.00061706814,0.0016948764,0.0009552826],"domain_scores_gemma":[0.9960395,0.0015218183,0.00008124723,0.00079200603,0.0008017921,0.0007636252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045544114,0.00024167566,0.00039930927,0.0005064337,0.00018280126,0.00009127884,0.0004254026,0.0001738324,0.0006771815],"category_scores_gemma":[0.0027227462,0.00018353392,0.00007217954,0.0015919352,0.0003035659,0.00015467971,0.0001689076,0.0011935062,0.0002760486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024121746,0.00094930816,0.048409455,0.00023274918,0.00015384075,0.00027980865,0.01138177,0.0033992971,0.33518052,0.00029171733,0.5690793,0.0065205125],"study_design_scores_gemma":[0.015240887,0.000981585,0.53785425,0.003146297,0.000035676632,0.00004952985,0.0016772798,0.00032620048,0.052141085,0.00025686357,0.3877894,0.0005009265],"about_ca_topic_score_codex":0.0067065377,"about_ca_topic_score_gemma":0.0032841878,"teacher_disagreement_score":0.4894448,"about_ca_system_score_codex":0.0025486483,"about_ca_system_score_gemma":0.003214896,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W2464312696","doi":"10.1158/1538-7445.am2015-5396","title":"Abstract 5396: Characterization of small molecule inhibitors of the PIM kinases in <i>in vitro</i> models of hematological malignancies","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"In vivo; Cancer research; Multiple myeloma; In vitro; Cell culture; Leukemia; Kinase; Lymphoma; Biology; Ex vivo; Viability assay; Immunology; Cell biology; Biochemistry","score_opus":0.13168544638096077,"score_gpt":0.36465266841857696,"score_spread":0.2329672220376162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464312696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791014,0.0007702094,0.000026869378,0.0004878703,0.00006329764,0.00044669528,0.000031963133,0.0000038000746,0.0002591732],"genre_scores_gemma":[0.99945873,0.00030532238,0.00003228682,0.00003919482,0.00003086601,0.00006835994,0.0000060756665,0.000011561724,0.000047583413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987411,0.000077880744,0.00034543156,0.00015530123,0.00046808616,0.00021221477],"domain_scores_gemma":[0.99925584,0.000039944884,0.00010967784,0.00023169299,0.00030530625,0.000057551864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060524733,0.000074495365,0.0003205003,0.00016882615,0.00001095728,0.0000033342503,0.00014157756,0.00007869374,0.000035281522],"category_scores_gemma":[0.000051511488,0.00005129822,0.00005786148,0.0005264047,0.00016279478,0.000048379152,0.00006385943,0.0002021778,4.2092609e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066790375,0.00017043803,0.0023249434,0.00020884146,0.000008022866,0.000008877227,0.0006084252,0.00006840295,0.9940159,0.00084677787,0.000021423417,0.0010500633],"study_design_scores_gemma":[0.0011291875,0.00014666106,0.009614394,0.00044326208,0.0000034430725,0.0000020085092,0.0003446213,0.00013555019,0.98719066,0.00090142875,0.00004586604,0.000042933487],"about_ca_topic_score_codex":0.0017323382,"about_ca_topic_score_gemma":0.00023770495,"teacher_disagreement_score":0.0072894506,"about_ca_system_score_codex":0.0001159223,"about_ca_system_score_gemma":0.00047880303,"threshold_uncertainty_score":0.26187888},"labels":[],"label_agreement":null},{"id":"W2466126443","doi":"10.1158/0008-5472.can-16-1071","title":"Tyrosine Phosphatase PTPRJ/DEP-1 Is an Essential Promoter of Vascular Permeability, Angiogenesis, and Tumor Progression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Vascular permeability; Matrigel; Protein tyrosine phosphatase; Cancer research; Vascular endothelial growth factor; Endothelial stem cell; Proto-oncogene tyrosine-protein kinase Src; Biology; Pathology; Cell biology; Chemistry; Phosphorylation; Medicine; Endocrinology; In vitro; VEGF receptors; Biochemistry","score_opus":0.030640675723164146,"score_gpt":0.36781215521702476,"score_spread":0.3371714794938606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466126443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437744,0.054296944,0.00013345618,0.0004925032,0.000054747543,0.0006762037,0.0005500902,0.000011685047,0.000009942931],"genre_scores_gemma":[0.99705476,0.0017520444,0.00037625132,0.000057286,0.00023654956,0.00028206356,0.00009971696,0.000037929763,0.000103388404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794686,0.0002032676,0.00023046281,0.0006648045,0.0004913415,0.00046325286],"domain_scores_gemma":[0.99856824,0.000019677429,0.00006898878,0.0007656153,0.0003662473,0.00021124307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074696605,0.00017039294,0.00019471326,0.00007377316,0.0001228474,0.0000343339,0.00034262871,0.00010740562,0.0002286363],"category_scores_gemma":[0.00018266997,0.00011828848,0.00007839498,0.00017952289,0.00061295996,0.000020980562,0.00046498835,0.000083405015,0.0000065588515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036920916,0.00016666428,0.009222919,0.00014657307,0.00004699623,0.0000076130345,0.00003572907,3.488194e-7,0.958546,0.00015145174,0.0020745217,0.029231988],"study_design_scores_gemma":[0.00088404183,0.00058044627,0.005549015,0.00014302813,0.000016432507,0.00000629314,0.000014033931,0.0000048411025,0.98421234,0.0001537481,0.00826746,0.0001682984],"about_ca_topic_score_codex":0.00023897337,"about_ca_topic_score_gemma":0.000053039363,"teacher_disagreement_score":0.053280342,"about_ca_system_score_codex":0.00003561754,"about_ca_system_score_gemma":0.00025772408,"threshold_uncertainty_score":0.48236644},"labels":[],"label_agreement":null},{"id":"W2467807723","doi":"10.1158/0008-5472.can-15-3079","title":"PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"PINK1; Warburg effect; Regulator; Anaerobic glycolysis; Glycolysis; Biology; Cancer research; Cell biology; Reactive oxygen species; Kinase; Oxidative stress; Biochemistry; Mitophagy; Apoptosis; Metabolism; Autophagy; Gene","score_opus":0.014556873411734051,"score_gpt":0.3278125906148195,"score_spread":0.3132557172030854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467807723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900708,0.0075773494,0.00001671349,0.001479379,0.0001489739,0.00036432184,0.000029436129,0.0000026071361,0.00031042588],"genre_scores_gemma":[0.99190193,0.006181967,0.00000945475,0.000107445216,0.00051834225,0.00018553494,5.2514645e-7,0.000014217683,0.0010805989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879926,0.000280032,0.00013265495,0.00027487677,0.00023047964,0.00028268938],"domain_scores_gemma":[0.99933785,0.00014889312,0.000037428494,0.00027640202,0.00013382807,0.00006560151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007547212,0.00009117727,0.00018388996,0.0000778672,0.00005147602,0.000010296017,0.00018788374,0.00008627871,0.000036563462],"category_scores_gemma":[0.0003458722,0.000048723454,0.000055592147,0.00020605815,0.0006899308,0.0000043104224,0.00016287125,0.00011124388,0.0000022773747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026220935,0.000013727452,0.0012393236,0.000056947654,0.00004532725,6.7413333e-7,0.00029819313,3.498634e-7,0.9667289,0.00037562277,0.0059380536,0.022680754],"study_design_scores_gemma":[0.0034849765,0.0003134371,0.0030580175,0.000082574916,0.0000074306286,0.0000019730817,0.000040838466,0.0000027274255,0.9752388,0.0008408208,0.016848551,0.00007984255],"about_ca_topic_score_codex":0.00048284384,"about_ca_topic_score_gemma":0.00020835057,"teacher_disagreement_score":0.02260091,"about_ca_system_score_codex":0.00002170952,"about_ca_system_score_gemma":0.00015660675,"threshold_uncertainty_score":0.25420788},"labels":[],"label_agreement":null},{"id":"W2470892830","doi":"10.1158/0008-5472.can-07-0211","title":"Re: The Terminology Issue for Myeloid-Derived Suppressor Cells","year":2007,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Terminology; Suppressor; Myeloid; Cancer research; Biology; Computational biology; Medicine; Cancer; Genetics; Linguistics; Philosophy","score_opus":0.0849909920073049,"score_gpt":0.3892800122188968,"score_spread":0.3042890202115919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470892830","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020011894,0.048205994,0.00010853729,0.9205645,0.017386189,0.0043035797,0.001023069,0.0001625838,0.006244358],"genre_scores_gemma":[0.002554971,0.0043886234,0.00009837411,0.5213236,0.01057324,0.004847316,0.001214104,0.00038669867,0.45461303],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994088,0.0011940354,0.0006361674,0.0011703875,0.00026988995,0.0026415156],"domain_scores_gemma":[0.99343747,0.0036203158,0.00024581063,0.0018785152,0.0007855856,0.000032325643],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0020698428,0.00055775774,0.0008049468,0.00049480755,0.00093025615,0.00008356326,0.0027295111,0.0033219382,0.010493837],"category_scores_gemma":[0.0002631707,0.0004126165,0.0003341033,0.0003826614,0.0028701406,0.000069034126,0.0006992167,0.00836858,0.0027688628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025361235,0.000018703035,0.000003028729,0.0002535169,0.00030652655,0.000055919365,0.00041422044,0.0000013181277,0.31451413,0.000008375486,0.68043244,0.0037382417],"study_design_scores_gemma":[0.00070847076,0.00013320566,0.0000068098407,0.000081787555,0.00004757011,0.000012952817,0.00015067715,2.8705762e-7,0.41335937,0.00009864044,0.58512694,0.0002732661],"about_ca_topic_score_codex":0.000834707,"about_ca_topic_score_gemma":0.00011970991,"teacher_disagreement_score":0.44836867,"about_ca_system_score_codex":0.00065294263,"about_ca_system_score_gemma":0.0008679739,"threshold_uncertainty_score":0.9998435},"labels":[],"label_agreement":null},{"id":"W2471959940","doi":"10.1158/0008-5472.can-15-3435","title":"Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Bevacizumab; Medicine; Triple-negative breast cancer; Chemotherapy; Tumor hypoxia; Metastasis; Cancer research; Metastatic breast cancer; Breast cancer; Camptothecin; Cancer; Oncology; Internal medicine; Radiation therapy; Biology","score_opus":0.0894083182333501,"score_gpt":0.3872218378570113,"score_spread":0.2978135196236612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471959940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730843,0.00079960603,0.000041715706,0.000256231,0.000103280094,0.0007522082,0.00062905264,0.000035893314,0.000073561016],"genre_scores_gemma":[0.99819475,0.000716645,0.00032277085,0.000006885363,0.00006888194,0.0004376279,0.000006531215,0.000052012023,0.00019390213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788505,0.00015047133,0.0005458557,0.00030288813,0.00063190144,0.00048383055],"domain_scores_gemma":[0.99804664,0.00093201565,0.000089398214,0.00035507762,0.00036684625,0.00021000222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044730247,0.00020155868,0.0004515566,0.00024960225,0.000041120566,0.000013628916,0.00024192285,0.000057537407,0.00054779614],"category_scores_gemma":[0.00010271624,0.00012879689,0.000059134876,0.0006744787,0.00060686463,0.00030916484,0.000026199774,0.00016682058,0.000009055852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056367912,0.0010427956,0.06086731,0.00046955646,0.00091908826,0.00003319863,0.00541078,0.01163923,0.8501094,0.00072007463,0.00038867246,0.06276311],"study_design_scores_gemma":[0.0131488545,0.0010079545,0.047951568,0.0008016431,0.00007193196,0.000007121266,0.00018211787,0.0013010668,0.9337739,0.0012413341,0.00021009675,0.00030246453],"about_ca_topic_score_codex":0.0015992965,"about_ca_topic_score_gemma":0.0036175763,"teacher_disagreement_score":0.083664455,"about_ca_system_score_codex":0.0008441775,"about_ca_system_score_gemma":0.0007401276,"threshold_uncertainty_score":0.5997984},"labels":[],"label_agreement":null},{"id":"W2475007102","doi":"10.1158/0008-5472.can-16-0376","title":"Functional Flow Patterns and Static Blood Pooling in Tumors Revealed by Combined Contrast-Enhanced Ultrasound and Photoacoustic Imaging","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Perfusion; Ultrasound; Blood flow; Contrast-enhanced ultrasound; Medicine; Hemoglobin; Biomedical engineering; Pathology; Cancer; Contrast (vision); Perfusion scanning; Hemodynamics; Nuclear medicine; Radiology; Internal medicine","score_opus":0.013886791381119284,"score_gpt":0.2680204082925956,"score_spread":0.2541336169114763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475007102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750915,0.0014852717,0.022368709,0.00014854872,0.00013505183,0.00035609453,0.00020162694,0.00008721542,0.000125985],"genre_scores_gemma":[0.99796635,0.0013706733,0.00009517059,0.00005853612,0.00006785419,0.00018507882,0.000010755178,0.000050895822,0.00019470752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981908,0.0000803475,0.00027075742,0.00036811756,0.00035842156,0.00073154847],"domain_scores_gemma":[0.9985082,0.0010337459,0.000024245106,0.0001612466,0.00008646902,0.0001860626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005763741,0.0001939167,0.0002572048,0.00020106665,0.00012643411,0.000089073095,0.00011044631,0.000044287928,0.00021320113],"category_scores_gemma":[0.00024175656,0.00016369688,0.00002004904,0.00022162551,0.00019704594,0.00021452857,0.00003943838,0.00037923697,0.0000041795242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006389638,0.000030027311,0.02445464,0.0002534698,0.00004675731,0.000032246317,0.0003817907,0.0006558575,0.96786195,0.000009098766,0.00095391495,0.0052563413],"study_design_scores_gemma":[0.030893829,0.00031179,0.23165382,0.0071509755,0.00023931665,0.00037830544,0.00431859,0.17981073,0.5394068,0.0028772953,0.00030472883,0.002653814],"about_ca_topic_score_codex":0.00030484257,"about_ca_topic_score_gemma":0.00007272331,"teacher_disagreement_score":0.42845514,"about_ca_system_score_codex":0.00020887321,"about_ca_system_score_gemma":0.00008690245,"threshold_uncertainty_score":0.6675365},"labels":[],"label_agreement":null},{"id":"W2475377084","doi":"10.1158/1538-7445.am2016-1016","title":"Abstract 1016: Variants in autophagy related genes and clinical characteristics in melanoma: a population-based study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Single-nucleotide polymorphism; Melanoma; Minor allele frequency; Breslow Thickness; ATG5; Medicine; Genotype; Internal medicine; Oncology; Allele; Population; Allele frequency; Gastroenterology; Cancer; Biology; Breast cancer; Genetics; Gene; Autophagy; Cancer research","score_opus":0.052876584720976,"score_gpt":0.4115149135000905,"score_spread":0.3586383287791145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475377084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988593,0.0003373606,0.0000063026646,0.00028097694,0.000057384146,0.0003199204,0.000023357661,0.0000051350676,0.00011026876],"genre_scores_gemma":[0.9990772,0.00012949138,0.00001196998,0.00002625703,0.00007693496,0.000055981553,0.000025972044,0.000012872736,0.0005833267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986844,0.0002431094,0.00033699337,0.00033667762,0.00017606164,0.00022274899],"domain_scores_gemma":[0.9994533,0.00007812757,0.00004783608,0.0002284281,0.000079296995,0.000113025155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008540192,0.00007856914,0.00013622122,0.00012379918,0.000037829763,0.000020277277,0.00010367138,0.00012172001,0.0001969968],"category_scores_gemma":[0.00033331654,0.000060292532,0.000026873513,0.00014801316,0.000059417667,0.000005637031,0.00005667247,0.000111441,0.000018185481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026986763,0.00025615338,0.9568379,0.000009952302,0.000011881735,0.000029862336,0.000014063634,0.000005909998,0.02735678,0.000013069494,0.0000585383,0.015136],"study_design_scores_gemma":[0.0021739446,0.00012088108,0.99647456,0.000033658394,0.000002797209,3.8382248e-7,0.000019169853,0.000079920675,0.0006270892,0.000047698555,0.00033665894,0.00008323181],"about_ca_topic_score_codex":0.00030369425,"about_ca_topic_score_gemma":0.0007380473,"teacher_disagreement_score":0.039636645,"about_ca_system_score_codex":0.000053092805,"about_ca_system_score_gemma":0.00024016407,"threshold_uncertainty_score":0.24586582},"labels":[],"label_agreement":null},{"id":"W2475418613","doi":"10.1158/1538-7445.am2016-3787","title":"Abstract 3787: Thyroid hormone induced proliferation of breast cancer cell lines: A novel approach to hormone therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Cell growth; Cancer research; Propylthiouracil; Cancer; Medicine; MTT assay; Internal medicine; Endocrinology; Cell culture; Thyroid; Pharmacology; Chemistry; Biology; Biochemistry","score_opus":0.043872848606805535,"score_gpt":0.3427515290763515,"score_spread":0.29887868046954597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475418613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465204,0.012219529,0.0002274901,0.0005949363,0.00006554665,0.0008380825,0.00014096023,0.000014070628,0.001247359],"genre_scores_gemma":[0.9860142,0.012036869,0.00011797491,0.000074733376,0.0005318862,0.00056495104,0.00002837012,0.000048743525,0.0005822696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820524,0.00008028921,0.0002590254,0.0005053437,0.00044409826,0.0005059772],"domain_scores_gemma":[0.9987516,0.000027404894,0.00008045996,0.00043437778,0.0004921937,0.0002139866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005047091,0.00019618646,0.00020727605,0.0000980222,0.000108833556,0.000027122918,0.00033668466,0.00030206703,0.000023274088],"category_scores_gemma":[0.000032650212,0.00012771972,0.00008844865,0.00029603782,0.000110076726,0.000014604597,0.00011807281,0.00023680904,0.000014229752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012101643,0.00034372543,0.00019465294,0.000026885455,0.00008484118,8.819931e-7,0.00012753814,0.000031082494,0.98545694,0.000019439587,0.004128401,0.0083754705],"study_design_scores_gemma":[0.0020587211,0.0007389607,0.010797267,0.000042698503,0.0000069969806,0.000005931481,0.000062912106,0.000013567723,0.9847745,0.0000073306237,0.0012833852,0.00020773143],"about_ca_topic_score_codex":0.0006235999,"about_ca_topic_score_gemma":0.000027036713,"teacher_disagreement_score":0.010602614,"about_ca_system_score_codex":0.000107741114,"about_ca_system_score_gemma":0.0004684737,"threshold_uncertainty_score":0.52082586},"labels":[],"label_agreement":null},{"id":"W2475582885","doi":"10.1158/1538-7445.am2016-560","title":"Abstract 560: Development of a novel class of traps that potently block transforming growth factor-beta (TGF-beta) thereby counteracting TGF-beta mediated immunosuppression and promoting T-cell infiltration into tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; National Research Council Canada","funders":"","keywords":"Cancer research; Transforming growth factor beta; Tumor microenvironment; T cell; Ex vivo; Immune system; CD8; In vivo; Tumor progression; Medicine; Biology; Immunology; Chemistry; Transforming growth factor; Cancer; Internal medicine","score_opus":0.07592625244875162,"score_gpt":0.3668120502085781,"score_spread":0.2908857977598265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475582885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447703,0.0011955186,0.00007606985,0.0018636783,0.000069836584,0.00097044994,0.00009048363,0.000024118644,0.0012328258],"genre_scores_gemma":[0.99787474,0.001075646,0.00039423053,0.000021886046,0.0001015207,0.00008146753,0.00003862191,0.0000500742,0.00036180153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99588627,0.0001428299,0.0008489823,0.00052001805,0.0018307613,0.00077113166],"domain_scores_gemma":[0.9974027,0.00091130845,0.00028925855,0.00027879025,0.0008120236,0.00030591982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015021136,0.00029803748,0.0005961392,0.00042424304,0.00031833397,0.000043633052,0.00032919538,0.00018120305,0.00026562033],"category_scores_gemma":[0.00014097744,0.0001918113,0.00012294078,0.00040457275,0.0004047786,0.00037481642,0.00015414078,0.00072377117,0.000007527542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276444,0.00031567173,0.025337242,0.0019709605,0.00014979918,0.000015059523,0.006194788,9.905636e-7,0.93654126,0.000036190188,0.000039847644,0.028370569],"study_design_scores_gemma":[0.0024870771,0.00031676938,0.05982426,0.0031004634,0.00002110397,0.000019652893,0.00123082,0.00008557252,0.9315459,0.000015700374,0.0011409095,0.00021175607],"about_ca_topic_score_codex":0.0013759894,"about_ca_topic_score_gemma":0.0001942048,"teacher_disagreement_score":0.03448702,"about_ca_system_score_codex":0.0002791309,"about_ca_system_score_gemma":0.0010959539,"threshold_uncertainty_score":0.78218377},"labels":[],"label_agreement":null},{"id":"W2476051190","doi":"10.1158/1538-7445.am2016-337","title":"Abstract 337: Genetic analysis of tumors from a phase II trial evaluating AZD1775, carboplatin and paclitaxel in patients with TP53-mutant ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carboplatin; Medicine; Cancer; Oncology; Paclitaxel; Internal medicine; Ovarian cancer; Chemotherapy; Wee1; Cancer research; Pharmacology; Cisplatin; Cell cycle; Cyclin-dependent kinase 1","score_opus":0.04570471968599468,"score_gpt":0.3924986953077981,"score_spread":0.34679397562180336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476051190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622536,0.0015828091,0.000029395851,0.00009802884,0.00007349688,0.00057256775,0.0013673691,0.0000026086823,0.000048387505],"genre_scores_gemma":[0.9986031,0.0006630098,0.00013508818,0.00002686774,0.00020142987,0.00022382225,0.000086292006,0.000025768444,0.000034588073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981353,0.00010659621,0.00037925455,0.0005347832,0.00045163409,0.0003924],"domain_scores_gemma":[0.99884367,0.00014856442,0.00014771828,0.00039565566,0.00032355284,0.00014084419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004840454,0.00015712465,0.00033454868,0.00024371171,0.000089275025,0.000024969151,0.00015987783,0.00010537565,0.00024682088],"category_scores_gemma":[0.00028309727,0.000115157934,0.00006664925,0.00048043835,0.00018531071,0.0000060956436,0.00017280999,0.00013131129,6.222679e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035485897,0.00070668204,0.18331476,0.000040156632,0.0010682736,0.000014386367,0.00048287582,0.00076323614,0.6950685,0.000015085274,0.00020883785,0.08283132],"study_design_scores_gemma":[0.09867616,0.00703039,0.8207164,0.00036367722,0.000473515,3.0397868e-7,0.00015482893,0.0005352594,0.070609815,0.00013762349,0.0007296876,0.0005723359],"about_ca_topic_score_codex":0.0075998562,"about_ca_topic_score_gemma":0.0077828006,"teacher_disagreement_score":0.63740164,"about_ca_system_score_codex":0.00014666833,"about_ca_system_score_gemma":0.00065916544,"threshold_uncertainty_score":0.9990086},"labels":[],"label_agreement":null},{"id":"W2476275359","doi":"10.1158/1538-7445.am2016-ct034","title":"Abstract CT034: A phase I study of GSK2857916, a BCMA-directed monoclonal antibody conjugated to microtubule-disrupting agent in patients with relapsed, refractory multiple myeloma and other BCMA-expressing hematologic malignancies","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Antibody; Tolerability; Immunogenicity; Pharmacology; Cancer research; Monoclonal antibody; Immunology; Internal medicine; Oncology; Adverse effect","score_opus":0.06872917316155,"score_gpt":0.40331119292844075,"score_spread":0.3345820197668907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476275359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956678,0.00047127565,0.000008288249,0.00016059841,0.000031741165,0.0033102124,0.00019039848,0.00006605806,0.000093612456],"genre_scores_gemma":[0.9987076,0.00005967627,0.00038545835,0.000033320895,0.000035445297,0.0004921647,0.000024480874,0.00006659622,0.00019528897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961375,0.00033640998,0.00057850865,0.00078539696,0.0011806845,0.0009815078],"domain_scores_gemma":[0.9975692,0.00056218024,0.00016149801,0.0005307124,0.00068821106,0.00048818474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074245286,0.00031560488,0.000664117,0.00068576046,0.00019718551,0.000050565613,0.00021164495,0.00012384854,0.00024175091],"category_scores_gemma":[0.00079980824,0.00019493874,0.00005085727,0.00069970364,0.0003193604,0.00017631172,0.00021412742,0.0004159497,0.000022015323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009676285,0.003207575,0.627841,0.00018718353,0.00018602493,0.0003385793,0.0011104622,0.0000018197053,0.34882486,0.0000010784652,0.00008378917,0.0085413065],"study_design_scores_gemma":[0.041582767,0.004588621,0.90317553,0.0024135907,0.000029899245,0.0000106977495,0.0009699625,0.000050645856,0.0466278,0.0000042142256,0.00028892886,0.00025731628],"about_ca_topic_score_codex":0.0025539263,"about_ca_topic_score_gemma":0.0005747893,"teacher_disagreement_score":0.30219707,"about_ca_system_score_codex":0.00045738695,"about_ca_system_score_gemma":0.000339074,"threshold_uncertainty_score":0.79493713},"labels":[],"label_agreement":null},{"id":"W2476304059","doi":"10.1158/1538-7445.am2016-1342","title":"Abstract 1342: A production-scalable cabazitaxel cellulose nanoparticle exhibits significant efficacy in a bone model of docetaxel-resistant prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Precision Nanosystems (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"LNCaP; Docetaxel; Prostate cancer; Chemistry; Cabazitaxel; Prostate; Pharmacology; Cancer; Medicine; Internal medicine; Androgen deprivation therapy","score_opus":0.08827190825515753,"score_gpt":0.3820867306795323,"score_spread":0.2938148224243748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476304059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809054,0.007569013,0.0000039093625,0.008026729,0.00011441647,0.0025073593,0.00018614525,0.00005127956,0.00063571945],"genre_scores_gemma":[0.96886265,0.0057071564,0.00007923214,0.000026217222,0.00015823786,0.001565251,0.0000087575945,0.0000730491,0.02351945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99534005,0.00015507071,0.00068631023,0.00090842816,0.0015106759,0.0013994555],"domain_scores_gemma":[0.99742323,0.00025439207,0.00013673467,0.0007109639,0.0010058399,0.00046881224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015631716,0.0002904369,0.00060907094,0.00058669015,0.00015451924,0.00003915422,0.0002547757,0.00013693607,0.00076626707],"category_scores_gemma":[0.00040785494,0.00018493645,0.00012848788,0.0013272722,0.0007242919,0.00027716794,0.00015860429,0.0005552801,0.00007520568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058732657,0.0012974474,0.0081024105,0.00065824046,0.00010543021,0.0001418992,0.001213224,0.00034262956,0.9655794,0.00006962481,0.003177986,0.013438466],"study_design_scores_gemma":[0.00763352,0.0004447161,0.018628819,0.0018938065,0.000038312945,0.0000034787834,0.00023651804,0.0003242454,0.96951663,0.00022542146,0.00079492875,0.00025958652],"about_ca_topic_score_codex":0.003073884,"about_ca_topic_score_gemma":0.0008610958,"teacher_disagreement_score":0.022883732,"about_ca_system_score_codex":0.0013189875,"about_ca_system_score_gemma":0.0025428291,"threshold_uncertainty_score":0.8390087},"labels":[],"label_agreement":null},{"id":"W2476422824","doi":"10.1158/1538-7445.am2016-ct097","title":"Abstract CT097: A first-in-human phase I dose escalation study of the OX40 agonist MOXR0916 in patients with refractory solid tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunotherapy; Internal medicine; Oncology; Agonist; Cohort; Adverse effect; Refractory (planetary science); Cancer; Gastroenterology; Urology; Receptor","score_opus":0.05143809461649836,"score_gpt":0.40633539807865404,"score_spread":0.3548973034621557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476422824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971999,0.00012475607,3.3362045e-7,0.00065690815,0.00006152132,0.0014673254,0.000020216472,0.000008544077,0.00046050406],"genre_scores_gemma":[0.9993313,0.000053007145,0.0000016739169,0.000027441061,0.00005333392,0.00018329252,0.0000041493904,0.000023603076,0.00032223278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804425,0.0001210756,0.00037434665,0.0002941681,0.0008095887,0.00035654273],"domain_scores_gemma":[0.99903125,0.000106095205,0.000111064546,0.0004768682,0.00020570373,0.00006901149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007051663,0.00012036668,0.00024824584,0.0002533811,0.000119309974,0.000014574754,0.00020239946,0.00005796872,0.00032264224],"category_scores_gemma":[0.00006213092,0.00006251152,0.000043953656,0.00058812567,0.0002683782,0.00011133383,0.00005219432,0.00035260324,0.0000033295921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0155921215,0.0051343,0.89144254,0.00013372373,0.0000883998,0.00002778683,0.0023734726,0.000009552436,0.055805422,0.0000057887014,0.00040592405,0.028980946],"study_design_scores_gemma":[0.022492666,0.0022015446,0.9689014,0.0009345818,0.000008307943,3.8052477e-7,0.0005492572,0.0000026395933,0.004221281,0.000008942707,0.0005913314,0.00008767283],"about_ca_topic_score_codex":0.0033392094,"about_ca_topic_score_gemma":0.007783757,"teacher_disagreement_score":0.077458836,"about_ca_system_score_codex":0.0007700637,"about_ca_system_score_gemma":0.00035561016,"threshold_uncertainty_score":0.5047908},"labels":[],"label_agreement":null},{"id":"W2476843004","doi":"10.1158/1538-7445.am2016-lb-329","title":"Abstract LB-329: Enhancing the resolution and accelerating the pace of translational fusion characterization in oncology by RNA sequencing","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Fusion gene; Fusion transcript; RNA; Cancer; Biology; Cancer research; Leukemia; Fluorescence in situ hybridization; Computational biology; Molecular biology; Gene; Genetics; Chromosome","score_opus":0.0730741370527523,"score_gpt":0.37938844147915074,"score_spread":0.30631430442639845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476843004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918462,0.0013495564,0.0014698439,0.0047494737,0.000035893016,0.00020602481,0.000038677666,0.0000018455011,0.00030248892],"genre_scores_gemma":[0.9968962,0.0025285918,0.000026709196,0.000058859157,0.00012658317,0.00010083914,0.000028426495,0.0000074178392,0.00022636661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916345,0.00014864128,0.00017620494,0.0001775236,0.0001671628,0.00016700124],"domain_scores_gemma":[0.99953216,0.00008850443,0.00006548848,0.00015837314,0.00013280817,0.000022672564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009769313,0.000052389878,0.000061007857,0.000033164913,0.00017719879,0.0000169094,0.00012286146,0.000078783334,0.000041219297],"category_scores_gemma":[0.000072199255,0.000028443312,0.000016916563,0.00012539995,0.00015556527,0.000011110022,0.000038538867,0.00012440872,8.538264e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047944995,0.000007944103,0.00046693755,0.000008962505,0.000005087317,1.37712e-7,0.0002545929,0.000021861051,0.95767707,0.00010911379,0.0002639057,0.04113645],"study_design_scores_gemma":[0.00035327635,0.000065861095,0.028733082,0.000076791424,0.0000025617155,0.0000015592776,0.00032056708,0.00013182579,0.9572846,0.000077717115,0.012888713,0.00006339465],"about_ca_topic_score_codex":0.00020414415,"about_ca_topic_score_gemma":0.00038733502,"teacher_disagreement_score":0.041073054,"about_ca_system_score_codex":0.00008521879,"about_ca_system_score_gemma":0.0002799441,"threshold_uncertainty_score":0.13628878},"labels":[],"label_agreement":null},{"id":"W2476989417","doi":"10.1158/1538-7445.am2016-3655","title":"Abstract 3655: Suppression of Plk3 expression by nickel may contribute to lung carcinogenesis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"MG132; A549 cell; Western blot; Biology; Ubiquitin; Cancer research; Kinase; Proteasome inhibitor; Cancer; Proteasome; Cell biology; Molecular biology; Biochemistry; Cell; Genetics","score_opus":0.06480075780510006,"score_gpt":0.4085627384576663,"score_spread":0.34376198065256625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476989417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857946,0.00494523,0.00010699894,0.0069477665,0.00018085628,0.0008414404,0.00037497922,0.00003254254,0.00077559537],"genre_scores_gemma":[0.9937673,0.0020039272,0.000055520617,0.00016031986,0.0002190043,0.00053813367,0.000015590782,0.000044673998,0.0031955128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997165,0.00011730014,0.00036424946,0.00050510245,0.0011541886,0.0006941389],"domain_scores_gemma":[0.99796337,0.00022982969,0.000076240955,0.0005806794,0.0006725099,0.00047737715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007511552,0.00017134938,0.0004124082,0.00021936197,0.00012773588,0.000018987586,0.00029064546,0.00015572611,0.0025858213],"category_scores_gemma":[0.00023484633,0.000104359635,0.00011992355,0.00040674018,0.00015887467,0.0001097628,0.00020346105,0.00023775065,0.00006910313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084999873,0.0001027771,0.03926347,0.00020835428,0.000034395063,0.000006864677,0.000082478975,7.7616403e-7,0.7689375,0.000018296862,0.172394,0.018101038],"study_design_scores_gemma":[0.0016150804,0.00024609402,0.040969424,0.0017266289,0.000023636258,0.0000015265317,0.000062728956,0.0000029068767,0.8878814,0.000009568796,0.06733327,0.00012772021],"about_ca_topic_score_codex":0.0005425566,"about_ca_topic_score_gemma":0.000016518097,"teacher_disagreement_score":0.11894387,"about_ca_system_score_codex":0.00042125015,"about_ca_system_score_gemma":0.00035441815,"threshold_uncertainty_score":0.99832594},"labels":[],"label_agreement":null},{"id":"W2477284221","doi":"10.1158/1538-7445.am2015-4629","title":"Abstract 4629: Multiple myeloma susceptibility loci examined in African and European ancestry populations","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Centre for Disease Control; BC Cancer Agency","funders":"","keywords":"Linkage disequilibrium; Genome-wide association study; Biology; Genetic association; Genetics; Medicine; Haplotype; Single-nucleotide polymorphism; Genotype; Gene","score_opus":0.3451657382263177,"score_gpt":0.44170158950947563,"score_spread":0.09653585128315795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477284221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97843975,0.0041201874,0.0000037517152,0.002820951,0.00009452018,0.00042310552,0.000020893913,0.00003900754,0.014037815],"genre_scores_gemma":[0.99860984,0.00016489995,0.00012374674,0.00006792377,0.00033006445,0.00006951912,0.000023097813,0.00002529585,0.0005856359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982462,0.0001572263,0.00023926425,0.00042114142,0.00048437036,0.00045177861],"domain_scores_gemma":[0.99888784,0.00010554661,0.000034109788,0.0003549796,0.000300327,0.00031720178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011200049,0.00012902729,0.00024979905,0.00019659719,0.000114583236,0.000037666985,0.000117494026,0.000049510913,0.00008131722],"category_scores_gemma":[0.00050886965,0.000113665934,0.00003617259,0.0005122714,0.00031803557,0.00010461724,0.00015081525,0.00047233902,0.00002563306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035515003,0.000100375706,0.97109085,0.00010886634,0.000022184939,0.00016487156,0.00247379,0.000009002586,0.004140495,0.00002514104,0.006060215,0.015449049],"study_design_scores_gemma":[0.0017425794,0.00014366058,0.99153346,0.00008454741,0.000009210044,0.000009685688,0.0024644015,0.000045719582,0.000394587,0.00013021092,0.0033307124,0.00011120723],"about_ca_topic_score_codex":0.0040560947,"about_ca_topic_score_gemma":0.009028597,"teacher_disagreement_score":0.02044262,"about_ca_system_score_codex":0.00039841083,"about_ca_system_score_gemma":0.00027211083,"threshold_uncertainty_score":0.61316293},"labels":[],"label_agreement":null},{"id":"W2477533041","doi":"10.1158/1538-7445.am2016-2179","title":"Abstract 2179: Macrolide toxin Mycalolide B is a potent inhibitor of HER2 cancer cell invasion and is the basis of actin targeted therapy for metastatic cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"SKBR3; Cancer research; Trastuzumab; Antibody-drug conjugate; Metastasis; Cancer cell; Cancer; Medicine; Biology; Breast cancer; Antibody; Immunology; Internal medicine; Monoclonal antibody","score_opus":0.11087585323305187,"score_gpt":0.439304725482549,"score_spread":0.32842887224949713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477533041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96294326,0.017687185,0.000008648476,0.016353901,0.00020185242,0.0017548891,0.0007296128,0.0000101883625,0.00031046764],"genre_scores_gemma":[0.9578278,0.037359934,0.000087138986,0.00093189784,0.00022255555,0.0010420945,0.0000060028824,0.00004039493,0.0024821726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806553,0.00011835804,0.00038261243,0.00039491136,0.00053131353,0.0005072455],"domain_scores_gemma":[0.9981182,0.00071777886,0.00018181671,0.00032409912,0.00047500926,0.00018308203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006413408,0.00019457388,0.00046885526,0.00013812323,0.0001167236,0.0000110691,0.00017580316,0.000084038715,0.0032723504],"category_scores_gemma":[0.00004893706,0.00010591233,0.00016241657,0.0003004726,0.00037510673,0.00009152535,0.00006200327,0.00020279162,0.0000037616287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004751037,0.00021410653,0.0036273971,0.000483621,0.0004561811,0.000007565377,0.0019856812,0.0000031852817,0.8630498,0.0000069671623,0.054908507,0.07050594],"study_design_scores_gemma":[0.0065010837,0.0008201014,0.007681766,0.00034129672,0.00012964584,0.0000027358046,0.00044926937,0.000016160055,0.9674817,0.00014383544,0.016320722,0.00011168726],"about_ca_topic_score_codex":0.019365015,"about_ca_topic_score_gemma":0.0017117602,"teacher_disagreement_score":0.10443188,"about_ca_system_score_codex":0.0007211806,"about_ca_system_score_gemma":0.0012002783,"threshold_uncertainty_score":0.9976388},"labels":[],"label_agreement":null},{"id":"W2477588388","doi":"10.1158/1538-7445.am2016-210","title":"Abstract 210: Targeting the mitochondrial DNA polymerase gamma with 2’3’-dideoxycytidine as a novel therapeutic strategy for acute myeloid leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitochondrial DNA; Myeloid leukemia; Biology; Molecular biology; Mitochondrion; Leukemia; Mitochondrial toxicity; Cancer research; Deoxycytidine kinase; Polymerase; Gene; Cancer; Genetics; Deoxycytidine","score_opus":0.04302454926009491,"score_gpt":0.36140852456143335,"score_spread":0.31838397530133844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477588388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98178315,0.0106800385,0.0019328217,0.0022947297,0.0009852694,0.0012362801,0.00032524066,0.00002511453,0.0007373282],"genre_scores_gemma":[0.9787205,0.0043678177,0.00020242999,0.0003922863,0.007809605,0.0010093043,0.000058841277,0.00009221692,0.0073470203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976999,0.0000751817,0.000254686,0.00063264446,0.00047171494,0.00086588465],"domain_scores_gemma":[0.99862653,0.00012445729,0.00009811057,0.00056118384,0.00039425195,0.0001954661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005247915,0.0002509235,0.00023592939,0.00007437536,0.00035158917,0.000096083786,0.00052429095,0.00018098275,0.00017117527],"category_scores_gemma":[0.0001084789,0.00013758586,0.00014194752,0.00020293317,0.00037671183,0.000016088094,0.00011265657,0.00026463548,0.00001785563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019978299,0.000033390443,0.000021633441,0.000021448006,0.00026997903,0.0000022095896,0.000061143306,0.00002123254,0.9578639,0.00018268997,0.008589746,0.030934796],"study_design_scores_gemma":[0.0027419776,0.00040227684,0.00036994414,0.000048068054,0.000051268653,0.000015216085,0.00012765062,0.0000050469816,0.7409504,0.0001641716,0.25488836,0.00023560504],"about_ca_topic_score_codex":0.0006203516,"about_ca_topic_score_gemma":0.00039374028,"teacher_disagreement_score":0.24629861,"about_ca_system_score_codex":0.00014067607,"about_ca_system_score_gemma":0.0017749427,"threshold_uncertainty_score":0.5610588},"labels":[],"label_agreement":null},{"id":"W2477620114","doi":"10.1158/1538-7445.am2016-1246","title":"Abstract 1246: Development of STAT3 dual-targeting strategies for the treatment of pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Cancer research; STAT3; Tumor microenvironment; Cancer cell; Cancer; Biology; Medicine; Signal transduction; Internal medicine; Cell biology","score_opus":0.1420294780004896,"score_gpt":0.4480318404632547,"score_spread":0.30600236246276513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477620114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835123,0.012631351,0.0009169251,0.0011967974,0.00015257717,0.0011953237,0.00010787305,0.000012266983,0.00027460585],"genre_scores_gemma":[0.98590297,0.010483019,0.00068085495,0.00001826888,0.00024232348,0.0013346077,0.0000038868125,0.000027696356,0.001306379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986017,0.000026096332,0.00032629134,0.00021216537,0.00045839706,0.0003753488],"domain_scores_gemma":[0.9986666,0.00045913123,0.00010259363,0.00024801667,0.00044398507,0.000079684665],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052851695,0.00011763159,0.00030783322,0.000090971,0.00012596913,0.000011722202,0.00009268262,0.00004547013,0.001145791],"category_scores_gemma":[0.000024715087,0.000056363468,0.00008680048,0.00015982552,0.00015528392,0.000050831924,0.000015298003,0.00006247788,0.000002664869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012362913,0.00019225113,0.0006320327,0.0003502928,0.00044551803,0.0000030159163,0.0035785888,0.000014017331,0.6640335,0.0009785692,0.0009051985,0.32763076],"study_design_scores_gemma":[0.004009286,0.0010974731,0.008796301,0.00078489684,0.00007159439,8.780433e-7,0.003573201,0.000017730154,0.89440906,0.0011338625,0.08597675,0.00012898436],"about_ca_topic_score_codex":0.0017941709,"about_ca_topic_score_gemma":0.0009412381,"teacher_disagreement_score":0.32750177,"about_ca_system_score_codex":0.00047547373,"about_ca_system_score_gemma":0.0019742302,"threshold_uncertainty_score":0.9997673},"labels":[],"label_agreement":null},{"id":"W2477682166","doi":"10.1158/1538-7445.am2016-3261","title":"Abstract 3261: Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Cyclophosphamide; Paclitaxel; Chemotherapy; Breast cancer; Regimen; Oncology; Cancer; Bolus (digestion); Internal medicine; Pharmacology; Cancer research","score_opus":0.06897503347927765,"score_gpt":0.4399733878566051,"score_spread":0.3709983543773275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477682166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199533,0.0007301827,0.0000056184062,0.005679166,0.00008672689,0.0006107293,0.00011507332,0.00001889456,0.00075825624],"genre_scores_gemma":[0.99435544,0.0043177484,0.000010810041,0.00012625613,0.0003065722,0.00018311312,0.000003159178,0.00004307003,0.00065385323],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980928,0.00009291224,0.00036194854,0.00041199347,0.0005397848,0.00050056155],"domain_scores_gemma":[0.99879277,0.00029194617,0.00011042049,0.000356685,0.0002946136,0.00015356546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089168793,0.00018026576,0.00041883477,0.00037384237,0.000044168613,0.000013731953,0.0001624357,0.00013617489,0.0028899442],"category_scores_gemma":[0.00004155408,0.00009843674,0.00016134068,0.0005578116,0.0004281578,0.00010071873,0.00001881349,0.0003897728,0.000014759578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06645164,0.00046177013,0.3804953,0.00012247595,0.0006133843,0.000012008491,0.0001545006,0.000013516222,0.4245895,0.000014984242,0.0032845705,0.12378634],"study_design_scores_gemma":[0.009507536,0.0014372943,0.9033603,0.0012741447,0.000016149519,0.000010494548,0.000030115127,0.0000071693794,0.08365407,0.000025478805,0.0005409858,0.00013626603],"about_ca_topic_score_codex":0.011716894,"about_ca_topic_score_gemma":0.00068220927,"teacher_disagreement_score":0.522865,"about_ca_system_score_codex":0.0017313206,"about_ca_system_score_gemma":0.0013022558,"threshold_uncertainty_score":0.99802154},"labels":[],"label_agreement":null},{"id":"W2477810116","doi":"10.1158/1538-7445.am2016-2206","title":"Abstract 2206: Development and characterization of an injectable copper clioquinol formulation: repurposing of a topical antifungal for treatment of cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Liposome; Pharmacokinetics; Clioquinol; Pharmacology; Bioavailability; Chemistry; Antifungal; Medicine; Drug; Biochemistry","score_opus":0.21133848983122602,"score_gpt":0.42584455172900404,"score_spread":0.21450606189777802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477810116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982297,0.0008714612,0.000045483554,0.00012187063,0.000030274596,0.00053656334,0.00003803203,0.0000035557734,0.00012307463],"genre_scores_gemma":[0.99825627,0.00048115716,0.0004957009,0.0000037372145,0.00006500974,0.000142217,0.000008705211,0.000009399645,0.0005377821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916124,0.000032641543,0.00028700766,0.00014391266,0.00022883713,0.00014638549],"domain_scores_gemma":[0.99932694,0.000077168654,0.00008538775,0.00013612058,0.000323233,0.000051171253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024644574,0.00006180552,0.00025945395,0.00009359479,0.000048026282,0.000005095597,0.000037424314,0.00004147547,0.00015752614],"category_scores_gemma":[0.000035432357,0.000035984158,0.000030490763,0.00007984134,0.00008272167,0.00008452904,0.000016554406,0.000019849771,2.4496921e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008403498,0.00008964782,0.026665341,0.00033983513,0.000044570083,2.9178833e-7,0.00065465237,2.8088914e-7,0.8092571,0.00007700443,0.000005154291,0.16202576],"study_design_scores_gemma":[0.0006863795,0.00054904626,0.22350991,0.0003823926,0.000013930475,8.062599e-7,0.000039414754,0.000023095341,0.772246,0.000011479794,0.0025043264,0.000033231492],"about_ca_topic_score_codex":0.0003049998,"about_ca_topic_score_gemma":0.00008760511,"teacher_disagreement_score":0.19684456,"about_ca_system_score_codex":0.000118079784,"about_ca_system_score_gemma":0.00026484006,"threshold_uncertainty_score":0.17248008},"labels":[],"label_agreement":null},{"id":"W2478026417","doi":"10.1158/1538-7445.am2016-2680","title":"Abstract 2680: Development and application of a novel model of human lung-to-brain metastasis: identification of TWIST2 and SPOCK1 as unique regulators of brain metastases","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Discovery Centre; McMaster University; University of Toronto","funders":"","keywords":"Brain metastasis; Metastasis; Xenotransplantation; Cancer research; Cancer; Primary tumor; In vivo; Pathology; Biology; Bioluminescence imaging; Population; Cancer stem cell; Medicine; Gene; Transplantation; Transfection; Internal medicine; Genetics","score_opus":0.0895804404630091,"score_gpt":0.42773277251829844,"score_spread":0.33815233205528933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478026417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898017,0.00095502136,0.006310083,0.0015409432,0.000007060307,0.0010069557,0.0003264045,0.00000635077,0.000045495326],"genre_scores_gemma":[0.99582475,0.00009963372,0.003546785,0.000024881389,0.000009775883,0.00021134912,0.000028818116,0.000021025931,0.00023298695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805963,0.00009712125,0.0006796878,0.00034655366,0.00060743385,0.00020958886],"domain_scores_gemma":[0.9982494,0.0002966332,0.0003076378,0.00043295624,0.0005573287,0.00015605084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022675507,0.00013515518,0.000459228,0.00040839263,0.00005008878,0.0000055132705,0.000113684626,0.000059058042,0.000030080673],"category_scores_gemma":[0.00026639376,0.00009690477,0.000055951772,0.00035203947,0.00035282804,0.000073411284,0.000094303796,0.00008267443,6.2214315e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037478868,0.0004012562,0.0014255224,0.0009976318,0.0003292433,0.0000010718841,0.00067535584,0.000046981706,0.95251155,0.008584228,0.0002188984,0.03443346],"study_design_scores_gemma":[0.0018776894,0.0002778989,0.0275945,0.0004749952,0.00010913212,0.0000035304295,0.00027471068,0.00017831915,0.9682183,0.0006351237,0.0002664895,0.000089261994],"about_ca_topic_score_codex":0.0006617408,"about_ca_topic_score_gemma":0.000092181166,"teacher_disagreement_score":0.0343442,"about_ca_system_score_codex":0.00012067338,"about_ca_system_score_gemma":0.00037969527,"threshold_uncertainty_score":0.3951662},"labels":[],"label_agreement":null},{"id":"W2478275846","doi":"10.1158/1538-7445.am2016-1994","title":"Abstract 1994: Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Cisplatin; Ovarian cancer; Cytoplasm; Proteasome; Molecular biology; Proteasome inhibitor; Apoptosis; Biology; Cancer research; Cell culture; Chemistry; Cancer; Cell biology; Biochemistry; Genetics; Chemotherapy","score_opus":0.02900561336668345,"score_gpt":0.3286054934270105,"score_spread":0.29959988006032706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478275846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794376,0.00079094665,0.00014163926,0.000540928,0.00013055328,0.00028044236,0.000061665865,8.3217634e-7,0.00010925193],"genre_scores_gemma":[0.9986205,0.0009227192,0.00006153141,0.000008186062,0.00014067824,0.000030242752,0.000008589783,0.000007677865,0.00019984305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916065,0.000070832364,0.0001889896,0.00017070385,0.00027070116,0.00013813777],"domain_scores_gemma":[0.99956256,0.00004536177,0.0000686459,0.0001605352,0.00013314896,0.000029755285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044135662,0.000055489396,0.00008751925,0.00008344638,0.00003938497,0.000004655483,0.000093403076,0.00009447518,0.00017630144],"category_scores_gemma":[0.00003261547,0.00003378985,0.000039828363,0.00015376686,0.00012653171,0.0000045395104,0.000048901387,0.000057947957,3.0310318e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029133048,0.000023814693,0.0034209045,0.000028680073,0.000015382102,1.1276324e-7,0.00005615494,0.00014676433,0.98290175,0.00021097605,0.00006912897,0.012835005],"study_design_scores_gemma":[0.0008289008,0.000050738487,0.22138578,0.00006213817,0.000002966614,1.8931549e-7,0.000013831654,0.000012346645,0.77653277,0.00028226053,0.0007913202,0.000036760666],"about_ca_topic_score_codex":0.0007413057,"about_ca_topic_score_gemma":0.00057155715,"teacher_disagreement_score":0.21796487,"about_ca_system_score_codex":0.000027024487,"about_ca_system_score_gemma":0.00016945755,"threshold_uncertainty_score":0.19303772},"labels":[],"label_agreement":null},{"id":"W2478299947","doi":"10.1158/1538-7445.am2016-920","title":"Abstract 920: Migratory cancer side population cells induces stem cell altruism in bone marrow mesenchymal stem cells to resist therapy, and enhance tumorigenic potential of non-tumorigenic cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Stem cell; Cancer stem cell; Mesenchymal stem cell; Cancer research; Biology; Population; Haematopoiesis; Bone marrow; Cell biology; Reprogramming; Endothelial stem cell; Cancer cell; Immunology; Cancer; Cell; Medicine; In vitro; Genetics","score_opus":0.05273411299676369,"score_gpt":0.363477363625364,"score_spread":0.3107432506286003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478299947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98341817,0.011358925,0.00001422239,0.00096202124,0.0006751482,0.0028267072,0.00017381327,0.000038104597,0.0005328965],"genre_scores_gemma":[0.97790205,0.008163929,0.00008703314,0.0000805186,0.00056874857,0.0005833235,0.0000061343208,0.00013535943,0.012472879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99204046,0.00063548,0.001234584,0.0014549554,0.002795793,0.0018387061],"domain_scores_gemma":[0.99613315,0.00061586336,0.000329774,0.0010824726,0.00084150734,0.0009972376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028815542,0.00053957035,0.0011016501,0.0012058993,0.00024891246,0.00009427721,0.0006609065,0.0003783781,0.0009601315],"category_scores_gemma":[0.000029607227,0.00041328382,0.00020741695,0.0014954921,0.00042447567,0.00031256818,0.00035395872,0.0011327277,0.00018268281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015793105,0.00025416262,0.007885911,0.0009058861,0.00006456725,0.0002519692,0.0007147822,0.00005310689,0.95170194,0.00000486617,0.0028991755,0.033684332],"study_design_scores_gemma":[0.0021291056,0.00052189926,0.08457497,0.0010109347,0.00002374381,0.000005263606,0.0004619872,0.00002624901,0.9094046,0.00002380527,0.0014111632,0.0004062951],"about_ca_topic_score_codex":0.009410996,"about_ca_topic_score_gemma":0.0022579392,"teacher_disagreement_score":0.07668906,"about_ca_system_score_codex":0.0014211609,"about_ca_system_score_gemma":0.0016385554,"threshold_uncertainty_score":0.99995315},"labels":[],"label_agreement":null},{"id":"W2478346170","doi":"10.1158/1538-7445.am2016-3605","title":"Abstract 3605: ICGC in the cloud","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; Ontario Genomics; University of Ottawa; Concordia University; McGill University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cloud computing; Computer science; Set (abstract data type); Download; Genome; World Wide Web; Biology; Operating system; Genetics","score_opus":0.048593967438662636,"score_gpt":0.3706453279726771,"score_spread":0.32205136053401445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478346170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841392,0.0015444665,0.00016135433,0.0033920035,0.00016466578,0.00021114963,0.00001793471,0.0000030687308,0.010366144],"genre_scores_gemma":[0.99681556,0.0011201927,0.000018975863,0.0002853287,0.0006030278,0.000063633095,0.0000055399387,0.000008048908,0.0010797156],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991841,0.00005435355,0.00012012214,0.00014000662,0.00018002288,0.00032140734],"domain_scores_gemma":[0.9995253,0.00004171899,0.000019496347,0.00031548808,0.00005711752,0.00004089819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009859016,0.000058271966,0.000053438045,0.00003194971,0.00006582832,0.000026173762,0.00035244864,0.00008572711,0.00011351709],"category_scores_gemma":[0.000039127648,0.00003027182,0.00003127229,0.00010129296,0.0001206385,0.0000024125343,0.000091739945,0.00015211977,0.000061092156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020034764,0.00006684662,0.0030126057,0.000042267777,0.000037093272,0.000011317374,0.00040147756,0.000026898912,0.613844,0.0022217587,0.18633357,0.19380186],"study_design_scores_gemma":[0.0009657282,0.0001601285,0.016665105,0.00008361813,0.0000023655534,0.000006805795,0.0003095941,0.0000141673545,0.049336918,0.0027956178,0.9294541,0.00020588454],"about_ca_topic_score_codex":0.000076127806,"about_ca_topic_score_gemma":0.0002421657,"teacher_disagreement_score":0.7431205,"about_ca_system_score_codex":0.00002669965,"about_ca_system_score_gemma":0.00010717588,"threshold_uncertainty_score":0.12429325},"labels":[],"label_agreement":null},{"id":"W2478397997","doi":"10.1158/1538-7445.am2016-2793","title":"Abstract 2793: ADP- dependent glucokinase enhances hypoxia- inducible factor-α target gene transactivation through modulation of ROS levels in hypoxic human cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Glycolysis; Gene knockdown; Anaerobic glycolysis; Cancer cell; Hypoxia (environmental); Glucokinase; Cell biology; Hypoxia-inducible factors; Cell culture; Cancer research; Molecular biology; Biochemistry; Chemistry; Cancer; Gene; Enzyme; Genetics","score_opus":0.08643737780038116,"score_gpt":0.38016709879971333,"score_spread":0.29372972099933214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478397997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138373,0.0047704745,0.0018033681,0.00015873584,0.00061867427,0.00058237405,0.00045437404,0.000011760764,0.0002165185],"genre_scores_gemma":[0.99311066,0.0043805162,0.000182261,0.000037251008,0.0010128211,0.0003448639,0.00003626064,0.000048726608,0.0008466409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973825,0.0001596953,0.000466217,0.0007086569,0.000651809,0.00063112855],"domain_scores_gemma":[0.99878633,0.000047000784,0.0001712081,0.00050525443,0.00037006478,0.000120160905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052955153,0.00024076428,0.00032388265,0.00019534359,0.00013349738,0.00002896311,0.00036457862,0.00028654662,0.0005788872],"category_scores_gemma":[0.000053850592,0.00019977182,0.00011066995,0.00032511944,0.00020256462,0.000057877507,0.00007128455,0.00025765868,0.000006894088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017879484,0.00012111062,0.0006320978,0.0000783468,0.00005290474,0.0000012996475,0.00027888134,0.0004532971,0.97808325,0.000023162122,0.00029115385,0.019805713],"study_design_scores_gemma":[0.0013739077,0.00010702353,0.049277328,0.00011083898,0.000007770522,6.6528077e-7,0.000060439525,0.0000057716584,0.9430342,0.0003950699,0.0053805504,0.00024648604],"about_ca_topic_score_codex":0.0028967166,"about_ca_topic_score_gemma":0.0017468912,"teacher_disagreement_score":0.048645232,"about_ca_system_score_codex":0.00022937334,"about_ca_system_score_gemma":0.0005672978,"threshold_uncertainty_score":0.8146458},"labels":[],"label_agreement":null},{"id":"W2478414973","doi":"10.1158/1538-7445.am2016-2386","title":"Abstract 2386: Microfluidic single cell exome-seq and RNA-seq analysis of tumor composition","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Exome sequencing; Biology; Exome; Population; Germline; Breast cancer; Cancer research; Primary tumor; Carcinogenesis; Cancer; Metastasis; Pathology; Gene; Genetics; Medicine; Phenotype","score_opus":0.035192499515050116,"score_gpt":0.33092111343491437,"score_spread":0.29572861391986427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478414973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873764,0.009507304,0.00020064715,0.00026715902,0.00006122201,0.00012639578,0.00027761373,0.0000034253685,0.0008186141],"genre_scores_gemma":[0.9921995,0.0071591055,0.00005259163,0.00007056787,0.00013931296,0.000028468887,0.000048018854,0.000016779082,0.00028565704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898064,0.00004114007,0.00018650349,0.00032020212,0.0001914226,0.00028007798],"domain_scores_gemma":[0.9992026,0.000082862054,0.000063963555,0.000300918,0.00023718078,0.00011248529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002859486,0.00009455506,0.0001745035,0.00018824439,0.00006907488,0.000026648373,0.00015793597,0.00007186996,0.00012835549],"category_scores_gemma":[0.000046411034,0.00007695806,0.00008164251,0.0002794302,0.00021753211,0.0000038960916,0.00013508342,0.0000732749,0.000006285824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011338094,0.00006968037,0.0030157287,0.000035327994,0.00012627916,0.000003983969,0.000025809013,0.000011984654,0.9892081,0.000022931892,0.0039997366,0.0033670315],"study_design_scores_gemma":[0.0004600212,0.0001694904,0.010251965,0.000030474572,0.00006675781,9.989033e-7,0.000030915402,0.0000050014924,0.97746,0.0000471866,0.011367101,0.00011004455],"about_ca_topic_score_codex":0.00040315985,"about_ca_topic_score_gemma":0.00013065616,"teacher_disagreement_score":0.011748082,"about_ca_system_score_codex":0.00007664614,"about_ca_system_score_gemma":0.00015507695,"threshold_uncertainty_score":0.31382585},"labels":[],"label_agreement":null},{"id":"W2478624812","doi":"10.1158/1538-7445.am2016-3808","title":"Abstract 3808: Novel compound conferring selectivity for cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Nocodazole; Paclitaxel; HeLa; Cancer cell; Cancer; Cancer research; Mechanism of action; Drug; Chemistry; Mitosis; Pharmacology; Biology; Medicine; In vitro; Cell; Cell biology; Biochemistry; Internal medicine; Cytoskeleton","score_opus":0.0731269667256204,"score_gpt":0.39461188015219384,"score_spread":0.3214849134265734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478624812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912331,0.00088367733,0.0057490882,0.00053256867,0.0002400239,0.0004706226,0.000340261,0.000010790762,0.00053988665],"genre_scores_gemma":[0.9944957,0.0015043283,0.00016002129,0.00010261284,0.0005896182,0.00041263606,0.000016478432,0.000035064484,0.0026835517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987215,0.000028648392,0.00013265279,0.000419451,0.00017665581,0.00052110205],"domain_scores_gemma":[0.99913555,0.000067829766,0.000039211754,0.00028125133,0.0003676026,0.00010856495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041927112,0.00012039313,0.00013125697,0.000052622603,0.00015997098,0.000036296726,0.00025253886,0.00013938348,0.00010370411],"category_scores_gemma":[0.00005058643,0.00009250055,0.000074667914,0.00008240151,0.00014200983,0.0000058799387,0.00011616813,0.00012959326,0.000010553849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013505378,0.000051833624,0.0006274953,0.00005289346,0.000055012293,5.999162e-7,0.00001691439,0.00002065763,0.9837341,0.00009000208,0.0076417644,0.0075737117],"study_design_scores_gemma":[0.0006940031,0.000070218346,0.0009772745,0.000051613122,0.0000049375685,0.0000011329554,0.000011990158,0.000019845895,0.83575654,0.000041080064,0.16223751,0.00013385761],"about_ca_topic_score_codex":0.00058506994,"about_ca_topic_score_gemma":0.0015776143,"teacher_disagreement_score":0.15459575,"about_ca_system_score_codex":0.00012818852,"about_ca_system_score_gemma":0.0004377128,"threshold_uncertainty_score":0.3772063},"labels":[],"label_agreement":null},{"id":"W2478972176","doi":"10.1158/1538-7445.am2016-448","title":"Abstract 448: Expression of Galectins in high grade serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Debulking; Ovarian cancer; Cancer; Galectin; Stromal cell; Medicine; Cancer research; Chemotherapy; Tissue microarray; Taxane; Serous fluid; Tumor microenvironment; Oncology; Pathology; Internal medicine; Breast cancer; Immunology","score_opus":0.06385847255078067,"score_gpt":0.37888854212115936,"score_spread":0.3150300695703787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478972176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910595,0.0054380363,0.000013033783,0.0013305784,0.00095535634,0.00028680416,0.00010794852,0.000026671209,0.0007820741],"genre_scores_gemma":[0.99417233,0.002190271,0.000012478024,0.00003862376,0.00014686947,0.00031609277,0.000008412083,0.000023022263,0.0030918894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979224,0.00032603537,0.00032452194,0.00045448463,0.000099561556,0.00087297586],"domain_scores_gemma":[0.99901783,0.0002775946,0.00009807714,0.00035887383,0.00019950035,0.000048116555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007112341,0.00015064182,0.00031955843,0.00029466837,0.00013033155,0.000006950494,0.00038908975,0.00033827635,0.007041455],"category_scores_gemma":[0.00011078594,0.00009967845,0.000059601614,0.00041798636,0.0004387126,0.00007923507,0.0001405588,0.0005607241,0.00010252701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039239263,0.00010361474,0.039609823,0.00003906691,0.00003405856,0.0000050527697,0.00020381554,0.0000036874876,0.9330298,0.00018548538,0.0055989292,0.020794308],"study_design_scores_gemma":[0.0018739912,0.00014084665,0.22835606,0.00029006254,0.000004092603,0.000005688633,0.000082349776,6.5315085e-8,0.7480877,0.00035315752,0.020677721,0.00012825557],"about_ca_topic_score_codex":0.01268863,"about_ca_topic_score_gemma":0.005854819,"teacher_disagreement_score":0.18874623,"about_ca_system_score_codex":0.00034456974,"about_ca_system_score_gemma":0.00047100568,"threshold_uncertainty_score":0.99388593},"labels":[],"label_agreement":null},{"id":"W2479321545","doi":"10.1158/1538-7445.am2016-118","title":"Abstract 118: A comprehensive profile of the genomic architecture of curable prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; PTEN; Exome sequencing; Chromoplexy; Medicine; Exome; Genomics; Cancer; Prostatectomy; TMPRSS2; Copy-number variation; Disease; Oncology; Biology; Cancer research; Bioinformatics; Genome; Gene; Internal medicine; Genetics; Mutation; PCA3","score_opus":0.07171690543858308,"score_gpt":0.4020554831768738,"score_spread":0.3303385777382907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479321545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790409,0.009262986,0.0000020576342,0.0065805097,0.00013677434,0.0019135331,0.00045077057,0.00001621895,0.0025962305],"genre_scores_gemma":[0.9829915,0.004702673,0.000041439267,0.00004272634,0.00014595604,0.00061015796,0.00000591327,0.000039258877,0.011420383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975291,0.00013455917,0.00032645458,0.0003636656,0.0009787957,0.0006674221],"domain_scores_gemma":[0.99780387,0.00025252448,0.00013021205,0.00060832856,0.0010329603,0.00017209568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037046187,0.00016318152,0.0003879948,0.00021250089,0.00013627813,0.0000107112755,0.00035449854,0.000089873975,0.00161854],"category_scores_gemma":[0.00008290229,0.000075497774,0.00014945105,0.00062973617,0.0010214872,0.00006200685,0.00021932217,0.00048114738,0.000025033132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018269592,0.0001348498,0.035731427,0.000964662,0.00021721094,0.000014332049,0.0007646779,0.000019874022,0.9024694,0.00005652362,0.005519939,0.052280128],"study_design_scores_gemma":[0.0039325245,0.00036774573,0.16565743,0.0021308272,0.000041216448,0.000007305792,0.00026610168,0.0000053041927,0.8030348,0.00045807223,0.023963748,0.0001349595],"about_ca_topic_score_codex":0.001797361,"about_ca_topic_score_gemma":0.0001794608,"teacher_disagreement_score":0.129926,"about_ca_system_score_codex":0.00047016938,"about_ca_system_score_gemma":0.0019452063,"threshold_uncertainty_score":0.9992941},"labels":[],"label_agreement":null},{"id":"W2479335544","doi":"10.1158/1538-7445.am2016-1981","title":"Abstract 1981: Histone demethyalase JMJD1A promotes the DNA damage response of prostate cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"DNA damage; Ectopic expression; Gene knockdown; Prostate cancer; Histone; Cancer research; DNA repair; Molecular biology; Cancer cell; Biology; Cancer; DNA; Chemistry; Cell culture; Genetics","score_opus":0.037109634228147816,"score_gpt":0.3941290600964328,"score_spread":0.35701942586828495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479335544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109876,0.0032672032,0.000010158338,0.003866115,0.00017434798,0.00084040564,0.00036256545,0.000013750846,0.00036671644],"genre_scores_gemma":[0.9808462,0.0016375488,0.00003936863,0.00004759886,0.00031904766,0.00063336955,0.000011190131,0.00006604393,0.016399603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963576,0.0008232082,0.0003776956,0.0006310873,0.00095664675,0.00085375115],"domain_scores_gemma":[0.9974217,0.00036809195,0.00012030906,0.0010280518,0.00083096814,0.00023088127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003528078,0.00021098448,0.00022931835,0.00019388093,0.0002746505,0.00003426095,0.00077509216,0.00018849006,0.0005267823],"category_scores_gemma":[0.0008845766,0.00012828955,0.00012452484,0.0004396897,0.001343408,0.000013147554,0.00040291197,0.00041653638,0.00008405188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002330803,0.000096752454,0.00029285037,0.000087011314,0.000059609294,0.00002194246,0.00025973876,0.000009507838,0.96185666,0.000009539074,0.02897857,0.0059970045],"study_design_scores_gemma":[0.0007404309,0.00030232515,0.002249698,0.00014696544,0.0000067592628,0.0000021977835,0.00007868247,0.000002798124,0.9274343,0.00002274813,0.06884443,0.00016865811],"about_ca_topic_score_codex":0.0010020564,"about_ca_topic_score_gemma":0.0005063394,"teacher_disagreement_score":0.03986586,"about_ca_system_score_codex":0.00031609667,"about_ca_system_score_gemma":0.0015902071,"threshold_uncertainty_score":0.5767897},"labels":[],"label_agreement":null},{"id":"W2479511601","doi":"10.1158/1538-7445.am2016-720","title":"Abstract 720: Novel prognostic stromal subtypes in triple-negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stromal cell; Breast cancer; Myoepithelial cell; Cancer research; Stroma; Triple-negative breast cancer; Gene expression profiling; Laser capture microdissection; Cancer; Biology; Pathology; Gene expression; Medicine; Oncology; Internal medicine; Gene; Immunohistochemistry; Genetics","score_opus":0.09637548559490165,"score_gpt":0.4134773975160358,"score_spread":0.3171019119211341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479511601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867401,0.0018711588,0.000023646397,0.007191761,0.00030094452,0.0010450621,0.00064003334,0.000035152498,0.0021521535],"genre_scores_gemma":[0.99236655,0.0019239786,0.00009402399,0.00010686575,0.00062576134,0.000693812,0.0000048893485,0.00004580273,0.004138298],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974579,0.000062238476,0.0003029633,0.0005271699,0.0008081356,0.0008415913],"domain_scores_gemma":[0.99845195,0.0003546884,0.00006253806,0.0003379133,0.00047589414,0.0003170019],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072133535,0.00018363532,0.00036897924,0.00035012126,0.00008618468,0.00003172011,0.00019160414,0.000103650775,0.005575971],"category_scores_gemma":[0.00027047802,0.00011952101,0.00009284271,0.0007387272,0.00031605535,0.00015393682,0.000087352426,0.0004945859,0.00010142588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038416064,0.00065330305,0.20607403,0.0004911572,0.00022383183,0.00018510748,0.00057408604,0.000009788697,0.5461834,0.0002624145,0.011532279,0.22996901],"study_design_scores_gemma":[0.00724686,0.00022831793,0.92702425,0.0017143738,0.000047784797,0.000033293963,0.00026281193,0.0000066010784,0.053742602,0.00011337278,0.009322524,0.00025723834],"about_ca_topic_score_codex":0.011437027,"about_ca_topic_score_gemma":0.006901284,"teacher_disagreement_score":0.7209502,"about_ca_system_score_codex":0.0009859322,"about_ca_system_score_gemma":0.001546495,"threshold_uncertainty_score":0.9953331},"labels":[],"label_agreement":null},{"id":"W2479615790","doi":"10.1158/1538-7445.am2016-5056","title":"Abstract 5056: RET-mediated invasion in three-dimensional microenvironment models","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glial cell line-derived neurotrophic factor; Cancer research; Biology; Receptor tyrosine kinase; Metastasis; Integrin; Cell biology; Stromal cell; Tumor microenvironment; PI3K/AKT/mTOR pathway; Signal transduction; Neurotrophic factors; Receptor; Cancer","score_opus":0.12894407321973264,"score_gpt":0.37077423733975706,"score_spread":0.24183016412002442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479615790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843503,0.0035122384,0.000038961458,0.006118274,0.00012218863,0.0005504311,0.00006136307,0.000019131776,0.0011423795],"genre_scores_gemma":[0.9943247,0.0033973285,0.00015971927,0.0002556315,0.00017815926,0.00016540365,0.00001461941,0.00003375175,0.0014706916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977704,0.00005456836,0.00027019257,0.00045082538,0.0008628036,0.0005912074],"domain_scores_gemma":[0.9990026,0.00019063536,0.000037832353,0.0003997722,0.000099891346,0.00026927455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008746965,0.00013209104,0.00025465508,0.00026003967,0.000064842294,0.000011649468,0.00013107582,0.000100261765,0.0028674267],"category_scores_gemma":[0.00007179222,0.000085532876,0.000069734895,0.00029793457,0.00020759326,0.00011363102,0.00013387257,0.00037933962,0.00030203574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008975179,0.0002121944,0.006184255,0.00010195665,0.000036886835,0.00015338574,0.00007767643,0.00008183393,0.92027634,0.0000605713,0.010199093,0.0617183],"study_design_scores_gemma":[0.019133998,0.0009145077,0.22331302,0.0050471043,0.000070234164,0.000052714768,0.00016904413,0.00043158294,0.6073791,0.0053009465,0.13729987,0.00088789774],"about_ca_topic_score_codex":0.001798334,"about_ca_topic_score_gemma":0.0016115981,"teacher_disagreement_score":0.31289724,"about_ca_system_score_codex":0.00088530505,"about_ca_system_score_gemma":0.0004602257,"threshold_uncertainty_score":0.9980441},"labels":[],"label_agreement":null},{"id":"W2479623820","doi":"10.1158/1538-7445.am2016-287","title":"Abstract 287: CPX-351 cytotoxicity against fresh AML blasts is increased for FLT3-ITD+ cells and correlates with drug uptake and clinical outcomes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Cytotoxicity; Pharmacology; Medicine; In vivo; Flow cytometry; Viability assay; Immunology; Internal medicine; Chemistry; Leukemia; Apoptosis; In vitro; Biology; Biochemistry","score_opus":0.035320387190619175,"score_gpt":0.3868457666866731,"score_spread":0.3515253794960539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479623820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978954,0.00040122087,0.00019087005,0.0007050302,0.0000335203,0.00040030968,0.00024838906,0.000025918538,0.00009931353],"genre_scores_gemma":[0.9935104,0.0037822942,0.0011946509,0.00028743446,0.00016104963,0.00004841958,0.000022790646,0.000029983903,0.000962929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983214,0.00008811355,0.00028648105,0.0006382815,0.00024105402,0.00042468339],"domain_scores_gemma":[0.99877226,0.00024866618,0.00009455301,0.00036936277,0.00030515922,0.00020996749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008209673,0.0001954227,0.00029219946,0.00007677035,0.00018567618,0.000050866875,0.0001608844,0.00020568816,0.000007084996],"category_scores_gemma":[0.00021249114,0.0001164457,0.000100286285,0.00010064145,0.0006793588,0.00000999161,0.0001484684,0.00020418793,0.0000019669817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004907401,0.00006973706,0.06822981,0.00003563726,0.00017756678,0.0000058599658,0.000018495783,3.0833883e-7,0.9082069,0.0000057259667,0.006839094,0.015920153],"study_design_scores_gemma":[0.0013250588,0.00036743842,0.045995772,0.00012324158,0.000035632,0.000002608154,0.000069479946,0.00001868715,0.94273514,0.00010281909,0.008958836,0.00026526998],"about_ca_topic_score_codex":0.00011296571,"about_ca_topic_score_gemma":0.00052843825,"teacher_disagreement_score":0.03452828,"about_ca_system_score_codex":0.00003334354,"about_ca_system_score_gemma":0.00013234594,"threshold_uncertainty_score":0.4748518},"labels":[],"label_agreement":null},{"id":"W2479729142","doi":"10.1158/1538-7445.am2016-ct156","title":"Abstract CT156: Safety and tolerability of metformin for chemoprevention in Li-Fraumeni syndrome (LFS)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Tolerability; Metformin; Medicine; Lactic acidosis; Internal medicine; Cancer; Nausea; Type 2 diabetes; Diabetes mellitus; Oncology; Adverse effect; Endocrinology; Gastroenterology","score_opus":0.06929829597060744,"score_gpt":0.4094126451936072,"score_spread":0.34011434922299977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479729142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938408,0.002255014,0.00045725552,0.0012766598,0.00007897468,0.0013359927,0.00007664911,0.0000151358245,0.0006634962],"genre_scores_gemma":[0.99740255,0.0012062002,0.00021891597,0.00001631948,0.000046422356,0.00025652288,0.000008384661,0.000024833133,0.0008198658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836123,0.000056708584,0.0003962988,0.0003622561,0.000427921,0.00039560968],"domain_scores_gemma":[0.9989,0.0002483936,0.00006795431,0.00036836986,0.00027414583,0.00014113513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018722843,0.00010529669,0.00035823567,0.00022825468,0.00004467806,0.0000069948132,0.00010178023,0.0001424518,0.0003908436],"category_scores_gemma":[0.00047601323,0.000078821235,0.000084844316,0.00032811897,0.00021526082,0.00010027146,0.00007245202,0.0002594956,0.000007273222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027367182,0.00023784218,0.004880591,0.0012217163,0.000093341725,0.000044037108,0.00025443002,0.0000070917145,0.74740034,0.00035502398,0.0005300587,0.24223879],"study_design_scores_gemma":[0.014216395,0.0015113062,0.28362998,0.0036495149,0.000072047944,0.00011493245,0.0002093346,0.000101326514,0.6631955,0.0038181313,0.029109016,0.00037250033],"about_ca_topic_score_codex":0.00044451893,"about_ca_topic_score_gemma":0.0002737645,"teacher_disagreement_score":0.2787494,"about_ca_system_score_codex":0.00064143277,"about_ca_system_score_gemma":0.00042381862,"threshold_uncertainty_score":0.42794636},"labels":[],"label_agreement":null},{"id":"W2479914491","doi":"10.1158/1538-7445.am2016-881","title":"Abstract 881: Dissecting chromatin dynamics in malignant progression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Enhancer; JUNB; Chromatin; Biology; Gene knockdown; Transcription factor; Cancer research; Chromatin remodeling; Enhancer RNAs; Chromatin immunoprecipitation; Cell biology; Gene expression; Gene; Genetics; Promoter","score_opus":0.027769354792397883,"score_gpt":0.37392036836236175,"score_spread":0.34615101356996386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479914491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972941,0.00058087916,0.00010386399,0.0004372145,0.00012688752,0.00023752813,0.000027002632,0.000008625813,0.0011838961],"genre_scores_gemma":[0.9980628,0.00070231466,0.00021187242,0.000014311746,0.00019726116,0.00011952218,0.000029016299,0.00003104336,0.0006318882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863327,0.000063806634,0.0002113088,0.00036521142,0.00024805503,0.00047837652],"domain_scores_gemma":[0.9993359,0.000033534438,0.000054139768,0.00032673357,0.00016044988,0.000089282854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006707766,0.000111954956,0.00010980173,0.000085122185,0.00009810804,0.000034557972,0.00027896345,0.00013279272,0.00007401258],"category_scores_gemma":[0.00017474244,0.00007829155,0.000042039777,0.00015109897,0.00010741745,0.000004599133,0.00020816879,0.00015021361,0.000018321678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047409434,0.00004578919,0.020254368,0.00004051781,0.000009903005,0.000009740527,0.000031665044,0.000015139401,0.9449052,0.00018468642,0.00036270404,0.03409288],"study_design_scores_gemma":[0.0023376527,0.00052639126,0.0791559,0.0015540943,0.000006144515,0.000018367109,0.00086764514,0.002352388,0.9049505,0.0014670377,0.0060026483,0.00076122844],"about_ca_topic_score_codex":0.00012801793,"about_ca_topic_score_gemma":0.0014310101,"teacher_disagreement_score":0.058901533,"about_ca_system_score_codex":0.00028606932,"about_ca_system_score_gemma":0.00019166451,"threshold_uncertainty_score":0.3192637},"labels":[],"label_agreement":null},{"id":"W2479991314","doi":"10.1158/1538-7445.am2016-1832","title":"Abstract 1832: Large variations in clinical and ethical aspects of genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ontario Genomics; Princess Margaret Cancer Centre","funders":"","keywords":"Data sharing; Harmonization; Clinical trial; Personal genomics; Genomics; Precision medicine; Medicine; Family medicine; Alternative medicine; Genome; Internal medicine; Biology; Genetics; Pathology","score_opus":0.18039835105784177,"score_gpt":0.4907765752139099,"score_spread":0.3103782241560681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479991314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903588,0.0039655003,0.0018075996,0.0016657173,0.00008368037,0.00046083544,0.0015198413,0.0000024280519,0.00013559728],"genre_scores_gemma":[0.9796749,0.019207723,0.00045945353,0.0003610213,0.00017496478,0.00006335403,0.000034786124,0.000015048368,0.000008776537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984864,0.00019813752,0.00039738737,0.00041215125,0.00011688523,0.00038903634],"domain_scores_gemma":[0.99882305,0.000484146,0.00010429262,0.00020796862,0.00022362452,0.00015691678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034784358,0.0000965006,0.00022860165,0.00003425958,0.000087846805,0.000022427961,0.0001348864,0.00021380102,0.000008323744],"category_scores_gemma":[0.00097416376,0.00008534038,0.00003701081,0.00009378045,0.00027464092,0.0000046175,0.00017289614,0.0002137219,0.0000010119301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012768052,0.00020472394,0.70206004,0.0004338255,0.00020143903,0.00000779483,0.0005118354,0.000047379708,0.22640471,0.041279297,0.002854819,0.02471732],"study_design_scores_gemma":[0.0019689128,0.0003713624,0.98857456,0.00009083717,0.0000037862008,0.000002063911,0.00006895323,0.000051480692,0.0026810819,0.0032723786,0.0027773236,0.000137258],"about_ca_topic_score_codex":0.0011343466,"about_ca_topic_score_gemma":0.014376048,"teacher_disagreement_score":0.28651452,"about_ca_system_score_codex":0.00024827005,"about_ca_system_score_gemma":0.0020172626,"threshold_uncertainty_score":0.80221725},"labels":[],"label_agreement":null},{"id":"W2480008428","doi":"10.1158/1538-7445.am2015-1822","title":"Abstract 1822: Proteome signatures distinguish lung cancer subtypes, define metabolism states, and have prognostic impact","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Proteome; Lung cancer; Cancer; Adenocarcinoma; Medicine; Oncology; Disease; Transcriptome; Cancer research; Carcinoma; Internal medicine; Biology; Bioinformatics; Gene; Gene expression; Genetics","score_opus":0.0780205109168688,"score_gpt":0.4261967432280289,"score_spread":0.3481762323111601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480008428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89997274,0.09398525,0.0000058011183,0.0024222604,0.00021292517,0.0018969272,0.0002397169,0.00008316403,0.0011812166],"genre_scores_gemma":[0.99006116,0.005883729,0.00012109697,0.00018278319,0.0009338003,0.0018242822,0.00007632452,0.00008778924,0.0008290079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964717,0.0001377696,0.000361021,0.00068810215,0.0012933651,0.0010480286],"domain_scores_gemma":[0.9970633,0.00017101475,0.00010778402,0.00042264588,0.0013420345,0.0008932524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001247841,0.00032240988,0.0005723776,0.00028417798,0.00021000496,0.00018077652,0.00023307225,0.00018693098,0.0007254185],"category_scores_gemma":[0.0008083435,0.00023701497,0.000109864806,0.00060364755,0.00035477732,0.00016708115,0.00017692203,0.0011042223,0.000013345771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029238386,0.0005211045,0.76709855,0.0018913645,0.0008928711,0.00027160707,0.0027778875,0.0002949448,0.022110315,0.0001674998,0.16594833,0.035101682],"study_design_scores_gemma":[0.0043091723,0.00070175534,0.9336972,0.0013745105,0.0003447166,0.000027846821,0.0005225061,0.0008456537,0.015443184,0.0003930917,0.041697916,0.0006424214],"about_ca_topic_score_codex":0.01741111,"about_ca_topic_score_gemma":0.0012268554,"teacher_disagreement_score":0.16659866,"about_ca_system_score_codex":0.0007243574,"about_ca_system_score_gemma":0.0018900782,"threshold_uncertainty_score":0.98913205},"labels":[],"label_agreement":null},{"id":"W2480100234","doi":"10.1158/1538-7445.am2016-4371","title":"Abstract 4371: Integrated molecular characterization of pheochromocytoma and paraganglioma including a novel, recurrent and prognostic fusion gene","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; BC Cancer Agency","funders":"","keywords":"Fusion gene; Biology; Germline mutation; Gene; Germline; Somatic cell; Genetics; Intron; Pheochromocytoma; Mutation; Cancer research","score_opus":0.0807457233435455,"score_gpt":0.38178458149580885,"score_spread":0.30103885815226333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480100234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970889,0.0010597787,0.00039733353,0.00075725804,0.00004929643,0.00049934536,0.000054525684,0.000021494541,0.000072056544],"genre_scores_gemma":[0.9993063,0.0003000045,0.00008380647,0.000023148004,0.00007925987,0.00006484582,0.000029160312,0.000019229292,0.000094241484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987554,0.000052529813,0.00022890393,0.00029091953,0.00039159306,0.00028064792],"domain_scores_gemma":[0.9991378,0.00012030185,0.00007586712,0.00015067589,0.00034188313,0.00017343381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042113155,0.00011768344,0.00022882012,0.00024397715,0.000081901904,0.000015975242,0.000061867846,0.00007328394,0.00012958252],"category_scores_gemma":[0.0002684886,0.00007409019,0.000025726888,0.0004236384,0.00023719083,0.00008378466,0.00011045997,0.0001798812,0.000004942946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053725054,0.000081729835,0.0018562436,0.00020923265,0.000029607098,0.0006431931,0.00020100451,1.0214467e-7,0.96129113,0.00010471852,0.000018023604,0.035027742],"study_design_scores_gemma":[0.0019845974,0.00048341983,0.19044568,0.0018997318,0.000029575767,0.0007991365,0.00004808047,0.000078885874,0.8038254,0.000094901865,0.00018503374,0.00012560913],"about_ca_topic_score_codex":0.00006591975,"about_ca_topic_score_gemma":0.000008655716,"teacher_disagreement_score":0.18858942,"about_ca_system_score_codex":0.00008982642,"about_ca_system_score_gemma":0.00019885563,"threshold_uncertainty_score":0.302131},"labels":[],"label_agreement":null},{"id":"W2480249297","doi":"10.1158/1538-7445.am2016-2384","title":"Abstract 2384: High-complexity neutral genomic barcoding technology reveals extensive clonal dynamics in multiple human cancer model systems","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network; University of Toronto","funders":"","keywords":"Biology; Computational biology; Cancer; Somatic evolution in cancer; clone (Java method); Barcode; Serial dilution; Tumor progression; Genetic heterogeneity; Evolutionary biology; Genetics; Computer science; Gene; Medicine; Phenotype; Pathology","score_opus":0.08668147097791329,"score_gpt":0.37082007716341275,"score_spread":0.28413860618549946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480249297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930555,0.0032435022,0.00037461022,0.0013296108,0.00029583354,0.0005680052,0.00092004344,0.000019836205,0.00019304841],"genre_scores_gemma":[0.9947775,0.0033165826,0.00014736275,0.000075748,0.00052910595,0.0005338581,0.00007075565,0.00006330348,0.0004857708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975773,0.00007383987,0.00041512435,0.0007642978,0.00025623362,0.00091316993],"domain_scores_gemma":[0.998583,0.00009505075,0.00011102276,0.0005969595,0.00044012326,0.0001738487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053977635,0.00023758713,0.0003315855,0.00030566222,0.00024130564,0.000057948313,0.0005606276,0.0003289299,0.00004114772],"category_scores_gemma":[0.00017972807,0.00020831046,0.000080012695,0.00025615934,0.0005211331,0.000010345745,0.00041040286,0.0003945185,0.000014038921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015187782,0.000053819535,0.020628128,0.000057486897,0.00004363609,0.000018914558,0.00002268683,0.0048299106,0.9629613,0.007894158,0.0016657996,0.0016722815],"study_design_scores_gemma":[0.012423169,0.0009772537,0.1341005,0.001782618,0.00007183585,0.00005105485,0.0011573303,0.021039536,0.78339905,0.03317826,0.008771174,0.00304824],"about_ca_topic_score_codex":0.0053742263,"about_ca_topic_score_gemma":0.013072181,"teacher_disagreement_score":0.17956227,"about_ca_system_score_codex":0.0012442203,"about_ca_system_score_gemma":0.00060094835,"threshold_uncertainty_score":0.8494654},"labels":[],"label_agreement":null},{"id":"W2480251564","doi":"10.1158/1538-7445.am2016-3587","title":"Abstract 3587: Multiplexed nuclear area and micronucleus screening identifies SKP1 as a human chromosome instability gene","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Biology; Chromosome instability; Gene silencing; Gene; Telomere; Genetics; Candidate gene; Genome instability; Molecular biology; Cancer research; Chromosome; DNA damage; DNA","score_opus":0.07704493571820085,"score_gpt":0.3787768720824462,"score_spread":0.30173193636424533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480251564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644965,0.0018272707,0.00003563851,0.00058441766,0.000049761617,0.00025302373,0.000082510946,0.000014576798,0.0007031593],"genre_scores_gemma":[0.99638283,0.0014280238,0.00012933873,0.000056863715,0.00021267073,0.00010998011,0.000018446099,0.000033796496,0.0016280459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985442,0.0000735695,0.00019411686,0.0005382456,0.0002509437,0.00039892364],"domain_scores_gemma":[0.9989932,0.000025379726,0.000050173177,0.0005336082,0.0002490334,0.00014860976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004709084,0.00012829997,0.00012801254,0.00007189741,0.00038361832,0.00009267304,0.0002795679,0.00012931316,0.0005923668],"category_scores_gemma":[0.00010676184,0.00010018537,0.000056916928,0.00010986726,0.0004751739,0.000015535628,0.00023764976,0.00014952103,0.000039280596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089659996,0.000037505753,0.0016170327,0.000024821433,0.000036972244,0.0000032652397,0.00007852695,0.0000019959964,0.9846459,0.00006764274,0.0014565808,0.011940083],"study_design_scores_gemma":[0.0009344104,0.00012895296,0.06024555,0.00007610395,0.000006592817,0.00000680592,0.00018965734,0.0000037292318,0.8806596,0.00019434294,0.05733058,0.00022368567],"about_ca_topic_score_codex":0.0006637749,"about_ca_topic_score_gemma":0.0002594769,"teacher_disagreement_score":0.10398632,"about_ca_system_score_codex":0.00007643587,"about_ca_system_score_gemma":0.00011662697,"threshold_uncertainty_score":0.64860004},"labels":[],"label_agreement":null},{"id":"W2480427128","doi":"10.1158/1538-7445.am2016-128","title":"Abstract 128: Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; HRAS; Cancer research; PTEN; Bladder cancer; ARID1A; Cancer; KRAS; APOBEC; CDKN2A; Gene; Colorectal cancer; Mutation; Genetics; PI3K/AKT/mTOR pathway; Genome","score_opus":0.10124883430881362,"score_gpt":0.38550400945704344,"score_spread":0.28425517514822984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480427128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944382,0.000884844,0.000046790246,0.0012166115,0.00014102286,0.001411146,0.0013584533,0.000015732601,0.00048722167],"genre_scores_gemma":[0.99667037,0.0015380834,0.000017740007,0.00014379021,0.00020913899,0.00045104793,0.000048194124,0.00004613118,0.0008755174],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99715984,0.00020391306,0.00046769547,0.00053543394,0.0011189744,0.00051415653],"domain_scores_gemma":[0.99747723,0.0001616788,0.00024185184,0.0007508225,0.0012374375,0.00013099368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023468732,0.00023404848,0.00062569376,0.00053985574,0.000114884526,0.000015609154,0.0003722788,0.0001318881,0.0012352554],"category_scores_gemma":[0.00008400504,0.00013691634,0.00037151,0.0016411702,0.00049203786,0.0001000453,0.0001461824,0.00026448138,0.000010168766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006404041,0.0001640246,0.03405564,0.00022692664,0.0021195586,0.000023282591,0.0007780459,0.000025171872,0.95793617,0.000029567513,0.00007884776,0.003922385],"study_design_scores_gemma":[0.0017216802,0.00020983217,0.6267866,0.0002734191,0.0008354654,0.000001404967,0.000087135566,0.000009642707,0.36875865,0.000014727725,0.001185971,0.000115484814],"about_ca_topic_score_codex":0.0045325775,"about_ca_topic_score_gemma":0.00037483577,"teacher_disagreement_score":0.59273094,"about_ca_system_score_codex":0.00045508228,"about_ca_system_score_gemma":0.0019311967,"threshold_uncertainty_score":0.9996778},"labels":[],"label_agreement":null},{"id":"W2480486994","doi":"10.1158/1538-7445.am2016-2961","title":"Abstract 2961: deBouganin conjugated to trastuzumab overcomes multiple mechanisms of T-DM1 drug resistance","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Trastuzumab; Saporin; Potency; In vitro; Epitope; In vivo; IC50; Biology; Pharmacology; Cytotoxicity; Immunotoxin; Molecular biology; Cancer research; Cancer; Antibody; Immunology; Biochemistry; Breast cancer","score_opus":0.03603838800851163,"score_gpt":0.3258748728605611,"score_spread":0.2898364848520495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480486994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896792,0.002670517,0.0021258646,0.0022250123,0.0008031629,0.00096421427,0.0003560523,0.00008066255,0.0010952764],"genre_scores_gemma":[0.9736193,0.00029588238,0.0002765063,0.000107592896,0.0000320883,0.0002291702,0.000012800491,0.00004582145,0.025380882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976487,0.00028409334,0.00044404698,0.0005328058,0.00020818166,0.0008821559],"domain_scores_gemma":[0.9982078,0.0005977666,0.000105372725,0.0006164401,0.0003887347,0.00008387675],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010126081,0.00022063583,0.00041074475,0.00028779465,0.00027752313,0.000021492586,0.0006713631,0.00022327219,0.004144827],"category_scores_gemma":[0.0004121195,0.00015753762,0.00010935616,0.00037115384,0.0003052198,0.00014091084,0.00020616988,0.00041310064,0.0008881595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007942986,0.000108005624,0.00010418964,0.000041029198,0.00011004435,0.000006850192,0.00042917408,0.0000010349274,0.97600424,0.0062272004,0.011997389,0.00417652],"study_design_scores_gemma":[0.001861517,0.00014584202,0.0032240981,0.00031279965,0.0000077770665,0.0000022983306,0.00033384212,1.8163112e-7,0.9472145,0.0023818207,0.04430518,0.0002101576],"about_ca_topic_score_codex":0.0009124839,"about_ca_topic_score_gemma":0.0012096503,"teacher_disagreement_score":0.032307792,"about_ca_system_score_codex":0.00028361796,"about_ca_system_score_gemma":0.0003124214,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W2480514246","doi":"10.1158/1538-7445.am2016-2598","title":"Abstract 2598: Predicting breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers using polygenic risk scores","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Breast cancer; Medicine; Ovarian cancer; Oncology; Hazard ratio; Population; Odds ratio; Internal medicine; BRCA mutation; Genetic model; Gynecology; Genetics; Cancer; Confidence interval; Biology; Environmental health; Gene","score_opus":0.07165886218957201,"score_gpt":0.4107038770476602,"score_spread":0.3390450148580882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480514246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916453,0.0072139874,0.0012849614,0.00058037665,0.0002131516,0.0005240911,0.00096296537,0.000012793895,0.000043168813],"genre_scores_gemma":[0.9950846,0.0030586924,0.00054939464,0.000037490623,0.00072454533,0.00035184715,0.000018395081,0.000048225542,0.00012683378],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838763,0.00009703508,0.00020657551,0.0005851369,0.0002498355,0.00047375582],"domain_scores_gemma":[0.9989851,0.00010735225,0.000104874845,0.00027131877,0.00036439215,0.00016694001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070649525,0.00014780396,0.00013672735,0.00011991584,0.0004299988,0.00007796186,0.00014735776,0.00016798895,0.000053815384],"category_scores_gemma":[0.00023944883,0.00012655792,0.00004432718,0.00015253233,0.00038628437,0.000020533686,0.00012714954,0.00016393031,8.7308024e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037884215,0.0000130572835,0.1002135,0.000098768025,0.00022183248,0.000002272498,0.00038583443,0.0002929218,0.70863444,0.000022925631,0.00066832127,0.18906727],"study_design_scores_gemma":[0.0052634412,0.0003310837,0.5750127,0.0004856031,0.00016406027,0.000100813995,0.001113053,0.0012422529,0.40903464,0.0010078816,0.0055159195,0.0007285458],"about_ca_topic_score_codex":0.004517974,"about_ca_topic_score_gemma":0.0016357059,"teacher_disagreement_score":0.47479922,"about_ca_system_score_codex":0.00032211503,"about_ca_system_score_gemma":0.0008145415,"threshold_uncertainty_score":0.6829855},"labels":[],"label_agreement":null},{"id":"W2480622474","doi":"10.1158/1538-7445.am2016-3335","title":"Abstract 3335: The high cMyc expression characterizes a small cell subpopulation in ALK-positive anaplastic large cell lymphoma that carry cancer stem-like properties","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer research; Biology; SOX2; Transfection; Luciferase; Cell; Ectopic expression; Anaplastic large-cell lymphoma; Cell culture; Molecular biology; Lymphoma; Transcription factor; Gene; Immunology; Biochemistry; Genetics","score_opus":0.08284343539010063,"score_gpt":0.3266995064549125,"score_spread":0.24385607106481189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480622474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931396,0.0054491987,0.0000034726054,0.0029026915,0.00031405667,0.0013773028,0.00019739008,0.000034190478,0.00040771128],"genre_scores_gemma":[0.99057895,0.0039092638,0.0000071647164,0.00016274168,0.00026541093,0.0018591615,0.000029887973,0.000050803937,0.0031366327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99731874,0.0002332589,0.00030586822,0.0005665691,0.0007751316,0.0008004333],"domain_scores_gemma":[0.99862856,0.0003228772,0.00011860317,0.00046512677,0.0002642161,0.00020064332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047476846,0.00026653442,0.0003650035,0.00021010241,0.00026676667,0.000075335745,0.00021884048,0.00015006206,0.00031312057],"category_scores_gemma":[0.000025489164,0.00013064772,0.00009464409,0.0002825591,0.00017975394,0.00020321459,0.0001494306,0.00018700745,0.00008104838],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030263902,0.0019897313,0.3609412,0.0005919672,0.00009725938,0.0003002228,0.0029836306,0.000010393106,0.5901326,0.000028817358,0.0020569337,0.037840847],"study_design_scores_gemma":[0.005521011,0.00019884495,0.5654341,0.0015029014,0.000032036438,0.0000031123577,0.0004345365,0.0000137112465,0.42452562,0.000008994452,0.0021818827,0.00014326173],"about_ca_topic_score_codex":0.009232475,"about_ca_topic_score_gemma":0.0027841055,"teacher_disagreement_score":0.20449291,"about_ca_system_score_codex":0.0015847273,"about_ca_system_score_gemma":0.0006599308,"threshold_uncertainty_score":0.9973651},"labels":[],"label_agreement":null},{"id":"W2480719297","doi":"10.1158/1538-7445.am2016-1334","title":"Abstract 1334: Lipid-based nanoparticulate hydroxychloroquine (HCQ) formulations for use in combination with autophagy inducing drugs for treatment of breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); Centre for Drug Research and Development; BC Cancer Agency","funders":"","keywords":"Hydroxychloroquine; In vivo; Autophagy; Pharmacology; Liposome; Pharmacokinetics; Tolerability; Chemistry; Cardiotoxicity; Breast cancer; Medicine; Toxicity; Cancer; Internal medicine; Biochemistry; Apoptosis; Adverse effect; Biology","score_opus":0.06633699814596984,"score_gpt":0.3619690904726868,"score_spread":0.295632092326717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480719297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478483,0.00009598619,0.00074607035,0.0014227595,0.00014952858,0.0019711412,0.0007832431,0.000039845756,0.000006611427],"genre_scores_gemma":[0.99543756,0.000027571885,0.0009937645,0.000025324434,0.00008510621,0.0031959992,0.000015476755,0.00004284209,0.00017635536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978069,0.00008781608,0.00042397805,0.00047880254,0.0004979466,0.0007045631],"domain_scores_gemma":[0.99748385,0.0010879129,0.00015576149,0.0003841642,0.00074938237,0.00013895668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083211594,0.00017841079,0.00031258675,0.00031082748,0.00018470506,0.000069343056,0.00018549839,0.000078377874,0.00024896528],"category_scores_gemma":[0.000089411325,0.000119355005,0.000070347385,0.0004412493,0.00020648431,0.0005592491,0.000026150768,0.000045380333,0.000010320412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001939659,0.0005179215,0.0042371615,0.00011812662,0.000018925944,0.0000022591037,0.0002968785,0.004977977,0.9783872,0.0002674043,0.00011201863,0.009124466],"study_design_scores_gemma":[0.008141956,0.0006652706,0.018559512,0.00041310562,0.00002433969,7.147817e-7,0.000030515388,0.005523097,0.96599513,0.00019956173,0.0002690915,0.0001777262],"about_ca_topic_score_codex":0.0040099556,"about_ca_topic_score_gemma":0.0029364964,"teacher_disagreement_score":0.014322351,"about_ca_system_score_codex":0.0012108855,"about_ca_system_score_gemma":0.0008292398,"threshold_uncertainty_score":0.606188},"labels":[],"label_agreement":null},{"id":"W2480823485","doi":"10.1158/1538-7445.am2016-1768","title":"Abstract 1768: Racial/ethnic differences in endometrioid endometrial cancer survival among cases identified through the National Cancer Database","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"","keywords":"Hazard ratio; Medicine; Ethnic group; Pacific islanders; Confidence interval; Demography; Endometrial cancer; Proportional hazards model; Cancer; Gerontology; Internal medicine; Population; Environmental health","score_opus":0.4135359845453174,"score_gpt":0.5084943011028129,"score_spread":0.09495831655749548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480823485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611646,0.026827842,0.000015365595,0.004169194,0.00234332,0.0016882387,0.0014040195,0.000056018718,0.0023314008],"genre_scores_gemma":[0.9662692,0.022661738,0.000011437676,0.00022935732,0.003097944,0.0033999295,0.000035197467,0.000055790875,0.004239423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932762,0.0005057612,0.0007536844,0.0009637049,0.0032692333,0.001231409],"domain_scores_gemma":[0.99112,0.006866283,0.00020770264,0.0005151631,0.0009335761,0.00035730147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002179366,0.00038324055,0.0007945168,0.0010621682,0.0003606619,0.00011316592,0.00065538526,0.0002020694,0.013065853],"category_scores_gemma":[0.004833679,0.00020545145,0.00025131527,0.005071056,0.00087204465,0.0005516343,0.00029811347,0.00088857225,0.00011189454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017097456,0.0018585342,0.6710695,0.0005898763,0.0020766945,0.0009051484,0.0021797274,0.000017028984,0.079409204,0.0013869669,0.012066562,0.21134332],"study_design_scores_gemma":[0.02392191,0.00045141968,0.9324301,0.0015151723,0.00018195689,0.000012358144,0.0006429093,0.0000042563147,0.029671209,0.00082206837,0.009780619,0.0005660112],"about_ca_topic_score_codex":0.062210724,"about_ca_topic_score_gemma":0.02782478,"teacher_disagreement_score":0.26136062,"about_ca_system_score_codex":0.0021467458,"about_ca_system_score_gemma":0.0016094778,"threshold_uncertainty_score":0.9899149},"labels":[],"label_agreement":null},{"id":"W2481191644","doi":"10.1158/1538-7445.am2016-1534","title":"Abstract 1534: Amplification of PITPNC1 affects breast cancer progression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Breast cancer; Cancer research; Biology; Invasive lobular carcinoma; Metastasis; Cancer; Carcinogenesis; Lymph node; Pathology; Comparative genomic hybridization; Breast carcinoma; Medicine; Gene; Immunology; Chromosome; Genetics","score_opus":0.05429425702146463,"score_gpt":0.4258953545274879,"score_spread":0.37160109750602327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481191644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929002,0.0029668985,0.0005239011,0.0022062736,0.00012456224,0.0003424708,0.00018682434,0.0000101501855,0.00073872355],"genre_scores_gemma":[0.9931054,0.0047054645,0.00005227746,0.00002315559,0.00029052125,0.00054529496,0.000016904325,0.000022703833,0.0012382889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987786,0.000068805806,0.00014921027,0.00035655877,0.00033746246,0.00030936155],"domain_scores_gemma":[0.998891,0.000024330893,0.00008237854,0.00046646147,0.00043818066,0.000097637014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040611802,0.000094897674,0.00010207019,0.00007596778,0.000101859514,0.000017596125,0.00026777945,0.00011281623,0.00040730846],"category_scores_gemma":[0.000037981736,0.00006334942,0.000051887062,0.00019360738,0.00022914496,0.000008706579,0.00007546133,0.00009276541,0.000018728206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012568559,0.00004806036,0.00497212,0.00004036405,0.000020349793,3.3679544e-7,0.000015562828,0.000005201874,0.82518405,0.00014065581,0.0058999904,0.16354764],"study_design_scores_gemma":[0.00045171558,0.000079474434,0.12695181,0.00021212763,0.000005189114,0.0000020682394,0.000028902214,0.0000022049474,0.83845115,0.00007569768,0.033617403,0.00012224595],"about_ca_topic_score_codex":0.00021853416,"about_ca_topic_score_gemma":0.0001016102,"teacher_disagreement_score":0.16342539,"about_ca_system_score_codex":0.000088067,"about_ca_system_score_gemma":0.00035013186,"threshold_uncertainty_score":0.4459742},"labels":[],"label_agreement":null},{"id":"W2481249436","doi":"10.1158/1538-7445.am2016-lb-345","title":"Abstract LB-345: Acetylenic tricyclic bis-(cyano enone) interacts with cysteine residues of actin and inhibits non-small cell lung cancer cell migration","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Actin; Cell migration; Cell biology; Actin cytoskeleton; Lamellipodium; Actin-binding protein; MDia1; Cytoskeleton; Actin remodeling; Chemistry; Cell; Biology; Biochemistry","score_opus":0.03811753371717346,"score_gpt":0.35697431123346596,"score_spread":0.3188567775162925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481249436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908236,0.0024344178,0.000052218136,0.003103672,0.000023131068,0.000551012,0.00009105034,0.000028700764,0.0028921657],"genre_scores_gemma":[0.9858982,0.0044246768,0.00006559763,0.000104774415,0.00021794417,0.00017002925,0.000023807645,0.000036695743,0.009058288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977726,0.00011543525,0.00041654587,0.0004991548,0.0006881796,0.0005081282],"domain_scores_gemma":[0.9981683,0.00028111282,0.00024511246,0.00038204956,0.00061040756,0.0003130023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005045115,0.0002175067,0.00043313822,0.00044358734,0.000113957,0.000039811566,0.0001293412,0.00013343449,0.0009927249],"category_scores_gemma":[0.000093196446,0.00013805671,0.000094434545,0.0006440981,0.00020147859,0.00024897268,0.000080897444,0.00038524673,0.000024280675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079511706,0.00018287956,0.011991791,0.0008047176,0.000078833225,0.000033034277,0.0006809041,0.0000053654753,0.9769066,0.0000023656785,0.004711272,0.0038071058],"study_design_scores_gemma":[0.0037023707,0.00043026247,0.010814714,0.0036296456,0.00009443575,0.0000069439416,0.00066909986,0.000039408435,0.97905475,0.000003094215,0.0013657579,0.00018952605],"about_ca_topic_score_codex":0.0058168704,"about_ca_topic_score_gemma":0.009724335,"teacher_disagreement_score":0.006166123,"about_ca_system_score_codex":0.00040793582,"about_ca_system_score_gemma":0.0006807029,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2481325258","doi":"10.1158/1538-7445.am2016-1800","title":"Abstract 1800: Inhibition of scavenger receptor class B type I suppresses androgen pathway activity and induces cytotoxic stress in C4-2 castration resistant prostate cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of British Columbia","funders":"","keywords":"Androgen receptor; LNCaP; Prostate cancer; Endocrinology; Androgen; Propidium iodide; Internal medicine; Cytotoxic T cell; Chemistry; Medicine; Cancer research; Apoptosis; In vitro; Cancer; Biochemistry; Hormone; Programmed cell death","score_opus":0.0692038344768584,"score_gpt":0.3741344729543396,"score_spread":0.3049306384774812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481325258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926447,0.0030976115,4.001056e-7,0.001867546,0.00011425955,0.0012641735,0.0006941653,0.000019704543,0.00029738943],"genre_scores_gemma":[0.98546755,0.012783115,0.000015155546,0.000008639559,0.00014713025,0.0004099516,0.00003001677,0.00003538984,0.0011030529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975606,0.00020465827,0.00030684084,0.0005124262,0.0008045493,0.00061088044],"domain_scores_gemma":[0.99854064,0.00022388868,0.00010513814,0.00028811675,0.00061960233,0.00022262809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007283124,0.00018961492,0.00034965624,0.00038888797,0.00011675045,0.00004406989,0.000093307586,0.00017083435,0.0005227798],"category_scores_gemma":[0.00009831754,0.00012561373,0.00004266395,0.000610563,0.0004485539,0.00032480218,0.000090320864,0.00042227973,0.000012466843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004213166,0.0002487023,0.011367744,0.00069499144,0.00006229901,0.00006613635,0.000552372,0.000003427752,0.9623554,0.000015024006,0.000551496,0.019869262],"study_design_scores_gemma":[0.0024831563,0.0005266739,0.04353639,0.001673165,0.000011977961,0.0000015619382,0.00025227945,0.0000033446445,0.95066136,0.00005582851,0.00065957935,0.00013465651],"about_ca_topic_score_codex":0.0023801017,"about_ca_topic_score_gemma":0.0019705899,"teacher_disagreement_score":0.032168645,"about_ca_system_score_codex":0.0006836264,"about_ca_system_score_gemma":0.0013001553,"threshold_uncertainty_score":0.57240725},"labels":[],"label_agreement":null},{"id":"W2481617806","doi":"10.1158/1538-7445.am2016-3791","title":"Abstract 3791: TRPV6 calcium channel peptide antagonists as novel antimyeloma and antiresorptive agents","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coccidia and coccidiosis research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Saint John Regional Hospital; Dalhousie University; University of New Brunswick","funders":"","keywords":"TRPV6; Cancer research; Multiple myeloma; Bone marrow; Medicine; Internal medicine; Endocrinology; Pathology; Calcium metabolism; Calcium","score_opus":0.13966130735504634,"score_gpt":0.38787541944450526,"score_spread":0.24821411208945893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481617806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985802,0.00071890163,0.000002411112,0.009130983,0.00011117038,0.0004302149,0.00017017624,0.000048475056,0.0035856774],"genre_scores_gemma":[0.991842,0.0025956796,0.0000048905576,0.00013292527,0.0005099101,0.000110792,0.000011044668,0.0000044112085,0.0047883727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99686074,0.00013804843,0.0002327212,0.0007052705,0.0009949753,0.0010682533],"domain_scores_gemma":[0.9983807,0.00060467125,0.000051584084,0.00014490612,0.00037847433,0.0004396483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086929946,0.0002074486,0.00025066265,0.00006888766,0.0005228475,0.00019373675,0.00055563723,0.00015094313,0.0021853563],"category_scores_gemma":[0.000226482,0.00007354813,0.000095005904,0.00063876674,0.0004449098,0.00025009815,0.00040646747,0.00034695992,0.00042377308],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001865616,0.00009584438,0.0067989994,0.000017179958,0.000025485968,0.000036435587,0.00010027651,1.3607365e-7,0.88114,0.00013378313,0.0052146968,0.10625062],"study_design_scores_gemma":[0.00071155216,0.00042404712,0.759058,0.00023885629,0.0000052864116,0.000018443978,0.00041783936,0.000014012703,0.17742051,0.0005598237,0.060775753,0.00035589555],"about_ca_topic_score_codex":0.003706,"about_ca_topic_score_gemma":0.00084370957,"teacher_disagreement_score":0.75225896,"about_ca_system_score_codex":0.00014978409,"about_ca_system_score_gemma":0.00010320667,"threshold_uncertainty_score":0.9987268},"labels":[],"label_agreement":null},{"id":"W2481876593","doi":"10.1158/1538-7445.am2016-1276","title":"Abstract 1276: Pannexin 1 regulates rhabdomyosarcoma tumor growth: a potential novel therapeutic target","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Rhabdomyosarcoma; In vivo; Skeletal muscle; Cell growth; Cell culture; Alveolar rhabdomyosarcoma; Myocyte; Cancer research; Biology; In vitro; Cell biology; Pathology; Medicine; Sarcoma; Anatomy; Biochemistry","score_opus":0.04248982657231065,"score_gpt":0.342263209831599,"score_spread":0.2997733832592884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481876593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122834,0.00309615,0.000533031,0.0035686966,0.00024385733,0.00028689,0.00012408337,0.000022692011,0.000896287],"genre_scores_gemma":[0.99537677,0.0005496637,0.00013522412,0.0002885818,0.0008207942,0.00013158667,0.00002905207,0.000040632884,0.0026276796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998042,0.0001202026,0.00022466407,0.00060000067,0.000272555,0.00074061565],"domain_scores_gemma":[0.9988779,0.00006481667,0.00005562065,0.00048682463,0.00035818527,0.00015667341],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006242303,0.00018662018,0.00018520004,0.00011458086,0.00017609735,0.00003710135,0.0004576383,0.00018110305,0.0010021754],"category_scores_gemma":[0.00013827332,0.00012504164,0.00012391976,0.00015511001,0.0004224331,0.0000072470525,0.00023898897,0.00020769791,0.000096160264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039668183,0.00008531169,0.00118517,0.000019431918,0.00007779184,0.000015439067,0.000017413206,0.0000015651933,0.98557884,0.0004883262,0.0044045914,0.007729472],"study_design_scores_gemma":[0.0014065125,0.00042409703,0.019543042,0.00005190945,0.0000080229565,0.000035224417,0.000044926648,0.000010138487,0.8491966,0.0010692694,0.12789898,0.00031129847],"about_ca_topic_score_codex":0.00023760466,"about_ca_topic_score_gemma":0.00006885393,"teacher_disagreement_score":0.13638222,"about_ca_system_score_codex":0.000056735687,"about_ca_system_score_gemma":0.00028930008,"threshold_uncertainty_score":0.99991107},"labels":[],"label_agreement":null},{"id":"W2482079801","doi":"10.1158/1538-7445.am2016-5277","title":"Abstract 5277: The cBioPortal for cancer genomics and its application in precision oncology","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Documentation; Software; Pipeline (software); Computer science; Data science; Timeline; Genomics; Visualization; Medicine; Data mining; Genome; Biology; Geography","score_opus":0.054326411644243316,"score_gpt":0.41708147310389626,"score_spread":0.36275506145965297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482079801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98643655,0.00902557,0.0003093725,0.0029350312,0.00013063605,0.00078357296,0.00017537439,0.0000025770723,0.00020132726],"genre_scores_gemma":[0.9710847,0.026736526,0.000034038294,0.00013625293,0.00044167944,0.0012391693,0.0000133687945,0.000019011557,0.00029526727],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990731,0.00002403759,0.00016526369,0.00033082062,0.00011000599,0.00029675988],"domain_scores_gemma":[0.9992946,0.00018608638,0.000050152656,0.0002192035,0.00018160287,0.000068365596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000631793,0.000079837555,0.00009980773,0.00004711836,0.00009903837,0.000016605392,0.0002018731,0.00012828126,0.000023000975],"category_scores_gemma":[0.00016587904,0.00005171284,0.000030667252,0.00007603577,0.00010925196,0.0000036215833,0.00013282578,0.00009759449,0.0000046114315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024385772,0.000025066709,0.0016062916,0.000017765398,0.000012833407,6.5174737e-7,0.00004987924,0.000030927244,0.81665355,0.00035124822,0.0018318677,0.17917609],"study_design_scores_gemma":[0.0013507267,0.0002633689,0.013339765,0.00005136974,0.000007936427,0.0000026309049,0.00007929412,0.00011531348,0.39764807,0.0014948702,0.58547366,0.00017299817],"about_ca_topic_score_codex":0.00045981674,"about_ca_topic_score_gemma":0.0044596,"teacher_disagreement_score":0.5836418,"about_ca_system_score_codex":0.00019765238,"about_ca_system_score_gemma":0.000490876,"threshold_uncertainty_score":0.24885614},"labels":[],"label_agreement":null},{"id":"W2482156283","doi":"10.1158/1538-7445.am2016-4666","title":"Abstract 4666: Phosphatidylinositol 3-kinase (PI3K) and mTOR inhibitors demonstrate broad efficacy and synergy in head and neck cancer cell lines and patient-derived xenografts","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Science Centre; University of Saskatchewan; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; Western University","funders":"","keywords":"Everolimus; PI3K/AKT/mTOR pathway; Cancer research; Medicine; Cancer; Kinase; Pharmacology; Biology; Oncology; Internal medicine; Signal transduction; Genetics","score_opus":0.031893132370459314,"score_gpt":0.3788481480947124,"score_spread":0.3469550157242531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482156283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477993,0.04858069,7.1024493e-7,0.002269861,0.00012102018,0.000809313,0.00008758745,0.00002252415,0.00030896952],"genre_scores_gemma":[0.9686844,0.030342352,0.00009074202,0.000101596066,0.0001630445,0.00028910005,0.0000066543303,0.00003217838,0.00028992962],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835557,0.000056829413,0.00028016279,0.0005261553,0.00029911197,0.0004821584],"domain_scores_gemma":[0.9989475,0.0002201047,0.00006524225,0.00018508373,0.00017692643,0.00040512465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013132037,0.00021307691,0.00031124198,0.00016145909,0.00019598471,0.00007724958,0.00004679187,0.00011526328,0.00011065963],"category_scores_gemma":[0.00005702452,0.00014510863,0.00002184262,0.00021051208,0.00040953213,0.0002251338,0.00009113951,0.00020331572,0.0000018617895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011126691,0.00037978336,0.22746865,0.00060619233,0.00015626315,0.00017860704,0.0027190703,0.0000029150945,0.25366014,0.000032614265,0.0014965861,0.5121865],"study_design_scores_gemma":[0.0147541845,0.001184516,0.78036714,0.0028355853,0.00012838491,0.000024062845,0.0009529759,0.000028730552,0.19184957,0.00006975293,0.007405385,0.00039973157],"about_ca_topic_score_codex":0.008951198,"about_ca_topic_score_gemma":0.0033933623,"teacher_disagreement_score":0.55289847,"about_ca_system_score_codex":0.00023220266,"about_ca_system_score_gemma":0.00035015703,"threshold_uncertainty_score":0.9976483},"labels":[],"label_agreement":null},{"id":"W2482841858","doi":"10.1158/1538-7445.am2016-3661","title":"Abstract 3661: ALDH1A3-inducible RARRES1 is a tumor suppressor in triple-negative breast cancer and is methylated in claudin-low breast cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Breast cancer; Cancer research; Triple-negative breast cancer; Cancer; Biology; Carcinogenesis; Gene knockdown; Pathology; Medicine; Internal medicine; Cell culture","score_opus":0.028158068229711678,"score_gpt":0.35185558155943364,"score_spread":0.32369751332972196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482841858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898134,0.005186446,0.0000057861334,0.0028963785,0.0001493187,0.00054438185,0.0007644456,0.000010782875,0.00062906946],"genre_scores_gemma":[0.99117553,0.0058493325,0.000024634459,0.00030777606,0.0002744842,0.0005945835,0.000013978217,0.000054248463,0.0017054012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702525,0.0001857095,0.00039042052,0.0009980092,0.00047981768,0.00092077046],"domain_scores_gemma":[0.9987246,0.00010332919,0.0001080957,0.00047151218,0.00036385973,0.00022861414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000800407,0.00029091144,0.0003517119,0.0002754313,0.00011873963,0.00006624683,0.00045844252,0.00028038386,0.00089315925],"category_scores_gemma":[0.00014341307,0.00022460936,0.00007293566,0.0006675127,0.0004780757,0.00003509738,0.00023474394,0.0005117661,0.000015493693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010169429,0.00006556556,0.01523495,0.0002016559,0.00008235825,0.000047611607,0.00053603336,0.000014318133,0.9628146,0.000009738771,0.009067154,0.01090904],"study_design_scores_gemma":[0.0032166105,0.00008222741,0.030633856,0.00059670577,0.0000087193675,0.000030242827,0.00031026168,0.000024946452,0.9614884,0.00025577273,0.0029872665,0.00036495147],"about_ca_topic_score_codex":0.010980397,"about_ca_topic_score_gemma":0.003011715,"teacher_disagreement_score":0.015398906,"about_ca_system_score_codex":0.0005829245,"about_ca_system_score_gemma":0.0016532108,"threshold_uncertainty_score":0.9956056},"labels":[],"label_agreement":null},{"id":"W2482856912","doi":"10.1158/1538-7445.am2016-4903","title":"Abstract 4903: Multimodal therapy with a potent vaccine, metronomic cyclophosphamide and anti-PD-1 enhances immunotherapy of advanced tumors by increasing activation and clonal expansion of tumor infiltrating T cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Immune system; Tumor microenvironment; Immunogenicity; Immunotherapy; Medicine; ELISPOT; CD8; Cancer research; Cancer; Immunology; Cancer immunotherapy; Combination therapy; Cyclophosphamide; Cancer vaccine; Flow cytometry; Pharmacology; Chemotherapy; Internal medicine","score_opus":0.014337855225604575,"score_gpt":0.29798321317535625,"score_spread":0.28364535794975165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482856912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97593695,0.023186289,0.0000938943,0.00015171223,0.000063070554,0.0004806651,0.000051195962,0.000015783333,0.000020454952],"genre_scores_gemma":[0.98735154,0.012179664,0.00022721707,0.000029539586,0.000012827747,0.00006735965,0.000009330375,0.0000320612,0.0000904368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982432,0.0004032095,0.0004493791,0.000359734,0.00012443982,0.00042002203],"domain_scores_gemma":[0.9982173,0.0009825762,0.0003143129,0.0002483475,0.00021138554,0.00002610906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090567727,0.00021807897,0.00044825012,0.00022668597,0.00022164703,0.000017650395,0.00018744387,0.00010900287,0.00016460888],"category_scores_gemma":[0.00006928851,0.00014162446,0.000048142465,0.00020137869,0.00051846093,0.00031092315,0.00004735544,0.0002757549,0.0000019396657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01101012,0.000094355266,0.0038674083,0.00004309694,0.0001769062,8.190802e-7,0.00047989268,0.0000075149424,0.88995934,0.000010186382,0.000026314165,0.09432403],"study_design_scores_gemma":[0.004118712,0.0006305589,0.13935444,0.00049845595,0.0000039463703,0.000010291566,0.00051060016,0.000001234033,0.85426426,0.0000132904825,0.00044133374,0.000152877],"about_ca_topic_score_codex":0.0019335644,"about_ca_topic_score_gemma":0.000011403654,"teacher_disagreement_score":0.13548702,"about_ca_system_score_codex":0.00007828283,"about_ca_system_score_gemma":0.0002560028,"threshold_uncertainty_score":0.57752776},"labels":[],"label_agreement":null},{"id":"W2482878683","doi":"10.1158/1538-7445.am2016-2569","title":"Abstract 2569: A genome wide association study of lung cancer identifies 11 novel susceptibility loci","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Genome-wide association study; Lung cancer; Lung cancer susceptibility; Genotyping; Biology; Genetic association; Population; Single-nucleotide polymorphism; Genetics; Oncology; Genotype; Medicine; Gene","score_opus":0.05652634631598292,"score_gpt":0.4010829701313199,"score_spread":0.34455662381533697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482878683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965286,0.001512423,0.00014132349,0.000802009,0.00012581203,0.000537357,0.00016272247,0.000007672935,0.00018203088],"genre_scores_gemma":[0.9931457,0.0012891553,0.000008053567,0.00003150012,0.00026078155,0.00046312055,0.000015543581,0.000021280475,0.0047648433],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982284,0.000101092184,0.0002887247,0.00046842432,0.00053253083,0.00038085776],"domain_scores_gemma":[0.9983098,0.00008244864,0.00014407469,0.0005466358,0.0008337833,0.000083273575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010657362,0.00011309941,0.00016159097,0.00008014884,0.00014348762,0.000034660537,0.0003306791,0.00012508094,0.00043132942],"category_scores_gemma":[0.00032111068,0.0000864876,0.00006712563,0.00022379406,0.00011506361,0.0000129524005,0.0001378669,0.00012453164,0.0000069893877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006108568,0.00019790464,0.31219867,0.00003478626,0.00008893335,3.3274247e-7,0.00014296468,0.000027009228,0.6828676,0.0000061877863,0.0036627052,0.0007118132],"study_design_scores_gemma":[0.0011498366,0.00013820216,0.8369264,0.000040030573,0.000022350521,1.1966536e-7,0.00043987882,0.000003544351,0.1502107,0.000024639521,0.010881075,0.00016321188],"about_ca_topic_score_codex":0.0033616931,"about_ca_topic_score_gemma":0.008827391,"teacher_disagreement_score":0.5326569,"about_ca_system_score_codex":0.0004574189,"about_ca_system_score_gemma":0.0003913694,"threshold_uncertainty_score":0.5081897},"labels":[],"label_agreement":null},{"id":"W2482895554","doi":"10.1158/1538-7445.am2016-2390","title":"Abstract 2390: The polyclonal nature of multinodular goitre revealed by DICER1 sequencing","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"RNase P; Sanger sequencing; Population; Biology; Mutation; Molecular biology; Genetics; Gene; Medicine; RNA","score_opus":0.08584549121065407,"score_gpt":0.4436718157012357,"score_spread":0.3578263244905816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482895554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.932503,0.013769211,0.000019048615,0.04999202,0.00017395655,0.0002775838,0.00006522896,0.00002546521,0.0031745078],"genre_scores_gemma":[0.9901754,0.0013959669,0.000068757174,0.00069515524,0.000337343,0.000058391863,0.000004742695,0.000016197773,0.0072480375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982267,0.00014741143,0.00020655597,0.00026603977,0.0007217475,0.00043155398],"domain_scores_gemma":[0.9983695,0.0007628197,0.000053246364,0.0003547746,0.00031499568,0.00014464032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014249536,0.000107242224,0.00025552494,0.0000731062,0.00017301843,0.0000058913124,0.00020750174,0.00015175177,0.00049633253],"category_scores_gemma":[0.001520389,0.000046117937,0.00007134454,0.00021855194,0.0010135663,0.00003386529,0.00009319,0.0010074887,0.00003717708],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021450761,0.00004909686,0.071757644,0.00021219978,0.00013775873,0.0001218125,0.000564572,1.7356403e-7,0.72960895,0.00006685378,0.16323091,0.034035537],"study_design_scores_gemma":[0.0066909227,0.0005063006,0.47737697,0.005026045,0.00017286469,0.00018128188,0.00199735,0.000031641055,0.29892755,0.0007738389,0.20784354,0.00047169224],"about_ca_topic_score_codex":0.00037612743,"about_ca_topic_score_gemma":0.00002402288,"teacher_disagreement_score":0.43068138,"about_ca_system_score_codex":0.00015165357,"about_ca_system_score_gemma":0.00032551776,"threshold_uncertainty_score":0.5434493},"labels":[],"label_agreement":null},{"id":"W2482951881","doi":"10.1158/1538-7445.am2016-2345","title":"Abstract 2345: SIRPαFc, a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by both classically (M1) and alternatively (M2) activated macrophages","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Phagocytosis; CD80; CD14; Cancer research; Macrophage; Tumor microenvironment; Biology; CD16; CD11c; Immunology; Cell biology; Immune system; Chemistry; CD40; In vitro; Cytotoxic T cell; Phenotype","score_opus":0.04692771795007719,"score_gpt":0.35355854986257673,"score_spread":0.3066308319124995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482951881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636118,0.034045942,0.0000481436,0.00088819454,0.00028401994,0.00043572055,0.0004057969,0.00004255889,0.000237837],"genre_scores_gemma":[0.98056144,0.014977518,0.000011113908,0.00006318677,0.00005442286,0.00018470496,0.000016920898,0.000054175165,0.0040765163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751407,0.00040490716,0.00049257185,0.00057134125,0.000227856,0.0007892272],"domain_scores_gemma":[0.9983856,0.0005836559,0.00028184088,0.00036944234,0.00031467277,0.000064803506],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068847986,0.00028707815,0.00051078026,0.00026336592,0.00031953768,0.000046592846,0.00044997796,0.00029648017,0.0014005243],"category_scores_gemma":[0.000055025597,0.00020452164,0.00012294033,0.00032692106,0.0009505686,0.00028289855,0.00016167805,0.00030240623,0.000044056054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086310355,0.00015196779,0.00043589843,0.000048434802,0.00048604596,0.0000022126637,0.00030585408,0.0000014438336,0.8242721,0.000040628933,0.0026591765,0.17073312],"study_design_scores_gemma":[0.0037719456,0.00018992444,0.015228066,0.00036590177,0.00003340066,0.0000040565324,0.00009951364,0.0000035869652,0.95303977,0.000046978083,0.0269725,0.00024437575],"about_ca_topic_score_codex":0.0017529419,"about_ca_topic_score_gemma":0.00003849432,"teacher_disagreement_score":0.17048874,"about_ca_system_score_codex":0.00048007967,"about_ca_system_score_gemma":0.00036420813,"threshold_uncertainty_score":0.9995123},"labels":[],"label_agreement":null},{"id":"W2482988738","doi":"10.1158/1538-7445.am2016-4489","title":"Abstract 4489: Using functional data from Roadmap Epigenomics to inform analysis of rare variants linked to gene expression in a large colorectal cancer study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Biology; Genome-wide association study; Epigenomics; Genetics; Enhancer; Gene; Genetic association; Colorectal cancer; Computational biology; Single-nucleotide polymorphism; Gene expression; Cancer; DNA methylation; Genotype","score_opus":0.14723502675737637,"score_gpt":0.43444730996934794,"score_spread":0.28721228321197156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482988738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932687,0.00075387955,0.0033281296,0.00009863298,0.00011876529,0.000522078,0.0018788738,0.0000028539087,0.000028070583],"genre_scores_gemma":[0.99832714,0.00030649657,0.000571596,0.000024627907,0.00022026112,0.00010330161,0.00035325295,0.000018612265,0.00007473226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99822044,0.00010522648,0.00033937703,0.00055919925,0.00042265977,0.00035310033],"domain_scores_gemma":[0.9987335,0.00006420027,0.000077184995,0.0006310866,0.00033372804,0.00016025557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009685676,0.00011824931,0.00023144437,0.00036317843,0.00009907139,0.000025638423,0.00042361545,0.000124809,0.00037924276],"category_scores_gemma":[0.0002424224,0.00009524924,0.000046032896,0.0007910784,0.000028209666,0.00001387614,0.00068003073,0.00010813701,0.0000065889985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005546419,0.00012088415,0.13027444,0.0000040340906,0.00022742624,0.0000021023732,0.0002331739,0.0030483326,0.86288214,5.254384e-7,0.00009077774,0.0025615403],"study_design_scores_gemma":[0.00063794455,0.00011530852,0.62367547,0.00003082671,0.00003965805,3.4530583e-8,0.00012998424,0.00028587645,0.37408823,0.00000869377,0.00087481504,0.000113139264],"about_ca_topic_score_codex":0.002690221,"about_ca_topic_score_gemma":0.0127549125,"teacher_disagreement_score":0.49340105,"about_ca_system_score_codex":0.00016752476,"about_ca_system_score_gemma":0.00042434753,"threshold_uncertainty_score":0.7117541},"labels":[],"label_agreement":null},{"id":"W2482989563","doi":"10.1158/1538-7445.am2016-5090","title":"Abstract 5090: α1β1 is pro-proliferative and promigratory integrin and its expression is upregulated by the MYC oncogenic factor in colorectal cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer research; Anoikis; Cell growth; Small hairpin RNA; Integrin; Biology; Integrin-linked kinase; Oncogene; KRAS; Cancer; Gene silencing; Colorectal cancer; Cell; Cancer cell; Cell culture; Cell cycle; Gene knockdown","score_opus":0.07481451505925497,"score_gpt":0.4123629042451252,"score_spread":0.3375483891858702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482989563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98055,0.010024716,0.0000010863815,0.006736884,0.00003810348,0.0022042778,0.00020616001,0.0000227364,0.00021605911],"genre_scores_gemma":[0.9900635,0.0043839663,0.000006986122,0.0002012298,0.00010118587,0.0011598095,0.0000043980917,0.000047537796,0.00403141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968643,0.00030563335,0.00030638173,0.0007061317,0.0010834881,0.000734033],"domain_scores_gemma":[0.9983531,0.0004033579,0.000060647766,0.00028683594,0.0005117028,0.0003843413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007440651,0.00023071977,0.0003339245,0.00019408452,0.000199426,0.00006882248,0.00024284996,0.00021987307,0.0026999605],"category_scores_gemma":[0.00032319585,0.00012117713,0.00004847461,0.00047785058,0.00048129496,0.00016111674,0.00032173356,0.0009868882,0.000040874696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011469759,0.000079288024,0.018891085,0.00015652481,0.000047758578,0.000028696797,0.002502926,8.1032276e-8,0.9339997,0.0000028132865,0.018095389,0.02504872],"study_design_scores_gemma":[0.0020300434,0.00028368703,0.07662938,0.00075814006,0.0000070494402,0.000008917406,0.0002786219,0.000069110334,0.91497433,0.000027220574,0.0047838907,0.00014962027],"about_ca_topic_score_codex":0.00091479765,"about_ca_topic_score_gemma":0.00044864215,"teacher_disagreement_score":0.057738293,"about_ca_system_score_codex":0.0006401184,"about_ca_system_score_gemma":0.0008207749,"threshold_uncertainty_score":0.9982117},"labels":[],"label_agreement":null},{"id":"W2483031173","doi":"10.1158/1538-7445.am2016-4526","title":"Abstract 4526: Proscillaridin A effects on chromatin modifications and oncogene degradation in acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Epigenetics; Chromatin; Cancer research; Cell cycle; Histone; Oncogene; Epigenetic therapy; Biology; Cancer; Medicine; DNA methylation; Gene expression; Internal medicine; Genetics; DNA; Gene","score_opus":0.031775199837238755,"score_gpt":0.3589140377913973,"score_spread":0.32713883795415855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483031173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975305,0.0005312242,0.0000994675,0.0006476159,0.0000582833,0.00057961507,0.000047879406,0.000011070841,0.0004943053],"genre_scores_gemma":[0.9962994,0.00096551894,0.00006923783,0.00002873379,0.00017137112,0.00060985476,0.000025718053,0.000030530857,0.001799667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981862,0.00018387829,0.00018648179,0.00051538914,0.00045932014,0.000468731],"domain_scores_gemma":[0.999066,0.00017472729,0.00003742853,0.00039610823,0.00016994396,0.00015577523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063899247,0.00013170233,0.0001301757,0.00024110074,0.00014772234,0.000038744667,0.00020802509,0.00015867315,0.000023844997],"category_scores_gemma":[0.00053513574,0.0001009623,0.000031862393,0.00030619546,0.00021860658,0.000009623695,0.00011893974,0.00018375576,0.00006414149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016999057,0.00003914261,0.0003053443,0.000055213266,0.000019082805,0.000012716361,0.00003683165,0.000016010521,0.97762835,0.000058613983,0.0023113827,0.019347293],"study_design_scores_gemma":[0.0010592156,0.00028146012,0.009396296,0.00020634601,0.0000032669013,0.000004623475,0.000011207703,0.000046767414,0.98601204,0.000044084194,0.002801288,0.00013342281],"about_ca_topic_score_codex":0.00022686589,"about_ca_topic_score_gemma":0.00031780847,"teacher_disagreement_score":0.01921387,"about_ca_system_score_codex":0.0007391166,"about_ca_system_score_gemma":0.00076730107,"threshold_uncertainty_score":0.41171232},"labels":[],"label_agreement":null},{"id":"W2483212393","doi":"10.1158/1538-7445.am2016-2983","title":"Abstract 2983: Stat3 regulates supernumerary centrosome clustering in cancer cells via Stathmin/PLK1","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Centrosome; Stathmin; PLK1; Biology; Mitosis; Cancer research; Cell biology; Cancer; Microtubule; Cell cycle; Genetics","score_opus":0.02990051274036755,"score_gpt":0.3450521778519326,"score_spread":0.31515166511156506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483212393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463844,0.0034630685,0.00029598724,0.00059037947,0.00024090661,0.00033065505,0.00021622897,0.000011121806,0.0002132009],"genre_scores_gemma":[0.9843583,0.012041693,0.00008068354,0.00011285324,0.00038957017,0.00017550077,0.000035448906,0.000051856558,0.0027540806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800444,0.0000923183,0.00026302578,0.00054816366,0.00029144576,0.00080058596],"domain_scores_gemma":[0.9991631,0.00003944521,0.00004336135,0.00043482688,0.00015830222,0.0001609804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003811699,0.00017872608,0.00018192365,0.0001270325,0.00009231015,0.000040433653,0.00035320575,0.0001755217,0.00047888554],"category_scores_gemma":[0.000024529027,0.0001399867,0.0000668567,0.0001708781,0.00017154815,0.00001561794,0.0002828781,0.00022737548,0.00004045422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017689505,0.000053955588,0.0037629225,0.00006768935,0.000032814154,0.000014743765,0.00009282103,0.00010077671,0.9726815,0.0000063972275,0.0030820456,0.019927401],"study_design_scores_gemma":[0.00088649837,0.000090261914,0.006629869,0.00015724626,0.0000035484768,0.0000022907057,0.00005698689,0.000059054357,0.9556533,0.000066202905,0.036154896,0.00023982584],"about_ca_topic_score_codex":0.0016418096,"about_ca_topic_score_gemma":0.0031867095,"teacher_disagreement_score":0.03307285,"about_ca_system_score_codex":0.00022263074,"about_ca_system_score_gemma":0.00033288696,"threshold_uncertainty_score":0.5708492},"labels":[],"label_agreement":null},{"id":"W2483324971","doi":"10.1158/1538-7445.am2016-4597","title":"Abstract 4597: The G protein-coupled P2Y6 pyrimidoceptor protects colorectal cancerous epithelial cells from apoptosis: Is this receptor a novel target against colorectal cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Colorectal cancer; Cancer research; Biology; Apoptosis; Tumor microenvironment; Mouse model of colorectal and intestinal cancer; Cancer; Genetics","score_opus":0.027811703330580122,"score_gpt":0.3083176316141316,"score_spread":0.2805059282835515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483324971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861706,0.004211801,0.00017106655,0.0022923772,0.00058554555,0.001992193,0.0017599729,0.000042119198,0.00032787252],"genre_scores_gemma":[0.9882651,0.0015466794,0.00023048595,0.00038011878,0.0033249655,0.0039399564,0.00006940866,0.00011098615,0.0021323303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99640244,0.0001825698,0.00042963083,0.0010254114,0.0008477318,0.0011122],"domain_scores_gemma":[0.99823767,0.00013386043,0.00020266141,0.00053476857,0.0006104112,0.00028060537],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070535985,0.00041517155,0.00036518945,0.00009644957,0.00051553326,0.00011067801,0.00091466634,0.00040550512,0.0038573008],"category_scores_gemma":[0.00016074101,0.00026062966,0.00020221651,0.00039702232,0.0005389094,0.000023490462,0.0003557847,0.0005993017,0.0001424384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001276735,0.000105640946,0.00015206491,0.00004145425,0.00027834115,0.0000027909398,0.00037554192,0.000058337184,0.9446838,0.0000063878088,0.050616827,0.002402105],"study_design_scores_gemma":[0.0015271099,0.00030030878,0.00023480365,0.00021446228,0.00001852688,7.8772075e-7,0.00012002854,0.000044290187,0.9422828,0.000029493654,0.05481351,0.00041385787],"about_ca_topic_score_codex":0.0071054157,"about_ca_topic_score_gemma":0.0004019619,"teacher_disagreement_score":0.006703454,"about_ca_system_score_codex":0.00037715508,"about_ca_system_score_gemma":0.0015260079,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W2483570148","doi":"10.1158/1538-7445.am2016-2475","title":"Abstract 2475: Bmi1 is a therapeutic target in recurrent medulloblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; BMI1; Medicine; Clinical trial; Oncology; Population; Internal medicine; Cancer research; Cancer","score_opus":0.1121185553653933,"score_gpt":0.44117007517775453,"score_spread":0.32905151981236125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483570148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96990186,0.0060375,0.0000023021864,0.021365581,0.00013219839,0.0005576692,0.000033144213,0.000022147613,0.0019476082],"genre_scores_gemma":[0.9962538,0.0020939473,0.00003203368,0.0002571436,0.00014633674,0.00058428495,0.0000027861186,0.000024338246,0.00060533977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998192,0.00006532816,0.000195502,0.00035252923,0.0006384541,0.0005561506],"domain_scores_gemma":[0.99904144,0.00020535015,0.000027093241,0.000345007,0.00017468026,0.00020645795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004646669,0.00012223398,0.00022047573,0.0002899533,0.000056151264,0.000019059244,0.00012250824,0.00007435623,0.0040857485],"category_scores_gemma":[0.0000701382,0.000070267095,0.000074377735,0.00039327575,0.0001219308,0.00005822772,0.00005072872,0.00023649257,0.000513464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011136543,0.0016534701,0.24365783,0.00018002975,0.00024021043,0.0006762238,0.0008903846,0.0000010549683,0.17791478,0.00052478496,0.040075045,0.53307253],"study_design_scores_gemma":[0.006763608,0.00090040633,0.62199503,0.001677317,0.000026532747,0.000019799756,0.00020546842,0.00001428534,0.24487627,0.0015099098,0.121776566,0.000234817],"about_ca_topic_score_codex":0.00040509008,"about_ca_topic_score_gemma":0.00021774696,"teacher_disagreement_score":0.5328377,"about_ca_system_score_codex":0.0006018424,"about_ca_system_score_gemma":0.00031573666,"threshold_uncertainty_score":0.9968247},"labels":[],"label_agreement":null},{"id":"W2483614610","doi":"10.1158/1538-7445.am2016-lb-324","title":"Abstract LB-324: Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Serous fluid; Ovarian cancer; Comparative genomic hybridization; Serous carcinoma; Loss of heterozygosity; Clear cell; Copy-number variation; Genetics; Indel; Cancer; Cancer research; Single-nucleotide polymorphism; Carcinoma; Genome; Gene; Genotype; Allele","score_opus":0.11047790301248933,"score_gpt":0.40950232723534824,"score_spread":0.2990244242228589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483614610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635219,0.010898211,0.000005548979,0.018058209,0.0003674125,0.0008164386,0.00026855076,0.00006841317,0.005995293],"genre_scores_gemma":[0.9881487,0.008089147,0.00017438937,0.00013752759,0.0004001582,0.00058983377,0.0000060054604,0.00003915946,0.0024151022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997548,0.000095991185,0.00044280378,0.0005706521,0.0007355439,0.0006070115],"domain_scores_gemma":[0.9982333,0.00028550113,0.00012553082,0.00060509366,0.00046370094,0.0002868793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066027907,0.00020261314,0.00046397676,0.00021850821,0.00013550067,0.00002068708,0.00020503135,0.00013393952,0.0068813697],"category_scores_gemma":[0.00008747431,0.00012786474,0.00018067153,0.00030031742,0.0007615226,0.000104141676,0.000054669606,0.00026527274,0.00009586887],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011083967,0.00047227088,0.088179976,0.0005654558,0.00089240196,0.00028724846,0.00059797673,0.0000074687573,0.8070613,0.0030081887,0.026810484,0.07100882],"study_design_scores_gemma":[0.004516496,0.00074609387,0.6130842,0.0020973017,0.00018427845,0.000018432911,0.0001798045,0.0000038675466,0.32005277,0.00093720265,0.05786252,0.00031702218],"about_ca_topic_score_codex":0.010783183,"about_ca_topic_score_gemma":0.0018173297,"teacher_disagreement_score":0.52490425,"about_ca_system_score_codex":0.0013299246,"about_ca_system_score_gemma":0.0025390987,"threshold_uncertainty_score":0.9958041},"labels":[],"label_agreement":null},{"id":"W2483718531","doi":"10.1158/1538-7445.am2016-3583","title":"Abstract 3583: Thymocyte selection-associated HMG box protein (TOX) induces genomic instability in T-cell acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Genome instability; Ku70; Biology; Zebrafish; Ku80; Molecular biology; Thymocyte; Cancer research; genomic DNA; DNA repair; T cell; Genetics; Gene; DNA damage; Transcription factor; DNA; DNA-binding protein","score_opus":0.03283124544548269,"score_gpt":0.331252740508325,"score_spread":0.2984214950628423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483718531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710345,0.00078885455,0.000058844405,0.0002908576,0.00007461752,0.0005492499,0.0000791952,0.00001627935,0.0010386691],"genre_scores_gemma":[0.9953785,0.00094153406,0.000029014705,0.000033855456,0.0001670625,0.0007257528,0.000023172195,0.00003337216,0.002667742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980465,0.00017512124,0.00028647482,0.00059408444,0.0003123101,0.0005854935],"domain_scores_gemma":[0.9990439,0.000039595736,0.00008302366,0.00040186415,0.0003072243,0.00012441738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007455544,0.00016200927,0.00016425115,0.00013465887,0.00017480529,0.00004897151,0.00036715964,0.00023738899,0.00023655477],"category_scores_gemma":[0.0001517773,0.00012722159,0.000065863955,0.0003962326,0.0001929264,0.000015539603,0.000125948,0.0002559677,0.00005548489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018738136,0.0000912234,0.0034233965,0.000021784783,0.000040399944,0.0000024143148,0.000046205132,0.00004140917,0.99041605,0.000017822249,0.0007615129,0.004950389],"study_design_scores_gemma":[0.0013598431,0.00016675072,0.07471568,0.00007380266,0.000006539395,0.0000013041779,0.000054958535,0.000012924849,0.918228,0.00015387163,0.0050054267,0.00022090261],"about_ca_topic_score_codex":0.0010518623,"about_ca_topic_score_gemma":0.001603038,"teacher_disagreement_score":0.07218807,"about_ca_system_score_codex":0.001421581,"about_ca_system_score_gemma":0.0018706516,"threshold_uncertainty_score":0.5187946},"labels":[],"label_agreement":null},{"id":"W2483834911","doi":"10.1158/1538-7445.am2016-4427","title":"Abstract 4427: Role of Smurf2 in regulation of Smad anchor necessary for receptor activation (SARA) in TGFβ-receptor signaling","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"SMAD; R-SMAD; Cell biology; Transforming growth factor; Cancer research; Ubiquitin; Receptor; Smad2 Protein; Signal transduction; Chemistry; Biology; TGF alpha; Growth factor; Biochemistry","score_opus":0.04329397913651037,"score_gpt":0.3672643514462524,"score_spread":0.323970372309742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483834911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983219,0.00067587564,0.00017460286,0.00015211954,0.000051244246,0.0004620086,0.000091691385,0.000004026376,0.00006656113],"genre_scores_gemma":[0.9988187,0.00008844703,0.0004102933,0.0000082294055,0.00019113462,0.00021890218,0.00008878438,0.000025011483,0.00015050758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985101,0.00013101485,0.00041472042,0.00033620282,0.00031692616,0.00029099887],"domain_scores_gemma":[0.99894583,0.00019268703,0.00015786773,0.00028001695,0.00036878846,0.00005478306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095551176,0.000101715945,0.00018479627,0.00021338405,0.00003137727,0.000008418446,0.00023354468,0.00015453318,0.00020448104],"category_scores_gemma":[0.0005911506,0.00008678254,0.00006253572,0.00024818556,0.000118729826,0.000017436982,0.000058762504,0.00009474706,0.0000031834961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091915036,0.00011017031,0.022036834,0.00012752558,0.000017242806,6.8411744e-8,0.00009776528,0.00027503647,0.9622236,0.000021981179,0.0006583367,0.013512322],"study_design_scores_gemma":[0.0008609152,0.00012252052,0.03212645,0.00038119397,0.0000018821577,4.204253e-8,0.0001380226,0.000015592905,0.9634588,0.00020059894,0.0025964037,0.00009762583],"about_ca_topic_score_codex":0.00018480011,"about_ca_topic_score_gemma":0.00008327984,"teacher_disagreement_score":0.013414696,"about_ca_system_score_codex":0.00011236034,"about_ca_system_score_gemma":0.00034598453,"threshold_uncertainty_score":0.35388893},"labels":[],"label_agreement":null},{"id":"W2483872834","doi":"10.1158/1538-7445.am2016-lb-022","title":"Abstract LB-022: The E3-ligase CHIP negatively regulates the expression and function of the tumor suppressor TAp63 through ubiquitination and subsequent proteasome-mediated degradation","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ubiquitin ligase; Ubiquitin; Proteasome; Biology; Ectopic expression; Mdm2; Cell biology; Transcription factor; Regulator; Transfection; Cancer research; Molecular biology; Apoptosis; Cell culture; Genetics; Gene","score_opus":0.054531144571363085,"score_gpt":0.3349489875563099,"score_spread":0.2804178429849468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483872834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830536,0.002176718,0.000063170526,0.012058353,0.0001173981,0.0021954712,0.00006197569,0.000025806075,0.00024749956],"genre_scores_gemma":[0.99819076,0.00057918904,0.000020717831,0.0001220148,0.0001451384,0.00055337226,0.000013106474,0.00003027086,0.00034542344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977209,0.00045237254,0.0002830922,0.00035313144,0.0008581047,0.00033241994],"domain_scores_gemma":[0.99819225,0.0005732191,0.00019655957,0.0004916336,0.00046324887,0.00008309185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012800115,0.00015412648,0.00017742689,0.000077618926,0.00046728374,0.000047074365,0.00018693467,0.00009672786,0.00011272881],"category_scores_gemma":[0.0010975774,0.00006361959,0.00005491527,0.00040965903,0.00083390507,0.00021233884,0.00015618704,0.0005309527,0.000004278542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006381226,0.00003961427,0.0006966601,0.00011524147,0.000039917584,0.000002979224,0.00084234704,0.0000059888334,0.98902017,0.0002943776,0.0011688499,0.0071357223],"study_design_scores_gemma":[0.0015421998,0.00017027683,0.11271496,0.00086324516,0.00004087136,0.00001448237,0.00046037947,0.000045727884,0.88088644,0.0009244003,0.0022572724,0.00007972269],"about_ca_topic_score_codex":0.0004084365,"about_ca_topic_score_gemma":0.00009152114,"teacher_disagreement_score":0.112018295,"about_ca_system_score_codex":0.00022901683,"about_ca_system_score_gemma":0.00033931047,"threshold_uncertainty_score":0.3594016},"labels":[],"label_agreement":null},{"id":"W2483975375","doi":"10.1158/1538-7445.am2016-3798","title":"Abstract 3798: A glycan-binding malaria protein provides therapeutic access to cisplatin-resistant bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Cisplatin; Bladder cancer; Gemcitabine; Chemotherapy; Medicine; Cancer research; Cancer; Cystectomy; Oncology; Internal medicine; Immunology","score_opus":0.1485938238233176,"score_gpt":0.4497339109973408,"score_spread":0.3011400871740232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483975375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96714175,0.002169934,0.00006257983,0.02048082,0.00026785643,0.0042283465,0.000265523,0.00011719724,0.0052660047],"genre_scores_gemma":[0.9789569,0.00031665424,0.000078997036,0.0006277281,0.0005865867,0.004926816,0.0000055529886,0.00010908793,0.014391694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99620646,0.00012337045,0.00038604529,0.00081726315,0.0012927355,0.0011741412],"domain_scores_gemma":[0.9979812,0.00017130359,0.00008347801,0.0006614663,0.00053783634,0.00056469836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062249025,0.0003245239,0.00043862918,0.0004033632,0.00031783216,0.00020216484,0.00050596736,0.00015949647,0.007319044],"category_scores_gemma":[0.00014101021,0.00020148547,0.00012534246,0.0007955522,0.00021467492,0.00033849364,0.00020465213,0.0004530802,0.0003181458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041741384,0.00018033879,0.01619753,0.0003424717,0.0005389165,0.00014539874,0.00042272813,0.0000032355672,0.87686193,0.00032139706,0.0078115235,0.09300041],"study_design_scores_gemma":[0.008730034,0.0015847952,0.29401043,0.004914112,0.00024156165,0.000015781701,0.00028125173,0.000010275171,0.6077006,0.0010594823,0.08058454,0.0008671344],"about_ca_topic_score_codex":0.0058565917,"about_ca_topic_score_gemma":0.0018621456,"teacher_disagreement_score":0.2778129,"about_ca_system_score_codex":0.0017844673,"about_ca_system_score_gemma":0.0024064197,"threshold_uncertainty_score":0.9935884},"labels":[],"label_agreement":null},{"id":"W2484288308","doi":"10.1158/1538-7445.am2016-638","title":"Abstract 638: Clinical characteristics of breast cancer xenograft models","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Biomarker; Internal medicine; Cancer; Biopsy; Stage (stratigraphy); Chemotherapy; Metastatic breast cancer; Pathology; Biology","score_opus":0.09244772595387152,"score_gpt":0.4284782041839601,"score_spread":0.3360304782300886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484288308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936405,0.0018819092,0.000275592,0.0013354182,0.0004057267,0.0002139909,0.0015724271,0.000006906615,0.00066757033],"genre_scores_gemma":[0.9703702,0.027466793,0.00005112324,0.00013058765,0.0012204805,0.000105498926,0.000022402031,0.000036797002,0.000596173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829,0.00007084741,0.00042240348,0.00043163166,0.0003213415,0.00046376753],"domain_scores_gemma":[0.9984032,0.00013276341,0.000118998614,0.00051870366,0.0006205145,0.00020580525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072266976,0.0001361824,0.00024295453,0.00007120763,0.00007262388,0.000023011704,0.00037897867,0.00019371576,0.00031871028],"category_scores_gemma":[0.00014116698,0.00010205328,0.00013108301,0.00012853387,0.00041124178,0.0000069143784,0.00024480443,0.0001867522,0.000017966491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071848603,0.0001959751,0.041865885,0.000085265456,0.00015098084,0.000007405187,0.00003669109,0.0000369086,0.72124106,0.00045594684,0.021389434,0.21381597],"study_design_scores_gemma":[0.0038427813,0.0006863516,0.5541734,0.00065141125,0.00006372847,0.000014151704,0.000081621474,0.00008427451,0.23990448,0.0017443548,0.19786195,0.00089147856],"about_ca_topic_score_codex":0.0005321859,"about_ca_topic_score_gemma":0.0002700165,"teacher_disagreement_score":0.5123075,"about_ca_system_score_codex":0.00007444987,"about_ca_system_score_gemma":0.00074459147,"threshold_uncertainty_score":0.4161612},"labels":[],"label_agreement":null},{"id":"W2484399975","doi":"10.1158/1538-7445.am2016-3440","title":"Abstract 3440: Time and regional incidence trends of human papillomavirus-associated oropharyngeal cancer in Ontario, Canada","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Queen's University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Incidence (geometry); Medicine; Human papillomavirus; Cohort; Cancer registry; Internal medicine; Retrospective cohort study; Cancer; Immunohistochemistry; Oncology","score_opus":0.09032333503848763,"score_gpt":0.4000908498621654,"score_spread":0.3097675148236778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484399975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888873,0.0027972134,2.6002091e-8,0.003905588,0.00006390706,0.00015304357,0.00009167485,0.00000884438,0.004092367],"genre_scores_gemma":[0.98527026,0.0013486581,0.0000023806804,0.00014716266,0.00008321571,0.00010690882,0.0000064489786,0.000018930976,0.0130160535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979326,0.000069101756,0.00030984753,0.00034364738,0.000807,0.0005378108],"domain_scores_gemma":[0.9990481,0.00019686829,0.00007328586,0.0002041141,0.00027388424,0.00020374256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004988424,0.00013985737,0.0004921878,0.000213159,0.0001279208,0.000006797007,0.00013098697,0.000083051804,0.00352227],"category_scores_gemma":[0.00007963209,0.000098150966,0.000036400386,0.000388277,0.0003193121,0.000084368585,0.00009379562,0.00040683395,0.000003527126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006224285,0.00012097203,0.55675924,0.00010852269,0.00016001026,0.00021083829,0.001041871,0.0000010512907,0.35554302,0.000045119872,0.052890375,0.032496564],"study_design_scores_gemma":[0.0019120134,0.00022456115,0.98643947,0.0012325114,0.000012933217,0.0000024060305,0.000054766642,0.0000015860898,0.00611186,0.0000320789,0.0038557998,0.00012003311],"about_ca_topic_score_codex":0.99182427,"about_ca_topic_score_gemma":0.9989131,"teacher_disagreement_score":0.42968023,"about_ca_system_score_codex":0.0029509647,"about_ca_system_score_gemma":0.0040593143,"threshold_uncertainty_score":0.99738866},"labels":[],"label_agreement":null},{"id":"W2484610442","doi":"10.1158/1538-7445.am2016-271","title":"Abstract 271: Influence of autophagy modulation on synergistic interactions of lapatinib and mTOR targeted agents in HER2-amplified lapatinib resistant breast cancer models in vitro and in vivo","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; Centre for Drug Research and Development; BC Cancer Agency","funders":"","keywords":"Lapatinib; Autophagy; mTORC1; In vivo; PI3K/AKT/mTOR pathway; Pharmacology; Cancer research; Breast cancer; Cancer; Medicine; Chemistry; Signal transduction; Biology; Apoptosis; Internal medicine; Trastuzumab; Biochemistry","score_opus":0.073837779111058,"score_gpt":0.40294037148538847,"score_spread":0.3291025923743305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484610442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977108,0.000525022,0.0000389651,0.00059600134,0.000042114963,0.00059697765,0.00039757587,0.000010507688,0.00008202616],"genre_scores_gemma":[0.99878526,0.00056133687,0.00012048959,0.000035315028,0.000036010442,0.00033199374,0.000004513114,0.000029669705,0.000095434465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980388,0.0001317222,0.0005524475,0.00041649793,0.00047989894,0.00038060782],"domain_scores_gemma":[0.9987736,0.00036895383,0.00016084148,0.00027969756,0.00030364376,0.00011327223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046767856,0.00016314162,0.00043146804,0.0006546564,0.00003176203,0.000008301353,0.000106183405,0.00008756166,0.00016145063],"category_scores_gemma":[0.00019684972,0.00013058605,0.000024868747,0.0005790373,0.0003109913,0.0002736081,0.000060781105,0.00034178325,7.067023e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008369692,0.00019859208,0.01944904,0.0003581914,0.000028574541,0.000020719432,0.0010421247,0.009435169,0.94070673,0.00010736482,0.000008774494,0.02027502],"study_design_scores_gemma":[0.003858493,0.000111635534,0.8796274,0.0032187377,0.0000064742235,0.0000033660974,0.0002022782,0.002366828,0.109305345,0.001125185,0.000036602025,0.00013764156],"about_ca_topic_score_codex":0.011511523,"about_ca_topic_score_gemma":0.004717308,"teacher_disagreement_score":0.86017835,"about_ca_system_score_codex":0.00069542095,"about_ca_system_score_gemma":0.00032071347,"threshold_uncertainty_score":0.99507093},"labels":[],"label_agreement":null},{"id":"W2484855820","doi":"10.1158/1538-7445.am2016-3479","title":"Abstract 3479: Parental coping to retinoblastoma at the onset of diagnosis: A global study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Retinoblastoma; Coping (psychology); Hospital Anxiety and Depression Scale; Fatalism; Anxiety; Clinical psychology; Medicine; Psychology; Psychiatry","score_opus":0.08963412297275782,"score_gpt":0.47305999916826447,"score_spread":0.38342587619550667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484855820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902824,0.0006244526,7.213118e-7,0.0068831616,0.00009527655,0.00107743,0.00009280208,0.0000122689435,0.00093148433],"genre_scores_gemma":[0.9979375,0.00010506151,0.0000066731304,0.00015353372,0.000072811126,0.00066886604,0.0000023177565,0.000008718272,0.0010445173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986509,0.0001470424,0.00015388108,0.00024078348,0.00048773747,0.00031966754],"domain_scores_gemma":[0.9990561,0.0002815339,0.000031268297,0.00034077646,0.00015005088,0.00014026283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005129149,0.000080125734,0.00017788295,0.00004600578,0.00014806859,0.0000057719903,0.00013999883,0.000050357587,0.0014087176],"category_scores_gemma":[0.00021029185,0.000040383726,0.000049958646,0.00024427145,0.00020893884,0.000025381314,0.0001825102,0.000119043914,0.00039182504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010415459,0.0005588409,0.9600238,0.000024630424,0.00018989439,0.0002158256,0.0002804777,4.293821e-7,0.0011788993,0.000008632135,0.02568812,0.010788903],"study_design_scores_gemma":[0.0023843825,0.0016573848,0.9757489,0.00033022757,0.000042439813,0.000017801516,0.00047170778,1.1759223e-7,0.0117239235,0.000028128408,0.0075455545,0.00004944756],"about_ca_topic_score_codex":0.0005360082,"about_ca_topic_score_gemma":0.00282001,"teacher_disagreement_score":0.018142564,"about_ca_system_score_codex":0.00073287135,"about_ca_system_score_gemma":0.00025249773,"threshold_uncertainty_score":0.99950415},"labels":[],"label_agreement":null},{"id":"W2485015016","doi":"10.1158/1538-7445.am2016-5031","title":"Abstract 5031: Melanoma progression involves a profound nuclear to cytoplasmic shift of the transcription factor SUM-6 (specifically upregulated in melanoma gene six)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Melanoma; Immunohistochemistry; Tissue microarray; Carcinogenesis; Pathology; Metastasis; Medicine; Transcription factor; Cancer research; Biology; Cancer; Gene; Internal medicine; Genetics","score_opus":0.05511329692753349,"score_gpt":0.34022616639567804,"score_spread":0.28511286946814457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485015016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592453,0.0010544469,0.000017860031,0.0014769293,0.00010942093,0.000992118,0.00011774625,0.0000119172355,0.00029502745],"genre_scores_gemma":[0.9988202,0.0002788151,0.00009083402,0.000064424334,0.00014365603,0.00017142693,0.000010690861,0.00003607545,0.00038386788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981918,0.00022142334,0.00028834338,0.0003941332,0.000442524,0.00046179598],"domain_scores_gemma":[0.9991458,0.000031649182,0.000066580054,0.0004600347,0.00016387069,0.00013206256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046974164,0.00015265809,0.00017087368,0.00010643833,0.00010499991,0.00003215985,0.00048680662,0.00021593277,0.0003344418],"category_scores_gemma":[0.000097895965,0.00009209131,0.00008814816,0.0002723073,0.00021667907,0.000011333808,0.00015719641,0.00021101932,0.000026782862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006798383,0.000079851,0.005837707,0.00006134118,0.000021660124,0.0000032835444,0.00037942486,0.00000252655,0.9825815,0.00007466383,0.00054004416,0.009738156],"study_design_scores_gemma":[0.00064603915,0.00033689817,0.095672995,0.00025136094,0.0000024385272,0.0000021935539,0.000045748286,0.0000019342854,0.89007056,0.00008953785,0.012750771,0.00012952992],"about_ca_topic_score_codex":0.0000904625,"about_ca_topic_score_gemma":0.0003260422,"teacher_disagreement_score":0.09251095,"about_ca_system_score_codex":0.00010466401,"about_ca_system_score_gemma":0.00023906383,"threshold_uncertainty_score":0.37553746},"labels":[],"label_agreement":null},{"id":"W2485024460","doi":"10.1158/1538-7445.am2016-4134","title":"Abstract 4134: Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunohistochemistry; Immune system; Tumor microenvironment; Medicine; Osteosarcoma; PD-L1; Immune checkpoint; Immunotherapy; Cancer research; CD68; Tumor-infiltrating lymphocytes; Antigen; Infiltration (HVAC); Antibody; Oncology; Internal medicine; Immunology","score_opus":0.05030626678690519,"score_gpt":0.35589875473078914,"score_spread":0.30559248794388394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485024460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526216,0.0068592858,0.0000024719573,0.0067109484,0.00004183758,0.0009295725,0.000010370451,0.0000069239086,0.00017643675],"genre_scores_gemma":[0.9967342,0.0024093853,0.000017333894,0.00017330553,0.000074525364,0.00039925787,0.000004124252,0.0000136668405,0.00017420771],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998574,0.00015583866,0.00025044172,0.00025229258,0.00042442748,0.00034300334],"domain_scores_gemma":[0.99933773,0.00025822883,0.0000518726,0.00027270446,0.000030519925,0.00004894752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010744447,0.000099534074,0.00015338487,0.00017234718,0.00007126855,0.000029147524,0.0001327584,0.000053476855,0.00027276692],"category_scores_gemma":[0.00009657824,0.000053368043,0.000030986,0.00024401705,0.0002323153,0.00009956695,0.000046511763,0.0002917234,0.000013037916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569667,0.00011312039,0.13318507,0.000086584834,0.0000073847013,0.00007267284,0.0005698165,3.5335876e-7,0.84046257,0.000002859707,0.0004199368,0.023522694],"study_design_scores_gemma":[0.002417576,0.00017135889,0.8716897,0.0014080364,0.000002989216,0.000018796723,0.00073489355,0.0000018574028,0.11994209,0.00003815587,0.0035059785,0.00006855818],"about_ca_topic_score_codex":0.0005035012,"about_ca_topic_score_gemma":0.00043963164,"teacher_disagreement_score":0.73850465,"about_ca_system_score_codex":0.00031564696,"about_ca_system_score_gemma":0.000115896786,"threshold_uncertainty_score":0.29866064},"labels":[],"label_agreement":null},{"id":"W2485032021","doi":"10.1158/1538-7445.am2016-3461","title":"Abstract 3461: Smoking cessation following a limited 5A intervention in a cohort of patients with head and neck cancer attending for treatment at a regional cancer program in Ontario, Canada","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Medicine; Smoking cessation; Cancer; Cohort; Head and neck cancer; Intervention (counseling); Cohort study; Nicotine; Nicotine replacement therapy; Internal medicine; Physical therapy; Psychiatry","score_opus":0.09950375084328782,"score_gpt":0.41032131591302473,"score_spread":0.3108175650697369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485032021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945725,0.001632857,0.0000013483423,0.0015127274,0.000104952574,0.0020441716,0.00006125479,0.000008981832,0.00006119606],"genre_scores_gemma":[0.9941466,0.000577117,0.00003167909,0.000032255855,0.000043968157,0.0046517467,0.000030976535,0.00002318047,0.00046250704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982038,0.00004084182,0.0003309284,0.00038964328,0.00055391784,0.0004808814],"domain_scores_gemma":[0.9992822,0.00014249806,0.00009496554,0.00012891734,0.0002441645,0.00010727553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029816065,0.00015298948,0.00042101182,0.00023432636,0.00009823008,0.000010782585,0.000052918946,0.000060034035,0.00009991899],"category_scores_gemma":[0.00004130511,0.000101197824,0.000056118177,0.0003012753,0.00007581702,0.000109048175,0.000039833834,0.00013104286,7.8813905e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019794933,0.00021303445,0.93886876,0.00021970957,0.00020048177,0.0000140897,0.00078881334,0.00000789648,0.00051720074,0.0000024651536,0.0003737603,0.056814298],"study_design_scores_gemma":[0.009554391,0.0007834863,0.9797745,0.00523421,0.00004306522,3.7356105e-7,0.00013380364,0.000017110668,0.00072950445,0.0000055227656,0.0036106782,0.00011336016],"about_ca_topic_score_codex":0.97542846,"about_ca_topic_score_gemma":0.9989663,"teacher_disagreement_score":0.056700937,"about_ca_system_score_codex":0.010086681,"about_ca_system_score_gemma":0.0017224035,"threshold_uncertainty_score":0.99371344},"labels":[],"label_agreement":null},{"id":"W2485051841","doi":"10.1158/1538-7445.am2016-3251","title":"Abstract 3251: A Senescence-like phenotype associates with rapid metastasis promotion following antiangiogenic drug resistance and therapy withdrawal","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Axitinib; Cancer research; Metastasis; Stromal cell; Melanoma; Sunitinib; In vivo; Cancer; Drug resistance; Angiogenesis; Primary tumor; Internal medicine; Biology","score_opus":0.033520718131920056,"score_gpt":0.3415427901668722,"score_spread":0.3080220720349522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485051841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736275,0.020461557,0.000036467256,0.0011911773,0.000056005345,0.0005091297,0.000070566864,0.000016630449,0.0002957085],"genre_scores_gemma":[0.9859629,0.010975875,0.00012661236,0.000028405439,0.00014956777,0.0002617109,0.000029267476,0.000041009145,0.002424619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783796,0.00017214913,0.00014201853,0.000587892,0.00060529384,0.0006546936],"domain_scores_gemma":[0.99910635,0.000050794308,0.000055936718,0.00035560713,0.00023764206,0.0001936979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064295053,0.00018438998,0.00018590137,0.000101579935,0.00027778256,0.00008424829,0.00021064648,0.00007814135,0.00009711814],"category_scores_gemma":[0.000053886688,0.000115768686,0.00009299195,0.0002845668,0.00021788207,0.00002396977,0.00009115641,0.00013228098,0.000011782812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015432012,0.00015023937,0.022684282,0.00004366515,0.0007462442,0.00005082019,0.00012879065,4.313485e-7,0.91295135,0.000011725553,0.0041027097,0.057586562],"study_design_scores_gemma":[0.005842133,0.00085198175,0.032349575,0.0003949325,0.000042098567,0.00000646143,0.00013884461,8.8605555e-7,0.92418575,0.00022115244,0.035484012,0.00048219782],"about_ca_topic_score_codex":0.00047031182,"about_ca_topic_score_gemma":0.002913139,"teacher_disagreement_score":0.057104364,"about_ca_system_score_codex":0.00012425265,"about_ca_system_score_gemma":0.00041458223,"threshold_uncertainty_score":0.472091},"labels":[],"label_agreement":null},{"id":"W2485198054","doi":"10.1158/1538-7445.am2016-lb-179","title":"Abstract LB-179: Integrated (epi)genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Princess Margaret Cancer Centre; Concordia University; McGill University; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre; University Health Network; University of Toronto","funders":"","keywords":"Epigenetics; Biology; Atypical teratoid rhabdoid tumor; DNA methylation; Epigenomics; SMARCB1; Genetics; Gene expression profiling; Genome; Comparative genomic hybridization; Gene; Cancer research; Bioinformatics; Gene expression","score_opus":0.11994697551658792,"score_gpt":0.43723333921635776,"score_spread":0.3172863636997698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485198054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97983193,0.018228639,0.00043457403,0.0003710408,0.00017209415,0.00025241837,0.000057353333,0.000020446212,0.0006314883],"genre_scores_gemma":[0.99147826,0.0066508213,0.000047334954,0.0000699642,0.00032668858,0.00014104582,0.000049699098,0.000049896975,0.0011863096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775887,0.00017795971,0.00036069864,0.0006362241,0.0003907217,0.0006755086],"domain_scores_gemma":[0.99890834,0.00005812831,0.000070759364,0.0005562707,0.00026723597,0.00013924629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007916899,0.00020841314,0.00024937707,0.00022228666,0.000121918485,0.00006762622,0.00048785086,0.00017236933,0.00074578554],"category_scores_gemma":[0.00006795715,0.00014827764,0.0001244918,0.0003860489,0.00024896284,0.000011087887,0.00013153336,0.00031516235,0.00010279605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018176448,0.000051817457,0.0024610711,0.000026112983,0.000056890196,0.000012794415,0.00007357523,0.000117496646,0.9715825,0.00001637239,0.002968649,0.02245098],"study_design_scores_gemma":[0.0012503694,0.00014833602,0.046327773,0.00024920516,0.000009309602,0.0000070224205,0.00031552443,0.00006375818,0.9180107,0.000492486,0.03272935,0.00039616518],"about_ca_topic_score_codex":0.0008537393,"about_ca_topic_score_gemma":0.0009128519,"teacher_disagreement_score":0.05357178,"about_ca_system_score_codex":0.00031212892,"about_ca_system_score_gemma":0.0004440359,"threshold_uncertainty_score":0.81658286},"labels":[],"label_agreement":null},{"id":"W2485297274","doi":"10.1158/1538-7445.am2016-846","title":"Abstract 846: Improving T-cell receptor clonotyping of T-cell lymphomas using hybrid-Capture and next-generation sequencing","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network; Calgary Laboratory Services","funders":"","keywords":"T-cell receptor; Biology; Sanger sequencing; T cell; Molecular biology; DNA sequencing; Gene rearrangement; Computational biology; Genetics; Gene","score_opus":0.1702651020974911,"score_gpt":0.37797427230038,"score_spread":0.2077091702028889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485297274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928238,0.0034845783,0.00022265584,0.00054429664,0.00016960445,0.0007400897,0.000033494474,0.000032517986,0.0019489952],"genre_scores_gemma":[0.99223715,0.001641193,0.00079464965,0.00006462491,0.0007622065,0.000050824645,0.000011045344,0.000078254765,0.0043600425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710727,0.00016268849,0.00039941815,0.00058880367,0.0009645908,0.00077721],"domain_scores_gemma":[0.9980743,0.00030909837,0.00012094003,0.0005103059,0.00065919553,0.00032618042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001738792,0.00020163324,0.00035886664,0.0004281122,0.00022557439,0.0000869542,0.00020033373,0.00015364587,0.002444728],"category_scores_gemma":[0.00022349013,0.00015346853,0.00009298107,0.00040412042,0.0003301872,0.00029974952,0.00016074686,0.000493919,0.000026798723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034788743,0.00004625761,0.0010374786,0.00051246036,0.000027702397,0.00002552683,0.00039581282,0.000008494758,0.9486371,0.000010939721,0.0004839158,0.04846641],"study_design_scores_gemma":[0.0020929466,0.00016045728,0.00024526002,0.00043435907,0.000018561244,0.000022497123,0.0003407623,0.001267085,0.9926419,0.000020507277,0.0025818776,0.00017373207],"about_ca_topic_score_codex":0.00339863,"about_ca_topic_score_gemma":0.00007168616,"teacher_disagreement_score":0.048292678,"about_ca_system_score_codex":0.0016212001,"about_ca_system_score_gemma":0.0016820247,"threshold_uncertainty_score":0.99846715},"labels":[],"label_agreement":null},{"id":"W2485401423","doi":"10.1158/1538-7445.am2016-935","title":"Abstract 935: Oral cancer cells may hijack stem cell altruism to survive during extreme hypoxia, and exposure to chemotherapeutic drugs","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Homeobox protein NANOG; Cancer cell; Stem cell; Cancer stem cell; Biology; Reprogramming; Cancer research; Population; Hypoxia (environmental); Embryonic stem cell; Apoptosis; Cancer; Cell biology; Immunology; Cell; Induced pluripotent stem cell; Medicine; Genetics; Chemistry; Gene","score_opus":0.051837298472486706,"score_gpt":0.3349859084418059,"score_spread":0.28314860996931923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485401423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854316,0.010408036,0.000032246597,0.0015783426,0.00096688024,0.00071163196,0.00020020877,0.000020658623,0.00065038004],"genre_scores_gemma":[0.96551204,0.00923263,0.000084332874,0.00050004607,0.0019300638,0.0004159292,0.000004914241,0.000088035296,0.022231996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971305,0.00012733127,0.00028390266,0.0009161524,0.00054338865,0.0009987124],"domain_scores_gemma":[0.99832696,0.000047912203,0.00006174073,0.00064794003,0.00034029532,0.0005751532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005917284,0.00029697377,0.00032222868,0.00017584916,0.00019303986,0.000078797646,0.0004391669,0.00021144227,0.0003837074],"category_scores_gemma":[0.000016858961,0.00023955698,0.00009333123,0.00029768646,0.00015110317,0.000015440939,0.0003178224,0.00023233758,0.00009151081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040233237,0.00003781399,0.0004445716,0.000094749084,0.000051632782,0.0000019641077,0.0004680246,0.00001971648,0.9256662,0.000005456209,0.007832,0.064975515],"study_design_scores_gemma":[0.0011218992,0.00015070791,0.00787861,0.00009200597,0.0000124439075,0.0000018754372,0.00022718213,4.2485456e-7,0.78547424,0.000011627021,0.20470797,0.00032100952],"about_ca_topic_score_codex":0.0012972135,"about_ca_topic_score_gemma":0.0011335445,"teacher_disagreement_score":0.19687597,"about_ca_system_score_codex":0.00018584549,"about_ca_system_score_gemma":0.0004169571,"threshold_uncertainty_score":0.97688496},"labels":[],"label_agreement":null},{"id":"W2485585585","doi":"10.1158/1538-7445.am2016-lb-205","title":"Abstract LB-205: Combination of DNA methyltransferase and PARP inhibitors as a novel therapy strategy for poor prognosis acute myeloid leukemia and triple-negative breast cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Decitabine; PARP1; Azacitidine; PARP inhibitor; Cancer research; Triple-negative breast cancer; Poly ADP ribose polymerase; Olaparib; Breast cancer; Cancer; DNMT1; Myeloid leukemia; DNA damage; Biology; Chemistry; Methyltransferase; Polymerase; Medicine; DNA methylation; DNA; Internal medicine; Genetics; Methylation","score_opus":0.09049719143922759,"score_gpt":0.4124340506577376,"score_spread":0.32193685921851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485585585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802894,0.0017854942,0.0001956358,0.005620244,0.00013101318,0.0028219519,0.0010516044,0.000039021637,0.00032607125],"genre_scores_gemma":[0.9857832,0.0113069005,0.00016213741,0.00018435738,0.00022480838,0.0018523337,0.000021564021,0.000059542166,0.0004051661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997568,0.00010552958,0.00044987482,0.0005910888,0.00073007954,0.0005554053],"domain_scores_gemma":[0.99771225,0.000666945,0.00013728447,0.00022179174,0.00094377727,0.00031794724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009786362,0.00025789114,0.000485882,0.00035983013,0.00018897004,0.0000452983,0.00012757053,0.00018297635,0.00026971102],"category_scores_gemma":[0.000100605255,0.00018546502,0.00009876919,0.00047860228,0.0008397139,0.00030216223,0.000026117477,0.00032264393,0.0000022430186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063554565,0.00014536557,0.0014197156,0.00022499324,0.00048363977,0.0000061369315,0.0007733293,0.0000023970108,0.8750194,0.00050193415,0.0014203032,0.11364737],"study_design_scores_gemma":[0.02233958,0.0019320926,0.020660913,0.0009370624,0.00007245368,0.000039501425,0.00052041054,0.000031699892,0.95022494,0.001640344,0.0013371599,0.00026382064],"about_ca_topic_score_codex":0.003029651,"about_ca_topic_score_gemma":0.0002679307,"teacher_disagreement_score":0.113383554,"about_ca_system_score_codex":0.0011723838,"about_ca_system_score_gemma":0.0019179665,"threshold_uncertainty_score":0.75630444},"labels":[],"label_agreement":null},{"id":"W2485638379","doi":"10.1158/1538-7445.am2016-5230","title":"Abstract 5230: Large scale whole genome sequencing with imputation into GWAS improves our understanding of the genetic architecture of colorectal cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital","funders":"","keywords":"Genome-wide association study; Imputation (statistics); Genetic architecture; Locus (genetics); Colorectal cancer; Genetics; 1000 Genomes Project; Biology; Allele; Cancer; Single-nucleotide polymorphism; Quantitative trait locus; Gene; Genotype; Missing data; Computer science","score_opus":0.055619323206598056,"score_gpt":0.3585167391066561,"score_spread":0.30289741590005803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485638379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394375,0.0013882407,0.0006162811,0.0030007202,0.00008031842,0.0006736406,0.000100700956,0.000012726429,0.00018363773],"genre_scores_gemma":[0.99883395,0.0003155454,0.0002571303,0.000043939926,0.00014529658,0.00020688008,0.0000027298859,0.000035475343,0.00015906099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981331,0.000078115896,0.0002679391,0.0003109399,0.0007643104,0.00044554757],"domain_scores_gemma":[0.9990331,0.00006886119,0.00014299437,0.00026706737,0.00037188194,0.000116124815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046341735,0.00013408388,0.00027977108,0.00015858332,0.00015983668,0.000016453747,0.00020745066,0.00008646363,0.00011843006],"category_scores_gemma":[0.0000449451,0.00006912467,0.00008843614,0.000526546,0.00027548394,0.00006517771,0.00009823365,0.00030212358,0.0000020611596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049654377,0.00004330515,0.03805125,0.00048428425,0.00010633635,0.0000027711903,0.0024560124,0.00026415262,0.95089406,0.000023948713,0.00011922397,0.0070580947],"study_design_scores_gemma":[0.00276979,0.0008579497,0.3625523,0.0019509544,0.000096746495,0.0000100295365,0.006712036,0.00010322041,0.62364334,0.00066304253,0.00042755975,0.00021305711],"about_ca_topic_score_codex":0.0015619661,"about_ca_topic_score_gemma":0.002940728,"teacher_disagreement_score":0.32725075,"about_ca_system_score_codex":0.0012397585,"about_ca_system_score_gemma":0.0012252183,"threshold_uncertainty_score":0.32419252},"labels":[],"label_agreement":null},{"id":"W2485781850","doi":"10.1158/1538-7445.am2016-2010","title":"Abstract 2010: Charactering the interactomes of the Myc family of oncogenes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Chromatin; Interactome; Transcription factor; Biology; Computational biology; Protein–protein interaction; Transcription (linguistics); Genetics; Cell biology; Cancer research; DNA; Gene","score_opus":0.06650298312443632,"score_gpt":0.38093169897425894,"score_spread":0.3144287158498226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485781850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130255,0.005193313,0.0000030214287,0.0018397336,0.000271104,0.000112568734,0.000028452096,0.0000016345333,0.0012476039],"genre_scores_gemma":[0.9901307,0.0075593633,0.000003515529,0.000033850567,0.00012867768,0.00001617875,7.8175856e-7,0.000007897407,0.002119003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932706,0.000061245366,0.00013418312,0.00012696728,0.00018032946,0.00017021631],"domain_scores_gemma":[0.9993854,0.000055317552,0.000060790342,0.00029450734,0.00018409238,0.000019892688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032468885,0.000058352663,0.000084404455,0.000022607708,0.000082045546,0.0000048495417,0.0003316979,0.00007617074,0.000039972954],"category_scores_gemma":[0.000085385676,0.000022723896,0.00007104904,0.00008919459,0.00042066196,0.0000019843367,0.0002676394,0.00012547786,0.0000042245515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046492674,0.000014199837,0.0037492616,0.00002533547,0.000072604846,2.2298703e-7,0.000086396256,5.631931e-7,0.98057777,0.00001564563,0.0028345091,0.012577026],"study_design_scores_gemma":[0.00013449739,0.000038891958,0.13750558,0.00011432894,0.0000035464661,6.775089e-7,0.00013126594,2.0240807e-7,0.83982927,0.000015458347,0.02219269,0.000033616052],"about_ca_topic_score_codex":0.00013508143,"about_ca_topic_score_gemma":0.000041073552,"teacher_disagreement_score":0.14074849,"about_ca_system_score_codex":0.0000126594,"about_ca_system_score_gemma":0.00008934109,"threshold_uncertainty_score":0.15499465},"labels":[],"label_agreement":null},{"id":"W2485992576","doi":"10.1158/1538-7445.am2016-541","title":"Abstract 541: Successful oncolytic virotherapy in a bortezomib resistant syngeneic mouse model of multiple myeloma: Implications for translational significance","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; In vivo; Carfilzomib; Oncolytic virus; Dexamethasone; Bone marrow; Cancer research; Immune system; Immunology; Pharmacology; Internal medicine; Biology","score_opus":0.08325885885024112,"score_gpt":0.40549006894257145,"score_spread":0.32223121009233036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485992576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011564,0.0012835541,0.0037638647,0.002166117,0.000016453514,0.0013432689,0.0011868154,0.000009275354,0.000115030445],"genre_scores_gemma":[0.995062,0.0015223323,0.00034772282,0.000044554083,0.000119509,0.002024634,0.0000430847,0.000057007164,0.0007791721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980026,0.00012610521,0.00038071198,0.00055927545,0.00034315675,0.00058817206],"domain_scores_gemma":[0.99845016,0.00024642824,0.00007563828,0.0005973063,0.00049427914,0.00013620408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010574886,0.00015596107,0.00021225539,0.0002167582,0.00012268787,0.0000194748,0.0005276721,0.00015826129,0.000055855577],"category_scores_gemma":[0.00014058006,0.00012798616,0.00011088219,0.00028476372,0.0003201362,0.000013528984,0.000042169457,0.00015442814,0.000003696206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006430063,0.00016562367,0.0024956078,0.00006327407,0.000050667495,3.435116e-7,0.000053689924,0.0014379221,0.9719942,0.00017839392,0.0003076744,0.016822493],"study_design_scores_gemma":[0.0026647837,0.0007448967,0.0049504135,0.00005057425,0.0000035458718,2.4011064e-7,0.000023418983,0.0007655016,0.9885465,0.0010058302,0.0010589827,0.00018533856],"about_ca_topic_score_codex":0.00018398477,"about_ca_topic_score_gemma":0.0047218474,"teacher_disagreement_score":0.016637154,"about_ca_system_score_codex":0.00017097381,"about_ca_system_score_gemma":0.0013428961,"threshold_uncertainty_score":0.5219124},"labels":[],"label_agreement":null},{"id":"W2485994046","doi":"10.1158/1538-7445.am2016-4177","title":"Abstract 4177: Dynamic visualization of cancer cell engraftment into immune compromised zebrafish","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Immune system; Cancer research; T cell; Recombination-activating gene; Transplantation; Cell biology; Cell; Immunology; Gene; Genetics; Medicine","score_opus":0.024656799709476956,"score_gpt":0.4074223064780161,"score_spread":0.38276550676853915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485994046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945445,0.005386728,0.0011072119,0.00192326,0.00007968439,0.00080503535,0.00014331967,0.000018010312,0.0010823262],"genre_scores_gemma":[0.9898244,0.0074540265,0.00010669956,0.00004819698,0.0001313269,0.0009281743,0.00010215144,0.000038478585,0.0013665581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779433,0.0001277837,0.00033267905,0.00047209216,0.0007481735,0.0005249406],"domain_scores_gemma":[0.99836665,0.00009030748,0.00009543849,0.00056687865,0.00063364743,0.0002470633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073103624,0.00013660679,0.00017440003,0.000105008214,0.00013730726,0.00002404302,0.0005525507,0.00016298861,0.0010378043],"category_scores_gemma":[0.00020867877,0.00010227093,0.00008238461,0.00033533745,0.000518851,0.000010239975,0.00029373445,0.00014240893,0.00003737317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001399648,0.00016865318,0.00033511536,0.00010521068,0.000050861174,9.282226e-7,0.00003843378,0.0000035737187,0.9740357,0.00009107754,0.0035940495,0.021436475],"study_design_scores_gemma":[0.0011167382,0.00018439052,0.008734107,0.000098825556,0.0000057763173,2.2978833e-7,0.000050572417,0.000033665005,0.9546396,0.00020590534,0.034795497,0.00013467434],"about_ca_topic_score_codex":0.0019481637,"about_ca_topic_score_gemma":0.0012442048,"teacher_disagreement_score":0.031201446,"about_ca_system_score_codex":0.00032383847,"about_ca_system_score_gemma":0.000667756,"threshold_uncertainty_score":0.99987537},"labels":[],"label_agreement":null},{"id":"W2486011716","doi":"10.1158/1538-7445.am2016-686","title":"Abstract 686: MNK1 promotes the progression of breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ductal carcinoma; Cancer research; In situ; Biology; Pathology; Medicine; Breast cancer; Cancer; Internal medicine; Chemistry","score_opus":0.032557358045713275,"score_gpt":0.3563394406453444,"score_spread":0.32378208259963115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486011716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992408,0.0018196567,0.00006660756,0.002992295,0.00014731473,0.0014782365,0.00012799366,0.000010262322,0.00094964885],"genre_scores_gemma":[0.99801594,0.0003134221,0.00005670572,0.000047298035,0.00040114456,0.00059539545,0.000027341255,0.00006857336,0.0004741527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99632865,0.00033650163,0.00039325593,0.00084259827,0.0010771098,0.0010218638],"domain_scores_gemma":[0.9978461,0.000108003864,0.00009363405,0.00092093734,0.00073441194,0.00029688567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011807397,0.00025953265,0.00026958794,0.00032305642,0.0001688376,0.00005121773,0.00092735875,0.00027165402,0.00019841113],"category_scores_gemma":[0.0004986576,0.00016825742,0.00013323959,0.00071596034,0.00047179172,0.000017597764,0.00084393437,0.0005097001,0.000046600628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008147816,0.00011675089,0.003315619,0.00009432274,0.000043883487,0.00011773029,0.00025313368,0.000013271563,0.98178667,0.000072274684,0.0017985335,0.011573035],"study_design_scores_gemma":[0.0010500967,0.00061939127,0.050854567,0.0002593273,0.000006396036,0.00008582467,0.00021474465,0.000003901149,0.94553334,0.000080492224,0.0010687055,0.00022321951],"about_ca_topic_score_codex":0.00096679205,"about_ca_topic_score_gemma":0.002694571,"teacher_disagreement_score":0.04753895,"about_ca_system_score_codex":0.0002450696,"about_ca_system_score_gemma":0.0014551945,"threshold_uncertainty_score":0.68613386},"labels":[],"label_agreement":null},{"id":"W2486450281","doi":"10.1158/1538-7445.am2016-698","title":"Abstract 698: Progranulin targeting in urothelial cancer cells inhibits motility, tumor growth <i>in vitro</i> and <i>in vivo</i> and sensitizes cells to cisplatin","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer research; Cancer; Cisplatin; Motility; Medicine; In vivo; Cancer cell; Cell growth; Tumor progression; Urothelial Cell; Tissue microarray; Biology; Internal medicine; Chemotherapy; Cell biology","score_opus":0.018231536559135612,"score_gpt":0.3062278980408381,"score_spread":0.2879963614817025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486450281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955416,0.002108203,0.000010819491,0.0011816503,0.00008504184,0.0006814295,0.00029087093,0.000006700429,0.000093719944],"genre_scores_gemma":[0.99689835,0.0022002906,0.00011157652,0.0002549728,0.00015796137,0.00019762719,0.000005009214,0.00003425086,0.00013992852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793786,0.00013122418,0.00032965475,0.0006458536,0.00026072364,0.0006946986],"domain_scores_gemma":[0.99942654,0.000090482004,0.000029352046,0.00016041624,0.00009304541,0.0002001755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008490268,0.00020070531,0.0002505475,0.00018213155,0.00006066488,0.000044222594,0.00013222975,0.0001255843,0.000048725215],"category_scores_gemma":[0.00004722222,0.0001641729,0.000036390345,0.00027034243,0.00017601144,0.000013232396,0.00013061956,0.0002636607,0.000005227876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081132783,0.000059043996,0.0055185067,0.00010447578,0.000005806642,0.000050827275,0.00018929936,0.000025557329,0.9900305,0.0000038156513,0.00047808583,0.0027227367],"study_design_scores_gemma":[0.0016262234,0.00010548328,0.0034016615,0.00021527903,0.000002449792,0.0000029308667,0.000058049616,0.00001475242,0.99319637,0.00003832837,0.0011431377,0.00019532262],"about_ca_topic_score_codex":0.0035929452,"about_ca_topic_score_gemma":0.0031942176,"teacher_disagreement_score":0.0031658644,"about_ca_system_score_codex":0.00006768181,"about_ca_system_score_gemma":0.00018470008,"threshold_uncertainty_score":0.6694777},"labels":[],"label_agreement":null},{"id":"W2486582555","doi":"10.1158/1538-7445.am2016-3792","title":"Abstract 3792: PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment <i>in vivo</i>","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nitrogen and Sulfur Effects on Brassica","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; Izaak Walton Killam Health Centre","funders":"","keywords":"Cisplatin; In vivo; Transfection; Spheroid; Cancer research; Small hairpin RNA; Zebrafish; Gene silencing; Chemistry; A549 cell; Cell; Nude mouse; Cancer; Cell culture; Cell growth; Molecular biology; Biology; Apoptosis; In vitro; Chemotherapy; Medicine; Biochemistry; Internal medicine; Gene knockdown","score_opus":0.018218032400875578,"score_gpt":0.325342509048043,"score_spread":0.30712447664716747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486582555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223256,0.0032211656,0.00011193314,0.0017886979,0.00020078268,0.0011193882,0.00036074792,0.000020770942,0.0009439433],"genre_scores_gemma":[0.99122196,0.0028504499,0.000105817,0.0003026731,0.00037744772,0.0011021149,0.000028086277,0.000070709255,0.0039407196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973842,0.00014176361,0.00032580912,0.00083857146,0.0003820109,0.0009276618],"domain_scores_gemma":[0.9987049,0.00011910271,0.000068030924,0.0004851592,0.00024499762,0.00037782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984645,0.0003203105,0.00031098866,0.00017395115,0.00016466054,0.00006410978,0.00019376329,0.00022671887,0.00045518996],"category_scores_gemma":[0.00006953918,0.0002371649,0.00012858392,0.0003632518,0.00012748752,0.000012165061,0.00015746107,0.00019249671,0.00007511317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007071718,0.00018844602,0.0037448856,0.000074021526,0.000047302063,0.00013149694,0.000115107745,0.000038370523,0.9652909,0.000004655553,0.012164436,0.017493207],"study_design_scores_gemma":[0.002165969,0.00042145216,0.0024578779,0.00033523428,0.000016021422,0.0000038206795,0.00005306539,0.000018033887,0.9811184,0.000010853443,0.01306647,0.00033283682],"about_ca_topic_score_codex":0.0030920696,"about_ca_topic_score_gemma":0.0026229483,"teacher_disagreement_score":0.01716037,"about_ca_system_score_codex":0.00049417466,"about_ca_system_score_gemma":0.00055089826,"threshold_uncertainty_score":0.9671304},"labels":[],"label_agreement":null},{"id":"W2486627444","doi":"10.1158/1538-7445.am2016-3315","title":"Abstract 3315: Breast cancer stem cell induction by COX-2 via EP4/PI3K-AKT/NOTCH-WNT axis: EP4 as therapeutic target","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University","funders":"","keywords":"Wnt signaling pathway; Cancer research; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer; Biology; Medicine; Internal medicine; Cell biology; Signal transduction","score_opus":0.04102825325602349,"score_gpt":0.3658064774027611,"score_spread":0.3247782241467376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486627444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143536,0.007986023,0.000057637437,0.00592078,0.0010749912,0.0012147962,0.00016628041,0.0001115574,0.0020325726],"genre_scores_gemma":[0.98577803,0.0023132134,0.000008243926,0.0003918731,0.0017602454,0.00070885656,0.000017036176,0.000107249594,0.008915271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99605715,0.0002694397,0.00041385513,0.00068724924,0.0014025994,0.0011697018],"domain_scores_gemma":[0.99782246,0.00024239824,0.00013571777,0.00059484557,0.000596246,0.0006083008],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014171763,0.00033675373,0.00047702302,0.00028282552,0.0002877802,0.000053193464,0.00030380063,0.00032912326,0.0051457873],"category_scores_gemma":[0.000027784385,0.00022332057,0.00013785846,0.00048288645,0.00041789404,0.00026863252,0.000089043526,0.00091102044,0.0010455471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011317334,0.00021530727,0.0072956323,0.0004869391,0.00014789496,0.00011004287,0.0004422079,0.0000040078794,0.7920758,0.000058962465,0.035139058,0.1628924],"study_design_scores_gemma":[0.0043919315,0.00063279446,0.03052299,0.0010537324,0.000078851386,0.000075979086,0.00036981824,0.00003515448,0.84607387,0.00032243095,0.11587605,0.0005664264],"about_ca_topic_score_codex":0.0023057796,"about_ca_topic_score_gemma":0.00009009812,"teacher_disagreement_score":0.16232598,"about_ca_system_score_codex":0.0012627123,"about_ca_system_score_gemma":0.0011899468,"threshold_uncertainty_score":0.99973226},"labels":[],"label_agreement":null},{"id":"W2486710394","doi":"10.1158/1538-7445.am2016-lb-057","title":"Abstract LB-057: 1-Benzylquinazoline-2,4(1H,3H)-diones as potent PARP inhibitors. SAR of the quinazoline group and in vivo efficacy of clinical candidate IMP4297","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Olaparib; Medicine; In vivo; Cancer; PARP inhibitor; Poly ADP ribose polymerase; Cancer research; Pharmacology; Quinazoline; Polymerase; Internal medicine; Enzyme; Stereochemistry; Biology; Chemistry; Biochemistry; Genetics","score_opus":0.1029621464948994,"score_gpt":0.4736846207194734,"score_spread":0.37072247422457405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486710394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856324,0.0025424687,0.000005432974,0.0064098043,0.00055568427,0.0009884296,0.00015180744,0.00002158374,0.00076157664],"genre_scores_gemma":[0.991107,0.007110821,0.000038571834,0.00018909827,0.00080444687,0.00008664175,0.0000044529997,0.00004773602,0.00061122625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591565,0.00035678473,0.0013090677,0.00058768585,0.001192654,0.00063817005],"domain_scores_gemma":[0.9970816,0.0009491626,0.00035516694,0.00083015667,0.00047783038,0.00030612343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027319891,0.00023590135,0.00078174635,0.00032445078,0.000098020035,0.000013859553,0.00034862745,0.00024866874,0.00076726556],"category_scores_gemma":[0.00076806446,0.00013898112,0.00022337092,0.0006911432,0.0012451739,0.00012711446,0.00023478552,0.0007407794,0.000015681968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078079524,0.0010827875,0.17255965,0.0005436888,0.00018495272,0.000073158044,0.0005096514,0.000020625337,0.7765207,0.00047664877,0.012009039,0.028211132],"study_design_scores_gemma":[0.015352877,0.000944918,0.38724598,0.0033411284,0.00004515744,0.000038779057,0.00020467541,0.000012704,0.57151926,0.0006496801,0.020374727,0.00027011958],"about_ca_topic_score_codex":0.0030286692,"about_ca_topic_score_gemma":0.0008750502,"teacher_disagreement_score":0.21468633,"about_ca_system_score_codex":0.00032851752,"about_ca_system_score_gemma":0.000909872,"threshold_uncertainty_score":0.840102},"labels":[],"label_agreement":null},{"id":"W2486745630","doi":"10.1158/1538-7445.am2016-4064","title":"Abstract 4064: The identification of UBR5-ZNF423 recurrent fusion gene in EBV-associated nasopharyngeal carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Nasopharyngeal carcinoma; Fusion gene; Cancer research; Fusion protein; Fusion transcript; Ubiquitin ligase; Transcriptome; Gene; Genetics; Gene expression; Ubiquitin; Medicine; Internal medicine","score_opus":0.05956272931156551,"score_gpt":0.37585324178915214,"score_spread":0.3162905124775866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486745630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942314,0.00375345,0.000036882942,0.0011544399,0.00015275506,0.00029726615,0.000095129704,0.0000038906974,0.0002748065],"genre_scores_gemma":[0.9958353,0.002541128,0.0000049652535,0.000019482997,0.0001565275,0.0002353084,0.000046570145,0.000015223201,0.0011454966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985836,0.00015277335,0.00031827256,0.00031814494,0.0003375366,0.00028968466],"domain_scores_gemma":[0.99896073,0.000042176838,0.00011668915,0.000471338,0.00035715185,0.000051881078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011202142,0.00008508336,0.000101709426,0.00008541568,0.00011060512,0.000019079705,0.00035782106,0.00010654016,0.00010657862],"category_scores_gemma":[0.0001628288,0.000054126358,0.000055443474,0.00026982732,0.00017551212,0.0000069851194,0.000102228274,0.00013949093,0.000015635942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010979283,0.00006907389,0.005507357,0.000013778143,0.00001437405,8.89327e-7,0.00006479177,0.000009288193,0.9678138,0.00004653739,0.0028947364,0.02345557],"study_design_scores_gemma":[0.0005041981,0.000073040814,0.26816443,0.00004340277,0.0000037305444,5.3332525e-7,0.00005190652,0.000015649633,0.7263303,0.000100026904,0.004635251,0.00007754611],"about_ca_topic_score_codex":0.00041997194,"about_ca_topic_score_gemma":0.00044250253,"teacher_disagreement_score":0.26265708,"about_ca_system_score_codex":0.0001556527,"about_ca_system_score_gemma":0.00027783628,"threshold_uncertainty_score":0.22072089},"labels":[],"label_agreement":null},{"id":"W2486756721","doi":"10.1158/1538-7445.am2016-3364","title":"Abstract 3364: Adaptive mechanisms upon LRP1 repression: Impact on sphingosine-1-phosphate-mediated signalling and migration of brain endothelial cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"LRP1; Sphingosine-1-phosphate; Gene silencing; Cell biology; Psychological repression; MAPK/ERK pathway; Biology; Crosstalk; Receptor; Signal transduction; LDL receptor; Sphingosine; Biochemistry; Gene; Lipoprotein; Gene expression; Cholesterol","score_opus":0.050882377144596994,"score_gpt":0.3717328179384304,"score_spread":0.3208504407938334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486756721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948163,0.001169496,0.00048589424,0.0021060295,0.00018065405,0.00063033256,0.00015813822,0.00003310893,0.00042002794],"genre_scores_gemma":[0.9970203,0.0017899822,0.00010338049,0.000149454,0.00030112924,0.000058377536,0.000010141076,0.00003310987,0.00053412904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979786,0.00012270853,0.00028712282,0.00040774897,0.00076761894,0.00043619485],"domain_scores_gemma":[0.9982894,0.0007306332,0.00010853933,0.00029164625,0.00031089768,0.00026890333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001040434,0.00017144813,0.0003313238,0.00024240896,0.00009402727,0.000021298332,0.00011307704,0.00013085715,0.00075249455],"category_scores_gemma":[0.00041288065,0.00009935279,0.00009046514,0.00027036032,0.00013584254,0.00015514278,0.000051613548,0.00027634608,0.000037995535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029395581,0.0001004868,0.0002983364,0.00007199816,0.00004952547,0.00001453668,0.00037785617,0.00003731281,0.98355186,0.0003390106,0.0025775353,0.009642013],"study_design_scores_gemma":[0.003107277,0.0006830739,0.0064326585,0.0007331299,0.000022712387,0.00000211278,0.0002424468,0.00017987356,0.98629093,0.0007792752,0.0013913108,0.00013521392],"about_ca_topic_score_codex":0.0015172047,"about_ca_topic_score_gemma":0.000066257264,"teacher_disagreement_score":0.009506799,"about_ca_system_score_codex":0.00011630991,"about_ca_system_score_gemma":0.00037893758,"threshold_uncertainty_score":0.8239288},"labels":[],"label_agreement":null},{"id":"W2486911263","doi":"10.1158/1538-7445.am2016-974","title":"Abstract 974: Characterization of the novel lncRNA, PCAT14, clinically associated with metastatic prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; Prostate; Cancer; Medicine; Transcriptome; Oncology; Prostatectomy; Disease; Computational biology; Biology; Gene; Bioinformatics; Gene expression; Internal medicine; Genetics","score_opus":0.05107292934418749,"score_gpt":0.37975987020902496,"score_spread":0.32868694086483746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486911263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942385,0.00032895704,0.0016380032,0.0018706538,0.00017346577,0.0009850389,0.0005327652,0.000012175557,0.00022044982],"genre_scores_gemma":[0.99331194,0.001507318,0.000039830913,0.00012250291,0.00013182628,0.0005039856,0.000054563938,0.00006602303,0.0042619924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972035,0.00024814418,0.00039803892,0.00053917355,0.0009769176,0.0006341747],"domain_scores_gemma":[0.9977286,0.00009262567,0.00023816086,0.00065696606,0.0011365465,0.00014708677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013034629,0.00018061341,0.00022959197,0.0001024256,0.00016073826,0.00003704786,0.00059619907,0.00016219955,0.00028412294],"category_scores_gemma":[0.00064393244,0.000103348226,0.00010988874,0.00056389405,0.00047548697,0.000013211345,0.0002835817,0.00038017612,0.000008760737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054641877,0.00011758828,0.000754887,0.00004291837,0.00024247017,0.0000027434448,0.000051190338,0.000042668922,0.99050623,0.00003859245,0.00041225663,0.0072420114],"study_design_scores_gemma":[0.0018749946,0.0003647542,0.022207614,0.00047710296,0.000029598961,0.0000024023282,0.000023853949,0.000016298258,0.9688497,0.000040424173,0.005924422,0.00018882848],"about_ca_topic_score_codex":0.00029546343,"about_ca_topic_score_gemma":0.00070159056,"teacher_disagreement_score":0.021656547,"about_ca_system_score_codex":0.00021457757,"about_ca_system_score_gemma":0.0015524965,"threshold_uncertainty_score":0.42144185},"labels":[],"label_agreement":null},{"id":"W2487553529","doi":"10.1158/1538-7445.am2016-951","title":"Abstract 951: Role of the MSC-derived exosomal and endogenous JAK2-SET/PP2A-β-catenin-modulator miR-300 in leukemic stem/progenitor proliferation and survival in CML","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CD38; Progenitor cell; Haematopoiesis; Cancer research; Stem cell; CD34; Biology; Clonogenic assay; Cell biology; Cell culture; Molecular biology; Genetics","score_opus":0.08059856188916881,"score_gpt":0.34483196839210617,"score_spread":0.26423340650293736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487553529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360424,0.0040103365,3.7142334e-7,0.0005749102,0.00007923277,0.0014596735,0.000049431485,0.000013782088,0.0002080295],"genre_scores_gemma":[0.998469,0.0006968464,0.000018447261,0.000013214758,0.00014765107,0.0003413751,0.0000050905974,0.000035562694,0.0002728035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978082,0.00019902729,0.00037430218,0.0004601321,0.0006209405,0.0005374062],"domain_scores_gemma":[0.9989827,0.00023721223,0.00007922384,0.0003826423,0.00016021258,0.0001579837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006543277,0.00018033475,0.0003585514,0.00021517943,0.000083801286,0.00002221627,0.00016176655,0.00014597617,0.00008259299],"category_scores_gemma":[0.00013008481,0.0001115602,0.000041809937,0.0003115217,0.00029763574,0.00012677729,0.00015499267,0.00036769707,0.000009782836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052682136,0.000074202624,0.3053904,0.0001342123,0.000043388103,0.00003303615,0.0007774082,0.000002134794,0.6845122,0.000020786538,0.000017403745,0.008468039],"study_design_scores_gemma":[0.0067163883,0.0001791846,0.54837096,0.0005031985,0.000018902021,0.000044172535,0.0003794417,0.00006938361,0.4433924,0.00008270034,0.00012677947,0.0001164798],"about_ca_topic_score_codex":0.0033077186,"about_ca_topic_score_gemma":0.0021435998,"teacher_disagreement_score":0.24298058,"about_ca_system_score_codex":0.0018309844,"about_ca_system_score_gemma":0.0014389263,"threshold_uncertainty_score":0.5000303},"labels":[],"label_agreement":null},{"id":"W2487792109","doi":"10.1158/1538-7445.am2016-1216","title":"Abstract 1216: Assays for the selection and functional characterization of antibody-drug conjugates at the National Research Council of Canada","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Antibody-drug conjugate; Antibody; Monoclonal antibody; Immunoconjugate; Drug development; Cancer; Cytotoxicity; Drug; Computational biology; Cancer research; Chemistry; Biology; Pharmacology; In vitro; Biochemistry; Immunology","score_opus":0.19338351874524193,"score_gpt":0.4123287445938077,"score_spread":0.21894522584856577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487792109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654305,0.0011121416,0.000027843578,0.030385166,0.00011015551,0.00086242275,0.00051954016,0.000004665264,0.0015475545],"genre_scores_gemma":[0.9788565,0.002056014,0.0000066123985,0.00008802075,0.0004343174,0.00020664856,0.000029955167,0.00001550524,0.018306425],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939848,0.00017596628,0.0002772194,0.000255006,0.004861309,0.00044565357],"domain_scores_gemma":[0.98659754,0.0035933591,0.00007716177,0.00014086906,0.009484105,0.00010694922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007993891,0.000092512535,0.00017837479,0.00011009771,0.000659334,0.000019262532,0.0001550179,0.000055161956,0.00088675786],"category_scores_gemma":[0.002003753,0.0000431385,0.000050782,0.0004128044,0.0007923385,0.000076818214,0.00012869287,0.00033574572,0.000004613404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018989719,0.000043022792,0.010571676,0.0002801099,0.000118630174,8.5411256e-7,0.00012145411,0.0000057593134,0.9360303,0.0011244365,0.046404306,0.0034004245],"study_design_scores_gemma":[0.0011569269,0.00020977396,0.48637518,0.0002900827,0.000014424242,0.000017979339,0.00012875457,0.00034999687,0.28708547,0.00044598468,0.22383739,0.00008803096],"about_ca_topic_score_codex":0.076511286,"about_ca_topic_score_gemma":0.1230215,"teacher_disagreement_score":0.64894485,"about_ca_system_score_codex":0.0017907945,"about_ca_system_score_gemma":0.009553387,"threshold_uncertainty_score":0.9960615},"labels":[],"label_agreement":null},{"id":"W2487905146","doi":"10.1158/1538-7445.am2016-3099","title":"Abstract 3099: <i>KRAS</i> and clinical context: Differential dynamic signaling output of <i>KRAS</i> mutant lung, colorectal and pancreatic cancer cell lines when exposed to targeted anticancer drugs","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"KRAS; Cancer research; Pancreatic cancer; Colorectal cancer; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer; Medicine; MEK inhibitor; Cetuximab; Context (archaeology); Trametinib; Selumetinib; Internal medicine; Oncology; Biology; Signal transduction; MAPK/ERK pathway; Cell biology","score_opus":0.025267706763196878,"score_gpt":0.34722112735358457,"score_spread":0.3219534205903877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487905146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637801,0.033008922,0.0002517421,0.0006221549,0.0009866564,0.0007260733,0.00048639707,0.000015174537,0.0001227565],"genre_scores_gemma":[0.96103144,0.035669506,0.00011975607,0.00020374692,0.0013268619,0.00022531673,0.000022644745,0.00005877915,0.0013419762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971796,0.00022583727,0.0005891512,0.00082007295,0.00047730148,0.0007080086],"domain_scores_gemma":[0.9983271,0.00024661695,0.00015803718,0.00036786505,0.00047006572,0.0004303276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070500246,0.0002971354,0.0005922653,0.00008937973,0.00014773903,0.00005198488,0.0002930428,0.00027128204,0.00026208558],"category_scores_gemma":[0.00019956841,0.00022499723,0.00014097954,0.00013875919,0.00066435325,0.000021581238,0.00029505682,0.0002590965,0.0000033805948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010271033,0.00010013816,0.0055848313,0.00019419398,0.00016891323,0.000002080166,0.00032828245,0.000003932431,0.95205045,0.000013415515,0.002721639,0.03780502],"study_design_scores_gemma":[0.0035068041,0.00046940742,0.018126179,0.00041447158,0.00012792033,0.0000033839924,0.00031211763,0.000068165595,0.9449686,0.000046761004,0.031510696,0.00044549376],"about_ca_topic_score_codex":0.0016976405,"about_ca_topic_score_gemma":0.0024936888,"teacher_disagreement_score":0.03735953,"about_ca_system_score_codex":0.000110056106,"about_ca_system_score_gemma":0.0005587243,"threshold_uncertainty_score":0.91751206},"labels":[],"label_agreement":null},{"id":"W2487912533","doi":"10.1158/1538-7445.am2016-3914","title":"Abstract 3914: Repurposing disulfiram for use as an anticancer drug: a story about metabolism and metal binding","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Spinal Cord Injury BC","funders":"","keywords":"Disulfiram; Chemistry; Liposome; Pharmacology; In vitro; Pharmacokinetics; Drug; Toxicity; IC50; Biochemistry; Medicine; Organic chemistry","score_opus":0.05639735655545858,"score_gpt":0.39146446062940216,"score_spread":0.3350671040739436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487912533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812171,0.014381919,0.00014298856,0.00042507626,0.002717952,0.0006591547,0.0002761441,0.000023332525,0.00015637216],"genre_scores_gemma":[0.9629987,0.016474811,0.0004456986,0.000186388,0.013147219,0.0006263494,0.000047234204,0.00010100827,0.005972625],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997553,0.00017665417,0.00024632504,0.00083025923,0.00041329156,0.0007804545],"domain_scores_gemma":[0.9984474,0.00014560479,0.00008648066,0.0005820884,0.00039772422,0.00034066726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013141242,0.00022954105,0.0003110666,0.0001731324,0.00038643042,0.0001475339,0.00029495682,0.00016329836,0.000084452215],"category_scores_gemma":[0.0004483371,0.00017446563,0.00012860581,0.00016183262,0.0004553165,0.00006292238,0.00017151707,0.00023139158,0.000009140671],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004954721,0.0000480467,0.0006645761,0.000054188586,0.0001070827,4.7382034e-7,0.00018355326,0.000001082391,0.91738254,0.00040515236,0.0130112395,0.0676466],"study_design_scores_gemma":[0.001438576,0.00010170945,0.007860906,0.00009248371,0.00004590628,0.0000068451263,0.0001659356,0.000005501509,0.17071657,0.00013805194,0.81913155,0.00029593366],"about_ca_topic_score_codex":0.000553168,"about_ca_topic_score_gemma":0.00046701208,"teacher_disagreement_score":0.80612034,"about_ca_system_score_codex":0.000086343076,"about_ca_system_score_gemma":0.0005187959,"threshold_uncertainty_score":0.7114502},"labels":[],"label_agreement":null},{"id":"W2487959321","doi":"10.1158/1538-7445.am2016-3632","title":"Abstract 3632: Adaptive operations and technology platform for nation-scale precision oncology","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lockheed Martin (Canada)","funders":"","keywords":"Workflow; Scalability; Computer science; Precision medicine; Analytics; Data science; Scale (ratio); Predictive analytics; Big data; Data mining; Database; Medicine","score_opus":0.07564222026282387,"score_gpt":0.40862806947769,"score_spread":0.3329858492148661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487959321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732131,0.0016662591,0.0068443185,0.012942169,0.00020493777,0.0014890617,0.0002636255,0.000025207488,0.003351354],"genre_scores_gemma":[0.987232,0.00407848,0.002344147,0.00008741786,0.00034725777,0.0005843924,0.000047721624,0.000021097238,0.0052574323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985639,0.000024828732,0.00024045024,0.00033073596,0.0003522544,0.00048785377],"domain_scores_gemma":[0.9984993,0.00016054316,0.000030263755,0.00026292732,0.0008660244,0.00018093798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091580616,0.00010411334,0.00013492757,0.00024105876,0.0002535833,0.000032254608,0.0002949002,0.00034575246,0.00014240677],"category_scores_gemma":[0.00068868214,0.00006986273,0.000036064335,0.00020388671,0.00067391683,0.000011630777,0.00024818227,0.00017508215,0.000047554848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022846986,0.000057486166,0.00016052721,0.00003116533,0.000033181946,7.5535314e-7,0.00006219808,0.0000030905692,0.638685,0.0004304982,0.009342066,0.3509656],"study_design_scores_gemma":[0.0019850305,0.002211369,0.0008416272,0.00009230909,0.00000711976,0.0000080059635,0.0004722049,0.0003057143,0.5403782,0.003076842,0.45038912,0.00023248132],"about_ca_topic_score_codex":0.000052052863,"about_ca_topic_score_gemma":0.00057334005,"teacher_disagreement_score":0.44104704,"about_ca_system_score_codex":0.00011205011,"about_ca_system_score_gemma":0.000625085,"threshold_uncertainty_score":0.28489193},"labels":[],"label_agreement":null},{"id":"W2487968868","doi":"10.1158/1538-7445.am2016-1434","title":"Abstract 1434: Diabetic metastatic castration-resistant prostate cancer patients administered metformin during docetaxel chemotherapy have improved prostate cancer-specific and overall survival","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Metformin; Oncology; Cancer; Internal medicine; Chemotherapy; Prostate; Biguanide; Insulin","score_opus":0.03910538314968834,"score_gpt":0.3404135034491448,"score_spread":0.3013081202994564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487968868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.892126,0.10471395,0.000003553592,0.00026362116,0.00037954154,0.0012701867,0.0011328461,0.000019054125,0.00009122009],"genre_scores_gemma":[0.81193084,0.18368202,0.000050861898,0.00008756248,0.00039510737,0.0015916667,0.00006265332,0.00009355236,0.0021057231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962489,0.00019570607,0.00058194273,0.0010534788,0.0007184275,0.0012015314],"domain_scores_gemma":[0.9980302,0.00006519548,0.00024791766,0.0005756263,0.0006916766,0.00038939773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068379607,0.00043734236,0.00050069194,0.00015524973,0.0003211803,0.00018722437,0.00036680273,0.00014910042,0.00046342018],"category_scores_gemma":[0.000076292155,0.0003272694,0.00012468487,0.00019909584,0.0004036247,0.00005782985,0.00016207316,0.00028745452,0.000007797371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017068035,0.00014439014,0.01021176,0.00034413923,0.00026412262,0.0000072116786,0.00042562367,0.0000067161786,0.85475236,0.000015266536,0.0008276487,0.13129398],"study_design_scores_gemma":[0.008808663,0.0004765712,0.08692772,0.00034046,0.000052622927,0.0000013649121,0.00020770993,0.000008635691,0.80832314,0.00015564442,0.09393196,0.0007655117],"about_ca_topic_score_codex":0.0009410872,"about_ca_topic_score_gemma":0.0017396307,"teacher_disagreement_score":0.13052848,"about_ca_system_score_codex":0.00029593325,"about_ca_system_score_gemma":0.0007213108,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W2487987960","doi":"10.1158/1538-7445.am2016-251","title":"Abstract 251: Stem cell altruism may serve as a novel drug resistance mechanism in oral cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Stem cell; Cancer stem cell; Abcg2; Cancer cell; Cancer research; Cancer; Embryonic stem cell; Flow cytometry; Cell; Immunology; Medicine; Biology; Internal medicine; Cell biology; Biochemistry; ATP-binding cassette transporter","score_opus":0.057596053598954054,"score_gpt":0.38074171328785616,"score_spread":0.32314565968890213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487987960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867687,0.0074290438,0.0002077716,0.0015749518,0.00021501457,0.0003458323,0.00008649891,0.000008931627,0.003363218],"genre_scores_gemma":[0.96734715,0.0048729535,0.00015160281,0.00007547881,0.00023286643,0.00026479218,0.000011599384,0.00003654791,0.02700699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980332,0.000119837285,0.0002562319,0.0005677824,0.00044159094,0.0005813101],"domain_scores_gemma":[0.99899083,0.00005612452,0.00007336463,0.0004442932,0.00028093197,0.00015445346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000985294,0.0001606736,0.0001618089,0.00011751499,0.00010084919,0.0000395112,0.0003436735,0.00017657196,0.00024928534],"category_scores_gemma":[0.000038361886,0.00012712437,0.000061126826,0.00023126796,0.00009863935,0.000009035887,0.00015490575,0.00021936871,0.000039675964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016141856,0.00005590266,0.0011572448,0.0000543651,0.000016528555,0.0000068862305,0.00009793072,0.00001867991,0.9917764,0.00050761335,0.001437096,0.004709921],"study_design_scores_gemma":[0.00092660007,0.000048136655,0.00324295,0.00011217258,0.0000035118594,2.3242953e-7,0.00006682872,0.0000033862098,0.93936515,0.0012151578,0.05482244,0.00019343475],"about_ca_topic_score_codex":0.0015975764,"about_ca_topic_score_gemma":0.008860124,"teacher_disagreement_score":0.053385347,"about_ca_system_score_codex":0.00018989717,"about_ca_system_score_gemma":0.0005150541,"threshold_uncertainty_score":0.5183981},"labels":[],"label_agreement":null},{"id":"W2488012951","doi":"10.1158/1538-7445.am2016-3718","title":"Abstract 3718: Sensitization of human tumor cells to chemotherapy drugs by antisense downregulation of RAD51: Targeting DNA repair to induce synthetic lethality","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Synthetic lethality; RAD51; Cancer research; DNA repair; Cisplatin; Biology; DU145; DNA damage; Poly ADP ribose polymerase; PARP inhibitor; Gene knockdown; Homologous recombination; LNCaP; Cancer cell; Molecular biology; Cell culture; Cancer; DNA; Polymerase; Chemotherapy; Genetics","score_opus":0.05097033972402663,"score_gpt":0.4053344101889845,"score_spread":0.3543640704649578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488012951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919131,0.00014653,0.0001908809,0.0058351313,0.00008712422,0.0010337082,0.00015481107,0.000052244308,0.0005865159],"genre_scores_gemma":[0.99822766,0.00009763962,0.00037679792,0.00031349898,0.00023296691,0.00008167544,0.000016105843,0.00005119018,0.0006024918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732476,0.00022584687,0.0005771052,0.0004810774,0.00096492824,0.0004262569],"domain_scores_gemma":[0.9978255,0.00031093945,0.00018616156,0.0005493766,0.0008792263,0.00024876877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018143333,0.00016051416,0.0004005305,0.00032504718,0.00010242812,0.0000109557,0.0001294518,0.000097107644,0.0008793857],"category_scores_gemma":[0.00021958591,0.00013216079,0.00010294796,0.000666611,0.00022021502,0.00009663958,0.00004536611,0.00018769215,0.00003442534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006032485,0.00010913963,0.00083384325,0.00025072784,0.00003509308,0.0000037554616,0.0009907477,0.000020854523,0.97746575,0.000058629143,0.015946712,0.0036814765],"study_design_scores_gemma":[0.0013755773,0.00026022267,0.012351413,0.0010755301,0.0000089418245,0.0000023112873,0.0001315381,0.000008295493,0.9821055,0.00013371445,0.0024079925,0.00013896945],"about_ca_topic_score_codex":0.00061332854,"about_ca_topic_score_gemma":0.000013528261,"teacher_disagreement_score":0.013538719,"about_ca_system_score_codex":0.0005645434,"about_ca_system_score_gemma":0.0002593682,"threshold_uncertainty_score":0.96286565},"labels":[],"label_agreement":null},{"id":"W2488116285","doi":"10.1158/1538-7445.am2016-ct074","title":"Abstract CT074: Phase I/II study of VAL-083 in patients with recurrent glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Phases of clinical research; Oncology; Glioma; Internal medicine; Clinical trial; Cancer; Radiation therapy; Glioblastoma; Methyltransferase; Cancer research; Chemotherapy; Biology; DNA","score_opus":0.06491319622575849,"score_gpt":0.4267035912718839,"score_spread":0.3617903950461254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488116285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772674,0.0002185224,2.0076895e-7,0.00048882695,0.000053425458,0.0013076507,0.00003636826,0.00000993109,0.00015833054],"genre_scores_gemma":[0.99935806,0.000079306854,0.00000567579,0.00000708249,0.000040675895,0.00038729853,0.0000031605452,0.000018851271,0.00009990137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998167,0.00006734625,0.0002328036,0.00030607294,0.00086537446,0.00036142286],"domain_scores_gemma":[0.99894804,0.00010704942,0.000053743748,0.00035338514,0.00038181347,0.00015598106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031135124,0.00011265691,0.00025851198,0.0003348491,0.000059673002,0.000006973928,0.00009757697,0.00003594034,0.0004228719],"category_scores_gemma":[0.000068588546,0.00005380339,0.00003103446,0.00044672782,0.00009111195,0.00006085826,0.00007222073,0.00015646932,0.00002471918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008128637,0.02832487,0.70993465,0.00007367233,0.00015870757,0.00014536789,0.0010223232,0.000001580144,0.003554702,0.0000072822572,0.0016206458,0.24702756],"study_design_scores_gemma":[0.038234588,0.033704374,0.913073,0.0008098426,0.00002918236,6.7531846e-7,0.00026978768,8.4189696e-7,0.013047664,0.000009936579,0.000733539,0.000086590786],"about_ca_topic_score_codex":0.00047054264,"about_ca_topic_score_gemma":0.00089623855,"teacher_disagreement_score":0.24694097,"about_ca_system_score_codex":0.00034210773,"about_ca_system_score_gemma":0.00016158802,"threshold_uncertainty_score":0.46301508},"labels":[],"label_agreement":null},{"id":"W2488156982","doi":"10.1158/1538-7445.am2016-3060","title":"Abstract 3060: Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted anticancer drugs bortezomib and carfilzomib","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Carfilzomib; Dexrazoxane; Bortezomib; Cardiotoxicity; Doxorubicin; Pharmacology; Chemistry; Myocyte; Medicine; Toxicity; Cancer; Multiple myeloma; Anthracycline; Internal medicine; Chemotherapy","score_opus":0.037619731588595405,"score_gpt":0.3877342246302499,"score_spread":0.35011449304165454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488156982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997587,0.0018006823,0.000016096295,0.0047509572,0.00020299062,0.0018493127,0.000115464885,0.000009728963,0.0012788692],"genre_scores_gemma":[0.9979414,0.00047156343,0.000025503512,0.00013247669,0.00009033033,0.00040437968,7.404769e-7,0.000022147045,0.0009114799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981912,0.00019220894,0.00023538675,0.00028147709,0.00073560036,0.00036412393],"domain_scores_gemma":[0.99878144,0.00014102818,0.000107045904,0.0005127301,0.00034986823,0.000107907625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056688813,0.00013047647,0.00033390702,0.000070303504,0.00010714705,0.0000057631896,0.00025698508,0.00009521994,0.00043685935],"category_scores_gemma":[0.00010364516,0.00005907334,0.00016036967,0.00038651098,0.00069173414,0.00003881872,0.00019352032,0.00028384003,0.0000022224865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039833327,0.000096533884,0.011555117,0.00017449561,0.00023125068,0.000006308341,0.0002076451,0.0000018277588,0.98190904,0.0005852163,0.0008740677,0.0039601726],"study_design_scores_gemma":[0.002069601,0.0001305219,0.100005805,0.0002859631,0.00009283864,0.0000046074656,0.00005922549,0.0000034886543,0.89520746,0.0008648702,0.0012121747,0.00006343001],"about_ca_topic_score_codex":0.0012201918,"about_ca_topic_score_gemma":0.00007488935,"teacher_disagreement_score":0.088450685,"about_ca_system_score_codex":0.00023926007,"about_ca_system_score_gemma":0.000726139,"threshold_uncertainty_score":0.47833037},"labels":[],"label_agreement":null},{"id":"W2488225102","doi":"10.1158/1538-7445.am2016-4430","title":"Abstract 4430: Implication of the primary cilium in the Hedgehog pathway in colorectal cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Hedgehog; GLI1; Hedgehog signaling pathway; Cilium; Colorectal cancer; Biology; Cancer research; Immunofluorescence; Cancer; Epithelium; Signal transduction; Cell biology; Pathology; Medicine; Immunology; Genetics","score_opus":0.048781762683542694,"score_gpt":0.3597673898459136,"score_spread":0.31098562716237094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488225102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946224,0.0021818439,0.000004344726,0.0015835871,0.00010831878,0.0004636774,0.00008157692,0.0000026456366,0.00095162005],"genre_scores_gemma":[0.99803644,0.0010209483,0.0000044649682,0.00009326495,0.00015709105,0.00048095302,0.0000037168797,0.000013900458,0.00018920102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985635,0.00022801416,0.00022321775,0.00029832326,0.00032865102,0.00035827424],"domain_scores_gemma":[0.9992468,0.00013241908,0.000059365073,0.0003601101,0.00017281629,0.00002853782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011448449,0.000097768505,0.00012677115,0.000061001567,0.00007648379,0.00001075177,0.00053865,0.00010373348,0.000027459764],"category_scores_gemma":[0.00014101296,0.000050002272,0.000055995886,0.0003259619,0.00032902055,0.0000042481875,0.00020011578,0.00020770488,0.000005569882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082006954,0.00004649457,0.014421933,0.00004106538,0.0000113211345,0.0000013344232,0.00036128447,0.000018345305,0.9776578,0.000020703606,0.0012291766,0.006108558],"study_design_scores_gemma":[0.00030426861,0.000041600957,0.2200514,0.00007845423,0.0000010346012,4.457407e-7,0.000115692885,5.8405675e-7,0.7749649,0.000048919544,0.004333492,0.000059169466],"about_ca_topic_score_codex":0.00071304705,"about_ca_topic_score_gemma":0.0020695794,"teacher_disagreement_score":0.20562945,"about_ca_system_score_codex":0.00016162782,"about_ca_system_score_gemma":0.0005326395,"threshold_uncertainty_score":0.20390335},"labels":[],"label_agreement":null},{"id":"W2488239967","doi":"10.1158/1538-7445.am2016-4243","title":"Abstract 4243: ChAcNLS-A14-B105, a novel fluorescence imaging agent for enhanced detection of muscle invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"BODIPY; Bladder cancer; Fluorescence; Chemistry; Intracellular; Biophysics; Cancer; Cancer research; Medicine; Molecular biology; Biochemistry; Biology; Internal medicine","score_opus":0.09028813708704128,"score_gpt":0.4038143285245093,"score_spread":0.31352619143746807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488239967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532224,0.0034753638,0.0033640238,0.002865003,0.00066752173,0.0026240214,0.00048892037,0.00007163053,0.0011213042],"genre_scores_gemma":[0.9931238,0.0023554955,0.00018254307,0.00017971371,0.00057499873,0.0021268055,0.0000067805026,0.000066327746,0.0013834768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749047,0.000040093968,0.0003606838,0.00060394837,0.00075304066,0.0007517774],"domain_scores_gemma":[0.99792856,0.00030728395,0.00012432344,0.00045795183,0.00095422764,0.00022766886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004206992,0.00022435914,0.00037144776,0.00026352372,0.00018309375,0.000023524932,0.00021490426,0.00009954826,0.0009532338],"category_scores_gemma":[0.0002736171,0.00015747784,0.00016575404,0.00039624763,0.0003073722,0.00018994628,0.00007971337,0.0002434863,0.000032691085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076703675,0.00016530238,0.00088374823,0.00027649518,0.00014762965,0.0000062436347,0.000394565,0.000002479986,0.8138668,0.000013749834,0.00089273206,0.18258324],"study_design_scores_gemma":[0.0046021966,0.00032007764,0.03430772,0.0010668184,0.00007696444,0.0000036953154,0.00020781215,0.000016919088,0.9551401,0.000105553605,0.0039750845,0.00017707326],"about_ca_topic_score_codex":0.0032371373,"about_ca_topic_score_gemma":0.0012899891,"teacher_disagreement_score":0.18240617,"about_ca_system_score_codex":0.0008512616,"about_ca_system_score_gemma":0.0011504053,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W2488345317","doi":"10.1158/1538-7445.am2016-2631","title":"Abstract 2631: Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Druggability; Medicine; Clinical trial; Cancer; Crizotinib; Oncology; Internal medicine; Genome; Bioinformatics; Gene; Genetics; Biology; Lung cancer","score_opus":0.13829842445853127,"score_gpt":0.4571358930025507,"score_spread":0.3188374685440194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488345317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508893,0.0022855531,0.00022739242,0.0011299191,0.00009878029,0.00061256136,0.00011801119,0.0000033520887,0.0004354786],"genre_scores_gemma":[0.9924533,0.006476996,0.000010658974,0.00017931843,0.00039491785,0.0003887676,0.000014398377,0.000016198523,0.00006544446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891454,0.00009003567,0.0002670867,0.0003096048,0.00018978804,0.00022896052],"domain_scores_gemma":[0.99889296,0.00018989836,0.00006022737,0.00051627407,0.00026782847,0.000072780465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006006752,0.00007286292,0.0001086567,0.000087082044,0.00007524953,0.00002828116,0.00044625756,0.00009683073,0.000008554235],"category_scores_gemma":[0.00019820298,0.000046633795,0.000052142746,0.00023721026,0.000090739566,0.0000037610594,0.00013121347,0.00014919088,0.000016679176],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019725054,0.000025509898,0.012483081,0.000022470535,0.000016495273,9.580556e-7,0.000119377124,0.001126901,0.9417655,0.00009679356,0.000955674,0.04319],"study_design_scores_gemma":[0.002265141,0.0012459044,0.39653897,0.00039760827,0.000009709323,0.00000313704,0.0011318605,0.000019716334,0.34968135,0.00023775706,0.24807784,0.00039100612],"about_ca_topic_score_codex":0.00090776454,"about_ca_topic_score_gemma":0.0010301784,"teacher_disagreement_score":0.5920841,"about_ca_system_score_codex":0.00029620755,"about_ca_system_score_gemma":0.00057825784,"threshold_uncertainty_score":0.1901671},"labels":[],"label_agreement":null},{"id":"W2488398097","doi":"10.1158/1538-7445.am2016-4197","title":"Abstract 4197: Combined contrast enhanced ultrasound and photoacoustic imaging reveals both functional flow patterns and dysfunctional vascular pooling in tumor models","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Photoacoustic and Ultrasonic Imaging","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Perfusion; Ultrasound; Biomedical engineering; Medicine; Pathology; Vascularity; Contrast-enhanced ultrasound; Radiology","score_opus":0.023101252367783928,"score_gpt":0.2690000848487635,"score_spread":0.24589883248097955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488398097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91724885,0.001540326,0.07988563,0.00007969387,0.0002735695,0.00035640373,0.000160473,0.00009614259,0.00035889688],"genre_scores_gemma":[0.9981482,0.001106131,0.00014077286,0.00006782701,0.0001895694,0.0002040889,0.000011032287,0.000058723497,0.00007363673],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99784446,0.000058406637,0.00032088513,0.00046494114,0.00053866784,0.00077261875],"domain_scores_gemma":[0.99854094,0.0008762455,0.000030383562,0.00020465773,0.00013876856,0.0002089971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606656,0.00023608266,0.00028964874,0.0002730786,0.00017835341,0.000113491435,0.00012388878,0.00005862848,0.00036632924],"category_scores_gemma":[0.00016356782,0.00020059144,0.00004306152,0.00020364324,0.00020034342,0.0004287977,0.000047352805,0.00047218875,0.000006657587],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010584914,0.000034625813,0.008093982,0.00029137332,0.00007865075,0.000034861932,0.0002513184,0.022341445,0.96279484,0.00007566498,0.00035420168,0.00554319],"study_design_scores_gemma":[0.011981711,0.00009085283,0.4923254,0.0035790154,0.000097684206,0.0001799749,0.0013238644,0.41881618,0.061530598,0.008219139,0.00021038992,0.0016451943],"about_ca_topic_score_codex":0.00032293066,"about_ca_topic_score_gemma":0.000079197795,"teacher_disagreement_score":0.90126425,"about_ca_system_score_codex":0.0003886188,"about_ca_system_score_gemma":0.00013025376,"threshold_uncertainty_score":0.81798816},"labels":[],"label_agreement":null},{"id":"W2488405903","doi":"10.1158/1538-7445.am2016-5038","title":"Abstract 5038: The repression of the extracellular matrix protein TGFBI induces chemoresistance in nasopharyngeal carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; TGFBI; Cancer research; Extracellular matrix; Small hairpin RNA; Biology; Medicine; Radiation therapy; Oncology; Cell culture; Internal medicine; Gene knockdown; Genetics","score_opus":0.06973018704596194,"score_gpt":0.3747127785575997,"score_spread":0.30498259151163776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488405903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498011,0.030787434,0.0000011329337,0.016900236,0.00011659526,0.0010963123,0.000013344131,0.000013736558,0.001270145],"genre_scores_gemma":[0.9932891,0.0004291965,0.000012099935,0.000033335367,0.00029436674,0.00043585149,9.1902245e-7,0.000026329777,0.005478793],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99763834,0.00016138912,0.00034780585,0.0004085066,0.0009439804,0.0004999717],"domain_scores_gemma":[0.9984687,0.00022419814,0.00011051497,0.0008322054,0.00027886423,0.000085531676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001042821,0.00015539837,0.0002996541,0.00011793303,0.00019586044,0.00002276207,0.00048765322,0.00009833052,0.00026635826],"category_scores_gemma":[0.00028622028,0.00006753445,0.00012551121,0.0005838714,0.0005968829,0.00011400291,0.00026159413,0.00056801626,0.000012492788],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006901163,0.00007852075,0.07508199,0.00028702628,0.00003797383,0.00005416235,0.0009188878,0.0000010659662,0.9128021,0.00023656213,0.0032626805,0.006548901],"study_design_scores_gemma":[0.0011669875,0.000056785033,0.5984227,0.0009837023,0.000012014461,0.0000047575218,0.00039287342,0.000001661311,0.39702195,0.00022413163,0.0016339201,0.00007853276],"about_ca_topic_score_codex":0.0013320032,"about_ca_topic_score_gemma":0.00048871135,"teacher_disagreement_score":0.5233407,"about_ca_system_score_codex":0.00032423725,"about_ca_system_score_gemma":0.000498785,"threshold_uncertainty_score":0.29164362},"labels":[],"label_agreement":null},{"id":"W2488470268","doi":"10.1158/1538-7445.am2016-2850","title":"Abstract 2850: Role of shelterin proteins for telomere shortening in chronic lymphocytic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Shelterin; Telomere; Chronic lymphocytic leukemia; Biology; Leukemia; Molecular biology; Cancer research; Immunology; Genetics; DNA; Gene; DNA-binding protein","score_opus":0.028472175632786197,"score_gpt":0.34546279346281006,"score_spread":0.31699061783002386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488470268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976397,0.001128373,0.00018580577,0.000033776552,0.00005249241,0.00036638736,0.000023948118,0.0000046937926,0.00056479225],"genre_scores_gemma":[0.9986119,0.00028262887,0.00014598598,0.000009352971,0.00031449785,0.0001844625,0.000007777453,0.000020900578,0.00042244926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916595,0.000023133582,0.00013617838,0.00024280626,0.00014011972,0.00029182283],"domain_scores_gemma":[0.99959123,0.000017128561,0.000030155983,0.00021153463,0.00010599852,0.000043960295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024315741,0.00007178343,0.00009746816,0.000075558084,0.000040836247,0.000008729625,0.00014450573,0.00010707071,0.000101200814],"category_scores_gemma":[0.00004724373,0.00005277587,0.000043889107,0.00009576237,0.0000886823,0.000006328009,0.00006416359,0.0000731886,0.000005527841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002452283,0.0000028061497,0.0004070537,0.000058957223,0.000014641542,7.8595787e-7,0.000019810272,0.00006314908,0.9379177,0.000077178534,0.00029679097,0.060895886],"study_design_scores_gemma":[0.0008435451,0.00032329434,0.0053820754,0.00010418154,0.000002560275,0.0000018564339,0.00004213998,0.00007281127,0.9685132,0.0003363537,0.024286736,0.00009125711],"about_ca_topic_score_codex":0.00045722516,"about_ca_topic_score_gemma":0.00050308293,"teacher_disagreement_score":0.060804628,"about_ca_system_score_codex":0.0010363536,"about_ca_system_score_gemma":0.0012269766,"threshold_uncertainty_score":0.2710029},"labels":[],"label_agreement":null},{"id":"W2488476560","doi":"10.1158/1538-7445.am2016-4941","title":"Abstract 4941: Overexpression of Reg proteins in human pancreatic ductal adenocarcinoma and acinar-to-ductal metaplasia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Immunohistochemistry; Pancreatic cancer; Metaplasia; Carcinogenesis; Cancer research; Medicine; Ductal cells; Pathology; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Cancer; CA19-9; Metastasis; Internal medicine","score_opus":0.0502826278165152,"score_gpt":0.36158519001973993,"score_spread":0.3113025622032247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488476560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924225,0.0054836017,0.0000030647686,0.0006392055,0.000111638576,0.00057946576,0.000047980826,0.00001551166,0.000697029],"genre_scores_gemma":[0.99732757,0.00032246136,0.000021584308,0.000017590168,0.000059332797,0.00026473787,0.0000076198653,0.000018878112,0.0019602282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982651,0.00028326493,0.0002955291,0.0004705721,0.00009249174,0.0005930653],"domain_scores_gemma":[0.9992514,0.00014907113,0.00007437856,0.0003352644,0.00013251595,0.00005733419],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057887525,0.00015189018,0.00034242094,0.00030404326,0.00015120034,0.000009282408,0.0002652289,0.00022846181,0.001270778],"category_scores_gemma":[0.00013874956,0.00010122789,0.000044975754,0.00026215753,0.00048732653,0.00008431018,0.00021253638,0.0003900234,0.000053075295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047948005,0.00006443533,0.07586034,0.00006344748,0.00005337198,0.000012493506,0.00035490497,2.1909356e-7,0.9193617,0.00035944115,0.0010195668,0.0023705666],"study_design_scores_gemma":[0.0011952072,0.00050874124,0.4652712,0.00034694804,0.0000069216508,0.000036395122,0.00018045759,4.6550475e-8,0.53058267,0.00032221773,0.0014347468,0.00011444327],"about_ca_topic_score_codex":0.0017843745,"about_ca_topic_score_gemma":0.0004530893,"teacher_disagreement_score":0.38941085,"about_ca_system_score_codex":0.0001497207,"about_ca_system_score_gemma":0.00016960577,"threshold_uncertainty_score":0.9996422},"labels":[],"label_agreement":null},{"id":"W2488572833","doi":"10.1158/1538-7445.am2016-233","title":"Abstract 233: Identification of cancer vulnerabilities to metabolic perturbation using genome wide CRISPR screens","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CRISPR; Biology; Synthetic lethality; Context (archaeology); Computational biology; Genetics; Gene; Cas9; Genetic screen; Cancer research; Phenotype; DNA repair","score_opus":0.08128684110599876,"score_gpt":0.4167071357468934,"score_spread":0.3354202946408946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488572833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784816,0.006484684,0.003659226,0.0011537713,0.000117528085,0.00034894454,0.00019442126,0.0000069204534,0.00018636325],"genre_scores_gemma":[0.99248004,0.0029898032,0.0001146837,0.00007412138,0.00034817395,0.00035523038,0.000017131115,0.000025758383,0.003595036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985442,0.00009121833,0.0003036957,0.00039645412,0.00034696673,0.00031745803],"domain_scores_gemma":[0.9984528,0.000039101,0.00009123427,0.0005093167,0.0008028292,0.00010475859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006502184,0.00010474911,0.00013619885,0.0001495447,0.00015127409,0.00003113832,0.00027426588,0.000088506575,0.00024121744],"category_scores_gemma":[0.0002324805,0.000080659556,0.00006278232,0.0002630957,0.00017462006,0.000015798083,0.00008002262,0.00008413912,0.000012012336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073142604,0.000024703057,0.002972244,0.00003465326,0.00004118283,1.5404383e-7,0.000104295024,0.00038836483,0.98691607,0.00023824516,0.00058205944,0.008624895],"study_design_scores_gemma":[0.00022392021,0.000040481245,0.095026456,0.00004794317,0.00001284224,3.7294558e-7,0.00014473406,0.000019554176,0.87374544,0.00019194704,0.030412473,0.00013384302],"about_ca_topic_score_codex":0.001657503,"about_ca_topic_score_gemma":0.00041666097,"teacher_disagreement_score":0.113170624,"about_ca_system_score_codex":0.00012946037,"about_ca_system_score_gemma":0.0003708479,"threshold_uncertainty_score":0.32892013},"labels":[],"label_agreement":null},{"id":"W2488801100","doi":"10.1158/1538-7445.am2016-3788","title":"Abstract 3788: Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ATCO (Canada)","funders":"","keywords":"KRAS; TLR3; Cancer research; Medicine; Colorectal cancer; Gene silencing; Multiplicity of infection; Innate immune system; Immunology; Cancer; Biology; Immune system; Toll-like receptor; Internal medicine; Virus","score_opus":0.04554576866558383,"score_gpt":0.4181639072591878,"score_spread":0.37261813859360393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488801100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991076,0.005166481,0.000049403152,0.0010500173,0.00028199365,0.0010832987,0.00080752815,0.000026672242,0.0004586233],"genre_scores_gemma":[0.9858157,0.0042311936,0.000103106446,0.00013388196,0.0005990747,0.0027843376,0.00020611919,0.0000823406,0.006044252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974937,0.00013139244,0.0002125363,0.00069860485,0.00047932068,0.0009844701],"domain_scores_gemma":[0.9985956,0.00007634914,0.000054415108,0.0004290267,0.0005133153,0.00033130162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048698374,0.00021774373,0.00020414946,0.00011907897,0.0002779457,0.00007751096,0.0004544088,0.00019081452,0.0023711545],"category_scores_gemma":[0.00008493002,0.00015771097,0.00012359001,0.00020263718,0.0003037866,0.000020472991,0.00011654386,0.00018095961,0.00012633763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031701915,0.00016069732,0.0014581651,0.000035115634,0.00028467586,0.0000075067414,0.00006186661,0.0000044184994,0.942711,0.000022947117,0.0125712175,0.039512187],"study_design_scores_gemma":[0.0024494776,0.0012102601,0.0011693767,0.000056830002,0.0000082549,0.000003343667,0.000048388734,0.0000037879768,0.75765395,0.0002675746,0.23691696,0.0002117799],"about_ca_topic_score_codex":0.0033290614,"about_ca_topic_score_gemma":0.003446628,"teacher_disagreement_score":0.22434573,"about_ca_system_score_codex":0.00037291995,"about_ca_system_score_gemma":0.001316785,"threshold_uncertainty_score":0.9985408},"labels":[],"label_agreement":null},{"id":"W2488932711","doi":"10.1158/1538-7445.am2016-3422","title":"Abstract 3422: The influence of genetic and clinical factors on the outcome following a diagnosis of small cell carcinoma of the ovary, hypercalcemic type","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Small-cell carcinoma; Germline; Germline mutation; SMARCA4; Oncology; Disease; Chemotherapy; Internal medicine; Medicine; Cancer; Somatic cell; Cohort; Biology; Mutation; Genetics; Gene; Chromatin remodeling","score_opus":0.10574712745662557,"score_gpt":0.3927439524542904,"score_spread":0.2869968249976648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488932711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766386,0.001590132,0.0000025544218,0.0003421714,0.00007922298,0.00021826154,0.000023839317,0.0000012058806,0.00007877799],"genre_scores_gemma":[0.99869615,0.0010852467,0.000011730335,0.000050647533,0.00004876033,0.000023359173,5.124256e-7,0.0000121524945,0.00007143602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988759,0.00016899018,0.00031730373,0.00020003605,0.00025815095,0.00017960941],"domain_scores_gemma":[0.99866897,0.00048667763,0.00010862739,0.00053304865,0.00016585793,0.000036826463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006614795,0.00008442331,0.00014948206,0.000019864334,0.00007027922,0.0000053347244,0.00044251035,0.00009197396,0.000022019522],"category_scores_gemma":[0.00045234573,0.000034192122,0.00013627,0.00011640329,0.00040515745,0.0000017622443,0.00018772954,0.00016787095,8.094995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049815608,0.00002608743,0.6408745,0.000035768247,0.000026619804,2.3686964e-7,0.00006236401,0.00007309425,0.35740983,0.0000047967173,0.00011931271,0.001317588],"study_design_scores_gemma":[0.0002455135,0.00016255189,0.7010484,0.00009082682,0.000015547072,2.8240993e-7,0.000069184665,0.0000076042893,0.29811257,0.000036278085,0.0001668651,0.00004440231],"about_ca_topic_score_codex":0.0006753451,"about_ca_topic_score_gemma":0.00010160956,"teacher_disagreement_score":0.060173873,"about_ca_system_score_codex":0.000019513902,"about_ca_system_score_gemma":0.00020260454,"threshold_uncertainty_score":0.14928195},"labels":[],"label_agreement":null},{"id":"W2489164082","doi":"10.1158/0008-5472.sabcs12-p4-16-02","title":"Abstract P4-16-02: A survival benefit from locoregional radiotherapy for node-positive and CMF treated breast cancer is most significant in Luminal A tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Lymph node; Radiation therapy; Proportional hazards model; Chemotherapy; Mastectomy; Cancer; Estrogen receptor; Hormone receptor","score_opus":0.04321870777981284,"score_gpt":0.36308496525879724,"score_spread":0.3198662574789844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489164082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98166525,0.01130138,0.000032098826,0.002106224,0.00012547243,0.0006543849,0.0039865924,0.0000091956135,0.00011941329],"genre_scores_gemma":[0.9936181,0.0030745573,0.00006763677,0.00023016096,0.0011844158,0.0013016151,0.00027568534,0.000054793927,0.0001930566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979451,0.00007371569,0.00022588014,0.0006080012,0.00034302505,0.00080432475],"domain_scores_gemma":[0.9990381,0.00012923771,0.00006963916,0.00025782807,0.0002896778,0.00021552433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029164224,0.0002740989,0.000328402,0.00011304126,0.00018795319,0.000040279327,0.00018634398,0.00015087627,0.00021043558],"category_scores_gemma":[0.000016726612,0.00024378163,0.000080514066,0.00023790747,0.00036220977,0.000017507722,0.00009465943,0.00020178728,0.0000029055802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048829825,0.00043220446,0.70748323,0.000069355876,0.0007596328,0.000012877019,0.0011436231,0.000025890968,0.2550607,0.000051076615,0.004931922,0.02514649],"study_design_scores_gemma":[0.0028958924,0.00013182272,0.90784454,0.00015634217,0.000033557575,0.00000971338,0.0003899403,0.000017629138,0.0855345,0.000049485458,0.00261624,0.0003203607],"about_ca_topic_score_codex":0.04142974,"about_ca_topic_score_gemma":0.004480698,"teacher_disagreement_score":0.20036128,"about_ca_system_score_codex":0.0005019315,"about_ca_system_score_gemma":0.00028731133,"threshold_uncertainty_score":0.9941127},"labels":[],"label_agreement":null},{"id":"W2489524233","doi":"10.1158/1538-7445.am2016-1682","title":"Abstract 1682: Lyn drives cancer metastasis via post-translational regulation of SNAI proteins","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LYN; Epithelial–mesenchymal transition; Cancer research; Metastasis; Biology; Protein kinase B; Cancer; Tyrosine kinase; Signal transduction; Cell biology","score_opus":0.033570736401520855,"score_gpt":0.3621538080569122,"score_spread":0.32858307165539136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489524233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973554,0.003598413,0.0020052074,0.003191569,0.00016740803,0.00065604824,0.00028934432,0.00001409111,0.00034239166],"genre_scores_gemma":[0.99657774,0.000986605,0.00026594076,0.000020228834,0.0005053755,0.0002962481,0.000103263104,0.00003688396,0.0012076945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981372,0.0001228888,0.00031089038,0.0004475719,0.00060996384,0.0003715162],"domain_scores_gemma":[0.9984802,0.000044744127,0.00012695028,0.00039255084,0.00085181795,0.00010373915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004949962,0.0001479376,0.0001641369,0.00016951948,0.00011843844,0.000016494461,0.00022027046,0.00019808128,0.0010547225],"category_scores_gemma":[0.00007960013,0.000117266674,0.00011341216,0.00029118202,0.00028518232,0.000021269121,0.00006719456,0.00013042669,0.0000147922565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032510384,0.000036541067,0.0014541143,0.000054167824,0.000119876764,3.467287e-7,0.000064567066,0.0005517014,0.91915727,0.00009387095,0.0010504178,0.07709203],"study_design_scores_gemma":[0.000688815,0.0001262298,0.08727979,0.00012989323,0.000017047894,0.0000018015414,0.000016238779,0.00003076525,0.89813066,0.0003629434,0.013057946,0.00015789078],"about_ca_topic_score_codex":0.0007363526,"about_ca_topic_score_gemma":0.0011648998,"teacher_disagreement_score":0.085825674,"about_ca_system_score_codex":0.00013329172,"about_ca_system_score_gemma":0.0006093115,"threshold_uncertainty_score":0.99985844},"labels":[],"label_agreement":null},{"id":"W2489675524","doi":"10.1158/1538-7445.am2016-4681","title":"Abstract 4681: Oseltamivir phosphate completely ablates tumor refractoriness to conventional chemotherapeutics abraxane and gemcitabine in xenografts of tumors in mouse model of human pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Medicine; Internal medicine; Oncology; Pancreatic tumor; Cancer; Metastasis; Cancer research; Chemotherapy","score_opus":0.06745116071745585,"score_gpt":0.3898088136830993,"score_spread":0.32235765296564345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489675524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681365,0.0019160468,0.000012426862,0.00023076173,0.000018711666,0.000491195,0.00042716277,0.0000035980188,0.00008646181],"genre_scores_gemma":[0.9970605,0.0019174722,0.000050286573,0.00003239127,0.00005058909,0.00029130824,0.000026228627,0.0000308848,0.0005403538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982347,0.00006608503,0.00037707688,0.00040184578,0.00041710836,0.000503216],"domain_scores_gemma":[0.99913394,0.000055511166,0.00009064702,0.00029083382,0.0002765776,0.00015249204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004595505,0.00016022248,0.00031989158,0.0002523582,0.000042264197,0.000012986647,0.00024114733,0.000067101915,0.00013505254],"category_scores_gemma":[0.000058106092,0.00012761004,0.000047682355,0.00028660372,0.00028680798,0.000017233735,0.00015332637,0.00014508728,0.0000017343282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007405909,0.00019526709,0.093112245,0.00018819277,0.00006492448,0.0000060854995,0.00006955162,0.00013981185,0.90259063,0.000060973587,0.00008571476,0.002746019],"study_design_scores_gemma":[0.0028317447,0.00032621535,0.10171617,0.00037066796,0.0000049895866,8.2354165e-7,0.00003590579,0.000052087904,0.8939335,0.0002676612,0.00031109538,0.00014916017],"about_ca_topic_score_codex":0.009629864,"about_ca_topic_score_gemma":0.008973842,"teacher_disagreement_score":0.008657149,"about_ca_system_score_codex":0.00017511971,"about_ca_system_score_gemma":0.0004044717,"threshold_uncertainty_score":0.9969651},"labels":[],"label_agreement":null},{"id":"W2489962920","doi":"10.1158/1538-7445.am2016-lb-114","title":"Abstract LB-114: GC1118, a new anti-EGFR antibody overcome acquired resistance to cetuximab in colorectal cancer xenograft model","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cetuximab; Panitumumab; Colorectal cancer; Amphiregulin; Medicine; Epiregulin; Cancer research; Epidermal growth factor receptor; Cancer; Oncology; Internal medicine; KRAS","score_opus":0.08400722138272548,"score_gpt":0.43923753231531637,"score_spread":0.3552303109325909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489962920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685118,0.0074650436,0.00003872747,0.01654868,0.0002435263,0.0014528439,0.00022566559,0.00007882014,0.005434892],"genre_scores_gemma":[0.9796859,0.0053726775,0.00017117687,0.00031775518,0.00041929708,0.00081770954,0.000009586246,0.00007342743,0.013132497],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960016,0.00007610004,0.00047182705,0.0009332069,0.0011742929,0.0013429853],"domain_scores_gemma":[0.998198,0.00022365611,0.00007517426,0.00047238427,0.00045632446,0.0005744978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052882213,0.00036171076,0.0007824617,0.0005341449,0.0002452463,0.00006244941,0.00034582336,0.00015922965,0.000817871],"category_scores_gemma":[0.0002100754,0.00024879046,0.00015430008,0.0012336919,0.00029036056,0.00023243084,0.00027010002,0.00032869974,0.0001041477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008704929,0.000614813,0.11193005,0.00031280046,0.00038073806,0.0004160105,0.0023267579,0.00014064422,0.79885954,0.00024258495,0.043446437,0.03262469],"study_design_scores_gemma":[0.014140874,0.0011238223,0.85356414,0.0034885262,0.000095684154,0.000010079589,0.00039752782,0.000119780845,0.091804005,0.0008161455,0.033566233,0.000873187],"about_ca_topic_score_codex":0.005106697,"about_ca_topic_score_gemma":0.017657002,"teacher_disagreement_score":0.7416341,"about_ca_system_score_codex":0.00262414,"about_ca_system_score_gemma":0.001885976,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W2490173279","doi":"10.1158/1538-7445.am2016-484","title":"Abstract 484: Pre-treatment platelet counts as a prognostic factor in stage II and III rectal adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Thrombocytosis; Internal medicine; Gastroenterology; Stage (stratigraphy); Platelet; Log-rank test; Colorectal cancer; Adjuvant; Adenocarcinoma; Adverse effect; Cancer; Adjuvant therapy; Surgery; Oncology; Survival analysis","score_opus":0.06089847911565007,"score_gpt":0.390520851160662,"score_spread":0.32962237204501194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490173279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281305,0.0024184058,4.003535e-7,0.0005501689,0.00008056845,0.0011127569,0.000101539015,0.000036729827,0.002886406],"genre_scores_gemma":[0.9935799,0.00071154494,0.000019958077,0.00002544938,0.00011767607,0.00049832556,0.0000061242404,0.000027125247,0.005013889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984904,0.000057803092,0.00018121357,0.00034829057,0.00047135653,0.00045094595],"domain_scores_gemma":[0.9991874,0.00017964534,0.000031761734,0.00024887602,0.00012101941,0.00023129024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025739166,0.0001342358,0.00018984047,0.00020215363,0.000094204544,0.00002253156,0.00009189051,0.00010199556,0.0027535327],"category_scores_gemma":[0.00019003669,0.0000882449,0.000037293117,0.00016663963,0.00020326255,0.00007882889,0.00009209892,0.00016253728,0.00014875726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019157609,0.0002488649,0.89770097,0.00027094522,0.00015459227,0.00090085954,0.0007529026,8.059179e-8,0.02413122,0.00004839428,0.0024251041,0.07145032],"study_design_scores_gemma":[0.0031676732,0.00057524204,0.9555075,0.00064010156,0.000016841333,0.000018151986,0.00009195859,0.0000061291503,0.025624322,0.00005548447,0.014147263,0.0001493122],"about_ca_topic_score_codex":0.00028941044,"about_ca_topic_score_gemma":0.00009017509,"teacher_disagreement_score":0.071301006,"about_ca_system_score_codex":0.0006807431,"about_ca_system_score_gemma":0.00060081575,"threshold_uncertainty_score":0.9981581},"labels":[],"label_agreement":null},{"id":"W2490190475","doi":"10.1158/1538-7445.am2016-754","title":"Abstract 754: Targeting carbonic anhydrase IX in multiple pancreatic ductal adenocarcinoma models results in tumor growth inhibition and increased survival","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; SignalChem (Canada); Vancouver General Hospital","funders":"","keywords":"Cancer research; Metastasis; Pancreatic cancer; Biology; Tumor hypoxia; Growth inhibition; Gene silencing; In vivo; Adenocarcinoma; Cell growth; Cancer; Medicine; Internal medicine; Radiation therapy","score_opus":0.040289971197373306,"score_gpt":0.3059747521227582,"score_spread":0.2656847809253849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490190475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879951,0.010647246,0.000010894282,0.00026433784,0.00018312964,0.0004166816,0.0001715975,0.000009784263,0.00030124714],"genre_scores_gemma":[0.99360645,0.0051170676,0.000043890926,0.00003458389,0.0008153527,0.00019140584,0.00006968899,0.000035588237,0.00008596133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770206,0.0002669287,0.00036777472,0.0006596943,0.0003423402,0.0006611776],"domain_scores_gemma":[0.9991579,0.00013125796,0.000069659014,0.000287789,0.0001697612,0.00018361652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013776117,0.00018350715,0.00026053155,0.0002371931,0.000082205,0.000033486256,0.0001491308,0.00013907948,0.000013510852],"category_scores_gemma":[0.000710037,0.00015432118,0.000048647555,0.00028333766,0.00021887272,0.000028486615,0.00016488039,0.0002771213,0.0000034908967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011905447,0.000066852284,0.037873935,0.000071779265,0.000015109601,0.00004023907,0.00016411835,0.000037763646,0.9591901,0.000037896174,0.0004995159,0.00081215665],"study_design_scores_gemma":[0.013940982,0.00029244725,0.46030423,0.00058630545,0.000019421503,0.000024394185,0.0005687758,0.0005252227,0.52059084,0.00093617174,0.00148059,0.00073064223],"about_ca_topic_score_codex":0.0117233945,"about_ca_topic_score_gemma":0.006192117,"teacher_disagreement_score":0.4385993,"about_ca_system_score_codex":0.00015593976,"about_ca_system_score_gemma":0.0004285365,"threshold_uncertainty_score":0.9948576},"labels":[],"label_agreement":null},{"id":"W2490532145","doi":"10.1158/1538-7445.am2016-5221","title":"Abstract 5221: Linking the molecular profile of colorectal tumors to germline genetic and environmental risk factors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Germline; Germline mutation; Genetics; Biology; Loss of heterozygosity; Penetrance; Colorectal cancer; Lynch syndrome; Population; Genetic testing; Gene; Cancer; Computational biology; Medicine; Mutation; DNA mismatch repair; Phenotype; Allele","score_opus":0.01698813658530704,"score_gpt":0.3033747185994985,"score_spread":0.2863865820141914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490532145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961246,0.0026281923,0.00015596018,0.0001798419,0.00005446205,0.0003426106,0.00042760608,0.0000025014756,0.00008417295],"genre_scores_gemma":[0.9976849,0.0018358106,0.00011090799,0.000035768502,0.00011920983,0.00007950935,0.000019699319,0.000023378341,0.000090791385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896705,0.00005667136,0.00015903416,0.00029751778,0.00022550113,0.00029424546],"domain_scores_gemma":[0.9994141,0.000099475634,0.000054159857,0.00026745614,0.0000469149,0.00011788609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026770253,0.000104043946,0.00010596045,0.000047330697,0.00010392319,0.000018860395,0.00021508368,0.00006916286,0.00008112182],"category_scores_gemma":[0.00013830612,0.00006531934,0.000046082816,0.00007100605,0.00025165113,0.00000198587,0.00026316594,0.00011409825,0.000005955596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109265115,0.000023070477,0.034157943,0.00001192791,0.00003069528,0.000003381168,0.000087356,0.00006685581,0.95635337,0.000015796924,0.00029324173,0.008847078],"study_design_scores_gemma":[0.0002930951,0.0003146991,0.13554758,0.000034807632,0.000007980875,0.00000193926,0.000101740436,0.0000104648325,0.8594006,0.00006262683,0.0041160826,0.00010841758],"about_ca_topic_score_codex":0.00028038927,"about_ca_topic_score_gemma":0.00007555588,"teacher_disagreement_score":0.10138963,"about_ca_system_score_codex":0.000053327116,"about_ca_system_score_gemma":0.0001228838,"threshold_uncertainty_score":0.26636454},"labels":[],"label_agreement":null},{"id":"W2490643784","doi":"10.1158/1538-7445.am2016-1319","title":"Abstract 1319: A novel formulation of CX-5461, a small-molecule inhibitor of rRNA synthesis, and its use for treatment of acute myeloid leukemia models","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"In vivo; Bioavailability; Pharmacokinetics; Chemistry; Pharmacology; Dosing; Medicine; Biology","score_opus":0.10647007136304806,"score_gpt":0.3607874416196003,"score_spread":0.2543173702565522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490643784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973841,0.0008559933,0.0007434306,0.00005748613,0.000025767886,0.0003751021,0.0005128041,0.000001744663,0.0000435885],"genre_scores_gemma":[0.99507713,0.0041962652,0.0001689527,0.000004852278,0.00006118926,0.00016003802,0.00001640473,0.000014907219,0.00030024513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991548,0.000020325011,0.00023590353,0.00023666742,0.0001465881,0.00020569432],"domain_scores_gemma":[0.999044,0.000082021405,0.00010254952,0.00021246482,0.00050272106,0.000056229695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015492192,0.000098782184,0.00019310325,0.00007082331,0.0000287331,0.00000732161,0.000110719244,0.00011125823,0.000010242101],"category_scores_gemma":[0.00007107761,0.00006979686,0.00008591004,0.00005979488,0.000075632226,0.000015187166,0.000054042466,0.000022261369,5.2085375e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008525513,0.000075811506,0.00015886528,0.00008659893,0.0001682198,4.3927872e-7,0.00006104946,0.000045571935,0.9919204,0.00008122004,0.00009602813,0.006453246],"study_design_scores_gemma":[0.00086699834,0.0007803768,0.0007911095,0.00014453313,0.000029827814,8.6713925e-7,0.000020526812,0.00024651168,0.9967087,0.000045034434,0.00029035332,0.000075170756],"about_ca_topic_score_codex":0.0002593378,"about_ca_topic_score_gemma":0.000080176775,"teacher_disagreement_score":0.0063780756,"about_ca_system_score_codex":0.00007131898,"about_ca_system_score_gemma":0.00028770772,"threshold_uncertainty_score":0.28462332},"labels":[],"label_agreement":null},{"id":"W2490975642","doi":"10.1158/1538-7445.am2016-4339","title":"Abstract 4339: Prognostic significance of copy number alteration burden in unfavorable intermediate-risk prostate cancers harboring intraductal carcinoma and cribriform architecture","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Cohort; Biochemical recurrence; Oncology; Internal medicine; Cribriform; Prostate; Cancer; Hazard ratio; Pathological; Clinical endpoint; Carcinoma; Pathology; Confidence interval; Clinical trial","score_opus":0.03260565768850089,"score_gpt":0.35373409606618317,"score_spread":0.3211284383776823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490975642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930077,0.0020138978,0.000029188535,0.0021234013,0.00013672652,0.0019305632,0.00018020794,0.000029641571,0.00054865447],"genre_scores_gemma":[0.99260587,0.0052989353,0.000113045564,0.0000132922,0.0003267251,0.00075719453,0.000023092136,0.000050390052,0.00081147935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970279,0.0001541641,0.0004735224,0.0006200675,0.00080922537,0.00091517554],"domain_scores_gemma":[0.99831426,0.00045597984,0.00012784451,0.00034807975,0.0004333836,0.0003204512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095953804,0.0002396167,0.00042767334,0.0003739205,0.00013349406,0.000055813696,0.00018500662,0.000119058146,0.00030751782],"category_scores_gemma":[0.00041653143,0.00015842251,0.00005880243,0.00060646544,0.0007239322,0.00025485203,0.00011448931,0.0007359119,0.000019262165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027110234,0.00008308121,0.7055578,0.0009211178,0.000096769276,0.00016752453,0.002585983,0.00005245272,0.19916491,0.000042829437,0.0003155974,0.0883009],"study_design_scores_gemma":[0.008620056,0.001241808,0.57165873,0.0034015134,0.00006325148,0.000033023112,0.00093758234,0.00016398303,0.41037935,0.0015569895,0.0014978203,0.00044588227],"about_ca_topic_score_codex":0.007414115,"about_ca_topic_score_gemma":0.0008165751,"teacher_disagreement_score":0.21121445,"about_ca_system_score_codex":0.0011909688,"about_ca_system_score_gemma":0.0016435235,"threshold_uncertainty_score":0.9991956},"labels":[],"label_agreement":null},{"id":"W2491027990","doi":"10.1158/1538-7445.am2016-2921","title":"Abstract 2921: The retinoblastoma protein regulates hypoxia-inducible factor-1α-mediated transcriptional programs, tumor cell invasiveness, tumor growth and metastasis in human breast cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Aryl hydrocarbon receptor nuclear translocator; Cancer research; Biology; Gene knockdown; Retinoblastoma; Retinoblastoma protein; Small hairpin RNA; PI3K/AKT/mTOR pathway; Carcinogenesis; SNAI1; Metastasis; Epithelial–mesenchymal transition; Transcription factor; Molecular biology; Cell; Cancer; Signal transduction; Gene; Cell biology; Cell cycle; Aryl hydrocarbon receptor","score_opus":0.03555327160495585,"score_gpt":0.303042263464484,"score_spread":0.2674889918595281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491027990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896539,0.006760109,0.000005291578,0.0011544001,0.00024545207,0.0012691829,0.0007632603,0.00002103745,0.00012737521],"genre_scores_gemma":[0.9948949,0.0018692245,0.000027538757,0.000087093686,0.0009780164,0.0014218908,0.00004565283,0.000068513444,0.00060715346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969213,0.0002946021,0.0003914742,0.000867732,0.0006239956,0.000900884],"domain_scores_gemma":[0.99872345,0.000060861534,0.00013134198,0.0004878113,0.00034269085,0.0002538288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007200263,0.00032380433,0.0003340805,0.00018130797,0.00029096336,0.00010869566,0.0005078148,0.00015458697,0.00033871352],"category_scores_gemma":[0.000057729932,0.00021258993,0.00012234227,0.00042170892,0.00066257745,0.000036732206,0.00016435077,0.00041309893,0.000009648076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003508051,0.000118183525,0.001843214,0.00018693988,0.000058187583,0.00000891104,0.00010068588,0.0000029138357,0.9915095,0.00003367339,0.00097150623,0.004815462],"study_design_scores_gemma":[0.0015942072,0.00014911551,0.050611276,0.00021625364,0.000017094088,0.000011375126,0.0001379623,9.223919e-7,0.9283717,0.00009842066,0.018485907,0.0003057559],"about_ca_topic_score_codex":0.0024674942,"about_ca_topic_score_gemma":0.0018987181,"teacher_disagreement_score":0.06313781,"about_ca_system_score_codex":0.00011733891,"about_ca_system_score_gemma":0.00073642045,"threshold_uncertainty_score":0.8669166},"labels":[],"label_agreement":null},{"id":"W2491139972","doi":"10.1158/1538-7445.am2016-1857","title":"Abstract 1857: Dysregulation of transsulfuration enzymes contribute to malignant transformation in a murine model of colitis-associated carcinogenesis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Azoxymethane; Colorectal cancer; Cancer; Carcinogenesis; Medicine; Ulcerative colitis; Cancer research; Colitis; Transsulfuration; Pathology; Tumor progression; Inflammatory bowel disease; Intestinal mucosa; Cystathionine beta synthase; Internal medicine; Biology; Enzyme; Disease; Biochemistry","score_opus":0.055772715555941106,"score_gpt":0.35126240519889007,"score_spread":0.29548968964294897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491139972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956903,0.00033524304,0.002421347,0.0006016366,0.000040392653,0.00046228475,0.00032001862,0.0000044455837,0.0001243455],"genre_scores_gemma":[0.9992365,0.00034409403,0.000067933426,0.000015032099,0.000034671433,0.00014026933,0.00008240693,0.000012651189,0.000066439185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986808,0.00015176511,0.0003879214,0.00022718626,0.00025805042,0.00029430346],"domain_scores_gemma":[0.99908584,0.00006463086,0.000080075806,0.00021015138,0.0005029792,0.00005628944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008025726,0.00009035745,0.00019398992,0.0001853201,0.00003180853,0.0000044792278,0.00017242797,0.00016160274,0.000025830537],"category_scores_gemma":[0.00015883283,0.00007367125,0.0000524351,0.00023307915,0.00011441642,0.000010075391,0.000029071418,0.000056711076,0.0000013793508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006492722,0.000057030196,0.0031403415,0.00004667688,0.000027963635,4.529038e-7,0.00024035756,0.0012083509,0.9904111,0.00043288586,0.000066328255,0.0037192358],"study_design_scores_gemma":[0.0011122654,0.00017448142,0.06128853,0.000106172134,0.0000048035795,5.484978e-7,0.00004568444,0.00029329385,0.9364731,0.00031714476,0.00009935557,0.000084624524],"about_ca_topic_score_codex":0.0004005502,"about_ca_topic_score_gemma":0.0017500063,"teacher_disagreement_score":0.058148187,"about_ca_system_score_codex":0.0001292328,"about_ca_system_score_gemma":0.00024698576,"threshold_uncertainty_score":0.30042264},"labels":[],"label_agreement":null},{"id":"W2491175387","doi":"10.1158/1538-7445.am2016-117","title":"Abstract 117: Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University","funders":"","keywords":"Cancer research; Diffuse large B-cell lymphoma; Mutation; Exome sequencing; KRAS; Lymphoma; Biology; Gene; Somatic evolution in cancer; Exome; Oncology; Medicine; Genetics; Immunology","score_opus":0.03747784840525626,"score_gpt":0.3503774187578832,"score_spread":0.31289957035262694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491175387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654354,0.009058812,0.0000014187119,0.00083471276,0.00005289336,0.00028347777,0.000067339846,0.000016553455,0.003141245],"genre_scores_gemma":[0.9875875,0.010490296,0.000042875257,0.000042880547,0.000111975096,0.00011360234,0.0000039372344,0.000021681866,0.0015852213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986618,0.000050410665,0.00018758293,0.00027863524,0.0004441506,0.00037737773],"domain_scores_gemma":[0.9989424,0.00030403584,0.000047908747,0.00033356008,0.00016263367,0.00020951583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025967453,0.00010654022,0.00023020618,0.00013811536,0.00006911544,0.000011765019,0.00007888171,0.00008345609,0.0005936133],"category_scores_gemma":[0.00007155298,0.00006152391,0.000053245734,0.0001266205,0.00010825296,0.000046784782,0.0000698085,0.00008001404,0.00005997859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084213226,0.0041729407,0.6267871,0.0005594184,0.0001742104,0.0003467332,0.0005449673,1.8128549e-7,0.2830772,0.00020047974,0.012795895,0.070498735],"study_design_scores_gemma":[0.015827194,0.0004500678,0.83700794,0.0003928672,0.000039824114,0.000009692979,0.000085844134,0.0000025886186,0.11535266,0.000083284474,0.030648762,0.000099246776],"about_ca_topic_score_codex":0.0003239542,"about_ca_topic_score_gemma":0.00007969203,"teacher_disagreement_score":0.21022086,"about_ca_system_score_codex":0.00023944881,"about_ca_system_score_gemma":0.0002961503,"threshold_uncertainty_score":0.6499649},"labels":[],"label_agreement":null},{"id":"W2491239775","doi":"10.1158/1538-7445.am2016-2312","title":"Abstract 2312: TEM8/ANTXR1 specific T cells co-target tumor stem cells and tumor vasculature in triple-negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; Cancer; Cancer research; Cancer stem cell; Breast cancer; Adoptive cell transfer; Cancer cell; Stem cell; Biology; Immunology; Medicine; T cell; Internal medicine; Immune system; Cell biology","score_opus":0.057578385945931426,"score_gpt":0.3638192499155905,"score_spread":0.3062408639696591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491239775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798501,0.011151791,0.000008621289,0.0021206238,0.00068776665,0.001804787,0.0020446028,0.000049881204,0.0022818297],"genre_scores_gemma":[0.9838017,0.009413971,0.00012752003,0.0002693671,0.0009770535,0.0004532769,0.0000068524823,0.00010139813,0.004848839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958528,0.00020404461,0.00052829017,0.0009997891,0.0011879714,0.0012271039],"domain_scores_gemma":[0.9977652,0.00032136956,0.00014122562,0.0006430943,0.00049404486,0.00063509867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012926577,0.00038447182,0.0007950252,0.0005106374,0.0001539658,0.00009240483,0.00028400694,0.00014080267,0.007699706],"category_scores_gemma":[0.000025796886,0.00025896713,0.00017769837,0.0008528173,0.0005650823,0.0002507437,0.00012741657,0.0009810722,0.00017322184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002530353,0.0002879835,0.011275982,0.0008076278,0.00016324923,0.0006899067,0.00075363467,0.000017384418,0.8441901,0.000037752943,0.088505454,0.05074056],"study_design_scores_gemma":[0.008780195,0.00020074872,0.064438194,0.0019903777,0.000053082058,0.00007564558,0.0011608237,0.000008123956,0.80319226,0.000100927056,0.11946993,0.0005296853],"about_ca_topic_score_codex":0.0036730112,"about_ca_topic_score_gemma":0.00088279037,"teacher_disagreement_score":0.053162213,"about_ca_system_score_codex":0.0012081042,"about_ca_system_score_gemma":0.0010737622,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2491668168","doi":"10.1158/1538-7445.am2016-3940","title":"Abstract 3940: Baseline molecular markers and risk of distant relapse in the NeoSphere study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Trastuzumab; Cancer; CD8; Immune system; Immunology","score_opus":0.06699181598170728,"score_gpt":0.44153113491877855,"score_spread":0.37453931893707126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491668168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884191,0.0035309887,0.00002708789,0.0041698306,0.000051489067,0.0016678639,0.00006394865,0.000012103021,0.002057589],"genre_scores_gemma":[0.99369395,0.0050641303,0.00005707726,0.000048138307,0.0000897879,0.00037303945,0.0000018405663,0.00003763852,0.00063441606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957579,0.0010228482,0.00039009145,0.0004838668,0.0017097809,0.00063551846],"domain_scores_gemma":[0.99722666,0.0012357755,0.00006341808,0.00087896234,0.0003815858,0.00021358309],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00829354,0.00014757045,0.00031348865,0.00018925505,0.000095024036,0.000029845914,0.00038690178,0.00008502812,0.0011380446],"category_scores_gemma":[0.001728059,0.00007825284,0.000060423525,0.00080626016,0.0005436699,0.00006619146,0.00017294544,0.00090092194,0.000026008527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044170143,0.001071376,0.75539184,0.0005832534,0.00029573456,0.001467929,0.0028950109,0.000012286595,0.06908973,0.00016726906,0.014713555,0.14989501],"study_design_scores_gemma":[0.00957094,0.002608324,0.9426674,0.0017401874,0.00009995396,0.000025130728,0.011601506,0.00008154665,0.012550008,0.0007908988,0.01794656,0.00031753868],"about_ca_topic_score_codex":0.0069910823,"about_ca_topic_score_gemma":0.0019947505,"teacher_disagreement_score":0.18727557,"about_ca_system_score_codex":0.0003564133,"about_ca_system_score_gemma":0.0006562562,"threshold_uncertainty_score":0.99977505},"labels":[],"label_agreement":null},{"id":"W2491825984","doi":"10.1158/1538-7445.am2016-102","title":"Abstract 102: Pan-cancer analysis of sex differences in somatic mutation profiles","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cancer; Confounding; Genetics; Oncology; Genome; Internal medicine; Gene; Medicine","score_opus":0.06798868161219904,"score_gpt":0.40769004868531866,"score_spread":0.3397013670731196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491825984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966318,0.0019031732,0.0001653064,0.000532493,0.00006899826,0.00024291084,0.00012331577,0.0000052015116,0.00032680316],"genre_scores_gemma":[0.99680316,0.0015793209,0.000082236984,0.000018674937,0.000109789515,0.00056502305,0.000025073448,0.000015082835,0.0008016432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985615,0.00012255146,0.00027825896,0.00036166067,0.0003753352,0.00030066253],"domain_scores_gemma":[0.9991674,0.000101256635,0.00008896336,0.00033018878,0.0002650586,0.000047141417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004787137,0.000101227255,0.00021030978,0.00038517546,0.000049436567,0.000017159708,0.00026473432,0.00010883014,0.00055667636],"category_scores_gemma":[0.0001375202,0.0000730907,0.00007760675,0.0008344131,0.00023053608,0.000008514049,0.00007755005,0.00009538242,0.000007518184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057842022,0.00005001688,0.15982978,0.00006245647,0.00037306684,0.0000018017421,0.00033296892,0.00016234498,0.79105693,0.000022046781,0.00040187003,0.047648862],"study_design_scores_gemma":[0.00037083583,0.00005691401,0.4457082,0.000091572634,0.00004719776,2.6627876e-7,0.0003386021,0.00008471274,0.5525788,0.00018890272,0.00041764523,0.000116389274],"about_ca_topic_score_codex":0.0007606222,"about_ca_topic_score_gemma":0.002146381,"teacher_disagreement_score":0.2858784,"about_ca_system_score_codex":0.00021220693,"about_ca_system_score_gemma":0.00053387036,"threshold_uncertainty_score":0.60952157},"labels":[],"label_agreement":null},{"id":"W2492043181","doi":"10.1158/1538-7445.am2016-441","title":"Abstract 441: Association of interferon inducible genes with tumor immune microenvironment and chemotherapy resistance in high-grade serous epithelial ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"","keywords":"Ovarian cancer; Tumor microenvironment; CD8; Medicine; Immune system; Chemotherapy; Cancer research; Biomarker; Immunotherapy; Oncology; Immunohistochemistry; Cancer; Immunology; Internal medicine; Biology","score_opus":0.030738922161102807,"score_gpt":0.3265439540054483,"score_spread":0.2958050318443455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492043181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603077,0.0059498386,0.000005070593,0.017009843,0.000082421684,0.0006762651,0.00011238957,0.000010348575,0.0001230821],"genre_scores_gemma":[0.9839518,0.013503882,0.00020142591,0.00010452756,0.00016153423,0.0005296538,0.0000043891164,0.00003888454,0.0015039106],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815154,0.00008329893,0.0003084636,0.00044741653,0.00055691606,0.00045238313],"domain_scores_gemma":[0.9991395,0.00014553395,0.00015254911,0.00033268027,0.00011673623,0.0001130371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060046115,0.00016594307,0.0003898749,0.00017612505,0.000060106784,0.000019890269,0.00010502765,0.00008763293,0.0004684593],"category_scores_gemma":[0.000021341873,0.00010757041,0.000037347072,0.0002543769,0.00015111985,0.00009290751,0.000042137308,0.00023243576,0.0000067080405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032631261,0.00058285816,0.47733238,0.00028832647,0.0003548213,0.00006777064,0.0005859389,0.0000058502064,0.49135253,0.00010150584,0.0011368485,0.024928046],"study_design_scores_gemma":[0.006286001,0.00035406757,0.6954974,0.0013038713,0.000027738413,0.0000018038296,0.00005772517,5.189889e-7,0.29266027,0.00007706495,0.0036291627,0.00010437999],"about_ca_topic_score_codex":0.005872514,"about_ca_topic_score_gemma":0.0053108525,"teacher_disagreement_score":0.21816503,"about_ca_system_score_codex":0.0021699835,"about_ca_system_score_gemma":0.00034911124,"threshold_uncertainty_score":0.88775235},"labels":[],"label_agreement":null},{"id":"W2492213756","doi":"10.1158/1538-7445.am2016-2789","title":"Abstract 2789: Investigating the role of DNA methylation in pediatric choroid plexus tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Choroid plexus papilloma; DNA methylation; Methylation; Papilloma; Pathology; Biology; Epigenetics; Population; Medicine; Cancer research; DNA; Genetics; Internal medicine; Central nervous system; Gene; Gene expression","score_opus":0.046071462063131174,"score_gpt":0.3651131548031301,"score_spread":0.31904169273999894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492213756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149984,0.0068345643,0.00003154281,0.00025007513,0.000036310834,0.00018488122,0.0000105485005,0.0000027974334,0.0011494154],"genre_scores_gemma":[0.9974826,0.001972208,0.00005294538,0.000009391195,0.00029213433,0.000059641694,0.0000074962377,0.00001408042,0.000109500004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887174,0.00015532429,0.00022085098,0.00022062333,0.0002840549,0.00024741556],"domain_scores_gemma":[0.99932784,0.00011287389,0.00007884816,0.00025156807,0.00017331926,0.000055532095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012490267,0.00007064102,0.000082005805,0.00009831568,0.000065133645,0.000012784853,0.00020235908,0.00008394283,0.000033427445],"category_scores_gemma":[0.0004817924,0.00004471347,0.000033732827,0.00026656833,0.00011948234,0.0000051981588,0.00008887404,0.00012533419,0.0000052914697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015800582,0.000011462606,0.06524397,0.000012191121,0.0000048267607,2.4084454e-7,0.00007256619,0.000067637324,0.91175705,0.0000825765,0.000032603413,0.022699064],"study_design_scores_gemma":[0.0001872302,0.000051762872,0.19336899,0.000017119039,0.0000020986045,9.637709e-8,0.000055178287,0.000011910975,0.80270994,0.0021258427,0.0014146096,0.00005526012],"about_ca_topic_score_codex":0.00026565176,"about_ca_topic_score_gemma":0.00025195032,"teacher_disagreement_score":0.12812501,"about_ca_system_score_codex":0.000038135902,"about_ca_system_score_gemma":0.00021306907,"threshold_uncertainty_score":0.18233624},"labels":[],"label_agreement":null},{"id":"W2492249469","doi":"10.1158/1538-7445.am2016-1721","title":"Abstract 1721: Desmoplasia stem and progenitor cells within the tumor microenvironment","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Desmoplasia; Stem cell; Cancer stem cell; Biology; Pathology; Progenitor cell; Cancer cell; Cancer research; Stromal cell; Cancer; Tumor microenvironment; Cell biology; Medicine; Pancreatic cancer","score_opus":0.07024541353817394,"score_gpt":0.35526885054625557,"score_spread":0.28502343700808164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492249469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904252,0.004202981,0.000007572065,0.0038847278,0.00018812987,0.0007847447,0.00004629959,0.00001549595,0.0004448169],"genre_scores_gemma":[0.991381,0.0016730082,0.00009447509,0.00018887233,0.00033880587,0.00027471996,7.9502774e-7,0.000031191696,0.0060171178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984351,0.00007193447,0.00019262916,0.000336381,0.00054027606,0.00042367366],"domain_scores_gemma":[0.99912053,0.00014452334,0.000048510636,0.0003778717,0.00007157542,0.00023696628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080857147,0.000121043704,0.000179602,0.0000673565,0.0001631261,0.000037310267,0.00013622303,0.00003926089,0.0006242888],"category_scores_gemma":[0.00001751772,0.000058935417,0.000052282612,0.0001330427,0.00034458924,0.000050505307,0.00010463983,0.0002777971,0.00013885816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003406172,0.000060160626,0.0067059468,0.00014720374,0.0000690137,0.00006544022,0.00023651784,6.195432e-7,0.942912,0.000037440288,0.0069713304,0.042453744],"study_design_scores_gemma":[0.0011744183,0.00015743029,0.014921222,0.00025273958,0.000036737463,0.0000380694,0.00035149933,9.213855e-7,0.86000615,0.000026186008,0.1229372,0.00009740519],"about_ca_topic_score_codex":0.00026456587,"about_ca_topic_score_gemma":0.0001064954,"teacher_disagreement_score":0.11596587,"about_ca_system_score_codex":0.00030596287,"about_ca_system_score_gemma":0.00029674123,"threshold_uncertainty_score":0.68355244},"labels":[],"label_agreement":null},{"id":"W2492313905","doi":"10.1158/1538-7445.am2016-3585","title":"Abstract 3585: KIF11 silencing or inhibition induces chromosome instability","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Gene silencing; Chromosome instability; Propidium iodide; Biology; DAPI; Molecular biology; Cancer research; Flow cytometry; Cancer; Genetics; Gene; Chromosome; Apoptosis; Programmed cell death","score_opus":0.06260038515357891,"score_gpt":0.37207378119707657,"score_spread":0.30947339604349766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492313905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979282,0.00047375506,0.000077349185,0.0003665692,0.00011168165,0.00024591672,0.000085800086,0.000013172295,0.0006975277],"genre_scores_gemma":[0.99661535,0.00154956,0.000035643057,0.00008056914,0.00044926355,0.00012662332,0.000021701608,0.000021748487,0.0010995631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986357,0.00008288529,0.00018104343,0.0004237328,0.00025474592,0.00042189602],"domain_scores_gemma":[0.99919116,0.000043109805,0.000039783656,0.00037682234,0.00023785848,0.000111271176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005603331,0.00011216252,0.000110629284,0.00006876104,0.00013626306,0.000031049098,0.00018492807,0.0001744525,0.0005487191],"category_scores_gemma":[0.00020697738,0.00007301527,0.000052122352,0.00015690485,0.00020087106,0.000011853595,0.00017684509,0.00017350726,0.000048882594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013342305,0.000044941753,0.00085906486,0.0000515147,0.000016084221,0.00000508667,0.00004673947,0.0000014101042,0.9828535,0.000023902745,0.0015399399,0.01442439],"study_design_scores_gemma":[0.00042791828,0.00014802755,0.0050503854,0.00010401307,0.0000022451259,0.0000039579672,0.00008890515,8.4716e-7,0.97986305,0.000085333944,0.014090836,0.00013450255],"about_ca_topic_score_codex":0.0002199419,"about_ca_topic_score_gemma":0.0006319852,"teacher_disagreement_score":0.014289888,"about_ca_system_score_codex":0.00014631222,"about_ca_system_score_gemma":0.0004381645,"threshold_uncertainty_score":0.6008089},"labels":[],"label_agreement":null},{"id":"W2492668869","doi":"10.1158/1538-7445.am2016-ct142","title":"Abstract CT142: A phase I open-label, dose escalation study of a novel peptide (SOR-C13) antagonistic to the TRPV6 ion channel in patients with advanced solid tumor cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Employment and Social Development Canada; London Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Nausea; Adverse effect; Internal medicine; Constipation; Anemia; Gastroenterology; Pharmacology","score_opus":0.14304136051591537,"score_gpt":0.4414717890103327,"score_spread":0.2984304284944173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492668869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528384,0.000016384658,0.00005794319,0.00069768523,0.00038011113,0.0032462063,0.00016340992,0.000015004386,0.00013939696],"genre_scores_gemma":[0.9986801,0.00004731014,0.000012424303,0.000103417784,0.00010616852,0.0006826792,0.0000024911399,0.000038268267,0.0003271297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970466,0.00019466462,0.00037844802,0.0006738442,0.0010502585,0.00065617065],"domain_scores_gemma":[0.998665,0.00030515954,0.000157521,0.00036690326,0.00032168435,0.0001837561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007321268,0.00019212863,0.00028426663,0.00028935846,0.0003016917,0.000084654064,0.00082633056,0.000041422598,0.0000947999],"category_scores_gemma":[0.00045837346,0.00010269168,0.000019731726,0.0011540715,0.00020761386,0.0003612675,0.00028623795,0.00030973286,0.000023843513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010375689,0.007920138,0.0016091882,0.00008188654,0.000024245297,0.00002350566,0.006047996,0.006629691,0.94487405,0.00004633098,0.00086516736,0.021502104],"study_design_scores_gemma":[0.113537565,0.022534078,0.05027491,0.0026443098,0.00003340977,0.0000040167324,0.0050263237,0.0024709597,0.8003196,0.00009884938,0.0017894175,0.0012665582],"about_ca_topic_score_codex":0.0015973413,"about_ca_topic_score_gemma":0.0015341262,"teacher_disagreement_score":0.14455445,"about_ca_system_score_codex":0.00057807815,"about_ca_system_score_gemma":0.00044326409,"threshold_uncertainty_score":0.41876453},"labels":[],"label_agreement":null},{"id":"W2492942510","doi":"10.1158/1538-7445.am2016-41","title":"Abstract 41: DCA bind to EGFR/EGFRvIII/PDK1 and affect the proliferation and growth in TMZ resistant glioblastoma model","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Temozolomide; Cancer research; Epidermal growth factor receptor; Cell growth; Context (archaeology); EGFR inhibitors; Growth inhibition; Biology; Cancer; Chemistry; Medicine; Internal medicine; Glioma; Biochemistry","score_opus":0.03105470993159651,"score_gpt":0.34249519405369894,"score_spread":0.3114404841221024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492942510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066573,0.0054929266,0.00010112226,0.0026746676,0.000112212445,0.0005347837,0.000050038172,0.0000056332437,0.00036286726],"genre_scores_gemma":[0.9929341,0.0049956413,0.00004145978,0.00016537486,0.0006179886,0.0002756227,0.0000030919066,0.000022141581,0.00094458106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986414,0.00010447028,0.00014903772,0.0004359077,0.00027028375,0.00039895694],"domain_scores_gemma":[0.99934775,0.000047150363,0.0000273869,0.0002684296,0.00016120539,0.00014806958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008121846,0.00012527734,0.00013796429,0.00011694971,0.00014433077,0.0000650865,0.00016489765,0.00011012386,0.00001428193],"category_scores_gemma":[0.00018394022,0.00007770024,0.000026952726,0.00018022647,0.00018276335,0.000012140792,0.00016635266,0.00015382195,0.0000045254187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007991467,0.000020218944,0.0008695585,0.00004070408,0.000014889772,0.0000014627241,0.00016842732,0.000019213208,0.9801232,0.00026976597,0.004956402,0.012716975],"study_design_scores_gemma":[0.0023985584,0.00065364345,0.064444855,0.00021238122,0.0000146533885,0.000010410523,0.0001371579,0.000125706,0.8801056,0.0009686899,0.050531805,0.0003965399],"about_ca_topic_score_codex":0.0002621046,"about_ca_topic_score_gemma":0.0025542073,"teacher_disagreement_score":0.10001763,"about_ca_system_score_codex":0.00005587633,"about_ca_system_score_gemma":0.00025680233,"threshold_uncertainty_score":0.3168524},"labels":[],"label_agreement":null},{"id":"W2492968022","doi":"10.1158/1538-7445.am2016-443","title":"Abstract 443: Prognostic significance of CXCL12 protein levels in high-grade serous ovarian carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Stromal cell; Ovarian cancer; Medicine; CXCR4; Tumor progression; Serous fluid; Metastasis; Ovarian carcinoma; Cancer research; Internal medicine; Oncology; Tumor microenvironment; Cancer; Immune system; Chemokine; Receptor; Immunology","score_opus":0.11066042585686144,"score_gpt":0.3813610573062134,"score_spread":0.27070063144935197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492968022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945212,0.0006070261,0.000076576776,0.0028404077,0.000066322864,0.001428322,0.000042388634,0.000022618222,0.00039511622],"genre_scores_gemma":[0.9975445,0.000038033784,0.00023847488,0.000018116165,0.00031910941,0.00044788062,0.0000037719628,0.000039231574,0.0013508828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769884,0.00010613274,0.000388279,0.0004108372,0.00077053596,0.0006253714],"domain_scores_gemma":[0.9987264,0.00029199867,0.00007728279,0.00036543232,0.000338773,0.0002000654],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009904942,0.0001487954,0.00037857113,0.00027287714,0.000052622778,0.000015478267,0.0002051981,0.00012758079,0.0010567398],"category_scores_gemma":[0.00042895423,0.0001016674,0.00006537466,0.00060784444,0.0002254277,0.00008502908,0.000067899084,0.00044249016,0.000029051418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022748574,0.00016153588,0.09830406,0.00045110908,0.000022981209,0.000085537824,0.0001935367,0.0000032428222,0.89085424,0.00027488818,0.00028818025,0.009133184],"study_design_scores_gemma":[0.0020050125,0.00019908657,0.30502108,0.0012784919,0.000007946434,0.000005055742,0.000069599686,0.000007040358,0.6901838,0.00048403736,0.00061859045,0.000120261226],"about_ca_topic_score_codex":0.0031809877,"about_ca_topic_score_gemma":0.00019520857,"teacher_disagreement_score":0.20671703,"about_ca_system_score_codex":0.00044424293,"about_ca_system_score_gemma":0.00085697044,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W2492981070","doi":"10.1158/1538-7445.am2016-3019","title":"Abstract 3019: High throughput drug screening identified spleen tyrosine kinase as a novel therapeutic target in head and neck cancer with potent in vitro and in vivo activity","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; London Health Sciences Centre","funders":"","keywords":"Syk; Head and neck squamous-cell carcinoma; Cancer research; In vivo; Cancer; Medicine; Cell culture; Tyrosine kinase; Pharmacology; Head and neck cancer; Biology; Internal medicine; Receptor","score_opus":0.06321611745639652,"score_gpt":0.3782479406194234,"score_spread":0.3150318231630269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492981070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943468,0.0009196745,0.000027282602,0.0038190486,0.000009518356,0.00023862545,0.00018750202,0.000016218286,0.00043532244],"genre_scores_gemma":[0.99760365,0.0006135037,0.00008986987,0.000042313593,0.00008429095,0.000530924,0.0000067548467,0.00002805394,0.0010006193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983186,0.00002536864,0.000212736,0.00058354344,0.00034253058,0.0005172231],"domain_scores_gemma":[0.99917954,0.00023514793,0.000060569735,0.00032631308,0.00006837544,0.00013006208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036005274,0.00017684507,0.00024974908,0.00009786009,0.00009731989,0.000067680965,0.0001922425,0.00010593051,0.00037784845],"category_scores_gemma":[0.000038363396,0.00013773919,0.000019498195,0.00038977084,0.0002381483,0.00023653942,0.00013909122,0.0005298519,0.0000018664352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009647693,0.0001952398,0.027391165,0.00016380913,0.000017247386,0.00002316239,0.00019627015,0.000030708958,0.9641735,0.00002731352,0.000043571683,0.006773274],"study_design_scores_gemma":[0.002726665,0.000008656606,0.0986139,0.0006688078,0.0000040511686,0.0000037393381,0.00012289465,0.00007011724,0.89674073,0.0002629138,0.0005948094,0.00018273108],"about_ca_topic_score_codex":0.024923382,"about_ca_topic_score_gemma":0.008808112,"teacher_disagreement_score":0.07122274,"about_ca_system_score_codex":0.00035878122,"about_ca_system_score_gemma":0.00022353696,"threshold_uncertainty_score":0.9815697},"labels":[],"label_agreement":null},{"id":"W2493026365","doi":"10.1158/1538-7445.am2016-4409","title":"Abstract 4409: Assessment of sonic hedgehog pathway inhibition in a novel orthotopic xenograft bladder cancer murine model","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Smoothened; GLI1; Cancer research; Medicine; Hedgehog signaling pathway; Cancer; Sonic hedgehog; Pathology; Biology; Signal transduction; Internal medicine; Cell biology","score_opus":0.10172040286063291,"score_gpt":0.42685479097969375,"score_spread":0.3251343881190608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493026365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498427,0.0016467946,0.0013364926,0.0006068712,0.000080291735,0.0003959085,0.00019159628,0.000010424164,0.00074735645],"genre_scores_gemma":[0.99604434,0.0017727544,0.00023904772,0.00005624063,0.00020147626,0.00056276924,0.000017097802,0.00003514226,0.0010711482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980346,0.000073412324,0.00035585035,0.00051271194,0.00045349257,0.0005699564],"domain_scores_gemma":[0.9989618,0.000046379548,0.00008755035,0.00039660884,0.0004064064,0.000101233236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007814892,0.0001749043,0.00024107861,0.00018199938,0.0000837316,0.00001453019,0.00017850645,0.00016064737,0.00012034846],"category_scores_gemma":[0.00009886931,0.00013277541,0.00008589167,0.00025957226,0.0002598118,0.000009992345,0.00024198074,0.00023987632,0.000004281456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056539222,0.0001508165,0.00580071,0.00010408912,0.00006365934,0.000006879691,0.00012760713,0.0011347065,0.98816526,0.00010136569,0.00030741614,0.003980936],"study_design_scores_gemma":[0.0017561156,0.00018340103,0.025399014,0.00041942968,0.0000074111726,0.000001626603,0.00008574577,0.00033152275,0.968689,0.00013778596,0.002737608,0.00025129603],"about_ca_topic_score_codex":0.0005091287,"about_ca_topic_score_gemma":0.001946067,"teacher_disagreement_score":0.019598305,"about_ca_system_score_codex":0.00026359447,"about_ca_system_score_gemma":0.0014049129,"threshold_uncertainty_score":0.54144245},"labels":[],"label_agreement":null},{"id":"W2493683322","doi":"10.1158/1538-7445.am2016-2055","title":"Abstract 2055: A first-in-class hemoglobin-floxuridine conjugate for the treatment of advanced stage liver cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada)","funders":"","keywords":"Floxuridine; Medicine; Liver cancer; Toxicity; Dosing; Hepatic arterial infusion; Pharmacology; Cancer; Fluorouracil; Internal medicine; Gastroenterology; Metastasis","score_opus":0.06757439806638155,"score_gpt":0.3699343594984386,"score_spread":0.30235996143205707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493683322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773164,0.0059583117,0.000029082174,0.0034340885,0.00037989754,0.001535569,0.0008130665,0.0000287026,0.000089651534],"genre_scores_gemma":[0.98639935,0.007481036,0.00007864236,0.00004764159,0.0001865849,0.002314843,0.0000017405043,0.000034459797,0.00345568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758685,0.000101926315,0.00036708536,0.0004967414,0.0005975057,0.0008499041],"domain_scores_gemma":[0.99709225,0.0016531252,0.00011249797,0.00059611636,0.00040638688,0.00013962071],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009375884,0.00018496983,0.00030896015,0.00012339829,0.00019633111,0.00004422653,0.00046986065,0.000064356784,0.003121785],"category_scores_gemma":[0.00012995668,0.00010139265,0.00009799797,0.0003252058,0.00046306872,0.00023617569,0.00007420589,0.000084385465,0.00016323918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001434452,0.0002473124,0.0006848566,0.0001129834,0.000024499921,0.000021749713,0.0003905307,0.0011552098,0.9738365,0.00016466633,0.002030455,0.01989678],"study_design_scores_gemma":[0.0032563608,0.00041010088,0.0020822682,0.00020723452,0.00001296261,4.2071412e-7,0.00011142985,0.00020451307,0.93009734,0.000062244544,0.063411556,0.00014353686],"about_ca_topic_score_codex":0.004011285,"about_ca_topic_score_gemma":0.007943933,"teacher_disagreement_score":0.0613811,"about_ca_system_score_codex":0.0011530699,"about_ca_system_score_gemma":0.000551964,"threshold_uncertainty_score":0.9977895},"labels":[],"label_agreement":null},{"id":"W2493759960","doi":"10.1158/1538-7445.am2016-2744","title":"Abstract 2744: Synthetic lethal killing of RAD54B-deficient cancer cells by PARP1 silencing and inhibition","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Synthetic lethality; Olaparib; PARP1; Gene silencing; Cancer; Cancer research; RNA interference; Carcinogenesis; Biology; PARP inhibitor; Cancer cell; Genetics; Poly ADP ribose polymerase; Medicine; DNA repair; Polymerase; Gene; RNA","score_opus":0.07891429543170508,"score_gpt":0.4083609491209152,"score_spread":0.3294466536892101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493759960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588514,0.008993559,0.00025719174,0.0030294305,0.00024272317,0.00052237004,0.00020675099,0.00003876263,0.000824061],"genre_scores_gemma":[0.9880798,0.010544688,0.000058267302,0.0001274026,0.00027238872,0.00028378514,0.000004783005,0.000046678975,0.00058219745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746853,0.00011198583,0.00039959286,0.00049704633,0.0009359585,0.0005868991],"domain_scores_gemma":[0.99846005,0.0004012094,0.00012478365,0.00034393382,0.00042744417,0.00024259492],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009961365,0.00017290571,0.0003379147,0.00025186857,0.00014700727,0.000022506374,0.00009968086,0.00013192001,0.0017248263],"category_scores_gemma":[0.00007291203,0.00012674012,0.00007208258,0.00035222236,0.0005544995,0.00012691574,0.000060472063,0.00037093987,0.000030638115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030097703,0.0000765836,0.0008567494,0.00029848528,0.000036011385,0.000014579628,0.00042113638,0.000019189662,0.968126,0.000054225235,0.005775293,0.024020743],"study_design_scores_gemma":[0.0017543382,0.0001631455,0.0007208483,0.0027085769,0.000019138159,0.000009456724,0.00026013926,0.000027112479,0.98897105,0.00016659996,0.005045746,0.00015383812],"about_ca_topic_score_codex":0.0009936108,"about_ca_topic_score_gemma":0.000023740316,"teacher_disagreement_score":0.023866905,"about_ca_system_score_codex":0.0007154406,"about_ca_system_score_gemma":0.00042649702,"threshold_uncertainty_score":0.9991877},"labels":[],"label_agreement":null},{"id":"W2493877979","doi":"10.1158/1538-7445.am2016-sy22-01","title":"Abstract SY22-01: The role of exercise in cancer progression and mortality: Observational and molecular epidemiologic evidence","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Cancer; Observational study; Cancer prevention; Breast cancer; Colorectal cancer; Randomized controlled trial; Prostate cancer; Oncology; Internal medicine","score_opus":0.2495987441225208,"score_gpt":0.5066679475581009,"score_spread":0.25706920343558004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493877979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535523,0.14171605,0.0000035455737,0.004051587,0.000029963723,0.0005976289,0.000010940728,0.0000055773053,0.000032428863],"genre_scores_gemma":[0.918566,0.08099334,0.000026333422,0.000057261095,0.000049663005,0.00027136912,0.0000012237,0.000008044605,0.000026799533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847806,0.00018290392,0.00023458627,0.0002640168,0.00053075695,0.0003096535],"domain_scores_gemma":[0.9988246,0.0005293714,0.000051960058,0.00026148136,0.00017871693,0.00015385164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025088408,0.00007996838,0.00027449313,0.00008501051,0.00006862136,0.000006861985,0.0000807998,0.000085333704,0.00006932624],"category_scores_gemma":[0.0007743614,0.00003774569,0.00005124223,0.00022204795,0.00036283917,0.00007783613,0.00007986262,0.0002579396,0.0000012472443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021033174,0.000019491867,0.81748104,0.00040076082,0.000027686005,0.000014198523,0.0001077319,0.0000036142624,0.0395362,0.000107526736,0.000102887636,0.14198855],"study_design_scores_gemma":[0.0004346664,0.000046445042,0.9844861,0.003326851,0.000021459373,0.0000032345492,0.000083287334,0.000025168996,0.009713517,0.00081933115,0.0009907492,0.000049213566],"about_ca_topic_score_codex":0.003940261,"about_ca_topic_score_gemma":0.00017838743,"teacher_disagreement_score":0.16700505,"about_ca_system_score_codex":0.000120151344,"about_ca_system_score_gemma":0.00044884626,"threshold_uncertainty_score":0.5956522},"labels":[],"label_agreement":null},{"id":"W2493885788","doi":"10.1158/1538-7445.am2016-2157","title":"Abstract 2157: Enhanced <i>in vitro</i> activity of dianhydrogalactitol (VAL-083) in combination with platinum drugs: Impact of p53 and platinum-resistance","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cisplatin; Oxaliplatin; Carboplatin; Cytotoxicity; Medicine; Cancer research; Pharmacology; Colorectal cancer; Cancer; Internal medicine; Oncology; Chemistry; Chemotherapy; In vitro; Biochemistry","score_opus":0.02298068253548204,"score_gpt":0.35251318885379873,"score_spread":0.3295325063183167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493885788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953014,0.00049255637,0.000079642785,0.00037997853,0.000037246748,0.00092013215,0.00008847133,0.000014691467,0.0026858486],"genre_scores_gemma":[0.99909145,0.00042206372,0.0000727606,0.000005936311,0.000030401425,0.00013809715,0.000006013975,0.00003972014,0.00019357761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773043,0.00013713058,0.0003712654,0.00043045363,0.00082245405,0.0005082773],"domain_scores_gemma":[0.99848616,0.00043679003,0.00020426487,0.00041473605,0.0003070036,0.00015104303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007594853,0.00018878389,0.0005192591,0.00054567924,0.000033956818,0.000010057091,0.00012543424,0.0001591565,0.000097542375],"category_scores_gemma":[0.00024446356,0.00013558858,0.00007460668,0.0008838669,0.00037048722,0.00021483876,0.000054868407,0.00053158216,0.000003518464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006342146,0.00027103577,0.006519998,0.00032302938,0.000064776024,0.000031392832,0.00079640007,0.000036267596,0.96790636,0.00002043243,0.00008002597,0.01760814],"study_design_scores_gemma":[0.0074488316,0.00044408804,0.11645847,0.001766759,0.000012540062,0.0000029875564,0.00009174335,0.00003321026,0.87347645,0.00008711152,0.000042978507,0.00013482058],"about_ca_topic_score_codex":0.0026530572,"about_ca_topic_score_gemma":0.0018512361,"teacher_disagreement_score":0.10993847,"about_ca_system_score_codex":0.001051975,"about_ca_system_score_gemma":0.00096321944,"threshold_uncertainty_score":0.55291414},"labels":[],"label_agreement":null},{"id":"W2493964347","doi":"10.1158/1538-7445.am2016-1654","title":"Abstract 1654: p21 WAF1/Cip1 -mediated radiosensitization of bladder cancer cells by mTOR inhibitor, RAD001 disrupts the balance between autophagy and apoptosis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; PI3K/AKT/mTOR pathway; Cancer research; Autophagy; Clonogenic assay; Medicine; Cancer; Radiation therapy; Apoptosis; Pathology; Biology; Internal medicine","score_opus":0.03358266723921748,"score_gpt":0.343630119982385,"score_spread":0.31004745274316753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493964347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822246,0.007879918,0.00013227722,0.0070908084,0.00038790825,0.001076647,0.00072219595,0.0000618715,0.0004238134],"genre_scores_gemma":[0.98878276,0.008645097,0.000027143768,0.0001663847,0.0006554454,0.00021479957,0.00005505035,0.000082311126,0.0013710182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968712,0.00021118694,0.0004745525,0.00059037947,0.0011088375,0.00074386015],"domain_scores_gemma":[0.99771357,0.0005908108,0.00017284825,0.00060087716,0.000573585,0.00034829899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078477454,0.00025784475,0.00048149953,0.0002059963,0.00018510703,0.000037154252,0.00022949115,0.0002670735,0.0006937275],"category_scores_gemma":[0.0002806567,0.00016407142,0.00009810533,0.00071812444,0.0006997196,0.00013852783,0.00013231221,0.0005933813,0.00005410845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022034827,0.00005567691,0.0022984075,0.00016062705,0.00021078784,0.0000111772615,0.00033139114,0.000006956044,0.92755586,0.000010736714,0.053001303,0.016136723],"study_design_scores_gemma":[0.0027600462,0.00017840718,0.015068154,0.0007132585,0.000095690375,0.0000046188775,0.00008123651,0.000055905486,0.9569618,0.000023866529,0.02384076,0.000216231],"about_ca_topic_score_codex":0.0011942155,"about_ca_topic_score_gemma":0.000077742756,"teacher_disagreement_score":0.029405957,"about_ca_system_score_codex":0.0006249633,"about_ca_system_score_gemma":0.0006955542,"threshold_uncertainty_score":0.75958294},"labels":[],"label_agreement":null},{"id":"W2494068176","doi":"10.1158/1538-7445.am2016-lb-046","title":"Abstract LB-046: Mechanism and consequences of HDAC6 regulation by RanBPM","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"HDAC6; Downregulation and upregulation; Cortactin; Cell biology; Cancer research; Microtubule; Biology; Chemistry; Histone deacetylase; Cell; Cytoskeleton; Histone; Genetics; Gene","score_opus":0.03853102373983399,"score_gpt":0.3775140445110598,"score_spread":0.33898302077122583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494068176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512124,0.0020902932,0.00015747518,0.0010604078,0.000051077957,0.00023339383,0.000098202036,0.000005966798,0.0011819676],"genre_scores_gemma":[0.994846,0.0014871531,0.000054840504,0.00001568729,0.00011837788,0.00006731017,0.000016149457,0.000017896487,0.0033766245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998546,0.0001360803,0.0001775362,0.00034482672,0.00046092534,0.00033465057],"domain_scores_gemma":[0.99914044,0.000068891255,0.000046715242,0.00028981402,0.0003317717,0.00012235138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008246419,0.00008846824,0.000119420954,0.00009451361,0.00010760199,0.000016699414,0.00018619196,0.00013949667,0.0002634557],"category_scores_gemma":[0.00024051758,0.00006560296,0.000033926102,0.00012833267,0.001036594,0.000007659917,0.00011422337,0.00011981826,0.000017325428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012951146,0.000018307683,0.00013203378,0.00003717775,0.00001792407,0.0000019158667,0.000029134142,3.772573e-7,0.97629255,0.0004806716,0.01775919,0.0051012198],"study_design_scores_gemma":[0.00048715863,0.00016216819,0.00030851943,0.00006740128,0.0000017857782,0.0000034746408,0.000032808646,0.000001440897,0.9828098,0.00119867,0.014840847,0.00008594996],"about_ca_topic_score_codex":0.00034329735,"about_ca_topic_score_gemma":0.00007119225,"teacher_disagreement_score":0.00651724,"about_ca_system_score_codex":0.00007374915,"about_ca_system_score_gemma":0.0003192279,"threshold_uncertainty_score":0.3819374},"labels":[],"label_agreement":null},{"id":"W2494076453","doi":"10.1158/1538-7445.am2016-4765","title":"Abstract 4765: Impact of TP53 status and functional classification on molecular profiles in breast cancer subtypes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Cancer; Oncology; Medicine; Internal medicine; Context (archaeology); Disease; Estrogen receptor; Progesterone receptor; Bioinformatics; Biology","score_opus":0.04320682695892818,"score_gpt":0.37404954822450787,"score_spread":0.3308427212655797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494076453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996372,0.0018825696,0.000017731129,0.00068022823,0.00005833359,0.00018608868,0.0005340023,0.000002409984,0.00026667397],"genre_scores_gemma":[0.9924815,0.0070533184,0.000008829019,0.000029519118,0.00014978758,0.00012977545,0.000028863367,0.000017418402,0.00010093534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990069,0.000039804705,0.00014500276,0.0003002159,0.00020681597,0.0003012441],"domain_scores_gemma":[0.99935263,0.000059414706,0.000049151193,0.00021087355,0.00022872856,0.00009917443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021653295,0.0000944052,0.00010321524,0.00011089528,0.000035082452,0.000015753956,0.00007946468,0.00009065636,0.00018023372],"category_scores_gemma":[0.00007316294,0.00006791432,0.000044125805,0.00012324355,0.00016440361,0.000004951727,0.000057429283,0.00009980013,0.000004100932],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063979457,0.000050892195,0.12540431,0.00002236661,0.00003205977,0.000001451401,0.00001337159,0.00010096223,0.8590929,0.00027183627,0.0015128475,0.012857233],"study_design_scores_gemma":[0.0005899555,0.0001734353,0.8234192,0.00007613696,0.0000033013525,0.0000011725026,0.000021442527,0.0000087304525,0.17445381,0.00016149267,0.0009985613,0.00009276855],"about_ca_topic_score_codex":0.0016754358,"about_ca_topic_score_gemma":0.00036305469,"teacher_disagreement_score":0.69801486,"about_ca_system_score_codex":0.00020327949,"about_ca_system_score_gemma":0.0006576202,"threshold_uncertainty_score":0.27694654},"labels":[],"label_agreement":null},{"id":"W2494171817","doi":"10.1158/1538-7445.am2016-1145","title":"Abstract 1145: Zhx2 promotes survival of B-cell acute lymphoblastic leukemia cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"B cell; Biology; Transcription factor; Cancer research; Cell growth; Cell culture; Cell; Gene silencing; Downregulation and upregulation; Gene; Immunology; Genetics; Antibody","score_opus":0.048363568495479035,"score_gpt":0.3640221147039392,"score_spread":0.3156585462084602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494171817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494333,0.00075597444,0.0002522509,0.0016301273,0.00030926135,0.0010632778,0.0001930902,0.00009281388,0.010759884],"genre_scores_gemma":[0.97574484,0.0016827731,0.00035238764,0.000049574486,0.0007509974,0.00023119591,0.000017024031,0.00012744377,0.021043774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940749,0.00022957417,0.00069141603,0.0008500187,0.0026126227,0.0015414597],"domain_scores_gemma":[0.9943657,0.0020241498,0.00016458964,0.0010668613,0.0016721098,0.00070660806],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001687863,0.00036280276,0.0007326406,0.00062954216,0.00017749632,0.00004748777,0.0007687271,0.00032943825,0.0020984258],"category_scores_gemma":[0.0008609838,0.00023381926,0.00021830131,0.0010663371,0.0010385806,0.00021025083,0.00047411778,0.00066421815,0.00080634747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001489193,0.00033673886,0.00226626,0.0010077399,0.00015748094,0.00031838685,0.00021088001,0.0000052527384,0.9758057,0.000059114307,0.012181333,0.0061619002],"study_design_scores_gemma":[0.009841514,0.00094923883,0.009584361,0.0009821203,0.00009983525,0.000038364247,0.00019093344,0.0001913686,0.97365904,0.00019042108,0.003938888,0.0003339247],"about_ca_topic_score_codex":0.0009162003,"about_ca_topic_score_gemma":0.000060671344,"teacher_disagreement_score":0.010283891,"about_ca_system_score_codex":0.0036778436,"about_ca_system_score_gemma":0.008403248,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W2494361622","doi":"10.1158/1538-7445.am2016-ct147","title":"Abstract CT147: Phase I studies of AZD1208, a PIM kinase inhibitor, in patients with recurrent or refractory acute myelogenous leukemia or advanced solid tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tolerability; Nausea; Rash; Vomiting; Internal medicine; Gastroenterology; Refractory (planetary science); Lethargy; Progressive disease; Leukemia; Chemotherapy; Adverse effect","score_opus":0.08981200097409352,"score_gpt":0.4508240963214299,"score_spread":0.36101209534733636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494361622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554783,0.0020557435,0.000009292904,0.0005184885,0.00026954524,0.001337283,0.00017449775,0.000029270215,0.000058020825],"genre_scores_gemma":[0.9918892,0.0061077084,0.0001327231,0.00008293892,0.00021903217,0.000486596,0.000012002412,0.00006331397,0.001006493],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971289,0.00008834959,0.0004787713,0.00054514036,0.0010269709,0.0007318707],"domain_scores_gemma":[0.9978942,0.00023617227,0.00018381774,0.0005258085,0.000903529,0.00025645274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005760078,0.00026043778,0.0007111282,0.00040343122,0.000107716085,0.00001167357,0.00020225036,0.00009482848,0.0005721647],"category_scores_gemma":[0.00021229054,0.0001325974,0.00006944278,0.00065345835,0.0003535499,0.00017995742,0.000099291494,0.0004658545,0.000013667073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112759285,0.001759439,0.001819708,0.0006601846,0.00053251156,0.0007800063,0.0021985802,0.000005057119,0.30066574,0.00003199728,0.0019932196,0.57679427],"study_design_scores_gemma":[0.15700723,0.077411115,0.05728224,0.022325577,0.0002367989,0.00003375876,0.003945368,0.000010698575,0.6395573,0.00045332022,0.04027223,0.0014643354],"about_ca_topic_score_codex":0.00023444253,"about_ca_topic_score_gemma":0.001082969,"teacher_disagreement_score":0.57532996,"about_ca_system_score_codex":0.0022243867,"about_ca_system_score_gemma":0.002601544,"threshold_uncertainty_score":0.6264803},"labels":[],"label_agreement":null},{"id":"W2494510295","doi":"10.1158/1538-7445.am2016-1695","title":"Abstract 1695: Vascularization of colorectal cancer liver metastasis: correlation with growth patterns","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Angiogenesis; Metastasis; Colorectal cancer; Bevacizumab; Medicine; Stroma; Pathology; Cancer; Neovascularization; Cancer research; Hypoxia (environmental); Biology; Chemotherapy; Internal medicine; Immunohistochemistry","score_opus":0.02794654785576495,"score_gpt":0.3169393288403847,"score_spread":0.2889927809846198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494510295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284375,0.0020312464,0.0039696326,0.00022982054,0.00011239697,0.00028055027,0.00030384958,0.000005352467,0.00022342906],"genre_scores_gemma":[0.990154,0.00913053,0.00008613764,0.00003232972,0.00019383345,0.00017659305,0.000050296265,0.000027217626,0.00014900744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988938,0.000052889747,0.00015834252,0.00030720863,0.00031927752,0.00026847966],"domain_scores_gemma":[0.998998,0.000059757862,0.000078436104,0.00020203144,0.0005789605,0.00008280668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027735173,0.00010530295,0.00012543064,0.00007876816,0.000069244204,0.000018652096,0.00016118164,0.00009676049,0.00023597175],"category_scores_gemma":[0.00009899019,0.00007370845,0.00005302634,0.00015393874,0.00013841472,0.000008789267,0.000082557046,0.000091175374,0.0000065726763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005489943,0.00007654032,0.09479862,0.00009875383,0.00020856784,0.0000057630673,0.00009228298,0.00034486648,0.88474905,0.00032029513,0.0016812335,0.01707504],"study_design_scores_gemma":[0.0012081574,0.00037118606,0.13573843,0.0001808475,0.000040583785,0.0000026142795,0.00005026648,0.000037076323,0.8585501,0.00006577047,0.0035611314,0.00019385092],"about_ca_topic_score_codex":0.0016600081,"about_ca_topic_score_gemma":0.0018736084,"teacher_disagreement_score":0.04093981,"about_ca_system_score_codex":0.00010078992,"about_ca_system_score_gemma":0.0003913932,"threshold_uncertainty_score":0.30057433},"labels":[],"label_agreement":null},{"id":"W2494641791","doi":"10.1158/1538-7445.am2016-2963","title":"Abstract 2963: VB7-756: a Her2-specific diabody armed with deBouganin, a plant toxin with a distinct MOA","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Furin; Cytotoxic T cell; Chemistry; Molecular biology; Linker; Protease; Potency; Cell culture; Cancer cell; Diphtheria toxin; In vitro; Cancer; Toxin; Biology; Biochemistry; Genetics; Enzyme","score_opus":0.03967782088522171,"score_gpt":0.3057539231138351,"score_spread":0.2660761022286134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494641791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093777,0.0036822888,0.0004622296,0.0011017218,0.0003047323,0.00083153637,0.00038062705,0.000121996134,0.0021771174],"genre_scores_gemma":[0.9902758,0.0008771813,0.00009330679,0.00006976144,0.00012321911,0.0005975067,0.00004982744,0.000077599994,0.007835825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971398,0.000254727,0.00030586132,0.0007441327,0.00025502662,0.001300431],"domain_scores_gemma":[0.9983707,0.00039685413,0.000105860105,0.0007431993,0.00027188423,0.00011148239],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00070480397,0.0003311072,0.00041617634,0.00022699457,0.00047509666,0.00007270574,0.00061016035,0.00025821963,0.0054745236],"category_scores_gemma":[0.00006198933,0.00017727434,0.00006947241,0.00040747976,0.00081566226,0.00017208752,0.0001551056,0.0007796322,0.001094656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029359343,0.00022150965,0.0016562213,0.000036227044,0.00024390448,0.00013446028,0.00049849215,9.730612e-7,0.96854526,0.0012012225,0.00904187,0.015483942],"study_design_scores_gemma":[0.0058267224,0.0017696621,0.03270227,0.0008797315,0.000020489957,0.00014240523,0.0007560814,4.2432742e-7,0.6469064,0.00026506046,0.31009573,0.0006350666],"about_ca_topic_score_codex":0.00071754045,"about_ca_topic_score_gemma":0.0012331805,"teacher_disagreement_score":0.32163888,"about_ca_system_score_codex":0.00030100872,"about_ca_system_score_gemma":0.00049144734,"threshold_uncertainty_score":0.9996831},"labels":[],"label_agreement":null},{"id":"W2494853337","doi":"10.1158/1538-7445.am2016-4136","title":"Abstract 4136: Properties of the immune microenvironment associated with clonal diversity in high-grade serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; Ovarian cancer; Somatic evolution in cancer; Tumor microenvironment; CD8; clone (Java method); Serous fluid; Immune system; Cancer research; Cancer; Immunology; Gene; Genetics","score_opus":0.0401223413146471,"score_gpt":0.2795207113230395,"score_spread":0.23939837000839242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494853337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948614,0.0030685177,0.000004159652,0.0014481372,0.00009399535,0.00027428876,0.00018980067,0.0000021471942,0.000057517118],"genre_scores_gemma":[0.9967019,0.0025353269,0.000008442827,0.00005532292,0.000085352185,0.0000781616,0.0000063169045,0.000016231936,0.0005129639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988873,0.00007262048,0.00014681781,0.00025922133,0.00030447583,0.00032956997],"domain_scores_gemma":[0.9994481,0.000028474497,0.0000712219,0.0003027354,0.00009827182,0.000051175026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030099897,0.00009960714,0.00012928798,0.000036141268,0.0001419273,0.0000115376915,0.0003463122,0.00008849365,0.00007461694],"category_scores_gemma":[0.000070559625,0.000056880042,0.00004392696,0.00012233316,0.00034454546,0.0000039852807,0.0005392388,0.00014614957,0.0000018798438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026652642,0.000096942815,0.09508705,0.000018765537,0.00007205964,0.0000029139505,0.000089247915,0.00014256197,0.9024214,0.00002637362,0.00048403218,0.0012920833],"study_design_scores_gemma":[0.00096290914,0.000075049655,0.41312763,0.00018266661,0.0000071710588,4.5170046e-7,0.000033060904,8.425442e-7,0.5840803,0.00002854556,0.0014182021,0.000083221064],"about_ca_topic_score_codex":0.0075852904,"about_ca_topic_score_gemma":0.009054272,"teacher_disagreement_score":0.3183412,"about_ca_system_score_codex":0.0003078908,"about_ca_system_score_gemma":0.00034744292,"threshold_uncertainty_score":0.99902326},"labels":[],"label_agreement":null},{"id":"W2494854480","doi":"10.1158/1538-7445.am2016-4593","title":"Abstract 4593: Analysis of transforming growth factor β receptor trafficking on different signaling transduction pathways","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Signal transduction; SMAD; Cell biology; R-SMAD; Biology; MAPK/ERK pathway; Transforming growth factor beta; Transforming growth factor; Growth factor receptor; Receptor; Cancer research; Growth factor; TGF alpha; Biochemistry","score_opus":0.06502657542314329,"score_gpt":0.34921481084063094,"score_spread":0.28418823541748767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494854480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975497,0.00056368473,0.0011178162,0.00010881914,0.00012533859,0.00020758828,0.00024005718,0.000019262794,0.0000677431],"genre_scores_gemma":[0.99904037,0.00036990276,0.00002532732,0.000011840339,0.00032086708,0.00007799966,0.00005740255,0.000031950727,0.000064367996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816555,0.00011688496,0.00030825313,0.00046385842,0.0005323173,0.00041312992],"domain_scores_gemma":[0.9991278,0.00012105393,0.00007209263,0.00028575127,0.00025132368,0.00014195811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032408597,0.00016677704,0.00024920385,0.000345507,0.00012855406,0.000021793077,0.00026927618,0.00013736717,0.0005606506],"category_scores_gemma":[0.00011123766,0.000118493845,0.00025835886,0.00038275478,0.00014358599,0.000008864408,0.000021025988,0.00014977217,0.0000053102435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034688314,0.000121640966,0.0016229477,0.000071777555,0.00046318973,0.0000010917192,0.00027323072,0.0002609933,0.97594494,0.000034421417,0.0000715892,0.020787323],"study_design_scores_gemma":[0.00040714993,0.00018652773,0.0078004827,0.0001582604,0.000073932395,1.4304239e-7,0.000084524254,0.000007639488,0.9903147,0.000011399779,0.00079628214,0.00015891485],"about_ca_topic_score_codex":0.000051065614,"about_ca_topic_score_gemma":0.00006460372,"teacher_disagreement_score":0.02062841,"about_ca_system_score_codex":0.000104305895,"about_ca_system_score_gemma":0.00015226238,"threshold_uncertainty_score":0.6138731},"labels":[],"label_agreement":null},{"id":"W2494861028","doi":"10.1158/1538-7445.am2016-4683","title":"Abstract 4683: Verapamil and tamoxifen modulate ABCB1 expression in multidrug-resistant cells and resensitize them to conventional chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ste. Anne's Hospital","funders":"","keywords":"Verapamil; Multiple drug resistance; Tamoxifen; P-glycoprotein; Cancer research; Cancer; Pharmacology; Ovarian cancer; Cancer cell; Breast cancer; Medicine; Chemotherapy; clone (Java method); Biology; Drug resistance; Internal medicine; Biochemistry","score_opus":0.05438021322129863,"score_gpt":0.3543881631609183,"score_spread":0.30000794993961966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494861028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386007,0.0005592292,0.00006827826,0.0041717924,0.00008883169,0.000628272,0.00005476296,0.000024169092,0.0005446182],"genre_scores_gemma":[0.99227196,0.0025573096,0.0005641342,0.00016536041,0.00012412429,0.00008441639,0.0000046876844,0.00003620025,0.0041917786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980935,0.000057938476,0.00024694926,0.00048229555,0.0006260559,0.00049326115],"domain_scores_gemma":[0.9990761,0.00014353656,0.000031717293,0.0002645497,0.00016780612,0.00031623393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007673556,0.00015541419,0.0002804027,0.00020567166,0.000112076574,0.000027084385,0.000093917835,0.00011404935,0.0004021855],"category_scores_gemma":[0.000026034304,0.00010014836,0.000043230357,0.0002159587,0.00021466624,0.00008428877,0.000046130473,0.00025465759,0.000025664332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022055572,0.00007383015,0.0027315426,0.0001478647,0.000019431329,0.00014038903,0.0004641497,0.0000018446591,0.9843753,0.00008773161,0.00081579405,0.00893655],"study_design_scores_gemma":[0.0052594827,0.00011392468,0.2078927,0.001655511,0.000006645731,0.0000061692335,0.00022520818,0.000023994497,0.77288896,0.0008726582,0.010863567,0.0001911775],"about_ca_topic_score_codex":0.00018305109,"about_ca_topic_score_gemma":0.00015804257,"teacher_disagreement_score":0.21148635,"about_ca_system_score_codex":0.0001469667,"about_ca_system_score_gemma":0.00014325498,"threshold_uncertainty_score":0.44036493},"labels":[],"label_agreement":null},{"id":"W2495165514","doi":"10.1158/1538-7445.am2016-4316","title":"Abstract 4316: Pharmacological targeting of the TGF-beta-induced epithelial-mesenchymal transition by anthocyanidins in glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Anthocyanidins; Epithelial–mesenchymal transition; Delphinidin; Cancer research; Tumor progression; Transforming growth factor beta; Biology; Cancer; Transforming growth factor; Chemistry; Medicine; Metastasis; Cell biology; Biochemistry; Internal medicine; Cyanidin; Flavonoid","score_opus":0.037572477378807485,"score_gpt":0.3590794399785888,"score_spread":0.32150696259978134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495165514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946215,0.0025430026,0.000040728857,0.001423383,0.00055887667,0.00034565676,0.00017128888,0.0000067042633,0.0002888181],"genre_scores_gemma":[0.99552894,0.0029431833,0.00001213057,0.0000929079,0.0010383724,0.00010648075,0.000005532477,0.000020359506,0.00025211563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820316,0.00024993788,0.00027035447,0.0003854968,0.00039027524,0.0005007925],"domain_scores_gemma":[0.9993719,0.000056096073,0.00007029146,0.0002215756,0.00017919239,0.000100976366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085675705,0.00013401551,0.00018925934,0.00006951384,0.00010746528,0.000013107851,0.0003595565,0.00017921162,0.00026009599],"category_scores_gemma":[0.0001162053,0.00008132092,0.000120119024,0.00026641268,0.00024572122,0.000009783411,0.00010885594,0.00026671542,0.000007677011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003655259,0.000078967634,0.00015572617,0.000020941676,0.00002612099,0.0000014170714,0.00009189445,0.000010190488,0.9799828,0.000019313053,0.00845425,0.010792873],"study_design_scores_gemma":[0.0011108626,0.00014350629,0.0023728055,0.000049595626,0.000008678015,0.0000019104366,0.000078838486,0.0000040528457,0.9561693,0.00003447372,0.03991012,0.000115863266],"about_ca_topic_score_codex":0.0002720004,"about_ca_topic_score_gemma":0.00021696767,"teacher_disagreement_score":0.031455867,"about_ca_system_score_codex":0.0000755587,"about_ca_system_score_gemma":0.00030811844,"threshold_uncertainty_score":0.3316171},"labels":[],"label_agreement":null},{"id":"W2495445624","doi":"10.1158/1538-7445.am2016-993","title":"Abstract 993: Identification of estrogen receptor alpha 1 bound lncRNAs in aggressive breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Breast cancer; Estrogen receptor alpha; Epigenetics; Cancer; Estrogen receptor; Transcriptome; Cancer research; Biology; Estrogen; Bioinformatics; Medicine; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.02991082104899416,"score_gpt":0.37974264944156305,"score_spread":0.3498318283925689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495445624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080133,0.0056038937,0.00032271014,0.0014915222,0.00031251443,0.0006246216,0.00057158316,0.00001016977,0.00026164262],"genre_scores_gemma":[0.99096894,0.006218999,0.000024589883,0.000024693094,0.0004155256,0.000590289,0.000040019167,0.00005660168,0.0016603635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971912,0.0002104422,0.00043214025,0.0006637969,0.0007950169,0.0007074023],"domain_scores_gemma":[0.99808824,0.00005040244,0.00021091539,0.0006521702,0.0008145581,0.000183711],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010350182,0.00017592795,0.00021078034,0.0002943773,0.00009898936,0.00004280506,0.0005809201,0.0002638346,0.0010261176],"category_scores_gemma":[0.00028386142,0.00014557927,0.00010238985,0.0005149098,0.0003791124,0.00001735009,0.00025589933,0.00032273165,0.000060470888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048932876,0.00007436471,0.001228572,0.00006381873,0.00008023619,0.000010684277,0.000043822103,0.000045604225,0.9629007,0.000092886105,0.0051999055,0.029770065],"study_design_scores_gemma":[0.001019682,0.00009513716,0.008679276,0.0003181561,0.0000061700607,0.000008236438,0.00007076247,0.0000068775607,0.9818384,0.0001571902,0.0076184436,0.00018164175],"about_ca_topic_score_codex":0.0018862053,"about_ca_topic_score_gemma":0.00082423637,"teacher_disagreement_score":0.029588422,"about_ca_system_score_codex":0.00041793258,"about_ca_system_score_gemma":0.0011813303,"threshold_uncertainty_score":0.9998871},"labels":[],"label_agreement":null},{"id":"W2495455858","doi":"10.1158/1538-7445.am2016-817","title":"Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Mendelian randomization; Lung cancer; Medicine; Oncology; Odds ratio; Cancer; Internal medicine; Genome-wide association study; Single-nucleotide polymorphism; Genetics; Biology; Genotype","score_opus":0.018413214331560762,"score_gpt":0.3622336866107197,"score_spread":0.3438204722791589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495455858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98294735,0.015677577,0.00021498388,0.0002986497,0.000044097575,0.00021531744,0.0004904357,0.0000038273984,0.00010774108],"genre_scores_gemma":[0.9308713,0.0686164,0.00003263811,0.000018366503,0.00016991183,0.00008497613,0.000059497354,0.0000108894465,0.0001360194],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898607,0.00011166256,0.00017547785,0.0003020288,0.0002308218,0.00019394532],"domain_scores_gemma":[0.99922186,0.000058791145,0.00007768036,0.00018727678,0.00031971277,0.00013465829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004430916,0.00008411009,0.00015813828,0.00020275782,0.0000966646,0.000019335735,0.00007311041,0.00008991018,0.00012104243],"category_scores_gemma":[0.00019051523,0.00006405733,0.00004929778,0.00024956473,0.0001733052,0.000008066035,0.0000514179,0.00005467769,4.3285755e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092293473,0.000049560025,0.30622646,0.0001184936,0.0006603912,6.97771e-7,0.0001212886,0.00010242172,0.66620845,0.000027196773,0.0021320381,0.023430057],"study_design_scores_gemma":[0.01070445,0.00017429642,0.6076008,0.00010225252,0.00069721683,5.779221e-7,0.0002638801,0.00074432854,0.37391227,0.00038909478,0.005021695,0.00038911076],"about_ca_topic_score_codex":0.0003835321,"about_ca_topic_score_gemma":0.00071214495,"teacher_disagreement_score":0.30137435,"about_ca_system_score_codex":0.000033432025,"about_ca_system_score_gemma":0.00014027805,"threshold_uncertainty_score":0.2612182},"labels":[],"label_agreement":null},{"id":"W2495491769","doi":"10.1158/1538-7445.am2016-lb-078","title":"Abstract LB-078: The role of CEACAM1 in neutrophil extracellular Trap mediated cancer metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Neutrophil extracellular traps; Metastasis; Cancer; Cancer cell; Chemistry; Cancer research; Extracellular; Molecular biology; Immunology; Cell biology; Biology; Inflammation; Medicine; Internal medicine","score_opus":0.05601027926710188,"score_gpt":0.3405575551201258,"score_spread":0.2845472758530239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495491769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555572,0.039700754,0.000010433698,0.0031957421,0.0002526462,0.00049602997,0.00028904967,0.000024330286,0.0004737991],"genre_scores_gemma":[0.9920009,0.0059307604,0.000007221289,0.000059513477,0.00007934354,0.00040872616,0.00001606233,0.00003561283,0.0014619008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974136,0.0006563733,0.00042672802,0.00047373053,0.00019898298,0.00083058747],"domain_scores_gemma":[0.9983784,0.0006480789,0.000120078155,0.0005178215,0.0002814531,0.0000541882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012946122,0.00021611973,0.0003935585,0.0003191363,0.00019155318,0.000014286196,0.0007002878,0.00022254059,0.005592313],"category_scores_gemma":[0.00011329171,0.00011841494,0.000115623225,0.00061117753,0.0007160822,0.00014327433,0.00015720986,0.00071212184,0.00034521136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003190604,0.000103857805,0.0010881205,0.000021119387,0.00015438134,0.000016527963,0.00032136097,0.0000040219475,0.95391214,0.0022485978,0.0006404158,0.041170403],"study_design_scores_gemma":[0.0012308432,0.000109931476,0.00788875,0.00014151247,0.000018997483,0.0000033316592,0.0004391889,5.4827717e-7,0.9287673,0.0011268914,0.06012074,0.00015193409],"about_ca_topic_score_codex":0.0025777137,"about_ca_topic_score_gemma":0.00074078,"teacher_disagreement_score":0.05948032,"about_ca_system_score_codex":0.00018848527,"about_ca_system_score_gemma":0.00034773775,"threshold_uncertainty_score":0.9953167},"labels":[],"label_agreement":null},{"id":"W2495493911","doi":"10.1158/1538-7445.am2016-511","title":"Abstract 511: Unbiased enrichment of circulating tumor cells directly from whole blood","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Immunomagnetic separation; Whole blood; Chemistry; Chromatography; Haematopoiesis; Circulating tumor cell; Molecular biology; Biology; Immunology; Cell biology; Stem cell; Cancer; Metastasis","score_opus":0.08330807974666764,"score_gpt":0.3849605803743465,"score_spread":0.30165250062767884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495493911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991749,0.002906109,0.000025630547,0.0009641834,0.00020108528,0.00042831796,0.0003608535,0.00002732703,0.003337477],"genre_scores_gemma":[0.996939,0.000583921,0.00028998815,0.000084420426,0.00042496383,0.00009951099,0.000012163483,0.000034918125,0.0015311074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977944,0.00007478058,0.00033618096,0.0004103321,0.0008722565,0.00051203155],"domain_scores_gemma":[0.99842775,0.00037898307,0.000099551326,0.0004935887,0.0003335158,0.0002666177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006608759,0.00013493655,0.00036572048,0.00016719208,0.000072569244,0.000017746786,0.00016371536,0.000053185133,0.0031996865],"category_scores_gemma":[0.00012914621,0.000091466674,0.00012723348,0.00035669812,0.000170731,0.000060542952,0.00008276974,0.00024624387,0.000100708356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022418163,0.00017582074,0.0022379502,0.00014993215,0.00013246154,0.000089610716,0.00017218043,0.0000035119795,0.948946,0.0000108704635,0.0027708465,0.04508663],"study_design_scores_gemma":[0.0023614923,0.00018010639,0.011401114,0.0007220312,0.00007802433,0.0000024857334,0.00011921559,0.0000023014215,0.9581684,0.00008433686,0.026768187,0.0001123203],"about_ca_topic_score_codex":0.00454333,"about_ca_topic_score_gemma":0.00018977109,"teacher_disagreement_score":0.04497431,"about_ca_system_score_codex":0.00025818206,"about_ca_system_score_gemma":0.000543178,"threshold_uncertainty_score":0.99771154},"labels":[],"label_agreement":null},{"id":"W2496068731","doi":"10.1158/1538-7445.am2016-850","title":"Abstract 850: Comprehensive genome and transcriptome structural analysis of a breast cancer cell line using single molecule sequencing","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Chromothripsis; Structural variation; Copy number analysis; Breakpoint; Copy-number variation; Genome; Context (archaeology); Computational biology; Biology; Genome instability; Genetics; Cancer; Genomics; Breast cancer; Cancer genome sequencing; Gene; Chromosome; DNA","score_opus":0.06582348315489081,"score_gpt":0.35863678482137423,"score_spread":0.29281330166648345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496068731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838246,0.009553251,0.00023527941,0.00014662961,0.000067093795,0.0001680742,0.0013578963,0.000004040325,0.00008525313],"genre_scores_gemma":[0.99545527,0.0040110145,0.00012137955,0.00006617039,0.00019658664,0.00002165943,0.00003163066,0.000027101181,0.00006920848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865264,0.0000470826,0.00024084572,0.0004165084,0.00024446496,0.000398489],"domain_scores_gemma":[0.99893165,0.000051224706,0.00008484059,0.00029721874,0.00048747865,0.00014756598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013886411,0.00014840795,0.00026653253,0.00015685734,0.00009743444,0.00003087305,0.00018316435,0.000105742714,0.00022071587],"category_scores_gemma":[0.000017166984,0.00011913206,0.00010969907,0.00034434465,0.00025572738,0.000009282913,0.00011735241,0.00009753477,5.66409e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014416054,0.000016986569,0.0017781536,0.00006242523,0.00031301499,0.0000045447096,0.00012489989,0.0017396179,0.99445003,0.000008498414,0.000027755947,0.0013299317],"study_design_scores_gemma":[0.0010534493,0.00018818413,0.041802056,0.00008128944,0.00026951337,0.0000080313985,0.00028799716,0.00053434947,0.9545764,0.00003457216,0.0008408659,0.0003233197],"about_ca_topic_score_codex":0.004471356,"about_ca_topic_score_gemma":0.0015939709,"teacher_disagreement_score":0.040023904,"about_ca_system_score_codex":0.00028930913,"about_ca_system_score_gemma":0.00036229403,"threshold_uncertainty_score":0.67593825},"labels":[],"label_agreement":null},{"id":"W2496159406","doi":"10.1158/1538-7445.am2016-3124","title":"Abstract 3124: Prognostic biomarkers for pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Genome-wide association study; Single-nucleotide polymorphism; Hazard ratio; Oncology; Internal medicine; Cohort; Proportional hazards model; Genotype; Population; Cancer; Medicine; Allele; SNP; Biology; Genetics; Bioinformatics; Gene; Confidence interval","score_opus":0.14834598617936634,"score_gpt":0.4830001377976661,"score_spread":0.33465415161829976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496159406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749061,0.00359257,0.0002127258,0.012957096,0.00018740646,0.0026509368,0.00012018159,0.00006837842,0.0053046155],"genre_scores_gemma":[0.97412026,0.0035775055,0.00048518178,0.00018436651,0.00070434116,0.005548777,0.000011195869,0.000060478254,0.015307886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970226,0.00011503973,0.00033081957,0.0005309751,0.0008373091,0.0011632433],"domain_scores_gemma":[0.99651533,0.001692027,0.000057869478,0.00046820895,0.0008671418,0.00039942097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016734983,0.00017933255,0.0005146672,0.00033596932,0.00026207382,0.000029853538,0.00025874045,0.00018704304,0.0042178556],"category_scores_gemma":[0.0017065415,0.00010783323,0.00012805303,0.00047010125,0.0006644686,0.000099339806,0.0000854649,0.00031354043,0.0002331103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025176732,0.00024694987,0.6120414,0.0009691128,0.00076532643,0.00008121802,0.00016061812,3.1461803e-7,0.15635702,0.00037034444,0.10042482,0.12606518],"study_design_scores_gemma":[0.010116604,0.0015849279,0.8602468,0.003346447,0.00040768206,0.000034800818,0.00032461053,0.00015895822,0.019484716,0.001849659,0.10198819,0.00045661032],"about_ca_topic_score_codex":0.00093330303,"about_ca_topic_score_gemma":0.00023854266,"teacher_disagreement_score":0.24820536,"about_ca_system_score_codex":0.000807322,"about_ca_system_score_gemma":0.0019361412,"threshold_uncertainty_score":0.9966924},"labels":[],"label_agreement":null},{"id":"W2496241743","doi":"10.1158/1538-7445.am2016-3269","title":"Abstract 3269: Recapitulating the BETH adjuvant breast cancer trial (NCT00625898) using clinically accurate orthotopic surgical resection models","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Metastasis; Bevacizumab; Adjuvant; Trastuzumab; Oncology; Cancer; Clinical trial; Biomarker; Chemotherapy; Internal medicine; Biology","score_opus":0.18441871417948946,"score_gpt":0.48373383417722854,"score_spread":0.2993151199977391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496241743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993093,0.0025028957,0.000093897994,0.0021483786,0.00035803134,0.00096439244,0.00026174626,0.000017139826,0.00056051],"genre_scores_gemma":[0.9897279,0.006322591,0.00003310508,0.000043237233,0.0021708242,0.0005671547,0.000023300257,0.00004736216,0.0010645163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99653983,0.00046978623,0.0004710304,0.0007496713,0.0008413327,0.00092834176],"domain_scores_gemma":[0.9981814,0.00021348738,0.0001348738,0.0006687727,0.0005225817,0.00027887232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017414804,0.00021772114,0.00025555913,0.00009891666,0.00050645816,0.00011564768,0.00047549157,0.00022994951,0.00045797988],"category_scores_gemma":[0.0001493639,0.00012328816,0.00019056916,0.00031438575,0.00046449577,0.000033617263,0.0003350625,0.00047005652,0.000017961873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14361939,0.0006641168,0.02375364,0.00016156478,0.0011121315,0.00020701606,0.00024066647,0.0016550635,0.47089657,0.0003178299,0.0060960418,0.35127598],"study_design_scores_gemma":[0.35143426,0.011531403,0.083692916,0.0043510273,0.0004498445,0.0005803145,0.0010923479,0.0058464976,0.38051897,0.009442007,0.14605913,0.0050012628],"about_ca_topic_score_codex":0.0041774423,"about_ca_topic_score_gemma":0.002222776,"teacher_disagreement_score":0.3462747,"about_ca_system_score_codex":0.00033693758,"about_ca_system_score_gemma":0.0012479909,"threshold_uncertainty_score":0.6315071},"labels":[],"label_agreement":null},{"id":"W2496874737","doi":"10.1158/1538-7445.am2016-lb-157","title":"Abstract LB-157: Chromatin alterations induce C-MYC and BRD4 downregulation in pediatric sarcoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epigenetics; Cancer research; Histone; Bromodomain; Epigenetic therapy; Biology; Acetylation; DNA methylation; Chromatin; Medicine; Genetics; Gene expression; Gene","score_opus":0.042489117674266434,"score_gpt":0.36345919230522294,"score_spread":0.3209700746309565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496874737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996414,0.001027363,0.000081101796,0.001423007,0.000053000877,0.00024230647,0.000015674297,0.000006870472,0.0007366904],"genre_scores_gemma":[0.99748445,0.001072513,0.000078909645,0.000040144947,0.00042407302,0.0001137053,0.000023554543,0.00001124836,0.0007513987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906886,0.00008462477,0.0001625511,0.00026024188,0.00019688094,0.0002268214],"domain_scores_gemma":[0.9995584,0.0000309561,0.000034335597,0.00019299526,0.00010827701,0.00007507462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042474802,0.000072640214,0.00006758645,0.00014030059,0.00008851987,0.000036662237,0.000103643615,0.0000994613,0.00011895408],"category_scores_gemma":[0.00016555031,0.00005589268,0.000018299954,0.00019297868,0.00007655964,0.000014786913,0.000074947995,0.000105430794,0.000020195159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002606383,0.000023932686,0.009952639,0.000018580613,0.0000034881884,0.0000011819492,0.000031182375,0.0000029905264,0.9700895,0.0001296532,0.0035943436,0.016126437],"study_design_scores_gemma":[0.0008869782,0.000106683874,0.3547906,0.00004677805,0.0000020575956,0.0000026051323,0.000023545053,0.000013483027,0.6326827,0.0002873083,0.011007442,0.00014981332],"about_ca_topic_score_codex":0.00010634168,"about_ca_topic_score_gemma":0.0002671682,"teacher_disagreement_score":0.34483796,"about_ca_system_score_codex":0.00005089879,"about_ca_system_score_gemma":0.00017048093,"threshold_uncertainty_score":0.22792374},"labels":[],"label_agreement":null},{"id":"W2496973033","doi":"10.1158/1538-7445.am2016-ct146","title":"Abstract CT146: A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Selumetinib; Wnt signaling pathway; Medicine; KRAS; MEK inhibitor; Colorectal cancer; Cancer research; Cancer; Oncology; MAPK/ERK pathway; Internal medicine; Pharmacology; Kinase; Biology; Signal transduction; Genetics","score_opus":0.018529683176438657,"score_gpt":0.3465377941984861,"score_spread":0.32800811102204747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496973033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981663,0.00026808135,0.0000029901253,0.000039125134,0.000022962788,0.00134938,0.00013634481,0.000001487123,0.000013309169],"genre_scores_gemma":[0.99910754,0.00045900597,0.000023753253,0.000006165101,0.000012992542,0.00033722626,0.000021394537,0.000023430513,0.000008483667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853706,0.00012783858,0.00030064554,0.00037122282,0.00038890075,0.0002743263],"domain_scores_gemma":[0.9991385,0.00005482512,0.0001576982,0.0002643979,0.0003106211,0.00007398287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044822972,0.00013214936,0.00025526714,0.00011726108,0.000043441712,0.000008929985,0.00018439347,0.00004196359,0.000013030116],"category_scores_gemma":[0.000082224426,0.000080371,0.000018294113,0.00031110298,0.00021204924,0.000015468539,0.000083114304,0.00011944111,1.3985147e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037466353,0.001328916,0.6321641,0.000037645957,0.0000554134,0.000004620981,0.00044439352,0.0003864114,0.3535852,0.0000028965958,0.000005312356,0.008238415],"study_design_scores_gemma":[0.009611392,0.003988065,0.693371,0.0001776255,0.000017531122,3.940539e-7,0.00049539347,0.000022628801,0.29216278,0.000016387798,0.000016832126,0.00011996305],"about_ca_topic_score_codex":0.0020736149,"about_ca_topic_score_gemma":0.012093878,"teacher_disagreement_score":0.061422437,"about_ca_system_score_codex":0.00010886235,"about_ca_system_score_gemma":0.00039374002,"threshold_uncertainty_score":0.6748668},"labels":[],"label_agreement":null},{"id":"W2497026976","doi":"10.1158/1538-7445.am2015-3106","title":"Abstract 3106: Elucidating molecular mechanisms linking microRNA-206 loss to tumor progression and metastasis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Invadopodia; Metastasis; Cancer research; Cancer; microRNA; Breast cancer; Cancer cell; Intravasation; Oncomir; Biology; Medicine; Pathology; Carcinogenesis; Internal medicine; Gene; Genetics","score_opus":0.09773781836944088,"score_gpt":0.4395858225694111,"score_spread":0.3418480041999702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497026976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97011286,0.018434709,0.0066552595,0.0036520464,0.00024438032,0.00062106113,0.00000822798,0.00006783845,0.0002036251],"genre_scores_gemma":[0.9880769,0.00006260316,0.010294855,0.00009489794,0.00041174697,0.0001337446,0.000012273723,0.000045577104,0.00086739584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813026,0.00007059438,0.00019290663,0.00036235593,0.0007709116,0.0004729959],"domain_scores_gemma":[0.9986971,0.00004899625,0.000032333603,0.00024897518,0.0003827241,0.0005898762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013930722,0.00014869992,0.00028043703,0.0002666602,0.00011009532,0.000040596915,0.00010822069,0.000056708028,0.000050425188],"category_scores_gemma":[0.00036230535,0.00010931191,0.000030865755,0.00042972263,0.00009839065,0.0000452041,0.00012389132,0.00051971135,0.000027413904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010132861,0.000048694656,0.00027000118,0.00025764265,0.000058217473,0.00060006883,0.000780185,0.00014255014,0.96173525,0.00046862353,0.0009849553,0.034552477],"study_design_scores_gemma":[0.0014374282,0.00063325616,0.0011582338,0.0016096268,0.000039377443,0.00012067596,0.00057067,0.0001629884,0.97509354,0.00015766441,0.018827569,0.00018896995],"about_ca_topic_score_codex":0.00012220908,"about_ca_topic_score_gemma":0.000008205763,"teacher_disagreement_score":0.03436351,"about_ca_system_score_codex":0.00018668459,"about_ca_system_score_gemma":0.00024330366,"threshold_uncertainty_score":0.44576105},"labels":[],"label_agreement":null},{"id":"W2497119792","doi":"10.1158/1538-7445.am2016-3114","title":"Abstract 3114: Soy isoflavones modulate global methylation in head and neck squamous cell carcinoma (HNSCC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Methylation; Head and neck squamous-cell carcinoma; Cancer; Head and neck cancer; Internal medicine; DNA methylation; Oncology; Clinical trial; Isoflavones; Gastroenterology; Cancer research; Biology; Gene expression; Gene","score_opus":0.0653956830680618,"score_gpt":0.40935987998360274,"score_spread":0.3439641969155409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497119792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892058,0.0042249463,0.00001010429,0.0030746856,0.00008771462,0.00074200245,0.00003766387,0.000025277268,0.0025918295],"genre_scores_gemma":[0.9981064,0.00037899264,0.00003912708,0.000038688646,0.00027270356,0.000111792506,0.0000051807206,0.000027260869,0.0010198418],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974296,0.00018313811,0.00024136103,0.00049355405,0.00081283646,0.0008394928],"domain_scores_gemma":[0.9987071,0.00027686488,0.00003420025,0.0003599049,0.0002579384,0.0003639769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010494655,0.00016023741,0.00029333774,0.00025357306,0.0001276044,0.000042317406,0.00015166104,0.00015408397,0.00023872897],"category_scores_gemma":[0.00018283146,0.00010209496,0.000060489234,0.00053294835,0.00027630484,0.00015338475,0.00013860455,0.0004375534,0.000089342364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010048231,0.00024901563,0.34017223,0.00047810914,0.000015740157,0.00028020598,0.00015195213,0.000012033191,0.60539794,0.00011373592,0.0009889856,0.051135268],"study_design_scores_gemma":[0.0043982686,0.00064069685,0.87678176,0.0002261896,0.000009055308,0.000016208072,0.000050690513,0.0001746334,0.11577707,0.00075915386,0.0010096704,0.00015662615],"about_ca_topic_score_codex":0.003558244,"about_ca_topic_score_gemma":0.00044393042,"teacher_disagreement_score":0.53660953,"about_ca_system_score_codex":0.00057068584,"about_ca_system_score_gemma":0.0005295441,"threshold_uncertainty_score":0.5379024},"labels":[],"label_agreement":null},{"id":"W2497307737","doi":"10.1158/1538-7445.am2016-716","title":"Abstract 716: STAT1 expression in the tumor-stroma microenvironment is influenced by loss of PTEN in prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"PTEN; Stromal cell; Cancer research; Tumor microenvironment; PI3K/AKT/mTOR pathway; Biology; Pathology; Medicine; Signal transduction; Cell biology","score_opus":0.018565422805473308,"score_gpt":0.33781787233533306,"score_spread":0.31925244952985976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497307737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891691,0.008590613,0.0000043873233,0.0009826771,0.00030244316,0.00045890367,0.000383007,0.000002075895,0.000106754494],"genre_scores_gemma":[0.9852768,0.012375163,0.000014100764,0.0002404859,0.0006785024,0.0005218967,0.00001345178,0.000020861098,0.00085869135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982315,0.00014537832,0.00028579414,0.00041083575,0.00041509717,0.00051142834],"domain_scores_gemma":[0.99931914,0.000035080513,0.00007916687,0.00042365873,0.00006881596,0.00007416204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006223334,0.00013615272,0.00017640123,0.00008244577,0.000046673344,0.000016018506,0.00040236182,0.000072124116,0.00021952114],"category_scores_gemma":[0.000040903662,0.00008449423,0.000048698388,0.0001631121,0.0003128915,0.000011731213,0.00014185054,0.00020681288,0.0000061510527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032813824,0.00006778609,0.02818647,0.000043829037,0.000009285866,0.0000010417382,0.0006011127,0.000014780768,0.9321041,0.0000020942118,0.03291815,0.005723221],"study_design_scores_gemma":[0.0011379715,0.00006544276,0.06837606,0.00017693597,0.0000021770475,0.0000011045804,0.00023293443,4.854361e-7,0.6629892,0.000035019017,0.2668739,0.00010878512],"about_ca_topic_score_codex":0.0020931226,"about_ca_topic_score_gemma":0.0009483995,"teacher_disagreement_score":0.26911488,"about_ca_system_score_codex":0.00015311992,"about_ca_system_score_gemma":0.00036296857,"threshold_uncertainty_score":0.3445575},"labels":[],"label_agreement":null},{"id":"W2497455641","doi":"10.1158/1538-7445.am2016-3668","title":"Abstract 3668: Investigating a tumor suppressor role for Parkinson's susceptibility gene LRRK2 in lung cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"LRRK2; Autophagy; Lung cancer; Cancer research; Gene knockdown; Biology; Cancer; Tumor suppressor gene; Medicine; Pathology; Gene; Carcinogenesis; Genetics; Mutation","score_opus":0.07226231417647683,"score_gpt":0.4272144947871791,"score_spread":0.3549521806107023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497455641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899414,0.005216122,0.000028952441,0.0026823212,0.00009790479,0.0014117482,0.0002473803,0.00004871858,0.00032545504],"genre_scores_gemma":[0.99508566,0.00048667568,0.0002432435,0.0004185321,0.00052850496,0.0022484623,0.000010989697,0.000052922285,0.0009249928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975964,0.00009468534,0.00032323127,0.0005725054,0.00057442265,0.00083876454],"domain_scores_gemma":[0.9983538,0.00037147952,0.00006948161,0.0004986991,0.000334469,0.00037208342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011373112,0.00017275922,0.00032955143,0.00018285052,0.00014381716,0.000028745008,0.0002434984,0.0001002001,0.0014183071],"category_scores_gemma":[0.0005093726,0.00012124187,0.00011025533,0.00031335079,0.00030899857,0.00014548919,0.00007631754,0.0003491578,0.000014774994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008237335,0.00014836091,0.12963675,0.00046341994,0.00007377928,0.000036938334,0.00046418599,0.000033209973,0.85303783,0.000075519274,0.0052972413,0.009909051],"study_design_scores_gemma":[0.004739658,0.00014777179,0.2509407,0.0010886672,0.000031461565,0.0000025597637,0.00013858484,0.0012252354,0.7330183,0.0022450355,0.006170476,0.00025154377],"about_ca_topic_score_codex":0.0011980924,"about_ca_topic_score_gemma":0.00087479805,"teacher_disagreement_score":0.121303976,"about_ca_system_score_codex":0.0007393825,"about_ca_system_score_gemma":0.0014415708,"threshold_uncertainty_score":0.99949455},"labels":[],"label_agreement":null},{"id":"W2497511815","doi":"10.1158/1538-7445.am2016-3367","title":"Abstract 3367: Overexpression of neuropilin-1 exacerbates endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital","funders":"","keywords":"Fibrosis; Cancer research; Epithelial–mesenchymal transition; Desmoplasia; Pancreatic cancer; Umbilical vein; Cancer; Biology; Pathology; Medicine; Internal medicine; Metastasis","score_opus":0.03391060537989334,"score_gpt":0.3330759735678288,"score_spread":0.2991653681879355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497511815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959779,0.0029919113,0.00004253915,0.00045198595,0.00004152523,0.00023111734,0.00011791797,0.0000036617546,0.00014144712],"genre_scores_gemma":[0.9966328,0.0026476297,0.000058427566,0.000040347702,0.00021507102,0.00008968255,0.0000070935484,0.00002160539,0.00028729893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988228,0.00009019494,0.000186223,0.00036671074,0.00023051034,0.00030355612],"domain_scores_gemma":[0.99947417,0.000056686164,0.00003344326,0.00022695636,0.000106812025,0.00010191809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025592628,0.00010701775,0.00014621967,0.000104594445,0.000049169863,0.000012079013,0.00013162036,0.00009540104,0.00014451114],"category_scores_gemma":[0.00006724211,0.000077188175,0.000050268045,0.00013217166,0.00014345832,0.0000084864305,0.000085616855,0.00007102439,0.000005555645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040712333,0.000027463357,0.0390785,0.00006518138,0.000012815813,0.0000034319423,0.00010578522,0.000011729433,0.9575888,0.000014436064,0.00044354823,0.002241172],"study_design_scores_gemma":[0.0005252576,0.00023374977,0.2279152,0.00025251534,0.0000037943562,0.0000032062678,0.0000631314,0.0000036721922,0.770029,0.000034742818,0.00084150187,0.00009422649],"about_ca_topic_score_codex":0.00036184248,"about_ca_topic_score_gemma":0.000059182326,"teacher_disagreement_score":0.18883671,"about_ca_system_score_codex":0.000035208093,"about_ca_system_score_gemma":0.00010946356,"threshold_uncertainty_score":0.31476426},"labels":[],"label_agreement":null},{"id":"W2497569838","doi":"10.1158/1538-7445.am2016-3976","title":"Abstract 3976: Molecular imaging of epigenetic regulation mediated by HDACs 4, 5 using PET/CT/MRI with 18F-TFAHA in a rat model of human glioma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioluminescence imaging; Epigenetics; In vivo; Angiogenesis; Cancer research; Luciferase; Glioma; Cancer; Chemistry; Medicine; Transfection; Biology; Gene; Internal medicine; Biochemistry; Genetics","score_opus":0.058581863710566874,"score_gpt":0.3864887388227297,"score_spread":0.3279068751121628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497569838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968478,0.0015505357,0.00014934689,0.0007197277,0.000012020441,0.0005289206,0.00003183754,0.000008734027,0.00015109076],"genre_scores_gemma":[0.99943846,0.00013996245,0.00023061002,0.00001047249,0.000013016225,0.000089430236,0.000016468048,0.000033084096,0.000028518936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982514,0.00006908821,0.00032092052,0.0002944838,0.00070827926,0.00035587273],"domain_scores_gemma":[0.9989522,0.00010301204,0.0001081002,0.00034045783,0.00037812628,0.00011810598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039843205,0.00012611874,0.00030132008,0.00042055539,0.000045788118,0.000009165711,0.000099019424,0.000013451188,0.00011400655],"category_scores_gemma":[0.00005757663,0.00008450052,0.000048013215,0.0004970614,0.00022261207,0.000077431076,0.00004256646,0.00011432697,0.0000024069673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017038529,0.00024577611,0.037005257,0.00012555497,0.000045279277,0.0004790494,0.00006960777,0.00087272155,0.95991254,0.000047400692,0.00016112294,0.0008652955],"study_design_scores_gemma":[0.003438692,0.00016634249,0.010603326,0.0010962798,0.000037183305,0.000032811517,0.000060411254,0.0032946712,0.98092324,0.0002411124,0.000012829833,0.000093076866],"about_ca_topic_score_codex":0.0014282753,"about_ca_topic_score_gemma":0.00016195301,"teacher_disagreement_score":0.026401931,"about_ca_system_score_codex":0.0003565437,"about_ca_system_score_gemma":0.00030614677,"threshold_uncertainty_score":0.34458312},"labels":[],"label_agreement":null},{"id":"W2497846237","doi":"10.1158/1538-7445.am2016-203","title":"Abstract 203: Single cell imaging of kinase inhibitor-induced effects in breast cancer cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"SKBR3; Cell culture; Context (archaeology); Cell; Cell cycle; Breast cancer; Cancer research; Cancer cell; Kinase; Cancer; Biology; Chemistry; Pathology; Medicine; Cell biology; Internal medicine; Biochemistry; Genetics","score_opus":0.027321012908803944,"score_gpt":0.35580535392343804,"score_spread":0.3284843410146341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497846237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908742,0.006764072,0.0000058223945,0.0005211103,0.00013610018,0.00041448092,0.000188832,0.000007365733,0.0010880178],"genre_scores_gemma":[0.9960893,0.002509739,0.000016146601,0.000027172227,0.00039232336,0.00031623623,0.00001437212,0.000041543582,0.0005931763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795896,0.00012280668,0.00022622528,0.00050939305,0.00046111428,0.00072150206],"domain_scores_gemma":[0.99891555,0.00007602874,0.00006420308,0.00041072862,0.00032347286,0.00020999991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032688663,0.00017776093,0.00019829738,0.00014070704,0.00006920639,0.000028694256,0.00029157172,0.00010368279,0.00020455444],"category_scores_gemma":[0.00004610547,0.00013205671,0.00008442488,0.00024985918,0.00016398642,0.000018813336,0.00021625169,0.0001754821,0.000018760464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043080118,0.00037745107,0.024750922,0.00021417759,0.000020949654,0.000040968287,0.00003135419,0.0000038464354,0.94456583,0.0000016080973,0.0024014034,0.0271607],"study_design_scores_gemma":[0.0022396166,0.00020292806,0.02441613,0.00028440444,0.000004807211,0.0000019744598,0.000036146317,0.0000022657507,0.9716251,0.000022923641,0.0010121528,0.00015158972],"about_ca_topic_score_codex":0.011975404,"about_ca_topic_score_gemma":0.0038944222,"teacher_disagreement_score":0.027059242,"about_ca_system_score_codex":0.00037172184,"about_ca_system_score_gemma":0.000568595,"threshold_uncertainty_score":0.99460393},"labels":[],"label_agreement":null},{"id":"W2497957984","doi":"10.1158/1538-7445.am2016-1611","title":"Abstract 1611: Epithelial-mesenchymal-epithelial transition induced by long term exposure to TGFB1 creates cellular heterogeneity","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Community College","funders":"","keywords":"Epithelial–mesenchymal transition; Cancer; Biology; Cancer research; Mesenchymal stem cell; Cancer cell; Cell biology; Metastasis; Genetics","score_opus":0.07369958976585989,"score_gpt":0.3778944040611247,"score_spread":0.3041948142952648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497957984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892082,0.0018099921,0.00031634475,0.0060556293,0.00032006393,0.0010993498,0.00063100585,0.000069401074,0.00048998295],"genre_scores_gemma":[0.9951069,0.0013498279,0.000055368535,0.00032614818,0.001090697,0.00036335533,0.00004311735,0.0000763834,0.0015882138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99658155,0.0001657301,0.00041031014,0.0007637564,0.001107887,0.0009707843],"domain_scores_gemma":[0.99795413,0.00014755347,0.00006339396,0.0006756802,0.0004464718,0.0007127886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010138506,0.0002890652,0.0004775982,0.0003066268,0.00022050132,0.00007130933,0.0002727352,0.00020891898,0.002191245],"category_scores_gemma":[0.00010043888,0.00020177804,0.00021306453,0.0004847427,0.00018207124,0.00017423579,0.000079723,0.00045800634,0.0003416565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008412532,0.00017035271,0.0020330355,0.00018025954,0.00010759999,0.00008723869,0.00035726785,0.000001805317,0.90048164,0.0000054228285,0.0024304998,0.093303606],"study_design_scores_gemma":[0.0023801285,0.00073309627,0.022092221,0.0005070989,0.00005921928,0.000009324844,0.0000692279,4.6322697e-7,0.963144,0.000021577134,0.010724027,0.0002596356],"about_ca_topic_score_codex":0.0017199315,"about_ca_topic_score_gemma":0.00041099483,"teacher_disagreement_score":0.09304397,"about_ca_system_score_codex":0.00057248643,"about_ca_system_score_gemma":0.00044754264,"threshold_uncertainty_score":0.9987209},"labels":[],"label_agreement":null},{"id":"W2498005805","doi":"10.1158/1538-7445.am2016-ct066","title":"Abstract CT066: First-in-human phase I trial of the oral PLK4 inhibitor CFI-400945 in patients with advanced solid tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Dosing; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Pharmacodynamics; Adverse effect; Clinical endpoint; Oncology; Clinical trial; Phases of clinical research","score_opus":0.021693462826656938,"score_gpt":0.3626859429826092,"score_spread":0.34099248015595224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498005805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872935,0.000089340385,0.0000043916875,0.00013673828,0.00009621937,0.00073559996,0.00007915863,0.0000023414743,0.00012683585],"genre_scores_gemma":[0.99932516,0.00010881127,0.000010899591,0.000020598003,0.00011486705,0.000135317,0.000022124437,0.000021268688,0.00024092982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986627,0.00007866292,0.0002641913,0.00030956816,0.00030101952,0.00038382426],"domain_scores_gemma":[0.99928755,0.000022163113,0.00007815165,0.0003886405,0.00016435595,0.00005912932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033194292,0.00011415066,0.00017304596,0.00008509173,0.00006432828,0.000010277924,0.00031167365,0.00009867142,0.000040600913],"category_scores_gemma":[0.00009233512,0.00006660885,0.000046971458,0.00020251809,0.00019954366,0.000008295851,0.00014005888,0.00018262707,0.0000019943689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015096096,0.00071612187,0.024893617,0.000044594355,0.000021008847,0.0000032048774,0.00006773011,0.00003914689,0.95096165,0.000014575119,0.00079396716,0.0073482934],"study_design_scores_gemma":[0.080489926,0.002251345,0.04637309,0.00043535657,0.0000048016327,2.8033728e-7,0.00005023754,0.0000026625028,0.8654548,0.00004032556,0.004669947,0.00022726145],"about_ca_topic_score_codex":0.00016718505,"about_ca_topic_score_gemma":0.0021367064,"teacher_disagreement_score":0.08550688,"about_ca_system_score_codex":0.00009754004,"about_ca_system_score_gemma":0.00023451583,"threshold_uncertainty_score":0.27162302},"labels":[],"label_agreement":null},{"id":"W2498008302","doi":"10.1158/1538-7445.am2016-2627","title":"Abstract 2627: Molecular analyses of histopathologic morphologic features in breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Lymphovascular invasion; Pathology; Biology; CDH1; Transcriptome; Cancer; Molecular pathology; Medicine; Metastasis; Gene; Gene expression; Cadherin; Genetics","score_opus":0.0615020584920251,"score_gpt":0.44165029958200713,"score_spread":0.380148241089982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498008302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131244,0.0048302016,0.00045130443,0.0020009389,0.000028133345,0.0002620644,0.00017543686,0.00001318455,0.00092631625],"genre_scores_gemma":[0.9949113,0.003645879,0.00024798737,0.00016394092,0.000060819777,0.000495541,0.000020901138,0.000017837086,0.00043576225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986223,0.00013438698,0.00021699224,0.00046490118,0.00018626849,0.00037516106],"domain_scores_gemma":[0.9991235,0.00002297664,0.00007535585,0.00048820605,0.00022107906,0.00006885987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043122485,0.00013187793,0.00018242806,0.00015336477,0.000049517508,0.0000069264584,0.00040510244,0.00023021684,0.0002705419],"category_scores_gemma":[0.00005739151,0.00008800013,0.00009190709,0.00028945698,0.00040833268,0.000003203577,0.00017528897,0.00017930755,0.0000051512275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007598754,0.000062830324,0.00851306,0.000015823382,0.000019061174,0.000020494452,0.000005126758,0.000018520057,0.9805364,0.00024749426,0.0027881395,0.007697078],"study_design_scores_gemma":[0.0002729065,0.0000719905,0.096702956,0.000053982425,0.0000061661763,0.00001565201,0.000011630381,5.169042e-7,0.899292,0.00045872343,0.0029866018,0.00012686574],"about_ca_topic_score_codex":0.0005597957,"about_ca_topic_score_gemma":0.00014359415,"teacher_disagreement_score":0.08818989,"about_ca_system_score_codex":0.000075342614,"about_ca_system_score_gemma":0.00016208687,"threshold_uncertainty_score":0.35885412},"labels":[],"label_agreement":null},{"id":"W2498107391","doi":"10.1158/1538-7445.am2016-2512","title":"Abstract 2512: Bmi1 identifies treatment-refractory stem cells in human glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"BMI1; Temozolomide; Cancer research; Chemoradiotherapy; Stem cell; Biology; Stem cell marker; Progenitor cell; Brain tumor; Cancer stem cell; Radiation therapy; Glioma; Medicine; Pathology; Internal medicine; Cell biology","score_opus":0.0705355967082496,"score_gpt":0.38640110253040444,"score_spread":0.31586550582215484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498107391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947102,0.0007876407,0.000020124988,0.000285532,0.00032021274,0.0003412775,0.000035875244,0.00017633956,0.0033227974],"genre_scores_gemma":[0.9918573,0.0013307475,0.0000091841375,0.0000049792184,0.00023305847,0.00028408502,0.0000010444244,0.000066510926,0.0062131253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703616,0.0001282787,0.00033147036,0.0004009516,0.0010231945,0.0010799166],"domain_scores_gemma":[0.99834603,0.0006776583,0.000020840127,0.00052602985,0.00013419449,0.0002952228],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011238226,0.00018876139,0.00023365078,0.0006468191,0.00012503154,0.000102431964,0.0005701024,0.00017058675,0.0019273772],"category_scores_gemma":[0.00006586573,0.00013550861,0.00006752092,0.0006065074,0.00037124177,0.00020944375,0.00015172108,0.0005195669,0.00090838975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033327662,0.000066117245,0.0011538545,0.000121799734,0.00003746903,0.00008832414,0.00020372268,0.000053142187,0.89702845,0.0000447939,0.00605506,0.095113955],"study_design_scores_gemma":[0.0010665817,0.00017874003,0.01031406,0.0004401999,0.0000022849158,0.0000011565719,0.0001192086,0.0000619486,0.9364014,0.00023864418,0.05093579,0.00023994494],"about_ca_topic_score_codex":0.00059087964,"about_ca_topic_score_gemma":0.0008067549,"teacher_disagreement_score":0.09487401,"about_ca_system_score_codex":0.0015702348,"about_ca_system_score_gemma":0.00016834463,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W2498190063","doi":"10.1158/1538-7445.am2016-1976","title":"Abstract 1976: Androgen receptor activity is reprogrammed by lysine-specific demethylase 1 in prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"FOXA1; Enzalutamide; Androgen receptor; Prostate cancer; Enhancer; Demethylase; Cancer research; Transcription factor; Histone; Coactivator; Biology; Chemistry; Cancer; Biochemistry; Genetics; Gene","score_opus":0.10823051482741243,"score_gpt":0.4313663604379637,"score_spread":0.3231358456105513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498190063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517189,0.020790726,0.000003851383,0.02387445,0.00017612297,0.0020306073,0.0005429667,0.00007606271,0.0007863103],"genre_scores_gemma":[0.9207543,0.05617313,0.00004960134,0.000120177996,0.00034673154,0.002706387,0.00004278592,0.00008770625,0.019719137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527615,0.00023041075,0.00038694535,0.0011089089,0.0014278922,0.0015697025],"domain_scores_gemma":[0.99758285,0.00029365317,0.00008935197,0.0007929449,0.0006213134,0.00061990053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015931766,0.0003098856,0.00052057486,0.0004881357,0.00021262815,0.00008443621,0.0003068389,0.00018739003,0.005773861],"category_scores_gemma":[0.00014984615,0.00019730107,0.00013974964,0.0014351305,0.00062130456,0.00029852206,0.00016917672,0.00083571207,0.00030302015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036328768,0.00039064162,0.046613645,0.00016424891,0.00012952604,0.00013920928,0.00034940397,2.837742e-7,0.49130476,0.000004790985,0.10850176,0.34876886],"study_design_scores_gemma":[0.006334654,0.00035330906,0.016178833,0.0006998896,0.000015247345,0.0000043532236,0.00011778838,0.0000036709314,0.6482944,0.00008030267,0.32764465,0.00027291646],"about_ca_topic_score_codex":0.0035927373,"about_ca_topic_score_gemma":0.00045395675,"teacher_disagreement_score":0.34849593,"about_ca_system_score_codex":0.002145529,"about_ca_system_score_gemma":0.0012928067,"threshold_uncertainty_score":0.995135},"labels":[],"label_agreement":null},{"id":"W2498363247","doi":"10.1158/1538-7445.am2016-4411","title":"Abstract 4411: Cadherin engagement induces a dramatic increase in tyr-705 phosphorylation of the signal transducer and activator of transcription-3 (Stat3α) but not the dominant-negative isoform Stat3β","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University","funders":"","keywords":"STAT3; STAT protein; Biology; Phosphorylation; Cancer research; Cell biology; Transcription factor; Tyrosine phosphorylation; SH2 domain; Autocrine signalling; Molecular biology; Receptor; Biochemistry; Gene","score_opus":0.08769687765132472,"score_gpt":0.3732763646211735,"score_spread":0.28557948696984875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498363247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958652,0.0002347538,0.00008422652,0.0024658884,0.00006529655,0.00088807195,0.00015523522,0.0000048853717,0.00023640606],"genre_scores_gemma":[0.9990105,0.00048293316,0.000029759514,0.000040291314,0.000053924963,0.00018484914,0.0000018647252,0.000016460124,0.00017943527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836946,0.00020883915,0.00039464704,0.00020198322,0.00056946184,0.00025560072],"domain_scores_gemma":[0.9984439,0.0008498795,0.00012333297,0.0002338276,0.0002741947,0.0000748893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012039023,0.000116483076,0.00023947116,0.00014956735,0.00014053495,0.00001505223,0.00014334996,0.000058897484,0.00097091816],"category_scores_gemma":[0.0002598217,0.00005650468,0.000081879654,0.00033523035,0.0003883729,0.00016274286,0.00003079127,0.00047773027,0.0000025668132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012234233,0.00015439889,0.00070330926,0.00020044709,0.000065021275,0.0000023482717,0.006573635,0.000011058828,0.96837384,0.000100717196,0.00010713698,0.02248467],"study_design_scores_gemma":[0.0016747228,0.00023034497,0.07249074,0.0009903995,0.00002971433,0.000002507698,0.0029512292,0.00005265051,0.9209067,0.00018394673,0.00042225697,0.000064742795],"about_ca_topic_score_codex":0.0069916034,"about_ca_topic_score_gemma":0.00067650323,"teacher_disagreement_score":0.071787424,"about_ca_system_score_codex":0.00024297509,"about_ca_system_score_gemma":0.0005036863,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W2498473468","doi":"10.1158/1538-7445.am2016-1240","title":"Abstract 1240: Targeting epigenetic regulation in clear cell renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clear cell renal cell carcinoma; Cancer research; Epigenetics; BAP1; Biology; Cancer; Renal cell carcinoma; Pathology; Gene; Medicine; Genetics; Melanoma","score_opus":0.06980876048259854,"score_gpt":0.353920215516742,"score_spread":0.2841114550341435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498473468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813941,0.0031017081,0.000027016446,0.0011366878,0.000083106024,0.00068144663,0.00000956112,0.000026183758,0.013540193],"genre_scores_gemma":[0.9922656,0.00036615328,0.00020255194,0.000029161305,0.000354722,0.00014337891,0.000012540499,0.000054780034,0.006571133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972774,0.0001740588,0.000373222,0.0005426758,0.000864587,0.0007680819],"domain_scores_gemma":[0.99865925,0.0002391738,0.00007137063,0.00047288445,0.00027411262,0.0002832021],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009493988,0.0001772685,0.00026534588,0.00037786446,0.00010460792,0.00002534894,0.00016399322,0.00013338351,0.0017458402],"category_scores_gemma":[0.00008272626,0.00012289501,0.00008978623,0.0004265223,0.00014723268,0.00009136843,0.00009137274,0.00039631475,0.00044610066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005877175,0.00014365376,0.04626741,0.00020047704,0.000007154186,0.00023854406,0.00025082438,0.000026068885,0.9419469,0.000008676685,0.0030283243,0.007294205],"study_design_scores_gemma":[0.001707187,0.0003225367,0.3891161,0.00014621211,0.000009632524,0.0000033913923,0.000074749885,0.000018634886,0.60629904,0.00008338238,0.0021168,0.00010230985],"about_ca_topic_score_codex":0.0011380193,"about_ca_topic_score_gemma":0.00009207761,"teacher_disagreement_score":0.3428487,"about_ca_system_score_codex":0.0012221129,"about_ca_system_score_gemma":0.00048368177,"threshold_uncertainty_score":0.9991667},"labels":[],"label_agreement":null},{"id":"W2498713656","doi":"10.1158/1538-7445.am2016-2985","title":"Abstract 2985: Molecular mechanisms of dianhydrogalactitol (VAL-083) in cancer treatment","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Cancer research; Propidium iodide; Cancer; Cell cycle; DNA damage; Cell cycle checkpoint; LNCaP; Molecular biology; Chemistry; Biology; Cancer cell; Medicine; DNA; Internal medicine; Programmed cell death; Apoptosis; Genetics","score_opus":0.04283624695851042,"score_gpt":0.3803845940722285,"score_spread":0.3375483471137181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498713656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555314,0.0013125024,0.00042959917,0.0006379986,0.00016455789,0.00046582424,0.00008520425,0.000012063732,0.0013390939],"genre_scores_gemma":[0.99517316,0.0024797807,0.00017730815,0.00003611851,0.00010717085,0.0006103911,0.000008336654,0.000043919845,0.0013638068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813694,0.00012118446,0.00024318113,0.0005147555,0.0004224791,0.00056145096],"domain_scores_gemma":[0.99903196,0.00003520236,0.00006577468,0.0005501619,0.00017645943,0.0001404646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043263458,0.00017376796,0.0002156994,0.00017948914,0.000040730734,0.000012493343,0.00030252014,0.00018207963,0.00043854376],"category_scores_gemma":[0.0000734115,0.00012606816,0.00010968909,0.000232623,0.00012310973,0.000007695503,0.00013317917,0.000108240965,0.000029327108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001382266,0.00015373429,0.00050556817,0.000029539506,0.00006481374,0.000027986034,0.000038853937,0.000021935715,0.9790166,0.00067774707,0.00021191596,0.019113075],"study_design_scores_gemma":[0.0010636314,0.00040095192,0.000893892,0.00011100867,0.000007101838,0.0000016810842,0.000041265306,0.0000039902757,0.9901575,0.0012448991,0.005922366,0.00015172745],"about_ca_topic_score_codex":0.0017995143,"about_ca_topic_score_gemma":0.0011874733,"teacher_disagreement_score":0.018961348,"about_ca_system_score_codex":0.0003303304,"about_ca_system_score_gemma":0.0004963784,"threshold_uncertainty_score":0.514091},"labels":[],"label_agreement":null},{"id":"W2499073646","doi":"10.1158/1538-7445.am2016-279","title":"Abstract 279: Combinatorial strategies for glioblastoma using brain tumor-initiating cells: targeting the JAK/STAT and EGFR pathways","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Calgary","funders":"","keywords":"Erlotinib; Temozolomide; Cancer research; Medicine; EGFR inhibitors; PTEN; Lapatinib; STAT3; Cancer; Epidermal growth factor receptor; Glioma; Signal transduction; PI3K/AKT/mTOR pathway; Biology; Internal medicine; Breast cancer","score_opus":0.09372862512398468,"score_gpt":0.39166309477325845,"score_spread":0.2979344696492738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499073646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994639,0.0012138685,0.000034494336,0.0025092221,0.00030641575,0.0008649652,0.00007778117,0.00003041118,0.0003238422],"genre_scores_gemma":[0.99862486,0.00011996709,0.00014822748,0.000101850455,0.0006411462,0.0003065851,0.0000031429204,0.0000380311,0.000016166667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982542,0.000098542754,0.00023635852,0.00033749494,0.00047037416,0.00060306164],"domain_scores_gemma":[0.9975384,0.0016863603,0.000079115256,0.00021417024,0.00032100538,0.00016098074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010879993,0.00015253857,0.00022869029,0.00011452414,0.00049446773,0.00014886611,0.00011174534,0.000058392176,0.00010448002],"category_scores_gemma":[0.00037114538,0.00008353071,0.00007127822,0.00018801169,0.0002304715,0.00016153665,0.00008696899,0.00020938535,0.000008599747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057756715,0.00020499114,0.002132798,0.00026698108,0.00010982523,0.00016439955,0.00094178127,0.000013847493,0.9774582,0.004501765,0.0052600233,0.008367824],"study_design_scores_gemma":[0.012391301,0.0019876028,0.003563887,0.0017763916,0.000095586925,0.00003869289,0.010091082,0.00055276847,0.94954944,0.0102353245,0.009312127,0.00040576918],"about_ca_topic_score_codex":0.00043458704,"about_ca_topic_score_gemma":0.00006824568,"teacher_disagreement_score":0.02790873,"about_ca_system_score_codex":0.00029177128,"about_ca_system_score_gemma":0.0005105872,"threshold_uncertainty_score":0.3803096},"labels":[],"label_agreement":null},{"id":"W2499116047","doi":"10.1158/1538-7445.am2016-3149","title":"Abstract 3149: Enumeration and mutational profiling of CTCs and comparison to ctDNA and colorectal cancer liver metastases","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"","keywords":"Circulating tumor cell; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Carcinoembryonic antigen; Liquid biopsy; Stage (stratigraphy); Primary tumor; Metastasis; Biology","score_opus":0.05246671886330808,"score_gpt":0.3909212690403962,"score_spread":0.33845455017708814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499116047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901868,0.008630714,0.00015865244,0.00038645562,0.00004262684,0.0002354108,0.00030953297,0.000001830662,0.000047951795],"genre_scores_gemma":[0.994249,0.005048765,0.00035691026,0.00004057238,0.00013418439,0.000097624936,0.000019740639,0.00000982077,0.000043413915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992965,0.00003114212,0.00012599726,0.00024415634,0.000141,0.00016120255],"domain_scores_gemma":[0.99949294,0.00010593241,0.00003565665,0.00007080053,0.00019421977,0.000100437705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023569654,0.000071134746,0.00010723992,0.000053471198,0.00007552186,0.000028262246,0.000046349585,0.000050759143,0.000030430174],"category_scores_gemma":[0.00014263162,0.000056819794,0.000012162936,0.000055491117,0.00016398614,0.0000061927426,0.00010509714,0.000053467917,7.5363437e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020922313,0.000018491313,0.0220262,0.00005168888,0.000033769753,0.0000013577423,0.00012025969,0.000041803232,0.9472137,0.00018150276,0.00081855454,0.029283468],"study_design_scores_gemma":[0.000542547,0.00023765168,0.06736118,0.000055571414,0.00001209779,0.0000031050254,0.00008981667,0.00006109174,0.9275571,0.000076113356,0.003898539,0.000105159634],"about_ca_topic_score_codex":0.00052789296,"about_ca_topic_score_gemma":0.0008959212,"teacher_disagreement_score":0.045334987,"about_ca_system_score_codex":0.000029842242,"about_ca_system_score_gemma":0.00018089125,"threshold_uncertainty_score":0.2317044},"labels":[],"label_agreement":null},{"id":"W2499226924","doi":"10.1158/1538-7445.am2016-5070","title":"Abstract 5070: CD44 alternative splice variants are associated with prostate cancer cell identity and migration","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CD44; Biology; Alternative splicing; RNA splicing; Cancer research; Prostate cancer; Metastasis; Cancer; Cancer cell; Cell; Cell biology; Exon; Genetics; Gene; RNA","score_opus":0.0379827382307279,"score_gpt":0.3831303193258666,"score_spread":0.3451475810951387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499226924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558616,0.001582531,0.00068272813,0.0009910564,0.000021481406,0.00041644368,0.0003111986,0.000014390811,0.00039401464],"genre_scores_gemma":[0.98927623,0.00873999,0.00006274855,0.00009013774,0.00007832833,0.0005983065,0.0000545731,0.000015891903,0.0010838212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989493,0.00007832336,0.000108975895,0.0004019093,0.00018329268,0.00027822444],"domain_scores_gemma":[0.99923486,0.000022087728,0.00008967928,0.00023669004,0.00033442586,0.000082232815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003242489,0.00010499756,0.000094291354,0.000030300227,0.00014189156,0.000026424483,0.00017112747,0.000119421,0.00007060773],"category_scores_gemma":[0.000046182453,0.00007110423,0.000022147387,0.00011396425,0.00018825421,0.000014191903,0.000106894135,0.00011276198,0.0000047230906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009331507,0.000047726204,0.010954488,0.000013153695,0.00004655248,0.0000036304298,0.00003803994,0.000002473825,0.98363066,0.00006197034,0.0033275187,0.0017804943],"study_design_scores_gemma":[0.00075968425,0.00020834038,0.07939965,0.00014208826,0.000014465621,0.0000021593132,0.0000745053,0.000006453305,0.90823066,0.0003427097,0.010600776,0.00021849673],"about_ca_topic_score_codex":0.001478852,"about_ca_topic_score_gemma":0.0067649833,"teacher_disagreement_score":0.075399965,"about_ca_system_score_codex":0.00008211034,"about_ca_system_score_gemma":0.00012549003,"threshold_uncertainty_score":0.37750196},"labels":[],"label_agreement":null},{"id":"W2499277221","doi":"10.1158/1538-7445.am2016-5220","title":"Abstract 5220: Evaluation of ACMG guideline classified variants in 180 cancer and incidental non-cancer genes in families with breast/ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Cancer; Exome sequencing; Ovarian cancer; Medicine; Medical genetics; Exome; Genetics; Locus (genetics); Genetic testing; Gene; Oncology; Internal medicine; Mutation; Bioinformatics; Biology","score_opus":0.07303932257255497,"score_gpt":0.4220357718887039,"score_spread":0.3489964493161489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499277221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860058,0.010157998,0.00005873344,0.001933969,0.0002052064,0.000767875,0.00046856992,0.000005553429,0.00039632464],"genre_scores_gemma":[0.98430264,0.012722156,0.00017252855,0.00009259259,0.00046189022,0.0018749717,0.000030322744,0.00005087421,0.00029204885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99706167,0.00019778738,0.0005281936,0.0007446689,0.0008993792,0.00056827173],"domain_scores_gemma":[0.9980558,0.000056042718,0.0001642204,0.00045904692,0.0011515195,0.000113365924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017577981,0.00023711994,0.00030278694,0.00035902718,0.00008474307,0.000032852,0.00034826476,0.00022861519,0.0007885026],"category_scores_gemma":[0.000103819904,0.00017982726,0.000039080478,0.0006166887,0.00042054203,0.000037869788,0.00020806886,0.00023894139,0.0000030733315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054028194,0.000066160486,0.13042867,0.00006887359,0.00009977249,0.000004161813,0.00024610353,0.0019182973,0.69153094,0.000012692035,0.0017282349,0.1733558],"study_design_scores_gemma":[0.006008141,0.00012429545,0.71348214,0.00080290105,0.0000498814,0.000008214562,0.00078617566,0.0006702994,0.27502733,0.0001404863,0.0024864345,0.00041370964],"about_ca_topic_score_codex":0.024203105,"about_ca_topic_score_gemma":0.112639226,"teacher_disagreement_score":0.58305347,"about_ca_system_score_codex":0.0011675842,"about_ca_system_score_gemma":0.0037409873,"threshold_uncertainty_score":0.9822948},"labels":[],"label_agreement":null},{"id":"W2499313172","doi":"10.1158/1538-7445.am2016-2524","title":"Abstract 2524: STAT3 is a key regulator of an “EMT-like” process mediated by Slug in GBM","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Slug; Epithelial–mesenchymal transition; STAT3; Twist transcription factor; Transcription factor; Cancer research; Biology; Transcriptome; STAT protein; Mesenchymal stem cell; Regulator; Cancer; Oncology; Medicine; Gene; Gene expression; Metastasis; Genetics","score_opus":0.0696681214274195,"score_gpt":0.4265279027589803,"score_spread":0.35685978133156077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499313172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902449,0.0019751382,0.000002255385,0.0057326634,0.00007208516,0.00063421973,0.00022888942,0.000030987165,0.0010788242],"genre_scores_gemma":[0.9961975,0.001527014,0.000023974651,0.00025877362,0.00012203893,0.0004546186,0.00002000711,0.000047843314,0.0013481871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971614,0.00009284432,0.0004009406,0.0005074897,0.0011771261,0.00066021184],"domain_scores_gemma":[0.9983091,0.00013354242,0.000086320746,0.0004893879,0.00063098455,0.00035071748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009360836,0.00015937135,0.00038947503,0.00028833165,0.00005366394,0.000019750907,0.00029223962,0.00015269309,0.00301421],"category_scores_gemma":[0.00017486577,0.00010660666,0.000059303093,0.0007741359,0.00031726452,0.00021420131,0.000056904733,0.00035761125,0.000047352234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028355075,0.0010961386,0.11289469,0.0014158456,0.00015886723,0.000053782263,0.0033820006,0.000002034399,0.6809163,0.000051381965,0.10340309,0.09379037],"study_design_scores_gemma":[0.0073133926,0.001353118,0.15017745,0.002350353,0.0000338466,0.0000048583274,0.0012309186,0.000054330627,0.7912161,0.00034157504,0.04551102,0.00041305635],"about_ca_topic_score_codex":0.0018511922,"about_ca_topic_score_gemma":0.0004063466,"teacher_disagreement_score":0.11029979,"about_ca_system_score_codex":0.00038705775,"about_ca_system_score_gemma":0.00093513867,"threshold_uncertainty_score":0.99789715},"labels":[],"label_agreement":null},{"id":"W2499454114","doi":"10.1158/1538-7445.am2015-3708","title":"Abstract 3708: Filling the void of Canadian T-cell lymphoma epidemiology: Data from the canadian institute for health information discharge abstract database","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epidemiology; Medicine; Population; Incidence (geometry); Database; Demography; Family medicine; Environmental health; Pathology; Computer science","score_opus":0.28314088388786635,"score_gpt":0.41281208181146434,"score_spread":0.129671197923598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499454114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6357001,0.09084721,0.00010181287,0.14169851,0.00531122,0.0038649598,0.11441026,0.00005546952,0.008010463],"genre_scores_gemma":[0.988418,0.0025159754,0.00005467739,0.0016447027,0.00018913763,0.00011652665,0.006759931,0.000012797084,0.00028828846],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979098,0.00026302878,0.00047183142,0.000286301,0.000099850375,0.0009692338],"domain_scores_gemma":[0.99730766,0.0010114528,0.0001864505,0.0009586513,0.00030759515,0.00022820216],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0046924697,0.00015054131,0.00029925068,0.00027204846,0.0015022352,0.000032223255,0.0012680877,0.00017811671,0.00014333047],"category_scores_gemma":[0.0013275727,0.00008544118,0.000049322785,0.00032186598,0.000796991,0.0003753247,0.00023472415,0.0005483811,0.00025471803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018766409,0.00004290134,0.0050311256,0.00010653545,0.0002320813,0.0000019377258,0.0030983784,0.00007522006,0.0026485408,0.00081777363,0.97304636,0.014711453],"study_design_scores_gemma":[0.0009976509,0.000052289586,0.016395593,0.00007587729,0.000013866084,0.0000020233504,0.002217117,0.000023374592,0.0014029306,0.00015743512,0.9785421,0.00011973001],"about_ca_topic_score_codex":0.9955357,"about_ca_topic_score_gemma":0.99713147,"teacher_disagreement_score":0.35271788,"about_ca_system_score_codex":0.00056509534,"about_ca_system_score_gemma":0.007345102,"threshold_uncertainty_score":0.9997977},"labels":[],"label_agreement":null},{"id":"W2499500444","doi":"10.1158/1538-7445.am2016-4445","title":"Abstract 4445: The estrogen related receptor alpha regulates one carbon metabolism and DNA methylation","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA methylation; Epigenetics; DNA methyltransferase; DNMT1; Methyltransferase; Biology; Methylation; Estrogen receptor; Estrogen receptor alpha; Molecular biology; Cancer research; Gene expression; Genetics; DNA; Cancer; Gene; Breast cancer","score_opus":0.041206882678874214,"score_gpt":0.34503790968978754,"score_spread":0.3038310270109133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499500444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673474,0.029002132,0.000023643252,0.0024922534,0.00011743662,0.0002712211,0.000018732844,0.000009848249,0.0007173331],"genre_scores_gemma":[0.9884157,0.009790176,0.000085708765,0.000016496208,0.00031198649,0.00007624462,0.000023187216,0.000026999067,0.0012534704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985954,0.00020965388,0.00020106805,0.0003610371,0.00031589088,0.0003169293],"domain_scores_gemma":[0.9991202,0.00009622264,0.00006704248,0.0003724659,0.0002472462,0.0000968324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011863126,0.00011153617,0.00011500217,0.00006508433,0.00015849741,0.000038195878,0.00017573261,0.0001718185,0.000088118715],"category_scores_gemma":[0.0002455961,0.000069215675,0.000043253825,0.0001667657,0.00023307183,0.0000064892215,0.000117578136,0.00014614822,0.000009604465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058941692,0.00001357815,0.000585443,0.0000072856337,0.00006738083,2.967125e-7,0.000058501428,0.000005570358,0.9620128,0.0004979959,0.00012676662,0.036565416],"study_design_scores_gemma":[0.0003858364,0.00006397437,0.020789962,0.000023651084,0.000013901295,3.9058236e-7,0.000025081825,0.000007930304,0.93575466,0.0016841342,0.041143887,0.00010658803],"about_ca_topic_score_codex":0.00017362379,"about_ca_topic_score_gemma":0.000047598092,"teacher_disagreement_score":0.041017123,"about_ca_system_score_codex":0.00003519193,"about_ca_system_score_gemma":0.00011002049,"threshold_uncertainty_score":0.28225332},"labels":[],"label_agreement":null},{"id":"W2499515594","doi":"10.1158/1538-7445.am2016-lb-180","title":"Abstract LB-180: The genetic landscape of Wilms tumor","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplasia; Wilms' tumor; Exome sequencing; Exome; Cancer; Oncology; Medicine; Copy-number variation; Gene; Genome; Biology; Genetics; Internal medicine; Mutation","score_opus":0.026727829516778982,"score_gpt":0.33998499222766126,"score_spread":0.3132571627108823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499515594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892387,0.0061537647,0.000018556984,0.0010903645,0.000117622585,0.00013808356,0.000023712093,0.0000037807358,0.0032154105],"genre_scores_gemma":[0.992985,0.0041167275,0.000011588829,0.00006953602,0.0003098336,0.00005914367,0.0000026498676,0.000014531224,0.0024310073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990403,0.00005738353,0.00013218517,0.00021368916,0.00026479975,0.00029162562],"domain_scores_gemma":[0.9993747,0.000034509885,0.000040659525,0.00032101097,0.00016076246,0.00006837059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028324904,0.00007365058,0.00008232393,0.00003698666,0.00007839385,0.00001025919,0.00031828074,0.000073022806,0.00027301974],"category_scores_gemma":[0.000051927138,0.00003440351,0.00006114352,0.00013316453,0.00028991027,0.0000018934592,0.0000915428,0.00013147033,0.00003271217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011607247,0.00001355732,0.0024840503,0.000024163646,0.000051032483,0.000004891,0.000021945258,0.000044014145,0.9642451,0.000028593475,0.017260117,0.015706481],"study_design_scores_gemma":[0.00061826495,0.00019906482,0.021724511,0.00011451453,0.000007917287,0.000009417825,0.00007580442,0.000003729666,0.8786046,0.0001713871,0.09835306,0.00011770991],"about_ca_topic_score_codex":0.00013292771,"about_ca_topic_score_gemma":0.000043726843,"teacher_disagreement_score":0.08564046,"about_ca_system_score_codex":0.000020138717,"about_ca_system_score_gemma":0.00023779295,"threshold_uncertainty_score":0.29893747},"labels":[],"label_agreement":null},{"id":"W2499543174","doi":"10.1158/1538-7445.am2016-2922","title":"Abstract 2922: Loss of retinoblastoma protein dysregulates HIF1-mediated genetic programs, and promotes tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia; Simon Fraser University","funders":"","keywords":"Aryl hydrocarbon receptor nuclear translocator; Neuroendocrine differentiation; Biology; Cancer research; LNCaP; Retinoblastoma protein; Metastasis; Protein kinase B; Prostate cancer; Cell biology; Transcription factor; Signal transduction; Cancer; Cell cycle; Gene; Genetics","score_opus":0.01618265521470905,"score_gpt":0.2856555323194923,"score_spread":0.26947287710478324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499543174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966974,0.008439285,0.0000031219306,0.00030671855,0.00012726642,0.0013358264,0.00009506834,0.000009051783,0.000013948542],"genre_scores_gemma":[0.9888988,0.009609054,0.000041486324,0.000013459373,0.00024316202,0.00068758207,0.0000204306,0.000039320432,0.0004466635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981892,0.00014214618,0.0003006121,0.0005583183,0.00029233363,0.0005173899],"domain_scores_gemma":[0.9991684,0.000036084115,0.00012819603,0.0002614678,0.00025877176,0.00014706168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022006544,0.00019285003,0.00025031331,0.0001393185,0.000059590846,0.000037711314,0.000159647,0.0000569164,0.000035007815],"category_scores_gemma":[0.00007084706,0.0001467975,0.000033343895,0.00020932528,0.00040304565,0.000014475036,0.00018594788,0.0001544851,0.0000014152047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038461213,0.00009771103,0.025321908,0.00045176796,0.000018432278,0.000011506985,0.00008824581,0.0000036839535,0.9544765,0.0000023932362,0.00008459244,0.019058665],"study_design_scores_gemma":[0.0015331008,0.00024663628,0.12255068,0.00027748803,0.0000088015995,0.0000063582456,0.000032468826,0.000007639341,0.8720998,0.0000550824,0.0030167329,0.00016518413],"about_ca_topic_score_codex":0.00061844575,"about_ca_topic_score_gemma":0.0010733996,"teacher_disagreement_score":0.09722877,"about_ca_system_score_codex":0.000039619255,"about_ca_system_score_gemma":0.00029146002,"threshold_uncertainty_score":0.5986228},"labels":[],"label_agreement":null},{"id":"W2499984200","doi":"10.1158/1538-7445.am2016-3069","title":"Abstract 3069: Investigation of pharmacodynamic and predictive biomarkers to define response to proteasome inhibitor marizomib in glioma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Pharmacodynamics; Proteasome; Proteasome inhibitor; Pharmacology; Internal medicine; Pharmacokinetics; Multiple myeloma; Cancer research; Biology; Biochemistry","score_opus":0.03602003086076601,"score_gpt":0.3523880702581249,"score_spread":0.3163680393973589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499984200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549335,0.0003327444,0.00005460825,0.0025930917,0.00004902299,0.0011285807,0.00022697124,0.0000063118387,0.00011531517],"genre_scores_gemma":[0.99871475,0.000084256666,0.00019089114,0.0000840501,0.000100727404,0.00063626125,0.0000101229225,0.000020889132,0.00015806772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852574,0.00026632557,0.00020676918,0.00039435798,0.0002690077,0.00033779457],"domain_scores_gemma":[0.99920994,0.00008487651,0.000039097315,0.00022135547,0.00019887672,0.00024586963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014843354,0.000109998306,0.00012297308,0.0003248254,0.000045623518,0.000014141351,0.00016898072,0.00010404916,0.000051639334],"category_scores_gemma":[0.0005716857,0.00008810986,0.000024774836,0.000417664,0.00017194424,0.000008904674,0.00021408188,0.00010476979,0.000012121832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062065166,0.000019382207,0.004538607,0.000054779946,0.000022439774,0.000006360196,0.00017400767,0.000005134154,0.9806582,0.000006094953,0.00091570633,0.0073927836],"study_design_scores_gemma":[0.0009362169,0.00062086905,0.058287654,0.00022268166,0.0000021654325,0.000002598673,0.000045080433,0.000005490975,0.9379641,0.0000908125,0.0017106845,0.00011169136],"about_ca_topic_score_codex":0.0001511697,"about_ca_topic_score_gemma":0.000095369614,"teacher_disagreement_score":0.053749047,"about_ca_system_score_codex":0.00010748839,"about_ca_system_score_gemma":0.0003119852,"threshold_uncertainty_score":0.3593016},"labels":[],"label_agreement":null},{"id":"W2500317367","doi":"10.1158/1538-7445.am2016-1944","title":"Abstract 1944: Integrated analysis of copy number and miRNA profiling in triple negative breast cancer of Latina women","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"MiRBase; Triple-negative breast cancer; microRNA; Breast cancer; Copy-number variation; Cancer research; Biology; Cancer; Oncology; Medicine; Computational biology; Bioinformatics; Internal medicine; Gene; Genetics; Genome","score_opus":0.026835560062153208,"score_gpt":0.37295946799325086,"score_spread":0.34612390793109765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500317367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870163,0.00030912744,0.000018917306,0.000105116385,0.000015616472,0.00021349966,0.0004824773,0.0000018890859,0.00015170232],"genre_scores_gemma":[0.9988841,0.00067144784,0.000057813177,0.000004724964,0.000028429478,0.000117546624,0.000024754583,0.000010404645,0.00020077165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990187,0.00009728093,0.0002218327,0.0002450793,0.00018911228,0.00022794149],"domain_scores_gemma":[0.99921715,0.000043505803,0.00009590539,0.00018506953,0.00039053158,0.00006784748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039708117,0.000077930716,0.00019616887,0.00017270411,0.000021412667,0.000006253792,0.000106341875,0.000080634585,0.0004560622],"category_scores_gemma":[0.00009175531,0.000056673583,0.00004332101,0.00063760846,0.00021352511,0.0000069663465,0.00006395205,0.00007433845,8.859363e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044901844,0.00003477698,0.18169664,0.000053619122,0.00023883658,6.078424e-7,0.00012423229,0.00003828567,0.81259304,0.000010195791,0.000112810914,0.0046479357],"study_design_scores_gemma":[0.0005950117,0.000022845265,0.38237596,0.000089461144,0.00002035842,2.9627546e-7,0.00014791373,0.000044842378,0.61652696,0.000043115262,0.00007339135,0.00005983325],"about_ca_topic_score_codex":0.0018354511,"about_ca_topic_score_gemma":0.00082611555,"teacher_disagreement_score":0.20067933,"about_ca_system_score_codex":0.0001460586,"about_ca_system_score_gemma":0.00029763914,"threshold_uncertainty_score":0.49935612},"labels":[],"label_agreement":null},{"id":"W2500424943","doi":"10.1158/1538-7445.am2016-664","title":"Abstract 664: Insulin receptor signaling contributes to mammary tumorigenesis in mice","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hyperinsulinemia; Insulin receptor; Cancer; Carcinogenesis; Metastasis; Insulin; Knockout mouse; Endocrinology; Cancer research; Internal medicine; Medicine; Biology; Breast cancer; Mammary gland; Type 2 diabetes; Receptor; Diabetes mellitus; Insulin resistance","score_opus":0.03711142063820537,"score_gpt":0.3512148377711076,"score_spread":0.31410341713290224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500424943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86416644,0.13413331,0.00016262422,0.00060456566,0.000271344,0.00028967735,0.00008794744,0.000009394293,0.00027472933],"genre_scores_gemma":[0.9392368,0.0582772,0.00012956621,0.00045162375,0.00062870956,0.0004056825,0.000018946148,0.000030990203,0.00082048716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998152,0.00014334708,0.00027195166,0.00050295476,0.00029088295,0.00063883566],"domain_scores_gemma":[0.99904,0.000080564976,0.000039405128,0.0003434937,0.00032092392,0.0001756042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001115042,0.00013857776,0.00019914408,0.00017329995,0.00007638147,0.000042389715,0.0004446376,0.00014323536,0.0003116524],"category_scores_gemma":[0.0003673394,0.0001079833,0.000059378453,0.00036070726,0.00008742936,0.000009142886,0.00017470199,0.00014891016,0.00011651427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020744823,0.000030053401,0.0015132324,0.0000268883,0.000025357067,0.0000031774987,0.00003576204,0.000008380859,0.8393081,0.0000569238,0.010364575,0.14842011],"study_design_scores_gemma":[0.00055271125,0.000052350377,0.0023062935,0.00009272897,0.0000019352713,1.9482393e-7,0.000037959213,4.100825e-7,0.6667397,0.00011658084,0.32997507,0.00012408441],"about_ca_topic_score_codex":0.00027113283,"about_ca_topic_score_gemma":0.00017356285,"teacher_disagreement_score":0.3196105,"about_ca_system_score_codex":0.00014009554,"about_ca_system_score_gemma":0.0004357617,"threshold_uncertainty_score":0.4403431},"labels":[],"label_agreement":null},{"id":"W2500435856","doi":"10.1158/1538-7445.am2016-5287","title":"Abstract 5287: Heterogeneity of mutation calling and annotation: a survey of cancer next-generation sequencing initiatives by the Global Alliance for Genomics and Health (GA4GH)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"dbSNP; Data sharing; Raw data; Genomics; Annotation; DNA sequencing; Genetics; Biology; Medicine; Genome; Gene; Computer science; Single-nucleotide polymorphism; Genotype","score_opus":0.2462458229443834,"score_gpt":0.44842355448525745,"score_spread":0.20217773154087404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500435856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734882,0.020724948,0.0031842485,0.0006663372,0.00005401503,0.0003671361,0.0015080464,0.0000012815811,0.0000057703637],"genre_scores_gemma":[0.9795618,0.019815514,0.0002175486,0.000093919814,0.00011016344,0.00010024056,0.000086032196,0.00000980734,0.0000049905293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991419,0.000086359556,0.00022517549,0.00023964419,0.00012226687,0.00018469265],"domain_scores_gemma":[0.99909526,0.00013146005,0.00014613173,0.00012886357,0.0004393289,0.00005895583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008688913,0.00007663989,0.00012545544,0.0000145095255,0.00013328495,0.00003096108,0.00008544402,0.000056667082,0.000002639328],"category_scores_gemma":[0.00017977464,0.000056987657,0.000020100051,0.00008207208,0.00023018966,0.000011453218,0.000048474027,0.00004191714,5.4715436e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016331922,0.000015128442,0.030677658,0.00011442249,0.000059641516,1.6488346e-7,0.00020324462,0.00035238187,0.9307672,0.000144325,0.00050535006,0.0369972],"study_design_scores_gemma":[0.0010320845,0.000367608,0.16763173,0.000110337205,0.000010401144,0.0000017557902,0.00016897806,0.00081091886,0.82875097,0.000200875,0.00076368504,0.00015066304],"about_ca_topic_score_codex":0.0069397236,"about_ca_topic_score_gemma":0.021813141,"teacher_disagreement_score":0.13695407,"about_ca_system_score_codex":0.00018177553,"about_ca_system_score_gemma":0.0008250584,"threshold_uncertainty_score":0.9996731},"labels":[],"label_agreement":null},{"id":"W2500442750","doi":"10.1158/1538-7445.am2016-4764","title":"Abstract 4764: Development of a multigenic bioluminescence imaging system to detect prostate cancer cells and assess their response to therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Luciferase; Prostate cancer; Promoter; Bioluminescence imaging; Biology; Circulating tumor cell; PCA3; LNCaP; Biomarker; Cancer; Cancer research; Gene; Computational biology; Gene expression; Metastasis; Genetics; Transfection","score_opus":0.05139595414194759,"score_gpt":0.3911308737661653,"score_spread":0.3397349196242177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500442750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438554,0.003638535,0.00018780882,0.00042896555,0.00006893928,0.0010266532,0.00022010195,0.000011386601,0.000032095977],"genre_scores_gemma":[0.99618405,0.0015977856,0.0005283199,0.000037000304,0.00007451878,0.0011605364,0.0000034284951,0.000034569824,0.00037977734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798787,0.00017195915,0.00023382885,0.00056894345,0.00039117146,0.0006462217],"domain_scores_gemma":[0.9987009,0.00008345211,0.000047320318,0.00038898404,0.00042620406,0.00035311922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009706279,0.00017693924,0.00018525378,0.00019125541,0.00016187066,0.000045825298,0.00030533684,0.00005395897,0.000029160256],"category_scores_gemma":[0.000064290565,0.000116286334,0.000042566666,0.000288408,0.0001288384,0.000009281687,0.00026112577,0.000090297,0.000016616254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031127094,0.000023455414,0.003064368,0.000060021703,0.00006253925,0.0000070978654,0.00033738898,0.0000037381815,0.79691005,3.6786273e-7,0.00028098634,0.19613726],"study_design_scores_gemma":[0.0010414943,0.00021791119,0.020666813,0.00033758598,0.0000015865668,0.0000019449171,0.00016769794,0.0000017981336,0.9510465,0.000001054962,0.02636255,0.00015305464],"about_ca_topic_score_codex":0.001122521,"about_ca_topic_score_gemma":0.0011564593,"teacher_disagreement_score":0.19598421,"about_ca_system_score_codex":0.00032215082,"about_ca_system_score_gemma":0.0010475167,"threshold_uncertainty_score":0.47420192},"labels":[],"label_agreement":null},{"id":"W2500497315","doi":"10.1158/1538-7445.am2016-98","title":"Abstract 98: The somatic mutational landscape of the mitochondrial genome in prostate cancer: evaluation of clinical impact","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Somatic cell; Sanger sequencing; Mitochondrial DNA; Biology; Genome; Genetics; Cancer; Germline mutation; Nonsynonymous substitution; Mutation; Gene","score_opus":0.09095607121849329,"score_gpt":0.46853377755469683,"score_spread":0.3775777063362035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500497315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951437,0.002561029,0.000004928708,0.0009651689,0.000259763,0.0005943579,0.00027073667,8.228125e-7,0.00019950539],"genre_scores_gemma":[0.9972513,0.0019749592,0.000012859336,0.000022421307,0.00042467058,0.00020631218,0.000013445995,0.000011368427,0.00008267151],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998362,0.00025923163,0.00040144834,0.00020639489,0.0005559328,0.00021497953],"domain_scores_gemma":[0.9985972,0.00027040302,0.0001679748,0.00035213167,0.000568137,0.000044168766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019339446,0.00007416201,0.0001491107,0.00004451667,0.00004926002,0.000010992099,0.00031099035,0.000070319,0.0002408298],"category_scores_gemma":[0.0009215227,0.000036490237,0.000113446884,0.00017010278,0.000261997,0.0000041416815,0.00011649074,0.00013095952,0.0000024386027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066177244,0.000113506845,0.13966206,0.00005256771,0.000121671466,7.3250243e-7,0.00022888259,0.004252246,0.826293,0.000041768384,0.0020694612,0.026502367],"study_design_scores_gemma":[0.002448351,0.00016989275,0.926307,0.00011961266,0.00002746384,0.0000011126949,0.000088852445,0.00016963128,0.06809402,0.001032791,0.0014495773,0.000091662485],"about_ca_topic_score_codex":0.00083927286,"about_ca_topic_score_gemma":0.0017227824,"teacher_disagreement_score":0.786645,"about_ca_system_score_codex":0.00009078061,"about_ca_system_score_gemma":0.002205518,"threshold_uncertainty_score":0.39124945},"labels":[],"label_agreement":null},{"id":"W2500651515","doi":"10.1158/1538-7445.am2016-2192","title":"Abstract 2192: Fusogenic targeted liposomes as next-generation nanomedicine for prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Liposome; Biodistribution; Doxorubicin; Bombesin; Drug delivery; Targeted drug delivery; Nanomedicine; Cancer research; Cancer; Prostate cancer; Nanocarriers; Medicine; Chemistry; Pharmacology; Drug; In vitro; Internal medicine; Chemotherapy; Biochemistry; Nanotechnology; Materials science; Receptor","score_opus":0.1553752418068312,"score_gpt":0.44108609140474436,"score_spread":0.28571084959791315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500651515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9322851,0.028827272,0.00001634415,0.033397127,0.0005755867,0.00340355,0.00030006963,0.00009650538,0.0010984935],"genre_scores_gemma":[0.9195687,0.025748119,0.00007022494,0.00030035988,0.002162416,0.004666511,0.00014470755,0.00009037987,0.04724856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963511,0.00008939972,0.00039373117,0.00074068987,0.0011816757,0.0012433828],"domain_scores_gemma":[0.9972968,0.00029397366,0.00008118866,0.0004950847,0.0012931391,0.00053982507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010021054,0.00026818528,0.00042917908,0.0004667858,0.00039041883,0.00008018772,0.00024266083,0.00017236914,0.004080139],"category_scores_gemma":[0.000338231,0.00015688644,0.00015484243,0.0006717497,0.0004550884,0.00030705947,0.00008958796,0.00037407948,0.00020446346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022408816,0.00013691181,0.0042426814,0.0003155013,0.0002598523,0.000050370814,0.0003367991,0.0000020503105,0.83729196,0.000104027335,0.040106446,0.11491251],"study_design_scores_gemma":[0.012034933,0.0017925458,0.0136820525,0.0011203655,0.00009990229,0.000015114682,0.0002630262,0.000059972364,0.8103406,0.00065723126,0.15955918,0.00037511144],"about_ca_topic_score_codex":0.0011822943,"about_ca_topic_score_gemma":0.00039400414,"teacher_disagreement_score":0.11945273,"about_ca_system_score_codex":0.0013259454,"about_ca_system_score_gemma":0.0024982356,"threshold_uncertainty_score":0.9968303},"labels":[],"label_agreement":null},{"id":"W2500702915","doi":"10.1158/1538-7445.am2016-1834","title":"Abstract 1834: Semaphorin 3C is an androgen receptor-regulated gene","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Androgen receptor; Prostate cancer; Biology; Semaphorin; LNCaP; Transcription factor; Cancer research; Enzalutamide; Cancer; Genetics; Cell biology; Gene; Receptor","score_opus":0.20825489387474233,"score_gpt":0.4177555612853219,"score_spread":0.20950066741057954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500702915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958379,0.00029470824,0.000020524234,0.0021395823,0.00021899483,0.00028656158,0.00009708136,0.0000920884,0.0010125416],"genre_scores_gemma":[0.9944985,0.0011700655,0.000024238389,0.000575866,0.00042686463,0.00009099171,0.0000016637533,0.000046867182,0.0031649673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968641,0.00024512113,0.00025322643,0.00079498795,0.001011341,0.00083124737],"domain_scores_gemma":[0.9985925,0.000319292,0.00005886574,0.00052249385,0.00017888276,0.00032794167],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007149974,0.0001637471,0.00017418765,0.00017468243,0.0003690868,0.00008446935,0.00064681715,0.0001049215,0.0045493753],"category_scores_gemma":[0.00024052424,0.00011564353,0.00006599844,0.00061910815,0.00031777992,0.00040321035,0.00014776523,0.0003281222,0.0010223488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014036009,0.00004537673,0.00042165536,0.000011745209,0.000004678126,0.000037980368,0.00014840138,0.0000046354844,0.971994,0.00013128055,0.0067119393,0.020347953],"study_design_scores_gemma":[0.00040625437,0.00011847532,0.0009759954,0.00007499497,0.0000018017024,0.0000065600657,0.000017684897,0.0000124061135,0.94878155,0.00045439656,0.048980974,0.0001688871],"about_ca_topic_score_codex":0.00018099294,"about_ca_topic_score_gemma":0.000021706852,"teacher_disagreement_score":0.042269036,"about_ca_system_score_codex":0.00019354663,"about_ca_system_score_gemma":0.00025486283,"threshold_uncertainty_score":0.99975544},"labels":[],"label_agreement":null},{"id":"W2500792444","doi":"10.1158/1538-7445.am2016-521","title":"Abstract 521: c-MYC as a differentiating marker between angiosarcoma and atypical vascular lesion","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Juravinski Cancer Centre; Western University; McMaster University","funders":"","keywords":"Angiosarcoma; Medicine; Malignancy; Pathology; Biopsy; Sarcoma; Hemangiosarcoma; Lesion; Histology; Radiology","score_opus":0.09031220744493977,"score_gpt":0.400911621920326,"score_spread":0.3105994144753862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500792444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199325,0.0032093937,0.00007841093,0.0034828167,0.000046741643,0.0003806087,0.000011887051,0.000045675457,0.0007512403],"genre_scores_gemma":[0.99714965,0.00081749045,0.000103649465,0.000070254464,0.0005771863,0.000057752277,0.000009276182,0.000043401207,0.0011713417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769175,0.00014084183,0.00023391974,0.00046114,0.000841474,0.0006308608],"domain_scores_gemma":[0.9987107,0.00027037621,0.000035699773,0.00041170925,0.00017839085,0.00039311656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086739036,0.00016166616,0.000332372,0.00019457217,0.00021381235,0.00004844998,0.0001451587,0.00012842822,0.0010496576],"category_scores_gemma":[0.00027930082,0.00009944063,0.00019013662,0.00023610018,0.00022177352,0.00009748008,0.00020675005,0.0003814089,0.00014296528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003997306,0.000113323724,0.636558,0.00027069158,0.00027329643,0.00020671626,0.000147556,5.6872437e-8,0.19251058,0.0003817389,0.0025464918,0.16659184],"study_design_scores_gemma":[0.001885097,0.00015942671,0.976994,0.0008515138,0.000051540123,0.00002209963,0.00005883123,0.0000057041602,0.009422279,0.0005841806,0.009814596,0.0001507272],"about_ca_topic_score_codex":0.00018086143,"about_ca_topic_score_gemma":0.000014136411,"teacher_disagreement_score":0.340436,"about_ca_system_score_codex":0.0001359489,"about_ca_system_score_gemma":0.00016059332,"threshold_uncertainty_score":0.9998635},"labels":[],"label_agreement":null},{"id":"W2501176776","doi":"10.1158/0008-5472.can-16-0446","title":"Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust; National Human Genome Research Institute; World Health Organization","keywords":"CYP2A6; Lung cancer; Cotinine; Nicotine; Medicine; Genome-wide association study; Oncology; Cancer; Internal medicine; Single-nucleotide polymorphism; Physiology; Genotype; Biology; Genetics; Cytochrome P450; Gene","score_opus":0.028709507524409223,"score_gpt":0.38072217599041364,"score_spread":0.35201266846600443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501176776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442834,0.0017556077,0.0022798323,0.0009218606,0.00011477355,0.0002015627,0.00011086709,0.000004257394,0.00018291322],"genre_scores_gemma":[0.991117,0.006825295,0.00040230143,0.00002161311,0.00021362222,0.00009742961,0.0000023189284,0.000015119388,0.0013052758],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860543,0.00035269753,0.00015450947,0.0003127544,0.0001994551,0.00037514517],"domain_scores_gemma":[0.9989964,0.0002889493,0.00017965802,0.00019029425,0.00027162995,0.000073116535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015094236,0.00008636718,0.00015703832,0.000058342044,0.00013357974,0.000008776223,0.00010994006,0.0001822379,0.000051903076],"category_scores_gemma":[0.0012568464,0.000067022,0.00004789011,0.00012513147,0.00009561638,0.0000036519698,0.00013536033,0.00013407641,0.0000013079429],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003641006,0.000012182688,0.47468692,0.000015214554,0.000068860914,8.273822e-8,0.000019299765,0.00002944344,0.5065799,0.0000021654782,0.0018227033,0.016726859],"study_design_scores_gemma":[0.0006265439,0.00009835925,0.9361914,0.000039245933,0.000026748196,7.233999e-7,0.00003263787,0.00014058813,0.06149359,0.000038842787,0.001209339,0.00010200229],"about_ca_topic_score_codex":0.0020146417,"about_ca_topic_score_gemma":0.0012183315,"teacher_disagreement_score":0.46150446,"about_ca_system_score_codex":0.00020103126,"about_ca_system_score_gemma":0.0001894888,"threshold_uncertainty_score":0.3045549},"labels":[],"label_agreement":null},{"id":"W2501435685","doi":"10.1158/1538-7445.am2016-3141","title":"Abstract 3141: Pro-Seq: A novel method to improve sequencing accuracy for liquid biopsy of ctDNA from healthy individuals and cancer patients","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"DNA sequencing; DNA sequencer; Computational biology; Illumina dye sequencing; Deep sequencing; DNA; Massive parallel sequencing; Polymerase chain reaction; Single cell sequencing; Sequence analysis; Sequencing by hybridization; Sequence (biology); Biology; Computer science; Genetics; Gene; Exome sequencing; Genome; Mutation","score_opus":0.08186324223502522,"score_gpt":0.4323682963341279,"score_spread":0.35050505409910265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501435685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868861,0.0018255463,0.003524972,0.0011885406,0.00020911328,0.0011423787,0.005184994,0.0000049483756,0.000033427405],"genre_scores_gemma":[0.99018466,0.0018149739,0.005811801,0.0003878826,0.0005443492,0.0010467106,0.00006672469,0.00004643446,0.000096466996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982499,0.00004510393,0.00032193292,0.0005945198,0.0002755872,0.00051297224],"domain_scores_gemma":[0.99825644,0.00040964226,0.000136871,0.00034465152,0.00060462806,0.00024776757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067709334,0.00015818825,0.00023507581,0.00010316652,0.00009262268,0.00003368327,0.00027431082,0.00015379017,0.000037559705],"category_scores_gemma":[0.00082579744,0.00012463014,0.000061019527,0.00013516148,0.00010272697,0.000009792299,0.0002960856,0.00011092248,0.000002000897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008185869,0.00005849231,0.002908581,0.00009372625,0.00007170408,2.9513564e-7,0.00018949668,0.000010346971,0.9555371,0.000040053,0.0011804593,0.039091203],"study_design_scores_gemma":[0.0020373338,0.0011568766,0.006961593,0.0001697807,0.000015591306,4.5485314e-7,0.00006584732,0.000006491284,0.95790285,0.00017741388,0.031281095,0.00022467106],"about_ca_topic_score_codex":0.003995756,"about_ca_topic_score_gemma":0.00038798316,"teacher_disagreement_score":0.03886653,"about_ca_system_score_codex":0.00022691714,"about_ca_system_score_gemma":0.0010643081,"threshold_uncertainty_score":0.6040415},"labels":[],"label_agreement":null},{"id":"W2501460328","doi":"10.1158/1538-7445.am2016-2302","title":"Abstract 2302: An ‘off the shelf,’ GMP-grade, IL-2-independent NK cell line expressing the high-affinity Fc-receptor to augment antibody therapeutics","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; CD16; Fc receptor; Molecular biology; Transfection; Antibody; Monoclonal antibody; Biology; Population; Cell culture; Receptor; Natural killer cell; Cancer research; Immunology; Cytotoxicity; Medicine; Antigen; CD3; CD8; Biochemistry","score_opus":0.12909101783637375,"score_gpt":0.44280230516688085,"score_spread":0.3137112873305071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501460328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93419075,0.0030214956,0.000067379704,0.05880139,0.000426794,0.0014356067,0.00033427172,0.000058487094,0.0016638484],"genre_scores_gemma":[0.97588456,0.0062943655,0.00013270935,0.0014666158,0.0020244187,0.00028936897,0.000053709846,0.00007855957,0.0137757035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99399567,0.0005812222,0.00048525402,0.00074317656,0.0027645356,0.0014301501],"domain_scores_gemma":[0.99614805,0.0011371063,0.0000905807,0.0012207908,0.0007373278,0.0006661334],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028096766,0.00035132622,0.0004067241,0.00022772938,0.0010420347,0.00023599098,0.0012248898,0.00018010713,0.0028259538],"category_scores_gemma":[0.0001328238,0.00015165904,0.00018184636,0.0006046393,0.0007087747,0.00018210137,0.0005893403,0.00139595,0.0010287557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016236434,0.0005536357,0.0023646504,0.0001412061,0.00014446463,0.00005510045,0.0010157134,0.000023519498,0.90038854,0.00026437984,0.009177981,0.08424716],"study_design_scores_gemma":[0.0019534416,0.0014620033,0.05059329,0.0005329855,0.000051879368,0.000017774977,0.0009507075,0.00007316571,0.5299542,0.0002958311,0.41371617,0.00039854538],"about_ca_topic_score_codex":0.001979121,"about_ca_topic_score_gemma":0.0003355098,"teacher_disagreement_score":0.40453818,"about_ca_system_score_codex":0.0004387484,"about_ca_system_score_gemma":0.0008033573,"threshold_uncertainty_score":0.99974906},"labels":[],"label_agreement":null},{"id":"W2501487382","doi":"10.1158/1538-7445.am2016-136","title":"Abstract 136: Refining the molecular profile of colorectal tumors to expand prevention and treatment opportunities","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Colorectal cancer; KRAS; Exome sequencing; Biology; Exome; Computational biology; DNA methylation; Precision medicine; Gene; Microsatellite instability; Genetics; Cancer; Bioinformatics; Mutation; Gene expression","score_opus":0.08688801255147545,"score_gpt":0.3778119616695866,"score_spread":0.29092394911811115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501487382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608666,0.001534709,0.00005374292,0.00085281034,0.000039247465,0.00023729091,0.00009071834,0.0000024017172,0.0011023998],"genre_scores_gemma":[0.9963626,0.0017940224,0.00006976135,0.00003448742,0.000080324266,0.0002787162,0.0000113930555,0.0000133958065,0.001355261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929804,0.000043127435,0.00011984817,0.00019809032,0.00013950294,0.00020137338],"domain_scores_gemma":[0.99950886,0.00005711128,0.00003587208,0.00018900922,0.0001281612,0.000080983154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026633494,0.000073615745,0.00008769381,0.000042599397,0.00007323533,0.000018818044,0.000104248975,0.000042233863,0.00004892919],"category_scores_gemma":[0.00009389467,0.000044366072,0.000033457058,0.000053618107,0.00014524568,0.0000025463198,0.000106614425,0.00003645547,0.000002439332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017424095,0.000025594178,0.00080347614,0.000011607017,0.00003155196,0.0000043013833,0.00009734476,0.000010020813,0.93421775,0.00026997144,0.0008782201,0.063475914],"study_design_scores_gemma":[0.00045834342,0.0009102703,0.0060178298,0.000081564525,0.0000070547717,0.0000026716366,0.0002809725,0.0000014802291,0.96561277,0.00010055326,0.026443077,0.00008344117],"about_ca_topic_score_codex":0.00024123726,"about_ca_topic_score_gemma":0.00020276742,"teacher_disagreement_score":0.063392475,"about_ca_system_score_codex":0.000058100242,"about_ca_system_score_gemma":0.00031414896,"threshold_uncertainty_score":0.18091959},"labels":[],"label_agreement":null},{"id":"W2501542080","doi":"10.1158/1538-7445.am2016-1923","title":"Abstract 1923: Claudin 1 expression levels affect miRNA dynamics in human basal-like breast cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Science Centre for Human and Animal Health; University of Manitoba","funders":"","keywords":"Claudin; microRNA; PDGFRB; CDH1; Biology; Breast cancer; Cancer research; Metastasis; Cancer; Gene expression profiling; Gene silencing; Gene expression; Gene; Tight junction; Cell; Cell biology; Cadherin; Genetics","score_opus":0.03968173553018689,"score_gpt":0.383346057800897,"score_spread":0.3436643222707101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501542080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912769,0.0019210862,0.0013370344,0.0015245328,0.00048573848,0.0010867013,0.0008856937,0.00003344761,0.0014488611],"genre_scores_gemma":[0.99243444,0.0019992148,0.000054161574,0.00011747096,0.0004948535,0.0006855488,0.00004948937,0.00012342844,0.004041371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957547,0.00039145365,0.00038449402,0.0010887573,0.0010329089,0.0013476862],"domain_scores_gemma":[0.998097,0.000078732424,0.000095729185,0.00092892564,0.00044007896,0.000359531],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012842832,0.00033036724,0.0003090081,0.00040567538,0.00025172363,0.00008175089,0.0008351028,0.0005007729,0.0016274961],"category_scores_gemma":[0.0000740254,0.00026531276,0.0001559994,0.0005480781,0.00033421567,0.000021924592,0.0006050829,0.00076386484,0.000069817725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034650494,0.00010043444,0.00038710545,0.00008778182,0.000047786678,0.000045322475,0.000029356337,0.00010214479,0.97986597,0.00006780394,0.010392913,0.00852688],"study_design_scores_gemma":[0.0016707862,0.00016036976,0.0046322383,0.0005700594,0.0000058103515,0.000006631133,0.000066813314,0.00005134719,0.9869827,0.00016542859,0.005302533,0.000385265],"about_ca_topic_score_codex":0.0023919733,"about_ca_topic_score_gemma":0.0075668953,"teacher_disagreement_score":0.0081416145,"about_ca_system_score_codex":0.0014349398,"about_ca_system_score_gemma":0.0008377142,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W2501803165","doi":"10.1158/1538-7445.am2016-2736","title":"Abstract 2736: Regulation of cytokinesis by polo-like kinase 4","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytokinesis; Cell biology; Polo-like kinase; Mitosis; Biology; Telophase; Cell division; Cell cycle; Anaphase; Cell; Biochemistry","score_opus":0.026394950385060827,"score_gpt":0.3436025478318718,"score_spread":0.31720759744681093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501803165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965473,0.0013390973,0.00028735714,0.000672088,0.0000708998,0.00014192791,0.0001665727,0.000005098222,0.0007696692],"genre_scores_gemma":[0.9942438,0.0017982721,0.00004267169,0.00005368742,0.00016599435,0.000041550928,0.000051965148,0.000018414054,0.0035836396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906516,0.000050881587,0.00014793585,0.00025523474,0.00021473294,0.00026607193],"domain_scores_gemma":[0.9992709,0.000025400328,0.000046626836,0.00033493584,0.00025155317,0.00007055447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031759296,0.00007707685,0.00008983553,0.000058670037,0.000052037576,0.000012928748,0.00020456778,0.0001384046,0.00020764845],"category_scores_gemma":[0.00008014206,0.000056854213,0.00004986511,0.0001103268,0.00015784157,0.0000060369753,0.00009422609,0.00007271718,0.000015181407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011136122,0.000031636748,0.0012231971,0.000025020412,0.000020004261,5.3136057e-7,0.000009162588,0.0000018213934,0.93571067,0.000050280676,0.04890381,0.013912512],"study_design_scores_gemma":[0.00037334388,0.00007845646,0.0067493008,0.00003917514,0.0000031240722,8.0719025e-7,0.000012741302,0.0000017066601,0.90399104,0.000067422596,0.0886062,0.00007665751],"about_ca_topic_score_codex":0.0002742083,"about_ca_topic_score_gemma":0.000101298414,"teacher_disagreement_score":0.039702393,"about_ca_system_score_codex":0.00004408526,"about_ca_system_score_gemma":0.000131955,"threshold_uncertainty_score":0.23184475},"labels":[],"label_agreement":null},{"id":"W2502050063","doi":"10.1158/1538-7445.am2016-5226","title":"Abstract 5226: Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Pancreas Centre (Canada); University of British Columbia; BC Cancer Agency","funders":"","keywords":"MUTYH; Sanger sequencing; Germline; KRAS; Cancer; Biology; Base excision repair; Colorectal cancer; Cancer research; Germline mutation; Medicine; Genetics; DNA repair; Gene; Mutation","score_opus":0.05096969974194279,"score_gpt":0.35407927720252447,"score_spread":0.30310957746058165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502050063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960868,0.0018383084,0.0000033841784,0.00055436953,0.00005234862,0.0006112221,0.00009345885,0.000017050032,0.0007430913],"genre_scores_gemma":[0.9989886,0.0003469254,0.000059278147,0.000036333087,0.00003814783,0.00023878107,0.000010108419,0.00003612711,0.00024566337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974337,0.00013393175,0.0004007569,0.00045792965,0.000958263,0.00061537384],"domain_scores_gemma":[0.9984271,0.00035219043,0.000120289034,0.00047144727,0.00043110637,0.0001978685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048165463,0.00016690226,0.00058515073,0.0010093291,0.000046827252,0.000011623805,0.00018875675,0.00011847073,0.0015433466],"category_scores_gemma":[0.00026472475,0.00010636036,0.00012743112,0.0022084955,0.00031198442,0.00004622685,0.000089239904,0.00029925283,0.000016640915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995467,0.00015257754,0.71199167,0.000054115742,0.0010694204,0.00012026718,0.00063542917,0.000039709063,0.28229126,0.0000046377913,0.00014007259,0.0025053879],"study_design_scores_gemma":[0.0014548189,0.0008648964,0.94729704,0.00036388502,0.00040978895,0.0000070040264,0.00022599085,0.00003284129,0.04916276,0.00001681233,0.00003492175,0.00012924556],"about_ca_topic_score_codex":0.0042667026,"about_ca_topic_score_gemma":0.0036248234,"teacher_disagreement_score":0.23530538,"about_ca_system_score_codex":0.0016062474,"about_ca_system_score_gemma":0.0007678752,"threshold_uncertainty_score":0.9993694},"labels":[],"label_agreement":null},{"id":"W2502092973","doi":"10.1158/1538-7445.am2016-lb-176","title":"Abstract LB-176: The human androgen receptor regulates DNA damage response (DDR) in prostate cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen receptor; Androgen; Cancer; Androgen deprivation therapy; Cancer research; Medicine; DNA damage; Radiation therapy; Internal medicine; Oncology; Gerontology; Biology; DNA; Hormone; Genetics","score_opus":0.08555712398716706,"score_gpt":0.4340862496885026,"score_spread":0.34852912570133554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502092973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551336,0.005983253,1.883677e-7,0.035629682,0.00013910733,0.0018821193,0.00018457705,0.0000594898,0.000987979],"genre_scores_gemma":[0.95273376,0.0057300893,0.000009592004,0.0001258538,0.0003711098,0.0017143936,0.000019071758,0.00007726162,0.039218865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957394,0.00056099,0.00041557537,0.0007033466,0.0012520421,0.0013286438],"domain_scores_gemma":[0.99747217,0.0006780581,0.0000765329,0.0008643364,0.0005396875,0.00036923372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034322022,0.00026702782,0.00038585695,0.00048932416,0.00046153317,0.000096314325,0.00048034493,0.00014226767,0.0042164265],"category_scores_gemma":[0.00033633978,0.00013488521,0.000112878086,0.001048531,0.0010003382,0.00022932151,0.0002394034,0.00079035084,0.00022916243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069621704,0.00019994342,0.06923786,0.00016406436,0.0001393227,0.0002753573,0.0012942011,0.000002443666,0.87267697,0.00006807647,0.02940463,0.019574955],"study_design_scores_gemma":[0.0075166877,0.0006008165,0.36980402,0.001817275,0.00002631444,0.000009934564,0.0008222538,0.000004547978,0.5134154,0.00048362536,0.1051743,0.00032482875],"about_ca_topic_score_codex":0.0024595764,"about_ca_topic_score_gemma":0.0012696565,"teacher_disagreement_score":0.35926157,"about_ca_system_score_codex":0.0016466412,"about_ca_system_score_gemma":0.0015829486,"threshold_uncertainty_score":0.99669385},"labels":[],"label_agreement":null},{"id":"W2502154102","doi":"10.1158/1538-7445.am2016-3767","title":"Abstract 3767: Highly effective inhibitory agent identified by high-throughput screening of genetically characterized anaplastic thyroid cancer cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; London Health Sciences Centre; Western University","funders":"","keywords":"Anaplastic thyroid cancer; Cancer; Cancer research; Cell culture; Cell growth; Apoptosis; Pharmacology; Kinase; Medicine; Thyroid cancer; Internal medicine; Biology; Biochemistry","score_opus":0.034716921253496756,"score_gpt":0.3448954273862801,"score_spread":0.31017850613278336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502154102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280907,0.011302216,0.0011700252,0.0012249439,0.000837958,0.0016607126,0.00045128065,0.00008296764,0.00046083998],"genre_scores_gemma":[0.989946,0.00623058,0.00019399998,0.00011985255,0.0008226437,0.00084836426,0.000049093127,0.00012420745,0.0016652719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957586,0.00025995955,0.0006673367,0.0008873569,0.0014620764,0.0009646829],"domain_scores_gemma":[0.9970555,0.00054692273,0.00023835401,0.0007118104,0.0009871882,0.00046023782],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082230463,0.0003502819,0.0006830305,0.0002741048,0.00015840452,0.000042917116,0.00033466384,0.00030439606,0.0013665302],"category_scores_gemma":[0.0003238514,0.00026515764,0.00020509219,0.000532908,0.00055717846,0.0001778102,0.00023701717,0.0006782697,0.00009817344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022140876,0.00019772242,0.0003453247,0.00043265606,0.00024314148,0.000084339634,0.0001656796,0.000021030506,0.9576234,0.000015462012,0.010783443,0.027873687],"study_design_scores_gemma":[0.0059162527,0.00081457687,0.027836217,0.0017452395,0.00011759466,0.0000054395177,0.000050323273,0.000025682044,0.9578143,0.000025579395,0.005346703,0.00030212628],"about_ca_topic_score_codex":0.0034801934,"about_ca_topic_score_gemma":0.00042709938,"teacher_disagreement_score":0.02757156,"about_ca_system_score_codex":0.001121122,"about_ca_system_score_gemma":0.00086971704,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W2502200958","doi":"10.1158/1538-7445.am2016-4552","title":"Abstract 4552: Profiling signalling protein expression, modifications and interactions with multi-dimensional antibody microarrays","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biotinylation; Protein microarray; Antibody microarray; Protein Array Analysis; Molecular biology; Antibody; Phosphorylation; Biology; Biotin; DNA microarray; Primary and secondary antibodies; Protein phosphorylation; Biochemistry; Cell biology; Protein kinase A; Gene expression; Immunology; Gene","score_opus":0.06266432547828137,"score_gpt":0.41337389950847186,"score_spread":0.3507095740301905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502200958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94759256,0.0002797404,0.05048706,0.00090369757,0.000012299636,0.0005465847,0.00005181972,0.000031164134,0.000095092204],"genre_scores_gemma":[0.9593858,0.00014663208,0.039157853,0.00002394141,0.00009951296,0.00035004702,0.000037134138,0.000022903938,0.00077617494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905235,0.00003403085,0.00012988232,0.00039342843,0.00014568145,0.00024460466],"domain_scores_gemma":[0.9992277,0.000030004538,0.00004962667,0.0002725866,0.00033016154,0.000089913374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017973411,0.00009902795,0.000073083334,0.00006183691,0.00030653286,0.000026698955,0.00011799295,0.00006432301,0.000017301587],"category_scores_gemma":[0.000044183453,0.00006449342,0.000021769407,0.000109887835,0.00023018115,0.000010806555,0.00009356519,0.0001541839,0.00000474183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006751364,0.00005132996,0.00013543943,0.00001164905,0.000010206036,9.654033e-7,0.000009794789,0.000027402757,0.9977299,0.00012955196,0.00020625438,0.0016199726],"study_design_scores_gemma":[0.00025100584,0.000056286746,0.00033997718,0.00020667499,0.00000240802,0.0000060470807,0.000033535598,0.000032189262,0.9939501,0.00017410945,0.0048339237,0.00011372862],"about_ca_topic_score_codex":0.000022490101,"about_ca_topic_score_gemma":0.000025377205,"teacher_disagreement_score":0.011793261,"about_ca_system_score_codex":0.00003161724,"about_ca_system_score_gemma":0.000120029275,"threshold_uncertainty_score":0.26299652},"labels":[],"label_agreement":null},{"id":"W2502314982","doi":"10.1158/1538-7445.am2016-5055","title":"Abstract 5055: SPEN stimulates primary cilia formation, cell migration and is associated with metastasis in breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Gene silencing; Biology; Transcription factor; Cell biology; Wnt signaling pathway; Cilium; Hedgehog signaling pathway; Hedgehog; PI3K/AKT/mTOR pathway; Signal transduction; Gene; Genetics","score_opus":0.04571622383067529,"score_gpt":0.34072302587066394,"score_spread":0.29500680203998864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502314982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523467,0.0023064562,0.0000268915,0.0016551923,0.000020756514,0.00023700707,0.00031215147,0.000006973075,0.00019989055],"genre_scores_gemma":[0.99655795,0.0025287902,0.000022180286,0.000098377735,0.00006594678,0.0001220832,0.00003245813,0.000017700537,0.000554507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887985,0.000071930066,0.00016045956,0.00029218596,0.00027280574,0.000322763],"domain_scores_gemma":[0.99931246,0.00005741318,0.00005386543,0.00015930562,0.00035031443,0.00006666405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005106585,0.00011424648,0.0001426492,0.000088673914,0.000097803844,0.000030630516,0.00011137746,0.000084421146,0.000102888385],"category_scores_gemma":[0.000052672443,0.00007643977,0.000022221973,0.00018556342,0.0001382647,0.000018370709,0.00008422222,0.00010592876,0.0000060791904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017439132,0.00004075377,0.053674005,0.000060605238,0.000068423215,0.000004493755,0.0003040527,0.000030673662,0.9349026,9.303419e-7,0.004809358,0.005929732],"study_design_scores_gemma":[0.0013567661,0.00011397156,0.26310456,0.00025971147,0.000015377489,0.000002355241,0.00016075377,0.000015870128,0.7316969,0.000032407406,0.0030360078,0.00020531974],"about_ca_topic_score_codex":0.00078232924,"about_ca_topic_score_gemma":0.0035264844,"teacher_disagreement_score":0.20943056,"about_ca_system_score_codex":0.00016134963,"about_ca_system_score_gemma":0.00022072799,"threshold_uncertainty_score":0.31171232},"labels":[],"label_agreement":null},{"id":"W2502600075","doi":"10.1158/1538-7445.am2016-896","title":"Abstract 896: The airway field of injury reflects gene expression changes associated with the presence of lung squamous premalignant lesions","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lung cancer; Carcinogenesis; Lung; Biology; Cancer research; Pathology; Cancer; Carcinoma; Internal medicine; Medicine","score_opus":0.047214354108046426,"score_gpt":0.3817521043405528,"score_spread":0.33453775023250637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502600075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928949,0.0025307606,0.00016951273,0.0035827456,0.000035966925,0.0003415482,0.000067396,0.000003565792,0.0003736016],"genre_scores_gemma":[0.99619836,0.0017801091,0.000010550079,0.000043846772,0.00008988139,0.0002489962,0.000004112155,0.000012547326,0.0016115719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892485,0.00015671387,0.00012342879,0.00021598916,0.00034262278,0.00023641018],"domain_scores_gemma":[0.9986862,0.00022917293,0.000110798166,0.0005561018,0.00037862427,0.000039137667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058982626,0.00007668466,0.00009380178,0.000033634544,0.00016247356,0.000009695864,0.00041926967,0.0000883534,0.00007179235],"category_scores_gemma":[0.00029215505,0.000031895866,0.000035369056,0.00017866389,0.0002706256,0.0000046677415,0.00013010563,0.00011937486,7.386914e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001758313,0.000035971796,0.0005279759,0.00001896195,0.000025732055,3.9824747e-7,0.00012098759,0.00001331669,0.9823868,0.000028258835,0.011908491,0.0047572553],"study_design_scores_gemma":[0.00018178085,0.00026650532,0.0039369552,0.00017401806,0.0000071132854,3.8010583e-7,0.000087996814,0.000003356156,0.99219775,0.000016897242,0.0030727282,0.000054533095],"about_ca_topic_score_codex":0.00016247376,"about_ca_topic_score_gemma":0.0003562724,"teacher_disagreement_score":0.009810917,"about_ca_system_score_codex":0.000029423423,"about_ca_system_score_gemma":0.00023782653,"threshold_uncertainty_score":0.13006756},"labels":[],"label_agreement":null},{"id":"W2502974874","doi":"10.1158/1538-7445.am2016-lb-128","title":"Abstract LB-128: High prevalence of elevated TRPV6 mRNA in pancreatic ductal adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Industries (Canada)","funders":"","keywords":"TRPV6; Neuroendocrine tumors; Medicine; Internal medicine; Adenocarcinoma; Prostate; Cancer research; Pathology; Cancer; Calcium; Calcium metabolism","score_opus":0.04564889769107428,"score_gpt":0.34107560865682146,"score_spread":0.2954267109657472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502974874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847419,0.013220832,0.000004613547,0.00062051544,0.00034765707,0.00031625875,0.000100999314,0.000021678907,0.0006255181],"genre_scores_gemma":[0.9918808,0.0032200364,0.0000069027583,0.000021005306,0.000065304725,0.00013212902,0.000008426521,0.000018069373,0.004647369],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980152,0.0003502523,0.0003600078,0.00045020107,0.000096820506,0.00072748197],"domain_scores_gemma":[0.998891,0.00035833212,0.00009297581,0.0003937146,0.00022646153,0.00003751557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007269879,0.00014725166,0.00032232783,0.00026274304,0.000077678975,0.000005760459,0.00044223928,0.0002629446,0.006655742],"category_scores_gemma":[0.00015001626,0.00010027472,0.000058384023,0.00038619275,0.0006845928,0.000079457684,0.00012074125,0.0004622694,0.00035101347],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043139426,0.00006911951,0.20773233,0.00012222369,0.000059512295,0.000013352176,0.00012571215,5.16389e-7,0.7863825,0.00039173284,0.001064867,0.003606733],"study_design_scores_gemma":[0.0013669311,0.00026804255,0.668519,0.00022241307,0.000009623778,0.00001510833,0.000060878177,7.813018e-8,0.3277684,0.00034955505,0.0013108074,0.00010916473],"about_ca_topic_score_codex":0.002828447,"about_ca_topic_score_gemma":0.00030291206,"teacher_disagreement_score":0.46078667,"about_ca_system_score_codex":0.00022162942,"about_ca_system_score_gemma":0.00036610995,"threshold_uncertainty_score":0.9942523},"labels":[],"label_agreement":null},{"id":"W2503256730","doi":"10.1158/1538-7445.am2016-2972","title":"Abstract 2972: Development and characterization of synthetic antibodies with a human framework that directly link metabolism to immune system in cancer cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Toronto","funders":"","keywords":"Cancer cell; Biology; Immune system; Reprogramming; Cell biology; Flux (metallurgy); Cancer; Nutrient sensing; Carcinogenesis; Glycosylation; Cell; Biochemistry; Signal transduction; Chemistry; Immunology; Genetics","score_opus":0.036714909779757963,"score_gpt":0.35454690391113136,"score_spread":0.3178319941313734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503256730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608994,0.0028091576,0.00007130869,0.0002880122,0.000047447433,0.00050252845,0.00008670411,0.0000068073086,0.0000981016],"genre_scores_gemma":[0.996744,0.0021769847,0.00010772511,0.000008770508,0.00009173588,0.0005259895,0.000015605356,0.000026939024,0.00030227265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854726,0.00007571186,0.0001917506,0.00039061488,0.00037023777,0.0004244497],"domain_scores_gemma":[0.9993184,0.00003033366,0.000059285307,0.00027644043,0.00018237978,0.00013313736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034212144,0.00013914422,0.00022618091,0.00017576243,0.00010426009,0.00003169878,0.00017162875,0.00009274436,0.000037128375],"category_scores_gemma":[0.000020250924,0.000091683454,0.00002492063,0.00019868111,0.00014172505,0.00001011687,0.00014239275,0.00011844698,0.000005034938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032865055,0.000042066702,0.008688816,0.00017619441,0.00009415154,0.000009334419,0.0002434393,0.0000016380454,0.9659725,0.000042388132,0.000008447019,0.02439237],"study_design_scores_gemma":[0.0004924001,0.00009448788,0.12908193,0.0009719228,0.000005376624,0.0000010236719,0.000054135686,2.8743162e-7,0.8663837,0.000006875084,0.0027991517,0.00010872594],"about_ca_topic_score_codex":0.0014558883,"about_ca_topic_score_gemma":0.0012062575,"teacher_disagreement_score":0.12039312,"about_ca_system_score_codex":0.00015827281,"about_ca_system_score_gemma":0.00030338852,"threshold_uncertainty_score":0.37387428},"labels":[],"label_agreement":null},{"id":"W2503509770","doi":"10.1158/1538-7445.sabcs16-p2-03-01","title":"Abstract P2-03-01: Mutational landscape of breast cancers from PALB2 germline mutation carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PALB2; Germline mutation; Breast cancer; Loss of heterozygosity; Genetics; Germline; Biology; Cancer research; Exome; Mutation; Missense mutation; Allele; Exome sequencing; Cancer; Gene","score_opus":0.04360570586021412,"score_gpt":0.39265521629479005,"score_spread":0.34904951043457594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503509770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992494,0.00208579,0.000087288194,0.00088450836,0.00038995585,0.00023985669,0.0012548593,0.000007872405,0.0025558975],"genre_scores_gemma":[0.9972561,0.00045145446,0.00027942364,0.00005013291,0.00084179064,0.00017593901,0.0004938235,0.000034050972,0.00041726374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983417,0.00006508876,0.0002558329,0.0004577286,0.00053264265,0.00034704412],"domain_scores_gemma":[0.9983208,0.000050311744,0.0001922828,0.00071303116,0.0005953821,0.00012814536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004259018,0.00013791365,0.00016491463,0.000099280325,0.00038418258,0.00008379845,0.00054244976,0.00016199124,0.00080207456],"category_scores_gemma":[0.00020132534,0.00014099215,0.000081440936,0.00010635934,0.00046802696,0.000017989425,0.00014607715,0.00023062743,0.000021309683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007121473,0.00006072938,0.023426706,0.000096246855,0.00042320957,0.00002951959,0.00071300037,0.005394105,0.91402704,0.00009486073,0.023377292,0.031645164],"study_design_scores_gemma":[0.0024466522,0.00015890831,0.48425183,0.00013693477,0.000042591924,0.00001854866,0.0010530906,0.0003988341,0.4943815,0.0008503313,0.015819836,0.00044097228],"about_ca_topic_score_codex":0.005241131,"about_ca_topic_score_gemma":0.0028554506,"teacher_disagreement_score":0.46082512,"about_ca_system_score_codex":0.0002843044,"about_ca_system_score_gemma":0.0017848648,"threshold_uncertainty_score":0.87821543},"labels":[],"label_agreement":null},{"id":"W2503576709","doi":"10.1158/1538-7445.am2016-1045","title":"Abstract 1045: Targeting NAMPT in Ewing's sarcoma cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"NAD+ kinase; Nicotinamide phosphoribosyltransferase; Cancer research; Gene knockdown; Apoptosis; Nicotinamide adenine dinucleotide; Cancer cell; DNA damage; Programmed cell death; Biology; Chemistry; Cell biology; Cancer; Biochemistry; Enzyme; DNA; Genetics","score_opus":0.12170945191887249,"score_gpt":0.45279326624017674,"score_spread":0.33108381432130424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503576709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793436,0.0021034286,0.000042497468,0.008205429,0.00030685714,0.0004945878,0.000029255161,0.00006133791,0.009413005],"genre_scores_gemma":[0.99368274,0.0014762027,0.00016710824,0.0003388344,0.0007043635,0.00025424297,0.0000035067417,0.00004555817,0.0033274516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975757,0.000119418255,0.0003203431,0.00041758857,0.00080638233,0.0007605662],"domain_scores_gemma":[0.9986939,0.00038341372,0.00004830764,0.00037237312,0.00027798204,0.00022405671],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014801538,0.00013137641,0.00024468935,0.00035388517,0.00009861155,0.000025528669,0.00019771003,0.000114137794,0.0051883506],"category_scores_gemma":[0.00017248077,0.000093686074,0.00006788857,0.0005283132,0.00024382831,0.00013939678,0.00006637045,0.0005343027,0.00052528223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036824305,0.00007793517,0.008456482,0.00008845678,0.00001880982,0.00010421806,0.0002656557,0.0000033653303,0.9324916,0.00008708673,0.030588165,0.027449982],"study_design_scores_gemma":[0.0037478798,0.00013381304,0.0206038,0.0012383531,0.0000033786466,0.0000068541003,0.00015997852,0.0000067405504,0.83556736,0.0006944259,0.13765733,0.00018008801],"about_ca_topic_score_codex":0.00046907982,"about_ca_topic_score_gemma":0.000065462285,"teacher_disagreement_score":0.107069165,"about_ca_system_score_codex":0.0010595203,"about_ca_system_score_gemma":0.00053247635,"threshold_uncertainty_score":0.99572104},"labels":[],"label_agreement":null},{"id":"W2503626267","doi":"10.1158/1538-7445.am2016-268","title":"Abstract 268: PARP3 inhibitors in cancer therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA damage; Poly ADP ribose polymerase; PARP1; DNA repair; Ku80; Molecular biology; Ku70; Cytotoxicity; DNA; Chemistry; Biology; Cancer research; Biochemistry; Polymerase; In vitro; DNA-binding protein; Transcription factor","score_opus":0.20895128257934573,"score_gpt":0.49957985701153984,"score_spread":0.29062857443219414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503626267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586495,0.010426724,0.000008382176,0.022565188,0.0004981011,0.0008490339,0.000054475964,0.000076321194,0.0068722474],"genre_scores_gemma":[0.9638545,0.028512288,0.000023159893,0.000764502,0.001248541,0.0015196855,0.00000318893,0.000064039494,0.0040101307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970398,0.00013477245,0.000385892,0.00055098394,0.0010290807,0.0008595055],"domain_scores_gemma":[0.99845135,0.0002881676,0.000065013875,0.00051884714,0.0003900094,0.00028661854],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010922893,0.00019513203,0.00033164528,0.00047919728,0.000105486695,0.000029911207,0.00023002745,0.00017034884,0.008199168],"category_scores_gemma":[0.00009084288,0.0001281527,0.00009853553,0.0008445081,0.0004024743,0.00018831978,0.00004993509,0.0005994511,0.00027114412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001345213,0.00021099143,0.091880985,0.000068629306,0.00006187452,0.00008360702,0.0004123266,0.0000055375112,0.6031771,0.00016802749,0.049358618,0.25322714],"study_design_scores_gemma":[0.008314261,0.00028211632,0.12408304,0.0019349253,0.000004327389,0.0000081772305,0.0001245256,0.0000023110522,0.53055817,0.0010118255,0.33338407,0.00029225386],"about_ca_topic_score_codex":0.0024941498,"about_ca_topic_score_gemma":0.0006265749,"teacher_disagreement_score":0.28402543,"about_ca_system_score_codex":0.001572124,"about_ca_system_score_gemma":0.0011407417,"threshold_uncertainty_score":0.9927075},"labels":[],"label_agreement":null},{"id":"W2503684199","doi":"10.1158/1538-7445.am2016-lb-019","title":"Abstract LB-019: FGFR1 abnormalities in seizure-associated familial and sporadic dysembryoplastic neuroepithelial tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sanger sequencing; Germline mutation; Germline; Exome sequencing; Biology; Monosomy; Genetics; Cancer research; Mutation; Karyotype; Gene; Chromosome","score_opus":0.03744067714107525,"score_gpt":0.33839220241965545,"score_spread":0.3009515252785802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503684199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971575,0.0011748449,0.000026788823,0.00057152857,0.00015309083,0.00019639566,0.0001282538,0.000010268998,0.0005813274],"genre_scores_gemma":[0.99441034,0.0022635763,0.0000068902373,0.00006706718,0.00027853926,0.00013834123,0.00001880193,0.000025467649,0.0027909514],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851835,0.00011734193,0.00021082044,0.0003988089,0.00027964922,0.00047502204],"domain_scores_gemma":[0.99934864,0.000062783714,0.00004809558,0.0002639605,0.00015416965,0.00012234255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050620537,0.00012699886,0.00014119716,0.00010011214,0.00011955513,0.000038568098,0.00020684327,0.000117723146,0.00010923496],"category_scores_gemma":[0.00021880909,0.00009736497,0.000037371014,0.00018664541,0.0002930767,0.000011373105,0.00009477544,0.00019256912,0.000017427274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028597823,0.00007043768,0.029286206,0.0000387363,0.000029382112,0.000027419583,0.000110840876,0.000028607483,0.9558731,0.00017991454,0.003713728,0.010355698],"study_design_scores_gemma":[0.002801692,0.00039245107,0.8210098,0.0002715241,0.000010377943,0.000014794291,0.00035978016,0.000034274573,0.14928685,0.00041316307,0.024936946,0.0004683158],"about_ca_topic_score_codex":0.0008824545,"about_ca_topic_score_gemma":0.0008589741,"teacher_disagreement_score":0.8065862,"about_ca_system_score_codex":0.00008408074,"about_ca_system_score_gemma":0.0003674084,"threshold_uncertainty_score":0.3970428},"labels":[],"label_agreement":null},{"id":"W2503724939","doi":"10.1158/1538-7445.am2016-2300","title":"Abstract 2300: Human CD133-specific chimeric antigen receptor (CAR) modified T cells target patient-derived glioblastoma brain tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Chimeric antigen receptor; Cancer research; Antigen; Immunoglobulin light chain; Flow cytometry; CD28; Single-chain variable fragment; Biology; CD8; Monoclonal antibody; Antibody; T cell; Immunology; Immune system","score_opus":0.06752122905625818,"score_gpt":0.3716309087200256,"score_spread":0.3041096796637674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503724939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987341,0.0010561829,0.000031211734,0.004352222,0.0003583645,0.0019311121,0.00015955635,0.00017101156,0.0045993514],"genre_scores_gemma":[0.9828219,0.0013701265,0.00012862358,0.0001833437,0.0010306237,0.0004654693,0.000038805214,0.0002053765,0.01375576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99324435,0.00048134162,0.00067884667,0.0011667449,0.002475381,0.001953312],"domain_scores_gemma":[0.9961975,0.00055455544,0.00014552279,0.0013377841,0.00084979675,0.0009147977],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014872977,0.0004303375,0.00069954916,0.00087717717,0.0005043219,0.0001277633,0.0007180665,0.00025928603,0.047370005],"category_scores_gemma":[0.00019388147,0.00031935427,0.00028219752,0.0012886728,0.0009474653,0.00023325175,0.00032979366,0.0011847871,0.0015885994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019205378,0.00025966333,0.00072563294,0.00010354175,0.00012848196,0.00015425887,0.00066498684,0.0000063002685,0.893455,0.000051405335,0.06663667,0.035893477],"study_design_scores_gemma":[0.0027929791,0.0012838272,0.0065249624,0.00040799164,0.0000048932375,0.00001171551,0.00035000604,0.000007815833,0.86872256,0.0001555473,0.119373925,0.00036377716],"about_ca_topic_score_codex":0.00081438135,"about_ca_topic_score_gemma":0.00007695466,"teacher_disagreement_score":0.05273726,"about_ca_system_score_codex":0.0012122021,"about_ca_system_score_gemma":0.0007657516,"threshold_uncertainty_score":0.99992585},"labels":[],"label_agreement":null},{"id":"W2503738091","doi":"10.1158/1538-7445.am2015-5099","title":"Abstract 5099: Abrogation of cancer cell extravasation in renal cell carcinoma PDX lines via invadopodia dysregulation mediated by PAK1 inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Invadopodia; Extravasation; Extracellular matrix; Cancer cell; Cancer research; Cancer; Cell biology; Cell; Medicine; Pathology; Chemistry; Biology; Internal medicine; Biochemistry","score_opus":0.08624873815171728,"score_gpt":0.3955185558654932,"score_spread":0.30926981771377593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503738091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906195,0.0054348656,0.000072734256,0.0036013797,0.000268541,0.0006543239,0.0000427868,0.000021567632,0.0008418577],"genre_scores_gemma":[0.99762017,0.0007219572,0.00007849986,0.00005923114,0.00044716906,0.00010720553,0.0004300065,0.000030749143,0.00050499325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705,0.00016709023,0.000576684,0.00035942186,0.0014682609,0.0003785634],"domain_scores_gemma":[0.9980585,0.0001605393,0.00019575938,0.00023952358,0.001015314,0.00033036008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001704948,0.00015216984,0.00027458655,0.00032972076,0.00006435107,0.000020588133,0.00011815246,0.00043101443,0.00034219783],"category_scores_gemma":[0.00011769043,0.00013000307,0.000052180378,0.0008378046,0.00048101041,0.00019234298,0.000046973008,0.00061798573,0.000013523862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041257468,0.00027115442,0.0345961,0.0005261382,0.000012920102,0.000007127152,0.0017083349,0.00022699675,0.93731624,0.000025306743,0.0072883717,0.01760873],"study_design_scores_gemma":[0.004534686,0.00038275632,0.32920492,0.00045493347,0.000034520395,0.0000012418544,0.00058334606,0.0058442475,0.6542669,0.00068928325,0.003761361,0.00024179037],"about_ca_topic_score_codex":0.02198152,"about_ca_topic_score_gemma":0.004470372,"teacher_disagreement_score":0.2946088,"about_ca_system_score_codex":0.00078477734,"about_ca_system_score_gemma":0.0011732574,"threshold_uncertainty_score":0.98453116},"labels":[],"label_agreement":null},{"id":"W2503754940","doi":"10.1158/1538-7445.am2016-2860","title":"Abstract 2860: Loss of expression of the metastasis suppressor CREB3L1 is associated with high-grade metastatic breast cancer and poorer prognosis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Metastasis; Cancer research; Cancer; Angiogenesis; Cancer cell; Microarray analysis techniques; Metastatic breast cancer; Medicine; Tissue microarray; Cell; Biology; Internal medicine; Gene expression; Gene; Biochemistry","score_opus":0.03003017455122109,"score_gpt":0.33433521661183985,"score_spread":0.30430504206061876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503754940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473876,0.0014396881,0.0000048138363,0.0014510659,0.0000335169,0.00032536942,0.0019548214,0.000003557627,0.00004838998],"genre_scores_gemma":[0.99828666,0.0011967449,0.000030352017,0.00003724193,0.000036716156,0.00020994242,0.000011089182,0.000024431596,0.00016682046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998426,0.00014782147,0.00021932053,0.00034885106,0.000520028,0.00033797286],"domain_scores_gemma":[0.9988582,0.00008710703,0.00015635176,0.00036433988,0.00040336605,0.00013059619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002659061,0.00014585766,0.00023355016,0.000052423115,0.00008701991,0.000015962483,0.00027083218,0.000072273,0.00029836773],"category_scores_gemma":[0.00011437007,0.00007184255,0.00008151216,0.0001829425,0.0005069497,0.0000106441275,0.00018775152,0.000106160755,5.6472567e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036279982,0.0001641737,0.08208845,0.00014686627,0.00023032859,0.000004033148,0.00005540657,0.000008152046,0.9134329,0.0000210965,0.0018871959,0.0015985876],"study_design_scores_gemma":[0.0010686882,0.000089341695,0.1709486,0.00043655094,0.000066024775,0.0000024439578,0.00005669394,0.0000014769945,0.8270632,0.00004714864,0.00012496427,0.00009488416],"about_ca_topic_score_codex":0.0013332313,"about_ca_topic_score_gemma":0.00015078981,"teacher_disagreement_score":0.08886014,"about_ca_system_score_codex":0.00003219553,"about_ca_system_score_gemma":0.00024766894,"threshold_uncertainty_score":0.32669172},"labels":[],"label_agreement":null},{"id":"W2503929404","doi":"10.1158/1538-7445.am2016-1689","title":"Abstract 1689: Resveratrol inhibits epithelial-to-mesenchymal transition and metastasis in colorectal cancer through regulating Snail/E-cadherin expression by TGFβ1/Smads signaling pathway","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Resveratrol; Epithelial–mesenchymal transition; Metastasis; Cancer research; In vivo; Transplantation; Vimentin; Medicine; Pathology; Cancer; Biology; Immunohistochemistry; Internal medicine; Pharmacology","score_opus":0.03188374163338628,"score_gpt":0.34303144882107534,"score_spread":0.311147707187689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503929404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898961,0.0033485368,0.0032297526,0.0018309122,0.0001223744,0.00096020324,0.0004292145,0.00002239381,0.00016049058],"genre_scores_gemma":[0.9962235,0.0014957133,0.00041829087,0.00012162341,0.00033924312,0.00085012725,0.00004878893,0.00009054318,0.0004121861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960219,0.00047087693,0.00044291763,0.0010801157,0.0009173368,0.0010668042],"domain_scores_gemma":[0.99877393,0.00010632145,0.00008427803,0.00036842364,0.00035823873,0.00030880648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013768949,0.00030875808,0.0003258269,0.0002367291,0.00027254008,0.00009651938,0.00032805637,0.00038256813,0.0003560241],"category_scores_gemma":[0.00024937664,0.00025657192,0.00010131214,0.00057461223,0.0002283686,0.000044132765,0.00029244114,0.0005528114,0.000014394357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010852502,0.000055690514,0.00005014075,0.00007290706,0.000052836163,0.000017590455,0.00045903111,0.0004815977,0.9764824,0.000022612705,0.0015945617,0.019625388],"study_design_scores_gemma":[0.0017677562,0.00039235692,0.00014697449,0.0005633262,0.000007659003,0.0000065737054,0.00020513889,0.000039972663,0.990062,0.00012185064,0.0063466444,0.0003397597],"about_ca_topic_score_codex":0.0013794081,"about_ca_topic_score_gemma":0.00081762194,"teacher_disagreement_score":0.019285629,"about_ca_system_score_codex":0.00036671528,"about_ca_system_score_gemma":0.0005490121,"threshold_uncertainty_score":0.9999887},"labels":[],"label_agreement":null},{"id":"W2503953076","doi":"10.1158/1538-7445.am2016-4369","title":"Abstract 4369: Genome-wide copy number dependency analysis identifies partial copy loss of SF3B1 as a novel cancer vulnerability","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer; Copy-number variation; Genetics; Gene; Spliceosome; Cancer cell; Copy number analysis; Genome instability; Cancer research; Genome; RNA splicing; RNA; DNA; DNA damage","score_opus":0.05675591501122405,"score_gpt":0.41607219557082376,"score_spread":0.3593162805595997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503953076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938208,0.0016673451,0.0016591131,0.00079429697,0.00014429244,0.0002983109,0.00043585172,0.000009810547,0.0011701909],"genre_scores_gemma":[0.990934,0.0038811744,0.000046304678,0.000057136578,0.00031421913,0.00054160977,0.000045588054,0.00002768852,0.004152265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756896,0.00012972059,0.00042277592,0.0007081702,0.0006216114,0.00054877345],"domain_scores_gemma":[0.99779123,0.000092448216,0.00014390773,0.00088996254,0.00089583563,0.00018662245],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009350806,0.00018018344,0.00030002504,0.00012967871,0.00019248879,0.000050553226,0.00052037014,0.00018834411,0.004642403],"category_scores_gemma":[0.00023624579,0.00013733967,0.00022940878,0.00061244506,0.00053382094,0.000018938368,0.00017310187,0.0002014922,0.00007168388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027976386,0.00012777116,0.20664193,0.000050351362,0.0005235189,0.0000024145365,0.0000651993,0.00016402616,0.7887652,0.000094109004,0.0012865927,0.0019991081],"study_design_scores_gemma":[0.0007847783,0.00006759873,0.15844749,0.000040635536,0.00011067396,0.0000015169234,0.00008363773,0.000006674296,0.81883234,0.00027142817,0.021094557,0.00025865194],"about_ca_topic_score_codex":0.004424269,"about_ca_topic_score_gemma":0.0024743068,"teacher_disagreement_score":0.04819445,"about_ca_system_score_codex":0.00019144345,"about_ca_system_score_gemma":0.00079761737,"threshold_uncertainty_score":0.9962675},"labels":[],"label_agreement":null},{"id":"W2504168572","doi":"10.1158/1538-7445.am2016-lb-051","title":"Abstract LB-051: Cancer cell binding, internalization and intracellular localization of a novel therapeutic peptide SOR-C13 targeting the TRPV6 oncochannel","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Industries (Canada)","funders":"","keywords":"Internalization; TRPV6; Peptide; Intracellular; Endocytosis; Cell; Cell-penetrating peptide; Cancer research; Biology; Chemistry; Cell biology; Biochemistry; Internal medicine; Medicine; Calcium; Calcium metabolism","score_opus":0.05064239758158065,"score_gpt":0.32940753940180767,"score_spread":0.27876514182022705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504168572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759959,0.011778394,0.010309909,0.0007231382,0.00033023642,0.00034880612,0.00011336779,0.000018571836,0.00038168236],"genre_scores_gemma":[0.9891163,0.0059649497,0.000013892138,0.00006614024,0.000101092286,0.000038355043,0.000016385346,0.000025888101,0.004656961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988301,0.00013983501,0.0002642888,0.00027470483,0.00009343436,0.00039766403],"domain_scores_gemma":[0.9992184,0.00020810358,0.000158616,0.00016444814,0.00022705639,0.000023366954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063742936,0.00012882939,0.00018976095,0.000079024365,0.00028876096,0.000042420892,0.00023163199,0.00014823051,0.0015238327],"category_scores_gemma":[0.000048466387,0.000080857084,0.00005248787,0.00014850314,0.0006106724,0.00018660049,0.00011774408,0.0002562126,0.000028154574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089957626,0.00006870382,0.001820983,0.000075998716,0.00007622242,6.84646e-7,0.0010260312,0.00008516132,0.985241,0.0001757844,0.0028371685,0.008502279],"study_design_scores_gemma":[0.0010556938,0.00009488421,0.0006123015,0.00047112926,0.000025441306,0.000003833496,0.0015543723,0.0000935541,0.97591454,0.00011749761,0.019891782,0.00016495193],"about_ca_topic_score_codex":0.0068879602,"about_ca_topic_score_gemma":0.001183905,"teacher_disagreement_score":0.017054614,"about_ca_system_score_codex":0.00014430449,"about_ca_system_score_gemma":0.00014239742,"threshold_uncertainty_score":0.9997253},"labels":[],"label_agreement":null},{"id":"W2504241715","doi":"10.1158/1538-7445.am2016-2269","title":"Abstract 2269: Comparative effectiveness of everolimus + endocrine therapy vs endocrine monotherapy among postmenopausal women with HR+/HER2- advanced breast cancer: a multicountry retrospective chart review","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Exemestane; Oncology; Breast cancer; Cancer; Aromatase inhibitor; Hazard ratio; Everolimus; Retrospective cohort study; Metastatic breast cancer; Gynecology; Aromatase; Confidence interval","score_opus":0.03510198508118839,"score_gpt":0.3965643395908768,"score_spread":0.3614623545096884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504241715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95193213,0.039953697,0.000057688747,0.0022844407,0.00015843287,0.0044901716,0.00070425175,0.00013153271,0.00028764052],"genre_scores_gemma":[0.9107776,0.082425065,0.00012364352,0.0003317128,0.0003424899,0.0054524653,0.000015042295,0.0001588532,0.00037308224],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9943631,0.0005384166,0.00067378505,0.0012041389,0.0016384698,0.0015820438],"domain_scores_gemma":[0.9949281,0.00074960367,0.0004122328,0.0010705643,0.0023278142,0.0005116344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010813317,0.000682501,0.0019114844,0.00036109844,0.0002142967,0.000026998618,0.00050179753,0.00010369357,0.0023166644],"category_scores_gemma":[0.00007054434,0.00042893225,0.00013363876,0.0011684258,0.0014035082,0.0005899241,0.00010476735,0.00083930336,0.000027061304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095521785,0.001004226,0.09129258,0.0034115466,0.0019860794,0.00019863728,0.0013018711,0.000052563708,0.68461955,0.00010209731,0.00017018752,0.120338894],"study_design_scores_gemma":[0.019305125,0.0037354298,0.802028,0.01743684,0.000058269678,0.00014484463,0.00029595642,0.000003976282,0.15223147,0.00015902432,0.004027636,0.00057340297],"about_ca_topic_score_codex":0.001616894,"about_ca_topic_score_gemma":0.00019185072,"teacher_disagreement_score":0.71073544,"about_ca_system_score_codex":0.00340216,"about_ca_system_score_gemma":0.0010754485,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W2504632565","doi":"10.1158/1538-7445.am2016-2521","title":"Abstract 2521: STAT3 is a central regulator of proliferation, invasion and metabolism in GBM tumor initiating cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; STAT3; Biology; STAT protein; Glioma; Cell growth; Cell culture; Gene signature; Regulator; Gene expression; Signal transduction; Gene; Cell biology; Genetics","score_opus":0.03791412548071164,"score_gpt":0.33666409317628965,"score_spread":0.298749967695578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504632565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914023,0.007271419,0.000027963837,0.00038083486,0.00026341525,0.00033848928,0.000116671894,0.00000415824,0.00019470074],"genre_scores_gemma":[0.9937041,0.004703719,0.00011105437,0.00012681332,0.00083489274,0.000092871545,0.000008376214,0.000021910053,0.0003962925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851775,0.00010029201,0.00027473646,0.00036934463,0.0002929935,0.00044485228],"domain_scores_gemma":[0.9992384,0.000034629342,0.00007819241,0.00026286964,0.0002497617,0.00013617802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056663924,0.000115207054,0.00019253198,0.000119928336,0.000063905536,0.00002414685,0.00014506702,0.00009131202,0.00011659671],"category_scores_gemma":[0.00014979084,0.000087994726,0.00004266162,0.00016631732,0.00017658326,0.000016159842,0.0001126894,0.00013384491,0.000002835391],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015083431,0.000033303237,0.0022125968,0.00006917628,0.000017484437,0.0000011971052,0.00029104593,0.000003548258,0.98236966,0.00008255517,0.0044844295,0.010284152],"study_design_scores_gemma":[0.0011122915,0.000043584914,0.038589362,0.000097381846,0.000005505887,0.0000020580078,0.0000898573,0.0000040562804,0.91121745,0.00015049388,0.048572134,0.00011580881],"about_ca_topic_score_codex":0.00031827256,"about_ca_topic_score_gemma":0.00033649316,"teacher_disagreement_score":0.07115221,"about_ca_system_score_codex":0.000037766637,"about_ca_system_score_gemma":0.0005015142,"threshold_uncertainty_score":0.35883206},"labels":[],"label_agreement":null},{"id":"W2504726256","doi":"10.1158/1538-7445.am2016-941","title":"Abstract 941: Differential roles for membrane-bound and soluble CD109 in breast cancer progression","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Cancer research; Epithelial–mesenchymal transition; Cancer; Vimentin; Biology; Cancer cell; SMAD; Medicine; Transforming growth factor; Immunology; Internal medicine; Metastasis; Endocrinology; Immunohistochemistry","score_opus":0.038786535409019884,"score_gpt":0.40068504608336203,"score_spread":0.36189851067434214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504726256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458593,0.0038685836,0.000036270274,0.0007869483,0.00011659632,0.00038939295,0.0001613904,0.000009728492,0.00004514962],"genre_scores_gemma":[0.9971587,0.0009656979,0.000025552818,0.000022692697,0.00048121202,0.00068890466,0.000022790067,0.00003046384,0.00060399424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867207,0.00005272227,0.00014998508,0.00041739744,0.00024866764,0.00045918828],"domain_scores_gemma":[0.9993964,0.000051852614,0.000036765225,0.00021682595,0.00016410569,0.00013404714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002521951,0.0001194658,0.00012292498,0.000076628676,0.0001293385,0.000054414813,0.00020228961,0.00012318236,0.00020597372],"category_scores_gemma":[0.000053042262,0.000083242856,0.00004148189,0.00006837486,0.00022125502,0.000008808326,0.00014518683,0.00009473535,0.0000030975648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007553589,0.00007404898,0.017372731,0.00012403568,0.000027614387,0.0000021721423,0.000028718483,0.000005061468,0.9485895,0.000012623653,0.0020107266,0.030997377],"study_design_scores_gemma":[0.0018555718,0.000089010595,0.091620974,0.00043511076,0.00000854411,0.0000025685474,0.00003382785,0.000013547548,0.89707255,0.00010198315,0.008559792,0.000206523],"about_ca_topic_score_codex":0.00018337746,"about_ca_topic_score_gemma":0.00056138006,"teacher_disagreement_score":0.07424824,"about_ca_system_score_codex":0.00006401512,"about_ca_system_score_gemma":0.0003437158,"threshold_uncertainty_score":0.33945453},"labels":[],"label_agreement":null},{"id":"W2504834966","doi":"10.1158/1538-7445.am2016-3446","title":"Abstract 3446: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of glioma: Results from the Glioma International Case Control Study","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Medicine; Aspirin; Internal medicine; Meta-analysis; Oncology; Subgroup analysis","score_opus":0.022342647583489476,"score_gpt":0.34036452122552685,"score_spread":0.3180218736420374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504834966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932231,0.00081768056,0.000010378836,0.002508641,0.00052199105,0.0018919151,0.00062366656,0.000022257873,0.00038037822],"genre_scores_gemma":[0.99812055,0.00022438879,0.000005126007,0.000058854814,0.0011912928,0.00023155952,0.0000038304056,0.0000328529,0.00013152217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658036,0.00075564475,0.00057653495,0.00045450518,0.0011863508,0.0004465931],"domain_scores_gemma":[0.993611,0.004564053,0.00024385362,0.0007707317,0.00061267073,0.00019771908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064159343,0.000207741,0.00044093112,0.0002002056,0.00030239296,0.000057949783,0.00039532737,0.00010901696,0.00018426467],"category_scores_gemma":[0.0012767965,0.00009078648,0.00012525832,0.00025464268,0.00093868555,0.00013552258,0.00019703351,0.0005928135,0.0000476806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048624635,0.0008647191,0.54951686,0.00027645734,0.0041175024,0.016210247,0.025187073,0.000018315424,0.25944906,0.00019429838,0.01146535,0.08407549],"study_design_scores_gemma":[0.07565133,0.00068922347,0.8681558,0.0007448263,0.00035630813,0.00028304366,0.004461747,0.00025093943,0.047211528,0.00013549029,0.0017605632,0.00029924721],"about_ca_topic_score_codex":0.0035106917,"about_ca_topic_score_gemma":0.0004980614,"teacher_disagreement_score":0.3186389,"about_ca_system_score_codex":0.00014638263,"about_ca_system_score_gemma":0.0003058352,"threshold_uncertainty_score":0.5307139},"labels":[],"label_agreement":null},{"id":"W2504921393","doi":"10.1158/1538-7445.am2016-2919","title":"Abstract 2919: Ultrasound-mediated neuropilin-1 shRNA minicircle delivery inhibits tumour growth in an orthotopic human pancreatic adenocarcinoma model","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital","funders":"","keywords":"Pancreatic cancer; Cancer research; Medicine; Pathology; Cancer; Internal medicine","score_opus":0.06016484858592872,"score_gpt":0.3553824011876775,"score_spread":0.29521755260174876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504921393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639565,0.0025006002,0.00003427725,0.000187196,0.00006637052,0.00032240755,0.000095803734,0.000017179544,0.0003804954],"genre_scores_gemma":[0.9961784,0.0021925734,0.000032518146,0.0001797361,0.0004032394,0.00020422107,0.00006379561,0.000059006226,0.000686509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976534,0.00017582288,0.00034444104,0.0007175143,0.0004051697,0.0007036026],"domain_scores_gemma":[0.9988294,0.00008434646,0.000068108464,0.000437629,0.00034161398,0.00023886397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005082577,0.00020859459,0.00022891621,0.00016624691,0.00016172374,0.000044788325,0.00045763797,0.0002014617,0.00016704442],"category_scores_gemma":[0.00015738103,0.00016841825,0.00009935583,0.00024810154,0.00023410204,0.00002342948,0.00014460646,0.00021945957,0.000035733578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010728256,0.000083445826,0.12565441,0.00003764119,0.00001940222,0.000017949098,0.000051552433,0.000038970487,0.87259203,0.00004074224,0.0006696738,0.0006868981],"study_design_scores_gemma":[0.0012411086,0.0003457643,0.3494027,0.00013801878,0.0000115424855,0.000006731217,0.00007634107,0.00006377361,0.64789003,0.00017092582,0.0003052317,0.0003478244],"about_ca_topic_score_codex":0.00060203194,"about_ca_topic_score_gemma":0.0010832362,"teacher_disagreement_score":0.224702,"about_ca_system_score_codex":0.00013235597,"about_ca_system_score_gemma":0.00044333586,"threshold_uncertainty_score":0.6867897},"labels":[],"label_agreement":null},{"id":"W2505302968","doi":"10.1158/1538-7445.am2016-792","title":"Abstract 792: Super-transactivation TP53 variant in the germline of a family with Li-Fraumeni variant","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Transactivation; Germline; Li–Fraumeni syndrome; Cancer research; Cancer; Genetics; Gene; Biology; Medicine; Germline mutation; Mutation; Gene expression","score_opus":0.07462164708247375,"score_gpt":0.37336010731722996,"score_spread":0.2987384602347562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505302968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844092,0.0009603312,0.0034802635,0.006635344,0.000085838496,0.0011746803,0.000058031917,0.000025029574,0.0031712854],"genre_scores_gemma":[0.9982189,0.00070719677,0.00016328084,0.00018726733,0.00015233556,0.0002787993,0.000008055395,0.000041727795,0.00024243422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743503,0.00018264972,0.00034121372,0.00038608856,0.0011385018,0.00051653694],"domain_scores_gemma":[0.9984392,0.0003246765,0.000065209475,0.00064206263,0.0004116866,0.000117172414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015429688,0.00015411945,0.00028654127,0.00032227056,0.00006893493,0.000019549914,0.00026896482,0.0001400523,0.0004175278],"category_scores_gemma":[0.00015075311,0.00008053036,0.00006674065,0.0009007105,0.00026321417,0.00011616188,0.00002802013,0.00063583744,0.000024469147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017872202,0.00029687322,0.0003635189,0.00017093518,0.00010903221,0.0007632206,0.0013839192,0.000060658032,0.96901935,0.000571884,0.0008438887,0.02462947],"study_design_scores_gemma":[0.028700178,0.0044280123,0.4493092,0.008426719,0.0002564733,0.0007601743,0.002412044,0.00035421783,0.46643823,0.0012431435,0.036727555,0.0009440357],"about_ca_topic_score_codex":0.002562042,"about_ca_topic_score_gemma":0.00051451474,"teacher_disagreement_score":0.5025811,"about_ca_system_score_codex":0.00042986753,"about_ca_system_score_gemma":0.0011651526,"threshold_uncertainty_score":0.45716366},"labels":[],"label_agreement":null},{"id":"W2505428260","doi":"10.1158/1538-7445.am2016-1646","title":"Abstract 1646: A glioblastoma methylation assay (GaMA) developedfrom genomic analysis of glioma spheroid cultures predicts response toradiation therapy in patients with glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Glioma; DNA methylation; CpG site; Epigenetics; Cancer research; Wnt signaling pathway; Biology; Oncology; Medicine; Gene; Genetics; Gene expression","score_opus":0.021021964060709414,"score_gpt":0.33125200704953817,"score_spread":0.3102300429888287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505428260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976821,0.001160895,0.00039517213,0.0001009766,0.00004517224,0.00045079016,0.00011334915,0.000010314359,0.00004125469],"genre_scores_gemma":[0.9989759,0.0005302948,0.0001509119,0.0000082215065,0.00007663953,0.0000923635,0.00006221043,0.000030459163,0.00007299809],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976493,0.0005250459,0.00036655366,0.00048552972,0.00061544264,0.00035812217],"domain_scores_gemma":[0.9984672,0.00016188541,0.00018324131,0.0004046684,0.00067807524,0.00010489877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001553138,0.00017250596,0.0002472144,0.0005579244,0.000077910496,0.000032250413,0.00023768534,0.00020164209,0.000078194884],"category_scores_gemma":[0.0003256548,0.00012023552,0.000080393365,0.0012294477,0.00012803386,0.000020317591,0.00006684881,0.000117260475,0.0000043039095],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007847305,0.00010587014,0.13105544,0.000007748847,0.00031563095,0.0000016804582,0.00017169928,0.0007908174,0.8468797,0.0000038999315,0.00006864321,0.01275152],"study_design_scores_gemma":[0.0011570834,0.00084140484,0.5551259,0.000022385619,0.000019246685,4.778254e-8,0.0000191644,0.000026406868,0.442132,0.000017159175,0.0005348599,0.00010436927],"about_ca_topic_score_codex":0.0001553831,"about_ca_topic_score_gemma":0.0012871695,"teacher_disagreement_score":0.42407042,"about_ca_system_score_codex":0.00019719974,"about_ca_system_score_gemma":0.00032997684,"threshold_uncertainty_score":0.4903062},"labels":[],"label_agreement":null},{"id":"W2505767045","doi":"10.1158/1538-7445.am2016-2414","title":"Abstract 2414: ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"ADAR; Plasma cell leukemia; RNA editing; Biology; RNA; Cancer research; Stem cell; Molecular biology; Gene; Immunology; Multiple myeloma; Genetics","score_opus":0.04406587871936923,"score_gpt":0.34820658549306477,"score_spread":0.30414070677369553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505767045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937919,0.0014889342,0.00008527437,0.00062034704,0.000059486454,0.000182251,0.00006192307,0.000005285817,0.0037046135],"genre_scores_gemma":[0.9932046,0.00034376106,0.000031124528,0.00006688109,0.00014602978,0.00006491098,0.000005751568,0.000017959941,0.0061190156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873567,0.00007243747,0.00020479759,0.00029353294,0.00037850405,0.00031505994],"domain_scores_gemma":[0.9992949,0.000024749914,0.00006906856,0.00029758885,0.00022494674,0.00008873955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041410135,0.00009155116,0.000107087566,0.000090924485,0.000075931624,0.000016787531,0.00022370981,0.00009289206,0.00033711633],"category_scores_gemma":[0.000043147345,0.0000710706,0.000047270136,0.0001238353,0.0001180139,0.0000066217162,0.00008077728,0.00008429782,0.00000992069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012617039,0.00004566526,0.000767075,0.00006513907,0.000009966573,0.0000055919027,0.00007917422,0.0000028658656,0.99532366,0.0010187769,0.0015784408,0.0009774577],"study_design_scores_gemma":[0.0008140686,0.000049709797,0.0047587818,0.000106935215,0.0000025567674,2.4423966e-7,0.00013067156,0.000002384994,0.98819536,0.0013930892,0.0044527524,0.000093448114],"about_ca_topic_score_codex":0.000086449654,"about_ca_topic_score_gemma":0.00039402064,"teacher_disagreement_score":0.0071283192,"about_ca_system_score_codex":0.00006932295,"about_ca_system_score_gemma":0.00024162002,"threshold_uncertainty_score":0.36911875},"labels":[],"label_agreement":null},{"id":"W2506034246","doi":"10.1158/1538-7445.am2016-4124","title":"Abstract 4124: Sub-cytotoxic concentrations of a novel polyphenol fatty acid ester derivative arrest breast cancer cell proliferation and metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chemistry; Cytotoxic T cell; Cell cycle; Apoptosis; Propidium iodide; Docosahexaenoic acid; Molecular biology; Cancer cell; Cell growth; Cell cycle checkpoint; Fatty acid; Biochemistry; Cancer research; Biology; Polyunsaturated fatty acid; In vitro; Cancer; Programmed cell death","score_opus":0.08601859574486052,"score_gpt":0.39431099826974003,"score_spread":0.3082924025248795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506034246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798986,0.0022582023,0.0010257752,0.013529675,0.00022909588,0.0013773333,0.0013949062,0.00003479052,0.00025165104],"genre_scores_gemma":[0.9969113,0.0016187341,0.0003644871,0.00015019947,0.00030937334,0.00053386425,0.000012867591,0.00004129289,0.000057870227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696505,0.0002416094,0.00040130626,0.00050773134,0.0009340634,0.0009502428],"domain_scores_gemma":[0.99791837,0.00033793217,0.00013335787,0.00035797138,0.00083474134,0.00041763257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000762636,0.00019931454,0.00030602675,0.00020514417,0.00043163102,0.000107199216,0.00026124791,0.00012819239,0.0006644322],"category_scores_gemma":[0.00014476714,0.00014235497,0.00005914646,0.00046866547,0.0006638286,0.00061639573,0.000098809614,0.0004418546,0.000019510659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094498694,0.00024041235,0.011741531,0.0003487819,0.000047499063,0.0000026637472,0.0010666081,0.000006319252,0.96530247,0.00013025056,0.001268938,0.018899556],"study_design_scores_gemma":[0.0019652497,0.00019154033,0.08078113,0.00037348518,0.000013967983,0.000004088909,0.00043167107,0.000069393056,0.9157211,0.000069751826,0.00021169637,0.00016689801],"about_ca_topic_score_codex":0.0037144674,"about_ca_topic_score_gemma":0.0056889416,"teacher_disagreement_score":0.0690396,"about_ca_system_score_codex":0.000735617,"about_ca_system_score_gemma":0.00086251,"threshold_uncertainty_score":0.72750664},"labels":[],"label_agreement":null},{"id":"W2506035177","doi":"10.1158/1538-7445.am2016-2587","title":"Abstract 2587: Comprehensive colorectal cancer risk prediction to inform personalized screening and intervention","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Newfoundland and Labrador; Memorial University of Newfoundland","funders":"","keywords":"Family history; Colorectal cancer; Medicine; Logistic regression; Internal medicine; Oncology; Epidemiology; Cancer; Risk assessment","score_opus":0.047636916109235664,"score_gpt":0.3843076531676711,"score_spread":0.3366707370584355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506035177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934638,0.0042034094,0.0006047715,0.00056141097,0.00012788341,0.00035093265,0.0005570738,0.00001194366,0.00011875003],"genre_scores_gemma":[0.9929276,0.005536557,0.000096879456,0.000067583074,0.00043402906,0.00028404986,0.00005032079,0.000016636095,0.00058633636],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998913,0.00007182586,0.00015423169,0.00031579222,0.0002571995,0.00028793735],"domain_scores_gemma":[0.9991403,0.000029513605,0.000043461005,0.00013669342,0.00042961573,0.00022039251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023908887,0.00009910826,0.00009357249,0.00009131136,0.00020118634,0.000038679264,0.00010424004,0.000089589696,0.00022723427],"category_scores_gemma":[0.00011419755,0.0000807563,0.000062946834,0.000110963774,0.00018926512,0.000009971021,0.00011881318,0.000095590374,0.0000091899365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015741554,0.000052050273,0.041378852,0.00008051307,0.00008625918,0.0000018366173,0.00013458957,0.000015205311,0.88079226,0.000019875,0.009350697,0.066513725],"study_design_scores_gemma":[0.004906368,0.0009578482,0.48153728,0.00041428255,0.000035266523,0.0000043040377,0.00063356047,0.00003184458,0.35468453,0.00018611015,0.1563003,0.0003083017],"about_ca_topic_score_codex":0.0004085937,"about_ca_topic_score_gemma":0.00037755337,"teacher_disagreement_score":0.5261077,"about_ca_system_score_codex":0.00006609314,"about_ca_system_score_gemma":0.000100100515,"threshold_uncertainty_score":0.32931462},"labels":[],"label_agreement":null},{"id":"W2506051311","doi":"10.1158/1538-7445.am2016-3405","title":"Abstract 3405: The analysis of TRPV6 expression in lymphoid tumours","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Lymphoma; Internal medicine; Medicine; Follicular lymphoma; Oncology; Chronic lymphocytic leukemia; Survival analysis; Proportional hazards model; Diffuse large B-cell lymphoma; Pathology; Leukemia","score_opus":0.0854602531922986,"score_gpt":0.43192560238846384,"score_spread":0.34646534919616523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506051311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925477,0.001555337,0.0000018088617,0.0037296347,0.000029369632,0.00024771265,0.000026183716,0.000006114022,0.0018561506],"genre_scores_gemma":[0.9974689,0.0016503204,0.000010274443,0.000043013137,0.000042664953,0.00016601702,0.0000039158044,0.000008310049,0.00060658035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869245,0.00007875811,0.00018981138,0.00020924865,0.0005498756,0.00027987067],"domain_scores_gemma":[0.9989097,0.0004432908,0.000040628827,0.0003755251,0.0001410172,0.00008983844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059088063,0.000071192124,0.00024385685,0.00037208357,0.000043815664,0.0000084388275,0.00013092112,0.000044125587,0.00105231],"category_scores_gemma":[0.000116656825,0.000030491055,0.000114972594,0.0008930725,0.00014717728,0.00004184424,0.000052199255,0.000071281,0.000031596934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028692256,0.00034400038,0.812253,0.000026505528,0.00026313198,0.000057752786,0.0002917105,0.0000119783535,0.13837107,0.000061680636,0.002873175,0.045159087],"study_design_scores_gemma":[0.0013930289,0.000050514216,0.809945,0.0002631324,0.00009252267,0.0000012058726,0.00011566769,0.0000068072904,0.18687981,0.000035518788,0.0011844668,0.0000323512],"about_ca_topic_score_codex":0.0018173185,"about_ca_topic_score_gemma":0.00051687955,"teacher_disagreement_score":0.048508756,"about_ca_system_score_codex":0.0004986101,"about_ca_system_score_gemma":0.00028302468,"threshold_uncertainty_score":0.9998609},"labels":[],"label_agreement":null},{"id":"W2506102763","doi":"10.1158/1538-7445.am2016-1481","title":"Abstract 1481: Preclinical validation of a novel CD133/CD3 bispecific T-cell engager (BiTE) antibody to target patient-derived glioblastoma cells","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Antigen; Cancer research; Flow cytometry; Antibody; CD3; Monoclonal antibody; Population; Peripheral blood mononuclear cell; Immunophenotyping; Medicine; Cancer; Immunology; Biology; Internal medicine; In vitro; CD8","score_opus":0.11999431366524654,"score_gpt":0.43986873323908154,"score_spread":0.319874419573835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506102763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192435,0.00034823344,0.00044554335,0.0016998494,0.00031461677,0.0020038784,0.00019333321,0.000059084883,0.0030111198],"genre_scores_gemma":[0.9914595,0.0007063936,0.00066566304,0.0000938173,0.000506076,0.00024434883,0.000024116385,0.0001102532,0.0061898693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994613,0.00039527487,0.00077379245,0.0008772758,0.0022256086,0.0011150608],"domain_scores_gemma":[0.99491954,0.0017031295,0.00014728766,0.0010799274,0.0014449779,0.0007051682],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025973707,0.00026512495,0.00058005156,0.00077349925,0.00016194671,0.00005895204,0.0004786429,0.00025768077,0.013376728],"category_scores_gemma":[0.00090799335,0.00020013678,0.00023104693,0.0011308878,0.0004390719,0.00017702911,0.00030999456,0.0009755026,0.00052392355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038084888,0.00096589915,0.0014533433,0.00023432382,0.000081310776,0.000057834342,0.00067582494,0.00002290179,0.9648573,0.00001204171,0.004884676,0.022946075],"study_design_scores_gemma":[0.003634847,0.0017509033,0.004116579,0.00045831376,0.000013220215,0.0000072466128,0.00017075118,0.000017202336,0.9449412,0.000023014542,0.04465321,0.00021346439],"about_ca_topic_score_codex":0.00029712834,"about_ca_topic_score_gemma":0.000029057384,"teacher_disagreement_score":0.039768536,"about_ca_system_score_codex":0.00056054734,"about_ca_system_score_gemma":0.000910837,"threshold_uncertainty_score":0.98752517},"labels":[],"label_agreement":null},{"id":"W2506190647","doi":"10.1158/1538-7445.am2016-2506","title":"Abstract 2506: Citral reduces breast tumor growth by inhibiting cancer stem cell marker ALDH1A3","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Mary's University; Dalhousie University","funders":"","keywords":"Aldehyde dehydrogenase; Cancer research; Breast cancer; Cancer stem cell; Cancer; Citral; Biology; Medicine; Internal medicine; Biochemistry; Gene","score_opus":0.025831584341303858,"score_gpt":0.3224892233228621,"score_spread":0.2966576389815583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506190647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750386,0.018477574,0.00001632181,0.0015182563,0.0008242674,0.00032951514,0.00072418764,0.000023597055,0.0030476754],"genre_scores_gemma":[0.9752312,0.009038592,0.00002188379,0.00020634929,0.0036251415,0.0003582535,0.000027867129,0.00007242369,0.011418297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723595,0.00013899631,0.00030336485,0.00076229003,0.00055804185,0.0010013805],"domain_scores_gemma":[0.9987425,0.000043939737,0.00010637534,0.00035044586,0.00042974856,0.00032695167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006925302,0.00025409725,0.00024935533,0.00010233993,0.00022166404,0.00007908043,0.0004414873,0.00016940416,0.00062550104],"category_scores_gemma":[0.000033420132,0.0001934438,0.0001355549,0.00023359644,0.00041870496,0.000021118782,0.00022160789,0.0003128514,0.000043835415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022099563,0.000045741333,0.00073575694,0.0000637248,0.000041435393,0.0000034681718,0.000040122268,0.0000010723136,0.8491762,0.00001458805,0.11377962,0.035877246],"study_design_scores_gemma":[0.0009087427,0.000049369475,0.0029651062,0.00013583837,0.000011638189,0.000012342921,0.0001214137,7.800059e-7,0.849805,0.000028565362,0.14568004,0.00028113337],"about_ca_topic_score_codex":0.0012581141,"about_ca_topic_score_gemma":0.00021754431,"teacher_disagreement_score":0.035596114,"about_ca_system_score_codex":0.00015067795,"about_ca_system_score_gemma":0.0007071292,"threshold_uncertainty_score":0.78884095},"labels":[],"label_agreement":null},{"id":"W2506500153","doi":"10.1158/1538-7445.am2016-ct079","title":"Abstract CT079: ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; T790M; Internal medicine; Tolerability; Oncology; Progressive disease; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Lung cancer; Clinical trial; Epidermal growth factor receptor; Chemotherapy; Cancer; Adverse effect; Gefitinib","score_opus":0.026487983187163024,"score_gpt":0.3484391199797316,"score_spread":0.3219511367925686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506500153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941213,0.0003041245,0.0000073956803,0.0004136815,0.00008540858,0.0038656334,0.0005511208,0.000029112705,0.0006221976],"genre_scores_gemma":[0.99636513,0.0001431697,0.00016972673,0.00004152987,0.0001941324,0.0018005257,0.000085379805,0.000094039955,0.0011063527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690586,0.00016628944,0.00045095818,0.0008063706,0.00089138956,0.00077913847],"domain_scores_gemma":[0.9977445,0.00014962,0.00015639822,0.00056468084,0.00093426113,0.0004505115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019159858,0.00040351506,0.0005824946,0.00047929265,0.00019207591,0.00003488511,0.00015090493,0.00011225462,0.000360797],"category_scores_gemma":[0.000022773744,0.00022088246,0.00006811678,0.00063143985,0.00021599226,0.00034628433,0.000080118865,0.00028366657,0.000021372793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011669451,0.013807172,0.9371259,0.00021669256,0.00050540786,0.00023350002,0.009621003,0.000004764786,0.013746662,0.0000029654266,0.00030978257,0.012756693],"study_design_scores_gemma":[0.03479932,0.031131253,0.84649134,0.0013747512,0.00022710668,0.000001730661,0.0014161335,0.0000026981056,0.084086135,0.0000035069572,0.00013489957,0.00033110764],"about_ca_topic_score_codex":0.0060575665,"about_ca_topic_score_gemma":0.0025969497,"teacher_disagreement_score":0.09063454,"about_ca_system_score_codex":0.0022249494,"about_ca_system_score_gemma":0.0011593006,"threshold_uncertainty_score":0.9157269},"labels":[],"label_agreement":null},{"id":"W2506569830","doi":"10.1158/1538-7445.am2016-296","title":"Abstract 296: Targeting the melanosome: overcoming MAPK-inhibitor resistance in melanoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Microphthalmia-associated transcription factor; Cancer research; Gene knockdown; Biology; Trametinib; Melanoma; Dabrafenib; Transcription factor; Medicine; MAPK/ERK pathway; Gene; Signal transduction; Vemurafenib; Cell biology; Genetics","score_opus":0.03441883247084821,"score_gpt":0.35560833304646783,"score_spread":0.3211895005756196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506569830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914938,0.0027627207,0.000046447974,0.0018445674,0.00019110274,0.00022016552,0.000018455865,0.0000057715965,0.0034169273],"genre_scores_gemma":[0.9950779,0.00081484707,0.00008901255,0.000077260804,0.00056487217,0.0001211159,0.0000146059465,0.000018951401,0.0032213968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986116,0.00015912145,0.00019137065,0.00031674816,0.0003277053,0.00039344907],"domain_scores_gemma":[0.9994081,0.000106097476,0.000043959466,0.00028466416,0.0000984191,0.000058710684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009570994,0.00009212621,0.000087013286,0.000057789428,0.00014569264,0.0000363153,0.00027192122,0.00009418479,0.00018275037],"category_scores_gemma":[0.00023396478,0.00005558743,0.00003871575,0.00014856276,0.00011617151,0.000007784091,0.000105487576,0.00016092963,0.000034533743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013692495,0.000014035371,0.0050617433,0.000020428351,0.000010453772,0.000007975627,0.00012104061,0.0000016324025,0.97332567,0.00025358642,0.019374168,0.001672339],"study_design_scores_gemma":[0.00069860026,0.00004359989,0.020902913,0.0001376438,0.0000017259275,9.787963e-7,0.00020073763,0.0000015384518,0.88282925,0.00042094264,0.09463189,0.00013017881],"about_ca_topic_score_codex":0.00011273441,"about_ca_topic_score_gemma":0.0006193345,"teacher_disagreement_score":0.09049642,"about_ca_system_score_codex":0.00010055896,"about_ca_system_score_gemma":0.00011719689,"threshold_uncertainty_score":0.22667897},"labels":[],"label_agreement":null},{"id":"W2506579659","doi":"10.1158/1538-7445.am2016-lb-091","title":"Abstract LB-091: Inhibition of Siglec-15 prevents bone loss in a mouse model of multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada)","funders":"","keywords":"Bortezomib; Multiple myeloma; Bone marrow; Medicine; Femur; Tibia; Bone disease; Osteoporosis; Internal medicine; Pathology; Anatomy; Surgery","score_opus":0.10278785322535819,"score_gpt":0.40310140440589864,"score_spread":0.3003135511805405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506579659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970619,0.00044364666,0.00006833553,0.0005067556,0.000016740705,0.001055487,0.00033596126,0.000015668991,0.0004954691],"genre_scores_gemma":[0.9958387,0.00074131304,0.00024481505,0.000010140468,0.00004764884,0.0003034148,0.000022046741,0.00003528534,0.0027566112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971465,0.0001250687,0.00047646114,0.00037436577,0.0012166651,0.00066094723],"domain_scores_gemma":[0.99833316,0.0003124078,0.000099027624,0.00047225552,0.0004983577,0.0002847693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078901334,0.00014912784,0.00041090092,0.00056206447,0.000044718057,0.0000068746,0.00014124667,0.00012846265,0.00036096983],"category_scores_gemma":[0.0006235582,0.00010345073,0.000103197744,0.00041437877,0.0003520978,0.00016317313,0.00013563964,0.00030827694,0.00003870703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553301,0.0008443858,0.082094535,0.0004927449,0.00007296188,0.00008631824,0.0002151584,0.000050421426,0.8917902,0.00003173871,0.00029841045,0.021469796],"study_design_scores_gemma":[0.0090561835,0.00037689798,0.067534335,0.0011575309,0.0000071249497,0.0000031873542,0.000053538944,0.0007489831,0.92057383,0.00033656842,0.000049895036,0.00010193036],"about_ca_topic_score_codex":0.0015307929,"about_ca_topic_score_gemma":0.00059177197,"teacher_disagreement_score":0.028783599,"about_ca_system_score_codex":0.00048808954,"about_ca_system_score_gemma":0.0006486649,"threshold_uncertainty_score":0.42185983},"labels":[],"label_agreement":null},{"id":"W2506773131","doi":"10.1158/1538-7445.am2016-3794","title":"Abstract 3794: Novel therapeutic targets in head and neck cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; Oakville-Trafalgar Memorial Hospital","funders":"","keywords":"Cancer research; Gene knockdown; Notch signaling pathway; Metastasis; Cancer; Primary tumor; Medicine; Biology; Signal transduction; Gene; Internal medicine; Genetics","score_opus":0.05925156697224,"score_gpt":0.4012854364662171,"score_spread":0.3420338694939771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506773131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964798,0.028090741,0.001798131,0.0030056245,0.00022767969,0.0007606694,0.00012057961,0.00001809113,0.0011805338],"genre_scores_gemma":[0.986225,0.0107198,0.00007395472,0.00020597955,0.0002961376,0.0005043303,0.000010661645,0.000060098002,0.001904001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975823,0.0001006352,0.00021538167,0.0006881264,0.000543484,0.00087004586],"domain_scores_gemma":[0.9989751,0.00004810121,0.000036809357,0.00045934683,0.00026332636,0.0002173116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006979897,0.00018379008,0.00018165677,0.00021608555,0.00011583208,0.000047984802,0.00035345127,0.00024981546,0.000589508],"category_scores_gemma":[0.00011637549,0.00014168156,0.000056156074,0.00032972425,0.00027187035,0.000010922762,0.00028709215,0.000398587,0.000025668483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030563833,0.00006231621,0.0006189204,0.000039401504,0.000051393923,0.000011385317,0.000046503785,0.00002859877,0.95150125,0.00014700874,0.0014527326,0.04573484],"study_design_scores_gemma":[0.002634485,0.00027226066,0.013856451,0.0002581044,0.0000050217473,0.000007655795,0.000047890826,0.000027182856,0.88743263,0.00033061497,0.09482186,0.00030585684],"about_ca_topic_score_codex":0.00138321,"about_ca_topic_score_gemma":0.0037535885,"teacher_disagreement_score":0.09336913,"about_ca_system_score_codex":0.0002468816,"about_ca_system_score_gemma":0.0006428863,"threshold_uncertainty_score":0.6454699},"labels":[],"label_agreement":null},{"id":"W2506835611","doi":"10.1158/1538-7445.am2016-1031","title":"Abstract 1031: Fumarate hydratase deficiency redirects glucose metabolism of hypoxic cancer cells into the pentose phosphate pathway","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Transfection; Cancer research; Glycolysis; Pentose phosphate pathway; Molecular biology; Hypoxia-inducible factors; Chemistry; Biochemistry; Metabolism; Gene","score_opus":0.030541415581559865,"score_gpt":0.3315918104976297,"score_spread":0.30105039491606983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506835611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85249543,0.1433956,0.000026296451,0.00066499395,0.0016720066,0.0005209806,0.00035646406,0.000015123351,0.00085308397],"genre_scores_gemma":[0.9056018,0.08842256,0.000036001627,0.00016691865,0.001774896,0.00046465476,0.000022715778,0.000056306184,0.0034541371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968985,0.00025041067,0.00043135113,0.00075058814,0.00077059213,0.0008986021],"domain_scores_gemma":[0.9978425,0.00009779945,0.00018777212,0.0010190826,0.000582287,0.00027057095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014170416,0.00029177126,0.00035399265,0.00013564198,0.00029300063,0.000055933357,0.0008746336,0.00019567246,0.00065524067],"category_scores_gemma":[0.0001942818,0.00017718766,0.0001950169,0.0004858661,0.00067549414,0.00002497598,0.00036127694,0.00029977717,0.000060143357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031065595,0.000082312385,0.00003642519,0.000060945826,0.00005854434,0.00000341363,0.00028522516,0.000024921275,0.86710095,0.00008123392,0.011676168,0.120279185],"study_design_scores_gemma":[0.0007482087,0.000056920537,0.0008378617,0.000059748734,0.000021282756,0.0000013310687,0.00007155044,0.0000022770612,0.6719293,0.00011270944,0.3259808,0.00017798782],"about_ca_topic_score_codex":0.0033270677,"about_ca_topic_score_gemma":0.0014128219,"teacher_disagreement_score":0.31430465,"about_ca_system_score_codex":0.00009984068,"about_ca_system_score_gemma":0.0011652004,"threshold_uncertainty_score":0.72255033},"labels":[],"label_agreement":null},{"id":"W2506849823","doi":"10.1158/1538-7445.am2016-3200","title":"Abstract 3200: New epigenetic mechanism of disulfiram targeting chromatin remodeling in neuroblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Neuroblastoma; Disulfiram; Epigenetics; Medicine; Epigenetic therapy; Cancer research; Histone; Pediatric cancer; Chromatin remodeling; DNA methylation; Cell cycle; Chromatin; Cancer; Pharmacology; Biology; Cell culture; Genetics; Internal medicine; DNA; Gene expression","score_opus":0.08095660397730985,"score_gpt":0.40300231589077834,"score_spread":0.3220457119134685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506849823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562293,0.00055458496,0.00021450031,0.0018969403,0.00006833598,0.00069468975,0.000015656886,0.000034739303,0.0008976229],"genre_scores_gemma":[0.9970143,0.00088591746,0.0004510995,0.000032541328,0.0001565748,0.00007522222,0.0000029621945,0.00005321613,0.0013281866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698395,0.00014776211,0.00043632573,0.00048257704,0.0010657355,0.00088366977],"domain_scores_gemma":[0.99845314,0.00036035158,0.000071065624,0.00041764302,0.00024891892,0.00044886788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070214825,0.0001677086,0.0003379081,0.0004850056,0.00007702748,0.000019099076,0.00023765236,0.000085792344,0.0008503109],"category_scores_gemma":[0.0006638958,0.00011492938,0.00008650465,0.0006153634,0.00013967893,0.00011365675,0.00015725369,0.00041608274,0.00013959337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051553315,0.000178109,0.0014758362,0.00016454926,0.000028818591,0.00024851682,0.000101232166,0.000022577597,0.9521814,0.00014103946,0.00073449383,0.04420787],"study_design_scores_gemma":[0.005004544,0.0010719597,0.036986,0.0018215964,0.000012539133,0.00002178359,0.00007163771,0.00032922707,0.95108587,0.0028812154,0.00053120125,0.000182459],"about_ca_topic_score_codex":0.0010528985,"about_ca_topic_score_gemma":0.00016785758,"teacher_disagreement_score":0.044025414,"about_ca_system_score_codex":0.0003292677,"about_ca_system_score_gemma":0.00085740286,"threshold_uncertainty_score":0.9310308},"labels":[],"label_agreement":null},{"id":"W2507008765","doi":"10.1158/1538-7445.am2016-281","title":"Abstract 281: Bendamustine has the biochemical properties of an alkylating agent that synergizes with nucleoside analogues in chronic lymphocytic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"George & Fay Yee Centre for Healthcare Innovation; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Pentostatin; Nucleoside analogue; Bendamustine; Chlorambucil; Fludarabine; Cladribine; Medicine; Cancer research; Programmed cell death; Leukemia; Nucleoside; Pharmacology; Apoptosis; Immunology; Biology; Chemotherapy; Lymphoma; Biochemistry; Internal medicine","score_opus":0.14330996894288175,"score_gpt":0.37017232212438095,"score_spread":0.2268623531814992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507008765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150187,0.0058169723,0.0000067101564,0.0012119359,0.000040581013,0.0009568384,0.000017442393,0.000050870807,0.00039676097],"genre_scores_gemma":[0.9973822,0.0011775088,0.00006154262,0.000046770456,0.00034664726,0.000316802,0.000009150383,0.00007562649,0.0005837258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956443,0.00022122117,0.0004838983,0.0006638189,0.0018131256,0.0011736912],"domain_scores_gemma":[0.99759394,0.0005177824,0.00011615572,0.0009926773,0.00045959014,0.00031985296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017237634,0.00027018963,0.0004991844,0.00037956602,0.0002157547,0.00007546927,0.00062775303,0.000169596,0.000358492],"category_scores_gemma":[0.0005558087,0.00012823807,0.000088111345,0.0008168706,0.0021842564,0.00023406529,0.00029930577,0.0005973297,0.000038500384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002209578,0.000068711364,0.0010090567,0.0010549872,0.00015310878,0.00032009327,0.0010189454,0.0006958425,0.9765929,0.00004207747,0.00096426136,0.015870411],"study_design_scores_gemma":[0.014969887,0.0008130042,0.007560405,0.005482568,0.000042362255,0.00014044232,0.0010062555,0.0075158617,0.9610476,0.000045267407,0.0010948697,0.00028150022],"about_ca_topic_score_codex":0.020969184,"about_ca_topic_score_gemma":0.0029799168,"teacher_disagreement_score":0.037019048,"about_ca_system_score_codex":0.09192653,"about_ca_system_score_gemma":0.054907486,"threshold_uncertainty_score":0.9855503},"labels":[],"label_agreement":null},{"id":"W2507033929","doi":"10.1158/1538-7445.am2016-167","title":"Abstract 167: Inferring subclonal relationships between multiple metastases from rapid autopsy of a single melanoma patient","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Melanoma; Medicine; Disease; Exome; Exome sequencing; Cancer; Somatic evolution in cancer; Targeted therapy; Cancer research; Oncology; Mutation; Internal medicine; Biology; Gene; Genetics","score_opus":0.10953067352087523,"score_gpt":0.3443921528185066,"score_spread":0.23486147929763138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507033929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437976,0.0028965385,0.00028296933,0.00025120287,0.000102224345,0.00019196588,0.0015575772,0.000006656841,0.00033111332],"genre_scores_gemma":[0.9984764,0.00049484964,0.0003243915,0.000015720134,0.00038239855,0.00006559743,0.00016109271,0.00002412137,0.000055461343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986759,0.00011440752,0.0002755551,0.00032993784,0.000290204,0.00031399913],"domain_scores_gemma":[0.9985994,0.00056329614,0.00008935591,0.00036898165,0.0002461957,0.00013274056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038236316,0.000111190624,0.0001621183,0.00008546639,0.000110029985,0.00002281663,0.00020289261,0.00011550852,0.00018619765],"category_scores_gemma":[0.00082869374,0.00008916274,0.00007928747,0.00011351299,0.00016392976,0.000006871806,0.00019538925,0.00014845266,0.000014978497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012300597,0.00006367029,0.10070604,0.00001399856,0.0000937654,0.000003174836,0.00007413257,0.00003302768,0.874038,0.000058108388,0.0017132616,0.023079807],"study_design_scores_gemma":[0.0007524109,0.00029445387,0.12023131,0.00008083105,0.000016429181,5.5721705e-7,0.00008117396,0.0000030175977,0.8307158,0.0003646299,0.047304288,0.0001551521],"about_ca_topic_score_codex":0.0011007484,"about_ca_topic_score_gemma":0.00069609727,"teacher_disagreement_score":0.045591027,"about_ca_system_score_codex":0.000097344295,"about_ca_system_score_gemma":0.00027586074,"threshold_uncertainty_score":0.3635951},"labels":[],"label_agreement":null},{"id":"W2507530438","doi":"10.1158/0008-5472.can-16-0266","title":"Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis","year":2016,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Metastasis; Biology; Plasticity; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.07222057186626829,"score_gpt":0.41726904982802104,"score_spread":0.34504847796175275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507530438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026740038,0.9952302,0.000021558686,0.000016865724,0.0004447645,0.0006459619,0.0006026634,0.000005833379,0.0003581304],"genre_scores_gemma":[0.0005659652,0.99606776,0.000059443053,0.000021743865,0.0017689723,0.00055828906,0.000026775355,0.00007337944,0.00085766765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972775,0.00042530085,0.00046482758,0.00074246,0.00046450042,0.0006254235],"domain_scores_gemma":[0.9986209,0.0001255099,0.00022042131,0.0004715553,0.00030735234,0.0002542328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006138513,0.00035921807,0.001361387,0.0002867222,0.00010554427,0.0000330908,0.0004969918,0.00025397673,0.00010607789],"category_scores_gemma":[0.0005303099,0.00024622478,0.00035997774,0.00031890054,0.0004965259,0.0000054976977,0.0005018625,0.00034988316,0.000019439245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070090515,0.000035589783,0.0000034109235,0.0063513205,0.00038747964,0.0000058352725,0.000017879707,2.9149872e-8,0.018819056,0.00029429447,0.0018664576,0.97214854],"study_design_scores_gemma":[0.0003253265,0.00012475149,0.000009112716,0.0021467444,0.00034692168,0.00005319489,0.000008182006,7.7230204e-8,0.027573815,0.000047611356,0.96909577,0.00026850533],"about_ca_topic_score_codex":0.00036799719,"about_ca_topic_score_gemma":0.000071634066,"teacher_disagreement_score":0.9718801,"about_ca_system_score_codex":0.000030095453,"about_ca_system_score_gemma":0.0015143498,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W2509111028","doi":"10.1158/0008-5472.can-16-0136","title":"Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Capecitabine; Medicine; Chemotherapy; In vivo; Cancer; Oncology; Pharmacology; Internal medicine; Cancer research; Colorectal cancer; Biology","score_opus":0.10186511112080873,"score_gpt":0.43537001063229597,"score_spread":0.3335048995114872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509111028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770724,0.013573202,0.00003516703,0.008081668,0.00006039754,0.0009837257,0.0000033387576,0.000014585442,0.00017549976],"genre_scores_gemma":[0.9921597,0.0068703126,0.000048239166,0.0003099521,0.00012818501,0.00030584735,6.008603e-7,0.000016787524,0.00016035548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982069,0.00034508418,0.00027765936,0.00030544875,0.00042046487,0.0004444461],"domain_scores_gemma":[0.9964699,0.0027085769,0.00006879176,0.0005876804,0.00011639153,0.000048614886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020954264,0.00011432341,0.00026511628,0.00017166609,0.0000725485,0.000016581227,0.0004427536,0.00008634425,0.00031375626],"category_scores_gemma":[0.00063775043,0.000055655968,0.000114220304,0.000647923,0.00050213706,0.00007289086,0.00006342436,0.00031657136,0.000022825756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038211169,0.00013256642,0.009442439,0.00008977964,0.000054753655,0.0000064782853,0.00034379444,2.0224348e-7,0.7802256,0.000048182028,0.00030026134,0.20553488],"study_design_scores_gemma":[0.005357889,0.0007278561,0.7505397,0.0020740903,0.00000949437,0.000008737249,0.00014258487,0.000003947812,0.23954433,0.000051136794,0.0014485702,0.000091613794],"about_ca_topic_score_codex":0.0006102685,"about_ca_topic_score_gemma":0.000030480895,"teacher_disagreement_score":0.74109733,"about_ca_system_score_codex":0.00044321027,"about_ca_system_score_gemma":0.00030880424,"threshold_uncertainty_score":0.34354112},"labels":[],"label_agreement":null},{"id":"W2510871939","doi":"10.1158/0008-5472.can-16-1571","title":"Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas; American Association for Cancer Research","keywords":"Intravasation; Oncomir; Carcinogenesis; Cancer research; Oncogene; Metastasis; PTEN; Metastasis Suppressor Gene; microRNA; Cancer; Tumor suppressor gene; Biology; Downregulation and upregulation; Suppressor; Breast cancer; Epithelial–mesenchymal transition; Medicine; PI3K/AKT/mTOR pathway; Gene; Signal transduction; Cell cycle; Cell biology; Genetics","score_opus":0.06721006629752968,"score_gpt":0.35439314720999865,"score_spread":0.28718308091246897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510871939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928527,0.005892299,0.0001960732,0.00045003826,0.0000415451,0.00021264933,0.0001324219,0.0000060442726,0.00021623434],"genre_scores_gemma":[0.99302816,0.00619712,0.0001930209,0.000016458625,0.000095501964,0.00019840043,0.000015061762,0.000019126777,0.00023713356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882567,0.00013770176,0.00017026707,0.00039670023,0.00021983303,0.00024983133],"domain_scores_gemma":[0.9990639,0.00006135234,0.00007704214,0.00036411805,0.00033156248,0.00010200192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031492897,0.00011242164,0.00015020024,0.0000909414,0.00011645065,0.000028474262,0.00016406427,0.000073525414,0.00003450044],"category_scores_gemma":[0.000106058316,0.00008140492,0.000032999775,0.0001342181,0.00015833142,0.000019787214,0.00016449022,0.00006609346,0.0000012436348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009993281,0.000024360597,0.0018451655,0.00004131689,0.000044706794,0.0000024122533,0.00005497346,0.000001670968,0.96945417,0.00026915205,0.00062902743,0.0275331],"study_design_scores_gemma":[0.0004022063,0.00014580673,0.008261917,0.00005096725,0.000012150485,0.0000092577275,0.00009822526,0.0000076142787,0.98468393,0.0002242577,0.005990192,0.000113465794],"about_ca_topic_score_codex":0.00023674851,"about_ca_topic_score_gemma":0.000050764174,"teacher_disagreement_score":0.027419636,"about_ca_system_score_codex":0.0000348552,"about_ca_system_score_gemma":0.00020659232,"threshold_uncertainty_score":0.3319596},"labels":[],"label_agreement":null},{"id":"W2512386861","doi":"10.1158/0008-5472.can-16-0584","title":"NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Thio-; Chemistry; Pharmacology; Hydrolysis; Cancer research; Medicine; Stereochemistry; Combinatorial chemistry; Biochemistry","score_opus":0.04125793781274631,"score_gpt":0.3821662443820351,"score_spread":0.34090830656928883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512386861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196255,0.0011364934,0.00043132954,0.0048360126,0.00022093397,0.00047435163,0.00004562781,0.000016203896,0.00087648677],"genre_scores_gemma":[0.9943879,0.001098804,0.00018237939,0.00027676424,0.0005051937,0.00019421909,0.0000048383718,0.000039320486,0.003310574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997974,0.00020888163,0.0002211649,0.0004494758,0.00060202176,0.0005444523],"domain_scores_gemma":[0.998463,0.00014971729,0.000051261268,0.0008127489,0.00035001777,0.0001732581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011227998,0.00013652243,0.0001704575,0.00009099321,0.00010596214,0.000017710805,0.0006965335,0.000117677635,0.000309312],"category_scores_gemma":[0.00066130026,0.000076488606,0.00009070621,0.00032895515,0.00030034746,0.000004567449,0.00043608018,0.00014917752,0.00010293735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025073014,0.000040059775,0.00040640272,0.000014934515,0.000054931654,0.000002502305,0.00011649864,0.000009903731,0.97871554,0.00038765426,0.008179733,0.011821091],"study_design_scores_gemma":[0.00064373977,0.0003536019,0.001903691,0.00006684788,0.000008222095,0.000002261958,0.000033168864,0.0000042909564,0.94299173,0.00026239955,0.05360933,0.00012073526],"about_ca_topic_score_codex":0.00012999444,"about_ca_topic_score_gemma":0.00011832608,"teacher_disagreement_score":0.0454296,"about_ca_system_score_codex":0.000056407887,"about_ca_system_score_gemma":0.0002904064,"threshold_uncertainty_score":0.33867493},"labels":[],"label_agreement":null},{"id":"W2512634266","doi":"10.1158/1538-7445.tme16-c06","title":"Abstract C06: Multi-lineage differentiation potential of carcinoma-associated fibroblasts isolated from primary tumors of metastatic prostate cancer patients","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"","keywords":"Metastasis; Pathology; Primary tumor; Cancer research; Mesenchymal stem cell; Prostate cancer; Cancer; CD90; Stroma; Carcinogenesis; Stromal cell; Prostate; Tumor microenvironment; Biology; Medicine; Tumor progression; Cell; Immunohistochemistry; CD44; Internal medicine","score_opus":0.04956639251163257,"score_gpt":0.35795732061138924,"score_spread":0.30839092809975666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512634266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939888,0.0018107106,0.00003291774,0.00037002272,0.00015765254,0.0015722504,0.0019846074,0.000032091953,0.000050942093],"genre_scores_gemma":[0.9958713,0.0014363474,0.00006239215,0.000014769903,0.000073848896,0.00029650462,0.00049444,0.00006406889,0.0016863329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99619174,0.00025557203,0.00073023577,0.0005459125,0.0015107956,0.0007657149],"domain_scores_gemma":[0.9969257,0.0002691412,0.00035426652,0.00041151285,0.0017598353,0.00027950728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048054702,0.00026187496,0.00069496385,0.00043505486,0.000116006944,0.00001951066,0.00024851706,0.00012703547,0.00088293874],"category_scores_gemma":[0.00022434202,0.00016840233,0.00017999226,0.00064278045,0.00042187536,0.000215769,0.0001708083,0.00039043595,0.000015152948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042146766,0.0013906722,0.30764323,0.0006987678,0.0006877171,0.000044963894,0.00063952425,0.00001634289,0.6746157,0.0000021679737,0.0005633782,0.0094828755],"study_design_scores_gemma":[0.010670934,0.0006626697,0.7589689,0.0013786842,0.00011823718,3.4816398e-7,0.00006646979,0.0001994951,0.22773877,0.000029349105,0.000018290282,0.00014789496],"about_ca_topic_score_codex":0.006032624,"about_ca_topic_score_gemma":0.0003548037,"teacher_disagreement_score":0.45132563,"about_ca_system_score_codex":0.0010594814,"about_ca_system_score_gemma":0.0012124925,"threshold_uncertainty_score":0.966756},"labels":[],"label_agreement":null},{"id":"W2512753852","doi":"10.1158/1538-7445.am2015-731","title":"Abstract 731: Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Medicine; LNCaP; Oncology; Cancer; Disease; Biology; Cancer research; Bioinformatics; Computational biology; Internal medicine","score_opus":0.12845619304502007,"score_gpt":0.47315546625779775,"score_spread":0.3446992732127777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512753852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980043,0.00807309,0.00006367295,0.006586861,0.00024789586,0.0024131918,0.00033394943,0.000050980158,0.0021873924],"genre_scores_gemma":[0.9775381,0.0023256156,0.00042640572,0.00014722496,0.00018610475,0.0025626482,0.00010794007,0.000062267565,0.016643697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9949106,0.0002793037,0.00066419726,0.0009905011,0.0019026496,0.0012527766],"domain_scores_gemma":[0.9965916,0.00012565292,0.000107750595,0.000672728,0.0015346847,0.000967561],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022404364,0.00034289394,0.000690339,0.0016546191,0.00021648905,0.0001530143,0.00039534824,0.00014619889,0.001094081],"category_scores_gemma":[0.0002793747,0.00026983226,0.00019367247,0.004309919,0.00021699542,0.00022550623,0.00018762186,0.0009120053,0.0001567264],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012486387,0.00054495176,0.025850171,0.00038230824,0.0022029546,0.0011020934,0.013066166,0.0018805079,0.9148884,0.00077990134,0.022375599,0.0044405665],"study_design_scores_gemma":[0.011089918,0.0014020132,0.6502618,0.001828506,0.0008284457,0.0000060163943,0.017493203,0.0002678746,0.28683195,0.005102952,0.02357879,0.0013084827],"about_ca_topic_score_codex":0.013264498,"about_ca_topic_score_gemma":0.075730115,"teacher_disagreement_score":0.6280564,"about_ca_system_score_codex":0.005134075,"about_ca_system_score_gemma":0.0031759893,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W2513824796","doi":"10.1158/0008-5472.sabcs12-p1-07-10","title":"Abstract P1-07-10: Comparison of three commercial ER/PR assays on a single clinical outcome series.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Alberta Health Services","funders":"","keywords":"Tissue microarray; Concordance; Tamoxifen; Medicine; Breast cancer; Immunohistochemistry; Internal medicine; Estrogen receptor; Oncology; Cohort; Cancer; Pathology; Gynecology","score_opus":0.33875013234363766,"score_gpt":0.5188132406932778,"score_spread":0.18006310834964018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513824796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883277,0.0029248279,0.0000165128,0.0010338903,0.00048232445,0.00028316607,0.00011880734,0.000013580698,0.006799209],"genre_scores_gemma":[0.9978293,0.00020362159,0.00008392905,0.00009595745,0.0011828874,0.00011344734,0.000052231237,0.00003294071,0.00040567692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979238,0.00015660787,0.00046062638,0.00035188827,0.00048406873,0.0006230293],"domain_scores_gemma":[0.99878037,0.00015010868,0.0001241494,0.00051258097,0.00025172278,0.00018107517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092989905,0.00018478271,0.00039756193,0.00006203275,0.00017261412,0.00001852017,0.00030783744,0.00020645365,0.00041972744],"category_scores_gemma":[0.0002551538,0.00015881233,0.00015564606,0.00013792935,0.0004961355,0.00001030133,0.00028361846,0.0003735029,0.00012262964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013134178,0.001172632,0.9221402,0.00006324035,0.00025317958,0.000002065417,0.0001436027,0.000009877124,0.01750962,0.00012621275,0.034342732,0.022923248],"study_design_scores_gemma":[0.0011753546,0.0007821735,0.87231517,0.000053159183,0.000032428256,0.0000018647432,0.00017536248,0.0000013205212,0.06383184,0.00003393925,0.061382502,0.00021488046],"about_ca_topic_score_codex":0.00042319167,"about_ca_topic_score_gemma":0.0011897237,"teacher_disagreement_score":0.049824998,"about_ca_system_score_codex":0.00013005978,"about_ca_system_score_gemma":0.0001424334,"threshold_uncertainty_score":0.6476179},"labels":[],"label_agreement":null},{"id":"W2515802788","doi":"","title":"Expression of kruppel-like factor 5 mediates anchorage-independent growth and good prognosis in human lung cancer.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Gene knockdown; MAPK/ERK pathway; Cancer research; Biology; Transcription factor; Cell growth; Carcinogenesis; Cell cycle; Signal transduction; Cell; Cancer; Cell culture; Cell biology; Gene; Genetics","score_opus":0.047501534557894944,"score_gpt":0.38700121281128913,"score_spread":0.33949967825339417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515802788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153185,0.007088614,0.000012665069,0.00018029762,0.00009076361,0.00071563316,0.00013870379,0.000010981118,0.00023046533],"genre_scores_gemma":[0.991011,0.0076483954,0.000038114576,0.000015684918,0.00021801757,0.000507928,0.000050343715,0.00004927567,0.0004612175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968334,0.0003395897,0.0003474377,0.00070318603,0.00097372703,0.00080268324],"domain_scores_gemma":[0.9987972,0.000068363086,0.00008239385,0.00038024544,0.00040152497,0.00027032275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046887383,0.00021812679,0.00030725257,0.0003311508,0.00019847568,0.000031212137,0.0005069149,0.00027790552,0.0002435459],"category_scores_gemma":[0.00017940572,0.00019726568,0.00006965609,0.00044826846,0.00047385046,0.000019572453,0.0005919645,0.00057278835,0.000002016178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009349097,0.00008609656,0.38010743,0.00016291441,0.000022847458,0.000017741431,0.0002487122,0.00000543757,0.61763316,0.0000049342557,0.0013404172,0.00027680615],"study_design_scores_gemma":[0.00084398116,0.0002552383,0.12608805,0.00013709739,0.0000036386998,0.0000049938353,0.00011705669,0.000015216154,0.8719224,0.000017076933,0.0004098505,0.00018543223],"about_ca_topic_score_codex":0.0027047682,"about_ca_topic_score_gemma":0.001063769,"teacher_disagreement_score":0.25428918,"about_ca_system_score_codex":0.00014936301,"about_ca_system_score_gemma":0.00055019365,"threshold_uncertainty_score":0.80442613},"labels":[],"label_agreement":null},{"id":"W2517493006","doi":"10.1158/0008-5472.can-15-3196","title":"An Integrated Nanotechnology-Enabled Transbronchial Image-Guided Intervention Strategy for Peripheral Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Canada Foundation for Innovation","keywords":"Medicine; Lung cancer; Peripheral; Lung; Cancer; In vivo; Pathology; Photothermal therapy; Ablation; Treatment of lung cancer; Radiology; Internal medicine; Biology; Materials science; Nanotechnology","score_opus":0.04741430579506813,"score_gpt":0.38188023961510836,"score_spread":0.33446593382004025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517493006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8673194,0.0028903836,0.1254296,0.0003897114,0.0010930944,0.0014291063,0.000555701,0.0007166287,0.00017635887],"genre_scores_gemma":[0.9945834,0.0009983846,0.00070401223,0.000015894144,0.00041764704,0.0020298555,0.000033657925,0.00014781115,0.0010693123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770886,0.000066210836,0.00040741538,0.00044218183,0.00037657752,0.0009987814],"domain_scores_gemma":[0.9987426,0.00009077459,0.000038629616,0.0004504394,0.0005003521,0.00017722363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005957718,0.0002759371,0.00031333783,0.00031439745,0.0001894641,0.000114770686,0.0005985135,0.00029679263,0.0014910531],"category_scores_gemma":[0.000054666754,0.00020711191,0.00014464042,0.0005311348,0.00026154824,0.00062299625,0.00002952193,0.0004809835,0.000011356092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031319386,0.00003937543,0.000145978,0.0002940627,0.00015129018,0.000004968706,0.0001715425,0.0020595875,0.8710552,0.00032015023,0.0063459547,0.11909873],"study_design_scores_gemma":[0.006752576,0.000657632,0.00021607587,0.0008047613,0.000066955756,0.000006387915,0.00034369694,0.029718708,0.9313977,0.0025510537,0.026745187,0.00073926355],"about_ca_topic_score_codex":0.00073430367,"about_ca_topic_score_gemma":0.0021490918,"teacher_disagreement_score":0.12726401,"about_ca_system_score_codex":0.0018869689,"about_ca_system_score_gemma":0.00030886833,"threshold_uncertainty_score":0.9994217},"labels":[],"label_agreement":null},{"id":"W2518518788","doi":"","title":"Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Paclitaxel; Prodrug; Drug; Pharmacokinetics; Pharmacology; Drug delivery; Chemistry; In vivo; Bioavailability; Micelle; Drug carrier; Targeted drug delivery; Cancer; Aqueous solution; Medicine; Organic chemistry","score_opus":0.09150125931938934,"score_gpt":0.4202588927023295,"score_spread":0.3287576333829402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518518788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950334,0.0011270394,0.000051110263,0.0011853002,0.000039896313,0.0023067968,0.000020613465,0.000020605085,0.0002152505],"genre_scores_gemma":[0.992539,0.0003311937,0.0010284705,0.00003503573,0.000060019494,0.00462408,0.00006158073,0.000016124253,0.0013045229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987944,0.000060041257,0.00029430696,0.00024513027,0.0003062106,0.00029993037],"domain_scores_gemma":[0.999181,0.0001635295,0.000051996503,0.00015981044,0.0003521222,0.00009154732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036543672,0.00008687704,0.00020765574,0.00021402998,0.00017707857,0.000004560692,0.00009237593,0.00004556339,0.00005808175],"category_scores_gemma":[0.000022553113,0.00008014053,0.000037529117,0.0004707258,0.0001562966,0.000043984084,0.00003242666,0.00013908769,0.000015308835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009574767,0.0012781811,0.005052744,0.00028874498,0.00007619321,0.000008672714,0.0059152115,0.00003675107,0.97249866,0.00046314776,0.0036656493,0.009758555],"study_design_scores_gemma":[0.006616022,0.00028803115,0.015648302,0.0000800469,0.0000284739,0.0000051019883,0.00037970766,0.00023020113,0.95831096,0.00016252228,0.018136518,0.00011411726],"about_ca_topic_score_codex":0.00019587463,"about_ca_topic_score_gemma":0.00039449934,"teacher_disagreement_score":0.014470869,"about_ca_system_score_codex":0.00052089273,"about_ca_system_score_gemma":0.0008873425,"threshold_uncertainty_score":0.3268036},"labels":[],"label_agreement":null},{"id":"W2518656184","doi":"10.1158/1538-7445.am2015-3661","title":"Abstract 3661: Development of novel small-molecule inhibitors of ETS oncoproteins as anti-prostate cancer agents","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prostate cancer; TMPRSS2; Erg; Cancer research; Cancer; Prostate; Chromoplexy; Medicine; Biology; Internal medicine; PCA3","score_opus":0.2218284548490204,"score_gpt":0.4605774152983867,"score_spread":0.2387489604493663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518656184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887456,0.0043934607,0.0000058737555,0.0013368871,0.0002185716,0.0015867732,0.00009378287,0.00002672592,0.0035922893],"genre_scores_gemma":[0.9947411,0.0012568895,0.00037064435,0.000052435094,0.00016993604,0.00056227105,0.000043602664,0.000061764214,0.0027413794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960539,0.00007226026,0.00060775457,0.00051268237,0.0018900953,0.0008633142],"domain_scores_gemma":[0.996971,0.0000540373,0.00017410942,0.00046917232,0.0017117662,0.0006198898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013166443,0.00024120513,0.00054507115,0.00050821045,0.0001295059,0.00002535046,0.00031825472,0.00015869169,0.00050401274],"category_scores_gemma":[0.00014455432,0.00019155031,0.000107479114,0.00097106287,0.00047278628,0.00010145992,0.00027606607,0.0005956979,0.00004553407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034605977,0.0017855637,0.07288853,0.0022768744,0.0009066186,0.0002627119,0.012782208,0.00012439786,0.8305074,0.000052287694,0.009581314,0.06537149],"study_design_scores_gemma":[0.0063637453,0.0005059139,0.035250366,0.0011549081,0.000030392563,0.0000047343206,0.0015205455,0.00002019088,0.94700736,0.00001907732,0.007928269,0.00019449831],"about_ca_topic_score_codex":0.006018364,"about_ca_topic_score_gemma":0.00050174724,"teacher_disagreement_score":0.116499946,"about_ca_system_score_codex":0.0011217003,"about_ca_system_score_gemma":0.008275749,"threshold_uncertainty_score":0.9973464},"labels":[],"label_agreement":null},{"id":"W2518731549","doi":"","title":"Comparison of physicochemical characteristics and stability of three novel formulations of paclitaxel: Abraxane, Nanoxel, and Genexol PM","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Diluent; Chromatography; Chemistry; Particle size; Nuclear chemistry; Medicine; Surgery; Chemotherapy","score_opus":0.26442089054524215,"score_gpt":0.4898383494715776,"score_spread":0.22541745892633547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518731549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974205,0.0015357963,0.00004227133,0.0001997723,0.000026719357,0.00038271825,0.00019477464,0.0000043215978,0.00019312356],"genre_scores_gemma":[0.9989852,0.000608267,0.0002378044,0.000007734762,0.000066728084,0.000036593905,0.000022782211,0.000008569877,0.000026350854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991034,0.000026044167,0.00027937672,0.00016044584,0.0002633834,0.00016729382],"domain_scores_gemma":[0.9990588,0.00023254397,0.00009193586,0.0001670685,0.00035995836,0.00008972624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015954682,0.00007305223,0.00040266287,0.00007537075,0.000049006976,0.000001499329,0.000046667392,0.00005846759,0.000115151895],"category_scores_gemma":[0.000056176552,0.00006311333,0.00003590893,0.00017995537,0.000693867,0.00003458703,0.000062608655,0.00016028357,2.613019e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041609487,0.00038229025,0.4392956,0.0003298062,0.00005571932,6.9192146e-7,0.0006647666,2.1406616e-7,0.5574662,0.00010949683,0.00016296984,0.0011161357],"study_design_scores_gemma":[0.0016334644,0.0004682608,0.47779033,0.00006027303,0.000054639448,0.0000042217584,0.00006572967,0.00020669203,0.51938635,0.00007526395,0.00021214645,0.000042617517],"about_ca_topic_score_codex":0.0005036653,"about_ca_topic_score_gemma":0.00007984549,"teacher_disagreement_score":0.038494732,"about_ca_system_score_codex":0.00006252869,"about_ca_system_score_gemma":0.00023050357,"threshold_uncertainty_score":0.2573687},"labels":[],"label_agreement":null},{"id":"W2521128555","doi":"10.1158/0008-5472.can-16-0888","title":"Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Sunitinib; Regorafenib; Breast cancer; Colorectal cancer; Adjuvant; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.02482104140546537,"score_gpt":0.3362703836230723,"score_spread":0.31144934221760695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521128555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873683,0.009094411,0.00004268798,0.0027605717,0.00003342617,0.0004971999,0.00008960398,0.0000021572873,0.00011166694],"genre_scores_gemma":[0.9977885,0.0014451265,0.000037598973,0.00008053367,0.00027127803,0.0002605622,0.000005160868,0.000015090148,0.00009618812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998705,0.00027111758,0.00017929016,0.00028931064,0.0002130846,0.00034216203],"domain_scores_gemma":[0.99907905,0.00048745115,0.000058968646,0.00017244548,0.00015190933,0.000050152357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018394459,0.00009688149,0.00015232527,0.000035269833,0.00015925494,0.000025658775,0.00020542507,0.00008113935,0.000010444757],"category_scores_gemma":[0.00016862301,0.00004614874,0.00007033263,0.00011875797,0.00065433607,0.0000051750817,0.00012792778,0.0000804348,3.1369987e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004638331,0.00003257063,0.0249214,0.000063580424,0.00008711892,0.0000038728867,0.001052315,0.000009500019,0.9147626,0.0005799014,0.0020145457,0.051834263],"study_design_scores_gemma":[0.023949236,0.0017663244,0.30787507,0.00093206373,0.00006336068,0.00010821011,0.0021077644,0.00016378712,0.593762,0.0006674573,0.06787101,0.00073373824],"about_ca_topic_score_codex":0.0005223533,"about_ca_topic_score_gemma":0.0001964369,"teacher_disagreement_score":0.3210006,"about_ca_system_score_codex":0.00003779452,"about_ca_system_score_gemma":0.00020485952,"threshold_uncertainty_score":0.24109285},"labels":[],"label_agreement":null},{"id":"W2521926181","doi":"","title":"The cancer-testis antigen MAGE-A3 is a target of FGFR2 and fibronectin signaling in thyroid cancer progression","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; Thyroid cancer; Biology; Cancer; Tumor progression; Metastasis; Anaplastic thyroid cancer; Thyroid; Endocrinology; Genetics","score_opus":0.05121891709607745,"score_gpt":0.40126329518529885,"score_spread":0.3500443780892214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521926181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553793,0.042663738,0.000012945013,0.0010686486,0.00006219137,0.00057635107,0.00009059503,0.000007711589,0.0001385134],"genre_scores_gemma":[0.9755289,0.022559434,0.00018857513,0.000032903954,0.00020632308,0.00047205092,0.000011413136,0.00004384832,0.00095655915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972949,0.00031259755,0.00029009912,0.0005865055,0.00071693683,0.0007989462],"domain_scores_gemma":[0.9987916,0.00013645635,0.00008071657,0.0004330005,0.00039679298,0.00016148145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088907464,0.00017668153,0.00021717798,0.00014846388,0.00039868386,0.000043921107,0.000497936,0.00016584131,0.0001536338],"category_scores_gemma":[0.00024579858,0.0001336311,0.0000560308,0.0005585965,0.00073997484,0.0000129709515,0.0004835624,0.00050569506,0.0000033004178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033534123,0.000030682477,0.16546944,0.000106787404,0.000035647674,0.000011561249,0.0003329239,0.000053764008,0.82483923,0.0000042750944,0.00410896,0.0046713827],"study_design_scores_gemma":[0.00061081455,0.00034130822,0.04151167,0.0002552622,0.0000023935615,0.000007152142,0.000105575535,0.00012795404,0.9472757,0.00006353651,0.0095334435,0.00016521473],"about_ca_topic_score_codex":0.0035933186,"about_ca_topic_score_gemma":0.0009252647,"teacher_disagreement_score":0.123957776,"about_ca_system_score_codex":0.00012498692,"about_ca_system_score_gemma":0.00093445805,"threshold_uncertainty_score":0.5449318},"labels":[],"label_agreement":null},{"id":"W2523469334","doi":"10.1158/0008-5472.can-16-1518","title":"UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen receptor; Cancer research; Androgen; Tumor progression; Biology; Cell growth; Cancer; Prostate; Internal medicine; Endocrinology; Medicine; Biochemistry; Hormone","score_opus":0.06782664749403781,"score_gpt":0.42718711304914425,"score_spread":0.3593604655551064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523469334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98595655,0.0074382517,0.000021460839,0.0036553715,0.00011324932,0.0019368909,0.00015508757,0.000056305526,0.00066685304],"genre_scores_gemma":[0.99188596,0.0022480157,0.000103992825,0.000019554112,0.0003161675,0.0009498543,0.000033184286,0.00005504851,0.0043882267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958673,0.00023920632,0.00049817277,0.0006117898,0.001820795,0.000962752],"domain_scores_gemma":[0.997733,0.00030675385,0.00016000729,0.0003950932,0.0009823577,0.00042278922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017514311,0.00022224942,0.00038575774,0.0002969536,0.0002867872,0.000057859117,0.00022723385,0.00013400531,0.00032824412],"category_scores_gemma":[0.00024428347,0.00013102194,0.00010068106,0.00058009697,0.00047463004,0.00021825037,0.0001244135,0.0004329057,0.000021324298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018013709,0.00015270872,0.013233047,0.0004978004,0.00011782508,0.00008644023,0.0010272382,0.0000022888812,0.9417056,0.000029050958,0.004048256,0.03729837],"study_design_scores_gemma":[0.003262992,0.0012665472,0.0008854198,0.002791016,0.000028188015,0.000007307556,0.00077061716,0.000029009834,0.98822147,0.00009839395,0.0024742666,0.00016476007],"about_ca_topic_score_codex":0.0005652216,"about_ca_topic_score_gemma":0.00007250757,"teacher_disagreement_score":0.04651588,"about_ca_system_score_codex":0.0012888013,"about_ca_system_score_gemma":0.0021202962,"threshold_uncertainty_score":0.534292},"labels":[],"label_agreement":null},{"id":"W2528843175","doi":"10.1158/0008-5472.can-15-3475","title":"Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Rehabilitation Institute; University of Toronto; Princess Margaret Cancer Centre; Ontario Drug Policy Research Network","funders":"","keywords":"Radiation therapy; Tumor microenvironment; Cancer research; Hypoxia (environmental); Tumor hypoxia; Medicine; Apoptosis; Chemistry; Internal medicine; Oxygen; Tumor cells; Biochemistry","score_opus":0.028288900032652838,"score_gpt":0.32502788293111873,"score_spread":0.2967389828984659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528843175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764626,0.021723092,0.00016489915,0.0006537041,0.00046634686,0.0002835993,0.000091618276,0.000020994956,0.00013311452],"genre_scores_gemma":[0.9833715,0.011537004,0.000044908375,0.00019915239,0.0015654075,0.00019581648,0.000028211316,0.000044084267,0.0030138937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981783,0.0001872415,0.00019763278,0.00046715423,0.00038246304,0.0005872345],"domain_scores_gemma":[0.9991391,0.000030919196,0.00006144963,0.0004079259,0.00019387023,0.00016676601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056068297,0.0001470978,0.00014948627,0.000070091795,0.00018395876,0.0000456599,0.00026599772,0.00005899485,0.000117155265],"category_scores_gemma":[0.00012625498,0.000108464934,0.00008270272,0.00013116645,0.00015833369,0.000015209643,0.00010357075,0.00011218205,0.000034424433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014742864,0.000029743846,0.0004448439,0.000008970797,0.00003351743,0.0000017894007,0.000023287274,0.0000080122545,0.87095416,0.000019636105,0.017556064,0.11077255],"study_design_scores_gemma":[0.0009469886,0.00008050327,0.0027615335,0.000018280034,0.0000047408626,0.0000059292342,0.000015529813,0.000010930501,0.7871584,0.00013878173,0.20871635,0.00014202148],"about_ca_topic_score_codex":0.00028818473,"about_ca_topic_score_gemma":0.000034286095,"teacher_disagreement_score":0.19116029,"about_ca_system_score_codex":0.000061972445,"about_ca_system_score_gemma":0.00016833567,"threshold_uncertainty_score":0.44230717},"labels":[],"label_agreement":null},{"id":"W2530382286","doi":"10.1158/0008-5472.can-16-1371","title":"Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canadian Cancer Society","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Breast cancer; Biology; Tamoxifen; Cancer research; Single-nucleotide polymorphism; Estrogen receptor; Estrogen receptor alpha; Aromatase inhibitor; Genotype; Cancer; Genetics; Internal medicine; Gene; Medicine","score_opus":0.03966205710775598,"score_gpt":0.3692288297621367,"score_spread":0.3295667726543807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530382286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876758,0.0033422627,0.0006080547,0.004892734,0.00020103187,0.0022239604,0.0010418379,0.0000049780474,0.000009329008],"genre_scores_gemma":[0.9931974,0.0029631136,0.000040007428,0.0005075313,0.0004014047,0.002558449,0.00001080606,0.00006572704,0.00025559482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686223,0.0007103253,0.00033283632,0.0005720653,0.0007432854,0.0007792777],"domain_scores_gemma":[0.99813384,0.0004268025,0.000077946206,0.0007202231,0.00048729745,0.0001539216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019461996,0.00020788255,0.00019520851,0.0002506393,0.00021552855,0.000047796617,0.0009865408,0.00013925323,0.00019733621],"category_scores_gemma":[0.00027493708,0.000116904506,0.00014238214,0.00057481026,0.0002369413,0.000009012716,0.00028117304,0.00023953737,0.000010781495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00794291,0.00011571811,0.0008678668,0.000018923163,0.000096975986,0.000005612555,0.00023535211,0.00007292257,0.95289934,0.000003182835,0.0049413578,0.032799862],"study_design_scores_gemma":[0.0025748014,0.0005254701,0.030950315,0.00015084387,0.000013566344,0.0000055032974,0.00006861201,0.000020458836,0.9599124,0.000012260364,0.0055826865,0.000183034],"about_ca_topic_score_codex":0.000840175,"about_ca_topic_score_gemma":0.00037819022,"teacher_disagreement_score":0.032616828,"about_ca_system_score_codex":0.00032581095,"about_ca_system_score_gemma":0.00075676996,"threshold_uncertainty_score":0.47672275},"labels":[],"label_agreement":null},{"id":"W2534319025","doi":"10.1158/1538-7445.tme16-ia23","title":"Abstract IA23: Deconvolution of the triple-negative breast cancer microenvironment","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Tumor microenvironment; Triple-negative breast cancer; Stromal cell; Breast cancer; CD8; Gene signature; Immune system; Cancer; Cancer research; Medicine; Biology; Oncology; Immunology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.05274078397056778,"score_gpt":0.3774184741006233,"score_spread":0.32467769013005554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534319025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894174,0.0030275441,0.0000075752705,0.016150437,0.00029684446,0.0006780629,0.00025236342,0.000010176463,0.0006352482],"genre_scores_gemma":[0.988546,0.005888618,0.000011155066,0.00018327379,0.00020763515,0.00020189933,0.0000010234455,0.000019151435,0.0049412353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984857,0.00008926913,0.00023593691,0.00025097743,0.0005720425,0.00036608125],"domain_scores_gemma":[0.9991518,0.00012225441,0.000089412315,0.00038601196,0.00016409848,0.000086409695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005282934,0.00010457274,0.00017875808,0.00008856704,0.0001227343,0.000007902193,0.0002012603,0.00007371258,0.0042965272],"category_scores_gemma":[0.00004046542,0.000052674,0.00013235302,0.00030243583,0.0006810315,0.00006909316,0.0000691166,0.00021172984,0.000026663965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026940654,0.00008707462,0.03223178,0.000076821656,0.00015697225,0.0000021979315,0.00019252628,8.5215726e-7,0.860422,0.00001794776,0.008633645,0.09548412],"study_design_scores_gemma":[0.0024555984,0.0000649793,0.69423956,0.00065127737,0.000017278813,0.000008893391,0.00010056636,0.0000011920986,0.29228753,0.00006224181,0.010045629,0.000065286185],"about_ca_topic_score_codex":0.004421448,"about_ca_topic_score_gemma":0.0006993707,"teacher_disagreement_score":0.66200775,"about_ca_system_score_codex":0.001106186,"about_ca_system_score_gemma":0.0005446624,"threshold_uncertainty_score":0.9966137},"labels":[],"label_agreement":null},{"id":"W2535232402","doi":"10.1158/1538-7445.tme16-a15","title":"Abstract A15: Mechanisms of CD8+ T cell immunosuppression in triple negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Triple-negative breast cancer; Stromal cell; Cancer research; Cytotoxic T cell; CD8; Estrogen receptor; Breast cancer; Stroma; Tumor microenvironment; Medicine; Immune system; Cancer; Biology; Pathology; Immunology; Internal medicine; Immunohistochemistry","score_opus":0.04951582192889033,"score_gpt":0.3846278011184199,"score_spread":0.33511197918952956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535232402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892597,0.003399177,0.000043813274,0.0038263672,0.00033936862,0.0008491747,0.0002981559,0.00002225996,0.0019619563],"genre_scores_gemma":[0.99081445,0.0053474368,0.000053155687,0.00008014707,0.00012352344,0.00028175284,0.0000035892726,0.000033625947,0.0032623056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979124,0.0001156419,0.00037403448,0.0003560997,0.00070931565,0.00053249625],"domain_scores_gemma":[0.99882627,0.00020793661,0.00010482079,0.00038785854,0.00035150917,0.00012159264],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008364493,0.0001515245,0.0003325947,0.00033050013,0.000072505616,0.000012610313,0.00023387233,0.0001412193,0.006975131],"category_scores_gemma":[0.000042725955,0.000094796545,0.00011156863,0.00062634714,0.00028052393,0.00013933865,0.00007778347,0.0003439433,0.000024449844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067821704,0.00017146193,0.0025833016,0.00017400978,0.000054143344,0.000018273973,0.0003142946,0.0000010966334,0.9251279,0.000035394278,0.003487784,0.061250165],"study_design_scores_gemma":[0.006574201,0.00020833149,0.115385465,0.0017551294,0.0000108698305,0.00000603083,0.00032400986,0.0000045223824,0.8736214,0.0005389251,0.0014385588,0.00013253216],"about_ca_topic_score_codex":0.0095853945,"about_ca_topic_score_gemma":0.0007082092,"teacher_disagreement_score":0.11280216,"about_ca_system_score_codex":0.00070357416,"about_ca_system_score_gemma":0.00080256746,"threshold_uncertainty_score":0.9970099},"labels":[],"label_agreement":null},{"id":"W2536248479","doi":"10.1158/0008-5472.can-16-1699","title":"Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Leptin; Internal medicine; Medicine; Adipokine; Adiponectin; Endocrinology; Leptin receptor; Body mass index; Pancreatic cancer; Obesity; Cancer; Case-control study; Oncology; Insulin resistance","score_opus":0.07155307431059629,"score_gpt":0.33777532521504455,"score_spread":0.2662222509044483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536248479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719477,0.00037917402,0.00004989161,0.0009816079,0.00008204357,0.00046140782,0.00045681238,0.00003621991,0.00035805936],"genre_scores_gemma":[0.99260336,0.0027989666,0.00006557973,0.00003452449,0.00009737393,0.00016368894,9.329938e-7,0.000032390024,0.0042031906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732584,0.0005171325,0.00025840173,0.00052900164,0.0008350915,0.00053451763],"domain_scores_gemma":[0.99701864,0.0020703382,0.00017445415,0.0003128129,0.00023700214,0.00018676401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005419239,0.00015732035,0.00026275482,0.00017867549,0.00024001599,0.000043236738,0.00028847787,0.00009771872,0.002264601],"category_scores_gemma":[0.002079,0.00010292901,0.00003523259,0.00055814564,0.00077363144,0.0001536722,0.00011619195,0.00022255802,0.000052311887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020610624,0.000064159845,0.20049718,0.000033151384,0.000026667887,0.0000078957055,0.000250829,0.00006432807,0.77907115,0.000101030804,0.0011338367,0.018543666],"study_design_scores_gemma":[0.000966039,0.00024790654,0.4510912,0.0004418909,0.000017692097,0.000001773313,0.000021414447,0.00007641407,0.54628915,0.00013439645,0.0005774405,0.00013471681],"about_ca_topic_score_codex":0.0008128802,"about_ca_topic_score_gemma":0.0005920004,"teacher_disagreement_score":0.25059402,"about_ca_system_score_codex":0.00023432814,"about_ca_system_score_gemma":0.00034427582,"threshold_uncertainty_score":0.99864745},"labels":[],"label_agreement":null},{"id":"W2536412330","doi":"10.1158/1538-7445.tme16-a18","title":"Abstract A18: Investigating the differential expressions of miRNAs and programmed-death-ligand-1 related to the T-bet positive tumor-infiltrating lymphocytes in axillary-node-negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Tumor-infiltrating lymphocytes; Cancer research; Tumor microenvironment; Medicine; microRNA; Cancer; Biology; Immunotherapy; Internal medicine; Gene","score_opus":0.04818138646503195,"score_gpt":0.37586560232068045,"score_spread":0.3276842158556485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536412330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793123,0.0019534773,0.0000038525195,0.016749388,0.00010647627,0.0013445703,0.00020436467,0.000021512225,0.00030405397],"genre_scores_gemma":[0.997723,0.0008909317,0.000042019692,0.0003114211,0.00014074687,0.00062410027,0.000004331976,0.000033909968,0.00022953984],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760777,0.00026865446,0.00045246084,0.00040454193,0.0006756337,0.0005909362],"domain_scores_gemma":[0.99802935,0.0009301123,0.00015103522,0.00035922864,0.00034584716,0.00018443236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009844553,0.00020400755,0.00031678143,0.00016258702,0.00036541524,0.000063326195,0.00027673994,0.000093424744,0.00027900928],"category_scores_gemma":[0.0003341064,0.00009383483,0.000082669845,0.0007296836,0.0008115997,0.000118351614,0.00016246883,0.00046166813,0.0000035009928],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017464563,0.000075107855,0.07485519,0.00010109343,0.00021070297,0.000020333742,0.0062602134,0.000006721596,0.85699034,0.000077305755,0.0006762737,0.058980275],"study_design_scores_gemma":[0.0031951645,0.00018160051,0.69883066,0.004559249,0.000030133968,0.000048399066,0.0022519527,0.000039549068,0.29026777,0.00016399992,0.00026387628,0.00016766439],"about_ca_topic_score_codex":0.013250039,"about_ca_topic_score_gemma":0.0013293141,"teacher_disagreement_score":0.62397546,"about_ca_system_score_codex":0.00048773582,"about_ca_system_score_gemma":0.0007879845,"threshold_uncertainty_score":0.9933208},"labels":[],"label_agreement":null},{"id":"W2539021942","doi":"10.1158/0008-5472.can-16-0860","title":"Big Data–Led Cancer Research, Application, and Insights","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Big data; Key (lock); Cancer; Irish; Data science; Precision medicine; Computer science; Computational biology; Medicine; Biology; Data mining; Pathology; Internal medicine","score_opus":0.11334891176990333,"score_gpt":0.4133608200046128,"score_spread":0.30001190823470947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539021942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97194934,0.017321205,0.0026465289,0.0044137225,0.00028602936,0.000725363,0.00020760788,0.000014876062,0.0024353417],"genre_scores_gemma":[0.9779717,0.01755335,0.000096925,0.00013629853,0.0009414161,0.00032572984,0.000065102526,0.000023917011,0.0028855752],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983448,0.00013834467,0.00017697805,0.00047590374,0.0003650202,0.00049898686],"domain_scores_gemma":[0.99830586,0.00006863535,0.000034090262,0.0009854787,0.00042661413,0.00017933517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012233852,0.00009475997,0.000108012646,0.00010263903,0.00026973162,0.000055263852,0.0006319257,0.00015149509,0.00003657923],"category_scores_gemma":[0.00009378828,0.0000661821,0.000017340511,0.00025032225,0.0004788621,0.00000932164,0.0009381765,0.00023149519,0.0000373595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011153603,0.000022390439,0.0006138506,0.00004373175,0.000053970125,0.0000011256082,0.0001404419,0.0000039052006,0.6314988,0.00075565977,0.073462985,0.2932916],"study_design_scores_gemma":[0.00071188086,0.000103176884,0.00096438086,0.00007209377,0.0000048613015,0.0000024640574,0.00011415377,0.0001546128,0.04837826,0.003079784,0.9462329,0.00018141158],"about_ca_topic_score_codex":0.00039585732,"about_ca_topic_score_gemma":0.0014898115,"teacher_disagreement_score":0.87276995,"about_ca_system_score_codex":0.00005991154,"about_ca_system_score_gemma":0.0004008807,"threshold_uncertainty_score":0.26988277},"labels":[],"label_agreement":null},{"id":"W2539221388","doi":"10.1158/0008-5472.can-16-2032","title":"Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Tissue transglutaminase; Cancer research; Cell biology; Cancer stem cell; YAP1; Cancer cell; Cancer; Stem cell; Integrin; Biology; Cell; CD44; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Chemistry; Transcription factor; Biochemistry; Enzyme; Genetics","score_opus":0.04163973397571593,"score_gpt":0.34676375915560936,"score_spread":0.30512402517989345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539221388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894985,0.00062891934,0.00888356,0.00028894743,0.00008203666,0.00041805254,0.000060944098,0.000014033882,0.00012501978],"genre_scores_gemma":[0.99780005,0.0007404204,0.000040516756,0.000025508132,0.00011577537,0.0002131764,0.00001580987,0.000025842415,0.0010228722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987304,0.00013470808,0.00016289894,0.00039486968,0.0002714879,0.00030562276],"domain_scores_gemma":[0.9992918,0.000041938325,0.000043464548,0.00017580006,0.0002952209,0.00015180533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041227182,0.00013729102,0.00013223056,0.000094279865,0.0001269319,0.00005365896,0.0000907486,0.00007433105,0.00004162266],"category_scores_gemma":[0.00001557901,0.000094762254,0.000018735835,0.00012264821,0.00010366906,0.000026303313,0.00005175953,0.0001265745,0.0000055531495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009478376,0.000025573614,0.0008690582,0.000096813994,0.000012132653,0.0000019560441,0.0005663776,0.0003106686,0.9797993,0.000010152166,0.000022409507,0.01733772],"study_design_scores_gemma":[0.0011541513,0.00056053704,0.00032113865,0.00018467364,0.000009536341,0.000003342162,0.00065755274,0.000101549114,0.99588543,0.000007790078,0.0009573924,0.00015690546],"about_ca_topic_score_codex":0.0002623511,"about_ca_topic_score_gemma":0.001670141,"teacher_disagreement_score":0.017180815,"about_ca_system_score_codex":0.000105854684,"about_ca_system_score_gemma":0.00013655724,"threshold_uncertainty_score":0.38642925},"labels":[],"label_agreement":null},{"id":"W2544530174","doi":"10.1158/0008-5472.can-15-3231","title":"Enhanced Detection of Cancer Biomarkers in Blood-Borne Extracellular Vesicles Using Nanodroplets and Focused Ultrasound","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Extracellular vesicle; HT1080; Extracellular; Biology; Fibrosarcoma; Sonication; Vesicle; Extracellular vesicles; Cancer research; Molecular biology; Microvesicles; Cell biology; Chemistry; Biochemistry; microRNA; Gene; Genetics","score_opus":0.030568534769992602,"score_gpt":0.34395359223351313,"score_spread":0.3133850574635205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544530174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728779,0.025671376,0.00089163694,0.00008057467,0.00007874068,0.00031542353,0.00004472049,0.000007184895,0.000032411066],"genre_scores_gemma":[0.9950712,0.00430102,0.00018397131,0.000007906795,0.00011918254,0.00009852837,0.0000036759443,0.000037731814,0.00017678332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982593,0.00023253239,0.00026820882,0.00049861416,0.0003004775,0.00044083814],"domain_scores_gemma":[0.9991303,0.000083179686,0.00008624763,0.00037712004,0.00018854527,0.00013460578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006054471,0.00014450685,0.00016258062,0.00016393556,0.00008195517,0.000019709254,0.00020831951,0.00015775465,0.00006202823],"category_scores_gemma":[0.00023281487,0.00012172675,0.00005229251,0.00031048083,0.0004575579,0.0000131566685,0.000117854135,0.00011256813,0.0000016007533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002963849,0.00007203998,0.006344707,0.00007400173,0.00009634919,0.000010438376,0.00005118792,0.000012395575,0.9698505,0.000016883714,0.00001661309,0.023158533],"study_design_scores_gemma":[0.0012587344,0.00011407177,0.0055963662,0.00016864137,0.00002356892,0.0000043317928,0.000047156456,0.000017674933,0.99211675,0.00017031435,0.0003187108,0.00016369352],"about_ca_topic_score_codex":0.0008918991,"about_ca_topic_score_gemma":0.00094183034,"teacher_disagreement_score":0.02299484,"about_ca_system_score_codex":0.00009043587,"about_ca_system_score_gemma":0.0002359488,"threshold_uncertainty_score":0.49638727},"labels":[],"label_agreement":null},{"id":"W2549800333","doi":"10.1158/0008-5472.can-16-1873","title":"PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Trastuzumab; Immune system; Cancer research; Monoclonal antibody; Immunotherapy; Breast cancer; Medicine; Immunology; CD8; Cancer; CpG site; Acquired immune system; Innate immune system; Immune checkpoint; Antibody; Biology; Internal medicine","score_opus":0.04022546538509793,"score_gpt":0.3621033141185209,"score_spread":0.321877848733423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549800333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436475,0.0036731577,0.000035584064,0.010120771,0.00006568153,0.0013132727,0.00020495658,0.00001999286,0.00020184048],"genre_scores_gemma":[0.9946817,0.0013722489,0.00015384943,0.000036112335,0.00017575592,0.0006859901,0.0000046926093,0.000040870873,0.002848743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832225,0.000051478262,0.00032282696,0.0003742993,0.00044177836,0.00048735685],"domain_scores_gemma":[0.99888587,0.00013945969,0.00006772399,0.00038935855,0.00031258108,0.0002049831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047654528,0.00016665636,0.00041606496,0.00024861368,0.00011132389,0.000018131259,0.00009205748,0.000060131446,0.00023170683],"category_scores_gemma":[0.000034431585,0.000089711,0.00010236099,0.00039929317,0.0003746227,0.000052299933,0.00003716839,0.000052099564,0.0000032924397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02458091,0.00017369975,0.002997148,0.00017384776,0.00022598603,0.000022784734,0.0003334942,3.1198357e-7,0.91797024,0.00006244378,0.0005463146,0.052912842],"study_design_scores_gemma":[0.011230122,0.006333421,0.09273808,0.001926551,0.000054204404,0.00007070795,0.0005116644,0.0000019460551,0.8708405,0.000043109718,0.016049547,0.00020018287],"about_ca_topic_score_codex":0.0025304486,"about_ca_topic_score_gemma":0.00025497575,"teacher_disagreement_score":0.08974093,"about_ca_system_score_codex":0.00062941044,"about_ca_system_score_gemma":0.0005433962,"threshold_uncertainty_score":0.38252982},"labels":[],"label_agreement":null},{"id":"W2551547026","doi":"10.1158/1538-7445.am2015-sy08-03","title":"Abstract SY08-03: Targeting chromatin regulation for cancer therapy: progress towards chemical probes for methyl-lysine readers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"","keywords":"Epigenetics; Computational biology; Chromatin; Biology; Small molecule; Drug discovery; Cell biology; Chemistry; Genetics; Biochemistry; Gene","score_opus":0.10991462225990885,"score_gpt":0.4304167817705773,"score_spread":0.32050215951066846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551547026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96275383,0.025279675,0.003639261,0.004540642,0.00038218749,0.0030437768,0.00014923928,0.000048493705,0.00016291042],"genre_scores_gemma":[0.98850304,0.0007803073,0.0031548433,0.00004349381,0.0018196871,0.0041696844,0.0006574132,0.00008522344,0.0007863158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792355,0.00007923066,0.0003240141,0.0005967721,0.0004816246,0.0005948094],"domain_scores_gemma":[0.99806523,0.000043413675,0.00013799116,0.00032673666,0.0012549469,0.00017169908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013334696,0.00019979091,0.00022727606,0.00010215624,0.00015358403,0.00006384783,0.00026417727,0.00030277393,0.000046856552],"category_scores_gemma":[0.00024970196,0.00018439691,0.00012604489,0.00027489784,0.00026917265,0.0000179669,0.00007414296,0.00017182107,0.0000027859967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001029804,0.000048005986,0.00009356136,0.00015468315,0.00012091146,1.881913e-7,0.00026975886,0.0012385123,0.85513103,0.000023012388,0.029838916,0.112051636],"study_design_scores_gemma":[0.001702222,0.0002535867,0.00044515292,0.000100825935,0.000017366927,0.0000010170597,0.00020535589,0.0018056723,0.9165835,0.00043117834,0.07822202,0.0002321025],"about_ca_topic_score_codex":0.0003322955,"about_ca_topic_score_gemma":0.00011210333,"teacher_disagreement_score":0.11181953,"about_ca_system_score_codex":0.0004054401,"about_ca_system_score_gemma":0.0010113583,"threshold_uncertainty_score":0.7519487},"labels":[],"label_agreement":null},{"id":"W2552702441","doi":"10.1158/0008-5472.can-16-2060","title":"Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Actin cytoskeleton; Cancer; Cell biology; Metastasis; Cancer research; Biology; Cancer cell; Cytoskeleton; Cell; Genetics","score_opus":0.08945704130337077,"score_gpt":0.3838074465223228,"score_spread":0.294350405218952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552702441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957415,0.0012915989,0.00023403297,0.002022442,0.000056744553,0.0003266396,0.00007879902,0.0000036083916,0.0002446412],"genre_scores_gemma":[0.9948385,0.0037386317,0.00014657286,0.00006645335,0.0001294471,0.000083587605,0.000010832118,0.000016204078,0.00096979813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898815,0.0001549807,0.00013711097,0.00027099127,0.00021981692,0.00022897046],"domain_scores_gemma":[0.99932283,0.000032847267,0.00006533826,0.00033832842,0.00020240791,0.0000382302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028361322,0.00008687327,0.00011051938,0.000028866361,0.00012040304,0.000013488844,0.0001995507,0.000089218396,0.00010346369],"category_scores_gemma":[0.00009123379,0.00004956634,0.000047654004,0.00013906507,0.0002644136,0.000007862638,0.0002446004,0.000086398584,0.0000015478793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006641086,0.000018376457,0.0025323315,0.00004555065,0.00003712449,1.0416168e-7,0.000074411044,0.0000034172454,0.97625023,0.00015414685,0.0032177286,0.017600145],"study_design_scores_gemma":[0.00034973695,0.00007411932,0.012564654,0.000095867275,0.000010660844,0.0000013824014,0.00003613892,0.000008822535,0.9506619,0.0003115256,0.035812456,0.000072746705],"about_ca_topic_score_codex":0.0006088626,"about_ca_topic_score_gemma":0.00083686,"teacher_disagreement_score":0.03259473,"about_ca_system_score_codex":0.00004679334,"about_ca_system_score_gemma":0.00016856268,"threshold_uncertainty_score":0.20212567},"labels":[],"label_agreement":null},{"id":"W2553390583","doi":"10.1158/0008-5472.can-16-1359","title":"Dietary Emulsifier–Induced Low-Grade Inflammation Promotes Colon Carcinogenesis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Crohn's and Colitis Foundation; U.S. Department of Veterans Affairs","keywords":"Inflammation; Colorectal cancer; Carcinogenesis; Gut flora; Cancer; Inflammatory bowel disease; Microbiome; Colitis; Immunology; Cancer research; Mouse model of colorectal and intestinal cancer; Medicine; Ulcerative colitis; Biology; Disease; Internal medicine; Bioinformatics","score_opus":0.08861770049874781,"score_gpt":0.3973975950989828,"score_spread":0.308779894600235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553390583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954439,0.0009113913,0.000015447715,0.002842538,0.00012577447,0.00040144875,0.000032436492,0.000012692324,0.00021437097],"genre_scores_gemma":[0.99674314,0.0010415354,0.000033225813,0.00006383629,0.00057738443,0.0001460907,0.00003244921,0.000024606537,0.0013377464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858737,0.00017742165,0.00016217468,0.00037090757,0.00021525218,0.000486858],"domain_scores_gemma":[0.9992042,0.000027279775,0.0000382992,0.00035444295,0.00023918695,0.0001365828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042171107,0.000108049586,0.00011380137,0.000085432934,0.00017956964,0.000021603877,0.00022073652,0.00016608044,0.00009281437],"category_scores_gemma":[0.00009580505,0.000078414,0.000050665534,0.00015516538,0.00010678414,0.000005832891,0.00012906817,0.00011943293,0.00006277134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009412108,0.000024019168,0.002898361,0.00006578802,0.000020966047,0.0000031695408,0.000069431866,6.206881e-7,0.9764322,0.000018481705,0.0023811194,0.017991735],"study_design_scores_gemma":[0.00045248508,0.00025467394,0.020942075,0.000062035484,0.0000040260693,0.0000030933377,0.000028619683,0.000002179386,0.9672317,0.000058828304,0.0108431075,0.00011721384],"about_ca_topic_score_codex":0.00028629968,"about_ca_topic_score_gemma":0.00044040722,"teacher_disagreement_score":0.018043714,"about_ca_system_score_codex":0.00009902757,"about_ca_system_score_gemma":0.00036650425,"threshold_uncertainty_score":0.319763},"labels":[],"label_agreement":null},{"id":"W2553579322","doi":"10.1158/1538-7445.am2015-4093","title":"Abstract 4093: Cadherin “switch” and ovarian cancer: Studies using in vitro models and patient samples","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Downregulation and upregulation; Metastasis; Epithelial–mesenchymal transition; Mesenchymal stem cell; Cadherin; Cancer research; Ovarian cancer; Cancer; Primary tumor; Biology; Ovarian tumor; Cell; Medicine; Pathology; Internal medicine","score_opus":0.4127630877697134,"score_gpt":0.4868159687511173,"score_spread":0.07405288098140395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553579322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94314355,0.054557443,0.00003954082,0.0014392079,0.00014598167,0.00047922085,0.000037020905,0.000014917447,0.00014312574],"genre_scores_gemma":[0.9876167,0.0112188645,0.00053137075,0.00019084066,0.00016963563,0.00017342418,0.0000020627394,0.000028793584,0.000068277666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984929,0.000052871485,0.00020672372,0.00035346826,0.00046733813,0.00042669114],"domain_scores_gemma":[0.9991478,0.00006707627,0.00003880975,0.00018549066,0.00029883886,0.00026203808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005427765,0.0001355073,0.00034179792,0.00019451925,0.00009665568,0.000039011884,0.00005606403,0.000069396214,0.00004150689],"category_scores_gemma":[0.00004405268,0.00011290138,0.000021518636,0.00026096782,0.00016598274,0.00015085656,0.0001112535,0.00033817877,7.4719895e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049902517,0.0001860021,0.0038138258,0.00064943585,0.00035607629,0.00023218262,0.027799662,0.0010766792,0.58922404,0.0014288608,0.0010321185,0.3692109],"study_design_scores_gemma":[0.049248602,0.004498056,0.03416023,0.007633904,0.00030330045,0.0002710097,0.10155197,0.027397154,0.59062076,0.112946525,0.068394475,0.0029740315],"about_ca_topic_score_codex":0.02418066,"about_ca_topic_score_gemma":0.0021500003,"teacher_disagreement_score":0.36623687,"about_ca_system_score_codex":0.0006424692,"about_ca_system_score_gemma":0.00056240667,"threshold_uncertainty_score":0.9823174},"labels":[],"label_agreement":null},{"id":"W2554916046","doi":"10.1158/0008-5472.can-16-1204","title":"Androgen-Dependent Repression of ERRγ Reprograms Metabolism in Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Prostate cancer; Cancer research; Prostate; Androgen receptor; Cancer; Biology; Androgen; Cancer cell; Endocrinology; Internal medicine; Medicine; Hormone","score_opus":0.09417733955383542,"score_gpt":0.4526365801995482,"score_spread":0.3584592406457128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554916046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959777,0.03194292,0.000003326237,0.0049663065,0.00017180177,0.0016067947,0.000089024965,0.000038609476,0.0014042023],"genre_scores_gemma":[0.9480614,0.033246614,0.000051703,0.00003218579,0.00019177693,0.0016371611,0.000009310189,0.000046577014,0.016723257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99632627,0.00025358013,0.00043258513,0.0007136358,0.0013529301,0.00092100946],"domain_scores_gemma":[0.9980436,0.00013991585,0.0000864569,0.0007348535,0.0006840816,0.00031107143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015310986,0.00018158821,0.00047596192,0.0004969287,0.00009296858,0.000022598584,0.00024569832,0.00011490541,0.0012261629],"category_scores_gemma":[0.00019854709,0.000102349775,0.00010393291,0.00094953366,0.00047537478,0.00016397782,0.00023966428,0.00045619928,0.000033764834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048887036,0.00044842658,0.20470132,0.00042089802,0.00018011032,0.00033369064,0.000948237,0.0000057951966,0.46339038,0.0001329393,0.0025857894,0.32196373],"study_design_scores_gemma":[0.011222361,0.0004941808,0.059046645,0.0029887555,0.000049969974,0.000020069801,0.0003587241,0.000015218038,0.8951276,0.0007663164,0.029660767,0.00024940656],"about_ca_topic_score_codex":0.0036598535,"about_ca_topic_score_gemma":0.0005337575,"teacher_disagreement_score":0.4317372,"about_ca_system_score_codex":0.00065113715,"about_ca_system_score_gemma":0.0010894777,"threshold_uncertainty_score":0.99968684},"labels":[],"label_agreement":null},{"id":"W2557907098","doi":"10.1158/1538-7445.am2012-4737","title":"Abstract 4737: Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is Sirt1-independent","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Resveratrol; Neuroinflammation; Angiogenesis; Matrix metalloproteinase; Inflammation; Chemistry; Cancer research; Pharmacology; Blood–brain barrier; Gene silencing; Molecular biology; Biology; Biochemistry; Immunology; Central nervous system; Endocrinology; Gene","score_opus":0.06981234084031741,"score_gpt":0.3730360365512661,"score_spread":0.3032236957109487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557907098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98977596,0.004347178,0.0000054680954,0.0024617896,0.00019691658,0.00076314516,0.00005192458,0.000023003646,0.0023746213],"genre_scores_gemma":[0.99773717,0.0007290495,0.00008236312,0.00014497897,0.0007801957,0.00018316042,0.000014425338,0.00004166113,0.00028700463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973479,0.00016068447,0.00039874914,0.0003463641,0.0010288125,0.0007175064],"domain_scores_gemma":[0.9986247,0.00020552041,0.00012584268,0.00030114787,0.000394332,0.0003484463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019510648,0.00017375374,0.0003208033,0.00028110054,0.00016843968,0.000038149254,0.00013571333,0.00016366002,0.0009017034],"category_scores_gemma":[0.00018647233,0.00015253919,0.00010037891,0.00036059244,0.00013755122,0.00019539536,0.000102466125,0.00048519555,0.000026776168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005106839,0.00008502215,0.08652573,0.000505002,0.0000941962,0.000005425565,0.001724361,0.0000013246477,0.8920226,0.000021156096,0.0068180226,0.011686486],"study_design_scores_gemma":[0.0018339991,0.00024799444,0.08670812,0.00016457817,0.000039099476,0.0000040608143,0.00091340434,0.000043564745,0.9037443,0.000010948236,0.006145724,0.00014424097],"about_ca_topic_score_codex":0.0019503954,"about_ca_topic_score_gemma":0.00005299065,"teacher_disagreement_score":0.0117216725,"about_ca_system_score_codex":0.0003055137,"about_ca_system_score_gemma":0.00039698556,"threshold_uncertainty_score":0.98730195},"labels":[],"label_agreement":null},{"id":"W2559527154","doi":"10.1158/0008-5472.can-16-1502","title":"A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Neuroblastoma; Metastasis; Cancer research; Biology; In vivo; Gene expression profiling; Primary tumor; Cancer; Pediatric cancer; Gene signature; Medicine; Gene expression; Gene; Cell culture; Genetics","score_opus":0.17641470719051666,"score_gpt":0.4283050756318561,"score_spread":0.25189036844133944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559527154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917767,0.0009471876,0.0003495948,0.005084504,0.00007392393,0.0009059721,0.00017758319,0.0001210787,0.0005634249],"genre_scores_gemma":[0.9322578,0.0026298845,0.00041311467,0.00013339437,0.00007831329,0.000581537,0.0000064194387,0.000090782574,0.06380876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99574,0.00035848469,0.00026817105,0.00071663683,0.0017579594,0.0011587574],"domain_scores_gemma":[0.9975911,0.00034864608,0.00005594979,0.0008614344,0.0005100048,0.0006328716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069136213,0.0002583031,0.000422971,0.0006356593,0.00027093606,0.00010185602,0.0003320195,0.00005404295,0.0007614816],"category_scores_gemma":[0.0002765753,0.00015638632,0.0001900472,0.00055967487,0.0005049141,0.0003345631,0.0003072081,0.00034030204,0.00054284075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012217576,0.00028422632,0.0006278608,0.00019988992,0.0004701532,0.000535765,0.00008675722,0.000042867672,0.95358336,0.00020396135,0.0085745,0.03416893],"study_design_scores_gemma":[0.00307147,0.0005497322,0.0010789179,0.0002069685,0.00010358361,0.00006967866,0.00005912518,0.0004423844,0.9905089,0.0011019686,0.002621206,0.00018605808],"about_ca_topic_score_codex":0.00017275897,"about_ca_topic_score_gemma":0.0001294396,"teacher_disagreement_score":0.06324534,"about_ca_system_score_codex":0.00032159014,"about_ca_system_score_gemma":0.00056870474,"threshold_uncertainty_score":0.83376896},"labels":[],"label_agreement":null},{"id":"W2559846904","doi":"10.1158/0008-5472.can-16-0963","title":"The SWI/SNF Complex Protein Snr1 Is a Tumor Suppressor in <i>Drosophila</i> Imaginal Tissues","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Natural Science Foundation of China; Florida State University; National Science Foundation; National Institutes of Health; National Institute of General Medical Sciences; Chinese Academy of Sciences","keywords":"Imaginal disc; Suppressor; Drosophila (subgenus); Biology; SWI/SNF; Cell biology; Drosophila melanogaster; Cancer research; Genetics; Cancer; Gene; Histone","score_opus":0.05683328050647543,"score_gpt":0.3883862089853966,"score_spread":0.33155292847892115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559846904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838112,0.004208105,0.00004195799,0.010134782,0.00006816097,0.00043486434,0.00007112925,0.000011671955,0.0012181392],"genre_scores_gemma":[0.9938936,0.00063326734,0.00008333635,0.0002347097,0.0004358843,0.00046832173,0.0000073276215,0.000028991528,0.0042145187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998281,0.00016044917,0.00019501042,0.00040880448,0.00039249973,0.0005622461],"domain_scores_gemma":[0.99910784,0.00003933828,0.000037978956,0.0004995875,0.00022251027,0.000092726965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006110291,0.00012576071,0.00012351027,0.00004144829,0.0002014317,0.00006504898,0.00046656706,0.00006160647,0.00018346157],"category_scores_gemma":[0.000115913834,0.00007480317,0.00005458576,0.00015466915,0.00037158234,0.000005656705,0.00021048724,0.0001804657,0.000048843292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017739776,0.000022880286,0.0002777984,0.000025622707,0.0000135457485,0.0000060749744,0.0000506683,0.0000028318923,0.96787846,0.0000843651,0.025118181,0.006342178],"study_design_scores_gemma":[0.00070675387,0.000111314665,0.00048375808,0.000122038786,0.0000019261843,0.000006136726,0.000046506208,0.00005089866,0.78416437,0.0010726016,0.2130993,0.00013439478],"about_ca_topic_score_codex":0.00045180265,"about_ca_topic_score_gemma":0.00030163085,"teacher_disagreement_score":0.18798111,"about_ca_system_score_codex":0.000091958966,"about_ca_system_score_gemma":0.00029203083,"threshold_uncertainty_score":0.30503848},"labels":[],"label_agreement":null},{"id":"W2559956750","doi":"10.1158/1538-7445.am2015-ct317","title":"Abstract CT317: Quantitative ultrasound for personalized chemotherapy in locally advanced breast cancer: Clinical trial results","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Ultrasound; Clinical trial; Histopathology; Cancer; Taxane; Oncology; Radiology; Internal medicine; Pathology","score_opus":0.1974454948074875,"score_gpt":0.4800304698340053,"score_spread":0.2825849750265178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559956750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896975,0.0022416152,0.00056233833,0.0019601502,0.0004952074,0.0020600697,0.00089450437,0.00014006397,0.0019485506],"genre_scores_gemma":[0.9902631,0.004315263,0.0010616132,0.00010121712,0.0007863512,0.002645551,0.00005849859,0.00008503213,0.0006833445],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795383,0.00008981773,0.0005336089,0.00041655664,0.00043176545,0.0005744467],"domain_scores_gemma":[0.9975597,0.0013982805,0.000051499253,0.00030682696,0.0004288623,0.00025483436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018046867,0.00017477073,0.00034892792,0.0001369241,0.00009511198,0.00006993761,0.0003447473,0.0001632259,0.00011880329],"category_scores_gemma":[0.00038128436,0.00016298598,0.000111623514,0.0004852616,0.0002590787,0.00015564746,0.000014343901,0.0005639489,0.000035336452],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3854771,0.0021202038,0.003758847,0.0006322136,0.000978372,0.000024789528,0.015262269,0.0328672,0.1536434,0.00934959,0.113606386,0.2822796],"study_design_scores_gemma":[0.34611312,0.001432597,0.022757264,0.0006416772,0.000045862147,0.000014379224,0.0046072407,0.004458489,0.0050687194,0.004414243,0.6089414,0.0015050481],"about_ca_topic_score_codex":0.0005465306,"about_ca_topic_score_gemma":0.0011585644,"teacher_disagreement_score":0.49533498,"about_ca_system_score_codex":0.00045478847,"about_ca_system_score_gemma":0.0006258131,"threshold_uncertainty_score":0.6646375},"labels":[],"label_agreement":null},{"id":"W2560318971","doi":"10.1158/0008-5472.can-16-1589","title":"RB Loss Promotes Prostate Cancer Metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Prostate Cancer Foundation; National Institutes of Health; American Cancer Society","keywords":"Prostate cancer; Metastasis; Cancer; Medicine; Prostate; Oncology; Cancer research; Cancer metastasis; Internal medicine","score_opus":0.12574478194958472,"score_gpt":0.46633990297391104,"score_spread":0.3405951210243263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560318971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92104506,0.018381784,0.000014654425,0.055289056,0.00025663275,0.0020626609,0.00033662355,0.00012703329,0.0024864783],"genre_scores_gemma":[0.8974911,0.030793995,0.000103140635,0.00014338677,0.0006310695,0.00272461,0.000016537542,0.000083390325,0.06801275],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960038,0.00023391731,0.00027965888,0.0007015155,0.0014335082,0.0013475852],"domain_scores_gemma":[0.99752045,0.00024569666,0.000049186314,0.0006060814,0.00103181,0.0005467712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011616633,0.00023856705,0.0004030559,0.00041343502,0.00029430265,0.00006676035,0.0002883155,0.00011305922,0.0039386563],"category_scores_gemma":[0.00021971032,0.0001283808,0.00013392477,0.0009732154,0.0008310239,0.0002237533,0.00021834775,0.0004824233,0.00041340932],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032330912,0.0004311684,0.110140026,0.00069664716,0.00081184146,0.0006359317,0.0009364437,0.0000010462763,0.35112712,0.0004066812,0.03934747,0.49223253],"study_design_scores_gemma":[0.008258779,0.0010714466,0.0137323635,0.0020798522,0.00012333572,0.0000405312,0.00024369941,0.000008659863,0.73118025,0.0011504197,0.24169233,0.00041829614],"about_ca_topic_score_codex":0.0009819178,"about_ca_topic_score_gemma":0.00015702173,"teacher_disagreement_score":0.49181423,"about_ca_system_score_codex":0.0010970556,"about_ca_system_score_gemma":0.0016914714,"threshold_uncertainty_score":0.9969719},"labels":[],"label_agreement":null},{"id":"W2560929237","doi":"10.1158/1538-7445.am2015-5208","title":"Abstract 5208: Neovascularization in brain metastasis is through both angiogenesis and vasculogenesis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Vasculogenesis; Angiogenesis; CD31; Pathology; Metastasis; Medicine; Brain metastasis; Neovascularization; Melanoma; Cancer research; Endothelial stem cell; Progenitor cell; Biology; Cancer; Stem cell; Internal medicine; In vitro","score_opus":0.19097245060625506,"score_gpt":0.432713613153634,"score_spread":0.24174116254737893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560929237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96493006,0.022813639,0.00010059824,0.010028343,0.00008548114,0.00065745297,0.000029319326,0.000035339694,0.0013197507],"genre_scores_gemma":[0.9915713,0.005672287,0.0005767802,0.00107198,0.00020344101,0.00041054556,0.000020212967,0.000050294206,0.00042317394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974817,0.00017318453,0.00028583236,0.000543913,0.0009717057,0.0005436762],"domain_scores_gemma":[0.99877113,0.0000974798,0.000042048014,0.00042522745,0.0003816635,0.0002824285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016269259,0.00017284903,0.0003856656,0.0003121353,0.000099992525,0.000066656234,0.00014306033,0.00014172443,0.00050604006],"category_scores_gemma":[0.00021056607,0.0001504499,0.00013307735,0.0012149282,0.0001743183,0.00020647704,0.00011172857,0.00025268013,0.000030799394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014099411,0.0008839162,0.46274686,0.0013241604,0.0014188458,0.00019062386,0.010343834,0.00017430661,0.069124535,0.00072991586,0.11579561,0.33585745],"study_design_scores_gemma":[0.009271048,0.00086850085,0.625465,0.00078829436,0.00037565533,0.000043458796,0.003998038,0.00027013954,0.18281727,0.0011806816,0.17408408,0.00083785754],"about_ca_topic_score_codex":0.0061435835,"about_ca_topic_score_gemma":0.00044962275,"teacher_disagreement_score":0.3350196,"about_ca_system_score_codex":0.00038219246,"about_ca_system_score_gemma":0.0005492174,"threshold_uncertainty_score":0.9287302},"labels":[],"label_agreement":null},{"id":"W2560940828","doi":"10.1158/1538-7445.am2015-4991","title":"Abstract 4991: RET and integrins cooperate in cell-microenvironment response","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glial cell line-derived neurotrophic factor; Integrin; Cell biology; Biology; Cell adhesion; GDNF family of ligands; Extracellular matrix; Cell migration; Neural crest; Receptor tyrosine kinase; Cell adhesion molecule; Neurotrophic factors; Signal transduction; Neural cell adhesion molecule; Cell; Receptor; Genetics; Embryo","score_opus":0.061471107208203216,"score_gpt":0.36327558214737093,"score_spread":0.30180447493916773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560940828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995709,0.002255922,0.0000061163423,0.0009331218,0.00005302528,0.00019056552,0.000012244095,0.000004791396,0.000835239],"genre_scores_gemma":[0.99600375,0.0010912145,0.000045056713,0.00011279078,0.00008234314,0.00006915211,0.000014855791,0.000015625445,0.0025652193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990537,0.00017507865,0.00011367508,0.00024939078,0.00017904183,0.00022907453],"domain_scores_gemma":[0.99956495,0.000013880212,0.000017062954,0.00020187485,0.000065577864,0.000136644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011431578,0.00007033802,0.000066706496,0.0000707017,0.00003939339,0.000029908302,0.000116517884,0.00008267356,0.00003836644],"category_scores_gemma":[0.00015827898,0.00006334017,0.000012901381,0.00009928341,0.00013142076,0.0000045956267,0.00014130984,0.00021291706,0.000031105486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007687595,0.000035946738,0.0017645626,0.000009504096,0.000003400034,0.000008397519,0.00010283837,0.000017876358,0.9806857,0.0000067425535,0.0150051555,0.0015910923],"study_design_scores_gemma":[0.0006449467,0.00018577222,0.008113354,0.000020395251,5.79617e-7,0.0000017884444,0.00023055267,0.0000073296073,0.84157145,0.00001717491,0.14912415,0.00008252041],"about_ca_topic_score_codex":0.00018017134,"about_ca_topic_score_gemma":0.00012463801,"teacher_disagreement_score":0.13911428,"about_ca_system_score_codex":0.000092975875,"about_ca_system_score_gemma":0.00022539574,"threshold_uncertainty_score":0.25829372},"labels":[],"label_agreement":null},{"id":"W2560952104","doi":"10.1158/1538-7445.am2015-296","title":"Abstract 296: Synergistic actions of oncolytic vaccinia virus and sunitinib on pancreatic neuroendocrine tumors in RIP-Tag2 mice","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Oncolytic virus; Vaccinia; Sunitinib; Cancer research; Apoptosis; Biology; Virus; Vascularity; Angiogenesis; Virology; Cancer; Pathology; Medicine","score_opus":0.11520660008098936,"score_gpt":0.42750368822819657,"score_spread":0.3122970881472072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560952104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954744,0.0012960193,0.0000016053764,0.00047599015,0.000057954592,0.00041484018,0.0000616695,0.000008235116,0.0022092885],"genre_scores_gemma":[0.9975749,0.0012701112,0.000011222978,0.00007693327,0.00016758102,0.00017134733,0.000029436636,0.00004170984,0.0006567278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785966,0.00032369958,0.0002843334,0.0004411745,0.00052050845,0.00057062967],"domain_scores_gemma":[0.998709,0.0001774454,0.00006094505,0.00047438138,0.0002979365,0.0002802406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077630853,0.00016233286,0.0002416404,0.00031208148,0.000081897524,0.000031833362,0.00032345732,0.00006239729,0.0001047032],"category_scores_gemma":[0.0005927035,0.00015742623,0.00004342594,0.00044744482,0.00022974238,0.000007819623,0.00015184382,0.00048424178,0.000024618621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00439663,0.00019110514,0.00120245,0.000093190094,0.000040442083,0.000078845944,0.00008824242,0.00033773217,0.9882169,0.000031484873,0.0015553102,0.0037676736],"study_design_scores_gemma":[0.002097999,0.0042645186,0.008917123,0.000131709,0.000010057519,0.000016277989,0.0003542255,0.000089657995,0.9788776,0.00012069949,0.0049054534,0.00021468308],"about_ca_topic_score_codex":0.001845317,"about_ca_topic_score_gemma":0.0034533055,"teacher_disagreement_score":0.009339298,"about_ca_system_score_codex":0.0001430609,"about_ca_system_score_gemma":0.0007612348,"threshold_uncertainty_score":0.6419655},"labels":[],"label_agreement":null},{"id":"W2560967424","doi":"10.1158/1538-7445.am2015-3898","title":"Abstract 3898: Exome analysis of an exceptional responder uncovers an activating GNAS mutation that may confer sensitivity to cytotoxic chemotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Exome; Crizotinib; Lung cancer; Exome sequencing; GNAS complex locus; Oncology; Medicine; Internal medicine; Cancer; Biology; Pathology; Cancer research; Mutation; Genetics; Gene","score_opus":0.11357896830203101,"score_gpt":0.4248612206656846,"score_spread":0.3112822523636536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560967424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982256,0.00007698007,0.00064718426,0.00029178456,0.00006734192,0.00023425867,0.00020163486,0.000007968461,0.00024722054],"genre_scores_gemma":[0.9985268,0.00008574686,0.00036284246,0.00023346215,0.00025980137,0.000045159257,0.0003247821,0.000025469744,0.00013593075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984414,0.00017289702,0.00016878628,0.00042572062,0.000488836,0.00030233688],"domain_scores_gemma":[0.9985796,0.00008924794,0.00007374513,0.00040247248,0.0005756455,0.00027928705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012577669,0.00012110636,0.00019456696,0.0002783468,0.00006738708,0.00005740775,0.00014726151,0.00012508345,0.00010072622],"category_scores_gemma":[0.00021809801,0.00012522281,0.00007646061,0.0004820435,0.00010887172,0.00001940798,0.00007244386,0.0001418027,0.0000045331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009900073,0.00010173191,0.005983027,0.000011013578,0.00021704934,0.0000093583,0.0006209452,0.017304393,0.9673261,0.000042161657,0.00064479205,0.00674939],"study_design_scores_gemma":[0.000979673,0.00054848986,0.14689085,0.000018973062,0.000039312607,0.0000029422713,0.0013008462,0.00084446213,0.84427124,0.00010412263,0.0047429944,0.0002560908],"about_ca_topic_score_codex":0.0013735554,"about_ca_topic_score_gemma":0.0019121278,"teacher_disagreement_score":0.14090782,"about_ca_system_score_codex":0.00019451635,"about_ca_system_score_gemma":0.0005390642,"threshold_uncertainty_score":0.5106438},"labels":[],"label_agreement":null},{"id":"W2561007053","doi":"10.1158/1538-7445.am2015-1707","title":"Abstract 1707: PACE4-dependent cellular uptake and retention of the Multi-Leucine peptide inhibitor into cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"DU145; Prostate cancer; LNCaP; Cancer research; Cancer; Cancer cell; Gene knockdown; Peptide; Prostate; Biology; Chemistry; Biochemistry; Internal medicine; Medicine; Apoptosis","score_opus":0.09214327955457371,"score_gpt":0.35989804915360335,"score_spread":0.26775476959902966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561007053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920623,0.0060176062,0.00003468234,0.0004903906,0.00028395024,0.00042781714,0.000060876868,0.000005595965,0.0006168116],"genre_scores_gemma":[0.99524695,0.00090277864,0.00018808892,0.000041865984,0.00041498366,0.00013584853,0.000013554473,0.000023631495,0.0030322836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985844,0.00015617578,0.00019753313,0.00033853945,0.0004227581,0.00030060238],"domain_scores_gemma":[0.9990294,0.000013013548,0.00007691616,0.00037832407,0.0003414229,0.00016093208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010406858,0.000117596035,0.00012746957,0.000045381756,0.00012130322,0.000027940983,0.00024226015,0.00014065602,0.000063311505],"category_scores_gemma":[0.00011285782,0.00008738584,0.000058313406,0.00010062973,0.00021276157,0.000006067156,0.00028515275,0.00030356253,0.000007845584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109985805,0.000040473686,0.0012299598,0.00010420205,0.000025257239,0.0000023695613,0.00025627203,0.000027143862,0.99090457,0.000018895436,0.0042669214,0.0030139391],"study_design_scores_gemma":[0.0007335869,0.00012616135,0.0015584045,0.000086343796,0.000007729541,0.0000011031627,0.00026298244,0.00002451266,0.9670875,0.000064421496,0.029945374,0.00010186485],"about_ca_topic_score_codex":0.0014083111,"about_ca_topic_score_gemma":0.0007145841,"teacher_disagreement_score":0.025678452,"about_ca_system_score_codex":0.00007392908,"about_ca_system_score_gemma":0.00034660214,"threshold_uncertainty_score":0.3563491},"labels":[],"label_agreement":null},{"id":"W2561061456","doi":"10.1158/1538-7445.am2015-3592","title":"Abstract 3592: Androgens interfere with enzalutamide agonism of mutant F876L androgen receptor","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; Androgen receptor; LNCaP; Androgen; Cancer research; Agonist; Cell culture; Prostate cancer; Internal medicine; Endocrinology; Mutant; Receptor; Ectopic expression; Biology; Chemistry; Medicine; Hormone; Genetics; Cancer; Gene","score_opus":0.14135436479740707,"score_gpt":0.4207292355133669,"score_spread":0.2793748707159598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561061456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841465,0.005959331,0.0000064383553,0.0020304585,0.00010945435,0.0009596357,0.00013013842,0.00004395733,0.006614091],"genre_scores_gemma":[0.9946913,0.0016858568,0.00013152705,0.000038967042,0.00024161168,0.00024452963,0.000055443063,0.000056569224,0.0028541845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969688,0.00011033654,0.00030022772,0.00045566785,0.0013816905,0.00078327034],"domain_scores_gemma":[0.9973913,0.000114302326,0.00006948397,0.00052566314,0.001228176,0.0006710617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010241164,0.00020057471,0.00043674756,0.00034349828,0.000107971195,0.00004103485,0.00025355807,0.00013074538,0.00083611143],"category_scores_gemma":[0.00013256536,0.0001326805,0.00008433624,0.0007070381,0.0006075411,0.0001279235,0.0001397191,0.00065693614,0.00012366823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021665284,0.0011095026,0.083716996,0.0012824105,0.0014020886,0.0011917806,0.0054805214,0.000036094058,0.81787837,0.0003177296,0.02387975,0.042039473],"study_design_scores_gemma":[0.0075172056,0.0021883699,0.0040339143,0.0009611147,0.00006469371,0.00007940969,0.0024608185,0.000021547214,0.95170933,0.0001962896,0.030514993,0.0002523048],"about_ca_topic_score_codex":0.0008730983,"about_ca_topic_score_gemma":0.00014755821,"teacher_disagreement_score":0.13383096,"about_ca_system_score_codex":0.0007522141,"about_ca_system_score_gemma":0.002306373,"threshold_uncertainty_score":0.91548336},"labels":[],"label_agreement":null},{"id":"W2561077980","doi":"10.1158/1538-7445.am2015-1664","title":"Abstract 1664: New moieties mimicking the trimethoxyphenyl (ring A) of combretastatin A-4: Synthesis and biological evaluation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Combretastatin; Chemistry; Tubulin; Stereochemistry; Cytotoxicity; Biological activity; Cell cycle; Cytoskeleton; Cell cycle checkpoint; In vitro; Apoptosis; Biochemistry; Cell; Microtubule; Biology; Cell biology","score_opus":0.4963652591700331,"score_gpt":0.4651974364154221,"score_spread":0.031167822754610996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561077980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036354,0.0027153878,0.00001550326,0.00084584026,0.000028157923,0.00012190893,0.000024723571,0.000016823466,0.0058681155],"genre_scores_gemma":[0.99915475,0.00034585383,0.00014523021,0.000014046129,0.00015541931,0.00007760941,0.000002441801,0.0000073517995,0.00009728404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983521,0.00032077468,0.00019923694,0.00026338248,0.0005855113,0.0002789936],"domain_scores_gemma":[0.9967242,0.002593255,0.00008382138,0.00021406602,0.00026414738,0.00012054129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004141832,0.00010140882,0.00021408667,0.000038224443,0.000119179,0.00004575166,0.00025821396,0.000116200885,0.0009558057],"category_scores_gemma":[0.0036777323,0.000055540044,0.00004987682,0.00014299685,0.0003516663,0.000053887838,0.00015200526,0.00032626843,0.0000042092192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030494222,0.00007637287,0.012524861,0.00007316148,0.000055568147,0.0000015371056,0.00040428335,0.000034913995,0.54669863,0.00015162636,0.0010078383,0.43866628],"study_design_scores_gemma":[0.0005392014,0.00005396587,0.030939678,0.00015936559,0.000025246867,0.0000027153558,0.0023540673,0.0005037207,0.95891315,0.0035756326,0.0027785692,0.00015466807],"about_ca_topic_score_codex":0.00126663,"about_ca_topic_score_gemma":0.000026436614,"teacher_disagreement_score":0.4385116,"about_ca_system_score_codex":0.000111178044,"about_ca_system_score_gemma":0.0002459742,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W2561110796","doi":"10.1158/1538-7445.am2015-4743","title":"Abstract 4743: A population-based approach to address clinical cancer care: The national genomics platform","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lockheed Martin (Canada)","funders":"","keywords":"Genomics; Big data; Informatics; Data science; Computer science; Scalability; Precision medicine; Personalized medicine; Medicine; Bioinformatics; Genome; Data mining; Biology; Engineering; Database; Genetics","score_opus":0.2202195237759935,"score_gpt":0.464918255005626,"score_spread":0.2446987312296325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561110796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698974,0.0036293683,0.00021749965,0.0012886917,0.0005408209,0.0007846375,0.0004946871,0.0000110268875,0.006043525],"genre_scores_gemma":[0.99454314,0.0004358988,0.00030600486,0.0014353497,0.002136244,0.0005988575,0.00028334238,0.000037202473,0.00022394951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808604,0.00006630372,0.00029686888,0.0004665083,0.0006241874,0.00046011008],"domain_scores_gemma":[0.9981481,0.00013073928,0.000064089014,0.00035314012,0.0009913411,0.00031263015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012990051,0.00013827719,0.00015098731,0.00007441745,0.00021656948,0.00010029464,0.00050445413,0.00017071023,0.000029524988],"category_scores_gemma":[0.00055672444,0.00011188682,0.00009373325,0.00022365103,0.00012454696,0.00000486039,0.00022443438,0.00032739417,0.000022169854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032434363,0.00072614243,0.11251732,0.00025468646,0.000450772,0.00000763052,0.0017640527,0.27027485,0.045498174,0.0026892794,0.5157696,0.046804085],"study_design_scores_gemma":[0.0025012915,0.00036887507,0.07312242,0.000049016184,0.000027473156,0.0000026917335,0.0008548922,0.00094976823,0.018216213,0.00038547395,0.90294224,0.00057967345],"about_ca_topic_score_codex":0.0028154382,"about_ca_topic_score_gemma":0.0018449938,"teacher_disagreement_score":0.38717264,"about_ca_system_score_codex":0.00052139326,"about_ca_system_score_gemma":0.002610941,"threshold_uncertainty_score":0.46316972},"labels":[],"label_agreement":null},{"id":"W2561230311","doi":"10.1158/1538-7445.am2015-2133","title":"Abstract 2133: Investigating the molecular interaction between KRAS mRNA and RNA binding protein CRD-BP","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"","keywords":"KRAS; Messenger RNA; Biology; RNA-binding protein; Molecular biology; RNA; Cancer research; Exon; CD44; Gene; Genetics; Mutation; Cell","score_opus":0.11727282582201061,"score_gpt":0.41886191641765197,"score_spread":0.3015890905956414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561230311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555403,0.0010969468,0.000046143774,0.0015390127,0.000041272506,0.0004347522,0.000009496031,0.000009859502,0.0012685122],"genre_scores_gemma":[0.99796736,0.000091082315,0.00011386125,0.000059290924,0.00037304524,0.00015081863,0.000021927704,0.000026966165,0.0011956252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982268,0.00022170272,0.00017094266,0.00034653133,0.0005291926,0.0005048086],"domain_scores_gemma":[0.99901086,0.000050819992,0.000051558567,0.00030785243,0.00026949434,0.00030940786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017196636,0.0001160556,0.00011084518,0.00009624379,0.0002597543,0.0001651715,0.00030140262,0.000105659245,0.0000156594],"category_scores_gemma":[0.00069960393,0.00008738149,0.000036885467,0.00023016153,0.00026625115,0.000015493746,0.00030174264,0.00056942744,0.000019492492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037680853,0.0000069883076,0.0029520467,0.000032557124,0.000036450183,0.0000073397246,0.00008923918,0.000020029613,0.98704183,0.00006185175,0.0014410886,0.00827288],"study_design_scores_gemma":[0.0003724791,0.00017753697,0.0013336412,0.00011121693,0.000004134696,0.0000040718855,0.0006237787,0.00005738397,0.9881959,0.0002443455,0.008748199,0.00012734253],"about_ca_topic_score_codex":0.0008990635,"about_ca_topic_score_gemma":0.00008510161,"teacher_disagreement_score":0.008145537,"about_ca_system_score_codex":0.000092776994,"about_ca_system_score_gemma":0.00034932158,"threshold_uncertainty_score":0.3563314},"labels":[],"label_agreement":null},{"id":"W2561264631","doi":"10.1158/1538-7445.am2015-3815","title":"Abstract 3815: Synergistic mechanisms of oncolytic reovirus with bortezomib in overcoming therapy resistance of multiple myeloma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"Bortezomib; Multiple myeloma; Oncolytic virus; Apoptosis; In vivo; Cancer research; Flow cytometry; Combination therapy; Oncolytic adenovirus; Ex vivo; Medicine; Cell cycle; Biology; Pharmacology; Immunology; Tumor cells","score_opus":0.07925027228251183,"score_gpt":0.3845768699638137,"score_spread":0.3053265976813019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561264631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427956,0.0035424647,0.00015632695,0.00011811835,0.000041158222,0.00054499856,0.000050835875,0.0000061520673,0.0012603697],"genre_scores_gemma":[0.998128,0.0006902189,0.00031122105,0.000031970147,0.000080468875,0.00016486416,0.000016879421,0.000050713086,0.0005256413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974532,0.00026239667,0.00036433898,0.00045517075,0.0009052679,0.0005595883],"domain_scores_gemma":[0.9982143,0.00012866988,0.00012387976,0.0006986709,0.000654051,0.00018040882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018963335,0.00016943256,0.00031289796,0.00024212312,0.00005239865,0.000016679596,0.0005264672,0.00015067155,0.000050376726],"category_scores_gemma":[0.00030768532,0.00014710281,0.000059247388,0.0005587284,0.00035938935,0.000009655629,0.00009344029,0.00033237357,0.0000042597353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016330354,0.00015584713,0.0016338717,0.00009295698,0.00006792092,0.000023574712,0.00016952875,0.00046475427,0.97783315,0.000093326336,0.00039583206,0.0027388837],"study_design_scores_gemma":[0.0029715358,0.002193737,0.0022262826,0.00016828385,0.0000029759287,0.0000010828215,0.0003124203,0.000043096203,0.9902373,0.00042344167,0.0012543207,0.00016553777],"about_ca_topic_score_codex":0.0009020334,"about_ca_topic_score_gemma":0.007814271,"teacher_disagreement_score":0.013358819,"about_ca_system_score_codex":0.0001894696,"about_ca_system_score_gemma":0.0014369708,"threshold_uncertainty_score":0.5998678},"labels":[],"label_agreement":null},{"id":"W2561288620","doi":"10.1158/1538-7445.am2015-3941","title":"Abstract 3941: Recurrent IL4R mutations in primary mediastinal large B cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Biology; Signal transduction; Genetics","score_opus":0.12411493138617716,"score_gpt":0.42216080363062897,"score_spread":0.2980458722444518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561288620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682873,0.005461462,0.0000020293735,0.0019454715,0.00021986681,0.0005547129,0.00006102884,0.000027167656,0.02344096],"genre_scores_gemma":[0.9973518,0.00067044614,0.00011582211,0.00014807328,0.0002639528,0.0006023937,0.00011624664,0.000022188995,0.0007090386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784595,0.000084474275,0.00024594448,0.00033074085,0.0009069186,0.0005859723],"domain_scores_gemma":[0.9987046,0.00019910852,0.000037942795,0.0002780007,0.00034054884,0.00043979965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008226145,0.00012657019,0.00023476558,0.00027955577,0.000078118945,0.000031299172,0.00011998422,0.00007690815,0.00031963925],"category_scores_gemma":[0.00015909498,0.000103239705,0.000057919053,0.0004844717,0.00009789792,0.00008528637,0.00008820834,0.00020341716,0.0003669603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025347588,0.020693125,0.5318561,0.0011622445,0.00018212215,0.0040954743,0.007645714,0.00003858112,0.0049061486,0.00050788635,0.14063832,0.28573954],"study_design_scores_gemma":[0.016584873,0.00050144177,0.9279855,0.0003709809,0.000030442987,0.000024350727,0.000832318,0.00004749397,0.00684899,0.0001878478,0.046425335,0.00016046334],"about_ca_topic_score_codex":0.00089784263,"about_ca_topic_score_gemma":0.00031530493,"teacher_disagreement_score":0.39612937,"about_ca_system_score_codex":0.0022335374,"about_ca_system_score_gemma":0.0021299631,"threshold_uncertainty_score":0.5840622},"labels":[],"label_agreement":null},{"id":"W2561293383","doi":"10.1158/1538-7445.am2015-3713","title":"Abstract 3713: Second malignant neoplasms after non-CNS embryonal tumors in North America","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pediatric Oncology Group; Atlantic School of Theology; Lunenfeld-Tanenbaum Research Institute; University of Manitoba; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cancer; Epidemiology; Cancer registry; Population; Internal medicine; Incidence (geometry); Oncology; Bone cancer; Leukemia","score_opus":0.083527628180569,"score_gpt":0.3989851772233598,"score_spread":0.3154575490427908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561293383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864809,0.0014231742,0.000008171722,0.0041728965,0.00033658338,0.00078493735,0.00014955996,0.000046566813,0.006597194],"genre_scores_gemma":[0.9934617,0.00012678401,0.00014176365,0.0016745608,0.00084304117,0.00048540815,0.000051445604,0.00007165192,0.0031435916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954898,0.00020108496,0.0006123577,0.00071976916,0.0018502212,0.0011268109],"domain_scores_gemma":[0.99752814,0.0002475977,0.00009866981,0.0007229624,0.00048073614,0.0009219027],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015961315,0.00027334143,0.00061811873,0.00049613765,0.000078888304,0.00006863089,0.00036917152,0.00012755283,0.0031718956],"category_scores_gemma":[0.00031784887,0.00025023628,0.00012607718,0.001186573,0.00041479012,0.00020208498,0.00022217323,0.0013124944,0.0007348664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069298595,0.0012457345,0.795567,0.0017874975,0.00029031668,0.0034778633,0.03094517,0.00025741282,0.0045503452,0.000030271383,0.1408158,0.014102753],"study_design_scores_gemma":[0.0035464857,0.00057255785,0.9261101,0.00070196873,0.000015850423,0.000043013875,0.0032876937,0.00006954173,0.0022556738,0.0000992071,0.062876254,0.0004216541],"about_ca_topic_score_codex":0.008736083,"about_ca_topic_score_gemma":0.036393743,"teacher_disagreement_score":0.13054311,"about_ca_system_score_codex":0.0008814642,"about_ca_system_score_gemma":0.002873729,"threshold_uncertainty_score":0.999995},"labels":[],"label_agreement":null},{"id":"W2561312100","doi":"10.1158/1538-7445.am2015-4597","title":"Abstract 4597: A novel variant in DNA repair gene GTF2H4 is associated with lung cancer risk: A reanalysis of GWAS datasets from the TRICL consortium","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Single-nucleotide polymorphism; Genome-wide association study; DNA repair; Lung cancer; Biology; Cancer; SNP; Genetics; Genetic association; DNA repair protein XRCC4; Gene; Cancer research; Medicine; DNA mismatch repair; Oncology; Genotype","score_opus":0.07238880144404866,"score_gpt":0.38228551649149317,"score_spread":0.30989671504744454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561312100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440325,0.0077809277,0.00016162162,0.0006539683,0.000047323516,0.00034867693,0.006403265,0.000007873485,0.00019307146],"genre_scores_gemma":[0.99565065,0.0025869184,0.000102023834,0.00012558127,0.00015109494,0.00033448482,0.00073120097,0.000025000301,0.0002930432],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799526,0.00021134222,0.00032827517,0.00051989115,0.0005663605,0.0003788447],"domain_scores_gemma":[0.99812037,0.000100677564,0.0002043564,0.0009171508,0.0005271201,0.00013033542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014915108,0.00014298418,0.00024164215,0.000090837304,0.00011318597,0.000034862383,0.00044146078,0.0001400357,0.00016039149],"category_scores_gemma":[0.00042102652,0.00009955513,0.000083068895,0.00060952595,0.00023203806,0.000010151141,0.00013518702,0.00031753787,0.0000023854177],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014083724,0.0005775492,0.10539258,0.00003636476,0.0021402605,0.00004576045,0.0012538355,0.0027237148,0.73196673,0.000024945046,0.151998,0.002431858],"study_design_scores_gemma":[0.00958594,0.0004837656,0.49353483,0.0004785956,0.00069910736,0.000009502467,0.001672804,0.00593339,0.41894338,0.00011485556,0.06752066,0.0010231613],"about_ca_topic_score_codex":0.038826402,"about_ca_topic_score_gemma":0.012920236,"teacher_disagreement_score":0.38814226,"about_ca_system_score_codex":0.00023042958,"about_ca_system_score_gemma":0.0012824726,"threshold_uncertainty_score":0.9675741},"labels":[],"label_agreement":null},{"id":"W2561366385","doi":"10.1158/1538-7445.am2015-ct311","title":"Abstract CT311: Results of a phase I/IIa dose-escalation study of the combination of decitabine and genistein against advanced solid tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Michelin (Canada); Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Medicine; Genistein; Pharmacology; Neutropenia; Pharmacokinetics; Maximum tolerated dose; Oncology; Hypomethylating agent; Phases of clinical research; Leukopenia; Internal medicine; Cancer; Chemotherapy; DNA methylation; Chemistry","score_opus":0.07540904835654774,"score_gpt":0.42652940508866094,"score_spread":0.35112035673211317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561366385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978896,0.0010579291,0.00002644353,0.000067203866,0.00004855786,0.0004793396,0.000041480507,0.0000014158346,0.00038807685],"genre_scores_gemma":[0.99953735,0.00025152747,0.00004467908,0.000002414399,0.00002990403,0.000025229667,0.00003274034,0.000009611269,0.00006652229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879616,0.00014415095,0.0003527395,0.00019102036,0.0003904867,0.00012546261],"domain_scores_gemma":[0.99869955,0.00003728495,0.00020350111,0.0002991638,0.0007048443,0.00005566993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009799416,0.000067715635,0.00013954622,0.00006888431,0.000043527227,0.00000618466,0.00014028324,0.000059240174,0.0000015421695],"category_scores_gemma":[0.00041495299,0.000053659547,0.000028242646,0.00020851662,0.00013889272,0.0000054753255,0.00010569722,0.00008462384,1.4947386e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007078674,0.00044283646,0.0026304543,0.000035019984,0.000023872813,3.0203586e-7,0.00056805013,0.000780768,0.9829566,0.000014064967,0.00003494953,0.011805242],"study_design_scores_gemma":[0.0052359765,0.0014417804,0.051925484,0.000041595682,0.00000800024,1.10391085e-7,0.0007335469,0.00018778606,0.94002074,0.00014026964,0.00020755111,0.000057132474],"about_ca_topic_score_codex":0.00018925947,"about_ca_topic_score_gemma":0.00018502069,"teacher_disagreement_score":0.049295027,"about_ca_system_score_codex":0.000024612322,"about_ca_system_score_gemma":0.00017032649,"threshold_uncertainty_score":0.21881728},"labels":[],"label_agreement":null},{"id":"W2561387856","doi":"10.1158/1538-7445.am2015-3652","title":"Abstract 3652: Development of novel chemical inhibitors targeting the N-terminal domain (NTD) of androgen receptor variants as anti-prostate cancer agents","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Enzalutamide; Bicalutamide; Prostate cancer; Androgen receptor; Cancer research; Antiandrogens; Medicine; Cancer; Androgen; Androgen deprivation therapy; Internal medicine; Hormone","score_opus":0.12083436678818402,"score_gpt":0.4247683232650827,"score_spread":0.3039339564768987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561387856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280316,0.0033223215,0.000004450778,0.0013491076,0.00024230922,0.0010827258,0.00011972766,0.00001712823,0.0010590963],"genre_scores_gemma":[0.9966857,0.0008006529,0.0007507908,0.000035727466,0.0003230381,0.0003513999,0.00006051949,0.000048124923,0.00094408786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962038,0.00010365204,0.0006196348,0.0004606894,0.0017881031,0.0008241223],"domain_scores_gemma":[0.9977974,0.000121376026,0.00018179351,0.0003669829,0.0010893851,0.00044301356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022138066,0.00022192126,0.00046609205,0.00023351847,0.0001817152,0.000030061468,0.0003726575,0.00014042607,0.0005072954],"category_scores_gemma":[0.00024270418,0.00014450127,0.000098322766,0.00074870355,0.000604755,0.000114608374,0.00030492613,0.00061818206,0.0000313234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003099136,0.0006902022,0.029219436,0.0008103964,0.0005043699,0.00013249564,0.011959896,0.000027948807,0.91995454,0.000024204224,0.016561167,0.017016217],"study_design_scores_gemma":[0.006033744,0.0002357666,0.0071127554,0.001067357,0.000036460795,0.000018343211,0.0028421255,0.000037574115,0.9680738,0.000051315117,0.014282284,0.00020848244],"about_ca_topic_score_codex":0.001006536,"about_ca_topic_score_gemma":0.00001970762,"teacher_disagreement_score":0.04811926,"about_ca_system_score_codex":0.00080099225,"about_ca_system_score_gemma":0.0048189424,"threshold_uncertainty_score":0.85485965},"labels":[],"label_agreement":null},{"id":"W2561439902","doi":"10.1158/1538-7445.am2015-2465","title":"Abstract 2465: Targeting HER2-positive brain metastases by incorporating the brain-penetrant Angiopep-2 peptide to an anti-HER2 antibody and anti-HER2 antibody drug conjugate","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; In vitro; Monoclonal antibody; Antibody; Cancer research; Docetaxel; Chemistry; Pharmacology; Trastuzumab; Blood–brain barrier; Receptor tyrosine kinase; Receptor; Biology; Cancer; Biochemistry; Immunology; Medicine; Internal medicine; Central nervous system; Breast cancer; Endocrinology","score_opus":0.06135352249237156,"score_gpt":0.41955658443168664,"score_spread":0.35820306193931506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561439902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95193475,0.005552719,0.000054854987,0.037148196,0.00019869371,0.0019564682,0.0007714929,0.00008767437,0.002295171],"genre_scores_gemma":[0.98994297,0.0008938393,0.00056959636,0.0027343575,0.00094442273,0.00012564842,0.0008641646,0.00014247998,0.0037825292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9920407,0.0013084458,0.0008524026,0.0013464276,0.0025599583,0.0018920524],"domain_scores_gemma":[0.9942321,0.0016238501,0.00021287822,0.0007836986,0.0014544145,0.0016930125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077862595,0.0006189416,0.0010217302,0.00048577145,0.0011011725,0.0005353371,0.00083309493,0.00018089682,0.0003754375],"category_scores_gemma":[0.001328699,0.00043662378,0.00019995164,0.0013878949,0.0012284684,0.00058215874,0.00068971416,0.0017808477,0.00018072192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001159375,0.00043154633,0.058141224,0.0003758247,0.00036992264,0.0008142294,0.0025866358,0.00008972561,0.79515785,0.00031481037,0.13613875,0.004420093],"study_design_scores_gemma":[0.009088399,0.0053743417,0.32265794,0.0032981243,0.0002625526,0.0005848802,0.019060686,0.002079454,0.360433,0.000659365,0.27360556,0.0028956984],"about_ca_topic_score_codex":0.024483597,"about_ca_topic_score_gemma":0.0009944511,"teacher_disagreement_score":0.43472484,"about_ca_system_score_codex":0.00027590434,"about_ca_system_score_gemma":0.0011508383,"threshold_uncertainty_score":0.99980855},"labels":[],"label_agreement":null},{"id":"W2561451097","doi":"10.1158/1538-7445.am2015-605","title":"Abstract 605: The clinical outcome of patients with FOXL2 402C-&amp;gt;G mutation positive adult-type Granulosa Cell Tumor of the ovary - a population based study with analysis of tissue and plasma ctDNA","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Population; Medicine; Internal medicine; Pathology; Ovary; Histopathology; Oncology","score_opus":0.1027224151146792,"score_gpt":0.43939191514479875,"score_spread":0.33666950003011953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561451097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977145,0.00009628437,0.0000064425326,0.00037756196,0.000037753554,0.001533312,0.00014568318,0.0000035742341,0.00008487801],"genre_scores_gemma":[0.99961305,0.000009547174,0.0001212197,0.000033550154,0.00002229373,0.000080828875,0.000078171666,0.000015102761,0.000026251544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787605,0.00027638688,0.0004452333,0.000263914,0.0009794843,0.0001589451],"domain_scores_gemma":[0.9974336,0.0004242568,0.0003067756,0.00041880968,0.0013179659,0.00009857965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074693956,0.00011470305,0.00044865056,0.00018265762,0.00006052738,0.000009313149,0.00010367717,0.000039272483,0.00004254898],"category_scores_gemma":[0.00015080319,0.000055118075,0.00006364906,0.0010014743,0.00018566947,0.000050821785,0.000036620786,0.00020124053,7.563324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038431424,0.0013824361,0.9914561,0.00009244782,0.0007053926,0.0000072897715,0.0007453209,0.00034647292,0.00003603575,0.0000065911127,0.000045669825,0.0013331086],"study_design_scores_gemma":[0.0051560313,0.0030680902,0.9884381,0.0001482942,0.0012480734,3.3916496e-7,0.0004458666,0.00010409578,0.0013211002,0.0000058679443,0.000009182738,0.00005494282],"about_ca_topic_score_codex":0.0050160014,"about_ca_topic_score_gemma":0.0032947634,"teacher_disagreement_score":0.0030179764,"about_ca_system_score_codex":0.00013796143,"about_ca_system_score_gemma":0.00031687293,"threshold_uncertainty_score":0.7582727},"labels":[],"label_agreement":null},{"id":"W2561468700","doi":"10.1158/1538-7445.am2015-lb-240","title":"Abstract LB-240: SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Lung cancer; Cancer research; Gene knockdown; Cancer; Gefitinib; Acquired resistance; Biology; Medicine; Epidermal growth factor receptor; Oncology; Internal medicine; Genetics; Cell culture","score_opus":0.05896258463966057,"score_gpt":0.415770564107877,"score_spread":0.3568079794682164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561468700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720297,0.026251176,0.000019173573,0.0007180724,0.00012037915,0.0003751713,0.000066625005,0.000009444389,0.00041024707],"genre_scores_gemma":[0.9955105,0.0028031792,0.00013684275,0.00014706177,0.0003447938,0.00032944384,0.000011796522,0.000027329314,0.0006890573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983614,0.00017129115,0.0002084488,0.00048684742,0.0003496877,0.00042231442],"domain_scores_gemma":[0.9990801,0.00008691939,0.00003612156,0.00026650025,0.000233198,0.00029715247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009069447,0.00014681021,0.00019387394,0.00013570304,0.000089820904,0.00007818503,0.00015851078,0.00014526228,0.000042810578],"category_scores_gemma":[0.00040300077,0.0001280333,0.00002528933,0.00015848741,0.00014068198,0.000011916326,0.0002586173,0.00022745553,0.0000016491915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009875855,0.000024025796,0.015313633,0.00009718903,0.000017478971,0.000007924897,0.00041171172,0.00028239828,0.9540483,0.0000036827178,0.02238592,0.006420203],"study_design_scores_gemma":[0.002784264,0.00032378052,0.011608347,0.0006129058,0.00001271882,0.0000074999375,0.00083751034,0.00024893327,0.92598504,0.00010420797,0.057093784,0.00038099455],"about_ca_topic_score_codex":0.002113443,"about_ca_topic_score_gemma":0.0009991466,"teacher_disagreement_score":0.034707867,"about_ca_system_score_codex":0.000110605964,"about_ca_system_score_gemma":0.00044260995,"threshold_uncertainty_score":0.5221046},"labels":[],"label_agreement":null},{"id":"W2561479353","doi":"10.1158/1538-7445.am2015-2562","title":"Abstract 2562: Dianhydrogalactitol inhibits the growth of glioma stem and non-stem cultures, including temozolomide-resistant cell lines, in vitro and in vivo","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Temozolomide; Methyltransferase; Cancer research; In vivo; Glioma; DNA repair; Cancer stem cell; Stem cell; Medicine; Dacarbazine; Cancer; Biology; Internal medicine; Methylation; Melanoma; DNA; Genetics","score_opus":0.07806133993561859,"score_gpt":0.36911943557508275,"score_spread":0.29105809563946416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561479353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874302,0.009240781,1.1666316e-7,0.0015345126,0.000041126877,0.0009374301,0.000027330287,0.0000074141008,0.0007810836],"genre_scores_gemma":[0.99865675,0.00083319086,0.000018918772,0.000026537584,0.00007307103,0.00029016816,0.0000030416986,0.00002193802,0.00007637994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982389,0.00011250106,0.00034411848,0.0003405905,0.0005530723,0.00041081267],"domain_scores_gemma":[0.99890417,0.00030905986,0.00007683264,0.00023280493,0.00023792015,0.00023922288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009112527,0.00016186017,0.00036935305,0.00036868872,0.00007234111,0.00005055255,0.000110180175,0.00011058076,0.000010621471],"category_scores_gemma":[0.000064454485,0.000102754246,0.000032488755,0.0006579788,0.00015827456,0.00011584887,0.00016772911,0.00038665632,0.000004181755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010782967,0.0003538858,0.1000709,0.000505302,0.00003933062,0.00042514803,0.0017280026,0.000007586414,0.89269143,0.00003248224,0.0016588948,0.0014087564],"study_design_scores_gemma":[0.0040162774,0.00017701063,0.057998307,0.00052565703,0.00001748031,0.000018100172,0.0018706,0.00007834849,0.9348027,0.000043989607,0.00034572798,0.000105818675],"about_ca_topic_score_codex":0.007952433,"about_ca_topic_score_gemma":0.0019613,"teacher_disagreement_score":0.04211127,"about_ca_system_score_codex":0.00038054358,"about_ca_system_score_gemma":0.0002578889,"threshold_uncertainty_score":0.9986537},"labels":[],"label_agreement":null},{"id":"W2561481549","doi":"10.1158/1538-7445.am2015-4569","title":"Abstract 4569: A simple method to screen patients for SNPs in NAT1 gene for prostate cancer risk","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Genotyping; Single-nucleotide polymorphism; SNP genotyping; SNP; Computational biology; Molecular Inversion Probe; Primer (cosmetics); Genetics; Gene; dbSNP; Biology; Genotype; Molecular biology; Chemistry","score_opus":0.08470499594100118,"score_gpt":0.45202371210390296,"score_spread":0.3673187161629018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561481549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818684,0.007196764,0.0028967264,0.00039136034,0.00066221494,0.0033063833,0.003431517,0.000011409053,0.00023526706],"genre_scores_gemma":[0.9519672,0.0046211164,0.01591371,0.0008696159,0.0059234397,0.015011685,0.00097640953,0.00020535025,0.004511474],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978712,0.00011667511,0.00026541087,0.00061265257,0.0003587653,0.00077530247],"domain_scores_gemma":[0.99809283,0.000066214714,0.00007294935,0.00035723392,0.0010664221,0.00034436624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016852412,0.00017023421,0.0002505625,0.0001560045,0.00011991049,0.000047766833,0.0003206437,0.00015224826,0.000019290888],"category_scores_gemma":[0.0005240069,0.00016137864,0.000100198944,0.0002743864,0.000056105244,0.0000099816425,0.00016024304,0.00019364277,0.000004938063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004856902,0.00021545762,0.010969213,0.00017428889,0.00015015026,6.607632e-7,0.0008673439,0.0019004332,0.39109513,0.00003138878,0.29576513,0.2939739],"study_design_scores_gemma":[0.0032636113,0.00039440137,0.007266634,0.000023206634,0.0000149519055,2.4511706e-7,0.000112122674,0.00006308789,0.20922169,0.00037334338,0.77904624,0.00022049414],"about_ca_topic_score_codex":0.007184981,"about_ca_topic_score_gemma":0.0082897,"teacher_disagreement_score":0.48328108,"about_ca_system_score_codex":0.000184647,"about_ca_system_score_gemma":0.0008901536,"threshold_uncertainty_score":0.99942625},"labels":[],"label_agreement":null},{"id":"W2561504086","doi":"10.1158/1538-7445.am2015-3551","title":"Abstract 3551: A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"microRNA; Cancer research; Medulloblastoma; Biology; Cancer; Carcinogenesis; Genetics; Gene","score_opus":0.07552390851186785,"score_gpt":0.3598332866735155,"score_spread":0.28430937816164764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561504086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977741,0.019274643,0.00019037901,0.00031265867,0.0011986246,0.00041142132,0.00016555337,0.000020641846,0.00068505475],"genre_scores_gemma":[0.98772764,0.0054739187,0.0011617021,0.00021046629,0.004604492,0.0002450854,0.00010208949,0.000041211293,0.00043340944],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973803,0.00021623717,0.0003310199,0.00067361764,0.00042818804,0.00097062724],"domain_scores_gemma":[0.9986372,0.00006356662,0.00009382691,0.00048788235,0.00034345023,0.0003740448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014426307,0.00023201876,0.00034671734,0.00012454676,0.00013113335,0.000056481033,0.000525473,0.00032042828,0.00011484066],"category_scores_gemma":[0.00035261404,0.00020147492,0.0001060272,0.00044659548,0.00037186092,0.000008079844,0.0003567981,0.0006162335,0.00004706437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015252798,0.00032779877,0.021715779,0.000037823003,0.00012005787,0.000015540973,0.0002539665,0.0024000541,0.8521277,0.00016249467,0.11259525,0.00871829],"study_design_scores_gemma":[0.0037320468,0.00046133882,0.058504805,0.00007813574,0.000012431193,0.000016368069,0.00031307424,0.000042293057,0.07061091,0.0007235795,0.8650115,0.0004935109],"about_ca_topic_score_codex":0.0029303294,"about_ca_topic_score_gemma":0.0018631032,"teacher_disagreement_score":0.78151673,"about_ca_system_score_codex":0.00012241153,"about_ca_system_score_gemma":0.000734678,"threshold_uncertainty_score":0.82159084},"labels":[],"label_agreement":null},{"id":"W2561523337","doi":"10.1158/1538-7445.am2015-3052","title":"Abstract 3052: NAMPT inhibition induces mitochondrial dysfunction leading to apoptosis in chronic lymphocytic leukemia cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Biology; Apoptosis; Programmed cell death; Mitochondrion; Cell biology; NAD+ kinase; Autophagy; Caspase; Chronic lymphocytic leukemia; Mitochondrial ROS; Apoptosis-inducing factor; Biochemistry; Leukemia; Immunology; Enzyme","score_opus":0.07224161997460704,"score_gpt":0.36225811349343806,"score_spread":0.290016493518831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561523337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945825,0.00044971996,0.0003700076,0.00015386676,0.0020662218,0.00048367985,0.000016267368,0.000019447307,0.0018583043],"genre_scores_gemma":[0.9942359,0.0002157386,0.00014105135,0.00019248192,0.0025003767,0.0003065785,0.00007971004,0.00003263727,0.0022955432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980166,0.0002015019,0.00026924137,0.00057928025,0.00038626802,0.00054713216],"domain_scores_gemma":[0.99905413,0.000033090004,0.000049111863,0.00032857765,0.00026478083,0.00027032153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006140568,0.000159979,0.00018154095,0.00030626988,0.0001047948,0.00006095128,0.00017484964,0.00031236754,0.00018254426],"category_scores_gemma":[0.00025260999,0.00016360807,0.00005844323,0.00047441546,0.00009277034,0.000014969122,0.00013495082,0.00034088275,0.00038122264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054002827,0.000011066316,0.000045364857,0.00002709098,0.000010610275,0.0000053940134,0.0001639954,0.004624319,0.9593388,0.000018093855,0.033330973,0.0018843022],"study_design_scores_gemma":[0.0016048502,0.00049981073,0.00009891626,0.00006762398,0.0000042026472,0.000004636806,0.0001869662,0.000038242713,0.9501113,0.000054462078,0.047140807,0.00018813448],"about_ca_topic_score_codex":0.0012577396,"about_ca_topic_score_gemma":0.0011688024,"teacher_disagreement_score":0.013809834,"about_ca_system_score_codex":0.004192403,"about_ca_system_score_gemma":0.0032271673,"threshold_uncertainty_score":0.99963033},"labels":[],"label_agreement":null},{"id":"W2561547425","doi":"10.1158/1538-7445.am2015-2292","title":"Abstract 2292: The role of immature colon carcinoma transcript 1 during c-myc deregulation in fast-onset mouse plasmacytoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Biology; Molecular biology; Retrovirus; Apoptosis; Metaphase; Transfection; Cancer research; Chromosomal translocation; Cell culture; Gene; Chromosome; Genetics","score_opus":0.03761822747853651,"score_gpt":0.34171263726892687,"score_spread":0.3040944097903904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561547425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960369,0.0018391021,0.0000044920916,0.0005043355,0.000037838825,0.00054590503,0.00005707202,0.0000063075936,0.0009680837],"genre_scores_gemma":[0.9985447,0.000107572334,0.000020347901,0.000014330858,0.00010854979,0.0001693594,0.000055829067,0.000022655327,0.00095667125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825644,0.00021037809,0.00022057901,0.0002921879,0.00059732364,0.0004230825],"domain_scores_gemma":[0.99902046,0.000027283786,0.000044706965,0.00038417103,0.00038848064,0.000134895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008003185,0.00011082573,0.00012705401,0.00016290708,0.00010721758,0.00003729802,0.00034625377,0.0001723079,0.000073117015],"category_scores_gemma":[0.00015266385,0.00008841075,0.000054299704,0.0003487939,0.00018291025,0.000010724302,0.0001031871,0.00039739782,0.0000121286575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014351053,0.000055104134,0.013191629,0.00005061639,0.00001538833,0.0000066250404,0.00060865225,0.00059005956,0.9817322,0.000028637429,0.00067751756,0.0016084696],"study_design_scores_gemma":[0.0010729672,0.00012215621,0.09818934,0.000022228809,0.0000018209913,0.000006562264,0.000933459,0.0002371353,0.8938902,0.00009410339,0.0053377277,0.00009228362],"about_ca_topic_score_codex":0.0011658937,"about_ca_topic_score_gemma":0.0018069171,"teacher_disagreement_score":0.08784198,"about_ca_system_score_codex":0.00011115704,"about_ca_system_score_gemma":0.0004604742,"threshold_uncertainty_score":0.3605286},"labels":[],"label_agreement":null},{"id":"W2561575791","doi":"10.1158/1538-7445.am2015-4621","title":"Abstract 4621: Validation and calibration of next-generation sequencing to identify Epstein-Barr Virus-positive gastric cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Cancer; Exome sequencing; Concordance; Epstein–Barr virus; DNA sequencing; Microsatellite instability; Comparative genomic hybridization; Genome; In situ hybridization; Polymerase chain reaction; Virus; Virology; Genetics; Mutation; Gene; Microsatellite; Gene expression","score_opus":0.19364654590463093,"score_gpt":0.42740071792378725,"score_spread":0.23375417201915633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561575791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942259,0.0023653207,0.00034064485,0.0014214481,0.00018284867,0.0006561834,0.00006731744,0.000021558932,0.00071873615],"genre_scores_gemma":[0.99799556,0.0007401598,0.00008229431,0.00022520492,0.00035139223,0.00018468137,0.000075808406,0.00002512718,0.00031977735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981637,0.00011771472,0.0002822973,0.0003216897,0.000778711,0.00033587613],"domain_scores_gemma":[0.9986179,0.00004709253,0.000096851945,0.00016871309,0.0007775236,0.0002919351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083093386,0.00011697835,0.00022392675,0.00030205504,0.00012225437,0.00008700095,0.00007514096,0.00011058774,0.00019296994],"category_scores_gemma":[0.00026245427,0.0001119839,0.00003792565,0.00071416737,0.00008170659,0.00034892996,0.000043666678,0.00026384942,0.000008476051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033429055,0.000034880202,0.0072377953,0.00009195365,0.000059045007,0.0000063572634,0.0018864505,0.0016923116,0.9654791,0.000054143977,0.011803777,0.011319913],"study_design_scores_gemma":[0.0036398533,0.0008779549,0.03534794,0.0006168771,0.00011115562,0.0000057567786,0.0037445861,0.0036594481,0.9508015,0.00030518367,0.00057233544,0.00031741563],"about_ca_topic_score_codex":0.01531415,"about_ca_topic_score_gemma":0.0023285572,"teacher_disagreement_score":0.028110143,"about_ca_system_score_codex":0.0012616942,"about_ca_system_score_gemma":0.001320656,"threshold_uncertainty_score":0.99124295},"labels":[],"label_agreement":null},{"id":"W2561604636","doi":"10.1158/1538-7445.am2015-2783","title":"Abstract 2783: Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Ovarian cancer; Single-nucleotide polymorphism; Breast cancer; Expression quantitative trait loci; Genome-wide association study; Genotype; Biology; SNP; Genotyping; SNP genotyping; Locus (genetics); Cancer; Oncology; Genetics; Population; Cancer research; Medicine; Gene","score_opus":0.16659045416834,"score_gpt":0.4095085992838504,"score_spread":0.2429181451155104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561604636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883229,0.0037562752,0.0007962166,0.0049495497,0.0003832742,0.00036436148,0.00009631755,0.000015656125,0.0013154182],"genre_scores_gemma":[0.9958043,0.0006054888,0.00003029229,0.00022489937,0.00027620376,0.00026164035,0.00006803371,0.000023254095,0.0027058967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826086,0.00018489637,0.00017247349,0.0005022854,0.00051864004,0.00036085767],"domain_scores_gemma":[0.998853,0.000027533391,0.00006237777,0.00050349266,0.00032453626,0.0002290411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008695546,0.00013554894,0.00011459332,0.000051467527,0.00038932852,0.00007613705,0.00023615417,0.0001443232,0.0005215189],"category_scores_gemma":[0.000039350336,0.00009861013,0.00004581466,0.0001815418,0.00026986175,0.000009132158,0.0002760536,0.00028498136,0.00002316204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040921458,0.000034390807,0.0031786994,0.000021138167,0.00003324863,0.0000010763916,0.0000867343,0.00015578719,0.94956636,0.00032601392,0.032024696,0.014162609],"study_design_scores_gemma":[0.0032605503,0.000352369,0.29593614,0.00012516949,0.00003841335,0.00005861025,0.0022903883,0.00023717414,0.4975645,0.0052613583,0.19419193,0.00068337645],"about_ca_topic_score_codex":0.0014496265,"about_ca_topic_score_gemma":0.002440742,"teacher_disagreement_score":0.4520019,"about_ca_system_score_codex":0.00027039685,"about_ca_system_score_gemma":0.00051442086,"threshold_uncertainty_score":0.57102656},"labels":[],"label_agreement":null},{"id":"W2561696552","doi":"10.1158/1538-7445.am2015-lb-075","title":"Abstract LB-075: The histone demethylase JMJD1A is essential to prostate cancer cells through regulation of c-Myc expression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Demethylase; Gene knockdown; Cancer research; Gene silencing; Biology; Prostate cancer; Cancer cell; EZH2; Epigenetics; Cell growth; Cell cycle; Molecular biology; Cancer; Chemistry; Apoptosis; Gene; Genetics","score_opus":0.07340472411262597,"score_gpt":0.43023688550083283,"score_spread":0.35683216138820684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561696552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874906,0.009326378,0.00053379126,0.0010753967,0.00029696117,0.0005190664,0.00007772576,0.000005542089,0.0006745356],"genre_scores_gemma":[0.9950177,0.0021029557,0.00035951397,0.00008884051,0.0004452574,0.0001856215,0.000034691868,0.00002863684,0.0017367804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828565,0.00015925734,0.00026021525,0.0003744858,0.00059152715,0.00032886633],"domain_scores_gemma":[0.9985163,0.000027092634,0.00010503356,0.00047054695,0.00074108,0.00013990565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087766355,0.0001228724,0.00013197905,0.000058868118,0.00013328278,0.000031377676,0.00026666583,0.0001326867,0.00012248212],"category_scores_gemma":[0.00010334841,0.00009288918,0.00005312377,0.00027673267,0.00015893544,0.000010431238,0.00018484995,0.00017363709,0.0000140247475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026658678,0.00003881893,0.0002823244,0.000035414323,0.00002113106,6.134136e-7,0.0009575098,0.0014773206,0.9795343,0.000014839628,0.014230478,0.0031406526],"study_design_scores_gemma":[0.0003590642,0.00012038758,0.0012224305,0.00004643386,0.000008313572,1.3623234e-7,0.00015103028,0.000026397704,0.9268426,0.00029064703,0.07082487,0.000107714506],"about_ca_topic_score_codex":0.001538358,"about_ca_topic_score_gemma":0.00022870586,"teacher_disagreement_score":0.05659439,"about_ca_system_score_codex":0.000090681875,"about_ca_system_score_gemma":0.0004463189,"threshold_uncertainty_score":0.3787911},"labels":[],"label_agreement":null},{"id":"W2561713551","doi":"10.1158/1538-7445.am2015-lb-212","title":"Abstract LB-212: Treehouse Childhood Cancer Project: a resource for sharing and multiple cohort analysis of pediatric cancer genomics data","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric cancer; Cancer; Genomics; Medicine; Carcinogenesis; Bioinformatics; Epigenetics; Cohort; Oncology; Computational biology; Genome; Gene; Genetics; Biology; Internal medicine","score_opus":0.2870224525171429,"score_gpt":0.4757871909772516,"score_spread":0.18876473846010866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561713551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744475,0.01716228,0.000030955438,0.001966516,0.00017044021,0.0026285108,0.0032652938,0.000075791526,0.00025269922],"genre_scores_gemma":[0.98666936,0.008343229,0.0003935806,0.00031612642,0.0021334442,0.0009144248,0.0005245158,0.0001397712,0.0005655607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512196,0.00014252418,0.0008596037,0.0014088168,0.0015265581,0.0009405516],"domain_scores_gemma":[0.9956817,0.0005914951,0.00033480962,0.0018879583,0.0009037506,0.00060029037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042463527,0.00033346182,0.0011355979,0.0011918185,0.00021445533,0.0000928316,0.0009820113,0.00021295044,0.00011614229],"category_scores_gemma":[0.0013533586,0.000317548,0.00018888513,0.0024616728,0.00028161405,0.00026228945,0.0008413997,0.000734149,0.000002787277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001377392,0.0003857067,0.9568107,0.0010269795,0.0032960395,0.000011043783,0.006564992,0.0008919876,0.0007994047,0.000015168007,0.023878334,0.0049422686],"study_design_scores_gemma":[0.00986858,0.00046619514,0.92138094,0.0005371046,0.006074515,0.0000065991358,0.0039607775,0.009955439,0.0018974544,0.00007712267,0.044874094,0.0009011839],"about_ca_topic_score_codex":0.078303225,"about_ca_topic_score_gemma":0.03587778,"teacher_disagreement_score":0.042425446,"about_ca_system_score_codex":0.0009248416,"about_ca_system_score_gemma":0.0035536457,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W2561747224","doi":"10.1158/1538-7445.am2015-1958","title":"Abstract 1958: Interaction between keratin intermediate filament proteins K8/18 and cancer related signal transduction proteins in epithelial cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Keratin 8; Intermediate filament; Keratin; Epithelial–mesenchymal transition; Cell biology; Protein kinase B; Biology; Vimentin; PI3K/AKT/mTOR pathway; Gene knockdown; Signal transduction; Cell; Cancer research; Wnt signaling pathway; Keratin 14; Cytoskeleton; Cancer; Cell culture; Immunology; Metastasis; Genetics; Transgene","score_opus":0.06579935596783996,"score_gpt":0.3767531071743827,"score_spread":0.31095375120654273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561747224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962398,0.0013941884,0.000049823895,0.00049854873,0.00019280706,0.0011748801,0.000070057315,0.000015057701,0.00036485973],"genre_scores_gemma":[0.9960082,0.0015431772,0.000056855184,0.000017014454,0.00059213105,0.0008464802,0.00011475857,0.000030922212,0.0007904624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977402,0.0004058502,0.0003204671,0.000575729,0.00039926148,0.0005584856],"domain_scores_gemma":[0.9991859,0.000031337233,0.00006438877,0.00023954947,0.00024346386,0.00023536905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014237989,0.00017116423,0.00020139654,0.00019721454,0.00010749655,0.00006024901,0.00022837783,0.00030768354,0.0003514461],"category_scores_gemma":[0.00006690021,0.0001603002,0.000052270996,0.00024532914,0.00027194046,0.000017092594,0.00013929434,0.0007650608,0.000026752283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000491157,0.0001003029,0.0041127,0.00006031502,0.00007043269,0.000022170414,0.00047353396,0.0000499413,0.9681122,0.0000046641617,0.0006695862,0.025833042],"study_design_scores_gemma":[0.0014291924,0.0006374408,0.0062483875,0.00010255435,0.000007959686,0.0000075867665,0.00032277725,0.00007175269,0.98207724,0.000100598474,0.008796177,0.00019831552],"about_ca_topic_score_codex":0.00135164,"about_ca_topic_score_gemma":0.00052771845,"teacher_disagreement_score":0.025634727,"about_ca_system_score_codex":0.00025043188,"about_ca_system_score_gemma":0.000570516,"threshold_uncertainty_score":0.6536853},"labels":[],"label_agreement":null},{"id":"W2561772980","doi":"10.1158/1538-7445.transcagen-a2-38","title":"Abstract A2-38: Interpretation and classification system for somatic variants identified in solid tumor molecular profiling","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Germline; Computational biology; Somatic cell; Germline mutation; In silico; Biology; Genetics; Bioinformatics; Gene; Mutation","score_opus":0.07298437890072526,"score_gpt":0.3983998149026422,"score_spread":0.3254154360019169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561772980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687576,0.0012552335,0.00076041196,0.000071595714,0.000111433415,0.0005644346,0.0000331559,0.000005690344,0.00032228688],"genre_scores_gemma":[0.9991758,0.0000397773,0.00015478724,0.000015024709,0.000075901335,0.00038549677,0.000087776294,0.000016942124,0.000048507667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999131,0.00006334629,0.0001749731,0.00027218656,0.00014704929,0.00021142045],"domain_scores_gemma":[0.99940336,0.000016626775,0.000048426748,0.00017404101,0.00025832202,0.00009924976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006138282,0.000070508344,0.0000924894,0.00008480124,0.000049559123,0.0000661602,0.00011628167,0.000056335437,0.0000016829295],"category_scores_gemma":[0.0001917671,0.000068195506,0.000026361442,0.00007866075,0.000043231288,0.0000066192433,0.000054770433,0.00006876654,0.0000041010126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019590075,0.000027465483,0.0006321752,0.00030750755,0.00001909336,0.0000073496954,0.00012175203,0.00013786156,0.9973673,0.0002557503,0.0001527464,0.0007750692],"study_design_scores_gemma":[0.0022329101,0.00024642065,0.021181462,0.00042241113,0.000023140694,0.000018113757,0.0055412264,0.013503399,0.9549356,0.0011736781,0.00038423567,0.00033737597],"about_ca_topic_score_codex":0.000043780194,"about_ca_topic_score_gemma":0.000032687825,"teacher_disagreement_score":0.0424317,"about_ca_system_score_codex":0.0000829068,"about_ca_system_score_gemma":0.00028683068,"threshold_uncertainty_score":0.27809322},"labels":[],"label_agreement":null},{"id":"W2561844368","doi":"10.1158/1538-7445.am2015-5518","title":"Abstract 5518: Development of bio-affinity nanoparticles: Applications for cancer imaging and therapeutics","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Jewish General Hospital","funders":"","keywords":"Cancer cell; Cancer research; Cancer; Immune system; Cell; Somatic cell; Medicine; Biology; Immunology; Gene; Genetics","score_opus":0.14299810998570603,"score_gpt":0.45776249141185577,"score_spread":0.3147643814261497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561844368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868214,0.011443026,0.00033061995,0.0003939085,0.000030201745,0.0006786441,0.000103151164,0.000006033433,0.00019301588],"genre_scores_gemma":[0.99612784,0.0011465799,0.00065791834,0.000039356808,0.00011201645,0.00171322,0.0000355181,0.000017705646,0.00014985896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989624,0.000029751985,0.00015002632,0.00026290765,0.00025423162,0.00034066167],"domain_scores_gemma":[0.9991057,0.000027811751,0.000037170867,0.00020544174,0.0004526772,0.00017122815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004467239,0.00008402482,0.00009785664,0.00005916137,0.0001396795,0.00002875555,0.00015295351,0.00004164367,0.000012976872],"category_scores_gemma":[0.00002835212,0.000074448675,0.00002647239,0.00013649778,0.0001880571,0.0000057974453,0.000112698086,0.00007885913,0.000003163344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030746005,0.00012418746,0.013092365,0.00009955385,0.00012441166,6.147572e-7,0.00031499483,0.000014265484,0.84924924,0.000053127405,0.0012059885,0.1354138],"study_design_scores_gemma":[0.00095950224,0.0000775399,0.0036081308,0.000022796808,0.000008547567,7.411244e-7,0.0002903938,0.000019593786,0.82245636,0.000210238,0.1722525,0.00009363375],"about_ca_topic_score_codex":0.00043811466,"about_ca_topic_score_gemma":0.0010525242,"teacher_disagreement_score":0.17104653,"about_ca_system_score_codex":0.000102716156,"about_ca_system_score_gemma":0.0010336734,"threshold_uncertainty_score":0.3035929},"labels":[],"label_agreement":null},{"id":"W2561844421","doi":"10.1158/1538-7445.am2015-1659","title":"Abstract 1659: The non-cardiotoxic anticancer drug pixantrone targets topoisomerase II","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Doxorubicin; Chemistry; Pharmacology; Cardiotoxicity; Topoisomerase; Anthracycline; Biochemistry; Medicine; Cancer; Toxicity; Chemotherapy; DNA; Internal medicine","score_opus":0.06262453649612093,"score_gpt":0.3869299334248218,"score_spread":0.32430539692870086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561844421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97784406,0.01294243,0.00021281735,0.0037560202,0.00080046215,0.00061631587,0.00006510633,0.00001535692,0.003747426],"genre_scores_gemma":[0.99038595,0.0026928242,0.00004833004,0.0006221302,0.0014174138,0.00030388226,0.000027557864,0.000045245913,0.004456675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793166,0.000099691904,0.00019389196,0.0004627426,0.0006337493,0.00067823945],"domain_scores_gemma":[0.99856454,0.000024687633,0.000050883213,0.00069552317,0.00039509585,0.0002692614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317756,0.00017763829,0.00018899531,0.00006480106,0.00036432705,0.00006992166,0.00052923284,0.00011007568,0.00019370065],"category_scores_gemma":[0.000054189743,0.0001301503,0.00011261116,0.00024116626,0.0002510746,0.000007430516,0.00034663096,0.0003757262,0.000057072957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028862891,0.000070299044,0.00016427504,0.000021226877,0.0001312742,0.000009755373,0.00043608045,0.00012793738,0.93026364,0.00016458366,0.05994529,0.008377007],"study_design_scores_gemma":[0.00088557665,0.00020575032,0.00050917704,0.000023400125,0.000013821061,0.0000048495463,0.00042759484,0.00004390785,0.55682445,0.00047901223,0.4403792,0.00020327294],"about_ca_topic_score_codex":0.00062714284,"about_ca_topic_score_gemma":0.00029902838,"teacher_disagreement_score":0.38043392,"about_ca_system_score_codex":0.00014126021,"about_ca_system_score_gemma":0.0007570596,"threshold_uncertainty_score":0.5307376},"labels":[],"label_agreement":null},{"id":"W2561846910","doi":"10.1158/1538-7445.am2015-3162","title":"Abstract 3162: NOD1 augments cancer cell metastatic potential through p38 MAP kinase activation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"NOD1; Biology; Cell biology; Cancer research; A549 cell; Cancer cell; Immunology; Chemistry; Immune system; Cell; Cancer; Innate immune system; Biochemistry; NOD2","score_opus":0.1889657898247708,"score_gpt":0.4691410370412729,"score_spread":0.2801752472165021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561846910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799039,0.003592983,0.00026392174,0.0047323117,0.00041978824,0.0015782798,0.000060979623,0.000070210255,0.009377668],"genre_scores_gemma":[0.98192585,0.0014993139,0.00046760484,0.00032499863,0.00054937694,0.0005917621,0.00008925936,0.0000912078,0.014460621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994682,0.0002721192,0.00038388337,0.00058294326,0.0030094553,0.0010695884],"domain_scores_gemma":[0.9970326,0.00014218008,0.00009148832,0.0006776479,0.0013471878,0.0007089053],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012196583,0.00024351792,0.00036867574,0.00018610236,0.00021233158,0.00011369802,0.0003847995,0.00013115947,0.0068283468],"category_scores_gemma":[0.00024938362,0.0002101365,0.000121943034,0.00068413455,0.00026688998,0.00036957953,0.00029222388,0.0010192974,0.00091381586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001762635,0.00065539376,0.0006829815,0.0007604665,0.00015497208,0.0004077002,0.0008663643,0.00024746874,0.868914,0.000031484655,0.109000154,0.016516378],"study_design_scores_gemma":[0.007526965,0.0006884529,0.007607128,0.0006129793,0.00009436017,0.0000134311385,0.0028722887,0.0004792756,0.8715568,0.0005619589,0.10753405,0.00045227888],"about_ca_topic_score_codex":0.016416306,"about_ca_topic_score_gemma":0.00029438103,"teacher_disagreement_score":0.016121924,"about_ca_system_score_codex":0.0020733366,"about_ca_system_score_gemma":0.0019240177,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W2561944026","doi":"10.1158/1538-7445.am2015-2377","title":"Abstract 2377: Bone-derived osteopontin mediates the migration and stem-like properties of breast cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Osteopontin; Cancer stem cell; CD44; Breast cancer; Cancer research; Cancer; Bone marrow; Cancer cell; Population; Bone metastasis; Tumor microenvironment; Stem cell; Metastasis; Pathology; Medicine; Biology; Immunology; Internal medicine; Cell; Cell biology","score_opus":0.11945237359223489,"score_gpt":0.36371036081289077,"score_spread":0.2442579872206559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561944026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575023,0.034580924,4.8955565e-7,0.0067193364,0.00013879966,0.0006660285,0.000029492789,0.000015750968,0.00034688777],"genre_scores_gemma":[0.9938333,0.0039044067,0.000007973027,0.0001038692,0.00021885568,0.00027955938,0.0000017027481,0.000016548416,0.0016337823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986065,0.00007782574,0.00020569653,0.0001970834,0.00064443215,0.00026843997],"domain_scores_gemma":[0.9989947,0.00005303249,0.000058436224,0.00019756833,0.00057080964,0.00012545819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000692561,0.000102076694,0.00023638213,0.00007416564,0.00012223572,0.00003093792,0.00008222397,0.000056592762,0.000051880892],"category_scores_gemma":[0.000035270696,0.000057239977,0.000033623954,0.00019438492,0.0004960262,0.000097825934,0.00012125046,0.000263724,0.000016370392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094591425,0.00006663744,0.0136655625,0.00046388505,0.00009220446,0.000013383884,0.004690339,0.0000040513455,0.95407766,0.000007261056,0.015042442,0.010930668],"study_design_scores_gemma":[0.0018239511,0.00024019349,0.09459488,0.0008050332,0.000056775058,0.000024152801,0.0135815805,0.000040586357,0.8838417,0.000049462105,0.004785964,0.00015572128],"about_ca_topic_score_codex":0.012041837,"about_ca_topic_score_gemma":0.00340567,"teacher_disagreement_score":0.08092932,"about_ca_system_score_codex":0.000098708624,"about_ca_system_score_gemma":0.00031996478,"threshold_uncertainty_score":0.99453706},"labels":[],"label_agreement":null},{"id":"W2561948781","doi":"10.1158/1538-7445.am2015-732","title":"Abstract 732: Using functional and chemical genomics to identify mechanisms of Enzalutamide resistance in prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Cancer research; Pharmacology; In vivo; Kinome; Cancer; Cancer cell; Signal transduction; Medicine; Biology; Internal medicine; Cell biology; Genetics","score_opus":0.1873124095930199,"score_gpt":0.46109082513293187,"score_spread":0.273778415539912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561948781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897291,0.0068432526,0.00003841586,0.001732846,0.00012687323,0.00094812206,0.000086310196,0.00001371743,0.00048136432],"genre_scores_gemma":[0.99615324,0.0009175451,0.0008265587,0.000076097764,0.00015665135,0.00030814824,0.000015688696,0.000037435293,0.0015086355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975484,0.00006597364,0.000317505,0.00045779068,0.0009924817,0.00061785866],"domain_scores_gemma":[0.9984566,0.00008949621,0.00005099516,0.00025572837,0.0006823805,0.0004648093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867777,0.00014655221,0.00032418725,0.00040599797,0.00006743191,0.000037550843,0.00012802337,0.000090338996,0.000156671],"category_scores_gemma":[0.00016665773,0.00012708039,0.000040104213,0.00071987754,0.00024520108,0.00011904076,0.00017640572,0.00047338984,0.000010353661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046459707,0.00012000984,0.012733941,0.00042268672,0.000073646916,0.000114407696,0.0012075553,0.00012133631,0.97627884,0.00028266074,0.0021133323,0.0018856252],"study_design_scores_gemma":[0.007562294,0.00029255054,0.08262184,0.0015507026,0.000046939233,0.000017876982,0.0015383059,0.00016637177,0.894197,0.007552756,0.0040942444,0.00035912366],"about_ca_topic_score_codex":0.001985717,"about_ca_topic_score_gemma":0.0007735681,"teacher_disagreement_score":0.08208183,"about_ca_system_score_codex":0.0017346469,"about_ca_system_score_gemma":0.002035278,"threshold_uncertainty_score":0.5182188},"labels":[],"label_agreement":null},{"id":"W2561988372","doi":"10.1158/1538-7445.am2015-lb-194","title":"Abstract LB-194: Cesarean delivery and risk of childhood leukemia: findings from the Childhood Leukemia International Consortium (CLIC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Odds ratio; Childhood leukemia; Confidence interval; Leukemia; Myeloid leukemia; Case-control study; Logistic regression; Pediatrics; Internal medicine; Lymphoblastic Leukemia","score_opus":0.06506656250840445,"score_gpt":0.3485528819392167,"score_spread":0.28348631943081226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561988372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97459006,0.015640434,0.0000043532496,0.0016172319,0.0002486307,0.00044808144,0.00036195782,0.00003063102,0.007058628],"genre_scores_gemma":[0.98431665,0.014524448,0.000067863795,0.00018276568,0.00048778,0.00007765471,0.000044717264,0.000023181672,0.000274921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791574,0.00014785027,0.00031544248,0.0003841854,0.00085175445,0.00038502165],"domain_scores_gemma":[0.9981531,0.0007286014,0.00010623222,0.00040756114,0.00040028893,0.00020419637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010853048,0.00016776618,0.0003235912,0.000114653696,0.00024556826,0.00004299634,0.00036929603,0.00013644766,0.0002163672],"category_scores_gemma":[0.00091117783,0.000116404146,0.0000848496,0.00021595189,0.00058283407,0.00014093732,0.00034639877,0.0010574037,0.000028566874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006588963,0.00013746477,0.92585236,0.00006987886,0.0012563344,0.000045119345,0.012057205,0.000031790863,0.0017816225,0.00018316555,0.03686614,0.021060035],"study_design_scores_gemma":[0.0027426127,0.00013222486,0.9822249,0.000614466,0.000100254,0.000012067409,0.0017138245,0.00002289309,0.0056067687,0.0009683409,0.0057357997,0.00012587248],"about_ca_topic_score_codex":0.008560055,"about_ca_topic_score_gemma":0.0007422591,"teacher_disagreement_score":0.056372527,"about_ca_system_score_codex":0.00052243087,"about_ca_system_score_gemma":0.0012113224,"threshold_uncertainty_score":0.99804205},"labels":[],"label_agreement":null},{"id":"W2561995968","doi":"10.1158/1538-7445.panca16-b47","title":"Abstract B47: Nanoliposomal irinotecan (nal-IRI) is an active treatment and reduces hypoxia as measured through longitudinal imaging using [18F]FAZA-PET in an orthotopic patient-derived model of pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Irinotecan; Hypoxia (environmental); Medicine; Tumor hypoxia; Pancreatic cancer; Pharmacodynamics; Pancreatic tumor; Positron emission tomography; Colorectal cancer; Cancer; Nuclear medicine; Active metabolite; Pharmacokinetics; Internal medicine; Cancer research; Chemistry; Radiation therapy","score_opus":0.10884963888032254,"score_gpt":0.39071895281989494,"score_spread":0.2818693139395724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561995968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921299,0.006592992,0.000034657223,0.00015658232,0.00018092195,0.0005274306,0.00026321097,0.000009615124,0.000104660656],"genre_scores_gemma":[0.99183685,0.0070214174,0.00024600542,0.000050083385,0.0004538486,0.00024631692,0.000017632337,0.00004696812,0.000080873186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976241,0.00018185985,0.0003363012,0.0007980729,0.00039888758,0.0006607924],"domain_scores_gemma":[0.99874,0.000024968995,0.00013967679,0.0004912111,0.00038936216,0.0002147356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021571947,0.0002833305,0.0003961475,0.00014856971,0.00016208427,0.000044431432,0.00022709821,0.00010041376,0.00008773817],"category_scores_gemma":[0.000044793695,0.00022079142,0.00008505527,0.00018533914,0.00040195775,0.00007700537,0.00011234458,0.00015598697,9.074236e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074202206,0.00017320708,0.004796933,0.000036909445,0.000094212024,0.0000076016413,0.0011253472,0.00018085445,0.9461426,0.000007855153,0.00002743794,0.04666503],"study_design_scores_gemma":[0.0014677413,0.00044296568,0.011258114,0.00018432477,0.00005074174,0.000015914318,0.0004926546,0.00021991391,0.98491096,0.0001616276,0.0005071039,0.0002879553],"about_ca_topic_score_codex":0.008515026,"about_ca_topic_score_gemma":0.0041818656,"teacher_disagreement_score":0.046377074,"about_ca_system_score_codex":0.0003016031,"about_ca_system_score_gemma":0.0011361532,"threshold_uncertainty_score":0.99808735},"labels":[],"label_agreement":null},{"id":"W2562019564","doi":"10.1158/1538-7445.am2015-2075","title":"Abstract 2075: Signaling thresholds and negative B cell selection in acute lymphoblastic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"breakpoint cluster region; Syk; Bruton's tyrosine kinase; Cancer research; Immunoreceptor tyrosine-based activation motif; Tyrosine kinase; Signal transduction; B-cell receptor; Biology; Receptor; Tyrosine phosphorylation; Phosphorylation; Tyrosine; Cell biology; Chronic lymphocytic leukemia; Leukemia; Immunology; B cell; Antibody; Biochemistry","score_opus":0.1374810381576881,"score_gpt":0.3949631932884652,"score_spread":0.2574821551307771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562019564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924931,0.0004036627,0.0000065614454,0.00010526424,0.000020392341,0.00008036082,0.0000075170215,0.000018275285,0.006864848],"genre_scores_gemma":[0.99910635,0.00017896581,0.00005049663,0.000017435279,0.00015115406,0.00008344795,0.000004155545,0.000009376214,0.0003985925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988501,0.000058550784,0.00014958747,0.0002688103,0.00038117782,0.00029177766],"domain_scores_gemma":[0.9992564,0.00032313008,0.000036889993,0.000068795714,0.00020100364,0.000113787726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091003155,0.00008397039,0.0001189274,0.0000707439,0.00007767455,0.000053691998,0.00010467255,0.00013438,0.00074386556],"category_scores_gemma":[0.00028396252,0.00006538033,0.000018708439,0.00023650563,0.00010097598,0.00008257089,0.00005353121,0.00028654464,0.000027562255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019005047,0.000026861562,0.012408727,0.000040050938,0.000011532565,0.0000060128355,0.000251601,0.00039866142,0.9806811,0.000009720642,0.0005381943,0.0054374808],"study_design_scores_gemma":[0.00083712756,0.00006543632,0.015984897,0.000108498694,0.000008523852,0.0000024792298,0.00050340913,0.001996967,0.97868544,0.0013907204,0.00028510447,0.00013137211],"about_ca_topic_score_codex":0.000813424,"about_ca_topic_score_gemma":0.00014671532,"teacher_disagreement_score":0.006613258,"about_ca_system_score_codex":0.00083173264,"about_ca_system_score_gemma":0.00042933453,"threshold_uncertainty_score":0.81448066},"labels":[],"label_agreement":null},{"id":"W2562145218","doi":"10.1158/1538-7445.am2015-1643","title":"Abstract 1643: Discovery of 1-benzylquinazoline-2,4(1H,3H)-diones as novel and potent PARP inhibitors. SAR of the benzyl group","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Olaparib; Poly ADP ribose polymerase; Cancer; Medicine; In vivo; PARP inhibitor; Breast cancer; Polymerase; Stereochemistry; Cancer research; Pharmacology; Enzyme; Biology; Chemistry; Internal medicine; Biochemistry; Genetics","score_opus":0.1411121291192604,"score_gpt":0.42598993652514633,"score_spread":0.2848778074058859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562145218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867391,0.0056583183,0.000029709245,0.0038369538,0.0004331517,0.0007605357,0.00014461907,0.000018783769,0.0023788374],"genre_scores_gemma":[0.99713343,0.0012038323,0.00007683618,0.00018458469,0.000601973,0.00008486615,0.000011893751,0.000040942767,0.000661641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997062,0.00009877192,0.00052263733,0.0003836072,0.0014891129,0.00044384832],"domain_scores_gemma":[0.99800825,0.00018267702,0.00019931591,0.00063823164,0.00072195294,0.00024959195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012404326,0.00018433179,0.00043254028,0.00021612695,0.000101945894,0.000030320281,0.00026660762,0.00014365213,0.000096608586],"category_scores_gemma":[0.00026511232,0.00012854776,0.00013191682,0.0005934554,0.000836819,0.00022417936,0.00021193195,0.0005632526,0.000009713332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021974547,0.0007039591,0.017648121,0.0007586644,0.0001982468,0.00002113841,0.0017170487,0.0001279738,0.9534702,0.002723085,0.016178327,0.0042557926],"study_design_scores_gemma":[0.007841965,0.0010342111,0.080905214,0.0019964057,0.00006605972,0.00007463275,0.0019428071,0.000044570792,0.8828489,0.0021020088,0.020838173,0.0003050376],"about_ca_topic_score_codex":0.002647155,"about_ca_topic_score_gemma":0.0001477651,"teacher_disagreement_score":0.070621274,"about_ca_system_score_codex":0.00036162607,"about_ca_system_score_gemma":0.0008981463,"threshold_uncertainty_score":0.5242026},"labels":[],"label_agreement":null},{"id":"W2562284149","doi":"10.1158/1538-7445.am2015-2902","title":"Abstract 2902: The effectiveness of autophagy inhibition in sensitizing triple-negative breast cancer cells to chemotherapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Autophagy; In vivo; Triple-negative breast cancer; Breast cancer; Chemotherapy; Cancer research; Epirubicin; Cancer; Biology; Medicine; Oncology; Pharmacology; Internal medicine; Apoptosis","score_opus":0.04962968147773571,"score_gpt":0.3868326647716493,"score_spread":0.33720298329391357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562284149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971653,0.00069181644,0.00010526064,0.0007243542,0.00014637427,0.00056138844,0.00010250779,0.000004084382,0.00049889245],"genre_scores_gemma":[0.9985986,0.00046347192,0.000028324424,0.00009357655,0.00020434977,0.00042541017,0.00000992232,0.000019911618,0.00015648169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865955,0.00032030157,0.0001618389,0.0002973832,0.0002836181,0.0002772914],"domain_scores_gemma":[0.9989721,0.00009423157,0.000045389625,0.00029617234,0.0004962727,0.00009584284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016107922,0.00009835823,0.0001364875,0.00009322229,0.00006377777,0.000023363034,0.00013236889,0.00008619994,0.00003960935],"category_scores_gemma":[0.0000743299,0.000076198405,0.00004250744,0.00042024557,0.00014087505,0.0000073790325,0.000062514795,0.00018225427,0.0000068741124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000882268,0.000048192876,0.0003850602,0.000042118194,0.000023379174,0.0000025363358,0.00027921703,0.0015851115,0.9902751,0.000045215264,0.0014182988,0.0050135194],"study_design_scores_gemma":[0.00092816877,0.000074381525,0.05587129,0.0001187776,0.0000024069825,0.0000025611912,0.0002906198,0.00002840927,0.94128966,0.00010740922,0.0011948777,0.00009144961],"about_ca_topic_score_codex":0.0035015966,"about_ca_topic_score_gemma":0.0006099144,"teacher_disagreement_score":0.055486232,"about_ca_system_score_codex":0.0002190976,"about_ca_system_score_gemma":0.0004992263,"threshold_uncertainty_score":0.52933896},"labels":[],"label_agreement":null},{"id":"W2562289595","doi":"10.1158/1538-7445.am2015-3034","title":"Abstract 3034: A high-content screen to identify novel chromosome instability genes","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; University of Winnipeg; University of Manitoba","funders":"","keywords":"Biology; Gene; Chromosome instability; Gene silencing; Genetics; Carcinogenesis; Candidate gene; Phenotype; Genome instability; Telomere; Chromosome; Molecular biology; DNA; DNA damage","score_opus":0.25682102833611403,"score_gpt":0.4467256235494571,"score_spread":0.18990459521334307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562289595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442613,0.0022547455,0.0004445845,0.0013355955,0.00020103762,0.00042239606,0.00016389876,0.000012383224,0.0007392226],"genre_scores_gemma":[0.9967492,0.00032466595,0.00028680128,0.00016520539,0.00057052146,0.00041616533,0.000066316694,0.000024935673,0.0013961836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983376,0.000056135905,0.0002040862,0.0005080467,0.00046804713,0.00042603174],"domain_scores_gemma":[0.998145,0.000011719145,0.000034760724,0.0006802729,0.0007830593,0.00034519113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008857353,0.00011888133,0.00013081626,0.00008402667,0.00012154304,0.00007783873,0.0004341486,0.000113064445,0.00012790512],"category_scores_gemma":[0.00016338806,0.00010834794,0.000055932287,0.00027136467,0.00014424532,0.00000955197,0.00024540126,0.00017437886,0.00009886059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013420408,0.000089932786,0.0018637328,0.000016350354,0.00003088148,0.0000015375055,0.000059351427,0.000118134136,0.9820402,0.00012304945,0.0072001996,0.008322373],"study_design_scores_gemma":[0.0010057933,0.00025915852,0.13889414,0.000034451572,0.000007068189,0.000003044312,0.0003218576,0.0000074117074,0.6979969,0.00011222586,0.16108252,0.00027541522],"about_ca_topic_score_codex":0.0043607107,"about_ca_topic_score_gemma":0.0010841441,"teacher_disagreement_score":0.28404334,"about_ca_system_score_codex":0.00019467417,"about_ca_system_score_gemma":0.00059809815,"threshold_uncertainty_score":0.65921193},"labels":[],"label_agreement":null},{"id":"W2562303110","doi":"10.1158/1538-7445.am2015-4087","title":"Abstract 4087: Epithelial to mesenchymal transition in the metastatic progression of gastroenteropancreatic neuroendocrine tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Epithelial–mesenchymal transition; Metastasis; Neuroendocrine tumors; Cancer research; Phenotype; Gene expression; Biology; Primary tumor; Cancer; Pathology; Medicine; Gene; Internal medicine; Genetics","score_opus":0.11297072657130955,"score_gpt":0.45906893307458657,"score_spread":0.34609820650327705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562303110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853642,0.00031487006,0.000017473705,0.011574084,0.00006770414,0.002007165,0.000037711052,0.000023760631,0.00059300783],"genre_scores_gemma":[0.998274,0.00010436456,0.00035156248,0.0002513843,0.0001406327,0.0006557322,0.00001264855,0.00003696045,0.00017267093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952928,0.00064570544,0.00047709126,0.00042790777,0.0022110874,0.0009454387],"domain_scores_gemma":[0.9981844,0.00028987403,0.00006694506,0.00051608606,0.00047596602,0.00046673743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013235825,0.00018480983,0.00043375633,0.0006287143,0.00006824839,0.00003811188,0.00043039038,0.0000051063553,0.0001207827],"category_scores_gemma":[0.001075914,0.000120933306,0.000084699546,0.0012036663,0.00030370566,0.00018413302,0.000105505824,0.0008127939,0.00004670766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029272906,0.004442711,0.042402185,0.0040441337,0.00019017258,0.058517978,0.008272313,0.0020749597,0.7978309,0.000546021,0.01556332,0.036842432],"study_design_scores_gemma":[0.024676722,0.027750544,0.21860008,0.0059361816,0.00017761567,0.008455381,0.017240336,0.00081035617,0.67968476,0.0021595345,0.01370252,0.0008059976],"about_ca_topic_score_codex":0.00075297296,"about_ca_topic_score_gemma":0.00021767862,"teacher_disagreement_score":0.17619789,"about_ca_system_score_codex":0.00020934877,"about_ca_system_score_gemma":0.00052196014,"threshold_uncertainty_score":0.4931517},"labels":[],"label_agreement":null},{"id":"W2562309431","doi":"10.1158/1538-7445.am2015-2966","title":"Abstract 2966: The mutational landscape of localized gleason 6 and 7 prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Chromothripsis; Chromoplexy; Biology; Prostate; Malignancy; Cancer; Disease; Copy-number variation; Epigenetics; Genome; Genetics; Cancer research; Gene; Medicine; Pathology; Genome instability; PCA3; DNA damage","score_opus":0.1208963960530381,"score_gpt":0.45020692789471284,"score_spread":0.32931053184167475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562309431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512298,0.034151748,0.0000022229194,0.009619554,0.000094633775,0.0009315822,0.00008813435,0.00001806931,0.0038642352],"genre_scores_gemma":[0.98977274,0.0045618326,0.00003235524,0.00008264553,0.0002172333,0.00049354415,0.000032500237,0.000023152672,0.004783991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979263,0.00009990409,0.00019086248,0.0002648418,0.0010822858,0.00043579165],"domain_scores_gemma":[0.99834466,0.00018788558,0.000047502916,0.00023315138,0.0008936321,0.0002931692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010448499,0.00011082582,0.00022275979,0.00014799181,0.0001288487,0.000039140086,0.00013130241,0.000064743705,0.00059387676],"category_scores_gemma":[0.0001506323,0.00006339464,0.00004204709,0.00047715582,0.00056294544,0.00008464918,0.00009179057,0.00041700993,0.000019531311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020306349,0.0007361146,0.5306929,0.002092901,0.0010997236,0.0004379595,0.013610254,0.000343785,0.03909148,0.001239565,0.22207358,0.16827543],"study_design_scores_gemma":[0.040056795,0.0026684552,0.5490034,0.0024890767,0.00027055098,0.00011989777,0.012685335,0.0018468391,0.1280308,0.0046504685,0.25742483,0.0007534919],"about_ca_topic_score_codex":0.0022727395,"about_ca_topic_score_gemma":0.00019606538,"teacher_disagreement_score":0.16752194,"about_ca_system_score_codex":0.00022296706,"about_ca_system_score_gemma":0.0017179411,"threshold_uncertainty_score":0.6502534},"labels":[],"label_agreement":null},{"id":"W2562315687","doi":"10.1158/1538-7445.am2015-4171","title":"Abstract 4171: Novel regulatory role of Neuropilin-1 in endothelial to mesenchymal transition as a potential source of carcinoma associated fibroblasts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Biology; Epithelial–mesenchymal transition; Cancer research; Neuropilin 1; Transfection; Gene silencing; Mesenchymal stem cell; Molecular biology; Cell biology; Gene knockdown; Cancer cell; Cancer; Vascular endothelial growth factor; Cell culture; Metastasis; Gene; Biochemistry","score_opus":0.02965438119542559,"score_gpt":0.3167140125191691,"score_spread":0.2870596313237435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562315687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973101,0.0015008927,0.000051504663,0.00010203696,0.00024850274,0.00029997798,0.00012406088,0.000004660622,0.00035825776],"genre_scores_gemma":[0.9986628,0.00010443634,0.000037864684,0.000042638716,0.0006861311,0.00004152727,0.000031494044,0.000026635396,0.0003664209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983427,0.00011744546,0.00028495374,0.0003321307,0.00055004,0.0003727196],"domain_scores_gemma":[0.9989863,0.000017128768,0.00007450235,0.00029170432,0.0004443236,0.00018602512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006296322,0.00011695894,0.00022839919,0.00017587376,0.000030178175,0.000009379604,0.00022773501,0.000154909,0.000027128097],"category_scores_gemma":[0.00021789636,0.00012388956,0.00009234683,0.00026409418,0.00014679783,0.0000072039597,0.00008952081,0.00019964647,0.0000034478396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000922322,0.0001315779,0.00035982183,0.000032907486,0.000024632094,0.0000015973869,0.0006199738,0.0023433152,0.99253255,0.00001828568,0.0005288986,0.0024841225],"study_design_scores_gemma":[0.0021160962,0.0004582259,0.02684657,0.000056540543,0.000011123272,0.0000047604267,0.0005052566,0.00007343657,0.96020937,0.00004903347,0.009525199,0.00014437795],"about_ca_topic_score_codex":0.004416385,"about_ca_topic_score_gemma":0.00084182416,"teacher_disagreement_score":0.032323167,"about_ca_system_score_codex":0.00007133915,"about_ca_system_score_gemma":0.0008228598,"threshold_uncertainty_score":0.6676283},"labels":[],"label_agreement":null},{"id":"W2562400679","doi":"10.1158/1538-7445.am2015-2782","title":"Abstract 2782: Risk loci for a breast-colon cancer phenotype: results from a genome-wide association study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Colorectal cancer; Genome-wide association study; Single-nucleotide polymorphism; Medicine; Family history; Oncology; Cancer; Population; Genetics; Internal medicine; Biology; Genotype; Gene","score_opus":0.05770284508850116,"score_gpt":0.38122453892918146,"score_spread":0.3235216938406803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562400679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864725,0.004878495,0.000059023274,0.0009228813,0.00023379478,0.001086585,0.006067436,0.000015640215,0.0002636846],"genre_scores_gemma":[0.99412185,0.0013702768,0.00007890217,0.00015411826,0.0016656328,0.00078760943,0.000658055,0.000038999973,0.0011245608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978479,0.00021463448,0.00027724076,0.0006040023,0.0005468055,0.00050941354],"domain_scores_gemma":[0.9977785,0.0001511366,0.00014190287,0.0004364186,0.0011725363,0.0003195582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012705242,0.00015276007,0.00017495257,0.00007132639,0.00019706086,0.00007824017,0.00028644054,0.00017710752,0.00006433361],"category_scores_gemma":[0.0012343769,0.000154943,0.000085477004,0.00016078631,0.00006402629,0.0000076242077,0.00010562929,0.0002050103,0.000021611704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016899811,0.0020319729,0.51390254,0.00011289366,0.0009510547,0.00001519079,0.0027331845,0.0011182795,0.15474601,0.000004358038,0.2944491,0.013035596],"study_design_scores_gemma":[0.016954727,0.0012302173,0.8176592,0.00005010741,0.00018330445,3.2275642e-7,0.0022990727,0.000046510428,0.026324613,0.0016269386,0.13298413,0.0006408821],"about_ca_topic_score_codex":0.0060331738,"about_ca_topic_score_gemma":0.0048891758,"teacher_disagreement_score":0.30375662,"about_ca_system_score_codex":0.00042637828,"about_ca_system_score_gemma":0.0008784556,"threshold_uncertainty_score":0.9120394},"labels":[],"label_agreement":null},{"id":"W2562409701","doi":"10.1158/1538-7445.am2015-1880","title":"Abstract 1880: Associations of coffee drinking with systemic immune and inflammatory markers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coffee research and impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Immune system; Logistic regression; Immunology; Internal medicine; Prostate cancer; Cancer; Inflammation; Gastroenterology; Oncology; Physiology","score_opus":0.11421740848323707,"score_gpt":0.4166944512652415,"score_spread":0.30247704278200443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562409701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875209,0.00420423,0.0000040933464,0.0006017096,0.000035068337,0.0005792789,0.000013864247,0.000020641713,0.0070202313],"genre_scores_gemma":[0.9985732,0.00051143783,0.00003144881,0.000012447368,0.000104719446,0.00006154712,0.000009421852,0.000021807036,0.00067399914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978532,0.00012028705,0.00021754765,0.00017910913,0.0011477655,0.00048209995],"domain_scores_gemma":[0.998016,0.00026713076,0.00007026386,0.0002743534,0.0009076308,0.00046462193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021297017,0.00008807299,0.0002628128,0.00028637346,0.00010039333,0.000037686306,0.000108916494,0.00006740735,0.000093317125],"category_scores_gemma":[0.00083937624,0.00006738109,0.000030669125,0.00040789912,0.00026989912,0.00012531574,0.00008889302,0.00049783045,0.000015733094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025996484,0.00015401683,0.7229882,0.0016101493,0.00057876646,0.00019972419,0.0026132995,0.000028932644,0.24368975,0.00032288124,0.010488634,0.014726021],"study_design_scores_gemma":[0.0031338749,0.00065594155,0.98078233,0.0016534826,0.00002818285,0.00005314992,0.0016473548,0.000052697356,0.010565906,0.000079673686,0.0012300079,0.00011740385],"about_ca_topic_score_codex":0.0011373688,"about_ca_topic_score_gemma":0.00020479716,"teacher_disagreement_score":0.25779414,"about_ca_system_score_codex":0.00053944095,"about_ca_system_score_gemma":0.0019638503,"threshold_uncertainty_score":0.34837863},"labels":[],"label_agreement":null},{"id":"W2562483530","doi":"10.1158/1538-7445.am2015-4609","title":"Abstract 4609: Risk loci in telomere structure and maintenance genes across five cancer types: GAME-ON Consortium","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Telomere; Single-nucleotide polymorphism; Biology; Telomerase; Genetics; Cancer; Telomerase reverse transcriptase; Gene; Telomerase RNA component; Population; Genotype; Medicine","score_opus":0.04166617836887501,"score_gpt":0.3918553944458054,"score_spread":0.35018921607693043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562483530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705198,0.027664151,0.0000027471451,0.00028040336,0.00014234892,0.0002705442,0.0008852374,0.00000646398,0.00022830072],"genre_scores_gemma":[0.98417425,0.014112769,0.000024439287,0.00016437193,0.00047416377,0.00010709887,0.000056017023,0.000025571242,0.0008612958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845535,0.00009922494,0.00016501937,0.00048341125,0.00028283187,0.0005141547],"domain_scores_gemma":[0.9989311,0.000023060687,0.000052337145,0.00031653183,0.00039754855,0.00027943822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003083685,0.00014843336,0.00015165811,0.000058686812,0.00009327119,0.000052184485,0.00019235174,0.00016673839,0.00007390287],"category_scores_gemma":[0.00020048478,0.0001337292,0.000035356785,0.0001512408,0.0003658412,0.000006032519,0.00009670822,0.00027437866,0.000008022087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041499287,0.00029905108,0.42781734,0.00046538154,0.00018906633,0.00009374762,0.0022899623,0.0031647298,0.44651833,0.00008429833,0.07489717,0.040030997],"study_design_scores_gemma":[0.006520448,0.0006667297,0.29786438,0.00025617736,0.000027815555,0.000010823259,0.0039969357,0.00007268638,0.57809836,0.0028210424,0.10883506,0.0008295546],"about_ca_topic_score_codex":0.0018309241,"about_ca_topic_score_gemma":0.0037336326,"teacher_disagreement_score":0.13158002,"about_ca_system_score_codex":0.00009853987,"about_ca_system_score_gemma":0.00044591725,"threshold_uncertainty_score":0.54533184},"labels":[],"label_agreement":null},{"id":"W2562519917","doi":"10.1158/1538-7445.am2015-1570","title":"Abstract 1570: Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Serous fluid; Oncology; Internal medicine; Asymptomatic; Disease","score_opus":0.17670933954968127,"score_gpt":0.46052400918555264,"score_spread":0.2838146696358714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562519917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585314,0.00070534425,0.002961651,0.0003631507,0.00007189924,0.00050206063,0.000044750082,0.000106911975,0.00939107],"genre_scores_gemma":[0.99505293,0.0002736453,0.0021675585,0.0000055672353,0.0006265648,0.0014160783,0.000019150564,0.00005128743,0.00038719998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721783,0.00011578128,0.00037986043,0.0004685766,0.0010296246,0.00078830705],"domain_scores_gemma":[0.997413,0.00024775465,0.00014553839,0.0005838004,0.0013818936,0.00022800537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030134725,0.00013258314,0.00018443615,0.00019516012,0.0004413101,0.00008118515,0.00043055785,0.00021264984,0.00045357196],"category_scores_gemma":[0.00026157068,0.00013990114,0.00006108206,0.0012521527,0.0002857487,0.0002018374,0.0002081428,0.000942451,0.00002039925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019549148,0.00004910147,0.0055500516,0.00016839993,0.000059709633,0.0000044449835,0.00034340651,0.0023101785,0.94974107,0.0007020445,0.0013088926,0.03956719],"study_design_scores_gemma":[0.00041673222,0.000039325394,0.0014011635,0.0002727244,0.000007729667,0.0000022279346,0.0003039325,0.00050844916,0.97801346,0.013628958,0.0052210707,0.00018420721],"about_ca_topic_score_codex":0.008645446,"about_ca_topic_score_gemma":0.00022222553,"teacher_disagreement_score":0.039382983,"about_ca_system_score_codex":0.0008554728,"about_ca_system_score_gemma":0.00050967577,"threshold_uncertainty_score":0.9979561},"labels":[],"label_agreement":null},{"id":"W2562544799","doi":"10.1158/1538-7445.am2015-5129","title":"Abstract 5129: Model osteosarcoma by Li-Fraumeni syndrome patient-specific induced pluripotent stem cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Osteosarcoma; Cancer research; Induced pluripotent stem cell; Li–Fraumeni syndrome; Cancer; Biology; Germline; Mesenchymal stem cell; Cancer stem cell; Stem cell; Genome instability; Mutation; Germline mutation; Gene; Genetics; Embryonic stem cell; DNA damage; DNA","score_opus":0.13281704763148297,"score_gpt":0.35519122212222365,"score_spread":0.22237417449074068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562544799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841858,0.008751754,0.00012486818,0.0013589201,0.00056977465,0.0015927296,0.00016084342,0.00013313352,0.0031221649],"genre_scores_gemma":[0.99616224,0.0006249744,0.00013551135,0.00019514676,0.00014370261,0.00042283724,0.00004697084,0.0001408695,0.0021277617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99493206,0.00015927496,0.000542321,0.00085840886,0.0023237297,0.0011842146],"domain_scores_gemma":[0.9967506,0.000069853355,0.000116929776,0.0010793647,0.0008469671,0.0011362727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007410975,0.0003348813,0.00051002315,0.00040578665,0.0001640035,0.00009721255,0.00041565057,0.00034785038,0.00028768298],"category_scores_gemma":[0.00003665148,0.0003172964,0.00016031302,0.00079120876,0.00020567584,0.00016359781,0.00027998595,0.0016258386,0.0006577443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007312585,0.00035319233,0.000062070176,0.00014562209,0.00013027486,0.0008196294,0.0011620088,0.0010923893,0.8546103,0.000043434295,0.107535675,0.03331411],"study_design_scores_gemma":[0.007197685,0.002438507,0.0002205728,0.000824772,0.0000629162,0.000247234,0.001890553,0.0028657396,0.8879668,0.0002057543,0.095301926,0.0007775265],"about_ca_topic_score_codex":0.0006443912,"about_ca_topic_score_gemma":0.000037634018,"teacher_disagreement_score":0.033356477,"about_ca_system_score_codex":0.0022352885,"about_ca_system_score_gemma":0.0016200446,"threshold_uncertainty_score":0.99992794},"labels":[],"label_agreement":null},{"id":"W2562564284","doi":"10.1158/1538-7445.am2015-727","title":"Abstract 727: Signaling redundancy between EGFR and c-Met: molecular analysis of concurrent inhibition of c-Src and therapeutic potential against prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; DU145; Crizotinib; Cancer research; Epidermal growth factor receptor; EGFR inhibitors; Proto-oncogene tyrosine-protein kinase Src; Lapatinib; Tyrosine kinase; Dasatinib; Growth factor receptor; C-Met; Pharmacology; Biology; Medicine; Cancer; Prostate cancer; Receptor; Lung cancer; Hepatocyte growth factor; Internal medicine; Breast cancer; Trastuzumab","score_opus":0.104109410838805,"score_gpt":0.43034218822915715,"score_spread":0.32623277739035217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562564284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96521854,0.032863278,0.000024060126,0.0006670026,0.000043186898,0.0007486669,0.0002460025,0.000011790299,0.00017744854],"genre_scores_gemma":[0.9937886,0.0056988895,0.000031653515,0.000033620126,0.00008340561,0.00013008864,0.000105843246,0.000026152486,0.000101773476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975949,0.00015220826,0.00039154265,0.00040018035,0.0010123239,0.00044887108],"domain_scores_gemma":[0.9982449,0.00009315373,0.00013272572,0.00022529237,0.0009621077,0.00034185784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010124588,0.00016311885,0.0005670097,0.0007013461,0.000083757266,0.000033068307,0.00007894762,0.00010051549,0.00006595815],"category_scores_gemma":[0.00004662918,0.0001292679,0.00010134183,0.0011344015,0.0006085605,0.00008305861,0.00010317577,0.00038191592,9.936776e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010905095,0.00017473038,0.14440648,0.000967917,0.0030406874,0.000086817665,0.002030241,0.00039019136,0.7375869,0.00006441956,0.00015512887,0.11000599],"study_design_scores_gemma":[0.009246617,0.0015607094,0.14560859,0.0015376242,0.002218388,0.0000022003987,0.0022489284,0.0007131078,0.83535606,0.00052236643,0.00060796086,0.00037743704],"about_ca_topic_score_codex":0.0009386958,"about_ca_topic_score_gemma":0.000046805584,"teacher_disagreement_score":0.10962855,"about_ca_system_score_codex":0.00028983632,"about_ca_system_score_gemma":0.0007728388,"threshold_uncertainty_score":0.5271392},"labels":[],"label_agreement":null},{"id":"W2562697299","doi":"10.1158/1538-7445.am2015-5349","title":"Abstract 5349: Discovery of retinoic acids as low affinity inhibitors of the leukemia stem cell target NR2F6","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Leukemia; Cancer research; Biology; Stem cell; Orphan receptor; Bone marrow; Transfection; Cancer stem cell; Nuclear receptor; Immunology; Cell biology; Cell culture; Transcription factor; Genetics; Gene","score_opus":0.03450847627219114,"score_gpt":0.3253653115830489,"score_spread":0.2908568353108577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562697299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98631656,0.0038434207,0.000018869767,0.0000789071,0.00026866433,0.0002430726,0.000043791006,0.000005068672,0.009181674],"genre_scores_gemma":[0.99492216,0.0005408551,0.000033750475,0.000027652522,0.00029918767,0.000041155283,0.00001923541,0.000028419878,0.004087588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801815,0.00019300169,0.0003325306,0.000359291,0.0007177377,0.00037928286],"domain_scores_gemma":[0.9984549,0.000044781333,0.00017131826,0.0006630165,0.0005446139,0.000121348094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010167739,0.00015233946,0.00020738684,0.000055005505,0.00008261819,0.000030278186,0.000698414,0.00022910947,0.00003452582],"category_scores_gemma":[0.00020617562,0.00011095888,0.00013324148,0.00032406312,0.000551822,0.000013630461,0.00041025435,0.00039458153,0.000009482178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022761435,0.000060978473,0.0081827,0.00036631024,0.000025815081,0.000003065335,0.00019229807,0.00031394596,0.983814,0.000047090867,0.00635581,0.0004103597],"study_design_scores_gemma":[0.0004767706,0.00020050466,0.0009910885,0.000101751895,0.0000071870427,0.000002058742,0.0005850729,0.0000051526376,0.9903311,0.00020367338,0.006972106,0.00012349214],"about_ca_topic_score_codex":0.00035185064,"about_ca_topic_score_gemma":0.000026895817,"teacher_disagreement_score":0.008605624,"about_ca_system_score_codex":0.00016652135,"about_ca_system_score_gemma":0.002800715,"threshold_uncertainty_score":0.4968348},"labels":[],"label_agreement":null},{"id":"W2562717999","doi":"10.1158/1538-7445.panca16-b13","title":"Abstract B13: Novel treatment strategy for pancreatic cancer by targeting the ‘undruggable’ Ras oncoprotein","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; GTPase; Cancer research; Biology; Protein tyrosine phosphatase; Pancreatic cancer; Signal transduction; Phosphorylation; Tyrosine phosphorylation; Anti-apoptotic Ras signalling cascade; Small GTPase; Cell growth; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine; Cancer; Cell biology; Biochemistry; Genetics; MAPK/ERK pathway","score_opus":0.07634599836698992,"score_gpt":0.4007290450485935,"score_spread":0.3243830466816036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562717999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8506873,0.13504949,0.0020881689,0.0045580897,0.00022286041,0.0036551673,0.0033230702,0.000035284676,0.0003805315],"genre_scores_gemma":[0.9832167,0.0053420677,0.00018822889,0.00009908329,0.0006834519,0.0056832917,0.00013529323,0.000057039826,0.0045948196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980458,0.00007471361,0.00023172576,0.0005356069,0.0003121343,0.00080002577],"domain_scores_gemma":[0.99889874,0.00013648573,0.000085287065,0.00049207907,0.0002716628,0.00011574518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007290648,0.00020834945,0.00018445958,0.00003315491,0.0003519618,0.000069794434,0.00042120623,0.00013198437,0.00026962633],"category_scores_gemma":[0.00026001065,0.000115282215,0.000094449286,0.0001307588,0.00025284893,0.000010750453,0.00012263603,0.00012303975,0.00001715246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029483307,0.00006994843,0.00023233438,0.000043903172,0.00010048484,0.0000010907943,0.000015718077,0.000035870802,0.8963244,0.00016606016,0.047130752,0.055584583],"study_design_scores_gemma":[0.0012143588,0.00042814374,0.00019324278,0.000081854065,0.000013198594,8.4835926e-7,0.000054943335,0.0000066741904,0.8308111,0.00010131975,0.16693892,0.00015543241],"about_ca_topic_score_codex":0.0040513217,"about_ca_topic_score_gemma":0.00055770786,"teacher_disagreement_score":0.1325294,"about_ca_system_score_codex":0.0003009045,"about_ca_system_score_gemma":0.0006335346,"threshold_uncertainty_score":0.6124413},"labels":[],"label_agreement":null},{"id":"W2562858959","doi":"10.1158/1538-7445.am2015-5381","title":"Abstract 5381: Therapeutic potential of HDAC inhibitors in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Biology; Cancer research; Ovarian cancer; Epigenetics; Cancer; Carcinogenesis; Chromatin remodeling; Genetics; Gene","score_opus":0.07566122524652157,"score_gpt":0.3480911253747909,"score_spread":0.27242990012826934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562858959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068415,0.007835339,0.000008001232,0.000101700796,0.00021795124,0.00018033736,0.000012257144,0.0000021775538,0.0009580733],"genre_scores_gemma":[0.9991619,0.00030852205,0.000026739208,0.000029187544,0.00017144933,0.000015974225,0.000006069752,0.0000186283,0.0002615468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989312,0.00010255584,0.00022291199,0.00021650216,0.00027653272,0.00025028203],"domain_scores_gemma":[0.99915916,0.000013474515,0.000062585576,0.00037577038,0.000327442,0.00006155601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005094296,0.000087780136,0.00012970976,0.000057812573,0.000029077046,0.0000069901625,0.00032998942,0.00012715766,0.000025003192],"category_scores_gemma":[0.000042429383,0.00006545708,0.00007057314,0.0002480568,0.00017389965,0.0000023611794,0.00015161916,0.0002252031,0.000002929963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021078966,0.000060691244,0.008258358,0.00007002727,0.000012112368,0.0000013305423,0.00014268144,0.0010093683,0.98658866,0.0000050262497,0.0010961185,0.0025448482],"study_design_scores_gemma":[0.0007832798,0.00019005596,0.01705329,0.00005261099,0.000007981124,0.0000022649422,0.0002835393,0.0001512501,0.9801073,0.0001306516,0.001143866,0.000093877265],"about_ca_topic_score_codex":0.001954402,"about_ca_topic_score_gemma":0.00027796818,"teacher_disagreement_score":0.008794933,"about_ca_system_score_codex":0.00006881708,"about_ca_system_score_gemma":0.0008063396,"threshold_uncertainty_score":0.29544842},"labels":[],"label_agreement":null},{"id":"W2562859610","doi":"10.1158/1538-7445.am2015-2787","title":"Abstract 2787: Exon sequencing of candidate genes for early onset ER negative breast cancer risk reveals novel gene-level associations","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Genome-wide association study; Genetics; Genetic association; Gene; Biology; Exon; Cancer; Copy-number variation; Disease; Oncology; Single-nucleotide polymorphism; Medicine; Genotype; Internal medicine; Genome","score_opus":0.16741791252368887,"score_gpt":0.42012090442728606,"score_spread":0.2527029919035972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562859610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98528033,0.0011195866,0.0013913898,0.00088185846,0.00019187578,0.00052634685,0.010456099,0.0000070417514,0.00014545405],"genre_scores_gemma":[0.994331,0.0012351093,0.0020853505,0.00008836591,0.00048593697,0.00051329174,0.00022021375,0.00003467534,0.0010060826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979956,0.00023394955,0.00040812642,0.00043792315,0.00032231593,0.0006020646],"domain_scores_gemma":[0.9975201,0.00021548223,0.00032669824,0.0003399798,0.0013994466,0.00019828072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002168591,0.0001606851,0.00030901525,0.000106141844,0.00023443956,0.000024742476,0.00028383502,0.0002627661,0.000038373026],"category_scores_gemma":[0.0010157939,0.00015170543,0.000117581054,0.00023905661,0.00016688847,0.000009599503,0.00012475945,0.0002316454,0.0000050945664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025738182,0.00008341598,0.4847867,0.000043961918,0.00047762253,8.921031e-7,0.0006702987,0.0026548824,0.4844274,0.00004102729,0.023823159,0.0027332809],"study_design_scores_gemma":[0.001413512,0.00018531278,0.9228127,0.000041421295,0.00005269339,0.0000037906268,0.0004174221,0.0001384074,0.07221624,0.0010796846,0.0013756627,0.0002631223],"about_ca_topic_score_codex":0.021176027,"about_ca_topic_score_gemma":0.0056707696,"teacher_disagreement_score":0.43802604,"about_ca_system_score_codex":0.0004365906,"about_ca_system_score_gemma":0.0014862383,"threshold_uncertainty_score":0.985342},"labels":[],"label_agreement":null},{"id":"W2562898571","doi":"10.1158/1538-7445.panca16-a84","title":"Abstract A84: PDAC initiation and progression occurs more rapidly from KrasG12D-expressing ductal cells than KrasG12D-expressing acinar cells in the absence of Trp53","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Ductal cells; Cancer research; Carcinogenesis; Acinar cell; KRAS; Pathology; Biology; Epigenetics; Cell; Pancreatic cancer; Medicine; Pancreas; Cancer; Pancreatic ductal adenocarcinoma; Immunohistochemistry; Gene; Endocrinology","score_opus":0.09018492482267111,"score_gpt":0.43995668632090906,"score_spread":0.34977176149823797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562898571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189776,0.0026049258,0.000062887906,0.0023364285,0.00012012136,0.0010702464,0.00009398055,0.00002344417,0.0017902269],"genre_scores_gemma":[0.99621946,0.0022309513,0.0006174327,0.00008007577,0.00035210373,0.00020905312,0.000016484242,0.000035112644,0.00023930104],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99600285,0.00058431755,0.0005482955,0.0006105753,0.0014334436,0.0008205078],"domain_scores_gemma":[0.9966671,0.0018970727,0.00019941603,0.00061100227,0.0003838567,0.0002415385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002358486,0.00023675444,0.0005734298,0.00037197003,0.00027877052,0.00007340373,0.00041267506,0.00022923425,0.00040505303],"category_scores_gemma":[0.00043090407,0.0001364592,0.00007830566,0.00049262994,0.0012058915,0.00034102597,0.0001955904,0.0008263954,0.000025400268],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008152593,0.00023090024,0.13611846,0.0002448677,0.00004329246,0.00017025697,0.003919533,0.0000018266041,0.83813673,0.000019587986,0.0013742747,0.018924983],"study_design_scores_gemma":[0.0037792493,0.0004632153,0.53714633,0.0042239362,0.000052135318,0.000019812884,0.0034213262,0.00019858342,0.44917718,0.00052772724,0.000742275,0.00024824942],"about_ca_topic_score_codex":0.0011896824,"about_ca_topic_score_gemma":0.00009127587,"teacher_disagreement_score":0.40102786,"about_ca_system_score_codex":0.00026402134,"about_ca_system_score_gemma":0.00079677795,"threshold_uncertainty_score":0.5564645},"labels":[],"label_agreement":null},{"id":"W2562950597","doi":"10.1158/1538-7445.am2015-4260","title":"Abstract 4260: Clinical testing and implementation of the TruSight Myeloid Next Generation Sequencing (NGS) panel for identification of clinically relevant variants in hematological malignancies","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CEBPA; Myeloid leukemia; Myeloid; Concordance; DNA sequencing; Computational biology; Medicine; Myeloproliferative neoplasm; CHEK2; Sanger sequencing; Cancer; Biology; Gene; Cancer research; Oncology; Genetics; Internal medicine; Germline mutation; Mutation; Myelofibrosis; Bone marrow","score_opus":0.5251459821520618,"score_gpt":0.5129109473678247,"score_spread":0.012235034784237042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562950597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961682,0.00031881058,0.00021291817,0.0015316078,0.00012334053,0.0015384643,0.000030912415,0.000009475734,0.00006625181],"genre_scores_gemma":[0.9968438,0.00037603267,0.002172225,0.00005867178,0.00020945183,0.00023349094,0.00001638174,0.000018926135,0.0000710227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964929,0.0004095782,0.001505584,0.0004048239,0.0008068732,0.0003802185],"domain_scores_gemma":[0.99585575,0.0017265059,0.00038741514,0.00037525498,0.0015032424,0.00015185561],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010382999,0.000105318686,0.00039977374,0.00017883164,0.00009614909,0.000035241577,0.00023446145,0.00017192464,0.000025463505],"category_scores_gemma":[0.010344733,0.00007354821,0.00007103567,0.0006013101,0.00042698256,0.00016505826,0.00016418294,0.0005296962,0.000002601654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046642238,0.00008455278,0.17017739,0.000392346,0.000033780183,0.000011306763,0.0007700375,0.000038678263,0.8074035,0.00033486882,0.0006639487,0.019623172],"study_design_scores_gemma":[0.0059484057,0.0010035674,0.78343195,0.00057315733,0.000055923425,0.00006042439,0.0046774843,0.013481814,0.18875869,0.0016947747,0.00013652901,0.00017726896],"about_ca_topic_score_codex":0.0011218328,"about_ca_topic_score_gemma":0.00025760042,"teacher_disagreement_score":0.61864483,"about_ca_system_score_codex":0.00051109964,"about_ca_system_score_gemma":0.0027063088,"threshold_uncertainty_score":0.99799156},"labels":[],"label_agreement":null},{"id":"W2562983905","doi":"10.1158/1538-7445.am2015-5017","title":"Abstract 5017: The discovery of novel therapeutics that restore antigen processing pathways in immune-edited metastatic cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemical Synthesis and Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Immune system; Biology; Major histocompatibility complex; Antigen; Antigen processing; Cancer research; Immunology; Immunotherapy; Antigen presentation; MHC class I; CTL*; Cancer; T cell; CD8; Genetics","score_opus":0.19845518548422933,"score_gpt":0.40605633492200094,"score_spread":0.2076011494377716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562983905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878045,0.011037345,0.00008812917,0.00035911208,0.000037033322,0.00014229903,0.00004180952,0.0000028591712,0.0004869652],"genre_scores_gemma":[0.99811786,0.0014210402,0.000052697815,0.00004710015,0.00011864364,0.000053791475,0.000025950874,0.000018423256,0.00014449314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998704,0.00007095122,0.00021240585,0.00025806637,0.00044060193,0.0003139587],"domain_scores_gemma":[0.99927837,0.000051690844,0.00008878716,0.00032550487,0.00019716172,0.000058461952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008911904,0.00010614335,0.00018235997,0.000064114065,0.00006649401,0.000050089995,0.00036940427,0.00006953198,0.000009589295],"category_scores_gemma":[0.00011690697,0.00006984447,0.000083612045,0.00034178537,0.00025992183,0.0000115079765,0.00011838845,0.00021614274,7.942613e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010790579,0.00006751347,0.0050444077,0.00003837212,0.00007170333,0.0000018103286,0.0002092369,0.00019940111,0.98688424,0.0000102569575,0.00020198218,0.0071631544],"study_design_scores_gemma":[0.0004799334,0.00004427639,0.0068930755,0.00011335081,0.000019046061,9.4826726e-7,0.0012984498,0.00028724837,0.9839565,0.000099226156,0.0066807163,0.000127212],"about_ca_topic_score_codex":0.0015151531,"about_ca_topic_score_gemma":0.00048375138,"teacher_disagreement_score":0.010313412,"about_ca_system_score_codex":0.000120257784,"about_ca_system_score_gemma":0.00064069947,"threshold_uncertainty_score":0.2848175},"labels":[],"label_agreement":null},{"id":"W2563046067","doi":"10.1158/1538-7445.am2015-1412","title":"Abstract 1412: Utilizing cell surface markers to define osteosarcoma and the stages of osteoblast differentiation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Osteosarcoma; Mesenchymal stem cell; CD44; Cluster of differentiation; Flow cytometry; Pathology; Progenitor cell; Osteoblast; Cancer research; Biology; Cell; Medicine; Stem cell; Immunology; Cell biology; In vitro","score_opus":0.10430460367793877,"score_gpt":0.38569605517773836,"score_spread":0.2813914514997996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563046067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859022,0.0062319213,0.0000026735918,0.0044379057,0.00005571865,0.0007553307,0.000024560499,0.000011140969,0.002578541],"genre_scores_gemma":[0.9986553,0.0006425769,0.00012051332,0.00006501945,0.000044569082,0.00008990107,0.000008724242,0.000017568946,0.0003558309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985861,0.00012843272,0.0001872237,0.000217258,0.0005944153,0.00028657893],"domain_scores_gemma":[0.9986784,0.00047147996,0.000045172943,0.0002792598,0.00030290717,0.00022281622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009138299,0.00010023504,0.00023573551,0.00009374902,0.000075792275,0.000033031596,0.00009315204,0.000041384304,0.000108849585],"category_scores_gemma":[0.00016677254,0.00006164149,0.000045667566,0.0002506745,0.00017023309,0.00004059709,0.000113466376,0.0001835554,0.000020423615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005373222,0.00064492674,0.892029,0.00052314537,0.0002281951,0.000063880936,0.0033685002,0.00006523459,0.053161938,0.00055460294,0.012454193,0.03153315],"study_design_scores_gemma":[0.010027569,0.00056874333,0.8626975,0.0003825549,0.00008648746,0.00000722922,0.0036538832,0.00006202451,0.119995154,0.00015316921,0.0022352447,0.00013046998],"about_ca_topic_score_codex":0.001722937,"about_ca_topic_score_gemma":0.00023633806,"teacher_disagreement_score":0.06683322,"about_ca_system_score_codex":0.00016055733,"about_ca_system_score_gemma":0.00016471159,"threshold_uncertainty_score":0.2604577},"labels":[],"label_agreement":null},{"id":"W2563172800","doi":"10.1158/1538-7445.transcagen-a1-64","title":"Abstract A1-64: Molecular and clinical characterization of 1,577 primary prostate cancer tumors reveals novel clinical and biological insights into its subtypes","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Erg; Prostate cancer; Random forest; Biology; Computational biology; Gene expression profiling; Gene expression; Gene; Cancer; Oncology; Medicine; Genetics; Computer science; Artificial intelligence","score_opus":0.2103270897464328,"score_gpt":0.4836738692890444,"score_spread":0.27334677954261155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563172800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835081,0.012202114,0.0000074352697,0.002394966,0.00016259457,0.0013502792,0.0000630121,0.000028042678,0.0002834259],"genre_scores_gemma":[0.9634564,0.034905408,0.00011277359,0.0002159093,0.0003251543,0.00020811922,0.00010681562,0.00003424167,0.0006351714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684477,0.00034597793,0.0007901104,0.0007098498,0.0007888021,0.00052050804],"domain_scores_gemma":[0.99740094,0.0003078178,0.0001624545,0.00031380335,0.0010939355,0.00072103296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025197251,0.00020962156,0.0007059523,0.00023170875,0.00010942365,0.000046165933,0.00016289933,0.0002835845,0.00005269987],"category_scores_gemma":[0.0006692718,0.00014415747,0.000085290034,0.00044895016,0.0013169307,0.0001745478,0.00029296154,0.00084456115,0.000010242613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003777065,0.00050481333,0.5761003,0.0005800054,0.00022427137,0.00014382567,0.0005917357,7.5396423e-7,0.3930974,0.00012813603,0.00033043136,0.024521276],"study_design_scores_gemma":[0.0054558166,0.0015355084,0.96676195,0.00066821545,0.000048826707,0.0000102372505,0.00012398642,0.000049013728,0.021797244,0.0002771222,0.0030718881,0.00020019729],"about_ca_topic_score_codex":0.00032094575,"about_ca_topic_score_gemma":0.000031462754,"teacher_disagreement_score":0.39066166,"about_ca_system_score_codex":0.00021192215,"about_ca_system_score_gemma":0.0015056403,"threshold_uncertainty_score":0.58785707},"labels":[],"label_agreement":null},{"id":"W2563207810","doi":"10.1158/1538-7445.panca16-a28","title":"Abstract A28: Differentially expressed microRNA profiles in pancreatic ductal and ampullary adenocarcinomas","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Pancreatic cancer; Adenocarcinoma; microRNA; Pancreas; Pathology; Cancer; Medicine; Pancreatic ductal adenocarcinoma; Cancer research; Biology; Internal medicine; Gene","score_opus":0.07701725177222908,"score_gpt":0.39349249318335433,"score_spread":0.31647524141112526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563207810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880147,0.0038111117,0.00001721166,0.0045399694,0.00005936008,0.00095210574,0.00003448028,0.000029391416,0.0025416864],"genre_scores_gemma":[0.9904961,0.004402641,0.00021416764,0.000053206342,0.00032494878,0.00042518062,0.000009027369,0.000036047182,0.0040387064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973563,0.00023197113,0.0003385409,0.00052759587,0.0006945979,0.00085102214],"domain_scores_gemma":[0.99820524,0.00074623106,0.000045486857,0.00040483073,0.00024234428,0.00035586988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093995023,0.00017883116,0.0005361387,0.00040290033,0.00012823517,0.000034990433,0.00020456842,0.00018670503,0.0015068816],"category_scores_gemma":[0.00051631697,0.00011391995,0.00005251189,0.00030134377,0.0007097868,0.00010823481,0.00019479291,0.00055723643,0.00009879799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006635639,0.00011370006,0.53445405,0.00024499992,0.000057713376,0.00031852492,0.00022936666,2.7662786e-8,0.45845205,0.00009319058,0.0014763223,0.0038964914],"study_design_scores_gemma":[0.0033472711,0.00030792147,0.9719423,0.00086871855,0.00003581645,0.000050492945,0.00021697783,0.000012141697,0.021598432,0.00058839953,0.00088853674,0.00014301365],"about_ca_topic_score_codex":0.00076336553,"about_ca_topic_score_gemma":0.00015752943,"teacher_disagreement_score":0.43748823,"about_ca_system_score_codex":0.00034035434,"about_ca_system_score_gemma":0.0008662121,"threshold_uncertainty_score":0.99940586},"labels":[],"label_agreement":null},{"id":"W2563324575","doi":"10.1158/1538-7445.am2015-4994","title":"Abstract 4994: RET isoforms differentially contribute to focal adhesion formation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Paxillin; Focal adhesion; Cell biology; Biology; Receptor tyrosine kinase; PTK2; Autophosphorylation; Cancer research; Tyrosine kinase; Signal transduction; Kinase; Protein kinase A; Protein kinase C","score_opus":0.13516702332079106,"score_gpt":0.4570160913918403,"score_spread":0.32184906807104924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563324575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979952,0.0004925882,0.00021983712,0.014429046,0.00022912826,0.0015487869,0.000048146863,0.00010118943,0.0029792825],"genre_scores_gemma":[0.9951713,0.00028080866,0.0001593198,0.00037833076,0.00044237217,0.00037369857,0.00005087756,0.00004118006,0.0031020904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99591255,0.00012450886,0.0003388387,0.00039962164,0.002134356,0.0010901494],"domain_scores_gemma":[0.9968806,0.00016699183,0.000048428556,0.00049266726,0.0012261203,0.0011852181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097356783,0.0001672302,0.00031910525,0.00044168034,0.00016226633,0.000100816986,0.0003229043,0.000026150845,0.00037935306],"category_scores_gemma":[0.001672841,0.00012728001,0.00007481356,0.0006506606,0.0001399074,0.00042510702,0.00028780842,0.00080755143,0.0007314004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011839801,0.0006359458,0.0075105014,0.0010277043,0.00010614007,0.0036535142,0.0008833012,0.0001114082,0.5767986,0.00079171895,0.32845685,0.068184525],"study_design_scores_gemma":[0.009687446,0.005213663,0.042306032,0.0009816805,0.00003231699,0.00048353008,0.0011642225,0.00042821854,0.6766971,0.003190629,0.25926998,0.0005451985],"about_ca_topic_score_codex":0.00037004086,"about_ca_topic_score_gemma":0.00029400026,"teacher_disagreement_score":0.09989848,"about_ca_system_score_codex":0.0007554324,"about_ca_system_score_gemma":0.0006637786,"threshold_uncertainty_score":0.94009167},"labels":[],"label_agreement":null},{"id":"W2563374801","doi":"10.1158/1538-7445.am2015-4762","title":"Abstract 4762: ITPKA expression in lung and other cancers, regulated via gene body methylation, functions as an oncogene","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Oncogene; Methylation; DNA methylation; Cancer research; Lung cancer; Biology; CpG site; Cancer; Gene expression; Gene; Medicine; Pathology; Cell cycle; Genetics","score_opus":0.06475764035287425,"score_gpt":0.4076910213119694,"score_spread":0.34293338095909515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563374801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705703,0.010595257,0.00064929714,0.00013536564,0.0001335418,0.00029932617,0.000027313581,0.000010333142,0.001092513],"genre_scores_gemma":[0.99751705,0.0007191485,0.00025394768,0.000045937126,0.0003528147,0.000108712775,0.00011994971,0.000034579236,0.00084785675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844384,0.00021092933,0.00021775479,0.00045593668,0.0003424291,0.00032909022],"domain_scores_gemma":[0.9989685,0.000021602098,0.00005650426,0.00036109108,0.00034417456,0.0002481344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010345086,0.00012610642,0.00012375717,0.0001526632,0.00012373083,0.000045808338,0.0001376451,0.0002035714,0.00010401196],"category_scores_gemma":[0.00011400435,0.000121332094,0.000025293148,0.00026625438,0.0001022666,0.000014203344,0.0000935548,0.0001944175,0.0000080650325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018580582,0.00003734109,0.0069702165,0.000012200695,0.000018999244,0.0000026666626,0.00018723909,0.0011440009,0.9864633,0.0000069963817,0.00050891476,0.004462307],"study_design_scores_gemma":[0.00076825084,0.00021399568,0.010345288,0.000024894603,0.0000065347836,0.0000015353858,0.0001388863,0.00044016345,0.96566767,0.00058842317,0.021635167,0.0001692029],"about_ca_topic_score_codex":0.0028024965,"about_ca_topic_score_gemma":0.0014017253,"teacher_disagreement_score":0.021126254,"about_ca_system_score_codex":0.0001735826,"about_ca_system_score_gemma":0.0004606845,"threshold_uncertainty_score":0.49477792},"labels":[],"label_agreement":null},{"id":"W2563413435","doi":"10.1158/1538-7445.am2015-496","title":"Abstract 496: Checkpoint kinase 1 inhibition suppresses cell growth and enhances cisplatin sensitivity in medulloblastoma cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CHEK1; Medulloblastoma; Cancer research; Biology; Cisplatin; Cell cycle; Viability assay; Cell growth; Mitotic catastrophe; Apoptosis; Cell cycle checkpoint; Chemotherapy; Biochemistry; Genetics","score_opus":0.06240447642858538,"score_gpt":0.36672629425197917,"score_spread":0.3043218178233938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563413435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417293,0.0013636928,0.0000022769814,0.001572055,0.000075305645,0.00051179464,0.000030643627,0.000020412217,0.0022508646],"genre_scores_gemma":[0.9987649,0.0007087641,0.00009303394,0.000046988083,0.00010855281,0.00017838673,0.000016356682,0.000018866958,0.000064177846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829656,0.000110755434,0.00020491451,0.00037328893,0.0005934283,0.0004210749],"domain_scores_gemma":[0.9989301,0.00024851033,0.00004289502,0.0001875436,0.00025754765,0.00033343243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082134944,0.00014272044,0.00025726607,0.00026136363,0.00006302691,0.000048359758,0.000033588058,0.000089392626,0.000118544296],"category_scores_gemma":[0.00015056216,0.00011701383,0.000037565267,0.0003437236,0.00017112207,0.00012888748,0.00008077997,0.00032874083,0.000042470092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003432961,0.0005864412,0.023495737,0.00027747013,0.000016726077,0.0012999974,0.0006344585,0.000016436856,0.9692985,0.000022811859,0.0027918837,0.0012162474],"study_design_scores_gemma":[0.0022187992,0.00027530652,0.0569354,0.00032161325,0.000013235334,0.000015851723,0.00043853302,0.000047746595,0.9392562,0.00015070512,0.00022693339,0.00009965449],"about_ca_topic_score_codex":0.0029918149,"about_ca_topic_score_gemma":0.0013040673,"teacher_disagreement_score":0.033439662,"about_ca_system_score_codex":0.00024083356,"about_ca_system_score_gemma":0.00027031437,"threshold_uncertainty_score":0.47716856},"labels":[],"label_agreement":null},{"id":"W2563449362","doi":"10.1158/1538-7445.am2015-3280","title":"Abstract 3280: Sequencing approaches define the mutation and fusion landscape of choroid plexus carcinomas","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"RNA; Biology; Carcinogenesis; Cancer; Genome; Copy-number variation; Gene; DNA; Transcriptome; Reference genome; DNA methylation; Genetics; Cancer research; Molecular biology; Medicine; Gene expression","score_opus":0.2845289781293946,"score_gpt":0.39160981880647927,"score_spread":0.10708084067708468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563449362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861604,0.008859529,0.0000015960852,0.001581527,0.000030781863,0.00040543976,0.000009232316,0.000009061384,0.00294243],"genre_scores_gemma":[0.9992968,0.0002904267,0.000065729204,0.00002074706,0.00010177158,0.0001302114,0.000019155916,0.000011217687,0.00006392994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898404,0.000052561987,0.00013038336,0.00017407993,0.0004589481,0.00019997603],"domain_scores_gemma":[0.99929625,0.00012873011,0.00003682398,0.0001979293,0.00021033066,0.00012994668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070205325,0.000070766924,0.00014347979,0.000107949054,0.00008055498,0.000019860665,0.00005616967,0.00004348517,0.00005272582],"category_scores_gemma":[0.00011837538,0.00004165935,0.000026434085,0.00022434874,0.00011399838,0.00004262699,0.000050706636,0.00016659113,0.0000074161817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010876188,0.0005473634,0.75138044,0.00077374524,0.00029420364,0.000547282,0.011840529,0.00050054543,0.12395527,0.0014862368,0.010874252,0.09671254],"study_design_scores_gemma":[0.0044698752,0.000715216,0.84848064,0.00029316428,0.00009374565,0.00013200393,0.006720973,0.0010307773,0.1360082,0.0006018664,0.0013179446,0.00013559444],"about_ca_topic_score_codex":0.0021585166,"about_ca_topic_score_gemma":0.00024600665,"teacher_disagreement_score":0.09710022,"about_ca_system_score_codex":0.00017104151,"about_ca_system_score_gemma":0.0002969066,"threshold_uncertainty_score":0.32630455},"labels":[],"label_agreement":null},{"id":"W2563468727","doi":"10.1158/1538-7445.am2015-1627","title":"Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immune system; Immunology; Bone marrow; Cancer; Peripheral blood cell; Lymphocyte; Oncology; Internal medicine","score_opus":0.09584440945163314,"score_gpt":0.3679274574908657,"score_spread":0.27208304803923256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563468727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304355,0.015411676,0.00001730027,0.00008421596,0.0003703658,0.00084961136,0.000058378348,0.0000047717417,0.00016012319],"genre_scores_gemma":[0.9985165,0.0006218079,0.000009407676,0.000012634377,0.000056324265,0.0002764855,0.00014342392,0.0000135611235,0.00034988046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987648,0.0003247437,0.00024215195,0.00021801714,0.000210407,0.00023989078],"domain_scores_gemma":[0.998859,0.00016550126,0.00011732781,0.00019617584,0.00064759643,0.00001438606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019827334,0.00009230433,0.0001729337,0.00011691402,0.000118187294,0.000006590771,0.0001265224,0.00014336435,0.0005769984],"category_scores_gemma":[0.00006321287,0.0000707813,0.000036227866,0.00017855124,0.00046225128,0.00006711235,0.00005896182,0.00023333861,0.00000865339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018311084,0.00010132915,0.016579524,0.000024552359,0.00020753568,7.103984e-8,0.0007843443,0.001106154,0.96885103,0.000036698122,0.002375444,0.008102217],"study_design_scores_gemma":[0.007769695,0.00028373735,0.48351312,0.000035172725,0.0000692113,0.000011101984,0.00021496972,0.00006579546,0.50712216,0.00035164232,0.00047505595,0.00008833184],"about_ca_topic_score_codex":0.0009292967,"about_ca_topic_score_gemma":0.00016603654,"teacher_disagreement_score":0.46693358,"about_ca_system_score_codex":0.00067423173,"about_ca_system_score_gemma":0.0007915959,"threshold_uncertainty_score":0.63177276},"labels":[],"label_agreement":null},{"id":"W2563518140","doi":"10.1158/1538-7445.am2015-3548","title":"Abstract 3548: Oncolytic adenovirus Ad5dlE1b replication efficiency is dependent on p53 mutation type in cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Lytic cycle; Oncolytic adenovirus; Oncolytic virus; Biology; Cell cycle; Cancer research; Viral replication; Mutant; Apoptosis; Mutation; DNA replication; Cell; Cancer; Adenoviridae; Virus; Gene; Virology; Genetic enhancement; Genetics","score_opus":0.12575917138081807,"score_gpt":0.45898048545679504,"score_spread":0.333221314075977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563518140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923946,0.0037585371,0.000011564636,0.0008822614,0.0001946536,0.0006917464,0.000050527666,0.00001322686,0.0020028397],"genre_scores_gemma":[0.9952464,0.0018111995,0.000014746639,0.0003163398,0.00033597715,0.0003924841,0.000049362952,0.000045457247,0.001788049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712753,0.00022450853,0.00026717674,0.00078732654,0.0009754667,0.00061800185],"domain_scores_gemma":[0.9981076,0.000047114503,0.0000673305,0.00089115766,0.00064744195,0.00023935412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018417716,0.00016157175,0.00015301381,0.0002606537,0.00010192771,0.000058857855,0.0005006523,0.0001972914,0.00034561165],"category_scores_gemma":[0.00023086416,0.00015757822,0.000044162232,0.00065136905,0.00013505999,0.000010032143,0.0001231598,0.00047173043,0.00028372198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032556164,0.00021773027,0.0005247524,0.00003610388,0.000026035561,0.000018357627,0.0003599038,0.003172221,0.956028,0.0000074123136,0.008664628,0.02768926],"study_design_scores_gemma":[0.0011161149,0.0022208192,0.0010511369,0.00005241316,0.0000035941187,0.0000017144688,0.0001775175,0.00019759781,0.9867143,0.000074780626,0.008201322,0.00018867443],"about_ca_topic_score_codex":0.0015953021,"about_ca_topic_score_gemma":0.0026121952,"teacher_disagreement_score":0.030686336,"about_ca_system_score_codex":0.00068861083,"about_ca_system_score_gemma":0.0017114214,"threshold_uncertainty_score":0.64258534},"labels":[],"label_agreement":null},{"id":"W2563523467","doi":"10.1158/1538-7445.panca16-pr04","title":"Abstract PR04: Nrf2 promotes mRNA translation in pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cell biology; Chemistry; Effector; Proteome; Cancer cell; Transcription factor; Pancreatic cancer; Cysteine; Biology; Biochemistry; Cancer research; Cancer; Gene","score_opus":0.06888436365764287,"score_gpt":0.3847135728191517,"score_spread":0.3158292091615088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563523467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929305,0.0042182445,0.000058803787,0.0011044984,0.00007510278,0.00039469916,0.00008682233,0.000007247201,0.001124086],"genre_scores_gemma":[0.99525976,0.0030383423,0.00008272971,0.000039933206,0.00038413063,0.00036328618,0.00002280373,0.000025706171,0.0007832797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860936,0.0000839745,0.0001983091,0.00042484715,0.00022787186,0.00045565717],"domain_scores_gemma":[0.999347,0.00006097607,0.000042169286,0.0002817176,0.00016872321,0.000099450095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037293055,0.00012608316,0.00014588267,0.00008281755,0.00006022152,0.000021632317,0.0002408409,0.00013223606,0.00031018732],"category_scores_gemma":[0.00012573888,0.00009448849,0.000050818995,0.00013949511,0.00018916272,0.000008444632,0.000055628796,0.00015916643,0.000021187707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014874685,0.000040877974,0.01660044,0.00005423127,0.000025486615,0.0000020198759,0.000112474736,0.000006855433,0.95686126,0.000012153639,0.0009792084,0.025156233],"study_design_scores_gemma":[0.0007599227,0.00006920503,0.036560062,0.00016677749,0.0000041227768,5.8134145e-7,0.000047020178,0.0000040485697,0.9525575,0.00044494084,0.00922814,0.00015768984],"about_ca_topic_score_codex":0.00052901596,"about_ca_topic_score_gemma":0.0014252503,"teacher_disagreement_score":0.024998544,"about_ca_system_score_codex":0.000106003674,"about_ca_system_score_gemma":0.00026222912,"threshold_uncertainty_score":0.38531286},"labels":[],"label_agreement":null},{"id":"W2563567519","doi":"10.1158/1538-7445.am2015-2098","title":"Abstract 2098: Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Transcription factor; Chromatin immunoprecipitation; B cell; Chromatin; Biology; Diffuse large B-cell lymphoma; Gene; Lymphoma; Transcription (linguistics); Genetics; Molecular biology; Promoter; Gene expression; Antibody; Immunology","score_opus":0.12263488186228408,"score_gpt":0.3806239632294893,"score_spread":0.2579890813672052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563567519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957261,0.04067814,0.0000010819833,0.00018910923,0.000111439855,0.00018232553,0.000044863726,0.000013532877,0.0015184946],"genre_scores_gemma":[0.9935493,0.0014174273,0.000014276925,0.000015973867,0.000034212793,0.00002948181,0.000021175736,0.000012853009,0.004905323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884254,0.00011943824,0.00025747935,0.00024377264,0.00008467269,0.00045207853],"domain_scores_gemma":[0.9993504,0.00022319726,0.000064997315,0.00016233724,0.00015393164,0.00004508058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061286567,0.000110610534,0.00031633605,0.00026748667,0.00012173795,0.000012826871,0.00017922287,0.00014926658,0.00011247287],"category_scores_gemma":[0.00011524679,0.00008892759,0.000029838087,0.00023377167,0.00043892718,0.000048924674,0.00022416793,0.00032399077,0.00014359535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023021914,0.00016910431,0.17809996,0.000084362335,0.000038967424,0.0000055479245,0.0019801217,0.000018203029,0.81489253,0.000009100089,0.0030265576,0.0014453428],"study_design_scores_gemma":[0.0026547038,0.0003556989,0.04368938,0.0000555832,0.000008660641,0.0000020081577,0.0039967936,0.000004533423,0.92646956,0.00004528629,0.022547964,0.00016984409],"about_ca_topic_score_codex":0.0019841956,"about_ca_topic_score_gemma":0.0010169804,"teacher_disagreement_score":0.13441058,"about_ca_system_score_codex":0.00013165917,"about_ca_system_score_gemma":0.00015952336,"threshold_uncertainty_score":0.3626362},"labels":[],"label_agreement":null},{"id":"W2563621071","doi":"10.1158/1538-7445.am2015-5574","title":"Abstract 5574: High prevalence of germline TP53 mutations in young osteosarcoma cases","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Germline; Sanger sequencing; Osteosarcoma; Li–Fraumeni syndrome; Germline mutation; Genetics; Allele; Malignancy; Biology; Cancer; Mutation; Medicine; Internal medicine; Cancer research; Gene","score_opus":0.13184360910381493,"score_gpt":0.43320421700304884,"score_spread":0.3013606078992339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563621071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049366,0.004975553,0.00002022425,0.00096430193,0.0001964578,0.00071839197,0.000119778255,0.000030701358,0.0024809577],"genre_scores_gemma":[0.9978951,0.00049110496,0.00016589052,0.000025198739,0.00015537639,0.00020057154,0.000031909312,0.000034816992,0.0010000039],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99774194,0.00011583653,0.00036725646,0.00033929263,0.00097453827,0.00046111617],"domain_scores_gemma":[0.9982034,0.000190153,0.00007146102,0.00047803044,0.0007812618,0.00027568458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091999234,0.000120842255,0.00026397142,0.000432062,0.000044407174,0.000014892445,0.0001896414,0.000117317104,0.00044488147],"category_scores_gemma":[0.00093562197,0.000116575386,0.000059238046,0.0008603772,0.0002906292,0.0000965405,0.00009274968,0.0006451958,0.00005818271],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033869776,0.0014737418,0.13232133,0.004503676,0.00026640767,0.004732519,0.006079909,0.002425071,0.79995716,0.0013021048,0.0129550975,0.030596018],"study_design_scores_gemma":[0.011564512,0.0020182924,0.61028403,0.0036194152,0.00016743541,0.0006311196,0.0016708149,0.00044408755,0.36402407,0.0012452113,0.00375601,0.0005749942],"about_ca_topic_score_codex":0.008276304,"about_ca_topic_score_gemma":0.0021050174,"teacher_disagreement_score":0.4779627,"about_ca_system_score_codex":0.00068180944,"about_ca_system_score_gemma":0.0015869001,"threshold_uncertainty_score":0.9983277},"labels":[],"label_agreement":null},{"id":"W2563632006","doi":"10.1158/1538-7445.am2015-3972","title":"Abstract 3972: MicroRNAs as potential therapeutic agents for AML: Targeting the AML1-ETO Oncogene by pre-miR-520 and -373","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myeloid leukemia; microRNA; Cancer research; Oncogene; Transfection; HL60; Fusion protein; Leukemia; Apoptosis; Myeloid; Chromosomal translocation; Downregulation and upregulation; Biology; Cell culture; Immunology; Gene; Genetics; Cell cycle","score_opus":0.08069914314257169,"score_gpt":0.41646000646167397,"score_spread":0.33576086331910227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563632006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96607935,0.030005317,0.000475783,0.0019366363,0.00017431314,0.00062916084,0.00011213657,0.000008090453,0.00057921995],"genre_scores_gemma":[0.99146634,0.0023429203,0.00006914996,0.00033085,0.00048057837,0.00046869836,0.00010779717,0.000034218217,0.0046994356],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866843,0.00008912342,0.00016497762,0.00038394582,0.00028406215,0.0004094811],"domain_scores_gemma":[0.99909616,0.000023600862,0.000055977343,0.00033295082,0.00033740277,0.00015392347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007956527,0.000120862445,0.00010078264,0.000030465457,0.00028661158,0.00010364932,0.0003301449,0.00011605488,0.00006184519],"category_scores_gemma":[0.000071517316,0.00009073339,0.00005731697,0.00009936471,0.00020262766,0.0000072687176,0.00011785075,0.0001734587,0.000011313512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022857105,0.000036064524,0.00016778303,0.000019503157,0.00006046265,7.119362e-7,0.00013007985,0.00005093301,0.9004103,0.00003081677,0.08299324,0.015871558],"study_design_scores_gemma":[0.00068358687,0.00017850519,0.0008390141,0.000010913241,0.000013886485,0.000003584267,0.00035585466,0.00006646097,0.39663118,0.00022682331,0.6008546,0.00013559373],"about_ca_topic_score_codex":0.00049543,"about_ca_topic_score_gemma":0.000048138507,"teacher_disagreement_score":0.51786137,"about_ca_system_score_codex":0.000067044304,"about_ca_system_score_gemma":0.0003438207,"threshold_uncertainty_score":0.37},"labels":[],"label_agreement":null},{"id":"W2563676032","doi":"10.1158/1538-7445.am2015-1018","title":"Abstract 1018: Role of Stat3 vs Stat5 in the differentiation of HC11, mouse breast epithelial cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"STAT3; Cancer research; STAT protein; STAT5; Biology; RAC1; Transcription factor; Cell biology; Signal transduction","score_opus":0.03550888559344341,"score_gpt":0.343940935701657,"score_spread":0.3084320501082136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563676032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753404,0.001187529,0.000018412373,0.00011494124,0.000042291926,0.00021421492,0.00061249477,0.0000016747982,0.00027440625],"genre_scores_gemma":[0.99878854,0.00072621414,0.000024032834,0.000020890506,0.00015690764,0.0000400183,0.00008655542,0.0000110366,0.00014578411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889916,0.00015188038,0.00018595831,0.00017438806,0.0003746744,0.00021392271],"domain_scores_gemma":[0.9991792,0.000024324268,0.000055853154,0.0002884958,0.00036175115,0.000090413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048367662,0.0000694894,0.00009933011,0.00007025913,0.00002654993,0.000013708489,0.00023569538,0.00006491854,0.00003966811],"category_scores_gemma":[0.00005146139,0.00005567705,0.00004345333,0.00010987602,0.00015030715,0.000003858768,0.000058287427,0.00009377242,0.0000033768588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068561523,0.0002612658,0.005552767,0.00007059447,0.000013927834,8.252679e-7,0.0003453241,0.000095270836,0.98902684,0.000029925868,0.0028595168,0.0010581476],"study_design_scores_gemma":[0.0010255821,0.00019174525,0.03385607,0.00001633753,0.000005798447,5.7884574e-7,0.00095840497,0.00001539216,0.96078265,0.0007325329,0.0023443205,0.00007056124],"about_ca_topic_score_codex":0.0006714693,"about_ca_topic_score_gemma":0.0002768761,"teacher_disagreement_score":0.028303305,"about_ca_system_score_codex":0.000026027557,"about_ca_system_score_gemma":0.000300251,"threshold_uncertainty_score":0.22704442},"labels":[],"label_agreement":null},{"id":"W2563684930","doi":"10.1158/1538-7445.am2015-4960","title":"Abstract 4960: ERp46 (thioredoxin domain-containing protein 5, TXND5) promotes prostate cancer growth in vitro and in vivo","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Prostate cancer; Prostate; Gene knockdown; Cancer research; In vivo; PCA3; LNCaP; Biology; Cancer; Pathology; Medicine; Cell culture; Internal medicine","score_opus":0.030796472863080782,"score_gpt":0.3457061690626303,"score_spread":0.3149096961995495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563684930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923654,0.0048596063,0.0000018361593,0.00069520087,0.000042585587,0.000877655,0.00008267126,0.0000083377645,0.0010666852],"genre_scores_gemma":[0.9974876,0.0006491252,0.00011348562,0.00005019082,0.00013853244,0.0012123372,0.00002164199,0.000031602634,0.0002954799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804693,0.00014830698,0.0002526228,0.0005442126,0.00036119513,0.0006467052],"domain_scores_gemma":[0.9991999,0.000021540935,0.000052079977,0.00022592582,0.00020622346,0.0002942876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078692706,0.00017511392,0.00020337003,0.00016078538,0.00006150819,0.00006981184,0.00020205615,0.00013662133,0.00003379796],"category_scores_gemma":[0.00023048322,0.0001577383,0.0000338283,0.00025706645,0.00021997966,0.000015328957,0.0001960595,0.0003462604,0.000003044001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017586851,0.0000901077,0.039857633,0.00015283772,0.000015914648,0.00010134798,0.00053057214,0.000030181729,0.9556911,0.00004385236,0.00030351387,0.0014242522],"study_design_scores_gemma":[0.0027505253,0.00019688778,0.012048046,0.0002660325,0.00000333055,0.0000039364195,0.0008519318,0.00004449011,0.9812381,0.0008447415,0.0014724088,0.00027955696],"about_ca_topic_score_codex":0.0043962696,"about_ca_topic_score_gemma":0.001785989,"teacher_disagreement_score":0.027809588,"about_ca_system_score_codex":0.00015299922,"about_ca_system_score_gemma":0.000750253,"threshold_uncertainty_score":0.66458744},"labels":[],"label_agreement":null},{"id":"W2563703436","doi":"10.1158/1538-7445.am2015-2792","title":"Abstract 2792: Polymorphisms in vitamin D-related genes and risk of breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Alberta Health Services; Queen's University","funders":"","keywords":"Calcitriol receptor; Breast cancer; Single-nucleotide polymorphism; Internal medicine; Estrogen receptor; Cancer; Vitamin D and neurology; Oncology; Estrogen receptor alpha; Endocrinology; Medicine; Biology; Cancer research; Gene; Genetics; Genotype","score_opus":0.07805761062360125,"score_gpt":0.41155314566273926,"score_spread":0.333495535039138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563703436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707982,0.024532115,4.0882063e-7,0.002602483,0.0000954573,0.0005375196,0.000167792,0.00001937346,0.0012466323],"genre_scores_gemma":[0.9720512,0.0257446,0.00003082269,0.000015046626,0.00014202071,0.00022723134,0.000004672896,0.000031831903,0.0017525565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972605,0.0002031919,0.00033242916,0.00038784344,0.001138844,0.00067720655],"domain_scores_gemma":[0.9981722,0.00024597094,0.00006860423,0.00034036132,0.00077341177,0.0003994196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020184247,0.00015340248,0.0004213402,0.0005453483,0.0000877993,0.000018104816,0.00017848653,0.0001291465,0.00034108618],"category_scores_gemma":[0.00038569618,0.00011887414,0.000048088918,0.0009054945,0.0008154328,0.00010703147,0.00020514808,0.0008265205,0.000023397202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044584158,0.0002045523,0.8758932,0.00028987307,0.0002996527,0.00015648591,0.002001687,0.000038792426,0.06910548,0.00002933655,0.00999044,0.04154467],"study_design_scores_gemma":[0.0027735648,0.00017471767,0.98346776,0.0005212176,0.000029899928,0.000024873778,0.0010179951,0.00008088023,0.010990947,0.00013113323,0.000669526,0.000117499556],"about_ca_topic_score_codex":0.022396209,"about_ca_topic_score_gemma":0.0029459172,"teacher_disagreement_score":0.10757456,"about_ca_system_score_codex":0.00048929156,"about_ca_system_score_gemma":0.00083044934,"threshold_uncertainty_score":0.98411375},"labels":[],"label_agreement":null},{"id":"W2563723783","doi":"10.1158/1538-7445.panca16-b87","title":"Abstract B87: Co-expression of GLUT1 and MCT4 is a poor prognostic marker and predicts response to adjuvant chemotherapy in PDAC","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Pancreas Centre (Canada)","funders":"","keywords":"GLUT1; Immunohistochemistry; KRAS; Tissue microarray; Internal medicine; Medicine; Glucose transporter; Staining; Cancer research; Cancer; Pathology; Oncology; Biology","score_opus":0.06362328116367764,"score_gpt":0.44399571467515425,"score_spread":0.3803724335114766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563723783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829682,0.0015330263,0.000011577814,0.013296427,0.000017740029,0.0012943096,0.000058540878,0.000014389145,0.00080576574],"genre_scores_gemma":[0.9939906,0.0025936353,0.00022637894,0.00026051461,0.00006787809,0.0002967778,0.0000015895854,0.00002406513,0.0025385807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978033,0.00028449512,0.0002880163,0.0004011254,0.00068382156,0.00053925987],"domain_scores_gemma":[0.99752843,0.0014853766,0.00004081625,0.0002943523,0.00026046438,0.00039053036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026681914,0.00012406782,0.0004379129,0.0004114298,0.00006611217,0.000012658989,0.00011727799,0.0001491863,0.0007754885],"category_scores_gemma":[0.0014982781,0.00007726381,0.000025053265,0.00030077653,0.000500205,0.000069550224,0.00010970224,0.00030233542,0.000022290624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01408495,0.00012138937,0.48448694,0.00021915168,0.000026361564,0.000061966224,0.0008136735,2.8900052e-8,0.4746925,0.000004176272,0.009058207,0.016430665],"study_design_scores_gemma":[0.004977262,0.0010424361,0.9336298,0.0018343674,0.000011229912,0.000015037227,0.00017219182,0.000025902082,0.053573713,0.0000807854,0.004553927,0.00008333187],"about_ca_topic_score_codex":0.00028231618,"about_ca_topic_score_gemma":0.000038700524,"teacher_disagreement_score":0.4491429,"about_ca_system_score_codex":0.00019178055,"about_ca_system_score_gemma":0.0007406066,"threshold_uncertainty_score":0.84910554},"labels":[],"label_agreement":null},{"id":"W2563726344","doi":"10.1158/1538-7445.am2015-1804","title":"Abstract 1804: The role of adipose derived stromal cells for reversal of radiation fibrosis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Public Health Ontario; Ontario Institute for Cancer Research; University of Waterloo; University of Toronto","funders":"","keywords":"Fibrosis; Adipose tissue; Medicine; Transplantation; Stromal cell; Pathology; Mesenchymal stem cell; Wound healing; Extracellular matrix; Cancer research; Internal medicine; Biology; Surgery; Cell biology","score_opus":0.11298219645197345,"score_gpt":0.4136969855295686,"score_spread":0.30071478907759513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563726344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897764,0.0040488075,0.00002567361,0.00068644044,0.00007805253,0.0014320686,0.00009251401,0.000008774111,0.0038512968],"genre_scores_gemma":[0.9979431,0.00027220524,0.00024767334,0.000011239773,0.0002257711,0.0001784768,0.000016450735,0.000024065823,0.0010810328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997585,0.00015551613,0.00030200536,0.00022758471,0.0012734499,0.0004564587],"domain_scores_gemma":[0.99748224,0.00063565036,0.00009461592,0.0004243513,0.0010934693,0.00026964792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002284014,0.00008980085,0.00026472504,0.00017044728,0.000071643626,0.00001528552,0.00028711447,0.00009624908,0.00036018726],"category_scores_gemma":[0.00073485455,0.000063384825,0.00009668603,0.00040086958,0.00029876604,0.00006830255,0.00009626858,0.0003386879,0.000022113409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016308476,0.00009165459,0.0034861926,0.00036781174,0.000076095406,0.000002723713,0.0007526194,0.000042618893,0.9541201,0.00012865999,0.007762692,0.031537976],"study_design_scores_gemma":[0.0015343587,0.00076102914,0.014175807,0.0001364315,0.00002565237,0.000001343913,0.0010497196,0.00034456636,0.964995,0.00021996001,0.016697763,0.00005835199],"about_ca_topic_score_codex":0.0020274916,"about_ca_topic_score_gemma":0.000063967025,"teacher_disagreement_score":0.031479623,"about_ca_system_score_codex":0.00026226096,"about_ca_system_score_gemma":0.0012202084,"threshold_uncertainty_score":0.3943798},"labels":[],"label_agreement":null},{"id":"W2563890673","doi":"10.1158/1538-7445.transcagen-pr09","title":"Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer; Transcriptome; Malignancy; Immune system; Gene; Lung cancer; Medicine; Cancer research; Biology; Oncology; Immunology; Pathology; Internal medicine; Gene expression; Genetics","score_opus":0.13552250610223382,"score_gpt":0.4371990046184987,"score_spread":0.3016764985162649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563890673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961223,0.016536407,9.764223e-7,0.0011577033,0.00011486994,0.0006561378,0.000027393457,0.000019223751,0.0018750741],"genre_scores_gemma":[0.9977604,0.001198885,0.000031640415,0.000056256253,0.0002819305,0.0003260097,0.0000063487337,0.000026291233,0.00031224254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819434,0.00007917102,0.00029234172,0.0002685271,0.0006837201,0.00048187957],"domain_scores_gemma":[0.9986964,0.00014285868,0.00008922002,0.0003328222,0.0005404567,0.00019826957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013535914,0.00012277954,0.00027282708,0.00006610574,0.00023954833,0.00006928358,0.00019462159,0.00007484875,0.00014600877],"category_scores_gemma":[0.00012068434,0.00007991879,0.000053320484,0.00038732262,0.00045266264,0.000082372055,0.0001298963,0.00042463094,0.0000059837744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003852888,0.00012985647,0.3431263,0.000930701,0.00020315498,0.000019735744,0.009244947,0.00013388258,0.60157466,0.00010030657,0.007761596,0.036389567],"study_design_scores_gemma":[0.0034789385,0.0013768754,0.34322438,0.001206043,0.0000973248,0.000019772284,0.02286001,0.00016975425,0.6127922,0.00011498701,0.0143228145,0.00033691258],"about_ca_topic_score_codex":0.0043688333,"about_ca_topic_score_gemma":0.0006723841,"teacher_disagreement_score":0.03605265,"about_ca_system_score_codex":0.00016572513,"about_ca_system_score_gemma":0.0006748569,"threshold_uncertainty_score":0.6604398},"labels":[],"label_agreement":null},{"id":"W2563906526","doi":"10.1158/1538-7445.am2015-628","title":"Abstract 628: Determinants of quality of next-generation sequencing output from the strand-specific TruSight Tumor Sequencing Panel in a clinical diagnostic setting","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sanger sequencing; DNA sequencing; Deep sequencing; Amplicon sequencing; Massive parallel sequencing; Transversion; Genetics; Biology; Amplicon; Computational biology; Illumina dye sequencing; DNA; Mutation; Gene; Genome; Polymerase chain reaction","score_opus":0.44331136772573587,"score_gpt":0.4503486999254398,"score_spread":0.007037332199703927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563906526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427485,0.0046084477,0.00006681798,0.00015126062,0.00025897604,0.00034709275,0.00016980396,0.0000028581246,0.00011987209],"genre_scores_gemma":[0.9968725,0.0019233343,0.0001869783,0.00009131141,0.00077539915,0.00005408831,0.000058928403,0.000021705104,0.000015744328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997589,0.0003576687,0.0008695019,0.00041594915,0.00042307374,0.00034480708],"domain_scores_gemma":[0.99775255,0.00095986476,0.00025998993,0.0004898838,0.000411329,0.00012637541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039635776,0.00013228167,0.0003148532,0.000056793586,0.0000684044,0.000043121854,0.00036387207,0.00013416391,0.000018370878],"category_scores_gemma":[0.0025260206,0.000109466506,0.00009981418,0.00017650383,0.00025103154,0.000010963559,0.00016133716,0.00032755628,0.0000026503253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021589533,0.000062481486,0.17123337,0.000062195446,0.000030538427,0.000020100113,0.0009013979,0.001236972,0.8088144,0.000035403973,0.001380829,0.016006403],"study_design_scores_gemma":[0.002313317,0.00036035583,0.28868538,0.0003623057,0.000018368359,0.0000036266497,0.0030329477,0.00087882864,0.70188725,0.0004475071,0.0016790121,0.00033108456],"about_ca_topic_score_codex":0.008793005,"about_ca_topic_score_gemma":0.0074590486,"teacher_disagreement_score":0.117452,"about_ca_system_score_codex":0.0002451473,"about_ca_system_score_gemma":0.0016055603,"threshold_uncertainty_score":0.9978075},"labels":[],"label_agreement":null},{"id":"W2563922287","doi":"10.1158/1538-7445.am2015-4990","title":"Abstract 4990: The RET receptor Y791F variant activates the kinase but diminishes ligand responsiveness","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital gastrointestinal and neural anomalies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glial cell line-derived neurotrophic factor; Proto-Oncogene Proteins c-ret; GDNF family of ligands; Receptor tyrosine kinase; Neurotrophic factors; Multiple endocrine neoplasia type 2; Biology; Cancer research; Tyrosine kinase; Endocrinology; Mutation; Internal medicine; Receptor; Cell biology; Signal transduction; Germline mutation; Medicine; Genetics; Gene","score_opus":0.1793328882236449,"score_gpt":0.39770124125519646,"score_spread":0.21836835303155155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563922287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94724035,0.0013115405,0.0000011190633,0.048267446,0.00020619265,0.000525275,0.000031207084,0.0000357999,0.0023810735],"genre_scores_gemma":[0.98522925,0.00023349206,0.000026407191,0.0003777861,0.0006742187,0.00019573723,0.000006054996,0.000025012843,0.013232049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979853,0.00024172735,0.00020047821,0.00030997195,0.00075986993,0.0005026623],"domain_scores_gemma":[0.99743265,0.0010953079,0.00004910775,0.0004817125,0.00067205465,0.00026915185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014339995,0.00015650004,0.00020563797,0.000074791365,0.0003440562,0.00011763242,0.00037801135,0.000053915497,0.00028080342],"category_scores_gemma":[0.0017616025,0.000072579416,0.00007987272,0.00041896605,0.0006205862,0.00010545968,0.00023425535,0.0007522607,0.00015622654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009572452,0.00018931778,0.00609099,0.0001471012,0.00012352898,0.0007241676,0.0019609735,0.000007712777,0.8936119,0.00034296245,0.0538541,0.033374805],"study_design_scores_gemma":[0.0018434231,0.0019521648,0.1477665,0.000814235,0.000079756406,0.0006553534,0.007925268,0.000038891332,0.61410373,0.0014025896,0.22307011,0.00034798775],"about_ca_topic_score_codex":0.00093778956,"about_ca_topic_score_gemma":0.00012115633,"teacher_disagreement_score":0.27950817,"about_ca_system_score_codex":0.0001386396,"about_ca_system_score_gemma":0.0006391204,"threshold_uncertainty_score":0.326824},"labels":[],"label_agreement":null},{"id":"W2563935720","doi":"10.1158/1538-7445.am2015-2969","title":"Abstract 2969: Progress in The Cancer Genome Atlas bladder cancer project","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; microRNA; PTEN; Bladder cancer; DNA methylation; HRAS; Cancer research; Genetics; Gene; Cancer; Bioinformatics; Mutation; Gene expression; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.21697498463621262,"score_gpt":0.48829513254434087,"score_spread":0.27132014790812825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563935720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91410553,0.056421366,0.000001205235,0.013745883,0.000433968,0.0031765471,0.00019757562,0.00006506617,0.011852829],"genre_scores_gemma":[0.98305583,0.0042366693,0.00003472082,0.000793173,0.0014970376,0.007368991,0.000028402234,0.00007579367,0.0029093635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960257,0.0002265128,0.00034613494,0.0006769073,0.0016438495,0.0010808923],"domain_scores_gemma":[0.99822515,0.00009476651,0.00006863499,0.00068572146,0.0006209883,0.00030471315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001333826,0.0002820585,0.00040408943,0.00033076323,0.00017125515,0.00011906283,0.0005634912,0.00016214835,0.0011278932],"category_scores_gemma":[0.000059864997,0.00017717258,0.00010376014,0.0012863773,0.0004216294,0.00016956824,0.00012351044,0.0010162804,0.00011133258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056094676,0.002177001,0.6303802,0.001069711,0.0013475057,0.0016545476,0.031624015,0.0001392551,0.00615503,0.00023420287,0.19173464,0.12787439],"study_design_scores_gemma":[0.010625049,0.0010877317,0.620833,0.000860526,0.00023024753,0.00006151108,0.0046207667,0.00005116063,0.0055159424,0.00033525412,0.3551153,0.00066352525],"about_ca_topic_score_codex":0.026930874,"about_ca_topic_score_gemma":0.005711552,"teacher_disagreement_score":0.16338065,"about_ca_system_score_codex":0.0014136548,"about_ca_system_score_gemma":0.0045497986,"threshold_uncertainty_score":0.9997852},"labels":[],"label_agreement":null},{"id":"W2563946775","doi":"10.1158/1538-7445.am2015-2750","title":"Abstract 2750: Modulation of BRCA1 expression as a preventative method for BRCA1-associated breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University of Alberta","funders":"","keywords":"Breast cancer; Haploinsufficiency; Medicine; Population; Cancer; Mutation; Tamoxifen; Oncology; Cancer research; Gene; Genetics; Biology; Bioinformatics; Internal medicine; Phenotype","score_opus":0.0850835620187684,"score_gpt":0.4663933789210913,"score_spread":0.3813098169023229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563946775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297893,0.002768664,0.0016965194,0.0003361331,0.00014769063,0.00070974376,0.00095233525,0.000009100633,0.0004008644],"genre_scores_gemma":[0.99645287,0.0005161634,0.0009315542,0.00006598929,0.00037943915,0.000523716,0.00027089025,0.00002940148,0.0008299668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849945,0.0002111286,0.00021434875,0.00036963064,0.00038753127,0.00031789736],"domain_scores_gemma":[0.9981233,0.000050466297,0.000107851454,0.0002455343,0.0012515244,0.00022132543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007692394,0.00011538119,0.00015694677,0.00007728696,0.000090635556,0.00002134161,0.00018324508,0.00014749696,0.00011684035],"category_scores_gemma":[0.00027139,0.00011174292,0.000089324574,0.00015151515,0.000100379344,0.00000928348,0.00008070354,0.00009782352,0.0000029175612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012362347,0.00022431772,0.002260577,0.00010902551,0.00007314819,8.872836e-7,0.00026139576,0.00052729936,0.97201663,0.0000244308,0.017105645,0.0061604143],"study_design_scores_gemma":[0.0035166268,0.00036190494,0.03667669,0.00019046142,0.000030371695,0.0000019442907,0.00051454146,0.00032330834,0.95039093,0.003638451,0.004124487,0.00023027253],"about_ca_topic_score_codex":0.0009509067,"about_ca_topic_score_gemma":0.0002578713,"teacher_disagreement_score":0.034416113,"about_ca_system_score_codex":0.000121942096,"about_ca_system_score_gemma":0.0007872607,"threshold_uncertainty_score":0.4556744},"labels":[],"label_agreement":null},{"id":"W2563952758","doi":"10.1158/1538-7445.panca16-a27","title":"Abstract A27: Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Genetics; Exome sequencing; Carcinogenesis; KRAS; Exome; Gene; Wnt signaling pathway; Mutation rate; Cancer research; Mutation","score_opus":0.05207082599166961,"score_gpt":0.36577154253219946,"score_spread":0.31370071654052983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563952758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991895,0.0058405334,0.000037408045,0.00070852507,0.000220729,0.00023048009,0.00007268584,0.0000060215593,0.0009885835],"genre_scores_gemma":[0.9956605,0.0030117938,0.0000594782,0.000041716678,0.0005062527,0.0001788937,0.000024669265,0.00002543095,0.0004912799],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986893,0.00005758731,0.00020328216,0.00038302256,0.0002399567,0.00042686326],"domain_scores_gemma":[0.9992218,0.000107831474,0.00003904887,0.00035318386,0.00015347124,0.00012469257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043412184,0.00010641829,0.00011801369,0.00013172465,0.00009226074,0.000029772009,0.00021414607,0.000097625976,0.00015103385],"category_scores_gemma":[0.0002808628,0.00008790767,0.00005167271,0.00017274205,0.00017567708,0.000005958207,0.00013275057,0.00014782464,0.00003857317],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015810273,0.000062914994,0.08594254,0.000039991322,0.000030517258,0.000029032935,0.00010970168,0.000034121982,0.8964242,0.0004039471,0.005808815,0.010956144],"study_design_scores_gemma":[0.0018902922,0.00033716334,0.73000807,0.0003532284,0.0000149636535,0.000014774388,0.00025337335,0.000015333295,0.24091987,0.001044765,0.024730919,0.00041725652],"about_ca_topic_score_codex":0.0002537122,"about_ca_topic_score_gemma":0.0007697144,"teacher_disagreement_score":0.6555043,"about_ca_system_score_codex":0.00024064977,"about_ca_system_score_gemma":0.00048709253,"threshold_uncertainty_score":0.3584771},"labels":[],"label_agreement":null},{"id":"W2563982570","doi":"10.1158/1538-7445.am2015-1813","title":"Abstract 1813: Tumor and normal tissue localization of trastuzumab-modified with a metal chelating polymer for auger electron radioimmunotherapy in HER2-positive xenografts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Trastuzumab; Radioimmunotherapy; Cancer research; Medicine; Chemistry; Monoclonal antibody; Cancer; Antibody; Internal medicine; Breast cancer; Immunology","score_opus":0.08106357759044634,"score_gpt":0.44111721902493234,"score_spread":0.360053641434486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563982570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936668,0.0033097228,0.00082826347,0.0005113762,0.000009074563,0.00076954014,0.000020256257,0.000011182952,0.00087374763],"genre_scores_gemma":[0.99890214,0.00008176151,0.00013224075,0.000051606065,0.00010903545,0.0003518317,0.000028568613,0.000020764675,0.00032202716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989805,0.000032037857,0.0001878912,0.00020852721,0.00029052616,0.000300521],"domain_scores_gemma":[0.9993881,0.00008840949,0.000043942007,0.0001170259,0.00022013589,0.00014238128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043850028,0.00009208533,0.0002040453,0.00008096742,0.000063263484,0.000013242718,0.000056102625,0.000051620267,0.000035949462],"category_scores_gemma":[0.000038068996,0.00007620672,0.00002110136,0.00035504161,0.00020394685,0.00007248805,0.000010076455,0.00027355345,8.7049307e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029948896,0.00024828964,0.001646873,0.00025882188,0.00009623151,0.000010816885,0.0011834844,0.0002108286,0.98585767,0.0002578807,0.00012555953,0.007108643],"study_design_scores_gemma":[0.0030753803,0.0004534388,0.003777909,0.00014040031,0.000027170825,0.000020328669,0.00023139801,0.00096387754,0.9903831,0.000040842373,0.0007965803,0.000089557856],"about_ca_topic_score_codex":0.0003860528,"about_ca_topic_score_gemma":0.000022156277,"teacher_disagreement_score":0.0070190853,"about_ca_system_score_codex":0.00017457297,"about_ca_system_score_gemma":0.0003216912,"threshold_uncertainty_score":0.310762},"labels":[],"label_agreement":null},{"id":"W2564024150","doi":"10.1158/1538-7445.am2015-847","title":"Abstract 847: Human papillomavirus (HPV) type distribution in multi-ethnic cohort of women: Implications for vaccination programs","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Genotyping; Cervical cancer; Vaccination; HPV vaccines; HPV infection; Human papillomavirus; Cancer; Genotype; Internal medicine; Oncology; Gynecology; Demography; Immunology; Biology; Gene; Genetics","score_opus":0.37564786948469825,"score_gpt":0.551806673614475,"score_spread":0.17615880412977675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564024150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927564,0.0016654021,0.00011854924,0.0010377115,0.000062099025,0.0025109614,0.000105125066,0.000031310177,0.0017124306],"genre_scores_gemma":[0.9958001,0.00047017352,0.000054640666,0.000022090493,0.00013685021,0.002479274,0.0004347106,0.000024100254,0.0005780768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979559,0.000077494195,0.00033812632,0.0003356526,0.00059882127,0.0006939707],"domain_scores_gemma":[0.996875,0.00011402064,0.000053392687,0.0003646186,0.0022042803,0.00038868465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025190744,0.000100647325,0.00028745414,0.00020620032,0.00009481399,0.000023922004,0.00019483017,0.0001261001,0.0006584012],"category_scores_gemma":[0.00062995765,0.00009059372,0.000056237037,0.0011003921,0.00012278471,0.00009266605,0.00007607489,0.000444374,0.000016782707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019960108,0.001331566,0.5197719,0.0009942784,0.00009244974,0.000004777547,0.00094913266,0.000014626764,0.026016302,0.0018649956,0.0029873133,0.4439767],"study_design_scores_gemma":[0.0029498476,0.00071578444,0.9871104,0.000033574517,0.000009502618,0.0000011129911,0.0002836869,0.000067292116,0.0034641342,0.0009889784,0.004288154,0.00008753556],"about_ca_topic_score_codex":0.0019303515,"about_ca_topic_score_gemma":0.0012480571,"teacher_disagreement_score":0.46733853,"about_ca_system_score_codex":0.0026600305,"about_ca_system_score_gemma":0.0009520196,"threshold_uncertainty_score":0.7209031},"labels":[],"label_agreement":null},{"id":"W2564057978","doi":"10.1158/1538-7445.am2015-956","title":"Abstract 956: The evolutionary history of lethal metastatic prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Prostate cancer; Metastasis; Cancer; Chromoplexy; Biology; Cancer research; Prostate; Context (archaeology); Metastasis Suppressor Gene; Malignancy; Androgen receptor; Medicine; Genetics; PCA3","score_opus":0.2362246798183436,"score_gpt":0.45672844248800526,"score_spread":0.22050376266966165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564057978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8074815,0.16053988,0.000002624149,0.011857065,0.00069628353,0.0018143574,0.00013885243,0.000045637957,0.017423794],"genre_scores_gemma":[0.94096905,0.0041462537,0.00006937345,0.00011299604,0.00033181376,0.0010749691,0.00003149658,0.000042367818,0.05322165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968026,0.00021292685,0.00029655476,0.0003470628,0.0016615673,0.0006792508],"domain_scores_gemma":[0.9975285,0.00022042812,0.00007876866,0.0004883263,0.0013111933,0.0003727891],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015470145,0.00015644028,0.0003138178,0.0002547624,0.00010533623,0.00001407734,0.0002863308,0.00006074585,0.0013959534],"category_scores_gemma":[0.00021057624,0.000094363095,0.000103459606,0.00050767296,0.0010870344,0.00013515087,0.00013935192,0.00075209996,0.00008057241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054426687,0.0006331846,0.027885826,0.0010868991,0.0007359553,0.00048034685,0.008076155,0.00015482982,0.042396728,0.00041413444,0.8853724,0.027320856],"study_design_scores_gemma":[0.011767699,0.0016230146,0.09357806,0.0011961916,0.00027016652,0.000090179106,0.004828874,0.00035348456,0.023856388,0.0019984248,0.8599327,0.0005048099],"about_ca_topic_score_codex":0.0060458593,"about_ca_topic_score_gemma":0.00018206624,"teacher_disagreement_score":0.15639363,"about_ca_system_score_codex":0.0037804297,"about_ca_system_score_gemma":0.008419128,"threshold_uncertainty_score":0.9995169},"labels":[],"label_agreement":null},{"id":"W2564086249","doi":"10.1158/1538-7445.am2015-ct226","title":"Abstract CT226: A pilot study of adoptive cell therapy with in vitro educated MART1 T cells in combination with ipilimumab for the treatment of metastatic melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Leukapheresis; Ipilimumab; CD80; Immunotherapy; Immunology; Priming (agriculture); CD8; Cell therapy; Antigen-presenting cell; T cell; Antigen; Cytotoxic T cell; Internal medicine; Oncology; Immune system; CD40; In vitro; Cell; Stem cell; Biology","score_opus":0.17990204074965363,"score_gpt":0.4271268304117442,"score_spread":0.24722478966209058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564086249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991084,0.001436171,0.000004992894,0.00034009464,0.000027645208,0.006747843,0.000028584072,0.0000058803907,0.00032482238],"genre_scores_gemma":[0.99616635,0.00059517956,0.00009732973,0.000008338514,0.00002268748,0.0020321398,0.000016450718,0.000044173445,0.0010173414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756294,0.00031136104,0.0003257916,0.00032582693,0.0010319282,0.00044213783],"domain_scores_gemma":[0.99766946,0.000769907,0.000102321705,0.00045864916,0.0008752934,0.00012435195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013681138,0.00017017312,0.00048751172,0.0005098297,0.00004420886,0.000016472828,0.00019318143,0.000027447857,0.00018252373],"category_scores_gemma":[0.000021948208,0.0000939431,0.00003336176,0.0010679411,0.0002453873,0.000060427126,0.000018744642,0.00028305582,0.0000020575421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18286918,0.039492495,0.015481436,0.00027151886,0.00061796565,0.000082142935,0.03178826,0.00043397833,0.69588053,0.000005893675,0.00019083678,0.03288575],"study_design_scores_gemma":[0.06488135,0.1372959,0.040710468,0.00014797744,0.000060142298,0.000003466945,0.03158998,0.00026951882,0.724399,0.000041802858,0.00044998917,0.00015043205],"about_ca_topic_score_codex":0.013154478,"about_ca_topic_score_gemma":0.0041476726,"teacher_disagreement_score":0.11798783,"about_ca_system_score_codex":0.000878306,"about_ca_system_score_gemma":0.0014544863,"threshold_uncertainty_score":0.993417},"labels":[],"label_agreement":null},{"id":"W2564134546","doi":"10.1158/1538-7445.am2015-2047","title":"Abstract 2047: CDK10 promotes tumour growth and chemoresistance in colorectal cancer, and is a potential target for treatment","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gene knockdown; Apoptosis; Cancer research; Cell growth; Chemistry; Kinase; Cell culture; Cell cycle; Transfection; Cell biology; Biology; Molecular biology; Genetics; Biochemistry","score_opus":0.063657489502782,"score_gpt":0.3782112917396291,"score_spread":0.3145538022368471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564134546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759115,0.017656883,0.000018229824,0.0039937105,0.00012218447,0.0017218504,0.00018080417,0.000026563526,0.00036825115],"genre_scores_gemma":[0.9952312,0.002355836,0.0003733504,0.000059500024,0.00027198723,0.0013015209,0.000023453105,0.000048739654,0.00033440598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981096,0.000039982708,0.00022355076,0.0005492231,0.00048167925,0.00059598015],"domain_scores_gemma":[0.99901783,0.00006362103,0.000051137464,0.00014289591,0.00033212834,0.0003923765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004293423,0.00019507788,0.00037597757,0.00021698659,0.000114404495,0.000064074055,0.00008460619,0.00014012064,0.000052984895],"category_scores_gemma":[0.00017496751,0.00017118773,0.0000524994,0.0003217818,0.00030515844,0.00008056366,0.000062702034,0.00026966745,0.000003020885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006050008,0.00038327664,0.009760468,0.0007894255,0.00020846815,0.000355119,0.002904278,0.000019244038,0.95919394,0.00009129068,0.00800188,0.012242582],"study_design_scores_gemma":[0.013599577,0.0020988102,0.032125615,0.0005576999,0.0000750252,0.00005636516,0.00042439613,0.000635971,0.94541955,0.00089491636,0.0037804157,0.00033165983],"about_ca_topic_score_codex":0.004947232,"about_ca_topic_score_gemma":0.001600816,"teacher_disagreement_score":0.022365145,"about_ca_system_score_codex":0.0008872946,"about_ca_system_score_gemma":0.0016058672,"threshold_uncertainty_score":0.74787676},"labels":[],"label_agreement":null},{"id":"W2564219340","doi":"10.1158/1538-7445.am2015-5297","title":"Abstract 5297: Chromosomal instability as a prognostic marker in cervical cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cervical cancer; Medicine; Hazard ratio; Cancer; Oncology; Internal medicine; Cohort; Chromosome instability; Proportional hazards model; Gastroenterology; Gene; Confidence interval; Biology; Genetics; Chromosome","score_opus":0.08298458269265552,"score_gpt":0.44804216333034846,"score_spread":0.36505758063769295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564219340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729498,0.0018365649,0.0000067197047,0.012260266,0.00021737331,0.00064575614,0.000007034202,0.000046286063,0.012030182],"genre_scores_gemma":[0.9973098,0.00022649288,0.00012532598,0.0005457216,0.00055500446,0.00038832426,0.000008636735,0.00003773985,0.0008029332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714106,0.00019767096,0.00031169795,0.00047398577,0.001136661,0.00073889445],"domain_scores_gemma":[0.9983239,0.0002695289,0.000036672398,0.00029434377,0.00038171114,0.0006938067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021141327,0.00014525693,0.0003249858,0.00022665059,0.00007452425,0.000052040916,0.00022777983,0.00013028474,0.00235565],"category_scores_gemma":[0.0028756226,0.00011871999,0.000059382815,0.0006582715,0.0003926031,0.00010201204,0.00015280419,0.0017936131,0.00012259913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007497193,0.00036091346,0.94055665,0.00041361977,0.00004367243,0.00055927504,0.00086473225,0.000091951726,0.0063159443,0.00013558017,0.007812912,0.04209503],"study_design_scores_gemma":[0.003275321,0.00024800492,0.9504141,0.00078098726,0.000020081688,0.00004791371,0.00034851997,0.004096279,0.0007106744,0.0007629854,0.039088763,0.00020632637],"about_ca_topic_score_codex":0.01092499,"about_ca_topic_score_gemma":0.00072597,"teacher_disagreement_score":0.041888706,"about_ca_system_score_codex":0.00091744127,"about_ca_system_score_gemma":0.002289475,"threshold_uncertainty_score":0.9985563},"labels":[],"label_agreement":null},{"id":"W2564219534","doi":"10.1158/1538-7445.am2015-3076","title":"Abstract 3076: Post-transcriptional regulatory mechanisms contributing to the evolution of paclitaxel resistance in breast cancer model cell line, SKBR3","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Alberta","funders":"","keywords":"SKBR3; Paclitaxel; microRNA; Biology; Drug resistance; Cancer research; Cell culture; Breast cancer; Cancer; Fold change; Multiple drug resistance; Downregulation and upregulation; Genetics; Gene","score_opus":0.03322365408288886,"score_gpt":0.32824982199824587,"score_spread":0.295026167915357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564219534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783119,0.011417571,0.0030413514,0.0040754257,0.00022662168,0.00049100566,0.0018165035,0.0000055297046,0.0006141116],"genre_scores_gemma":[0.9977115,0.0006220001,0.00031263402,0.00024509177,0.00032624626,0.00020878391,0.000046463567,0.000026143487,0.0005011482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819744,0.0000772175,0.00029413772,0.00038189895,0.0004947461,0.00055456406],"domain_scores_gemma":[0.998222,0.000045886492,0.00007530113,0.00040320202,0.0010707442,0.0001828684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014885798,0.00013096641,0.00016039694,0.00010294084,0.000115235904,0.00002765631,0.0003605412,0.00013933763,0.000024875597],"category_scores_gemma":[0.00015194484,0.000114841496,0.00006576181,0.00027425544,0.00011541247,0.000007913287,0.00016036503,0.0002554953,0.0000048138695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008658953,0.00007909548,0.0010998092,0.000058678597,0.000018974792,0.0000021092962,0.00026507067,0.02818279,0.9591836,0.0037153023,0.00620848,0.0003202345],"study_design_scores_gemma":[0.0069407686,0.00067462696,0.1495309,0.00073939067,0.000060607887,0.000008606463,0.0043961625,0.0044830246,0.7874198,0.017844459,0.02661908,0.0012825712],"about_ca_topic_score_codex":0.0036668258,"about_ca_topic_score_gemma":0.01224906,"teacher_disagreement_score":0.17176376,"about_ca_system_score_codex":0.000627231,"about_ca_system_score_gemma":0.0018868633,"threshold_uncertainty_score":0.68352634},"labels":[],"label_agreement":null},{"id":"W2564226737","doi":"10.1158/1538-7445.am2015-2718","title":"Abstract 2718: Genomic and microRNAome subtraction identifies pathogenic viral sequences in pancreatic ductal adenocarcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Pancreatic cancer; Biology; Representational difference analysis; In silico; Cancer; microRNA; Carcinogenesis; RefSeq; Cancer research; Genome; Computational biology; Gene; Genetics; Gene expression","score_opus":0.07621316829272827,"score_gpt":0.3686543106044883,"score_spread":0.29244114231176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564226737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775233,0.021569254,0.000007979518,0.0002513791,0.00015779337,0.00020111828,0.000025995683,0.0000054370526,0.0002577076],"genre_scores_gemma":[0.9953662,0.0031618553,0.00003589554,0.0000233978,0.0002587801,0.00015356818,0.000034267625,0.000016769342,0.00094927446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884653,0.00009133501,0.0001744272,0.00036753714,0.000209847,0.00031031005],"domain_scores_gemma":[0.9994322,0.000013382527,0.000042461514,0.00024719597,0.00014926771,0.00011547354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006209992,0.00009832078,0.000108693566,0.000115787334,0.00008858948,0.00008054253,0.00017201445,0.00010146796,0.00003652407],"category_scores_gemma":[0.000054062642,0.00009475605,0.000030545616,0.00014125068,0.00020234201,0.000016341666,0.000078996694,0.00019577006,0.00002184228],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000927602,0.000020508944,0.052375883,0.000023251821,0.000016805652,0.00001179458,0.00015644066,0.000027212283,0.9457657,0.000024732579,0.0008239688,0.0006609412],"study_design_scores_gemma":[0.000661227,0.00014267882,0.852677,0.000034353474,0.000010410147,0.00004040558,0.0010263157,0.000019426101,0.140862,0.000548771,0.0037673982,0.00020999563],"about_ca_topic_score_codex":0.0014584447,"about_ca_topic_score_gemma":0.000737615,"teacher_disagreement_score":0.8049037,"about_ca_system_score_codex":0.00014182822,"about_ca_system_score_gemma":0.00037967294,"threshold_uncertainty_score":0.38640395},"labels":[],"label_agreement":null},{"id":"W2564350780","doi":"10.1158/1538-7445.am2015-4487","title":"Abstract 4487: Design, synthesis, and biological activity of N-phenyl ureidobenzenesulfonates (PUB-SOs) as new and innovative small-molecule drugs inhibiting proteins involved in DNA repair/replication mechanisms","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pharmacophore; Cell cycle; Cell cycle checkpoint; DNA repair; Chemistry; DNA damage; DNA replication; Context (archaeology); DNA; Biochemistry; Cell biology; Biology; Cell","score_opus":0.16344807268126613,"score_gpt":0.37652441204879256,"score_spread":0.21307633936752643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564350780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928863,0.0018067934,0.0013694676,0.0014138609,0.000026649761,0.0019403386,0.000013129945,0.00007356641,0.0004698842],"genre_scores_gemma":[0.9963306,0.00037822465,0.0025458117,0.00009043564,0.00006450478,0.0004890829,0.000010072298,0.000040653653,0.000050573108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974225,0.00037737557,0.00038703933,0.0007585542,0.00057482143,0.00047967865],"domain_scores_gemma":[0.9978682,0.00039303082,0.00017702031,0.0004441415,0.00073358923,0.00038404006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031686027,0.00021613712,0.00044326117,0.0004027806,0.00008301629,0.00003286756,0.00013009792,0.00028452673,0.000033355966],"category_scores_gemma":[0.0048072767,0.00019209956,0.000043917826,0.0011528691,0.00027695452,0.00011935699,0.0002234181,0.00073086115,0.0000059210333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012372301,0.00013709419,0.0007966883,0.00016352844,0.00006535133,0.000041210824,0.000920138,0.00000868708,0.9821643,0.000820893,0.0002385231,0.013406335],"study_design_scores_gemma":[0.0016636505,0.0005151698,0.00536971,0.00067321403,0.000017159566,0.000013939879,0.00057206675,0.00019318357,0.9881942,0.0025099705,0.000094814895,0.00018290932],"about_ca_topic_score_codex":0.004052348,"about_ca_topic_score_gemma":0.00021902524,"teacher_disagreement_score":0.013223426,"about_ca_system_score_codex":0.00048823672,"about_ca_system_score_gemma":0.0020928395,"threshold_uncertainty_score":0.7833593},"labels":[],"label_agreement":null},{"id":"W2564386366","doi":"10.1158/1538-7445.am2015-1058","title":"Abstract 1058: Novel insights into the genetic and epigenetic regulation of the MLH1 CpG island and shore in colorectal cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"DNA methylation; CpG site; MLH1; Biology; Epigenetics; Methylation; Single-nucleotide polymorphism; Cancer epigenetics; Cancer research; Genetics; Cancer; Colorectal cancer; Genotype; DNA mismatch repair; Gene; Gene expression","score_opus":0.08176183225242775,"score_gpt":0.379967727752289,"score_spread":0.2982058954998612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564386366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800892,0.01648246,0.000008929074,0.0017115177,0.00022164172,0.0009593061,0.000009807244,0.0000060647653,0.00051110337],"genre_scores_gemma":[0.99746364,0.0016602022,0.00007417629,0.0000659462,0.00017300968,0.00035129386,0.0000017631542,0.000025664542,0.00018428388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981648,0.000114779235,0.00028847207,0.00034666486,0.0007622845,0.00032302755],"domain_scores_gemma":[0.9988931,0.00020252175,0.000069294074,0.00030613382,0.0003715671,0.00015742221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005774481,0.000144231,0.00024096391,0.00014370971,0.000107131404,0.00002906412,0.00020340826,0.0001318539,0.00013141165],"category_scores_gemma":[0.0002506911,0.000084202744,0.000030417317,0.0005644877,0.0007959559,0.00003934808,0.00021518656,0.00046802717,0.0000015634423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010596191,0.00010640217,0.35341924,0.0003365749,0.000082849045,0.0000066924613,0.021855159,0.0010332833,0.58794147,0.00006883929,0.0018994602,0.032190375],"study_design_scores_gemma":[0.0012737564,0.00022646973,0.92976916,0.00023618764,0.000023127666,0.00000843006,0.0007080459,0.000658531,0.06448733,0.00092882616,0.0015852909,0.00009484727],"about_ca_topic_score_codex":0.0047585242,"about_ca_topic_score_gemma":0.02313334,"teacher_disagreement_score":0.5763499,"about_ca_system_score_codex":0.0003750499,"about_ca_system_score_gemma":0.0008932601,"threshold_uncertainty_score":0.9946919},"labels":[],"label_agreement":null},{"id":"W2564416929","doi":"10.1158/1538-7445.panca16-b45","title":"Abstract B45: Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Organoid; Pancreatic cancer; Induced pluripotent stem cell; Cancer research; Cancer; Progenitor cell; KRAS; Cancer stem cell; Stem cell; Biology; Progenitor; Medicine; Internal medicine; Cell biology; Embryonic stem cell; Genetics","score_opus":0.10683363418171457,"score_gpt":0.39647165796589007,"score_spread":0.28963802378417547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564416929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904423,0.0068459525,0.00024415553,0.0011116839,0.00005818871,0.00088674884,0.000037104663,0.000040079678,0.00033383636],"genre_scores_gemma":[0.9958779,0.0021410151,0.0005328444,0.000086987246,0.00025164682,0.0001850688,0.0000028932086,0.00006393582,0.000857703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691206,0.00020701902,0.00041908174,0.0006406106,0.0008685998,0.000952641],"domain_scores_gemma":[0.99822694,0.00029498353,0.00008673429,0.00034702662,0.00048820753,0.0005560866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085896015,0.00024400894,0.00059514435,0.0003154074,0.00059239415,0.00006556197,0.00014323537,0.000112631686,0.00052054966],"category_scores_gemma":[0.000078116405,0.0001685857,0.000052773576,0.00026692913,0.0005470895,0.00018932445,0.0002877409,0.00057717337,0.000008398512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046167703,0.000085648746,0.09649386,0.00045886182,0.00014531091,0.0002268157,0.001703175,0.00003573376,0.88487506,0.000017777904,0.00022875446,0.01526731],"study_design_scores_gemma":[0.039431557,0.0036190357,0.28273052,0.01879634,0.0016993076,0.00082360214,0.03319519,0.06769742,0.54536825,0.001215787,0.002125189,0.0032977879],"about_ca_topic_score_codex":0.004265482,"about_ca_topic_score_gemma":0.00021386406,"teacher_disagreement_score":0.3395068,"about_ca_system_score_codex":0.0005075103,"about_ca_system_score_gemma":0.00075558835,"threshold_uncertainty_score":0.6874725},"labels":[],"label_agreement":null},{"id":"W2564450738","doi":"10.1158/1538-7445.am2015-4078","title":"Abstract 4078: Investigating chemoresistance mechanisms in colorectal cancer stem cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Cancer stem cell; Cancer research; Colorectal cancer; Population; Cell culture; Cancer; Stem cell; Flow cytometry; Biology; Cell; Cisplatin; Cancer cell; Immunology; Medicine; Chemotherapy; Cell biology; Genetics","score_opus":0.17812034652127887,"score_gpt":0.4171137726131103,"score_spread":0.2389934260918314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564450738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98612225,0.0054961797,0.000020227335,0.0023383193,0.00047631742,0.00075794355,0.00006155769,0.0000481116,0.004679087],"genre_scores_gemma":[0.99502885,0.0008727576,0.00059001765,0.00027434475,0.00038823724,0.00059701264,0.000006185753,0.0000580387,0.002184551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696463,0.000102886406,0.00036383158,0.000551728,0.0011774809,0.00083946617],"domain_scores_gemma":[0.9983815,0.0000879717,0.00008425904,0.0003024541,0.0004957423,0.00064806535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001650734,0.00019880256,0.00043577477,0.00027181755,0.000092700815,0.0000567689,0.00023752476,0.00013320717,0.0005241751],"category_scores_gemma":[0.00008216956,0.00018097638,0.00007692647,0.001012214,0.00029610994,0.00012255517,0.00012179474,0.0008447269,0.00007316189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005522986,0.00010802599,0.0028085355,0.00042580985,0.000049546805,0.00015476708,0.0013132776,0.0001873161,0.9576529,0.00033176274,0.014878498,0.021537242],"study_design_scores_gemma":[0.0025128613,0.00018599398,0.0032013056,0.00068929844,0.00002332766,0.000006018552,0.0016678846,0.00008571536,0.9816353,0.00067889853,0.00907952,0.00023388921],"about_ca_topic_score_codex":0.006189059,"about_ca_topic_score_gemma":0.004335934,"teacher_disagreement_score":0.023982368,"about_ca_system_score_codex":0.0016008324,"about_ca_system_score_gemma":0.0023469825,"threshold_uncertainty_score":0.93560475},"labels":[],"label_agreement":null},{"id":"W2564513551","doi":"10.1158/1538-7445.am2015-2980","title":"Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"HRAS; Neuroblastoma RAS viral oncogene homolog; KRAS; Cancer research; Biology; PTPN11; Neuroblastoma; Somatic cell; MAPK/ERK pathway; Mutation; Genetics; Gene; Signal transduction; Cell culture","score_opus":0.16477273974514448,"score_gpt":0.42997173741673006,"score_spread":0.2651989976715856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564513551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972172,0.0006724416,0.000015695257,0.004335889,0.00029575688,0.0011703316,0.00007907655,0.00014296606,0.021115797],"genre_scores_gemma":[0.99038774,0.00015557489,0.00014012311,0.00020020889,0.0003182933,0.00053003663,0.00006049981,0.00007412162,0.008133379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958818,0.00024147156,0.00030494563,0.000602195,0.0019114891,0.0010580886],"domain_scores_gemma":[0.99666023,0.00030059635,0.00005133209,0.0006735362,0.0009778542,0.0013364747],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007969398,0.00022211083,0.0003083293,0.0005053456,0.0002489595,0.000102633,0.00027818605,0.000113212554,0.0009382814],"category_scores_gemma":[0.00092138216,0.00018436006,0.00012290555,0.00088867615,0.0003647974,0.00020594081,0.00015440972,0.0010880608,0.0015120868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051370966,0.0033112871,0.017017417,0.000641361,0.0007233568,0.010768029,0.0018859496,0.0002517328,0.7129263,0.0016778862,0.19643265,0.0492269],"study_design_scores_gemma":[0.026464775,0.007814745,0.13250746,0.0011042156,0.0001224707,0.00049483334,0.0014384729,0.00036763164,0.6271871,0.0038670786,0.1976508,0.0009804708],"about_ca_topic_score_codex":0.00067413744,"about_ca_topic_score_gemma":0.00020831916,"teacher_disagreement_score":0.115490034,"about_ca_system_score_codex":0.00075850537,"about_ca_system_score_gemma":0.0022572624,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2564586450","doi":"10.1158/1538-7445.am2015-570","title":"Abstract 570: PD-L1 expression in paired non-small cell lung cancer tumor samples","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Concordance; Medicine; Lung cancer; Immunohistochemistry; Internal medicine; PD-L1; Cancer; Confidence interval; Gastroenterology; Pathology; Oncology; Nuclear medicine; Immunotherapy","score_opus":0.14249879872615298,"score_gpt":0.41428909081230464,"score_spread":0.2717902920861517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564586450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749942,0.017978745,0.000015153199,0.0015296008,0.00039863662,0.0010140418,0.000049855615,0.000043986576,0.0039757933],"genre_scores_gemma":[0.99262,0.0023866966,0.00018997466,0.00037382488,0.0005556445,0.00073559774,0.00002127169,0.00005881216,0.003058193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730486,0.00012460536,0.00037759662,0.00051791023,0.0008628687,0.0008121356],"domain_scores_gemma":[0.9985345,0.00014982584,0.00008026965,0.00049772847,0.0003636734,0.00037402613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014962186,0.00020910097,0.00036370213,0.00035545396,0.00011149692,0.00005631775,0.00030181935,0.0001367851,0.00131537],"category_scores_gemma":[0.00009675852,0.00017049273,0.00010537382,0.00069108186,0.00019437891,0.00012196596,0.00011492855,0.0007042914,0.00003398349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007305214,0.00029705916,0.1169026,0.00076236925,0.000060761824,0.00021608916,0.002749385,0.000054758573,0.7664375,0.0000022255485,0.09180512,0.013406964],"study_design_scores_gemma":[0.011868639,0.00041340615,0.3487483,0.0031399054,0.000033312743,0.0000123773025,0.0027284066,0.00025908064,0.5520836,0.000057395686,0.08014969,0.00050587906],"about_ca_topic_score_codex":0.017960425,"about_ca_topic_score_gemma":0.0027097485,"teacher_disagreement_score":0.23184569,"about_ca_system_score_codex":0.0012934824,"about_ca_system_score_gemma":0.002121978,"threshold_uncertainty_score":0.99959755},"labels":[],"label_agreement":null},{"id":"W2564710210","doi":"10.1158/1538-7445.am2015-3381","title":"Abstract 3381: Standardizing the analysis of Ki-67 immunohistochemical assays","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Tissue microarray; Breast cancer; Significant difference; Pathology; Immunohistochemistry; Internal medicine; Cancer","score_opus":0.10321755814778107,"score_gpt":0.4375328179851265,"score_spread":0.33431525983734545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564710210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432773,0.010805787,0.00005886509,0.00086520734,0.00008868021,0.00015541552,0.00015049489,0.000006839247,0.0035410004],"genre_scores_gemma":[0.9988851,0.00047895496,0.000049707396,0.000037032798,0.00016740664,0.000117667056,0.000055424982,0.000014461862,0.00019427473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859023,0.000093439725,0.00017651799,0.0002838408,0.000539262,0.00031672153],"domain_scores_gemma":[0.9987203,0.00006277013,0.000057141755,0.0004947506,0.000578387,0.00008665116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087120774,0.000106506086,0.00020649796,0.00008227387,0.00012106887,0.000019792475,0.0003204919,0.00007807528,0.00006085103],"category_scores_gemma":[0.00021146015,0.00007460161,0.00014113808,0.000556231,0.00038484437,0.0000032504229,0.00023358013,0.00018128498,0.000005381778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000971672,0.00013884707,0.03856612,0.00003757123,0.004790076,0.0000074390587,0.0010546598,0.00052743603,0.904946,0.0001357758,0.040025193,0.008799163],"study_design_scores_gemma":[0.001951683,0.00021396956,0.16702546,0.00006549916,0.00076297735,0.000004137884,0.0023376453,0.000036677953,0.73652875,0.00023906677,0.09043773,0.00039637502],"about_ca_topic_score_codex":0.0011666863,"about_ca_topic_score_gemma":0.00027197256,"teacher_disagreement_score":0.16841727,"about_ca_system_score_codex":0.00020894388,"about_ca_system_score_gemma":0.00037905757,"threshold_uncertainty_score":0.30421653},"labels":[],"label_agreement":null},{"id":"W2564718551","doi":"10.1158/1538-7445.panca16-a48","title":"Abstract A48: Multi-omics characterization of PDAC subtypes using PDX reveals that epigenetic but not genetic analysis permit a clinically relevant classification","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre","funders":"","keywords":"Epigenetics; Transcriptome; Carcinogenesis; Biology; Cancer; Exome sequencing; Cancer research; Wnt signaling pathway; Exome; microRNA; Bioinformatics; Medicine; Pathology; Gene; Genetics; Gene expression; Phenotype","score_opus":0.2762846177686377,"score_gpt":0.4822962790034726,"score_spread":0.2060116612348349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564718551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273664,0.0002624665,0.004324273,0.0014440204,0.00006865974,0.0009012977,0.00012865872,0.000021764308,0.00011223851],"genre_scores_gemma":[0.9877755,0.0067513473,0.0025522704,0.000072165865,0.0002097354,0.00013809341,0.0000449049,0.00003881646,0.0024171667],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99658394,0.00043983833,0.0008473358,0.00058954064,0.0009046123,0.0006347325],"domain_scores_gemma":[0.9965687,0.00089627434,0.00032080957,0.00076895824,0.0011373168,0.000307932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024229246,0.00017390512,0.0007883447,0.0006694114,0.00016156683,0.000026162801,0.00029555886,0.00028858258,0.00080418895],"category_scores_gemma":[0.0011787585,0.00012255197,0.00020412306,0.00088869437,0.00061721413,0.00009021546,0.00010533452,0.00040289323,0.00007577576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048899784,0.00012519809,0.45338196,0.000111365836,0.00028843054,0.000010407782,0.000098434044,0.0000034976438,0.53773046,0.000009740106,0.000009132695,0.007742342],"study_design_scores_gemma":[0.0013546259,0.0002383597,0.9677775,0.000285638,0.00050316885,0.0000055744695,0.00009677239,0.0029415484,0.02649466,0.000033541037,0.00013980237,0.00012879378],"about_ca_topic_score_codex":0.00044193488,"about_ca_topic_score_gemma":0.00007839633,"teacher_disagreement_score":0.51439553,"about_ca_system_score_codex":0.00046296287,"about_ca_system_score_gemma":0.0013243202,"threshold_uncertainty_score":0.88053054},"labels":[],"label_agreement":null},{"id":"W2564762951","doi":"10.1158/1538-7445.am2015-763","title":"Abstract 763: Implications of resistance patterns with NSCLC targeted agents","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Population; Tumor progression; T790M; Cancer research; Cancer; Mutation; Discontinuation; Oncology; Internal medicine; ROS1; Biology; Adenocarcinoma; Gene; Genetics","score_opus":0.1377646992956434,"score_gpt":0.48178957406990697,"score_spread":0.3440248747742636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564762951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96875566,0.0014923374,0.00009796708,0.004982696,0.000055857137,0.0007164097,0.00022799247,0.000030418923,0.02364066],"genre_scores_gemma":[0.9940295,0.000152553,0.0002611355,0.00008883656,0.00008632058,0.00036398062,0.00007465077,0.000022671724,0.0049203015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987906,0.00002963823,0.00016017244,0.000226227,0.0005116183,0.00028174042],"domain_scores_gemma":[0.99842364,0.000046227724,0.000052593503,0.00039106893,0.00083469664,0.0002517849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021076977,0.00008170045,0.00015863053,0.00012976471,0.00008102316,0.000014451446,0.00011092549,0.00003981353,0.0003149228],"category_scores_gemma":[0.00005009089,0.00005960871,0.000031913798,0.00041502234,0.00011662367,0.00007162181,0.000025544234,0.00017427938,0.00002609801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002554115,0.0014035545,0.7526609,0.0009526581,0.0012878329,0.00015361233,0.006633669,0.00009848592,0.025819056,0.0023165338,0.18554829,0.02057132],"study_design_scores_gemma":[0.0034168612,0.000306239,0.95319873,0.00049303053,0.00009816131,0.0000053182516,0.001034731,0.0000034547666,0.010309454,0.00036507958,0.030648705,0.000120241115],"about_ca_topic_score_codex":0.0011602406,"about_ca_topic_score_gemma":0.00090704043,"teacher_disagreement_score":0.20053786,"about_ca_system_score_codex":0.00042852655,"about_ca_system_score_gemma":0.0011225687,"threshold_uncertainty_score":0.34481838},"labels":[],"label_agreement":null},{"id":"W2564840758","doi":"10.1158/1538-7445.panca16-b83","title":"Abstract B83: Targeting TRPV6 oncochannel for the treatment of pancreatic cancer: A Phase I trial experience","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; London Health Sciences Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Phases of clinical research; Prostate cancer; Gastroenterology; Cancer; Adverse effect; Urology; Toxicity; Oncology","score_opus":0.25103753202063767,"score_gpt":0.5556311703651444,"score_spread":0.30459363834450676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564840758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97597253,0.014621167,0.00005424272,0.0050471397,0.0006298046,0.0031899074,0.00020197786,0.000021829277,0.00026140994],"genre_scores_gemma":[0.9632296,0.022742754,0.000033610042,0.000059550977,0.0018025038,0.007725565,0.000009111994,0.000029092811,0.004368227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829924,0.00006897876,0.0003206777,0.0003481552,0.00040169866,0.0005612475],"domain_scores_gemma":[0.99776685,0.0013710824,0.00010103484,0.00028913753,0.00030323202,0.00016867055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038708965,0.00016450183,0.00040695324,0.000111211775,0.00019889754,0.000012675014,0.00016110372,0.00007028178,0.0021978808],"category_scores_gemma":[0.00010556112,0.00007964868,0.00018745089,0.00024431173,0.0003446315,0.00006252471,0.000020209343,0.00009641216,0.000011207072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16254261,0.0028882327,0.0011962851,0.00018900375,0.00080872414,0.000034208755,0.006330673,0.000007332329,0.49761605,0.00005854834,0.01491426,0.31341407],"study_design_scores_gemma":[0.23931468,0.014185225,0.0007489684,0.00041624942,0.00045949558,0.0000039938154,0.0011803346,0.000088486995,0.5080697,0.00011871605,0.23519862,0.00021553074],"about_ca_topic_score_codex":0.0030433647,"about_ca_topic_score_gemma":0.0002556813,"teacher_disagreement_score":0.31319854,"about_ca_system_score_codex":0.0009315705,"about_ca_system_score_gemma":0.0008138774,"threshold_uncertainty_score":0.99871427},"labels":[],"label_agreement":null},{"id":"W2564860930","doi":"10.1158/1538-7445.am2015-4525","title":"Abstract 4525: The impact of chemoimmunotherapy dose intensity in diffuse large b-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Chemoimmunotherapy; International Prognostic Index; Cyclophosphamide; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; CHOP; Chemotherapy; Oncology; Doxorubicin; Lymphoma; Etoposide; Gastroenterology","score_opus":0.10880168487972303,"score_gpt":0.4353498910117899,"score_spread":0.32654820613206686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564860930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915776,0.004208223,2.586725e-7,0.00086555554,0.000054766704,0.0005338705,0.00002152394,0.000011597613,0.0027265623],"genre_scores_gemma":[0.99804014,0.0012239085,0.000007752949,0.00009743755,0.000082849,0.00013585418,0.0000098388355,0.000020666925,0.00038156114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985076,0.000059486425,0.00021679165,0.00021598597,0.0005401754,0.0004599338],"domain_scores_gemma":[0.99872285,0.0001277811,0.000051307892,0.00051710225,0.00040152846,0.00017942712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009620064,0.00012781417,0.00030935765,0.00014215105,0.00005229834,0.00002220242,0.00018190306,0.00007681197,0.00016067704],"category_scores_gemma":[0.0000785957,0.000069680085,0.00013937784,0.00041151195,0.0001531045,0.00005444712,0.00008262208,0.00017997908,0.00005687524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065703876,0.030406237,0.8587884,0.00013766419,0.00040876583,0.0003776275,0.007443608,0.000013957815,0.029846938,0.00007184393,0.03242508,0.03350951],"study_design_scores_gemma":[0.031166919,0.00048830407,0.9314114,0.0001304215,0.000011131646,0.0000106902025,0.00065448304,0.0000508023,0.034094132,0.000083776846,0.0018210751,0.000076854194],"about_ca_topic_score_codex":0.022109054,"about_ca_topic_score_gemma":0.00029574323,"teacher_disagreement_score":0.07262303,"about_ca_system_score_codex":0.001410718,"about_ca_system_score_gemma":0.001049643,"threshold_uncertainty_score":0.98440284},"labels":[],"label_agreement":null},{"id":"W2564868894","doi":"10.1158/1538-7445.am2015-4955","title":"Abstract 4955: Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinomas","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"BAP1; Somatic cell; Biology; Cancer research; Cancer; Germline mutation; Molecular biology; Gene; Mutation; Genetics","score_opus":0.04782666599461489,"score_gpt":0.3455297631856425,"score_spread":0.2977030971910276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564868894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627346,0.0024857982,0.000011950949,0.000053833406,0.000050052622,0.00021112747,0.000023771494,0.0000031237455,0.00088688167],"genre_scores_gemma":[0.9994354,0.0001532127,0.00008734411,0.000026287827,0.00014513277,0.000031249194,0.00003285076,0.000020938587,0.00006754486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999079,0.00006204908,0.00018787848,0.00024346088,0.00020277576,0.0002248708],"domain_scores_gemma":[0.99942344,0.000032044456,0.000047915044,0.00022851095,0.00014649416,0.0001215953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000353196,0.000082102204,0.00011567985,0.00008875709,0.00005836392,0.000030203606,0.00012843107,0.00009555255,0.00002412279],"category_scores_gemma":[0.00009982828,0.00008250644,0.000022093365,0.00008679158,0.00008780127,0.000005497599,0.0001403826,0.00013573033,0.0000024196192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091347196,0.00005957796,0.0077153435,0.00008417485,0.0000023148261,0.000010652361,0.00033760007,0.00017671306,0.98938984,0.00004620951,0.0017597766,0.0003264758],"study_design_scores_gemma":[0.0015980472,0.00040172838,0.0269788,0.000043207416,0.0000044269877,0.000002475899,0.00032584276,0.00017568338,0.9686331,0.00034494884,0.001355625,0.00013609078],"about_ca_topic_score_codex":0.00079071947,"about_ca_topic_score_gemma":0.00033698388,"teacher_disagreement_score":0.020756692,"about_ca_system_score_codex":0.000065878936,"about_ca_system_score_gemma":0.00022566442,"threshold_uncertainty_score":0.3364515},"labels":[],"label_agreement":null},{"id":"W2564878012","doi":"10.1158/1538-7445.panca16-a40","title":"Abstract A40: Gene expression profiling of pancreatic cancer precursors directly from formalin fixed paraffin embedded (FFPE) tissue without nucleic acid extraction","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pancreatic cancer; RNA; Gene expression profiling; RNA extraction; Gene expression; Nucleic acid; Cancer research; Pancreas; Biology; Tissue microarray; Pancreatic Intraepithelial Neoplasia; Adenocarcinoma; Microarray; Cancer; Gene; Pathology; Molecular biology; Medicine; Pancreatic ductal adenocarcinoma; Genetics; Biochemistry","score_opus":0.08603887391368814,"score_gpt":0.4470476502379163,"score_spread":0.3610087763242282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564878012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975134,0.004914548,0.0006642821,0.0010439237,0.00021681024,0.0017194995,0.00015884667,0.0000822973,0.0014484263],"genre_scores_gemma":[0.98564607,0.0053648204,0.004020689,0.000033558626,0.00063347194,0.0012938736,0.000042638858,0.00007638373,0.002888487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99579495,0.00040540332,0.00068883353,0.0006980518,0.0014090233,0.0010037214],"domain_scores_gemma":[0.99691164,0.0008845114,0.00025184226,0.0007331498,0.0007653971,0.00045342816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015166501,0.0002875226,0.0009187992,0.00036271397,0.00023909681,0.000030263518,0.00034367744,0.00035746768,0.004410753],"category_scores_gemma":[0.00077723176,0.00019057505,0.000118400305,0.00046677783,0.00048259198,0.00031826913,0.0001471193,0.00071289414,0.00016798612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025971013,0.0002224258,0.106727056,0.0003194923,0.00019406885,0.000041216703,0.0006707838,0.0000051901134,0.86737454,0.000016864626,0.0010954675,0.020735782],"study_design_scores_gemma":[0.0029417726,0.00038944877,0.05836843,0.0020345284,0.00013304097,0.000008567038,0.00027226546,0.00015942282,0.9345977,0.00021604935,0.0006725595,0.00020624991],"about_ca_topic_score_codex":0.0040852134,"about_ca_topic_score_gemma":0.00036464326,"teacher_disagreement_score":0.06722311,"about_ca_system_score_codex":0.0007202531,"about_ca_system_score_gemma":0.0015020979,"threshold_uncertainty_score":0.99649936},"labels":[],"label_agreement":null},{"id":"W2564913205","doi":"10.1158/1538-7445.am2015-2174","title":"Abstract 2174: Identification of genetic factors contributing to development of common cancers through tissue-specific protein interaction analysis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Cancer; Biology; Genome-wide association study; Breast cancer; Prostate cancer; Cancer research; Gene; Computational biology; Bioinformatics; Genetics; Single-nucleotide polymorphism","score_opus":0.0907623931143601,"score_gpt":0.40106331329213557,"score_spread":0.31030092017777544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564913205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606586,0.0007658202,0.01236515,0.00005681352,0.000087088265,0.00039550915,0.000032761574,0.000002848963,0.00022816347],"genre_scores_gemma":[0.99866676,0.00008258448,0.0008937138,0.000008081586,0.00006375986,0.00006691776,0.000106718784,0.000009666993,0.0001017647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864066,0.0000487847,0.00051587546,0.00019840154,0.00031180927,0.00028446154],"domain_scores_gemma":[0.9988797,0.000014813742,0.0002099922,0.00028866672,0.00049409695,0.00011275413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007997827,0.00008887186,0.00018879981,0.00012246368,0.00007725735,0.000022925953,0.00021825351,0.00008853334,0.000023146626],"category_scores_gemma":[0.000059676393,0.00008375196,0.00004786102,0.00043145817,0.00006674745,0.0000074621853,0.0001284992,0.000119677585,0.000004830456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015118491,0.0000393035,0.0043712705,0.00007058213,0.00025989173,3.312135e-7,0.0019760306,0.008187629,0.96458304,0.0000232367,0.00089736003,0.019440126],"study_design_scores_gemma":[0.00020427123,0.00008383474,0.019070553,0.00004028012,0.00001705229,1.6900677e-7,0.001106016,0.00013503936,0.9654363,0.000041926374,0.013762553,0.00010201491],"about_ca_topic_score_codex":0.00056842715,"about_ca_topic_score_gemma":0.0006964717,"teacher_disagreement_score":0.01933811,"about_ca_system_score_codex":0.00020799742,"about_ca_system_score_gemma":0.0003871182,"threshold_uncertainty_score":0.3415306},"labels":[],"label_agreement":null},{"id":"W2565056401","doi":"10.1158/1538-7445.am2015-1812","title":"Abstract 1812: Ultrasound-stimulated microbubble based biomechanical enhancement of radiation cell death: Role of acid sphingomyelinase and ceramide","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Microbubbles; Acid sphingomyelinase; Ceramide; CD31; Extravasation; Chemistry; Ultrasound; Pathology; Medicine; Apoptosis; Biochemistry; Immunohistochemistry","score_opus":0.04330694668438253,"score_gpt":0.31786705768741697,"score_spread":0.27456011100303446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565056401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484193,0.002882078,0.0011782062,0.00004353728,0.000037420734,0.00027439327,0.000080231395,0.000036628528,0.0006255661],"genre_scores_gemma":[0.9987007,0.00042631556,0.00064709666,0.000007193419,0.00004693725,0.0000717975,0.000045243916,0.000025005636,0.000029724333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990101,0.000028579308,0.00024657368,0.000171914,0.00028757352,0.0002553],"domain_scores_gemma":[0.9992418,0.00014179407,0.000038480317,0.00023001728,0.00019998378,0.00014789839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004033415,0.00009974223,0.00016731951,0.00014704159,0.00004689025,0.000021346217,0.00014797447,0.0000862831,0.00013338207],"category_scores_gemma":[0.000047189144,0.0000998077,0.00003227032,0.00030744245,0.00007111113,0.000067982925,0.000019739855,0.00018667054,0.0000133317035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003184682,0.00007178745,0.00042732878,0.00011709901,0.000018303861,4.4315175e-7,0.00025080633,0.0032400426,0.9919446,0.000056528585,0.00018524347,0.0036559824],"study_design_scores_gemma":[0.0006192755,0.00005790682,0.0006590568,0.000040507646,0.000010227374,7.0779845e-7,0.00011378261,0.0054898052,0.9900662,0.0002951564,0.0025484757,0.00009890875],"about_ca_topic_score_codex":0.00052812445,"about_ca_topic_score_gemma":0.00003259681,"teacher_disagreement_score":0.0038587474,"about_ca_system_score_codex":0.00014348987,"about_ca_system_score_gemma":0.00014880678,"threshold_uncertainty_score":0.407004},"labels":[],"label_agreement":null},{"id":"W2565090883","doi":"10.1158/1538-7445.am2015-5341","title":"Abstract 5341: Bifunctional integrated molecules with combined retinoic acid receptor agonist/protein deacetylase inhibitory activities as therapeutic agents for breast cancer and neuroblastoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; Université de Montréal","funders":"","keywords":"Retinoic acid receptor; Retinoic acid receptor beta; Retinoic acid; Cancer research; Retinoic acid receptor alpha; Retinoic acid receptor gamma; Vorinostat; Pharmacology; Neuroblastoma; Romidepsin; Tretinoin; Biology; Clonogenic assay; Histone deacetylase; Chemistry; Cell culture; Biochemistry; Cell","score_opus":0.044625326493234745,"score_gpt":0.34518043633729645,"score_spread":0.3005551098440617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565090883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944173,0.0017272774,0.00006736595,0.0015564804,0.00019390645,0.0011648458,0.0005988325,0.000037993028,0.00023596449],"genre_scores_gemma":[0.99261653,0.0002717795,0.00012420697,0.0001609256,0.00052546215,0.0017001085,0.00015784941,0.00011438212,0.004328748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969081,0.00027028422,0.00026710477,0.00083089416,0.00091058534,0.00081301306],"domain_scores_gemma":[0.9979137,0.00006193919,0.00009751885,0.00043645166,0.0010098534,0.0004805073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007779569,0.00033343502,0.00027450293,0.00024073666,0.00037503018,0.0001495921,0.0003257495,0.00025492674,0.00018050053],"category_scores_gemma":[0.0001657998,0.00028635963,0.00008323216,0.0003756808,0.00087802886,0.000030390242,0.00019640673,0.000629315,0.000024851484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072029675,0.00016163885,0.00020257829,0.00012370376,0.00014579203,0.000015192565,0.00014162397,0.00007727389,0.9690073,0.000042672935,0.017115094,0.0057641226],"study_design_scores_gemma":[0.0028824615,0.001576182,0.00074613467,0.00018532253,0.00001516452,0.000033274056,0.0004860782,0.000071776936,0.9603513,0.000039827122,0.033246357,0.00036615232],"about_ca_topic_score_codex":0.00080437004,"about_ca_topic_score_gemma":0.0005232006,"teacher_disagreement_score":0.016131263,"about_ca_system_score_codex":0.00039214068,"about_ca_system_score_gemma":0.0022094278,"threshold_uncertainty_score":0.9999589},"labels":[],"label_agreement":null},{"id":"W2565124624","doi":"10.1158/1538-7445.am2015-2123","title":"Abstract 2123: Protein synthesis and its control in cancer development, progression and treatment","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Translation (biology); Cancer; PI3K/AKT/mTOR pathway; EIF4E; Biology; MAPK/ERK pathway; Protein biosynthesis; Signal transduction; Cancer research; Genetics; Messenger RNA; Gene","score_opus":0.0852366454917909,"score_gpt":0.40089065713448563,"score_spread":0.31565401164269474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565124624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94430053,0.054164834,0.0000025481374,0.0003888145,0.00010584339,0.000726075,0.000028434702,0.0000056451945,0.00027728605],"genre_scores_gemma":[0.98874736,0.0076731546,0.000057624235,0.000031328273,0.00048828934,0.0021525424,0.000005929287,0.000019889047,0.0008239141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987764,0.00008777872,0.0001459144,0.0003811755,0.00023261625,0.00037614483],"domain_scores_gemma":[0.99943614,0.000017709282,0.000035627843,0.0001384737,0.0001544028,0.00021763444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004894419,0.0001325005,0.00017574998,0.000087735214,0.000081401486,0.000037259637,0.00008842145,0.00011437276,0.000025536227],"category_scores_gemma":[0.000098590535,0.00010614126,0.000017529006,0.00010193226,0.0000901651,0.000007901083,0.00007198081,0.000112756476,0.0000030722956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057340815,0.00009032328,0.003600797,0.00006385451,0.0000545089,0.0000046483406,0.00033040618,0.0000060205443,0.72398317,0.000015070023,0.0008484904,0.2704293],"study_design_scores_gemma":[0.0022368603,0.00016042238,0.015471815,0.0001690689,0.000009563628,0.000002836422,0.00012471371,0.000015541373,0.6520919,0.000016366106,0.3295073,0.00019360258],"about_ca_topic_score_codex":0.0005500758,"about_ca_topic_score_gemma":0.0019120425,"teacher_disagreement_score":0.3286588,"about_ca_system_score_codex":0.00013484138,"about_ca_system_score_gemma":0.00081529905,"threshold_uncertainty_score":0.4328315},"labels":[],"label_agreement":null},{"id":"W2565128187","doi":"10.1158/1538-7445.am2015-2853","title":"Abstract 2853: Investigating DNAPK as a biomarker and a novel therapeutic target in aggressive prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"LNCaP; DU145; Prostate cancer; Cancer research; Wnt signaling pathway; Kinase; Cancer; Androgen receptor; Medicine; Signal transduction; Biology; Internal medicine; Cell biology","score_opus":0.21754230794918522,"score_gpt":0.47188783092270986,"score_spread":0.25434552297352464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565128187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499766,0.03664518,0.000002344574,0.008052816,0.00011794205,0.0015157107,0.00006299628,0.000039277646,0.0035870862],"genre_scores_gemma":[0.9911431,0.0034144542,0.00015088524,0.00035981304,0.00017614017,0.0013353371,0.000029088096,0.000060622468,0.003330527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968315,0.00013016594,0.00030790345,0.0006042067,0.0011235531,0.0010026966],"domain_scores_gemma":[0.9980506,0.00017818932,0.00010213901,0.00031336452,0.0006364659,0.000719272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00137412,0.00023510293,0.0003745233,0.000491885,0.00015591722,0.00010558549,0.00017342599,0.00014243438,0.00037547847],"category_scores_gemma":[0.0004227825,0.0001750222,0.000046498128,0.0010468839,0.00071592454,0.00021623232,0.00018029174,0.00087537244,0.000038918155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053175054,0.00067506975,0.44426706,0.0011872499,0.0005846501,0.0013515484,0.012905728,0.000052052997,0.4279957,0.00033566653,0.010840027,0.09448771],"study_design_scores_gemma":[0.048228968,0.0026175536,0.7047666,0.009878886,0.00014295385,0.00025218155,0.0104878815,0.0032696112,0.15815416,0.0129640475,0.04768809,0.0015491126],"about_ca_topic_score_codex":0.0077634347,"about_ca_topic_score_gemma":0.0006219811,"teacher_disagreement_score":0.26984155,"about_ca_system_score_codex":0.00097199884,"about_ca_system_score_gemma":0.0033123037,"threshold_uncertainty_score":0.99884397},"labels":[],"label_agreement":null},{"id":"W2565187189","doi":"10.1158/1538-7445.am2015-1648","title":"Abstract 1648: Targeting ETS factor ETV4 as a novel therapeutic for the management of breast and prostate cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"ETS transcription factor family; Prostate cancer; Cancer research; Medicine; Metastasis; Targeted therapy; Transcription factor; Carcinogenesis; Prostate; Cancer; PTEN; PI3K/AKT/mTOR pathway; Bioinformatics; Biology; Internal medicine; Signal transduction; Gene; Genetics","score_opus":0.23309215931570884,"score_gpt":0.5046206176878456,"score_spread":0.2715284583721368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565187189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973589,0.009355591,0.00010510795,0.01285866,0.000055815108,0.0017753271,0.00023003678,0.000019547788,0.0020109285],"genre_scores_gemma":[0.9957437,0.001303566,0.00011267602,0.00012403374,0.0001732746,0.0010384783,0.000006229288,0.00001543787,0.0014825829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990523,0.000009352066,0.0001361569,0.00019231126,0.0003406113,0.00026928322],"domain_scores_gemma":[0.99920326,0.00014265707,0.000033264474,0.00017022138,0.00027759926,0.000172996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043145654,0.000074626376,0.0001130215,0.000022210654,0.000106594984,0.000020768617,0.00011456344,0.000035972407,0.00016384896],"category_scores_gemma":[0.000019603927,0.000048102003,0.00003007488,0.00017187392,0.00019371092,0.00003181186,0.000046904515,0.000239411,0.000003728506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020356853,0.00045173313,0.0036969883,0.00305709,0.0007868157,0.000009659598,0.0017652474,0.00010764381,0.85929775,0.001405525,0.005404375,0.12198147],"study_design_scores_gemma":[0.011235461,0.00035543073,0.08957295,0.0012938107,0.00042213022,0.000053294058,0.0057510566,0.0022948561,0.5935064,0.0016849127,0.29334903,0.0004806648],"about_ca_topic_score_codex":0.00020165871,"about_ca_topic_score_gemma":0.000003571938,"teacher_disagreement_score":0.28794464,"about_ca_system_score_codex":0.00011078635,"about_ca_system_score_gemma":0.00020462337,"threshold_uncertainty_score":0.19615428},"labels":[],"label_agreement":null},{"id":"W2565206027","doi":"10.1158/1538-7445.am2015-3100","title":"Abstract 3100: Characterisation of novel chalcone derivatives, CTR compounds as tubulin polymerisation inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tubulin; Chalcone; Colchicine; HeLa; Microtubule polymerization; Apoptosis; Chemistry; Cell culture; Mitosis; Microtubule; Flow cytometry; Cancer cell; Cell cycle; Cytotoxicity; Molecular biology; Biology; Cell; Cancer; Biochemistry; Cell biology; In vitro; Stereochemistry","score_opus":0.20231109591767554,"score_gpt":0.3979757821359631,"score_spread":0.19566468621828753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565206027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895424,0.00033118646,0.000011137451,0.00081712846,0.00007686249,0.000099100536,0.0000716695,0.00003209132,0.009018395],"genre_scores_gemma":[0.9989262,0.0001147946,0.000040198433,0.000024219398,0.000462127,0.000069337686,0.000049692924,0.000014501678,0.00029889055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998456,0.000056756242,0.00027941656,0.0002994709,0.00059685746,0.0003115129],"domain_scores_gemma":[0.99888206,0.0002630804,0.00014984525,0.00022914351,0.0003208012,0.0001550957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007881092,0.00012368594,0.00022926074,0.000080827274,0.00008507091,0.00003719861,0.00021038696,0.00016741882,0.0010315168],"category_scores_gemma":[0.0004740068,0.00009938881,0.000057281206,0.00022652856,0.00025408246,0.00015827158,0.00009457294,0.00032843222,0.000028428194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020040703,0.00027527838,0.006179257,0.000057610807,0.000024474308,0.000001290018,0.00028398712,0.0000018551999,0.9739606,0.00007916712,0.0002903034,0.0186458],"study_design_scores_gemma":[0.0004747704,0.000061536695,0.030709863,0.00009057216,0.0000033200124,0.0000013721196,0.0004891592,0.000035855493,0.96432734,0.00014101881,0.003543993,0.000121209465],"about_ca_topic_score_codex":0.0021469803,"about_ca_topic_score_gemma":0.000025358135,"teacher_disagreement_score":0.024530604,"about_ca_system_score_codex":0.00025438427,"about_ca_system_score_gemma":0.00024383517,"threshold_uncertainty_score":0.9998817},"labels":[],"label_agreement":null},{"id":"W2565225485","doi":"10.1158/1538-7445.am2015-ct217","title":"Abstract CT217: Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Clinical trial; Regimen; Oncology; Cancer; Adverse effect; Internal medicine; Chemotherapy; Dosing; Phases of clinical research; Radiosensitizer; Pharmacology; Radiation therapy","score_opus":0.08462065460431194,"score_gpt":0.4219218915988156,"score_spread":0.33730123699450365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565225485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729216,0.0002379311,1.134047e-7,0.00017300039,0.000086983746,0.0018685752,0.0000328286,0.000012162731,0.00029626983],"genre_scores_gemma":[0.9993271,0.00003528961,0.000013820034,0.000007240003,0.000047063175,0.0005062753,0.000013464665,0.000023882829,0.00002583747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774754,0.0000673756,0.00028827775,0.00032990723,0.0011396061,0.0004272918],"domain_scores_gemma":[0.9986067,0.000058942776,0.00007387463,0.00036955733,0.00056627457,0.0003246741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042383614,0.00014366418,0.0003268871,0.00045655048,0.000062089355,0.000014026428,0.00011078919,0.00004860989,0.00011421913],"category_scores_gemma":[0.000089194255,0.00009621349,0.000033702894,0.00064435136,0.000078802266,0.00009870661,0.00008474373,0.00027776993,0.000025649664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009023441,0.040340498,0.90703344,0.000104341365,0.0001699694,0.0003356875,0.0035818114,0.00003862766,0.0006944385,0.00000516702,0.0013050707,0.03736753],"study_design_scores_gemma":[0.068520926,0.050210595,0.86252975,0.00075650663,0.00006366138,0.0000027466695,0.0027178081,0.000045485293,0.013668118,0.000007092292,0.0012905739,0.00018673504],"about_ca_topic_score_codex":0.002489526,"about_ca_topic_score_gemma":0.0021713504,"teacher_disagreement_score":0.059497487,"about_ca_system_score_codex":0.0005390266,"about_ca_system_score_gemma":0.00033413444,"threshold_uncertainty_score":0.39234722},"labels":[],"label_agreement":null},{"id":"W2565239144","doi":"10.1158/1538-7445.am2015-2526","title":"Abstract 2526: Detection of Ara-CTP following exposure to CPX-351 and potentiation of action by fludarabine in leukemia cell lines using a bioluminescent bacterial biosensor","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Fludarabine; Cytarabine; Intracellular; Pharmacology; Chemistry; Biology; Leukemia; Biochemistry; Medicine; Immunology; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.0814055769761631,"score_gpt":0.3756048735572448,"score_spread":0.2941992965810817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565239144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978772,0.0011421116,0.00032105955,0.000048213984,0.00030590512,0.00025489175,0.00003325771,0.0000025970864,0.000014765576],"genre_scores_gemma":[0.9992466,0.00033450528,0.00009723784,0.000013118634,0.00018651676,0.000021623531,0.000028540224,0.000015962774,0.000055881716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991053,0.000052348772,0.00020983262,0.00023336623,0.00020718528,0.00019199832],"domain_scores_gemma":[0.9994827,0.0000065353393,0.00007329473,0.00014629678,0.00021023846,0.000080919686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040996308,0.00008636025,0.00013577365,0.00012723757,0.000031993968,0.000015721373,0.000070592236,0.000121268575,0.0000042588385],"category_scores_gemma":[0.00003323594,0.000087654866,0.00003995873,0.0001951055,0.000030686646,0.000008323448,0.000052438303,0.00008598679,3.4865988e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052173994,0.00003581353,0.0003050561,0.00006514171,0.000015716147,6.0342205e-7,0.00008838528,0.00013021762,0.9918209,5.8391674e-7,0.00003399351,0.0069818944],"study_design_scores_gemma":[0.000981971,0.00041106355,0.0009919186,0.00004568495,0.000009395203,9.2796597e-7,0.0001954804,0.00008863853,0.9956347,0.000009972819,0.0015456885,0.00008460165],"about_ca_topic_score_codex":0.0012279006,"about_ca_topic_score_gemma":0.0004913327,"teacher_disagreement_score":0.0068972926,"about_ca_system_score_codex":0.0001535449,"about_ca_system_score_gemma":0.00021737331,"threshold_uncertainty_score":0.35744616},"labels":[],"label_agreement":null},{"id":"W2565400400","doi":"10.1158/1538-7445.am2015-lb-096","title":"Abstract LB-096: Blood-brain barrier-penetrating terpolymer nanoparticles deliver docetaxel and trastuzumab to brain metastases of breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Docetaxel; Cancer; Pathology; Blood–brain barrier; Trastuzumab; Biodistribution; Taxane; Paclitaxel; Bioluminescence imaging; Cancer research; In vivo; Internal medicine; Central nervous system; Chemistry; Biology","score_opus":0.09232008843512071,"score_gpt":0.4096417667064673,"score_spread":0.3173216782713466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565400400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97877216,0.009449219,0.000008375103,0.00979194,0.00007458966,0.00077956147,0.0008053953,0.000028506676,0.0002902464],"genre_scores_gemma":[0.9971223,0.00018214501,0.0005748086,0.00083101424,0.00022716665,0.00032658805,0.000018158178,0.000048984373,0.00066885387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701756,0.00025162005,0.0004290183,0.00055770815,0.0010067046,0.0007373622],"domain_scores_gemma":[0.9976324,0.00043734183,0.00008631364,0.0004202548,0.00049987057,0.00092384213],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016144778,0.00025519734,0.0005030449,0.0002828981,0.00015202886,0.00006845547,0.00016967834,0.00007742981,0.0011585436],"category_scores_gemma":[0.00037654646,0.00019810925,0.00009877228,0.00055435,0.00032319664,0.00016178661,0.00014365582,0.00032346192,0.000021465059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014361147,0.00074595615,0.03021884,0.000426364,0.0009781797,0.0003325151,0.0022727067,0.00008225233,0.8424017,0.00026824418,0.02514365,0.095693484],"study_design_scores_gemma":[0.013260028,0.0023304466,0.23130237,0.0013842033,0.0007099272,0.00035338665,0.0046542883,0.0001052792,0.7363236,0.00021736983,0.008634618,0.00072446465],"about_ca_topic_score_codex":0.008216892,"about_ca_topic_score_gemma":0.0013676989,"teacher_disagreement_score":0.20108353,"about_ca_system_score_codex":0.00021672348,"about_ca_system_score_gemma":0.0008158466,"threshold_uncertainty_score":0.99975455},"labels":[],"label_agreement":null},{"id":"W2565502203","doi":"10.1158/1538-7445.am2015-5289","title":"Abstract 5289: The role of the immune system in lymph node positive ER+ breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Breast cancer; Medicine; Tissue microarray; Lymph node; Immune system; Oncology; Estrogen receptor; Cancer; Population; Immunohistochemistry; Internal medicine; Stage (stratigraphy); Tamoxifen; Immunology; Biology","score_opus":0.043079388725031295,"score_gpt":0.36983007657160044,"score_spread":0.32675068784656913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565502203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473624,0.03654689,5.8791613e-7,0.0060564866,0.00033869644,0.00082553364,0.00017932034,0.000017223803,0.008672859],"genre_scores_gemma":[0.99809104,0.000574333,0.0000027832648,0.00013174512,0.00024647874,0.00026450993,0.0000033676,0.000026266058,0.0006594818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979118,0.00020553573,0.00031861546,0.00023617472,0.00088254345,0.000445312],"domain_scores_gemma":[0.9986195,0.00012131372,0.00009564612,0.0005648127,0.000498271,0.00010048136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015514607,0.00012794558,0.00026342957,0.00011698845,0.00012512377,0.000026749683,0.00042569597,0.000094796254,0.00021825198],"category_scores_gemma":[0.00003813103,0.00006832152,0.00012112919,0.0008118378,0.0004479934,0.00006529382,0.0001223983,0.0004489992,0.000013571204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017506592,0.00040450643,0.24313717,0.00068599504,0.0007502459,0.000056212768,0.007535105,0.00017984759,0.60257524,0.0008829155,0.0037415808,0.12254461],"study_design_scores_gemma":[0.0030222468,0.000051774055,0.876907,0.0018827254,0.000028238052,0.00005821246,0.0067632375,0.00010349198,0.10655756,0.000045499946,0.004464862,0.00011515755],"about_ca_topic_score_codex":0.058655012,"about_ca_topic_score_gemma":0.0011785217,"teacher_disagreement_score":0.6337698,"about_ca_system_score_codex":0.0015988701,"about_ca_system_score_gemma":0.0017051339,"threshold_uncertainty_score":0.9476135},"labels":[],"label_agreement":null},{"id":"W2565525749","doi":"10.1158/1538-7445.am2015-1180","title":"Abstract 1180: Hexokinase II plays a pivotal role in colorectal cancer cell proliferation and survival","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Hexokinase; Warburg effect; Glycolysis; Protein kinase B; Biology; Cell growth; Cancer research; Cancer cell; Cancer; Downregulation and upregulation; Anaerobic glycolysis; PI3K/AKT/mTOR pathway; Colorectal cancer; Blot; Signal transduction; Cell biology; Enzyme; Biochemistry","score_opus":0.03990078112580211,"score_gpt":0.3500949206998435,"score_spread":0.3101941395740414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565525749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97596097,0.020104349,0.0000041404737,0.0001879104,0.0005472811,0.00040313796,0.000090032314,0.00000840101,0.0026937511],"genre_scores_gemma":[0.9921776,0.0044240276,0.000021269941,0.0000464316,0.0018654233,0.00041404722,0.000051499308,0.000027591277,0.0009720793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840724,0.00010898321,0.00017888597,0.0004413313,0.00038303435,0.00048053495],"domain_scores_gemma":[0.9992568,0.000015029338,0.000040276456,0.00017624798,0.0002668778,0.00024476543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007400035,0.00014421661,0.00017740604,0.00007820816,0.0001305609,0.00005044797,0.00015998993,0.00016559394,0.00007306897],"category_scores_gemma":[0.000080498074,0.00014095532,0.00003622379,0.00017537331,0.00014030428,0.00001599508,0.00019744175,0.00027287984,0.000004704149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008000267,0.00012350944,0.0077152867,0.000043066237,0.000019058509,0.0000045178185,0.0007249544,0.00012450274,0.97758573,0.00003438402,0.006957585,0.005867388],"study_design_scores_gemma":[0.0034763345,0.00053189293,0.03066195,0.00004492503,0.00001220087,0.000007833065,0.0011323489,0.0001406932,0.8381732,0.00011411628,0.12531585,0.00038863454],"about_ca_topic_score_codex":0.0066654305,"about_ca_topic_score_gemma":0.022021689,"teacher_disagreement_score":0.13941249,"about_ca_system_score_codex":0.00014866702,"about_ca_system_score_gemma":0.0009425106,"threshold_uncertainty_score":0.9999493},"labels":[],"label_agreement":null},{"id":"W2565542345","doi":"10.1158/1538-7445.transcagen-a1-03","title":"Abstract A1-03: Mutational analysis of ionizing radiation-induced neoplasms","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Carcinogenesis; Ionizing radiation; Cancer research; Biology; Cancer; Radiation therapy; Germline mutation; Germline; Carcinogen; Mutation; Genetics; Gene; Medicine; Irradiation; Internal medicine","score_opus":0.09522829112130379,"score_gpt":0.40541499063741,"score_spread":0.3101866995161062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565542345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929044,0.0048162513,0.00006871848,0.00017755853,0.00045522896,0.00013213987,0.00007222196,0.0000053589492,0.0013681044],"genre_scores_gemma":[0.99720925,0.0007072444,0.000089702946,0.00004571269,0.0010775643,0.000063498745,0.00019660937,0.000014305147,0.0005961034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998663,0.000075387856,0.00020294003,0.00028468785,0.00049899553,0.00027495273],"domain_scores_gemma":[0.998845,0.00003792814,0.0000716571,0.00027764717,0.0005995167,0.00016825741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070580386,0.00008608378,0.00018075849,0.00028149527,0.00007291314,0.00002648806,0.00019270062,0.000106896434,0.00013452569],"category_scores_gemma":[0.0002490454,0.000085228196,0.00011340316,0.000733353,0.00008454059,0.0000072323273,0.000063394655,0.00014443976,0.000013857797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017970466,0.00005878836,0.0032297706,0.000021856147,0.00067919045,0.0000014720532,0.00041781188,0.003466347,0.96281147,0.00015882972,0.011290612,0.017684177],"study_design_scores_gemma":[0.0018488854,0.00019300038,0.11165129,0.000023935962,0.0002720008,0.000003527725,0.00068055774,0.00048174866,0.6971601,0.00023074436,0.1871064,0.00034776668],"about_ca_topic_score_codex":0.0009967223,"about_ca_topic_score_gemma":0.0005341022,"teacher_disagreement_score":0.2656513,"about_ca_system_score_codex":0.00007092242,"about_ca_system_score_gemma":0.00092989666,"threshold_uncertainty_score":0.34755048},"labels":[],"label_agreement":null},{"id":"W2565572864","doi":"10.1158/1538-7445.am2015-1031","title":"Abstract 1031: Cadherin-11 function is required for full neoplastic transformation of mouse fibroblasts by activated Src","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"STAT3; STAT protein; Transcription factor; Cell biology; Biology; Cancer research; Proto-oncogene tyrosine-protein kinase Src; E2F; Signal transduction; Gene","score_opus":0.07472545633196828,"score_gpt":0.3765899325441688,"score_spread":0.30186447621220047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565572864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630183,0.00029059258,0.0013847182,0.00039546515,0.00011413278,0.00072912005,0.0004250201,0.000015386566,0.00034375404],"genre_scores_gemma":[0.99664825,0.00015059175,0.000045591834,0.000025836474,0.00014429119,0.00023739644,0.0004252971,0.00004472524,0.00227804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799466,0.00010447212,0.00029248823,0.0003801505,0.00065765635,0.00057054457],"domain_scores_gemma":[0.9982771,0.000058724458,0.00007405209,0.00035799356,0.0009984877,0.00023358928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068229355,0.00015617994,0.00018160538,0.00014390446,0.00008662156,0.00004249726,0.00028852792,0.00025192904,0.0001417001],"category_scores_gemma":[0.00028140188,0.0001498523,0.00008483863,0.00028734497,0.00016272074,0.000029416067,0.00007281423,0.00022088362,0.000025740435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020849558,0.00007064518,0.000119378696,0.00017712357,0.000054426368,3.4247446e-7,0.00018614836,0.000085793596,0.9141162,0.0000076096944,0.08154114,0.0015562124],"study_design_scores_gemma":[0.0011554803,0.0010349705,0.00016263736,0.000032952634,0.000006411373,0.0000012973334,0.00024610385,0.00012578198,0.9448725,0.000034458604,0.05218524,0.00014217534],"about_ca_topic_score_codex":0.00074757385,"about_ca_topic_score_gemma":0.000302568,"teacher_disagreement_score":0.030756267,"about_ca_system_score_codex":0.00018635241,"about_ca_system_score_gemma":0.00062314456,"threshold_uncertainty_score":0.61108},"labels":[],"label_agreement":null},{"id":"W2565575823","doi":"10.1158/1538-7445.am2015-1510","title":"Abstract 1510: The sonic hedgehog pathway as a therapeutic target in bladder cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"GLI1; Sonic hedgehog; Cancer research; Cyclopamine; Hedgehog signaling pathway; GLI2; Bladder cancer; Biology; Cancer; Cell biology; Signal transduction; Genetics","score_opus":0.14447065315714464,"score_gpt":0.4270930874386888,"score_spread":0.28262243428154415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565575823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94604117,0.046990324,0.000018854005,0.0023509194,0.00028377527,0.0004681766,0.00003559702,0.000015612233,0.0037956026],"genre_scores_gemma":[0.9939845,0.0017395071,0.000019515226,0.00056980754,0.000638724,0.00067268027,0.0000133584945,0.00004604794,0.0023158586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769914,0.0002630947,0.0002293152,0.00049695384,0.0005544807,0.00075700285],"domain_scores_gemma":[0.99878854,0.000070417846,0.000047741854,0.00052629446,0.0004018992,0.00016508129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016215001,0.0001904533,0.0001901703,0.000094636045,0.00018090318,0.00006053091,0.0005549169,0.00016279278,0.00023137707],"category_scores_gemma":[0.00026170228,0.00013461478,0.00007539505,0.00038292567,0.0003700648,0.000006254227,0.00026938866,0.0005198585,0.00011020137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038570922,0.00015549225,0.00883274,0.000061710234,0.00028640055,0.0000623196,0.002759421,0.0011038638,0.9434937,0.00018887145,0.025433475,0.017236276],"study_design_scores_gemma":[0.001685209,0.0004175048,0.009886616,0.00013647508,0.000013543455,0.000009795599,0.002983992,0.00008588379,0.5842575,0.0018084557,0.3982049,0.0005101472],"about_ca_topic_score_codex":0.002062231,"about_ca_topic_score_gemma":0.0022737726,"teacher_disagreement_score":0.37277144,"about_ca_system_score_codex":0.00019408144,"about_ca_system_score_gemma":0.0016432008,"threshold_uncertainty_score":0.5489431},"labels":[],"label_agreement":null},{"id":"W2565630856","doi":"10.1158/1538-7445.am2015-2976","title":"Abstract 2976: Comprehensive Pan-Genomic characterization of adrenocortical carcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University Health Network","funders":"","keywords":"Biology; Adrenocortical carcinoma; Comparative genomic hybridization; Epigenetics; Copy-number variation; Epigenomics; Genetics; Cancer research; Loss of heterozygosity; Transcriptome; Gene; DNA methylation; Genome; Gene expression; Allele; Endocrinology","score_opus":0.1762917988919564,"score_gpt":0.4134517822041365,"score_spread":0.23715998331218008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565630856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967299,0.00049368094,0.000013910326,0.0006636687,0.00012276373,0.0003791102,0.00003495443,0.000018373588,0.001543639],"genre_scores_gemma":[0.99830604,0.00003647207,0.000020872842,0.00008169953,0.00035084586,0.000044057062,0.00006805853,0.000019435261,0.001072525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986152,0.00006224821,0.00024249392,0.00021074004,0.0005418612,0.00032747403],"domain_scores_gemma":[0.99865,0.00006230057,0.000053236025,0.00024168687,0.0007051254,0.00028765667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002547579,0.00009016474,0.00024741978,0.00015798189,0.000044580138,0.000010112712,0.00011122576,0.00006899717,0.00055373425],"category_scores_gemma":[0.000075687,0.00007393549,0.000051109168,0.00032115425,0.00022107657,0.00005450599,0.00006741529,0.00033754169,0.00016785038],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018454135,0.00022695743,0.040441513,0.00034487539,0.000071567316,0.0009382778,0.0010004903,0.000010151934,0.941152,0.00050584704,0.0024017545,0.011061173],"study_design_scores_gemma":[0.0012782604,0.00030345298,0.92264014,0.000106478365,0.000018678069,0.00013202934,0.0001926913,0.000054216012,0.07195407,0.00009263423,0.0031399967,0.00008733279],"about_ca_topic_score_codex":0.00051842636,"about_ca_topic_score_gemma":0.000011959487,"teacher_disagreement_score":0.88219863,"about_ca_system_score_codex":0.0001783791,"about_ca_system_score_gemma":0.00086320605,"threshold_uncertainty_score":0.6063002},"labels":[],"label_agreement":null},{"id":"W2565634272","doi":"10.1158/1538-7445.am2015-4246","title":"Abstract 4246: Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Serous fluid; Histology; Clear cell; DNA methylation; Medicine; Hematopathology; Pathology; Not Otherwise Specified; Immunohistochemistry; Methylation; Oncology; Carcinoma; Exact test; CDKN2A; Clear cell carcinoma; Cancer; Internal medicine; Biology; Gene; Gene expression; Genetics; Cytogenetics","score_opus":0.6418373939969689,"score_gpt":0.5769529930669741,"score_spread":0.06488440092999481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565634272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907998,0.004445549,0.00063492253,0.0024492827,0.0007068622,0.00058098655,0.00012056951,0.000016114196,0.00024593595],"genre_scores_gemma":[0.99549615,0.00010157563,0.0037922536,0.00007390882,0.0002856282,0.00005868593,0.00013906974,0.000027116628,0.00002558887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970577,0.00043880288,0.000753603,0.00067654025,0.0006647546,0.00040861347],"domain_scores_gemma":[0.9971192,0.000716261,0.00021850264,0.0010655584,0.00046637488,0.00041409943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022752383,0.00016309472,0.0006819874,0.00020081617,0.000106338586,0.00001753559,0.0002648777,0.00021526817,0.00020430873],"category_scores_gemma":[0.00063119736,0.00013484435,0.000060109032,0.00021294066,0.00043643697,0.00008228519,0.00027719617,0.0004544861,0.000008248495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021984663,0.000782017,0.97379786,0.000107335065,0.0001526394,0.00022382475,0.00023335895,0.00008988038,0.010469709,0.00007283831,0.0043378407,0.0075342115],"study_design_scores_gemma":[0.022109257,0.002247819,0.9131618,0.00016969419,0.00045384487,0.000021988373,0.0005017747,0.002197491,0.04985877,0.0001202536,0.0088672815,0.00029003338],"about_ca_topic_score_codex":0.0012374667,"about_ca_topic_score_gemma":0.00019862603,"teacher_disagreement_score":0.06063609,"about_ca_system_score_codex":0.0006914603,"about_ca_system_score_gemma":0.0013737708,"threshold_uncertainty_score":0.54987925},"labels":[],"label_agreement":null},{"id":"W2565686580","doi":"10.1158/1538-7445.am2015-2214","title":"Abstract 2214: Dynamic transcriptome analysis of DNA damage pathways under hypoxia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"RNA; DU145; Transcription (linguistics); Molecular biology; Biology; DNA damage; DNA repair; Messenger RNA; Transcriptome; DNA; Gene expression; Cell biology; Cancer cell; Gene; Biochemistry; Cancer; Genetics","score_opus":0.11079031627816888,"score_gpt":0.3979708028520565,"score_spread":0.2871804865738876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565686580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381435,0.0024498212,0.00059968425,0.00026332893,0.00007177125,0.00013703364,0.00017051034,0.000006790058,0.0024866941],"genre_scores_gemma":[0.99785626,0.0006494879,0.000052375188,0.000047595157,0.00006315428,0.000087700435,0.00015196315,0.000018586421,0.0010728765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868923,0.000079523554,0.00020067659,0.00033172328,0.0003948255,0.0003039898],"domain_scores_gemma":[0.99878305,0.000014018421,0.000048782833,0.00055158994,0.00044461596,0.00015792802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062001706,0.00009748716,0.00017584513,0.00024269155,0.000064726955,0.000025736259,0.00032819828,0.00011345757,0.00018524424],"category_scores_gemma":[0.000034331068,0.00008981907,0.00012782037,0.000767849,0.0001952572,0.000006041688,0.00005179385,0.0001527203,0.0000114426375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007550265,0.0000620367,0.00039730043,0.000016873535,0.0003403214,0.0000013949044,0.00012095947,0.001398499,0.9939764,0.00020935098,0.0016045927,0.001796773],"study_design_scores_gemma":[0.0020405657,0.0004981467,0.28130454,0.000049593953,0.00043659218,0.0000019470717,0.0026079433,0.0016913017,0.6614539,0.0010174568,0.048236642,0.00066137343],"about_ca_topic_score_codex":0.00037114817,"about_ca_topic_score_gemma":0.0005600738,"teacher_disagreement_score":0.33252248,"about_ca_system_score_codex":0.0000969477,"about_ca_system_score_gemma":0.0004437973,"threshold_uncertainty_score":0.36627153},"labels":[],"label_agreement":null},{"id":"W2565706366","doi":"10.1158/0008-5472.can-16-2529","title":"MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Prevention of Organ Failure; BC Cancer Agency; Genome British Columbia","funders":"University of Adelaide","keywords":"Cancer research; Prostate cancer; Metastasis; Prostate; Cancer; Medicine; Biology; microRNA; Oncology; Internal medicine","score_opus":0.03621151588358335,"score_gpt":0.3665198245481529,"score_spread":0.33030830866456956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565706366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851597,0.01071079,0.0001340051,0.0027478647,0.000075160315,0.0004989275,0.00047988296,0.000018810837,0.0001748495],"genre_scores_gemma":[0.99257004,0.0019585353,0.000097294665,0.000081145256,0.00034335136,0.0005163327,0.0000646769,0.000050811985,0.004317831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981355,0.00018740314,0.00020152611,0.0005318769,0.00034806272,0.00059563125],"domain_scores_gemma":[0.999074,0.000028865179,0.0000722771,0.0002679779,0.00039342538,0.00016349845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056680286,0.00015142949,0.00013118693,0.00007507315,0.00017649686,0.000051543753,0.00022480084,0.0001120525,0.0003394241],"category_scores_gemma":[0.00015457037,0.00011200103,0.00007253424,0.00020665339,0.00025297268,0.0000111639965,0.00022035613,0.00012303262,0.00003667421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009309713,0.00003055001,0.0015142824,0.00005598238,0.00006901906,0.000002011242,0.000039364106,0.0000016768485,0.92199874,0.00000983526,0.0397396,0.036445834],"study_design_scores_gemma":[0.0005220571,0.000060106948,0.0004881896,0.0001229061,0.00001074829,0.0000018902499,0.00002860767,0.0000027244898,0.9272512,0.00007650945,0.07127124,0.00016381888],"about_ca_topic_score_codex":0.00024820646,"about_ca_topic_score_gemma":0.000113694834,"teacher_disagreement_score":0.036282018,"about_ca_system_score_codex":0.00017129682,"about_ca_system_score_gemma":0.0004156223,"threshold_uncertainty_score":0.45672694},"labels":[],"label_agreement":null},{"id":"W2565709678","doi":"10.1158/1538-7445.am2015-4986","title":"Abstract 4986: Distinct temporal regulation of RET isoform internalization: Roles of clathrin and AP2","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; Queen's University","funders":"","keywords":"Internalization; Clathrin; Biology; Cell biology; Receptor tyrosine kinase; Glial cell line-derived neurotrophic factor; Tyrosine kinase; Receptor; Signal transducing adaptor protein; Proto-Oncogene Proteins c-ret; Colocalization; Gene isoform; Cancer research; Endocytosis; Neurotrophic factors; Signal transduction; Genetics","score_opus":0.052469241414237706,"score_gpt":0.36980027827391465,"score_spread":0.31733103685967695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565709678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967123,0.0014157024,0.0005831305,0.00006498928,0.00003678205,0.00011301377,0.000033274322,0.0000018838275,0.0010389183],"genre_scores_gemma":[0.9988993,0.00031744887,0.00010534293,0.0000072810444,0.00010231328,0.000010230262,0.000088277884,0.000009563473,0.0004602686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992742,0.000040456107,0.00020441496,0.0001586531,0.00020095566,0.00012134933],"domain_scores_gemma":[0.9992918,0.00000918701,0.0000849785,0.00020370992,0.00035103614,0.000059289505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051571795,0.000057568097,0.00010568482,0.000050304672,0.000022087657,0.000010009158,0.00011868504,0.00008282625,0.000029851182],"category_scores_gemma":[0.00008661129,0.000051184757,0.000027748578,0.000081630205,0.00014990463,0.000005125183,0.000109546905,0.00007336673,9.3658787e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002519934,0.000037709542,0.056281384,0.00010580754,0.000029154278,5.9043515e-7,0.00019884821,0.00005698015,0.9332365,0.00030114615,0.0034394183,0.0060604857],"study_design_scores_gemma":[0.0007885938,0.00033935398,0.06153366,0.0001195939,0.000008676839,0.0000044812473,0.0002791783,0.0003010105,0.91583776,0.0007562984,0.01990216,0.00012919895],"about_ca_topic_score_codex":0.00024074194,"about_ca_topic_score_gemma":0.0005190989,"teacher_disagreement_score":0.017398687,"about_ca_system_score_codex":0.00002217326,"about_ca_system_score_gemma":0.00013963075,"threshold_uncertainty_score":0.20872538},"labels":[],"label_agreement":null},{"id":"W2565738065","doi":"10.1158/1538-7445.am2015-395","title":"Abstract 395: Effect of pantoprazole to enhance activity of docetaxel against human tumor xenografts by inhibiting autophagy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Docetaxel; Pantoprazole; Apoptosis; Chemistry; Pharmacology; Programmed cell death; Cancer research; Chemotherapy; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.060458474715807085,"score_gpt":0.46113869298917787,"score_spread":0.4006802182733708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565738065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364823,0.0020644006,0.000009748612,0.00019277183,0.000082220606,0.00077882514,0.00006630045,0.000036897596,0.0031205767],"genre_scores_gemma":[0.99892825,0.00009495192,0.000019950152,0.000092103815,0.0002222044,0.0001639398,0.0000137040515,0.000036129913,0.0004287765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976106,0.00018273327,0.00032067543,0.00035710077,0.0010006449,0.0005281977],"domain_scores_gemma":[0.9983509,0.00020197153,0.00013812541,0.00041020068,0.0004334337,0.00046534016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016242432,0.00017356269,0.0005212767,0.00022100209,0.000091272355,0.000014961063,0.00022732388,0.000078943965,0.0001615306],"category_scores_gemma":[0.00031722226,0.00014446203,0.00011365071,0.0005309405,0.00023583551,0.00011443963,0.000111802765,0.00045400212,0.0000316564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010414016,0.00025104266,0.0017170683,0.00048011832,0.00008329382,0.000054332333,0.00041834006,0.000011741324,0.97036207,0.000011321488,0.0046380153,0.02093123],"study_design_scores_gemma":[0.0015154661,0.00100355,0.008987568,0.000521323,0.000015995269,0.0000018322676,0.00006866811,0.000014220172,0.986488,0.000028901086,0.0012406628,0.000113850554],"about_ca_topic_score_codex":0.00083569024,"about_ca_topic_score_gemma":0.000024087794,"teacher_disagreement_score":0.02081738,"about_ca_system_score_codex":0.00021836215,"about_ca_system_score_gemma":0.0004336789,"threshold_uncertainty_score":0.5890991},"labels":[],"label_agreement":null},{"id":"W2565751032","doi":"10.1158/1538-7445.am2015-4612","title":"Abstract 4612: Genetic variants in epigenetic pathways and risk of multiple cancer types in the GAME-ON consortium","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Biology; Single-nucleotide polymorphism; DNA methylation; Genome-wide association study; Genetics; Prostate cancer; Cancer; Chromatin remodeling; Histone; Chromatin; Odds ratio; Colorectal cancer; Oncology; Bioinformatics; Gene; Genotype; Internal medicine; Medicine; Gene expression","score_opus":0.07522854201692025,"score_gpt":0.3634726553402808,"score_spread":0.28824411332336053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565751032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97912586,0.019822026,0.0000061283704,0.000119216435,0.00007507197,0.0003617261,0.00016383013,0.000002145397,0.00032402278],"genre_scores_gemma":[0.98354757,0.015934777,0.000032506647,0.00006461218,0.00016025724,0.00019047318,0.000014440746,0.000015687549,0.00003966846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985628,0.00027543175,0.00021644893,0.00032702056,0.0002941792,0.0003240872],"domain_scores_gemma":[0.9992225,0.000080199374,0.000052307518,0.00033575512,0.00018137415,0.00012784552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819769,0.00010723962,0.00013402752,0.000110909314,0.00003805173,0.000020833782,0.00022624298,0.000102696,0.0000271128],"category_scores_gemma":[0.0003525597,0.00008688911,0.000030139881,0.00018300467,0.00023399292,0.0000029318048,0.000056750054,0.0001887889,0.0000039320153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009046953,0.00037875448,0.76328117,0.00012887502,0.000041644846,0.000026926196,0.00090938574,0.0020383773,0.22388436,0.000021443002,0.0017216078,0.0066627786],"study_design_scores_gemma":[0.0020932928,0.00029452512,0.901102,0.00007850832,0.000012249532,0.0000016562119,0.00052853784,0.00009192711,0.092917174,0.00075082533,0.0019809187,0.00014837546],"about_ca_topic_score_codex":0.0026892193,"about_ca_topic_score_gemma":0.0044437065,"teacher_disagreement_score":0.13782085,"about_ca_system_score_codex":0.00003955638,"about_ca_system_score_gemma":0.00041743653,"threshold_uncertainty_score":0.40653133},"labels":[],"label_agreement":null},{"id":"W2565843701","doi":"10.1158/1538-7445.am2015-2344","title":"Abstract 2344: The PD-1:PD-L1 pathway in the context of the osteosarcoma tumor microenvironment","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immune system; Tumor microenvironment; Cancer research; PD-L1; Cancer; Tumor-infiltrating lymphocytes; Medicine; Antibody; Context (archaeology); Immunology; Biology; Immunotherapy; Internal medicine","score_opus":0.10120100545151116,"score_gpt":0.37393525672491523,"score_spread":0.27273425127340406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565843701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96390617,0.009615334,3.676242e-7,0.022345096,0.00018903578,0.0011499139,0.000035555564,0.0000056763547,0.0027528577],"genre_scores_gemma":[0.99612725,0.0004305276,0.0000037367263,0.0020102367,0.00017095798,0.00023643272,0.0000032535283,0.000018997109,0.0009986112],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765676,0.0003641493,0.00029963983,0.00022310368,0.0010314909,0.00042483542],"domain_scores_gemma":[0.99865234,0.00028088107,0.00008275537,0.00080478046,0.00010412637,0.00007512425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028061308,0.00012397932,0.00019547984,0.00006668185,0.00014239634,0.00003239222,0.00067324477,0.00005267644,0.00031072582],"category_scores_gemma":[0.00010919374,0.000053375137,0.00012649671,0.00043649122,0.00082774536,0.000042117033,0.00012718809,0.00066550303,0.000032526408],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111752255,0.00086311094,0.051378287,0.00031058918,0.0003103272,0.00016199195,0.02668108,0.000012494567,0.68501073,0.0003532142,0.09142562,0.13231735],"study_design_scores_gemma":[0.004433086,0.00046474882,0.37103367,0.00040638185,0.000017401731,0.000055840985,0.019524429,0.0000084010035,0.16100878,0.000143866,0.44276637,0.00013701683],"about_ca_topic_score_codex":0.004620254,"about_ca_topic_score_gemma":0.0014938789,"teacher_disagreement_score":0.52400196,"about_ca_system_score_codex":0.00045726885,"about_ca_system_score_gemma":0.00065170234,"threshold_uncertainty_score":0.6984473},"labels":[],"label_agreement":null},{"id":"W2565869021","doi":"10.1158/1538-7445.am2015-1154","title":"Abstract 1154: Serum and urine markers of metabolic dysfunction in colorectal cancer: A pilot study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Gastroenterology; Cancer; Creatinine; Chemotherapy","score_opus":0.06174674505797225,"score_gpt":0.36758197764066863,"score_spread":0.3058352325826964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565869021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193074,0.026056824,0.0000019946015,0.00013381786,0.00059081026,0.0005881997,0.00006019735,0.0000054705074,0.0006319699],"genre_scores_gemma":[0.9902653,0.008016289,0.000012982636,0.000024636427,0.00078284246,0.0003466682,0.000010514663,0.000022808885,0.00051795726],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984285,0.00015774257,0.00023030065,0.00040332324,0.0003907864,0.0003893407],"domain_scores_gemma":[0.9992152,0.00001912591,0.00005959754,0.00022112162,0.0003028947,0.00018205383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011187645,0.00013455971,0.00025542418,0.00017384933,0.000050690476,0.000021504342,0.00017115324,0.000066797904,0.000072958785],"category_scores_gemma":[0.00011772922,0.00012719243,0.000029935423,0.000340538,0.00017162951,0.000009990161,0.0001690509,0.0002388928,0.0000028250715],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045379847,0.0005381715,0.10040632,0.00007811625,0.00015931402,0.0000045625443,0.00040436213,0.00013078863,0.86105657,0.000027103019,0.00535609,0.027300602],"study_design_scores_gemma":[0.005160513,0.0025980787,0.7586628,0.00004130239,0.000035645422,0.000005110149,0.001426506,0.000017100669,0.16615155,0.000045831322,0.065605685,0.00024987434],"about_ca_topic_score_codex":0.009712581,"about_ca_topic_score_gemma":0.013597583,"teacher_disagreement_score":0.69490504,"about_ca_system_score_codex":0.000054361393,"about_ca_system_score_gemma":0.0006267031,"threshold_uncertainty_score":0.99688184},"labels":[],"label_agreement":null},{"id":"W2565876409","doi":"10.1158/1538-7445.am2015-206","title":"Abstract 206: Development of a molecular imaging system based on the transcriptional activity of the DD3/PCA3 non-coding RNA for imaging specifically the prostate cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Prostate cancer; Luciferase; Bioluminescence imaging; Biology; In vivo; PCA3; Reporter gene; Cancer research; Molecular biology; Gene; Cancer; Gene expression; Transfection; Genetics","score_opus":0.05660134420996308,"score_gpt":0.3614324020910386,"score_spread":0.3048310578810755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565876409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95570296,0.0007196078,0.035872113,0.0044902675,0.00010616392,0.0019296235,0.00018273281,0.000009786982,0.0009867655],"genre_scores_gemma":[0.9977578,0.000039154886,0.00064635766,0.00015362728,0.00006121564,0.001252648,0.000011884767,0.000020967014,0.00005633665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987122,0.00012881805,0.00022424325,0.00029415818,0.00035083765,0.00028976932],"domain_scores_gemma":[0.9988642,0.00005607901,0.000121329555,0.000474192,0.0004306898,0.000053558553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012889822,0.00012107738,0.00012221378,0.000037705853,0.00023601088,0.000022092792,0.0005270538,0.000053340133,0.00000870016],"category_scores_gemma":[0.000036988637,0.000067139845,0.000112633024,0.00016727293,0.00030503824,0.0000032699886,0.00009457494,0.0002175317,6.240553e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001467853,0.000041556763,0.00020573197,0.00007125473,0.000027778047,4.887987e-7,0.00009654705,0.00032049252,0.9942553,0.0004087529,0.0013355609,0.0030897465],"study_design_scores_gemma":[0.00028279392,0.000024580164,0.0014534595,0.00011963315,0.0000091743095,6.415603e-7,0.00014869988,0.0011009849,0.9882699,0.00004332272,0.008465668,0.000081097736],"about_ca_topic_score_codex":0.000118009935,"about_ca_topic_score_gemma":0.000028213797,"teacher_disagreement_score":0.04205487,"about_ca_system_score_codex":0.00010652394,"about_ca_system_score_gemma":0.0007492745,"threshold_uncertainty_score":0.27378833},"labels":[],"label_agreement":null},{"id":"W2565911184","doi":"10.1158/1538-7445.am2015-2080","title":"Abstract 2080: Differential transcription profile of epithelia in fimbria versus the ampulla of the fallopian tube","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fallopian tube; Biology; Oviduct; Ampulla; Andrology; Transcriptome; Serous carcinoma; Serous fluid; Fimbria; Ovarian cancer; Pathology; Endocrinology; Gene expression; Gene; Genetics; Medicine; Anatomy; Cancer","score_opus":0.15886252703050416,"score_gpt":0.4115752757942397,"score_spread":0.2527127487637355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565911184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894448,0.0010268159,0.0000013698703,0.004877132,0.00045656526,0.00084403256,0.0000633492,0.000004819662,0.003281116],"genre_scores_gemma":[0.9986755,0.00033290815,0.000012072411,0.000018652203,0.00015785953,0.00022147562,0.000007504879,0.000013826544,0.00056017283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985019,0.00012877406,0.00024188633,0.00018532306,0.00068540656,0.00025670757],"domain_scores_gemma":[0.99909467,0.00011758824,0.0000561021,0.00040039665,0.0002452446,0.00008601892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987303,0.00008896699,0.00021457512,0.00007872144,0.000043935037,0.000010966638,0.00020292867,0.00006326392,0.0006104676],"category_scores_gemma":[0.00008617353,0.00004686325,0.00009413611,0.0003516895,0.00023095941,0.000034403096,0.0000427083,0.00030537124,0.000010949431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024022141,0.0048031355,0.3952065,0.0020869873,0.0014710503,0.00008548762,0.019470591,0.00031618972,0.33803344,0.0070772525,0.06468011,0.14274712],"study_design_scores_gemma":[0.0073371227,0.00048563146,0.8914347,0.0004943644,0.00006565947,0.000001455396,0.0006980346,0.00005341563,0.092989765,0.00015343135,0.006213982,0.000072398005],"about_ca_topic_score_codex":0.004805906,"about_ca_topic_score_gemma":0.0019507251,"teacher_disagreement_score":0.49622825,"about_ca_system_score_codex":0.00030798762,"about_ca_system_score_gemma":0.00059370056,"threshold_uncertainty_score":0.72651243},"labels":[],"label_agreement":null},{"id":"W2565995632","doi":"10.1158/1538-7445.am2015-2086","title":"Abstract 2086: Role of the transcription factor NFE2L3 in TNFα signaling pathway in colorectal cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Transcription factor; Cancer; Carcinogenesis; Cancer research; Tumor necrosis factor alpha; Medicine; Biology; Cytokine; Immunology; Internal medicine; Genetics; Gene","score_opus":0.06670328750554999,"score_gpt":0.3686269425020895,"score_spread":0.3019236549965395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565995632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911642,0.007859717,0.0000018439288,0.00009528105,0.000116077,0.0003098748,0.000102107944,0.0000029994699,0.00034788295],"genre_scores_gemma":[0.99941176,0.00018366276,0.0000038464377,0.000019189316,0.00012626518,0.00017691767,0.000012369643,0.000017326878,0.000048673865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998724,0.00015776757,0.00018600907,0.00025509208,0.00037190985,0.00030523812],"domain_scores_gemma":[0.99948364,0.000018680834,0.000038948117,0.00020175012,0.00017260617,0.00008434224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043110645,0.00008758164,0.00011481841,0.000082925944,0.000030034587,0.00001514388,0.0003074555,0.00011386552,0.00009568017],"category_scores_gemma":[0.00016542636,0.000072622424,0.000063997744,0.00027573746,0.00014124901,0.000006620262,0.00007789302,0.0002452535,0.0000022446904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018715493,0.00006964969,0.0657167,0.000028494766,0.000011893281,0.000002589489,0.00032980443,0.0008151791,0.9297662,0.000011672963,0.00014165508,0.0029190236],"study_design_scores_gemma":[0.00064779044,0.00004331809,0.09405646,0.00007971849,0.0000015711199,4.87977e-7,0.00038893722,0.000021910493,0.9026697,0.00013373149,0.0018750201,0.000081318016],"about_ca_topic_score_codex":0.0028150096,"about_ca_topic_score_gemma":0.00710536,"teacher_disagreement_score":0.02833976,"about_ca_system_score_codex":0.00019489217,"about_ca_system_score_gemma":0.0008165651,"threshold_uncertainty_score":0.42554712},"labels":[],"label_agreement":null},{"id":"W2566058335","doi":"10.1158/1538-7445.am2015-5270","title":"Abstract 5270: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Isocitrate dehydrogenase; Hazard ratio; IDH1; Mitotic index; Confidence interval; Internal medicine; Glioma; Biology; Oncology; Mutant; Pathology; Gastroenterology; Medicine; Cancer research; Mitosis; Genetics; Gene; Enzyme","score_opus":0.07471666626770028,"score_gpt":0.3880452188091104,"score_spread":0.3133285525414101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566058335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920796,0.0063696066,1.9373711e-7,0.0007751038,0.000039336166,0.0005011651,0.000014954631,0.000006591072,0.0002134539],"genre_scores_gemma":[0.9985454,0.0012112153,0.0000124776925,0.000013595611,0.00004170649,0.00010901437,0.000011845652,0.000016055226,0.000038698166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.00008704155,0.00023577877,0.0002733113,0.0005584806,0.000398172],"domain_scores_gemma":[0.9992418,0.00016657577,0.000042525866,0.00016637862,0.000116024574,0.00026665014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047184763,0.00011176566,0.00029630077,0.0004965416,0.000035780344,0.000024107096,0.000048239188,0.000082027684,0.000019994726],"category_scores_gemma":[0.00013263231,0.0000947392,0.000020693215,0.00040462558,0.00014426393,0.00010333705,0.00007849248,0.0002749307,0.0000011215056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004712018,0.00085251225,0.9764496,0.00011907075,0.000041080842,0.00029646023,0.003286502,0.000043025237,0.013968483,0.00020584936,0.00016126665,0.0041049677],"study_design_scores_gemma":[0.010089554,0.0003292586,0.9766038,0.0002482857,0.000011646683,0.000007644234,0.0010218553,0.0002827401,0.00982758,0.001306272,0.00019166488,0.00007970217],"about_ca_topic_score_codex":0.021753576,"about_ca_topic_score_gemma":0.0065258094,"teacher_disagreement_score":0.015227765,"about_ca_system_score_codex":0.00030671334,"about_ca_system_score_gemma":0.00022762452,"threshold_uncertainty_score":0.98476064},"labels":[],"label_agreement":null},{"id":"W2566164036","doi":"10.1158/1538-7445.am2015-3788","title":"Abstract 3788: Contributions of novel nuclear nucleoside transporters, HNP36 and HNP32, to DNA synthesis during cell cycle","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Toronto Metropolitan University","funders":"","keywords":"Nucleoside; Nucleoside transporter; Biology; Cell biology; Transporter; DNA; Gene isoform; Biochemistry; Gene","score_opus":0.041921191581926635,"score_gpt":0.3419223003573668,"score_spread":0.3000011087754402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566164036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667716,0.0014249198,0.00007617873,0.0005466498,0.000033935186,0.0001718927,0.00013769146,0.000008061297,0.00092353945],"genre_scores_gemma":[0.9991171,0.0002450268,0.00015136262,0.00004374708,0.0001853479,0.000034567252,0.0000103207585,0.000024818382,0.0001877139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896425,0.00003005049,0.00017140625,0.00027423396,0.00023768102,0.000322394],"domain_scores_gemma":[0.99921685,0.00003043152,0.000034668512,0.00022444324,0.00024322628,0.0002503568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036810833,0.00009617738,0.00014143642,0.000075945274,0.00010174286,0.00002492026,0.00017599901,0.00009841662,0.00006396591],"category_scores_gemma":[0.00008322904,0.00009497863,0.000044544853,0.00013865338,0.00010460354,0.0000062737404,0.00008250362,0.00013459208,0.000006771503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020345025,0.000071841096,0.00028686775,0.0000526386,0.00003200476,0.0000060238567,0.00021618741,0.0002615024,0.9960364,0.000030733365,0.0025959439,0.0002063983],"study_design_scores_gemma":[0.0007543355,0.000089466484,0.003463679,0.00006080654,0.000015976217,0.000004597243,0.0005508055,0.000018880834,0.98634845,0.000015438565,0.008539741,0.0001378285],"about_ca_topic_score_codex":0.00044891585,"about_ca_topic_score_gemma":0.00003186513,"teacher_disagreement_score":0.009687963,"about_ca_system_score_codex":0.000036840844,"about_ca_system_score_gemma":0.00013425146,"threshold_uncertainty_score":0.38731164},"labels":[],"label_agreement":null},{"id":"W2566190653","doi":"10.1158/1538-7445.am2015-2555","title":"Abstract 2555: The mechanism of action of bendamustine alone or in combination with nucleoside analogs in chronic lymphocytic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Pentostatin; Bendamustine; Chronic lymphocytic leukemia; Cladribine; Nucleoside analogue; Fludarabine; Chlorambucil; Cytotoxicity; Pharmacology; Medicine; Deoxycoformycin; MTT assay; Leukemia; Nucleoside; Cancer research; Immunology; Apoptosis; Chemistry; In vitro; Chemotherapy; Lymphoma; Biochemistry; Adenosine; Adenosine deaminase; Internal medicine","score_opus":0.14535627696262285,"score_gpt":0.42463775318634744,"score_spread":0.27928147622372457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566190653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966112,0.0007344863,0.000027596487,0.00047549926,0.000054055818,0.0011548286,0.000009424026,0.00001538862,0.000917538],"genre_scores_gemma":[0.9983914,0.0006568239,0.000060615366,0.000026491003,0.00009045322,0.00018834039,0.000015628759,0.00003925358,0.00053103216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644417,0.0002345173,0.00056103634,0.0003657344,0.0017603552,0.0006341695],"domain_scores_gemma":[0.9977895,0.00053530553,0.00015289123,0.00058083324,0.00075753964,0.0001839016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031395096,0.00015819179,0.00047831138,0.0007339609,0.00004539709,0.000015579504,0.0003398009,0.00015410178,0.00023603131],"category_scores_gemma":[0.00070506067,0.000100633835,0.00004384354,0.002027014,0.0004897309,0.00015795359,0.00014174687,0.0006900228,0.000015113743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06015679,0.0014595216,0.0070711044,0.01176797,0.0007218873,0.0027367976,0.013688517,0.05015499,0.7745022,0.0086694965,0.007608837,0.061461873],"study_design_scores_gemma":[0.15113123,0.0066300835,0.040977165,0.005609978,0.00009917762,0.0003259953,0.0070085768,0.14127225,0.643282,0.0022098008,0.0009380424,0.00051570113],"about_ca_topic_score_codex":0.061494637,"about_ca_topic_score_gemma":0.023297008,"teacher_disagreement_score":0.13122022,"about_ca_system_score_codex":0.1370573,"about_ca_system_score_gemma":0.08466781,"threshold_uncertainty_score":0.99452525},"labels":[],"label_agreement":null},{"id":"W2566230668","doi":"10.1158/1538-7445.am2015-5333","title":"Abstract 5333: TH-302 potentiates the antitumor activity of topotecan in neuroblastoma and rhabdomyosarcoma preclinical models","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Topotecan; Rhabdomyosarcoma; Neuroblastoma; In vivo; Pharmacology; Medicine; Cytotoxicity; Tumor hypoxia; Hypoxia (environmental); Cancer research; Combination therapy; Cytotoxic T cell; Apoptosis; Cell culture; Chemotherapy; In vitro; Chemistry; Internal medicine; Pathology; Biology; Sarcoma; Radiation therapy","score_opus":0.24096027495622055,"score_gpt":0.4650983606613697,"score_spread":0.22413808570514918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566230668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932363,0.00071584515,0.0000063342136,0.0035358171,0.000056646088,0.00082160725,0.000024507566,0.000019763187,0.0015831814],"genre_scores_gemma":[0.99886346,0.0005436097,0.000040121453,0.000047839094,0.000077039265,0.00011112117,0.0000021698668,0.000027150943,0.0002874746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973346,0.00033041695,0.00026864215,0.00042131718,0.0010334839,0.0006115563],"domain_scores_gemma":[0.9981936,0.0005155504,0.000058913545,0.00048296573,0.00033046826,0.00041849076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012869957,0.0001460802,0.00034420693,0.0002636908,0.00009378741,0.000042236396,0.00024669696,0.00007999451,0.00005878678],"category_scores_gemma":[0.00048162878,0.00009785246,0.00007009686,0.000514678,0.0006154904,0.00019959571,0.0002850876,0.00090983446,0.00001613869],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028344424,0.0067505823,0.15618223,0.0016980744,0.0007080579,0.004454113,0.00234958,0.00084204087,0.60097337,0.0013933812,0.008200032,0.18810412],"study_design_scores_gemma":[0.00914207,0.003281808,0.8028837,0.00057587336,0.000043481436,0.0001501784,0.0003537052,0.0037104061,0.17486463,0.0040763956,0.0006617053,0.00025604578],"about_ca_topic_score_codex":0.0017996199,"about_ca_topic_score_gemma":0.0005791299,"teacher_disagreement_score":0.64670146,"about_ca_system_score_codex":0.00013348821,"about_ca_system_score_gemma":0.00071893254,"threshold_uncertainty_score":0.39903075},"labels":[],"label_agreement":null},{"id":"W2566303163","doi":"10.1158/1538-7445.panca16-b72","title":"Abstract B72: Pancreatic cancer cell drives stroma composition","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Industrielle du Québec","funders":"","keywords":"Stroma; Biology; Stromal cell; Transcriptome; Pancreatic cancer; Desmoplasia; In silico; Exome sequencing; Deep sequencing; Gene; Cancer research; Cell biology; Cancer; Genetics; Genome; Phenotype; Gene expression; Immunology","score_opus":0.09316345379063919,"score_gpt":0.45189585032504853,"score_spread":0.35873239653440936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566303163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632092,0.0035630453,0.00006664086,0.0053434502,0.0001223417,0.0007892907,0.000071437964,0.000058896574,0.026775686],"genre_scores_gemma":[0.97616994,0.009583168,0.00021076821,0.00013333818,0.0006048717,0.00070244155,0.000011611285,0.00004039886,0.012543439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970827,0.00020670278,0.0003062994,0.0004661976,0.00102083,0.0009172638],"domain_scores_gemma":[0.9977258,0.0007107641,0.000061263076,0.00048645146,0.00056486536,0.00045087916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008565741,0.00017333984,0.00048443102,0.00018882116,0.00026023816,0.000031672338,0.00024331066,0.00017366893,0.010931093],"category_scores_gemma":[0.00011313913,0.00010957495,0.00009553365,0.0003013143,0.00059203815,0.00016693544,0.00010959831,0.00045883065,0.00050125533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007619827,0.00027177896,0.23748386,0.00031283838,0.00015424093,0.00011896048,0.00025704753,7.1483606e-7,0.7325319,0.00023326535,0.014753705,0.013119733],"study_design_scores_gemma":[0.0054664267,0.00091654074,0.8669754,0.0017035075,0.00016271914,0.000027126829,0.00046423962,0.000056005127,0.11236811,0.0005118111,0.011043156,0.00030494868],"about_ca_topic_score_codex":0.0029521305,"about_ca_topic_score_gemma":0.00031937964,"teacher_disagreement_score":0.62949157,"about_ca_system_score_codex":0.0011718355,"about_ca_system_score_gemma":0.0012415182,"threshold_uncertainty_score":0.98997307},"labels":[],"label_agreement":null},{"id":"W2566328755","doi":"10.1158/1538-7445.am2015-3193","title":"Abstract 3193: Expression analysis reveals candidate genes involved in highly invasive high-hyaluronan binding subpopulations of prostate cancer cell lines","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Biology; Cancer research; Metastasis; Cell sorting; Prostate cancer; Cell culture; Flow cytometry; Angiogenesis; Cancer; Molecular biology; Cell growth; Genetics","score_opus":0.0714138095521858,"score_gpt":0.38220499002539354,"score_spread":0.31079118047320775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566328755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410295,0.004497748,0.000006542697,0.00019842522,0.00009547248,0.0005830194,0.00039722607,0.000009942505,0.00010865422],"genre_scores_gemma":[0.9953261,0.0023352902,0.0001517101,0.000011671697,0.00020287317,0.00038593254,0.00045688325,0.00004636761,0.0010831782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694234,0.0003486456,0.0004890865,0.00065034634,0.0008418273,0.0007277361],"domain_scores_gemma":[0.9979196,0.00009230749,0.00016956833,0.0005998557,0.00091032404,0.00030833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010993883,0.00021418268,0.00037137262,0.00059337326,0.00011805925,0.00005503098,0.00050142105,0.00021106307,0.000118958116],"category_scores_gemma":[0.00027219407,0.00019342123,0.00010940881,0.001394253,0.00022322376,0.000032629614,0.0004068495,0.00033334558,0.000009475385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002681493,0.00006109964,0.2601679,0.0001434876,0.00008397319,0.000006543466,0.00022159223,0.0024238562,0.7350762,0.0000045473084,0.0012949362,0.0002477464],"study_design_scores_gemma":[0.0008386246,0.0001976692,0.089124575,0.00015311217,0.000025890922,1.7697997e-7,0.00041972805,0.000040201947,0.9084539,0.000050879742,0.0004890642,0.00020622573],"about_ca_topic_score_codex":0.027342737,"about_ca_topic_score_gemma":0.033163916,"teacher_disagreement_score":0.17337766,"about_ca_system_score_codex":0.000337366,"about_ca_system_score_gemma":0.0011313274,"threshold_uncertainty_score":0.9844783},"labels":[],"label_agreement":null},{"id":"W2566368716","doi":"10.1158/1538-7445.panca16-a44","title":"Abstract A44: Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Cancer; Methyltransferase; Medicine; Cancer research; Inflammation; Internal medicine; Biology; Biochemistry; Methylation; Gene","score_opus":0.04701450265618198,"score_gpt":0.3844991842654717,"score_spread":0.3374846816092897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566368716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981627,0.013982887,0.0011697904,0.0022249543,0.00005743327,0.00038153943,0.00029787357,0.0000048549236,0.00025368505],"genre_scores_gemma":[0.9930515,0.005241153,0.000027919876,0.00001924999,0.00018043176,0.00022651885,0.000041725547,0.000022231276,0.0011892504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985874,0.00020229138,0.00022815654,0.00029288235,0.0003929802,0.0002962724],"domain_scores_gemma":[0.998867,0.0001597401,0.000069763024,0.0003266979,0.0005032998,0.00007350852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008844858,0.00011218233,0.0001408527,0.000056492292,0.00011308711,0.000023228238,0.00025655824,0.00010631707,0.00031735713],"category_scores_gemma":[0.00020432964,0.00006520439,0.000060724644,0.00019638616,0.00022733244,0.0000068322643,0.00004937947,0.00010694444,0.0000037806824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071437906,0.00004962714,0.0035025214,0.00004834923,0.00007489915,3.983235e-7,0.00004888372,0.000034719833,0.9618778,0.000029730116,0.001292974,0.03296866],"study_design_scores_gemma":[0.0004049094,0.00013899965,0.0045638126,0.00008716757,0.000017493534,1.2980996e-7,0.00003471847,0.000010351421,0.99016213,0.00031089562,0.0041733724,0.00009602399],"about_ca_topic_score_codex":0.0009527762,"about_ca_topic_score_gemma":0.00039287686,"teacher_disagreement_score":0.032872636,"about_ca_system_score_codex":0.00004556793,"about_ca_system_score_gemma":0.00023850509,"threshold_uncertainty_score":0.3474838},"labels":[],"label_agreement":null},{"id":"W2566445060","doi":"10.1158/1538-7445.transcagen-a2-14","title":"Abstract A2-14: Integrated genetic and epigenetic analysis of model and patient acute myeloid leukemias","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire Sainte-Justine; Université Laval","funders":"","keywords":"Myeloid leukemia; Epigenetics; Leukemia; Context (archaeology); Fusion gene; Cancer research; DNA methylation; Chromosomal translocation; Biology; Myeloid; CD34; Gene; Immunology; Genetics; Gene expression; Stem cell","score_opus":0.09162343728472427,"score_gpt":0.3942510717701566,"score_spread":0.30262763448543234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566445060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963636,0.0076792003,0.00014185756,0.0008129044,0.000028222854,0.0006446317,0.000115219664,0.000024505965,0.0009171042],"genre_scores_gemma":[0.99118704,0.006293243,0.0012847366,0.000109815366,0.000041967254,0.00013614552,0.000038233316,0.00004349479,0.0008653177],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967898,0.00015706588,0.00045132462,0.00060023397,0.0013035283,0.0006980383],"domain_scores_gemma":[0.996922,0.00018937708,0.00008310901,0.0005932076,0.0014087481,0.000803537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009071325,0.00021469583,0.00063998403,0.0012046711,0.00009832591,0.00005075994,0.00021815441,0.00019006353,0.0001435422],"category_scores_gemma":[0.00035935504,0.0001734926,0.000090521185,0.001955041,0.000708227,0.0000829524,0.00032684868,0.0008415075,0.000012686512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006393553,0.0005870876,0.080463,0.001008248,0.010851847,0.000919578,0.014099481,0.02204698,0.4840353,0.00016547863,0.035990704,0.34343874],"study_design_scores_gemma":[0.012103415,0.003542866,0.43757778,0.0006688017,0.0039721937,0.00013821182,0.0050020423,0.4313918,0.095684834,0.0011934146,0.007553259,0.0011713854],"about_ca_topic_score_codex":0.0027007004,"about_ca_topic_score_gemma":0.000334353,"teacher_disagreement_score":0.40934482,"about_ca_system_score_codex":0.0010211215,"about_ca_system_score_gemma":0.002450879,"threshold_uncertainty_score":0.70748234},"labels":[],"label_agreement":null},{"id":"W2566463587","doi":"10.1158/1538-7445.am2015-2508","title":"Abstract 2508: Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Immunovaccine (Canada)","funders":"","keywords":"Medicine; ELISPOT; Ovarian cancer; Immunogenicity; Immune system; Cancer research; Cyclophosphamide; CD8; Cytotoxic T cell; Cancer vaccine; Tumor microenvironment; Immunology; Cancer; Combination therapy; Immunotherapy; Pharmacology; Chemotherapy; Internal medicine; Biology; In vitro","score_opus":0.044988841709597084,"score_gpt":0.3446947686963435,"score_spread":0.2997059269867464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566463587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667685,0.031167446,0.00021376023,0.00010048344,0.0000806789,0.0014891039,0.00009661845,0.000022130102,0.00006125397],"genre_scores_gemma":[0.9977393,0.0011786798,0.000107580105,0.000013490527,0.00001673907,0.00047010064,0.000031308464,0.00003628219,0.0004064786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99789536,0.0005457536,0.0003721561,0.00044590066,0.00009957462,0.00064126786],"domain_scores_gemma":[0.9984744,0.0008079568,0.00012586397,0.00030516705,0.00023101129,0.000055576358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091082155,0.0002682049,0.00062862394,0.0003683853,0.00014167183,0.000023587303,0.00021917952,0.00015919772,0.00004134264],"category_scores_gemma":[0.000109360466,0.00019762095,0.00007125769,0.00024438355,0.00042784208,0.00024938167,0.000058610905,0.00042365116,0.00001791276],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016702345,0.0005939258,0.14174339,0.00005531729,0.0005614942,0.000027259612,0.001520242,0.0021439216,0.82405895,0.000039629336,0.000036697264,0.012516824],"study_design_scores_gemma":[0.030649915,0.0026420963,0.51039547,0.0002888794,0.00003672545,0.000035035315,0.0012391551,0.00095578516,0.45232797,0.000060668666,0.0010043212,0.0003639745],"about_ca_topic_score_codex":0.014225532,"about_ca_topic_score_gemma":0.00082618324,"teacher_disagreement_score":0.37173095,"about_ca_system_score_codex":0.00042808382,"about_ca_system_score_gemma":0.0006327105,"threshold_uncertainty_score":0.99233884},"labels":[],"label_agreement":null},{"id":"W2566496740","doi":"10.1158/1538-7445.am2015-5303","title":"Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"BCL6; Internal medicine; Medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Oncology; Immunohistochemistry; Lymphoma; Clinical trial; Immunology; B cell","score_opus":0.054822729887369526,"score_gpt":0.3757569179760937,"score_spread":0.32093418808872415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566496740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930717,0.0005388347,0.0000029053322,0.00021509055,0.00015223633,0.004926596,0.00078020286,0.000037857997,0.0002745958],"genre_scores_gemma":[0.997788,0.00014312362,0.000088674096,0.00007508906,0.00007466742,0.0013027298,0.000088107176,0.00007311631,0.00036649496],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9946556,0.00089560036,0.0007237425,0.0009371765,0.0019546095,0.00083323976],"domain_scores_gemma":[0.99609995,0.0014511055,0.00024243923,0.00095929817,0.00058266235,0.00066456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022520241,0.0003752672,0.0008122719,0.0005948754,0.00015640483,0.00005501108,0.00030381538,0.00014654385,0.000043576198],"category_scores_gemma":[0.00079064467,0.00027378937,0.00010723365,0.0010084963,0.000081942526,0.00018030137,0.00018639734,0.0003774249,0.000048291684],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50587225,0.09665333,0.34662172,0.000018935283,0.00061434775,0.00079311023,0.037856586,0.000047784568,0.000614425,0.000002246564,0.0021248849,0.008780374],"study_design_scores_gemma":[0.47621268,0.015640335,0.49785194,0.00043045566,0.00007731097,5.4230435e-7,0.004496746,0.00002580737,0.0042087464,0.00001032103,0.00083445857,0.00021067896],"about_ca_topic_score_codex":0.03486647,"about_ca_topic_score_gemma":0.0033723325,"teacher_disagreement_score":0.15123022,"about_ca_system_score_codex":0.0019282679,"about_ca_system_score_gemma":0.001250502,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W2566531305","doi":"10.1158/1538-7445.am2015-3016","title":"Abstract 3016: APOBEC3 enzymes induce damage to the cellular genome during DNA replication","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Cytidine deaminase; Biology; DNA damage; Genome instability; DNA; DNA repair; DNA replication; Genetics; Molecular biology; Cell biology","score_opus":0.08803859679044682,"score_gpt":0.3883707517582479,"score_spread":0.3003321549678011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566531305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034446,0.003041043,0.000072298244,0.0038031507,0.000062570594,0.00053793925,0.000026060265,0.00001467684,0.002097813],"genre_scores_gemma":[0.99452716,0.00022758101,0.00004700113,0.00022318693,0.0007091206,0.00034238218,0.000083657644,0.00003691786,0.0038030157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977066,0.00015674147,0.00017790237,0.00066060317,0.00068106694,0.000617109],"domain_scores_gemma":[0.99785525,0.000017128537,0.00003114182,0.0012179003,0.00047589137,0.00040269562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014093342,0.00013643301,0.000109817025,0.00008620869,0.00021972672,0.000090518275,0.0008134266,0.00016350468,0.000071343464],"category_scores_gemma":[0.00048740424,0.00010325185,0.00006506736,0.00039134853,0.0001705887,0.000005864956,0.000657506,0.00043609037,0.0001847752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013723606,0.000037999875,0.000100122874,0.000028093487,0.000025125855,0.000011270605,0.00010751077,0.000029197296,0.989578,0.000052644213,0.008865215,0.0010275899],"study_design_scores_gemma":[0.00025251994,0.00008572017,0.002368626,0.00001265915,0.0000025250922,0.0000029933947,0.0001293521,0.0000027103342,0.85891753,0.00004651082,0.13805588,0.00012295967],"about_ca_topic_score_codex":0.00028356496,"about_ca_topic_score_gemma":0.00007145541,"teacher_disagreement_score":0.13066044,"about_ca_system_score_codex":0.00011390997,"about_ca_system_score_gemma":0.00035185434,"threshold_uncertainty_score":0.42104882},"labels":[],"label_agreement":null},{"id":"W2566638276","doi":"10.1158/1538-7445.am2015-3653","title":"Abstract 3653: Structure-based study to overcome cross-reactivity of novel androgen receptor inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Androgen receptor; Chemistry; Ligand (biochemistry); Morpholine; Reactivity (psychology); Receptor; Partial agonist; Prostate cancer; Antiandrogens; Stereochemistry; Biochemistry; Internal medicine; Agonist; Cancer; Medicine","score_opus":0.2155590177075112,"score_gpt":0.5129882517829365,"score_spread":0.2974292340754253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566638276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702245,0.000103429105,0.000016307165,0.0009707681,0.000067003464,0.00092576933,0.00017714949,0.000024552104,0.00069259846],"genre_scores_gemma":[0.9990111,0.0000023053424,0.00013884538,0.00006968908,0.0003290743,0.00013714553,0.000015585583,0.000019587926,0.00027669466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827754,0.000032387652,0.00022799049,0.00032889243,0.0008101513,0.00032304085],"domain_scores_gemma":[0.9982872,0.00013806116,0.00004056441,0.0004162632,0.00054794323,0.0005699782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069664617,0.00010996879,0.00023295126,0.00009003921,0.00007701544,0.000026526452,0.00017970795,0.00006801904,0.00040032386],"category_scores_gemma":[0.00034884634,0.00009436155,0.00004798112,0.00058513234,0.00015711525,0.000060817183,0.00006605576,0.00049955136,0.000022038681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079219305,0.0011864626,0.051979315,0.00011427447,0.000037547725,0.0000051377087,0.00030409722,0.0002020908,0.942715,0.000010021077,0.0016367333,0.0010171154],"study_design_scores_gemma":[0.0027068413,0.00025296022,0.044747543,0.000055681616,0.000016370805,0.0000017179578,0.00022472297,0.00003738715,0.9438161,0.000017648836,0.008022721,0.00010029237],"about_ca_topic_score_codex":0.00038222413,"about_ca_topic_score_gemma":0.00001939466,"teacher_disagreement_score":0.0072317687,"about_ca_system_score_codex":0.0003553396,"about_ca_system_score_gemma":0.00063983887,"threshold_uncertainty_score":0.43832657},"labels":[],"label_agreement":null},{"id":"W2566672770","doi":"10.1158/1538-7445.am2015-5355","title":"Abstract 5355: Oncolytic viral therapy with immune modulation is an effective novel treatment strategy for non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Lung cancer; Oncolytic virus; Cancer research; Immune system; Tumor microenvironment; Medicine; Cancer; Immunology; Cytotoxic T cell; Immunotherapy; Lewis lung carcinoma; Combination therapy; Biology; Oncology; Pharmacology; Internal medicine; Metastasis; In vitro","score_opus":0.08636254781418344,"score_gpt":0.42391325491658766,"score_spread":0.3375507071024042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566672770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910475,0.004506148,0.00055289216,0.00009751234,0.00006893759,0.0028920257,0.00035445933,0.00001129554,0.00046923436],"genre_scores_gemma":[0.9913821,0.001378116,0.0001486482,0.00003466851,0.00044348848,0.0049793017,0.0002472587,0.000063122105,0.0013232641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796027,0.00006952722,0.00016767353,0.0006360724,0.00041530756,0.00075115595],"domain_scores_gemma":[0.9985029,0.000033878336,0.0000658614,0.00045491525,0.0006010248,0.00034142498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037694976,0.00025036777,0.000230232,0.00010243806,0.00020396407,0.00010160974,0.0002341448,0.00014035156,0.00005362632],"category_scores_gemma":[0.000010382847,0.00018781301,0.00009340605,0.0001753892,0.00012162423,0.000022237147,0.000052519477,0.0001629277,0.0000051938596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006822025,0.000984965,0.0051253224,0.00008934454,0.00051251566,0.000010993804,0.0006468434,0.0033817182,0.9234084,0.000006158188,0.0011135943,0.05789811],"study_design_scores_gemma":[0.013783501,0.009905215,0.019868286,0.00006402455,0.00003208008,0.000002636463,0.00025398657,0.0020002422,0.95014364,0.000035005887,0.0035799474,0.0003314399],"about_ca_topic_score_codex":0.015080026,"about_ca_topic_score_gemma":0.0043132026,"teacher_disagreement_score":0.057566673,"about_ca_system_score_codex":0.00087607634,"about_ca_system_score_gemma":0.0015976444,"threshold_uncertainty_score":0.9914786},"labels":[],"label_agreement":null},{"id":"W2566735365","doi":"10.1158/1538-7445.am2015-4533","title":"Abstract 4533: New antimicrotubule phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonate prodrugs bioactivated selectively in breast cancer cells by CYP1A1: An innovative approach for the personalized treatment of breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Prodrug; Breast cancer; Cancer research; Cancer; Moiety; Chemistry; Triple-negative breast cancer; Cancer cell; In vivo; Medicine; Pharmacology; Stereochemistry; Internal medicine; Biology","score_opus":0.10631792959534644,"score_gpt":0.39232339956816076,"score_spread":0.2860054699728143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566735365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98272246,0.0020797634,0.000054614582,0.004172715,0.00004558031,0.0013773267,0.00833142,0.00006253054,0.0011535787],"genre_scores_gemma":[0.9902249,0.0014791874,0.00010988301,0.0000479928,0.0005409056,0.0045802733,0.00031256073,0.00009334918,0.00261096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676937,0.00007139971,0.00053236145,0.0009651267,0.00068864424,0.0009730881],"domain_scores_gemma":[0.9968523,0.00028263204,0.00028391732,0.0006278292,0.0015732566,0.00038007283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005210574,0.00043513568,0.00054080813,0.00012622717,0.00031582097,0.000100888996,0.0007147072,0.00025754815,0.00088840816],"category_scores_gemma":[0.000029668096,0.0003355227,0.000118433585,0.0017228674,0.0004981875,0.00027070893,0.00009545895,0.00053974043,0.0000035468622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001713307,0.001290715,0.002162176,0.00024476202,0.00031636673,0.0000017051018,0.0028906565,0.0004047757,0.9689585,0.000052104366,0.007912202,0.014052756],"study_design_scores_gemma":[0.0041406746,0.00003985758,0.0014307692,0.00012641262,0.000043283584,0.00001039729,0.0025240923,0.0007047747,0.98012614,0.000062504856,0.010395078,0.0003960262],"about_ca_topic_score_codex":0.023896463,"about_ca_topic_score_gemma":0.0005061868,"teacher_disagreement_score":0.023390276,"about_ca_system_score_codex":0.0019787818,"about_ca_system_score_gemma":0.0031497478,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W2566737927","doi":"10.1158/1538-7445.am2015-4891","title":"Abstract 4891: Comprehensive genetic profiling of chromosomal translocations in lung cancer tumors: development and validation of a next-generation sequencing panel in an international multicenter study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Crizotinib; ROS1; Fluorescence in situ hybridization; Fusion gene; Lung cancer; Cancer research; Biology; Immunohistochemistry; Cancer; Anaplastic lymphoma kinase; Gene duplication; Targeted therapy; Pathology; Gene; Adenocarcinoma; Medicine; Genetics; Immunology","score_opus":0.3260875125507967,"score_gpt":0.4778528570219041,"score_spread":0.1517653444711074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566737927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975136,0.00084024196,0.00003529604,0.00012225799,0.000069667105,0.001350805,0.000020537755,0.000005378191,0.0000422288],"genre_scores_gemma":[0.99768376,0.00009196285,0.001423528,0.000009542074,0.00006748676,0.0006239081,0.0000737988,0.00001270722,0.000013323139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986708,0.00008828052,0.00039781677,0.00024155204,0.00043547768,0.00016605928],"domain_scores_gemma":[0.9990177,0.000037912363,0.00007470735,0.00012055355,0.0006632934,0.00008583544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277393,0.00008555883,0.00018479595,0.00034583075,0.000036350593,0.000020371956,0.00007049755,0.0000352051,0.000027497657],"category_scores_gemma":[0.00003520436,0.00007923839,0.000013064947,0.00029083897,0.00005742352,0.00023341451,0.000021772235,0.00014631383,3.6060476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018638541,0.000558823,0.76431423,0.00022144291,0.00009366779,0.00002137892,0.029651932,0.0063567483,0.19325522,0.000010410778,0.0000036862605,0.0053260582],"study_design_scores_gemma":[0.0045571784,0.00021715756,0.8201943,0.000568635,0.00004137438,0.000002008846,0.012019171,0.0119806705,0.15030952,0.0000063558928,0.000009623938,0.000094011906],"about_ca_topic_score_codex":0.0047578816,"about_ca_topic_score_gemma":0.0035248548,"teacher_disagreement_score":0.055880032,"about_ca_system_score_codex":0.0010007018,"about_ca_system_score_gemma":0.0014599833,"threshold_uncertainty_score":0.7192526},"labels":[],"label_agreement":null},{"id":"W2566803722","doi":"","title":"Mitochondrial targeting of FGF-2 antisense proteins and their function in cancer cell proliferation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; Cell biology; Mitochondrion; Cancer cell; Molecular biology; Cancer; Genetics","score_opus":0.02844544984878371,"score_gpt":0.3297692036707637,"score_spread":0.30132375382197996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566803722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971873,0.026360698,0.0001781595,0.00026281388,0.00041942805,0.00059480977,0.000034622146,0.000004805465,0.00027165006],"genre_scores_gemma":[0.98349863,0.011408717,0.00017366653,0.000050314997,0.003640122,0.00034448947,0.000025044334,0.000019875823,0.0008391453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889696,0.00012466393,0.00018952606,0.00031662048,0.00017912076,0.00029313867],"domain_scores_gemma":[0.9994914,0.0000109269195,0.000053575724,0.00016661944,0.00021150336,0.00006599491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003516673,0.00010086954,0.0001397998,0.000073236566,0.00007615051,0.000020765568,0.000084252504,0.00011926444,0.00006700896],"category_scores_gemma":[0.000052483385,0.000088683206,0.00003494948,0.00015423028,0.00009610226,0.000012823297,0.0000705729,0.0001679742,0.0000012143063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036727005,0.000050287,0.0008731861,0.000060750623,0.0000115959765,1.3963238e-7,0.0002923802,0.00013489691,0.9712047,0.000011669503,0.0036046042,0.023388503],"study_design_scores_gemma":[0.00090237934,0.00013387392,0.0011015077,0.000030931067,0.0000044243934,7.3752864e-7,0.00016719833,0.000110737754,0.8528728,0.00002022935,0.14455806,0.00009710978],"about_ca_topic_score_codex":0.0013947407,"about_ca_topic_score_gemma":0.00465621,"teacher_disagreement_score":0.14095347,"about_ca_system_score_codex":0.000059157,"about_ca_system_score_gemma":0.0003143561,"threshold_uncertainty_score":0.36163962},"labels":[],"label_agreement":null},{"id":"W2566823815","doi":"10.1158/1538-7445.am2015-4795","title":"Abstract 4795: A novel gene fusion in glioblastoma and a radiation response methylation signature identified by genomic characterization of glioma sphere-forming cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioma; Biology; PTEN; Cancer research; Wnt signaling pathway; Transcriptome; DNA methylation; Stem cell; Population; Cancer stem cell; Genetics; Gene; Gene expression; Medicine","score_opus":0.024969954696791457,"score_gpt":0.3274630094891057,"score_spread":0.30249305479231425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566823815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935979,0.0023867101,0.0029824784,0.0001207084,0.00012004637,0.0006441619,0.000121346835,0.0000074710074,0.000019147266],"genre_scores_gemma":[0.99857366,0.00069397915,0.00010259056,0.00001878988,0.00009457798,0.000102660175,0.00013274161,0.000041573483,0.00023945309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795663,0.00027745886,0.00031859044,0.00047042576,0.0005879784,0.000388928],"domain_scores_gemma":[0.99895054,0.00004106996,0.0001273842,0.0003004054,0.0004133088,0.00016731805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019960706,0.00014607339,0.00017440917,0.00036386258,0.000073212716,0.00005426012,0.0002052227,0.00032663564,0.000033941647],"category_scores_gemma":[0.0002489682,0.00015908155,0.00004103068,0.00060113874,0.00009386818,0.000025719313,0.00019506272,0.00033864108,0.0000046290406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046519083,0.000060477305,0.000018773148,0.000047200007,0.000024075236,0.0000071639447,0.0002542373,0.00027704582,0.9881288,0.000004280633,0.00026460233,0.0062614456],"study_design_scores_gemma":[0.0016481288,0.00035701756,0.0029014952,0.000052489344,0.000005324313,0.000005573219,0.00011242499,0.00058501615,0.99182296,0.000022710452,0.0023390795,0.000147793],"about_ca_topic_score_codex":0.00028696368,"about_ca_topic_score_gemma":0.00014602288,"teacher_disagreement_score":0.0061136526,"about_ca_system_score_codex":0.00028060042,"about_ca_system_score_gemma":0.0005637436,"threshold_uncertainty_score":0.64871573},"labels":[],"label_agreement":null},{"id":"W2566826550","doi":"10.1158/1538-7445.am2015-4747","title":"Abstract 4747: Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Ductal carcinoma; Breast cancer; Biology; Comparative genomic hybridization; Housekeeping gene; Cancer; Chromosome; Polymerase chain reaction; Pathology; Gene; Oncology; Cancer research; Genetics; Medicine; Gene expression","score_opus":0.07586636444755944,"score_gpt":0.40166468917938,"score_spread":0.3257983247318205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566826550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647796,0.0003982132,0.000022348766,0.0005352124,0.000015593305,0.0011204276,0.00013252896,0.000010279868,0.0012874474],"genre_scores_gemma":[0.99753267,0.00025726997,0.0002493703,0.00003638613,0.00007175235,0.001543982,0.00014286177,0.000023869708,0.00014183878],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984497,0.00021577392,0.00023222824,0.00051884,0.00019846784,0.00038498195],"domain_scores_gemma":[0.99908113,0.00002906533,0.00005781709,0.00038242817,0.00031945345,0.00013010312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049350195,0.00014883679,0.00020136604,0.00017144211,0.00008391409,0.00003256871,0.0002963461,0.000101446414,0.000032194406],"category_scores_gemma":[0.000028985927,0.00013464902,0.000028015213,0.00038332,0.00020279967,0.000007922956,0.00015193483,0.00027207486,0.000017220658],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005316445,0.00030338668,0.0882317,0.000010354366,0.000037302543,0.000050029936,0.0007421925,0.00041402577,0.90833825,0.00009385328,0.0011377156,0.00010953972],"study_design_scores_gemma":[0.0034995447,0.0013112688,0.8365237,0.00009920807,0.000017339242,0.000041364197,0.0040830444,0.00013766215,0.15304743,0.00017123383,0.0005582982,0.00050992245],"about_ca_topic_score_codex":0.012214065,"about_ca_topic_score_gemma":0.04102288,"teacher_disagreement_score":0.7552908,"about_ca_system_score_codex":0.00022858981,"about_ca_system_score_gemma":0.0009898663,"threshold_uncertainty_score":0.99436367},"labels":[],"label_agreement":null},{"id":"W2566856572","doi":"10.1158/1538-7445.am2015-1629","title":"Abstract 1629: Prednisone versus dexamethasone acute toxicity and cumulative doses variations in childhood acute lymphoblastic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Association of Canadian Universities for Northern Studies; Université de Montréal","funders":"","keywords":"Medicine; Prednisone; Dexamethasone; Toxicity; Cumulative dose; Internal medicine; Glucocorticoid; Oncology; Pediatrics","score_opus":0.08641930271181895,"score_gpt":0.4073619656560583,"score_spread":0.32094266294423934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566856572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113226,0.0009108991,0.00031346834,0.0016692332,0.00026293515,0.0014491482,0.00017753504,0.00009539428,0.0039891363],"genre_scores_gemma":[0.99562746,0.0010322026,0.001235478,0.00011574152,0.0004200917,0.0004512785,0.00006326482,0.0000854792,0.0009689815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947359,0.00032929613,0.00055521505,0.00093005266,0.002080493,0.0013690225],"domain_scores_gemma":[0.9952935,0.0018695123,0.00011014503,0.0007140444,0.00093155884,0.0010812676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018931185,0.00036337462,0.0006753981,0.000834919,0.00024718954,0.00013929971,0.00041913238,0.00034673017,0.00023378378],"category_scores_gemma":[0.002619306,0.0003246968,0.00008763218,0.0018355696,0.0007033649,0.00042082308,0.0005412406,0.0012701391,0.00016381142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.14373216,0.011487236,0.123682655,0.002466154,0.0196719,0.015636947,0.08391202,0.0049209534,0.3463792,0.010598674,0.11478956,0.12272255],"study_design_scores_gemma":[0.14381608,0.006603295,0.76958215,0.0018750189,0.0010659363,0.00058565626,0.003966449,0.025345316,0.037648186,0.0039577656,0.0037153491,0.0018387777],"about_ca_topic_score_codex":0.0037359197,"about_ca_topic_score_gemma":0.0006300019,"teacher_disagreement_score":0.64589953,"about_ca_system_score_codex":0.009055896,"about_ca_system_score_gemma":0.009241485,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2566864507","doi":"10.1158/1538-7445.am2015-524","title":"Abstract 524: Assessing the interaction between acetylenic tricyclic bis-(cyano enone) and cysteine residues of actin to inhibit non-small cell lung cancer cell migration","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Actin; Cell migration; Actin cytoskeleton; Cell biology; Cytoskeleton; MDia1; Actin-binding protein; Lamellipodium; Actin remodeling; Chemistry; Cell; A549 cell; Stress fiber; Biology; Biochemistry","score_opus":0.14258017605746467,"score_gpt":0.4768796802546522,"score_spread":0.33429950419718757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566864507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828098,0.006047787,0.000018605455,0.006241284,0.00024887483,0.0011325254,0.000044138716,0.00002126616,0.003435745],"genre_scores_gemma":[0.9923681,0.0016761799,0.000058250185,0.00010245621,0.000748832,0.00033879056,0.00003569653,0.000030192767,0.004641506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814636,0.00019097471,0.00035088562,0.00038115124,0.0005024895,0.0004281446],"domain_scores_gemma":[0.99834466,0.0004492178,0.00018743779,0.0002731849,0.0004554468,0.00029005457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357202,0.00018197745,0.00035776864,0.0002620471,0.00014773429,0.00006694975,0.00014433911,0.00012375174,0.00023288747],"category_scores_gemma":[0.00006744337,0.00013269995,0.000063769025,0.00054527936,0.000100819576,0.00022000507,0.00011117896,0.0005422069,0.000012614207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008376237,0.0002754521,0.1862438,0.00062082335,0.0001292475,0.000019633653,0.004989683,0.00008483668,0.75510746,9.731715e-7,0.03860173,0.013088735],"study_design_scores_gemma":[0.0047723697,0.0010682282,0.102481216,0.0005300019,0.00036848488,0.000006901206,0.0029313865,0.00010947269,0.8587873,0.000008029417,0.028709188,0.00022742915],"about_ca_topic_score_codex":0.023540566,"about_ca_topic_score_gemma":0.0046844804,"teacher_disagreement_score":0.10367984,"about_ca_system_score_codex":0.0009608066,"about_ca_system_score_gemma":0.0009756207,"threshold_uncertainty_score":0.9829618},"labels":[],"label_agreement":null},{"id":"W2566881126","doi":"10.1158/1538-7445.am2015-4235","title":"Abstract 4235: Anti-proliferative effects of ZR2002, a novel combi-molecule with EGFR/DNA binary targeting properties compared to Gefitinib in glioblastoma cell lines and brain tumor stem cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Cancer research; Neurosphere; Epidermal growth factor receptor; Radioresistance; Biology; Stem cell; EGFR inhibitors; Cell culture; Cell growth; Cancer; Medicine; Internal medicine; In vitro; Endothelial stem cell; Cell biology; Genetics","score_opus":0.06548675684605668,"score_gpt":0.3424375078877957,"score_spread":0.27695075104173905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566881126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366397,0.0026599998,0.0000017748247,0.0014760835,0.00004502704,0.0019314934,0.000029111778,0.000020845026,0.00017172535],"genre_scores_gemma":[0.99891645,0.00003612632,0.0001386128,0.00015033675,0.000064185544,0.0005230759,0.0000036502183,0.000039367635,0.00012822276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800956,0.00012326357,0.0002991251,0.00042237222,0.0006403813,0.0005053124],"domain_scores_gemma":[0.9985041,0.00027832377,0.00007889921,0.00022546458,0.0005527462,0.00036048042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005168445,0.00021322687,0.0005246259,0.0003626531,0.00007514707,0.000043452674,0.00011362348,0.000052467738,0.0000122264955],"category_scores_gemma":[0.00009729137,0.0001472068,0.00003402463,0.0005973611,0.00019068233,0.000065206594,0.000119153,0.0002785964,0.000012353999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002008945,0.0013284727,0.019635137,0.0012703671,0.000063592284,0.0006933347,0.0029763978,0.0003634196,0.96748996,0.000005705464,0.003981922,0.00018277483],"study_design_scores_gemma":[0.0071995216,0.002620129,0.019002065,0.00189704,0.00002114049,0.000013690252,0.0017247816,0.00036419684,0.9668255,0.0000015605862,0.00017231794,0.00015806516],"about_ca_topic_score_codex":0.0010183782,"about_ca_topic_score_gemma":0.00021752172,"teacher_disagreement_score":0.005252483,"about_ca_system_score_codex":0.00020959627,"about_ca_system_score_gemma":0.00043126137,"threshold_uncertainty_score":0.60029185},"labels":[],"label_agreement":null},{"id":"W2567019745","doi":"10.1158/1538-7445.am2015-3810","title":"Abstract 3810: Leptomycin B sensitizes ovarian and endometrial cancer cells to TRAIL-induced apoptosis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Nuclear export signal; Cancer research; Ovarian cancer; Apoptosis; Cancer; Cancer cell; Biology; Programmed cell death; Endometrial cancer; Cell biology; Cell nucleus; Nucleus; Genetics","score_opus":0.08188468625569228,"score_gpt":0.37613778676695875,"score_spread":0.29425310051126646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567019745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960265,0.0004528155,0.000025207913,0.00074727414,0.000704962,0.00030181868,0.000045075085,0.000011931293,0.0016843738],"genre_scores_gemma":[0.9970167,0.00026177597,0.00015872454,0.0002164389,0.0015814179,0.00006290797,0.000014205413,0.000029663952,0.00065814937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864185,0.00008697066,0.00013580965,0.00041369794,0.0003354301,0.00038622986],"domain_scores_gemma":[0.99910164,0.000025934132,0.000027897837,0.0002512877,0.00027203903,0.0003212158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005204546,0.00012579285,0.00014886164,0.00015319769,0.00010889582,0.00007283198,0.00013091293,0.00016333096,0.00013786026],"category_scores_gemma":[0.000140625,0.00011418635,0.000042026448,0.00030321183,0.00006586842,0.000006625917,0.000120127785,0.00022426364,0.000029927765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056792796,0.000011448699,0.00015959865,0.000013903332,0.000043904176,0.0000022858017,0.00016010237,0.000022014186,0.9559548,0.000018735213,0.02016829,0.022877023],"study_design_scores_gemma":[0.0010757678,0.00030570227,0.0021004851,0.000015922515,0.000009585792,0.000002524756,0.00021897643,0.0000037473053,0.92105836,0.000038217237,0.075016685,0.00015403937],"about_ca_topic_score_codex":0.0019349975,"about_ca_topic_score_gemma":0.000455925,"teacher_disagreement_score":0.05484839,"about_ca_system_score_codex":0.00007721091,"about_ca_system_score_gemma":0.0002623762,"threshold_uncertainty_score":0.46563843},"labels":[],"label_agreement":null},{"id":"W2567026559","doi":"10.1158/1538-7445.am2015-3110","title":"Abstract 3110: Urinary miR-1825 and miR-484: An oncogene and a tumor- suppressor gene among prostate cancer patients","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"microRNA; Prostate cancer; Oncogene; DDR1; Biology; Gene expression; Cancer; Cancer research; Gene expression profiling; Gene; Microarray; Prostate; Genetics; Cell cycle; Receptor","score_opus":0.04325082823099759,"score_gpt":0.3620527970500551,"score_spread":0.31880196881905754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567026559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017525,0.008630749,0.0000013555143,0.00011140814,0.00008274121,0.0006036493,0.0002762396,0.000010781233,0.0001078319],"genre_scores_gemma":[0.99821365,0.00056646974,0.00006992875,0.000042528103,0.00024554,0.00030390598,0.00022379626,0.00004106065,0.00029313576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983174,0.00012732999,0.00018804491,0.0005569268,0.00036751333,0.00044278774],"domain_scores_gemma":[0.998676,0.000011297412,0.0000679451,0.00033368528,0.0004625218,0.00044856334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003748132,0.00016428954,0.00014728117,0.00008085604,0.00012776871,0.00007431221,0.00016945541,0.000111629306,0.000044914064],"category_scores_gemma":[0.00007035911,0.0001570598,0.000026164038,0.0001157355,0.00031451092,0.000024597886,0.00026093755,0.0001583315,0.0000034950874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055605074,0.000168397,0.103938505,0.00010557989,0.000049540908,0.000018413502,0.00026347837,0.00004141741,0.88894856,0.0000013419292,0.0035340025,0.002374696],"study_design_scores_gemma":[0.0017130796,0.0005150041,0.46204916,0.000060548253,0.000017560948,0.0000072695343,0.000101865015,0.000082043895,0.52751136,0.00005760751,0.007607456,0.00027705065],"about_ca_topic_score_codex":0.0009855899,"about_ca_topic_score_gemma":0.00031171466,"teacher_disagreement_score":0.3614372,"about_ca_system_score_codex":0.00010500883,"about_ca_system_score_gemma":0.00032861828,"threshold_uncertainty_score":0.6404712},"labels":[],"label_agreement":null},{"id":"W2567043620","doi":"10.1158/1538-7445.am2015-2111","title":"Abstract 2111: Regulation and localization of the cleaved form of PAR-4 in ovarian and endometrial cancers","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Apoptosis; Cisplatin; Ovarian cancer; Cancer research; Cleavage (geology); Endometrial cancer; Molecular biology; Cancer cell; Biology; Cell culture; Cancer; Chemistry; Biochemistry; Chemotherapy; Genetics","score_opus":0.16210080936872906,"score_gpt":0.43809089986111655,"score_spread":0.2759900904923875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567043620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960527,0.0011669226,0.00009914997,0.00075648644,0.00012273368,0.0005841642,0.000015135742,0.0000041942185,0.0011985381],"genre_scores_gemma":[0.9990925,0.00057652633,0.000041749077,0.000039100698,0.00011746165,0.000052307503,0.000003995823,0.00001050715,0.0000658495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988308,0.00008594446,0.00025643792,0.00015084264,0.0005170134,0.00015893765],"domain_scores_gemma":[0.9991709,0.00012616812,0.00009351335,0.00018517186,0.00033762652,0.00008660286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011170709,0.000057875877,0.00018256524,0.00023917799,0.000036294627,0.000007557877,0.000057475925,0.00006971039,0.00006509496],"category_scores_gemma":[0.00031000128,0.00004379529,0.000019680127,0.0007147822,0.00034919634,0.000081230246,0.000036191672,0.00017499889,3.592416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011623875,0.0001720027,0.56306577,0.0010674149,0.00014090989,0.000006670648,0.012210073,0.0014073624,0.35721913,0.0022272156,0.0062592826,0.04460029],"study_design_scores_gemma":[0.014931295,0.0004395708,0.57949704,0.0009640924,0.000021552729,0.0000076624,0.0009668337,0.0010811613,0.39264008,0.0060357917,0.0032937438,0.00012120866],"about_ca_topic_score_codex":0.00310484,"about_ca_topic_score_gemma":0.0006542995,"teacher_disagreement_score":0.04447908,"about_ca_system_score_codex":0.00042886555,"about_ca_system_score_gemma":0.0006418837,"threshold_uncertainty_score":0.469361},"labels":[],"label_agreement":null},{"id":"W2567069116","doi":"10.1158/1538-7445.am2015-2154","title":"Abstract 2154: ERK/MAPK pathway inhibits tumorigenesis and cellular reprogramming of pancreatic cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pancreatic cancer; Cancer research; MAPK/ERK pathway; Reprogramming; Cancer; Carcinogenesis; Cancer stem cell; Stem cell; Biology; Cancer cell; Metastasis; Downregulation and upregulation; Cell; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.14099987910899395,"score_gpt":0.39898121867758446,"score_spread":0.2579813395685905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567069116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96503365,0.03153082,0.000020202859,0.00042326166,0.00027486417,0.0007436227,0.00007255526,0.000034308337,0.0018667352],"genre_scores_gemma":[0.9911273,0.005206054,0.00039713597,0.00006145926,0.0004983962,0.00031256714,0.000011544533,0.000059465732,0.002326084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711555,0.00010436945,0.00043427106,0.0005801733,0.0010721533,0.0006934738],"domain_scores_gemma":[0.9977575,0.00012728156,0.00012746698,0.0005588354,0.0007930965,0.0006358519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001624087,0.00020913567,0.0005724214,0.00027605976,0.000103360915,0.00004410341,0.00015230488,0.00011386623,0.00043777074],"category_scores_gemma":[0.00014539325,0.00017742456,0.00010688704,0.00070405396,0.00033400883,0.00009624509,0.00014010702,0.00044308667,0.000024548226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046413907,0.00014656303,0.0062376796,0.0011118773,0.00013227567,0.00010948681,0.0009810937,0.000021164356,0.90342134,0.000042305408,0.0028497234,0.084482335],"study_design_scores_gemma":[0.0014720437,0.00026477032,0.0021534613,0.00060050876,0.000097789416,0.0000064488554,0.0008726508,0.000011324951,0.95364493,0.000064549116,0.04063494,0.00017656558],"about_ca_topic_score_codex":0.011651633,"about_ca_topic_score_gemma":0.00040280368,"teacher_disagreement_score":0.08430577,"about_ca_system_score_codex":0.00039116826,"about_ca_system_score_gemma":0.0014507013,"threshold_uncertainty_score":0.99492985},"labels":[],"label_agreement":null},{"id":"W2567166227","doi":"10.1158/1538-7445.transcagen-a1-06","title":"Abstract A1-06: Recurrent mutations of hormone-positive breast cancer and association with outcome","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Oncology; Massive parallel sequencing; Internal medicine; Exome; Exome sequencing; Medicine; Cancer; DNA sequencing; Biology; Genetics; Gene; Mutation","score_opus":0.04976387151254262,"score_gpt":0.38367929496909453,"score_spread":0.3339154234565519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567166227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992034,0.0051918374,0.00002808902,0.001176423,0.000075576936,0.00021110818,0.00079729495,0.0000031640575,0.0004824899],"genre_scores_gemma":[0.99664986,0.0025061562,0.000057924244,0.000047940262,0.00021829047,0.00010906618,0.00008670936,0.0000158862,0.0003081746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990409,0.00003414434,0.00014923175,0.0002255875,0.00031458176,0.00023553566],"domain_scores_gemma":[0.99880576,0.000053192634,0.000087397086,0.00014603412,0.00076463586,0.00014297829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039674802,0.00008364453,0.00011875246,0.000055769702,0.00006349586,0.000030882733,0.000092993665,0.0000845895,0.000008941553],"category_scores_gemma":[0.000119084514,0.00007406042,0.000024483892,0.00013416489,0.00010455327,0.000005730328,0.000076122575,0.00015122542,0.0000031233797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001606429,0.0002796532,0.6490947,0.00010268908,0.0004429865,0.00001094918,0.0010529596,0.000987538,0.2722794,0.0004008377,0.056698665,0.017043201],"study_design_scores_gemma":[0.0030708653,0.00086489465,0.9055546,0.000096168296,0.00007275872,0.000010511345,0.0007693487,0.000059838614,0.07102005,0.00026252054,0.01781788,0.00040054708],"about_ca_topic_score_codex":0.0016396218,"about_ca_topic_score_gemma":0.0011505922,"teacher_disagreement_score":0.25645992,"about_ca_system_score_codex":0.00024631308,"about_ca_system_score_gemma":0.0005314033,"threshold_uncertainty_score":0.30200964},"labels":[],"label_agreement":null},{"id":"W2567244697","doi":"10.1158/1538-7445.am2015-209","title":"Abstract 209: A quantitative analysis of paclitaxel-induced mitotic catastrophe of MDA-MB-231 cells by high frequency ultrasound","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Apoptosis; Programmed cell death; Mitotic catastrophe; Flow cytometry; Ultrasound; TUNEL assay; Paclitaxel; Propidium iodide; Chemistry; Pathology; Medicine; Materials science; Chemotherapy; Immunology; Radiology; Surgery","score_opus":0.08063834714958039,"score_gpt":0.3622330432607651,"score_spread":0.2815946961111847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567244697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951881,0.0017887346,0.00036565246,0.000060558657,0.00007924021,0.00025061268,0.0010876146,0.00003712199,0.0011423596],"genre_scores_gemma":[0.9985553,0.0003452311,0.00069312303,0.0000045887477,0.00004192762,0.000120160126,0.00010985898,0.00003300808,0.00009678122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983367,0.000071658644,0.00037716856,0.00025071806,0.00057005184,0.00039372745],"domain_scores_gemma":[0.99822134,0.00054513855,0.00007199073,0.0004724561,0.0004904759,0.00019862383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047430617,0.00014649154,0.0003916773,0.00035884324,0.00005611334,0.000026727264,0.00036319395,0.00009801901,0.00034578607],"category_scores_gemma":[0.00012408206,0.00013782585,0.00011237917,0.0016736113,0.00019109155,0.000112361435,0.000020754376,0.00033635076,0.000042460724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014823001,0.000082790866,0.0010107035,0.00008092375,0.0006652261,0.0000018872181,0.0010022857,0.003914472,0.98904335,0.0005154761,0.0034137203,0.0002543416],"study_design_scores_gemma":[0.0012552218,0.00033376794,0.02442301,0.0001445172,0.0007337603,0.000002303762,0.004559062,0.0011203494,0.9630899,0.0014829313,0.0021989993,0.0006562146],"about_ca_topic_score_codex":0.006585633,"about_ca_topic_score_gemma":0.0006447561,"teacher_disagreement_score":0.025953488,"about_ca_system_score_codex":0.0002131303,"about_ca_system_score_gemma":0.00019611849,"threshold_uncertainty_score":0.99555504},"labels":[],"label_agreement":null},{"id":"W2567264730","doi":"10.1158/1538-7445.panca16-b86","title":"Abstract B86: Novel assessment of SPARC expression by hierarchical clustering in pancreatic ductal adenocarcinoma shows distinct prognostic and predictive groups","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Pancreas Centre (Canada); University of British Columbia","funders":"","keywords":"Medicine; Stromal cell; Pancreatic ductal adenocarcinoma; Immunohistochemistry; Pancreatic cancer; Tissue microarray; Adenocarcinoma; Oncology; Internal medicine; Cancer research; Pathology; Cancer","score_opus":0.06872293765542359,"score_gpt":0.4075241464552246,"score_spread":0.338801208799801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567264730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309254,0.0010636108,0.0015796551,0.0011268618,0.000045754838,0.0013368593,0.00016442424,0.000017878489,0.0015724463],"genre_scores_gemma":[0.99728566,0.00060022925,0.00071163883,0.000014896198,0.00016028326,0.0006417332,0.000020762594,0.000032647673,0.0005321731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968893,0.00024528237,0.00047483822,0.0005727695,0.0010541867,0.000763634],"domain_scores_gemma":[0.9972307,0.0016924982,0.00008179584,0.00035899167,0.00024703483,0.00038894394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015338443,0.00018989474,0.0006318746,0.00032130207,0.00011610246,0.000019632334,0.00020385395,0.000176916,0.00047581867],"category_scores_gemma":[0.00092168094,0.00012291716,0.00005083875,0.0003057397,0.0009419657,0.00013153204,0.0003302905,0.0006751572,0.000003916954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007878041,0.0003069441,0.6702139,0.0003696732,0.000053999305,0.00007786593,0.00022118381,7.109555e-7,0.32652375,0.00004074499,0.00035828943,0.0010451647],"study_design_scores_gemma":[0.0036086424,0.0010241411,0.9876894,0.0019246751,0.00004800753,0.000046338195,0.00023021903,0.00124317,0.0038403699,0.00016704047,0.000053451586,0.00012455588],"about_ca_topic_score_codex":0.00033807507,"about_ca_topic_score_gemma":0.00014501046,"teacher_disagreement_score":0.3226834,"about_ca_system_score_codex":0.00054589927,"about_ca_system_score_gemma":0.0007852989,"threshold_uncertainty_score":0.52098805},"labels":[],"label_agreement":null},{"id":"W2567285457","doi":"10.1158/1538-7445.am2015-4124","title":"Abstract 4124: Potent anti-tumor and metastatic breast cancer efficacy of bevacizumab with CRLX101, an investigational chemotherapy nanoparticle-drug conjugate that secondarily suppresses HIF-1α","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Cancer research; Metastasis; Breast cancer; Camptothecin; Cancer; Primary tumor; Chemotherapy; Oncology; Internal medicine; Biology","score_opus":0.06838471154283565,"score_gpt":0.3295536353781001,"score_spread":0.26116892383526447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567285457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946467,0.0032269899,0.000041683637,0.0004962583,0.00019869609,0.0005938691,0.0005936932,0.00010542312,0.00009668146],"genre_scores_gemma":[0.99855316,0.0005644565,0.0003178639,0.00008386854,0.00013338614,0.00015593503,0.000026033038,0.00011040876,0.000054910004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975305,0.00006435211,0.00035235434,0.00039531384,0.0009861343,0.00067130406],"domain_scores_gemma":[0.9983005,0.00018424813,0.00009066017,0.00041372844,0.00049807766,0.00051280175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061874476,0.00029683544,0.00043389137,0.00020744995,0.00013494305,0.00014588615,0.00034611239,0.000058900943,0.00037891534],"category_scores_gemma":[0.000032987926,0.00024650074,0.000042869346,0.00046647506,0.0006079161,0.0006557429,0.00005668205,0.00046975407,0.0000099150175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001888296,0.00031710352,0.021193348,0.0014567355,0.00091142,0.00010061952,0.005362117,0.044096474,0.9032063,0.0002817378,0.0039279037,0.017257936],"study_design_scores_gemma":[0.0071789823,0.0002538168,0.071419135,0.00043263534,0.00008039281,0.00007079425,0.0009580534,0.003540381,0.9127378,0.0009925008,0.001733994,0.000601514],"about_ca_topic_score_codex":0.0014793861,"about_ca_topic_score_gemma":0.0008521134,"teacher_disagreement_score":0.050225783,"about_ca_system_score_codex":0.0003906789,"about_ca_system_score_gemma":0.0008630446,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W2567289032","doi":"10.1158/1538-7445.am2015-2260","title":"Abstract 2260: Defining molecular mechanisms linking Endophilin A2 to metastasis in human breast cancer models","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Invadopodia; Cancer research; Metastasis; Breast cancer; Internalization; Triple-negative breast cancer; Cancer; Estrogen receptor; Epithelial–mesenchymal transition; Extracellular matrix; Biology; Pathology; Medicine; Receptor; Internal medicine; Cell biology","score_opus":0.12367040410652676,"score_gpt":0.41318513727047984,"score_spread":0.2895147331639531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567289032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260294,0.0036852888,0.0014729669,0.0005192782,0.00014726113,0.00042647414,0.00027878227,0.000023580113,0.0008434481],"genre_scores_gemma":[0.9977555,0.000084553154,0.00078753504,0.00033256417,0.00020345821,0.00060418266,0.00007229268,0.000073686955,0.000086214335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972357,0.0002007577,0.00030245955,0.0007288226,0.00075609057,0.00077617215],"domain_scores_gemma":[0.9983853,0.000026135715,0.000054866705,0.00059031084,0.0004568212,0.00048653962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015325309,0.00021845923,0.00023129207,0.00022974833,0.00012116059,0.00008021326,0.00060904236,0.00017299684,0.00009616578],"category_scores_gemma":[0.00013503087,0.00023084955,0.00009445126,0.00046856614,0.00008832816,0.000012395392,0.00043649922,0.0004036459,0.000023747209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018577669,0.0000907397,0.00040098067,0.000047363053,0.00006235507,0.00008342194,0.00022326378,0.036397062,0.95700437,0.0013326148,0.00073033053,0.0034416954],"study_design_scores_gemma":[0.0010214165,0.00013071664,0.00029410515,0.00023932975,0.000018045306,0.000008304842,0.0002598494,0.00022882523,0.9886236,0.008123678,0.00067600416,0.0003761081],"about_ca_topic_score_codex":0.0017131419,"about_ca_topic_score_gemma":0.00050293637,"teacher_disagreement_score":0.036168236,"about_ca_system_score_codex":0.00028801727,"about_ca_system_score_gemma":0.00081447815,"threshold_uncertainty_score":0.9413771},"labels":[],"label_agreement":null},{"id":"W2567293234","doi":"10.1158/1538-7445.am2015-5393","title":"Abstract 5393: Evaluation of compounds developed against the TAM family kinases","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"Receptor tyrosine kinase; Kinase; Cancer research; Angiogenesis; Carcinogenesis; Cancer; Metastasis; Cell growth; Tyrosine kinase; AXL receptor tyrosine kinase; Pharmacology; Receptor Protein-Tyrosine Kinases; Biology; Signal transduction; Cell biology; Biochemistry; Genetics; JAK-STAT signaling pathway","score_opus":0.3472581245041805,"score_gpt":0.45590297076737796,"score_spread":0.10864484626319748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567293234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676796,0.023954665,0.0000051172374,0.000383329,0.00037105443,0.00036892237,0.000015320622,0.0000132427385,0.0072087524],"genre_scores_gemma":[0.99878925,0.0004624469,0.000005764673,0.00004398045,0.000045688605,0.000118453994,0.000078433346,0.000010248513,0.0004457473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984321,0.00058753946,0.00024059645,0.00017037682,0.00028627636,0.00028309095],"domain_scores_gemma":[0.9980858,0.00018343514,0.0000849237,0.000297558,0.0013270434,0.000021265216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038518738,0.00008234734,0.00015263542,0.00011082522,0.00019475144,0.00001968824,0.0002969231,0.00010656055,0.00014787591],"category_scores_gemma":[0.00032226727,0.000055828332,0.00004084278,0.00030637925,0.00036830603,0.00009825738,0.00009534756,0.00028450618,0.00013610418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001311857,0.000064356405,0.0009283442,0.000011984985,0.00007624506,2.6663477e-7,0.00056007085,0.00019956376,0.90937376,0.00017384667,0.027022457,0.06145792],"study_design_scores_gemma":[0.0023910669,0.00011524777,0.2838367,0.00011031624,0.00003388539,0.0000022818515,0.0016747377,0.00010523496,0.6193866,0.0006113228,0.09158188,0.00015074294],"about_ca_topic_score_codex":0.0006633379,"about_ca_topic_score_gemma":0.000083317325,"teacher_disagreement_score":0.28998715,"about_ca_system_score_codex":0.0002544571,"about_ca_system_score_gemma":0.0010026555,"threshold_uncertainty_score":0.22766133},"labels":[],"label_agreement":null},{"id":"W2567345722","doi":"10.1158/1538-7445.am2015-249","title":"Abstract 249: Assessment of PD-L1 expression and tumor-associated lymphocytes in pediatric cancer tissues","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tissue microarray; Cancer; Medicine; Immune system; Neuroblastoma; Lymphoma; CD8; Cancer research; Immunohistochemistry; Tumor microenvironment; Medulloblastoma; Pathology; Immunology; Biology; Internal medicine; Cell culture","score_opus":0.11647109820823748,"score_gpt":0.4798312401294477,"score_spread":0.36336014192121024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567345722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138933,0.005600554,3.4950193e-7,0.0003621724,0.000063918,0.00055714365,0.000039944167,0.000020082643,0.001966488],"genre_scores_gemma":[0.9940763,0.004702825,0.00005552693,0.000023006212,0.000121191406,0.00028673466,0.000011267018,0.000027081813,0.00069602847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974332,0.00017474545,0.0002565736,0.00035219788,0.0012146733,0.00056862284],"domain_scores_gemma":[0.9985656,0.00021958529,0.000070939306,0.00023181156,0.00046760982,0.0004444124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008000483,0.00013405264,0.00032774796,0.0004455309,0.000059633217,0.000027968781,0.00012753229,0.00006941019,0.0002378689],"category_scores_gemma":[0.000337398,0.00010588919,0.000033837423,0.00064826955,0.00013999199,0.00011969535,0.00015534103,0.00040546583,0.000011397868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008312405,0.0007206195,0.91581273,0.0004469978,0.00005567891,0.0005791542,0.0003302533,0.000024965135,0.07221928,0.000011372352,0.0054790117,0.0034886952],"study_design_scores_gemma":[0.0059194984,0.00067316275,0.91807675,0.0005197618,0.000020485586,0.000006200395,0.00019909236,0.00009535963,0.073848315,0.000095805946,0.00043726337,0.000108277316],"about_ca_topic_score_codex":0.0041772434,"about_ca_topic_score_gemma":0.00056558946,"teacher_disagreement_score":0.0050882576,"about_ca_system_score_codex":0.0009944006,"about_ca_system_score_gemma":0.001978341,"threshold_uncertainty_score":0.63147706},"labels":[],"label_agreement":null},{"id":"W2567370878","doi":"10.1158/1538-7445.am2015-2645","title":"Abstract 2645: Preclinical validation of Myc inhibition by a new generation of Omomyc-based inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"In vivo; Cancer research; Transgene; Nanocarriers; Transactivation; Medicine; Cancer; Targeted therapy; Genetically modified mouse; Pharmacology; Biology; Drug; Internal medicine; Gene expression; Gene","score_opus":0.19463225345157056,"score_gpt":0.4238829600853473,"score_spread":0.22925070663377675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567370878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713045,0.0010563392,0.0004363498,0.00030181464,0.00009412823,0.0002946311,0.00006288789,0.000004877827,0.00061854685],"genre_scores_gemma":[0.9984211,0.00008996651,0.0002409894,0.000026168853,0.0004882161,0.000052002437,0.00037806956,0.000013811664,0.0002897224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987604,0.0001517498,0.00028383534,0.00023036612,0.0004012869,0.00017238913],"domain_scores_gemma":[0.99905545,0.000026502978,0.00010755515,0.00021740406,0.0004565416,0.00013656086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001029899,0.000074650314,0.00011493609,0.00005626507,0.000049375325,0.000021851514,0.00009649278,0.00016188703,0.00005913024],"category_scores_gemma":[0.00034135758,0.000072356,0.000053680415,0.00015277654,0.00011106959,0.0000071590034,0.00004670286,0.00013586384,0.000005987705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017532466,0.000071467955,0.0009308644,0.000047427988,0.0000107327105,3.2844022e-7,0.000048647184,0.00012414897,0.9571833,0.000013107115,0.03814521,0.0032494322],"study_design_scores_gemma":[0.0007824958,0.0004097392,0.00011739913,0.0000527695,0.00000410167,3.5611782e-7,0.000026811216,0.000052165884,0.9918283,0.00009599071,0.0065589244,0.000070895716],"about_ca_topic_score_codex":0.00045285604,"about_ca_topic_score_gemma":0.000045405064,"teacher_disagreement_score":0.034645043,"about_ca_system_score_codex":0.000038714166,"about_ca_system_score_gemma":0.000827121,"threshold_uncertainty_score":0.2950592},"labels":[],"label_agreement":null},{"id":"W2567374232","doi":"10.1158/1538-7445.am2015-1270","title":"Abstract 1270: Ribosome biogenesis is reduced by oncogenic stress in normal cells and is sufficient to trigger cellular senescence","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Ribosome biogenesis; Senescence; Biology; Cell biology; Ribosome; Biogenesis; Carcinogenesis; Telomere; Ribosomal protein; Genetics; RNA; Cancer; Gene","score_opus":0.059592877945580505,"score_gpt":0.363209993677947,"score_spread":0.3036171157323665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567374232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908664,0.006739422,0.000047278107,0.0012005323,0.000097091404,0.00034482052,0.0004428556,0.0000051761044,0.0002564041],"genre_scores_gemma":[0.99500316,0.0019522496,0.000034814562,0.00023070049,0.00015531383,0.00017791943,0.000040827257,0.000025065474,0.0023799567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981849,0.00007883569,0.00022473956,0.00058885,0.00041672259,0.00050591363],"domain_scores_gemma":[0.99890316,0.0000131600755,0.000039889037,0.00040816504,0.00029980965,0.00033579613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005665514,0.00014620612,0.00014504191,0.00014029238,0.00009345204,0.000063885505,0.00031521972,0.00014632972,0.000117111165],"category_scores_gemma":[0.000027878,0.00014120516,0.000045102108,0.0004217283,0.00012704296,0.000008214222,0.00016401093,0.00016319523,0.000042908996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011731873,0.00009457147,0.0011846143,0.000024064331,0.000015150549,0.0000038948,0.00044376965,0.000051553765,0.9589964,0.0000022479785,0.036944102,0.0021223146],"study_design_scores_gemma":[0.00043772467,0.00012541345,0.0013428733,0.000026466067,0.0000041149947,8.5171774e-7,0.00036190343,0.000020026171,0.9284895,0.0000039681686,0.06901527,0.00017190262],"about_ca_topic_score_codex":0.0015529481,"about_ca_topic_score_gemma":0.00012722562,"teacher_disagreement_score":0.032071166,"about_ca_system_score_codex":0.00013989159,"about_ca_system_score_gemma":0.0004531999,"threshold_uncertainty_score":0.57581794},"labels":[],"label_agreement":null},{"id":"W2567404859","doi":"10.1158/1538-7445.am2015-4956","title":"Abstract 4956: Hsp27 negatively affects Hippo tumor suppressor pathway to regulate cell survival in cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hippo signaling pathway; Hsp27; Biology; Cancer research; Prostate cancer; Cell growth; Suppressor; Cancer; Cancer cell; Heat shock protein; Cell biology; Signal transduction; Hsp70; Genetics; Gene","score_opus":0.09113640116516784,"score_gpt":0.4015735818127056,"score_spread":0.3104371806475377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567404859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892597,0.0018437384,0.00002142457,0.0011776321,0.00023903596,0.0014071368,0.00015975218,0.000016038352,0.005875507],"genre_scores_gemma":[0.9913848,0.00015563692,0.00011011691,0.00011509756,0.0006001664,0.0013756857,0.000032770808,0.00008205588,0.0061436617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955437,0.00063411647,0.00028843162,0.0008976272,0.0012335584,0.0014025258],"domain_scores_gemma":[0.9975804,0.00009331424,0.00004591179,0.00075879385,0.00070248276,0.00081908633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026836626,0.00026295384,0.00031901174,0.00032545326,0.00013097953,0.000103475795,0.00082565495,0.00021821512,0.0003364964],"category_scores_gemma":[0.0007617097,0.0002487347,0.000077456614,0.0007794514,0.00021803805,0.00001679586,0.00071968255,0.0007469839,0.00016027474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007161904,0.00012838509,0.0024811462,0.00013674307,0.000022271439,0.000095058575,0.00029614748,0.0005469521,0.9798745,0.000018327197,0.013401777,0.0022825247],"study_design_scores_gemma":[0.0012844697,0.00044448406,0.008864894,0.00010522685,0.0000017683997,0.0000018683115,0.00021683655,0.000024794306,0.9354702,0.000072644114,0.053219352,0.00029341728],"about_ca_topic_score_codex":0.0053341,"about_ca_topic_score_gemma":0.0055234334,"teacher_disagreement_score":0.04440423,"about_ca_system_score_codex":0.0005266991,"about_ca_system_score_gemma":0.0024822091,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W2567545195","doi":"10.1158/1538-7445.am2015-484","title":"Abstract 484: Fidelity of subclonal representation in human neuroblastoma-derived cell line and patient-derived xenograft models: A report from the NCI-TARGET project","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Neuroblastoma; Exome sequencing; Bone marrow; Cell culture; Progenitor cell; Biology; Cancer; Somatic cell; Genetics; Stem cell; Mutation; Immunology; Gene","score_opus":0.18566669039065425,"score_gpt":0.43047100412637873,"score_spread":0.24480431373572448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567545195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552923,0.00091644673,0.000014989046,0.00084320776,0.00004745128,0.0015616323,0.000107441636,0.000028426595,0.00095116324],"genre_scores_gemma":[0.9988446,0.00021713902,0.00021398623,0.000066190754,0.00009149527,0.00029649102,0.00012622512,0.00003674157,0.000107087304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99642795,0.00040418972,0.000560539,0.0006281956,0.0014117268,0.0005674176],"domain_scores_gemma":[0.99778086,0.0003359943,0.00016053993,0.000654689,0.00075113494,0.00031675646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007895702,0.00018964254,0.00036616463,0.00026461785,0.00013051736,0.000048906088,0.00019736847,0.00008848775,0.000068887],"category_scores_gemma":[0.0004907224,0.00013673202,0.00007811266,0.0006033032,0.0003885798,0.00021518231,0.0002565717,0.00072846276,0.000005476496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004488236,0.0011777612,0.032092556,0.00017390095,0.00012963657,0.00250516,0.0036385804,0.00042214716,0.9465909,0.0000075557596,0.0049027726,0.0038707803],"study_design_scores_gemma":[0.009068966,0.0023745906,0.274496,0.00034219725,0.00004193378,0.00008403579,0.0022780974,0.001895988,0.7065876,0.0020033037,0.00056642445,0.00026086182],"about_ca_topic_score_codex":0.01951368,"about_ca_topic_score_gemma":0.0011209671,"teacher_disagreement_score":0.24240345,"about_ca_system_score_codex":0.00021797574,"about_ca_system_score_gemma":0.00096654793,"threshold_uncertainty_score":0.9870155},"labels":[],"label_agreement":null},{"id":"W2567545214","doi":"10.1158/1538-7445.am2015-3039","title":"Abstract 3039: Targeting mitochondrial DNA polymerase gamma (POLG) as a novel therapeutic strategy for acute myeloid leukemia (AML)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitochondrial DNA; Biology; Myeloid leukemia; Mitochondrion; Molecular biology; Stem cell; Viability assay; Cancer research; Gene; Cell; Cell biology; Genetics","score_opus":0.07691059702245574,"score_gpt":0.396308340858549,"score_spread":0.31939774383609326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567545214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645325,0.027351722,0.00082427886,0.00063575193,0.0027984183,0.0011936992,0.00038005118,0.000036700458,0.0022469005],"genre_scores_gemma":[0.9745957,0.0029535405,0.00042574693,0.0004736567,0.013133971,0.00086519367,0.0002982989,0.00012063115,0.007133225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972743,0.00008483736,0.00033116055,0.0007229851,0.0005825045,0.0010042033],"domain_scores_gemma":[0.9982783,0.000052053787,0.0000996245,0.00051273813,0.0005931221,0.00046417135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068746915,0.00027525699,0.0003011776,0.00012243408,0.0002371983,0.00013849197,0.0005157273,0.0003010881,0.000109701774],"category_scores_gemma":[0.0001949573,0.00025823934,0.0001886563,0.00024131416,0.00023958687,0.000018997256,0.00015788068,0.0003920637,0.00003583704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014545915,0.00005943992,0.000016811004,0.00003429713,0.00021876088,0.0000033714523,0.00015025352,0.00010240568,0.95315814,0.00016642678,0.0300014,0.014634117],"study_design_scores_gemma":[0.0028717828,0.00035645175,0.00012143385,0.000021179847,0.000046870184,0.000011567901,0.00031749392,0.00003233267,0.6067781,0.00024871135,0.3889003,0.00029380267],"about_ca_topic_score_codex":0.0014592281,"about_ca_topic_score_gemma":0.00030309916,"teacher_disagreement_score":0.3588989,"about_ca_system_score_codex":0.00023141099,"about_ca_system_score_gemma":0.0033071719,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2567548614","doi":"10.1158/1538-7445.panca16-b81","title":"Abstract B81: Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Pancreas Centre (Canada); BC Cancer Agency","funders":"","keywords":"Transcriptome; Subtyping; Adenocarcinoma; Cancer research; Cancer; KRAS; Gene; RNA extraction; Oncology; Biology; Gene expression; Medicine; Pathology; Internal medicine; Colorectal cancer; Genetics","score_opus":0.04123909146071594,"score_gpt":0.3459317926352883,"score_spread":0.30469270117457237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567548614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873985,0.00987022,0.00030861204,0.00032095867,0.000075959804,0.00035645277,0.00013610494,0.000008443137,0.00018338914],"genre_scores_gemma":[0.9947134,0.003919125,0.00042940472,0.000032498145,0.0002533358,0.00028593294,0.00006779951,0.000031481082,0.0002669833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801004,0.00013336285,0.0003100212,0.0005983696,0.00034110446,0.0006070865],"domain_scores_gemma":[0.99880373,0.00025403424,0.00007159883,0.00047697147,0.00021385835,0.00017979872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056142063,0.0001822781,0.00027181124,0.00031734727,0.00010294105,0.000057769084,0.00031993858,0.00010573387,0.00024739845],"category_scores_gemma":[0.00047662505,0.00013482281,0.000122962,0.0006038334,0.00021764505,0.000010078401,0.00017341155,0.00016063637,0.000031368225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013304348,0.00005932338,0.34911412,0.000026719383,0.00015948512,0.000039898754,0.000031236046,0.00009864076,0.6488894,0.000021022812,0.0005616178,0.00086545525],"study_design_scores_gemma":[0.00076586986,0.00017829814,0.403362,0.00009400973,0.00012848918,0.0000060726816,0.000102043865,0.000025534782,0.5942008,0.0003177413,0.00056621066,0.0002529287],"about_ca_topic_score_codex":0.00056911266,"about_ca_topic_score_gemma":0.0013203245,"teacher_disagreement_score":0.054688632,"about_ca_system_score_codex":0.0001233112,"about_ca_system_score_gemma":0.0004586816,"threshold_uncertainty_score":0.54979146},"labels":[],"label_agreement":null},{"id":"W2567613149","doi":"10.1158/1538-7445.am2015-5452","title":"Abstract 5452: Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Gefitinib; Erlotinib; Sorafenib; Dasatinib; Pharmacology; Lapatinib; Sunitinib; Vandetanib; Tyrosine-kinase inhibitor; Tyrosine kinase; Chemistry; IC50; Imatinib; Medicine; Biochemistry; Cancer research; Internal medicine; Cancer; In vitro; Epidermal growth factor receptor; Receptor","score_opus":0.05912482178897417,"score_gpt":0.36292261986793095,"score_spread":0.3037977980789568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567613149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907932,0.003906751,0.00001371772,0.00096761744,0.00016759077,0.0010208056,0.00017305669,0.00005898872,0.002898253],"genre_scores_gemma":[0.99621135,0.00094184815,0.00003087355,0.00007109936,0.0003529964,0.00019237756,0.00008029919,0.00007552981,0.0020436314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948678,0.00014735955,0.0005438798,0.00066456414,0.0028542506,0.0009221547],"domain_scores_gemma":[0.99758524,0.00020196983,0.00011127798,0.0005765908,0.0006348053,0.00089009263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00215493,0.00027608906,0.0005274851,0.00046689934,0.00014696048,0.000054749886,0.00019333464,0.0002654476,0.00041826552],"category_scores_gemma":[0.00020830729,0.00024889625,0.00010651171,0.0005128121,0.0008728431,0.00032724495,0.00017914189,0.0009583788,0.000036306126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0056785517,0.0010115097,0.004617715,0.0018285913,0.00019691324,0.0010652627,0.0025811386,0.000021684393,0.9445419,0.00018879087,0.025983218,0.012284729],"study_design_scores_gemma":[0.020473279,0.00078744546,0.0018529799,0.0006586057,0.000054628345,0.00009520485,0.00216228,0.0001460593,0.9695272,0.00015061638,0.0038009367,0.00029076525],"about_ca_topic_score_codex":0.009824669,"about_ca_topic_score_gemma":0.00055428705,"teacher_disagreement_score":0.024985302,"about_ca_system_score_codex":0.008714648,"about_ca_system_score_gemma":0.008642246,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W2567638003","doi":"10.1158/1538-7445.am2015-497","title":"Abstract 497: Understanding oncogenic fusions: Lessons learned from inflammatory myofibroblastic tumor","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anaplastic lymphoma kinase; Crizotinib; Cancer research; Fusion gene; Biology; Cancer; ROS1; Medicine; Pathology; Gene; Genetics; Lung cancer","score_opus":0.42186579402823476,"score_gpt":0.4890023643430388,"score_spread":0.06713657031480402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567638003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441006,0.003091878,0.00007284625,0.0138505325,0.00042077227,0.0010570748,0.00008322534,0.00020758386,0.0068060327],"genre_scores_gemma":[0.99483544,0.0008877744,0.00017568459,0.00018616382,0.0007702667,0.00026846447,0.00002720989,0.000097865275,0.0027511101],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496144,0.00029936974,0.00040055628,0.0007678225,0.002274898,0.0012959376],"domain_scores_gemma":[0.9962772,0.00079746987,0.00008604558,0.00077581283,0.0007895893,0.0012738955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009907989,0.0002509131,0.00043087063,0.00057813665,0.00031399453,0.0001265674,0.0004754457,0.000030603584,0.0014145992],"category_scores_gemma":[0.0036800192,0.0002220781,0.000119848584,0.00084744225,0.0006052554,0.0003064302,0.0004473464,0.0015841943,0.0006950356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073614675,0.0006898834,0.015891535,0.0009301335,0.00046879816,0.02466381,0.0011757147,0.00052738184,0.7935134,0.004752507,0.14060217,0.009423185],"study_design_scores_gemma":[0.031803645,0.004746536,0.037393138,0.0066980673,0.00028044725,0.0010908352,0.033240564,0.0011587397,0.33119056,0.14473908,0.4050906,0.0025678168],"about_ca_topic_score_codex":0.0011242959,"about_ca_topic_score_gemma":0.00049955543,"teacher_disagreement_score":0.46232286,"about_ca_system_score_codex":0.0020710437,"about_ca_system_score_gemma":0.0029619788,"threshold_uncertainty_score":0.99949825},"labels":[],"label_agreement":null},{"id":"W2567676868","doi":"10.1158/1538-7445.am2015-3901","title":"Abstract 3901: Identification of novel tumor suppressor candidates and characterizing their potential driver role in familial cholangiocarcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bridgepoint Active Healthcare","funders":"","keywords":"Exome sequencing; Biology; Malignancy; Metastasis; Primary tumor; Exome; Germline; Somatic evolution in cancer; Cancer; Cancer research; Genetics; Mutation; Gene","score_opus":0.07360631575385061,"score_gpt":0.3521426317077781,"score_spread":0.27853631595392747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567676868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932133,0.004577035,0.0000044417943,0.0010621289,0.00016686581,0.00046478712,0.00012575858,0.000017003344,0.00036868858],"genre_scores_gemma":[0.9990265,0.00024157003,0.00002054169,0.000059389145,0.00030983737,0.00012517635,0.000039338513,0.000024920992,0.00015276746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998307,0.000047011807,0.00034248794,0.0003740402,0.00051785965,0.00041161748],"domain_scores_gemma":[0.9990008,0.00005555924,0.00008535644,0.0002865584,0.00038655623,0.00018519381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006964353,0.00014550811,0.00033463314,0.00031937924,0.000076017815,0.000044593005,0.00015085885,0.00006672281,0.0000328029],"category_scores_gemma":[0.00010248943,0.00012347702,0.000058632813,0.00030980047,0.000249795,0.00018553503,0.000156138,0.00036401307,0.000006832904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065395806,0.00013715384,0.20457141,0.00014932588,0.000058266774,0.000035342695,0.003474555,0.00000414602,0.78881234,0.00001939408,0.00048795185,0.0015961466],"study_design_scores_gemma":[0.0025655015,0.00011417847,0.88577384,0.00014252616,0.00002059637,0.000019468254,0.0020311193,0.00018478188,0.10858046,0.000042183372,0.00041758415,0.000107754284],"about_ca_topic_score_codex":0.00284714,"about_ca_topic_score_gemma":0.00035511356,"teacher_disagreement_score":0.6812024,"about_ca_system_score_codex":0.0002108039,"about_ca_system_score_gemma":0.0003054839,"threshold_uncertainty_score":0.50352466},"labels":[],"label_agreement":null},{"id":"W2567717834","doi":"10.1158/1538-7445.am2015-1000","title":"Abstract 1000: Tyrosine kinase receptor EGFR regulates the switch between cell survival and cell death induced by autophagy under hypoxia in cancer cells","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Autophagy; Programmed cell death; Hypoxia (environmental); Cell biology; Cancer cell; Cancer research; Tyrosine kinase; Receptor tyrosine kinase; Biology; Cell; Kinase; Chemistry; Apoptosis; Signal transduction; Cancer; Biochemistry","score_opus":0.07168070882385823,"score_gpt":0.3524546105303704,"score_spread":0.2807739017065122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567717834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642312,0.03199475,0.000006535652,0.0009530192,0.00083824864,0.0004915704,0.00020604076,0.000013060599,0.0012655805],"genre_scores_gemma":[0.9845184,0.008442235,0.00003291705,0.00012510402,0.0018749626,0.0001921818,0.000083937695,0.00006536988,0.004664911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973629,0.00025861937,0.00031643402,0.00069449964,0.00056289905,0.0008046644],"domain_scores_gemma":[0.99857485,0.00008818189,0.000094040755,0.000557534,0.0003156548,0.00036971795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012464572,0.00027701826,0.000326487,0.00010817421,0.00016398281,0.00010271929,0.00047774301,0.00031746336,0.0001276663],"category_scores_gemma":[0.000037864356,0.00022214372,0.00006830476,0.00034915126,0.00021914745,0.000016583996,0.00028763543,0.0005822596,0.00002039931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016372581,0.00007704277,0.0010362836,0.000051158313,0.000026552263,0.0000011727535,0.00017298541,0.000053535874,0.965398,0.000015928868,0.029621234,0.0033823915],"study_design_scores_gemma":[0.0015514034,0.0001297167,0.012020867,0.000028552455,0.000017440505,4.3903e-7,0.00032386775,0.000006017532,0.8740674,0.000090949026,0.11149545,0.00026787768],"about_ca_topic_score_codex":0.008251818,"about_ca_topic_score_gemma":0.0012839694,"teacher_disagreement_score":0.09133057,"about_ca_system_score_codex":0.0002053342,"about_ca_system_score_gemma":0.00091825373,"threshold_uncertainty_score":0.9983523},"labels":[],"label_agreement":null},{"id":"W2571458784","doi":"10.1158/0008-5472.can-16-1106","title":"Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Foundation Medicine; National Institutes of Health","keywords":"Biology; Computational biology; Genetics; Profiling (computer programming); Computer science","score_opus":0.057213529962671476,"score_gpt":0.40956587095046015,"score_spread":0.35235234098778867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571458784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484855,0.0027356867,0.0001235276,0.00006090251,0.00016237186,0.00024672656,0.0016569126,0.0000020259695,0.00016328909],"genre_scores_gemma":[0.99664843,0.0025760976,0.00014024,0.000013334618,0.00038213716,0.000034995253,0.00003669459,0.000016541157,0.00015153266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900866,0.000020438576,0.00018519284,0.00027886117,0.00017707134,0.0003297544],"domain_scores_gemma":[0.9989999,0.000038110993,0.00015145911,0.00042542446,0.00030514982,0.00007998964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042524267,0.00008735078,0.00015088299,0.000059714683,0.0003362743,0.000058199996,0.00031614673,0.00005694621,0.00002027514],"category_scores_gemma":[0.00026261515,0.000091202935,0.000050609575,0.000071853654,0.00034809855,0.0000075067005,0.0004573659,0.00011883454,0.0000014897978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014291465,0.000031466043,0.06973128,0.00020141303,0.000056374618,0.000003072498,0.0003952069,0.00016735466,0.9280633,0.0004143161,0.00051415036,0.0002792064],"study_design_scores_gemma":[0.0020465888,0.00031588227,0.12147351,0.000049304293,0.000059572554,0.000003943065,0.0019332181,0.00013183035,0.87038493,0.00034781764,0.0030006361,0.00025278938],"about_ca_topic_score_codex":0.0017548221,"about_ca_topic_score_gemma":0.0020501977,"teacher_disagreement_score":0.05767834,"about_ca_system_score_codex":0.000060357732,"about_ca_system_score_gemma":0.0005885819,"threshold_uncertainty_score":0.37191477},"labels":[],"label_agreement":null},{"id":"W2571908121","doi":"","title":"Mitochondria-to-nucleus crosstalk mediated by Ets-1 in ovarian carcinoma cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"TFAM; Mitochondrion; Biology; NRF1; Transfection; Mitochondrial DNA; Transcription factor; Cell biology; Oxidative phosphorylation; Crosstalk; Gene; Molecular biology; Mitochondrial biogenesis; Genetics; Biochemistry","score_opus":0.03174706816368261,"score_gpt":0.3450488339944956,"score_spread":0.313301765830813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571908121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914423,0.0010706548,0.00031678024,0.0023258617,0.00067445176,0.0005249473,0.00018705912,0.000013932433,0.0034440036],"genre_scores_gemma":[0.98257655,0.00029285965,0.00056647597,0.0012747927,0.0011434576,0.000280891,0.00015788176,0.00004635436,0.013660712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794775,0.0002618553,0.00024278845,0.0005882561,0.00030555576,0.0006538061],"domain_scores_gemma":[0.99901813,0.000041471165,0.000029446666,0.00044997304,0.00018552928,0.00027543714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045609244,0.00015150278,0.00016853675,0.00017531162,0.00011568166,0.000047860623,0.00034356685,0.0002712129,0.0005932733],"category_scores_gemma":[0.00018641025,0.00015196635,0.00005508827,0.00042228616,0.000132489,0.0000057189472,0.00018270667,0.00036229007,0.0004177605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002759416,0.000124887,0.0007915552,0.0000075613666,0.000008218598,0.000010958066,0.00013868684,0.00003554971,0.84668225,0.000019911942,0.15097067,0.00093383976],"study_design_scores_gemma":[0.0014359738,0.00016483112,0.00036871285,0.0000064517117,0.0000014867645,0.0000035317103,0.000044311895,0.000014068777,0.5006275,0.0000074150157,0.49720252,0.0001231592],"about_ca_topic_score_codex":0.00059787586,"about_ca_topic_score_gemma":0.0016410435,"teacher_disagreement_score":0.34623185,"about_ca_system_score_codex":0.0001257582,"about_ca_system_score_gemma":0.00029465492,"threshold_uncertainty_score":0.6495927},"labels":[],"label_agreement":null},{"id":"W2572769405","doi":"","title":"Impact of circulating endothelial progenitor cells on the growth of viable tumor rim after treatment with a vascular disrupting agent.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Lewis lung carcinoma; Medicine; Homing (biology); Cancer research; Progenitor cell; Cytotoxic T cell; Primary tumor; Bone marrow; Cancer; Immunology; Pathology; Stem cell; Internal medicine; Biology; Metastasis; Cell biology; In vitro","score_opus":0.03042491727122053,"score_gpt":0.3415825962225363,"score_spread":0.31115767895131574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572769405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974419,0.0015825754,0.000048103597,0.000019956018,0.000026852735,0.00041776375,0.00010849486,0.0000029159846,0.00035146408],"genre_scores_gemma":[0.9988025,0.00014034461,0.000075646865,0.000010099051,0.00037240467,0.00035131944,0.000010256168,0.000030259978,0.0002071729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987488,0.000116427174,0.00018017633,0.0002746056,0.00033782478,0.00034220182],"domain_scores_gemma":[0.9992555,0.000037651924,0.000086132146,0.0003257624,0.0002484631,0.000046534595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028184304,0.00013696101,0.00016665315,0.00004883447,0.00008877119,0.000016197353,0.00014224274,0.000048580026,0.00010195031],"category_scores_gemma":[0.00001401381,0.00007670401,0.00021498444,0.00017447703,0.00016779175,0.000003064288,0.000051222403,0.00006750323,0.0000025061283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003739907,0.0001408127,0.06753584,0.00004500526,0.00019869859,0.0000066797506,0.00005597932,0.0003308092,0.93065,0.000023975232,0.00015781484,0.00048041664],"study_design_scores_gemma":[0.0005572538,0.0012517974,0.010428136,0.00007111346,0.000027502847,0.0000023918822,0.000053604585,0.000038587365,0.98679584,0.000014041703,0.0006547988,0.00010494474],"about_ca_topic_score_codex":0.003145737,"about_ca_topic_score_gemma":0.00009847296,"teacher_disagreement_score":0.057107702,"about_ca_system_score_codex":0.00012794607,"about_ca_system_score_gemma":0.0003068744,"threshold_uncertainty_score":0.47554344},"labels":[],"label_agreement":null},{"id":"W2573357394","doi":"10.1158/0008-5472.can-16-1022","title":"Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Breast cancer; Basal (medicine); Internal medicine; Cancer research; Medicine; Biology; Oncology; Cancer","score_opus":0.04521315335446267,"score_gpt":0.37609471241587716,"score_spread":0.3308815590614145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573357394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954479,0.00056626805,0.000050249288,0.0011085003,0.00013294838,0.00020567073,0.000049173388,0.0000021574497,0.0024371583],"genre_scores_gemma":[0.9989555,0.00017446939,0.000051999952,0.000042041764,0.00017178012,0.000052437637,0.000020906995,0.000005740552,0.000525136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928147,0.00008061243,0.00009379257,0.00019492618,0.00014451027,0.00020469658],"domain_scores_gemma":[0.9993455,0.00002116542,0.00006491934,0.0002677083,0.00026363612,0.00003708352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005053588,0.00006425847,0.0000752777,0.000023766137,0.00048639817,0.000024246217,0.00035124604,0.00008271421,0.00003991551],"category_scores_gemma":[0.000109723835,0.00004485951,0.00003293428,0.000044153945,0.0010202004,0.000004823806,0.00017750864,0.000111365654,0.000004661437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016267886,0.000010717677,0.033695135,0.000019798406,0.00007154917,0.0000011875636,0.000089669935,0.0000128921465,0.96027577,0.00039730684,0.0012572902,0.0040059825],"study_design_scores_gemma":[0.00022565511,0.00006218513,0.044399414,0.00003467448,0.0000041329577,0.0000044517233,0.000075270495,0.000007329133,0.953538,0.00035715775,0.0012248302,0.00006690134],"about_ca_topic_score_codex":0.00055380375,"about_ca_topic_score_gemma":0.00027352522,"teacher_disagreement_score":0.01070428,"about_ca_system_score_codex":0.000039880357,"about_ca_system_score_gemma":0.00051666354,"threshold_uncertainty_score":0.3758971},"labels":[],"label_agreement":null},{"id":"W2577835345","doi":"10.1158/0008-5472.can-16-1829","title":"Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Academy of Medical Sciences; Royal Society; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Immunoglobulin E; Tumor necrosis factor alpha; Immunology; Receptor; Cancer research; Signal transduction; Antibody; Medicine; Biology; Cell biology; Internal medicine","score_opus":0.1286211338534513,"score_gpt":0.41865280116422726,"score_spread":0.29003166731077595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577835345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193,0.0074777477,0.00005390222,0.002471797,0.0036483388,0.0009674925,0.0001569222,0.000102200436,0.003191601],"genre_scores_gemma":[0.94745827,0.0011714377,0.00012442756,0.00033890156,0.00040482724,0.00037086022,0.0000364158,0.00010048934,0.049994398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596435,0.0005968607,0.00049781584,0.0009757831,0.00027697624,0.0016882158],"domain_scores_gemma":[0.9969301,0.00033063025,0.0002134969,0.0017658755,0.00062606717,0.00013383344],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020022052,0.00035967003,0.00060838903,0.00032738617,0.0021183454,0.00023886796,0.0021313187,0.00042922224,0.00669154],"category_scores_gemma":[0.00055093796,0.00034581305,0.0001538151,0.0002922344,0.0009960071,0.0002744903,0.0011403247,0.001636763,0.008545869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004592766,0.000048735677,0.0012164267,0.00008018126,0.00015739797,0.000043303495,0.0005750248,0.000039114027,0.9343066,0.000059751077,0.041081015,0.02193313],"study_design_scores_gemma":[0.00094414037,0.00022616397,0.0036055692,0.00030270452,0.000014285238,0.000016177779,0.00014050021,0.0000024453864,0.833966,0.000057158788,0.1603591,0.0003657151],"about_ca_topic_score_codex":0.002518953,"about_ca_topic_score_gemma":0.00013321167,"teacher_disagreement_score":0.11927808,"about_ca_system_score_codex":0.0005420304,"about_ca_system_score_gemma":0.00046736313,"threshold_uncertainty_score":0.9998994},"labels":[],"label_agreement":null},{"id":"W2581548097","doi":"","title":"Lactoferricin, a peptide derived from bovine lactoferrin, has anti-angiogenic activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Infant Nutrition and Health","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Angiogenesis; Basic fibroblast growth factor; Matrigel; Vascular endothelial growth factor; Cell biology; Cancer research; Chemistry; Biology; Growth factor; Endocrinology; Internal medicine; Biochemistry; Medicine; Receptor","score_opus":0.15321278279129502,"score_gpt":0.4329202678722933,"score_spread":0.2797074850809983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581548097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556384,0.0018758522,0.00005307351,0.038920093,0.00039918005,0.00053776987,0.00018571726,0.00016172524,0.0022281937],"genre_scores_gemma":[0.9947176,0.00046887758,0.00028742268,0.001704533,0.0016973808,0.00011352755,0.000044997338,0.000060401373,0.0009052344],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996816,0.00045357694,0.0002831108,0.0005600385,0.00082342356,0.0010638416],"domain_scores_gemma":[0.9983061,0.00031974015,0.000077846365,0.0005541936,0.00037896674,0.00036318466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006997675,0.00020778617,0.00036181192,0.00034739857,0.0006962369,0.00016151508,0.0003770372,0.00018726444,0.0033593678],"category_scores_gemma":[0.00014273843,0.00020426988,0.00014649541,0.0006119716,0.00026359444,0.00031555968,0.00012470642,0.0009608954,0.0007512886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00220522,0.000488168,0.014331567,0.00012744112,0.00008647306,0.000030058502,0.002082205,0.000023820736,0.77912205,0.00010388876,0.17457241,0.026826685],"study_design_scores_gemma":[0.0030185047,0.00033969939,0.17856574,0.00023903478,0.00003335371,0.000008085425,0.0002552602,0.00064492313,0.3695794,0.0003153809,0.44653007,0.00047052265],"about_ca_topic_score_codex":0.0104954215,"about_ca_topic_score_gemma":0.006181554,"teacher_disagreement_score":0.40954265,"about_ca_system_score_codex":0.00092083705,"about_ca_system_score_gemma":0.000352629,"threshold_uncertainty_score":0.9975517},"labels":[],"label_agreement":null},{"id":"W2582803780","doi":"10.1158/1538-7445.tummet15-b18","title":"Abstract B18: Role of the tumor suppressor gene DLC-2 in ERBB2 induced mouse mammary tumorigenesis and metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Carcinogenesis; Cancer research; Mammary tumor; Biology; Oncogene; Tumor suppressor gene; Metastasis; Cancer; Cre recombinase; Gene silencing; Mouse mammary tumor virus; Tumor progression; Gene; Breast cancer; Cell cycle; Genetics; Genetically modified mouse; Transgene","score_opus":0.03349442439767474,"score_gpt":0.3281997102116064,"score_spread":0.29470528581393163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582803780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906145,0.0076190014,0.0000050117005,0.00049479515,0.0005737179,0.00030338595,0.00017889391,0.00000466701,0.00020608274],"genre_scores_gemma":[0.99323523,0.004094984,0.00004296839,0.00006210576,0.0016251581,0.0001835659,0.0000053800118,0.000027019512,0.000723591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845517,0.00016142472,0.00023247756,0.00039828345,0.00032816292,0.00042445742],"domain_scores_gemma":[0.9990204,0.00004278753,0.00006621343,0.0005834204,0.00017422899,0.000112972586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006084176,0.00013394548,0.0002104806,0.00010623889,0.000075314776,0.00002085569,0.00043527063,0.000091392154,0.000058741938],"category_scores_gemma":[0.0001605573,0.00008449531,0.000079618134,0.00021150663,0.0001949373,0.0000114951545,0.0003413253,0.00015383353,0.0000028399043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014062255,0.000044425644,0.0024191716,0.000035880763,0.000036943493,3.36265e-7,0.00006191488,0.0000019458903,0.9831318,0.000050756727,0.002528177,0.011547994],"study_design_scores_gemma":[0.0006612958,0.00004365338,0.034161475,0.000032832322,0.000007664301,0.0000033759864,0.00006773383,8.33293e-7,0.8933214,0.00009513272,0.07149552,0.000109098015],"about_ca_topic_score_codex":0.001117631,"about_ca_topic_score_gemma":0.00083248643,"teacher_disagreement_score":0.08981044,"about_ca_system_score_codex":0.000048457092,"about_ca_system_score_gemma":0.00040919037,"threshold_uncertainty_score":0.34456187},"labels":[],"label_agreement":null},{"id":"W2584054735","doi":"10.1158/1538-7445.crc16-pr06","title":"Abstract PR06: Interactions between nonsteroidal anti-inflammatory drugs and other risk factors on colorectal cancer risk","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Aspirin; Medicine; Colorectal cancer; Internal medicine; Body mass index; Cancer; Family history; Oncology","score_opus":0.03988385047769919,"score_gpt":0.38098452967667434,"score_spread":0.34110067919897513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584054735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924104,0.001154283,0.0000072429575,0.00013873792,0.0029497454,0.0003597355,0.0010182591,0.000014506718,0.0019470633],"genre_scores_gemma":[0.9829227,0.0052629425,0.000009351657,0.00002991431,0.010583323,0.00015689705,0.000019288766,0.00004814109,0.00096748635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822867,0.00014727881,0.0002102042,0.000559545,0.0003387265,0.000515579],"domain_scores_gemma":[0.9987256,0.00008360599,0.00020774534,0.0005829675,0.00016737681,0.0002327276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055189116,0.00021283512,0.00024578065,0.000113855094,0.0009328699,0.00018748065,0.0004072812,0.00017527085,0.00019464442],"category_scores_gemma":[0.00019894865,0.0001865797,0.00010527729,0.000051312258,0.0005088749,0.000020600277,0.00023120928,0.000665128,0.000020347792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002676787,0.000052038547,0.739619,0.000037996673,0.0002730499,3.3225595e-7,0.000581049,0.000032940046,0.2150753,0.000013897121,0.018488074,0.025558619],"study_design_scores_gemma":[0.0006079433,0.00008084453,0.54726595,0.00004832585,0.000030133988,5.60925e-7,0.00018362697,0.0000038544813,0.13093643,0.0000182072,0.32063392,0.00019020884],"about_ca_topic_score_codex":0.008663545,"about_ca_topic_score_gemma":0.0038040234,"teacher_disagreement_score":0.30214584,"about_ca_system_score_codex":0.00007843204,"about_ca_system_score_gemma":0.00031661603,"threshold_uncertainty_score":0.99793786},"labels":[],"label_agreement":null},{"id":"W2588844395","doi":"10.1158/1538-7445.sabcs16-pd4-04","title":"Abstract PD4-04: Effectiveness of myofascial techniques in addition to a standard physical therapy program as postoperative intervention for upper limb pain in breast cancer patients: A randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Physical therapy; Blinding; Visual analogue scale; Placebo; Surgery; Cancer; Internal medicine","score_opus":0.03877268631580662,"score_gpt":0.492489072785143,"score_spread":0.4537163864693364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588844395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661467,0.00016312432,0.000015194113,0.0016080863,0.00019053879,0.031411737,0.0002706173,0.00001703658,0.00017698103],"genre_scores_gemma":[0.92249525,0.00032286,0.000026011252,0.000052489475,0.0003067645,0.076652914,0.00006233559,0.000022312797,0.000059059428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741477,0.0010638568,0.0004082445,0.00034302793,0.0004176763,0.0003524056],"domain_scores_gemma":[0.9976437,0.0011404377,0.0001657428,0.00017818005,0.00078032375,0.00009159806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004220586,0.00017348256,0.0012668415,0.0003793264,0.000111554196,0.00004893006,0.00014129143,0.000105293046,0.0002666775],"category_scores_gemma":[0.0007250017,0.00012153859,0.00038150017,0.0001717508,0.00024080367,0.00013946155,0.00003920933,0.00030209956,0.0000013343154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83393586,0.0029430643,0.002049435,0.00013269902,0.00024422325,0.000005249588,0.00055539893,0.000001972681,0.011227142,0.000026825439,0.00033540663,0.1485427],"study_design_scores_gemma":[0.9259991,0.012415989,0.023505522,0.0014703932,0.000052344054,2.871836e-7,0.00005222062,0.000055235974,0.035647936,0.0002470537,0.00043908216,0.00011485912],"about_ca_topic_score_codex":0.0042865146,"about_ca_topic_score_gemma":0.00089457387,"teacher_disagreement_score":0.14842784,"about_ca_system_score_codex":0.00090869894,"about_ca_system_score_gemma":0.0005534476,"threshold_uncertainty_score":0.6479956},"labels":[],"label_agreement":null},{"id":"W2591582741","doi":"10.1158/1538-7445.sabcs16-p1-06-11","title":"Abstract P1-06-11: A targetable EGFR-driven tumor-initiating program in breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Gefitinib; Breast cancer; Cancer research; Population; Exome sequencing; Epidermal growth factor receptor; Cancer; Targeted therapy; Exome; Biology; Lung cancer; KRAS; Medicine; Oncology; Internal medicine; Mutation; Gene; Genetics","score_opus":0.052154933348141495,"score_gpt":0.4013921229974361,"score_spread":0.3492371896492946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591582741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920002,0.0023522605,0.00000556194,0.0013447535,0.00024140775,0.000575495,0.00030733555,0.000014054844,0.0031589319],"genre_scores_gemma":[0.99451524,0.0025947746,0.00019006716,0.00017267947,0.0010392166,0.0009211817,0.000060466322,0.000049411534,0.00045694102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980099,0.000048179452,0.0002481166,0.00055662374,0.00032693852,0.0008102343],"domain_scores_gemma":[0.99861234,0.000038400278,0.0001270764,0.00073512975,0.00029377692,0.00019329187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908672,0.00017810914,0.00021119099,0.00009314663,0.00046420083,0.00030279526,0.0006918832,0.00013400523,0.00023826826],"category_scores_gemma":[0.00020068443,0.00018094493,0.00007987957,0.000112244976,0.0002733738,0.000015935519,0.00045744632,0.00036933448,0.000020558875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002800452,0.0003775261,0.49313298,0.00023862031,0.000098713754,0.00012486137,0.0001700464,0.0011480416,0.43843296,0.00025033066,0.028450027,0.037295856],"study_design_scores_gemma":[0.0027593784,0.00022892447,0.6257383,0.0004880409,0.000020967767,0.00001756786,0.00026157795,0.0005874251,0.10336152,0.00027950248,0.26545507,0.0008017344],"about_ca_topic_score_codex":0.00936811,"about_ca_topic_score_gemma":0.014065841,"teacher_disagreement_score":0.33507144,"about_ca_system_score_codex":0.00022052451,"about_ca_system_score_gemma":0.00089505553,"threshold_uncertainty_score":0.9972286},"labels":[],"label_agreement":null},{"id":"W2591643510","doi":"10.1158/1538-7445.sabcs16-s5-06","title":"Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Medicine; Duloxetine; Brief Pain Inventory; Breast cancer; Internal medicine; Placebo; Randomized controlled trial; Discontinuation; Aromatase inhibitor; Cancer; Oncology; Physical therapy; Chronic pain; Tamoxifen","score_opus":0.04056827726578983,"score_gpt":0.4423527158761176,"score_spread":0.40178443861032775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591643510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785505,0.0009503903,0.000002040852,0.00486069,0.00088451913,0.012199353,0.0017470599,0.000038083777,0.0007673709],"genre_scores_gemma":[0.9808524,0.0010776875,0.000008005139,0.00007727169,0.0014603259,0.0111318715,0.00016566852,0.00007292243,0.005153821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995943,0.00044556864,0.00094161514,0.00064937316,0.0009245005,0.0010959416],"domain_scores_gemma":[0.99636114,0.0013787624,0.0005421562,0.0006670863,0.000700993,0.00034986256],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037949216,0.00036496416,0.0020007691,0.00047590042,0.00038174572,0.00009942887,0.00042372601,0.00030315912,0.0016912017],"category_scores_gemma":[0.001052277,0.00028757247,0.00063935947,0.0002619216,0.00073201855,0.00025369067,0.00015673605,0.0008194062,0.000022875376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970678,0.0014075756,0.0066566346,0.0004264687,0.0012640506,0.00009410144,0.00029526945,0.00001732747,0.010765907,0.000054015447,0.0058326563,0.0025080456],"study_design_scores_gemma":[0.97459173,0.0010529313,0.018329445,0.0004906254,0.0004479243,0.0000025229078,0.000046399826,0.0001756059,0.0035054113,0.00006166362,0.0010445693,0.00025115663],"about_ca_topic_score_codex":0.016299805,"about_ca_topic_score_gemma":0.003563973,"teacher_disagreement_score":0.0127358325,"about_ca_system_score_codex":0.000954186,"about_ca_system_score_gemma":0.001562129,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W2591728390","doi":"10.1158/1538-7445.sabcs16-p1-05-27","title":"Abstract P1-05-27: Evaluation of the Oncomine focus and comprehensive assays for therapeutic stratification in early hormone receptor positive breast cancers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Oncology; Medicine; Personalized medicine; Precision medicine; Internal medicine; Biomarker; Cancer; Bioinformatics; Clinical trial; Targeted therapy; Computational biology; Biology; Pathology; Genetics","score_opus":0.08791883727772222,"score_gpt":0.40472259299662167,"score_spread":0.31680375571889946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591728390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916102,0.005206419,0.000029211851,0.0013715688,0.00014906068,0.00096070813,0.00035357333,0.0000010762709,0.0003181483],"genre_scores_gemma":[0.99750435,0.0019473397,0.000032018008,0.000024481322,0.00016480965,0.00023713196,0.000026381778,0.000014669808,0.00004879186],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99897856,0.000090388196,0.00016641598,0.00026624568,0.00029272906,0.00020566916],"domain_scores_gemma":[0.998552,0.000089975314,0.00014198927,0.00042819107,0.0007413278,0.00004648014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073786534,0.00008834027,0.00012056182,0.000040127365,0.00020997046,0.000065780296,0.0002613203,0.00009304509,0.000007901338],"category_scores_gemma":[0.00013365813,0.00007397216,0.00004256302,0.00005383811,0.00027944281,0.000008729673,0.0000919934,0.00012923997,5.180293e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046998422,0.00003500164,0.004261919,0.000023059523,0.000054589567,1.6485083e-7,0.00019132165,0.00017351763,0.95015043,0.00022412944,0.0014892401,0.042926613],"study_design_scores_gemma":[0.0018744719,0.0002874694,0.71993697,0.00007250002,0.000030110261,0.0000014222103,0.0002085902,0.00023572751,0.2746521,0.000950844,0.0016188967,0.0001309038],"about_ca_topic_score_codex":0.004421296,"about_ca_topic_score_gemma":0.00333789,"teacher_disagreement_score":0.71567506,"about_ca_system_score_codex":0.00021604524,"about_ca_system_score_gemma":0.00068275275,"threshold_uncertainty_score":0.66837066},"labels":[],"label_agreement":null},{"id":"W2591741565","doi":"10.1158/1538-7445.sabcs16-p6-09-20","title":"Abstract P6-09-20: Clinical utility of PgR with various cutpoints using 3 commercial assays relative to 15yr survival","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Alberta Health Services","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Cohort; Internal medicine; Cancer; Immunohistochemistry; Hormonal therapy; Estrogen receptor; Adjuvant therapy; Estrogen; Gynecology","score_opus":0.3464387059699872,"score_gpt":0.5525184117322334,"score_spread":0.20607970576224616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591741565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550487,0.0003015559,0.0017354072,0.002757853,0.00044753912,0.0009804181,0.00012829909,0.00003452485,0.008109554],"genre_scores_gemma":[0.9958174,0.000060459348,0.0026391742,0.00010084792,0.00068853673,0.000055167147,0.00000693307,0.00005863862,0.0005727921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655694,0.00030091807,0.000535922,0.00062085496,0.0012677418,0.00071761984],"domain_scores_gemma":[0.9961011,0.00057611306,0.0002736354,0.0013778048,0.0012151842,0.00045617452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002531418,0.00022125948,0.0007390946,0.00016208261,0.0005308398,0.000053308908,0.00054768205,0.0001887384,0.00066007563],"category_scores_gemma":[0.0011179713,0.00017950239,0.00012732855,0.00026378268,0.0014541118,0.00030275292,0.00032667222,0.0013780516,0.00004400245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020959077,0.00078695564,0.73804736,0.0003930559,0.00080046966,0.00028136623,0.00239254,0.000093206996,0.021878816,0.00032549727,0.0008503464,0.21319133],"study_design_scores_gemma":[0.0035692728,0.00063177315,0.9833832,0.0007149513,0.00005898261,0.00001624885,0.000270411,0.000119745746,0.004064065,0.00064953696,0.006307166,0.00021467858],"about_ca_topic_score_codex":0.004917332,"about_ca_topic_score_gemma":0.0028090624,"teacher_disagreement_score":0.24533582,"about_ca_system_score_codex":0.0004147515,"about_ca_system_score_gemma":0.0014239148,"threshold_uncertainty_score":0.74335676},"labels":[],"label_agreement":null},{"id":"W2591749608","doi":"10.1158/1538-7445.sabcs16-p4-06-10","title":"Abstract P4-06-10: Rates of successful engraftment in breast cancer xenograft models based on tissue type: Primary vs relapsed disease","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Metastatic breast cancer; Biomarker; Cancer; Internal medicine; Primary tumor; Triple-negative breast cancer; Pathology; Metastasis; Biology","score_opus":0.051037895237427855,"score_gpt":0.41267432035659857,"score_spread":0.3616364251191707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591749608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907712,0.0035214897,0.0000059077256,0.0020569835,0.0000895471,0.00076914957,0.0008516553,0.000008112071,0.0019259786],"genre_scores_gemma":[0.9935862,0.003693677,0.000018267225,0.00008728305,0.00018365539,0.00060189964,0.0002467546,0.000043823467,0.0015384805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975835,0.00012886828,0.00024661908,0.00061378215,0.0007442336,0.000682978],"domain_scores_gemma":[0.99801034,0.00004368562,0.0001084547,0.0010603241,0.00042052075,0.0003567051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047262528,0.00021683439,0.00026114495,0.00019204494,0.0002696672,0.00010634046,0.00066775,0.000125001,0.0005675282],"category_scores_gemma":[0.0000824505,0.00019062574,0.00008608495,0.00017743926,0.0003646245,0.000025886857,0.00024465309,0.00030748648,0.000028902303],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040592223,0.003309306,0.2731744,0.0016057921,0.0005937714,0.00051644456,0.00015173857,0.014048307,0.57400995,0.00010324107,0.039139044,0.052755784],"study_design_scores_gemma":[0.007006926,0.0009584924,0.62575877,0.00076673157,0.000033016968,0.0000016124717,0.000026806856,0.0009781317,0.3479847,0.00031343775,0.015626121,0.0005452594],"about_ca_topic_score_codex":0.009982644,"about_ca_topic_score_gemma":0.0021757248,"teacher_disagreement_score":0.35258436,"about_ca_system_score_codex":0.0003405065,"about_ca_system_score_gemma":0.0015382126,"threshold_uncertainty_score":0.99661},"labels":[],"label_agreement":null},{"id":"W2591772998","doi":"10.1158/1538-7445.sabcs16-p6-02-03","title":"Abstract P6-02-03: Leptin receptor (OB-R) in breast carcinoma tissue: Ubiquitous expression and correlation with leptin-mediated signaling, but not with systemic markers of obesity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Statistics Canada; Mount Sinai Hospital","funders":"","keywords":"Leptin; Internal medicine; Medicine; Breast cancer; Estrogen receptor; Adipose tissue; Endocrinology; Leptin receptor; Cancer; Adiponectin; Oncology; Obesity; Insulin resistance","score_opus":0.027221922437640978,"score_gpt":0.31503158503021916,"score_spread":0.2878096625925782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591772998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965068,0.0016321742,0.000021147602,0.0002299768,0.000054900782,0.0009689356,0.00009358537,0.000022457953,0.00047003158],"genre_scores_gemma":[0.9988414,0.00025069318,0.00006496935,0.000011334533,0.0001747077,0.00008625443,0.000053656837,0.00003576122,0.00048124563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977166,0.00018411622,0.0002631988,0.00047825865,0.00093797094,0.00041986632],"domain_scores_gemma":[0.9983622,0.00012395189,0.00017507214,0.0006891118,0.00034663288,0.00030303828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009390497,0.00018569834,0.00047095818,0.00020038181,0.00027313753,0.00006543003,0.00019099815,0.00015674696,0.00014598253],"category_scores_gemma":[0.00009187489,0.0001402219,0.000066220986,0.00016980365,0.00038356904,0.00019041389,0.00010790994,0.00057434884,0.000015147349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005943652,0.00011191696,0.5051862,0.0009227563,0.00012508524,0.00022293793,0.00031172042,0.000056299665,0.483773,0.0000018285613,0.0003380369,0.0030065652],"study_design_scores_gemma":[0.0036493063,0.0003138777,0.87346125,0.003238736,0.00010340999,0.00011438506,0.00047417826,0.00007001725,0.11833465,0.0000011012391,0.00007040151,0.00016868435],"about_ca_topic_score_codex":0.0041343872,"about_ca_topic_score_gemma":0.00020258414,"teacher_disagreement_score":0.36827505,"about_ca_system_score_codex":0.00019638836,"about_ca_system_score_gemma":0.00047271495,"threshold_uncertainty_score":0.62499845},"labels":[],"label_agreement":null},{"id":"W2591788734","doi":"10.1158/1538-7445.sabcs16-p3-14-13","title":"Abstract P3-14-13: Total mastectomy and immediate breast reconstruction for breast cancer: A ten-year Canadian single institution experience","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Breast reconstruction; Stage (stratigraphy); Cancer; Total Mastectomy; Surgery; Retrospective cohort study; Breast-conserving surgery; Internal medicine","score_opus":0.06148613540320345,"score_gpt":0.3594706777324724,"score_spread":0.2979845423292689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591788734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218774,0.00028262867,0.000011659997,0.0030603518,0.0014213257,0.0007897713,0.000913331,0.00003361245,0.0012995709],"genre_scores_gemma":[0.99746585,0.00022606904,0.00010883047,0.000017225453,0.0013442938,0.00032685365,0.000021319134,0.000026821446,0.00046273027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982372,0.000027856759,0.00023474307,0.00046119996,0.0003419598,0.0006970491],"domain_scores_gemma":[0.9984028,0.00003581961,0.00011563472,0.0003576717,0.000518947,0.0005691294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036023438,0.00017371424,0.00026523002,0.00033773758,0.0011468055,0.00021706332,0.00015679687,0.00020285086,0.000394786],"category_scores_gemma":[0.00004579327,0.00015227309,0.00006492776,0.00014136473,0.0008578832,0.00053559436,0.00005305222,0.00043455488,0.000015063345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009651219,0.00003255944,0.081775546,0.00020577817,0.000059351787,0.000026667867,0.0003251789,0.0000028376603,0.014070438,0.00007481295,0.00030578804,0.90215594],"study_design_scores_gemma":[0.003664184,0.00013622847,0.94883907,0.0009814397,0.000046477995,0.039473593,0.0012271486,0.00017421227,0.0043311445,0.000104972205,0.0006997312,0.00032180178],"about_ca_topic_score_codex":0.15843561,"about_ca_topic_score_gemma":0.09461764,"teacher_disagreement_score":0.90183413,"about_ca_system_score_codex":0.00076566916,"about_ca_system_score_gemma":0.0013343372,"threshold_uncertainty_score":0.92190325},"labels":[],"label_agreement":null},{"id":"W2591800574","doi":"10.1158/1538-7445.sabcs16-p1-09-08","title":"Abstract P1-09-08: Predictive effect of cytotoxic tumor infiltrating lymphocytes in HER2-positive metastatic breast cancer: A correlative study with CCTG MA.31","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; University of Ottawa; Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lapatinib; Trastuzumab; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Tissue microarray; Taxane; Cancer; Tumor-infiltrating lymphocytes; Immunotherapy","score_opus":0.036816695995706514,"score_gpt":0.396372866378245,"score_spread":0.35955617038253845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591800574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918997,0.0013697451,0.000005325214,0.00035846847,0.00012228031,0.003831121,0.00041157618,0.000026109143,0.0019756737],"genre_scores_gemma":[0.9975743,0.00031066168,0.000024128189,0.000031887914,0.00012957238,0.0016221377,0.000011314131,0.00005636997,0.00023961462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966206,0.00043164458,0.0004981314,0.0006291431,0.0011146909,0.00070577645],"domain_scores_gemma":[0.99753034,0.00069321744,0.00039459992,0.0007000221,0.00049277325,0.00018902148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019436857,0.00033583117,0.0008454297,0.00037937236,0.00045071376,0.00010287422,0.0004193083,0.000074554424,0.0003062989],"category_scores_gemma":[0.00022376182,0.00024288497,0.00012168694,0.00056097814,0.0010220035,0.00033708024,0.00012730507,0.00078332616,0.000008580587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08822941,0.0011974402,0.8016578,0.0009704285,0.0023278128,0.0009177266,0.0079337405,0.00015641071,0.074000604,0.000010811387,0.00026588808,0.022331933],"study_design_scores_gemma":[0.015255635,0.006971937,0.91242176,0.0036187917,0.00019111176,0.00008219448,0.0039611435,0.00017606362,0.05703174,0.0000094089055,0.000023840974,0.00025639744],"about_ca_topic_score_codex":0.037082966,"about_ca_topic_score_gemma":0.0066215936,"teacher_disagreement_score":0.110763945,"about_ca_system_score_codex":0.001517806,"about_ca_system_score_gemma":0.0023196174,"threshold_uncertainty_score":0.99045616},"labels":[],"label_agreement":null},{"id":"W2591837371","doi":"10.1158/0008-5472.can-16-2179","title":"Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical Practice","year":2017,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Canada Research Chairs; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Context (archaeology); Germline; Cancer; Exon; Intron; Gene nomenclature; RNA splicing; Gene; Clinical Practice; Genetics; Germline mutation; Medicine; Biology; Bioinformatics; Computational biology; Mutation; Family medicine; Nomenclature; RNA","score_opus":0.8346961994101539,"score_gpt":0.7184339784851268,"score_spread":0.11626222092502714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591837371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007070449,0.99083,0.00030913288,0.0028910523,0.00056752935,0.0039557135,0.00019207106,0.00001716423,0.0011666148],"genre_scores_gemma":[0.00008668685,0.99477094,0.0027031254,0.00021730087,0.00073293457,0.000950961,0.00010873125,0.000076590135,0.0003527343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99009943,0.0016933711,0.0060510426,0.0008442573,0.0008046801,0.0005072153],"domain_scores_gemma":[0.9834041,0.004441456,0.006014923,0.001298582,0.004611063,0.0002298878],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.043387238,0.00027214538,0.0033989092,0.00033779288,0.00014030085,0.00005704696,0.0003033185,0.00060569396,0.000022034299],"category_scores_gemma":[0.23824964,0.00022812848,0.0004597926,0.00033485377,0.00022495963,0.00012921686,0.00017674429,0.0015142069,0.000003476515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004678269,0.00012560983,0.00009876696,0.01758161,0.0004231639,0.000058738897,0.00003440411,5.234862e-7,0.00004851814,0.0000984949,0.017030446,0.9640319],"study_design_scores_gemma":[0.0027422037,0.00023074103,0.000063946834,0.023740383,0.000685772,0.00009433649,0.000040039893,0.000012622673,0.000024961952,0.000099364544,0.9720822,0.0001834127],"about_ca_topic_score_codex":0.0011270526,"about_ca_topic_score_gemma":0.00014901134,"teacher_disagreement_score":0.9638485,"about_ca_system_score_codex":0.00042011612,"about_ca_system_score_gemma":0.0051593445,"threshold_uncertainty_score":0.98503417},"labels":[],"label_agreement":null},{"id":"W2591887089","doi":"10.1158/1538-7445.sabcs16-p1-09-19","title":"Abstract P1-09-19: Tumor RNA disruption index as a tool to predict response to neoadjuvant chemotherapy in breast cancer: Optimizing timing of biopsy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Jewish General Hospital; Kingston General Hospital","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Neoadjuvant therapy; Cancer; Internal medicine; Biopsy; Surgery","score_opus":0.03922696090824905,"score_gpt":0.39882845996073724,"score_spread":0.35960149905248817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591887089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889947,0.0006512877,0.000049101,0.008856751,0.00014370163,0.00070440845,0.00030619008,0.000012204299,0.0002816474],"genre_scores_gemma":[0.9973621,0.0007080618,0.0002472483,0.0002550944,0.00032483955,0.00080550404,0.0000093784165,0.00004963013,0.00023815595],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778664,0.000102081685,0.0003097726,0.00066061446,0.000489529,0.0006513532],"domain_scores_gemma":[0.9984617,0.000049655187,0.00013045986,0.0008329646,0.00028315588,0.00024201605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008879599,0.00023251068,0.00031319275,0.00024658078,0.00033129207,0.00008809644,0.00058962684,0.000112625945,0.00014393473],"category_scores_gemma":[0.00027956662,0.00021937388,0.00008347504,0.00023531173,0.00021166872,0.000020654665,0.00042156395,0.00022928587,0.000012943064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015329287,0.00013822105,0.06007098,0.000082364975,0.000139258,0.0000540631,0.000757192,0.000946097,0.87163347,0.0000048567863,0.0015883362,0.049255844],"study_design_scores_gemma":[0.002236184,0.00024199479,0.82479864,0.0005084174,0.000010220401,0.000023780216,0.00031836235,0.000040982857,0.16877104,0.000016470918,0.0027447438,0.00028916597],"about_ca_topic_score_codex":0.010913951,"about_ca_topic_score_gemma":0.0008854348,"teacher_disagreement_score":0.76472765,"about_ca_system_score_codex":0.00048252253,"about_ca_system_score_gemma":0.00070138875,"threshold_uncertainty_score":0.99567246},"labels":[],"label_agreement":null},{"id":"W2591894216","doi":"10.1158/1538-7445.sabcs16-p3-08-08","title":"Abstract P3-08-08: Preferences for breast cancer risk reduction among <i>BRCA1</i> and <i>BRCA2</i> mutation carriers: A discrete choice experiment","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Mutation; Reduction (mathematics); Internal medicine; Genetics; Biology; Mathematics; Gene","score_opus":0.16560260357528683,"score_gpt":0.3569536558425063,"score_spread":0.1913510522672195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591894216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911492,0.0035929724,0.00012131499,0.0008213052,0.0005072712,0.0007877616,0.0012236104,0.000016964288,0.0017796038],"genre_scores_gemma":[0.99250793,0.004808504,0.00010270807,0.000020300171,0.00050727866,0.0013086866,0.000032824468,0.000033326458,0.0006784507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998357,0.000031223575,0.00040505923,0.0006708991,0.00010080984,0.00043501257],"domain_scores_gemma":[0.9988088,0.00006712163,0.00046423063,0.00044833432,0.000052999603,0.00015854031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011235111,0.00016684577,0.00028101614,0.0001270208,0.001004476,0.0003756012,0.00030075875,0.00012338326,0.0007295811],"category_scores_gemma":[0.00008848663,0.00018192825,0.00007410155,0.000055421973,0.00042356557,0.0009371894,0.00011045903,0.0002637498,0.0000647612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022644493,0.0000804988,0.9458783,0.00017011339,0.00025163658,0.0000010480567,0.002755419,0.0008842625,0.0023710353,0.0012977353,0.0027139068,0.043369543],"study_design_scores_gemma":[0.0011430169,0.00008003531,0.9872336,0.000070941045,0.000014248121,0.0000016792679,0.00075178046,0.0008477219,0.0027219104,0.0044116634,0.0024579223,0.00026547792],"about_ca_topic_score_codex":0.016185524,"about_ca_topic_score_gemma":0.0010692247,"teacher_disagreement_score":0.043104067,"about_ca_system_score_codex":0.00061619584,"about_ca_system_score_gemma":0.000059821912,"threshold_uncertainty_score":0.9903658},"labels":[],"label_agreement":null},{"id":"W2591981550","doi":"10.1158/1538-7445.sabcs16-p1-10-06","title":"Abstract P1-10-06: Hypofractionated nodal radiotherapy (RT) did not increase arm morbidity compared to conventional fractionated nodal RT","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; BC Cancer Agency; Alberta Health Services","funders":"","keywords":"Medicine; Lymphedema; Breast cancer; Cohort; Activities of daily living; Physical therapy; Internal medicine; Cancer; Surgery","score_opus":0.09175168652366972,"score_gpt":0.42515715302574164,"score_spread":0.3334054665020719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591981550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98980385,0.0007613474,0.000059007172,0.005534345,0.00052185147,0.0005294392,0.0007245046,0.000038790142,0.0020268497],"genre_scores_gemma":[0.9934369,0.0006287135,0.00016894215,0.0004063543,0.0012304864,0.0004934138,0.0005530693,0.000053522224,0.003028618],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973591,0.00013247793,0.00029650226,0.0007940463,0.0007796246,0.00063825754],"domain_scores_gemma":[0.99777526,0.00010127298,0.00016863755,0.0008481162,0.0007825219,0.00032421068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005307988,0.0002877058,0.0003124869,0.00014592995,0.0012294629,0.00017406284,0.00060927053,0.00019469726,0.0022624156],"category_scores_gemma":[0.00031681499,0.00028410746,0.00015326888,0.00014429224,0.00045686984,0.000040989053,0.0002990962,0.00040105588,0.00022062617],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069107534,0.0012128052,0.044325516,0.00007107724,0.0013079316,0.00006969285,0.00009581764,0.0004099623,0.7506857,0.00009726616,0.1874658,0.0073476783],"study_design_scores_gemma":[0.0030982275,0.00014714518,0.6772466,0.00005003749,0.00002255359,0.000016773396,0.000055139753,0.00004846996,0.10763411,0.00004830279,0.21128848,0.00034420937],"about_ca_topic_score_codex":0.008536494,"about_ca_topic_score_gemma":0.00096964114,"teacher_disagreement_score":0.64305156,"about_ca_system_score_codex":0.0005087762,"about_ca_system_score_gemma":0.0005851595,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2591983590","doi":"10.1158/1538-7445.sabcs16-pd5-05","title":"Abstract PD5-05: Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Aromatase; Endocrinology; Body mass index; Cancer; Adipose tissue; Inflammation; Oncology","score_opus":0.019613809428741656,"score_gpt":0.34223982351484095,"score_spread":0.3226260140860993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591983590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973016,0.00073394825,0.000006641403,0.00059595134,0.0000946497,0.00052240165,0.0005169403,0.0000120809345,0.00021578315],"genre_scores_gemma":[0.9943373,0.00502874,0.000014872182,0.000010770763,0.0002816414,0.00015515115,0.000012729087,0.000025644587,0.00013312403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980322,0.000061254075,0.0002553313,0.00033846873,0.0007666806,0.00054604444],"domain_scores_gemma":[0.9987002,0.000030788873,0.00021268697,0.0005043618,0.00027463728,0.00027730706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067294127,0.00015990017,0.00038502127,0.00033339934,0.00026137143,0.00009317667,0.00023718117,0.00011459675,0.0005287915],"category_scores_gemma":[0.000040973984,0.00012925679,0.0000346592,0.00020448893,0.00048141342,0.00039682703,0.00013473377,0.0006332835,0.0000049383593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035763225,0.0000797926,0.9184404,0.00027190833,0.00021525258,0.000118529104,0.00080517196,0.00018796434,0.037589554,0.00001865152,0.00031494096,0.038381528],"study_design_scores_gemma":[0.0033296058,0.00013466626,0.98860353,0.00029670383,0.0000522336,0.000013973392,0.00034131636,0.00015430519,0.006062543,0.000048160793,0.0008269405,0.00013604238],"about_ca_topic_score_codex":0.05122461,"about_ca_topic_score_gemma":0.0059197573,"teacher_disagreement_score":0.07016312,"about_ca_system_score_codex":0.00036877109,"about_ca_system_score_gemma":0.0006605894,"threshold_uncertainty_score":0.9550934},"labels":[],"label_agreement":null},{"id":"W2592004895","doi":"10.1158/1538-7445.sabcs16-p3-03-18","title":"Abstract P3-03-18: An ex-vivo platform predicts anti-tumor outcome of metabolically-targeted, algorithm-driven combination therapy in triple-negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Triple-negative breast cancer; Cancer; Cancer cell; Breast cancer; Ex vivo; Combination therapy; Cancer research; In vivo; Cytotoxic T cell; Chemotherapy; Biology; Medicine; Pharmacology; Internal medicine; In vitro; Biochemistry; Genetics","score_opus":0.0712473250410316,"score_gpt":0.3991291990429764,"score_spread":0.3278818740019448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592004895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923174,0.0033783843,0.000036199483,0.0003461244,0.0011384477,0.0009266578,0.001109498,0.000013832176,0.000733468],"genre_scores_gemma":[0.9858764,0.011262171,0.00016554217,0.00009089783,0.0014162653,0.00037739117,0.000071523595,0.000053401574,0.00068644044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997358,0.00012796243,0.0004786743,0.00066422747,0.000676112,0.00069497386],"domain_scores_gemma":[0.9978757,0.00003526271,0.00029901214,0.0009105643,0.0006285879,0.00025088876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009189245,0.00026077632,0.0005017014,0.000227546,0.0002869706,0.000101202415,0.0008990679,0.00023221299,0.00041734744],"category_scores_gemma":[0.00015110512,0.00024100872,0.00014731316,0.0002133795,0.00050115265,0.00007282065,0.00021129205,0.0004848629,0.0000057700045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010679902,0.0005537374,0.03307067,0.00009466243,0.00021346103,0.0000064133174,0.0003752909,0.00010056171,0.7739508,0.00009607769,0.0022235736,0.18824673],"study_design_scores_gemma":[0.005148599,0.0003038197,0.69977933,0.00007384686,0.000018550414,0.0000052658283,0.00012800429,0.00024148347,0.27821887,0.00031295855,0.0154318055,0.00033748662],"about_ca_topic_score_codex":0.010652544,"about_ca_topic_score_gemma":0.0056258505,"teacher_disagreement_score":0.66670865,"about_ca_system_score_codex":0.0001155123,"about_ca_system_score_gemma":0.00063124794,"threshold_uncertainty_score":0.9959356},"labels":[],"label_agreement":null},{"id":"W2592117673","doi":"10.1158/1538-7445.sabcs16-p2-06-01","title":"Abstract P2-06-01: Non-genetic risk factors improve accuracy of breast cancer risk assessment for women at high familial risk: Comparison of risk estimation models using the prospective family study cohort (ProF-SC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Estimation; Risk assessment; Prospective cohort study; Environmental health; Demography; Cancer; Oncology; Internal medicine; Computer science; Engineering","score_opus":0.09920281031481215,"score_gpt":0.46866598673704035,"score_spread":0.3694631764222282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592117673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809581,0.0004570356,0.0018325123,0.00005243651,0.0005180232,0.007963224,0.008117838,0.000026689597,0.00007412811],"genre_scores_gemma":[0.9945103,0.0026276796,0.00036587517,0.0000036015522,0.00038318933,0.0018929507,0.00003376155,0.000099137804,0.000083518105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948147,0.0003434314,0.0010704489,0.0009669947,0.001824167,0.0009802682],"domain_scores_gemma":[0.9933246,0.00092574954,0.0022536977,0.001607835,0.0015734877,0.0003146482],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0025113504,0.0004662552,0.0012343873,0.00027457558,0.001774796,0.00014681698,0.0007519817,0.00021956609,0.00011144517],"category_scores_gemma":[0.0006389734,0.00032705982,0.00027320412,0.00032716256,0.000735869,0.0003996572,0.00042478513,0.001506021,0.000002024659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021388493,0.0007293432,0.93595123,0.0002266702,0.0010512895,0.0000016074423,0.0077159936,0.02894909,0.005899269,0.0000034105499,0.00022820114,0.017105028],"study_design_scores_gemma":[0.004453482,0.0009167473,0.9003448,0.00019232322,0.0006803006,5.647473e-7,0.0055862423,0.08286214,0.0042230147,0.0004402179,0.000015918347,0.00028425304],"about_ca_topic_score_codex":0.35576713,"about_ca_topic_score_gemma":0.008576214,"teacher_disagreement_score":0.34719092,"about_ca_system_score_codex":0.003492311,"about_ca_system_score_gemma":0.0016521103,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W2592269944","doi":"10.1158/1538-7445.sabcs16-p5-16-17","title":"Abstract P5-16-17: Population based long term outcomes of pathologic complete response after neoadjuvant chemotherapy in stage I-III breast cancer: The British Columbia experience","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Population; Stage (stratigraphy); Trastuzumab; Neoadjuvant therapy; Chemotherapy; Cancer; Cohort","score_opus":0.05405633469643205,"score_gpt":0.388615046723567,"score_spread":0.33455871202713494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592269944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570644,0.0013708349,0.0000062958075,0.0015373263,0.00010539537,0.0005182768,0.0006841727,0.0000082119595,0.0000630605],"genre_scores_gemma":[0.99692225,0.0007763936,0.000017070983,0.00022910106,0.0000945812,0.0009369585,0.000036609184,0.000027796621,0.00095921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814695,0.00018844618,0.000282193,0.00050385593,0.00039960825,0.000478921],"domain_scores_gemma":[0.99861896,0.00007515678,0.00017476417,0.00084785064,0.00021429721,0.00006896616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006265534,0.00015535441,0.00029441022,0.000039235336,0.0006743959,0.00033665352,0.0005631469,0.00011400902,0.0004581644],"category_scores_gemma":[0.0000859399,0.00015156146,0.00009747976,0.00009762158,0.00058284303,0.00001900064,0.00021959303,0.0002049056,0.0000011978718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00178609,0.00009572475,0.9605235,0.000030360834,0.00004577902,0.000057837988,0.00017555889,0.000015535592,0.023080377,2.3836785e-7,0.00040218374,0.013786804],"study_design_scores_gemma":[0.00187397,0.000063741296,0.99439335,0.00015253565,0.0000062691893,0.0000074633163,0.0001365084,0.0000050597714,0.0027708572,0.000007957896,0.00042203398,0.00016025196],"about_ca_topic_score_codex":0.15916722,"about_ca_topic_score_gemma":0.2659204,"teacher_disagreement_score":0.106753185,"about_ca_system_score_codex":0.00026723422,"about_ca_system_score_gemma":0.00022755412,"threshold_uncertainty_score":0.846432},"labels":[],"label_agreement":null},{"id":"W2592274899","doi":"10.1158/1538-7445.sabcs16-p3-02-06","title":"Abstract P3-02-06: Magnetic resonance imaging (MRI) surveillance for patients with dense breasts and a previous breast cancer (BC) and/or high risk lesion","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Mammography; Breast MRI; Magnetic resonance imaging; Radiology; Stage (stratigraphy); Cancer; Retrospective cohort study; Breast imaging; Internal medicine","score_opus":0.022629211773663532,"score_gpt":0.3667564128170577,"score_spread":0.3441272010433941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592274899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844614,0.00797322,0.000059121787,0.005976481,0.00012010107,0.0010599042,0.00022004382,0.000032613658,0.000097092874],"genre_scores_gemma":[0.9879546,0.009714246,0.0006304892,0.0001409373,0.00036651976,0.00027798154,0.000016697655,0.00006590882,0.00083259965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977055,0.00009856306,0.00023634968,0.0006450129,0.00064011366,0.0006744306],"domain_scores_gemma":[0.99806094,0.00032857448,0.00016184725,0.00054847065,0.0005187123,0.00038143722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010484073,0.00021773455,0.00038816908,0.00012390669,0.0008346101,0.00023042005,0.00023857229,0.000069555324,0.000119433236],"category_scores_gemma":[0.00060992053,0.00015104518,0.000036075224,0.00010727564,0.0007122608,0.00017601447,0.00017288026,0.00073116715,0.0000034160435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001560314,0.00005628651,0.6266386,0.00027386268,0.00001647387,0.000038342223,0.0000814478,0.0000038179764,0.000146208,0.000007159547,0.0019843231,0.36919317],"study_design_scores_gemma":[0.0051237796,0.00030703156,0.98396474,0.0012306091,0.00003779214,0.000054976696,0.00002365357,0.0022074094,0.000033978067,0.00006800646,0.006751745,0.00019625758],"about_ca_topic_score_codex":0.013163713,"about_ca_topic_score_gemma":0.00091260875,"teacher_disagreement_score":0.36899692,"about_ca_system_score_codex":0.00016665565,"about_ca_system_score_gemma":0.00032901636,"threshold_uncertainty_score":0.9934077},"labels":[],"label_agreement":null},{"id":"W2592303973","doi":"10.1158/1538-7445.sabcs16-p1-03-01","title":"Abstract P1-03-01: An international multicenter study to evaluate reproducibility of automated scoring methods for assessment of Ki67 in breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Reproducibility; Intraclass correlation; Medicine; Breast cancer; Nuclear proliferation; Medical physics; Cancer; Biopsy; Nuclear medicine; Pathology; Statistics; Mathematics; Internal medicine","score_opus":0.2166136544018778,"score_gpt":0.6358156388975048,"score_spread":0.419201984495627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592303973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355394,0.000054120104,0.0003048054,0.003803583,0.00045202632,0.0014472115,0.000035863035,0.000021963482,0.0003265095],"genre_scores_gemma":[0.98704946,0.000054860735,0.012198557,0.000042021155,0.00022238297,0.00032465896,0.0000059695385,0.000023645658,0.0000784452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743885,0.0003123266,0.00047699513,0.0007543466,0.00069440977,0.00032306535],"domain_scores_gemma":[0.9972701,0.00023222253,0.0001825186,0.0013687903,0.0007679304,0.0001784013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015847158,0.00010290741,0.0003858974,0.0002648795,0.000113372305,0.000046812504,0.00049918337,0.00003584389,0.00026335113],"category_scores_gemma":[0.0033394767,0.00008578576,0.000058555474,0.00013595582,0.00017273746,0.0001610475,0.00023897819,0.00048979797,6.210914e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006840203,0.0009197711,0.7794078,0.00028248198,0.00012619385,0.00000708917,0.0010085677,0.0009150617,0.117513545,0.000009900622,0.0001379235,0.09898763],"study_design_scores_gemma":[0.0023624843,0.0001962763,0.8969678,0.0005192716,0.00002579257,0.0000010206762,0.0002954651,0.09409505,0.005322974,0.000021336695,0.00012777989,0.000064702486],"about_ca_topic_score_codex":0.012015209,"about_ca_topic_score_gemma":0.00037438984,"teacher_disagreement_score":0.11756002,"about_ca_system_score_codex":0.00046037167,"about_ca_system_score_gemma":0.00051520945,"threshold_uncertainty_score":0.9945639},"labels":[],"label_agreement":null},{"id":"W2592506457","doi":"10.1158/1538-7445.sabcs16-p2-05-19","title":"Abstract P2-05-19: Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer; Hazard ratio; Cohort; Triple-negative breast cancer; Exact test; Clinical significance; Confidence interval","score_opus":0.08773705134991443,"score_gpt":0.48183785678670543,"score_spread":0.394100805436791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592506457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975238,0.00026939518,0.000004355947,0.00022199591,0.0005574295,0.00021746168,0.00077647826,0.0000021272438,0.0004269878],"genre_scores_gemma":[0.99765974,0.0016476874,0.000018137385,0.0000631518,0.00028068226,0.00003640655,0.00009985638,0.000019783707,0.000174571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878013,0.00004021293,0.00030784262,0.00029425728,0.00033496405,0.00024258294],"domain_scores_gemma":[0.9981574,0.00010929887,0.00024805262,0.000497328,0.00085613504,0.00013178399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035120753,0.0001110167,0.00021217503,0.000061602186,0.0001343629,0.000023480286,0.00027852817,0.00012433178,0.00022656882],"category_scores_gemma":[0.00074372324,0.000093040435,0.00016220714,0.000058474598,0.0002624213,0.00000811936,0.00013217781,0.0001758947,0.000006573437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027719813,0.0003760714,0.9006534,0.00004724979,0.00026736557,0.0000022027045,0.00002608277,0.0020845807,0.05139045,0.000044404936,0.012379417,0.029956762],"study_design_scores_gemma":[0.0012778905,0.0009550319,0.9858551,0.00003640627,0.000011549822,4.5380438e-7,0.000012247389,0.000007708378,0.010462121,0.000060868282,0.0012256367,0.000095001444],"about_ca_topic_score_codex":0.0021718286,"about_ca_topic_score_gemma":0.00041895438,"teacher_disagreement_score":0.08520165,"about_ca_system_score_codex":0.000115884635,"about_ca_system_score_gemma":0.0008641056,"threshold_uncertainty_score":0.37940788},"labels":[],"label_agreement":null},{"id":"W2592525030","doi":"10.1158/1538-7445.sabcs16-p6-17-02","title":"Abstract P6-17-02: Evaluation of the impact of oncotype DX test results on systemic therapy in breast cancer patients at the BC cancer agency (BCCA)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Concordance; Breast cancer; Internal medicine; Cancer; Gynecology; Oncology; Hormone therapy","score_opus":0.17179414089313771,"score_gpt":0.4837780664100055,"score_spread":0.31198392551686777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592525030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842712,0.0028860548,2.4735474e-8,0.0023525653,0.00034614504,0.0020587144,0.001766446,0.0000063053226,0.0063125235],"genre_scores_gemma":[0.9922582,0.0057612276,5.0769063e-7,0.00008686006,0.0002637313,0.0004868313,0.000031061045,0.000035302834,0.0010763167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962229,0.00033084356,0.00057705335,0.00044334115,0.0019181744,0.00050765305],"domain_scores_gemma":[0.99602115,0.00038134694,0.0005361863,0.0014029386,0.0015338759,0.00012447422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025329867,0.00021841707,0.00043314326,0.000167748,0.00038354122,0.00003688917,0.00072297844,0.00014349444,0.0025935299],"category_scores_gemma":[0.0005281857,0.000116217896,0.0002065321,0.0003434871,0.00048482014,0.00015284854,0.00015260007,0.0006830576,0.000011526073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005184086,0.00033718042,0.80833155,0.00020901878,0.00020005218,0.0000026452008,0.0017162539,0.0018032858,0.067751974,0.0000019907675,0.014685659,0.099776335],"study_design_scores_gemma":[0.006087299,0.0004061325,0.97963506,0.001527116,0.000036097717,0.0000016940111,0.000062963074,0.00031259094,0.011515991,0.000013985843,0.0002878039,0.000113291906],"about_ca_topic_score_codex":0.07497452,"about_ca_topic_score_gemma":0.007377942,"teacher_disagreement_score":0.17130351,"about_ca_system_score_codex":0.0039198236,"about_ca_system_score_gemma":0.004288849,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W2592547112","doi":"10.1158/1538-7445.sabcs16-p6-12-11","title":"Abstract P6-12-11: A randomized, double-blind, placebo-controlled window of opportunity trial evaluating clinical effects of high dose vitamin D in patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; Juravinski Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Window of opportunity; Breast cancer; Double blind; Placebo; Cancer; Randomized controlled trial; Clinical trial; Vitamin; Oncology; Internal medicine; Alternative medicine; Pathology; Computer science","score_opus":0.1650859736408032,"score_gpt":0.4921462164581939,"score_spread":0.32706024281739066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592547112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818208,0.0003506918,0.000001764945,0.0010080894,0.0004161323,0.015882023,0.00008633022,0.000014416852,0.000419709],"genre_scores_gemma":[0.99346054,0.0006405589,0.000053308122,0.000019187475,0.0005053319,0.0046847113,0.00001693192,0.000054840064,0.00056457944],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918071,0.0017222569,0.0015209487,0.0007112302,0.0032460454,0.0009924379],"domain_scores_gemma":[0.98881805,0.005857379,0.0009712501,0.0012623374,0.00255681,0.00053415087],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0162762,0.0003459181,0.0030016545,0.00059440115,0.000355313,0.00006494324,0.0006922652,0.00026595301,0.0003761101],"category_scores_gemma":[0.014879808,0.00022209153,0.00038797408,0.00033102767,0.002371203,0.00025908172,0.0004961058,0.001464796,0.00000492563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8651341,0.0016491748,0.119016565,0.0012012012,0.0010987177,0.00006146304,0.00029365395,0.000015442214,0.0006267295,0.000011691914,0.00031349313,0.010577739],"study_design_scores_gemma":[0.598047,0.0015984146,0.3975895,0.0016333745,0.00019650486,6.668071e-7,0.00005370909,0.0000365031,0.00070550264,0.000017802158,0.0000024777132,0.000118527554],"about_ca_topic_score_codex":0.014569581,"about_ca_topic_score_gemma":0.0036791647,"teacher_disagreement_score":0.27857295,"about_ca_system_score_codex":0.00046537092,"about_ca_system_score_gemma":0.0034374534,"threshold_uncertainty_score":0.9934183},"labels":[],"label_agreement":null},{"id":"W2592573955","doi":"10.1158/1538-7445.sabcs16-pd5-08","title":"Abstract PD5-08: Expression of LAG-3 in breast cancer, and its association with subtype and outcome","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Breast cancer; Medicine; Immune checkpoint; Tumor-infiltrating lymphocytes; Context (archaeology); Cancer; Oncology; Breast carcinoma; Biomarker; Internal medicine; Pathology; Cancer research; Biology; Immunotherapy","score_opus":0.08472194768660533,"score_gpt":0.42787809987824466,"score_spread":0.3431561521916393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592573955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047107,0.004166427,1.382046e-7,0.0042458083,0.000060154835,0.00028217986,0.000053112697,0.0000054369125,0.0007156658],"genre_scores_gemma":[0.99352455,0.0051531363,0.0000089133155,0.000037431208,0.000082358405,0.0000546769,0.0000022146542,0.000012861246,0.0011238606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989319,0.000031136642,0.00016308608,0.00020298517,0.00042446516,0.00024643398],"domain_scores_gemma":[0.9992851,0.00007210816,0.00013741471,0.00021055165,0.00021692965,0.00007787254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000782217,0.000078858975,0.000211923,0.00011153195,0.00014392559,0.00004134665,0.00009209442,0.000091883376,0.00018637699],"category_scores_gemma":[0.00007614464,0.000057429086,0.000017759152,0.000099527475,0.00012260975,0.00014360723,0.00005264059,0.00027449557,0.0000013202532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002454796,0.000032126656,0.7755486,0.00022963014,0.0000297319,0.000011717864,0.00018646398,4.3748403e-7,0.21274737,0.00000637705,0.00037703186,0.008375716],"study_design_scores_gemma":[0.0027387745,0.00008145396,0.95658755,0.0007113143,0.0000091142765,0.0000071227228,0.000084793624,0.0000084321155,0.038983073,0.000008855288,0.0007146012,0.00006491527],"about_ca_topic_score_codex":0.005651057,"about_ca_topic_score_gemma":0.0011563101,"teacher_disagreement_score":0.18103895,"about_ca_system_score_codex":0.0002944649,"about_ca_system_score_gemma":0.00023856909,"threshold_uncertainty_score":0.8542746},"labels":[],"label_agreement":null},{"id":"W2592575712","doi":"10.1158/1538-7445.sabcs16-p3-04-25","title":"Abstract P3-04-25: Role of <i>H19</i>, a long non-coding RNA, in development of resistance to endocrine therapy in breast cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Gene knockdown; Cancer research; Breast cancer; Estrogen receptor; Estrogen; Endocrine system; Cancer; Antiestrogen; Medicine; Internal medicine; Biology; Endocrinology; Cell culture; Hormone; Genetics","score_opus":0.031213452926251856,"score_gpt":0.3719638727776225,"score_spread":0.34075041985137067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592575712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376005,0.002961293,0.00020743957,0.00047574542,0.0000989827,0.00082312076,0.000091141024,0.000003354197,0.0015788721],"genre_scores_gemma":[0.9939908,0.0045090476,0.00029144424,0.000032297463,0.00010361371,0.00048240024,0.000009842073,0.000048798138,0.00053175783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972083,0.00009895132,0.0005034007,0.0006206687,0.0007580931,0.0008106152],"domain_scores_gemma":[0.99826634,0.00002915722,0.0001639408,0.0008805076,0.00048326666,0.00017677578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011054071,0.00020233296,0.00034713827,0.0003900071,0.000151457,0.00004850039,0.001002927,0.0001620075,0.00016103683],"category_scores_gemma":[0.0000777589,0.00020850138,0.00007576261,0.00038477077,0.00018890723,0.00001576733,0.00048741617,0.00048076798,0.0000059065037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011522636,0.00012117536,0.0015595447,0.00015005234,0.000050665654,0.000027094957,0.0003827905,0.00029122035,0.9691583,0.000012171244,0.0002989339,0.02679582],"study_design_scores_gemma":[0.0013385334,0.00008323353,0.03889707,0.0005447979,0.000001618851,0.0000012589284,0.00014243048,0.000017797902,0.95595855,0.000023255023,0.0027997761,0.00019167017],"about_ca_topic_score_codex":0.003974233,"about_ca_topic_score_gemma":0.016983053,"teacher_disagreement_score":0.037337527,"about_ca_system_score_codex":0.00035619404,"about_ca_system_score_gemma":0.0014108552,"threshold_uncertainty_score":0.9476942},"labels":[],"label_agreement":null},{"id":"W2592651061","doi":"10.1158/1538-7445.sabcs16-p2-06-09","title":"Abstract P2-06-09: Prediction of relapse in patients with locally advanced breast cancer after neoadjuvant treatment","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Oncology; Neoadjuvant therapy; Internal medicine; Cancer","score_opus":0.020425790591924314,"score_gpt":0.3322003329644278,"score_spread":0.31177454237250346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592651061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956264,0.0017922831,0.0000036362535,0.00048832665,0.00011520203,0.00058047834,0.0010587374,0.0000068051286,0.00032815788],"genre_scores_gemma":[0.99613607,0.0021198872,0.000036597292,0.000017118036,0.00015696044,0.001122524,0.00008253346,0.000035076682,0.00029323995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983656,0.000045157427,0.00022024929,0.00051172,0.00040362717,0.000453687],"domain_scores_gemma":[0.9986222,0.000013846572,0.00012919598,0.0007072741,0.00042514474,0.000102344595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013398785,0.00020911323,0.0002474334,0.00008667414,0.00019465966,0.0000305535,0.00024808163,0.000110386856,0.0000768035],"category_scores_gemma":[0.000023276367,0.00015629563,0.000058320733,0.00008648965,0.000358487,0.000022612378,0.00015007298,0.00014611922,0.000006653206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047894004,0.00044012655,0.9380436,0.000050431478,0.00020973996,0.000011404527,0.00015291256,0.00015637596,0.006248815,0.0000028303798,0.0002633078,0.049631048],"study_design_scores_gemma":[0.004930582,0.0004940044,0.9810068,0.00029250927,0.000021830609,0.0000010150167,0.00005100583,0.0000022475379,0.011669358,0.000008679913,0.0013893623,0.00013262812],"about_ca_topic_score_codex":0.0033418932,"about_ca_topic_score_gemma":0.004421686,"teacher_disagreement_score":0.04949842,"about_ca_system_score_codex":0.0004171008,"about_ca_system_score_gemma":0.00036322774,"threshold_uncertainty_score":0.6373551},"labels":[],"label_agreement":null},{"id":"W2592743355","doi":"10.1158/1538-7445.crc16-a23","title":"Abstract A23: Rare variants in the FAT1 gene may predispose to familial colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pedigree chart; Genetics; Colorectal cancer; Exome; Germline mutation; Medicine; Germline; Population; Genetic predisposition; Cohort; Cancer; Exome sequencing; Biology; Oncology; Internal medicine; Mutation; Gene","score_opus":0.11851691971658007,"score_gpt":0.4471477067550161,"score_spread":0.328630787038436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592743355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810869,0.0009772929,0.000003363948,0.0066162758,0.0010903509,0.0020393468,0.00021802382,0.000026988044,0.007941463],"genre_scores_gemma":[0.9943527,0.00058880704,0.00010469908,0.0004862149,0.0013272639,0.0018594201,0.000011332012,0.000055601744,0.0012139603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962858,0.00017393033,0.0003312194,0.0006878029,0.0014941439,0.0010270841],"domain_scores_gemma":[0.9977627,0.00024502017,0.000084218176,0.0011281368,0.00043704975,0.00034287633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014946341,0.00024575385,0.00038132377,0.00024219864,0.0005580411,0.00020548207,0.0012560057,0.00021271456,0.0017916157],"category_scores_gemma":[0.00089783315,0.00017704409,0.00009672984,0.0004034164,0.00042992464,0.00012724049,0.00038801777,0.0011172845,0.00014166087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004583201,0.00043210827,0.29549363,0.00031563247,0.00015792476,0.00075478957,0.0055778436,0.0001811695,0.5943813,0.000055419307,0.051189393,0.0468776],"study_design_scores_gemma":[0.0017405882,0.0004114009,0.9167841,0.0002764141,0.000020643418,0.000017223438,0.0003368053,0.00003279762,0.0720675,0.0000801171,0.008034216,0.00019816268],"about_ca_topic_score_codex":0.011329947,"about_ca_topic_score_gemma":0.012090381,"teacher_disagreement_score":0.6212905,"about_ca_system_score_codex":0.00095479365,"about_ca_system_score_gemma":0.0014678085,"threshold_uncertainty_score":0.9991209},"labels":[],"label_agreement":null},{"id":"W2592770830","doi":"10.1158/1538-7445.sabcs16-p3-07-03","title":"Abstract P3-07-03: GPNMB activates EGFR to overcome Mek-inhibition: Implications for the development of rational targeted therapy combinations in triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Triple-negative breast cancer; MAPK/ERK pathway; Medicine; Cancer research; Targeted therapy; Breast cancer; Melanoma; Oncology; Cancer; Internal medicine; Signal transduction; Biology; Cell biology","score_opus":0.2165357930011002,"score_gpt":0.5071941370836902,"score_spread":0.29065834408259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592770830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87166446,0.0010691938,0.00040032834,0.11766074,0.00027402138,0.0063449778,0.001262281,0.000033652297,0.0012903204],"genre_scores_gemma":[0.98739433,0.00066009135,0.000644606,0.00019886359,0.00029214815,0.009539528,0.000059178365,0.00004573398,0.0011655446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99723965,0.00011250746,0.0005123963,0.00047786842,0.0009954976,0.000662055],"domain_scores_gemma":[0.9956605,0.001053332,0.00016157562,0.0008175707,0.0020591817,0.00024784767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018603757,0.00018417125,0.00034121363,0.00038606662,0.0012682083,0.00014326215,0.0006084758,0.00011465412,0.0018389991],"category_scores_gemma":[0.0007258083,0.00014039996,0.00009637668,0.00063041964,0.0004480913,0.0002694548,0.00017847627,0.0006210675,0.00003731541],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005891187,0.002027032,0.07659571,0.0006507029,0.00078696216,0.0000073709216,0.011774977,0.00035214477,0.6505403,0.005616671,0.05580945,0.18994752],"study_design_scores_gemma":[0.0035406358,0.00014626398,0.8901727,0.00037070262,0.000007846481,0.0000024784897,0.00044269804,0.00007893792,0.09761251,0.0013555157,0.0061188424,0.00015084755],"about_ca_topic_score_codex":0.0036486674,"about_ca_topic_score_gemma":0.0048673167,"teacher_disagreement_score":0.813577,"about_ca_system_score_codex":0.001662104,"about_ca_system_score_gemma":0.0043905904,"threshold_uncertainty_score":0.99907345},"labels":[],"label_agreement":null},{"id":"W2592784720","doi":"10.1158/1538-7445.sabcs16-p4-22-10","title":"Abstract P4-22-10: Evaluation of the effects of palbociclib (PAL) + letrozole (LET) on QTc","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Palbociclib; Medicine; Letrozole; QT interval; Dosing; Internal medicine; Breast cancer; Clinical trial; Cancer; Pharmacology; Oncology; Metastatic breast cancer; Tamoxifen","score_opus":0.14008148373842555,"score_gpt":0.49721510235534105,"score_spread":0.3571336186169155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592784720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637146,0.0024363028,0.0000037353961,0.0015685139,0.00030002368,0.0010776012,0.000016127246,0.00001126972,0.008214985],"genre_scores_gemma":[0.9977598,0.00015855256,0.000022659377,0.00006189196,0.00029281792,0.0002333865,0.0000025021163,0.00003062819,0.001437713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969879,0.00018974153,0.00023373871,0.00027059522,0.0019685547,0.00034951404],"domain_scores_gemma":[0.9969641,0.00035293112,0.00024031418,0.0012843721,0.0010676776,0.00009062213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016474903,0.00012307195,0.0002881742,0.00011724564,0.00025888986,0.000019415505,0.0004906123,0.00008436777,0.0008423175],"category_scores_gemma":[0.0017763362,0.000083565596,0.000113427806,0.00016948234,0.0006370128,0.00010652414,0.00012943221,0.00044337544,0.00002917227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017389932,0.00027057368,0.017671702,0.0013189228,0.0002506534,0.0000078632065,0.0007057459,0.00014951196,0.6724765,0.00039986448,0.001934756,0.30307493],"study_design_scores_gemma":[0.0033678953,0.00030583583,0.44381586,0.0013252525,0.000059504386,0.0000016509299,0.00006648504,0.000060604438,0.5464215,0.00079818384,0.0037020643,0.00007514607],"about_ca_topic_score_codex":0.0005799029,"about_ca_topic_score_gemma":0.00008813082,"teacher_disagreement_score":0.42614418,"about_ca_system_score_codex":0.00042611288,"about_ca_system_score_gemma":0.00069611415,"threshold_uncertainty_score":0.9222785},"labels":[],"label_agreement":null},{"id":"W2592880966","doi":"10.1158/1538-7445.sabcs16-p4-22-03","title":"Abstract P4-22-03: Palbociclib in combination with endocrine therapy in treatment-naive and previously treated elderly women with HR+, HER2– advanced breast cancer: a pooled analysis from randomized phase 2 and 3 studies","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Palbociclib; Fulvestrant; Medicine; Letrozole; Internal medicine; Breast cancer; Metastatic breast cancer; Cancer; Clinical endpoint; Neutropenia; Oncology; Randomized controlled trial; Placebo; Gastroenterology; Gynecology; Chemotherapy; Estrogen receptor; Tamoxifen; Pathology","score_opus":0.04410407231845639,"score_gpt":0.42231124401593967,"score_spread":0.3782071716974833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592880966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720466,0.022391194,0.0000082173665,0.0023968196,0.000019741065,0.002855717,0.00017954258,0.000039217208,0.00006292352],"genre_scores_gemma":[0.94885373,0.046031497,0.00011327958,0.000047675403,0.00006574609,0.004533134,0.000039969225,0.000057854395,0.00025709506],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970297,0.0003010282,0.00044089815,0.00085883384,0.0005683754,0.0008011431],"domain_scores_gemma":[0.99778014,0.00054427894,0.00030057775,0.0006109314,0.00050253107,0.0002615208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006047475,0.00043529758,0.0018151037,0.00066252373,0.00029443204,0.00012428465,0.00017708143,0.00007810912,0.00020164362],"category_scores_gemma":[0.000088083674,0.0002766118,0.00006576499,0.0007433656,0.0011226458,0.0004825323,0.000054966178,0.0004052376,9.901012e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3924493,0.0008133489,0.17141455,0.000116449446,0.0063336845,0.000364613,0.00843737,0.000087816195,0.0071969796,0.000011558873,0.0000031094337,0.41277122],"study_design_scores_gemma":[0.57328576,0.0034680506,0.41264024,0.0011592787,0.00063526095,0.000023753035,0.0037740998,0.00018169792,0.0039498494,0.00035999974,0.0001203566,0.00040164482],"about_ca_topic_score_codex":0.02496292,"about_ca_topic_score_gemma":0.020114264,"teacher_disagreement_score":0.41236958,"about_ca_system_score_codex":0.0014161698,"about_ca_system_score_gemma":0.00038507508,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W2592886309","doi":"10.1158/1538-7445.sabcs16-p3-02-05","title":"Abstract P3-02-05: Does MRI influence surgical planning more than clinical outcome? A cohort study of breast cancer patients receiving neoadjuvant therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Waterloo; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Neoadjuvant therapy; Breast MRI; Magnetic resonance imaging; Stage (stratigraphy); Cohort; Cancer; Adjuvant therapy; Internal medicine; Oncology; Radiology; Mammography","score_opus":0.08588065825082672,"score_gpt":0.48076604057735645,"score_spread":0.3948853823265297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592886309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640363,0.0011981535,6.8987197e-7,0.0006332227,0.00040794577,0.00090188306,0.0002267578,0.000013684516,0.0002140141],"genre_scores_gemma":[0.9958596,0.0027994502,0.000010972172,0.000042722302,0.0005067976,0.0005528576,0.000020537158,0.0000444709,0.00016255661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968807,0.00021453919,0.00060220726,0.00085226283,0.0008112867,0.00063900964],"domain_scores_gemma":[0.9975256,0.00012530842,0.000346813,0.0010581856,0.0007554928,0.00018862802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010215351,0.000286366,0.0005412989,0.000080410406,0.0006366796,0.000094810355,0.00083124626,0.00018810338,0.000062801],"category_scores_gemma":[0.00017924357,0.00019823405,0.00014864086,0.0001038609,0.0006477649,0.000026234595,0.0006015467,0.00046680256,0.0000039770152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013834663,0.00079526403,0.98479104,0.000032780474,0.0005271503,0.00003603016,0.00044659566,0.00007796637,0.001106962,0.0000010180803,0.00057849067,0.0102232145],"study_design_scores_gemma":[0.003503594,0.00042630095,0.99264693,0.00015520123,0.000027146114,0.000003184207,0.0004248387,0.0000029513244,0.0017864759,0.000006868251,0.00079005706,0.00022647044],"about_ca_topic_score_codex":0.008889527,"about_ca_topic_score_gemma":0.0017431605,"teacher_disagreement_score":0.009996744,"about_ca_system_score_codex":0.00013194092,"about_ca_system_score_gemma":0.00026660442,"threshold_uncertainty_score":0.99771035},"labels":[],"label_agreement":null},{"id":"W2592927667","doi":"10.1158/1538-7445.sabcs16-p1-01-01","title":"Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Circulating tumor cell; Oncology; Progression-free survival; Breast cancer; Cancer; Adjuvant; Clinical trial; Chemotherapy; Metastasis","score_opus":0.11514751256542281,"score_gpt":0.4960428507092594,"score_spread":0.3808953381438366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592927667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920654,0.00057430513,0.0000053624585,0.0024440999,0.00048205582,0.0024693115,0.0013041681,0.0000187641,0.00063651643],"genre_scores_gemma":[0.99798447,0.0005628152,0.00006149961,0.00022335832,0.00039189702,0.0003969651,0.000019548255,0.00006544465,0.0002940112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957973,0.00046033828,0.0010743664,0.00067935634,0.0012593898,0.00072925264],"domain_scores_gemma":[0.9964548,0.0009938411,0.00067400147,0.0010094715,0.0006096523,0.0002582529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016385696,0.00031331132,0.00092525594,0.00017564702,0.0003593535,0.00008086625,0.00053103274,0.000085383814,0.00039776647],"category_scores_gemma":[0.00083348964,0.00020626739,0.00021629535,0.00030963673,0.0012219124,0.00033194103,0.00028080895,0.0012266011,0.0000045679485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077613175,0.0022735232,0.8652611,0.00017356448,0.00041911824,0.00006467776,0.0007626403,0.000029915731,0.0019449915,0.000009652568,0.00024069002,0.051206946],"study_design_scores_gemma":[0.146301,0.0005318903,0.84969544,0.00054930156,0.000047822632,0.000012154922,0.0002299836,0.000045804012,0.0018629848,0.00011608428,0.00042935327,0.00017816598],"about_ca_topic_score_codex":0.006683263,"about_ca_topic_score_gemma":0.00059427053,"teacher_disagreement_score":0.06868782,"about_ca_system_score_codex":0.00041391488,"about_ca_system_score_gemma":0.0007413612,"threshold_uncertainty_score":0.99993134},"labels":[],"label_agreement":null},{"id":"W2592994249","doi":"10.1158/1538-7445.sabcs16-p4-22-06","title":"Abstract P4-22-06: Treatment postprogression in women with endocrine-resistant HR+/HER2- advanced breast cancer who received palbociclib plus fulvestrant in PALOMA-3","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Palbociclib; Fulvestrant; Medicine; Metastatic breast cancer; Internal medicine; Hazard ratio; Breast cancer; Progression-free survival; Cancer; Oncology; Chemotherapy; Placebo; Gynecology; Tamoxifen; Confidence interval; Pathology","score_opus":0.050303170002198555,"score_gpt":0.41754668635269787,"score_spread":0.36724351635049934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592994249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840457,0.0055672918,0.0000027050598,0.0067293444,0.0001395991,0.0021806115,0.00026503127,0.00007445018,0.0009952715],"genre_scores_gemma":[0.9868677,0.006844601,0.0002350339,0.0001210393,0.0003517101,0.004179331,0.000020934543,0.00014630433,0.0012333489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99469316,0.00017933609,0.0006360347,0.0011925352,0.0012877784,0.0020111797],"domain_scores_gemma":[0.9969857,0.00016605525,0.0002993352,0.0014731621,0.00047171855,0.0006040607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006308164,0.00057461445,0.0010581805,0.00052660384,0.00045917038,0.00015940075,0.00062813895,0.00017465769,0.0009257027],"category_scores_gemma":[0.00007978477,0.00042365037,0.00009265084,0.00056939595,0.0008335046,0.00055374054,0.00015601351,0.0010701827,0.000026322323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087089576,0.0009949948,0.14186561,0.000719488,0.0003507771,0.0034552386,0.0050334106,0.0008152225,0.17425863,0.00004814939,0.00009595171,0.58527297],"study_design_scores_gemma":[0.022172,0.0013546643,0.94865525,0.0053851814,0.000024467423,0.0000812374,0.001881893,0.000045041947,0.012678602,0.00019475218,0.0070000477,0.00052686123],"about_ca_topic_score_codex":0.0139015475,"about_ca_topic_score_gemma":0.013434012,"teacher_disagreement_score":0.80678964,"about_ca_system_score_codex":0.007236811,"about_ca_system_score_gemma":0.0021543705,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W2593132556","doi":"10.1158/1538-7445.sabcs16-p6-12-16","title":"Abstract P6-12-16: Delivery and anti-tumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) in metastatic xenograft models of triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metal complexes synthesis and properties","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Irinotecan; Medicine; Breast cancer; Triple negative; Oncology; Cancer; Metastatic breast cancer; Internal medicine; Cancer research; Colorectal cancer","score_opus":0.20234659260184112,"score_gpt":0.4046409164559133,"score_spread":0.2022943238540722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593132556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412453,0.0027583921,0.000009931523,0.0005988252,0.00007607724,0.0006765572,0.00030342911,0.000008017353,0.0014442501],"genre_scores_gemma":[0.9977172,0.0015715617,0.00009480168,0.000019101795,0.00007030888,0.0001303032,0.0000019105073,0.000030280456,0.00036454643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997718,0.0002358985,0.0003999091,0.0003964636,0.0007531283,0.0004966057],"domain_scores_gemma":[0.998227,0.00022670144,0.00026743425,0.00061011553,0.00049071334,0.00017802877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010677206,0.0001978841,0.00079291285,0.00032423064,0.00021460003,0.000049946855,0.00032898106,0.00006097895,0.00048237885],"category_scores_gemma":[0.00022761436,0.00015122259,0.00011256167,0.00018533741,0.0009127769,0.00037849825,0.00022695969,0.00047645535,0.0000023527464],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044326955,0.00052271783,0.029800482,0.0020299267,0.0003646509,0.00004588664,0.0012574509,0.00010956966,0.9075904,0.00008501142,0.00029443708,0.053466793],"study_design_scores_gemma":[0.0019530917,0.000263621,0.5135874,0.0011281121,0.00006895415,0.000015790984,0.00028686336,0.0010704199,0.48104608,0.00032909284,0.000080121026,0.00017046466],"about_ca_topic_score_codex":0.06170559,"about_ca_topic_score_gemma":0.0074381875,"teacher_disagreement_score":0.4837869,"about_ca_system_score_codex":0.00018674045,"about_ca_system_score_gemma":0.0007066717,"threshold_uncertainty_score":0.9445426},"labels":[],"label_agreement":null},{"id":"W2593142478","doi":"10.1158/1538-7445.sabcs16-p2-08-02","title":"Abstract P2-08-02: Progression-free survival results in patient subgroups from a Phase 3 randomized trial of fulvestrant 500 mg vs anastrozole for hormone receptor-positive advanced breast cancer (FALCON)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anastrozole; Fulvestrant; Medicine; Internal medicine; Clinical endpoint; Hazard ratio; Oncology; Metastatic breast cancer; Breast cancer; Progression-free survival; Randomized controlled trial; Cancer; Estrogen receptor; Tamoxifen; Confidence interval; Chemotherapy","score_opus":0.048925185894192355,"score_gpt":0.4243854917778676,"score_spread":0.37546030588367524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593142478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682123,0.003519246,0.00012835472,0.0069492864,0.0008730391,0.008442379,0.0115365125,0.00005192475,0.0002869568],"genre_scores_gemma":[0.98913604,0.001889905,0.0014043453,0.000052887965,0.0011202686,0.0057772924,0.00037197614,0.00011324162,0.00013404897],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941031,0.0004437886,0.0013590083,0.0011133208,0.001736371,0.0012444311],"domain_scores_gemma":[0.9940842,0.001447574,0.0009313138,0.0017039168,0.0013588695,0.00047412186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025384894,0.0004959966,0.0018790928,0.0003777785,0.00044376397,0.00010061804,0.0008775282,0.0002610248,0.0003054218],"category_scores_gemma":[0.0016205184,0.00040261346,0.00040464694,0.00034453633,0.0014373244,0.00055282953,0.0002781275,0.00097145163,0.0000073301535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7204437,0.00096116576,0.00013779549,0.000121698744,0.0003451331,0.000048035185,0.0009899647,0.000037186295,0.08671026,0.000034971414,0.00032488888,0.1898452],"study_design_scores_gemma":[0.93065906,0.002658262,0.010330671,0.00238008,0.000108681015,0.0000054362204,0.00066193566,0.0001135661,0.05064107,0.0005314855,0.0014930853,0.00041667017],"about_ca_topic_score_codex":0.0071724453,"about_ca_topic_score_gemma":0.0015416088,"teacher_disagreement_score":0.21021535,"about_ca_system_score_codex":0.00095627294,"about_ca_system_score_gemma":0.001385605,"threshold_uncertainty_score":0.9998426},"labels":[],"label_agreement":null},{"id":"W2593195084","doi":"10.1158/1538-7445.sabcs16-p1-11-01","title":"Abstract P1-11-01: The effect of close and positive surgical margins on 10-year local recurrence and survival outcomes in women treated with breast conserving surgery plus adjuvant radiotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Breast-conserving surgery; Adjuvant radiotherapy; Radiation therapy; Surgery; Overall survival; Breast cancer; Adjuvant; General surgery; Oncology; Mastectomy; Internal medicine; Cancer","score_opus":0.022727646638451324,"score_gpt":0.3472049528725891,"score_spread":0.3244773062341378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593195084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965623,0.0017349668,9.1930326e-7,0.00096772774,0.000031831023,0.00032830003,0.00019988969,0.0000034566099,0.00017058656],"genre_scores_gemma":[0.99741566,0.0022528407,0.0000024901117,0.000013861462,0.000056839566,0.00014850903,0.000012690989,0.000019035555,0.00007808706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985313,0.00027735115,0.00014162756,0.00039716135,0.00026214175,0.00039042032],"domain_scores_gemma":[0.99877024,0.00058678706,0.000079424884,0.00038718394,0.00008578898,0.00009056458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080349593,0.00018588055,0.0004133515,0.00006479986,0.0002459537,0.000050778774,0.00017741848,0.000081524784,0.000028608141],"category_scores_gemma":[0.000070997114,0.0001089756,0.00003847312,0.000071433125,0.001040174,0.0000093602375,0.00014069384,0.0001688793,6.1405876e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01045367,0.00006178601,0.96278566,0.000079852376,0.0002758092,0.00008284808,0.00023981044,0.00000810264,0.0018838636,0.000012074362,0.00018376825,0.023932757],"study_design_scores_gemma":[0.002966555,0.00048769527,0.98615265,0.00022617541,0.000010047026,0.000021150674,0.00018073988,0.000005678089,0.009610757,0.0000031601132,0.00020873423,0.00012664883],"about_ca_topic_score_codex":0.0037920077,"about_ca_topic_score_gemma":0.0015415654,"teacher_disagreement_score":0.023806108,"about_ca_system_score_codex":0.00015435765,"about_ca_system_score_gemma":0.00015357674,"threshold_uncertainty_score":0.57324064},"labels":[],"label_agreement":null},{"id":"W2593203574","doi":"10.1158/1538-7445.sabcs16-p6-07-06","title":"Abstract P6-07-06: Effect of serum biomarkers (activin A, CAIX, HER2, TIMP-1, and uPA) on outcome in HER2+ metastatic breast cancer patients treated in first line with lapatinib or trastuzumab combined with taxane: CCTG MA.31","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lapatinib; Trastuzumab; Internal medicine; Metastatic breast cancer; Taxane; Breast cancer; Univariate analysis; Proportional hazards model; Multivariate analysis; Cancer; Oncology; Gastroenterology","score_opus":0.07355459369102431,"score_gpt":0.430158884603077,"score_spread":0.3566042909120527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593203574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915389,0.00020665867,5.6152805e-7,0.00255388,0.000068062305,0.0039407467,0.00085872965,0.00003238036,0.0008001211],"genre_scores_gemma":[0.9966229,0.0004968249,0.000027750233,0.000043002972,0.000062713916,0.0015390242,0.000052925185,0.00014388729,0.0010109342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99431735,0.00048450712,0.00074611657,0.0010331435,0.0020414863,0.0013774148],"domain_scores_gemma":[0.9964657,0.000928665,0.00035630833,0.001137796,0.0005713365,0.00054018886],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021353364,0.000554463,0.0013835906,0.0009122474,0.0003153496,0.00014637197,0.0006053312,0.00020169368,0.0010174806],"category_scores_gemma":[0.000604101,0.0003582338,0.000080574624,0.0010705733,0.0010277521,0.00031401985,0.00019634188,0.0014799117,0.000027267548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045296572,0.0010744808,0.92530483,0.002624019,0.00039538057,0.0007010936,0.00047982912,0.00006847141,0.00043506434,0.0000019860502,0.0005442973,0.023073949],"study_design_scores_gemma":[0.025096033,0.009680797,0.95423645,0.0044372533,0.000080521386,0.000024596493,0.00016980356,0.00020404455,0.005522427,0.0000030957244,0.00017704394,0.00036790685],"about_ca_topic_score_codex":0.063794084,"about_ca_topic_score_gemma":0.111325696,"teacher_disagreement_score":0.04753161,"about_ca_system_score_codex":0.0019528458,"about_ca_system_score_gemma":0.0015701492,"threshold_uncertainty_score":0.99989575},"labels":[],"label_agreement":null},{"id":"W2593264550","doi":"10.1158/1538-7445.sabcs16-p4-19-02","title":"Abstract P4-19-02: Young women with early stage breast cancer and their supportive care needs: Results from a regional survey","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Breast cancer; Needs assessment; Distress; Medicine; Family medicine; Social support; Cancer; Health care; Quality of life (healthcare); Gerontology; Nursing; Psychology; Clinical psychology; Internal medicine","score_opus":0.21521851305199888,"score_gpt":0.43729361002985434,"score_spread":0.22207509697785546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593264550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684686,0.0020243947,0.000003243368,0.002384643,0.00009910151,0.0005451736,0.005881934,0.000032934036,0.0021817395],"genre_scores_gemma":[0.9959374,0.00124334,0.000019980838,0.00020816072,0.00052277575,0.00026330503,0.00011747328,0.000043651304,0.0016438847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968877,0.00011860013,0.000301926,0.0006744248,0.0010758766,0.00094150007],"domain_scores_gemma":[0.9967026,0.00025075188,0.00020893088,0.00090787583,0.0012597374,0.00067007844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013147698,0.00026202778,0.00044476884,0.00018108176,0.00075007736,0.00032784548,0.00046728196,0.00014922328,0.00042472634],"category_scores_gemma":[0.00028118823,0.00018741567,0.000045083616,0.00027203833,0.00075706455,0.00043634526,0.00021689104,0.0008433048,0.0000139854055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018665554,0.000038227565,0.9391824,0.00013038538,0.00029343113,0.00037492297,0.022439048,0.0000115153225,0.0028174673,0.0000146842485,0.004738634,0.011293735],"study_design_scores_gemma":[0.0029636603,0.00033808852,0.97829515,0.0007712668,0.000014452472,0.000024307032,0.014495566,0.000007231918,0.0007393472,0.00002853664,0.002097814,0.00022455644],"about_ca_topic_score_codex":0.47118855,"about_ca_topic_score_gemma":0.06228759,"teacher_disagreement_score":0.40890095,"about_ca_system_score_codex":0.0010949136,"about_ca_system_score_gemma":0.0020123234,"threshold_uncertainty_score":0.9548232},"labels":[],"label_agreement":null},{"id":"W2593317530","doi":"10.1158/1538-7445.sabcs16-p1-02-03","title":"Abstract P1-02-03: Circulating inflammatory markers, growth factors, and tumor associated antigens in women with early stage breast cancer receiving neoadjuvant metformin","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; CancerCare Manitoba; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; Statistics Canada","funders":"","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Cancer; Diabetes mellitus; Endocrinology; Hyperinsulinemia; Oncology; Inflammatory breast cancer; Insulin; Insulin resistance","score_opus":0.027736206813125837,"score_gpt":0.3205716767795887,"score_spread":0.29283546996646287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593317530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98039067,0.018405732,0.0000013516996,0.000046717698,0.000131429,0.0003827643,0.00029740512,0.000013687373,0.0003302415],"genre_scores_gemma":[0.9786068,0.020518994,0.000014396237,0.000050618743,0.0002671508,0.00024383879,0.000019028013,0.00006189045,0.0002172839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973403,0.00015442149,0.0003009112,0.0006443261,0.00052437553,0.0010356382],"domain_scores_gemma":[0.9985566,0.000048607766,0.00024604134,0.0005537537,0.0003192973,0.00027568356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014554879,0.00027395508,0.00037319647,0.00014576563,0.0005092894,0.00026615575,0.00046066288,0.00017487418,0.0002316667],"category_scores_gemma":[0.0002660639,0.00023034847,0.00004673736,0.00014717468,0.0003508373,0.000057508016,0.00025804254,0.0005084157,0.0000025050826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044132525,0.000041736133,0.86461645,0.0001471786,0.00019007592,0.000048785565,0.00071049324,0.00001571632,0.10005236,0.000010156688,0.00029960266,0.033426125],"study_design_scores_gemma":[0.0010827627,0.00008337322,0.96932393,0.00029756146,0.000009421436,0.0000023552088,0.00052497914,0.000010961262,0.02474414,0.000022461663,0.0035699802,0.00032809682],"about_ca_topic_score_codex":0.0077103125,"about_ca_topic_score_gemma":0.0055374363,"teacher_disagreement_score":0.104707465,"about_ca_system_score_codex":0.00032656317,"about_ca_system_score_gemma":0.0006618593,"threshold_uncertainty_score":0.99889743},"labels":[],"label_agreement":null},{"id":"W2593342009","doi":"10.1158/1538-7445.sabcs16-p5-03-09","title":"Abstract P5-03-09: A high specificity and sensitivity qPCR Assay for HER2, ER and PR gene expression in breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Breast cancer; Medicine; Cancer; Cancer research; Molecular biology; Oncology; Internal medicine; Biology","score_opus":0.03669206895460214,"score_gpt":0.381909945050108,"score_spread":0.34521787609550586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593342009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969346,0.00038775548,0.00037124738,0.0010540561,0.00003488183,0.0006032129,0.00046814515,0.000005987741,0.0001401247],"genre_scores_gemma":[0.9967012,0.0017819386,0.0005242776,0.0000583183,0.00016423623,0.0005331777,0.000078213634,0.00001780112,0.00014082971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890417,0.000081509635,0.00012232586,0.00047323422,0.00011963899,0.00029910327],"domain_scores_gemma":[0.9992231,0.000025953113,0.00006908376,0.00039453834,0.0001930515,0.000094285104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057293056,0.0001131312,0.00013165921,0.000040018243,0.00032970615,0.000060344995,0.00012413715,0.00018905062,0.00001775743],"category_scores_gemma":[0.00006320708,0.000099218356,0.000027720322,0.000032226042,0.0002637458,0.0000075892076,0.00027220842,0.00017449589,7.9681394e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014643984,0.00007420679,0.055331144,0.000031615837,0.000011633449,0.0000027121207,0.0000125961715,0.000001591409,0.93305707,0.00004085555,0.0019166663,0.009373458],"study_design_scores_gemma":[0.0005088677,0.000053587584,0.483248,0.00004357918,0.0000032043567,0.0000028855775,0.000006965071,0.000016833606,0.51012045,0.00015667168,0.005720369,0.000118618824],"about_ca_topic_score_codex":0.001314077,"about_ca_topic_score_gemma":0.0007689216,"teacher_disagreement_score":0.42791685,"about_ca_system_score_codex":0.000038144055,"about_ca_system_score_gemma":0.00007250547,"threshold_uncertainty_score":0.4046007},"labels":[],"label_agreement":null},{"id":"W2593375333","doi":"10.1158/1538-7445.sabcs16-p3-03-13","title":"Abstract P3-03-13: Chronic inhibition of signal transducer and activator of transcription 3/5 in treatment-resistant human breast cancer cell subtypes: Convergence on the reactive oxyten species/SUMOylation pathway and its effects on xCT expression and system xc- activity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"SUMO protein; STAT5; STAT3; STAT protein; Biology; Phosphorylation; Cancer research; Cancer cell; Cell biology; Chemistry; Biochemistry; Cancer; Gene","score_opus":0.051982429336635196,"score_gpt":0.32968430945634586,"score_spread":0.27770188011971064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593375333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955462,0.0016653935,0.0000037616894,0.00030301668,0.000065808774,0.0015590062,0.00023843019,0.000011852543,0.0006065364],"genre_scores_gemma":[0.9978905,0.0016430854,0.0000011874818,0.00000612199,0.000107935535,0.00025897057,0.000009372117,0.00003108843,0.000051774517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981593,0.00023983841,0.00024676303,0.00048386763,0.0005718672,0.0002983937],"domain_scores_gemma":[0.998895,0.0002128153,0.00023512216,0.00034919416,0.00018084825,0.00012704167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049315114,0.000219164,0.00039485496,0.00016506565,0.00028987468,0.000034028784,0.000079849175,0.00017260354,0.00006818399],"category_scores_gemma":[0.000023252067,0.00015823983,0.00005920367,0.00011868057,0.0002644125,0.00024377317,0.000025439276,0.000415089,9.386585e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043422678,0.00018865727,0.0007574357,0.001548229,0.0000553757,0.00002341099,0.0009753188,0.000015190441,0.9875049,0.00010554822,0.000010473024,0.0044732196],"study_design_scores_gemma":[0.0028467337,0.0010918176,0.21614216,0.003545723,0.0000388279,0.0000030805236,0.00020476214,0.00010918878,0.7758929,0.000008276559,0.000016916592,0.00009956716],"about_ca_topic_score_codex":0.0035153874,"about_ca_topic_score_gemma":0.0014220407,"teacher_disagreement_score":0.21538474,"about_ca_system_score_codex":0.0014033739,"about_ca_system_score_gemma":0.0003400287,"threshold_uncertainty_score":0.6452833},"labels":[],"label_agreement":null},{"id":"W2593410709","doi":"10.1158/1538-7445.sabcs16-p5-08-05","title":"Abstract P5-08-05: Prospective family cohort analyses of gene-environment interactions in breast cancer: Body mass index","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Body mass index; Medicine; Oncology; Cancer; Internal medicine; Prospective cohort study","score_opus":0.12291374459004159,"score_gpt":0.47952237456396263,"score_spread":0.35660862997392107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593410709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991946,0.0010169016,0.000024141973,0.0014876446,0.0002609324,0.00089053006,0.00035200396,0.000014108215,0.0040077306],"genre_scores_gemma":[0.99265534,0.005379148,0.000024032528,0.000037402366,0.00034130045,0.0005536853,0.000012841926,0.00003530208,0.0009609761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768394,0.000048876853,0.00037427695,0.0005071101,0.0008692087,0.00051658845],"domain_scores_gemma":[0.9984408,0.00006190002,0.00019049531,0.0008238087,0.00026110158,0.00022190106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046656374,0.00018245171,0.00046965934,0.00036938657,0.0002614321,0.00006676779,0.00033186845,0.00008394264,0.0014774519],"category_scores_gemma":[0.000046566176,0.00015669633,0.00012644562,0.0002169055,0.0004795221,0.0002279415,0.00011822002,0.0008509566,0.000030044197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061194756,0.00016281568,0.8140363,0.00007490245,0.00023053122,0.000050518775,0.00014596169,0.00016967006,0.17876598,0.000009246937,0.0013675038,0.004374623],"study_design_scores_gemma":[0.0012619543,0.000070474925,0.9718844,0.0002977904,0.00005324308,0.000006948663,0.00038505817,0.0001249527,0.023959966,0.000047830483,0.0017689165,0.00013842496],"about_ca_topic_score_codex":0.09904084,"about_ca_topic_score_gemma":0.002915375,"teacher_disagreement_score":0.15784815,"about_ca_system_score_codex":0.0017700625,"about_ca_system_score_gemma":0.0006812767,"threshold_uncertainty_score":0.9994353},"labels":[],"label_agreement":null},{"id":"W2593426794","doi":"10.1158/1538-7445.sabcs16-p5-09-01","title":"Abstract P5-09-01: Plasma osteoprotegerin and the risk of breast cancer in <i>BRCA1</i> and <i>BRCA2</i> mutation carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Osteoprotegerin; Medicine; Internal medicine; Oncology; Cancer; Mutation; Cancer research; Genetics; Biology; Gene","score_opus":0.018152553846116845,"score_gpt":0.33223896503015277,"score_spread":0.3140864111840359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593426794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869942,0.010888666,0.000001991535,0.00071777805,0.00007518128,0.00035657673,0.0004813025,0.0000023792525,0.00048191994],"genre_scores_gemma":[0.9882941,0.011183618,0.000009391276,0.000030468163,0.0001534472,0.00018976766,0.0000078017365,0.000014062467,0.00011731575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892586,0.00013395725,0.0001562134,0.00030255312,0.000221645,0.00025977756],"domain_scores_gemma":[0.9991997,0.000045275294,0.000110228044,0.0004119295,0.0001256864,0.00010720547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070918247,0.00010553466,0.00016870984,0.00004515917,0.00028214746,0.00008251587,0.00022938385,0.00008946467,0.000029842835],"category_scores_gemma":[0.0002056276,0.000075428026,0.000038831586,0.000058873346,0.000963841,0.0000143481075,0.00019635927,0.00019610369,8.1677854e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006337614,0.00010145116,0.28966075,0.00046756375,0.000273893,0.000026182164,0.0010826226,0.0002281789,0.5135693,0.00035994727,0.0018600322,0.18603246],"study_design_scores_gemma":[0.0042882594,0.00004555803,0.89649147,0.00008266822,0.000035693905,0.000008541828,0.0004447022,0.00005898192,0.09551193,0.00035163696,0.0025169419,0.0001636454],"about_ca_topic_score_codex":0.010634319,"about_ca_topic_score_gemma":0.0039534434,"teacher_disagreement_score":0.6068307,"about_ca_system_score_codex":0.00001546358,"about_ca_system_score_gemma":0.0002260627,"threshold_uncertainty_score":0.995954},"labels":[],"label_agreement":null},{"id":"W2593434036","doi":"10.1158/1538-7445.sabcs16-p3-12-01","title":"Abstract P3-12-01: Value-based approach to treatment of HER2-positive breast cancer: Examining the evidence","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pertuzumab; Trastuzumab; Capecitabine; Lapatinib; Metastatic breast cancer; Nice; Breast cancer; Oncology; Internal medicine; Regimen; Cancer; Cost effectiveness; Colorectal cancer","score_opus":0.24476797528306762,"score_gpt":0.46907792851226093,"score_spread":0.2243099532291933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593434036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598462,0.01036104,0.0006126073,0.019520095,0.0003107576,0.0031051592,0.00036372908,0.00006824749,0.0058121914],"genre_scores_gemma":[0.9947484,0.0010632575,0.0006397467,0.00024166626,0.0006959176,0.0015853931,0.0000064493825,0.00006525088,0.00095392135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969062,0.00016659629,0.00031638768,0.0006731886,0.0011587413,0.00077884295],"domain_scores_gemma":[0.99676174,0.0005206559,0.00020292707,0.001566837,0.0006176943,0.00033015673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086499867,0.00028089806,0.0005163796,0.00017646658,0.0007356122,0.00010692457,0.0007171687,0.000097843935,0.0002787635],"category_scores_gemma":[0.00017098585,0.00018474442,0.00012426908,0.00027043535,0.0008876861,0.00023248189,0.00013550706,0.0003967469,0.000022040796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010193211,0.0010225092,0.057231016,0.00063322484,0.00067441474,0.000078133366,0.005375427,0.0038842259,0.121724874,0.0002470744,0.00053800934,0.7983979],"study_design_scores_gemma":[0.0032577468,0.0013707351,0.89815795,0.003287243,0.00012181712,0.00003973764,0.0011892777,0.0003348156,0.08671444,0.00007368781,0.005125689,0.0003268857],"about_ca_topic_score_codex":0.014880006,"about_ca_topic_score_gemma":0.00039453054,"teacher_disagreement_score":0.8409269,"about_ca_system_score_codex":0.001645974,"about_ca_system_score_gemma":0.0014199552,"threshold_uncertainty_score":0.99167997},"labels":[],"label_agreement":null},{"id":"W2593524310","doi":"10.1158/1538-7445.sabcs16-p2-05-30","title":"Abstract P2-05-30: OncotypeDX® for breast cancer: A multigene assay that makes a difference?","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; Hôpital Charles-Le Moyne","funders":"","keywords":"Concordance; Medicine; Guideline; Breast cancer; Oncology; Internal medicine; Chemotherapy; Cancer; Adjuvant chemotherapy; Gynecology; Pathology","score_opus":0.1086414101150585,"score_gpt":0.4304310550306251,"score_spread":0.3217896449155666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593524310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818546,0.0066933464,0.000082643346,0.0059907874,0.00063652836,0.0009470786,0.0024411727,0.000028366476,0.0013254682],"genre_scores_gemma":[0.9897712,0.0043377527,0.00010430546,0.000119546734,0.0012355023,0.0018851546,0.0000544706,0.0000584931,0.0024335918],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778616,0.00006666797,0.00017590032,0.00072722527,0.0004310811,0.0008129825],"domain_scores_gemma":[0.9981278,0.00008438708,0.00013660165,0.00097388844,0.0004871642,0.00019014445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046939583,0.0002704349,0.00029992854,0.000067094705,0.001108738,0.00018821059,0.00075824,0.0001959809,0.00031111826],"category_scores_gemma":[0.00014973324,0.00022655248,0.0001513562,0.00005368725,0.0005070089,0.000011270511,0.0003948212,0.00023565619,0.000025563977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002043243,0.00038101352,0.160876,0.00034626498,0.001037744,0.000031205054,0.00042337997,0.000023900251,0.47502282,0.00010311422,0.034217108,0.3254942],"study_design_scores_gemma":[0.0022562044,0.00013073588,0.8485886,0.00017166793,0.000043098473,0.000010470942,0.00019080358,0.000016312522,0.12065742,0.00017154517,0.027397012,0.00036616583],"about_ca_topic_score_codex":0.0050471155,"about_ca_topic_score_gemma":0.0057797064,"teacher_disagreement_score":0.68771255,"about_ca_system_score_codex":0.00023367628,"about_ca_system_score_gemma":0.0005412498,"threshold_uncertainty_score":0.92385423},"labels":[],"label_agreement":null},{"id":"W2593632499","doi":"10.1158/1538-7445.sabcs16-pd6-05","title":"Abstract PD6-05: A prospective evaluation of clinical outcomes in women with pregnancy-associated breast cancer (PABC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Pregnancy; Proportional hazards model; Prospective cohort study; Gynecology; Multivariate analysis; Internal medicine; Cancer; Obstetrics; Oncology; Biology","score_opus":0.246261723990198,"score_gpt":0.5532727662263079,"score_spread":0.30701104223611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593632499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939636,0.0005700434,3.998347e-7,0.0016384921,0.00021035015,0.0015699859,0.0002031037,0.000015976611,0.0018280569],"genre_scores_gemma":[0.9968135,0.0009551899,0.000006316246,0.00003315909,0.00015666535,0.0013034642,0.0000044011363,0.000033385677,0.0006939286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965497,0.00017118928,0.00050094206,0.0004765924,0.0017124481,0.0005891241],"domain_scores_gemma":[0.99698263,0.00018106341,0.00033953693,0.0006738332,0.0016029137,0.00022000879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033273739,0.00015915149,0.0006735951,0.00018669765,0.00017731512,0.000051958203,0.00027914482,0.00016117658,0.0010719635],"category_scores_gemma":[0.00093931775,0.00011285626,0.000083179635,0.00026216632,0.00048400293,0.00020493625,0.000094629286,0.0007994485,0.0000074256877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021780373,0.00044007742,0.92248636,0.00009454133,0.00028135572,0.00002036439,0.001125495,0.000018601613,0.0003267035,0.000008324913,0.00034994303,0.07267017],"study_design_scores_gemma":[0.007578695,0.0003902931,0.9891593,0.0017401974,0.00005705215,0.0000016560456,0.00030922444,0.00006616367,0.00032755386,0.00013616208,0.00010972377,0.00012397181],"about_ca_topic_score_codex":0.026424197,"about_ca_topic_score_gemma":0.018731613,"teacher_disagreement_score":0.0725462,"about_ca_system_score_codex":0.0019771636,"about_ca_system_score_gemma":0.0030034056,"threshold_uncertainty_score":0.9998412},"labels":[],"label_agreement":null},{"id":"W2593744678","doi":"10.1158/1538-7445.sabcs16-p5-14-05","title":"Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Triple-negative breast cancer; Anthracycline; Taxane; Fluorouracil; Randomized controlled trial; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","score_opus":0.28977627776189213,"score_gpt":0.5348622269796955,"score_spread":0.2450859492178034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593744678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9421445,0.029288577,0.0000026907608,0.01798848,0.00033803115,0.0053417115,0.0007366014,0.0000185857,0.0041407975],"genre_scores_gemma":[0.98065615,0.006689601,0.000016159445,0.00011402454,0.00036928518,0.0055227345,0.000022445207,0.000027569027,0.0065820296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946867,0.0015360244,0.0015916957,0.0005113594,0.0010556524,0.0006185513],"domain_scores_gemma":[0.9931241,0.003952015,0.0008936574,0.00081001665,0.000969401,0.0002508014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015302081,0.0002793737,0.011523407,0.001302603,0.0001941267,0.00008652464,0.0004036171,0.00016214061,0.020671705],"category_scores_gemma":[0.0021344246,0.0001658056,0.0041759214,0.0006849687,0.00063593365,0.00013939252,0.00009411166,0.0005594815,0.000015951648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51184154,0.0006149035,0.010440876,0.00013415872,0.4525256,0.0001546351,0.00060417264,0.0001032704,0.017533774,0.00012112275,0.0035339824,0.0023920166],"study_design_scores_gemma":[0.58495486,0.00015739298,0.0789163,0.000063386644,0.3315175,0.0000033766466,0.000047109963,0.00018122568,0.0032570076,0.000115960116,0.00059582473,0.00019006793],"about_ca_topic_score_codex":0.058821496,"about_ca_topic_score_gemma":0.009692314,"teacher_disagreement_score":0.1210081,"about_ca_system_score_codex":0.0004213551,"about_ca_system_score_gemma":0.00095086294,"threshold_uncertainty_score":0.98022354},"labels":[],"label_agreement":null},{"id":"W2593748288","doi":"10.1158/1538-7445.sabcs16-p5-08-13","title":"Abstract P5-08-13: Phyllodes tumours of the breast: The British Columbia cancer agency experience","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Univariate analysis; Mastectomy; Population; Proportional hazards model; Cancer; Radiation therapy; Internal medicine; Surgical margin; Surgery; Oncology; Multivariate analysis","score_opus":0.08554055566444466,"score_gpt":0.4037896831633827,"score_spread":0.3182491274989381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593748288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560023,0.0030608815,6.2816287e-7,0.0043617683,0.00031914658,0.00053137075,0.00011353488,0.000012422458,0.0059999865],"genre_scores_gemma":[0.9868269,0.0008971841,0.0000048377738,0.00012215953,0.00044643306,0.00037302388,0.0000013065472,0.00002600292,0.011302166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790907,0.000088457964,0.0002151731,0.00033009413,0.0009291592,0.0005280446],"domain_scores_gemma":[0.9978684,0.000069562695,0.00012612114,0.0012552793,0.00051364774,0.00016695862],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062862627,0.00009478353,0.0002246812,0.000022705335,0.0021606928,0.0005577553,0.0010284533,0.00007858563,0.002955412],"category_scores_gemma":[0.00015533679,0.00007396424,0.00013932613,0.00021349522,0.0014192396,0.00012700412,0.0003394747,0.0006207962,0.000015352947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008034646,0.0001184777,0.83766496,0.00014773018,0.000035753936,0.0000638572,0.001161541,0.000002737255,0.033485726,0.000023524393,0.03286848,0.09434686],"study_design_scores_gemma":[0.00049354363,0.000028279652,0.9924316,0.0006762727,0.000019797944,0.00011308636,0.0006533249,0.000010778274,0.002293451,0.00010782235,0.0030874263,0.00008462684],"about_ca_topic_score_codex":0.34825268,"about_ca_topic_score_gemma":0.10836081,"teacher_disagreement_score":0.23989189,"about_ca_system_score_codex":0.00016045175,"about_ca_system_score_gemma":0.0009568918,"threshold_uncertainty_score":0.99913836},"labels":[],"label_agreement":null},{"id":"W2593766912","doi":"10.1158/1538-7445.sabcs16-p3-10-10","title":"Abstract P3-10-10: Planning and implementation of two regional one-stop breast health centres within a large geographic health authority: Outcomes and quality improvements in health service delivery","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health","funders":"","keywords":"Medicine; Breast cancer; Population; Presentation (obstetrics); Cancer; General surgery; Family medicine; Surgery; Internal medicine","score_opus":0.33769741152368044,"score_gpt":0.565483987923851,"score_spread":0.22778657640017058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593766912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611876,0.005372155,0.000010757593,0.03216462,0.000050116756,0.0008735155,0.00028900566,0.000015324125,0.00003687798],"genre_scores_gemma":[0.99589026,0.0014628026,0.0002352822,0.0021197163,0.000077436045,0.000055717268,0.00007303658,0.000016079744,0.000069654634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965681,0.00029784255,0.00076225324,0.00049642584,0.001029714,0.00084565143],"domain_scores_gemma":[0.99803907,0.000102025835,0.00060850923,0.0004061449,0.00035689966,0.00048738305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005769209,0.00016660533,0.0005929784,0.00029070757,0.00073683,0.00008672606,0.00019559092,0.00005771407,0.00012618942],"category_scores_gemma":[0.00006164314,0.00015784691,0.000041999865,0.00023342753,0.00016116054,0.00031706822,0.0002153912,0.00048635443,0.0000013621826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007637402,0.00009369863,0.965173,0.0019530976,0.00006408516,0.0000070937544,0.0034287304,0.0000060700486,0.00022646786,0.00037285115,0.0006462314,0.027264902],"study_design_scores_gemma":[0.004085605,0.00044187965,0.9869038,0.0015215296,0.0000051659836,0.000006867202,0.006343486,0.000066873006,0.000045264365,0.00015001271,0.00032180295,0.00010775281],"about_ca_topic_score_codex":0.4676488,"about_ca_topic_score_gemma":0.12266768,"teacher_disagreement_score":0.3449811,"about_ca_system_score_codex":0.0005607867,"about_ca_system_score_gemma":0.0018627131,"threshold_uncertainty_score":0.89334136},"labels":[],"label_agreement":null},{"id":"W2593998160","doi":"10.1158/0008-5472.can-16-2066","title":"<i>Cyp24a1</i> Attenuation Limits Progression of <i>BrafV600E</i> -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Shriners Hospitals for Children - Canada","funders":"National Institutes of Health; King Abdulaziz City for Science and Technology; Cancer Research UK","keywords":"Papillary thyroid cancer; Cancer; Thyroid cancer; Medicine; Medullary thyroid cancer; Cancer research; Internal medicine; Oncology","score_opus":0.11062930608357449,"score_gpt":0.4237736229790994,"score_spread":0.3131443168955249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593998160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773231,0.0050683403,0.0000023277285,0.014221944,0.00041203652,0.0016563984,0.00011990683,0.000043742984,0.0011521647],"genre_scores_gemma":[0.98759097,0.009383466,0.0001593792,0.00048949633,0.00083498476,0.00083656475,0.000012757694,0.00006615041,0.00062625034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699587,0.0001139029,0.0003729732,0.00071394636,0.0011295866,0.00067374285],"domain_scores_gemma":[0.9974286,0.00018617055,0.0002154819,0.00094113126,0.0007357887,0.00049282546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006475299,0.00028219292,0.0005538944,0.00017286545,0.00058873964,0.00014112449,0.0002622617,0.00017433612,0.00009914366],"category_scores_gemma":[0.00015378947,0.00021686939,0.00010520594,0.0002777183,0.00027260804,0.00020961072,0.00030072042,0.000415882,0.000044468776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081114564,0.00027693345,0.0335219,0.00034574373,0.00014632315,0.000076381104,0.0007976719,0.0000062220874,0.8601776,0.000057632456,0.02261166,0.08117083],"study_design_scores_gemma":[0.0027262613,0.0010051882,0.051487345,0.0016614171,0.00009324277,0.000010851334,0.0001973191,0.000017491288,0.9375238,0.000052803633,0.004995443,0.00022884029],"about_ca_topic_score_codex":0.0017405045,"about_ca_topic_score_gemma":0.0004420724,"teacher_disagreement_score":0.08094199,"about_ca_system_score_codex":0.00041223245,"about_ca_system_score_gemma":0.0006104043,"threshold_uncertainty_score":0.8843677},"labels":[],"label_agreement":null},{"id":"W2594049437","doi":"10.1158/1538-7445.sabcs16-p4-22-08","title":"Abstract P4-22-08: A single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre","funders":"","keywords":"Enzalutamide; Trastuzumab; Medicine; Oncology; Internal medicine; Metastatic breast cancer; Regimen; Cancer; Phases of clinical research; Breast cancer; Clinical endpoint; Prostate cancer; Androgen receptor; Clinical trial","score_opus":0.257187020499096,"score_gpt":0.5508135852009494,"score_spread":0.2936265647018534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594049437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165565,0.0006816967,0.000032535158,0.002305842,0.00010135911,0.004491494,0.00025577878,0.000025426109,0.00045019938],"genre_scores_gemma":[0.9966879,0.0013404196,0.00017459742,0.00004588086,0.00015796488,0.00076707936,0.000007982224,0.00007387461,0.00074433273],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995404,0.00041505866,0.0006585997,0.0009780289,0.0015168154,0.0010274678],"domain_scores_gemma":[0.99647105,0.0007989721,0.00022798977,0.0010253319,0.0007559144,0.00072076014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025226763,0.00034910106,0.0011461427,0.0004343609,0.00037444616,0.00015472273,0.0005054823,0.000092215894,0.0005776803],"category_scores_gemma":[0.000557957,0.00022912849,0.000084084386,0.0006130364,0.000908824,0.00036443947,0.00035956252,0.0011731783,0.000009565855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2011483,0.02921875,0.15319902,0.0011026097,0.0012530583,0.0023574766,0.0019105817,0.00013884171,0.043253943,0.0000067505403,0.00022959345,0.56618106],"study_design_scores_gemma":[0.06269563,0.018313421,0.89957625,0.0026725656,0.00019725712,0.000049771963,0.0017313267,0.00007803757,0.013917338,0.00001518074,0.00037636602,0.00037683724],"about_ca_topic_score_codex":0.005078137,"about_ca_topic_score_gemma":0.0110481065,"teacher_disagreement_score":0.7463772,"about_ca_system_score_codex":0.0010323024,"about_ca_system_score_gemma":0.0030885653,"threshold_uncertainty_score":0.93435884},"labels":[],"label_agreement":null},{"id":"W2594101301","doi":"10.1158/1538-7445.sabcs16-p4-05-02","title":"Abstract P4-05-02: Conditional inactivation of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) in the mouse mammary epithelium alters mammary gland development","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"CYP24A1; Mammary gland; Endocrinology; Conditional gene knockout; Internal medicine; Calcitriol receptor; Knockout mouse; Biology; Vitamin D and neurology; Epithelium; Carcinogenesis; Cancer research; Cancer; Breast cancer; Receptor; Medicine; Gene; Phenotype; Biochemistry; Genetics","score_opus":0.07872674350119241,"score_gpt":0.3903915947019546,"score_spread":0.3116648512007622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594101301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97388315,0.00048626246,0.00005446776,0.02144974,0.00014212774,0.0013338916,0.00006327985,0.000016528025,0.0025705425],"genre_scores_gemma":[0.9951779,0.0007019479,0.000114323295,0.00024757875,0.00020651426,0.000651062,0.000046786034,0.000027395696,0.0028264492],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99602884,0.00033871838,0.00043362562,0.00043909735,0.0020376479,0.000722051],"domain_scores_gemma":[0.99727935,0.00056464056,0.00019198422,0.0013396852,0.00047823892,0.00014610999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029495512,0.00021401973,0.00034544108,0.00033229272,0.00094559486,0.00013343678,0.0014025067,0.00012400359,0.00009017332],"category_scores_gemma":[0.0013104602,0.00012628207,0.00010164859,0.00035471076,0.00094769686,0.00038565774,0.00078875193,0.0011764026,0.000026263542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008154796,0.0021928495,0.15615447,0.003179606,0.0011434731,0.0011587783,0.012520254,0.00014580008,0.6672925,0.005261989,0.11854884,0.031585976],"study_design_scores_gemma":[0.00193088,0.00011804694,0.861881,0.00035074016,0.000009711809,0.000020995389,0.0004873817,0.00006258417,0.12845737,0.0007471211,0.0057951757,0.00013899204],"about_ca_topic_score_codex":0.0010972937,"about_ca_topic_score_gemma":0.000579422,"teacher_disagreement_score":0.7057265,"about_ca_system_score_codex":0.0006869377,"about_ca_system_score_gemma":0.0013053793,"threshold_uncertainty_score":0.72728467},"labels":[],"label_agreement":null},{"id":"W2594130610","doi":"10.1158/1538-7445.sabcs16-p3-17-01","title":"Abstract P3-17-01: Long-term rates of breast preservation after breast-conserving therapy for ductal carcinoma in situ","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; Institute for Clinical Evaluative Sciences; Juravinski Hospital; London Health Sciences Centre; Kingston General Hospital; Mount Sinai Hospital; Thunder Bay Regional Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Breast-conserving surgery; Breast cancer; Mastectomy; Population; Radiation therapy; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.07064292411429103,"score_gpt":0.4016608059122232,"score_spread":0.3310178817979322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594130610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935704,0.0034665558,0.000007732987,0.0017197208,0.00009183129,0.0005965982,0.00026978977,0.0000044269436,0.0002729593],"genre_scores_gemma":[0.9976512,0.00068765046,0.000032998312,0.00003920166,0.0003788971,0.0008683631,0.000077068675,0.000031132,0.0002334754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862885,0.000051169933,0.00020921938,0.00043366587,0.00023878679,0.00043829007],"domain_scores_gemma":[0.9987427,0.00004708346,0.00011160859,0.0006429247,0.0003899129,0.000065774875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035585326,0.00016617619,0.0002057717,0.00008474448,0.00022089433,0.000069439135,0.00043048212,0.000116352494,0.00007216001],"category_scores_gemma":[0.000048850805,0.0001482445,0.00008852483,0.00006825746,0.00029353672,0.000030849285,0.00024456054,0.00013037634,0.000002142869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025549713,0.00011565689,0.7331428,0.000111889996,0.000096033626,0.000010686922,0.00014076433,0.0000045515962,0.25637096,0.0000043919254,0.00049128395,0.006955984],"study_design_scores_gemma":[0.0016484703,0.00009413825,0.87291473,0.000098888064,0.0000063057682,0.000013587851,0.000043011903,0.0000036546016,0.12490897,0.000049339968,0.00009618384,0.00012271451],"about_ca_topic_score_codex":0.0022428,"about_ca_topic_score_gemma":0.0050401646,"teacher_disagreement_score":0.13977192,"about_ca_system_score_codex":0.000090554415,"about_ca_system_score_gemma":0.00025657128,"threshold_uncertainty_score":0.6045235},"labels":[],"label_agreement":null},{"id":"W2594171470","doi":"10.1158/1538-7445.sabcs16-p2-05-06","title":"Abstract P2-05-06: Analytical and clinical validation of a fully automated tissue-based quantitative assay (MetaSite <i>Breast</i>™) to detect the likelihood of distant metastasis in hormone receptor (HR)-positive, HER2-negative early stage breast cancer (ESBC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Metastasis; Confidence interval; Odds ratio; Cancer; Pathology; Cohort","score_opus":0.05801775533931678,"score_gpt":0.43317397608367963,"score_spread":0.37515622074436283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594171470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146175,0.00095945294,0.00013054578,0.0024856692,0.00006472516,0.0008156348,0.0040019327,0.000012595569,0.000067700385],"genre_scores_gemma":[0.99815416,0.0008535493,0.00053799246,0.000035419802,0.000077030905,0.00020673784,0.00005911798,0.0000365089,0.00003949264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969109,0.0006870263,0.00058161624,0.0006871048,0.0006095455,0.00052376575],"domain_scores_gemma":[0.9973334,0.00046193413,0.0003666409,0.00068044517,0.0009655345,0.00019205334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019530179,0.0002754925,0.00056857575,0.00015788132,0.0002858912,0.00009781757,0.00046445453,0.00015439141,0.000052849606],"category_scores_gemma":[0.0005652349,0.00020478741,0.00013447425,0.00036800333,0.0010854248,0.000036365032,0.0003273964,0.0003342412,0.0000053355548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019315772,0.0011690304,0.2373548,0.00035135998,0.0038239642,0.00005138291,0.0019038602,0.00044195828,0.68005574,0.0000949922,0.0029807733,0.05245637],"study_design_scores_gemma":[0.0018060326,0.0006907608,0.78071326,0.00020151369,0.00011374523,0.000002375612,0.00031089596,0.00008792533,0.21572284,0.000031344203,0.0001258226,0.00019345802],"about_ca_topic_score_codex":0.018000124,"about_ca_topic_score_gemma":0.0047250693,"teacher_disagreement_score":0.5433585,"about_ca_system_score_codex":0.00018035252,"about_ca_system_score_gemma":0.0005335445,"threshold_uncertainty_score":0.9885391},"labels":[],"label_agreement":null},{"id":"W2594198507","doi":"10.1158/1538-7445.sabcs16-p6-09-15","title":"Abstract P6-09-15: Mechanism of drug resistance in relation to sites of metastases: Meta-analyses of randomized controlled trials in advanced breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Metastatic breast cancer; Hazard ratio; Targeted therapy; Endocrine system; Cancer; Meta-analysis; Clinical trial; Confidence interval; Hormone","score_opus":0.2132482164782858,"score_gpt":0.5060859911771813,"score_spread":0.29283777469889555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594198507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9375136,0.04759633,0.00035672353,0.0047121528,0.00015311842,0.0077069527,0.0011698555,0.000017494232,0.0007737697],"genre_scores_gemma":[0.99186623,0.0020928304,0.0021602032,0.000034729783,0.00007557204,0.002832921,0.00001475352,0.000042917232,0.0008798622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99150324,0.0023102637,0.0032867691,0.000606083,0.0017347505,0.000558878],"domain_scores_gemma":[0.9888915,0.005470876,0.0024972989,0.0011495567,0.0018225242,0.00016824831],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.024122508,0.00034320226,0.009297279,0.001308559,0.00009219779,0.000025887999,0.00053526234,0.0001321944,0.0013808875],"category_scores_gemma":[0.013673617,0.00023040806,0.0013335424,0.00076167047,0.0005849883,0.0003764073,0.00012223968,0.0005355525,0.0000024022174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.432409,0.00027166557,0.00079063204,0.00078915927,0.0065498236,0.000018667315,0.0014033074,0.0014194964,0.55203867,0.0016942816,0.00008212884,0.0025331741],"study_design_scores_gemma":[0.42545044,0.0001237991,0.022775304,0.003105944,0.005494428,0.000002430859,0.0009580801,0.000094825424,0.5316457,0.009779674,0.0001832685,0.00038608912],"about_ca_topic_score_codex":0.007479482,"about_ca_topic_score_gemma":0.012171401,"teacher_disagreement_score":0.054352608,"about_ca_system_score_codex":0.00044429672,"about_ca_system_score_gemma":0.0009010013,"threshold_uncertainty_score":0.999532},"labels":[],"label_agreement":null},{"id":"W2594250383","doi":"10.1158/1538-7445.sabcs16-p3-01-02","title":"Abstract P3-01-02: Trends in positive predictive values following transition from screen film to digital mammography","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Ductal carcinoma; Mammography; Malignancy; Biopsy; Digital mammography; Calcification; Breast cancer; Radiology; Hyperplasia; Lobular carcinoma; Cancer; Pathology; Internal medicine","score_opus":0.043557704291088205,"score_gpt":0.3889454276124338,"score_spread":0.3453877233213456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594250383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469172,0.00034128828,0.00008695364,0.0028554047,0.00011229708,0.0003781667,0.001456059,0.00004863059,0.047804024],"genre_scores_gemma":[0.9987439,0.000025718111,0.000065750806,0.00010384284,0.0003214052,0.000095485746,0.00026710235,0.00003319726,0.00034360436],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776804,0.000038527312,0.0002252445,0.00052447635,0.0008274672,0.00061626476],"domain_scores_gemma":[0.99885505,0.0001235887,0.000045022327,0.00047801778,0.00013999706,0.0003583437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038411884,0.00018375127,0.000313082,0.0010714403,0.00031725576,0.000512537,0.00031571556,0.00008883582,0.00014640944],"category_scores_gemma":[0.0000863584,0.00017029479,0.0003031953,0.0006725587,0.00026354,0.0010694105,0.00008332226,0.0005191821,0.000029368934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052097263,0.0006637231,0.2116018,0.00006755382,0.000856434,0.0013972339,0.0062735863,0.000083250634,0.010918793,0.000043873453,0.0049520168,0.757932],"study_design_scores_gemma":[0.0016460981,0.00042459584,0.99145585,0.0013586429,0.00004073325,0.000006722332,0.0011801724,0.000103512684,0.0026447182,0.0006970178,0.00024177918,0.00020014912],"about_ca_topic_score_codex":0.004760447,"about_ca_topic_score_gemma":0.00024790602,"teacher_disagreement_score":0.77985406,"about_ca_system_score_codex":0.00016239357,"about_ca_system_score_gemma":0.000104384526,"threshold_uncertainty_score":0.7196404},"labels":[],"label_agreement":null},{"id":"W2594264017","doi":"10.1158/1538-7445.sabcs16-p2-05-33","title":"Abstract P2-05-33: Refining the prognostic value of Ki67 biomarker by ataxia telangiectasia mutated (ATM) status in a retrospective study of early stage hormone receptor positive breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Immunohistochemistry; Internal medicine; Lymph node; Cancer; Tissue microarray; Biomarker; Survival analysis; Ataxia-telangiectasia; Pathology; Biology","score_opus":0.048514029062086295,"score_gpt":0.3850064021910685,"score_spread":0.3364923731289822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594264017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942566,0.0034060562,0.0000035522226,0.0005475677,0.00017204798,0.002410507,0.003122664,0.0000305167,0.00088144664],"genre_scores_gemma":[0.9978843,0.0007716979,0.000023222216,0.000017350232,0.00007343294,0.00062787434,0.00005761709,0.00009645328,0.0004480973],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99565804,0.00040392842,0.00064258894,0.0007550158,0.0015696485,0.000970768],"domain_scores_gemma":[0.9965236,0.00023671119,0.0005123865,0.0012098252,0.0012571526,0.0002603215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014628165,0.00031323868,0.0007001009,0.0003887052,0.00034277156,0.00008106195,0.0005768707,0.0002075569,0.00028458802],"category_scores_gemma":[0.00083596143,0.000244246,0.00011744779,0.00094842416,0.0007931718,0.00019893402,0.00031956323,0.0013678088,0.000011627653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069661075,0.0011019416,0.38090643,0.00017574235,0.0009536383,0.00028349026,0.00812252,0.000046564597,0.5917487,0.0000210771,0.0037761577,0.005897639],"study_design_scores_gemma":[0.005511998,0.0017665859,0.9669053,0.0010141218,0.000110256005,0.000010991383,0.0023114656,0.000063366984,0.021863595,0.000008582957,0.0002146601,0.00021910627],"about_ca_topic_score_codex":0.14673036,"about_ca_topic_score_gemma":0.0055254055,"teacher_disagreement_score":0.58599883,"about_ca_system_score_codex":0.0016373965,"about_ca_system_score_gemma":0.0013670926,"threshold_uncertainty_score":0.99600637},"labels":[],"label_agreement":null},{"id":"W2594292461","doi":"10.1158/1538-7445.epso16-a18","title":"Abstract A18: A novel 3D co-culture system for the study of adipocyte and extracellular matrix influences on the breast cancer phenotype","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Memorial University of Newfoundland","funders":"","keywords":"Breast cancer; Cancer; Extracellular matrix; Adipocyte; Tumor microenvironment; Cancer research; Adipose tissue; Stromal cell; Mammary tumor; Tumor progression; Cancer cell; Biology; Pathology; Medicine; Internal medicine; Cell biology","score_opus":0.12392293200405463,"score_gpt":0.4477609333394836,"score_spread":0.32383800133542895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594292461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729484,0.019811457,0.000013580731,0.0031245495,0.00023829106,0.002734893,0.00046042388,0.00001344602,0.0006549704],"genre_scores_gemma":[0.9950862,0.0015834642,0.000021512906,0.000038741648,0.00051342393,0.00093098555,0.0000019706424,0.00002724671,0.0017964698],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981951,0.000055703782,0.00024872695,0.00034860417,0.0007638786,0.0003879651],"domain_scores_gemma":[0.99799,0.00033425484,0.00018745572,0.0008397558,0.0005244632,0.00012408676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014006214,0.00016021155,0.0003278071,0.00006509409,0.0009721068,0.00014824691,0.00047492742,0.000071661365,0.00020296377],"category_scores_gemma":[0.00010551551,0.0000775146,0.000075914155,0.00012843606,0.00042939337,0.000078216115,0.00009246443,0.00046155226,0.0000056684644],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017058343,0.0022035385,0.061457347,0.007411255,0.004113666,0.00009688907,0.019236052,0.000537705,0.64953107,0.00466503,0.026599154,0.20708995],"study_design_scores_gemma":[0.02063167,0.003283648,0.6294258,0.005033808,0.0018358086,0.00009228958,0.045250744,0.00056395744,0.061175395,0.000061595296,0.23177944,0.0008658321],"about_ca_topic_score_codex":0.011134266,"about_ca_topic_score_gemma":0.0015188627,"teacher_disagreement_score":0.58835566,"about_ca_system_score_codex":0.00019508558,"about_ca_system_score_gemma":0.00037594832,"threshold_uncertainty_score":0.9954507},"labels":[],"label_agreement":null},{"id":"W2594298541","doi":"10.1158/1538-7445.crc16-ia27","title":"Abstract IA27: Understanding more about risk and prognostic factors: Lessons from the Colon Cancer Family Registry","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Penetrance; Cancer; Lynch syndrome; Family history; Oncology; Familial adenomatous polyposis; Cancer registry; Disease; Epidemiology; Internal medicine; Genetics; Biology; Gene; DNA mismatch repair","score_opus":0.2998381464020249,"score_gpt":0.47640056160512384,"score_spread":0.17656241520309895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594298541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97774863,0.009536022,0.000027707512,0.0076109436,0.0006041146,0.0010357846,0.00055692316,0.000041121013,0.002838746],"genre_scores_gemma":[0.98979276,0.008490423,0.000036188423,0.0001647737,0.0006504814,0.00036266012,0.000017046259,0.000058619593,0.00042701876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972306,0.00011951698,0.00024770838,0.0006519252,0.0010215861,0.0007286799],"domain_scores_gemma":[0.9969854,0.00106125,0.00020818332,0.0011545403,0.00028050714,0.00031016214],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00071152695,0.00024835506,0.00035729978,0.000079492434,0.0015479767,0.0003701413,0.0006318783,0.0002274281,0.00036997802],"category_scores_gemma":[0.0015624798,0.00016865422,0.000083994855,0.00015688267,0.0014941716,0.00011854066,0.00033838637,0.0014085246,0.000011142033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052723836,0.000054827375,0.93848443,0.00017765522,0.00025739305,0.000057703754,0.002182125,0.00001879458,0.031072656,0.0001698332,0.018661655,0.008335672],"study_design_scores_gemma":[0.0010211137,0.00013058071,0.98355883,0.0009019459,0.000109504275,0.0000024272272,0.0038603889,0.0000419396,0.004030662,0.001213176,0.0049321745,0.00019728157],"about_ca_topic_score_codex":0.03587141,"about_ca_topic_score_gemma":0.005978366,"teacher_disagreement_score":0.04507436,"about_ca_system_score_codex":0.0011671876,"about_ca_system_score_gemma":0.0011078054,"threshold_uncertainty_score":0.99975187},"labels":[],"label_agreement":null},{"id":"W2594323317","doi":"10.1158/1538-7445.crc16-pr02","title":"Abstract PR02: Epigenetic and molecular drivers of inflammation-driven colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Azoxymethane; Inflammation; Colorectal cancer; Ulcerative colitis; Medicine; Inflammatory bowel disease; Cancer; Colitis; Carcinogenesis; Primary sclerosing cholangitis; Mouse model of colorectal and intestinal cancer; Cancer research; Immunology; Gastroenterology; Internal medicine; Disease","score_opus":0.03415950238651665,"score_gpt":0.39181638902255067,"score_spread":0.357656886636034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594323317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925694,0.003199532,0.00001259771,0.0004704107,0.00013815306,0.00034640956,0.000036372905,0.0000035248925,0.0032236075],"genre_scores_gemma":[0.99571395,0.0036790564,0.000027659897,0.000010559729,0.00014051668,0.00009159443,0.000010522019,0.000016477152,0.00030965914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989581,0.000067166846,0.00016450664,0.00027310807,0.00024876965,0.00028833063],"domain_scores_gemma":[0.9991162,0.000017567694,0.0001224037,0.00030116359,0.00031741918,0.00012525142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032182244,0.00009100907,0.00013759198,0.000060393155,0.000280419,0.000038931947,0.00026630276,0.00015747859,0.000056675868],"category_scores_gemma":[0.00011805153,0.00008161286,0.000038496273,0.000046165278,0.00043462898,0.00000654116,0.0001573579,0.0001629611,0.0000057170932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000622996,0.0000123417685,0.03368975,0.00013784095,0.000072029645,0.0000069814027,0.00011997918,0.00012099518,0.9608781,0.00018982548,0.0004343203,0.0042755846],"study_design_scores_gemma":[0.00048971316,0.00014798914,0.18608107,0.00016131903,0.000008866025,0.0000016492446,0.000074614494,0.00001910263,0.8092481,0.00005942724,0.003600866,0.000107281114],"about_ca_topic_score_codex":0.0010209561,"about_ca_topic_score_gemma":0.00050660805,"teacher_disagreement_score":0.15239131,"about_ca_system_score_codex":0.00004198603,"about_ca_system_score_gemma":0.0004384067,"threshold_uncertainty_score":0.33280757},"labels":[],"label_agreement":null},{"id":"W2594337335","doi":"10.1158/1538-7445.sabcs16-p6-09-30","title":"Abstract P6-09-30: Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with Trastuzumab","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Sunnybrook Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Proportional hazards model; Oncology; Internal medicine; Breast cancer; Metastatic breast cancer; Trastuzumab; Metastasis; Cancer; Cohort; Cancer registry; Univariate analysis; Hazard ratio; Survival analysis; Retrospective cohort study; Multivariate analysis; Confidence interval","score_opus":0.03348944860399794,"score_gpt":0.3443764690958599,"score_spread":0.31088702049186195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594337335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968975,0.00032202702,0.00000725895,0.00017507278,0.000073178475,0.00061729125,0.0010826731,0.00001923857,0.00080576155],"genre_scores_gemma":[0.99868697,0.00021574525,0.000019788562,0.000018424542,0.00015609851,0.00043779123,0.00015305879,0.00007898826,0.00023314139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738675,0.00011368906,0.00020370515,0.0007576391,0.0007410418,0.00079718966],"domain_scores_gemma":[0.9979314,0.000051324925,0.00019754209,0.0007134607,0.0008786208,0.00022762729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019287532,0.00038536714,0.00037850885,0.00009253371,0.0009744873,0.00018930326,0.00046549804,0.00009781698,0.00019738448],"category_scores_gemma":[0.00003746718,0.00026114282,0.000070497656,0.00014997134,0.00088560197,0.0000428822,0.00019875175,0.00031887912,0.00000991136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011973752,0.00022992569,0.99014753,0.00005435678,0.001112246,0.000026050562,0.0005058826,0.00009040863,0.0031246275,0.0000027098713,0.00022553047,0.0032833281],"study_design_scores_gemma":[0.0025137847,0.0003741531,0.9730172,0.00025182223,0.000099947916,0.0000022051095,0.00053530216,0.0000014029741,0.022767132,0.0000029656321,0.00010329469,0.00033076896],"about_ca_topic_score_codex":0.033592124,"about_ca_topic_score_gemma":0.013059212,"teacher_disagreement_score":0.020532912,"about_ca_system_score_codex":0.00045306757,"about_ca_system_score_gemma":0.00048365947,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2594363445","doi":"10.1158/1538-7445.sabcs16-p2-07-06","title":"Abstract P2-07-06: Obesity, dyslipidemia, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ejection fraction; Dyslipidemia; Internal medicine; Breast cancer; Diabetes mellitus; Asymptomatic; Heart failure; Cancer; Cardiology; Obesity; Endocrinology","score_opus":0.0454532322374997,"score_gpt":0.38076851914591275,"score_spread":0.33531528690841306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594363445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558675,0.00047108126,0.0000015975517,0.0009350237,0.00022130847,0.0016417649,0.00052303425,0.000031576503,0.0005878754],"genre_scores_gemma":[0.9974393,0.0013818437,0.000008845463,0.00007207915,0.00032104328,0.00037048836,0.00005202677,0.000049558417,0.0003047673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975944,0.000121549914,0.00033586394,0.00056911097,0.0006655906,0.00071347086],"domain_scores_gemma":[0.998242,0.00033585128,0.00017346913,0.00050172996,0.00043281107,0.00031413697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011544294,0.00023179657,0.0005585428,0.00021624145,0.00063612225,0.00012675811,0.0002493728,0.0003257449,0.00018184535],"category_scores_gemma":[0.0006089569,0.00020758771,0.00016922031,0.00015706789,0.00037683002,0.0002981285,0.000104652856,0.0009236833,0.000014385638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017482675,0.00015680223,0.91987383,0.00023956243,0.00020846483,0.0000033634958,0.00065158174,0.0000149329335,0.06640597,0.000012152968,0.0008272735,0.011431256],"study_design_scores_gemma":[0.0031065247,0.00012880508,0.8739586,0.00041994563,0.000049198625,9.853981e-7,0.00015201047,0.00005633303,0.12127408,0.00036776435,0.0003003901,0.00018536982],"about_ca_topic_score_codex":0.008313428,"about_ca_topic_score_gemma":0.0006412773,"teacher_disagreement_score":0.05486811,"about_ca_system_score_codex":0.00090724416,"about_ca_system_score_gemma":0.00042521567,"threshold_uncertainty_score":0.9982903},"labels":[],"label_agreement":null},{"id":"W2594366189","doi":"10.1158/1538-7445.sabcs16-p4-20-04","title":"Abstract P4-20-04: Young women with breast cancer in Mexico: A report of the pilot phase of the “Mujer Joven y Fuerte” prospective cohort","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Cohort; Anxiety; Population; Prospective cohort study; Family medicine; Gynecology; Cancer; Psychological intervention; Gerontology; Psychiatry; Internal medicine","score_opus":0.03974684698142271,"score_gpt":0.39811578521688396,"score_spread":0.35836893823546123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594366189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993102,0.000514162,0.000005426526,0.0013946254,0.00021667975,0.0009382552,0.00033773543,0.0000027006618,0.0034883837],"genre_scores_gemma":[0.9968713,0.00020308113,0.000014125898,0.000031344884,0.00017416984,0.001073992,0.0000042606403,0.00003144393,0.0015963188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813676,0.00009495723,0.00029576963,0.0004411613,0.0006276772,0.0004036639],"domain_scores_gemma":[0.9974434,0.000017708899,0.00032375584,0.0014607193,0.0006924909,0.000061965875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009041236,0.00014014887,0.00020976485,0.00005200696,0.00027069583,0.000039847437,0.0009135347,0.000090093046,0.00016607656],"category_scores_gemma":[0.00015702267,0.000084556435,0.0000565233,0.00024778178,0.0009698262,0.000013941109,0.00037959503,0.00035357333,8.5227725e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009423517,0.00019381223,0.52888113,0.00006450632,0.00021187108,0.000010554369,0.0005020347,0.00027757237,0.4660271,0.000017375134,0.0012499028,0.0016217785],"study_design_scores_gemma":[0.001093661,0.00013413497,0.68780535,0.00012544674,0.000012118607,0.000030605897,0.00017412915,0.0000072924527,0.30959997,0.000088352834,0.0008361605,0.00009279245],"about_ca_topic_score_codex":0.0042280084,"about_ca_topic_score_gemma":0.0075054914,"teacher_disagreement_score":0.1589242,"about_ca_system_score_codex":0.00060828985,"about_ca_system_score_gemma":0.0022527762,"threshold_uncertainty_score":0.6391512},"labels":[],"label_agreement":null},{"id":"W2594388257","doi":"10.1158/1538-7445.sabcs16-p6-09-04","title":"Abstract P6-09-04: Nuclear grade has a limited role in predicting recurrence in DCIS following breast conserving surgery: A population-based study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences North; Juravinski Hospital; London Health Sciences Centre; Kingston General Hospital; Thunder Bay Regional Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast-conserving surgery; Population; Breast cancer; Oncology; General surgery; Internal medicine; Mastectomy; Cancer; Environmental health","score_opus":0.09127164922913739,"score_gpt":0.38554594448277185,"score_spread":0.29427429525363447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594388257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969497,0.0008425481,6.980723e-7,0.0013360685,0.0001521911,0.0005370482,0.000055188135,0.000016250095,0.0001103262],"genre_scores_gemma":[0.99931425,0.000065248336,0.000024824933,0.000031312604,0.00014429633,0.00032289154,0.000044245447,0.00003937113,0.000013546979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778074,0.00021706808,0.00032520466,0.00063402223,0.0004304482,0.0006125046],"domain_scores_gemma":[0.9987728,0.00018862038,0.00013072492,0.0006863699,0.00012344032,0.000098020246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011192313,0.00019715769,0.00030986124,0.00024312538,0.00065615686,0.00020091659,0.00043384172,0.00011487473,0.000024191999],"category_scores_gemma":[0.0006501143,0.0002022589,0.00009981164,0.00026174524,0.00011412239,0.000024644134,0.00029630202,0.00035482782,0.000005244272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027706803,0.00030057383,0.98741263,0.00003552963,0.000071517235,0.00005995958,0.00055016676,0.000100016245,0.005690267,0.0000010277814,0.000117038326,0.0053842147],"study_design_scores_gemma":[0.0013337249,0.000055090757,0.99594253,0.00039676862,0.000010706851,0.0000022370773,0.0009454361,0.00016375277,0.00082602364,0.000021148997,0.00011964073,0.00018293298],"about_ca_topic_score_codex":0.043075167,"about_ca_topic_score_gemma":0.03683521,"teacher_disagreement_score":0.0085299155,"about_ca_system_score_codex":0.00028941926,"about_ca_system_score_gemma":0.00038083163,"threshold_uncertainty_score":0.98074},"labels":[],"label_agreement":null},{"id":"W2594437638","doi":"10.1158/1538-7445.sabcs16-p2-11-10","title":"Abstract P2-11-10: Effect of supplementation with eicosapentaenoic and docosahexaenoic omega-3 polyunsaturated fatty acid on the chemotoxicity in Mexican patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NeoCT)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eicosapentaenoic acid; Docosahexaenoic acid; Medicine; Breast cancer; Internal medicine; Polyunsaturated fatty acid; Placebo; Adiponectin; Gastroenterology; Oncology; Cancer; Endocrinology; Fatty acid; Insulin; Insulin resistance; Pathology; Biology","score_opus":0.011658850443646458,"score_gpt":0.3169217476637988,"score_spread":0.3052628972201524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594437638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665284,0.00045074246,0.000008067008,0.00063197524,0.000115735915,0.0016444777,0.00032689574,0.000009360583,0.00015993345],"genre_scores_gemma":[0.9975112,0.0010346838,0.00002578082,0.000102695965,0.0004247764,0.00052858255,0.00014730661,0.00005676491,0.0001681952],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99777055,0.00015716159,0.00024316218,0.00066015346,0.00059602695,0.00057293184],"domain_scores_gemma":[0.99845165,0.00005125521,0.00024436598,0.0007178884,0.0003845984,0.0001502631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043687352,0.00033814227,0.0004011676,0.00011089878,0.0003213222,0.000101769045,0.000402478,0.00011680987,0.00015437717],"category_scores_gemma":[0.000029799401,0.0001899149,0.00004151862,0.00025083803,0.0006430342,0.000036754842,0.00007497957,0.000311277,0.0000010875966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034528628,0.0002917981,0.3041203,0.00017564578,0.00027696314,0.0000020024604,0.00022004831,0.00011691108,0.59944606,0.000012212314,0.00085951376,0.05994993],"study_design_scores_gemma":[0.008520517,0.0015678463,0.51431215,0.0002844278,0.000024552115,0.0000026934263,0.000064494605,0.000008641459,0.4727006,0.0000014276291,0.0022981795,0.00021448908],"about_ca_topic_score_codex":0.00420245,"about_ca_topic_score_gemma":0.013251356,"teacher_disagreement_score":0.21019185,"about_ca_system_score_codex":0.00015316109,"about_ca_system_score_gemma":0.00038203807,"threshold_uncertainty_score":0.7744505},"labels":[],"label_agreement":null},{"id":"W2594446929","doi":"10.1158/1538-7445.sabcs16-p4-20-09","title":"Abstract P4-20-09: Diagnosing cognitive impairment (“chemo brain”) in breast cancer survivors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Breast cancer; Internal medicine; Cancer; Stage (stratigraphy); Oncology; Dementia; Disease","score_opus":0.08559401894759668,"score_gpt":0.4511333317682293,"score_spread":0.3655393128206326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594446929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417283,0.0021759176,0.000003187652,0.044926688,0.0005934225,0.0019670639,0.0004705479,0.000068979636,0.0080659175],"genre_scores_gemma":[0.9894587,0.004800832,0.000007307055,0.0007515595,0.0009900108,0.0018409406,0.000026209174,0.000090162415,0.0020343035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995662,0.00016477465,0.00048030398,0.0008908321,0.0013423982,0.0014597167],"domain_scores_gemma":[0.9966632,0.0008659332,0.00021323268,0.00064591714,0.0011790064,0.0004326862],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016098211,0.00038523806,0.0006577348,0.00052789727,0.0009966799,0.00020910589,0.00040676678,0.00020964952,0.0021514269],"category_scores_gemma":[0.00085896964,0.0003540777,0.00016919781,0.000498051,0.0011134194,0.00040010054,0.0004872462,0.0015023499,0.00016461482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030056634,0.0008307213,0.8941954,0.0006164982,0.0005791648,0.00066021277,0.0021842252,0.000019119276,0.008631096,0.000017534969,0.022202589,0.06705778],"study_design_scores_gemma":[0.005747777,0.00023884985,0.97816116,0.0044115502,0.00007358293,0.00003101623,0.001470568,0.000034311845,0.006773319,0.000081178674,0.002600171,0.00037650784],"about_ca_topic_score_codex":0.044572912,"about_ca_topic_score_gemma":0.022041265,"teacher_disagreement_score":0.08396577,"about_ca_system_score_codex":0.0023763352,"about_ca_system_score_gemma":0.0012057007,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W2594457906","doi":"10.1158/1538-7445.sabcs16-p4-12-09","title":"Abstract P4-12-09: The immune response in triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Breast cancer; Triple-negative breast cancer; Immunosuppression; Tumor microenvironment; Medicine; Chemokine; Immunology; Oncology; Cancer; Internal medicine","score_opus":0.09840107818208124,"score_gpt":0.4436234260459285,"score_spread":0.3452223478638473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594457906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493359,0.0053144787,5.871405e-7,0.04004525,0.00043123346,0.0010768436,0.00012680344,0.000021010293,0.0036479319],"genre_scores_gemma":[0.98778176,0.0036472734,0.000007007703,0.0002622975,0.00040886807,0.00067754905,0.0000029827138,0.000037228972,0.007175036],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757504,0.00028467493,0.00032555437,0.00038791835,0.00074271637,0.0006841027],"domain_scores_gemma":[0.9979061,0.00040835844,0.00013474969,0.0011551527,0.0002639255,0.00013171707],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033633017,0.00017214907,0.00031264537,0.00021443218,0.00077442435,0.00017390792,0.00068134087,0.00012698949,0.00304373],"category_scores_gemma":[0.00041204615,0.00011290723,0.00013828723,0.00031395932,0.0009621834,0.00017093451,0.00015960638,0.0009571728,0.000051208106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17840804,0.00030966726,0.02931172,0.00018668557,0.0004227259,0.0002669462,0.003913224,0.000010634972,0.5961974,0.00006370929,0.01600788,0.17490135],"study_design_scores_gemma":[0.0049204812,0.00015933796,0.94595456,0.00054690975,0.0000127294325,0.00002113968,0.000598959,0.000018562698,0.031207697,0.00007565035,0.016346412,0.00013755177],"about_ca_topic_score_codex":0.057358008,"about_ca_topic_score_gemma":0.006951955,"teacher_disagreement_score":0.91664284,"about_ca_system_score_codex":0.0009592029,"about_ca_system_score_gemma":0.0015081877,"threshold_uncertainty_score":0.99786764},"labels":[],"label_agreement":null},{"id":"W2594478488","doi":"10.1158/1538-7445.sabcs16-pd2-07","title":"Abstract PD2-07: 10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Exemestane; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Tamoxifen; Clinical endpoint; Adjuvant therapy; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.144528455159949,"score_gpt":0.45249150022353896,"score_spread":0.30796304506358996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594478488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834711,0.0032265864,0.000015619764,0.006585219,0.0007242721,0.002633764,0.00044947604,0.000019851126,0.002874101],"genre_scores_gemma":[0.9832999,0.0011470997,0.00008364352,0.00007100961,0.0007063914,0.0004883784,0.000011654728,0.00004903417,0.014142871],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790156,0.00007414542,0.00034648197,0.000445439,0.00069963856,0.0005327571],"domain_scores_gemma":[0.99763876,0.00037811953,0.00022454203,0.0012093412,0.00042017136,0.00012907309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009900681,0.00017766883,0.00040426207,0.00010181462,0.00047198145,0.00009682329,0.00047719548,0.00007667332,0.00016272008],"category_scores_gemma":[0.0010205032,0.00010825621,0.00017028903,0.00011358783,0.00087053835,0.00027312915,0.00020998894,0.00032347927,0.0000065843847],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53397787,0.00026966532,0.0025726287,0.00030762597,0.0004894239,0.000010856917,0.00057330367,0.000002500672,0.2390546,0.00022931704,0.016740903,0.2057713],"study_design_scores_gemma":[0.30490217,0.0019216237,0.15431234,0.0009572227,0.00007057471,0.000016856726,0.00059162144,0.000018552684,0.18253754,0.0016236738,0.35269397,0.00035384018],"about_ca_topic_score_codex":0.0009086582,"about_ca_topic_score_gemma":0.00017789984,"teacher_disagreement_score":0.3359531,"about_ca_system_score_codex":0.00016697473,"about_ca_system_score_gemma":0.0005519549,"threshold_uncertainty_score":0.441456},"labels":[],"label_agreement":null},{"id":"W2594485103","doi":"10.1158/1538-7445.sabcs16-p4-18-01","title":"Abstract P4-18-01: Waiting for Treatment: Addressing Inequities in access to essential medications for metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Formulary; Medicine; Metastatic breast cancer; Reimbursement; Breast cancer; Cancer; Expanded access; Cancer drugs; Disease; Family medicine; Health care; Oncology; Internal medicine; Economic growth","score_opus":0.40810931697739355,"score_gpt":0.4931743813461004,"score_spread":0.08506506436870687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594485103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95821416,0.0043401252,0.0012510084,0.017221054,0.001069952,0.0026603967,0.0075181415,0.000030684692,0.0076944935],"genre_scores_gemma":[0.9914531,0.0012580733,0.0002648563,0.00019822644,0.0010501194,0.0047178953,0.000031290016,0.000057553385,0.0009688853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977963,0.000012790745,0.00065155834,0.000589055,0.00007856349,0.00087171263],"domain_scores_gemma":[0.99835443,0.0002865191,0.00040955402,0.0005311758,0.0001978747,0.00022042115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012090907,0.00019523603,0.00058826606,0.00048014062,0.0009139539,0.0008412795,0.00085461285,0.00009314056,0.0011043767],"category_scores_gemma":[0.00039036226,0.00021203325,0.00013605172,0.00015544365,0.00022075331,0.0010832867,0.00015571325,0.00015118999,0.000036249945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031533546,0.0012288587,0.26855108,0.0029047478,0.0018034393,0.000027216993,0.008784936,0.003592056,0.004246096,0.20176002,0.06754187,0.4364063],"study_design_scores_gemma":[0.013309164,0.00046767583,0.73161274,0.0017521862,0.00011960186,0.000005995766,0.000979468,0.006660297,0.010171697,0.0868742,0.14613251,0.0019144508],"about_ca_topic_score_codex":0.020029921,"about_ca_topic_score_gemma":0.012926751,"teacher_disagreement_score":0.46306166,"about_ca_system_score_codex":0.0008893363,"about_ca_system_score_gemma":0.00055626506,"threshold_uncertainty_score":0.9998087},"labels":[],"label_agreement":null},{"id":"W2594486864","doi":"10.1158/1538-7445.sabcs16-cs1-2","title":"Abstract CS1-2: CS1-2 Clinical utility of multi-gene testing in metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Clinical trial; Cancer; Genetic testing; Oncology; Disease; Precision medicine; Personalized medicine; Druggability; Internal medicine; Bioinformatics; Gene; Pathology; Biology; Genetics","score_opus":0.2661490040577115,"score_gpt":0.5060532173571834,"score_spread":0.23990421329947192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594486864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951492,0.0026413833,0.00003166474,0.00034114506,0.00028743772,0.00030537116,0.0006223804,0.0000038567846,0.00061756937],"genre_scores_gemma":[0.99583733,0.0028573498,0.0005601616,0.00005460939,0.00038294992,0.00011766628,0.00001953812,0.00002758873,0.00014281891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816346,0.000107874665,0.00045867372,0.00050850934,0.00028373662,0.0004777424],"domain_scores_gemma":[0.9980623,0.00018952708,0.00019829764,0.00087743864,0.00050917175,0.00016325508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717989,0.00013930605,0.00028807044,0.00007241216,0.00019573128,0.00006714466,0.00062205724,0.0001292768,0.00014795516],"category_scores_gemma":[0.001578912,0.00013521285,0.00009616916,0.00011205766,0.0005239131,0.000008273311,0.0004239247,0.00037657295,0.0000065031613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003699044,0.00037377208,0.5807386,0.0001523889,0.000095287825,0.000026516462,0.00004561364,0.00016481726,0.3316772,0.000014307533,0.002456658,0.08388491],"study_design_scores_gemma":[0.0013837254,0.000089082576,0.9249814,0.00011079363,0.000013626713,0.000003756546,0.00004410596,0.00040128487,0.0701286,0.000070551156,0.002600793,0.0001722418],"about_ca_topic_score_codex":0.012453345,"about_ca_topic_score_gemma":0.010542782,"teacher_disagreement_score":0.34424284,"about_ca_system_score_codex":0.00006314961,"about_ca_system_score_gemma":0.0010198865,"threshold_uncertainty_score":0.9941228},"labels":[],"label_agreement":null},{"id":"W2594516673","doi":"10.1158/1538-7445.sabcs16-p4-19-03","title":"Abstract P4-19-03: A meta-analysis of cognitive impairment in breast cancer survivors treated with chemotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; York University; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Cognition; Meta-analysis; Chemotherapy; Cancer; Verbal memory; Internal medicine; Neurocognitive; Verbal learning; Oncology; Clinical psychology; Psychiatry","score_opus":0.13953769669472227,"score_gpt":0.45368787721660075,"score_spread":0.3141501805218785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594516673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831096,0.002599521,0.0000045656425,0.008941642,0.000035742338,0.0017536861,0.0010046872,0.000030952546,0.0025195833],"genre_scores_gemma":[0.9931486,0.0033958913,0.000009041403,0.00025254552,0.00008864058,0.0016633637,0.000035146368,0.000055863657,0.0013508544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964987,0.00017034082,0.0004855019,0.0007339002,0.0013038308,0.00080773595],"domain_scores_gemma":[0.99672174,0.00042584035,0.0003348392,0.0006974174,0.0015351343,0.00028500735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012192315,0.00034908621,0.00165792,0.0011181951,0.00035251386,0.00006558534,0.00030343328,0.00013232596,0.005325814],"category_scores_gemma":[0.00014645502,0.00024364634,0.00056125387,0.0016063194,0.0010264332,0.00018402972,0.00012393664,0.000670919,0.000015675376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009710733,0.0010131019,0.7822305,0.0002468094,0.19813327,0.00019083518,0.0019148721,0.00011248912,0.0021116834,0.0000075646044,0.000809408,0.0035187488],"study_design_scores_gemma":[0.005149803,0.00043892668,0.9518273,0.00034511762,0.03572081,0.0000064152473,0.00097474124,0.00005797393,0.0051244097,0.000009667146,0.00010049447,0.0002443405],"about_ca_topic_score_codex":0.13416997,"about_ca_topic_score_gemma":0.048817262,"teacher_disagreement_score":0.16959682,"about_ca_system_score_codex":0.0009414057,"about_ca_system_score_gemma":0.00079472223,"threshold_uncertainty_score":0.9955835},"labels":[],"label_agreement":null},{"id":"W2594523044","doi":"10.1158/1538-7445.sabcs16-p2-09-14","title":"Abstract P2-09-14: Association between BMI and residual estradiol levels in post-menopausal women using adjuvant letrozole: Results of a prospective study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University Health Network; University of Toronto; Statistics Canada; Sunnybrook Health Science Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Letrozole; Medicine; Aromatase inhibitor; Anastrozole; Body mass index; Breast cancer; Tamoxifen; Overweight; Internal medicine; Prospective cohort study; Gynecology; Estrone; Estrogen; Multivitamin; Cancer; Vitamin","score_opus":0.1600313856943843,"score_gpt":0.4665626511030858,"score_spread":0.3065312654087015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594523044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966636,0.00027082063,6.0596506e-7,0.00057310925,0.00008554528,0.0013893668,0.0005027192,0.000012199809,0.0005020453],"genre_scores_gemma":[0.99887896,0.00010085798,0.000018515244,0.000007647304,0.00040048166,0.00010506278,0.00001062612,0.00002815573,0.00044969894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727607,0.0001290671,0.00045641552,0.00047290072,0.0010362337,0.0006292919],"domain_scores_gemma":[0.99821323,0.00023992291,0.0002969643,0.00048822194,0.0005592458,0.0002024304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027139005,0.00015734576,0.0005375045,0.00030916499,0.000278413,0.00009979179,0.00020941887,0.00013636047,0.00005628501],"category_scores_gemma":[0.0011257305,0.00014020115,0.000021623095,0.000209363,0.00019685164,0.00023594583,0.00015709113,0.0008056001,0.00000431714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014862262,0.00023383132,0.9356667,0.00010145296,0.00025878084,0.00007009204,0.00597864,0.0000074244626,0.049474727,0.000003622133,0.00017992676,0.006538601],"study_design_scores_gemma":[0.006307159,0.0016676809,0.9842456,0.0002468161,0.000044589426,0.0000017775104,0.0022431095,0.000007829118,0.0049628536,0.00005223884,0.00009219564,0.00012817272],"about_ca_topic_score_codex":0.020199291,"about_ca_topic_score_gemma":0.0029525657,"teacher_disagreement_score":0.048578903,"about_ca_system_score_codex":0.0025296216,"about_ca_system_score_gemma":0.0009794604,"threshold_uncertainty_score":0.98632526},"labels":[],"label_agreement":null},{"id":"W2594604923","doi":"10.1158/1538-7445.sabcs16-p4-21-23","title":"Abstract P4-21-23: A retrospective evaluation of cardiovascular recovery and oncologic outcomes associated with interrupted and continuous adjuvant trastuzumab in the setting of mild left ventricular dysfunction","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Ejection fraction; Breast cancer; Internal medicine; Asymptomatic; Oncology; Cancer; Adjuvant therapy; Cardiac function curve; Cardiology; Metastatic breast cancer; Surgery; Heart failure","score_opus":0.13438231319708782,"score_gpt":0.43730653060470037,"score_spread":0.30292421740761255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594604923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916052,0.005023607,0.0000078412,0.00069799635,0.00006578061,0.0018293837,0.00003143409,0.000008261274,0.000730446],"genre_scores_gemma":[0.99876225,0.0008723264,0.000016699105,0.000015756117,0.000049515613,0.00019425192,0.000013193778,0.00002052004,0.000055465174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957418,0.00077858113,0.00035694093,0.00041410048,0.0023054252,0.00040319026],"domain_scores_gemma":[0.9971755,0.00048225018,0.00023134373,0.0006172698,0.0014138735,0.000079737576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009788614,0.00014535802,0.0006794593,0.00028727952,0.00020670025,0.00006340395,0.00023004439,0.00014507923,0.000055834844],"category_scores_gemma":[0.004621276,0.00009452098,0.00010907514,0.0002893104,0.00050286925,0.00014084941,0.00011511798,0.00079058454,8.3621643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008455056,0.00021159134,0.95274466,0.00032600635,0.0010351768,0.0000901829,0.001828244,0.0001441223,0.0032371914,0.0000058301234,0.00024162559,0.03928985],"study_design_scores_gemma":[0.0043654293,0.0010848613,0.9885516,0.0010009143,0.00024348599,0.000018661816,0.0017832613,0.000356278,0.0023299817,0.00011321362,0.000062845975,0.00008944714],"about_ca_topic_score_codex":0.004127968,"about_ca_topic_score_gemma":0.0025675388,"teacher_disagreement_score":0.039200407,"about_ca_system_score_codex":0.0012660482,"about_ca_system_score_gemma":0.0007347224,"threshold_uncertainty_score":0.6240281},"labels":[],"label_agreement":null},{"id":"W2594666077","doi":"10.1158/1538-7445.sabcs16-p2-10-04","title":"Abstract P2-10-04: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multi-center trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Clinical endpoint; Neoadjuvant therapy; Internal medicine; Oncology; Hormonal therapy; Breast-conserving surgery; Cancer; Clinical trial; Mastectomy","score_opus":0.19620968973576544,"score_gpt":0.4605891565298436,"score_spread":0.2643794667940782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594666077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983414,0.0048244074,0.000079854755,0.0049817087,0.0007540909,0.0016661963,0.0042124027,0.000014160642,0.000053200685],"genre_scores_gemma":[0.9914332,0.0024710605,0.00032636637,0.00029822992,0.0027385412,0.0017867287,0.000110549874,0.00006939685,0.0007658977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978653,0.0000833567,0.00024312019,0.0006951311,0.00038846876,0.000724582],"domain_scores_gemma":[0.9980149,0.00008770562,0.0001442477,0.0010595619,0.0005217137,0.00017186627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053193676,0.0002884434,0.00031109355,0.00006328675,0.0012116707,0.0002302267,0.000848106,0.00015714104,0.00018785379],"category_scores_gemma":[0.00014072336,0.00019833054,0.00018336756,0.0000916607,0.000380223,0.000015708858,0.0004160659,0.00020666982,0.0000123728805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046061635,0.00074515975,0.01586993,0.000035678062,0.0012063063,0.000011690609,0.0008606008,0.0001269168,0.78809863,0.000005078222,0.021945491,0.12503287],"study_design_scores_gemma":[0.102902815,0.0006470776,0.31631112,0.00035191444,0.00011445562,0.000014967336,0.0010102927,0.00020250677,0.48163083,0.00008738451,0.09567897,0.0010476377],"about_ca_topic_score_codex":0.013559133,"about_ca_topic_score_gemma":0.00261841,"teacher_disagreement_score":0.3064678,"about_ca_system_score_codex":0.00023528097,"about_ca_system_score_gemma":0.00048009458,"threshold_uncertainty_score":0.9930097},"labels":[],"label_agreement":null},{"id":"W2594669550","doi":"10.1158/1538-7445.sabcs16-ot1-03-01","title":"Abstract OT1-03-01: The UK LORIS trial: Randomizing patients with low or low intermediate grade ductal carcinoma in situ (DCIS) to surgery or active monitoring","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Ductal carcinoma; Breast cancer; Mammography; Randomized controlled trial; Breast-conserving surgery; Natural history; Breast surgery; Biopsy; Mastectomy; Surgery; Cancer; General surgery; Internal medicine","score_opus":0.07067132631598565,"score_gpt":0.38075162387981815,"score_spread":0.3100802975638325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594669550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715716,0.00031981445,0.0000017107336,0.0004909877,0.000708049,0.0011607953,0.00006097793,0.0000073019773,0.00009319462],"genre_scores_gemma":[0.99694264,0.0005811558,0.000010063487,0.000026660216,0.0010872091,0.0011397839,0.000021501566,0.000044082994,0.0001468994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978747,0.00014641491,0.00025448215,0.0005636441,0.00048023945,0.0006805369],"domain_scores_gemma":[0.99839723,0.00038315004,0.00013958686,0.00069506094,0.00023986633,0.00014511563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005585275,0.00024357327,0.00037528382,0.00013521677,0.0004498195,0.00014132704,0.0005076862,0.00010036942,0.000032669723],"category_scores_gemma":[0.0008870795,0.00013923748,0.00009571568,0.00018282389,0.00029466688,0.000022752452,0.0003985974,0.00031998917,0.000011062133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44154328,0.0004752333,0.50812364,0.00016995014,0.0006193263,0.00030647815,0.002132381,0.00004285739,0.023815878,6.388177e-7,0.0026095437,0.020160787],"study_design_scores_gemma":[0.02931714,0.00034037398,0.8235591,0.0003301082,0.000020386524,0.0000022164022,0.0004931332,4.832314e-7,0.14547656,0.000003380682,0.00022820715,0.00022888965],"about_ca_topic_score_codex":0.0021418468,"about_ca_topic_score_gemma":0.005832758,"teacher_disagreement_score":0.41222614,"about_ca_system_score_codex":0.00030778712,"about_ca_system_score_gemma":0.00057357195,"threshold_uncertainty_score":0.567794},"labels":[],"label_agreement":null},{"id":"W2594719587","doi":"10.1158/1538-7445.sabcs16-p3-02-09","title":"Abstract P3-02-09: Do radiographic features influence the decision to order a breast MRI? A prospective cohort study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast MRI; Breast cancer; Neoadjuvant therapy; Radiology; Magnetic resonance imaging; Prospective cohort study; Lymph node; Breast imaging; Cohort; Cancer; Mammography; Internal medicine","score_opus":0.042877963986593166,"score_gpt":0.4715116377246202,"score_spread":0.428633673738027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594719587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692328,0.00023894879,0.0001991592,0.02350242,0.00004619912,0.00456848,0.000019875177,0.000075874326,0.0021162604],"genre_scores_gemma":[0.99416053,0.000323786,0.001042479,0.00027103708,0.00024026325,0.0033306098,0.000001992328,0.000025371555,0.00060392945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975659,0.000055873887,0.00019732316,0.0005267601,0.0012170898,0.00043700216],"domain_scores_gemma":[0.9968277,0.00019835829,0.000061997795,0.0016515843,0.0009215221,0.00033880104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018337227,0.00013522118,0.00023562067,0.0001917967,0.0010086374,0.00028696642,0.0008406695,0.00007004939,0.00025578326],"category_scores_gemma":[0.0008420602,0.00008061974,0.000060238148,0.0006434471,0.00054805767,0.00009933098,0.0003385872,0.0009774502,0.000059539867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042294725,0.00045621837,0.90033007,0.000033693927,0.00011561115,0.000059147318,0.0006407124,0.0000058512937,0.0050511556,0.00036719633,0.057177443,0.03533996],"study_design_scores_gemma":[0.0005458535,0.00018351473,0.9914945,0.00028572616,0.000029732213,0.000034358312,0.00018708008,0.000014637977,0.00043633036,0.00085544586,0.005840287,0.000092532675],"about_ca_topic_score_codex":0.0040315064,"about_ca_topic_score_gemma":0.00034560278,"teacher_disagreement_score":0.09116443,"about_ca_system_score_codex":0.00015860662,"about_ca_system_score_gemma":0.0003098714,"threshold_uncertainty_score":0.77577245},"labels":[],"label_agreement":null},{"id":"W2594782791","doi":"10.1158/1538-7445.sabcs16-p6-09-39","title":"Abstract P6-09-39: The role of quantitative estrogen receptor status in predicting breast tumor response to neoadjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Logistic regression; Internal medicine; Confounding; Estrogen receptor; Proportional hazards model; Odds ratio; Chemotherapy; Cancer; Neoadjuvant therapy","score_opus":0.03673876524185959,"score_gpt":0.39523180507134137,"score_spread":0.3584930398294818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594782791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930211,0.0026956114,0.0000031140385,0.002922844,0.00007733966,0.00048199872,0.00036672398,0.0000059276194,0.00042537396],"genre_scores_gemma":[0.9986038,0.00051701313,0.00017816562,0.00005213227,0.00016199205,0.00033444623,0.000011381242,0.000031736374,0.00010931725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982698,0.000189427,0.00021753088,0.00040749952,0.00035761148,0.00055811054],"domain_scores_gemma":[0.99860704,0.0001349248,0.00012601062,0.0007106751,0.00030518297,0.00011617363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010084657,0.0001536328,0.0002031143,0.000082827646,0.00035593798,0.000054844797,0.00052775705,0.0000613192,0.000058740432],"category_scores_gemma":[0.0004896014,0.00011533867,0.00006431351,0.00012922673,0.00038222838,0.000010451909,0.00029240822,0.00021483327,0.000015390684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076211034,0.000095908916,0.136624,0.000017258868,0.00013235121,0.000005243326,0.0016824045,0.000046293462,0.83189815,0.00003578748,0.0004555539,0.021385929],"study_design_scores_gemma":[0.0011314095,0.00027122127,0.6308335,0.00012213059,0.0000054262405,0.000004086234,0.002301241,0.000008795543,0.355896,0.000058835893,0.009244114,0.00012323068],"about_ca_topic_score_codex":0.0059917076,"about_ca_topic_score_gemma":0.0010637714,"teacher_disagreement_score":0.4942095,"about_ca_system_score_codex":0.00016873163,"about_ca_system_score_gemma":0.00047057917,"threshold_uncertainty_score":0.90577096},"labels":[],"label_agreement":null},{"id":"W2594801147","doi":"10.1158/0008-5472.can-16-2568","title":"<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Medical Research Council; National Institute for Health and Care Research; Wellcome Trust; Francis Crick Institute; National Cancer Institute; Cancer Research UK; World Health Organization; American Association for Cancer Research","keywords":"Missense mutation; Breast cancer; Medicine; Cancer; Genetics; Oncology; Biology; Internal medicine; Mutation; Gene","score_opus":0.16804250893273548,"score_gpt":0.4533280885141192,"score_spread":0.28528557958138373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594801147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98860466,0.004058177,0.00013845385,0.0025619832,0.00045341504,0.000355117,0.00073962606,0.000008869103,0.0030796865],"genre_scores_gemma":[0.9929031,0.0033602521,0.00013865769,0.00014490148,0.0006209627,0.00027906528,0.000023928547,0.000048480546,0.002480637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998112,0.00015330232,0.00023753782,0.00053892727,0.000442678,0.00051550235],"domain_scores_gemma":[0.997358,0.00002624946,0.00015496604,0.0012542842,0.0010502957,0.00015620531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006499472,0.00016616804,0.00021799817,0.00008227942,0.00051232113,0.000116141084,0.00073426677,0.00019794294,0.0006132534],"category_scores_gemma":[0.00014840461,0.00016103256,0.000079648846,0.00010727181,0.00069354306,0.000012853027,0.00035680586,0.00029913586,0.000021652519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066146627,0.00007022126,0.004661755,0.0000693578,0.00021794246,0.000016900494,0.00011832005,0.0006810777,0.95404524,0.00016563397,0.028138947,0.011153166],"study_design_scores_gemma":[0.0018806591,0.00013032195,0.052835956,0.00015480825,0.000041106312,0.00004868114,0.000106965126,0.00045558394,0.9156481,0.00059999817,0.027700722,0.0003970714],"about_ca_topic_score_codex":0.0037429528,"about_ca_topic_score_gemma":0.00104678,"teacher_disagreement_score":0.0481742,"about_ca_system_score_codex":0.00016065319,"about_ca_system_score_gemma":0.001617981,"threshold_uncertainty_score":0.6714695},"labels":[],"label_agreement":null},{"id":"W2594815867","doi":"10.1158/1538-7445.sabcs16-p3-09-05","title":"Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germline; Breast cancer; Germline mutation; PALB2; Medicine; Cancer; Oncology; Triple-negative breast cancer; Genetic testing; Internal medicine; Somatic cell; Genetics; Homologous recombination; Gene; Biology; Mutation","score_opus":0.0884480401652624,"score_gpt":0.446192496076065,"score_spread":0.35774445591080256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594815867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654305,0.00025365545,0.000011382951,0.00093839667,0.00027922587,0.0015102631,0.00017199028,0.000012984236,0.00027902276],"genre_scores_gemma":[0.997809,0.0005377697,0.00082791434,0.000043082808,0.000081543236,0.0003457402,0.0000142447325,0.000044109114,0.00029661428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974525,0.00014293625,0.0005716315,0.00054149836,0.00080842857,0.00048300863],"domain_scores_gemma":[0.99753803,0.00029792316,0.00037107265,0.0006360626,0.0009438583,0.00021303404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091438397,0.00020457362,0.00063230796,0.00022321993,0.00017532619,0.00003836673,0.0002765746,0.00015224278,0.00029822034],"category_scores_gemma":[0.0005571584,0.0001451361,0.000041369345,0.00026402136,0.0007499368,0.00019346635,0.00013311634,0.0006856227,0.000004012565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005103539,0.00041430598,0.93951803,0.00028101337,0.00008901449,0.00004054391,0.0002380955,0.000034847686,0.0011909769,0.000003956596,0.000076802615,0.053008858],"study_design_scores_gemma":[0.010617788,0.0015909707,0.9836961,0.0005926725,0.00004074327,0.0000078365965,0.000062638166,0.0000782334,0.0030195266,0.00012208518,0.000017863862,0.00015352908],"about_ca_topic_score_codex":0.0023271583,"about_ca_topic_score_gemma":0.0031622627,"teacher_disagreement_score":0.052855328,"about_ca_system_score_codex":0.00044710864,"about_ca_system_score_gemma":0.0006718206,"threshold_uncertainty_score":0.59184784},"labels":[],"label_agreement":null},{"id":"W2594831399","doi":"10.1158/1538-7445.sabcs16-p1-05-24","title":"Abstract P1-05-24: A head-to-head comparison of paraffin-embedded MammaPrnt versus oncotype DX: A Mcgill University Healh Center experience","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Concordance; Breast cancer; Internal medicine; Oncology; Cancer; Population; Gynecology; Stage (stratigraphy)","score_opus":0.19223385201050625,"score_gpt":0.4880484086905109,"score_spread":0.29581455668000467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594831399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947321,0.00044698574,0.000047331534,0.0010892219,0.0006722824,0.00036521044,0.00026457832,0.000010744204,0.0023715529],"genre_scores_gemma":[0.99782586,0.00024902588,0.00048833777,0.00004908157,0.00017971885,0.00004338736,0.000021666843,0.000024608442,0.0011182942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817264,0.00009272568,0.0002245499,0.0005597419,0.00043814178,0.00051218015],"domain_scores_gemma":[0.9981258,0.00004340816,0.0001335038,0.0010763445,0.00040469848,0.00021623258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120274,0.00015392833,0.00023771284,0.00011523814,0.00054937485,0.00003370828,0.00092233217,0.00016254745,0.00013994517],"category_scores_gemma":[0.0001853229,0.00016593459,0.00009050545,0.00016174726,0.00037698084,0.000014972245,0.0004994412,0.0002947593,0.000034148383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005654634,0.00041119815,0.01218141,0.00013760531,0.00019055947,0.000041388594,0.0017106375,0.0012748952,0.89957017,0.00011328159,0.050382156,0.028332068],"study_design_scores_gemma":[0.0025642533,0.0006911457,0.02026443,0.00010463166,0.000012271608,0.0000027554227,0.0013479079,0.00006522762,0.5529447,0.000014668298,0.42168722,0.00030077543],"about_ca_topic_score_codex":0.0019379213,"about_ca_topic_score_gemma":0.0051951627,"teacher_disagreement_score":0.37130505,"about_ca_system_score_codex":0.0005594471,"about_ca_system_score_gemma":0.000579942,"threshold_uncertainty_score":0.6766616},"labels":[],"label_agreement":null},{"id":"W2594859485","doi":"10.1158/1538-7445.sabcs16-p4-07-06","title":"Abstract P4-07-06: MicroRNAs associated with acquired taxane resistance in a breast cancer cell line model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"microRNA; Paclitaxel; Taxane; Fold change; Breast cancer; Drug resistance; Cancer research; Biology; Cancer; Downregulation and upregulation; Gene; Genetics","score_opus":0.04152032540265908,"score_gpt":0.3547081671602331,"score_spread":0.313187841757574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594859485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920674,0.004399192,0.000025779504,0.0010651596,0.000039641593,0.00039211492,0.00049033586,0.000010986493,0.0015094144],"genre_scores_gemma":[0.9934517,0.00128145,0.00009579062,0.000056875033,0.00021408265,0.00024263155,0.00012712764,0.000053227002,0.004477086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980958,0.00008304599,0.0002238738,0.00057614985,0.0004167926,0.00060433475],"domain_scores_gemma":[0.99826574,0.000017524613,0.00020160447,0.00085384544,0.00049969216,0.00016161129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005464413,0.00018771036,0.00019587082,0.000062215164,0.00030925742,0.00012377679,0.0006052619,0.00021391136,0.0001676745],"category_scores_gemma":[0.00009236104,0.00017501386,0.000056542183,0.00010778695,0.00030812286,0.000023753193,0.00020118218,0.0002008968,0.000014140089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006920786,0.00013411533,0.006189031,0.000081988685,0.00005094421,0.000018257844,0.000055575383,0.0010986921,0.9853773,0.000009496919,0.0060152602,0.00027726075],"study_design_scores_gemma":[0.0032125642,0.0000643072,0.340387,0.0006906185,0.0000259205,0.0000024304532,0.000049655064,0.00074669265,0.6520377,0.00016065834,0.0020833192,0.00053916464],"about_ca_topic_score_codex":0.0018423029,"about_ca_topic_score_gemma":0.015688282,"teacher_disagreement_score":0.33419797,"about_ca_system_score_codex":0.00042400567,"about_ca_system_score_gemma":0.00085304485,"threshold_uncertainty_score":0.8754429},"labels":[],"label_agreement":null},{"id":"W2594893579","doi":"10.1158/1538-7445.sabcs16-p6-16-02","title":"Abstract P6-16-02: Beta-adrenergic receptor blockers (BB) and increased progression free survival (PFS) in patients with advanced triple negative breast cancer (TNBC): A retrospective analysis of the ROSE/TRIO012 study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Progression-free survival; Breast cancer; Oncology; Exact test; Cancer; Population; Clinical trial; Proportional hazards model; Placebo; Retrospective cohort study; Hazard ratio; Chemotherapy; Confidence interval","score_opus":0.026465790597698876,"score_gpt":0.3629179496894112,"score_spread":0.33645215909171233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594893579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947103,0.0010754105,2.2610621e-7,0.0009174816,0.00015434223,0.0024759895,0.000487684,0.000017628332,0.0001609302],"genre_scores_gemma":[0.998106,0.0006904699,0.0000203983,0.000018024886,0.00015148142,0.00063157803,0.000024797708,0.00004979459,0.0003074601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957335,0.0005138017,0.00050123036,0.0007664101,0.0018272116,0.0006578362],"domain_scores_gemma":[0.996327,0.00027028745,0.0005060011,0.001545717,0.0011115683,0.00023943778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012767354,0.00032825232,0.0010720756,0.000600699,0.000596412,0.00010096146,0.00067025545,0.00013838655,0.0003635164],"category_scores_gemma":[0.0006231816,0.00021045563,0.00019138739,0.0015544525,0.00096440624,0.0002811105,0.0003074675,0.00079792616,0.0000012021156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020502504,0.0010517552,0.95971316,0.00008281681,0.0012485227,0.000014837901,0.001674531,0.00002421911,0.0011366972,0.0000032300463,0.0003009301,0.014246776],"study_design_scores_gemma":[0.013146105,0.001001922,0.9790806,0.0006724459,0.00058017106,0.0000010515638,0.001504161,0.000023254368,0.0036530432,0.000008536187,0.00010309325,0.00022560639],"about_ca_topic_score_codex":0.04399241,"about_ca_topic_score_gemma":0.034412332,"teacher_disagreement_score":0.01936743,"about_ca_system_score_codex":0.001213265,"about_ca_system_score_gemma":0.0010372504,"threshold_uncertainty_score":0.9832071},"labels":[],"label_agreement":null},{"id":"W2598458592","doi":"10.1158/1538-7445.am2017-326","title":"Abstract 326: Baseline IL-17 receptor signaling is essential for controlling aberrant JNK-dependent cellular proliferation via maintenance of endogenous level of ubiquitin-editing enzyme A20","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Downregulation and upregulation; Gene knockdown; Cancer research; Biology; Cell growth; Signal transduction; Small hairpin RNA; Cell biology; Cell culture; Biochemistry","score_opus":0.14435837372062463,"score_gpt":0.36805693997169175,"score_spread":0.22369856625106713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598458592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97382236,0.0046045547,0.015426319,0.0011224503,0.0012586747,0.0016192263,0.0016301796,0.000025590301,0.00049062143],"genre_scores_gemma":[0.9954212,0.0002805246,0.00016482273,0.000044826047,0.0003289559,0.00017384457,0.00009232923,0.000036890946,0.0034566058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976133,0.00026456694,0.0007410608,0.00040856647,0.00019734689,0.0007751565],"domain_scores_gemma":[0.997061,0.00059200625,0.00054499856,0.000517895,0.0012422,0.0000418636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031952031,0.00020134792,0.0005409369,0.0001873555,0.0006688114,0.000053557476,0.00059866195,0.00024616637,0.0015390272],"category_scores_gemma":[0.0010356033,0.00018105823,0.0001952999,0.000056247623,0.0005046967,0.00015878046,0.00014147052,0.00052911753,0.000040773157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037660303,0.00013818961,0.00006388183,0.00027613898,0.00023598364,0.000005184197,0.00087873294,0.00006224109,0.9871019,0.00010563894,0.0028809393,0.0044851536],"study_design_scores_gemma":[0.0027684353,0.00038050427,0.0000586292,0.00043368997,0.000032513228,0.000009309675,0.00047105007,0.00021762309,0.99145323,0.000048431702,0.0039680344,0.00015853014],"about_ca_topic_score_codex":0.0013719209,"about_ca_topic_score_gemma":0.00015546057,"teacher_disagreement_score":0.021598816,"about_ca_system_score_codex":0.00014209453,"about_ca_system_score_gemma":0.00042824625,"threshold_uncertainty_score":0.9993737},"labels":[],"label_agreement":null},{"id":"W2603085196","doi":"10.1158/0008-5472.can-16-3247","title":"Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Medical Research Council; Directorate for Biological Sciences; Medical Research Council Canada; University of Oxford; National Institute for Health and Care Research; Cancer Research UK; Pancreatic Cancer UK","keywords":"Epitope; Cancer immunotherapy; Cancer; Immunotherapy; Cancer research; Monoclonal antibody; Antibody; Antigen; T cell; T-cell receptor; Cancer cell; Biology; Immune system; Context (archaeology); Immunology","score_opus":0.13443582584041167,"score_gpt":0.4802923012255702,"score_spread":0.3458564753851585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603085196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888831,0.0038804954,0.00004943371,0.0016850405,0.00045859642,0.002087076,0.000047088226,0.000044419503,0.0028647901],"genre_scores_gemma":[0.9094595,0.024964243,0.005553625,0.000280133,0.0010847627,0.0016099551,0.00010362546,0.00030557188,0.056638606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967291,0.00010467662,0.00044058458,0.00055298524,0.0012059999,0.0009666489],"domain_scores_gemma":[0.99664164,0.00017776969,0.0001694618,0.0012367805,0.001507023,0.00026735573],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018895086,0.00022149296,0.00053300505,0.000345499,0.00061251107,0.00010203838,0.0008278824,0.00017519885,0.0028201144],"category_scores_gemma":[0.0002158207,0.00019342042,0.00015531093,0.00032711707,0.000521518,0.000119515025,0.00020782143,0.0006164765,0.000046953555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031750822,0.00020627884,0.003922232,0.00046586076,0.00022616265,0.0000055580085,0.0011391959,0.0000022217432,0.864158,0.0000150957285,0.005289755,0.12139461],"study_design_scores_gemma":[0.0029399851,0.0002616232,0.0028188333,0.0003520814,0.000008791551,7.9839396e-7,0.00016753707,0.00003721569,0.6036591,0.00001548059,0.38959208,0.0001464407],"about_ca_topic_score_codex":0.001012652,"about_ca_topic_score_gemma":0.00034951177,"teacher_disagreement_score":0.38430235,"about_ca_system_score_codex":0.00084612734,"about_ca_system_score_gemma":0.0035899442,"threshold_uncertainty_score":0.99809146},"labels":[],"label_agreement":null},{"id":"W2603709537","doi":"10.1158/1538-7445.transcontrol16-a31","title":"Abstract A31: eIF4F links translation to energy stress response in cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; British Columbia Institute of Technology; McGill University","funders":"","keywords":"Cancer; Cancer cell; Biology; mTORC1; Kinase; Cancer research; Integrated stress response; PI3K/AKT/mTOR pathway; Carcinogenesis; Translational efficiency; Translation (biology); Cell biology; Signal transduction; Genetics; Gene","score_opus":0.08489605755528071,"score_gpt":0.4272989880783974,"score_spread":0.34240293052311666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603709537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835468,0.011179602,0.0000641269,0.0024723662,0.0009127587,0.0002661981,0.00016984445,0.0000080365935,0.0013802754],"genre_scores_gemma":[0.98634493,0.007691148,0.00005108941,0.00021882905,0.0022958016,0.000456096,0.000025930569,0.000036430698,0.0028797528],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981734,0.00015123734,0.00020642894,0.0005195287,0.00037772645,0.00057164085],"domain_scores_gemma":[0.9986877,0.000038419916,0.000059953472,0.0007764889,0.00022423464,0.00021323009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008973354,0.00014805322,0.00018109955,0.00017345104,0.00028482612,0.00012122475,0.00057769753,0.00030406908,0.0001896533],"category_scores_gemma":[0.00020120658,0.00014949536,0.00007144756,0.00013539864,0.0001523297,0.000013850581,0.0001427832,0.00038849222,0.000010982314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025824488,0.000050394883,0.0013049812,0.000029204442,0.000025376861,0.000005117028,0.00021644936,0.00038619436,0.8635359,0.000030631418,0.0070791696,0.12475412],"study_design_scores_gemma":[0.00088166207,0.00011614844,0.082855225,0.00009638319,0.0000050597523,7.7398664e-7,0.00005752109,0.000016983233,0.34258294,0.00004521294,0.5731396,0.00020247068],"about_ca_topic_score_codex":0.009345298,"about_ca_topic_score_gemma":0.026041234,"teacher_disagreement_score":0.5660604,"about_ca_system_score_codex":0.000103319166,"about_ca_system_score_gemma":0.0006801186,"threshold_uncertainty_score":0.9972516},"labels":[],"label_agreement":null},{"id":"W2604477542","doi":"","title":"Uterine cancer cells proliferate differently in response to 17β-estradiol in presence or absence of tamoxifen, raloxifen and ICI 182 780","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Tamoxifen; Cell culture; HeLa; Cell growth; Endometrial cancer; Endocrinology; Cancer; Internal medicine; Cancer research; Cell; Cancer cell; Chemistry; Intracellular; Breast cancer; Medicine; Biology; Biochemistry","score_opus":0.031495730041236174,"score_gpt":0.38075484260503234,"score_spread":0.34925911256379616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604477542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947621,0.0033897797,0.0000096930025,0.0009327256,0.000058685826,0.0007385428,0.00004187774,0.000005397406,0.000061185616],"genre_scores_gemma":[0.99295086,0.003988637,0.00013162046,0.00007949645,0.00013280523,0.00036641958,0.000004983676,0.00002430526,0.002320846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980803,0.00036041797,0.00027433128,0.00047330113,0.00027351605,0.00053809106],"domain_scores_gemma":[0.9992415,0.00008793866,0.000041740954,0.00031532897,0.00012379886,0.00018973576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007062546,0.00016046481,0.00023244755,0.00021076854,0.00004328749,0.000022302758,0.00027358293,0.0001754029,0.000045284574],"category_scores_gemma":[0.00016781679,0.00012863173,0.000026817428,0.00048538027,0.00018071834,0.00001074195,0.0002064955,0.000355123,0.0000057495495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050476645,0.00008745642,0.010760064,0.00009078389,0.000018596515,0.000039770657,0.00035746198,0.00068090635,0.97777236,0.0000069937373,0.0008773669,0.0042605847],"study_design_scores_gemma":[0.0013020419,0.00066528394,0.04704674,0.00024947934,0.00000279985,0.000008868953,0.000052615967,0.0002833753,0.94538474,0.000007683375,0.0048046997,0.00019165206],"about_ca_topic_score_codex":0.000869265,"about_ca_topic_score_gemma":0.0017659821,"teacher_disagreement_score":0.036286674,"about_ca_system_score_codex":0.00009946506,"about_ca_system_score_gemma":0.00044507137,"threshold_uncertainty_score":0.524545},"labels":[],"label_agreement":null},{"id":"W2605882734","doi":"","title":"The western diet, endogenous cytotoxin and genotoxin formation, a possible cause of carcinogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biochemistry; Oxidative stress; Glutathione; Hepatocyte; Cytotoxicity; Dihydroxyacetone; Reactive oxygen species; Fructose; Chemistry; Biology","score_opus":0.17009672597449554,"score_gpt":0.38514149563567,"score_spread":0.21504476966117447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605882734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685302,0.028752537,0.000010574214,0.0005517715,0.000059922248,0.0006706081,0.000050192437,0.000020193816,0.0013540357],"genre_scores_gemma":[0.983964,0.013300537,0.000017950642,0.00012301536,0.00019830585,0.00023061194,0.00000707086,0.000023317674,0.0021351867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982332,0.00013617749,0.0002556415,0.00020925274,0.00069965364,0.00046609613],"domain_scores_gemma":[0.99856037,0.00014941617,0.000051461953,0.00043692582,0.00049478107,0.00030704803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005408954,0.000110818524,0.0002378582,0.00015227638,0.00045728436,0.000027193488,0.00016060544,0.000055497374,0.000041528026],"category_scores_gemma":[0.00017849449,0.000074553434,0.000065117405,0.00037135824,0.00045685956,0.000114906405,0.000102497,0.00018592953,0.000020213776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066427905,0.0006321671,0.5645823,0.0015475868,0.0004162444,0.0009091989,0.015649673,0.000016827285,0.375906,0.00049970334,0.01686451,0.016333045],"study_design_scores_gemma":[0.0047034407,0.0008419379,0.6358305,0.00018715196,0.00018064624,0.00036500013,0.0016970377,0.00006564842,0.3309631,0.0002121765,0.024659377,0.00029399522],"about_ca_topic_score_codex":0.0009043971,"about_ca_topic_score_gemma":0.00029933554,"teacher_disagreement_score":0.07124823,"about_ca_system_score_codex":0.00008729883,"about_ca_system_score_gemma":0.0006234789,"threshold_uncertainty_score":0.3517108},"labels":[],"label_agreement":null},{"id":"W2606220448","doi":"10.1158/0008-5472.can-16-3217","title":"Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Institute of Technology","funders":"National Cancer Institute","keywords":"Cancer; Cancer detection; Computational biology; Medicine; Cancer research; Biology; Internal medicine","score_opus":0.08548452062858268,"score_gpt":0.4310294747293291,"score_spread":0.3455449541007464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606220448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948867,0.017773727,0.0282338,0.00012630218,0.0013169498,0.00091841083,0.000083295185,0.00009917362,0.0025813307],"genre_scores_gemma":[0.9937578,0.0016183022,0.0037603453,0.0000051453403,0.00030001978,0.00036258838,9.980411e-7,0.00005691494,0.00013792155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891305,0.00002274732,0.00016932296,0.00020596142,0.00026151817,0.00042738556],"domain_scores_gemma":[0.99897075,0.00017838356,0.00003993747,0.0004561244,0.00023260886,0.00012222274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079195783,0.000114517214,0.00022083728,0.000118680764,0.0003121074,0.00005918591,0.00026906436,0.0001184047,0.000041348354],"category_scores_gemma":[0.00018863151,0.00011083973,0.00004768076,0.000081118334,0.0002735895,0.00016269418,0.00007502257,0.00025079917,0.0000014895236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000773118,0.0000064901296,0.00008802422,0.00031259912,0.00007382634,0.0000016646509,0.00016523413,0.0003801738,0.7947657,0.0006749127,0.00009513986,0.20335895],"study_design_scores_gemma":[0.0005325698,0.00009213383,0.0024605868,0.000072371884,0.000019571724,0.0000020669506,0.000030324722,0.0027395063,0.98039085,0.0044818274,0.00904398,0.00013422256],"about_ca_topic_score_codex":0.00030563903,"about_ca_topic_score_gemma":0.0006540703,"teacher_disagreement_score":0.20322472,"about_ca_system_score_codex":0.00032620676,"about_ca_system_score_gemma":0.00012904806,"threshold_uncertainty_score":0.4519913},"labels":[],"label_agreement":null},{"id":"W2606795521","doi":"","title":"Phosphorylation of Akt isoforms induces resistance to cisplatin, doxorubicin and paclitaxel in human uterine cancer cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"AKT2; PTEN; AKT1; Tensin; Protein kinase B; AKT3; Cisplatin; Cancer research; Endometrial cancer; Cancer; PI3K/AKT/mTOR pathway; Protein phosphatase 2; Biology; Phosphorylation; Phosphatase; Chemistry; Medicine; Internal medicine; Signal transduction; Chemotherapy; Cell biology","score_opus":0.04474266785740266,"score_gpt":0.4083974752365446,"score_spread":0.36365480737914196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606795521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922372,0.0057687876,0.000047515525,0.00060915534,0.000091752874,0.0003804679,0.00008552451,0.0000065765707,0.0007729805],"genre_scores_gemma":[0.9947902,0.0011899304,0.00036152496,0.0001543339,0.00036470237,0.0002578721,0.000014636781,0.0000314047,0.0028353794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827546,0.000083306884,0.00032523964,0.00048199334,0.00037696635,0.0004570121],"domain_scores_gemma":[0.99914134,0.000032186384,0.0000819597,0.00036131468,0.0002558505,0.00012735622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006961634,0.00015136086,0.00020765617,0.00016529261,0.0000982706,0.000028115137,0.00027008087,0.00015204593,0.00017371158],"category_scores_gemma":[0.000058511694,0.0001457872,0.000034399665,0.00037005896,0.0001732661,0.000013954842,0.00018157804,0.00021813858,0.000003459367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025530808,0.00003415346,0.0024903275,0.000095957235,0.000020381725,0.0000016339476,0.00033545544,0.0004875127,0.98592335,0.00006783622,0.0044336244,0.0058544655],"study_design_scores_gemma":[0.0005699235,0.00018974348,0.0046836184,0.00016843835,0.0000034465438,3.947833e-7,0.00007660019,0.000014647986,0.9598158,0.00010028119,0.03420956,0.00016753974],"about_ca_topic_score_codex":0.0010869834,"about_ca_topic_score_gemma":0.006146157,"teacher_disagreement_score":0.029775938,"about_ca_system_score_codex":0.00020140386,"about_ca_system_score_gemma":0.00021112298,"threshold_uncertainty_score":0.5945029},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2607157154","doi":"10.1158/0008-5472.can-16-2171","title":"Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Alberta Cancer Foundation; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Notch signaling pathway; JAG1; Glioma; Biology; Cancer research; Extracellular matrix; Integrin; Signal transduction; Pathology; Cell biology; Medicine; Genetics; Receptor","score_opus":0.10887561803449435,"score_gpt":0.43856009363092285,"score_spread":0.3296844755964285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607157154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950733,0.000097339864,0.000020130816,0.0016446811,0.00001821758,0.0006882207,0.00001688311,0.000008352027,0.0024328444],"genre_scores_gemma":[0.9988332,0.000030141775,0.0001388526,0.000033799242,0.00008101303,0.00006837937,0.000011986018,0.00003352295,0.0007691371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731463,0.00021968303,0.00039264542,0.0003340224,0.0012515661,0.00048747862],"domain_scores_gemma":[0.99774474,0.0004746497,0.00020070399,0.0005583389,0.0008825101,0.0001390856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020764105,0.000107714244,0.0003398318,0.00030624776,0.00024722246,0.00004149533,0.00043626074,0.000076847035,0.0003514527],"category_scores_gemma":[0.0019384667,0.000096770986,0.00006512126,0.0003425662,0.00041222732,0.00013407972,0.00024610845,0.0006360803,0.000007409223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014719866,0.0001519133,0.020632517,0.000788484,0.000019148552,0.000022488694,0.00038278813,0.0000020987075,0.97511184,0.000053725413,0.001182514,0.0015052553],"study_design_scores_gemma":[0.0011493192,0.00037972318,0.012035952,0.00090691325,0.0000043419827,0.0000010472446,0.0002332736,0.00014151771,0.98481786,0.00018370488,0.00006923548,0.00007711404],"about_ca_topic_score_codex":0.0041565364,"about_ca_topic_score_gemma":0.00006595381,"teacher_disagreement_score":0.009705989,"about_ca_system_score_codex":0.00021120872,"about_ca_system_score_gemma":0.00036697017,"threshold_uncertainty_score":0.62834674},"labels":[],"label_agreement":null},{"id":"W2607233662","doi":"","title":"NPR1 over expression reduces the proliferation of rhybdomyosarcoma (RMS) cells by inhibiting MAPK/ERK1,2 signaling in vitro","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Angiogenesis; Neuropilin 1; Biology; Molecular biology; Cell culture; Cell growth; Flow cytometry; Cancer research; Vascular endothelial growth factor; Genetics","score_opus":0.045208968393566,"score_gpt":0.3505049607067014,"score_spread":0.3052959923131354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607233662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932362,0.005935158,0.00006983569,0.00017364023,0.000059837792,0.00028260713,0.00003332998,0.0000038237695,0.00020556449],"genre_scores_gemma":[0.9973788,0.0014243928,0.000101030804,0.00007743862,0.0003367455,0.00016602903,0.000036008685,0.000021585969,0.00045794222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985457,0.00019802286,0.00023933202,0.00031342736,0.00037402665,0.0003294738],"domain_scores_gemma":[0.999455,0.000044798424,0.00007406811,0.00020939333,0.00016574675,0.00005099017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006136916,0.00010459973,0.0001295533,0.00006326815,0.00019792558,0.00001764173,0.0002234292,0.000113793394,0.000054339205],"category_scores_gemma":[0.000047126872,0.00007703942,0.00006654165,0.00021236113,0.00020106851,0.000008401311,0.00013646432,0.00017981227,0.0000023036343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021584693,0.000039762403,0.0009960865,0.000024323917,0.000010535807,0.0000025281386,0.00019816117,0.000117348514,0.9884939,0.0000029877795,0.008601754,0.0012967617],"study_design_scores_gemma":[0.00033883916,0.000060134582,0.00019113823,0.00006759923,0.0000021222131,0.0000022940935,0.00015071842,0.00004817192,0.9947222,0.000012492301,0.0043115364,0.000092770504],"about_ca_topic_score_codex":0.00018782067,"about_ca_topic_score_gemma":0.000014259237,"teacher_disagreement_score":0.0062282793,"about_ca_system_score_codex":0.00005056763,"about_ca_system_score_gemma":0.00021770947,"threshold_uncertainty_score":0.3141576},"labels":[],"label_agreement":null},{"id":"W2607528826","doi":"","title":"Preclinical assessment of a fixed dose combination of novel liposome formulations of idarubicin and gemcitabine showing improved antitumor activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pharmacology; Drug; Idarubicin; Medicine; Liposome; Therapeutic index; Pharmacokinetics; Chemotherapy; Cytarabine; Chemistry; Internal medicine","score_opus":0.2040143750113472,"score_gpt":0.5404268104338324,"score_spread":0.3364124354224852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607528826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964862,0.000337131,0.00017262291,0.0015155029,0.00005326966,0.00075549295,0.00005867627,0.000006769218,0.00061432703],"genre_scores_gemma":[0.998121,0.00026770076,0.0011398353,0.000016834007,0.00008537654,0.00008198099,0.000012982648,0.000010342034,0.00026395408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99893606,0.00006726021,0.0003088736,0.00018018897,0.00032007872,0.00018752507],"domain_scores_gemma":[0.9988438,0.00037283165,0.00012547943,0.00016828741,0.0004094962,0.00008014039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062895863,0.00007617265,0.0003446375,0.0002071769,0.000043800388,0.0000037372183,0.00006144183,0.0000636,0.00016227247],"category_scores_gemma":[0.000095762465,0.00006627323,0.000060717248,0.00029013687,0.00020893327,0.00011527771,0.00007094109,0.00023245436,2.1810756e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084058597,0.0016168158,0.0455864,0.00035771378,0.00013620673,7.600405e-7,0.00026121287,0.000023937471,0.937836,0.00048761413,0.00007078804,0.012781971],"study_design_scores_gemma":[0.011059665,0.0017218632,0.6240474,0.00019427144,0.00012879075,0.0000026618145,0.000045002376,0.011490284,0.35102215,0.000047611,0.00017358258,0.00006670695],"about_ca_topic_score_codex":0.0006049274,"about_ca_topic_score_gemma":0.00018562026,"teacher_disagreement_score":0.5868138,"about_ca_system_score_codex":0.00018716113,"about_ca_system_score_gemma":0.00047299714,"threshold_uncertainty_score":0.27025437},"labels":[],"label_agreement":null},{"id":"W2609245071","doi":"10.1158/0008-5472.can-16-2258","title":"Widespread Use of Misidentified Cell Line KB (HeLa): Incorrect Attribution and Its Impact Revealed through Mining the Scientific Literature","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"HeLa; Attribution; Authorship attribution; Scientific literature; Cancer; Cancer cell lines; Cell culture; Medicine; Psychology; Computer science; Biology; Internal medicine; Genetics; Cancer cell; Natural language processing; Social psychology","score_opus":0.09198637834454246,"score_gpt":0.4459731720196674,"score_spread":0.353986793675125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609245071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923691,0.0066083786,0.00015086713,0.0002676192,0.000060346934,0.0003054997,0.00005742551,0.000007019256,0.00017370311],"genre_scores_gemma":[0.9902817,0.0024822627,0.0001476918,0.000024903009,0.00013952769,0.000043322954,0.000118488104,0.000016381566,0.0067457035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985029,0.00022411392,0.0001943716,0.0004416869,0.0003284528,0.000308459],"domain_scores_gemma":[0.99779516,0.000078004115,0.00015809055,0.0010445791,0.0008605713,0.000063594205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013472905,0.00012227819,0.0001672028,0.000086839915,0.00064758415,0.0006627892,0.0004965638,0.00014137677,0.00002639321],"category_scores_gemma":[0.0007914542,0.00008631319,0.00010549925,0.0002411224,0.00045223357,0.000042660457,0.00047690226,0.00025154414,0.0000024609453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010243604,0.000027317443,0.0034984767,0.000052010488,0.00004257563,0.000005758762,0.00021560167,0.000007285516,0.9657609,0.00000439325,0.028967036,0.0013162019],"study_design_scores_gemma":[0.00020719074,0.00011140849,0.0035875188,0.00014836446,0.00002395775,0.000004440237,0.000031648447,0.00011672452,0.9829874,0.00004198251,0.012645372,0.00009399885],"about_ca_topic_score_codex":0.00045155748,"about_ca_topic_score_gemma":0.00027330648,"teacher_disagreement_score":0.017226486,"about_ca_system_score_codex":0.00004227882,"about_ca_system_score_gemma":0.00017171535,"threshold_uncertainty_score":0.63912916},"labels":[],"label_agreement":null},{"id":"W2611264160","doi":"","title":"Expression of cytokines in the vitreous of a uveal melanoma animal model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Macrophage migration inhibitory factor; Cytokine; Proinflammatory cytokine; Vascular endothelial growth factor; Cancer research; Angiogenesis; Macrophage; Immune system; Interferon; Medicine; Chemistry; Immunology; Pathology; Inflammation; Molecular biology; Biology; VEGF receptors; In vitro; Biochemistry","score_opus":0.0617313806445227,"score_gpt":0.37062691353886523,"score_spread":0.3088955328943425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611264160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652374,0.0021253482,0.00002505287,0.0004366279,0.000039156446,0.0002073766,0.000057105368,0.0000056254803,0.00057996303],"genre_scores_gemma":[0.9988665,0.00005751284,0.000051420382,0.000024684052,0.000044126715,0.0000749917,0.0000071782106,0.0000068548497,0.00086675433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989589,0.00034045376,0.00022729055,0.00014621756,0.00010093689,0.00022619725],"domain_scores_gemma":[0.9993849,0.00017739717,0.000056540248,0.00022824683,0.00014352231,0.000009404137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005099047,0.00006404437,0.00014335521,0.00014253652,0.000060231163,0.000004147959,0.00029592906,0.00010374271,0.00062370097],"category_scores_gemma":[0.00006591172,0.000042673953,0.00003829521,0.00018443806,0.00025721802,0.000053156353,0.000072382434,0.00030229078,0.000027479044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003791472,0.0000881925,0.0017316232,0.000025684736,0.0000066427797,0.000001528708,0.002566833,0.0001712505,0.9872199,0.00017452776,0.006664851,0.00096977607],"study_design_scores_gemma":[0.00055704935,0.00012854702,0.0019396129,0.00003834646,0.000002225832,0.0000036812771,0.00039716234,0.000091406684,0.993628,0.00003886292,0.0031336579,0.00004144535],"about_ca_topic_score_codex":0.00027498257,"about_ca_topic_score_gemma":0.000263254,"teacher_disagreement_score":0.0064080595,"about_ca_system_score_codex":0.000046492936,"about_ca_system_score_gemma":0.00014059484,"threshold_uncertainty_score":0.68290883},"labels":[],"label_agreement":null},{"id":"W2612316553","doi":"10.1158/1538-7445.transcontrol16-a49","title":"Abstract A49: Transcription factor upregulation after mTOR inhibition by Torin1 induces growth factor receptor expression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Temsirolimus; mTORC2; RPTOR; mTORC1; Stable isotope labeling by amino acids in cell culture; Everolimus; Cancer research; Mechanistic target of rapamycin; Biology; Downregulation and upregulation; Cell growth; Cell biology; Sirolimus; Signal transduction; Biochemistry; Proteomics; Discovery and development of mTOR inhibitors; Genetics","score_opus":0.06851902910668384,"score_gpt":0.3793653549044034,"score_spread":0.31084632579771954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612316553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957431,0.0016213162,0.00015282237,0.00041759806,0.00078838266,0.00043428954,0.000534269,0.000026842574,0.00028139935],"genre_scores_gemma":[0.9959906,0.00072782335,0.00007660953,0.0000456422,0.0014178805,0.00044102297,0.00020939614,0.00005754893,0.001033494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977115,0.00013103627,0.00027040375,0.0006775637,0.0006803747,0.0005291608],"domain_scores_gemma":[0.9985067,0.000024483477,0.00015600758,0.00067433965,0.0004383267,0.00020013645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033121128,0.00023202035,0.00017712751,0.00008952843,0.0004918964,0.0002608656,0.00041457333,0.0003963633,0.0010692735],"category_scores_gemma":[0.00018067844,0.00021925905,0.0001068959,0.000073582676,0.0002367178,0.000076365905,0.00012807311,0.00039527638,0.000043885088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004648946,0.0000537555,0.0028680987,0.00007605502,0.000025843983,0.0000016876716,0.00017315258,0.0000026315984,0.98145074,0.000004341983,0.010597501,0.0042813187],"study_design_scores_gemma":[0.0005783746,0.00016164864,0.040072743,0.00017614214,0.00000404344,5.452439e-7,0.00003172253,0.0000020644393,0.9398389,0.000051057257,0.018829947,0.00025279977],"about_ca_topic_score_codex":0.00034185263,"about_ca_topic_score_gemma":0.000067263216,"teacher_disagreement_score":0.041611806,"about_ca_system_score_codex":0.00025096073,"about_ca_system_score_gemma":0.00020388454,"threshold_uncertainty_score":0.9998439},"labels":[],"label_agreement":null},{"id":"W2612348884","doi":"10.1158/1538-7445.transcontrol16-b13","title":"Abstract B13: EGF/Ras/Erk signaling controls growth and proliferation through regulation of tRNA synthesis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cell biology; Biology; Gene knockdown; Cell growth; MAPK/ERK pathway; RNA interference; Signal transduction; Protein biosynthesis; Epidermal growth factor; Small interfering RNA; Translation (biology); Transcription factor; Messenger RNA; RNA; Molecular biology; Cell culture; Genetics; Gene","score_opus":0.045344381750907145,"score_gpt":0.41079602543770527,"score_spread":0.3654516436867981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612348884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621046,0.0013251401,0.0011607697,0.00025226202,0.000047084257,0.00021007552,0.000013152721,0.000003988446,0.0007770459],"genre_scores_gemma":[0.9986464,0.00065201113,0.00025643382,0.000008423776,0.00026549777,0.00007400262,0.000007166765,0.000013310542,0.00007675641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927264,0.00003265458,0.00013238475,0.00020318647,0.00018072412,0.00017838897],"domain_scores_gemma":[0.99943346,0.000040277882,0.00005704982,0.00027205696,0.00015532963,0.000041834486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033855854,0.00007092541,0.000106255866,0.000030103107,0.00019260413,0.000060323055,0.00014040091,0.0000937179,0.000022353684],"category_scores_gemma":[0.00038793997,0.00006722542,0.000030024843,0.000026689253,0.00011315124,0.000009889509,0.00006055944,0.000095053896,8.627294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073853575,0.000010640094,0.0026914403,0.00008969933,0.000026486992,5.0181563e-7,0.000085415035,0.00022529007,0.9939137,0.00013443838,0.00011499875,0.0026335283],"study_design_scores_gemma":[0.00025906714,0.0000660486,0.033333104,0.00005899189,0.0000075293624,9.744442e-7,0.000041259387,0.00009338113,0.9655559,0.00023592218,0.00027626104,0.00007156863],"about_ca_topic_score_codex":0.00018058416,"about_ca_topic_score_gemma":0.000052181313,"teacher_disagreement_score":0.030641664,"about_ca_system_score_codex":0.000012262651,"about_ca_system_score_gemma":0.00005982522,"threshold_uncertainty_score":0.2741373},"labels":[],"label_agreement":null},{"id":"W2612513030","doi":"","title":"The role of integrin-linked kinase in the regulation of the Wnt signaling pathway","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Wnt signaling pathway; Integrin-linked kinase; Cell biology; Transcription factor; Signal transduction; Catenin; Biology; LRP6; Beta-catenin; Chemistry; Kinase; Protein kinase A; Genetics; Gene; Cyclin-dependent kinase 2","score_opus":0.027063455461984874,"score_gpt":0.3301104916027551,"score_spread":0.3030470361407702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612513030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421775,0.003966753,0.000034020977,0.0009912156,0.0000745098,0.00037559916,0.00000642565,0.0000016619352,0.0003320634],"genre_scores_gemma":[0.99937725,0.00024673453,0.00001339204,0.0000141954315,0.00013903802,0.00007224445,0.000007966737,0.0000099597,0.0001192087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881375,0.0002452673,0.0002092145,0.00015931147,0.00037975534,0.00019269851],"domain_scores_gemma":[0.9991782,0.000057172925,0.0000858452,0.00042593855,0.00023496705,0.000017922544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010966166,0.00006392935,0.00007131016,0.00003945021,0.0001274417,0.000013805242,0.00039114844,0.00009638324,0.000007738183],"category_scores_gemma":[0.00014370083,0.000034365923,0.00006483326,0.0003746042,0.00025828063,0.0000031527752,0.00010070722,0.00022477149,8.363937e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001063396,0.00002116567,0.0003981061,0.000010492881,0.000013169706,1.0360118e-7,0.00040163592,0.012212582,0.97530216,0.0013447077,0.000043696207,0.010145815],"study_design_scores_gemma":[0.00033297055,0.000074359545,0.007839853,0.000072039096,0.000003626055,0.0000010830132,0.00055903796,0.00009027003,0.9822697,0.0035712603,0.0051440094,0.000041805586],"about_ca_topic_score_codex":0.0006623239,"about_ca_topic_score_gemma":0.00119284,"teacher_disagreement_score":0.012122312,"about_ca_system_score_codex":0.00009972838,"about_ca_system_score_gemma":0.0003939314,"threshold_uncertainty_score":0.14014018},"labels":[],"label_agreement":null},{"id":"W2612577894","doi":"10.1158/1538-7445.tummet15-b03","title":"Abstract B03: Formation of lymph node metastases is not angiogenesis dependent","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Angiogenesis; Lymph node; Lymph; Metastasis; Lymphatic system; Sprouting angiogenesis; Cancer; Oncology; Pathology; Cancer research; Internal medicine; Neovascularization","score_opus":0.056187977901063606,"score_gpt":0.36207027206700493,"score_spread":0.3058822941659413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612577894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936188,0.0032949443,0.00071604725,0.0006905434,0.000106975356,0.00015053438,0.00089721126,0.0000039590927,0.0005209856],"genre_scores_gemma":[0.9930575,0.0059250994,0.00011460916,0.00017280591,0.00019911202,0.00007440994,0.000027863769,0.000017874398,0.0004107463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989437,0.000036393365,0.00019298909,0.00023693852,0.000302873,0.00028709412],"domain_scores_gemma":[0.99911773,0.00006685106,0.00006277905,0.0003496103,0.00031524824,0.00008779928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003700169,0.00008813387,0.00011208646,0.000084696454,0.00006384424,0.000018344854,0.00021598008,0.0000777553,0.00021699711],"category_scores_gemma":[0.00013818387,0.000066750035,0.00008380143,0.000095903924,0.0001003041,0.0000067837846,0.00014218954,0.000035326753,0.000028572058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015576504,0.000032742948,0.0016909561,0.00004337773,0.00003870127,0.0000018877903,0.000026910206,0.000029430677,0.96422994,0.00005686526,0.0059059607,0.027787488],"study_design_scores_gemma":[0.00053214154,0.00005399451,0.005507324,0.00003737082,0.000010656667,0.0000020122438,0.000035625555,0.0000049309233,0.97023183,0.000051077357,0.023437513,0.00009551311],"about_ca_topic_score_codex":0.00045966802,"about_ca_topic_score_gemma":0.00014958956,"teacher_disagreement_score":0.027691975,"about_ca_system_score_codex":0.000085757005,"about_ca_system_score_gemma":0.00025049393,"threshold_uncertainty_score":0.27219874},"labels":[],"label_agreement":null},{"id":"W2612881589","doi":"10.1158/1538-7445.transcontrol16-pr03","title":"Abstract PR03: NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cell biology; Effector; Chemistry; Cancer cell; Transcription factor; Proteome; Pancreatic cancer; Cysteine; Biology; Cancer research; Biochemistry; Cancer; Gene","score_opus":0.06379987774543545,"score_gpt":0.3857065127459092,"score_spread":0.3219066350004738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612881589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370927,0.003370452,0.0000494157,0.0006491658,0.00008759931,0.00048289396,0.00013341817,0.000006695246,0.0015111095],"genre_scores_gemma":[0.9974299,0.00096813287,0.00017349159,0.00004711626,0.0003222007,0.00035567814,0.000052700423,0.000033343706,0.0006174426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983471,0.00006704569,0.0002419831,0.00052282074,0.00025468212,0.0005663809],"domain_scores_gemma":[0.99899584,0.000034194654,0.00012830048,0.0005355069,0.00019755484,0.00010860571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048708095,0.00016051922,0.00019742936,0.00005137068,0.00028046468,0.000107682106,0.0004933461,0.00010899122,0.00008753821],"category_scores_gemma":[0.00030502162,0.00015371953,0.000057155707,0.000065235596,0.00028349253,0.000017297927,0.000111493704,0.00031664027,0.0000066146895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119059696,0.000042337047,0.02604296,0.000097936674,0.00002543623,0.000004001924,0.00013729646,0.000057021392,0.96382606,0.00000762848,0.0015327587,0.008107495],"study_design_scores_gemma":[0.00085568253,0.00006353198,0.07157281,0.0002497441,0.000005522825,0.0000010937406,0.000104406354,0.00023406396,0.92228043,0.000354279,0.004037776,0.00024068482],"about_ca_topic_score_codex":0.0022921825,"about_ca_topic_score_gemma":0.0014947066,"teacher_disagreement_score":0.04552985,"about_ca_system_score_codex":0.000107253334,"about_ca_system_score_gemma":0.00021277771,"threshold_uncertainty_score":0.62685007},"labels":[],"label_agreement":null},{"id":"W2613099917","doi":"10.1158/1538-7445.transcontrol16-ia09","title":"Abstract IA09: Translational control of the tumor microenvironment","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Metastasis; Tumor microenvironment; EIF4E; Carcinogenesis; Phosphorylation; Kinase; Biology; Cancer; Medicine; Pathology; Internal medicine; Messenger RNA; Cell biology; Translation (biology)","score_opus":0.04745255617192055,"score_gpt":0.3773613233355155,"score_spread":0.3299087671635949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613099917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940544,0.0022547892,0.000094191324,0.0017037677,0.00019583107,0.00026138625,0.00013773571,0.0000019006291,0.0012960025],"genre_scores_gemma":[0.9987059,0.00014067892,0.000029208726,0.00010515185,0.0003303316,0.000078795965,0.000004835024,0.000015387162,0.00058970746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989529,0.000057147772,0.00013568094,0.00023147356,0.00037344024,0.0002493165],"domain_scores_gemma":[0.9990695,0.0000233739,0.00008965302,0.00067038223,0.000094547315,0.00005250206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045360878,0.00007627677,0.00009068162,0.000018125509,0.00028884533,0.000030617328,0.000667116,0.000059601796,0.00026525138],"category_scores_gemma":[0.000082797786,0.000057728357,0.00008594607,0.000023810606,0.00050232816,0.0000035871462,0.00009770261,0.00018331084,0.000009036679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011881559,0.000025899804,0.018969689,0.00002251905,0.00004288288,0.0000011665163,0.000020433556,0.00019191125,0.9772575,0.000036567373,0.0018149809,0.0014976449],"study_design_scores_gemma":[0.00070023397,0.00005008878,0.16364494,0.00004124438,0.0000064613146,0.0000014701415,0.000009525669,0.00001434364,0.79509133,0.00010392862,0.040263545,0.000072871524],"about_ca_topic_score_codex":0.00019266769,"about_ca_topic_score_gemma":0.00010013053,"teacher_disagreement_score":0.18216614,"about_ca_system_score_codex":0.00003946088,"about_ca_system_score_gemma":0.00026109128,"threshold_uncertainty_score":0.29043168},"labels":[],"label_agreement":null},{"id":"W2613587621","doi":"10.1158/1538-7445.transcontrol16-a12","title":"Abstract A12: Role of eIF5-mimic protein 1 (5MP1) for translational control in cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Eukaryotic initiation factor; Initiation factor; EIF4A1; Eukaryotic translation initiation factor 4 gamma; Internal ribosome entry site; Eukaryotic translation; eIF2; Biology; Eukaryotic Ribosome; EIF4E; Cell biology; Start codon; Translation (biology); Five prime untranslated region; Messenger RNA; Genetics; Gene","score_opus":0.0618991808394186,"score_gpt":0.4001390681194236,"score_spread":0.33823988728000504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613587621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926445,0.0034482293,0.0003498479,0.0009903122,0.00006309669,0.0012410053,0.00024371763,0.0000029160904,0.0010164127],"genre_scores_gemma":[0.9969804,0.00020160152,0.00018935648,0.000024659828,0.00024896668,0.0017249727,0.00001230414,0.000020597969,0.0005970868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892217,0.000056519184,0.00018103758,0.00027801874,0.00024090044,0.00032134843],"domain_scores_gemma":[0.9992507,0.000031400406,0.00008638454,0.00036577327,0.00020642647,0.00005929589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073677296,0.00009081922,0.00015145689,0.000060433216,0.00016748298,0.00003294444,0.00040171726,0.00014139854,0.00020190045],"category_scores_gemma":[0.0001352217,0.000085148364,0.00007398752,0.000033491662,0.0001317344,0.000007787751,0.00003384072,0.00011803711,0.0000027594374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053530844,0.000037696598,0.001503598,0.00006726079,0.000030264924,6.2494576e-7,0.000034318986,0.000043618635,0.96585774,0.00030112802,0.00014982212,0.0314386],"study_design_scores_gemma":[0.0010523912,0.00011195795,0.00806702,0.00009929037,0.0000038326493,2.4692565e-7,0.000025163778,0.000051111336,0.97451746,0.0020821707,0.0138874985,0.00010187521],"about_ca_topic_score_codex":0.0009864762,"about_ca_topic_score_gemma":0.0011964077,"teacher_disagreement_score":0.031336725,"about_ca_system_score_codex":0.00002602876,"about_ca_system_score_gemma":0.00038095217,"threshold_uncertainty_score":0.34722495},"labels":[],"label_agreement":null},{"id":"W2613733532","doi":"","title":"Growth arrest by sulfasalazine (SASP) of subrenal capsule prostate cancer xenografts in immuno-deficient mice is coupled to a decrease in the number of tumor-associated macrophages","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"LNCaP; Cystine; Cancer research; Prostate cancer; Cancer cell; Pharmacology; Internal medicine; Chemistry; Cancer; Endocrinology; Biology; Medicine; Cysteine; Biochemistry","score_opus":0.014844082025570797,"score_gpt":0.3402039076393006,"score_spread":0.3253598256137298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613733532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836607,0.009504843,0.0000028479137,0.0010777549,0.00006125749,0.00050273177,0.0003516307,0.0000027898845,0.00013008145],"genre_scores_gemma":[0.9956257,0.002844158,0.00003920725,0.0003916471,0.00009241249,0.00031739712,0.00006050416,0.000025256348,0.00060371554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803203,0.0002119706,0.00036956306,0.00035204785,0.00046541283,0.0005689934],"domain_scores_gemma":[0.999042,0.000029943263,0.00010017422,0.0003056924,0.00038543198,0.0001367558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095104624,0.00015637424,0.00026643986,0.00010788707,0.000050308907,0.000016622525,0.00042685994,0.00008916251,0.00017556404],"category_scores_gemma":[0.00023513376,0.00012351984,0.00006554437,0.00072863564,0.00019110857,0.000007299567,0.00015431565,0.00025585934,0.000006245379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000318403,0.00032287493,0.014187478,0.000048226106,0.000032059936,0.000007242766,0.0011141225,0.000099681645,0.97572464,0.00001823119,0.007564089,0.0005629303],"study_design_scores_gemma":[0.0018096245,0.00012341248,0.041634,0.000119647,0.000012538093,0.0000027416868,0.000428446,0.000066099965,0.94347817,0.000011427039,0.012129014,0.00018486218],"about_ca_topic_score_codex":0.019613188,"about_ca_topic_score_gemma":0.0042816387,"teacher_disagreement_score":0.032246478,"about_ca_system_score_codex":0.000102054706,"about_ca_system_score_gemma":0.0004846731,"threshold_uncertainty_score":0.9869153},"labels":[],"label_agreement":null},{"id":"W2613804347","doi":"","title":"Functional promoter SNPs in TGFβ1 and the susceptibility to childhood leukemia","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Single-nucleotide polymorphism; Haplotype; Genetics; Gene; Electrophoretic mobility shift assay; Transcription factor; Allele; In silico; Transforming growth factor; Leukemia; Promoter; Molecular biology; Cancer research; Gene expression; Cell biology; Genotype","score_opus":0.03457007901107241,"score_gpt":0.3638603710877774,"score_spread":0.329290292076705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613804347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969618,0.0015154744,0.00013029116,0.00049652613,0.000056321052,0.00040485238,0.000008497583,0.000005351633,0.0004209074],"genre_scores_gemma":[0.9986403,0.000043555752,0.000054223867,0.0002357831,0.00034801848,0.00009824934,0.000014145691,0.000012142209,0.0005535644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879956,0.00012741935,0.00013474224,0.0003349228,0.00026589475,0.0003374538],"domain_scores_gemma":[0.99938315,0.00006928674,0.000013847831,0.00029321064,0.00012483983,0.00011567152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017226372,0.000075177464,0.000078206176,0.00006270216,0.000108833214,0.000028658425,0.00017174114,0.00007220575,0.00009556114],"category_scores_gemma":[0.0003456265,0.00005443446,0.00002984217,0.00017507313,0.00027401777,0.000002483808,0.00019943593,0.0002029928,0.00001414757],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034247956,0.00020734881,0.09499791,0.000077556535,0.00007338464,0.000012588274,0.0010361073,0.00030943312,0.8588761,0.0002499591,0.016163306,0.024571477],"study_design_scores_gemma":[0.0020111636,0.00015286266,0.65831715,0.00004089112,0.000004748158,0.0000045149973,0.00020042187,0.000009151989,0.31824872,0.0004151783,0.020432606,0.00016261556],"about_ca_topic_score_codex":0.0002114236,"about_ca_topic_score_gemma":0.0011856735,"teacher_disagreement_score":0.5633192,"about_ca_system_score_codex":0.00010566997,"about_ca_system_score_gemma":0.00036068063,"threshold_uncertainty_score":0.22197728},"labels":[],"label_agreement":null},{"id":"W2613945615","doi":"10.1158/1538-7445.transcontrol16-b06","title":"Abstract B06: Translational control of mitochondria through mTORC1/4E-BP signaling pathway","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council","keywords":"mTORC1; Biology; Cell biology; Mitochondrion; EIF4E; Translation (biology); PI3K/AKT/mTOR pathway; Protein biosynthesis; Mechanistic target of rapamycin; Translational regulation; Ribosome profiling; eIF2; Biochemistry; Signal transduction; Messenger RNA; Gene","score_opus":0.08084362163994556,"score_gpt":0.40558291745798924,"score_spread":0.32473929581804367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613945615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820304,0.006463247,0.0041134674,0.0009750722,0.00060327596,0.0005437223,0.00038446006,0.000014809612,0.004871535],"genre_scores_gemma":[0.99729526,0.00021941352,0.00032353227,0.00010194952,0.0012638462,0.0001504407,0.000038063452,0.00004191807,0.0005655705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978753,0.0001086353,0.00032193147,0.0005025646,0.0006763249,0.0005152733],"domain_scores_gemma":[0.9982333,0.000098443415,0.00017633416,0.00081721385,0.0005567897,0.000117922864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007324386,0.00017281213,0.00024308971,0.000053413758,0.0004098374,0.00009026493,0.0008063395,0.00023993998,0.00049412553],"category_scores_gemma":[0.00025064673,0.00016659871,0.00015685832,0.00007098007,0.0005139332,0.000020033574,0.00009089581,0.0003643309,0.000018795346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039463336,0.000048951653,0.0027268678,0.00007207268,0.000119143355,0.000006649506,0.00010705719,0.0005405321,0.99082196,0.00036116876,0.0024851048,0.0023158602],"study_design_scores_gemma":[0.0015935343,0.00016730317,0.0027634853,0.0001210939,0.000012302217,0.0000019856652,0.000031166324,0.000031461535,0.9501597,0.0008418306,0.04406947,0.00020665753],"about_ca_topic_score_codex":0.0004389953,"about_ca_topic_score_gemma":0.000111389505,"teacher_disagreement_score":0.04158436,"about_ca_system_score_codex":0.000057908437,"about_ca_system_score_gemma":0.00075216073,"threshold_uncertainty_score":0.6793698},"labels":[],"label_agreement":null},{"id":"W2614086487","doi":"10.1158/1538-7445.transcontrol16-a08","title":"Abstract A08: A 5' UTR RNA G-Quadruplex structure affects both the cap-dependent and independent translation of BAG-1, an mRNA involved in colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Internal ribosome entry site; Five prime untranslated region; Messenger RNA; Untranslated region; Gene isoform; Translational regulation; Translation (biology); Open reading frame; Biology; Eukaryotic translation; Three prime untranslated region; Coding region; Start codon; Ribosome; RNA; Stop codon; Genetics; Molecular biology; Gene; Peptide sequence","score_opus":0.05368488310099916,"score_gpt":0.3669599382385744,"score_spread":0.31327505513757525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614086487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485373,0.0037064953,0.000015986203,0.00035621802,0.000121820536,0.0006550493,0.000090945665,0.0000036933752,0.00019605097],"genre_scores_gemma":[0.99794537,0.0014748223,0.000056401877,0.00002439221,0.00020207632,0.00018613064,0.000015903566,0.000024825931,0.000070077804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984114,0.00021764734,0.00017292971,0.00040476338,0.00044031467,0.00035291506],"domain_scores_gemma":[0.9991604,0.00004128654,0.00012415777,0.00046598882,0.00010291255,0.000105259416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009191566,0.00014656539,0.00018070002,0.00007171191,0.00028746817,0.00010297323,0.00051198254,0.00022534114,0.00013998922],"category_scores_gemma":[0.00007637989,0.00010982869,0.000043932578,0.000058947782,0.0002365085,0.00002056033,0.00012275293,0.0003087955,5.496612e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003910855,0.000035861704,0.004975566,0.0000642642,0.000036505633,0.0000059175436,0.00031763795,0.00007211929,0.969049,0.00004179779,0.00006234579,0.0249479],"study_design_scores_gemma":[0.0007105189,0.00021043561,0.070173815,0.00006832749,0.0000076189485,0.000002021096,0.00017915216,0.00005284389,0.92786795,0.00032002147,0.00027950498,0.00012781806],"about_ca_topic_score_codex":0.004497451,"about_ca_topic_score_gemma":0.034440238,"teacher_disagreement_score":0.06519825,"about_ca_system_score_codex":0.000051888124,"about_ca_system_score_gemma":0.00028888363,"threshold_uncertainty_score":0.98317873},"labels":[],"label_agreement":null},{"id":"W2616621711","doi":"10.1158/0008-5472.can-16-3304","title":"Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PKM2; Anaerobic glycolysis; Medulloblastoma; Pyruvate kinase; Glycolysis; Warburg effect; Cell growth; Neurogenesis; Biology; Chemistry; Cell biology; Cancer research; Biochemistry; Metabolism","score_opus":0.06007245052806907,"score_gpt":0.3820467915286796,"score_spread":0.3219743410006105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616621711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939026,0.0011884947,9.998334e-7,0.003914271,0.00005930854,0.0006578475,0.000028038712,0.000025147852,0.00022325866],"genre_scores_gemma":[0.9980143,0.0013316644,0.00002311667,0.000028320563,0.00015447589,0.00029045544,0.000018386756,0.000020299405,0.00011900576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987997,0.00005154701,0.00013990342,0.00025726194,0.00044175016,0.0003098515],"domain_scores_gemma":[0.9990664,0.00003637203,0.00005654536,0.0003819948,0.00028248606,0.00017616771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019608636,0.00010517779,0.00014678974,0.00016061254,0.0007692594,0.00020745376,0.00009024339,0.000056421522,0.00006019198],"category_scores_gemma":[0.00017763012,0.00008660335,0.00003172225,0.00008196343,0.00011965999,0.00035162532,0.00014667233,0.0001408406,0.000023473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006039705,0.00019328801,0.13930552,0.0006324014,0.00006734789,0.00047923165,0.00043643813,0.00000895855,0.85150224,0.000108723136,0.00068796077,0.0059739337],"study_design_scores_gemma":[0.001474253,0.00017139374,0.21360205,0.00016649278,0.000025370775,0.00005839187,0.0000446568,0.000101324666,0.783959,0.000017177874,0.00031954766,0.000060391194],"about_ca_topic_score_codex":0.00019895988,"about_ca_topic_score_gemma":0.00016755384,"teacher_disagreement_score":0.07429653,"about_ca_system_score_codex":0.00012046975,"about_ca_system_score_gemma":0.000088443056,"threshold_uncertainty_score":0.5916599},"labels":[],"label_agreement":null},{"id":"W2617230784","doi":"10.1158/0008-5472.can-16-2953","title":"A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute","keywords":"Haematopoiesis; Medicine; Graft-versus-host disease; Cancer; Transplantation; Cancer research; Disease; Pathology; Hematopoietic stem cell transplantation; Biodistribution; Immunology; Internal medicine; Stem cell; Biology","score_opus":0.055183902424877765,"score_gpt":0.410408689904324,"score_spread":0.35522478747944625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617230784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275047,0.00043037304,0.00014201693,0.0028147846,0.00020057375,0.0016510097,0.0004267342,0.000070604685,0.001513453],"genre_scores_gemma":[0.99628997,0.0012126707,0.0000608103,0.0002300308,0.00007323405,0.00043940832,0.00014140172,0.00009019647,0.0014622991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963018,0.00022927766,0.00046279264,0.00079595065,0.0011067014,0.001103537],"domain_scores_gemma":[0.997517,0.00024175268,0.00009592021,0.00097079185,0.0002553197,0.00091925316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007017916,0.00032106694,0.00048722327,0.00042911782,0.0003511965,0.0002008468,0.0005806793,0.00008875299,0.00055474066],"category_scores_gemma":[0.0000524284,0.0003063718,0.00012366645,0.00047599289,0.00021231553,0.00022614532,0.00007471528,0.00067279395,0.00020248238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044144536,0.00029019147,0.0067785378,0.0007435519,0.00008922442,0.0020587943,0.0012366325,0.000017483433,0.981019,0.000033176813,0.0030823469,0.00023655927],"study_design_scores_gemma":[0.009627009,0.00039647284,0.015067994,0.0014297646,0.00024913615,0.00004983203,0.0005893795,0.0004275667,0.97009665,0.000037870464,0.0014993057,0.00052904664],"about_ca_topic_score_codex":0.001308305,"about_ca_topic_score_gemma":0.00017509947,"teacher_disagreement_score":0.010922425,"about_ca_system_score_codex":0.00042432293,"about_ca_system_score_gemma":0.0006725867,"threshold_uncertainty_score":0.99993885},"labels":[],"label_agreement":null},{"id":"W2617326768","doi":"","title":"The chemokine stromal cell derived factor 1α(SDF-1α )upregulates MT2-MMP expression in human glioma cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Stromal cell; Cancer research; Biology; CXCR4; Chemokine; Gene silencing; Cancer cell; Stromal cell-derived factor 1; Chemotaxis; Flow cytometry; Cell culture; Chemokine receptor; Small hairpin RNA; Metastasis; Downregulation and upregulation; Gene knockdown; Cancer; Immunology; Receptor; Inflammation; Gene; Genetics","score_opus":0.05438383422739528,"score_gpt":0.38266266380557856,"score_spread":0.3282788295781833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617326768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955774,0.0018585705,0.00002057235,0.00095200795,0.0001379673,0.0006221955,0.000013665433,0.000042362026,0.0007752601],"genre_scores_gemma":[0.9973465,0.0003465747,0.000108738495,0.000029023164,0.0005444661,0.00011470987,0.000017772556,0.000054215267,0.0014379685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973369,0.00010715304,0.0003527753,0.00045905975,0.00090296846,0.0008411378],"domain_scores_gemma":[0.9987632,0.00017952654,0.00006677204,0.00048219107,0.00024176952,0.00026656047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005552287,0.00021345206,0.0003293443,0.00020779931,0.0004050953,0.00009184263,0.00033368263,0.00016817222,0.0008668977],"category_scores_gemma":[0.00006370209,0.00014601959,0.0001173571,0.00057146524,0.00025730603,0.0000873995,0.00020573643,0.00083147525,0.000029639741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019571645,0.00014326653,0.0014612424,0.00011973984,0.000015597576,0.000058530688,0.00090486626,0.00009589061,0.9951024,0.0000138627365,0.0008933586,0.000995532],"study_design_scores_gemma":[0.0028724459,0.00021092291,0.0042982604,0.00042321382,0.000008217282,0.000005457496,0.000648279,0.00002928797,0.988951,0.00016272978,0.002233798,0.00015634032],"about_ca_topic_score_codex":0.0006487783,"about_ca_topic_score_gemma":0.00012702789,"teacher_disagreement_score":0.0061513493,"about_ca_system_score_codex":0.000621627,"about_ca_system_score_gemma":0.00035653365,"threshold_uncertainty_score":0.9491922},"labels":[],"label_agreement":null},{"id":"W2622113037","doi":"","title":"Kallikrein 6 as a biomarker for the detection of metastatic cancer cells in blood of ovarian cancer patients","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Ovarian cancer; Cancer; Prostate cancer; Biology; Cancer research; Proteases; Biomarker; Metastasis; Molecular biology; Enzyme; Genetics; Biochemistry","score_opus":0.07789343386399433,"score_gpt":0.4007027487214303,"score_spread":0.32280931485743597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622113037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826283,0.008667924,0.00014514371,0.00096675684,0.000249684,0.0014869014,0.00012436582,0.000009487772,0.00008687758],"genre_scores_gemma":[0.99614626,0.0022495028,0.000074423704,0.00007584032,0.00009634762,0.0008695746,0.000008252346,0.000030243516,0.00044955965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827844,0.00007535815,0.0003990917,0.0002653557,0.0005954019,0.00038635373],"domain_scores_gemma":[0.9986331,0.00027488623,0.00013199405,0.00025773066,0.0006101271,0.00009220314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063132273,0.00012382098,0.000309626,0.0002660825,0.00009434738,0.000011066775,0.00015207226,0.000058285754,0.000332706],"category_scores_gemma":[0.00015636126,0.000090097245,0.00011350946,0.00080646586,0.00020972223,0.000072111834,0.000042059095,0.00017519339,0.0000025513127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003607957,0.0013272195,0.08381796,0.001722408,0.0010613494,0.0000127374105,0.0045992867,0.001297051,0.79452586,0.0005225953,0.00049596577,0.10700963],"study_design_scores_gemma":[0.007159739,0.0005207847,0.17536572,0.0007044791,0.00023080483,0.0000014429327,0.00025082854,0.00038345714,0.81290364,0.0007819503,0.0015721504,0.00012498433],"about_ca_topic_score_codex":0.056559846,"about_ca_topic_score_gemma":0.010379222,"teacher_disagreement_score":0.106884636,"about_ca_system_score_codex":0.00027565227,"about_ca_system_score_gemma":0.0009013985,"threshold_uncertainty_score":0.9497226},"labels":[],"label_agreement":null},{"id":"W2623282334","doi":"","title":"Targeted delivery of CD4+ Th-APC’s stimulatory effect to CD8+ memory T cell responses via acquired synapse-composed pMHC I complexes","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"CD80; Immunological synapse; T cell; Cell biology; Antigen-presenting cell; CD8; Immune system; Cytotoxic T cell; Internalization; Immunology; Chemistry; Biology; Cell; CD40; T-cell receptor; In vitro; Biochemistry","score_opus":0.02654660047234643,"score_gpt":0.32584966938196186,"score_spread":0.29930306890961544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623282334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95479393,0.04258354,0.00004814591,0.00019530384,0.0006463307,0.0010309544,0.00014733763,0.00010869396,0.00044576055],"genre_scores_gemma":[0.9883564,0.00029102343,0.0000465779,0.000120373705,0.00008305732,0.00020986031,0.000098224315,0.00007057815,0.010723885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940212,0.003352702,0.0006331727,0.00060504605,0.0002626229,0.0011252791],"domain_scores_gemma":[0.9953556,0.0030966934,0.00015641899,0.0008585911,0.00047190892,0.000060789553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020528063,0.00037251308,0.0007435571,0.00078641885,0.00055600377,0.00003599238,0.0008559215,0.0003891961,0.002129092],"category_scores_gemma":[0.0002297702,0.00033084085,0.0002375968,0.00073484145,0.00097520597,0.00014684434,0.0002878262,0.00056609605,0.00064912654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019366687,0.00026422407,0.0017173542,0.00013003504,0.0002204556,0.000016993967,0.00043653013,0.00017312741,0.9607965,0.000024379135,0.014158848,0.0026949102],"study_design_scores_gemma":[0.003202616,0.0014695685,0.026463449,0.00013531443,0.00003064379,0.000014430973,0.00013413472,0.000004954359,0.9504517,0.000032471187,0.017728556,0.0003321861],"about_ca_topic_score_codex":0.0044502546,"about_ca_topic_score_gemma":0.00011919122,"teacher_disagreement_score":0.042292517,"about_ca_system_score_codex":0.00028128005,"about_ca_system_score_gemma":0.000514189,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W2625967112","doi":"","title":"Mtor expression in carcinoma in situ adjacent to seminoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"PI3K/AKT/mTOR pathway; Seminoma; Biology; Germ cell; Sertoli cell; Immunohistochemistry; Pathology; Cancer research; Spermatogenesis; Endocrinology; Cell biology; Medicine; Signal transduction","score_opus":0.11123091934007823,"score_gpt":0.41992299137345007,"score_spread":0.30869207203337184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625967112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933095,0.0042535868,0.000001568783,0.00069920655,0.000043191158,0.00064020464,0.000009204532,0.000012736112,0.0010308211],"genre_scores_gemma":[0.9983132,0.00021256726,0.00010839463,0.00009764503,0.000085104344,0.0003448881,0.00001058808,0.00001671909,0.00081090594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986434,0.00006221414,0.00013465867,0.00029059,0.00045504514,0.00041407204],"domain_scores_gemma":[0.9992834,0.000043584765,0.0000110291485,0.00026881488,0.00008301642,0.0003101559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012600081,0.00008495493,0.0001664641,0.00028873552,0.00005024585,0.00000624727,0.00008222755,0.000047319805,0.00020431523],"category_scores_gemma":[0.000121707,0.00006974013,0.0000347401,0.0004943051,0.00004536107,0.00003617863,0.000089913025,0.0002115916,0.00009763817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004382703,0.00041087126,0.93072206,0.00005797681,0.00000617707,0.002581694,0.00071255764,0.00001869633,0.056637287,0.0000053241447,0.0035533258,0.0048557892],"study_design_scores_gemma":[0.0019669123,0.00019127835,0.9577089,0.0003086931,0.0000039347974,0.000017701166,0.00011406482,0.000017845847,0.037536886,0.000010983777,0.0020579442,0.00006487281],"about_ca_topic_score_codex":0.0012957203,"about_ca_topic_score_gemma":0.00038974258,"teacher_disagreement_score":0.026986852,"about_ca_system_score_codex":0.00063529826,"about_ca_system_score_gemma":0.00039125275,"threshold_uncertainty_score":0.28439197},"labels":[],"label_agreement":null},{"id":"W2626353417","doi":"","title":"Whole genome BAC array detects described and novel regions of alteration in oral tumors","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Plant Disease Resistance and Genetics","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Genome; Biology; Cancer; Human genome; clone (Java method); Chromosome; Bacterial artificial chromosome; Gene; Genetics","score_opus":0.09630170355857512,"score_gpt":0.3282175608297284,"score_spread":0.2319158572711533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626353417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761945,0.00091221364,0.000023033606,0.0010686982,0.000011290862,0.00015889607,0.00011781782,0.0000055946753,0.000082986444],"genre_scores_gemma":[0.9994027,0.0003222591,0.000059799448,0.000034861663,0.000050302446,0.000029495834,0.00002771789,6.0624825e-7,0.000072271454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925536,0.00003820157,0.00010509997,0.0001641215,0.0002038169,0.00023341441],"domain_scores_gemma":[0.99974084,0.0000472064,0.000020010913,0.000036720037,0.00007218521,0.00008303823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020351463,0.000051629675,0.000092243885,0.000025897803,0.00008660692,0.000026814525,0.00010287828,0.00003529477,0.000020846712],"category_scores_gemma":[0.000029135974,0.000023279961,0.000018193357,0.0003612387,0.0000959621,0.00005676223,0.00002544175,0.0000985169,0.000003591687],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003913209,0.000037075824,0.0012360604,0.000012159887,0.0000024366193,0.0000042857173,0.00007541088,0.00009013991,0.99686605,0.00015621565,0.000023407307,0.0014576569],"study_design_scores_gemma":[0.0008976696,0.00038561286,0.77023995,0.0002883167,0.0000063532398,0.0000058930777,0.00079795264,0.000027205648,0.21424948,0.0060111703,0.0068363263,0.00025408078],"about_ca_topic_score_codex":0.00076577027,"about_ca_topic_score_gemma":0.008467967,"teacher_disagreement_score":0.78261656,"about_ca_system_score_codex":0.000053883497,"about_ca_system_score_gemma":0.000049169186,"threshold_uncertainty_score":0.47253245},"labels":[],"label_agreement":null},{"id":"W2644262902","doi":"","title":"The association between the anti-inflammatory protein CC10 and smoking status among participants in a chemoprevention trial.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bronchoalveolar lavage; Medicine; Internal medicine; Gastroenterology; Lung cancer; Placebo; Lung; Pathology","score_opus":0.11873305690267943,"score_gpt":0.4598221213501084,"score_spread":0.341089064447429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2644262902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945904,0.0038465478,0.0000015435147,0.0026014976,0.00005673466,0.0035107012,0.000009004006,0.000015859778,0.0004990759],"genre_scores_gemma":[0.9950409,0.0006604244,0.000003141333,0.000022894108,0.000517448,0.0015194514,0.0000053944573,0.00002565179,0.0022046852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528223,0.001019585,0.0004589488,0.00031685736,0.0016644353,0.0012579451],"domain_scores_gemma":[0.99782777,0.0011424728,0.00012451205,0.0003547434,0.00033976528,0.00021073682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010383957,0.00010887408,0.00023300682,0.00018507306,0.00055559067,0.00012803833,0.00017931634,0.00014359171,0.00003869929],"category_scores_gemma":[0.002251875,0.0000682515,0.00004454157,0.0006916422,0.00029964163,0.00012863133,0.00014362596,0.0012384676,0.000014848559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002648233,0.000059565118,0.92087954,0.00028952232,0.000048713697,0.000025973522,0.00017330785,0.0000034737309,0.005502663,0.00017039054,0.00035591188,0.069842696],"study_design_scores_gemma":[0.010129128,0.00018846877,0.95123905,0.00029268386,0.000015049035,2.60831e-7,0.00014534197,0.00007118183,0.008576775,0.00053669687,0.028727999,0.00007734818],"about_ca_topic_score_codex":0.0037420231,"about_ca_topic_score_gemma":0.002700446,"teacher_disagreement_score":0.069765344,"about_ca_system_score_codex":0.0015732909,"about_ca_system_score_gemma":0.0010497741,"threshold_uncertainty_score":0.5656845},"labels":[],"label_agreement":null},{"id":"W2648190077","doi":"","title":"Encapsulation of crystalline topotecan in sphingosomes: a formulation suitable for clinical development","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"Topotecan; Camptothecin; Chemistry; Liposome; Ionophore; Vesicle; Carboplatin; Biophysics; Stereochemistry; Drug delivery; Combinatorial chemistry; Chromatography; Membrane; Biochemistry; Organic chemistry; Cisplatin","score_opus":0.1729158394740243,"score_gpt":0.4619214534110887,"score_spread":0.28900561393706437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2648190077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973822,0.00029759688,0.0011462726,0.00039967615,0.00007412643,0.00060341676,0.000012660829,0.00001849022,0.00006552164],"genre_scores_gemma":[0.9934968,0.000046197776,0.005778315,0.000029256516,0.00016617998,0.0002052249,0.0000089174755,0.000012745117,0.00025641517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811804,0.00014170342,0.0005846991,0.00027226642,0.00046822082,0.00041505572],"domain_scores_gemma":[0.9988484,0.0004282369,0.00008528025,0.00019895712,0.000361158,0.000077979406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004310055,0.00006895249,0.00017861823,0.00018144492,0.000085997,0.00003074242,0.00019900463,0.000075597054,0.00027884988],"category_scores_gemma":[0.0004076819,0.000066875895,0.00003325231,0.0003452124,0.00006824831,0.00029098187,0.00007478268,0.00013360918,0.000030019095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003201285,0.0001864703,0.005020824,0.00009041271,0.000004149677,8.450119e-7,0.0006206087,0.0059682494,0.9656496,0.0005297419,0.00035805305,0.021250922],"study_design_scores_gemma":[0.0013636928,0.0001146525,0.008370073,0.00009775983,0.0000028112581,2.9074405e-7,0.00009948736,0.006891621,0.97407746,0.0005184627,0.008355993,0.000107697546],"about_ca_topic_score_codex":0.00025050517,"about_ca_topic_score_gemma":0.0009523184,"teacher_disagreement_score":0.021143224,"about_ca_system_score_codex":0.0004119084,"about_ca_system_score_gemma":0.0005691519,"threshold_uncertainty_score":0.30532104},"labels":[],"label_agreement":null},{"id":"W2653933210","doi":"10.1158/0008-5472.can-16-2224","title":"<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Ovarian cancer; Cancer research; Serous fluid; Missense mutation; Biology; Exome; Cancer; Exome sequencing; Mutation; Medicine; Internal medicine; Genetics; Gene; Colorectal cancer","score_opus":0.05179880731973089,"score_gpt":0.39843911550986866,"score_spread":0.34664030819013775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2653933210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496126,0.0020572548,0.000018130939,0.0012913572,0.000034759298,0.00030657995,0.00006802701,0.0000044962558,0.0012581376],"genre_scores_gemma":[0.9947849,0.0023128486,0.000041141324,0.00011691356,0.0001413493,0.00011241793,0.00003621584,0.000020117317,0.00243408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985575,0.00013860215,0.00013093771,0.00041729704,0.00023726119,0.00051838206],"domain_scores_gemma":[0.99910855,0.00003356607,0.000030956937,0.00045142084,0.0001468332,0.00022868301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066839956,0.000109699424,0.00013529714,0.000092172886,0.0005932553,0.00025997745,0.00028263486,0.00010639404,0.000016547609],"category_scores_gemma":[0.00021842199,0.00010335738,0.000019321376,0.0000842871,0.0004810523,0.000015707123,0.00026748626,0.00031670064,0.0000053555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012300999,0.00003078619,0.06838752,0.000069177535,0.000020801755,0.000052834483,0.000119536286,0.00001666059,0.9265239,0.00011499443,0.0020488298,0.002491927],"study_design_scores_gemma":[0.0049736826,0.0006453006,0.2608517,0.0002297517,0.000011309293,0.0000643124,0.0005962509,0.00085390935,0.7017196,0.00031138796,0.029147498,0.00059529627],"about_ca_topic_score_codex":0.0033646917,"about_ca_topic_score_gemma":0.00303212,"teacher_disagreement_score":0.22480431,"about_ca_system_score_codex":0.00003347075,"about_ca_system_score_gemma":0.00028655617,"threshold_uncertainty_score":0.508643},"labels":[],"label_agreement":null},{"id":"W2654209411","doi":"10.1158/0008-5472.can-17-0190","title":"Functionally Null <i>RAD51D</i> Missense Mutation Associates Strongly with Ovarian Carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; McGill Genome Centre; Montreal Neurological Institute and Hospital; Centre Hospitalier Universitaire Sainte-Justine; Occupational Cancer Research Centre; Centre hospitalier de l'Université Laval; Jewish General Hospital; McGill University; McGill University Health Centre; Institute for Research in Immunology and Cancer; McGill University and Génome Québec Innovation Centre; Children's Hospital of Eastern Ontario","funders":"Cancer Research UK","keywords":"Missense mutation; Ovarian cancer; Biology; Cancer research; DNA repair; Cancer; Genetics; Oncology; Mutation; Medicine; Gene","score_opus":0.11267073488232499,"score_gpt":0.42971915551476964,"score_spread":0.31704842063244465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2654209411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678976,0.0006985487,0.00011571517,0.0117982365,0.00030361832,0.00073406886,0.00006481004,0.000065969965,0.018321453],"genre_scores_gemma":[0.9874908,0.00011643595,0.00031029433,0.00028715032,0.0009782158,0.00040933274,0.000042384556,0.000051871797,0.010313549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997418,0.0001419273,0.00022641812,0.00044020877,0.0012184645,0.00055501057],"domain_scores_gemma":[0.9975615,0.00016625578,0.00016368768,0.0007478297,0.0010989116,0.00026181308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092987437,0.00016462729,0.00031576236,0.00017746502,0.0008845665,0.0001993452,0.00023571601,0.00011801584,0.0011993945],"category_scores_gemma":[0.00023464242,0.0001344321,0.00008256416,0.00018168995,0.00043353077,0.00023651219,0.000053136675,0.00060475233,0.00012451486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026207492,0.0008821258,0.5888761,0.000703296,0.0017354534,0.0030407575,0.0029031092,0.00035097596,0.20819758,0.0074526686,0.13911179,0.020538647],"study_design_scores_gemma":[0.020222364,0.0016856382,0.83987725,0.00082340516,0.00014598166,0.0003289303,0.00067247933,0.0002614738,0.06505589,0.0013495996,0.06903113,0.00054586784],"about_ca_topic_score_codex":0.0012554843,"about_ca_topic_score_gemma":0.00033043962,"teacher_disagreement_score":0.25100112,"about_ca_system_score_codex":0.00085631624,"about_ca_system_score_gemma":0.0013750059,"threshold_uncertainty_score":0.99971366},"labels":[],"label_agreement":null},{"id":"W2662801289","doi":"10.1158/0008-5472.can-16-3427","title":"Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Triple-negative breast cancer; Stromal cell; Desmoplasia; Subtyping; Breast cancer; Stroma; Cancer; Cancer research; Triple negative; Medicine; Tumor microenvironment; Oncology; Internal medicine; Pathology; Immunohistochemistry; Computer science","score_opus":0.060757647709943075,"score_gpt":0.44065140085678406,"score_spread":0.379893753146841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2662801289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969616,0.0007937604,0.000009382171,0.0011410352,0.00022562723,0.00022354673,0.00024893697,0.0000031403442,0.00039300232],"genre_scores_gemma":[0.99801666,0.0007938001,0.000018036444,0.000009311798,0.0002640296,0.0003321028,0.00000930364,0.000015180766,0.0005415888],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886227,0.00009202435,0.00020762274,0.0003264473,0.00023075649,0.0002808569],"domain_scores_gemma":[0.99897003,0.000041398755,0.00016741724,0.00044070734,0.0003389753,0.00004149028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003747252,0.000097439806,0.00014915442,0.000085678585,0.00024080764,0.000049235143,0.00035134648,0.00006173888,0.00006905726],"category_scores_gemma":[0.0002818563,0.000090568756,0.00004475107,0.00008689951,0.00030295804,0.000016764929,0.0002596203,0.00015787166,0.0000037838233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074416125,0.000107359425,0.27155232,0.00006595209,0.00015815686,0.0000042062525,0.0005989892,0.00004336965,0.704843,0.000050224546,0.0013332042,0.020499071],"study_design_scores_gemma":[0.0008564031,0.000034569297,0.6010058,0.00012253087,0.000007913439,0.0000023821917,0.00047831662,0.00001886065,0.39715838,0.000067510206,0.00016435556,0.000083006424],"about_ca_topic_score_codex":0.00804912,"about_ca_topic_score_gemma":0.007025481,"teacher_disagreement_score":0.32945344,"about_ca_system_score_codex":0.00014846795,"about_ca_system_score_gemma":0.0002035362,"threshold_uncertainty_score":0.9985564},"labels":[],"label_agreement":null},{"id":"W2673863654","doi":"","title":"Hypoxia increases ursolic acid induced caspase-3/7 activation","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ursolic acid; Apoptosis; Caspase 3; Caspase; Hypoxia (environmental); Chemistry; Caspase-9; Pharmacology; Molecular biology; Cancer research; Biochemistry; Medicine; Programmed cell death; Biology; Oxygen","score_opus":0.054776186242103835,"score_gpt":0.3726026390346065,"score_spread":0.31782645279250266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2673863654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958762,0.0013349231,0.00024076297,0.0003635798,0.00006487617,0.00019045238,0.0000074802547,0.000016302552,0.0019054381],"genre_scores_gemma":[0.9976748,0.000642325,0.00010259852,0.0001649971,0.0005811088,0.00018048611,0.000060550807,0.000027033158,0.00056610256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987091,0.0000901191,0.00012590903,0.00035796736,0.000329307,0.00038763057],"domain_scores_gemma":[0.9992117,0.000015862288,0.000034977937,0.00034542606,0.0002715344,0.00012049767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031050429,0.00011451495,0.00009713537,0.000084104984,0.00019589649,0.000046743327,0.0002838925,0.0001695124,0.000065866654],"category_scores_gemma":[0.0003085948,0.0001071019,0.000046236164,0.0002863314,0.00013013817,0.000008111457,0.00013429917,0.0002604691,0.000034823028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077460194,0.000051542316,0.0002641193,0.000033632743,0.000022516931,0.0000054634097,0.000055707995,0.000041272553,0.995913,0.0001725969,0.00086929754,0.0024933808],"study_design_scores_gemma":[0.00053762516,0.00019226302,0.00069740403,0.000040308623,0.000004250435,0.000008642411,0.000114984075,0.000001185838,0.9897212,0.0005329026,0.008016425,0.00013283086],"about_ca_topic_score_codex":0.000911021,"about_ca_topic_score_gemma":0.00008521477,"teacher_disagreement_score":0.007147128,"about_ca_system_score_codex":0.00014058649,"about_ca_system_score_gemma":0.00079395866,"threshold_uncertainty_score":0.43674886},"labels":[],"label_agreement":null},{"id":"W2725733926","doi":"10.1158/0008-5472.can-16-2704","title":"Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Cancer research; Gene silencing; PARP inhibitor; PARP1; DNA damage; Poly ADP ribose polymerase; Biology; Olaparib; DNA repair; Downregulation and upregulation; Molecular biology; Chromatin immunoprecipitation; Chemistry; DNA; Gene expression; Polymerase; Genetics; Gene; Promoter","score_opus":0.08398978919994851,"score_gpt":0.41120291101909184,"score_spread":0.3272131218191433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725733926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724664,0.004205277,0.000039604904,0.017835066,0.00018989359,0.00072310184,0.00034708914,0.000053405904,0.0041401256],"genre_scores_gemma":[0.98936707,0.0009389393,0.0004883154,0.00026282965,0.00026255238,0.0002473836,0.0000282687,0.000027035068,0.0083776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781096,0.000110177665,0.0003305652,0.00045083152,0.00091541867,0.00038206088],"domain_scores_gemma":[0.9981714,0.00011701378,0.00009957501,0.0006908034,0.0006525474,0.0002686422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097549235,0.00013404743,0.00027217108,0.00016733774,0.00043148443,0.000050735023,0.00018353794,0.00010083704,0.00027221107],"category_scores_gemma":[0.00027400625,0.00012930129,0.00007927144,0.00019521329,0.0006432587,0.00021451327,0.000060968505,0.0002884264,0.000018452396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012121648,0.00005167458,0.009823745,0.00022767135,0.000047849015,0.0000039934366,0.00057578745,0.0000023395974,0.8132125,0.00068267493,0.17331864,0.0008409319],"study_design_scores_gemma":[0.002597442,0.0003846235,0.087229505,0.001071283,0.000021556307,0.0000058522696,0.00020930088,0.00001279333,0.62520057,0.002623538,0.28042045,0.0002231104],"about_ca_topic_score_codex":0.00036674214,"about_ca_topic_score_gemma":0.00015859351,"teacher_disagreement_score":0.18801199,"about_ca_system_score_codex":0.00027532448,"about_ca_system_score_gemma":0.00028127557,"threshold_uncertainty_score":0.5272753},"labels":[],"label_agreement":null},{"id":"W2729462511","doi":"10.1158/0008-5472.can-17-0668","title":"Highly Accurate Detection of Cancer <i>In Situ</i> with Intraoperative, Label-Free, Multimodal Optical Spectroscopy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Polytechnique Montréal; Montreal Neurological Institute and Hospital","funders":"","keywords":"In situ; Cancer; Medicine; Cancer detection; Spectroscopy; Biomedical engineering; Chemistry; Internal medicine; Physics","score_opus":0.02954146071358561,"score_gpt":0.42350690956114406,"score_spread":0.39396544884755846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729462511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216294,0.0008684781,0.0006557407,0.0013875297,0.00007050265,0.000371242,0.000051128853,0.000012872806,0.0044195796],"genre_scores_gemma":[0.9942652,0.0030559232,0.0011800107,0.0000419117,0.00029291052,0.00039506963,0.000009376684,0.000027564816,0.00073206204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978541,0.00008741092,0.00021885149,0.00052218547,0.0006637415,0.00065367576],"domain_scores_gemma":[0.9984703,0.00004432896,0.00006819091,0.00086290896,0.00035976386,0.0001945222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005424853,0.00015928633,0.00022519319,0.00009889904,0.00022221744,0.00007565107,0.0010271717,0.00022600846,0.00010183125],"category_scores_gemma":[0.00045058058,0.00012126778,0.000040751034,0.00020889491,0.001294548,0.000014687817,0.0005563195,0.0006430479,0.0000035664577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010802042,0.00012785973,0.0028563105,0.000050529292,0.00003721087,0.0000125978095,0.000016551001,0.0000028337283,0.9901307,0.00011908174,0.0008133396,0.004752761],"study_design_scores_gemma":[0.0012099216,0.00074012915,0.003375654,0.00010605815,0.0000049914293,0.0000017562014,0.000017117367,0.000058894107,0.9910874,0.00022153373,0.0030272675,0.00014928746],"about_ca_topic_score_codex":0.0012611077,"about_ca_topic_score_gemma":0.0033879252,"teacher_disagreement_score":0.0046034735,"about_ca_system_score_codex":0.00015710924,"about_ca_system_score_gemma":0.00037489124,"threshold_uncertainty_score":0.49451566},"labels":[],"label_agreement":null},{"id":"W2729472857","doi":"","title":"Good long term results of multidrug resistance-reversal chemotherapy for advanced intraocular retinoblastoma without upfront elective consolidation radiation","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Vincristine; Surgery; Enucleation; Retinoblastoma; Chemotherapy; Chemotherapy regimen; Cyclophosphamide","score_opus":0.026936469101754318,"score_gpt":0.40409778871386404,"score_spread":0.37716131961210975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729472857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988086,0.0015065649,0.0011237849,0.0037864165,0.000088165405,0.0022217778,0.00008302577,0.00003561808,0.0012737827],"genre_scores_gemma":[0.9923127,0.0006515078,0.002769936,0.000093041475,0.00024131514,0.00039591506,0.0001363617,0.000030819894,0.0033683833],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983658,0.00017738708,0.0003094739,0.0003836618,0.00038752216,0.00037611515],"domain_scores_gemma":[0.99867487,0.00021503918,0.00014361061,0.0002972472,0.0005596978,0.00010955442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007789665,0.00013277434,0.00030773343,0.00017208807,0.00013918907,0.000009096354,0.00009287771,0.00019225462,0.00004342451],"category_scores_gemma":[0.0003522451,0.000120699806,0.00008178448,0.00025064853,0.00020175143,0.00013988944,0.000016692087,0.00033694107,0.000010384193],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071192086,0.0015420062,0.13389976,0.0005229129,0.0013844252,0.00004596264,0.0039842613,0.00013446699,0.37970304,0.00030381462,0.0070113544,0.40027592],"study_design_scores_gemma":[0.023997827,0.0010166907,0.077703506,0.00032446117,0.00009228177,0.0000052078412,0.00009518399,0.0002753762,0.8850107,0.000069258465,0.0112643335,0.00014517343],"about_ca_topic_score_codex":0.0000666138,"about_ca_topic_score_gemma":0.00070773036,"teacher_disagreement_score":0.5053077,"about_ca_system_score_codex":0.0008637696,"about_ca_system_score_gemma":0.00046238126,"threshold_uncertainty_score":0.4921995},"labels":[],"label_agreement":null},{"id":"W2732580804","doi":"","title":"expression of GPR54 and KiSS1 in human breast cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kisspeptin; Biology; Cancer research; Autocrine signalling; Breast cancer; Metastasis Suppressor Gene; Syncytiotrophoblast; Cancer; Hypogonadotropic hypogonadism; Comparative genomic hybridization; Metastasis; Internal medicine; Endocrinology; Receptor; Gene; Genetics; Hormone; Placenta; Medicine; Chromosome; Fetus","score_opus":0.052479420579864385,"score_gpt":0.41013643940826583,"score_spread":0.35765701882840145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732580804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781645,0.0070367656,0.0000032427988,0.0027315433,0.000031391497,0.00039659484,0.00002090486,0.000011800064,0.0019513061],"genre_scores_gemma":[0.9972204,0.00030858142,0.00003191438,0.000014183974,0.00037010884,0.00013886958,0.0000026020818,0.0000184413,0.0018949136],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985082,0.00008660058,0.00019590436,0.00032839662,0.00057528383,0.00030557244],"domain_scores_gemma":[0.9991414,0.000054003576,0.000037404057,0.0002824188,0.00041666994,0.00006809821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006977144,0.00008365916,0.00025495913,0.00027212524,0.000053025473,0.000008870599,0.00008119369,0.000060087907,0.00039009363],"category_scores_gemma":[0.00005848579,0.000068542206,0.000026983547,0.00027316116,0.00026132938,0.000067155794,0.000080238075,0.00030581746,0.00000284472],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021766391,0.00008020625,0.17583174,0.000109216395,0.000007263537,0.000018082657,0.00010716648,0.000007939281,0.81460273,0.000109995926,0.0022102767,0.0066977274],"study_design_scores_gemma":[0.0016008787,0.000069226684,0.79923904,0.0003611192,0.000008449028,0.000015244529,0.00009155321,0.000011204893,0.19613118,0.00036675454,0.0020381024,0.000067254296],"about_ca_topic_score_codex":0.010771558,"about_ca_topic_score_gemma":0.0011456434,"teacher_disagreement_score":0.6234073,"about_ca_system_score_codex":0.00024706873,"about_ca_system_score_gemma":0.00021967579,"threshold_uncertainty_score":0.9958158},"labels":[],"label_agreement":null},{"id":"W2733097072","doi":"","title":"Response of breast cancer cell lines to aminoflavone (NSC 686288) is associated with histone H2AX phosphorylation and estrogen receptor expression","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Aryl hydrocarbon receptor; Estrogen receptor; Cancer research; DNA damage; Cell culture; Cell cycle; Cell growth; Molecular biology; Estrogen receptor alpha; Chemistry; Cancer; Breast cancer; Biology; Internal medicine; Medicine; DNA; Transcription factor; Biochemistry","score_opus":0.012308047424317603,"score_gpt":0.31866656096602913,"score_spread":0.3063585135417115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733097072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872802,0.011443305,0.000019728595,0.00051727105,0.00005121538,0.00036481055,0.00018888323,0.000010930905,0.00012365631],"genre_scores_gemma":[0.9942701,0.0012810333,0.0001235662,0.00004894049,0.00013449772,0.00013343043,0.000077223536,0.00003669939,0.0038945067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847883,0.00023941329,0.0001846701,0.00039447064,0.00035327944,0.00034936354],"domain_scores_gemma":[0.99906427,0.00005365979,0.00008566978,0.0002493582,0.00041137869,0.00013567018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051524566,0.00014991972,0.0001785154,0.00007756983,0.00013242083,0.000018432504,0.00013575215,0.00021530334,0.00009322129],"category_scores_gemma":[0.000045702483,0.000121212106,0.000039684182,0.0002714137,0.00016456196,0.000008368894,0.00010461302,0.00017323793,0.0000047277485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038308527,0.000100859135,0.004133264,0.000025817533,0.00003871886,0.0000036685642,0.00011275369,0.000086266395,0.9766309,0.000002633672,0.014238927,0.00079532847],"study_design_scores_gemma":[0.00090083864,0.0005288839,0.008954022,0.00015796698,0.000016081769,0.000003303625,0.000052556352,0.000018382007,0.98656577,0.000004020074,0.0026440248,0.00015413681],"about_ca_topic_score_codex":0.0015479209,"about_ca_topic_score_gemma":0.00011156619,"teacher_disagreement_score":0.011594902,"about_ca_system_score_codex":0.00015908219,"about_ca_system_score_gemma":0.0002630593,"threshold_uncertainty_score":0.49428862},"labels":[],"label_agreement":null},{"id":"W2735056166","doi":"","title":"Investigations into molecular alterations present in ductal carcinoma in situ of the breast using a murine mammary tumor model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myoepithelial cell; Ductal carcinoma; Pathology; Breast cancer; Basement membrane; Biology; Stroma; Mammary gland; Carcinoma in situ; Immunohistochemistry; Cancer; Carcinoma; Medicine","score_opus":0.08275560105659248,"score_gpt":0.39029181770957744,"score_spread":0.307536216652985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735056166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882687,0.001573793,0.00018172518,0.008706376,0.00003009343,0.0006014823,0.000022571578,0.0000049751984,0.0006102894],"genre_scores_gemma":[0.99715924,0.00006879093,0.002116095,0.00016235033,0.00011318793,0.00015047865,0.000005833657,0.000016425169,0.00020757619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986053,0.00012132572,0.00027180545,0.00023580735,0.00046742507,0.00029831208],"domain_scores_gemma":[0.9992346,0.000027935883,0.00003659291,0.0003944058,0.00018678866,0.00011963936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036232077,0.000087485685,0.0001840644,0.00031630212,0.00006385026,0.000016200815,0.00016919083,0.000032125234,0.000042559255],"category_scores_gemma":[0.000052545154,0.000070776914,0.000059461865,0.0008972711,0.00018876219,0.00011220164,0.00018075456,0.0003801874,0.0000014599398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008241743,0.00020266167,0.017213909,0.00018882063,0.000018469867,0.000055480003,0.0016690074,0.052529242,0.9250065,0.00074647303,0.00035226322,0.0019347597],"study_design_scores_gemma":[0.003596038,0.00008730867,0.051161714,0.0008131153,0.00005319255,0.00019631226,0.00047407884,0.17257065,0.7683827,0.0013960392,0.0010125424,0.00025627992],"about_ca_topic_score_codex":0.006737848,"about_ca_topic_score_gemma":0.005926925,"teacher_disagreement_score":0.15662377,"about_ca_system_score_codex":0.00060105737,"about_ca_system_score_gemma":0.0014654634,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W2736456985","doi":"","title":"Functional significance of missense variants in BRCA1","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Missense mutation; Biology; Genetics; Gene; Allele; Ovarian cancer; Tumor suppressor gene; Transcription factor; Loss function; Phenotype; Cancer research; Cancer; Carcinogenesis","score_opus":0.0429198932877899,"score_gpt":0.39605091560542166,"score_spread":0.35313102231763177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736456985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950017,0.0016363855,0.0024091578,0.00020164534,0.00008416379,0.00011645903,0.000009717725,0.000002625983,0.00053818914],"genre_scores_gemma":[0.9988811,0.00029887678,0.00019144519,0.000018244978,0.00013134842,0.000040215487,0.000008460592,0.0000096509075,0.00042063245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931836,0.000024544745,0.0001026788,0.00018319898,0.00016730158,0.0002039095],"domain_scores_gemma":[0.9996673,0.000010588243,0.000011146222,0.00016771985,0.00009709855,0.000046142806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025551257,0.000050409704,0.0000655948,0.000063938096,0.000021825259,0.000004993674,0.0000922679,0.00005708869,0.000058727805],"category_scores_gemma":[0.00006312227,0.000051736602,0.000023544575,0.00017642725,0.00006550727,0.000001251373,0.00004289135,0.000108359294,0.0000056531694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006538943,0.00003112661,0.0006528215,0.000025964984,0.00000937172,0.0000062330682,0.000041663363,0.012265956,0.98540884,0.00012972468,0.00050706166,0.00085582776],"study_design_scores_gemma":[0.0006191211,0.000086866596,0.025620297,0.00003126386,0.0000012380266,0.000004733727,0.000061468214,0.000015892036,0.97024983,0.00021745531,0.0030203324,0.00007149616],"about_ca_topic_score_codex":0.00031206332,"about_ca_topic_score_gemma":0.00020398188,"teacher_disagreement_score":0.024967475,"about_ca_system_score_codex":0.00003438297,"about_ca_system_score_gemma":0.00021563937,"threshold_uncertainty_score":0.21097575},"labels":[],"label_agreement":null},{"id":"W2736733526","doi":"10.1158/0008-5472.can-16-3233","title":"Hsp72 and Nek6 Cooperate to Cluster Amplified Centrosomes in Cancer Cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Medical Research Council Canada; University of Leicester; Chinese Academy of Sciences; Hope Against Cancer; Cancer Research UK; Worldwide Cancer Research; Wellcome Trust","keywords":"Centrosome; Mitosis; Cell biology; Biology; Cancer cell; Multipolar spindles; Chromosome instability; Microtubule; Chromosome segregation; Cancer research; Genetics; Cancer; Gene; Cell cycle; Chromosome","score_opus":0.05250374214245875,"score_gpt":0.4044841487437258,"score_spread":0.35198040660126706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736733526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550974,0.0015412002,0.000048248963,0.0017599333,0.00018057777,0.00037598162,0.000063436455,0.0000029624475,0.0005178874],"genre_scores_gemma":[0.9876979,0.0060258005,0.00005680336,0.0005867562,0.00028057853,0.00019890236,0.000011399476,0.000022748516,0.0051191263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988411,0.00006420183,0.0001159464,0.00039303832,0.00013667704,0.0004490068],"domain_scores_gemma":[0.9991855,0.000010398652,0.000027755203,0.00048546024,0.00014536655,0.00014551012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029335296,0.000104425184,0.0001277596,0.00006452626,0.00023165255,0.00015578666,0.00035258947,0.00011002605,0.000055176177],"category_scores_gemma":[0.00005687352,0.00009615752,0.000023450339,0.00006097814,0.00014207273,0.0000062972704,0.00044290244,0.00017714904,0.000016654203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001485342,0.00002167137,0.007893047,0.000028565071,0.000015799422,0.000003458389,0.00010245588,0.00009254663,0.97719836,0.00003382768,0.010218984,0.0042427336],"study_design_scores_gemma":[0.0009985293,0.00011397338,0.012317485,0.000071421724,0.0000042380675,0.0000013177653,0.00006610896,0.00008283693,0.8445034,0.00002469185,0.14160739,0.00020860726],"about_ca_topic_score_codex":0.002023829,"about_ca_topic_score_gemma":0.006358862,"teacher_disagreement_score":0.13269497,"about_ca_system_score_codex":0.000054813823,"about_ca_system_score_gemma":0.00018318449,"threshold_uncertainty_score":0.392119},"labels":[],"label_agreement":null},{"id":"W2738332138","doi":"","title":"cIAP2 is a K63 ubiquitin ligase for RIP1 which is blocked by IAP BIR antagonists during death receptor-mediated apoptosis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Inhibitor of apoptosis; Cell biology; Ubiquitin ligase; Signal transducing adaptor protein; Caspase; Autocrine signalling; Apoptosis; Caspase 8; Programmed cell death; Biology; Cancer cell; Ubiquitin; Cancer research; Signal transduction; Chemistry; Receptor; Cancer; Biochemistry; Genetics","score_opus":0.043399881130480045,"score_gpt":0.35180946511407846,"score_spread":0.3084095839835984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738332138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856198,0.0080183735,0.000034529836,0.0018983736,0.0017076468,0.000770796,0.0015786806,0.00003651596,0.0003353154],"genre_scores_gemma":[0.9267884,0.03855085,0.0002595304,0.0010009849,0.014038129,0.0015734325,0.00070674706,0.00015236603,0.016929563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703354,0.0001243428,0.00034698966,0.00088168966,0.0005469425,0.0010664815],"domain_scores_gemma":[0.99807286,0.000048757836,0.0000893602,0.0006257559,0.00078970846,0.00037353474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047898127,0.0002848737,0.00034979254,0.00015910449,0.00059050944,0.000058060315,0.00046815758,0.0003326107,0.00034118613],"category_scores_gemma":[0.00025476768,0.0002895541,0.00017618455,0.000510953,0.00022977128,0.000011627099,0.00022179325,0.00034976765,0.00004260398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037517957,0.000060812337,0.0011011327,0.00007860287,0.00007199058,1.7214624e-7,0.00031553934,7.6900614e-7,0.61339206,0.0000036646297,0.38408193,0.00051812286],"study_design_scores_gemma":[0.0011089941,0.0001158839,0.00018349083,0.000027431111,0.000009251697,0.000004126193,0.00007923114,0.0000075217513,0.5265893,0.000007402296,0.47167006,0.00019731531],"about_ca_topic_score_codex":0.0008460678,"about_ca_topic_score_gemma":0.00016992603,"teacher_disagreement_score":0.08758813,"about_ca_system_score_codex":0.00015413035,"about_ca_system_score_gemma":0.00082275114,"threshold_uncertainty_score":0.99995565},"labels":[],"label_agreement":null},{"id":"W2739197067","doi":"","title":"Radiation effects on tumour microcirculation assessed by high-frequency power doppler micro-ultrasound imaging in mice","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Ultrasound; Medicine; Haematoxylin; CD31; Radiation therapy; Microcirculation; Pathology; Blood flow; Nuclear medicine; Microbubbles; Immunohistochemistry; Radiology","score_opus":0.016894473452190518,"score_gpt":0.29613793682787953,"score_spread":0.279243463375689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739197067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530673,0.0021619285,0.000345316,0.00033163698,0.00013635743,0.0004516671,0.000038286074,0.000118130694,0.0011099617],"genre_scores_gemma":[0.99824613,0.0007410289,0.0001623748,0.00009180809,0.00014510514,0.0003547542,0.00008791654,0.000056467754,0.00011438452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986343,0.0000897009,0.00019841902,0.00029599777,0.00032168807,0.00045994116],"domain_scores_gemma":[0.99914384,0.00043666497,0.00002308778,0.0002121539,0.000094754796,0.00008952496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002460896,0.00015195002,0.00015019481,0.0002449887,0.00019564193,0.000055290355,0.00020039566,0.0000811734,0.00012180945],"category_scores_gemma":[0.000058034286,0.00016253244,0.00003640699,0.0005802957,0.00006458349,0.00018917487,0.000010947731,0.00043398954,0.00013468646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006403807,0.000040096395,0.013610644,0.000036438352,0.000010930247,0.0000069206226,0.00037177416,0.00063640584,0.97621876,0.000097804616,0.008086879,0.00087697257],"study_design_scores_gemma":[0.0012100688,0.000026252777,0.23774579,0.00010602536,0.00000776444,0.000031013416,0.00007705285,0.0002285204,0.75503075,0.00044258373,0.0046959366,0.00039823682],"about_ca_topic_score_codex":0.00085515453,"about_ca_topic_score_gemma":0.00005732755,"teacher_disagreement_score":0.22413515,"about_ca_system_score_codex":0.00061551004,"about_ca_system_score_gemma":0.0000887928,"threshold_uncertainty_score":0.66278803},"labels":[],"label_agreement":null},{"id":"W2739306705","doi":"","title":"Distinct mouse chromosome 11 (human 17q) amplifications develop in mouse breast tumors induced by oncogenic ERBB2 or polyoma virus middle T antigen","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Infectious Diseases and Mycology","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Amplicon; Biology; Locus (genetics); Mouse mammary tumor virus; Gene; Molecular biology; Bacterial artificial chromosome; Gene duplication; Comparative genomic hybridization; Chromosome 17 (human); Contig; Genetics; Chromosome; Genome; Polymerase chain reaction","score_opus":0.16548618911543136,"score_gpt":0.42851162415175875,"score_spread":0.26302543503632736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739306705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626786,0.00034512868,0.000007848146,0.0005014612,0.00007175977,0.00085868797,0.0011030008,0.00014141282,0.0007028724],"genre_scores_gemma":[0.99326783,0.00014551336,0.00003465878,0.0001526782,0.0003762738,0.0010218783,0.0001918335,0.00009645455,0.0047128554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966661,0.00043064434,0.000508952,0.0007062552,0.00050839514,0.0011796857],"domain_scores_gemma":[0.99832433,0.00016523647,0.00010003995,0.0006761886,0.00036094032,0.0003732359],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005709606,0.00027503638,0.00035891528,0.00046785487,0.00061682606,0.00010749782,0.0006230872,0.00019823338,0.003682767],"category_scores_gemma":[0.00012620506,0.00025813867,0.00008918852,0.0011385734,0.0002619933,0.00023334564,0.00031029544,0.0006446056,0.0006497562],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006118253,0.000931382,0.014855665,0.000080769925,0.00006684639,0.00015572408,0.0008369271,0.00000575245,0.971449,0.00035467435,0.008425304,0.0022261108],"study_design_scores_gemma":[0.010221906,0.0037284172,0.58774513,0.00044417314,0.00008452039,0.0014869266,0.0021982566,0.00029717686,0.27203038,0.0003754682,0.11806306,0.003324583],"about_ca_topic_score_codex":0.021327164,"about_ca_topic_score_gemma":0.031687003,"teacher_disagreement_score":0.69941866,"about_ca_system_score_codex":0.0014606462,"about_ca_system_score_gemma":0.0011845994,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W2739480369","doi":"10.1158/1538-7445.am2017-4196","title":"Abstract 4196: Anti-tumor activity of a TAM kinase-targeting compound in CT-26 syngeneic mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"Tumor microenvironment; Cancer research; Immune system; Kinase; Receptor tyrosine kinase; Cancer; CD8; Immune checkpoint; Metastasis; Biology; Medicine; Immunotherapy; Immunology; Internal medicine; Cell biology","score_opus":0.10644497133387802,"score_gpt":0.3972439327358291,"score_spread":0.29079896140195105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739480369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958733,0.00282898,0.000017249164,0.00022029897,0.00015010464,0.0002981289,0.000049334936,0.000019948999,0.0005426771],"genre_scores_gemma":[0.9987885,0.00039594507,0.000016134472,0.0000083975965,0.0000289597,0.000060268547,0.000012361663,0.00002533658,0.000664102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858695,0.0001847285,0.00026673204,0.0003208853,0.00011172928,0.00052897737],"domain_scores_gemma":[0.99889344,0.00011402101,0.0002016822,0.00059273606,0.00017105117,0.000027072598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011029375,0.00013132062,0.0003423054,0.00019270576,0.000488786,0.00004820808,0.00052623806,0.00009496291,0.0001378295],"category_scores_gemma":[0.00019211601,0.00012217436,0.000074594296,0.00009375617,0.00048969244,0.00028789716,0.0002462862,0.0005893112,0.00005873031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016373863,0.00018010385,0.007394868,0.000077187025,0.00004418443,0.000006547494,0.00010934429,0.000662236,0.9867024,0.00006882971,0.0007270358,0.0038635398],"study_design_scores_gemma":[0.0009188885,0.00003797156,0.109742574,0.00010127901,0.000005032809,0.0000025068794,0.000043772343,0.00065311557,0.88761485,0.00008352507,0.00067781133,0.000118689735],"about_ca_topic_score_codex":0.0036764522,"about_ca_topic_score_gemma":0.00036372646,"teacher_disagreement_score":0.1023477,"about_ca_system_score_codex":0.00018805645,"about_ca_system_score_gemma":0.00028750076,"threshold_uncertainty_score":0.55577207},"labels":[],"label_agreement":null},{"id":"W2739485112","doi":"10.1158/1538-7445.am2017-ng05","title":"Abstract NG05: TP53-mediated human cancer susceptibility is defined by epigenetic dysregulation of microRNA-34A","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"DNA methylation; Biology; Epigenetics; Germline; Cancer research; Cancer; Germline mutation; Genetics; Epigenome; Methylation; Mutation; Gene; Gene expression","score_opus":0.07408713493701012,"score_gpt":0.4264076967565441,"score_spread":0.352320561819534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739485112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915293,0.0061826077,0.000048086556,0.0006964525,0.0001384527,0.00033470622,0.00036760335,0.0000063750244,0.00069641613],"genre_scores_gemma":[0.9956946,0.002750199,0.00005953281,0.000031674877,0.00024540047,0.00008405878,0.00019292756,0.000033415712,0.000908208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981683,0.00010751996,0.0003411955,0.00052946166,0.00042490158,0.0004286135],"domain_scores_gemma":[0.9979813,0.00003691955,0.00023556995,0.0009792596,0.00062756677,0.0001393628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083749223,0.00015983808,0.00020038056,0.00007339867,0.00046077953,0.00007642654,0.00050313515,0.00024653305,0.0005020284],"category_scores_gemma":[0.00022845453,0.00015843469,0.00009067396,0.00009443907,0.00043349032,0.0000095548,0.00019666266,0.00020469599,0.000012069529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006941409,0.0000752029,0.04716439,0.000064126696,0.00004876773,5.133215e-7,0.00005818535,0.000024942165,0.94528186,0.000010291117,0.0031239039,0.0040784],"study_design_scores_gemma":[0.00042599285,0.00010362269,0.27144063,0.00002703076,0.000009047258,6.420572e-8,0.0000151123995,0.000014073781,0.72039634,0.00022513724,0.007215516,0.00012741431],"about_ca_topic_score_codex":0.0037618198,"about_ca_topic_score_gemma":0.0019797229,"teacher_disagreement_score":0.22488551,"about_ca_system_score_codex":0.000088992405,"about_ca_system_score_gemma":0.00026033193,"threshold_uncertainty_score":0.64607793},"labels":[],"label_agreement":null},{"id":"W2739509734","doi":"10.1158/1538-7445.am2017-5228","title":"Abstract 5228: The impact of microtubules on solution conductance and capacitance; implications for the use of AC electric fields in cancer therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Communication and Nanonetworks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Conductance; Microtubule; Capacitance; Ion; Mitosis; Tubulin; Materials science; Biophysics; Ionic bonding; Chemistry; Electrode; Nanotechnology; Condensed matter physics; Physics; Biology; Cell biology","score_opus":0.30834996753242044,"score_gpt":0.45703103704096704,"score_spread":0.1486810695085466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739509734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98104906,0.01570916,0.00053725677,0.0018142674,0.000036406313,0.0006643277,0.000046674948,0.0000063884795,0.00013645126],"genre_scores_gemma":[0.9670735,0.0323858,0.000035810615,0.000016283107,0.000028770748,0.00041915412,0.0000015651991,0.000010738339,0.000028395752],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99947846,0.00004025922,0.00012948007,0.00008501815,0.000083922925,0.0001828588],"domain_scores_gemma":[0.998673,0.00045674236,0.000056468456,0.00065802113,0.00013513121,0.000020632804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033421573,0.00006202103,0.000097454096,0.00005639845,0.0002208277,0.000039496088,0.00039466203,0.00005546524,0.000018925231],"category_scores_gemma":[0.00007483947,0.000037420137,0.000044463155,0.00013697945,0.00015301074,0.00006791326,0.000019166033,0.0002725263,2.3955047e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018843211,0.00005038126,0.008964368,0.00005947439,0.00014228126,1.2859651e-7,0.00063616195,0.023223061,0.8531784,0.0011776134,0.010579711,0.10180002],"study_design_scores_gemma":[0.0007965893,0.00011675345,0.87217075,0.00016967773,0.0000067866454,6.756956e-7,0.000032195574,0.017294282,0.10457108,0.00085908035,0.0038452079,0.00013690918],"about_ca_topic_score_codex":0.0030325155,"about_ca_topic_score_gemma":0.0016417889,"teacher_disagreement_score":0.8632064,"about_ca_system_score_codex":0.00008777529,"about_ca_system_score_gemma":0.000078714605,"threshold_uncertainty_score":0.45842764},"labels":[],"label_agreement":null},{"id":"W2739562807","doi":"10.1158/1538-7445.am2017-lb-223","title":"Abstract LB-223: Whole genome sequencing of rhabdomyosarcoma germline cohort identifies low frequency of pathogenic mutations","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Genetics; Frameshift mutation; Biology; MUTYH; Germline mutation; Germline; Cancer; 1000 Genomes Project; Nonsynonymous substitution; MSH6; Mutation; Single-nucleotide polymorphism; Gene; Genome; Genotype","score_opus":0.04537993529525883,"score_gpt":0.368181101517747,"score_spread":0.3228011662224882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739562807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371725,0.0036794276,0.00008277902,0.00017630366,0.00016802044,0.0003176002,0.0007731119,0.0000036929562,0.001081817],"genre_scores_gemma":[0.996959,0.0018627294,0.00020068832,0.000016842247,0.00028491393,0.000088248955,0.00017440929,0.00002781939,0.00038536673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985429,0.00004261057,0.00036605523,0.00035334725,0.0003430057,0.00035204773],"domain_scores_gemma":[0.99798405,0.000058336278,0.00024136736,0.00093725475,0.0006717431,0.00010722333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067936844,0.0001227581,0.00022584581,0.0001009375,0.00028317852,0.00006504056,0.00061968976,0.0001247461,0.00010204772],"category_scores_gemma":[0.0004988357,0.00012806767,0.0001216793,0.000087705164,0.00054780947,0.0000119931865,0.00027605979,0.00018332605,0.000009935948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003235409,0.00005277118,0.016239535,0.00013649558,0.00008593381,0.00001099382,0.00008201421,0.00018663162,0.98190403,0.000115139774,0.00027338613,0.0008807367],"study_design_scores_gemma":[0.00066320534,0.0001327168,0.22167142,0.00010461057,0.000028585771,0.0000045536503,0.00015133087,0.00002084239,0.7745502,0.0010058604,0.0014702133,0.00019647175],"about_ca_topic_score_codex":0.00242314,"about_ca_topic_score_gemma":0.00125865,"teacher_disagreement_score":0.20735382,"about_ca_system_score_codex":0.000103547216,"about_ca_system_score_gemma":0.00084232906,"threshold_uncertainty_score":0.52224475},"labels":[],"label_agreement":null},{"id":"W2739563006","doi":"10.1158/1538-7445.am2017-4557","title":"Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Oncolytic virus; Immunotherapy; Tumor microenvironment; Medicine; CD8; Cancer research; Immune system; Immunology; Adjuvant; Vaccination; Cytotoxic T cell; Cancer immunotherapy; Vaccine therapy; Biology","score_opus":0.0780061838803215,"score_gpt":0.41824962046617115,"score_spread":0.34024343658584966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739563006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829289,0.012713585,0.00016274133,0.00095372717,0.00042269105,0.0019956313,0.00015008645,0.000032560867,0.000640104],"genre_scores_gemma":[0.9894503,0.0058801365,0.00010876336,0.00021186488,0.0004771387,0.0018462958,0.00010522609,0.00012749142,0.0017927777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99641234,0.0004178829,0.00038540285,0.00086027,0.0008826166,0.0010414833],"domain_scores_gemma":[0.9972207,0.00012727719,0.00027082305,0.0015016514,0.0006631391,0.00021640475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023844582,0.0003397641,0.00035850453,0.00023190097,0.0011778035,0.0005028245,0.0013348062,0.00016416129,0.00049738964],"category_scores_gemma":[0.0003532057,0.00031101052,0.00018063778,0.00017489004,0.0003234869,0.000059279875,0.00030945003,0.00070301583,0.00003622728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020622383,0.00012485412,0.001768072,0.0001299685,0.00032630755,0.000022862872,0.00014765632,0.00021296002,0.93331116,0.000016147334,0.00017697287,0.06170079],"study_design_scores_gemma":[0.0021483116,0.00060103653,0.01052566,0.000096862466,0.000015790532,0.0000018708831,0.00021200046,0.00063083484,0.9827457,0.00025163536,0.0024141935,0.00035612527],"about_ca_topic_score_codex":0.0015485043,"about_ca_topic_score_gemma":0.0046025408,"teacher_disagreement_score":0.061344665,"about_ca_system_score_codex":0.00037182076,"about_ca_system_score_gemma":0.0012430849,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2739576500","doi":"10.1158/1538-7445.am2017-2801","title":"Abstract 2801: Identification of oncogenic/metastatic driver genes that cooperate with p53 or p53/Rb-loss to induce triple-negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute","funders":"","keywords":"Cancer research; Carcinogenesis; Breast cancer; Triple-negative breast cancer; Metastasis; Cancer; Biology; Pathology; Medicine; Genetics","score_opus":0.1400376364416579,"score_gpt":0.4381666766932693,"score_spread":0.2981290402516114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739576500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921243,0.0010181683,0.00011091818,0.0031025843,0.00035533385,0.0021400612,0.00068244914,0.000030187413,0.0004360058],"genre_scores_gemma":[0.99196553,0.001609013,0.00017395006,0.00013379577,0.00025678083,0.0008683716,0.000022146924,0.000093311704,0.0048771077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964526,0.00014871999,0.00047592385,0.0007620156,0.0014388561,0.0007218456],"domain_scores_gemma":[0.99579227,0.00012839385,0.0003648819,0.0013367111,0.0019308088,0.00044692928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00099292,0.00029077395,0.0005723671,0.00038749477,0.000503685,0.00017180365,0.00062765164,0.000140378,0.0013510874],"category_scores_gemma":[0.00037752488,0.0002164881,0.00010228801,0.00069021084,0.00068315136,0.00026625715,0.00020258091,0.0007455758,0.00011425574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006727138,0.00027613936,0.006794307,0.00054374605,0.00076088373,0.00041883072,0.001917073,0.00050567894,0.924988,0.00004919854,0.0026973719,0.054321688],"study_design_scores_gemma":[0.0047613373,0.00046920555,0.221528,0.0013242961,0.00019995453,0.000100047706,0.0005598239,0.000097962795,0.7678632,0.00002688001,0.0027258478,0.00034342194],"about_ca_topic_score_codex":0.01025707,"about_ca_topic_score_gemma":0.006275691,"teacher_disagreement_score":0.21473369,"about_ca_system_score_codex":0.0009796444,"about_ca_system_score_gemma":0.0030982874,"threshold_uncertainty_score":0.9995618},"labels":[],"label_agreement":null},{"id":"W2739577140","doi":"10.1158/1538-7445.am2017-lb-055","title":"Abstract LB-055: Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) for patients with advanced melanoma (MEL) who progressed after prior ipilimumab (IPI) treatment","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Expanded access; Adverse effect; Oncology; Melanoma; Stage (stratigraphy); Immunotherapy; Cancer","score_opus":0.06117101554433939,"score_gpt":0.43848929324547986,"score_spread":0.37731827770114046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739577140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930943,0.0014415615,0.00000529046,0.00023705508,0.00017097346,0.004445674,0.00033683225,0.00003798692,0.00023028941],"genre_scores_gemma":[0.9943517,0.0010727021,0.00046238178,0.000023001696,0.00017080728,0.0034744425,0.00008284659,0.00005631356,0.00030580172],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974683,0.000071109214,0.00036489434,0.00064616883,0.0007666411,0.00068287057],"domain_scores_gemma":[0.99790275,0.00012420262,0.00023119405,0.0009476896,0.0005123465,0.00028179967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002971997,0.00028586344,0.0005552643,0.000109757595,0.0004221844,0.00021534105,0.0004052369,0.00012925318,0.00024546226],"category_scores_gemma":[0.000060110608,0.00020332776,0.00010165096,0.000109578905,0.00069023774,0.0007524439,0.000115745475,0.000179076,6.099514e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11361209,0.0016251808,0.4153545,0.00024706183,0.00035811454,0.000014128064,0.0027175345,9.124723e-7,0.0034525618,0.0000040031014,0.000049688104,0.46256423],"study_design_scores_gemma":[0.024592238,0.0058531235,0.9459767,0.00065073115,0.000047859194,7.292732e-7,0.00040909485,0.000031051,0.018046487,0.000012915508,0.004126815,0.00025230195],"about_ca_topic_score_codex":0.0028985532,"about_ca_topic_score_gemma":0.0012954903,"teacher_disagreement_score":0.5306222,"about_ca_system_score_codex":0.00048619282,"about_ca_system_score_gemma":0.00046987674,"threshold_uncertainty_score":0.8291465},"labels":[],"label_agreement":null},{"id":"W2739590162","doi":"10.1158/1538-7445.am2017-2248","title":"Abstract 2248: Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Internal medicine; Hazard ratio; Lung cancer; Genotype; Oncology; Medicine; Topotecan; Topoisomerase; Irinotecan; Cancer; Confidence interval; Biology; Genetics; Chemotherapy; Gene; DNA; Colorectal cancer","score_opus":0.07079258910405739,"score_gpt":0.43121373376579725,"score_spread":0.36042114466173986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739590162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820564,0.002222962,0.0000018270816,0.00771022,0.001242825,0.0044898638,0.00031751048,0.000026232916,0.0019321641],"genre_scores_gemma":[0.99328923,0.0014731141,0.000011188383,0.0003017893,0.00061948295,0.0031183516,0.0000387416,0.00006882701,0.0010792913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99500287,0.00036360516,0.0006639274,0.0008902994,0.002039657,0.0010396477],"domain_scores_gemma":[0.99703556,0.0006575401,0.0002356455,0.0010202801,0.00074657734,0.00030439434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001863487,0.00031676696,0.00055357936,0.00041346057,0.00053807895,0.00028795624,0.0012866146,0.00013724333,0.0007251578],"category_scores_gemma":[0.00071893295,0.00024545527,0.00009381767,0.00042391173,0.0003830025,0.00036823834,0.0010802463,0.0016630609,0.000019537521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016476248,0.0007547576,0.9809944,0.000085012696,0.00025774696,0.000094401235,0.006097305,0.00020363998,0.0019757678,0.0000029075054,0.0061983885,0.0016880302],"study_design_scores_gemma":[0.0070146862,0.000115557224,0.9878211,0.0011365104,0.000055070745,7.899271e-8,0.00097211223,0.0009199972,0.0011969499,0.0000071812465,0.0005250783,0.00023565673],"about_ca_topic_score_codex":0.4126386,"about_ca_topic_score_gemma":0.42314604,"teacher_disagreement_score":0.0112328185,"about_ca_system_score_codex":0.0036438962,"about_ca_system_score_gemma":0.00088577473,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2739596457","doi":"10.1158/1538-7445.am2017-4043","title":"Abstract 4043: Design of a novel MGMT inhibitor targeted to EGFR overexpressing tumor cells: a new approach to selectively potentiate temozolomide in refractory tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Temozolomide; Cancer research; Methyltransferase; Epidermal growth factor receptor; In vivo; EGFR inhibitors; Melanoma; Pharmacology; Chemistry; Cancer; Biology; Glioma; Medicine; Internal medicine; Biochemistry; DNA; Methylation","score_opus":0.1473369223247984,"score_gpt":0.40004375382945284,"score_spread":0.25270683150465445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739596457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480003,0.0004314879,0.00038092877,0.00077989924,0.00009199142,0.002033619,0.000054973516,0.00002290576,0.0014041836],"genre_scores_gemma":[0.99197274,0.00003161811,0.0067303516,0.000109905784,0.00022046675,0.00049552973,0.0000065544477,0.000058199515,0.000374629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713796,0.000102325095,0.00041675687,0.0007102911,0.0008452387,0.0007874221],"domain_scores_gemma":[0.9979122,0.00018391864,0.00016752898,0.00076677103,0.0003559169,0.0006136411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176596,0.00023841074,0.0005443143,0.0006388625,0.00024883432,0.00012833401,0.00040440971,0.00009616105,0.00008504655],"category_scores_gemma":[0.0007432631,0.00020595375,0.00009302114,0.0005051264,0.00011417489,0.00018726257,0.0002326526,0.0005108113,0.00005395015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014954787,0.001477523,0.005073181,0.00017281243,0.00008545781,0.00017006013,0.00087998353,0.0011322949,0.9763419,0.000014524314,0.010312592,0.0028442065],"study_design_scores_gemma":[0.0044263992,0.0005159663,0.25130495,0.0015179758,0.000028626211,0.000011705738,0.00029022677,0.00030320894,0.7404958,0.000028858616,0.00084226264,0.00023403515],"about_ca_topic_score_codex":0.009417829,"about_ca_topic_score_gemma":0.00019268402,"teacher_disagreement_score":0.24623178,"about_ca_system_score_codex":0.0009338743,"about_ca_system_score_gemma":0.0012752163,"threshold_uncertainty_score":0.99717855},"labels":[],"label_agreement":null},{"id":"W2739609750","doi":"10.1158/1538-7445.am2017-2019","title":"Abstract 2019: Synergistic anticancer activity of the RAD51 inhibitor IBR2 with inhibitors of receptor tyrosine kinases and microtubule protein","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Cancer cell; Cancer research; Receptor tyrosine kinase; Cancer; Tyrosine kinase; RAD51; Cytotoxicity; Biology; Synthetic lethality; Growth inhibition; Cell growth; Apoptosis; Kinase; DNA damage; Chemistry; Pharmacology; Molecular biology; DNA repair; Receptor; Cell biology; DNA; Biochemistry; In vitro","score_opus":0.033206588024516266,"score_gpt":0.34213865422282125,"score_spread":0.308932066198305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739609750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968294,0.0016459465,0.00002087288,0.0005432518,0.00014599154,0.0005154248,0.00013514052,0.000002422337,0.00016156744],"genre_scores_gemma":[0.9981519,0.0007437283,0.000062081555,0.000014031564,0.00024516857,0.00008870028,0.0000038837825,0.000024967581,0.00066553307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891204,0.00005392005,0.00014540495,0.0003022491,0.0003194979,0.00026688573],"domain_scores_gemma":[0.9987695,0.000017429127,0.00019133795,0.0006723947,0.0002775725,0.000071766626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034425026,0.00012315305,0.000183271,0.000039004488,0.00024056082,0.000040910974,0.00034233287,0.000099366865,0.00003748757],"category_scores_gemma":[0.00008386556,0.00008407599,0.00005197993,0.00007709541,0.00079250184,0.000009310065,0.000263982,0.00018289691,6.7974025e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005544532,0.00006321974,0.0007560934,0.0001544823,0.000051287076,6.4321887e-7,0.000028799086,0.0000032849925,0.9913988,0.00010229442,0.0005691651,0.0063174376],"study_design_scores_gemma":[0.00059927197,0.0003307728,0.007401286,0.00031864908,0.000011599272,8.756724e-7,0.000023070259,0.0000020504317,0.9857694,0.0000516217,0.0053854682,0.000105937725],"about_ca_topic_score_codex":0.0012820194,"about_ca_topic_score_gemma":0.00038382123,"teacher_disagreement_score":0.006645193,"about_ca_system_score_codex":0.0000356555,"about_ca_system_score_gemma":0.00038752717,"threshold_uncertainty_score":0.34285194},"labels":[],"label_agreement":null},{"id":"W2739611600","doi":"10.1158/1538-7445.am2017-ct161","title":"Abstract CT161: METIS: A phase 3 study of radiosurgery with TTFields for 1-10 brain metastases from NSCLC","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Neurocognitive; Lung cancer; Internal medicine; Oncology; Population; Clinical trial; Radiation therapy","score_opus":0.2179382020617295,"score_gpt":0.5174172766170859,"score_spread":0.2994790745553564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739611600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299103,0.0006663357,0.000052663065,0.0025343716,0.0001040301,0.0010349952,0.00030131926,0.000024543879,0.0022907075],"genre_scores_gemma":[0.99638486,0.000045129415,0.0005878418,0.000050694947,0.00048300377,0.0005512743,0.00003474985,0.000043204447,0.0018192693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787736,0.000070707625,0.0003059864,0.0004623675,0.0008521661,0.0004313917],"domain_scores_gemma":[0.99633175,0.0013498178,0.00017431956,0.0013679262,0.00056314934,0.00021303451],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013277348,0.00016235052,0.0005149994,0.00008605408,0.0002960288,0.00008485049,0.00047359365,0.000101230486,0.0019422818],"category_scores_gemma":[0.0013136183,0.00012816684,0.0000905594,0.000114265604,0.00036803877,0.00012525302,0.0001281293,0.0004861276,0.000008939577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023147246,0.0077147703,0.041022573,0.0014753577,0.0032892765,0.0008725037,0.0019967183,0.000008925028,0.5463436,0.000039728562,0.27903566,0.095053636],"study_design_scores_gemma":[0.047913186,0.004698863,0.031030893,0.001727339,0.00057524064,0.000034304176,0.0052907434,0.0000910121,0.8666452,0.00043055962,0.040920142,0.0006424996],"about_ca_topic_score_codex":0.0030077782,"about_ca_topic_score_gemma":0.000352317,"teacher_disagreement_score":0.32030162,"about_ca_system_score_codex":0.00013876351,"about_ca_system_score_gemma":0.0006935354,"threshold_uncertainty_score":0.9989701},"labels":[],"label_agreement":null},{"id":"W2739614293","doi":"10.1158/1538-7445.am2017-4499","title":"Abstract 4499: The oncometabolite fumarate prevents hypoxia-induced ER stress by enhancing the pentose phosphate pathway","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Unfolded protein response; Downregulation and upregulation; Thapsigargin; Integrated stress response; Cancer research; Tunicamycin; Proteostasis; Biology; Cell biology; Chemistry; Endoplasmic reticulum; Molecular biology; Biochemistry; Messenger RNA; Gene; Translation (biology)","score_opus":0.050266525747540924,"score_gpt":0.3743779298322865,"score_spread":0.3241114040847456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739614293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626641,0.030986983,0.000015174856,0.0011273132,0.0017580434,0.0007434948,0.00018306196,0.000011554967,0.0025102657],"genre_scores_gemma":[0.9712315,0.012423579,0.0000074640716,0.0002653378,0.0027323635,0.0004500113,0.000039580827,0.000055631972,0.012794504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709857,0.00027358453,0.0003249572,0.0006419118,0.0007348594,0.0009261363],"domain_scores_gemma":[0.9973098,0.000068227215,0.00022442147,0.0018698953,0.0003150698,0.00021256311],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001916314,0.00026745023,0.00026189536,0.000045716504,0.0015911891,0.00047384657,0.001796903,0.00018468224,0.00022756319],"category_scores_gemma":[0.00030592008,0.00016624836,0.00017810205,0.0001296844,0.0004167016,0.000029422785,0.0006580468,0.00067514734,0.00004812575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014815124,0.00006318294,0.00030697812,0.00003379179,0.00011244136,0.000002275728,0.00021324027,0.000007535443,0.9316989,0.000040320978,0.011999877,0.05537329],"study_design_scores_gemma":[0.0005434251,0.000040968764,0.013781616,0.00004251802,0.000015460828,0.0000017557875,0.00013872415,0.0000025921918,0.59609103,0.00004760655,0.38913402,0.00016030335],"about_ca_topic_score_codex":0.0020450084,"about_ca_topic_score_gemma":0.0012216324,"teacher_disagreement_score":0.37713414,"about_ca_system_score_codex":0.000061845974,"about_ca_system_score_gemma":0.0005752239,"threshold_uncertainty_score":0.9997086},"labels":[],"label_agreement":null},{"id":"W2739628513","doi":"10.1158/1538-7445.am2017-811","title":"Abstract 811: Histological heterogeneity contributes to sunitinib resistance in clear cell renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Sunitinib; Clear cell renal cell carcinoma; Cancer research; Tyrosine-kinase inhibitor; Cancer; Renal cell carcinoma; Medicine; Biology; Pathology; Internal medicine","score_opus":0.14786720823785504,"score_gpt":0.4071043491768963,"score_spread":0.25923714093904127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739628513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95336497,0.0051368093,0.0000042500856,0.0037937416,0.00012347831,0.0010669956,0.000052131327,0.000026842561,0.03643081],"genre_scores_gemma":[0.99320537,0.00018353589,0.00019944983,0.00018823109,0.00019320795,0.0003251766,0.000017781738,0.00004175685,0.005645477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967557,0.0002032672,0.0004241903,0.00075842533,0.00082754466,0.0010308722],"domain_scores_gemma":[0.99730706,0.0002640427,0.000120456556,0.0013322463,0.00045756498,0.0005186278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012019894,0.00024953755,0.0005408711,0.0003185466,0.0004919704,0.00013402311,0.0006214281,0.00020372898,0.00036352748],"category_scores_gemma":[0.00038167072,0.00021095765,0.00013893789,0.000237739,0.0004235368,0.00009647815,0.0003151,0.0009118266,0.00026967132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008382169,0.00093127746,0.28386855,0.0006989731,0.000049310875,0.0052878154,0.00044621612,0.000012811536,0.6717252,0.00019514817,0.026881697,0.0015208035],"study_design_scores_gemma":[0.00220206,0.00037783402,0.6124173,0.00013403488,0.000016650632,0.0000041533767,0.000060363203,0.0000021014057,0.36891866,0.000082942955,0.015645597,0.00013829616],"about_ca_topic_score_codex":0.002641287,"about_ca_topic_score_gemma":0.0038061924,"teacher_disagreement_score":0.32854873,"about_ca_system_score_codex":0.0016079098,"about_ca_system_score_gemma":0.0005986546,"threshold_uncertainty_score":0.8602603},"labels":[],"label_agreement":null},{"id":"W2739628621","doi":"10.1158/1538-7445.am2017-1642","title":"Abstract 1642: Evaluation of ENMD-2076 in combination with anti-PD1 in syngeneic cancer models","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cancer; Ovarian cancer; Breast cancer; Triple-negative breast cancer; Cancer research; Immune checkpoint; Internal medicine; Oncology; Immunotherapy","score_opus":0.10868744951256835,"score_gpt":0.43594932666036246,"score_spread":0.3272618771477941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739628621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591017,0.0019427495,0.00003731831,0.00018622,0.000051410734,0.00045488146,0.000024599045,0.0000015232615,0.001391107],"genre_scores_gemma":[0.9968884,0.0025922647,0.000023831624,0.000012513381,0.00005136434,0.00026268646,0.00003292735,0.00001588136,0.00012015719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876946,0.00009786978,0.00016891118,0.00028604924,0.00041885432,0.0002588377],"domain_scores_gemma":[0.9989761,0.000010210347,0.0000906312,0.00043408936,0.00045164351,0.00003733073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012510412,0.000084306674,0.00013246121,0.00012788932,0.00007908119,0.000029152747,0.0002910937,0.000118829084,0.000037922775],"category_scores_gemma":[0.000068645364,0.000077742494,0.000023222707,0.00009916699,0.0001311441,0.000016915885,0.00009172102,0.0001744636,0.0000012162684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014701142,0.00013912149,0.04031839,0.00007731376,0.000026419124,0.0000023115385,0.00012815408,0.009481211,0.9313794,0.00009526344,0.00015548845,0.01804993],"study_design_scores_gemma":[0.003217372,0.00017087419,0.318503,0.00034573022,0.00001533907,0.0000010563963,0.000114626,0.009126308,0.6672308,0.00066801044,0.00039496814,0.00021195045],"about_ca_topic_score_codex":0.0044167545,"about_ca_topic_score_gemma":0.018053217,"teacher_disagreement_score":0.2781846,"about_ca_system_score_codex":0.00015017852,"about_ca_system_score_gemma":0.00062442455,"threshold_uncertainty_score":0.99986476},"labels":[],"label_agreement":null},{"id":"W2739683903","doi":"10.1158/1538-7445.am2017-989","title":"Abstract 989: Do physician-reported toxicities accurately reflect patient-reported symptom burden? An analysis of ESAS and CTCAE for patients with lung cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Nausea; Dysphagia; Lung cancer; Physical therapy; Adverse effect; Internal medicine; Surgery","score_opus":0.12812252448258954,"score_gpt":0.4785880423956385,"score_spread":0.350465517913049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739683903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942212,0.0021075415,0.000005135703,0.00041305769,0.00013327524,0.0013145946,0.0002758721,0.000031347245,0.001497948],"genre_scores_gemma":[0.9974743,0.0010092427,0.00004680886,0.00007238406,0.00021882878,0.0007289631,0.00007494883,0.000048140006,0.00032637306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701536,0.00005502773,0.0005485426,0.00068295735,0.0010303857,0.00066773087],"domain_scores_gemma":[0.99601483,0.00018461182,0.0005082649,0.00095858146,0.0020650313,0.0002686825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004616171,0.0002655831,0.0009424911,0.00044370114,0.00071589556,0.00012642867,0.00022299185,0.00011133145,0.00014623771],"category_scores_gemma":[0.00031386202,0.0001986541,0.0001433944,0.00054004247,0.000547821,0.0003455471,0.00011918686,0.0003169863,4.844002e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046141976,0.0005050179,0.8949824,0.0009647159,0.009826048,0.000063194006,0.0057313573,0.000107933556,0.016896974,0.000036362395,0.0023684313,0.06390338],"study_design_scores_gemma":[0.0032355376,0.0013944488,0.98121226,0.00084193615,0.0015661116,9.590601e-7,0.0010441447,0.0004169111,0.00875299,0.000027669139,0.0012113296,0.00029568645],"about_ca_topic_score_codex":0.007568157,"about_ca_topic_score_gemma":0.002932843,"teacher_disagreement_score":0.08622988,"about_ca_system_score_codex":0.00036116753,"about_ca_system_score_gemma":0.0007132297,"threshold_uncertainty_score":0.99904054},"labels":[],"label_agreement":null},{"id":"W2739693212","doi":"10.1158/1538-7445.am2017-3351","title":"Abstract 3351: Aberrant RNA editing of GLI1 promotes malignant regeneration in multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"RNA editing; Biology; Cancer research; RNA; Adenosine deaminase; ADAR; Plasma cell leukemia; Multiple myeloma; Genome editing; Adenosine; Immunology; Gene; Genetics; CRISPR","score_opus":0.07316091589593994,"score_gpt":0.38030176130114357,"score_spread":0.30714084540520364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739693212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971983,0.0006603193,0.000027115912,0.0006059919,0.000100548226,0.00022205191,0.000025436648,0.000003215514,0.0011570663],"genre_scores_gemma":[0.99868387,0.0001489942,0.00007435042,0.000013949649,0.00038796398,0.00006386438,0.000036971163,0.000011971356,0.0005780379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999062,0.000051392017,0.00017420757,0.00023717253,0.00024470128,0.00023051744],"domain_scores_gemma":[0.99918634,0.000012835112,0.00009291786,0.00042017354,0.0002072516,0.00008051306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048715627,0.000068751484,0.00008986375,0.00006125532,0.00019128495,0.000053192634,0.00022898705,0.00008054006,0.000060671075],"category_scores_gemma":[0.00046962386,0.00006267713,0.000041049385,0.00004570465,0.000151034,0.000010129011,0.00009836381,0.00009068549,0.000004809425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010755227,0.000043786345,0.024497109,0.00005004924,0.000008478088,0.0000059961967,0.00004310758,0.00009919264,0.9648131,0.00004922546,0.0009625414,0.009319821],"study_design_scores_gemma":[0.000539247,0.000039885046,0.204436,0.00006548536,0.0000014720184,5.18149e-7,0.000045519188,0.00034360163,0.7932333,0.00006814457,0.0011622555,0.000064588494],"about_ca_topic_score_codex":0.0005091733,"about_ca_topic_score_gemma":0.0008652729,"teacher_disagreement_score":0.1799389,"about_ca_system_score_codex":0.000028022825,"about_ca_system_score_gemma":0.00018658685,"threshold_uncertainty_score":0.2555899},"labels":[],"label_agreement":null},{"id":"W2739703387","doi":"10.1158/1538-7445.am2017-289","title":"Abstract 289: The key role of Mitostatin in the maintenance of genome stability","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Spindle checkpoint; Mad2; Cell biology; Centrosome; Mitosis; Biology; Nocodazole; Anaphase; Chromosome instability; Mitotic exit; Anaphase-promoting complex; Chromosome segregation; Genome instability; Multipolar spindles; Spindle apparatus; Mitotic catastrophe; Cell cycle checkpoint; G2-M DNA damage checkpoint; PLK1; Cell cycle; Genetics; Chromosome; Cell division; DNA damage; Cancer; Cell; Cytoskeleton","score_opus":0.04540620729255348,"score_gpt":0.3647144532904397,"score_spread":0.31930824599788626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739703387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463713,0.0019520125,0.000011099627,0.0007430333,0.000024695466,0.0002773062,0.000076043114,6.0695845e-7,0.0022780981],"genre_scores_gemma":[0.99766445,0.0020583589,0.00002108379,0.000032358388,0.00006463631,0.000057384652,0.000008877067,0.0000071947193,0.00008567318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991002,0.00011565851,0.00016926437,0.00017657473,0.00020364465,0.00023467197],"domain_scores_gemma":[0.99874187,0.000048049467,0.00009576262,0.0008991046,0.00019337397,0.000021872744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012838268,0.000060238966,0.000100153375,0.000019831621,0.00012482617,0.000022583012,0.0008866528,0.00006109909,0.000030277697],"category_scores_gemma":[0.00021804834,0.0000355031,0.000051078416,0.000051628325,0.00048273866,0.0000033279955,0.00018568948,0.0002019997,0.00000160129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085475964,0.00004704465,0.008263546,0.000040629027,0.00001271925,6.6474774e-7,0.00051541306,0.000015343052,0.9885167,0.00014745397,0.00032152244,0.0020334763],"study_design_scores_gemma":[0.00032460602,0.00010149001,0.24685772,0.000033134023,0.0000034516784,0.000001021654,0.0014216048,0.000019274059,0.7259594,0.00042493828,0.024782108,0.0000712278],"about_ca_topic_score_codex":0.0013011534,"about_ca_topic_score_gemma":0.0025832392,"teacher_disagreement_score":0.2625573,"about_ca_system_score_codex":0.000019338695,"about_ca_system_score_gemma":0.00017712942,"threshold_uncertainty_score":0.19669634},"labels":[],"label_agreement":null},{"id":"W2739707476","doi":"10.1158/1538-7445.am2017-2547","title":"Abstract 2547: Discovery and characterization of late-stage breast cancer estrogen receptor alpha 1 bound long non-coding RNAs","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Breast cancer; Estrogen receptor alpha; Cancer; Cancer research; Biology; Estrogen receptor; Oncology; Medicine; Internal medicine; Bioinformatics","score_opus":0.03379128112278367,"score_gpt":0.3661397689007743,"score_spread":0.33234848777799064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739707476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953595,0.0008850835,0.0013142129,0.00063788117,0.00025914703,0.00053884287,0.00069856417,0.000007759859,0.00029901124],"genre_scores_gemma":[0.98840594,0.0070012915,0.000022604521,0.000029016406,0.0004661215,0.00020214546,0.00015430494,0.00006583012,0.0036527219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777716,0.000081669416,0.00026899704,0.00062723865,0.0006018095,0.0006431255],"domain_scores_gemma":[0.99831486,0.000017907134,0.00019870537,0.0008233143,0.0004408976,0.00020431206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006797269,0.00020325906,0.00024512765,0.0001465563,0.0005285387,0.00036346793,0.00059855095,0.0002542054,0.00027979224],"category_scores_gemma":[0.00009322675,0.00020370078,0.00008817727,0.0001338365,0.0004660737,0.00006250905,0.00057671964,0.00042944122,0.000008763054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039455973,0.000041150925,0.0031583733,0.00019729028,0.00012797909,0.000012538164,0.000055177054,0.000039248273,0.98750454,0.000041831354,0.00023738127,0.008189925],"study_design_scores_gemma":[0.0007168484,0.00009743576,0.059460245,0.00023087657,0.000012171838,0.000003787092,0.00003943671,0.00009221252,0.9361809,0.000010241546,0.0029454387,0.00021038906],"about_ca_topic_score_codex":0.0024506433,"about_ca_topic_score_gemma":0.00041373709,"teacher_disagreement_score":0.056301873,"about_ca_system_score_codex":0.00015891794,"about_ca_system_score_gemma":0.0007238313,"threshold_uncertainty_score":0.8306677},"labels":[],"label_agreement":null},{"id":"W2739713532","doi":"10.1158/1538-7445.am2017-2427","title":"Abstract 2427: Alterations in gene expression after exposure of MDA-MB-231 cells to isobutylparaben","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects and risks of endocrine disrupting chemicals","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University; University of Toronto","funders":"","keywords":"Aryl hydrocarbon receptor; Gene expression; Estrogen receptor; Biology; Cancer; Hormone receptor; Receptor; Cancer research; Breast cancer; Downregulation and upregulation; Internal medicine; Endocrinology; Gene; Medicine; Transcription factor; Genetics","score_opus":0.04313627447439303,"score_gpt":0.44685712194252714,"score_spread":0.4037208474681341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739713532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526286,0.00014951262,0.0000056547865,0.00050084945,0.000079550366,0.00033096268,0.00003413099,0.0000064366172,0.0036300137],"genre_scores_gemma":[0.9979416,0.00011110336,0.0004929736,0.000037355752,0.000085975815,0.0002049747,0.0000026102189,0.0000137566985,0.001109641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985673,0.000049522347,0.00019553752,0.00032960414,0.0004565733,0.00040148667],"domain_scores_gemma":[0.9990596,0.000096734904,0.000056659264,0.0006079898,0.000029127616,0.00014987851],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004811068,0.000094452334,0.00014364957,0.000058139616,0.00019843731,0.000077346,0.0005395661,0.00004991558,0.0020101503],"category_scores_gemma":[0.000137566,0.000074864045,0.00004034943,0.00009698363,0.00018686226,0.00020201104,0.0004538162,0.000255359,0.00021427288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006881758,0.00007126689,0.039383747,0.00002382082,0.0000023870919,0.000019736379,0.00032461714,0.00057675195,0.953643,0.0000020666482,0.0041775233,0.0017062223],"study_design_scores_gemma":[0.00022984328,0.00004314076,0.15724434,0.00012172644,0.0000012317058,3.1400305e-7,0.000030332538,0.000015589754,0.84042794,0.000060658607,0.0017376634,0.000087226275],"about_ca_topic_score_codex":0.0029980426,"about_ca_topic_score_gemma":0.0005295601,"teacher_disagreement_score":0.11786059,"about_ca_system_score_codex":0.00012174835,"about_ca_system_score_gemma":0.000024022831,"threshold_uncertainty_score":0.99890214},"labels":[],"label_agreement":null},{"id":"W2739716917","doi":"10.1158/1538-7445.am2017-2602","title":"Abstract 2602: The ICGC data portal and its underlying open source software architecture","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Computer science; SPARK (programming language); Cloud computing; Software; Scalability; Modular design; Big data; World Wide Web; Database; Data mining; Operating system","score_opus":0.2886565470393278,"score_gpt":0.48399468956232566,"score_spread":0.19533814252299786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739716917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654724,0.007438353,0.0010401213,0.008890121,0.00023729619,0.00081372284,0.00014727005,0.000015123971,0.00487074],"genre_scores_gemma":[0.9941481,0.0010525031,0.00007017238,0.0001580121,0.00027029877,0.00009683845,0.00008986011,0.00002176717,0.0040924856],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987933,0.00007192792,0.00010421302,0.00049795466,0.00025989336,0.00027268627],"domain_scores_gemma":[0.9980755,0.000024557627,0.00008086202,0.0016001512,0.00011627855,0.00010266517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073939626,0.00009241968,0.00008156784,0.0000277464,0.0010141939,0.0004752365,0.0022704084,0.00009397295,0.00011203658],"category_scores_gemma":[0.00033663033,0.00006443691,0.000018851966,0.000043885848,0.00019329807,0.000017495142,0.0022523075,0.00029372703,0.000008029631],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013435229,0.000025085683,0.0013978247,0.00004876264,0.00004876989,0.0000041845087,0.0001437451,0.000044429966,0.8092818,0.00008169638,0.049545206,0.1392441],"study_design_scores_gemma":[0.0009108259,0.00009167483,0.061613057,0.00012905971,0.000013665221,0.000017174101,0.0006741176,0.00006892879,0.12647606,0.0005567058,0.80914104,0.00030767746],"about_ca_topic_score_codex":0.00025186097,"about_ca_topic_score_gemma":0.0004276945,"teacher_disagreement_score":0.7595959,"about_ca_system_score_codex":0.000012682241,"about_ca_system_score_gemma":0.0002896874,"threshold_uncertainty_score":0.78004616},"labels":[],"label_agreement":null},{"id":"W2739723571","doi":"10.1158/1538-7445.am2017-3860","title":"Abstract 3860: Magnetization transfer and T2-weighted MRI studies are useful for visualizing phenotypic presentations of orthotopic, patient-derived xenograft mouse models of glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Magnetic resonance imaging; Magnetization transfer; Pathology; Histology; Immunohistochemistry; Histopathology; Glioblastoma; H&E stain; Medicine; Nuclear medicine; Cancer research; Radiology","score_opus":0.1485336723711772,"score_gpt":0.4371568334530729,"score_spread":0.2886231610818957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739723571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944331,0.0030436353,0.00017344039,0.0006040241,0.000041423937,0.0014779244,0.0001329841,0.000012191146,0.00008129779],"genre_scores_gemma":[0.9964063,0.0025977504,0.00021735173,0.0000106629295,0.000034193123,0.0006373151,0.000017403067,0.00002380375,0.000055232245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875635,0.00004289546,0.00029916887,0.00025866352,0.00039062326,0.0002522733],"domain_scores_gemma":[0.99831426,0.00018112961,0.000111556816,0.00034635534,0.0009490802,0.00009762802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599524,0.000119661985,0.00034549186,0.000209161,0.0002844219,0.000031798714,0.00009568104,0.00006212374,0.000041996584],"category_scores_gemma":[0.00010596592,0.00009708526,0.00007435429,0.00011462048,0.00029158947,0.00017177248,0.000052444895,0.00009320051,6.034767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003482613,0.0021923808,0.27165282,0.004950549,0.0017975386,0.000050322036,0.014580459,0.00055183953,0.6731026,0.0019633875,0.0020778289,0.023597622],"study_design_scores_gemma":[0.0049226843,0.0011061849,0.18827225,0.0005845463,0.00018592367,0.0000019111478,0.0026196865,0.00094866974,0.8003579,0.00057745376,0.00028337134,0.00013941151],"about_ca_topic_score_codex":0.00035420014,"about_ca_topic_score_gemma":0.0005753515,"teacher_disagreement_score":0.12725526,"about_ca_system_score_codex":0.00004404362,"about_ca_system_score_gemma":0.00008632075,"threshold_uncertainty_score":0.3959022},"labels":[],"label_agreement":null},{"id":"W2739723599","doi":"10.1158/1538-7445.am2017-3409","title":"Abstract 3409: Age of cancer onset differentiated by sex and TP53 codon change in Li-Fraumeni Syndrome patient population","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Germline; Cancer; Medicine; Germline mutation; Cohort; Age of onset; Oncology; Family history; Population; Disease; Internal medicine; Genetics; Mutation; Biology; Gene","score_opus":0.10001619275484579,"score_gpt":0.4163405195572684,"score_spread":0.3163243268024226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739723599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927138,0.0047745304,0.000002319896,0.00069867016,0.0001827783,0.0011016199,0.0002838536,0.000020138332,0.00022225997],"genre_scores_gemma":[0.9965224,0.0024559067,0.000009379331,0.000054571716,0.000053767206,0.00043849967,0.00019021743,0.00004556015,0.00022967518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979321,0.00009982652,0.0003310977,0.0004267167,0.00071958144,0.0004907284],"domain_scores_gemma":[0.99880624,0.000046873985,0.00016820397,0.0006122505,0.00015952122,0.00020689654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038751512,0.00016989671,0.0004063079,0.000288992,0.00017252647,0.000054528347,0.00018425711,0.0001950117,0.00037913793],"category_scores_gemma":[0.00012310877,0.00016030799,0.00005216075,0.00019960558,0.00022421198,0.00012737514,0.00017011921,0.0006119653,0.0000060482503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094967283,0.00047150798,0.59238243,0.0011800735,0.00023609815,0.0008864807,0.0025002647,0.000016071212,0.3121782,0.00002418178,0.0026108022,0.08656426],"study_design_scores_gemma":[0.0020525486,0.0003282749,0.9695572,0.0011657476,0.00003250235,0.000013554984,0.000054606382,0.0001343391,0.025524052,0.000045644178,0.0009395772,0.00015191089],"about_ca_topic_score_codex":0.06221303,"about_ca_topic_score_gemma":0.0074937367,"teacher_disagreement_score":0.37717482,"about_ca_system_score_codex":0.0005824453,"about_ca_system_score_gemma":0.00015691161,"threshold_uncertainty_score":0.9440318},"labels":[],"label_agreement":null},{"id":"W2739727619","doi":"10.1158/1538-7445.am2017-1825","title":"Abstract 1825: Angiopoietin-Tie-2 functional axis in colorectal cancer liver metastasis (CRCLM) provides a new marker for stratification and evaluation of tumor progression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Angiogenesis; Colorectal cancer; Immunohistochemistry; Medicine; Metastasis; Tumor progression; Cancer; Angiopoietin; Neovascularization; Pathology; Cancer research; Internal medicine; Vascular endothelial growth factor; VEGF receptors","score_opus":0.18905929183752304,"score_gpt":0.4674038553093952,"score_spread":0.2783445634718722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739727619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876053,0.007549858,0.000018517543,0.0016346934,0.00017069843,0.0023944268,0.000066891196,0.00000910476,0.00055050786],"genre_scores_gemma":[0.9969249,0.00063863554,0.00037905286,0.000020114536,0.00030995495,0.0014095239,0.00003858342,0.000018667726,0.00026061275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99803954,0.00010756748,0.00025934947,0.00035614846,0.0009481989,0.00028916344],"domain_scores_gemma":[0.9983701,0.00012745018,0.00016419572,0.00025552756,0.0009432581,0.00013945035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022647586,0.00011170097,0.00023879494,0.00020123941,0.00021243417,0.00006702444,0.00011183428,0.000070701106,0.0006265923],"category_scores_gemma":[0.000932236,0.00009046184,0.000059753256,0.00014869041,0.00025713013,0.00027648313,0.00005008264,0.00018830104,0.0000027074796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004982677,0.00032602836,0.11747017,0.00094867643,0.00013014908,0.000002858271,0.0008056816,0.000029626388,0.17106889,0.00022788794,0.009172642,0.6948347],"study_design_scores_gemma":[0.0037725787,0.00016431324,0.9503301,0.0003367479,0.00012959732,0.0000018869156,0.0003517404,0.001274093,0.0403037,0.00045665292,0.0027762284,0.000102358965],"about_ca_topic_score_codex":0.0040145945,"about_ca_topic_score_gemma":0.0021101593,"teacher_disagreement_score":0.83285993,"about_ca_system_score_codex":0.00016413342,"about_ca_system_score_gemma":0.0019343863,"threshold_uncertainty_score":0.6860747},"labels":[],"label_agreement":null},{"id":"W2739739467","doi":"10.1158/1538-7445.am2017-254","title":"Abstract 254: The potential of <i>Lactobacillus</i> probiotic treatments in colorectal cancer (CRC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Probiotic; Cancer; Medicine; Immune system; Gut flora; Microbiome; Cancer prevention; Gut microbiome; Cancer research; Immunology; Internal medicine; Oncology; Bioinformatics; Biology; Bacteria; Genetics","score_opus":0.04944246599821011,"score_gpt":0.40390016322636785,"score_spread":0.35445769722815773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739739467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571854,0.0016041824,0.0000011355258,0.0010940568,0.00017720438,0.00048589302,0.00012285238,0.0000024583474,0.0007936949],"genre_scores_gemma":[0.9960969,0.0028650556,0.000009954185,0.000045307468,0.00019510019,0.00011857436,0.000024643301,0.000016512107,0.0006279639],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988242,0.0000738644,0.00017490696,0.0002931805,0.00019412965,0.00043971709],"domain_scores_gemma":[0.9992294,0.000011736747,0.000096136486,0.0004310524,0.0001616334,0.00007004772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039919151,0.00010606183,0.00014440279,0.000047620782,0.00032532937,0.000048831138,0.00051194715,0.00013220841,0.00011119268],"category_scores_gemma":[0.000046394496,0.000075031785,0.000055286782,0.00006516996,0.00038730414,0.0000060595476,0.00019888583,0.00025100313,0.000011394464],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023201374,0.00008422539,0.017536735,0.000057679168,0.00004415864,0.0000059445306,0.00007190303,0.000028716468,0.97628057,0.000010498096,0.0022415072,0.0034060515],"study_design_scores_gemma":[0.0009292875,0.00016446205,0.5092976,0.000064928274,0.000008515175,0.0000028715235,0.000078762634,0.000005429362,0.4852776,0.000025764317,0.0040513156,0.00009346889],"about_ca_topic_score_codex":0.0065989834,"about_ca_topic_score_gemma":0.006188501,"teacher_disagreement_score":0.49176088,"about_ca_system_score_codex":0.00010601843,"about_ca_system_score_gemma":0.0006031688,"threshold_uncertainty_score":0.9975733},"labels":[],"label_agreement":null},{"id":"W2739741429","doi":"10.1158/1538-7445.am2017-lb-088","title":"Abstract LB-088: Role of histone demethylase JMJD1A in the generation of AR-V7","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Gene knockdown; Demethylase; Androgen receptor; RNA splicing; Cancer research; Histone; Alternative splicing; Chemistry; Cancer; Biology; Medicine; Messenger RNA; Gene; Internal medicine; Biochemistry; RNA","score_opus":0.22564015854489028,"score_gpt":0.5274943529837348,"score_spread":0.30185419443884454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739741429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138815,0.008933539,0.0000015601437,0.002922847,0.000060679766,0.0006497449,0.000026436535,0.000004025315,0.0060130265],"genre_scores_gemma":[0.99587137,0.0025634987,0.000036005677,0.00002244233,0.00023517318,0.00019825887,0.000016656302,0.000014202921,0.0010423987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815196,0.00011959276,0.00025277125,0.00022097374,0.0008965594,0.00035813104],"domain_scores_gemma":[0.9985654,0.00010424956,0.000104092534,0.0007338318,0.00040698386,0.00008544825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017046198,0.00008702941,0.00023789609,0.00022032142,0.00020769009,0.00002974799,0.00039155147,0.000079004865,0.0002832422],"category_scores_gemma":[0.00027381646,0.000055631073,0.000064977045,0.00020189027,0.000539881,0.000106799496,0.000087591034,0.00044944923,0.0000137172065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065304927,0.00029127672,0.02095421,0.00025271502,0.000056233326,0.000050042847,0.0012695343,0.000007967227,0.9354304,0.00025263362,0.0022110287,0.03857089],"study_design_scores_gemma":[0.0023293388,0.00031945642,0.16807687,0.00025107243,0.000020148369,0.0000032355608,0.00066977553,0.00010530989,0.8230252,0.00032944683,0.0047968556,0.00007324295],"about_ca_topic_score_codex":0.004921013,"about_ca_topic_score_gemma":0.0008107845,"teacher_disagreement_score":0.14712267,"about_ca_system_score_codex":0.00025901792,"about_ca_system_score_gemma":0.0006492586,"threshold_uncertainty_score":0.74391323},"labels":[],"label_agreement":null},{"id":"W2739745402","doi":"10.1158/1538-7445.am2017-5101","title":"Abstract 5101: Defining exposure-PD and efficacy relationships with the novel liver-targeting nucleotide prodrug MIV-818 for the treatment of liver cancers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Prodrug; Hepatocellular carcinoma; Pharmacology; Cell growth; Cancer research; Metabolite; In vivo; Bioavailability; Drug; Medicine; Pharmacokinetics; Biology; Internal medicine; Biochemistry","score_opus":0.08854071083125188,"score_gpt":0.35275622682971375,"score_spread":0.2642155159984619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739745402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800986,0.017426018,0.00014301753,0.0010690901,0.0000724808,0.0008129709,0.00013060943,0.0000030761666,0.0002441246],"genre_scores_gemma":[0.9869884,0.0117372,0.00036243224,0.00002953613,0.00030687713,0.00030931892,0.000017883833,0.000026196123,0.00022213162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99906343,0.000034541416,0.00013597113,0.00029596986,0.00017624795,0.00029382732],"domain_scores_gemma":[0.99847984,0.00054965104,0.00013389271,0.0005260445,0.00024631724,0.000064222826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058987556,0.00011878344,0.000120314326,0.000024249672,0.0011308008,0.00010974989,0.0003084649,0.00006311427,0.0000076085403],"category_scores_gemma":[0.00036413004,0.00006968562,0.000056132027,0.000041945845,0.00043633225,0.0000067569263,0.00008734842,0.00014414314,0.0000012772056],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005523503,0.0007279243,0.07777503,0.0005014444,0.0015778356,0.000021130041,0.01076063,0.011066903,0.7220338,0.0028859044,0.021398341,0.14572755],"study_design_scores_gemma":[0.0060423994,0.0024644937,0.4965623,0.00023349132,0.0002223382,0.000007754329,0.0020742058,0.0010577076,0.22481224,0.000057449415,0.2659388,0.00052682013],"about_ca_topic_score_codex":0.0032313226,"about_ca_topic_score_gemma":0.0054025277,"teacher_disagreement_score":0.49722156,"about_ca_system_score_codex":0.000105261475,"about_ca_system_score_gemma":0.0004025715,"threshold_uncertainty_score":0.86973196},"labels":[],"label_agreement":null},{"id":"W2739748895","doi":"10.1158/1538-7445.am2017-5025","title":"Abstract 5025: EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Reprogramming; Transdifferentiation; PRC2; Biology; Cancer research; Enzalutamide; EZH2; Prostate cancer; Cancer stem cell; Embryonic stem cell; Androgen receptor; Epigenome; Cancer; Cell biology; Stem cell; Cell; Histone; Genetics; DNA methylation; Gene expression; Gene","score_opus":0.13512764506508818,"score_gpt":0.3859632692914189,"score_spread":0.2508356242263307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739748895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902273,0.0041590603,0.00000146999,0.0026976904,0.00016616189,0.001694852,0.000030239316,0.00007372839,0.0021540602],"genre_scores_gemma":[0.9804806,0.008000757,0.000068417714,0.000045767676,0.0002489707,0.00094331015,0.00000709179,0.0000647283,0.010140335],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99660814,0.0000810359,0.00033147042,0.00080666057,0.0009788333,0.0011938794],"domain_scores_gemma":[0.9983458,0.0001216816,0.00011804399,0.0003877614,0.0005148335,0.00051187084],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0004868475,0.00028543815,0.00041920005,0.00025818343,0.0013827687,0.0005206543,0.0003451276,0.000062654995,0.00026794375],"category_scores_gemma":[0.00016404616,0.0002135679,0.000063018706,0.00018431028,0.00103858,0.0003658094,0.0005927861,0.0009651059,0.0000394787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002494306,0.00026359953,0.3607624,0.0018912834,0.00024972716,0.0013128205,0.0019148639,0.0000069851462,0.27233723,0.000023425955,0.0019037628,0.3568396],"study_design_scores_gemma":[0.007156523,0.0006695447,0.45349514,0.0020841635,0.00007940834,0.00009625001,0.0028401637,0.00011887963,0.50869083,0.00003257106,0.024198344,0.0005382046],"about_ca_topic_score_codex":0.0030562037,"about_ca_topic_score_gemma":0.0007377432,"teacher_disagreement_score":0.3563014,"about_ca_system_score_codex":0.00077526085,"about_ca_system_score_gemma":0.0015942305,"threshold_uncertainty_score":0.99991727},"labels":[],"label_agreement":null},{"id":"W2739754888","doi":"10.1158/1538-7445.am2017-3981","title":"Abstract 3981: The Shc1 scaffold protein simultaneously balances Stat1 and Stat3 activity in breast cancer to promote immune suppression and resistance to immunotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Kinome; Cancer research; Immune system; Tyrosine; STAT1; Immune checkpoint; Tumor microenvironment; Breast cancer; Tyrosine kinase; Signal transduction; Immunotherapy; Receptor tyrosine kinase; Phosphorylation; SH2 domain; Biology; Cancer; Medicine; Immunology; Cell biology; Internal medicine; Biochemistry","score_opus":0.04685278862979508,"score_gpt":0.4147381791904989,"score_spread":0.3678853905607038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739754888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9281318,0.004576603,0.000001911754,0.06407965,0.00005910046,0.0022610622,0.0002724743,0.000014991304,0.000602367],"genre_scores_gemma":[0.9853631,0.0049133906,0.00013570166,0.00017831009,0.00020872899,0.0007333117,0.0000029583784,0.000038529564,0.008425951],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969877,0.00016659895,0.00026122874,0.0006302143,0.0010598588,0.00089442753],"domain_scores_gemma":[0.99818355,0.0002446787,0.0000792443,0.0007309115,0.00035629157,0.0004053371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014561486,0.00023399667,0.00041376616,0.0001932329,0.0009165551,0.00031445074,0.00048454668,0.000096354954,0.00027846012],"category_scores_gemma":[0.00019393975,0.00014917826,0.00004331488,0.00027183726,0.0005502734,0.00021810006,0.00045885096,0.00079159846,0.000015202057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012165666,0.00013766809,0.026120212,0.0005467856,0.00006913449,0.00018421694,0.0016913688,0.000009386486,0.8363691,0.000058763402,0.0012087347,0.121438965],"study_design_scores_gemma":[0.0014549098,0.00029214122,0.891133,0.0021817263,0.0000055576834,0.000018165818,0.00018237354,0.00007315162,0.06738016,0.00020659083,0.036816355,0.00025583166],"about_ca_topic_score_codex":0.020755317,"about_ca_topic_score_gemma":0.0070071598,"teacher_disagreement_score":0.8650128,"about_ca_system_score_codex":0.00029978258,"about_ca_system_score_gemma":0.0005900364,"threshold_uncertainty_score":0.9857656},"labels":[],"label_agreement":null},{"id":"W2739759579","doi":"10.1158/1538-7445.am2017-5791","title":"Abstract 5791: 3D tissue engineering bladder model for cancer invasion study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bladder cancer; Spheroid; Cell culture; Cancer; Tissue engineering; In vivo; Cancer research; Cancer cell; Fluorescence microscope; Cell; Biology; Pathology; Cell biology; Medicine; Internal medicine; Biomedical engineering; Biotechnology; Biochemistry; Fluorescence; Genetics","score_opus":0.21091231598042645,"score_gpt":0.48146321909995254,"score_spread":0.2705509031195261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739759579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795419,0.009021154,0.00506461,0.0032869012,0.0007739306,0.0019460677,0.000037434053,0.00008797017,0.00024004625],"genre_scores_gemma":[0.9720355,0.00047324752,0.00077579985,0.000016592196,0.0016053399,0.0011051276,0.000008010891,0.00006824568,0.023912108],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982479,0.000015230291,0.00020294863,0.000399097,0.00059044105,0.0005443706],"domain_scores_gemma":[0.9985399,0.00008410696,0.000046427183,0.00067430915,0.0003891511,0.00026605238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075266283,0.00017954933,0.0003419264,0.00019419918,0.00043927578,0.00006651919,0.00027334059,0.000095284755,0.00021417691],"category_scores_gemma":[0.00043698173,0.00013816025,0.00004600639,0.00010108974,0.00011077667,0.000099271514,0.00009884717,0.00055095257,0.000015869435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044191486,0.0005504943,0.006002839,0.0011779076,0.000548291,0.00018394155,0.004303433,0.075234324,0.81183296,0.00023432469,0.023211703,0.07627789],"study_design_scores_gemma":[0.016137635,0.0026111312,0.13142721,0.0030526742,0.0003889402,0.000025960118,0.0010779863,0.48268688,0.20959571,0.000058936384,0.15172601,0.0012109332],"about_ca_topic_score_codex":0.00093139935,"about_ca_topic_score_gemma":0.00027784583,"teacher_disagreement_score":0.6022372,"about_ca_system_score_codex":0.00024232228,"about_ca_system_score_gemma":0.0003174452,"threshold_uncertainty_score":0.56340116},"labels":[],"label_agreement":null},{"id":"W2739779320","doi":"10.1158/1538-7445.am2017-3395","title":"Abstract 3395: Alternative splicing of the MEAF6 gene promotes neuroendocrine prostate cancer development","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Cancer research; Neuroendocrine differentiation; Biology; Alternative splicing; Prostate; Cancer; RNA splicing; Gene; Exon; RNA; Genetics","score_opus":0.1437343466086203,"score_gpt":0.4574495561367498,"score_spread":0.3137152095281295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739779320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825581,0.0022309371,0.0000015143734,0.010757735,0.00030566205,0.0018079007,0.00006109291,0.000020432068,0.0022566689],"genre_scores_gemma":[0.98287463,0.004055897,0.000079939724,0.00005691468,0.00030611904,0.0008153571,0.00000803184,0.00004799463,0.01175511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686885,0.000086929824,0.00033357833,0.0005002265,0.0013768576,0.00083358266],"domain_scores_gemma":[0.99766773,0.000086722466,0.0002001268,0.0009708772,0.0008427671,0.00023178522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006097233,0.0002055028,0.00034694627,0.00016976567,0.00095989933,0.00010673032,0.0007315985,0.000037989827,0.00034449005],"category_scores_gemma":[0.00022931269,0.00012237216,0.00009958578,0.00024718652,0.0007254366,0.00016562633,0.0005949135,0.0007304302,0.000021638833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017804254,0.00039002835,0.20646045,0.0011330575,0.0006228379,0.00039787038,0.0031791744,0.000049647384,0.6771018,0.00007477766,0.0020451306,0.10676481],"study_design_scores_gemma":[0.0018302606,0.000116913456,0.21471214,0.00072218507,0.00002203686,0.0000103824,0.00008387491,0.00003686728,0.7765446,0.000110336456,0.0057040346,0.00010637452],"about_ca_topic_score_codex":0.0048659183,"about_ca_topic_score_gemma":0.00062969443,"teacher_disagreement_score":0.10665843,"about_ca_system_score_codex":0.00064982363,"about_ca_system_score_gemma":0.0019447149,"threshold_uncertainty_score":0.7382867},"labels":[],"label_agreement":null},{"id":"W2739801000","doi":"10.1158/1538-7445.am2017-5397","title":"Abstract 5397: Characterizing the genomic landscape of bladder cancer with circulating tumor DNA","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CDKN2A; PTEN; Liquid biopsy; Cancer research; STK11; Cancer; Bladder cancer; Medicine; Oncology; KRAS; Biology; Colorectal cancer; Internal medicine; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.0499179782495615,"score_gpt":0.3585666365981924,"score_spread":0.30864865834863087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739801000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939357,0.0024155932,0.000008295666,0.00088222144,0.00016033323,0.00026615144,0.000117599826,0.0000036198371,0.0022104527],"genre_scores_gemma":[0.99703354,0.0015229086,0.00002523181,0.00015402648,0.0008286772,0.00015266225,0.000017424465,0.000036695128,0.00022886645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879843,0.00003116151,0.00017659893,0.00033145316,0.0002585506,0.00040377813],"domain_scores_gemma":[0.998616,0.000051648658,0.00018455145,0.00079878507,0.0002642285,0.00008478259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044513747,0.00012637314,0.00015567733,0.00004016467,0.0005023047,0.00014481723,0.0006065078,0.00006314582,0.00019613319],"category_scores_gemma":[0.00012604875,0.00009009717,0.000058116915,0.000054186152,0.00032778908,0.000007575437,0.00028577898,0.0002295833,0.0000071363484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014586469,0.000020268337,0.027428245,0.00004983548,0.00009871256,0.000009242585,0.00011141045,0.00013615402,0.96716505,0.000043238462,0.0014807536,0.0033112452],"study_design_scores_gemma":[0.0008978158,0.00015651406,0.46798164,0.00014978729,0.000028494962,0.000010094687,0.00024267075,0.0000665275,0.4996319,0.000046397698,0.030523079,0.00026508523],"about_ca_topic_score_codex":0.0015919383,"about_ca_topic_score_gemma":0.0012741025,"teacher_disagreement_score":0.4675331,"about_ca_system_score_codex":0.00004881241,"about_ca_system_score_gemma":0.00062037475,"threshold_uncertainty_score":0.38633722},"labels":[],"label_agreement":null},{"id":"W2739804683","doi":"10.1158/1538-7445.am2017-3064","title":"Abstract 3064: Retinoic acid: An effective therapy for basal-like breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Breast cancer; DNA methylation; Gene silencing; Retinoic acid; Cancer; Methylation; Biology; Medicine; Oncology; Cell culture; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.04461621840247569,"score_gpt":0.41305916798500786,"score_spread":0.36844294958253215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739804683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997384,0.0065789847,0.000079571364,0.00056783686,0.00038400307,0.00085987727,0.00019860054,0.0000149500065,0.0013423244],"genre_scores_gemma":[0.989947,0.0048731137,0.000059178452,0.00017411928,0.001573764,0.0017472049,0.00006648019,0.000060839884,0.0014982988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981349,0.00010347219,0.00015545632,0.00066145894,0.00033474734,0.00060996093],"domain_scores_gemma":[0.9981091,0.00003783698,0.000105351435,0.00095379807,0.0006155576,0.00017833678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008580635,0.00019496688,0.00018433084,0.000052039704,0.00081584736,0.00021953417,0.00089575874,0.00024658552,0.00023267217],"category_scores_gemma":[0.00012282302,0.00016615991,0.00012947072,0.00006168759,0.0004288751,0.000021643647,0.00015913667,0.00031050912,0.000010744722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009550756,0.000067492576,0.0048058215,0.00011802594,0.00009441521,0.0000045888514,0.000072995674,0.000015553256,0.9116752,0.000020841158,0.008298267,0.07387169],"study_design_scores_gemma":[0.0012713111,0.0003634258,0.037520766,0.00006462323,0.00000871955,0.0000042827032,0.00006580017,0.00002276444,0.9195094,0.0002511493,0.040664457,0.0002532979],"about_ca_topic_score_codex":0.0006651694,"about_ca_topic_score_gemma":0.0002465611,"teacher_disagreement_score":0.07361839,"about_ca_system_score_codex":0.00010179791,"about_ca_system_score_gemma":0.0005026554,"threshold_uncertainty_score":0.6775804},"labels":[],"label_agreement":null},{"id":"W2739823755","doi":"10.1158/1538-7445.am2017-3001","title":"Abstract 3001: Germline mutations in cancer predisposition genes and risk for subsequent neoplasms among long-term survivors of childhood cancer in the St. Jude Lifetime Cohort","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine; Germline; Germline mutation; Breast cancer; Cohort; Exome; Exome sequencing; Mutation; Genetics; Biology; Gene","score_opus":0.060156844885271295,"score_gpt":0.41804501066159044,"score_spread":0.35788816577631916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739823755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822228,0.0076904604,0.0000199237,0.0045315498,0.0003111885,0.0035751774,0.0015205528,0.000022040387,0.00010628399],"genre_scores_gemma":[0.9791219,0.016766934,0.000041458472,0.000097931246,0.0006652078,0.0030047167,0.00012782084,0.000061311745,0.00011268075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617946,0.00037225883,0.00079807633,0.00071070855,0.0011768274,0.00076265767],"domain_scores_gemma":[0.997117,0.0007713776,0.0004477752,0.0009341895,0.00049416325,0.00023553969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037587893,0.00028823246,0.00066972215,0.00040262184,0.0004900166,0.0001400288,0.0005816484,0.00020819608,0.00024713174],"category_scores_gemma":[0.000565772,0.0002382122,0.00013703546,0.00038809446,0.00081058434,0.0003419693,0.00014035577,0.0009127239,0.0000019831364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005064416,0.00039368295,0.9811384,0.0006790454,0.0002234152,0.000024642219,0.0047178795,0.00042800297,0.0013463281,0.000024392577,0.00023343564,0.010284322],"study_design_scores_gemma":[0.0030387472,0.00019110895,0.9898654,0.0016000278,0.00012912143,0.0000050105355,0.00050169596,0.00020253107,0.0040174737,0.0001362619,0.00008183743,0.00023076596],"about_ca_topic_score_codex":0.17761342,"about_ca_topic_score_gemma":0.45207953,"teacher_disagreement_score":0.2744661,"about_ca_system_score_codex":0.0005463665,"about_ca_system_score_gemma":0.0011094012,"threshold_uncertainty_score":0.9714012},"labels":[],"label_agreement":null},{"id":"W2739843036","doi":"10.1158/1538-7445.am2017-5868","title":"Abstract 5868: Role of STAT3 vs AKT in cellular survival","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Focal adhesion; Protein kinase B; Cell biology; PI3K/AKT/mTOR pathway; Proto-oncogene tyrosine-protein kinase Src; Integrin; Cell adhesion; Phosphorylation; Chemistry; Cell migration; Kinase; Biology; Signal transduction; Cell; Biochemistry","score_opus":0.20821498026634186,"score_gpt":0.5194455924197172,"score_spread":0.31123061215337533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739843036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94659114,0.0024316339,0.0000028829054,0.0027434449,0.00027571406,0.0007866757,0.000061416285,0.000019632354,0.04708744],"genre_scores_gemma":[0.99394506,0.0011944385,0.000054572432,0.0000241769,0.0005662599,0.00020062664,0.000010007166,0.00005909198,0.003945754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956869,0.0001937783,0.00041593047,0.00052098016,0.0021086743,0.0010737568],"domain_scores_gemma":[0.9969547,0.00027070113,0.000105374784,0.0015782594,0.00069863274,0.0003923396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036661406,0.00016319737,0.00050159876,0.00045419578,0.00025372003,0.00010042325,0.0009280797,0.0001756908,0.0024801677],"category_scores_gemma":[0.0010197872,0.00015043403,0.00009880191,0.00035615158,0.00080508046,0.0001655816,0.000411809,0.001428404,0.0001997841],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019694064,0.00039191244,0.3213555,0.0011689349,0.00008824825,0.00037643735,0.0009820958,0.00002049386,0.61448276,0.0007083607,0.009322389,0.049133506],"study_design_scores_gemma":[0.003354335,0.0005491176,0.47192818,0.0010853781,0.0000123012605,0.000003969323,0.0009685882,0.00012196082,0.4336801,0.0011561454,0.08688027,0.00025965864],"about_ca_topic_score_codex":0.021643175,"about_ca_topic_score_gemma":0.0021874977,"teacher_disagreement_score":0.18080264,"about_ca_system_score_codex":0.00067715824,"about_ca_system_score_gemma":0.001986387,"threshold_uncertainty_score":0.9984317},"labels":[],"label_agreement":null},{"id":"W2739845973","doi":"10.1158/1538-7445.am2017-3053","title":"Abstract 3053: Stability and stemness of the hybrid epithelial-mesenchymal phenotype","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Phenotype; Mesenchymal stem cell; Epithelial–mesenchymal transition; Gene knockdown; Biology; Phenotypic plasticity; Embryonic stem cell; Metastasis; Cancer; Cancer research; Cell biology; Cell culture; Genetics; Gene","score_opus":0.15195912026082717,"score_gpt":0.42795518832866236,"score_spread":0.27599606806783517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739845973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884271,0.0018637172,0.000002375621,0.0024337117,0.00029523156,0.00049555727,0.00012339835,0.0000066272614,0.0063522886],"genre_scores_gemma":[0.9979178,0.0008340174,0.000021409078,0.00003464105,0.000247435,0.00004402562,0.0000013313592,0.000015285015,0.00088407745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852544,0.000072215305,0.00018770271,0.00027607236,0.00061455887,0.00032398663],"domain_scores_gemma":[0.99821377,0.00010304033,0.000096572556,0.0010557553,0.00038288865,0.00014795185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001244992,0.000090309215,0.00025400196,0.00004413625,0.00038865855,0.00005168752,0.000313392,0.00003889563,0.0009839125],"category_scores_gemma":[0.00036023112,0.00005695407,0.00007660517,0.00008456484,0.00083579944,0.00007958865,0.00027134904,0.0003872551,0.000008204217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013052364,0.00030276764,0.109448396,0.0020028118,0.00016971174,0.000035302826,0.0008531517,0.0000031914024,0.67814386,0.00042214704,0.003421337,0.2038921],"study_design_scores_gemma":[0.0011640945,0.00010486161,0.47133452,0.00024954867,0.000039324987,0.0000055564383,0.00020990423,0.000007633622,0.50830257,0.00028883188,0.018206196,0.000086934335],"about_ca_topic_score_codex":0.004895706,"about_ca_topic_score_gemma":0.0004969101,"teacher_disagreement_score":0.3618861,"about_ca_system_score_codex":0.00011679882,"about_ca_system_score_gemma":0.0005948426,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W2739855284","doi":"10.1158/1538-7445.am2017-8","title":"Abstract 8: Anandamide reduces cell migration, invasion, and induces apoptosis in an <i>in vitro</i> model of prostate cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"DU145; LNCaP; Cannabinoid receptor; Anandamide; Cancer research; Cancer; Cancer cell; Endocannabinoid system; Apoptosis; Fatty acid amide hydrolase; Angiogenesis; Prostate cancer; Cell growth; Biology; Paracrine signalling; Receptor; Medicine; Internal medicine; Agonist; Biochemistry","score_opus":0.08127629373602889,"score_gpt":0.3967918460242559,"score_spread":0.315515552288227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739855284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962397,0.002178901,4.6291052e-7,0.0010578142,0.000051169973,0.00024033162,0.00006519785,0.0000018281636,0.00016454408],"genre_scores_gemma":[0.9896451,0.009751966,0.00006041574,0.000113782604,0.00006418962,0.00015908148,0.000021978718,0.000014090601,0.00016938812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891865,0.000072107934,0.00020426472,0.00035878146,0.0001614365,0.00028477106],"domain_scores_gemma":[0.99929756,0.000013197761,0.00008800706,0.0002817159,0.00023048885,0.00008904438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000489757,0.00009557717,0.00016778267,0.00011734243,0.00013980966,0.000045262488,0.00026664915,0.00012443456,0.000016804583],"category_scores_gemma":[0.000045899164,0.00008443106,0.000020380778,0.000068924615,0.00024932311,0.000023305145,0.00014743225,0.00021014984,4.1525107e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031477385,0.000091068556,0.013705346,0.00004791136,0.000006229706,0.0000019208858,0.00024146597,0.00029736754,0.98113304,0.0000034819213,0.0010677443,0.003089635],"study_design_scores_gemma":[0.00074463215,0.00008616447,0.012114653,0.000036677004,0.0000034242726,2.5291789e-7,0.00013091895,0.00034347462,0.98604727,0.00008685516,0.00031436997,0.00009132185],"about_ca_topic_score_codex":0.002915345,"about_ca_topic_score_gemma":0.005363481,"teacher_disagreement_score":0.007573065,"about_ca_system_score_codex":0.000023737806,"about_ca_system_score_gemma":0.00035731096,"threshold_uncertainty_score":0.44071487},"labels":[],"label_agreement":null},{"id":"W2739860370","doi":"10.1158/1538-7445.am2017-5528","title":"Abstract 5528: The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Melanoma; Suppressor; DNA replication; Protein subunit; Gene; Biology; Chromosome; Phosphatase; Cancer; Protein phosphatase 2; Tumor suppressor gene; Metastasis; Molecular biology; Genetics; Cancer research; Phosphorylation; Carcinogenesis","score_opus":0.05024468403096167,"score_gpt":0.37483054817086614,"score_spread":0.3245858641399045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739860370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971635,0.005098415,0.000003818773,0.001781247,0.00013991655,0.0006897328,0.00044306822,0.000008986995,0.002118489],"genre_scores_gemma":[0.9934554,0.0002609766,0.00003372888,0.00016779847,0.0006237187,0.0004943717,0.00010794677,0.00002879442,0.004827265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812454,0.00019840628,0.0001923925,0.00056900573,0.00029850754,0.0006171584],"domain_scores_gemma":[0.99786574,0.000031902,0.00013587269,0.0015351577,0.00028379157,0.00014755053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073676,0.000190154,0.00017284058,0.00004043992,0.001109422,0.0001406904,0.0013014595,0.00019301637,0.00045837834],"category_scores_gemma":[0.0002732772,0.0001332231,0.00009871237,0.00005829499,0.0011911308,0.000015160756,0.00055145647,0.0004555299,0.00007548348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005577456,0.000053131855,0.0055722,0.00003897937,0.00010966746,0.00003974771,0.00006719544,0.0000019016637,0.9743857,0.00021508138,0.016984746,0.0019739016],"study_design_scores_gemma":[0.00050374,0.00014910244,0.087535925,0.000034651675,0.0000063826155,0.000006726325,0.00005172648,0.0000028682944,0.8453046,0.00016217434,0.06608831,0.00015376991],"about_ca_topic_score_codex":0.0004871293,"about_ca_topic_score_gemma":0.0002009,"teacher_disagreement_score":0.12908109,"about_ca_system_score_codex":0.00003689395,"about_ca_system_score_gemma":0.00035505893,"threshold_uncertainty_score":0.8532889},"labels":[],"label_agreement":null},{"id":"W2739868546","doi":"10.1158/1538-7445.am2017-3952","title":"Abstract 3952: Rapid autopsy programs: A systematic review","year":2017,"lang":"en","type":"review","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tissue bank; Tissue Donation; Translational research; Cancer; MEDLINE; Intensive care medicine; Oncology; Pathology; Internal medicine; Organ donation; Transplantation; Biology","score_opus":0.3031024963029514,"score_gpt":0.567224672339668,"score_spread":0.2641221760367166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739868546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.723162e-7,0.9843699,0.0000036910776,0.001319379,0.00034067236,0.007958744,0.000015923397,0.000102270315,0.0058885454],"genre_scores_gemma":[0.0000026669195,0.9867672,0.00008498274,0.0002496139,0.0008528548,0.004398904,0.00015620413,0.00015282708,0.0073347874],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947299,0.0006582046,0.0012011932,0.00078345253,0.0016582648,0.00096901075],"domain_scores_gemma":[0.9957904,0.00045628648,0.00065421296,0.0020436808,0.00045063384,0.0006047749],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0071248137,0.0004811804,0.0049151694,0.00040511464,0.0003746003,0.00025290746,0.0011459012,0.0002912471,0.0006412865],"category_scores_gemma":[0.005346285,0.00030584665,0.0009286064,0.00047745724,0.00046743843,0.000078487086,0.0002553063,0.0040676044,0.00080529397],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019607546,0.000033949316,4.811826e-7,0.51754254,0.00022726721,0.00019125202,0.000010603118,5.3738005e-9,2.2373283e-7,0.000009666427,0.006593572,0.4753885],"study_design_scores_gemma":[0.00011342399,0.000041588657,0.0000010995683,0.49790272,0.0011280825,0.0001453574,0.0000028077577,0.0000036802708,5.266218e-8,0.0000038135963,0.5005203,0.00013710077],"about_ca_topic_score_codex":0.00018617648,"about_ca_topic_score_gemma":0.0000033163024,"teacher_disagreement_score":0.4939267,"about_ca_system_score_codex":0.00067401596,"about_ca_system_score_gemma":0.0026909418,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W2739876775","doi":"10.1158/1538-7445.am2017-3459","title":"Abstract 3459: BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Biology; Cell division; Progenitor cell; Phenotype; Asymmetric cell division; Cell biology; Cancer cell; Mammary tumor; Cancer research; Stem cell; Cancer; Mitosis; Cell; Genetics; Breast cancer; Gene","score_opus":0.03374274433993695,"score_gpt":0.35881155265660164,"score_spread":0.3250688083166647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739876775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872024,0.008428484,0.000010999606,0.0005271013,0.00005490905,0.00027825125,0.000064079904,0.000002803601,0.0019131305],"genre_scores_gemma":[0.9933511,0.0055635204,0.000013622761,0.00008686544,0.00020356766,0.000047915724,0.00001539592,0.000013779895,0.000704202],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990253,0.00006846297,0.000113171496,0.0003221642,0.00019536303,0.00027555446],"domain_scores_gemma":[0.99918425,0.00003055491,0.000045116758,0.0005213398,0.00009123334,0.00012750961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039632592,0.000093295115,0.000097898635,0.000030513138,0.00042641704,0.00017773174,0.00030515835,0.000089398905,0.000027577522],"category_scores_gemma":[0.000060452552,0.000075045566,0.000027057557,0.000023711333,0.0003067899,0.000008596874,0.0003004557,0.0001587377,0.000002960102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009488724,0.00007120924,0.01728737,0.00007650103,0.000010325336,0.000007658991,0.000066817454,0.000003291472,0.9770122,0.00005321814,0.0024235637,0.0028929617],"study_design_scores_gemma":[0.00258966,0.00021656044,0.5770522,0.000056114633,0.000008896128,7.7830725e-7,0.00014767387,0.00001986568,0.39684188,0.0012964032,0.021558315,0.00021164399],"about_ca_topic_score_codex":0.0007211351,"about_ca_topic_score_gemma":0.0004957064,"teacher_disagreement_score":0.5801703,"about_ca_system_score_codex":0.000020003967,"about_ca_system_score_gemma":0.00008765865,"threshold_uncertainty_score":0.32796982},"labels":[],"label_agreement":null},{"id":"W2739890452","doi":"10.1158/1538-7445.am2017-5897","title":"Abstract 5897: Single cell-derived analysis of desmoid tumors for studying tumor-stroma interactions","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Mutant; Wnt signaling pathway; Stroma; Stromal cell; Population; Mutation; Cancer research; AXIN2; Cell sorting; Molecular biology; Cell; Genetics; Signal transduction; Immunology; Gene; Immunohistochemistry","score_opus":0.24136697340115693,"score_gpt":0.4818672642993679,"score_spread":0.24050029089821096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739890452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942224,0.00066851877,0.0000403784,0.0006762064,0.00016058382,0.0007600634,0.00009576571,0.000034394885,0.0033416767],"genre_scores_gemma":[0.9976144,0.000042090487,0.00038105622,0.000023635115,0.00018565726,0.0004065119,0.000017047776,0.000036192603,0.0012934426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981007,0.000046461082,0.0003582001,0.00040120614,0.0005806463,0.0005127672],"domain_scores_gemma":[0.99729884,0.00056218234,0.00023255878,0.0008301652,0.0009096941,0.00016653682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006667789,0.00015314406,0.00060996687,0.0005962844,0.0007763604,0.00007352566,0.00031271766,0.000030683845,0.00039461337],"category_scores_gemma":[0.0010546343,0.00014012838,0.0002600347,0.00045580554,0.00046313665,0.00014274202,0.0001986168,0.00037134538,0.000016394679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006317943,0.00044431447,0.11959541,0.0004348696,0.0017764753,0.00018848268,0.0017117509,0.000050311497,0.8704693,0.000018150813,0.002610031,0.0020691692],"study_design_scores_gemma":[0.0015881575,0.0004676212,0.77610403,0.00033568274,0.0009389396,0.0000094395,0.00403062,0.00016279696,0.21460035,0.00003145706,0.0015610203,0.0001698861],"about_ca_topic_score_codex":0.0013489851,"about_ca_topic_score_gemma":0.00088956184,"teacher_disagreement_score":0.6565086,"about_ca_system_score_codex":0.00035814673,"about_ca_system_score_gemma":0.0002526964,"threshold_uncertainty_score":0.5971215},"labels":[],"label_agreement":null},{"id":"W2739895887","doi":"10.1158/1538-7445.am2017-3863","title":"Abstract 3863: A subset of poorly prognostic pediatric posterior fossa ependymomas exhibit lowered H3K27me3 and DNA hypomethylation and show epigenetic similarities with H3K27M mutant diffuse intrinsic pontine gliomas","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Ependymoma; Biology; DNA methylation; Histone; Posterior fossa; Cancer research; Pathology; Genetics; Gene; Medicine; Anatomy; Gene expression","score_opus":0.05502151398334043,"score_gpt":0.34755073169307926,"score_spread":0.29252921770973883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739895887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98716277,0.009002534,0.0000014434195,0.0019021337,0.00006523805,0.0015335965,0.0001499764,0.000024793657,0.00015751332],"genre_scores_gemma":[0.99725455,0.001985464,0.00010533606,0.00001882454,0.00018710612,0.00029398332,0.000026580281,0.000049993465,0.00007815231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975072,0.00008245825,0.00039113723,0.0005948877,0.00082027406,0.00060404115],"domain_scores_gemma":[0.997771,0.00041204502,0.00022052033,0.0006912034,0.00054022984,0.00036494853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058687513,0.00028381826,0.000562924,0.0005634774,0.0004059154,0.000234997,0.0001829012,0.00013568472,0.000106675005],"category_scores_gemma":[0.0005801508,0.00021385313,0.00006360371,0.00031835955,0.0005692525,0.0002204147,0.00020896025,0.00031586224,0.0000044488716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017084767,0.0007975627,0.871576,0.0010642778,0.00022371962,0.001323278,0.00066802977,0.0000011366993,0.10316754,0.000034910227,0.00010721598,0.01932782],"study_design_scores_gemma":[0.0057097627,0.0017990262,0.9368141,0.00039626486,0.0002404435,0.00014161087,0.0001661104,0.000015072172,0.05432757,0.00012684063,0.00006307981,0.00020008124],"about_ca_topic_score_codex":0.001383115,"about_ca_topic_score_gemma":0.0011495046,"teacher_disagreement_score":0.06523811,"about_ca_system_score_codex":0.00012328911,"about_ca_system_score_gemma":0.0003109175,"threshold_uncertainty_score":0.87206775},"labels":[],"label_agreement":null},{"id":"W2739917672","doi":"10.1158/1538-7445.am2017-4492","title":"Abstract 4492: Androgen receptor affects GLI activity by promoting transcriptionally active states of GLI upon androgen stimulation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Androgen receptor; Prostate cancer; Cancer research; Hedgehog signaling pathway; Smoothened; Gene knockdown; Androgen; GLI2; Hedgehog; Enzalutamide; Dihydrotestosterone; Biology; Bicalutamide; Chemistry; Endocrinology; Internal medicine; Signal transduction; Cell biology; Medicine; Cell culture; Cancer; Genetics","score_opus":0.08696871614001951,"score_gpt":0.42705944335871004,"score_spread":0.34009072721869055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739917672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236286,0.0019410456,0.00002676985,0.0025817547,0.00010897974,0.0017134603,0.00050325895,0.000035336332,0.0007265651],"genre_scores_gemma":[0.9969233,0.0015063084,0.000081998245,0.000009949914,0.00018804554,0.0002913073,0.00014849409,0.000046843004,0.0008037146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970509,0.0002167927,0.00022673275,0.0005363708,0.0012617733,0.0007074597],"domain_scores_gemma":[0.99796927,0.00025481448,0.00018349032,0.00054351403,0.0007087082,0.0003402136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014090108,0.00020842011,0.00040529852,0.00020540677,0.00064035715,0.00011746005,0.0003137764,0.00017170605,0.0006660102],"category_scores_gemma":[0.00030125864,0.0001719121,0.00012851876,0.00021377862,0.0004243642,0.00049093785,0.000101279744,0.0006684745,0.00001632474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039880346,0.00041979918,0.017358867,0.00062534015,0.00031081628,0.000031972577,0.0007454605,0.000015720338,0.8985041,0.00002024679,0.0017484552,0.07623122],"study_design_scores_gemma":[0.0036421937,0.0006420074,0.07701404,0.0005272404,0.000042658776,0.0000033755584,0.000107290885,0.0004232702,0.9142826,0.00019524539,0.0029553056,0.00016473576],"about_ca_topic_score_codex":0.0013108337,"about_ca_topic_score_gemma":0.00015482726,"teacher_disagreement_score":0.07606648,"about_ca_system_score_codex":0.0006610427,"about_ca_system_score_gemma":0.00082036457,"threshold_uncertainty_score":0.72923446},"labels":[],"label_agreement":null},{"id":"W2739919424","doi":"10.1158/1538-7445.am2017-ct158","title":"Abstract CT158: Unmutated IGHV is not an adverse predictor of outcome to therapy with ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"IGHV@; Ibrutinib; Medicine; Chronic lymphocytic leukemia; Internal medicine; Bendamustine; Oncology; Chlorambucil; Venetoclax; Rituximab; Fludarabine; Leukemia; Gastroenterology; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.08559694955695976,"score_gpt":0.38998828228705973,"score_spread":0.3043913327301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739919424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399394,0.00032842043,0.000010218381,0.00023660663,0.00015772636,0.0039722472,0.00020884245,0.000103630235,0.0009883993],"genre_scores_gemma":[0.9962761,0.00037121054,0.00020021906,0.00033347902,0.0002957504,0.0006579456,0.00007801998,0.00024440317,0.0015428927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99110776,0.00024404885,0.0011020242,0.0016141135,0.0035927221,0.0023393505],"domain_scores_gemma":[0.9926052,0.00037119264,0.000430416,0.0035472298,0.0017410325,0.0013048995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016521069,0.00070852815,0.0013287839,0.0010858795,0.00051282765,0.00018901429,0.0018633996,0.00040860721,0.0007608612],"category_scores_gemma":[0.0004234572,0.0005221217,0.00016824578,0.0012019513,0.0015649963,0.0005740734,0.0005043104,0.00069169427,0.00018864348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.15443778,0.00237013,0.71826196,0.0050800657,0.0020967198,0.0034399915,0.008758094,0.008181485,0.014622273,0.00012333815,0.0016107003,0.08101744],"study_design_scores_gemma":[0.17968176,0.007996061,0.7670398,0.0024647266,0.000090329726,0.000057210753,0.00029096706,0.0055184513,0.0341769,0.000018783907,0.0017528548,0.000912183],"about_ca_topic_score_codex":0.06061924,"about_ca_topic_score_gemma":0.0060674306,"teacher_disagreement_score":0.09246389,"about_ca_system_score_codex":0.19753176,"about_ca_system_score_gemma":0.10506788,"threshold_uncertainty_score":0.999723},"labels":[],"label_agreement":null},{"id":"W2739948294","doi":"10.1158/1538-7445.am2017-996","title":"Abstract 996: A translational phosphoproteomic approach to study differences in <i>KRAS</i> signaling in pancreatic, colorectal and lung cancers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"KRAS; Cancer research; PI3K/AKT/mTOR pathway; MEK inhibitor; Cancer; Context (archaeology); Colorectal cancer; Medicine; Trametinib; Pancreatic cancer; Protein kinase B; Targeted therapy; Internal medicine; Biology; Kinase; Signal transduction; MAPK/ERK pathway; Cell biology","score_opus":0.09423952860968912,"score_gpt":0.40247385021357057,"score_spread":0.3082343216038814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739948294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106807,0.0026385877,0.000002803185,0.0006478131,0.000055899523,0.0024168363,0.000025679801,0.000011047681,0.0031332937],"genre_scores_gemma":[0.99701077,0.00043956598,0.000121269426,0.000027461787,0.00008800446,0.0021757826,0.0000033616545,0.000018139199,0.00011562032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981092,0.000074286036,0.00025863043,0.0005145436,0.000559881,0.00048341346],"domain_scores_gemma":[0.9993202,0.00014504757,0.000048265698,0.00022363642,0.000106465806,0.000156373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007210234,0.00017480511,0.00046700516,0.0002350961,0.00038945462,0.0001047837,0.00017998635,0.0000597163,0.00008703925],"category_scores_gemma":[0.000112963266,0.0001397819,0.000036127774,0.00024885108,0.00019906252,0.00010808436,0.000097815406,0.0004228444,0.0000019690942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020053026,0.00039966084,0.97700906,0.000102143065,0.00014009349,0.00006901117,0.008022904,0.000031758947,0.005854753,0.00001652045,0.000046937814,0.006301871],"study_design_scores_gemma":[0.0035317612,0.00045021626,0.990958,0.00024303723,0.00002879151,0.000002630583,0.0023575486,0.0001779709,0.0020361405,0.000058653633,0.000018392768,0.00013686495],"about_ca_topic_score_codex":0.02802567,"about_ca_topic_score_gemma":0.012456748,"teacher_disagreement_score":0.015568922,"about_ca_system_score_codex":0.0007261727,"about_ca_system_score_gemma":0.0004352224,"threshold_uncertainty_score":0.9784468},"labels":[],"label_agreement":null},{"id":"W2739957222","doi":"10.1158/1538-7445.am2017-3571","title":"Abstract 3571: Precise somatic mutation prediction in the absence of matching normal DNA","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Somatic cell; DNA sequencing; Computational biology; Exome sequencing; Germline mutation; Exome; Biology; Germline; Genome; Genetics; Human genome; Cancer; Mutation; Algorithm; DNA; Computer science; Gene","score_opus":0.04467166073500187,"score_gpt":0.3777409040859927,"score_spread":0.33306924335099086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739957222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968378,0.00044706182,0.000067220804,0.00024398368,0.000120893346,0.00023296049,0.00005057724,0.0000016159676,0.0019978958],"genre_scores_gemma":[0.99886805,0.00063097297,0.000038935224,0.000021940532,0.00022219293,0.00009037284,0.00002147997,0.000008411077,0.000097616576],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921083,0.00004182225,0.00015553262,0.00016313212,0.00023914501,0.00018950604],"domain_scores_gemma":[0.9992708,0.00006259358,0.000083241175,0.0004440775,0.00010919924,0.000030088568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007360109,0.000056371577,0.000068450645,0.000043123226,0.00019001953,0.00007452031,0.0003952809,0.000060747032,0.000029195582],"category_scores_gemma":[0.00025510738,0.000046296143,0.000030392432,0.000045175377,0.00012969307,0.000009492203,0.000099759396,0.00014233313,0.000005380347],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015358551,0.0000863831,0.016075078,0.00015577397,0.000021513273,0.000011801191,0.0011776038,0.0015715343,0.9623725,0.00015930312,0.001924757,0.016290165],"study_design_scores_gemma":[0.0008377292,0.00020966207,0.60011536,0.00018689764,0.000006501022,0.0000070669316,0.0007956731,0.00022045613,0.39321917,0.001873784,0.0023908615,0.00013681973],"about_ca_topic_score_codex":0.001133146,"about_ca_topic_score_gemma":0.0011437421,"teacher_disagreement_score":0.5840403,"about_ca_system_score_codex":0.000035118082,"about_ca_system_score_gemma":0.00018222899,"threshold_uncertainty_score":0.18879019},"labels":[],"label_agreement":null},{"id":"W2739963469","doi":"10.1158/1538-7445.am2017-3910","title":"Abstract 3910: Analysis of metastatic potential by breast cancer type through a microfluidic blood-brain niche","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Innovative Microfluidic and Catalytic Techniques Innovation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cancer; Brain metastasis; Metastasis; Circulating tumor cell; Cancer cell; Cancer research; Breast cancer; In vivo; Pathology; Biology; Medicine; Internal medicine","score_opus":0.055807835501602426,"score_gpt":0.39014214470693664,"score_spread":0.33433430920533425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739963469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97537506,0.011946684,0.007785721,0.0012437801,0.00031340533,0.00039792302,0.0012967451,0.00012626607,0.0015144293],"genre_scores_gemma":[0.99643373,0.0024056644,0.000107180866,0.00006905787,0.00009673176,0.0001083118,0.000111393616,0.000046364625,0.00062156294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825156,0.000041287072,0.00040923938,0.00030876586,0.00050580053,0.0004833759],"domain_scores_gemma":[0.9982472,0.00005163153,0.00012569553,0.0007235928,0.00080204423,0.000049847557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087174703,0.00018637921,0.00038784154,0.0003827437,0.00025920258,0.00009608465,0.0006667709,0.000106383166,0.0011396325],"category_scores_gemma":[0.00006767963,0.0001778843,0.00010192229,0.001578095,0.0004127315,0.00027112238,0.00012941136,0.000488489,0.000012904378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003060538,0.000041263018,0.00078758074,0.00012548121,0.0013865295,0.000009020205,0.00016048542,0.000033367865,0.8721604,0.00034416403,0.120764,0.0041571255],"study_design_scores_gemma":[0.00044246356,0.000032540866,0.012327657,0.00009694023,0.0003773488,0.000004154906,0.00008698926,0.00022392784,0.97356254,0.00023047008,0.012370999,0.00024397582],"about_ca_topic_score_codex":0.0031116987,"about_ca_topic_score_gemma":0.000020548709,"teacher_disagreement_score":0.108393006,"about_ca_system_score_codex":0.00022090449,"about_ca_system_score_gemma":0.00018895947,"threshold_uncertainty_score":0.99977344},"labels":[],"label_agreement":null},{"id":"W2739974947","doi":"10.1158/1538-7445.am2017-lb-039","title":"Abstract LB-039: Translational research in a phase I proof-of-concept study supports that DCC-2618 is a pan-KIT inhibitor","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"GiST; Medicine; Cmax; Pharmacokinetics; Pharmacology; Cancer research; Internal medicine; Oncology; Stromal cell","score_opus":0.2966865577858194,"score_gpt":0.5364016987494453,"score_spread":0.2397151409636259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739974947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856044,0.0010924481,0.0000049064306,0.006473028,0.000070795904,0.004126751,0.00014346605,0.000018931974,0.0024652653],"genre_scores_gemma":[0.996829,0.000057867503,0.00009395987,0.00001643927,0.00033296467,0.0011375803,0.000030191206,0.000052458374,0.0014495427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302894,0.0004037044,0.00053628354,0.0008406814,0.0037093447,0.0014810311],"domain_scores_gemma":[0.996363,0.00050966605,0.00012290571,0.0012169724,0.0011648681,0.00062263187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043255007,0.00025428165,0.0005650132,0.00090318103,0.00061273173,0.00018895346,0.0006294969,0.00009362356,0.0016545265],"category_scores_gemma":[0.00058422127,0.00020751578,0.00014805404,0.0005712269,0.0011673555,0.00032085174,0.00026779147,0.0017889072,0.00006132403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011330885,0.020527167,0.7394024,0.0011562123,0.00054394826,0.0140739,0.010714344,0.000007686697,0.023397148,0.00012105889,0.00844362,0.1702816],"study_design_scores_gemma":[0.03273874,0.012555358,0.6717454,0.0032927152,0.00006537717,0.00017350684,0.005586082,0.00012447097,0.2695134,0.0014798688,0.0023009258,0.00042413938],"about_ca_topic_score_codex":0.005561773,"about_ca_topic_score_gemma":0.0012086283,"teacher_disagreement_score":0.24611625,"about_ca_system_score_codex":0.00052057614,"about_ca_system_score_gemma":0.0024252832,"threshold_uncertainty_score":0.9992581},"labels":[],"label_agreement":null},{"id":"W2739976955","doi":"10.1158/1538-7445.am2017-3867","title":"Abstract 3867: Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy to reactivate p53 in high-risk neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Neuroblastoma; Cancer research; Druggability; Medicine; Biology; Bioinformatics; Genetics; Gene; Cell culture","score_opus":0.08423110711649892,"score_gpt":0.4401295376420932,"score_spread":0.35589843052559433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739976955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533844,0.0002062138,0.0000020426262,0.002156524,0.00004778088,0.0011342025,0.000049008246,0.000031461135,0.0010343145],"genre_scores_gemma":[0.9979967,0.00090104004,0.00002383133,0.00012585145,0.00015955343,0.00026970514,0.000012741585,0.00005624274,0.00045434482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99694335,0.00017978338,0.00027395264,0.00071718363,0.0009744415,0.0009113033],"domain_scores_gemma":[0.9980205,0.0002084852,0.00008442195,0.0007770516,0.0002466344,0.00066287676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005985691,0.00022305959,0.00033063046,0.0004239712,0.0003693795,0.00028110103,0.0002492989,0.00012899448,0.00022501958],"category_scores_gemma":[0.00046868916,0.00019484444,0.000059530925,0.00029343946,0.00036723874,0.00023490361,0.00028470694,0.0010840957,0.0002568927],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022130609,0.00033237087,0.019102108,0.0001287603,0.000088914225,0.0015993194,0.000102103055,0.000008785291,0.9181979,0.00006860614,0.00026950013,0.05788862],"study_design_scores_gemma":[0.002701692,0.0011741564,0.64208096,0.00031528258,0.000018602617,0.000045250963,0.000055588476,0.000017296972,0.3521509,0.0011760918,0.00013176705,0.00013243195],"about_ca_topic_score_codex":0.00633142,"about_ca_topic_score_gemma":0.0009321324,"teacher_disagreement_score":0.62297887,"about_ca_system_score_codex":0.0002915309,"about_ca_system_score_gemma":0.0004008643,"threshold_uncertainty_score":0.95712554},"labels":[],"label_agreement":null},{"id":"W2739996467","doi":"10.1158/1538-7445.am2017-2746","title":"Abstract 2746: Detection of tumor-specific mutations in plasma DNA: A potential esophageal adenocarcinoma biomarker","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Liquid biopsy; COLD-PCR; Biomarker; Polymerase chain reaction; Digital polymerase chain reaction; Biology; Multiplex; Mutation; Point mutation; Cancer research; Cancer; Gene; Genetics","score_opus":0.04694906734423573,"score_gpt":0.3502590255386084,"score_spread":0.3033099581943727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739996467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626887,0.002284115,0.000071521485,0.00014068662,0.00029220455,0.00023733235,0.00010025537,0.0000031263614,0.000601865],"genre_scores_gemma":[0.9984946,0.0008642293,0.000040638475,0.000010856923,0.00030874953,0.00009814146,0.000029365581,0.000022078817,0.00013128722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988387,0.000041838364,0.00021713058,0.0003389108,0.00023535591,0.00032804153],"domain_scores_gemma":[0.99903524,0.000032418975,0.000101761434,0.00052975194,0.00021360956,0.000087204484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037014144,0.00010031574,0.00012763053,0.00014338687,0.00025036064,0.00008378395,0.00035673848,0.00010395331,0.000066517525],"category_scores_gemma":[0.00016800578,0.00010817702,0.000067878216,0.0000962066,0.0003004052,0.000008355249,0.00019004049,0.00018637521,0.000012537442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030334445,0.000058675814,0.007510867,0.000030539642,0.000024144081,0.00004612691,0.000045037537,0.00013588884,0.9811585,0.000041730633,0.00055446336,0.010090663],"study_design_scores_gemma":[0.0008274843,0.00010731932,0.42906848,0.00002482503,0.00000433669,0.000007260096,0.00006846128,0.00009410379,0.56694657,0.00011674423,0.002633004,0.00010144619],"about_ca_topic_score_codex":0.0011151418,"about_ca_topic_score_gemma":0.0016378076,"teacher_disagreement_score":0.4215576,"about_ca_system_score_codex":0.00008883555,"about_ca_system_score_gemma":0.0002733613,"threshold_uncertainty_score":0.44113308},"labels":[],"label_agreement":null},{"id":"W2740016085","doi":"10.1158/1538-7445.am2017-4908","title":"Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Metastasis; Medicine; Cancer research; Neuropilin 1; LNCaP; Oncology; Cancer; Internal medicine","score_opus":0.07307304048342193,"score_gpt":0.4053733394701176,"score_spread":0.33230029898669566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740016085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231714,0.0060662385,0.0000015724498,0.0005983837,0.000020306015,0.0008186659,0.00016187897,0.000001435705,0.000014364377],"genre_scores_gemma":[0.99889356,0.0007399147,0.000050257746,0.000079275684,0.000012674156,0.00017271834,0.000004868534,0.000013207953,0.000033552104],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869734,0.00025002958,0.00022119489,0.000304243,0.0003052177,0.00022196658],"domain_scores_gemma":[0.9990763,0.0000587361,0.00013459643,0.0004031001,0.00026565336,0.000061632214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079892256,0.00010741298,0.00017053042,0.00006201933,0.00013853141,0.000032976634,0.00020745744,0.000044143733,0.000015819383],"category_scores_gemma":[0.00016647899,0.000070915994,0.000036091926,0.000101274054,0.00041804867,0.000008316303,0.00016808539,0.000089698384,2.841316e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036870409,0.00010925233,0.1424561,0.00014664001,0.00012791522,0.000012650852,0.0057995436,0.000009099085,0.82950234,0.000010465316,0.00054731226,0.017591609],"study_design_scores_gemma":[0.0003523375,0.00074852677,0.5011581,0.00011681199,0.000010155449,0.0000017187625,0.00063756964,0.000019974546,0.49640784,0.000044322598,0.0004309617,0.00007170443],"about_ca_topic_score_codex":0.00035613883,"about_ca_topic_score_gemma":0.000069209505,"teacher_disagreement_score":0.35870197,"about_ca_system_score_codex":0.000011264413,"about_ca_system_score_gemma":0.0001679923,"threshold_uncertainty_score":0.289187},"labels":[],"label_agreement":null},{"id":"W2740022358","doi":"10.1158/1538-7445.am2017-4346","title":"Abstract 4346: S-Adenosyl methionine (SAM) blocks breast cancer growth, invasion and metastasis <i>in vitro</i> and <i>in vivo</i>","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"In vivo; Metastasis; Cancer research; Cancer; Breast cancer; Cell growth; Mammary tumor; Biology; In vitro; Pathology; Medicine; Biochemistry","score_opus":0.053139920496008804,"score_gpt":0.3736075102781526,"score_spread":0.3204675897821438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740022358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856638,0.00936854,0.0000064891938,0.0033609793,0.000080706464,0.00029507207,0.00023433824,0.000004481103,0.0009855953],"genre_scores_gemma":[0.9733479,0.02525764,0.000060277816,0.00012453606,0.00020262343,0.00032996084,0.00000996545,0.000026547837,0.0006405286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983385,0.0000901587,0.00022203357,0.0006076875,0.00027828998,0.00046333764],"domain_scores_gemma":[0.9989849,0.000032033644,0.00008392561,0.0005461643,0.00019541319,0.0001575972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080890325,0.00016610479,0.00021822154,0.00014519296,0.00033428738,0.0001620284,0.00035252943,0.00016632832,0.00009292284],"category_scores_gemma":[0.00007858187,0.00015228576,0.000038898215,0.00013853566,0.0003668844,0.000026164535,0.0002951895,0.00035827927,0.0000017463668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003673622,0.0000485945,0.01860065,0.000057684607,0.000029478359,0.000010301571,0.000064070184,0.000009499771,0.96352106,0.00003524543,0.0014805237,0.015775532],"study_design_scores_gemma":[0.001317285,0.000045772555,0.16033761,0.000115360155,0.000013695826,0.000012263023,0.0000883585,0.000019088402,0.8289833,0.00016779982,0.00864937,0.00025007885],"about_ca_topic_score_codex":0.007863633,"about_ca_topic_score_gemma":0.0033079938,"teacher_disagreement_score":0.14173697,"about_ca_system_score_codex":0.00007885041,"about_ca_system_score_gemma":0.00022055456,"threshold_uncertainty_score":0.9987431},"labels":[],"label_agreement":null},{"id":"W2740028716","doi":"10.1158/1538-7445.am2017-2741","title":"Abstract 2741: Assessing the utility of circulating tumor DNA as a surveillance tool for sarcomas and Li-Fraumeni syndrome using a pre-clinical model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Circulating tumor cell; Li–Fraumeni syndrome; Liquid biopsy; Cancer; Cancer research; Internal medicine; Pathology; Oncology; Mutation; Gene; Germline mutation; Metastasis; Biology","score_opus":0.16246852968159214,"score_gpt":0.48910502344003304,"score_spread":0.3266364937584409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740028716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963138,0.0014803796,0.00096933794,0.00020441737,0.00011070793,0.0005148969,0.00013471473,0.000003239258,0.00026847975],"genre_scores_gemma":[0.99858016,0.00036659624,0.0006091657,0.000053908374,0.0002082845,0.0000710142,0.00001169273,0.00002545502,0.00007373271],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854213,0.00008548876,0.00034002215,0.00042913287,0.00023087458,0.00037237283],"domain_scores_gemma":[0.9982817,0.0003206356,0.00021273718,0.0007687303,0.0003271363,0.00008905732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021748159,0.00011977069,0.00023264936,0.000026511021,0.00056706346,0.00021331086,0.0004166618,0.00010876489,0.000014291777],"category_scores_gemma":[0.001729437,0.000100976424,0.00009242097,0.000038437134,0.0005093818,0.000012887013,0.00040313412,0.00022472018,4.5897738e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045659847,0.00015426372,0.14722945,0.00048109636,0.00019096448,0.000021155613,0.00016135153,0.001290626,0.8281656,0.00018004376,0.0010581281,0.020610744],"study_design_scores_gemma":[0.0018260204,0.00033175465,0.8308007,0.0002296379,0.000035476634,0.0000579982,0.00013050389,0.12307301,0.03932809,0.0020762417,0.0016852153,0.000425321],"about_ca_topic_score_codex":0.0008026511,"about_ca_topic_score_gemma":0.00017449021,"teacher_disagreement_score":0.7888375,"about_ca_system_score_codex":0.000035261466,"about_ca_system_score_gemma":0.0008127071,"threshold_uncertainty_score":0.4361451},"labels":[],"label_agreement":null},{"id":"W2740043261","doi":"10.1158/1538-7445.am2017-220","title":"Abstract 220: Proteomic identification of therapeutics targets for Enzalutamide resistance in Castration Resistant Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Université Laval","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Androgen deprivation therapy; Context (archaeology); Cancer research; Androgen; Testosterone (patch); Medicine; Cancer; Cancer cell; Internal medicine; Oncology; Biology; Hormone","score_opus":0.13488509338651117,"score_gpt":0.46738906757130333,"score_spread":0.33250397418479216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740043261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811358,0.0077268383,0.000010490626,0.005665321,0.00014815899,0.0042382185,0.00033997177,0.00001772804,0.000717498],"genre_scores_gemma":[0.98430645,0.0050105047,0.0002077738,0.00002034042,0.00017265508,0.0034068015,0.00004937031,0.000044544246,0.0067815618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973825,0.000083844774,0.00054681365,0.00050494575,0.00081865804,0.00066319446],"domain_scores_gemma":[0.9976236,0.00011196499,0.00029823728,0.0007865384,0.0010540654,0.00012556693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018164015,0.00016678248,0.0003396094,0.0003071054,0.00047097605,0.00013162517,0.00035529395,0.00012862614,0.00007787892],"category_scores_gemma":[0.00023847992,0.00013914682,0.000085979314,0.00024419843,0.00049174746,0.0002717286,0.000062374245,0.00044450612,0.000006163355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007579906,0.00018645547,0.019618493,0.0014092396,0.000102029044,0.000027652526,0.0010218853,0.000015420015,0.9615861,0.00025429696,0.0006886328,0.0075098993],"study_design_scores_gemma":[0.0034508933,0.00019520884,0.37568644,0.00085908873,0.000030054935,5.658891e-7,0.00018585178,0.000053071693,0.6148503,0.0015710819,0.0029816919,0.00013576569],"about_ca_topic_score_codex":0.0017931473,"about_ca_topic_score_gemma":0.004857943,"teacher_disagreement_score":0.35606796,"about_ca_system_score_codex":0.0009328649,"about_ca_system_score_gemma":0.0015836805,"threshold_uncertainty_score":0.5674243},"labels":[],"label_agreement":null},{"id":"W2740051833","doi":"10.1158/1538-7445.am2017-5239","title":"Abstract 5239: Probing the cancer epigenome: empowering target validation by open innovation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bromodomain; Epigenetics; Drug discovery; Computational biology; Biology; BRD4; Cancer; Cancer research; Genetics; Biochemistry; Gene","score_opus":0.11734665393967945,"score_gpt":0.46940098872065295,"score_spread":0.3520543347809735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740051833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942655,0.003229261,0.0005082645,0.0020028045,0.0002315648,0.0006121908,0.00004876961,0.0000049721875,0.0039356337],"genre_scores_gemma":[0.9953459,0.0017619764,0.000109149514,0.000052451393,0.00039093525,0.0003994371,0.00013303969,0.000026721016,0.0017804033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987429,0.0000775807,0.00020481907,0.0003714201,0.0002846513,0.0003186562],"domain_scores_gemma":[0.99863094,0.000018771429,0.00016126102,0.0006915153,0.00045149864,0.000046004523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00178603,0.0000999368,0.00009067729,0.00005164794,0.0010187872,0.0005626391,0.0010016357,0.00010514306,0.00015278377],"category_scores_gemma":[0.0002600069,0.000080178,0.000024517507,0.00014684269,0.00013709172,0.000025105595,0.00054057647,0.0002200261,0.000008823791],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037010323,0.000017057326,0.0056336103,0.000016518648,0.000028919761,3.9586433e-7,0.000104238294,0.00022421656,0.97884494,0.00011797443,0.0029736697,0.012001453],"study_design_scores_gemma":[0.00023795041,0.000040264415,0.013178674,0.000026303773,0.000002963665,8.2896506e-8,0.00004736663,0.000020368165,0.868865,0.0006050975,0.11686454,0.00011135759],"about_ca_topic_score_codex":0.0016790681,"about_ca_topic_score_gemma":0.0001935632,"teacher_disagreement_score":0.11389087,"about_ca_system_score_codex":0.00007843131,"about_ca_system_score_gemma":0.00029555304,"threshold_uncertainty_score":0.783579},"labels":[],"label_agreement":null},{"id":"W2740073617","doi":"10.1158/1538-7445.am2017-ct022","title":"Abstract CT022: Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: Analyses from CheckMate 141","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nivolumab; Medicine; Oncology; Internal medicine; Immunotherapy; Microbiome; Head and neck squamous-cell carcinoma; Biomarker; Head and neck cancer; Cancer; Bioinformatics; Biology","score_opus":0.31867354510485224,"score_gpt":0.5246116718909729,"score_spread":0.20593812678612067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740073617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903013,0.0064935014,1.3549447e-7,0.0012696506,0.00007990839,0.0007179237,0.00007754462,0.000003688672,0.0010563578],"genre_scores_gemma":[0.9994431,0.0001560237,0.000045847297,0.000019747069,0.000026716316,0.00008244066,0.0000046023138,0.000015071806,0.00020642416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980041,0.00035420942,0.00031575304,0.00029127023,0.0007306104,0.0003040712],"domain_scores_gemma":[0.9984119,0.00016142927,0.00015510993,0.0006053474,0.00059261074,0.00007358007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030681945,0.00011136278,0.00037769284,0.0002228173,0.0001983317,0.000024482402,0.00021892259,0.00008016295,0.00012314976],"category_scores_gemma":[0.001002132,0.000076405115,0.00006664397,0.0002705421,0.00046679808,0.000077205936,0.00019786823,0.00025810106,0.0000031506352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023380786,0.000088368724,0.15871347,0.00019928238,0.000030424302,0.000009127211,0.00092988956,0.0000034819554,0.8341565,9.5098886e-7,0.00020283725,0.0033275825],"study_design_scores_gemma":[0.0022356596,0.00012439844,0.60915864,0.0002658398,0.000038513503,9.767333e-7,0.00030711942,0.00011787671,0.38761032,0.000031878866,0.00006536118,0.000043400858],"about_ca_topic_score_codex":0.02424538,"about_ca_topic_score_gemma":0.0023373414,"teacher_disagreement_score":0.45044518,"about_ca_system_score_codex":0.0002478517,"about_ca_system_score_gemma":0.0011449384,"threshold_uncertainty_score":0.98225224},"labels":[],"label_agreement":null},{"id":"W2740075965","doi":"10.1158/1538-7445.am2017-2486","title":"Abstract 2486: Tumor hypoxia induces DNA repair vulnerabilities through contextual loss of heterozygosity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"RAD51; Loss of heterozygosity; DNA repair; Biology; DNA damage; Clonogenic assay; Homologous recombination; Cancer research; Hypoxia (environmental); Molecular biology; Gene; Cell; Genetics; DNA; Allele; Chemistry","score_opus":0.08031988130136664,"score_gpt":0.3905555593293572,"score_spread":0.31023567802799057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740075965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808455,0.006403707,0.000007659266,0.000273946,0.0009897805,0.00031704787,0.0001793476,0.000017986804,0.0037259948],"genre_scores_gemma":[0.99314356,0.0024063746,0.00007385989,0.00009955702,0.002224209,0.00013047487,0.000020141617,0.00003155594,0.001870248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793607,0.0001349702,0.00030944,0.00056091935,0.0004893723,0.0005692242],"domain_scores_gemma":[0.9979294,0.0000521793,0.00017352197,0.001236298,0.0004722685,0.00013636456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008800389,0.00018895998,0.00032955664,0.000053439482,0.0005212996,0.000087055305,0.00074390543,0.00016708022,0.00016840671],"category_scores_gemma":[0.00057634065,0.00017339102,0.00020378186,0.0000630697,0.0012402433,0.000028691056,0.0004149436,0.00037576538,0.000012306429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004061651,0.00010493874,0.002530945,0.00017433205,0.00012103159,0.0000067204314,0.0004070937,0.000006769175,0.9773879,0.00029465018,0.014078956,0.0044804937],"study_design_scores_gemma":[0.00094698346,0.00021605598,0.040007718,0.00007837703,0.000015083169,0.000008733213,0.0004489692,0.0000016493742,0.7739081,0.000403308,0.18371786,0.00024715907],"about_ca_topic_score_codex":0.0036155446,"about_ca_topic_score_gemma":0.0011377364,"teacher_disagreement_score":0.20347981,"about_ca_system_score_codex":0.00005287944,"about_ca_system_score_gemma":0.0005168407,"threshold_uncertainty_score":0.707068},"labels":[],"label_agreement":null},{"id":"W2740081852","doi":"10.1158/1538-7445.am2017-3237","title":"Abstract 3237: Development of direct inhibitors of KRAS mutants for the treatment of cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"KRAS; Cancer research; Mutant; Pancreatic cancer; Cancer; Colorectal cancer; Mutation; Biology; Medicine; Genetics; Gene","score_opus":0.1781052100265384,"score_gpt":0.49091180503324583,"score_spread":0.31280659500670743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740081852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995437,0.0016530835,0.000007120257,0.00080043054,0.000041543328,0.00047557152,0.000120063996,0.000003937644,0.0014612445],"genre_scores_gemma":[0.9967918,0.0012670165,0.00007466018,0.000008931776,0.00013058547,0.00028442848,0.0000060001626,0.0000114469685,0.0014251389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987995,0.000019261079,0.0003221579,0.00016030292,0.00048492814,0.00021383859],"domain_scores_gemma":[0.9986205,0.00017388198,0.00019859808,0.00041021747,0.0005195062,0.000077263925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004362011,0.00008260544,0.000318747,0.00013049501,0.00021724383,0.000009157532,0.0001451652,0.000045417,0.0005405378],"category_scores_gemma":[0.00011913512,0.00004947312,0.00014463249,0.00012468934,0.00032387403,0.000032638156,0.000028419066,0.00007071761,0.000002308471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000898548,0.00087689,0.03448356,0.0007885451,0.0011127904,0.000007942597,0.0029679355,0.000037271806,0.67157304,0.000026109336,0.0024976851,0.2847297],"study_design_scores_gemma":[0.0012468072,0.00017486741,0.07488745,0.00084999885,0.00006189353,2.0529951e-7,0.00028796052,0.000036003396,0.9129634,0.000010926735,0.009434627,0.000045860892],"about_ca_topic_score_codex":0.002708605,"about_ca_topic_score_gemma":0.0020313417,"teacher_disagreement_score":0.28468382,"about_ca_system_score_codex":0.0002245856,"about_ca_system_score_gemma":0.0007409817,"threshold_uncertainty_score":0.591851},"labels":[],"label_agreement":null},{"id":"W2740084540","doi":"10.1158/1538-7445.am2017-3068","title":"Abstract 3068: Proteotoxic stress associated with mTORC1 activation in ovarian carcinoma: proteasome inhibition as a therapeutic strategy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"mTORC1; Unfolded protein response; PTEN; Cancer research; PI3K/AKT/mTOR pathway; Ovarian cancer; Proteasome; Bortezomib; Gene knockdown; Transfection; Biology; XBP1; Cell culture; Endoplasmic reticulum; Cell biology; Cancer; Signal transduction; Apoptosis; Immunology; Biochemistry; Gene","score_opus":0.09593577194359741,"score_gpt":0.39143276591206244,"score_spread":0.295496993968465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740084540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988336,0.00021951414,0.000030892083,0.0017283517,0.000047275567,0.0040610563,0.00002784534,0.000048282123,0.003953438],"genre_scores_gemma":[0.9971564,0.000035637466,0.000012276429,0.000052592615,0.00017853754,0.0019634636,0.00006443056,0.000073066934,0.00046360103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99713665,0.00018702439,0.0002788286,0.0005640872,0.0011234948,0.00070992665],"domain_scores_gemma":[0.9979566,0.0000611015,0.00021692933,0.0010130056,0.0005441914,0.00020819316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008999829,0.00022110183,0.00031804456,0.00028115645,0.00041441273,0.00020125674,0.00029937158,0.00028554865,0.0002899272],"category_scores_gemma":[0.0005778055,0.00019176552,0.000058241378,0.00045123624,0.00030117633,0.00034537836,0.00009958696,0.0014311963,0.00003301546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025973686,0.0005858314,0.022629917,0.00033350597,0.0001676722,0.0004574456,0.0006434028,0.00012598789,0.96498543,0.00032998732,0.00012677762,0.0070166825],"study_design_scores_gemma":[0.0052536023,0.0010532411,0.5083534,0.0023104348,0.000026623778,0.0000117772925,0.00022043247,0.000082069615,0.48172283,0.000640857,0.00008308439,0.00024161192],"about_ca_topic_score_codex":0.0074215103,"about_ca_topic_score_gemma":0.0024309757,"teacher_disagreement_score":0.48572353,"about_ca_system_score_codex":0.0017445071,"about_ca_system_score_gemma":0.0018664706,"threshold_uncertainty_score":0.9991882},"labels":[],"label_agreement":null},{"id":"W2740132397","doi":"10.1158/1538-7445.am2017-61","title":"Abstract 61: Zymelink drug conjugate platform: redefining the therapeutic window for ADCs","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Trastuzumab; Pharmacology; Tolerability; Antibody-drug conjugate; Drug; Therapeutic index; Neutropenia; Pharmacokinetics; Irinotecan; Cancer; Toxicity; Internal medicine; Monoclonal antibody; Breast cancer; Antibody; Adverse effect; Immunology; Colorectal cancer","score_opus":0.2573506167744027,"score_gpt":0.4862937703441147,"score_spread":0.228943153569712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740132397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9220499,0.0049858494,0.000011917022,0.04940872,0.00033314712,0.0014653887,0.00010389968,0.000036139114,0.02160504],"genre_scores_gemma":[0.9670319,0.0020858217,0.0000762667,0.0006819807,0.0012561625,0.00045991823,0.000024293618,0.000046657646,0.028337026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971378,0.000061525,0.0002829938,0.00041325588,0.0010997271,0.0010047132],"domain_scores_gemma":[0.9972265,0.00084928516,0.00009987419,0.0009487659,0.00059535744,0.00028021174],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0024089194,0.00018474228,0.00032374595,0.00012082305,0.0028333128,0.00042440827,0.00086635957,0.00010680316,0.00070324854],"category_scores_gemma":[0.00044564644,0.00010962005,0.00018956809,0.00011700459,0.0011634959,0.00016190774,0.00028502927,0.001128744,0.00020099584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138556985,0.0003958049,0.044581838,0.002100967,0.0013135923,0.00032607495,0.0043200753,0.000031071613,0.21041173,0.03015985,0.11340809,0.57909524],"study_design_scores_gemma":[0.003757351,0.0005114182,0.1695227,0.00073988753,0.00006312258,0.00004314636,0.0007442205,0.00051962526,0.053728398,0.00667766,0.76332563,0.00036680544],"about_ca_topic_score_codex":0.0026128574,"about_ca_topic_score_gemma":0.00038801698,"teacher_disagreement_score":0.6499176,"about_ca_system_score_codex":0.000136597,"about_ca_system_score_gemma":0.000866603,"threshold_uncertainty_score":0.9984649},"labels":[],"label_agreement":null},{"id":"W2740133950","doi":"10.1158/1538-7445.am2017-lb-274","title":"Abstract LB-274: Whole-exome sequencing reveals tyrosine kinase-resistant mutations in pretreatment EGFR-mutant lung adenocarcinomas","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"","keywords":"Cancer research; KRAS; Exome sequencing; Lung cancer; Epidermal growth factor receptor; Mutation; Gene; Medicine; Malignancy; Cancer; Tyrosine kinase; Exome; T790M; Biology; Oncology; Internal medicine; Genetics; Receptor","score_opus":0.10090290041638919,"score_gpt":0.45124048624093493,"score_spread":0.35033758582454577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740133950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97571105,0.0063210735,0.000012612912,0.0067673833,0.00021972969,0.0018408432,0.00029919323,0.00005445103,0.008773668],"genre_scores_gemma":[0.9914374,0.0005170463,0.00028109885,0.00008864021,0.00027944107,0.0011128689,0.00013035093,0.000064202206,0.0060889875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99697196,0.00009390415,0.0004834736,0.0006733299,0.0008993344,0.00087799557],"domain_scores_gemma":[0.99767256,0.00016019288,0.00017388425,0.001144047,0.00046789245,0.00038142654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006713143,0.0002712965,0.0004568585,0.0004435152,0.0009614751,0.00025071503,0.00033945128,0.00013512844,0.0005110337],"category_scores_gemma":[0.00031674892,0.00022437121,0.00012433428,0.00037987292,0.00034397017,0.0003445603,0.00012981064,0.0005604004,0.00009808339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010293667,0.0008453299,0.27443787,0.0011103913,0.00077297987,0.0040488304,0.0053871037,0.0002099381,0.69611204,0.0018867402,0.0048002107,0.009359205],"study_design_scores_gemma":[0.005391925,0.0004494132,0.9543288,0.0019455095,0.00026378894,0.00003119477,0.0012032476,0.00015632332,0.031965956,0.0007638681,0.0031715685,0.000328402],"about_ca_topic_score_codex":0.011132718,"about_ca_topic_score_gemma":0.0023868184,"teacher_disagreement_score":0.67989093,"about_ca_system_score_codex":0.005165558,"about_ca_system_score_gemma":0.001841476,"threshold_uncertainty_score":0.9986534},"labels":[],"label_agreement":null},{"id":"W2740164441","doi":"10.1158/1538-7445.am2017-575","title":"Abstract 575: PD-L1 positive tumor-infiltrating lymphocytes and mutational load in breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Tumor-infiltrating lymphocytes; Medicine; PD-L1; Oncology; Immunotherapy; FOXP3; Internal medicine; Cancer; CD8; Immune system; Immune checkpoint; Immunology","score_opus":0.057195156088499045,"score_gpt":0.4192581731660861,"score_spread":0.36206301707758703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740164441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98396015,0.0048006955,7.8402144e-7,0.005834075,0.00013356093,0.00039273466,0.00017631841,0.000014302537,0.0046874047],"genre_scores_gemma":[0.99691886,0.0014812964,0.000033889602,0.00036206638,0.00036831497,0.00019186074,0.000008953623,0.000023004939,0.0006117397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982488,0.000048361006,0.00022630101,0.00035872398,0.0006600899,0.0004577022],"domain_scores_gemma":[0.99892145,0.00015614246,0.00009548716,0.00029578517,0.00039029957,0.00014084463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080312096,0.00013607494,0.00022509949,0.0001452906,0.0004549185,0.0001665937,0.00018081443,0.00007100876,0.0011846377],"category_scores_gemma":[0.000105567466,0.0001185206,0.00005131762,0.00015646813,0.0005480713,0.00023955156,0.00007329561,0.00037023742,0.000012135817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012765271,0.00019799938,0.43394887,0.00047054133,0.00032144462,0.0006679692,0.0021982454,0.000017956361,0.3765602,0.00015301048,0.004808341,0.16789013],"study_design_scores_gemma":[0.0035125988,0.00006710638,0.9773505,0.0009480972,0.000010101181,0.00011848861,0.0003738238,0.00007611063,0.016457986,0.000072164505,0.0008750499,0.00013797396],"about_ca_topic_score_codex":0.03407469,"about_ca_topic_score_gemma":0.0028979897,"teacher_disagreement_score":0.5434016,"about_ca_system_score_codex":0.0012534802,"about_ca_system_score_gemma":0.0019854142,"threshold_uncertainty_score":0.99972844},"labels":[],"label_agreement":null},{"id":"W2740187823","doi":"10.1158/1538-7445.am2017-4258","title":"Abstract 4258: Influence of lifestyle factors on adipocyte size in human breast tissue","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Terry Fox Research Institute; McMaster University; Kelowna General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adipose tissue; Breast cancer; Adipocyte; Body mass index; Internal medicine; Obesity; Endocrinology; Physiology; Pathology; Cancer","score_opus":0.05604404289552668,"score_gpt":0.42314569223542964,"score_spread":0.36710164933990297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740187823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947453,0.0005827341,1.3442967e-7,0.0003684475,0.000034329103,0.00034936183,0.00004909345,0.000011840461,0.0038587395],"genre_scores_gemma":[0.998816,0.00014207856,0.0000022317222,0.000028168923,0.00016148288,0.000032417833,0.00000556207,0.000018178656,0.00079387194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843484,0.0000661755,0.00017537629,0.00028378627,0.0006862363,0.00035359344],"domain_scores_gemma":[0.9984926,0.000114391296,0.000057497167,0.00093321246,0.00016172533,0.00024056349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052149704,0.000105982166,0.00030216822,0.0001326477,0.00022572282,0.00004175149,0.00029855352,0.00008930448,0.00027805966],"category_scores_gemma":[0.00031926922,0.00009135105,0.00012253642,0.00011856275,0.0002860917,0.00011738237,0.000111468435,0.00050580373,0.00002957755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003804412,0.00027648412,0.5357029,0.0003886322,0.00021836719,0.00031520976,0.00022525582,0.00010541355,0.45654914,0.00012527048,0.00036501497,0.005347853],"study_design_scores_gemma":[0.0008818104,0.00008238501,0.8734817,0.00049014826,0.000027104286,0.000004160357,0.000025886546,7.9722207e-7,0.12410675,0.00002835506,0.0007984081,0.000072523646],"about_ca_topic_score_codex":0.0049671372,"about_ca_topic_score_gemma":0.00022340156,"teacher_disagreement_score":0.33777875,"about_ca_system_score_codex":0.000117919684,"about_ca_system_score_gemma":0.00023778414,"threshold_uncertainty_score":0.7508859},"labels":[],"label_agreement":null},{"id":"W2740198247","doi":"10.1158/1538-7445.am2017-1135","title":"Abstract 1135: DRD2 is critical for pancreatic cancer and promises pharmacological therapy by already established antagonists","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pancreatic cancer; Gemcitabine; Transcriptome; Medicine; Cancer; Microarray; Gene expression profiling; Context (archaeology); Cancer research; Oncology; Tissue microarray; Pancreatitis; Bioinformatics; Internal medicine; Biology; Gene expression; Gene; Genetics","score_opus":0.21297315477410578,"score_gpt":0.5485772497350753,"score_spread":0.3356040949609695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740198247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95157176,0.008437781,0.000009661308,0.032363348,0.0001376615,0.002306115,0.0003077166,0.000037887152,0.0048280666],"genre_scores_gemma":[0.96083874,0.026867185,0.00033117348,0.0008725754,0.0006679985,0.0035160666,0.000024233168,0.000047912403,0.0068341293],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99694985,0.000116064184,0.0003211727,0.0006978095,0.000791318,0.0011237579],"domain_scores_gemma":[0.9968634,0.0011337489,0.0000791784,0.00055124104,0.0008279707,0.00054440903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014739502,0.00023630941,0.00071916106,0.00012701802,0.0012729781,0.00030872578,0.00044279266,0.00026336583,0.002774829],"category_scores_gemma":[0.0015849579,0.0001725924,0.000093118615,0.00011287127,0.0019473097,0.00024430128,0.00016717328,0.00077643845,0.000024147632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061433,0.00084633223,0.26008558,0.0009358969,0.0006517488,0.00014815715,0.00052951113,8.620695e-8,0.3291083,0.00027995495,0.34853092,0.052740213],"study_design_scores_gemma":[0.019392332,0.003657756,0.5754835,0.0009758313,0.0005840598,0.00006936928,0.0006831439,0.00084150623,0.14901051,0.001903405,0.24655668,0.0008418716],"about_ca_topic_score_codex":0.0026340575,"about_ca_topic_score_gemma":0.0000653349,"teacher_disagreement_score":0.31539795,"about_ca_system_score_codex":0.0003076983,"about_ca_system_score_gemma":0.0011160616,"threshold_uncertainty_score":0.99813676},"labels":[],"label_agreement":null},{"id":"W2740201411","doi":"10.1158/1538-7445.am2017-5042","title":"Abstract 5042: Defining an optimal single time point sampling strategy representative of overall capecitabine pharmacokinetics","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Western University","funders":"","keywords":"Capecitabine; Medicine; Tolerability; Discontinuation; Pharmacokinetics; Adverse effect; Colorectal cancer; Dosing; Internal medicine; Therapeutic drug monitoring; Pharmacology; Oncology; Cancer","score_opus":0.21267208672154864,"score_gpt":0.49189765927745266,"score_spread":0.279225572555904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740201411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753269,0.0021903152,0.0000075552293,0.0006439194,0.000088929606,0.00041380734,0.00009963195,0.000022436065,0.021206494],"genre_scores_gemma":[0.9972464,0.000703297,0.0005829366,0.000025971438,0.0002462598,0.0000829068,0.000026049162,0.000031086372,0.0010551156],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981997,0.000049275655,0.0002736421,0.00040590035,0.00059520843,0.00047626265],"domain_scores_gemma":[0.99842274,0.00015703852,0.00014353481,0.00051621563,0.0005678469,0.00019262476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042709376,0.00016172562,0.00038573515,0.00011932439,0.00043474123,0.00009364687,0.00022949057,0.000056500925,0.0015099528],"category_scores_gemma":[0.00021233373,0.00013459798,0.00008224685,0.00009090317,0.00040589133,0.00021324803,0.000201938,0.00036382792,0.000024111183],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074522337,0.0014711373,0.018861124,0.00044884498,0.0011272101,0.00038473058,0.0055463403,0.0011517089,0.8621197,0.00020120713,0.0054124016,0.09582338],"study_design_scores_gemma":[0.008805011,0.0050724326,0.69231284,0.0008479052,0.00023163046,0.000030014617,0.002566727,0.0009867755,0.2859923,0.00035933137,0.0022971532,0.00049789675],"about_ca_topic_score_codex":0.002677242,"about_ca_topic_score_gemma":0.00012273043,"teacher_disagreement_score":0.6734517,"about_ca_system_score_codex":0.0003151892,"about_ca_system_score_gemma":0.00026834357,"threshold_uncertainty_score":0.9994028},"labels":[],"label_agreement":null},{"id":"W2740223430","doi":"10.1158/1538-7445.am2017-2935","title":"Abstract 2935: Sex disparity in the response of the immune microenvironment to colon cancer liver metastases","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Immune system; Medicine; Tumor microenvironment; Metastasis; Cancer; Colorectal cancer; Liver cancer; Context (archaeology); Internal medicine; Cancer research; Immunology; Biology","score_opus":0.07159318684873471,"score_gpt":0.3866956963159876,"score_spread":0.3151025094672529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740223430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653619,0.026809707,0.000001322369,0.005594967,0.00069715176,0.000940543,0.0002119473,0.0000055546984,0.00037691777],"genre_scores_gemma":[0.99163413,0.0024966924,0.0000073402234,0.00022469996,0.000041748346,0.0006106729,0.0000047739286,0.00002052998,0.0049594063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703526,0.0013639167,0.00033616528,0.00037622367,0.0002196025,0.00066882867],"domain_scores_gemma":[0.99726254,0.00072321354,0.00017738054,0.0017190173,0.00009459466,0.000023269964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038726449,0.00017021091,0.00029932457,0.000105495186,0.0008462346,0.00005612874,0.002232245,0.00015795886,0.0018751429],"category_scores_gemma":[0.00047026627,0.00010406811,0.00011386972,0.000179967,0.0014369251,0.00009298264,0.00087070017,0.001014915,0.00016061691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021297648,0.00016827986,0.009659054,0.00005362588,0.00010563674,0.000011978214,0.0020439331,0.00006123865,0.9675411,0.00004936856,0.013305967,0.0048700618],"study_design_scores_gemma":[0.00052383094,0.000058558224,0.42291248,0.000121847,0.000013154298,0.0000029354092,0.00030119586,3.6068352e-7,0.49794376,0.00001669043,0.078023456,0.0000817311],"about_ca_topic_score_codex":0.01824324,"about_ca_topic_score_gemma":0.0030682546,"teacher_disagreement_score":0.4695973,"about_ca_system_score_codex":0.00047904678,"about_ca_system_score_gemma":0.00037888458,"threshold_uncertainty_score":0.99903727},"labels":[],"label_agreement":null},{"id":"W2740227314","doi":"10.1158/1538-7445.am2017-107","title":"Abstract 107: Mechanism of anticancer activity of BPS-001 (lyophilized leech saliva extract)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Healthcare and Venom Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; In vivo; Prostate cancer; Cancer research; In vitro; Chemistry; Angiogenesis; Cancer; Pharmacology; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.3202823422064761,"score_gpt":0.5556552722153316,"score_spread":0.2353729300088555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740227314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801659,0.00080200186,0.000022557453,0.0053972127,0.0001571634,0.00094487687,0.00008593993,0.000020155081,0.01240417],"genre_scores_gemma":[0.99421114,0.0029057858,0.00009379789,0.00003970112,0.00038655338,0.0001125425,0.0000061137184,0.000045102297,0.0021992482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961364,0.00020235054,0.00042520158,0.00046934624,0.0018747601,0.0008919357],"domain_scores_gemma":[0.9959664,0.00042695206,0.00023102514,0.0015401595,0.0013921694,0.00044333137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032936481,0.00016701313,0.0006826636,0.00035127174,0.0003575577,0.000043561766,0.0006581242,0.00024831275,0.0024414635],"category_scores_gemma":[0.0011766027,0.00014247459,0.00014630653,0.00027368247,0.00076111127,0.00021502013,0.00029290112,0.0012197101,0.000055275523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018803478,0.0006250608,0.0055711833,0.0020790393,0.00014351738,0.00012921223,0.00022496964,4.8421157e-7,0.86269027,0.0015943362,0.0014963156,0.12356525],"study_design_scores_gemma":[0.0031735993,0.0008003623,0.19523448,0.0009392784,0.00003077601,0.000011913685,0.00013643423,0.000071359755,0.7929649,0.0014918853,0.004965882,0.0001791674],"about_ca_topic_score_codex":0.017106364,"about_ca_topic_score_gemma":0.00056725007,"teacher_disagreement_score":0.1896633,"about_ca_system_score_codex":0.00031475682,"about_ca_system_score_gemma":0.002285248,"threshold_uncertainty_score":0.9984704},"labels":[],"label_agreement":null},{"id":"W2740242936","doi":"10.1158/1538-7445.am2017-4906","title":"Abstract 4906: Sphingolipid regulates pro-inflammatory cytokines to subdue the neoplastic lesions in hepatocellular carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Programmed cell death; Cancer research; Apoptosis; Biology; Pyroptosis; Inflammation; Proinflammatory cytokine; Hepatocellular carcinoma; Immunology; Pharmacology; Medicine; Biochemistry","score_opus":0.09677864983292969,"score_gpt":0.3851317293387774,"score_spread":0.28835307950584765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740242936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812574,0.001317181,4.7185912e-7,0.00803259,0.00015237795,0.0014754644,0.000029784369,0.000022204315,0.0008442139],"genre_scores_gemma":[0.9973115,0.00030151897,0.0000107058895,0.000100272,0.00047136698,0.0011167326,0.000009919463,0.00003363066,0.00064436084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980857,0.00006997043,0.000224468,0.00041133768,0.00063338934,0.0005751449],"domain_scores_gemma":[0.998036,0.00024189259,0.000057994752,0.0010557373,0.00025132895,0.0003570135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532569,0.00016567143,0.00025307687,0.0001871519,0.0006374335,0.0001600191,0.00042271437,0.00007297465,0.00028165817],"category_scores_gemma":[0.00038356773,0.00010654122,0.00009260932,0.00016221184,0.00023778388,0.000115242496,0.00023782933,0.00036559728,0.00018890158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031010906,0.00023369696,0.9823036,0.00022386905,0.00006218339,0.0007439005,0.0005724865,0.000021397278,0.0075694383,0.00024417773,0.004066348,0.0036487442],"study_design_scores_gemma":[0.0010761637,0.000112069916,0.9733476,0.00048574523,0.00003650535,0.0000057074126,0.00015172211,0.00012245525,0.02071201,0.000117246986,0.0037230512,0.00010974006],"about_ca_topic_score_codex":0.004642259,"about_ca_topic_score_gemma":0.0012478256,"teacher_disagreement_score":0.013142573,"about_ca_system_score_codex":0.00037827026,"about_ca_system_score_gemma":0.00068500167,"threshold_uncertainty_score":0.7017738},"labels":[],"label_agreement":null},{"id":"W2740244858","doi":"10.1158/1538-7445.am2017-385","title":"Abstract 385: Network-driven discovery of cancer drivers and pathways using 2,500 whole cancer genomes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Genetics; Indel; Gene; Genome; Computational biology; Enhancer; Cancer; Coding region; Mutation; Untranslated region; Transcription factor; Single-nucleotide polymorphism; Messenger RNA","score_opus":0.10398873324798258,"score_gpt":0.4073381017853712,"score_spread":0.30334936853738864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740244858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746028,0.023581294,0.00005920582,0.00038774253,0.00023333388,0.00024836135,0.00032379682,0.0000043767454,0.00055904884],"genre_scores_gemma":[0.9710441,0.026642693,0.00010667029,0.000040633426,0.000786653,0.0001805375,0.000018736277,0.000031304826,0.0011486422],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854064,0.000045733428,0.00019542791,0.00045560952,0.00028928224,0.00047328346],"domain_scores_gemma":[0.99873084,0.000015164284,0.00017101456,0.0006812313,0.00028831424,0.000113407856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028554755,0.00014660956,0.00019869508,0.000054413114,0.00060110417,0.0001546731,0.00047226343,0.00013538905,0.000093070885],"category_scores_gemma":[0.000025686542,0.0001355036,0.000070693735,0.00008380913,0.0005698158,0.000033339227,0.0003090378,0.0002051518,0.0000018532048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089617686,0.000024731815,0.084219545,0.000077265104,0.00010587472,0.0000029053026,0.00010303127,0.0025523298,0.8928544,0.00012422136,0.001882232,0.017963845],"study_design_scores_gemma":[0.0017742263,0.00018930416,0.45137686,0.00056119374,0.000088231835,0.000002772941,0.0004852398,0.00074868015,0.42198953,0.00035044827,0.121692106,0.0007414192],"about_ca_topic_score_codex":0.004953864,"about_ca_topic_score_gemma":0.0029080382,"teacher_disagreement_score":0.47086486,"about_ca_system_score_codex":0.00012569684,"about_ca_system_score_gemma":0.0007110173,"threshold_uncertainty_score":0.7488794},"labels":[],"label_agreement":null},{"id":"W2740258560","doi":"10.1158/1538-7445.am2017-352","title":"Abstract 352: The role of p62 (SQTSM1) in the transforming growth factor β signaling pathway","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell biology; Signal transduction; Biology; Phosphorylation; Gene silencing; Endosome; Autophagy; R-SMAD; Scaffold protein; Signal transducing adaptor protein; Smad2 Protein; Gene knockdown; Small interfering RNA; Transforming growth factor beta; Endoglin; Apoptosis; Transfection; Gene; Genetics","score_opus":0.04836834834399228,"score_gpt":0.3703958102777219,"score_spread":0.3220274619337296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740258560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890427,0.0038403673,0.00023163867,0.0010853896,0.000086226886,0.00078762096,0.00006634057,0.0000046891346,0.00485502],"genre_scores_gemma":[0.99838126,0.0008811667,0.000015910908,0.000052592968,0.00024534238,0.00023180564,0.000010658587,0.000032072243,0.00014917734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977313,0.00023238477,0.00024085084,0.00037001754,0.0008128415,0.0006126032],"domain_scores_gemma":[0.9985022,0.00009240997,0.000085771564,0.0009484472,0.00029494546,0.000076258926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017878969,0.00014262651,0.00015131135,0.00010016399,0.00055015774,0.00014717222,0.001617882,0.00017891143,0.000110959016],"category_scores_gemma":[0.0003479353,0.00009198399,0.0001240671,0.00016280382,0.00038805787,0.0000129741065,0.00021904377,0.00075022475,0.000007930459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001284302,0.000036511552,0.00018578747,0.000038768565,0.0000368667,0.000009781023,0.0005597507,0.000044416614,0.9809521,0.00053402205,0.000088501394,0.01738508],"study_design_scores_gemma":[0.000414958,0.00012777165,0.0012543623,0.00007022493,0.0000036968422,0.0000034899404,0.0007871878,0.000027193855,0.9836569,0.00080526044,0.012737864,0.00011112941],"about_ca_topic_score_codex":0.0020309489,"about_ca_topic_score_gemma":0.0009852716,"teacher_disagreement_score":0.017273951,"about_ca_system_score_codex":0.00006986318,"about_ca_system_score_gemma":0.0005272671,"threshold_uncertainty_score":0.42314243},"labels":[],"label_agreement":null},{"id":"W2740294870","doi":"10.1158/1538-7445.am2017-ct132","title":"Abstract CT132: A Phase 2b randomized study of selinexor in patients with relapsed/refractory Diffuse Large B-Cell Lymphoma (DLBCL) demonstrates durable responses in both GCB &amp; Non-GCB subtypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Downregulation and upregulation; Oncology; Cancer research; Phases of clinical research; Refractory (planetary science); Clinical trial; Biology; Gene","score_opus":0.021947199877744652,"score_gpt":0.3411317881802795,"score_spread":0.3191845883025349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740294870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980308,0.0003670268,0.000007782391,0.000039252012,0.00009544652,0.0009972054,0.000052367093,0.000005089124,0.00040506572],"genre_scores_gemma":[0.99868387,0.0003059321,0.000046996694,0.000018694942,0.00007432871,0.00012487726,0.000046214147,0.00003544207,0.0006636531],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980692,0.00031547804,0.0003549189,0.00045339114,0.00037416347,0.00043281107],"domain_scores_gemma":[0.9986474,0.00010667641,0.00019773084,0.0007127073,0.00024380577,0.00009166914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00116708,0.0001817031,0.00039197938,0.0002060195,0.00019866599,0.00006552667,0.00034820876,0.00016626784,0.000047768888],"category_scores_gemma":[0.00041374945,0.00013992365,0.000059546594,0.00014128658,0.00022701919,0.000025454694,0.00012523837,0.00026879596,0.000007236277],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34169057,0.017361848,0.35041177,0.00015225503,0.00017410837,0.000040134502,0.0010310267,0.000020018535,0.2837021,0.0000041869353,0.0013571915,0.004054804],"study_design_scores_gemma":[0.5372708,0.0015452042,0.43484613,0.00012294821,0.000030266947,9.92389e-7,0.0005933721,0.000029786881,0.022920908,0.000023403953,0.0023135736,0.00030265233],"about_ca_topic_score_codex":0.0020070379,"about_ca_topic_score_gemma":0.005250488,"teacher_disagreement_score":0.2607812,"about_ca_system_score_codex":0.000067474204,"about_ca_system_score_gemma":0.00031525842,"threshold_uncertainty_score":0.5705921},"labels":[],"label_agreement":null},{"id":"W2740294919","doi":"10.1158/1538-7445.am2017-5306","title":"Abstract 5306: p16INH4a status helps predict clinical outcome of dysplasia in the oral cavity irrespective of HPV status","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Dysplasia; Staining; Clinical significance; Pathology; Medicine; Cancer; HPV infection; Immunohistochemistry; Cervix; Cervical cancer; Internal medicine","score_opus":0.20210096809345832,"score_gpt":0.5216998138311494,"score_spread":0.31959884573769104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740294919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279076,0.0012292373,0.00002008435,0.00032896304,0.00014957631,0.00036856806,0.00030399588,0.000002153041,0.0048066904],"genre_scores_gemma":[0.9967754,0.0025131905,0.00004491164,0.000023163004,0.0001594218,0.00011028931,0.000023806186,0.000013763184,0.00033608256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804753,0.0002619191,0.0004397053,0.00034917222,0.00044508209,0.00045661617],"domain_scores_gemma":[0.9981223,0.00009658695,0.00021859609,0.0010754262,0.0003842412,0.00010286029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019497323,0.00010378448,0.00023392927,0.0000663051,0.00016766683,0.000040472736,0.00067886774,0.00014906903,0.0001259787],"category_scores_gemma":[0.00069554657,0.00007628547,0.0001026371,0.00011049791,0.00079011614,0.000010925614,0.00018671804,0.00042865705,0.000004166497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008339164,0.00036179868,0.8758196,0.000093501905,0.00009888816,0.000008272156,0.00034183363,0.00005355027,0.07943473,0.0002830829,0.0039663007,0.038704496],"study_design_scores_gemma":[0.0008157021,0.0002568181,0.96159774,0.00001813768,0.000008130694,6.335364e-7,0.0004037646,0.000012336667,0.023492908,0.00012596932,0.013188141,0.0000797022],"about_ca_topic_score_codex":0.0066649523,"about_ca_topic_score_gemma":0.0041321847,"teacher_disagreement_score":0.085778125,"about_ca_system_score_codex":0.00007397714,"about_ca_system_score_gemma":0.00058652245,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2740295960","doi":"10.1158/1538-7445.am2017-1577","title":"Abstract 1577: GRK3 is a direct target of ADT-induced CREB1 activation and it promotes neuroendocrine differentiation of prostate cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Cancer research; Neuroendocrine differentiation; Medicine; Prostate; LNCaP; CREB1; Internal medicine; Cancer; Oncology; Biology; CREB; Transcription factor; Genetics","score_opus":0.1008513406943512,"score_gpt":0.4272876459490915,"score_spread":0.3264363052547403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740295960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989359,0.0009861471,0.0000010768096,0.0066630845,0.00010927599,0.0014641584,0.00018327833,0.000015338996,0.0012186387],"genre_scores_gemma":[0.9910425,0.0055343406,0.00002845268,0.000029938314,0.00013521446,0.00034952187,0.000028519298,0.000037341764,0.0028141525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771637,0.00008410911,0.0003325048,0.00044357867,0.00090416,0.0005192864],"domain_scores_gemma":[0.9980371,0.00013342925,0.0002604898,0.00056843105,0.00080776535,0.00019279991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003748543,0.00018022148,0.0004315978,0.00028268588,0.0002930323,0.00006969085,0.00022005671,0.00006006797,0.0005427071],"category_scores_gemma":[0.000218123,0.00013752983,0.00007440377,0.00021719777,0.0003566922,0.00027512197,0.00017225413,0.0004198633,0.000003948522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001469267,0.00024273513,0.06858043,0.0013533339,0.00017792197,0.000021599182,0.00092820846,0.0000018212974,0.9125279,0.0000069802404,0.0016948206,0.012994972],"study_design_scores_gemma":[0.0020211656,0.00040527224,0.2159563,0.00061961106,0.000030362713,0.0000011394535,0.00009204584,0.000092220456,0.78003377,0.000072382994,0.00058942835,0.000086287386],"about_ca_topic_score_codex":0.004749024,"about_ca_topic_score_gemma":0.00012638322,"teacher_disagreement_score":0.14737588,"about_ca_system_score_codex":0.00020491885,"about_ca_system_score_gemma":0.0006131762,"threshold_uncertainty_score":0.7179135},"labels":[],"label_agreement":null},{"id":"W2740300715","doi":"10.1158/1538-7445.am2017-5599","title":"Abstract 5599: Soluble PD-L1 as a surrogate biomarker of metastatic progression and resistance to antiangiogenic therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Biomarker; Melanoma; Cancer; Cancer research; PD-L1; Tumor progression; Oncology; Immune checkpoint; Metastasis; Immunotherapy; Internal medicine; Biology","score_opus":0.14572625433992165,"score_gpt":0.47668867404966764,"score_spread":0.330962419709746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740300715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676389,0.021992993,0.000003736009,0.0055871313,0.00016918163,0.0010692016,0.000026785683,0.000020011124,0.003492056],"genre_scores_gemma":[0.9881611,0.007439029,0.00035023346,0.00014117717,0.00006997785,0.00018382195,0.0000054538277,0.00003614692,0.0036130967],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793357,0.00008927527,0.00029351094,0.00041797728,0.00075112184,0.00051457493],"domain_scores_gemma":[0.99831206,0.00010857599,0.00015015657,0.0008256937,0.00037105588,0.00023249027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015695404,0.00015974973,0.00034757872,0.00024763448,0.00043144944,0.00011398434,0.00032333244,0.00007243705,0.0006331405],"category_scores_gemma":[0.00017868854,0.00012112782,0.00012118221,0.0002925276,0.0005717058,0.00015038352,0.00011968378,0.00021079362,0.000023237835],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018133415,0.00017480673,0.0079007875,0.0004165748,0.00044709668,0.00009493651,0.00055474223,1.4330875e-7,0.84852296,0.00006156943,0.009310313,0.11438267],"study_design_scores_gemma":[0.006945249,0.00088943256,0.50916415,0.0021030926,0.00004736255,0.000023247663,0.0002645278,0.000007268669,0.3792789,0.00042498743,0.100549884,0.00030187948],"about_ca_topic_score_codex":0.0014083677,"about_ca_topic_score_gemma":0.000490991,"teacher_disagreement_score":0.5012634,"about_ca_system_score_codex":0.00011781421,"about_ca_system_score_gemma":0.0005014228,"threshold_uncertainty_score":0.69324446},"labels":[],"label_agreement":null},{"id":"W2740304714","doi":"10.1158/1538-7445.am2017-2215","title":"Abstract 2215: Detection of novel markers of transitional cell carcinoma of the ovary, the TCC-like variant of high grade serous carcinoma, using proteomics and immunohistochemistry","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Serous carcinoma; Immunohistochemistry; Pathology; Tissue microarray; Serous fluid; Proteomics; Ovary; Ovarian carcinoma; Medicine; Cancer; Biology; Ovarian cancer; Internal medicine","score_opus":0.06934991612424295,"score_gpt":0.3434500804043707,"score_spread":0.27410016428012773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740304714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725604,0.0011527387,0.000075352895,0.00038748694,0.000096947035,0.00068772025,0.00015708721,0.000001908017,0.00018474195],"genre_scores_gemma":[0.9994779,0.000118560194,0.00020408776,0.000008910612,0.000058337955,0.00006712527,0.0000028107777,0.00001898402,0.00004327227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985381,0.000052564425,0.00035915972,0.00021371656,0.0006204741,0.00021599446],"domain_scores_gemma":[0.998411,0.000071455295,0.00034244117,0.00064657064,0.0004756059,0.000052907126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064894755,0.0001128211,0.0003054713,0.00006372139,0.00023184149,0.000010876612,0.0003220295,0.00010493005,0.000040110554],"category_scores_gemma":[0.000044151857,0.00007524054,0.00012356712,0.0001445402,0.0009366205,0.000055116347,0.00010482175,0.00037307013,5.2978045e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009916939,0.00018260213,0.013492513,0.0013316604,0.000060315986,0.0000017268444,0.00035892095,0.000041043615,0.982879,0.000014892525,0.000025099032,0.00062055566],"study_design_scores_gemma":[0.0011607425,0.00012720052,0.36557734,0.00022603296,0.00006155015,0.000012481839,0.0002180234,0.00024544887,0.63230485,0.000015507583,0.0000070433093,0.000043765467],"about_ca_topic_score_codex":0.015846465,"about_ca_topic_score_gemma":0.00006316629,"teacher_disagreement_score":0.35208485,"about_ca_system_score_codex":0.00016320293,"about_ca_system_score_gemma":0.0006375818,"threshold_uncertainty_score":0.9907071},"labels":[],"label_agreement":null},{"id":"W2740310721","doi":"10.1158/1538-7445.am2017-ct098","title":"Abstract CT098: Phase 1 first-in-human study of anti-clusterin antibody AB-16B5 in patients with advanced solid malignancies","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada); Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Clusterin; Cancer; Internal medicine; Sarcoma; Antibody; Oncology; Bone marrow; Urology; Cancer research; Pathology; Immunology; Adverse effect; Apoptosis; Biology","score_opus":0.07865060191518167,"score_gpt":0.4884078122763769,"score_spread":0.4097572103611953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740310721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968587,0.0001360993,0.0000012265185,0.00017614645,0.000112290894,0.0020824205,0.00006292215,0.000016311717,0.00055389205],"genre_scores_gemma":[0.999325,0.00008375294,0.000022185995,0.000016516175,0.000059533675,0.0002900552,0.000028759874,0.000045458964,0.00012878419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734807,0.00010436769,0.000483743,0.00056218094,0.000812729,0.00068888],"domain_scores_gemma":[0.99787,0.00008622219,0.00019611864,0.0012458403,0.00042224192,0.0001795713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063483196,0.00020326147,0.0006104071,0.0004954934,0.00024739283,0.000042520787,0.00051270635,0.000089009205,0.00030696465],"category_scores_gemma":[0.00029581072,0.00017455257,0.000041923042,0.00025145337,0.00047512318,0.00020750133,0.0004102226,0.00049999845,0.000011388068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003126987,0.0050001615,0.94057727,0.00054302096,0.00004161687,0.0007083613,0.001368423,0.00013609408,0.04694117,0.0000030051845,0.000086717286,0.0014671499],"study_design_scores_gemma":[0.022668196,0.0027538144,0.96942747,0.000961642,0.000016223607,0.000002357889,0.0007115692,0.00002313071,0.0031825982,0.000009830646,0.00008469459,0.00015845081],"about_ca_topic_score_codex":0.0016936384,"about_ca_topic_score_gemma":0.0032166191,"teacher_disagreement_score":0.04375857,"about_ca_system_score_codex":0.00028355964,"about_ca_system_score_gemma":0.0002261034,"threshold_uncertainty_score":0.7118047},"labels":[],"label_agreement":null},{"id":"W2740312400","doi":"10.1158/1538-7445.am2017-1375","title":"Abstract 1375: Loss of C-MYC and chromatin acetylation induce epigenetic reprogramming in acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epigenetics; Acetylation; Cancer research; Epigenetic therapy; Epigenome; Chromatin; Histone; Histone H3; Reprogramming; Biology; Cancer cell; Cancer; Molecular biology; Gene expression; Cell biology; Gene; Genetics; DNA methylation","score_opus":0.042099461780625416,"score_gpt":0.3926203307686357,"score_spread":0.35052086898801027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740312400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971789,0.0014461065,0.000022562832,0.00021479618,0.00006570797,0.0003675282,0.000024460865,0.0000054506786,0.0006744657],"genre_scores_gemma":[0.9978094,0.0012179238,0.00015258431,0.000006970667,0.00017837962,0.00013089932,0.000023687446,0.000031524167,0.00044863703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980148,0.00012462122,0.00030077374,0.0005251515,0.0005127468,0.0005219225],"domain_scores_gemma":[0.99853927,0.0000603869,0.00013298816,0.0008412989,0.00028281217,0.00014324952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012639514,0.00013427812,0.00019952624,0.00018419856,0.00028047574,0.00012553085,0.0004889531,0.00023752668,0.000033381366],"category_scores_gemma":[0.00089566177,0.00013790766,0.000044974502,0.00015785146,0.00068553525,0.000021732674,0.000431931,0.0003719382,0.000010952923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016534982,0.000033361124,0.008540606,0.00012527365,0.000032453627,0.000032444,0.00017115704,0.000058831807,0.96728325,0.000013427594,0.00030016922,0.023243675],"study_design_scores_gemma":[0.0009878682,0.00017825849,0.114468604,0.00019568618,0.0000051841653,0.00001012026,0.000071080605,0.0000975766,0.882376,0.000051916373,0.0014086699,0.00014902488],"about_ca_topic_score_codex":0.0020069506,"about_ca_topic_score_gemma":0.00097520195,"teacher_disagreement_score":0.105928,"about_ca_system_score_codex":0.0002827165,"about_ca_system_score_gemma":0.0007094341,"threshold_uncertainty_score":0.56237113},"labels":[],"label_agreement":null},{"id":"W2740313422","doi":"10.1158/1538-7445.am2017-2464","title":"Abstract 2464: Papillary renal cell carcinoma, proposal of a new classification system based on integrated molecular, histological and clinical analysis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; St. Michael's Hospital","funders":"","keywords":"Subtyping; Papillary renal cell carcinomas; Univariate analysis; Immunohistochemistry; Medicine; Pathology; Oncology; Internal medicine; Cohort; Multivariate analysis; Proportional hazards model; Carcinoma","score_opus":0.17082387007948965,"score_gpt":0.43255706327360416,"score_spread":0.2617331931941145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740313422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895873,0.0009242546,0.00010691535,0.0015104363,0.000059584723,0.0007245727,0.00002117381,0.000023382932,0.007042395],"genre_scores_gemma":[0.9987118,0.00007350798,0.00039994196,0.000027483138,0.000100672405,0.00006465207,0.00005348566,0.000021580767,0.0005468761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973227,0.00031794864,0.0005150731,0.0006163194,0.0008734127,0.0003545568],"domain_scores_gemma":[0.9974822,0.00021535775,0.0002729054,0.0011110784,0.00048526868,0.00043318607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012161577,0.00018396537,0.00061548763,0.00038048511,0.00019596482,0.000057422378,0.0002754348,0.0002261929,0.0001258354],"category_scores_gemma":[0.00030555303,0.00012833123,0.0002633468,0.000325708,0.0005107365,0.00004291047,0.00007722577,0.0006528578,0.000017051241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073047513,0.0012615875,0.6629207,0.0012931197,0.0010242251,0.0018860839,0.00015713125,0.00013629257,0.29727733,0.000546137,0.0046999636,0.021492654],"study_design_scores_gemma":[0.0022331497,0.001455737,0.93119484,0.00021186894,0.00065576204,0.0000068044396,0.00015866381,0.0041994676,0.05954007,0.00001220232,0.00020686263,0.00012454216],"about_ca_topic_score_codex":0.0023963407,"about_ca_topic_score_gemma":0.00011160885,"teacher_disagreement_score":0.26827416,"about_ca_system_score_codex":0.00068107626,"about_ca_system_score_gemma":0.0015426534,"threshold_uncertainty_score":0.5233196},"labels":[],"label_agreement":null},{"id":"W2740313962","doi":"10.1158/1538-7445.am2017-sy10-02","title":"Abstract SY10-02: Pan-cancer study of recurrent and heterogeneous RNA aberrations and association with whole-genome variants","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Genetics; Gene; Exome; Computational biology; RNA; Genome; Exome sequencing; Transcriptome; Gene expression; Phenotype","score_opus":0.05292955889693162,"score_gpt":0.37729970360457993,"score_spread":0.3243701447076483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740313962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940347,0.0045399466,0.000007847891,0.0003661921,0.00010960765,0.00042549297,0.00026344447,0.0000023526695,0.00025042292],"genre_scores_gemma":[0.9930907,0.0062185107,0.000015484144,0.000020583,0.00017895595,0.00016449956,0.000022149734,0.000018099172,0.0002710168],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989436,0.000043824624,0.00015535158,0.00034119491,0.00026416726,0.00025181065],"domain_scores_gemma":[0.9990186,0.000039978455,0.00015691995,0.00039507062,0.00030862234,0.00008077513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000374606,0.00010390136,0.0001507798,0.00004718865,0.00036104076,0.00014036866,0.00017958568,0.000087382956,0.000018810084],"category_scores_gemma":[0.00014400482,0.00009408763,0.00001797704,0.00004277269,0.000116940544,0.0000088613615,0.00019557672,0.00015326703,0.0000011518792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004093072,0.00037484636,0.08512031,0.000093323004,0.0003744213,0.0000114649065,0.00075735396,0.00023114264,0.88806975,0.000021809705,0.00089008856,0.02364619],"study_design_scores_gemma":[0.0031341806,0.002092061,0.9226226,0.000115424,0.00008867605,0.0000049861355,0.00052080216,0.000042943375,0.056269094,0.00010073617,0.014633941,0.00037451996],"about_ca_topic_score_codex":0.00144893,"about_ca_topic_score_gemma":0.0045623076,"teacher_disagreement_score":0.8375023,"about_ca_system_score_codex":0.00008451598,"about_ca_system_score_gemma":0.00020834962,"threshold_uncertainty_score":0.38367823},"labels":[],"label_agreement":null},{"id":"W2740328978","doi":"10.1158/1538-7445.am2017-1242","title":"Abstract 1242: Ornithine decarboxylase as a therapeutic target in endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Emergency Physicians","funders":"","keywords":"Ornithine decarboxylase; Endometrial cancer; Medicine; Hazard ratio; Oncology; Cancer; Cohort; Cancer research; Internal medicine; Clinical trial; Biomarker; Biology; Enzyme; Confidence interval; Genetics","score_opus":0.10125390500700264,"score_gpt":0.4588618222258061,"score_spread":0.3576079172188035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740328978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800553,0.014964225,0.000030565556,0.0005597253,0.0003395718,0.00032152951,0.000037489765,0.0000048988227,0.0036866984],"genre_scores_gemma":[0.9912808,0.0065155,0.000056737772,0.000056180063,0.00079194154,0.00022685637,0.000023811299,0.000029331315,0.0010188272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845374,0.00010952487,0.00019791155,0.00040498975,0.00038441792,0.0004494249],"domain_scores_gemma":[0.99887663,0.000054491597,0.00008821869,0.00062758685,0.00022603695,0.00012701977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100544,0.00012654139,0.0001531195,0.00016193137,0.00027764053,0.00013363214,0.00048211648,0.00017196928,0.00048638153],"category_scores_gemma":[0.00061736774,0.00011563065,0.000061614155,0.00014523907,0.00018143015,0.000008262525,0.00018737807,0.0003156391,0.000025974325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036972805,0.000057510282,0.030346699,0.00001913113,0.000045906207,0.000013517362,0.000054295593,0.00015950104,0.94664806,0.000045639445,0.00025183882,0.021988148],"study_design_scores_gemma":[0.0016822523,0.00019205656,0.07801679,0.000037609636,0.000005900602,4.82894e-7,0.000027890912,0.000034548055,0.8710779,0.0013362126,0.0473989,0.00018948926],"about_ca_topic_score_codex":0.0038546827,"about_ca_topic_score_gemma":0.002651928,"teacher_disagreement_score":0.07557021,"about_ca_system_score_codex":0.00008422732,"about_ca_system_score_gemma":0.0004919784,"threshold_uncertainty_score":0.5827153},"labels":[],"label_agreement":null},{"id":"W2740336333","doi":"10.1158/1538-7445.am2017-1314","title":"Abstract 1314: Trans-ethnic HLA fine-mapping of the MHC region identified several independent variants influencing susceptibility to lung cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Linkage disequilibrium; Human leukocyte antigen; Lung cancer; Major histocompatibility complex; Single-nucleotide polymorphism; Biology; Genotyping; Genetics; Haplotype; Allele; Lung cancer susceptibility; SNP; Genotype; Immunology; Medicine; Oncology; Gene; Antigen","score_opus":0.09944985542437919,"score_gpt":0.4046318470298721,"score_spread":0.3051819916054929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740336333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862462,0.009642875,0.00006108367,0.001471757,0.0012697033,0.0008788227,0.000047929763,0.000023237055,0.00035837758],"genre_scores_gemma":[0.9922918,0.00084089703,0.00000431104,0.00008433447,0.00007357229,0.00019078635,0.000004161651,0.000027984323,0.0064821746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973514,0.0006134691,0.00049527874,0.0005077946,0.00023844015,0.00079363893],"domain_scores_gemma":[0.99753314,0.00028733842,0.00024457928,0.0014727574,0.00041917217,0.000043037788],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020533511,0.000213043,0.00037509252,0.000206302,0.0013533967,0.0000907226,0.0015421049,0.00030993755,0.0013232599],"category_scores_gemma":[0.0004862319,0.00016313822,0.00019200462,0.00029049293,0.0006639612,0.00029707677,0.00036693885,0.0011235664,0.000039297815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010739786,0.00006802385,0.016028317,0.00014100432,0.0002670093,0.000005030732,0.0039300695,0.00008974052,0.9629901,0.00003260349,0.0020514133,0.013322678],"study_design_scores_gemma":[0.0011275556,0.000047131103,0.6798473,0.0005470596,0.000016306445,0.0000073689125,0.00031211457,0.000003008233,0.31487238,0.000056563214,0.0030006375,0.00016255422],"about_ca_topic_score_codex":0.014896406,"about_ca_topic_score_gemma":0.0040319515,"teacher_disagreement_score":0.663819,"about_ca_system_score_codex":0.00040991712,"about_ca_system_score_gemma":0.0008379707,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W2740370896","doi":"10.1158/1538-7445.am2017-5146","title":"Abstract 5146: Increasing penetration of anticancer drugs through sortilin receptor-mediated cancer therapy: A new targeted and personalized Approach in the treatment of ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada); Université du Québec à Montréal","funders":"","keywords":"Doxorubicin; Cancer research; Ovarian cancer; Pharmacology; Cancer cell; Cytotoxic T cell; Receptor; Cancer; Chemistry; Biology; Internal medicine; Medicine; In vitro; Biochemistry; Chemotherapy","score_opus":0.08861486313494384,"score_gpt":0.41004984451416154,"score_spread":0.3214349813792177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740370896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806674,0.01623971,0.000022447011,0.0010947993,0.000050890838,0.0009790985,0.00010402525,0.00000348521,0.00083810673],"genre_scores_gemma":[0.95308375,0.04551051,0.00019149564,0.000042340183,0.00023047085,0.00045371288,0.00007310964,0.000022363505,0.00039227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794644,0.00031272255,0.00029678852,0.00041801445,0.00063287414,0.0003931333],"domain_scores_gemma":[0.9987931,0.00008072978,0.00018018899,0.000528884,0.00032718683,0.00008990367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095050235,0.00016503042,0.00026775888,0.00009735931,0.0002495605,0.00007820132,0.00038707763,0.00016295986,0.00042045914],"category_scores_gemma":[0.0001488882,0.00011684575,0.000073597614,0.000222879,0.0005185567,0.000025051038,0.0000551075,0.00020033102,0.0000010937664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023691654,0.00029683384,0.03491777,0.00009141458,0.00014177144,0.0000015504036,0.004150101,0.000052010782,0.9205081,0.00008517768,0.00061577815,0.036770362],"study_design_scores_gemma":[0.0076183444,0.000737902,0.32608947,0.0001828304,0.000017567549,0.0000016909887,0.0016069576,0.00034800477,0.6317836,0.00014392573,0.03115185,0.00031788868],"about_ca_topic_score_codex":0.060024615,"about_ca_topic_score_gemma":0.0032765476,"teacher_disagreement_score":0.2911717,"about_ca_system_score_codex":0.00011639806,"about_ca_system_score_gemma":0.0010403093,"threshold_uncertainty_score":0.94623476},"labels":[],"label_agreement":null},{"id":"W2740373989","doi":"10.1158/1538-7445.am2017-5860","title":"Abstract 5860: Genomic architecture of prostate cancer at recurrence following radiotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute of Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Radiation therapy; Radioresistance; Prostate; Cancer; Genome instability; Oncology; Brachytherapy; Internal medicine; Biology; Genetics","score_opus":0.08254376366879411,"score_gpt":0.4400533376853527,"score_spread":0.3575095740165586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740373989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597469,0.032046117,0.0000020060797,0.0048754197,0.0004034703,0.0011743844,0.0001706585,0.000020637437,0.0015604282],"genre_scores_gemma":[0.966849,0.029895792,0.00014461068,0.00011104835,0.00031306833,0.00091440225,0.000014734818,0.00004903632,0.0017082561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783695,0.00004862952,0.0002804933,0.00051133824,0.0006724403,0.00065014337],"domain_scores_gemma":[0.9982811,0.00010826946,0.00017894333,0.0009379293,0.00023118476,0.0002625383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005411015,0.00019959453,0.0004484247,0.000152238,0.00052798016,0.000073185955,0.00037577414,0.00008860301,0.00067016605],"category_scores_gemma":[0.000086606466,0.00015521038,0.00019132467,0.00012977453,0.00037026318,0.00010305147,0.00016041039,0.00045234073,0.000018579554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013972588,0.00021768318,0.50065655,0.0005922892,0.0005923659,0.0002211968,0.001900891,0.00007215499,0.15364844,0.000033518718,0.005139641,0.33552805],"study_design_scores_gemma":[0.005449281,0.0006457652,0.7244325,0.0023522063,0.00009320633,0.000011014966,0.0000792628,0.000020539406,0.17936468,0.00025579584,0.08698087,0.00031483124],"about_ca_topic_score_codex":0.0033042373,"about_ca_topic_score_gemma":0.0006845037,"teacher_disagreement_score":0.3352132,"about_ca_system_score_codex":0.0013477161,"about_ca_system_score_gemma":0.0008287675,"threshold_uncertainty_score":0.73378485},"labels":[],"label_agreement":null},{"id":"W2740384655","doi":"10.1158/1538-7445.am2017-378","title":"Abstract 378: The Cancer Genome Collaboratory","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Concordia University; McGill University; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Collaboratory; Cloud computing; Interoperability; Computer science; Genome; Metadata; Software; Genomics; Computational biology; Data mining; Data science; Biology; World Wide Web; Genetics; Gene; Operating system","score_opus":0.06700933428036979,"score_gpt":0.4164437830424406,"score_spread":0.34943444876207086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740384655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747849,0.015000118,0.000009129908,0.0035049713,0.00053246494,0.00033152578,0.00029123685,0.000005711802,0.0055399346],"genre_scores_gemma":[0.9803923,0.015175399,0.000015509537,0.00042145743,0.0017899928,0.00036152854,0.000017050343,0.000032555105,0.0017942052],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986835,0.000041257492,0.00013416997,0.0003899266,0.00029284792,0.00045826848],"domain_scores_gemma":[0.9980705,0.00004101307,0.00008166343,0.0012330204,0.00044244644,0.00013137463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006673698,0.000115686984,0.00010791143,0.000033031087,0.0010055106,0.0002946645,0.0010988774,0.00011243903,0.00028902735],"category_scores_gemma":[0.0002956566,0.00008954163,0.000055552136,0.000076733304,0.00047612362,0.0000052468145,0.00048472753,0.00026608125,0.000044522563],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011758669,0.000030110083,0.005663961,0.00002907711,0.00007693707,0.00000997922,0.00008322953,0.0001657871,0.9287452,0.00026455708,0.058705058,0.006108508],"study_design_scores_gemma":[0.00042665636,0.0000659042,0.09622494,0.000022111411,0.000008884511,0.0000010709665,0.00009966158,0.0000051332545,0.13830893,0.00013084788,0.7645299,0.00017595402],"about_ca_topic_score_codex":0.0018914791,"about_ca_topic_score_gemma":0.00302695,"teacher_disagreement_score":0.79043627,"about_ca_system_score_codex":0.0001141865,"about_ca_system_score_gemma":0.0010665489,"threshold_uncertainty_score":0.7733676},"labels":[],"label_agreement":null},{"id":"W2740388256","doi":"10.1158/1538-7445.am2017-4035","title":"Abstract 4035: A novel combi-molecule engineered to target the putative synthetic lethal interactions between the epidermal growth factor receptor (EGFR) and poly(ADP-ribose)polymerase (PARP)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Synthetic lethality; Cancer research; Olaparib; Poly ADP ribose polymerase; Epidermal growth factor receptor; PARP inhibitor; Biology; DNA repair; Cancer; Polymerase; Biochemistry; Genetics; Enzyme; DNA","score_opus":0.1299726238395984,"score_gpt":0.4405425160021295,"score_spread":0.3105698921625311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740388256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8672713,0.0013946138,0.0012144288,0.12451578,0.00058648974,0.0017040307,0.0013062559,0.00006529249,0.0019417997],"genre_scores_gemma":[0.9956798,0.000160512,0.0002424718,0.0007724564,0.0012737892,0.0007837223,0.000032839172,0.00007003688,0.0009843668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720633,0.00022990297,0.0003782934,0.00055958395,0.0008552834,0.00077058596],"domain_scores_gemma":[0.9964897,0.0014063588,0.00015887791,0.0010007913,0.0004943505,0.0004499216],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009833119,0.00028264843,0.00040565064,0.00021342807,0.0013783661,0.00028851486,0.00066172995,0.00010793494,0.0010330958],"category_scores_gemma":[0.0011135169,0.00018254081,0.00012831826,0.00028468372,0.0009416596,0.00025795752,0.00020637955,0.0013663744,0.00012674744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015121995,0.00037599084,0.0076312814,0.00023328546,0.0009913173,0.0000882062,0.009890961,0.000024073788,0.9311356,0.0008911887,0.032929376,0.014296541],"study_design_scores_gemma":[0.0038843923,0.00047163814,0.16566867,0.00069997454,0.000086985834,0.00009334464,0.0014595862,0.00011396543,0.78384817,0.00039184824,0.042759735,0.00052168354],"about_ca_topic_score_codex":0.0020911326,"about_ca_topic_score_gemma":0.00005238235,"teacher_disagreement_score":0.1580374,"about_ca_system_score_codex":0.0004577411,"about_ca_system_score_gemma":0.00047986305,"threshold_uncertainty_score":0.9999217},"labels":[],"label_agreement":null},{"id":"W2740444617","doi":"10.1158/1538-7445.am2017-4852","title":"Abstract 4852: Targeting cancer progression genes upregulated in CREB3L1-deficient breast cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Cancer research; Breast cancer; Downregulation and upregulation; Microarray analysis techniques; Cancer; Metastasis; Gene knockdown; Cell; Metastatic breast cancer; Cancer cell; Cell culture; Gene; Medicine; Biology; Gene expression; Internal medicine; Biochemistry; Genetics","score_opus":0.041674021313131866,"score_gpt":0.43829678967541114,"score_spread":0.3966227683622793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740444617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887838,0.007449324,0.00006463959,0.0019859492,0.00014638294,0.000654028,0.00019552451,0.000023036484,0.00069734367],"genre_scores_gemma":[0.9884735,0.008709731,0.000219538,0.000077718694,0.00034951995,0.0015550078,0.0000614123,0.000039237566,0.0005143733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980955,0.00008474532,0.00024850183,0.0006569828,0.00027989966,0.0006343798],"domain_scores_gemma":[0.99863684,0.000009802306,0.00014374744,0.0007642418,0.00031430725,0.00013105963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005953505,0.0001820854,0.00017447848,0.000086436,0.0005663939,0.00010309633,0.00071300985,0.00028535182,0.0002812905],"category_scores_gemma":[0.000027974682,0.00015863102,0.00007502242,0.00013353475,0.0003646573,0.00000843103,0.00043689957,0.0003526188,0.0000088815395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008539259,0.000075971155,0.010784458,0.00003781849,0.00002331439,0.0000063976177,0.000021213264,0.00015459552,0.95027256,0.00003039,0.004825857,0.03368203],"study_design_scores_gemma":[0.00034372148,0.00003952705,0.041616727,0.00016202986,0.0000059798863,0.0000022697054,0.000023529967,0.000093125454,0.9246005,0.000044989345,0.032849066,0.00021855057],"about_ca_topic_score_codex":0.003396239,"about_ca_topic_score_gemma":0.0008024579,"teacher_disagreement_score":0.033463478,"about_ca_system_score_codex":0.000115753675,"about_ca_system_score_gemma":0.00033829355,"threshold_uncertainty_score":0.64687854},"labels":[],"label_agreement":null},{"id":"W2740470992","doi":"10.1158/1538-7445.am2017-lb-103","title":"Abstract LB-103: Landscape of somatic ERBB2 Mutations: Findings from AACR GENIE and comparison to ongoing ERBB2 mutant basket study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Missense mutation; Cohort; Neratinib; Indel; Cancer; Medicine; Breast cancer; Oncology; Exome; Colorectal cancer; Germline mutation; Internal medicine; Mutation; Genetics; Exome sequencing; Biology; Gene; Single-nucleotide polymorphism; Genotype","score_opus":0.12130764087997967,"score_gpt":0.4710490454831226,"score_spread":0.34974140460314296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740470992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470294,0.0017653353,0.00007661668,0.0013783993,0.00012795631,0.0013303127,0.00010276756,0.000035619745,0.00048004297],"genre_scores_gemma":[0.99834645,0.000089816924,0.00072825793,0.0000539208,0.00022904521,0.00029200115,0.000013874774,0.00004678647,0.00019983824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758285,0.000078067475,0.000433331,0.0004960211,0.0008999476,0.0005097505],"domain_scores_gemma":[0.9978996,0.0003997148,0.00016224658,0.0008715713,0.00037600705,0.00029084724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007395583,0.00019438169,0.0005652034,0.0002768291,0.00049445155,0.00013263983,0.00038801596,0.00007473189,0.0005525453],"category_scores_gemma":[0.000518306,0.00017134285,0.000052940155,0.00021889502,0.0002807661,0.00023464898,0.00023644924,0.00048507756,0.00004414265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014782046,0.00056422886,0.7560088,0.00042249841,0.0004473529,0.0001074087,0.016126465,0.00014075269,0.17820558,0.000028811519,0.00046598318,0.046003893],"study_design_scores_gemma":[0.0037501128,0.0005213914,0.957725,0.00087031076,0.00007340177,0.000007067525,0.008832856,0.00023342871,0.026485385,0.00047715555,0.00082319224,0.00020068903],"about_ca_topic_score_codex":0.0035850576,"about_ca_topic_score_gemma":0.0016627631,"teacher_disagreement_score":0.20171618,"about_ca_system_score_codex":0.00023702244,"about_ca_system_score_gemma":0.00031837088,"threshold_uncertainty_score":0.69871587},"labels":[],"label_agreement":null},{"id":"W2740477437","doi":"10.1158/1538-7445.am2017-ct149","title":"Abstract CT149: Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Bendamustine; Neutropenia; Rituximab; Clinical endpoint; Febrile neutropenia; Follicular lymphoma; Lymphoma; Surgery; Chemotherapy; Clinical trial","score_opus":0.054265676133059305,"score_gpt":0.37646925240102275,"score_spread":0.3222035762679634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740477437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986559,0.00028355737,1.5007507e-7,0.00030077435,0.00017596476,0.0032582423,0.000078344165,0.000017340542,0.009326645],"genre_scores_gemma":[0.9957004,0.00013635814,0.000015364982,0.00003825496,0.0001681488,0.0002586193,0.000020321266,0.00006704307,0.0035954744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941968,0.0003232026,0.0006657517,0.00075109047,0.0031140759,0.0009490866],"domain_scores_gemma":[0.99534714,0.00048519493,0.00034399526,0.0027034432,0.0008369762,0.00028323193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022424674,0.0002610436,0.0005739376,0.0003114711,0.0004429902,0.00009136887,0.0012736996,0.00017615079,0.00014084214],"category_scores_gemma":[0.0012360682,0.00014990964,0.00008673595,0.00051235285,0.0010377085,0.000250333,0.0008824305,0.0010111564,0.00003812739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.1518796,0.0291677,0.74142104,0.002944619,0.00050982146,0.0014580745,0.0072265943,0.00007323194,0.006752612,0.000009645531,0.01725438,0.041302677],"study_design_scores_gemma":[0.13090473,0.0028435302,0.85959685,0.0008594706,0.000025365205,0.000003899204,0.00042003213,0.000021698736,0.0041157333,0.0000027807218,0.0010471174,0.00015876678],"about_ca_topic_score_codex":0.011594665,"about_ca_topic_score_gemma":0.0023152942,"teacher_disagreement_score":0.11817583,"about_ca_system_score_codex":0.019671494,"about_ca_system_score_gemma":0.024159255,"threshold_uncertainty_score":0.9949872},"labels":[],"label_agreement":null},{"id":"W2740491863","doi":"10.1158/1538-7445.am2017-3332","title":"Abstract 3332: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and the acquisition of resistance against BRAF inhibition","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Melanoma; Cancer research; Biology; Autocrine signalling; Gene knockdown; Cancer; Carcinogenesis; Metastasis; Oncogene; Cell culture; Cell cycle; Genetics","score_opus":0.04154748017096628,"score_gpt":0.34904840559399275,"score_spread":0.3075009254230265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740491863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456614,0.0019265314,0.000020310046,0.0017110627,0.000024851792,0.00075728976,0.0001511772,0.0000021732355,0.0008404794],"genre_scores_gemma":[0.9975639,0.0019306828,0.00007851289,0.000075614764,0.00007270706,0.00015174493,0.000031935007,0.00001765961,0.00007726262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829775,0.0002457386,0.00029016854,0.00041042725,0.00038564848,0.00037027095],"domain_scores_gemma":[0.99888736,0.0000566196,0.0001224412,0.00052994816,0.00031529876,0.000088345245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009223336,0.00011844106,0.00023503779,0.00009639502,0.00027936636,0.0000615402,0.00024846435,0.00013790936,0.000012571403],"category_scores_gemma":[0.0002632136,0.00008941557,0.000038498696,0.000083706655,0.0008539062,0.000036501122,0.00029781376,0.00019899591,0.0000010383752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014321303,0.00006692506,0.0013755995,0.00017413567,0.000015753656,0.000013808896,0.0014354902,0.0000027725273,0.99440634,0.00010469614,0.000513183,0.00045914226],"study_design_scores_gemma":[0.0020147508,0.0002024993,0.00845466,0.00045732842,0.0000037614707,0.00000207184,0.00019866023,0.000007937778,0.98777324,0.00030401998,0.00048804734,0.000092999195],"about_ca_topic_score_codex":0.0009872519,"about_ca_topic_score_gemma":0.00088034564,"teacher_disagreement_score":0.00707906,"about_ca_system_score_codex":0.000055214616,"about_ca_system_score_gemma":0.00015516384,"threshold_uncertainty_score":0.3646261},"labels":[],"label_agreement":null},{"id":"W2740497624","doi":"10.1158/1538-7445.am2017-4885","title":"Abstract 4885: Identification of actionable targets for refractory/relapsed childhood cancer leading to personalized targeted therapy (TRICEPS Study)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Targeted therapy; Refractory (planetary science); Oncology; Cancer; Internal medicine; Disease","score_opus":0.15449733952701106,"score_gpt":0.48273325006585266,"score_spread":0.3282359105388416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740497624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816703,0.0039006786,0.00010102807,0.008137368,0.000833733,0.004626098,0.00024918627,0.000068419366,0.00041315713],"genre_scores_gemma":[0.9904436,0.0013181398,0.00018794867,0.00029309597,0.0010856332,0.0023427622,0.00004281993,0.00009846001,0.004187576],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955779,0.00020417705,0.0007981961,0.0008693498,0.0017264907,0.0008239254],"domain_scores_gemma":[0.9956453,0.00041903663,0.0005492269,0.0013419772,0.0016491691,0.00039532533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037206942,0.0002847502,0.00074613193,0.0005095078,0.0011896362,0.00018317696,0.00076563924,0.0001707104,0.0010077569],"category_scores_gemma":[0.0017728828,0.00027080244,0.00023306732,0.00046213207,0.0002605303,0.00041855813,0.000124631,0.00067454745,0.00005076559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009114753,0.0039716107,0.052418962,0.0010569278,0.0016470153,0.00001755671,0.03239558,0.00007017789,0.8163179,0.00016284965,0.03684286,0.045983795],"study_design_scores_gemma":[0.01027187,0.0014225119,0.7770887,0.00055518333,0.00009283239,0.0000021350518,0.00482052,0.000023134033,0.16245346,0.00020003966,0.042622074,0.00044753766],"about_ca_topic_score_codex":0.0076954276,"about_ca_topic_score_gemma":0.00094859157,"teacher_disagreement_score":0.72466975,"about_ca_system_score_codex":0.000812862,"about_ca_system_score_gemma":0.0013519689,"threshold_uncertainty_score":0.9999744},"labels":[],"label_agreement":null},{"id":"W2740568283","doi":"10.1158/1538-7445.am2017-1302","title":"Abstract 1302: Genome-wide association study of glioma reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glioma; Genome-wide association study; Odds ratio; Glioblastoma; Oncology; Medicine; Internal medicine; Cancer; Biology; Cancer research; Single-nucleotide polymorphism; Genetics; Genotype; Gene","score_opus":0.05034432380698348,"score_gpt":0.36579834398548194,"score_spread":0.31545402017849844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740568283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980061,0.00038937916,0.000015398562,0.00045777444,0.000114347014,0.0007800571,0.000022620061,0.0000044655453,0.00020984824],"genre_scores_gemma":[0.9987039,0.00047286498,0.000024552312,0.00002328361,0.00017173977,0.00021379901,0.0000030558324,0.000018583818,0.00036820327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979039,0.0001818715,0.000354803,0.00063775404,0.00053101464,0.00039067157],"domain_scores_gemma":[0.9983268,0.00006662839,0.00021415348,0.00087556365,0.0003583562,0.00015854857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009977568,0.00014624817,0.00024588147,0.00023596089,0.00025062478,0.00011775094,0.000534773,0.00014903196,0.00006901248],"category_scores_gemma":[0.0004594224,0.0001388707,0.000038435788,0.0002280401,0.000114535425,0.000012041081,0.00032313107,0.00020417098,0.000009080375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002738869,0.00014136771,0.42469317,0.000023975379,0.000014931356,0.000003038137,0.00029185606,0.000008907428,0.572069,6.399389e-7,0.0008715134,0.0016077356],"study_design_scores_gemma":[0.00074749,0.0008717425,0.8992541,0.00004544525,0.0000033203119,3.0830955e-7,0.0006536386,0.000002725634,0.09757441,0.00004567262,0.00067345315,0.00012769397],"about_ca_topic_score_codex":0.0003742094,"about_ca_topic_score_gemma":0.0032414142,"teacher_disagreement_score":0.47456092,"about_ca_system_score_codex":0.00016374784,"about_ca_system_score_gemma":0.00012440438,"threshold_uncertainty_score":0.5662983},"labels":[],"label_agreement":null},{"id":"W2740581458","doi":"10.1158/1538-7445.am2017-1928","title":"Abstract 1928: The lung microenvironment promotes stem-like phenotype and behavior of breast cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CD44; Cancer stem cell; Metastasis; Stem cell; Cancer research; Biology; Bone marrow; Breast cancer; Pathology; Lung cancer; Cancer; Immunology; Cell; Medicine; Cell biology","score_opus":0.06982856159809663,"score_gpt":0.3909120597850869,"score_spread":0.3210834981869903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740581458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834212,0.011541981,0.0000012472296,0.002981733,0.00026532833,0.000962808,0.00028717224,0.000007100428,0.000531441],"genre_scores_gemma":[0.98700285,0.009237068,0.000032994012,0.00006916921,0.00028128346,0.00034428004,0.0000028035818,0.000031947315,0.0029975788],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838656,0.000044154738,0.0002097319,0.00033948701,0.0005910513,0.00042903522],"domain_scores_gemma":[0.9986947,0.000054255408,0.00012808958,0.00078600814,0.00015162441,0.00018530639],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058842474,0.00013910867,0.00027591386,0.00006511047,0.00040242163,0.0000761756,0.00029891753,0.000063022555,0.0012407795],"category_scores_gemma":[0.000008405998,0.00009155741,0.000071663344,0.00007059611,0.0006977149,0.00008123027,0.00022450439,0.00040305284,0.000012518137],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038338508,0.00025833026,0.043813925,0.0007706166,0.00014326496,0.000034753135,0.0005729958,0.0000029874436,0.82476604,0.000013217179,0.007712388,0.121528104],"study_design_scores_gemma":[0.0013706761,0.000108153894,0.6856795,0.00047303003,0.00027480812,0.000015278747,0.0002905488,0.000008119321,0.29484236,0.000007543941,0.016778449,0.00015150313],"about_ca_topic_score_codex":0.008564531,"about_ca_topic_score_gemma":0.0005378819,"teacher_disagreement_score":0.6418656,"about_ca_system_score_codex":0.00023380488,"about_ca_system_score_gemma":0.00031437105,"threshold_uncertainty_score":0.99967223},"labels":[],"label_agreement":null},{"id":"W2740602103","doi":"10.1158/1538-7445.am2017-3335","title":"Abstract 3335: Role of TGF-beta type III receptor in cell migration, invasion, and proliferation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell biology; Signal transduction; SMAD; Biology; Receptor; Transforming growth factor beta; Phosphorylation; Lipid raft; Cancer research; Chemistry; Biochemistry","score_opus":0.04438537728976521,"score_gpt":0.36735063018666914,"score_spread":0.3229652528969039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740602103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957271,0.0031876685,0.0000023753728,0.00023508201,0.0000448968,0.00020495076,0.000012343308,0.0000027178044,0.00058283895],"genre_scores_gemma":[0.99835664,0.00087794196,0.00005323142,0.000013594516,0.0001511025,0.000049031598,0.000045204593,0.000011640249,0.00044162112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923056,0.000047829428,0.00014503884,0.0002302277,0.00018199853,0.00016434236],"domain_scores_gemma":[0.9992,0.00001542637,0.00006898019,0.00035910573,0.00029338337,0.00006309789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035640624,0.00006392448,0.00008238013,0.000051600102,0.00014419711,0.000051905223,0.00021266611,0.000088406814,0.000070666734],"category_scores_gemma":[0.00019339813,0.000061009385,0.000016252778,0.000048212278,0.00013849171,0.000009942525,0.00011149972,0.000103772836,0.0000068619734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017557235,0.000049160837,0.053716592,0.000052092695,0.000006756483,4.866367e-7,0.00012343557,0.000025037893,0.9419178,0.000016559838,0.0025412997,0.0013752551],"study_design_scores_gemma":[0.00035424312,0.000077196804,0.059259415,0.000044832745,0.0000020414664,1.7677765e-7,0.00007976419,0.000013286447,0.9308412,0.000054987864,0.009207155,0.00006569759],"about_ca_topic_score_codex":0.00045984788,"about_ca_topic_score_gemma":0.0010152196,"teacher_disagreement_score":0.011076544,"about_ca_system_score_codex":0.000019606832,"about_ca_system_score_gemma":0.000320013,"threshold_uncertainty_score":0.24878904},"labels":[],"label_agreement":null},{"id":"W2740611655","doi":"10.1158/1538-7445.am2017-216","title":"Abstract 216: Tracking expression, post-translational modifications and interactions of EGF signalling proteins in A431 cells with antibody microarrays","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Protein microarray; Antibody microarray; Phosphorylation; A431 cells; Biology; Antibody; Epidermal growth factor; DNA microarray; Kinase; Protein Array Analysis; Proteomics; Cell biology; Molecular biology; Protein phosphorylation; Biotin; Epidermal growth factor receptor; Lysis; Protein kinase A; Biochemistry; Cell; Cell cycle; Gene expression; Oncogene; Receptor; Gene; Immunology","score_opus":0.05801667145791806,"score_gpt":0.4190404033792071,"score_spread":0.36102373192128906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740611655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880828,0.00020108648,0.010148637,0.0006385655,0.000012597267,0.00042739743,0.000077635785,0.0000073929077,0.00040386477],"genre_scores_gemma":[0.99027115,0.00029343955,0.009109971,0.000009996466,0.000061488005,0.00010529468,0.000049373895,0.000014624921,0.00008465235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992448,0.000023279783,0.00015574759,0.0002704604,0.00013412163,0.00017157529],"domain_scores_gemma":[0.9991558,0.000025732545,0.000097960976,0.00034977836,0.00032329836,0.000047400048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019503222,0.000076955286,0.00008579239,0.0000747627,0.00033464693,0.00004871434,0.00019345056,0.00006277353,0.0000108256245],"category_scores_gemma":[0.000035758996,0.00006799286,0.000022890745,0.000063048894,0.0002609708,0.000017759798,0.000056807334,0.00020201808,6.322604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006437297,0.000062184416,0.00075573195,0.000025782678,0.0000072816333,0.0000010501434,0.00007412797,0.00018260017,0.9970523,0.00011450188,0.00003971997,0.0016203426],"study_design_scores_gemma":[0.00019443022,0.000049572016,0.013567158,0.000168641,0.0000025335162,0.0000027527599,0.00008672952,0.00005193821,0.984297,0.00022362993,0.0012707495,0.000084888656],"about_ca_topic_score_codex":0.0002346533,"about_ca_topic_score_gemma":0.00033091256,"teacher_disagreement_score":0.012811426,"about_ca_system_score_codex":0.000013736773,"about_ca_system_score_gemma":0.00012269884,"threshold_uncertainty_score":0.27726683},"labels":[],"label_agreement":null},{"id":"W2740615432","doi":"10.1158/1538-7445.am2017-1764","title":"Abstract 1764: Accurate and reproducible detection of fusions and exon skipping events in NSCLC-derived samples using a comprehensive, targeted RNA-Seq system across multiple laboratories","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Computational biology; Workflow; Biology; Computer science; Bioinformatics; Database","score_opus":0.14243485448232926,"score_gpt":0.42292287118895117,"score_spread":0.28048801670662193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740615432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995775,0.003464375,0.00016241932,0.000058574646,0.00010431093,0.00031171434,0.00010290956,0.0000053321314,0.000015402728],"genre_scores_gemma":[0.9979837,0.0016665051,0.000108673215,0.0000039993442,0.0000977532,0.00008380447,0.000012104247,0.000014879145,0.000028606304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988816,0.000082120074,0.00019623291,0.00042994312,0.00014944696,0.00026069],"domain_scores_gemma":[0.9987884,0.00002830402,0.00013733013,0.00054027,0.00044226967,0.00006338473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323366,0.00009562869,0.00015504473,0.000058860136,0.0005876692,0.00006476784,0.00015163943,0.00009881234,0.0000026638754],"category_scores_gemma":[0.0002907573,0.00008555715,0.00001975937,0.0001199537,0.00023297561,0.000023441855,0.00021697638,0.00013889893,2.9685046e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014528538,0.000015748938,0.018575512,0.000157925,0.000021211199,0.0000011393759,0.00021254856,0.000116350304,0.9769561,0.0000040038763,0.000006152363,0.003788018],"study_design_scores_gemma":[0.00058215193,0.000034620436,0.30817202,0.00018290732,0.0000034692373,0.0000021944074,0.0014246939,0.0003205268,0.68866587,0.000008791747,0.0005099386,0.000092834096],"about_ca_topic_score_codex":0.0045987857,"about_ca_topic_score_gemma":0.0020002578,"teacher_disagreement_score":0.2895965,"about_ca_system_score_codex":0.000058962174,"about_ca_system_score_gemma":0.00014791447,"threshold_uncertainty_score":0.6952019},"labels":[],"label_agreement":null},{"id":"W2740617618","doi":"10.1158/1538-7445.am2017-2558","title":"Abstract 2558: MYC-dependent transformation model of triple-negative breast cancer in vivo","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Cancer research; Myoepithelial cell; Triple-negative breast cancer; PI3K/AKT/mTOR pathway; In vivo; Cancer; Medicine; Biology; Pathology; Internal medicine; Signal transduction; Immunohistochemistry; Cell biology","score_opus":0.10417180535879887,"score_gpt":0.44607321248032406,"score_spread":0.34190140712152517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740617618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982653,0.0010556233,0.00039199606,0.006352412,0.00023261122,0.0013624929,0.0010516148,0.000033405933,0.006866824],"genre_scores_gemma":[0.99594706,0.0015273845,0.000122006444,0.000055197797,0.00018868853,0.00050838373,0.0000032011985,0.000040894494,0.0016071887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762547,0.00005219452,0.00040458742,0.00035625522,0.0009862784,0.0005752373],"domain_scores_gemma":[0.9983003,0.0000674902,0.00018213179,0.00064726186,0.0006256943,0.00017708182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073069707,0.00018085151,0.00042166858,0.00032461467,0.00023694354,0.00004201182,0.00040042214,0.00012479661,0.0013025231],"category_scores_gemma":[0.00008504387,0.00015920671,0.00008786894,0.00020381286,0.00046771034,0.00060695235,0.00006608356,0.00067537616,0.000010553961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00953592,0.00046580864,0.013977648,0.0012827833,0.00027978193,0.000043494103,0.010276032,0.010488369,0.6834433,0.00086371053,0.00040947594,0.26893365],"study_design_scores_gemma":[0.018613148,0.000250717,0.326381,0.0031519192,0.000067537476,0.000036458943,0.002607861,0.0125008365,0.6294856,0.005511171,0.0007978317,0.0005959099],"about_ca_topic_score_codex":0.008207396,"about_ca_topic_score_gemma":0.0035950097,"teacher_disagreement_score":0.31240335,"about_ca_system_score_codex":0.00097173813,"about_ca_system_score_gemma":0.0010039748,"threshold_uncertainty_score":0.9996104},"labels":[],"label_agreement":null},{"id":"W2740620121","doi":"10.1158/1538-7445.am2017-3799","title":"Abstract 3799: Technical validation of a micro-flow cytometry platform for prostate cancer biomarker discovery","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biomarker discovery; Prostate cancer; Biomarker; Flow cytometry; Population; Extracellular vesicles; Cytometry; Reproducibility; Cancer; Medicine; Chemistry; Chromatography; Biology; Immunology; Internal medicine; Proteomics; Biochemistry","score_opus":0.07004815125740786,"score_gpt":0.4258889240903708,"score_spread":0.35584077283296295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740620121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417025,0.0029132976,0.00048648517,0.0003289484,0.00014994881,0.0007630937,0.0007729567,0.000007914909,0.000407096],"genre_scores_gemma":[0.9959714,0.0010128295,0.0006086446,0.000019899822,0.00025195917,0.00058233883,0.00015688004,0.0000409677,0.0013550807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850976,0.000028969427,0.00024615787,0.00043668103,0.00034341295,0.00043501286],"domain_scores_gemma":[0.99845487,0.000044223496,0.00016078164,0.000860776,0.000359437,0.00011988571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079578545,0.00013339876,0.00015773278,0.00010133107,0.00028687945,0.00013755074,0.0006227394,0.00017644426,0.000052213974],"category_scores_gemma":[0.00047355253,0.00012325437,0.00013100056,0.0000954861,0.00047043728,0.000031944175,0.00032006204,0.00017074686,0.000004074213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083666825,0.000093873954,0.008826792,0.00023300636,0.00006640093,0.000003842764,0.00001763596,0.00002576827,0.9729648,0.00001979687,0.004626737,0.012284657],"study_design_scores_gemma":[0.00080132135,0.000098710974,0.02883246,0.00010595725,0.000015835585,0.0000014507646,0.000025842628,0.000030029092,0.9628413,0.00022694172,0.006865245,0.00015494986],"about_ca_topic_score_codex":0.0002120561,"about_ca_topic_score_gemma":0.000100310885,"teacher_disagreement_score":0.020005668,"about_ca_system_score_codex":0.000097065036,"about_ca_system_score_gemma":0.00048779763,"threshold_uncertainty_score":0.5026167},"labels":[],"label_agreement":null},{"id":"W2740631697","doi":"10.1158/1538-7445.am2017-5894","title":"Abstract 5894: Stromal fibroblasts from metastatic breast cancer promote proliferation and migration of breast cancer cell and regulate its stemness","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cancer-Associated Fibroblasts; Stromal cell; Tumor microenvironment; Cancer research; Breast cancer; Cancer cell; Cancer; Carcinogenesis; Medicine; Biology; Internal medicine","score_opus":0.0672273992655599,"score_gpt":0.3889683962121717,"score_spread":0.32174099694661185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740631697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331714,0.008534423,0.000010534601,0.003995756,0.00016366014,0.0011823867,0.00261341,0.00001751497,0.0001652073],"genre_scores_gemma":[0.9884072,0.00943272,0.00013206025,0.00003528341,0.00046290798,0.00039090725,0.000039458442,0.000049163,0.001050281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975956,0.000099243116,0.0003977698,0.0006215653,0.0007875356,0.0004982722],"domain_scores_gemma":[0.9979647,0.000061731684,0.0002994502,0.000542107,0.00079621683,0.0003358033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055983337,0.00025002332,0.00052867696,0.0001279122,0.00040019728,0.00020555223,0.00018143906,0.00010528439,0.0010687326],"category_scores_gemma":[0.00002626104,0.00020818917,0.00006506684,0.00013527284,0.00033153416,0.0005584448,0.00014722518,0.00035157803,0.0000035870726],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002483967,0.00024350546,0.036990434,0.0029489323,0.00035873204,0.000034037945,0.0013525529,0.000060123188,0.8581952,0.000028378594,0.0013919766,0.09591216],"study_design_scores_gemma":[0.0033089053,0.00017869526,0.8195252,0.0016757741,0.00026257875,0.000038807786,0.00025746104,0.0006520119,0.17294025,0.000050101527,0.0008495406,0.00026069456],"about_ca_topic_score_codex":0.0485494,"about_ca_topic_score_gemma":0.020838788,"teacher_disagreement_score":0.7825348,"about_ca_system_score_codex":0.0003133472,"about_ca_system_score_gemma":0.0007871153,"threshold_uncertainty_score":0.99984443},"labels":[],"label_agreement":null},{"id":"W2740639320","doi":"10.1158/1538-7445.am2017-5881","title":"Abstract 5881: Identification of resistance mechanisms to IGF-IR targeting in triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Fibroblast growth factor receptor 1; Cancer; Receptor tyrosine kinase; Breast cancer; Growth factor; Medicine; Biology; Receptor; Internal medicine; Fibroblast growth factor","score_opus":0.03921608406817839,"score_gpt":0.38449422606122474,"score_spread":0.34527814199304635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740639320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092966,0.004682236,0.00020982376,0.0012531957,0.00101313,0.0006254334,0.00043038622,0.0000065730833,0.00084956904],"genre_scores_gemma":[0.9922411,0.0027417531,0.00017620972,0.000051500934,0.0009245438,0.0004102144,0.000017983904,0.000028450062,0.0034082583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982269,0.000085817905,0.00033394943,0.00049994467,0.00040177765,0.00045165152],"domain_scores_gemma":[0.9984497,0.000022235181,0.00019798128,0.0006674418,0.0005313005,0.00013135125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011454667,0.00012970611,0.00021406256,0.00013041354,0.00027295173,0.00008055943,0.0006025556,0.00012369761,0.00012839549],"category_scores_gemma":[0.00042911677,0.00013191838,0.00006671919,0.00018553308,0.00016895717,0.000019291581,0.00020107013,0.00022648345,0.000009444723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004571403,0.00003748345,0.00039777212,0.00007244045,0.000025197087,0.0000011096796,0.0002456408,0.00007117745,0.9786256,0.00014865925,0.014550541,0.0053672693],"study_design_scores_gemma":[0.0007909509,0.000027620854,0.11534509,0.00012695626,0.000006744982,5.811341e-7,0.00029374164,0.0000074292766,0.86432236,0.00052679545,0.018375207,0.00017654333],"about_ca_topic_score_codex":0.0045236107,"about_ca_topic_score_gemma":0.010199566,"teacher_disagreement_score":0.11494732,"about_ca_system_score_codex":0.00012573384,"about_ca_system_score_gemma":0.0005014897,"threshold_uncertainty_score":0.6838376},"labels":[],"label_agreement":null},{"id":"W2740653063","doi":"10.1158/1538-7445.am2017-1774","title":"Abstract 1774: Progression-free survival curves suggest a dichotomous determinant of PD-L1 inhibitor efficacy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Internal medicine; Medicine; Oncology; Population; Lung cancer; Progression-free survival; Epidermal growth factor receptor; Area under the curve; Receiver operating characteristic; Tyrosine-kinase inhibitor; Proportional hazards model; Cancer; Chemotherapy","score_opus":0.09293664651431557,"score_gpt":0.5037445147351651,"score_spread":0.4108078682208496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740653063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800784,0.005283667,0.0000015853495,0.0040755495,0.00041737038,0.0013533203,0.00015502438,0.000034630502,0.008600429],"genre_scores_gemma":[0.99434084,0.0021013778,0.00010811875,0.000037876565,0.00044245203,0.00043764466,0.000029170675,0.00003899805,0.0024635536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976696,0.00006022423,0.00029835975,0.0003786437,0.0010843156,0.0005088533],"domain_scores_gemma":[0.9974218,0.00022755751,0.00017142121,0.0013170487,0.00057645974,0.0002857385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063885347,0.00015928803,0.00037219422,0.00014783563,0.0004995886,0.00007440856,0.0004940575,0.000092004564,0.0004026968],"category_scores_gemma":[0.00092663243,0.000113892915,0.00011428437,0.00014740734,0.00054323033,0.00015591554,0.00024556273,0.00039467876,0.00003430023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052944054,0.0048429496,0.33637282,0.007847979,0.0012579451,0.0019690858,0.0027940513,0.000003793553,0.1111457,0.00043185055,0.08654964,0.44148976],"study_design_scores_gemma":[0.0063619255,0.00093775615,0.9108248,0.006008517,0.00017635779,0.000018721263,0.00014963072,0.0000086938835,0.05929219,0.00012234396,0.015878595,0.00022047975],"about_ca_topic_score_codex":0.0021184117,"about_ca_topic_score_gemma":0.00050291547,"teacher_disagreement_score":0.574452,"about_ca_system_score_codex":0.0002544451,"about_ca_system_score_gemma":0.0010606967,"threshold_uncertainty_score":0.4644418},"labels":[],"label_agreement":null},{"id":"W2740659912","doi":"10.1158/1538-7445.am2017-ct021","title":"Abstract CT021: Tumor-associated immune cell PD-L1 expression and peripheral immune profiling: Analyses from CheckMate 141","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nivolumab; Medicine; Internal medicine; Immune system; Oncology; Hazard ratio; Context (archaeology); PD-L1; Immunotherapy; Gastroenterology; Cancer; Immunology; Confidence interval; Biology","score_opus":0.13261298521661807,"score_gpt":0.4479654569332892,"score_spread":0.31535247171667113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740659912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710485,0.02319696,0.000003042759,0.0008877518,0.00027668633,0.0006078703,0.00010002025,0.000055787157,0.0038234289],"genre_scores_gemma":[0.99123836,0.0038841402,0.00013012328,0.000071834715,0.0003011043,0.00015072506,0.000086721935,0.00005750478,0.004079473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973248,0.00013606984,0.00046056253,0.0005714429,0.00079358165,0.00071349106],"domain_scores_gemma":[0.99800897,0.00011991196,0.00028603896,0.0010170524,0.00035007944,0.0002179735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011132429,0.00025849795,0.0005501518,0.00015151313,0.00097040704,0.00032198505,0.00046369203,0.00018043254,0.001878572],"category_scores_gemma":[0.00022848931,0.00020662435,0.00018810965,0.00017022791,0.0005624159,0.00025996997,0.00025500136,0.0007830099,0.000022266993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034041328,0.00016682966,0.013499347,0.00013755291,0.00020711131,0.000089722314,0.00040646215,0.0000017644182,0.97747207,0.0000013199393,0.0010253419,0.0035883524],"study_design_scores_gemma":[0.0035799968,0.00015375232,0.34716377,0.0005923033,0.000037651156,0.0000028832949,0.00040772549,0.000055649536,0.6460324,0.000036009777,0.0017581903,0.00017968618],"about_ca_topic_score_codex":0.01444583,"about_ca_topic_score_gemma":0.00014536326,"teacher_disagreement_score":0.33366442,"about_ca_system_score_codex":0.00044172432,"about_ca_system_score_gemma":0.00048018052,"threshold_uncertainty_score":0.99903387},"labels":[],"label_agreement":null},{"id":"W2740660726","doi":"10.1158/1538-7445.am2017-1576","title":"Abstract 1576: UGT2B17 promotes castration-resistant prostate cancer progression through enhancing ligand-independent AR signaling","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Androgen receptor; Androgen; Cancer research; Enzalutamide; Biology; Endocrinology; Internal medicine; Androgen deprivation therapy; Prostate; Tumor progression; Cancer; Medicine; Hormone","score_opus":0.12445719061752251,"score_gpt":0.47607702450033507,"score_spread":0.35161983388281254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740660726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760503,0.010269382,0.000008390639,0.0066012344,0.00036957135,0.002951139,0.00010111891,0.000099032244,0.0035498205],"genre_scores_gemma":[0.9858109,0.0049712975,0.00025893055,0.00005201075,0.00095879525,0.0018829014,0.000049309154,0.00009415499,0.0059217336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946258,0.000120373836,0.0005408595,0.00097288913,0.0022541443,0.001485922],"domain_scores_gemma":[0.99681765,0.00015365031,0.00027539014,0.0010746381,0.0012011896,0.00047745783],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0016225643,0.0003716391,0.0005343802,0.00023360328,0.002244489,0.00071084744,0.0005706113,0.00022934227,0.0006927264],"category_scores_gemma":[0.00032320677,0.00027286581,0.00016171679,0.0003012126,0.0006391892,0.0006912848,0.00031011854,0.001310694,0.00009419578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002479448,0.0003227454,0.017498955,0.001089072,0.0002607264,0.0007291796,0.0024142337,0.000018438086,0.95032835,0.00006799042,0.0012059235,0.02358494],"study_design_scores_gemma":[0.00351341,0.00064235803,0.033471834,0.003821583,0.00006586182,0.000014508516,0.0007587582,0.000038353253,0.9527582,0.00046606944,0.0041068327,0.0003422152],"about_ca_topic_score_codex":0.0046395757,"about_ca_topic_score_gemma":0.0015691733,"teacher_disagreement_score":0.023242723,"about_ca_system_score_codex":0.0011763654,"about_ca_system_score_gemma":0.002899679,"threshold_uncertainty_score":0.99997234},"labels":[],"label_agreement":null},{"id":"W2740662559","doi":"10.1158/1538-7445.am2017-4287","title":"Abstract 4287: <i>HABP2</i> p.G534E variant in patients with family history of thyroid and breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sanger sequencing; Family history; Proband; Exome sequencing; Thyroid carcinoma; Medicine; Germline mutation; Genetics; Population; Internal medicine; Thyroid cancer; Exome; Breast cancer; Mutation; Cancer; Oncology; Biology; Thyroid; Gene","score_opus":0.04606590724856942,"score_gpt":0.34594296157403054,"score_spread":0.29987705432546113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740662559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808649,0.012671047,3.6985912e-7,0.0012990744,0.00018946864,0.00064066594,0.0001760158,0.000009649518,0.0041488106],"genre_scores_gemma":[0.99395794,0.004569607,0.000023379598,0.00012962136,0.00012157057,0.00037507122,0.000008080996,0.000033339413,0.0007814109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819833,0.000037202117,0.00022340962,0.0004127248,0.00069071405,0.0004376202],"domain_scores_gemma":[0.99857676,0.000057212506,0.00013241425,0.0006468319,0.00037527137,0.00021150609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031837646,0.00016146724,0.00037368335,0.00016825608,0.00011459395,0.00002913961,0.00019999009,0.00007809515,0.00030238234],"category_scores_gemma":[0.000025698446,0.00011847373,0.000040220817,0.00009049125,0.0004627353,0.00016102107,0.000106035724,0.00035991112,0.0000061530563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001901181,0.00065333565,0.95567137,0.00025486603,0.00013973472,0.00012120172,0.0004292011,0.00000520629,0.002317017,0.00007130564,0.014570321,0.023865238],"study_design_scores_gemma":[0.006074248,0.00041503503,0.9864183,0.00072891684,0.000038013928,0.000003143229,0.00004714758,0.0000027359033,0.00038630882,0.000017518632,0.005750641,0.000117966076],"about_ca_topic_score_codex":0.023448994,"about_ca_topic_score_gemma":0.002471526,"teacher_disagreement_score":0.030746933,"about_ca_system_score_codex":0.0016865515,"about_ca_system_score_gemma":0.001173299,"threshold_uncertainty_score":0.9830539},"labels":[],"label_agreement":null},{"id":"W2740681758","doi":"10.1158/1538-7445.am2017-536","title":"Abstract 536: Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Biology; Carcinogenesis; Cancer research; STAT1; Transcriptome; Transcription factor; Signal transduction; Cell biology; Cancer; Gene expression; Genetics; Gene","score_opus":0.14900902949361608,"score_gpt":0.529443425600651,"score_spread":0.380434396107035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740681758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944284,0.00039002925,0.000014474323,0.0011951813,0.00032764755,0.0007069604,0.00018434679,0.0000103818165,0.0027426055],"genre_scores_gemma":[0.99759734,0.00027457744,0.00006468296,0.000014043895,0.00030173032,0.00031924585,0.000020573343,0.000022546652,0.0013852827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982842,0.00002452229,0.00036548963,0.0002612234,0.0007766507,0.00028789343],"domain_scores_gemma":[0.99796003,0.00009294029,0.00027322603,0.00067176024,0.00083760923,0.00016440799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059415615,0.00009230149,0.00026574603,0.00019110097,0.00024345335,0.000037775724,0.00025868742,0.00007110543,0.00032044802],"category_scores_gemma":[0.00055422226,0.00007807089,0.0000791384,0.00015304983,0.00022825705,0.00014479294,0.000060560316,0.0001722131,0.000027513845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003917144,0.00040994395,0.012167391,0.00036656906,0.00026899518,0.000017092123,0.0015624472,0.0000034395796,0.95702916,0.00060590863,0.0005707977,0.026606545],"study_design_scores_gemma":[0.0016099446,0.00014381408,0.45465082,0.00014133193,0.000089261106,0.0000019558333,0.00034039424,0.000007332548,0.5420014,0.00017321577,0.00077958306,0.000060926246],"about_ca_topic_score_codex":0.0056717386,"about_ca_topic_score_gemma":0.0002991108,"teacher_disagreement_score":0.44248343,"about_ca_system_score_codex":0.00036650882,"about_ca_system_score_gemma":0.002172576,"threshold_uncertainty_score":0.85740095},"labels":[],"label_agreement":null},{"id":"W2740705692","doi":"10.1158/1538-7445.am2017-795","title":"Abstract 795: The capacity of high-grade serous ovarian cancer cells to form spontaneous multicellular structures (SMCS) <i>in vitro</i> predicts their <i>in vivo</i> tumorigenicity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ascites; Serous fluid; Ovarian cancer; Medicine; Cancer; Pathology; Cancer cell; Cancer research; Internal medicine","score_opus":0.038805391621140536,"score_gpt":0.33768294459534065,"score_spread":0.2988775529742001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740705692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949559,0.0012140969,0.000010881008,0.0007132671,0.00025655702,0.0012886621,0.0012403505,0.000007266849,0.00031302965],"genre_scores_gemma":[0.99716157,0.0014062546,0.00008830374,0.0001014773,0.0003341796,0.0005223381,0.00002469657,0.0000459362,0.0003152678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996951,0.00018326592,0.00036203023,0.00071044464,0.00071726413,0.0010760339],"domain_scores_gemma":[0.99792165,0.000085221094,0.00013993563,0.0013188494,0.00024157831,0.00029275214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083627255,0.0002878351,0.00036516998,0.00014897117,0.000401109,0.00012695705,0.0013131355,0.00019078338,0.00011309075],"category_scores_gemma":[0.0001453633,0.00020973946,0.00012417547,0.00021341168,0.00044510476,0.000021150981,0.00047233904,0.00060439983,0.000005763316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017381625,0.00016983482,0.0021381883,0.00009544455,0.00010144914,0.00022455161,0.00039553284,0.000449739,0.990161,0.000025144567,0.00078148354,0.0037194488],"study_design_scores_gemma":[0.0017239255,0.00019004292,0.01985875,0.00007935323,0.0000090683225,0.0000143942525,0.00010370943,0.000030487243,0.9726342,0.00032978284,0.0048242076,0.00020206781],"about_ca_topic_score_codex":0.13106208,"about_ca_topic_score_gemma":0.1079301,"teacher_disagreement_score":0.023131972,"about_ca_system_score_codex":0.00039598322,"about_ca_system_score_gemma":0.0006256212,"threshold_uncertainty_score":0.90834785},"labels":[],"label_agreement":null},{"id":"W2740718973","doi":"10.1158/1538-7445.am2017-ct007","title":"Abstract CT007: Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Temozolomide; Internal medicine; Radiation therapy; Progression-free survival; Concomitant; Randomized controlled trial; Chemotherapy; Surgery; Randomization; Oncology","score_opus":0.10038874220199501,"score_gpt":0.45690327810855214,"score_spread":0.35651453590655713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740718973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905747,0.0003859829,0.000015302167,0.0035237737,0.00020270271,0.004304234,0.00023059403,0.000020312946,0.0007423853],"genre_scores_gemma":[0.9967555,0.0005078163,0.00032262978,0.00011059807,0.00035925364,0.0016320786,0.000017529837,0.000034709,0.000259896],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996931,0.00020113176,0.0008311044,0.00052997225,0.0008830867,0.0006237109],"domain_scores_gemma":[0.9972086,0.00096080004,0.00029787412,0.0008140878,0.00039310826,0.0003255422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023075666,0.00023703507,0.001196767,0.00043616464,0.00022832662,0.0001073342,0.00032334865,0.00011213752,0.00030458026],"category_scores_gemma":[0.0031944027,0.00018071679,0.00029498828,0.0002455453,0.0002495063,0.00010395611,0.000097037664,0.00042909052,0.00001341122],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93995833,0.0038597684,0.0010658595,0.00008075297,0.00020264283,0.0009197787,0.0012471662,0.000013516984,0.0038527178,0.000009015168,0.0042508096,0.044539627],"study_design_scores_gemma":[0.9329215,0.0030363451,0.0027294515,0.0011240861,0.00003963809,0.000005317972,0.00017304544,0.00014786502,0.058592107,0.000013156567,0.0010790596,0.00013838544],"about_ca_topic_score_codex":0.0072536636,"about_ca_topic_score_gemma":0.0036744706,"teacher_disagreement_score":0.05473939,"about_ca_system_score_codex":0.0003699375,"about_ca_system_score_gemma":0.00051557744,"threshold_uncertainty_score":0.9993571},"labels":[],"label_agreement":null},{"id":"W2740721894","doi":"","title":"The effect of a topical COX-2 inhibitor on the expression of C-Met in a rabbit model of uveal melanoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Immunostaining; Medicine; Monoclonal antibody; Uvea; Pathology; Antibody; Immunohistochemistry; Cancer research; Immunology","score_opus":0.047869704682722086,"score_gpt":0.3195427817596928,"score_spread":0.27167307707697075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740721894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980659,0.00065665506,0.00009520759,0.00003713044,0.00008406288,0.00039117306,0.000025594338,0.000009807326,0.00063450646],"genre_scores_gemma":[0.9994029,0.00030205512,0.000027858414,0.000003099133,0.00004666446,0.00012229496,6.6618264e-7,0.000020082602,0.000074370706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987256,0.00009571436,0.0002658351,0.00010286828,0.0005438648,0.00026610814],"domain_scores_gemma":[0.9985631,0.00095018285,0.000035460595,0.00034167236,0.00007255805,0.000036995072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006377323,0.000092085225,0.00022062236,0.000096953634,0.00006290412,0.000003931911,0.00033350888,0.0000762241,0.000018282492],"category_scores_gemma":[0.00014334987,0.000049604314,0.000062400664,0.00030412842,0.00027496202,0.000037270438,0.0000679395,0.00037690275,0.0000017271169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006020446,0.0000172692,0.0044225734,0.00017556958,0.00002015824,0.0000030424485,0.00095584267,0.01634351,0.97481066,0.0002733556,0.00066402735,0.0017119177],"study_design_scores_gemma":[0.00068375125,0.0004243345,0.00053605146,0.0002207407,0.0000028165878,7.1828777e-7,0.000052350366,0.0064227595,0.991278,0.00018377694,0.00014637632,0.000048344675],"about_ca_topic_score_codex":0.00011604338,"about_ca_topic_score_gemma":0.000060928465,"teacher_disagreement_score":0.01646729,"about_ca_system_score_codex":0.00014965085,"about_ca_system_score_gemma":0.000089415895,"threshold_uncertainty_score":0.20228052},"labels":[],"label_agreement":null},{"id":"W2740723111","doi":"10.1158/1538-7445.am2017-3844","title":"Abstract 3844: Identification and validation of novel therapeutic targets driving clonal heterogeneity in treatment-refractory GBM","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Temozolomide; Chemoradiotherapy; Somatic evolution in cancer; Radiation therapy; Tumor progression; Cancer research; Brain tumor; Oncology; Primary tumor; Cancer; Medicine; Biology; Genetic heterogeneity; Internal medicine; Pathology; Gene; Phenotype; Metastasis; Genetics","score_opus":0.10732491019342921,"score_gpt":0.4449669543281436,"score_spread":0.3376420441347144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740723111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666137,0.0025761598,0.000043890002,0.000134897,0.000049793543,0.0003021825,0.00006474593,0.0000024197993,0.000164545],"genre_scores_gemma":[0.99669665,0.0027818438,0.000018950654,0.000004254932,0.00009061813,0.00015489124,0.00007906668,0.00001388948,0.00015986092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890554,0.000055960525,0.00015929497,0.00032988275,0.0002677573,0.00028153963],"domain_scores_gemma":[0.9992164,0.000024478843,0.000091636095,0.00044440737,0.0001396085,0.00008351138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039938002,0.00009506474,0.0001148079,0.00009305189,0.00021394632,0.00008309865,0.00020362846,0.000079420766,0.000029176786],"category_scores_gemma":[0.00007855838,0.000085452564,0.000041688472,0.00004579235,0.00021441568,0.000020702835,0.00010250571,0.00010037089,0.000002879556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015083037,0.00022674477,0.10017406,0.000025921114,0.000070897324,0.0000025343425,0.00005458154,0.000013767388,0.88014156,0.000014650367,0.000030496418,0.019093934],"study_design_scores_gemma":[0.0010673911,0.000163294,0.35334376,0.000022847787,0.0000044182384,0.0000010476464,0.000019473371,0.000017483893,0.644323,0.000059208753,0.0009173089,0.000060778446],"about_ca_topic_score_codex":0.0024077538,"about_ca_topic_score_gemma":0.0032760915,"teacher_disagreement_score":0.2531697,"about_ca_system_score_codex":0.0001385126,"about_ca_system_score_gemma":0.00021381542,"threshold_uncertainty_score":0.36398196},"labels":[],"label_agreement":null},{"id":"W2740730446","doi":"10.1158/1538-7445.am2017-322","title":"Abstract 322: Distinct pools of ShcA coupled tyrosine kinase signaling influences breast tumor heterogeneity and therapeutic responsiveness","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University","funders":"","keywords":"Cancer research; Proto-oncogene tyrosine-protein kinase Src; Receptor tyrosine kinase; Tyrosine kinase; Tyrosine; Signal transduction; Signal transducing adaptor protein; Biology; GRB2; Tyrosine phosphorylation; Cell biology; Biochemistry","score_opus":0.058429083209752826,"score_gpt":0.39113388160255386,"score_spread":0.33270479839280104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740730446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97817063,0.02080641,0.000026189433,0.0002204612,0.000050109218,0.00034484672,0.00035472735,0.00000617248,0.000020480826],"genre_scores_gemma":[0.99925417,0.00031633233,0.000040462794,0.000040749746,0.00014420149,0.00011993881,0.000031400163,0.00002365128,0.000029072598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985176,0.00012005956,0.00021591375,0.00042581258,0.00034045262,0.00038020205],"domain_scores_gemma":[0.99848825,0.00006285896,0.00016305139,0.0007239535,0.00043013852,0.00013177778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082949735,0.0001539717,0.00020740359,0.000056909503,0.00043702216,0.00012995918,0.00054924045,0.00007906201,0.00004013181],"category_scores_gemma":[0.00045403864,0.00013537827,0.000052831616,0.00007143185,0.00080350053,0.000013475665,0.00038123506,0.00017417921,0.0000027370393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010021523,0.00004106372,0.03476707,0.00012814823,0.000051029892,0.000018857656,0.000010873676,0.00002246891,0.95971364,0.00007992335,0.000032810018,0.0041319737],"study_design_scores_gemma":[0.00038245326,0.00011846323,0.32899725,0.00010974981,0.000008030306,0.000009595288,0.000013462266,0.000012851702,0.66990066,0.000097232354,0.00024464456,0.00010561436],"about_ca_topic_score_codex":0.001584006,"about_ca_topic_score_gemma":0.0002890876,"teacher_disagreement_score":0.2942302,"about_ca_system_score_codex":0.00002934056,"about_ca_system_score_gemma":0.00031714793,"threshold_uncertainty_score":0.5520566},"labels":[],"label_agreement":null},{"id":"W2740745639","doi":"10.1158/1538-7445.am2017-1044","title":"Abstract 1044: Development of a miRNA-based signature to predict human cancer metastasis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intravasation; HT1080; Metastasis; microRNA; Cancer; Cancer research; Biology; Cancer cell; Microarray analysis techniques; Cell migration; Cell; Gene expression; Gene; Genetics","score_opus":0.08000162629100853,"score_gpt":0.43128176861268697,"score_spread":0.3512801423216784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740745639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967203,0.0015452786,0.00010491654,0.00039194373,0.00007395255,0.00041151134,0.00013658905,0.000005308445,0.0006101832],"genre_scores_gemma":[0.9982554,0.00003688846,0.0005962607,0.000042816006,0.00019400293,0.00031830647,0.00006388384,0.000023446011,0.00046901882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986164,0.000049945058,0.00020150532,0.00036256717,0.00043699882,0.00033260265],"domain_scores_gemma":[0.9985919,0.000009897272,0.00010835649,0.0006836598,0.0004353017,0.00017089349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005248533,0.000116886586,0.00013741667,0.000098675664,0.00039071558,0.000053318632,0.00055416493,0.00012314126,0.00038572578],"category_scores_gemma":[0.00012129619,0.00011010928,0.00006415608,0.00007823591,0.0001476239,0.000005516376,0.00020319536,0.00014991222,0.000009399045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014107452,0.00005143211,0.0023173783,0.00012257988,0.00009161737,0.0000022055433,0.00005587674,0.00021451144,0.9805956,0.000008343678,0.0071384665,0.009260918],"study_design_scores_gemma":[0.00036343432,0.000043991182,0.10865154,0.0001139855,0.000009357127,1.2089438e-7,0.000013370906,0.000006080105,0.8543381,0.00001202383,0.036338735,0.000109250905],"about_ca_topic_score_codex":0.00033859353,"about_ca_topic_score_gemma":0.0009547254,"teacher_disagreement_score":0.1262575,"about_ca_system_score_codex":0.00012188804,"about_ca_system_score_gemma":0.00090277375,"threshold_uncertainty_score":0.4490126},"labels":[],"label_agreement":null},{"id":"W2740751263","doi":"10.1158/1538-7445.am2017-1846","title":"Abstract 1846: Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis therapies to target breast cancer metastasis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Metastasis; Cancer; Medicine; Cancer research; Metastatic breast cancer; Angiogenesis; Biomarker; Immune system; Oncology; Pathology; Immunology; Biology; Internal medicine","score_opus":0.08183349292734995,"score_gpt":0.4064475362473942,"score_spread":0.3246140433200443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740751263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95390254,0.020678496,0.0015156111,0.006877404,0.00024707642,0.0030134611,0.013535499,0.000028911241,0.00020098167],"genre_scores_gemma":[0.9749704,0.0055775666,0.008909482,0.00022205344,0.0003596576,0.008169019,0.00018206082,0.00013257234,0.0014771756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956736,0.00014559652,0.00054611964,0.0010702731,0.0011043136,0.0014600854],"domain_scores_gemma":[0.99634236,0.00004820605,0.00021215089,0.0013048718,0.0014909481,0.0006014389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010965781,0.0004962369,0.0006459509,0.00032629003,0.0010131894,0.00029465777,0.0014789202,0.0001610058,0.000754672],"category_scores_gemma":[0.0000476632,0.000411892,0.00031863892,0.00026459503,0.0003487365,0.00006230724,0.00073596416,0.00028656592,0.000015852323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047530783,0.0005886335,0.0034763466,0.00030232067,0.0050189416,0.000017455039,0.0018788788,0.002313754,0.789844,0.00007787789,0.0069572506,0.18477148],"study_design_scores_gemma":[0.0032024765,0.0004686106,0.026616478,0.00027768317,0.00008768207,0.000018025215,0.00072117784,0.00005805994,0.8126645,0.00032838687,0.1546496,0.0009073291],"about_ca_topic_score_codex":0.016195828,"about_ca_topic_score_gemma":0.01021484,"teacher_disagreement_score":0.18386415,"about_ca_system_score_codex":0.0005140946,"about_ca_system_score_gemma":0.0018170574,"threshold_uncertainty_score":0.9998333},"labels":[],"label_agreement":null},{"id":"W2740755677","doi":"10.1158/1538-7445.am2017-4741","title":"Abstract 4741: Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in pediatric osteosarcoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Osteosarcoma; Medicine; Cohort; microRNA; Biomarker; Oncology; Internal medicine; Chemotherapy; Cancer research; Gene; Biology; Genetics","score_opus":0.04547270091180628,"score_gpt":0.36059166760861977,"score_spread":0.3151189666968135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740755677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327195,0.005580689,0.0000014528852,0.00022203941,0.000058351918,0.0004263173,0.00008421122,0.0000050362405,0.0003499518],"genre_scores_gemma":[0.99823874,0.0011992416,0.00009157918,0.000011196282,0.00013894415,0.00009541535,0.00002260013,0.000024207366,0.0001780571],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99855995,0.00009307762,0.00023833913,0.00047174742,0.00026730663,0.00036956827],"domain_scores_gemma":[0.99897563,0.000050806117,0.0001387559,0.0005375798,0.00014826554,0.0001489582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005858946,0.00013409222,0.00017667668,0.0001441644,0.00014539443,0.00007639473,0.00031190435,0.0001253485,0.00004190667],"category_scores_gemma":[0.00022555234,0.00013770787,0.000037720933,0.00010476358,0.0004183052,0.000015560128,0.0002795369,0.00016105866,0.0000035920943],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031684994,0.000054215252,0.09465425,0.00028086128,0.000020576541,0.000025020285,0.000046866928,0.0000029912908,0.8990602,0.000008749595,0.0017521891,0.003777231],"study_design_scores_gemma":[0.00091188255,0.000070506416,0.822509,0.00004566778,0.000008669911,0.000005187495,0.000032729775,0.00004251732,0.17379864,0.000052386575,0.0023817327,0.00014111014],"about_ca_topic_score_codex":0.00046587316,"about_ca_topic_score_gemma":0.0004615386,"teacher_disagreement_score":0.7278547,"about_ca_system_score_codex":0.000039691415,"about_ca_system_score_gemma":0.00022866439,"threshold_uncertainty_score":0.5615564},"labels":[],"label_agreement":null},{"id":"W2740757969","doi":"10.1158/1538-7445.am2017-4265","title":"Abstract 4265: Risks of familial breast cancer associated with known and proposed breast cancer susceptibility genes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CHEK2; Breast cancer; Penetrance; PALB2; Genetics; MUTYH; Cancer; Germline mutation; Exome sequencing; Exome; Biology; Mutation; Gene; Medicine; Phenotype","score_opus":0.08561347114410305,"score_gpt":0.4234817046966212,"score_spread":0.33786823355251816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740757969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913204,0.003355208,0.000006354611,0.0014671105,0.00023448878,0.0005797333,0.0026102453,0.00001290834,0.0004135523],"genre_scores_gemma":[0.9940292,0.004232662,0.000039770894,0.000035224683,0.0006099367,0.00025600396,0.000043408647,0.00005367165,0.0007001107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99763054,0.00014025842,0.00028387827,0.00075811805,0.0005850544,0.0006021836],"domain_scores_gemma":[0.99719137,0.00003829142,0.00025767123,0.0009296794,0.0013994472,0.0001835604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007686799,0.0002405755,0.0003018586,0.00008482864,0.00058791164,0.00011391191,0.00059950363,0.00025808057,0.00042038792],"category_scores_gemma":[0.000109702836,0.00020091646,0.000070796224,0.00016389239,0.0014284443,0.000025214516,0.00032802715,0.00037052087,0.0000025625748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000885513,0.00012945606,0.31360382,0.00014530128,0.00032911732,0.000004952152,0.0001469477,0.00018416565,0.6287867,0.000007795903,0.0020353235,0.053740963],"study_design_scores_gemma":[0.0012926301,0.00011592871,0.8069968,0.0001958729,0.00004095526,0.000008281952,0.00014582126,0.00003655785,0.18981798,0.000032512253,0.0010556867,0.0002609184],"about_ca_topic_score_codex":0.020277571,"about_ca_topic_score_gemma":0.031704847,"teacher_disagreement_score":0.49339303,"about_ca_system_score_codex":0.0004825077,"about_ca_system_score_gemma":0.0023236354,"threshold_uncertainty_score":0.98624647},"labels":[],"label_agreement":null},{"id":"W2740761294","doi":"10.1158/1538-7445.am2017-5272","title":"Abstract 5272: Chemopreventive activities of a polyphenol rich purified extract from olive oil processing on colon cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tannin, Tannase and Anticancer Activities","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Casa","funders":"","keywords":"Hydroxytyrosol; In vivo; Polyphenol; Cell growth; Apoptosis; Cell culture; Cell; Resveratrol; Oleuropein; Biology; Flow cytometry; Chemistry; Biochemistry; Food science; Pharmacology; Olive oil; Molecular biology; Biotechnology; Antioxidant","score_opus":0.07772422341214676,"score_gpt":0.3959522749897891,"score_spread":0.31822805157764233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740761294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974406,0.013160132,0.0000032212272,0.0003961205,0.00065942784,0.00024302442,0.00083225913,0.000039343875,0.010260476],"genre_scores_gemma":[0.98510313,0.004458205,0.000013052469,0.000050815885,0.00028431963,0.00032970443,0.000024802379,0.000045694018,0.009690279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977811,0.0001926486,0.0003227661,0.0006098363,0.00024932763,0.00084434956],"domain_scores_gemma":[0.9981798,0.00043504577,0.00041145933,0.0006814507,0.00023094693,0.000061315404],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003797417,0.00028838002,0.00055047154,0.00020415137,0.0010441928,0.00014547331,0.0008024278,0.00032500882,0.0016108403],"category_scores_gemma":[0.00009013528,0.00025674174,0.00012741375,0.00013307772,0.0013501262,0.0004603664,0.00021297255,0.0010978254,0.000077573364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012394105,0.00027536837,0.0009017242,0.0002593177,0.0003100584,0.000019310526,0.0026713626,0.0000067065616,0.9310343,0.0000330047,0.003934877,0.059314534],"study_design_scores_gemma":[0.0011609343,0.000150129,0.009711132,0.0012763645,0.000043395645,0.0000013136275,0.0020066535,0.0000023710495,0.9809016,0.00015356427,0.0043236157,0.000268949],"about_ca_topic_score_codex":0.010531671,"about_ca_topic_score_gemma":0.0009928044,"teacher_disagreement_score":0.059045587,"about_ca_system_score_codex":0.00022212519,"about_ca_system_score_gemma":0.0008450218,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W2740763395","doi":"10.1158/1538-7445.am2017-2167","title":"Abstract 2167: Preclinical validation of an Omomyc cell-penetrating peptide as a viable anti-Myc therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cancer research; Transactivation; Carcinogenesis; Cancer; In vivo; Cell; Biology; Cell-penetrating peptide; Medicine; Gene; Gene expression; Internal medicine","score_opus":0.12499727173023903,"score_gpt":0.48950589247767495,"score_spread":0.36450862074743595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740763395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907547,0.0012050263,0.000003993868,0.00015762988,0.00007139757,0.0004380489,0.000050090362,0.000006577308,0.007312509],"genre_scores_gemma":[0.9953784,0.0028395634,0.00011062006,0.000021691832,0.00034414433,0.00016019028,0.00009201013,0.000029381048,0.0010240092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809474,0.00014097367,0.00023322507,0.00048005793,0.00055588374,0.00049509795],"domain_scores_gemma":[0.9983026,0.00004503088,0.00013541154,0.0009465314,0.0003587841,0.00021165497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009651307,0.00012981123,0.0001724796,0.00006692747,0.00044980508,0.00017675893,0.0006257855,0.0001378029,0.00031909623],"category_scores_gemma":[0.00025773433,0.00011556553,0.000087810164,0.000069715796,0.00027984974,0.000028940898,0.00018731364,0.00026567472,0.00003070516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048453198,0.00027658584,0.028222378,0.00004766216,0.000072614035,0.00001400096,0.000052711952,0.000029272025,0.9583579,0.00000977377,0.0007461141,0.011686492],"study_design_scores_gemma":[0.0014134154,0.00086284627,0.041169964,0.000042106367,0.0000038521707,0.000002309196,0.00005133257,0.000011343013,0.9517923,0.00015081205,0.0043848585,0.00011486521],"about_ca_topic_score_codex":0.006833374,"about_ca_topic_score_gemma":0.0005028228,"teacher_disagreement_score":0.012947585,"about_ca_system_score_codex":0.00005144068,"about_ca_system_score_gemma":0.0006920205,"threshold_uncertainty_score":0.99978024},"labels":[],"label_agreement":null},{"id":"W2740764258","doi":"10.1158/1538-7445.am2017-4775","title":"Abstract 4775: PTHrP regulate CSC and promote EMT in the PyMT model of breast cancer progression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Progenitor cell; Cancer stem cell; Cancer research; Population; Circulating tumor cell; Cancer cell; Tumor progression; Chemistry; Epithelial cell adhesion molecule; Cancer; Biology; Stem cell; Internal medicine; Metastasis; Cell biology; Medicine","score_opus":0.1785244687630861,"score_gpt":0.5214463890131866,"score_spread":0.3429219202501005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740764258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821609,0.0019296694,4.4770866e-7,0.013433891,0.000037816506,0.0009768149,0.000057305046,0.0000070562864,0.0013960786],"genre_scores_gemma":[0.9968425,0.001860052,0.000051389852,0.00006236855,0.00006380249,0.0003401651,0.0000036900885,0.00001642612,0.0007595972],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998537,0.000048681206,0.00018349268,0.00025082304,0.0005581235,0.00042186625],"domain_scores_gemma":[0.99898016,0.00003211464,0.00008961593,0.00054824544,0.0001877973,0.00016204664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080030767,0.00009488295,0.00020813024,0.000089511435,0.0002895184,0.000035840094,0.00018224085,0.00008392006,0.00006111621],"category_scores_gemma":[0.000044382938,0.00005544524,0.000027051885,0.000094265575,0.00031302517,0.000108314234,0.00008088207,0.0004127542,0.0000043218647],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029025069,0.00071029353,0.4100426,0.0018415117,0.00008994182,0.00016877128,0.003203999,0.00003375811,0.018285295,0.00016869021,0.0022724355,0.5602802],"study_design_scores_gemma":[0.0022497228,0.00014087684,0.9909649,0.0012080069,0.000017173874,0.000016626458,0.00006546904,0.001431504,0.003043228,0.0004977391,0.0003015584,0.00006319619],"about_ca_topic_score_codex":0.0077045634,"about_ca_topic_score_gemma":0.0015779427,"teacher_disagreement_score":0.5809223,"about_ca_system_score_codex":0.00013532233,"about_ca_system_score_gemma":0.00062715635,"threshold_uncertainty_score":0.9989032},"labels":[],"label_agreement":null},{"id":"W2740776800","doi":"10.1158/1538-7445.am2017-1509","title":"Abstract 1509: RUNX1 dosage dictates gene signature and <i>in vitro</i> response to glucocorticoids in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"RUNX1; Myeloid leukemia; Myeloid; Leukemia; Gene knockdown; Gene signature; Biology; Cancer research; Ex vivo; Cytarabine; Small hairpin RNA; Glucocorticoid receptor; Haematopoiesis; Internal medicine; Stem cell; Cell culture; In vivo; Medicine; Gene; Gene expression; Glucocorticoid; Immunology; Genetics","score_opus":0.03676145882723393,"score_gpt":0.388285097323117,"score_spread":0.3515236384958831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740776800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97956,0.0022070045,0.000004186395,0.015013912,0.00011136663,0.0017972643,0.000112806505,0.000043787786,0.0011496725],"genre_scores_gemma":[0.9910557,0.0029363967,0.00046346558,0.00055982557,0.00030960477,0.00069191726,0.00002523338,0.00009847698,0.0038593244],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9948888,0.00036469867,0.00053077127,0.0010397012,0.0014466485,0.0017293713],"domain_scores_gemma":[0.9963957,0.0007101579,0.00009399213,0.0015474561,0.0003779113,0.000874775],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042912248,0.00034569757,0.0006834828,0.0011805248,0.00046560052,0.00032056845,0.00089649466,0.00040464438,0.00021051285],"category_scores_gemma":[0.0020906196,0.0003071469,0.00008800963,0.00083287724,0.0007068842,0.00036566667,0.0009145224,0.0029808255,0.00013504668],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026335916,0.00007833296,0.010967192,0.00014230834,0.00006876044,0.0038752186,0.0008091891,0.000021553386,0.9379214,0.0000072404537,0.003514441,0.016258458],"study_design_scores_gemma":[0.005507172,0.00030844656,0.5336051,0.0004188075,0.000017798006,0.00005840437,0.00023422814,0.00019100404,0.4528961,0.000102806116,0.0063597374,0.0003004039],"about_ca_topic_score_codex":0.004420741,"about_ca_topic_score_gemma":0.0008915253,"teacher_disagreement_score":0.5226379,"about_ca_system_score_codex":0.0036583757,"about_ca_system_score_gemma":0.002998422,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W2740810776","doi":"10.1158/1538-7445.am2017-3770","title":"Abstract 3770: CAR-T cell harboring a camelid single domain antibody as a targeting agent to kill tumors expressing VEGFR2","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Antibody; Angiogenesis; Cancer research; Kinase insert domain receptor; Vascular endothelial growth factor; Biology; Antigen; Molecular biology; Immunology; Vascular endothelial growth factor A; VEGF receptors","score_opus":0.09703834215230762,"score_gpt":0.44731707181678015,"score_spread":0.35027872966447254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740810776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96045434,0.0015495644,0.000031597836,0.0023583653,0.0003555848,0.0014547686,0.000022956072,0.00009024206,0.033682555],"genre_scores_gemma":[0.9844723,0.00032262603,0.0005917285,0.00018998995,0.0014860231,0.0003178039,0.00001673346,0.00016507157,0.012437721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939084,0.00023504399,0.0005057487,0.0010363456,0.0023508447,0.001963585],"domain_scores_gemma":[0.99575907,0.00027102948,0.00016258047,0.0017214104,0.0007553835,0.0013305143],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031065133,0.00035076498,0.00060435757,0.0005889474,0.0015526469,0.00079722144,0.001042911,0.000179894,0.0052544414],"category_scores_gemma":[0.0013586862,0.0003325126,0.00020865438,0.0004382318,0.00044637808,0.00030658976,0.0008292411,0.0016013532,0.0004928886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077158003,0.0001729794,0.006717017,0.0004019393,0.00005748014,0.0011906308,0.0023910801,0.000034798893,0.9762496,0.000014488602,0.003189103,0.008809343],"study_design_scores_gemma":[0.00224994,0.0005639209,0.01370211,0.0016251928,0.000017752704,0.000027059212,0.0019986443,0.000040273415,0.8832486,0.00009352164,0.09599403,0.0004389183],"about_ca_topic_score_codex":0.008718015,"about_ca_topic_score_gemma":0.00014188256,"teacher_disagreement_score":0.093000926,"about_ca_system_score_codex":0.0015092024,"about_ca_system_score_gemma":0.001349414,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W2740846483","doi":"10.1158/1538-7445.am2017-2607","title":"Abstract 2607: The cBioPortal for Cancer Genomics: an open source platform for accessing and interpreting complex cancer genomics data in the era of precision medicine","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Genomics; Precision medicine; Personalized medicine; Big data; Medicine; Data science; Cancer; Bioinformatics; Computer science; Genome; Biology; Data mining; Genetics; Pathology; Internal medicine","score_opus":0.24137197567955274,"score_gpt":0.5013311722427092,"score_spread":0.25995919656315647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740846483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565316,0.006762798,0.00058692746,0.0036396927,0.00021852324,0.0017959748,0.0011526378,0.0000019698964,0.00018828784],"genre_scores_gemma":[0.98814136,0.009179262,0.00041418726,0.00040772854,0.00089827226,0.0006397668,0.00022842287,0.00004251554,0.000048484137],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840456,0.000042361207,0.00037499558,0.00055772695,0.00020794611,0.0004124201],"domain_scores_gemma":[0.9976177,0.00037917923,0.0002944414,0.0013679388,0.00026081415,0.00007992557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026551564,0.00015669389,0.0002634078,0.000040799252,0.0007442527,0.0003871,0.003117059,0.00010999169,0.0000277704],"category_scores_gemma":[0.0006006658,0.00010351408,0.000034844797,0.000050481398,0.0005416624,0.00004408961,0.0016103538,0.00027241075,1.2179216e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017204833,0.00007947813,0.007813893,0.00023015233,0.00012598277,0.0000014345768,0.0025579778,0.0005210583,0.56017447,0.00013150067,0.008732628,0.41791096],"study_design_scores_gemma":[0.008653088,0.001608905,0.115253195,0.001610962,0.00018900767,0.000012518852,0.008961932,0.024822308,0.0887029,0.0029452613,0.7461918,0.001048123],"about_ca_topic_score_codex":0.016874608,"about_ca_topic_score_gemma":0.030150706,"teacher_disagreement_score":0.7374592,"about_ca_system_score_codex":0.00012115487,"about_ca_system_score_gemma":0.0007078741,"threshold_uncertainty_score":0.9896721},"labels":[],"label_agreement":null},{"id":"W2740852255","doi":"10.1158/1538-7445.am2017-31","title":"Abstract 31: Preclinical development of a novel biparatopic HER2 antibody with activity in low to high HER2 expressing cancers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Internalization; Antibody; Cancer research; Cancer; Cell culture; Receptor; Epitope; Cancer cell; Humanized antibody; Chemistry; Molecular biology; Medicine; Monoclonal antibody; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.20545774378279388,"score_gpt":0.5134407570563625,"score_spread":0.3079830132735686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740852255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408257,0.00021427554,0.00006860702,0.0025337161,0.00009622748,0.00078782625,0.000030723197,0.000011660279,0.0021743993],"genre_scores_gemma":[0.99527264,0.00017068411,0.0018210236,0.00006021858,0.00022868541,0.0001962807,0.000007869869,0.00002832658,0.0022142571],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969237,0.000061740786,0.0003764999,0.0005537457,0.0012674424,0.0008168914],"domain_scores_gemma":[0.99813014,0.00024536139,0.000118498414,0.00067446043,0.00040938926,0.00042216157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011947847,0.00019081615,0.0005218722,0.00028814594,0.0004030707,0.00008871133,0.00052390114,0.00012742792,0.00021538303],"category_scores_gemma":[0.00026689706,0.00014196418,0.00005901064,0.0003039286,0.00050819514,0.00017333294,0.0003542577,0.0009099429,0.000026096464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077045835,0.000986174,0.22432987,0.0015084943,0.0001972371,0.00023125249,0.0014694456,0.00015351774,0.6992153,0.00005631852,0.0006706375,0.06347718],"study_design_scores_gemma":[0.00194684,0.0003055774,0.7720205,0.0023269167,0.0000055678665,0.0000046275154,0.00009221857,0.000091455884,0.2184838,0.0000087040235,0.0045454428,0.00016832964],"about_ca_topic_score_codex":0.018927043,"about_ca_topic_score_gemma":0.0064020674,"teacher_disagreement_score":0.54769063,"about_ca_system_score_codex":0.00059047656,"about_ca_system_score_gemma":0.0034803848,"threshold_uncertainty_score":0.987606},"labels":[],"label_agreement":null},{"id":"W2740853602","doi":"10.1158/1538-7445.am2017-2737","title":"Abstract 2737: Development of a clinically actionable, ultra-sensitive multi-oncogene panel compatible with ctDNA testing in urine and plasma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"","keywords":"Liquid biopsy; Multiplex; T790M; Amplicon; Medicine; Multiplex polymerase chain reaction; Internal medicine; Cancer research; KRAS; Oncology; Cancer; Polymerase chain reaction; Bioinformatics; Biology; Genetics; Gene","score_opus":0.1642935471794588,"score_gpt":0.41002049327240947,"score_spread":0.24572694609295068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740853602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838454,0.00021705666,0.000081325066,0.00008217113,0.000040873274,0.00023239221,0.00004096148,0.0000023991684,0.00091826776],"genre_scores_gemma":[0.9935822,0.00046584886,0.005625733,0.000017810842,0.000095558345,0.00005658716,0.000019149982,0.000017266331,0.000119858305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890393,0.000026226984,0.00027567815,0.00032497584,0.00018560537,0.0002836087],"domain_scores_gemma":[0.99895096,0.00015337761,0.00014260891,0.00029397468,0.00035871752,0.000100373756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005826275,0.00010211858,0.00016742699,0.000060771137,0.00022432415,0.000046214765,0.00018069317,0.00008153747,0.0000074900913],"category_scores_gemma":[0.00062102015,0.00009322311,0.000016754844,0.000066386405,0.00026366665,0.0000057569982,0.00014539932,0.00018852587,0.0000018557581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054185104,0.0001346291,0.113554746,0.000084760286,0.00005268833,0.000023123745,0.00019461573,0.0003446469,0.86677694,0.00000697658,0.000079770005,0.018205244],"study_design_scores_gemma":[0.001863505,0.00026746362,0.35494146,0.00017200399,0.0000050318376,0.00000992078,0.00020210531,0.00014573985,0.64053667,0.000008930827,0.0016834599,0.00016371811],"about_ca_topic_score_codex":0.0010960057,"about_ca_topic_score_gemma":0.0034855013,"teacher_disagreement_score":0.24138673,"about_ca_system_score_codex":0.000060233313,"about_ca_system_score_gemma":0.00079427863,"threshold_uncertainty_score":0.3801528},"labels":[],"label_agreement":null},{"id":"W2740859764","doi":"10.1158/1538-7445.am2017-3870","title":"Abstract 3870: Clonal evolution of medulloblastoma BTICs in response to therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Biology; Population; Cancer research; Gene; Stem cell; Targeted therapy; Oncology; Medicine; Cancer; Genetics","score_opus":0.11986778240458384,"score_gpt":0.4718307302488754,"score_spread":0.35196294784429155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740859764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911838,0.0010489846,0.000001280481,0.006295572,0.00007347524,0.00047387235,0.000017213488,0.0000060913903,0.0008996919],"genre_scores_gemma":[0.9990477,0.00031180438,0.00007335342,0.000029931489,0.00008236564,0.00020002047,0.0000012925365,0.000012894968,0.00024061682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869,0.00007907855,0.00016250755,0.000199557,0.0005697874,0.00029907422],"domain_scores_gemma":[0.99882144,0.00019176451,0.000044363067,0.0005117749,0.00027611095,0.00015454508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094793807,0.000073169744,0.00017881686,0.0002893109,0.00013329212,0.000027012418,0.00018054053,0.000060957034,0.00020321873],"category_scores_gemma":[0.0004308143,0.000057751076,0.000047301975,0.00016724125,0.0001476597,0.0000491499,0.000062075494,0.00019270414,0.00004422001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010670259,0.0007420254,0.3557346,0.00004999365,0.000064989945,0.00028951693,0.00050563406,0.00003922039,0.6082203,0.00027528653,0.002745229,0.02066296],"study_design_scores_gemma":[0.002119373,0.0005099873,0.8911638,0.00023565967,0.0000032856592,0.000004039377,0.00009762614,0.000013364355,0.10258579,0.000110166904,0.0031134672,0.000043391843],"about_ca_topic_score_codex":0.0029691744,"about_ca_topic_score_gemma":0.0005384058,"teacher_disagreement_score":0.53542924,"about_ca_system_score_codex":0.00056699716,"about_ca_system_score_gemma":0.0005212942,"threshold_uncertainty_score":0.44885233},"labels":[],"label_agreement":null},{"id":"W2740865831","doi":"10.1158/1538-7445.am2017-2250","title":"Abstract 2250: Systemic inflammation and sarcopenia predict colorectal cancer survival","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sarcopenia; Medicine; Internal medicine; Colorectal cancer; Cancer; Body mass index; Overweight; Systemic inflammation; Cohort; Stage (stratigraphy); Oncology; Gastroenterology; Inflammation","score_opus":0.09192932611739167,"score_gpt":0.4204542465074367,"score_spread":0.328524920390045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740865831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882674,0.0028075625,0.0000016092731,0.0016059482,0.00050508365,0.0012786938,0.00009012083,0.00006824709,0.0053752935],"genre_scores_gemma":[0.9958177,0.0016669867,0.000029170153,0.000014221051,0.00094119494,0.0009510169,0.00001515809,0.000044330853,0.0005201953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975465,0.0001307372,0.0003074903,0.00045923257,0.0009869412,0.00056910265],"domain_scores_gemma":[0.99810946,0.00014037798,0.00015180229,0.0006064912,0.0006243403,0.00036753452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015475615,0.00017722916,0.00031902874,0.00019123283,0.0007837309,0.0002611231,0.0003702819,0.00017166328,0.00066858897],"category_scores_gemma":[0.0005975189,0.00015732214,0.0000665716,0.00011909628,0.00067037845,0.00031641152,0.00029103836,0.00048891746,0.00006892507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020390728,0.000036897516,0.7073876,0.0015296561,0.00026403216,0.00017662431,0.00032805072,0.0000027864603,0.24814433,0.00009871618,0.003925873,0.036066316],"study_design_scores_gemma":[0.002095898,0.00008573506,0.937538,0.0013716724,0.0000689536,0.00002236523,0.00016798882,0.00015336041,0.05607734,0.000058846457,0.0021767446,0.00018304138],"about_ca_topic_score_codex":0.0012132718,"about_ca_topic_score_gemma":0.00046592578,"teacher_disagreement_score":0.23015042,"about_ca_system_score_codex":0.00053121365,"about_ca_system_score_gemma":0.0009061773,"threshold_uncertainty_score":0.73205805},"labels":[],"label_agreement":null},{"id":"W2740869922","doi":"10.1158/1538-7445.am2017-2473","title":"Abstract 2473: Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Breast cancer; Oncology; Cancer; Genome instability; Medicine; PARP inhibitor; Germline mutation; Internal medicine; Genetics; Biology; Mutation; Gene; DNA","score_opus":0.04842925033553031,"score_gpt":0.3763340612358634,"score_spread":0.3279048109003331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740869922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98015267,0.008671086,0.000053090567,0.007559045,0.00038035007,0.00040630912,0.00028604176,0.000013685471,0.0024777306],"genre_scores_gemma":[0.98980874,0.007146976,0.000047894428,0.00023694533,0.0004509205,0.00028785018,0.000043104414,0.000046713776,0.0019308302],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831563,0.00004383901,0.00018314243,0.00053036783,0.00035279657,0.0005742441],"domain_scores_gemma":[0.9983076,0.00004945147,0.00013342737,0.000897457,0.00047063478,0.00014142202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043121504,0.00018997346,0.00019884392,0.0000895875,0.00072443957,0.00026911878,0.00070573797,0.00015970024,0.00017513148],"category_scores_gemma":[0.00006905645,0.00015426491,0.000074357275,0.00007696157,0.00039427116,0.000014809322,0.00023683248,0.00029585327,0.000031491807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063842174,0.00033220396,0.27839983,0.00016239985,0.0003140951,0.000048764592,0.00026973628,0.0006840662,0.33279094,0.0008568877,0.005865977,0.3796367],"study_design_scores_gemma":[0.0017470905,0.00042794936,0.90848285,0.00008204016,0.000038324244,0.000021927563,0.00011585897,0.000034071425,0.038493294,0.0010254588,0.049015656,0.0005154646],"about_ca_topic_score_codex":0.0021981548,"about_ca_topic_score_gemma":0.0020990625,"teacher_disagreement_score":0.630083,"about_ca_system_score_codex":0.00016863237,"about_ca_system_score_gemma":0.0007110291,"threshold_uncertainty_score":0.62907404},"labels":[],"label_agreement":null},{"id":"W2740875518","doi":"10.1158/1538-7445.am2017-3528","title":"Abstract 3528: <i>PTCH53</i> as a potential secondary modifier in Li-Fraumeni syndrome","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Germline; Genetics; Genotype; Cancer research; Wild type; Mutant; Germline mutation; Phenotype; Loss of heterozygosity; Allele; Gene; Mutation","score_opus":0.0671438418983128,"score_gpt":0.41218880358223386,"score_spread":0.34504496168392107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740875518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503425,0.0029346037,0.000014575511,0.0042145345,0.0005607931,0.0009105814,0.000050769337,0.000050348866,0.0409213],"genre_scores_gemma":[0.99263203,0.00081080355,0.00004709656,0.00028985244,0.0003218908,0.00030658385,0.00002152458,0.000079901954,0.0054903044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99671906,0.00008589557,0.00035097337,0.00067451695,0.0011945273,0.0009750448],"domain_scores_gemma":[0.9977002,0.0000500695,0.000103644896,0.0014338531,0.00029090274,0.00042128706],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010584842,0.00022140896,0.00042418594,0.00042297522,0.00041922077,0.00019072536,0.0006057406,0.00031052413,0.0032759455],"category_scores_gemma":[0.00031974365,0.00021932945,0.00015527013,0.00026570735,0.0004508455,0.0002535172,0.00035224942,0.0021087786,0.00080536614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025548474,0.0006213205,0.0028648484,0.0008431309,0.00039286236,0.023568591,0.0009493502,0.00029484567,0.838621,0.00032066798,0.03343626,0.09553225],"study_design_scores_gemma":[0.03072328,0.002442198,0.4958349,0.0046512242,0.00020762299,0.0031115378,0.00092897844,0.0008792421,0.2805404,0.0050509884,0.17372276,0.0019068782],"about_ca_topic_score_codex":0.006666618,"about_ca_topic_score_gemma":0.0006349627,"teacher_disagreement_score":0.5580806,"about_ca_system_score_codex":0.0007683614,"about_ca_system_score_gemma":0.0019600077,"threshold_uncertainty_score":0.99997264},"labels":[],"label_agreement":null},{"id":"W2740875883","doi":"10.1158/1538-7445.am2017-4722","title":"Abstract 4722: Evaluation of the prognostic value of ATG4B expression in different breast cancer subtypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Tissue microarray; Internal medicine; Proportional hazards model; Cancer; Population; Cohort; Immunohistochemistry; Pathology","score_opus":0.07290922582000203,"score_gpt":0.4351240143499221,"score_spread":0.36221478852992006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740875883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648446,0.0015135837,0.0000014834849,0.0005372289,0.00014179021,0.0006526655,0.00009568346,0.0000015285467,0.00057157746],"genre_scores_gemma":[0.9988473,0.0003662883,0.0000048854126,0.000003666535,0.00020142416,0.00032047345,0.000008671466,0.000018396602,0.00022889493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975432,0.00037177256,0.00023828125,0.00031088124,0.0012119132,0.00032390768],"domain_scores_gemma":[0.9980648,0.000048581052,0.00015120432,0.0008472367,0.0008235397,0.00006459321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016202965,0.0001033264,0.00015956929,0.000089706446,0.00019215979,0.000024144289,0.00068338215,0.00012726651,0.00016198853],"category_scores_gemma":[0.00075740524,0.00006947758,0.000073760195,0.000108566055,0.00048730333,0.000008548402,0.00039989306,0.00029142035,0.0000023565137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016334311,0.00010267801,0.09368469,0.00010831077,0.000016030044,6.328352e-7,0.00008807291,0.00019885466,0.9001191,0.000009572978,0.0008841908,0.004624487],"study_design_scores_gemma":[0.00038151006,0.000025781821,0.44543603,0.0002671087,0.0000049591627,5.4966324e-7,0.000024553327,0.00008069235,0.55357534,0.000030180725,0.00013040715,0.000042905955],"about_ca_topic_score_codex":0.0020561053,"about_ca_topic_score_gemma":0.0015722,"teacher_disagreement_score":0.35175133,"about_ca_system_score_codex":0.00018018711,"about_ca_system_score_gemma":0.00082679326,"threshold_uncertainty_score":0.310823},"labels":[],"label_agreement":null},{"id":"W2740877401","doi":"10.1158/1538-7445.am2017-lb-102","title":"Abstract LB-102: Landscape analysis of the initial data release from AACR Project GENIE","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Clinical trial; Interoperability; Citation; Medicine; Precision medicine; Data science; Computer science; Internal medicine; Library science; World Wide Web; Pathology","score_opus":0.15670329196889035,"score_gpt":0.4564489004946577,"score_spread":0.29974560852576737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740877401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912621,0.0023172207,0.000015874371,0.00040220466,0.00020056732,0.00021106243,0.0035509185,0.0000023791415,0.0020377159],"genre_scores_gemma":[0.9957737,0.0026883455,0.00003961318,0.000069030815,0.0006327833,0.000033875254,0.0005802687,0.000016027903,0.0001664069],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99872917,0.000058302685,0.000178796,0.00043888533,0.00032043745,0.0002744355],"domain_scores_gemma":[0.9969035,0.00007148707,0.00013015784,0.0026123258,0.00021362006,0.000068911475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004430825,0.00009501732,0.00017307172,0.00007826926,0.0003073638,0.000112877024,0.0016979739,0.00010710239,0.00016723665],"category_scores_gemma":[0.0007218876,0.0000728888,0.00010776042,0.00018066265,0.00026726435,0.00000712678,0.0013436174,0.00020064478,0.000004918929],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009436503,0.000238639,0.12902793,0.00007388213,0.002825698,0.000028021386,0.00025769588,0.00054044876,0.70496404,0.00009650993,0.12470467,0.036298804],"study_design_scores_gemma":[0.0015236974,0.00014816242,0.5471326,0.00007052456,0.0006339303,9.969496e-7,0.00023536672,0.0010549176,0.2765175,0.00018034509,0.1721036,0.00039834407],"about_ca_topic_score_codex":0.011069163,"about_ca_topic_score_gemma":0.011236237,"teacher_disagreement_score":0.42844656,"about_ca_system_score_codex":0.00002695105,"about_ca_system_score_gemma":0.00075967103,"threshold_uncertainty_score":0.99551624},"labels":[],"label_agreement":null},{"id":"W2740884875","doi":"10.1158/1538-7445.am2017-2137","title":"Abstract 2137: JAK2 as a novel therapeutic target in anaplastic thyroid cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; Western University","funders":"","keywords":"Anaplastic thyroid cancer; Cancer research; Apoptosis; Medicine; Cancer; Thyroid cancer; Cell growth; Internal medicine; Pharmacology; Biology; Biochemistry","score_opus":0.08910604118631107,"score_gpt":0.445423522895852,"score_spread":0.3563174817095409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740884875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875336,0.0043872884,0.000038429527,0.0013177487,0.00026491427,0.00051082,0.0001228579,0.000010591734,0.005813711],"genre_scores_gemma":[0.9927279,0.0021190792,0.000037418846,0.000121315716,0.00051787344,0.00043282684,0.000032112886,0.000062055595,0.003949417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698985,0.00010804427,0.00024289687,0.0007295319,0.00081716594,0.0011124866],"domain_scores_gemma":[0.9980236,0.00007259018,0.00008381629,0.0011544012,0.0004022159,0.00026334552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009488156,0.00022171895,0.00023481998,0.0002143781,0.00040296334,0.000250105,0.0013293683,0.00026851482,0.001079223],"category_scores_gemma":[0.00058960053,0.00020224995,0.000090325986,0.00019553577,0.0005283651,0.000021058051,0.0005640467,0.00080454815,0.00013646242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004858587,0.00012627151,0.032182902,0.00006525608,0.00007368188,0.000026512362,0.000077611374,0.0001031025,0.9590407,0.00007317948,0.0036235685,0.0041213236],"study_design_scores_gemma":[0.0024202284,0.00058516505,0.25605276,0.00016782338,0.0000072556572,0.0000075154844,0.00018726768,0.00014559513,0.6658315,0.00048598737,0.07358856,0.0005203389],"about_ca_topic_score_codex":0.00866136,"about_ca_topic_score_gemma":0.008512732,"teacher_disagreement_score":0.29320922,"about_ca_system_score_codex":0.00027761454,"about_ca_system_score_gemma":0.0014795287,"threshold_uncertainty_score":0.99983394},"labels":[],"label_agreement":null},{"id":"W2740892462","doi":"10.1158/1538-7445.am2017-5447","title":"Abstract 5447: A microRNA signature for the classification of renal cell carcinoma subtypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; University Health Network; Western University; St. Michael's Hospital; London Health Sciences Centre","funders":"","keywords":"Chromophobe cell; Oncocytoma; Renal oncocytoma; Clear cell; Renal cell carcinoma; Pathology; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Medicine; Kidney cancer; Biology","score_opus":0.1489919598155708,"score_gpt":0.4105002076269631,"score_spread":0.26150824781139226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740892462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98169357,0.007116794,0.000021793297,0.0047652987,0.000108605585,0.0011660694,0.000060653707,0.000007609842,0.0050596157],"genre_scores_gemma":[0.9942471,0.00024535807,0.000078423625,0.000026353007,0.0003375496,0.00034684237,0.00002096101,0.0000259929,0.004671465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986341,0.000038450988,0.00018834688,0.0002924994,0.00050688226,0.0003397215],"domain_scores_gemma":[0.99781716,0.00032818655,0.00014718041,0.0009818351,0.00061536743,0.00011027226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006810606,0.00011030197,0.00019727716,0.00008880542,0.00043460814,0.00005636754,0.0003814314,0.00011091446,0.00020801192],"category_scores_gemma":[0.0001675027,0.000067794856,0.00012974802,0.00008250513,0.00036787192,0.000059061946,0.000071299124,0.00040342734,0.000022894414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009482523,0.00009549751,0.009553444,0.00032632847,0.000051777053,0.000018860157,0.00019077904,0.0000044288895,0.9664395,0.00007893849,0.013546131,0.008746062],"study_design_scores_gemma":[0.00087546627,0.0002007889,0.48090908,0.00005666251,0.00004509576,0.000002721203,0.000104338185,0.000030710577,0.51127857,0.000053358002,0.0063993344,0.00004386488],"about_ca_topic_score_codex":0.0009690791,"about_ca_topic_score_gemma":0.00018192641,"teacher_disagreement_score":0.47135565,"about_ca_system_score_codex":0.00024498263,"about_ca_system_score_gemma":0.00053935545,"threshold_uncertainty_score":0.33426982},"labels":[],"label_agreement":null},{"id":"W2740897264","doi":"10.1158/1538-7445.am2017-130","title":"Abstract 130: Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Erg; Prostate cancer; Cancer research; Cancer; Biology; Genetics; Biochemistry","score_opus":0.06609275750511132,"score_gpt":0.39553695194516914,"score_spread":0.3294441944400578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740897264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360234,0.0018902005,0.0000033185272,0.0029477275,0.00007232225,0.00090639654,0.00016528934,0.0000051525626,0.00040722967],"genre_scores_gemma":[0.9925673,0.006057478,0.000032260672,0.000012455905,0.000096141055,0.00025450604,0.000033087385,0.000024367984,0.00092237786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99836296,0.00009538575,0.00029166188,0.00028234292,0.0005195259,0.00044811136],"domain_scores_gemma":[0.99898386,0.00010899711,0.00018425313,0.0003693491,0.00026686373,0.000086685046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011847472,0.00011835398,0.00028127834,0.00020139481,0.0002837811,0.000092130875,0.00023970184,0.0000605047,0.00006641453],"category_scores_gemma":[0.00014890726,0.000076143406,0.000044403696,0.00020120379,0.0006417837,0.00023462369,0.00020218024,0.00039361848,0.0000012347274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007538832,0.00006426921,0.15930669,0.0006171404,0.000060492028,0.00004742458,0.0014022734,0.0000041620588,0.8309768,0.00007937892,0.000035608067,0.006651907],"study_design_scores_gemma":[0.0017132101,0.000114832066,0.6173874,0.0011385357,0.000012512274,0.0000015345734,0.0005752182,0.00004778229,0.37852034,0.00013728204,0.00027124299,0.000080054626],"about_ca_topic_score_codex":0.0021822029,"about_ca_topic_score_gemma":0.000524091,"teacher_disagreement_score":0.45808077,"about_ca_system_score_codex":0.00020702262,"about_ca_system_score_gemma":0.0005323987,"threshold_uncertainty_score":0.32988527},"labels":[],"label_agreement":null},{"id":"W2740904755","doi":"10.1158/1538-7445.am2017-4688","title":"Abstract 4688: AVID200: a novel computationally-designed TGF beta trap promoting anti-tumor T cell activity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; National Research Council Canada","funders":"","keywords":"Cancer research; Cancer immunotherapy; Immunotherapy; CD8; T cell; TGF beta signaling pathway; Immune system; Transforming growth factor beta; Tumor progression; Medicine; Immunology; Biology; Chemistry; Cancer; Receptor; Internal medicine","score_opus":0.0902593332430274,"score_gpt":0.4227910147309898,"score_spread":0.3325316814879624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740904755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949149,0.0006033459,0.00024744784,0.00073333207,0.00009038589,0.00066396745,0.00015980094,0.0000139631,0.002572866],"genre_scores_gemma":[0.9979832,0.00022008488,0.00017656256,0.00003537724,0.00040103172,0.00026212868,0.00006650576,0.000042128348,0.00081296347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764276,0.00008590222,0.00016574291,0.0006451015,0.00068551477,0.00077500223],"domain_scores_gemma":[0.9984459,0.000050590137,0.00012698473,0.0007211925,0.00037075373,0.00028456253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072549813,0.00019012051,0.00020087001,0.00009458093,0.0009277069,0.00030876044,0.00068951846,0.00010630719,0.00011695894],"category_scores_gemma":[0.0001306791,0.000179259,0.000113577975,0.000098160854,0.000340222,0.000025628928,0.00033148067,0.00036580296,0.00004780613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027080902,0.00038568937,0.0048385453,0.00009666419,0.00008892542,0.00004091489,0.00005558935,0.000031051128,0.9812343,0.000010976264,0.0013434491,0.011603081],"study_design_scores_gemma":[0.002101068,0.00032156275,0.11831761,0.00006355867,0.000009213781,0.0000068473933,0.00002190681,0.000079785845,0.87397826,0.000051549872,0.0048262514,0.00022236312],"about_ca_topic_score_codex":0.0023932229,"about_ca_topic_score_gemma":0.000908866,"teacher_disagreement_score":0.11347906,"about_ca_system_score_codex":0.00014736742,"about_ca_system_score_gemma":0.00092396745,"threshold_uncertainty_score":0.730997},"labels":[],"label_agreement":null},{"id":"W2740909577","doi":"10.1158/1538-7445.am2017-1254","title":"Abstract 1254: Mechanistic interrogation of pre-treatment low dose aspirin effects in HER 2 positive breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aspirin; Angiogenesis; Medicine; Cancer; Metastasis; Cancer research; Breast cancer; Lymphangiogenesis; Stromal cell; Immunohistochemistry; Pathology; Internal medicine; Pharmacology","score_opus":0.034328561958357456,"score_gpt":0.41153298043717024,"score_spread":0.3772044184788128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740909577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966363,0.000440472,0.0000074763634,0.00042576253,0.00035487572,0.0012949964,0.00006126074,0.0000142522795,0.0007646291],"genre_scores_gemma":[0.9981733,0.00019327301,0.000014041924,0.000028609675,0.0003664636,0.00065089576,0.000012830071,0.00003052012,0.0005300411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998356,0.00012271418,0.00022818956,0.00032154206,0.0005240934,0.00044748132],"domain_scores_gemma":[0.9986962,0.00019419398,0.00012580649,0.00049711217,0.00029748998,0.00018916627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000619313,0.00016516601,0.00036096876,0.00021884748,0.00015340072,0.0000378114,0.00017849202,0.00012420064,0.0003674423],"category_scores_gemma":[0.00010857851,0.00012922888,0.00007597273,0.00011559358,0.00019638955,0.00013246854,0.000079762125,0.00033573492,0.00003937046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008027997,0.0012417661,0.12411203,0.0049748016,0.0004478659,0.0014206127,0.0045912475,0.00009234093,0.6564963,0.0005336972,0.0006013583,0.19746],"study_design_scores_gemma":[0.0027472551,0.0005112693,0.7663616,0.0029587462,0.000032522858,0.000007758027,0.0000688039,0.00023784155,0.22683981,0.00007963381,0.000050891922,0.00010390339],"about_ca_topic_score_codex":0.010325976,"about_ca_topic_score_gemma":0.0036190844,"teacher_disagreement_score":0.6422495,"about_ca_system_score_codex":0.0013370787,"about_ca_system_score_gemma":0.00078475627,"threshold_uncertainty_score":0.99626434},"labels":[],"label_agreement":null},{"id":"W2740911729","doi":"10.1158/1538-7445.am2017-2277","title":"Abstract 2277: Adherence to cancer prevention guidelines and risk of cancer among older white and black adults in the Health ABC Study","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Cancer prevention; Body mass index; Population; Internal medicine; Gerontology; Environmental health","score_opus":0.15363071001183895,"score_gpt":0.5207439133782833,"score_spread":0.3671132033664444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740911729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792444,0.014264178,0.000003340152,0.0033506965,0.00013286005,0.0028501188,0.00006027851,0.000006622404,0.00008747136],"genre_scores_gemma":[0.9422961,0.05644559,0.000019588457,0.00010243566,0.00027373232,0.0005449152,0.000002127478,0.000017342043,0.0002981899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997574,0.00028691068,0.00043155643,0.00043638825,0.0007965268,0.00047462483],"domain_scores_gemma":[0.99822545,0.000084002844,0.00018896184,0.0006774119,0.0005238455,0.00030029792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034204992,0.00013808411,0.00043026236,0.00016877252,0.00037319525,0.000058998405,0.00021602285,0.00007300904,0.000099322795],"category_scores_gemma":[0.0004150558,0.00008890274,0.00006706347,0.00021794926,0.00028619435,0.000109189146,0.00011812736,0.0005535768,0.0000022463798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037058454,0.00008985124,0.85880405,0.0005601163,0.00009216562,0.000008282187,0.007194491,0.000030115218,0.000025246163,7.466282e-7,0.0020696074,0.13075472],"study_design_scores_gemma":[0.002294082,0.00053449103,0.9908866,0.0016596364,0.00004558641,0.0000011582422,0.0035444023,0.000046097386,0.00005993461,0.000009761684,0.00083532324,0.000082885475],"about_ca_topic_score_codex":0.31613103,"about_ca_topic_score_gemma":0.2761204,"teacher_disagreement_score":0.13208257,"about_ca_system_score_codex":0.00018218136,"about_ca_system_score_gemma":0.0008455254,"threshold_uncertainty_score":0.73708856},"labels":[],"label_agreement":null},{"id":"W2740916795","doi":"10.1158/1538-7445.am2017-lb-018","title":"Abstract LB-018: Cleavage of SNX2 protein by initiator caspases promotes hepatocyte growth factor (MET) receptor tyrosine kinase signaling","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Endosome; Sorting nexin; Cell biology; Caspase; Receptor tyrosine kinase; Biology; Hepatocyte growth factor; Apoptosis; Programmed cell death; Cancer research; Chemistry; Signal transduction; Receptor; Intracellular; Biochemistry","score_opus":0.07470650958841293,"score_gpt":0.37714479386882077,"score_spread":0.30243828428040787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740916795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953801,0.0023996225,0.000017439677,0.00037648308,0.00009719179,0.00062485517,0.0006128048,0.00001160064,0.0004798747],"genre_scores_gemma":[0.99801916,0.0005295199,0.0001099554,0.00004041343,0.00041601917,0.00019899814,0.00011804659,0.000040679537,0.00052720046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981773,0.0001525386,0.00028946256,0.00053930277,0.00028546588,0.00055593415],"domain_scores_gemma":[0.9984372,0.000046829675,0.00019171379,0.0007057233,0.0004435487,0.00017493723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052001706,0.00020157837,0.00027081964,0.000083574734,0.0003770565,0.000087483546,0.000614696,0.0002496484,0.00035484962],"category_scores_gemma":[0.0007644906,0.00017646255,0.00010493974,0.000080411635,0.0005218355,0.0000146250895,0.00032448414,0.00032636378,0.000019205538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037519657,0.00010441857,0.0045401673,0.00015823652,0.000060997598,0.000011640047,0.000050026123,1.7086785e-7,0.9862532,0.000052738615,0.0039850846,0.004408093],"study_design_scores_gemma":[0.00060237374,0.00068819337,0.0025112282,0.00012850293,0.000005401249,0.0000016142877,0.000053622738,0.0000019014265,0.97973484,0.0000376559,0.01602724,0.00020743799],"about_ca_topic_score_codex":0.0017821448,"about_ca_topic_score_gemma":0.00021503809,"teacher_disagreement_score":0.012042156,"about_ca_system_score_codex":0.000052185555,"about_ca_system_score_gemma":0.00034178115,"threshold_uncertainty_score":0.7195934},"labels":[],"label_agreement":null},{"id":"W2740928213","doi":"10.1158/1538-7445.am2017-2650","title":"Abstract 2650: Radioimmunotherapy for acute myeloid leukemia targeting human aspartyl (asparaginyl) β-hydroxylase","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Radioimmunotherapy; Monoclonal antibody; Myeloid leukemia; Cancer research; Medicine; Leukemia; Antibody; Flow cytometry; Myeloid; Immunoconjugate; Immunology","score_opus":0.14791145025782482,"score_gpt":0.5129920384086425,"score_spread":0.3650805881508177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740928213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814897,0.0015853784,0.0000885611,0.006141067,0.000097042066,0.0010083166,0.00009002366,0.00006871296,0.009431163],"genre_scores_gemma":[0.987758,0.00090688147,0.00026696725,0.000218058,0.0011744559,0.0011241783,0.000082385544,0.000051824874,0.008417264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981181,0.00002244861,0.00027365595,0.0004568535,0.00043855843,0.00069037813],"domain_scores_gemma":[0.9982207,0.00015170904,0.00010366489,0.000904624,0.00027943766,0.00033987142],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0008335536,0.00016847465,0.0002982802,0.00006231455,0.0016494963,0.00017258244,0.0005192495,0.00013576414,0.0009012256],"category_scores_gemma":[0.00016225339,0.00015294955,0.0001390438,0.00010286557,0.0004986047,0.00014256325,0.00007255272,0.0007779959,0.00006505617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034881744,0.00007158278,0.00051808206,0.00017459446,0.00019416976,0.000031602212,0.0000884188,0.000012454524,0.96758795,0.00039325023,0.025949666,0.0046294373],"study_design_scores_gemma":[0.0027233833,0.00008751942,0.005040338,0.00013058275,0.000066887784,0.000012796068,0.0000383422,0.00025875264,0.77699924,0.0006396679,0.21381322,0.00018930205],"about_ca_topic_score_codex":0.00016621566,"about_ca_topic_score_gemma":0.000004373511,"teacher_disagreement_score":0.1905887,"about_ca_system_score_codex":0.00048492113,"about_ca_system_score_gemma":0.0004295065,"threshold_uncertainty_score":0.99965024},"labels":[],"label_agreement":null},{"id":"W2740934573","doi":"10.1158/1538-7445.am2017-lb-257","title":"Abstract LB-257: Estrogen signaling in mature luminal and luminal progenitor cells of BRCA2 carriers and non-carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Progenitor cell; Biology; Cancer research; Breast cancer; Estrogen receptor; Transcriptome; Population; Cancer; Stem cell; Cell biology; Gene expression; Genetics; Gene; Medicine","score_opus":0.030816978603551936,"score_gpt":0.3696765034863338,"score_spread":0.33885952488278187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740934573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950621,0.0037842114,0.000005805229,0.0002185182,0.00020984469,0.00033973277,0.00009239828,0.0000025146428,0.00028483837],"genre_scores_gemma":[0.9982299,0.0005836994,0.00031663728,0.000016318103,0.00050172576,0.000121092104,0.000012316,0.000026847076,0.0001914529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986241,0.00005089982,0.00019475326,0.00044571052,0.0002916107,0.00039295707],"domain_scores_gemma":[0.9990528,0.000023860714,0.00010125617,0.0004495115,0.00021403641,0.00015850412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005668915,0.00013784383,0.0001729834,0.00010318602,0.0002584779,0.000091907896,0.00033141347,0.00019909274,0.000026301219],"category_scores_gemma":[0.000109764915,0.00014126401,0.00004041893,0.000082622966,0.0007761876,0.000013685323,0.00022404653,0.00031896064,0.0000011605161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019473353,0.000014814692,0.032908194,0.00015602866,0.000056315905,0.000014928232,0.00042416493,0.00004778493,0.96198773,0.000004812454,0.0008959802,0.0032945117],"study_design_scores_gemma":[0.0006822417,0.00012955659,0.029279314,0.00009226865,0.0000140072025,0.000008240817,0.00095908623,0.00002254344,0.964817,0.0000408728,0.0037932233,0.0001616739],"about_ca_topic_score_codex":0.00061417656,"about_ca_topic_score_gemma":0.00025812114,"teacher_disagreement_score":0.0036288782,"about_ca_system_score_codex":0.00011666442,"about_ca_system_score_gemma":0.000742009,"threshold_uncertainty_score":0.5760579},"labels":[],"label_agreement":null},{"id":"W2740941930","doi":"10.1158/1538-7445.am2017-3337","title":"Abstract 3337: The G protein-coupled P2Y6 pyrimidoceptor increases tumorigenesis potential of epithelial cell in colorectal cancer associated to colitis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Carcinogenesis; Inflammatory bowel disease; Colitis; Cancer research; Azoxymethane; Immune system; Inflammation; Colorectal cancer; Biology; Proinflammatory cytokine; Cancer; Immunology; Medicine; Pathology; Internal medicine; Disease","score_opus":0.02884557585202011,"score_gpt":0.347744286281552,"score_spread":0.3188987104295319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740941930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675393,0.001460579,0.000005627525,0.00048475587,0.00012352293,0.00066171854,0.00021912807,0.0000049801083,0.00028573407],"genre_scores_gemma":[0.9975933,0.00038618554,0.00001261818,0.000039272254,0.0006495589,0.0005335902,0.000024876206,0.000028635546,0.000731973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835926,0.00013557097,0.00024436507,0.00034880408,0.00041431663,0.00049767183],"domain_scores_gemma":[0.99895644,0.000040061663,0.00014191006,0.00035607463,0.00038372874,0.00012179245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007461965,0.00013953529,0.00020516687,0.00007550677,0.00035273994,0.000069409325,0.00067074335,0.00013552715,0.0003425369],"category_scores_gemma":[0.00032868044,0.00011134345,0.00008422658,0.00013480538,0.0002342096,0.000008067453,0.00029771842,0.00022680065,0.000007904741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066884496,0.000109009634,0.005617791,0.000038337672,0.000050807153,0.000017523835,0.00007032709,0.00036236196,0.99049,0.0000053343897,0.0022482786,0.0003213846],"study_design_scores_gemma":[0.00071812276,0.00017275898,0.13349229,0.000082588325,0.0000114529685,8.097186e-7,0.000104878134,0.00004245689,0.8644769,0.0000213033,0.00074089004,0.00013552049],"about_ca_topic_score_codex":0.036065105,"about_ca_topic_score_gemma":0.0030898324,"teacher_disagreement_score":0.12787451,"about_ca_system_score_codex":0.000102819606,"about_ca_system_score_gemma":0.00068165833,"threshold_uncertainty_score":0.97035384},"labels":[],"label_agreement":null},{"id":"W2740952463","doi":"10.1158/1538-7445.am2017-1300","title":"Abstract 1300: Genetic predictors of gene expression associated with risk of colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome-wide association study; Colorectal cancer; Genotyping; Single-nucleotide polymorphism; Biology; Genetic association; Expression quantitative trait loci; Transcriptome; Gene; Genetics; False discovery rate; Genotype; Cancer; Gene expression","score_opus":0.06334997067141335,"score_gpt":0.38762337301824423,"score_spread":0.3242734023468309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740952463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521405,0.0024408994,0.000004487141,0.00017100763,0.00014337934,0.00058885524,0.00027000104,0.000016134496,0.0011511736],"genre_scores_gemma":[0.9956026,0.0034135038,0.00013266606,0.000008125683,0.00017668692,0.000374624,0.000009419848,0.00003848152,0.00024390162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774396,0.00009625468,0.0003097872,0.0003418881,0.0010818506,0.00042624873],"domain_scores_gemma":[0.99784404,0.000113369766,0.0004023545,0.0005546678,0.00089375256,0.00019183815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061391405,0.00014270478,0.00043490983,0.00013766823,0.00026873522,0.000025853897,0.00035058983,0.00014220735,0.0008450664],"category_scores_gemma":[0.00038234657,0.00010186473,0.00009511835,0.00019587015,0.000635462,0.000084070234,0.00010023897,0.00045461158,0.0000024327608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008355351,0.00016316898,0.6717306,0.00015352436,0.00025374297,0.000008584837,0.00027363998,0.0000572643,0.32150733,0.0000010434818,0.0016485141,0.00336706],"study_design_scores_gemma":[0.0010476207,0.00039487574,0.5588771,0.0007518662,0.00007076629,5.475982e-7,0.000056396253,0.000025437792,0.4386001,0.000004543225,0.00011203781,0.0000586937],"about_ca_topic_score_codex":0.0055736853,"about_ca_topic_score_gemma":0.0010156365,"teacher_disagreement_score":0.11709277,"about_ca_system_score_codex":0.0002661518,"about_ca_system_score_gemma":0.0008165184,"threshold_uncertainty_score":0.92528844},"labels":[],"label_agreement":null},{"id":"W2740970948","doi":"10.1158/1538-7445.am2017-3903","title":"Abstract 3903: Targeting oral cancer stem cells in the hypoxic niche by BCG infected mesenchymal stem cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer stem cell; Mesenchymal stem cell; Cancer research; Stem cell; Tumor microenvironment; Tumor hypoxia; Cancer cell; Biology; Immunology; Cancer; Medicine; Immune system; Cell biology; Internal medicine; Radiation therapy","score_opus":0.0665809149755679,"score_gpt":0.3990948049661024,"score_spread":0.3325138899905345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740970948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897674,0.0068147047,0.000004059043,0.00088102545,0.0002443684,0.0008180024,0.00037671276,0.000011419107,0.0010823519],"genre_scores_gemma":[0.9909309,0.005053095,0.000009469789,0.00009668389,0.00036361665,0.0007022173,0.000042173804,0.000048474605,0.0027533513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654037,0.00038220698,0.0002976716,0.00072307873,0.0008653867,0.0011912843],"domain_scores_gemma":[0.9982295,0.00008641218,0.00013385035,0.001033937,0.00027517494,0.00024112359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013792041,0.00026671737,0.00026064483,0.000102536455,0.0007121095,0.0003898615,0.0013026076,0.00021746857,0.00020841465],"category_scores_gemma":[0.000042495492,0.00019844936,0.00012104706,0.0002219888,0.00046224595,0.0000274505,0.0004571416,0.00073188375,0.00006490284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026254458,0.00015270838,0.012129446,0.00007283712,0.00011070759,0.00006010316,0.00016431077,0.00004046413,0.91851395,0.0000054885854,0.052418604,0.016068848],"study_design_scores_gemma":[0.0014737106,0.000232446,0.0063052936,0.00006835656,0.000010727753,0.00000197185,0.00028616915,0.000024181969,0.92996365,0.000023184177,0.06135936,0.00025094853],"about_ca_topic_score_codex":0.01530188,"about_ca_topic_score_gemma":0.0069275075,"teacher_disagreement_score":0.015817901,"about_ca_system_score_codex":0.00027793614,"about_ca_system_score_gemma":0.0007385709,"threshold_uncertainty_score":0.9912553},"labels":[],"label_agreement":null},{"id":"W2740994490","doi":"10.1158/1538-7445.am2017-1898","title":"Abstract 1898: MEG3 as a competing endogenous RNA binds with miR-27a to promote PHLPP2 protein translation, and consequently impairs bladder cancer invasion","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Competing endogenous RNA; Bladder cancer; MEG3; Cancer research; Metastasis; Downregulation and upregulation; Cancer; Cancer cell; Biology; Translation (biology); Long non-coding RNA; Messenger RNA; Gene","score_opus":0.11893552469883022,"score_gpt":0.3847096783543609,"score_spread":0.26577415365553064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740994490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071753,0.0031585956,0.000051435112,0.0024684314,0.000044691154,0.0012521265,0.00008020601,0.000013037138,0.0022139358],"genre_scores_gemma":[0.9967199,0.00054350984,0.00035044938,0.00010201094,0.00022834342,0.0011618042,0.000026395286,0.000043988675,0.00082358095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982134,0.000075283824,0.00020553413,0.0005975081,0.00040353945,0.0005047389],"domain_scores_gemma":[0.99850726,0.000014265659,0.00011054263,0.0006732423,0.00044697485,0.0002477254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005831401,0.00018458639,0.00017308004,0.00009211746,0.0008386573,0.00024192367,0.00040016466,0.0001287001,0.00017229028],"category_scores_gemma":[0.00007868296,0.0001546308,0.000041656793,0.00012217739,0.00035964735,0.000020269144,0.00011537595,0.00026363885,0.000013971017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037157463,0.000043450375,0.0008966944,0.00006837074,0.000081728074,0.000013834595,0.00047890024,0.00003603947,0.96683735,0.00002820442,0.0003347051,0.030809168],"study_design_scores_gemma":[0.0012445893,0.0005527176,0.0052772015,0.00027500163,0.000018642966,0.000020939891,0.00024262108,0.000027549107,0.95868,0.000072014256,0.033265185,0.0003235482],"about_ca_topic_score_codex":0.005265145,"about_ca_topic_score_gemma":0.0024769534,"teacher_disagreement_score":0.03293048,"about_ca_system_score_codex":0.00009198301,"about_ca_system_score_gemma":0.00089944893,"threshold_uncertainty_score":0.7959359},"labels":[],"label_agreement":null},{"id":"W2741004392","doi":"10.1158/1538-7445.am2017-2795","title":"Abstract 2795: Integrating multiomics discovery approaches to identify biomarkers of therapeutic resistance in metastatic colorectal cancer through analyses of multiple sequential tumor and liquid biopsies; Qcroc01: NCT00984048","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Moncton Hospital; Mount Sinai Hospital; Jewish General Hospital; Sunnybrook Health Science Centre; Dr. Georges-L.-Dumont University Hospital Centre; Hôpital Maisonneuve-Rosemont; St Mary's Hospital Centre; McGill University Health Centre; Simon Fraser University; Hôpital du Sacré-Cœur de Montréal; Hôtel-Dieu de Québec; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal; Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Colorectal cancer; Metastasis; Cancer; Transcriptome; Loss of heterozygosity; Liquid biopsy; KRAS; Medicine; Somatic evolution in cancer; Oncology; Cancer research; Biology; Pathology; Internal medicine; Gene; Genetics; Allele; Gene expression","score_opus":0.23143409669182835,"score_gpt":0.45066006132125985,"score_spread":0.2192259646294315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741004392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909921,0.007194034,0.00027055724,0.00022848854,0.00013448654,0.00049193896,0.0005110271,0.0000026349373,0.000174716],"genre_scores_gemma":[0.9962447,0.0023013765,0.001009966,0.000029195668,0.0000916022,0.00020733693,0.000030886462,0.00003088816,0.00005403768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828905,0.00009848444,0.0004320106,0.00049870275,0.00028721907,0.0003945538],"domain_scores_gemma":[0.9987912,0.00017017734,0.00027276136,0.00047102667,0.00021102671,0.00008377852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006310764,0.00018739582,0.00035921985,0.00015015445,0.00018478215,0.00012599236,0.0004622665,0.000082464714,0.000010949601],"category_scores_gemma":[0.0006210759,0.00017244236,0.00009802793,0.00019851631,0.0006279257,0.00003560483,0.0003557009,0.00018838256,4.5229558e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018704648,0.0000904311,0.012547571,0.0002675594,0.00024932294,0.0000065424692,0.0004777754,0.0003684848,0.98306733,0.00012479625,0.00009833875,0.00083136495],"study_design_scores_gemma":[0.00094900746,0.00020274772,0.04863497,0.0002449827,0.00003972643,0.0000010694296,0.00077841093,0.00014970211,0.94828606,0.0001459932,0.00036540854,0.00020192527],"about_ca_topic_score_codex":0.0132915275,"about_ca_topic_score_gemma":0.032699604,"teacher_disagreement_score":0.036087397,"about_ca_system_score_codex":0.00012071094,"about_ca_system_score_gemma":0.00052790355,"threshold_uncertainty_score":0.99327904},"labels":[],"label_agreement":null},{"id":"W2741056151","doi":"10.1158/1538-7445.am2017-2653","title":"Abstract 2653: The anti-myeloma activity of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, is enhanced when combined with a proteasome inhibitor","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Cancer research; Bortezomib; Phagocytosis; Macrophage; Proteasome inhibitor; Immune system; Immunology; Multiple myeloma; Medicine; Biology; In vitro; Biochemistry","score_opus":0.06647886095438363,"score_gpt":0.3651098816259278,"score_spread":0.2986310206715441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741056151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261236,0.002912126,0.000027620172,0.0022147095,0.00021875679,0.0010849069,0.000032047854,0.000026134885,0.0008713131],"genre_scores_gemma":[0.99739426,0.0003311474,0.000012484622,0.000040713832,0.00006988697,0.00031337314,0.000007617106,0.000034691366,0.0017958332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981953,0.00029091362,0.00027981677,0.0003995833,0.00022084112,0.0006135804],"domain_scores_gemma":[0.99780655,0.00017999265,0.0003703797,0.0011957191,0.00041993512,0.00002742094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009935427,0.00021152539,0.00041455857,0.00012473627,0.0012958134,0.00012818449,0.0008673177,0.0002211288,0.0006299846],"category_scores_gemma":[0.00008718215,0.00013710053,0.00011031546,0.00013405608,0.0011342923,0.00033866498,0.00025451856,0.0007677627,0.000055666093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015554425,0.00016107167,0.0016377335,0.000068731366,0.00033855104,0.0000014747316,0.001393883,0.000002198979,0.9665308,0.00009206826,0.0004602087,0.027757822],"study_design_scores_gemma":[0.0017884097,0.00031451124,0.19683334,0.00025108227,0.00001870465,0.0000039031715,0.000111836656,0.0000053094545,0.7964472,0.00011293203,0.0039710086,0.00014177189],"about_ca_topic_score_codex":0.0014145547,"about_ca_topic_score_gemma":0.00013240568,"teacher_disagreement_score":0.1951956,"about_ca_system_score_codex":0.00013916104,"about_ca_system_score_gemma":0.0003861439,"threshold_uncertainty_score":0.99664795},"labels":[],"label_agreement":null},{"id":"W2741060852","doi":"10.1158/1538-7445.am2017-2964","title":"Abstract 2964: Stromal Hedgehog pathway activation suppresses growth and metastases of lung adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyclopamine; Paracrine signalling; Sonic hedgehog; Autocrine signalling; Cancer research; Hedgehog signaling pathway; Stromal cell; Adenocarcinoma; Biology; Smoothened; Lung cancer; Cell culture; Cancer; Internal medicine; Cell biology; Signal transduction; Medicine; Receptor","score_opus":0.0816974495336739,"score_gpt":0.3913524634962764,"score_spread":0.3096550139626025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741060852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455816,0.0040369867,0.000034372217,0.00038968152,0.000068212306,0.00021299148,0.000117575146,0.0000095771275,0.0005724571],"genre_scores_gemma":[0.9986893,0.0007295172,0.00007356593,0.000015906995,0.00026514457,0.000070625734,0.000026326428,0.000030187148,0.000099422454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998716,0.0000871505,0.00017349739,0.00037469427,0.0003099809,0.00033867374],"domain_scores_gemma":[0.99889964,0.00007099577,0.00011222204,0.00049387256,0.0003324563,0.00009083486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004555458,0.00013057968,0.00018604044,0.000078778816,0.0003591862,0.000080113336,0.00035814598,0.00009691399,0.000021808508],"category_scores_gemma":[0.0007574396,0.00011838333,0.000050262097,0.000051065632,0.0004988387,0.000016641045,0.00037956113,0.00017407125,0.0000010879734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000123223,0.000033874763,0.035899058,0.0002199896,0.00010324582,0.0000055861324,0.00010809902,0.000004081036,0.9611295,0.00010806625,0.00120013,0.0010651776],"study_design_scores_gemma":[0.00033756747,0.00013587947,0.16244537,0.00006713487,0.000008949613,0.0000014099807,0.00012724719,0.000003465886,0.8358463,0.00005552181,0.0008702638,0.00010089904],"about_ca_topic_score_codex":0.0006134848,"about_ca_topic_score_gemma":0.00006942995,"teacher_disagreement_score":0.12654631,"about_ca_system_score_codex":0.000020229274,"about_ca_system_score_gemma":0.00020471762,"threshold_uncertainty_score":0.4827532},"labels":[],"label_agreement":null},{"id":"W2741071796","doi":"10.1158/1538-7445.am2017-608","title":"Abstract 608: Augmenting and broadening T cell responses against mutated tumour neo-antigens","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CTL*; Antigen; Immunology; Cytotoxic T cell; Immune system; Immunotherapy; Vaccination; Context (archaeology); Cancer immunotherapy; FOXP3; Tumor antigen; Cancer research; Biology; Medicine; CD8; In vitro; Genetics","score_opus":0.11606581956224846,"score_gpt":0.4364360629494028,"score_spread":0.32037024338715436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741071796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98361826,0.0041893143,0.000002369984,0.003009412,0.00018141851,0.00039521747,0.000019638177,0.000040746938,0.008543615],"genre_scores_gemma":[0.9867017,0.0033091025,0.00007284228,0.00016312173,0.00027915233,0.000047436737,0.0000075628323,0.00003729224,0.009381768],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981414,0.000082945255,0.00023966629,0.00038911973,0.0005395204,0.0006073659],"domain_scores_gemma":[0.9987978,0.00015306243,0.00011947124,0.0005128207,0.0002247657,0.00019213294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001323794,0.00014514285,0.00023481857,0.00020780116,0.0010648653,0.0002952686,0.00025439268,0.00009688414,0.00035385176],"category_scores_gemma":[0.00025314113,0.0001139015,0.000075129916,0.00014100967,0.00047109625,0.00016270166,0.00015268681,0.0005406838,0.000029366569],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027541043,0.00004065477,0.018984465,0.00018443656,0.000079453544,0.00022719709,0.000528374,0.0000011490539,0.9258714,0.0000021909952,0.0033444716,0.04798214],"study_design_scores_gemma":[0.0036445907,0.00017881811,0.5030547,0.00075063546,0.000024796971,0.00002683619,0.0007322084,0.00006191354,0.46265334,0.000016872324,0.028637484,0.00021780893],"about_ca_topic_score_codex":0.0019231687,"about_ca_topic_score_gemma":0.00012961555,"teacher_disagreement_score":0.48407024,"about_ca_system_score_codex":0.00019296892,"about_ca_system_score_gemma":0.0004724108,"threshold_uncertainty_score":0.8190191},"labels":[],"label_agreement":null},{"id":"W2741082662","doi":"10.1158/1538-7445.am2017-5423","title":"Abstract 5423: ZAP70 alters metabolism in chronic lymphocytic leukemic cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"","keywords":"ZAP70; Biology; Chronic lymphocytic leukemia; Pyruvate kinase; Cell biology; Cancer research; CD8; Natural killer T cell; Biochemistry; Immunology; Antigen; Glycolysis; Metabolism; Leukemia","score_opus":0.049079860496525615,"score_gpt":0.38121187120493916,"score_spread":0.3321320107084135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741082662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964342,0.030281106,0.00001046247,0.00018870174,0.0016028575,0.00038192776,0.00005060731,0.000010331059,0.0031319894],"genre_scores_gemma":[0.9656452,0.025847584,0.00003482699,0.000114654504,0.0041737705,0.00021884186,0.000022389624,0.00005053668,0.0038922117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764895,0.00009524943,0.00026294612,0.00065095146,0.00043859074,0.0009033231],"domain_scores_gemma":[0.9982993,0.000022567416,0.000108630666,0.0011842082,0.0001688402,0.00021645229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085298606,0.00020977517,0.0002858042,0.00016230292,0.0003542274,0.00016487687,0.0009842705,0.00021691984,0.0002078096],"category_scores_gemma":[0.00009787773,0.00020687365,0.00012828826,0.00011958814,0.0004257665,0.000019260648,0.00036629863,0.0004010167,0.000097166296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013806812,0.000015775771,0.00009942026,0.00006718321,0.00003960363,0.000007490261,0.00007049271,0.00035329215,0.9680262,0.000048808713,0.011387447,0.019746175],"study_design_scores_gemma":[0.0018482371,0.000045381254,0.013893501,0.00006261003,0.000011134395,0.0000035986675,0.000044276174,0.00004624608,0.5431582,0.00008173747,0.440563,0.00024213652],"about_ca_topic_score_codex":0.0060093417,"about_ca_topic_score_gemma":0.002658907,"teacher_disagreement_score":0.42917556,"about_ca_system_score_codex":0.0010595268,"about_ca_system_score_gemma":0.003669966,"threshold_uncertainty_score":0.9084367},"labels":[],"label_agreement":null},{"id":"W2741084470","doi":"10.1158/1538-7445.am2017-3265","title":"Abstract 3265: Characterization of epithelial oral dysplasia in non-smokers: working towards precision medicine","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Cancer; Epithelial dysplasia; Disease; Dysplasia; Internal medicine; Loss of heterozygosity; Pathology; Oncology; Biology; Genetics; Gene; Allele","score_opus":0.17289892679785004,"score_gpt":0.49013928218586206,"score_spread":0.317240355388012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741084470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951215,0.0001542408,0.000016985863,0.0010029064,0.0008664472,0.00043361506,0.000041412994,0.000010194777,0.0023527243],"genre_scores_gemma":[0.9980652,0.00045805014,0.000036472116,0.000020217378,0.0003233259,0.000101533034,0.000029942144,0.000016329013,0.00094896584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826425,0.00014593394,0.00034922065,0.00030618842,0.0005235905,0.0004107837],"domain_scores_gemma":[0.9989425,0.00008500135,0.00018873681,0.00051645166,0.00017021956,0.0000971039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016048828,0.000108419794,0.0002818791,0.00021216107,0.0003078596,0.00003083797,0.00037172102,0.00018179468,0.00065006776],"category_scores_gemma":[0.00022616985,0.00008749259,0.000032015065,0.00015226855,0.00032612807,0.00018289844,0.0001379071,0.000471592,0.00011380578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015107363,0.00025043945,0.4427507,0.00034433388,0.000040327774,0.0006606267,0.0013556596,0.0000049501523,0.17013824,0.00017682028,0.00035415633,0.38241303],"study_design_scores_gemma":[0.0015160015,0.00016082982,0.97696996,0.0007691784,0.000006346692,0.00000481486,0.000051100516,0.000026256794,0.019223938,0.00021921395,0.0009870273,0.00006531507],"about_ca_topic_score_codex":0.002890215,"about_ca_topic_score_gemma":0.0014560109,"teacher_disagreement_score":0.53421926,"about_ca_system_score_codex":0.00023940625,"about_ca_system_score_gemma":0.00019731444,"threshold_uncertainty_score":0.7117786},"labels":[],"label_agreement":null},{"id":"W2741098695","doi":"10.1158/1538-7445.am2017-5433","title":"Abstract 5433: β-Tubulin inhibitors reduce GLUT1 membrane trafficking to attenuate tumorigenesis in glioblastoma subtypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"GLUT1; Carcinogenesis; Cancer research; Downregulation and upregulation; Mesenchymal stem cell; Warburg effect; Biology; Cancer cell; Tumor microenvironment; Cancer stem cell; Stem cell; Cancer; Cell biology; Glucose transporter; Chemistry; Biochemistry; Endocrinology; Genetics; Tumor cells; Gene","score_opus":0.04383007522533303,"score_gpt":0.3727595579142421,"score_spread":0.32892948268890904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741098695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991667,0.004202824,0.00000385802,0.00132414,0.0014361006,0.0004379717,0.000041567175,0.000015529811,0.0008710417],"genre_scores_gemma":[0.9907191,0.0031778894,0.00004298877,0.00009646687,0.0040270993,0.00022169402,0.000009641094,0.000056198332,0.0016489642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754995,0.0000947759,0.0003026933,0.0007353137,0.0004924405,0.00082481065],"domain_scores_gemma":[0.9983886,0.00002739009,0.000095821575,0.0009323994,0.0002670774,0.00028869516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010750262,0.0002155653,0.00028197333,0.00023304668,0.00042329892,0.00017673882,0.00078985275,0.00018788874,0.00010374541],"category_scores_gemma":[0.0003969935,0.00021682346,0.0001083553,0.0002371491,0.00022688136,0.0000178914,0.00032183737,0.00035762932,0.00006831966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059115177,0.000055866618,0.000903165,0.00006284384,0.000028205086,0.000016041009,0.00021213078,0.0002512667,0.95728767,0.000012105518,0.0076749683,0.03290458],"study_design_scores_gemma":[0.0007190488,0.0001267121,0.026434625,0.00012711369,0.0000068571685,0.0000051430234,0.00013184875,0.0000062047607,0.8171918,0.000013905282,0.15497808,0.00025870517],"about_ca_topic_score_codex":0.0021522695,"about_ca_topic_score_gemma":0.006349988,"teacher_disagreement_score":0.1473031,"about_ca_system_score_codex":0.00011179514,"about_ca_system_score_gemma":0.0005225962,"threshold_uncertainty_score":0.8841804},"labels":[],"label_agreement":null},{"id":"W2741105765","doi":"10.1158/1538-7445.am2017-3080","title":"Abstract 3080: Y-box binding protein 1 is crucial in acquiring drug resistance in advanced renal cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Cancer research; Metastasis; Cancer; Tumor microenvironment; Medicine; Cancer cell; Cell culture; Secretion; Malignancy; Drug resistance; Cell; Pharmacology; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.08336362563502914,"score_gpt":0.3939532803539316,"score_spread":0.3105896547189025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741105765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727197,0.0024195754,7.734589e-7,0.002217841,0.00010452669,0.001660615,0.000020765981,0.00002000866,0.020836158],"genre_scores_gemma":[0.9805986,0.00012776103,0.0004332219,0.000026206255,0.00024910757,0.0007562351,0.0000084129,0.000060825532,0.017739592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964166,0.00012549853,0.00047603133,0.00081321754,0.0010825866,0.0010860474],"domain_scores_gemma":[0.9981081,0.00010032402,0.00016385573,0.0011311416,0.00021112025,0.0002854578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012737802,0.00026204225,0.00048166304,0.0006081409,0.0003919104,0.0001447424,0.00056143134,0.00013596816,0.00035974878],"category_scores_gemma":[0.00021977324,0.00024484604,0.00010416783,0.0003871015,0.00028773112,0.00031508226,0.00026847716,0.0010586756,0.00010400839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002513017,0.00022511926,0.09909633,0.00076246663,0.000016046915,0.002560079,0.0017805925,0.000009296114,0.8875313,0.000036757447,0.0013707265,0.0040982957],"study_design_scores_gemma":[0.0037782,0.000093739596,0.31757122,0.0013469117,0.0000067115493,0.0000026283112,0.00022293997,0.0000050929384,0.6755707,0.0001461185,0.0010582963,0.00019744394],"about_ca_topic_score_codex":0.0025286435,"about_ca_topic_score_gemma":0.0042105266,"teacher_disagreement_score":0.21847488,"about_ca_system_score_codex":0.0020615687,"about_ca_system_score_gemma":0.00083285006,"threshold_uncertainty_score":0.9984532},"labels":[],"label_agreement":null},{"id":"W2741116527","doi":"10.1158/1538-7445.am2017-2709","title":"Abstract 2709: Evaluation of CD37 expression and binding of AGS67E, an antibody-drug conjugate (ADC) against CD37, on white blood cells (WBCs) collected from phase I non-Hodgkin lymphoma (NHL) patients","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Antibody-drug conjugate; Flow cytometry; Antibody; Lymphoma; Internal medicine; Pharmacology; Immunology; Cancer research; Monoclonal antibody","score_opus":0.08431074331432094,"score_gpt":0.45560902501239237,"score_spread":0.37129828169807144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741116527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938458,0.00040442892,0.0000022622107,0.00007556026,0.00022193103,0.0021611643,0.00058890495,0.000022492288,0.0026774616],"genre_scores_gemma":[0.9976381,0.00100271,0.00010458812,0.000023749864,0.00020644299,0.00014726307,0.00038942663,0.000078021556,0.0004096706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934258,0.00049784867,0.0007311474,0.0008793624,0.003650959,0.00081487745],"domain_scores_gemma":[0.99451345,0.00048317216,0.0005192362,0.001601802,0.0023622669,0.00052009907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031250494,0.0003112704,0.0007242006,0.0006425772,0.0005586343,0.0001394302,0.00065401813,0.00024742968,0.00046580523],"category_scores_gemma":[0.0011651586,0.00027110148,0.000106814245,0.00043821987,0.0007666582,0.00039033467,0.00038424548,0.0004772223,0.000023502747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0036433546,0.001779398,0.008047765,0.0005275816,0.00018779692,0.00006604602,0.0015866294,0.00007469297,0.9617996,0.0000024819533,0.0013497727,0.02093486],"study_design_scores_gemma":[0.07429463,0.0011189957,0.07038896,0.0027267388,0.00013467636,0.0000018711304,0.0003217919,0.009381104,0.8412581,0.000028590724,0.00010859258,0.00023592552],"about_ca_topic_score_codex":0.005396929,"about_ca_topic_score_gemma":0.00028951044,"teacher_disagreement_score":0.12054149,"about_ca_system_score_codex":0.0040044347,"about_ca_system_score_gemma":0.008203636,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2741118473","doi":"10.1158/1538-7445.am2017-2104","title":"Abstract 2104: <i>In vitro</i> drug effects on cancer cell morphology and functional state revealed by multiparameter imaging mass cytometry","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Cisplatin; Cancer research; Cancer cell; Biology; Chemistry; Molecular biology; Cell biology; Cancer; Chemotherapy","score_opus":0.023909035780181838,"score_gpt":0.3724915394158087,"score_spread":0.3485825036356269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741118473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508977,0.002064559,0.00059592276,0.0012179487,0.00008382821,0.00037721678,0.00012451911,0.000014282484,0.00043194002],"genre_scores_gemma":[0.99444664,0.0023885833,0.0009145161,0.00033113366,0.00013845167,0.000299716,0.00004837913,0.000028584678,0.0014040156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987299,0.0000578195,0.00013288672,0.0005067184,0.00017567025,0.00039700686],"domain_scores_gemma":[0.9991517,0.00006881839,0.00007852806,0.0004985426,0.00010617058,0.00009625845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032783952,0.00013522487,0.00013715772,0.000056461628,0.0002889806,0.000063509855,0.00020319242,0.00007790403,0.000012850904],"category_scores_gemma":[0.000058387923,0.00012697435,0.00003550426,0.000058153644,0.00024057843,0.000010616519,0.00015081717,0.00030650094,0.000004327061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021467851,0.000034317363,0.0024566525,0.000037467853,0.0000082637935,0.0000078991125,0.000007863719,0.000010155378,0.97437036,0.0000028839302,0.010159061,0.012690399],"study_design_scores_gemma":[0.0006093193,0.000032782733,0.009699778,0.000038729646,0.0000029248258,0.0000018312231,0.000009761268,0.000039665214,0.977022,0.00018944393,0.012208901,0.00014488028],"about_ca_topic_score_codex":0.0007844234,"about_ca_topic_score_gemma":0.00009602896,"teacher_disagreement_score":0.012545519,"about_ca_system_score_codex":0.00009682563,"about_ca_system_score_gemma":0.000066334156,"threshold_uncertainty_score":0.5177864},"labels":[],"label_agreement":null},{"id":"W2741141842","doi":"10.1158/1538-7445.am2017-1429","title":"Abstract 1429: DNA damage response to dianhydrogalactitol (VAL-083) in p53-deficient non-small cell lung cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"T790M; Carboplatin; KRAS; Cancer research; Lung cancer; Cisplatin; Medicine; DNA damage; Cancer; non-small cell lung cancer (NSCLC); Cytotoxicity; Oncology; A549 cell; Internal medicine; Biology; Chemotherapy; DNA; Genetics; In vitro; Colorectal cancer","score_opus":0.050340795519868066,"score_gpt":0.3982538258673498,"score_spread":0.3479130303474817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741141842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97808325,0.0016993675,0.000034739205,0.005119298,0.0009895138,0.002539706,0.0001398335,0.00005696207,0.011337304],"genre_scores_gemma":[0.9905564,0.0007842297,0.00010578072,0.000304764,0.00045311372,0.001076265,0.0000092552555,0.0001453104,0.0065648467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951313,0.00024849977,0.0005172011,0.0011023621,0.0014034424,0.0015971726],"domain_scores_gemma":[0.9959622,0.0002693957,0.00017745722,0.002220349,0.0005077852,0.0008628034],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025850143,0.0003789905,0.0005818915,0.0008772239,0.00055153866,0.00026553514,0.00095426396,0.00033859815,0.0010876661],"category_scores_gemma":[0.000522304,0.00037816557,0.00018830539,0.0006838298,0.00030596828,0.00017741315,0.0005521583,0.0018392889,0.0004919077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034405957,0.00028068677,0.0049091172,0.00044153564,0.000053133434,0.0011961024,0.001739033,0.0010827436,0.9685877,0.0000050004546,0.01581264,0.002451695],"study_design_scores_gemma":[0.004482118,0.00036208195,0.14214511,0.0016583788,0.000058861602,0.0000075187777,0.00032557134,0.0005510204,0.8141673,0.000007643186,0.035738327,0.0004960483],"about_ca_topic_score_codex":0.012231881,"about_ca_topic_score_gemma":0.0048135025,"teacher_disagreement_score":0.15442039,"about_ca_system_score_codex":0.002960307,"about_ca_system_score_gemma":0.0031404663,"threshold_uncertainty_score":0.999867},"labels":[],"label_agreement":null},{"id":"W2741152687","doi":"10.1158/1538-7445.am2017-2447","title":"Abstract 2447: The mutational landscape of chemo-refractory Burkitt lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Institute; Fraser Health; Simon Fraser University; Université de Montréal; McGill University","funders":"","keywords":"Cancer research; Lymphoma; Biology; Mutation; Exome sequencing; Missense mutation; Medicine; Genetics; Immunology; Gene","score_opus":0.10027272897972947,"score_gpt":0.4331984253548513,"score_spread":0.3329256963751218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741152687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96749866,0.0021475814,3.529514e-7,0.005091375,0.00011343085,0.0002931403,0.000032369677,0.000008826077,0.02481429],"genre_scores_gemma":[0.9972634,0.0006287717,0.000017751989,0.000083891384,0.00033722562,0.00018842536,0.000015349695,0.000013451748,0.0014517771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998679,0.000026928508,0.0001498983,0.00019281382,0.00068793836,0.00026343644],"domain_scores_gemma":[0.99865496,0.00019543614,0.00008789325,0.0006302522,0.00032284355,0.00010863636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044584397,0.00008373013,0.00017025905,0.00006560088,0.0003760548,0.000057089466,0.0002649741,0.00005848519,0.0011316026],"category_scores_gemma":[0.00021755496,0.00004941702,0.00008124092,0.00006706925,0.00033051014,0.00007326725,0.00008771541,0.00011145997,0.00009996742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009328116,0.0021127926,0.5135884,0.00042792136,0.0007867742,0.0005166828,0.0013944159,0.000012228032,0.027268486,0.0021817712,0.07758952,0.3731882],"study_design_scores_gemma":[0.0022689921,0.00010210468,0.94495475,0.00012410125,0.000024534604,0.000012285851,0.00013423324,0.000014823219,0.031716768,0.00014835622,0.020450264,0.000048773087],"about_ca_topic_score_codex":0.0015990282,"about_ca_topic_score_gemma":0.00008219685,"teacher_disagreement_score":0.43136635,"about_ca_system_score_codex":0.00021738713,"about_ca_system_score_gemma":0.00068601704,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W2741169533","doi":"10.1158/1538-7445.am2017-1454","title":"Abstract 1454: Estrogen receptor signaling in FTE of BRCA mutation carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Estrogen receptor; Biology; Carcinogenesis; Estrogen; Cancer research; Ovarian cancer; Fulvestrant; Estrogen receptor alpha; Cancer; Genetics; Breast cancer","score_opus":0.1244530271342358,"score_gpt":0.4584024839307533,"score_spread":0.3339494567965175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741169533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265003,0.0014159294,0.0000012832089,0.0027220757,0.00013202973,0.00044261856,0.000037930768,0.000007525042,0.002590575],"genre_scores_gemma":[0.99859303,0.0005899278,0.00015490898,0.000024486946,0.00018485518,0.0002123713,0.000012838836,0.000018519739,0.00020906114],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987215,0.000038226823,0.00020565414,0.0002516791,0.0004741236,0.00030881818],"domain_scores_gemma":[0.9990102,0.000091349466,0.00009254585,0.0004353443,0.00023220814,0.00013832733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059452676,0.00008260159,0.0002199213,0.00015651979,0.00014917798,0.000042060296,0.00015287029,0.000068325244,0.00080059917],"category_scores_gemma":[0.00020061554,0.00007282034,0.00005985409,0.00012022556,0.00017251872,0.00010005397,0.000042453597,0.00025568358,0.000028948192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010817228,0.00046138495,0.6337185,0.0006527984,0.0003414804,0.00040671678,0.002208945,0.000214572,0.21824345,0.00069550314,0.004026061,0.13794887],"study_design_scores_gemma":[0.004525966,0.00040629078,0.48704353,0.0012704877,0.000045298777,0.00000415313,0.0005943876,0.00003007514,0.50021183,0.0002881203,0.00543252,0.00014733308],"about_ca_topic_score_codex":0.0050609023,"about_ca_topic_score_gemma":0.0002911574,"teacher_disagreement_score":0.28196838,"about_ca_system_score_codex":0.0005040355,"about_ca_system_score_gemma":0.0006065908,"threshold_uncertainty_score":0.87659997},"labels":[],"label_agreement":null},{"id":"W2741228199","doi":"10.1158/1538-7445.am2017-ct116","title":"Abstract CT116: BMS-986205, an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic (PD) activity, alone and in combination with nivolumab (nivo) in advanced cancers in a phase 1/2a trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacology; Nivolumab; Pharmacodynamics; In vivo; Pharmacokinetics; Adverse effect; Cancer; Cancer research; Internal medicine; Immunotherapy; Biology","score_opus":0.06802588785724402,"score_gpt":0.4034455019186154,"score_spread":0.3354196140613714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741228199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579287,0.00013982208,0.000013416772,0.00088301656,0.00012971694,0.0025659653,0.00006092931,0.00003744555,0.00037680712],"genre_scores_gemma":[0.99830306,0.00055377214,0.00005812703,0.00012414565,0.000056370827,0.0006302497,0.000012017309,0.000059857684,0.00020239763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99623257,0.00043095526,0.00039300806,0.0011059663,0.0009138951,0.00092357746],"domain_scores_gemma":[0.99858636,0.00019255345,0.00023343806,0.00058923685,0.0001377228,0.00026070004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085847714,0.00034306754,0.0005424563,0.00080564164,0.0003386842,0.00024553694,0.0005884177,0.0001416923,0.00011873917],"category_scores_gemma":[0.00020986203,0.00030392347,0.000033838693,0.0009866161,0.0006359458,0.0012746118,0.00015662776,0.001113918,0.0000055158525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21003212,0.0026463824,0.00093285745,0.00013862422,0.00001662411,0.0007174668,0.0012415003,0.004430421,0.75183827,0.000008255294,0.00008288822,0.027914591],"study_design_scores_gemma":[0.34362248,0.002610754,0.023889918,0.0006020676,0.0000048712336,0.0000112656635,0.0005268381,0.021261077,0.6066787,0.000056425437,0.0000961599,0.00063942396],"about_ca_topic_score_codex":0.010006634,"about_ca_topic_score_gemma":0.02737657,"teacher_disagreement_score":0.14515956,"about_ca_system_score_codex":0.0009943204,"about_ca_system_score_gemma":0.0009426245,"threshold_uncertainty_score":0.9999413},"labels":[],"label_agreement":null},{"id":"W2741242877","doi":"10.1158/1538-7445.am2017-5507","title":"Abstract 5507: Investigation of the effects of alterations in the glutamate receptor, GRIK2 on osteosarcoma tumorigenesis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Osteosarcoma; Cancer research; Biology; Carcinogenesis; Tumor suppressor gene; CDKN2A; Cancer; Pathology; Medicine; Genetics","score_opus":0.03710673174183232,"score_gpt":0.3585288758298723,"score_spread":0.32142214408804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741242877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979412,0.00045017994,0.0000019736624,0.0007800863,0.00012316194,0.0004387642,0.000023177041,0.0000011919509,0.00024029033],"genre_scores_gemma":[0.9994975,0.00014010651,0.000012216745,0.0000306528,0.00010932413,0.00010941262,0.000017075463,0.000008524648,0.0000752278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990455,0.00022551136,0.00014840576,0.00015494335,0.00028473794,0.00014088095],"domain_scores_gemma":[0.9989297,0.00007504858,0.0001236685,0.00069771404,0.00014699808,0.000026890786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005458574,0.000061061866,0.00007166349,0.000042791737,0.0001977754,0.000029444089,0.00049247674,0.00005806825,0.0000129358705],"category_scores_gemma":[0.0004492329,0.00003932114,0.000048311293,0.00009309793,0.00028230966,0.0000060609163,0.00009272534,0.00010774991,0.000002597559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051914198,0.000024770661,0.010656801,0.00012530727,0.000010807987,4.1311006e-7,0.00014730604,0.000039830655,0.9869265,0.00014898898,0.0009310448,0.00093633315],"study_design_scores_gemma":[0.00015663667,0.000048887225,0.35210785,0.00010565037,0.0000026834314,2.005467e-7,0.000018300232,0.00000439078,0.64709526,0.0001334815,0.00030038372,0.000026253276],"about_ca_topic_score_codex":0.00034034654,"about_ca_topic_score_gemma":0.00021969403,"teacher_disagreement_score":0.34145105,"about_ca_system_score_codex":0.00003336748,"about_ca_system_score_gemma":0.00018158149,"threshold_uncertainty_score":0.16034697},"labels":[],"label_agreement":null},{"id":"W2741245320","doi":"10.1158/1538-7445.am2017-ct075","title":"Abstract CT075: Overall survival (OS) results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naïve patients with advanced melanoma (CheckMate 067)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Placebo; Hazard ratio; Oncology; Gastroenterology; Cancer; Immunotherapy; Confidence interval; Pathology","score_opus":0.06454676551010405,"score_gpt":0.3935429647153974,"score_spread":0.3289961992052933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741245320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260795,0.00028858407,0.0000015763414,0.0005319189,0.00026971253,0.0027427175,0.0009340172,0.000029533003,0.0025940035],"genre_scores_gemma":[0.9973155,0.00072179356,0.00007316449,0.00002100841,0.00014957786,0.00032392095,0.0003420864,0.00006305497,0.0009898735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99655527,0.0001492805,0.00064788805,0.00073143217,0.0011933119,0.00072281546],"domain_scores_gemma":[0.9972251,0.0002735664,0.00044829978,0.0013633205,0.00047181698,0.00021791687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006752751,0.00034235656,0.0008690629,0.0002611901,0.00028581574,0.0000894135,0.00042135076,0.00015733184,0.00035722338],"category_scores_gemma":[0.00013272035,0.00023661758,0.00012723393,0.0002544485,0.00057889376,0.0003103579,0.00007579215,0.0004300475,0.000007878902],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93391156,0.0028677795,0.010720823,0.000064356886,0.0006115,0.00012078672,0.00092623464,0.00000762927,0.010721288,0.0000063578773,0.00022902268,0.03981267],"study_design_scores_gemma":[0.7277348,0.019085763,0.24009226,0.0009072899,0.00007210392,9.853159e-7,0.0002304047,0.000028303404,0.010270478,0.00002360068,0.0012720166,0.0002820067],"about_ca_topic_score_codex":0.030924348,"about_ca_topic_score_gemma":0.011161885,"teacher_disagreement_score":0.22937144,"about_ca_system_score_codex":0.0009664787,"about_ca_system_score_gemma":0.0011399095,"threshold_uncertainty_score":0.97552884},"labels":[],"label_agreement":null},{"id":"W2741250293","doi":"10.1158/1538-7445.am2017-5831","title":"Abstract 5831: Activated Wnt signaling for the treatment of recurrent medulloblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cancer research; Cancer stem cell; SOX2; Biology; CD44; Stem cell; Beta-catenin; Medicine; Signal transduction; Cell biology; Transcription factor; Gene; In vitro; Genetics","score_opus":0.09780445104124628,"score_gpt":0.43266921253532953,"score_spread":0.33486476149408323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741250293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572134,0.002888538,0.00005996244,0.00049370655,0.00011961754,0.00056295557,0.00005857966,0.0000028262757,0.0000925025],"genre_scores_gemma":[0.99818206,0.0008886177,0.00003673183,0.000003959841,0.0003220633,0.00032089598,0.000028047823,0.000014535101,0.00020310792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927217,0.000030730855,0.00011273569,0.00020485297,0.0001746145,0.00020488794],"domain_scores_gemma":[0.9990454,0.000054381282,0.00009128931,0.0004977687,0.0002570403,0.00005412507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002544435,0.00007497842,0.00008279677,0.000026356238,0.0003304276,0.000040314066,0.0002839961,0.00006195251,0.00004566003],"category_scores_gemma":[0.000113592454,0.000051047256,0.0000850923,0.000027659169,0.00017337874,0.0000032138914,0.000046968566,0.000044629705,0.0000022552488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043597247,0.00008563484,0.00015648289,0.00003204741,0.000097543496,4.480174e-7,0.000037770882,0.0000899678,0.9638997,0.000023397064,0.00089094107,0.034250095],"study_design_scores_gemma":[0.0005154189,0.0003051284,0.0075599146,0.000035194924,0.00001232878,3.0145347e-7,0.00004051643,0.00003735711,0.9654517,0.000048585574,0.025939096,0.00005444063],"about_ca_topic_score_codex":0.00014721068,"about_ca_topic_score_gemma":0.000084528816,"teacher_disagreement_score":0.034195654,"about_ca_system_score_codex":0.00008540496,"about_ca_system_score_gemma":0.0001880712,"threshold_uncertainty_score":0.25414154},"labels":[],"label_agreement":null},{"id":"W2741264910","doi":"10.1158/1538-7445.am2017-4997","title":"Abstract 4997: Specialized microRNP and translation mechanisms in quiescent cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"EIF4G; Translation (biology); Eukaryotic translation; Biology; EIF4E; Internal ribosome entry site; microRNA; Protein biosynthesis; Eukaryotic translation initiation factor 4 gamma; Downregulation and upregulation; Messenger RNA; Translational regulation; Cell biology; Molecular biology; Gene; Genetics","score_opus":0.1103781148992685,"score_gpt":0.415954662981745,"score_spread":0.3055765480824765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741264910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98250085,0.012219541,0.000016387517,0.0017516692,0.0009804772,0.0004041329,0.00005965287,0.000015495698,0.00205178],"genre_scores_gemma":[0.99021167,0.0053960434,0.0000181504,0.000049985367,0.000055447417,0.00010374227,0.000007212137,0.000017354238,0.004140424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987162,0.00021383012,0.00020709976,0.00029721236,0.00007027457,0.0004954339],"domain_scores_gemma":[0.9993696,0.00011002835,0.00006537186,0.00033965544,0.00008799348,0.000027319218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006976027,0.00012275325,0.00021962533,0.00018383138,0.000453702,0.00009314011,0.00034192382,0.00019301714,0.00297206],"category_scores_gemma":[0.000050660194,0.00010992353,0.000043618733,0.00005625548,0.00040532768,0.00013074747,0.00010117707,0.0005362267,0.00018263604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001115507,0.000043534048,0.000231909,0.000035918438,0.00003580522,0.000007654151,0.0006362287,7.6013924e-7,0.9602276,0.00032611378,0.0018280207,0.035510942],"study_design_scores_gemma":[0.0016535186,0.000065933746,0.023130797,0.00016110935,0.0000051175025,0.0000027118294,0.00021649779,0.0000014665956,0.9272021,0.00022248614,0.04721506,0.00012318789],"about_ca_topic_score_codex":0.0064318012,"about_ca_topic_score_gemma":0.003335692,"teacher_disagreement_score":0.04538704,"about_ca_system_score_codex":0.00015295373,"about_ca_system_score_gemma":0.00021026163,"threshold_uncertainty_score":0.99793935},"labels":[],"label_agreement":null},{"id":"W2741290782","doi":"10.1158/1538-7445.am2017-5669","title":"Abstract 5669: Targeting post-surgical breast cancer metastasis through combining natural killer T cell immunotherapy and low dose chemotherapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Immunotherapy; Metastasis; Cancer research; Cyclophosphamide; Cancer; Metastatic breast cancer; Natural killer T cell; Gemcitabine; Breast cancer; Immunology; Immune system; Chemotherapy; T cell; Internal medicine","score_opus":0.033052100796363386,"score_gpt":0.3625150090815346,"score_spread":0.3294629082851712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741290782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582184,0.027881818,0.0000035841172,0.0049906713,0.005302705,0.0003643904,0.00003155854,0.000057084617,0.003149797],"genre_scores_gemma":[0.97069436,0.0118384175,0.000019792573,0.00037331088,0.00019555083,0.00010980799,0.00005443152,0.000047970858,0.016666377],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981158,0.00023000764,0.00031454585,0.0004925687,0.00014265682,0.00070444425],"domain_scores_gemma":[0.99870193,0.00018510401,0.0002008241,0.0004930453,0.00037799703,0.000041070027],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069242244,0.0002476706,0.00034494782,0.000115109026,0.0016220849,0.0002376655,0.000443743,0.0002392016,0.011407563],"category_scores_gemma":[0.000038898303,0.00020313686,0.00013244466,0.000095163174,0.0005891887,0.0005632274,0.00015310053,0.0013325261,0.0002494047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025384238,0.00016256885,0.0011945466,0.00005774233,0.00031143785,0.000013784005,0.0011720344,0.0000045613706,0.93393725,0.000074442636,0.021256166,0.039277054],"study_design_scores_gemma":[0.009734358,0.00023290736,0.06040856,0.00029424252,0.000028077384,0.00012064294,0.0014990501,0.000025305979,0.42292687,0.000060157254,0.50404716,0.0006226457],"about_ca_topic_score_codex":0.0058810674,"about_ca_topic_score_gemma":0.00005675004,"teacher_disagreement_score":0.51101035,"about_ca_system_score_codex":0.00018165282,"about_ca_system_score_gemma":0.00017322684,"threshold_uncertainty_score":0.99967766},"labels":[],"label_agreement":null},{"id":"W2741305525","doi":"10.1158/1538-7445.am2017-2445","title":"Abstract 2445: Integrative genetic analysis identifies therapeutic relevance of cell of origin-specific genetic alterations in diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"PTEN; Diffuse large B-cell lymphoma; Biology; Cancer research; Tissue microarray; Germinal center; Population; Cancer; Lymphoma; Genetics; PI3K/AKT/mTOR pathway; Oncology; B cell; Medicine; Immunology; Signal transduction","score_opus":0.07320957182474293,"score_gpt":0.3995682224925213,"score_spread":0.32635865066777836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741305525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847172,0.0127796,0.000057458357,0.00020138336,0.00008211185,0.0005558169,0.00010115935,0.0000067709907,0.00149848],"genre_scores_gemma":[0.98398256,0.014246966,0.00024637574,0.0000158989,0.000060293354,0.00026085656,0.00001757663,0.000021964606,0.0011475309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791276,0.00011567178,0.00048851455,0.00042658247,0.0006383728,0.00041807248],"domain_scores_gemma":[0.9977938,0.0002968734,0.00024069543,0.0010612118,0.00048636523,0.00012105472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032848958,0.000179016,0.0005425959,0.00052531034,0.000203804,0.00007491948,0.0003500987,0.00008481721,0.00026865472],"category_scores_gemma":[0.000055126042,0.00013691382,0.00020823124,0.00054924004,0.00033373034,0.000096379794,0.000090808295,0.0001531239,0.000028642733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072757807,0.01567352,0.72497416,0.0006632641,0.0011519637,0.0003081421,0.0047600823,0.00013455174,0.22398204,0.00035843506,0.0008406225,0.026425652],"study_design_scores_gemma":[0.006205947,0.00016249633,0.78507006,0.00018218867,0.0001824586,0.0000010476847,0.000388847,0.00016050844,0.20660834,0.00013058892,0.0008113116,0.000096218886],"about_ca_topic_score_codex":0.0026948284,"about_ca_topic_score_gemma":0.0024614562,"teacher_disagreement_score":0.060095888,"about_ca_system_score_codex":0.00042454313,"about_ca_system_score_gemma":0.0004070654,"threshold_uncertainty_score":0.5583184},"labels":[],"label_agreement":null},{"id":"W2741345495","doi":"10.1158/1538-7445.am2017-ct039","title":"Abstract CT039: INDUCE-1: a phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with selected, advanced solid tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Tolerability; Pharmacokinetics; Immunogenicity; Antibody; Pharmacodynamics; Immunotherapy; CD28; Internal medicine; Cancer; Oncology; Agonist; Pharmacology; T cell; Immunology; Adverse effect; Receptor; Immune system","score_opus":0.09170124266370266,"score_gpt":0.46638821067488734,"score_spread":0.3746869680111847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741345495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959918,0.00014821063,7.6068875e-7,0.00020145267,0.000029815616,0.0033812704,0.00003369163,0.000010003122,0.00020295753],"genre_scores_gemma":[0.99932355,0.00009609119,0.000038798644,0.00002285604,0.000016158327,0.00032592154,0.000070753194,0.00004068827,0.0000652057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977283,0.00014335623,0.0004039871,0.0005320207,0.0007288797,0.00046344358],"domain_scores_gemma":[0.9982822,0.000046244506,0.00025699372,0.00068243936,0.0005749348,0.00015716862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819758,0.00020217372,0.00054210384,0.00039219222,0.0002710805,0.000167346,0.00042926558,0.00007666193,0.00003885065],"category_scores_gemma":[0.00007960606,0.00015741575,0.00001024681,0.000558204,0.00039503997,0.0005594955,0.00013195713,0.00049833057,7.2867755e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17526306,0.022605069,0.693554,0.0002680452,0.00016587494,0.00019865127,0.0025576132,0.0000034974014,0.06375692,0.000003344903,0.000022537903,0.041601405],"study_design_scores_gemma":[0.14504121,0.017911049,0.8296299,0.0008530805,0.00001619494,0.0000054308007,0.0009139559,0.000037906142,0.0053966697,0.0000049433443,0.000020178466,0.0001694849],"about_ca_topic_score_codex":0.0063727987,"about_ca_topic_score_gemma":0.012484534,"teacher_disagreement_score":0.13607591,"about_ca_system_score_codex":0.00034799264,"about_ca_system_score_gemma":0.00091448316,"threshold_uncertainty_score":0.9633808},"labels":[],"label_agreement":null},{"id":"W2741351188","doi":"10.1158/1538-7445.am2017-3657","title":"Abstract 3657: Phosphatidylserine-targeting antibodies enhance anti-tumor activity of a tumor vaccine in a HPV-induced tumor model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Antibody; Antigen; CD8; Cytotoxic T cell; Tumor antigen; Cancer research; Immunotherapy; Immunology; Granzyme B; Immune system; Medicine; Biology; In vitro","score_opus":0.06949657368046472,"score_gpt":0.39754326005630786,"score_spread":0.3280466863758431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741351188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461013,0.0035748268,0.000016972353,0.0003314653,0.0002649111,0.00048961956,0.00004473131,0.000024946128,0.0006423704],"genre_scores_gemma":[0.99905264,0.00039401388,0.00003326261,0.000018741097,0.000050308114,0.000119248485,0.000012729657,0.000030764208,0.00028830464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794966,0.00017731928,0.00045276596,0.0005026548,0.00015592772,0.0007616436],"domain_scores_gemma":[0.9984394,0.00014491825,0.00031921585,0.0007331825,0.0003249458,0.000038341637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013244156,0.00022299845,0.0005878999,0.00024153592,0.0005745213,0.000057260466,0.0006834604,0.000105703344,0.00034154323],"category_scores_gemma":[0.00053993,0.0002024693,0.00010373156,0.0001842123,0.0002509911,0.0005228037,0.0003620491,0.0007434768,0.000047928483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052982604,0.00020542798,0.010026749,0.0001657633,0.000057676072,0.000015231424,0.00023457396,0.00012736808,0.98270446,0.00006437113,0.0003881371,0.0054804105],"study_design_scores_gemma":[0.00092063413,0.00006595257,0.31073302,0.0001887881,0.0000055016462,0.000003824437,0.00005834891,0.0005105654,0.6871527,0.00006746165,0.00015212697,0.00014105631],"about_ca_topic_score_codex":0.0040452867,"about_ca_topic_score_gemma":0.00038926405,"teacher_disagreement_score":0.30070627,"about_ca_system_score_codex":0.00017241319,"about_ca_system_score_gemma":0.00040180492,"threshold_uncertainty_score":0.8256458},"labels":[],"label_agreement":null},{"id":"W2741360647","doi":"10.1158/1538-7445.am2017-1643","title":"Abstract 1643: Cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; CD8; Hazard ratio; Proportional hazards model; Oncology; Internal medicine; Immune system; Multivariate analysis; Lymphocyte; Cytotoxic T cell; CD3; Cancer; Urology; Immunology; Confidence interval; Biology","score_opus":0.04157411918238067,"score_gpt":0.3824690089953049,"score_spread":0.3408948898129242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741360647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893651,0.0029798797,3.0638026e-7,0.0005661731,0.00018082505,0.0013915836,0.00004359722,0.000022220514,0.005450327],"genre_scores_gemma":[0.9961488,0.0009287707,0.000022518732,0.00014785884,0.00019236183,0.00094963424,0.000014156562,0.00005003125,0.0015458602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763286,0.00008477886,0.0002639586,0.0005207414,0.0008076924,0.0006899488],"domain_scores_gemma":[0.99862427,0.00009248642,0.00006296427,0.0007049203,0.00019542618,0.0003199508],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041633696,0.00021214937,0.0003464891,0.0002146295,0.00028972412,0.00015261983,0.00025626656,0.00015990391,0.0010550618],"category_scores_gemma":[0.00032329955,0.00017087064,0.00006624073,0.00013698768,0.0005165048,0.00020294837,0.00021416975,0.00051990274,0.00016255207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004784353,0.00032216698,0.9659638,0.00026651102,0.00010422179,0.00046220556,0.0002770598,1.5916656e-7,0.0016239926,0.0000071575037,0.00038753377,0.025800852],"study_design_scores_gemma":[0.009128906,0.0005468897,0.98353064,0.0008189849,0.000033119264,0.000011906161,0.0000312282,0.000005365921,0.0026897371,0.000094013005,0.0029534807,0.00015573192],"about_ca_topic_score_codex":0.0031020243,"about_ca_topic_score_gemma":0.00023854479,"teacher_disagreement_score":0.02564512,"about_ca_system_score_codex":0.00066433527,"about_ca_system_score_gemma":0.0007812341,"threshold_uncertainty_score":0.9998581},"labels":[],"label_agreement":null},{"id":"W2741366593","doi":"10.1158/1538-7445.am2017-2522","title":"Abstract 2522: MiRNA-652 induces neuroendocrine-like differentiation in LNCaP prostate cancer cells through decreased PP2A function","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Prostate cancer; LNCaP; Biochemical recurrence; microRNA; Metastasis; Cancer research; Cancer; Medicine; Oncogene; Blot; Proportional hazards model; Oncology; Prostatectomy; Transfection; Internal medicine; Biology; Cell culture; Cell cycle; Gene","score_opus":0.11484140774258013,"score_gpt":0.43149004823756554,"score_spread":0.3166486404949854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741366593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845458,0.0045754155,0.0000029830646,0.0058682524,0.00088480965,0.001880414,0.00009113387,0.000059327922,0.0020918201],"genre_scores_gemma":[0.97310203,0.01828374,0.00001852193,0.00016440966,0.0005242822,0.0013551818,0.00008837635,0.000072873816,0.006390579],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960386,0.00017015183,0.00040793867,0.0008144885,0.0013449654,0.0012238516],"domain_scores_gemma":[0.99784416,0.00013649947,0.00017726627,0.0009312885,0.00055153447,0.00035927448],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004857732,0.00030812438,0.000446462,0.00039178043,0.0007615126,0.0003370223,0.0004476742,0.00011402494,0.0012605992],"category_scores_gemma":[0.00015107678,0.00024497,0.00012319647,0.000413701,0.00044102463,0.00066013745,0.00022984276,0.0012028837,0.00011430463],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008399086,0.00098532,0.18637529,0.001196579,0.00034395544,0.0009177657,0.00128299,0.000050960953,0.721216,0.00007693104,0.016611198,0.0625439],"study_design_scores_gemma":[0.0075247795,0.00045536365,0.7193716,0.00081787194,0.0000649649,0.000007072927,0.00031407538,0.00009023541,0.2559269,0.0004285616,0.014693229,0.00030532668],"about_ca_topic_score_codex":0.016138505,"about_ca_topic_score_gemma":0.0025037453,"teacher_disagreement_score":0.5329963,"about_ca_system_score_codex":0.00096613506,"about_ca_system_score_gemma":0.0011841514,"threshold_uncertainty_score":0.9996524},"labels":[],"label_agreement":null},{"id":"W2741381450","doi":"10.1158/1538-7445.am2017-4419","title":"Abstract 4419: HER2 expression and 17β-estradiol induce ACSL4 expression in estrogen receptor positive mammary carcinoma cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Gene silencing; Arachidonic acid; Eicosapentaenoic acid; Biology; Polyunsaturated fatty acid; Endocrinology; Estrogen receptor; Internal medicine; Cell growth; Fatty acid; Biochemistry; Cancer; Breast cancer; Medicine","score_opus":0.049316861991788204,"score_gpt":0.3733886735445674,"score_spread":0.3240718115527792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741381450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946102,0.0016173108,0.000003373552,0.00060382555,0.00035389076,0.0009506372,0.000027475591,0.000026774816,0.0018065415],"genre_scores_gemma":[0.99748987,0.0007565397,0.00021109341,0.00005123073,0.0006641263,0.00024058006,0.000015970976,0.00004527726,0.00052529346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975243,0.00020971596,0.000275304,0.0005800861,0.0007035366,0.00070701435],"domain_scores_gemma":[0.99816775,0.00021406954,0.00012037913,0.0008196474,0.0001880935,0.00049004477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010928416,0.00022870315,0.00038224275,0.00025551068,0.0004654107,0.00013103081,0.00037441915,0.00029370748,0.0001391884],"category_scores_gemma":[0.0002432035,0.00018901753,0.00006285965,0.00011525443,0.0002923511,0.0004072025,0.00029855839,0.0010698201,0.0000513483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000612278,0.00017605096,0.046885822,0.0003092213,0.000012371432,0.0005745111,0.00078259717,6.094284e-7,0.9364177,0.000016736805,0.0044315285,0.009780578],"study_design_scores_gemma":[0.002791473,0.00017871486,0.26898623,0.0011907293,0.0000058760234,0.000012683424,0.0001360862,0.00001708112,0.7254526,0.000026866055,0.0010482821,0.00015337176],"about_ca_topic_score_codex":0.000776055,"about_ca_topic_score_gemma":0.00003102778,"teacher_disagreement_score":0.2221004,"about_ca_system_score_codex":0.00031862987,"about_ca_system_score_gemma":0.0005359133,"threshold_uncertainty_score":0.7707911},"labels":[],"label_agreement":null},{"id":"W2741390109","doi":"10.1158/1538-7445.am2017-2470","title":"Abstract 2470: Compromised BRCA1-PALB2 interaction is associated with breast cancer risk","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"PALB2; Missense mutation; Breast cancer; Genetics; Germline mutation; Biology; Cancer research; Exome sequencing; DNA repair; Exome; BRCA2 Protein; Germline; Mutation; Cancer; Gene","score_opus":0.0577600010823274,"score_gpt":0.41079406961094994,"score_spread":0.3530340685286225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741390109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926694,0.00071415375,0.000033145065,0.0020382472,0.0003859936,0.00038060555,0.0007010864,0.000017896697,0.0030594738],"genre_scores_gemma":[0.9947158,0.0014704183,0.000044464447,0.00014332456,0.00063856284,0.00043201723,0.000069187525,0.00005463899,0.002431602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99810076,0.0001125758,0.00019175326,0.0005946817,0.00048919045,0.00051106856],"domain_scores_gemma":[0.9977981,0.00004092411,0.00025229403,0.00092409475,0.00084134325,0.00014326794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057440455,0.00018299048,0.00017983449,0.00008587068,0.0008916973,0.0002484473,0.00062835,0.0001939849,0.0010506161],"category_scores_gemma":[0.0001828202,0.0001618518,0.00007291469,0.0001291282,0.00042342555,0.000024366236,0.00020457283,0.0005446611,0.000039712555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020116104,0.0003000819,0.14631471,0.00009534666,0.001348047,0.000028973313,0.00078443723,0.0009852041,0.6571784,0.00001768799,0.124642685,0.06629282],"study_design_scores_gemma":[0.0027723047,0.00019518798,0.6835356,0.00029253322,0.00005665945,0.000014628479,0.0002777039,0.00020327857,0.27459717,0.000090015266,0.037488487,0.00047643337],"about_ca_topic_score_codex":0.0042620213,"about_ca_topic_score_gemma":0.0051226537,"teacher_disagreement_score":0.5372209,"about_ca_system_score_codex":0.00060878217,"about_ca_system_score_gemma":0.00097056833,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W2741390687","doi":"10.1158/1538-7445.am2017-2697","title":"Abstract 2697: A role for the membrane type-1 matrix metalloproteinase in the transcriptional regulation of carcinogen-induced inflammasome components","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Inflammasome; Gene silencing; Microphthalmia-associated transcription factor; Cell biology; Biology; Inflammation; Transcriptional regulation; Matrix metalloproteinase; Signal transduction; Cancer research; Transcription factor; Chemistry; Immunology; Biochemistry; Gene","score_opus":0.13102589229283854,"score_gpt":0.41849685913848494,"score_spread":0.28747096684564644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741390687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943546,0.0010264515,0.0000038596213,0.0020012117,0.00019143996,0.002094939,0.000019851399,0.0000066520874,0.00030100092],"genre_scores_gemma":[0.99859947,0.000098697004,0.000019984544,0.000029821678,0.00042879218,0.00054153695,0.000018232284,0.000018933666,0.00024455675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983194,0.00012458146,0.00024981753,0.00019099128,0.00078759826,0.0003276274],"domain_scores_gemma":[0.9985053,0.00035473032,0.000103340295,0.0006252573,0.00034248678,0.00006890321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027223614,0.000105860214,0.00022535189,0.00012853568,0.00039762547,0.000044781264,0.00040232012,0.00009390716,0.00013499934],"category_scores_gemma":[0.00036128494,0.000060884904,0.00010246637,0.00013823273,0.00019728564,0.00011399245,0.000031350148,0.0003936878,0.000011851356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012991953,0.00005979584,0.004414611,0.00033614473,0.000057589987,0.0000135687915,0.00078625535,0.000037617083,0.9904631,0.000790814,0.00010532491,0.0016360244],"study_design_scores_gemma":[0.0021587475,0.00016900216,0.7104618,0.0001677026,0.000043242937,0.0000053619588,0.00019201354,0.0006033938,0.28239053,0.00025032918,0.0034857825,0.00007208446],"about_ca_topic_score_codex":0.0012450455,"about_ca_topic_score_gemma":0.0003243439,"teacher_disagreement_score":0.70807254,"about_ca_system_score_codex":0.00011018666,"about_ca_system_score_gemma":0.0003066816,"threshold_uncertainty_score":0.30582538},"labels":[],"label_agreement":null},{"id":"W2741399273","doi":"10.1158/1538-7445.am2017-2410","title":"Abstract 2410: Toward mutation analysis of regulatory elements: Epigenetic profiling of primary breast tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Breast cancer; Cancer research; Biology; Immune system; Computational biology; Cancer; Immunology; Genetics","score_opus":0.04923558668021001,"score_gpt":0.37539206395443464,"score_spread":0.32615647727422464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741399273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969572,0.0013772182,0.00009819367,0.000092832335,0.00006535713,0.00021310261,0.00032441618,0.000001915288,0.0008697809],"genre_scores_gemma":[0.9984249,0.000855604,0.00028760085,0.0000145659815,0.00012487301,0.000047527494,0.00014761154,0.000016114042,0.00008123957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987521,0.000036470457,0.00032574212,0.0002911816,0.00034473004,0.0002497409],"domain_scores_gemma":[0.9984561,0.000031116524,0.0002627334,0.0006833792,0.0004904355,0.00007619809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006356906,0.00008988203,0.00023574417,0.00017880388,0.00011967849,0.000029826346,0.00039146858,0.00007880246,0.00006300232],"category_scores_gemma":[0.00015915708,0.000092538954,0.00012268043,0.000160754,0.00027441524,0.0000055244673,0.00020473027,0.00009907311,0.0000012767711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016184195,0.000065520646,0.055202838,0.00016807154,0.00045406647,0.000003652814,0.000064251115,0.0010041982,0.93106055,0.00008876142,0.000167325,0.011558936],"study_design_scores_gemma":[0.0003078583,0.0000864785,0.4978116,0.000039487062,0.00008822272,7.7084445e-7,0.000081839215,0.0000729377,0.5011748,0.00006288766,0.00018612093,0.00008700936],"about_ca_topic_score_codex":0.00059334276,"about_ca_topic_score_gemma":0.00016404755,"teacher_disagreement_score":0.44260874,"about_ca_system_score_codex":0.00008184264,"about_ca_system_score_gemma":0.00051570794,"threshold_uncertainty_score":0.3773629},"labels":[],"label_agreement":null},{"id":"W2741404559","doi":"10.1158/1538-7445.am2017-1463","title":"Abstract 1463: Intravital discovery of miRNA drivers of human cancer cell directional invasion","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metastasis; Biology; Cancer; Cancer cell; microRNA; Cancer research; Cell; Cell adhesion; Pathology; Cell biology; Medicine; Gene; Genetics","score_opus":0.05126804894372124,"score_gpt":0.3918313284332882,"score_spread":0.340563279489567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741404559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964336,0.001332596,0.00000854207,0.000059773287,0.00011743073,0.00015794474,0.00015358854,0.0000019967056,0.0017345207],"genre_scores_gemma":[0.99807286,0.0007882643,0.000020930576,0.000003832792,0.00021489436,0.00003520407,0.000054724424,0.000014408337,0.0007948527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906224,0.000037298843,0.0001605678,0.0002398415,0.00031250005,0.00018753613],"domain_scores_gemma":[0.9990706,0.000012022637,0.0001540948,0.0004357024,0.0002691788,0.000058422676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023072214,0.00007739446,0.00010994319,0.000043157514,0.00018966141,0.00003089992,0.00032181694,0.00009543774,0.0001858855],"category_scores_gemma":[0.000050289393,0.00007533846,0.00007656893,0.00003606557,0.0003728001,0.000020433861,0.00018697987,0.00009993401,0.0000016677477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009648431,0.00006912037,0.015048241,0.00012298572,0.000037294223,0.0000010660432,0.000035655834,0.000037344547,0.98156124,0.000032519805,0.0020472668,0.00091078645],"study_design_scores_gemma":[0.00029942623,0.000056664012,0.18715818,0.00006655298,0.000006465532,2.3265024e-7,0.000037546706,0.0000018409,0.8115896,0.00005351529,0.00066726445,0.000062728635],"about_ca_topic_score_codex":0.003087568,"about_ca_topic_score_gemma":0.0011399187,"teacher_disagreement_score":0.17210995,"about_ca_system_score_codex":0.0000909788,"about_ca_system_score_gemma":0.00030538213,"threshold_uncertainty_score":0.46675},"labels":[],"label_agreement":null},{"id":"W2741415354","doi":"10.1158/1538-7445.am2017-2234","title":"Abstract 2234: Efatutazone reduces mammosphere formation in <i>Brca1</i>WT/fl11/Cre/p53+/- and <i>Brca1</i>fl11/fl11/Cre/p53+/- mice","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Progenitor cell; Mammary gland; Biology; Andrology; Stem cell; Fat pad; Molecular biology; Endocrinology; Internal medicine; Adipose tissue; Medicine; Cancer; Cell biology; Breast cancer","score_opus":0.06844101546448855,"score_gpt":0.39688062372166777,"score_spread":0.3284396082571792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741415354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488782,0.024161026,0.0000056192353,0.0071415463,0.0005355499,0.0015822094,0.000069349815,0.00010534206,0.017521149],"genre_scores_gemma":[0.9672234,0.022478307,0.0001831192,0.00032322446,0.0015022565,0.00046619243,0.000065069355,0.00009432144,0.007664075],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99434936,0.00035293002,0.00094870606,0.0010879667,0.0015855747,0.001675473],"domain_scores_gemma":[0.996123,0.00052320183,0.0004247511,0.0016972704,0.0006631883,0.00056854426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023499462,0.00057404867,0.0010200727,0.00045888626,0.0011581155,0.00063558976,0.0009659267,0.00048301206,0.0007211472],"category_scores_gemma":[0.0009685183,0.00053621223,0.00021966845,0.0005660727,0.0012014337,0.0013384814,0.00038536792,0.0018468928,0.00021686887],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018517837,0.0011001282,0.014662086,0.0038419424,0.00047335625,0.0017087104,0.0072629657,0.00007543108,0.54186946,0.0005029677,0.07286874,0.3371164],"study_design_scores_gemma":[0.016202604,0.0014800733,0.25718573,0.006136504,0.00021870276,0.0009813246,0.006728305,0.00030937814,0.31509092,0.0005185458,0.39335474,0.0017931856],"about_ca_topic_score_codex":0.009421401,"about_ca_topic_score_gemma":0.0028061885,"teacher_disagreement_score":0.33532318,"about_ca_system_score_codex":0.0008985235,"about_ca_system_score_gemma":0.0011852791,"threshold_uncertainty_score":0.99970895},"labels":[],"label_agreement":null},{"id":"W2741418391","doi":"10.1158/1538-7445.am2017-614","title":"Abstract 614: VB4-845 tumor cell killing in a combination study with the anti-PD-1, Nivolumab","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Calreticulin; Immunogenic cell death; Cell; Cancer research; Immunogenicity; T cell; Chemistry; Priming (agriculture); Immune system; Biology; Molecular biology; Immunotherapy; Endoplasmic reticulum; Immunology; Cell biology; Biochemistry","score_opus":0.04819953702972642,"score_gpt":0.40422872144127536,"score_spread":0.35602918441154896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741418391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581295,0.00093067874,0.000009687063,0.00056021754,0.00005053413,0.00088560866,0.000018749102,0.000004651294,0.0017269107],"genre_scores_gemma":[0.99814576,0.00020870568,0.00000783449,0.000016755224,0.00011622512,0.00043615967,0.000016579823,0.000025365582,0.0010266185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983562,0.000115977135,0.00011587283,0.00041826957,0.00047709967,0.0005165652],"domain_scores_gemma":[0.9988089,0.000029118824,0.00006678924,0.0007760594,0.00021466684,0.00010443559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000703766,0.00012333048,0.00012793357,0.000078728604,0.00073973363,0.0002781916,0.0006234242,0.00004636899,0.000060536837],"category_scores_gemma":[0.00006349873,0.000084169376,0.000035785146,0.00011863315,0.00034187062,0.000014262366,0.00020103873,0.00033912953,0.00002180905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016361623,0.0017430967,0.74626684,0.00013203107,0.00020639494,0.00041389273,0.0010464337,0.00014463463,0.23249845,0.000030500307,0.0053819926,0.010499589],"study_design_scores_gemma":[0.0075981673,0.0021860942,0.78798497,0.000102002494,0.000014335689,0.0000053862373,0.001779604,0.000047471327,0.1911242,0.000084782,0.00877361,0.00029936753],"about_ca_topic_score_codex":0.0058408733,"about_ca_topic_score_gemma":0.010360528,"teacher_disagreement_score":0.04171815,"about_ca_system_score_codex":0.000100606296,"about_ca_system_score_gemma":0.00050282764,"threshold_uncertainty_score":0.88296926},"labels":[],"label_agreement":null},{"id":"W2741419410","doi":"10.1158/1538-7445.am2017-3247","title":"Abstract 3247: Discovery of a novel drug that affects centrosome clustering","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Centrosome; Nocodazole; Mitosis; Microtubule; Cancer cell; Biology; Cell biology; Cancer; Cancer research; Paclitaxel; Cell; Cell cycle; Biochemistry; Genetics; Cytoskeleton","score_opus":0.05708498960673539,"score_gpt":0.3766537107045577,"score_spread":0.3195687210978223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741419410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963041,0.0009040088,0.0006610218,0.00025053555,0.00020444544,0.00021942996,0.00008731038,0.000003437202,0.0013657351],"genre_scores_gemma":[0.99587035,0.001387857,0.00007428654,0.000030953153,0.00027907852,0.00004020956,0.000023899891,0.000022831264,0.0022705176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989957,0.000023190709,0.00008611459,0.00029310543,0.00023273242,0.0003691297],"domain_scores_gemma":[0.999047,0.000017052093,0.00008778142,0.0007015053,0.00007845283,0.00006823636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032772447,0.00009961999,0.00013210058,0.000045052042,0.00021831652,0.00012024044,0.00053053716,0.00008850105,0.000016484624],"category_scores_gemma":[0.000073148025,0.00009135566,0.00007927279,0.000028980807,0.00021858858,0.000015457383,0.00048074534,0.00017501363,0.0000032009996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009838891,0.00004601458,0.0038547402,0.00011730939,0.000036488687,0.0000026726323,0.000039730552,0.0000671305,0.9926578,0.000037172977,0.001894776,0.0011477674],"study_design_scores_gemma":[0.0007633135,0.000050047012,0.019718861,0.00012814757,0.000005303423,0.000002304186,0.0000686545,0.000078921774,0.97158283,0.000010362399,0.0074582063,0.00013305254],"about_ca_topic_score_codex":0.000462126,"about_ca_topic_score_gemma":0.000834417,"teacher_disagreement_score":0.021074982,"about_ca_system_score_codex":0.000036831745,"about_ca_system_score_gemma":0.0001595621,"threshold_uncertainty_score":0.37253755},"labels":[],"label_agreement":null},{"id":"W2741422412","doi":"10.1158/1538-7445.am2017-1184","title":"Abstract 1184: Characterization of novel STAT5 inhibitors to interfere with the oncogenic activities of STAT5 in hematopoietic diseases","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"STAT5; Cancer research; Myeloid leukemia; Tyrosine kinase; Biology; Chemistry; Cell biology; Signal transduction","score_opus":0.09147110691658578,"score_gpt":0.4148508879130521,"score_spread":0.3233797809964663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741422412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968273,0.000057689707,0.00006033569,0.0019402766,0.000072458926,0.0004639375,0.00022123974,0.0000063838906,0.00035034577],"genre_scores_gemma":[0.9993823,0.000064210595,0.000013851737,0.00002645037,0.00011694765,0.00011208002,0.000015514712,0.000019146291,0.0002494518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989394,0.000028550101,0.00021979192,0.00017178632,0.0004274449,0.00021300634],"domain_scores_gemma":[0.99892545,0.00012573026,0.00014318828,0.00043316616,0.00028410906,0.00008837154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002537716,0.00008695475,0.00023057897,0.00020614579,0.00012248747,0.000040238698,0.00018900527,0.00002995855,0.00016792197],"category_scores_gemma":[0.00014546083,0.000056110723,0.000049381433,0.000165794,0.00025256904,0.0001614468,0.00008921122,0.0002841636,0.0000023989871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086668355,0.00026749948,0.009649577,0.00026656233,0.000043507844,0.000006070326,0.0017602037,0.000021019601,0.9842529,0.000058968242,0.00027649142,0.002530458],"study_design_scores_gemma":[0.00090797176,0.00049470755,0.22750229,0.0015912715,0.000021561582,0.000004051236,0.0018657431,0.000023307603,0.76661676,0.000009409579,0.0008877621,0.00007517428],"about_ca_topic_score_codex":0.0013329311,"about_ca_topic_score_gemma":0.0005580035,"teacher_disagreement_score":0.21785271,"about_ca_system_score_codex":0.0001302171,"about_ca_system_score_gemma":0.0004463073,"threshold_uncertainty_score":0.22881289},"labels":[],"label_agreement":null},{"id":"W2741423221","doi":"10.1158/1538-7445.am2017-ct131","title":"Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; Queen's University; Juravinski Hospital; McGill University; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Clinical endpoint; Randomized controlled trial; Gastroenterology; Chemotherapy; Toxicity; Breast cancer; Paclitaxel; Surgery; Cancer; Urology","score_opus":0.09781890425160464,"score_gpt":0.49897512447704734,"score_spread":0.40115622022544273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741423221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841132,0.0063175755,0.00004924329,0.0009837812,0.00016823878,0.0056142667,0.0021444233,0.000012251295,0.0005969893],"genre_scores_gemma":[0.98490065,0.0065551847,0.000057377256,0.000047695903,0.00033426672,0.0059920186,0.00007611523,0.0000743519,0.0019623134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99618036,0.000382717,0.00053989637,0.00083711266,0.0011290994,0.0009308069],"domain_scores_gemma":[0.99660707,0.0002095568,0.00033461145,0.0013721595,0.0011104385,0.0003661396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024253058,0.00033262157,0.00091663183,0.00018936118,0.0010616779,0.000200231,0.0009012114,0.00012088826,0.0004945712],"category_scores_gemma":[0.0006206937,0.0002594323,0.00034040542,0.00015753656,0.0007496775,0.000031627947,0.0003712001,0.00034349467,0.000008079933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6272456,0.005012301,0.00095265335,0.00032946453,0.004644087,0.00012235841,0.0014714295,0.00006842335,0.212453,0.00008339592,0.01004988,0.1375674],"study_design_scores_gemma":[0.75598085,0.023529204,0.0016785235,0.00032221552,0.00029048408,0.00001947887,0.0017978942,0.000084866406,0.19400187,0.0011234746,0.020429157,0.0007419596],"about_ca_topic_score_codex":0.026934847,"about_ca_topic_score_gemma":0.0070607355,"teacher_disagreement_score":0.13682544,"about_ca_system_score_codex":0.0004883554,"about_ca_system_score_gemma":0.0026522393,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W2741424057","doi":"10.1158/1538-7445.am2017-1286","title":"Abstract 1286: Targeted deep sequencing of colorectal tumor tissues to study associations of tumor subtypes with germline genetic, lifestyle, and environmental risk factors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"KRAS; Colorectal cancer; Biology; Microsatellite instability; DNA sequencing; Genetics; Whole genome sequencing; Germline; Penetrance; Germline mutation; Exome sequencing; Cancer; Genome; Microsatellite; Gene; Mutation","score_opus":0.027599065664763136,"score_gpt":0.3325136015154231,"score_spread":0.30491453585066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741424057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975671,0.0011561427,0.000014137853,0.000019417133,0.000039860523,0.0004488973,0.0007097012,0.0000022481108,0.00004245313],"genre_scores_gemma":[0.9989687,0.00043642268,0.00036623664,0.000007226825,0.000087293854,0.000051490344,0.000038768972,0.000022165443,0.000021689051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895316,0.00005477708,0.00019989144,0.0002902582,0.00026144888,0.00024044902],"domain_scores_gemma":[0.9991542,0.000072734685,0.00019863552,0.00033750336,0.00011644842,0.00012044162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002942074,0.00011248948,0.00019581683,0.00005939786,0.00024771225,0.000038182006,0.00023450158,0.000041932588,0.00003717049],"category_scores_gemma":[0.0003492684,0.000100198566,0.000030257794,0.000045988352,0.00021587513,0.000005255816,0.00021422707,0.00012588767,0.000001041909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001151814,0.00009271813,0.63459396,0.0000119836495,0.00009386729,0.000007573278,0.00039176812,0.00019373879,0.36393926,0.0000011956272,0.00003529541,0.0005234473],"study_design_scores_gemma":[0.0003710083,0.00066335895,0.65243566,0.000009857784,0.000020491027,9.2083917e-7,0.0006367516,0.000023082632,0.34566832,0.000006422222,0.00008207537,0.00008206448],"about_ca_topic_score_codex":0.004190342,"about_ca_topic_score_gemma":0.0033938393,"teacher_disagreement_score":0.018270943,"about_ca_system_score_codex":0.00008019733,"about_ca_system_score_gemma":0.0001975167,"threshold_uncertainty_score":0.6334571},"labels":[],"label_agreement":null},{"id":"W2741428492","doi":"10.1158/1538-7445.am2017-ct055","title":"Abstract CT055: A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC) (HER2CLIMB)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Rash; Trastuzumab; Placebo; Taxane; Gastroenterology; Adverse effect; Population; Diarrhea; Oncology; Pertuzumab; Progression-free survival; Cancer; Chemotherapy; Breast cancer; Colorectal cancer; Pathology","score_opus":0.05602476690837405,"score_gpt":0.39824079362522813,"score_spread":0.3422160267168541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741428492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837898,0.00033419253,0.0000024723277,0.0004276082,0.00005671957,0.014625453,0.000043483607,0.000015454785,0.00070482097],"genre_scores_gemma":[0.99471503,0.00013786588,0.000047163765,0.000018141282,0.000026946434,0.0043541286,0.000041150728,0.0000544829,0.000605084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99661255,0.0004645906,0.00068412645,0.0006363337,0.00093087705,0.00067153247],"domain_scores_gemma":[0.997279,0.0007913662,0.0003781242,0.0005222016,0.0008036681,0.00022565124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014133133,0.0003499705,0.0017224024,0.00061759556,0.00020021752,0.0000756174,0.00024771382,0.00008968666,0.00038713854],"category_scores_gemma":[0.00016317572,0.00021762426,0.00005748091,0.00054945174,0.00049594755,0.00030612227,0.00007496726,0.0006217095,0.0000021238384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65411806,0.0053905686,0.33470342,0.00024469188,0.0005301547,0.00015896815,0.0015743836,0.0000932452,0.00015031555,0.000004001808,0.000021395905,0.0030107978],"study_design_scores_gemma":[0.56643057,0.006620121,0.4249361,0.00037441807,0.00021847607,0.000008129578,0.0008397006,0.00013340861,0.00029649033,0.0000059590884,0.0000039706347,0.00013266846],"about_ca_topic_score_codex":0.024300953,"about_ca_topic_score_gemma":0.05457018,"teacher_disagreement_score":0.09023268,"about_ca_system_score_codex":0.00075365667,"about_ca_system_score_gemma":0.001160577,"threshold_uncertainty_score":0.98219633},"labels":[],"label_agreement":null},{"id":"W2741436390","doi":"10.1158/1538-7445.am2017-2056","title":"Abstract 2056: MYC and HIF-2alpha mediates resistance to Epidermal Growth Factor Receptor (EGFR) antagonism in oral squamous carcinoma cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Erlotinib; Clonogenic assay; Cancer research; Chemosensitizer; Medicine; Population; Cancer; EGFR inhibitors; Epidermal growth factor receptor; Pharmacology; Biology; Immunology; Cell; Internal medicine; Drug resistance; Multiple drug resistance","score_opus":0.05529005630285983,"score_gpt":0.36952626256797805,"score_spread":0.3142362062651182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741436390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992223,0.003531911,0.000013954395,0.0024700619,0.00024265522,0.00036942348,0.00024834948,0.0000065760923,0.00089405885],"genre_scores_gemma":[0.9944205,0.002281816,0.00014012387,0.00011180717,0.00037931153,0.00022066836,0.000033885382,0.00003214621,0.0023797275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982056,0.000090036294,0.00022933817,0.0005958598,0.00030470637,0.00057443423],"domain_scores_gemma":[0.9986811,0.00004444524,0.00007825266,0.00069696555,0.000249853,0.000249356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000489358,0.00016482569,0.00019293478,0.000109215245,0.0004197576,0.0001696564,0.0005606527,0.0001603895,0.00010962372],"category_scores_gemma":[0.00024436554,0.00015646902,0.000044384527,0.00010683169,0.0002886702,0.00002047752,0.00023782424,0.00027800884,0.000032742344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022945378,0.00008526779,0.01786889,0.0000666377,0.000012364589,0.000012662024,0.00017724662,0.0000028206941,0.9631255,0.000063807354,0.014606253,0.003749086],"study_design_scores_gemma":[0.0011776844,0.00009276252,0.19564171,0.000031049025,0.0000029257353,8.398543e-7,0.00009653597,0.0000041121593,0.76741856,0.00008279666,0.03521947,0.00023152215],"about_ca_topic_score_codex":0.00184472,"about_ca_topic_score_gemma":0.0018687607,"teacher_disagreement_score":0.19570692,"about_ca_system_score_codex":0.00012399038,"about_ca_system_score_gemma":0.00028345382,"threshold_uncertainty_score":0.6380621},"labels":[],"label_agreement":null},{"id":"W2741451749","doi":"10.1158/1538-7445.am2017-973","title":"Abstract 973: Methylation accurately predicts age of cancer onset in patients with Li Fraumeni Syndrome","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Germline; Cancer; Germline mutation; Medicine; Age of onset; Family history; Oncology; Confounding; Internal medicine; Genetics; Biology; Mutation; Gene; Disease","score_opus":0.08179535131614629,"score_gpt":0.41713933429099037,"score_spread":0.3353439829748441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741451749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973429,0.0014406798,0.000026916103,0.00009283567,0.00008847245,0.00036353877,0.000108501445,0.0000028196457,0.00053336984],"genre_scores_gemma":[0.9984467,0.0009538856,0.000057982008,0.0000073656465,0.000060459308,0.00010611841,0.00013260449,0.000021160755,0.00021373531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870574,0.000074115815,0.00020166687,0.00031047154,0.000416644,0.0002913737],"domain_scores_gemma":[0.9989044,0.000024156183,0.00014392412,0.00051433203,0.0003338165,0.00007938561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051318645,0.0001053021,0.00014894434,0.000101177764,0.0001477283,0.000054519427,0.00031302052,0.00014129306,0.00006767416],"category_scores_gemma":[0.00016327444,0.00009072805,0.000029566027,0.00009693703,0.00018224522,0.00001451764,0.00012339526,0.00019221418,0.0000027609813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040626072,0.000110172245,0.7579641,0.00007050273,0.00006567036,0.000008850751,0.00009187363,0.0004669648,0.23040515,0.0000071701756,0.00009436988,0.01030897],"study_design_scores_gemma":[0.0008042101,0.0002565815,0.80951333,0.00007047214,0.0000051871893,7.058353e-8,0.000010120131,0.0000093537865,0.18812506,0.000076985,0.001039465,0.0000891542],"about_ca_topic_score_codex":0.0020335224,"about_ca_topic_score_gemma":0.0022330116,"teacher_disagreement_score":0.051549293,"about_ca_system_score_codex":0.00005890743,"about_ca_system_score_gemma":0.0002387789,"threshold_uncertainty_score":0.36997825},"labels":[],"label_agreement":null},{"id":"W2741466867","doi":"10.1158/1538-7445.am2017-3298","title":"Abstract 3298: Diindolylmethane and its halogenated analogues induce autophagy in human prostate cancer cells via induction of the astrocyte-elevated gene-1 (AEG-1)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Autophagy; LNCaP; AMPK; Chemistry; Downregulation and upregulation; Vacuole; Cancer research; Cell biology; Small interfering RNA; Cancer cell; Transfection; Apoptosis; Biology; Protein kinase A; Kinase; Cancer; Biochemistry; Cytoplasm; Gene","score_opus":0.10114083009609173,"score_gpt":0.4172872777588086,"score_spread":0.3161464476627168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741466867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946211,0.0027993815,0.0000015909417,0.0009224061,0.0003493957,0.0010868984,0.0000831868,0.000018140034,0.00011789654],"genre_scores_gemma":[0.9965816,0.0019638906,0.000014660728,0.000054703465,0.00022942899,0.0002580239,0.000013083996,0.00003957795,0.000845033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789053,0.00012369797,0.00034702773,0.00045470404,0.00064323965,0.00054081774],"domain_scores_gemma":[0.99846977,0.00003716636,0.00023839074,0.0006064363,0.00048788218,0.00016037033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092558766,0.00018753631,0.00039084337,0.0002765796,0.00040492095,0.00006218356,0.00035126175,0.00018008947,0.00029070346],"category_scores_gemma":[0.00006675849,0.00013858461,0.00006645223,0.00038269733,0.00030178067,0.00017054926,0.00016510105,0.00083579874,0.00000366007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047784648,0.000089620466,0.0039295363,0.00015374056,0.00008313052,0.000024647541,0.0006665274,0.00002772392,0.9816269,0.000057251207,0.000070065864,0.012792993],"study_design_scores_gemma":[0.0020867337,0.0001815161,0.22433466,0.0002990529,0.000015882091,0.0000047000785,0.00007429178,0.000049555554,0.7724106,0.00019236833,0.00025069973,0.00009998162],"about_ca_topic_score_codex":0.01412252,"about_ca_topic_score_gemma":0.0039049198,"teacher_disagreement_score":0.22040513,"about_ca_system_score_codex":0.0003631122,"about_ca_system_score_gemma":0.00051867205,"threshold_uncertainty_score":0.99244255},"labels":[],"label_agreement":null},{"id":"W2741473121","doi":"10.1158/1538-7445.am2017-1896","title":"Abstract 1896: Soluble lung-derived selectins promote breast cancer cell migration","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Breast cancer; Metastasis; Metastatic breast cancer; Lung cancer; Cancer research; Medicine; Selectin; Cell migration; Cancer; Lung; Immunology; Cell; Pathology; Internal medicine; Chemistry; Cell adhesion molecule; Biochemistry","score_opus":0.0751614261229342,"score_gpt":0.4319943728274749,"score_spread":0.3568329467045407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741473121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97300494,0.0017766363,0.000012455951,0.011269094,0.00025440907,0.0014222526,0.00008003293,0.00007085337,0.0121093225],"genre_scores_gemma":[0.97650474,0.0039879465,0.000077825134,0.000091733906,0.0006298215,0.00056771433,0.00003350551,0.00006889199,0.018037817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960028,0.00011994584,0.00030044524,0.0007167905,0.0017022904,0.0011577288],"domain_scores_gemma":[0.9965575,0.00008787568,0.00013071515,0.0012482266,0.0014034235,0.00057225744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010743764,0.00022635073,0.00033992372,0.0001568195,0.0011837741,0.00037801746,0.00067308027,0.00020198272,0.007924113],"category_scores_gemma":[0.00022327514,0.0001989393,0.00012809671,0.0002853692,0.0003937305,0.000331003,0.00036007148,0.0012084108,0.0003908569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006348141,0.00025708682,0.01825231,0.0005284563,0.00006709955,0.00012423714,0.00035548012,0.000008359716,0.90922004,0.00000614278,0.051048394,0.019497557],"study_design_scores_gemma":[0.002535003,0.0002316405,0.26228586,0.00042041315,0.0000397638,0.00003547311,0.0001802801,0.00089808245,0.70387024,0.00003144482,0.02915002,0.00032177582],"about_ca_topic_score_codex":0.028538425,"about_ca_topic_score_gemma":0.009215687,"teacher_disagreement_score":0.24403356,"about_ca_system_score_codex":0.0012404562,"about_ca_system_score_gemma":0.0017225011,"threshold_uncertainty_score":0.9929828},"labels":[],"label_agreement":null},{"id":"W2741488474","doi":"10.1158/1538-7445.am2017-5212","title":"Abstract 5212: Metabolic reprogramming of radiation fibrosis using adipose derived stromal cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Fibrosis; Adipose tissue; Cancer research; Stromal cell; Paracrine signalling; Mesenchymal stem cell; Medicine; Transplantation; Cell biology; Endocrinology; Internal medicine; Chemistry; Pathology; Biology; Receptor","score_opus":0.189470798511161,"score_gpt":0.4709039549925599,"score_spread":0.2814331564813989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741488474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916378,0.00430148,0.000031723426,0.000304147,0.00015234532,0.00093880016,0.000022097636,0.000022837557,0.0025887443],"genre_scores_gemma":[0.9964564,0.0010373882,0.0010280514,0.00000824756,0.00043294014,0.00008204794,0.000008455043,0.00004677741,0.0008996821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964777,0.0001689631,0.0003961814,0.0005162874,0.0015779199,0.00086290913],"domain_scores_gemma":[0.9971539,0.0002219156,0.00021789066,0.0012980658,0.0006914466,0.0004168242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022558575,0.00015780274,0.00044856704,0.00035366626,0.0005973626,0.00017585074,0.0005186819,0.00015537074,0.001045522],"category_scores_gemma":[0.0009463941,0.00014288652,0.00014626737,0.00031428054,0.00051980215,0.00025873698,0.00029328134,0.000691733,0.00005331588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003581614,0.00008360608,0.021079117,0.00037542143,0.00010132634,0.00005026755,0.00020388445,0.000024036304,0.8702192,0.000038827977,0.00018267882,0.10728352],"study_design_scores_gemma":[0.0010135688,0.00015546907,0.18869898,0.0003037761,0.000042099367,0.0000054618063,0.00012311398,0.00031296498,0.8055127,0.000020264008,0.0037054156,0.00010614939],"about_ca_topic_score_codex":0.0073639704,"about_ca_topic_score_gemma":0.000093713374,"teacher_disagreement_score":0.16761987,"about_ca_system_score_codex":0.0002848829,"about_ca_system_score_gemma":0.000875125,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W2741490837","doi":"10.1158/1538-7445.am2017-533","title":"Abstract 533: XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"XIAP; Cancer research; Inhibitor of apoptosis; Cancer; Phosphorylation; MAPK/ERK pathway; Cancer cell; Transcription factor; Cell growth; Apoptosis; Cell biology; Chemistry; Biology; Programmed cell death; Caspase; Biochemistry; Gene; Genetics","score_opus":0.06236645200690547,"score_gpt":0.3604688548758536,"score_spread":0.2981024028689481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741490837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575408,0.03961138,0.0000104404935,0.00059050735,0.00016201584,0.0008465005,0.00014415936,0.000019306915,0.0010748842],"genre_scores_gemma":[0.99447155,0.0030452108,0.00004116584,0.000008822426,0.000043051565,0.00028735166,0.000018597739,0.000028936232,0.002055287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823606,0.00036037786,0.00029590365,0.00044048743,0.00015206572,0.0005150962],"domain_scores_gemma":[0.99894124,0.00014621697,0.00016720162,0.0004214829,0.00026876837,0.000055091838],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071010494,0.00020023742,0.00030333427,0.00014133721,0.0005820389,0.00010431757,0.00037132122,0.00028227715,0.0016439888],"category_scores_gemma":[0.00008658568,0.0001625563,0.00005103869,0.000054859993,0.0008292148,0.00037146165,0.00017614455,0.0005218935,0.000018173861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012111502,0.0001082055,0.0017032074,0.00034658916,0.00007151397,0.0000064156793,0.0010869004,2.558814e-7,0.99019766,0.000048820853,0.00081276137,0.0044064927],"study_design_scores_gemma":[0.0016372676,0.00023594024,0.02119092,0.0004224195,0.000012931394,0.0000064451924,0.0004235755,0.0000013737445,0.9724666,0.0001812814,0.0032490245,0.00017223344],"about_ca_topic_score_codex":0.004762711,"about_ca_topic_score_gemma":0.0007265641,"teacher_disagreement_score":0.036930773,"about_ca_system_score_codex":0.00008453925,"about_ca_system_score_gemma":0.00023369888,"threshold_uncertainty_score":0.99926865},"labels":[],"label_agreement":null},{"id":"W2741510694","doi":"10.1158/1538-7445.am2017-4293","title":"Abstract 4293: Siramesine and lapatinib induce ferroptosis in glioblastoma and lung adenocarcinoma cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Programmed cell death; Lapatinib; Necroptosis; Cancer research; Pharmacology; A549 cell; Chemistry; Lysosome; Cancer cell; Deferoxamine; Tyrosine kinase; Cell; Apoptosis; Medicine; Cancer; Biochemistry; Signal transduction; Internal medicine","score_opus":0.08835514515599159,"score_gpt":0.40889200730287945,"score_spread":0.32053686214688787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741510694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860755,0.006998053,6.73734e-7,0.004438796,0.00010803504,0.00061855104,0.000021475144,0.000021106807,0.0017177593],"genre_scores_gemma":[0.9950818,0.0036714124,0.00005839538,0.00014562136,0.00024298682,0.00024662574,0.0000017767157,0.000041656473,0.0005097638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979037,0.000066980814,0.00026611437,0.0005753682,0.0005701451,0.00061770563],"domain_scores_gemma":[0.99863863,0.00011070806,0.00008865988,0.0006125856,0.00022008613,0.00032935193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007587946,0.00019038761,0.0003904678,0.000284035,0.00040274378,0.00024172933,0.00024243504,0.00017155443,0.00033568573],"category_scores_gemma":[0.00018079257,0.00016741935,0.000042527765,0.00020701367,0.0005066169,0.00022856225,0.0003000346,0.000774523,0.0000135941245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010689131,0.00020311234,0.7737538,0.00094205217,0.00008671928,0.00016057327,0.0011422621,0.000001758978,0.14938533,0.0000936613,0.0048222155,0.06833959],"study_design_scores_gemma":[0.0021114734,0.00039674962,0.87606764,0.00068791956,0.000029483223,0.000012376169,0.00035886178,0.00011582911,0.11858895,0.000038945876,0.0014033444,0.00018844247],"about_ca_topic_score_codex":0.00277499,"about_ca_topic_score_gemma":0.0007052336,"teacher_disagreement_score":0.102313824,"about_ca_system_score_codex":0.00021323733,"about_ca_system_score_gemma":0.00026208578,"threshold_uncertainty_score":0.6827163},"labels":[],"label_agreement":null},{"id":"W2741510848","doi":"10.1158/1538-7445.am2017-169","title":"Abstract 169: Preclinical efficacy and sensitivity determinants of evofosfamide in molecularly defined models of head and neck squamous cell carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Cancer; Context (archaeology); Biology; Medicine; Chemistry; Head and neck cancer; Internal medicine","score_opus":0.08079064317014557,"score_gpt":0.3972518678086911,"score_spread":0.31646122463854554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741510848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907064,0.008358493,0.000016414102,0.000048739872,0.00010582507,0.00030737495,0.00006204521,0.0000018045275,0.00039291178],"genre_scores_gemma":[0.9974006,0.0021740329,0.00011391345,0.000013528331,0.00015762026,0.000024001949,0.0000046962473,0.000019480893,0.000092135786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99856687,0.00012937131,0.00029157207,0.00042658515,0.00024069683,0.0003448808],"domain_scores_gemma":[0.9988465,0.00009405292,0.0001357006,0.00058826484,0.0002014131,0.0001340975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000821432,0.00012866789,0.00033111798,0.00007798933,0.00009728814,0.000030026602,0.0001617502,0.00018046449,0.000003627511],"category_scores_gemma":[0.0003727483,0.00012638302,0.00005424149,0.000050347076,0.0004831296,0.00001412388,0.0003061874,0.00022450397,3.6205466e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079548394,0.00013893575,0.058982633,0.00025920646,0.000009333849,0.000016261258,0.0001310556,0.000054860895,0.92738944,0.000014079673,0.00008346477,0.012125256],"study_design_scores_gemma":[0.0024105664,0.00024925414,0.5927754,0.00005835864,0.000011518078,0.000006632614,0.000022862887,0.00026672232,0.40370363,0.00009051277,0.00028423738,0.00012029579],"about_ca_topic_score_codex":0.004517357,"about_ca_topic_score_gemma":0.003148048,"teacher_disagreement_score":0.5337928,"about_ca_system_score_codex":0.00001579998,"about_ca_system_score_gemma":0.00029953444,"threshold_uncertainty_score":0.68289226},"labels":[],"label_agreement":null},{"id":"W2741515220","doi":"10.1158/1538-7445.am2017-2912","title":"Abstract 2912: Size based enrichment and sorting of Ov90 cancer cells and clusters with a new multistage filtration cartridge reveals distinct phenotypes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McGill University","funders":"","keywords":"Filtration (mathematics); Cartridge; Population; Chemistry; Size-exclusion chromatography; Cell; Cytoplasm; Cluster (spacecraft); Circulating tumor cell; Cell sorting; Cancer cell; Chromatography; Biophysics; Metastasis; Cancer; Biology; Materials science; Biochemistry; Genetics; Medicine; Computer science; Mathematics","score_opus":0.07369438283546322,"score_gpt":0.3958786462738577,"score_spread":0.3221842634383945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741515220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933164,0.0032008179,0.00013023234,0.0013157668,0.00008954826,0.00076757465,0.00013758513,0.000011381984,0.0010307019],"genre_scores_gemma":[0.99616367,0.0011829531,0.0005895295,0.000082834355,0.00022653335,0.000092340706,0.000006629216,0.000026033056,0.0016294767],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838793,0.000042742085,0.00025766948,0.0003841286,0.00052222476,0.00040529933],"domain_scores_gemma":[0.99860376,0.000250015,0.00021347665,0.0004151415,0.00022638301,0.00029124913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007176881,0.00014934482,0.00035024164,0.00007937025,0.0003155551,0.00009692083,0.00010457564,0.00005775018,0.00029777558],"category_scores_gemma":[0.00019587515,0.000115224226,0.0000379043,0.00009702348,0.0003808291,0.00011348766,0.00007576756,0.00026550837,0.0000011757105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002520053,0.00012432158,0.11897397,0.0025686026,0.00019134932,0.000061842795,0.0013324384,0.00008852967,0.7571105,0.000030483534,0.0051067774,0.11189113],"study_design_scores_gemma":[0.0072949072,0.0005668078,0.67947114,0.0017646555,0.00022298505,0.0000053765953,0.00045028277,0.00022469643,0.30406412,0.000031561103,0.0055781784,0.00032527783],"about_ca_topic_score_codex":0.022039937,"about_ca_topic_score_gemma":0.0036899194,"teacher_disagreement_score":0.56049716,"about_ca_system_score_codex":0.00017658329,"about_ca_system_score_gemma":0.000665762,"threshold_uncertainty_score":0.9844724},"labels":[],"label_agreement":null},{"id":"W2741543570","doi":"10.1158/1538-7445.am2017-ct054","title":"Abstract CT054: Phase II study of dianhydrogalactitol in patients with <i>MGMT</i>-unmethylated bevacizumab-naive recurrent glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Tolerability; Oncology; Regimen; Internal medicine; Phases of clinical research; Radiation therapy; Dacarbazine; Cancer research; Clinical trial; Chemotherapy; Adverse effect","score_opus":0.058587703470748195,"score_gpt":0.4280164182227051,"score_spread":0.3694287147519569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741543570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964424,0.00020555084,7.766674e-8,0.00034596745,0.00012504119,0.0022092306,0.000052571977,0.000014818731,0.0006043898],"genre_scores_gemma":[0.99923915,0.00008634827,0.000008185307,0.000006047343,0.00006128878,0.0005070892,0.000014819352,0.000033086737,0.000043997286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744403,0.00009378192,0.00033965052,0.0004806207,0.0011235125,0.00051841594],"domain_scores_gemma":[0.9979363,0.00010267379,0.00019642359,0.0009307091,0.000580248,0.00025365996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041253548,0.00020025104,0.00046290658,0.00046363779,0.00038668953,0.000051921765,0.00028673685,0.000081144004,0.00025397228],"category_scores_gemma":[0.00018848407,0.00013279715,0.000057734942,0.00036924574,0.00019893139,0.00018166426,0.00018871418,0.00050437485,0.00002338207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012276391,0.02993625,0.8696298,0.00013118847,0.00038021494,0.0005867865,0.0019500444,0.000013524486,0.0014252764,0.0000054878037,0.000721954,0.082943074],"study_design_scores_gemma":[0.041180223,0.029431513,0.9066502,0.00063714024,0.00007925096,0.000001533593,0.0004222128,0.000012036667,0.020941455,0.000009647055,0.00047786432,0.00015696861],"about_ca_topic_score_codex":0.003133924,"about_ca_topic_score_gemma":0.0039599002,"teacher_disagreement_score":0.082786106,"about_ca_system_score_codex":0.0004489604,"about_ca_system_score_gemma":0.00025831623,"threshold_uncertainty_score":0.5415311},"labels":[],"label_agreement":null},{"id":"W2741548122","doi":"10.1158/1538-7445.am2017-ct046","title":"Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with <i>RAS</i> mutant solid tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Palbociclib; Medicine; Tolerability; Pharmacokinetics; Pharmacology; Neutropenia; Leukopenia; Internal medicine; Oncology; Cancer; Adverse effect; Chemotherapy","score_opus":0.03961281957013143,"score_gpt":0.3934869420847642,"score_spread":0.3538741225146328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741548122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945274,0.00009063914,0.0000039934775,0.0017952949,0.000108196,0.0032701546,0.000025853451,0.000014752112,0.00016368742],"genre_scores_gemma":[0.99914885,0.000013100607,0.000011664957,0.00005532538,0.00013279397,0.0005014245,0.000008985514,0.000051028223,0.00007685698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689496,0.00021693282,0.00042374228,0.00043394917,0.0015275052,0.0005029211],"domain_scores_gemma":[0.99781156,0.00015458213,0.00035742883,0.0009637959,0.0006121269,0.000100482685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097117637,0.00021822835,0.0003967361,0.00022080349,0.0003884332,0.000070805894,0.00045074854,0.000068764806,0.000044711065],"category_scores_gemma":[0.00016555151,0.000115571966,0.000037079113,0.00059812004,0.00063144823,0.00038629273,0.00015216149,0.00086457253,0.0000029796013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016433854,0.005776777,0.9221536,0.00018864333,0.00010972538,0.000055796594,0.0093281,0.0003983154,0.01872931,0.000029238268,0.00008696723,0.026709707],"study_design_scores_gemma":[0.030944163,0.0022182395,0.94528025,0.0009467469,0.000019930416,0.0000018633273,0.0028282087,0.000047710102,0.017381372,0.00007578694,0.00010936627,0.00014634035],"about_ca_topic_score_codex":0.001179266,"about_ca_topic_score_gemma":0.0041332147,"teacher_disagreement_score":0.026563369,"about_ca_system_score_codex":0.00058786577,"about_ca_system_score_gemma":0.00046283688,"threshold_uncertainty_score":0.4712888},"labels":[],"label_agreement":null},{"id":"W2741568168","doi":"10.1158/1538-7445.am2017-lb-144","title":"Abstract LB-144: Tff2 labels pancreatic progenitors that lack proliferative potential during tissue regeneration but can serve as the origin of pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Progenitor cell; Pancreas; Biology; Acinar cell; Regeneration (biology); Population; Stem cell; Cell biology; Pancreatic cancer; Progenitor; Ductal cells; Cancer; Endocrinology; Genetics; Medicine","score_opus":0.1454416736564983,"score_gpt":0.4660234021360874,"score_spread":0.3205817284795891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741568168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98312104,0.0024035014,0.0000070022884,0.008348923,0.00026059573,0.0031146747,0.00011885296,0.000037393187,0.002588033],"genre_scores_gemma":[0.97494996,0.0031572713,0.00009768654,0.00007992785,0.0013077012,0.0021184518,0.000031719774,0.00006762962,0.018189644],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954733,0.00048314704,0.00054608606,0.0006630033,0.0017543808,0.0010800301],"domain_scores_gemma":[0.9963421,0.00032682988,0.00036068424,0.0013335502,0.001232935,0.00040390316],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017555997,0.00032860652,0.0008965563,0.00024160565,0.0015917919,0.00021006695,0.000749874,0.00027708992,0.0015502361],"category_scores_gemma":[0.0008639911,0.0002223128,0.0001316285,0.00030318182,0.001266746,0.0002581636,0.00026908665,0.0011082175,0.000080905265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019993188,0.00028190785,0.58476907,0.0014160888,0.0010365568,0.000355701,0.0024657683,0.000048397796,0.40235522,0.00033461585,0.0018055406,0.003131845],"study_design_scores_gemma":[0.0030173846,0.00058183435,0.4811377,0.0010815939,0.00040605833,0.0000693356,0.0009368751,0.00026873808,0.5112456,0.00034444247,0.0006360083,0.0002744091],"about_ca_topic_score_codex":0.030988479,"about_ca_topic_score_gemma":0.0043781595,"teacher_disagreement_score":0.1088904,"about_ca_system_score_codex":0.0008279266,"about_ca_system_score_gemma":0.0033683805,"threshold_uncertainty_score":0.999708},"labels":[],"label_agreement":null},{"id":"W2741601345","doi":"10.1158/1538-7445.am2017-910","title":"Abstract 910: Phloridzin docosahexaenoate (PZ-DHA) inhibits breast cancer cell invasion and angiogenesis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Docosahexaenoic acid; Angiogenesis; Molecular biology; Western blot; Chemistry; Biology; Biochemistry; Fatty acid; Cancer research; Polyunsaturated fatty acid","score_opus":0.11808672314505901,"score_gpt":0.4299207953578667,"score_spread":0.3118340722128077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741601345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95917845,0.009149574,0.0000018725027,0.02432189,0.00065223145,0.00088594126,0.00034318207,0.000060521263,0.0054063424],"genre_scores_gemma":[0.98481464,0.012698738,0.00006110222,0.00022221779,0.0010526278,0.00029973855,0.000012715478,0.00007627599,0.00076193735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957714,0.00022132997,0.00031951978,0.00078869925,0.0012836985,0.0016153689],"domain_scores_gemma":[0.9972515,0.00021148317,0.00014449423,0.0009948106,0.0005712719,0.0008264418],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018843029,0.00026116677,0.00035104234,0.00026239775,0.0024383934,0.0006412355,0.0008199741,0.00021941566,0.0018019477],"category_scores_gemma":[0.00016279328,0.00023080867,0.00009357155,0.0002506318,0.0006790278,0.0007500408,0.0005092329,0.00091612985,0.00018833409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022312668,0.00022004907,0.032600988,0.0013342446,0.00004999705,0.00007958342,0.0010200263,0.000014552321,0.6956916,0.00006556439,0.046753682,0.21993846],"study_design_scores_gemma":[0.0018146831,0.00019535077,0.41492593,0.0005098223,0.000014577649,0.00001383191,0.00027291957,0.00006078082,0.567754,0.00023223936,0.013855837,0.0003500322],"about_ca_topic_score_codex":0.06012735,"about_ca_topic_score_gemma":0.017644687,"teacher_disagreement_score":0.38232496,"about_ca_system_score_codex":0.0008302072,"about_ca_system_score_gemma":0.0006239234,"threshold_uncertainty_score":0.9991105},"labels":[],"label_agreement":null},{"id":"W2741639876","doi":"10.1158/1538-7445.am2017-1876","title":"Abstract 1876: Cell cycle-dependent front polarized cell migration requires Aurora kinase A","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Centrosome; Cell biology; Aurora inhibitor; Mitosis; Aurora A kinase; Biology; Microtubule organizing center; Cell migration; Microtubule nucleation; Cell polarity; Cancer research; Cell cycle; Cell; Genetics","score_opus":0.03415240202877716,"score_gpt":0.3546007317155496,"score_spread":0.32044832968677245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741639876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124706,0.0024332616,0.00022263602,0.0005174484,0.00022040942,0.000369298,0.000091463844,0.0000119254255,0.0048865103],"genre_scores_gemma":[0.9895642,0.0025327292,0.00016630824,0.00008041477,0.00045440605,0.00011067924,0.000091382266,0.000039290706,0.00696059],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832183,0.00008709926,0.00020526184,0.00051171257,0.000351853,0.0005222215],"domain_scores_gemma":[0.99841624,0.000014870233,0.00012242871,0.0010429862,0.0002374462,0.00016600301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005435287,0.00016273986,0.00015012338,0.000071993134,0.00055221445,0.00024693433,0.00068527885,0.00022682916,0.00017060133],"category_scores_gemma":[0.0000900322,0.00015607444,0.00009936423,0.00003081587,0.00017696651,0.000015516493,0.00034759133,0.00033645975,0.00011104314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018999094,0.00011118383,0.0014363612,0.00006846406,0.000018131552,0.00001705714,0.00008289843,0.000018642788,0.9906241,0.000009967717,0.005686921,0.0017362799],"study_design_scores_gemma":[0.00096631184,0.00013728463,0.0037500844,0.000030308964,0.000010408397,0.0000014066014,0.00009333876,0.00006208172,0.9595272,0.000070092196,0.03514396,0.0002075224],"about_ca_topic_score_codex":0.003957533,"about_ca_topic_score_gemma":0.0036172203,"teacher_disagreement_score":0.0310969,"about_ca_system_score_codex":0.00008869484,"about_ca_system_score_gemma":0.0003398172,"threshold_uncertainty_score":0.6364531},"labels":[],"label_agreement":null},{"id":"W2741647816","doi":"10.1158/1538-7445.am2017-2834","title":"Abstract 2834: Metastatic colorectal cancer: characterization of distinct histological growth patterns which demonstrate different response to current treatment regimes","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Stromal cell; Metastasis; Immunohistochemistry; Bevacizumab; Angiogenesis; Cancer; Pathology; Cancer research; Parenchyma; Oncology; Internal medicine; Chemotherapy","score_opus":0.08142278276832707,"score_gpt":0.43258168008465897,"score_spread":0.3511588973163319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741647816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853881,0.00035695155,0.00020589102,0.01266338,0.0003533755,0.000732469,0.00013687406,0.000026421165,0.0001365368],"genre_scores_gemma":[0.9972886,0.0016056126,0.00004296705,0.000034525234,0.00022031163,0.0004177187,0.000055734366,0.000028882196,0.0003056386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775535,0.0002867885,0.00035423317,0.0004438221,0.0006625891,0.00049724086],"domain_scores_gemma":[0.9982786,0.00028154472,0.00020703912,0.00041455304,0.00040846516,0.00040978155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087346317,0.00020085479,0.0005125504,0.00020435883,0.00036772632,0.00008788683,0.0003109802,0.00005534347,0.00030841137],"category_scores_gemma":[0.0014340859,0.00013854347,0.00009313447,0.00014214843,0.0002826612,0.00007593977,0.00012230004,0.00054506207,0.000010260816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004051117,0.0005157526,0.38135102,0.0003741571,0.0001668874,0.00011200542,0.00053935515,0.0000044496946,0.44328827,0.000062776446,0.0002345687,0.16929966],"study_design_scores_gemma":[0.0013719971,0.00069651136,0.9619839,0.00064745866,0.00007877702,0.000010563855,0.000030928113,0.00041837493,0.03284281,0.000030983567,0.001754623,0.00013302371],"about_ca_topic_score_codex":0.0018005576,"about_ca_topic_score_gemma":0.00023719079,"teacher_disagreement_score":0.5806329,"about_ca_system_score_codex":0.00070480705,"about_ca_system_score_gemma":0.00055321323,"threshold_uncertainty_score":0.5649639},"labels":[],"label_agreement":null},{"id":"W2741655923","doi":"10.1158/1538-7445.am2017-319","title":"Abstract 319: Cholesterol inhibition reduces Hh mediated chondrosarcoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Lovastatin; In vivo; Cholesterol; Simvastatin; HMG-CoA reductase; Pharmacology; High cholesterol; Endocrinology; Internal medicine; Biology; Chemistry; Medicine; Reductase; Biochemistry","score_opus":0.05995871721572353,"score_gpt":0.3962895581012677,"score_spread":0.33633084088554416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741655923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875246,0.0022378895,0.000006657405,0.0014049791,0.0045508603,0.00028686636,0.00008309896,0.000015466008,0.0038895297],"genre_scores_gemma":[0.97614163,0.004165363,0.000019465453,0.00015044038,0.015513898,0.00020330554,0.00011892239,0.000034974815,0.0036519698],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983163,0.00007095278,0.00018883383,0.0004802538,0.0004164705,0.0005272119],"domain_scores_gemma":[0.998603,0.000016979086,0.000100310914,0.00079332694,0.0002827144,0.00020365632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005967194,0.00014643245,0.0001660147,0.00008804461,0.0005492621,0.0002096192,0.0004715151,0.00019282069,0.00018314285],"category_scores_gemma":[0.00030334445,0.00013851808,0.0000822398,0.00007020322,0.00041383316,0.000020065987,0.00024289014,0.00033080194,0.00007873679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011150934,0.0000377409,0.000730085,0.000027658365,0.000026046735,5.3665866e-7,0.000057777754,0.0000026965126,0.88472164,0.000015972562,0.102757886,0.011510453],"study_design_scores_gemma":[0.0008274827,0.00006662694,0.04878759,0.000052382286,0.0000051295347,0.0000037256968,0.00004856932,0.0000020066625,0.4145466,0.00005480699,0.53545666,0.00014838875],"about_ca_topic_score_codex":0.0010304085,"about_ca_topic_score_gemma":0.00089661183,"teacher_disagreement_score":0.47017503,"about_ca_system_score_codex":0.000051914853,"about_ca_system_score_gemma":0.00035113737,"threshold_uncertainty_score":0.56486034},"labels":[],"label_agreement":null},{"id":"W2741673148","doi":"10.1158/1538-7445.am2017-4396","title":"Abstract 4396: Multiomics assessment of the cancer and stromal compartments of patient-derived pancreatic xenografts reveals clinically-relevant subtypes and novel targeted therapies","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Compute Canada","funders":"","keywords":"Pancreatic cancer; Transcriptome; Stromal cell; Adenocarcinoma; Cancer research; Gene expression profiling; Stroma; Biology; Cancer; Pathology; Medicine; Immunohistochemistry; Gene; Gene expression; Genetics","score_opus":0.12541144618618807,"score_gpt":0.48158894748878256,"score_spread":0.3561775013025945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741673148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489987,0.0019533392,0.000012358691,0.001383824,0.00010723147,0.0011417228,0.00014961981,0.0000061664027,0.00034588043],"genre_scores_gemma":[0.99334925,0.0050952034,0.0010738774,0.00004127136,0.000077033845,0.00018244496,0.0000051553743,0.000019683648,0.00015607596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977303,0.0001998816,0.0005589555,0.00034120306,0.00074134924,0.0004283164],"domain_scores_gemma":[0.9974795,0.00067801983,0.00038211062,0.00068783597,0.0005830085,0.0001894986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015403556,0.00014944818,0.00070938474,0.00010105876,0.0003938488,0.0000381713,0.00031640395,0.00012704126,0.00012450719],"category_scores_gemma":[0.0006194149,0.000095149604,0.00007143571,0.00010012133,0.0017961322,0.000080418635,0.00034101907,0.0004981198,7.1573015e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004060892,0.00024034061,0.7352251,0.0003330169,0.00036149393,0.0000035099274,0.0005055911,0.0000017095188,0.2596539,0.00008689463,0.00012105713,0.0030613237],"study_design_scores_gemma":[0.0029518984,0.00057442207,0.9860331,0.0006715539,0.00011437295,0.00000251414,0.0004779821,0.00032567544,0.008538287,0.00013392062,0.00009570155,0.000080560894],"about_ca_topic_score_codex":0.0025886733,"about_ca_topic_score_gemma":0.00022471324,"teacher_disagreement_score":0.25111562,"about_ca_system_score_codex":0.00013240761,"about_ca_system_score_gemma":0.0008000394,"threshold_uncertainty_score":0.6617924},"labels":[],"label_agreement":null},{"id":"W2741674151","doi":"10.1158/1538-7445.am2017-3758","title":"Abstract 3758: The efficacy of CD133 BiTEs and CAR-T cells in preclinical model of glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Antigen; Population; Flow cytometry; Antibody; Peripheral blood mononuclear cell; Immunophenotyping; Cancer research; Monoclonal antibody; Immunology; Chimeric antigen receptor; Medicine; CD3; Biology; Immunotherapy; CD8; In vitro; Immune system","score_opus":0.19397652111056424,"score_gpt":0.4941647106937867,"score_spread":0.30018818958322246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741674151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936969,0.00090487656,0.0000016290209,0.0015083043,0.000045588233,0.0007955973,0.000033404263,0.000006049047,0.0030076231],"genre_scores_gemma":[0.9954449,0.0019111012,0.000037436574,0.000017906728,0.00013393913,0.00006302622,9.955135e-7,0.000027392882,0.0023632788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976932,0.00013608045,0.00040009824,0.00032924625,0.000978736,0.00046263414],"domain_scores_gemma":[0.9969025,0.0012978627,0.00011631814,0.001104808,0.00041119877,0.00016726018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027080723,0.00011038296,0.000408522,0.00024376715,0.00013999346,0.00004119938,0.0005593926,0.00013141337,0.00063118106],"category_scores_gemma":[0.0010252378,0.000075340526,0.00009803046,0.00020456225,0.0014530881,0.00007437633,0.00033809218,0.00090584275,0.00000812055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030397333,0.00024520015,0.020813549,0.00035137203,0.00006304229,0.000016679704,0.0007446402,0.00020862813,0.95212877,0.000069669426,0.0007256742,0.021593064],"study_design_scores_gemma":[0.004427833,0.00073608174,0.21550031,0.0006016187,0.000020022537,0.000003749901,0.00022840186,0.0046459935,0.77238953,0.00035675807,0.00097193185,0.000117764415],"about_ca_topic_score_codex":0.0018450614,"about_ca_topic_score_gemma":0.0005961178,"teacher_disagreement_score":0.19468677,"about_ca_system_score_codex":0.00010110221,"about_ca_system_score_gemma":0.00064811524,"threshold_uncertainty_score":0.691099},"labels":[],"label_agreement":null},{"id":"W2741677201","doi":"10.1158/1538-7445.am2017-3826","title":"Abstract 3826: Clinical validation of a serum protein panel (FLNA, FLNB and KRT19) for diagnosis and prognosis of prostate cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Oncology; Prostate; Cancer; Internal medicine; Biopsy; Population; Prostate biopsy; FLNA; Pathology; Urology; Filamin; Biology","score_opus":0.22960820517903782,"score_gpt":0.5078346451430792,"score_spread":0.2782264399640414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741677201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955781,0.0006227761,0.00005762291,0.0013107253,0.000009827179,0.001567282,0.0006493783,0.000018190172,0.00018610862],"genre_scores_gemma":[0.9814955,0.0044025225,0.0028772906,0.0000053055173,0.00008753718,0.010799618,0.000008494022,0.00002529598,0.00029843306],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878263,0.00001839572,0.000369568,0.00035600289,0.00021525797,0.00025812845],"domain_scores_gemma":[0.9985453,0.0001862863,0.0003212042,0.00042921922,0.00042263477,0.00009538487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819205,0.000102869664,0.00024337022,0.00004337106,0.0002705062,0.000064254804,0.00026220747,0.00012536145,0.000102756574],"category_scores_gemma":[0.00029606943,0.00009524012,0.00004953699,0.000056857552,0.0005006004,0.00016762174,0.00018095314,0.00026554122,3.205255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027706998,0.00020737172,0.43899727,0.002539763,0.00007409262,8.5898637e-7,0.00021706063,0.0000053833937,0.33288357,0.00064074696,0.0004127973,0.22374402],"study_design_scores_gemma":[0.00056592276,0.000073904215,0.021561425,0.00049344497,0.000015669191,2.7670364e-7,0.00006391515,0.000047363377,0.97122,0.0034911295,0.00236089,0.00010604364],"about_ca_topic_score_codex":0.0007377644,"about_ca_topic_score_gemma":0.00009528424,"teacher_disagreement_score":0.6383364,"about_ca_system_score_codex":0.000044696928,"about_ca_system_score_gemma":0.00015831791,"threshold_uncertainty_score":0.38837793},"labels":[],"label_agreement":null},{"id":"W2741691866","doi":"10.1158/1538-7445.am2017-5553","title":"Abstract 5553: A computational model for integrating genomic data with public datasets for molecular tumor board recommendations","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"KRAS; Cancer research; Protein kinase B; MAPK/ERK pathway; Computational biology; Biology; PI3K/AKT/mTOR pathway; MEK inhibitor; Mutation; Bioinformatics; Signal transduction; Genetics; Gene","score_opus":0.1683051277947682,"score_gpt":0.4485859715422653,"score_spread":0.2802808437474971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741691866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5339576,0.0012630238,0.39459372,0.012092121,0.00027366867,0.002654064,0.05471252,0.000017687276,0.00043563033],"genre_scores_gemma":[0.9357088,0.00018924127,0.046783555,0.00037121546,0.00028640585,0.00086451456,0.015638921,0.000053356092,0.00010396376],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986513,0.00001867514,0.0001854969,0.0005671557,0.00017102041,0.00040631482],"domain_scores_gemma":[0.9979937,0.000118163705,0.00012531095,0.0011912516,0.00043931074,0.00013226082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065714575,0.00012648966,0.00013123044,0.000060283342,0.0007149063,0.0003793577,0.0010967136,0.000058476333,0.000014833406],"category_scores_gemma":[0.0006960207,0.00011980662,0.00004280797,0.00003532533,0.00016900613,0.000023615745,0.0005840571,0.00014172842,0.000002172593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014437956,0.00034708527,0.0012144874,0.00038372623,0.00057338725,0.000011282727,0.00014325611,0.033467837,0.42213005,0.009319304,0.48061964,0.050346173],"study_design_scores_gemma":[0.005159754,0.0006502971,0.0012536421,0.0001606123,0.000074423464,0.000010349561,0.0002481763,0.5054223,0.025185995,0.006004857,0.4549877,0.0008419011],"about_ca_topic_score_codex":0.00022462064,"about_ca_topic_score_gemma":0.0017538844,"teacher_disagreement_score":0.47195446,"about_ca_system_score_codex":0.00008074524,"about_ca_system_score_gemma":0.0011951783,"threshold_uncertainty_score":0.54985535},"labels":[],"label_agreement":null},{"id":"W2741693251","doi":"10.1158/1538-7445.am2017-4420","title":"Abstract 4420: Elevated glycolytic gene signature in patient-derived neuroendocrine prostate cancer xenograft models and its clinical relevance","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Prostate cancer; Cancer research; Cancer; Transdifferentiation; Metastasis; Biology; Androgen receptor; Androgen deprivation therapy; Adenocarcinoma; Prostate; Angiogenesis; Medicine; Genetics; Cell","score_opus":0.1440937020400715,"score_gpt":0.4653851312555976,"score_spread":0.3212914292155261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741693251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962795,0.02557329,0.0000010173792,0.008116857,0.00029078723,0.002547622,0.00015511335,0.000054292002,0.0004659954],"genre_scores_gemma":[0.91488403,0.08116587,0.000035554294,0.00018666674,0.00027651523,0.0009842002,0.00003571446,0.00008041046,0.002351047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99554604,0.00021877681,0.00062903867,0.0010464536,0.0011444344,0.0014152299],"domain_scores_gemma":[0.99714094,0.00029332738,0.00019375463,0.0009058196,0.0008277349,0.00063841796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077121024,0.00033675454,0.000657902,0.00035373677,0.00059482077,0.0002059855,0.00046189228,0.00016823682,0.00023090077],"category_scores_gemma":[0.0006445608,0.00026665264,0.00011222813,0.0004256721,0.00066281523,0.0005124674,0.0004533735,0.0021251447,0.000027866088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016480504,0.0011044625,0.07674192,0.0014741842,0.0004856654,0.008349192,0.0011787963,0.00041407882,0.72283804,0.00009386325,0.004970236,0.16586906],"study_design_scores_gemma":[0.038132463,0.0039255186,0.38680005,0.0040899906,0.00018258263,0.00015789343,0.00045425483,0.010441991,0.5365659,0.0022416895,0.015563848,0.0014438267],"about_ca_topic_score_codex":0.0015952544,"about_ca_topic_score_gemma":0.00067049137,"teacher_disagreement_score":0.31005815,"about_ca_system_score_codex":0.0005026076,"about_ca_system_score_gemma":0.0012617896,"threshold_uncertainty_score":0.99997854},"labels":[],"label_agreement":null},{"id":"W2741707209","doi":"10.1158/1538-7445.am2017-1304","title":"Abstract 1304: The contribution of rare and low-frequency variants to colorectal cancer heritability","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital","funders":"","keywords":"Heritability; Minor allele frequency; Genome-wide association study; Imputation (statistics); Missing heritability problem; Genetics; Genetic association; Biology; Colorectal cancer; Genotype; SNP; Sample size determination; Allele frequency; Single-nucleotide polymorphism; Cancer; Missing data; Statistics; Mathematics; Gene","score_opus":0.04437936903080681,"score_gpt":0.4024574306567739,"score_spread":0.3580780616259671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741707209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402726,0.0013514034,0.00003194661,0.0035856823,0.00012702735,0.00033283842,0.000114636525,0.0000019666015,0.00042723436],"genre_scores_gemma":[0.99850994,0.0008862869,0.00004487329,0.000065712,0.00017832505,0.00019175276,0.000013648703,0.0000069882335,0.00010248672],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990026,0.0001450551,0.00016084117,0.00025781442,0.00013740228,0.00029628945],"domain_scores_gemma":[0.99891806,0.000066070905,0.00008950425,0.00039636533,0.0004493235,0.00008070794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012515112,0.000069702786,0.00013733009,0.000018328696,0.0004094805,0.000029957791,0.00031069768,0.00012322466,0.00007456855],"category_scores_gemma":[0.0015220289,0.000051722665,0.000034824883,0.00004710576,0.0003136972,0.0000039551187,0.00020839488,0.00014028893,0.0000031531306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085917505,0.00002434768,0.3159692,0.000016528003,0.000042793607,6.8472593e-7,0.000070868555,0.000023720493,0.6777748,0.00011243134,0.0018852908,0.003993449],"study_design_scores_gemma":[0.00025431134,0.000095236,0.95374286,0.000019471567,0.0000047410426,7.229025e-7,0.00005717527,0.000012340199,0.044108894,0.00043583976,0.0012081696,0.00006024959],"about_ca_topic_score_codex":0.0034007365,"about_ca_topic_score_gemma":0.0035609156,"teacher_disagreement_score":0.63777363,"about_ca_system_score_codex":0.000055286757,"about_ca_system_score_gemma":0.00026807687,"threshold_uncertainty_score":0.5140919},"labels":[],"label_agreement":null},{"id":"W2741722460","doi":"10.1158/1538-7445.am2017-ct070","title":"Abstract CT070: A open-label phase 3b/4 safety trial of flat-dose nivolumab in combination with ipilimumab in patients with advanced non-small cell lung cancer (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent","funders":"","keywords":"Nivolumab; Medicine; Ipilimumab; Internal medicine; Oncology; Lung cancer; Adverse effect; Combination therapy; Discontinuation; Cancer; Immunotherapy","score_opus":0.057571217029514475,"score_gpt":0.4162801374752172,"score_spread":0.35870892044570274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741722460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906305,0.000754517,0.000006348629,0.00050354406,0.00019677482,0.005425888,0.00009037315,0.000010135056,0.0023818957],"genre_scores_gemma":[0.99708664,0.0010718966,0.00012410796,0.000045923953,0.000057673704,0.00086777617,0.00004703966,0.000057226673,0.0006417124],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718493,0.000109551285,0.0005557037,0.0005872742,0.0009080088,0.00065451773],"domain_scores_gemma":[0.997921,0.00010590823,0.00035900227,0.0008840925,0.0005813502,0.00014867367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011677239,0.00025066372,0.00061582855,0.00038482083,0.0002525833,0.000103852675,0.00067445997,0.00014116096,0.0002165965],"category_scores_gemma":[0.00006504664,0.00019639371,0.000042838707,0.00054688705,0.00036837562,0.00046739198,0.00016374205,0.0006940511,0.0000023599503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78007317,0.005097571,0.08137662,0.00060127355,0.00015188758,0.000053423104,0.0011071061,0.000023557826,0.023483975,0.0000056199174,0.00035098247,0.10767479],"study_design_scores_gemma":[0.6266828,0.0067111496,0.35112825,0.0027390362,0.0000356032,5.528665e-7,0.00019017066,0.0001485485,0.011670183,0.0000070465435,0.000421402,0.00026523936],"about_ca_topic_score_codex":0.014663556,"about_ca_topic_score_gemma":0.0115328,"teacher_disagreement_score":0.2697516,"about_ca_system_score_codex":0.0013363877,"about_ca_system_score_gemma":0.0022362126,"threshold_uncertainty_score":0.9918979},"labels":[],"label_agreement":null},{"id":"W2741722655","doi":"10.1158/1538-7445.am2017-3960","title":"Abstract 3960: Tumor cell drug resistance induced by the programmed death ligand 1 (PD-L1) immune checkpoint is associated with autophagy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Autophagy; Protein kinase B; PI3K/AKT/mTOR pathway; Cell biology; Cancer research; Programmed cell death; Signal transduction; MAPK/ERK pathway; Immune checkpoint; Cancer cell; Biology; Kinase; Cytotoxic T cell; Immune system; Chemistry; Cancer; Apoptosis; Immunology; Immunotherapy; Biochemistry","score_opus":0.06270573317777184,"score_gpt":0.3857097267998381,"score_spread":0.3230039936220663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741722655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766008,0.0074670454,0.0000011967793,0.0068712197,0.000105305335,0.0013925507,0.000063198844,0.00008069894,0.007417929],"genre_scores_gemma":[0.9713908,0.00044937964,0.00001647723,0.00039895237,0.00020692496,0.0006228733,0.000030292644,0.000076942946,0.026807377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676234,0.0001311551,0.00035428026,0.0005575758,0.0012447272,0.00094995316],"domain_scores_gemma":[0.9971345,0.00018833693,0.00029920187,0.0014778174,0.0005538405,0.00034630726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001509112,0.00027357542,0.0004442394,0.000086514316,0.0012125141,0.00030017787,0.0008218905,0.000122005586,0.0004654389],"category_scores_gemma":[0.00029324635,0.00017213872,0.00014387592,0.00026414785,0.0005020628,0.00016633394,0.00013617094,0.0011401857,0.000067767265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006995931,0.0020477993,0.00814503,0.0006155018,0.001324555,0.001255874,0.004793673,9.1540244e-7,0.91239786,0.00014177662,0.052767646,0.009513452],"study_design_scores_gemma":[0.0041389284,0.00020464568,0.19877331,0.0006149997,0.000067285735,0.000004364025,0.00024168886,0.000011261612,0.78387517,0.0002623687,0.011562135,0.00024381772],"about_ca_topic_score_codex":0.0016404723,"about_ca_topic_score_gemma":0.00027699157,"teacher_disagreement_score":0.19062828,"about_ca_system_score_codex":0.00043135945,"about_ca_system_score_gemma":0.0010954443,"threshold_uncertainty_score":0.9325801},"labels":[],"label_agreement":null},{"id":"W2741738423","doi":"10.1158/1538-7445.am2017-4267","title":"Abstract 4267: Association of polygenic risk scores and family history with the risk of chronic lymphocytic leukemia (CLL)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Odds ratio; Chronic lymphocytic leukemia; Single-nucleotide polymorphism; Confidence interval; Medicine; Family history; Internal medicine; Case-control study; Logistic regression; SNP; Oncology; Leukemia; Genetics; Biology; Genotype; Gene","score_opus":0.04556132682735299,"score_gpt":0.3513485043354729,"score_spread":0.3057871775081199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741738423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97557425,0.020121682,0.0000066864573,0.00022953222,0.00011218362,0.00079511123,0.000064114785,0.000018129092,0.003078302],"genre_scores_gemma":[0.9799465,0.015859934,0.000023958846,0.000018929522,0.00030599124,0.000115960276,0.0000043343093,0.000048499216,0.0036759276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961392,0.0003028973,0.00037677723,0.00045630883,0.001983553,0.0007412254],"domain_scores_gemma":[0.9956901,0.0010953877,0.0006717034,0.0014526296,0.00086981105,0.0002203543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003474543,0.00019453547,0.0005045609,0.00024299187,0.0004666612,0.000047963254,0.00066169497,0.00019876148,0.00021730109],"category_scores_gemma":[0.0017012747,0.00012596253,0.00011900593,0.00020588565,0.001705249,0.00016552334,0.0003094348,0.00097328745,0.000022945194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014416667,0.0003887842,0.5066313,0.007720455,0.0059662918,0.00036546707,0.007825798,0.0023655219,0.22770663,0.0005428934,0.11821224,0.10785795],"study_design_scores_gemma":[0.028865984,0.0013615442,0.9259394,0.0012537627,0.0004801157,0.00003081403,0.0005529412,0.008678242,0.02280882,0.00014499997,0.00956462,0.000318771],"about_ca_topic_score_codex":0.1018923,"about_ca_topic_score_gemma":0.0050688065,"teacher_disagreement_score":0.4193081,"about_ca_system_score_codex":0.17259055,"about_ca_system_score_gemma":0.070449285,"threshold_uncertainty_score":0.9348204},"labels":[],"label_agreement":null},{"id":"W2741745850","doi":"","title":"PML nuclear bodies are juxtaposed to DNA-DSBs following IR-induced DNA damage","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"DNA damage; DNA; Promyelocytic leukemia protein; Molecular biology; RAD51; Death-associated protein 6; DNA repair; Biology; DNA replication; Cell cycle; Chemistry; Nuclear protein; Cancer research; Cell; Genetics; Transcription factor","score_opus":0.06706161447952784,"score_gpt":0.3627520009959195,"score_spread":0.2956903865163916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741745850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921116,0.0011097534,0.0000219544,0.00059442804,0.00023107725,0.00029587373,0.000012061783,0.000031184198,0.0055920593],"genre_scores_gemma":[0.99379253,0.00055735663,0.00013232509,0.00036842222,0.0005538501,0.000110305475,0.00002489754,0.00006394649,0.0043963855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782515,0.0001497575,0.00020279846,0.00060423557,0.00053885614,0.0006791807],"domain_scores_gemma":[0.99883,0.000027261767,0.000044576747,0.0005866322,0.00026980907,0.0002416853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042853176,0.00019232125,0.00021680993,0.000114064685,0.0005210167,0.00007566939,0.0005849091,0.00020690648,0.00011429099],"category_scores_gemma":[0.00034241224,0.00018439132,0.00013612318,0.0002766599,0.00015471129,0.0000120736395,0.00037633465,0.0003324029,0.00012970701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010934614,0.000033852506,0.0016200432,0.00005390396,0.00005653464,0.0000980406,0.00039201448,0.000010200079,0.97966313,0.000019421175,0.017266639,0.0006768598],"study_design_scores_gemma":[0.0005062042,0.00025877514,0.0026440753,0.00006850831,0.000008492952,0.000010858237,0.000652251,0.0000066638227,0.9193411,0.0000339768,0.07620131,0.00026777174],"about_ca_topic_score_codex":0.00011267991,"about_ca_topic_score_gemma":0.000064110616,"teacher_disagreement_score":0.06032203,"about_ca_system_score_codex":0.000111607784,"about_ca_system_score_gemma":0.000381172,"threshold_uncertainty_score":0.751926},"labels":[],"label_agreement":null},{"id":"W2741759459","doi":"10.1158/1538-7445.am2017-2014","title":"Abstract 2014: Genitourinary cancer-derived cells produce microenvironment proteinases that regulate proteinase activated receptors (PARs) to drive oncogenic signaling","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Receptor; Furin; Protease-activated receptor; Cell biology; Cancer cell; Biology; Thrombin; Chemistry; Molecular biology; Enzyme; Biochemistry; Cancer; Immunology","score_opus":0.12336290269839714,"score_gpt":0.39065643504927716,"score_spread":0.26729353235088005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741759459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540485,0.00075944734,0.000021627322,0.007435048,0.000450248,0.0056000035,0.000046313395,0.00009106842,0.00019141099],"genre_scores_gemma":[0.99091953,0.00084363844,0.0008310203,0.00016848001,0.00070131134,0.0026433924,0.000020926695,0.000113207774,0.0037585213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960666,0.00020570689,0.00038653094,0.0010730225,0.0012566268,0.0010115311],"domain_scores_gemma":[0.9971118,0.000058131653,0.00029004918,0.0015182162,0.00035830622,0.0006635164],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009581913,0.00037189084,0.00053970393,0.00029725197,0.0011319325,0.00020446876,0.0006276987,0.00020736859,0.0026643772],"category_scores_gemma":[0.00012789191,0.00033790563,0.00015567115,0.00020269134,0.00031733926,0.00028902193,0.0004334868,0.0008076308,0.00038181222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010227096,0.00035653723,0.0011719075,0.00029558042,0.00020364086,0.00011026634,0.00039561256,0.0000998773,0.98317325,0.000007688023,0.0035508755,0.009612044],"study_design_scores_gemma":[0.0014840409,0.0005501803,0.022110514,0.0010493906,0.00006535074,0.0000075969897,0.00024056889,0.000009971728,0.96765584,0.00006871138,0.0064090686,0.0003487415],"about_ca_topic_score_codex":0.0019320877,"about_ca_topic_score_gemma":0.0001179074,"teacher_disagreement_score":0.020938607,"about_ca_system_score_codex":0.00088658184,"about_ca_system_score_gemma":0.000692163,"threshold_uncertainty_score":0.9999073},"labels":[],"label_agreement":null},{"id":"W2741775332","doi":"10.1158/1538-7445.am2017-1309","title":"Abstract 1309: Association between insulin resistance and breast cancer risk: A Mendelian randomization analysis of data from 228,000 women of European descent","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Mendelian randomization; Medicine; Proinsulin; Breast cancer; Insulin resistance; Internal medicine; Type 2 diabetes; Oncology; Insulin; Genome-wide association study; Odds ratio; Endocrinology; Diabetes mellitus; Cancer; Single-nucleotide polymorphism; Biology; Genetic variants; Genetics; Genotype","score_opus":0.115908827501368,"score_gpt":0.4261166334722689,"score_spread":0.3102078059709009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741775332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861733,0.0012921137,0.000042342017,0.0025061935,0.0000423018,0.00035039627,0.009100641,0.0000104035125,0.0004823488],"genre_scores_gemma":[0.9902756,0.008709454,0.000042284148,0.000040854502,0.00034667747,0.000029704433,0.00026892702,0.000025107707,0.0002613654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976307,0.00026253212,0.00046486783,0.00045279376,0.0008417266,0.00034735037],"domain_scores_gemma":[0.9972179,0.0002872856,0.0006685657,0.001099568,0.000556468,0.00017022723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025862663,0.0001237278,0.0006299173,0.00032426696,0.00023129446,0.000070811555,0.00046075447,0.00009283566,0.00059937],"category_scores_gemma":[0.00047875274,0.00010727436,0.000069282316,0.00047067914,0.00018646079,0.0002502051,0.00023683443,0.00042947632,0.0000023957505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018602019,0.00005218468,0.96543694,0.00011679605,0.0023671784,0.000004948014,0.0010053588,0.000025156376,0.0032541866,0.0000015513928,0.002550736,0.023324756],"study_design_scores_gemma":[0.0040595694,0.000025927018,0.9909523,0.00023911119,0.0008049834,5.5364822e-8,0.0001436386,0.00018915728,0.0009311391,0.000023321594,0.002537693,0.00009308976],"about_ca_topic_score_codex":0.049469814,"about_ca_topic_score_gemma":0.00837837,"teacher_disagreement_score":0.041091446,"about_ca_system_score_codex":0.00073284813,"about_ca_system_score_gemma":0.00029178246,"threshold_uncertainty_score":0.9568598},"labels":[],"label_agreement":null},{"id":"W2741781751","doi":"10.1158/1538-7445.am2017-2848","title":"Abstract 2848: Identifying and targeting competing endogenous RNA (ceRNAs) networks to inhibit lung metastasis in triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Competing endogenous RNA; microRNA; Metastasis; Biology; Cancer research; Breast cancer; Triple-negative breast cancer; Transcriptome; RNA; Long non-coding RNA; Cancer; Lung cancer; Primary tumor; Gene; Gene expression; Pathology; Medicine; Genetics","score_opus":0.06736299163641184,"score_gpt":0.3887789335634106,"score_spread":0.32141594192699874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741781751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837328,0.010705587,0.0013886029,0.0010452737,0.00037530935,0.0013368627,0.00019205292,0.000019977933,0.0012035242],"genre_scores_gemma":[0.99415827,0.0039884774,0.00024057229,0.00010295767,0.0006421858,0.00048072095,0.000027429254,0.00009362593,0.00026574335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963567,0.0002803172,0.00040010162,0.0009767108,0.0007276956,0.0012584309],"domain_scores_gemma":[0.99811995,0.00007113121,0.0001712298,0.0007273116,0.00051382923,0.0003965533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021024449,0.0002848124,0.00035322394,0.0003068115,0.0010060783,0.0005036712,0.0008080123,0.00024241868,0.0002785855],"category_scores_gemma":[0.00054073095,0.00030152913,0.00010202135,0.00036092135,0.00026664065,0.00003602176,0.001309453,0.0009961638,0.000009676114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048083655,0.00004274312,0.0011755402,0.00012383396,0.00015564646,0.00009698956,0.0003398015,0.0027678434,0.96487105,0.000022903556,0.0014274846,0.028495329],"study_design_scores_gemma":[0.0024894655,0.00013438262,0.010546117,0.00070121675,0.00003083201,0.00003777481,0.0008874705,0.0018042164,0.980594,0.00007023199,0.0020684323,0.00063589204],"about_ca_topic_score_codex":0.01492997,"about_ca_topic_score_gemma":0.0065866974,"teacher_disagreement_score":0.027859436,"about_ca_system_score_codex":0.00043382752,"about_ca_system_score_gemma":0.00045764734,"threshold_uncertainty_score":0.9999437},"labels":[],"label_agreement":null},{"id":"W2741789238","doi":"10.1158/1538-7445.am2017-4512","title":"Abstract 4512: The landscape of hypoxia-driven alternative splicing in breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Alternative splicing; RNA splicing; Exon; Biology; Gene; Breast cancer; Exonic splicing enhancer; Cancer research; Genetics; RNA; Cancer","score_opus":0.06513415156299326,"score_gpt":0.40671537250394485,"score_spread":0.34158122094095156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741789238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308705,0.001337724,0.000009668815,0.002190055,0.00010378226,0.00018962636,0.00011140225,0.0000017849579,0.0029688866],"genre_scores_gemma":[0.99496704,0.003728144,0.00000945423,0.00004215852,0.00037716626,0.00021824268,0.0000064686956,0.000014165172,0.00063717796],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990556,0.000048707818,0.00014077673,0.00025571074,0.00023496144,0.00026421502],"domain_scores_gemma":[0.99893695,0.000020025902,0.000099728386,0.00065791863,0.00023916355,0.00004618627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040769827,0.00007764173,0.00010310213,0.0000525485,0.0002447413,0.000055054566,0.00066050777,0.000063767264,0.00020164553],"category_scores_gemma":[0.000039211056,0.000055594224,0.000043903165,0.000077283636,0.00026403894,0.0000083586865,0.00017616837,0.00020819981,0.000005169484],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001674923,0.00005107298,0.07354439,0.00003647844,0.000059722628,0.0000032896405,0.00022902258,0.001183321,0.89617807,0.00021356405,0.004922093,0.023411471],"study_design_scores_gemma":[0.0006996705,0.000047142956,0.8423228,0.00013948228,0.000006133975,0.0000028108457,0.00028819757,0.00027463888,0.14810275,0.00011559583,0.007859769,0.0001409681],"about_ca_topic_score_codex":0.0064028306,"about_ca_topic_score_gemma":0.0028420286,"teacher_disagreement_score":0.76877844,"about_ca_system_score_codex":0.00004891541,"about_ca_system_score_gemma":0.0002528138,"threshold_uncertainty_score":0.9679207},"labels":[],"label_agreement":null},{"id":"W2741791382","doi":"10.1158/1538-7445.am2017-3162","title":"Abstract 3162: HRAS G12V predicts for innate resistance to PI3Kα inhibition in head and neck squamous cell cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Western University","funders":"","keywords":"HRAS; PI3K/AKT/mTOR pathway; Cancer research; Head and neck squamous-cell carcinoma; Medicine; Cancer; Biology; Internal medicine; Head and neck cancer; KRAS; Genetics; Signal transduction","score_opus":0.06512195766660148,"score_gpt":0.4036999864886649,"score_spread":0.33857802882206345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741791382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883321,0.0056679137,0.00006497662,0.00248907,0.0001270383,0.0007226162,0.00021963175,0.000006021363,0.0023706667],"genre_scores_gemma":[0.99096847,0.0025046342,0.00015099083,0.00015237142,0.00034974175,0.0014753803,0.00003157102,0.000028272638,0.004338579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860984,0.000034131346,0.0001849496,0.0005130762,0.00021822819,0.000439769],"domain_scores_gemma":[0.99875104,0.00002123439,0.00007236853,0.0007140832,0.00029234544,0.00014891248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004676764,0.00011987593,0.0001295744,0.00009231993,0.00038636662,0.00013260845,0.00028602887,0.00013325943,0.000031724197],"category_scores_gemma":[0.00014116809,0.000119295626,0.000033830853,0.00009503462,0.00019025267,0.000016367036,0.00017856677,0.00018031965,0.0000051296834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072834553,0.00008108669,0.0064572804,0.00024765445,0.000010502737,0.0000060950583,0.0001645646,0.00008108524,0.95549345,0.00012541542,0.028416805,0.008187687],"study_design_scores_gemma":[0.0024031524,0.0002638642,0.12673734,0.0002554145,0.000007199821,8.6761827e-7,0.00008029473,0.000045863355,0.61178535,0.0004159099,0.25768664,0.00031810495],"about_ca_topic_score_codex":0.0011874799,"about_ca_topic_score_gemma":0.013384953,"teacher_disagreement_score":0.34370813,"about_ca_system_score_codex":0.00012657247,"about_ca_system_score_gemma":0.00033029486,"threshold_uncertainty_score":0.7469118},"labels":[],"label_agreement":null},{"id":"W2741806598","doi":"10.1158/1538-7445.am2017-1198","title":"Abstract 1198: Neuropilin-1 blockade chemosensitizes pancreatic cancer cells via dual inhibition of epithelial-mesenchymal transition and autophagy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autophagy; Epithelial–mesenchymal transition; Cancer research; Pancreatic cancer; Gene silencing; Transfection; Cancer cell; Mesenchymal stem cell; Cancer; Biology; Chemistry; Medicine; Cell culture; Apoptosis; Cell biology; Internal medicine; Metastasis","score_opus":0.029382598638717308,"score_gpt":0.3344358222129584,"score_spread":0.30505322357424114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741806598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203885,0.00574678,0.000048379698,0.00059278443,0.0006487117,0.0003481378,0.00025092,0.000010042934,0.00031537973],"genre_scores_gemma":[0.98314667,0.0136456,0.000055101085,0.00006727091,0.002366352,0.00009590864,0.000030039875,0.000035426077,0.0005576194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832577,0.00009676675,0.00026104477,0.00049177377,0.0003763094,0.0004483626],"domain_scores_gemma":[0.9988138,0.000030070418,0.00013950157,0.00053223287,0.00032242044,0.00016194563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043271304,0.00018232646,0.00028312337,0.000086593114,0.00035312676,0.000072344104,0.00016444737,0.00018288862,0.000095313146],"category_scores_gemma":[0.00007542172,0.00017853826,0.00009397812,0.00007097983,0.00056541717,0.000019238989,0.00012274175,0.00027178257,0.000005139175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002804135,0.0000472421,0.000058781417,0.00016475318,0.00004807799,0.000007544532,0.00018577413,0.00005540252,0.9833723,0.000009421843,0.0008226359,0.014947695],"study_design_scores_gemma":[0.0010593132,0.00012245106,0.013750452,0.0000921116,0.000036983543,0.00001049555,0.0000574106,0.000055360048,0.9768805,0.00008328515,0.007671408,0.00018022444],"about_ca_topic_score_codex":0.0025413616,"about_ca_topic_score_gemma":0.0005101275,"teacher_disagreement_score":0.014767471,"about_ca_system_score_codex":0.000033834483,"about_ca_system_score_gemma":0.0003120309,"threshold_uncertainty_score":0.7280579},"labels":[],"label_agreement":null},{"id":"W2741815454","doi":"10.1158/1538-7445.am2017-1351","title":"Abstract 1351: Alternative splicing of neurofibromin 1 is associated with elevated MAPK activity and poor prognosis in glioma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurofibromin 1; Cancer research; Glioma; MAPK/ERK pathway; Neurofibromatosis; Brain tumor; Anaplastic astrocytoma; Gene isoform; PDGFRA; Medicine; PI3K/AKT/mTOR pathway; Biology; Neuroblastoma RAS viral oncogene homolog; Internal medicine; Cancer; Signal transduction; Pathology; Astrocytoma; KRAS; Gene; Genetics; Stromal cell","score_opus":0.10097998642049817,"score_gpt":0.414509978387785,"score_spread":0.31352999196728687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741815454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956757,0.00014003186,1.7491126e-7,0.0029122764,0.000022773662,0.0007540096,0.000051578747,0.000009791248,0.000433668],"genre_scores_gemma":[0.99941933,0.00019537844,0.000015999598,0.000018787478,0.00003056538,0.00022199602,0.0000035300268,0.000023054423,0.00007138072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985254,0.000068345056,0.00015536748,0.0003491983,0.0005315338,0.00037019022],"domain_scores_gemma":[0.99888104,0.00023563264,0.00015734788,0.00028305422,0.00031116523,0.0001317604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044195176,0.00012847861,0.00035239558,0.0002687469,0.0001610478,0.00006145067,0.00012212512,0.00007025019,0.000079706835],"category_scores_gemma":[0.00032782232,0.000095831194,0.000036047517,0.0002510964,0.00023731937,0.0001349901,0.000099946374,0.00029760462,0.0000036091735],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006500216,0.00052487623,0.45684132,0.00011203372,0.0002032566,0.00073572295,0.000402013,0.0000018467531,0.5362074,0.000009548259,0.00022557865,0.004086384],"study_design_scores_gemma":[0.0019049051,0.00031003696,0.53216577,0.0005679431,0.00001872462,0.0000052811884,0.000038253846,0.000070033275,0.4648482,0.000017096332,0.000008023975,0.000045727596],"about_ca_topic_score_codex":0.010932048,"about_ca_topic_score_gemma":0.001203074,"teacher_disagreement_score":0.075324446,"about_ca_system_score_codex":0.00023217926,"about_ca_system_score_gemma":0.00016701716,"threshold_uncertainty_score":0.9956542},"labels":[],"label_agreement":null},{"id":"W2741818496","doi":"10.1158/1538-7445.am2017-5220","title":"Abstract 5220: Chronic exposure to a novel AR-NTD inhibitor induces resistance via a selective metabolism pathway","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Androgen receptor; Cancer research; Biology; Context (archaeology); Cancer; Pharmacology; Medicine; Chemistry; Internal medicine","score_opus":0.09116199209982083,"score_gpt":0.4191056136093095,"score_spread":0.32794362150948864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741818496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657574,0.013168849,0.000027417818,0.009782107,0.00042914567,0.0021800909,0.00017515916,0.00007428384,0.008405538],"genre_scores_gemma":[0.97507447,0.0011637995,0.00018033343,0.00011939282,0.0020509223,0.0014262367,0.000021173753,0.00008098894,0.019882662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995567,0.00009411467,0.0003428753,0.00092726236,0.0016623043,0.0014064424],"domain_scores_gemma":[0.9964191,0.00014982138,0.00012627212,0.001296034,0.0012626993,0.00074611977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012476587,0.00031742384,0.0005755673,0.0004576307,0.0012471738,0.0003214313,0.0007183367,0.00023128025,0.00050571363],"category_scores_gemma":[0.00051530777,0.00024779647,0.0001505167,0.0006095742,0.00054495456,0.00036985075,0.0003775193,0.0013773195,0.00031691388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028247254,0.00042986887,0.0011350402,0.00042418696,0.00032603223,0.00025888404,0.0014243909,0.0000042283327,0.9551711,0.00019223629,0.010758663,0.027050612],"study_design_scores_gemma":[0.007235244,0.00084953493,0.14288142,0.0011394644,0.000046872636,0.000011678922,0.00025943673,0.000004915424,0.7534872,0.0003119176,0.09335792,0.00041433977],"about_ca_topic_score_codex":0.0015422096,"about_ca_topic_score_gemma":0.0020534005,"teacher_disagreement_score":0.20168388,"about_ca_system_score_codex":0.0017699281,"about_ca_system_score_gemma":0.0033052433,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2741828858","doi":"10.1158/1538-7445.am2017-5497","title":"Abstract 5497: LSD1 modulates androgen receptor cistrome in prostate cancer via regulation of FOXA1 chromatin binding","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"FOXA1; Enhancer; Prostate cancer; Chromatin; Androgen receptor; Transcription factor; Epigenomics; Cancer research; Biology; Pioneer factor; Epigenetics; Epigenome; Genetics; Cancer; DNA methylation; Gene expression; Gene","score_opus":0.09032408893395469,"score_gpt":0.43229427222358596,"score_spread":0.34197018328963125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741828858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916072,0.0030431678,0.0000011993209,0.0025444825,0.00016506233,0.0013785765,0.00015500044,0.000024863573,0.0010804301],"genre_scores_gemma":[0.9913105,0.0034375358,0.000096157964,0.000008137197,0.00022897868,0.0005979966,0.00007933574,0.000049522976,0.004191876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971809,0.00010921906,0.00041599653,0.00049494125,0.0010081849,0.00079077814],"domain_scores_gemma":[0.9982019,0.00011841041,0.00020329833,0.00073239626,0.00050925114,0.00023471222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014172351,0.00019156073,0.00044436977,0.0004783722,0.00039755966,0.00009925581,0.00035249133,0.00012928761,0.0013108968],"category_scores_gemma":[0.00022386966,0.0001574725,0.00008949611,0.00039681295,0.00051442225,0.00032512416,0.00017762525,0.0005545207,0.000053485368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015850617,0.00015071858,0.166868,0.0007224711,0.0001216755,0.00005572163,0.00081961066,0.000044584605,0.7913119,0.000016716205,0.0010583436,0.03724517],"study_design_scores_gemma":[0.0031410935,0.00027021326,0.49858093,0.0014767457,0.000018203651,0.000004421769,0.00014166922,0.00031602473,0.49443308,0.00027796824,0.0011695985,0.00017002584],"about_ca_topic_score_codex":0.0058517097,"about_ca_topic_score_gemma":0.0005771066,"teacher_disagreement_score":0.33171296,"about_ca_system_score_codex":0.0011413236,"about_ca_system_score_gemma":0.00087975303,"threshold_uncertainty_score":0.999602},"labels":[],"label_agreement":null},{"id":"W2741843640","doi":"10.1158/1538-7445.am2017-151","title":"Abstract 151: Inhibition of AKT-1 for the treatment of human non-small cell lung cancer (NSCLC) in-vitro","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Carcinogenesis; Biology; Cell growth; Chemistry; Phosphorylation; Cancer; Medicine; Cell biology; Signal transduction; Internal medicine; Biochemistry","score_opus":0.11344639084406657,"score_gpt":0.44913198863831344,"score_spread":0.3356855977942469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741843640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904115,0.005292017,0.00004021773,0.0010331856,0.00016490443,0.0016899498,0.00011095617,0.000004693353,0.001252547],"genre_scores_gemma":[0.9924005,0.0047063767,0.000044399676,0.000027825174,0.00038020083,0.001113405,0.000009757686,0.000028450444,0.0012890374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882776,0.000019243125,0.0002503679,0.00023499614,0.00032776047,0.00033988475],"domain_scores_gemma":[0.9987713,0.0001135472,0.0001553041,0.00058452017,0.00030134062,0.00007395627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044213716,0.0001137499,0.00031523063,0.00013329965,0.0002453402,0.000023856664,0.00017288305,0.00007606957,0.0003338289],"category_scores_gemma":[0.00001293253,0.000077161036,0.00013435479,0.000091314134,0.00017149402,0.00004799624,0.000028198356,0.00016235701,0.0000012079419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013196729,0.00033638004,0.0016834253,0.00046380915,0.00008016001,0.0000075063567,0.0013412756,0.000012571728,0.95586014,0.00010664668,0.00044693347,0.038341492],"study_design_scores_gemma":[0.004972264,0.00075010565,0.022522055,0.00040232777,0.00004455287,2.9027404e-7,0.00024701108,0.00010179456,0.9687017,0.00019451704,0.0019915625,0.000071815746],"about_ca_topic_score_codex":0.017437875,"about_ca_topic_score_gemma":0.0028657867,"teacher_disagreement_score":0.038269676,"about_ca_system_score_codex":0.00045812654,"about_ca_system_score_gemma":0.00048429324,"threshold_uncertainty_score":0.9891051},"labels":[],"label_agreement":null},{"id":"W2741852062","doi":"10.1158/1538-7445.am2017-3381","title":"Abstract 3381: TERT promoter mutation in granulosa cell tumours of the ovary: Prevalence and prognostic significance","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; BC Cancer Agency; McGill University; University of British Columbia","funders":"","keywords":"Missense mutation; Mutation; Biology; Cancer research; Somatic cell; Germline mutation; Mutation rate; Gene; Ovarian cancer; Cancer; Genetics; Medicine; Internal medicine; Oncology","score_opus":0.06707070759494381,"score_gpt":0.3901435211171679,"score_spread":0.32307281352222406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741852062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160963,0.0016018057,8.5854623e-7,0.0038752141,0.00008334867,0.0014870239,0.00002655829,0.0000058815635,0.0013096547],"genre_scores_gemma":[0.99818355,0.0007433125,0.0000442565,0.000025469628,0.00007527935,0.0005357101,0.000001979182,0.000015325713,0.00037514797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998668,0.00006949979,0.00018644893,0.00031959813,0.00046767094,0.00028876844],"domain_scores_gemma":[0.99897087,0.00012858429,0.00010913107,0.0005408414,0.00016443511,0.000086155356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052967365,0.00010009072,0.00018147017,0.00007876332,0.00017821505,0.00005428963,0.000217005,0.000051166484,0.00009709257],"category_scores_gemma":[0.00017154955,0.00006608822,0.000039744074,0.00012135535,0.00037500198,0.00010926782,0.000086696855,0.00029348774,0.0000054413968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014075889,0.00028084437,0.9803438,0.0010757779,0.000012314994,0.00008825503,0.0005244948,0.0000035634396,0.0104993265,0.000027364686,0.00025368892,0.006749788],"study_design_scores_gemma":[0.0012158058,0.00017410456,0.92866117,0.0011098493,0.000029625713,0.0000056668227,0.000035624726,0.000015000077,0.06838202,0.00022760702,0.00008557933,0.000057933168],"about_ca_topic_score_codex":0.0016356352,"about_ca_topic_score_gemma":0.00026265616,"teacher_disagreement_score":0.05788269,"about_ca_system_score_codex":0.00017166063,"about_ca_system_score_gemma":0.00037986462,"threshold_uncertainty_score":0.26949996},"labels":[],"label_agreement":null},{"id":"W2741862285","doi":"10.1158/1538-7445.am2017-5850","title":"Abstract 5850: Salicylate sensitizes prostate cancer (PrCa) to radiotherapy; activation of AMPK and suppression of lipogenesis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"AMPK; LNCaP; Medicine; Cancer research; Internal medicine; Lipogenesis; Prostate cancer; Endocrinology; Clonogenic assay; Cancer; Pharmacology; Chemistry; Protein kinase A; Kinase; Cell; Adipose tissue; Biochemistry","score_opus":0.04321449176635561,"score_gpt":0.39629894388703035,"score_spread":0.35308445212067474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741862285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176633,0.0064701946,0.000021028838,0.00076012994,0.00030009702,0.00038693423,0.00012987474,0.000003701307,0.00016168448],"genre_scores_gemma":[0.9769175,0.021177901,0.00012937131,0.000050201645,0.00078166986,0.00009954684,0.000011984481,0.000026882584,0.000804955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988424,0.000059206814,0.0001884589,0.00032975982,0.00029607583,0.0002840593],"domain_scores_gemma":[0.99880046,0.000022186581,0.00014568584,0.0005178643,0.00039635474,0.00011743208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004134285,0.00011485438,0.00022014802,0.00009659042,0.00017856443,0.000039789717,0.00022388887,0.00011247488,0.00004887415],"category_scores_gemma":[0.00012154298,0.00010207052,0.000051153445,0.00007935801,0.00023804941,0.000014152768,0.00015037833,0.00010504016,5.456578e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070367666,0.000022703209,0.0022724972,0.00013106849,0.000060885137,3.4934828e-7,0.00031462422,0.00007781949,0.9353402,0.00000833563,0.0035741066,0.057493698],"study_design_scores_gemma":[0.0005925499,0.000095026524,0.067189515,0.00012862086,0.00000817281,7.383908e-7,0.0000549405,0.0000074429818,0.87754995,0.000018012652,0.05425306,0.00010197515],"about_ca_topic_score_codex":0.0035307875,"about_ca_topic_score_gemma":0.0003669184,"teacher_disagreement_score":0.06491701,"about_ca_system_score_codex":0.00003225478,"about_ca_system_score_gemma":0.00026413056,"threshold_uncertainty_score":0.5337518},"labels":[],"label_agreement":null},{"id":"W2741869046","doi":"10.1158/1538-7445.am2017-ct038","title":"Abstract CT038: A phase I, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin's lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Lymphoma; Oncology; Toxicity; Internal medicine; Adverse effect","score_opus":0.0878451362308189,"score_gpt":0.4873701892797131,"score_spread":0.3995250530488942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741869046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965117,0.00027294172,0.000034252593,0.0010502775,0.000103155966,0.0018469197,0.000045809487,0.0000039070837,0.0001310671],"genre_scores_gemma":[0.99834436,0.0011411635,0.000049869563,0.00004229406,0.00018096685,0.00011215679,0.000012902641,0.000032104945,0.000084174724],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981026,0.00026610369,0.0003485574,0.00059849827,0.00033593446,0.00034829677],"domain_scores_gemma":[0.9986639,0.00007844362,0.00021940171,0.00058572565,0.0002473542,0.0002051763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019441672,0.00017516909,0.00028768776,0.00010283503,0.00032463443,0.0001570634,0.00052830094,0.00009381567,0.000008807919],"category_scores_gemma":[0.00018152478,0.00013961867,0.000019973348,0.00017399956,0.00067688915,0.000034885612,0.00073559355,0.0002814273,9.981632e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007887641,0.0013092807,0.063231155,0.000070870745,0.00020967527,0.000017801505,0.00045349527,0.00055711495,0.7937227,0.0000041230332,0.00033900494,0.13219716],"study_design_scores_gemma":[0.017643029,0.0024178787,0.7930932,0.00015779641,0.000049878206,0.0000061696796,0.00014701778,0.003844737,0.18198158,0.000031182397,0.00036830042,0.00025923268],"about_ca_topic_score_codex":0.0024176876,"about_ca_topic_score_gemma":0.005165511,"teacher_disagreement_score":0.72986203,"about_ca_system_score_codex":0.00009445081,"about_ca_system_score_gemma":0.0004917572,"threshold_uncertainty_score":0.5693484},"labels":[],"label_agreement":null},{"id":"W2741873611","doi":"10.1158/1538-7445.am2017-1238","title":"Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"SMARCA4; Cancer research; Biology; Ovarian cancer; Ponatinib; SWI/SNF; Receptor tyrosine kinase; Cancer; Growth factor receptor; Kinase; Dasatinib; Chromatin remodeling; Genetics; Epigenetics; Imatinib","score_opus":0.04527327854559892,"score_gpt":0.3137254290354365,"score_spread":0.26845215048983756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741873611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941667,0.0024978844,0.0000049375712,0.0020631969,0.0002536864,0.0005021749,0.00008255485,0.0000053956846,0.00042348687],"genre_scores_gemma":[0.9981116,0.00056272943,0.000096221724,0.00010030573,0.00047454057,0.000089259265,0.000025991618,0.00004203705,0.00049732387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836826,0.00018676228,0.00024323283,0.00039008723,0.0003620078,0.00044961929],"domain_scores_gemma":[0.9983698,0.00009127725,0.00018363967,0.0008531254,0.0004336118,0.00006851651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070404884,0.00018446022,0.00017542542,0.0000344074,0.0005710259,0.00008551373,0.001078184,0.000131618,0.00012343928],"category_scores_gemma":[0.00030980108,0.00009282329,0.00007985265,0.00016570893,0.00051318796,0.000009014554,0.00035958772,0.00057940057,0.000008679815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004372829,0.000042024574,0.0061687212,0.00007536946,0.000018912071,0.0000015865083,0.00036129318,0.00005602418,0.985466,0.0000056995013,0.0059039243,0.001463159],"study_design_scores_gemma":[0.00083812646,0.00014798218,0.0193645,0.00010699655,0.0000049483097,0.0000015857509,0.0003755008,0.000045538847,0.9721318,0.000011307311,0.006818702,0.00015299578],"about_ca_topic_score_codex":0.0021181218,"about_ca_topic_score_gemma":0.00073905656,"teacher_disagreement_score":0.013334188,"about_ca_system_score_codex":0.00009435288,"about_ca_system_score_gemma":0.00056092686,"threshold_uncertainty_score":0.4391927},"labels":[],"label_agreement":null},{"id":"W2741874881","doi":"10.1158/1538-7445.am2017-685","title":"Abstract 685: GPC2 is an oncogene and immunotherapeutic target in high-risk neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroblastoma; Immunohistochemistry; Antibody; Cancer research; Gene; Biology; Molecular biology; Gene expression; Cell culture; Immunology; Genetics","score_opus":0.0949390673230858,"score_gpt":0.43632583397830144,"score_spread":0.3413867666552156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741874881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467474,0.0010066468,9.566597e-7,0.0022873827,0.00008430376,0.0006552255,0.000074724194,0.000027935836,0.001188054],"genre_scores_gemma":[0.9946764,0.003159231,0.00008756421,0.00019070183,0.00016211419,0.00016097019,0.000007720739,0.000058282072,0.0014969916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99738556,0.00017614097,0.00021536472,0.0005916992,0.00080046104,0.00083076593],"domain_scores_gemma":[0.99809474,0.00012332435,0.00007620469,0.0010551227,0.00019734328,0.00045326035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006614929,0.00018716336,0.00031040443,0.00034368536,0.0005551855,0.00020724845,0.00037461275,0.000098828226,0.00092063966],"category_scores_gemma":[0.00017111313,0.00015704306,0.000051428662,0.00017870322,0.00047007078,0.0003002044,0.00020419408,0.0009167563,0.00013402266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051696594,0.0013248689,0.28803888,0.00031468514,0.000332904,0.0030075328,0.00082129095,0.000008860832,0.5258028,0.000081477054,0.0021649308,0.1729321],"study_design_scores_gemma":[0.0041595926,0.0015352382,0.886718,0.00016185304,0.000015742857,0.00003113606,0.0000533454,0.000091802714,0.102882795,0.0005813534,0.0036238055,0.00014536837],"about_ca_topic_score_codex":0.007692249,"about_ca_topic_score_gemma":0.00090239884,"teacher_disagreement_score":0.59867907,"about_ca_system_score_codex":0.00021339976,"about_ca_system_score_gemma":0.0004190458,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2741882389","doi":"10.1158/1538-7445.am2017-3639","title":"Abstract 3639: Therapeutic targeting of tumorigenic EphA2+/EphA3+ brain tumor initiating cells with bi-specific antibody in human glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Erythropoietin-producing hepatocellular (Eph) receptor; Cancer research; EPH receptor A2; Population; Biology; SOX2; Brain tumor; Medicine; Receptor; Pathology; Internal medicine; Receptor tyrosine kinase; Embryonic stem cell","score_opus":0.13695180123214112,"score_gpt":0.43324451287540716,"score_spread":0.29629271164326604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741882389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968682,0.00048602282,0.000021743903,0.00027362086,0.00014566744,0.00047485984,0.000020815416,0.000034976954,0.0016741194],"genre_scores_gemma":[0.999099,0.00018102441,0.000025915408,0.00017443864,0.00026105996,0.00006870495,0.0000011857304,0.0000651794,0.00012345015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963626,0.000273038,0.00051616284,0.0007673523,0.0011031519,0.0009776542],"domain_scores_gemma":[0.9978053,0.00082117843,0.00038587046,0.0006682606,0.00017390725,0.00014549245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015917113,0.00023436414,0.00035894386,0.0003637579,0.0010872845,0.00023872431,0.0012188888,0.00006025842,0.00032523676],"category_scores_gemma":[0.00030697472,0.00020268607,0.00007625419,0.0005390679,0.0007174287,0.0004876394,0.00024217603,0.00093932863,0.00003791337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024803227,0.00009280987,0.005876067,0.00010017325,0.0000053636495,0.00036045586,0.0003575688,0.00019239385,0.99127513,0.00040019472,0.00010520401,0.000986586],"study_design_scores_gemma":[0.0007937205,0.0003257264,0.022157786,0.00041665457,0.0000023022194,0.000007602464,0.00019390695,0.0001010711,0.97481084,0.00035755197,0.00060500234,0.00022784359],"about_ca_topic_score_codex":0.00047842483,"about_ca_topic_score_gemma":0.00014139408,"teacher_disagreement_score":0.01646432,"about_ca_system_score_codex":0.00015265516,"about_ca_system_score_gemma":0.0002617943,"threshold_uncertainty_score":0.8362624},"labels":[],"label_agreement":null},{"id":"W2741892369","doi":"10.1158/1538-7445.am2017-5202","title":"Abstract 5202: Additive benefits of radium-223 dichloride and bortezomib combination in a syngeneic 5TGM1 multiple myeloma mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Weyerhauser (Canada)","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Osteoclast; Prostate cancer; Osteoblast; Bone marrow; In vivo; Cancer research; Osteolysis; Cancer; Urology; Nuclear medicine; Pathology; Internal medicine; Chemistry; In vitro; Surgery; Biology","score_opus":0.1437467403986456,"score_gpt":0.44749219775290466,"score_spread":0.30374545735425906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741892369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492836,0.0006549774,0.000011994766,0.0017039288,0.000014615317,0.00047607368,0.00021443529,0.000012102775,0.0019835106],"genre_scores_gemma":[0.9971392,0.0015468076,0.000057878307,0.000028466742,0.000089962596,0.0003185146,0.000030461772,0.000016504859,0.0007721702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886537,0.000016274955,0.00020021417,0.0002807817,0.00035466213,0.00028271077],"domain_scores_gemma":[0.998925,0.00017752906,0.00007060774,0.00039685707,0.00023168138,0.00019837926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038059053,0.00009286855,0.00020600305,0.00008510117,0.0002080113,0.000031005507,0.00018764602,0.00009086262,0.00005925922],"category_scores_gemma":[0.0004103267,0.00008862952,0.00003242083,0.00011117452,0.00035259232,0.000120349236,0.00008274075,0.00042877402,0.00000518732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007816397,0.0005646013,0.01565567,0.000453386,0.000065032116,0.00001583693,0.00037605778,0.00039753722,0.94956595,0.0010419945,0.0008486937,0.030233592],"study_design_scores_gemma":[0.0027909214,0.000042634074,0.18065654,0.00018223804,0.000016783959,0.0000027003316,0.0000710468,0.010589428,0.80496556,0.00026884768,0.0003204855,0.00009282978],"about_ca_topic_score_codex":0.0003594145,"about_ca_topic_score_gemma":0.00010224276,"teacher_disagreement_score":0.16500087,"about_ca_system_score_codex":0.00015331949,"about_ca_system_score_gemma":0.00018791814,"threshold_uncertainty_score":0.36142066},"labels":[],"label_agreement":null},{"id":"W2741923037","doi":"10.1158/1538-7445.am2017-2479","title":"Abstract 2479: A functionally null <i>RAD51D</i> missense mutation is strongly associated with ovarian carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Montreal Neurological Institute and Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier de l'Université Laval; Jewish General Hospital; University of Ottawa; McGill University Health Centre; Children's Hospital of Eastern Ontario; McGill University","funders":"","keywords":"Biology; Cancer research; Ovarian cancer; Genetics; Missense mutation; Cancer; Mutation; Gene","score_opus":0.04732708050226118,"score_gpt":0.34560406196734667,"score_spread":0.29827698146508547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741923037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925803,0.00073174137,0.000058574322,0.0012444049,0.00020000341,0.00031161314,0.00025699515,0.0000083574605,0.004608019],"genre_scores_gemma":[0.99631214,0.00024284203,0.00005968002,0.00019566248,0.00054466835,0.00011873174,0.00017037874,0.000038815055,0.0023170672],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846005,0.000046019086,0.00017219828,0.00045473123,0.00042141002,0.0004456036],"domain_scores_gemma":[0.99834883,0.00006243741,0.00014164785,0.0006576601,0.0006210502,0.00016835061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047420448,0.00015181243,0.00016527197,0.000060818915,0.00058740115,0.00024467945,0.00034842404,0.00015385005,0.00020032395],"category_scores_gemma":[0.00042823277,0.00013959056,0.0000737909,0.00007002069,0.00023574871,0.000010228241,0.00013522143,0.00025310024,0.000022871323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004351934,0.00047485734,0.0762219,0.00012918554,0.00093754596,0.00046592276,0.00052494253,0.0010746167,0.7818885,0.0008150423,0.12311927,0.009996323],"study_design_scores_gemma":[0.0061138985,0.0011021808,0.7184726,0.00016957837,0.000078871184,0.000034940185,0.00022640076,0.0001835062,0.18447606,0.0003816107,0.08803708,0.00072329526],"about_ca_topic_score_codex":0.0013430578,"about_ca_topic_score_gemma":0.0019283746,"teacher_disagreement_score":0.64225066,"about_ca_system_score_codex":0.00015063901,"about_ca_system_score_gemma":0.0009555069,"threshold_uncertainty_score":0.5692337},"labels":[],"label_agreement":null},{"id":"W2741925895","doi":"10.1158/1538-7445.am2017-1516","title":"Abstract 1516: Androgen-repressed and androgen-induced genes: challenging the traditional dogma of prostate cancer therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Antiandrogens; Enzalutamide; Androgen receptor; Prostate cancer; LNCaP; Bicalutamide; Androgen; Cancer research; Antiandrogen; Internal medicine; Endocrinology; Medicine; Biology; Cancer; Hormone","score_opus":0.253175196669624,"score_gpt":0.44641369464574376,"score_spread":0.19323849797611975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741925895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93939424,0.04800451,5.81093e-7,0.009217218,0.00013841268,0.0013800195,0.00014971777,0.00002125807,0.0016940765],"genre_scores_gemma":[0.91798687,0.07966086,0.000009310717,0.00005327499,0.0003999885,0.0008654613,0.000017991311,0.000040625262,0.0009656354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742824,0.00009609418,0.00026941387,0.0004966777,0.0010344613,0.0006751122],"domain_scores_gemma":[0.99806905,0.0001936173,0.00013216691,0.0008003861,0.00054330745,0.00026146063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010034251,0.00020420337,0.00035685138,0.00017396203,0.0010842212,0.00015130405,0.00040848152,0.00011535505,0.00051657204],"category_scores_gemma":[0.000069891095,0.0001254497,0.00010293239,0.00017466258,0.0008375322,0.00021055496,0.00013651286,0.00058868976,0.0000068668605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042104335,0.00049776107,0.09769668,0.0007742709,0.0011552352,0.000232318,0.0039551086,0.000020066984,0.60600007,0.000526804,0.0020247607,0.28290647],"study_design_scores_gemma":[0.009272804,0.00068042066,0.3643765,0.00080604,0.000054830693,0.000036581343,0.0009586621,0.00014759735,0.61345387,0.0007902479,0.009119396,0.0003030572],"about_ca_topic_score_codex":0.0019532056,"about_ca_topic_score_gemma":0.000114960705,"teacher_disagreement_score":0.2826034,"about_ca_system_score_codex":0.00019659621,"about_ca_system_score_gemma":0.00090365775,"threshold_uncertainty_score":0.83390623},"labels":[],"label_agreement":null},{"id":"W2741931616","doi":"10.1158/1538-7445.am2017-3669","title":"Abstract 3669: Screening platform for development of antibody-drug conjugates against novel targets at the National Research Council of Canada","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Immunoconjugate; Antibody-drug conjugate; Antibody; Monoclonal antibody; Conjugate; Drug; Cancer; Conjugated system; Linker; Chemistry; Cancer research; Computational biology; Medicine; Pharmacology; Biology; Immunology; Computer science; Internal medicine","score_opus":0.37406959709684595,"score_gpt":0.473878833817445,"score_spread":0.09980923672059905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741931616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674155,0.0020063259,0.000018917,0.0068563437,0.000117251904,0.0011637917,0.00060854084,0.0000057040143,0.02180761],"genre_scores_gemma":[0.9847312,0.0004110324,0.0007572956,0.00008661711,0.00031517952,0.00021170854,0.00006977784,0.000031316195,0.013385852],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98927593,0.00004999296,0.0005330596,0.00039328367,0.00875555,0.000992208],"domain_scores_gemma":[0.9843155,0.0015959743,0.00018655029,0.0004525376,0.013168317,0.00028107688],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.012931059,0.00016503676,0.00038911393,0.00017095233,0.002302899,0.00005940402,0.00084614457,0.000084792104,0.00034758495],"category_scores_gemma":[0.004308022,0.00011097151,0.00010005837,0.00021884094,0.001296531,0.00012069199,0.00063342176,0.0007659911,0.0000073349074],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048623392,0.00027951185,0.009906219,0.0022800502,0.0005946468,0.000027948981,0.0020633098,0.00010217276,0.82545054,0.0014040319,0.1387733,0.014255907],"study_design_scores_gemma":[0.0022004356,0.00011022414,0.100374825,0.00093652436,0.0000083727455,0.0000067918972,0.00061228126,0.0005424089,0.4351249,0.0001775194,0.4597113,0.00019440759],"about_ca_topic_score_codex":0.18704453,"about_ca_topic_score_gemma":0.3878908,"teacher_disagreement_score":0.39032567,"about_ca_system_score_codex":0.0031178447,"about_ca_system_score_gemma":0.034316305,"threshold_uncertainty_score":0.99899596},"labels":[],"label_agreement":null},{"id":"W2741932103","doi":"10.1158/1538-7445.am2017-2483","title":"Abstract 2483: Molecular mechanisms of dianhydrogalactitol (VAL-083) in overcoming chemoresistance in glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; DNA damage; Cell cycle; Cancer; Methyltransferase; Chemotherapy; O-6-methylguanine-DNA methyltransferase; Cell cycle checkpoint; Biology; Glioma; Medicine; Internal medicine; DNA; Genetics","score_opus":0.049627209194013484,"score_gpt":0.4018099123291654,"score_spread":0.35218270313515193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741932103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939369,0.00080033095,0.000004979661,0.0015638414,0.000068594476,0.0005046226,0.000009730662,0.0000078448675,0.003103155],"genre_scores_gemma":[0.9991375,0.000348944,0.00009054435,0.000026934542,0.000037016678,0.00026624475,0.0000015170671,0.000025693987,0.000065595625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998235,0.000042547686,0.0002617861,0.00034147443,0.00064227305,0.00047690267],"domain_scores_gemma":[0.9988457,0.00010008253,0.00009586672,0.00070150197,0.00012451177,0.00013236661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059213175,0.00012798622,0.00035048154,0.00040463894,0.00009014887,0.000042999713,0.00025392155,0.00009832688,0.00019037935],"category_scores_gemma":[0.0002851535,0.00011682587,0.00007758807,0.00026033018,0.00014363673,0.00012054246,0.00011280866,0.00036893523,0.000022357372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091039663,0.0010752729,0.099324614,0.00046303394,0.0000787269,0.0037433452,0.00033470677,0.00005213613,0.8829045,0.0021090016,0.0003282227,0.008676043],"study_design_scores_gemma":[0.0025915436,0.00012062407,0.2939256,0.0008308345,0.000008434723,0.0000043411133,0.00008567148,0.00004279121,0.70126104,0.0008854421,0.00016397642,0.0000796467],"about_ca_topic_score_codex":0.0046641207,"about_ca_topic_score_gemma":0.004038554,"teacher_disagreement_score":0.19460101,"about_ca_system_score_codex":0.00049594906,"about_ca_system_score_gemma":0.00023937669,"threshold_uncertainty_score":0.7050786},"labels":[],"label_agreement":null},{"id":"W2741945807","doi":"10.1158/1538-7445.am2017-4336","title":"Abstract 4336: Human mesodermal-derived CNS metastasis-associated stromal cells induce a fibrotic response to limit tumor growth","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network","funders":"","keywords":"Biology; Stromal cell; Cancer research; DNA methylation; Metastasis; Epigenetics; Mesenchymal stem cell; Somatic cell; Extracellular matrix; Cancer; Pathology; TGFBI; Cell biology; Gene; Medicine; Gene expression; Genetics","score_opus":0.1510666473087653,"score_gpt":0.4378756883364141,"score_spread":0.2868090410276488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741945807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886431,0.00027048538,0.0000036467363,0.008184298,0.00013884471,0.0014266103,0.00031171352,0.00006388467,0.0009573857],"genre_scores_gemma":[0.99627316,0.00004545014,0.00033840642,0.00031307325,0.00018482894,0.00043662713,0.000040716917,0.0000791013,0.0022886363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960808,0.0005459265,0.00038847254,0.0007047416,0.0011590928,0.0011209563],"domain_scores_gemma":[0.9967027,0.00044951445,0.00017533684,0.0012705972,0.00062553334,0.0007763302],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025236616,0.00030839784,0.00059988303,0.00035634442,0.0012062222,0.00029417028,0.0005950481,0.00011804771,0.0011261716],"category_scores_gemma":[0.0014187297,0.0002607721,0.00021256285,0.0002822111,0.00030227297,0.00018635024,0.00036505988,0.0008253152,0.000314214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040636067,0.00081341405,0.003700223,0.0001848038,0.000813951,0.0019218259,0.000715391,0.000010584745,0.9764238,0.000081034195,0.009066364,0.0022049854],"study_design_scores_gemma":[0.00533281,0.0019553765,0.5549789,0.0005793946,0.00023242088,0.000021036372,0.00040762222,0.0000128712,0.4337904,0.00012401512,0.002219595,0.00034557935],"about_ca_topic_score_codex":0.0031206126,"about_ca_topic_score_gemma":0.00041036788,"teacher_disagreement_score":0.55127865,"about_ca_system_score_codex":0.0008142592,"about_ca_system_score_gemma":0.0007759135,"threshold_uncertainty_score":0.99998444},"labels":[],"label_agreement":null},{"id":"W2741950369","doi":"10.1158/1538-7445.am2017-79","title":"Abstract 79: Trastuzumab and C6.5 diabody armed with deBouganin overcome drug resistance to ADCs comprised of anti-microtubule agents","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Trastuzumab; Antibody; Chemistry; Mechanism of action; Cancer research; In vitro; Pharmacology; Medicine; Cancer; Immunology; Biochemistry; Internal medicine","score_opus":0.04294500251125982,"score_gpt":0.3513632244022061,"score_spread":0.30841822189094625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741950369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460506,0.0024506098,0.0000395097,0.0005130612,0.0002643346,0.0006995833,0.00014855742,0.000023038168,0.0012562254],"genre_scores_gemma":[0.99169433,0.00062647276,0.00017593574,0.00006495962,0.00003140051,0.00010818215,0.000015547314,0.000036335074,0.0072468617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982562,0.000121301004,0.0002890707,0.00048130908,0.00016444427,0.0006876428],"domain_scores_gemma":[0.9985178,0.00014125009,0.00016024707,0.0008529212,0.00024425157,0.000083529674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069953874,0.00020106233,0.00043002662,0.0001660606,0.00081295084,0.00008588593,0.0007605488,0.00015181,0.00068732246],"category_scores_gemma":[0.00012941183,0.00016771122,0.000049703132,0.00013311548,0.0006537241,0.00015527668,0.00028627925,0.00057894737,0.000101222664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076388585,0.00013581537,0.004696,0.00010970577,0.00014023241,0.000017819408,0.000981831,0.000001933547,0.9837293,0.0002788865,0.007392884,0.0017517294],"study_design_scores_gemma":[0.0025536472,0.00019790058,0.22149172,0.00040242722,0.00001610806,0.000004701298,0.0004086473,5.871456e-7,0.73844093,0.00012911423,0.03610625,0.00024792936],"about_ca_topic_score_codex":0.0008547777,"about_ca_topic_score_gemma":0.0008411862,"teacher_disagreement_score":0.24528833,"about_ca_system_score_codex":0.000115157025,"about_ca_system_score_gemma":0.00024170706,"threshold_uncertainty_score":0.7525699},"labels":[],"label_agreement":null},{"id":"W2741961643","doi":"10.1158/1538-7445.am2017-2292","title":"Abstract 2292: Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Mendelian randomization; Lung cancer; Hazard ratio; Vital capacity; Internal medicine; Cohort; Proportional hazards model; Oncology; Lung cancer screening; Lung; Confidence interval; Diffusing capacity; Lung function; Genotype; Biology","score_opus":0.022048804043852885,"score_gpt":0.3805365370417535,"score_spread":0.3584877329979006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741961643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97837806,0.016278699,0.0008531208,0.00091889384,0.00057492807,0.0022880025,0.00015359565,0.000008702635,0.0005459914],"genre_scores_gemma":[0.9725881,0.02496866,0.0000104700985,0.00004485993,0.00037357336,0.0014008037,0.000028865661,0.000039056205,0.0005455815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99738914,0.0003127586,0.00035505104,0.000669311,0.0008396643,0.00043409123],"domain_scores_gemma":[0.998024,0.00008330802,0.0002890043,0.0006786861,0.0007825451,0.00014248755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021539354,0.00020291778,0.0003025481,0.00017240056,0.0007548389,0.00025116606,0.00053228164,0.00018533041,0.00032422037],"category_scores_gemma":[0.00046649764,0.00015962192,0.0000715832,0.0001421327,0.00059075566,0.00002480664,0.00056822743,0.0005212425,5.661665e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015672764,0.00022873723,0.29057428,0.00031047215,0.003733138,0.000012631468,0.00081656355,0.002096143,0.66311055,0.00024608008,0.01082547,0.012373142],"study_design_scores_gemma":[0.096177325,0.0008941693,0.49501342,0.0008913866,0.0015684742,0.000018812607,0.0020796002,0.04951616,0.34683216,0.00037080003,0.0052485396,0.0013891647],"about_ca_topic_score_codex":0.018323995,"about_ca_topic_score_gemma":0.007038107,"teacher_disagreement_score":0.31627843,"about_ca_system_score_codex":0.00021025447,"about_ca_system_score_gemma":0.0005248828,"threshold_uncertainty_score":0.98821306},"labels":[],"label_agreement":null},{"id":"W2741973413","doi":"10.1158/1538-7445.am2017-4349","title":"Abstract 4349: Adverse &amp; anticancer activities of 5-azaCdR &amp; DNA methyltransferase (DNMT) isoform specific inhibitors: therapeutic implications","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNMT1; DNA methylation; Methyltransferase; Biology; DNA methyltransferase; Cancer research; Carcinogenesis; Epigenetics; Transcriptome; Gene isoform; Methylation; Gene expression; Cancer; Gene; Genetics","score_opus":0.12277684891548882,"score_gpt":0.4284923054907416,"score_spread":0.3057154565752528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741973413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891981,0.0051997113,0.0007344744,0.0007166901,0.00020715327,0.00039490045,0.00015370504,0.000009417138,0.003385833],"genre_scores_gemma":[0.9854591,0.012611994,0.00021884231,0.000024833389,0.0005318801,0.00013770821,0.00008781356,0.00003960732,0.00088824285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982455,0.000093548835,0.00030414827,0.0004592792,0.0003981869,0.00049934007],"domain_scores_gemma":[0.9979708,0.0000808174,0.00014282326,0.0012823065,0.0003727052,0.00015053057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008520898,0.00017475897,0.00020800662,0.0001263289,0.00051284157,0.00008528772,0.0005355024,0.00019062904,0.00027610603],"category_scores_gemma":[0.00012604384,0.00016613645,0.00014210668,0.000120149976,0.00057745,0.000023330396,0.0001371726,0.00028187773,0.000026005637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120395634,0.00008005761,0.005110558,0.000045709607,0.000089172376,4.0935348e-7,0.00016091905,0.000031843385,0.9761726,0.00019751838,0.0006361389,0.01735464],"study_design_scores_gemma":[0.00039598724,0.0000708211,0.06955877,0.000038189057,0.000015049785,4.1457594e-7,0.00007392888,8.719492e-7,0.8152013,0.00076130376,0.113706894,0.00017647739],"about_ca_topic_score_codex":0.00044754017,"about_ca_topic_score_gemma":0.0011048684,"teacher_disagreement_score":0.16097134,"about_ca_system_score_codex":0.00007873256,"about_ca_system_score_gemma":0.000350384,"threshold_uncertainty_score":0.6774848},"labels":[],"label_agreement":null},{"id":"W2741977028","doi":"10.1158/1538-7445.am2017-4752","title":"Abstract 4752: Inflammatory cytokines and hematopoietic stem cells are associated with fatigue and insomnia in breast cancer patients undergoing adjuvant radiation therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Anxiety; Oncology; Hospital Anxiety and Depression Scale; Depression (economics); White blood cell; Gastroenterology; Cancer; CD34; Bone marrow; Immunology; Stem cell; Psychiatry","score_opus":0.052543252619209085,"score_gpt":0.35583052806711446,"score_spread":0.30328727544790535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741977028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912796,0.0070478693,4.1043245e-7,0.0005688032,0.0000971376,0.0008891189,0.00006148322,0.000015898093,0.000039682312],"genre_scores_gemma":[0.97188056,0.027723255,0.0000012839779,0.000048282698,0.0001015446,0.00016306435,0.000007638229,0.00002969809,0.00004467588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983573,0.00010589109,0.0002108514,0.00032058754,0.00059203885,0.00041335082],"domain_scores_gemma":[0.99888504,0.00013056991,0.00015462782,0.00030639375,0.00027664492,0.0002467252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057840726,0.00014553644,0.00035620938,0.00018375371,0.00034822398,0.00008983702,0.00008684815,0.00012494878,0.000024216395],"category_scores_gemma":[0.000050557755,0.000106190586,0.000036873374,0.00012459818,0.00019755134,0.00017972196,0.000047914258,0.00042333276,0.0000013462837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035458492,0.000053725642,0.957984,0.0003836315,0.000093183706,0.000035091256,0.00063413865,0.000010882649,0.00058722065,0.0000019205652,0.00013188095,0.039729763],"study_design_scores_gemma":[0.004994027,0.0001027965,0.99129456,0.0013985783,0.000015227024,0.0000040837126,0.0002322061,0.000022689148,0.0015006516,0.0000064667734,0.00030918504,0.000119524426],"about_ca_topic_score_codex":0.002838464,"about_ca_topic_score_gemma":0.004039309,"teacher_disagreement_score":0.039610237,"about_ca_system_score_codex":0.00040939965,"about_ca_system_score_gemma":0.00056221266,"threshold_uncertainty_score":0.43303266},"labels":[],"label_agreement":null},{"id":"W2741978326","doi":"10.1158/1538-7445.am2017-873","title":"Abstract 873: Evaluating immunotherapy effects using preclinical molecular imaging tools for quantitative immune cell tracking","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Immune system; CD8; Cancer immunotherapy; Magnetic resonance imaging; Cancer; Cancer research; Oncology; Immunology; Internal medicine","score_opus":0.2610743072178658,"score_gpt":0.5714686006991136,"score_spread":0.31039429348124786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741978326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042125,0.015607326,0.0015623859,0.00023113078,0.00019477712,0.0013972933,0.0000637692,0.000010298367,0.00051180256],"genre_scores_gemma":[0.9955735,0.00088712544,0.0024001985,0.000045324294,0.00024552955,0.0005875727,0.000052554078,0.00007222427,0.00013593909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744695,0.00021390585,0.00029877876,0.0006495033,0.00055184617,0.0008389964],"domain_scores_gemma":[0.9978201,0.00035729152,0.00018161874,0.0008910853,0.00059815723,0.0001517706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018612491,0.00020759604,0.00026384782,0.000084703046,0.0010218453,0.00060958567,0.00067726953,0.00011516121,0.000038049544],"category_scores_gemma":[0.001598908,0.00019897016,0.00022513256,0.000072885734,0.0003328473,0.00004890418,0.000264222,0.00034708402,0.000009003931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00125205,0.00010491151,0.0015171423,0.00014303917,0.00015349171,0.000022484304,0.00007081235,0.000106443375,0.9332278,0.000031178555,0.00010465882,0.06326602],"study_design_scores_gemma":[0.0034688092,0.0007900104,0.00784179,0.0002084216,0.000019927096,0.000002713387,0.00008711922,0.00062563055,0.98507035,0.0003511657,0.0012908111,0.00024326808],"about_ca_topic_score_codex":0.0013069295,"about_ca_topic_score_gemma":0.00008899192,"teacher_disagreement_score":0.06302275,"about_ca_system_score_codex":0.00017564323,"about_ca_system_score_gemma":0.00065119314,"threshold_uncertainty_score":0.8113767},"labels":[],"label_agreement":null},{"id":"W2741986277","doi":"10.1158/1538-7445.am2017-1979","title":"Abstract 1979: Cell lines that genomically resemble high-grade serous ovarian carcinomas display differences in growth and invasive capacities in an orthometastatic nude mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Serous fluid; Peritoneal cavity; Cancer research; Ovary; Fallopian tube; In vivo; Disease; Pathology; Medicine; Cancer; Biology; Internal medicine; Genetics","score_opus":0.1639494731255377,"score_gpt":0.3763137029339241,"score_spread":0.21236422980838637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741986277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442273,0.0012017848,0.00000481922,0.0026582088,0.00006829039,0.00092435814,0.00018216172,0.000015810358,0.0005218451],"genre_scores_gemma":[0.9936564,0.0044807727,0.00046019777,0.000072805175,0.00012590078,0.000637437,0.000031519015,0.00004780433,0.0004871589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974796,0.00014979119,0.00033910127,0.00069250044,0.00060010934,0.0007388513],"domain_scores_gemma":[0.99833167,0.00031121526,0.00011722388,0.00073119183,0.00014722902,0.00036149196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052159553,0.00027079752,0.00059385656,0.00045763078,0.00031472876,0.00028089454,0.00038136216,0.00013627975,0.00005857421],"category_scores_gemma":[0.00013937897,0.00021514547,0.000051948355,0.00015828488,0.00053342833,0.0003927044,0.0001787074,0.0006284485,0.0000065352096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058472744,0.0007533668,0.9562651,0.00075581815,0.00007357676,0.00048419432,0.0042288983,0.00013522599,0.0352235,0.0006415974,0.00014855944,0.0007054606],"study_design_scores_gemma":[0.004002068,0.00038067903,0.9405553,0.00037678293,0.000038158534,0.000004285082,0.0011323945,0.00053388055,0.051600754,0.0011310147,0.000008326845,0.00023637882],"about_ca_topic_score_codex":0.045277998,"about_ca_topic_score_gemma":0.05112458,"teacher_disagreement_score":0.016377253,"about_ca_system_score_codex":0.00042428903,"about_ca_system_score_gemma":0.0007921375,"threshold_uncertainty_score":0.9661899},"labels":[],"label_agreement":null},{"id":"W2741997980","doi":"10.1158/1538-7445.am2017-1087","title":"Abstract 1087: CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Midostaurin; Cytarabine; Viability assay; Pharmacology; Flow cytometry; Ex vivo; Cancer research; In vivo; Leukemia; Myeloid leukemia; Medicine; Chemistry; Cell; Biology; Internal medicine; Immunology; Biochemistry; Genetics","score_opus":0.05326379269320802,"score_gpt":0.3919127049360759,"score_spread":0.33864891224286786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741997980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635185,0.0003677635,0.000078027995,0.008628126,0.000108187276,0.0014545877,0.000016077563,0.00006668182,0.02576205],"genre_scores_gemma":[0.99440277,0.0007607537,0.00038241586,0.00013218587,0.00046111338,0.00048964797,0.00005130538,0.00011049942,0.0032093218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994895,0.00017268812,0.0004049712,0.00082029396,0.0023435026,0.0013635852],"domain_scores_gemma":[0.99617267,0.00040803928,0.00014257403,0.0014645075,0.0012027706,0.0006094555],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002101569,0.00031098738,0.00053127157,0.000670864,0.0006546281,0.00043243894,0.0008035312,0.0002956415,0.00036358627],"category_scores_gemma":[0.001110564,0.00022621258,0.00006034276,0.00074534176,0.0014719823,0.00048333264,0.00032721093,0.0027917402,0.0001657232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028220544,0.0027649393,0.41006276,0.0026651477,0.0009067759,0.014419736,0.002735017,0.0009942577,0.10460027,0.0034793394,0.047064915,0.3820863],"study_design_scores_gemma":[0.025541307,0.0030292857,0.91121215,0.009091681,0.00007503292,0.00008579258,0.001622978,0.0023239017,0.031405874,0.00037559506,0.014152063,0.001084344],"about_ca_topic_score_codex":0.0029385749,"about_ca_topic_score_gemma":0.002538076,"teacher_disagreement_score":0.50114936,"about_ca_system_score_codex":0.0022470132,"about_ca_system_score_gemma":0.0029647634,"threshold_uncertainty_score":0.99950886},"labels":[],"label_agreement":null},{"id":"W2742022133","doi":"10.1158/1538-7445.am2017-2646","title":"Abstract 2646: Intratumoral delivery of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, inhibits tumor growth and prolongs animal survival in a subcutaneous B cell lymphoma model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Medicine; In vivo; Phagocytosis; Cancer research; Flow cytometry; Lymphoma; Macrophage; Immunology; Pharmacology; In vitro; Chemistry; Biology","score_opus":0.055801870142840666,"score_gpt":0.3347721452299192,"score_spread":0.27897027508707856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742022133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985847,0.012535573,0.0000033433257,0.00021784288,0.00013734815,0.00043902532,0.000040548297,0.000018804827,0.0007605368],"genre_scores_gemma":[0.9983129,0.0012665407,0.000024293338,0.000020306235,0.00003539952,0.00007593694,0.000014587165,0.000035759098,0.00021430578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801856,0.00021658423,0.00043550722,0.00046043488,0.00015968298,0.00070921745],"domain_scores_gemma":[0.9988503,0.00013626748,0.00024659288,0.00047454552,0.00025266266,0.000039629398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008560987,0.0002197075,0.00044755996,0.00026119183,0.00048429397,0.00010128566,0.00051289424,0.00022121174,0.00005526102],"category_scores_gemma":[0.000071913746,0.0002076578,0.00007646222,0.00013746318,0.0007373087,0.00031802087,0.00031296213,0.0005039441,0.000012063202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021463472,0.0002472005,0.008492647,0.00014684067,0.000059348306,0.000037310954,0.000750589,0.000021565236,0.98223126,0.00022664938,0.00004430197,0.005595951],"study_design_scores_gemma":[0.0036449837,0.00041966396,0.13694863,0.00026146404,0.000017677097,0.000064579,0.00022794795,0.0005128354,0.85725844,0.00026213686,0.00011067192,0.000270949],"about_ca_topic_score_codex":0.0026061402,"about_ca_topic_score_gemma":0.00033536396,"teacher_disagreement_score":0.12845598,"about_ca_system_score_codex":0.0001601673,"about_ca_system_score_gemma":0.00048720147,"threshold_uncertainty_score":0.8468039},"labels":[],"label_agreement":null},{"id":"W2742024316","doi":"10.1158/1538-7445.am2017-4510","title":"Abstract 4510: ADP- dependent glucokinase controls hypoxic gradients, <i>ex vivo</i> avascular and <i>in vivo</i> tumor growth through modulation of HIF-1α/mTOR signaling","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gene knockdown; Biology; Ex vivo; HIF1A; Transactivation; Tumor progression; Cancer research; Glucokinase; In vivo; Tumor microenvironment; PI3K/AKT/mTOR pathway; Cancer cell; Cell biology; Molecular biology; Transcription factor; Cancer; Signal transduction; Gene; Angiogenesis; Biochemistry; Genetics","score_opus":0.032816654312417676,"score_gpt":0.32938255383542553,"score_spread":0.2965658995230078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742024316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829548,0.014416807,0.00009347829,0.00019624055,0.0005262818,0.0006473894,0.00016183,0.000008217897,0.0009949587],"genre_scores_gemma":[0.9908965,0.00716065,0.00014037987,0.00010749112,0.0010890028,0.00015296998,0.000019327663,0.00004547452,0.00038815846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975218,0.000139268,0.00039489503,0.00068916136,0.0006080854,0.00064676814],"domain_scores_gemma":[0.99829733,0.000046580033,0.00021969169,0.0008863817,0.00037042992,0.00017957322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010210085,0.00023822793,0.00040065552,0.00011124671,0.00033058273,0.0001170622,0.0006004658,0.00016744634,0.00010342121],"category_scores_gemma":[0.00039060105,0.00023420838,0.00014548755,0.00011357123,0.00037541948,0.000044007964,0.00032744772,0.0003037657,0.0000043181767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048027807,0.000099210694,0.0025041753,0.00015135306,0.00008234946,0.000012273805,0.00009655015,0.000092377035,0.9933131,0.00009632805,0.0017639975,0.0013080132],"study_design_scores_gemma":[0.0031969554,0.00013204668,0.014041196,0.00013981131,0.000034368903,0.000008541981,0.0001082676,0.00007808784,0.9598855,0.00057712646,0.02149832,0.0002998042],"about_ca_topic_score_codex":0.0030403333,"about_ca_topic_score_gemma":0.000984227,"teacher_disagreement_score":0.033427622,"about_ca_system_score_codex":0.00007048261,"about_ca_system_score_gemma":0.00027174244,"threshold_uncertainty_score":0.955074},"labels":[],"label_agreement":null},{"id":"W2742055748","doi":"10.1158/1538-7445.am2017-2495","title":"Abstract 2495: The metabolic secretome of cachexia inducing pancreatic ductal adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cachexia; Pancreatic cancer; Medicine; Cancer; Cancer research; Pathology; Internal medicine","score_opus":0.07588944674458677,"score_gpt":0.3873394210589425,"score_spread":0.3114499743143557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742055748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473415,0.048878096,0.000007153274,0.00045411527,0.0007059571,0.00031458397,0.00006248057,0.000005844018,0.0022302459],"genre_scores_gemma":[0.9860829,0.008914688,0.000031444655,0.000049719143,0.0030978646,0.0001405205,0.000018199344,0.00003525342,0.0016293798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819565,0.00011919569,0.00023855614,0.00042516997,0.00047502358,0.0005464327],"domain_scores_gemma":[0.9979969,0.000037995513,0.00015968406,0.0013431851,0.0003202122,0.00014198272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010502525,0.00016205398,0.00027320848,0.00008119534,0.0005656381,0.00010605042,0.00097778,0.00015550276,0.00016690552],"category_scores_gemma":[0.00039577324,0.0001208638,0.00013739773,0.00011595773,0.0006288958,0.000013964825,0.00039369025,0.0004107153,0.000015192765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001307616,0.000029837536,0.011733083,0.000059389316,0.00016585436,0.0000043167247,0.0003300761,0.000011100235,0.9764864,0.00025775854,0.003996379,0.006795041],"study_design_scores_gemma":[0.0007046033,0.00007285204,0.5050215,0.000054193453,0.000057160756,0.000020167701,0.00035904892,0.00000639685,0.38422632,0.00015542727,0.10911881,0.0002034751],"about_ca_topic_score_codex":0.0035414333,"about_ca_topic_score_gemma":0.0005205473,"teacher_disagreement_score":0.59226006,"about_ca_system_score_codex":0.00002813014,"about_ca_system_score_gemma":0.00056454685,"threshold_uncertainty_score":0.5353611},"labels":[],"label_agreement":null},{"id":"W2742056064","doi":"10.1158/1538-7445.am2017-741","title":"Abstract 741: Rapid detection of necrosis in breast cancer with <i>ex vivo</i> and <i>in situ</i> mass spectrometry analysis methods","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network","funders":"","keywords":"Cancer; Breast cancer; Pathology; Mass spectrometry imaging; Cancer cell; Tissue microarray; Cancer research; Mass spectrometry; Chemistry; Biology; Medicine; Internal medicine; Chromatography","score_opus":0.0391313560561059,"score_gpt":0.40992917469449724,"score_spread":0.37079781863839134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742056064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756688,0.0011115209,0.00069686817,0.0010335161,0.000012667013,0.0002098926,0.00016121483,0.000033831995,0.021071691],"genre_scores_gemma":[0.99301714,0.0031664548,0.0029763763,0.0000118590615,0.000066335066,0.0004078789,0.0000037876357,0.000026610018,0.00032356477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981918,0.000059265523,0.00030855343,0.00053317513,0.00041649377,0.0004907455],"domain_scores_gemma":[0.99850386,0.00016046922,0.0001956379,0.0008608232,0.00015871368,0.00012051075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010645302,0.00016690903,0.00041831334,0.00068295124,0.00022470028,0.00012388121,0.00047947775,0.00014564872,0.0027567872],"category_scores_gemma":[0.00003782263,0.00015106454,0.00008145003,0.0015473603,0.0002986438,0.00016511056,0.0001246365,0.00066860893,9.932403e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016283571,0.00007058529,0.07838125,0.00015285025,0.000112965725,0.0000052236187,0.00004369705,0.000015611455,0.90626764,0.00005852675,0.000039341085,0.014689454],"study_design_scores_gemma":[0.00041786834,0.000018561002,0.1642799,0.00009965773,0.000052299147,0.000002295201,0.00008684504,0.00013064843,0.8338117,0.0004858758,0.00045889386,0.00015547701],"about_ca_topic_score_codex":0.015707266,"about_ca_topic_score_gemma":0.008735314,"teacher_disagreement_score":0.085898645,"about_ca_system_score_codex":0.00042490652,"about_ca_system_score_gemma":0.000120194476,"threshold_uncertainty_score":0.9981548},"labels":[],"label_agreement":null},{"id":"W2742062606","doi":"10.1158/1538-7445.am2017-1517","title":"Abstract 1517: AKT inhibition induces neuroendocrine phenotype in prostate cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Protein kinase B; Cancer research; Ubiquitin ligase; Prostate cancer; Degron; PI3K/AKT/mTOR pathway; LNCaP; Carcinogenesis; Biology; Ubiquitin; Gene silencing; Signal transduction; Cancer; Chemistry; Cell biology; Biochemistry; Genetics; Gene","score_opus":0.14054911809857382,"score_gpt":0.44039945453802637,"score_spread":0.2998503364394526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742062606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832999,0.00095270266,2.3392157e-7,0.0121693155,0.00018674655,0.000504205,0.00001489977,0.000020173331,0.0028518173],"genre_scores_gemma":[0.9949366,0.002161906,0.000012249975,0.00024352189,0.00031084623,0.00012271095,0.000009662205,0.000025685094,0.0021768082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99840677,0.000043626133,0.00019581655,0.00030470654,0.00062783266,0.00042127926],"domain_scores_gemma":[0.99897426,0.00004385507,0.000066398796,0.00038232584,0.000355731,0.00017740726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003316591,0.00010447699,0.00020792523,0.0002240278,0.00027482118,0.00008927906,0.000117197895,0.000037264905,0.00072170293],"category_scores_gemma":[0.00016022255,0.00008582206,0.00003730378,0.0001627955,0.00018460119,0.00020182112,0.00009625187,0.0005568451,0.00010977736],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053645426,0.00010747903,0.009759996,0.00011953155,0.000013646658,0.00068165804,0.00026014872,0.00002943911,0.9279339,0.000083064915,0.0046421015,0.05583263],"study_design_scores_gemma":[0.0018764683,0.00010804442,0.67257386,0.00045096732,0.0000092136825,0.0000116350875,0.00013118458,0.00010196294,0.30459332,0.0001747125,0.019852804,0.00011580992],"about_ca_topic_score_codex":0.0064773583,"about_ca_topic_score_gemma":0.0009903929,"teacher_disagreement_score":0.66281384,"about_ca_system_score_codex":0.00023202895,"about_ca_system_score_gemma":0.00044474218,"threshold_uncertainty_score":0.97918713},"labels":[],"label_agreement":null},{"id":"W2742074347","doi":"10.1158/1538-7445.am2017-5694","title":"Abstract 5694: Multi institutional evaluation of a new NGS assay for mutation detection from cfDNA in lung cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"KRAS; Multiplex; Lung cancer; Liquid biopsy; Neuroblastoma RAS viral oncogene homolog; COLD-PCR; Ion semiconductor sequencing; Cancer; Biology; Molecular biology; Cancer research; DNA sequencing; Computational biology; Mutation; Gene; Oncology; Medicine; Genetics; Point mutation; Colorectal cancer","score_opus":0.12824419646318824,"score_gpt":0.46732953542874556,"score_spread":0.3390853389655573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742074347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904974,0.0031942215,0.0046168957,0.00022931228,0.0003680516,0.0006721178,0.00026480478,0.000002186818,0.00015497293],"genre_scores_gemma":[0.99770325,0.0006422676,0.00031135822,0.000021262298,0.00057854335,0.0005008486,0.00012261647,0.000013889674,0.00010593122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989182,0.000047872618,0.00018360085,0.00029677176,0.0003496287,0.00020397655],"domain_scores_gemma":[0.9988679,0.000059951188,0.00011894061,0.0002947975,0.0005933668,0.00006499383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010941749,0.000084041596,0.00010772095,0.000078416335,0.0001984477,0.000054695698,0.00020461099,0.00012617132,0.00007866732],"category_scores_gemma":[0.0010985585,0.00008540313,0.00005184812,0.000053473515,0.00010196207,0.000013545143,0.00007053991,0.00011766376,0.0000013486195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040533766,0.00006239506,0.008255515,0.000057664663,0.00006453624,0.0000010277633,0.00017287419,0.008571326,0.7547128,0.0000370463,0.0016876159,0.22597185],"study_design_scores_gemma":[0.0044099786,0.00009529952,0.24891953,0.00014575176,0.00004666434,5.08278e-7,0.000065229775,0.023832267,0.71534353,0.0008404851,0.0061095003,0.00019123369],"about_ca_topic_score_codex":0.022966083,"about_ca_topic_score_gemma":0.04428737,"teacher_disagreement_score":0.24066402,"about_ca_system_score_codex":0.00032379356,"about_ca_system_score_gemma":0.0015653331,"threshold_uncertainty_score":0.98354006},"labels":[],"label_agreement":null},{"id":"W2742102900","doi":"10.1158/1538-7445.am2017-ct047","title":"Abstract CT047: Phase 1 dose-escalation study of the CDK inhibitor dinaciclib in combination with the PARP inhibitor veliparib in patients with advanced solid tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Veliparib; PARP inhibitor; Medicine; Neutropenia; Febrile neutropenia; Mucositis; Internal medicine; Oncology; Nausea; Pharmacology; Chemotherapy; Poly ADP ribose polymerase; Chemistry","score_opus":0.044301939687582274,"score_gpt":0.40816896319788265,"score_spread":0.36386702351030037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742102900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949269,0.0001091747,0.000005705046,0.0014572837,0.00010681183,0.0032359716,0.000017256552,0.000014185543,0.0001266865],"genre_scores_gemma":[0.9990239,0.000012614266,0.000021189453,0.00003075683,0.000102545535,0.000673059,0.000009064618,0.000045261895,0.0000816231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972517,0.0001709726,0.00038425744,0.00041986335,0.0012984705,0.00047476948],"domain_scores_gemma":[0.9979058,0.00013493797,0.00033987412,0.00094308075,0.00058943836,0.000086852975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007318069,0.00020309578,0.00037818728,0.00020753157,0.0003759463,0.00005668284,0.000432634,0.00006341492,0.000029472187],"category_scores_gemma":[0.00017770742,0.000109566594,0.000031612784,0.00056725804,0.00055454543,0.00045251093,0.00014302149,0.00080582715,0.0000024261544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016276645,0.0045039877,0.8973666,0.00015068737,0.00007384797,0.00002216059,0.005303443,0.0008040093,0.009312685,0.000029504028,0.000051668136,0.06610481],"study_design_scores_gemma":[0.028354567,0.0024643384,0.95508116,0.000928075,0.000015947706,8.666835e-7,0.0021435523,0.000046242985,0.010646518,0.000049506638,0.0001370452,0.00013216103],"about_ca_topic_score_codex":0.000819723,"about_ca_topic_score_gemma":0.003080738,"teacher_disagreement_score":0.06597265,"about_ca_system_score_codex":0.00060366705,"about_ca_system_score_gemma":0.00038757277,"threshold_uncertainty_score":0.4467996},"labels":[],"label_agreement":null},{"id":"W2742105399","doi":"10.1158/1538-7445.am2017-3543","title":"Abstract 3543: Targeting the metabolic mevalonate pathway with statins as anti-breast cancer agents","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Statin; Atorvastatin; Fluvastatin; Medicine; Breast cancer; Cancer; Apoptosis; Pharmacology; Mevalonate pathway; Cancer research; HMG-CoA reductase; Oncology; Internal medicine; Simvastatin; Chemistry","score_opus":0.0491511074851894,"score_gpt":0.3886884118912544,"score_spread":0.339537304406065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742105399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98068446,0.010356345,0.000010108448,0.0022042892,0.0025754317,0.0004955384,0.00046855045,0.000014746515,0.003190517],"genre_scores_gemma":[0.9696722,0.015389906,0.000029614888,0.00029812774,0.010658998,0.0003994212,0.000037043137,0.00006513605,0.0034495394],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748623,0.00014390296,0.00022195526,0.0006093306,0.00071057974,0.0008279995],"domain_scores_gemma":[0.9980054,0.000024870049,0.0001784101,0.0010140609,0.0005557377,0.0002215491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010562238,0.00023742703,0.00026543587,0.000064750195,0.0012163129,0.00028536076,0.0009850358,0.0001241163,0.0005390348],"category_scores_gemma":[0.0001457171,0.00015575031,0.00010455919,0.00012596647,0.00056868844,0.000023467626,0.00034417948,0.000466534,0.00003941313],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069197465,0.00010689867,0.02524791,0.0001048894,0.00049996795,0.000005410817,0.00070456945,0.0003828665,0.8298809,0.00039599606,0.08986854,0.052110113],"study_design_scores_gemma":[0.00086286274,0.000045810946,0.17160514,0.00005722647,0.000026145972,0.00000899391,0.0002515459,0.00001178991,0.09322653,0.00003842703,0.73362684,0.0002386693],"about_ca_topic_score_codex":0.00827497,"about_ca_topic_score_gemma":0.0017096512,"teacher_disagreement_score":0.73665434,"about_ca_system_score_codex":0.000051700095,"about_ca_system_score_gemma":0.0010992403,"threshold_uncertainty_score":0.998329},"labels":[],"label_agreement":null},{"id":"W2742110227","doi":"10.1158/1538-7445.am2017-923","title":"Abstract 923: Human embryonic stem cells exhibit altruistic cell death that release death signals having potent anti-cancer activity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Embryonic stem cell; Stem cell; Apoptosis; Biology; Flow cytometry; Cancer cell; Cancer stem cell; Programmed cell death; Mesenchymal stem cell; Cell biology; Cancer research; Immunology; Cancer; Genetics","score_opus":0.12089880191060233,"score_gpt":0.39968218289895446,"score_spread":0.27878338098835215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742110227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027807,0.0030416888,0.000076886165,0.00040771673,0.00027662978,0.0009876343,0.00021414987,0.000029889048,0.004687321],"genre_scores_gemma":[0.97331876,0.0048339963,0.000026963755,0.000049004055,0.0006404401,0.0003654543,0.0000321135,0.000121347184,0.020611953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946157,0.00039701286,0.00032595167,0.0014183326,0.0014832036,0.001759805],"domain_scores_gemma":[0.99625653,0.00009866614,0.00029812704,0.0021301047,0.0005736902,0.00064286106],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0017483602,0.00044397323,0.0004737918,0.00022106519,0.0018962953,0.00059268856,0.0018777698,0.0003937483,0.0005100665],"category_scores_gemma":[0.0000831236,0.00042614227,0.00026583273,0.00012544278,0.00042401737,0.00004561644,0.0012667768,0.0011214465,0.00016305204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019575663,0.00024343103,0.0134198135,0.00039052797,0.00009814069,0.00011937849,0.000028495997,0.0002957701,0.97830015,0.000012317103,0.0032311506,0.0036650912],"study_design_scores_gemma":[0.0009974347,0.00020354961,0.03704684,0.00020059639,0.000025043137,0.00000377208,0.000050453607,0.000101089936,0.95515585,0.000028651639,0.005721883,0.00046481105],"about_ca_topic_score_codex":0.003056477,"about_ca_topic_score_gemma":0.00040077456,"teacher_disagreement_score":0.023627026,"about_ca_system_score_codex":0.00046064227,"about_ca_system_score_gemma":0.0009790933,"threshold_uncertainty_score":0.99981904},"labels":[],"label_agreement":null},{"id":"W2742113981","doi":"10.1158/1538-7445.am2017-2258","title":"Abstract 2258: Genome-wide association studies of breast cancer prognosis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Oncology; Genotype; Medicine; Proportional hazards model; Internal medicine; Cancer; Genome-wide association study; SNP; Single-nucleotide polymorphism; Disease; Biology; Genetics; Gene","score_opus":0.09750459280749589,"score_gpt":0.4464497097541425,"score_spread":0.3489451169466466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742113981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98240626,0.008471174,0.000005363746,0.007049497,0.00032806312,0.00031991774,0.00027409798,0.0000068540116,0.0011387984],"genre_scores_gemma":[0.98661494,0.009742613,0.0000691995,0.000110704714,0.0006373067,0.00060452236,0.000017139024,0.000027414295,0.002176134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984731,0.00006942566,0.00021734167,0.0003655437,0.00048214922,0.00039244688],"domain_scores_gemma":[0.9976431,0.000102358536,0.00024386848,0.0005736149,0.0013691419,0.0000678872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009048118,0.000114258146,0.00017996883,0.00007433286,0.00044019803,0.00006786765,0.000520711,0.00014094477,0.00017530023],"category_scores_gemma":[0.0009876451,0.00010882365,0.000075404736,0.000101117956,0.00031220072,0.000012635668,0.00029712162,0.00020263376,0.000012796147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012498323,0.00006830383,0.45894772,0.00018522271,0.0006405102,0.000002240666,0.0003383247,0.00016883292,0.4840454,0.000013915299,0.04555197,0.009912568],"study_design_scores_gemma":[0.0004223276,0.0000527556,0.70388734,0.00008201299,0.000023342705,6.565612e-7,0.00028395027,0.0000026135376,0.26448363,0.000114004455,0.030497983,0.000149383],"about_ca_topic_score_codex":0.00073516864,"about_ca_topic_score_gemma":0.0010109568,"teacher_disagreement_score":0.24493961,"about_ca_system_score_codex":0.00073108316,"about_ca_system_score_gemma":0.00078034867,"threshold_uncertainty_score":0.44376996},"labels":[],"label_agreement":null},{"id":"W2742123207","doi":"10.1158/1538-7445.am2017-5775","title":"Abstract 5775: A unique 3D tissue-engineered human melanoma model combining lymphatic and blood microvasculature to study cancer cell dissemination","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"CD31; Lymphatic system; Pathology; Melanoma; Metastasis; Medicine; Tumor microenvironment; Lymphatic vessel; Cancer; Cancer research; Immunohistochemistry; Internal medicine","score_opus":0.06593859560795126,"score_gpt":0.4366646552455169,"score_spread":0.37072605963756566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742123207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909303,0.0050818166,0.000048100912,0.00065700244,0.00010112645,0.0014921816,0.000053700514,0.00003086118,0.0016049208],"genre_scores_gemma":[0.9935728,0.001469866,0.00040556575,0.000050412687,0.00019106432,0.0005707128,0.000015072381,0.000059950526,0.0036645827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801755,0.000055721943,0.00024783265,0.0005358828,0.0006327197,0.0005102639],"domain_scores_gemma":[0.9983198,0.00006098157,0.00008367705,0.0008087106,0.00036067088,0.00036616594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008158357,0.00021065059,0.00040362286,0.00017062077,0.0006274428,0.00019368745,0.00029478944,0.00010856703,0.000334298],"category_scores_gemma":[0.00006243735,0.00018968113,0.00005639653,0.00015898391,0.000099207464,0.00015804071,0.00016483109,0.00036991638,0.000005763562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021492093,0.00071932864,0.0067450167,0.0006669003,0.0003400906,0.00013196407,0.0061765485,0.00021267285,0.9451674,0.000039625826,0.0017599361,0.037825573],"study_design_scores_gemma":[0.0108141,0.0014720934,0.19767319,0.0017278562,0.0009000058,0.000026666197,0.0023660439,0.0007669466,0.78002936,0.000113549824,0.0032880453,0.00082214957],"about_ca_topic_score_codex":0.007024737,"about_ca_topic_score_gemma":0.0026442865,"teacher_disagreement_score":0.19092818,"about_ca_system_score_codex":0.00032623205,"about_ca_system_score_gemma":0.0002720954,"threshold_uncertainty_score":0.9995876},"labels":[],"label_agreement":null},{"id":"W2742123569","doi":"10.1158/1538-7445.am2017-5143","title":"Abstract 5143: Fusogenic targeted liposomes: novel nanotherapy for specific treatment of prostate cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Biodistribution; Liposome; Bombesin; Doxorubicin; Prostate cancer; Cancer; Cancer research; In vivo; Chemistry; Prostate; Targeted drug delivery; Medicine; Pharmacology; Biology; In vitro; Chemotherapy; Internal medicine; Biochemistry; Drug; Receptor","score_opus":0.11445109240031276,"score_gpt":0.42060368472735854,"score_spread":0.3061525923270458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742123569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98396903,0.013963561,0.000029344015,0.0003821488,0.0002635921,0.00065591186,0.000489797,0.000004303212,0.00024230986],"genre_scores_gemma":[0.9636306,0.030540064,0.000092667135,0.000027135406,0.00053890387,0.0007260454,0.00005866449,0.00003071407,0.0043551866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987948,0.000017463512,0.00018840621,0.00039795772,0.00019425183,0.00040710298],"domain_scores_gemma":[0.9987212,0.000017348473,0.00011319599,0.00065174676,0.0004156126,0.00008090523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001786393,0.0001425507,0.00018717254,0.000063229745,0.00025942328,0.000063127554,0.00040606956,0.00011226033,0.00020067746],"category_scores_gemma":[0.000022883705,0.00011657215,0.00013787538,0.000044216657,0.0002171725,0.000007986675,0.00005331655,0.00006423436,0.000008117561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083828723,0.00014491544,0.0029375826,0.00004057955,0.00016427466,0.0000014103653,0.00015514642,0.000030334397,0.9621871,0.00001128396,0.00418013,0.029308954],"study_design_scores_gemma":[0.0013488093,0.00080988934,0.009009673,0.000044366778,0.0000061711153,6.215295e-7,0.0000555376,0.0000061037663,0.86289215,0.000029397073,0.12567544,0.000121833466],"about_ca_topic_score_codex":0.000962631,"about_ca_topic_score_gemma":0.00067678036,"teacher_disagreement_score":0.121495314,"about_ca_system_score_codex":0.000088700865,"about_ca_system_score_gemma":0.00036752326,"threshold_uncertainty_score":0.47536743},"labels":[],"label_agreement":null},{"id":"W2742126530","doi":"10.1158/1538-7445.am2017-1943","title":"Abstract 1943: High-throughput chemical screening identifies Focal Adhesion Kinase and Aurora Kinase B inhibition as a synergistic treatment combination in Ewing sarcoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Aurora inhibitor; Sarcoma; Cancer research; Focal adhesion; Aurora kinase; Ewing's sarcoma; Kinase; Aurora B kinase; Medicine; Cell growth; Viability assay; Cell culture; Biology; Cancer; Cell; Internal medicine; Pathology; Cell cycle; Spindle apparatus; Cell biology; Cell division; Biochemistry; Genetics","score_opus":0.04983997827201839,"score_gpt":0.3716651660643212,"score_spread":0.32182518779230285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742126530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793524,0.00091411424,0.00013312769,0.000404815,0.00010365762,0.00031486663,0.00002610089,0.000008117973,0.00015996599],"genre_scores_gemma":[0.9979173,0.0011953324,0.0001080978,0.00002923342,0.00017592104,0.00013348911,0.00017288944,0.000024136732,0.00024360769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986431,0.00007712732,0.00019882648,0.0004748677,0.0002369925,0.000369103],"domain_scores_gemma":[0.9992443,0.000035712375,0.000076007935,0.00041243774,0.00012488509,0.00010669612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036987005,0.00015247328,0.00016168601,0.00010464035,0.000364994,0.00019096592,0.00016188239,0.00017633045,0.000019880341],"category_scores_gemma":[0.00022394405,0.00014962936,0.000048344773,0.000061317776,0.00025140465,0.00002565851,0.00031975703,0.00020204786,0.0000072318544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021745209,0.00013636297,0.0011461609,0.000058152276,0.00002042185,0.00006748799,0.000076559205,0.000012759383,0.9765889,0.00017808865,0.00023253549,0.021265112],"study_design_scores_gemma":[0.0017450508,0.00028917604,0.013787206,0.00023237718,0.00001197132,0.0000059646095,0.00010991009,0.00016024016,0.98218745,0.0005835603,0.0007061068,0.00018100855],"about_ca_topic_score_codex":0.0039408617,"about_ca_topic_score_gemma":0.0008335922,"teacher_disagreement_score":0.021084104,"about_ca_system_score_codex":0.00016029125,"about_ca_system_score_gemma":0.0001227837,"threshold_uncertainty_score":0.61017084},"labels":[],"label_agreement":null},{"id":"W2742128580","doi":"10.1158/1538-7445.am2017-830","title":"Abstract 830: MiRNA-106a and LITAF are novel modulators of prostate cancer radioresistance","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Sunnybrook Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Radioresistance; Clonogenic assay; Prostate cancer; Cancer research; microRNA; Gene knockdown; Carcinogenesis; Cancer; Biology; Medicine; Radiation therapy; Gene; Internal medicine; Cell; Genetics","score_opus":0.04772409668259939,"score_gpt":0.38439036048377895,"score_spread":0.3366662638011796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742128580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890237,0.009665756,0.000012280663,0.00043564703,0.0001013611,0.00032746178,0.00024004778,0.0000045009224,0.00018928276],"genre_scores_gemma":[0.9964868,0.0021251687,0.00007777896,0.000014142,0.00019726952,0.000119918084,0.000016207658,0.000025761416,0.00093695713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882644,0.000029400637,0.00016801528,0.00037793245,0.00028653018,0.00031168127],"domain_scores_gemma":[0.9986766,0.000010847576,0.00017075881,0.00064907636,0.00036317128,0.00012952028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033436806,0.00011248036,0.00014695038,0.000053597072,0.00025711945,0.00006900444,0.00031757547,0.00010783703,0.00004384559],"category_scores_gemma":[0.00015694978,0.00010810948,0.00004658537,0.000056448494,0.00045884697,0.000012199827,0.00017500404,0.00012961059,0.0000016044711],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023678558,0.00003544981,0.04168213,0.00021001679,0.000054211225,0.0000023898506,0.000053511718,0.000052220785,0.95337284,0.00003892811,0.0020590809,0.0022024424],"study_design_scores_gemma":[0.0005671648,0.000025773816,0.5192896,0.00014909677,0.0000066615357,7.4406245e-7,0.00003172778,0.000028310951,0.4731331,0.000052090272,0.006606524,0.000109197696],"about_ca_topic_score_codex":0.0006596342,"about_ca_topic_score_gemma":0.0004549984,"teacher_disagreement_score":0.48023975,"about_ca_system_score_codex":0.00006699553,"about_ca_system_score_gemma":0.00025978085,"threshold_uncertainty_score":0.44085768},"labels":[],"label_agreement":null},{"id":"W2742146827","doi":"10.1158/1538-7445.am2017-3149","title":"Abstract 3149: Identification of genes associated with the cisplatin resistance in cervical cancer cells expressing E545K mutation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cisplatin; Cervical cancer; Medicine; Mutation; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Gene; Phenotype; Molecular biology; Pathology; Internal medicine; Biology; Chemotherapy; Genetics; Signal transduction","score_opus":0.07989371942787618,"score_gpt":0.4571750191036448,"score_spread":0.3772812996757686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742146827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909548,0.0023177532,0.00002741557,0.003905779,0.00009002797,0.0006496245,0.00007329278,0.000011842665,0.0019694485],"genre_scores_gemma":[0.9967866,0.00033335557,0.000056200843,0.00002963548,0.00009294276,0.00046070854,0.000023953166,0.000021939604,0.0021946535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847674,0.00008336501,0.0002628751,0.00027052275,0.0006245214,0.0002819476],"domain_scores_gemma":[0.9984695,0.00018966204,0.0002638574,0.00048823407,0.00052323367,0.0000655584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064061506,0.00009733316,0.00018880093,0.000113249174,0.00045971212,0.000107715394,0.00021717284,0.0000703624,0.00013095025],"category_scores_gemma":[0.00013703115,0.00006409493,0.00003539565,0.00023435795,0.00030440738,0.00018767982,0.000035718407,0.00027208903,0.0000048617744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001456787,0.0006034939,0.13468345,0.00072979904,0.0005527569,0.00015283354,0.008847559,0.0009228485,0.81054074,0.00044703836,0.004811923,0.03625076],"study_design_scores_gemma":[0.0016491312,0.00004316976,0.85417634,0.00087515207,0.00007602306,5.560204e-7,0.00050645595,0.00011388689,0.14173526,0.00015538845,0.00058462116,0.0000840222],"about_ca_topic_score_codex":0.003533179,"about_ca_topic_score_gemma":0.014401918,"teacher_disagreement_score":0.7194929,"about_ca_system_score_codex":0.00053748995,"about_ca_system_score_gemma":0.0006227821,"threshold_uncertainty_score":0.8036608},"labels":[],"label_agreement":null},{"id":"W2742153223","doi":"10.1158/1538-7445.am2017-4439","title":"Abstract 4439: The urine miRNA transcriptome of prostate cancer is temporally stable and predicts disease aggressivity","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Cancer; Prostate; Malignancy; Medicine; Disease; Oncology; microRNA; Rectal examination; Prostate-specific antigen; Cohort; Internal medicine; Bioinformatics; Biology; Gene; Genetics","score_opus":0.04172406870721467,"score_gpt":0.3794567399899947,"score_spread":0.33773267128278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742153223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97153103,0.020902162,0.000044524997,0.0049484773,0.0001691951,0.001027597,0.000741769,0.000009618629,0.0006256271],"genre_scores_gemma":[0.9777311,0.017869476,0.000017888451,0.000105200466,0.00023899971,0.0004990572,0.000027523065,0.00005090373,0.0034598394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740016,0.00014048097,0.00025033188,0.0006214323,0.00088702096,0.0007005855],"domain_scores_gemma":[0.9976011,0.000025505227,0.0001632132,0.0012651475,0.0005817949,0.00036324965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010191791,0.00020116077,0.0002176252,0.000092153314,0.0006667784,0.00018366467,0.0008724292,0.0001450499,0.00023239652],"category_scores_gemma":[0.0002550177,0.00015423993,0.00009921127,0.00013346516,0.0009025821,0.00002421498,0.0004809233,0.0005245619,0.0000042952897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011729349,0.00009012525,0.0040572225,0.00038781887,0.00017173034,0.000034907946,0.00022523619,0.00006491534,0.97542906,0.0000463306,0.008043105,0.010276642],"study_design_scores_gemma":[0.001811499,0.00026616012,0.053653892,0.00041414093,0.00003774351,0.000003539819,0.00007750635,0.00012125881,0.8831826,0.00034485213,0.05979677,0.00029005404],"about_ca_topic_score_codex":0.003259916,"about_ca_topic_score_gemma":0.00080638315,"teacher_disagreement_score":0.09224644,"about_ca_system_score_codex":0.00007748958,"about_ca_system_score_gemma":0.0011672468,"threshold_uncertainty_score":0.6289721},"labels":[],"label_agreement":null},{"id":"W2742154546","doi":"10.1158/1538-7445.am2017-ct011","title":"Abstract CT011: Circulating tumor DNA (ctDNA) sequencing for <i>HER2</i> mutation (<i>HER2</i>mut) screening and response monitoring to neratinib in metastatic breast cancer (MBC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neratinib; Concordance; Medicine; Circulating tumor DNA; Internal medicine; Oncology; Incidence (geometry); Population; Metastatic breast cancer; Cancer; Breast cancer; Trastuzumab","score_opus":0.09485501271102145,"score_gpt":0.4129818172002849,"score_spread":0.31812680448926345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742154546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561244,0.0011530936,0.0005200888,0.0012674147,0.0002490109,0.0007940643,0.00031379052,0.000009048254,0.0000810674],"genre_scores_gemma":[0.9958341,0.00032856173,0.0019186552,0.00015697767,0.00077102927,0.000797631,0.000020809743,0.000064514716,0.00010771781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979203,0.000113592345,0.00033238076,0.00065040134,0.00031618567,0.0006671605],"domain_scores_gemma":[0.9984503,0.00026851337,0.00015533133,0.0005175409,0.00037375116,0.00023455573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017197399,0.00020948122,0.0002491666,0.00015395712,0.000662336,0.00038853797,0.0003497871,0.00008568861,0.000015980895],"category_scores_gemma":[0.001086504,0.00022791351,0.000066102235,0.00013260261,0.00013179886,0.000032045045,0.00025941205,0.00026801167,0.0000019754398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010456707,0.000022427355,0.013006013,0.000119881806,0.000048285452,0.000047730347,0.00044389933,0.003878866,0.9596286,0.00001842277,0.00032465399,0.021415537],"study_design_scores_gemma":[0.0039007892,0.00049474335,0.28762692,0.0011340724,0.000051042873,0.00006709536,0.0021579785,0.0014746402,0.697263,0.00024498632,0.004678774,0.0009059278],"about_ca_topic_score_codex":0.005706049,"about_ca_topic_score_gemma":0.0028849046,"teacher_disagreement_score":0.27462092,"about_ca_system_score_codex":0.00036791753,"about_ca_system_score_gemma":0.0008576856,"threshold_uncertainty_score":0.92940426},"labels":[],"label_agreement":null},{"id":"W2742157260","doi":"10.1158/1538-7445.am2017-4898","title":"Abstract 4898: eIF4E reshapes the surface of migrating AML cells through regulating Hyaluronic Acid synthesis &amp; CD44 expression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Cell biology; Filopodia; Cell; CD44; Pseudopodia; Biology; Chemistry; Molecular biology; Messenger RNA; Translation (biology); Biochemistry","score_opus":0.14771599367082558,"score_gpt":0.42769006927043546,"score_spread":0.27997407559960985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742157260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736421,0.0009184421,0.000010793694,0.0013582289,0.000028383733,0.00013353309,0.00010758269,0.00003592251,0.023765031],"genre_scores_gemma":[0.99452364,0.00034562327,0.00044514565,0.000009276401,0.00031790574,0.00018500118,0.0000099776635,0.000035461988,0.004127974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979311,0.000051745385,0.0003676131,0.00046821768,0.00065665616,0.0005246158],"domain_scores_gemma":[0.9964183,0.0010847364,0.00034918264,0.0018183842,0.00024035721,0.00008905941],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008092287,0.00017341338,0.0002282373,0.000014184176,0.0016923005,0.00019344946,0.0013452559,0.00016464833,0.0023012762],"category_scores_gemma":[0.00089415885,0.0001329586,0.000115668394,0.000115137016,0.00057547266,0.00021925464,0.00044556957,0.0007384421,0.00004209969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003570155,0.000044799057,0.0004948122,0.00032478594,0.000022224784,0.0000011322311,0.00053065136,0.00017225348,0.992042,0.000052440286,0.0036918055,0.0025874027],"study_design_scores_gemma":[0.00014450873,0.0000030656158,0.0002876538,0.0006760196,0.000011256974,0.0000011596308,0.0006664504,0.000060365317,0.98297966,0.0003839648,0.014646154,0.00013977212],"about_ca_topic_score_codex":0.0012368143,"about_ca_topic_score_gemma":0.0002241484,"teacher_disagreement_score":0.020881552,"about_ca_system_score_codex":0.00012994252,"about_ca_system_score_gemma":0.00019154318,"threshold_uncertainty_score":0.9996074},"labels":[],"label_agreement":null},{"id":"W2745136137","doi":"","title":"Abstract #5446: Mechanisms of myocyte cytotoxicity induced by the anticancer serine/threonine multikinase inhibitor sorafenib","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sorafenib; Pharmacology; Cardiotoxicity; Kinase; Myocyte; Medicine; Apoptosis; Chemistry; Cancer research; Biochemistry; Internal medicine; Toxicity; Hepatocellular carcinoma","score_opus":0.06600494864659141,"score_gpt":0.3899573391278255,"score_spread":0.3239523904812341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745136137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907735,0.00051649916,0.00018504367,0.006000711,0.00013238372,0.0011368983,0.000056534907,0.000056152356,0.0011422599],"genre_scores_gemma":[0.9975694,0.00042123834,0.0001183334,0.00082222995,0.00044263035,0.000111612266,0.00002340158,0.000035225665,0.00045596957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973301,0.000120017634,0.00038700656,0.00043073605,0.0011416812,0.0005904523],"domain_scores_gemma":[0.9983802,0.00013789236,0.00011714077,0.00060132187,0.00053472153,0.00022876292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011636427,0.00021539869,0.0004337509,0.00016225455,0.00021882587,0.000038696184,0.00026595348,0.00021761614,0.00036301644],"category_scores_gemma":[0.0001788019,0.00016018603,0.00016840301,0.00071393664,0.00022813633,0.00014281298,0.000052704258,0.00095215114,0.000018987663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006273382,0.00021010503,0.00006385698,0.00009062941,0.00006978283,0.000015232129,0.00028464265,0.0000070596943,0.9796967,0.0003762834,0.0018644067,0.01669396],"study_design_scores_gemma":[0.002265915,0.00044750064,0.011591135,0.00024927355,0.00002524542,0.000011857187,0.0002165193,0.000048594095,0.98329824,0.00081253337,0.0008770016,0.0001561972],"about_ca_topic_score_codex":0.0006532401,"about_ca_topic_score_gemma":0.000060177634,"teacher_disagreement_score":0.016537765,"about_ca_system_score_codex":0.00040658994,"about_ca_system_score_gemma":0.00048333587,"threshold_uncertainty_score":0.6532197},"labels":[],"label_agreement":null},{"id":"W2745907548","doi":"10.1158/0008-5472.can-17-0314","title":"Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Prostate cancer; Bromodomain; Enzalutamide; Cancer research; Cancer; Androgen receptor; Medicine; Cabazitaxel; Coactivator; Acetylation; Androgen deprivation therapy; Biology; Internal medicine; Gene; Transcription factor","score_opus":0.04591500442893147,"score_gpt":0.37063317064976653,"score_spread":0.32471816622083505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745907548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923901,0.0029842234,0.000012738298,0.0031203814,0.0001393648,0.0004782631,0.00006162951,0.0000021513742,0.000811148],"genre_scores_gemma":[0.9974021,0.000540858,0.000019864738,0.000052278683,0.00016949007,0.00014439116,0.0000050976864,0.000012589993,0.0016533582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988439,0.00018302749,0.00019399909,0.00019014535,0.00036405114,0.0002248484],"domain_scores_gemma":[0.99877185,0.000024360326,0.0001836883,0.00057438656,0.0004114637,0.000034276836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007504839,0.00007939079,0.00009561506,0.00002373959,0.0004818232,0.000043770866,0.00064785563,0.00006380271,0.000067131245],"category_scores_gemma":[0.00023596233,0.000045299337,0.00006898609,0.00009478132,0.0005758775,0.0000065810677,0.00020047235,0.00017703678,6.700472e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103728824,0.000018281622,0.0054767076,0.000039785205,0.000038976003,2.7042526e-7,0.00014193887,0.0000134651555,0.98979497,0.0003016222,0.002660815,0.0014094425],"study_design_scores_gemma":[0.00027695982,0.000070186004,0.012536064,0.000059188023,0.000006956184,4.11255e-7,0.000119252516,0.000017592674,0.98193073,0.00030766113,0.004616891,0.00005807974],"about_ca_topic_score_codex":0.0017989846,"about_ca_topic_score_gemma":0.00069691136,"teacher_disagreement_score":0.007864208,"about_ca_system_score_codex":0.000028752094,"about_ca_system_score_gemma":0.0004123383,"threshold_uncertainty_score":0.37058434},"labels":[],"label_agreement":null},{"id":"W2746271885","doi":"","title":"Pharmacokinetics of once daily IV busulfan: Implications of fixed-infusion rate dosing","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Busulfan; Dosing; Pharmacokinetics; Body surface area; Medicine; Pharmacology; Urology; Transplantation; Dose rate; Hematopoietic stem cell transplantation; Chemistry; Internal medicine","score_opus":0.12647436966958656,"score_gpt":0.507927610903224,"score_spread":0.38145324123363744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746271885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824763,0.0021236718,0.00013517994,0.002314836,0.00015957162,0.00051157264,0.0000397126,0.000016865613,0.006450962],"genre_scores_gemma":[0.995419,0.0023957016,0.00018737344,0.00013358901,0.00026886328,0.000048162787,0.000018547846,0.000018069306,0.0015106496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872947,0.000073815274,0.0003084076,0.00020997529,0.0003119015,0.0003664171],"domain_scores_gemma":[0.9985735,0.00033193483,0.00009133825,0.00025436183,0.00060061016,0.00014827232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009049159,0.00008871149,0.0002365261,0.00025910322,0.00008448552,0.000004492414,0.00013641124,0.00006285097,0.0008101928],"category_scores_gemma":[0.000052458636,0.00007905314,0.00006246689,0.000751715,0.00025845706,0.00004051605,0.0000787365,0.0002821784,0.000009208709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096173486,0.00020507231,0.013284551,0.00017682152,0.00007436425,0.000009942697,0.0003925458,0.00003262868,0.9368471,0.00017433157,0.007010621,0.040830325],"study_design_scores_gemma":[0.0027358842,0.00040765473,0.08249295,0.000155356,0.00009671024,0.000006645837,0.00009020866,0.000102294754,0.88528544,0.00008334784,0.028471204,0.000072307485],"about_ca_topic_score_codex":0.00057050464,"about_ca_topic_score_gemma":0.000084839405,"teacher_disagreement_score":0.0692084,"about_ca_system_score_codex":0.00023995627,"about_ca_system_score_gemma":0.00038418022,"threshold_uncertainty_score":0.8871043},"labels":[],"label_agreement":null},{"id":"W2746335487","doi":"","title":"Insight into the biological activity of a naturally-derived dithiopyrrolone with a wide spectrum activity against metastatic cancer models","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Medicine; Breast cancer; Trastuzumab; Metastatic breast cancer; Biodistribution; Metastasis; Cancer research; Melanoma; Pharmacology; Oncology; Internal medicine; In vivo; Biology","score_opus":0.10617945973386739,"score_gpt":0.3955781173763287,"score_spread":0.2893986576424613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746335487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902025,0.0007477665,0.0006021865,0.0034247206,0.000016237616,0.00026179143,0.000059981052,0.000045068024,0.00463974],"genre_scores_gemma":[0.9977079,0.000963094,0.000078617246,0.00006912846,0.00014931842,0.00047768172,0.000010310111,0.000024233681,0.0005197213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801075,0.000085534106,0.00020619154,0.0004980977,0.0006033714,0.00059606804],"domain_scores_gemma":[0.99788445,0.0009420147,0.0001424816,0.00063852983,0.0002270264,0.00016546871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007275733,0.00020664171,0.00031034776,0.000054997934,0.0003660171,0.000035711797,0.00057102874,0.00013796205,0.00032181802],"category_scores_gemma":[0.00012942913,0.00012761835,0.000085900196,0.00065796176,0.0008532463,0.0001688092,0.00022598504,0.0011823663,0.0000036162594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008268644,0.00020344337,0.00052928156,0.00013590146,0.00013133186,0.000012686857,0.0010249749,0.00032730823,0.98908794,0.0001614818,0.00009879155,0.0074599963],"study_design_scores_gemma":[0.0004975081,0.000033829998,0.0012673271,0.00009800767,0.00001971083,0.0000025899528,0.00022824528,0.0004929489,0.9946912,0.0009256509,0.0015722172,0.00017076943],"about_ca_topic_score_codex":0.0022280167,"about_ca_topic_score_gemma":0.00283103,"teacher_disagreement_score":0.007505387,"about_ca_system_score_codex":0.00037770096,"about_ca_system_score_gemma":0.00039679234,"threshold_uncertainty_score":0.5204125},"labels":[],"label_agreement":null},{"id":"W2746632276","doi":"10.1158/0008-5472.can-17-0925","title":"Human Pluripotent Stem Cell–Derived <i>TSC2</i> -Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Esri (Canada); University of Ottawa","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Tehran University of Medical Sciences and Health Services; McGill University Health Centre; University of Ottawa","keywords":"Lymphangioleiomyomatosis; TSC2; Induced pluripotent stem cell; Biology; TSC1; Cancer research; Reprogramming; Haploinsufficiency; Stem cell; Germline mutation; Cell biology; Tuberous sclerosis; Mutation; Cell; Pathology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction; Embryonic stem cell; Phenotype; Gene; Medicine","score_opus":0.11137806562708612,"score_gpt":0.3869183949985294,"score_spread":0.2755403293714433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746632276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855128,0.0026544062,0.0000138322885,0.0017773538,0.0002535134,0.0014477315,0.00008604451,0.00008733177,0.008166997],"genre_scores_gemma":[0.99251175,0.0006890501,0.00017989214,0.0001081062,0.00028879647,0.00030502887,0.000011548423,0.000116794276,0.0057890126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941407,0.00038491673,0.00058427907,0.0009208578,0.0025108329,0.001458412],"domain_scores_gemma":[0.99513334,0.00015371876,0.00028817222,0.002614026,0.0011643288,0.0006464368],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001832294,0.0003409774,0.0007383933,0.0005948769,0.0014267308,0.0002715439,0.0014473229,0.00022325687,0.0005540111],"category_scores_gemma":[0.0000730029,0.00029868947,0.00031934062,0.00045310264,0.0012458967,0.00017067215,0.0010715519,0.0007726046,0.00013695231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021246291,0.00057928456,0.0015934323,0.0005956057,0.00008121092,0.000071083996,0.0008441447,0.000043137512,0.9746794,0.00015971278,0.009437757,0.011702778],"study_design_scores_gemma":[0.002653402,0.000598487,0.25371155,0.00074125844,0.000045908375,0.0000045537986,0.00043515896,0.00006215408,0.735476,0.000047374942,0.0059531466,0.00027095655],"about_ca_topic_score_codex":0.004032996,"about_ca_topic_score_gemma":0.00025387673,"teacher_disagreement_score":0.2521181,"about_ca_system_score_codex":0.00068615703,"about_ca_system_score_gemma":0.00067549484,"threshold_uncertainty_score":0.99994653},"labels":[],"label_agreement":null},{"id":"W2748550961","doi":"10.1158/0008-5472.can-17-0150","title":"PADI2-Mediated Citrullination Promotes Prostate Cancer Progression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Research and Development; National Natural Science Foundation of China","keywords":"Prostate cancer; Citrullination; Cancer; Prostate; Cancer research; Medicine; Internal medicine; Biology; Biochemistry; Citrulline","score_opus":0.07136284535761812,"score_gpt":0.4310078475038303,"score_spread":0.3596450021462122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748550961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116355,0.0032347767,0.000012899393,0.002247291,0.00019347314,0.0008402536,0.000105578954,0.00001959079,0.002182585],"genre_scores_gemma":[0.99203247,0.0023669885,0.00009418713,0.000053097996,0.0005809259,0.0012475364,0.00010442757,0.00003069926,0.00348964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984617,0.00013139947,0.00013479115,0.00041745778,0.0003900047,0.00046465057],"domain_scores_gemma":[0.99872607,0.000014568318,0.000099834724,0.00056666014,0.0004558913,0.00013697553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007597043,0.00011908744,0.000106803556,0.000058367215,0.0006749385,0.00017094708,0.00045405672,0.00015061213,0.000173359],"category_scores_gemma":[0.00041795048,0.00009994349,0.00004202446,0.0000779879,0.0002875473,0.000011687187,0.00027887677,0.00025452604,0.000036087873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017825632,0.000044572193,0.015659424,0.000083444516,0.000025833839,0.0000057077195,0.00014221405,0.0000022856327,0.9192655,0.00004378466,0.0029159032,0.061633036],"study_design_scores_gemma":[0.0005529512,0.00022677502,0.008492607,0.00013269874,0.0000037514408,0.0000013660631,0.000027459571,0.000059682523,0.91589934,0.00022216585,0.07422941,0.00015179582],"about_ca_topic_score_codex":0.0002834371,"about_ca_topic_score_gemma":0.00021968642,"teacher_disagreement_score":0.07131351,"about_ca_system_score_codex":0.000052541713,"about_ca_system_score_gemma":0.00039127187,"threshold_uncertainty_score":0.5191149},"labels":[],"label_agreement":null},{"id":"W2748605232","doi":"","title":"Aberrant STAT3 Ser727 phosphorylation and Its association with negative estrogen receptor status in breast infiltrating ductal carcinoma","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Breast cancer; Immunohistochemistry; Tamoxifen; Cancer research; STAT3; Estrogen receptor; Breast carcinoma; Phosphorylation; Medicine; Cancer; Pathology; Internal medicine; Biology","score_opus":0.029855252758356713,"score_gpt":0.32860366445334627,"score_spread":0.29874841169498956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748605232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326915,0.002413468,0.000010692262,0.0025188215,0.000056064924,0.0008899834,0.00011174469,0.000031898646,0.00069817464],"genre_scores_gemma":[0.99813944,0.00047863452,0.00038694093,0.000066515946,0.00022702415,0.00018159482,0.000050586787,0.000042138094,0.0004271098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997643,0.00017370532,0.00025343095,0.00040026053,0.0008641545,0.0006654283],"domain_scores_gemma":[0.9987979,0.00013030703,0.00010325767,0.00016352453,0.00056813966,0.00023689207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067317276,0.0001520832,0.00023839858,0.00023760763,0.00012489164,0.000046217683,0.00005805579,0.00013680506,0.00023710977],"category_scores_gemma":[0.00021786265,0.00014119089,0.000027578006,0.0007321697,0.00006882213,0.0002257166,0.00004423875,0.00079541653,0.000025288475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024296609,0.000162132,0.4975132,0.0001706923,0.00018556633,0.00008467459,0.00859446,0.0007362042,0.4688227,0.00019715354,0.0016891657,0.019414378],"study_design_scores_gemma":[0.011845544,0.0011127627,0.4976062,0.00093595707,0.00008839921,0.00015793936,0.0028597517,0.0058461786,0.47519195,0.00005266095,0.0037379167,0.0005647503],"about_ca_topic_score_codex":0.002462982,"about_ca_topic_score_gemma":0.0013281604,"teacher_disagreement_score":0.018849628,"about_ca_system_score_codex":0.0029281757,"about_ca_system_score_gemma":0.0011121021,"threshold_uncertainty_score":0.7657078},"labels":[],"label_agreement":null},{"id":"W2748952677","doi":"","title":"P-glycoprotein (P-gp1) as direct modulator of collateral sensitivity in multidrug resistant tumor cells.","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Verapamil; Multiple drug resistance; P-glycoprotein; Biology; ATP-binding cassette transporter; Efflux; Pharmacology; Chemistry; Biochemistry; Transporter; Antibiotics; Calcium","score_opus":0.03253034188937504,"score_gpt":0.3676230530036841,"score_spread":0.33509271111430905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748952677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253875,0.000528075,0.00003032215,0.00034329007,0.0001967363,0.0010606124,0.00006267274,0.00003668941,0.005202858],"genre_scores_gemma":[0.99506766,0.000108869914,0.00045799543,0.000057831126,0.00015771553,0.00005457815,0.000009854509,0.000043980544,0.004041515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708927,0.00012575979,0.00045076187,0.0004585405,0.0010737072,0.00080198614],"domain_scores_gemma":[0.99871683,0.00013633702,0.00006953981,0.0004346708,0.0003638814,0.00027876295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033109793,0.00017702644,0.0005079775,0.0004507472,0.0000924665,0.0000132237565,0.00011770718,0.00011864137,0.0001963751],"category_scores_gemma":[0.00006378355,0.00014989707,0.00011043818,0.0009527932,0.00024958188,0.00006397561,0.00004599701,0.00056785834,0.000026955675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004236769,0.00023986594,0.005764155,0.0004566153,0.000034044002,0.002913277,0.00062226417,0.000036668112,0.9839575,0.0001699341,0.00019797296,0.0013708873],"study_design_scores_gemma":[0.0019335762,0.00022426972,0.039697126,0.0006924505,0.000013786681,0.00001157255,0.00037154314,0.00011169347,0.9528806,0.0001378559,0.003765273,0.00016022823],"about_ca_topic_score_codex":0.006125246,"about_ca_topic_score_gemma":0.0077274,"teacher_disagreement_score":0.03393297,"about_ca_system_score_codex":0.00046379503,"about_ca_system_score_gemma":0.0005517153,"threshold_uncertainty_score":0.9259581},"labels":[],"label_agreement":null},{"id":"W2750783852","doi":"","title":"Spontaneous murine mammary tumours demonstrate a range of sensitivities to adoptively transferred T cells: defining the molecular and histological determinants of regression versus progression","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Adoptive cell transfer; CD8; Biology; Epitope; Genetically modified mouse; Immune system; T cell; Cancer; Transgene; Cancer research; Immunology; Pathology; Antigen; Medicine; Gene","score_opus":0.0354972838121635,"score_gpt":0.33583757443622736,"score_spread":0.30034029062406387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750783852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558483,0.04313507,0.000036808022,0.00021313799,0.00014926225,0.0003895338,0.00003651007,0.000015554073,0.00017582295],"genre_scores_gemma":[0.9985756,0.0008507588,0.00012364239,0.000013309073,0.000007595795,0.000061265244,0.000005525525,0.000014978274,0.00034728326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980207,0.0009011335,0.00029957073,0.00025188163,0.00012350404,0.00040322405],"domain_scores_gemma":[0.9988742,0.0006243194,0.00008580821,0.00023874838,0.00015772459,0.000019188501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006958636,0.0001538643,0.00033906565,0.0001717513,0.00021333506,0.000011361659,0.0002336802,0.00016075998,0.000034899098],"category_scores_gemma":[0.00007555525,0.00009980882,0.00007314467,0.00022099983,0.000839826,0.00005114972,0.00010682054,0.00034005567,0.0000042712445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012552945,0.00008712887,0.00060586096,0.000060265495,0.000042133808,0.0003365171,0.0005963925,0.000007728007,0.95312864,0.00026665902,0.00010048373,0.032215267],"study_design_scores_gemma":[0.0016405749,0.0010544163,0.0072885905,0.00040090815,0.000020048134,0.0003151302,0.00046466003,0.0000051170437,0.9880162,0.00003861988,0.00063708227,0.00011868799],"about_ca_topic_score_codex":0.0005146771,"about_ca_topic_score_gemma":0.000081756756,"teacher_disagreement_score":0.04272734,"about_ca_system_score_codex":0.00005551418,"about_ca_system_score_gemma":0.00018204456,"threshold_uncertainty_score":0.40700856},"labels":[],"label_agreement":null},{"id":"W2751803734","doi":"","title":"Modeling bone marrow: A novel 3-D culture system for characterization of the multiple myeloma stem cell niche","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bone marrow; Stem cell; In vivo; Multiple myeloma; Extracellular matrix; Cell culture; Biology; Cancer research; In vitro; Malignancy; Pathology; Immunology; Cell biology; Medicine; Genetics","score_opus":0.09413340389435801,"score_gpt":0.37733525524240585,"score_spread":0.2832018513480479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751803734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892911,0.0005557525,0.006503767,0.00029992926,0.00014083456,0.0025189454,0.0002231366,0.000033663528,0.00043287297],"genre_scores_gemma":[0.9946844,0.00008386639,0.00037117553,0.000024839444,0.00025202736,0.00038728787,0.000067569854,0.000041972926,0.004086842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756545,0.000077138786,0.00035599023,0.00034361606,0.00097498536,0.0006828224],"domain_scores_gemma":[0.9980879,0.00014776849,0.00007664986,0.00047852428,0.0009715737,0.00023757944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012436619,0.00014586696,0.0002909091,0.00018042402,0.00026772256,0.000026961092,0.0002258122,0.00014136717,0.000015632422],"category_scores_gemma":[0.00010942466,0.00009283147,0.00014481496,0.0005498401,0.000098697245,0.000075481774,0.000121420584,0.00037648858,0.000008813317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00166957,0.00020323138,0.0079296,0.0013040984,0.000074637624,0.000011903698,0.0005681644,0.00005899507,0.9822552,0.00006409682,0.00008640203,0.005774092],"study_design_scores_gemma":[0.00778503,0.0003323218,0.0139779085,0.0008326306,0.000052482505,0.000021595282,0.0013781352,0.05400859,0.9194247,0.0000045849206,0.0020343224,0.00014771786],"about_ca_topic_score_codex":0.00031384558,"about_ca_topic_score_gemma":0.00011805906,"teacher_disagreement_score":0.06283052,"about_ca_system_score_codex":0.0005542127,"about_ca_system_score_gemma":0.0003810235,"threshold_uncertainty_score":0.37855574},"labels":[],"label_agreement":null},{"id":"W2752439433","doi":"","title":"Anthocyanin-rich berry extracts and epigallocatechin gallate reduce the enhanced invasiveness of estrogen-negative human breast carcinoma cells elicited by serum","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemicals and Antioxidant Activities","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Bilberry; Anthocyanin; Estrogen receptor; Berry; Epigallocatechin gallate; Cancer research; Motility; Estrogen; Breast cancer; Cancer; Medicine; Chemistry; Internal medicine; Endocrinology; Biology; Polyphenol; Biochemistry; Cell biology; Botany; Food science","score_opus":0.04778112068771507,"score_gpt":0.37967718900417663,"score_spread":0.33189606831646157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752439433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957199,0.0016947973,0.00002824225,0.0007332745,0.00005257986,0.0006019644,0.00009336125,0.000022884635,0.0010529729],"genre_scores_gemma":[0.99846554,0.00040533705,0.000035207147,0.0000601549,0.00019678775,0.000048190177,0.00000993535,0.00003642529,0.0007424196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978916,0.0001337306,0.00032360005,0.00039608811,0.0006212484,0.0006337068],"domain_scores_gemma":[0.99844754,0.00041873043,0.00012200833,0.00033794192,0.0004632589,0.00021054974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010616331,0.00019111013,0.0003727967,0.00016302247,0.0002532953,0.00003206888,0.00022534096,0.00012720651,0.000053286614],"category_scores_gemma":[0.00008290657,0.00014029133,0.00006110828,0.0005742665,0.0007604537,0.00011649254,0.00013785955,0.0006697856,0.0000033299377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003879211,0.00025612282,0.0036974393,0.00020910222,0.00006519603,0.000025508147,0.0008991833,7.6806845e-7,0.9918321,0.00006369655,0.0005576256,0.002005385],"study_design_scores_gemma":[0.0015031144,0.00016257282,0.046420377,0.00034187656,0.000026413654,0.000037675596,0.001068107,0.000007556455,0.9499955,0.0001855411,0.00011780011,0.00013346528],"about_ca_topic_score_codex":0.0012967789,"about_ca_topic_score_gemma":0.00010211028,"teacher_disagreement_score":0.04272294,"about_ca_system_score_codex":0.0001456517,"about_ca_system_score_gemma":0.00026017008,"threshold_uncertainty_score":0.57209146},"labels":[],"label_agreement":null},{"id":"W2753741461","doi":"10.1158/0008-5472.can-17-0707","title":"CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut du Savoir Montfort; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Fonds De La Recherche Scientifique - FNRS; National Health and Medical Research Council; Breast Cancer Research Foundation; Susan G. Komen for the Cure","keywords":"Trastuzumab; Cancer research; Immune system; Stromal cell; Antibody; Cancer cell; Medicine; Monoclonal antibody; Breast cancer; Cancer; Immunology; Biology; Internal medicine","score_opus":0.1319793339646701,"score_gpt":0.4944404438853889,"score_spread":0.3624611099207188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753741461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94509095,0.007263843,0.000018177252,0.030258384,0.00033313752,0.0012458651,0.000025450472,0.000055655393,0.015708543],"genre_scores_gemma":[0.95962465,0.004934776,0.00020414715,0.0007930844,0.0006461357,0.00029293748,0.0000076196793,0.000048219517,0.0334484],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978066,0.00008973726,0.00020316272,0.00046961798,0.0007865025,0.00064434746],"domain_scores_gemma":[0.99789476,0.00006554206,0.00006461258,0.0013099625,0.0004181035,0.0002469994],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011513331,0.00015373774,0.00027335473,0.00017142648,0.0007958186,0.00022053526,0.00057927053,0.000099083336,0.00094025605],"category_scores_gemma":[0.00021250569,0.0001207924,0.00010411546,0.00028264528,0.00041232764,0.00013593589,0.00011574958,0.0003944397,0.00012494269],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008059503,0.0001638052,0.023643464,0.00014631801,0.00018457934,0.0000931734,0.0007247302,2.1457339e-7,0.8427351,0.00015043371,0.045437396,0.07866127],"study_design_scores_gemma":[0.0026010456,0.0005170637,0.2009431,0.0006113898,0.0000068541344,0.0000062064487,0.000102123646,0.000002442623,0.21456997,0.00018784424,0.5802581,0.0001938727],"about_ca_topic_score_codex":0.0016447151,"about_ca_topic_score_gemma":0.000720021,"teacher_disagreement_score":0.6281651,"about_ca_system_score_codex":0.00029338564,"about_ca_system_score_gemma":0.000540346,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W2754114582","doi":"","title":"Immunohistochemical expression of human tissue kallikreins in neoplasms of various organs","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Pathology; Prostate; Kallikrein; Immunohistochemistry; Biology; Cancer; Prostate cancer; Cancer research; Medicine","score_opus":0.0416100782361249,"score_gpt":0.4017751060663796,"score_spread":0.3601650278302547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754114582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338096,0.0033673535,0.000025507064,0.00024993482,0.00004788919,0.0003115304,0.000010958813,0.000015712914,0.002590134],"genre_scores_gemma":[0.9969226,0.00009588204,0.00012260917,0.000010968181,0.0001423598,0.00003666482,0.000036788395,0.00002320646,0.002608883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847376,0.00005742733,0.0003906028,0.00022266514,0.00054598803,0.00030956004],"domain_scores_gemma":[0.99915326,0.000106837295,0.00007230828,0.00031603663,0.0002820057,0.00006957236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003352475,0.00009462908,0.00031292698,0.0002483609,0.00005829444,0.0000056893346,0.00014905802,0.000118177566,0.000660255],"category_scores_gemma":[0.00007401208,0.000086431886,0.00005148912,0.0004764945,0.00025806768,0.000045817535,0.00007295578,0.0002602329,0.0000070149417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018970383,0.00021203882,0.031599775,0.00017159432,0.000007391801,0.000014566609,0.0005657935,0.000018648057,0.9636601,0.00062220363,0.0020596774,0.0008784802],"study_design_scores_gemma":[0.001230485,0.0002799882,0.06176003,0.00044755524,0.000009933482,0.000004470363,0.000080353944,0.000021055172,0.9338085,0.00075245975,0.0015298427,0.00007532988],"about_ca_topic_score_codex":0.010163231,"about_ca_topic_score_gemma":0.0005151599,"teacher_disagreement_score":0.030160254,"about_ca_system_score_codex":0.00018689956,"about_ca_system_score_gemma":0.0002839564,"threshold_uncertainty_score":0.9964282},"labels":[],"label_agreement":null},{"id":"W2754906663","doi":"","title":"Differentially androgen regulated genes in androgen dependent (LNCaP) and independent (C4-2) prostate cancer cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"LNCaP; Androgen receptor; Androgen; Prostate cancer; Biology; Cancer research; Microarray analysis techniques; Microarray; Gene expression; Gene; Endocrinology; Internal medicine; Cancer; Medicine; Genetics; Hormone","score_opus":0.0512169071297593,"score_gpt":0.3791991388490173,"score_spread":0.327982231719258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754906663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95016927,0.04290149,0.0000024061505,0.0040352023,0.00013735169,0.0020299365,0.000117295065,0.00005537199,0.00055167376],"genre_scores_gemma":[0.9408583,0.045728754,0.00006923458,0.00010288868,0.00038068264,0.001030433,0.000048034806,0.00007639734,0.0117053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956536,0.00025324055,0.00045744496,0.000889045,0.0014402638,0.001306369],"domain_scores_gemma":[0.9983253,0.00008021014,0.00006898821,0.0004854512,0.00046038756,0.0005796452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088135095,0.00032589905,0.00053063245,0.00065445586,0.0002444789,0.00013363938,0.0002654438,0.00023217933,0.0010869786],"category_scores_gemma":[0.000025127923,0.00025707047,0.000083998304,0.000755873,0.0003696257,0.000211531,0.00033978603,0.00086369965,0.00005544434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004084399,0.00068950566,0.21936758,0.0006047959,0.00049360597,0.0006592706,0.0027335696,0.00019186069,0.53739333,0.000041407442,0.0019704655,0.23177019],"study_design_scores_gemma":[0.011997448,0.00055842614,0.051440295,0.00063982274,0.00009871268,0.000059305043,0.00047170426,0.0005855765,0.9143039,0.00016752271,0.01917829,0.00049901346],"about_ca_topic_score_codex":0.0027018625,"about_ca_topic_score_gemma":0.00473664,"teacher_disagreement_score":0.37691054,"about_ca_system_score_codex":0.0012243901,"about_ca_system_score_gemma":0.0010067554,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W2755463114","doi":"","title":"Erythropoietin improves learning and memory impairment after whole brain irradiation.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Erythropoietin; Memory impairment; Neuroscience; Medicine; Psychology; Internal medicine; Cognition","score_opus":0.02708552830306233,"score_gpt":0.3813115361764382,"score_spread":0.3542260078733759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755463114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427781,0.008129256,0.000024840008,0.04628769,0.00015624714,0.0009973871,0.000013583751,0.00008338227,0.0015294836],"genre_scores_gemma":[0.9858459,0.0012810597,0.00009873523,0.0007527706,0.00048073698,0.00076021795,0.000010155239,0.000044676934,0.010725716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979108,0.000121143086,0.00021701699,0.0004533706,0.0006679939,0.0006296516],"domain_scores_gemma":[0.9990265,0.00015760715,0.000044404274,0.00017011777,0.00035841548,0.0002429593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487949,0.00017183981,0.00025675923,0.00027238575,0.00033701747,0.000054711665,0.00006125855,0.00009273906,0.0004510598],"category_scores_gemma":[0.00035559776,0.00015316207,0.00006400285,0.00044022896,0.0005015655,0.000121256526,0.0001756081,0.00080939796,0.00012944495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009341586,0.0018212708,0.13657406,0.0029078012,0.0021156885,0.0009952695,0.03422652,0.00049109623,0.4118025,0.00027707563,0.112988025,0.2864591],"study_design_scores_gemma":[0.018777385,0.0059071206,0.7603713,0.0020797853,0.00020170731,0.00012144617,0.012520796,0.00008342215,0.023578182,0.0012147478,0.17430246,0.0008416303],"about_ca_topic_score_codex":0.0006220046,"about_ca_topic_score_gemma":0.00013964825,"teacher_disagreement_score":0.62379724,"about_ca_system_score_codex":0.00097506866,"about_ca_system_score_gemma":0.00047763754,"threshold_uncertainty_score":0.62457675},"labels":[],"label_agreement":null},{"id":"W2755644324","doi":"10.1158/0008-5472.can-17-0496","title":"LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; University Health Network; Ontario Institute for Cancer Research; Genome British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Reprogramming; Prostate cancer; Epigenetics; Cancer research; Cancer; Chromatin; Epigenetic therapy; Androgen receptor; Biology; Androgen deprivation therapy; Regulator; Medicine; Gene expression; DNA methylation; Cell; Gene; Genetics","score_opus":0.09539327455615022,"score_gpt":0.4810607586295137,"score_spread":0.3856674840733635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755644324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95701045,0.03223682,0.000003227359,0.0072012316,0.00021693796,0.0021398421,0.00004805574,0.00008501437,0.0010584536],"genre_scores_gemma":[0.95741737,0.031459197,0.00030471748,0.000040865667,0.00043871574,0.0021226706,0.00004459987,0.000069598,0.008102263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996376,0.00017632724,0.00027866598,0.00086438784,0.0011762988,0.0011283577],"domain_scores_gemma":[0.9974663,0.000129063,0.00014022215,0.0010206759,0.00062435464,0.0006193791],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0009404866,0.00024841848,0.00038837356,0.0002731466,0.0015635958,0.00036115534,0.0003590958,0.00017603028,0.0002870873],"category_scores_gemma":[0.0004414618,0.00017401966,0.00007109194,0.0002573489,0.001188838,0.00027296398,0.00056542904,0.0007793641,0.000034084827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016685444,0.0001850826,0.32676685,0.00058454886,0.00009726949,0.00028701936,0.0013778262,0.0000013458335,0.34690854,0.000013091608,0.0020955647,0.3200143],"study_design_scores_gemma":[0.009761228,0.0015092446,0.32968086,0.0058395904,0.000092594586,0.00003551092,0.00088599167,0.00022850413,0.57903856,0.00036464908,0.07198029,0.0005829927],"about_ca_topic_score_codex":0.0009152832,"about_ca_topic_score_gemma":0.00012659386,"teacher_disagreement_score":0.3194313,"about_ca_system_score_codex":0.0003557564,"about_ca_system_score_gemma":0.0007896922,"threshold_uncertainty_score":0.99973625},"labels":[],"label_agreement":null},{"id":"W2755991611","doi":"10.1158/1538-7445.tummet15-a12","title":"Abstract A12: Regulation of the mitochondrial stress response and metabolism by the intraperitoneal tumor environment during ovarian cancer transcoelomic metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"SOD2; Ovarian cancer; Cancer cell; Metastasis; Cancer research; Biology; Mitochondrion; SIRT3; Oxidative stress; Ascites; Superoxide dismutase; Cancer; Cell biology; Chemistry; Sirtuin; Endocrinology; Internal medicine; Medicine; Biochemistry; Acetylation","score_opus":0.01776476474015956,"score_gpt":0.29722699899335386,"score_spread":0.2794622342531943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755991611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892404,0.016684053,0.000036246085,0.0025315122,0.00062850217,0.0005044764,0.00066697237,0.000004219486,0.000020007823],"genre_scores_gemma":[0.9896012,0.0077476567,0.000035538003,0.00004412058,0.0012617436,0.00031912696,0.000006566349,0.000030918,0.0009531095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801666,0.00041473666,0.00025968158,0.00042851907,0.00047469005,0.0004057096],"domain_scores_gemma":[0.9990919,0.0000745257,0.0000993915,0.0005465774,0.00008463935,0.00010295923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062164495,0.00016486237,0.00019884616,0.000053066742,0.00026534987,0.000033134536,0.00037930036,0.00009915693,0.00023284805],"category_scores_gemma":[0.00007925173,0.000090190464,0.00011163743,0.00012437576,0.0005888179,0.000013526323,0.00014283776,0.00019700821,0.0000015536802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018057693,0.000029216157,0.00015176919,0.000028845234,0.00010619765,2.9289964e-7,0.00018019119,0.00002924557,0.9809438,0.000020203499,0.0012747467,0.01542974],"study_design_scores_gemma":[0.0012503376,0.000024004154,0.09381082,0.00004608992,0.000039631646,0.0000037024456,0.00007164722,0.0000011433704,0.8099105,0.000031054893,0.09470028,0.00011083971],"about_ca_topic_score_codex":0.00081342127,"about_ca_topic_score_gemma":0.00032448024,"teacher_disagreement_score":0.17103332,"about_ca_system_score_codex":0.000072537965,"about_ca_system_score_gemma":0.00028303932,"threshold_uncertainty_score":0.36778605},"labels":[],"label_agreement":null},{"id":"W2757862658","doi":"10.1158/0008-5472.can-17-0336","title":"<i>dcmqi</i> : An Open Source Library for Standardized Communication of Quantitative Image Analysis Results Using DICOM","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; National Institutes of Health","keywords":"DICOM; Computer science; Metadata; Interoperability; Digital imaging; Open source; Information retrieval; Digital image; Software; Image (mathematics); Image processing; Artificial intelligence; World Wide Web; Operating system","score_opus":0.17938538750494795,"score_gpt":0.5412057766962901,"score_spread":0.3618203891913422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757862658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626396,0.00082295487,0.016401617,0.013916182,0.000052057392,0.0012302513,0.0003530571,0.000040751114,0.0045435773],"genre_scores_gemma":[0.92839164,0.0006366456,0.068779595,0.00015613814,0.00010055467,0.00008238624,0.00022223456,0.000057197933,0.0015735838],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99826527,0.00035546342,0.00031936503,0.00031014008,0.00046327533,0.00028649875],"domain_scores_gemma":[0.9973097,0.0004966853,0.0002516462,0.0012987697,0.00044921035,0.00019401382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031961936,0.00008855415,0.00045114552,0.0002434738,0.00077020103,0.0003671678,0.001075278,0.000053546017,0.00006958544],"category_scores_gemma":[0.0021352198,0.00007495806,0.00009730765,0.0003291543,0.0006752035,0.0006087104,0.000617743,0.00046525517,8.78735e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04322419,0.0015486577,0.083588354,0.001651504,0.006335629,0.00006906579,0.018783202,0.0030154504,0.57036877,0.0093036005,0.06888925,0.19322233],"study_design_scores_gemma":[0.03161113,0.0025920135,0.05409671,0.002616841,0.0023552189,0.000010427429,0.005026611,0.62333095,0.07179857,0.0046499507,0.20109989,0.0008117151],"about_ca_topic_score_codex":0.003056386,"about_ca_topic_score_gemma":0.00008162078,"teacher_disagreement_score":0.6203155,"about_ca_system_score_codex":0.00008055026,"about_ca_system_score_gemma":0.00047453304,"threshold_uncertainty_score":0.59238416},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"software","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"software","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2758011263","doi":"","title":"Production of the extracellular domain of Siglec-9 using and an E.coli expression system and generation of anti-Siglec-9 antibodies","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"SIGLEC; Biology; Immunoglobulin superfamily; Antibody; CD33; Sialic acid; Immune system; Cell biology; Receptor; Genetics; Stem cell","score_opus":0.07386273593389311,"score_gpt":0.3784158470334046,"score_spread":0.30455311109951144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758011263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952521,0.0038792435,0.00022545287,0.00010695867,0.000044272143,0.00044000582,0.00001077913,0.0000021507237,0.000039058075],"genre_scores_gemma":[0.9983429,0.000546832,0.00070487405,0.0000018932817,0.00019615963,0.00001744221,0.000007574668,0.000010701241,0.00017165368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987355,0.0002904209,0.00021614978,0.00024515437,0.0003522447,0.00016056783],"domain_scores_gemma":[0.9991511,0.00000915354,0.00009652689,0.00028945808,0.0004064172,0.00004733933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007439383,0.00007079872,0.00013050315,0.0000949647,0.00013282029,0.000013246761,0.00011280892,0.00008803918,0.000008321436],"category_scores_gemma":[0.000078140336,0.000053164997,0.00002504335,0.00016988613,0.00033399955,0.000014797755,0.00013289391,0.000102030644,1.1040477e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076854696,0.000037136495,0.004060158,0.00026066316,0.000011514485,2.1453322e-7,0.00019660512,0.0004263405,0.9931676,0.00010574087,0.00007341508,0.0015837523],"study_design_scores_gemma":[0.00025626193,0.00011088755,0.002640084,0.00012025167,0.0000041707735,0.00000409237,0.00030362277,0.001207655,0.99462837,0.0000110776255,0.0006624849,0.00005103041],"about_ca_topic_score_codex":0.00014488694,"about_ca_topic_score_gemma":0.00007512817,"teacher_disagreement_score":0.0033324116,"about_ca_system_score_codex":0.000024694673,"about_ca_system_score_gemma":0.00012500583,"threshold_uncertainty_score":0.21680056},"labels":[],"label_agreement":null},{"id":"W2758346346","doi":"","title":"Abstract #1692: Sulfhydryl-modulated mechanisms of the cytotoxicity of cadmium and inhibition of DNA topoisomerase II\\#945;","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cadmium; Cytotoxicity; Cadmium chloride; Chemistry; Topoisomerase; Glutathione; Carcinogen; Toxicity; Buthionine sulfoximine; Biochemistry; DNA damage; Molecular biology; DNA; Biology; In vitro; Enzyme","score_opus":0.14147026283885356,"score_gpt":0.4784770320984604,"score_spread":0.3370067692596068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758346346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657387,0.00034835952,0.000009046566,0.0012511796,0.00010461595,0.00035366006,0.0001090845,0.000008560446,0.0012416429],"genre_scores_gemma":[0.9990821,0.00046804815,0.000016524402,0.00012351884,0.00004618891,0.000018960995,0.0000053225026,0.0000070112565,0.00023232818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880016,0.00014926608,0.00032991904,0.0001816192,0.00028211085,0.0002569406],"domain_scores_gemma":[0.99902135,0.00023105471,0.00013956662,0.00019294811,0.00030849042,0.000106577434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007250217,0.00009544706,0.00022267505,0.00010268939,0.00015516435,0.000004172536,0.00016041246,0.00019767658,0.0006848806],"category_scores_gemma":[0.00017568581,0.00007160066,0.00007468084,0.00039638256,0.000388264,0.00007004679,0.00009896021,0.0006487145,0.0000014504908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002744085,0.00029221948,0.00032227594,0.00008224938,0.000036897494,0.0000018649732,0.00023127923,0.000038141017,0.99326193,0.0015232898,0.0006047892,0.0033306486],"study_design_scores_gemma":[0.00064290804,0.00016872172,0.010543182,0.00006733033,0.000021363261,0.0000020347106,0.00007798956,0.00008678395,0.9829781,0.004449072,0.0008987724,0.00006372225],"about_ca_topic_score_codex":0.00036694904,"about_ca_topic_score_gemma":0.000051049872,"teacher_disagreement_score":0.010283816,"about_ca_system_score_codex":0.000072496114,"about_ca_system_score_gemma":0.00014386639,"threshold_uncertainty_score":0.7498962},"labels":[],"label_agreement":null},{"id":"W2762379106","doi":"10.1158/0008-5472.can-17-1397","title":"PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada; Canadian Cancer Society; Movember Foundation","keywords":"Cancer; Alternative splicing; Cancer research; RNA splicing; Medicine; Biology; Genetics; Gene; Exon; RNA","score_opus":0.12085181411984758,"score_gpt":0.4837802840963316,"score_spread":0.36292846997648404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762379106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517417,0.0016835323,0.000051910698,0.001052503,0.00012880168,0.00030116522,0.000020572546,0.000006167958,0.0015812052],"genre_scores_gemma":[0.9891862,0.0037677153,0.000040759256,0.000081831444,0.00066927273,0.00026174594,0.000012320325,0.000033958593,0.0059461733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783814,0.0001894644,0.00015788472,0.0005518928,0.00048447435,0.0007781309],"domain_scores_gemma":[0.9985569,0.000029504132,0.000061992825,0.0008497223,0.00026364293,0.00023821212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008153,0.00013417787,0.00016223897,0.00013790399,0.0005221833,0.00020091292,0.00088106596,0.00012192376,0.00013107134],"category_scores_gemma":[0.00027652006,0.00012143361,0.00005222191,0.0001145482,0.00026625115,0.000024411383,0.00044278774,0.00044959047,0.000016464493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000213143,0.00005121017,0.033205956,0.000026862032,0.00004186668,0.000030180578,0.00012513892,0.00018992276,0.9481713,0.00010613325,0.001045866,0.016792381],"study_design_scores_gemma":[0.001587565,0.0005171834,0.04025851,0.00018748906,0.000005179416,0.000004802503,0.0005564935,0.0010445205,0.9451511,0.000613586,0.009724776,0.0003488325],"about_ca_topic_score_codex":0.026333442,"about_ca_topic_score_gemma":0.044590976,"teacher_disagreement_score":0.018257534,"about_ca_system_score_codex":0.00021412014,"about_ca_system_score_gemma":0.0006183525,"threshold_uncertainty_score":0.9801503},"labels":[],"label_agreement":null},{"id":"W2762533155","doi":"","title":"Abstract #1513: Recruitment of histone acetyltransferase activity by the N-terminal homology domain of Pygopus augments TCF-dependent transcriptional activation","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Histone acetyltransferase; CREB-binding protein; Biology; Acetyltransferase; Enhancer; Histone; Molecular biology; Chromatin immunoprecipitation; Transcription (linguistics); Cell biology; Transcription factor; Promoter; Gene; CREB; Genetics; Gene expression; Acetylation","score_opus":0.0687592301962292,"score_gpt":0.41721641256542247,"score_spread":0.34845718236919326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762533155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503946,0.0013903825,0.000992825,0.0014245994,0.00011348076,0.00067599,0.00009235354,0.000004570284,0.00026634734],"genre_scores_gemma":[0.9984652,0.0006435273,0.000038808514,0.000032759046,0.00012120337,0.00012846806,0.00010262551,0.000013463867,0.0004539389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984082,0.00019319501,0.0002607768,0.0003204522,0.0005315894,0.0002858042],"domain_scores_gemma":[0.99924296,0.000030293255,0.00010582669,0.00032934456,0.00022877808,0.00006281019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005947885,0.00012601839,0.00016705255,0.00008612479,0.00009036942,0.000008202324,0.0002324015,0.00017721317,0.00018482655],"category_scores_gemma":[0.000021107015,0.00010882679,0.00009357023,0.00017118648,0.0002685595,0.00001164557,0.000023439981,0.00025248452,0.0000013425598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012054504,0.0002348733,0.00005943023,0.00003252331,0.000065307984,0.0000014711682,0.00013449673,0.00020096345,0.9621622,0.00007520164,0.0014500149,0.034378074],"study_design_scores_gemma":[0.0010109787,0.0004629649,0.012468057,0.000041976902,0.000013421353,0.000011427921,0.00004746225,0.000008205989,0.98159933,0.00020047207,0.0040390496,0.00009666838],"about_ca_topic_score_codex":0.0003583146,"about_ca_topic_score_gemma":0.00010114984,"teacher_disagreement_score":0.034281407,"about_ca_system_score_codex":0.00026101177,"about_ca_system_score_gemma":0.0003082864,"threshold_uncertainty_score":0.44378278},"labels":[],"label_agreement":null},{"id":"W2762622819","doi":"","title":"CD44 modulates cofilin expression in human colon cancer cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cofilin; CD44; Biology; Protein kinase B; Cancer research; Knockout mouse; Apoptosis; Actin cytoskeleton; Cell biology; Western blot; Molecular biology; Phosphorylation; Cell; Cytoskeleton; Receptor; Biochemistry","score_opus":0.07276575714585722,"score_gpt":0.44273632082211384,"score_spread":0.36997056367625664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762622819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898009,0.0029858993,0.000009381011,0.0011941312,0.00009261815,0.0010442594,0.000023767197,0.000045671768,0.0048034247],"genre_scores_gemma":[0.97458756,0.00080898055,0.00012454938,0.0000783648,0.0004045044,0.00065376644,0.00003580345,0.00006358015,0.023242887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961882,0.0003141991,0.0003732519,0.00062209315,0.0014981995,0.0010040449],"domain_scores_gemma":[0.9985312,0.0001498642,0.000043515905,0.0005436651,0.00046815557,0.00026357084],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009732858,0.00018026623,0.0003483224,0.0004795594,0.00021246435,0.0000572603,0.00031673585,0.00019938059,0.003388496],"category_scores_gemma":[0.00007326727,0.00015819988,0.00007888646,0.0008584263,0.00031622447,0.00007692377,0.00027191968,0.0011051928,0.00014804352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025315626,0.00024615566,0.012762666,0.00019690521,0.000008047739,0.0002238298,0.00009445955,0.0003859058,0.9567274,0.00004630832,0.027006574,0.0020486065],"study_design_scores_gemma":[0.0017860857,0.0001827809,0.021402106,0.00045297126,0.0000053745907,0.0000026659416,0.00006329834,0.00037036827,0.958543,0.00021891591,0.016818725,0.00015369791],"about_ca_topic_score_codex":0.018822948,"about_ca_topic_score_gemma":0.0031230422,"teacher_disagreement_score":0.018439462,"about_ca_system_score_codex":0.0010136339,"about_ca_system_score_gemma":0.00047652924,"threshold_uncertainty_score":0.99752253},"labels":[],"label_agreement":null},{"id":"W2763968816","doi":"","title":"Development of a predictive microRNA signature for node-negative breast cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Breast cancer; microRNA; Cancer; Medicine; Immunohistochemistry; Oncology; TaqMan; Internal medicine; Pathology; Cancer research; Biology; Real-time polymerase chain reaction; Gene; Genetics","score_opus":0.037856608719243574,"score_gpt":0.3613625606596431,"score_spread":0.32350595194039955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763968816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635448,0.007076283,0.022835972,0.00085217424,0.00031916884,0.0026080047,0.0019471804,0.000025634996,0.000790807],"genre_scores_gemma":[0.98845077,0.0017758226,0.0037748727,0.00011506643,0.000452192,0.002318812,0.00012964556,0.00008862307,0.0028941857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755996,0.00012558846,0.00028375754,0.0006334695,0.0006980048,0.0006992432],"domain_scores_gemma":[0.9977543,0.00004896669,0.0000861393,0.00038748526,0.0015323902,0.00019076465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005264351,0.0001952144,0.0002361894,0.00018430404,0.000335973,0.000013930991,0.0004348283,0.00029767407,0.00025502214],"category_scores_gemma":[0.00013537587,0.00018754398,0.00012062732,0.000445973,0.00040608158,0.0000069737084,0.0003005098,0.0004518606,0.0000066808516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014631787,0.00008692658,0.000057544472,0.00010734315,0.00027025279,0.0000055230644,0.0006097444,0.00033823628,0.9775554,0.000017947556,0.013943149,0.0055447714],"study_design_scores_gemma":[0.0013091816,0.00019263374,0.00071500475,0.00011214599,0.0000106385605,0.000016194412,0.00020472426,0.000074065814,0.9716537,0.0000400347,0.025472885,0.00019879511],"about_ca_topic_score_codex":0.00029609786,"about_ca_topic_score_gemma":0.00052349176,"teacher_disagreement_score":0.024906004,"about_ca_system_score_codex":0.00031986617,"about_ca_system_score_gemma":0.0030046606,"threshold_uncertainty_score":0.76478213},"labels":[],"label_agreement":null},{"id":"W2765719474","doi":"10.1158/0008-5472.can-17-1584","title":"Cross-Cancer Analysis Reveals Novel Pleiotropic Associations—Response","year":2017,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Synteny; Biology; Genetics; Genome; Cancer; Gene; Carcinogenesis; Centimorgan; Genome-wide association study; Congenic; Computational biology; Gene mapping; Single-nucleotide polymorphism; Chromosome; Genotype","score_opus":0.060964437622075866,"score_gpt":0.4232185390716114,"score_spread":0.3622541014495355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765719474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8691069,0.0032940395,0.00018636887,0.12096826,0.0005657782,0.00052357704,0.004757565,0.000015892676,0.0005816041],"genre_scores_gemma":[0.4960068,0.007701129,0.00067055493,0.10867967,0.022191899,0.0023917202,0.009251415,0.00047922094,0.3526276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966341,0.00033247937,0.00039660838,0.00095173676,0.00077515375,0.00090988434],"domain_scores_gemma":[0.9967684,0.00012226199,0.0003718867,0.0016578289,0.0009658958,0.00011372848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013662355,0.00032834272,0.00052785175,0.00037066688,0.00065890845,0.00049800624,0.0014022999,0.0012706151,0.00043668758],"category_scores_gemma":[0.00058499,0.00033337256,0.00043896318,0.00035107933,0.00035783226,0.000005967055,0.0005530018,0.0015274232,0.000039689465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001583251,0.000037855116,0.014794995,0.00010913065,0.0023863816,0.000037453927,0.000040337934,0.0004978904,0.22706044,0.0000068788568,0.75453603,0.00033427088],"study_design_scores_gemma":[0.00059542956,0.00010183669,0.055047426,0.00004512739,0.00030277873,0.0000025091445,0.0000069285406,0.0001505219,0.004496117,0.000069398964,0.93864626,0.0005356867],"about_ca_topic_score_codex":0.00088305835,"about_ca_topic_score_gemma":0.0004299213,"teacher_disagreement_score":0.3731001,"about_ca_system_score_codex":0.0004905502,"about_ca_system_score_gemma":0.001126646,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W2765874857","doi":"","title":"Potential use for sulfasalazine in lung cancer therapy","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cystine; Pharmacology; Cancer research; Sulfasalazine; Cisplatin; Cancer cell; Cell growth; Biology; Chemistry; Cancer; Medicine; Biochemistry; Internal medicine; Cysteine; Chemotherapy; Ulcerative colitis","score_opus":0.05196524295770454,"score_gpt":0.40959399646317024,"score_spread":0.3576287535054657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765874857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005575,0.017440377,0.0007696028,0.0008358345,0.00025241138,0.00050526945,0.0000660519,0.000005980073,0.00006871728],"genre_scores_gemma":[0.9751948,0.020479873,0.00022888824,0.00024851365,0.0008082055,0.000671011,0.000046661513,0.00003280549,0.002289234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998854,0.00004231639,0.00012459577,0.00032338174,0.00018795647,0.0004677394],"domain_scores_gemma":[0.99945,0.000009714199,0.000021010743,0.00023817117,0.00019773257,0.000083372506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029282586,0.0000999086,0.00011719488,0.00007891095,0.00007981111,0.000035422257,0.00019134952,0.00011650176,0.000055603665],"category_scores_gemma":[0.000047528996,0.00008816591,0.000063281266,0.0001654034,0.00009169254,0.0000072301564,0.000072588045,0.00014972911,0.0000019302954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036847973,0.00005601727,0.0027132041,0.00002365114,0.000035232188,0.000004424028,0.00007035547,0.0014554786,0.982316,0.00028748656,0.005351676,0.0073179477],"study_design_scores_gemma":[0.003935207,0.00016409635,0.020379726,0.000038901075,0.0000064164005,0.0000021969518,0.000045742214,0.000054383818,0.71146435,0.0001881227,0.2635019,0.0002189653],"about_ca_topic_score_codex":0.0016680212,"about_ca_topic_score_gemma":0.00092455366,"teacher_disagreement_score":0.2708517,"about_ca_system_score_codex":0.00007551082,"about_ca_system_score_gemma":0.0003847935,"threshold_uncertainty_score":0.35953012},"labels":[],"label_agreement":null},{"id":"W2766352057","doi":"10.1158/0008-5472.can-17-0067","title":"STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China; National Cancer Institute; Public Health Agency of Canada","keywords":"Cancer research; Pancreatic cancer; Biology; Transcription factor; Cancer; Mediator; Kinase; Tumor progression; Gene; Cell biology; Genetics","score_opus":0.039072098330950725,"score_gpt":0.42930164678905514,"score_spread":0.3902295484581044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766352057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97236663,0.025244318,0.000006278842,0.00076962775,0.00031989958,0.00034888994,0.00011062159,0.0000040761684,0.000829636],"genre_scores_gemma":[0.9800962,0.018231446,0.00014682673,0.00001677649,0.0009556021,0.0002463849,0.000009028574,0.000021182954,0.00027650717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855024,0.00009858901,0.00020714509,0.00035830963,0.00042235584,0.00036338836],"domain_scores_gemma":[0.9986835,0.00005097202,0.00010559794,0.0005150011,0.0004654059,0.0001795394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040164625,0.00012318157,0.00027292076,0.00006967413,0.0001820909,0.00003709272,0.00033889216,0.00014438966,0.000089494555],"category_scores_gemma":[0.0011637788,0.000100477984,0.00005909811,0.00006999267,0.0010449678,0.000011574107,0.0002890483,0.00016688614,0.0000012325045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031086736,0.00008579797,0.012308343,0.0004900679,0.000076017444,0.0000017334263,0.00015335999,2.0385805e-7,0.9620941,0.0004143337,0.0012453877,0.02281976],"study_design_scores_gemma":[0.00074969814,0.0003764837,0.009277045,0.0002833632,0.000044735763,0.0000041007697,0.0000809548,0.0000053441963,0.9816456,0.00041323563,0.0069976184,0.00012182107],"about_ca_topic_score_codex":0.0017221308,"about_ca_topic_score_gemma":0.00023743845,"teacher_disagreement_score":0.022697939,"about_ca_system_score_codex":0.000017219705,"about_ca_system_score_gemma":0.0006029943,"threshold_uncertainty_score":0.40973735},"labels":[],"label_agreement":null},{"id":"W2766393924","doi":"","title":"Squalene protects mice bone marrow hematopoietic and mesenchymal stem cells against high-dose cisplatin in vivo by restoring antioxidant balance: implications in cancer chemotherapy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cisplatin; Bone marrow; Pharmacology; Toxicity; In vivo; Medicine; Stem cell; Squalene; Mesenchymal stem cell; Cancer research; Chemotherapy; Chemistry; Immunology; Pathology; Biology; Internal medicine; Biochemistry","score_opus":0.042422883180788885,"score_gpt":0.3845504276158072,"score_spread":0.3421275444350183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766393924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132247,0.0104943635,0.000004475457,0.005686236,0.00011698,0.001794977,0.000098306125,0.000031711344,0.00045049598],"genre_scores_gemma":[0.9854719,0.007099397,0.00007611461,0.00018777935,0.0002509682,0.00209139,0.000010960829,0.000046941816,0.0047645485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977596,0.0001621379,0.00038854568,0.0005734919,0.00040292385,0.0007133064],"domain_scores_gemma":[0.9991924,0.00015270017,0.00008176936,0.00028552793,0.00013108132,0.00015648105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055929285,0.0002124593,0.00043753308,0.00036119932,0.00011458298,0.000030121655,0.00012659065,0.0001419855,0.00025578562],"category_scores_gemma":[0.000007784135,0.0002022876,0.000038910126,0.0009106743,0.00017936621,0.00009659432,0.000059297934,0.00056059397,0.0000058155597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060520973,0.00038043305,0.05122532,0.00034219466,0.000025075817,0.000073839656,0.00037112317,0.00006507272,0.9338802,0.00007091253,0.009309391,0.0036512176],"study_design_scores_gemma":[0.010904508,0.00032082462,0.08566927,0.00075093657,0.000024207257,0.000019045614,0.00014814662,0.0002030357,0.8911239,0.00016972881,0.010334856,0.0003315509],"about_ca_topic_score_codex":0.011547275,"about_ca_topic_score_gemma":0.003199619,"teacher_disagreement_score":0.04275632,"about_ca_system_score_codex":0.001134247,"about_ca_system_score_gemma":0.00044728653,"threshold_uncertainty_score":0.99503493},"labels":[],"label_agreement":null},{"id":"W2766758581","doi":"10.1158/0008-5472.can-17-0598","title":"Developing Cancer Informatics Applications and Tools Using the NCI Genomic Data Commons API","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Research Committee, Aristotle University of Thessaloniki; National Institutes of Health; National Natural Science Foundation of China","keywords":"Informatics; Cancer; Commons; Computational biology; Data science; Computer science; Medicine; Biology; Political science; Internal medicine; Ecology","score_opus":0.2802541606702012,"score_gpt":0.47553095533546114,"score_spread":0.19527679466525993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766758581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96998376,0.0049206223,0.01575288,0.005581447,0.00019957518,0.0013392306,0.00059302,0.000012108844,0.0016173742],"genre_scores_gemma":[0.9729546,0.020297391,0.0041071214,0.00045694128,0.00092166814,0.00034710916,0.0002512878,0.000032801036,0.00063113146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983701,0.00006829437,0.00029370206,0.00024049108,0.0004819762,0.00054542563],"domain_scores_gemma":[0.9975786,0.000068544236,0.00011673979,0.001723035,0.000333445,0.00017961195],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0013852331,0.00012396889,0.00013523869,0.00006389231,0.0014774441,0.0006466817,0.002061996,0.00013667971,0.000023643515],"category_scores_gemma":[0.00038912412,0.00008957725,0.000026378482,0.00009710053,0.0010997355,0.000036617985,0.0031569568,0.00034629554,0.00001272246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014676397,0.00007386722,0.017106889,0.0007703152,0.00034553555,0.0000031914146,0.0012861931,0.00011574598,0.38192612,0.0012371126,0.02410025,0.572888],"study_design_scores_gemma":[0.0008017883,0.0000934069,0.012295465,0.0001338173,0.00003284489,0.000014046942,0.0019736122,0.0053444915,0.044869237,0.00043978737,0.9335811,0.0004203829],"about_ca_topic_score_codex":0.0006927957,"about_ca_topic_score_gemma":0.0011036344,"teacher_disagreement_score":0.90948087,"about_ca_system_score_codex":0.00008908696,"about_ca_system_score_gemma":0.0010833711,"threshold_uncertainty_score":0.9998225},"labels":[],"label_agreement":null},{"id":"W2766865378","doi":"10.1158/1538-7445.am10-ss02-04","title":"Abstract SS02-04: How much can we afford to pay for new drugs, and how do we make those decisions?","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Excellence; Medicine; Cancer drugs; Citation; Cancer; Competitor analysis; Actuarial science; Family medicine; Marketing; Business; Political science; Internal medicine; Law","score_opus":0.13588680562988004,"score_gpt":0.3696776593660022,"score_spread":0.23379085373612218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766865378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77026135,0.013321111,0.00084209524,0.20661612,0.0017713418,0.0014781969,0.0013389275,0.000047865888,0.004322984],"genre_scores_gemma":[0.9501164,0.018027293,0.0016534888,0.00045300048,0.0015600879,0.00038245335,0.000008792757,0.000087512766,0.027710976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749327,0.000014587435,0.0003761756,0.00088163995,0.000133462,0.0011008829],"domain_scores_gemma":[0.9976301,0.00046059547,0.00019204002,0.0007098935,0.00020214017,0.00080518215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016150798,0.00027789458,0.00058727764,0.00057134894,0.00037314714,0.00076901674,0.0006444872,0.00028160558,0.00050406606],"category_scores_gemma":[0.000994226,0.00026416391,0.00014836567,0.00040752196,0.00017257381,0.00037054686,0.00022088853,0.00080970867,0.00014279841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027402665,0.000053226784,0.005056609,0.000090033725,0.000063939246,0.000005253256,0.0016074895,0.000008236397,0.0010264494,0.05476532,0.24977382,0.6872756],"study_design_scores_gemma":[0.0009771214,0.00015656247,0.009532415,0.00010336624,0.00000397744,0.0000020140048,0.00039930473,0.00003813222,0.00097157265,0.07778377,0.90964264,0.00038914144],"about_ca_topic_score_codex":0.0014792637,"about_ca_topic_score_gemma":0.00431764,"teacher_disagreement_score":0.6868865,"about_ca_system_score_codex":0.00030903408,"about_ca_system_score_gemma":0.0005313609,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2766877747","doi":"10.1158/0008-5472.can-17-0323","title":"An Image Analysis Resource for Cancer Research: PIIP—Pathology Image Informatics Platform for Visualization, Analysis, and Management","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Instituto Tecnológico de Costa Rica; Sunnybrook Research Institute","keywords":"Computer science; Plug-in; Digital pathology; Visualization; Resource (disambiguation); Informatics; Software; World Wide Web; Health informatics; Multimedia; Pathology; Artificial intelligence; Medicine; Programming language","score_opus":0.13866535845606107,"score_gpt":0.49729864132371504,"score_spread":0.35863328286765395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766877747","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06494418,0.00034807855,0.9297735,0.0016243398,0.0001694173,0.0019581786,0.00017192008,0.00010056188,0.00090980524],"genre_scores_gemma":[0.8480141,0.0050162026,0.1312111,0.00040031658,0.00093225064,0.011102814,0.0002006963,0.000120074335,0.0030024138],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99598014,0.00025518017,0.0005492488,0.0008641932,0.0012094199,0.0011418383],"domain_scores_gemma":[0.9946133,0.00044829748,0.00030392033,0.0023410239,0.0019900512,0.00030340772],"candidate_categories":["sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.006810416,0.00022281456,0.0004813327,0.0025773146,0.0027932709,0.0018892513,0.0025738445,0.00015925046,0.000043265158],"category_scores_gemma":[0.00029862393,0.00021721286,0.00019980897,0.0033072862,0.0007664698,0.0020569775,0.0010358274,0.0003930753,0.0000058717237],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027559183,0.00081828475,0.025207985,0.0057045855,0.018262751,0.000104318264,0.036636412,0.010691477,0.033385944,0.13232577,0.0834713,0.65063524],"study_design_scores_gemma":[0.003262085,0.0010973196,0.034044173,0.00013018589,0.0016151629,0.0000051074717,0.0024524091,0.7885335,0.03822209,0.013447931,0.11615899,0.0010310488],"about_ca_topic_score_codex":0.001154656,"about_ca_topic_score_gemma":0.004356174,"teacher_disagreement_score":0.7985624,"about_ca_system_score_codex":0.0007137356,"about_ca_system_score_gemma":0.00027179281,"threshold_uncertainty_score":0.9991469},"labels":[],"label_agreement":null},{"id":"W2766962557","doi":"10.1158/0008-5472.can-17-0491","title":"Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Blockade; Cancer; Antibody; Cancer therapy; Cancer research; Medicine; Immunology; Internal medicine; Receptor","score_opus":0.14389260925883182,"score_gpt":0.4744422395084106,"score_spread":0.33054963024957873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766962557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916856,0.0019597223,0.000048225953,0.0037867965,0.00018506893,0.0016272909,0.00007403488,0.0000127138255,0.000620502],"genre_scores_gemma":[0.9938328,0.0043936917,0.000026190208,0.00041520808,0.00025474027,0.00063992187,0.000013436552,0.000029912926,0.00039405256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828,0.00018444509,0.0002305343,0.00041214545,0.00050378736,0.00038909825],"domain_scores_gemma":[0.99884766,0.000039725775,0.0000875982,0.0005026876,0.00038723537,0.00013511788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008048668,0.00014258668,0.00029273008,0.00035092115,0.00019084293,0.0000525408,0.00022713664,0.00010224024,0.00038020714],"category_scores_gemma":[0.000041169274,0.00012331764,0.00008935215,0.00031813723,0.00027714553,0.00016523838,0.000034702523,0.00035138003,0.0000056111007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072842385,0.0002302789,0.010009065,0.00008518708,0.00010537147,0.000020742094,0.0043490175,0.000005975544,0.91205627,0.0000127075355,0.00020093637,0.06564019],"study_design_scores_gemma":[0.003977356,0.0012026026,0.18895933,0.00064481515,0.000009071613,0.0000016666928,0.00021904628,0.000044486304,0.80361027,0.00006346049,0.0011570974,0.000110830086],"about_ca_topic_score_codex":0.033472598,"about_ca_topic_score_gemma":0.003682276,"teacher_disagreement_score":0.17895027,"about_ca_system_score_codex":0.0005052355,"about_ca_system_score_gemma":0.00027336582,"threshold_uncertainty_score":0.9729636},"labels":[],"label_agreement":null},{"id":"W2767391926","doi":"10.1158/0008-5472.can-17-0599","title":"Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Government of Canada","keywords":"Oncolytic virus; Microglia; Virotherapy; Cancer research; Glioma; Macrophage; Viral replication; Gene silencing; Biology; Virus; Immunology; Virology; Medicine; Gene; Inflammation","score_opus":0.051584124298836215,"score_gpt":0.4327873251448476,"score_spread":0.38120320084601134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767391926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785018,0.01782628,0.000014962321,0.0021086365,0.0000735,0.0004454746,0.00012622538,0.000010901362,0.00089224457],"genre_scores_gemma":[0.9664767,0.014119395,0.00006690966,0.00020060975,0.0004531576,0.00023711068,0.000023411947,0.00006579978,0.018356936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780935,0.00023045861,0.00015913084,0.0005979908,0.0004773803,0.0007256868],"domain_scores_gemma":[0.99840766,0.00003488876,0.00006079838,0.0010490584,0.00020631064,0.00024126146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093107595,0.00017350577,0.00017371753,0.00008096769,0.0008203372,0.00030763977,0.00082091824,0.00015935744,0.00022685109],"category_scores_gemma":[0.00012808458,0.00016135054,0.000051912448,0.00007006499,0.0009489196,0.000011005423,0.0003791303,0.0003422169,0.000032232725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014901101,0.00004478179,0.0011806514,0.000028202698,0.000074330484,0.000012709172,0.0000708553,0.000001520105,0.9311178,0.0000063441844,0.014339146,0.051633563],"study_design_scores_gemma":[0.0010635525,0.0014671345,0.00051693385,0.000023600494,0.0000034180368,0.000004108693,0.0000359007,0.000012111087,0.874826,0.000114497845,0.12176014,0.00017259762],"about_ca_topic_score_codex":0.00057125755,"about_ca_topic_score_gemma":0.00073434133,"teacher_disagreement_score":0.10742099,"about_ca_system_score_codex":0.00009820367,"about_ca_system_score_gemma":0.00048588042,"threshold_uncertainty_score":0.65796846},"labels":[],"label_agreement":null},{"id":"W2767717304","doi":"","title":"Potential molecular mechanisms of insulin like growth factor-1 (IGF-1)/insulin like growth factor-1 receptor (IGF-1R) interaction in prostate cancer invasion","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"DU145; Wortmannin; Insulin-like growth factor; MAPK/ERK pathway; Growth factor; Cancer research; Biology; Prostate cancer; Endocrinology; Signal transduction; Internal medicine; Cell biology; Cancer; Receptor; PI3K/AKT/mTOR pathway; Medicine; LNCaP","score_opus":0.041202553856968596,"score_gpt":0.33960749728094863,"score_spread":0.29840494342398005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767717304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889951,0.003407871,0.0006247867,0.0023175227,0.0014169547,0.002403783,0.0003706954,0.00014887104,0.00031443255],"genre_scores_gemma":[0.9877724,0.009457792,0.00047779983,0.000528912,0.0003534395,0.0006106192,0.00017659795,0.00020607674,0.00041636356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99250084,0.0005454978,0.0014254429,0.0014181276,0.0024474398,0.0016626562],"domain_scores_gemma":[0.99593997,0.00016514567,0.00041199394,0.0008338168,0.0018670204,0.00078206946],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009800759,0.00073632254,0.0011626169,0.001754099,0.0002684522,0.00011935202,0.00070448813,0.0005891077,0.0010127685],"category_scores_gemma":[0.00062268676,0.0006751748,0.0003929448,0.002445504,0.0004021701,0.00083128613,0.0004504352,0.002546642,0.00018749083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036795137,0.0011382074,0.010037893,0.0010132736,0.0002937061,0.00033005208,0.003545629,0.00012319066,0.97321314,0.0007558682,0.0010602078,0.0048092958],"study_design_scores_gemma":[0.009379099,0.0020746987,0.038058497,0.0017204473,0.00009407787,0.000034423174,0.0011892878,0.000082240644,0.9418027,0.0033679851,0.0013085278,0.0008880491],"about_ca_topic_score_codex":0.016505549,"about_ca_topic_score_gemma":0.0007165832,"teacher_disagreement_score":0.031410497,"about_ca_system_score_codex":0.0027893868,"about_ca_system_score_gemma":0.0024621212,"threshold_uncertainty_score":0.99990046},"labels":[],"label_agreement":null},{"id":"W2767843030","doi":"","title":"Long-term results of a low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukemia and myelodysplastic syndrome in children with Down syndrome","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cytarabine; Medicine; Regimen; Chemotherapy; Internal medicine; Leukemia; Acute megakaryoblastic leukemia; Population; Myelodysplastic syndromes; Gastroenterology; Refractory (planetary science); Chemotherapy regimen; Surgery; Pediatrics; Bone marrow","score_opus":0.02188701874693273,"score_gpt":0.3266099236945285,"score_spread":0.3047229049475958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767843030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925373,0.0016398816,0.00010468873,0.001005894,0.000025443493,0.004136766,0.00044565415,0.000021691023,0.000082668375],"genre_scores_gemma":[0.9961633,0.0009239382,0.00020270042,0.000015074961,0.00007267143,0.0012137598,0.00015396642,0.000060560826,0.0011940367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965483,0.000170024,0.00061833556,0.0006745602,0.00108521,0.0009035739],"domain_scores_gemma":[0.9968559,0.0014513519,0.00016308326,0.0008464744,0.00047316164,0.00021002839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084773224,0.0003152414,0.00077392807,0.000717424,0.00013863806,0.00003156286,0.00035990344,0.00016025086,0.000032701042],"category_scores_gemma":[0.00012340388,0.00019286235,0.00011326742,0.0011710224,0.0010719897,0.00009043869,0.00006475243,0.00045522416,0.000004354745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12787114,0.0045120935,0.7294297,0.0049951635,0.006921902,0.0052641183,0.0015161295,0.007943787,0.09257066,0.00030970914,0.0030797357,0.015585835],"study_design_scores_gemma":[0.02735976,0.009054633,0.9435651,0.0011673595,0.00035472563,0.0006733206,0.000031025473,0.0016992532,0.015821217,0.000032526033,0.00003317104,0.00020794681],"about_ca_topic_score_codex":0.0046295826,"about_ca_topic_score_gemma":0.0006853996,"teacher_disagreement_score":0.21413533,"about_ca_system_score_codex":0.002043866,"about_ca_system_score_gemma":0.0025639536,"threshold_uncertainty_score":0.7864698},"labels":[],"label_agreement":null},{"id":"W2768576952","doi":"10.1158/0008-5472.can-16-1911","title":"TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; American Association for Cancer Research","keywords":"Triple-negative breast cancer; Triple negative; Cancer; Breast cancer; Medicine; Cancer research; Internal medicine","score_opus":0.14082927648636506,"score_gpt":0.4641538463131926,"score_spread":0.32332456982682756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768576952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96328115,0.0074305767,0.000028382034,0.011090313,0.0010911907,0.0069611906,0.0010591458,0.00010776369,0.008950284],"genre_scores_gemma":[0.88678557,0.02628738,0.00014555121,0.00035176103,0.002945665,0.0045686862,0.000035222583,0.00021106674,0.07866909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948926,0.00028502336,0.00038997483,0.0010051081,0.0017960966,0.0016311782],"domain_scores_gemma":[0.99481565,0.0004352296,0.0001542888,0.0017908846,0.0021322314,0.0006717437],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001966191,0.00035708855,0.0006949723,0.0004623504,0.0013797721,0.000378819,0.0010729308,0.00027101618,0.031630263],"category_scores_gemma":[0.0002630711,0.0002923628,0.00031800653,0.0005023631,0.0011073448,0.00026046648,0.00023474325,0.00125229,0.0002497669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010696272,0.00022252345,0.0024877407,0.00014818991,0.00029204687,0.00007689295,0.0011288659,0.000004274082,0.8047775,0.00012223597,0.09844898,0.08159447],"study_design_scores_gemma":[0.012693544,0.0010318765,0.02222161,0.0003602678,0.000024867837,0.00003194436,0.0009318937,0.00012585019,0.6421467,0.0006451297,0.319359,0.00042728533],"about_ca_topic_score_codex":0.010855762,"about_ca_topic_score_gemma":0.0006631694,"teacher_disagreement_score":0.22091001,"about_ca_system_score_codex":0.0012902103,"about_ca_system_score_gemma":0.0022052648,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W2768980689","doi":"10.1158/1538-7445.sabcs16-p4-15-01","title":"Abstract P4-15-01: Cost-effectiveness of pre-implantation genetic diagnosis for BRCA mutation carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Sunnybrook Health Science Centre","funders":"","keywords":"BRCA mutation; Medicine; Breast cancer; Cost effectiveness; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.16342309159103743,"score_gpt":0.5106488479463663,"score_spread":0.34722575635532893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768980689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386436,0.00053254486,0.0009821279,0.0020147988,0.00024914634,0.0019802677,0.00009247083,0.0000104273795,0.00027387048],"genre_scores_gemma":[0.9977067,0.00056302466,0.00014188151,0.00001987564,0.00019736933,0.0012001421,0.000076186094,0.00001727846,0.00007752015],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986887,0.00009013695,0.00018316194,0.00022254909,0.0005774892,0.00023795987],"domain_scores_gemma":[0.9982709,0.0005819168,0.00011097951,0.00029449933,0.00059744605,0.00014424569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013809154,0.000071231945,0.00018123297,0.0001273354,0.00031308737,0.0000392444,0.00013138984,0.00017964815,0.00009452839],"category_scores_gemma":[0.00056010264,0.000058774818,0.00006031258,0.000097979006,0.0006942975,0.000079387195,0.000031818126,0.00024953793,0.0000029668595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044415146,0.00028196786,0.054572128,0.0084812455,0.00030056434,0.000039567953,0.001680414,0.0003502197,0.25745004,0.0014319803,0.0012082458,0.66976213],"study_design_scores_gemma":[0.0017814399,0.0002658796,0.8931709,0.00063403987,0.000036956542,0.0000038217536,0.000050600072,0.0003930783,0.1004847,0.001967515,0.0011484153,0.00006264821],"about_ca_topic_score_codex":0.0022607073,"about_ca_topic_score_gemma":0.0002867016,"teacher_disagreement_score":0.8385988,"about_ca_system_score_codex":0.00018781314,"about_ca_system_score_gemma":0.00046181396,"threshold_uncertainty_score":0.34175283},"labels":[],"label_agreement":null},{"id":"W2771911821","doi":"10.1158/1538-7445.newfront17-ia37","title":"Abstract IA37: Prevention of Hepatocellular Carcinoma (HCC) with antiviral therapy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lamivudine; Entecavir; Hepatocellular carcinoma; Internal medicine; Cirrhosis; Nucleoside analogue; Hepatitis B; Randomized controlled trial; Gastroenterology; Hepatitis B virus; Immunology; Virus; Nucleoside","score_opus":0.20349800652861919,"score_gpt":0.46549441068227376,"score_spread":0.26199640415365455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771911821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97649366,0.0010042329,0.000015217917,0.0009956011,0.00004954424,0.0010554437,0.000021641496,0.000018493207,0.020346165],"genre_scores_gemma":[0.99397534,0.0017628131,0.00009342585,0.000015871263,0.00022586672,0.00018781757,0.000011477332,0.000046911922,0.003680469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712664,0.00013826719,0.00023859082,0.00038086527,0.0014996754,0.00061598705],"domain_scores_gemma":[0.9976611,0.0000733582,0.00011245395,0.0011490075,0.00080280256,0.0002012683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013392314,0.00013642195,0.00035296121,0.0002612604,0.0003784698,0.00009024844,0.00046881937,0.000112294445,0.00081830483],"category_scores_gemma":[0.00020722671,0.000103421924,0.00009195761,0.00021062602,0.00073166174,0.00023504725,0.00013359742,0.0006777116,0.00007899217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011584894,0.00019387816,0.75752026,0.00025200497,0.000087676126,0.00023890447,0.000193906,4.0172847e-7,0.1510653,0.000082242295,0.0011877393,0.0880192],"study_design_scores_gemma":[0.0026540454,0.0010479132,0.6895758,0.0004287945,0.00000907284,0.0000040180503,0.00006147951,0.00012326185,0.29716617,0.00011530075,0.008695866,0.00011829863],"about_ca_topic_score_codex":0.005136559,"about_ca_topic_score_gemma":0.00035691072,"teacher_disagreement_score":0.14610085,"about_ca_system_score_codex":0.00019182365,"about_ca_system_score_gemma":0.0012073778,"threshold_uncertainty_score":0.89598644},"labels":[],"label_agreement":null},{"id":"W2772692099","doi":"10.1158/0008-5472.can-17-1679","title":"Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Wellcome Trust; Wellcome","keywords":"Transcription factor; Drug; Cancer drugs; Cancer; Cancer research; Sensitivity (control systems); Biology; Chemistry; Computational biology; Pharmacology; Genetics; Gene","score_opus":0.06211322106196542,"score_gpt":0.4139242630047016,"score_spread":0.35181104194273616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772692099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960365,0.0025354936,0.00011709067,0.00026013586,0.00015057238,0.0001752548,0.00006642605,0.0000021179214,0.00065635535],"genre_scores_gemma":[0.99382025,0.0047882823,0.00003329158,0.000007509214,0.00013819011,0.00006488713,0.000008183873,0.000012762082,0.0011266416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989996,0.00015205053,0.00012057533,0.00025015706,0.00023698584,0.0002406135],"domain_scores_gemma":[0.99935323,0.000024544941,0.00006899613,0.00037400326,0.00013290028,0.00004631757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063843594,0.00007662478,0.000115641815,0.000064963824,0.00013645616,0.00003272964,0.00015123615,0.00008385802,0.000054564473],"category_scores_gemma":[0.000091031965,0.00007700492,0.000043630174,0.000050252365,0.0002125339,0.000010390124,0.00006575003,0.00015322003,8.802815e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018036475,0.000025876121,0.02747142,0.00004309426,0.000016003136,0.0000012474733,0.00015614394,0.00005924775,0.9524173,0.000008740591,0.00010852378,0.019512028],"study_design_scores_gemma":[0.00019528139,0.000049777154,0.13476445,0.000040386003,0.0000020223983,6.826975e-8,0.000072077,0.000030490872,0.8627604,0.000054477227,0.0019579032,0.00007262364],"about_ca_topic_score_codex":0.004299748,"about_ca_topic_score_gemma":0.01602985,"teacher_disagreement_score":0.10729303,"about_ca_system_score_codex":0.000056411798,"about_ca_system_score_gemma":0.0001785441,"threshold_uncertainty_score":0.8945033},"labels":[],"label_agreement":null},{"id":"W2772712497","doi":"10.1158/0008-5472.can-17-1688","title":"The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Government of Canada","keywords":"Immunosurveillance; Biology; Cancer research; MHC class I; Cancer cell; Cancer; Immune system; Major histocompatibility complex; Immunology","score_opus":0.04934613662014481,"score_gpt":0.33991111687773384,"score_spread":0.29056498025758903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772712497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781024,0.017311038,0.00009609161,0.0004509854,0.0026352296,0.00033840883,0.000028067941,0.000031987176,0.0010057802],"genre_scores_gemma":[0.9860094,0.01034353,0.000001745734,0.000030056994,0.00010771334,0.00019590779,0.000029954514,0.000010665653,0.0032709814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868715,0.00042066205,0.00029895853,0.00020034246,0.00009020046,0.0003026961],"domain_scores_gemma":[0.9987867,0.00024856225,0.00008926633,0.00017478091,0.0006842845,0.000016424694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009860146,0.0000996814,0.00013193222,0.00013891938,0.00072561525,0.000028597504,0.00010867926,0.00014662837,0.00056099007],"category_scores_gemma":[0.00011942118,0.000075763935,0.00005261139,0.00025927924,0.0007037667,0.00021518831,0.000032210435,0.00041473174,0.00019688008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007345587,0.000015190858,0.0001014904,0.000027293667,0.000060589235,5.968963e-8,0.0011199152,5.470012e-7,0.7696369,0.000013727607,0.0012482173,0.22704147],"study_design_scores_gemma":[0.00058828644,0.00035631182,0.0025008582,0.000060494385,0.000008055589,0.000007484174,0.001209429,0.000013846946,0.80761594,0.000109393884,0.1874511,0.00007880609],"about_ca_topic_score_codex":0.0022359698,"about_ca_topic_score_gemma":0.00074930256,"teacher_disagreement_score":0.22696266,"about_ca_system_score_codex":0.00017298729,"about_ca_system_score_gemma":0.000100833975,"threshold_uncertainty_score":0.6142448},"labels":[],"label_agreement":null},{"id":"W2772722798","doi":"","title":"Resveratrol mediates cell fate in human uterine cancer cells through prostaglandin inhibition","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Resveratrol; Cell growth; Prostaglandin E2 receptor; Prostaglandin; Cancer cell; Apoptosis; Cell culture; Arachidonic acid; Receptor; Prostaglandin E2; Cell; Cell cycle; HeLa; Prostaglandin E; Chemistry; MTT assay; Cancer research; Biology; Cancer; Pharmacology; Endocrinology; Internal medicine; Biochemistry; Medicine; Enzyme","score_opus":0.050764921919470636,"score_gpt":0.41102543111936063,"score_spread":0.36026050919989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772722798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925132,0.0020147557,0.0000050438616,0.0020312574,0.00024166521,0.0011536726,0.000044356413,0.000050924096,0.0019451157],"genre_scores_gemma":[0.9912892,0.0020468123,0.00007049584,0.0003341033,0.0019142823,0.00090108,0.00003599397,0.000051230727,0.0033567983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974711,0.00019818547,0.0003438721,0.00043213254,0.00075728196,0.0007974237],"domain_scores_gemma":[0.9991036,0.000091446025,0.00005988631,0.00031639583,0.00021389435,0.0002147999],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009677303,0.0001924328,0.00033805287,0.00029450777,0.00016774214,0.000040683608,0.00011157294,0.0001598077,0.0015695859],"category_scores_gemma":[0.000035211546,0.0001621334,0.00006222339,0.0005057969,0.00016819323,0.00021341883,0.00008782073,0.0008044439,0.00014402156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035673231,0.00016007882,0.014993465,0.000644391,0.00001706958,0.00021234868,0.0018670326,0.00010561324,0.9626474,0.000057905494,0.017094893,0.0018430897],"study_design_scores_gemma":[0.0035699501,0.0002628183,0.0045339875,0.0004041444,0.000011882738,0.0000033122542,0.000092192335,0.00013241654,0.9415697,0.000077002485,0.0491614,0.00018122814],"about_ca_topic_score_codex":0.0017928963,"about_ca_topic_score_gemma":0.0015073749,"teacher_disagreement_score":0.032066505,"about_ca_system_score_codex":0.0007647941,"about_ca_system_score_gemma":0.0003798692,"threshold_uncertainty_score":0.9993431},"labels":[],"label_agreement":null},{"id":"W2772938013","doi":"10.1158/0008-5472.can-17-0524","title":"Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Vlaamse Liga Tegen Kanker; Universiteit Gent","keywords":"Paracrine signalling; Cancer research; Medicine; Colorectal cancer; Cancer; Insulin-like growth factor 1 receptor; Stromal cell; Cancer cell; Tumor progression; Autocrine signalling; PI3K/AKT/mTOR pathway; Growth factor; Internal medicine; Oncology; Biology; Signal transduction; Receptor; Cell biology","score_opus":0.13138101741591407,"score_gpt":0.4883485119338059,"score_spread":0.35696749451789184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772938013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998035,0.002178316,0.000046655445,0.014136816,0.0003465408,0.0017134077,0.000066843175,0.00011065762,0.0014203856],"genre_scores_gemma":[0.99004424,0.0033203287,0.0004937724,0.00022256655,0.0007612171,0.0009273635,0.000044551703,0.00009239461,0.0040935427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968429,0.00016871984,0.00031923194,0.00065069145,0.001132988,0.000885431],"domain_scores_gemma":[0.9976765,0.00007458809,0.00031027631,0.0009392999,0.0007272006,0.0002721268],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072063436,0.00026099695,0.00051316386,0.00015403173,0.0009549624,0.0001940971,0.0003841967,0.00013598654,0.0011614419],"category_scores_gemma":[0.0004048804,0.00021087592,0.0001292839,0.00043397222,0.00036653335,0.0004754473,0.00015960453,0.00079194154,0.000013269415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001799394,0.00035907788,0.00418491,0.0003148311,0.00027004667,0.000058860718,0.0005473614,0.000013907312,0.88633835,0.000031307794,0.011057691,0.09502427],"study_design_scores_gemma":[0.003904969,0.00064424635,0.017606745,0.0020267202,0.000047484747,0.000009220845,0.0000718382,0.000094990784,0.8600409,0.00013998525,0.11515234,0.0002605472],"about_ca_topic_score_codex":0.009088628,"about_ca_topic_score_gemma":0.0005424133,"teacher_disagreement_score":0.10409464,"about_ca_system_score_codex":0.0013968138,"about_ca_system_score_gemma":0.0010548364,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W2772948229","doi":"10.1158/1538-7445.newfront17-ia13","title":"Abstract IA13: Combination of DNA methyltransferase and PARP inhibitors as a novel therapy strategy for multiple cancers: Key data in AML and triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"PARP1; Decitabine; Cancer research; Poly ADP ribose polymerase; Triple-negative breast cancer; PARP inhibitor; Breast cancer; Olaparib; Azacitidine; Cancer; DNA damage; Biology; Synthetic lethality; DNA repair; Polymerase; DNA methylation; DNA; Genetics; Gene expression; Gene","score_opus":0.2356626354221195,"score_gpt":0.4819503572045696,"score_spread":0.2462877217824501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772948229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647094,0.0037616491,0.000055116503,0.0039684917,0.00018816418,0.0023190854,0.002941788,0.000016862452,0.00027790203],"genre_scores_gemma":[0.98560035,0.012616234,0.0001303445,0.00012166047,0.00026755623,0.0010088733,0.00007988953,0.000048159625,0.00012691406],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976528,0.0000911594,0.00043580148,0.000698049,0.0006201894,0.0005019983],"domain_scores_gemma":[0.9976005,0.000502777,0.00019476606,0.0008443298,0.00062497635,0.0002326607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014096595,0.00022620508,0.0005013822,0.0002993786,0.00033326185,0.00011815927,0.00037753602,0.00016040236,0.00020207101],"category_scores_gemma":[0.00030846708,0.00020422255,0.000047469763,0.00024565935,0.0008355226,0.00060115696,0.00009934986,0.00049121084,8.907777e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015127109,0.0007550753,0.069068566,0.0009907373,0.0005200137,0.000021367621,0.004096736,0.00006155769,0.7454193,0.00051540654,0.002931315,0.1604928],"study_design_scores_gemma":[0.05194023,0.0011188736,0.5261932,0.0020669869,0.00006217027,0.0000228071,0.0018649565,0.0016994653,0.4100119,0.001860963,0.002641438,0.0005169869],"about_ca_topic_score_codex":0.054712664,"about_ca_topic_score_gemma":0.014168248,"teacher_disagreement_score":0.45712465,"about_ca_system_score_codex":0.0005077145,"about_ca_system_score_gemma":0.0014866907,"threshold_uncertainty_score":0.9515821},"labels":[],"label_agreement":null},{"id":"W2772964465","doi":"10.1158/0008-5472.can-17-1231","title":"Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Terry Fox Research Institute; Canada Research Chairs; Government of Canada","keywords":"Prenylation; Statin; RHOB; HRAS; Geranylgeranylation; Fluvastatin; Cancer research; Farnesyl pyrophosphate; Mevalonate pathway; Cancer cell; Cancer; Mevalonic acid; Ectopic expression; Biology; Pharmacology; Signal transduction; Cell biology; Cell culture; RHOA; Biochemistry; Simvastatin; Genetics; Enzyme","score_opus":0.08952582082911523,"score_gpt":0.3929057072076376,"score_spread":0.3033798863785224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772964465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906435,0.0024748386,0.00056464045,0.00043819624,0.0020299763,0.00077465636,0.001010775,0.000010070359,0.0020533407],"genre_scores_gemma":[0.9877215,0.003454568,0.0005379177,0.00011408323,0.00579572,0.00053715263,0.00013929413,0.0000447416,0.0016550234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979824,0.00013379676,0.0002683759,0.00054112234,0.0005841218,0.0004901875],"domain_scores_gemma":[0.997981,0.000033814278,0.00018393662,0.0009023693,0.0007022868,0.00019660861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004853323,0.00017716372,0.00026755632,0.00004748791,0.00034291283,0.00011414048,0.0006194444,0.00021358904,0.00021132575],"category_scores_gemma":[0.00028686412,0.00016775572,0.00008241466,0.000065037886,0.0001592052,0.000015647282,0.00027694888,0.00026274557,0.0000026960508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032793952,0.00005524175,0.000894133,0.00005769112,0.000061798535,2.8862198e-7,0.00018661402,0.000020204006,0.98690695,0.00024066021,0.0050310935,0.0062173856],"study_design_scores_gemma":[0.0016132931,0.0002521842,0.014213238,0.000074038006,0.00003775294,2.07193e-7,0.00018168632,0.00011669129,0.921655,0.00048822621,0.06112554,0.0002421564],"about_ca_topic_score_codex":0.09748454,"about_ca_topic_score_gemma":0.033475276,"teacher_disagreement_score":0.06525196,"about_ca_system_score_codex":0.00014345716,"about_ca_system_score_gemma":0.0015146141,"threshold_uncertainty_score":0.98416126},"labels":[],"label_agreement":null},{"id":"W2773386546","doi":"","title":"Indian hedgehog signaling in osteosarcoma: Co-expression of GLI1, PTCH1, and IHH","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Cyclopamine; GLI1; Smoothened; Indian hedgehog; Hedgehog signaling pathway; Hedgehog; PTCH1; Patched; Osteosarcoma; Biology; Cancer research; Internal medicine; Endocrinology; Signal transduction; Medicine; Cell biology","score_opus":0.0597152562900938,"score_gpt":0.41404402476879665,"score_spread":0.35432876847870287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773386546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294055,0.005937352,0.000060857765,0.00007523742,0.00004905236,0.00022816687,0.000018810117,0.0000055573423,0.0006844003],"genre_scores_gemma":[0.99892014,0.0004661445,0.00015562301,0.000033479588,0.00018233444,0.00003097012,0.000015328824,0.000021302885,0.0001746534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846375,0.00013197624,0.00025520317,0.00035268944,0.00031279726,0.0004835823],"domain_scores_gemma":[0.99931866,0.00009633891,0.00004842618,0.00024087344,0.00018101199,0.00011467267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017240106,0.00011421748,0.00017930452,0.0002110803,0.00010645738,0.000013955893,0.00019463114,0.00015186249,0.000019739757],"category_scores_gemma":[0.00022537232,0.000107208565,0.000034695324,0.00026597132,0.00028946914,0.000004054687,0.00021069129,0.00025387463,0.0000031996256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016111016,0.00003550387,0.031511128,0.000093807066,0.00001270826,0.000023777424,0.0007912206,0.000015417841,0.96377397,0.000010645596,0.00035592058,0.003214772],"study_design_scores_gemma":[0.0005702253,0.00018301375,0.0069649937,0.00014252687,0.0000019647846,0.0000031345746,0.0010556978,0.0000015485028,0.98769736,0.00004997694,0.0032172133,0.000112361166],"about_ca_topic_score_codex":0.00019737308,"about_ca_topic_score_gemma":0.00043311415,"teacher_disagreement_score":0.024546133,"about_ca_system_score_codex":0.000045552555,"about_ca_system_score_gemma":0.00014801601,"threshold_uncertainty_score":0.43718386},"labels":[],"label_agreement":null},{"id":"W2776882820","doi":"10.1158/0008-5472.can-17-1345","title":"ConsensusDriver Improves upon Individual Algorithms for Predicting Driver Alterations in Different Cancer Types and Individual Patients","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer; Algorithm; Computer science; Computational biology; Medicine; Biology; Internal medicine","score_opus":0.6910529857859166,"score_gpt":0.6218502542468978,"score_spread":0.06920273153901879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776882820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406236,0.000118790995,0.0008097489,0.0008113506,0.0006809739,0.001569275,0.0017590709,0.00002292745,0.00016547424],"genre_scores_gemma":[0.94979036,0.00020169061,0.04740934,0.00005855181,0.000839252,0.0013371306,0.000013367156,0.000050469174,0.00029983607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716276,0.0005295271,0.0005229457,0.0005000939,0.00071894017,0.00056574534],"domain_scores_gemma":[0.98187625,0.016878735,0.0002165493,0.0004319797,0.0004174506,0.00017905056],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026361044,0.00017912778,0.00044836395,0.00014843694,0.0006169616,0.0003135639,0.00047647805,0.00017696587,0.00011583493],"category_scores_gemma":[0.03814259,0.00014210882,0.00005638622,0.000081271784,0.00050163403,0.00013548827,0.0004168479,0.00055492163,0.0000021713242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001063167,0.0010646043,0.5071095,0.0010922786,0.0008778756,0.000018119828,0.0059015774,0.000008632028,0.003193449,0.027120642,0.012820605,0.43972954],"study_design_scores_gemma":[0.0067640957,0.000540737,0.5990061,0.0006652169,0.00018484704,5.7811695e-7,0.00023556696,0.0013028167,0.007583956,0.38260296,0.00067665876,0.00043646828],"about_ca_topic_score_codex":0.0004349605,"about_ca_topic_score_gemma":0.0006874936,"teacher_disagreement_score":0.43929306,"about_ca_system_score_codex":0.00014000772,"about_ca_system_score_gemma":0.00017494422,"threshold_uncertainty_score":0.96995956},"labels":[],"label_agreement":null},{"id":"W2778994189","doi":"10.1158/0008-5472.can-15-3308","title":"Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Oncolytic virus; Sunitinib; Cancer research; Biology; CD8; Cancer cell; Primary tumor; Metastasis; Immunology; Virus; Immune system; Cancer","score_opus":0.088023798999917,"score_gpt":0.4160395260466699,"score_spread":0.32801572704675286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778994189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436325,0.0017490174,0.0012154425,0.00035136074,0.00011792546,0.00061543274,0.00019972945,0.000011853559,0.0013759715],"genre_scores_gemma":[0.9958046,0.0017402989,0.00039109783,0.00008178092,0.00018627178,0.0002740484,0.00009321498,0.00006067016,0.0013679818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976533,0.00026496194,0.0002821038,0.0005530028,0.0006182901,0.0006283478],"domain_scores_gemma":[0.99760646,0.00011444687,0.00018092975,0.0013728867,0.0005752625,0.00014999739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011986373,0.00017113792,0.00021817788,0.00007875327,0.00056101807,0.00010820973,0.001126895,0.00014717928,0.00018551743],"category_scores_gemma":[0.00039767943,0.00017078238,0.00008867643,0.0001310252,0.000287595,0.000017521175,0.00033623524,0.00034741848,0.000046817742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016607067,0.00012515674,0.0002945669,0.0000662892,0.000037517977,0.0000032311154,0.00009155409,0.000024765064,0.9917965,0.00004462145,0.003097531,0.0027575789],"study_design_scores_gemma":[0.0010509737,0.0013783084,0.00013755725,0.00004502089,0.000006682857,0.0000012244976,0.00013448975,0.00010711375,0.9870978,0.00041387306,0.009451844,0.00017512354],"about_ca_topic_score_codex":0.0015563781,"about_ca_topic_score_gemma":0.00086751196,"teacher_disagreement_score":0.0063543133,"about_ca_system_score_codex":0.000098426885,"about_ca_system_score_gemma":0.00049082254,"threshold_uncertainty_score":0.6964304},"labels":[],"label_agreement":null},{"id":"W2779312016","doi":"10.1158/0008-5472.can-17-1987","title":"Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":423,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Zürich; SCIEX; Novartis Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Germinal center; Lung cancer; Chemotherapy; Medicine; Lymph node; Pathology; Cancer research; Oncology; Internal medicine; Immunology; B cell; Antibody","score_opus":0.024703178921962294,"score_gpt":0.31717231793625755,"score_spread":0.2924691390142953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779312016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360489,0.06272076,0.0000019904442,0.00039699706,0.00022468841,0.00049495086,0.000063565494,0.000008168654,0.000039950613],"genre_scores_gemma":[0.9974318,0.0010782427,0.0000035747814,0.00005767359,0.000018003428,0.00011443952,0.000009567884,0.000021917185,0.0012647773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982234,0.0005210393,0.00029965563,0.00030216578,0.000095642616,0.0005580753],"domain_scores_gemma":[0.99844396,0.00059603667,0.00019368126,0.0006361151,0.0001064656,0.000023736526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047453138,0.00016472707,0.00026650785,0.00011831722,0.0005537391,0.00005843406,0.0006457529,0.00014741247,0.00009485276],"category_scores_gemma":[0.00035066708,0.0001169056,0.000051360432,0.000076952485,0.0012229859,0.00012796992,0.00023977563,0.00044828144,0.000004332863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012052684,0.000053351177,0.34871936,0.000104106715,0.000017788692,0.00001691532,0.0005502984,6.510958e-7,0.6411594,0.0000025102788,0.00087054365,0.0072998074],"study_design_scores_gemma":[0.0018330405,0.00019482113,0.6068408,0.000080338934,0.000010744827,0.00004939958,0.00024790937,0.000011950478,0.3897055,0.000020019328,0.00090537354,0.00010010277],"about_ca_topic_score_codex":0.0018243266,"about_ca_topic_score_gemma":0.00015275778,"teacher_disagreement_score":0.25812143,"about_ca_system_score_codex":0.00010382016,"about_ca_system_score_gemma":0.00016506361,"threshold_uncertainty_score":0.4767272},"labels":[],"label_agreement":null},{"id":"W2782376830","doi":"","title":"Abstract #3559: A quantitative survey of tyrosine phosphorylation changes with erlotinib treatment in EGFR mutant and wildtype NSCLC cell lines","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Epidermal growth factor receptor; Cancer research; T790M; Erlotinib Hydrochloride; Tyrosine kinase; EGFR inhibitors; Lung cancer; Wild type; Gefitinib; Cancer; Biology; Chemistry; Oncology; Medicine; Mutant; Internal medicine; Receptor; Gene; Genetics","score_opus":0.11233706393893941,"score_gpt":0.4535162266702026,"score_spread":0.34117916273126314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782376830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003154,0.0063506323,0.000005615959,0.0016795294,0.000024825844,0.0008930698,0.00009026765,0.000011452155,0.00091308664],"genre_scores_gemma":[0.9963931,0.0024943158,0.00024869526,0.00003656616,0.000031251435,0.00011123062,0.000074871125,0.0000149912075,0.0005950057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989819,0.00006690888,0.00014824426,0.0002581355,0.00029277342,0.00025204313],"domain_scores_gemma":[0.99907804,0.00020202766,0.00006268531,0.00015970293,0.0004003987,0.00009717316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031904058,0.000121589765,0.00026458272,0.0002037741,0.00006186638,0.000015242553,0.000037741753,0.000048980233,0.000059308753],"category_scores_gemma":[0.000053227373,0.00008209476,0.00001686565,0.0005233509,0.00011192497,0.000059210994,0.000008651499,0.00012104911,0.000003434973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01482804,0.003886979,0.55018306,0.0006010695,0.0005274492,0.00030240152,0.01746031,0.00026453123,0.26022166,0.0005857565,0.0007656079,0.15037312],"study_design_scores_gemma":[0.0036028177,0.0034862154,0.93798804,0.00034332217,0.000046445013,0.0000029656771,0.0004239758,0.000066781984,0.05365488,0.000029001683,0.00026897748,0.00008654447],"about_ca_topic_score_codex":0.01487551,"about_ca_topic_score_gemma":0.018335085,"teacher_disagreement_score":0.38780499,"about_ca_system_score_codex":0.00037366824,"about_ca_system_score_gemma":0.0005808612,"threshold_uncertainty_score":0.99957776},"labels":[],"label_agreement":null},{"id":"W2783581317","doi":"10.1158/0008-5472.can-17-3139","title":"The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":304,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Foundation for Innovation; Canadian Cancer Society; Government of Canada; Canadian Institutes of Health Research; European Hematology Association","keywords":"Hippo signaling pathway; Biology; Cancer research; Cell biology; Oncogene; Immune system; Transcription factor; PD-L1; YAP1; Kinase; Cancer cell; Cancer; Cell cycle; Immunology; Gene; Genetics; Immunotherapy","score_opus":0.08530420885373377,"score_gpt":0.41473815927086005,"score_spread":0.3294339504171263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783581317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866252,0.00983849,0.000027401467,0.0009952567,0.0002785993,0.000457825,0.00003490501,0.000016109208,0.0017262242],"genre_scores_gemma":[0.99443245,0.0016751642,0.000036322454,0.00010030204,0.0009351485,0.00040247978,0.000045780755,0.000039405117,0.0023329675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761105,0.00038202488,0.00029198287,0.0005143475,0.000466083,0.0007345215],"domain_scores_gemma":[0.99877167,0.00005125991,0.000064377244,0.00062507216,0.00039284318,0.00009476322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013632863,0.00017437927,0.00017686033,0.000060227467,0.00074121467,0.00007970822,0.0005695875,0.00017759581,0.00015289591],"category_scores_gemma":[0.00010850306,0.0001260359,0.00008011475,0.000295824,0.00061392266,0.000006952326,0.00030258065,0.0004253972,0.000041608175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016445853,0.00006708298,0.0006429255,0.000028094775,0.00003094506,0.0000058093965,0.00048579788,0.000012828332,0.99101573,0.00016939508,0.0007169572,0.0066599757],"study_design_scores_gemma":[0.00051053555,0.00039634292,0.0011235762,0.000140142,0.0000033684432,0.0000020591167,0.00017158694,0.0000331669,0.88564575,0.000464304,0.11134344,0.0001657095],"about_ca_topic_score_codex":0.00327711,"about_ca_topic_score_gemma":0.002449883,"teacher_disagreement_score":0.11062648,"about_ca_system_score_codex":0.00013384293,"about_ca_system_score_gemma":0.00043218854,"threshold_uncertainty_score":0.5700899},"labels":[],"label_agreement":null},{"id":"W2785356110","doi":"","title":"EGF and S100A7 interact to regulate Jab1 in breast cancer and may influence progression of DCIS and early breast cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Cancer research; Estrogen receptor; Biology; Cancer; Epidermal growth factor receptor; Tumor progression; Internal medicine; Endocrinology; Medicine","score_opus":0.02024993747048823,"score_gpt":0.40146829954952545,"score_spread":0.3812183620790372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785356110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992643,0.005404485,0.000005321755,0.0013403893,0.00003601449,0.00038844836,0.0001195944,0.000004069673,0.000058656555],"genre_scores_gemma":[0.9962502,0.0030015118,0.0000689855,0.000095521944,0.00012389898,0.00013563919,0.0000025501024,0.00002129308,0.00030036137],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99861634,0.000053331685,0.0002078923,0.00045436432,0.000235773,0.00043228152],"domain_scores_gemma":[0.99925464,0.000020236062,0.000051717176,0.00020564852,0.00025834958,0.0002093899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057833974,0.00013810025,0.00017840911,0.00016221365,0.00008009575,0.00004633488,0.00013774911,0.00012442024,0.00003975397],"category_scores_gemma":[0.000024472392,0.00011601989,0.00001946345,0.0002677171,0.0002859569,0.00001841306,0.00031645916,0.00020914737,5.39607e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006906829,0.000026427935,0.39295098,0.0000945056,0.000018089164,0.00000792916,0.00024670805,0.00000743367,0.4898583,0.000014078584,0.00018476351,0.115900084],"study_design_scores_gemma":[0.000581778,0.00018552183,0.8684324,0.0005816105,0.0000043624877,0.000027373148,0.000092088885,0.0000107807,0.12774482,0.000022759334,0.0021641997,0.00015233467],"about_ca_topic_score_codex":0.008869904,"about_ca_topic_score_gemma":0.0041241758,"teacher_disagreement_score":0.4754814,"about_ca_system_score_codex":0.000046224715,"about_ca_system_score_gemma":0.0001476627,"threshold_uncertainty_score":0.99773014},"labels":[],"label_agreement":null},{"id":"W2785440134","doi":"","title":"T-cell protein tyrosine phosphatase (TC-PTP) regulates Stat3 signaling in mouse epidermis after UVB irradiation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; STAT3; Signal transduction; Molecular biology; Protein tyrosine phosphatase; Dephosphorylation; Phosphorylation; Cell biology; STAT protein; Gene knockdown; Cyclin D1; Cancer research; Apoptosis; Phosphatase; Cell cycle; Biochemistry","score_opus":0.026966431737012617,"score_gpt":0.341650756526441,"score_spread":0.31468432478942837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785440134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9342484,0.06373366,0.00025683304,0.000282555,0.000061541046,0.0010568444,0.0002655127,0.00001982893,0.00007480906],"genre_scores_gemma":[0.99508053,0.000536932,0.0009326274,0.00014696889,0.00029274687,0.0006151891,0.00037202082,0.00006177985,0.0019612322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738187,0.00018096423,0.00039796068,0.0006450203,0.0004895338,0.00090466684],"domain_scores_gemma":[0.9987902,0.00005461649,0.00008596855,0.00058178615,0.00026816834,0.00021924842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019151381,0.00021911369,0.00019652215,0.00021340093,0.0001186098,0.0000691601,0.00033849076,0.00019628611,0.0002163974],"category_scores_gemma":[0.0003265152,0.00022239663,0.00006306408,0.00046341374,0.00019799038,0.000022185164,0.00022498154,0.00035550556,0.00004373669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010123348,0.00012621131,0.0024446915,0.00011617878,0.000014842399,0.00006358625,0.000055677046,0.00017477256,0.98927426,0.00013875852,0.0030989249,0.0034797853],"study_design_scores_gemma":[0.0010119982,0.00020374836,0.0017649733,0.00008324153,0.000003902274,0.0000019693653,0.000053517044,0.000023511315,0.9863714,0.00017787742,0.010045997,0.00025788447],"about_ca_topic_score_codex":0.0013131856,"about_ca_topic_score_gemma":0.0005380951,"teacher_disagreement_score":0.06319673,"about_ca_system_score_codex":0.00020321018,"about_ca_system_score_gemma":0.00028587374,"threshold_uncertainty_score":0.90690714},"labels":[],"label_agreement":null},{"id":"W2787239610","doi":"","title":"Abstract #850: Cytotoxic activity of two pleurocidin-like cationic antimicrobial peptides against human breast cancer cells","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Propidium iodide; Cytotoxic T cell; Cancer cell; Cancer; Cytotoxicity; Antimicrobial; Antimicrobial peptides; Cancer research; Chemistry; Biology; Molecular biology; Biochemistry; Microbiology; Apoptosis; Medicine; In vitro; Internal medicine; Programmed cell death","score_opus":0.044891390544931305,"score_gpt":0.3583459679076097,"score_spread":0.3134545773626784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787239610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552363,0.000598506,0.000007810334,0.00088983553,0.00043443963,0.00043991485,0.0005836293,0.000063839754,0.0014583644],"genre_scores_gemma":[0.99499977,0.0014576905,0.000016246071,0.00024331607,0.00022450674,0.000040608822,0.000054779415,0.000037374142,0.002925718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977153,0.000246649,0.00037833885,0.00056954526,0.00015328969,0.000936883],"domain_scores_gemma":[0.998733,0.00013439651,0.00021962362,0.00046125342,0.0003867355,0.00006500645],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051912013,0.0002909828,0.000488967,0.0002917092,0.0006906191,0.000065678236,0.00054973294,0.00024140479,0.0010687405],"category_scores_gemma":[0.000013994826,0.00027872663,0.00019163727,0.00039395192,0.00083696726,0.00031275288,0.00014290966,0.0009876998,0.00015781916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023966753,0.00030287696,0.0005233509,0.00007896422,0.00011622537,0.0000071101367,0.00027478795,0.00014891155,0.968287,0.00014661199,0.022891022,0.006983477],"study_design_scores_gemma":[0.0011149175,0.00010138803,0.028570617,0.0002476083,0.000018169285,0.000013561866,0.00008573926,0.0000017544833,0.96772873,0.00007936065,0.0017502913,0.00028787955],"about_ca_topic_score_codex":0.005345906,"about_ca_topic_score_gemma":0.00087684114,"teacher_disagreement_score":0.028047265,"about_ca_system_score_codex":0.00030917788,"about_ca_system_score_gemma":0.00051610504,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W2788510207","doi":"","title":"Hsp27 blockade selectively inhibits growth of tumors with an activated PI3K pathway by regulating Akt and PEA-15","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hsp27; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; PTEN; Biology; FADD; Phosphorylation; LNCaP; Cell growth; Cell biology; Apoptosis; Signal transduction; Cancer cell; Heat shock protein; Programmed cell death; Hsp70; Cancer; Caspase; Biochemistry","score_opus":0.03638821545285852,"score_gpt":0.33347155521306554,"score_spread":0.297083339760207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788510207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997753,0.00077625335,0.000060047994,0.0001872825,0.0000065963923,0.00055741396,0.000051441468,0.000012495424,0.00059541856],"genre_scores_gemma":[0.99786943,0.00020644844,0.0002368498,0.00001839836,0.00012695929,0.0001718097,0.00004665673,0.000053000473,0.0012704671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973684,0.00041204153,0.0002128055,0.00060474145,0.0007268539,0.0006751892],"domain_scores_gemma":[0.99841887,0.000045615634,0.000055339344,0.0003629511,0.00083195197,0.0002852784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068598153,0.0001741562,0.00022336455,0.00016145088,0.00032373477,0.00002509497,0.00028230468,0.0001654678,0.00003606517],"category_scores_gemma":[0.00031727768,0.00014974191,0.000028449329,0.0006213148,0.0005917441,0.000017476372,0.00024497614,0.00047063333,0.0000018554108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005961188,0.000105620114,0.0061342334,0.00008348375,0.00004518955,0.000012840682,0.0002708351,0.0000082220495,0.99110353,0.000011790763,0.0009041116,0.0007240061],"study_design_scores_gemma":[0.000816306,0.0018365921,0.0022233522,0.00007924126,0.0000021476471,0.000045141223,0.00014004383,0.000028158112,0.9940593,0.00002496981,0.0005660629,0.00017866628],"about_ca_topic_score_codex":0.0011364614,"about_ca_topic_score_gemma":0.0002268583,"teacher_disagreement_score":0.0039108815,"about_ca_system_score_codex":0.000087270106,"about_ca_system_score_gemma":0.0009181576,"threshold_uncertainty_score":0.6106298},"labels":[],"label_agreement":null},{"id":"W2789253089","doi":"10.1158/1538-7445.sabcs17-ot3-06-07","title":"Abstract OT3-06-07: A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fulvestrant; Medicine; Bromodomain; Tolerability; Breast cancer; Estrogen receptor; Pharmacodynamics; Pharmacology; Metastatic breast cancer; Oncology; Internal medicine; Cancer; Pharmacokinetics; Adverse effect; Biology; Histone","score_opus":0.04596986603111417,"score_gpt":0.42089003142566656,"score_spread":0.37492016539455236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789253089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997456,0.00017122277,0.000036124104,0.0010490259,0.000040394578,0.001172899,0.00004432191,0.0000038943995,0.00002610476],"genre_scores_gemma":[0.9988367,0.00080507476,0.000032784934,0.00006537234,0.00009965651,0.00010181959,0.000014463977,0.00001575035,0.000028385717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857575,0.00027044094,0.00024632472,0.00037803935,0.00030143317,0.00022802826],"domain_scores_gemma":[0.99931884,0.000041958978,0.000082649975,0.00017781812,0.00025545427,0.0001232877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011088613,0.00012346279,0.00015832216,0.00012502399,0.000112252914,0.00002522847,0.000116873234,0.000059282655,0.0000171001],"category_scores_gemma":[0.00004421417,0.00008543184,0.000012400038,0.00034859485,0.00045445075,0.000022985074,0.00012157835,0.0002925794,4.7110885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077845105,0.001566464,0.14295678,0.000060703627,0.00005703443,0.0000072689395,0.00094790396,0.00009767283,0.7870776,0.0000079960055,0.00013985671,0.059296213],"study_design_scores_gemma":[0.010791986,0.004133139,0.76142704,0.00020391075,0.000020920565,0.000005422734,0.00035927724,0.0013955767,0.22120856,0.00001667356,0.00024564078,0.00019186804],"about_ca_topic_score_codex":0.0013732136,"about_ca_topic_score_gemma":0.007924435,"teacher_disagreement_score":0.61847025,"about_ca_system_score_codex":0.000057583657,"about_ca_system_score_gemma":0.00031273512,"threshold_uncertainty_score":0.44220206},"labels":[],"label_agreement":null},{"id":"W2789267266","doi":"10.1158/1538-7445.sabcs17-p4-10-11","title":"Abstract P4-10-11: An active approach to genetic counseling in Trinidadian women with breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Genetic counseling; Medicine; Family medicine; Breast cancer; Proband; Genetic testing; Cancer; Internal medicine; Mutation; Genetics","score_opus":0.04188441801485583,"score_gpt":0.37688083733420874,"score_spread":0.3349964193193529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789267266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621093,0.00037056135,0.00012848877,0.0003335811,0.00009264313,0.00056091207,0.0001827906,0.000011907975,0.002108198],"genre_scores_gemma":[0.9951375,0.00020476407,0.0007106935,0.00024771894,0.0010691481,0.001809038,0.000026447162,0.00006308766,0.00073160016],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99765354,0.00011703477,0.00019714351,0.00076758704,0.00044295244,0.00082172686],"domain_scores_gemma":[0.9983811,0.000017119684,0.00004468172,0.00056722754,0.0006672774,0.00032259597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005438639,0.000184544,0.00017286642,0.00023566838,0.00017949329,0.00007883655,0.00047459445,0.00015455004,0.00064446294],"category_scores_gemma":[0.000027945196,0.00017057205,0.000022058339,0.0006973857,0.00032737892,0.000014875186,0.00009849313,0.00021873157,0.00002666583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004782716,0.00046148564,0.0119593935,0.00013212766,0.00022517134,0.000017342996,0.010665349,0.007872299,0.8398409,0.000019688583,0.012877562,0.11114599],"study_design_scores_gemma":[0.003959772,0.0019431447,0.4698738,0.00023743944,0.000023022689,0.00005620276,0.007879558,0.0004002037,0.40558395,0.0001110317,0.108576804,0.0013550913],"about_ca_topic_score_codex":0.0023169813,"about_ca_topic_score_gemma":0.013261936,"teacher_disagreement_score":0.45791438,"about_ca_system_score_codex":0.0010043194,"about_ca_system_score_gemma":0.0018365731,"threshold_uncertainty_score":0.74004716},"labels":[],"label_agreement":null},{"id":"W2789295860","doi":"10.1158/1538-7445.sabcs17-ot1-01-01","title":"Abstract OT1-01-01: IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Atezolizumab; Medicine; Internal medicine; Triple-negative breast cancer; Oncology; Taxane; Paclitaxel; Metastatic breast cancer; Chemotherapy; Breast cancer; Placebo; Cancer; Immunotherapy; Pathology; Pembrolizumab","score_opus":0.06763732471246466,"score_gpt":0.4113377107985923,"score_spread":0.3437003860861277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789295860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902647,0.00057315076,0.000042000338,0.00054293295,0.000101107325,0.007530788,0.0003583052,0.000072126,0.00051484787],"genre_scores_gemma":[0.99335134,0.0004114321,0.0002596348,0.0001534994,0.00015155038,0.0040080994,0.00006138474,0.00013695363,0.0014661087],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9946435,0.0003892797,0.00071542646,0.0011891385,0.0015992782,0.0014633565],"domain_scores_gemma":[0.9968486,0.00033920328,0.00030310443,0.00082099834,0.0011747943,0.00051330664],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073193375,0.00068775273,0.0012805035,0.00059341284,0.0005082305,0.00014869218,0.0003422149,0.000102893326,0.0016872715],"category_scores_gemma":[0.000055628076,0.00037761667,0.00009019456,0.0021258418,0.0010160565,0.0005623262,0.00008760927,0.00077262206,0.000020334628],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77738047,0.007892428,0.15378015,0.00027858122,0.0026834551,0.0006666397,0.01323636,0.00016405077,0.0020468363,0.0000032230366,0.00082415855,0.04104367],"study_design_scores_gemma":[0.40572926,0.072309025,0.48657447,0.0048016026,0.00050547847,0.00008270462,0.021021815,0.00037352045,0.0058978484,0.000009946464,0.0015372755,0.0011570477],"about_ca_topic_score_codex":0.044815823,"about_ca_topic_score_gemma":0.081294574,"teacher_disagreement_score":0.3716512,"about_ca_system_score_codex":0.0034383556,"about_ca_system_score_gemma":0.0034602336,"threshold_uncertainty_score":0.99986756},"labels":[],"label_agreement":null},{"id":"W2789479293","doi":"10.1158/1538-7445.sabcs17-p1-06-04","title":"Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Grading (engineering); Concordance; Cohort; Breast cancer; Internal medicine; Oncology; Nottingham Prognostic Index; Gynecology; Pathology; Cancer","score_opus":0.04064832601378644,"score_gpt":0.35854083604150666,"score_spread":0.31789251002772023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789479293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991835,0.0044124415,0.000048923088,0.0018602555,0.00020529247,0.000572056,0.00085829396,0.000010100529,0.00019762655],"genre_scores_gemma":[0.99773633,0.0008073954,0.00011639851,0.00009901067,0.00054944964,0.0005032302,0.000045508827,0.000032648848,0.000110038374],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806297,0.0000754432,0.00033473418,0.00067434076,0.00020200052,0.00065048796],"domain_scores_gemma":[0.9988623,0.00007697282,0.0001221637,0.00031167915,0.0004880366,0.00013884061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036987496,0.00022707984,0.0003743488,0.00012081318,0.00024482506,0.000025181847,0.00024323443,0.00016822295,0.00004714711],"category_scores_gemma":[0.000053903364,0.00020355436,0.00009271954,0.00018327124,0.0010383062,0.0000114975,0.00019824877,0.00019162471,0.0000011871642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026185762,0.00018870806,0.14110485,0.00022753459,0.0002222277,0.000012290697,0.00018663255,0.0000043376385,0.8314175,0.0002728301,0.0036826339,0.020061858],"study_design_scores_gemma":[0.004191518,0.00039733158,0.9134215,0.00017983424,0.000058128728,0.00011702908,0.0004093699,0.00011516483,0.07828842,0.00035533676,0.0020459578,0.00042041932],"about_ca_topic_score_codex":0.00427181,"about_ca_topic_score_gemma":0.0022814476,"teacher_disagreement_score":0.77231663,"about_ca_system_score_codex":0.00029264658,"about_ca_system_score_gemma":0.00039202085,"threshold_uncertainty_score":0.83007056},"labels":[],"label_agreement":null},{"id":"W2789504493","doi":"10.1158/1538-7445.sabcs17-gs4-04","title":"Abstract GS4-04: Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (S1200)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acupuncture; Breast cancer; Randomized controlled trial; Physical therapy; Clinical endpoint; WOMAC; Brief Pain Inventory; Internal medicine; Quality of life (healthcare); Discontinuation; Stage (stratigraphy); Osteoarthritis; Cancer; Chronic pain","score_opus":0.03686217012736246,"score_gpt":0.39061491416644156,"score_spread":0.3537527440390791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789504493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726311,0.0011329269,0.000004597338,0.0052536903,0.00014661928,0.01999878,0.00045582769,0.000043041106,0.00033339552],"genre_scores_gemma":[0.9825874,0.0005833206,0.00009093261,0.00011455327,0.00044277578,0.01396128,0.000021809665,0.00007104887,0.0021269065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953861,0.000343195,0.0008314638,0.0007748634,0.0014583854,0.0012059424],"domain_scores_gemma":[0.99623007,0.0012608924,0.00020752048,0.0005377783,0.0012147224,0.0005490489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035891586,0.00055581937,0.002583321,0.0008591879,0.00020633769,0.00007030759,0.00020142572,0.00023305322,0.00061101076],"category_scores_gemma":[0.0013180431,0.00023820235,0.00022185741,0.0009548235,0.0011686035,0.00015532489,0.00017730164,0.0006985528,0.000009736153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97742236,0.00041559373,0.0010805905,0.0003944835,0.0015315233,0.0000735985,0.0036903205,0.000008499595,0.007962898,0.0000265696,0.0024754237,0.0049181567],"study_design_scores_gemma":[0.9726301,0.004176726,0.015864622,0.0009938494,0.00020297176,0.000008792137,0.0006583094,0.00004702934,0.0043612095,0.00012797661,0.00066167704,0.00026675253],"about_ca_topic_score_codex":0.0030394334,"about_ca_topic_score_gemma":0.0009836211,"teacher_disagreement_score":0.014784031,"about_ca_system_score_codex":0.0010634984,"about_ca_system_score_gemma":0.0011068848,"threshold_uncertainty_score":0.971361},"labels":[],"label_agreement":null},{"id":"W2789531094","doi":"10.1158/1538-7445.sabcs17-p5-20-06","title":"Abstract P5-20-06: Phase 1 dose escalation with ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-high breast cancer (BC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Lapatinib; Pertuzumab; Trastuzumab; Internal medicine; Cancer; Oncology; Metastatic breast cancer; Breast cancer; Gastroenterology; Nuclear medicine","score_opus":0.04813735197770432,"score_gpt":0.4099717730259086,"score_spread":0.3618344210482043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789531094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907959,0.00040774138,0.000009200896,0.004164244,0.000117396274,0.0014431663,0.00043839976,0.000052345444,0.0025716133],"genre_scores_gemma":[0.992845,0.00070949463,0.00012928928,0.0001499845,0.00096554233,0.00030589403,0.00041648076,0.00009349525,0.0043848217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99473596,0.00019620375,0.0004556696,0.00089412543,0.0023453513,0.001372695],"domain_scores_gemma":[0.9967808,0.00015141627,0.00011205646,0.000579277,0.0017807457,0.0005956703],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072685536,0.0003775891,0.00055513514,0.0006609516,0.00036596024,0.00011285207,0.00036134225,0.00018844064,0.0058488175],"category_scores_gemma":[0.00004234981,0.0002529645,0.00007436451,0.0018548997,0.0011087001,0.00029266914,0.00014601159,0.0012232469,0.00033770016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037327796,0.0029747458,0.8817895,0.00063847634,0.0003212267,0.00040236837,0.0008944284,0.000046749035,0.025732841,0.00010782786,0.012109065,0.03765496],"study_design_scores_gemma":[0.011003819,0.0029050182,0.9618207,0.001303251,0.000026787204,0.00002409044,0.00015263673,0.00020048572,0.006316401,0.00003714576,0.01583424,0.00037537992],"about_ca_topic_score_codex":0.030634899,"about_ca_topic_score_gemma":0.009197836,"teacher_disagreement_score":0.08003122,"about_ca_system_score_codex":0.0007188454,"about_ca_system_score_gemma":0.0012020817,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W2789535714","doi":"10.1158/1538-7445.sabcs17-p1-07-34","title":"Abstract P1-07-34: Clinical outcomes of single versus double hormone receptor positive breast cancer patients treated with neoadjuvant chemotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Chemotherapy; Oncology; Cancer; Progesterone receptor; Hormone receptor; Gastroenterology; Estrogen receptor; Retrospective cohort study; Gynecology","score_opus":0.06029954904900002,"score_gpt":0.40159230512113137,"score_spread":0.34129275607213133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789535714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958194,0.0009120009,0.0000025174663,0.0008411167,0.00023337499,0.0004754544,0.0006505791,0.000016013812,0.0010495483],"genre_scores_gemma":[0.99701494,0.0015344912,0.00006041209,0.00008704519,0.00055365707,0.00020847225,0.00012226116,0.000055453143,0.00036328426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979077,0.000085292726,0.00033079536,0.000634967,0.0004887038,0.0005525647],"domain_scores_gemma":[0.99803776,0.00007517329,0.00015325732,0.0004336215,0.0011406646,0.00015951888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024620793,0.00025671173,0.00039241777,0.00007134161,0.00018258608,0.00002569159,0.0002732069,0.00017284126,0.00030009306],"category_scores_gemma":[0.00002712861,0.00018913722,0.00012003814,0.00024742255,0.0008929631,0.000013148987,0.00013463598,0.00019289461,0.00003263525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046651483,0.0017098398,0.8005083,0.0000303123,0.0024296937,0.0000046718806,0.00031466538,0.0000034009825,0.10643252,0.000009336225,0.013521445,0.028384332],"study_design_scores_gemma":[0.010909045,0.0022973388,0.82433563,0.000073656374,0.000047023408,8.9631715e-7,0.000111699555,4.622979e-7,0.15988411,0.000001888635,0.0021158305,0.00022240395],"about_ca_topic_score_codex":0.004330174,"about_ca_topic_score_gemma":0.0011298561,"teacher_disagreement_score":0.053451598,"about_ca_system_score_codex":0.00028503913,"about_ca_system_score_gemma":0.0003028715,"threshold_uncertainty_score":0.7712792},"labels":[],"label_agreement":null},{"id":"W2789586959","doi":"10.1158/1538-7445.sabcs17-p6-09-01","title":"Abstract P6-09-01: Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Prospective cohort study; Ovarian cancer; Cancer; Cohort; Proportional hazards model; Oncology; Gynecology; Obstetrics; Internal medicine","score_opus":0.03603972753166326,"score_gpt":0.4009744998574583,"score_spread":0.3649347723257951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789586959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202,0.0036137267,0.00009114909,0.00010574106,0.0004883558,0.0018426211,0.0015905044,0.000015195094,0.00023271242],"genre_scores_gemma":[0.9930779,0.004384055,0.00009458507,0.000018333549,0.0016455499,0.0005738496,0.000008100112,0.00006934214,0.00012830489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966051,0.0004960933,0.00040983316,0.0009963972,0.00069680787,0.00079576497],"domain_scores_gemma":[0.9977624,0.00010199695,0.00033355004,0.00083993707,0.00082368596,0.00013842262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024231854,0.0002859847,0.0003224332,0.000104140985,0.0011248564,0.00011132453,0.0005257328,0.00018527219,0.00009397511],"category_scores_gemma":[0.00023643012,0.00022476068,0.00009980935,0.00065683754,0.001398675,0.000017851618,0.00050573476,0.0008423106,0.000006854866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074651465,0.0001618125,0.8361607,0.000029693645,0.0006582441,0.0000029607636,0.0041424176,0.00071833323,0.14646335,0.0000017992038,0.0009184677,0.009995703],"study_design_scores_gemma":[0.0012319856,0.00041505598,0.8966173,0.000055702123,0.00011160027,0.000008524371,0.0039571146,0.0003210003,0.09646229,0.00010717969,0.00045736926,0.00025488198],"about_ca_topic_score_codex":0.07138894,"about_ca_topic_score_gemma":0.0136613725,"teacher_disagreement_score":0.060456593,"about_ca_system_score_codex":0.0006042726,"about_ca_system_score_gemma":0.0012676067,"threshold_uncertainty_score":0.9347948},"labels":[],"label_agreement":null},{"id":"W2789592353","doi":"10.1158/1538-7445.sabcs17-p1-13-01","title":"Abstract P1-13-01: Duration of adjuvant trastuzumab in HER-2 positive breast cancer: Pooled results of overall, and disease-free survivals from meta-analyses of randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Hazard ratio; Breast cancer; Meta-analysis; Oncology; Randomized controlled trial; Confidence interval; Odds ratio; Adjuvant; Cancer","score_opus":0.11543517970789688,"score_gpt":0.43127034958413507,"score_spread":0.31583516987623816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789592353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579317,0.029423716,0.000023698958,0.0016714752,0.000077313256,0.0016448668,0.009060032,0.0000035235325,0.0001636705],"genre_scores_gemma":[0.9932134,0.0055942205,0.000045821333,0.000022907267,0.00022022467,0.0006664098,0.00016170063,0.000020948048,0.000054360997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99486923,0.001990212,0.0016488031,0.00052743143,0.00066038274,0.0003039235],"domain_scores_gemma":[0.99550164,0.0018364012,0.0009645407,0.0005279204,0.001044835,0.00012465476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046381154,0.00026339307,0.0036165048,0.00020159806,0.00006282365,0.000017134726,0.00026249405,0.000118040916,0.00018677529],"category_scores_gemma":[0.0044513564,0.00017001331,0.0007408381,0.00021657979,0.000848165,0.000016324204,0.00016689964,0.00011549231,3.9759578e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4562168,0.00026956366,0.0014268588,0.000077513134,0.019334154,0.000003730151,0.00032698325,0.00006285807,0.520491,0.00002615843,0.0006666186,0.0010977128],"study_design_scores_gemma":[0.29190913,0.00025590367,0.16135384,0.00028660469,0.006661578,7.7879366e-7,0.00021958463,0.00004356898,0.5383466,0.0006816484,0.000015267775,0.00022547372],"about_ca_topic_score_codex":0.04239594,"about_ca_topic_score_gemma":0.006544012,"teacher_disagreement_score":0.1643077,"about_ca_system_score_codex":0.00009373301,"about_ca_system_score_gemma":0.0006378802,"threshold_uncertainty_score":0.96398085},"labels":[],"label_agreement":null},{"id":"W2789645874","doi":"10.1158/1538-7445.sabcs17-p1-17-08","title":"Abstract P1-17-08: Efficacy of lapatinib and capecitabine combination therapy in brain metastases from HER-2 positive metastatic breast cancer: A systematic review and meta- analysis","year":2018,"lang":"en","type":"review","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lapatinib; Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Cancer; Meta-analysis; Brain metastasis; Subgroup analysis; Trastuzumab; Metastasis; Colorectal cancer","score_opus":0.1646593688347147,"score_gpt":0.47156725095177415,"score_spread":0.30690788211705944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789645874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011391692,0.981271,0.000003911959,0.0013804139,0.000020032741,0.007889783,0.008256912,0.000013567531,0.000025155488],"genre_scores_gemma":[0.0016664694,0.99304134,0.00015284526,0.00022888344,0.00004241413,0.0035939228,0.000993213,0.00007284446,0.00020804896],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934759,0.0024306811,0.0015496893,0.0009874816,0.0010314467,0.0005247711],"domain_scores_gemma":[0.99446523,0.002914655,0.0008245865,0.0008518651,0.0006498262,0.00029382022],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035888313,0.0006682782,0.009332112,0.0010554872,0.000108092,0.00006948193,0.00024697013,0.0001435656,0.0019558487],"category_scores_gemma":[0.00040445273,0.00041115546,0.0011211961,0.0023561649,0.000422266,0.00011976816,0.00012304133,0.0006163931,0.000007927268],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017472846,0.0011829843,0.000031845055,0.7198737,0.21034086,0.00015584465,0.00029939832,9.520644e-7,0.0000049115465,0.000049942453,0.00085804984,0.067026734],"study_design_scores_gemma":[0.0040407185,0.0007782999,0.0013006841,0.1810705,0.806628,0.00007264151,0.00012448158,0.000009168419,0.00001735104,0.000046108813,0.00533251,0.0005795163],"about_ca_topic_score_codex":0.009097591,"about_ca_topic_score_gemma":0.0012676668,"teacher_disagreement_score":0.59628713,"about_ca_system_score_codex":0.0004112675,"about_ca_system_score_gemma":0.00065762183,"threshold_uncertainty_score":0.999834},"labels":[],"label_agreement":null},{"id":"W2789799773","doi":"10.1158/1538-7445.sabcs17-p3-04-08","title":"Abstract P3-04-08: Genomic analysis of breast papillomas","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Papilloma; Breast cancer; Ductal carcinoma; Carcinoma; Cancer; Breast carcinoma; Pathology; Cancer research; Medicine; Biology; Internal medicine","score_opus":0.036573458835097356,"score_gpt":0.3724630932677114,"score_spread":0.335889634432614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789799773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939064,0.0018789567,0.00006062996,0.00019199407,0.00013443797,0.00013338166,0.00037453743,0.000004396323,0.0033152767],"genre_scores_gemma":[0.99671006,0.0017873043,0.00007692351,0.00009440191,0.00068790466,0.00003417672,0.00009227921,0.000022314987,0.00049465714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987141,0.00004045912,0.0002197441,0.00037737214,0.00025871332,0.00038962546],"domain_scores_gemma":[0.99867797,0.000043138323,0.00006574024,0.0005479412,0.0005344801,0.00013074846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044583206,0.00010746944,0.00020317532,0.00023331055,0.00010993369,0.000029927622,0.00032899497,0.00011394628,0.0007200045],"category_scores_gemma":[0.00007216378,0.00010535241,0.00014348744,0.0005786824,0.00038773287,0.0000023206728,0.00021478962,0.00012588756,0.00004482103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021652305,0.000048854607,0.009732889,0.000019707984,0.0005823875,0.0000028733116,0.0000699739,0.000147467,0.97491765,0.0001215342,0.007002934,0.0071371803],"study_design_scores_gemma":[0.0008106087,0.00053001184,0.38560644,0.000032468222,0.00026175714,0.0000054854145,0.00017263336,0.000194059,0.5000816,0.00017915462,0.11174527,0.00038053584],"about_ca_topic_score_codex":0.0010870476,"about_ca_topic_score_gemma":0.0015280658,"teacher_disagreement_score":0.47483608,"about_ca_system_score_codex":0.0000761471,"about_ca_system_score_gemma":0.0003632352,"threshold_uncertainty_score":0.78835446},"labels":[],"label_agreement":null},{"id":"W2790039224","doi":"10.1158/1538-7445.sabcs17-p2-01-05","title":"Abstract P2-01-05: Comprehensive analysis of genomic alterations in tumor tissue associated with presence of various subpopulations of circulating tumor cells (CTCs) in primary breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Circulating tumor cell; Breast cancer; Cancer research; microRNA; Gene; Cancer; Primary tumor; Biology; Epithelial–mesenchymal transition; Metastasis; Genetics","score_opus":0.0635996448107265,"score_gpt":0.38356615334464716,"score_spread":0.31996650853392067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790039224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695325,0.00073370454,0.000028429491,0.00014471245,0.000055273133,0.00075813354,0.0009255495,0.000006917729,0.00039402774],"genre_scores_gemma":[0.99924403,0.00012833542,0.00023114208,0.000037568505,0.00006341452,0.00011245202,0.00008028951,0.000026506948,0.00007623053],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99756557,0.00016592517,0.0007445403,0.0003836244,0.0007145083,0.00042585764],"domain_scores_gemma":[0.9975974,0.00033194167,0.00037061432,0.00040963312,0.0011733223,0.00011708333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925201,0.0001520942,0.000814237,0.0010815351,0.00006515199,0.000011743083,0.0001780264,0.000055476892,0.0008626653],"category_scores_gemma":[0.00007222602,0.00013954123,0.000094255585,0.002893739,0.0004484275,0.00009949386,0.00007870675,0.00035823212,0.000001604417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005895664,0.00040574605,0.21794243,0.0005106875,0.0006383424,0.0000501971,0.0019722132,0.015835572,0.7604458,0.000021958276,0.00012892322,0.0014585766],"study_design_scores_gemma":[0.0013406688,0.0001661944,0.9451445,0.00074259,0.0003066239,0.0000042880047,0.00037174483,0.0013055644,0.050439533,0.000010972052,0.000049175615,0.00011816372],"about_ca_topic_score_codex":0.054498777,"about_ca_topic_score_gemma":0.047506265,"teacher_disagreement_score":0.72720206,"about_ca_system_score_codex":0.0007712253,"about_ca_system_score_gemma":0.0012738999,"threshold_uncertainty_score":0.96987426},"labels":[],"label_agreement":null},{"id":"W2790162266","doi":"10.1158/1538-7445.sabcs17-p5-13-01","title":"Abstract P5-13-01: Effects of a 16-week combined aerobic and resistance exercise intervention on metabolic syndrome in overweight/Obese Hispanic breast cancer survivors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overweight; Waist; Breast cancer; Metabolic syndrome; Aerobic exercise; Internal medicine; Type 2 diabetes; Physical therapy; Blood pressure; Cancer; Obesity; Diabetes mellitus; Endocrinology","score_opus":0.048286399048072665,"score_gpt":0.3970148385227175,"score_spread":0.3487284394746448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790162266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831856,0.012858336,0.0000031050843,0.0019516572,0.00032320156,0.0010915714,0.000032873006,0.000028418968,0.00052526634],"genre_scores_gemma":[0.9895226,0.008437844,0.000032253698,0.00015018779,0.00013963674,0.00042107832,0.000009458229,0.00003778138,0.0012491663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976414,0.0002060265,0.00045032336,0.00044270337,0.000674622,0.00058494543],"domain_scores_gemma":[0.99863666,0.00023040542,0.000119942284,0.00035923722,0.00037055562,0.00028318714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011593953,0.00017429036,0.0005605917,0.0006476092,0.0001282564,0.000025916164,0.00015151,0.000118028176,0.00080420554],"category_scores_gemma":[0.00009104433,0.00015795659,0.00007909619,0.0008458707,0.00034501412,0.00012388444,0.00006927409,0.0006318673,0.000027955984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0761634,0.016625535,0.37502936,0.12515771,0.0009898911,0.0019376635,0.010743458,0.000008178528,0.23795743,0.011829554,0.034610633,0.1089472],"study_design_scores_gemma":[0.006403229,0.0008864188,0.9593561,0.018106353,0.000043294636,0.000019240213,0.00018079381,0.000019201749,0.012679984,0.0007519208,0.0013685228,0.00018490653],"about_ca_topic_score_codex":0.009731284,"about_ca_topic_score_gemma":0.017978191,"teacher_disagreement_score":0.5843268,"about_ca_system_score_codex":0.00049809174,"about_ca_system_score_gemma":0.0002483177,"threshold_uncertainty_score":0.9999412},"labels":[],"label_agreement":null},{"id":"W2790250024","doi":"10.1158/1538-7445.sabcs17-ot3-05-04","title":"Abstract OT3-05-04: A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Palbociclib; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Population; Discontinuation; Chemotherapy; Randomization; Hazard ratio; Cancer; Randomized controlled trial; Progression-free survival; Surgery; Confidence interval","score_opus":0.15398987287476085,"score_gpt":0.49702976487793793,"score_spread":0.3430398920031771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790250024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824352,0.000691628,0.000028473989,0.0009520141,0.00011805575,0.014659782,0.00084646227,0.000057172056,0.00021117966],"genre_scores_gemma":[0.9856343,0.00050170464,0.0021224967,0.00009629767,0.00022657815,0.010620892,0.00014287082,0.00017782018,0.00047700474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99324584,0.0013697738,0.0010189092,0.0013855897,0.0013980989,0.001581817],"domain_scores_gemma":[0.99625593,0.0011215516,0.0004250602,0.0006975982,0.0010937861,0.00040605158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016566626,0.00079000223,0.0018214785,0.00080756797,0.0003292164,0.00016401714,0.0003836674,0.000071657676,0.0008813775],"category_scores_gemma":[0.00011777402,0.0005640833,0.00011697784,0.001698574,0.00072558864,0.00045069394,0.00012308356,0.00064254855,0.000017935332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7348509,0.022210438,0.026819719,0.000075352444,0.0019495251,0.00021995802,0.007036232,0.0004123199,0.0020837937,0.000002810839,0.000026052261,0.2043129],"study_design_scores_gemma":[0.90781516,0.021891847,0.05996639,0.0012849725,0.00025318054,0.0000039765887,0.0033339048,0.0024555915,0.002409525,0.000010228857,0.000052057323,0.00052319496],"about_ca_topic_score_codex":0.04156261,"about_ca_topic_score_gemma":0.05541593,"teacher_disagreement_score":0.20378971,"about_ca_system_score_codex":0.010527216,"about_ca_system_score_gemma":0.0026586675,"threshold_uncertainty_score":0.99968106},"labels":[],"label_agreement":null},{"id":"W2790267268","doi":"10.1158/1538-7445.sabcs17-p5-22-21","title":"Abstract P5-22-21: Radioactive seed and targeted axillary dissection: A feasibility study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Axilla; Breast cancer; Sentinel node; Sentinel lymph node; Axillary Lymph Node Dissection; Dissection (medical); Lymph node; Biopsy; Radiology; Surgery; Nuclear medicine; Cancer; Internal medicine","score_opus":0.05888053137862003,"score_gpt":0.41169872867449686,"score_spread":0.3528181972958768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790267268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947106,0.0026271082,0.000010711935,0.00033739718,0.00018452387,0.00067002996,0.000047632893,0.000018582175,0.0013933837],"genre_scores_gemma":[0.9981669,0.00035953204,0.000034213645,0.00003679848,0.00074841606,0.00027415567,0.000017198148,0.000023737884,0.00033901926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983166,0.00015149731,0.00014089626,0.00063381344,0.00036342957,0.00039375617],"domain_scores_gemma":[0.9989515,0.000035922963,0.000036217818,0.0004145653,0.00043462086,0.00012720274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046297704,0.00016231087,0.00017258129,0.00006519717,0.0004113052,0.000042051695,0.00014846238,0.00009033862,0.00012161662],"category_scores_gemma":[0.00011578035,0.00014019801,0.00004225947,0.00024312673,0.0005175211,0.000008580083,0.00023101167,0.0001927328,0.000011101793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028294309,0.00086059625,0.61258674,0.000056519624,0.0007703264,0.00003071553,0.002001349,0.000002145109,0.37133795,0.000011663789,0.003827894,0.0056846826],"study_design_scores_gemma":[0.0013184878,0.0007824348,0.91484356,0.000015799476,0.00002061474,0.00001053896,0.0023393596,0.0000020177224,0.07873655,0.00006107127,0.0017091455,0.00016043805],"about_ca_topic_score_codex":0.00064699684,"about_ca_topic_score_gemma":0.0008377517,"teacher_disagreement_score":0.30225682,"about_ca_system_score_codex":0.00016780685,"about_ca_system_score_gemma":0.00019994477,"threshold_uncertainty_score":0.5717109},"labels":[],"label_agreement":null},{"id":"W2790338852","doi":"10.1158/1538-7445.sabcs17-ot3-04-04","title":"Abstract OT3-04-04: LUCY: A phase IIIb, single-arm, open-label multicenter study of olaparib in patients with HER2-negative metastatic breast cancer and a germline <i>BRCA1/2</i> mutation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Olaparib; Medicine; Metastatic breast cancer; Internal medicine; BRCA mutation; Oncology; PARP inhibitor; Hazard ratio; Breast cancer; Taxane; Progression-free survival; Eribulin; Cancer; Chemotherapy; Confidence interval","score_opus":0.13096376115481537,"score_gpt":0.46960491233777,"score_spread":0.3386411511829547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790338852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377227,0.00032828224,0.00001562958,0.00084878283,0.00011653128,0.004131279,0.0004706248,0.000020995625,0.00029563042],"genre_scores_gemma":[0.9975932,0.00011344136,0.0003235765,0.00031099303,0.00015414068,0.0012263232,0.000038253158,0.00006888094,0.000171155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658763,0.00029101607,0.0006298418,0.00070863933,0.0011789332,0.00060394855],"domain_scores_gemma":[0.9969446,0.00026719007,0.0002720536,0.00045736224,0.001791289,0.0002674759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009144811,0.00028184865,0.0006265687,0.00043559805,0.00017362586,0.00008884017,0.00027017755,0.00007105565,0.00089478865],"category_scores_gemma":[0.00011070638,0.00022674524,0.000025323021,0.0010433139,0.0006565238,0.00044880572,0.00014893818,0.00056497316,0.000012111267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15107776,0.14053904,0.38942015,0.0018948665,0.002867321,0.0004283284,0.05919161,0.00009650896,0.066024184,0.000039051665,0.004366918,0.18405426],"study_design_scores_gemma":[0.31059307,0.026457863,0.6082453,0.004108063,0.0003095817,0.000018844672,0.0057739243,0.0006183043,0.042253874,0.0001580424,0.0006959559,0.0007671518],"about_ca_topic_score_codex":0.008515189,"about_ca_topic_score_gemma":0.006649112,"teacher_disagreement_score":0.21882518,"about_ca_system_score_codex":0.0008135775,"about_ca_system_score_gemma":0.0005980227,"threshold_uncertainty_score":0.99808717},"labels":[],"label_agreement":null},{"id":"W2790356395","doi":"10.1158/1538-7445.sabcs17-pd6-07","title":"Abstract PD6-07: Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Internal medicine; Hazard ratio; Oncology; Tumor microenvironment; Cancer; Clinical significance; Biomarker; Lymph node; Confidence interval","score_opus":0.18868776947471436,"score_gpt":0.5067743855567192,"score_spread":0.31808661608200484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790356395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928191,0.0037507138,0.00009897708,0.0007045354,0.0010422593,0.0008414074,0.00042071904,0.000006937027,0.00031536727],"genre_scores_gemma":[0.9874439,0.0029557557,0.00005915938,0.00018315658,0.008608443,0.00025873922,0.000049684324,0.000030347326,0.00041078235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630195,0.0008843871,0.0010306041,0.000745981,0.00052815676,0.0005089315],"domain_scores_gemma":[0.99752647,0.00083886314,0.0002891809,0.00065037154,0.0005097263,0.00018540586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030311348,0.00019566616,0.00047653512,0.000059778387,0.0001579168,0.000030142435,0.0006856879,0.00035069333,0.000980341],"category_scores_gemma":[0.000682273,0.00013523542,0.00021103071,0.00030505654,0.0010854077,0.000010064588,0.000286339,0.0008074829,0.000020790565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16983442,0.0018268634,0.02065042,0.00004347786,0.00039089864,0.000037336864,0.0005152825,0.000047827256,0.5610843,0.000014683105,0.16698232,0.07857223],"study_design_scores_gemma":[0.15853712,0.004413022,0.09998681,0.0009252332,0.00010440014,0.0000036114936,0.0010668946,0.00017131314,0.68867534,0.00044439753,0.044853993,0.0008178587],"about_ca_topic_score_codex":0.005002662,"about_ca_topic_score_gemma":0.00094245496,"teacher_disagreement_score":0.1275911,"about_ca_system_score_codex":0.00005062205,"about_ca_system_score_gemma":0.0012029146,"threshold_uncertainty_score":0.9999329},"labels":[],"label_agreement":null},{"id":"W2790385254","doi":"10.1158/1538-7445.sabcs17-ot3-05-02","title":"Abstract OT3-05-02: BYLieve: A phase 2 study of alpelisib with fulvestrant or letrozole for treatment of <i>PIK3CA</i> mutant, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2<i>–</i>) advanced breast cancer (aBC) progressing on/after cyclin-dependent kinase (CDK)4/6 inhibitor therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Letrozole; Medicine; Aromatase inhibitor; Internal medicine; Oncology; Cancer; Metastatic breast cancer; Breast cancer; Estrogen receptor; Aromatase","score_opus":0.06258979464817743,"score_gpt":0.42228201938771043,"score_spread":0.359692224739533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790385254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218507,0.0030932536,0.000073543655,0.00094634836,0.00027615917,0.008615672,0.0046366197,0.000095227944,0.00007812502],"genre_scores_gemma":[0.98916787,0.0014335272,0.0011315914,0.00014253554,0.0014278787,0.0060253954,0.00007954911,0.00027360918,0.00031803624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99344546,0.0003757075,0.0012312781,0.0015337261,0.0019269033,0.0014869013],"domain_scores_gemma":[0.9940882,0.0006088927,0.0007841623,0.0009683499,0.002955083,0.00059531257],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052271027,0.00093415804,0.0016921521,0.0005461192,0.0005363459,0.00007323373,0.00043169718,0.00023805484,0.0011206907],"category_scores_gemma":[0.00008343095,0.0006348911,0.00027732473,0.0010476861,0.001689901,0.0005561458,0.00008552951,0.00059085095,0.000010687007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18156907,0.01063111,0.0029827817,0.0003049499,0.0015185998,0.00014035717,0.0099797025,0.000021179,0.59192884,0.000007756569,0.00015512493,0.2007605],"study_design_scores_gemma":[0.05790029,0.060939584,0.029108183,0.0018328748,0.00018084,0.000036994486,0.004884804,0.000008860823,0.843198,0.000031799376,0.0011633984,0.00071437465],"about_ca_topic_score_codex":0.0023088346,"about_ca_topic_score_gemma":0.001135822,"teacher_disagreement_score":0.25126913,"about_ca_system_score_codex":0.0019297285,"about_ca_system_score_gemma":0.0014015338,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W2790544699","doi":"10.1158/1538-7445.sabcs17-p6-08-08","title":"Abstract P6-08-08: Age-Related differences in clinicopathologic features and survival amongst women with triple negative breast cancer: A population-based study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Cohort; Population; Epidemiology; Surveillance, Epidemiology, and End Results; Internal medicine; Oncology; Lymph node; Cancer; Proportional hazards model; Cancer registry","score_opus":0.04196174710520688,"score_gpt":0.3690502648356509,"score_spread":0.327088517730444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790544699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735695,0.0008328293,9.734867e-7,0.00052296557,0.00013933738,0.00077598495,0.0001968994,0.000018941906,0.000155091],"genre_scores_gemma":[0.9980627,0.0003070513,0.000019227777,0.000046921177,0.00023020673,0.0010454947,0.000033898625,0.000029278792,0.00022526938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766415,0.00032629445,0.00025994607,0.0007374635,0.00040391868,0.00060825126],"domain_scores_gemma":[0.9990278,0.00011551538,0.0001043122,0.00031982106,0.00030086623,0.00013172027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006007529,0.0002546671,0.00037464828,0.00014968726,0.00029939055,0.00006839062,0.00023315415,0.00014281791,0.0001398185],"category_scores_gemma":[0.000085533145,0.00018611664,0.000029960267,0.00046446905,0.0005897378,0.000011724668,0.00014559753,0.00033316575,0.0000047641324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002531899,0.0003294211,0.98893154,0.000027193746,0.00017463639,0.000040757925,0.0016540551,0.00001544571,0.002020499,0.0000035987441,0.00012637753,0.0041445713],"study_design_scores_gemma":[0.0035062754,0.0009540947,0.9918588,0.000083197345,0.000017688646,0.000003837303,0.0024646646,0.0000033677902,0.00079276005,0.00008244147,0.000016391019,0.00021649495],"about_ca_topic_score_codex":0.014783834,"about_ca_topic_score_gemma":0.040987667,"teacher_disagreement_score":0.026203834,"about_ca_system_score_codex":0.00026488886,"about_ca_system_score_gemma":0.00031417562,"threshold_uncertainty_score":0.9917768},"labels":[],"label_agreement":null},{"id":"W2790568424","doi":"10.1158/1538-7445.sabcs17-p4-15-01","title":"Abstract P4-15-01: Integration of clinical and pathological data with the DCIS score to predict the risk of local recurrence","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Covariate; Statistics; Proportional hazards model; Nomogram; Population; Akaike information criterion; Concordance; Oncology; Internal medicine; Mathematics","score_opus":0.17840605323403766,"score_gpt":0.4670533626982829,"score_spread":0.2886473094642452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790568424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533904,0.0014517519,0.0009797226,0.0013577375,0.000054682845,0.00029116462,0.0003306585,0.0000023832533,0.00019287046],"genre_scores_gemma":[0.997732,0.0016772135,0.00013943267,0.00005361071,0.00028113517,0.00006325385,0.000026888116,0.000006579384,0.000019885836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99876547,0.00023328411,0.0001942064,0.00035501117,0.00027710898,0.00017493911],"domain_scores_gemma":[0.99864095,0.00018424875,0.00008322485,0.00070360705,0.00033763854,0.000050305975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014682242,0.000082750725,0.00014686096,0.000018078728,0.00013474177,0.000011060742,0.00047699796,0.000069631154,0.0000210978],"category_scores_gemma":[0.00041891847,0.000036538633,0.000024940397,0.00015646018,0.002272709,0.000004763524,0.0005143615,0.0002289362,0.0000019592164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004959109,0.000267712,0.46264717,0.00006622521,0.00045474086,0.000005537035,0.0009186242,0.000022820797,0.029773472,0.00011499598,0.036089588,0.46468],"study_design_scores_gemma":[0.0005089337,0.0011987766,0.953934,0.00010208747,0.00004043375,0.0000042868996,0.0007209273,0.000033609074,0.03885729,0.000054626584,0.0044747596,0.00007027871],"about_ca_topic_score_codex":0.00063965656,"about_ca_topic_score_gemma":0.0022543287,"teacher_disagreement_score":0.4912868,"about_ca_system_score_codex":0.000009988845,"about_ca_system_score_gemma":0.00017697547,"threshold_uncertainty_score":0.8373891},"labels":[],"label_agreement":null},{"id":"W2790581706","doi":"10.1158/1538-7445.sabcs17-p3-12-11","title":"Abstract P3-12-11: Disparities in adjuvant hormone adherence in breast cancer patients within a universal healthcare model","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Hormonal therapy; Internal medicine; Tamoxifen; Hormone therapy; Cancer; Oncology; Ethnic group; Comorbidity","score_opus":0.14250842021340246,"score_gpt":0.4307526780518826,"score_spread":0.2882442578384802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790581706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864865,0.0010343329,0.000014199246,0.007901302,0.0001298689,0.00066844077,0.00009693593,0.000024141496,0.001482121],"genre_scores_gemma":[0.9944238,0.0015026286,0.00006225604,0.000593008,0.00016186673,0.00041850365,0.000020911673,0.000022065844,0.0027949268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975338,0.000077837576,0.00037295828,0.00046370458,0.00089470035,0.00065699616],"domain_scores_gemma":[0.99857396,0.000049519007,0.00008295648,0.00035668115,0.00061986846,0.0003169912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005138294,0.00015153311,0.00030550745,0.00030139508,0.00010158595,0.000023544655,0.00029715995,0.00012394712,0.0008559819],"category_scores_gemma":[0.00006679571,0.00013617791,0.000030074321,0.00069011596,0.00044910132,0.00019425178,0.000095867115,0.00074872695,0.00019769273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017910689,0.0004628073,0.95498973,0.0004051817,0.000017659882,0.00004859535,0.0019582193,0.00009289054,0.0038607658,0.00050152396,0.02061039,0.015261145],"study_design_scores_gemma":[0.0028056598,0.00030669008,0.98915327,0.0016993464,0.0000046338487,0.0000028520903,0.0007624533,0.0037327793,0.0006309109,0.00038055304,0.0003454594,0.00017542296],"about_ca_topic_score_codex":0.036197376,"about_ca_topic_score_gemma":0.01930476,"teacher_disagreement_score":0.03416349,"about_ca_system_score_codex":0.0008511014,"about_ca_system_score_gemma":0.0019494725,"threshold_uncertainty_score":0.99859035},"labels":[],"label_agreement":null},{"id":"W2790615713","doi":"10.1158/1538-7445.sabcs17-pd7-12","title":"Abstract PD7-12: Molecular subtyping of male breast cancer by the International male breast cancer program (IMBC): EORTC 10085/TBCRC 0-29/BIG 2-07/NABCG/BOOG 2009-04","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Amplicon; Cancer; Male breast cancer; Logistic regression; Medicine; Biology; Bioinformatics; Gene; Genetics; Polymerase chain reaction","score_opus":0.07447266777076844,"score_gpt":0.43287202656413937,"score_spread":0.3583993587933709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790615713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8911645,0.014519688,0.000019522411,0.06823738,0.0013224003,0.0030469105,0.0025846327,0.00012851616,0.018976444],"genre_scores_gemma":[0.97371036,0.0044370256,0.000085140164,0.001142606,0.0032377036,0.0025727656,0.000060020095,0.0001229137,0.014631454],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99411064,0.00018620607,0.00080956443,0.0009429583,0.0023653812,0.0015852676],"domain_scores_gemma":[0.9953744,0.00016280042,0.00032355115,0.00090332486,0.0027162172,0.0005197475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015953804,0.00044081357,0.00067649636,0.00033569106,0.000528697,0.00009987759,0.0009851396,0.00024366366,0.016884997],"category_scores_gemma":[0.00013279983,0.00033650664,0.00020679613,0.00080242136,0.0016162737,0.00017883771,0.0005282714,0.0012805345,0.00019391534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041108374,0.0011194231,0.26378265,0.0022747826,0.0010855314,0.00021371596,0.0013043795,0.000038680224,0.056711543,0.00023980638,0.35092664,0.318192],"study_design_scores_gemma":[0.0038697356,0.00040687426,0.7970864,0.0027671035,0.00018065891,0.00088259537,0.0009563184,0.00034430303,0.011907143,0.00006946882,0.18088247,0.00064692623],"about_ca_topic_score_codex":0.035915416,"about_ca_topic_score_gemma":0.006929893,"teacher_disagreement_score":0.53330374,"about_ca_system_score_codex":0.0013468557,"about_ca_system_score_gemma":0.0027779022,"threshold_uncertainty_score":0.9999087},"labels":[],"label_agreement":null},{"id":"W2790627206","doi":"10.1158/1538-7445.sabcs17-p2-09-18","title":"Abstract P2-09-18: Multiplexed (18-Plex) measurement of protein targets in trastuzumab-treated patients using imaging mass cytometry","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Trastuzumab; Mass cytometry; Medicine; Cancer research; Breast cancer; Flow cytometry; Pathology; Cancer; Oncology; Internal medicine; Immunology; Biology; Phenotype","score_opus":0.10178741415222244,"score_gpt":0.4166769103020577,"score_spread":0.3148894961498353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790627206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952678,0.00039308544,0.0029641164,0.000059608607,0.000027392785,0.000865509,0.000053189095,0.000018338165,0.0003509583],"genre_scores_gemma":[0.99365914,0.00005159272,0.0059293853,0.000015091865,0.000114023984,0.00012045095,0.000039091734,0.00003097176,0.000040267787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836504,0.00007001512,0.0002777466,0.00041160538,0.00044927886,0.00042632694],"domain_scores_gemma":[0.9985315,0.000008693063,0.00009526426,0.00037410142,0.0009122702,0.00007816364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053956953,0.00013724096,0.0001512246,0.00017806367,0.00012449818,0.000017631997,0.00022287706,0.00009586578,0.000045938737],"category_scores_gemma":[0.0001466351,0.00013214046,0.00004721641,0.00043436888,0.00026944265,0.000007899845,0.000115049166,0.00018840388,0.0000031069164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012250352,0.000117028816,0.008835993,0.00003498043,0.000014171852,0.0000014415225,0.000017293341,0.000012844789,0.9851627,0.0000044177564,0.00031919824,0.0053574773],"study_design_scores_gemma":[0.00056366465,0.00011930139,0.012770694,0.00013442985,0.0000031773295,4.3462393e-7,0.00003524481,0.00016809443,0.9835025,0.000101114725,0.0024600949,0.00014122737],"about_ca_topic_score_codex":0.00056475645,"about_ca_topic_score_gemma":0.00013310989,"teacher_disagreement_score":0.00521625,"about_ca_system_score_codex":0.0002649665,"about_ca_system_score_gemma":0.00017217528,"threshold_uncertainty_score":0.5388531},"labels":[],"label_agreement":null},{"id":"W2790694922","doi":"10.1158/1538-7445.sabcs17-ot3-05-06","title":"Abstract OT3-05-06: EarLEE-2: A phase 3 study of ribociclib + endocrine therapy (ET) for adjuvant treatment of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), intermediate-risk, early breast cancer (EBC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Exemestane; Anastrozole; Oncology; Tamoxifen; Breast cancer; Placebo; Adjuvant therapy; Aromatase inhibitor; Gynecology; Cancer; Pathology","score_opus":0.055043549115642465,"score_gpt":0.41281874523035256,"score_spread":0.3577751961147101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790694922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984402,0.0014719238,0.0000403115,0.0003509059,0.00017864809,0.0062973867,0.0071574952,0.00005911574,0.000042234686],"genre_scores_gemma":[0.99365,0.0018740661,0.00024930044,0.000048618236,0.00069853436,0.0028362551,0.00020426077,0.0001822611,0.00025670382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513036,0.00045709783,0.00090482715,0.0010141488,0.001390287,0.0011032557],"domain_scores_gemma":[0.99361414,0.000632573,0.00072940486,0.0007091915,0.003879768,0.00043490835],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041842696,0.00062931806,0.0013322543,0.00048644037,0.00035333788,0.000037685084,0.00038878864,0.00013199517,0.0012278792],"category_scores_gemma":[0.000116975905,0.00044998428,0.00022276271,0.0007561387,0.0012896471,0.00044795702,0.00009896557,0.0005761079,0.0000146368075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119947664,0.019383516,0.3950163,0.00029676277,0.004988421,0.00002812627,0.050276548,0.000007085537,0.11991409,0.000020544456,0.00088344386,0.28923747],"study_design_scores_gemma":[0.049661722,0.0437831,0.7777028,0.0004004027,0.00013000904,0.0000024769863,0.002204255,0.0000033339543,0.12506923,0.000045047887,0.00061712874,0.00038050784],"about_ca_topic_score_codex":0.016335525,"about_ca_topic_score_gemma":0.0015899842,"teacher_disagreement_score":0.38268647,"about_ca_system_score_codex":0.0014077083,"about_ca_system_score_gemma":0.00072661525,"threshold_uncertainty_score":0.9997952},"labels":[],"label_agreement":null},{"id":"W2790751595","doi":"10.1158/1538-7445.sabcs17-p3-08-16","title":"Abstract P3-08-16: ER, PR and HER2 biomarkers in UK and Irish clinical breast cancer testing: analysis of results from &amp;gt;168,000 patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Oncology; Cancer; Internal medicine; Immunohistochemistry; Metastasis; Pathology; Gynecology","score_opus":0.10237587191104928,"score_gpt":0.4694576276018339,"score_spread":0.3670817556907846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790751595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438244,0.0011056636,0.000012465264,0.0023297446,0.00014731007,0.00029740288,0.0003877773,0.000014531091,0.0013226588],"genre_scores_gemma":[0.99721915,0.0014125245,0.00048381364,0.00020917907,0.00037636087,0.000025659283,0.00009774797,0.000025169238,0.00015042708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726975,0.00021944458,0.0006944885,0.00064012123,0.0007020733,0.00047414156],"domain_scores_gemma":[0.997356,0.0012004146,0.00017777263,0.00038538215,0.00047666163,0.00040377397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025541508,0.000152138,0.0005736659,0.0005210877,0.00010878498,0.000046546735,0.0001650243,0.00014907192,0.00046846265],"category_scores_gemma":[0.0031583766,0.00012586056,0.00007118777,0.0013449306,0.0010927833,0.00006341918,0.00015385354,0.0008259736,0.000004161867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012070173,0.00012845935,0.8045811,0.00004642897,0.00052552327,0.000011248473,0.00028196053,0.0000065699633,0.0010620216,4.842725e-7,0.008894517,0.18325469],"study_design_scores_gemma":[0.00364559,0.00016444894,0.9886313,0.0005806401,0.00021814054,0.0000018989737,0.00007085718,0.0035637503,0.00004933132,0.00002837873,0.002924576,0.000121069344],"about_ca_topic_score_codex":0.044392504,"about_ca_topic_score_gemma":0.0028950581,"teacher_disagreement_score":0.18405023,"about_ca_system_score_codex":0.0001770366,"about_ca_system_score_gemma":0.0002833219,"threshold_uncertainty_score":0.961971},"labels":[],"label_agreement":null},{"id":"W2790762219","doi":"10.1158/1538-7445.sabcs17-p2-09-17","title":"Abstract P2-09-17: Evaluation of the oncomine comprehensive assay for the identification of actionable mutations for therapeutic stratification from the TEAM pathology cohort","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; University of Toronto; Thermo Fisher Scientific (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Ion semiconductor sequencing; Oncology; Internal medicine; Computational biology; Targeted therapy; Informatics; Bioinformatics; DNA sequencing; Cancer; Gene; Biology; Genetics","score_opus":0.11617117490519555,"score_gpt":0.4377438177813983,"score_spread":0.3215726428762028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790762219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840605,0.0023510372,0.0064398763,0.0027317444,0.00044296135,0.002904617,0.0008779508,0.0000023877199,0.00018890956],"genre_scores_gemma":[0.99722904,0.00039606387,0.00006735563,0.00008546363,0.00043795002,0.0013558106,0.000256542,0.0000127813055,0.00015899383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988632,0.00016809891,0.00028702428,0.00022180311,0.00031545537,0.00014440448],"domain_scores_gemma":[0.99589825,0.000953329,0.00022653636,0.0005353217,0.0023698981,0.000016653858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019376121,0.000067972585,0.00008878208,0.000022250324,0.0003438597,0.000026643618,0.0003343674,0.00008085281,0.00003449131],"category_scores_gemma":[0.0005823065,0.000041242925,0.00007694039,0.00012714611,0.00044025705,0.000005067511,0.000044652483,0.00008631919,0.0000012127153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001681747,0.000048263253,0.0010552586,0.000014578731,0.00011729993,6.3389067e-9,0.00020386874,0.0011652538,0.97730166,0.0004973419,0.0076447427,0.011783563],"study_design_scores_gemma":[0.00074309355,0.00018969587,0.16457348,0.0000178458,0.00017314698,5.412123e-7,0.000841934,0.0044793487,0.7993299,0.0053386805,0.024236899,0.00007548011],"about_ca_topic_score_codex":0.00039356246,"about_ca_topic_score_gemma":0.0010331627,"teacher_disagreement_score":0.17797178,"about_ca_system_score_codex":0.00007629234,"about_ca_system_score_gemma":0.0006025422,"threshold_uncertainty_score":0.26447254},"labels":[],"label_agreement":null},{"id":"W2790762419","doi":"10.1158/1538-7445.sabcs17-ot1-05-03","title":"Abstract OT1-05-03: TRIO030: A presurgical tissue-acquisition study to evaluate molecular alterations in human breast cancer tissue following short-term exposure to the androgen receptor antagonist darolutamide","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Androgen receptor; Triple-negative breast cancer; Prostate cancer; Cancer; Internal medicine; Estrogen receptor; Oncology; Androgen; Hormone","score_opus":0.07141023382588961,"score_gpt":0.46241183048143847,"score_spread":0.39100159665554884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790762419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819096,0.0015917274,0.000020434189,0.009340927,0.00032059706,0.005920073,0.00026610153,0.00005350567,0.00057704136],"genre_scores_gemma":[0.99283534,0.00014704604,0.000041330295,0.00023143104,0.0010459725,0.003556299,0.000100568985,0.000077596094,0.0019644357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949831,0.0005355794,0.00052404206,0.00095293333,0.0018441667,0.0011602134],"domain_scores_gemma":[0.9976912,0.00010625561,0.000040030925,0.0008379899,0.00071134296,0.00061318406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002260728,0.00031813333,0.0004978535,0.0005149156,0.00076724077,0.00029690794,0.00048688796,0.000114027505,0.0018968009],"category_scores_gemma":[0.00007207659,0.00022869802,0.000105360436,0.0014973013,0.00022360974,0.00018426118,0.00030511688,0.00069118233,0.00022121817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005032405,0.0012948209,0.04014796,0.00011926495,0.0004741591,0.0011555708,0.010599283,0.00020965506,0.9073837,0.000017577513,0.008098859,0.025466794],"study_design_scores_gemma":[0.012737206,0.013017403,0.4380292,0.0018693681,0.00030909528,0.00008596604,0.003429771,0.000088447705,0.50688463,0.000072501905,0.022442102,0.0010342913],"about_ca_topic_score_codex":0.004493546,"about_ca_topic_score_gemma":0.0043132924,"teacher_disagreement_score":0.40049902,"about_ca_system_score_codex":0.0014143488,"about_ca_system_score_gemma":0.0008596813,"threshold_uncertainty_score":0.9990156},"labels":[],"label_agreement":null},{"id":"W2790782410","doi":"10.1158/1538-7445.sabcs17-p2-03-01","title":"Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Juravinski Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Reproducibility; Nuclear proliferation; Breast cancer; Medicine; Protocol (science); External quality assessment; Tissue microarray; Pathology; Nuclear medicine; Cancer; Internal medicine; Statistics; Mathematics","score_opus":0.10014535302222251,"score_gpt":0.5028299828616966,"score_spread":0.40268462983947406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790782410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97510904,0.000007998042,0.0008428909,0.00073679484,0.00023090016,0.021718282,0.0005735505,0.000015741718,0.00076477265],"genre_scores_gemma":[0.9474413,0.000008581973,0.0003604973,0.000021990498,0.0008665286,0.051020842,0.00016206896,0.000021817295,0.000096403375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986129,0.00008757899,0.00022657725,0.00039211556,0.0004537026,0.00022717385],"domain_scores_gemma":[0.9979271,0.00005113718,0.000089944195,0.00027547026,0.0015887355,0.00006759647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083919,0.000114931114,0.00013135903,0.0001325311,0.00019712286,0.00007338397,0.00016497391,0.00008786086,0.00009785893],"category_scores_gemma":[0.00018765293,0.0001013728,0.000052320738,0.00021090801,0.00016311921,0.0000332744,0.000069438014,0.00008947329,0.000006735838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024078483,0.0013976677,0.02429402,0.00022244231,0.0005033437,0.0000022937575,0.00054847234,0.0005927719,0.9293985,0.00020965305,0.006738144,0.012014201],"study_design_scores_gemma":[0.0067718956,0.0012518571,0.060459808,0.00027918752,0.000021991078,0.0000024727558,0.0004984574,0.0005786368,0.9066037,0.00007988685,0.02325772,0.0001943981],"about_ca_topic_score_codex":0.00009773937,"about_ca_topic_score_gemma":0.00020756933,"teacher_disagreement_score":0.036165785,"about_ca_system_score_codex":0.00024179781,"about_ca_system_score_gemma":0.00029922012,"threshold_uncertainty_score":0.41338632},"labels":[],"label_agreement":null},{"id":"W2790876819","doi":"10.1158/1538-7445.sabcs17-p2-10-02","title":"Abstract P2-10-02: Basal biomarkers nestin and INPP4b predict gemcitabine benefit in metastatic breast cancer: Results from the phase III SBG0102 clinical trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemcitabine; Breast cancer; Medicine; Oncology; Internal medicine; Nestin; Metastatic breast cancer; Docetaxel; Capecitabine; Eribulin; Immunohistochemistry; Tissue microarray; Predictive marker; Triple-negative breast cancer; Cancer; Biology; Stem cell","score_opus":0.1138208310218671,"score_gpt":0.4577968833309308,"score_spread":0.3439760523090637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790876819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559475,0.0037438099,0.0000055453293,0.005611678,0.0004814527,0.00090133183,0.0033083495,0.000015300446,0.00033781104],"genre_scores_gemma":[0.9928419,0.003224788,0.000066688764,0.00022146417,0.0025605517,0.00054437446,0.000262882,0.00004092964,0.00023639963],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9968371,0.0003312568,0.00069036195,0.00095395575,0.00050259754,0.0006847266],"domain_scores_gemma":[0.9979842,0.0005928447,0.0001623327,0.0006658389,0.00037946398,0.00021533098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018917298,0.00028264016,0.00040756527,0.00009234909,0.0003073212,0.00007718668,0.00044842728,0.0001667496,0.00032870422],"category_scores_gemma":[0.00055184134,0.00020274318,0.000106135805,0.00039200246,0.0012702651,0.000016142209,0.00040782246,0.00038848084,0.000016090164],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5285991,0.0019582158,0.0658749,0.00007307488,0.002046779,0.000104246814,0.0010865749,0.000025941838,0.02520783,0.000029054063,0.12056482,0.2544295],"study_design_scores_gemma":[0.25186467,0.0024376754,0.7086341,0.00041342166,0.00023854396,0.0000152323255,0.0007243006,0.00015117673,0.0097731445,0.0003596637,0.024704145,0.0006839451],"about_ca_topic_score_codex":0.01856021,"about_ca_topic_score_gemma":0.014441424,"teacher_disagreement_score":0.6427592,"about_ca_system_score_codex":0.0001503826,"about_ca_system_score_gemma":0.00062662933,"threshold_uncertainty_score":0.9879753},"labels":[],"label_agreement":null},{"id":"W2790928047","doi":"10.1158/1538-7445.sabcs17-p3-15-02","title":"Abstract P3-15-02: Treat ER+ight Canadian prospective observational study in HR+ advanced breast cancer: <i>2nd interim analysis</i>","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Windsor Regional Hospital; Cambridge Memorial Hospital; BC Cancer Agency; Ottawa Hospital; Hôpital du Sacré-Cœur de Montréal; Grand River Hospital","funders":"","keywords":"Medicine; Palbociclib; Exemestane; Letrozole; Fulvestrant; Interim analysis; Internal medicine; Breast cancer; Oncology; Cancer; Metastatic breast cancer; Tamoxifen; Clinical trial","score_opus":0.13054642356143598,"score_gpt":0.4649339112295577,"score_spread":0.3343874876681217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790928047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861146,0.001846538,0.000018693563,0.004960457,0.00027061338,0.00227553,0.0005575155,0.000071366674,0.0038846426],"genre_scores_gemma":[0.99333644,0.00021012218,0.00013883576,0.0004998616,0.0009798927,0.00196205,0.000059886075,0.00008625865,0.0027266396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99553025,0.0001684361,0.0005771667,0.0011210358,0.0012423493,0.0013607797],"domain_scores_gemma":[0.99647796,0.00012848307,0.00012911245,0.00082680886,0.0017326925,0.00070495135],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080329966,0.00039685974,0.00079627516,0.0014785015,0.00038687483,0.000085480766,0.0004858081,0.00014992716,0.0057959496],"category_scores_gemma":[0.00009095068,0.00035769626,0.0001576414,0.0042674798,0.0006529276,0.00047019223,0.000122019475,0.0009977359,0.000081867795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044689137,0.0006096984,0.92421967,0.00008916222,0.0011370544,0.0002227163,0.0033807706,0.0002672606,0.011876375,0.00010301812,0.0008198918,0.052805483],"study_design_scores_gemma":[0.0038323808,0.0006092806,0.98130125,0.00028327986,0.00016444719,0.000018820261,0.0019790023,0.000083507155,0.003265791,0.00020886536,0.007902461,0.00035089932],"about_ca_topic_score_codex":0.30932143,"about_ca_topic_score_gemma":0.8237663,"teacher_disagreement_score":0.5144449,"about_ca_system_score_codex":0.0058529885,"about_ca_system_score_gemma":0.0034095363,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W2791147626","doi":"10.1158/1538-7445.sabcs17-p4-12-05","title":"Abstract P4-12-05: Cost-effectiveness analysis of second-generation multi-gene expression prognostic assays compared with the standard 21-gene recurrence score assay to guide adjuvant therapy decisions in women with early stage breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Oncology; Breast cancer; Tamoxifen; Internal medicine; Cancer; Gynecology","score_opus":0.08837461583284571,"score_gpt":0.40034452467082315,"score_spread":0.3119699088379774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791147626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932505,0.0010080689,0.0015559508,0.0002168524,0.00006611205,0.0017625184,0.0020928103,0.000009969278,0.00003723359],"genre_scores_gemma":[0.9946731,0.0007053006,0.0004004881,0.00007452729,0.00015397927,0.0037565161,0.00012217424,0.000041509353,0.00007245038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969835,0.00047934076,0.00031221577,0.0008102208,0.0007729925,0.0006417191],"domain_scores_gemma":[0.9973597,0.0002159917,0.00015948497,0.0006909759,0.0013906481,0.00018322757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013420166,0.0002981009,0.00048936985,0.00028338516,0.0003268093,0.00006837823,0.00041747955,0.00010305643,0.00016112867],"category_scores_gemma":[0.000092007984,0.0001817526,0.00006035613,0.0012422277,0.00045587964,0.000023434392,0.00017870414,0.00023393218,0.0000019311847],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008236373,0.00021168505,0.18135364,0.000020597381,0.00092478865,0.000009120991,0.0012682688,0.0029524434,0.79256296,0.000001058146,0.0004975201,0.01196155],"study_design_scores_gemma":[0.0016940549,0.0005605918,0.6130059,0.00018936477,0.000043530268,0.0000016320853,0.00023066821,0.00003541737,0.38335395,7.973964e-7,0.00071500626,0.00016911625],"about_ca_topic_score_codex":0.002991473,"about_ca_topic_score_gemma":0.04862995,"teacher_disagreement_score":0.43165222,"about_ca_system_score_codex":0.00061941217,"about_ca_system_score_gemma":0.0008383643,"threshold_uncertainty_score":0.9687301},"labels":[],"label_agreement":null},{"id":"W2791208672","doi":"10.1158/1538-7445.sabcs17-p2-10-01","title":"Abstract P2-10-01: Validation that a histone gene signature predicts anthracycline response in early breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; University of British Columbia; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Anthracycline; Breast cancer; Oncology; Medicine; Internal medicine; Epirubicin; Biomarker; Gene signature; Cardiotoxicity; Cancer; Proportional hazards model; Chemotherapy; Gene expression; Biology; Gene","score_opus":0.04692194259938843,"score_gpt":0.3991737923766309,"score_spread":0.3522518497772425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791208672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894376,0.0065109883,0.000012834439,0.0029908633,0.00027786818,0.00041983227,0.0005586746,0.000023087157,0.00026207915],"genre_scores_gemma":[0.994451,0.0021904223,0.00005171663,0.00012704036,0.0012230488,0.0005100743,0.00010486219,0.00005259316,0.0012892591],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975513,0.00025548792,0.00023796798,0.0007123885,0.00056606793,0.0006767905],"domain_scores_gemma":[0.9986572,0.00007633627,0.0000882761,0.00052342296,0.0005038523,0.000150882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008333965,0.00023956642,0.00023388499,0.00020807867,0.00024289079,0.000046537974,0.00033468156,0.00025541798,0.0008006143],"category_scores_gemma":[0.0001220748,0.00021869654,0.00006959858,0.00043141155,0.0005458577,0.000020837517,0.00023235868,0.00034383894,0.000049308805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014756471,0.000259491,0.04265201,0.00005002009,0.00018609998,0.00004166287,0.0006459734,0.00005035427,0.91016525,0.0000033420802,0.02301908,0.008170224],"study_design_scores_gemma":[0.0014535564,0.00024620118,0.5910839,0.00011582739,0.000014584053,0.000009600277,0.00007008359,0.0000053957815,0.39866236,0.000022141121,0.008118586,0.00019776261],"about_ca_topic_score_codex":0.0031645854,"about_ca_topic_score_gemma":0.0020157096,"teacher_disagreement_score":0.5484319,"about_ca_system_score_codex":0.0005026465,"about_ca_system_score_gemma":0.0005835773,"threshold_uncertainty_score":0.8918186},"labels":[],"label_agreement":null},{"id":"W2791287855","doi":"10.1158/1538-7445.sabcs17-p2-03-12","title":"Abstract P2-03-12: Incidence and implications for hormone receptor status change pre- and post- neoadjuvant chemotherapy for locally advanced breast cancer: A retrospective single-center cohort study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"NOSM University; Ottawa Hospital; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Chemotherapy; Cancer; Incidence (geometry); Logistic regression; Estrogen receptor; Hormone receptor; Statistical significance; Cohort","score_opus":0.03588479690384509,"score_gpt":0.37651852060313656,"score_spread":0.34063372369929146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791287855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832881,0.0053047445,0.000109181026,0.0032012768,0.00010083234,0.004794814,0.0031391094,0.000019010886,0.00004292642],"genre_scores_gemma":[0.9807146,0.006691638,0.00029511005,0.0002465732,0.0006788984,0.011084549,0.00010727813,0.000056900866,0.00012442427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804837,0.00004002279,0.00020970077,0.0008466293,0.00021189642,0.0006433686],"domain_scores_gemma":[0.99805665,0.00006380436,0.0000976889,0.00033856215,0.0012659536,0.00017735145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031458147,0.00023542828,0.0002862808,0.00007332203,0.00043638932,0.00006211719,0.00016070317,0.00010207492,0.000017591066],"category_scores_gemma":[0.000076880795,0.00021191535,0.000049078837,0.00013940103,0.00045407342,0.000026825717,0.00017146349,0.00011841134,0.0000010576429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051234663,0.00046905078,0.5364865,0.000059732323,0.00042006583,3.744008e-7,0.0011174598,3.7064112e-7,0.37148264,0.000011972082,0.0018861127,0.08294227],"study_design_scores_gemma":[0.004142686,0.0023902124,0.9803096,0.000066902954,0.00003364532,0.0000064694077,0.00035926173,0.000004221704,0.008829459,0.000043604206,0.0035864413,0.00022750776],"about_ca_topic_score_codex":0.0016931287,"about_ca_topic_score_gemma":0.004053358,"teacher_disagreement_score":0.4438231,"about_ca_system_score_codex":0.00038505477,"about_ca_system_score_gemma":0.00023111321,"threshold_uncertainty_score":0.8641657},"labels":[],"label_agreement":null},{"id":"W2791378653","doi":"10.1158/1538-7445.sabcs17-p5-20-15","title":"Abstract P5-20-15: Dosing patterns and economic burden of drug wastage among postmenopausal women with HR+/HER2- metastatic breast cancer receiving palbociclib","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Palbociclib; Medicine; Dosing; Metastatic breast cancer; Breast cancer; Cancer; Adverse effect; Regimen; Internal medicine; Oncology","score_opus":0.030252377590410134,"score_gpt":0.3630037483925001,"score_spread":0.33275137080208994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791378653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950953,0.001366652,0.0000310341,0.0015586611,0.00014173205,0.00077755534,0.0006131034,0.000054250933,0.0003616812],"genre_scores_gemma":[0.99667424,0.0006499456,0.00025403628,0.00009476406,0.00084860425,0.00040329123,0.000013313218,0.00012630493,0.0009354903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969538,0.00013850135,0.00044754584,0.00070679677,0.00067471585,0.0010786486],"domain_scores_gemma":[0.99809223,0.00023254001,0.00022733392,0.000554059,0.00045959858,0.00043424085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091549894,0.00032946252,0.0006486151,0.00033072746,0.00024282583,0.00008114941,0.00027295866,0.00007177756,0.0032356132],"category_scores_gemma":[0.000024241443,0.00026922638,0.000040047606,0.0003301661,0.0011880064,0.0004324569,0.0001701641,0.0006127868,0.000018706805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013250622,0.00029418108,0.49965152,0.0030966634,0.0021903366,0.0002524697,0.04174731,0.00061592076,0.24370559,0.000059203554,0.0006098101,0.19452639],"study_design_scores_gemma":[0.006848712,0.0012876724,0.9368247,0.0039628525,0.00015334663,0.00017523782,0.013608749,0.00021815965,0.03361671,0.0002299421,0.0023626664,0.0007112702],"about_ca_topic_score_codex":0.017330876,"about_ca_topic_score_gemma":0.005760132,"teacher_disagreement_score":0.43717316,"about_ca_system_score_codex":0.0014068485,"about_ca_system_score_gemma":0.0008111513,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W2791404523","doi":"10.1158/1538-7445.sabcs17-p2-12-08","title":"Abstract P2-12-08: Rates of re-excision surgery after implementation of consensus guidelines on margins for breast- conserving surgery in stage I and II invasive breast cancer: A Nova Scotian experience","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast-conserving surgery; Guideline; Breast cancer; Surgery; Breast surgery; Stage (stratigraphy); Ductal carcinoma; General surgery; Cancer; Mastectomy; Internal medicine","score_opus":0.1558971247693938,"score_gpt":0.4661771311899863,"score_spread":0.3102800064205925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791404523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936265,0.0017484557,0.0000037548566,0.0019265618,0.00018062346,0.00048386236,0.0020076071,0.000003881362,0.000018756564],"genre_scores_gemma":[0.9969353,0.0021259245,0.00007050531,0.00012201186,0.0002181484,0.00041527537,0.000043007738,0.000026953334,0.000042885473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813044,0.000093097566,0.0005404432,0.00049098884,0.00030790674,0.00043713325],"domain_scores_gemma":[0.9977901,0.00052531366,0.00020769394,0.00030240347,0.0010946285,0.00007984483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007490272,0.00019007527,0.00037331835,0.00024648686,0.00012925791,0.000016531718,0.000118375596,0.00009129014,0.0002623192],"category_scores_gemma":[0.00025964523,0.00017204613,0.00008475071,0.00024340596,0.00057221466,0.000012905593,0.00019928247,0.000081498874,7.0129846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041172393,0.00011828068,0.73311114,0.00045552553,0.0001515844,0.000010700154,0.0010612897,0.000009737944,0.23431508,0.000005362966,0.00848365,0.018160427],"study_design_scores_gemma":[0.0006832924,0.00012122738,0.70265543,0.00071143836,0.000010239335,0.000008445918,0.0025964724,0.0000041353696,0.29268664,0.000010491749,0.00035844848,0.00015371235],"about_ca_topic_score_codex":0.015447997,"about_ca_topic_score_gemma":0.038616993,"teacher_disagreement_score":0.05837155,"about_ca_system_score_codex":0.000117825155,"about_ca_system_score_gemma":0.0008415419,"threshold_uncertainty_score":0.99110824},"labels":[],"label_agreement":null},{"id":"W2791439302","doi":"10.1158/1538-7445.sabcs17-p3-07-08","title":"Abstract P3-07-08: Temozolomide as a targeted therapy strategy for triple negative breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Temozolomide; Breast cancer; Triple-negative breast cancer; O-6-methylguanine-DNA methyltransferase; Cancer research; Methyltransferase; Medicine; Population; Cancer; Synthetic lethality; Oncology; DNA methylation; Chemotherapy; Methylation; DNA repair; Internal medicine; Biology; Gene; Gene expression; Genetics","score_opus":0.11708995324075429,"score_gpt":0.46327633522660916,"score_spread":0.3461863819858549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791439302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690984,0.010711406,0.00024326518,0.0097277835,0.0007570316,0.004422969,0.0010345136,0.00022812861,0.0037765007],"genre_scores_gemma":[0.9836129,0.0018578861,0.00044860394,0.0009533494,0.003192093,0.0029908344,0.000033756543,0.00014905276,0.0067615225],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963728,0.00012134999,0.0004217083,0.0008326348,0.00094005326,0.0013114376],"domain_scores_gemma":[0.9962451,0.00034170868,0.00014813982,0.00064197124,0.002173196,0.00044989813],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007793408,0.00036068316,0.00057739206,0.00031632322,0.00048264145,0.00008436392,0.0004058825,0.00021113749,0.012499688],"category_scores_gemma":[0.00016263168,0.0002939396,0.00018051943,0.00084270904,0.0010414193,0.00032459645,0.00007091085,0.0007460173,0.0003417477],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034947447,0.00040015916,0.002350436,0.00028854463,0.0009131897,0.000048766484,0.0024233703,0.000062811385,0.341118,0.00039401386,0.021350695,0.5957025],"study_design_scores_gemma":[0.030755423,0.005039443,0.15427864,0.0013011076,0.000101044425,0.00018095445,0.004344782,0.0003169241,0.5981532,0.013083319,0.1911375,0.0013076717],"about_ca_topic_score_codex":0.0062973336,"about_ca_topic_score_gemma":0.0011316336,"teacher_disagreement_score":0.59439486,"about_ca_system_score_codex":0.0010861611,"about_ca_system_score_gemma":0.0025352933,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2791564187","doi":"10.1158/1538-7445.sabcs17-p3-05-12","title":"Abstract P3-05-12: VISTA expression on tumor-infiltrating lymphocytes in breast cancer: Clinical correlates and association with PD-1","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Tumor-infiltrating lymphocytes; Breast cancer; Immune checkpoint; Tissue microarray; Medicine; Immunohistochemistry; Oncology; Internal medicine; Cancer; PD-L1; Immune system; Antibody; Proportional hazards model; Cancer research; Immunotherapy; Immunology","score_opus":0.05990005739500917,"score_gpt":0.4214375950081101,"score_spread":0.3615375376131009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791564187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391174,0.0011357844,0.0000021031435,0.0027129496,0.0002505848,0.00045198578,0.00004633745,0.00003315388,0.0014553302],"genre_scores_gemma":[0.9956105,0.0022999612,0.00003392997,0.00054397044,0.0007229626,0.0001225534,0.000008968861,0.000031976007,0.00062520907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773324,0.00016481694,0.00039019567,0.0004535142,0.00074806367,0.0005101831],"domain_scores_gemma":[0.9984955,0.00055520266,0.00015662693,0.00025063046,0.000381876,0.00016016299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018309283,0.00015805489,0.00031349625,0.00018136142,0.00021363512,0.00007804765,0.00011631004,0.00015855733,0.0005693836],"category_scores_gemma":[0.00016924833,0.00011605014,0.000045512086,0.00045297696,0.00035645018,0.00012844753,0.000044321318,0.00064185035,0.00001587324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0190095,0.00017834906,0.84941375,0.00012129494,0.000101232516,0.0000579864,0.00047726757,0.0000037731493,0.06962879,0.0000072979537,0.012141025,0.04885976],"study_design_scores_gemma":[0.0064587826,0.0013513482,0.9588013,0.003062421,0.000019548126,0.000036003938,0.00043239095,0.00022109611,0.024787428,0.00001719893,0.0046058707,0.00020657186],"about_ca_topic_score_codex":0.0037497438,"about_ca_topic_score_gemma":0.0012455251,"teacher_disagreement_score":0.109387614,"about_ca_system_score_codex":0.0013115386,"about_ca_system_score_gemma":0.0009347189,"threshold_uncertainty_score":0.62343514},"labels":[],"label_agreement":null},{"id":"W2791622018","doi":"10.1158/1538-7445.sabcs17-p3-17-02","title":"Abstract P3-17-02: Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Breast cancer; Meta-analysis; Confidence interval; Oncology; Clinical endpoint; Randomized controlled trial; Cancer; Progression-free survival; Clinical trial; Disease; Chemotherapy","score_opus":0.05747750975229474,"score_gpt":0.4432716736565262,"score_spread":0.38579416390423144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791622018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567103,0.0003435265,4.1065442e-7,0.001215704,0.00012644642,0.0012135624,0.00036143785,0.000014987454,0.0010528693],"genre_scores_gemma":[0.99827623,0.00014170478,0.000029118379,0.00013582341,0.00017956886,0.000636284,0.000023136525,0.00003360031,0.00054453756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973197,0.000103080754,0.00026224973,0.00041558352,0.0013119112,0.0005874762],"domain_scores_gemma":[0.9979754,0.00015878535,0.000092265596,0.00048101097,0.000934444,0.00035810212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005036546,0.00018483558,0.00036246603,0.0002919029,0.00010481828,0.000015580998,0.00025269348,0.000042981836,0.0019866887],"category_scores_gemma":[0.00007788219,0.00012818414,0.000045592536,0.00071954174,0.0005263799,0.00013427847,0.00008286077,0.00043596554,0.00002950521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021376332,0.0016702403,0.9583722,0.00040915437,0.00018414589,0.00008727353,0.00022951218,0.00019653667,0.0024521637,0.000007816145,0.005736166,0.009278483],"study_design_scores_gemma":[0.007806742,0.0014042126,0.98629385,0.0012491937,0.000070082875,8.386821e-7,0.00002618364,0.000025319418,0.002532922,0.00003710003,0.00042596055,0.00012757353],"about_ca_topic_score_codex":0.0037128741,"about_ca_topic_score_gemma":0.0017767408,"teacher_disagreement_score":0.027921695,"about_ca_system_score_codex":0.0005630495,"about_ca_system_score_gemma":0.0012672173,"threshold_uncertainty_score":0.9989256},"labels":[],"label_agreement":null},{"id":"W2791680186","doi":"10.1158/1538-7445.sabcs17-gs1-01","title":"Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Taxane; Anthracycline; Internal medicine; Chemotherapy; Oncology; Cancer; Clinical trial; Meta-analysis; Surgery","score_opus":0.1549016581717648,"score_gpt":0.45159358259743515,"score_spread":0.2966919244256704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791680186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888908,0.0054407837,0.000021443566,0.00062141725,0.00003327286,0.0007607534,0.0042131026,0.000005511479,0.000012892826],"genre_scores_gemma":[0.99656093,0.002394941,0.000015335105,0.000043030806,0.00018179683,0.000487532,0.00023799048,0.000022532027,0.000055883214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996262,0.0013373711,0.00075668574,0.00064029644,0.00054933754,0.000454309],"domain_scores_gemma":[0.9980933,0.0004028303,0.0004462854,0.00044919804,0.00039247374,0.00021588821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005118357,0.0002581589,0.0012694407,0.00014503415,0.00016921537,0.00006305977,0.00031825693,0.000087907414,0.00032263214],"category_scores_gemma":[0.00027298168,0.00016615474,0.00027857666,0.00047881503,0.00089197635,0.000031526997,0.0000997295,0.0001590035,1.3493057e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05695115,0.00065585016,0.17866795,0.00019469537,0.07264944,0.000008157118,0.0030577262,0.000027980217,0.6621109,0.000002444741,0.0022893513,0.02338433],"study_design_scores_gemma":[0.0070066843,0.00036518724,0.32921562,0.000108759836,0.016931836,0.0000018770879,0.002157816,0.00004413658,0.64355046,0.000044767312,0.00016554433,0.000407323],"about_ca_topic_score_codex":0.011851832,"about_ca_topic_score_gemma":0.0050469995,"teacher_disagreement_score":0.15054765,"about_ca_system_score_codex":0.000178245,"about_ca_system_score_gemma":0.0006684822,"threshold_uncertainty_score":0.9947283},"labels":[],"label_agreement":null},{"id":"W2791899085","doi":"10.1158/1538-7445.sabcs17-p4-10-21","title":"Abstract P4-10-21: Disparities in the risk of mortality in breast cancer based on health insurance status","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medicaid; Hazard ratio; Demography; Proportional hazards model; Breast cancer; Population; Confidence interval; Health care; Cancer; Emergency medicine; Internal medicine; Environmental health","score_opus":0.218065938965968,"score_gpt":0.5019822557366014,"score_spread":0.2839163167706334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791899085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883811,0.001777668,0.000003211876,0.0063174223,0.000087133936,0.0005825055,0.0005770621,0.000010629778,0.0022632624],"genre_scores_gemma":[0.9953604,0.0028236771,0.000019643312,0.0012293862,0.0002523744,0.00023673523,0.00001025104,0.000015273565,0.000052289604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967261,0.00038965614,0.00040754743,0.00035980312,0.0012965171,0.00082036457],"domain_scores_gemma":[0.99852353,0.0002929901,0.000119090386,0.0005267253,0.00037169366,0.0001659834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029590146,0.00013991435,0.00036200133,0.00024617236,0.00013453423,0.000027486305,0.00028649482,0.00007651446,0.0006460398],"category_scores_gemma":[0.00021666588,0.000098096425,0.00006122158,0.0010389836,0.0005372089,0.00010959116,0.000040050152,0.00086431846,0.000012230003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014930536,0.0001367609,0.9815952,0.0002531402,0.000016581258,0.000023928314,0.0006373675,0.00032448344,0.00023081504,0.00004948947,0.004987108,0.010252056],"study_design_scores_gemma":[0.001200763,0.0003118428,0.99485517,0.0012894762,0.000004397121,0.0000016417755,0.0004935375,0.00032668168,0.00046331508,0.00012119619,0.00084676995,0.00008519729],"about_ca_topic_score_codex":0.35228136,"about_ca_topic_score_gemma":0.087683834,"teacher_disagreement_score":0.26459754,"about_ca_system_score_codex":0.00085443095,"about_ca_system_score_gemma":0.0018195125,"threshold_uncertainty_score":0.92896354},"labels":[],"label_agreement":null},{"id":"W2792000535","doi":"10.1158/1538-7445.sabcs17-p6-09-04","title":"Abstract P6-09-04: Benign breast disease and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Prospective cohort study; Family history; Breast disease; Oncology; Cohort; Cohort study; Proportional hazards model; Hazard ratio; Internal medicine; Obstetrics; Cancer; Gynecology; Confidence interval","score_opus":0.031516479358602065,"score_gpt":0.3917303816591015,"score_spread":0.36021390230049943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792000535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907039,0.0026310217,0.00007665693,0.0002835183,0.00030540605,0.0017901049,0.004067635,0.00001305422,0.00012871053],"genre_scores_gemma":[0.99574447,0.0017913687,0.000031446136,0.00003289662,0.0015356324,0.00061296334,0.000015060215,0.00006113308,0.00017502563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969501,0.0003522054,0.00034511517,0.0009116783,0.0007205694,0.000720367],"domain_scores_gemma":[0.99777186,0.00005896569,0.0002068172,0.0008475636,0.0008950141,0.00021977094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014492512,0.00026467687,0.00026641798,0.00008093933,0.00087780587,0.00010366381,0.0005085382,0.00013069889,0.000099079974],"category_scores_gemma":[0.00011178678,0.0002069234,0.00009630957,0.0004956768,0.0014980739,0.000018732631,0.0004944328,0.0005437577,0.000006560851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014739495,0.0002472313,0.9249342,0.000039920473,0.00060383417,0.0000061202204,0.0018774873,0.00048378372,0.0632832,0.0000064641563,0.0009702858,0.006073502],"study_design_scores_gemma":[0.0011278748,0.00026445597,0.9827569,0.000050264494,0.00012460991,0.000010696378,0.0023178544,0.000284632,0.012339515,0.00018504269,0.00029385276,0.00024431883],"about_ca_topic_score_codex":0.022258949,"about_ca_topic_score_gemma":0.00841825,"teacher_disagreement_score":0.05782266,"about_ca_system_score_codex":0.00047166913,"about_ca_system_score_gemma":0.0014571606,"threshold_uncertainty_score":0.9842519},"labels":[],"label_agreement":null},{"id":"W2792162513","doi":"10.1158/1538-7445.sabcs17-p5-20-17","title":"Abstract P5-20-17: Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Western University","funders":"","keywords":"Trastuzumab; Medicine; Ejection fraction; Internal medicine; Breast cancer; Cardiotoxicity; Oncology; Discontinuation; Cancer; Chemotherapy; Heart failure","score_opus":0.059842956214187816,"score_gpt":0.3978346777628723,"score_spread":0.33799172154868445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792162513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969217,0.00013712427,0.00009088369,0.00034113886,0.00014147577,0.0016046489,0.00002304639,0.000029312318,0.0007106451],"genre_scores_gemma":[0.99879164,0.000086211745,0.000078269106,0.00009491455,0.0006589355,0.00002796456,0.000011212196,0.00003850419,0.00021236997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767846,0.0001575722,0.00041230762,0.00046592453,0.00081929314,0.00046645247],"domain_scores_gemma":[0.9985632,0.000065483706,0.00010567154,0.00030322076,0.0008293642,0.00013307761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011423286,0.00017504141,0.0005067054,0.00044800338,0.00017503272,0.000030036255,0.00012020598,0.00013343038,0.00076492404],"category_scores_gemma":[0.00022182918,0.00016705594,0.00011023428,0.0006888424,0.00018619836,0.00016530172,0.00005092068,0.0004921842,0.0000079950405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008407216,0.00022995067,0.19715181,0.000066251145,0.00012119235,0.000015763046,0.005100357,0.0000064699607,0.79429704,0.000012898741,0.00026653986,0.0018909927],"study_design_scores_gemma":[0.0021681408,0.0005480229,0.48744944,0.00033106294,0.000010709012,0.00000426511,0.0009920434,0.00001216619,0.5080951,0.000033098368,0.00025179746,0.00010418811],"about_ca_topic_score_codex":0.001682913,"about_ca_topic_score_gemma":0.00047839133,"teacher_disagreement_score":0.29029763,"about_ca_system_score_codex":0.0012918728,"about_ca_system_score_gemma":0.0001677269,"threshold_uncertainty_score":0.8375382},"labels":[],"label_agreement":null},{"id":"W2792242511","doi":"","title":"Multiple post-translational modifications of E-cadherin during ER stress and apoptosis","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Tunicamycin; Furin; Endoplasmic reticulum; Unfolded protein response; Wheat germ agglutinin; Glycosylation; Biology; Cell biology; Cadherin; Glycoprotein; Brefeldin A; Molecular biology; Chemistry; Biochemistry; Cell; Golgi apparatus; Enzyme","score_opus":0.03677911416417488,"score_gpt":0.3183335299544124,"score_spread":0.2815544157902375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792242511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526244,0.003126282,0.000081698396,0.00036433982,0.000098747645,0.00021644101,0.00033950488,0.000017523838,0.0004930274],"genre_scores_gemma":[0.9966172,0.00019263083,0.00011739046,0.0000054184766,0.000029534203,0.00009980338,0.00007004998,0.000012232901,0.0028557417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991734,0.00010423761,0.00017721478,0.00019907723,0.00006920733,0.00027685307],"domain_scores_gemma":[0.999459,0.00011109571,0.00003459159,0.00017990702,0.00020084881,0.000014503431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017250582,0.0000745075,0.00011785926,0.00013641774,0.00025040543,0.000012490607,0.00014045382,0.00011370692,0.00074610964],"category_scores_gemma":[0.00002921237,0.000070178256,0.00003423895,0.00015125131,0.00025075546,0.0000713698,0.00005449468,0.00025184144,0.00003980212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087098284,0.000077399,0.0034945137,0.000042064992,0.000033560853,2.0421368e-7,0.00018738667,0.00005117016,0.9924426,0.0026769643,0.0001774482,0.0007295934],"study_design_scores_gemma":[0.0007280418,0.000039297855,0.10180922,0.000037670787,0.0000054352367,0.0000015810762,0.00021058899,0.000006988048,0.895323,0.000232911,0.001531835,0.00007347335],"about_ca_topic_score_codex":0.0026404492,"about_ca_topic_score_gemma":0.00034608276,"teacher_disagreement_score":0.0983147,"about_ca_system_score_codex":0.000027723276,"about_ca_system_score_gemma":0.0000720339,"threshold_uncertainty_score":0.8169377},"labels":[],"label_agreement":null},{"id":"W2792254139","doi":"10.1158/1538-7445.sabcs17-p1-06-02","title":"Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Oncology; Internal medicine; Proportional hazards model; Cohort; Univariate; Breast cancer; Relative risk; Cancer; Pathology; Confidence interval; Statistics; Multivariate statistics","score_opus":0.09915924678519566,"score_gpt":0.4532615843887494,"score_spread":0.35410233760355375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792254139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951216,0.0028396354,0.000026131365,0.0004975379,0.00009194055,0.00088712655,0.00006633079,0.000005158216,0.0004645229],"genre_scores_gemma":[0.99878675,0.00025585052,0.00008278235,0.00011074426,0.00014021341,0.000517743,0.000043382155,0.000018407656,0.000044125714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718446,0.0005926321,0.00032274096,0.00070309464,0.0006468543,0.0005502132],"domain_scores_gemma":[0.99808276,0.00034224844,0.00008828491,0.0008338534,0.00055474724,0.00009810202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012281683,0.00022201076,0.00048637617,0.00057413883,0.00014618372,0.00007643718,0.00065060984,0.00010493438,0.00004812308],"category_scores_gemma":[0.00033413165,0.00016177702,0.00012153824,0.0023648872,0.00045815972,0.0000136198005,0.0003670389,0.0002417749,0.000022068332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000806017,0.0020051915,0.84659505,0.000032513395,0.002661592,0.00008001593,0.018503461,0.0007510681,0.11572153,0.000040515108,0.002213675,0.010589344],"study_design_scores_gemma":[0.0009049688,0.0007997236,0.9679092,0.000034679888,0.00016198764,0.0000017463233,0.00965204,0.000014412368,0.019450322,0.00004219499,0.0008387238,0.00018997582],"about_ca_topic_score_codex":0.0017774163,"about_ca_topic_score_gemma":0.016887996,"teacher_disagreement_score":0.121314146,"about_ca_system_score_codex":0.00013132369,"about_ca_system_score_gemma":0.0001507098,"threshold_uncertainty_score":0.94238985},"labels":[],"label_agreement":null},{"id":"W2792257754","doi":"10.1158/1538-7445.sabcs17-p2-10-07","title":"Abstract P2-10-07: A prospective clinical utility study of the impact of the 21-gene recurrence score (RS) assay in the treatment of estrogen receptor positive (ER+), HER2 negative (HER2-), 1-3 node positive (N+) breast cancer (BC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Stage (stratigraphy); Cancer; Clinical trial; Prospective cohort study; Oncology; Hormonal therapy; Breast cancer; Estrogen receptor; Gynecology; Gastroenterology","score_opus":0.07061136293116974,"score_gpt":0.4396268728493783,"score_spread":0.36901550991820853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792257754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257004,0.00096917443,0.000001126584,0.0005463052,0.00018023323,0.0025652084,0.0027596846,0.000003325731,0.0004049009],"genre_scores_gemma":[0.99794954,0.00080842647,0.000013280882,0.000018932116,0.000343099,0.00075240387,0.00001672252,0.000026661617,0.00007091757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597317,0.0014721684,0.0005804609,0.00073768344,0.0007179657,0.0005185269],"domain_scores_gemma":[0.99660695,0.00039486046,0.00040835986,0.0010063284,0.0015034275,0.00008009568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001085195,0.000336609,0.0005425213,0.00005566835,0.00027050785,0.000017670269,0.0007934595,0.00016327498,0.00016423663],"category_scores_gemma":[0.00024289699,0.0001670757,0.0003836732,0.0007239783,0.0020969592,0.000014140117,0.0003197515,0.00036072102,0.0000035693172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050970884,0.00443404,0.958124,0.000024730089,0.0016132523,0.0000022450579,0.008941909,0.000029745124,0.013890362,0.000006880315,0.0007621013,0.007073674],"study_design_scores_gemma":[0.0018992504,0.0024884148,0.83576465,0.00018544857,0.000079505946,0.0000030521962,0.002149658,0.0000046942537,0.1572418,0.00004160705,0.000021729684,0.000120203855],"about_ca_topic_score_codex":0.055261433,"about_ca_topic_score_gemma":0.01035642,"teacher_disagreement_score":0.14335144,"about_ca_system_score_codex":0.00068642944,"about_ca_system_score_gemma":0.001329866,"threshold_uncertainty_score":0.95102966},"labels":[],"label_agreement":null},{"id":"W2792282698","doi":"10.1158/1538-7445.sabcs17-p5-21-03","title":"Abstract P5-21-03: Palbociclib (PAL) + letrozole (LET) as first-line therapy in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Efficacy and safety updates with longer follow-up across patient subgroups","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Population; Progression-free survival; Breast cancer; Estrogen receptor; Metastatic breast cancer; Letrozole; Clinical endpoint; Cancer; Gynecology; Gastroenterology; Oncology; Randomized controlled trial; Overall survival; Tamoxifen","score_opus":0.032542310586138413,"score_gpt":0.3694373333917152,"score_spread":0.33689502280557676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792282698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542374,0.00457476,0.000030195986,0.0045589185,0.0003404313,0.0030677058,0.0015757872,0.00014518536,0.00028327174],"genre_scores_gemma":[0.9909325,0.0046517346,0.00041659668,0.00061461877,0.001042936,0.0012948088,0.0002049803,0.0002627839,0.00057901896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99333334,0.00038021128,0.00091565517,0.0016846902,0.0015619814,0.002124111],"domain_scores_gemma":[0.99530363,0.0007230273,0.00040196086,0.0008222758,0.0019750344,0.0007740977],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069781236,0.00087498594,0.0011938978,0.00036808194,0.0010184398,0.00014799993,0.0005119735,0.0003360303,0.0048482637],"category_scores_gemma":[0.00020209358,0.0006998837,0.00017516504,0.0013652913,0.0023250058,0.000841472,0.00028616085,0.001610183,0.00015548266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11987945,0.0017258947,0.19546431,0.000540608,0.0021767567,0.00022823867,0.041782975,0.000138982,0.16463552,0.00021345213,0.0012251819,0.47198862],"study_design_scores_gemma":[0.037744362,0.0066158753,0.66030604,0.002827488,0.000063307365,0.000092914706,0.0043964195,0.000018870769,0.27423763,0.00027494412,0.011873296,0.0015488492],"about_ca_topic_score_codex":0.006925947,"about_ca_topic_score_gemma":0.0039391466,"teacher_disagreement_score":0.47043976,"about_ca_system_score_codex":0.002193628,"about_ca_system_score_gemma":0.00076766853,"threshold_uncertainty_score":0.999687},"labels":[],"label_agreement":null},{"id":"W2792297805","doi":"10.1158/1538-7445.sabcs17-gs1-02","title":"Abstract GS1-02: NSABP B-47 (NRG oncology): Phase III randomized trial comparing adjuvant chemotherapy with adriamycin (A) and cyclophosphamide (C) → weekly paclitaxel (WP), or docetaxel (T) and C with or without a year of trastuzumab (H) in women with node-positive or high-risk node-negative invasive breast cancer (IBC) expressing HER2 staining intensity of IHC 1+ or 2+ with negative FISH (HER2-Low IBC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Docetaxel; Cyclophosphamide; Internal medicine; Paclitaxel; Trastuzumab; Breast cancer; Chemotherapy; Oncology; Cohort; Cancer","score_opus":0.028015874978869516,"score_gpt":0.3486141053068592,"score_spread":0.3205982303279897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792297805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487275,0.00029458938,0.00017312684,0.00041421448,0.000041642666,0.0033308833,0.0007486073,0.000019500496,0.00010465792],"genre_scores_gemma":[0.9931186,0.0020450768,0.0024595899,0.00014919134,0.00021932632,0.0017414329,0.000022576962,0.00011152505,0.00013269497],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99590355,0.00054753677,0.0007166902,0.0011893784,0.00069778267,0.00094508455],"domain_scores_gemma":[0.9959832,0.0009371308,0.00086776895,0.0004570009,0.0014636043,0.00029129323],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010133864,0.0006705536,0.0022771796,0.00023258063,0.00034761964,0.000075939366,0.00028232633,0.00022341973,0.00012566097],"category_scores_gemma":[0.0002748707,0.00035491074,0.00005802181,0.00069066655,0.0039344337,0.00008648932,0.00021197023,0.0006080088,3.4540673e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9530799,0.00087340694,0.013641293,0.00027692714,0.0027962818,0.0001351909,0.01725964,0.00010383503,0.0063251215,0.0000013575504,0.00010103946,0.0054060514],"study_design_scores_gemma":[0.77857816,0.019314904,0.049004484,0.004177928,0.00037071295,0.00011374668,0.030872839,0.00009026083,0.11668535,0.000015297728,0.00002614313,0.000750185],"about_ca_topic_score_codex":0.024287155,"about_ca_topic_score_gemma":0.06005204,"teacher_disagreement_score":0.1745017,"about_ca_system_score_codex":0.000719287,"about_ca_system_score_gemma":0.003319313,"threshold_uncertainty_score":0.99989027},"labels":[],"label_agreement":null},{"id":"W2792387368","doi":"10.1158/1538-7445.sabcs17-p3-17-01","title":"Abstract P3-17-01: Geographic variation in adverse event reporting patterns in breast cancer clinical trials","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology; University of Alberta","funders":"","keywords":"Breast cancer; Medicine; Adverse effect; Clinical trial; Cancer; Febrile neutropenia; Demography; Neutropenia; Internal medicine; Chemotherapy","score_opus":0.7512322962443306,"score_gpt":0.7122671443859411,"score_spread":0.03896515185838956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792387368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781863,0.00036081852,0.00003230715,0.017745323,0.00066152023,0.0014967397,0.00007012955,0.000033758355,0.0014130793],"genre_scores_gemma":[0.9882275,0.0070547815,0.0000752838,0.00055324496,0.0025518523,0.00060057413,0.000012924076,0.000051737577,0.00087209727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9861385,0.002591678,0.0054021426,0.0012488908,0.0032544204,0.0013643665],"domain_scores_gemma":[0.97426957,0.020075355,0.0013044043,0.0012606243,0.0023907858,0.0006992383],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.16310841,0.00020837695,0.0010824146,0.0009703292,0.00015063083,0.000054257187,0.00047555106,0.00082067045,0.005363676],"category_scores_gemma":[0.09386071,0.00017655648,0.00034413108,0.0016160253,0.00077722716,0.00017142478,0.00036624345,0.0068420297,0.00009449579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023347859,0.0005408907,0.96941274,0.0003950507,0.00009049269,0.00035130032,0.00039631195,0.000025955342,0.0031956178,0.00014100023,0.0008778784,0.022237983],"study_design_scores_gemma":[0.003317003,0.00029542323,0.98941773,0.002877735,0.000020595795,0.000009724284,0.0002362706,0.00032921863,0.00027421897,0.0024474813,0.00061250135,0.00016210874],"about_ca_topic_score_codex":0.031073662,"about_ca_topic_score_gemma":0.04538761,"teacher_disagreement_score":0.06924769,"about_ca_system_score_codex":0.0010169883,"about_ca_system_score_gemma":0.0040953783,"threshold_uncertainty_score":0.99554557},"labels":[],"label_agreement":null},{"id":"W2792555662","doi":"10.1158/1538-7445.sabcs17-p2-10-04","title":"Abstract P2-10-04: Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Sunnybrook Health Science Centre; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Context (archaeology); Epirubicin; Anthracycline; Breast cancer; Oncology; Internal medicine; Cancer; Mutation; Biology; Medicine; Cancer research; Genetics; Gene","score_opus":0.04111673837082069,"score_gpt":0.38265191735269016,"score_spread":0.34153517898186947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792555662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953338,0.001313172,0.00012679616,0.0003034694,0.00010154827,0.00031345675,0.002356998,0.0000062359354,0.00014452226],"genre_scores_gemma":[0.99829656,0.0008401818,0.000060443937,0.000008894765,0.00023839813,0.00025752204,0.00013875468,0.000022126671,0.00013714567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851215,0.000038562877,0.00039663457,0.0003889902,0.00033746587,0.00032617955],"domain_scores_gemma":[0.99825644,0.00003862352,0.00018909655,0.00032300895,0.0011312489,0.00006159313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036399576,0.0001277892,0.00020600461,0.00018398791,0.00011213744,0.00001183435,0.00021601719,0.000096503114,0.00011670081],"category_scores_gemma":[0.00007762415,0.00012435368,0.0000497676,0.00046975247,0.0005687648,0.000017182692,0.000109372544,0.00012922853,0.0000032690966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000650364,0.0001358147,0.03940688,0.000072256655,0.00018020728,0.0000012121841,0.00090503605,0.0009128057,0.95502275,0.000021438105,0.00021030588,0.0024809283],"study_design_scores_gemma":[0.000838649,0.00009942411,0.48526877,0.00011787856,0.00001670058,0.0000016606865,0.00028870406,0.00013358048,0.5130662,0.000037029546,0.000051476425,0.000079975725],"about_ca_topic_score_codex":0.021952124,"about_ca_topic_score_gemma":0.00769818,"teacher_disagreement_score":0.4458619,"about_ca_system_score_codex":0.0003399498,"about_ca_system_score_gemma":0.0006116848,"threshold_uncertainty_score":0.9845608},"labels":[],"label_agreement":null},{"id":"W2792617792","doi":"10.1158/1538-7445.sabcs17-pd7-11","title":"Abstract PD7-11: The role of multi-gene hereditary cancer panels in male patients with breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CHEK2; PALB2; Breast cancer; Medicine; Oncology; Cancer; Population; Internal medicine; Prostate cancer; Male breast cancer; Family history; Genetic testing; CDH1; Pancreatic cancer; Genetics; Biology; Gene; Germline mutation; Mutation","score_opus":0.0336588545570063,"score_gpt":0.35763481653124884,"score_spread":0.32397596197424255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792617792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928611,0.0046108495,0.000009851013,0.0006035356,0.00024625368,0.00051639345,0.000832473,0.000005424206,0.00031413816],"genre_scores_gemma":[0.99676156,0.00073194347,0.000102620805,0.00010913142,0.0007840027,0.0007776191,0.000046749596,0.000047339487,0.0006390099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812365,0.000106751526,0.00024963185,0.00048248915,0.0005037162,0.0005337941],"domain_scores_gemma":[0.9982865,0.000025448737,0.00009372919,0.00054913823,0.000953085,0.00009211097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037120748,0.00017068686,0.00016802333,0.00010182674,0.00015514217,0.00002319546,0.0005119394,0.00014202141,0.0010987392],"category_scores_gemma":[0.000028449562,0.00012248711,0.00004640042,0.00045065462,0.0006733683,0.0000130215185,0.00019016209,0.00026313355,0.000010790501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074386375,0.00026820222,0.5445151,0.00006664784,0.0001744613,0.000004844898,0.00080685393,0.0010002649,0.4117791,0.000007337631,0.0061992807,0.03443408],"study_design_scores_gemma":[0.0012232165,0.00012610125,0.58509195,0.000110049245,0.000013178637,0.0000041832895,0.0004126978,0.000055775345,0.39722732,0.000020148045,0.015514477,0.00020092864],"about_ca_topic_score_codex":0.011817504,"about_ca_topic_score_gemma":0.025260678,"teacher_disagreement_score":0.040576868,"about_ca_system_score_codex":0.0003410204,"about_ca_system_score_gemma":0.0012072446,"threshold_uncertainty_score":0.9998144},"labels":[],"label_agreement":null},{"id":"W2792681611","doi":"10.1158/1538-7445.sabcs17-pd3-03","title":"Abstract PD3-03: Circulating tumor DNA in HER2 amplified breast cancer: A translational research substudy of the NeoALTTO phase 3 trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lapatinib; Internal medicine; Oncology; Breast cancer; Trastuzumab; Digital polymerase chain reaction; Mastectomy; Circulating tumor DNA; Cancer; Polymerase chain reaction; Biology; Gene","score_opus":0.1100644516344011,"score_gpt":0.44925042635106854,"score_spread":0.33918597471666745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792681611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502563,0.0012639445,0.000008953841,0.0010455775,0.00035021405,0.001083411,0.00042814336,0.0000041204294,0.00079002813],"genre_scores_gemma":[0.9973363,0.00039745538,0.000018603687,0.000073150215,0.0016111275,0.00039335273,0.000025340014,0.000035830497,0.000108801716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972262,0.0002855264,0.0004292293,0.0005404552,0.00083273824,0.00068584393],"domain_scores_gemma":[0.9981483,0.0001847846,0.00009295984,0.00057084765,0.00086870225,0.00013437141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021484268,0.00014769983,0.00021719688,0.00017163933,0.00031437917,0.00005969231,0.00059082464,0.00012694288,0.0003282312],"category_scores_gemma":[0.0003234017,0.00012560861,0.00010958835,0.0007560661,0.00068360905,0.000007773276,0.00021352801,0.0005190799,0.000009361437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016093101,0.0006278414,0.012305997,0.000094951436,0.000083304054,0.000011231145,0.00076854386,0.00024367467,0.95492125,0.0002694992,0.0036525694,0.01092803],"study_design_scores_gemma":[0.09099332,0.002574518,0.2602079,0.00085510034,0.000045634577,0.000033128432,0.0016059174,0.0005754834,0.6073085,0.0021502264,0.032653183,0.0009970854],"about_ca_topic_score_codex":0.006027071,"about_ca_topic_score_gemma":0.01007247,"teacher_disagreement_score":0.34761274,"about_ca_system_score_codex":0.00018151775,"about_ca_system_score_gemma":0.002022395,"threshold_uncertainty_score":0.91111684},"labels":[],"label_agreement":null},{"id":"W2792685695","doi":"10.1158/1538-7445.sabcs17-p5-07-11","title":"Abstract P5-07-11: BHLHE40-AS1 is an enhancer associated noncoding RNA critical to breast cancer progression","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Ductal carcinoma; Cancer research; Biomarker; Long non-coding RNA; Medicine; Cancer; Prostate cancer; Oncology; Biology; Internal medicine; RNA; Gene","score_opus":0.059310597354647825,"score_gpt":0.46574169340731547,"score_spread":0.40643109605266764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792685695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865281,0.002233326,0.001229151,0.0057598595,0.00084633776,0.0011688817,0.00055280613,0.00007540243,0.0016061388],"genre_scores_gemma":[0.9928142,0.0008057559,0.00024084077,0.0006855227,0.0024303296,0.0009099999,0.00007261828,0.00014895665,0.0018918179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943257,0.0003966652,0.00042357703,0.0014026432,0.001661523,0.0017899235],"domain_scores_gemma":[0.9955642,0.00006757665,0.00008027513,0.0009859523,0.0023896222,0.0009123605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017520906,0.0003693575,0.00033998681,0.0003190572,0.0006904578,0.0002646412,0.00095952366,0.0006382809,0.0045842268],"category_scores_gemma":[0.00061778026,0.00036088313,0.00015037833,0.00090989895,0.0005974077,0.000037833997,0.0007009395,0.00093768165,0.0003428284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061600923,0.00020798642,0.00017287626,0.000062594154,0.00009821135,0.00002654706,0.0002974881,0.000019347755,0.94519013,0.00006611611,0.027419824,0.025822857],"study_design_scores_gemma":[0.0008074954,0.0008150753,0.0019802272,0.00045238706,0.000020517376,0.000011691117,0.00016595263,0.00016155883,0.96105033,0.00009218913,0.03394092,0.0005016337],"about_ca_topic_score_codex":0.0018151802,"about_ca_topic_score_gemma":0.0026404285,"teacher_disagreement_score":0.025321225,"about_ca_system_score_codex":0.0007375089,"about_ca_system_score_gemma":0.0014817575,"threshold_uncertainty_score":0.9998843},"labels":[],"label_agreement":null},{"id":"W2792709310","doi":"10.1158/1538-7445.sabcs17-p2-09-10","title":"Abstract P2-09-10: Comprehensive gene expression biomarker analysis of CDK 4/6 and endocrine pathways from the PALOMA-2 study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Palbociclib; Biomarker; Internal medicine; Cyclin-dependent kinase; Oncology; Cancer; Medicine; Letrozole; Gene expression; Cancer research; Biology; Gene; Breast cancer; Cell cycle; Metastatic breast cancer; Genetics","score_opus":0.16357835949288654,"score_gpt":0.4464824614363966,"score_spread":0.28290410194351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792709310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991542,0.0064306785,0.00005636231,0.0004949097,0.00007952829,0.0007822442,0.00023939053,0.0000289635,0.00034594414],"genre_scores_gemma":[0.9984945,0.00039400253,0.00024358623,0.0000913603,0.00036109856,0.00016793697,0.000040383482,0.000032912256,0.00017421426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975461,0.00022180927,0.0003381852,0.0005346266,0.0009132777,0.00044603314],"domain_scores_gemma":[0.99726576,0.00062598864,0.000116544004,0.0008533265,0.0009666858,0.00017167364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040744516,0.00018926643,0.0005208577,0.0003183708,0.00024552262,0.000029155432,0.00026926261,0.000055172804,0.002297647],"category_scores_gemma":[0.000104043356,0.000120813434,0.00010247701,0.0011910415,0.0008176706,0.000090210415,0.00026719074,0.0003180536,0.000021200856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023324792,0.00026012104,0.065214835,0.000035187506,0.0018912404,0.000057178666,0.002715105,0.000009198168,0.8846685,0.0000068663953,0.00072349806,0.042085737],"study_design_scores_gemma":[0.0022532416,0.00040029237,0.8372033,0.00013490683,0.0003555641,0.0000036915035,0.0037029702,0.000067683446,0.1507226,0.00011249066,0.0049205674,0.00012266637],"about_ca_topic_score_codex":0.0033699367,"about_ca_topic_score_gemma":0.00055159273,"teacher_disagreement_score":0.7719885,"about_ca_system_score_codex":0.00014041107,"about_ca_system_score_gemma":0.00016770768,"threshold_uncertainty_score":0.9986144},"labels":[],"label_agreement":null},{"id":"W2792884593","doi":"10.1158/1538-7445.sabcs17-p6-13-08","title":"Abstract P6-13-08: A novel comparative analysis approach to personalize chemotherapy dose in early breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Body surface area; Chemotherapy; Lean body mass; Cancer; Oncology; Internal medicine; Stage (stratigraphy); Cardiac function curve; Body weight; Heart failure","score_opus":0.18192019229288123,"score_gpt":0.49760801932010545,"score_spread":0.3156878270272242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792884593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530144,0.00019874355,0.0019213181,0.0146110905,0.00001955973,0.0010345666,0.00012059491,0.0000641542,0.0067285458],"genre_scores_gemma":[0.99195015,0.00014450328,0.00375422,0.001095125,0.00042546054,0.0013635055,0.000017796747,0.000019814162,0.0012294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979428,0.0000398371,0.00024046437,0.0005159421,0.0007360918,0.0005248502],"domain_scores_gemma":[0.9985237,0.000065940236,0.000040315517,0.00044678984,0.00052825856,0.00039501017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069224427,0.00014259457,0.00039667435,0.0004807991,0.00012099334,0.000048066475,0.00028868025,0.00008652998,0.0018832441],"category_scores_gemma":[0.000025378356,0.00011553862,0.000097925535,0.0027211404,0.00042923982,0.000058776142,0.00006942057,0.0005743433,0.00006510798],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035816599,0.005146897,0.20321292,0.0004916203,0.002335379,0.000029855419,0.04204032,0.00008933846,0.44024372,0.0020934856,0.26388526,0.036849555],"study_design_scores_gemma":[0.0018604043,0.00013056582,0.96772856,0.00025534348,0.00009732805,0.000008166547,0.0005141431,0.0033772578,0.006686925,0.00005657815,0.019038625,0.000246124],"about_ca_topic_score_codex":0.017722782,"about_ca_topic_score_gemma":0.00096629397,"teacher_disagreement_score":0.76451564,"about_ca_system_score_codex":0.00041056707,"about_ca_system_score_gemma":0.0003795929,"threshold_uncertainty_score":0.99902916},"labels":[],"label_agreement":null},{"id":"W2792910895","doi":"10.1158/1538-7445.sabcs17-p4-10-14","title":"Abstract P4-10-14: Pilot data from the development of the Senior Women's Breast Cancer Clinic at Sunnybrook Odette Cancer Centre","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Pharmacy; Cancer; Family medicine; Medical record; Referral; Gerontology; Internal medicine","score_opus":0.18698544948872417,"score_gpt":0.4423200051147236,"score_spread":0.2553345556259994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792910895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96199805,0.0018947952,0.0000015484028,0.029682677,0.0009499573,0.0011997968,0.0027108444,0.000039190163,0.0015231237],"genre_scores_gemma":[0.9504107,0.0010096154,0.00009178722,0.0013325863,0.0022505592,0.00044123977,0.00011176036,0.000091022164,0.044260725],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951769,0.00022442943,0.0006649841,0.0008850346,0.0018830125,0.0011656225],"domain_scores_gemma":[0.99526554,0.0006100756,0.00021575655,0.002512633,0.0010487004,0.0003472959],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016224759,0.00029589032,0.00044956242,0.00008221811,0.0005923374,0.00005146589,0.001929894,0.00013525943,0.051123213],"category_scores_gemma":[0.00028750984,0.00017085533,0.000072477094,0.0006536573,0.0012927973,0.00015510521,0.0016978015,0.00094026304,0.0007136204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030894638,0.00033230596,0.13592632,0.00034698995,0.00080949045,0.000015631405,0.009273515,0.000005997839,0.039185632,0.0000029838825,0.7671294,0.043882236],"study_design_scores_gemma":[0.0026924245,0.00009782667,0.63284403,0.001566617,0.0000710386,0.000005810793,0.00086795044,0.000054088585,0.026425254,0.000026437448,0.3350821,0.00026642997],"about_ca_topic_score_codex":0.015476044,"about_ca_topic_score_gemma":0.09128852,"teacher_disagreement_score":0.4969177,"about_ca_system_score_codex":0.0023671882,"about_ca_system_score_gemma":0.004251541,"threshold_uncertainty_score":0.99108},"labels":[],"label_agreement":null},{"id":"W2792965236","doi":"10.1158/1538-7445.sabcs17-p2-12-15","title":"Abstract P2-12-15: ReFilx- synthetic biodegradable soft tissue fillers for breast conserving surgery in breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reconstructive Surgery and Microvascular Techniques","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Grand River Hospital; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Soft tissue; Medicine; Mastectomy; Surgery; Breast reconstruction; Biomaterial; Plastic surgery; Breast augmentation; Breast tissue; Biocompatibility; Biomedical engineering; Implant; Cancer; Materials science; Internal medicine","score_opus":0.07432215260175502,"score_gpt":0.3879752395405487,"score_spread":0.3136530869387937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792965236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872482,0.0034567607,0.00010407128,0.0044486574,0.00052219443,0.001375701,0.00074313034,0.00014303601,0.0019582459],"genre_scores_gemma":[0.9948118,0.0016598518,0.00034199102,0.00023743775,0.00057396834,0.00087603455,0.000029508945,0.00007986186,0.0013895626],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723995,0.00015278254,0.00045099843,0.0006708061,0.0004699466,0.0010155187],"domain_scores_gemma":[0.9975296,0.0007206827,0.000094754665,0.00056745956,0.00083280366,0.000254648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022519047,0.00024562425,0.0006178241,0.0006887346,0.00028046555,0.000060346538,0.00021852291,0.00021919372,0.0041486854],"category_scores_gemma":[0.00022773641,0.00021676574,0.00020666193,0.00065175176,0.00088875846,0.0001949878,0.00009271073,0.00054461975,0.00004821488],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001996583,0.0002197644,0.092012286,0.0012065206,0.0002801742,0.00012392136,0.00023012028,0.0000019298707,0.31080988,0.000060926195,0.08934658,0.50371134],"study_design_scores_gemma":[0.001935576,0.00017803168,0.21938895,0.0068269065,0.00009399252,0.0013624722,0.000733976,0.00008469901,0.64486176,0.0005662596,0.12308396,0.00088344543],"about_ca_topic_score_codex":0.0077273943,"about_ca_topic_score_gemma":0.0021042172,"teacher_disagreement_score":0.5028279,"about_ca_system_score_codex":0.00060105656,"about_ca_system_score_gemma":0.0013420805,"threshold_uncertainty_score":0.9988802},"labels":[],"label_agreement":null},{"id":"W2793000301","doi":"10.1158/1538-7445.sabcs17-gs3-03","title":"Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Clinical endpoint; Celecoxib; Placebo; Breast cancer; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Oncology; Clinical trial; Surgery; Confidence interval","score_opus":0.08332244430336941,"score_gpt":0.4029894656007412,"score_spread":0.3196670212973718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793000301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521865,0.00013674813,0.0000011668354,0.00021447273,0.00029891083,0.004017262,0.00041361133,0.000052429183,0.042678885],"genre_scores_gemma":[0.9929084,0.0003739637,0.0000106722655,0.00001781311,0.0016953314,0.0028542248,0.0002848766,0.000081168924,0.0017735193],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958723,0.00020590339,0.0011647311,0.00084541616,0.0009696659,0.0009419787],"domain_scores_gemma":[0.99646086,0.0011898413,0.00046948594,0.0008275049,0.0006738969,0.0003784359],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016727109,0.0003721201,0.0007596375,0.0001768051,0.00028870508,0.00008969408,0.00081775675,0.00023618482,0.006183366],"category_scores_gemma":[0.00033006247,0.00035690583,0.0002806108,0.00065129163,0.00044485097,0.00020573946,0.00019344714,0.00093168986,0.00007980999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74559736,0.002653518,0.0000294515,0.0001945709,0.00013709863,0.0000070896112,0.00039671035,0.000009216082,0.244231,0.0000019350352,0.0015392305,0.0052028154],"study_design_scores_gemma":[0.7280487,0.00015458906,0.00003989397,0.00016347744,0.00005656584,4.3696804e-7,0.00010867946,0.00003427897,0.26846159,0.0000036359834,0.0026713824,0.00025681584],"about_ca_topic_score_codex":0.0009401179,"about_ca_topic_score_gemma":0.00031825562,"teacher_disagreement_score":0.040905368,"about_ca_system_score_codex":0.00080033654,"about_ca_system_score_gemma":0.00097629766,"threshold_uncertainty_score":0.9998883},"labels":[],"label_agreement":null},{"id":"W2793013648","doi":"10.1158/1538-7445.sabcs17-p5-19-02","title":"Abstract P5-19-02: Withdrawn","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.22503624746681697,"score_gpt":0.3695769001438169,"score_spread":0.14454065267699992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793013648","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2378117,0.0021757404,0.000026690508,0.0009530853,0.0021058104,0.00017263462,0.0002547669,0.00003562248,0.75646394],"genre_scores_gemma":[0.8000606,0.00046556923,0.000058527876,0.00018391058,0.0006387592,0.00005807952,0.0000026135938,0.000016045025,0.19851595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850863,0.000009847506,0.00029642353,0.0005358168,0.00007430247,0.00057499984],"domain_scores_gemma":[0.99919677,0.000055461962,0.0000844249,0.00038808232,0.00012131697,0.00015396769],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015530006,0.000096646174,0.0002276241,0.00028931824,0.00047410955,0.00017332679,0.00040145876,0.000061243394,0.051753458],"category_scores_gemma":[0.00016027201,0.00010417823,0.0000633675,0.00037667723,0.0007254308,0.00020673119,0.0001949919,0.00020567489,0.07079766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003274446,0.000040334144,0.009400504,0.000025081474,0.0000670586,0.0000046992523,0.0012806342,0.000005778685,0.00013119944,0.066200204,0.9211476,0.0016641879],"study_design_scores_gemma":[0.00032473583,0.00004186637,0.010213039,0.000014986657,0.0000011280266,6.260324e-7,0.00050635845,0.000046806865,0.00047068627,0.009085606,0.9791318,0.00016234863],"about_ca_topic_score_codex":0.0017036529,"about_ca_topic_score_gemma":0.00015311885,"teacher_disagreement_score":0.5622488,"about_ca_system_score_codex":0.0002657052,"about_ca_system_score_gemma":0.00008015143,"threshold_uncertainty_score":0.94911337},"labels":[],"label_agreement":null},{"id":"W2793038494","doi":"10.1158/1538-7445.sabcs17-p5-19-07","title":"Abstract P5-19-07: Defining priorities for research: Interim results of the Canadian metastatic breast cancer priority setting partnership","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim; Psychosocial; Family medicine; Breast cancer; Population; General partnership; Health professionals; Health care; Disease; Cancer; Internal medicine; Psychiatry; Environmental health","score_opus":0.34021107067543266,"score_gpt":0.4429268827533479,"score_spread":0.10271581207791525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793038494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8947278,0.007952183,0.000027795153,0.01991238,0.0017238789,0.0019362343,0.008943545,0.000038059155,0.064738125],"genre_scores_gemma":[0.9951133,0.0005219131,0.00018330992,0.0003112098,0.0008982058,0.00041565156,0.000010132612,0.000058934776,0.0024873295],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963595,0.000114319155,0.000980058,0.0007152646,0.0002479998,0.0015828209],"domain_scores_gemma":[0.9966756,0.00066566997,0.0004082084,0.00074626715,0.0010484409,0.00045582818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009012012,0.00021820246,0.00053577876,0.00063058315,0.0012937378,0.00028642712,0.00095792644,0.00018132843,0.0006634443],"category_scores_gemma":[0.0023441352,0.00020728531,0.00018450992,0.00076089293,0.0014742538,0.000411538,0.0002373809,0.00092717167,0.00017947033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002706154,0.00021519027,0.21345526,0.0018102218,0.00071573374,0.000015326566,0.02203527,0.0001912803,0.0007959221,0.4366772,0.26703143,0.05435099],"study_design_scores_gemma":[0.002883977,0.00036373906,0.3582794,0.00084061566,0.000020640262,0.000007897561,0.0017232379,0.00039009776,0.0030189734,0.06647041,0.5652508,0.0007502176],"about_ca_topic_score_codex":0.46533808,"about_ca_topic_score_gemma":0.5136028,"teacher_disagreement_score":0.3702068,"about_ca_system_score_codex":0.0023727228,"about_ca_system_score_gemma":0.003949434,"threshold_uncertainty_score":0.9950516},"labels":[],"label_agreement":null},{"id":"W2793272169","doi":"10.1158/1538-7445.sabcs17-pd2-16","title":"Abstract PD2-16: Risk of breast cancer after a false-positive screening mammogram in relation to mammographic abnormality: A population-based study in British Columbia","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Mammography; Breast cancer; Breast cancer screening; Gynecology; Cancer; Population; Relative risk; Obstetrics; Poisson regression; Demography; Internal medicine; Confidence interval; Environmental health","score_opus":0.06765720310711305,"score_gpt":0.4057624070436012,"score_spread":0.3381052039364882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793272169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654037,0.00054876076,0.00005396797,0.0003193115,0.00007578953,0.0019526365,0.00032061632,0.000028292343,0.00016027673],"genre_scores_gemma":[0.99821776,0.00006060383,0.0002090442,0.000181718,0.00020928794,0.00097396894,0.00002760637,0.00003639559,0.000083607025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633193,0.0003768687,0.0006460948,0.00063306146,0.0012757874,0.0007362387],"domain_scores_gemma":[0.99809176,0.00017582998,0.00013752742,0.00038784798,0.0009482458,0.0002588073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002470051,0.00015196585,0.00046352934,0.00063802785,0.0001645286,0.00015119604,0.00020224246,0.00015424752,0.0008695949],"category_scores_gemma":[0.00022609031,0.00021171045,0.00010009989,0.0028437318,0.00016321808,0.0002509949,0.00009036945,0.00079931156,0.0000076226124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018092783,0.00025846917,0.96799886,0.000082926395,0.00005907646,0.00017536191,0.0006303242,0.00029074305,0.00014980737,8.300419e-7,0.00017010391,0.028374242],"study_design_scores_gemma":[0.002328629,0.0005127677,0.9926572,0.0028166655,0.000042093467,0.000009756996,0.0011510253,0.0001618588,0.000046945075,0.00005342873,0.00002724493,0.00019242751],"about_ca_topic_score_codex":0.839341,"about_ca_topic_score_gemma":0.9404392,"teacher_disagreement_score":0.10109827,"about_ca_system_score_codex":0.0009554374,"about_ca_system_score_gemma":0.0004941018,"threshold_uncertainty_score":0.95214546},"labels":[],"label_agreement":null},{"id":"W2793284812","doi":"10.1158/1538-7445.sabcs17-p5-12-01","title":"Abstract P5-12-01: The joint effect of modifiable risk factors on risk of invasive breast cancer among Canadian women","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cohort; Hazard ratio; Internal medicine; Cancer; Proportional hazards model; Cohort study; Oncology; Confidence interval; Anthropometry; Demography","score_opus":0.05505985779227562,"score_gpt":0.3619304919965877,"score_spread":0.3068706342043121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793284812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930218,0.00034061432,6.700106e-7,0.00027566616,0.0003362473,0.0011625877,0.0018827439,0.00001567631,0.0029640207],"genre_scores_gemma":[0.9964833,0.0020960649,0.0000014220209,0.000033700057,0.00046867898,0.00031852082,0.000010631314,0.0000547867,0.00053285586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968136,0.00030733048,0.00040645926,0.00045412165,0.0010092504,0.0010092383],"domain_scores_gemma":[0.99710774,0.00061999494,0.00027101886,0.00079617504,0.00054605614,0.0006589873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001745998,0.00026426613,0.0006297472,0.0004779637,0.00037623983,0.000031327687,0.00035247538,0.00017464173,0.0036656947],"category_scores_gemma":[0.00044403903,0.00015828684,0.00018101552,0.0006560193,0.0012238825,0.000093518596,0.0000820199,0.0011140598,0.00002840649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015837024,0.00007488462,0.96958834,0.00036046316,0.00059097214,0.000012495364,0.005432656,0.0005157661,0.0073323892,0.000013580892,0.007206598,0.0072881654],"study_design_scores_gemma":[0.0013035156,0.0012146612,0.9022994,0.0005333027,0.00009002216,0.0000015405632,0.0009108296,0.00008225863,0.09176066,0.000038840983,0.0016073164,0.00015762266],"about_ca_topic_score_codex":0.9499636,"about_ca_topic_score_gemma":0.48072788,"teacher_disagreement_score":0.46923575,"about_ca_system_score_codex":0.001985769,"about_ca_system_score_gemma":0.0021644298,"threshold_uncertainty_score":0.9972451},"labels":[],"label_agreement":null},{"id":"W2793303753","doi":"10.1158/1538-7445.sabcs17-p4-12-08","title":"Abstract P4-12-08: Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Palbociclib; Letrozole; Statistics; Breast cancer; Cost effectiveness; Medicine; Oncology; Econometrics; Mathematics; Cancer; Internal medicine; Metastatic breast cancer; Aromatase","score_opus":0.05739803345899822,"score_gpt":0.4316350572997205,"score_spread":0.37423702384072227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793303753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256034,0.005571507,0.0001755796,0.006286653,0.0002278478,0.0018561289,0.0010867092,0.000120568904,0.0021146857],"genre_scores_gemma":[0.993681,0.0021716258,0.00031181853,0.00042149826,0.00090250844,0.0013947912,0.000087276465,0.00008391932,0.0009455385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99515957,0.0002548955,0.0006093082,0.0011553396,0.0013364765,0.0014844323],"domain_scores_gemma":[0.9965099,0.0002901403,0.00016757674,0.0009704153,0.0014961051,0.0005658826],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012338152,0.0003918554,0.00091681164,0.0009347317,0.0003117424,0.000059229737,0.0004445025,0.00023101011,0.005910557],"category_scores_gemma":[0.00015628153,0.0003589956,0.00025443477,0.003758089,0.0012346182,0.00040666203,0.00019041322,0.001268068,0.00019334337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023120316,0.0007306808,0.13925779,0.00020817814,0.001994706,0.00012412503,0.0031587621,0.00015636586,0.2642487,0.00008388023,0.0021114836,0.56480503],"study_design_scores_gemma":[0.0052558244,0.00036653705,0.954506,0.0004359354,0.00019137752,0.000016864558,0.00088365783,0.0002495651,0.025679464,0.00018195066,0.011796863,0.00043596394],"about_ca_topic_score_codex":0.0073467963,"about_ca_topic_score_gemma":0.008172477,"teacher_disagreement_score":0.8152482,"about_ca_system_score_codex":0.0023845625,"about_ca_system_score_gemma":0.0011118527,"threshold_uncertainty_score":0.9998862},"labels":[],"label_agreement":null},{"id":"W2793314752","doi":"10.1158/1538-7445.sabcs17-p3-08-08","title":"Abstract P3-08-08: Prognostic associations of plasma hepcidin in early breast cancer (BC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Hepcidin; Medicine; Internal medicine; Breast cancer; Proportional hazards model; Ferroportin; Gastroenterology; Cancer; Prospective cohort study; Oncology; Soluble transferrin receptor; Anemia; Endocrinology; Iron deficiency; Iron status","score_opus":0.0488991418707918,"score_gpt":0.3775358110842115,"score_spread":0.3286366692134197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793314752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344695,0.0016569793,0.000006358238,0.00047197167,0.0018896319,0.0003914869,0.0005179454,0.000009072883,0.0016095977],"genre_scores_gemma":[0.9881583,0.0017127612,0.0000343197,0.000049358285,0.008462251,0.0003099517,0.000039850132,0.000032648462,0.0012005947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981207,0.000110095025,0.0002970795,0.00042429456,0.00044389835,0.0006038857],"domain_scores_gemma":[0.9987147,0.00005154953,0.00009588865,0.00034662388,0.000652378,0.00013884703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006412686,0.00014404487,0.0002327899,0.00016235092,0.00012230217,0.00003480921,0.00032908938,0.00019967316,0.00039005448],"category_scores_gemma":[0.00018614781,0.0001420584,0.00008188826,0.0004354267,0.00034085094,0.0000118679545,0.00013634848,0.0002990795,0.000044680055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042749528,0.00019026628,0.18944858,0.00009557632,0.00012477787,5.954948e-7,0.0005790949,0.000042291635,0.7430372,0.0001346983,0.050539114,0.015380255],"study_design_scores_gemma":[0.0011995981,0.00019165898,0.7779202,0.00012738274,0.000017097116,0.0000026896446,0.00012040069,0.000019230065,0.119610645,0.00007839218,0.100479476,0.00023326706],"about_ca_topic_score_codex":0.014096764,"about_ca_topic_score_gemma":0.019322332,"teacher_disagreement_score":0.6234266,"about_ca_system_score_codex":0.000159541,"about_ca_system_score_gemma":0.00094426295,"threshold_uncertainty_score":0.99857247},"labels":[],"label_agreement":null},{"id":"W2793337941","doi":"10.1158/1538-7445.sabcs17-p6-12-26","title":"Abstract P6-12-26: The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Peripheral neuropathy; Internal medicine; Oncology; Biomarker; Cancer; Gastroenterology; Endocrinology","score_opus":0.06557520019117179,"score_gpt":0.40540570186538544,"score_spread":0.33983050167421364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793337941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818095,0.00077153073,0.000001249148,0.00879268,0.0007434291,0.0012049424,0.00004156938,0.000057410252,0.0065777074],"genre_scores_gemma":[0.9904034,0.0012299304,0.0000116344445,0.0016263892,0.00090870383,0.00017361794,0.000015318054,0.000089284345,0.0055416864],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969926,0.0003476455,0.00038172162,0.00052011455,0.0009627007,0.0007952134],"domain_scores_gemma":[0.9982277,0.00020640764,0.00011780221,0.0006036536,0.0005667977,0.00027762112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010030122,0.0002633154,0.00037855134,0.00021086224,0.0003022363,0.000044330733,0.00038061413,0.00013710835,0.01398255],"category_scores_gemma":[0.000058986236,0.00018967221,0.00017076841,0.00062538433,0.000640308,0.000081532984,0.00016435666,0.0008719355,0.00019790466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020469502,0.00097447087,0.014402402,0.00017042307,0.0005703057,0.0005045291,0.0010605137,0.000003686597,0.88432485,0.000028122004,0.046017636,0.03147358],"study_design_scores_gemma":[0.0060619772,0.0025602872,0.57981807,0.00012430208,0.00012613047,0.00006918477,0.00019935341,0.00023701062,0.37191907,0.0000663527,0.038601723,0.00021657374],"about_ca_topic_score_codex":0.0022944433,"about_ca_topic_score_gemma":0.00021900551,"teacher_disagreement_score":0.5654156,"about_ca_system_score_codex":0.00027632504,"about_ca_system_score_gemma":0.0009449072,"threshold_uncertainty_score":0.9869188},"labels":[],"label_agreement":null},{"id":"W2793367203","doi":"10.1158/1538-7445.sabcs17-p2-05-15","title":"Abstract P2-05-15: Oncotype DX Breast Recurrence Score®: Real-life utilization among node positive patients in Ontario","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Interim analysis; Stage (stratigraphy); Interim; Concordance; Cancer; Gynecology; Clinical Practice; Clinical trial; Family medicine","score_opus":0.07241857294409132,"score_gpt":0.37547188433943157,"score_spread":0.30305331139534025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793367203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415386,0.0002702442,0.000011168489,0.00018995945,0.00027218822,0.00039415248,0.0001404027,0.0000103644925,0.0045576785],"genre_scores_gemma":[0.99815375,0.0006146255,0.000025452362,0.000084562744,0.00029547434,0.0001581619,0.00028878573,0.000028478662,0.0003507361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808466,0.000107975015,0.00022989656,0.000603836,0.00042498065,0.00054863986],"domain_scores_gemma":[0.9985865,0.000030139925,0.000077215656,0.00036689223,0.000786652,0.00015262977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002772054,0.00018958568,0.00018169812,0.00012260379,0.00021017413,0.00003873126,0.00025841998,0.000152368,0.00022157672],"category_scores_gemma":[0.00010114815,0.00018030689,0.000046484325,0.00031176154,0.00047534326,0.000018292329,0.00023613063,0.00029173295,0.000045979097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075134414,0.00021378501,0.9842777,0.000019741206,0.000071177165,0.0000054606626,0.0006286161,0.000008293532,0.00453699,0.000020948713,0.0039003142,0.005565579],"study_design_scores_gemma":[0.0009422537,0.00022393015,0.98528475,0.00018043915,0.000008450396,0.0000014317397,0.00007988422,0.0000044042736,0.01206509,0.000027202448,0.0010085782,0.00017357459],"about_ca_topic_score_codex":0.20556645,"about_ca_topic_score_gemma":0.53479606,"teacher_disagreement_score":0.3292296,"about_ca_system_score_codex":0.0006749885,"about_ca_system_score_gemma":0.0008549339,"threshold_uncertainty_score":0.79972374},"labels":[],"label_agreement":null},{"id":"W2793372579","doi":"10.1158/1538-7445.sabcs17-p5-20-12","title":"Abstract P5-20-12: Adjuvant DCH vs TCH for low-risk (node negative); and FECDH vs TCH for high-risk (node positive) HER2+ breast cancer – A retrospective provincial analysis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Trastuzumab; Internal medicine; Oncology; Cohort; Regimen; Gynecology; Cancer; Proportional hazards model","score_opus":0.015229976185450127,"score_gpt":0.33938659058507886,"score_spread":0.32415661439962873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793372579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758239,0.0018616918,0.0010131574,0.0023789604,0.00030114426,0.0021211936,0.01627861,0.00003542301,0.00018592893],"genre_scores_gemma":[0.9897912,0.0026160723,0.00069111865,0.00016905165,0.002284714,0.0032666745,0.00033201088,0.000105945954,0.000743217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959906,0.00022312645,0.0004205425,0.0015560645,0.00059728074,0.001212395],"domain_scores_gemma":[0.99657106,0.0002452614,0.0002987728,0.0006627641,0.001939051,0.00028309203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083019584,0.00050449546,0.0007778631,0.0002610285,0.0011422263,0.00013960234,0.00041629796,0.00031759634,0.00014117014],"category_scores_gemma":[0.00031675876,0.0004430412,0.00032622964,0.00061556307,0.0009377922,0.000033710363,0.00036450857,0.00041912158,0.000007264681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03118073,0.0008823353,0.80891275,0.0005417398,0.01248785,0.00001847332,0.0022698273,0.00031306111,0.074556895,0.00012268567,0.031842116,0.036871556],"study_design_scores_gemma":[0.005241216,0.0012610494,0.8931027,0.00014785242,0.0011168513,0.0000049819228,0.00032696378,0.00024121992,0.09533777,0.0005613302,0.0019976827,0.0006603919],"about_ca_topic_score_codex":0.03323481,"about_ca_topic_score_gemma":0.05077749,"teacher_disagreement_score":0.08418996,"about_ca_system_score_codex":0.0008842625,"about_ca_system_score_gemma":0.0008671995,"threshold_uncertainty_score":0.9998021},"labels":[],"label_agreement":null},{"id":"W2793394432","doi":"10.1158/1538-7445.sabcs17-p4-15-09","title":"Abstract P4-15-09: Refined estimates of local recurrence risk in a clinical utility study: Integrating the DCIS score, patient age and DCIS tumor size","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mastectomy; Oncology; Internal medicine; Population; Cohort; Breast cancer; Radiation therapy; Cancer; Gynecology","score_opus":0.08380279084137397,"score_gpt":0.4372987683688454,"score_spread":0.3534959775274714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793394432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672353,0.0020930702,0.000036287194,0.00016431713,0.00010882184,0.0005210034,0.00008810176,0.000005985523,0.0002588591],"genre_scores_gemma":[0.99885267,0.00053665816,0.00018440056,0.0000363606,0.0001373357,0.0002230242,0.000006002223,0.000014621295,0.000008931952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997896,0.00036932333,0.0004638234,0.0005586879,0.00033665198,0.00037550388],"domain_scores_gemma":[0.99838334,0.00054110953,0.00014296043,0.0004920315,0.0003595169,0.000081031074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001617584,0.00016505073,0.00028712364,0.00004231047,0.00020523526,0.000027490465,0.00026869835,0.000075081116,0.000043526317],"category_scores_gemma":[0.0018057092,0.00010922945,0.00005897286,0.0002690399,0.0015356238,0.0000060988186,0.00044958,0.00042432902,0.0000034267566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012799143,0.0005108508,0.732873,0.00005256351,0.00014343466,0.000027345988,0.0010301402,0.0000029636178,0.0033949355,0.0000064634996,0.0007227219,0.2599556],"study_design_scores_gemma":[0.00096416526,0.0011651295,0.9774169,0.00014626562,0.000020799069,0.0000023568791,0.0018640388,0.000053864074,0.017620627,0.000193827,0.00043382403,0.000118202326],"about_ca_topic_score_codex":0.0061660493,"about_ca_topic_score_gemma":0.012102576,"teacher_disagreement_score":0.25983742,"about_ca_system_score_codex":0.00006530175,"about_ca_system_score_gemma":0.00023619943,"threshold_uncertainty_score":0.9321263},"labels":[],"label_agreement":null},{"id":"W2793419309","doi":"10.1158/1538-7445.sabcs17-p3-14-06","title":"Abstract P3-14-06: The prevention and management of chemotherapy-induced peripheral neuropathy in breast cancer patients: A systematic review","year":2018,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Internal medicine; Observational study; Adverse effect; Systematic review; Peripheral neuropathy; Randomized controlled trial; Cancer; Oncology; Physical therapy; MEDLINE","score_opus":0.11496525183868346,"score_gpt":0.4825476662749586,"score_spread":0.36758241443627515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793419309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002995997,0.98632854,1.0958302e-7,0.00061414053,0.00018011685,0.009504159,0.000082188664,0.000010839541,0.00028392143],"genre_scores_gemma":[0.00090095523,0.99136984,0.000003083873,0.00018888483,0.00020085921,0.0059106136,0.0000463806,0.000062067615,0.0013173104],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969761,0.0006099044,0.0008450539,0.0005023154,0.00063902774,0.00042759295],"domain_scores_gemma":[0.99856156,0.00012073903,0.00038879973,0.0004912515,0.00033037915,0.00010725519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001200615,0.00033142115,0.0018255259,0.00021122975,0.000083818246,0.000022943132,0.000290496,0.00013496558,0.0007515052],"category_scores_gemma":[0.000017385473,0.0001956051,0.0002762074,0.0007437053,0.00018084637,0.000055682034,0.00012060122,0.0005849633,0.000018216031],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010749682,0.00031665488,0.00007927881,0.8730903,0.00067430374,0.000022879382,0.0000940628,2.3505658e-8,0.0000053818544,0.00000485673,0.0031579155,0.122446805],"study_design_scores_gemma":[0.001824436,0.00038087612,0.0011389289,0.9143188,0.0027539067,0.000025929856,0.00002485451,0.0000013601976,0.0000043735245,0.000006104594,0.07932142,0.00019901799],"about_ca_topic_score_codex":0.00035234354,"about_ca_topic_score_gemma":0.000094182404,"teacher_disagreement_score":0.122247785,"about_ca_system_score_codex":0.0008792915,"about_ca_system_score_gemma":0.0005032445,"threshold_uncertainty_score":0.82284546},"labels":[],"label_agreement":null},{"id":"W2793424225","doi":"10.1158/1538-7445.sabcs17-p6-12-22","title":"Abstract P6-12-22: Sexual health in long-term breast cancer survivors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Statistics Canada; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Cohort; Sexual function; Gynecology; Internal medicine; Quality of life (healthcare); Cancer","score_opus":0.10223818493176706,"score_gpt":0.45124401561366606,"score_spread":0.349005830681899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793424225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777949,0.0046642963,0.00000790994,0.012107268,0.001098912,0.0007748161,0.00028003452,0.00007057499,0.0032012914],"genre_scores_gemma":[0.9895993,0.0022793836,0.000004659526,0.0011430823,0.002364557,0.000318751,0.000045116107,0.00007324756,0.004171927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627906,0.00020476822,0.00042120705,0.00071723876,0.0010720753,0.0013056364],"domain_scores_gemma":[0.9979601,0.000117645934,0.00007928727,0.0006610745,0.0005873548,0.00059453334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015877916,0.00024257193,0.00049629994,0.0004759773,0.00022752956,0.00006769836,0.00033727594,0.00017146037,0.007113635],"category_scores_gemma":[0.000040713716,0.00021953303,0.000076009324,0.0010624952,0.0005245081,0.00015186949,0.00015011568,0.001063691,0.00017689425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015195105,0.0002748884,0.7424743,0.001032482,0.00009089567,0.00013716146,0.0054113157,0.0000036617785,0.0035561002,0.000043978547,0.020659773,0.22479591],"study_design_scores_gemma":[0.0013833521,0.00035842118,0.9863427,0.0007916499,0.0000091394695,0.00003316391,0.00086771906,0.0000096461445,0.0010211553,0.000025743213,0.008920296,0.00023699272],"about_ca_topic_score_codex":0.26283616,"about_ca_topic_score_gemma":0.685362,"teacher_disagreement_score":0.42252582,"about_ca_system_score_codex":0.001697136,"about_ca_system_score_gemma":0.002702681,"threshold_uncertainty_score":0.993794},"labels":[],"label_agreement":null},{"id":"W2793456616","doi":"10.1158/1538-7445.sabcs17-p2-02-02","title":"Abstract P2-02-02: Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Digital polymerase chain reaction; Liquid biopsy; Neoadjuvant therapy; Clinical trial; Exome; Exome sequencing; Gene; Mutation; Biology; Polymerase chain reaction","score_opus":0.02149482641056054,"score_gpt":0.34570981492713115,"score_spread":0.3242149885165706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793456616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961032,0.0008445212,0.0000054510137,0.000906319,0.00028825263,0.00045645668,0.0008842259,0.0000051080115,0.00050646276],"genre_scores_gemma":[0.99214065,0.0064319465,0.000029275267,0.00011596186,0.0006652771,0.00017387088,0.00006428804,0.00004468052,0.0003340439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983596,0.000050960232,0.00025576405,0.00045370404,0.00033378316,0.0005461743],"domain_scores_gemma":[0.9987681,0.000042541527,0.00011185235,0.00034915362,0.0006058266,0.00012254155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028527275,0.0001738782,0.000230966,0.00016722814,0.00010477302,0.000027798149,0.00033235358,0.00016133276,0.0002809036],"category_scores_gemma":[0.000093840186,0.00017161109,0.000058347847,0.00031570005,0.0003516076,0.000006679706,0.00018204175,0.00023175759,0.0000063683215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034919987,0.0006408381,0.14538693,0.0003203602,0.00021346105,0.000010632884,0.0013051307,0.00013376045,0.770424,0.00009991837,0.004147701,0.07382526],"study_design_scores_gemma":[0.003194761,0.0004228683,0.45981532,0.00018562339,0.000006634453,0.0000015259054,0.0002051403,0.00009642995,0.5341756,0.0001178211,0.0015031035,0.000275195],"about_ca_topic_score_codex":0.0047832537,"about_ca_topic_score_gemma":0.024438275,"teacher_disagreement_score":0.3144284,"about_ca_system_score_codex":0.0003719754,"about_ca_system_score_gemma":0.000394533,"threshold_uncertainty_score":0.9933632},"labels":[],"label_agreement":null},{"id":"W2793495237","doi":"10.1158/1538-7445.sabcs17-pd6-10","title":"Abstract PD6-10: KEYNOTE-086 cohort B: Pembrolizumab monotherapy for PD-L1–positive, previously untreated, metastatic triple-negative breast cancer (mTNBC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Cohort; Triple-negative breast cancer; Clinical endpoint; Breast cancer; Metastatic breast cancer; Cancer; Response Evaluation Criteria in Solid Tumors; Progressive disease; Chemotherapy; Clinical trial; Immunotherapy","score_opus":0.0679343402304146,"score_gpt":0.4227587382644817,"score_spread":0.35482439803406707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793495237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96928877,0.0086779315,0.0002127393,0.005723311,0.00066857063,0.007784202,0.0020289612,0.00017626093,0.0054392293],"genre_scores_gemma":[0.9659118,0.007379084,0.00032259605,0.0010341988,0.0015033445,0.004093145,0.00012823052,0.00019564353,0.019431932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953823,0.00025707638,0.00067587226,0.0010433226,0.001176766,0.0014646653],"domain_scores_gemma":[0.99598587,0.000546373,0.00022608052,0.00077349984,0.002027115,0.00044104614],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014875405,0.0004960157,0.0008615394,0.00048813355,0.00061204605,0.00015179753,0.00045073216,0.00021491878,0.011073613],"category_scores_gemma":[0.00014172425,0.00040233895,0.00037713372,0.0011936985,0.0011983247,0.00028078863,0.00006840799,0.0006248132,0.00014359965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30957258,0.0014096508,0.01554967,0.00153001,0.009161467,0.00018019226,0.0055661877,0.00002620021,0.15189466,0.00014610536,0.1560513,0.34891197],"study_design_scores_gemma":[0.06605431,0.007043747,0.56881917,0.0036545317,0.0010795784,0.00030768875,0.0011768771,0.0007468941,0.2325926,0.0007356675,0.115911804,0.001877132],"about_ca_topic_score_codex":0.015266002,"about_ca_topic_score_gemma":0.0021747448,"teacher_disagreement_score":0.5532695,"about_ca_system_score_codex":0.0019116639,"about_ca_system_score_gemma":0.0022406732,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2793577335","doi":"10.1158/1538-7445.sabcs17-p2-12-02","title":"Abstract P2-12-02: Is breast-conserving therapy effective in women with large ductal carcinoma in situ (DCIS) lesions? A population-based analysis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"NOSM University; Sudbury Regional Hospital; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; London Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; Health Sciences Centre; Thunder Bay Regional Health Sciences Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Ductal carcinoma; Cohort; Breast-conserving surgery; Population; Radiation therapy; Oncology; Breast cancer; Proportional hazards model; Internal medicine; Hazard ratio; Gynecology; Mastectomy; Cancer; Confidence interval","score_opus":0.025141563975367324,"score_gpt":0.3539586612541918,"score_spread":0.32881709727882447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793577335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974789,0.0010061939,0.000012092078,0.00068774016,0.000026942962,0.00047109317,0.00010725278,0.000008023948,0.00020177952],"genre_scores_gemma":[0.9985437,0.000119224176,0.000027368913,0.00023619777,0.00016389505,0.0007910198,0.00005765485,0.000027314192,0.00003363001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803984,0.0001887515,0.00018587659,0.0006001451,0.00032989163,0.000655473],"domain_scores_gemma":[0.99912095,0.00008052953,0.0000538709,0.00041019786,0.00023764327,0.000096836884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052303646,0.00019378983,0.00028160366,0.00041589036,0.00017687313,0.000033570755,0.00020242247,0.00010836212,0.00018468486],"category_scores_gemma":[0.00003114639,0.00016025864,0.00006287166,0.001012153,0.00015553093,0.00001081887,0.00009725739,0.0002056372,0.000007503174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027928131,0.00020980932,0.9581601,0.000022438599,0.00036787643,0.000026056616,0.0010405437,0.000079582154,0.03180188,0.0000023637306,0.00011859861,0.005377953],"study_design_scores_gemma":[0.0023809096,0.00025672498,0.9690038,0.000051919505,0.000016115231,0.0000025979969,0.00043471044,0.00003986013,0.027503215,0.000020527312,0.000119046934,0.00017057659],"about_ca_topic_score_codex":0.012169086,"about_ca_topic_score_gemma":0.043657336,"teacher_disagreement_score":0.03148825,"about_ca_system_score_codex":0.00051846093,"about_ca_system_score_gemma":0.00030408602,"threshold_uncertainty_score":0.99440897},"labels":[],"label_agreement":null},{"id":"W2793725623","doi":"10.1158/1538-7445.sabcs17-is-3","title":"Abstract IS-3: Breast Imaging in Resource Constrained Regions: Lessons from Uganda","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Hormonal therapy; Breast lumps; Health care; Family medicine; Internal medicine; Economic growth","score_opus":0.22426930752058163,"score_gpt":0.48614366043989515,"score_spread":0.2618743529193135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793725623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91901046,0.0028263165,0.00004258417,0.045494374,0.000111995374,0.00040277722,0.00016073904,0.000060725517,0.031890023],"genre_scores_gemma":[0.9958781,0.00020703854,0.00013777798,0.002058716,0.0009356286,0.000060751932,0.000020665508,0.000025760432,0.0006755567],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975734,0.000080421,0.00027625638,0.00051100703,0.0008353067,0.0007236408],"domain_scores_gemma":[0.99857205,0.00017639686,0.000048412916,0.0004819047,0.0004450516,0.0002761896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091160287,0.00014102839,0.0002584277,0.00026335294,0.00020981317,0.00007336633,0.0002699944,0.00009028837,0.0022753382],"category_scores_gemma":[0.00018975958,0.00012920973,0.00006547503,0.00068941136,0.00077327644,0.00015373644,0.00011389583,0.00070895953,0.0001822253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034028306,0.00019491586,0.2652917,0.00012995076,0.000115291004,0.0014338327,0.004695301,0.0000057374664,0.095833756,0.0013026213,0.3566131,0.27098095],"study_design_scores_gemma":[0.0049695442,0.00023071293,0.7752733,0.0045150197,0.00004105418,0.00026441246,0.008412103,0.0002620921,0.01796668,0.0033550959,0.18420804,0.0005019375],"about_ca_topic_score_codex":0.013942215,"about_ca_topic_score_gemma":0.0016926911,"teacher_disagreement_score":0.50998163,"about_ca_system_score_codex":0.00047316749,"about_ca_system_score_gemma":0.000804272,"threshold_uncertainty_score":0.9986367},"labels":[],"label_agreement":null},{"id":"W2793731594","doi":"10.1158/1538-7445.sabcs17-p4-10-09","title":"Abstract P4-10-09: Delay in diagnosis of breast cancer in Mexican young women: Report of the “Joven y Fuerte” prospective cohort pilot phase","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Breast cancer; Prospective cohort study; Cohort; Cancer; Stage (stratigraphy); Confidence interval; Pediatrics; Internal medicine; Gynecology","score_opus":0.11436429448548732,"score_gpt":0.4617266188589295,"score_spread":0.34736232437344217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793731594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125123,0.0008983445,0.0000013036529,0.001310554,0.00015332634,0.0012156176,0.00016110181,0.000010179716,0.00499832],"genre_scores_gemma":[0.99713457,0.0005328366,0.000012730781,0.00007565766,0.0002845558,0.0014508798,0.0000037558593,0.000025974236,0.000479036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671394,0.00011910591,0.0006583387,0.0004959232,0.0013052557,0.0007074419],"domain_scores_gemma":[0.9978346,0.000116093885,0.00021770944,0.00061387074,0.0010365933,0.00018110407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021853377,0.00016741958,0.00052369654,0.00028841663,0.00008354987,0.000014781732,0.00037092413,0.00009360942,0.0022337453],"category_scores_gemma":[0.00039311475,0.00012400399,0.00007764397,0.0016114968,0.0007630101,0.00015496138,0.0001608217,0.00061992265,0.000006234983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026592761,0.00043411602,0.9740694,0.0001435467,0.00009608417,0.0002508338,0.0018350193,0.000021319947,0.013456657,0.000028193155,0.0022153605,0.004790204],"study_design_scores_gemma":[0.0022528756,0.00072522403,0.961687,0.0012241129,0.00002066491,0.00007796872,0.00082800165,0.00002929057,0.0325166,0.00012991737,0.00039046837,0.00011785393],"about_ca_topic_score_codex":0.07870845,"about_ca_topic_score_gemma":0.02890488,"teacher_disagreement_score":0.049803566,"about_ca_system_score_codex":0.0019813948,"about_ca_system_score_gemma":0.0016673845,"threshold_uncertainty_score":0.9986783},"labels":[],"label_agreement":null},{"id":"W2793754166","doi":"10.1158/1538-7445.sabcs17-p5-07-06","title":"Abstract P5-07-06: Kaiso regulates miRNA-31 and miRNA-200 expression in triple negative breast cancer (TNBC) cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Metastasis; Cancer research; microRNA; Medicine; Oncology; Cancer; Population; Prostate cancer; Internal medicine; Biology; Gene; Genetics","score_opus":0.027494068030099447,"score_gpt":0.360238423179468,"score_spread":0.33274435514936856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793754166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900309,0.0057870494,0.00011815742,0.0010213823,0.0003340912,0.001098021,0.00027378116,0.000023403449,0.0013132086],"genre_scores_gemma":[0.9865437,0.0064457436,0.00021857285,0.00014046355,0.0009060187,0.00054874056,0.000047862202,0.00009565661,0.0050532282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99619013,0.00030384277,0.00038599674,0.0010994014,0.0008369934,0.001183606],"domain_scores_gemma":[0.99797535,0.00007083558,0.00010166654,0.0007163031,0.0007491916,0.00038662733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010312556,0.00032526097,0.00032450285,0.0003574912,0.00033156373,0.00013707299,0.0005812775,0.00046491186,0.001068781],"category_scores_gemma":[0.00014435047,0.0003093916,0.00009646565,0.00064865185,0.0007554147,0.000027993028,0.0005849232,0.0008215627,0.00010267216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092759036,0.00009084571,0.0002207526,0.00008562855,0.000058863036,0.000034930177,0.00028725425,0.000055008855,0.9676594,0.000012948131,0.025816867,0.0047498704],"study_design_scores_gemma":[0.0019537797,0.0002688926,0.0062837917,0.0003472423,0.000008175714,0.000014713398,0.00026968544,0.00010736042,0.97227377,0.00022053331,0.017895916,0.00035616945],"about_ca_topic_score_codex":0.0036874416,"about_ca_topic_score_gemma":0.002518013,"teacher_disagreement_score":0.007920951,"about_ca_system_score_codex":0.00037134206,"about_ca_system_score_gemma":0.0009889791,"threshold_uncertainty_score":0.9999358},"labels":[],"label_agreement":null},{"id":"W2793879924","doi":"10.1158/1538-7445.sabcs17-p3-12-04","title":"Abstract P3-12-04: Efficacy of extended adjuvant aromatase inhibitors in subgroups of women with early breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Breast cancer; Oncology; Anastrozole; Tamoxifen; Hazard ratio; Exemestane; Aminoglutethimide; Gynecology; Cancer; Aromatase; Confidence interval","score_opus":0.036412960105669766,"score_gpt":0.3754610829437527,"score_spread":0.33904812283808294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793879924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961284,0.0016836341,0.000008874661,0.0005824681,0.00011125345,0.0008462607,0.0002857971,0.000031906544,0.00032140687],"genre_scores_gemma":[0.99842113,0.00023310394,0.00014267018,0.00004795636,0.000489818,0.00041586353,0.000009874653,0.00007403664,0.00016556634],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99656725,0.00010328935,0.0005444458,0.00054188643,0.0011912298,0.0010519138],"domain_scores_gemma":[0.9977507,0.0001786634,0.00020764502,0.0007039514,0.00079250784,0.00036651638],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009063332,0.0002512821,0.00070064573,0.0005447982,0.00007134873,0.000013953975,0.0003152117,0.0001203785,0.0014959933],"category_scores_gemma":[0.00007411373,0.00019617996,0.000060846232,0.0011058154,0.0014098586,0.00022438739,0.000111309215,0.00061239727,0.000016777365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049909238,0.0014113615,0.15608585,0.0013260902,0.00048688368,0.00019472039,0.012499164,0.000077809076,0.49543992,0.00010257383,0.0005250627,0.28194135],"study_design_scores_gemma":[0.006357614,0.0012855962,0.8913106,0.0019658285,0.00002048402,0.000031247713,0.0011142418,0.00000769059,0.0965786,0.00013017569,0.0009905932,0.00020736172],"about_ca_topic_score_codex":0.008631103,"about_ca_topic_score_gemma":0.0019695035,"teacher_disagreement_score":0.7352247,"about_ca_system_score_codex":0.0013803721,"about_ca_system_score_gemma":0.0012870096,"threshold_uncertainty_score":0.99941677},"labels":[],"label_agreement":null},{"id":"W2793884481","doi":"10.1158/1538-7445.sabcs17-p6-13-04","title":"Abstract P6-13-04: IMPACt trial: MammaPrint and BluePrint molecular subtyping guide treatment decisions in breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Stage (stratigraphy); Confidence interval; Oncology; Chemotherapy; Subtyping; Clinical trial; Cancer","score_opus":0.06642430066225631,"score_gpt":0.44077151446741775,"score_spread":0.37434721380516145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793884481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184483,0.004702409,0.00003054788,0.001628451,0.00016830325,0.0007447194,0.00015888266,0.000015355068,0.0007065223],"genre_scores_gemma":[0.9894649,0.008635559,0.00009044276,0.00008483377,0.0005692868,0.00089380087,0.000021392887,0.000048132537,0.00019167409],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975948,0.0001358618,0.00033350015,0.00080099894,0.00036852036,0.00076636],"domain_scores_gemma":[0.9986466,0.00007633262,0.00006833753,0.0006167049,0.00035550518,0.0002365222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503847,0.0002977355,0.00032205836,0.00019798128,0.00022556414,0.00007107813,0.00026005294,0.00015551776,0.00025037772],"category_scores_gemma":[0.00009985679,0.00023675224,0.0001291674,0.00031410984,0.000419232,0.000009926853,0.00036297922,0.00019534171,0.000024038738],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023224944,0.0007588434,0.10860082,0.000039356186,0.001051539,0.00013774548,0.0009461527,0.00032115637,0.6639424,0.00009315934,0.0039299307,0.19695394],"study_design_scores_gemma":[0.023292035,0.00089064345,0.754511,0.00030676415,0.00005286439,0.000042350148,0.00031413356,0.000027837907,0.20984825,0.00034797358,0.009807408,0.0005587191],"about_ca_topic_score_codex":0.02074657,"about_ca_topic_score_gemma":0.011297844,"teacher_disagreement_score":0.6459102,"about_ca_system_score_codex":0.0008449578,"about_ca_system_score_gemma":0.0007084395,"threshold_uncertainty_score":0.98577434},"labels":[],"label_agreement":null},{"id":"W2793893733","doi":"10.1158/1538-7445.sabcs17-pd4-11","title":"Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Copy number analysis; PTEN; Targeted therapy; Context (archaeology); CDKN2A; Cancer; Copy-number variation; Internal medicine; Hazard ratio; Bioinformatics; Biology; PI3K/AKT/mTOR pathway; Genetics; Gene; Confidence interval","score_opus":0.06039617734441132,"score_gpt":0.4124373564085102,"score_spread":0.3520411790640989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793893733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453616,0.001236416,0.0007099801,0.00092886295,0.0001572883,0.0014593014,0.00089209265,0.000022965305,0.000056924924],"genre_scores_gemma":[0.99640846,0.00072009093,0.00048251974,0.00023757298,0.0005931914,0.0012821723,0.00015237744,0.000056654753,0.00006692907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980127,0.00007299881,0.00031059107,0.00070529006,0.000248414,0.00064999575],"domain_scores_gemma":[0.99798125,0.000111806316,0.00008868861,0.00036355233,0.0011617778,0.00029295284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031103866,0.00022186317,0.00022424586,0.00015286377,0.0005059797,0.00020152156,0.00023932582,0.00008811455,0.00006848224],"category_scores_gemma":[0.00026190034,0.00020630342,0.000074141935,0.00057918445,0.00020060808,0.000015057945,0.0001404948,0.000119597265,0.000006911231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057194027,0.00003948561,0.095028296,0.000030095109,0.0001284305,0.0000012608086,0.00040003768,0.00009285173,0.8926482,0.000034584835,0.0068497183,0.0041750665],"study_design_scores_gemma":[0.0005848717,0.00092155614,0.67635494,0.000064285814,0.000022744267,0.00000714175,0.0002825131,0.000017774244,0.30594763,0.00014699905,0.015328732,0.0003208244],"about_ca_topic_score_codex":0.0068490333,"about_ca_topic_score_gemma":0.010396671,"teacher_disagreement_score":0.5867006,"about_ca_system_score_codex":0.0003952237,"about_ca_system_score_gemma":0.00057353347,"threshold_uncertainty_score":0.99976444},"labels":[],"label_agreement":null},{"id":"W2793936413","doi":"10.1158/1538-7445.sabcs17-p4-15-05","title":"Abstract P4-15-05: The presence of one or multiple foci of microinvasion is not associated with an increased risk of local recurrence in women with ductal carcinoma in situ treated with breast conserving therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sudbury Regional Hospital; Institute for Clinical Evaluative Sciences; London Health Sciences Centre; Kingston General Hospital; University of Toronto; University Health Network; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Thunder Bay Regional Health Sciences Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Ductal carcinoma; Breast cancer; Proportional hazards model; Oncology; Internal medicine; Cohort; Population; Hazard ratio; Breast-conserving surgery; Cancer; Radiation therapy; Mastectomy; Confidence interval","score_opus":0.04607616101305225,"score_gpt":0.3179863112159911,"score_spread":0.27191015020293885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793936413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985123,0.00044549844,0.000007038615,0.00010922743,0.0000061554747,0.0005218051,0.00036016788,0.0000036226975,0.000034134722],"genre_scores_gemma":[0.99925786,0.00041312154,0.000058889305,0.000021695532,0.000026754307,0.00016295322,0.00002476904,0.000024353823,0.000009577146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815327,0.0003187609,0.00026097818,0.00042665564,0.00042286678,0.0004174716],"domain_scores_gemma":[0.9983085,0.00021592324,0.00022575863,0.00044639563,0.0007326946,0.000070760616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005803918,0.00018431811,0.00034268055,0.00011066522,0.00008249774,0.000008801999,0.00031215185,0.00009357999,0.000028460378],"category_scores_gemma":[0.00008764429,0.00010523519,0.000021434804,0.00064093876,0.0013956487,0.000016240185,0.00009722445,0.00021218257,2.3809885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03195795,0.00048944214,0.56602997,0.000054598975,0.00023664863,0.000012787219,0.0016283196,0.000024884066,0.3968696,4.2749554e-7,0.000024839299,0.0026705512],"study_design_scores_gemma":[0.0030374646,0.0018586579,0.55644315,0.0003275621,0.000009516187,0.000006603142,0.0010437802,0.000020327585,0.43716943,0.0000018479553,0.0000024588771,0.0000792085],"about_ca_topic_score_codex":0.04072411,"about_ca_topic_score_gemma":0.05790144,"teacher_disagreement_score":0.040299833,"about_ca_system_score_codex":0.0001674971,"about_ca_system_score_gemma":0.0007084416,"threshold_uncertainty_score":0.9656638},"labels":[],"label_agreement":null},{"id":"W2794016097","doi":"10.1158/1538-7445.sabcs17-pd6-05","title":"Abstract PD6-05: Distinct tumor microenvironments stratify triple negative breast cancer into immune subtypes","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Tumor microenvironment; CD8; Immune system; Stroma; Cytotoxic T cell; Tumor-infiltrating lymphocytes; Cancer research; Breast cancer; Tumor progression; Medicine; T cell; Immunohistochemistry; Pathology; Biology; Cancer; Immunology; Internal medicine","score_opus":0.04269010630005453,"score_gpt":0.3853015084727795,"score_spread":0.34261140217272495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794016097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812646,0.004316744,0.0000049447517,0.004095399,0.00058045913,0.0009231707,0.00026768498,0.00004583788,0.0016392746],"genre_scores_gemma":[0.9926913,0.0014726099,0.00007146609,0.00035298846,0.0011230997,0.00035683514,0.000030050529,0.00006149278,0.0038401987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972418,0.00011671707,0.00042325773,0.0005935413,0.00083556504,0.00078911067],"domain_scores_gemma":[0.9986039,0.00011600839,0.00012402993,0.0005597291,0.00034135737,0.0002550024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072961336,0.00026225386,0.00038820927,0.00020042674,0.00045029147,0.000081481834,0.0003376538,0.00011199591,0.011220904],"category_scores_gemma":[0.000063293875,0.00021339118,0.0001485984,0.00060920924,0.0012872965,0.00017075348,0.00011973517,0.00062936265,0.0002362293],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011548075,0.00032815427,0.023284879,0.00025574135,0.0004979125,0.0000920617,0.0013723295,5.1889987e-7,0.8605143,0.00001075269,0.025244169,0.076851144],"study_design_scores_gemma":[0.0037930876,0.00049581967,0.74046516,0.000505649,0.000042139094,0.000041164545,0.00056607585,0.00001243135,0.23027776,0.00010719806,0.02342472,0.00026881823],"about_ca_topic_score_codex":0.023290126,"about_ca_topic_score_gemma":0.0031851714,"teacher_disagreement_score":0.71718025,"about_ca_system_score_codex":0.0011964502,"about_ca_system_score_gemma":0.0008397911,"threshold_uncertainty_score":0.989683},"labels":[],"label_agreement":null},{"id":"W2794019020","doi":"10.1158/0008-5472.can-17-3677","title":"Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Prostate Cancer Canada; Cancer Research UK; Government of Canada","keywords":"Prostate cancer; Cancer; Prostate; Medicine; Biology; Internal medicine","score_opus":0.07030192512802515,"score_gpt":0.4178915228822316,"score_spread":0.34758959775420645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794019020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476934,0.011084989,0.000003028444,0.002019303,0.000092462855,0.0015901593,0.000037564805,0.000034062217,0.00036909975],"genre_scores_gemma":[0.9894316,0.0025080603,0.00026967115,0.00004881546,0.000276204,0.0017426832,0.000018736964,0.000044136163,0.005660101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737626,0.00014235408,0.00032086362,0.00046721302,0.00094725087,0.00074606173],"domain_scores_gemma":[0.9983319,0.00007895479,0.00008810868,0.0002978691,0.0008931043,0.0003100655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039537295,0.00018605919,0.0003630675,0.0003201302,0.0002479175,0.000035628607,0.00017132619,0.000043455715,0.00055216864],"category_scores_gemma":[0.00012317396,0.00013465504,0.000036319005,0.0005844042,0.00096397277,0.00010256969,0.0002550764,0.00034549,0.000023661913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033352764,0.00029977062,0.052685246,0.002494197,0.00031291612,0.00038531632,0.003354094,0.000001422809,0.7671202,0.00005912065,0.0021208576,0.1678316],"study_design_scores_gemma":[0.0025997306,0.00071298145,0.020256162,0.0014569586,0.000017375929,0.000019167168,0.0001895582,0.000033333567,0.96214604,0.00008770763,0.012345648,0.00013533261],"about_ca_topic_score_codex":0.00056201336,"about_ca_topic_score_gemma":0.00025050354,"teacher_disagreement_score":0.19502588,"about_ca_system_score_codex":0.00028141955,"about_ca_system_score_gemma":0.001245578,"threshold_uncertainty_score":0.60458595},"labels":[],"label_agreement":null},{"id":"W2794031477","doi":"10.1158/1538-7445.sabcs17-p3-08-12","title":"Abstract P3-08-12: Prognostic relevance of neutrophil-to-lymphocyte ratio (NLR) in young women with breast cancer (BC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Breast cancer; Prospective cohort study; Pregnancy; Oncology; Clinical significance; Survival analysis; Stage (stratigraphy); Hazard ratio; Cancer; Gynecology; Confidence interval","score_opus":0.04578594428916057,"score_gpt":0.3799066116589658,"score_spread":0.3341206673698052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794031477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942145,0.00071251096,0.000015116156,0.0016072039,0.00022649048,0.001232107,0.00014493494,0.00003384277,0.0018133391],"genre_scores_gemma":[0.9954677,0.0012795439,0.00006524196,0.00013948871,0.00079768297,0.0009626671,0.000005922309,0.00006902629,0.0012126773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996892,0.0000646225,0.00040604948,0.00060699123,0.0010197236,0.0010106219],"domain_scores_gemma":[0.99795455,0.00013069516,0.000100977195,0.0005623433,0.00082870043,0.00042276047],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005924044,0.00023080267,0.0004889463,0.00043283147,0.00012236115,0.000042743246,0.0002745706,0.00010930459,0.0014737023],"category_scores_gemma":[0.00011165576,0.0001808037,0.00004342356,0.0012369863,0.00053845457,0.000166675,0.00010081844,0.0005604765,0.0000733422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021599187,0.0004718929,0.7849102,0.0011355431,0.0002135787,0.00020270653,0.008070987,0.0004355309,0.10761523,0.00008048042,0.004453155,0.07081152],"study_design_scores_gemma":[0.0030156255,0.0012343506,0.9789486,0.0012208426,0.000020554195,0.000030915893,0.00048629203,0.00009610243,0.010292141,0.000032057178,0.0043813894,0.00024112259],"about_ca_topic_score_codex":0.037101965,"about_ca_topic_score_gemma":0.02442967,"teacher_disagreement_score":0.19403842,"about_ca_system_score_codex":0.002068225,"about_ca_system_score_gemma":0.0021937932,"threshold_uncertainty_score":0.99943906},"labels":[],"label_agreement":null},{"id":"W2794108628","doi":"10.1158/1538-7445.sabcs17-ot3-05-03","title":"Abstract OT3-05-03: POLARIS: Palbociclib (P) in hormone receptor-positive (HR+) advanced breast cancer: A prospective multicenter noninterventional study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Tolerability; Oncology; Population; Palbociclib; Cancer; Clinical trial; Metastatic breast cancer; Gynecology; Adverse effect","score_opus":0.03918688413333515,"score_gpt":0.42678278171469725,"score_spread":0.3875958975813621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794108628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985454,0.0050070677,0.00003537925,0.0034769818,0.0004687288,0.0036916533,0.0005796696,0.00011093292,0.0011755407],"genre_scores_gemma":[0.99358815,0.00044651603,0.00030533248,0.00022275123,0.0012923564,0.0024779441,0.000030429619,0.00012492633,0.0015115865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951447,0.00027607023,0.0006636622,0.0011746653,0.0014502193,0.0012906347],"domain_scores_gemma":[0.99673474,0.00015844437,0.00019106473,0.0006323466,0.0018912628,0.00039212353],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010360575,0.00042945644,0.0006769784,0.0005701129,0.00034772273,0.00008206369,0.00042665107,0.00017097195,0.00275381],"category_scores_gemma":[0.0001240644,0.00038961763,0.00018323793,0.001305244,0.00087338674,0.00056550174,0.0002680137,0.001492909,0.00028496273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045726188,0.0057747466,0.6158477,0.0002850836,0.0013774034,0.00034243774,0.014912729,0.00003552816,0.15697381,0.00013216987,0.0023848428,0.15620732],"study_design_scores_gemma":[0.014742723,0.002095862,0.9620239,0.0013938653,0.00004793368,0.000037476093,0.005426253,0.000030365507,0.011185809,0.00015621749,0.0024405366,0.00041901562],"about_ca_topic_score_codex":0.004196627,"about_ca_topic_score_gemma":0.004200084,"teacher_disagreement_score":0.3461762,"about_ca_system_score_codex":0.003255925,"about_ca_system_score_gemma":0.0008144802,"threshold_uncertainty_score":0.9998556},"labels":[],"label_agreement":null},{"id":"W2794210822","doi":"10.1158/0008-5472.can-17-2215","title":"RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Glycolysis; Phosphofructokinase; Anaerobic glycolysis; Kinase; Phosphorylation; Biology; Cancer cell; Melanoma; Biochemistry; Cell biology; Cancer research; Chemistry; Metabolism; Cancer; Genetics","score_opus":0.04771806656824178,"score_gpt":0.3858673780776538,"score_spread":0.338149311509412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794210822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990772,0.0058679325,0.000042359876,0.00067118404,0.0006307966,0.0004579585,0.000020885356,0.0000134006505,0.0015234756],"genre_scores_gemma":[0.9896425,0.0016290621,0.00021482469,0.00013752119,0.003859644,0.00025339192,0.000007110871,0.000038078328,0.0042178947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980476,0.00016087503,0.00015799861,0.00059113675,0.0003418102,0.0007005685],"domain_scores_gemma":[0.9988854,0.000012831131,0.000031519226,0.00057781953,0.0002857755,0.00020668811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089928135,0.00014981168,0.0002222695,0.00020617315,0.00014144083,0.000049312905,0.0003667449,0.00014598136,0.00011243788],"category_scores_gemma":[0.00019470177,0.00014421776,0.000062034545,0.0005640505,0.0001946814,0.0000095914265,0.00033900407,0.0002504042,0.000058579117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026628494,0.000036825822,0.00070803304,0.000016890508,0.000027544716,0.0000014666057,0.00021901913,0.000007974731,0.9245463,0.000062096966,0.005491668,0.06861589],"study_design_scores_gemma":[0.00030847694,0.00012136635,0.012098518,0.000024690886,0.0000039041274,0.0000024406522,0.00002055648,0.0000105926,0.5790624,0.00006829054,0.40816206,0.000116701194],"about_ca_topic_score_codex":0.0011977904,"about_ca_topic_score_gemma":0.0029785736,"teacher_disagreement_score":0.40267038,"about_ca_system_score_codex":0.00006394536,"about_ca_system_score_gemma":0.0003384357,"threshold_uncertainty_score":0.58810294},"labels":[],"label_agreement":null},{"id":"W2794244422","doi":"10.1158/1538-7445.sabcs17-p2-11-01","title":"Abstract P2-11-01: Effects of radiotherapy on breast cancer outcomes among stage I, low-Recurrence risk, hormone-Sensitive breast cancer: Pooled analysis of individual data from phase III trials","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Hazard ratio; Oncology; Hormonal therapy; Internal medicine; Proportional hazards model; Clinical endpoint; Confidence interval; Cancer; Hormone therapy; Meta-analysis; Breast-conserving surgery; Randomized controlled trial; Gynecology; Mastectomy","score_opus":0.06795679256107624,"score_gpt":0.43526529340670456,"score_spread":0.3673085008456283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794244422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.906543,0.006345652,0.00006768026,0.00031647892,0.00028889978,0.0008315611,0.08556636,0.000013873826,0.00002646997],"genre_scores_gemma":[0.9848285,0.012567179,0.000037294296,0.00008285863,0.00076860655,0.00035912718,0.0012308356,0.00005510755,0.000070547896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952809,0.00082811416,0.0007974572,0.0012336171,0.0011351476,0.0007247607],"domain_scores_gemma":[0.99570423,0.0008430998,0.00078839215,0.0015374026,0.0008960702,0.0002307827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017493828,0.00046778022,0.0015184109,0.0004491394,0.00025487435,0.000057013203,0.0010854043,0.00024811085,0.00054844236],"category_scores_gemma":[0.00032867354,0.0003741606,0.00034748326,0.0010463111,0.0012729377,0.00003973689,0.00051247183,0.00036848578,0.0000031693457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017688386,0.0019981104,0.4450921,0.00023556531,0.053534962,0.000033524695,0.0021615862,0.00035800287,0.37654242,0.000009049849,0.011187676,0.09115861],"study_design_scores_gemma":[0.008093554,0.0003064667,0.8314203,0.0002626346,0.0020695545,6.02894e-7,0.00026012253,0.00009923334,0.15696062,0.0000039505285,0.00019000345,0.00033293566],"about_ca_topic_score_codex":0.08306072,"about_ca_topic_score_gemma":0.02273174,"teacher_disagreement_score":0.38632822,"about_ca_system_score_codex":0.00028441977,"about_ca_system_score_gemma":0.0007177439,"threshold_uncertainty_score":0.999871},"labels":[],"label_agreement":null},{"id":"W2794287998","doi":"10.1158/1538-7445.sabcs17-p4-11-01","title":"Abstract P4-11-01: Effects of high anxiety scores on surgical and overall treatment plan in breast cancer patients treated with neoadjuvant therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wilfrid Laurier University; University of British Columbia; University of Waterloo; BC Cancer Agency","funders":"","keywords":"Medicine; Anxiety; Breast cancer; Psychosocial; Cancer; Referral; BRCA mutation; Mastectomy; Neoadjuvant therapy; Internal medicine; Surgery; Family medicine; Psychiatry","score_opus":0.07412685281509299,"score_gpt":0.39060195683837956,"score_spread":0.3164751040232866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794287998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967247,0.0015042231,1.2869276e-7,0.00048280097,0.0000503701,0.00083986996,0.00009419935,0.000016489286,0.0002871987],"genre_scores_gemma":[0.9940886,0.0052231536,0.000008797166,0.0000875312,0.0002318633,0.00020869123,0.000021730088,0.000024226387,0.000105396495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979925,0.00008715974,0.0002107404,0.0004474735,0.0007468689,0.00051526475],"domain_scores_gemma":[0.9990188,0.00014337638,0.00006133377,0.0002586095,0.00029989146,0.00021798712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020462951,0.00020264515,0.0004090816,0.00018121183,0.00008860512,0.000023716077,0.000099516314,0.00009949897,0.00024013597],"category_scores_gemma":[0.000013914836,0.00012537737,0.000042122687,0.0003394322,0.00033294762,0.000087301,0.000029601324,0.00023270595,0.0000045454894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011523673,0.0003960249,0.9458919,0.000095507035,0.00008957579,0.00016615646,0.00035736256,0.000012324361,0.00311763,0.000035868034,0.00056908425,0.037744906],"study_design_scores_gemma":[0.009406251,0.0041473997,0.9545526,0.0014290198,0.000016403972,0.000014432647,0.000025622814,0.000013171898,0.029438702,0.000012477323,0.0008199452,0.00012400685],"about_ca_topic_score_codex":0.070267506,"about_ca_topic_score_gemma":0.0043538217,"teacher_disagreement_score":0.065913685,"about_ca_system_score_codex":0.0006151428,"about_ca_system_score_gemma":0.0003208164,"threshold_uncertainty_score":0.93592364},"labels":[],"label_agreement":null},{"id":"W2794342932","doi":"10.1158/1538-7445.sabcs17-pd3-12","title":"Abstract PD3-12: <i>PIK3CA</i> alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+ breast cancer: Correlative analyses of the phase III ExteNET trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Neratinib; Medicine; Trastuzumab; Breast cancer; Oncology; Internal medicine; Clinical endpoint; Placebo; Population; Cancer; Randomized controlled trial; Pathology","score_opus":0.09401084786466163,"score_gpt":0.4463718082474957,"score_spread":0.3523609603828341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794342932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221057,0.0032485179,0.00012676627,0.0014017787,0.0001544727,0.0020381613,0.0005887647,0.000023305733,0.00020767],"genre_scores_gemma":[0.9961899,0.0007632466,0.00011507071,0.00033225227,0.00058264786,0.0013315191,0.000015488546,0.00006019349,0.00060969044],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972838,0.00015235471,0.000501354,0.0005783929,0.00088728045,0.0005968039],"domain_scores_gemma":[0.9980415,0.00023906541,0.0001977135,0.0005989011,0.0007208684,0.00020193688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046561292,0.00030134874,0.0005900761,0.00027700816,0.00025626906,0.000059948714,0.00023043183,0.00010932637,0.0011031972],"category_scores_gemma":[0.00002580715,0.00018771131,0.00009992154,0.0008598555,0.0013121538,0.0002486539,0.000051780666,0.0006788119,0.0000026386708],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59339654,0.0023810435,0.09149704,0.00025002446,0.00093109545,0.00011352913,0.011167898,0.0021125306,0.13156705,0.000116860836,0.00031274685,0.16615361],"study_design_scores_gemma":[0.2425966,0.007292726,0.6149693,0.0021912586,0.00015328643,0.000031057047,0.0011005885,0.0011033945,0.126846,0.00019561099,0.0028641662,0.0006560261],"about_ca_topic_score_codex":0.0095669525,"about_ca_topic_score_gemma":0.009696918,"teacher_disagreement_score":0.52347225,"about_ca_system_score_codex":0.00039632656,"about_ca_system_score_gemma":0.0011353584,"threshold_uncertainty_score":0.9998099},"labels":[],"label_agreement":null},{"id":"W2794357716","doi":"10.1158/1538-7445.sabcs17-ms1-1","title":"Abstract MS1-1: Targeting DNA repair deficiency in triple negative breast cancers (TNBC) with G-quadruplex stabilisers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genome instability; Breast cancer; DNA repair; Triple-negative breast cancer; Cancer research; Homologous recombination; Olaparib; Cancer; DNA damage; DNA; Medicine; Synthetic lethality; Biology; Poly ADP ribose polymerase; Genetics; Internal medicine; Polymerase","score_opus":0.024349129029687902,"score_gpt":0.33528801883336906,"score_spread":0.3109388898036812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794357716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890602,0.000687087,0.000009283093,0.00019516557,0.000089515255,0.00028256324,0.000063831634,0.000025769128,0.009586551],"genre_scores_gemma":[0.99800783,0.00022969657,0.00019596281,0.00007102005,0.00046596446,0.0001275858,0.00003524358,0.000040070438,0.0008266085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978321,0.00007483083,0.00023898725,0.00066192594,0.00043812295,0.00075403636],"domain_scores_gemma":[0.998875,0.000034002835,0.00006868024,0.00043641252,0.00040900148,0.00017688223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068684615,0.00018558529,0.00017449337,0.00008256914,0.00020956222,0.000036388778,0.00036733702,0.00015671446,0.0004328704],"category_scores_gemma":[0.00015885146,0.00016080044,0.00006534907,0.0004903821,0.0007410005,0.000013292583,0.00015053409,0.0003572165,0.000017535214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008755359,0.00007198248,0.009066098,0.00009177883,0.000036681267,0.000023571705,0.0004536077,0.0000583861,0.9712031,0.000008419384,0.016916752,0.0011941092],"study_design_scores_gemma":[0.0015162893,0.00043188527,0.016077306,0.00013212666,0.000007782285,0.000012423983,0.002814488,0.00007428256,0.9674071,0.000042119853,0.011084713,0.00039950066],"about_ca_topic_score_codex":0.0020037345,"about_ca_topic_score_gemma":0.0023067852,"teacher_disagreement_score":0.008947615,"about_ca_system_score_codex":0.0003222398,"about_ca_system_score_gemma":0.00092546095,"threshold_uncertainty_score":0.6557251},"labels":[],"label_agreement":null},{"id":"W2794392673","doi":"10.1158/0008-5472.can-17-2926","title":"2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Endoplasmic reticulum; Downregulation and upregulation; Autophagy; Mutant; IDH1; Cell biology; Biosynthesis; Phospholipid; Chemistry; Biology; Biochemistry; Enzyme; Gene; Apoptosis","score_opus":0.04535303779201242,"score_gpt":0.39577592531780903,"score_spread":0.3504228875257966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794392673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997246,0.0003531146,0.0000055813825,0.00079385977,0.00014337129,0.00077491725,0.000066097826,0.000022092856,0.0005949376],"genre_scores_gemma":[0.9992267,0.00009375762,0.000035103087,0.00012586002,0.00021084647,0.00008843273,0.000009044367,0.00003036474,0.00017992716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976875,0.00029047663,0.00040938144,0.00034090143,0.00081608817,0.00045562797],"domain_scores_gemma":[0.9984041,0.00015909651,0.00009632303,0.0006566997,0.00048066082,0.00020311773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082179456,0.00014138584,0.00034603683,0.00042630942,0.00008419018,0.000009920517,0.00032863414,0.0001289133,0.0007050894],"category_scores_gemma":[0.00032490998,0.000100462545,0.00008314646,0.001816989,0.00065324607,0.000084364525,0.00009510362,0.00024712275,0.000041371975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012191241,0.00024704574,0.0078893015,0.00007960749,0.00004428198,0.00001533006,0.0013506429,0.000041388612,0.98666734,0.00029853368,0.00014279372,0.002004591],"study_design_scores_gemma":[0.0010580114,0.0006158975,0.12055676,0.00026409136,0.000019423538,0.0000040997675,0.00014418694,0.0007692876,0.87584955,0.00015921258,0.00047601512,0.00008348635],"about_ca_topic_score_codex":0.0009310765,"about_ca_topic_score_gemma":0.00031507193,"teacher_disagreement_score":0.11266745,"about_ca_system_score_codex":0.00020187936,"about_ca_system_score_gemma":0.0006568986,"threshold_uncertainty_score":0.7720235},"labels":[],"label_agreement":null},{"id":"W2796398617","doi":"","title":"Growth inhibition of synovial sarcoma cells by curcumin","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Silk-based biomaterials and applications","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Curcumin; Doxorubicin; Cancer research; Synovial sarcoma; Cell culture; Flow cytometry; Apoptosis; Wnt signaling pathway; Annexin; Cell growth; Cytotoxicity; Molecular biology; Chemistry; Biology; Sarcoma; Pharmacology; Medicine; Pathology; Cell biology; Internal medicine; Signal transduction; Biochemistry; Chemotherapy; In vitro","score_opus":0.044942431918966824,"score_gpt":0.36504740186191065,"score_spread":0.3201049699429438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796398617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996826,0.0002791792,0.00017068355,0.001502762,0.000108889195,0.00026765544,0.00036236402,0.000033641852,0.00044883488],"genre_scores_gemma":[0.99861884,0.0000712724,0.00035800747,0.00006966731,0.0003563927,0.00019646173,0.000019845545,0.000014322597,0.0002951758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998557,0.000119331846,0.00023594286,0.00026972182,0.0004681786,0.00034985587],"domain_scores_gemma":[0.9992881,0.000080177844,0.00005999937,0.0002361821,0.00024226296,0.00009332349],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073940016,0.00008036387,0.0001323094,0.000084789564,0.00014629796,0.000060978433,0.0002350778,0.000064116735,0.002328696],"category_scores_gemma":[0.000026828297,0.00007077422,0.00003080951,0.00030621458,0.0002881241,0.00012630291,0.00008817659,0.0000797514,0.00041275952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036885296,0.00009572703,0.00003721878,0.000037947866,0.0000017189539,6.1389636e-7,0.00006548975,0.000003512831,0.9585778,0.00071567105,0.03940336,0.0010240212],"study_design_scores_gemma":[0.0002660602,0.000052903648,0.000083211504,0.00003335701,0.0000026200905,6.557974e-7,0.000030021185,0.000012462705,0.98478985,0.00029995595,0.01435058,0.000078306184],"about_ca_topic_score_codex":0.0010014417,"about_ca_topic_score_gemma":0.000035956073,"teacher_disagreement_score":0.026212033,"about_ca_system_score_codex":0.000120831966,"about_ca_system_score_gemma":0.0001320857,"threshold_uncertainty_score":0.9985833},"labels":[],"label_agreement":null},{"id":"W2797428908","doi":"10.1158/0008-5472.can-18-1976","title":"ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Breast cancer; Genome-wide association study; Estrogen receptor; FOXA1; Computational biology; Computer science; Biology; Bioinformatics; Oncology; Cancer; Medicine; Genotype; Genetics; Single-nucleotide polymorphism; Gene","score_opus":0.04527363588759568,"score_gpt":0.3747989320578658,"score_spread":0.3295252961702701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797428908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250484,0.0030634592,0.0032999197,0.00017103618,0.0002068407,0.00051280414,0.000024445268,0.0000033879135,0.00021328164],"genre_scores_gemma":[0.9920575,0.00054933736,0.004905326,0.00006349241,0.00041636586,0.00010581903,0.00005458715,0.000019583555,0.0018279981],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99890494,0.000057870537,0.00018534191,0.00022503645,0.00019521962,0.0004315967],"domain_scores_gemma":[0.9994635,0.000038605773,0.000058220325,0.00019741715,0.00019061961,0.00005164055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071498763,0.000076631855,0.00010815425,0.00009794768,0.00008269455,0.000032337663,0.0001602504,0.00017529057,0.000040151474],"category_scores_gemma":[0.00004960749,0.00007946426,0.000053006173,0.00024210966,0.000024482899,0.0000052309474,0.00010808523,0.00017668841,0.000010281415],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031557208,0.000099150464,0.37738234,0.0002450816,0.00021363326,0.000002545184,0.00040186202,0.031432796,0.5351865,0.00014577461,0.01706535,0.03750936],"study_design_scores_gemma":[0.009083475,0.0013290436,0.15678175,0.000713391,0.00007977652,0.000015896285,0.001174249,0.56527966,0.044865165,0.0055825347,0.21315074,0.0019443104],"about_ca_topic_score_codex":0.00011748541,"about_ca_topic_score_gemma":0.00007372632,"teacher_disagreement_score":0.53384686,"about_ca_system_score_codex":0.00030327184,"about_ca_system_score_gemma":0.0002495398,"threshold_uncertainty_score":0.32404587},"labels":[],"label_agreement":null},{"id":"W2798116182","doi":"10.1158/0008-5472.can-17-1383","title":"CrosstalkNet: A Visualization Tool for Differential Co-expression Networks and Communities","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Government of Canada; Stand Up To Cancer Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"DECIPHER; Visualization; Biological network; Laser capture microdissection; Computer science; Stromal cell; Bipartite graph; Complex network; Computational biology; Scale (ratio); Biology; Data mining; Bioinformatics; Gene expression; Theoretical computer science; Gene; Genetics; Cancer research; World Wide Web; Physics","score_opus":0.0437639864106198,"score_gpt":0.3989783666803139,"score_spread":0.3552143802696941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798116182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91135263,0.0007580769,0.08697051,0.000042796968,0.00014173161,0.00036945316,0.00004436969,0.000007130649,0.00031329042],"genre_scores_gemma":[0.99725527,0.0005720375,0.00016448362,0.00010109653,0.0009321498,0.0001284396,0.00024544416,0.00001754676,0.00058355264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992923,0.00006129096,0.00012810265,0.00012393681,0.00010937414,0.00028497473],"domain_scores_gemma":[0.9994601,0.000029123225,0.000033083707,0.00020914827,0.00021600237,0.00005254284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032375957,0.00007942848,0.0000818467,0.00003490263,0.00041056634,0.00010151526,0.0001385405,0.00013143057,0.000059443835],"category_scores_gemma":[0.000015225317,0.00006975931,0.0000262023,0.0000516599,0.0003482935,0.0000048800653,0.00016258194,0.000099482546,0.0000017314638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018414832,0.00010862581,0.0051220856,0.0002555882,0.00013585831,4.888441e-7,0.001912129,0.0003231439,0.8142651,0.003062229,0.12877947,0.044193815],"study_design_scores_gemma":[0.0046631354,0.0028059392,0.0043103998,0.00031165167,0.000030942858,0.000010148602,0.0015318647,0.08385973,0.46886197,0.0020689412,0.43065825,0.000887017],"about_ca_topic_score_codex":0.000040754847,"about_ca_topic_score_gemma":0.00010009658,"teacher_disagreement_score":0.3454031,"about_ca_system_score_codex":0.000014715598,"about_ca_system_score_gemma":0.000052074272,"threshold_uncertainty_score":0.31577858},"labels":[],"label_agreement":null},{"id":"W2801494164","doi":"10.1158/0008-5472.can-17-3014","title":"miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2–Versican Pathway","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; York University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; American University in Cairo; Government of Canada; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Versican; Ovarian cancer; Metastasis; Cancer research; Medicine; Cancer; Internal medicine; Anatomy; Proteoglycan","score_opus":0.06337049475879815,"score_gpt":0.3576765748006361,"score_spread":0.29430608004183795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801494164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994005,0.0011020984,0.0019876368,0.0014916327,0.00017755381,0.00043064225,0.00026313562,0.000019347308,0.00052293245],"genre_scores_gemma":[0.998031,0.0002079486,0.00046921542,0.00010585027,0.0004614599,0.00015760344,0.000053872387,0.00003144712,0.00048156807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984503,0.00010837818,0.00014775307,0.0005100972,0.00035522564,0.00042828827],"domain_scores_gemma":[0.99905753,0.000014586413,0.000040604897,0.00030133236,0.0004162706,0.00016965863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035936892,0.00014643792,0.00013711554,0.00010742857,0.0002347955,0.00005731733,0.00020636755,0.00013264088,0.00025122604],"category_scores_gemma":[0.0000610113,0.00013612014,0.000053777658,0.00028011895,0.0004975707,0.000014410282,0.000109910674,0.0001674134,0.000008383266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015972489,0.00004566678,0.001726724,0.000047876714,0.00009342017,9.669322e-7,0.00017561139,0.0000012388879,0.9906145,0.00022162904,0.0010479628,0.0058647343],"study_design_scores_gemma":[0.0008030183,0.0003296005,0.011430597,0.000028903396,0.000017682496,0.0000044414896,0.000054072156,0.000070727685,0.9474613,0.00013022007,0.03948087,0.00018853661],"about_ca_topic_score_codex":0.0020057138,"about_ca_topic_score_gemma":0.0013643435,"teacher_disagreement_score":0.04315311,"about_ca_system_score_codex":0.000069032816,"about_ca_system_score_gemma":0.0002546225,"threshold_uncertainty_score":0.55508184},"labels":[],"label_agreement":null},{"id":"W2802060268","doi":"10.1158/0008-5472.can-17-2900","title":"HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of Environmental Health Sciences; National Cancer Institute; Cancer Council Victoria; National Human Genome Research Institute; Cancer Council NSW; Medical Research Council; Institut National Du Cancer; Centers for Disease Control and Prevention; National Institutes of Health; Cancer Research UK; Blood Cancer UK; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Cancerfonden; Bundesamt für Strahlenschutz; Leukemia and Lymphoma Research; National Health and Medical Research Council; U.S. Public Health Service; Regione Autonoma della Sardegna; Associazione Italiana per la Ricerca sul Cancro; University of Utah; Fondation de France; Generalitat de Catalunya; Canadian Institutes of Health Research; Bundesministerium für Bildung und Forschung; Leukaemia and Lymphoma Research; Ministerstvo Školství, Mládeže a Tělovýchovy; World Health Organization; University of Southern California; University of Sydney; Stockholms Läns Landsting; Utah Department of Health; Leukemia and Lymphoma Society; Health Research Board; José Carreras Leukämie-Stiftung; U.S. Department of Health and Human Services; Mayo Clinic; University of California, San Francisco; Frederick National Laboratory for Cancer Research; Yale University; Karolinska Institutet; Utah State University; Huntsman Cancer Institute; European Commission; Compagnia di San Paolo; U.S. Department of Veterans Affairs; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center","keywords":"Human leukocyte antigen; Lymphoma; Hodgkin lymphoma; Immunology; Biology; Genetics; Medicine; Antigen","score_opus":0.05160377625414884,"score_gpt":0.3517192042981436,"score_spread":0.3001154280439947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802060268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939711,0.00185205,0.00006987432,0.0016938671,0.0012609259,0.00023629522,0.000011854768,0.000012455957,0.00089158246],"genre_scores_gemma":[0.9944571,0.00027346902,0.0000029092812,0.00033735848,0.000054138356,0.000027372327,0.000009010534,0.000004216257,0.004834386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908,0.0002933457,0.00011963364,0.00019764926,0.000047196016,0.00026217976],"domain_scores_gemma":[0.99918413,0.00015906371,0.000037468933,0.00021000922,0.00039233535,0.000017002689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070566754,0.00006967014,0.00013486651,0.00010099751,0.00094936707,0.000011240274,0.00022025037,0.00012025275,0.0006247379],"category_scores_gemma":[0.00014987796,0.000046977468,0.000035498757,0.00019833546,0.00060513883,0.000044972992,0.0006629937,0.00017496194,0.00024429173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011099235,0.000067794645,0.019448118,0.000011558303,0.0001397243,4.851958e-7,0.0007957797,0.0000021227336,0.87114346,0.00023351847,0.09856902,0.00847851],"study_design_scores_gemma":[0.0006165923,0.0006406125,0.1005636,0.000022300297,0.000009944742,0.0000043645323,0.00033765892,0.0000076480965,0.5853145,0.000042214226,0.31238428,0.00005627888],"about_ca_topic_score_codex":0.001292735,"about_ca_topic_score_gemma":0.0004593942,"teacher_disagreement_score":0.28582895,"about_ca_system_score_codex":0.0000865923,"about_ca_system_score_gemma":0.0000549399,"threshold_uncertainty_score":0.730186},"labels":[],"label_agreement":null},{"id":"W2802605863","doi":"","title":"A new approach for the quantification of mitochondrial DNA damage and repair in prostate cancer cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"LNCaP; Mitochondrial DNA; DNA damage; DNA supercoil; Prostate cancer; DNA; Molecular biology; Biology; DNA repair; Cancer cell; Chemistry; Cancer; Biochemistry; Gene; Genetics","score_opus":0.05207738766480216,"score_gpt":0.40692937787295463,"score_spread":0.3548519902081525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802605863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8130145,0.0048301043,0.17661192,0.0015787149,0.00009514214,0.0033347234,0.00018103575,0.00001902263,0.00033484367],"genre_scores_gemma":[0.9664018,0.003985604,0.023745028,0.00015686738,0.0004122767,0.0020132798,0.000118860255,0.000033530152,0.0031327396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992159,0.000044615295,0.00015070799,0.0002855113,0.00009063736,0.00021260443],"domain_scores_gemma":[0.99944234,0.00004026895,0.00004166369,0.0003104749,0.000122038,0.00004324099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071589585,0.00006054977,0.000075112766,0.000049476646,0.000073083815,0.0000071802906,0.00016546743,0.000087872424,0.000007767667],"category_scores_gemma":[0.000036576912,0.000045963512,0.00003848132,0.00016846915,0.0001543264,0.0000017132396,0.00007233587,0.00010771486,2.55537e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019702634,0.000022707845,0.0003675571,0.00003316072,0.00001506701,1.6969238e-7,0.000049954262,0.00003054328,0.9829534,0.0004304923,0.011641714,0.004258149],"study_design_scores_gemma":[0.0003236684,0.00007007236,0.0011739677,0.000009708705,0.000006000689,5.1847553e-7,0.00007553838,0.00018037665,0.93439865,0.00010387518,0.06359888,0.000058757236],"about_ca_topic_score_codex":0.0008094882,"about_ca_topic_score_gemma":0.0004958883,"teacher_disagreement_score":0.15338732,"about_ca_system_score_codex":0.000018771454,"about_ca_system_score_gemma":0.00015355987,"threshold_uncertainty_score":0.18743376},"labels":[],"label_agreement":null},{"id":"W2803426430","doi":"","title":"Up-regulation of Hsp27 in prostate cancer cell lines induces resistance to various chemotherapeutics through Bax interaction","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hsp27; Apoptosis; LNCaP; Heat shock protein; Cancer research; Cancer cell; Biology; Transfection; Gene knockdown; Cell biology; Molecular biology; Cell culture; Cancer; Hsp70; Biochemistry","score_opus":0.08119250948418788,"score_gpt":0.4171389630057872,"score_spread":0.3359464535215993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803426430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932276,0.0034637428,0.0001283615,0.00087923463,0.00012809377,0.00084337883,0.000035468787,0.0000066542298,0.001287439],"genre_scores_gemma":[0.98468065,0.00612382,0.0004930552,0.00008744811,0.0002340754,0.00051903795,0.000022584358,0.000038335573,0.007800973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979531,0.00020834824,0.0003086933,0.0004532876,0.00057508925,0.00050149194],"domain_scores_gemma":[0.9987639,0.000034616463,0.00005741211,0.00041408333,0.0006342989,0.00009569394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051025645,0.0001372357,0.0001850164,0.00013416314,0.0001267337,0.000019471807,0.00030795584,0.00014426175,0.0001403039],"category_scores_gemma":[0.000112839865,0.00013462252,0.000043161053,0.0006075562,0.0001657837,0.000021943717,0.00017826664,0.00032586907,0.0000097909015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006990091,0.00008225924,0.0022027986,0.00013827733,0.000019922554,0.0000034498598,0.0014772047,0.00036063275,0.9903167,0.000012988825,0.0020434542,0.002643307],"study_design_scores_gemma":[0.0005239294,0.00017499567,0.0036506797,0.00010448877,0.0000018977166,0.0000017698096,0.00021318786,0.00002739279,0.95365417,0.000070600705,0.041443482,0.00013339132],"about_ca_topic_score_codex":0.0043373927,"about_ca_topic_score_gemma":0.006343754,"teacher_disagreement_score":0.039400026,"about_ca_system_score_codex":0.00030871353,"about_ca_system_score_gemma":0.0007385905,"threshold_uncertainty_score":0.6556869},"labels":[],"label_agreement":null},{"id":"W2803528938","doi":"10.1158/1538-7445.mousemodels17-a29","title":"Abstract A29: Generation of a novel transgenic mouse model with regulatable β-catenin expression to examine importance of activated β-catenin signaling to long-term maintenance of mammary tumor growth","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Cre recombinase; Biology; Genetically modified mouse; Transgene; Catenin; Mammary tumor; Chimera (genetics); Tumor initiation; Carcinogenesis; Cancer research; Cell biology; Genetics; Wnt signaling pathway; Gene; Signal transduction; Cancer","score_opus":0.0802555236614484,"score_gpt":0.3439358210122373,"score_spread":0.2636802973507889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803528938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97769225,0.00020777508,0.021374606,0.00012087641,0.000026360141,0.00047768487,0.0000608401,0.0000048808915,0.000034726483],"genre_scores_gemma":[0.9936738,0.00012540125,0.005076357,0.000020090258,0.00017642292,0.00007967278,0.000042268337,0.00003450162,0.0007714838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998383,0.00003225734,0.00035363907,0.0005413401,0.0003694183,0.0003203885],"domain_scores_gemma":[0.99812007,0.000006878903,0.00015462024,0.00042864442,0.0011717991,0.00011801625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046096454,0.0001427174,0.00022219862,0.0001330041,0.000067603585,0.000009921626,0.00028629552,0.00008862704,0.000014704384],"category_scores_gemma":[0.000054668046,0.00011635898,0.0000466056,0.00035415558,0.00017117904,0.000014126157,0.000109948014,0.00010752308,5.8805335e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012796272,0.0001406498,0.0012618563,0.00015211098,0.00003835032,6.246949e-7,0.00015068406,0.005277981,0.9912176,0.000019607756,0.00022923216,0.00023164663],"study_design_scores_gemma":[0.0005174937,0.0008740933,0.004711044,0.00016649885,0.000007957986,0.000002032485,0.000026431379,0.00036655806,0.9931733,0.000006325177,0.000010903094,0.0001373722],"about_ca_topic_score_codex":0.00014117567,"about_ca_topic_score_gemma":0.00013140084,"teacher_disagreement_score":0.016298248,"about_ca_system_score_codex":0.000041074672,"about_ca_system_score_gemma":0.00026787835,"threshold_uncertainty_score":0.47449812},"labels":[],"label_agreement":null},{"id":"W2803548693","doi":"","title":"Abstract #4284: Blockade of VEGFR2/KDR increases malignancy in human epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Cancer research; Cancer; Vascular endothelial growth factor; Ovarian cancer; Ovarian carcinoma; Receptor tyrosine kinase; Internal medicine; Receptor; VEGF receptors","score_opus":0.04856896836707687,"score_gpt":0.3785064158509066,"score_spread":0.32993744748382975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803548693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158007,0.0055677565,0.0000076098654,0.00023135757,0.00005042629,0.00021224614,0.00007040451,0.0000054156208,0.0022747065],"genre_scores_gemma":[0.9979884,0.0007107008,0.00004499036,0.000083373205,0.0005937641,0.000060481096,0.000038216996,0.000021069805,0.00045899372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984185,0.00009742166,0.00028694942,0.0003982616,0.00032374318,0.000475125],"domain_scores_gemma":[0.99920434,0.000018847059,0.00006397796,0.00041120313,0.00019004355,0.00011159745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005104955,0.00014035228,0.00020323845,0.00014372566,0.000098656266,0.000018733506,0.00035159956,0.00017226263,0.00030370968],"category_scores_gemma":[0.00005336082,0.00013385029,0.0001089573,0.0002554238,0.00015495472,0.0000052841847,0.00008937671,0.0001772577,0.0000062362997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015940724,0.00014401415,0.025621286,0.00003723969,0.000018410381,0.000018611536,0.000045889265,0.000030101673,0.9671745,0.00023004046,0.0011069722,0.0054135523],"study_design_scores_gemma":[0.0006697702,0.00029307732,0.2847975,0.00008029952,0.0000052770083,0.0000028416596,0.00005325393,0.0000028626096,0.7085578,0.00022440695,0.0051648645,0.00014805522],"about_ca_topic_score_codex":0.002865505,"about_ca_topic_score_gemma":0.00046389882,"teacher_disagreement_score":0.2591762,"about_ca_system_score_codex":0.00006817898,"about_ca_system_score_gemma":0.00032593048,"threshold_uncertainty_score":0.54582566},"labels":[],"label_agreement":null},{"id":"W2804495644","doi":"10.1158/0008-5472.can-18-0221","title":"Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced NMR Techniques and Applications","field":"Chemistry","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"West Park Healthcare Centre; CARE Canada","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Memorial Sloan-Kettering Cancer Center; Dana Foundation","keywords":"Human brain; Brain tumor; Medicine; Pathology","score_opus":0.034146525798816094,"score_gpt":0.3780790875817051,"score_spread":0.343932561782889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804495644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529266,0.00012426462,0.000036044974,0.002698346,0.000012288989,0.00038593684,0.000031082425,0.000047598565,0.0013717535],"genre_scores_gemma":[0.9981756,0.000020067286,0.00040509063,0.00007802461,0.000118383025,0.00039280296,0.000009828047,0.000032265518,0.0007678909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986158,0.000061728155,0.00022605805,0.00035308854,0.0003692692,0.0003740676],"domain_scores_gemma":[0.99889094,0.00005726891,0.00010997393,0.00048084592,0.00040878108,0.000052211748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037799374,0.0001185269,0.0001603777,0.00009690148,0.00028081553,0.000029376752,0.00036720978,0.000033122305,0.00011265412],"category_scores_gemma":[0.00016490907,0.00008444083,0.00003364135,0.0006865833,0.00065120746,0.00014976099,0.00012300913,0.00042343044,0.0000038233725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005051143,0.00009091402,0.059175838,0.000050077666,0.000011600383,6.941387e-7,0.00025512045,0.000015005381,0.9367548,0.00073222234,0.0003875529,0.002475617],"study_design_scores_gemma":[0.000642721,0.000023535244,0.017872363,0.00022285002,0.0000070016295,0.0000015404868,0.00016709903,0.000039830302,0.97318226,0.0039082556,0.0038086784,0.0001238628],"about_ca_topic_score_codex":0.00094151666,"about_ca_topic_score_gemma":0.00048084912,"teacher_disagreement_score":0.041303474,"about_ca_system_score_codex":0.00014817833,"about_ca_system_score_gemma":0.00018632706,"threshold_uncertainty_score":0.3443397},"labels":[],"label_agreement":null},{"id":"W2808796425","doi":"10.1158/0008-5472.can-18-0027","title":"CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Toronto; Calgary Laboratory Services; University of Manitoba; Ottawa Hospital; Children's Hospital Research Institute of Manitoba","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada","keywords":"Medulloblastoma; Vismodegib; Selumetinib; Sonic hedgehog; Cancer research; Smoothened; Progenitor cell; Biology; MEK inhibitor; Population; MAPK/ERK pathway; Medicine; Stem cell; Hedgehog signaling pathway; Signal transduction; Cell biology","score_opus":0.034729770139126225,"score_gpt":0.33415707932083216,"score_spread":0.29942730918170596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808796425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761474,0.0012947603,0.0000215664,0.00020898654,0.00009112352,0.00040011495,0.000033240456,0.000008404017,0.0003270789],"genre_scores_gemma":[0.99813074,0.00087714795,0.000031873322,0.00005086992,0.00027535675,0.00015535842,0.000008032287,0.00002009642,0.00045053734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986373,0.00016076415,0.0001077684,0.0004613616,0.00019429845,0.0004384718],"domain_scores_gemma":[0.999287,0.00013191545,0.00003233293,0.00023660636,0.00015378337,0.00015833159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040894336,0.00012304215,0.00014023716,0.00009543172,0.00011160878,0.000041111267,0.00012408677,0.00014249381,0.000048441347],"category_scores_gemma":[0.00046027455,0.000113815455,0.000016543745,0.0001849916,0.00036265855,0.0000060693123,0.00024231174,0.00020162223,0.000016104654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014181946,0.000047433907,0.043128,0.00007810266,0.000013149201,0.000027525788,0.000098460805,5.5062696e-7,0.95092344,0.000018876206,0.0015615039,0.003961134],"study_design_scores_gemma":[0.00056238944,0.00055919547,0.112317406,0.000101048456,0.0000052046666,0.000008468266,0.00008476053,0.00003683486,0.8798975,0.000080178455,0.006198305,0.00014874719],"about_ca_topic_score_codex":0.0002278971,"about_ca_topic_score_gemma":0.0013348527,"teacher_disagreement_score":0.07102598,"about_ca_system_score_codex":0.000029162034,"about_ca_system_score_gemma":0.00013336087,"threshold_uncertainty_score":0.46412596},"labels":[],"label_agreement":null},{"id":"W2808941070","doi":"10.1158/0008-5472.can-17-3696","title":"Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Ottawa; Occupational Cancer Research Centre; McGill University","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Government of Canada","keywords":"Cancer research; Breast cancer; Biology; Signal transduction; Cancer; Cell biology","score_opus":0.043957620337485515,"score_gpt":0.39234700441853987,"score_spread":0.34838938408105435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808941070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285704,0.0047119525,0.00013674752,0.0006976966,0.00039416767,0.00022175291,0.00011968466,0.000008637914,0.00085233536],"genre_scores_gemma":[0.9935428,0.0012874054,0.000111320995,0.00019668113,0.0020517707,0.00018672064,0.00002684894,0.000022789645,0.0025736934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983801,0.00032262178,0.0001976549,0.00044996914,0.00018169223,0.00046793942],"domain_scores_gemma":[0.99931985,0.000051903487,0.00003092019,0.00023312001,0.0002394278,0.00012478458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007703921,0.00012481822,0.00021369889,0.00016059105,0.00015246647,0.000041230924,0.00017592039,0.00016275163,0.0012065925],"category_scores_gemma":[0.00009005903,0.00011150527,0.000040416628,0.00025766608,0.0004096822,0.000009018299,0.00014421262,0.0002910679,0.000019362667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036825472,0.00001966491,0.05186841,0.000032812524,0.000050053517,0.00000247053,0.0004289258,0.000019007728,0.9354294,0.000097339376,0.006431973,0.0052517215],"study_design_scores_gemma":[0.0012326861,0.00030587992,0.009712029,0.000067213696,0.000017961924,0.000011958076,0.0004652399,0.00003234205,0.780791,0.0002807728,0.2067944,0.00028856477],"about_ca_topic_score_codex":0.0018589819,"about_ca_topic_score_gemma":0.0012950605,"teacher_disagreement_score":0.20036241,"about_ca_system_score_codex":0.000042465574,"about_ca_system_score_gemma":0.00024240733,"threshold_uncertainty_score":0.99970645},"labels":[],"label_agreement":null},{"id":"W2809105329","doi":"10.1158/0008-5472.can-18-0326","title":"Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk","year":2018,"lang":"en","type":"review","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health","keywords":"Medicine; Aspirin; Colorectal cancer; Internal medicine; Odds ratio; Body mass index; Cancer; Confidence interval; Risk factor; Logistic regression; Oncology; Obesity","score_opus":0.03181884511896381,"score_gpt":0.39106792081118674,"score_spread":0.3592490756922229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809105329","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6815149,0.3151078,1.4651833e-7,0.000006695526,0.00019678213,0.002711851,0.00023177665,0.0000139567,0.00021607419],"genre_scores_gemma":[0.4285974,0.57006407,4.5509802e-7,0.000012836761,0.00036410973,0.0007431431,0.0000062572817,0.000090399866,0.00012133448],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99431175,0.002178572,0.0007000021,0.00067457487,0.00146202,0.0006731051],"domain_scores_gemma":[0.9942022,0.0037969283,0.00072482694,0.00068460446,0.00035695822,0.00023445838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035464675,0.0005800081,0.0020334707,0.0005825958,0.00019990744,0.000024010971,0.0004536976,0.0005269969,0.0001902944],"category_scores_gemma":[0.00092397,0.00031926352,0.00040319384,0.0005682176,0.0013137662,0.000055249224,0.00017085507,0.00189161,0.000018752688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047160224,0.00031919742,0.6781401,0.1368181,0.0054355524,0.00011471553,0.0034368075,0.00004850906,0.002281226,0.00016735203,0.003539756,0.16498268],"study_design_scores_gemma":[0.006839259,0.012960994,0.08640272,0.27143413,0.003911454,0.000019009847,0.0002470199,0.000047211008,0.14553113,0.000039945233,0.47077805,0.0017890685],"about_ca_topic_score_codex":0.0007309917,"about_ca_topic_score_gemma":0.000042650157,"teacher_disagreement_score":0.5917374,"about_ca_system_score_codex":0.0004373597,"about_ca_system_score_gemma":0.0011663995,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W2809721154","doi":"10.1158/1538-7445.am2018-858","title":"Abstract 858: Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Enzalutamide; LNCaP; Prostate cancer; Medicine; Radiosensitizer; Oncology; Cancer research; Androgen deprivation therapy; Internal medicine; Androgen receptor; Cancer; Radiation therapy","score_opus":0.08356082446428732,"score_gpt":0.4311890294150546,"score_spread":0.3476282049507673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809721154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97493887,0.005113715,9.031686e-7,0.0043173637,0.0005058391,0.001870459,0.000118351054,0.00007417125,0.013060349],"genre_scores_gemma":[0.9760622,0.010190448,0.00005791383,0.0002576287,0.0011346005,0.0006946608,0.000035681784,0.000084090054,0.011482774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954024,0.00022165242,0.00040914209,0.00089357636,0.001395756,0.0016774912],"domain_scores_gemma":[0.9973357,0.00028813598,0.00007177562,0.0005805476,0.0011647098,0.00055913074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001147478,0.0003371136,0.00055464497,0.0006662625,0.00029575426,0.000103366234,0.00022221384,0.0002201851,0.0009810281],"category_scores_gemma":[0.00013745739,0.00027535376,0.000111496716,0.0012904434,0.0011787784,0.00022386805,0.00018700704,0.0011938983,0.0009686908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03169651,0.00031388208,0.0018869834,0.00022519416,0.0003481024,0.002112495,0.0037121882,0.000012948404,0.92028946,0.000068452704,0.020181505,0.019152291],"study_design_scores_gemma":[0.017209763,0.002438055,0.053480897,0.0006789998,0.00006400783,0.000024680772,0.0015060769,0.00008447738,0.90995914,0.00016130273,0.013914912,0.00047767718],"about_ca_topic_score_codex":0.010945897,"about_ca_topic_score_gemma":0.0018723231,"teacher_disagreement_score":0.051593915,"about_ca_system_score_codex":0.002187365,"about_ca_system_score_gemma":0.0020972933,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W2809959753","doi":"10.1158/1538-7445.am2018-4437","title":"Abstract 4437: Down-modulation of ADAR1-mediated GLI1 editing alters extracellular and immune response genes in multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"RNA editing; Biology; Small hairpin RNA; Cancer research; Gene knockdown; Molecular biology; RNA; Genetics; Cell culture; Gene","score_opus":0.037558229341292014,"score_gpt":0.3485542607502268,"score_spread":0.3109960314089348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809959753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995829,0.003441724,0.00005149893,0.0002650144,0.00007679555,0.00021249506,0.000031707652,0.0000056422423,0.00008614429],"genre_scores_gemma":[0.9990563,0.00020077395,0.000086057196,0.000015692687,0.000317905,0.00003363408,0.000065383145,0.000015044106,0.00020922779],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988392,0.00017036744,0.00022886494,0.00026612324,0.00024332502,0.0002521085],"domain_scores_gemma":[0.99926484,0.00007612219,0.00006504348,0.00023537068,0.0002560777,0.00010253745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009032516,0.00008380093,0.00010269101,0.00014308206,0.00008969082,0.000019599584,0.00010940378,0.000101761594,0.00008983139],"category_scores_gemma":[0.0005225315,0.00008316882,0.000031874017,0.00019161892,0.00029893636,0.000009378154,0.00007998991,0.00009069577,0.0000060963985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016404222,0.000032194926,0.023228643,0.000032282256,0.000011160049,0.0000046877935,0.000097579585,0.00008371761,0.96756923,0.0000062119175,0.00021216214,0.007081695],"study_design_scores_gemma":[0.0008593101,0.00010330439,0.54359627,0.000039167655,0.0000018446758,9.3838673e-7,0.00015331812,0.00095851347,0.45114747,0.000018425504,0.003041247,0.00008017323],"about_ca_topic_score_codex":0.00024830212,"about_ca_topic_score_gemma":0.0001337233,"teacher_disagreement_score":0.5203676,"about_ca_system_score_codex":0.00003392885,"about_ca_system_score_gemma":0.00017122255,"threshold_uncertainty_score":0.33915263},"labels":[],"label_agreement":null},{"id":"W2809970088","doi":"10.1158/1538-7445.am2018-2177","title":"Abstract 2177: Sensitive single cell copy number profiling using a novel microfluidic droplet based platform","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Breast cancer; Computational biology; Copy number analysis; Single-cell analysis; Comparative genomic hybridization; Glioma; Single cell sequencing; Cell; Copy-number variation; Genetics; Genome; Cancer; Exome sequencing; Phenotype; Gene","score_opus":0.0796068385377826,"score_gpt":0.37248794067320445,"score_spread":0.29288110213542184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809970088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140966,0.00079435797,0.0033659944,0.000092048394,0.00029125297,0.00035353316,0.00025486993,0.000010710002,0.0034275972],"genre_scores_gemma":[0.99566925,0.0002448344,0.00206243,0.00034447355,0.0012693456,0.00003579459,0.00010316635,0.000057771977,0.00021294979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982494,0.000027905062,0.00021112109,0.0005103133,0.00030193798,0.00069928396],"domain_scores_gemma":[0.9986375,0.00007311162,0.00006651882,0.0003910779,0.0006611205,0.00017065943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004914232,0.00017394584,0.00015874152,0.000076236334,0.00029815803,0.000091854265,0.00021231272,0.00018291242,0.00019757677],"category_scores_gemma":[0.00011352357,0.00018157787,0.000078575744,0.0002253148,0.00035249782,0.000006531173,0.000205411,0.00024630543,0.00006609555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025862333,0.00011954732,0.0012060606,0.000047845188,0.000023564986,0.000007802359,0.000060941205,0.000046533332,0.9938081,0.000025269188,0.003999894,0.00039581192],"study_design_scores_gemma":[0.0008108987,0.00020385059,0.00019354423,0.000053507752,0.000010406538,0.000007165402,0.00014341497,0.00022157325,0.9614284,0.00002226855,0.03668114,0.00022382419],"about_ca_topic_score_codex":0.00081546773,"about_ca_topic_score_gemma":0.00015205273,"teacher_disagreement_score":0.032681245,"about_ca_system_score_codex":0.00024361229,"about_ca_system_score_gemma":0.00094424206,"threshold_uncertainty_score":0.74045306},"labels":[],"label_agreement":null},{"id":"W2810015216","doi":"10.1158/1538-7445.am2018-5531","title":"Abstract 5531: Detection of co-occurring and potential resistance mutations in cell-free, circulating tumor DNA from patients with <i>BRAF</i> <i>mutant</i> metastatic melanoma undergoing treatment with BRAF-targeted therapies","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"","keywords":"Digital polymerase chain reaction; Neuroblastoma RAS viral oncogene homolog; Multiplex; V600E; Medicine; Melanoma; Cancer research; Vemurafenib; Mutation; Oncology; Molecular biology; Internal medicine; Cancer; KRAS; Biology; Metastatic melanoma; Polymerase chain reaction; Bioinformatics; Gene; Genetics; Colorectal cancer","score_opus":0.015708745819969366,"score_gpt":0.28403208309423766,"score_spread":0.26832333727426827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810015216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969754,0.0016693723,0.00035735106,0.00003260566,0.000039383,0.00040088632,0.00035837447,0.000005665348,0.00016096124],"genre_scores_gemma":[0.998886,0.00027838387,0.0004902231,0.000029490255,0.0000987883,0.000087413966,0.000085234446,0.00003260312,0.000011903129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987585,0.0000693597,0.0002189654,0.00038844885,0.00026216946,0.00030255291],"domain_scores_gemma":[0.99916744,0.000102669226,0.00012544716,0.00029089107,0.00023776211,0.00007577026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014221824,0.00015320687,0.0001798242,0.00009737236,0.00017711893,0.000050316143,0.00012418082,0.00004288165,0.000014503994],"category_scores_gemma":[0.000047964055,0.00012845334,0.00002736566,0.00019351568,0.0002396744,0.000014060497,0.000051528783,0.000101701,7.1583975e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008613998,0.00015825726,0.031940944,0.0000782403,0.0001464486,0.000019249888,0.0005351495,0.00031615346,0.9640143,0.00000606162,0.000025003676,0.0018988264],"study_design_scores_gemma":[0.0048705107,0.0015048871,0.059336506,0.00018336158,0.000048103357,0.0000024883548,0.0005842256,0.000074773016,0.93257,0.00017071268,0.00040899141,0.00024548502],"about_ca_topic_score_codex":0.0013140499,"about_ca_topic_score_gemma":0.0144679975,"teacher_disagreement_score":0.031444307,"about_ca_system_score_codex":0.00012741498,"about_ca_system_score_gemma":0.00033916847,"threshold_uncertainty_score":0.80734825},"labels":[],"label_agreement":null},{"id":"W2810067024","doi":"10.1158/1538-7445.am2018-1726","title":"Abstract 1726: A novel delivery platform containing up to 14 neoantigens can induce robust immune responses in a single formulation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Adjuvant; Immune system; Antigen; Splenocyte; CD8; Immunopotentiator; Immunology; Immunogenicity; Flow cytometry; T cell; Cancer immunotherapy; Epitope; Immunotherapy; Medicine; Biology","score_opus":0.15080534491755732,"score_gpt":0.3763361204778105,"score_spread":0.2255307755602532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810067024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244076,0.0045093885,0.00009598652,0.0006430392,0.00080419326,0.00068530405,0.000062188425,0.000056468085,0.0007026521],"genre_scores_gemma":[0.99356383,0.00023649729,0.000062655534,0.00021990357,0.00010405552,0.00016566174,0.000040797164,0.000047593297,0.0055589853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744457,0.00026516296,0.00053340744,0.0004725638,0.00016382246,0.001120462],"domain_scores_gemma":[0.99803895,0.0007476287,0.00010568849,0.00050603866,0.00055042375,0.00005129056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019082662,0.0002414653,0.0003715549,0.00088397873,0.0006303449,0.000081186554,0.00049172266,0.00035421125,0.0009808565],"category_scores_gemma":[0.0006434824,0.00023194174,0.00008815046,0.0008556215,0.00038271386,0.00028137636,0.00021095668,0.0008764704,0.00033184074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012656784,0.00012211384,0.00069665787,0.000016595273,0.00009957788,0.000011351547,0.006805538,0.000027720067,0.96258634,0.00017181113,0.00051194156,0.016293542],"study_design_scores_gemma":[0.0032683513,0.001311554,0.0708692,0.00040670804,0.0000070917995,0.000042771095,0.0026303474,0.000007696616,0.88248235,0.000039963652,0.038584404,0.00034958476],"about_ca_topic_score_codex":0.007979595,"about_ca_topic_score_gemma":0.0035625158,"teacher_disagreement_score":0.08010404,"about_ca_system_score_codex":0.0006214327,"about_ca_system_score_gemma":0.0007767032,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W2810339633","doi":"10.1158/1538-7445.am2018-4670","title":"Abstract 4670: Evidence of neoantigen-reactive T cell response in a case of relapsing, mismatch-repair gene proficient, colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University","funders":"","keywords":"Cancer research; T cell; Metastasis; CD8; Cancer; T-cell receptor; clone (Java method); Colorectal cancer; Biology; Antigen; Immunology; Medicine; Gene; Immune system; Genetics","score_opus":0.09864081204970468,"score_gpt":0.44366097450097436,"score_spread":0.34502016245126965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810339633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834936,0.014026903,0.000004072228,0.0005251308,0.00024864773,0.0011430825,0.00006812356,0.000025889847,0.00046452304],"genre_scores_gemma":[0.9968915,0.0016923118,0.00013920656,0.000053115455,0.00015233875,0.00023581559,0.0000020390462,0.000036152724,0.00079750584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972945,0.00034487285,0.00057473144,0.0004907816,0.00070749014,0.000587639],"domain_scores_gemma":[0.99754286,0.0005942816,0.00022080795,0.0004757759,0.0010160103,0.00015027684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030972376,0.00018033064,0.00043947672,0.00053783634,0.00011442285,0.000012232623,0.0002143866,0.00016665111,0.0011594091],"category_scores_gemma":[0.00037103117,0.00015686499,0.00016679279,0.001372928,0.0011050107,0.00013466469,0.000092091825,0.0004989571,0.00001332248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07791796,0.00030983254,0.0134427035,0.00051819213,0.00010074462,0.0006257212,0.005057375,0.000005796132,0.8976266,0.0000020568914,0.0017176088,0.0026754406],"study_design_scores_gemma":[0.0023061812,0.002163286,0.07540273,0.0023464242,0.000030004978,0.00013120289,0.0013365383,0.00010376812,0.91517174,0.0000070358437,0.0008536033,0.00014746508],"about_ca_topic_score_codex":0.023517486,"about_ca_topic_score_gemma":0.0030407226,"teacher_disagreement_score":0.075611785,"about_ca_system_score_codex":0.00087822124,"about_ca_system_score_gemma":0.0025586132,"threshold_uncertainty_score":0.99975365},"labels":[],"label_agreement":null},{"id":"W2810389335","doi":"10.1158/1538-7445.am2018-1871","title":"Abstract 1871: Development of pelorol analogues to activate the SHIP1 lipid phosphatase; a novel paradigm to suppress B-cell receptor signaling in human B-cell cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Cancer research; Protein kinase B; Chronic lymphocytic leukemia; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; breakpoint cluster region; Biology; B-cell receptor; Cell signaling; B cell; Chemistry; Receptor; Leukemia; Immunology; Biochemistry; Antibody","score_opus":0.10018194669799689,"score_gpt":0.4088280008356745,"score_spread":0.3086460541376776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810389335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937926,0.0006268962,0.000061286395,0.0011777286,0.00020302927,0.002145857,0.00008672431,0.000029462968,0.0018764493],"genre_scores_gemma":[0.99577516,0.000081615675,0.00083873974,0.0002947928,0.00061266526,0.00082875486,0.000047717345,0.00007945291,0.0014410826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948224,0.00014896992,0.00071886525,0.0008405096,0.0019568198,0.0015124469],"domain_scores_gemma":[0.99707395,0.00054631475,0.000108566936,0.00095493475,0.0006254938,0.00069071294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028031536,0.00030397944,0.0005403215,0.0006657173,0.00038371963,0.000082400504,0.0010358907,0.0001633671,0.0013082715],"category_scores_gemma":[0.00030194988,0.00023432027,0.00008862873,0.0018342696,0.0004941897,0.00012575311,0.00051298254,0.00090317224,0.00027803608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0020830638,0.00039308783,0.00048005724,0.00064513815,0.00008285073,0.000030985568,0.011092272,0.00037435594,0.96599925,0.00004445415,0.01468417,0.0040902914],"study_design_scores_gemma":[0.006915909,0.00047008556,0.0015892141,0.0008065303,0.000012077452,0.0000027118147,0.0014225551,0.00012555782,0.9450164,0.000010745322,0.043369994,0.00025823025],"about_ca_topic_score_codex":0.015858654,"about_ca_topic_score_gemma":0.004556366,"teacher_disagreement_score":0.028685825,"about_ca_system_score_codex":0.020057924,"about_ca_system_score_gemma":0.01600108,"threshold_uncertainty_score":0.99960464},"labels":[],"label_agreement":null},{"id":"W2810440190","doi":"10.1158/1538-7445.am2018-ct151","title":"Abstract CT151: TTFields and radiosurgery for 1 to 10 brain metastases from NSCLC in the phase III METIS study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Oncology; Internal medicine; Neurocognitive; Lung cancer; Adverse effect; Population; Clinical trial; Radiation therapy","score_opus":0.16852932305861046,"score_gpt":0.49865214588546697,"score_spread":0.3301228228268565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810440190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478526,0.0011429352,0.0000086669515,0.011451416,0.00007082603,0.0020321175,0.0001451081,0.000008901789,0.00035474115],"genre_scores_gemma":[0.9969227,0.00007832956,0.00009504602,0.0006296335,0.0003606663,0.001715793,0.00002298837,0.000015403266,0.0001594959],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985213,0.0001516507,0.00019476489,0.00034657738,0.00043243295,0.00035326544],"domain_scores_gemma":[0.9975768,0.001702924,0.000022577839,0.00037076318,0.00017385249,0.00015311057],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016822956,0.00010747686,0.00027465532,0.0001844933,0.00014424672,0.000063900596,0.00012304296,0.00004152372,0.0013604565],"category_scores_gemma":[0.0005126731,0.00006678796,0.000050613995,0.00038097662,0.00010045603,0.00004702508,0.00005164347,0.00015973239,0.000037288733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062255263,0.006784487,0.052729968,0.000080097154,0.0008434225,0.00090324297,0.011175963,0.0000012053671,0.024079835,0.00013320215,0.55956167,0.33748138],"study_design_scores_gemma":[0.06558495,0.012348987,0.5275104,0.00066929567,0.0004935117,0.000030118159,0.019225426,0.000065905166,0.09420949,0.00090527866,0.2783787,0.0005779321],"about_ca_topic_score_codex":0.005958372,"about_ca_topic_score_gemma":0.002262745,"teacher_disagreement_score":0.47478044,"about_ca_system_score_codex":0.00008728247,"about_ca_system_score_gemma":0.0001330144,"threshold_uncertainty_score":0.9995524},"labels":[],"label_agreement":null},{"id":"W2810456709","doi":"10.1158/1538-7445.am2018-ct046","title":"Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in <i>PIK3CA</i>-mutated locally advanced or metastatic solid tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; KRAS; Internal medicine; Clinical endpoint; Cancer; Oncology; Adverse effect; Colorectal cancer; Cancer research; Clinical trial","score_opus":0.09041560544615307,"score_gpt":0.47746959028198604,"score_spread":0.387053984835833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810456709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938324,0.0008775415,0.000054574517,0.0010347423,0.00027696678,0.0034886058,0.0001256778,0.000059007576,0.00025049638],"genre_scores_gemma":[0.9972872,0.00008840018,0.00026330145,0.0003030618,0.0003623564,0.0008723594,0.0000109572975,0.000100232035,0.0007121224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951777,0.00043062284,0.0009076819,0.00075270137,0.0016832202,0.001048115],"domain_scores_gemma":[0.9967213,0.00040640248,0.00025972005,0.0010837443,0.0012245607,0.0003042537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014992445,0.00035696354,0.00082562835,0.00047112207,0.0002371915,0.000036787176,0.0006138328,0.000079262216,0.0012883645],"category_scores_gemma":[0.00072846434,0.0002301273,0.000107535976,0.002575423,0.001032656,0.0002772288,0.00025720662,0.0010499225,0.00003465731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061749604,0.014303262,0.0072346064,0.0013959401,0.0010392893,0.0013864699,0.019187547,0.00121517,0.6516757,0.00003083884,0.0042693336,0.23651226],"study_design_scores_gemma":[0.123646505,0.02381974,0.041782588,0.0069473498,0.00035213766,0.00020206414,0.049482986,0.0011496131,0.73720163,0.0006254407,0.013426678,0.0013632731],"about_ca_topic_score_codex":0.0016305783,"about_ca_topic_score_gemma":0.005003737,"teacher_disagreement_score":0.235149,"about_ca_system_score_codex":0.000682861,"about_ca_system_score_gemma":0.0018854687,"threshold_uncertainty_score":0.9996246},"labels":[],"label_agreement":null},{"id":"W2810502634","doi":"10.1158/1538-7445.am2018-2213","title":"Abstract 2213: A simple risk prediction model for high-risk adenomatous polyps at the time of colonoscopy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Medicine; Colonoscopy; Colorectal cancer; Logistic regression; Family history; Body mass index; Internal medicine; Population; Cancer; Physical therapy","score_opus":0.054592447195001136,"score_gpt":0.38424008819864397,"score_spread":0.32964764100364286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810502634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952525,0.0006853708,0.0012386001,0.00039883103,0.00014337602,0.0010413076,0.0006282625,0.00006291349,0.00054886105],"genre_scores_gemma":[0.99617124,0.0002911535,0.00014672251,0.00003761086,0.0006966442,0.00046985035,0.000026855672,0.000031633666,0.0021282723],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841154,0.00008804583,0.00025127357,0.00031956262,0.00053584937,0.00039375617],"domain_scores_gemma":[0.9984036,0.00034064567,0.00013506963,0.00040290022,0.0005932821,0.00012451185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011063151,0.00010817765,0.00021748134,0.00013871073,0.0005273518,0.000019762612,0.00013996733,0.00012153583,0.00040626506],"category_scores_gemma":[0.00037151508,0.000078418336,0.00008815704,0.00035707664,0.0003719229,0.000058272402,0.00008728435,0.00039503683,0.000058396454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1921728,0.0005475081,0.042126384,0.00084743754,0.0010886565,0.000009821335,0.008205597,0.0062446008,0.31104162,0.00013786076,0.31992242,0.11765531],"study_design_scores_gemma":[0.0064009028,0.019867603,0.10907091,0.0003086127,0.00037040692,0.000024092531,0.00036476587,0.36531013,0.48503008,0.0026852607,0.010241537,0.00032569826],"about_ca_topic_score_codex":0.007636759,"about_ca_topic_score_gemma":0.0021056896,"teacher_disagreement_score":0.35906553,"about_ca_system_score_codex":0.0004968411,"about_ca_system_score_gemma":0.0004060471,"threshold_uncertainty_score":0.99897146},"labels":[],"label_agreement":null},{"id":"W2810555606","doi":"10.1158/1538-7445.am2018-2355","title":"Abstract 2355: Penile cancer in vitro models useful for the identification of targeted therapies","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genital Health and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer research; Biology; PI3K/AKT/mTOR pathway; Cancer; Cisplatin; Molecular biology; Genetics; Apoptosis; Chemotherapy","score_opus":0.1615904586307936,"score_gpt":0.47555115617011806,"score_spread":0.31396069753932443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810555606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833479,0.011818128,0.00006877055,0.0027689447,0.00015245525,0.0012647414,0.00023363186,0.00001073899,0.00033470738],"genre_scores_gemma":[0.99726474,0.00028744183,0.000024497147,0.00013924703,0.00030710117,0.0010057848,0.000015059395,0.000016220187,0.000939902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987674,0.00003904639,0.00026531416,0.00018938583,0.00038654654,0.00035232728],"domain_scores_gemma":[0.99866265,0.00018535355,0.000054983266,0.00028794026,0.0006791546,0.00012989223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008251485,0.0000639049,0.00013076636,0.0001307289,0.00012830403,0.000014747801,0.00014646059,0.000048994993,0.0004951029],"category_scores_gemma":[0.00013443032,0.000043313386,0.0000472546,0.00031781156,0.00022972772,0.000082698476,0.000022624097,0.00017076262,0.000014766113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009648604,0.00029733757,0.00459285,0.0015252895,0.000044414686,0.0000037891832,0.0034039326,0.00022027116,0.9303718,0.00022530976,0.01105095,0.03861541],"study_design_scores_gemma":[0.0038931463,0.0003537013,0.3018758,0.00013640134,0.00005482017,0.0000011639635,0.0020359363,0.013861622,0.6660479,0.0053274864,0.0062284395,0.00018360412],"about_ca_topic_score_codex":0.0028693152,"about_ca_topic_score_gemma":0.00053542625,"teacher_disagreement_score":0.29728296,"about_ca_system_score_codex":0.00015472432,"about_ca_system_score_gemma":0.00084034656,"threshold_uncertainty_score":0.542103},"labels":[],"label_agreement":null},{"id":"W2810630089","doi":"10.1158/1538-7445.am2018-4736","title":"Abstract 4736: Bone marrow microenvironment-induced miR-300 expression impairs natural killer cell proliferation and antitumor activity","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Stromal cell; Bone marrow; Cancer research; Cytotoxic T cell; Tumor microenvironment; Immunology; Biology; Cell growth; Natural killer cell; Cell; Lymphokine-activated killer cell; Cancer cell; Interleukin 21; Immune system; Cancer; Chemistry; T cell; In vitro","score_opus":0.023590803792811164,"score_gpt":0.3270572600724172,"score_spread":0.30346645627960606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810630089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975007,0.0013982537,0.000026303711,0.00026520577,0.0001611518,0.00046243687,0.000014829899,0.000009862591,0.00016125236],"genre_scores_gemma":[0.99818295,0.00021828817,0.000105389976,0.00003484561,0.0005028889,0.0000811804,0.000057273588,0.000027265285,0.0007899425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986321,0.00011528493,0.00012905494,0.0004643938,0.0002930804,0.00036611807],"domain_scores_gemma":[0.99935246,0.000011470914,0.000062351675,0.00033208902,0.00010741921,0.00013424088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033008066,0.00013693667,0.00010531922,0.00007405655,0.00023469402,0.00006050287,0.0001226391,0.00013407627,0.00017131052],"category_scores_gemma":[0.000036810234,0.00012570442,0.000040409523,0.00008727394,0.00020355544,0.000018706363,0.00017742554,0.00020108472,0.000026376822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003441023,0.00007049606,0.0015948577,0.000063226704,0.00001100677,0.000003161587,0.000051909257,0.0000018651531,0.98980194,7.85488e-7,0.006262149,0.0017944765],"study_design_scores_gemma":[0.00050827226,0.000120906465,0.06203901,0.00003739685,0.000004394873,0.000003735176,0.000023632172,0.000043271844,0.93317735,0.000009572014,0.0038970788,0.00013537059],"about_ca_topic_score_codex":0.00007703265,"about_ca_topic_score_gemma":0.00007008345,"teacher_disagreement_score":0.06044415,"about_ca_system_score_codex":0.000092935465,"about_ca_system_score_gemma":0.00013023918,"threshold_uncertainty_score":0.51260775},"labels":[],"label_agreement":null},{"id":"W2810633885","doi":"10.1158/1538-7445.am2018-218","title":"Abstract 218: The evolutionary history of 2,658 cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Toronto","funders":"","keywords":"Somatic evolution in cancer; Biology; Isochromosome; KRAS; Genetics; Genome; Cancer; Colorectal cancer; Computational biology; Gene; Chromosome; Karyotype","score_opus":0.055254238135194665,"score_gpt":0.36235028310456335,"score_spread":0.3070960449693687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810633885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493988,0.027255224,0.00003391422,0.0007169855,0.0010092173,0.00024746152,0.00008765166,0.000005371978,0.02124534],"genre_scores_gemma":[0.99118966,0.0034403473,0.00005435018,0.0002440518,0.0012957695,0.00008147192,0.000016133568,0.000018350067,0.0036598712],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902743,0.000042658914,0.00014079074,0.00023788767,0.0002598435,0.00029141587],"domain_scores_gemma":[0.998957,0.000054456636,0.000048977654,0.00042433088,0.00044446252,0.00007079476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037154552,0.00007609458,0.00008261253,0.00004674091,0.00009847298,0.000007481695,0.00034867763,0.00007899727,0.00039753556],"category_scores_gemma":[0.00014076699,0.00006145931,0.000046571557,0.000105004096,0.0008630925,0.0000022621034,0.00015977473,0.0001543622,0.000024604886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018906163,0.000027362135,0.0009335572,0.000023815504,0.00004131838,0.0000014720752,0.00016368824,0.000043931734,0.49786645,0.00031977773,0.4949704,0.0054191463],"study_design_scores_gemma":[0.00031499992,0.00025764803,0.0078102504,0.000024251362,0.0000062184786,0.0000020023247,0.0000991058,0.000034831453,0.07017048,0.00018401518,0.92099315,0.000103075625],"about_ca_topic_score_codex":0.0028284132,"about_ca_topic_score_gemma":0.0012074218,"teacher_disagreement_score":0.427696,"about_ca_system_score_codex":0.0006006574,"about_ca_system_score_gemma":0.0021442815,"threshold_uncertainty_score":0.43527356},"labels":[],"label_agreement":null},{"id":"W2810679476","doi":"10.1158/1538-7445.am2018-2891","title":"Abstract 2891: Molecular profiling of hormone-resistant prostate cancer cells with TRPV6 oncochannel knockout/knockdown","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Employment and Social Development Canada; Mount Allison University","funders":"","keywords":"TRPV6; Prostate cancer; Biology; Cancer research; Gene knockdown; DU145; NFAT; LNCaP; Cancer; Internal medicine; Medicine; Calcium metabolism; Gene; Genetics; Calcium; Transcription factor","score_opus":0.07350528472699211,"score_gpt":0.38215047582065964,"score_spread":0.3086451910936675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810679476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937666,0.0014534844,0.000043531672,0.0006221723,0.0005054191,0.0009926453,0.00018175451,0.000052906566,0.002381483],"genre_scores_gemma":[0.99570674,0.0014415773,0.00011370499,0.00009827825,0.00043094758,0.00028988847,0.0000025420354,0.0000736659,0.0018426484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962483,0.00018804825,0.00037947274,0.0007959342,0.0013635948,0.0010246335],"domain_scores_gemma":[0.9983129,0.00014334015,0.00016797971,0.00038357757,0.00071929075,0.0002729501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068724254,0.00025564124,0.00032611133,0.00029733306,0.00037148505,0.00009041011,0.0005995827,0.0001265847,0.0003751899],"category_scores_gemma":[0.00011380409,0.00018399309,0.00008711486,0.0011378223,0.0010375008,0.00018803171,0.00018334408,0.00059752946,0.000093251205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008897591,0.000098140416,0.000020091878,0.0001271379,0.00001802647,0.000047157304,0.0011422676,0.00047953887,0.993582,0.00016371855,0.0019600391,0.0014721304],"study_design_scores_gemma":[0.0007269691,0.0006446408,0.00012167505,0.00021508023,0.00000894837,0.0000021536578,0.0003510916,0.00022961955,0.9948408,0.00014553872,0.0024580418,0.00025544863],"about_ca_topic_score_codex":0.0016980151,"about_ca_topic_score_gemma":0.00019699344,"teacher_disagreement_score":0.0020645452,"about_ca_system_score_codex":0.00028399768,"about_ca_system_score_gemma":0.0008201479,"threshold_uncertainty_score":0.7503021},"labels":[],"label_agreement":null},{"id":"W2810783330","doi":"10.1158/1538-7445.am2018-140","title":"Abstract 140: A novel signature of mesenchymal stromal cells in high-grade serous ovarian carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Fibroblast activation protein, alpha; Stromal cell; Cancer-Associated Fibroblasts; Serous fluid; Mesenchymal stem cell; Cancer research; Ovarian cancer; Tumor microenvironment; Biology; Cell sorting; Extracellular matrix; Fibroblast; Cancer cell; Ovarian carcinoma; Cell; Cell culture; Pathology; Cancer; Medicine; Cell biology; Genetics; Tumor cells","score_opus":0.06710790154249652,"score_gpt":0.38271088004458775,"score_spread":0.31560297850209124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810783330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953222,0.00012732024,0.000025767737,0.0019106624,0.000046355814,0.0002518844,0.00011997675,0.000017182876,0.0021786115],"genre_scores_gemma":[0.99771315,0.000018431221,0.0002768167,0.00014510435,0.0005461704,0.000034394623,0.000025830492,0.00002161723,0.0012184768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798566,0.00006679311,0.00029783355,0.00034950222,0.00079098577,0.0005092354],"domain_scores_gemma":[0.9988395,0.00008195046,0.000058910162,0.00035088364,0.00044845542,0.000220328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005801871,0.00012671009,0.00032421475,0.0005157107,0.00007552424,0.000020044881,0.00016427136,0.00016917275,0.0021233873],"category_scores_gemma":[0.000072194154,0.000109322835,0.000099518904,0.0009991542,0.00034449797,0.0000744062,0.00007075854,0.0007423397,0.000055983048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028507368,0.00031457836,0.0055263564,0.0001401853,0.00004661834,0.00014179827,0.00042960318,0.00001231733,0.98897225,0.00023926093,0.0034006943,0.00049124303],"study_design_scores_gemma":[0.0036363786,0.00047479605,0.26352906,0.0007410415,0.000029016765,0.000014575547,0.0006181771,0.00030077572,0.7292268,0.00010010222,0.0011550118,0.00017420763],"about_ca_topic_score_codex":0.005243356,"about_ca_topic_score_gemma":0.000953932,"teacher_disagreement_score":0.25974542,"about_ca_system_score_codex":0.00023015575,"about_ca_system_score_gemma":0.0005115643,"threshold_uncertainty_score":0.99878883},"labels":[],"label_agreement":null},{"id":"W2810851394","doi":"10.1158/1538-7445.am2018-3304","title":"Abstract 3304: The mutation landscape of cancers serves as a record of early malignant transformation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Biology; Epigenetics; Chromatin; Cancer research; Somatic cell; Cancer; Malignant transformation; Genetics; Gene","score_opus":0.03673534010969729,"score_gpt":0.3596247359676132,"score_spread":0.3228893958579159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810851394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479276,0.0010343035,0.00006617427,0.00028601606,0.00012688272,0.00024062883,0.00008272951,0.000002082291,0.0033684052],"genre_scores_gemma":[0.9976019,0.001854252,0.000031019175,0.00004244303,0.00024703325,0.00005636673,0.000025430649,0.00001150103,0.00013003642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991896,0.000041581014,0.00020500635,0.00014932064,0.0002247495,0.00018974411],"domain_scores_gemma":[0.9991919,0.000044600347,0.0000821246,0.00023207121,0.00040684608,0.000042475815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041661898,0.0000649734,0.000093106595,0.00006972163,0.00007546577,0.000016225013,0.00019629934,0.00006788128,0.00011657641],"category_scores_gemma":[0.000070103786,0.000049776565,0.000050013157,0.00021177283,0.00023923487,0.0000056905496,0.000036567602,0.0000845198,0.0000054280727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010659089,0.00003928014,0.0034102856,0.00016555608,0.00009475064,0.00000157635,0.001990325,0.0002346138,0.9464142,0.0005940175,0.0036831677,0.042306356],"study_design_scores_gemma":[0.0005124388,0.00090700143,0.0220524,0.00007726709,0.00001203407,0.0000017798673,0.0006061258,0.00005359383,0.95986426,0.00039359354,0.015425511,0.00009396673],"about_ca_topic_score_codex":0.005014796,"about_ca_topic_score_gemma":0.002786466,"teacher_disagreement_score":0.04221239,"about_ca_system_score_codex":0.000038036134,"about_ca_system_score_gemma":0.000482569,"threshold_uncertainty_score":0.75809044},"labels":[],"label_agreement":null},{"id":"W2810882198","doi":"10.1158/0008-5472.can-18-0267","title":"Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Cancer research; Receptor tyrosine kinase; Population; Cancer stem cell; EPH receptor A2; Medicine; Tyrosine kinase; Stem cell; Gene knockdown; Clonogenic assay; Cancer; In vivo; Biology; Receptor; Internal medicine; Cell culture; Cell biology","score_opus":0.12439528548640309,"score_gpt":0.39733822709874744,"score_spread":0.27294294161234434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810882198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956638,0.0025062237,0.0000027400577,0.0007885299,0.0004013752,0.00034421947,0.000057874488,0.000023302915,0.0002119155],"genre_scores_gemma":[0.9951349,0.0038633973,0.000024417566,0.00012524679,0.00037612423,0.00012771082,3.1211175e-7,0.000028776081,0.00031911393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972758,0.00040039443,0.00035496618,0.00062693184,0.0007094021,0.00063247],"domain_scores_gemma":[0.9988009,0.0004697438,0.00011904354,0.00018203403,0.00028152228,0.00014676861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072358316,0.00015690489,0.00025449044,0.00028815158,0.00021811151,0.000050068244,0.00036894475,0.00006483499,0.00033600265],"category_scores_gemma":[0.0002543101,0.00012916398,0.000035257584,0.0010815947,0.00086115306,0.00023617834,0.00024140209,0.0004132996,0.000025964557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059607404,0.00006265348,0.0011215997,0.00011161934,0.0000026393204,0.000009827473,0.00043456221,0.0000070780484,0.9822999,0.00020421152,0.0019032456,0.013246569],"study_design_scores_gemma":[0.00037635514,0.00063759397,0.0003868893,0.0005655348,0.000002498817,0.0000016828587,0.000113695,0.0000970388,0.9942394,0.000098894605,0.003338597,0.00014182177],"about_ca_topic_score_codex":0.00055850734,"about_ca_topic_score_gemma":0.0003096965,"teacher_disagreement_score":0.013104747,"about_ca_system_score_codex":0.00016903802,"about_ca_system_score_gemma":0.00024046362,"threshold_uncertainty_score":0.52671546},"labels":[],"label_agreement":null},{"id":"W2810900290","doi":"10.1158/1538-7445.am2018-5218","title":"Abstract 5218: Boosting doxorubicin-induced immunogenic cell death by using tumor microenvironment modulating nanoparticles","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Centre for Social Innovation","funders":"","keywords":"Tumor microenvironment; Immunogenic cell death; Cancer research; Medicine; Doxorubicin; Immune system; Cancer; Immunology; Pharmacology; Immunotherapy; Chemotherapy; Internal medicine","score_opus":0.06661792322269293,"score_gpt":0.3272679275622562,"score_spread":0.26065000433956326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810900290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946155,0.0035674856,0.00015709348,0.000019353396,0.00040212314,0.00042092227,0.000042375956,0.00015932051,0.0006158531],"genre_scores_gemma":[0.99842227,0.00016482205,0.00067002134,0.00003455366,0.00040921502,0.000057303125,0.000006227117,0.00014933762,0.00008626562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972757,0.00003652938,0.00043133876,0.0004052696,0.0006385827,0.0012125501],"domain_scores_gemma":[0.9989772,0.0001254809,0.00008438076,0.00049299456,0.00011336349,0.00020662455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005837044,0.00028061794,0.00025858227,0.00015254982,0.00046503005,0.00013034063,0.0004166107,0.00009840213,0.0003640972],"category_scores_gemma":[0.000044966808,0.00028850246,0.00007520666,0.00038539167,0.0001531727,0.00026112108,0.0001514423,0.000566272,0.00016697773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036383088,0.00002740575,0.0008392009,0.00010870216,0.0000463519,0.000012724074,0.00035009897,0.002332589,0.99236304,0.000003123612,0.00033220617,0.0035481548],"study_design_scores_gemma":[0.00058128836,0.000087172026,0.0007907069,0.00017258384,0.000016478214,0.000005934798,0.0001697428,0.010793768,0.98596656,0.00006898069,0.0010247853,0.00032201578],"about_ca_topic_score_codex":0.00075400394,"about_ca_topic_score_gemma":0.00004460212,"teacher_disagreement_score":0.008461179,"about_ca_system_score_codex":0.001312473,"about_ca_system_score_gemma":0.00011891006,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W2810901052","doi":"10.1158/1538-7445.am2018-1209","title":"Abstract 1209: Patterns of treatment with immune check point inhibitors and targeted therapy in patients with metastatic melanoma presumed BRAF V600 positive","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Ipilimumab; Pembrolizumab; Dabrafenib; Vemurafenib; Nivolumab; Trametinib; Internal medicine; Metastatic melanoma; Oncology; Melanoma; Targeted therapy; Combination therapy; Cancer; Immunotherapy; Cancer research; Kinase","score_opus":0.030878174585815075,"score_gpt":0.33888517476556507,"score_spread":0.30800700017974997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810901052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606484,0.0017066814,0.0000027965339,0.00038541065,0.00003735368,0.0015444466,0.00009916085,0.000011080808,0.00014822457],"genre_scores_gemma":[0.99847937,0.00089292316,0.00005943161,0.000052847554,0.000053634172,0.00019969964,0.000046779234,0.000035868765,0.00017947178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983497,0.00010737151,0.00029077224,0.00034054162,0.00051241333,0.00039917396],"domain_scores_gemma":[0.9990283,0.00008554342,0.000103496015,0.0002946092,0.0003778511,0.00011017768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034413606,0.00019328341,0.00037635767,0.00025934802,0.000073404684,0.000021558686,0.00008333006,0.000051545667,0.0003657589],"category_scores_gemma":[0.000009915682,0.000115153925,0.00004405554,0.00037976765,0.00041262328,0.00010695959,0.000023449064,0.00019006092,0.0000021316503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061165884,0.0011124518,0.7701927,0.00016525107,0.001295265,0.00004700884,0.0056728716,0.0000011789989,0.07326516,0.0000032585601,0.00007582057,0.08700314],"study_design_scores_gemma":[0.014822401,0.0128725385,0.8072023,0.00056700286,0.000024399735,0.0000031762343,0.00039290127,0.0000031101574,0.16382399,0.0000041133426,0.00016871048,0.00011537067],"about_ca_topic_score_codex":0.011990184,"about_ca_topic_score_gemma":0.0014703359,"teacher_disagreement_score":0.090558834,"about_ca_system_score_codex":0.000495113,"about_ca_system_score_gemma":0.00043732816,"threshold_uncertainty_score":0.99458903},"labels":[],"label_agreement":null},{"id":"W2810934500","doi":"10.1158/1538-7445.am2018-lb-231","title":"Abstract LB-231: Genomic profiling in serial metastatic colorectal tumors identifies copy number alterations and spatio temporal intra-patient heterogeneity profiles associated with clinical response. Q-CROC-01: NCT00984048","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Mount Sinai Hospital; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; St Mary's Hospital Centre; Hôpital du Sacré-Cœur de Montréal; Hôtel-Dieu de Québec; Hôpital Charles-Le Moyne; Dr. Georges-L.-Dumont University Hospital Centre; Jewish General Hospital","funders":"","keywords":"Loss of heterozygosity; Colorectal cancer; Copy-number variation; Exome sequencing; Transcriptome; SNP; SNP array; Metastasis; Exome; Single-nucleotide polymorphism; Primary tumor; Copy number analysis; Gene expression profiling; Biology; Tumour heterogeneity; Cancer research; Microsatellite instability; Medicine; Cancer; Gene; Internal medicine; Genotype; Genetics; Gene expression; Genome; Allele; Phenotype; Microsatellite","score_opus":0.05316157453149529,"score_gpt":0.39683427180264813,"score_spread":0.34367269727115285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810934500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979644,0.0002788248,0.000038237806,0.00017356347,0.00026272246,0.00086874125,0.0003300391,0.0000109206685,0.000072542854],"genre_scores_gemma":[0.9981586,0.00018279407,0.00047777928,0.000075275726,0.0004002424,0.00031456558,0.0002934364,0.00004010521,0.000057201687],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760133,0.00045600373,0.00051895477,0.00060992915,0.00030694963,0.0005068105],"domain_scores_gemma":[0.99870974,0.0002636212,0.00015566465,0.000275453,0.00042421787,0.00017131411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015546329,0.00019642684,0.00028578847,0.00010145403,0.00026045943,0.0001714974,0.00018894853,0.00013796435,0.00008037919],"category_scores_gemma":[0.00088015216,0.00018234951,0.000056880664,0.0002302226,0.0006919525,0.000016765323,0.00020776442,0.00033036456,0.000013988147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010532964,0.00035527832,0.50954014,0.000062878,0.00024953898,0.000056135104,0.00052865734,0.0002376476,0.47485203,0.000037316564,0.0027313107,0.0008160912],"study_design_scores_gemma":[0.0023949803,0.0018584242,0.2804769,0.00014324763,0.000030723728,0.000015674252,0.00035748852,0.00022220617,0.71250486,0.0001235521,0.0014559272,0.00041604557],"about_ca_topic_score_codex":0.00064720603,"about_ca_topic_score_gemma":0.011801243,"teacher_disagreement_score":0.23765281,"about_ca_system_score_codex":0.00019204209,"about_ca_system_score_gemma":0.0011432383,"threshold_uncertainty_score":0.7435997},"labels":[],"label_agreement":null},{"id":"W2811076414","doi":"10.1158/1538-7445.am2018-4882","title":"Abstract 4882: Identification and optimization of chemical inhibitors that directly target KRAS G12D mutant","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"KRAS; Cancer research; Pancreatic cancer; Mutant; Colorectal cancer; Cetuximab; Cancer; Chemistry; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.06580164678984012,"score_gpt":0.39701009566939893,"score_spread":0.3312084488795588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811076414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943798,0.0020541581,0.000036064244,0.0009294786,0.000128964,0.0003691687,0.000021949108,0.00001907835,0.0020613172],"genre_scores_gemma":[0.99816424,0.00094121724,0.00020582332,0.000018151784,0.00025774946,0.0001006163,0.000015112102,0.000013853561,0.00028323443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989302,0.000024119943,0.00016879638,0.0002463899,0.00041974173,0.0002107404],"domain_scores_gemma":[0.99922943,0.00006267041,0.000052200186,0.0001529495,0.00041650666,0.00008627106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030477808,0.00008188987,0.00018190723,0.00011053617,0.00010019959,0.0000203863,0.000049997812,0.000055584598,0.00034037203],"category_scores_gemma":[0.00011601686,0.00006389357,0.000031194126,0.00026110717,0.00040003128,0.00006975624,0.00006012033,0.00012978076,0.0000064172086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013867816,0.0002917122,0.034961116,0.00035104784,0.00025907863,0.000018327128,0.0029934356,0.0000322483,0.92876554,0.00006315309,0.0045208195,0.026356755],"study_design_scores_gemma":[0.00079517975,0.0002553415,0.03562783,0.00016911453,0.000030505269,0.00000417542,0.00035225504,0.00024644186,0.96086276,0.00008014688,0.0014983362,0.00007791148],"about_ca_topic_score_codex":0.00043637393,"about_ca_topic_score_gemma":0.00003233335,"teacher_disagreement_score":0.032097235,"about_ca_system_score_codex":0.00020378832,"about_ca_system_score_gemma":0.00012997372,"threshold_uncertainty_score":0.3726835},"labels":[],"label_agreement":null},{"id":"W2811139024","doi":"10.1158/1538-7445.am2018-pl04-04","title":"Abstract PL04-04: Oncohistones in cancer: How to turn a cell's symphony into non harmonic rap","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenetics; Epigenome; Carcinogenesis; Biology; Cancer; Histone; Cancer research; Genetics; Chromatin; Gene; DNA methylation; Gene expression","score_opus":0.051562774117584045,"score_gpt":0.40605654848538464,"score_spread":0.3544937743678006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811139024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865487,0.009240019,0.00012317886,0.0018560718,0.00032205114,0.0003934587,0.00002094775,0.0000070481433,0.0014884791],"genre_scores_gemma":[0.9915633,0.004448393,0.00020130922,0.00012072535,0.0009162752,0.00030498163,0.000022145248,0.00003754298,0.0023853274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982797,0.00009047907,0.00018404894,0.0005430328,0.00036324945,0.0005395089],"domain_scores_gemma":[0.9989072,0.00002709926,0.000050478408,0.00043524872,0.00038065674,0.0001992899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069258834,0.00015228125,0.00016054668,0.0001980155,0.00015416849,0.00006872337,0.00035932747,0.00018538114,0.0001262086],"category_scores_gemma":[0.00008761274,0.00014959194,0.000054964185,0.00039741627,0.00017441456,0.0000067308138,0.00019644659,0.0002421062,0.00005101228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001493571,0.00004950332,0.003003679,0.00004602722,0.000013846046,0.0000043680993,0.0004567113,0.00006445708,0.9678544,0.000003190649,0.003962535,0.024391962],"study_design_scores_gemma":[0.00046342536,0.00034521206,0.015631089,0.0000490282,0.00000341347,2.1338916e-7,0.00009798335,0.000031027692,0.874104,0.000086611275,0.10901151,0.00017644712],"about_ca_topic_score_codex":0.0045355638,"about_ca_topic_score_gemma":0.008420294,"teacher_disagreement_score":0.10504898,"about_ca_system_score_codex":0.00028682547,"about_ca_system_score_gemma":0.0005818752,"threshold_uncertainty_score":0.6856446},"labels":[],"label_agreement":null},{"id":"W2811401701","doi":"10.1158/1538-7445.am2018-819","title":"Abstract 819: High response rates with entospletinib in patients with t(v;11q23.3);<i>KMT2A</i> rearranged acute myeloid leukemia and acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Myeloid leukemia; Leukemia; Acute leukemia; Chemotherapy; Internal medicine; Gastroenterology; Induction chemotherapy; Myeloid; Acute lymphocytic leukemia; Vincristine; Oncology; Immunology; Cyclophosphamide","score_opus":0.02137495479313491,"score_gpt":0.3333395373591177,"score_spread":0.3119645825659828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811401701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937611,0.0002469752,0.000016336819,0.002148842,0.00009804608,0.0022735803,0.00020302588,0.00011735282,0.001134711],"genre_scores_gemma":[0.9931114,0.00073037995,0.00065899995,0.0004897826,0.0004322142,0.0005981949,0.00012292252,0.00021670833,0.0036394529],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9924517,0.00061715516,0.0006352695,0.0014855759,0.0026544328,0.0021558404],"domain_scores_gemma":[0.99473965,0.0010201492,0.0001705504,0.0012648938,0.00183434,0.0009704363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026630207,0.0006204398,0.0009362362,0.0011595605,0.00049929396,0.00022270168,0.0006474349,0.00038672084,0.00070425996],"category_scores_gemma":[0.0005407858,0.00044971876,0.0000714087,0.0023484733,0.0023095664,0.0004343518,0.00041887598,0.0020134281,0.00026344715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.36720395,0.0005794413,0.34055647,0.00073557737,0.0021435767,0.0033013965,0.0038201213,0.0000477368,0.23882465,0.00009898884,0.030681001,0.012007067],"study_design_scores_gemma":[0.026931265,0.0068258173,0.90998447,0.0014182759,0.00019673117,0.00010579604,0.00035248837,0.00012920905,0.04728318,0.000042986878,0.0060205963,0.0007091819],"about_ca_topic_score_codex":0.0037167047,"about_ca_topic_score_gemma":0.0008937503,"teacher_disagreement_score":0.56942797,"about_ca_system_score_codex":0.007520325,"about_ca_system_score_gemma":0.0079254005,"threshold_uncertainty_score":0.99979544},"labels":[],"label_agreement":null},{"id":"W2814722636","doi":"","title":"Metronomic ABI-007 therapy: antiangiogenic and antitumor activity of a nanoparticle albumin-bound paclitaxel","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paclitaxel; Medicine; Pharmacology; Chemotherapy; Angiogenesis; Cancer; Toxicity; Cancer research; Internal medicine","score_opus":0.11926687460562532,"score_gpt":0.46720650383466705,"score_spread":0.34793962922904176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2814722636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185015,0.01376056,0.000002041191,0.0032526231,0.00007305421,0.0005010408,0.000025052046,0.000017458444,0.0005180261],"genre_scores_gemma":[0.9943455,0.0035735506,0.00005772651,0.00010948549,0.0002969184,0.00010612973,0.000002812259,0.000020553558,0.0014873138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878055,0.0001115076,0.0001500729,0.00028071905,0.00025518378,0.00042199367],"domain_scores_gemma":[0.99929774,0.00014089735,0.000043220636,0.0002267364,0.00012083415,0.0001705761],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004726248,0.00010960236,0.00028377652,0.0001894435,0.00010054808,0.000015916376,0.00008288428,0.000054005042,0.0010133652],"category_scores_gemma":[0.000020584685,0.00009197027,0.00007848094,0.00032426036,0.0003639701,0.00010380414,0.00005761507,0.00019638643,0.000032511263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013792162,0.0004131678,0.03964074,0.000055112298,0.0002305695,0.000011849951,0.00032637766,0.0000024675367,0.90473706,0.000049332204,0.0025595932,0.05059454],"study_design_scores_gemma":[0.004063277,0.00076800614,0.09537591,0.00003549594,0.00006076738,0.00001373986,0.000056282213,0.000094667455,0.88037485,0.00003559901,0.019026734,0.00009466408],"about_ca_topic_score_codex":0.0013049048,"about_ca_topic_score_gemma":0.00032174907,"teacher_disagreement_score":0.05573517,"about_ca_system_score_codex":0.00026573104,"about_ca_system_score_gemma":0.00036440883,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W2843267514","doi":"10.1158/0008-5472.can-18-1022","title":"Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University","funders":"Canadian Cancer Society; Ontario Research Foundation; Cummings Foundation; Chesapeake Research Consortium","keywords":"Brain metastasis; Cancer; Cancer research; Metastasis; Lung cancer; Adenocarcinoma; Medicine; Biology; Oncology; Internal medicine","score_opus":0.13827163373964393,"score_gpt":0.48441090874425596,"score_spread":0.34613927500461206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2843267514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933935,0.0015776876,0.00010694582,0.0065404074,0.00008003885,0.0013130967,0.00005775199,0.000011770042,0.00097296084],"genre_scores_gemma":[0.9961625,0.000028060414,0.00047449803,0.0005300078,0.0001123206,0.00021543556,0.0000062143467,0.000028909233,0.0024420626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975814,0.0005536955,0.0003017228,0.00030959368,0.00075118995,0.0005024028],"domain_scores_gemma":[0.9987442,0.0002392797,0.00005765899,0.0005309749,0.0002950977,0.00013277725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023004885,0.00012342415,0.00029515298,0.000257249,0.00017339292,0.000019019037,0.00024540548,0.000034503813,0.0013195821],"category_scores_gemma":[0.0002870886,0.00007595846,0.0000956172,0.001092493,0.0003190499,0.000039107403,0.0001584142,0.00032035448,0.000019967718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012225208,0.0015725311,0.16538517,0.001707883,0.0015947984,0.00012685388,0.0104544815,0.0001523673,0.7167469,0.0099190865,0.03429648,0.05682087],"study_design_scores_gemma":[0.0079905195,0.0036000072,0.20720263,0.001459102,0.00038635338,0.000010705275,0.004034991,0.0004947529,0.6967525,0.0020245775,0.075556494,0.00048740485],"about_ca_topic_score_codex":0.0013439103,"about_ca_topic_score_gemma":0.0005626384,"teacher_disagreement_score":0.056333464,"about_ca_system_score_codex":0.00027877465,"about_ca_system_score_gemma":0.00028801308,"threshold_uncertainty_score":0.9995933},"labels":[],"label_agreement":null},{"id":"W2883813435","doi":"10.1158/0008-5472.can-18-0951","title":"A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; National Center for Research Resources; NIHR Cambridge Biomedical Research Centre; Instituto de Salud Carlos III; National Health and Medical Research Council; World Cancer Research Fund; Medical Research Council; Canadian Institutes of Health Research; Health Canada; National Institutes of Health; BC Cancer Foundation; Hebei Medical University; Pomorski Uniwersytet Medyczny W Szczecinie; Mutuelle Générale de l'Education Nationale; Deutsche Krebshilfe; Institut Gustave-Roussy; Norges Forskningsråd; Helse Vest; Japan Society for the Promotion of Science; Hellenic Health Foundation; Ministry of Health, Labour and Welfare; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Associazione Italiana per la Ricerca sul Cancro; Canadian HIV Trials Network, Canadian Institutes of Health Research; Institut National de la Santé et de la Recherche Médicale; Cancerfonden; National Cancer Institute; Peter MacCallum Foundation; University College London; Cancer Institute NSW; European Commission; Fred C. and Katherine B. Andersen Foundation; University of Cambridge; Roswell Park Cancer Institute; National Institute for Health and Care Research; Swedish Cancer Foundation; Ovarian Cancer Australia; U.S. Department of Defense; Cancer Research UK; World Health Organization; Wellcome Trust; Kreftforeningen; Cancer Research Society; Centre International de Recherche sur le Cancer; Ligue Contre le Cancer; Vanderbilt University Medical Center; Deutsches Krebsforschungszentrum; Cancer Council Victoria; Kræftens Bekæmpelse; Mayo Foundation for Medical Education and Research; Radboud Universiteit; Lon V. Smith Foundation; European Social Fund; State of Connecticut Department of Public Health; Korea Health Industry Development Institute; Oregon Health and Science University; Minnesota Ovarian Cancer Alliance; Moffitt Cancer Center; Vanderbilt University; Rutgers Cancer Institute of New Jersey; Cancer Australia; Oak Foundation; NordForsk; Vetenskapsrådet; Georgia Clinical and Translational Science Alliance","keywords":"Transcriptome; Ovarian cancer; Candidate gene; Gene; Biology; Epithelial ovarian cancer; Cancer; Oncology; Genetics; Internal medicine; Bioinformatics; Computational biology; Medicine; Gene expression","score_opus":0.0684549278744645,"score_gpt":0.4351848266239564,"score_spread":0.3667298987494919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883813435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871917,0.0005365193,0.000104183164,0.0050505907,0.0008135839,0.0051741013,0.00088298647,0.00006446231,0.00018192129],"genre_scores_gemma":[0.98187613,0.00069371035,0.000098284436,0.00038653595,0.0018618607,0.011140945,0.000020782703,0.000069498274,0.0038522636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957198,0.0004290752,0.00046593035,0.0009720783,0.0011806412,0.0012324827],"domain_scores_gemma":[0.99667203,0.0004930436,0.00013971778,0.0006973144,0.0013962601,0.00060163374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034948485,0.0002684246,0.0005744062,0.00033365906,0.00059077766,0.00016088308,0.00027309425,0.00015563112,0.0019615768],"category_scores_gemma":[0.00069259165,0.00022997752,0.00015395129,0.0008603363,0.00016174959,0.00015930481,0.00008917466,0.0004049166,0.00012268119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017833237,0.0008064975,0.95369804,0.000097769785,0.000908454,0.000015515621,0.008690793,0.00000892876,0.005443186,0.000009128574,0.010049392,0.018488996],"study_design_scores_gemma":[0.0064551574,0.0026452972,0.94254315,0.00014026802,0.00026510903,2.5060115e-7,0.001564645,0.000019654206,0.013822715,0.00017750854,0.03212971,0.00023652811],"about_ca_topic_score_codex":0.043629564,"about_ca_topic_score_gemma":0.05497668,"teacher_disagreement_score":0.022080317,"about_ca_system_score_codex":0.0061425827,"about_ca_system_score_gemma":0.0010377651,"threshold_uncertainty_score":0.9989508},"labels":[],"label_agreement":null},{"id":"W2883970069","doi":"10.1158/0008-5472.can-18-0316","title":"Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Selumetinib; Medicine; KRAS; Colorectal cancer; Internal medicine; Oncology; Adverse effect; Cancer; MEK inhibitor; Rash; MAPK/ERK pathway; Kinase","score_opus":0.05148537216304206,"score_gpt":0.43448374862232564,"score_spread":0.3829983764592836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883970069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997358,0.000632755,0.0000012708148,0.0004284,0.00004306707,0.0011376452,0.000084763764,0.0000033737826,0.00031072862],"genre_scores_gemma":[0.99883837,0.00044973008,0.000097643206,0.00001302099,0.000028655071,0.0004475731,0.000017681186,0.000010605137,0.00009675388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985036,0.00014803131,0.000323016,0.0002701812,0.0005393205,0.00021581302],"domain_scores_gemma":[0.99906516,0.00011326769,0.000104593346,0.00013676865,0.0005251647,0.00005502813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064651057,0.00009768275,0.00032334335,0.00018467673,0.000070570546,0.0000052601317,0.00006961513,0.000025752137,0.00004478209],"category_scores_gemma":[0.00014973171,0.0000613854,0.000019916992,0.00070408825,0.00049989735,0.000092145696,0.000050812603,0.00017356146,2.3110495e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056967888,0.0032189265,0.7390528,0.0003208536,0.0002542134,0.000047186633,0.011917031,0.00015860339,0.14014006,0.00014943644,0.0002185868,0.047554463],"study_design_scores_gemma":[0.018077344,0.0067155305,0.8317873,0.00064730365,0.000039351933,0.000004169511,0.0016410125,0.00076233153,0.14005181,0.000107705324,0.000078566496,0.000087590255],"about_ca_topic_score_codex":0.003632726,"about_ca_topic_score_gemma":0.01988267,"teacher_disagreement_score":0.092734516,"about_ca_system_score_codex":0.000299973,"about_ca_system_score_gemma":0.00061439123,"threshold_uncertainty_score":0.99800193},"labels":[],"label_agreement":null},{"id":"W2885032805","doi":"10.1158/1538-7445.am2018-5268","title":"Abstract 5268: Interactions between genetic predictors of gene expression and dietary factors associated with risk of colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Colorectal cancer; Genome-wide association study; Heritability; Biology; Genetics; Red meat; Genetic association; Cancer; SNP; False discovery rate; Transcriptome; Computational biology; Gene; Bioinformatics; Gene expression; Genotype; Food science","score_opus":0.04609154697474737,"score_gpt":0.35958091621629196,"score_spread":0.3134893692415446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885032805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619335,0.0022366438,0.000023453758,0.000014973288,0.00009296455,0.00023244854,0.0011229734,0.000005657998,0.00007753396],"genre_scores_gemma":[0.99782246,0.0014944439,0.000083036284,0.0000039254883,0.0003259735,0.000055978217,0.00013671439,0.000021764172,0.000055725555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988321,0.00011996988,0.00020863867,0.00029958008,0.0002884969,0.00025117883],"domain_scores_gemma":[0.99889743,0.00006680468,0.00013411939,0.00019973016,0.0005427098,0.00015920316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016320997,0.00011677721,0.00017118052,0.0000931315,0.00013036051,0.000010591203,0.00014317285,0.000103870836,0.000106827596],"category_scores_gemma":[0.00013925773,0.00009680847,0.000049048944,0.00014636917,0.0005828389,0.00000642391,0.00007925509,0.00014078994,3.9725873e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019390414,0.000055912227,0.4767525,0.000028517685,0.00011656785,3.187605e-7,0.0001281935,0.000013376946,0.52191114,7.85705e-8,0.0005495322,0.0002499644],"study_design_scores_gemma":[0.00035834737,0.00031054585,0.5011522,0.000066379136,0.000033994544,1.10154986e-7,0.0000953394,0.0000030513324,0.49778736,0.000010653382,0.00012365893,0.000058310263],"about_ca_topic_score_codex":0.00070885225,"about_ca_topic_score_gemma":0.00093922624,"teacher_disagreement_score":0.024399756,"about_ca_system_score_codex":0.00003839875,"about_ca_system_score_gemma":0.00024469363,"threshold_uncertainty_score":0.3947735},"labels":[],"label_agreement":null},{"id":"W2885044386","doi":"10.1158/1538-7445.am2018-2269","title":"Abstract 2269: Transcription factor relationships associated with androgen-deprivation therapy response and metastatic progression in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Androgen deprivation therapy; Prostate cancer; JUNB; Androgen receptor; Transcription factor; Cancer research; Medicine; Enzalutamide; Oncology; Metastasis; Biology; Cancer; Internal medicine; Gene; Genetics","score_opus":0.19113687417518735,"score_gpt":0.4525648911335739,"score_spread":0.2614280169583866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885044386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880835,0.0059103067,0.0000045558068,0.0035162093,0.000047971676,0.002198245,0.000078138975,0.000050061386,0.000111044385],"genre_scores_gemma":[0.9928302,0.004676649,0.00006369464,0.000041411255,0.00007673268,0.0011180394,0.000059152844,0.000046135745,0.0010879908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712384,0.0005932575,0.00027414694,0.0004798519,0.0009218173,0.00060708367],"domain_scores_gemma":[0.99841523,0.00034655796,0.00007661394,0.00023838099,0.00070376304,0.00021947897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020098807,0.00018380495,0.00027110055,0.0005223783,0.0003665152,0.0000807654,0.00008815912,0.000096381445,0.00035913824],"category_scores_gemma":[0.00029002942,0.00012360574,0.000032308126,0.0011373216,0.00053062,0.00029181142,0.000024695504,0.0007459552,0.000010496025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039777108,0.0005100373,0.5694975,0.00017153779,0.00027072695,0.00014769917,0.008156639,0.0000058710034,0.32530707,0.000021731768,0.00042152245,0.055712506],"study_design_scores_gemma":[0.00730169,0.0015002782,0.9151682,0.001151724,0.000020186386,0.0000063960283,0.00052029383,0.00010174098,0.0727215,0.00014767794,0.0011979713,0.00016231062],"about_ca_topic_score_codex":0.00048084126,"about_ca_topic_score_gemma":0.0012871661,"teacher_disagreement_score":0.34567067,"about_ca_system_score_codex":0.00080445723,"about_ca_system_score_gemma":0.0010265645,"threshold_uncertainty_score":0.5040496},"labels":[],"label_agreement":null},{"id":"W2885064212","doi":"10.1158/1538-7445.am2018-2243","title":"Abstract 2243: Cell-phone radiofrequency enhances angiogenesis and stimulates cell invasion of human head and neck cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Economic Institute","funders":"","keywords":"Angiogenesis; Cell; Cancer cell; Cancer research; Cancer; Medicine; Chorioallantoic membrane; Biology; Cell biology; Pathology; Internal medicine; Genetics","score_opus":0.0916415247246021,"score_gpt":0.4120705320822909,"score_spread":0.32042900735768876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885064212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666641,0.031287458,0.0000020274583,0.00025927482,0.00008131576,0.00049425784,0.000022199363,0.000020508334,0.0011688609],"genre_scores_gemma":[0.9872294,0.011529376,0.00007425751,0.0001079835,0.00030216083,0.00006411534,0.000005934007,0.000021294933,0.00066545565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839956,0.00011043828,0.00024198557,0.00042965866,0.00035810447,0.0004602722],"domain_scores_gemma":[0.9989787,0.00021332677,0.00006855176,0.00023571412,0.00024683535,0.00025688566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005093006,0.00016962808,0.0003706817,0.00013719115,0.00020588576,0.000020808093,0.00012379864,0.00015743372,0.0008924238],"category_scores_gemma":[0.000019879242,0.00011860604,0.000055187098,0.00026789107,0.0007395487,0.000056438006,0.00008707641,0.00023850783,0.000023033343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023903819,0.00013402799,0.015614323,0.00056874385,0.00004154823,0.00001662229,0.00038199665,0.0000013231712,0.97157186,0.0000071755585,0.0002509236,0.011172416],"study_design_scores_gemma":[0.0012589997,0.0012844229,0.026701586,0.0003253656,0.000033677916,0.0000021761075,0.000047561116,0.000023343959,0.9688552,0.0001993804,0.0011383909,0.0001298844],"about_ca_topic_score_codex":0.0026978175,"about_ca_topic_score_gemma":0.00014400149,"teacher_disagreement_score":0.020565327,"about_ca_system_score_codex":0.00006851147,"about_ca_system_score_gemma":0.00014622282,"threshold_uncertainty_score":0.9771415},"labels":[],"label_agreement":null},{"id":"W2885066464","doi":"10.1158/1538-7445.am2018-4479","title":"Abstract 4479: Protein arginine methyltransferase PRMT6 regulates cancer stemness through CRAF methylation in hepatocellular carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Methylation; Protein arginine methyltransferase 5; Cancer research; Carcinogenesis; Gene silencing; MAPK/ERK pathway; Biology; Methyltransferase; Cancer; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.05860742552811902,"score_gpt":0.37662778241301786,"score_spread":0.3180203568848988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885066464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98751855,0.008677959,0.00040340435,0.0010331068,0.00028184714,0.0014831623,0.0000633684,0.000026650376,0.0005119339],"genre_scores_gemma":[0.99496675,0.00075127627,0.00018633035,0.000041432435,0.0012715835,0.0010770248,0.0001349157,0.00008020178,0.0014904945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690765,0.00032378972,0.00046673766,0.00087544386,0.00066044566,0.00076593785],"domain_scores_gemma":[0.99831617,0.000036547106,0.00010050292,0.00067006995,0.0007359893,0.00014071939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011277313,0.0002812012,0.0002972873,0.00023349203,0.00022280896,0.00006404251,0.00036848997,0.00040060226,0.00060412893],"category_scores_gemma":[0.00009837867,0.0002818826,0.00010161497,0.00088501314,0.00042078068,0.000034886114,0.00011653993,0.0004556805,0.000026575262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005771658,0.00006762144,0.0075348597,0.00013662795,0.000067068766,0.000008347973,0.00040996514,0.0006254221,0.98302853,0.00007402722,0.0008294549,0.0066408888],"study_design_scores_gemma":[0.0011920925,0.00025235768,0.018749941,0.00018960152,0.0000146874045,0.0000024547749,0.000096239404,0.00061511813,0.9643718,0.00039918025,0.013791818,0.00032472934],"about_ca_topic_score_codex":0.0058618695,"about_ca_topic_score_gemma":0.0037589704,"teacher_disagreement_score":0.018656772,"about_ca_system_score_codex":0.00039113665,"about_ca_system_score_gemma":0.00079501653,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W2885068254","doi":"10.1158/1538-7445.am2018-1936","title":"Abstract 1936: The central role of NFAT signalling in the mechanism of action of the TRPV6 oncochannel inhibitor and clinical candidate SOR-C13","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"NFAT; Prostate cancer; Cancer research; Reporter gene; Transfection; Medicine; Biology; Chemistry; Internal medicine; Calcineurin; Cell culture; Gene expression; Cancer; Gene; Biochemistry","score_opus":0.07705651906599703,"score_gpt":0.4153374700789012,"score_spread":0.3382809510129042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885068254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982427,0.00088943186,0.000027190505,0.0002407474,0.00014287505,0.00028880316,0.000050340936,0.0000012193536,0.000116691706],"genre_scores_gemma":[0.9990849,0.00040462657,0.000009519305,0.000043275246,0.0004021941,0.000020675001,0.0000042993897,0.0000100565785,0.000020488424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986018,0.00033428395,0.000285399,0.00019723823,0.0003470279,0.00023427188],"domain_scores_gemma":[0.99913853,0.00013855175,0.0001266997,0.00034822905,0.00020451211,0.000043472894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015750419,0.00007308811,0.00012015258,0.000026930795,0.000079469224,0.000009989188,0.00041897516,0.00010735067,0.00002346511],"category_scores_gemma":[0.00026188404,0.000040169332,0.00008181768,0.00015181195,0.00059293286,0.0000038106243,0.00015212402,0.0002456432,5.3879774e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031476025,0.00007326525,0.0037848908,0.000038895996,0.000033408716,4.5911423e-7,0.00044267497,0.000030375784,0.993459,0.00013408602,0.00026947202,0.0014187511],"study_design_scores_gemma":[0.00036510246,0.00020732268,0.009368802,0.000084862346,0.000013120813,7.806609e-7,0.0009003397,0.00009934094,0.9879389,0.0006741894,0.0003028285,0.000044432076],"about_ca_topic_score_codex":0.0008165835,"about_ca_topic_score_gemma":0.00061244785,"teacher_disagreement_score":0.005583911,"about_ca_system_score_codex":0.000021871441,"about_ca_system_score_gemma":0.0003143881,"threshold_uncertainty_score":0.21846858},"labels":[],"label_agreement":null},{"id":"W2885084321","doi":"10.1158/1538-7445.am2018-4340","title":"Abstract 4340: Integrating whole genome and transcriptome analysis to inform treatment decisions in the metastatic cancer clinical setting","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"3v Geomatics (Canada)","funders":"","keywords":"Genome; Disease; Genomics; Personalized medicine; Computational biology; Cancer; Genomic information; Transcriptome; Bioinformatics; Medicine; Biology; Internal medicine; Gene; Genetics","score_opus":0.1195489562150339,"score_gpt":0.4777597416016384,"score_spread":0.3582107853866045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885084321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940844,0.0024613412,0.00023617064,0.002004491,0.000084687636,0.00041323272,0.00025860505,0.000003100187,0.00045394443],"genre_scores_gemma":[0.99388105,0.004088126,0.00043199107,0.00063175196,0.00041141038,0.00032366085,0.000056646375,0.000015215351,0.00016013732],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984412,0.00011146978,0.0003673447,0.00040152643,0.00026007456,0.00041835287],"domain_scores_gemma":[0.99887407,0.0003146004,0.000047883248,0.00038284968,0.00022208574,0.00015849603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00146144,0.00013465103,0.00022599968,0.00021019613,0.00024324853,0.00011733778,0.00028785205,0.0000701324,0.00007125703],"category_scores_gemma":[0.00040197166,0.00009319356,0.0001143336,0.00080999744,0.00019710671,0.0000062588842,0.00009953328,0.00020569605,0.000011938617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000698047,0.00047636993,0.054087397,0.000029913566,0.0017350967,0.000037304708,0.00915993,0.0014624996,0.5133777,0.00020324404,0.004585852,0.4141466],"study_design_scores_gemma":[0.0024222624,0.002789348,0.35322317,0.000109847686,0.00044321135,0.000005900897,0.005753269,0.00060860644,0.01667151,0.0002381808,0.6171185,0.0006162122],"about_ca_topic_score_codex":0.0025114985,"about_ca_topic_score_gemma":0.029837081,"teacher_disagreement_score":0.6125326,"about_ca_system_score_codex":0.00013303358,"about_ca_system_score_gemma":0.00038526164,"threshold_uncertainty_score":0.98786587},"labels":[],"label_agreement":null},{"id":"W2885084402","doi":"10.1158/1538-7445.am2018-4595","title":"Abstract 4595: The VAR2CSA malaria protein efficiently retrieves CTCs from a broad spectrum of cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Circulating tumor cell; Metastasis; Cancer; Cancer cell; Cancer research; Intravasation; Biology; Antibody; Medicine; Immunology; Internal medicine","score_opus":0.07504403972290045,"score_gpt":0.39660779658741213,"score_spread":0.32156375686451166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885084402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98081183,0.0041041924,0.000029014092,0.005840164,0.0003912132,0.0012944079,0.0002198668,0.000029283952,0.007280014],"genre_scores_gemma":[0.9942408,0.00058329065,0.00014152577,0.00016427218,0.0013401988,0.00018094234,0.000012788032,0.00004141324,0.003294764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718213,0.00009247662,0.0003513522,0.0004835369,0.0011962395,0.000694252],"domain_scores_gemma":[0.99817616,0.00016282558,0.000116905314,0.00081492134,0.0004978231,0.00023138616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012014533,0.00017341273,0.00037006108,0.00017737235,0.00023056199,0.000048801183,0.0003989698,0.000111896385,0.0052861976],"category_scores_gemma":[0.00023082126,0.00011702953,0.00013485448,0.0010518678,0.0009977056,0.00006131179,0.00014872548,0.0007077031,0.00011327731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037427193,0.00021639527,0.0027861474,0.00035211645,0.00040836146,0.000056503373,0.002187542,0.000016322067,0.93136054,0.0006648099,0.027792342,0.03041617],"study_design_scores_gemma":[0.0017789141,0.00064128207,0.040406086,0.0006129423,0.00007648109,0.0000042695565,0.00061716477,0.000033027638,0.85753876,0.00040944596,0.0977073,0.00017430117],"about_ca_topic_score_codex":0.03288387,"about_ca_topic_score_gemma":0.0031886492,"teacher_disagreement_score":0.07382178,"about_ca_system_score_codex":0.00063917105,"about_ca_system_score_gemma":0.00175465,"threshold_uncertainty_score":0.9956231},"labels":[],"label_agreement":null},{"id":"W2885098219","doi":"10.1158/1538-7445.am2018-110","title":"Abstract 110: PPARγ loss increases the metastatic potential of HER2+ breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Peroxisome proliferator-activated receptor; Cancer research; Carcinogenesis; Internal medicine; Breast cancer; Metastatic breast cancer; Metastasis; Endocrinology; Tumor progression; Cancer; Medicine; Biology; Receptor","score_opus":0.0349456361641638,"score_gpt":0.3764722958599897,"score_spread":0.3415266596958259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885098219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827859,0.014103324,0.000040498526,0.0007721712,0.0007759941,0.00031686088,0.00050666014,0.000007798894,0.0006908147],"genre_scores_gemma":[0.9864293,0.0071922545,0.000031478605,0.00019303623,0.004748802,0.00018310887,0.000025696214,0.000033278102,0.0011630447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981566,0.00016504215,0.00023941227,0.00038778828,0.00051914755,0.00053200894],"domain_scores_gemma":[0.9984677,0.000034224864,0.00008950932,0.00055201334,0.0007105034,0.00014608998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007048271,0.00015496869,0.00021142543,0.000074128395,0.00022697102,0.00004119817,0.0005075412,0.00008621403,0.001245359],"category_scores_gemma":[0.00007627167,0.00011097292,0.0001237,0.00028215104,0.00096889446,0.000008630765,0.00021972223,0.00023243457,0.000024735644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006509402,0.00013218471,0.0009343318,0.00009749884,0.00025318345,0.000004040405,0.00010618062,0.000050633313,0.9119944,0.00008603377,0.059413433,0.02627713],"study_design_scores_gemma":[0.0016610785,0.00026258195,0.084665515,0.00013039984,0.00012079076,0.00006918522,0.00045607667,0.00002697464,0.55709445,0.00029955778,0.3548243,0.00038908605],"about_ca_topic_score_codex":0.010931735,"about_ca_topic_score_gemma":0.003097788,"teacher_disagreement_score":0.35489994,"about_ca_system_score_codex":0.000043387565,"about_ca_system_score_gemma":0.00078908936,"threshold_uncertainty_score":0.99966764},"labels":[],"label_agreement":null},{"id":"W2885104851","doi":"10.1158/1538-7445.am2018-2417","title":"Abstract 2417: eIF4E phosphorylation licenses Myc-driven metabolic and stress reprogramming","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"EIF4E; Cancer research; Biology; Phosphorylation; Glutamine; Translation (biology); Cell biology; Genetics; Messenger RNA; Gene; Amino acid","score_opus":0.05843536011057339,"score_gpt":0.4017604550093474,"score_spread":0.343325094898774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885104851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821235,0.015714638,0.000102477105,0.0001869353,0.00025036035,0.00027399766,0.000058843583,0.00002000877,0.0012692634],"genre_scores_gemma":[0.99421555,0.0028090915,0.00042616684,0.00008183258,0.0015382977,0.000083836,0.00003791083,0.0000396886,0.00076759903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982569,0.00008527487,0.00018560664,0.0005914073,0.00037473175,0.00050606916],"domain_scores_gemma":[0.9987854,0.00003930604,0.00006558147,0.00047767867,0.00048273645,0.00014931198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005433635,0.0001455318,0.00014901982,0.000086711996,0.00023407154,0.00009995963,0.00026701658,0.00016546644,0.00024975557],"category_scores_gemma":[0.000169362,0.00014160156,0.000048581678,0.00023644001,0.00046759486,0.00001083487,0.00020116397,0.00024744024,0.000041001924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020494458,0.000041263465,0.012772013,0.000052817133,0.000094143346,0.0000053436465,0.0002916406,0.000027138827,0.8885731,0.00006717088,0.004304215,0.093566224],"study_design_scores_gemma":[0.00036681793,0.00018112514,0.012765683,0.00007076554,0.000012485084,0.0000033851775,0.00014788793,0.00005335783,0.7871468,0.000044769837,0.19902353,0.00018336887],"about_ca_topic_score_codex":0.00052286,"about_ca_topic_score_gemma":0.00035481487,"teacher_disagreement_score":0.19471931,"about_ca_system_score_codex":0.000049200968,"about_ca_system_score_gemma":0.00022923358,"threshold_uncertainty_score":0.57743436},"labels":[],"label_agreement":null},{"id":"W2885129760","doi":"10.1158/1538-7445.am2018-5359","title":"Abstract 5359: Regulatory germline variants in 10,389 adult cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Germline; Biology; Genetics; Germline mutation; Cancer; Gene; Mutation","score_opus":0.051238821571493655,"score_gpt":0.3988787062271243,"score_spread":0.3476398846556306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885129760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712486,0.0016814684,0.00002990481,0.0006557437,0.00019325965,0.0002240853,0.000044103777,0.000009109227,0.010037463],"genre_scores_gemma":[0.9880571,0.0012667432,0.00005859425,0.0001869273,0.0010644714,0.00024303475,0.000034812532,0.000028657749,0.009059697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984276,0.000072715,0.00021103189,0.00047728105,0.0003186371,0.00049270963],"domain_scores_gemma":[0.9986361,0.000013130381,0.00004490211,0.00059358764,0.00058698293,0.00012526172],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055232394,0.0001156001,0.00011792857,0.00012396516,0.00014598887,0.000034853765,0.0003423227,0.00015397723,0.0014284193],"category_scores_gemma":[0.000101207785,0.000112097114,0.000044184035,0.00033974004,0.00035482974,0.0000076209512,0.000097035954,0.00021587919,0.00011492884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030128146,0.00005372361,0.00198811,0.000032037464,0.000033536067,0.0000062183235,0.00009960723,0.00007337024,0.9251813,0.00027332734,0.05660867,0.015348762],"study_design_scores_gemma":[0.0017265843,0.00038889388,0.21211827,0.0001696412,0.000007894027,0.0000051487946,0.0002658791,0.00016545165,0.46386042,0.00030033273,0.32049385,0.0004976613],"about_ca_topic_score_codex":0.0015795683,"about_ca_topic_score_gemma":0.0038209355,"teacher_disagreement_score":0.46132094,"about_ca_system_score_codex":0.0002560293,"about_ca_system_score_gemma":0.0008559625,"threshold_uncertainty_score":0.9994844},"labels":[],"label_agreement":null},{"id":"W2885137592","doi":"10.1158/1538-7445.am2018-4461","title":"Abstract 4461: Sirt6 deletion slows mouse mammary tumorigenesis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SIRT6; Carcinogenesis; Cancer research; Mammary tumor; Biology; Warburg effect; Cancer; Cancer cell; Cell culture; NAD+ kinase; Breast cancer; Chemistry; Sirtuin; Enzyme; Biochemistry; Genetics","score_opus":0.09298844124227353,"score_gpt":0.4336415317087286,"score_spread":0.3406530904664551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885137592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789358,0.0022503708,0.00012491147,0.005806722,0.0005906394,0.00049981714,0.000009446488,0.000089757494,0.011692557],"genre_scores_gemma":[0.97880816,0.002406234,0.0002714797,0.00072482834,0.004282009,0.00013555131,0.000021427855,0.000044133034,0.013306195],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975785,0.000079622645,0.0002523398,0.00040980286,0.0010404204,0.0006393417],"domain_scores_gemma":[0.99807924,0.00010150811,0.00003863472,0.0005896343,0.0008261499,0.00036483764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011269408,0.00014508623,0.00026950476,0.0002997108,0.0002669364,0.00004017993,0.00023810219,0.00014040693,0.0024814536],"category_scores_gemma":[0.00022133125,0.00010713229,0.00007972953,0.00056058797,0.00041996577,0.00009798712,0.00009456405,0.00058389537,0.0004136296],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008174392,0.00022268854,0.004452171,0.0002691227,0.00012601611,0.00034781778,0.00039810274,0.0000035782525,0.7923308,0.00036850866,0.14570546,0.054958314],"study_design_scores_gemma":[0.004876155,0.002351289,0.10553627,0.0007209257,0.00008072372,0.000095130476,0.0007204013,0.0004628596,0.420964,0.00035663173,0.4633638,0.00047184285],"about_ca_topic_score_codex":0.0007757071,"about_ca_topic_score_gemma":0.000096144846,"teacher_disagreement_score":0.3713668,"about_ca_system_score_codex":0.00031130516,"about_ca_system_score_gemma":0.0005241158,"threshold_uncertainty_score":0.99843043},"labels":[],"label_agreement":null},{"id":"W2885145075","doi":"10.1158/1538-7445.am2018-ct115","title":"Abstract CT115: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Pembrolizumab; Population; Internal medicine; Oncology; Hazard ratio; Clinical endpoint; Cetuximab; Regimen; Head and neck squamous-cell carcinoma; Confidence interval; Progression-free survival; Head and neck cancer; Surgery; Chemotherapy; Radiation therapy; Cancer; Randomized controlled trial; Immunotherapy","score_opus":0.11656350883304448,"score_gpt":0.43926108155197646,"score_spread":0.32269757271893196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885145075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231815,0.002923903,0.0000021770747,0.00072540395,0.00022488685,0.0023897756,0.0006673291,0.000009477855,0.00073888205],"genre_scores_gemma":[0.9989262,0.0003507224,0.000071486385,0.000024881827,0.00013849925,0.00013871229,0.000011275214,0.00003622479,0.00030197267],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974177,0.00018081126,0.0005983477,0.00040310845,0.00095764257,0.0004423942],"domain_scores_gemma":[0.9968917,0.0004100358,0.00020234767,0.0005705372,0.0018043508,0.00012107235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000898173,0.0001858806,0.00082222896,0.00015347476,0.00017858601,0.000010019029,0.0002409611,0.000058027104,0.00009418153],"category_scores_gemma":[0.00031189297,0.00011291513,0.00009704867,0.00054867077,0.00052873295,0.000039659793,0.00012324564,0.00028864117,7.1536346e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69329375,0.004078682,0.05570816,0.013212662,0.0008600143,0.000037706995,0.094144896,0.000012123209,0.038559105,0.000046967554,0.033021837,0.067024104],"study_design_scores_gemma":[0.086952105,0.08500957,0.41769403,0.0012249725,0.00031422422,0.000004757519,0.026348198,0.000061587634,0.36629346,0.00004793989,0.015683169,0.00036601003],"about_ca_topic_score_codex":0.0015821683,"about_ca_topic_score_gemma":0.004665698,"teacher_disagreement_score":0.60634166,"about_ca_system_score_codex":0.00020478632,"about_ca_system_score_gemma":0.0010317874,"threshold_uncertainty_score":0.46045452},"labels":[],"label_agreement":null},{"id":"W2885150911","doi":"10.1158/1538-7445.am2018-724","title":"Abstract 724: A novel heterologous prime boost vaccine system drives tumor specific and potent CD8 T cell responses for cancer immunotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Antigen; Cancer immunotherapy; Viral vector; CD8; Biology; Virology; Vaccination; Heterologous; Expression cassette; Immune system; Vector (molecular biology); T cell; Immunotherapy; Immunology; MHC class I; Recombinant DNA; Genetics","score_opus":0.049360260555517996,"score_gpt":0.3489953938297942,"score_spread":0.2996351332742762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885150911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88425314,0.11164242,0.00018996139,0.00076988223,0.0011364245,0.0013648784,0.0003399307,0.00015441174,0.00014894917],"genre_scores_gemma":[0.985713,0.0070026773,0.0001087949,0.00022720256,0.00033556236,0.0009508864,0.000030485404,0.00012672048,0.005504669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99683416,0.00048531604,0.0005545068,0.00075723114,0.00015230564,0.0012164669],"domain_scores_gemma":[0.99757373,0.0008672105,0.00019730003,0.0007123134,0.0005888254,0.00006060553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015117907,0.00038133108,0.00058314996,0.00043879848,0.00092954066,0.00011491534,0.00061063655,0.00030272483,0.0005991611],"category_scores_gemma":[0.00007068704,0.0003174516,0.00016153559,0.00030078154,0.0008668307,0.00017010764,0.00015898421,0.00066312216,0.00013907626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02173947,0.00019774814,0.0004519762,0.00013461131,0.00030789126,0.000008524268,0.0010381811,0.0000013833808,0.9582046,0.00009831612,0.0041349353,0.013682339],"study_design_scores_gemma":[0.004623296,0.0011757377,0.016765397,0.00023328452,0.000014701543,0.00007219875,0.0005991016,0.000003937945,0.68678504,0.0000143887355,0.2894153,0.00029762936],"about_ca_topic_score_codex":0.0010289222,"about_ca_topic_score_gemma":0.000101762715,"teacher_disagreement_score":0.28528038,"about_ca_system_score_codex":0.00036840822,"about_ca_system_score_gemma":0.0004618838,"threshold_uncertainty_score":0.99992776},"labels":[],"label_agreement":null},{"id":"W2885171554","doi":"10.1158/1538-7445.am2018-4327","title":"Abstract 4327: The epigenetic effects of benzo[<i>a</i>]pyrene exposure","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"DNA methylation; Epigenetics; Methylation; Molecular biology; Biology; Differentially methylated regions; CpG site; Bisulfite sequencing; Benzo(a)pyrene; Carcinogen; Genetics; DNA; Gene; Gene expression","score_opus":0.04549960162514135,"score_gpt":0.37550657740541943,"score_spread":0.3300069757802781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885171554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873741,0.0007778157,0.00008457454,0.000882096,0.00015154202,0.0007130427,0.000007860442,0.000014162466,0.00999479],"genre_scores_gemma":[0.9979051,0.0006573276,0.000069236805,0.00030207742,0.00023294149,0.0001825831,0.0000013708083,0.00002702869,0.00062233716],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99728566,0.00033215707,0.00022742931,0.00048571173,0.000970672,0.00069839513],"domain_scores_gemma":[0.99848515,0.000598465,0.000070601534,0.0006322937,0.00003376591,0.00017974677],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017666126,0.00012750931,0.00014654672,0.00005265059,0.00038776486,0.000023830451,0.00056341547,0.00007677099,0.0045103612],"category_scores_gemma":[0.00026542394,0.000093243274,0.000046125504,0.00045362103,0.0015250207,0.00010671672,0.00037162344,0.00045636483,0.0012960305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056140416,0.00013857569,0.06017508,0.00015742441,0.000030501467,0.00002009723,0.0023192412,0.00011783068,0.73284596,0.000038739836,0.005203476,0.19889694],"study_design_scores_gemma":[0.0002996634,0.00028170415,0.6361742,0.000088674235,0.0000069047705,0.0000010837184,0.00012155498,0.000027019461,0.3475131,0.0004251455,0.014945336,0.000115610375],"about_ca_topic_score_codex":0.0022332857,"about_ca_topic_score_gemma":0.00066586386,"teacher_disagreement_score":0.5759991,"about_ca_system_score_codex":0.00032292947,"about_ca_system_score_gemma":0.00007136119,"threshold_uncertainty_score":0.99948156},"labels":[],"label_agreement":null},{"id":"W2885182581","doi":"10.1158/1538-7445.am2018-4623","title":"Abstract 4623: Meta-analysis of transcriptomic profiles identifies prognostic model for pancreatic ductal adenocarcinoma patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; Mount Sinai Hospital; University Health Network","funders":"","keywords":"Hazard ratio; Medicine; Pancreatic ductal adenocarcinoma; Oncology; Pancreatic cancer; Internal medicine; Proportional hazards model; Survival analysis; Gene expression profiling; Meta-analysis; Adenocarcinoma; Bioinformatics; Confidence interval; Cancer; Biology; Gene; Gene expression","score_opus":0.2726165992546015,"score_gpt":0.46609480297155614,"score_spread":0.19347820371695462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885182581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921206,0.0028597328,0.0004867285,0.0006307779,0.00006887819,0.002621684,0.0004019857,0.000027001008,0.0007825732],"genre_scores_gemma":[0.9918679,0.00018683319,0.0007403886,0.00005207255,0.0001594244,0.0020907598,0.00012861873,0.000042219537,0.004731788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965021,0.00016493065,0.00064962864,0.0005993235,0.0012674812,0.0008165062],"domain_scores_gemma":[0.9960554,0.0006060036,0.00013299251,0.00060884363,0.002359596,0.00023714277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016525683,0.00022265257,0.0016772137,0.00094416953,0.00025719544,0.00003563818,0.00034526584,0.00017574534,0.001727563],"category_scores_gemma":[0.000779796,0.00016483937,0.00081182225,0.0011846846,0.0010674442,0.00012790321,0.00007353987,0.00037462142,0.000035923615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034801466,0.0010281185,0.80965483,0.001659306,0.14987639,0.000018695751,0.0030291192,0.00005071509,0.024036098,0.00035738686,0.006446379,0.00036282957],"study_design_scores_gemma":[0.0024972816,0.0012956591,0.7871441,0.00007106604,0.16630183,0.0000021359335,0.00046050068,0.034627106,0.0066081085,0.0006684903,0.00007908466,0.0002445896],"about_ca_topic_score_codex":0.00048158495,"about_ca_topic_score_gemma":0.0003814481,"teacher_disagreement_score":0.03457639,"about_ca_system_score_codex":0.00022183685,"about_ca_system_score_gemma":0.0008948395,"threshold_uncertainty_score":0.99918497},"labels":[],"label_agreement":null},{"id":"W2885188866","doi":"10.1158/1538-7445.am2018-3849","title":"Abstract 3849: Identification and optimization of chemical compounds as potent agonists of human STING with anticancer activity in mice","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sting; Pharmacology; Agonist; Cancer; Stimulator of interferon genes; Medicine; Cancer immunotherapy; In vitro; Melanoma; Innate immune system; Cancer research; Immunotherapy; Chemistry; Immune system; Biochemistry; Immunology; Receptor; Internal medicine","score_opus":0.05348788033366492,"score_gpt":0.39312465295121796,"score_spread":0.33963677261755304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885188866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856114,0.00048605888,0.00005434127,0.00011911915,0.000048135065,0.00016108838,0.000009120175,0.000005741121,0.00055527856],"genre_scores_gemma":[0.9995697,0.000087711676,0.000030669453,0.000005039997,0.0000140880975,0.000017323375,0.000010553119,0.000008301333,0.0002566176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920064,0.00014989328,0.00019583077,0.00018187665,0.0000725967,0.00019916985],"domain_scores_gemma":[0.9993128,0.000114966555,0.00009861437,0.00013749504,0.00032407133,0.000012034274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052357296,0.00006540564,0.00016501281,0.00015140585,0.00007891893,0.000011162567,0.00012205461,0.00008975533,0.00016980548],"category_scores_gemma":[0.00008542352,0.000056666075,0.00001534045,0.00018112584,0.0008860984,0.00007594248,0.00006213372,0.00023482463,0.00000657746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191678,0.00009747197,0.0013279241,0.00007005956,0.00003528945,6.6232974e-7,0.00047578866,0.000017785933,0.9947403,0.000086062464,0.00006229099,0.0017671977],"study_design_scores_gemma":[0.00060072634,0.00025016774,0.031424675,0.00017817762,0.000005141895,0.000005072557,0.00018214394,0.000030258043,0.96720856,0.000014032966,0.000047094105,0.000053947973],"about_ca_topic_score_codex":0.0018570345,"about_ca_topic_score_gemma":0.00009890509,"teacher_disagreement_score":0.03009675,"about_ca_system_score_codex":0.00008320226,"about_ca_system_score_gemma":0.00013349726,"threshold_uncertainty_score":0.32648665},"labels":[],"label_agreement":null},{"id":"W2885193471","doi":"10.1158/1538-7445.am2018-ct110","title":"Abstract CT110: Clinical pharmacology of tisagenlecleucel (CTL019) in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Cmax; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Pharmacokinetics; Cytokine release syndrome; CD19; Oncology; Logistic regression; Lymphoma; Immunotherapy; Immunology; Gastroenterology; Pharmacology; Cancer; Peripheral blood","score_opus":0.08152018180211967,"score_gpt":0.4497604693759716,"score_spread":0.3682402875738519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885193471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898593,0.0005271569,0.0000030120812,0.00032081266,0.00048604698,0.0013852728,0.000064041466,0.00003371295,0.0073206904],"genre_scores_gemma":[0.9914572,0.0009469558,0.000052760864,0.0002689742,0.00094254245,0.0001486388,0.000032690572,0.00010051504,0.0060497024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949938,0.0005550206,0.0007411398,0.0007502526,0.0016631066,0.0012966583],"domain_scores_gemma":[0.9966214,0.00069058064,0.00015257561,0.0007816509,0.0012344926,0.00051935914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002752496,0.0002463508,0.0006650346,0.00063785695,0.00013393574,0.000022101298,0.000504298,0.00032691527,0.011140714],"category_scores_gemma":[0.00022564841,0.0002017599,0.00013791745,0.0010376471,0.0012197522,0.00013841956,0.00027755057,0.001283153,0.00032489115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02644935,0.034359165,0.6965763,0.0005177759,0.00030589986,0.00025864714,0.000846915,6.776166e-7,0.15542337,0.00001541834,0.032759823,0.052486658],"study_design_scores_gemma":[0.080131546,0.004604172,0.8165335,0.0002295005,0.00003468425,0.0000027191986,0.0001301969,0.00003228559,0.044249095,0.000014823768,0.053797875,0.000239605],"about_ca_topic_score_codex":0.00080126035,"about_ca_topic_score_gemma":0.00039797818,"teacher_disagreement_score":0.11995721,"about_ca_system_score_codex":0.0007096326,"about_ca_system_score_gemma":0.0015117849,"threshold_uncertainty_score":0.98976326},"labels":[],"label_agreement":null},{"id":"W2885198180","doi":"10.1158/1538-7445.am2018-1284","title":"Abstract 1284: How can you interpret gene lists from -omics experiments","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene; Workflow; Computational biology; Function (biology); Relevance (law); Gene nomenclature; Resource (disambiguation); Similarity (geometry); Computer science; Biological network; Biology; World Wide Web; Genetics; Artificial intelligence; Database","score_opus":0.046461195006748286,"score_gpt":0.36949589885519424,"score_spread":0.32303470384844596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885198180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936579,0.0016578246,0.00041846966,0.00058907684,0.00047975115,0.00020312592,0.00022357958,0.000009351426,0.0027609612],"genre_scores_gemma":[0.99517035,0.0005798196,0.0004126857,0.00032953708,0.0017493032,0.00005981952,0.0002325684,0.000029078463,0.0014368283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878335,0.000030025216,0.0001581891,0.00032556494,0.00023241031,0.00047045515],"domain_scores_gemma":[0.9990619,0.000012622378,0.00003845706,0.0005114442,0.00020759403,0.00016801052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002798736,0.0001350181,0.0001234856,0.00004741943,0.00015395967,0.00011687792,0.0004333339,0.00018639312,0.00019601244],"category_scores_gemma":[0.000028223694,0.0001263357,0.00005622885,0.00008837773,0.0002740173,0.0000052253386,0.00032163385,0.00022956177,0.000042237807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014232952,0.000025568546,0.0004481675,0.000010034017,0.00008031989,0.0000029682892,0.0005183118,0.0000041539365,0.9587707,0.00003537365,0.029974964,0.009987123],"study_design_scores_gemma":[0.00045796882,0.00018335538,0.0010690528,0.000031112806,0.000004550479,0.0000018078915,0.0002581947,0.00018446354,0.9171993,0.0003920817,0.0800111,0.00020702607],"about_ca_topic_score_codex":0.0006308999,"about_ca_topic_score_gemma":0.0004127046,"teacher_disagreement_score":0.050036136,"about_ca_system_score_codex":0.00008458254,"about_ca_system_score_gemma":0.00018190655,"threshold_uncertainty_score":0.515182},"labels":[],"label_agreement":null},{"id":"W2885205424","doi":"10.1158/1538-7445.am2018-3410","title":"Abstract 3410: Copy number estimation from whole-exome sequencing in tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exome sequencing; Exome; Prostate cancer; Copy-number variation; Computational biology; Computer science; Medicine; Cancer; Biology; Genetics; Mutation; Internal medicine; Gene; Genome","score_opus":0.05409366897306008,"score_gpt":0.396378226207766,"score_spread":0.34228455723470597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885205424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948474,0.0004925078,0.00016929285,0.0002621847,0.00018106478,0.00017933722,0.000113086644,0.0000068952195,0.0037481892],"genre_scores_gemma":[0.9977158,0.00031273032,0.0004347466,0.00017194104,0.00083315733,0.000079461766,0.00013729041,0.000026079426,0.00028880898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876857,0.0000427462,0.00018972701,0.00037369196,0.0002388956,0.0003863463],"domain_scores_gemma":[0.9992588,0.000056074514,0.000039739323,0.00032939544,0.00021287853,0.00010311076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039549574,0.000103370396,0.000115299525,0.0000645085,0.000099672565,0.00006309161,0.00022507958,0.00011625474,0.00041671828],"category_scores_gemma":[0.00020977878,0.00010919077,0.00003366687,0.00019544034,0.00019629931,0.0000065027857,0.00013414619,0.00020927668,0.00023246705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018486896,0.00003032655,0.019725047,0.000024744766,0.000023099663,0.000022789562,0.0002811282,0.00078818854,0.9571536,0.00012444616,0.013919892,0.007721853],"study_design_scores_gemma":[0.0011907002,0.0002221404,0.059507683,0.00020353367,0.0000066028233,0.000005107533,0.00030942447,0.0011075437,0.8875806,0.0024310194,0.0470446,0.00039104433],"about_ca_topic_score_codex":0.0058477474,"about_ca_topic_score_gemma":0.0029875394,"teacher_disagreement_score":0.069573015,"about_ca_system_score_codex":0.0003341354,"about_ca_system_score_gemma":0.0006909486,"threshold_uncertainty_score":0.8840084},"labels":[],"label_agreement":null},{"id":"W2885213394","doi":"10.1158/1538-7445.am2018-3171","title":"Abstract 3171: Vangl2 regulates cancer stem cell self-renewal and growth in rhabdomyosarcoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Wnt signaling pathway; Cancer stem cell; Zebrafish; Cancer; Cancer research; Biology; Stem cell; Rhabdomyosarcoma; Progenitor cell; Cell growth; Cell biology; Medicine; Signal transduction; Pathology; Genetics; Sarcoma","score_opus":0.035323099794773494,"score_gpt":0.3412482997971545,"score_spread":0.305925200002381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885213394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126655,0.0060553453,0.0000046724863,0.0002842833,0.00013236409,0.00020794,0.000036372803,0.000018662406,0.001993834],"genre_scores_gemma":[0.995815,0.0017980452,0.00007820743,0.00007017762,0.0006912272,0.00011506377,0.000012939128,0.00003433983,0.0013850129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983071,0.00012269491,0.00019172023,0.0005177121,0.0002877269,0.0005730603],"domain_scores_gemma":[0.9991873,0.00003601121,0.000040884064,0.00027958764,0.0002888857,0.00016731616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006320633,0.00015600638,0.00015964956,0.00012773881,0.00016222402,0.00005334792,0.0002626663,0.000192674,0.00010365338],"category_scores_gemma":[0.000019755824,0.0001439486,0.000040914052,0.0002490367,0.0003205974,0.000006568756,0.00016025829,0.00025968856,0.000022590373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012850482,0.00005825494,0.011978317,0.000095999574,0.000026706792,0.000012573965,0.00039798435,0.0000056335703,0.9826915,0.000033638767,0.0009131856,0.0036576616],"study_design_scores_gemma":[0.00066093635,0.00024369416,0.005587781,0.00008092681,0.0000055545343,0.0000031761153,0.00013550262,0.000023119153,0.98529524,0.00021756774,0.0075457087,0.0002007745],"about_ca_topic_score_codex":0.0018669562,"about_ca_topic_score_gemma":0.0010707536,"teacher_disagreement_score":0.006632523,"about_ca_system_score_codex":0.00007672018,"about_ca_system_score_gemma":0.00037522425,"threshold_uncertainty_score":0.5870054},"labels":[],"label_agreement":null},{"id":"W2885232520","doi":"10.1158/1538-7445.am2018-3413","title":"Abstract 3413: A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-β pathway","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Epigenomics; Transcriptome; Gene; Genetics; Cancer research; Gene expression; DNA methylation","score_opus":0.06552515134943829,"score_gpt":0.4167186050792456,"score_spread":0.35119345372980726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885232520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899049,0.003064661,0.00005944475,0.0051742787,0.00011829966,0.00045701533,0.000018901572,0.000009904911,0.0011926392],"genre_scores_gemma":[0.99695426,0.0014285325,0.00014143297,0.00045467765,0.00059820607,0.00013082914,0.000007669199,0.0000234569,0.00026091287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985491,0.00016784447,0.0002695466,0.00028130252,0.00035939485,0.0003727844],"domain_scores_gemma":[0.999218,0.00016818033,0.000042783344,0.0003004388,0.00014530546,0.00012532416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00160416,0.00009902814,0.00022068703,0.00019462792,0.00016566066,0.00004503038,0.00022647307,0.000060743238,0.00047688565],"category_scores_gemma":[0.000098535,0.00006881339,0.00004146886,0.00021753374,0.0005682806,0.00007962897,0.000029439989,0.00072063337,0.00001765212],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031517862,0.0001469424,0.0140572665,0.00016686732,0.000047767007,0.000026383745,0.010993667,0.000027633072,0.8968726,0.00056206266,0.0015170322,0.07526664],"study_design_scores_gemma":[0.004702072,0.0009672391,0.8875936,0.00073299854,0.00006849987,0.000055681845,0.0030033125,0.007071339,0.03750867,0.0014597682,0.05648044,0.0003563665],"about_ca_topic_score_codex":0.0035938167,"about_ca_topic_score_gemma":0.0011968887,"teacher_disagreement_score":0.87353635,"about_ca_system_score_codex":0.00013225384,"about_ca_system_score_gemma":0.00045062246,"threshold_uncertainty_score":0.54328},"labels":[],"label_agreement":null},{"id":"W2885254097","doi":"10.1158/1538-7445.am2018-1878","title":"Abstract 1878: Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted anticancer drugs bortezomib, carfilzomib, ixazomib, oprozomib, and delanzomib","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ixazomib; Carfilzomib; Bortezomib; Cardiotoxicity; Pharmacology; Chemistry; Proteasome inhibitor; Proteasome; Medicine; Biochemistry; Toxicity; Multiple myeloma; Internal medicine","score_opus":0.025100125993766452,"score_gpt":0.31942173083443604,"score_spread":0.2943216048406696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885254097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946468,0.0007974611,0.00009148611,0.0008397939,0.0005627688,0.0022837876,0.00024216241,0.00003852517,0.00049724156],"genre_scores_gemma":[0.9986979,0.000050990304,0.0003261452,0.00015000904,0.00016404744,0.00042857055,0.0000010336671,0.00005478631,0.00012651274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99500465,0.00072719966,0.00065772224,0.0007242639,0.0019502578,0.00093590736],"domain_scores_gemma":[0.99651283,0.00024306134,0.00033767824,0.0015402929,0.0011615438,0.00020457007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030566123,0.00029243526,0.00054154644,0.00014183132,0.00048730854,0.0000868498,0.0014836449,0.0001839105,0.00043726],"category_scores_gemma":[0.0005025265,0.00018447085,0.00021366507,0.001094381,0.0025778771,0.0002167977,0.0009553015,0.00053928397,0.000030393754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028813732,0.000102237806,0.0013547236,0.00016626903,0.000051452134,0.000004535034,0.0005176965,0.00007985617,0.9950625,0.0013607042,0.00044249857,0.00056941307],"study_design_scores_gemma":[0.0010074929,0.00012329205,0.010988912,0.0002483315,0.000045018445,0.0000047546205,0.00026815987,0.00016829318,0.98451257,0.0022194507,0.00020406288,0.00020966363],"about_ca_topic_score_codex":0.003110548,"about_ca_topic_score_gemma":0.0002286809,"teacher_disagreement_score":0.010549908,"about_ca_system_score_codex":0.00028888253,"about_ca_system_score_gemma":0.0011302552,"threshold_uncertainty_score":0.9498295},"labels":[],"label_agreement":null},{"id":"W2885257451","doi":"10.1158/1538-7445.am2018-1995","title":"Abstract 1995: PTHrP drives tumor initiation signaling pathways in the PyMT model of breast cancer progression","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Stromal cell; Tumor progression; Breast cancer; Cancer; Mammary tumor; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Signal transduction; Biology; Endocrinology; Internal medicine; Medicine; Cell biology","score_opus":0.18065699817568812,"score_gpt":0.4738079915336838,"score_spread":0.29315099335799566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885257451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946669,0.0009275303,0.000008101498,0.00209653,0.00005443524,0.0007539403,0.00008087008,0.000013404374,0.0013983363],"genre_scores_gemma":[0.9986259,0.0003181237,0.00009794674,0.00022179696,0.00020033409,0.00045691367,0.0000135565615,0.000017260922,0.00004820987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834377,0.00009449732,0.00024739743,0.00022158216,0.0006790811,0.00041370039],"domain_scores_gemma":[0.99910235,0.00009675782,0.000076704164,0.00022616952,0.00037753372,0.00012046801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077254156,0.0000916875,0.00017631089,0.00016454312,0.00015265097,0.000014205847,0.000116364085,0.000059023245,0.00018871573],"category_scores_gemma":[0.000045922974,0.000057035613,0.000034034434,0.00038241348,0.00021619211,0.00009624206,0.00003250304,0.00036260934,0.000015726882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005785814,0.0022644894,0.39747956,0.002342918,0.00014797469,0.00021707121,0.02163535,0.0004223458,0.36602613,0.0007862628,0.0035300825,0.199362],"study_design_scores_gemma":[0.005577598,0.0009822621,0.8765317,0.0040918123,0.00005187528,0.00002937723,0.0014561233,0.007724894,0.101207405,0.0017297214,0.0003800885,0.00023710425],"about_ca_topic_score_codex":0.0029120082,"about_ca_topic_score_gemma":0.00085927016,"teacher_disagreement_score":0.47905216,"about_ca_system_score_codex":0.00024919992,"about_ca_system_score_gemma":0.00104977,"threshold_uncertainty_score":0.44021046},"labels":[],"label_agreement":null},{"id":"W2885286334","doi":"10.1158/1538-7445.am2018-ct075","title":"Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Sunnybrook Health Science Centre; Centre Intégré de Santé et de Services Sociaux des Laurentides; Health Sciences Centre; Santé Montérégie","funders":"","keywords":"Carboplatin; Medicine; Pembrolizumab; Placebo; Internal medicine; Oncology; Pemetrexed; Tolerability; Nausea; Population; Interim analysis; Cisplatin; Clinical trial; Chemotherapy; Cancer; Adverse effect; Immunotherapy; Pathology","score_opus":0.20242464594605009,"score_gpt":0.4864854517590442,"score_spread":0.2840608058129941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885286334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792759,0.005496708,0.00017362532,0.0011832191,0.00030007743,0.012693554,0.00008999512,0.00005223068,0.0007347076],"genre_scores_gemma":[0.9894989,0.0035361385,0.00020817237,0.00019669978,0.0005619998,0.0032230788,0.00003668601,0.00009759316,0.0026407398],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995855,0.00032384216,0.0009929386,0.00077486964,0.0012234895,0.0008298817],"domain_scores_gemma":[0.99529564,0.0022530523,0.00031330352,0.00072944025,0.001103726,0.00030481067],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004102607,0.00041019832,0.0014222863,0.0006705037,0.0004366137,0.00009808259,0.00035452654,0.0001516417,0.0025273622],"category_scores_gemma":[0.0005395791,0.0002767956,0.00027095847,0.0009815183,0.0010507223,0.00017295472,0.000096230884,0.0005042614,0.00001631541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9449865,0.0017373352,0.00007178399,0.00054158526,0.0018049092,0.000040482795,0.0039305207,0.0000074606955,0.012158276,0.000022397,0.0018618427,0.032836866],"study_design_scores_gemma":[0.95420414,0.013105188,0.00025091754,0.0004435728,0.00027446655,0.000035750738,0.0022833762,0.0005267515,0.02353289,0.00010261194,0.0049234233,0.00031691891],"about_ca_topic_score_codex":0.0041684965,"about_ca_topic_score_gemma":0.0016161044,"teacher_disagreement_score":0.032519944,"about_ca_system_score_codex":0.00036408534,"about_ca_system_score_gemma":0.0013921768,"threshold_uncertainty_score":0.9999684},"labels":[],"label_agreement":null},{"id":"W2885300646","doi":"10.1158/1538-7445.am2018-ct167","title":"Abstract CT167: Phase II study of dianhydrogalactitol (VAL-083) in patients with bevacizumab-naive recurrent glioblastoma, MGMT-unmethylated","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Phases of clinical research; Internal medicine; Refractory (planetary science); Cancer research; Clinical trial; Radiation therapy; Chemotherapy; Biology","score_opus":0.04938797880228195,"score_gpt":0.41764172200441796,"score_spread":0.368253743202136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885300646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964711,0.00021807365,1.9714386e-7,0.00023818202,0.00014398075,0.0023484307,0.000049062935,0.00002282135,0.00050814444],"genre_scores_gemma":[0.99933684,0.00007494262,0.000012995976,0.000012478659,0.00012043352,0.00032478856,0.000020337822,0.00003876582,0.000058393303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970752,0.00013999223,0.00040087476,0.00053453294,0.0012494778,0.00059994974],"domain_scores_gemma":[0.9980104,0.00013137476,0.00012172588,0.0005606843,0.0009053031,0.00027053227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043610897,0.0002204672,0.00046288656,0.0007114666,0.00018463137,0.000021682552,0.00017260191,0.000088243774,0.0006400024],"category_scores_gemma":[0.0001264063,0.00014546853,0.000056360455,0.0012679029,0.00025015895,0.00012168828,0.00012886975,0.00045702563,0.00006374345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026317224,0.05698091,0.80720586,0.00020112534,0.00077183556,0.00041904344,0.007775902,0.000017309283,0.00412488,0.000008385326,0.002799246,0.093378276],"study_design_scores_gemma":[0.054788247,0.08994604,0.78955895,0.00091116555,0.00013596746,0.000002267431,0.0012595417,0.00003534035,0.061614607,0.00001498407,0.0014657916,0.00026712217],"about_ca_topic_score_codex":0.002198241,"about_ca_topic_score_gemma":0.0023523166,"teacher_disagreement_score":0.09311115,"about_ca_system_score_codex":0.00061160955,"about_ca_system_score_gemma":0.00031070944,"threshold_uncertainty_score":0.7007578},"labels":[],"label_agreement":null},{"id":"W2885316730","doi":"10.1158/1538-7445.am2018-ct029","title":"Abstract CT029: Pharmacokinetic (PK), safety, and tolerability profile of DCC-2618 in a phase I trial supports 150mg QD selected for a pivotal phase III trial in gastrointestinal stromal tumor (GIST)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Nausea; Adverse effect; GiST; Internal medicine; Pharmacokinetics; Population; Gastroenterology; Dosing; Phases of clinical research; Oncology; Pharmacology; Surgery; Clinical trial","score_opus":0.08057106924318462,"score_gpt":0.4635713052647935,"score_spread":0.3830002360216089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885316730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892516,0.00013588206,0.000051747982,0.00054496416,0.00008216334,0.00950175,0.0004672968,0.000032910277,0.00025812478],"genre_scores_gemma":[0.9962429,0.000016993148,0.00085426983,0.000013052482,0.0006898194,0.0017699542,0.00016619285,0.0000483527,0.00019849259],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99497736,0.00035841053,0.0011945256,0.0008781149,0.0011118262,0.0014797639],"domain_scores_gemma":[0.9969164,0.000702184,0.00020805921,0.00040832066,0.0010882072,0.0006768273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026962038,0.0003416143,0.0009880429,0.0006788225,0.0001389138,0.00004999478,0.00023399453,0.00005553762,0.0012231432],"category_scores_gemma":[0.0021373043,0.0002981081,0.00014100884,0.001069007,0.000911557,0.00014579245,0.00014687472,0.00095033325,0.000008175239],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8859203,0.008131982,0.00706872,0.00049975404,0.000060557097,0.0010097446,0.00020835263,0.000001777093,0.092023835,0.000013306319,0.0005512626,0.0045104143],"study_design_scores_gemma":[0.87288207,0.07435861,0.015617944,0.0010647974,0.00006454691,0.00046911807,0.00022652865,0.0015237314,0.03335256,0.00007945904,0.00012790496,0.00023274892],"about_ca_topic_score_codex":0.0019789855,"about_ca_topic_score_gemma":0.00075323484,"teacher_disagreement_score":0.06622663,"about_ca_system_score_codex":0.0007548743,"about_ca_system_score_gemma":0.0027251067,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W2885330205","doi":"10.1158/1538-7445.am2018-ct163","title":"Abstract CT163: KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Head and neck squamous-cell carcinoma; Placebo; Internal medicine; Head and neck cancer; Regimen; Oncology; Phases of clinical research; Chemoradiotherapy; Radiation therapy; Cancer; Urology; Surgery; Chemotherapy; Immunotherapy; Pathology","score_opus":0.04528575789131785,"score_gpt":0.36670612020297155,"score_spread":0.3214203623116537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885330205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883449,0.0051153633,0.0001368422,0.0024789872,0.0003014824,0.0017010863,0.000062875624,0.00005802384,0.0018004525],"genre_scores_gemma":[0.99495786,0.0005603265,0.000348839,0.0004892639,0.0011028169,0.00040638293,0.00009547281,0.00006864273,0.0019703936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997626,0.000046184872,0.00037264737,0.0005943219,0.0006319601,0.000728861],"domain_scores_gemma":[0.9982801,0.00017846399,0.00012122759,0.0004431247,0.0007097285,0.00026734933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065207673,0.00023280752,0.000405769,0.00026058205,0.00034284475,0.000079206955,0.00017087195,0.00020412372,0.0003483935],"category_scores_gemma":[0.00014187698,0.0002214449,0.000109720015,0.00049698894,0.00037907792,0.0002524616,0.000047882728,0.00035209107,0.000034301447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10973626,0.00039603197,0.006707124,0.002121319,0.00010451141,0.000041156018,0.002634843,0.00005108706,0.71110004,0.00003515686,0.02447992,0.14259256],"study_design_scores_gemma":[0.07695229,0.006052916,0.27973637,0.00035848445,0.00009659072,0.000046824687,0.00044252208,0.0037759128,0.56794643,0.00019866232,0.06367476,0.00071821845],"about_ca_topic_score_codex":0.0013504296,"about_ca_topic_score_gemma":0.0004497835,"teacher_disagreement_score":0.27302924,"about_ca_system_score_codex":0.0011381675,"about_ca_system_score_gemma":0.0011471648,"threshold_uncertainty_score":0.90302616},"labels":[],"label_agreement":null},{"id":"W2885335871","doi":"10.1158/1538-7445.am2018-1134","title":"Abstract 1134: The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer research; Biology; Stem cell; Progenitor cell; Paracrine signalling; CD34; Ectopic expression; Stromal cell; Mesenchymal stem cell; Cell biology; Immunology; Cell culture","score_opus":0.05542209391359252,"score_gpt":0.35625045759253193,"score_spread":0.3008283636789394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885335871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996241,0.0006694498,0.0008147348,0.00014009402,0.000119444216,0.0014191718,0.00040448157,0.0000069154717,0.00018472417],"genre_scores_gemma":[0.99652,0.000032678618,0.0005270102,0.00006398462,0.0003345534,0.0007796637,0.000057236066,0.000038816797,0.0016460851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835503,0.00006096364,0.0002561664,0.0004684728,0.0003221591,0.00053717854],"domain_scores_gemma":[0.9985642,0.00009549592,0.00014729651,0.00047820117,0.0006112156,0.00010358149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007378528,0.00015572623,0.00016447254,0.00005573441,0.00027474255,0.000033297496,0.0004420903,0.00011821262,0.000057494977],"category_scores_gemma":[0.00006419442,0.00012450536,0.00011541452,0.00012004709,0.00035104924,0.000010589524,0.0001780747,0.00011150423,0.000008355604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011642659,0.00003854703,0.00008628074,0.00022768143,0.000059454327,5.151063e-7,0.000156102,0.000010445597,0.96908194,0.000007811405,0.025916649,0.0032502885],"study_design_scores_gemma":[0.0010870235,0.00018856449,0.004006111,0.00005640868,0.000011225124,0.0000012354016,0.00013627119,0.00011364035,0.9536737,0.000029265953,0.040552806,0.00014371684],"about_ca_topic_score_codex":0.00016565154,"about_ca_topic_score_gemma":0.00010231489,"teacher_disagreement_score":0.015408229,"about_ca_system_score_codex":0.0007224076,"about_ca_system_score_gemma":0.0018230216,"threshold_uncertainty_score":0.5077181},"labels":[],"label_agreement":null},{"id":"W2885340034","doi":"10.1158/1538-7445.am2018-4026","title":"Abstract 4026: Mechanism of cisplatin resistance and enhanced cell migration in cervical cancer cells expressing <i>PIK3CA</i>-E545K mutation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cisplatin; PI3K/AKT/mTOR pathway; Cervical cancer; Medicine; Cancer research; Cancer; Radiation therapy; Mutation; Chemotherapy; Oncology; Internal medicine; Gene; Biology; Genetics; Signal transduction","score_opus":0.04044493040350706,"score_gpt":0.41346176074547075,"score_spread":0.3730168303419637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885340034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905102,0.0020507765,0.0003352155,0.0008300533,0.00015689843,0.00071544,0.000056174104,0.000019798475,0.0053254343],"genre_scores_gemma":[0.9960654,0.0009092802,0.00094638264,0.00008260192,0.00021663832,0.00032604704,0.000021575719,0.000029697858,0.0014024057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998242,0.00007937869,0.00034890135,0.00040881927,0.00054279057,0.00037807223],"domain_scores_gemma":[0.9988634,0.0001396734,0.00011504761,0.00024447739,0.000499467,0.00013791509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036476017,0.00014106931,0.00026160254,0.00025167008,0.00015244239,0.000036413425,0.000085530744,0.00011607107,0.00042849683],"category_scores_gemma":[0.000037988855,0.00012614754,0.000037511574,0.00048878527,0.00021815521,0.0001757479,0.0000388668,0.00027452112,0.000011414274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004961615,0.00015341236,0.0009834402,0.0004911078,0.000034083634,0.000019846246,0.0042039044,0.00002096307,0.98716044,0.00024183934,0.0009274351,0.005267334],"study_design_scores_gemma":[0.0021494182,0.00018783647,0.01751111,0.0008085573,0.00004624619,0.0000010321182,0.00063968595,0.00018089321,0.97696906,0.00069688464,0.00068624766,0.00012300111],"about_ca_topic_score_codex":0.003275906,"about_ca_topic_score_gemma":0.008032645,"teacher_disagreement_score":0.016527671,"about_ca_system_score_codex":0.00040980446,"about_ca_system_score_gemma":0.0005408764,"threshold_uncertainty_score":0.5144147},"labels":[],"label_agreement":null},{"id":"W2885350429","doi":"10.1158/1538-7445.am2018-1644","title":"Abstract 1644: Progression-free survival (PFS) as a surrogate for overall survival (OS)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Progression-free survival; Medicine; Internal medicine; Oncology; Surrogate endpoint; Clinical endpoint; Overall survival; Clinical trial","score_opus":0.08406891724616299,"score_gpt":0.48166759877610843,"score_spread":0.39759868152994543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885350429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443716,0.0010710236,0.000347289,0.02562759,0.0015894114,0.0013081924,0.00003262324,0.00013788638,0.025514377],"genre_scores_gemma":[0.98406035,0.00040002682,0.0012848175,0.00056462287,0.003868822,0.000336935,0.000035016645,0.0001020493,0.009347337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963698,0.0001607784,0.00032786606,0.0005893148,0.0015306206,0.0010216482],"domain_scores_gemma":[0.9970632,0.00072586804,0.00007785705,0.00068987976,0.00088289566,0.0005602713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039451327,0.00020151101,0.0004125906,0.00022387711,0.00035922122,0.00012735835,0.00051968516,0.00014968732,0.0018436926],"category_scores_gemma":[0.0036903603,0.00015929108,0.00014732014,0.00034486994,0.00069503835,0.00012078185,0.00025746837,0.001196993,0.0001985055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008719906,0.0010882505,0.062498063,0.002172272,0.00077646156,0.00059460837,0.0022819033,0.000019701924,0.12739551,0.014099826,0.4048921,0.37546143],"study_design_scores_gemma":[0.016955642,0.0026866551,0.075976804,0.0025308337,0.00011684406,0.00006773695,0.0004209591,0.0052545494,0.021277696,0.0108102495,0.8630816,0.0008204791],"about_ca_topic_score_codex":0.001620131,"about_ca_topic_score_gemma":0.0001589011,"teacher_disagreement_score":0.4581895,"about_ca_system_score_codex":0.00025288225,"about_ca_system_score_gemma":0.00094280776,"threshold_uncertainty_score":0.99906874},"labels":[],"label_agreement":null},{"id":"W2885416623","doi":"10.1158/1538-7445.am2018-4768","title":"Abstract 4768: Characteristics of patients diagnosed de novo with AJCC7 stage III or regionally advanced cutaneous melanoma and trends in adjuvant therapy: An analysis of the SEER cancer registry in the United States","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Ipilimumab; Systemic therapy; Melanoma; Internal medicine; Radiation therapy; Cancer registry; Cancer; Stage (stratigraphy); Oncology; Adjuvant therapy; Nivolumab; Dabrafenib; Adjuvant; Surgery; Breast cancer; Immunotherapy; Vemurafenib; Metastatic melanoma","score_opus":0.04965723613258807,"score_gpt":0.38306094428132687,"score_spread":0.33340370814873876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885416623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978514,0.0004777578,0.0000015227727,0.0007524449,0.000030868978,0.0004449796,0.0003780308,0.000005187136,0.000057860667],"genre_scores_gemma":[0.9945981,0.0043482464,0.000014402494,0.00035545853,0.00004074617,0.00012775049,0.00013000022,0.000020933932,0.00036439364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806297,0.00022165962,0.00038954173,0.00029059473,0.0006688922,0.00036636423],"domain_scores_gemma":[0.9984357,0.0002876852,0.00022290308,0.000536138,0.0004489027,0.00006871204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006573674,0.0001546832,0.00041091748,0.0006082383,0.00007945846,0.000019856636,0.00031518872,0.00008466727,0.0003647724],"category_scores_gemma":[0.000057673213,0.00007868307,0.00006147098,0.0027994735,0.00074871903,0.0000632763,0.00003520578,0.00034367686,9.7041486e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03463075,0.0005186986,0.8994998,0.000104120045,0.00058527925,0.000108387365,0.009064488,0.00009698548,0.009269405,0.0000062060417,0.0001374786,0.0459784],"study_design_scores_gemma":[0.0042913756,0.0010459543,0.987711,0.00032357255,0.00007567999,0.0000045560373,0.0018484782,0.00023703603,0.002329508,0.000003333272,0.0020261675,0.00010334394],"about_ca_topic_score_codex":0.018793002,"about_ca_topic_score_gemma":0.04680954,"teacher_disagreement_score":0.08821119,"about_ca_system_score_codex":0.00029659024,"about_ca_system_score_gemma":0.0004654342,"threshold_uncertainty_score":0.98774093},"labels":[],"label_agreement":null},{"id":"W2885431388","doi":"10.1158/1538-7445.am2018-1759","title":"Abstract 1759: AVID200, a highly potent TGF-beta trap, exhibits optimal isoform selectivity for enhancing anti-tumor T-cell activity, without promoting metastasis or cardiotoxicity","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; National Research Council Canada","funders":"","keywords":"Cancer research; Ectodomain; Metastasis; TGF beta signaling pathway; Antibody; Cancer cell; Cancer; Tumor microenvironment; T cell; Biology; Transforming growth factor; Transforming growth factor beta; Immune system; Immunology; Medicine; Receptor; Cell biology; Internal medicine","score_opus":0.09743525780904905,"score_gpt":0.41248020584209655,"score_spread":0.3150449480330475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885431388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893511,0.00089049834,0.002495889,0.00094681175,0.00042438263,0.0036328943,0.00031187397,0.00014159168,0.0018049858],"genre_scores_gemma":[0.992808,0.00033747352,0.0021113937,0.00014781582,0.0018146462,0.00096080464,0.00001662281,0.00015432086,0.0016489166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943304,0.00022871002,0.0005888015,0.0013133097,0.0015709181,0.0019678532],"domain_scores_gemma":[0.99639165,0.00039636245,0.00025572442,0.0008168901,0.0014182186,0.0007211653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039820415,0.0005093254,0.0012382155,0.0004984921,0.0008205877,0.00019092984,0.0003857032,0.00019592792,0.00043968845],"category_scores_gemma":[0.00037726597,0.00040642024,0.00047796554,0.001264481,0.0004586387,0.00042164102,0.00025679145,0.0011311845,0.000050209466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003201387,0.0007215369,0.001124923,0.0018387256,0.00044471712,0.00008761601,0.0009082152,0.000020976187,0.9208259,0.000006780069,0.0025136303,0.068305604],"study_design_scores_gemma":[0.0034296608,0.0017900375,0.0059884586,0.0005162477,0.0003110079,0.00007385225,0.00027967631,0.00024287448,0.9752481,0.0000102938475,0.011657602,0.00045219724],"about_ca_topic_score_codex":0.0030858654,"about_ca_topic_score_gemma":0.003267853,"teacher_disagreement_score":0.067853406,"about_ca_system_score_codex":0.0013173438,"about_ca_system_score_gemma":0.0027002138,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W2885453810","doi":"10.1158/1538-7445.am2018-5076","title":"Abstract 5076: Pancreatic ductal adenocarcinoma associated stellate cells promote a pro-metastatic microenvironment in the liver","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Hepatic stellate cell; Metastasis; Microvesicles; Cancer research; Tumor microenvironment; Stroma; Pancreatic cancer; Medicine; Stromal cell; Cancer; Pathology; Biology; Internal medicine; microRNA; Immunohistochemistry","score_opus":0.09861020766120093,"score_gpt":0.37616171079747335,"score_spread":0.2775515031362724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885453810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947628,0.001927139,0.0000010651843,0.0009004891,0.00009310818,0.0012337003,0.000022524382,0.00001351341,0.0010456778],"genre_scores_gemma":[0.99771696,0.0005377648,0.000054414006,0.00035012982,0.00023314453,0.00017559231,0.000018417073,0.000021446866,0.00089211157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775505,0.0005833708,0.00022916148,0.00038481594,0.0004112403,0.0006363843],"domain_scores_gemma":[0.9991121,0.00024180926,0.000059713064,0.0003949685,0.00009999313,0.00009139278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013813397,0.00014238771,0.00027969954,0.000138982,0.00016803887,0.000017300965,0.00025202494,0.000105268795,0.0013136972],"category_scores_gemma":[0.00008078992,0.00009469783,0.000057051348,0.00033360295,0.0007435594,0.0000518772,0.00009336392,0.000774053,0.00066799927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010837798,0.00094084477,0.06636452,0.00038792507,0.0002902547,0.002348816,0.013463469,0.000004327379,0.9069452,0.000035091303,0.006171963,0.0019637616],"study_design_scores_gemma":[0.0014536853,0.0011865789,0.9589381,0.00021071895,0.00007701407,0.00007160946,0.00047036668,0.000057932928,0.036456198,0.00024920935,0.0007008843,0.00012767443],"about_ca_topic_score_codex":0.00042614792,"about_ca_topic_score_gemma":0.00010734643,"teacher_disagreement_score":0.8925736,"about_ca_system_score_codex":0.00024509587,"about_ca_system_score_gemma":0.0002236318,"threshold_uncertainty_score":0.9995992},"labels":[],"label_agreement":null},{"id":"W2885458596","doi":"10.1158/1538-7445.am2018-5434","title":"Abstract 5434: Screen for immune-related transcriptional targets of the Hippo pathway in human breast cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hippo signaling pathway; Immune system; Cancer; Cancer research; Biology; Breast cancer; Cancer cell; Transcriptional regulation; CTGF; Cell biology; Signal transduction; Immunology; Transcription factor; Gene; Genetics; Growth factor; Receptor","score_opus":0.04220918037204496,"score_gpt":0.3544543599238938,"score_spread":0.31224517955184883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885458596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953038,0.002112408,0.00002460956,0.00042026036,0.00021109547,0.00044564824,0.0008149425,0.0000057424336,0.0006614933],"genre_scores_gemma":[0.99799764,0.00011813617,0.000022501212,0.00004462544,0.00037133944,0.0001826551,0.000059894508,0.000029408915,0.0011738045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984786,0.00011407575,0.00030570725,0.0003410137,0.00031399878,0.00044658664],"domain_scores_gemma":[0.9990554,0.000023618166,0.000071366,0.00033423753,0.0004434722,0.000071921306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008661333,0.0001250867,0.00015679651,0.0000798415,0.00022349234,0.00001665134,0.00043094304,0.00018801614,0.00040345633],"category_scores_gemma":[0.000023749095,0.00009739375,0.0001407772,0.00022218018,0.000433053,0.0000051151105,0.00006830118,0.00026792698,0.0000051185475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001874142,0.00007153217,0.00079902785,0.000051341565,0.000045117118,7.616643e-7,0.00019664143,0.00008196987,0.9961482,0.00016992902,0.00043071617,0.0018173461],"study_design_scores_gemma":[0.0008185832,0.00013790891,0.016478676,0.00012229479,0.000004471391,0.0000013319473,0.000059224876,0.00002193784,0.9733166,0.00024914186,0.008666388,0.00012344657],"about_ca_topic_score_codex":0.0017932405,"about_ca_topic_score_gemma":0.0010331617,"teacher_disagreement_score":0.02283161,"about_ca_system_score_codex":0.00006691508,"about_ca_system_score_gemma":0.0004943031,"threshold_uncertainty_score":0.4417564},"labels":[],"label_agreement":null},{"id":"W2885463118","doi":"10.1158/1538-7445.am2018-746","title":"Abstract 746: Development of novel formats of anti-AXL ADCs","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"GAS6; AXL receptor tyrosine kinase; Cancer research; Receptor tyrosine kinase; Antibody-drug conjugate; Metastasis; Cancer; Tyrosine kinase; Biology; Monoclonal antibody; Chemistry; Antibody; Kinase; Medicine; Immunology; Internal medicine; Cell biology; Signal transduction","score_opus":0.13287962007076845,"score_gpt":0.4119754639694412,"score_spread":0.2790958438986727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885463118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637616,0.0016103983,0.00011839283,0.000056942077,0.00020982622,0.0001527139,0.000019721025,0.000007843752,0.0014480187],"genre_scores_gemma":[0.9991946,0.00011122303,0.00016925068,0.000007667483,0.000029893079,0.000019715879,0.000021833257,0.000008222989,0.00043757414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991182,0.000039698745,0.00032261608,0.00013318588,0.000091883536,0.00029443306],"domain_scores_gemma":[0.99916834,0.000059857095,0.00010369429,0.00020814176,0.00044563785,0.000014310477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006437983,0.000068928435,0.00018743466,0.00015407716,0.00014205492,0.000004225547,0.00022078799,0.00011585525,0.000778405],"category_scores_gemma":[0.00004396651,0.000057891088,0.000037363166,0.00020672011,0.00042384016,0.000089464316,0.00010972631,0.00016694819,0.00009158762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089874244,0.00012084303,0.0011684969,0.000064933774,0.00007153856,7.7285506e-8,0.00086235243,0.0000016823107,0.97559005,0.00021358742,0.001329676,0.02048687],"study_design_scores_gemma":[0.00060771743,0.0000660394,0.1345353,0.00010195458,0.0000028299796,0.000001374257,0.00011496323,0.0000028225038,0.8434104,0.000015416997,0.021090321,0.000050906234],"about_ca_topic_score_codex":0.00014767908,"about_ca_topic_score_gemma":0.000037057984,"teacher_disagreement_score":0.13336681,"about_ca_system_score_codex":0.00006444983,"about_ca_system_score_gemma":0.0003517144,"threshold_uncertainty_score":0.85229886},"labels":[],"label_agreement":null},{"id":"W2885490407","doi":"10.1158/1538-7445.am2018-ct001","title":"Abstract CT001: Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Population; Hazard ratio; Ipilimumab; Melanoma; Interim analysis; Surgery; Placebo; Oncology; Nivolumab; Gastroenterology; Clinical trial; Cancer; Immunotherapy; Confidence interval; Pathology","score_opus":0.12376313014069187,"score_gpt":0.41874513784396916,"score_spread":0.2949820077032773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885490407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950386,0.0016243893,0.000025091706,0.001605911,0.0011322018,0.0029545121,0.0013769367,0.000046576864,0.0017305295],"genre_scores_gemma":[0.99375045,0.0023330024,0.000034368404,0.000068685375,0.0024344898,0.00023750636,0.00016467359,0.00005004063,0.0009267999],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960358,0.0004053379,0.0008594167,0.00076141476,0.0012214942,0.0007165342],"domain_scores_gemma":[0.99622834,0.0015900745,0.00032211165,0.0010777251,0.0005507957,0.0002309634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028952048,0.00029022386,0.00062364066,0.00024268856,0.0005396758,0.000097553464,0.00036187377,0.00025524912,0.0015477681],"category_scores_gemma":[0.00030219392,0.00020538045,0.00015913133,0.0006522326,0.0012744054,0.00015691314,0.0001761193,0.0010198442,0.000020964608],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95095944,0.00030477322,0.000058477544,0.000047495076,0.0006878556,0.000031065694,0.0016418487,0.000004061831,0.023742763,0.000021628728,0.0039493926,0.018551212],"study_design_scores_gemma":[0.91476524,0.0069372132,0.020756634,0.0003526376,0.000185547,0.0000039504644,0.00044809494,0.000076941484,0.016563326,0.000030463932,0.03961729,0.00026265113],"about_ca_topic_score_codex":0.04799245,"about_ca_topic_score_gemma":0.008134977,"teacher_disagreement_score":0.039857473,"about_ca_system_score_codex":0.0005430028,"about_ca_system_score_gemma":0.00076550856,"threshold_uncertainty_score":0.999365},"labels":[],"label_agreement":null},{"id":"W2885498560","doi":"10.1158/1538-7445.am2018-5641","title":"Abstract 5641: Synergy of immunomodulators delivered by an HSV-1 oncolytic virus can enhance its therapeutic effects in vivo","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Virus; Immune system; In vivo; Virology; Interleukin 12; Spleen; Immunotherapy; Biology; Tumor necrosis factor alpha; Cancer research; Immunology; In vitro; Cytotoxic T cell","score_opus":0.029321428567278,"score_gpt":0.38598782972756157,"score_spread":0.3566664011602836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885498560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901224,0.008496981,0.000018266528,0.00010192892,0.00011383494,0.00060094893,0.000103734594,0.0000110129995,0.00043094295],"genre_scores_gemma":[0.9967501,0.0017971473,0.000011875091,0.00010658109,0.00025366596,0.00024703742,0.000032621978,0.00006834145,0.0007326336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969847,0.0004722218,0.00032275912,0.00066937594,0.0006672148,0.00088372006],"domain_scores_gemma":[0.9982465,0.0000824281,0.00008041513,0.00081761304,0.00055199035,0.00022106778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011156473,0.00022880301,0.00028522685,0.00022014424,0.00014808934,0.00003926148,0.0008098988,0.00023938336,0.00041633658],"category_scores_gemma":[0.000102680664,0.00022417861,0.00007685136,0.0005566334,0.00050464575,0.000014002803,0.00017199024,0.00039189844,0.000027657949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025151744,0.00018108115,0.00023776334,0.0000830913,0.00009277997,0.000008010316,0.00024157712,0.000047584414,0.9719791,0.00000824495,0.0007494253,0.02385618],"study_design_scores_gemma":[0.0009172576,0.004444598,0.0010598352,0.00008169952,0.0000047146536,0.0000012956493,0.00007168057,0.000098223536,0.9897649,0.000057696714,0.0032703443,0.00022774414],"about_ca_topic_score_codex":0.0032878292,"about_ca_topic_score_gemma":0.010668283,"teacher_disagreement_score":0.023628436,"about_ca_system_score_codex":0.00026225628,"about_ca_system_score_gemma":0.0008171681,"threshold_uncertainty_score":0.91417384},"labels":[],"label_agreement":null},{"id":"W2885522312","doi":"10.1158/1538-7445.am2018-367","title":"Abstract 367: Methods to enhance the optical resolution for 3D-SIM for the study of Hodgkin's lymphoma nuclei","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Fluorescence Microscopy Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; University of Manitoba","funders":"","keywords":"Chromatin; Lymphoma; High resolution; Sample (material); Biology; Chemistry; Computational biology; Optics; Physics; Immunology; Genetics; DNA; Chromatography","score_opus":0.07084636938115481,"score_gpt":0.5230914771021183,"score_spread":0.45224510772096355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885522312","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45200965,0.0008749614,0.542194,0.00090998324,0.00016469715,0.0036193957,0.00005205286,0.000016647533,0.00015861199],"genre_scores_gemma":[0.8176303,0.00016231173,0.17828614,0.00015974803,0.00064495945,0.0027432016,0.0000061520595,0.000042260035,0.00032491962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998563,0.00013307044,0.0002143271,0.00041427455,0.00022942157,0.00044588573],"domain_scores_gemma":[0.9981008,0.00035483635,0.00005746213,0.0007003042,0.00072634505,0.000060263283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021712685,0.00011394913,0.00013502028,0.000043773525,0.00038830598,0.000031173233,0.000684236,0.00010228666,0.000013163574],"category_scores_gemma":[0.00085908023,0.000071621915,0.00006193225,0.00020829793,0.00048748282,0.000005398831,0.0002678366,0.00011093771,0.0000022097438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079392566,0.000094385556,0.000025072934,0.000019141293,0.000034048677,1.2448625e-7,0.00022392513,0.000015376241,0.87527776,0.00009819176,0.006154846,0.117263205],"study_design_scores_gemma":[0.00026560214,0.0016858976,0.00071071374,0.000021807915,0.000010918951,5.0357886e-7,0.00048299195,0.00011174428,0.9031026,0.00020464776,0.09331819,0.000084406944],"about_ca_topic_score_codex":0.00012519995,"about_ca_topic_score_gemma":0.00021095035,"teacher_disagreement_score":0.36562067,"about_ca_system_score_codex":0.000076109245,"about_ca_system_score_gemma":0.00016752083,"threshold_uncertainty_score":0.2986575},"labels":[],"label_agreement":null},{"id":"W2885524635","doi":"10.1158/1538-7445.am2018-3563","title":"Abstract 3563: Impact of the affinity of chimeric antigen receptor on immune activation profiles of T cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Chimeric antigen receptor; Epitope; Antigen; Chemistry; Human leukocyte antigen; Antibody; Molecular biology; Immune system; T cell; Cell biology; Biology; Immunology","score_opus":0.10411668772737546,"score_gpt":0.4527555669926724,"score_spread":0.3486388792652969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885524635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935272,0.00016752604,0.0000011694908,0.0002729519,0.0000979404,0.0010382242,0.00006604913,0.000007699934,0.004821247],"genre_scores_gemma":[0.9975522,0.0004967172,0.00003153055,0.000006871061,0.00023570533,0.00003889499,0.000007561374,0.000030187986,0.001600315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975657,0.0002273447,0.00036228745,0.00022778344,0.001229535,0.0003873586],"domain_scores_gemma":[0.99748695,0.00033575334,0.00019869984,0.0007582128,0.0011270144,0.0000933479],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013852206,0.000117522315,0.00036011715,0.00028799757,0.00008473909,0.0000073342517,0.00037363355,0.00010230374,0.010238091],"category_scores_gemma":[0.00035550687,0.000073963165,0.00021871539,0.0010932687,0.0009053916,0.00005802913,0.00011992644,0.000542142,0.000029259627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025787873,0.00030327056,0.012179792,0.00023633067,0.00015989559,3.598709e-7,0.00055679004,0.000009719948,0.97116846,0.000012937534,0.0020338418,0.010759842],"study_design_scores_gemma":[0.00052837137,0.0010088205,0.30956376,0.00032614573,0.0000043674486,3.0498506e-7,0.00009120609,0.0000079558,0.6880157,0.000016552784,0.00039795114,0.000038881833],"about_ca_topic_score_codex":0.0045370357,"about_ca_topic_score_gemma":0.000023237182,"teacher_disagreement_score":0.29738396,"about_ca_system_score_codex":0.0003128351,"about_ca_system_score_gemma":0.0011629598,"threshold_uncertainty_score":0.9906667},"labels":[],"label_agreement":null},{"id":"W2885540822","doi":"10.1158/1538-7445.am2018-5728","title":"Abstract 5728: DNA demethylating agents and interferons as modulators of Wnt/β-catenin signaling in colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Wnt signaling pathway; Demethylating agent; Colorectal cancer; Cancer research; Cancer; IRF7; Cancer cell; Catenin; Biology; Medicine; Signal transduction; Immunology; DNA methylation; Innate immune system; Internal medicine; Genetics; Gene; Immune system","score_opus":0.06738647868434161,"score_gpt":0.4155903932026902,"score_spread":0.3482039145183486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885540822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630195,0.0027205497,0.00003124423,0.00006991962,0.0001002573,0.000196898,0.000013801082,0.0000033416763,0.0005620285],"genre_scores_gemma":[0.99860704,0.0008794223,0.0001022041,0.000014095676,0.0002270136,0.00005935788,0.000010942993,0.000021595988,0.00007834419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987816,0.000100759404,0.0002384847,0.00032704623,0.00023293882,0.00031916946],"domain_scores_gemma":[0.99943465,0.00004236951,0.00006884003,0.00010717432,0.00025871344,0.00008825609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073717535,0.00010131498,0.00013430009,0.00013103899,0.00008866421,0.000022112165,0.00014618922,0.00013357616,0.0001409136],"category_scores_gemma":[0.00017063064,0.00010015047,0.000031645006,0.00021530915,0.00024271998,0.0000058953815,0.00015411641,0.00017468583,0.0000034684608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011178485,0.000021364509,0.03493535,0.000029037154,0.000030949675,0.0000012038896,0.0003033977,0.00016848328,0.9562569,0.000015586284,0.000041082705,0.00808481],"study_design_scores_gemma":[0.0003129172,0.00023981751,0.051077455,0.000070908274,0.0000042012093,2.612703e-7,0.0001250344,0.00015856765,0.94737154,0.00024773987,0.00029256378,0.00009900298],"about_ca_topic_score_codex":0.0018854265,"about_ca_topic_score_gemma":0.0014925161,"teacher_disagreement_score":0.016142104,"about_ca_system_score_codex":0.00005438593,"about_ca_system_score_gemma":0.00018909968,"threshold_uncertainty_score":0.4084018},"labels":[],"label_agreement":null},{"id":"W2885545279","doi":"10.1158/1538-7445.am2018-2709","title":"Abstract 2709: TTI-622 (SIRPα-IgG4 Fc), a CD47-blocking innate immune checkpoint inhibitor, suppresses tumor growth and demonstrates enhanced efficacy in combination with antitumor antibodies in both hematologic and solid tumor models","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Phagocytosis; Cancer research; In vivo; Daratumumab; Antibody; Macrophage; Immune system; In vitro; Immunology; Chemistry; Monoclonal antibody; Medicine; Biology","score_opus":0.03808320839186958,"score_gpt":0.336023819973344,"score_spread":0.29794061158147445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885545279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748165,0.011018643,0.000023297029,0.00031367285,0.00011456606,0.0007229717,0.000017356462,0.00004188228,0.0002659813],"genre_scores_gemma":[0.9982091,0.0014429794,0.000055635068,0.000023152905,0.000029310375,0.00013486296,0.000036568323,0.000031183234,0.000037187943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975806,0.00030295446,0.0005846934,0.00061577425,0.00014658226,0.0007694338],"domain_scores_gemma":[0.99897283,0.00027058204,0.00019697176,0.00025155803,0.0002641987,0.000043871045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092877145,0.00028850808,0.000594367,0.000577121,0.0003575224,0.00011099982,0.00022730707,0.00015410545,0.000049298753],"category_scores_gemma":[0.00017503183,0.0002379632,0.00003730486,0.0005397347,0.0012673481,0.0005618763,0.00022806934,0.0006669141,0.000010763498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008660847,0.00034235042,0.009495072,0.00026314985,0.000053685104,0.00003692453,0.0012964505,0.000029032437,0.986332,0.00046960532,0.000031148116,0.0007844784],"study_design_scores_gemma":[0.003265493,0.0004625054,0.19788593,0.00097255694,0.000009342432,0.00007715029,0.00055326516,0.00021221642,0.7955377,0.0007593466,0.000015596312,0.00024890876],"about_ca_topic_score_codex":0.0012940454,"about_ca_topic_score_gemma":0.00069213496,"teacher_disagreement_score":0.19079433,"about_ca_system_score_codex":0.00011842153,"about_ca_system_score_gemma":0.00022603896,"threshold_uncertainty_score":0.9703858},"labels":[],"label_agreement":null},{"id":"W2885570830","doi":"10.1158/1538-7445.am2018-3007","title":"Abstract 3007: Monogenic and polygenic associations with subsequent breast cancer risk in survivors of childhood cancer: The St. Jude Lifetime Cohort Study (SJLIFE)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CHEK2; Odds ratio; Breast cancer; Cancer; Medicine; Penetrance; Allele; PALB2; Population; Genetics; Cohort; Oncology; Incidence (geometry); Internal medicine; Demography; Biology; Germline mutation; Mutation; Gene","score_opus":0.01985309110319979,"score_gpt":0.3474782945014764,"score_spread":0.3276252033982766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885570830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899668,0.0061935326,0.0000069240496,0.0008667866,0.0001726358,0.0013353174,0.0012913456,0.0000092409,0.00015740341],"genre_scores_gemma":[0.99175465,0.0060422984,0.000021990556,0.00006362716,0.0005938293,0.001248912,0.000032719065,0.000051280727,0.00019069969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973487,0.00040535265,0.00037378338,0.00064571004,0.00066469057,0.0005617079],"domain_scores_gemma":[0.9982712,0.00009032557,0.0002071221,0.0006453956,0.0006616923,0.0001242516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017247086,0.00021084589,0.00027692248,0.00015298203,0.0003414973,0.000051926996,0.00047277953,0.00013975886,0.0002756997],"category_scores_gemma":[0.00008595619,0.00016057337,0.000060071423,0.0006751738,0.0005877013,0.000013107405,0.00021244457,0.00045636966,0.000004279652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020980428,0.00022626873,0.9798594,0.000014340472,0.00059165515,0.0000016346579,0.0010613117,0.00052126555,0.013135629,0.0000051914863,0.0011977685,0.0031757222],"study_design_scores_gemma":[0.0010034628,0.00027339268,0.98334795,0.000044299642,0.00006455983,0.0000033665706,0.0007731228,0.000025083436,0.013510664,0.000024805833,0.0007343461,0.00019493586],"about_ca_topic_score_codex":0.05932634,"about_ca_topic_score_gemma":0.19190367,"teacher_disagreement_score":0.13257731,"about_ca_system_score_codex":0.00059573154,"about_ca_system_score_gemma":0.0020471506,"threshold_uncertainty_score":0.9469377},"labels":[],"label_agreement":null},{"id":"W2885574494","doi":"10.1158/1538-7445.am2018-583","title":"Abstract 583: Rapid release of ctDNA as a biomarker of treatment response in preclinical models of head and neck squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck squamous-cell carcinoma; Apoptosis; Cancer research; Biomarker; Programmed cell death; Medicine; Cell culture; DNA damage; Pathology; Radiation therapy; Biology; Oncology; Head and neck cancer; Internal medicine; DNA","score_opus":0.09315469117093927,"score_gpt":0.407834326172086,"score_spread":0.3146796350011467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885574494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922388,0.0061557656,0.000005913347,0.000097261276,0.000040246992,0.0003116796,0.00016772372,0.0000011132721,0.00098147],"genre_scores_gemma":[0.9973088,0.0023137203,0.000085358384,0.000017596145,0.00006619255,0.00004454699,0.000012230934,0.000017635031,0.00013393407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875104,0.00014199284,0.00036446677,0.00031980049,0.00016880727,0.00025389102],"domain_scores_gemma":[0.9988276,0.00025008395,0.000099671175,0.0004195122,0.00029070757,0.000112428716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200795,0.00010568063,0.00023705552,0.00012493141,0.000025840676,0.0000056557537,0.00014887066,0.00013996415,0.000059769423],"category_scores_gemma":[0.00029139625,0.00009751593,0.00006987993,0.00015038997,0.00046113366,0.0000034427503,0.00012887748,0.00008365145,0.0000013336337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014354203,0.00038611557,0.008019632,0.00013225475,0.000022997838,0.000007779292,0.00031464538,0.00009786279,0.9707647,0.000021703068,0.000578124,0.005299986],"study_design_scores_gemma":[0.0028668323,0.0060076774,0.06151811,0.000053168107,0.000012371263,0.000002028147,0.00010170614,0.00033498666,0.9272244,0.00017877655,0.0015902919,0.00010965762],"about_ca_topic_score_codex":0.0041801133,"about_ca_topic_score_gemma":0.0006619521,"teacher_disagreement_score":0.05349848,"about_ca_system_score_codex":0.0000803112,"about_ca_system_score_gemma":0.0009648091,"threshold_uncertainty_score":0.63191086},"labels":[],"label_agreement":null},{"id":"W2885576714","doi":"10.1158/1538-7445.am2018-5423","title":"Abstract 5423: Lysine-52 stabilizes the MYC oncoprotein through a SCFFBXW7-independent mechanism","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Ubiquitin ligase; Cullin; SUMO protein; Ubiquitin; Transcription factor; Biology; Protein degradation; Lysine; Cancer research; Proteasome; Cell biology; Genetics; Gene; Amino acid","score_opus":0.08697750545203671,"score_gpt":0.3980285465622924,"score_spread":0.3110510411102557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885576714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797067,0.0024211805,0.0003235302,0.0018694671,0.0002840183,0.000935712,0.00006238217,0.000025768064,0.014371243],"genre_scores_gemma":[0.99368423,0.00068637903,0.00023331784,0.00035973912,0.0017269497,0.00053665834,0.000022669816,0.000042882686,0.0027071997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759465,0.00023714693,0.00021994021,0.0005680717,0.0006836853,0.0006964778],"domain_scores_gemma":[0.9984455,0.000045633165,0.0000631343,0.0008152012,0.000506566,0.00012394665],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014564127,0.00018454746,0.00015519116,0.000047238722,0.00051064725,0.00011074708,0.00070062786,0.000205429,0.0014805801],"category_scores_gemma":[0.0002057761,0.00013008693,0.00010358274,0.0002559177,0.00051499513,0.0000096953945,0.00040801003,0.00044672188,0.00029507503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020029338,0.00005523924,0.00005853537,0.000042028874,0.000052951495,0.000006585083,0.00040976558,0.0000018978591,0.9864757,0.001969327,0.0054304954,0.0052971467],"study_design_scores_gemma":[0.00039795917,0.00039621093,0.00027069982,0.00004240487,0.000005645104,0.000005410699,0.0003756238,0.000006723299,0.8730978,0.004200159,0.121040255,0.00016113697],"about_ca_topic_score_codex":0.00099002,"about_ca_topic_score_gemma":0.0008107714,"teacher_disagreement_score":0.11560976,"about_ca_system_score_codex":0.00008949374,"about_ca_system_score_gemma":0.0005339274,"threshold_uncertainty_score":0.9994322},"labels":[],"label_agreement":null},{"id":"W2885592427","doi":"10.1158/1538-7445.am2018-1948","title":"Abstract 1948: Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Centrosome; Cancer research; Mitosis; Polo-like kinase; Lung cancer; Mitotic catastrophe; Cancer; Pathology; Cancer cell; Cell cycle; Cell biology; Medicine; Genetics","score_opus":0.032228354074868786,"score_gpt":0.36000683428599867,"score_spread":0.3277784802111299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885592427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955275,0.0030056732,0.00002586337,0.00016448808,0.000116426825,0.00026901497,0.00004732803,0.00000603481,0.0008376484],"genre_scores_gemma":[0.9971075,0.001688952,0.00006769704,0.00007633243,0.00043100628,0.000056570425,0.00003440641,0.000020359388,0.00051715155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989182,0.000040335402,0.0001497573,0.00036127702,0.0001940685,0.00033636906],"domain_scores_gemma":[0.99929035,0.000010224564,0.000048554557,0.00027713127,0.00027979043,0.00009397527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032426533,0.00010184758,0.000113802664,0.00008653805,0.00012930145,0.000022929877,0.00011973875,0.000106705374,0.000061851824],"category_scores_gemma":[0.000044269724,0.000095761054,0.00003287594,0.00012864494,0.00035353008,0.0000067945175,0.00012813663,0.00014013264,0.0000043048585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012908918,0.000025317393,0.004870192,0.00008956653,0.000033141376,0.0000015588171,0.000094406976,0.0000050701647,0.9907623,0.00007811947,0.0025480555,0.0013632062],"study_design_scores_gemma":[0.0003324916,0.00026088016,0.009768678,0.000077719335,0.000009423922,0.0000033754575,0.00008260083,0.000027201539,0.98420346,0.000051916162,0.005063552,0.00011869424],"about_ca_topic_score_codex":0.0019658327,"about_ca_topic_score_gemma":0.00075748365,"teacher_disagreement_score":0.0065588094,"about_ca_system_score_codex":0.00007592806,"about_ca_system_score_gemma":0.00033363848,"threshold_uncertainty_score":0.39050224},"labels":[],"label_agreement":null},{"id":"W2885605091","doi":"10.1158/1538-7445.am2018-303","title":"Abstract 303: Novel role of nuclear BH3-only protein BNIP3 in regulation of cellular proliferation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cytoplasm; Cell biology; Nucleus; Apoptosis; Programmed cell death; Embryonic stem cell; Cell growth; Biology; Wild type; HEK 293 cells; Cell nucleus; Cell culture; Mutant; Gene; Genetics","score_opus":0.037717915571991265,"score_gpt":0.33654420612751207,"score_spread":0.2988262905555208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885605091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970077,0.00013381713,0.00022058464,0.00011266749,0.000078503246,0.0004014352,0.000015290869,0.0000027169644,0.002027234],"genre_scores_gemma":[0.9986445,0.000020925927,0.00033612963,0.000017478418,0.00035640804,0.00003535111,0.000032832664,0.0000132647465,0.000543167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904186,0.00009544776,0.00024942987,0.00022886219,0.00021723859,0.0001671781],"domain_scores_gemma":[0.99921095,0.000007857722,0.0000820936,0.0002650147,0.00039803624,0.00003606571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057919725,0.000061210536,0.000111226575,0.000104844294,0.000039305873,0.000007079393,0.0001223338,0.0001495536,0.0003829494],"category_scores_gemma":[0.00014207623,0.000058795136,0.000034279623,0.00017045396,0.00017232215,0.0000051204106,0.000051276154,0.000117624295,0.0000144398355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044033193,0.000066466164,0.0012162795,0.000034797842,0.0000070166843,2.4374205e-7,0.00013339033,0.000018888093,0.9955928,0.0007595468,0.00047752226,0.0012527565],"study_design_scores_gemma":[0.00042602958,0.0003509482,0.008570118,0.000031627267,0.0000013615751,9.959235e-7,0.00006587491,0.00007907597,0.97623944,0.00015644077,0.014024695,0.00005338863],"about_ca_topic_score_codex":0.00018279524,"about_ca_topic_score_gemma":0.00021998417,"teacher_disagreement_score":0.019353315,"about_ca_system_score_codex":0.000021972712,"about_ca_system_score_gemma":0.00019346297,"threshold_uncertainty_score":0.41930273},"labels":[],"label_agreement":null},{"id":"W2885654872","doi":"10.1158/1538-7445.am2018-1763","title":"Abstract 1763: BiTEs vs CAR-Ts: Preclinical targeting of CD133+ brain tumor initiating cells using immunotherapy-based treatment strategies","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Chimeric antigen receptor; Antigen; Immunotherapy; Cytotoxic T cell; Cancer research; Brain tumor; Antibody; Monoclonal antibody; Glioma; T cell; Tumor antigen; Immunology; Biology; Medicine; Immune system; Pathology; In vitro","score_opus":0.18447562576547308,"score_gpt":0.49285059538041026,"score_spread":0.30837496961493716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885654872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358416,0.001987946,0.00004801242,0.00081921346,0.00018492925,0.0012842537,0.00007124328,0.00006539293,0.001954879],"genre_scores_gemma":[0.9957745,0.0003438847,0.0014660073,0.00020696173,0.0012127513,0.00016002382,0.000026093432,0.000116749514,0.0006930089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954345,0.000525791,0.00083094335,0.0006646445,0.001402085,0.0011420043],"domain_scores_gemma":[0.99545413,0.0020793553,0.00021526488,0.0007247893,0.001231607,0.00029487716],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025983981,0.00030924418,0.0007177492,0.00053352397,0.00035039056,0.00014322854,0.00036121035,0.00017643893,0.007552085],"category_scores_gemma":[0.00051502197,0.0002574694,0.0002713675,0.0009007794,0.0011367938,0.00018572898,0.0001002146,0.00081167254,0.000047730195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029132778,0.00037632757,0.0053804824,0.0003538287,0.00023125515,0.000074634176,0.0018797757,0.00014883063,0.97529155,0.000012742085,0.00039509975,0.012942206],"study_design_scores_gemma":[0.0041596116,0.0030862691,0.0042868447,0.00077095133,0.00002856838,0.0000073415613,0.0026307337,0.0017826669,0.9763525,0.00009000166,0.0065466347,0.00025786084],"about_ca_topic_score_codex":0.0074918675,"about_ca_topic_score_gemma":0.00035136842,"teacher_disagreement_score":0.012684345,"about_ca_system_score_codex":0.0012411138,"about_ca_system_score_gemma":0.005060204,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W2885657565","doi":"10.1158/1538-7445.am2018-5610","title":"Abstract 5610: CD125xCNE bispecific antibody development to treat bladder cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Bladder cancer; Antibody; Urothelium; Cancer; Cancer research; Carcinogenesis; Monoclonal antibody; Chemistry; Molecular biology; Medicine; Internal medicine; Immunology; Biology; Urinary system","score_opus":0.06982365025542799,"score_gpt":0.4249242238991406,"score_spread":0.3551005736437126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885657565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767633,0.012180965,0.00010852301,0.00053837145,0.0017144567,0.0004907122,0.00008792958,0.00002346544,0.008092294],"genre_scores_gemma":[0.96138436,0.0073347273,0.0003175628,0.00048493786,0.01063388,0.00054294267,0.00009945378,0.00007947009,0.019122697],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974755,0.00006429329,0.0002632086,0.00074998965,0.0005556003,0.00089140004],"domain_scores_gemma":[0.998341,0.00001674224,0.000044395056,0.0005863876,0.00064045005,0.00037097684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005188919,0.00022851602,0.00022793065,0.00020116518,0.00034188412,0.000085526684,0.0004622765,0.00017731392,0.001948905],"category_scores_gemma":[0.00006108179,0.00020809087,0.000078483325,0.00045785253,0.00028033313,0.000008172701,0.0002657201,0.0002414602,0.00042886956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022666,0.000054260112,0.0005631403,0.000029727,0.00006022314,0.0000026300386,0.00029128272,0.000009099041,0.83328265,0.000022200245,0.11080345,0.054654665],"study_design_scores_gemma":[0.00034219658,0.00007970145,0.012885828,0.000031674812,0.0000057339157,0.0000021834092,0.00006464127,6.454137e-7,0.4093124,0.0000060161783,0.57709366,0.00017531983],"about_ca_topic_score_codex":0.0010417957,"about_ca_topic_score_gemma":0.00210459,"teacher_disagreement_score":0.46629024,"about_ca_system_score_codex":0.0001611077,"about_ca_system_score_gemma":0.0010848317,"threshold_uncertainty_score":0.9989635},"labels":[],"label_agreement":null},{"id":"W2885667502","doi":"10.1158/1538-7445.am2018-2788","title":"Abstract 2788: VB6-845d tumor cell killing elicits biologic features of immunogenic cell death","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Calreticulin; Immunogenic cell death; Cell biology; Biology; Programmed cell death; Cell; Endoplasmic reticulum; Apoptosis; Biochemistry","score_opus":0.05001909451829093,"score_gpt":0.3442963983476252,"score_spread":0.29427730382933426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885667502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96483,0.025930658,0.000033309636,0.00008830931,0.000966773,0.0004641714,0.00011541939,0.000058448983,0.0075129555],"genre_scores_gemma":[0.9907283,0.0018633228,0.0001773275,0.00010282425,0.00018385556,0.00009414581,0.00004010786,0.000043893197,0.006766232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748796,0.00029266457,0.000436544,0.00055872934,0.0001505831,0.0010735033],"domain_scores_gemma":[0.9983521,0.00024984262,0.00017726964,0.0006691379,0.00049754395,0.00005407807],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010710339,0.00026700628,0.00041821678,0.00029988805,0.00051962317,0.00003411327,0.00088621327,0.00036149874,0.0040793656],"category_scores_gemma":[0.000078478275,0.00021597918,0.0001721092,0.00041601298,0.0006435628,0.00009560572,0.0003189101,0.0010530519,0.0012327179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032356035,0.00017020304,0.00029993005,0.000076016884,0.000069928414,0.000007267869,0.00037329,0.0000024533,0.9924473,0.00033605396,0.003144652,0.0027493553],"study_design_scores_gemma":[0.00096798217,0.0007032379,0.0073618195,0.00009273386,0.00001618957,0.000010678339,0.00045292798,0.0000011150925,0.9686532,0.00036268664,0.021142635,0.00023476836],"about_ca_topic_score_codex":0.0015687575,"about_ca_topic_score_gemma":0.00007536461,"teacher_disagreement_score":0.025898336,"about_ca_system_score_codex":0.00014092308,"about_ca_system_score_gemma":0.00035109036,"threshold_uncertainty_score":0.9995449},"labels":[],"label_agreement":null},{"id":"W2885680330","doi":"10.1158/1538-7445.am2018-ct096","title":"Abstract CT096: Trastuzumab emtansine (T-DM1) + capecitabine in HER2-positive metastatic breast cancer (mBC) and HER2-positive locally advanced (LA)/metastatic gastric cancer (mGC): Results from the phase I/randomized phase II TRAXHER2 study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Trastuzumab; Gastroenterology; Breast cancer; Cancer; Phases of clinical research; Trastuzumab emtansine; Oncology; Toxicity; Colorectal cancer","score_opus":0.05435336479656514,"score_gpt":0.4505987041799581,"score_spread":0.39624533938339296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885680330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636332,0.010852214,0.00006985568,0.009448481,0.00044477676,0.007875631,0.0069392,0.000066710345,0.0006699311],"genre_scores_gemma":[0.9857473,0.006696987,0.00016918458,0.00064628205,0.00093799585,0.0042684395,0.00031509838,0.00013738076,0.0010813392],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921268,0.0019967868,0.0013866844,0.0015865329,0.0014109395,0.0014922043],"domain_scores_gemma":[0.99334115,0.003713487,0.0004022305,0.0006903663,0.0012147981,0.0006379474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027758675,0.0008121424,0.0019713335,0.0005757457,0.0007084128,0.00014073914,0.0004586998,0.00014420731,0.0031417098],"category_scores_gemma":[0.0003949198,0.0005714371,0.00025610605,0.0019332335,0.002097488,0.0003754412,0.0002109334,0.0015318273,0.000025166924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63614243,0.021027142,0.0010572803,0.00021846617,0.0054295477,0.002639926,0.030585868,0.00015669291,0.050178792,0.000020515168,0.0058579734,0.24668536],"study_design_scores_gemma":[0.9116795,0.015149681,0.044032343,0.002526116,0.0035754875,0.00017658417,0.008174412,0.0012745329,0.010333471,0.0001906241,0.001837298,0.0010499385],"about_ca_topic_score_codex":0.062491197,"about_ca_topic_score_gemma":0.044038177,"teacher_disagreement_score":0.27553707,"about_ca_system_score_codex":0.0019274931,"about_ca_system_score_gemma":0.0025945415,"threshold_uncertainty_score":0.9996737},"labels":[],"label_agreement":null},{"id":"W2885686369","doi":"10.1158/1538-7445.am2018-3211","title":"Abstract 3211: Therapeutic effects of radiotherapy on cancer cell lines using <i>RadioGx</i> computational platform","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radiogenomics; Medicine; Clonogenic assay; Radiosensitivity; Cancer; Pharmacogenomics; Oncology; Radiation therapy; Cancer research; Drug response; Internal medicine; Cell culture; Drug; Pharmacology; Biology; Radiomics","score_opus":0.06281588839087622,"score_gpt":0.40383579834909683,"score_spread":0.3410199099582206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885686369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97127116,0.026651096,0.0005032637,0.00012162613,0.00033205622,0.00026940028,0.000031895193,0.0000053440017,0.000814163],"genre_scores_gemma":[0.9883946,0.009532721,0.0005369192,0.00022576873,0.00096064626,0.00005325301,0.000009757269,0.000028445318,0.00025788398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987898,0.00004362569,0.000167218,0.00030592785,0.00031987883,0.0003735609],"domain_scores_gemma":[0.99923986,0.00008151613,0.000072772964,0.00022132379,0.00032052366,0.000064014086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003022379,0.0001341519,0.00019541949,0.00008523841,0.00017905829,0.000019452036,0.00020136604,0.000090836365,0.00013503456],"category_scores_gemma":[0.00002413055,0.00011215196,0.00007257648,0.00019386272,0.00027486312,0.00000487808,0.00006375692,0.00013466255,0.0000028234178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023254036,0.00008219446,0.00075569534,0.00010431312,0.00015765609,0.0000011198617,0.00008299951,0.0003822588,0.99202424,0.00018878788,0.0012979688,0.004690246],"study_design_scores_gemma":[0.0008107376,0.00056990323,0.004611554,0.00005257303,0.000012708045,9.36226e-7,0.00003641371,0.00032722717,0.97664005,0.00025322783,0.016538147,0.00014651525],"about_ca_topic_score_codex":0.00051149394,"about_ca_topic_score_gemma":0.000143434,"teacher_disagreement_score":0.017123451,"about_ca_system_score_codex":0.00009136146,"about_ca_system_score_gemma":0.0002232721,"threshold_uncertainty_score":0.45734242},"labels":[],"label_agreement":null},{"id":"W2885720538","doi":"10.1158/1538-7445.am2018-3058","title":"Abstract 3058: Data and resource sharing: Advancing our understanding of glioblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Stem cell; Glioblastoma; Medicine; Cancer stem cell; Cancer research; Bioinformatics; Biology; Oncology; Genetics","score_opus":0.1259085109219665,"score_gpt":0.4139185672794925,"score_spread":0.28801005635752597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885720538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940913,0.002235051,0.00044942976,0.00039486747,0.00010641849,0.00014545991,0.00015387275,0.000005276601,0.0024183409],"genre_scores_gemma":[0.99779576,0.0010661527,0.00013391262,0.00006011198,0.00066789775,0.00000841872,0.000037679696,0.000022865599,0.00020718217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884397,0.00002138467,0.00015184963,0.00043989354,0.00020509919,0.00033779253],"domain_scores_gemma":[0.99897313,0.000038444552,0.00004930977,0.00068736315,0.00013567225,0.0001160692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007197116,0.00008340575,0.000106866035,0.000079597514,0.0001457493,0.000043065007,0.00046237724,0.0000776876,0.00002340422],"category_scores_gemma":[0.00024385082,0.00008535557,0.00001819149,0.00014022428,0.00019353702,0.00000616168,0.0009749195,0.00013635785,0.0000036050951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050316897,0.00003868619,0.005538968,0.00014784184,0.000068212335,0.000007082009,0.00020336625,0.000036096786,0.9498748,0.000619201,0.037767816,0.005194746],"study_design_scores_gemma":[0.001487676,0.0012277201,0.0031520291,0.000367428,0.000026025658,0.000015627102,0.0046130856,0.00064163073,0.6675872,0.001687723,0.31873867,0.00045513862],"about_ca_topic_score_codex":0.00019369774,"about_ca_topic_score_gemma":0.00091481314,"teacher_disagreement_score":0.28228757,"about_ca_system_score_codex":0.00007548522,"about_ca_system_score_gemma":0.00019877925,"threshold_uncertainty_score":0.3480699},"labels":[],"label_agreement":null},{"id":"W2885728304","doi":"10.1158/1538-7445.am2018-227","title":"Abstract 227: Germline variation at 8q24 and prostate cancer risk in men of European ancestry","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Imputation (statistics); Population; Logistic regression; Stepwise regression; Medicine; Oncology; Biology; Internal medicine; Genetics; Cancer; Statistics; Mathematics","score_opus":0.0545613784987183,"score_gpt":0.40176222387245786,"score_spread":0.3472008453737396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885728304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944211,0.0020990577,0.000018883145,0.00038045982,0.000060878472,0.00017117716,0.00008416468,0.0000027010074,0.0027615286],"genre_scores_gemma":[0.9905974,0.007792196,0.00014125454,0.000034020853,0.0003440158,0.00004918418,0.00002562575,0.000013741205,0.0010025146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881715,0.0002745058,0.00021950106,0.00028471288,0.00012296274,0.0002811799],"domain_scores_gemma":[0.99937534,0.000037582166,0.00011210702,0.00019088136,0.0002272267,0.000056885427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014466603,0.00007249486,0.00012073172,0.00005838868,0.00009630849,0.000007659202,0.00011248985,0.000083741885,0.000095184114],"category_scores_gemma":[0.00022516686,0.0000660644,0.000020106385,0.00013559785,0.00020839034,0.0000031763484,0.00015320488,0.00013967068,0.000007777397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014707624,0.000031466112,0.51591074,0.000033072964,0.000038287733,0.0000012830258,0.00038737306,0.00015915933,0.4701929,0.000010856933,0.004442931,0.008644877],"study_design_scores_gemma":[0.00045614803,0.00013290925,0.97242785,0.000024759589,0.0000047372696,6.206692e-7,0.000055253036,0.00010998228,0.019919742,0.00011586523,0.0066777025,0.000074416734],"about_ca_topic_score_codex":0.0022675095,"about_ca_topic_score_gemma":0.0020015077,"teacher_disagreement_score":0.45651716,"about_ca_system_score_codex":0.00006316737,"about_ca_system_score_gemma":0.00012403603,"threshold_uncertainty_score":0.3427811},"labels":[],"label_agreement":null},{"id":"W2885787877","doi":"10.1158/1538-7445.am2018-3919","title":"Abstract 3919: Targeting urease to human VEGFR2 elicits antitumor activity in triple-negative breast cancer models","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Antibody; Flow cytometry; Cancer research; In vivo; Cancer; Cancer cell; Molecular biology; Chemistry; Biology; Immunology; Medicine; Internal medicine","score_opus":0.06022259180128843,"score_gpt":0.40587346348231906,"score_spread":0.34565087168103065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885787877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434596,0.0018582899,0.00006875083,0.00058124505,0.0006586015,0.0006579041,0.00034510985,0.000016248168,0.0014678674],"genre_scores_gemma":[0.99208826,0.0012793603,0.00006409838,0.00023701378,0.004695718,0.00045693247,0.000021537491,0.000051932773,0.0011051572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974243,0.0001652321,0.0002534258,0.0007721983,0.0004870708,0.00089778064],"domain_scores_gemma":[0.9984883,0.000026735845,0.000074409196,0.00044690084,0.0006154841,0.00034815984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008754662,0.00023307391,0.0002933449,0.00023259477,0.00030551694,0.00006887804,0.00042172906,0.0001726794,0.0002999922],"category_scores_gemma":[0.00014582434,0.00022958234,0.000089353016,0.0005638707,0.00028285247,0.000028343336,0.000268375,0.0004406034,0.00002817164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005951838,0.00011134063,0.00073083,0.000048818885,0.00004146306,0.0000037424345,0.00035658278,0.00031214376,0.9717027,0.000047353566,0.015376654,0.010673208],"study_design_scores_gemma":[0.0020258268,0.00021310663,0.09952842,0.00019669453,0.000014532476,0.0000055455116,0.00020375026,0.000109264445,0.87143403,0.00027091661,0.025465412,0.00053250283],"about_ca_topic_score_codex":0.015679171,"about_ca_topic_score_gemma":0.0121726,"teacher_disagreement_score":0.10026865,"about_ca_system_score_codex":0.00021145445,"about_ca_system_score_gemma":0.0007539255,"threshold_uncertainty_score":0.9908755},"labels":[],"label_agreement":null},{"id":"W2885788645","doi":"10.1158/1538-7445.am2018-ct031","title":"Abstract CT031: Updated efficacy and safety profile of durvalumab monotherapy in urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Gastroenterology; Chemotherapy; Oncology; Carcinoma; Urology; Urothelial carcinoma; Surgery; Immunotherapy; Cancer; Bladder cancer; Pembrolizumab","score_opus":0.06887245459075661,"score_gpt":0.408279224729423,"score_spread":0.3394067701386664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885788645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890237,0.0011644756,0.000003390822,0.0007117243,0.00009341747,0.001137176,0.00009106243,0.000020292166,0.0077547682],"genre_scores_gemma":[0.99775237,0.00054347387,0.000079307625,0.00009437444,0.00034061313,0.0001272747,0.000017134113,0.000037364753,0.0010080705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983495,0.00009272337,0.00028591562,0.00036440196,0.00047679836,0.00043066347],"domain_scores_gemma":[0.99909854,0.00007118336,0.000043234653,0.00033476873,0.00029706216,0.00015519142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004645832,0.00013814516,0.00031636262,0.00024634175,0.000090534035,0.0000148534455,0.00012201123,0.00010263054,0.0023514768],"category_scores_gemma":[0.000044452467,0.000113057096,0.00003910565,0.00045945673,0.00044907985,0.00006520046,0.00004872316,0.0003166895,0.00004913607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040892158,0.001464213,0.3104986,0.00056634657,0.0003930018,0.00017780255,0.0055409656,0.0000033359208,0.46104434,0.00030378616,0.008253334,0.17086214],"study_design_scores_gemma":[0.013389766,0.0013389935,0.8214221,0.00021979993,0.000020887508,0.0000090643525,0.0001296696,0.00003376658,0.15630199,0.0000908533,0.0069128247,0.00013029021],"about_ca_topic_score_codex":0.0041821664,"about_ca_topic_score_gemma":0.00032574552,"teacher_disagreement_score":0.5109235,"about_ca_system_score_codex":0.00024395026,"about_ca_system_score_gemma":0.00067747955,"threshold_uncertainty_score":0.9985605},"labels":[],"label_agreement":null},{"id":"W2885819346","doi":"10.1158/1538-7445.am2018-5513","title":"Abstract 5513: Role of the evolutionarily conserved TBX2 subfamily of transcription factors in the molecular pathogenesis of human lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Subfamily; Biology; Gene; Adenocarcinoma; Transcription factor; Lung cancer; Pathogenesis; Cancer research; Genetics; Cancer; Pathology; Immunology; Medicine","score_opus":0.047592796019561893,"score_gpt":0.36189013540703513,"score_spread":0.31429733938747323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885819346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920611,0.0066379593,0.0000046381874,0.00007985869,0.000034292658,0.0005339979,0.00009678651,0.0000017863014,0.0005495847],"genre_scores_gemma":[0.9996622,0.000110319445,0.0000063690677,0.000011779222,0.000050304603,0.00005646387,0.000017055647,0.000017249458,0.00006825825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791414,0.00047522708,0.00030837746,0.0002640494,0.00070031616,0.00033787644],"domain_scores_gemma":[0.9985758,0.00007384128,0.00007135689,0.0006019182,0.0006301393,0.000046934496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009794503,0.000106689666,0.00017100258,0.00013038739,0.00010931273,0.0000093748595,0.0006222825,0.00013514039,0.00007405992],"category_scores_gemma":[0.0001436075,0.00007353091,0.00014976568,0.0005103881,0.00083418045,0.0000060268035,0.00013610584,0.00022956688,0.0000011398879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012180432,0.00007536067,0.115900025,0.000115182374,0.000032504886,0.0000011938188,0.00041746369,0.00000527309,0.8827881,0.00012716696,0.00009664629,0.00031928133],"study_design_scores_gemma":[0.00019678171,0.00018194015,0.43534595,0.000033890574,0.0000059904028,7.976992e-7,0.00043279442,0.000011819837,0.56356007,0.00007826756,0.0001106758,0.00004101997],"about_ca_topic_score_codex":0.002974673,"about_ca_topic_score_gemma":0.0018195207,"teacher_disagreement_score":0.3194459,"about_ca_system_score_codex":0.00005376862,"about_ca_system_score_gemma":0.00041053683,"threshold_uncertainty_score":0.44968355},"labels":[],"label_agreement":null},{"id":"W2885831129","doi":"10.1158/1538-7445.am2018-1848","title":"Abstract 1848: A comprehensive image cytometry method to identify and functionally characterize a rare subpopulation of platinum-induced aneuploid tumor cells in high-grade serous carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; McGill University; Concordia University; St. Michael's Hospital","funders":"","keywords":"Flow cytometry; Biology; Cell cycle; Population; Cancer research; Cytometry; Aneuploidy; Cell; Pathology; Immunology; Medicine; Genetics","score_opus":0.05511986000258955,"score_gpt":0.3886622609428236,"score_spread":0.333542400940234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885831129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851215,0.00017119668,0.00034869867,0.000104437124,0.00011993061,0.00048152803,0.00022525246,0.000005793404,0.00003104085],"genre_scores_gemma":[0.99787956,0.000055390825,0.0013203077,0.00012247784,0.000274973,0.00008032895,0.00014795766,0.000029181932,0.0000898101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984655,0.00015511467,0.0002804621,0.00046881437,0.00027770386,0.00035244215],"domain_scores_gemma":[0.998969,0.00005074591,0.00008648344,0.00029003932,0.0004849485,0.00011874613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039858345,0.00014564648,0.00022528492,0.0002714508,0.00008260861,0.00004128442,0.00018305628,0.0001285956,0.000053089043],"category_scores_gemma":[0.000049615726,0.00015028224,0.000043974724,0.00037282752,0.00010126208,0.000013466034,0.00019978869,0.00022413695,0.000010526701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036105132,0.00005045861,0.008612536,0.00010909047,0.000024732162,0.000012843411,0.00015536931,0.0000065851837,0.9890545,0.000005613378,0.00028675754,0.0013204465],"study_design_scores_gemma":[0.0004523259,0.00019597825,0.40131935,0.00003351047,0.000004228758,0.000007563312,0.00009114186,0.000024569921,0.59730864,0.000014376477,0.0004514505,0.00009686295],"about_ca_topic_score_codex":0.00208929,"about_ca_topic_score_gemma":0.0007774629,"teacher_disagreement_score":0.3927068,"about_ca_system_score_codex":0.00007726092,"about_ca_system_score_gemma":0.00016380925,"threshold_uncertainty_score":0.6128332},"labels":[],"label_agreement":null},{"id":"W2885832508","doi":"10.1158/1538-7445.am2018-5530","title":"Abstract 5530: PD-L1 expression in patients screened for phase 2 head and neck squamous cell carcinoma clinical studies (HAWK and CONDOR)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Concordance; Medicine; Biopsy; Immunohistochemistry; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Pathology; Biomarker; Primary tumor; Cancer; Head and neck cancer; Metastasis; Biology","score_opus":0.19271039759958067,"score_gpt":0.510435567361243,"score_spread":0.3177251697616623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885832508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653007,0.011239777,0.0000023247744,0.0005126958,0.00018592093,0.0012206627,0.000059533475,0.000012136984,0.00023685845],"genre_scores_gemma":[0.9969883,0.0016772901,0.00012796771,0.00025872016,0.00034525763,0.00017632252,0.000016457143,0.00002498047,0.00038468535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825686,0.00010251105,0.00039980735,0.00045037066,0.00034738897,0.0004430542],"domain_scores_gemma":[0.9986299,0.00043683557,0.00006483229,0.00025662038,0.0004303094,0.00018144787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011067692,0.00014157896,0.00036634828,0.00016216225,0.00019235161,0.000029637013,0.000088583954,0.00012656291,0.00009466905],"category_scores_gemma":[0.00024847654,0.000109731904,0.00005603664,0.00018219021,0.00078084733,0.00009086833,0.000099121076,0.00030090375,0.0000033852273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07153076,0.0012244524,0.7072557,0.0009356063,0.00007907969,0.000027405053,0.0017420595,1.1350903e-7,0.07472845,0.0000034536251,0.024707695,0.1177652],"study_design_scores_gemma":[0.050170302,0.007526364,0.8806983,0.00043321212,0.000023683633,0.0000018041185,0.00079503236,0.00002765577,0.04667493,0.00004154672,0.0134232035,0.0001839223],"about_ca_topic_score_codex":0.0005064949,"about_ca_topic_score_gemma":0.00036984653,"teacher_disagreement_score":0.17344262,"about_ca_system_score_codex":0.000155489,"about_ca_system_score_gemma":0.00021763942,"threshold_uncertainty_score":0.44747373},"labels":[],"label_agreement":null},{"id":"W2885840167","doi":"10.1158/1538-7445.am2018-5878","title":"Abstract 5878: Effect of cannabinoid WIN 55,212-2 on prostate cancer cell proliferation, migration, invasion, and tumor growth","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"DU145; Prostate cancer; Angiogenesis; Cancer; Cell growth; Cancer research; Cancer cell; Medicine; Cannabinoid receptor; Cannabinoid; Cell migration; Cell; Internal medicine; Pharmacology; Receptor; Biology; LNCaP","score_opus":0.03563280715130795,"score_gpt":0.3805744399512674,"score_spread":0.34494163279995943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885840167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98412025,0.0048175678,9.770109e-7,0.0055037644,0.00015553168,0.00254961,0.00010736419,0.000039592825,0.0027053321],"genre_scores_gemma":[0.9866905,0.004727666,0.00001910486,0.00017951896,0.00062391645,0.0014012557,0.000051632047,0.00005644226,0.006249965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968272,0.00024001753,0.00038487528,0.00062387745,0.0011857298,0.0007382978],"domain_scores_gemma":[0.9970604,0.00019868817,0.00010735581,0.00041094943,0.0018325071,0.00039007637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012889035,0.00026789753,0.0004363167,0.00033466035,0.00036321318,0.00007309346,0.00017923754,0.0001117204,0.0007953057],"category_scores_gemma":[0.00026556678,0.00018430904,0.00006915509,0.00071427,0.00076302915,0.00021904951,0.00009729781,0.0005223197,0.0000631341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128997,0.00051770837,0.41523832,0.004109144,0.00023674328,0.000119307064,0.0045221844,0.000006869797,0.42651296,0.00012886137,0.12556103,0.010147203],"study_design_scores_gemma":[0.004237411,0.0033307392,0.06681109,0.0006892749,0.000047937847,0.0000071132736,0.00017091409,0.000044128516,0.919346,0.00010169439,0.0050217165,0.00019202988],"about_ca_topic_score_codex":0.009122715,"about_ca_topic_score_gemma":0.0028452142,"teacher_disagreement_score":0.49283302,"about_ca_system_score_codex":0.0006465955,"about_ca_system_score_gemma":0.0015331218,"threshold_uncertainty_score":0.9974756},"labels":[],"label_agreement":null},{"id":"W2885846020","doi":"10.1158/0008-5472.can-18-0618","title":"Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Montréal; Université Laval; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Cisplatin; DNA damage; DNA replication; DNA repair; Replication protein A; Nucleotide excision repair; Biology; Cell biology; Eukaryotic DNA replication; Replication factor C; Cancer research; Cell culture; DNA; Molecular biology; Genetics; DNA-binding protein; Transcription factor; Gene; Chemotherapy","score_opus":0.032526580124558,"score_gpt":0.3621449714801736,"score_spread":0.3296183913556156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885846020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739283,0.00046887057,0.00009354288,0.00034631306,0.00004375803,0.0011339944,0.00012274506,0.00000999767,0.00038796518],"genre_scores_gemma":[0.99437296,0.0001284823,0.0009075368,0.000024131994,0.00017329397,0.0014508954,0.000017160797,0.000029257295,0.0028962737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997618,0.00021520557,0.00037522602,0.0010184442,0.00037075824,0.00040236782],"domain_scores_gemma":[0.9971198,0.000015331298,0.00015663901,0.002076265,0.0005502454,0.00008173897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012759026,0.00012677278,0.00016574388,0.00010962331,0.00011031408,0.000020132418,0.0004136689,0.00016712103,0.00015537375],"category_scores_gemma":[0.00029175857,0.00012923387,0.00004812913,0.00041105377,0.0002349,0.000010237389,0.00021073075,0.00017628424,0.000009180535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005011145,0.0000654898,0.002541291,0.0002493441,0.000013083143,0.0000015784876,0.0002679068,0.0000010930659,0.99479103,0.000058475856,0.00033937173,0.0011702463],"study_design_scores_gemma":[0.00047292176,0.000121093275,0.012321818,0.00023764708,0.0000040327755,5.714269e-7,0.000040081904,0.00003195681,0.9848685,0.00025256872,0.0015201685,0.00012862892],"about_ca_topic_score_codex":0.0010886538,"about_ca_topic_score_gemma":0.0054277503,"teacher_disagreement_score":0.009922494,"about_ca_system_score_codex":0.0002194084,"about_ca_system_score_gemma":0.0003472032,"threshold_uncertainty_score":0.5270004},"labels":[],"label_agreement":null},{"id":"W2885847247","doi":"10.1158/1538-7445.am2018-5449","title":"Abstract 5449: Characterization of clinically relevant mechanism of resistance to angiogenic inhibitors in different growth patterns of human colorectal cancer liver metastases (CRCLM) by studying the angiopoietins-Tie2 mechanisms","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Colorectal cancer; Regimen; Bevacizumab; Oncology; Chemotherapy; Internal medicine; Cancer; Angiogenesis","score_opus":0.044180115240091286,"score_gpt":0.356035046302605,"score_spread":0.3118549310625137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885847247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967178,0.0010810189,0.00045754938,0.00018378622,0.00015333986,0.0006730328,0.0007012753,0.0000042122697,0.000027951011],"genre_scores_gemma":[0.9973487,0.0017931595,0.00004426821,0.000060349776,0.00025911588,0.00027474778,0.000070818445,0.000039017053,0.00010978455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757427,0.000254666,0.0007388394,0.0004703258,0.0005676855,0.00039418926],"domain_scores_gemma":[0.99844605,0.00007107111,0.0003466997,0.0003642283,0.00068101846,0.00009093265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010587755,0.00019303431,0.0003781087,0.00014465251,0.00011210989,0.000013570004,0.00047700145,0.00014900765,0.00014204299],"category_scores_gemma":[0.00010650085,0.00014435069,0.00018898363,0.00034462166,0.0002337557,0.0000096370895,0.00028080773,0.00014417479,0.0000011035868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053562596,0.0001778042,0.010176743,0.00014462126,0.00013222205,0.0000012978106,0.0004207141,0.0000014654074,0.98708504,0.00024818603,0.0004897449,0.00058650534],"study_design_scores_gemma":[0.0004286983,0.00077260355,0.040325895,0.00026874384,0.000029028159,2.8694038e-7,0.00024711405,0.00000327683,0.957463,0.00008130978,0.00023511468,0.00014490122],"about_ca_topic_score_codex":0.0013215811,"about_ca_topic_score_gemma":0.0023585316,"teacher_disagreement_score":0.030149153,"about_ca_system_score_codex":0.0000857716,"about_ca_system_score_gemma":0.00017254427,"threshold_uncertainty_score":0.58864504},"labels":[],"label_agreement":null},{"id":"W2885929747","doi":"10.1158/1538-7445.am2018-1033","title":"Abstract 1033: Patient-derived xenografts for prognostication and personalized treatment for head and neck squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Radiation therapy; Hazard ratio; Cohort; Cancer; Head and neck cancer; Personalized medicine; Bioinformatics","score_opus":0.05693991319063952,"score_gpt":0.36575297922985706,"score_spread":0.30881306603921754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885929747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913462,0.0062242583,0.00015760434,0.0003027356,0.00009754962,0.0014016882,0.00032816463,0.0000044395406,0.00013738057],"genre_scores_gemma":[0.99621266,0.0009312286,0.0007183312,0.00007723598,0.00054087775,0.0011951107,0.00014387308,0.000027077229,0.00015361357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990468,0.0000181675,0.00012275045,0.00038571982,0.00009286226,0.00033371837],"domain_scores_gemma":[0.99918866,0.00011878022,0.00003946571,0.00017657093,0.00034446982,0.00013205358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012074767,0.000115915704,0.00011447031,0.000043287637,0.00022806913,0.000057017514,0.00006603153,0.000088354675,0.000011693087],"category_scores_gemma":[0.00012719094,0.00010663003,0.00004210554,0.000045106284,0.00023794467,0.0000034662905,0.00005525071,0.000038498976,0.0000011758966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015128596,0.00015023761,0.0041088685,0.00016841426,0.000026914768,9.952039e-7,0.00074708357,0.0000019442484,0.9578364,0.00009735991,0.0039097746,0.031439144],"study_design_scores_gemma":[0.004751156,0.006072489,0.010841481,0.000019337578,0.00003325337,0.000002855673,0.00029941963,0.00011984423,0.8287663,0.00018195686,0.14868723,0.00022469342],"about_ca_topic_score_codex":0.00027475783,"about_ca_topic_score_gemma":0.0004544243,"teacher_disagreement_score":0.14477746,"about_ca_system_score_codex":0.00006656755,"about_ca_system_score_gemma":0.00022754968,"threshold_uncertainty_score":0.43482465},"labels":[],"label_agreement":null},{"id":"W2885934812","doi":"10.1158/1538-7445.am2018-3862","title":"Abstract 3862: Empowering research on ubiquitin and ubiquitin-like protein modification cascade using recombinant enzyme systems","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"ISG15; Ubiquitin; Neddylation; NEDD8; SUMO protein; Cell biology; Ubiquitin-Protein Ligases; Biology; Biochemistry; Neurodegeneration; Ubiquitin ligase; Chemistry","score_opus":0.19668960409220168,"score_gpt":0.4501856943563207,"score_spread":0.253496090264119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885934812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222296,0.0022904284,0.00008174893,0.00032357764,0.0003202541,0.0014099517,0.000040080584,0.000026650503,0.0032843256],"genre_scores_gemma":[0.99545085,0.00040775226,0.00011047687,0.000039803464,0.0012571355,0.0006299266,0.000030998373,0.00006935569,0.0020036937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99629784,0.0006042979,0.000342416,0.00087799993,0.00083544484,0.0010420332],"domain_scores_gemma":[0.9979854,0.00008198237,0.00008789727,0.00069211517,0.0008764499,0.0002761284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041805506,0.00021883223,0.00021647659,0.0003124723,0.00078384095,0.00022548853,0.00043222067,0.00031960796,0.00008439148],"category_scores_gemma":[0.0002782272,0.00020926412,0.00005126003,0.00042065486,0.0006277098,0.000016352797,0.00036384413,0.0007620288,0.000070234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032208613,0.000065629174,0.00006085456,0.00021480124,0.000026823356,0.000012231355,0.00026550883,0.000030077326,0.9939948,0.0008282084,0.0016187759,0.0025602337],"study_design_scores_gemma":[0.0004813362,0.0008188297,0.00043430662,0.0005182013,0.0000034033117,0.000020106017,0.0006205078,0.00045042112,0.96320665,0.00015826397,0.033024877,0.00026307467],"about_ca_topic_score_codex":0.0015071713,"about_ca_topic_score_gemma":0.00011400533,"teacher_disagreement_score":0.031406105,"about_ca_system_score_codex":0.000222918,"about_ca_system_score_gemma":0.0004586882,"threshold_uncertainty_score":0.85335433},"labels":[],"label_agreement":null},{"id":"W2885940108","doi":"10.1158/1538-7445.am2018-3161","title":"Abstract 3161: The macrolide toxin mycalolide B disrupts actin-driven invasion and metastasis of HER2-positive cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Metastasis; Trastuzumab; Cancer; Medicine; Cancer cell; Actin cytoskeleton; Breast cancer; Biology; Cell; Internal medicine; Cytoskeleton","score_opus":0.13896822554050128,"score_gpt":0.47725381539821765,"score_spread":0.3382855898577164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885940108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97618765,0.0023482232,0.000017194669,0.00912371,0.0002334053,0.001457985,0.0001846891,0.00003323233,0.010413916],"genre_scores_gemma":[0.99339217,0.003422029,0.000184369,0.0003678002,0.0007589516,0.00033683833,0.000012198517,0.00007143359,0.0014542161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954363,0.00044016328,0.0004516507,0.00069347257,0.0018896365,0.0010887568],"domain_scores_gemma":[0.9963475,0.0009133908,0.00012150339,0.0008811233,0.0012328335,0.0005036783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024266548,0.0002520987,0.00051679555,0.00035444426,0.00044943645,0.00008704023,0.0005369668,0.0001652122,0.0018627259],"category_scores_gemma":[0.0007459291,0.00017311514,0.00012797583,0.0011177447,0.002342917,0.00015901972,0.0004623243,0.0012817852,0.00010386477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005393456,0.00033514,0.026838593,0.0015863104,0.0010034313,0.00043716046,0.009357513,0.000036125348,0.65667623,0.00064794044,0.07551554,0.22217256],"study_design_scores_gemma":[0.0024962723,0.0016971144,0.122672625,0.0017312012,0.00012564569,0.00010024491,0.0028914034,0.00018281132,0.8069651,0.0004489114,0.060314994,0.0003736385],"about_ca_topic_score_codex":0.01899517,"about_ca_topic_score_gemma":0.0046174317,"teacher_disagreement_score":0.22179893,"about_ca_system_score_codex":0.0012250573,"about_ca_system_score_gemma":0.0020600494,"threshold_uncertainty_score":0.9990497},"labels":[],"label_agreement":null},{"id":"W2885949455","doi":"10.1158/1538-7445.am2018-225","title":"Abstract 225: Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Germline; Genome-wide association study; Ovarian cancer; Tumor-infiltrating lymphocytes; Serous fluid; Biology; CD8; Oncology; Cancer; Internal medicine; Medicine; Immunology; Genotype; Single-nucleotide polymorphism; Immune system; Genetics","score_opus":0.02219199917606012,"score_gpt":0.3159344986800157,"score_spread":0.2937424995039556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885949455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970481,0.0008599481,0.00003378243,0.0005631219,0.000081211736,0.0005181843,0.00070902985,0.000009227257,0.00017743945],"genre_scores_gemma":[0.99770194,0.0006617365,0.00009885589,0.000311721,0.00034367086,0.00034545272,0.000375195,0.00004663186,0.000114811475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708647,0.00027058297,0.0004980175,0.00074774266,0.00048729219,0.00090992154],"domain_scores_gemma":[0.998159,0.00053030264,0.0002844736,0.00034911945,0.0005390099,0.00013811712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013444315,0.00024979687,0.00046775784,0.0005574269,0.0001347623,0.000107037195,0.00031251766,0.00025786232,0.00008869253],"category_scores_gemma":[0.0016828588,0.00025751643,0.00007525176,0.0019668166,0.0001230796,0.000020082014,0.00014744807,0.00048031218,0.0000050578146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040507095,0.00021679545,0.9105824,0.000021833286,0.00033449323,0.000100375415,0.00040769138,0.007842301,0.07963452,0.0000057516145,0.00016347977,0.00028525508],"study_design_scores_gemma":[0.0028449728,0.00017508748,0.966142,0.00022294026,0.000042601598,7.2362576e-7,0.00025809882,0.0010557252,0.028754685,0.000037798483,0.00015121711,0.00031416482],"about_ca_topic_score_codex":0.05320846,"about_ca_topic_score_gemma":0.5000111,"teacher_disagreement_score":0.44680262,"about_ca_system_score_codex":0.002612134,"about_ca_system_score_gemma":0.0010507756,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2885950763","doi":"10.1158/1538-7445.am2018-2443","title":"Abstract 2443: Oxygen metabolism and hypoxia tolerance in organoid models of pancreatic ductal adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hypoxia (environmental); Biology; Organoid; Metabolism; Autophagy; Cell biology; Cancer research; Tumor hypoxia; Oxygen; Internal medicine; Endocrinology; Chemistry; Medicine; Biochemistry; Apoptosis","score_opus":0.040419983408856955,"score_gpt":0.3286938894950924,"score_spread":0.28827390608623543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885950763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93910897,0.058871634,0.00003476514,0.00012157044,0.00037607376,0.00030761244,0.000055889344,0.000006312551,0.0011171672],"genre_scores_gemma":[0.9871381,0.009811756,0.00021584204,0.000073170224,0.0020169269,0.000099794735,0.000014016677,0.000036616846,0.0005938094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817777,0.00010014515,0.00029233182,0.00052750204,0.00036213855,0.00054012873],"domain_scores_gemma":[0.998931,0.00002411943,0.000066390705,0.00046244854,0.00036173043,0.00015430288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056886586,0.00017197304,0.00032018806,0.00016478132,0.00009170602,0.000027285509,0.00030899027,0.0001647113,0.00011109148],"category_scores_gemma":[0.00008768066,0.00016498205,0.000058049303,0.00033954732,0.0005217036,0.000017905111,0.00019975858,0.00023912887,0.000007948197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032197085,0.000047984184,0.0019376985,0.000084597836,0.000048952963,0.0000028807017,0.00041490002,0.000041101113,0.99202085,0.00022992207,0.0018695308,0.0029795917],"study_design_scores_gemma":[0.0022158215,0.00021928082,0.29432976,0.00011452095,0.00003917483,0.000024815638,0.00035677364,0.00018431852,0.66960967,0.0012790329,0.031205297,0.00042151293],"about_ca_topic_score_codex":0.0012945397,"about_ca_topic_score_gemma":0.00069437164,"teacher_disagreement_score":0.32241118,"about_ca_system_score_codex":0.00003220794,"about_ca_system_score_gemma":0.00037820445,"threshold_uncertainty_score":0.6727773},"labels":[],"label_agreement":null},{"id":"W2885986993","doi":"10.1158/1538-7445.am2018-5673","title":"Abstract 5673: Complex, patient-derived, multi-cell type, 3D models of breast cancer for personalized prediction of therapeutic response","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Stromal cell; Cancer research; Medicine; Tumor progression; Breast cancer; Immune system; Cancer; Triple-negative breast cancer; In vivo; Immunology; Biology; Internal medicine","score_opus":0.24443262311571903,"score_gpt":0.4378499666924287,"score_spread":0.19341734357670967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885986993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923784,0.0054991036,0.00064179034,0.00059359375,0.00025837985,0.0012892167,0.0021056691,0.000020261956,0.00035412068],"genre_scores_gemma":[0.99606,0.0015376006,0.00075869507,0.000105376435,0.00023216006,0.0002469462,0.000029344477,0.00004584903,0.0009840274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812555,0.00013245484,0.00036109856,0.00032919203,0.00063548493,0.00041620454],"domain_scores_gemma":[0.9971541,0.00017888247,0.00014358938,0.00035184814,0.0020114866,0.00016008547],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007441479,0.00014145323,0.00038795115,0.00022237221,0.00010919391,0.000009672761,0.00013778202,0.000094062096,0.001666092],"category_scores_gemma":[0.000042840493,0.00011797141,0.00012838232,0.00042550982,0.00057662325,0.00008085988,0.000049410224,0.00021087567,0.000005733136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024650753,0.00036683754,0.00043732813,0.000611275,0.00018650139,0.0000020850684,0.0016011463,0.000066036664,0.94109505,0.000018260756,0.0024427914,0.028521923],"study_design_scores_gemma":[0.018923827,0.004193641,0.04701745,0.0011271792,0.00045057773,0.00002172121,0.0020328301,0.007874071,0.8585213,0.000114736176,0.05934678,0.00037592836],"about_ca_topic_score_codex":0.0025461845,"about_ca_topic_score_gemma":0.00017257551,"teacher_disagreement_score":0.08257381,"about_ca_system_score_codex":0.00029550816,"about_ca_system_score_gemma":0.0010453596,"threshold_uncertainty_score":0.99924654},"labels":[],"label_agreement":null},{"id":"W2886008759","doi":"10.1158/1538-7445.am2018-1501","title":"Abstract 1501: Developing novel strategy for the treatment of acute myeloid leukemia by targeting retinoic acid signaling pathways","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoid; Retinoic acid; Retinoid X receptor; Cancer research; Chemistry; Receptor; Cell biology; Acute promyelocytic leukemia; Nuclear receptor; Retinoic acid-inducible orphan G protein-coupled receptor; Retinoic acid receptor beta; Retinoic acid receptor; Transcription factor; Biology; Biochemistry","score_opus":0.07435143331726715,"score_gpt":0.3685975923718291,"score_spread":0.294246159054562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886008759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98171794,0.009906187,0.006978977,0.0001330359,0.00014838888,0.00052512117,0.00015005945,0.000011420269,0.00042884157],"genre_scores_gemma":[0.99146116,0.0055551673,0.0010213266,0.000041955023,0.0008955567,0.00033875767,0.00014289422,0.00004155831,0.0005016156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832124,0.000045269728,0.00030573,0.00045482244,0.00031004054,0.0005629286],"domain_scores_gemma":[0.9987422,0.00010444246,0.00011907635,0.00033302698,0.0006263668,0.0000748492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006628401,0.00018699981,0.00018495217,0.000042668456,0.00042630572,0.000058094625,0.00043054813,0.00017965648,0.000050702187],"category_scores_gemma":[0.00008762998,0.00013292377,0.00010863513,0.00019293325,0.0003966329,0.0000073317256,0.00007283049,0.00014305252,0.0000046506702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021856869,0.000034750497,0.000088932,0.00008522124,0.0001821228,0.0000011450583,0.00021153885,0.000050508803,0.9880357,0.00006407141,0.0024093906,0.008618096],"study_design_scores_gemma":[0.0006451812,0.0007414393,0.000056161804,0.00004593691,0.000026651041,0.0000021551896,0.00034989073,0.00007786582,0.95543414,0.00008031042,0.042380266,0.00015999547],"about_ca_topic_score_codex":0.00013197017,"about_ca_topic_score_gemma":0.000017766197,"teacher_disagreement_score":0.039970875,"about_ca_system_score_codex":0.00026355445,"about_ca_system_score_gemma":0.0011906165,"threshold_uncertainty_score":0.54204744},"labels":[],"label_agreement":null},{"id":"W2886012737","doi":"10.1158/1538-7445.am2018-390","title":"Abstract 390: Genome-wide CRISPR screens in brain tumor initiating cells (BTICs) identify potent sensitizers and resistors of conventional chemoradiotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"CRISPR; Temozolomide; Chemoradiotherapy; Cancer research; Medicine; Biology; Radiation therapy; Gene; Glioblastoma; Genetics; Internal medicine","score_opus":0.03223462503692623,"score_gpt":0.40212389956831507,"score_spread":0.36988927453138887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886012737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965294,0.0017024647,0.0008053491,0.000269818,0.00009020016,0.00018507881,0.000031735563,0.0000046119603,0.0003813504],"genre_scores_gemma":[0.9984364,0.0003807783,0.0005298635,0.00013998715,0.00027173944,0.000017301385,0.000018434457,0.000024750674,0.00018076577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988164,0.00006151503,0.00023499515,0.0003029209,0.0002537439,0.0003304811],"domain_scores_gemma":[0.9993754,0.0000624336,0.000047335834,0.00020502925,0.00021561582,0.00009418122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007324298,0.0001050925,0.00015406721,0.00014221235,0.00007193132,0.000021329372,0.00012733896,0.00007570571,0.00006598762],"category_scores_gemma":[0.00013189518,0.00011443299,0.000046785954,0.00015451695,0.0002751748,0.0000042482043,0.0000836729,0.0001694929,0.000002814215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094309704,0.00002157913,0.0038207672,0.00009292576,0.000030423824,0.000011221552,0.0001490418,0.00019450371,0.9937334,0.000008369864,0.0013290696,0.00051439786],"study_design_scores_gemma":[0.00068511115,0.000130594,0.09949906,0.00006723607,0.000003562236,0.0000046457963,0.00030339236,0.00009549256,0.89582384,0.000032599088,0.0032176413,0.00013680455],"about_ca_topic_score_codex":0.00033987148,"about_ca_topic_score_gemma":0.00029102652,"teacher_disagreement_score":0.09790953,"about_ca_system_score_codex":0.00005551816,"about_ca_system_score_gemma":0.00013554526,"threshold_uncertainty_score":0.4666442},"labels":[],"label_agreement":null},{"id":"W2886013149","doi":"10.1158/1538-7445.am2018-5468","title":"Abstract 5468: Neratinib significantly inhibits responses to androgen in human prostate cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Androgen receptor; LNCaP; Cancer research; Neratinib; Androgen; Bicalutamide; Signal transduction; Endocrinology; Internal medicine; Medicine; Biology; Cancer; Breast cancer; Cell biology; Hormone; Trastuzumab","score_opus":0.0555986928178827,"score_gpt":0.4041794870028419,"score_spread":0.3485807941849592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886013149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992659,0.0029226977,0.0000038938406,0.00054043176,0.0018026849,0.0007684785,0.00021777317,0.000013959492,0.0010710976],"genre_scores_gemma":[0.9772454,0.0018678018,0.00006517075,0.00040635673,0.012225478,0.00069421274,0.000029338324,0.000054265467,0.0074120085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975634,0.00019029167,0.00031569923,0.00070424593,0.00042014668,0.00080617465],"domain_scores_gemma":[0.9986835,0.000028543604,0.000053343996,0.00048951333,0.0004650965,0.00027998866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096659205,0.00019965829,0.00023401224,0.00023851162,0.00024263612,0.00008895392,0.00035776716,0.00016151647,0.00038237317],"category_scores_gemma":[0.00010374325,0.00019149932,0.000062002204,0.00047604105,0.00030792062,0.000010536811,0.00020678353,0.00030797467,0.000058010548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069228275,0.000050241342,0.0013387512,0.00003429158,0.000020785026,9.649996e-7,0.0005905519,0.000030077123,0.9018274,0.000020320595,0.090465456,0.0049289004],"study_design_scores_gemma":[0.00054428173,0.00021486386,0.004129618,0.00005583831,0.0000031720517,7.7487584e-7,0.00012625083,0.0000011433656,0.6295273,0.000021542635,0.36520404,0.00017118611],"about_ca_topic_score_codex":0.0030721477,"about_ca_topic_score_gemma":0.009640782,"teacher_disagreement_score":0.27473858,"about_ca_system_score_codex":0.000117222,"about_ca_system_score_gemma":0.0008665649,"threshold_uncertainty_score":0.78091156},"labels":[],"label_agreement":null},{"id":"W2886023660","doi":"10.1158/1538-7445.am2018-21","title":"Abstract 21: p66ShcA is a contextual breast cancer metastasis promoter or suppressor depending on the tumor microenvironment","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Metastasis; Cancer research; Cancer; Metastatic breast cancer; Mammary tumor; Medicine; Pathology; Primary tumor; Lung cancer; Biology; Internal medicine","score_opus":0.06123376126744564,"score_gpt":0.36407229436827926,"score_spread":0.30283853310083364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886023660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894717,0.0012550507,0.000014493142,0.0061238464,0.00025346363,0.0006351718,0.00151197,0.0000069622256,0.00072737085],"genre_scores_gemma":[0.99287736,0.0016656598,0.00003496316,0.0020880513,0.0012959547,0.000531122,0.00002236872,0.00005377667,0.0014307154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797755,0.00009565461,0.00022235591,0.0005970337,0.0004314902,0.00067589],"domain_scores_gemma":[0.9988292,0.00011257972,0.00007331924,0.0006251398,0.00018930163,0.00017048692],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005363902,0.00021245597,0.00017812237,0.00006570965,0.00037042503,0.00012462708,0.0005150211,0.00009128397,0.004616078],"category_scores_gemma":[0.00010039514,0.00013996747,0.000098574055,0.00014048682,0.00047066645,0.0000058760284,0.00033584697,0.0003081355,0.00013293867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014791831,0.00014461679,0.0009984017,0.00004302812,0.00022721205,0.00002438261,0.00029406973,0.000014117405,0.8656755,0.000070583716,0.120323256,0.010705653],"study_design_scores_gemma":[0.00061892066,0.00039940394,0.00575314,0.000088229586,0.000023794575,0.00001870234,0.0002200888,0.000015235445,0.77662367,0.000031104515,0.2159853,0.00022244359],"about_ca_topic_score_codex":0.0012055241,"about_ca_topic_score_gemma":0.0015724102,"teacher_disagreement_score":0.09566204,"about_ca_system_score_codex":0.00020305198,"about_ca_system_score_gemma":0.0004027574,"threshold_uncertainty_score":0.99629384},"labels":[],"label_agreement":null},{"id":"W2886059231","doi":"10.1158/1538-7445.am2018-5237","title":"Abstract 5237: Sex-dependent association of circulating sex steroids, pituitary hormones and treatment-free survival in patients with chronic lymphocytic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Internal medicine; Hormone; Medicine; Chronic lymphocytic leukemia; Sex hormone-binding globulin; Endocrinology; Hazard ratio; Sex steroid; Luteinizing hormone; Cancer; Oncology; Leukemia; Androgen; Steroid","score_opus":0.036033832784782394,"score_gpt":0.33789495992203833,"score_spread":0.30186112713725594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886059231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960502,0.001270459,0.0000030120777,0.000076877164,0.00008290602,0.0011861047,0.00006259812,0.000031843505,0.0012359937],"genre_scores_gemma":[0.9970363,0.00077987165,0.00003477455,0.000014291203,0.00039836386,0.00014014087,0.00003574313,0.000060996972,0.0014995269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955551,0.0002194158,0.00046694977,0.0006187993,0.0021406594,0.0009990599],"domain_scores_gemma":[0.99764395,0.00053501327,0.00014976959,0.00076861354,0.00064269884,0.0002599769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014795824,0.00024827756,0.0005549412,0.00042192033,0.00016373323,0.000050044127,0.0002850853,0.00020741859,0.00016936827],"category_scores_gemma":[0.00036272386,0.00019982025,0.00005339318,0.0005541698,0.00039617132,0.00019553892,0.0002630291,0.00040350537,0.000022406148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0032499237,0.00031229874,0.92649627,0.0009949605,0.000703411,0.0002052633,0.0028581698,0.00029951564,0.019512255,0.000022612112,0.00083323417,0.044512074],"study_design_scores_gemma":[0.11108028,0.0055113323,0.84192324,0.0010928564,0.00011289586,0.000021288552,0.0008300671,0.005055844,0.03344966,0.00011140634,0.00031303152,0.00049807853],"about_ca_topic_score_codex":0.027641272,"about_ca_topic_score_gemma":0.007192377,"teacher_disagreement_score":0.18115096,"about_ca_system_score_codex":0.20664562,"about_ca_system_score_gemma":0.025494656,"threshold_uncertainty_score":0.9800299},"labels":[],"label_agreement":null},{"id":"W2886087618","doi":"10.1158/1538-7445.am2018-3359","title":"Abstract 3359: Elucidating the oncogenic mechanism of the TAZ-CAMTA1 and YAP-TFE3 fusion proteins","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Hippo signaling pathway; Fusion protein; Fusion gene; Biology; Cancer research; Sarcoma; Cancer; Cell biology; Pathology; Gene; Signal transduction; Medicine; Genetics","score_opus":0.053665197013491435,"score_gpt":0.36639785814239434,"score_spread":0.3127326611289029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886087618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671453,0.0008787714,0.0001242516,0.0005888002,0.0001104296,0.00041631598,0.00002374854,0.0000057365746,0.0011374083],"genre_scores_gemma":[0.99821216,0.00023940299,0.000059940336,0.00008622136,0.0005152558,0.00008714259,0.000004352549,0.000018933735,0.00077657565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871606,0.00016953198,0.00015980516,0.00028412096,0.0003527219,0.00031777352],"domain_scores_gemma":[0.99907535,0.00003738496,0.00006970254,0.00047771208,0.00027581994,0.0000640061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001187685,0.000095955365,0.00009408228,0.000030897136,0.00043064106,0.00003158835,0.00038710664,0.00011643217,0.00010442347],"category_scores_gemma":[0.00020158579,0.00005578549,0.000058496396,0.00017284015,0.00039492166,0.0000031311567,0.0003205959,0.00027037528,0.000011164921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050590017,0.000016615753,0.000107172025,0.000028230595,0.000021049706,6.4927826e-7,0.0002141392,0.0000024656752,0.9936952,0.00016503675,0.00019820569,0.0055006635],"study_design_scores_gemma":[0.00023603716,0.00020290822,0.0006947251,0.00007013721,0.000005760545,0.0000031172171,0.00017412052,0.000031124615,0.9897689,0.0004032637,0.00833548,0.00007439381],"about_ca_topic_score_codex":0.0004416241,"about_ca_topic_score_gemma":0.0002302982,"teacher_disagreement_score":0.008137274,"about_ca_system_score_codex":0.000022826845,"about_ca_system_score_gemma":0.00028648524,"threshold_uncertainty_score":0.33121863},"labels":[],"label_agreement":null},{"id":"W2886096504","doi":"10.1158/1538-7445.am2018-44","title":"Abstract 44: Characterization and targeting of a temporal micro-metastatic signature in human brain metastases","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Brain metastasis; Intracardiac injection; In vivo; Metastasis; Medicine; Cancer research; Pathology; Cancer; Biology; Internal medicine","score_opus":0.06788390477445741,"score_gpt":0.4169021160596451,"score_spread":0.34901821128518773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886096504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642104,0.0013318134,0.00003282392,0.0013817992,0.000033643,0.00055543624,0.00014596945,0.0000104639,0.0000869908],"genre_scores_gemma":[0.9983205,0.000098812256,0.0006901254,0.00013485501,0.00013701017,0.000062782885,0.00025451212,0.000021682501,0.00027968822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985748,0.00017677106,0.00028644883,0.00028088808,0.0003566816,0.00032443058],"domain_scores_gemma":[0.99926925,0.00014451695,0.00008093818,0.00017881312,0.00021518634,0.00011129473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001296965,0.000115674586,0.0002937953,0.0003026199,0.0001018781,0.0000238134,0.000066611945,0.0000468132,0.0005587854],"category_scores_gemma":[0.00017294494,0.000092111375,0.000040602812,0.00042627455,0.00028577552,0.00008820911,0.00005470738,0.00028945008,0.0000050657413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019993521,0.00020198472,0.016094169,0.00033430406,0.00008105124,0.00008152432,0.0004840513,5.650795e-7,0.97366375,0.00010391702,0.0010228434,0.007731898],"study_design_scores_gemma":[0.0060172905,0.0018525737,0.34826422,0.0011881405,0.00010627627,0.000027711858,0.0010816986,0.000052158517,0.6247478,0.00035059327,0.016013963,0.00029757124],"about_ca_topic_score_codex":0.00087851105,"about_ca_topic_score_gemma":0.00017242623,"teacher_disagreement_score":0.34891596,"about_ca_system_score_codex":0.000090762216,"about_ca_system_score_gemma":0.0001610033,"threshold_uncertainty_score":0.61183083},"labels":[],"label_agreement":null},{"id":"W2886102052","doi":"10.1158/1538-7445.am2018-1118","title":"Abstract 1118: DOT1L epigenetically regulates cancer stem cell properties and tumor progression in glioblastoma brain tumor stem cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Biology; Stem cell; Carcinogenesis; Epigenetics; Cancer stem cell; DNA methylation; SOX2; Cancer; Genetics; Transcription factor; Gene expression; Gene","score_opus":0.04515677392952932,"score_gpt":0.3486450869884888,"score_spread":0.30348831305895946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886102052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97955406,0.01882041,0.000011632688,0.00044058965,0.0001526523,0.0006597339,0.00002652909,0.000013094651,0.00032127392],"genre_scores_gemma":[0.996056,0.0015402572,0.00008658684,0.000073867326,0.00044884294,0.0002946642,0.0000033991787,0.00005153742,0.0014448114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976488,0.00022034172,0.00034367523,0.00068260316,0.00045160632,0.0006530059],"domain_scores_gemma":[0.9988592,0.000042215426,0.00009284736,0.00039085932,0.00041050077,0.00020434125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090538315,0.00021494653,0.00021098484,0.00015300684,0.00019649845,0.00010760568,0.0002789541,0.00014199529,0.00007176321],"category_scores_gemma":[0.000022577935,0.00017805825,0.00004436287,0.00027420442,0.0005893628,0.000010837074,0.00026815187,0.00026741592,0.000017125823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004130835,0.00006950068,0.0036181943,0.00016024179,0.000014041722,0.000011936925,0.0002112355,0.000054452863,0.9713134,0.0000069045022,0.0005263695,0.023600621],"study_design_scores_gemma":[0.00054994435,0.0007356507,0.006412385,0.00021592944,0.0000047854046,0.0000013190026,0.0001759995,0.00012037055,0.98166704,0.000056405388,0.009826957,0.00023322429],"about_ca_topic_score_codex":0.00027647024,"about_ca_topic_score_gemma":0.0010134734,"teacher_disagreement_score":0.023367396,"about_ca_system_score_codex":0.00008715326,"about_ca_system_score_gemma":0.00039060082,"threshold_uncertainty_score":0.72610044},"labels":[],"label_agreement":null},{"id":"W2886125280","doi":"10.1158/1538-7445.am2018-368","title":"Abstract 368: B-lymphoid transcriptional repression of the pentose phosphate pathway reveals a unique therapeutic vulnerability of B cell malignancies","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Protein phosphatase 2; Pentose phosphate pathway; Biology; Programmed cell death; Psychological repression; B cell; Cell growth; Cell biology; Cancer research; Phosphatase; Biochemistry; Glycolysis; Enzyme; Phosphorylation; Genetics; Apoptosis; Gene; Gene expression","score_opus":0.0501632828112794,"score_gpt":0.3531860202309873,"score_spread":0.30302273741970787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886125280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822838,0.015331041,0.000054427896,0.00015620401,0.0005245165,0.00040389865,0.0001387764,0.000004445614,0.001102903],"genre_scores_gemma":[0.9940122,0.0029454916,0.000047364945,0.00008108796,0.0005812443,0.00009797637,0.000011173913,0.000019158622,0.0022043532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982431,0.00027281724,0.00031283722,0.00037217906,0.00046866434,0.00033040871],"domain_scores_gemma":[0.9984048,0.00003636699,0.00012958482,0.00068678014,0.00066577265,0.00007670707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012089388,0.00012481744,0.00019903103,0.000044454882,0.00014576328,0.000012070111,0.00044066441,0.00014052918,0.0003352105],"category_scores_gemma":[0.00008368451,0.00008829082,0.00015909868,0.00022462047,0.0007128784,0.000007588046,0.00012179905,0.00018308504,0.0000025186812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038286857,0.00011170706,0.0014146557,0.00014223023,0.000025918522,1.669157e-7,0.00028602534,0.00001186609,0.99225545,0.0001468536,0.0009498369,0.0042724023],"study_design_scores_gemma":[0.0005137286,0.0001222911,0.029491007,0.00008443697,0.000009394211,0.0000017271287,0.000073843075,0.0000025636123,0.9169007,0.00041196754,0.05230049,0.000087827095],"about_ca_topic_score_codex":0.0005262671,"about_ca_topic_score_gemma":0.00018195172,"teacher_disagreement_score":0.07535475,"about_ca_system_score_codex":0.000041680585,"about_ca_system_score_gemma":0.00067672256,"threshold_uncertainty_score":0.367032},"labels":[],"label_agreement":null},{"id":"W2886128131","doi":"10.1158/1538-7445.am2018-684","title":"Abstract 684: Inhibition of translation by aglaiastatins: Mechanism of action","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical compounds biological activities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University Health Centre; McGill University","funders":"","keywords":"eIF4A; PI3K/AKT/mTOR pathway; Biology; Translation (biology); Eukaryotic translation; MAPK/ERK pathway; Mechanism of action; Eukaryotic initiation factor; RNA; Protein subunit; Kinase; Biochemistry; Cancer research; Chemistry; Cell biology; Molecular biology; Signal transduction; In vitro; Messenger RNA; Gene","score_opus":0.1179160544185608,"score_gpt":0.41002681974843463,"score_spread":0.29211076532987384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886128131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714875,0.00029771365,0.0008709961,0.00008831342,0.000038412654,0.00014268205,0.00008861458,0.000004796366,0.0013197195],"genre_scores_gemma":[0.999307,0.00022342807,0.00013086594,0.000016702204,0.00014587377,0.000036534373,0.000078989964,0.000007697921,0.000052959153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992175,0.00006595915,0.00015649048,0.00018616255,0.00021109826,0.00016278774],"domain_scores_gemma":[0.999453,0.00003676015,0.00006655488,0.0001317325,0.00027563516,0.00003631345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027533981,0.00006241466,0.00009678507,0.000040158746,0.00004273457,0.00000524874,0.00008965172,0.000112435395,0.0001037655],"category_scores_gemma":[0.000066128734,0.00005536281,0.00004022182,0.00011791317,0.00030278487,0.000006475703,0.00003797662,0.000110906374,0.0000025480606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022113326,0.00005846828,0.000035780326,0.000047453243,0.000014025271,9.58314e-8,0.00003588451,5.168532e-7,0.992561,0.00007337649,0.0008648748,0.0060873823],"study_design_scores_gemma":[0.00021824599,0.000436859,0.00026060664,0.000029167402,0.0000021351893,3.52714e-7,0.000061199404,0.000007883382,0.9949208,0.002628506,0.0013787766,0.000055466822],"about_ca_topic_score_codex":0.0001399764,"about_ca_topic_score_gemma":0.000049057984,"teacher_disagreement_score":0.0060319155,"about_ca_system_score_codex":0.000023268574,"about_ca_system_score_gemma":0.00005669097,"threshold_uncertainty_score":0.22576298},"labels":[],"label_agreement":null},{"id":"W2886137812","doi":"10.1158/1538-7445.am2018-1140","title":"Abstract 1140: Genes preserving stem cell state in group 3 medulloblastoma brain tumor initiating cells contribute to therapy evasion and relapse","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Biology; Population; Cancer research; Gene knockdown; Stem cell; Brain tumor; Gene; Internal medicine; Oncology; Medicine; Pathology; Genetics","score_opus":0.06814970929215117,"score_gpt":0.380308724834273,"score_spread":0.3121590155421219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886137812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913473,0.0048841084,0.0000056186464,0.0019396581,0.00010597798,0.0012824053,0.00004450593,0.00002702764,0.00036339706],"genre_scores_gemma":[0.9971168,0.0015226924,0.00010114107,0.0004053367,0.0001946541,0.0004144808,0.00000643656,0.0000399015,0.00019856142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776196,0.000185233,0.0003009554,0.00047560802,0.0006110936,0.0006651386],"domain_scores_gemma":[0.9983927,0.0005476713,0.000059717997,0.00033279305,0.00032538848,0.00034173686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013063228,0.00017040387,0.00029882486,0.00033736,0.0001760266,0.00008184974,0.00014262807,0.000058893227,0.00020936626],"category_scores_gemma":[0.00007368493,0.00013523622,0.000040784897,0.00049872644,0.00010681825,0.00011678053,0.00016986897,0.0003033765,0.000058233916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001248642,0.00044553404,0.050552417,0.00024726946,0.000059753886,0.0006355998,0.0026864568,0.000024866062,0.8884327,0.000009799235,0.0057274057,0.049929563],"study_design_scores_gemma":[0.005398763,0.0016153461,0.14508495,0.0009362691,0.000008907596,0.000010904678,0.00058339804,0.00016818328,0.8382,0.000084138,0.0077219014,0.0001872942],"about_ca_topic_score_codex":0.0025991884,"about_ca_topic_score_gemma":0.0017937082,"teacher_disagreement_score":0.09453253,"about_ca_system_score_codex":0.0003276489,"about_ca_system_score_gemma":0.00016993537,"threshold_uncertainty_score":0.5514773},"labels":[],"label_agreement":null},{"id":"W2886138140","doi":"10.1158/0008-5472.can-18-0234","title":"Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; Musculoskeletal Research Center, Washington University in St. Louis; Stand Up To Cancer; Foundation for Barnes-Jewish Hospital","keywords":"Stromal cell; Medicine; Breast cancer; Cancer research; Cancer; Metastatic breast cancer; Cancer cell; Metastasis; Chemotherapy; CA15-3; Oncology; Internal medicine; Pathology","score_opus":0.09270798373048636,"score_gpt":0.4163822444934966,"score_spread":0.3236742607630102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886138140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891692,0.0013744184,9.2192903e-7,0.007969289,0.00011556748,0.00065306306,0.0002905895,0.000014767807,0.00041220005],"genre_scores_gemma":[0.9976093,0.00073398394,0.000025864476,0.0004756707,0.00027718747,0.00016997811,0.000007516988,0.000024562245,0.00067593495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983959,0.00013108984,0.00019891425,0.0002735344,0.0005594955,0.0004410384],"domain_scores_gemma":[0.9988774,0.000056356643,0.00006695978,0.0003082574,0.0004670661,0.00022392764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038438974,0.00011761802,0.00024673264,0.000102932114,0.00021146926,0.000014144795,0.00006131472,0.000078477104,0.00039992316],"category_scores_gemma":[0.000037171012,0.0000746526,0.000049407536,0.00041128055,0.00039587863,0.00006870886,0.000053266605,0.0002813444,0.000011109097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004258865,0.00083780894,0.24170017,0.0008502665,0.00040100637,0.000067436966,0.0017423359,3.715591e-7,0.5172735,0.0003057557,0.0055936426,0.22696884],"study_design_scores_gemma":[0.004590044,0.00079619343,0.456523,0.00066593074,0.000053971784,0.00008791012,0.00015030653,0.0000116840865,0.53341794,0.00012905634,0.0034664525,0.00010752011],"about_ca_topic_score_codex":0.0041937563,"about_ca_topic_score_gemma":0.001334596,"teacher_disagreement_score":0.22686133,"about_ca_system_score_codex":0.00020868494,"about_ca_system_score_gemma":0.0007963342,"threshold_uncertainty_score":0.6339733},"labels":[],"label_agreement":null},{"id":"W2886178511","doi":"10.1158/1538-7445.am2018-1189","title":"Abstract 1189: Deciphering the impact of immune editing on liver cancer clonal evolution using immunogenomics","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; Immune system; Somatic evolution in cancer; Liver cancer; Cancer; Cancer research; Hepatocellular carcinoma; Antigen; FOXP3; Hepatitis B virus; Immunogenicity; Immunology; Genetics; Virus","score_opus":0.08535430800547973,"score_gpt":0.3972476672695433,"score_spread":0.3118933592640636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886178511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943829,0.004426896,0.00014978804,0.000034243658,0.00016323592,0.00020239023,0.00004960358,0.0000035493956,0.00058738515],"genre_scores_gemma":[0.9978156,0.0008877616,0.000107547254,0.000010265164,0.0010463268,0.00003116522,0.000014864215,0.000023841103,0.00006261602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988568,0.00004727405,0.00027985897,0.0001771465,0.00024078881,0.00039817032],"domain_scores_gemma":[0.9990271,0.000026458754,0.00013270733,0.00038417277,0.0003864422,0.000043164313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073065766,0.0001261688,0.0001294056,0.000058090096,0.0003155417,0.00004441301,0.0003539116,0.00009758512,0.00013342117],"category_scores_gemma":[0.00007641252,0.00008739017,0.00013783845,0.00018376719,0.00020750296,0.000011665068,0.00022073969,0.00024505446,0.000007254617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002729839,0.000031783027,0.0017491805,0.000032122778,0.0001399551,3.5741252e-7,0.00024153317,0.0032567787,0.98868215,0.000039639188,0.00047709435,0.0050763916],"study_design_scores_gemma":[0.0009099458,0.00077541464,0.16011333,0.00028270506,0.000022914317,0.000013999277,0.00094848225,0.01237267,0.822179,0.00008104536,0.0019861304,0.000314307],"about_ca_topic_score_codex":0.0051024104,"about_ca_topic_score_gemma":0.000093802046,"teacher_disagreement_score":0.16650313,"about_ca_system_score_codex":0.00026371953,"about_ca_system_score_gemma":0.00043556554,"threshold_uncertainty_score":0.77133524},"labels":[],"label_agreement":null},{"id":"W2886184165","doi":"10.1158/1538-7445.am2018-ct182","title":"Abstract CT182: The anti-PD-1 antibody spartalizumab (PDR001) in combination with dabrafenib and trametinib in previously untreated patients with advanced <i>BRAF</i> V600-mutant melanoma: First efficacy, safety, and biomarker findings from the part 2 biomarker cohort of COMBi-i","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Dabrafenib; Trametinib; Biomarker; CD8; Peripheral blood mononuclear cell; Internal medicine; Melanoma; Gastroenterology; Oncology; Cancer; Immunology; Cancer research; Immune system; Metastatic melanoma; Biology; MAPK/ERK pathway; Vemurafenib","score_opus":0.025198491763443628,"score_gpt":0.32818624777733774,"score_spread":0.3029877560138941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886184165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924985,0.0017727079,0.000003709183,0.0022107868,0.00007354122,0.0030285981,0.0001369413,0.000020006231,0.00025519135],"genre_scores_gemma":[0.9967468,0.0026938457,0.00001806026,0.00011597101,0.000026824655,0.000130298,0.00018657531,0.00004906781,0.00003258413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970591,0.00027056213,0.0005902571,0.0006395837,0.00083120813,0.0006092862],"domain_scores_gemma":[0.9979232,0.00085553026,0.00019176966,0.00056863995,0.000340432,0.00012041975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00146521,0.00030714984,0.0005718118,0.00024325194,0.00029092733,0.00007922888,0.00027077223,0.00014534855,0.00018055123],"category_scores_gemma":[0.00012513006,0.0001654151,0.000045470315,0.0013335058,0.0018720744,0.00017920868,0.00010228922,0.00042310468,0.0000022748904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030816767,0.00069526746,0.943991,0.00011912432,0.00036453392,0.00003074032,0.0014071335,0.000002013242,0.008695424,0.0000129999735,0.00026534716,0.0135996705],"study_design_scores_gemma":[0.02369082,0.0015607623,0.96492064,0.0017081323,0.00007252309,0.000010699674,0.00031356193,0.00005466958,0.0045594615,0.000013225813,0.0028789816,0.00021651351],"about_ca_topic_score_codex":0.006330185,"about_ca_topic_score_gemma":0.007249151,"teacher_disagreement_score":0.02092967,"about_ca_system_score_codex":0.00023297312,"about_ca_system_score_gemma":0.0002816168,"threshold_uncertainty_score":0.95693886},"labels":[],"label_agreement":null},{"id":"W2886193277","doi":"10.1158/1538-7445.am2018-lb-362","title":"Abstract LB-362: A TGF-beta linked ECM-dysregulation programme in CAFs drives immune evasion and immunotherapy resistance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Transcriptome; Biology; Cancer; Gene signature; Cancer research; Gene; Computational biology; Gene expression; Genetics","score_opus":0.0908745723282965,"score_gpt":0.4113459860111314,"score_spread":0.32047141368283494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886193277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97435,0.016990103,0.000012259293,0.005104386,0.000117918404,0.0012036075,0.000007949075,0.00005206895,0.0021617317],"genre_scores_gemma":[0.99082184,0.0060470747,0.00033903457,0.00011245282,0.0004568998,0.0005511543,0.0000170116,0.000050877698,0.0016036798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99741477,0.00013815754,0.00041328138,0.00055196154,0.0007549879,0.0007268384],"domain_scores_gemma":[0.99860436,0.000105232764,0.000084986816,0.00051350583,0.0005179519,0.00017394632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013719813,0.00019056465,0.00036935628,0.00033199193,0.00024182764,0.00010008077,0.0001893188,0.00017816394,0.0005290572],"category_scores_gemma":[0.0000801538,0.0001618526,0.00007460156,0.0008038422,0.0005839768,0.00017964703,0.000080318125,0.0005503768,0.00002543868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042368295,0.0004617136,0.07704987,0.000644116,0.0001471684,0.000030985968,0.003665645,0.0000028272266,0.5521319,0.00046908006,0.0024620884,0.3586978],"study_design_scores_gemma":[0.0035735925,0.0006668889,0.8850891,0.0015024628,0.00001732746,0.00000415632,0.00046236443,0.00006637789,0.06691831,0.00033022257,0.04112854,0.00024068002],"about_ca_topic_score_codex":0.0018985531,"about_ca_topic_score_gemma":0.0023271209,"teacher_disagreement_score":0.8080392,"about_ca_system_score_codex":0.00048346093,"about_ca_system_score_gemma":0.00040028818,"threshold_uncertainty_score":0.66001576},"labels":[],"label_agreement":null},{"id":"W2886224969","doi":"10.1158/1538-7445.am2018-222","title":"Abstract 222: Genome-wide association study of acute lymphoblastic leukemia in children with Down syndrome","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Genome-wide association study; Minor allele frequency; Single-nucleotide polymorphism; Medicine; Odds ratio; SNP; 1000 Genomes Project; Exome; Cohort; Oncology; Genetic association; Imputation (statistics); Genetics; Internal medicine; Biology; Genotype; Exome sequencing; Mutation; Gene","score_opus":0.02458685171431126,"score_gpt":0.34287244958859536,"score_spread":0.3182855978742841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886224969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960054,0.000104289116,0.000015178876,0.0003047555,0.000054938635,0.0021553964,0.000052187243,0.000042723386,0.0012651287],"genre_scores_gemma":[0.9979919,0.00012958112,0.0000578138,0.0000835036,0.00024408314,0.00035342624,0.000029471767,0.000074596945,0.0010356127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458176,0.00023994519,0.00055018644,0.0007013647,0.0027420549,0.0011847052],"domain_scores_gemma":[0.99677247,0.00074636133,0.00017450984,0.00073901634,0.0012270893,0.00034055638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019271802,0.0002540519,0.0006267521,0.00091589364,0.00017445552,0.000054529617,0.00050825893,0.00021882525,0.00076495745],"category_scores_gemma":[0.00070374727,0.00020166115,0.000060581613,0.002033479,0.0004092878,0.00018297309,0.00026937734,0.00088658714,0.00024394626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015049493,0.00048373404,0.9877335,0.0000842728,0.0010897092,0.00032742662,0.001159706,0.000065977656,0.0056921197,0.000004213162,0.0014446529,0.00040977195],"study_design_scores_gemma":[0.0093913255,0.0026920212,0.9847334,0.0002529694,0.00012682744,0.00007596983,0.00043309305,0.00009489869,0.0018911198,0.000021783275,0.00009871195,0.00018789509],"about_ca_topic_score_codex":0.0077892425,"about_ca_topic_score_gemma":0.001074588,"teacher_disagreement_score":0.010857094,"about_ca_system_score_codex":0.016486198,"about_ca_system_score_gemma":0.005629103,"threshold_uncertainty_score":0.998818},"labels":[],"label_agreement":null},{"id":"W2886226874","doi":"10.1158/1538-7445.am2018-1817","title":"Abstract 1817: Establishment and characterization of non-small cell lung cancer cell line variants selected for resistance to osimertinib","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Osimertinib; T790M; Cancer research; Lung cancer; Epidermal growth factor receptor; Cell culture; Medicine; Biology; Cancer; Oncology; Gefitinib; Internal medicine; Erlotinib; Genetics","score_opus":0.036383641769147504,"score_gpt":0.40245924002207756,"score_spread":0.36607559825293007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886226874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915341,0.0012500323,0.0006841899,0.0011449351,0.00020048926,0.0023923246,0.00044381488,0.000021904401,0.0023281777],"genre_scores_gemma":[0.98580694,0.0009790653,0.0010830952,0.00018788052,0.0004698638,0.0012050528,0.00012430298,0.00004445756,0.010099325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984722,0.000029502482,0.0002929719,0.00041683775,0.0003394469,0.00044902437],"domain_scores_gemma":[0.9977587,0.000088574234,0.0001018397,0.00027207463,0.0015389234,0.00023989468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029927705,0.0001428037,0.0002602278,0.00014994467,0.00018706442,0.00004021173,0.00010777061,0.00008035925,0.00035694987],"category_scores_gemma":[0.0000500507,0.00012482122,0.00003302936,0.00057978684,0.000084776984,0.00011290848,0.0000467605,0.00013586569,0.000004985148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011056912,0.000280788,0.007088058,0.001137246,0.00011022649,0.0000039523943,0.0018835939,0.000004144812,0.98010176,0.000014309945,0.0049658157,0.0033044214],"study_design_scores_gemma":[0.0036080005,0.0007125117,0.20820731,0.00072668405,0.00019684531,5.539087e-7,0.00012884526,0.00029827838,0.77040046,0.000010516102,0.015528332,0.00018166992],"about_ca_topic_score_codex":0.0014540706,"about_ca_topic_score_gemma":0.0012010636,"teacher_disagreement_score":0.2097013,"about_ca_system_score_codex":0.00047168075,"about_ca_system_score_gemma":0.0010384587,"threshold_uncertainty_score":0.50900614},"labels":[],"label_agreement":null},{"id":"W2886241722","doi":"10.1158/1538-7445.am2018-2802","title":"Abstract 2802: Discovery of the first selective and cell-active eIF4A3 inhibitors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Eukaryotic initiation factor; Helicase; Ribosome; Eukaryotic translation; Initiation factor; RNA; Genetics; Biochemistry; Messenger RNA; Gene; Translation (biology)","score_opus":0.025882490146401795,"score_gpt":0.32380496679884735,"score_spread":0.29792247665244553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886241722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501693,0.00073722424,0.00002288021,0.00026219626,0.00012247832,0.00026047238,0.000028822276,0.0000021575636,0.0035468123],"genre_scores_gemma":[0.9984079,0.00026238943,0.000019797402,0.00004220746,0.0003547617,0.00006728676,0.0000016105321,0.000014130507,0.0008299183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991524,0.00006796146,0.00009524679,0.00024647586,0.00021441282,0.00022350033],"domain_scores_gemma":[0.9994377,0.000033627344,0.00004738636,0.00024880047,0.00019424506,0.00003827926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000289196,0.000077976474,0.00008271365,0.000031002775,0.00019556528,0.000024300187,0.00019572975,0.000095236246,0.00003174961],"category_scores_gemma":[0.00008159214,0.000054261865,0.000042713073,0.00014015504,0.00037779423,0.0000067679307,0.00018474886,0.00012670564,0.000004118607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015762175,0.00002145111,0.0007667306,0.000028391572,0.000021666987,3.5100368e-7,0.00018766531,8.6320796e-7,0.99398685,0.00003815197,0.0017210766,0.0030691656],"study_design_scores_gemma":[0.00015085115,0.00022592997,0.0076923138,0.0000403093,0.000003442085,8.015924e-7,0.00015551918,6.90711e-7,0.9823744,0.00023896573,0.009049805,0.00006693398],"about_ca_topic_score_codex":0.00030603685,"about_ca_topic_score_gemma":0.0002673008,"teacher_disagreement_score":0.0116124265,"about_ca_system_score_codex":0.000027397777,"about_ca_system_score_gemma":0.00017127967,"threshold_uncertainty_score":0.22127347},"labels":[],"label_agreement":null},{"id":"W2886253811","doi":"10.1158/1538-7445.am2018-854","title":"Abstract 854: Validation of a viability assay for assessing radiation response and investigating drug/radiation combinations","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clonogenic assay; Viability assay; Medicine; Ionizing radiation; Radiosensitivity; Radiation therapy; Cancer; Cancer research; Radiosensitizer; Therapeutic index; Oncology; Pharmacology; Drug; Biology; In vitro; Internal medicine; Irradiation","score_opus":0.07065408337188975,"score_gpt":0.4691616969422217,"score_spread":0.39850761357033193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886253811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884173,0.00019661918,0.0021865736,0.008195076,0.00011802806,0.0005900808,0.000010252435,0.000023749593,0.00026228957],"genre_scores_gemma":[0.99745363,0.00003930373,0.0018763319,0.000102302816,0.00026310675,0.00009726421,0.000041959218,0.000017642718,0.00010846352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845064,0.00038302966,0.0002751954,0.00023802515,0.0004295888,0.00022350972],"domain_scores_gemma":[0.9972282,0.0016854409,0.0001231107,0.00017462563,0.0006465641,0.00014203413],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0074444916,0.00007022584,0.00016419838,0.0002476454,0.0002982093,0.00006814028,0.00006376846,0.000059994054,0.00004293129],"category_scores_gemma":[0.010284508,0.00006692703,0.000032612945,0.00035219922,0.00045375916,0.0002028959,0.000028467308,0.00032964395,0.0000013562741],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048307705,0.00018381777,0.133084,0.0007460921,0.00005852318,0.0000014262558,0.0033747596,0.00008682188,0.6173226,0.00082588464,0.003257914,0.24057506],"study_design_scores_gemma":[0.003206577,0.00030662783,0.7887422,0.0005194638,0.00005330382,0.0000050972703,0.0005282634,0.052748356,0.14414889,0.0037797967,0.0058045005,0.00015694457],"about_ca_topic_score_codex":0.00032220111,"about_ca_topic_score_gemma":0.00000626179,"teacher_disagreement_score":0.6556582,"about_ca_system_score_codex":0.00023728484,"about_ca_system_score_gemma":0.00049488497,"threshold_uncertainty_score":0.9980523},"labels":[],"label_agreement":null},{"id":"W2886258832","doi":"10.1158/1538-7445.am2018-5342","title":"Abstract 5342: Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma (ESC RCC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Renal cell carcinoma; Tuberous sclerosis; Somatic cell; Kidney cancer; Germline; Germline mutation; Allele; TSC1; Cancer; Cancer research; Medicine; Clear cell; Gene; Biology; Mutation; Pathology; Genetics; Internal medicine; PI3K/AKT/mTOR pathway","score_opus":0.0782673445800243,"score_gpt":0.3809542869781105,"score_spread":0.30268694239808625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886258832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861523,0.009899928,0.000003953491,0.00045444572,0.000081496815,0.0008283688,0.000018845882,0.000017966593,0.0025426897],"genre_scores_gemma":[0.99774534,0.00069931144,0.000134547,0.00003767941,0.00039238425,0.00015062619,0.0000115656985,0.000049063434,0.00077946647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972088,0.00015650668,0.0004928707,0.00052789843,0.00086928887,0.00074468716],"domain_scores_gemma":[0.9982639,0.00026153016,0.00009660531,0.00061527395,0.00043338802,0.0003292874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007482182,0.00023427416,0.0005202482,0.00058017543,0.00011375505,0.000029691373,0.00021729615,0.00014249295,0.00047851916],"category_scores_gemma":[0.0000991541,0.00019186163,0.00008062456,0.0005840274,0.0007224123,0.00008089947,0.00016283565,0.00043330184,0.00010480171],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024866,0.00048365473,0.14699057,0.0021432263,0.00007716984,0.0009208207,0.0017239081,0.000017925766,0.83927804,0.000041387382,0.0006413637,0.006679451],"study_design_scores_gemma":[0.0024118903,0.0012174713,0.53604186,0.00042839817,0.000048762045,0.00007031138,0.00020926671,0.00014436862,0.45874238,0.00025390726,0.00027153993,0.00015986814],"about_ca_topic_score_codex":0.002549376,"about_ca_topic_score_gemma":0.0004950632,"teacher_disagreement_score":0.3890513,"about_ca_system_score_codex":0.00047495798,"about_ca_system_score_gemma":0.0006728031,"threshold_uncertainty_score":0.78238904},"labels":[],"label_agreement":null},{"id":"W2886280626","doi":"10.1158/1538-7445.am2018-4699","title":"Abstract 4699: Identification of novel potential biomarkers of response to sunitinib in glioblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Sunitinib; Cancer research; Gene knockdown; Temozolomide; Medicine; Angiogenesis; Receptor tyrosine kinase; Biology; microRNA; Cancer; Internal medicine; Receptor; Glioma; Gene; Genetics","score_opus":0.08848228104639382,"score_gpt":0.43331721350294705,"score_spread":0.3448349324565532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886280626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680775,0.00015662164,0.000049277354,0.0019098948,0.00012166512,0.000520725,0.00006297936,0.0000088970455,0.00036221242],"genre_scores_gemma":[0.9992973,0.00006730699,0.00009464731,0.000041382238,0.00012806586,0.00012890823,0.0000026902321,0.000019445852,0.00022024343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981626,0.00010137789,0.00044443546,0.00026835199,0.00070963555,0.00031358478],"domain_scores_gemma":[0.9983463,0.000108795044,0.00009025932,0.00036319395,0.0009579137,0.00013352896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022563846,0.000079899015,0.00022231328,0.00072211644,0.00004421161,0.000012281728,0.00018891942,0.00007887615,0.0005394189],"category_scores_gemma":[0.00045266564,0.00007523226,0.00006026126,0.0012630881,0.00035863518,0.000062056206,0.000074811265,0.00017658106,0.000022130705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013461661,0.00028226734,0.0030322105,0.00016503072,0.000042333402,0.0000049137866,0.00052697817,0.000008575201,0.97139156,0.00002443528,0.0015052566,0.009554782],"study_design_scores_gemma":[0.0012212573,0.00074293336,0.30162254,0.00034516182,0.000009575472,0.000002065588,0.00048397158,0.00005810279,0.69459844,0.0000075263565,0.00085426355,0.000054193206],"about_ca_topic_score_codex":0.001246817,"about_ca_topic_score_gemma":0.00030214575,"teacher_disagreement_score":0.2985903,"about_ca_system_score_codex":0.00019650813,"about_ca_system_score_gemma":0.00048613953,"threshold_uncertainty_score":0.5906259},"labels":[],"label_agreement":null},{"id":"W2886290918","doi":"10.1158/1538-7445.am2018-2204","title":"Abstract 2204: Influence of chronic comorbidities on colorectal cancer screening adherence in a population-based Canadian cohort","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Population; Cohort; Fecal occult blood; Sigmoidoscopy; Colonoscopy; Cancer; Cancer screening; COPD","score_opus":0.07216987008897785,"score_gpt":0.4000298390245847,"score_spread":0.32785996893560687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886290918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965482,0.0005358908,0.000007472468,0.0005546405,0.00015623542,0.00067619653,0.000066042245,0.000033273023,0.0014220723],"genre_scores_gemma":[0.9987659,0.000097192205,0.00003131396,0.000117348194,0.00037791734,0.00046709902,0.000020508405,0.000025875494,0.00009683025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783343,0.00009311803,0.00030110497,0.0003897787,0.00075603527,0.0006265346],"domain_scores_gemma":[0.9984948,0.00020863028,0.000079678066,0.00025376002,0.00066647964,0.0002966356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007040045,0.0001464264,0.0002940182,0.00071551243,0.0002188402,0.000027892409,0.00017154579,0.00013780496,0.0008296307],"category_scores_gemma":[0.00028547144,0.00014415465,0.000054577427,0.0010525917,0.00035386058,0.00009575493,0.000027569531,0.0006296437,0.00001940826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026868535,0.000053375454,0.96041554,0.0001743162,0.000044251323,0.000029725532,0.00021366696,0.0027866492,0.010876343,0.00003666761,0.00038414588,0.022298442],"study_design_scores_gemma":[0.0008727209,0.002250939,0.9640385,0.0012567681,0.000009419998,0.0000024808755,0.00005764379,0.0018587431,0.02896233,0.000020250036,0.0005347313,0.00013545433],"about_ca_topic_score_codex":0.8086051,"about_ca_topic_score_gemma":0.8557704,"teacher_disagreement_score":0.047165338,"about_ca_system_score_codex":0.0024385836,"about_ca_system_score_gemma":0.0034967999,"threshold_uncertainty_score":0.9083874},"labels":[],"label_agreement":null},{"id":"W2886303958","doi":"10.1158/1538-7445.am2018-sy28-01","title":"Abstract SY28-01: Management of MAP kinase and apoptosis signaling thresholds by microRNAs","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; microRNA; Caenorhabditis elegans; Cell biology; Apoptosis; Kinase; MAPK/ERK pathway; Signal transduction; Effector; Translation (biology); Genetics; Gene; Messenger RNA","score_opus":0.0469611527045251,"score_gpt":0.370948485557746,"score_spread":0.3239873328532209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886303958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98981136,0.007816683,0.0003339529,0.00033725318,0.00010145528,0.00027172887,0.00008341945,0.0000062224026,0.0012379102],"genre_scores_gemma":[0.99523777,0.0021884406,0.0014074652,0.00007764895,0.0002073889,0.00009243661,0.000024595141,0.00002820113,0.0007360321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856025,0.000056260258,0.00019019067,0.00042664775,0.0003738367,0.00039279717],"domain_scores_gemma":[0.9991824,0.000013614459,0.00005855337,0.00039472268,0.00022340275,0.00012730512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071782694,0.0001234039,0.00014691478,0.000073044575,0.00011677462,0.000033197914,0.00030738622,0.00009664897,0.0003496603],"category_scores_gemma":[0.000011415907,0.00012024796,0.000047252546,0.00013979987,0.00030899435,0.000005317652,0.00028154836,0.00012847803,0.000013761237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017104385,0.000033133332,0.000096249125,0.0002130291,0.00012228356,0.0000020234156,0.000029022765,0.0000016752243,0.96851224,0.00020589944,0.018617995,0.0119954245],"study_design_scores_gemma":[0.0003987382,0.00020880063,0.00011313711,0.000095727984,0.000015987302,7.061666e-7,0.00015390529,0.0000014475714,0.93588406,0.00018274607,0.06282863,0.000116097246],"about_ca_topic_score_codex":0.00013402227,"about_ca_topic_score_gemma":0.000021475616,"teacher_disagreement_score":0.04421063,"about_ca_system_score_codex":0.0000362086,"about_ca_system_score_gemma":0.00006702337,"threshold_uncertainty_score":0.49035695},"labels":[],"label_agreement":null},{"id":"W2886320592","doi":"10.1158/1538-7445.am2018-1477","title":"Abstract 1477: The interactomes of H3.1 and H3.3 reveal novel interactions, and associations with histone chaperones","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Histone H3; Chromatin; Histone; Interactome; Biotinylation; Biology; Cell biology; Histone code; Computational biology; Chromodomain; Genetics; Molecular biology; DNA; Gene; Nucleosome; RNA","score_opus":0.056717987110529854,"score_gpt":0.39611803925477257,"score_spread":0.33940005214424274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886320592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632365,0.0014124473,0.00011719432,0.0011614929,0.00006637485,0.0001750429,0.000037586207,0.000003076732,0.00070311694],"genre_scores_gemma":[0.99779147,0.0005401341,0.0002251067,0.000056647532,0.0002046599,0.00006476289,0.0000070732963,0.000011481943,0.0010986413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993355,0.000051399194,0.0001073262,0.00018813602,0.00015842893,0.00015918899],"domain_scores_gemma":[0.9994064,0.0000786183,0.00006017577,0.0001798064,0.00023090359,0.000044122673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041923713,0.000067692206,0.00008913244,0.000045935933,0.00018718667,0.000028939065,0.00011166722,0.000049672595,0.00006507895],"category_scores_gemma":[0.00012151937,0.00004486156,0.000016357906,0.000077271645,0.00032902058,0.000008227015,0.00009031572,0.00011874566,0.0000022612007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010050342,0.000024913948,0.00096578454,0.000016993465,0.000047262685,3.0414319e-7,0.00026584265,2.3278446e-7,0.9902329,0.0001496939,0.00080804416,0.007387524],"study_design_scores_gemma":[0.00029668908,0.00034109296,0.033311248,0.00007996491,0.000011305205,0.0000099457175,0.0004348723,0.0000047508624,0.9371747,0.0001086914,0.028129935,0.00009682651],"about_ca_topic_score_codex":0.00034744898,"about_ca_topic_score_gemma":0.0005005515,"teacher_disagreement_score":0.053058222,"about_ca_system_score_codex":0.000023297502,"about_ca_system_score_gemma":0.00007927728,"threshold_uncertainty_score":0.18294014},"labels":[],"label_agreement":null},{"id":"W2886326884","doi":"10.1158/1538-7445.am2018-5575","title":"Abstract 5575: A multiplexed RE-qPCR cell-free DNA assay to assess response and resistance to cancer therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Multiplex; Cell-free fetal DNA; Liquid biopsy; Biomarker; Real-time polymerase chain reaction; Cancer; Receiver operating characteristic; Biology; DNA; Molecular biology; Medicine; Computational biology; Bioinformatics; Internal medicine; Gene; Genetics","score_opus":0.08162189215095406,"score_gpt":0.4055351979438273,"score_spread":0.32391330579287325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886326884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599654,0.0046455995,0.000096442425,0.0055952906,0.0003208808,0.0007717773,0.00040314865,0.000014945924,0.0021553908],"genre_scores_gemma":[0.9864458,0.0038846552,0.0011273832,0.001777782,0.0011745624,0.00067997095,0.00001393799,0.000071092996,0.0048248293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749875,0.00022667323,0.0002517445,0.0008203808,0.0004646169,0.00073781266],"domain_scores_gemma":[0.9974427,0.00028164132,0.00005484741,0.00103273,0.0007153981,0.00047266242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017392196,0.00022339099,0.00022023912,0.00016801596,0.00030018899,0.00015279552,0.00066618976,0.000180055,0.00021335938],"category_scores_gemma":[0.0010810879,0.0002183326,0.000058097896,0.00040628202,0.00023278796,0.000007066369,0.00051048456,0.00024118694,0.000038943934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051255873,0.000048687725,0.00095686427,0.000024736735,0.00003072126,0.000008570127,0.00032253875,0.00002025294,0.84145325,0.000023471677,0.14902116,0.0029641695],"study_design_scores_gemma":[0.00089007907,0.00040145218,0.017281359,0.000057095735,0.0000035897642,5.400969e-7,0.000112110596,0.000002625292,0.5947165,0.00007934787,0.38621825,0.00023708158],"about_ca_topic_score_codex":0.0009489838,"about_ca_topic_score_gemma":0.010515517,"teacher_disagreement_score":0.24673676,"about_ca_system_score_codex":0.00021259174,"about_ca_system_score_gemma":0.0008145495,"threshold_uncertainty_score":0.89033455},"labels":[],"label_agreement":null},{"id":"W2886327718","doi":"10.1158/1538-7445.am2018-4360","title":"Abstract 4360: Altering the regulation of KRAS GTPase cycle via Src and SHP2 creates a potential therapeutic vulnerability for pancreatic cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"GTPase; KRAS; Guanine nucleotide exchange factor; Phosphorylation; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Kinase; Chemistry; Cancer research; Effector; GTP'; Dephosphorylation; Biology; Biochemistry; Phosphatase; Mutation","score_opus":0.044370621129463814,"score_gpt":0.39167402339827895,"score_spread":0.3473034022688151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886327718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328244,0.0041637043,0.0010035093,0.0007216696,0.00005243801,0.0006008304,0.000041849948,0.000005847634,0.0001277358],"genre_scores_gemma":[0.99818933,0.0005661156,0.000086084925,0.00007485972,0.0004352353,0.0003748621,0.000024876,0.000023531822,0.00022512839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985814,0.00011766781,0.00018725818,0.00039689208,0.00030814135,0.00040862858],"domain_scores_gemma":[0.9989499,0.000052890133,0.000047864858,0.0003824547,0.00047802224,0.00008891167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007803643,0.000117943964,0.0001418692,0.000043495806,0.0002577557,0.000041707182,0.0002432954,0.00012542457,0.00014362902],"category_scores_gemma":[0.000113589216,0.00008357072,0.00007353675,0.00014230702,0.0007499934,0.000006475314,0.00017556373,0.00017588126,0.0000019034396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054262526,0.00004072649,0.00065785635,0.00014457386,0.00007740765,3.6167555e-7,0.000060929906,0.000018364633,0.97004205,0.00003106939,0.00036253704,0.02802149],"study_design_scores_gemma":[0.00048639197,0.00029404982,0.014345884,0.000043189884,0.000020276588,0.000002590375,0.000043586613,0.0007221722,0.9801199,0.001075222,0.0027390218,0.00010772957],"about_ca_topic_score_codex":0.0010579977,"about_ca_topic_score_gemma":0.00021941838,"teacher_disagreement_score":0.02791376,"about_ca_system_score_codex":0.000038828137,"about_ca_system_score_gemma":0.00014085657,"threshold_uncertainty_score":0.3407915},"labels":[],"label_agreement":null},{"id":"W2886339606","doi":"10.1158/1538-7445.am2018-1381","title":"Abstract 1381: Targeting histone acetyltransferases to reprogram high C-MYC expressing cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epigenetics; Histone Acetyltransferases; Cancer research; Histone; Biology; Histone acetyltransferase; Oncogene; Chromatin; Acetylation; Cancer; Cancer cell; Molecular biology; Gene; Genetics; Cell cycle","score_opus":0.04929201030443629,"score_gpt":0.42575504007862425,"score_spread":0.37646302977418794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886339606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927914,0.0024343617,0.00031830752,0.0010000578,0.00046210925,0.00068386534,0.000074883916,0.00005422041,0.0021807675],"genre_scores_gemma":[0.99185336,0.0003747042,0.0010894494,0.00020341044,0.0028209432,0.0005413255,0.00010159309,0.00009977855,0.002915464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592215,0.00023280442,0.00037375552,0.0011127422,0.0010259253,0.0013326306],"domain_scores_gemma":[0.9974554,0.00006387702,0.000048965918,0.00088864967,0.0010170313,0.0005260769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015423262,0.00025847214,0.00025804466,0.0002745832,0.00070887746,0.00013941946,0.0006903096,0.00023627475,0.00065231085],"category_scores_gemma":[0.00067420217,0.000263993,0.00011050826,0.00070293556,0.0008490474,0.000016343727,0.00033026104,0.000590916,0.00021183453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039303678,0.00005210393,0.00014194624,0.00005442604,0.00003855467,0.000020349076,0.00033616804,0.00006364236,0.9055923,0.000011375549,0.08179735,0.01149875],"study_design_scores_gemma":[0.00036474218,0.00040961718,0.00028562942,0.00010865362,0.0000038075766,0.0000035099965,0.00015890358,0.000005789678,0.7845513,0.000012058058,0.21384466,0.00025133218],"about_ca_topic_score_codex":0.0058653513,"about_ca_topic_score_gemma":0.0014441374,"teacher_disagreement_score":0.13204731,"about_ca_system_score_codex":0.00073286484,"about_ca_system_score_gemma":0.0011226031,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2886354473","doi":"10.1158/1538-7445.am2018-1962","title":"Abstract 1962: Dianhydrogalactitol (VAL-083) has a distinct mechanism of action that suggests combination with PARP inhibitors as an effective therapeutic strategy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cisplatin; DNA repair; Cancer research; DNA damage; Ovarian cancer; Homologous recombination; Cancer; Cell cycle checkpoint; RAD51; Poly ADP ribose polymerase; Biology; Chemistry; Chemotherapy; Cell cycle; DNA; Genetics; Polymerase","score_opus":0.08787104211829191,"score_gpt":0.3996476303538502,"score_spread":0.3117765882355583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886354473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993393,0.00033653743,0.00022070852,0.00054837426,0.00030808846,0.0019183217,0.000020235746,0.00008052009,0.003174211],"genre_scores_gemma":[0.9987765,0.000083894905,0.000019110377,0.000032582695,0.00034523747,0.00042316594,0.000043628974,0.00007865929,0.00019722334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709886,0.00028440083,0.00024066457,0.0005637339,0.0012565255,0.000555814],"domain_scores_gemma":[0.9979066,0.00016726424,0.00016312109,0.0006796777,0.0008062016,0.00027712563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000823031,0.00023893731,0.00034753233,0.00037004263,0.00027533437,0.00007349351,0.00020713838,0.00023112066,0.0003926124],"category_scores_gemma":[0.00011658663,0.00019745438,0.0000816376,0.0006856748,0.00075990096,0.00027446996,0.000060953513,0.00080889824,0.0000699675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048995544,0.00091395306,0.0034555956,0.00048419982,0.0004655105,0.00014801207,0.0027466302,0.000026843993,0.9143414,0.0018823422,0.00032869715,0.0703073],"study_design_scores_gemma":[0.003541939,0.0064991284,0.05476428,0.00064642006,0.000110296816,0.000049759517,0.00077350304,0.00022731318,0.9306932,0.001677006,0.00078130665,0.00023582525],"about_ca_topic_score_codex":0.004116419,"about_ca_topic_score_gemma":0.0025373613,"teacher_disagreement_score":0.07007147,"about_ca_system_score_codex":0.00089587783,"about_ca_system_score_gemma":0.0014472469,"threshold_uncertainty_score":0.8051956},"labels":[],"label_agreement":null},{"id":"W2886364267","doi":"10.1158/1538-7445.am2018-2515","title":"Abstract 2515: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and BRAF-inhibitor resistance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Melanoma; Cancer research; Biology; Autocrine signalling; Small hairpin RNA; Cancer; Gene knockdown; Carcinogenesis; Metastasis; Cell culture; Molecular biology; Genetics","score_opus":0.053638940093703444,"score_gpt":0.3392327324144388,"score_spread":0.28559379232073534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886364267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561036,0.0020567107,0.000039405975,0.0005668364,0.00006275495,0.00047529713,0.00012244625,0.000004216514,0.0010619559],"genre_scores_gemma":[0.9982777,0.00067810394,0.0003218123,0.00015721281,0.00022324588,0.00009238826,0.00001779404,0.000019658532,0.00021204454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985441,0.00010851685,0.00022661967,0.0004992798,0.0002165757,0.00040492558],"domain_scores_gemma":[0.9992977,0.000025230187,0.000047531285,0.00030360324,0.00020210941,0.00012382271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035592707,0.00013304058,0.00020070066,0.00007606696,0.00011184172,0.00003373051,0.00018162208,0.0001451523,0.00003599189],"category_scores_gemma":[0.000074777265,0.00011193743,0.00002441065,0.00011093378,0.000268835,0.000017347942,0.00019666392,0.00012718441,0.00000328163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005245561,0.000059357644,0.003611184,0.00011526878,0.000013238459,0.000019294279,0.0010734657,1.4486076e-7,0.9921249,0.00010787922,0.0019132112,0.00043747283],"study_design_scores_gemma":[0.00078919186,0.0006771826,0.007149469,0.0002147066,0.0000037713814,0.0000052500823,0.00013147466,0.000001593182,0.982665,0.000331899,0.007899416,0.00013105274],"about_ca_topic_score_codex":0.00036574676,"about_ca_topic_score_gemma":0.00090979383,"teacher_disagreement_score":0.009459934,"about_ca_system_score_codex":0.00002452588,"about_ca_system_score_gemma":0.00013148876,"threshold_uncertainty_score":0.4564676},"labels":[],"label_agreement":null},{"id":"W2886405078","doi":"10.1158/1538-7445.am2018-2720","title":"Abstract 2720: The CD47-blocking innate immune checkpoint inhibitor, TTI-621, triggers CD47-mediated tumor cell apoptosis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Apoptosis; Phagocytosis; Immune system; Flow cytometry; Cancer research; Macrophage; Antibody; Cell biology; Biology; Immunology; Molecular biology; Chemistry; In vitro; Biochemistry","score_opus":0.04809370789063499,"score_gpt":0.3399361158854514,"score_spread":0.2918424079948164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886405078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989917,0.012848027,0.0000062041686,0.0014305761,0.0013864671,0.0006885424,0.00004536994,0.000092234644,0.0036033927],"genre_scores_gemma":[0.99529564,0.0008902672,0.00000922746,0.00013135711,0.00040860503,0.00024527434,0.000076362674,0.000056508336,0.0028867344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967941,0.0005462182,0.0006653787,0.0005738247,0.0002641846,0.001156306],"domain_scores_gemma":[0.99786705,0.0004258825,0.00024387409,0.0007654014,0.0006324189,0.00006534584],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023907227,0.00029626486,0.00041563177,0.00033429803,0.0011193908,0.00011038167,0.0007824243,0.00029715622,0.0026835864],"category_scores_gemma":[0.00028467734,0.00021213849,0.00020518857,0.00090070744,0.0012561162,0.00022669535,0.0003538555,0.0012716606,0.0017233647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037333497,0.0001276016,0.000301775,0.00004783201,0.00013077946,0.000002542582,0.00091731455,0.000005829912,0.9834025,0.00003700526,0.008299866,0.006353609],"study_design_scores_gemma":[0.0015820081,0.00020944807,0.011397828,0.00015224512,0.000022286398,0.000008123823,0.00051019125,0.000018756575,0.9091646,0.00006373866,0.076626524,0.00024425212],"about_ca_topic_score_codex":0.0017693812,"about_ca_topic_score_gemma":0.00007348936,"teacher_disagreement_score":0.07423791,"about_ca_system_score_codex":0.00040812863,"about_ca_system_score_gemma":0.00045637917,"threshold_uncertainty_score":0.9990539},"labels":[],"label_agreement":null},{"id":"W2886413162","doi":"10.1158/1538-7445.am2018-10","title":"Abstract 10: Evaluation of metronomic chemotherapy regimens in preclinical orthotopically implanted colon cancer models, and in patient-derived xenografts","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Bevacizumab; Colorectal cancer; Internal medicine; Capecitabine; Regimen; Oncology; Cancer; Etoposide; Chemotherapy","score_opus":0.14213763304903945,"score_gpt":0.4781424179465738,"score_spread":0.3360047848975344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886413162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617386,0.0023326252,0.0000033709694,0.000244488,0.000040099512,0.00074877386,0.00005497766,0.0000026376076,0.00039915668],"genre_scores_gemma":[0.99635893,0.002874107,0.000039445335,0.000027962325,0.00009680666,0.000502922,0.00003864281,0.000016170141,0.000045036322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982926,0.00021499938,0.00026793708,0.00040914695,0.00042245977,0.00039285087],"domain_scores_gemma":[0.999163,0.000039468436,0.000060669885,0.00025045683,0.00038698167,0.00009945118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085180294,0.00010489671,0.00018153862,0.00015995951,0.00004345767,0.000015892549,0.00013856443,0.00012708113,0.00022630827],"category_scores_gemma":[0.00008849788,0.00009712965,0.00003477158,0.00026241757,0.00027436353,0.000010729934,0.000093026225,0.0001741811,0.000002457073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053176684,0.00038233158,0.048913114,0.000058133635,0.00015344346,0.000007362557,0.0004197173,0.00028927682,0.85387516,0.000007284378,0.0011844143,0.0893921],"study_design_scores_gemma":[0.010143267,0.0018176385,0.29315352,0.00024013343,0.000019701265,0.0000031872346,0.0001602368,0.0018292018,0.68947995,0.00048366023,0.002386977,0.0002825016],"about_ca_topic_score_codex":0.007915052,"about_ca_topic_score_gemma":0.047776226,"teacher_disagreement_score":0.24424042,"about_ca_system_score_codex":0.0002345966,"about_ca_system_score_gemma":0.00074080477,"threshold_uncertainty_score":0.9986913},"labels":[],"label_agreement":null},{"id":"W2886434870","doi":"10.1158/1538-7445.am2018-3976","title":"Abstract 3976: Antihistamines as synergists with targeted therapies in chronic lymphocytic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Pharmacology; Ibrutinib; Bendamustine; Cancer research; Bruton's tyrosine kinase; Chlorambucil; Medicine; Cancer cell; Programmed cell death; Cancer; Leukemia; Immunology; Apoptosis; Tyrosine kinase; Biology; Internal medicine; Receptor; Chemotherapy; Biochemistry; Cyclophosphamide","score_opus":0.04787148710888368,"score_gpt":0.4001497695578863,"score_spread":0.3522782824490026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886434870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97970027,0.0075059067,0.0000067810374,0.00046933498,0.00013423228,0.0010922322,0.000011588433,0.00011775601,0.010961922],"genre_scores_gemma":[0.98722744,0.0021805514,0.00008210732,0.00015915296,0.0011320878,0.00040017092,0.000023568467,0.00011876139,0.008676152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99470335,0.0001753269,0.00045337935,0.00089983654,0.0020450675,0.0017230404],"domain_scores_gemma":[0.9969793,0.0004037628,0.00007664124,0.0010715342,0.0010185775,0.00045019638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013707282,0.0003409571,0.0005649246,0.00083029224,0.00027612204,0.00011552965,0.00056447706,0.00024675735,0.0029347339],"category_scores_gemma":[0.00038046567,0.00025629334,0.00008588249,0.0020587794,0.0020506529,0.00022180835,0.00021232435,0.00088451453,0.00087780174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.018758046,0.0003564435,0.0075703952,0.0048406324,0.0011867211,0.010249834,0.008618093,0.001152396,0.8587206,0.0017941783,0.03635719,0.050395455],"study_design_scores_gemma":[0.1127528,0.009159632,0.083557606,0.008210252,0.000119846074,0.0013564884,0.0029857522,0.023860566,0.6175329,0.00091464835,0.1374698,0.0020796868],"about_ca_topic_score_codex":0.038886942,"about_ca_topic_score_gemma":0.0063767214,"teacher_disagreement_score":0.2411877,"about_ca_system_score_codex":0.21439585,"about_ca_system_score_gemma":0.13118933,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W2886441288","doi":"10.1158/1538-7445.am2018-3005","title":"Abstract 3005: International Cancer Genome Consortium","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Genomics; Globe; Cancer; Library science; Biology; Computational biology; Geography; Genetics; Computer science; Gene","score_opus":0.05616339917084291,"score_gpt":0.41036130908220647,"score_spread":0.3541979099113636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886441288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793163,0.0038059088,0.0000658917,0.0014673572,0.001070206,0.00019697532,0.00029493944,0.000009976108,0.013772476],"genre_scores_gemma":[0.9855171,0.006969689,0.00006624465,0.00053305976,0.004105949,0.0001735793,0.00006985566,0.0000294824,0.0025350482],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987045,0.000025420752,0.00016141044,0.00039733964,0.00029816086,0.00041315777],"domain_scores_gemma":[0.9988522,0.000027325605,0.00004222626,0.00033352536,0.00060382107,0.00014092452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003289736,0.00010555979,0.00009393114,0.000080354635,0.00015077105,0.0000716915,0.0004281487,0.000106379965,0.0019792886],"category_scores_gemma":[0.00013034999,0.00010619639,0.00005274349,0.00012394368,0.00036506244,0.000004100832,0.00026131983,0.00017723584,0.00012777663],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018131828,0.00004187268,0.0038164104,0.000013489441,0.00008786492,0.00000578218,0.00007120485,0.000052431616,0.9398916,0.00022690414,0.048724584,0.0068865586],"study_design_scores_gemma":[0.00041130724,0.0001157694,0.017596362,0.000017660974,0.0000048324337,0.0000023370692,0.000049954233,0.000013959472,0.20295878,0.00012536085,0.7785477,0.00015598444],"about_ca_topic_score_codex":0.0008863458,"about_ca_topic_score_gemma":0.0013203899,"teacher_disagreement_score":0.7369328,"about_ca_system_score_codex":0.00013690005,"about_ca_system_score_gemma":0.00055631046,"threshold_uncertainty_score":0.998933},"labels":[],"label_agreement":null},{"id":"W2886442897","doi":"10.1158/1538-7445.am2018-1696","title":"Abstract 1696: Glycogen synthase kinase (GSK-3) inactivation downregulates PD-1 and synergizes with PD-1/PL1 and CTLA-4 blockade in cancer immunotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Granzyme B; GSK-3; Cancer research; Immune checkpoint; Chemistry; Cytotoxic T cell; Cancer immunotherapy; CD8; CTLA-4; Immunotherapy; Immune system; Biology; Immunology; Kinase; Biochemistry; In vitro","score_opus":0.023876072218342818,"score_gpt":0.35196811939033945,"score_spread":0.32809204717199664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886442897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860153,0.012283143,0.000024016894,0.0008865458,0.0000784768,0.0004865204,0.000032327447,0.000020180867,0.00017344487],"genre_scores_gemma":[0.99162096,0.0070613534,0.00007976497,0.000048857182,0.00050464546,0.00026614507,0.000034492426,0.00006109017,0.00032268272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828255,0.00010002055,0.00022192745,0.0006045884,0.00032372467,0.00046721534],"domain_scores_gemma":[0.9990809,0.000046870715,0.00008549394,0.0003529324,0.00031071034,0.00012311057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043171868,0.00020878486,0.00019524075,0.00020836122,0.0001760556,0.00007791823,0.00014586933,0.00023217157,0.00010617415],"category_scores_gemma":[0.000049424663,0.00018530151,0.00002657651,0.0003925735,0.0005811697,0.000025619927,0.000096661104,0.00024570248,0.0000022582783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017698593,0.00004816095,0.004485728,0.00005669139,0.00009138928,0.0000051969414,0.00022844126,0.00019881183,0.95967484,0.000014293529,0.00048199052,0.032944616],"study_design_scores_gemma":[0.001826819,0.00048405954,0.07652113,0.0002219744,0.000012760485,0.0000118797925,0.00014511011,0.00014752614,0.9089046,0.000088806664,0.011347829,0.00028747122],"about_ca_topic_score_codex":0.0036681017,"about_ca_topic_score_gemma":0.004053872,"teacher_disagreement_score":0.0720354,"about_ca_system_score_codex":0.00021032998,"about_ca_system_score_gemma":0.00036904716,"threshold_uncertainty_score":0.7556376},"labels":[],"label_agreement":null},{"id":"W2886469292","doi":"10.1158/1538-7445.am2018-3853","title":"Abstract 3853: AXL inhibitor promotes anti-tumor immunity through modulation of macrophage polarization","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"GAS6; Tumor microenvironment; Cancer research; Macrophage polarization; PI3K/AKT/mTOR pathway; Protein kinase B; Metastasis; Tumor progression; Immune system; Cytokine; Medicine; Chemistry; Cancer; Immunology; Macrophage; Biology; Receptor tyrosine kinase; Signal transduction; Cell biology; In vitro; Internal medicine","score_opus":0.06326518915086406,"score_gpt":0.37476087103485756,"score_spread":0.3114956818839935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886469292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551433,0.0024263167,0.00018306109,0.00015788205,0.00044855571,0.00042389138,0.00004915811,0.0000353651,0.0007614304],"genre_scores_gemma":[0.99887925,0.00010838132,0.000053681666,0.000017403661,0.00015397307,0.000036056863,0.00013438126,0.00002217939,0.0005946618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853384,0.0003126484,0.00035364824,0.0002640495,0.00013529413,0.00040052814],"domain_scores_gemma":[0.99867004,0.000091745285,0.00015571386,0.00038221403,0.0006817441,0.00001855845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007669509,0.00012568833,0.0002294858,0.00016239638,0.00042336542,0.000025773792,0.0002446847,0.00018464956,0.0011989928],"category_scores_gemma":[0.00016733482,0.00011295021,0.000061406725,0.00047642397,0.0006303284,0.00035452674,0.00012902723,0.00040042683,0.00019700351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013838966,0.00013380442,0.00322722,0.000059311868,0.000054374414,5.8999956e-7,0.00059235236,0.0000070721735,0.9886059,0.00039229018,0.0005599515,0.00622872],"study_design_scores_gemma":[0.0005454879,0.00017004824,0.22459404,0.00009267298,0.0000065202357,0.00000315212,0.0000869124,0.000033145647,0.77191967,0.0003425674,0.0021173572,0.00008844493],"about_ca_topic_score_codex":0.0017053686,"about_ca_topic_score_gemma":0.00004217658,"teacher_disagreement_score":0.22136682,"about_ca_system_score_codex":0.00012580754,"about_ca_system_score_gemma":0.00018573379,"threshold_uncertainty_score":0.999714},"labels":[],"label_agreement":null},{"id":"W2886489617","doi":"10.1158/1538-7445.am2018-3174","title":"Abstract 3174: PLK4 is a rational target for very high-risk medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; PTCH1; Genome instability; Sonic hedgehog; Cancer; Medicine; Cancer research; Internal medicine; Oncology; Biology; Pathology; Genetics; DNA damage; Gene","score_opus":0.05834911024689419,"score_gpt":0.3923045353475862,"score_spread":0.333955425100692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886489617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955324,0.0012390323,0.00076213176,0.00074644363,0.0003216412,0.00036057387,0.00043940253,0.000013492214,0.00058490224],"genre_scores_gemma":[0.9941081,0.00027151877,0.00084484223,0.00021029265,0.0023950934,0.0003878638,0.00007397458,0.000032324642,0.0016760215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984993,0.00006563618,0.00016714146,0.0004406837,0.00034989434,0.0004773852],"domain_scores_gemma":[0.99870455,0.000081442726,0.000047590896,0.00030043555,0.00076188566,0.00010407898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071573845,0.00012492437,0.00013125628,0.000074149386,0.00039577874,0.00003797028,0.00025835665,0.00013220597,0.00031434494],"category_scores_gemma":[0.00041524708,0.00011580872,0.000076997625,0.00013959962,0.00037668966,0.000004402578,0.00014483315,0.00016886693,0.00009072915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039086174,0.000044122782,0.0012934399,0.0000413251,0.00015323548,0.0000018665351,0.00020891364,0.000022745711,0.8280999,0.00008707243,0.16677068,0.0028857964],"study_design_scores_gemma":[0.00055313634,0.00056485325,0.003629596,0.000022001292,0.0000063925872,7.137071e-7,0.0000764547,0.00002902206,0.78121364,0.0005513562,0.21321441,0.00013845421],"about_ca_topic_score_codex":0.0002080536,"about_ca_topic_score_gemma":0.00020746751,"teacher_disagreement_score":0.04688632,"about_ca_system_score_codex":0.000059018275,"about_ca_system_score_gemma":0.0004503411,"threshold_uncertainty_score":0.47225425},"labels":[],"label_agreement":null},{"id":"W2886502302","doi":"10.1158/1538-7445.am2018-3743","title":"Abstract 3743: Translational regulation by ERα in hormone-dependent cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Translation (biology); Translational regulation; Biology; Translational efficiency; Messenger RNA; Cell biology; Estrogen receptor; Transcription (linguistics); Transcription factor; Cancer research; Cancer; Gene; Genetics; Breast cancer","score_opus":0.024993873044202298,"score_gpt":0.36340137666968275,"score_spread":0.33840750362548044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886502302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843294,0.0072398465,0.000079576406,0.0002407741,0.00008575458,0.0002369063,0.000028945342,0.00000818819,0.0036470757],"genre_scores_gemma":[0.9968317,0.0013484954,0.00003659384,0.00003244408,0.00033618393,0.000076973796,0.00008690754,0.000021216365,0.0012294588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987472,0.00008331015,0.0001460058,0.00031759846,0.00032794723,0.00037787925],"domain_scores_gemma":[0.99951184,0.000016535834,0.00002549658,0.00018466478,0.0001643443,0.000097119344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005089338,0.0000947212,0.000080539714,0.00008589449,0.0001421403,0.000024806604,0.00015785935,0.00019136479,0.00015025401],"category_scores_gemma":[0.000028243758,0.000089825684,0.00003699029,0.00022086408,0.00031170584,0.00000793804,0.000034571243,0.0002583534,0.000040754723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003123562,0.000028189104,0.0012111207,0.000010976473,0.000025811902,0.0000027860108,0.000107648055,0.00015465033,0.9761251,0.000032536012,0.013219606,0.008769223],"study_design_scores_gemma":[0.0014167622,0.00046162683,0.033592515,0.000049423845,0.00000536384,0.000004839182,0.000065910746,0.00015596625,0.9403726,0.0003940805,0.023255471,0.00022543587],"about_ca_topic_score_codex":0.0007789764,"about_ca_topic_score_gemma":0.00047846805,"teacher_disagreement_score":0.035752494,"about_ca_system_score_codex":0.00014695527,"about_ca_system_score_gemma":0.00031199792,"threshold_uncertainty_score":0.3662985},"labels":[],"label_agreement":null},{"id":"W2886513339","doi":"10.1158/1538-7445.am2018-900","title":"Abstract 900: Dianhydrogalactitol (VAL-083) has the potential to overcome major challenges in the treatment of DIPG","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Cancer research; DNA repair; Radiation therapy; Regimen; Clinical trial; Cancer; Oncology; Pharmacology; Internal medicine; Glioma; Biology; DNA","score_opus":0.19697318233172142,"score_gpt":0.43635978012198956,"score_spread":0.23938659779026814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886513339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385418,0.007657021,3.4412022e-7,0.04994674,0.00014218845,0.001214154,0.000022585218,0.000008956177,0.0024662083],"genre_scores_gemma":[0.99245006,0.0057495325,0.000011353253,0.0001196332,0.000602513,0.00087548373,0.0000039841416,0.00001898546,0.00016844037],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99817204,0.0001336812,0.000197779,0.00030000697,0.00074071414,0.0004557904],"domain_scores_gemma":[0.9987547,0.000277607,0.000035150708,0.00063547265,0.00017401078,0.00012306849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005281673,0.000138431,0.00024367507,0.00018781591,0.00019274202,0.000042364776,0.0002269116,0.00006238151,0.000497221],"category_scores_gemma":[0.00005080092,0.000066212546,0.00010807471,0.00036592386,0.00036622214,0.000041286512,0.00004203524,0.00016344221,0.00017341421],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055046435,0.020821664,0.07677633,0.00060165534,0.0020636304,0.0028080086,0.094703674,0.000073938805,0.10914355,0.0024212592,0.040301774,0.64477986],"study_design_scores_gemma":[0.003971805,0.0038446868,0.8116181,0.00025216836,0.00010127079,0.000029796256,0.0035029496,0.000015833899,0.059270125,0.00031408216,0.11694594,0.0001332391],"about_ca_topic_score_codex":0.00509142,"about_ca_topic_score_gemma":0.0028776855,"teacher_disagreement_score":0.73484176,"about_ca_system_score_codex":0.00037086656,"about_ca_system_score_gemma":0.00019099955,"threshold_uncertainty_score":0.76967376},"labels":[],"label_agreement":null},{"id":"W2886518982","doi":"10.1158/1538-7445.am2018-4318","title":"Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"SMARCA4; Biology; Carcinogenesis; SWI/SNF; Chromatin remodeling; Transcription factor; Gene; Gene expression; Chromatin; Transcriptome; Cancer research; Genetics; Cell biology; Molecular biology","score_opus":0.0688615713162637,"score_gpt":0.42612206816094766,"score_spread":0.357260496844684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886518982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928211,0.0026687796,0.0034165825,0.00008083165,0.0001512568,0.00017917153,0.00013797515,0.000010261375,0.00053407345],"genre_scores_gemma":[0.99686,0.0009908475,0.00029189704,0.000032887427,0.00018344175,0.00005655596,0.0000839046,0.000024244775,0.0014761649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981521,0.00010515477,0.00029444488,0.0005407376,0.0004727675,0.0004348264],"domain_scores_gemma":[0.9985178,0.000030600422,0.00011156356,0.00047673832,0.0007438184,0.000119479766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006908547,0.00015889756,0.00025088753,0.00023317822,0.00020262734,0.000042230968,0.00040475733,0.00012436547,0.00032402502],"category_scores_gemma":[0.0001110561,0.00013971694,0.00020059707,0.0007420319,0.0004911025,0.0000063387656,0.00016782619,0.00019960882,0.000024824301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008968865,0.00007246316,0.0032989685,0.000040096926,0.00044107068,0.0000012963374,0.00040859808,0.000363479,0.9859543,0.0000058167698,0.0064844475,0.0028397604],"study_design_scores_gemma":[0.00048122046,0.0001398082,0.00442961,0.000063970394,0.00008949052,6.673933e-7,0.0011244001,0.0014135453,0.98852766,0.000015199618,0.0035224766,0.00019197393],"about_ca_topic_score_codex":0.0031196084,"about_ca_topic_score_gemma":0.0015563115,"teacher_disagreement_score":0.004038988,"about_ca_system_score_codex":0.00016671055,"about_ca_system_score_gemma":0.00031811188,"threshold_uncertainty_score":0.5697491},"labels":[],"label_agreement":null},{"id":"W2886522468","doi":"10.1158/1538-7445.am2018-3673","title":"Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Biology; Epigenome; Cancer research; Chromatin remodeling; EZH2; Chromatin; Epigenetics; Cell cycle checkpoint; Histone; Cell cycle; Cell biology; Cancer; Genetics; DNA methylation; Gene expression","score_opus":0.05717682523361722,"score_gpt":0.3411357614902597,"score_spread":0.2839589362566425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886522468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899429,0.0066627148,0.000016507533,0.00019876873,0.00025352265,0.00025150352,0.000028639552,0.000004593768,0.0026408662],"genre_scores_gemma":[0.9976495,0.00075723045,0.000088625304,0.000078199315,0.0005854754,0.000023250997,0.000010007837,0.000031116444,0.00077658077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985131,0.00013839871,0.00029728143,0.00031144999,0.00034427078,0.00039547106],"domain_scores_gemma":[0.99845356,0.00005588151,0.00010867762,0.0006882932,0.00063428195,0.000059318907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007988053,0.00012718314,0.00016131483,0.00003997834,0.00020592174,0.00001288501,0.0007371841,0.00013811434,0.00015494559],"category_scores_gemma":[0.00013442959,0.00007814469,0.00011890203,0.0003109995,0.0006297834,0.0000027506626,0.0003144975,0.00030835115,0.000014160276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013562318,0.00003166287,0.0037316154,0.00008510037,0.000026102898,4.61423e-7,0.00022600678,0.00011002037,0.9916446,0.000009466551,0.0027595046,0.0012398358],"study_design_scores_gemma":[0.00031383874,0.00021087569,0.008154817,0.000055834527,0.000014361882,0.0000023991981,0.0002809408,0.00014635402,0.98213273,0.0000665068,0.0085088285,0.000112533446],"about_ca_topic_score_codex":0.0013089546,"about_ca_topic_score_gemma":0.00013575607,"teacher_disagreement_score":0.00951189,"about_ca_system_score_codex":0.000060154813,"about_ca_system_score_gemma":0.00061445584,"threshold_uncertainty_score":0.3186648},"labels":[],"label_agreement":null},{"id":"W2886537366","doi":"10.1158/1538-7445.am2018-3107","title":"Abstract 3107: Modeling DICER1 syndrome in cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dicer; Biology; Cancer research; Mesenchymal stem cell; Molecular biology; microRNA; Oncogene; Cell biology; Genetics; Cell; Cell cycle; RNA; Gene; Small interfering RNA","score_opus":0.15924701640181582,"score_gpt":0.44886930687649185,"score_spread":0.289622290474676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886537366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757608,0.001231161,0.000016024926,0.0013768069,0.00015954846,0.00043753715,0.000008562829,0.000031823824,0.020977719],"genre_scores_gemma":[0.9971521,0.00031286414,0.00008193877,0.00009864571,0.00023714855,0.00014307536,0.0000016003177,0.000027354685,0.001945277],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819916,0.000045503955,0.00024309786,0.0002929186,0.0006500188,0.0005692784],"domain_scores_gemma":[0.9990141,0.00013877662,0.000016687547,0.00031592385,0.00035097072,0.00016354141],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008398811,0.00010399878,0.00024997743,0.0002986481,0.00010386555,0.00002553603,0.0001462862,0.00007111818,0.0014136195],"category_scores_gemma":[0.00021910627,0.00008998748,0.000043552198,0.0005216617,0.00022948664,0.00006878186,0.00013744677,0.0004807444,0.00097467593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021803135,0.0014540635,0.09182045,0.0037078732,0.0009521866,0.00503252,0.019132102,0.0006239651,0.64533323,0.00049730326,0.031079374,0.19818664],"study_design_scores_gemma":[0.013581414,0.0027456882,0.8043531,0.008048618,0.00017446639,0.00025873422,0.008036886,0.060131423,0.064490885,0.005059673,0.031194631,0.0019244568],"about_ca_topic_score_codex":0.0016774292,"about_ca_topic_score_gemma":0.0011353604,"teacher_disagreement_score":0.7125327,"about_ca_system_score_codex":0.00034248328,"about_ca_system_score_gemma":0.00029948464,"threshold_uncertainty_score":0.9998032},"labels":[],"label_agreement":null},{"id":"W2886543388","doi":"10.1158/1538-7445.am2018-2652","title":"Abstract 2652: Metabolomics biomarkers for endometrial cancer and its recurrence after surgery in postmenopausal women","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Endometrial cancer; Metabolomics; Medicine; Biomarker; Serous fluid; Internal medicine; Cancer; Metabolite; Gastroenterology; Oncology; Physiology; Biology; Bioinformatics; Biochemistry","score_opus":0.057765267543919856,"score_gpt":0.3816395771092767,"score_spread":0.32387430956535684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886543388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95625,0.037027616,0.0000075739977,0.00025990783,0.005274854,0.00062005175,0.00044173124,0.000006601769,0.00011163075],"genre_scores_gemma":[0.9596684,0.023277212,0.00004864368,0.00015957415,0.014241675,0.0020681694,0.000032728873,0.000039264174,0.00046435863],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978686,0.00010118774,0.00029145554,0.0006129736,0.00028073494,0.00084505044],"domain_scores_gemma":[0.9988704,0.00017595965,0.0000659313,0.0002668754,0.00040420206,0.00021668554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016736004,0.00018247846,0.00031389963,0.00034867827,0.00011351881,0.00005583533,0.00020808858,0.00018513533,0.00018583333],"category_scores_gemma":[0.00061406725,0.0001741048,0.00006502313,0.000472377,0.00029100646,0.000016435932,0.00015352119,0.00019209656,0.0000060067064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008092654,0.00009406156,0.005939291,0.00018580152,0.000208104,8.527857e-7,0.0003912093,0.0000020906086,0.8809089,0.000045984933,0.037595537,0.0665355],"study_design_scores_gemma":[0.0023963028,0.0003340931,0.02645331,0.000086430264,0.00001788049,0.0000030538297,0.00016701757,0.0000106729885,0.13526557,0.00011631613,0.8347633,0.00038605943],"about_ca_topic_score_codex":0.00054583256,"about_ca_topic_score_gemma":0.0010333278,"teacher_disagreement_score":0.7971678,"about_ca_system_score_codex":0.00014485071,"about_ca_system_score_gemma":0.0008248665,"threshold_uncertainty_score":0.7099788},"labels":[],"label_agreement":null},{"id":"W2886595616","doi":"10.1158/1538-7445.am2018-244","title":"Abstract 244: Pathway analysis of OncoArray data identifies biological pathways involved in lung cancer development","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"KEGG; Lung cancer; Genome-wide association study; Cancer; Missing heritability problem; Biology; Computational biology; Single-nucleotide polymorphism; Candidate gene; Genetics; Gene; Bioinformatics; Oncology; Medicine; Genotype; Transcriptome; Gene expression","score_opus":0.15457732757675516,"score_gpt":0.39675707106078734,"score_spread":0.24217974348403218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886595616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945446,0.0038850135,0.00029690188,0.000069673515,0.00014926179,0.00021251859,0.00022628672,0.000004778019,0.00061096926],"genre_scores_gemma":[0.99726725,0.0013991566,0.00025251924,0.00006256273,0.00025045327,0.00007924042,0.0005342694,0.000011223605,0.000143351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833304,0.0000740015,0.0004332283,0.0004284548,0.00028533302,0.00044593625],"domain_scores_gemma":[0.99874914,0.000035001227,0.00010762212,0.00072997797,0.0002835167,0.00009471946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014973585,0.00012824134,0.00025825202,0.00023489048,0.00010923392,0.00003711862,0.00077875843,0.00019935927,0.00028075284],"category_scores_gemma":[0.000072745985,0.000105034036,0.000056958503,0.00064565626,0.0003278112,0.000009927629,0.00069500576,0.00021890178,0.0000064992014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026682988,0.00013455254,0.071256824,0.00014581833,0.0011577447,0.0000054441575,0.0012077063,0.00027144872,0.88694257,0.00008306718,0.009422637,0.029105395],"study_design_scores_gemma":[0.001305538,0.0002449253,0.26217523,0.00027347676,0.00010872478,6.3177583e-7,0.0013128842,0.0055532013,0.6563295,0.00017293105,0.07177491,0.0007480327],"about_ca_topic_score_codex":0.0006685721,"about_ca_topic_score_gemma":0.012247244,"teacher_disagreement_score":0.23061301,"about_ca_system_score_codex":0.00008917622,"about_ca_system_score_gemma":0.0006511137,"threshold_uncertainty_score":0.683425},"labels":[],"label_agreement":null},{"id":"W2886614406","doi":"10.1158/1538-7445.am2018-1044","title":"Abstract 1044: Establishment and characterization of rare breast patient-derived xenograft models as a potential resource for personalized medicine","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Personalized medicine; Cancer; Biomarker; Oncology; KRAS; Pathology; Internal medicine; Cancer research; Bioinformatics; Biology; Genetics","score_opus":0.03001319428699945,"score_gpt":0.3285365729046281,"score_spread":0.2985233786176287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886614406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601084,0.0010749097,0.0006427802,0.00087626657,0.0000878752,0.0004821186,0.00044019063,0.0000040205737,0.0003809832],"genre_scores_gemma":[0.9971718,0.0013236002,0.00006364024,0.00015357826,0.00061216083,0.00013017554,0.0003277161,0.000023696033,0.00019363448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989505,0.000035205205,0.00018737119,0.00031253367,0.00024613904,0.00026829427],"domain_scores_gemma":[0.998994,0.000027222539,0.000079318794,0.00021187215,0.0005708855,0.00011668601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025494435,0.000100382575,0.00014321279,0.00007662968,0.00013180022,0.000027893628,0.00011817672,0.000090880865,0.00010258685],"category_scores_gemma":[0.00007057151,0.00009222635,0.000038486793,0.000095995,0.0004262695,0.0000072558214,0.00012317889,0.000070457,8.8504424e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001057568,0.000035216428,0.000046063396,0.00006425916,0.000038929884,0.000001176263,0.00047812585,0.000014245883,0.9825593,0.0001503582,0.0019537283,0.013601031],"study_design_scores_gemma":[0.0038659733,0.0023823823,0.0036731479,0.00022734319,0.000045464843,0.000023601444,0.0011193249,0.00050552073,0.8738878,0.00082812743,0.11311818,0.00032313957],"about_ca_topic_score_codex":0.00033157645,"about_ca_topic_score_gemma":0.00004557702,"teacher_disagreement_score":0.11116445,"about_ca_system_score_codex":0.000034738005,"about_ca_system_score_gemma":0.00019322611,"threshold_uncertainty_score":0.37608814},"labels":[],"label_agreement":null},{"id":"W2886615727","doi":"10.1158/1538-7445.am2018-1418","title":"Abstract 1418: Identification of recurrent regulatory mutations in breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Biology; Transcriptome; Exome; Gene; Genetics; Computational biology; Cancer; Exome sequencing; PTEN; Promoter; Phenotype; Cancer research; Gene expression","score_opus":0.04141982774118143,"score_gpt":0.3957083891451344,"score_spread":0.354288561403953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886615727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961797,0.0021172212,0.00002707562,0.0004977136,0.00028239522,0.0001930037,0.00029706702,0.000002879023,0.0004029596],"genre_scores_gemma":[0.9967825,0.002220698,0.000020876658,0.00003457831,0.00052162184,0.0001566256,0.00004725795,0.000015687128,0.00020014521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897456,0.00003917795,0.00024949055,0.0002756641,0.0002197794,0.00024131588],"domain_scores_gemma":[0.9990007,0.000025653668,0.00007317147,0.00031813653,0.0005175088,0.00006481162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046658862,0.000070243186,0.000088906105,0.00012181349,0.00006941551,0.000019870333,0.00019284767,0.000080802194,0.00020587722],"category_scores_gemma":[0.000073242256,0.00007447734,0.000035339843,0.00025465505,0.00029351504,0.0000044966446,0.000081468825,0.000119443845,0.000012914464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001487039,0.00007727228,0.010963497,0.000046820307,0.000020205935,8.591654e-7,0.0001428718,0.00010673119,0.96176976,0.00022283847,0.008471285,0.018029159],"study_design_scores_gemma":[0.00043915643,0.000081823935,0.44646406,0.0000859922,0.0000063887815,0.000001668091,0.00010862716,0.0000507575,0.54208785,0.0003984826,0.0101450905,0.00013013359],"about_ca_topic_score_codex":0.0010423211,"about_ca_topic_score_gemma":0.0026755657,"teacher_disagreement_score":0.43550056,"about_ca_system_score_codex":0.00012590023,"about_ca_system_score_gemma":0.00051523733,"threshold_uncertainty_score":0.30370978},"labels":[],"label_agreement":null},{"id":"W2886620332","doi":"10.1158/1538-7445.am2018-5325","title":"Abstract 5325: 5-hydroxymethylcytosine profiling identifies differential targeting in <i>IDH1</i> mutant versus <i>IDH1</i> wild-type high-grade gliomas","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"IDH1; Mutant; Wild type; Biology; Bisulfite; Glioma; Isocitrate dehydrogenase; Epigenetics; Molecular biology; Cancer research; Gene; Gene expression; DNA methylation; Genetics; Biochemistry; Enzyme","score_opus":0.053883376568583684,"score_gpt":0.3795269478443188,"score_spread":0.3256435712757351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886620332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913064,0.0061151125,0.00012478777,0.00022123531,0.0012996681,0.00039690424,0.0000332485,0.00002127089,0.00048136822],"genre_scores_gemma":[0.9952543,0.0021498392,0.0002733083,0.00002694602,0.0018203593,0.00007504979,0.00019766671,0.000059037848,0.00014349043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718004,0.00022950402,0.00043769102,0.0007260685,0.00062745594,0.000799243],"domain_scores_gemma":[0.998653,0.00008998386,0.0001090643,0.00048100928,0.0005066649,0.00016026583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010950282,0.00023955149,0.00024760704,0.00024460407,0.00029048655,0.00012889357,0.00041104166,0.0002690591,0.00014494946],"category_scores_gemma":[0.00042030317,0.00023324408,0.00008101169,0.00066586724,0.00035812298,0.000016503938,0.00030975835,0.0004360925,0.000039047645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006487551,0.00008363146,0.0015663522,0.000047751284,0.000054922868,0.000012170771,0.00009611375,0.00007834915,0.9954714,0.000055182663,0.0005717442,0.0013136255],"study_design_scores_gemma":[0.0014310391,0.00040226104,0.0019378486,0.00005169209,0.000012543799,5.570429e-7,0.0001263791,0.00008378789,0.9886604,0.00026453324,0.0067594405,0.00026954172],"about_ca_topic_score_codex":0.00092386134,"about_ca_topic_score_gemma":0.0006777714,"teacher_disagreement_score":0.006811025,"about_ca_system_score_codex":0.000109771696,"about_ca_system_score_gemma":0.000280179,"threshold_uncertainty_score":0.9511417},"labels":[],"label_agreement":null},{"id":"W2886622074","doi":"10.1158/1538-7445.am2018-3912","title":"Abstract 3912: Towards development of next-generation biparatopic ADCs using a novel linker-toxin with expanded therapeutic window","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Tolerability; In vivo; Monoclonal antibody; Medicine; Antibody-drug conjugate; Trastuzumab; Linker; Pharmacology; Conjugate; Cancer research; Antibody; Cancer; Oncology; Internal medicine; Immunology; Biology; Breast cancer; Adverse effect","score_opus":0.43996607786333497,"score_gpt":0.47828145995678273,"score_spread":0.03831538209344776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886622074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526757,0.0013124094,0.00051665126,0.0007670373,0.00009025084,0.00056608603,0.0000118035405,0.000016895947,0.0014512822],"genre_scores_gemma":[0.9927331,0.00018576927,0.004279529,0.00013253471,0.0008710547,0.00007981554,0.000020589012,0.000030419797,0.0016671931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973413,0.00006234088,0.00034002258,0.00036546882,0.0012916231,0.00059928396],"domain_scores_gemma":[0.99833584,0.000065493645,0.000066324574,0.00029462628,0.0010085294,0.00022916228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006427496,0.00016871361,0.00031015647,0.00029097244,0.0003145365,0.000052853244,0.00020144467,0.00011356309,0.0009350338],"category_scores_gemma":[0.00003969193,0.00011681714,0.00005405063,0.00060512155,0.0004994522,0.000117291806,0.00009887589,0.000464447,0.000040119692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009483396,0.00018293459,0.0041561495,0.00021593393,0.00015814952,0.000012012349,0.0011627685,0.0000085677175,0.9427152,0.00010767536,0.00011859653,0.05021364],"study_design_scores_gemma":[0.0017635913,0.0006990569,0.071234755,0.0005054397,0.000024023724,0.00003369683,0.00029136203,0.0010436729,0.908275,0.00003367152,0.015888078,0.0002076571],"about_ca_topic_score_codex":0.0008645815,"about_ca_topic_score_gemma":0.0004760692,"teacher_disagreement_score":0.067078605,"about_ca_system_score_codex":0.00026339342,"about_ca_system_score_gemma":0.0026091076,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W2886633519","doi":"10.1158/1538-7445.am2018-4322","title":"Abstract 4322: Atrx inactivation drives motility and dysregulates differentiation in glioma cells of origin through global epigenomic remodeling","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"ATRX; Biology; Epigenomics; Chromatin; Epigenetics; Death-associated protein 6; Genetics; Chromatin remodeling; Phenotype; Cancer research; Cell biology; DNA methylation; Gene; Mutation; Gene expression; Transcription factor; Nuclear protein","score_opus":0.04464081322358235,"score_gpt":0.36298494102424067,"score_spread":0.31834412780065835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886633519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987849,0.00052858266,0.0001148569,0.000059209866,0.000068556554,0.00018263055,0.000019739731,0.0000025899535,0.00023893957],"genre_scores_gemma":[0.99905235,0.0006426092,0.00020353285,0.000010622812,0.000031867516,0.000011816633,0.000020503448,0.00000864144,0.000018082792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991122,0.000052179093,0.00017150035,0.00029609655,0.00015577725,0.00021226915],"domain_scores_gemma":[0.99962413,0.000009977454,0.000044528082,0.00015116719,0.00013649616,0.000033716493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018654666,0.00008225551,0.00009113928,0.00004369754,0.00006731217,0.000016231264,0.00010726762,0.000078967336,0.00002011367],"category_scores_gemma":[0.000025043775,0.00008248736,0.000019834053,0.00016808024,0.00017596628,0.000005593016,0.0001070661,0.000069247035,0.0000017797228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009064038,0.00003567128,0.032691177,0.00003558828,0.000009896576,2.8046315e-7,0.00014966118,0.0000864441,0.9637471,0.0000200518,0.000036325026,0.003097152],"study_design_scores_gemma":[0.0002261752,0.00006646063,0.4284614,0.0000175215,0.0000012558489,2.82412e-7,0.00008650527,0.00013378574,0.5701775,0.00067927106,0.000100037134,0.00004978421],"about_ca_topic_score_codex":0.000557157,"about_ca_topic_score_gemma":0.0005901066,"teacher_disagreement_score":0.39577022,"about_ca_system_score_codex":0.00006115766,"about_ca_system_score_gemma":0.00010298931,"threshold_uncertainty_score":0.3363737},"labels":[],"label_agreement":null},{"id":"W2886646469","doi":"10.1158/1538-7445.am2018-1099","title":"Abstract 1099: Molecular drivers of neutrophil recruitment to primary non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"CXCL1; Cancer research; Lung cancer; Tumor microenvironment; KRAS; Biology; Tumor progression; Immunology; Cancer; Immune system; Medicine; Pathology; Internal medicine; Chemokine","score_opus":0.06080613882888465,"score_gpt":0.3749933089116324,"score_spread":0.31418717008274777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886646469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667241,0.016207106,0.00006827543,0.00070926314,0.0018480353,0.0015965878,0.000086930115,0.000032873486,0.012726846],"genre_scores_gemma":[0.9837772,0.001768452,0.00016902847,0.0005366014,0.00020097996,0.0010578805,0.000025727782,0.00006599326,0.012398115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976063,0.00019891831,0.00038153195,0.00061424414,0.00020250227,0.0009965363],"domain_scores_gemma":[0.9981927,0.000126007,0.0001171946,0.0007684068,0.00071075326,0.00008491391],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006869352,0.00023762687,0.00038769736,0.00032475888,0.00024187753,0.00001958313,0.00083836296,0.000284646,0.005085761],"category_scores_gemma":[0.000027881144,0.00022970751,0.00011906683,0.000545351,0.00072871544,0.00006622382,0.00047296262,0.000763919,0.0005943662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029121974,0.00010312638,0.0016308348,0.0002401876,0.00017476412,0.00001557683,0.0011274511,0.00008535268,0.9461169,0.000032965658,0.04306591,0.0071156938],"study_design_scores_gemma":[0.0010421065,0.00026833994,0.007516428,0.00023058683,0.000030139416,0.0000016987996,0.00011515828,0.0000012022382,0.8626461,0.000017051865,0.1279161,0.00021508908],"about_ca_topic_score_codex":0.002513709,"about_ca_topic_score_gemma":0.00014897893,"teacher_disagreement_score":0.084850185,"about_ca_system_score_codex":0.0008442082,"about_ca_system_score_gemma":0.0010568072,"threshold_uncertainty_score":0.99582374},"labels":[],"label_agreement":null},{"id":"W2886676741","doi":"10.1158/1538-7445.am2018-788","title":"Abstract 788: Modeling tumor microenvironmental heterogeneity identifies CREBBP as a novel tumor suppressor in breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Gene silencing; Breast cancer; Biology; FOXM1; Cancer; Triple-negative breast cancer; Gene; Cell cycle; Genetics","score_opus":0.053459720836074955,"score_gpt":0.3657119381814463,"score_spread":0.31225221734537134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886676741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977638,0.0006714254,0.000077579636,0.00046995,0.00019904309,0.0003442105,0.00035288234,0.000011747634,0.00010931968],"genre_scores_gemma":[0.9987247,0.00009989834,0.000043889002,0.00016212584,0.00042083746,0.00019797751,0.00006640392,0.00004033988,0.00024381097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981318,0.00005981283,0.0002608361,0.00058403995,0.00042435236,0.00053917663],"domain_scores_gemma":[0.99931955,0.000006002035,0.000046708472,0.00035945387,0.00015732073,0.0001109411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508903,0.00017247205,0.00014699184,0.0001279794,0.000235965,0.00006616725,0.00031091095,0.00009117859,0.0007028602],"category_scores_gemma":[0.000018712542,0.00017756851,0.000076703334,0.0001546847,0.0003492784,0.000024071089,0.0001876326,0.00023927972,0.00004830179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039206856,0.0001173691,0.004203237,0.00003708839,0.000031708576,0.000004660038,0.0001245051,0.0009866143,0.99318707,0.0000045654165,0.0007759767,0.00013515302],"study_design_scores_gemma":[0.0008656956,0.00008865289,0.04774993,0.00007625297,0.0000061669207,0.000024217154,0.00012836915,0.0010404775,0.94759625,0.000022339053,0.0021870472,0.00021462764],"about_ca_topic_score_codex":0.0030399999,"about_ca_topic_score_gemma":0.0028413278,"teacher_disagreement_score":0.04559083,"about_ca_system_score_codex":0.0002179529,"about_ca_system_score_gemma":0.00018469816,"threshold_uncertainty_score":0.76958257},"labels":[],"label_agreement":null},{"id":"W2886686678","doi":"10.1158/1538-7445.am2018-4693","title":"Abstract 4693: Characterization of the tumor immune microenvironment in head and neck squamous cell carcinoma (SCCHN)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Tumor microenvironment; Immune system; Immunohistochemistry; FOXP3; Head and neck squamous-cell carcinoma; CD20; Medicine; CD8; Cancer research; PD-L1; Tumor-infiltrating lymphocytes; Immunotherapy; Pathology; Immunology; Cancer; Internal medicine; Head and neck cancer","score_opus":0.03359121070307398,"score_gpt":0.3265311620853214,"score_spread":0.29293995138224743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886686678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955949,0.0019056424,7.014865e-7,0.0012007916,0.00011674435,0.0005731223,0.000021262253,0.0000045813135,0.0005822591],"genre_scores_gemma":[0.9985307,0.0003875677,0.00000887653,0.0001566292,0.00012703327,0.000054019823,0.000006622148,0.000017720558,0.0007108375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887544,0.00006044485,0.00024290397,0.00021148247,0.00032501054,0.00028473831],"domain_scores_gemma":[0.9994588,0.00003018049,0.00006713931,0.00032392336,0.000068500114,0.000051443385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040930105,0.000088830035,0.00016439678,0.00010821151,0.000089365676,0.000013192138,0.00013105645,0.00004866185,0.00055089005],"category_scores_gemma":[0.000015387779,0.00006310952,0.00004486511,0.000294356,0.0004702709,0.00004677644,0.00007977991,0.0002418966,0.000008716715],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013515339,0.00010557933,0.08038937,0.00015934987,0.0000061967203,0.000006389408,0.0005436625,1.2007429e-7,0.9130558,0.0000017299906,0.00010120033,0.0042790836],"study_design_scores_gemma":[0.0013425389,0.00020488547,0.5925771,0.000100526246,0.0000035955115,0.00000422373,0.000057897276,0.000005712484,0.402929,0.0000025131476,0.0027342045,0.00003779636],"about_ca_topic_score_codex":0.0023982355,"about_ca_topic_score_gemma":0.0002331323,"teacher_disagreement_score":0.5121877,"about_ca_system_score_codex":0.00026030862,"about_ca_system_score_gemma":0.00018904744,"threshold_uncertainty_score":0.60318595},"labels":[],"label_agreement":null},{"id":"W2886691025","doi":"10.1158/1538-7445.am2018-4174","title":"Abstract 4174: Differential response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiation therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epidermal growth factor receptor; Cancer research; Lung cancer; Protein kinase domain; Tyrosine kinase; Biology; Molecular biology; Medicine; Cancer; Pathology; Receptor; Internal medicine; Gene; Mutant","score_opus":0.0958552930638048,"score_gpt":0.4322334388283293,"score_spread":0.3363781457645245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886691025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235594,0.001213985,0.0004561369,0.0041575385,0.00055756647,0.0008354575,0.00012518225,0.000030742685,0.0002674711],"genre_scores_gemma":[0.9959603,0.0012683386,0.00013638882,0.00020309111,0.0009040409,0.0004465717,0.0000152128005,0.000032483185,0.0010335823],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997814,0.00032478524,0.0003353738,0.00040333992,0.0005794603,0.00054306275],"domain_scores_gemma":[0.99776095,0.00079555385,0.00009328377,0.0002553379,0.00078219536,0.00031266944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058649067,0.00018322558,0.00039316426,0.00033980256,0.00026454875,0.000019901006,0.0001618118,0.00010391294,0.0015086738],"category_scores_gemma":[0.00061841396,0.00013867354,0.000083449224,0.00036694465,0.00045670665,0.000056631197,0.00007842279,0.00053234777,0.00003107699],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031972537,0.00021886971,0.16018692,0.00022155631,0.0002029532,0.0000132081805,0.01107997,0.0000030693034,0.80733216,0.000006200359,0.006152749,0.011385091],"study_design_scores_gemma":[0.0013252775,0.0003637863,0.63590586,0.00025426384,0.000024584391,5.232968e-7,0.00020545546,0.00010503311,0.3612417,0.0000071928207,0.00046271225,0.000103610255],"about_ca_topic_score_codex":0.0008887162,"about_ca_topic_score_gemma":0.00006143048,"teacher_disagreement_score":0.47571895,"about_ca_system_score_codex":0.00030510718,"about_ca_system_score_gemma":0.00041627444,"threshold_uncertainty_score":0.9994041},"labels":[],"label_agreement":null},{"id":"W2886698194","doi":"10.1158/1538-7445.am2018-2503","title":"Abstract 2503: Rational design of small-molecule immune checkpoints' inhibitors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Monoclonal antibody; Rational design; Small molecule; Cancer; Immunotherapy; Immune system; Cancer immunotherapy; Medicine; Cancer research; Antibody; Cancer cell; Immunology; Chemistry; Biology; Internal medicine; Biochemistry","score_opus":0.11384304322974825,"score_gpt":0.4063370127493758,"score_spread":0.29249396951962753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886698194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758304,0.0036173444,0.0005220452,0.0021867617,0.0003392476,0.00080475723,0.000017062437,0.00003167039,0.004898051],"genre_scores_gemma":[0.9964885,0.00041921233,0.00044868828,0.00013013858,0.0006396571,0.00010348578,0.000011935147,0.000027401145,0.0017309538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834526,0.00008926462,0.00033764387,0.0002525153,0.00060654106,0.00036877458],"domain_scores_gemma":[0.9987022,0.0001210022,0.00007347985,0.00032945094,0.00067180925,0.00010200115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013662227,0.000107864624,0.00021019686,0.00021637359,0.0001357753,0.000020654908,0.00016839622,0.000099313,0.0032079685],"category_scores_gemma":[0.00013177289,0.00009135146,0.00009849746,0.00054047635,0.0006717737,0.000056850768,0.000050919538,0.00029685846,0.00007703459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035501346,0.00011377517,0.0005109787,0.00009154674,0.00012861984,0.0000106001025,0.00030969086,0.000002851707,0.97818375,0.00004566659,0.008309954,0.008742436],"study_design_scores_gemma":[0.0019523326,0.0006426855,0.02195819,0.000306299,0.000012618491,0.00000850671,0.0001346187,0.000051588275,0.9689959,0.00006942662,0.0057641016,0.00010369598],"about_ca_topic_score_codex":0.0010512896,"about_ca_topic_score_gemma":0.000053836662,"teacher_disagreement_score":0.021447212,"about_ca_system_score_codex":0.0002443118,"about_ca_system_score_gemma":0.00097010063,"threshold_uncertainty_score":0.99770325},"labels":[],"label_agreement":null},{"id":"W2886701506","doi":"10.1158/1538-7445.am2018-1891","title":"Abstract 1891: Cross-resistance and synergy between idelalisib and bendamustine in chronic lymphocytic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Bendamustine; Idelalisib; Chronic lymphocytic leukemia; Peripheral blood mononuclear cell; Cancer research; Cytotoxic T cell; Cytotoxicity; In vitro; Leukemia; Biology; Immunology; Biochemistry; Ibrutinib","score_opus":0.07210203326680378,"score_gpt":0.4383313000038043,"score_spread":0.3662292667370005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886701506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822069,0.011550986,0.000008399088,0.00046543553,0.00007871323,0.0006987055,0.000042716016,0.000058547055,0.004889624],"genre_scores_gemma":[0.98994565,0.0029446722,0.00008049511,0.00008475157,0.0014300101,0.00016538861,0.000019771176,0.000077445286,0.0052518323],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99555635,0.0001358059,0.00055209483,0.00097454054,0.0013128892,0.0014683285],"domain_scores_gemma":[0.9972077,0.00074965256,0.00007247309,0.0007330976,0.00060262205,0.0006344536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020497034,0.0002898885,0.00057576364,0.00058560824,0.00033061326,0.00018779564,0.0002886301,0.0002921879,0.0006337224],"category_scores_gemma":[0.0007194194,0.00026299656,0.000052211006,0.0010809798,0.00251986,0.00025459786,0.00047606236,0.000891576,0.00009598433],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02203335,0.00035218522,0.24112466,0.03415103,0.0022324438,0.013869243,0.011544376,0.0010845524,0.3486429,0.010714987,0.07713814,0.23711216],"study_design_scores_gemma":[0.09016033,0.0020425154,0.70962757,0.0066593713,0.00013446316,0.00047352698,0.00053113804,0.013885754,0.08971389,0.0025801645,0.08260688,0.0015843881],"about_ca_topic_score_codex":0.01577029,"about_ca_topic_score_gemma":0.005839982,"teacher_disagreement_score":0.4685029,"about_ca_system_score_codex":0.11291995,"about_ca_system_score_gemma":0.044122487,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W2886703310","doi":"10.1158/1538-7445.am2018-ng06","title":"Abstract NG06: The clinico-genomics of localized, non-indolent prostate cancer: the CPC-GENE experience","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Canadian Cancer Society; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Genomics; Cancer; Medicine; Oncology; Internal medicine; Gene; Biology; Genetics; Genome","score_opus":0.12336988011150987,"score_gpt":0.47449907915610734,"score_spread":0.3511291990445975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886703310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742266,0.010038615,0.000009997745,0.010548237,0.00045694583,0.0023249367,0.000121018624,0.000024562281,0.0022490632],"genre_scores_gemma":[0.969314,0.023344727,0.000035143486,0.0003533345,0.0010868278,0.0015290366,0.000014375424,0.000052550782,0.0042700227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962829,0.00018643963,0.0005137977,0.0005563776,0.0014103777,0.0010501047],"domain_scores_gemma":[0.996867,0.0003764178,0.00014309243,0.0011002949,0.001230789,0.00028237505],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019568163,0.00023112321,0.00039447614,0.00015228236,0.0006846826,0.00007760576,0.0008013687,0.00011993847,0.0010318161],"category_scores_gemma":[0.00015215097,0.00011528947,0.00015690102,0.00091579976,0.0031469772,0.0000988893,0.0003516114,0.00091313926,0.00011868502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017474405,0.0009887551,0.085830405,0.0009761581,0.0010971903,0.0001909904,0.056519132,0.000103745064,0.5339885,0.000191343,0.047422756,0.25521663],"study_design_scores_gemma":[0.004734146,0.001212346,0.041556057,0.00060092856,0.000072544244,0.000015790974,0.0048390483,0.00025540346,0.81138575,0.00020572785,0.13485901,0.0002632173],"about_ca_topic_score_codex":0.0045886054,"about_ca_topic_score_gemma":0.00058115926,"teacher_disagreement_score":0.27739727,"about_ca_system_score_codex":0.00070971594,"about_ca_system_score_gemma":0.002555351,"threshold_uncertainty_score":0.9998814},"labels":[],"label_agreement":null},{"id":"W2886705530","doi":"10.1158/1538-7445.am2018-5173","title":"Abstract 5173: Genetic profiling of central nervous system dissemination of B-acute lymphoblastic leukemia reveals clonal selection and therapeutic vulnerability","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Leukemia; Cancer research; Bone marrow; Transplantation; Acute lymphocytic leukemia; Immunology; Medicine; Lymphoblastic Leukemia; Internal medicine","score_opus":0.03444912164532636,"score_gpt":0.37826518598262104,"score_spread":0.34381606433729467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886705530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968327,0.0005627963,0.00075849117,0.000102994876,0.00012672615,0.0010768869,0.000066294626,0.000038580903,0.00043448035],"genre_scores_gemma":[0.9982993,0.00015973873,0.00071667193,0.000010282902,0.00042042378,0.00013845175,0.000013320999,0.00004438008,0.00019740178],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99640864,0.0002830263,0.0006333882,0.00053241797,0.0013768922,0.0007656274],"domain_scores_gemma":[0.99672383,0.0007072523,0.00018135013,0.00039315276,0.001705816,0.0002885957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001440298,0.00019485412,0.0004882588,0.00035480532,0.0001900917,0.000027589513,0.00021149896,0.000200933,0.00016810029],"category_scores_gemma":[0.00044007707,0.00016423462,0.00008297173,0.00087883306,0.0008696198,0.00008060615,0.00011823962,0.00043461082,0.000008795386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018930786,0.0001068991,0.037003685,0.002831712,0.00029032072,0.000023078475,0.00053746224,0.00006446309,0.9409825,0.00026448924,0.00024087616,0.015761424],"study_design_scores_gemma":[0.0014860698,0.0011289913,0.55377376,0.0013413179,0.00015745974,0.00015604566,0.00033942208,0.017846335,0.4234756,0.000110786255,0.000023998491,0.00016022085],"about_ca_topic_score_codex":0.0008687704,"about_ca_topic_score_gemma":0.000037255348,"teacher_disagreement_score":0.51750696,"about_ca_system_score_codex":0.0036969213,"about_ca_system_score_gemma":0.0026240582,"threshold_uncertainty_score":0.966732},"labels":[],"label_agreement":null},{"id":"W2886731183","doi":"10.1158/1538-7445.am2018-2965","title":"Abstract 2965: Functionally informed genome-wide interaction analysis of nonsteroidal anti-inflammatory drugs on colorectal cancer risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Colorectal cancer; Aspirin; Cancer; Heritability; Medicine; False discovery rate; Genome-wide association study; Oncology; Internal medicine; Bioinformatics; Gene; Biology; Genotype; Genetics; Single-nucleotide polymorphism","score_opus":0.0310908007968886,"score_gpt":0.3737618562834952,"score_spread":0.3426710554866066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886731183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381727,0.00020651707,0.0000106757625,0.00023082932,0.0007718736,0.0006397899,0.0001063965,0.000044502252,0.0041721235],"genre_scores_gemma":[0.9972945,0.0006329119,0.000013957307,0.00017421303,0.0011567577,0.00024659937,0.000061545565,0.000035736546,0.00038379463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706495,0.00015638025,0.00051957485,0.00042180993,0.0012437389,0.00059353793],"domain_scores_gemma":[0.99713427,0.00073813164,0.00026220156,0.00038382568,0.0011096061,0.00037199535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013933941,0.00021927827,0.0005484399,0.0013857582,0.00026581934,0.000034634606,0.00018466791,0.00018497038,0.003338913],"category_scores_gemma":[0.0006695636,0.00018447325,0.00025980215,0.0013551072,0.000492812,0.00019611514,0.000076326156,0.0008312428,0.0002139033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006144448,0.00022585179,0.8427463,0.00048417912,0.0033649136,0.00004812019,0.0029987253,0.0007429559,0.123842716,0.000031778778,0.006952079,0.012417906],"study_design_scores_gemma":[0.0012669006,0.00056621083,0.91395104,0.00024060906,0.00041656758,0.0000017088981,0.00036296106,0.0005257328,0.07290733,0.0000058048595,0.009580501,0.00017462586],"about_ca_topic_score_codex":0.0011057414,"about_ca_topic_score_gemma":0.0016758085,"teacher_disagreement_score":0.07120472,"about_ca_system_score_codex":0.00078431464,"about_ca_system_score_gemma":0.0016262679,"threshold_uncertainty_score":0.9975722},"labels":[],"label_agreement":null},{"id":"W2886734554","doi":"10.1158/1538-7445.am2018-1761","title":"Abstract 1761: Combination of a T cell activating immunotherapy with immune modulators alters the tumor microenvironment and promotes more effective tumor control in preclinical models","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Immune system; Tumor microenvironment; ELISPOT; Medicine; T cell; Immunotherapy; Cancer research; Immunology; Tumor antigen; Antigen","score_opus":0.0264873496599106,"score_gpt":0.3367414603745109,"score_spread":0.3102541107146003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886734554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909785,0.0062896605,0.000084704596,0.00041087868,0.00014921294,0.0018824465,0.000020883646,0.00001279325,0.00017094295],"genre_scores_gemma":[0.9988117,0.0002226247,0.00004719038,0.00009889878,0.00002790004,0.0006180347,0.0000057394504,0.000038732414,0.00012914253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979238,0.0005554441,0.00041009238,0.0004275649,0.0001546948,0.00052840065],"domain_scores_gemma":[0.9982709,0.0008843767,0.00022181752,0.00043347775,0.0001688427,0.000020537023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015693485,0.00019837572,0.00037843504,0.00014231044,0.0002497531,0.000022882978,0.00035589145,0.00010845651,0.00015483433],"category_scores_gemma":[0.000059408612,0.00013557376,0.000052999232,0.00021538528,0.0020023454,0.00013094889,0.000119314165,0.0009318681,0.000011548541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023202621,0.0002648678,0.0031241179,0.00008745734,0.00015393524,0.0000036741856,0.002751554,0.00016176411,0.98589396,0.000032464908,0.000059529943,0.005146387],"study_design_scores_gemma":[0.005810988,0.0009768076,0.06916892,0.00030600172,0.000012444467,0.000011457459,0.00068590156,0.0003476429,0.9220042,0.00024202009,0.0002623637,0.00017120104],"about_ca_topic_score_codex":0.0013501022,"about_ca_topic_score_gemma":0.000045476896,"teacher_disagreement_score":0.0660448,"about_ca_system_score_codex":0.00028794765,"about_ca_system_score_gemma":0.00017264366,"threshold_uncertainty_score":0.7377725},"labels":[],"label_agreement":null},{"id":"W2886734654","doi":"10.1158/1538-7445.am2018-ct053","title":"Abstract CT053: Preliminary safety, efficacy, and PK/PD characterization from GARNET, a phase 1 clinical trial of the anti-PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced NSCLC and MSI-H endometrial cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pharmacokinetics; Lung cancer; Monoclonal antibody; Clinical trial; Antibody; non-small cell lung cancer (NSCLC); Cancer; Response Evaluation Criteria in Solid Tumors; Adverse effect; Phases of clinical research; Immunology","score_opus":0.05732046664254814,"score_gpt":0.4303570550663582,"score_spread":0.37303658842381004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886734654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554217,0.0011844212,0.000024731187,0.00015575702,0.00065478426,0.0013720681,0.0010250831,0.0000032690557,0.000037729504],"genre_scores_gemma":[0.9907279,0.0076409415,0.000059171707,0.00004873946,0.0010442579,0.000097385295,0.00031813854,0.000028097804,0.000035337736],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99802125,0.00018399005,0.0005020569,0.0005794347,0.00036747797,0.00034581128],"domain_scores_gemma":[0.99865514,0.00030302376,0.00021690737,0.00036888,0.00031857498,0.00013744393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057467114,0.00017843729,0.00033198507,0.00010149385,0.00012477106,0.000042195734,0.00024249911,0.0001704219,0.00008101461],"category_scores_gemma":[0.0006483809,0.00012578978,0.000051110674,0.00029517934,0.0005531692,0.000013758777,0.0003276326,0.00028830848,7.4346013e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49538276,0.0016630933,0.096912816,0.000073793075,0.00018297056,0.000005096069,0.00020384113,0.000017452427,0.18774769,0.0000090471885,0.0005537806,0.21724768],"study_design_scores_gemma":[0.1041566,0.008487035,0.8587316,0.00031504149,0.000042297772,5.590291e-7,0.000023641322,0.000056110533,0.019721514,0.000012165714,0.008206424,0.00024699242],"about_ca_topic_score_codex":0.00041258702,"about_ca_topic_score_gemma":0.00063895725,"teacher_disagreement_score":0.7618188,"about_ca_system_score_codex":0.00006191317,"about_ca_system_score_gemma":0.0006428856,"threshold_uncertainty_score":0.51295584},"labels":[],"label_agreement":null},{"id":"W2886741180","doi":"10.1158/1538-7445.am2018-516","title":"Abstract 516: Long noncoding RNA NEAT1 promotes lung metastasis of soft tissue sarcoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"KRAS; Metastasis; Lung; Sarcoma; Cancer research; Pathology; Primary tumor; Biology; Long non-coding RNA; Downregulation and upregulation; RNA; In situ hybridization; Medicine; Cancer; Gene expression; Gene; Internal medicine","score_opus":0.049417303148450865,"score_gpt":0.4087529658239968,"score_spread":0.3593356626755459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886741180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695884,0.009617272,0.013138181,0.0006614342,0.00036490234,0.0012575354,0.00012920561,0.00003513513,0.005207935],"genre_scores_gemma":[0.9963276,0.0006644771,0.0005422886,0.00004616959,0.0007943177,0.00016897077,0.000049826886,0.000081542414,0.0013248487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676406,0.00022582208,0.00035803966,0.000717114,0.0009876331,0.0009473351],"domain_scores_gemma":[0.9976695,0.00005985408,0.00010048968,0.0008240409,0.0010838849,0.00026222543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014308995,0.00022609561,0.00028603626,0.00028980916,0.0002820812,0.000077997865,0.00073150377,0.00027102834,0.0009666539],"category_scores_gemma":[0.00040572922,0.00022346475,0.00012704179,0.0006537591,0.00059135736,0.000013860272,0.0005808754,0.0005344498,0.000060288483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025791358,0.000073611445,0.000090755144,0.0001776039,0.00018206397,0.000026679498,0.00010468719,0.00003431779,0.95231235,0.000058850223,0.0045027155,0.042178437],"study_design_scores_gemma":[0.0005891218,0.0005741786,0.0003856946,0.00013441093,0.000020223952,0.000011367291,0.00006809046,0.00014452757,0.98120886,0.0000793609,0.016564716,0.00021943833],"about_ca_topic_score_codex":0.0007852841,"about_ca_topic_score_gemma":0.00051382923,"teacher_disagreement_score":0.041959,"about_ca_system_score_codex":0.00017904177,"about_ca_system_score_gemma":0.0007722802,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W2886752543","doi":"10.1158/1538-7445.am2018-660","title":"Abstract 660: Integration of radiomics with \"omic\" analyses to predict survival in newly diagnosed IDH-1 wild-type glioblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Radiomics; Subtyping; IDH1; Isocitrate dehydrogenase; Glioblastoma; Computational biology; Omics; Phenotype; Biology; Transcriptome; Glioma; Proportional hazards model; Oncology; Medicine; Pathology; Bioinformatics; Internal medicine; Cancer research; Radiology; Gene; Genetics; Computer science; Gene expression; Mutation","score_opus":0.07418230351218844,"score_gpt":0.4484428351935904,"score_spread":0.37426053168140194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886752543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445754,0.00022617106,0.00073898415,0.0026615635,0.00021272998,0.00047818403,0.00000761909,0.00002795715,0.0011892425],"genre_scores_gemma":[0.99768853,0.0002448185,0.00095031224,0.0002163906,0.0005795567,0.000040630748,0.000012770449,0.00003843921,0.00022857277],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978589,0.00013315926,0.00034675293,0.00037294332,0.0008204352,0.00046783817],"domain_scores_gemma":[0.9983293,0.00031824765,0.000072930095,0.00036844346,0.00061309803,0.00029797986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013963068,0.00014588606,0.00040491117,0.0006625071,0.00007841125,0.0000378787,0.00023633275,0.00008760401,0.00025021622],"category_scores_gemma":[0.0014079426,0.00010935272,0.000047851507,0.0012342973,0.00043078477,0.00009697599,0.00006580328,0.0007797205,0.000023148474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069353776,0.00035634532,0.15178876,0.0002554941,0.00022598532,0.0002570452,0.0033104967,0.00133188,0.7399047,0.00014416683,0.009796326,0.08569344],"study_design_scores_gemma":[0.010240598,0.0069601736,0.7736779,0.0037095647,0.00013491427,0.000048347873,0.0020581572,0.022788476,0.16749316,0.00019121013,0.012130853,0.00056668255],"about_ca_topic_score_codex":0.0045555206,"about_ca_topic_score_gemma":0.0021416184,"teacher_disagreement_score":0.6218891,"about_ca_system_score_codex":0.00030607564,"about_ca_system_score_gemma":0.0006293932,"threshold_uncertainty_score":0.6886615},"labels":[],"label_agreement":null},{"id":"W2886776738","doi":"10.1158/1538-7445.am2018-221","title":"Abstract 221: Inherited variants at 3q13.33 and 3p24.1 influences risk of diffuse large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Genotyping; Odds ratio; Single-nucleotide polymorphism; Meta-analysis; Heritability; Diffuse large B-cell lymphoma; Lymphoma; Genetic association; Biology; Oncology; Genetics; Internal medicine; Medicine; Genotype; Gene","score_opus":0.05480390068234936,"score_gpt":0.3861801328818536,"score_spread":0.33137623219950424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886776738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184066,0.0033709733,5.969204e-7,0.00027937576,0.00008694907,0.000427017,0.00021646568,0.000022472506,0.0037555157],"genre_scores_gemma":[0.99360394,0.005074616,0.000055493594,0.00009574884,0.00020243828,0.00012264721,0.000012527732,0.000023537976,0.0008090575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981241,0.00010231805,0.00025656167,0.00038379032,0.0006178976,0.0005153189],"domain_scores_gemma":[0.99858826,0.00025377527,0.00009269047,0.00041069693,0.0003784713,0.00027612943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443615,0.00015023886,0.00030652795,0.00017313892,0.00024292212,0.000032038275,0.00012812942,0.00011547103,0.0007052912],"category_scores_gemma":[0.00016678104,0.00011021598,0.0000598105,0.0003611683,0.0004324272,0.000086037755,0.00019056651,0.000115657014,0.00013280385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089617155,0.0038686746,0.9324686,0.00028263434,0.00025928434,0.00015374033,0.0011793684,2.1610764e-7,0.037588917,0.00006425153,0.006181514,0.017056629],"study_design_scores_gemma":[0.012097267,0.0005406924,0.9127914,0.00021197007,0.00006322698,0.000010044054,0.00013973765,0.00002860155,0.062385555,0.00006303459,0.0115686245,0.00009987869],"about_ca_topic_score_codex":0.0038558058,"about_ca_topic_score_gemma":0.00055546936,"teacher_disagreement_score":0.02479664,"about_ca_system_score_codex":0.00035794187,"about_ca_system_score_gemma":0.00031327942,"threshold_uncertainty_score":0.77224445},"labels":[],"label_agreement":null},{"id":"W2886803370","doi":"10.1158/1538-7445.am2018-ct009","title":"Abstract CT009: Results of a dose- and regimen-finding Phase Ib study of HDM201 in combination with ribociclib in patients with locally advanced or metastatic liposarcoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Regimen; Neutropenia; Internal medicine; Liposarcoma; Adverse effect; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy; Sarcoma; Pathology","score_opus":0.07042861192374962,"score_gpt":0.4342547883557902,"score_spread":0.36382617643204057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886803370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997083,0.00022289639,0.000023882125,0.00015493846,0.000020334308,0.0023417815,0.000034225934,0.000011180802,0.000107761385],"genre_scores_gemma":[0.99886096,0.00003722354,0.00073300034,0.000014395985,0.000018848208,0.00021121706,0.000013263383,0.000036850633,0.00007425307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975448,0.00015894398,0.0005083592,0.00043364125,0.00094119756,0.0004130462],"domain_scores_gemma":[0.9981839,0.00027143082,0.00024336285,0.00038954467,0.0008000718,0.00011166365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008610472,0.00017285331,0.0005095165,0.00060601527,0.00005304526,0.0000106545385,0.00014366415,0.00004123467,0.00003544415],"category_scores_gemma":[0.00018818231,0.00011827877,0.000013165785,0.0012581578,0.0005054069,0.00026449072,0.00005810239,0.00037667263,8.9819247e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3616083,0.012612462,0.37807223,0.0010228673,0.0003790984,0.00018942558,0.021260278,0.00016874284,0.014594328,0.000046985064,0.000023970617,0.21002132],"study_design_scores_gemma":[0.1335966,0.030367838,0.8189775,0.0023500514,0.000036103942,0.000004683766,0.0051592146,0.000067016,0.009114835,0.000083447034,0.00006378146,0.00017893536],"about_ca_topic_score_codex":0.0011823019,"about_ca_topic_score_gemma":0.0040891953,"teacher_disagreement_score":0.44090527,"about_ca_system_score_codex":0.00032689908,"about_ca_system_score_gemma":0.0004500513,"threshold_uncertainty_score":0.48232684},"labels":[],"label_agreement":null},{"id":"W2886821453","doi":"10.1158/1538-7445.am2018-3000","title":"Abstract 3000: Pervasive intra-tumour heterogeneity and subclonal selection across cancer types","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Toronto","funders":"","keywords":"Biology; Cancer; Tumour heterogeneity; Genome; Genetics; Selection (genetic algorithm); Gene; Cancer research; Computational biology","score_opus":0.044998767603235075,"score_gpt":0.4044382970885711,"score_spread":0.35943952948533603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886821453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936682,0.0048632985,0.000028109233,0.0004589832,0.00027016996,0.00018539485,0.00019201229,0.000008002224,0.00032581203],"genre_scores_gemma":[0.99134785,0.0059681125,0.00004297805,0.00022783481,0.0019991407,0.00012431777,0.000025305144,0.000027104254,0.00023737848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867684,0.000042648877,0.00013401631,0.00044092245,0.00021603316,0.0004895354],"domain_scores_gemma":[0.99908704,0.000033285418,0.00003941893,0.00017769552,0.0005084497,0.00015413841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003518977,0.00012587696,0.000117487485,0.000037765236,0.00032414214,0.00009158882,0.00016697228,0.00013683343,0.00015949397],"category_scores_gemma":[0.00010565327,0.00012368415,0.000041876876,0.00014971498,0.0003782642,0.000006200708,0.00015005037,0.00020748789,0.000020053672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026282057,0.000032050986,0.025177475,0.000036866117,0.00006576603,0.000003740544,0.00013108276,0.00003744463,0.9581258,0.00003571722,0.0075386106,0.00855259],"study_design_scores_gemma":[0.000413369,0.00029454802,0.07395978,0.000026040128,0.000007809364,0.000008647458,0.00007915703,0.000026808131,0.87756264,0.00008632506,0.047356684,0.00017819359],"about_ca_topic_score_codex":0.00202689,"about_ca_topic_score_gemma":0.014912991,"teacher_disagreement_score":0.0805632,"about_ca_system_score_codex":0.00011151723,"about_ca_system_score_gemma":0.00040686727,"threshold_uncertainty_score":0.8321799},"labels":[],"label_agreement":null},{"id":"W2886842073","doi":"10.1158/1538-7445.am2018-2925","title":"Abstract 2925: Tandem targeting of poly (ADP-ribose) polymerase (PARP) and epidermal growth factor receptor (EGFR) as a novel strategy for enhancing radio- and chemosensitivity of refractory tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Synthetic lethality; Olaparib; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Gefitinib; Epidermal growth factor receptor; DNA repair; EGFR inhibitors; Temozolomide; Biology; Polymerase; Chemistry; Cancer; Enzyme; DNA; Biochemistry; Glioma; Genetics","score_opus":0.09278853847039492,"score_gpt":0.41094891737547967,"score_spread":0.31816037890508475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886842073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924892,0.0044053462,0.00029521025,0.0009826812,0.00013709073,0.0008302641,0.00035565926,0.000027926639,0.0004765918],"genre_scores_gemma":[0.99718416,0.000636747,0.000659264,0.00013304959,0.0010298435,0.00008880719,0.000023111195,0.000058477068,0.00018653455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997379,0.000118016214,0.00061507156,0.0005635592,0.0006714486,0.00065288896],"domain_scores_gemma":[0.9972038,0.00084934855,0.00029901488,0.00028814067,0.0010099298,0.00034973293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015110937,0.00024058556,0.0006518388,0.0002807878,0.00020991328,0.000026747468,0.00011046303,0.00017809724,0.0004270484],"category_scores_gemma":[0.0008191167,0.00022680977,0.00009109705,0.0003458875,0.0010660882,0.00023228479,0.00007143169,0.0004984997,0.0000030883105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016356916,0.00014590943,0.0029990491,0.0007145425,0.000111285444,0.0000076613205,0.0010905429,3.7733236e-7,0.98539376,0.000116649426,0.0010807202,0.0067037996],"study_design_scores_gemma":[0.0034196218,0.0010192117,0.018756418,0.0007761321,0.000021831182,0.000025348334,0.0007311259,0.000041596453,0.97413146,0.00011812883,0.0007590517,0.00020008234],"about_ca_topic_score_codex":0.0019937786,"about_ca_topic_score_gemma":0.00011126162,"teacher_disagreement_score":0.015757369,"about_ca_system_score_codex":0.00031975997,"about_ca_system_score_gemma":0.0010339257,"threshold_uncertainty_score":0.9249034},"labels":[],"label_agreement":null},{"id":"W2886849270","doi":"10.1158/1538-7445.am2018-419","title":"Abstract 419: Reproducibility assessment of mutations calls in exome- and whole-genome sequencing using consensus calling from TCGA and ICGC","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Genetics; Exome sequencing; Biology; Exome; Exon; Genome; Whole genome sequencing; Computational biology; Gene; Mutation","score_opus":0.125098620890485,"score_gpt":0.4358100989058114,"score_spread":0.3107114780153264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886849270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650145,0.002391177,0.00017132901,0.00017080139,0.00006371922,0.00023884335,0.0003130373,0.0000023084415,0.00014734558],"genre_scores_gemma":[0.99754727,0.000616429,0.0014617372,0.000034915127,0.0002403555,0.000018839142,0.000046838257,0.000014336102,0.000019296023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986004,0.00007285324,0.00026071974,0.0006529915,0.00015963109,0.0002533797],"domain_scores_gemma":[0.9989651,0.00010826788,0.00006386906,0.00047641827,0.00029122352,0.000095127616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011709916,0.00008883614,0.0001594333,0.00008056053,0.00010468239,0.000035583544,0.00008265735,0.00008886515,0.000022251455],"category_scores_gemma":[0.0004513962,0.00009415884,0.000020174166,0.00012984888,0.00056590984,0.0000036057402,0.00017165446,0.00016853852,4.7457416e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039653518,0.000019672954,0.03427533,0.000040766783,0.00002109859,0.0000057945667,0.00023807642,0.00040428503,0.96405125,0.000021914339,0.000021547365,0.00086062145],"study_design_scores_gemma":[0.001513135,0.0003916233,0.476597,0.00022957982,0.000030923664,0.00000874271,0.0013353273,0.0024646495,0.5132955,0.0014434231,0.002282296,0.0004078017],"about_ca_topic_score_codex":0.0077024833,"about_ca_topic_score_gemma":0.0022073304,"teacher_disagreement_score":0.45075575,"about_ca_system_score_codex":0.00017116356,"about_ca_system_score_gemma":0.00071091315,"threshold_uncertainty_score":0.9989053},"labels":[],"label_agreement":null},{"id":"W2886869721","doi":"10.1158/1538-7445.am2018-1269","title":"Abstract 1269: Diosgenin, a naturally occurring steroidal saponin, prevents colon cancer in animal models of hereditary and sporadic CRC","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Diosgenin; Azoxymethane; Medicine; Colorectal cancer; Internal medicine; Gastroenterology; Cancer; Physiology; Endocrinology; Biology","score_opus":0.048274181265741886,"score_gpt":0.3740706092354418,"score_spread":0.3257964279696999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886869721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839093,0.015229545,0.0000029023456,0.0001082693,0.00008080025,0.00023129888,0.00013418456,0.0000039023753,0.00029978302],"genre_scores_gemma":[0.9973934,0.0020046232,0.000027061446,0.000045560984,0.00034504113,0.00009014458,0.000009286863,0.000014162416,0.000070690374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877083,0.00004903178,0.00017737482,0.00034553278,0.00025967744,0.00039754962],"domain_scores_gemma":[0.9995346,0.000025111565,0.000050150724,0.00015041327,0.00017060485,0.000069102825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027505145,0.00012254783,0.00018151103,0.000052673975,0.00009858145,0.000015839343,0.00018958985,0.00012376432,0.000034686407],"category_scores_gemma":[0.000031770025,0.000107365806,0.000035878627,0.00013155394,0.0004264011,0.000013637007,0.0002890196,0.0002691259,6.532308e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008388275,0.00006361069,0.006459321,0.00010959118,0.00006427138,0.0000065748636,0.00018812962,0.00001438067,0.9864456,0.0000054079605,0.0011903815,0.004613905],"study_design_scores_gemma":[0.00094730995,0.000751824,0.03229255,0.00028736686,0.00000885563,0.0000044275193,0.00036484064,0.00016133882,0.9627312,0.00020637,0.0020022646,0.00024168733],"about_ca_topic_score_codex":0.0014698472,"about_ca_topic_score_gemma":0.0010523373,"teacher_disagreement_score":0.025833227,"about_ca_system_score_codex":0.000071149,"about_ca_system_score_gemma":0.00014551617,"threshold_uncertainty_score":0.43782505},"labels":[],"label_agreement":null},{"id":"W2886935157","doi":"10.1158/1538-7445.am2018-2077","title":"Abstract 2077: Genome-wide association study identifies the <i>GLDC/IL33</i> locus associated with survival of osteosarcoma patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Genome-wide association study; Osteosarcoma; Hazard ratio; Medicine; Proportional hazards model; Internal medicine; Single-nucleotide polymorphism; Oncology; SNP; Confidence interval; Survival analysis; Genotype; Genetics; Biology; Pathology; Gene","score_opus":0.028532881862841235,"score_gpt":0.3275866136890662,"score_spread":0.29905373182622497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886935157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972047,0.00044278748,0.000007150085,0.00026602618,0.00027413774,0.00061457284,0.00017604703,0.0000060079938,0.0010085535],"genre_scores_gemma":[0.9982402,0.00024615537,0.0000029925286,0.00009361451,0.0003617503,0.00009803593,0.00009625019,0.000030433119,0.0008306127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980168,0.00020157368,0.0002620163,0.00034479046,0.0007348587,0.00044000312],"domain_scores_gemma":[0.9974509,0.00035255938,0.00019470393,0.00044173392,0.0014844333,0.00007567087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013487836,0.00013437319,0.00018064679,0.000060298087,0.00026544457,0.00008064982,0.00041323312,0.0001102754,0.000064779815],"category_scores_gemma":[0.0012469732,0.00010058526,0.000055080876,0.0003009852,0.00024231394,0.000006741208,0.00023731904,0.000217064,0.0000150383385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035453474,0.00045614346,0.9469087,0.00001633686,0.00034903572,0.0000027814715,0.0004991808,0.000031132637,0.040884033,0.00000664916,0.0099198865,0.00057155284],"study_design_scores_gemma":[0.0014871117,0.0013179571,0.9401027,0.0000288875,0.00003697342,8.6299835e-8,0.0005908557,0.0000015229757,0.048293788,0.00005248264,0.0079124,0.00017525481],"about_ca_topic_score_codex":0.0009971727,"about_ca_topic_score_gemma":0.010819019,"teacher_disagreement_score":0.009821846,"about_ca_system_score_codex":0.0002250639,"about_ca_system_score_gemma":0.00033961696,"threshold_uncertainty_score":0.6037267},"labels":[],"label_agreement":null},{"id":"W2886975402","doi":"10.1158/1538-7445.am2018-407","title":"Abstract 407: Novel targets in metastatic HNSCC","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Metastasis; Head and neck squamous-cell carcinoma; Malignancy; Cancer research; Biology; Cancer; Medicine; Head and neck cancer; Pathology; Internal medicine","score_opus":0.11383637566506963,"score_gpt":0.4421137880163334,"score_spread":0.32827741235126373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886975402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895737,0.0027976332,0.00057001656,0.00060280506,0.00014231165,0.00022517313,0.000039752937,0.000005601261,0.0060430095],"genre_scores_gemma":[0.9964663,0.0006009765,0.000273253,0.0001133442,0.00039561585,0.00020591187,0.00002303855,0.000017522641,0.0019040337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989391,0.00003768834,0.00013892355,0.00030937034,0.00021973858,0.00035519025],"domain_scores_gemma":[0.9992956,0.000013185043,0.000024607298,0.0003418374,0.00024878507,0.00007598758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053360267,0.0000760258,0.00008294105,0.00009417632,0.00009729949,0.00002933311,0.00024275624,0.000056009958,0.00042073868],"category_scores_gemma":[0.000076987635,0.000069635425,0.000032027867,0.0002484728,0.00021743886,0.0000043690466,0.00007441637,0.00015719011,0.000077711215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007127932,0.00006867178,0.0005337655,0.000015539501,0.000018716346,0.0000017862465,0.0000638635,0.000023035613,0.9843615,0.000200438,0.008380539,0.0062608314],"study_design_scores_gemma":[0.0009090657,0.00018435105,0.031083705,0.000036158795,0.000003918002,0.0000026650393,0.00017012324,0.00006234233,0.6303203,0.00023507392,0.33679935,0.00019294812],"about_ca_topic_score_codex":0.0005895375,"about_ca_topic_score_gemma":0.000986126,"teacher_disagreement_score":0.35404122,"about_ca_system_score_codex":0.000060676688,"about_ca_system_score_gemma":0.00030032254,"threshold_uncertainty_score":0.46067935},"labels":[],"label_agreement":null},{"id":"W2886987556","doi":"10.1158/1538-7445.am2018-1562","title":"Abstract 1562: Clusters of circulating tumor cells were selectively isolated in the blood of 12/12 epithelial ovarian cancer patients using facile gravity-flow-based filtration method adapted to clinical use","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Université de Montréal; McGill University","funders":"","keywords":"Circulating tumor cell; Ovarian cancer; Epithelial ovarian cancer; Filtration (mathematics); Metastasis; Cluster (spacecraft); Cancer; Cancer research; Limiting; Internal medicine; Biology; Oncology; Medicine; Computer science; Mathematics","score_opus":0.17601558215878407,"score_gpt":0.4522964009053452,"score_spread":0.2762808187465611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886987556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952194,0.000054752116,0.0020472142,0.0002080624,0.00027214256,0.0015127477,0.000586742,0.000010910256,0.00008802283],"genre_scores_gemma":[0.9937195,0.000028767057,0.0055500767,0.0002413765,0.00027567134,0.0000875346,0.000028460532,0.000036022513,0.000032546297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963993,0.00074784394,0.00085090735,0.00050178595,0.0009606713,0.00053948775],"domain_scores_gemma":[0.9972986,0.00072308537,0.00028906317,0.00041148489,0.0010885466,0.00018920196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002768615,0.00019055944,0.0005698453,0.00035296538,0.00013797941,0.000038655795,0.00023599683,0.00011594309,0.0003492318],"category_scores_gemma":[0.0005553519,0.000150622,0.00016180419,0.0009565882,0.00022955006,0.00011808269,0.00006174039,0.00066491525,0.0000031175775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056217,0.0012930173,0.08590335,0.0005429984,0.0003189993,0.000033904336,0.0034130549,0.005467091,0.87404966,0.000007675732,0.00046619732,0.022882342],"study_design_scores_gemma":[0.012539277,0.0035947037,0.3442959,0.0020394733,0.00048548626,0.0000061397072,0.00083049707,0.024121499,0.60953146,0.000031594864,0.0020249803,0.00049903116],"about_ca_topic_score_codex":0.025178533,"about_ca_topic_score_gemma":0.0049064965,"teacher_disagreement_score":0.26451823,"about_ca_system_score_codex":0.00030424085,"about_ca_system_score_gemma":0.001344511,"threshold_uncertainty_score":0.9813129},"labels":[],"label_agreement":null},{"id":"W2887009286","doi":"10.1158/1538-7445.am2018-3006","title":"Abstract 3006: Molecular characterization of baseline and serial multiple myeloma patients from the MMRF CoMMpass study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exome; Multiple myeloma; Medicine; Cohort; Oncology; Cancer; Internal medicine; Malignancy; Interim analysis; Exome sequencing; Clinical trial; Gene; Genetics; Mutation; Biology","score_opus":0.061295271302341595,"score_gpt":0.38951777232327417,"score_spread":0.3282225010209326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887009286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693847,0.0000972133,0.000022102655,0.00061654404,0.0001027254,0.0017145732,0.00038129697,0.000015026619,0.000112069494],"genre_scores_gemma":[0.99882495,0.00008611242,0.00004144748,0.00006801536,0.0003780837,0.0001866096,0.00031089818,0.000026837539,0.00007706095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977416,0.00033011485,0.00025998184,0.00033194176,0.00095408055,0.0003822947],"domain_scores_gemma":[0.99803096,0.0003484769,0.00006697378,0.00046792655,0.0008793649,0.00020627378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007218376,0.00012949992,0.00024156815,0.000102905746,0.00021398811,0.000042477815,0.00018103298,0.000062308376,0.00049020053],"category_scores_gemma":[0.00062123674,0.00008532282,0.000037244205,0.00029868857,0.0003349205,0.00008573503,0.00018058944,0.0002841129,0.000035858386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023474684,0.0008843337,0.6981141,0.0000386217,0.00020830045,0.000032089556,0.0008200473,2.3529779e-7,0.27348298,0.0000027363153,0.00031137018,0.023757711],"study_design_scores_gemma":[0.0059013334,0.00093226874,0.9246195,0.00009128246,0.000026156114,4.7426985e-7,0.00022273215,0.0001875899,0.06720475,0.000010409552,0.00073874823,0.000064761356],"about_ca_topic_score_codex":0.0040809694,"about_ca_topic_score_gemma":0.00066744816,"teacher_disagreement_score":0.22650538,"about_ca_system_score_codex":0.00010454544,"about_ca_system_score_gemma":0.00018684176,"threshold_uncertainty_score":0.6169232},"labels":[],"label_agreement":null},{"id":"W2887018003","doi":"10.1158/1538-7445.am2018-ct180","title":"Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nivolumab; Medicine; Pharmacodynamics; Pharmacology; Pharmacokinetics; CD8; Antibody; Cancer; Internal medicine; Immune system; Immunotherapy; Immunology","score_opus":0.021496653413219064,"score_gpt":0.38212317834452997,"score_spread":0.3606265249313109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887018003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987624,0.0002941301,0.00004589962,0.000030826166,0.000021715969,0.0005109159,0.00002864634,0.0000047968842,0.00030062848],"genre_scores_gemma":[0.99928063,0.000038826405,0.00015323794,0.000012675996,0.00007357069,0.00007181526,0.0002655683,0.000026134869,0.00007751956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986634,0.00008044816,0.00021469941,0.00035932084,0.00033206685,0.00035004504],"domain_scores_gemma":[0.9991103,0.000013578162,0.00008512904,0.00027648226,0.0004469372,0.00006760894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029822215,0.000119270815,0.00017572592,0.00017268486,0.000059051414,0.000012842212,0.00019787785,0.00007931388,0.00006535672],"category_scores_gemma":[0.000027369426,0.00009886587,0.000014980429,0.00036053354,0.00023712253,0.000023775157,0.00006595679,0.00018674553,0.0000021473531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009702028,0.0024930846,0.34191316,0.00019811429,0.000046554214,0.000037051796,0.00047891116,0.00057209306,0.6388069,0.000021613805,0.0006592693,0.0050712298],"study_design_scores_gemma":[0.00842746,0.011256435,0.39907315,0.0003788416,0.000005547749,0.0000018491528,0.00023698783,0.00016661575,0.5800471,0.000016341468,0.00016437218,0.00022534121],"about_ca_topic_score_codex":0.000353185,"about_ca_topic_score_gemma":0.00012022478,"teacher_disagreement_score":0.058759835,"about_ca_system_score_codex":0.000042732776,"about_ca_system_score_gemma":0.00028048223,"threshold_uncertainty_score":0.4031633},"labels":[],"label_agreement":null},{"id":"W2887027423","doi":"10.1158/1538-7445.am2018-4707","title":"Abstract 4707: Pelareorep promotes the expression of a chemokine signature that predicts response to immunotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immunotherapy; Gene signature; Cancer research; Chemokine; Biology; Immunology; Immune system; Cancer immunotherapy; Gene expression profiling; Gene expression; Cancer; Medicine; Gene","score_opus":0.04393244366651001,"score_gpt":0.3908144199903686,"score_spread":0.3468819763238586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887027423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929629,0.0031467208,0.000027739725,0.0022822563,0.00008940635,0.00092931377,0.00006935531,0.000018123723,0.00047419276],"genre_scores_gemma":[0.99696934,0.0005424001,0.000062607425,0.0002356671,0.00057236856,0.0003046243,0.000019151275,0.00005627346,0.001237565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971968,0.00052220427,0.00020968895,0.0005127408,0.0009321889,0.00062637415],"domain_scores_gemma":[0.99776566,0.00013994257,0.000065499466,0.0011212386,0.0007471378,0.00016049945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027472936,0.0001776139,0.00017265901,0.00015778949,0.00027520518,0.000050544248,0.0009779028,0.00021867652,0.0004756727],"category_scores_gemma":[0.00040474077,0.00012035149,0.00009157313,0.00046973018,0.0006039831,0.0000074069544,0.00033640125,0.00046870369,0.00003086317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029224405,0.00007780676,0.00041742902,0.000027448006,0.000050247316,0.0000035015653,0.0006615986,0.000010585092,0.9526603,0.0000017947489,0.009902052,0.0069627967],"study_design_scores_gemma":[0.0007353816,0.0032824392,0.0046420856,0.00010365651,0.0000021068643,0.0000024004432,0.00013656978,0.000005191833,0.9587254,0.000047120157,0.032188766,0.00012886722],"about_ca_topic_score_codex":0.00008075615,"about_ca_topic_score_gemma":0.00013994655,"teacher_disagreement_score":0.028489023,"about_ca_system_score_codex":0.00006895991,"about_ca_system_score_gemma":0.00052057084,"threshold_uncertainty_score":0.52082825},"labels":[],"label_agreement":null},{"id":"W2887040748","doi":"10.1158/1538-7445.am2018-1911","title":"Abstract 1911: Uncovering novel targets of recurrent glioblastoma using transcriptomic profiling in a patient-derived xenograft model","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Radiation therapy; Medicine; Transcriptome; Brain tumor; Cancer research; Stem cell; Cancer stem cell; Chemotherapy; Population; Glioblastoma; Oncology; Multimodal therapy; Cancer; Biology; Pathology; Internal medicine; Gene; Gene expression","score_opus":0.11027186916378236,"score_gpt":0.40256746135288357,"score_spread":0.2922955921891012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887040748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973121,0.0012253153,0.000099689,0.00016776808,0.00013150265,0.0008487943,0.000058102625,0.000017709985,0.00013900595],"genre_scores_gemma":[0.99787796,0.00015480323,0.0016453923,0.000022026683,0.00008950979,0.000163564,0.000006542175,0.00003486679,0.000005357109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980348,0.000032603893,0.00037944366,0.00037384473,0.00061027776,0.00056907564],"domain_scores_gemma":[0.9990547,0.000049815993,0.000072488765,0.0002735506,0.0003874603,0.00016203163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033412798,0.00015909228,0.00032836033,0.00046785868,0.00009254734,0.000018770661,0.00010721648,0.00008276652,0.000075453725],"category_scores_gemma":[0.000062322055,0.00012553035,0.000093578994,0.0005606623,0.00018913743,0.000103325,0.000059458816,0.00031607723,0.000006646239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013292313,0.0007096099,0.004464263,0.00024617827,0.00006661402,0.000047378333,0.0014113113,0.0017963608,0.9835104,0.000020673775,0.0000426706,0.0063553406],"study_design_scores_gemma":[0.0031100942,0.0009848088,0.004322829,0.0011705412,0.000027478454,0.000009421698,0.0003240841,0.021944823,0.9678056,0.000059104204,0.00010670321,0.00013449459],"about_ca_topic_score_codex":0.0010677382,"about_ca_topic_score_gemma":0.00078058575,"teacher_disagreement_score":0.020148462,"about_ca_system_score_codex":0.0006035576,"about_ca_system_score_gemma":0.00048310446,"threshold_uncertainty_score":0.5118979},"labels":[],"label_agreement":null},{"id":"W2887042787","doi":"10.1158/1538-7445.am2018-1642","title":"Abstract 1642: Alectinib in treatment-naïve anaplastic lymphoma kinase-positive (<i>ALK</i>+) metastatic non-small-cell lung cancer (mNSCLC): Systematic literature review (SLR) and network meta-analysis (NMA)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Alectinib; Medicine; Crizotinib; Ceritinib; Internal medicine; Oncology; Anaplastic lymphoma kinase; Lung cancer; Pemetrexed; Chemotherapy","score_opus":0.07856360242995693,"score_gpt":0.43501263597532397,"score_spread":0.35644903354536706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887042787","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11034522,0.8783718,0.00007173409,0.0015354342,0.00019780349,0.0063610836,0.0005698852,0.00004699945,0.0025000917],"genre_scores_gemma":[0.85170346,0.13368885,0.0005890116,0.0008542,0.00045956371,0.007829964,0.00023750566,0.00010593109,0.0045315404],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99598324,0.00055557676,0.00078842766,0.000953205,0.0007635375,0.00095600286],"domain_scores_gemma":[0.9968163,0.0008634948,0.0002715196,0.0007398026,0.0008846457,0.00042423554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010696931,0.00050787453,0.0023571684,0.00067686103,0.00037099048,0.00017531845,0.00019989593,0.0001256782,0.00083262497],"category_scores_gemma":[0.00013170217,0.0003393124,0.0006469937,0.0038441734,0.0002252513,0.00018586169,0.000071608745,0.00034429756,0.000028195669],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021252045,0.003498144,0.019459786,0.33196935,0.58036953,0.0045306464,0.016604751,0.00095710915,0.0020628136,0.00022264369,0.029153695,0.009046321],"study_design_scores_gemma":[0.013508313,0.0029708159,0.034118127,0.104240924,0.83430016,0.00014960769,0.001125915,0.0026146444,0.003265452,0.0001260164,0.0020620602,0.0015179482],"about_ca_topic_score_codex":0.0032874823,"about_ca_topic_score_gemma":0.00783017,"teacher_disagreement_score":0.7446829,"about_ca_system_score_codex":0.0015701352,"about_ca_system_score_gemma":0.0011277992,"threshold_uncertainty_score":0.9999059},"labels":[],"label_agreement":null},{"id":"W2887048340","doi":"10.1158/1538-7445.am2018-3956","title":"Abstract 3956: Omomyc-based cell-penetrating peptides: From proof of concept to a clinically viable anti-Myc therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Transactivation; Cancer research; Cancer; Carcinogenesis; Medicine; In vivo; Transcription factor; Biology; Internal medicine; Gene; Biochemistry","score_opus":0.0779958275227587,"score_gpt":0.4353003007753622,"score_spread":0.3573044732526035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887048340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942115,0.0018606305,0.0001708173,0.0002478458,0.000084963685,0.0008042786,0.0002480456,0.0000095293,0.0023624073],"genre_scores_gemma":[0.9973697,0.00025937342,0.0006105958,0.00022043718,0.00063580985,0.00027809548,0.00010437264,0.000040000992,0.00048161685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975554,0.00015222607,0.00035956482,0.0006277907,0.0006363704,0.00066868047],"domain_scores_gemma":[0.99813443,0.000118478616,0.00009088435,0.00063692953,0.0007181696,0.00030111882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065907,0.00017285795,0.00024325056,0.00010021063,0.00017509254,0.000062501225,0.00050169276,0.00014583263,0.000724704],"category_scores_gemma":[0.00018947401,0.00014928247,0.00011229219,0.00031259333,0.00041424631,0.000007865424,0.00015229793,0.00025319078,0.00003845561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010739921,0.00029950237,0.011000018,0.0000313583,0.00010069501,0.000009131309,0.00015003624,0.00006801472,0.96488327,0.0000020387238,0.0075783175,0.014803624],"study_design_scores_gemma":[0.001815868,0.0022931646,0.0043672156,0.00009005214,0.000004069199,2.909786e-7,0.00008711704,0.000025235553,0.9778246,0.00004474012,0.013293968,0.00015366748],"about_ca_topic_score_codex":0.004931662,"about_ca_topic_score_gemma":0.0009080668,"teacher_disagreement_score":0.0146499565,"about_ca_system_score_codex":0.00007808507,"about_ca_system_score_gemma":0.0011946791,"threshold_uncertainty_score":0.79350007},"labels":[],"label_agreement":null},{"id":"W2887070251","doi":"10.1158/1538-7445.am2018-lb-391","title":"Abstract LB-391: Hsa_circ_001783 regulates breast cancer progression via sponging miR-200c","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Breast cancer; microRNA; Cancer; Oncology; Cancer research; Internal medicine; Biology; Medicine; Gene; Genetics","score_opus":0.03373241565060672,"score_gpt":0.41042019035400906,"score_spread":0.3766877747034023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887070251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886522,0.008130075,0.00004265544,0.00074626354,0.00038940678,0.00048080538,0.00014533255,0.000040388742,0.001372866],"genre_scores_gemma":[0.9954573,0.00071851665,0.00006778957,0.000117751944,0.002283018,0.00032925542,0.000072292714,0.000074310025,0.0008797961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737215,0.00012835258,0.00023928407,0.00074452517,0.00066328334,0.00085242983],"domain_scores_gemma":[0.99812365,0.000026777663,0.00007845012,0.00077205955,0.0007009557,0.0002981346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060573703,0.00022192828,0.00018057786,0.0001437423,0.00038165046,0.000101893915,0.000573358,0.00021488134,0.0015429221],"category_scores_gemma":[0.00011020308,0.00020673173,0.00011865787,0.00035865608,0.0006611211,0.000014950973,0.0003347254,0.00029528348,0.00010621263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032668514,0.0000947082,0.013798897,0.000091363785,0.00008480713,0.000021862834,0.000051222036,0.000016587688,0.9200794,0.00001510323,0.014941269,0.050478075],"study_design_scores_gemma":[0.0006763254,0.00012521779,0.13594571,0.00035601106,0.000021275378,0.000042145777,0.00006686613,0.000068556605,0.80717206,0.00015353455,0.054969173,0.00040310598],"about_ca_topic_score_codex":0.0005275202,"about_ca_topic_score_gemma":0.00033263664,"teacher_disagreement_score":0.122146815,"about_ca_system_score_codex":0.0001747336,"about_ca_system_score_gemma":0.0005378161,"threshold_uncertainty_score":0.9993698},"labels":[],"label_agreement":null},{"id":"W2887078648","doi":"10.1158/1538-7445.am2018-3465","title":"Abstract 3465: Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer research; Epidermal growth factor receptor; Signal transduction; Phosphorylation; MAPK/ERK pathway; Biology; Cell biology; ERBB3; EGFR inhibitors; Receptor tyrosine kinase; Cancer","score_opus":0.16573674846723718,"score_gpt":0.46068769895449674,"score_spread":0.29495095048725956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887078648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893903,0.000399477,0.000012930469,0.006328651,0.0004019714,0.0019999207,0.00020446834,0.00007341456,0.0011888307],"genre_scores_gemma":[0.9957665,0.00012993936,0.00062115025,0.00012412683,0.0012860685,0.00042532268,0.000017642053,0.00009569652,0.0015335045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941504,0.00069282384,0.00065734156,0.00086717674,0.0022545964,0.0013776371],"domain_scores_gemma":[0.9926395,0.0023309414,0.00011675538,0.0008329005,0.0031565353,0.0009234013],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035040216,0.00031637022,0.0006583007,0.0009408999,0.00032482445,0.00009317529,0.0005282711,0.0002480024,0.0035256888],"category_scores_gemma":[0.006730308,0.00027121836,0.00015064985,0.0018426282,0.0010774003,0.00017532836,0.00025085645,0.0010530909,0.00053733686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04396143,0.00018954014,0.0028304749,0.00045459502,0.00019103571,0.000047361482,0.0026499552,0.000011199593,0.93274397,0.000029089339,0.011786296,0.005105052],"study_design_scores_gemma":[0.0033140567,0.003925722,0.017076796,0.0011704685,0.000021096743,0.000004999458,0.00061598216,0.000030699517,0.9688555,0.000040622763,0.0046910103,0.0002530637],"about_ca_topic_score_codex":0.0011527519,"about_ca_topic_score_gemma":0.00013492996,"teacher_disagreement_score":0.040647376,"about_ca_system_score_codex":0.0012254592,"about_ca_system_score_gemma":0.0031237216,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W2887093835","doi":"10.1158/1538-7445.am2018-2149","title":"Abstract 2149: Use of PDXs and patient-derived cell lines to uncover unconventional drug therapies and combinations for the treatment of drug-resistant cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pertuzumab; Olaparib; Irinotecan; Drug resistance; Drug; Breast cancer; Cancer; Oncology; Trastuzumab; Chemotherapy; Internal medicine; Cancer research; Pharmacology; Biology","score_opus":0.09892927371864663,"score_gpt":0.4042414725818121,"score_spread":0.30531219886316546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887093835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676324,0.005888325,0.00000431206,0.0057230266,0.00007747398,0.0010321134,0.0003936521,0.000004022565,0.00011386354],"genre_scores_gemma":[0.9909656,0.0052481955,0.00019104179,0.00007902738,0.0001124554,0.0002474464,0.000013970753,0.0000140032125,0.0031282522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875826,0.000053331627,0.00021996089,0.00021119596,0.0004901895,0.00026704127],"domain_scores_gemma":[0.9978273,0.000945366,0.00005458895,0.00017517863,0.00085862575,0.00013896097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022229034,0.00010532253,0.00021772394,0.00014075839,0.00023215183,0.000025952137,0.0000764207,0.000028987353,0.00017779038],"category_scores_gemma":[0.000056698966,0.0000629837,0.00006681748,0.00020093808,0.0007303148,0.000053965032,0.000051204268,0.00008622953,0.000002021109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008636127,0.0010143331,0.02028744,0.00097117136,0.0006728866,0.0000073405004,0.015230503,0.000034614026,0.87397164,0.0012458533,0.021373818,0.056554247],"study_design_scores_gemma":[0.0039502922,0.0038444942,0.12858704,0.0003632631,0.0000763992,0.0000021730966,0.0032971313,0.00016186024,0.64506656,0.00063219434,0.2138419,0.00017668358],"about_ca_topic_score_codex":0.009701511,"about_ca_topic_score_gemma":0.002731709,"teacher_disagreement_score":0.2289051,"about_ca_system_score_codex":0.00013570489,"about_ca_system_score_gemma":0.0003810787,"threshold_uncertainty_score":0.996893},"labels":[],"label_agreement":null},{"id":"W2887099535","doi":"10.1158/1538-7445.am2018-5176","title":"Abstract 5176: Cell free malignant ascites fluid facilitates gastric adenocarcinoma peritoneal metastasis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Metastasis; Peritoneum; Medicine; Cancer; Pathology; Cancer cell; Adenocarcinoma; Ascites; Peritoneal cavity; Peritoneal fluid; Cancer research; In vivo; Cell; Internal medicine; Biology; Surgery","score_opus":0.05611734338064272,"score_gpt":0.36934513188344753,"score_spread":0.3132277885028048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887099535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782005,0.017346183,0.000028200055,0.0004173463,0.00013275935,0.0004607984,0.0007211255,0.000019699402,0.0026734013],"genre_scores_gemma":[0.99384373,0.0021134156,0.0002513522,0.00005331567,0.00078507094,0.00035498277,0.00013621358,0.00004559605,0.002416316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684954,0.00017179268,0.00024203944,0.00078612,0.0008124944,0.0011380329],"domain_scores_gemma":[0.9979743,0.000053157783,0.00004279429,0.0009333299,0.0005891032,0.00040731332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006389594,0.00024391332,0.00021905033,0.00022620663,0.00040377548,0.00013499818,0.0007670644,0.00013534991,0.0011482997],"category_scores_gemma":[0.00017924009,0.00021036358,0.00014839522,0.00046308737,0.00065606355,0.00001497472,0.00054481556,0.00028633125,0.00031245867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005633979,0.00016496326,0.012033197,0.00007707622,0.00017128121,0.000053556163,0.00013846942,0.000003702099,0.9379652,0.0000133953035,0.042484313,0.0063314415],"study_design_scores_gemma":[0.0013077096,0.001348922,0.020744411,0.000031242915,0.000017260354,0.000013627571,0.0002819397,0.000007959652,0.9293479,0.00014121848,0.046510436,0.00024739438],"about_ca_topic_score_codex":0.0039160727,"about_ca_topic_score_gemma":0.0013172542,"teacher_disagreement_score":0.01564325,"about_ca_system_score_codex":0.00017258302,"about_ca_system_score_gemma":0.0006310039,"threshold_uncertainty_score":0.9997648},"labels":[],"label_agreement":null},{"id":"W2887119137","doi":"10.1158/1538-7445.am2018-lb-177","title":"Abstract LB-177: Quantification of cell signaling proteins by immuno-MALDI","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Victoria","funders":"","keywords":"Phosphopeptide; Lysis buffer; Phosphorylation; Chemistry; Alkaline phosphatase; Protein kinase B; Lysis; Trypsin; Molecular biology; AKT1; PI3K/AKT/mTOR pathway; Biochemistry; Biology; Signal transduction; Enzyme","score_opus":0.04687994403944528,"score_gpt":0.3988450161478662,"score_spread":0.35196507210842093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887119137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855283,0.0013676009,0.010131112,0.0002746473,0.000028754393,0.00051345624,0.00007327057,0.000014089372,0.002068788],"genre_scores_gemma":[0.99682397,0.00043603827,0.0012420608,0.0000431298,0.00014477021,0.00036121975,0.000189157,0.000015323378,0.00074431475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989972,0.000067527035,0.00018811651,0.0003255025,0.00016256659,0.00025907665],"domain_scores_gemma":[0.9989916,0.0000112705175,0.00007561205,0.00047271917,0.00039589006,0.000052902607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051601295,0.00008426657,0.000089223475,0.00004894682,0.00014477955,0.000015077546,0.00032430358,0.00015863277,0.00014028183],"category_scores_gemma":[0.000035392448,0.00008000157,0.00004915556,0.00017260785,0.00035847066,0.000002410126,0.00009894504,0.00015402981,0.0000139404265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004223119,0.000063854975,0.0001182937,0.000024885192,0.00001277733,1.9110682e-7,0.000015838992,0.0000016587402,0.9900184,0.00019983058,0.008057197,0.0014448088],"study_design_scores_gemma":[0.00011448779,0.00020220848,0.0002442985,0.000016839744,0.000002845568,5.293202e-7,0.000024966172,0.000006278628,0.93611485,0.0001203537,0.06307054,0.000081783386],"about_ca_topic_score_codex":0.00023777108,"about_ca_topic_score_gemma":0.000017534248,"teacher_disagreement_score":0.055013344,"about_ca_system_score_codex":0.000019875324,"about_ca_system_score_gemma":0.00013438112,"threshold_uncertainty_score":0.32623693},"labels":[],"label_agreement":null},{"id":"W2887121914","doi":"10.1158/1538-7445.am2018-1206","title":"Abstract 1206: Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Melanoma; Metastatic melanoma; Internal medicine; Mutation; Oncology; Cancer research; Biology","score_opus":0.05028103803597944,"score_gpt":0.3394714339502016,"score_spread":0.28919039591422213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887121914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986071,0.00015839022,0.000010760685,0.000024642977,0.000023139362,0.0004158133,0.00013509506,0.0000026888883,0.0006223976],"genre_scores_gemma":[0.9994222,0.000035735964,0.0001673064,0.000013883767,0.000073982184,0.000078971105,0.000045185905,0.0000152047105,0.00014755435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902844,0.000079124206,0.00013740324,0.00028435525,0.00019452772,0.00027613566],"domain_scores_gemma":[0.9993702,0.00006326017,0.000048125625,0.00019575436,0.00024413722,0.00007849933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017998411,0.00010204927,0.00013640124,0.000074082265,0.00005414024,0.000014662425,0.000093061186,0.000044334745,0.000031270167],"category_scores_gemma":[0.00007816078,0.000076431905,0.00001584116,0.00010398042,0.000133517,0.000005260274,0.000069279995,0.00007137265,0.000002320365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005413723,0.0001981333,0.8075425,0.00005560249,0.00008443388,0.000012676375,0.00027436405,0.0000028520408,0.17143837,0.000009899769,0.000051752682,0.019788062],"study_design_scores_gemma":[0.001427755,0.0024154251,0.7510838,0.000077434765,0.000007707705,0.0000012500798,0.00004451269,0.0000052198898,0.2447018,0.000012862031,0.0001422389,0.00007998739],"about_ca_topic_score_codex":0.0018870039,"about_ca_topic_score_gemma":0.0014685502,"teacher_disagreement_score":0.07326344,"about_ca_system_score_codex":0.000041711843,"about_ca_system_score_gemma":0.00015812046,"threshold_uncertainty_score":0.3116803},"labels":[],"label_agreement":null},{"id":"W2887125093","doi":"10.1158/1538-7445.am2018-2598","title":"Abstract 2598: <i>In silico</i> gene expression analysis of PTHrP and its association with molecular subtypes and organ-specific metastasis in human triple-negative breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Metastasis; Cancer research; Gene expression profiling; Triple-negative breast cancer; Biology; In silico; Gene expression; microRNA; Cancer; Gene; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.053545663249132076,"score_gpt":0.4040820727932967,"score_spread":0.35053640954416465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887125093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406826,0.0045884126,0.0000014739671,0.00053478277,0.000014147675,0.00050620816,0.00013561558,0.0000057278385,0.00014534005],"genre_scores_gemma":[0.99710387,0.0024851419,0.000050176728,0.00003716597,0.000031357937,0.0001243637,0.000019253172,0.000016179589,0.00013252054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838805,0.00013828934,0.00024535053,0.0003563812,0.0005174867,0.00035441603],"domain_scores_gemma":[0.9990475,0.000108619904,0.000105430816,0.00016103072,0.00041698647,0.00016040589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061490596,0.00011362301,0.0004271053,0.0005849599,0.00008862828,0.000014734324,0.00004550472,0.000089319576,0.00026359453],"category_scores_gemma":[0.000044500794,0.00008712379,0.000026453312,0.0014400891,0.0001067391,0.00008986047,0.000032384152,0.0002519113,0.0000015637106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011792926,0.00019050132,0.69540334,0.00012366631,0.0004316989,0.00004275719,0.00095721416,0.000008658842,0.29758802,0.00001308107,0.00013500435,0.003926802],"study_design_scores_gemma":[0.0024107033,0.00016814144,0.70955515,0.00021179544,0.0001230313,0.0000012253265,0.0001270608,0.000024368463,0.2872686,0.000016377915,0.0000337181,0.0000598052],"about_ca_topic_score_codex":0.0076553673,"about_ca_topic_score_gemma":0.011355622,"teacher_disagreement_score":0.014151841,"about_ca_system_score_codex":0.0004987187,"about_ca_system_score_gemma":0.00021581455,"threshold_uncertainty_score":0.99895275},"labels":[],"label_agreement":null},{"id":"W2887130112","doi":"10.1158/1538-7445.am2018-4237","title":"Abstract 4237: Differences in the frequencies of tumor <i>VHL</i> mutation and HIF-2α expression between black and white patients with clear cell renal carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunohistochemistry; Kidney cancer; Internal medicine; Oncology; Kidney disease; Pathology; Cancer research","score_opus":0.06345583324635751,"score_gpt":0.3232579458300653,"score_spread":0.2598021125837078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887130112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974133,0.00039205162,0.0000018921849,0.00023669905,0.000011780343,0.0006455149,0.00002815131,0.0000053408953,0.0012653207],"genre_scores_gemma":[0.9995712,0.00006390157,0.00008198367,0.000026135123,0.000106135754,0.000046886325,0.000015472568,0.0000148468,0.00007342446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983284,0.00014212656,0.00020564883,0.00029785396,0.0007399839,0.0002859714],"domain_scores_gemma":[0.99908644,0.00019734254,0.00007926024,0.00023635995,0.00029377275,0.000106846535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004091238,0.00012653555,0.00023474688,0.00015467106,0.00010742986,0.000033579287,0.000108797,0.000048030226,0.00005715093],"category_scores_gemma":[0.000034161538,0.000069969836,0.000018308934,0.0002575466,0.00071751483,0.00009603328,0.00005636593,0.00027369944,0.00000419847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005807468,0.00007769639,0.9726228,0.00021843205,0.000011459485,0.000042211,0.003777612,3.1036242e-7,0.02168128,0.000002004767,0.00021343342,0.0007719721],"study_design_scores_gemma":[0.0015607197,0.0016871791,0.9222041,0.00028898133,0.000023398825,0.0000030346414,0.0010001886,0.000007507327,0.073080294,0.00004959403,0.00002839836,0.00006664949],"about_ca_topic_score_codex":0.0010069796,"about_ca_topic_score_gemma":0.00015060681,"teacher_disagreement_score":0.051399015,"about_ca_system_score_codex":0.00010143252,"about_ca_system_score_gemma":0.00013689071,"threshold_uncertainty_score":0.2853287},"labels":[],"label_agreement":null},{"id":"W2887148258","doi":"10.1158/1538-7445.am2018-3195","title":"Abstract 3195: The molecular mechanism of action and cellular targets of TTFields","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Electrochemical Analysis and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Microtubule; Solvation; Tubulin; Conductance; Biophysics; Dynamic light scattering; Materials science; Chemistry; Ion; Nanotechnology; Organic chemistry","score_opus":0.0468249639998481,"score_gpt":0.3772806816175733,"score_spread":0.3304557176177252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887148258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942409,0.000787088,0.00049613084,0.00060447195,0.0000045624734,0.00004021182,0.000006622,0.000004210323,0.003815829],"genre_scores_gemma":[0.99932265,0.00022246865,0.00002894112,0.000013666401,0.00007132956,0.00003585639,0.000003716929,0.0000055013766,0.0002958494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993872,0.000010473954,0.00011233632,0.0001248525,0.00023003633,0.0001351067],"domain_scores_gemma":[0.99948394,0.000053285334,0.000043583444,0.00021261112,0.00017231022,0.000034282828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001867742,0.000040754476,0.00008024956,0.000023261968,0.000072397466,0.000007147767,0.00015189398,0.00005715472,0.00063057744],"category_scores_gemma":[0.000022124435,0.000028702667,0.000035452835,0.00015823539,0.0001860921,0.000015964322,0.000048703547,0.00018513452,0.0000039977776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010034091,0.000021265603,0.000024038107,0.000059143542,0.000027260328,2.1436736e-7,0.00005581203,5.604796e-7,0.9932689,0.0048707593,0.0002441444,0.0014178761],"study_design_scores_gemma":[0.000056311248,0.000012911463,0.00001824281,0.00001653253,0.000009895621,1.7349805e-7,0.00009046689,0.00011413691,0.9914709,0.006413062,0.0017692484,0.000028174172],"about_ca_topic_score_codex":0.00028099844,"about_ca_topic_score_gemma":0.000025784315,"teacher_disagreement_score":0.0050817966,"about_ca_system_score_codex":0.000018689207,"about_ca_system_score_gemma":0.000040239713,"threshold_uncertainty_score":0.6904381},"labels":[],"label_agreement":null},{"id":"W2887159463","doi":"10.1158/1538-7445.am2018-1751","title":"Abstract 1751: MSC-1 is a first-in-class humanized monoclonal antibody that modulates the tumor microenvironment by inhibiting a novel cancer immunotherapy target, LIF","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Tumor microenvironment; Leukemia inhibitory factor; Cancer; Immunotherapy; Tumor progression; Medicine; Biology; Immunology; Cytokine; Internal medicine; Interleukin 6","score_opus":0.07485835641612114,"score_gpt":0.3935851950193582,"score_spread":0.31872683860323703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887159463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838521,0.0044730837,0.00006218055,0.00990209,0.00021385537,0.000787705,0.00019953384,0.000044643304,0.00046480563],"genre_scores_gemma":[0.9947342,0.0014895201,0.00012953037,0.0012572114,0.00077643263,0.00039480504,0.000029993545,0.00009098171,0.0010973148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758595,0.000052714833,0.00037149896,0.00052549405,0.00071237725,0.0007519774],"domain_scores_gemma":[0.99896115,0.00019455423,0.00011473255,0.00039780987,0.00019840446,0.00013336196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006781399,0.00023517715,0.00033162688,0.00019296285,0.00046342288,0.00010937919,0.0002793426,0.000079066056,0.0049430304],"category_scores_gemma":[0.000048341026,0.00016983927,0.00014019037,0.00034262647,0.00042730907,0.00013380959,0.00011726224,0.0009009764,0.000077784985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046285265,0.00027658406,0.007055954,0.000059722734,0.000119430486,0.000016926122,0.0015055044,0.00003092078,0.9727695,0.000013273011,0.016845874,0.0008434504],"study_design_scores_gemma":[0.0024242124,0.00024930655,0.019749759,0.0008120222,0.00001534016,0.000019638881,0.0004924162,0.0016013514,0.814955,0.000037198693,0.159431,0.0002127578],"about_ca_topic_score_codex":0.008479731,"about_ca_topic_score_gemma":0.000517721,"teacher_disagreement_score":0.15781452,"about_ca_system_score_codex":0.00072926586,"about_ca_system_score_gemma":0.00028109795,"threshold_uncertainty_score":0.9981229},"labels":[],"label_agreement":null},{"id":"W2887174538","doi":"10.1158/1538-7445.am2018-lb-196","title":"Abstract LB-196: EGFR-mutant lung adenocarcinomas mutation profiles reveal ARID1A might be a novel tyrosine kinase resistance pathway","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"","keywords":"Cancer research; Biology; Afatinib; ARID1A; Epidermal growth factor receptor; T790M; Gefitinib; Erlotinib; Lung cancer; Frameshift mutation; PTEN; Mutation; Cancer; Genetics; Gene; Medicine; PI3K/AKT/mTOR pathway; Signal transduction; Oncology","score_opus":0.07828186150283632,"score_gpt":0.3875666327799134,"score_spread":0.30928477127707704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887174538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730721,0.009303125,0.00047341405,0.009531153,0.0006336871,0.0018860241,0.00035819813,0.00012639276,0.0046159],"genre_scores_gemma":[0.9871287,0.00039613928,0.0009340895,0.00062669086,0.0021174913,0.0005278196,0.0000740431,0.00009413933,0.008100911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964917,0.000078866564,0.00044876375,0.0007723739,0.0012955478,0.00091276295],"domain_scores_gemma":[0.9975552,0.00012063435,0.00013371796,0.0007232382,0.0010846065,0.000382577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011205339,0.0002760303,0.00042067457,0.00033477292,0.0004308097,0.00010302143,0.0002836905,0.00019148018,0.0016547049],"category_scores_gemma":[0.00014792696,0.00023638642,0.00012322118,0.0008684449,0.0004275082,0.0001877136,0.000088356304,0.000727691,0.00006972853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027148472,0.0002462397,0.000551095,0.00051438855,0.00009900976,0.00030500768,0.00137201,0.0000015173996,0.9702707,0.004032551,0.015479057,0.0044135903],"study_design_scores_gemma":[0.0043652067,0.0008239507,0.02177356,0.0012018229,0.000045371555,0.000043779037,0.00047262266,0.00011009339,0.8874865,0.00089298317,0.082387395,0.00039668925],"about_ca_topic_score_codex":0.0012628452,"about_ca_topic_score_gemma":0.0012296742,"teacher_disagreement_score":0.08278416,"about_ca_system_score_codex":0.0010214016,"about_ca_system_score_gemma":0.0013493316,"threshold_uncertainty_score":0.9992579},"labels":[],"label_agreement":null},{"id":"W2887204597","doi":"10.1158/1538-7445.am2018-1864","title":"Abstract 1864: Pharmacologic inhibition of NAMPT sensitizes pancreatic cancer cells to the antineoplastic effects of metformin","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Metformin; Pancreatic cancer; Cancer; Medicine; In vivo; Cancer research; Internal medicine; Cancer cell; Pharmacology; Oncology; Endocrinology; Diabetes mellitus; Biology","score_opus":0.027984692733342195,"score_gpt":0.3679192102310504,"score_spread":0.3399345174977082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887204597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93795615,0.060586244,0.000045842968,0.000057121066,0.0004543988,0.00053321436,0.00007785826,0.000005145672,0.00028401174],"genre_scores_gemma":[0.9679898,0.030344693,0.000054097058,0.00021032734,0.00090107595,0.0002480008,0.000010246318,0.000021085969,0.00022064237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984623,0.00016959589,0.0002472655,0.00031095077,0.000385852,0.000424036],"domain_scores_gemma":[0.9987431,0.0001476996,0.000103864855,0.00031037867,0.0005909378,0.000104004655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006859235,0.00013754443,0.00025335667,0.00009660698,0.000106166815,0.000014028389,0.00021961419,0.00009893533,0.0002838757],"category_scores_gemma":[0.00018674353,0.000097198565,0.00007911478,0.0003467696,0.00035205742,0.0000058239016,0.00013427962,0.0001587203,0.000020236586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021833698,0.000042248754,0.00013677923,0.0003287764,0.00008320325,0.0000022344987,0.00015984729,0.00005413242,0.9617488,0.000012953086,0.011272944,0.025939746],"study_design_scores_gemma":[0.0005044631,0.00030659308,0.0012659368,0.00014744478,0.00004487076,6.751694e-7,0.000060160073,0.000015523668,0.96008104,0.000030035728,0.03743763,0.000105605446],"about_ca_topic_score_codex":0.000630591,"about_ca_topic_score_gemma":0.00033763718,"teacher_disagreement_score":0.03024155,"about_ca_system_score_codex":0.000037422866,"about_ca_system_score_gemma":0.0003094584,"threshold_uncertainty_score":0.39636424},"labels":[],"label_agreement":null},{"id":"W2887228234","doi":"10.1158/1538-7445.am2018-4118","title":"Abstract 4118: Rapid, non-subjective characterization of disease in preclinical cancer research using desorption electrospray ionization mass spectrometry","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Hospital for Sick Children; University Health Network","funders":"","keywords":"Breast cancer; Cancer; Pathology; Mass spectrometry; Medicine; Grading (engineering); Prostate cancer; Biomedical engineering; Chemistry; Chromatography; Biology; Internal medicine","score_opus":0.10610411922141265,"score_gpt":0.45757770463432695,"score_spread":0.3514735854129143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887228234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422455,0.00023279316,0.0020795658,0.00040340918,0.000054607135,0.0006260535,0.0001423641,0.00006055664,0.0021761064],"genre_scores_gemma":[0.9950071,0.0020470186,0.00076673285,0.000012065378,0.00087297306,0.000716788,0.00010487111,0.000061603794,0.00041086142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964681,0.00018918798,0.00057883427,0.00074648985,0.0011553206,0.00086202926],"domain_scores_gemma":[0.99725974,0.00026508683,0.00019926859,0.0006523443,0.0013955828,0.00022795411],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00206952,0.00019050932,0.0003022436,0.00087547075,0.0003355836,0.000093913215,0.00050056074,0.0002446734,0.007089856],"category_scores_gemma":[0.00034718943,0.00020002191,0.000081379745,0.0034499406,0.0005304894,0.00027445395,0.00013924888,0.0011622171,0.00002144696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045325988,0.00028416413,0.035610445,0.00019748359,0.000028259283,0.000002402287,0.000113574395,0.000013107048,0.96042854,0.00078404474,0.00005969028,0.002025054],"study_design_scores_gemma":[0.0005104207,0.000114695526,0.10496013,0.0003599071,0.000012975959,4.3186358e-7,0.000052319112,0.0018790333,0.8889127,0.002540831,0.00045058952,0.00020598585],"about_ca_topic_score_codex":0.0014689305,"about_ca_topic_score_gemma":0.00016710414,"teacher_disagreement_score":0.071515836,"about_ca_system_score_codex":0.0016491327,"about_ca_system_score_gemma":0.0009106443,"threshold_uncertainty_score":0.9938178},"labels":[],"label_agreement":null},{"id":"W2887233605","doi":"10.1158/1538-7445.am2018-3689","title":"Abstract 3689: Identification of candidate therapeutic targets in BCG unresponsive bladder cancer- inflammatory subtypes of BCG unresponsive bladder cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Immunotherapy; Transcriptome; Cystectomy; Cancer; Immune system; Medicine; Cancer research; Immunology; Oncology; Internal medicine; Biology; Gene; Gene expression","score_opus":0.058954576434500194,"score_gpt":0.4182035846874836,"score_spread":0.3592490082529834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887233605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763682,0.01831116,0.000015476688,0.001464635,0.00057241955,0.0016889304,0.0005643965,0.00003591343,0.0009788908],"genre_scores_gemma":[0.98959947,0.0058849053,0.000019005789,0.0002512612,0.00052492076,0.0009790096,0.00003643814,0.000093419294,0.002611601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956033,0.00042819418,0.00096125965,0.0007683166,0.0013235987,0.0009153247],"domain_scores_gemma":[0.9957325,0.00041732914,0.0003995418,0.00083928386,0.0023283823,0.00028297983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011254833,0.00037248453,0.00075113494,0.0009126442,0.00017995844,0.000034156412,0.00043079068,0.0002768873,0.0043253787],"category_scores_gemma":[0.00026788164,0.0003248402,0.00016358576,0.0012872374,0.0011615719,0.00024619044,0.00012559061,0.00067167555,0.00006969277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013528833,0.00056033477,0.10321501,0.0007957731,0.0016453444,0.00011071346,0.008699682,0.00012983281,0.8410468,0.00020188437,0.0061367634,0.023928998],"study_design_scores_gemma":[0.0030275853,0.0005122981,0.44564432,0.00060916774,0.0001805171,0.0000048473116,0.00094931416,0.000052567877,0.54417723,0.00034937958,0.0042255786,0.00026716688],"about_ca_topic_score_codex":0.018810812,"about_ca_topic_score_gemma":0.013446898,"teacher_disagreement_score":0.3424293,"about_ca_system_score_codex":0.0010265923,"about_ca_system_score_gemma":0.004467555,"threshold_uncertainty_score":0.99992037},"labels":[],"label_agreement":null},{"id":"W2887237327","doi":"10.1158/1538-7445.am2018-773","title":"Abstract 773: A heterochromatin gene signature unveils HP1α mediating neuroendocrine prostate cancer development and aggressiveness","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Biology; Transdifferentiation; Heterochromatin; Cancer research; Histone; Prostate cancer; Ectopic expression; LNCaP; Gene silencing; Cell biology; Chromatin; Genetics; Gene; Cancer; Cell","score_opus":0.06771988756278126,"score_gpt":0.41690073912139464,"score_spread":0.3491808515586134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887237327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97183853,0.022443753,0.0000047577796,0.0035813192,0.00025806084,0.0013663346,0.000074026175,0.00008028865,0.00035290906],"genre_scores_gemma":[0.986878,0.007247861,0.0004052318,0.00026943363,0.000957543,0.0013265717,0.00007019363,0.000081912476,0.0027632788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99610335,0.00013810299,0.0003980488,0.00078084524,0.0013116673,0.0012680154],"domain_scores_gemma":[0.99784344,0.00018333658,0.000115958275,0.00038800717,0.0009047074,0.00056453526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676531,0.00031098904,0.0004356894,0.00028289197,0.00060566835,0.00012706278,0.00024437613,0.00009494223,0.0006682665],"category_scores_gemma":[0.00017582282,0.00023308661,0.000055894543,0.0007261378,0.0006952473,0.0001821147,0.0003139778,0.0010926272,0.00005731189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023843697,0.0002652409,0.034733,0.0015142368,0.00040823765,0.0017408056,0.0052617877,0.000009448237,0.6183803,0.000010679631,0.003912435,0.33137944],"study_design_scores_gemma":[0.004141193,0.0005155855,0.065417,0.0016175578,0.000032917545,0.00007464445,0.00033696144,0.00009953489,0.9128042,0.0000754499,0.014556606,0.00032838722],"about_ca_topic_score_codex":0.0006350078,"about_ca_topic_score_gemma":0.00025681301,"teacher_disagreement_score":0.33105105,"about_ca_system_score_codex":0.0006464636,"about_ca_system_score_gemma":0.0016397266,"threshold_uncertainty_score":0.95049965},"labels":[],"label_agreement":null},{"id":"W2887246354","doi":"10.1158/1538-7445.am2018-2991","title":"Abstract 2991: Cytoplasmic mislocalization of CTCF by NPM1c in acute myeloid leukemia resulting in inhibited CTCF regulatory functions generating aberrant genetic and epigenetic profiles","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"CTCF; Epigenetics; Biology; Cytoplasm; Cell biology; Molecular biology; Cancer research; Gene expression; Genetics; Gene; Enhancer","score_opus":0.03573272656724166,"score_gpt":0.34782331184081655,"score_spread":0.3120905852735749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887246354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943263,0.002774906,0.00013260084,0.00074954855,0.000084630505,0.0013784902,0.00007632136,0.00003678986,0.0004404183],"genre_scores_gemma":[0.99530935,0.0017171497,0.0009624016,0.00008349593,0.00031209845,0.00033336965,0.000102535654,0.00008261094,0.001096999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99571174,0.00037687365,0.0009330676,0.0008369615,0.0011047233,0.0010366233],"domain_scores_gemma":[0.99789125,0.00031989848,0.00015922125,0.0005876304,0.000752512,0.00028947936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020249232,0.00027300918,0.000523422,0.0011378229,0.00024963112,0.00006115541,0.00024805966,0.0003214637,0.00020618114],"category_scores_gemma":[0.0006628609,0.00026306068,0.000055084463,0.001978685,0.0009806892,0.00016972165,0.0002328348,0.0011809677,0.000027019321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067080586,0.00008247749,0.05818309,0.00040191357,0.000062549676,0.00007603274,0.0012555475,0.0004563269,0.921727,0.0000104438495,0.005021221,0.012052617],"study_design_scores_gemma":[0.0064757275,0.00069744186,0.37915927,0.0017930417,0.000047389563,0.00006254008,0.0012285174,0.034111816,0.57485,0.000085365486,0.0010435391,0.0004453176],"about_ca_topic_score_codex":0.0045091156,"about_ca_topic_score_gemma":0.002114295,"teacher_disagreement_score":0.34687695,"about_ca_system_score_codex":0.0022916822,"about_ca_system_score_gemma":0.0021592416,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2887246750","doi":"10.1158/1538-7445.am2018-3192","title":"Abstract 3192: Aptamers, antibodies and radiotherapy for the treatment of DIPG","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Aptamer; Antibody; Immune system; Context (archaeology); Medicine; Agonist; Immunotherapy; Cancer research; Cancer; Immunology; Cancer immunotherapy; Pharmacology; Receptor; Internal medicine; Biology; Molecular biology","score_opus":0.1292210772869072,"score_gpt":0.4728928234638105,"score_spread":0.3436717461769033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887246750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96549314,0.02918615,0.000004376886,0.004024627,0.00007322172,0.0009002064,0.00003394335,0.000006754483,0.00027755255],"genre_scores_gemma":[0.9608207,0.037930526,0.00014799245,0.00004175462,0.00034895027,0.00038153128,0.0000033382387,0.000013107049,0.00031214015],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993127,0.000015600102,0.00009506408,0.00015880726,0.00019773885,0.00022006196],"domain_scores_gemma":[0.99913895,0.00035964913,0.000023013039,0.00021729605,0.00019529225,0.00006576934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016920538,0.000074016556,0.00017135002,0.00007174143,0.00015058539,0.0000155388,0.000045519522,0.000029562703,0.0001890565],"category_scores_gemma":[0.00002081215,0.000038076363,0.000057808298,0.00010424979,0.000430784,0.00001838171,0.000007812385,0.000037369144,0.0000035782798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016400547,0.0013517744,0.10651555,0.00018671744,0.00143667,0.000025829939,0.003619745,0.0000010126003,0.11015501,0.0007641019,0.016077623,0.7582259],"study_design_scores_gemma":[0.0059533766,0.005231273,0.4577484,0.00015670447,0.00012222973,0.00000789725,0.0006023898,0.000086755375,0.26279846,0.00015534864,0.26704562,0.00009152198],"about_ca_topic_score_codex":0.00086863514,"about_ca_topic_score_gemma":0.00014145792,"teacher_disagreement_score":0.75813437,"about_ca_system_score_codex":0.00012975313,"about_ca_system_score_gemma":0.000084557,"threshold_uncertainty_score":0.20700361},"labels":[],"label_agreement":null},{"id":"W2887247967","doi":"10.1158/1538-7445.am2018-2663","title":"Abstract 2663: CR42-24, a novel colchicine derivative, a therapeutic for bladder cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Colchicine; Tubulin; Bladder cancer; Cancer; Cancer research; Medicine; Paclitaxel; Gemcitabine; Cisplatin; Prostate cancer; Chemotherapy; Pharmacology; Microtubule; Internal medicine; Biology; Cell biology","score_opus":0.10520226637106564,"score_gpt":0.4304339625024371,"score_spread":0.3252316961313715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887247967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492583,0.025875205,0.003390492,0.003268877,0.0113101015,0.0022344147,0.0007149833,0.0000454083,0.003902177],"genre_scores_gemma":[0.9361995,0.004036598,0.0003686364,0.0016231398,0.04567679,0.0020858988,0.0000706689,0.00010298518,0.00983582],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800336,0.00004784818,0.0002320512,0.0006040718,0.0003601403,0.00075252773],"domain_scores_gemma":[0.9982791,0.0000537843,0.00006970934,0.00047682808,0.0009437341,0.00017684595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053780497,0.00020541491,0.00023925448,0.00010647187,0.00030940433,0.000055618235,0.0003820715,0.00018637432,0.0006380295],"category_scores_gemma":[0.00011214427,0.00018087075,0.000117765645,0.00029303113,0.00052284804,0.000008937755,0.00012875313,0.00024836906,0.000018275223],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061825477,0.00007598312,0.00023141768,0.000057076013,0.00016974386,5.73937e-8,0.00020209533,0.000007775008,0.8375129,0.00028993844,0.1474352,0.013399553],"study_design_scores_gemma":[0.0014839602,0.00025982386,0.004208079,0.000041710875,0.000021449652,0.0000015379105,0.00011667054,0.000021549164,0.21022929,0.00015375148,0.7832626,0.0001995437],"about_ca_topic_score_codex":0.0011496826,"about_ca_topic_score_gemma":0.003143619,"teacher_disagreement_score":0.6358274,"about_ca_system_score_codex":0.000092898525,"about_ca_system_score_gemma":0.00093102636,"threshold_uncertainty_score":0.7375695},"labels":[],"label_agreement":null},{"id":"W2887266288","doi":"10.1158/1538-7445.am2018-3269","title":"Abstract 3269: Metformin to prevent metabolic syndrome associated with androgen deprivation therapy (ADT): Metabolic analysis from a placebo-controlled study of metformin in non-diabetic men initiating ADT for advanced prostate cancer (PCa)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Metformin; Medicine; Internal medicine; Insulin resistance; Endocrinology; Metabolic syndrome; Hyperinsulinemia; Placebo; Insulin; Cohort; Prostate cancer; Diabetes mellitus; Cancer","score_opus":0.030412197846573286,"score_gpt":0.3620606462872641,"score_spread":0.3316484484406908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887266288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250224,0.06891547,0.00007171712,0.00002303815,0.00007644302,0.005431958,0.0003887875,0.000013019703,0.00005711573],"genre_scores_gemma":[0.9738623,0.013982252,0.00028617113,0.00008029637,0.00018704096,0.011223616,0.0001798189,0.000078822726,0.00011967352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959886,0.00042530618,0.00084413687,0.0009552015,0.0008385652,0.0009481723],"domain_scores_gemma":[0.99733084,0.00021641944,0.0004513958,0.000685026,0.0010894556,0.00022688581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025384172,0.00039823353,0.0013866451,0.00069651945,0.00019738798,0.00006748288,0.0005438897,0.00018684467,0.00014864425],"category_scores_gemma":[0.00043448535,0.00032076717,0.00022764535,0.0020398386,0.00012881176,0.00005070999,0.00014396486,0.00026550793,0.0000023659977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027461145,0.0029106906,0.05655841,0.00013885417,0.021884384,0.000015881684,0.009304051,0.00485697,0.61927485,0.000020654508,0.0002507665,0.25732335],"study_design_scores_gemma":[0.039123155,0.0023815497,0.0861089,0.00020207332,0.0013161073,6.0065435e-7,0.0022700913,0.00063931127,0.8634516,0.00012707335,0.003587248,0.0007922732],"about_ca_topic_score_codex":0.0025079611,"about_ca_topic_score_gemma":0.010160037,"teacher_disagreement_score":0.25653106,"about_ca_system_score_codex":0.00014263025,"about_ca_system_score_gemma":0.00061735295,"threshold_uncertainty_score":0.9999244},"labels":[],"label_agreement":null},{"id":"W2887291669","doi":"10.1158/1538-7445.am2018-5258","title":"Abstract 5258: Determinants of impaired lung function among never-smokers in the UK Biobank Cohort","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Vital capacity; Cohort; Internal medicine; Pulmonary function testing; Logistic regression; Cohort study; Demography; Lung; Lung function; Diffusing capacity","score_opus":0.052114571798593,"score_gpt":0.4016197857255518,"score_spread":0.34950521392695877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887291669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919767,0.0012698191,0.0000037329094,0.00040478547,0.000214303,0.0016843888,0.000049679835,0.000021369504,0.0043752417],"genre_scores_gemma":[0.99819547,0.00024335689,0.000009161883,0.00007801734,0.0005058811,0.000351262,0.00002007534,0.00003799551,0.0005587625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960895,0.0002872591,0.00042012104,0.000538904,0.0017481183,0.00091606216],"domain_scores_gemma":[0.99785304,0.00026696763,0.00008759597,0.0008184692,0.00071681937,0.0002571304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002350584,0.00018471866,0.00035180326,0.000504452,0.00020908866,0.000040300303,0.00046262957,0.00015214531,0.0022375272],"category_scores_gemma":[0.00027256607,0.00013607234,0.00012599182,0.001337271,0.0015225426,0.00023340614,0.00017285581,0.0008083213,0.000070213566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001297151,0.00016997913,0.9702023,0.00049577333,0.000075161086,0.0001584545,0.0003308326,0.0000025488775,0.0075070886,0.000024464585,0.0054382267,0.014297993],"study_design_scores_gemma":[0.0013136315,0.00026306155,0.9911803,0.00040875064,0.00003993331,0.000011229084,0.0008300465,0.0005262227,0.0043628975,0.0001123537,0.00082954,0.000122041114],"about_ca_topic_score_codex":0.007857008,"about_ca_topic_score_gemma":0.0016499755,"teacher_disagreement_score":0.020977966,"about_ca_system_score_codex":0.0010488009,"about_ca_system_score_gemma":0.0011968198,"threshold_uncertainty_score":0.99874973},"labels":[],"label_agreement":null},{"id":"W2887295820","doi":"10.1158/1538-7445.am2018-3111","title":"Abstract 3111: Expansion of mouse prostate epithelial stem cells in serum-free ProstaCult Organoid Growth Medium","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; Cell biology; Dispase; Cell culture; Biology; Epithelium; Cell; Cell growth; Stem cell; Cell type; Collagenase; Chemistry; Biochemistry","score_opus":0.04617059369655559,"score_gpt":0.35341971495564933,"score_spread":0.30724912125909376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887295820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943924,0.0017653476,0.000032051164,0.0022414925,0.00039358463,0.0008575575,0.00010781831,0.000045923043,0.0001638106],"genre_scores_gemma":[0.98095506,0.0005992959,0.00018531845,0.000020771724,0.0009485184,0.000098555895,0.000009262496,0.00005347858,0.017129727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977134,0.00008395258,0.0003583163,0.0003650637,0.0009224124,0.0005568845],"domain_scores_gemma":[0.99833125,0.00007733711,0.000055909244,0.0004685634,0.00082732615,0.00023961502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009824547,0.00017068269,0.00038040115,0.0003794703,0.00007464883,0.000011310375,0.0002317128,0.00012010471,0.00027401565],"category_scores_gemma":[0.00017088704,0.00012160614,0.00003983123,0.00070687727,0.00047206695,0.00007043578,0.000112338384,0.0006231865,0.000053486725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038337286,0.00009632153,0.0024136126,0.0006308958,0.000028242277,0.000072158786,0.002464377,0.000018003444,0.9865931,0.00004347942,0.0050684353,0.0021879997],"study_design_scores_gemma":[0.0026181214,0.0007678646,0.010801823,0.0006544592,0.000009913357,0.0000064260626,0.000503816,0.00004730272,0.9815634,0.0000144955575,0.002897251,0.00011513547],"about_ca_topic_score_codex":0.0005677196,"about_ca_topic_score_gemma":0.00013316434,"teacher_disagreement_score":0.016965916,"about_ca_system_score_codex":0.00022928006,"about_ca_system_score_gemma":0.00054628303,"threshold_uncertainty_score":0.49589545},"labels":[],"label_agreement":null},{"id":"W2887304191","doi":"10.1158/1538-7445.am2018-3914","title":"Abstract 3914: ZW49, a HER2-targeted biparatopic antibody-drug conjugate for the treatment of HER2-expressing cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-drug conjugate; Trastuzumab; Medicine; In vivo; Antibody; Cancer research; Cancer; Conjugate; Therapeutic index; Cytotoxicity; In vitro; Pharmacology; Breast cancer; Drug; Monoclonal antibody; Immunology; Internal medicine; Chemistry; Biology; Biochemistry","score_opus":0.11878429002041489,"score_gpt":0.472216537494243,"score_spread":0.3534322474738281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887304191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97518927,0.014105154,0.000025589172,0.005828938,0.00031626332,0.0016179157,0.0001927144,0.000027496482,0.0026966503],"genre_scores_gemma":[0.97769475,0.010240052,0.00019493118,0.00015737773,0.0015329667,0.00050196185,0.000043709642,0.000044977154,0.009589278],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723864,0.00011210554,0.00036951335,0.00045734298,0.0009065396,0.00091588456],"domain_scores_gemma":[0.9973629,0.0007494337,0.00008691668,0.00052762916,0.0009992075,0.00027392764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006982855,0.00022153834,0.00045132914,0.00019458082,0.0005663082,0.000058202466,0.00032364987,0.00009183742,0.0013034111],"category_scores_gemma":[0.00009405891,0.00013197928,0.00021573334,0.00047652362,0.0013223023,0.00007225317,0.000067659144,0.00031697526,0.000067219386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009785932,0.00090069405,0.029526213,0.001421437,0.0012963319,0.000107355474,0.005746413,0.00005384816,0.7730265,0.0006025259,0.04343566,0.13409708],"study_design_scores_gemma":[0.002757023,0.002040441,0.042180378,0.00048652652,0.00006697804,0.000010393866,0.00063431857,0.000753452,0.4628027,0.00020859204,0.48785436,0.000204827],"about_ca_topic_score_codex":0.017017417,"about_ca_topic_score_gemma":0.0014554431,"teacher_disagreement_score":0.4444187,"about_ca_system_score_codex":0.00047393184,"about_ca_system_score_gemma":0.0011799909,"threshold_uncertainty_score":0.99960953},"labels":[],"label_agreement":null},{"id":"W2887311716","doi":"10.1158/1538-7445.am2018-3133","title":"Abstract 3133: Reprogramming of tumor-associated macrophages by a short synthetic peptide eradicates ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beef Farmers of Ontario","funders":"","keywords":"Cancer research; Ovarian cancer; Tumor microenvironment; Macrophage polarization; Cytotoxic T cell; Cytokine; Immune system; Biology; Cancer; Ovarian tumor; Medicine; Immunology; Internal medicine; Macrophage; In vitro","score_opus":0.042405761705364885,"score_gpt":0.3674562431069298,"score_spread":0.32505048140156495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887311716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562328,0.037811406,0.0000110340325,0.0005409548,0.0011201942,0.0005959246,0.00024072763,0.00010078536,0.003346209],"genre_scores_gemma":[0.9907677,0.0013352401,0.000039256225,0.00008604291,0.00014575692,0.00048990856,0.000051620744,0.00007197956,0.007012491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968412,0.00038663665,0.0005481392,0.00074214773,0.00024865544,0.0012332029],"domain_scores_gemma":[0.9978633,0.00039682,0.00017267336,0.00077114714,0.00073056755,0.000065510016],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001724824,0.00026534422,0.0004917711,0.00024240681,0.00048183033,0.000044789664,0.00083563145,0.0003080013,0.008855289],"category_scores_gemma":[0.00039229015,0.00024772767,0.00013141624,0.00068438076,0.0023336818,0.00010780343,0.00027142654,0.0010578352,0.00034674178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002827087,0.00018152074,0.0052091707,0.000089513436,0.00041426078,0.000013452643,0.00065055967,0.0000020764862,0.90527654,0.000040480383,0.06599655,0.021843169],"study_design_scores_gemma":[0.0007310771,0.00023275583,0.0075141913,0.00040818402,0.000042054377,0.000010291368,0.00028549408,0.0000028470915,0.9013572,0.000096643176,0.08904985,0.00026942132],"about_ca_topic_score_codex":0.009038693,"about_ca_topic_score_gemma":0.00069521496,"teacher_disagreement_score":0.036476165,"about_ca_system_score_codex":0.00058598595,"about_ca_system_score_gemma":0.0005800933,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W2887318173","doi":"10.1158/1538-7445.am2018-4765","title":"Abstract 4765: The impact of the Medicare Part D donut hole closure on use and out-of-pocket costs for aromatase inhibitors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Taxation and Legal Issues","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medicare Part D; Medical prescription; Prescription drug; Quarter (Canadian coin); Breast cancer; Family medicine; Population; Demography; Subsidy; Generic drug; Cancer; Environmental health; Drug; Internal medicine; Nursing; Political science; Law; Psychiatry","score_opus":0.11894710045867443,"score_gpt":0.4079616832422098,"score_spread":0.2890145827835354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887318173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955458,0.00020864453,7.955249e-7,0.0017265895,0.0002924237,0.0004936352,0.000102153295,0.000010525878,0.0016194279],"genre_scores_gemma":[0.99818003,0.000029836767,0.000002282736,0.00018060833,0.0012627402,0.000048738366,0.000014594333,0.000013015434,0.00026816034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901426,0.00003177464,0.00016518279,0.00015145064,0.0004211212,0.00021618573],"domain_scores_gemma":[0.9988614,0.00022278712,0.0001512049,0.00028894,0.00045759155,0.00001808808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008241143,0.00008352482,0.00011788338,0.00009055971,0.00022486641,0.00014506326,0.00024910012,0.00004977736,0.0003050635],"category_scores_gemma":[0.0007208819,0.00004173454,0.00007194396,0.0002762531,0.00040904147,0.00030927846,0.000114649716,0.00017907291,0.000017774464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006001137,0.00013998826,0.11616926,0.0003654677,0.0001190387,0.0000020210903,0.0011601943,0.000023163677,0.006742283,0.002933043,0.85892874,0.01281669],"study_design_scores_gemma":[0.0012152283,0.00014494531,0.37177214,0.0006988828,0.00003031372,1.7833236e-7,0.0012540325,0.00016509659,0.014727181,0.00056715833,0.60924536,0.00017946646],"about_ca_topic_score_codex":0.006246314,"about_ca_topic_score_gemma":0.0010622334,"teacher_disagreement_score":0.2556029,"about_ca_system_score_codex":0.000040476112,"about_ca_system_score_gemma":0.00007261858,"threshold_uncertainty_score":0.94426},"labels":[],"label_agreement":null},{"id":"W2887326992","doi":"10.1158/1538-7445.am2018-2648","title":"Abstract 2648: Prognostic significance of thyroid hormone receptor-alpha-2 (THRα2) expression in triple-negative breast cancer: A TCGA study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Triple-negative breast cancer; Oncology; Internal medicine; Proportional hazards model; Thyroid; Hormone receptor; Hormone; Cancer; Thyroid hormone receptor; Cohort; Cancer research; Biology","score_opus":0.05822526624427419,"score_gpt":0.3890653003139894,"score_spread":0.3308400340697152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887326992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705095,0.004766307,0.00003383317,0.0008437841,0.0003719396,0.0052750306,0.00026888645,0.000073373696,0.0013158834],"genre_scores_gemma":[0.9943675,0.0017292899,0.00018543488,0.00004519257,0.0006633952,0.0024163923,0.00001632187,0.00010380955,0.00047265686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994913,0.0004482326,0.00077195984,0.001014051,0.001798459,0.0010543233],"domain_scores_gemma":[0.9966471,0.000331667,0.0002536533,0.0008860202,0.0014857606,0.00039576675],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016378004,0.0003574382,0.00075802166,0.00069177145,0.00019999016,0.00003845494,0.00048036405,0.00024816106,0.0012647666],"category_scores_gemma":[0.00069892337,0.00031719392,0.00012835124,0.0022292004,0.0008595025,0.00019314732,0.00022962259,0.0014442037,0.00009894769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059436206,0.0014325298,0.019279929,0.00023299184,0.00015163973,0.00011983782,0.0040820255,0.000028588865,0.9441391,0.0000068806903,0.0090669375,0.01551588],"study_design_scores_gemma":[0.012428081,0.0040997528,0.39935884,0.0025260563,0.00008014605,0.000016508173,0.0035752372,0.00008455297,0.57632905,0.000090239126,0.00093709707,0.00047441447],"about_ca_topic_score_codex":0.008027897,"about_ca_topic_score_gemma":0.0018182131,"teacher_disagreement_score":0.3800789,"about_ca_system_score_codex":0.0014522675,"about_ca_system_score_gemma":0.0021361336,"threshold_uncertainty_score":0.999928},"labels":[],"label_agreement":null},{"id":"W2887327758","doi":"10.1158/1538-7445.am2018-lb-265","title":"Abstract LB-265: The novel oral Chk1 inhibitor, SRA737, is active in both PARP inhibitor resistant and <i>CCNE1</i> amplified high grade serous ovarian cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alterra Power (Canada)","funders":"","keywords":"Cancer research; CHEK1; PARP inhibitor; Olaparib; Cancer; Medicine; Cell cycle; Biology; Cell cycle checkpoint; Internal medicine; Polymerase; Poly ADP ribose polymerase; DNA; Genetics","score_opus":0.11130941383387813,"score_gpt":0.4127934726606565,"score_spread":0.3014840588267784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887327758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750598,0.0014787499,0.00003061952,0.01790418,0.0008291277,0.0017589101,0.0003974269,0.00008849515,0.002452671],"genre_scores_gemma":[0.9911093,0.0012149626,0.0002088287,0.0030722693,0.0024292422,0.0008017433,0.000025676185,0.00011114845,0.0010268432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99520636,0.00023773347,0.0006430118,0.0010527582,0.0015431199,0.0013169987],"domain_scores_gemma":[0.99737734,0.00039926113,0.00018591977,0.0009325369,0.0006406141,0.00046430706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016191612,0.0004154786,0.00061639823,0.00043229526,0.00058923877,0.00016612715,0.00041052778,0.00030868908,0.00087391725],"category_scores_gemma":[0.00015859914,0.00032207364,0.0001052058,0.0014936792,0.0017324099,0.00030204334,0.00019974049,0.0016619009,0.00005821275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013749972,0.0005339019,0.003961353,0.00035463224,0.00040458026,0.00018003883,0.0098713385,0.00001809965,0.8578236,0.0015492111,0.09854068,0.013012603],"study_design_scores_gemma":[0.020788763,0.002003607,0.17357507,0.0023894696,0.0000925178,0.00007953483,0.0039280187,0.00008378569,0.59166235,0.0025527258,0.20176592,0.0010782483],"about_ca_topic_score_codex":0.025202418,"about_ca_topic_score_gemma":0.009242092,"teacher_disagreement_score":0.26616126,"about_ca_system_score_codex":0.0027331659,"about_ca_system_score_gemma":0.002142579,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W2887351230","doi":"10.1158/1538-7445.am2018-2377","title":"Abstract 2377: Design, synthesis, and characterization of 4-aminopyrazole quinazolines as potent inhibitors of G protein-coupled receptor kinase GRK6 for the potential treatment of multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Kinome; G protein-coupled receptor kinase; Kinase; Gene silencing; Cancer research; Quinazoline; Biology; Chemistry; Pharmacology; Cell biology; Signal transduction; Biochemistry; Gene; G protein-coupled receptor; Combinatorial chemistry","score_opus":0.04760173757001532,"score_gpt":0.3384234975738504,"score_spread":0.2908217600038351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887351230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948507,0.0012361174,0.0021769607,0.00020367689,0.00012421745,0.0012319752,0.00016874932,0.0000025281379,0.0000050733734],"genre_scores_gemma":[0.9964394,0.002234844,0.00023826354,0.00000889012,0.00034979705,0.00054624665,0.00003346484,0.000022590362,0.00012652582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904305,0.00005334945,0.00024703838,0.00023332068,0.00020947591,0.0002137546],"domain_scores_gemma":[0.99894094,0.000059239566,0.00015362656,0.0002566844,0.00053832517,0.00005118714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039698902,0.00011289614,0.00018039002,0.000062171086,0.00009950046,0.000010673681,0.00013334726,0.000096744785,0.00003404372],"category_scores_gemma":[0.00007026096,0.00008161452,0.00007541009,0.00009293019,0.00027387746,0.0000048232537,0.000049838207,0.00003559903,5.960268e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016297824,0.00013934154,0.000041056286,0.000095853815,0.00010673739,2.6259966e-7,0.00011954656,0.000008017737,0.9486185,0.000028177968,0.00001413748,0.049198598],"study_design_scores_gemma":[0.0007566726,0.0015923851,0.0011074564,0.000063692394,0.000028890927,7.8586436e-7,0.000117127376,0.00028477507,0.99358374,0.00004441514,0.0023415275,0.000078560275],"about_ca_topic_score_codex":0.00041423077,"about_ca_topic_score_gemma":0.000057928704,"teacher_disagreement_score":0.049120035,"about_ca_system_score_codex":0.000035467434,"about_ca_system_score_gemma":0.00022778398,"threshold_uncertainty_score":0.33281434},"labels":[],"label_agreement":null},{"id":"W2887356477","doi":"10.1158/1538-7445.am2018-5489","title":"Abstract 5489: Characterization of mitochondrial STAT3 (mitostat3) function and the mitoStat3 interactome as a therapeutic strategy for multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"STAT3; Biology; Transfection; Gene knockdown; Cancer cell; Cell biology; Transcription factor; Cell culture; Cancer research; Molecular biology; Signal transduction; Cancer; Genetics; Gene","score_opus":0.058783121034714024,"score_gpt":0.3751009235972814,"score_spread":0.3163178025625674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887356477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426234,0.0019376866,0.0004406012,0.0005796049,0.0012899922,0.0010736044,0.00015332032,0.00002228267,0.00024056525],"genre_scores_gemma":[0.9959001,0.00046559682,0.0000074010945,0.000117844116,0.00022724838,0.00029675034,0.00010753937,0.000025860478,0.0028516408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983583,0.0004753824,0.00033472336,0.00029320415,0.00009814133,0.00044023292],"domain_scores_gemma":[0.9979914,0.000991967,0.00013260519,0.00027068154,0.00058750034,0.000025880083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006318761,0.00015001163,0.0002570852,0.00021768195,0.000338947,0.00006236205,0.0002327435,0.00016648765,0.0009414154],"category_scores_gemma":[0.0002869648,0.000101779304,0.00008149943,0.00019786556,0.0012063168,0.00016374445,0.00008078719,0.00038154953,0.000110215595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030721117,0.000063786894,0.00014266054,0.000057819936,0.00021600745,3.923017e-7,0.0011889641,2.4763338e-7,0.93713665,0.00088089984,0.0005839573,0.029007489],"study_design_scores_gemma":[0.0068790005,0.001900987,0.024713159,0.00012430882,0.0000370212,0.000011269053,0.0013100023,0.000024517989,0.9116484,0.00062431337,0.0525679,0.0001591205],"about_ca_topic_score_codex":0.00054155587,"about_ca_topic_score_gemma":0.00014527314,"teacher_disagreement_score":0.05198394,"about_ca_system_score_codex":0.00005863806,"about_ca_system_score_gemma":0.0002562341,"threshold_uncertainty_score":0.99997187},"labels":[],"label_agreement":null},{"id":"W2887359485","doi":"10.1158/1538-7445.am2018-ct168","title":"Abstract CT168: Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed glioblastoma, MGMT-unmethylated","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Cancer research; Radiation therapy; Oncology; Radiosensitizer; Cancer; Internal medicine; DNA repair; Chemotherapy; Biology; DNA","score_opus":0.0366241965840547,"score_gpt":0.3865486394441334,"score_spread":0.34992444286007873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887359485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963542,0.00024533892,7.068196e-7,0.0002360291,0.00005528894,0.002858163,0.00002156444,0.000025687403,0.00020302406],"genre_scores_gemma":[0.9988732,0.00021034606,0.000020810267,0.000028815413,0.0001123666,0.00065650116,0.000022612872,0.00004695293,0.000028440461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748766,0.0001381515,0.00030665175,0.00045916135,0.0011186071,0.0004897822],"domain_scores_gemma":[0.998312,0.00018097066,0.00012714019,0.0004911874,0.00068026804,0.00020844537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037103944,0.00021102799,0.00040057377,0.00062258093,0.00016513694,0.000028451119,0.00013421274,0.00007997389,0.00037567512],"category_scores_gemma":[0.00006436092,0.00013747314,0.00003610264,0.0013574603,0.00020620361,0.00016612548,0.00003635299,0.00031469815,0.000021976326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012487408,0.020068757,0.89141196,0.00003509304,0.00039125924,0.00019440589,0.0034494929,0.000037507496,0.0032584316,0.000002245804,0.0005043236,0.068159126],"study_design_scores_gemma":[0.063097596,0.054872874,0.83886003,0.0002316672,0.000041561994,8.7077603e-7,0.0004471707,0.00001841924,0.041907497,0.0000026985313,0.00038159345,0.00013802483],"about_ca_topic_score_codex":0.0047731986,"about_ca_topic_score_gemma":0.0031737618,"teacher_disagreement_score":0.068021104,"about_ca_system_score_codex":0.0003758056,"about_ca_system_score_gemma":0.00032547492,"threshold_uncertainty_score":0.72156805},"labels":[],"label_agreement":null},{"id":"W2887362478","doi":"10.1158/1538-7445.am2018-1224","title":"Abstract 1224: Deep targeted tumor sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; KRAS; MLH1; MSH6; Colorectal cancer; Genetics; MSH2; Exome sequencing; Cancer; Indel; Sanger sequencing; DNA sequencing; Mutation; Gene; Cancer research; Single-nucleotide polymorphism; DNA mismatch repair; Genotype","score_opus":0.055956300712583264,"score_gpt":0.3988769542376575,"score_spread":0.3429206535250742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887362478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997128,0.001668834,0.00004097253,0.000024902263,0.000084392675,0.00053531874,0.0004700907,0.000003884333,0.000043586624],"genre_scores_gemma":[0.9983079,0.0008695985,0.00048852025,0.0000308704,0.0001619704,0.000088771085,0.000015500264,0.000027757864,0.000009130623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985617,0.00014300508,0.00033005993,0.0003809202,0.00028694927,0.00029736597],"domain_scores_gemma":[0.9983919,0.00021945476,0.00017500827,0.00026054517,0.0007889941,0.00016409588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005184951,0.00012597024,0.00025232352,0.00008465224,0.00013182197,0.000022021335,0.00018246514,0.00007834396,0.000051372346],"category_scores_gemma":[0.000872202,0.00011035572,0.00004826674,0.00024377156,0.00031527216,0.0000036003105,0.00015772735,0.00016018355,0.0000011645463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022919796,0.0001264759,0.65653986,0.000016171458,0.00021229859,0.00001059202,0.00037296658,0.00033270562,0.34118897,0.0000025775591,0.00015829281,0.0008098948],"study_design_scores_gemma":[0.0004459775,0.0018136743,0.55204654,0.000018259761,0.000042742566,0.0000010406964,0.00058783195,0.000018186425,0.44476908,0.0000092405,0.00013934432,0.00010807761],"about_ca_topic_score_codex":0.010321063,"about_ca_topic_score_gemma":0.013305339,"teacher_disagreement_score":0.104493305,"about_ca_system_score_codex":0.00008042633,"about_ca_system_score_gemma":0.0007100175,"threshold_uncertainty_score":0.9962693},"labels":[],"label_agreement":null},{"id":"W2887366161","doi":"10.1158/1538-7445.am2018-4401","title":"Abstract 4401: Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and novel therapeutic nanomedicine in head and neck cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"microRNA; Cancer research; Biology; Head and neck squamous-cell carcinoma; Cancer; Metastasis; DNA methylation; Gene expression; Gene; Head and neck cancer; Genetics","score_opus":0.04214341995578969,"score_gpt":0.3622951131057896,"score_spread":0.3201516931499999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887366161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98277557,0.016320627,0.000042800955,0.0003813754,0.00006097565,0.00026436886,0.00010298181,0.0000049503014,0.00004633371],"genre_scores_gemma":[0.9981554,0.00093713554,0.000030412217,0.00013112999,0.00021167712,0.000098152734,0.000081505306,0.000019245716,0.0003353415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875623,0.00005817292,0.00019819751,0.00049302675,0.0001904445,0.0003039173],"domain_scores_gemma":[0.99933946,0.00002935962,0.00005345202,0.00020520939,0.00024489814,0.00012763476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034372174,0.00014089982,0.00018923682,0.00025204633,0.00012595867,0.00007113388,0.00009003738,0.00009282703,0.0004739678],"category_scores_gemma":[0.00004727666,0.00012437848,0.00003216425,0.0003295672,0.00056354783,0.000011120185,0.000121765355,0.00015942853,0.000004190649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004009975,0.00003522514,0.027012968,0.000059757094,0.0002614112,0.0000031762577,0.00011198276,0.000011441985,0.9706274,0.000008410924,0.00050954235,0.000957644],"study_design_scores_gemma":[0.0011335374,0.000110853485,0.79711276,0.00007060431,0.00007120504,0.000008622316,0.00012978894,0.00016861949,0.19682689,0.000068274494,0.0041572805,0.00014158043],"about_ca_topic_score_codex":0.0025562597,"about_ca_topic_score_gemma":0.0039052381,"teacher_disagreement_score":0.77380055,"about_ca_system_score_codex":0.00008464154,"about_ca_system_score_gemma":0.00024979268,"threshold_uncertainty_score":0.51896155},"labels":[],"label_agreement":null},{"id":"W2887369800","doi":"10.1158/1538-7445.am2018-3228","title":"Abstract 3228: Tobacco smoking and circulating immune-related biomarkers in monozygotic twins","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cotinine; Medicine; Biomarker; Cohort; Internal medicine; Lung cancer; Oncology; Population; Cancer; Immune system; Immunology; DNA methylation; Nicotine; Physiology; Environmental health; Biology; Genetics","score_opus":0.0521168562836695,"score_gpt":0.3846754592809207,"score_spread":0.33255860299725115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887369800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881584,0.0080214515,0.000027122436,0.00011548755,0.000118145916,0.00018710752,0.0000039226534,0.000006145188,0.0027047468],"genre_scores_gemma":[0.998704,0.0009024243,0.00007169236,0.000014153557,0.0001604703,0.00002684419,0.00001711864,0.000021353451,0.0000819432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877244,0.000092763956,0.00023237703,0.00034376158,0.00019726912,0.00036140362],"domain_scores_gemma":[0.9994418,0.000035776575,0.000047301415,0.00024690453,0.00015371684,0.0000744762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010448634,0.00009424247,0.00009932442,0.00013833019,0.00014556859,0.000048795566,0.00013127767,0.00015755491,0.00006817385],"category_scores_gemma":[0.00017919071,0.0000961899,0.000031989908,0.00027929762,0.00020621545,0.000005663376,0.00013137599,0.00019392488,0.000006590257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033822715,0.000015264905,0.065017365,0.000014338184,0.00005105105,0.0000035010323,0.00014858146,0.000048269325,0.91261315,0.000023334282,0.00002715749,0.02200414],"study_design_scores_gemma":[0.00074294204,0.00016519871,0.40958208,0.00009838227,0.0000068200475,0.0000018975165,0.00022446769,0.0002883569,0.5861069,0.00050252915,0.0020677194,0.00021266949],"about_ca_topic_score_codex":0.0007192573,"about_ca_topic_score_gemma":0.00034532623,"teacher_disagreement_score":0.34456474,"about_ca_system_score_codex":0.000058111433,"about_ca_system_score_gemma":0.00011587197,"threshold_uncertainty_score":0.392251},"labels":[],"label_agreement":null},{"id":"W2887371040","doi":"10.1158/1538-7445.am2018-245","title":"Abstract 245: Genetic variation related to innate immunity and colorectal cancer risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Colorectal cancer; Medicine; Minor allele frequency; Oncology; Internal medicine; Cancer; Prostate cancer; Population; Logistic regression; Biology; Genetics; Genotype; Gene","score_opus":0.022405372175871196,"score_gpt":0.3669134868446983,"score_spread":0.34450811466882714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887371040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940271,0.0027448821,0.00064478547,0.0004658441,0.00030582683,0.00077543093,0.00011354875,0.000023971952,0.00089862617],"genre_scores_gemma":[0.99335635,0.0046611694,0.00025221947,0.00009888016,0.0003934049,0.0004400085,0.000030541945,0.000064475265,0.0007029627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972884,0.00037528833,0.00027214043,0.0006989405,0.0006035036,0.00076174684],"domain_scores_gemma":[0.99825186,0.000043191692,0.00007310773,0.0005016664,0.0008011004,0.00032910187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012140729,0.00019619154,0.000176237,0.00025880197,0.00048680688,0.00009910356,0.00040899857,0.00032851356,0.00057987485],"category_scores_gemma":[0.00044461302,0.00020101506,0.000055904715,0.00073672493,0.00035682644,0.000009205686,0.0005329102,0.0007250448,0.00009238179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048260478,0.00003737246,0.0006305838,0.000025063917,0.00013021218,0.000006794239,0.00037133766,0.00019992993,0.976442,0.000037345573,0.00201673,0.019620052],"study_design_scores_gemma":[0.0010082612,0.0009312101,0.10840291,0.00007327329,0.000021503964,0.000010650044,0.00008141854,0.0003209872,0.87226343,0.00048397138,0.016063401,0.00033898235],"about_ca_topic_score_codex":0.00507812,"about_ca_topic_score_gemma":0.0020617186,"teacher_disagreement_score":0.10777233,"about_ca_system_score_codex":0.00024405505,"about_ca_system_score_gemma":0.0006556702,"threshold_uncertainty_score":0.8197157},"labels":[],"label_agreement":null},{"id":"W2887376020","doi":"10.1158/1538-7445.am2018-1087","title":"Abstract 1087: Semaphorin 3C drives invasiveness in prostate cells through epithelial-to-mesenchymal transition and stemness","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Semaphorin; Paracrine signalling; Prostate cancer; Biology; Metastasis; Autocrine signalling; Cancer research; Cancer; Neuropilin; Tumor progression; Immunology; Neuropilin 1; Receptor; Vascular endothelial growth factor","score_opus":0.1302837593430808,"score_gpt":0.4034022535351657,"score_spread":0.2731184941920849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887376020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686426,0.00012748325,0.0000674204,0.001113865,0.00024595298,0.0007805618,0.000058066915,0.000031217216,0.0007111558],"genre_scores_gemma":[0.99788666,0.00073614036,0.000035744037,0.00051439204,0.00029112786,0.00020672698,9.894629e-7,0.0000317557,0.00029645523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972497,0.0003166226,0.00028363627,0.00073842687,0.0006960044,0.00071556476],"domain_scores_gemma":[0.998983,0.00040466504,0.000046805882,0.00024151913,0.00016239155,0.00016157288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007503518,0.00016683037,0.00021648941,0.00022177734,0.0003407717,0.00011585091,0.000296768,0.00006608843,0.0001858239],"category_scores_gemma":[0.00013780479,0.00015330108,0.000033668748,0.00091985177,0.00051358156,0.00043766573,0.00012341663,0.00043603362,0.00013859743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003344129,0.00005110115,0.0003352132,0.000109711465,0.0000020018854,0.00011511109,0.0044904845,0.00013285849,0.99153364,0.00021233106,0.0001309303,0.0025522208],"study_design_scores_gemma":[0.0004991163,0.00023561026,0.005143766,0.0002967367,0.0000017844247,0.0000068385534,0.000408213,0.000049600643,0.9897091,0.0007173269,0.0027506775,0.0001812615],"about_ca_topic_score_codex":0.0006755219,"about_ca_topic_score_gemma":0.00031069593,"teacher_disagreement_score":0.0048085526,"about_ca_system_score_codex":0.000110242,"about_ca_system_score_gemma":0.000233698,"threshold_uncertainty_score":0.62514365},"labels":[],"label_agreement":null},{"id":"W2887377336","doi":"10.1158/1538-7445.am2018-3515","title":"Abstract 3515: Down the rabbit hole with structural effects of FK866 in primary CLL B cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface; University of Manitoba","funders":"","keywords":"Biology; NAD+ kinase; Chlorambucil; Phalloidin; Cell biology; Nicotinamide phosphoribosyltransferase; Bendamustine; Cancer research; Molecular biology; Cytoskeleton; Cell; Biochemistry; Enzyme; Chronic lymphocytic leukemia; Immunology; Leukemia; Chemotherapy; Genetics","score_opus":0.015211718620195455,"score_gpt":0.33421676146001694,"score_spread":0.3190050428398215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887377336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952728,0.0018144997,0.0000191046,0.00032331783,0.00006017392,0.00047360378,0.000013675206,0.000003988317,0.0020188466],"genre_scores_gemma":[0.99845,0.0002915626,0.00007190791,0.00013521843,0.0002721918,0.00009978023,0.000021817224,0.000023193183,0.00063433417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826115,0.00014155092,0.0001566425,0.0003830021,0.000520157,0.00053749216],"domain_scores_gemma":[0.9990007,0.000062627696,0.000036987403,0.0004914117,0.00029980508,0.00010846259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048634902,0.00012788657,0.00014918997,0.00007288576,0.00010283699,0.000028264105,0.0005135389,0.00014561588,0.000072335024],"category_scores_gemma":[0.000073236624,0.00007866238,0.000053915817,0.00033193312,0.0009557996,0.000004387471,0.00029937236,0.0004275166,0.00001481345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047676024,0.000035028082,0.00080311036,0.0001523367,0.00003275772,0.000011927958,0.00006208587,0.0000062217914,0.99188256,0.000018917695,0.002370695,0.004147596],"study_design_scores_gemma":[0.00071555784,0.0004490183,0.0130290305,0.00007740343,0.000003609607,0.0000023637056,0.000024340708,0.000005989362,0.9785012,0.000053026393,0.007030239,0.00010819563],"about_ca_topic_score_codex":0.0004552464,"about_ca_topic_score_gemma":0.00021570241,"teacher_disagreement_score":0.013381337,"about_ca_system_score_codex":0.000051248422,"about_ca_system_score_gemma":0.00032900355,"threshold_uncertainty_score":0.35216832},"labels":[],"label_agreement":null},{"id":"W2887378393","doi":"10.1158/1538-7445.am2018-2102","title":"Abstract 2102: UFH-001: A novel triple-negative, CAIX-positive cell line for small-molecule targeting of human breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Context (archaeology); Metastasis; Metastatic breast cancer; Breast cancer; Cancer; Cell culture; Medicine; Biology; Internal medicine","score_opus":0.05550998769905873,"score_gpt":0.3783807602736805,"score_spread":0.32287077257462177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887378393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926397,0.0006083486,0.00092501176,0.0003650007,0.00020700168,0.0006058427,0.000990149,0.00001166108,0.0036472476],"genre_scores_gemma":[0.9938257,0.00015290576,0.00020732686,0.00017691086,0.0012368859,0.00028946213,0.00028620605,0.00003764872,0.0037870023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998606,0.000054890173,0.00026019756,0.0004223774,0.00023220785,0.0004242742],"domain_scores_gemma":[0.99813217,0.000037882397,0.00011623708,0.0002153745,0.0013833898,0.00011495006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004937136,0.00014354693,0.00016182892,0.00009969388,0.00027165667,0.0000275609,0.00017943633,0.00015771188,0.0006300496],"category_scores_gemma":[0.00010020634,0.00013689826,0.00009070057,0.00020902377,0.00030348494,0.000008490173,0.0000955507,0.0002070354,0.000007944197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000488112,0.00017292696,0.00008970609,0.0000848552,0.00004016534,5.47261e-7,0.000091864,0.0000085465745,0.97328454,0.000044021876,0.02518462,0.00051006896],"study_design_scores_gemma":[0.0017660351,0.00064056396,0.0010282802,0.00008802917,0.000010916242,0.0000013759341,0.00014804245,0.000035964258,0.99170333,0.000022787717,0.0043993373,0.00015533513],"about_ca_topic_score_codex":0.0014321253,"about_ca_topic_score_gemma":0.00095112476,"teacher_disagreement_score":0.020785283,"about_ca_system_score_codex":0.000088126144,"about_ca_system_score_gemma":0.00027504194,"threshold_uncertainty_score":0.68986017},"labels":[],"label_agreement":null},{"id":"W2887382383","doi":"10.1158/1538-7445.am2018-601","title":"Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Cognition; Neuropsychology; Verbal memory; Medicine; Visual memory; Verbal learning; Breast cancer; Effects of sleep deprivation on cognitive performance; Neuropsychological test; Psychology; Oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.09025587577286223,"score_gpt":0.4455968988243318,"score_spread":0.35534102305146953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887382383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042517,0.0018041292,0.0000062947365,0.0012323576,0.00016094625,0.003142767,0.0014135396,0.00004592316,0.0017688768],"genre_scores_gemma":[0.98716915,0.0041595525,0.000008240096,0.00022955037,0.00056930765,0.004081611,0.00003001874,0.000076428514,0.0036761225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697536,0.00010694755,0.00045267507,0.00059115794,0.000718909,0.0011549452],"domain_scores_gemma":[0.99661416,0.00041771156,0.00012824411,0.00026382072,0.0023423666,0.00023367154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006933024,0.0002769395,0.0006382977,0.0005564599,0.00016471634,0.000021953394,0.00015963854,0.00011573084,0.004995499],"category_scores_gemma":[0.00016888652,0.00022980024,0.000103676626,0.000992776,0.0009063147,0.00014408982,0.00009404592,0.00056194,0.000031286738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037253514,0.0016652608,0.6446271,0.0010734794,0.0020498256,0.0001847677,0.012857645,0.0000057776615,0.099316716,0.000026749503,0.007360941,0.19357824],"study_design_scores_gemma":[0.0144420015,0.0020026013,0.8916524,0.0015600043,0.000040087303,0.000008808245,0.002674233,0.000017889399,0.08582075,0.00004941426,0.0014923533,0.00023944142],"about_ca_topic_score_codex":0.01214701,"about_ca_topic_score_gemma":0.0021844646,"teacher_disagreement_score":0.24702533,"about_ca_system_score_codex":0.0013474124,"about_ca_system_score_gemma":0.00079634757,"threshold_uncertainty_score":0.99591404},"labels":[],"label_agreement":null},{"id":"W2887394080","doi":"10.1158/1538-7445.am2018-5314","title":"Abstract 5314: DNA methylation quantitative trait loci and breast cancer risk: Data from nearly 230,000 women of European descent","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; DNA methylation; CpG site; Oncology; Methylation; Cancer; Expression quantitative trait loci; Genotype; Biology; Medicine; Internal medicine; Genetics; Single-nucleotide polymorphism; Gene; Gene expression","score_opus":0.10493858328059108,"score_gpt":0.40926759154454506,"score_spread":0.304329008263954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887394080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079025,0.0052055935,0.00052698044,0.00013244545,0.0000773712,0.00019717102,0.0024677734,0.0000052035566,0.0005972382],"genre_scores_gemma":[0.9935672,0.0051067653,0.00036154265,0.000016220172,0.0004943966,0.000023122271,0.00029796193,0.000030647672,0.00010213108],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982535,0.00035223193,0.0002394723,0.00051415584,0.00031571268,0.00032492532],"domain_scores_gemma":[0.9986724,0.000063444306,0.00012832756,0.0005465028,0.0004524855,0.00013682507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014370462,0.00011954493,0.00014551099,0.00007070021,0.0001473271,0.000052889463,0.00035744574,0.000087149725,0.00036787245],"category_scores_gemma":[0.00014649151,0.00011105313,0.000023605628,0.0001626922,0.00037123112,0.000016212027,0.00028958725,0.00018377231,0.00001093175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031251163,0.000044039924,0.009858222,0.00002376917,0.000116309406,0.0000010406422,0.00081748964,0.000027042262,0.93993056,0.000013152108,0.0005584732,0.04829741],"study_design_scores_gemma":[0.0005968578,0.0003014432,0.6212839,0.00004363658,0.000019778532,2.6311048e-7,0.00035700787,0.00024570638,0.36722028,0.00027087887,0.009488499,0.00017177557],"about_ca_topic_score_codex":0.004591212,"about_ca_topic_score_gemma":0.001201725,"teacher_disagreement_score":0.61142564,"about_ca_system_score_codex":0.000057295903,"about_ca_system_score_gemma":0.00017357274,"threshold_uncertainty_score":0.69405705},"labels":[],"label_agreement":null},{"id":"W2887396525","doi":"10.1158/1538-7445.am2018-1184","title":"Abstract 1184: Clonal evolution of diffuse intrinsic pontine glioma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Exome sequencing; ATRX; Genetics; Histone; Histone H3; Transcriptome; Somatic evolution in cancer; Mutation; Glioma; Cancer; Gene; Gene expression","score_opus":0.0655812258447342,"score_gpt":0.4059868945116018,"score_spread":0.3404056686668676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887396525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288934,0.0018344391,0.0000029105236,0.0015524906,0.00013709629,0.00034421458,0.00002328543,0.000020501038,0.0031956905],"genre_scores_gemma":[0.9987319,0.0001521585,0.00006344096,0.000019870447,0.00070731674,0.00010484613,0.000009450225,0.00001723446,0.00019375508],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985099,0.0000377504,0.00020036269,0.0002401978,0.0006488517,0.00036297072],"domain_scores_gemma":[0.99868786,0.00009461384,0.00004525495,0.00032123976,0.0006849054,0.0001660962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037907873,0.00009023733,0.00020216122,0.00033422897,0.000094271374,0.000013384774,0.000098967204,0.00006662731,0.0009475415],"category_scores_gemma":[0.00015063657,0.00006954242,0.000069442525,0.0005858717,0.00032738605,0.000051090024,0.000070072616,0.0001918751,0.0001760247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012966683,0.00196242,0.14682274,0.00020369286,0.00024200688,0.00031052876,0.00028460677,8.0334166e-7,0.7784556,0.0019846023,0.027551003,0.04088533],"study_design_scores_gemma":[0.0030774018,0.0007911905,0.7155893,0.00022893035,0.00003132408,0.00002596049,0.00008138574,0.000009336135,0.2738564,0.00033239677,0.005906263,0.00007009631],"about_ca_topic_score_codex":0.0019268742,"about_ca_topic_score_gemma":0.0002449795,"teacher_disagreement_score":0.5687666,"about_ca_system_score_codex":0.00042048114,"about_ca_system_score_gemma":0.00031138523,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2887402464","doi":"10.1158/1538-7445.prca2017-a033","title":"Abstract A033: Identity fraud: Lineage plasticity as a mechanism of antiandrogen resistance and target for therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Reprogramming; Enzalutamide; Cancer research; Biology; Transdifferentiation; EZH2; Prostate cancer; Androgen receptor; Epigenetics; Cancer; Genetics; Cell; Gene","score_opus":0.10144636960819897,"score_gpt":0.4559655279573779,"score_spread":0.3545191583491789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887402464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835725,0.0063943863,0.00044068473,0.0010015047,0.00010896336,0.0014416712,0.0001944493,0.000026192793,0.0020349137],"genre_scores_gemma":[0.9893316,0.005312936,0.0006525849,0.00006819793,0.00046153864,0.0002862062,0.000019318875,0.000034971268,0.0038326336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979186,0.00006116576,0.00024233485,0.00042059147,0.0007823158,0.00057497673],"domain_scores_gemma":[0.9981644,0.00025600256,0.000063490996,0.00026960962,0.0010016259,0.00024487643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009549957,0.00014199545,0.00032836536,0.0002247815,0.00027905518,0.000046970297,0.00018882313,0.00012397864,0.00075664197],"category_scores_gemma":[0.00025158568,0.00010892184,0.000079086225,0.00040686256,0.0006428505,0.00016295527,0.00008936535,0.00030794903,0.000023437096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020127105,0.0006807619,0.0097354455,0.0019225306,0.0007673275,0.00013021058,0.0018242471,8.598095e-7,0.9347579,0.010495564,0.013120688,0.0064373524],"study_design_scores_gemma":[0.0050333967,0.0016805818,0.010338204,0.000365931,0.000022641416,0.0000044943527,0.00018017642,0.000047800644,0.95863694,0.00771974,0.01582878,0.00014130831],"about_ca_topic_score_codex":0.0005018859,"about_ca_topic_score_gemma":0.00029590834,"teacher_disagreement_score":0.023879036,"about_ca_system_score_codex":0.00015003677,"about_ca_system_score_gemma":0.0006799835,"threshold_uncertainty_score":0.8284699},"labels":[],"label_agreement":null},{"id":"W2887411043","doi":"10.1158/1538-7445.am2018-3222","title":"Abstract 3222: Evaluation of associations between circulating proteins and breast cancer risk using genetic variants","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Genome-wide association study; Oncology; Expression quantitative trait loci; Genetic association; Cancer; Genotyping; Single-nucleotide polymorphism; Internal medicine; Genotype; Medicine; Biology; Bioinformatics; Genetics; Gene","score_opus":0.11814273637245631,"score_gpt":0.4380555594026982,"score_spread":0.3199128230302419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887411043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959982,0.0021008935,0.00021745596,0.0000686467,0.000062459694,0.00049159303,0.0009134037,0.0000041812937,0.00014314995],"genre_scores_gemma":[0.9977829,0.0005536474,0.00033306735,0.000010998032,0.0011471215,0.00008760179,0.000051911156,0.000020311385,0.000012475846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983887,0.00025028092,0.00021757587,0.00032453038,0.0005357933,0.00028310588],"domain_scores_gemma":[0.99805254,0.00002371932,0.00012877675,0.00023938958,0.0014324841,0.00012306382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010883429,0.00009085242,0.00011817539,0.00008346104,0.00028194257,0.000033378066,0.00011296992,0.00011389841,0.00013747627],"category_scores_gemma":[0.00024612638,0.00009670302,0.000038041868,0.00017829657,0.00022373033,0.0000068139434,0.000079530066,0.000108768196,0.0000017386272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037888927,0.000052018975,0.41157687,0.00005081063,0.00010149657,3.5593453e-7,0.000106016676,0.00025455243,0.5736914,0.000004335418,0.00015383592,0.013970386],"study_design_scores_gemma":[0.00075223634,0.0000581577,0.95376635,0.00005797962,0.000092617294,0.0000011560858,0.00006046343,0.0005761965,0.044068348,0.00040460748,0.000048530994,0.00011337973],"about_ca_topic_score_codex":0.0019237523,"about_ca_topic_score_gemma":0.00037342033,"teacher_disagreement_score":0.5421895,"about_ca_system_score_codex":0.00011418721,"about_ca_system_score_gemma":0.0007366815,"threshold_uncertainty_score":0.39434347},"labels":[],"label_agreement":null},{"id":"W2887432613","doi":"10.1158/1538-7445.am2018-2351","title":"Abstract 2351: Transcriptome-wide association study reveals candidate causal genes for lung cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Lung cancer; Genome-wide association study; Adenocarcinoma; Expression quantitative trait loci; Cancer; Biology; Transcriptome; Genetic association; Candidate gene; Genetics; Oncology; Gene; Medicine; Single-nucleotide polymorphism; Gene expression; Genotype","score_opus":0.05951745625882883,"score_gpt":0.4295893468398744,"score_spread":0.37007189058104556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887432613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911095,0.0049972977,0.000354887,0.0011404483,0.00045063233,0.0011600252,0.00030412382,0.00001412332,0.00046898943],"genre_scores_gemma":[0.98558336,0.0017699831,0.000046550165,0.00021650181,0.0015593976,0.0023648518,0.000065141074,0.00004148374,0.00835271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998104,0.00011794863,0.00025236272,0.0005190338,0.0004237707,0.0005828972],"domain_scores_gemma":[0.99831474,0.00006492601,0.00009209203,0.00041157776,0.000992327,0.00012436067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011655404,0.00014455148,0.00016985046,0.00009182725,0.00040751,0.00008606586,0.0003158281,0.00014962221,0.00033778898],"category_scores_gemma":[0.00016537088,0.00013616575,0.00007742989,0.00024309666,0.00009916356,0.000011288942,0.00004929774,0.00016700791,0.000008667213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002602519,0.00011760261,0.13859774,0.000058714813,0.00023587016,9.536431e-7,0.0003265582,0.000032430977,0.7398236,0.00001740307,0.11643952,0.0040893434],"study_design_scores_gemma":[0.003197979,0.0010080076,0.26717716,0.00009787246,0.00012577261,5.617123e-7,0.00084168185,0.00011693106,0.3859366,0.00012310232,0.34071845,0.0006558722],"about_ca_topic_score_codex":0.002123278,"about_ca_topic_score_gemma":0.0054481365,"teacher_disagreement_score":0.35388702,"about_ca_system_score_codex":0.00037890527,"about_ca_system_score_gemma":0.00050905196,"threshold_uncertainty_score":0.5552678},"labels":[],"label_agreement":null},{"id":"W2887441655","doi":"10.1158/1538-7445.am2018-3209","title":"Abstract 3209: Numerical modeling of intracellular mechanisms in tumor-treating fields","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Communication and Nanonetworks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biophysics; Microtubule; Tubulin; Intracellular; Mitosis; Cytoskeleton; Cytosol; Materials science; Chemistry; Cell; Biology; Cell biology; Biochemistry; Enzyme","score_opus":0.05697486879809632,"score_gpt":0.34853923933157693,"score_spread":0.2915643705334806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887441655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8284093,0.0025037618,0.1577219,0.00012892108,0.0001235926,0.00020977142,0.000002247573,0.00006860493,0.01083188],"genre_scores_gemma":[0.9980255,0.00021654548,0.0015890443,0.000015010737,0.000068767076,0.000038506914,0.0000021556762,0.000020180276,0.000024296889],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991288,0.00005508046,0.00020213622,0.00011270392,0.00022955168,0.0002716874],"domain_scores_gemma":[0.9994535,0.000060010858,0.000013882034,0.0003132448,0.00010369436,0.000055683056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005195377,0.00006516802,0.00011806347,0.00013017513,0.00004835389,0.000015226312,0.00026260584,0.00006784981,0.00033548896],"category_scores_gemma":[0.00004211838,0.00006760383,0.000026627637,0.0003758973,0.000042045645,0.000041341016,0.00007147033,0.00044337809,0.00001944121],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007054921,0.00008062125,0.00033324226,0.00022622223,0.00005129855,0.00003518226,0.0016176444,0.57513875,0.38244873,0.004596381,0.0007016475,0.03469973],"study_design_scores_gemma":[0.00016489199,0.000027197295,0.00006984331,0.00012746229,0.0000013296905,8.967981e-7,0.00008856901,0.9284117,0.06978792,0.00096949533,0.00026867128,0.00008198123],"about_ca_topic_score_codex":0.00041013438,"about_ca_topic_score_gemma":0.00013691375,"teacher_disagreement_score":0.353273,"about_ca_system_score_codex":0.00007873716,"about_ca_system_score_gemma":0.000041736872,"threshold_uncertainty_score":0.3673369},"labels":[],"label_agreement":null},{"id":"W2887442903","doi":"10.1158/1538-7445.am2018-1853","title":"Abstract 1853: The Chk1 inhibitor, SRA737, synergizes with niraparib to kill cancer cells via multiple cell death pathways","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alterra Power (Canada)","funders":"","keywords":"Cancer research; DNA repair; ATG5; Programmed cell death; Autophagy; Cancer; DNA damage; PI3K/AKT/mTOR pathway; Biology; CHEK1; Cell cycle; Cell cycle checkpoint; Signal transduction; Cell biology; Apoptosis; DNA; Biochemistry; Genetics","score_opus":0.09870132601912379,"score_gpt":0.3943640729461013,"score_spread":0.2956627469269775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887442903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815469,0.0023936974,0.00021325109,0.004642069,0.0008678608,0.0019965642,0.0002059578,0.00014542171,0.00798831],"genre_scores_gemma":[0.98773146,0.0011491737,0.00038869283,0.0022301592,0.0033243669,0.0019253356,0.000015341475,0.00013791518,0.0030975863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954371,0.00018080056,0.00044588797,0.00089739705,0.0017172145,0.0013216143],"domain_scores_gemma":[0.9963066,0.00041502027,0.00012674888,0.001138352,0.0013691245,0.0006441733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010822867,0.00038553463,0.00047259373,0.00032713424,0.0007006319,0.00012825213,0.00057286315,0.0001942147,0.0028482594],"category_scores_gemma":[0.000065445594,0.0002526051,0.00012629255,0.0011701774,0.0008097549,0.00017118445,0.00017499762,0.0010846552,0.00071118586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022848793,0.0002506764,0.004899512,0.000182313,0.00012308444,0.0000666531,0.0022234572,0.00015777008,0.9124569,0.00004922875,0.07067495,0.00663054],"study_design_scores_gemma":[0.0029630375,0.000985847,0.006953027,0.00060304557,0.000033420587,0.000010063802,0.00034930362,0.000099459256,0.8446296,0.000085053034,0.1429498,0.0003383717],"about_ca_topic_score_codex":0.0060147047,"about_ca_topic_score_gemma":0.00236788,"teacher_disagreement_score":0.072274856,"about_ca_system_score_codex":0.0011310896,"about_ca_system_score_gemma":0.0014404731,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W2887447252","doi":"10.1158/1538-7445.am2018-1203","title":"Abstract 1203: Incidence of AJCC7 stage III or regionally advanced cutaneous melanoma in the United States","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Melanoma; Medicine; Incidence (geometry); Population; Stage (stratigraphy); Cancer registry; Epidemiology; Cancer; Internal medicine; Oncology; Cancer research","score_opus":0.07902727626775277,"score_gpt":0.4082642082407952,"score_spread":0.3292369319730424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887447252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911517,0.00016653856,0.000033063487,0.0025378494,0.00011530277,0.00083292,0.000015519014,0.00002987581,0.005117218],"genre_scores_gemma":[0.9872208,0.001006394,0.00007437775,0.0006428178,0.00015773083,0.00011330906,0.000018315855,0.000020184012,0.010746058],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979441,0.0001317391,0.00031351869,0.000292511,0.000901041,0.00041706458],"domain_scores_gemma":[0.998404,0.000418451,0.00008233045,0.0004882692,0.00050374755,0.00010315884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008424474,0.00011889236,0.00021769335,0.00047055475,0.00012855223,0.0000274505,0.00032169075,0.000062134786,0.0017368922],"category_scores_gemma":[0.0002699476,0.00007628022,0.000042680174,0.0011732273,0.00041734643,0.000052195755,0.00010013218,0.00044289939,0.0000554234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0989458,0.0033990869,0.021672267,0.004597456,0.0010868568,0.032182287,0.05247915,0.0027879695,0.36965638,0.007013056,0.14478089,0.26139882],"study_design_scores_gemma":[0.006808694,0.00701898,0.040727038,0.0016731998,0.00006578848,0.0012683535,0.026099656,0.0015125615,0.057838686,0.0007839028,0.8556273,0.0005758638],"about_ca_topic_score_codex":0.004243251,"about_ca_topic_score_gemma":0.005751255,"teacher_disagreement_score":0.71084636,"about_ca_system_score_codex":0.0002531812,"about_ca_system_score_gemma":0.0003246525,"threshold_uncertainty_score":0.99917567},"labels":[],"label_agreement":null},{"id":"W2887462216","doi":"10.1158/1538-7445.am2018-2835","title":"Abstract 2835: Temporal sequencing of anticancer drugs, <i>ex vivo</i>, optimizes therapeutic effect by targeting drug-induced glucose-6-phosphate dehydrogenase","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Biology; Context (archaeology); Cancer cell; Cancer; Drug resistance; Reprogramming; Combination therapy; Population; Cancer research; Pharmacology; In vivo; Ex vivo; Drug; Medicine; Cell; Genetics","score_opus":0.02778807119473027,"score_gpt":0.34776225379782777,"score_spread":0.3199741826030975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887462216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96059215,0.036787543,0.000059825466,0.00017127284,0.0009495723,0.0006098391,0.000111299094,0.000026191534,0.0006923052],"genre_scores_gemma":[0.9902118,0.006037621,0.00017320018,0.00022060386,0.0023403054,0.00016072279,0.000054236614,0.00008680065,0.000714708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967617,0.0002936425,0.00044617354,0.0007739103,0.0007329572,0.000991658],"domain_scores_gemma":[0.99827695,0.00010231836,0.00018236245,0.00061994616,0.0005508231,0.00026759095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019661419,0.00032647242,0.0004494791,0.000120567485,0.0003115457,0.00006516352,0.00054565584,0.00021314644,0.00030921982],"category_scores_gemma":[0.00014468808,0.00029225255,0.0001958193,0.0004204052,0.00057944807,0.000021533497,0.00020972881,0.00040193676,0.000025706693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051311165,0.00004342363,0.00032192856,0.00013376075,0.00015161748,0.0000022847114,0.00028096107,0.000023633316,0.97425336,0.0000087908,0.015009643,0.009257494],"study_design_scores_gemma":[0.0012102283,0.00027684213,0.000057438065,0.00009245045,0.000032500247,0.00000224097,0.00021433954,0.00005698721,0.922016,0.000023424423,0.075716324,0.00030120864],"about_ca_topic_score_codex":0.002319924,"about_ca_topic_score_gemma":0.00018427824,"teacher_disagreement_score":0.06070668,"about_ca_system_score_codex":0.00015504459,"about_ca_system_score_gemma":0.0008152419,"threshold_uncertainty_score":0.999953},"labels":[],"label_agreement":null},{"id":"W2887473512","doi":"10.1158/1538-7445.am2018-3062","title":"Abstract 3062: Ablation of parathyroid hormone-related protein in the triple negative human breast cancer line MDA-MB-231 inhibits its cancer stem cell phenotype","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"CD44; Parathyroid hormone-related protein; Triple-negative breast cancer; Cancer research; Phenotype; Cancer stem cell; Cancer; CD24; Stem cell; Biology; Cell; Internal medicine; Endocrinology; Breast cancer; Medicine; Parathyroid hormone; Cell biology; Gene; Genetics","score_opus":0.09227688671802556,"score_gpt":0.42199586275865497,"score_spread":0.3297189760406294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887473512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802626,0.010643716,6.854212e-7,0.0031972073,0.000083059254,0.003170833,0.000251382,0.000026369084,0.002364161],"genre_scores_gemma":[0.99337053,0.0012168532,0.000010248158,0.00013523163,0.0003130137,0.0014805257,0.00003244588,0.00004577941,0.0033953495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969174,0.000279568,0.0006034696,0.00047747424,0.000949701,0.00077237346],"domain_scores_gemma":[0.9980113,0.000102383594,0.00023354527,0.00040857805,0.000992598,0.0002515791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010309828,0.00023264321,0.00042122576,0.0002848181,0.00030466355,0.000027380718,0.00021538766,0.00021208926,0.00062161405],"category_scores_gemma":[0.00003529495,0.00016213796,0.00006713058,0.0013045605,0.00035265897,0.0001734651,0.00005580977,0.0008907567,0.00008573709],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008162978,0.0020421108,0.014512642,0.0012227405,0.00034267243,0.00010342614,0.01573039,0.00007928621,0.90324736,0.00032277158,0.010714477,0.043519124],"study_design_scores_gemma":[0.012838619,0.0018447919,0.6961024,0.0013560009,0.000093891795,0.000008016217,0.00080968183,0.0002937793,0.2844437,0.00033820735,0.0015304718,0.0003404417],"about_ca_topic_score_codex":0.032263555,"about_ca_topic_score_gemma":0.010480547,"teacher_disagreement_score":0.6815897,"about_ca_system_score_codex":0.00084928656,"about_ca_system_score_gemma":0.0014586342,"threshold_uncertainty_score":0.9741807},"labels":[],"label_agreement":null},{"id":"W2887484107","doi":"10.1158/1538-7445.am2018-923","title":"Abstract 923: The cBioPortal for Cancer Genomics: An intuitive open-source platform for exploration, analysis and visualization of cancer genomics data","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Visualization; Genomics; Computer science; Data visualization; Interface (matter); Data science; World Wide Web; Computational biology; Genome; Data mining; Biology; Genetics; Gene","score_opus":0.13369627575077309,"score_gpt":0.4486295561516438,"score_spread":0.3149332804008707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887484107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9079434,0.003088706,0.083660014,0.00041329075,0.00018264304,0.001957859,0.0026321039,0.00000570508,0.00011625661],"genre_scores_gemma":[0.9898592,0.0053974143,0.00078797725,0.00020770887,0.0009714787,0.0007647979,0.0017101398,0.00003879954,0.00026243046],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987208,0.00002656057,0.00035628115,0.00041946807,0.00014581195,0.00033105965],"domain_scores_gemma":[0.9982729,0.000051598894,0.00021186053,0.0006443522,0.00072770246,0.00009158502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012129286,0.00013107779,0.0002148955,0.00009065229,0.0003711879,0.00014942349,0.00080950785,0.00013688978,0.000049671537],"category_scores_gemma":[0.000051365925,0.00010463616,0.000052115058,0.00025367623,0.00033740408,0.000054706423,0.00051680853,0.00009052895,5.094878e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038184072,0.0002380573,0.0059917644,0.0005200718,0.0046670376,3.8584108e-7,0.008795058,0.0055247834,0.48420697,0.0028527055,0.02114378,0.462241],"study_design_scores_gemma":[0.0034831192,0.0014503289,0.0045974245,0.00012423146,0.00081853365,0.0000015451254,0.006136679,0.12555808,0.38068488,0.003635725,0.47258586,0.0009235915],"about_ca_topic_score_codex":0.0022824733,"about_ca_topic_score_gemma":0.022619095,"teacher_disagreement_score":0.4613174,"about_ca_system_score_codex":0.00008388214,"about_ca_system_score_gemma":0.0005589443,"threshold_uncertainty_score":0.99521554},"labels":[],"label_agreement":null},{"id":"W2887539911","doi":"10.1158/1538-7445.am2018-3889","title":"Abstract 3889: <i>RPL28</i> promoter polymorphism rs4806668 is associated with reduced survival in FOLFIRI-treated metastatic colorectal cancer patients","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"FOLFIRI; Irinotecan; Colorectal cancer; Medicine; Genotyping; Internal medicine; Oncology; Hazard ratio; Genotype; Folinic acid; Proportional hazards model; Population; Cancer; Biology; Gene; Genetics; Confidence interval","score_opus":0.07442548901406928,"score_gpt":0.3913941600963674,"score_spread":0.3169686710822981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887539911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898605,0.0012837839,2.4453723e-7,0.0020434905,0.0002779463,0.0017305089,0.0002990965,0.000064537635,0.004439895],"genre_scores_gemma":[0.9959061,0.00036035554,0.0000124994995,0.00023868516,0.00021528354,0.0012280747,0.00007560375,0.00007966101,0.0018837083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621546,0.00018059227,0.00042055527,0.00076801714,0.0013011971,0.0011141489],"domain_scores_gemma":[0.99781406,0.00019267517,0.00013178813,0.00029737418,0.0012746212,0.0002894622],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000536936,0.00036535494,0.0007152134,0.00036345603,0.00032823894,0.000061302,0.00019764222,0.00010777807,0.0015893701],"category_scores_gemma":[0.0002032119,0.00026113368,0.00010111263,0.0013868035,0.0005980478,0.00015143289,0.00012846397,0.000557533,0.000053540174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078116595,0.0021474971,0.93458843,0.00012368786,0.001674736,0.00043308665,0.0042932737,0.0000012227714,0.020604286,0.000008161059,0.012112554,0.01620142],"study_design_scores_gemma":[0.00824714,0.0026256891,0.94333225,0.00073522615,0.00017311552,0.000004518209,0.00026572397,0.00002882826,0.042911056,0.000036796406,0.0012987395,0.00034094005],"about_ca_topic_score_codex":0.012344645,"about_ca_topic_score_gemma":0.017529823,"teacher_disagreement_score":0.022306772,"about_ca_system_score_codex":0.0019364457,"about_ca_system_score_gemma":0.00091098424,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2887555658","doi":"10.1158/1538-7445.am2018-462","title":"Abstract 462: Hyperactivation of ERK/MAPK pathway reduces pancreatic cancer cells' proliferation and tumor progression through phosphoproteome reprogramming","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Concordia University; Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Cancer research; Pancreatic Intraepithelial Neoplasia; Pancreatic cancer; Kinase; Cancer; Biology; KRAS; Oncogene; Tumor progression; Ribosome biogenesis; Medicine; Cell cycle; Cell biology; Internal medicine","score_opus":0.04114209434249995,"score_gpt":0.38272030066734497,"score_spread":0.34157820632484504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887555658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486476,0.0036193468,0.000074376825,0.00015669799,0.0001074027,0.00094293867,0.000027348562,0.000014426086,0.00019271641],"genre_scores_gemma":[0.9972044,0.00049627613,0.00084166595,0.00002052373,0.00061111426,0.0006146698,0.000056304183,0.000031203792,0.00012384047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984205,0.00010427618,0.00026768746,0.000496308,0.0003928551,0.0003183843],"domain_scores_gemma":[0.99875665,0.000022603583,0.00017414632,0.00032358486,0.00064243464,0.000080578764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005054768,0.00013697776,0.00015107157,0.00006462831,0.00021293566,0.000056386278,0.00013108815,0.000114961826,0.00009291025],"category_scores_gemma":[0.00014801559,0.00012136278,0.000038949827,0.0002398538,0.0003290855,0.00003082925,0.00010012667,0.0001479656,0.0000038414837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038484135,0.00007086529,0.0019904743,0.00017526906,0.00003565765,0.0000013483714,0.00023844549,0.000012456744,0.97687656,0.000017932782,0.00035249963,0.019843651],"study_design_scores_gemma":[0.0003509724,0.00023711882,0.009031398,0.0002742275,0.0000105649615,0.000002403356,0.0001159255,0.00004996315,0.98632646,0.000079087244,0.0033904877,0.00013138873],"about_ca_topic_score_codex":0.00030517808,"about_ca_topic_score_gemma":0.00006557568,"teacher_disagreement_score":0.019712264,"about_ca_system_score_codex":0.00008450183,"about_ca_system_score_gemma":0.00039628928,"threshold_uncertainty_score":0.49490303},"labels":[],"label_agreement":null},{"id":"W2887561950","doi":"10.1158/1538-7445.am2018-ct124","title":"Abstract CT124: A phase Ib/II study of BMS-813160, a CC chemokine receptor (CCR) 2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with advanced pancreatic or colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; CCR2; Tumor microenvironment; Pancreatic cancer; CC chemokine receptors; Chemokine receptor; Cancer research; Myeloid; Immunology; Cancer; Internal medicine; Chemokine; Immune system","score_opus":0.029626792745536826,"score_gpt":0.3657353482256614,"score_spread":0.3361085554801246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887561950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563175,0.0006250295,0.0000029733071,0.0001501464,0.00031861788,0.0029263017,0.00010367534,0.000034939232,0.0002065792],"genre_scores_gemma":[0.9958821,0.00047470685,0.00005679195,0.000046333203,0.000059113812,0.0015267606,0.0000795321,0.00008380018,0.0017908805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694043,0.0003563379,0.0006336423,0.0007634091,0.00036620777,0.00093997247],"domain_scores_gemma":[0.9981085,0.00023674138,0.0002932039,0.0004918825,0.00081881863,0.000050875336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072258106,0.00036229068,0.0007507091,0.0004939289,0.00028552217,0.000024314946,0.00045499593,0.0002474181,0.003461276],"category_scores_gemma":[0.00010804292,0.00025305356,0.000034213248,0.00153503,0.0010169081,0.00024628828,0.00014710487,0.0008988041,0.000028333285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2960692,0.03825708,0.10847437,0.0004341506,0.0008829154,0.00007095245,0.021659838,0.000038007613,0.45375064,0.0000104440205,0.0033015937,0.0770508],"study_design_scores_gemma":[0.24744746,0.0640714,0.14896771,0.0015637183,0.00006229476,0.0000133962285,0.0054729856,0.000021715174,0.52588624,0.000010419745,0.005633259,0.00084941933],"about_ca_topic_score_codex":0.006271228,"about_ca_topic_score_gemma":0.024490416,"teacher_disagreement_score":0.07620138,"about_ca_system_score_codex":0.0012990822,"about_ca_system_score_gemma":0.001274091,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W2887575612","doi":"10.1158/1538-7445.am2018-425","title":"Abstract 425: Linked Target Capture: Rapid and high-performance NGS target enrichment for clinical sequencing applications","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computational biology; DNA sequencing; Nanopore sequencing; DNA; Workflow; Hybrid capture; Computer science; Biology; Genetics; Cancer; Database","score_opus":0.07224738320156773,"score_gpt":0.40412273031499824,"score_spread":0.3318753471134305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887575612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851634,0.0074570426,0.0040836507,0.0007878754,0.00036773243,0.0010932826,0.0002689823,0.000013852916,0.00076417724],"genre_scores_gemma":[0.9819382,0.010284278,0.0032982177,0.00045741396,0.0025250562,0.00089060934,0.00016318912,0.0000324886,0.00041055944],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985055,0.000037962,0.0002885299,0.00052313146,0.00019033565,0.0004545681],"domain_scores_gemma":[0.99875593,0.00012078232,0.00007000517,0.00039980814,0.00046706788,0.00018640654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009691181,0.00013196876,0.00016663325,0.000055659333,0.00029437186,0.000056195237,0.0002509429,0.00018749923,0.00008367765],"category_scores_gemma":[0.0001495982,0.00012719544,0.00005327732,0.0001253674,0.0003837567,0.000006089682,0.00016974405,0.00023088469,0.000016595353],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000913763,0.0002105355,0.013867704,0.00037398725,0.00026095248,0.000003364335,0.00031395315,0.00021490337,0.80345714,0.0010680134,0.11434375,0.06497193],"study_design_scores_gemma":[0.0012318555,0.0007636847,0.009683168,0.00003318864,0.00001616906,0.0000028521802,0.000106229585,0.00034311178,0.21663472,0.0006689815,0.7702109,0.0003051132],"about_ca_topic_score_codex":0.00017620093,"about_ca_topic_score_gemma":0.000061568906,"teacher_disagreement_score":0.65586716,"about_ca_system_score_codex":0.00010467742,"about_ca_system_score_gemma":0.00057889003,"threshold_uncertainty_score":0.51868796},"labels":[],"label_agreement":null},{"id":"W2887578713","doi":"10.1158/1538-7445.am2018-5736","title":"Abstract 5736: In silico analysis shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Prostate cancer; CD8; Cancer research; Immune system; Tumor microenvironment; Biology; Medicine; Internal medicine; Infiltration (HVAC); Oncology; Cancer; Immunology; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.05045462756739969,"score_gpt":0.37018063480674057,"score_spread":0.31972600723934086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887578713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887308,0.008861291,4.5539804e-7,0.00087884895,0.000015796984,0.0011199804,0.0002025521,0.000017402552,0.0001728989],"genre_scores_gemma":[0.9898399,0.0088653425,0.000010474188,0.000060635175,0.00005875091,0.00032582722,0.000053562595,0.000028367262,0.00075711176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714583,0.00025311127,0.00022464588,0.00080295285,0.0008169507,0.0007564944],"domain_scores_gemma":[0.9983593,0.00024803422,0.00009506534,0.00032132442,0.00037388172,0.00060239166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091338507,0.00024463717,0.0005147899,0.0006638279,0.00021222184,0.000106415144,0.00010538071,0.00011465592,0.000167362],"category_scores_gemma":[0.00019086032,0.00017475711,0.00003696966,0.0012880997,0.0008106698,0.00023387461,0.00018243467,0.00066494255,0.0000019618033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047187028,0.00024706442,0.98263866,0.000358491,0.00016009394,0.00043025738,0.0009799437,0.0000033387655,0.007249227,0.0000015649983,0.00021313968,0.0029995486],"study_design_scores_gemma":[0.005031248,0.00022031563,0.9821107,0.0017290737,0.00012388705,0.0000018738108,0.00042342575,0.0005407671,0.009457658,0.000054198023,0.0001017534,0.0002051191],"about_ca_topic_score_codex":0.006999808,"about_ca_topic_score_gemma":0.020555135,"teacher_disagreement_score":0.0135553265,"about_ca_system_score_codex":0.00055555475,"about_ca_system_score_gemma":0.00063075445,"threshold_uncertainty_score":0.9996127},"labels":[],"label_agreement":null},{"id":"W2887597714","doi":"10.1158/1538-7445.am2018-2271","title":"Abstract 2271: Pathway analysis suggests biological processes driven by germline genetic associations with breast cancer prognosis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Genome-wide association study; Germline; Proportional hazards model; Genetic association; Survival analysis; Oncology; Germline mutation; Biology; Hazard ratio; Cancer; Computational biology; Medicine; Bioinformatics; Internal medicine; Genotype; Gene; Single-nucleotide polymorphism; Genetics; Mutation; Confidence interval","score_opus":0.03149301531913937,"score_gpt":0.3406790888724154,"score_spread":0.309186073553276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887597714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929686,0.0036717146,0.00045428064,0.00081896514,0.000047717593,0.00036545747,0.0011777135,0.00001742066,0.00047809456],"genre_scores_gemma":[0.9957014,0.002133893,0.00024370117,0.0001428428,0.00063970266,0.00035822598,0.00037388157,0.000022011754,0.0003843551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837035,0.00006022768,0.00025382408,0.00042123094,0.00032530437,0.0005690879],"domain_scores_gemma":[0.99841934,0.000034403438,0.00011975376,0.0002928057,0.00096415187,0.00016955039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031748947,0.00016939608,0.00021854354,0.00010249548,0.00028554656,0.0000912135,0.0003403851,0.00021911076,0.00031847818],"category_scores_gemma":[0.000039426217,0.00012351875,0.00007467175,0.00088550843,0.00037696,0.000007766998,0.00012958639,0.00023165658,0.000016559648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046814582,0.00048394557,0.6878283,0.00018535569,0.0030249099,0.000008753604,0.00047547705,0.00077056146,0.217273,0.000028194616,0.038559325,0.05089401],"study_design_scores_gemma":[0.001612063,0.0012665471,0.844703,0.00015130153,0.0003178308,0.0000136556355,0.00026815626,0.0008783705,0.10471514,0.000125576,0.04481824,0.001130099],"about_ca_topic_score_codex":0.00043857563,"about_ca_topic_score_gemma":0.0029849804,"teacher_disagreement_score":0.1568747,"about_ca_system_score_codex":0.00008574199,"about_ca_system_score_gemma":0.00056071056,"threshold_uncertainty_score":0.50369483},"labels":[],"label_agreement":null},{"id":"W2887598813","doi":"10.1158/1538-7445.am2018-2930","title":"Abstract 2930: Synergistic and additive anti-tumor effects of MIV-818 in combination with sorafenib in nonclinical hepatocellular carcinoma models","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Pharmacology; Medicine; In vivo; Cancer research; Cell growth; Chemistry; Biology; Biochemistry","score_opus":0.03460536473925656,"score_gpt":0.3410718426205555,"score_spread":0.30646647788129894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887598813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516743,0.0037052543,0.00011586006,0.000048114573,0.00017208989,0.00049623265,0.000035461908,0.0000030350336,0.0002565192],"genre_scores_gemma":[0.99808955,0.00114483,0.00004647905,0.000032752854,0.00039626108,0.00015717106,0.00003080058,0.000022546548,0.000079634534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856,0.00014122632,0.00023607793,0.00041936143,0.00027956642,0.0003637384],"domain_scores_gemma":[0.99919176,0.00010260322,0.00006460647,0.00025071166,0.00029272833,0.00009760419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053537433,0.00012585768,0.00026209702,0.00016266253,0.00004812435,0.000016100026,0.00015547436,0.00012056352,0.0000144296555],"category_scores_gemma":[0.00016954665,0.000114241695,0.000031967356,0.00026690814,0.00053537945,0.00001132775,0.00010104491,0.00025068075,0.0000018955373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010917862,0.00033485258,0.029089991,0.0003720167,0.00004108546,0.000051411833,0.00039787358,0.00006877809,0.96148044,0.0003403648,0.0006627677,0.0060686595],"study_design_scores_gemma":[0.005097265,0.0010903733,0.1910764,0.00034494116,0.000017671624,0.0000056849635,0.00014637882,0.0018406207,0.79722494,0.00046748825,0.0024039175,0.0002843511],"about_ca_topic_score_codex":0.0015535094,"about_ca_topic_score_gemma":0.0013072572,"teacher_disagreement_score":0.1642555,"about_ca_system_score_codex":0.000048502243,"about_ca_system_score_gemma":0.00039160598,"threshold_uncertainty_score":0.4658641},"labels":[],"label_agreement":null},{"id":"W2887609307","doi":"10.1158/1538-7445.am2018-1117","title":"Abstract 1117: Norrin signaling is protumorigenic in glioblastoma progression","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Wnt signaling pathway; Cancer research; Biology; Carcinogenesis; Signal transduction; Tumor progression; Gene knockdown; Cell culture; Cell growth; Cell biology; Cancer; Genetics","score_opus":0.037686625576336265,"score_gpt":0.4074602505850838,"score_spread":0.3697736250087475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887609307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671006,0.0014310089,0.000028449705,0.00033003857,0.00018280066,0.00063104404,0.000009482546,0.000013402005,0.00066371204],"genre_scores_gemma":[0.9974275,0.00014904531,0.00007618654,0.000038314854,0.0011694956,0.0003185435,0.000012004219,0.00003357088,0.00077533256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982991,0.00008264566,0.00021519115,0.0004830284,0.0004193294,0.00050067005],"domain_scores_gemma":[0.9991409,0.000011723239,0.000054766304,0.00035726282,0.00033494833,0.00010036807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062544673,0.0001223522,0.000108527325,0.00017310056,0.00013930288,0.000039744977,0.0002396014,0.00018134441,0.00039938497],"category_scores_gemma":[0.000056400328,0.00011795338,0.000049323462,0.00047848508,0.00021474437,0.000007646662,0.0001391698,0.00027451743,0.00008013134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046732466,0.000040441802,0.002544066,0.000038866983,0.00001622032,0.000004181346,0.00015245951,0.00008023541,0.97200596,0.0000066813122,0.0036514439,0.02099211],"study_design_scores_gemma":[0.00050114305,0.00044142292,0.0062421635,0.00016016376,0.0000023193904,0.0000038823373,0.000044321954,0.00010786312,0.97016853,0.00007307482,0.02211,0.00014510122],"about_ca_topic_score_codex":0.00021142443,"about_ca_topic_score_gemma":0.0009179451,"teacher_disagreement_score":0.020847008,"about_ca_system_score_codex":0.00018141656,"about_ca_system_score_gemma":0.0004374535,"threshold_uncertainty_score":0.48099992},"labels":[],"label_agreement":null},{"id":"W2887612248","doi":"10.1158/1538-7445.am2018-5229","title":"Abstract 5229: Expression and regulation of chondroitin sulfate in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chondroitin sulfate; Prostate cancer; Cancer research; Sulfation; Chemistry; Chondroitin; Biology; Cancer; Cell biology; Glycosaminoglycan; Biochemistry","score_opus":0.0806933443805099,"score_gpt":0.4446827894765815,"score_spread":0.3639894450960716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887612248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990529,0.004617109,9.822671e-7,0.0014836245,0.00008036791,0.000882161,0.000037451093,0.00001658923,0.002352718],"genre_scores_gemma":[0.9888395,0.004926042,0.000052932257,0.000020796397,0.00023347967,0.00031739665,0.000018296101,0.000026277787,0.005565278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808127,0.00008139508,0.0002635299,0.0003725267,0.00068346027,0.00051781547],"domain_scores_gemma":[0.99885225,0.0000855949,0.00005762807,0.000265374,0.0005627918,0.00017634609],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007417894,0.000116109106,0.00024905257,0.00041021928,0.00011074273,0.000024063076,0.00009386333,0.00008121343,0.0011249096],"category_scores_gemma":[0.00007793419,0.00008828631,0.000030093219,0.0006284349,0.00059711275,0.00015034268,0.00009952359,0.0003750287,0.00001459823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023968914,0.00010378209,0.11794356,0.00044052288,0.000025843432,0.000029277786,0.0010140336,0.0000038247695,0.85022885,0.00003986586,0.0027520976,0.025021479],"study_design_scores_gemma":[0.0027239197,0.00027844476,0.44232455,0.0011536307,0.000006829436,0.0000029716355,0.0001615098,0.000058900314,0.55019456,0.00029192548,0.0027205993,0.0000821374],"about_ca_topic_score_codex":0.0023835676,"about_ca_topic_score_gemma":0.0006212321,"teacher_disagreement_score":0.324381,"about_ca_system_score_codex":0.00029919963,"about_ca_system_score_gemma":0.00060397544,"threshold_uncertainty_score":0.9997882},"labels":[],"label_agreement":null},{"id":"W2887612865","doi":"10.1158/1538-7445.am2018-2632","title":"Abstract 2632: Identification of PTHrP as a biomarker of short survival &amp; brain metastasis in a tissue microarray retrospective analysis of triple-negative breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Concordia University; University of Alberta; McGill University Health Centre","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Tissue microarray; Biomarker; Oncology; Progesterone receptor; Cancer; Internal medicine; Immunohistochemistry; Estrogen receptor; Metastasis; Univariate analysis; Tumor progression; Cancer research; Biology; Multivariate analysis","score_opus":0.10799290936634437,"score_gpt":0.4847178118804109,"score_spread":0.37672490251406654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887612865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994993,0.0006750562,0.000024496221,0.0010691427,0.00010339425,0.00090770726,0.0013716932,0.000006653614,0.00084888045],"genre_scores_gemma":[0.99804676,0.00038211996,0.00007928136,0.000019485022,0.000037639216,0.00019676368,0.0000664312,0.000021289832,0.0011502175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715465,0.00027883414,0.00077353703,0.00045401647,0.0009238421,0.00041510546],"domain_scores_gemma":[0.9970272,0.00025142403,0.00026408373,0.00051491405,0.0017617722,0.00018058433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020189045,0.00014852821,0.00082737656,0.0013006083,0.000059135175,0.000007592654,0.00015147803,0.0001165639,0.0023519183],"category_scores_gemma":[0.0004916071,0.00012783347,0.0001504334,0.003997505,0.00062836806,0.000093370705,0.000046447003,0.0002569027,0.000015699356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034733138,0.0007238356,0.5170023,0.0003978557,0.0031197025,0.000010572086,0.0022187636,0.0000027014883,0.45138684,0.000037523958,0.0012768888,0.020349732],"study_design_scores_gemma":[0.0012213796,0.00017751286,0.83407205,0.0001814283,0.00037969716,0.0000017856481,0.00027042153,0.000023230134,0.16340627,0.00006945927,0.00012962238,0.000067156616],"about_ca_topic_score_codex":0.0961626,"about_ca_topic_score_gemma":0.062031474,"teacher_disagreement_score":0.31706977,"about_ca_system_score_codex":0.00070033956,"about_ca_system_score_gemma":0.00095280824,"threshold_uncertainty_score":0.9985601},"labels":[],"label_agreement":null},{"id":"W2887617683","doi":"10.1158/1538-7445.am2018-2654","title":"Abstract 2654: Immunologic and prognostic correlates of WISP1 in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Stromal cell; Cancer; Cancer research; Proportional hazards model; Internal medicine","score_opus":0.05195799266170875,"score_gpt":0.40064859056802243,"score_spread":0.3486905979063137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887617683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868098,0.011821863,0.0000015232555,0.00022954922,0.00007179569,0.0005814504,0.00004129604,0.0000058475553,0.00043687626],"genre_scores_gemma":[0.99612886,0.0028936083,0.000012873345,0.000009661296,0.00011488293,0.0003065641,0.000008610903,0.000021463915,0.0005034855],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984677,0.00013149963,0.00018584859,0.00041423572,0.00028474955,0.00051597756],"domain_scores_gemma":[0.99899226,0.000094954885,0.00004410686,0.0002675451,0.00052026106,0.0000808717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067832315,0.00011357486,0.00015581025,0.0001755072,0.00008265899,0.000024190782,0.00024595796,0.00010712364,0.0003105986],"category_scores_gemma":[0.0005171605,0.000101211495,0.000025162788,0.00036063668,0.0008723046,0.0000072956486,0.00030879708,0.00033235594,0.000014260148],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030509828,0.00003975613,0.35868728,0.00007493933,0.000030313147,0.00000712649,0.00019778502,0.0000031942548,0.63013476,0.000027249767,0.0002776216,0.010214875],"study_design_scores_gemma":[0.000605844,0.00058299385,0.6139918,0.00013569526,0.0000030651108,0.0000031095972,0.00019436475,0.000016025175,0.3816881,0.00019793474,0.0024536564,0.00012742102],"about_ca_topic_score_codex":0.001754479,"about_ca_topic_score_gemma":0.0018207283,"teacher_disagreement_score":0.25530452,"about_ca_system_score_codex":0.00007146549,"about_ca_system_score_gemma":0.0003519469,"threshold_uncertainty_score":0.4127285},"labels":[],"label_agreement":null},{"id":"W2887630629","doi":"10.1158/1538-7445.am2018-lb-162","title":"Abstract LB-162: Causal role of body mass index in lung cancer in mendelian randomization analysis accounting for genetic pleiotropism","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mendelian randomization; Body mass index; Lung cancer; Overweight; Medicine; Single-nucleotide polymorphism; Cancer; Oncology; Internal medicine; Obesity; Biology; Genotype; Genetics; Genetic variants","score_opus":0.0161243106262669,"score_gpt":0.37314983937474644,"score_spread":0.35702552874847954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887630629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98127866,0.0033758117,0.012925416,0.000607656,0.00010586113,0.0013817195,0.00010925357,0.000008030598,0.00020760445],"genre_scores_gemma":[0.996979,0.0010776923,0.00026050833,0.000094491166,0.00044292063,0.00089311844,0.000069152964,0.000052443116,0.00013065393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971759,0.00021203018,0.00048767167,0.00065989175,0.0006403839,0.0008241453],"domain_scores_gemma":[0.9985125,0.00006486051,0.000122991,0.00045604928,0.00074452,0.0000990929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012045435,0.00018275164,0.00035820808,0.000980491,0.00010169499,0.00005016926,0.00042793,0.0003502782,0.00027066495],"category_scores_gemma":[0.00025893518,0.00019372517,0.00014055343,0.0016857199,0.00018395369,0.000013178044,0.00015308413,0.0004489918,0.0000019392592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012619637,0.000041017876,0.017889801,0.00010399819,0.00030209954,0.000006010235,0.00010030551,0.01233853,0.9648181,0.000019462332,0.00032150856,0.0027972106],"study_design_scores_gemma":[0.005778105,0.00019980737,0.03586302,0.0001230295,0.00007919461,8.273452e-7,0.00018835263,0.05311497,0.9020342,0.00024941843,0.0020491325,0.0003199454],"about_ca_topic_score_codex":0.0060086157,"about_ca_topic_score_gemma":0.011930431,"teacher_disagreement_score":0.06278389,"about_ca_system_score_codex":0.00038360932,"about_ca_system_score_gemma":0.00080674945,"threshold_uncertainty_score":0.908327},"labels":[],"label_agreement":null},{"id":"W2887639123","doi":"10.1158/1538-7445.am2018-2894","title":"Abstract 2894: Neratinib effects significant changes in human brain endothelial cells, demonstrating that it may have a therapeutic use in cancers with brain metastasis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neratinib; Brain metastasis; Medicine; Tyrosine-kinase inhibitor; Cancer research; Breast cancer; Cancer; Internal medicine; Metastasis; Oncology; Trastuzumab","score_opus":0.12807098152279556,"score_gpt":0.4465441814490924,"score_spread":0.31847319992629686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887639123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98700094,0.00046323208,0.000035774756,0.008658791,0.000108046115,0.0020895554,0.00011451453,0.00003399856,0.0014951538],"genre_scores_gemma":[0.9948562,0.00012186898,0.00029065055,0.001217073,0.00031443036,0.0012130933,0.000031299704,0.00006588585,0.001889506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711466,0.00039385265,0.00027404274,0.00062333775,0.00072534813,0.0008687587],"domain_scores_gemma":[0.9982403,0.00086245587,0.00009073755,0.0003928393,0.0001922219,0.0002214611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010836959,0.00027303016,0.00042670046,0.0005243289,0.00023313359,0.00014070031,0.00017072305,0.000109448534,0.00039637001],"category_scores_gemma":[0.00010456133,0.00020480582,0.00005579834,0.000609846,0.0004554487,0.00018623065,0.00004126317,0.0006310722,0.000012380156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001014478,0.0004645335,0.0967314,0.00054763054,0.0005515972,0.00088481494,0.012351055,0.00013154668,0.83909875,0.00026524754,0.0038564235,0.044102542],"study_design_scores_gemma":[0.015216522,0.004179637,0.14920023,0.0031200098,0.00021574054,0.000024635123,0.007090268,0.00031496727,0.8074523,0.0001506451,0.012288256,0.0007467867],"about_ca_topic_score_codex":0.032832157,"about_ca_topic_score_gemma":0.17424987,"teacher_disagreement_score":0.14141771,"about_ca_system_score_codex":0.0013948303,"about_ca_system_score_gemma":0.0013017558,"threshold_uncertainty_score":0.9736083},"labels":[],"label_agreement":null},{"id":"W2887649851","doi":"10.1158/1538-7445.am2018-3199","title":"Abstract 3199: Computational studies show that Tumor Treating Fields can be delivered to the infratentorial brain at therapeutic levels","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Communication and Nanonetworks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brain tumor; Glioblastoma; Human head; Human brain; Pathology; Cancer research; Physics; Acoustics","score_opus":0.20923683343714455,"score_gpt":0.4176872208770351,"score_spread":0.20845038743989053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887649851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710443,0.0059248693,0.001841724,0.015964821,0.000986933,0.0007570357,0.000049387545,0.0001368983,0.003294014],"genre_scores_gemma":[0.9975098,0.00014442508,0.0001363293,0.0010026194,0.00052300596,0.00013566174,0.000009498448,0.000022385197,0.0005162781],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988733,0.00012952574,0.00013563009,0.0001474543,0.00039630468,0.0003177901],"domain_scores_gemma":[0.99884164,0.00047538424,0.000018552237,0.0003198866,0.00024981477,0.000094708055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056910026,0.0001008822,0.000114322924,0.00006773746,0.00041053662,0.00006617386,0.00036687838,0.00004674671,0.0003468102],"category_scores_gemma":[0.00009486698,0.00007659637,0.00003632376,0.00027639416,0.00012235378,0.00003696247,0.00017110187,0.00029303684,0.00003111648],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039730675,0.000075564225,0.0021724927,0.00020880529,0.0012604236,0.0000327419,0.036902543,0.3330432,0.04942323,0.001931826,0.4648201,0.1097318],"study_design_scores_gemma":[0.004707032,0.00077372766,0.06119,0.0008739798,0.00007732663,0.00002571194,0.005992239,0.18217686,0.08592059,0.0032254583,0.6532388,0.0017983213],"about_ca_topic_score_codex":0.00020518087,"about_ca_topic_score_gemma":0.0029423728,"teacher_disagreement_score":0.18841867,"about_ca_system_score_codex":0.00030921426,"about_ca_system_score_gemma":0.00008812369,"threshold_uncertainty_score":0.37973288},"labels":[],"label_agreement":null},{"id":"W2887654090","doi":"10.1158/1538-7445.am2018-4464","title":"Abstract 4464: CPEB-2 is a tumor-suppressor gene in human breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon University; Western University","funders":"","keywords":"Biology; Cancer research; Cancer; HIF1A; Cancer cell; Angiogenesis; Genetics","score_opus":0.06173481598643117,"score_gpt":0.42645588885017693,"score_spread":0.3647210728637458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887654090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307615,0.00090489245,8.235438e-7,0.0016609555,0.00034902358,0.00070989056,0.00009861893,0.000042341926,0.003157318],"genre_scores_gemma":[0.99440354,0.00012395982,0.000015504032,0.00063882826,0.0028903307,0.00051422406,0.000008210559,0.000057164336,0.0013482587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727833,0.00010562875,0.00030271013,0.0004913959,0.000892233,0.0009297067],"domain_scores_gemma":[0.99847406,0.00008080122,0.000054519096,0.0005137881,0.00050732534,0.00036949952],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011005691,0.00018968199,0.00035549916,0.00037173013,0.00022638326,0.0000410601,0.00024948764,0.00013245776,0.010357515],"category_scores_gemma":[0.00006775009,0.00016019818,0.00007697533,0.00057481194,0.00046149807,0.00011454162,0.00011325538,0.0008027101,0.00036024352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000810005,0.00017330288,0.067014426,0.00052703003,0.000071128205,0.0005720073,0.0016204765,0.0000016630067,0.8546678,0.00007148408,0.06966327,0.004807412],"study_design_scores_gemma":[0.0024941145,0.00023615491,0.4814305,0.0007480709,0.000018719671,0.000045904562,0.00010197259,0.00005552479,0.49854046,0.00010332408,0.01599034,0.00023493609],"about_ca_topic_score_codex":0.0054791975,"about_ca_topic_score_gemma":0.0015209038,"teacher_disagreement_score":0.41441607,"about_ca_system_score_codex":0.0005871977,"about_ca_system_score_gemma":0.0007343472,"threshold_uncertainty_score":0.9905472},"labels":[],"label_agreement":null},{"id":"W2887691830","doi":"10.1158/1538-7445.am2018-5015","title":"Abstract 5015: Drug screening and phenotypic analysis in a microwell-based 3D cell culture system","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Spheroid; Lapatinib; Paclitaxel; Drug; Cell culture; Biology; 3D cell culture; Cell; Cancer; Pharmacology; Chemistry; Breast cancer; Genetics","score_opus":0.032276355842405104,"score_gpt":0.346326675457966,"score_spread":0.3140503196155609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887691830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402077,0.0028559703,0.0016453856,0.00016316786,0.0001055656,0.00033132258,0.000022183269,0.00015941935,0.010696187],"genre_scores_gemma":[0.99776936,0.00012518589,0.0012463338,0.000014740969,0.00025082173,0.00008089302,0.000008355933,0.00003754054,0.00046679022],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975652,0.0001377851,0.0002623731,0.00040033384,0.0008175834,0.00081670686],"domain_scores_gemma":[0.99881244,0.00027286948,0.000020771804,0.0003757916,0.00024364279,0.0002744621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002009935,0.00015284933,0.00025866815,0.00085110875,0.00015266992,0.00013163406,0.00042167067,0.00014172807,0.00036176096],"category_scores_gemma":[0.000110293244,0.00013935902,0.000058810325,0.0024202694,0.00035615254,0.000074771786,0.00013919188,0.00093932624,0.000097979086],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058089924,0.0002628041,0.120262615,0.010435705,0.0012646503,0.00040937896,0.008296399,0.027175423,0.7124066,0.00011842054,0.04645845,0.07232869],"study_design_scores_gemma":[0.0041906326,0.00019908645,0.18057977,0.0023957586,0.00016857736,0.0000041985263,0.002766815,0.3861699,0.3720773,0.00007188854,0.049945477,0.0014306186],"about_ca_topic_score_codex":0.0013414371,"about_ca_topic_score_gemma":0.0011905516,"teacher_disagreement_score":0.35899448,"about_ca_system_score_codex":0.0003896531,"about_ca_system_score_gemma":0.00012122589,"threshold_uncertainty_score":0.5682896},"labels":[],"label_agreement":null},{"id":"W2887698070","doi":"10.1158/1538-7445.am2018-ct112","title":"Abstract CT112: Durvalumab + tremelimumab in patients with metastatic urothelial cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Tremelimumab; Discontinuation; Internal medicine; Refractory (planetary science); Blockade; Cancer; Gastroenterology; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Cohort; Oncology; Phases of clinical research; Immunotherapy; Pembrolizumab","score_opus":0.07978595004423476,"score_gpt":0.41202032060803323,"score_spread":0.33223437056379845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887698070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067223,0.00076017994,0.0000049549885,0.0007578978,0.00023427585,0.0014212361,0.00015637556,0.00004165447,0.005951221],"genre_scores_gemma":[0.9963337,0.00021619104,0.00009672134,0.00031897385,0.0005320778,0.00071443315,0.0000227084,0.000076926204,0.0016882733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968994,0.000110025925,0.00030329925,0.0005687821,0.0012758101,0.0008426778],"domain_scores_gemma":[0.9983822,0.000071768474,0.00005738055,0.0004743056,0.00073401444,0.000280325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040236302,0.00024058543,0.00040893973,0.0003680389,0.00017491651,0.000045946268,0.00020570985,0.00007545722,0.005487926],"category_scores_gemma":[0.00006136808,0.00017347919,0.00006410289,0.0008160633,0.0004287361,0.00015708883,0.000058737816,0.00051366724,0.00024370398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018384013,0.002211463,0.8610356,0.00045343957,0.0007464794,0.0001857036,0.0020888008,0.000017175575,0.003911827,0.00008004936,0.009518149,0.10136733],"study_design_scores_gemma":[0.018992396,0.002292772,0.95883095,0.00063018606,0.00010621693,0.0000028706968,0.00013571316,0.000014440397,0.009557004,0.00011896747,0.009044577,0.00027390572],"about_ca_topic_score_codex":0.008196265,"about_ca_topic_score_gemma":0.0048164893,"teacher_disagreement_score":0.10109343,"about_ca_system_score_codex":0.0009337496,"about_ca_system_score_gemma":0.0014514636,"threshold_uncertainty_score":0.99840826},"labels":[],"label_agreement":null},{"id":"W2887712943","doi":"10.1158/1538-7445.am2018-4985","title":"Abstract 4985: M4OC-Prevent: Clinical evaluation of metformin for oral cancer precision prevention","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Metformin; Head and neck squamous-cell carcinoma; PI3K/AKT/mTOR pathway; Cancer; Ipilimumab; Oncology; Internal medicine; Head and neck cancer; Immunotherapy; Insulin; Apoptosis","score_opus":0.29772944944844615,"score_gpt":0.5771741379978838,"score_spread":0.2794446885494376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887712943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.879538,0.117804155,0.00028244389,0.00003150027,0.0007202846,0.0010435488,0.0000974787,0.0000050763238,0.00047749205],"genre_scores_gemma":[0.94542825,0.049636643,0.0003787541,0.000056005392,0.0022476115,0.001205277,0.00009947644,0.000034957407,0.000913048],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974417,0.00038677012,0.00047114393,0.00048694434,0.00079843495,0.00041500115],"domain_scores_gemma":[0.99715394,0.000068449706,0.0001664567,0.00044269412,0.0020555789,0.00011290856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0073379567,0.0001262455,0.0002464513,0.00009165238,0.0001267535,0.00002249099,0.00031409902,0.0002258306,0.00092538085],"category_scores_gemma":[0.000672022,0.00011173142,0.0001825308,0.00020183955,0.00026735768,0.000014832446,0.0001120409,0.00016427485,0.00001228261],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046846812,0.00013310344,0.00045894223,0.00007553836,0.00010574885,7.0628424e-8,0.00004794513,0.000023627934,0.08012514,0.000036597037,0.01433312,0.90419173],"study_design_scores_gemma":[0.0018970557,0.00067902403,0.0037518519,0.00013698878,0.000100037054,3.013092e-7,0.000055226676,0.0003428715,0.6225524,0.0018718609,0.36844376,0.00016861029],"about_ca_topic_score_codex":0.0001902534,"about_ca_topic_score_gemma":0.0008754456,"teacher_disagreement_score":0.9040231,"about_ca_system_score_codex":0.0000942053,"about_ca_system_score_gemma":0.001105693,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W2887716299","doi":"10.1158/1538-7445.am2018-2354","title":"Abstract 2354: Candidate non-coding driver mutations in super-enhancers and long-range chromatin interaction networks across 1,800 whole cancer genomes","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Enhancer; Genetics; Chromatin; Genome; Gene; Computational biology; Carcinogenesis; Indel; Transcription factor; Epigenetics; Exome; Regulatory sequence; Exome sequencing; Mutation; Single-nucleotide polymorphism","score_opus":0.029086090872542547,"score_gpt":0.364137060523798,"score_spread":0.33505096965125547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887716299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964487,0.0018210262,0.00025351992,0.00047121805,0.00025718956,0.0002628451,0.000111340334,0.000007838883,0.00036633608],"genre_scores_gemma":[0.9956579,0.001980252,0.000033888708,0.000088732566,0.0007659936,0.00027362234,0.00010011137,0.000024975376,0.0010744773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99865294,0.00006219458,0.00022201664,0.00038044454,0.00016394861,0.0005184715],"domain_scores_gemma":[0.9993738,0.000033621243,0.00005530525,0.00021622895,0.00022410524,0.00009695589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003696409,0.00013830935,0.00014248137,0.000088543035,0.0003631625,0.00012443909,0.00017026703,0.00012952213,0.00034381193],"category_scores_gemma":[0.00002493479,0.00013760763,0.00003700193,0.00021633788,0.00029236678,0.000031571995,0.00015487144,0.0002459707,0.000018014709],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032845442,0.00009591117,0.20683129,0.00019199442,0.00016116865,0.000021064232,0.008503609,0.0035940288,0.75961626,0.00003452587,0.0055866675,0.015035038],"study_design_scores_gemma":[0.00225694,0.0004146305,0.75205344,0.0003967214,0.000023990782,0.000020196043,0.005957203,0.002852224,0.20980959,0.00006929604,0.025422288,0.0007234749],"about_ca_topic_score_codex":0.0044261264,"about_ca_topic_score_gemma":0.022113184,"teacher_disagreement_score":0.54980665,"about_ca_system_score_codex":0.000205448,"about_ca_system_score_gemma":0.00021007967,"threshold_uncertainty_score":0.9957307},"labels":[],"label_agreement":null},{"id":"W2887718061","doi":"10.1158/1538-7445.am2018-2556","title":"Abstract 2556: Expanded ovarian cancer patient NK cells represent a novel, cytotoxic phenotype and reduce autologous tumor in a patient-derived xenograft ovarian cancer model","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ovarian cancer; Cancer research; Medicine; Adoptive cell transfer; Cytotoxic T cell; Cancer; Lymphokine-activated killer cell; Immunotherapy; Immunology; Interleukin 21; Biology; T cell; Internal medicine; Immune system; In vitro","score_opus":0.05412749166558638,"score_gpt":0.34368101733641576,"score_spread":0.28955352567082937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887718061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916364,0.00434688,0.00007323327,0.0009111685,0.003007088,0.0010875621,0.00008467497,0.00008124579,0.0012445297],"genre_scores_gemma":[0.9949138,0.00134232,0.00007544492,0.00042851933,0.00017227167,0.0011370972,0.000037446578,0.00005737226,0.0018357396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968388,0.00031374325,0.0006255545,0.0009281018,0.00021232646,0.0010814364],"domain_scores_gemma":[0.99839836,0.00013353296,0.0002263953,0.0005901533,0.0005406846,0.00011089235],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044547772,0.00033678455,0.00044662372,0.00047663407,0.00052429765,0.00008450099,0.00031166108,0.00032722554,0.004474657],"category_scores_gemma":[0.00011793469,0.0003093116,0.00008997419,0.00053685444,0.00064470724,0.00024479607,0.00029370296,0.001186764,0.00018355281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023622068,0.00032121473,0.00023803717,0.000058996877,0.00014953157,0.000016446864,0.0044040782,0.00036205558,0.9654533,0.000049113172,0.010530863,0.016054114],"study_design_scores_gemma":[0.002879758,0.0005590139,0.0033821482,0.00035414635,0.000026647462,0.000028956785,0.0012954855,0.00090624206,0.9633609,0.000068714435,0.026704373,0.00043358188],"about_ca_topic_score_codex":0.023783619,"about_ca_topic_score_gemma":0.0030597057,"teacher_disagreement_score":0.020723913,"about_ca_system_score_codex":0.0007361028,"about_ca_system_score_gemma":0.00082118035,"threshold_uncertainty_score":0.9999359},"labels":[],"label_agreement":null},{"id":"W2887734322","doi":"10.1158/1538-7445.am2018-144","title":"Abstract 144: Dasatinib enhances the effects of paclitaxel on chemotherapy-resistant breast cancer through targeting breast cancer stem cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dasatinib; Paclitaxel; Cancer research; Chemotherapy; Breast cancer; Stem cell; Cancer stem cell; Medicine; Triple-negative breast cancer; Metastasis; Oncology; Internal medicine; Cancer; Biology; Imatinib; Cell biology","score_opus":0.035407558111773194,"score_gpt":0.3721154891941509,"score_spread":0.3367079310823777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887734322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423357,0.011086118,0.000024225534,0.0083723925,0.0013565168,0.0020770957,0.0007537871,0.000087944085,0.0020083743],"genre_scores_gemma":[0.9864844,0.008260186,0.000048156733,0.0008609814,0.0021137793,0.0009268774,0.0000079983065,0.00015414073,0.0011434774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950203,0.00030815284,0.00064286776,0.0009240528,0.001848599,0.0012560647],"domain_scores_gemma":[0.99648386,0.0005961561,0.0003350631,0.0010241648,0.0012704696,0.00029025803],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011145665,0.00045075206,0.0006950063,0.00019684233,0.0004792795,0.000074414216,0.0006181803,0.00027730796,0.0022554703],"category_scores_gemma":[0.000070842536,0.00031220826,0.00025298333,0.0011331447,0.0014347568,0.00015567387,0.00014548947,0.0012902751,0.00008398255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029143968,0.00024789243,0.0006304001,0.0012758304,0.00045704635,0.000041559713,0.0025897122,0.000031288324,0.9385544,0.00009090043,0.023401313,0.029765239],"study_design_scores_gemma":[0.0027301477,0.00060418353,0.020790137,0.0042139604,0.0001019041,0.000014928575,0.00074398424,0.000036454367,0.9596492,0.000065867294,0.010700874,0.0003483458],"about_ca_topic_score_codex":0.01159554,"about_ca_topic_score_gemma":0.0013392564,"teacher_disagreement_score":0.029416893,"about_ca_system_score_codex":0.0012205399,"about_ca_system_score_gemma":0.0017384652,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W2887806952","doi":"10.1158/1538-7445.am2018-756","title":"Abstract 756: Development of next-generation antibody-drug conjugates for resistant HER2-positive tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Antibody-drug conjugate; Cytotoxic T cell; Cancer research; Antibody; Cancer; Chemistry; Cancer cell; Drug delivery; In vivo; Pharmacology; In vitro; Medicine; Biology; Biochemistry; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.22731882205759396,"score_gpt":0.49274887540770745,"score_spread":0.2654300533501135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887806952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898303,0.0015937284,0.00018055702,0.0021967452,0.00022509937,0.0020707126,0.00011520079,0.000038283557,0.0037493529],"genre_scores_gemma":[0.9921828,0.00031603986,0.0031191267,0.000111684385,0.0012125054,0.0006307189,0.00013296312,0.00007018352,0.0022239913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99624014,0.00014946287,0.0006006465,0.0006033646,0.0014948574,0.00091155566],"domain_scores_gemma":[0.995889,0.00035404915,0.00010841581,0.0004902717,0.002822112,0.00033616612],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002988444,0.00019810388,0.0004250835,0.00039781714,0.00045334577,0.00008337597,0.000326232,0.00011571852,0.0009882429],"category_scores_gemma":[0.000545469,0.0001740907,0.000091616545,0.00066180085,0.0008017914,0.00014543107,0.00013846264,0.0004963267,0.00009865482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015117759,0.00016464584,0.0013969844,0.00079535134,0.00011392816,0.000022210113,0.0021663145,0.0000020789394,0.95527315,0.00026477638,0.019121496,0.019167317],"study_design_scores_gemma":[0.0012320288,0.00068510993,0.016723754,0.0011642558,0.000014567427,0.000003743658,0.0007176148,0.00022791179,0.94683164,0.000103680846,0.03210995,0.00018571029],"about_ca_topic_score_codex":0.0011650842,"about_ca_topic_score_gemma":0.0011702392,"teacher_disagreement_score":0.018981608,"about_ca_system_score_codex":0.000930249,"about_ca_system_score_gemma":0.0038814272,"threshold_uncertainty_score":0.999925},"labels":[],"label_agreement":null},{"id":"W2887831040","doi":"10.1158/1538-7445.am2018-5535","title":"Abstract 5535: C-EDRN and US-EDRN collaboration on systematic review and meta-analysis of the association between <i>RAD51</i> 135G/C genetic biomarker and cancer risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cochrane Library; Meta-analysis; Medicine; Odds ratio; Confidence interval; Oncology; Biomarker; Publication bias; MEDLINE; Internal medicine; Cancer; Bioinformatics; Genetics; Biology","score_opus":0.05960457041680374,"score_gpt":0.4144859706367135,"score_spread":0.35488140021990977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887831040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171259,0.07887176,0.00010639542,0.0017854824,0.0000126139985,0.00140789,0.0005666895,0.0000060951793,0.00011717242],"genre_scores_gemma":[0.9613412,0.03720507,0.00008103106,0.0003737213,0.000039614344,0.0006516812,0.00003060195,0.000012339531,0.00026472355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985786,0.00037752744,0.00028368575,0.00035922718,0.00022442953,0.00017651252],"domain_scores_gemma":[0.9987466,0.00007873615,0.00026213424,0.0004179478,0.0004363542,0.00005822981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010474641,0.000118620796,0.00048487599,0.00007734467,0.00019738512,0.000032153337,0.00014773819,0.00014936723,0.000032659784],"category_scores_gemma":[0.00021087678,0.00007748946,0.00011087554,0.00053058105,0.00023557243,0.000003694959,0.00011997442,0.0001248709,7.6258067e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009904386,0.00013716173,0.15231243,0.024131538,0.11671605,0.000001122194,0.00022756713,0.000019983618,0.6906784,0.00029064753,0.013360718,0.002025311],"study_design_scores_gemma":[0.00075280294,0.00064394495,0.4828702,0.0012773382,0.28555664,0.000003503806,0.000088889006,0.00015294424,0.21500197,0.0003517348,0.012508265,0.00079175644],"about_ca_topic_score_codex":0.00039940592,"about_ca_topic_score_gemma":0.00060506683,"teacher_disagreement_score":0.47567645,"about_ca_system_score_codex":0.000040599523,"about_ca_system_score_gemma":0.00007596663,"threshold_uncertainty_score":0.31599283},"labels":[],"label_agreement":null},{"id":"W2887852867","doi":"10.1158/1538-7445.am2018-760","title":"Abstract 760: Conjugation of daratumumab with 225actinium greatly increases its antitumor activity against multiple myeloma tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Antibody; Cancer research; Pharmacology; Immunology; Internal medicine; Bortezomib","score_opus":0.12098331309588525,"score_gpt":0.4430536604930638,"score_spread":0.32207034739717855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887852867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860022,0.00019108853,0.000019490804,0.00065768976,0.000018446723,0.0005424454,0.00008078726,0.000052393174,0.012435472],"genre_scores_gemma":[0.9988526,0.00010828431,0.000074041156,0.00004086611,0.00033874056,0.0001624727,0.000025544181,0.000022433758,0.00037500376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851996,0.000047051624,0.00018549494,0.00033527552,0.0005546034,0.0003575982],"domain_scores_gemma":[0.9983444,0.00024916817,0.0000843041,0.00035763273,0.00073883997,0.00022565987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035056882,0.00012588789,0.00024308177,0.000086819484,0.00023174276,0.000021703221,0.0001496175,0.00007070863,0.0003001929],"category_scores_gemma":[0.00029902943,0.00010144435,0.00004247663,0.0005287373,0.00066088774,0.0001334413,0.000043226402,0.00046154947,0.000047811027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017353615,0.0003226263,0.009588302,0.00040228074,0.000054819062,0.0000341929,0.00006394854,0.0000054940488,0.9830038,0.00007758611,0.0005906467,0.004120926],"study_design_scores_gemma":[0.0013201454,0.00018395294,0.08870078,0.0003104881,0.00002202943,0.000019412273,0.00012893153,0.00039202673,0.9065002,0.000009530915,0.0023128847,0.000099585784],"about_ca_topic_score_codex":0.0002559859,"about_ca_topic_score_gemma":0.000035917616,"teacher_disagreement_score":0.07911248,"about_ca_system_score_codex":0.00014841316,"about_ca_system_score_gemma":0.0004739058,"threshold_uncertainty_score":0.41367805},"labels":[],"label_agreement":null},{"id":"W2887876969","doi":"10.1158/1538-7445.am2018-2952","title":"Abstract 2952: Targeting CDK9 reactivates epigenetically silenced genes in cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Epigenome; H3K4me3; Cancer epigenetics; Cancer research; Genetics; Molecular biology; Promoter; Gene; Gene expression; Histone methyltransferase","score_opus":0.07100962441953756,"score_gpt":0.4219052701682606,"score_spread":0.35089564574872306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887876969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867862,0.00956991,0.00006216563,0.0006830531,0.00018735281,0.0002598258,0.00003107977,0.0000104762985,0.002409961],"genre_scores_gemma":[0.98914284,0.0077577,0.00018785872,0.000107909524,0.0011698762,0.00050958275,0.000025408213,0.000033203458,0.0010655993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981889,0.00009221675,0.00024786903,0.0005474078,0.00032393783,0.000599629],"domain_scores_gemma":[0.99888504,0.00003342271,0.00005169765,0.00040476254,0.00049871986,0.00012638325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000640864,0.00013761282,0.00013525948,0.00011416081,0.00019843345,0.00005264202,0.0003807854,0.00015620768,0.0008569793],"category_scores_gemma":[0.0001396325,0.00012731239,0.000048446775,0.00036260264,0.00037772584,0.000008639925,0.0001349024,0.0002528924,0.000044310298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010554868,0.000048392827,0.008761645,0.000021420428,0.00001998372,0.0000021413564,0.000082499486,0.00007155008,0.956571,0.00004838092,0.004697197,0.029570263],"study_design_scores_gemma":[0.00030017493,0.00011809347,0.036105223,0.00006132554,0.0000028900163,5.92223e-7,0.00018044698,0.000037247268,0.8835097,0.00013089618,0.07936682,0.00018661813],"about_ca_topic_score_codex":0.0020439175,"about_ca_topic_score_gemma":0.0014383446,"teacher_disagreement_score":0.07466962,"about_ca_system_score_codex":0.00011941644,"about_ca_system_score_gemma":0.00050625124,"threshold_uncertainty_score":0.9383322},"labels":[],"label_agreement":null},{"id":"W2887883538","doi":"10.1158/1538-7445.am2018-148","title":"Abstract 148: Canonical Wnt activation as a therapeutic strategy in pediatric medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; SOX2; Medulloblastoma; Cancer research; LRP5; BMI1; Cancer stem cell; Biology; LRP6; Stem cell; Medicine; Oncology; Transcription factor; Cell biology; Signal transduction; Gene; Genetics","score_opus":0.05206779678739998,"score_gpt":0.40435904771868164,"score_spread":0.35229125093128166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887883538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963897,0.0008658958,0.000022340904,0.00029403256,0.000054516822,0.00027235187,0.000005292563,0.000008028219,0.00208787],"genre_scores_gemma":[0.9982516,0.0003150273,0.000008241552,0.000064924454,0.0008799165,0.0001068104,0.000026994778,0.000022054966,0.00032441545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866855,0.000116355965,0.00016501213,0.00035208868,0.000322085,0.0003759263],"domain_scores_gemma":[0.99930817,0.000026721367,0.00004027091,0.0002647179,0.00025581193,0.00010430312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042897707,0.00009727976,0.00008189078,0.00013496757,0.000081473,0.000036200898,0.00020579094,0.0001559759,0.00036596076],"category_scores_gemma":[0.00009130528,0.00009387521,0.000036656314,0.00033220448,0.00014902637,0.0000075121275,0.0000763075,0.00019708651,0.00007701656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002943913,0.00007016219,0.0044361553,0.000032117507,0.000016179474,0.0000031737427,0.00003586718,0.000072728784,0.9886857,0.00012518435,0.0013509997,0.0048773303],"study_design_scores_gemma":[0.0005778646,0.00032507072,0.32501662,0.00002575397,0.000005727829,0.0000027187884,0.000055033914,0.000043248354,0.66881794,0.00047611847,0.004492049,0.00016184985],"about_ca_topic_score_codex":0.00047865437,"about_ca_topic_score_gemma":0.0007842482,"teacher_disagreement_score":0.32058045,"about_ca_system_score_codex":0.0001543492,"about_ca_system_score_gemma":0.0009818678,"threshold_uncertainty_score":0.40070137},"labels":[],"label_agreement":null},{"id":"W2887883897","doi":"10.1158/1538-7445.am2018-5476","title":"Abstract 5476: Inhibiting lactate transporters MCT-1 and MCT-4 target hypoxic HNSCC cells and sensitize them to metformin","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Metformin; Hypoxia (environmental); Head and neck squamous-cell carcinoma; Radioresistance; Extracellular; Biology; Cancer research; Glycolysis; Glucose transporter; Chemistry; Cell culture; Pharmacology; Cell biology; Metabolism; Oxygen; Internal medicine; Biochemistry; Endocrinology; Medicine; Cancer; Head and neck cancer; Diabetes mellitus; Insulin","score_opus":0.041172361454797315,"score_gpt":0.333185373582648,"score_spread":0.2920130121278507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887883897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939287,0.0030045265,0.00008020948,0.00037263244,0.0003677807,0.0003564622,0.00014210762,0.000013833898,0.0017337822],"genre_scores_gemma":[0.9917305,0.0039288523,0.0005741763,0.0003902001,0.001886352,0.000058192083,0.000023373064,0.000042856096,0.0013654844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820215,0.00006334698,0.00021683748,0.00057537074,0.000297072,0.0006452358],"domain_scores_gemma":[0.99908036,0.000035387486,0.00004443031,0.0002727608,0.00023159961,0.0003354809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079318025,0.00019117442,0.0002284188,0.00010341181,0.0002300442,0.00007372193,0.0001436035,0.00014146572,0.00010650807],"category_scores_gemma":[0.0000455265,0.00017829616,0.000055242523,0.00019403642,0.0003599884,0.000013549027,0.00011948136,0.00023499149,0.000023676972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024102269,0.000015495187,0.00014614883,0.000056210494,0.000037899124,0.000006780462,0.0005992494,0.0000035317346,0.967927,0.0000148461395,0.00673216,0.024219697],"study_design_scores_gemma":[0.000594146,0.00012853454,0.0016206574,0.00003953112,0.000012087476,0.000014494533,0.0003273202,0.000008189329,0.7937648,0.000069027104,0.2032171,0.00020410107],"about_ca_topic_score_codex":0.00042196512,"about_ca_topic_score_gemma":0.00037536173,"teacher_disagreement_score":0.19648494,"about_ca_system_score_codex":0.000031370997,"about_ca_system_score_gemma":0.00019254973,"threshold_uncertainty_score":0.7270706},"labels":[],"label_agreement":null},{"id":"W2887887860","doi":"10.1158/1538-7445.am2018-4056","title":"Abstract 4056: Immune regulation by miR-1227 LO","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Prostate cancer; Immune system; Cancer research; Microvesicles; Cancer; microRNA; Stromal cell; Cancer cell; Prostate; Immunology; Biology; Immunotherapy; Gene","score_opus":0.03434951456023669,"score_gpt":0.3867912546678661,"score_spread":0.3524417401076294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887887860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641586,0.00743862,0.00016475096,0.00042661684,0.00016953408,0.00023275292,0.000048286456,0.000015547068,0.00508804],"genre_scores_gemma":[0.99180543,0.00022008603,0.00010016462,0.000071268885,0.00084322866,0.000068238485,0.00015151741,0.000035038258,0.0067050504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985463,0.000093697214,0.00017412199,0.00039727555,0.00036276664,0.00042580653],"domain_scores_gemma":[0.9988594,0.000016608496,0.00004351585,0.0005938998,0.0003384619,0.00014813352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057707523,0.000107506035,0.000085776366,0.00005201424,0.00018510128,0.00005809713,0.00035572355,0.00014546463,0.00088749325],"category_scores_gemma":[0.0001340389,0.00010886719,0.00005910402,0.00017330034,0.0004325708,0.0000064590404,0.00016998714,0.00018189853,0.00023486103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014303776,0.00005505172,0.0003685553,0.000022014936,0.00001893958,0.000002525271,0.00002663763,0.0000027019037,0.9104064,0.000048885555,0.08431893,0.0045862887],"study_design_scores_gemma":[0.00031953352,0.0001061151,0.0047192234,0.000016719894,0.0000036327592,0.0000012651666,0.000028430544,0.000016357217,0.81619656,0.00020086858,0.17827453,0.00011677844],"about_ca_topic_score_codex":0.00013690827,"about_ca_topic_score_gemma":0.000034104254,"teacher_disagreement_score":0.094209895,"about_ca_system_score_codex":0.00006443496,"about_ca_system_score_gemma":0.00019020132,"threshold_uncertainty_score":0.9717429},"labels":[],"label_agreement":null},{"id":"W2887896405","doi":"10.1158/1538-7445.am2018-395","title":"Abstract 395: Identifying the functional drivers of noncoding somatic mutations in ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Somatic cell; Epigenetics; Epigenomics; Genetics; Ovarian cancer; Transcriptome; Germline; Gene; Germline mutation; Cancer research; Computational biology; Cancer; DNA methylation; Mutation; Gene expression","score_opus":0.08999697430389697,"score_gpt":0.40228760565864863,"score_spread":0.31229063135475166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887896405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964973,0.0010872814,0.00020832047,0.0004993673,0.0003355873,0.00019758233,0.00005320481,0.0000021877645,0.0011191976],"genre_scores_gemma":[0.9981031,0.0008272922,0.00006433897,0.00007241228,0.0005788532,0.00012540774,0.000019750452,0.000013344655,0.00019550657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990741,0.000042322627,0.00017704503,0.00020974684,0.00024049064,0.0002562689],"domain_scores_gemma":[0.99933416,0.00009042707,0.000053687418,0.00022555754,0.0002482492,0.00004793714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045139395,0.00006841977,0.00008277727,0.00009356686,0.00017838422,0.00003353177,0.00020172232,0.00006278427,0.00042662665],"category_scores_gemma":[0.00013301804,0.000058263162,0.00004270387,0.00022702609,0.00029836208,0.000005454183,0.000115015704,0.00015592968,0.000013323064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068075526,0.000032779266,0.016809534,0.000047055084,0.000047972586,0.0000022485108,0.0005247946,0.0008880867,0.97458726,0.00031046447,0.004262915,0.0024188217],"study_design_scores_gemma":[0.0012744624,0.00014428128,0.44736114,0.00020717685,0.000022939657,0.0000031703469,0.0015864581,0.00030406046,0.5336534,0.0011073699,0.014099656,0.00023589365],"about_ca_topic_score_codex":0.0019514028,"about_ca_topic_score_gemma":0.0061015813,"teacher_disagreement_score":0.44093385,"about_ca_system_score_codex":0.000110171626,"about_ca_system_score_gemma":0.00053535466,"threshold_uncertainty_score":0.46712625},"labels":[],"label_agreement":null},{"id":"W2887898086","doi":"10.1158/1538-7445.am2018-1931","title":"Abstract 1931: Targeting master neuronal transcription factor BRN2 in neuroendocrine prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer research; Enzalutamide; SOX2; Prostate cancer; Transcription factor; Biology; Medicine; Androgen receptor; Bioinformatics; Cancer; Internal medicine; Genetics","score_opus":0.12513314642690165,"score_gpt":0.4222211547800229,"score_spread":0.29708800835312127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887898086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525465,0.0030510435,0.000002836656,0.007888655,0.00043429545,0.0013992023,0.00013531942,0.000063272426,0.001770709],"genre_scores_gemma":[0.9861493,0.003724411,0.000032161017,0.00027613412,0.0010308712,0.0006847433,0.00004711464,0.000075194635,0.007980067],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962089,0.00016209975,0.0003972134,0.0007091473,0.0011657709,0.0013568875],"domain_scores_gemma":[0.9985933,0.00009424413,0.00005060139,0.00032748177,0.00056780543,0.00036661868],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043882692,0.00025013505,0.00034126846,0.00053877354,0.00023928254,0.000092532515,0.00022840226,0.00006544632,0.004935961],"category_scores_gemma":[0.00009132496,0.00019708775,0.000095334915,0.0009189984,0.00051306415,0.0002758531,0.00009749933,0.0011441531,0.0001708337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045103086,0.00033883032,0.16113901,0.0005828444,0.000085193016,0.0006208816,0.001539773,0.000012433903,0.7639292,0.00002058229,0.009958994,0.057261966],"study_design_scores_gemma":[0.008053254,0.0013922494,0.6198372,0.0008129666,0.000027634951,0.000024193296,0.0004158101,0.00027054528,0.2874242,0.00014700375,0.08118453,0.00041035615],"about_ca_topic_score_codex":0.0024420226,"about_ca_topic_score_gemma":0.0010308722,"teacher_disagreement_score":0.47650498,"about_ca_system_score_codex":0.0007305205,"about_ca_system_score_gemma":0.000876252,"threshold_uncertainty_score":0.99597365},"labels":[],"label_agreement":null},{"id":"W2887908010","doi":"10.1158/1538-7445.am2018-1388","title":"Abstract 1388: Pharmacologic targeting of DNA methylation blocks breast cancer growth and metastasis","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; Cancer research; Epigenetics; Decitabine; Metastasis; Cancer; Demethylating agent; Breast cancer; Metastatic breast cancer; Methylation; Biology; Cancer cell; Medicine; Gene; Gene expression; Internal medicine; Genetics","score_opus":0.05469067231001409,"score_gpt":0.4076107121087112,"score_spread":0.3529200397986971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887908010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902717,0.008001456,0.00013643863,0.0004435201,0.00011957599,0.00019637524,0.00009859379,0.0000056074346,0.00072677265],"genre_scores_gemma":[0.9925078,0.006430501,0.00022963666,0.00003891246,0.0005969997,0.00006534723,0.000024313946,0.000017629105,0.00008882408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987645,0.00012594779,0.00020781829,0.00033165998,0.00027246017,0.0002975991],"domain_scores_gemma":[0.99904585,0.000043180455,0.00008983121,0.00014273167,0.0005827675,0.000095660114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008955402,0.00010498851,0.00013238311,0.00009727622,0.00015351984,0.000023170442,0.00014143187,0.00011058145,0.00032213842],"category_scores_gemma":[0.00009798886,0.00009360964,0.000041061492,0.00022594612,0.0002794357,0.0000069841717,0.00012704075,0.00014166463,0.0000021635758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010913925,0.000026838652,0.0044941874,0.000044634286,0.00007169834,5.604083e-7,0.0000672713,0.000020250807,0.97743326,0.000017772461,0.00064820034,0.017066186],"study_design_scores_gemma":[0.00031659775,0.000122322,0.017796595,0.000015405516,0.000020418698,4.973891e-7,0.00005076725,0.000038204365,0.97801936,0.00019710309,0.0033198139,0.00010293419],"about_ca_topic_score_codex":0.0005671191,"about_ca_topic_score_gemma":0.00008180544,"teacher_disagreement_score":0.016963251,"about_ca_system_score_codex":0.000026710697,"about_ca_system_score_gemma":0.00014528671,"threshold_uncertainty_score":0.38172904},"labels":[],"label_agreement":null},{"id":"W2887923686","doi":"10.1158/1538-7445.am2018-1918","title":"Abstract 1918: Patient-derived hormone-naive prostate cancer xenograft models reveal <i>GRB10</i> as an AR-repressed gene driving the development of castration-resistant prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Androgen receptor; Gene knockdown; Cancer research; Medicine; Cancer; Downregulation and upregulation; Oncology; Internal medicine; Biology; Gene; Genetics","score_opus":0.08406928269049439,"score_gpt":0.3961882916589949,"score_spread":0.3121190089685005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887923686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834499,0.00845811,0.000013020153,0.0022371332,0.0002476931,0.0040466045,0.0003703224,0.00007985496,0.0010973654],"genre_scores_gemma":[0.9870844,0.0051043076,0.00063831644,0.00013924547,0.0004986754,0.0042838245,0.00014568091,0.00012663867,0.0019789157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934728,0.00030314902,0.001010697,0.0011319111,0.002404889,0.0016765132],"domain_scores_gemma":[0.9948349,0.00016481316,0.00035145265,0.0010139733,0.0029453407,0.0006895474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014323912,0.0005017209,0.000658394,0.00038632503,0.0011843267,0.00019118139,0.0005888125,0.00019905655,0.000573658],"category_scores_gemma":[0.00009357103,0.00034159998,0.00014725422,0.001152955,0.0013079958,0.00056544534,0.0003319573,0.00097293296,0.000035400983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061805574,0.00040483032,0.004709201,0.00034881206,0.00057819224,0.00008525309,0.02490626,0.00025881216,0.91068065,0.000021815926,0.0028704263,0.048955202],"study_design_scores_gemma":[0.0043454664,0.0016078497,0.05044364,0.0011233138,0.00011507496,0.000009149379,0.0030787622,0.0003621471,0.9328576,0.00048277347,0.005033836,0.00054038194],"about_ca_topic_score_codex":0.009030598,"about_ca_topic_score_gemma":0.005585032,"teacher_disagreement_score":0.04841482,"about_ca_system_score_codex":0.0013673609,"about_ca_system_score_gemma":0.006738339,"threshold_uncertainty_score":0.9999036},"labels":[],"label_agreement":null},{"id":"W2887931996","doi":"10.1158/1538-7445.am2018-991","title":"Abstract 991: Development and characterization of patient derived xenografts from central nervous system metastasis reveal minor clone expansion linked with aggressive tumor behavior","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Downregulation and upregulation; Metastasis; Cancer research; Biology; Cancer; Pathology; Gene; Medicine; Genetics","score_opus":0.029999810771665192,"score_gpt":0.318444644707394,"score_spread":0.2884448339357288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887931996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789125,0.0009156235,0.000022995315,0.00002683794,0.000074019365,0.00072670024,0.00030860765,0.000008970078,0.000024976807],"genre_scores_gemma":[0.99810886,0.00019867336,0.0003963274,0.00001343429,0.0002115158,0.0004864503,0.00051639345,0.00002810872,0.000040256775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815285,0.00010643468,0.00024626686,0.00045677237,0.0005050068,0.00053269404],"domain_scores_gemma":[0.9988214,0.000013365437,0.00016865034,0.00028098974,0.0004791107,0.00023649269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014033627,0.00016393034,0.00020732523,0.0000961608,0.00020564605,0.00004195927,0.00014292203,0.00007552448,0.000039356262],"category_scores_gemma":[0.000020822286,0.00012966464,0.000034421224,0.0001598126,0.00026431395,0.000011920944,0.00016999392,0.00012645913,0.000004917159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012423382,0.0001349491,0.009143386,0.00009070649,0.00015974785,0.00008019196,0.00049025915,5.1096447e-7,0.94341075,9.0434435e-7,0.00006196888,0.045184303],"study_design_scores_gemma":[0.00082427426,0.00062335806,0.19676407,0.00022877508,0.000023920249,0.000008252066,0.00023153152,0.0000020123753,0.80020905,4.3907124e-7,0.0009680397,0.00011626145],"about_ca_topic_score_codex":0.0018791532,"about_ca_topic_score_gemma":0.00090007094,"teacher_disagreement_score":0.18762068,"about_ca_system_score_codex":0.00015561456,"about_ca_system_score_gemma":0.0004782631,"threshold_uncertainty_score":0.52875704},"labels":[],"label_agreement":null},{"id":"W2887967777","doi":"10.1158/1538-7445.am2018-4187","title":"Abstract 4187: Targeting the cytoskeleton protein ezrin sensitizes metastatic breast cancer cells to anthracycline based chemotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Ezrin; Medicine; Anthracycline; Metastasis; Chemotherapy; Cancer; Cancer research; Metastatic breast cancer; Breast cancer; Tissue microarray; Doxorubicin; Oncology; Internal medicine; Cell; Biology; Cytoskeleton","score_opus":0.02701173445904384,"score_gpt":0.36614939404828645,"score_spread":0.3391376595892426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887967777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918164,0.00057086605,0.00071005104,0.0054390114,0.00014189332,0.0009264882,0.00021706012,0.000015517877,0.000162715],"genre_scores_gemma":[0.99495906,0.0004718006,0.0007163123,0.0013830694,0.0012503293,0.0003570632,0.000038470796,0.00005965467,0.0007642543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980431,0.00017175922,0.00024175877,0.0005191147,0.00036553538,0.00065870455],"domain_scores_gemma":[0.9986921,0.00004058779,0.000067997506,0.00050781714,0.000529147,0.00016235777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009485483,0.00019805015,0.00018159428,0.00008002279,0.00032811626,0.0000800246,0.00040682816,0.00009698283,0.0005079565],"category_scores_gemma":[0.00005796533,0.00014582655,0.000088901106,0.00030758686,0.00030754684,0.000005989804,0.00013852528,0.00028974673,0.000056091394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033504673,0.00006426865,0.000084195824,0.00005543245,0.000058548925,0.000004025671,0.00009293303,0.00012936012,0.97803926,0.0000051975385,0.013220129,0.007911592],"study_design_scores_gemma":[0.0005318298,0.00014745591,0.0006665881,0.0000843336,0.000007977533,0.000002399701,0.00012554765,0.00024016925,0.95811844,0.000013137407,0.039870054,0.0001920733],"about_ca_topic_score_codex":0.0015333599,"about_ca_topic_score_gemma":0.0011197822,"teacher_disagreement_score":0.026649926,"about_ca_system_score_codex":0.00008678501,"about_ca_system_score_gemma":0.00044550558,"threshold_uncertainty_score":0.59466344},"labels":[],"label_agreement":null},{"id":"W2887985782","doi":"10.1158/1538-7445.am2018-3672","title":"Abstract 3672: The three-dimensional (3D) spatial lamin A/C organization in normal lymphocytes, and in Hodgkin and Reed-Sternberg cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital; University of Manitoba","funders":"","keywords":"Telomere; Lamin; Genome instability; Downregulation and upregulation; Shelterin; Biology; Cell biology; Molecular biology; DNA damage; Cancer research; DNA; Genetics; Gene; Nucleus; DNA-binding protein","score_opus":0.015796709142161924,"score_gpt":0.2901347021639574,"score_spread":0.2743379930217955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887985782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987259,0.00045023044,0.00003333294,0.00022262447,0.000120566285,0.00013436588,0.00000672644,0.0000021176147,0.00030415427],"genre_scores_gemma":[0.99906766,0.00019382102,0.00004480512,0.0001068204,0.00033810537,0.000007640731,0.000017120434,0.000013586136,0.00021041076],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992904,0.00004994778,0.000099400815,0.00022683888,0.000141893,0.00019150104],"domain_scores_gemma":[0.99967,0.000018953719,0.00002032527,0.00013404727,0.000121425626,0.00003524786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029188304,0.00006731136,0.00006152,0.000058812388,0.000088269895,0.00003128145,0.00007805025,0.000101305595,0.00017096376],"category_scores_gemma":[0.000042493008,0.000051882987,0.0000059977715,0.00019125122,0.00019265129,0.000006467738,0.0001333123,0.00013179153,0.00001300715],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037139526,0.000016484675,0.04183116,0.000018993767,0.000009083749,0.0000048637476,0.000121459656,0.000045849643,0.9394286,0.00001391461,0.0020447236,0.016093468],"study_design_scores_gemma":[0.0012988639,0.0002421535,0.60119534,0.000037403024,0.0000033536762,0.000013268874,0.000051994026,0.00043902476,0.38504848,0.0000632845,0.011453826,0.00015299904],"about_ca_topic_score_codex":0.0021331934,"about_ca_topic_score_gemma":0.012962315,"teacher_disagreement_score":0.5593642,"about_ca_system_score_codex":0.00003736316,"about_ca_system_score_gemma":0.000108546126,"threshold_uncertainty_score":0.72332764},"labels":[],"label_agreement":null},{"id":"W2888792762","doi":"10.1158/1538-7445.prca2017-b098","title":"Abstract B098: Genomic variations associated with prostate cancer in large cohort of African American men","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Race (biology); Oncology; Cohort; Internal medicine; Incidence (geometry); Health equity; Demography; Pathology; Biology; Public health","score_opus":0.04575613373163134,"score_gpt":0.41053103649439265,"score_spread":0.3647749027627613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888792762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830108,0.00083140976,0.0000042448623,0.0022163808,0.000044993118,0.0016511211,0.000448107,0.000033786142,0.011759103],"genre_scores_gemma":[0.99210715,0.0018323037,0.000036474856,0.00004214723,0.00017548837,0.0010282536,0.00006841168,0.000053111424,0.0046566264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698055,0.00016310216,0.00033458264,0.000484999,0.0010157508,0.0010210389],"domain_scores_gemma":[0.99792683,0.00017644609,0.00014063659,0.0003991382,0.001091917,0.00026503394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013406882,0.00017802253,0.00047791205,0.00053050014,0.00019108556,0.00003137248,0.00022100723,0.00007281194,0.0014129888],"category_scores_gemma":[0.00014608893,0.00013211252,0.00005261888,0.0020365294,0.0009850839,0.000101146055,0.0001056131,0.00059398054,0.000035634603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032943764,0.0005883096,0.945772,0.00011291362,0.0006100792,0.00008026591,0.0029561373,0.000015534088,0.038599323,0.000067749315,0.0023710444,0.0055322614],"study_design_scores_gemma":[0.003422152,0.000913925,0.9826645,0.0003920428,0.000049711543,0.0000013445291,0.0008623369,0.00015287509,0.009429749,0.000053423868,0.0019072711,0.00015066714],"about_ca_topic_score_codex":0.013136283,"about_ca_topic_score_gemma":0.009390073,"teacher_disagreement_score":0.036892496,"about_ca_system_score_codex":0.0017535641,"about_ca_system_score_gemma":0.00239305,"threshold_uncertainty_score":0.99949986},"labels":[],"label_agreement":null},{"id":"W2890255088","doi":"10.1158/1538-7445.prca2017-a079","title":"Abstract A079: MicroRNA-139 regulates prostate cancer aggressiveness by targeting IGF1R","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Biochemical recurrence; Medicine; Prostatectomy; Proportional hazards model; microRNA; Oncology; Hazard ratio; Internal medicine; Metastasis; Cancer; Lymph node; Biology; Gene; Confidence interval","score_opus":0.02320774681538244,"score_gpt":0.37176432744023086,"score_spread":0.3485565806248484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890255088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641602,0.031055342,0.00026834596,0.0014707281,0.000591602,0.0010015958,0.00035008063,0.00004752303,0.001054595],"genre_scores_gemma":[0.98184973,0.00843414,0.00013902789,0.0002091688,0.001542134,0.0007709017,0.00023515428,0.00015170609,0.0066680117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957293,0.00027232664,0.00038530657,0.0011284287,0.0009826147,0.0015020171],"domain_scores_gemma":[0.9972249,0.00004264583,0.00014491084,0.000763927,0.0014444668,0.00037912294],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012452967,0.0003315424,0.0002800814,0.00020931964,0.00059881434,0.00018106672,0.0008460575,0.00039332197,0.0011243781],"category_scores_gemma":[0.00029130437,0.0003236526,0.00013423113,0.00065481605,0.0008008042,0.000018048106,0.000600983,0.0007542677,0.00010081687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050046464,0.00005589035,0.00013809981,0.00009307345,0.0001283176,0.000019875817,0.00013100792,0.000062768726,0.88491774,0.000012546291,0.10259365,0.011346549],"study_design_scores_gemma":[0.0006920541,0.00023250016,0.0001621775,0.00018454914,0.00000875868,0.0000052112246,0.00010221808,0.000035703863,0.76894194,0.00008490754,0.22924368,0.0003063122],"about_ca_topic_score_codex":0.0017946189,"about_ca_topic_score_gemma":0.00045557154,"teacher_disagreement_score":0.12665004,"about_ca_system_score_codex":0.0003206963,"about_ca_system_score_gemma":0.0010844673,"threshold_uncertainty_score":0.99992156},"labels":[],"label_agreement":null},{"id":"W2890269457","doi":"10.1158/1538-7445.prca2017-b100","title":"Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Oncology; Germline; Internal medicine; Germline mutation; Disease; Cancer research; Pathology; Mutation; Biology; Gene; Genetics","score_opus":0.05720151627534745,"score_gpt":0.4092838500741783,"score_spread":0.3520823337988308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890269457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97345394,0.020983944,8.2552623e-7,0.0019281524,0.00018395882,0.0011610825,0.00034248873,0.000039337297,0.0019062796],"genre_scores_gemma":[0.9602283,0.034827676,0.00009192023,0.000073869094,0.000550203,0.0003768687,0.000021579874,0.000046651512,0.003782912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973195,0.00014363544,0.00029155696,0.00059297594,0.00079949165,0.0008528196],"domain_scores_gemma":[0.9981432,0.00015018505,0.00010504574,0.00046139775,0.00081678753,0.0003233794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010033326,0.00021126398,0.00042559937,0.00034012416,0.0003117982,0.00005116639,0.00021169875,0.00015301263,0.0011373588],"category_scores_gemma":[0.00013085124,0.00014522679,0.000069473506,0.0005423481,0.0014492236,0.000095066236,0.00021909534,0.0007854937,0.000046192526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048853033,0.00026285095,0.14566156,0.0008076263,0.00040394184,0.00057329715,0.0026487035,0.0000061676733,0.6997322,0.00018089535,0.010339213,0.13449827],"study_design_scores_gemma":[0.0039006271,0.0015283757,0.7317479,0.00046847895,0.000078778095,0.00004318834,0.00043767985,0.000012549146,0.25492522,0.0008514002,0.005788993,0.00021678538],"about_ca_topic_score_codex":0.007583149,"about_ca_topic_score_gemma":0.0008498392,"teacher_disagreement_score":0.58608633,"about_ca_system_score_codex":0.0004552308,"about_ca_system_score_gemma":0.00097371894,"threshold_uncertainty_score":0.9997757},"labels":[],"label_agreement":null},{"id":"W2890332162","doi":"10.1158/1538-7445.prca2017-a066","title":"Abstract A066: Rb and ZBTB7A cooperatively mediate the transcriptional repression function of androgen receptor","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Androgen receptor; Gene silencing; Prostate cancer; Biology; Cancer research; Psychological repression; Gene; Promoter; Gene expression; Cancer; Genetics","score_opus":0.11903039228287253,"score_gpt":0.4257675368277292,"score_spread":0.3067371445448567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890332162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850408,0.0074233473,0.000026320005,0.00415519,0.00018387522,0.0007209441,0.000069553615,0.00001696317,0.0023630245],"genre_scores_gemma":[0.9903229,0.0040767784,0.000027022845,0.00007279997,0.0005784267,0.0001901409,0.000033962653,0.000018022136,0.004679932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828815,0.00013134615,0.00019232577,0.00030669288,0.00074116787,0.00034030934],"domain_scores_gemma":[0.9985998,0.0001451501,0.000037225807,0.00023997591,0.00081655505,0.00016126515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009768868,0.00010086452,0.00017893803,0.00013258657,0.00032979914,0.00003727531,0.000106621235,0.00008421131,0.0015500125],"category_scores_gemma":[0.00010061803,0.000056619057,0.000045089884,0.00037650563,0.0010005867,0.0001533881,0.000052446958,0.00038260393,0.000036346242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006028532,0.0001580075,0.010433824,0.00022326747,0.00022210699,0.000009774134,0.0017901469,0.0000019422885,0.9220646,0.00035162442,0.016482918,0.04223326],"study_design_scores_gemma":[0.0057646767,0.002442092,0.2767599,0.0007261713,0.00007808674,0.000013150161,0.0011103194,0.00008715706,0.58558017,0.0005465241,0.12669541,0.00019636219],"about_ca_topic_score_codex":0.00017656687,"about_ca_topic_score_gemma":0.00004195182,"teacher_disagreement_score":0.33648443,"about_ca_system_score_codex":0.00012562516,"about_ca_system_score_gemma":0.00055767206,"threshold_uncertainty_score":0.9993627},"labels":[],"label_agreement":null},{"id":"W2891267694","doi":"10.1158/1538-7445.prca2017-b063","title":"Abstract B063: Towards the use of Raman spectroscopy to guide prostate biopsy procedure","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Polytechnique Montréal; Université de Montréal","funders":"","keywords":"Prostate; Ex vivo; Prostate cancer; Pathology; In vivo; Prostatectomy; Medicine; Nuclear medicine; Raman spectroscopy; Biopsy; Cancer; Biomedical engineering; Biology; Internal medicine; Optics","score_opus":0.08912987523063355,"score_gpt":0.453969501734024,"score_spread":0.36483962650339047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891267694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898382,0.0003460483,0.0003861221,0.004448115,0.00008608846,0.0007623265,0.000074921794,0.000025203686,0.0040329886],"genre_scores_gemma":[0.9857639,0.0009151573,0.0038812142,0.00059146364,0.001017147,0.00045729423,0.00003319501,0.00004583811,0.0072947643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975502,0.00007385139,0.00027168627,0.00050472585,0.0008559923,0.0007435611],"domain_scores_gemma":[0.9982135,0.00004864045,0.00004433151,0.0006954215,0.0007330998,0.00026499078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008559563,0.0001493142,0.00015633597,0.00010192937,0.00017305816,0.00007145779,0.0008219581,0.00017326248,0.00044413618],"category_scores_gemma":[0.0009845118,0.00009700083,0.00007613212,0.0006321396,0.0012668801,0.000006403994,0.00057430856,0.00040901577,0.00003594377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033628274,0.000051794195,0.00040185527,0.000045981145,0.000024788638,0.0000027350532,0.000061158644,3.7250584e-7,0.81439614,0.00006575987,0.18219416,0.0024189658],"study_design_scores_gemma":[0.00010811866,0.00045144022,0.0009820354,0.000049441755,0.0000021149215,0.0000029705095,0.000024903187,0.000004612462,0.67702705,0.0001840328,0.3210812,0.00008207933],"about_ca_topic_score_codex":0.0006112997,"about_ca_topic_score_gemma":0.00006965622,"teacher_disagreement_score":0.13888702,"about_ca_system_score_codex":0.00010922261,"about_ca_system_score_gemma":0.0006098904,"threshold_uncertainty_score":0.48629797},"labels":[],"label_agreement":null},{"id":"W2892055825","doi":"10.1158/1538-7445.prca2017-b065","title":"Abstract B065: Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Gene knockdown; Prostate cancer; Prostatectomy; Cancer research; Cancer; Transcriptome; Oncology; Prostate; Medicine; Phenotype; Metastasis; Biology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.038326593350954,"score_gpt":0.4219512778868498,"score_spread":0.38362468453589577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892055825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899696,0.008921902,0.00004556828,0.000064987806,0.00012094821,0.0003200548,0.00014614686,0.0000041397698,0.0004066464],"genre_scores_gemma":[0.99379104,0.0038791692,0.00013583737,0.000027752296,0.00013836683,0.00011766816,0.0000738856,0.00002089487,0.0018153902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984315,0.0001091366,0.00031879713,0.00035468154,0.00043373147,0.0003521283],"domain_scores_gemma":[0.99855727,0.000018513458,0.00016582053,0.0004062024,0.00075409864,0.000098067394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005774754,0.00012309253,0.0003378933,0.00024693806,0.0000816809,0.000017843347,0.00028310408,0.00007801435,0.00079544605],"category_scores_gemma":[0.000062354724,0.000099687495,0.00015111126,0.0006128104,0.0006886113,0.0000073629667,0.0001894939,0.00011760247,0.000010589203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036564053,0.000059335434,0.005299121,0.00009238318,0.0009547537,0.0000024001406,0.00036077914,0.000111270056,0.98291636,0.00004247374,0.0020919426,0.007703553],"study_design_scores_gemma":[0.00051982666,0.00017332399,0.033045024,0.000048439557,0.00028460246,5.0238344e-7,0.00020167221,0.00006672564,0.94412214,0.000053052685,0.021369737,0.000114970004],"about_ca_topic_score_codex":0.0015921752,"about_ca_topic_score_gemma":0.0006914073,"teacher_disagreement_score":0.03879422,"about_ca_system_score_codex":0.000031779327,"about_ca_system_score_gemma":0.00038103847,"threshold_uncertainty_score":0.8709576},"labels":[],"label_agreement":null},{"id":"W2892139286","doi":"10.1158/1538-7445.prca2017-a072","title":"Abstract A072: Serum sex steroids as prognostic biomarkers in patients receiving androgen-deprivation therapy for recurrent prostate cancer post-radiotherapy: A post hoc analysis of the PR.7 trial","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Cancer Society; University of Toronto; Université Laval","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Androstenediol; Testosterone (patch); Internal medicine; Androgen; Dihydrotestosterone; Oncology; Estrone; Cancer; Dehydroepiandrosterone; Endocrinology; Urology; Estrogen; Hormone","score_opus":0.05896490622204424,"score_gpt":0.4162091243379175,"score_spread":0.35724421811587326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892139286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98192436,0.006252242,0.0000013689669,0.002448527,0.00034360643,0.008452821,0.00047608977,0.000022196476,0.000078804704],"genre_scores_gemma":[0.9907324,0.0058051716,0.000031509393,0.00014171869,0.00026383655,0.0023972103,0.00016029384,0.000059357888,0.00040853577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963627,0.00031314074,0.0005666945,0.0006589939,0.00128108,0.00081742124],"domain_scores_gemma":[0.99672776,0.00032118737,0.00021207,0.0005817209,0.001971035,0.00018623279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015559029,0.0002538458,0.00054659153,0.0009527698,0.0002755485,0.00007723465,0.00036023118,0.00015154517,0.00033651068],"category_scores_gemma":[0.00037049485,0.00016396478,0.00026710393,0.0028047103,0.00047569364,0.00016779308,0.00009215697,0.00040573417,0.0000033791853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17837237,0.0009091538,0.60495,0.00024847075,0.0029788963,0.0000038252065,0.0031828978,0.000009152557,0.013822849,0.000004504827,0.00073195394,0.19478594],"study_design_scores_gemma":[0.06164609,0.012217863,0.8991146,0.0007268401,0.00024861985,4.383219e-7,0.0004918453,0.00023131138,0.023352645,0.00004685521,0.0016671686,0.00025568515],"about_ca_topic_score_codex":0.0015067147,"about_ca_topic_score_gemma":0.0020218845,"teacher_disagreement_score":0.29416463,"about_ca_system_score_codex":0.0012030241,"about_ca_system_score_gemma":0.0017657197,"threshold_uncertainty_score":0.668629},"labels":[],"label_agreement":null},{"id":"W2892485569","doi":"10.1158/0008-5472.can-18-1250","title":"Precise Spatiotemporal Interruption of Regulatory T-cell–Mediated CD8+ T-cell Suppression Leads to Tumor Immunity","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China","keywords":"Immunity; Cell mediated immunity; CD8; Cytotoxic T cell; Cell; Biology; Cell biology; Cancer research; T cell; Immunology; Immune system; Genetics","score_opus":0.058771286175285646,"score_gpt":0.35490562777891427,"score_spread":0.2961343416036286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892485569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167496,0.0027428332,0.000046096196,0.000305177,0.0014403695,0.0006325298,0.00007771457,0.00007308873,0.0030072602],"genre_scores_gemma":[0.98543906,0.0001799962,0.00005428514,0.00007147274,0.00014609851,0.00012896243,0.00012599443,0.00004212929,0.013811983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968491,0.0010492522,0.000530955,0.0005405101,0.00018362717,0.0008465529],"domain_scores_gemma":[0.9978038,0.00027598595,0.00017644756,0.0008839212,0.00077321526,0.0000866406],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012129145,0.0002443343,0.00042382523,0.00051349297,0.00039916605,0.000020210304,0.00081163156,0.00038853486,0.0036783358],"category_scores_gemma":[0.0001834173,0.00021611716,0.0001068269,0.000598402,0.0013073515,0.00013691763,0.0006089426,0.001011738,0.0022462134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013648728,0.00039522798,0.0019742812,0.000089340094,0.00003016203,0.000004259518,0.0011379931,0.0000025457055,0.9612247,0.000024014005,0.03158348,0.0021691357],"study_design_scores_gemma":[0.0016220943,0.0011898949,0.0013798194,0.00014596363,0.00001429337,0.000007053805,0.0003640929,0.000004610689,0.9573762,0.000053795047,0.037628826,0.00021334497],"about_ca_topic_score_codex":0.0017149474,"about_ca_topic_score_gemma":0.00020824996,"teacher_disagreement_score":0.010804723,"about_ca_system_score_codex":0.00022130308,"about_ca_system_score_gemma":0.00040890792,"threshold_uncertainty_score":0.9985306},"labels":[],"label_agreement":null},{"id":"W2893919806","doi":"10.1158/0008-5472.can-18-0362","title":"Sex Differences in Cancer Driver Genes and Biomarkers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Terry Fox Research Institute; Ontario Institute for Cancer Research","keywords":"Cancer; Microsatellite instability; Somatic cell; Gene; Mutation; Germline mutation; Biology; Oncology; BAP1; Medicine; Internal medicine; Genetics; Bioinformatics; Microsatellite; Allele","score_opus":0.05859867445819356,"score_gpt":0.3803946211040359,"score_spread":0.3217959466458423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893919806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668826,0.01153138,0.000017228733,0.00047626375,0.00017372008,0.0001601494,0.000045980887,0.0000034133102,0.0009036346],"genre_scores_gemma":[0.97739655,0.02062695,0.00004826518,0.00014337529,0.0006211829,0.0001345342,0.0000072157777,0.000015265414,0.0010066904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989723,0.00005996266,0.00010652625,0.00035631927,0.00015640279,0.00034850414],"domain_scores_gemma":[0.9995054,0.00003585541,0.000019781857,0.00020035007,0.00013956275,0.000099052115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025588777,0.00009216881,0.00010873321,0.000092385955,0.000104341685,0.000043266526,0.00017160994,0.00009236347,0.00013989372],"category_scores_gemma":[0.00005329395,0.000084730775,0.000020385067,0.00017103119,0.00045704888,0.000002802815,0.00021230082,0.00009643681,0.0000061393553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014545418,0.000033854303,0.29217073,0.00002815059,0.00005756535,0.000005004343,0.00023017473,0.0000033670133,0.65029794,0.00008386729,0.008561554,0.048382305],"study_design_scores_gemma":[0.0012620516,0.0005706854,0.1467702,0.00008848981,0.000011564107,0.0000038283088,0.0004226554,0.00015746435,0.6646961,0.00042869817,0.18518104,0.00040722732],"about_ca_topic_score_codex":0.0030276852,"about_ca_topic_score_gemma":0.0071221474,"teacher_disagreement_score":0.17661947,"about_ca_system_score_codex":0.00005705114,"about_ca_system_score_gemma":0.00025734658,"threshold_uncertainty_score":0.45769745},"labels":[],"label_agreement":null},{"id":"W2895892480","doi":"10.1158/0008-5472.can-18-0901","title":"Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Princess Margaret Cancer Foundation","keywords":"Renal cell carcinoma; Medicine; Cancer research; Leiomyomatosis; Pathology; Carcinoma; Internal medicine; Leiomyoma","score_opus":0.03128694529924472,"score_gpt":0.3317008787702896,"score_spread":0.30041393347104484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895892480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953306,0.0031025787,0.000053322947,0.000075874916,0.000043837576,0.0001370311,0.000021140351,0.0000028411043,0.001232772],"genre_scores_gemma":[0.9988963,0.0006248068,0.00009723277,0.000020103013,0.000121770245,0.000045609297,0.000041576095,0.000008560504,0.00014401322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991721,0.000093803,0.00013269403,0.00024144974,0.00016459313,0.00019537935],"domain_scores_gemma":[0.9995581,0.00001929942,0.000036221176,0.0001736131,0.00015175418,0.000061048595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023917742,0.00006902571,0.00008492421,0.000076460135,0.00005993947,0.000012503225,0.000089116336,0.00008455965,0.000048517202],"category_scores_gemma":[0.000048127615,0.00006279102,0.00002187321,0.00013474665,0.00028193856,0.00000582039,0.000092591436,0.000074499134,0.000002784902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015664019,0.000040486353,0.06837458,0.000062510226,0.0000042665756,0.000008484115,0.00013462841,0.000011377202,0.9287986,0.000047126458,0.0009778311,0.0013834717],"study_design_scores_gemma":[0.00048199302,0.00026802078,0.07358484,0.000022942213,0.000004154269,0.000002460214,0.00033482313,0.000051948493,0.9246314,0.0002335305,0.0003113595,0.00007254056],"about_ca_topic_score_codex":0.0003943031,"about_ca_topic_score_gemma":0.00018126254,"teacher_disagreement_score":0.0052102595,"about_ca_system_score_codex":0.000022944172,"about_ca_system_score_gemma":0.00011071694,"threshold_uncertainty_score":0.25605437},"labels":[],"label_agreement":null},{"id":"W2896121809","doi":"","title":"Gene expression profiling of hepatocellular cancer identifies a consistent pattern in cancerous and distant liver tissue: Arguments for a field defect","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hepatocellular carcinoma; Liver cancer; Gene expression profiling; Gene expression; Pathology; Liver biopsy; Cancer; Chronic liver disease; Gene; Context (archaeology); Biology; Liver disease; Liver tissue; Microarray; Medicine; Biopsy; Cancer research; Cirrhosis; Internal medicine; Genetics","score_opus":0.06243191097902148,"score_gpt":0.3823276061678708,"score_spread":0.3198956951888493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896121809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978282,0.018741874,0.0017341981,0.00031525752,0.000108775894,0.0007192746,0.00005853011,0.0000043970267,0.00003572035],"genre_scores_gemma":[0.9917992,0.0057586012,0.00029892268,0.00008151895,0.00017895075,0.0013125172,0.00003240069,0.000019402809,0.00051849004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998683,0.000095732925,0.00024254194,0.0004299875,0.00024941663,0.0002993565],"domain_scores_gemma":[0.99933827,0.000033135057,0.00008076075,0.00026728338,0.00020078899,0.00007973435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034876695,0.00011359969,0.00015725978,0.00009885107,0.00008652785,0.000026122527,0.00015424867,0.00011232826,0.00005918504],"category_scores_gemma":[0.000058305035,0.00010298429,0.000049491904,0.000119285294,0.00008574773,0.000008524317,0.00012313674,0.00011827742,9.5117383e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023936972,0.000046432033,0.015341684,0.00018069833,0.000020486183,0.0000015893863,0.00018518786,0.00004956383,0.95166206,0.000005268152,0.0016551926,0.030612469],"study_design_scores_gemma":[0.00073789764,0.00013901721,0.00088725233,0.00018390811,0.0000089225705,0.0000011784645,0.00014124786,0.00026365492,0.9882645,0.00002314292,0.009233558,0.000115740055],"about_ca_topic_score_codex":0.0007965497,"about_ca_topic_score_gemma":0.0010861306,"teacher_disagreement_score":0.036602423,"about_ca_system_score_codex":0.00009590791,"about_ca_system_score_gemma":0.00019646,"threshold_uncertainty_score":0.41995776},"labels":[],"label_agreement":null},{"id":"W2896158951","doi":"","title":"Identification and characterization of a novel interaction between peroxisome-proliferator activated receptor gamma (PPARγ) and human mesoderm induction-early response 1 and potential implications for adipogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Coactivator; Nuclear receptor; Adipogenesis; Peroxisome proliferator-activated receptor; Troglitazone; Transcription factor; Cell biology; Biology; Response element; Corepressor; Chemistry; Receptor; Gene expression; Biochemistry; Promoter; Gene","score_opus":0.06738720606905375,"score_gpt":0.3670486667864218,"score_spread":0.29966146071736804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896158951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973622,0.00015822095,0.00073688896,0.0006506703,0.00006781643,0.00074063044,0.00026728804,0.000014627266,0.000001645634],"genre_scores_gemma":[0.99790263,0.00066408684,0.00010140227,0.000014032535,0.0002813698,0.0005194379,0.00029610473,0.000038188275,0.00018276207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998575,0.00018989957,0.0003061611,0.0005107639,0.00016761743,0.00025058334],"domain_scores_gemma":[0.99884033,0.00004963217,0.00015586278,0.00024029671,0.000572476,0.0001413845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004890477,0.00014945069,0.00018775095,0.00025609936,0.00048227236,0.0000566892,0.00010740839,0.000222751,0.000008448001],"category_scores_gemma":[0.00016623116,0.00015688184,0.00003319008,0.00025456524,0.00031511654,0.00005644652,0.00009748139,0.00016870415,4.916842e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088787713,0.00006269567,0.030515593,0.000042201867,0.00009356163,6.878161e-8,0.00023920243,0.0000010336531,0.96657455,0.000015250009,0.00006695707,0.0015009822],"study_design_scores_gemma":[0.0006380342,0.00023872363,0.23609772,0.000020400645,0.000016207285,0.00000996525,0.00005701046,0.0000070194906,0.7621437,0.000008503144,0.00064625946,0.000116502335],"about_ca_topic_score_codex":0.00005263654,"about_ca_topic_score_gemma":0.0000063500775,"teacher_disagreement_score":0.20558214,"about_ca_system_score_codex":0.00006909738,"about_ca_system_score_gemma":0.00015527433,"threshold_uncertainty_score":0.6397456},"labels":[],"label_agreement":null},{"id":"W2896257009","doi":"","title":"The combi-targeting concept: a new cell signaling-based model for the selective targeting of the epidermal growth factor receptor (EGFR)- and Her2-expressing solid tumor cells by the complex combi-molecule RB24 (NSC 741279)","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada","funders":"","keywords":"Transfection; Comet assay; DNA damage; Apoptosis; Biology; Epidermal growth factor receptor; Cancer cell; Cell biology; Cancer research; Annexin; Epidermal growth factor; Molecular biology; DNA; Cell culture; Receptor; Cancer; Biochemistry; Genetics","score_opus":0.08819268868269484,"score_gpt":0.4062163210851354,"score_spread":0.3180236324024406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896257009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8569578,0.036991514,0.036450226,0.048352968,0.0010450064,0.01704018,0.0012357363,0.00019379852,0.0017327516],"genre_scores_gemma":[0.9953723,0.00027557556,0.00067072915,0.0011687,0.0005558607,0.00039825478,0.000027466667,0.00015001945,0.0013810865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99299765,0.0011297787,0.0009016339,0.00078695413,0.002197257,0.0019867485],"domain_scores_gemma":[0.98808134,0.008566416,0.00039290806,0.0008325169,0.0016669928,0.00045982815],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.006756672,0.00042916427,0.0006176407,0.00012150315,0.002691855,0.00028190875,0.0014627618,0.00017436837,0.00019553026],"category_scores_gemma":[0.0017706258,0.00022131698,0.00028509114,0.0010015123,0.002279714,0.00010830391,0.0004995725,0.0022256554,0.0000064438896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012150098,0.00013953313,0.0011253805,0.00039848886,0.00013596012,0.000004120529,0.0038620967,0.0019436077,0.8083559,0.00008409737,0.18104175,0.0016940524],"study_design_scores_gemma":[0.0028277214,0.00038436087,0.0003107305,0.00038678088,0.000060070095,0.000003259985,0.0027811583,0.07902195,0.9008181,0.00022906373,0.01289408,0.00028271604],"about_ca_topic_score_codex":0.0026406415,"about_ca_topic_score_gemma":0.00024521997,"teacher_disagreement_score":0.16814767,"about_ca_system_score_codex":0.0007384296,"about_ca_system_score_gemma":0.0027129035,"threshold_uncertainty_score":0.9986065},"labels":[],"label_agreement":null},{"id":"W2896278697","doi":"10.1158/0008-5472.can-18-1995","title":"Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; Cancer Prevention and Research Institute of Texas","keywords":"Protein arginine methyltransferase 5; Biology; Carcinogenesis; Methyltransferase; Methylation; Cancer research; Arginine; DNA methylation; Mammary gland; Cancer; Cell biology; Molecular biology; Genetics; Breast cancer; Gene; Gene expression; Amino acid","score_opus":0.06231910300655972,"score_gpt":0.3850320352062143,"score_spread":0.3227129321996546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896278697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935097,0.0016985461,0.0034494754,0.00014615463,0.00006738989,0.00084596203,0.00015138609,0.000009485441,0.000121918296],"genre_scores_gemma":[0.9962717,0.00022262457,0.00022906794,0.000008221968,0.0006005037,0.0003055939,0.00013714306,0.000035690457,0.0021894411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869096,0.000118424075,0.00020942681,0.0003628248,0.00030409533,0.00031428484],"domain_scores_gemma":[0.99886906,0.000028204415,0.00005271119,0.00036434855,0.00060140993,0.000084257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029430888,0.00012403876,0.00016618392,0.00007511955,0.00010860235,0.000013060614,0.00019977453,0.00015077107,0.00005720156],"category_scores_gemma":[0.0000996744,0.00010472558,0.00008024128,0.00015303692,0.00020948135,0.0000062073896,0.00008778503,0.00011482665,0.000002002523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014440621,0.000056084973,0.00007160733,0.00008452338,0.000054661854,1.06895435e-7,0.000053225904,0.00027935187,0.99018234,0.000082095525,0.0021710633,0.005520898],"study_design_scores_gemma":[0.0007222382,0.000811751,0.00016218844,0.00012932977,0.000011858113,5.595836e-7,0.00001816418,0.00081472157,0.99333066,0.0005541338,0.0033259054,0.000118496246],"about_ca_topic_score_codex":0.00011400371,"about_ca_topic_score_gemma":0.00021339967,"teacher_disagreement_score":0.0054024016,"about_ca_system_score_codex":0.000076442775,"about_ca_system_score_gemma":0.00023233912,"threshold_uncertainty_score":0.42705852},"labels":[],"label_agreement":null},{"id":"W2896360542","doi":"10.1158/1538-7445.pedca17-b44","title":"Abstract B44: Identification of epigenomic changes induced by H3 K27M mutation in glioblastoma using patient-derived and CRISPR/Cas9 edited cell lines","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Chromatin immunoprecipitation; Histone H3; Epigenomics; Histone; Biology; H3K4me3; Chromatin; Epigenetics; Genetics; Methylation; Histone methylation; DNA methylation; Cancer research; Molecular biology; Gene expression; Gene; Promoter","score_opus":0.03484336375706161,"score_gpt":0.39287898568490126,"score_spread":0.35803562192783966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896360542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760723,0.0016180058,0.00032426405,0.000055012722,0.00013223736,0.00021480593,0.00002984405,0.000003945532,0.000014634591],"genre_scores_gemma":[0.99929446,0.00032789,0.000045928857,0.000009628893,0.00023334472,0.000031071824,0.000024344616,0.000017410972,0.000015917998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917024,0.00003991298,0.0001840485,0.0002453742,0.00014542631,0.0002149668],"domain_scores_gemma":[0.9994425,0.0000151525155,0.00006006502,0.00016027638,0.00027204343,0.00004993576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024263308,0.00008130416,0.00008927868,0.00013884966,0.00005521031,0.00002040403,0.00008718297,0.00010178629,0.000015128413],"category_scores_gemma":[0.000065679815,0.0000870783,0.0000135735545,0.00020396213,0.00008782047,0.000005254461,0.000063320804,0.00009468062,0.0000016044866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007206385,0.000022951719,0.00017134302,0.0000618326,0.000007484176,7.413405e-7,0.00037923447,0.00012967642,0.9938199,3.2411384e-7,0.00018645772,0.005147976],"study_design_scores_gemma":[0.00027722746,0.0002409833,0.0043514315,0.000027469432,0.0000034211196,0.0000010132067,0.0003129143,0.0005574011,0.99384093,0.0000064334113,0.00029530938,0.0000854747],"about_ca_topic_score_codex":0.00036278818,"about_ca_topic_score_gemma":0.00052497763,"teacher_disagreement_score":0.0050625014,"about_ca_system_score_codex":0.00003445306,"about_ca_system_score_gemma":0.00006618559,"threshold_uncertainty_score":0.355095},"labels":[],"label_agreement":null},{"id":"W2899215722","doi":"10.1158/0008-5472.can-18-2313","title":"Tau Mutations as a Novel Risk Factor for Cancer—Letter","year":2018,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Medical Research Council; National Institute on Aging; National Institutes of Health","keywords":"Tau protein; Frontotemporal dementia; Biology; Mutation; Cancer; Genetics; Cancer research; Oncology; Frontotemporal lobar degeneration; Internal medicine; Medicine; Dementia; Gene; Alzheimer's disease; Disease","score_opus":0.16645166046187562,"score_gpt":0.47983803704359396,"score_spread":0.3133863765817183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899215722","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0268477,0.015449102,0.00013436291,0.91247034,0.0009377578,0.0081852125,0.034137163,0.00017548438,0.0016628909],"genre_scores_gemma":[0.067323424,0.011147412,0.0012254297,0.7074556,0.09605436,0.049389113,0.007230311,0.0013335767,0.058840785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99416184,0.00022011633,0.00037715325,0.0011200259,0.0022460532,0.0018747804],"domain_scores_gemma":[0.9954859,0.0007383286,0.00014856113,0.00096512714,0.002014756,0.00064730435],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039686056,0.00047373513,0.000678396,0.000710351,0.00064770225,0.00015968716,0.00047714278,0.0007239175,0.00707496],"category_scores_gemma":[0.00046441084,0.00038231586,0.00041777044,0.0006100581,0.0007983441,0.00012468771,0.00017776142,0.0030627619,0.0010182075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005121845,0.00020521581,0.00087720953,0.00066922035,0.009269666,0.0004166202,0.00019779628,5.990958e-7,0.00028829023,0.0000048812462,0.98267305,0.004885264],"study_design_scores_gemma":[0.0036242227,0.0009204122,0.0013347098,0.0006385035,0.0009051933,0.000015866417,0.00003194357,0.000028848192,0.003576038,0.00034115755,0.98819554,0.00038754224],"about_ca_topic_score_codex":0.004830705,"about_ca_topic_score_gemma":0.0003636013,"teacher_disagreement_score":0.20501474,"about_ca_system_score_codex":0.0014589104,"about_ca_system_score_gemma":0.0047785286,"threshold_uncertainty_score":0.99986285},"labels":[],"label_agreement":null},{"id":"W2899414535","doi":"10.1158/0008-5472.can-18-1018","title":"Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Cancer Research UK; Wellcome Trust","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Cohort","score_opus":0.03161867576488786,"score_gpt":0.36812046883644706,"score_spread":0.3365017930715592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899414535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987959,0.0002676662,0.00003337325,0.0001766763,0.00015587844,0.00015533798,0.00033505884,0.0000017849666,0.000078299556],"genre_scores_gemma":[0.9986456,0.00084636244,0.0000114621425,0.000010994406,0.00033770743,0.000060291135,0.0000123847285,0.000014692937,0.000060529008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991454,0.000103177226,0.00015997165,0.00024392025,0.00017647371,0.00017108137],"domain_scores_gemma":[0.99940896,0.000021459557,0.000057046338,0.00019274492,0.00027544613,0.00004432246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001438565,0.000076326316,0.00014830321,0.00009821341,0.000054313674,0.000011217999,0.00010120191,0.0000707796,0.00008071245],"category_scores_gemma":[0.000033671717,0.00007370767,0.0000142526,0.00012371178,0.00035814254,0.0000039112774,0.000117621144,0.00011699677,4.2667932e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006373789,0.00003046791,0.017670782,0.00009038239,0.000031694424,9.205131e-7,0.0002664906,0.000012592492,0.96240956,0.000019183899,0.0000968491,0.01873368],"study_design_scores_gemma":[0.00073699397,0.00027152285,0.25852925,0.00012905698,0.000008936488,0.0000036811093,0.0001689433,0.00059646316,0.73905814,0.00006424077,0.00033093046,0.00010184259],"about_ca_topic_score_codex":0.004937344,"about_ca_topic_score_gemma":0.0025105996,"teacher_disagreement_score":0.24085848,"about_ca_system_score_codex":0.00006809058,"about_ca_system_score_gemma":0.0001973222,"threshold_uncertainty_score":0.74638206},"labels":[],"label_agreement":null},{"id":"W2899422210","doi":"","title":"Incidence and survival of esophageal and gastric cancers in BC, Canada.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Esophagus; Incidence (geometry); Cancer; Adenocarcinoma; Cancer registry; Internal medicine; Esophageal cancer; Gastroenterology; Population; Survival analysis; Oncology","score_opus":0.06563105854676271,"score_gpt":0.38852787482730344,"score_spread":0.32289681628054073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899422210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690278,0.029120293,0.0000014718569,0.00078931643,0.000040345658,0.00042583476,0.000032193668,0.000005908143,0.0005568404],"genre_scores_gemma":[0.9889753,0.010042102,0.000048841757,0.000044493543,0.00007014474,0.000118062846,0.000004134512,0.000014686552,0.00068225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978281,0.00012343473,0.0001996257,0.00033040784,0.00096714596,0.000551261],"domain_scores_gemma":[0.9989253,0.00021393338,0.000029474006,0.00020245678,0.0002363347,0.00039249804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047971267,0.00011411131,0.00031659234,0.0002659767,0.00011240627,0.000007746845,0.0000947021,0.000046921312,0.00012915519],"category_scores_gemma":[0.0001609806,0.000098209304,0.000017684397,0.0006780254,0.0004959829,0.00006817404,0.00011474301,0.00043290385,0.0000012237645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052462216,0.000036436464,0.99096143,0.00022455613,0.000038305792,0.0015641814,0.0002908908,0.000010512507,0.00070558256,0.00007663943,0.0011798356,0.004387012],"study_design_scores_gemma":[0.0023095505,0.0004321285,0.9915783,0.00016713628,0.000008382013,0.000107442196,0.00020599554,0.0000569368,0.00469472,0.00004719243,0.00031380382,0.0000784054],"about_ca_topic_score_codex":0.8494562,"about_ca_topic_score_gemma":0.73239756,"teacher_disagreement_score":0.11705862,"about_ca_system_score_codex":0.001257621,"about_ca_system_score_gemma":0.0057777218,"threshold_uncertainty_score":0.9998586},"labels":[],"label_agreement":null},{"id":"W2899550130","doi":"","title":"Transformation of normal NIH-3T3 cells into highly oncogenic and invasive cancer cells by MBD2 overexpression","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; Biology; Carcinogenesis; Cancer research; Cell culture; Cancer cell; Gene knockdown; Malignant transformation; Molecular biology; 3T3 cells; Cell biology; Cancer; Transfection; Gene expression; Gene; Genetics","score_opus":0.023860250937063912,"score_gpt":0.35839760783850005,"score_spread":0.33453735690143616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899550130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892337,0.008662242,0.00087731675,0.00010088936,0.000107868065,0.00028655655,0.00007585607,0.0000037466762,0.00065185444],"genre_scores_gemma":[0.9853826,0.013680207,0.00015377117,0.00003487039,0.00015726092,0.00003756437,0.0000617807,0.000018631816,0.00047329118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987118,0.00009074084,0.00025679986,0.0002686572,0.0003491397,0.0003228458],"domain_scores_gemma":[0.99926454,0.00005318066,0.00007620008,0.00019440116,0.00027978345,0.00013191169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007111687,0.000110679335,0.00012403126,0.000091402086,0.00011499106,0.000019823552,0.00014689167,0.00018220177,0.000052909578],"category_scores_gemma":[0.000024377592,0.00010368404,0.000044006018,0.00016012683,0.00014276544,0.000011741146,0.000080866084,0.00016296456,0.0000029054038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018109665,0.000030668874,0.00048024498,0.00010211879,0.000023692453,5.2785424e-7,0.00043761494,0.0000890018,0.9856334,0.000011603447,0.0012932646,0.011716779],"study_design_scores_gemma":[0.0005008459,0.0002294212,0.0004956246,0.000053945732,0.000007725562,1.8425428e-7,0.00013275644,0.000018714687,0.9796516,0.00006915201,0.01872318,0.00011687392],"about_ca_topic_score_codex":0.001266179,"about_ca_topic_score_gemma":0.00058394525,"teacher_disagreement_score":0.017429916,"about_ca_system_score_codex":0.00006320108,"about_ca_system_score_gemma":0.0002055412,"threshold_uncertainty_score":0.42281124},"labels":[],"label_agreement":null},{"id":"W2899868868","doi":"","title":"The RET receptor tyrosine kinase causes activation of the β-catenin pathway","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Proto-Oncogene Proteins c-ret; Proto-oncogene tyrosine-protein kinase Src; Catenin; ROR1; Tyrosine phosphorylation; Biology; Cell biology; Phosphorylation; Tyrosine; Endocrinology; Signal transduction; Internal medicine; Chemistry; Receptor; Platelet-derived growth factor receptor; Wnt signaling pathway; Medicine; Mutation; Biochemistry; Germline mutation","score_opus":0.08261682961077423,"score_gpt":0.40200590390108104,"score_spread":0.31938907429030683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899868868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98146296,0.0040498725,0.0000062948025,0.01237387,0.00023068323,0.00065287517,0.000023157378,0.000014298809,0.0011859895],"genre_scores_gemma":[0.9944936,0.0020493942,0.000020208692,0.00012929412,0.00029553787,0.00019521435,0.000006168523,0.000018934843,0.0027916585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984787,0.0000946149,0.00019902196,0.00019054412,0.0006735775,0.00036350614],"domain_scores_gemma":[0.9985935,0.00039231617,0.000067290035,0.00044196827,0.00041040702,0.00009453812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001057092,0.00008574577,0.00013470846,0.00006238908,0.0002925268,0.000020434672,0.00017297697,0.000055238033,0.00015260078],"category_scores_gemma":[0.00026202414,0.0000419972,0.00007098558,0.0005534856,0.00028604953,0.00003930383,0.00007731993,0.00029630595,0.000016206965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015498837,0.00040418582,0.048295487,0.00011774404,0.00018149169,0.000012093549,0.0008735487,0.000008051559,0.79205716,0.0035529307,0.061477326,0.09147007],"study_design_scores_gemma":[0.0007128913,0.0001911029,0.08250478,0.00020958137,0.00001255759,0.000001242323,0.00026025408,0.0000013843493,0.8334915,0.00008281156,0.08249169,0.00004017987],"about_ca_topic_score_codex":0.0011589746,"about_ca_topic_score_gemma":0.00048293866,"teacher_disagreement_score":0.09142989,"about_ca_system_score_codex":0.00052115356,"about_ca_system_score_gemma":0.000410134,"threshold_uncertainty_score":0.22499092},"labels":[],"label_agreement":null},{"id":"W2900038271","doi":"","title":"Inhibition of skeletal metastasis in prostate cancer growth by S-adenosylmethionine (SAM) and methyl binding domain protein 2 (MBD2) knockdown.","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Gene knockdown; Metastasis; LNCaP; Prostate cancer; Biology; Tumor progression; Gene silencing; Cancer; Cancer cell; Intravasation; Cell culture; Gene","score_opus":0.028399180415972326,"score_gpt":0.36888114102026387,"score_spread":0.34048196060429153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900038271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98048836,0.017794712,0.0003545396,0.00034689117,0.000040084768,0.0006231789,0.000115406016,0.0000046643754,0.00023214376],"genre_scores_gemma":[0.9937524,0.004587159,0.0008063294,0.000014198791,0.000101866295,0.00019771195,0.00008808208,0.000028153454,0.00042409234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981226,0.0002537958,0.00033625358,0.00042392124,0.00039866098,0.00046477764],"domain_scores_gemma":[0.9992588,0.00004625172,0.000099091274,0.00017954955,0.00029892474,0.000117354604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026919122,0.00014065804,0.00019214793,0.00026934317,0.00010122404,0.000026298369,0.000105098785,0.00014403049,0.00004732657],"category_scores_gemma":[0.00016355472,0.0001339473,0.00004373281,0.0005388217,0.00021658503,0.000011046203,0.0001398371,0.00028238472,0.0000012702984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016388844,0.000049053233,0.0044268025,0.00010616577,0.000036274127,0.0000045010493,0.00019147283,0.0000081468,0.9807329,0.00009800656,0.00015116384,0.014031586],"study_design_scores_gemma":[0.0007667487,0.000256157,0.0018338768,0.00008059159,0.000007453393,6.120587e-7,0.00019322216,0.0000048509864,0.9918527,0.00063197035,0.004225452,0.00014634653],"about_ca_topic_score_codex":0.0012400328,"about_ca_topic_score_gemma":0.0008397531,"teacher_disagreement_score":0.01388524,"about_ca_system_score_codex":0.00009266653,"about_ca_system_score_gemma":0.00015775811,"threshold_uncertainty_score":0.5462212},"labels":[],"label_agreement":null},{"id":"W2900166117","doi":"","title":"Lipid encapsulation promotes co-localization of methylated CpG ODN and TLR9 in late endosomes: A new model for the immunostimulatory activity of CpG DNA","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada); University of British Columbia","funders":"","keywords":"TLR9; CpG Oligodeoxynucleotide; CpG site; Toll-Like Receptor 9; DNA methylation; Immune system; Methylation; Innate immune system; Cell biology; Biology; Chemistry; DNA; Cancer research; Molecular biology; Immunology; Biochemistry; Gene; Gene expression","score_opus":0.09721256468504698,"score_gpt":0.3786951196497882,"score_spread":0.2814825549647412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900166117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881603,0.004050923,0.006626036,0.0002177454,0.0000580045,0.000823337,0.00001737584,0.0000107664655,0.00003548526],"genre_scores_gemma":[0.99745035,0.0014247078,0.000021900603,0.000006916019,0.000014761825,0.00014200242,0.00003191915,0.00001231397,0.0008951143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988311,0.00036888217,0.00029506165,0.00017312894,0.000086670036,0.00024518065],"domain_scores_gemma":[0.99872035,0.0006708877,0.00012856652,0.00021841015,0.00024874063,0.000013040338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095067744,0.00009395421,0.00022814808,0.00024164756,0.00018598826,0.0000051763814,0.00013800904,0.00017513457,0.000067393084],"category_scores_gemma":[0.0003635912,0.00007269144,0.0000462803,0.00029771723,0.0003307716,0.00016894421,0.000049553444,0.00023844691,0.0000034653126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014804914,0.000048180536,0.0006729568,0.00007220448,0.00007842621,2.682758e-7,0.003592982,0.00734442,0.9779328,0.0001582605,0.0002507466,0.008368225],"study_design_scores_gemma":[0.0017309927,0.00016391155,0.006756709,0.00008172725,0.00001338334,0.0000020443754,0.000052635798,0.052751224,0.93730146,0.0004755409,0.0005977978,0.00007255558],"about_ca_topic_score_codex":0.0009922636,"about_ca_topic_score_gemma":0.00005502172,"teacher_disagreement_score":0.045406803,"about_ca_system_score_codex":0.00007230582,"about_ca_system_score_gemma":0.0004715534,"threshold_uncertainty_score":0.2964271},"labels":[],"label_agreement":null},{"id":"W2900166679","doi":"","title":"Zebularine, a cytidine deaminase and DNA methylation inhibitor, has in vitro growth inhibitory effects on human leukemia cells in association with demethylation and re-expression of p15INK4B","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Trichostatin A; DNA methylation; Cancer research; Molecular biology; Histone deacetylase inhibitor; Biology; Methylation; Cytidine deaminase; Chromatin immunoprecipitation; Histone deacetylase; Chemistry; Promoter; Histone; Gene expression; Biochemistry; DNA","score_opus":0.026958349515718086,"score_gpt":0.32865620014223007,"score_spread":0.301697850626512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900166679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744576,0.00171391,0.00008761126,0.00017630581,0.000026952732,0.0004261025,0.000008231574,0.00000356487,0.00011157007],"genre_scores_gemma":[0.99847436,0.00070324424,0.0003945091,0.000015274094,0.0001919511,0.00007548451,0.000060537463,0.0000220346,0.000062630636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831,0.00038712868,0.00027279498,0.0003883893,0.0003803464,0.0002612913],"domain_scores_gemma":[0.9992918,0.00015230177,0.00012962858,0.00016268015,0.00019146128,0.000072138646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013878726,0.00013464027,0.00018489844,0.00031834593,0.00009604248,0.000032311797,0.0000626134,0.00023436171,0.0000029713617],"category_scores_gemma":[0.00021515635,0.00012667374,0.000020226813,0.00028152682,0.00007810437,0.000020035513,0.00008098814,0.00027561275,5.4852325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036368516,0.00004896197,0.026216505,0.000082633116,0.000008516724,0.0000017731963,0.00020315983,0.0003164507,0.96600986,0.000012020999,0.000029852363,0.0067065577],"study_design_scores_gemma":[0.0015503091,0.00044190057,0.0572473,0.00013348373,0.0000063923076,1.3681337e-7,0.00002891673,0.00014585398,0.9399151,0.00014874748,0.0002589039,0.00012296202],"about_ca_topic_score_codex":0.0004132908,"about_ca_topic_score_gemma":0.0007756669,"teacher_disagreement_score":0.031030795,"about_ca_system_score_codex":0.0003393982,"about_ca_system_score_gemma":0.00012880265,"threshold_uncertainty_score":0.51656055},"labels":[],"label_agreement":null},{"id":"W2900286453","doi":"","title":"Role of KATP channel activation on measures of mitochondrial function in cancer cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Membrane potential; Flow cytometry; Reactive oxygen species; Potassium channel; Cell biology; Mitochondrion; Myocyte; Inner mitochondrial membrane; Chemistry; Biology; Apoptosis; Cancer cell; Molecular biology; Biochemistry; Cancer; Endocrinology","score_opus":0.06663590391448149,"score_gpt":0.3751141014068356,"score_spread":0.3084781974923541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900286453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517363,0.0009976102,0.000011054608,0.0006743266,0.00021578059,0.00042435282,0.000008751339,0.0000074704685,0.002487017],"genre_scores_gemma":[0.9974406,0.000721168,0.000016008564,0.000033332202,0.0009196765,0.000113538714,0.0000054399716,0.000014680719,0.0007355525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986273,0.0000678479,0.00019473404,0.00019076912,0.0007125754,0.00020674533],"domain_scores_gemma":[0.99928015,0.00006558352,0.00005214113,0.00018979103,0.00035287338,0.000059427002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031443406,0.00007076357,0.00021647353,0.0002890733,0.000030316607,0.0000032798384,0.000052538886,0.000113863585,0.00019869088],"category_scores_gemma":[0.00006908505,0.00005730855,0.000073218325,0.0003928236,0.00007234623,0.00005073612,0.000027449723,0.00031969894,0.000006517086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021813638,0.00013924808,0.00073507166,0.00009411077,0.000024245572,4.6946244e-7,0.0005195981,0.0009731927,0.9711656,0.00001539725,0.0022661902,0.021885535],"study_design_scores_gemma":[0.0013050222,0.00022678793,0.004084157,0.00044512175,0.000013411495,3.4395057e-7,0.00022970825,0.00012647161,0.9875385,0.00002273629,0.005960031,0.00004767422],"about_ca_topic_score_codex":0.0020108037,"about_ca_topic_score_gemma":0.00024590731,"teacher_disagreement_score":0.02183786,"about_ca_system_score_codex":0.00032371096,"about_ca_system_score_gemma":0.00034163464,"threshold_uncertainty_score":0.30397472},"labels":[],"label_agreement":null},{"id":"W2900461132","doi":"","title":"Anti-CD44 antibody, ARH460-16-2, binds to human AML CD34+CD38- cancer stem cells and demonstrates anti-tumor activity in an AML xenograft model","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arius3D (Canada)","funders":"","keywords":"CD44; CD38; Cancer stem cell; Haematopoiesis; Stem cell; CD34; Cancer research; Multiple myeloma; Leukemia; Monoclonal antibody; Bone marrow; Cancer; Medicine; Antibody; Immunology; Biology; Internal medicine; Cell","score_opus":0.0843073514688126,"score_gpt":0.4123204611587021,"score_spread":0.3280131096898895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900461132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673975,0.0009603058,0.00025061992,0.00044871165,0.00006161387,0.0009532801,0.00016930774,0.00002463986,0.00039175843],"genre_scores_gemma":[0.99552613,0.0019028254,0.000099538796,0.00011980207,0.00019923647,0.00032972192,0.000046393397,0.00006283425,0.0017135134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644434,0.00036112624,0.00031331356,0.0010191903,0.00075304357,0.0011089882],"domain_scores_gemma":[0.99823594,0.000026189307,0.000065366636,0.00066469284,0.00047609708,0.0005317102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080108066,0.00030278155,0.00038678013,0.00047410827,0.0005422299,0.00013332562,0.0005342972,0.00024067644,0.00010887604],"category_scores_gemma":[0.000029143424,0.00029570924,0.00007682757,0.00080233533,0.0006090469,0.00004454068,0.00042170763,0.00064227585,0.00001939408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018729751,0.00020331304,0.047434293,0.00007803958,0.000027968379,0.00004791649,0.00016009025,0.0019558903,0.94605774,0.000025023211,0.0010264828,0.002795925],"study_design_scores_gemma":[0.0010648838,0.00045138274,0.027064672,0.00007615769,0.000004924817,0.000012295018,0.00013886453,0.0027775336,0.965113,0.000031856307,0.002861446,0.00040302172],"about_ca_topic_score_codex":0.0032876346,"about_ca_topic_score_gemma":0.0053023156,"teacher_disagreement_score":0.02036962,"about_ca_system_score_codex":0.00017341516,"about_ca_system_score_gemma":0.0007828563,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W2901177278","doi":"","title":"The CAMA-1 breast cancer cell line as a model to investigate the role of environmental anti-androgens in breast carcinogenesis.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cell growth; Endocrinology; Carcinogenesis; Internal medicine; Androgen receptor; Dihydrotestosterone; Estrogen receptor; Cell culture; Estrogen; Androgen; Breast cancer; Cancer; Cancer research; Cell; Biology; Chemistry; Hormone; Medicine; Biochemistry; Prostate cancer","score_opus":0.013331547740103877,"score_gpt":0.29699295880046184,"score_spread":0.28366141106035797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901177278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736837,0.023554957,0.0000034324162,0.0018517793,0.000035907688,0.000427162,0.00023570567,0.00000354879,0.00020380862],"genre_scores_gemma":[0.9906808,0.008524648,0.000011817925,0.00012210732,0.000114682094,0.00020344385,0.000013049949,0.000031098243,0.0002983312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850404,0.0001322568,0.00018621594,0.0003329983,0.00034129672,0.00050316413],"domain_scores_gemma":[0.99928945,0.000019478217,0.00004135983,0.0004147229,0.000060503324,0.00017448659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004225653,0.00014632494,0.00013693814,0.000041767053,0.00021995173,0.000023020095,0.00042448286,0.00014024705,0.000017794697],"category_scores_gemma":[0.000009642278,0.00009073394,0.000077344936,0.00021021736,0.0003488207,0.0000048485786,0.00026490548,0.00027747612,0.000014429244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018132837,0.0000724635,0.0056969444,0.000010440865,0.00004274038,0.0000048659886,0.00024437462,0.018291177,0.97346544,0.00006461702,0.00009793994,0.0018276583],"study_design_scores_gemma":[0.0006599553,0.00011779616,0.0060972264,0.000037687714,0.000015478388,0.000038176393,0.00038250402,0.00040751955,0.9912012,0.00018857357,0.00071543443,0.00013840022],"about_ca_topic_score_codex":0.0042722146,"about_ca_topic_score_gemma":0.0007488651,"teacher_disagreement_score":0.017883658,"about_ca_system_score_codex":0.00016556225,"about_ca_system_score_gemma":0.000541564,"threshold_uncertainty_score":0.6458339},"labels":[],"label_agreement":null},{"id":"W2901651273","doi":"","title":"Connexin43 induced breast tumor cell re-differentiation in three-dimensional cultures","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Connexin; Gap junction; Matrigel; Cell biology; Cell culture; Biology; Cell growth; Extracellular matrix; Extracellular; Intracellular; Cell; Cell signaling; Cell junction; Signal transduction; Biochemistry; Genetics","score_opus":0.042251966547806837,"score_gpt":0.355588460595359,"score_spread":0.31333649404755215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901651273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972698,0.0008652809,0.000020801659,0.0009366705,0.00011676472,0.00023604555,0.000033421376,0.000007908203,0.00051330007],"genre_scores_gemma":[0.998993,0.000060780796,0.00003750226,0.0002132683,0.00029559407,0.000093631104,0.00008843634,0.000016794389,0.00020104247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998706,0.00010814941,0.0001648276,0.00040846606,0.00020426909,0.00040831658],"domain_scores_gemma":[0.9994092,0.00001695314,0.00003595839,0.00025853736,0.00019222494,0.00008712618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003237696,0.00011901164,0.00012720576,0.000106886386,0.00010260191,0.00002251457,0.00020295719,0.00015531237,0.00021513227],"category_scores_gemma":[0.00004340009,0.00010137397,0.00004997277,0.00018715532,0.000106733656,0.0000040130267,0.00015740602,0.00029698183,0.000032673644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023092779,0.00009594434,0.004097012,0.0000158559,0.000012407297,0.000011762804,0.00005141144,0.00013559996,0.9937167,0.0002570938,0.00058136083,0.00079392974],"study_design_scores_gemma":[0.002726275,0.00047708704,0.0673351,0.00006408123,0.0000055832525,0.000026502094,0.00016624235,0.000036978814,0.92246205,0.0013905256,0.0049954588,0.0003140953],"about_ca_topic_score_codex":0.0013771494,"about_ca_topic_score_gemma":0.0071894643,"teacher_disagreement_score":0.071254626,"about_ca_system_score_codex":0.00009022101,"about_ca_system_score_gemma":0.00031512167,"threshold_uncertainty_score":0.41339105},"labels":[],"label_agreement":null},{"id":"W2902248289","doi":"","title":"Safety, tolerability, pharmacokinetic and escalating single doses of PCK3145 in patients with metastatic hormone resistant prostatic cancer (HRPC)","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Tolerability; Pharmacokinetics; Prostate cancer; Medicine; In vivo; Toxicity; Cancer; Internal medicine; Pharmacology; Therapeutic index; Oncology; Prostate; Hormone; Adverse effect; Gastroenterology; Biology; Drug","score_opus":0.06460426671474814,"score_gpt":0.39543610236139004,"score_spread":0.33083183564664187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902248289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749244,0.007684108,0.000009956229,0.001980292,0.00003167167,0.0022603762,0.00011260259,0.000020309435,0.000408239],"genre_scores_gemma":[0.9968726,0.0017199415,0.00047896034,0.000041542666,0.000039844705,0.00047823478,0.000031775995,0.000047514055,0.0002895855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967844,0.00019408876,0.00048650295,0.0005286916,0.0012409248,0.0007654269],"domain_scores_gemma":[0.99838877,0.0002300493,0.00009651523,0.0003151553,0.0006943988,0.0002751292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076467113,0.00022086078,0.0005495774,0.0004194851,0.0001433381,0.00003771768,0.00013898443,0.000051667077,0.00013084746],"category_scores_gemma":[0.00016036561,0.00015538822,0.000042299802,0.0011623717,0.0006757849,0.00015893768,0.00014511484,0.00052549154,0.000002732282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036806986,0.0041665975,0.6797422,0.004525194,0.00064135046,0.00023672785,0.0053407787,0.0008416372,0.21347214,0.00013086115,0.0002047024,0.0538908],"study_design_scores_gemma":[0.038752545,0.006053332,0.8801289,0.0032274898,0.00019287005,0.0000051893517,0.0007687249,0.00008188557,0.06929787,0.00078606716,0.00031577787,0.00038933623],"about_ca_topic_score_codex":0.0032606504,"about_ca_topic_score_gemma":0.0008013,"teacher_disagreement_score":0.20038669,"about_ca_system_score_codex":0.0012234969,"about_ca_system_score_gemma":0.0010091617,"threshold_uncertainty_score":0.6336547},"labels":[],"label_agreement":null},{"id":"W2902344075","doi":"","title":"Preclinical development of huARH460-16-2, a humanized antibody to the CD44 cancer stem cell target","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arius3D (Canada)","funders":"","keywords":"CD44; Cancer; Stem cell; Cancer research; Medicine; Bone marrow; Prostate cancer; Colorectal cancer; Breast cancer; Prostate; Pathology; Biology; Internal medicine; Cell","score_opus":0.25302951645855665,"score_gpt":0.49402157460707974,"score_spread":0.2409920581485231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902344075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97990173,0.01135313,0.0003267885,0.0029956475,0.00038886548,0.001420644,0.00006136913,0.000029751205,0.0035220566],"genre_scores_gemma":[0.97183144,0.00345878,0.0014279633,0.00040547503,0.0005712516,0.00064654736,0.000017188979,0.00005116324,0.021590168],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968163,0.0001911014,0.0005578509,0.00049866043,0.0012469655,0.00068916014],"domain_scores_gemma":[0.9980713,0.00017575864,0.00009273287,0.0006150667,0.0006846548,0.00036050356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014158218,0.00018012505,0.0005043446,0.00018880013,0.00036832594,0.000016827944,0.0003959284,0.000093287206,0.0023160956],"category_scores_gemma":[0.00005431303,0.00012128392,0.00013776029,0.0007960425,0.00032677292,0.000043805034,0.00025143664,0.00058322377,0.00011840023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057074586,0.0016803684,0.053529996,0.001930168,0.00080871984,0.00016255281,0.02399444,0.00017589174,0.4675208,0.00017404066,0.27293137,0.17138419],"study_design_scores_gemma":[0.0021736962,0.00030644317,0.012001129,0.00029392066,0.000045173274,0.0000070223828,0.0006215862,0.00000786635,0.3194718,0.000010633987,0.66487485,0.00018585888],"about_ca_topic_score_codex":0.0015932751,"about_ca_topic_score_gemma":0.00076857116,"teacher_disagreement_score":0.39194348,"about_ca_system_score_codex":0.0005843947,"about_ca_system_score_gemma":0.003037718,"threshold_uncertainty_score":0.9985959},"labels":[],"label_agreement":null},{"id":"W2902534318","doi":"10.1158/0008-5472.can-17-3864","title":"Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Canadian Institute for Advanced Research; McGill University; McGill Genome Centre; University of Toronto","funders":"Medical Research and Materiel Command; National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust; National Institute of General Medical Sciences; Ovarian Cancer Research Foundation; Ovarian Cancer Research Fund; Canadian Institutes of Health Research; National Institute for Health and Care Research; American Cancer Society","keywords":"Ovarian cancer; Biology; Single-nucleotide polymorphism; Locus (genetics); Genotyping; Genetics; Genome-wide association study; Gene; Genotype; Genetic association; Cancer; Computational biology","score_opus":0.04642929855767353,"score_gpt":0.36156776943165275,"score_spread":0.3151384708739792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902534318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865597,0.0026599222,0.0080939885,0.001362718,0.00022251157,0.0004250996,0.000103528524,0.000007336753,0.0005651796],"genre_scores_gemma":[0.9964781,0.00047531226,0.00008244236,0.00007108664,0.00048936205,0.00012971085,0.000020400219,0.000020951484,0.002232676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779856,0.00029657767,0.00021533629,0.0005617741,0.0006651486,0.0004626245],"domain_scores_gemma":[0.9981514,0.000031965596,0.00006240249,0.00071538653,0.0009126098,0.0001262083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010452761,0.0001255437,0.00018305801,0.00022284352,0.00028700402,0.000033526954,0.00035500733,0.00016837852,0.0009967501],"category_scores_gemma":[0.00022724873,0.000098765435,0.00013821424,0.001540259,0.0008076506,0.0000047338713,0.0005533361,0.00034682467,0.000005644235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019040576,0.000029073499,0.003650331,0.000037454374,0.00045863702,8.190876e-7,0.00006482006,0.00014223046,0.98709226,0.00008575762,0.0024195546,0.0058286707],"study_design_scores_gemma":[0.0005467144,0.00016017875,0.02764959,0.000035408728,0.00006736714,0.0000023330842,0.00007535028,0.00021256668,0.95881605,0.0001860592,0.01211299,0.00013538962],"about_ca_topic_score_codex":0.0030738376,"about_ca_topic_score_gemma":0.010164974,"teacher_disagreement_score":0.028276196,"about_ca_system_score_codex":0.00012801537,"about_ca_system_score_gemma":0.0006441185,"threshold_uncertainty_score":0.9999165},"labels":[],"label_agreement":null},{"id":"W2904971160","doi":"10.1158/1538-7445.prca2017-a014","title":"Abstract A014: Raman microscopy to assess biochemical recurrence risk after radical prostatectomy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Polytechnique Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Raman spectroscopy; Prostate cancer; Prostatectomy; Microscopy; Prostate; Medicine; Pathology; Raman microspectroscopy; Autofluorescence; Raman microscope; Nuclear medicine; Cancer; Urology; Internal medicine; Raman scattering; Optics","score_opus":0.044695680608834346,"score_gpt":0.45931194160856176,"score_spread":0.4146162609997274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904971160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939638,0.0010414167,0.0009372407,0.00081245665,0.00017221713,0.0006623511,0.00016072273,0.00004670888,0.0022031036],"genre_scores_gemma":[0.9920503,0.0012261686,0.002905806,0.0003523354,0.0014313051,0.001012256,0.00006023544,0.000049191796,0.00091238803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963463,0.00016209249,0.00030692323,0.000985117,0.0009933632,0.0012062168],"domain_scores_gemma":[0.9978094,0.00008524386,0.000043072752,0.0007447338,0.0005825872,0.0007349595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012962406,0.00023521298,0.00021637503,0.00016092756,0.00022160367,0.00011338903,0.00094730733,0.0003936665,0.0013201565],"category_scores_gemma":[0.0010680823,0.00019901694,0.00010136821,0.0006660856,0.0018294932,0.0000071597497,0.0007958793,0.0010090589,0.0002558981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010001427,0.000113985756,0.0020405734,0.000050386177,0.000025430109,0.000011143176,0.000025604342,3.2414558e-8,0.87896496,0.000017306858,0.114159666,0.0035907393],"study_design_scores_gemma":[0.00028379163,0.0005389091,0.0016782245,0.000103374776,0.0000035931305,0.0000035709618,0.0000126439,0.0000027125918,0.7852233,0.0003775909,0.21156543,0.00020682886],"about_ca_topic_score_codex":0.00013988058,"about_ca_topic_score_gemma":0.000020146463,"teacher_disagreement_score":0.09740576,"about_ca_system_score_codex":0.00017868084,"about_ca_system_score_gemma":0.00044461712,"threshold_uncertainty_score":0.9995928},"labels":[],"label_agreement":null},{"id":"W2905141927","doi":"10.1158/0008-5472.can-18-2726","title":"Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Alberta Health Services; Vancouver Hospital and Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; Japan Society for the Promotion of Science; Novo Nordisk Fonden; Vanderbilt University Medical Center; Cancer Research UK; Government of Canada; World Health Organization; European Commission; National Center for Advancing Translational Sciences; Wellcome Trust; Vanderbilt University; National Center for Research Resources; Roswell Park Cancer Institute; National Institutes of Health; Ovarian Cancer Research Fund","keywords":"DNA methylation; Cancer; Epithelial ovarian cancer; Ovarian cancer; Methylation; Oncology; Medicine; Biology; Internal medicine; DNA; Gynecology; Genetics; Gene; Gene expression","score_opus":0.06539679892286754,"score_gpt":0.36521845281331167,"score_spread":0.29982165389044413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905141927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890792,0.0070256335,0.0015141574,0.0000824953,0.0001917027,0.00027807974,0.0014088531,0.000007067959,0.00041282419],"genre_scores_gemma":[0.9878065,0.009887773,0.00084933394,0.000019323661,0.001097,0.000035736186,0.0001696962,0.00003685255,0.000097804455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779665,0.0006135643,0.00026197507,0.00059570983,0.00035637507,0.0003757326],"domain_scores_gemma":[0.998544,0.000047095476,0.000118635064,0.0007855043,0.0003284452,0.00017634234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014239491,0.00012882403,0.00014041635,0.00009234154,0.00016914208,0.00005418206,0.00043754524,0.00010742526,0.00019057422],"category_scores_gemma":[0.00023300697,0.000121905134,0.000022968807,0.00020465898,0.0003893503,0.000010340971,0.0005001864,0.00014221465,0.000008616371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002581331,0.00002756249,0.027126377,0.000017033924,0.000161036,0.0000012226504,0.00037415393,0.000016902924,0.88763815,0.0000021423893,0.00042306847,0.08395419],"study_design_scores_gemma":[0.0009300694,0.00042329446,0.39009494,0.000041203155,0.000035941805,2.4867305e-7,0.000092465685,0.0006824748,0.58213204,0.00030220184,0.025089229,0.00017591407],"about_ca_topic_score_codex":0.0040883063,"about_ca_topic_score_gemma":0.000809396,"teacher_disagreement_score":0.36296856,"about_ca_system_score_codex":0.00005830753,"about_ca_system_score_gemma":0.00021688145,"threshold_uncertainty_score":0.61803234},"labels":[],"label_agreement":null},{"id":"W2905682161","doi":"10.1158/1538-7445.pedca17-ia06","title":"Abstract IA06: The role of hypermutation and replication repair deficiency in response of childhood cancers to immune checkpoint inhibitors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Cancer; Biology; Genetics; Cancer research; Mutation; Gene; B cell","score_opus":0.02193353266436965,"score_gpt":0.35708999664591273,"score_spread":0.3351564639815431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905682161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938665,0.005210044,0.00001456041,0.00021628036,0.00002851026,0.00030441058,0.00001030885,0.000002498563,0.00034687546],"genre_scores_gemma":[0.99919116,0.00052286213,0.000097482174,0.000008117189,0.00007051506,0.000062554784,0.0000066529014,0.000008999324,0.000031669373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990187,0.00013009421,0.00025606985,0.00025011567,0.00019570897,0.00014929955],"domain_scores_gemma":[0.99914485,0.000045694575,0.000080991,0.0003955371,0.00029689734,0.000036008125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001994768,0.00005400856,0.00007806141,0.000101401834,0.000060414885,0.000006395317,0.00011527831,0.00006343219,0.000007757914],"category_scores_gemma":[0.00056846434,0.00004438526,0.000030732645,0.00029368105,0.00018511231,0.0000035637581,0.00007814908,0.000080827114,9.748395e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383212,0.000023955608,0.0076641445,0.000011398187,0.000005760503,8.029729e-8,0.00078786316,0.00009964663,0.9822133,0.00002029765,0.00001254231,0.008822701],"study_design_scores_gemma":[0.000114807975,0.0002396091,0.326538,0.000021558655,0.0000015532701,1.8202539e-7,0.00028334066,0.000022474607,0.67182875,0.00013807564,0.0007793279,0.00003233361],"about_ca_topic_score_codex":0.0012091344,"about_ca_topic_score_gemma":0.00041680687,"teacher_disagreement_score":0.31887385,"about_ca_system_score_codex":0.00005493624,"about_ca_system_score_gemma":0.000259424,"threshold_uncertainty_score":0.18278575},"labels":[],"label_agreement":null},{"id":"W2905763177","doi":"10.1158/0008-5472.can-17-3053","title":"Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Government of Canada","keywords":"CD8; Biology; Cancer research; Peroxisome proliferator-activated receptor; Cytokine; Receptor; T cell; Adoptive cell transfer; Cell biology; Chemistry; Immunology; Immune system; Biochemistry","score_opus":0.029419517262053156,"score_gpt":0.334696640865995,"score_spread":0.3052771236039418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905763177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733436,0.0006473475,0.00007383963,0.00023382356,0.00040072174,0.0004914699,0.0000025081035,0.00002876897,0.0007871724],"genre_scores_gemma":[0.9913985,0.00037914285,0.000020334997,0.00010703507,0.00007302736,0.00016999358,0.000012205457,0.000019895884,0.0078198435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988521,0.00029950315,0.00018195683,0.0002865047,0.000093001116,0.0002869329],"domain_scores_gemma":[0.99878395,0.00012148792,0.00008514218,0.00018439442,0.00079278636,0.00003225839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003513413,0.000121225974,0.00017153446,0.00024019189,0.00022244078,0.000019031317,0.00011353545,0.0001294368,0.001974724],"category_scores_gemma":[0.00004977245,0.00009334865,0.000020603713,0.00035817715,0.00038048258,0.00020547732,0.000045663197,0.00034124378,0.00012477796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033719293,0.00006682332,0.00079321716,0.000019356547,0.0000713463,2.283905e-7,0.0015915284,0.0000050665917,0.9837314,0.000021945361,0.0065597324,0.003767458],"study_design_scores_gemma":[0.00048240717,0.0014398656,0.001084249,0.00009233173,0.0000025973284,0.0000014659504,0.0008598689,8.724052e-7,0.93237895,0.000005559955,0.06354938,0.000102468526],"about_ca_topic_score_codex":0.0001392089,"about_ca_topic_score_gemma":0.000013124977,"teacher_disagreement_score":0.056989644,"about_ca_system_score_codex":0.0001066714,"about_ca_system_score_gemma":0.00016968584,"threshold_uncertainty_score":0.9989376},"labels":[],"label_agreement":null},{"id":"W2905792303","doi":"","title":"DNA amplification is a common mechanism of oncogene activation in lung cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gene duplication; Biology; Comparative genomic hybridization; Cancer; Gene; Genetics; Genome; Copy-number variation; Cancer research; Molecular biology","score_opus":0.05893459474203226,"score_gpt":0.36828289561368616,"score_spread":0.3093483008716539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905792303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980643,0.00054805493,0.00028754346,0.00034717307,0.000041788247,0.00019995307,0.00004234248,0.0000028991603,0.00046598027],"genre_scores_gemma":[0.9972689,0.0013089904,0.00005730786,0.000064220854,0.000113608054,0.0002199565,0.000045580065,0.000011178107,0.00091025967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991993,0.00007379177,0.00016417642,0.00018939041,0.00018455359,0.0001887964],"domain_scores_gemma":[0.99952084,0.000011583527,0.000051016515,0.00021095517,0.00017135195,0.000034233653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020991536,0.000062151674,0.00009286694,0.00008761788,0.000092954026,0.000006371107,0.0001399697,0.00008550635,0.00016579298],"category_scores_gemma":[0.000016755748,0.000063175576,0.000029116127,0.00019373297,0.000064297645,0.00000561155,0.00006352188,0.00009493493,0.000002040331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005925774,0.000041781976,0.010087145,0.000041073174,0.00002098495,4.5529006e-7,0.0006167978,0.00006919025,0.98652565,0.00083757384,0.0011943566,0.00050570094],"study_design_scores_gemma":[0.0002984697,0.000053677853,0.009197416,0.000029894387,0.000002756327,0.0000013626914,0.00016271077,0.00008607152,0.987829,0.00024036136,0.0020265058,0.000071770744],"about_ca_topic_score_codex":0.0024677068,"about_ca_topic_score_gemma":0.00046663798,"teacher_disagreement_score":0.0020010688,"about_ca_system_score_codex":0.00010899753,"about_ca_system_score_gemma":0.00027186587,"threshold_uncertainty_score":0.3730451},"labels":[],"label_agreement":null},{"id":"W2905814499","doi":"","title":"UCHL1 expression is a poor prognostic marker in non-small cell lung cancer","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cohort; Stage (stratigraphy); Lung cancer; Cancer; Internal medicine; Immunohistochemistry; Oncology; Pathology; Medicine; Carcinoma; Biology; Cancer research; Gastroenterology","score_opus":0.024769736899166606,"score_gpt":0.354848526352942,"score_spread":0.3300787894537754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905814499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978914,0.016904436,0.0002646704,0.0002488522,0.00010646043,0.0005195371,0.00003064872,0.0000052182745,0.0030061568],"genre_scores_gemma":[0.9916561,0.0020630872,0.00022221575,0.000063278356,0.00041132208,0.0005225954,0.00004511699,0.000033251545,0.0049829953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845743,0.00012517534,0.00019987136,0.00044853435,0.00028740108,0.00048158714],"domain_scores_gemma":[0.9993566,0.00003145158,0.000044060595,0.0002765724,0.00020976375,0.0000815225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046777911,0.00012770898,0.00011612328,0.000119075565,0.00009368359,0.000042599102,0.00020846157,0.00017507577,0.00021669612],"category_scores_gemma":[0.000036540554,0.0001190455,0.000049044025,0.00025615262,0.00006233033,0.0000038508456,0.00015467718,0.00022090752,0.000008676166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006493618,0.000060011575,0.14299858,0.00007315964,0.000005671752,0.0000044399007,0.000051383726,0.00023054164,0.8479952,0.000002286184,0.0072346814,0.0012790986],"study_design_scores_gemma":[0.0005702397,0.00006610469,0.061253317,0.00009276975,0.0000058097908,1.8066035e-7,0.000027590453,0.00042582455,0.9226985,0.00008355553,0.014618215,0.0001579087],"about_ca_topic_score_codex":0.002131324,"about_ca_topic_score_gemma":0.0013356071,"teacher_disagreement_score":0.08174525,"about_ca_system_score_codex":0.00008442611,"about_ca_system_score_gemma":0.00026465824,"threshold_uncertainty_score":0.48545346},"labels":[],"label_agreement":null},{"id":"W2907400097","doi":"","title":"Analysis of epithelial ovarian cancer morphology, adhesion and migration in response to bone morphogenetic protein 4","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cell biology; Integrin; Extracellular matrix; Cell adhesion; Focal adhesion; Biology; Cell adhesion molecule; Actin cytoskeleton; Cell migration; Morphogenesis; Laminin; Cytoskeleton; Chemistry; Signal transduction; Receptor; Cell; Biochemistry","score_opus":0.03215150692179273,"score_gpt":0.37208619944376725,"score_spread":0.3399346925219745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907400097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944348,0.0037432397,0.00005143497,0.0012206605,0.000016114298,0.00040917323,0.00011327942,0.0000042359766,0.000007103358],"genre_scores_gemma":[0.99829966,0.00022511507,0.0003741698,0.00007357437,0.00011461754,0.00043213883,0.000030235813,0.00001594095,0.000434562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837327,0.00045452465,0.00023211706,0.0003959527,0.00025749835,0.0002866187],"domain_scores_gemma":[0.9992914,0.00004241712,0.000045933208,0.00031288137,0.00018414,0.00012323669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010213332,0.00009759596,0.00018192011,0.00048942794,0.00006316838,0.000014961233,0.00015767217,0.00011456886,0.00013077041],"category_scores_gemma":[0.00032450634,0.00009663514,0.000049472084,0.0007222972,0.00013228302,0.000003978546,0.00012738365,0.00012576471,0.0000040825435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023804412,0.00006429745,0.016158933,0.00001836291,0.00008751409,0.000004679728,0.00018953856,0.0033459319,0.97351193,0.0000024966146,0.00020421903,0.004031656],"study_design_scores_gemma":[0.0004631745,0.0001907599,0.12052481,0.000045249708,0.000040249335,6.5441014e-7,0.00004830074,0.0002175523,0.87421435,0.0000046851023,0.004145923,0.00010430246],"about_ca_topic_score_codex":0.0016095354,"about_ca_topic_score_gemma":0.006087752,"teacher_disagreement_score":0.10436588,"about_ca_system_score_codex":0.000085891625,"about_ca_system_score_gemma":0.00032586476,"threshold_uncertainty_score":0.3940667},"labels":[],"label_agreement":null},{"id":"W2907571060","doi":"","title":"Monitoring the T cell response to spontaneous mammary tumors using a novel transgenic mouse model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD8; Biology; Epitope; T cell; Immune system; Cytotoxic T cell; MHC class I; Genetically modified mouse; Cancer research; Transgene; Immunology; T-cell receptor; Major histocompatibility complex; Antigen; In vitro; Genetics","score_opus":0.08270287152653602,"score_gpt":0.365743287360512,"score_spread":0.283040415833976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907571060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838387,0.011510995,0.0016161347,0.0019983498,0.0002189389,0.0005740971,0.00004058505,0.000065427324,0.00013678623],"genre_scores_gemma":[0.96337885,0.0007135791,0.00064409344,0.00020517014,0.00009611347,0.00016375724,0.0000020535394,0.000054094537,0.03474231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972995,0.00084802246,0.00031622805,0.0004043345,0.0001651472,0.00096675515],"domain_scores_gemma":[0.9983896,0.00059189834,0.000044380085,0.0007343864,0.00018798691,0.000051719428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019591865,0.00021979897,0.00024795122,0.00032284795,0.00081310264,0.00007053423,0.0009337895,0.00019353462,0.00023391492],"category_scores_gemma":[0.00011174016,0.00017017592,0.00012745737,0.00045692554,0.00025849644,0.00016249319,0.00017968402,0.00093117496,0.0002529526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00969519,0.00011557326,0.000012160105,0.000011682508,0.00006827384,0.000009717412,0.0031832955,0.005887083,0.9755704,0.00003013579,0.00022039087,0.0051961197],"study_design_scores_gemma":[0.0011275114,0.00018621798,0.00013543526,0.00007186832,0.000010224199,0.00012910416,0.00046717472,0.00022283976,0.9705772,0.000010727751,0.026843995,0.00021774769],"about_ca_topic_score_codex":0.00039288076,"about_ca_topic_score_gemma":0.000027934107,"teacher_disagreement_score":0.034605525,"about_ca_system_score_codex":0.00047760506,"about_ca_system_score_gemma":0.00080074667,"threshold_uncertainty_score":0.69395727},"labels":[],"label_agreement":null},{"id":"W2907596927","doi":"","title":"Lysophosphatidic acid-induced transactivation of the EGF receptor regulates connexin43-mediated gap junctional communication in ovarian surface epithelial cells.","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lysophosphatidic acid; Phosphorylation; Cell biology; Pertussis toxin; MAPK/ERK pathway; Transactivation; Proto-oncogene tyrosine-protein kinase Src; Biology; Kinase; Signal transduction; MEK inhibitor; Cancer research; Receptor; G protein; Biochemistry","score_opus":0.04364554913675305,"score_gpt":0.3273904433523362,"score_spread":0.28374489421558313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907596927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459773,0.0012138701,0.00004150216,0.0033935981,0.00013151324,0.00032275016,0.000058308517,0.000004829655,0.00023592077],"genre_scores_gemma":[0.9981528,0.0009202093,0.00011330016,0.0001076354,0.0001367597,0.000036459107,0.00009693604,0.00001545295,0.00042047453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985496,0.0004584547,0.00025065496,0.00026377355,0.0002161827,0.0002613609],"domain_scores_gemma":[0.9990612,0.00008642453,0.000081087346,0.00045511458,0.000269998,0.000046167646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080963783,0.00010158807,0.00013270351,0.000060536808,0.000125902,0.00001129694,0.00035071638,0.00020526184,0.00030606022],"category_scores_gemma":[0.00011578003,0.00008083908,0.0000611194,0.00033250908,0.00022041256,0.000008146844,0.00008118454,0.0002832733,0.000010862962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033796928,0.00007041338,0.00067512214,0.000011731775,0.000024214973,9.878227e-8,0.00020241844,0.00025014876,0.9951562,0.00020026798,0.0006056554,0.00246575],"study_design_scores_gemma":[0.0007968803,0.000109916095,0.005040961,0.000026931235,0.0000032925236,6.7941966e-7,0.00012921865,0.000117002004,0.9783798,0.00008022457,0.015225236,0.00008985145],"about_ca_topic_score_codex":0.0006344039,"about_ca_topic_score_gemma":0.0011047273,"teacher_disagreement_score":0.016776403,"about_ca_system_score_codex":0.000093174414,"about_ca_system_score_gemma":0.0003226991,"threshold_uncertainty_score":0.33511448},"labels":[],"label_agreement":null},{"id":"W2908456822","doi":"10.1158/0008-5472.can-18-2545","title":"Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Ministry of Health and Welfare; Ministry of Science, ICT and Future Planning; Ministry of Education","keywords":"Cancer research; Anaerobic glycolysis; Tumor hypoxia; Hypoxia (environmental); Glycolysis; Immunotherapy; Medicine; Tumor progression; Tumor microenvironment; Cancer; Cancer cell; Biology; Internal medicine; Chemistry; Metabolism; Radiation therapy","score_opus":0.017259484724332926,"score_gpt":0.3320996672847342,"score_spread":0.3148401825604013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908456822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974139,0.023528019,0.0000075973035,0.00018772561,0.00065821374,0.00041825374,0.000051039835,0.000017922877,0.0009922577],"genre_scores_gemma":[0.9798527,0.0050215716,0.000052091003,0.00030455805,0.0009220228,0.00018838169,0.000032909906,0.000045200653,0.013580603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978999,0.0001773594,0.00019598806,0.00065095426,0.00040458146,0.00067120395],"domain_scores_gemma":[0.9989224,0.000038498776,0.00006946602,0.0004849097,0.00029604835,0.000188641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060090446,0.00018377662,0.0002722191,0.000108100285,0.0001619628,0.00007656782,0.00031617988,0.00010820469,0.00036912123],"category_scores_gemma":[0.00015983348,0.00017748124,0.00008750078,0.0003539577,0.00020956644,0.000008959326,0.00027173015,0.00030654424,0.0000928833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015495802,0.000042699157,0.0013226632,0.000049029437,0.0000753362,0.0000044460744,0.000056947065,0.00001012252,0.9810175,0.000027648439,0.012699297,0.00453938],"study_design_scores_gemma":[0.0011371566,0.0002663313,0.013988601,0.00006181066,0.00002474875,0.000012734968,0.00014040401,0.0000178677,0.7066442,0.00007305533,0.27730265,0.00033046608],"about_ca_topic_score_codex":0.00044937874,"about_ca_topic_score_gemma":0.0003572936,"teacher_disagreement_score":0.27437332,"about_ca_system_score_codex":0.000075561875,"about_ca_system_score_gemma":0.00034036327,"threshold_uncertainty_score":0.7237475},"labels":[],"label_agreement":null},{"id":"W2908738258","doi":"","title":"SPARC promoter hypermethylation in colon cancer and the effect of 5-Aza-2’deoxycytidine in enhancing SPARC gene expression and therapy sensitivity.","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Demethylating agent; DNA methylation; Cancer research; Methylation; Epigenetics; Promoter; Bisulfite sequencing; Osteonectin; Biology; Molecular biology; Gene expression; Gene; Genetics; Biochemistry","score_opus":0.04692635034388595,"score_gpt":0.3993442398221891,"score_spread":0.3524178894783031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908738258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812395,0.016174618,0.00001957202,0.0009378742,0.00003537087,0.0014335935,0.0000027009557,0.0000057786447,0.00015101777],"genre_scores_gemma":[0.99395305,0.0055466536,0.000051160394,0.000038043556,0.00010521125,0.00018650401,0.0000014147349,0.000013379014,0.0001045932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849606,0.00035319166,0.00022085763,0.00024702767,0.00037563348,0.0003072588],"domain_scores_gemma":[0.99895036,0.0007202516,0.000044131513,0.00013863723,0.00009100405,0.00005559249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044295853,0.00010531143,0.0003543274,0.00020810973,0.00007967444,0.000010518452,0.000029746318,0.00007558889,0.000018776189],"category_scores_gemma":[0.00021270727,0.000063237254,0.000022859333,0.0003494009,0.00036340387,0.00006311961,0.00010350195,0.0003811764,6.480468e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004868452,0.000024144892,0.12344038,0.00017803305,0.000015671212,0.000051426727,0.0011029306,0.00000387906,0.83481276,0.0000039494726,0.00002154949,0.035476845],"study_design_scores_gemma":[0.00508776,0.00035009373,0.15332279,0.00053502666,0.0000060181064,0.000009936247,0.00013415985,0.000077630786,0.8403127,0.000053532665,0.000056578105,0.000053758424],"about_ca_topic_score_codex":0.0045314324,"about_ca_topic_score_gemma":0.0034379058,"teacher_disagreement_score":0.03542309,"about_ca_system_score_codex":0.00012590818,"about_ca_system_score_gemma":0.00005499237,"threshold_uncertainty_score":0.68502},"labels":[],"label_agreement":null},{"id":"W2910884233","doi":"","title":"RANKL/OPG expression ratio in prostate cancer cell lines with varying bone metastatic potential","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"RANKL; Osteoprotegerin; Bone metastasis; Prostate cancer; Medicine; Osteoclast; Bone resorption; Cancer research; LNCaP; Metastasis; Denosumab; Oncology; Cancer; Internal medicine; RANK Ligand; Osteoporosis; Receptor; Activator (genetics)","score_opus":0.09568427064604165,"score_gpt":0.42211414820316867,"score_spread":0.32642987755712705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910884233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500335,0.01120301,0.00002734964,0.0017894281,0.00009078797,0.0013278018,0.000023328337,0.000028235625,0.00050670275],"genre_scores_gemma":[0.98601055,0.0061147725,0.0005640161,0.00015324316,0.00010528707,0.0010822845,0.00002832693,0.000038077964,0.0059034596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978272,0.00014929837,0.00026526928,0.0003659187,0.00073944614,0.0006528767],"domain_scores_gemma":[0.9990626,0.000059232283,0.00005460409,0.00024930527,0.00027779004,0.00029646629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003130738,0.00014722437,0.00031982685,0.00018400252,0.00025425514,0.000015258867,0.00006557993,0.00004324669,0.00039740617],"category_scores_gemma":[0.000026975149,0.00010171753,0.000033748314,0.00046206516,0.000117230964,0.00015879325,0.000043541142,0.00043149866,0.000026633052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03222785,0.0035051124,0.29674393,0.004780427,0.00033056884,0.016521657,0.01322147,0.0028223249,0.58274305,0.000016220874,0.017161045,0.02992636],"study_design_scores_gemma":[0.062374532,0.0031620131,0.09474905,0.004390454,0.0002464711,0.0005541384,0.0009395278,0.0029303571,0.8216283,0.00013802192,0.008012246,0.0008749069],"about_ca_topic_score_codex":0.01422285,"about_ca_topic_score_gemma":0.0016318982,"teacher_disagreement_score":0.23888525,"about_ca_system_score_codex":0.0003995043,"about_ca_system_score_gemma":0.0014103538,"threshold_uncertainty_score":0.9923415},"labels":[],"label_agreement":null},{"id":"W2911216374","doi":"10.1158/0008-5472.can-18-1602","title":"MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <i>In Situ</i>","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta; McGill University Health Centre; Northern Alberta Institute of Technology; McGill University; Jewish General Hospital","funders":"Canadian Cancer Society; Réseau de cancérologie Rossy; Canadian Institutes of Health Research; Cancer Research Society; National Cancer Institute; Government of Canada; Israel Cancer Research Fund","keywords":"Ductal carcinoma; Nodal signaling; Cancer research; NODAL; Tumor progression; Metastasis; Cancer; Breast cancer; Biology; Medicine; Oncology; Internal medicine","score_opus":0.055852314297619346,"score_gpt":0.388667489394008,"score_spread":0.3328151750963887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911216374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922043,0.0028312274,0.0000016674712,0.00076204527,0.0001429454,0.0011414726,0.000035977704,0.000013601537,0.002866741],"genre_scores_gemma":[0.99845326,0.00022541302,0.00014625068,0.000039975646,0.00023370174,0.00012183995,0.000016909546,0.000032074626,0.0007305568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978417,0.00012106145,0.0002795917,0.00040059656,0.0008272185,0.00052979623],"domain_scores_gemma":[0.99887687,0.00012349745,0.00006839006,0.00034416126,0.00040915483,0.00017790742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007492653,0.00013115873,0.00037740247,0.0002937254,0.000045188342,0.000017476448,0.00015729836,0.00008452441,0.0008225035],"category_scores_gemma":[0.000065594424,0.00010603729,0.00009306138,0.00066906505,0.0001580743,0.000092188624,0.00013512914,0.00049098884,0.000047681395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007447313,0.0001653789,0.13420649,0.00086502056,0.00002906577,0.000099770405,0.0007026307,0.00000846357,0.85320145,0.00003366506,0.00038798383,0.0095553445],"study_design_scores_gemma":[0.002379867,0.00058368413,0.03701573,0.0012729273,0.000023783205,0.00008007254,0.00074857956,0.00001305607,0.9570058,0.000047362,0.0006985619,0.0001306063],"about_ca_topic_score_codex":0.0011261089,"about_ca_topic_score_gemma":0.000344103,"teacher_disagreement_score":0.10380432,"about_ca_system_score_codex":0.00027466065,"about_ca_system_score_gemma":0.0010930749,"threshold_uncertainty_score":0.9005837},"labels":[],"label_agreement":null},{"id":"W2911340974","doi":"10.1158/1538-7445.sabcs18-p5-09-08","title":"Abstract P5-09-08: Germline variants in non-BRCA homologous recombination genes detected in HER2-negative breast cancer patients","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PALB2; CHEK2; Breast cancer; Medicine; Oncology; Population; Cancer; Internal medicine; Olaparib; Germline mutation; PARP inhibitor; Cancer research; Genetics; Mutation; Biology; Gene","score_opus":0.020533908590305024,"score_gpt":0.34850299732732176,"score_spread":0.32796908873701675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911340974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667776,0.0006397755,0.000008034303,0.000411817,0.0004950131,0.0009280588,0.0002502714,0.0000094207235,0.00057985994],"genre_scores_gemma":[0.99677056,0.0012428382,0.000083679384,0.00006412457,0.00018078877,0.00075804564,0.00012268723,0.000050101506,0.00072714646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99768317,0.00020460464,0.0003685738,0.00070587196,0.00041866396,0.000619119],"domain_scores_gemma":[0.9986352,0.00005667882,0.00010569656,0.00042147064,0.00069090043,0.00009007062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006005533,0.00019984788,0.00022470739,0.0003546608,0.00007745947,0.000040764808,0.00039245046,0.00028334145,0.0006647306],"category_scores_gemma":[0.00012318503,0.00020751757,0.000046352583,0.00084878644,0.0001340251,0.000021459155,0.00018720489,0.00046858654,0.00006864048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093581184,0.00061373675,0.39674547,0.00017849589,0.00011013369,0.000021709577,0.0007188621,0.0030586412,0.50678015,0.000008807893,0.0019946985,0.0888335],"study_design_scores_gemma":[0.002451387,0.00016826362,0.88928354,0.00013269439,0.0000039701995,0.0000028729928,0.00013055866,0.00020439448,0.10677759,0.00012809462,0.00045906258,0.0002575648],"about_ca_topic_score_codex":0.0067440886,"about_ca_topic_score_gemma":0.010953509,"teacher_disagreement_score":0.49253806,"about_ca_system_score_codex":0.0010529156,"about_ca_system_score_gemma":0.000979973,"threshold_uncertainty_score":0.99987006},"labels":[],"label_agreement":null},{"id":"W2911838586","doi":"10.1158/1538-7445.sabcs18-es7-1","title":"Abstract ES7-1: Methods to minimize the false negative rate of sentinel lymph node surgery after neoadjuvant chemotherapy for node positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Sentinel node; Sentinel lymph node; Lymph node; Axillary Lymph Node Dissection; Axillary Dissection; Axilla; Chemotherapy; Dissection (medical); Neoadjuvant therapy; Surgery; Cancer; Radiology; Internal medicine; Oncology","score_opus":0.03892264565437673,"score_gpt":0.4034938767912588,"score_spread":0.36457123113688206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911838586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247653,0.0035071322,0.00067996135,0.010138859,0.00031403662,0.001026951,0.0016420647,0.00000995556,0.0002044939],"genre_scores_gemma":[0.9907208,0.0015977827,0.0016822453,0.0018601713,0.0005066365,0.00254437,0.0000528722,0.000082116036,0.00095302623],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99784666,0.00028359538,0.00030719818,0.00063631963,0.00027010113,0.0006561016],"domain_scores_gemma":[0.99771523,0.00066161755,0.00012646243,0.0005488279,0.0008246326,0.00012320571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010656761,0.00027010572,0.00043259314,0.00010343664,0.0001396956,0.000036510977,0.00030453128,0.00012504119,0.00028140325],"category_scores_gemma":[0.000116590876,0.00019200661,0.00023957885,0.00030717877,0.00026195042,0.000010337857,0.00020450541,0.00014512481,0.00001832065],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011922729,0.00024554878,0.13525903,0.0002673766,0.0015150467,0.0000058481114,0.0010698717,0.0002887769,0.79421926,0.000013612036,0.0101612015,0.045031708],"study_design_scores_gemma":[0.0013629275,0.000017917293,0.6541463,0.00018050494,0.000033991615,0.000003396615,0.00030923975,0.000017620965,0.34171635,0.00004792869,0.0019459435,0.00021787788],"about_ca_topic_score_codex":0.0024624479,"about_ca_topic_score_gemma":0.00007977941,"teacher_disagreement_score":0.5188873,"about_ca_system_score_codex":0.00019112545,"about_ca_system_score_gemma":0.00052240584,"threshold_uncertainty_score":0.7829802},"labels":[],"label_agreement":null},{"id":"W2911986230","doi":"10.1158/1538-7445.prca2017-a087","title":"Abstract A087: Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; LNCaP; Prostate cancer; Angiogenesis; Cancer research; Androgen receptor; Hypoxia (environmental); In vivo; Cancer cell; Downregulation and upregulation; Medicine; Cancer; Chemistry; Biology; Internal medicine; Gene; Biochemistry","score_opus":0.08902120461178369,"score_gpt":0.4159187538479698,"score_spread":0.3268975492361861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911986230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98454297,0.012431077,0.000008964737,0.0011770205,0.00035867476,0.0009622206,0.00017540758,0.000012604451,0.0003310456],"genre_scores_gemma":[0.99165994,0.0042204517,0.00026092838,0.00017890891,0.0010256675,0.0005794548,0.000008680028,0.000055186876,0.002010806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969013,0.00037446464,0.00053612335,0.00088586024,0.0005217097,0.0007805685],"domain_scores_gemma":[0.9980618,0.0001890149,0.00011819102,0.0006390109,0.00070585456,0.0002861703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025195938,0.0002401466,0.00039812154,0.00024864537,0.00013241703,0.00004771591,0.0004072021,0.00024402175,0.000055232875],"category_scores_gemma":[0.00092793046,0.00022840244,0.00007443192,0.0005148616,0.00049697567,0.000023724011,0.00031728984,0.0003873326,0.00000771302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071951766,0.00008262114,0.0019745834,0.00012148789,0.00004682495,0.000003231328,0.00091507187,0.00005528002,0.9751312,0.00004169862,0.0031705282,0.011262272],"study_design_scores_gemma":[0.0014926344,0.0005538527,0.055178337,0.00040923248,0.000015061397,0.0000023853931,0.00019758713,0.00003541779,0.89814395,0.00072864804,0.04288535,0.00035752027],"about_ca_topic_score_codex":0.0014221887,"about_ca_topic_score_gemma":0.009537844,"teacher_disagreement_score":0.07698725,"about_ca_system_score_codex":0.00010708035,"about_ca_system_score_gemma":0.0011020143,"threshold_uncertainty_score":0.93139815},"labels":[],"label_agreement":null},{"id":"W2912167963","doi":"10.1158/0008-5472.can-18-1261","title":"<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Insertional mutagenesis; Biology; Mutagenesis; Genetics; Central nervous system; Neuroscience; Mutation; Gene; Genome","score_opus":0.02393133425581393,"score_gpt":0.31730528128264623,"score_spread":0.2933739470268323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912167963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936562,0.004832208,0.00017481553,0.000053492706,0.0002502319,0.00038355845,0.000065348635,0.000009009708,0.0005751397],"genre_scores_gemma":[0.99792176,0.00076979416,0.0002977759,0.000024303705,0.00029301542,0.00005097207,0.00006697372,0.000031517608,0.00054388714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978467,0.00018164526,0.00040273578,0.00043381262,0.0005797893,0.0005552824],"domain_scores_gemma":[0.99892825,0.000032177,0.0001339575,0.00038603044,0.0003496968,0.00016988588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064503,0.0001364246,0.0002056292,0.00011349573,0.00009843959,0.000021309384,0.00028048473,0.00013894902,0.00009174016],"category_scores_gemma":[0.000058337748,0.00013650936,0.0001115278,0.0002359066,0.000113944996,0.000004834707,0.0001445757,0.00015051352,0.000014001624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074273616,0.00002374538,0.13834825,0.00015205122,0.000054374894,0.0000060824473,0.000050513874,0.0016695961,0.8584564,0.0001333376,0.000118573524,0.0009128019],"study_design_scores_gemma":[0.0004954739,0.00025359474,0.24516024,0.00011608909,0.000014779486,0.0000047859576,0.00018018746,0.0002967447,0.75132704,0.00005957649,0.0018929234,0.00019855669],"about_ca_topic_score_codex":0.00025418674,"about_ca_topic_score_gemma":0.000040105748,"teacher_disagreement_score":0.10712934,"about_ca_system_score_codex":0.00012106995,"about_ca_system_score_gemma":0.00043679125,"threshold_uncertainty_score":0.55666906},"labels":[],"label_agreement":null},{"id":"W2912562571","doi":"10.1158/1538-7445.pedca19-b20","title":"Abstract B20: Integrative analysis of whole-genome and RNA sequencing in high-risk pediatric malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric cancer; Medicine; Malignancy; Oncology; Cohort; Cancer; Germline; DNA sequencing; Deep sequencing; Internal medicine; Disease; Whole genome sequencing; Gene; Genome; Bioinformatics; Genetics; Biology","score_opus":0.07810768387643549,"score_gpt":0.3827964756568468,"score_spread":0.3046887917804113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912562571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963631,0.0017248428,0.000007517799,0.0009690596,0.0000105373465,0.00038509027,0.00024688046,0.000012883173,0.00028008746],"genre_scores_gemma":[0.99615884,0.0033947893,0.000062097424,0.000048219154,0.00008054928,0.00006999565,0.000029292112,0.000016055346,0.00014014676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980829,0.00015042015,0.0002586329,0.0003838272,0.00068572536,0.00043854018],"domain_scores_gemma":[0.99883956,0.0002692416,0.000065048516,0.00019584583,0.0002970416,0.0003332902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043568757,0.00012473037,0.0004419664,0.0009083793,0.0000672702,0.000025164658,0.00012579141,0.000054123324,0.00023800356],"category_scores_gemma":[0.0004791983,0.00009432577,0.00008125347,0.0029995278,0.00017790672,0.00009342036,0.00011218699,0.0006231969,0.000021357644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010564192,0.0001238051,0.49879792,0.00050580304,0.0010770203,0.0009422766,0.003473812,0.00036896236,0.48977542,0.00006413491,0.00020637226,0.0036080582],"study_design_scores_gemma":[0.0018742839,0.00089582783,0.9674181,0.00008296656,0.00035482037,0.000001879406,0.0012550488,0.00037411184,0.027451364,0.0000745207,0.00010432809,0.00011279339],"about_ca_topic_score_codex":0.0042807576,"about_ca_topic_score_gemma":0.00070093485,"teacher_disagreement_score":0.46862015,"about_ca_system_score_codex":0.00039253198,"about_ca_system_score_gemma":0.0006372784,"threshold_uncertainty_score":0.64712536},"labels":[],"label_agreement":null},{"id":"W2912563026","doi":"10.1158/1538-7445.pedca17-a39","title":"Abstract A39: Characterizing the epigenetic effects of the histone 3.3 G34W mutation in giant cell tumors of bone","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Histone; Epigenetics; Mutant; Epigenomics; Genetics; Histone H3; Cancer research; Mutation; Molecular biology; DNA methylation; Gene; Gene expression","score_opus":0.03836921567002212,"score_gpt":0.3795995273537059,"score_spread":0.3412303116836838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912563026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994339,0.002830747,6.289312e-7,0.0015066004,0.000105077954,0.00075356656,0.000005380225,0.000003174888,0.00045585132],"genre_scores_gemma":[0.9992643,0.0002981734,0.000013481985,0.000045209912,0.00008042298,0.00016808638,0.0000022047773,0.000012942302,0.00011517735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884814,0.00010324976,0.00022530842,0.00014954792,0.00044180287,0.00023197215],"domain_scores_gemma":[0.99907786,0.00026132143,0.000096121315,0.0003260036,0.00019164871,0.000047076483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048628406,0.000070704344,0.00019189186,0.00012722981,0.00006929256,0.000005884776,0.00010735907,0.000035359244,0.00009239885],"category_scores_gemma":[0.00012993593,0.000037993304,0.00005739015,0.00038872348,0.00032425445,0.000021423999,0.00005110559,0.00018496634,0.000013976098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010499208,0.00031348426,0.01289133,0.00044205098,0.000020216294,0.00006494247,0.001257693,0.0000038493677,0.976524,0.000024074243,0.0002025417,0.008150847],"study_design_scores_gemma":[0.00056375033,0.00016087829,0.466319,0.00038956708,0.000011313285,0.000002428013,0.000059612743,0.000012715058,0.5323085,0.000018836865,0.00013472365,0.000018651843],"about_ca_topic_score_codex":0.0017763053,"about_ca_topic_score_gemma":0.0002448805,"teacher_disagreement_score":0.45342767,"about_ca_system_score_codex":0.00017768782,"about_ca_system_score_gemma":0.00019977793,"threshold_uncertainty_score":0.2685254},"labels":[],"label_agreement":null},{"id":"W2912563975","doi":"10.1158/1538-7445.sabcs18-pd6-01","title":"Abstract PD6-01: Prevalence and predictors of self-reported memory ability in a large sample of breast cancer survivors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Toronto Metropolitan University; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Cancer; Cohort; Breast cancer chemotherapy; Internal medicine; Physical therapy","score_opus":0.04062294443365776,"score_gpt":0.3806035818793602,"score_spread":0.33998063744570245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912563975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930206,0.0029447575,0.0000012703791,0.00050853344,0.00020984336,0.0017366859,0.00087395735,0.00003147991,0.00067290047],"genre_scores_gemma":[0.99456155,0.004757367,0.000014383968,0.000023008804,0.000085220425,0.00025660722,0.000009346637,0.000026972251,0.00026556072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971888,0.0001566602,0.0005796453,0.00052222615,0.0009770246,0.0005756141],"domain_scores_gemma":[0.9976835,0.0006353303,0.00019058147,0.000435725,0.0008956779,0.00015918695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019495849,0.00017689263,0.00056236144,0.00032835078,0.000052180283,0.0000066104403,0.00013696284,0.00012472608,0.001852062],"category_scores_gemma":[0.0004678631,0.00015590899,0.00007599946,0.0008003869,0.00041469405,0.0001290016,0.00019038896,0.0005822312,0.0000047104695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010318119,0.00041767344,0.9789183,0.0036751209,0.00038024667,0.0000085691445,0.0015874975,0.000015525211,0.012717673,0.0000050048834,0.00025096844,0.0009916114],"study_design_scores_gemma":[0.0025277277,0.00024442872,0.989674,0.0013573411,0.000090606205,0.0000065817158,0.0005995068,0.0000487165,0.0051140334,0.000026193029,0.00019152368,0.000119365],"about_ca_topic_score_codex":0.025078936,"about_ca_topic_score_gemma":0.0061999285,"teacher_disagreement_score":0.018879006,"about_ca_system_score_codex":0.00056930556,"about_ca_system_score_gemma":0.000907105,"threshold_uncertainty_score":0.9990604},"labels":[],"label_agreement":null},{"id":"W2912606030","doi":"10.1158/0008-5472.can-18-1604","title":"Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Transcriptome; Phenotype; Stromal cell; Biology; Cancer research; Computational biology; Genetics; Gene; Gene expression","score_opus":0.02690901987792392,"score_gpt":0.34038244395481204,"score_spread":0.3134734240768881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912606030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973045,0.0010250342,0.00006169016,0.0002279587,0.000038546317,0.00032936584,0.000079311256,0.0000060028287,0.0009275731],"genre_scores_gemma":[0.9866491,0.0000978079,0.000043372467,0.000017956745,0.000058645168,0.00009236492,0.00010173537,0.000016682336,0.012922368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871695,0.0001398864,0.00012600175,0.0002638782,0.00041272413,0.0003405445],"domain_scores_gemma":[0.9990824,0.000033700282,0.00007520086,0.0002611316,0.000465478,0.000082105194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028876078,0.00008199466,0.00012275763,0.00009999054,0.00024380453,0.000065505425,0.00019543248,0.000054206394,0.00023421556],"category_scores_gemma":[0.00014351886,0.00006672686,0.00003747738,0.00023907347,0.00039174178,0.00000995668,0.000060122515,0.00014853114,0.000011194097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034237318,0.000037012378,0.011812955,0.0000306488,0.00007798136,0.000002379016,0.00020347204,0.000052951316,0.9857826,0.00019322158,0.0012853692,0.00017898995],"study_design_scores_gemma":[0.0007799772,0.0007565321,0.01782574,0.000105184416,0.000007212739,0.0000024976132,0.00024808676,0.00013216521,0.9748252,0.000033124492,0.0051700515,0.00011420662],"about_ca_topic_score_codex":0.00011011951,"about_ca_topic_score_gemma":0.00059622654,"teacher_disagreement_score":0.011994795,"about_ca_system_score_codex":0.00007796933,"about_ca_system_score_gemma":0.0004788385,"threshold_uncertainty_score":0.27210423},"labels":[],"label_agreement":null},{"id":"W2912835372","doi":"10.1158/1538-7445.prca2017-b012","title":"Abstract B012: Histone demethylase JMJD1A promotes the generation of androgen receptor variant 7 (AR-V7) in prostate cancer cells","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen receptor; Gene knockdown; Cancer research; Demethylase; Enzalutamide; Coactivator; Histone; Cancer cell; Biology; Chemistry; Cancer; Medicine; Internal medicine; Transcription factor; Apoptosis; Gene; Genetics","score_opus":0.1178138050440875,"score_gpt":0.43600555049494644,"score_spread":0.31819174545085893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912835372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780136,0.012578429,0.0000038111011,0.0059495056,0.00033195593,0.0021715523,0.00018190575,0.00002209883,0.0007471625],"genre_scores_gemma":[0.98489046,0.0077230213,0.00012791883,0.00008676956,0.0009054614,0.0011589956,0.00005224841,0.000050536357,0.005004602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969806,0.000259503,0.00042848906,0.0005150825,0.0010192248,0.00079708855],"domain_scores_gemma":[0.9980287,0.00013151517,0.00010358943,0.00051951804,0.0009944725,0.00022220127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018992255,0.00019573356,0.00034836587,0.00034122565,0.00026457445,0.000046682577,0.00027419106,0.000114917144,0.0016980476],"category_scores_gemma":[0.00013478934,0.00012413136,0.00007688122,0.0010398272,0.00088671345,0.00014479343,0.0001246536,0.0006536887,0.0000834694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013883562,0.0003082089,0.0037717454,0.00033102295,0.00013474992,0.00007875968,0.0024285987,0.000009878047,0.95410675,0.000035058343,0.013301439,0.024105417],"study_design_scores_gemma":[0.0022906375,0.000556796,0.0036792397,0.0004047838,0.000029123179,0.0000054126713,0.00023966981,0.00019042878,0.97642523,0.00006432186,0.015975075,0.000139266],"about_ca_topic_score_codex":0.005425168,"about_ca_topic_score_gemma":0.001485038,"teacher_disagreement_score":0.02396615,"about_ca_system_score_codex":0.000963822,"about_ca_system_score_gemma":0.0021541666,"threshold_uncertainty_score":0.99921453},"labels":[],"label_agreement":null},{"id":"W2912997017","doi":"10.1158/1538-7445.sabcs18-p4-06-03","title":"Abstract P4-06-03: Unravelling triple-negative breast cancer tumor microenvironment heterogeneity using an integrative multiomic analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Triple-negative breast cancer; Immune system; Tumor microenvironment; Breast cancer; Biology; Cancer research; Immune checkpoint; Stromal cell; Computational biology; Cancer; Oncology; Medicine; Immunotherapy; Immunology; Genetics","score_opus":0.07217865534394961,"score_gpt":0.4058792502545535,"score_spread":0.3337005949106039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912997017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953827,0.002066312,0.00009836953,0.0003897822,0.00019395119,0.0012421992,0.0004831795,0.000030731626,0.000112749745],"genre_scores_gemma":[0.99668765,0.0015527094,0.0002720767,0.00025734684,0.00026068688,0.0001679431,0.000060522434,0.00005609372,0.00068494264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968112,0.00025363098,0.00046566082,0.0008474524,0.00084335124,0.00077866367],"domain_scores_gemma":[0.99844253,0.00013583421,0.00017814376,0.00064436835,0.0003006618,0.00029847605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009460457,0.00032157844,0.0006460217,0.00064356666,0.00025861565,0.00008768743,0.00029029444,0.00012533904,0.0040106415],"category_scores_gemma":[0.000020225722,0.00025680903,0.00035612262,0.001362723,0.0004057367,0.00024083153,0.00008408841,0.0007495912,0.00008795241],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041350196,0.00032042165,0.09215453,0.00012343032,0.0023952115,0.000031957454,0.0013939895,0.001438366,0.89246166,0.0000021234698,0.000109956134,0.005433313],"study_design_scores_gemma":[0.0049848347,0.00030257995,0.5508669,0.0006892905,0.00051187933,0.000030116778,0.0023267434,0.0072445427,0.43184832,0.00001396401,0.0006967089,0.0004841069],"about_ca_topic_score_codex":0.029618647,"about_ca_topic_score_gemma":0.0036905971,"teacher_disagreement_score":0.46061334,"about_ca_system_score_codex":0.0027468014,"about_ca_system_score_gemma":0.00068444246,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W2913030727","doi":"10.1158/1538-7445.prca2017-b069","title":"Abstract B069: Drug response variability between luminal and basal prostate cancer tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Carboplatin; Prostate cancer; Medicine; Olaparib; Internal medicine; Context (archaeology); Cancer; Oncology; Erlotinib; Prospective cohort study; Pathology; Cisplatin; Biology; Chemotherapy; Epidermal growth factor receptor","score_opus":0.0770861135182678,"score_gpt":0.4474507220578358,"score_spread":0.370364608539568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913030727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98067343,0.0018848049,0.000001812038,0.013643831,0.00018314685,0.0014773663,0.00024195653,0.000067590634,0.001826048],"genre_scores_gemma":[0.9850313,0.0011597485,0.00006487283,0.00012238476,0.0016237294,0.00067761797,0.000026626742,0.000059322967,0.011234395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957182,0.00055895356,0.0003693421,0.0008504148,0.0012777281,0.00122538],"domain_scores_gemma":[0.99674743,0.0007776971,0.0000631505,0.00060038833,0.001080754,0.0007305867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051698345,0.00025958658,0.00045630595,0.00037565126,0.0005420222,0.00011205895,0.0002511449,0.0001306292,0.0015803757],"category_scores_gemma":[0.00053783174,0.00019927564,0.00007730511,0.0008310183,0.0019835273,0.00020249079,0.00027525862,0.001036571,0.000114710085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029973278,0.0003160611,0.77712846,0.001010474,0.00038907598,0.0003761379,0.0048466753,9.767915e-7,0.11108809,0.000037349215,0.03394405,0.040889356],"study_design_scores_gemma":[0.0033688666,0.0008404986,0.8728856,0.00061352376,0.000055653745,0.000008878837,0.0004831487,0.000018946039,0.09878941,0.0005986102,0.022067802,0.00026904795],"about_ca_topic_score_codex":0.0032165523,"about_ca_topic_score_gemma":0.00023572728,"teacher_disagreement_score":0.09575714,"about_ca_system_score_codex":0.0010477373,"about_ca_system_score_gemma":0.0027657761,"threshold_uncertainty_score":0.9993323},"labels":[],"label_agreement":null},{"id":"W2913194197","doi":"10.1158/1538-7445.pedca17-a19","title":"Abstract A19: Human models of multilineage leukemia induced by NUP98-KDM5A chimeric fusion oncogene","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; BC Cancer Agency; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Acute megakaryoblastic leukemia; Cancer research; Fusion gene; Myeloid; Leukemia; Bone marrow; Myeloid leukemia; Myelofibrosis; Oncogene; Biology; Medicine; Immunology; Cancer; Genetics; Cell cycle; Gene","score_opus":0.14019311718461736,"score_gpt":0.4541145200893945,"score_spread":0.31392140290477716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913194197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248124,0.0009566402,0.000057072244,0.00061163487,0.00011949875,0.0011778636,0.000081009384,0.00007468825,0.014440361],"genre_scores_gemma":[0.9923889,0.00061987934,0.00027475698,0.00015356943,0.0009716675,0.00019610961,0.0000851497,0.00011135446,0.005198629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951026,0.00022000454,0.0006296954,0.00079238566,0.0020410672,0.0012142455],"domain_scores_gemma":[0.99632454,0.0002327942,0.00014032607,0.0011189084,0.0015687455,0.0006147088],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001955339,0.00029157577,0.0006114627,0.0006165902,0.00040790407,0.00003972747,0.0006940344,0.00035399268,0.0025326347],"category_scores_gemma":[0.00030883797,0.00025213312,0.00014941157,0.0013349932,0.00096469885,0.0002241295,0.00047378705,0.0016787045,0.0002669068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007396459,0.00019238685,0.00035256695,0.00023994285,0.00010286472,0.00003966924,0.0005985775,0.00001393409,0.9571504,0.00006813,0.024906961,0.0155949015],"study_design_scores_gemma":[0.004212546,0.0013776884,0.00568947,0.00041901943,0.00003238232,0.0000133819585,0.00035677192,0.0037951816,0.97692007,0.00023712877,0.006643398,0.0003029637],"about_ca_topic_score_codex":0.008740338,"about_ca_topic_score_gemma":0.00022879748,"teacher_disagreement_score":0.019769648,"about_ca_system_score_codex":0.002435478,"about_ca_system_score_gemma":0.0028318218,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W2913463884","doi":"10.1158/1538-7445.sabcs18-p4-14-03","title":"Abstract P4-14-03: Influence of competing risks of death on the interpretation of adjuvant endocrine therapy trials for breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Letrozole; Oncology; Cancer; Cumulative incidence; Internal medicine; Adjuvant therapy; Incidence (geometry); Survival analysis; Disease; Hormonal therapy; Tamoxifen; Cohort","score_opus":0.1659255413835808,"score_gpt":0.4723998340794506,"score_spread":0.3064742926958698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913463884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421,0.0033813263,0.00001242084,0.0004621008,0.000071979266,0.0008664494,0.0007674682,0.000002518873,0.00022573484],"genre_scores_gemma":[0.9958982,0.0034799725,0.00002794287,0.00004245502,0.00009711278,0.00038648548,0.000015866503,0.000017720628,0.00003425616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862427,0.00018539764,0.0003925446,0.00025245475,0.00030970477,0.00023562693],"domain_scores_gemma":[0.99802613,0.0005515167,0.00030202093,0.00033201935,0.00075987936,0.000028411492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008903782,0.00012317822,0.0003788612,0.00006422381,0.00005115403,0.0000061115097,0.00025583705,0.000051154344,0.000119341326],"category_scores_gemma":[0.00025777027,0.000078366436,0.00013359955,0.00011891617,0.00017871063,0.0000054476186,0.0000778504,0.0001119753,0.0000015084453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00413304,0.00011579299,0.058031883,0.00021464423,0.0004417874,2.3865587e-7,0.00032625056,0.0026241252,0.904683,0.00015640057,0.00017990927,0.029092964],"study_design_scores_gemma":[0.0014566281,0.00031057344,0.30694783,0.00033262363,0.000018071369,7.791051e-7,0.00017532683,0.000032600336,0.6903286,0.00006513576,0.00026144498,0.000070394],"about_ca_topic_score_codex":0.0027300527,"about_ca_topic_score_gemma":0.00016484244,"teacher_disagreement_score":0.24891596,"about_ca_system_score_codex":0.00005704507,"about_ca_system_score_gemma":0.00022957605,"threshold_uncertainty_score":0.41270414},"labels":[],"label_agreement":null},{"id":"W2913585936","doi":"10.1158/1538-7445.prca2017-a029","title":"Abstract A029: Targeting neural transcription factor BRN2 in neuroendocrine prostate tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SOX2; Enzalutamide; Cancer research; Neuroendocrine differentiation; Prostate cancer; LNCaP; Androgen receptor; In vivo; Transcription factor; Neuroendocrine tumors; Medicine; Biology; Internal medicine; Cancer; Gene; Genetics","score_opus":0.1013053681014257,"score_gpt":0.42843080601204653,"score_spread":0.3271254379106208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913585936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896147,0.0018160891,0.0000021298692,0.0051897513,0.00023717961,0.0013264349,0.000052954452,0.000074206386,0.0016865346],"genre_scores_gemma":[0.9942473,0.0010497273,0.000031895725,0.00012940238,0.0006371035,0.00032957495,0.00004785496,0.000057860856,0.0034692765],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99666953,0.00016144819,0.00036330777,0.0005788478,0.0009866448,0.001240207],"domain_scores_gemma":[0.99870974,0.00009121552,0.000041597355,0.00031079684,0.00050300016,0.0003436435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005363458,0.00020610493,0.0003123576,0.00053393806,0.00023698324,0.000078959674,0.00020538563,0.00004878036,0.0014513801],"category_scores_gemma":[0.00013869775,0.0001612453,0.00008541436,0.0009827174,0.0005014772,0.0002493125,0.00007595392,0.0010363172,0.00014539798],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038369356,0.00035279966,0.10159571,0.00054197107,0.00005484059,0.0016524135,0.0018660674,0.000010412437,0.844687,0.000029778308,0.0046802904,0.04069178],"study_design_scores_gemma":[0.008262564,0.0022398583,0.5477738,0.00073958654,0.000018367582,0.00007500358,0.0010188522,0.00073464087,0.422804,0.00022885978,0.015690597,0.00041391506],"about_ca_topic_score_codex":0.0016411864,"about_ca_topic_score_gemma":0.00030378395,"teacher_disagreement_score":0.44617805,"about_ca_system_score_codex":0.0005830881,"about_ca_system_score_gemma":0.0005579547,"threshold_uncertainty_score":0.9994614},"labels":[],"label_agreement":null},{"id":"W2913972996","doi":"10.1158/1538-7445.sabcs18-p4-02-01","title":"Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University of British Columbia","funders":"","keywords":"Reproducibility; Breast cancer; Protocol (science); Medicine; Standardization; Medical physics; Tissue microarray; Digital image analysis; Cancer; Pathology; Artificial intelligence; Computer science; Internal medicine; Statistics; Mathematics; Computer vision","score_opus":0.07730096198235493,"score_gpt":0.5323393647668984,"score_spread":0.45503840278454344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913972996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503605,0.0000013388985,0.000086786975,0.00074996165,0.0001368046,0.047746666,0.000016378037,0.000058486316,0.0008430825],"genre_scores_gemma":[0.9761319,5.772079e-7,0.0002661141,0.000024419272,0.00023571783,0.02294205,0.00006188017,0.000022808472,0.00031450493],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99838495,0.000052556068,0.0003042127,0.00027759248,0.0007534065,0.0002272655],"domain_scores_gemma":[0.99874383,0.00013763053,0.00008060385,0.00020767454,0.00070175907,0.00012852336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009795689,0.00008236805,0.00018304036,0.00022425514,0.000055902132,0.000133993,0.00015320565,0.000046986726,0.00031135252],"category_scores_gemma":[0.00066594646,0.00006891265,0.00003882141,0.00026417998,0.000067069486,0.00032724597,0.000050592666,0.00030303877,0.00001605582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057637473,0.003695283,0.8455542,0.0013127255,0.0004546356,0.000039653256,0.002387745,0.0035386584,0.0996901,0.00021904307,0.0028622907,0.034481943],"study_design_scores_gemma":[0.01682967,0.0021716522,0.2539874,0.0007833054,0.000042384363,0.0000052370056,0.0019176282,0.6916401,0.02459361,0.000057543362,0.007738072,0.00023340927],"about_ca_topic_score_codex":0.00012414559,"about_ca_topic_score_gemma":0.0000066609214,"teacher_disagreement_score":0.6881014,"about_ca_system_score_codex":0.00021716417,"about_ca_system_score_gemma":0.00028344698,"threshold_uncertainty_score":0.34090918},"labels":[],"label_agreement":null},{"id":"W2914471889","doi":"10.1158/1538-7445.prca2017-a041","title":"Abstract A041: LSD1 inhibition disrupts FOXA1-dependent AR cistrome","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"FOXA1; Transcription factor; Androgen receptor; Enhancer; Chromatin; Biology; Demethylase; Cancer research; Pioneer factor; Epigenetics; Epigenomics; Histone; Epigenome; Cell biology; Prostate cancer; Genetics; DNA methylation; Gene; Gene expression; Cancer","score_opus":0.12556389661233372,"score_gpt":0.4711247264731977,"score_spread":0.345560829860864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914471889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973694,0.0019394065,0.000014418004,0.004479847,0.00029222312,0.0009610018,0.00008040564,0.00008294117,0.018455748],"genre_scores_gemma":[0.98286146,0.0011523097,0.00005557358,0.00013571767,0.0016271457,0.000391434,0.000076582626,0.000051672985,0.01364812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964701,0.00012232733,0.00026880298,0.0005712216,0.0015510711,0.0010164854],"domain_scores_gemma":[0.9978883,0.00017510711,0.00004516102,0.00055091735,0.00086525286,0.00047522513],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001285943,0.00018851981,0.0002821753,0.00037873656,0.0003975173,0.00009583909,0.00017717855,0.00014801088,0.0040884106],"category_scores_gemma":[0.0002214725,0.00014538452,0.00010245852,0.0006440567,0.0007119074,0.0001767068,0.00017167174,0.00078221946,0.0013039876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007297258,0.0010160125,0.033367686,0.0008888968,0.00042212923,0.0016579055,0.0017102285,0.0000021027327,0.8181423,0.00056492863,0.06972456,0.06520597],"study_design_scores_gemma":[0.008334309,0.0027173292,0.23118772,0.0011443752,0.000067807465,0.00009323128,0.000819126,0.000033678454,0.6889929,0.0013387738,0.06478971,0.000481037],"about_ca_topic_score_codex":0.0006942566,"about_ca_topic_score_gemma":0.00020780569,"teacher_disagreement_score":0.19782002,"about_ca_system_score_codex":0.0010351192,"about_ca_system_score_gemma":0.00081998756,"threshold_uncertainty_score":0.99947363},"labels":[],"label_agreement":null},{"id":"W2914672684","doi":"10.1158/1538-7445.sabcs18-pd6-09","title":"Abstract PD6-09: Cost effectiveness of bilateral prophylactic mastectomy with and without different breast reconstruction techniques versus screening in women with high risk of breast cancer in the Canadian Province of Ontario","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Breast reconstruction; Mastectomy; Quality-adjusted life year; Cost effectiveness; Economic evaluation; Gynecology; Cancer; Internal medicine","score_opus":0.023869179554838974,"score_gpt":0.3041533007712953,"score_spread":0.28028412121645635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914672684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766576,0.000035687834,0.0000019178847,0.00006962771,0.000050728602,0.0018952471,0.00013905343,0.0000049179116,0.0001370304],"genre_scores_gemma":[0.999578,0.000019883984,0.00006582334,9.869597e-7,0.000027175616,0.00026177612,0.000004189344,0.000016546886,0.000025607254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854195,0.00020333866,0.00023648216,0.0002634894,0.00040126103,0.00035350112],"domain_scores_gemma":[0.9991506,0.000105357554,0.00016590742,0.0002014169,0.00027455718,0.00010221197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076076505,0.00014431415,0.00041065452,0.0004731452,0.000048982154,0.000015549716,0.000095528536,0.000098505094,0.00008461666],"category_scores_gemma":[0.0000045979796,0.00008207327,0.000017264758,0.00038326302,0.00040940935,0.00014096114,0.000019770441,0.00065444043,2.2925009e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02300666,0.00004909203,0.8392595,0.00082580704,0.00008766032,0.0000081346525,0.000576468,0.00003094398,0.004870747,0.000006112719,1.8284399e-7,0.13127871],"study_design_scores_gemma":[0.0040897797,0.00069338636,0.9818835,0.0030076324,0.00003085363,0.0015629143,0.00048291663,0.000011754619,0.008130697,0.00001018837,0.0000016670975,0.00009470146],"about_ca_topic_score_codex":0.8494783,"about_ca_topic_score_gemma":0.921264,"teacher_disagreement_score":0.14262404,"about_ca_system_score_codex":0.0013371432,"about_ca_system_score_gemma":0.002381482,"threshold_uncertainty_score":0.42246464},"labels":[],"label_agreement":null},{"id":"W2914802774","doi":"10.1158/1538-7445.sabcs18-p3-11-05","title":"Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Epirubicin; Medicine; Oncology; Internal medicine; Docetaxel; Breast cancer; Triple-negative breast cancer; Hazard ratio; Cyclophosphamide; Fluorouracil; Cancer; Gene signature; Chemotherapy; Confidence interval; Gene expression; Colorectal cancer; Biology","score_opus":0.053868755868043065,"score_gpt":0.41678518531308084,"score_spread":0.36291642944503777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914802774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558116,0.0044325697,2.8860282e-7,0.0039171805,0.0005433492,0.0032673122,0.0007186392,0.000010048376,0.0015294731],"genre_scores_gemma":[0.9947969,0.0017060769,0.0000073791707,0.00019121062,0.00066512614,0.0012476216,0.000035927158,0.000026364625,0.0013234066],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976062,0.00020308816,0.00040248432,0.00043500774,0.00076462014,0.0005885963],"domain_scores_gemma":[0.9985683,0.00059204944,0.00010425075,0.00031895255,0.00031068258,0.00010579503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089060713,0.00019298366,0.0005396007,0.00041220195,0.00005056029,0.000013846672,0.00028990832,0.00016655627,0.0045565492],"category_scores_gemma":[0.000055710276,0.00013033372,0.000106861335,0.0009642614,0.00021265897,0.00010445303,0.00007011161,0.00090924196,0.000015585909],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4656403,0.0048521953,0.18218699,0.0009436155,0.000835148,0.00060331135,0.016525552,0.0043582553,0.24980682,0.00033511085,0.02928852,0.044624176],"study_design_scores_gemma":[0.11108379,0.0023455352,0.8569054,0.00045123903,0.00009680512,0.000012974627,0.00130785,0.0003446216,0.02508499,0.00029647743,0.0018475243,0.00022279518],"about_ca_topic_score_codex":0.026555391,"about_ca_topic_score_gemma":0.016673066,"teacher_disagreement_score":0.67471844,"about_ca_system_score_codex":0.00084106723,"about_ca_system_score_gemma":0.001184757,"threshold_uncertainty_score":0.99635345},"labels":[],"label_agreement":null},{"id":"W2914874789","doi":"10.1158/1538-7445.sabcs18-pd6-04","title":"Abstract PD6-04: Lifestyle intervention study (LISA) in early breast cancer (BC): An RCT of the effects of a telephone-based weight loss intervention (with educational materials) vs educational materials alone on disease-free survival (DFS)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Weight loss; Randomized controlled trial; Body mass index; Breast cancer; Telephone counseling; Obesity; Overweight; Internal medicine; Cancer; Physical therapy","score_opus":0.02437038166898508,"score_gpt":0.3819516922928525,"score_spread":0.3575813106238674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914874789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260545,0.00020024912,8.840492e-7,0.0022577613,0.0016801403,0.0023310652,0.0008851559,0.0000101353735,0.0000291618],"genre_scores_gemma":[0.99757504,0.00006176275,0.0000050733447,0.00002902765,0.000646578,0.0008936343,0.00014910479,0.00005294106,0.0005868169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965668,0.00055723864,0.00062809483,0.0005197691,0.0013294066,0.00039874075],"domain_scores_gemma":[0.99774945,0.00034137038,0.0003241823,0.00082372956,0.0005683051,0.00019296096],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011828276,0.00023902401,0.00053397403,0.00040356987,0.000074482276,0.000059104852,0.0004511235,0.000087983295,0.004693109],"category_scores_gemma":[0.00016758958,0.00016821295,0.00013836024,0.0005413416,0.00024022216,0.00021688608,0.00011633183,0.0003215187,0.000021085369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013685928,0.005364873,0.9008751,0.0027391743,0.00018730112,0.000007574149,0.00059610547,0.000040822608,0.07510314,0.00009431275,0.00063171773,0.0006739786],"study_design_scores_gemma":[0.0059209643,0.0011508208,0.91494906,0.003668891,0.00006794114,0.0000019087242,0.00016809648,0.0000028965794,0.073809385,0.00008043136,0.00003030909,0.00014930087],"about_ca_topic_score_codex":0.04912013,"about_ca_topic_score_gemma":0.0060709324,"teacher_disagreement_score":0.043049198,"about_ca_system_score_codex":0.00067852647,"about_ca_system_score_gemma":0.0013643873,"threshold_uncertainty_score":0.9962167},"labels":[],"label_agreement":null},{"id":"W2915144541","doi":"10.1158/1538-7445.am2017-3020","title":"Abstract 3020: Novel therapeutic targets in head and neck cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Digital Humanities; Oakville-Trafalgar Memorial Hospital","funders":"","keywords":"Notch signaling pathway; Cancer research; Metastasis; Biology; Cancer; Gene knockdown; Primary tumor; Exome; Head and neck squamous-cell carcinoma; Exome sequencing; Phenotype; Medicine; Gene; Head and neck cancer; Genetics","score_opus":0.08130814490490479,"score_gpt":0.43121927189047204,"score_spread":0.34991112698556726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915144541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704552,0.023191603,0.00039952007,0.0020255698,0.0002841377,0.0007392207,0.000084713916,0.000011866951,0.0028081194],"genre_scores_gemma":[0.989593,0.007946872,0.00008006003,0.00016392086,0.00035383814,0.00042328672,0.000018405519,0.00005678942,0.0013638003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997677,0.00007133588,0.00019661277,0.0006831921,0.0005392836,0.0008325246],"domain_scores_gemma":[0.99855614,0.000021965197,0.00006694076,0.00087422,0.0002646785,0.0002160601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076926814,0.0001857799,0.00019730472,0.00015914362,0.00043367714,0.0002023774,0.0006803741,0.00026372308,0.0003469243],"category_scores_gemma":[0.00017837025,0.00018254765,0.000059354697,0.00013369479,0.00038678583,0.000014868139,0.0005196857,0.0006694625,0.000016490076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028864498,0.0000708539,0.001280577,0.0000620186,0.00006242879,0.0000208541,0.00007106831,0.00009378979,0.9719049,0.00014892999,0.0012074854,0.02478845],"study_design_scores_gemma":[0.0032361154,0.00031967426,0.07901998,0.00025673935,0.000009246459,0.0000102466765,0.000092348084,0.00021776489,0.8213516,0.0004218512,0.09460946,0.0004549816],"about_ca_topic_score_codex":0.004773149,"about_ca_topic_score_gemma":0.008615191,"teacher_disagreement_score":0.1505533,"about_ca_system_score_codex":0.00017269755,"about_ca_system_score_gemma":0.000644657,"threshold_uncertainty_score":0.7444077},"labels":[],"label_agreement":null},{"id":"W2915409618","doi":"10.1158/1538-7445.sabcs15-p4-14-20","title":"Abstract P4-14-20: A phase 1b study of ONT 380, an oral HER2-specific inhibitor, combined with ado trastuzumab emtansine (T DM1), in HER2+ metastatic breast cancer (MBC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Lapatinib; Tolerability; Internal medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Trastuzumab emtansine; Taxane; Capecitabine; Oncology; Context (archaeology); Cancer; Breast cancer; Gastroenterology; Adverse effect; Pharmacology","score_opus":0.12941939372273326,"score_gpt":0.47064189096229636,"score_spread":0.3412224972395631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915409618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921125,0.0015290508,0.000005173899,0.002859211,0.00023813537,0.002592597,0.00040246852,0.00004810937,0.00021271959],"genre_scores_gemma":[0.99602914,0.0010450454,0.000037666534,0.00007586669,0.00033352908,0.0012196226,0.000034871104,0.00009130824,0.0011329479],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961136,0.00039117874,0.0006218156,0.0007879313,0.0011621702,0.0009232874],"domain_scores_gemma":[0.9979048,0.00022858298,0.00015160456,0.0005872103,0.00066553487,0.00046228955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008118,0.00037818207,0.0009266216,0.0005701898,0.00012189708,0.00003259918,0.00027774245,0.000094988565,0.004312965],"category_scores_gemma":[0.00001964347,0.00024039645,0.00008519381,0.0010796738,0.0004419013,0.0002710992,0.00007078614,0.0006048536,0.00002441987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12634353,0.09163655,0.10769818,0.0009684209,0.002341817,0.004358383,0.012631822,0.00007943428,0.45688492,0.000046747777,0.018418455,0.17859174],"study_design_scores_gemma":[0.3690428,0.074781075,0.45890495,0.0037718513,0.0009660949,0.0002082479,0.008274022,0.00007276989,0.06832683,0.0001297719,0.014101261,0.0014203149],"about_ca_topic_score_codex":0.016794443,"about_ca_topic_score_gemma":0.06796332,"teacher_disagreement_score":0.38855806,"about_ca_system_score_codex":0.0017827934,"about_ca_system_score_gemma":0.0016136119,"threshold_uncertainty_score":0.99659723},"labels":[],"label_agreement":null},{"id":"W2916625407","doi":"10.1158/1538-7445.am2015-3865","title":"Abstract 3865: Thymocyte selection-associated HMG box protein (TOX) induces genomic instability in T-cell acute lymphoblastic leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute","funders":"","keywords":"Ku70; Thymocyte; Genome instability; Ku80; Biology; Zebrafish; DNA repair; T cell; Cancer research; T-cell receptor; Molecular biology; Cell biology; DNA damage; Genetics; Gene; DNA; DNA-binding protein; Transcription factor","score_opus":0.053609758882631184,"score_gpt":0.34878993770427874,"score_spread":0.29518017882164754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916625407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571276,0.0013332064,0.000028053035,0.00015384398,0.00009477902,0.0005820308,0.000050847026,0.000016629938,0.0020278657],"genre_scores_gemma":[0.9969082,0.00036716365,0.000048831964,0.0000395818,0.00018500217,0.0006551499,0.00006160986,0.000033071,0.0017013741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998022,0.00019767783,0.00028562936,0.00055307883,0.00038573903,0.00055586896],"domain_scores_gemma":[0.99885213,0.0000213615,0.00008159659,0.00038189726,0.00046925177,0.00019375679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001070247,0.00016231007,0.00017371088,0.00013765536,0.00014512043,0.00007057973,0.00036878762,0.00024522148,0.00008320831],"category_scores_gemma":[0.00018872153,0.00015845436,0.00005657309,0.00051257503,0.00016005767,0.000014876138,0.00013758171,0.00039136628,0.000044631543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023819633,0.00012237689,0.003113767,0.000024020752,0.00004069364,0.000003532737,0.00014636056,0.0005044919,0.99254924,0.000013585616,0.0017629795,0.001480727],"study_design_scores_gemma":[0.002275082,0.0003518943,0.05224477,0.000056088295,0.000012157262,0.0000028223687,0.0003605181,0.00014966173,0.9341172,0.00026200898,0.009809054,0.00035872727],"about_ca_topic_score_codex":0.0023041295,"about_ca_topic_score_gemma":0.0020935535,"teacher_disagreement_score":0.058432054,"about_ca_system_score_codex":0.0016485795,"about_ca_system_score_gemma":0.0032492043,"threshold_uncertainty_score":0.64615816},"labels":[],"label_agreement":null},{"id":"W2917040313","doi":"10.1158/1538-7445.sabcs17-p5-17-03","title":"Abstract P5-17-03: Breast cancer in young women in Canada: A needs assessment","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Test (biology); Descriptive statistics; Family medicine; Gerontology; Gynecology; Internal medicine","score_opus":0.12729464226817955,"score_gpt":0.45850194597054206,"score_spread":0.3312073037023625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917040313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373146,0.0007547643,0.0000011178457,0.0043622935,0.00026541273,0.00047002363,0.0000888975,0.000014125664,0.020311913],"genre_scores_gemma":[0.9963287,0.00046814536,0.00002150497,0.00052765524,0.0006363528,0.0006157312,0.000004866203,0.000027154732,0.001369858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99624133,0.000088858695,0.00037915853,0.0004082553,0.0013840194,0.0014983511],"domain_scores_gemma":[0.9985846,0.00007590951,0.000052620915,0.00036867074,0.0004724026,0.00044577083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015808247,0.00017430038,0.00039114468,0.00048949284,0.00010949184,0.000044928445,0.00030790555,0.00009253473,0.0052114767],"category_scores_gemma":[0.000060546554,0.0001592386,0.0000340706,0.0017500336,0.0001886972,0.00018012858,0.00013022288,0.0009810388,0.000026054851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006366914,0.000051477844,0.9652445,0.000098295124,0.000037130645,0.00030510782,0.00137018,0.00007279393,0.0052288147,0.000042215885,0.01306891,0.013843883],"study_design_scores_gemma":[0.0013453995,0.000116851734,0.9887388,0.0007985411,0.0000047858366,0.00002905606,0.0050383685,0.00015224954,0.00057617266,0.000054687986,0.002978078,0.00016703602],"about_ca_topic_score_codex":0.9865865,"about_ca_topic_score_gemma":0.99347275,"teacher_disagreement_score":0.023494273,"about_ca_system_score_codex":0.019761613,"about_ca_system_score_gemma":0.01623842,"threshold_uncertainty_score":0.9956979},"labels":[],"label_agreement":null},{"id":"W2918937810","doi":"10.1158/1538-7445.sabcs18-p5-13-10","title":"Abstract P5-13-10: Recommendations to improve the lived experience of early stage and metastatic breast cancer patients in Canada","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Cancer; Quality of life (healthcare); Stage (stratigraphy); Disease; Family medicine; Oncology; Internal medicine; Nursing","score_opus":0.08142245563599101,"score_gpt":0.34266580212754305,"score_spread":0.261243346491552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918937810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925815,0.0007191191,0.0000036543559,0.0017221508,0.0003748811,0.0006603238,0.0017636386,0.0000030509632,0.0021716894],"genre_scores_gemma":[0.9966996,0.0009359531,0.000017034961,0.0002306642,0.000041963092,0.00029764808,0.0000048805696,0.000020634057,0.0017516762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984695,0.000025356918,0.0005284939,0.00039379083,0.000099702644,0.00048319812],"domain_scores_gemma":[0.9990057,0.00015642653,0.0002063782,0.0003266085,0.00015757246,0.00014734652],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005664342,0.00012534019,0.0003388719,0.0001918061,0.000088985405,0.00006268654,0.00035647626,0.000036063913,0.0034385053],"category_scores_gemma":[0.00009256216,0.00011656136,0.00003249053,0.00035572975,0.00009138393,0.00031087856,0.0001298289,0.00027263036,0.00007470653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017041586,0.00006653925,0.97823524,0.000089959656,0.000043795088,0.0000012712815,0.003597302,0.00023375933,0.00020668254,0.0016265112,0.002728866,0.012999633],"study_design_scores_gemma":[0.0006225866,0.00007372731,0.9858034,0.00006351822,0.0000014629388,1.2663084e-7,0.0008804414,0.00009485864,0.0002563385,0.00030357577,0.011733878,0.0001660845],"about_ca_topic_score_codex":0.9561938,"about_ca_topic_score_gemma":0.7875604,"teacher_disagreement_score":0.1686334,"about_ca_system_score_codex":0.0010587962,"about_ca_system_score_gemma":0.0007814807,"threshold_uncertainty_score":0.99747247},"labels":[],"label_agreement":null},{"id":"W2919008715","doi":"10.1158/1538-7445.sabcs18-gs4-03","title":"Abstract GS4-03: RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Calgary; Okanagan University College; University of British Columbia; University of Manitoba; Western University","funders":"","keywords":"Medicine; Lumpectomy; Cosmesis; Breast-conserving surgery; Breast cancer; Radiation therapy; Mastectomy; Ductal carcinoma; Urology; Cancer; Radiology; Surgery; Internal medicine","score_opus":0.056016289547008685,"score_gpt":0.3857384227969081,"score_spread":0.3297221332498994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919008715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952696,0.002222119,0.000021572598,0.00023819358,0.000420099,0.0013148913,0.000114833994,0.000009882513,0.00038882266],"genre_scores_gemma":[0.99789304,0.00071401714,0.00014330489,0.00006332932,0.0006933328,0.00020454745,0.00012600294,0.000030080395,0.00013235235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803215,0.00025572762,0.0003848781,0.0003779646,0.0005089368,0.00044036776],"domain_scores_gemma":[0.9989065,0.00011763037,0.0001596545,0.00031444937,0.00041073418,0.00009101823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009812966,0.00018587081,0.0004744747,0.000119484335,0.00012216638,0.000032327378,0.00017650223,0.00015675098,0.0008207952],"category_scores_gemma":[0.000058204776,0.00015414578,0.00016590423,0.00020032287,0.00030097537,0.000016155966,0.00008160185,0.00018200194,0.000016110016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5701909,0.00016839149,0.00052477716,0.000041119227,0.0005863562,0.0000019381841,0.00013046374,0.0010690333,0.42176557,0.000029117578,0.0005432552,0.0049490607],"study_design_scores_gemma":[0.8682193,0.0005019065,0.00447163,0.00009097883,0.00006221642,0.00001824332,0.00007971546,0.0017005163,0.12211441,0.000018533217,0.002386892,0.00033562694],"about_ca_topic_score_codex":0.0010010549,"about_ca_topic_score_gemma":0.000022727627,"teacher_disagreement_score":0.29965115,"about_ca_system_score_codex":0.0001463013,"about_ca_system_score_gemma":0.0006710046,"threshold_uncertainty_score":0.8987132},"labels":[],"label_agreement":null},{"id":"W2919391629","doi":"","title":"Interstitial fluid pressure (IFP) and metastasis in a panel of tumor models","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cervix; Medicine; Metastasis; Pathology; Cancer; Cancer research; Mammary carcinoma; Radiation therapy; Fibrosarcoma; Mammary tumor; Carcinoma; Internal medicine; Breast cancer","score_opus":0.059892355827906266,"score_gpt":0.34553865664122746,"score_spread":0.2856463008133212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919391629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844227,0.013793295,0.00021290623,0.00013737049,0.000051829098,0.00018311698,0.00017971771,0.0000020107314,0.0010170743],"genre_scores_gemma":[0.9978849,0.0014290892,0.00012889746,0.000036929465,0.00017242246,0.00006971284,0.00002208805,0.000013815138,0.00024212823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991593,0.00005139883,0.00015276235,0.00024671477,0.00015110176,0.0002387182],"domain_scores_gemma":[0.9995828,0.000029713236,0.000025517284,0.00019202304,0.0001230096,0.000046888883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026692753,0.00007424859,0.00012504408,0.00008479011,0.000029986102,0.000018961744,0.0001360705,0.000052531173,0.000023612254],"category_scores_gemma":[0.00004591901,0.0000736827,0.00003102916,0.00011245734,0.00015648403,0.0000035163825,0.00017791915,0.000102567836,7.0589385e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044463802,0.0001019566,0.0026896675,0.00014090775,0.000052984753,0.0000135502305,0.000109236804,0.0057565295,0.97687495,0.001963385,0.007870429,0.0039817686],"study_design_scores_gemma":[0.0020493593,0.00055129785,0.00417949,0.00012376938,0.00003652191,0.000011646604,0.00024800978,0.0026575068,0.9214578,0.004125221,0.06423172,0.00032764365],"about_ca_topic_score_codex":0.0042886985,"about_ca_topic_score_gemma":0.0020367622,"teacher_disagreement_score":0.05636129,"about_ca_system_score_codex":0.000022537588,"about_ca_system_score_gemma":0.00016875908,"threshold_uncertainty_score":0.6483258},"labels":[],"label_agreement":null},{"id":"W2919532882","doi":"10.1158/1538-7445.sabcs18-p5-16-01","title":"Abstract P5-16-01: Is breast reconstruction safe in women over 70? An analysis of the national surgical quality improvement program (NSQIP) database","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast reconstruction; Breast cancer; Mastectomy; Surgery; Demographics; Database; Lymph node; Cancer; Internal medicine; Demography","score_opus":0.07634660072219543,"score_gpt":0.4410974108764067,"score_spread":0.3647508101542113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919532882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676424,0.000041285504,6.21616e-7,0.00053891045,0.00021207033,0.0007529017,0.00051827525,0.000014466848,0.0011572549],"genre_scores_gemma":[0.99908596,0.00004503256,0.00002834304,0.000036345293,0.00018763954,0.00014030075,0.00010039774,0.000010106168,0.0003658846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975266,0.00017005332,0.00043914537,0.00038457065,0.0010878432,0.0003917744],"domain_scores_gemma":[0.99888813,0.00009765473,0.00013279701,0.00034491962,0.00038342125,0.00015305159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001985669,0.00011158417,0.00033820717,0.0004931417,0.00007410767,0.000028036535,0.0001537672,0.00011633147,0.0049628196],"category_scores_gemma":[0.000020675472,0.00007703983,0.0001238192,0.0013022829,0.00023982536,0.00021036518,0.000075460375,0.0005163577,0.000012416378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017093797,0.00046049824,0.32123044,0.00021568387,0.0004935239,0.0000032238963,0.000348715,0.000022916462,0.016505815,0.00014656312,0.00016996845,0.65869325],"study_design_scores_gemma":[0.0020845376,0.0001298199,0.9919365,0.0001608847,0.00005924557,0.0004444266,0.0008538684,0.000484676,0.00305835,0.00009532301,0.0005707817,0.00012155891],"about_ca_topic_score_codex":0.0038720905,"about_ca_topic_score_gemma":0.00091603806,"teacher_disagreement_score":0.6707061,"about_ca_system_score_codex":0.0010296669,"about_ca_system_score_gemma":0.00057386537,"threshold_uncertainty_score":0.99594676},"labels":[],"label_agreement":null},{"id":"W2920021859","doi":"10.1158/1538-7445.sabcs18-p1-13-08","title":"Abstract P1-13-08: A prospective non-randomized clinical trial of adjuvant carboplatin chemotherapy in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Carboplatin; Medicine; Regimen; Internal medicine; Oncology; Triple-negative breast cancer; Taxane; Breast cancer; Docetaxel; Chemotherapy; Anthracycline; Cancer; Cisplatin","score_opus":0.08622547739423342,"score_gpt":0.503429888189596,"score_spread":0.4172044107953626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920021859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839921,0.0008570565,0.000001100763,0.0020534364,0.00087014935,0.007561469,0.00012855323,0.000017289347,0.0045188493],"genre_scores_gemma":[0.9903494,0.0035039403,0.000023108149,0.00015718781,0.0009046295,0.0021824173,0.000012343463,0.00004189896,0.0028250443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969091,0.00047554725,0.0008086488,0.0005777805,0.00066207786,0.00056683715],"domain_scores_gemma":[0.9973682,0.001440216,0.00022543945,0.0003322338,0.0004363918,0.00019752819],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002850938,0.00022171561,0.0014957339,0.00031039855,0.00004357691,0.000012733436,0.00017757658,0.0002113769,0.006609314],"category_scores_gemma":[0.00019385271,0.00016705321,0.0003216426,0.0006842746,0.00063054776,0.00008582987,0.00005569312,0.0009849773,0.00004585964],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91511685,0.0013921575,0.051437873,0.00017193322,0.00064528687,0.00003419681,0.0026016564,0.000015935506,0.009603602,0.00001697289,0.0023797923,0.01658375],"study_design_scores_gemma":[0.80173415,0.0012615231,0.18526815,0.00035554133,0.00009195948,0.0000035109008,0.0003751264,0.00023505835,0.01016618,0.00015137932,0.0002032187,0.00015422782],"about_ca_topic_score_codex":0.016739817,"about_ca_topic_score_gemma":0.0025686512,"teacher_disagreement_score":0.13383026,"about_ca_system_score_codex":0.00080205244,"about_ca_system_score_gemma":0.002043598,"threshold_uncertainty_score":0.99429876},"labels":[],"label_agreement":null},{"id":"W2920791670","doi":"10.1158/1538-7445.sabcs18-p3-10-11","title":"Abstract P3-10-11: Clinical implications of 63-gene signature associated with response to PARP inhibition in triple-negative and luminal B breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Olaparib; Medicine; Gene signature; Oncology; Internal medicine; Cancer; Lymph node; Cohort; Proportional hazards model; Gene expression; Cancer research; Gene; Biology; Poly ADP ribose polymerase; Genetics","score_opus":0.09127050448730092,"score_gpt":0.46599694516867,"score_spread":0.37472644068136907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920791670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98179835,0.00043805264,0.000006960873,0.014857191,0.00009425492,0.0016155398,0.00082669395,0.000025339512,0.00033762198],"genre_scores_gemma":[0.99657327,0.00034353381,0.00007088785,0.00044423196,0.00021919595,0.00071979145,0.00004437825,0.000040726107,0.001543956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99717885,0.0004926123,0.0005401385,0.0005764592,0.0007210634,0.00049085915],"domain_scores_gemma":[0.99689627,0.001083924,0.000175886,0.00040942617,0.0011283486,0.0003061496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025492525,0.0001769826,0.0004893772,0.00044633297,0.00008336644,0.000022952507,0.00010725518,0.00024458638,0.0013293672],"category_scores_gemma":[0.00044014535,0.00015134976,0.000065567576,0.0013685793,0.00039342762,0.0001361305,0.00005897149,0.0007363474,0.000020349962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046352047,0.00067152584,0.31420684,0.00017339013,0.00021598767,0.00005108229,0.0011893413,0.0001342918,0.61221856,0.00006503118,0.020011254,0.004710662],"study_design_scores_gemma":[0.007272007,0.0008680056,0.94636536,0.0014454807,0.000023266626,0.000018930272,0.00024027834,0.00001548686,0.04238546,0.00015549888,0.0010324675,0.0001777672],"about_ca_topic_score_codex":0.0008513313,"about_ca_topic_score_gemma":0.0021627273,"teacher_disagreement_score":0.6321585,"about_ca_system_score_codex":0.0009647491,"about_ca_system_score_gemma":0.0015383341,"threshold_uncertainty_score":0.99958354},"labels":[],"label_agreement":null},{"id":"W2920933986","doi":"","title":"Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501) - an initial analysis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nedaplatin; Radiation therapy; Regimen; Population; Chemoradiotherapy; Carcinoma; Nuclear medicine; Radiology; Urology; Surgery; Oncology; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.08506566676896396,"score_gpt":0.4673650728284652,"score_spread":0.3822994060595012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920933986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959,0.00071290723,0.00012929222,0.00048118172,0.00010291163,0.002224703,0.000036527694,0.00003676399,0.00037570964],"genre_scores_gemma":[0.998375,0.000320357,0.00014031299,0.0001627493,0.00020997808,0.00043719175,0.0002654457,0.000029288069,0.00005969227],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99657005,0.0005505958,0.000685919,0.0006014147,0.00095656916,0.0006354652],"domain_scores_gemma":[0.99807423,0.0005797237,0.00018779564,0.00042379354,0.00038479196,0.0003496533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015963247,0.00023436389,0.000861325,0.0013343042,0.00016345819,0.000017097585,0.00021424863,0.00018327357,0.00073187455],"category_scores_gemma":[0.00014098211,0.00017677371,0.00009563933,0.004381906,0.00016225639,0.00020063118,0.00007567148,0.0005288472,0.0000032348473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08477394,0.02344653,0.2155189,0.000061538165,0.00085264706,0.00049776083,0.0024020371,0.00025378828,0.008002399,0.00005445583,0.000017224345,0.66411877],"study_design_scores_gemma":[0.10887044,0.17745462,0.70469147,0.000022555194,0.00025701008,0.000004322992,0.0016953007,0.0004249246,0.005753993,0.000051913896,0.0005703517,0.00020307049],"about_ca_topic_score_codex":0.004682101,"about_ca_topic_score_gemma":0.010113385,"teacher_disagreement_score":0.6639157,"about_ca_system_score_codex":0.0012936337,"about_ca_system_score_gemma":0.00044716816,"threshold_uncertainty_score":0.8013513},"labels":[],"label_agreement":null},{"id":"W2921804231","doi":"10.1158/0008-5472.can-18-1545","title":"SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Jewish General Hospital; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Cancer Institute; Government of Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Fondation du cancer du sein du Québec","keywords":"Bromodomain; SWI/SNF; Cancer; Medicine; Cancer research; Biology; Internal medicine; Genetics; Transcription factor; Epigenetics; Gene","score_opus":0.03389902320710113,"score_gpt":0.3579223199509577,"score_spread":0.32402329674385655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921804231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939214,0.00075137144,0.00008778316,0.0012379467,0.00046130372,0.00088344805,0.000032917196,0.000021893395,0.0026019583],"genre_scores_gemma":[0.9830183,0.00014714935,0.00013313523,0.00044952714,0.000646632,0.00029712726,0.0000385585,0.000041107905,0.015228475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802625,0.00016143895,0.00019067735,0.00056496763,0.00048616302,0.0005705002],"domain_scores_gemma":[0.9988397,0.00001820726,0.000049294256,0.0005452386,0.0002820721,0.00026549547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005771756,0.00015205397,0.00016473902,0.00016040399,0.00013545218,0.000084616324,0.00037809194,0.00014987889,0.0005025959],"category_scores_gemma":[0.00012416256,0.0001470942,0.00007787205,0.0004421773,0.0000942462,0.0000115537505,0.00023143909,0.00025911035,0.00034884686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000174451,0.000021377838,0.0036773898,0.000035022527,0.000021095175,0.0000021515962,0.00005296751,0.00013739374,0.9302563,0.000098427416,0.06393642,0.0015870034],"study_design_scores_gemma":[0.0006673523,0.0003457941,0.0009773767,0.000069204725,0.0000018298654,0.000001158482,0.00024147077,0.000012279141,0.7767355,0.000045931767,0.2207112,0.00019093502],"about_ca_topic_score_codex":0.00063082605,"about_ca_topic_score_gemma":0.00042320427,"teacher_disagreement_score":0.15677479,"about_ca_system_score_codex":0.00026084314,"about_ca_system_score_gemma":0.00047120085,"threshold_uncertainty_score":0.5998327},"labels":[],"label_agreement":null},{"id":"W2922125039","doi":"10.1158/0008-5472.can-18-2565","title":"Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Brain Tumour Charity; Cancer Research UK; California Institute for Regenerative Medicine","keywords":"Choroid plexus; Carcinoma; Medicine; Anatomy; Internal medicine; Central nervous system","score_opus":0.04535723781499659,"score_gpt":0.369028638054103,"score_spread":0.32367140023910645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922125039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947632,0.0016367509,0.00006589704,0.000495266,0.000082039696,0.0009691971,0.000046941343,0.000008674404,0.0019320144],"genre_scores_gemma":[0.9987015,0.0003168137,0.0000717487,0.00006929229,0.00004924734,0.000060965023,0.000013169733,0.000020472702,0.0006967846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987063,0.00006500695,0.00022756921,0.0002099374,0.0005131805,0.00027803384],"domain_scores_gemma":[0.99870497,0.0000453134,0.00004921582,0.00033734774,0.0007072989,0.00015585986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003894518,0.00008123869,0.0002594911,0.00025343595,0.000030567942,0.000008001703,0.00009714571,0.00007793321,0.00021477335],"category_scores_gemma":[0.00009265128,0.000073829164,0.000035046432,0.00050514523,0.00010463952,0.000070917595,0.00010556841,0.0002631219,0.000044704426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007733576,0.000038873513,0.013891681,0.0006130856,0.000035646543,0.000015122274,0.0018270464,0.00013622962,0.97677547,0.00027822034,0.0020385226,0.0035767434],"study_design_scores_gemma":[0.0025845664,0.0011430164,0.0301725,0.0004761233,0.000023447305,0.000024386947,0.0003803753,0.00050693477,0.95992076,0.000032034066,0.0046325596,0.000103268954],"about_ca_topic_score_codex":0.00080578093,"about_ca_topic_score_gemma":0.00012955164,"teacher_disagreement_score":0.016854685,"about_ca_system_score_codex":0.00022644798,"about_ca_system_score_gemma":0.00038989092,"threshold_uncertainty_score":0.30106658},"labels":[],"label_agreement":null},{"id":"W2922126224","doi":"10.1158/0008-5472.can-18-3441","title":"Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; Amgen (Canada); Alberta Children's Hospital; Canada's Michael Smith Genome Sciences Centre; Alberta Cancer Foundation; University of Calgary","funders":"Canadian Institutes of Health Research; Stand Up To Cancer; Medical Research Council; Wellcome; Royal Society; Cancer Research UK; Wellcome Trust","keywords":"Nonsynonymous substitution; Biology; Pediatric cancer; Somatic cell; Genome; Cancer; Genetics; Stem cell; Mutation; Somatic evolution in cancer; Progenitor cell; Cancer research; Gene","score_opus":0.05154577427380286,"score_gpt":0.3664987135499801,"score_spread":0.31495293927617724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922126224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946491,0.0039072186,4.7147876e-7,0.000644047,0.0001001574,0.00039800187,0.000004636524,0.0000094276875,0.00028692736],"genre_scores_gemma":[0.9984516,0.00094910583,0.00002957041,0.000056343782,0.0001978106,0.00016076892,0.0000028371771,0.000011318456,0.00014067751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894476,0.00005119795,0.00010566891,0.00025915066,0.0003502777,0.00028892673],"domain_scores_gemma":[0.99954724,0.000060993578,0.00001223009,0.00015685217,0.00009081701,0.00013187516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017984128,0.000070943686,0.00013567912,0.00026174367,0.000034621786,0.000020518692,0.000032662294,0.000044722834,0.00040056783],"category_scores_gemma":[0.000021300451,0.00005790326,0.000025606454,0.0003929355,0.00004507375,0.00003225194,0.000054871212,0.00020706015,0.00013827447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022302229,0.00014142865,0.9906781,0.00007941194,0.000013413553,0.00011731753,0.00003100471,0.000020396446,0.0053875544,0.00004476731,0.00097252656,0.0022911108],"study_design_scores_gemma":[0.0017834572,0.00042280962,0.98960555,0.000028652958,0.000011192977,0.00003404164,0.000020408383,0.00007268716,0.0074339644,0.000051688752,0.0004838824,0.00005166351],"about_ca_topic_score_codex":0.00018527657,"about_ca_topic_score_gemma":0.00029230528,"teacher_disagreement_score":0.0038024553,"about_ca_system_score_codex":0.00016290555,"about_ca_system_score_gemma":0.00016492767,"threshold_uncertainty_score":0.4385937},"labels":[],"label_agreement":null},{"id":"W2923068106","doi":"10.1158/0008-5472.can-18-1220","title":"4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Institute of General Medical Sciences; National Natural Science Foundation of China","keywords":"Suppressor; PI3K/AKT/mTOR pathway; Head and neck cancer; Head and neck; Cancer; Cancer research; Medicine; Internal medicine; Biology; Cell biology; Surgery; Signal transduction","score_opus":0.03254111249192489,"score_gpt":0.36421155924718457,"score_spread":0.3316704467552597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923068106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992705,0.004481139,0.0000048204665,0.0010720299,0.00011100503,0.00097161793,0.00022104963,0.000013426229,0.0004199159],"genre_scores_gemma":[0.9948429,0.0003310009,0.000037500504,0.00036812597,0.00024316,0.0010449801,0.00006211046,0.000050540257,0.0030196903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979079,0.00016627609,0.0002198566,0.0006912658,0.00041666804,0.0005980611],"domain_scores_gemma":[0.9991229,0.000024311541,0.00006120952,0.00039469378,0.00025361232,0.00014323898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043320996,0.00017900746,0.00020754531,0.00011140365,0.00007261528,0.00006098632,0.00016890529,0.00018854422,0.000614274],"category_scores_gemma":[0.000088926856,0.00017506805,0.000040516097,0.00031770818,0.00015908224,0.000017019558,0.00018477805,0.0004383826,0.000026695889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054143585,0.000055808287,0.005855837,0.000119511766,0.000027306773,0.000007528936,0.00010436415,0.000010404989,0.9690932,0.000009662952,0.02361153,0.0005633933],"study_design_scores_gemma":[0.0014303724,0.0003185421,0.0015915155,0.00032671008,0.000003103907,0.0000033126444,0.00004121369,0.000035442692,0.9398209,0.00006474508,0.056150075,0.0002140793],"about_ca_topic_score_codex":0.0032273594,"about_ca_topic_score_gemma":0.00052923965,"teacher_disagreement_score":0.032538544,"about_ca_system_score_codex":0.00024504372,"about_ca_system_score_gemma":0.00043730304,"threshold_uncertainty_score":0.7139068},"labels":[],"label_agreement":null},{"id":"W2923104374","doi":"10.1158/0008-5472.can-18-3704","title":"Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"PRC2; Epigenomics; Cancer research; Biology; Histone deacetylase; Histone H3; Carcinogenesis; Nerve sheath neoplasm; DNA methylation; Histone; Epigenetics; Cell biology; Malignant peripheral nerve sheath tumor; Genetics; Cancer; Gene expression","score_opus":0.032962211055523265,"score_gpt":0.3531052575641115,"score_spread":0.3201430465085882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923104374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940186,0.0030479883,0.000016726071,0.00097462843,0.00018359901,0.0011486678,0.000052047813,0.000017369799,0.0005403694],"genre_scores_gemma":[0.9908914,0.00025248088,0.000043526717,0.00013334422,0.00027286576,0.000662857,0.00003925669,0.00009216809,0.007612086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99619275,0.0005872497,0.0004019106,0.0009244079,0.00069361174,0.0012000595],"domain_scores_gemma":[0.9985328,0.00006926391,0.000042623782,0.0008203583,0.00024790276,0.00028709142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013251951,0.00027389269,0.0003585264,0.00030750615,0.00018982223,0.000090602225,0.00067537714,0.00022280158,0.0002611979],"category_scores_gemma":[0.00012799745,0.00026864008,0.000112314825,0.0005205293,0.00024391152,0.000014783964,0.00043142174,0.0005726203,0.0001057702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042115684,0.000079895806,0.016457027,0.0000704627,0.000031174804,0.000023065018,0.0006639889,0.00026817573,0.9786515,0.000025418922,0.000695348,0.0026127798],"study_design_scores_gemma":[0.0007314937,0.0008003995,0.002758375,0.00011001427,0.0000024951482,0.000009779195,0.00086751475,0.000040046027,0.987389,0.000019637118,0.006901791,0.0003694054],"about_ca_topic_score_codex":0.0036936216,"about_ca_topic_score_gemma":0.0011498379,"teacher_disagreement_score":0.013698651,"about_ca_system_score_codex":0.00072925433,"about_ca_system_score_gemma":0.000905674,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W2924618238","doi":"10.1158/1538-7445.sabcs18-p1-13-02","title":"Abstract P1-13-02: Real world outcomes of adjuvant FECD, ddACT and ACT for the treatment of early stage breast cancer - A multicenter retrospective analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Docetaxel; Clinical endpoint; Internal medicine; Oncology; Taxane; Cancer; Febrile neutropenia; Chemotherapy; Clinical trial; Neutropenia","score_opus":0.03659728711831629,"score_gpt":0.3964822091366644,"score_spread":0.3598849220183481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924618238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929203,0.0031557414,0.0000058890523,0.00048233356,0.00008666679,0.00091418315,0.002236677,0.0000045700344,0.0001936595],"genre_scores_gemma":[0.99032444,0.0072853197,0.000024050933,0.0000146490775,0.00010363198,0.0005489259,0.00003380675,0.000026350666,0.0016388387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848396,0.000058459427,0.00025165142,0.00047554044,0.00033757152,0.0003928315],"domain_scores_gemma":[0.99870306,0.00018153261,0.0001548645,0.00050971657,0.0003774645,0.00007334592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022818994,0.00020834571,0.000506848,0.0001656493,0.00011178453,0.000020980297,0.00018855394,0.00006904961,0.0001910109],"category_scores_gemma":[0.00001569894,0.00012963609,0.000265932,0.0003492568,0.00028518343,0.000009283422,0.00008891592,0.00008957754,0.0000014642101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014331519,0.00024276503,0.96687,0.00006350293,0.004890389,0.0000010833883,0.0006246478,0.00008024663,0.020458769,0.000014573294,0.00008994241,0.005230946],"study_design_scores_gemma":[0.0019994217,0.0003960519,0.9672934,0.000028972072,0.0004046852,2.1712295e-7,0.00031953806,0.00002566065,0.028788531,0.00000500031,0.0006230023,0.00011554535],"about_ca_topic_score_codex":0.028975928,"about_ca_topic_score_gemma":0.024035215,"teacher_disagreement_score":0.008329762,"about_ca_system_score_codex":0.00028885534,"about_ca_system_score_gemma":0.0001775286,"threshold_uncertainty_score":0.9937736},"labels":[],"label_agreement":null},{"id":"W2924646294","doi":"10.1158/1538-7445.sabcs18-p6-18-04","title":"Abstract P6-18-04: Ribociclib with a non-steroidal aromatase inhibitor and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: MONALEESA-7 age subgroup analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Goserelin; Breast cancer; Internal medicine; Letrozole; Tamoxifen; Anastrozole; Aromatase inhibitor; Cancer; Hazard ratio; Gynecology; Oncology; Metastatic breast cancer; Clinical endpoint; Gastroenterology; Clinical trial; Confidence interval","score_opus":0.017254391296530298,"score_gpt":0.32690857408632235,"score_spread":0.30965418278979207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924646294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927754,0.0024348856,0.000029565688,0.0010655625,0.000048569134,0.0022561296,0.0010532977,0.0000671905,0.00026942673],"genre_scores_gemma":[0.9944891,0.0012503329,0.0008497579,0.00016758178,0.00025252212,0.0018811339,0.00012944968,0.00013693249,0.00084324233],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99505836,0.00018544953,0.00052678457,0.0013192464,0.0014749563,0.0014352311],"domain_scores_gemma":[0.99747205,0.00028589246,0.00023821357,0.0007448906,0.0006405733,0.0006183559],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073346106,0.0005606233,0.0011543856,0.00079206383,0.00017759715,0.00010431807,0.00030796247,0.00017863556,0.0010474075],"category_scores_gemma":[0.000024380337,0.00043594712,0.00006413441,0.002606394,0.0007496147,0.0006606419,0.00017052391,0.0012859268,0.000037461763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11789869,0.0010147238,0.26319113,0.0010082388,0.004002805,0.000870133,0.011221305,0.0026061418,0.55224186,0.000013117112,0.00037244966,0.0455594],"study_design_scores_gemma":[0.014555707,0.0028565428,0.96125114,0.0015442197,0.00018128585,0.00004830234,0.0039884755,0.00010237624,0.014203041,0.00004596369,0.0005424041,0.0006805176],"about_ca_topic_score_codex":0.0060776374,"about_ca_topic_score_gemma":0.0054694316,"teacher_disagreement_score":0.69806004,"about_ca_system_score_codex":0.0022880896,"about_ca_system_score_gemma":0.0007850008,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W2924881066","doi":"10.1158/0008-5472.can-18-3411","title":"Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; Institute for Work & Health; Ontario Institute for Cancer Research; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Hospital for Sick Children","keywords":"Picosecond; Infrared; Mass spectrometry; Medulloblastoma; Laser; Chemistry; Materials science; Analytical Chemistry (journal); Medicine; Optics; Cancer research; Physics; Environmental chemistry; Chromatography","score_opus":0.03860737610287122,"score_gpt":0.3571895101204142,"score_spread":0.318582134017543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924881066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98834735,0.00079853524,0.0000026386463,0.0010406588,0.00019336278,0.00069906947,0.000025024343,0.000051189334,0.008842193],"genre_scores_gemma":[0.9836243,0.0005336102,0.00006779142,0.0001288376,0.00024273874,0.00023984954,0.00003918208,0.00003427007,0.015089428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770385,0.00013595424,0.00021819904,0.00046253696,0.0009317719,0.0005476995],"domain_scores_gemma":[0.99876934,0.00028230768,0.000032238317,0.0004540572,0.00021138917,0.00025066556],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00049600017,0.00016611283,0.00031720666,0.00038559458,0.00009219949,0.00008760481,0.00014097027,0.00013095209,0.01973319],"category_scores_gemma":[0.00007192314,0.0001300831,0.00011754627,0.0006425555,0.00013924613,0.00010305451,0.00004699247,0.00046317853,0.004025283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002995513,0.0019650215,0.22441585,0.000522336,0.0006976347,0.00093131734,0.0004353788,0.00006812446,0.7046672,0.00169322,0.044206914,0.017401494],"study_design_scores_gemma":[0.0051079476,0.0017738147,0.2980653,0.00055518874,0.000061008075,0.000040223076,0.0002905316,0.00009996569,0.6806248,0.0012568916,0.011850741,0.0002735725],"about_ca_topic_score_codex":0.0001025436,"about_ca_topic_score_gemma":0.00004814266,"teacher_disagreement_score":0.07364946,"about_ca_system_score_codex":0.0005438299,"about_ca_system_score_gemma":0.00013002641,"threshold_uncertainty_score":0.9967502},"labels":[],"label_agreement":null},{"id":"W2929422481","doi":"","title":"Pre-clinical studies of CHIR258, a small molecule inhibitor that targets FGFR3, for the treatment of t(4;14) multiple myeloma","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Chromosomal translocation; Fibroblast growth factor receptor 3; Tyrosine kinase; Receptor tyrosine kinase; In vitro; Molecular biology; Biology; Cell culture; Tyrosine-kinase inhibitor; Multiple myeloma; Apoptosis; Kinase; Fibroblast growth factor; Receptor; Signal transduction; Cancer; Cell biology; Immunology; Biochemistry; Genetics; Gene","score_opus":0.28849269390962157,"score_gpt":0.5027094238483805,"score_spread":0.2142167299387589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929422481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675463,0.026294049,0.00009038124,0.0017820114,0.00017981822,0.003800275,0.00017137949,0.00002033627,0.0001154855],"genre_scores_gemma":[0.98078793,0.014285089,0.0009447449,0.000028207325,0.0003499532,0.0019436375,0.000029246505,0.000041727602,0.0015894477],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997297,0.00018276132,0.00050092017,0.00045957754,0.0008535883,0.00070613576],"domain_scores_gemma":[0.9960952,0.0018849095,0.00012436716,0.0006512696,0.000969067,0.00027523437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886786,0.0002166099,0.0006860046,0.00019217785,0.00021446828,0.00001305753,0.00023874118,0.0001144141,0.000055651904],"category_scores_gemma":[0.0012253709,0.00012366513,0.0003567485,0.00034230755,0.0008785468,0.0000429273,0.00010855439,0.00024448548,0.000011317278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050286833,0.018358141,0.48096162,0.00371758,0.014906499,0.0004275269,0.016133113,0.00029575554,0.12074499,0.00041637145,0.0063888226,0.28736275],"study_design_scores_gemma":[0.031853445,0.013945045,0.18028565,0.00065899553,0.00026755437,0.000009383733,0.0014811647,0.00024020996,0.76157486,0.00032503484,0.0091505945,0.00020808069],"about_ca_topic_score_codex":0.0013842174,"about_ca_topic_score_gemma":0.0010639373,"teacher_disagreement_score":0.64082986,"about_ca_system_score_codex":0.00050275953,"about_ca_system_score_gemma":0.00077150995,"threshold_uncertainty_score":0.5042918},"labels":[],"label_agreement":null},{"id":"W2930167574","doi":"","title":"Environmental variables and family history of breast cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Family history; Breast cancer; Medicine; Population; Cancer; Gynecology; Menopause; Demography; Oncology; Internal medicine; Environmental health","score_opus":0.03099953740808939,"score_gpt":0.32639324489371213,"score_spread":0.29539370748562277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930167574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96649176,0.031538777,0.00007874979,0.0003315754,0.00020857016,0.00014048546,0.0001973374,0.0000037349384,0.001008989],"genre_scores_gemma":[0.99145097,0.006231602,0.00021481511,0.00012380602,0.00021887831,0.00015226429,0.0000141207565,0.000020711532,0.0015728399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991145,0.00004330777,0.00011191306,0.00027977934,0.0002275257,0.00022298608],"domain_scores_gemma":[0.9995991,0.000008739073,0.000031405798,0.00023052248,0.00006179523,0.000068450805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002043517,0.000078486955,0.00008717437,0.000058832222,0.000046990226,0.0000059665517,0.0001489169,0.000085299,0.0002297733],"category_scores_gemma":[0.000009831483,0.00007947124,0.00002566079,0.00006608739,0.00045120774,0.0000041983812,0.0001328981,0.00011842742,0.0000036447723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007002208,0.000035750832,0.0020892,0.000026904449,0.000043403168,0.0000012176981,0.00020348889,0.0003794197,0.9820495,0.00008599742,0.008438485,0.0065765944],"study_design_scores_gemma":[0.0023889765,0.000274924,0.08914438,0.00012378629,0.00003469987,0.00003227473,0.00074198586,0.00001722867,0.56373644,0.0006820222,0.34239694,0.0004263162],"about_ca_topic_score_codex":0.0011076648,"about_ca_topic_score_gemma":0.00013809538,"teacher_disagreement_score":0.41831306,"about_ca_system_score_codex":0.0010271921,"about_ca_system_score_gemma":0.0011854451,"threshold_uncertainty_score":0.3240743},"labels":[],"label_agreement":null},{"id":"W2935812534","doi":"10.1158/1538-7445.sabcs18-p6-13-06","title":"Abstract P6-13-06: Estrogen-based hormone replacement [HRT] therapy is substantially more effective than tamoxifen in reducing breast cancer mortality and breast cancer case fatality ratio: Emergence of a new paradigm","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of Victoria; University of British Columbia; Providence Health Care; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Tamoxifen; Hormone replacement therapy (female-to-male); Oncology; Gynecology; Internal medicine; Placebo; Cancer; Case fatality rate; Obstetrics; Confidence interval; Epidemiology","score_opus":0.08287715097738929,"score_gpt":0.43215635064714475,"score_spread":0.34927919966975546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935812534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799374,0.01190415,0.000017768887,0.002857474,0.00020347076,0.0029734483,0.0020282287,0.000031839172,0.000046223297],"genre_scores_gemma":[0.99085206,0.00771471,0.000014244706,0.00016058558,0.00033057024,0.00065260864,0.000040245995,0.00006702244,0.00016794694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958865,0.00018998554,0.0007062026,0.0010973604,0.0012220112,0.00089793367],"domain_scores_gemma":[0.99764365,0.0001493348,0.00027787758,0.00094663503,0.0004558454,0.00052666245],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001204505,0.00041429247,0.0008295804,0.0003056664,0.0001654724,0.00006021169,0.00024083236,0.0002015003,0.002444852],"category_scores_gemma":[0.000027941212,0.00035433582,0.0001736317,0.0010261388,0.00038818756,0.00026291734,0.00009175872,0.000836788,0.000005655901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007410632,0.0003325884,0.88558775,0.00060209096,0.00046394378,0.00028054402,0.0045254547,0.0006507851,0.08032756,0.000015234845,0.0029645774,0.016838804],"study_design_scores_gemma":[0.0055987462,0.00030785523,0.9645506,0.0007772593,0.00007030895,0.000108778215,0.0006442522,0.00068554597,0.026714293,0.000026096137,0.00016451284,0.0003517136],"about_ca_topic_score_codex":0.536768,"about_ca_topic_score_gemma":0.027036166,"teacher_disagreement_score":0.5097319,"about_ca_system_score_codex":0.0009727996,"about_ca_system_score_gemma":0.0029107672,"threshold_uncertainty_score":0.99989086},"labels":[],"label_agreement":null},{"id":"W2935839383","doi":"","title":"Does Glypican 3 expression in non-small cell lung cancer suggest an oncogenic function?","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Glypican 3; Immunohistochemistry; Stain; Tissue microarray; Adenocarcinoma; Medicine; Pathology; Lung cancer; Carcinoma; Hepatocellular carcinoma; Cancer; Staining; Internal medicine","score_opus":0.0364320093701061,"score_gpt":0.4387566909922535,"score_spread":0.4023246816221474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935839383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902144,0.0025820096,0.00017315004,0.0008778426,0.00052056945,0.0011080779,0.000039550356,0.000043031432,0.0044413526],"genre_scores_gemma":[0.98729706,0.000890902,0.000247921,0.00021434389,0.0007457402,0.0006931493,0.000047976526,0.000047556845,0.009815377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978679,0.000076843404,0.0002746171,0.0005073767,0.00055300444,0.00072028406],"domain_scores_gemma":[0.99868554,0.00010991292,0.000049782655,0.000432738,0.00033388007,0.00038816335],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065609283,0.00016305133,0.00023882512,0.00039252944,0.00021413984,0.000039226183,0.00015500959,0.00012607884,0.0011261238],"category_scores_gemma":[0.000022816297,0.00010303598,0.00006217969,0.0006952281,0.00010445358,0.00014721489,0.00006433312,0.0005291328,0.000021995127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001850686,0.0009921566,0.6216936,0.00049406354,0.00013477249,0.00024051729,0.0038978318,0.000113918104,0.323548,0.000048847935,0.0057281125,0.041257475],"study_design_scores_gemma":[0.008144983,0.00093459146,0.7067013,0.0009956025,0.00023180096,0.000005272824,0.0036554243,0.00019588764,0.24078913,0.00013198395,0.03780052,0.00041350626],"about_ca_topic_score_codex":0.008233449,"about_ca_topic_score_gemma":0.013134176,"teacher_disagreement_score":0.08500767,"about_ca_system_score_codex":0.001475001,"about_ca_system_score_gemma":0.0010573261,"threshold_uncertainty_score":0.999787},"labels":[],"label_agreement":null},{"id":"W2937369489","doi":"","title":"Benzopyrene disrupts cell growth dynamics and DNA methylation in breast cancer cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"DNA methylation; Carcinogenesis; Cell growth; Cell cycle; Carcinogen; Methylation; Cancer research; Biology; Benzopyrene; Benzo(a)pyrene; Cell; Cancer; Gene expression; Molecular biology; Chemistry; Cell biology; DNA; Gene; Genetics","score_opus":0.016671872435247106,"score_gpt":0.3349601812865968,"score_spread":0.31828830885134973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937369489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912118,0.006373981,0.00032095402,0.00053052884,0.00009150314,0.00020516299,0.0001253919,0.000004856257,0.0011358642],"genre_scores_gemma":[0.99326915,0.0052990355,0.00009835139,0.000019265693,0.0002848903,0.00008495725,0.000107551125,0.000025119522,0.0008116963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987335,0.00012921469,0.00017912152,0.0003711102,0.00024386843,0.00034314647],"domain_scores_gemma":[0.9994656,0.00002666483,0.000042903164,0.00018137075,0.00021078683,0.00007270895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045781035,0.000112977155,0.00010989182,0.00012550174,0.00009048808,0.000043771037,0.00011823547,0.0001455735,0.000036899997],"category_scores_gemma":[0.000010919233,0.00011214158,0.000028500765,0.00026022698,0.000099274504,0.000006617957,0.000104786835,0.00016479217,0.000002623193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051178697,0.000043810716,0.026159197,0.000038153743,0.0000060533853,0.0000017736011,0.000024258345,0.0004122327,0.96878695,0.00015700422,0.0002558136,0.004063582],"study_design_scores_gemma":[0.00045125923,0.000047630456,0.081054285,0.000016817476,0.0000053997737,4.5576397e-7,0.000031802032,0.0006918459,0.9160456,0.00079829275,0.0007107096,0.00014589854],"about_ca_topic_score_codex":0.0039319578,"about_ca_topic_score_gemma":0.004858669,"teacher_disagreement_score":0.05489509,"about_ca_system_score_codex":0.000116667565,"about_ca_system_score_gemma":0.00012938982,"threshold_uncertainty_score":0.59439707},"labels":[],"label_agreement":null},{"id":"W2937737908","doi":"10.1158/0008-5472.can-18-3631","title":"Exploiting DNA Replication Stress for Cancer Treatment","year":2019,"lang":"en","type":"review","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Replication (statistics); DNA replication; Biology; Computational biology; DNA; Genetics; Virology","score_opus":0.269096033623929,"score_gpt":0.5108488175910731,"score_spread":0.24175278396714417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937737908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065446,0.9947651,0.00007338323,0.000049243186,0.00030404484,0.0030006173,0.00083368394,0.00001980399,0.00029965042],"genre_scores_gemma":[0.00006349028,0.97008234,0.0001174809,0.000015829612,0.0012004821,0.015082676,0.0010226162,0.00012429664,0.012290792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747217,0.0002040899,0.00032765468,0.0011225332,0.00029040634,0.00058316375],"domain_scores_gemma":[0.9979353,0.00008007611,0.00017252816,0.0013762659,0.00032188022,0.00011397544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055905385,0.00030220475,0.00066067325,0.00012415282,0.0001343461,0.00005394998,0.0004790878,0.00038991953,0.0000700261],"category_scores_gemma":[0.0001329902,0.0002492481,0.00038115826,0.00018396918,0.00005567525,0.0000033447525,0.00019006421,0.00019107442,0.00003498803],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002391869,0.00004011313,0.000002902633,0.0065764906,0.0002315946,9.311911e-7,0.00001852422,0.0000030350043,0.008287438,0.000073640615,0.0020668793,0.98267454],"study_design_scores_gemma":[0.0002307132,0.00028875485,2.4719736e-7,0.002716384,0.00013938459,0.0000018802103,0.000025315607,0.000004002941,0.055973332,0.00001786674,0.940366,0.00023609487],"about_ca_topic_score_codex":0.00020717546,"about_ca_topic_score_gemma":0.00015457686,"teacher_disagreement_score":0.98243845,"about_ca_system_score_codex":0.0005951721,"about_ca_system_score_gemma":0.0014368753,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2939897919","doi":"10.1158/0008-5472.can-18-1991","title":"DR4-Ser424<i>O</i>-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Sensitization; Cancer; Cancer research; Medicine; Biology; Immunology; Internal medicine","score_opus":0.040075066963342024,"score_gpt":0.35286852999863644,"score_spread":0.31279346303529443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939897919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956805,0.0008746207,0.00013645894,0.0012389371,0.0000811093,0.0010757244,0.0000915007,0.00000721763,0.00081392645],"genre_scores_gemma":[0.9960818,0.00043916813,0.0001809469,0.000090292146,0.000116208765,0.00012990809,0.000044892513,0.000030679814,0.002886054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810344,0.00018860065,0.00023076926,0.0004915705,0.00055856665,0.00042707013],"domain_scores_gemma":[0.9988504,0.000038130005,0.000053199252,0.00032228662,0.00054266193,0.0001933047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727582,0.00014086724,0.00018916259,0.00019939587,0.00011753877,0.00005404465,0.00017249174,0.00013399764,0.0002971373],"category_scores_gemma":[0.00006972487,0.00013232398,0.000059125847,0.0003467059,0.000103545564,0.000012573309,0.00011793158,0.000176433,0.000021461781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004594757,0.000035668603,0.0032298726,0.00017956803,0.000037457543,0.0000015352246,0.0004323749,0.0005088108,0.9907525,0.000078938894,0.0005320713,0.0037517038],"study_design_scores_gemma":[0.0008425978,0.0005156065,0.011838703,0.00012606099,0.000008533564,0.0000017720572,0.00024977425,0.00071979663,0.9756435,0.000032785952,0.009828405,0.00019244762],"about_ca_topic_score_codex":0.0009547793,"about_ca_topic_score_gemma":0.00065770093,"teacher_disagreement_score":0.015109007,"about_ca_system_score_codex":0.0000806287,"about_ca_system_score_gemma":0.00031064925,"threshold_uncertainty_score":0.53960156},"labels":[],"label_agreement":null},{"id":"W2940274498","doi":"10.1158/1538-7445.sabcs18-p2-07-11","title":"Abstract P2-07-11: Prediction of the Oncotype Dx recurrence score (RS) from clinicopathologic factors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Algoma University; NOSM University; Sault Area Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Lymph node; Oncology; Exact test; Cancer; Adjuvant chemotherapy; Gynecology","score_opus":0.11189825201752923,"score_gpt":0.3952486033664299,"score_spread":0.2833503513489007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940274498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955494,0.0022542453,0.0000029173889,0.00021570706,0.0006602947,0.00034530295,0.00038056952,0.000008736131,0.00058284606],"genre_scores_gemma":[0.99824506,0.0010941848,0.00001619742,0.00003203937,0.00022048147,0.000065324115,0.000077509074,0.000015614165,0.00023359057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861044,0.00012056967,0.00019834479,0.00042405643,0.00036059535,0.0002859937],"domain_scores_gemma":[0.9989606,0.00008037599,0.00009673761,0.00057476474,0.00023696818,0.000050551687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029862826,0.0001276538,0.00016745269,0.00003370773,0.00010953884,0.000016000056,0.00038205157,0.00014308706,0.00027639355],"category_scores_gemma":[0.00014890044,0.00008463368,0.0000970818,0.00016550877,0.00026393303,0.0000074558016,0.0002713365,0.00024434642,0.000035808585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011737988,0.000059185986,0.8020916,0.000025791493,0.00004769412,6.4082747e-7,0.00016944487,0.000019789006,0.19446856,0.0000063797643,0.0013176088,0.0016759351],"study_design_scores_gemma":[0.0003857011,0.00012789457,0.87622166,0.000096333875,0.0000119257775,5.005116e-7,0.00027274044,0.0000018282669,0.12007645,0.00004990118,0.0026861422,0.0000689147],"about_ca_topic_score_codex":0.0015668116,"about_ca_topic_score_gemma":0.00055178755,"teacher_disagreement_score":0.07439211,"about_ca_system_score_codex":0.00009078727,"about_ca_system_score_gemma":0.00027225737,"threshold_uncertainty_score":0.34512612},"labels":[],"label_agreement":null},{"id":"W2942888026","doi":"10.1158/1538-7445.sabcs18-p4-13-13","title":"Abstract P4-13-13: Meta-analyses of visceral versus non-visceral metastases treated by AI &amp; SERD agents as 2nd line endocrine therapy (ET) for HR+ breast cancer (BC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Metastatic breast cancer; Hazard ratio; Medicine; Internal medicine; Oncology; Cancer; Breast cancer; Confidence interval; Estrogen receptor","score_opus":0.2967427410094357,"score_gpt":0.5427007026166639,"score_spread":0.24595796160722821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942888026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97095984,0.013729363,0.00010449559,0.0070727877,0.00040335354,0.0030598105,0.0037952594,0.00009723625,0.00077788025],"genre_scores_gemma":[0.9764827,0.003675288,0.00023204552,0.0009248964,0.0005309047,0.0018159754,0.0005704601,0.00021267943,0.015555082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945815,0.00027914732,0.0008827194,0.0011390938,0.0017210038,0.0013965205],"domain_scores_gemma":[0.99559796,0.0006343198,0.0003554234,0.0011746477,0.0017444494,0.0004931943],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089471537,0.0006956401,0.0018697474,0.0005486537,0.00019631133,0.000093728944,0.0005822831,0.00016649335,0.018120086],"category_scores_gemma":[0.00011831898,0.000510365,0.00086052757,0.0010198347,0.0004405007,0.0004748164,0.00015005392,0.0008943814,0.00011538285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07639739,0.0017364005,0.0081479335,0.0012169981,0.037370715,0.00007541552,0.00086513534,0.0033738478,0.78307056,0.00006306659,0.03067239,0.057010133],"study_design_scores_gemma":[0.05244205,0.003673318,0.030336652,0.00060222135,0.00509534,0.000088070745,0.00045981532,0.00040219145,0.7241886,0.00038063864,0.18084373,0.0014873625],"about_ca_topic_score_codex":0.049540635,"about_ca_topic_score_gemma":0.0028305694,"teacher_disagreement_score":0.15017132,"about_ca_system_score_codex":0.0007882183,"about_ca_system_score_gemma":0.0011319533,"threshold_uncertainty_score":0.9997348},"labels":[],"label_agreement":null},{"id":"W2943311090","doi":"","title":"The affect of androgens on fatty acid oxidation in prostate cancer cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Bicalutamide; Androgen; Endocrinology; Prostate cancer; Internal medicine; Androgen receptor; Chemistry; Carnitine; Beta oxidation; Fatty acid; Biology; Biochemistry; Cancer; Medicine; Hormone","score_opus":0.04200338564129511,"score_gpt":0.3644601635894813,"score_spread":0.32245677794818617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943311090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838466,0.009210597,0.000008251755,0.0002774741,0.0012458434,0.00040760532,0.000050693183,0.0000035806927,0.0004113104],"genre_scores_gemma":[0.9543516,0.042018514,0.000013344627,0.000055848734,0.0019442418,0.00032274623,0.000014469023,0.00001775949,0.0012614632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874234,0.00016174071,0.00015461801,0.00027292047,0.00030542884,0.0003629677],"domain_scores_gemma":[0.99935406,0.00003297659,0.000046250578,0.00031928765,0.00018405162,0.000063339634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004971227,0.00009312211,0.0001260828,0.000069110334,0.00015796433,0.000011711111,0.00020131328,0.00006858802,0.00002741325],"category_scores_gemma":[0.000058580677,0.00006903784,0.00005417335,0.00024464034,0.00025958224,0.0000038003373,0.000071716386,0.00018578603,0.0000058046053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036538593,0.000031367857,0.003158812,0.000024162742,0.000019500696,3.2634506e-7,0.00018577046,0.00012461736,0.96936035,0.000028385406,0.02022054,0.006480762],"study_design_scores_gemma":[0.00048117212,0.00011539321,0.007278454,0.000025226065,0.0000025839358,0.0000012174473,0.000056691955,0.0000057351376,0.82404727,0.000014262444,0.16790263,0.00006937752],"about_ca_topic_score_codex":0.0008302033,"about_ca_topic_score_gemma":0.0018049264,"teacher_disagreement_score":0.1476821,"about_ca_system_score_codex":0.00006739979,"about_ca_system_score_gemma":0.00042243785,"threshold_uncertainty_score":0.28152812},"labels":[],"label_agreement":null},{"id":"W2943505680","doi":"10.1158/1538-7445.sabcs18-gs3-06","title":"Abstract GS3-06: Dynamics of breast cancer relapse reveal molecularly defined late recurring ER-positive subgroups: Results from the METABRIC study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Cohort; Proportional hazards model","score_opus":0.02600438203463081,"score_gpt":0.33256852039589335,"score_spread":0.30656413836126256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943505680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987871,0.004723026,0.000013495627,0.0019179543,0.00023386761,0.0010543054,0.0034959717,0.00001501104,0.00067536667],"genre_scores_gemma":[0.99692374,0.0012465449,0.0000592521,0.00008866168,0.0002749454,0.0003311889,0.00032878036,0.00006107441,0.00068577926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996951,0.00036514286,0.00045540783,0.00088603643,0.00071874517,0.00062370294],"domain_scores_gemma":[0.9977514,0.00025760086,0.0002130263,0.0009867996,0.0006798822,0.00011126975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009068178,0.0003012766,0.00040380776,0.000088179455,0.00023120463,0.00005636139,0.0006150874,0.0001520099,0.00006688527],"category_scores_gemma":[0.00013834452,0.00022693056,0.00015415016,0.00048914447,0.00024610807,0.000017634451,0.0005080184,0.00049445743,0.000031807605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011653413,0.0014720547,0.52768666,0.00015582357,0.0057888334,0.00009626213,0.005069609,0.0010413817,0.42043194,0.00017422147,0.0061061787,0.020323602],"study_design_scores_gemma":[0.004085607,0.00033262974,0.9695684,0.00027860052,0.00017004041,0.0000051053344,0.0016000761,0.00005064495,0.023057126,0.0001113715,0.00037902224,0.00036141646],"about_ca_topic_score_codex":0.02789445,"about_ca_topic_score_gemma":0.007591429,"teacher_disagreement_score":0.4418817,"about_ca_system_score_codex":0.00037425707,"about_ca_system_score_gemma":0.00038137138,"threshold_uncertainty_score":0.97857887},"labels":[],"label_agreement":null},{"id":"W2943700813","doi":"","title":"PI-3 kinase-PTEN pathway regulates the expression of E- and N-cadherin in melanoma progression","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Melanoma; Cancer research; Cadherin; Catenin; Metastasis; Cell adhesion molecule; PTEN; Biology; Signal transduction; Tumor progression; Beta-catenin; Focal adhesion; Cancer; Cell; Cell biology; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Genetics","score_opus":0.044522971213067856,"score_gpt":0.39365569027675285,"score_spread":0.349132719063685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943700813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652357,0.012388,0.00003640452,0.0002059043,0.000068084024,0.00027827412,0.000010276937,0.000005194384,0.0004842918],"genre_scores_gemma":[0.9984626,0.00048636823,0.00014864355,0.000022234974,0.00019390389,0.00008128126,0.000008185725,0.000020237618,0.00057655043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864435,0.00014850975,0.00019590413,0.00031205988,0.00033443613,0.00036474707],"domain_scores_gemma":[0.9993015,0.000072132454,0.0000565082,0.00035413596,0.00014456637,0.00007117206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015703054,0.0000977279,0.000114703005,0.00007856874,0.00008646519,0.000016960292,0.00026971125,0.0001461332,0.000035274392],"category_scores_gemma":[0.00011578912,0.000066775516,0.00002997499,0.00020390026,0.00030582058,0.00000446504,0.00023554798,0.00022948612,0.00000149978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003117628,0.000027965105,0.010006082,0.00004380366,0.00000704091,0.0000068587565,0.00015941121,0.000013788356,0.96132505,0.000034007357,0.0006321013,0.027432136],"study_design_scores_gemma":[0.0003845961,0.00020859357,0.008171343,0.0001887874,0.000001565995,0.0000025878069,0.00014172349,0.000014510222,0.97681856,0.0001164849,0.0138682155,0.00008303798],"about_ca_topic_score_codex":0.0001554284,"about_ca_topic_score_gemma":0.00018461709,"teacher_disagreement_score":0.027349098,"about_ca_system_score_codex":0.000048986847,"about_ca_system_score_gemma":0.00014121832,"threshold_uncertainty_score":0.27230266},"labels":[],"label_agreement":null},{"id":"W2943705882","doi":"10.1158/1538-7445.sabcs18-p5-14-05","title":"Abstract P5-14-05: Use of complementary and alternative medicine in cancer patients receiving chemotherapy in Ireland","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Family medicine; Alternative medicine; Quality of life (healthcare); Cancer treatment; Chemotherapy; Population; Internal medicine; Health care; Nursing; Pathology; Environmental health","score_opus":0.18167835564542642,"score_gpt":0.473614036468517,"score_spread":0.2919356808230906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943705882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424547,0.0012758473,6.8708107e-7,0.0024610893,0.00024422447,0.0010611031,0.000052221916,0.0000051062007,0.0006542351],"genre_scores_gemma":[0.9940311,0.005037058,0.000025501402,0.0002841742,0.0001895396,0.00008873325,0.000030671377,0.000018510216,0.00029475303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804413,0.00009961451,0.00042704938,0.00036245657,0.0006751071,0.00039162525],"domain_scores_gemma":[0.99885803,0.00052479364,0.00009225442,0.00017514561,0.00025736415,0.00009240937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006236223,0.00015005766,0.00049075554,0.00047017052,0.000040605915,0.0000058082433,0.00011555946,0.000017260678,0.0020089066],"category_scores_gemma":[0.00012940029,0.00011673919,0.000024203262,0.00042256384,0.00030200812,0.00013473326,0.00012895132,0.0004597081,0.0000025846637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007372186,0.00018795034,0.96792257,0.00027598432,0.00009785731,0.000021001679,0.0034148083,0.000011424793,0.006697795,0.00002048607,0.001323272,0.019289656],"study_design_scores_gemma":[0.009481798,0.00090130913,0.9803361,0.0023624075,0.000009477923,7.9991935e-7,0.0011312286,0.00006416271,0.0019159535,0.0000868886,0.0036133248,0.00009651926],"about_ca_topic_score_codex":0.028237207,"about_ca_topic_score_gemma":0.0065040193,"teacher_disagreement_score":0.021733187,"about_ca_system_score_codex":0.00034286006,"about_ca_system_score_gemma":0.00008135047,"threshold_uncertainty_score":0.9989034},"labels":[],"label_agreement":null},{"id":"W2943834620","doi":"10.1158/1538-7445.sabcs18-p1-05-05","title":"Abstract P1-05-05: eEF1A2 facilitates PTEN-GSK3β mediated Aurora-A protein degradation during S-G2 phase inactivated in PTEN-deficient breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"PTEN; Cancer research; Protein kinase B; Ubiquitin ligase; Skp1; SKP2; Phosphorylation; Biology; F-box protein; Mitosis; Cell cycle; Kinase; Protein degradation; Ubiquitin; Cell biology; Chemistry; Signal transduction; PI3K/AKT/mTOR pathway; Cell; Gene; Biochemistry","score_opus":0.02787972265049142,"score_gpt":0.3469134506743491,"score_spread":0.31903372802385765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943834620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959426,0.0014308227,0.000012889109,0.0004873709,0.00015357208,0.001274703,0.00045478408,0.00002396093,0.00021931641],"genre_scores_gemma":[0.9962776,0.0008869822,0.000019634435,0.00005084568,0.00011683025,0.00054667285,0.00033890182,0.000049851868,0.0017127193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974236,0.00015448796,0.0003873652,0.00075010024,0.00047820876,0.0008062488],"domain_scores_gemma":[0.99879605,0.000031077212,0.0001048941,0.00050436694,0.00039149594,0.00017209211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057191856,0.00025688196,0.00027021483,0.00027766553,0.00013752982,0.0000666519,0.00037586867,0.0002647046,0.00045710904],"category_scores_gemma":[0.00010151127,0.00024167892,0.00008355031,0.0005447111,0.0001432579,0.000026005115,0.00019979944,0.0005296504,0.00006128734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007845042,0.00026699583,0.0049921414,0.00019875819,0.000054993787,0.000015736487,0.0001295185,0.00024318635,0.9883629,0.000010143942,0.0006168473,0.004324291],"study_design_scores_gemma":[0.0036118866,0.00020015889,0.028066624,0.00028438386,0.000008065638,0.000010765504,0.0004491902,0.000305183,0.9592598,0.000015572114,0.0073674354,0.00042095155],"about_ca_topic_score_codex":0.003554988,"about_ca_topic_score_gemma":0.0016226767,"teacher_disagreement_score":0.029103098,"about_ca_system_score_codex":0.0004076122,"about_ca_system_score_gemma":0.0005331406,"threshold_uncertainty_score":0.98553807},"labels":[],"label_agreement":null},{"id":"W2943834628","doi":"10.1158/1538-7445.sabcs18-pd2-04","title":"Abstract PD2-04: Baseline circulating <i>ESR1</i> mutation analysis in the randomised phase III EFECT study of fulvestrant versus exemestane in advanced hormone receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Medicine; Internal medicine; Oncology; Aromatase inhibitor; Breast cancer; Hazard ratio; Metastatic breast cancer; Cancer; Triptorelin; Estrogen receptor; Gynecology; Aromatase; Gastroenterology; Confidence interval; Hormone","score_opus":0.04074556143826198,"score_gpt":0.4134207069088296,"score_spread":0.3726751454705676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943834628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214226,0.0024710146,0.00007447081,0.00060826924,0.000121658435,0.0041946117,0.00020643661,0.000023204231,0.00015804937],"genre_scores_gemma":[0.9980337,0.00041235314,0.00007980078,0.00006219454,0.00013617174,0.001078893,0.000094722905,0.000047908274,0.000054255917],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956833,0.0006800523,0.0008456636,0.0007155524,0.001367898,0.0007075224],"domain_scores_gemma":[0.99698246,0.0013133193,0.00028066165,0.00064127083,0.0006456481,0.00013665012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028652686,0.00029897553,0.00094804744,0.0008662379,0.00010022454,0.00002728085,0.0003108155,0.000099656994,0.00076386146],"category_scores_gemma":[0.00017710845,0.00023017252,0.00018123828,0.0036386333,0.00017247898,0.00029347176,0.00004787712,0.00091103266,0.0000074520876],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2537874,0.0030794148,0.02447042,0.0003157564,0.0016282388,0.00028475325,0.015313587,0.025599722,0.5811372,0.000009960289,0.000026466285,0.094347104],"study_design_scores_gemma":[0.3758089,0.0027593737,0.57385427,0.00088859914,0.0007341235,0.000023306187,0.03233597,0.002871389,0.010109603,0.000025381712,0.0000551789,0.0005339303],"about_ca_topic_score_codex":0.008365841,"about_ca_topic_score_gemma":0.003451707,"teacher_disagreement_score":0.5710276,"about_ca_system_score_codex":0.0010135311,"about_ca_system_score_gemma":0.0005291214,"threshold_uncertainty_score":0.99823755},"labels":[],"label_agreement":null},{"id":"W2943847562","doi":"10.1158/1538-7445.sabcs18-p4-08-27","title":"Abstract P4-08-27: The 21-gene Recurrence® (RS) Score assay in estrogen receptor positive node negative breast cancer: Real-world chemotherapy usage and patient characteristics within the intermediate and high-risk RS category","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Chemotherapy; Docetaxel; Estrogen receptor; Cyclophosphamide; Cancer; Hormonal therapy; Prospective cohort study; Cohort; Stage (stratigraphy); Gynecology","score_opus":0.016613025234149967,"score_gpt":0.3066937909120844,"score_spread":0.2900807656779344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943847562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190855,0.0023652522,0.0000018145528,0.0027382749,0.0003330481,0.00092253374,0.0015681583,0.000008233542,0.00015411581],"genre_scores_gemma":[0.9787131,0.019952236,0.00002668867,0.00032353253,0.00026776711,0.0004655571,0.0000909614,0.00004287776,0.00011727401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777097,0.00037123397,0.00030123946,0.0006700621,0.00036476564,0.00052170997],"domain_scores_gemma":[0.9987056,0.00022569273,0.00022182016,0.00045017886,0.0002775752,0.000119108874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066701666,0.00029946395,0.0003086311,0.00008695628,0.00027772758,0.00008499206,0.0003137241,0.00011654186,0.00007816374],"category_scores_gemma":[0.00006474446,0.00018888156,0.000050472256,0.00028783685,0.0007638514,0.0000183386,0.00031024363,0.00058915024,0.000010145636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028943487,0.00016666255,0.8180356,0.0000973391,0.0006749202,0.000013380808,0.006346378,0.000041567844,0.07692235,0.00008754616,0.0016315943,0.093088314],"study_design_scores_gemma":[0.0012463091,0.00018215865,0.9228935,0.00020919622,0.000029349638,0.0000068383506,0.0009164731,0.000021873151,0.0737287,0.00008971952,0.0004209439,0.0002549042],"about_ca_topic_score_codex":0.019400928,"about_ca_topic_score_gemma":0.0050672884,"teacher_disagreement_score":0.10485794,"about_ca_system_score_codex":0.0002913369,"about_ca_system_score_gemma":0.0003658956,"threshold_uncertainty_score":0.987129},"labels":[],"label_agreement":null},{"id":"W2943859409","doi":"10.1158/1538-7445.sabcs18-p6-16-09","title":"Abstract P6-16-09: What research questions matters most to patients? Final results of the metastatic breast cancer priority setting partnership","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; BC Cancer Agency","funders":"","keywords":"Interim; Medicine; General partnership; Breast cancer; Alliance; Metastatic breast cancer; Family medicine; Health professionals; Prioritization; Health care; Cancer; Nursing; Internal medicine; Political science","score_opus":0.5213237977363223,"score_gpt":0.5453529134305777,"score_spread":0.024029115694255365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943859409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8369926,0.0013339407,0.000008730999,0.15557815,0.00078990916,0.002270082,0.0017057137,0.000019837453,0.0013009944],"genre_scores_gemma":[0.9917249,0.0005920494,0.00013566535,0.0035329394,0.00035256048,0.00073800184,0.000040245133,0.00005569551,0.002827908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927338,0.0015829211,0.0027486535,0.00092328555,0.0008113179,0.001200058],"domain_scores_gemma":[0.9933741,0.0030245124,0.0009396668,0.001216714,0.0010658865,0.0003790969],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.041221365,0.00021030004,0.00072764244,0.0007015151,0.0005681888,0.00033562985,0.00093348545,0.00013027116,0.001488141],"category_scores_gemma":[0.0043647285,0.00020850317,0.00013078547,0.0014098546,0.00031847504,0.0009127563,0.000351999,0.0010645154,0.0018671372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007566111,0.000689682,0.4932496,0.003456027,0.00032359845,0.0000023251114,0.015927942,0.0036718915,0.00023543493,0.016540002,0.4563777,0.008769176],"study_design_scores_gemma":[0.0027206629,0.00017076982,0.87271315,0.0024825858,0.000011279572,0.0000024084522,0.006577144,0.00043637268,0.00022746823,0.0054068943,0.10868494,0.0005663017],"about_ca_topic_score_codex":0.03936909,"about_ca_topic_score_gemma":0.0059340233,"teacher_disagreement_score":0.37946358,"about_ca_system_score_codex":0.002996778,"about_ca_system_score_gemma":0.0014757033,"threshold_uncertainty_score":0.99942464},"labels":[],"label_agreement":null},{"id":"W2943874905","doi":"10.1158/1538-7445.sabcs18-gs6-06","title":"Abstract GS6-06: Local therapy and quality of life outcomes in young women with breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Psychosocial; Mastectomy; Quality of life (healthcare); Sexual function; Breast-conserving surgery; Cohort; Gynecology; Prospective cohort study; Cancer; Internal medicine","score_opus":0.21272549127512383,"score_gpt":0.47526317965737286,"score_spread":0.262537688382249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943874905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945645,0.0021599203,0.000004724917,0.001380719,0.000041994146,0.00049511646,0.000051648665,0.000011960061,0.0012894213],"genre_scores_gemma":[0.9976758,0.0012130414,0.000016626374,0.00028537092,0.00006879537,0.00016343495,0.000002268146,0.000018368937,0.0005562934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978072,0.000086231,0.00029634594,0.00033137162,0.0009384872,0.0005403563],"domain_scores_gemma":[0.99892014,0.000118555494,0.000070803406,0.00030149583,0.00034532917,0.00024368893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012576046,0.0001297563,0.00048693042,0.00015415542,0.00004066948,0.000021792584,0.00014461133,0.00008297671,0.0011184664],"category_scores_gemma":[0.00004308988,0.000089289315,0.00002998301,0.0004096511,0.00028691813,0.00015047088,0.000055083747,0.00047525606,0.000013037046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036792192,0.000058623653,0.97655517,0.00019088479,0.000079146084,0.000008285534,0.0009981089,0.000057323068,0.0061903466,0.000057024314,0.0001597573,0.011966124],"study_design_scores_gemma":[0.002859126,0.00024830076,0.99324113,0.0003421981,0.0000026310395,0.0000047430353,0.0023847837,0.000018934465,0.00058992684,0.000025170059,0.00017679342,0.000106258376],"about_ca_topic_score_codex":0.047749877,"about_ca_topic_score_gemma":0.0073896055,"teacher_disagreement_score":0.040360272,"about_ca_system_score_codex":0.00057706,"about_ca_system_score_gemma":0.000907565,"threshold_uncertainty_score":0.99979466},"labels":[],"label_agreement":null},{"id":"W2943879513","doi":"10.1158/1538-7445.sabcs18-pd2-05","title":"Abstract PD2-05: Biomarker analysis by baseline circulating tumor DNA alterations in the MONALEESA-3 study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Hazard ratio; Medicine; Internal medicine; Oncology; Biomarker; Cancer; Cancer research; Confidence interval; Breast cancer; Biology; Genetics; Estrogen receptor","score_opus":0.08727560084411412,"score_gpt":0.44179070129384373,"score_spread":0.3545151004497296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943879513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325603,0.001520526,0.0001109871,0.0026506258,0.0000627713,0.0014577262,0.000062654886,0.000026754682,0.0008519149],"genre_scores_gemma":[0.99790484,0.000026605429,0.000059113565,0.0004355386,0.00014788435,0.00050524354,0.00006001237,0.000031553904,0.00082918943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709225,0.00036283652,0.00038121556,0.00050347135,0.0011223967,0.00053780974],"domain_scores_gemma":[0.99820364,0.00056473044,0.00007334243,0.00072376535,0.00032311655,0.0001114288],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002501681,0.00016488037,0.00035994963,0.00052495534,0.00016450448,0.00006968279,0.00029598805,0.00004115791,0.00198701],"category_scores_gemma":[0.0001690112,0.000117078635,0.00011504067,0.0025498297,0.0001116284,0.00015923636,0.000062103085,0.00061252824,0.00008087133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012895658,0.0017073998,0.58719677,0.00020170526,0.001822448,0.0003078759,0.007101138,0.0025638884,0.3626253,0.00006429271,0.0030553713,0.032064237],"study_design_scores_gemma":[0.004015827,0.00031163773,0.96911883,0.00017931474,0.0002412655,0.000023568238,0.011450869,0.0042594676,0.0024485982,0.00011784041,0.0075262333,0.00030653155],"about_ca_topic_score_codex":0.0020749418,"about_ca_topic_score_gemma":0.0010501484,"teacher_disagreement_score":0.38192207,"about_ca_system_score_codex":0.00038751814,"about_ca_system_score_gemma":0.00028531742,"threshold_uncertainty_score":0.9989253},"labels":[],"label_agreement":null},{"id":"W2943896988","doi":"10.1158/1538-7445.sabcs18-p6-13-04","title":"Abstract P6-13-04: Estrogen-alone based hormone replacement therapy (HRT) reduces breast cancer (BrCa) incidence and mortality whereas estrogen plus progestin Provera based HRT increases both BrCa incidence and BrCa mortality: A comparative analysis of Women's Health Initiative trials","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of Victoria; University of British Columbia; Providence Health Care; BC Cancer Agency","funders":"","keywords":"Medicine; Hazard ratio; Hormone replacement therapy (female-to-male); Breast cancer; Gynecology; Estrogen; Internal medicine; Incidence (geometry); Progestin; Cancer; Confidence interval; Oncology","score_opus":0.17567896742658373,"score_gpt":0.46890730331724256,"score_spread":0.29322833589065883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943896988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97587943,0.015858386,0.000019529529,0.0011892975,0.00006427304,0.004692502,0.0021645306,0.000059827864,0.00007223431],"genre_scores_gemma":[0.9909172,0.0061476943,0.0001200027,0.00052701146,0.00016554572,0.0018361743,0.00018339575,0.000054014086,0.000048974784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99189126,0.0013932764,0.001553222,0.0015069703,0.0023557802,0.0012994744],"domain_scores_gemma":[0.99418336,0.0013711355,0.00119314,0.0010333471,0.0011430277,0.0010760063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0072222347,0.00063069985,0.0029938386,0.0008257734,0.00032778757,0.00017650046,0.0003624884,0.00021243676,0.0010736618],"category_scores_gemma":[0.000483978,0.00051683356,0.00030425657,0.0021377278,0.0010550943,0.00044727302,0.0001807623,0.00087090174,0.000003006798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01653698,0.0007429737,0.9454236,0.0008921327,0.0046403464,0.000052367915,0.0047895536,0.0006384656,0.02031614,0.000038489306,0.00050683715,0.0054221307],"study_design_scores_gemma":[0.009185401,0.002128092,0.9675752,0.0010628712,0.00063899445,0.000010362804,0.0022386117,0.0032283878,0.013221866,0.0000385099,0.00016643302,0.00050528167],"about_ca_topic_score_codex":0.17200904,"about_ca_topic_score_gemma":0.008756725,"teacher_disagreement_score":0.16325231,"about_ca_system_score_codex":0.0032473123,"about_ca_system_score_gemma":0.010103784,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W2943901493","doi":"10.1158/1538-7445.sabcs18-p5-04-24","title":"Abstract P5-04-24: Molecular stratification of ER+/HER2- breast cancer cell lines to predict sensitivity to targeted agents","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Breast cancer; Tamoxifen; Estrogen receptor; Protein kinase B; Cyclin-dependent kinase; Targeted therapy; Palbociclib; Cell growth; Signal transduction; Medicine; Trastuzumab; Cancer; Internal medicine; Cell cycle; Biology; Oncology; Metastatic breast cancer; Cell biology; Genetics","score_opus":0.04704236855036565,"score_gpt":0.39613543442364596,"score_spread":0.3490930658732803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943901493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900005,0.0011848754,0.000435174,0.0043679825,0.00035986464,0.0020671287,0.00058320834,0.00006331309,0.0009379727],"genre_scores_gemma":[0.995826,0.000198921,0.00075496826,0.00048905145,0.00036153183,0.00039356708,0.000042285945,0.000080719954,0.0018529749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967902,0.0001463912,0.0004006316,0.00069918507,0.0012511512,0.0007124928],"domain_scores_gemma":[0.9971149,0.000107607826,0.00011244359,0.0008242036,0.0013489134,0.00049193564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007028776,0.00025277288,0.00046398802,0.00025348997,0.00007706755,0.000029895593,0.00023904149,0.00013527353,0.0022276675],"category_scores_gemma":[0.00007232168,0.0002360356,0.00009963656,0.0008560438,0.00012033111,0.00018190512,0.00012095222,0.0004571902,0.00018254064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015308124,0.0001985916,0.009751336,0.00048381262,0.00010520345,0.000030033932,0.0005463493,0.00251603,0.9525966,0.000020642452,0.0021601075,0.030060504],"study_design_scores_gemma":[0.0013249347,0.0002910138,0.33438805,0.0006568424,0.00003155511,0.000011921668,0.00049404777,0.00018013606,0.65593266,0.000028723518,0.0063969037,0.00026321187],"about_ca_topic_score_codex":0.005998396,"about_ca_topic_score_gemma":0.00076132215,"teacher_disagreement_score":0.3246367,"about_ca_system_score_codex":0.00084005576,"about_ca_system_score_gemma":0.000835653,"threshold_uncertainty_score":0.9986844},"labels":[],"label_agreement":null},{"id":"W2943908605","doi":"10.1158/1538-7445.am2017-lb-139","title":"Abstract LB-139: PRMT6-dependent CRAF/ERK signaling regulates cancer stem cell plasticity in liver cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cancer stem cell; Cancer research; Biology; Liver cancer; Stem cell; Metastasis; Cancer cell; Chromatin; Cancer; Stem cell marker; Protein arginine methyltransferase 5; Methyltransferase; Methylation; Molecular biology; Cell biology; Hepatocellular carcinoma; Biochemistry; Genetics","score_opus":0.05945667565335749,"score_gpt":0.3715499427149234,"score_spread":0.3120932670615659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943908605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594844,0.011430361,0.00003548566,0.0005331994,0.00053519214,0.00064219127,0.00013650916,0.000020403491,0.00071819307],"genre_scores_gemma":[0.9871635,0.006379424,0.000026787955,0.000038146514,0.0012021111,0.0005704619,0.000024019946,0.00007740086,0.0045181694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688935,0.0001362793,0.00040119345,0.0009183588,0.0007478751,0.000906927],"domain_scores_gemma":[0.9982073,0.000055688204,0.0002491505,0.0007916298,0.00046990954,0.00022635865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006120683,0.0002952502,0.00030379614,0.00018371096,0.0005576563,0.0002154463,0.0007819148,0.00041854574,0.00065775024],"category_scores_gemma":[0.000060823353,0.00029874872,0.00011310369,0.00017706254,0.00039626023,0.000034636687,0.00041967075,0.00064236805,0.000032034255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004602236,0.00007925386,0.009940975,0.0001961489,0.00008354173,0.000021851693,0.00020676869,0.021677753,0.94580853,0.000010494651,0.0034399654,0.01807451],"study_design_scores_gemma":[0.001192832,0.00009253,0.057198536,0.0003663468,0.000024493598,0.0000021188912,0.00008906801,0.00060444773,0.9329326,0.00004600221,0.007064356,0.00038665667],"about_ca_topic_score_codex":0.0133903045,"about_ca_topic_score_gemma":0.022315862,"teacher_disagreement_score":0.047257558,"about_ca_system_score_codex":0.0007068598,"about_ca_system_score_gemma":0.0010587596,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W2943912106","doi":"10.1158/1538-7445.tummet15-a29","title":"Abstract A29: Gram-negative bacterial infection enhances the potential of gastric adenocarcinoma peritoneal metastasis via TNFR1 dependent manner","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Metastasis; Peritoneum; Cancer cell; Medicine; Tumor necrosis factor alpha; Cytokine; Cancer research; In vivo; Adenocarcinoma; Immunology; Pathology; Biology; Internal medicine","score_opus":0.031392577410903885,"score_gpt":0.35501994458893005,"score_spread":0.32362736717802615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943912106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969424,0.0011902369,0.00031130755,0.00043165425,0.00025478355,0.00046760423,0.0002199442,0.000006948266,0.00017513809],"genre_scores_gemma":[0.99598634,0.0023937356,0.000032334345,0.0000099799145,0.000670212,0.0003548176,0.000034121018,0.000024564082,0.00049387716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781424,0.0002664509,0.00022716435,0.00044792914,0.0006690598,0.0005751842],"domain_scores_gemma":[0.9989168,0.000057896974,0.00008741338,0.0004014227,0.00038553015,0.00015094856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005307964,0.00016382405,0.00017268215,0.00012620742,0.0002327006,0.000053782398,0.00031693847,0.00010464555,0.00065725774],"category_scores_gemma":[0.00010888869,0.00009508922,0.00013904485,0.00023247664,0.00044402984,0.000018994535,0.00023400533,0.00019302085,0.000035395504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010932771,0.00010560859,0.0029466392,0.00002643062,0.00027064243,0.00001282924,0.000037367983,0.0000070022293,0.95967215,0.000008466263,0.0010019043,0.034817707],"study_design_scores_gemma":[0.0012116296,0.0006075634,0.06405712,0.000032019507,0.000025486588,0.000015479067,0.00005110705,0.0000017266058,0.93187237,0.00015633563,0.0018540698,0.000115115974],"about_ca_topic_score_codex":0.006191179,"about_ca_topic_score_gemma":0.002692677,"teacher_disagreement_score":0.061110478,"about_ca_system_score_codex":0.00015287846,"about_ca_system_score_gemma":0.0003571351,"threshold_uncertainty_score":0.93592525},"labels":[],"label_agreement":null},{"id":"W2943918523","doi":"10.1158/1538-7445.sabcs18-gs6-01","title":"Abstract GS6-01: Surgical treatment after neoadjuvant systemic therapy in young women with breast cancer: Results from a prospective cohort study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Cohort; Cancer; Prospective cohort study; Neoadjuvant therapy; Stage (stratigraphy); Inflammatory breast cancer; Internal medicine; Breast-conserving surgery; Cohort study; Gynecology; Obstetrics; Surgery","score_opus":0.017104436345542873,"score_gpt":0.32836320962678667,"score_spread":0.3112587732812438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943918523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911341,0.0037508383,2.060689e-7,0.0002410796,0.00013576595,0.003018363,0.0010977295,0.00001897021,0.0006029357],"genre_scores_gemma":[0.98539025,0.0042415736,0.0000038059004,0.000013373242,0.00037353925,0.009267656,0.00006665846,0.000056101184,0.0005870528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689627,0.00020565584,0.00032598968,0.001169308,0.00061086065,0.0007918898],"domain_scores_gemma":[0.9987019,0.00006443411,0.000088253,0.00070861,0.00028554242,0.00015129213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044690736,0.00035021268,0.0005004274,0.000112635404,0.00010259723,0.000060542243,0.00024480873,0.0001264185,0.00024211516],"category_scores_gemma":[0.0000075524767,0.00023889623,0.00005749251,0.00031761063,0.00015615234,0.00001386436,0.00012798957,0.0002537017,0.00003541585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026089616,0.0007641569,0.9596866,0.000014932536,0.0009518098,0.00016556519,0.0029305927,0.000077783225,0.0056393235,8.0527775e-7,0.00005558487,0.003623244],"study_design_scores_gemma":[0.012321948,0.0014464573,0.98037523,0.00017026943,0.000018617004,0.000027129958,0.0023234233,0.0000019594659,0.0027539118,0.0000063337825,0.00027657408,0.00027814266],"about_ca_topic_score_codex":0.041539773,"about_ca_topic_score_gemma":0.016981054,"teacher_disagreement_score":0.024558717,"about_ca_system_score_codex":0.0018799262,"about_ca_system_score_gemma":0.00056776777,"threshold_uncertainty_score":0.9741906},"labels":[],"label_agreement":null},{"id":"W2943920148","doi":"10.1158/1538-7445.sabcs18-p4-09-01","title":"Abstract P4-09-01: The DCIS score predicts risk of local recurrence risk after breast-conserving surgery more accurately than ER plus HER2","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Covariate; Breast-conserving surgery; Proportional hazards model; Breast cancer; Ductal carcinoma; Internal medicine; Mastectomy; Oncology; Cancer; Gynecology; Statistics","score_opus":0.052999263900750306,"score_gpt":0.3515615899298794,"score_spread":0.2985623260291291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943920148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739713,0.009719297,0.000033589145,0.00064278283,0.000311853,0.00051901693,0.0010842883,0.000013957637,0.00027808655],"genre_scores_gemma":[0.9925699,0.006345734,0.0000145650665,0.00005602217,0.00033268088,0.00039201084,0.000054030785,0.00004344976,0.0001915816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736786,0.00031119812,0.0003298201,0.0006608675,0.00063734956,0.0006928935],"domain_scores_gemma":[0.9979007,0.0003691717,0.00020185435,0.0009203487,0.00047209454,0.00013579718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010149666,0.00027005514,0.00034403137,0.00009372178,0.00021800464,0.000046442365,0.0005004564,0.0001829067,0.0002654452],"category_scores_gemma":[0.00017517053,0.00018825896,0.00019982204,0.00035024167,0.00070206,0.000017884264,0.00047078196,0.0005473739,0.000054845754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024641317,0.00010404213,0.9442083,0.0002414968,0.0006040047,0.000020007317,0.00056791573,0.00028274977,0.004892112,0.0000034645477,0.0071367873,0.03947499],"study_design_scores_gemma":[0.0006592335,0.000081664475,0.96676123,0.00033736535,0.000056565743,0.000015306265,0.00067493494,0.000040950144,0.029303838,0.000042357493,0.0017997446,0.00022680782],"about_ca_topic_score_codex":0.0083596725,"about_ca_topic_score_gemma":0.0021936921,"teacher_disagreement_score":0.039248183,"about_ca_system_score_codex":0.00016607191,"about_ca_system_score_gemma":0.0007730351,"threshold_uncertainty_score":0.99824375},"labels":[],"label_agreement":null},{"id":"W2943923947","doi":"10.1158/0008-5472.sabcs12-p2-10-33","title":"Abstract P2-10-33: Mitotic Component of Grade Can Distinguish Breast Cancer Patients at Greatest Risk of Local Relapse","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Lymphovascular invasion; Oncology; Pathology; Cancer; Internal medicine; Metastasis","score_opus":0.03496165846036479,"score_gpt":0.34109691860048447,"score_spread":0.30613526014011966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943923947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187994,0.004631066,0.000002670045,0.00018949254,0.00021877697,0.00029192463,0.002368087,0.0000077215855,0.0004103402],"genre_scores_gemma":[0.9970971,0.0017534608,0.000015547566,0.000013362125,0.00035437147,0.00018195584,0.0001512565,0.00004218973,0.000390775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788845,0.00014414248,0.00033944417,0.00038485802,0.0005669095,0.000676227],"domain_scores_gemma":[0.99845326,0.00007802035,0.00021745196,0.00043663903,0.0005911554,0.0002234666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027396038,0.00022417777,0.00031973745,0.00008258619,0.00018401728,0.000007496371,0.00026898945,0.00012692678,0.0003044591],"category_scores_gemma":[0.000081602004,0.00019342515,0.00012461877,0.00021572191,0.0006643492,0.000006923092,0.00035705295,0.00020628443,0.000012049142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004979583,0.0006998323,0.96166575,0.00020364228,0.00042872605,0.0000021663545,0.00035917107,0.000066021086,0.022898173,0.000007952463,0.007970847,0.005199766],"study_design_scores_gemma":[0.0012529808,0.00012963293,0.8999538,0.0001396332,0.000075755015,0.0000035379935,0.00012297157,0.0000043360833,0.09570826,0.0000067503724,0.0024205523,0.00018180857],"about_ca_topic_score_codex":0.013220985,"about_ca_topic_score_gemma":0.002051455,"teacher_disagreement_score":0.07281008,"about_ca_system_score_codex":0.0004202995,"about_ca_system_score_gemma":0.000125291,"threshold_uncertainty_score":0.9933501},"labels":[],"label_agreement":null},{"id":"W2943928304","doi":"10.1158/1538-7445.sabcs18-p2-13-03","title":"Abstract P2-13-03: The impact of neratinib with or without anti-diarrheal prophylaxis on health-related quality of life in HER2+ early-stage breast cancer: Analyses from the ExteNET and CONTROL trials","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Neratinib; Medicine; Internal medicine; Breast cancer; Placebo; Diarrhea; Oncology; Gastroenterology; Cancer; Trastuzumab; Pathology","score_opus":0.2077961484088687,"score_gpt":0.5178687893869703,"score_spread":0.3100726409781016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943928304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821714,0.008988797,0.000009443615,0.004065798,0.000059667087,0.0031286466,0.0015127634,0.000017155216,0.00004629725],"genre_scores_gemma":[0.9976703,0.0014290994,0.000024647372,0.00018805453,0.00020180695,0.0002766321,0.000012340772,0.00005164888,0.00014549252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946702,0.0018392279,0.0012097845,0.000536327,0.0011205131,0.0006239514],"domain_scores_gemma":[0.99505424,0.0025034063,0.0008005469,0.00085259834,0.0005364034,0.0002527929],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004851822,0.00029988584,0.0018520964,0.0001879134,0.00013436457,0.000041411146,0.00032406455,0.00013107073,0.0010668363],"category_scores_gemma":[0.0005496653,0.00012853419,0.00016632283,0.00088248664,0.00076135306,0.0001380192,0.000049672864,0.0010145104,0.000004480151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049357425,0.0002490806,0.87051946,0.00034231468,0.0011277654,0.000007159864,0.0025790369,0.0034289223,0.054188926,0.000012731177,0.00008165999,0.018105507],"study_design_scores_gemma":[0.011130925,0.0017689529,0.9825495,0.0010678507,0.00003281242,0.0000042552315,0.001155952,0.00015567822,0.0019245069,0.000040204206,0.00002507233,0.0001443229],"about_ca_topic_score_codex":0.3783088,"about_ca_topic_score_gemma":0.015329059,"teacher_disagreement_score":0.36297974,"about_ca_system_score_codex":0.00044229103,"about_ca_system_score_gemma":0.0032231635,"threshold_uncertainty_score":0.99984634},"labels":[],"label_agreement":null},{"id":"W2943954869","doi":"10.1158/1538-7445.sabcs16-p5-14-11","title":"Abstract P5-14-11: An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Immunotherapy; Oncology; Population; Internal medicine; Cancer; Randomized controlled trial; Clinical trial","score_opus":0.04441204506597225,"score_gpt":0.39099478143219035,"score_spread":0.3465827363662181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943954869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966231,0.0009788747,0.00015318241,0.0010381897,0.000166815,0.00037783213,0.00063111295,0.0000015547924,0.000029359573],"genre_scores_gemma":[0.99569947,0.0037020782,0.00009619806,0.000026746635,0.00024195852,0.00008366374,0.00003772686,0.000021551026,0.000090594775],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99927694,0.00001500873,0.00016961167,0.0002011895,0.00017068737,0.00016656106],"domain_scores_gemma":[0.9989395,0.00003665346,0.00016434492,0.000503464,0.0003163101,0.00003968388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035661925,0.000082174614,0.00013223197,0.000027939424,0.00024863437,0.0000392631,0.00028742536,0.000088602814,0.00003593756],"category_scores_gemma":[0.000064966596,0.000066486675,0.00005275346,0.000036548754,0.00017008408,0.000009696916,0.00006696013,0.00006092811,6.955083e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013939233,0.00015611896,0.22771733,0.00027685685,0.00011932254,1.57743e-7,0.0001820172,0.005878607,0.5273268,0.0007304426,0.00040159168,0.23581679],"study_design_scores_gemma":[0.0012616555,0.0001298367,0.8444188,0.00007262946,0.000007901108,6.861526e-7,0.00001794916,0.0007712275,0.15104866,0.000899627,0.0012738067,0.00009718388],"about_ca_topic_score_codex":0.0068658493,"about_ca_topic_score_gemma":0.010730913,"teacher_disagreement_score":0.6167015,"about_ca_system_score_codex":0.000038782047,"about_ca_system_score_gemma":0.00010995716,"threshold_uncertainty_score":0.9997475},"labels":[],"label_agreement":null},{"id":"W2943958543","doi":"10.1158/1538-7445.sabcs18-p5-09-17","title":"Abstract P5-09-17: Risk reducing interventions among BRCA 1 and 2 female carriers in Newfoundland and Labrador: A provincial analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; BRCA mutation; Population; Breast cancer; Ovarian cancer; Family history; Psychological intervention; Gynecology; Cancer; Founder effect; Oncology; Mammography; Genetic testing; Malignancy; Germline mutation; Demography; Internal medicine; Mutation; Genetics; Environmental health; Allele; Gene; Biology","score_opus":0.03144736235400187,"score_gpt":0.37506622642205784,"score_spread":0.343618864068056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943958543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950256,0.0034752125,0.00003492691,0.000118545206,0.000079836325,0.00037149596,0.00009810124,0.000005445048,0.00079086603],"genre_scores_gemma":[0.9971157,0.00096206606,0.00010542017,0.000013225866,0.00013689045,0.00013311711,0.000040366645,0.00001800831,0.001475223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864715,0.000120011464,0.000206557,0.000504794,0.00020557268,0.00031591763],"domain_scores_gemma":[0.999342,0.000037892984,0.00006615884,0.0003182325,0.00012895274,0.0001067223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007502512,0.00010684409,0.00017071304,0.00030562587,0.00013317264,0.000089898575,0.00014124987,0.00012457118,0.00017417502],"category_scores_gemma":[0.00012211208,0.00010868299,0.000080118996,0.00052655017,0.00024389129,0.000013965852,0.00017725704,0.00030658228,0.0000035276735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100769335,0.00003024717,0.9491296,0.00012516769,0.00031178934,0.0000042018364,0.00084319466,0.001228297,0.037078768,0.000012002368,0.00056791765,0.0105680525],"study_design_scores_gemma":[0.0008717107,0.00014850183,0.9894448,0.00010352725,0.00009162229,0.0000023185198,0.0010730205,0.00032469435,0.0049200645,0.000053731266,0.0027569756,0.00020905101],"about_ca_topic_score_codex":0.022910638,"about_ca_topic_score_gemma":0.09812952,"teacher_disagreement_score":0.07521888,"about_ca_system_score_codex":0.00028490188,"about_ca_system_score_gemma":0.00035411873,"threshold_uncertainty_score":0.9835959},"labels":[],"label_agreement":null},{"id":"W2943960627","doi":"10.1158/1538-7445.sabcs18-p2-07-02","title":"Abstract P2-07-02: A newly derived combined clinical treatment score and immunohistochemical-4 prognostic tool","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Oncology; Internal medicine; Exemestane; Tamoxifen; Proportional hazards model; Breast cancer; Cohort; Cancer","score_opus":0.07046322590671575,"score_gpt":0.40847446803243215,"score_spread":0.3380112421257164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943960627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914688,0.0059807375,0.0000038017558,0.0006996814,0.00018383673,0.00091450784,0.000047989124,0.000019301307,0.0006813803],"genre_scores_gemma":[0.9946241,0.003271358,0.00009203979,0.00009016265,0.00027282204,0.00055929995,0.00008785479,0.000037585985,0.0009647914],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981515,0.00008886177,0.00028988556,0.00067693985,0.0002747146,0.0005181449],"domain_scores_gemma":[0.9989013,0.00014844556,0.000063797896,0.0005258662,0.00021949348,0.00014106515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029849942,0.00022588305,0.0003137667,0.0000503051,0.00015059442,0.00004586231,0.00020301394,0.0001738056,0.00019989604],"category_scores_gemma":[0.00014577479,0.00018603062,0.00011368878,0.000108621185,0.0003851251,0.000006719958,0.00024386235,0.00021958078,0.00013126849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017774324,0.00045026297,0.3505517,0.0000940099,0.0005849764,0.000019802827,0.0001668173,0.000004852552,0.6189846,0.00003321288,0.0031044725,0.024227899],"study_design_scores_gemma":[0.007959649,0.0021183759,0.81509763,0.00019720063,0.00008264982,0.000016226655,0.00020537392,0.000009437538,0.1575103,0.00012539036,0.016178885,0.0004989024],"about_ca_topic_score_codex":0.0004404761,"about_ca_topic_score_gemma":0.00007579115,"teacher_disagreement_score":0.4645459,"about_ca_system_score_codex":0.00016579943,"about_ca_system_score_gemma":0.00040820782,"threshold_uncertainty_score":0.7586109},"labels":[],"label_agreement":null},{"id":"W2943969736","doi":"10.1158/1538-7445.sabcs18-p2-09-12","title":"Abstract P2-09-12: Perilymphatic IRX-2 cytokine therapy to enhance tumor infiltrating lymphocytes (TILs) and PD-L1 expression preceding curative-intent therapy in early stage breast cancer (ESBC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tumor-infiltrating lymphocytes; Breast cancer; Oncology; Immunotherapy; FOXP3; Cancer; Tumor microenvironment; Immune system; Internal medicine; Immunology","score_opus":0.06277159747553,"score_gpt":0.4128210084473238,"score_spread":0.35004941097179376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943969736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886918,0.006188954,0.0000035092494,0.001633412,0.00017391944,0.0025081786,0.00010947969,0.000049127248,0.00064161036],"genre_scores_gemma":[0.9841573,0.012279696,0.00009053165,0.00036273478,0.00024175573,0.002034399,0.000012015819,0.000080982405,0.0007405649],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965498,0.00015388672,0.0004999819,0.00089706766,0.0009789674,0.0009203332],"domain_scores_gemma":[0.9981482,0.0004140548,0.00013639028,0.0005210094,0.0003827097,0.0003976305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066538865,0.0003945372,0.00063059357,0.00035401687,0.00031279068,0.00029748175,0.00023812661,0.00010454354,0.0013851078],"category_scores_gemma":[0.000081087295,0.00029231797,0.000101889345,0.00056079624,0.00014872522,0.00035711363,0.00013422102,0.00032897023,0.00005680687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002728389,0.0004136953,0.38039672,0.00015746217,0.0000858726,0.00006965322,0.0033909185,0.00006003033,0.51962835,0.000011193284,0.0002239435,0.092833795],"study_design_scores_gemma":[0.0037483675,0.0006703058,0.6013872,0.0021838122,0.0000054489574,0.000017700619,0.0009504614,0.00010149287,0.38941085,0.0000087210055,0.0012813716,0.00023425986],"about_ca_topic_score_codex":0.013582664,"about_ca_topic_score_gemma":0.00095511373,"teacher_disagreement_score":0.2209905,"about_ca_system_score_codex":0.0017309745,"about_ca_system_score_gemma":0.0007713426,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W2943976685","doi":"10.1158/1538-7445.sabcs18-es10-2","title":"Abstract ES10-2: Mining noncoding mutations for drivers of development in ER alpha-positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Biology; Transcription factor; Gene; Genetics; Genomics; Cancer; Genome; Computational biology","score_opus":0.03538025505095563,"score_gpt":0.37150348304178643,"score_spread":0.33612322799083083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943976685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975589,0.0006694642,0.00011420598,0.0001898077,0.00013602113,0.00046560323,0.0003159358,0.0000020439818,0.00054800947],"genre_scores_gemma":[0.99819654,0.00044003988,0.000554592,0.000054144108,0.00012890383,0.00027972713,0.000083348765,0.000020719408,0.00024196469],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899924,0.000018549159,0.00019308126,0.00028861352,0.00017558681,0.00032495573],"domain_scores_gemma":[0.9992864,0.00010602011,0.000056548128,0.00015030931,0.000334945,0.00006577925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030718598,0.00008921629,0.00013559895,0.00011332489,0.00006612348,0.00001839122,0.00015841809,0.0000814387,0.00012892653],"category_scores_gemma":[0.000045042503,0.00009480872,0.000043967168,0.00014835387,0.00007394673,0.0000053644144,0.00009164853,0.00010004249,0.0000047425196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003277551,0.000074970565,0.064739645,0.00014314991,0.00009685833,0.0000028435218,0.0011855602,0.0019244233,0.9092201,0.00011089143,0.0018767877,0.020297041],"study_design_scores_gemma":[0.00225029,0.00016392872,0.23223594,0.00037780995,0.00001301309,0.0000025242514,0.0016883721,0.00016347955,0.74606496,0.00005568585,0.016654808,0.00032920038],"about_ca_topic_score_codex":0.0007204261,"about_ca_topic_score_gemma":0.0018102911,"teacher_disagreement_score":0.1674963,"about_ca_system_score_codex":0.00021191637,"about_ca_system_score_gemma":0.0010073576,"threshold_uncertainty_score":0.38661873},"labels":[],"label_agreement":null},{"id":"W2943982578","doi":"10.1158/1538-7445.sabcs18-p2-08-03","title":"Abstract P2-08-03: Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence and an increased risk of breast cancer mortality in women with ductal carcinoma in situ treated with breast-conserving therapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Ductal carcinoma; Cohort; Internal medicine; Proportional hazards model; Cancer registry; Hazard ratio; Population; Cancer; Malignancy; Gynecology; Confidence interval","score_opus":0.02445755725224513,"score_gpt":0.3070455560603221,"score_spread":0.28258799880807695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943982578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954555,0.0010460411,0.0000014170922,0.000027429265,0.000008266933,0.0008740593,0.0025503517,0.0000068839013,0.000030070489],"genre_scores_gemma":[0.9977652,0.0017181585,0.000037525595,0.000017380911,0.000024461344,0.0002518539,0.00013638205,0.000046027722,0.0000030377944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971121,0.0006150751,0.00040118134,0.00078762294,0.0005090209,0.0005749913],"domain_scores_gemma":[0.99779505,0.00018728939,0.00044313105,0.00059512036,0.0007912128,0.00018822779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079158286,0.00034149052,0.00066898484,0.00022428535,0.00008081974,0.000015561352,0.00028129946,0.00017897633,0.000042554893],"category_scores_gemma":[0.000057981248,0.000249858,0.000039820632,0.0006660828,0.00077710615,0.000050592054,0.00011128457,0.00035396506,3.0558638e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01604315,0.0005675988,0.7462835,0.00012742182,0.00049648684,0.000018131579,0.0010654752,0.00011432018,0.23381835,3.0650736e-7,0.000004337663,0.0014609232],"study_design_scores_gemma":[0.007588613,0.0014272548,0.7862176,0.00056238053,0.000047049303,0.00001548328,0.0015997072,0.00005005603,0.20226172,0.0000062318377,5.005623e-7,0.00022344173],"about_ca_topic_score_codex":0.260347,"about_ca_topic_score_gemma":0.1375214,"teacher_disagreement_score":0.1228256,"about_ca_system_score_codex":0.00036310274,"about_ca_system_score_gemma":0.0011870408,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2943986860","doi":"10.1158/1538-7445.sabcs18-p2-08-07","title":"Abstract P2-08-07: Prognostic impact of the 21-gene recurrence score assay among young women with node-negative and node-positive ER+/HER2- breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Proportional hazards model; Estrogen receptor; Oncology; Stage (stratigraphy); Cancer; Prospective cohort study; Gynecology; Confidence interval","score_opus":0.0196200214291696,"score_gpt":0.3284000945178351,"score_spread":0.3087800730886655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943986860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495924,0.0017830697,0.000004783631,0.00036305666,0.00010303218,0.0009396342,0.0011426014,0.000008143458,0.0006964537],"genre_scores_gemma":[0.9978874,0.0008768007,0.00002556872,0.000041950247,0.00015037242,0.00071559654,0.000023949464,0.000042396547,0.00023597646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772185,0.00018617572,0.00019834639,0.0006636343,0.0005319326,0.0006980854],"domain_scores_gemma":[0.998349,0.00012424139,0.00015656449,0.0005022543,0.0006854072,0.00018251651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042397407,0.00029018422,0.00031437606,0.0000674946,0.00022365643,0.000048959762,0.00035070363,0.00012637729,0.0002489963],"category_scores_gemma":[0.00009616783,0.00018186725,0.00007906833,0.0003752782,0.00087500387,0.000021119225,0.00032623007,0.00036375935,0.00001001137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012847779,0.00009932846,0.92723846,0.00011391458,0.00065875566,0.0000049269465,0.001148092,0.00020440303,0.06678993,0.000003007598,0.0005585658,0.0018958051],"study_design_scores_gemma":[0.0010732453,0.0002787579,0.9548576,0.00042567195,0.000032812717,0.000019744468,0.00043174846,0.0000096090425,0.04261421,0.00002019182,0.000020267873,0.00021616377],"about_ca_topic_score_codex":0.00813709,"about_ca_topic_score_gemma":0.0015336671,"teacher_disagreement_score":0.027619082,"about_ca_system_score_codex":0.0005698724,"about_ca_system_score_gemma":0.0009934396,"threshold_uncertainty_score":0.9984678},"labels":[],"label_agreement":null},{"id":"W2944006832","doi":"10.1158/1538-7445.sabcs16-p4-03-11","title":"Abstract P4-03-11: Fibroblasts isolated from the “normal-like” tissue adjacent to breast tumours suppress healthy epithelial progenitor cell proliferation while supporting tumour cell growth","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Progenitor cell; Matrigel; Breast cancer; Cancer research; Cell growth; Breast tissue; Biology; Fibroblast; Pathology; Stem cell; Cell; Cell culture; Medicine; Cancer; Angiogenesis; Cell biology","score_opus":0.050025639962967335,"score_gpt":0.37314727452880286,"score_spread":0.32312163456583554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944006832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776368,0.0008162231,0.00004707009,0.015360749,0.0008106042,0.0029406985,0.0010778729,0.0000651928,0.0012447655],"genre_scores_gemma":[0.9934378,0.0003339301,0.00020772839,0.0004504256,0.002757582,0.0005929553,0.00014436894,0.000104284656,0.001970873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956432,0.00022118924,0.00063051016,0.00085287524,0.001292325,0.0013598946],"domain_scores_gemma":[0.99660796,0.00017014984,0.00034287697,0.0010890533,0.0009359208,0.000854039],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014155499,0.00034780995,0.000509541,0.0001705614,0.0012357093,0.00048673974,0.00078697916,0.00016406631,0.0016974873],"category_scores_gemma":[0.00014308453,0.00026397698,0.00014600328,0.00029124902,0.00020255217,0.00033550308,0.00038264474,0.000964265,0.00038035057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045325393,0.0006007241,0.029435052,0.0009362702,0.00007484914,0.00019061274,0.0028509786,0.00005891156,0.8794893,0.00000833923,0.07073191,0.011090502],"study_design_scores_gemma":[0.003177083,0.00080476044,0.08925272,0.00049455266,0.00009928818,0.00003814638,0.0006459234,0.000103958715,0.8801594,0.000020146765,0.02479732,0.0004067402],"about_ca_topic_score_codex":0.024424478,"about_ca_topic_score_gemma":0.003579106,"teacher_disagreement_score":0.059817668,"about_ca_system_score_codex":0.0005250764,"about_ca_system_score_gemma":0.0015349629,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2944045371","doi":"10.1158/1538-7445.sabcs18-pd6-05","title":"Abstract PD6-05: Withdrawn","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Cancer; Breast cancer; Gerontology; Gynecology; Internal medicine","score_opus":0.07358829241651378,"score_gpt":0.4467943645613154,"score_spread":0.3732060721448016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944045371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97105736,0.002972583,0.00002055504,0.0036476792,0.00033460322,0.0007075642,0.000013648486,0.00008542772,0.021160578],"genre_scores_gemma":[0.98007244,0.00020583972,0.00020508283,0.0004308916,0.000523473,0.00014955312,0.0000073867004,0.00005251436,0.018352836],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979848,0.000034896573,0.00016127854,0.00038154758,0.0008209949,0.000616484],"domain_scores_gemma":[0.99869764,0.00011514926,0.00003382099,0.0005609504,0.00037485763,0.00021757769],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00043736745,0.00012698454,0.00024790078,0.00018666184,0.000091293485,0.000031054064,0.00019123913,0.000081168175,0.007107102],"category_scores_gemma":[0.00005430816,0.00010510199,0.00006368667,0.00045558595,0.00021907606,0.00014478275,0.00007432836,0.00066735176,0.0016714534],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027171888,0.00020152875,0.043276966,0.0007183586,0.00023344893,0.00017061092,0.0010126065,0.000099721125,0.7375992,0.0012362733,0.0116484305,0.20108567],"study_design_scores_gemma":[0.004630869,0.00054364046,0.17769067,0.0007828452,0.000018617242,0.00008213906,0.0008371775,0.000028822727,0.09610475,0.0013322325,0.7176053,0.00034296047],"about_ca_topic_score_codex":0.00033705254,"about_ca_topic_score_gemma":0.000034150566,"teacher_disagreement_score":0.7059568,"about_ca_system_score_codex":0.0004497577,"about_ca_system_score_gemma":0.00057655695,"threshold_uncertainty_score":0.9991059},"labels":[],"label_agreement":null},{"id":"W2944046125","doi":"10.1158/1538-7445.sabcs18-p5-03-11","title":"Abstract P5-03-11: Sensitivity to cell cycle inhibitors in taxane resistant breast cancer models","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Taxane; Cyclin-dependent kinase 1; Paclitaxel; Cancer research; SKBR3; Cell cycle; Cell cycle checkpoint; Biology; Breast cancer; Cancer; Medicine; Internal medicine","score_opus":0.04379726349217531,"score_gpt":0.3776442483570133,"score_spread":0.333846984864838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944046125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860913,0.0017629486,0.00002999311,0.006647312,0.0003184648,0.001505526,0.00030374806,0.00007659005,0.0032640928],"genre_scores_gemma":[0.99530536,0.0003018437,0.00017699182,0.00046990952,0.0005711636,0.00041131937,0.000010410841,0.0001067838,0.0026461922],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960009,0.00017008546,0.00041239403,0.0008821142,0.0012976016,0.0012369109],"domain_scores_gemma":[0.9978249,0.00021012838,0.00008727259,0.00079638115,0.0005710766,0.0005102322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012125908,0.0003051909,0.0005731191,0.00055172475,0.00011393253,0.000050090715,0.0002190081,0.00017311066,0.0011394887],"category_scores_gemma":[0.00004032005,0.00028231874,0.00010399792,0.0012444555,0.00018856596,0.00035367906,0.00020678376,0.0009779817,0.00031684956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049367817,0.000367026,0.024849294,0.00073969946,0.00005897288,0.00035254107,0.0016088461,0.020837642,0.8946455,0.00013551845,0.0017751745,0.049692977],"study_design_scores_gemma":[0.014214709,0.0007137155,0.57807714,0.0063660746,0.00006323219,0.00014676314,0.004853681,0.0029496024,0.35122526,0.0016441172,0.037772715,0.00197298],"about_ca_topic_score_codex":0.022212377,"about_ca_topic_score_gemma":0.009998403,"teacher_disagreement_score":0.55322784,"about_ca_system_score_codex":0.0021770485,"about_ca_system_score_gemma":0.001081899,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W2944090377","doi":"10.1158/1538-7445.sabcs18-p6-17-29","title":"Abstract P6-17-29: Withdrawn","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Cancer; Breast cancer; Citation; Gerontology; Gynecology; Library science; Internal medicine; Computer science","score_opus":0.07313228600122833,"score_gpt":0.44365908483177796,"score_spread":0.3705267988305496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944090377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538482,0.003675873,0.000023311568,0.0036138538,0.0002633262,0.0007789269,0.000016235204,0.00009514246,0.037685145],"genre_scores_gemma":[0.96351075,0.00021513728,0.00021748342,0.0004828555,0.00057536573,0.0001741969,0.000008858831,0.00005721889,0.034758154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778616,0.00003652329,0.00018077888,0.0004219181,0.0008945007,0.00068008935],"domain_scores_gemma":[0.9985799,0.00011478223,0.000039047478,0.00062292616,0.00039916154,0.0002441408],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00047481625,0.00014351892,0.00027625437,0.00020199454,0.00010207331,0.000035495133,0.00021716302,0.0000920807,0.010060325],"category_scores_gemma":[0.000049932616,0.00011938691,0.000071006914,0.00048923586,0.000244594,0.00015871557,0.00008359558,0.0007771111,0.0014361091],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034428446,0.00025921254,0.065090336,0.00078366254,0.00031541087,0.00014762908,0.0017663032,0.00018329335,0.7246135,0.0009372408,0.020946419,0.18151416],"study_design_scores_gemma":[0.004668202,0.00049345713,0.22060859,0.0008229144,0.000020584976,0.000050810668,0.00082591386,0.000032320822,0.07066108,0.0011519627,0.7002989,0.00036528098],"about_ca_topic_score_codex":0.0004225459,"about_ca_topic_score_gemma":0.00006295358,"teacher_disagreement_score":0.67935246,"about_ca_system_score_codex":0.00049547566,"about_ca_system_score_gemma":0.0006397611,"threshold_uncertainty_score":0.99934137},"labels":[],"label_agreement":null},{"id":"W2944106285","doi":"10.1158/1538-7445.sabcs18-p3-12-10","title":"Abstract P3-12-10: Utilization patterns and temporal trends of internal mammary nodal irradiation (IMNI) at a tertiary cancer centre","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Logistic regression; Cancer; Internal medicine; Continuous variable; Exact test; Surgery","score_opus":0.040374835891025036,"score_gpt":0.3555763554693162,"score_spread":0.3152015195782912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944106285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948254,0.0031695806,0.000016113658,0.0006846652,0.00015329686,0.00016424886,0.00027661165,0.000007973022,0.0007020992],"genre_scores_gemma":[0.99383366,0.0018832486,0.000016474985,0.00006546187,0.00019813674,0.0000734097,0.00022933587,0.000022691158,0.00367756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987645,0.00006234721,0.00018400008,0.00039880446,0.00028792984,0.00030237972],"domain_scores_gemma":[0.9994035,0.000019043417,0.00008318189,0.0002588483,0.00015545264,0.00007999394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014260138,0.00014086784,0.00015483379,0.00011566804,0.00007173062,0.00002023981,0.0001541252,0.000101856174,0.0007890457],"category_scores_gemma":[0.000011370472,0.00012754672,0.00005408293,0.00010916888,0.00009641836,0.000014758599,0.00025559173,0.00010597829,0.000008597274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049088214,0.00006175714,0.8860057,0.00013684052,0.00015944472,0.000004111653,0.00021637659,0.000021650078,0.0762317,0.000007458002,0.0045608524,0.032103226],"study_design_scores_gemma":[0.0011511246,0.00010329032,0.9349405,0.00011651985,0.000014278121,0.000003753406,0.00008317047,0.000056661305,0.05480214,0.0000102460845,0.008575169,0.00014311113],"about_ca_topic_score_codex":0.00275021,"about_ca_topic_score_gemma":0.0033253198,"teacher_disagreement_score":0.04893484,"about_ca_system_score_codex":0.00016535689,"about_ca_system_score_gemma":0.00012437247,"threshold_uncertainty_score":0.8639497},"labels":[],"label_agreement":null},{"id":"W2944119619","doi":"10.1158/1538-7445.sabcs18-gs4-02","title":"Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Interquartile range; Lymph node; Radiation therapy; Cancer; Axilla; NODAL; Stage (stratigraphy); Internal medicine; Nuclear medicine; Oncology; Surgery","score_opus":0.145434642989795,"score_gpt":0.4251038146600995,"score_spread":0.2796691716703045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944119619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933503,0.0038077633,0.0000015434115,0.00072679465,0.00005772655,0.0004449704,0.0013648528,0.0000054433185,0.00024059742],"genre_scores_gemma":[0.9960756,0.0018866186,0.000014789361,0.000090596484,0.000121251906,0.0009332278,0.00014778318,0.00002832051,0.000701863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687153,0.0005673644,0.00058631954,0.0006831953,0.0006263508,0.0006652299],"domain_scores_gemma":[0.9985779,0.0001509173,0.00021891645,0.0005979444,0.00031558998,0.00013872281],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028126615,0.00021930395,0.0011077083,0.0006124532,0.00005130211,0.00003364414,0.00034279225,0.00017192414,0.0014321639],"category_scores_gemma":[0.00008074808,0.00018631213,0.0003505486,0.0010228142,0.00013923319,0.000025060173,0.00010960531,0.00019313474,0.000008903722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003183647,0.00044750056,0.87753403,0.00012327699,0.031866044,0.000010785889,0.0017493742,0.011682768,0.07051857,0.000043921344,0.00027497683,0.0025650875],"study_design_scores_gemma":[0.0017769145,0.00007537846,0.9917266,0.000014588874,0.0014100365,5.960833e-7,0.000406967,0.00005356591,0.0038456656,0.000031105174,0.00046795266,0.00019064687],"about_ca_topic_score_codex":0.04319398,"about_ca_topic_score_gemma":0.014015749,"teacher_disagreement_score":0.11419254,"about_ca_system_score_codex":0.00069581217,"about_ca_system_score_gemma":0.0005671489,"threshold_uncertainty_score":0.99948066},"labels":[],"label_agreement":null},{"id":"W2944121148","doi":"10.1158/1538-7445.sabcs18-p5-13-20","title":"Abstract P5-13-20: Overall survival of women with breast cancer treated with newly approved targeted drugs in Manitoba: A population based study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Palbociclib; Pertuzumab; Fulvestrant; Population; Trastuzumab emtansine; Breast cancer; Cancer; Internal medicine; Cancer registry; Clinical trial; Oncology; Trastuzumab; Metastatic breast cancer; Tamoxifen","score_opus":0.031767779054204935,"score_gpt":0.34074401945450433,"score_spread":0.3089762404002994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944121148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959531,0.000234142,0.000010610447,0.0005047579,0.00005765355,0.0028438065,0.00012893573,0.00006125919,0.00020573594],"genre_scores_gemma":[0.99793816,0.000018184943,0.0001018247,0.000057630397,0.00013558562,0.0011496762,0.00005367362,0.00010737809,0.00043789978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628836,0.00020302169,0.00040309117,0.0006978432,0.0014311337,0.00097653706],"domain_scores_gemma":[0.99803466,0.00014240447,0.00018062824,0.0006441689,0.00073504273,0.00026309997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000764303,0.00032406455,0.0007563433,0.00052282243,0.000070702205,0.00003135522,0.0002343759,0.00010265574,0.0009623477],"category_scores_gemma":[0.000017408807,0.0002348221,0.000040747076,0.0012496397,0.0001312174,0.0002710946,0.000047633792,0.00066276925,0.000010280904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029541755,0.00073770166,0.93437624,0.00038237896,0.0002864884,0.00003927402,0.0018798754,0.003942145,0.022206187,0.000006609993,0.000011083028,0.0065902444],"study_design_scores_gemma":[0.016474824,0.0012793445,0.97427297,0.0006818142,0.000030774267,0.0000051146117,0.0053415806,0.0002189304,0.0013205016,0.000016406648,0.00008908493,0.00026863578],"about_ca_topic_score_codex":0.0664878,"about_ca_topic_score_gemma":0.025748266,"teacher_disagreement_score":0.04073953,"about_ca_system_score_codex":0.003369588,"about_ca_system_score_gemma":0.0011567797,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W2944131206","doi":"10.1158/1538-7445.sabcs18-p6-22-03","title":"Abstract P6-22-03: Tumor phenotype and concordance in synchronous bilateral breast cancer in young women","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Concordance; Mastectomy; Cancer; Internal medicine; Incidence (geometry); Cohort; Oncology; Prospective cohort study; Gynecology","score_opus":0.014494678186862363,"score_gpt":0.32932106642406656,"score_spread":0.3148263882372042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944131206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927781,0.004995727,3.7065766e-7,0.00048139322,0.00018973422,0.00041087525,0.00016226461,0.000007634626,0.0009738854],"genre_scores_gemma":[0.9964705,0.0020735608,0.0000104845585,0.00008797527,0.00021513304,0.00061705755,0.000011751302,0.00003324893,0.00048025505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981525,0.00007189015,0.00020727377,0.00059010065,0.00024196824,0.0007362918],"domain_scores_gemma":[0.9994033,0.000029698302,0.0000449524,0.00029832133,0.000118703654,0.00010499903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033941917,0.00018808541,0.00026125138,0.00013150317,0.00006107282,0.000037117465,0.00020264075,0.00008565909,0.0004150219],"category_scores_gemma":[0.000017065639,0.00017278189,0.000026554957,0.00027392613,0.00020042971,0.000014410296,0.00021550136,0.00028596554,0.000034840516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086853467,0.0000937392,0.8647993,0.00013837403,0.00006641388,0.000030897532,0.0007743831,0.00013163581,0.12602541,0.000013028438,0.0002572944,0.006800973],"study_design_scores_gemma":[0.0018115347,0.00009281524,0.9916293,0.00016194579,0.0000027258475,0.000014913393,0.0003804698,0.000017557906,0.0050186072,0.000049973398,0.00061186956,0.00020826631],"about_ca_topic_score_codex":0.012145985,"about_ca_topic_score_gemma":0.010586832,"teacher_disagreement_score":0.12683001,"about_ca_system_score_codex":0.00062807114,"about_ca_system_score_gemma":0.0003963583,"threshold_uncertainty_score":0.9944322},"labels":[],"label_agreement":null},{"id":"W2944144205","doi":"10.1158/1538-7445.am2008-lb-242","title":"Abstract LB-242: Aberrant crypt foci (ACF) are not surrogate biomarkers of sporadic adenoma prevention with celecoxib: Results from the Adenoma Prevention with Celecoxib (APC) trial","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Celecoxib; Medicine; Adenoma; Gastroenterology; Internal medicine; Aberrant crypt foci; Colorectal adenoma; Biopsy; Pathology; Rectum; Tubular adenoma; Oncology; Colonoscopy; Colorectal cancer; Cancer","score_opus":0.1006532383297222,"score_gpt":0.35885472708144717,"score_spread":0.258201488751725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944144205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267393,0.001360599,0.000020192176,0.0011089311,0.00029343562,0.0036472639,0.00017395838,0.00006729354,0.00065440434],"genre_scores_gemma":[0.9961623,0.000624699,0.00013250811,0.00004173861,0.00095436064,0.00048579817,0.00019467849,0.00009511967,0.0013087956],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99503654,0.0004883669,0.00082455145,0.000823856,0.0019205007,0.00090616924],"domain_scores_gemma":[0.9967503,0.0007059916,0.0006071703,0.0009348953,0.0006296005,0.00037207155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024845025,0.00038467915,0.00073659874,0.00030875823,0.00045153685,0.000041179945,0.0004065811,0.00027713404,0.00039525892],"category_scores_gemma":[0.00035016617,0.00024600237,0.0002260398,0.00088201463,0.00070793874,0.00024722805,0.000072512565,0.0010170151,0.00004884537],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7730192,0.002615317,0.057987347,0.0015576918,0.0027474642,0.0028469963,0.006585836,0.00010859872,0.102373235,0.00006274833,0.03174448,0.018351119],"study_design_scores_gemma":[0.11927673,0.0077846358,0.7252216,0.0038016313,0.00038601147,0.000103752456,0.0010993368,0.0000961577,0.13696343,0.00009411923,0.0045372685,0.0006353395],"about_ca_topic_score_codex":0.0022831063,"about_ca_topic_score_gemma":0.0019890517,"teacher_disagreement_score":0.66723424,"about_ca_system_score_codex":0.00046261534,"about_ca_system_score_gemma":0.0018023866,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2944152537","doi":"10.1158/1538-7445.sabcs18-p5-07-02","title":"Abstract P5-07-02: Not presented","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Chatterjee; Medicine; Cancer; Breast cancer; Citation; Gerontology; Oncology; Library science; Internal medicine; Philosophy; Computer science","score_opus":0.10633973551445756,"score_gpt":0.46212629530816507,"score_spread":0.3557865597937075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944152537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752747,0.0022434525,0.000020907633,0.006964216,0.00033356453,0.0009793247,0.000030317986,0.00010564857,0.014047891],"genre_scores_gemma":[0.9737006,0.0002813616,0.00011524212,0.0004365707,0.0005849404,0.00021640558,0.000012467828,0.00006174042,0.024590684],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745715,0.000049051716,0.00021231633,0.00046482682,0.0010784875,0.0007381838],"domain_scores_gemma":[0.99831367,0.00018794545,0.00004460927,0.00069849374,0.00049607997,0.0002591981],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005130758,0.00015327238,0.0002958199,0.00021693572,0.00009477107,0.00003407946,0.0002607037,0.00010334373,0.009459607],"category_scores_gemma":[0.00010767325,0.00013027394,0.00008469302,0.00043420287,0.0002241813,0.00017469219,0.00012047237,0.0008172595,0.0031328355],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032877557,0.0001836739,0.023580704,0.0005824596,0.00021670277,0.00010241333,0.0005631121,0.000089885645,0.88039464,0.0004946686,0.0070435884,0.083460405],"study_design_scores_gemma":[0.0050979163,0.00041543524,0.2281904,0.00073062454,0.000022140353,0.000043783723,0.00066595845,0.00006873721,0.26358286,0.0005353442,0.50030035,0.0003464226],"about_ca_topic_score_codex":0.00057867577,"about_ca_topic_score_gemma":0.000032442324,"teacher_disagreement_score":0.61681175,"about_ca_system_score_codex":0.00047494555,"about_ca_system_score_gemma":0.0005312506,"threshold_uncertainty_score":0.99764335},"labels":[],"label_agreement":null},{"id":"W2944165579","doi":"10.1158/1538-7445.sabcs18-p1-13-05","title":"Abstract P1-13-05: Efficacy and safety of eflapegrastim confirmed in reducing severe neutropenia in breast cancer patients treated with myelosuppressive chemotherapy in the second Phase 3 randomized controlled multinational trial compared to pegfilgrastim (RECOVER trial)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pegfilgrastim; Medicine; Neutropenia; Docetaxel; Breast cancer; Internal medicine; Febrile neutropenia; Clinical endpoint; Cyclophosphamide; Oncology; Phases of clinical research; Chemotherapy; Cancer; Surgery; Clinical trial","score_opus":0.02701083480219315,"score_gpt":0.3725926572760232,"score_spread":0.34558182247383007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944165579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781307,0.0001266766,9.4721605e-7,0.0013984716,0.00018236987,0.018959505,0.0002795372,0.000010267212,0.00091151154],"genre_scores_gemma":[0.99520624,0.0001680737,0.000010209044,0.00017889735,0.00014839935,0.0037817087,0.00006613681,0.000038371454,0.00040195396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99625987,0.0008377458,0.0009866605,0.000581722,0.00080019416,0.0005338238],"domain_scores_gemma":[0.9966474,0.0021185884,0.00027639986,0.0003097887,0.0004893344,0.000158446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017940949,0.0002948074,0.0017666311,0.00065906945,0.00008514404,0.000054840835,0.00021847447,0.00012319974,0.002952156],"category_scores_gemma":[0.00022398391,0.00018492014,0.00013539591,0.0010053882,0.00025290946,0.00015348548,0.00004125272,0.00076674926,0.000005545563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97047657,0.0017736849,0.015379983,0.00011084018,0.00022677252,0.000019229625,0.0014931434,0.0008165028,0.007382055,0.000007720574,0.00037795788,0.0019355522],"study_design_scores_gemma":[0.8396253,0.0010886224,0.15677734,0.0007650614,0.000053429667,0.0000062743457,0.0002099151,0.00027373695,0.00088061875,0.0000040333593,0.00014622888,0.00016942012],"about_ca_topic_score_codex":0.005456289,"about_ca_topic_score_gemma":0.0036705462,"teacher_disagreement_score":0.14139736,"about_ca_system_score_codex":0.0005461277,"about_ca_system_score_gemma":0.00091225863,"threshold_uncertainty_score":0.99795926},"labels":[],"label_agreement":null},{"id":"W2944192183","doi":"10.1158/1538-7445.sabcs18-pd3-10","title":"Abstract PD3-10: Higher serum PD-L1 predicts for increased overall survival to lapatinib vs trastuzumab in the phase 3 CCTG MA.31 trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; Trastuzumab; Taxane; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Population; Biomarker; Breast cancer; Cancer","score_opus":0.11753207521934145,"score_gpt":0.44622672142565545,"score_spread":0.328694646206314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944192183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809888,0.000496431,0.000003288887,0.0064650327,0.00088528707,0.0055491733,0.00038496318,0.0000351285,0.0051918975],"genre_scores_gemma":[0.98845136,0.00014266728,0.000028381839,0.0011518316,0.0012938846,0.001396747,0.00009709809,0.000052484986,0.0073855654],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676603,0.00024572777,0.00045787395,0.0005319024,0.0011523168,0.00084617507],"domain_scores_gemma":[0.9980453,0.000761742,0.00007310502,0.00064769946,0.00025673426,0.00021538732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031086064,0.00022556445,0.00045727647,0.0002741575,0.00012914873,0.00009223303,0.00045669597,0.00017428522,0.0057633403],"category_scores_gemma":[0.0001903027,0.00015810035,0.00019232678,0.00060495513,0.00012047851,0.00011790683,0.000056663455,0.0005740352,0.00011888931],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7832549,0.0014605925,0.0027140048,0.00047648232,0.00028534138,0.00005325571,0.0013775942,0.000007748358,0.0681523,0.0001255987,0.1216733,0.020418864],"study_design_scores_gemma":[0.31121635,0.010627013,0.22073868,0.00061259355,0.000057964506,0.0000060552065,0.000559228,0.000058488757,0.008866311,0.00017375323,0.44664767,0.00043588894],"about_ca_topic_score_codex":0.0037730462,"about_ca_topic_score_gemma":0.000672389,"teacher_disagreement_score":0.47203857,"about_ca_system_score_codex":0.00065093854,"about_ca_system_score_gemma":0.0011532229,"threshold_uncertainty_score":0.9951455},"labels":[],"label_agreement":null},{"id":"W2944198235","doi":"10.1158/1538-7445.sabcs18-p3-14-08","title":"Abstract P3-14-08: Preclinical and clinical evidence about the use of betablockers for the treatment of triple negative breast cancer: A systematic review","year":2019,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; In vivo; Triple-negative breast cancer; Cancer; Clinical trial; Oncology; Repurposing; Internal medicine; Pharmacology; Biology","score_opus":0.5234732220272433,"score_gpt":0.5669310911386269,"score_spread":0.04345786911138361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944198235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021386718,0.9762797,0.000001989843,0.0016940063,0.00039835766,0.020641863,0.00075331784,0.000010368632,0.0000065383742],"genre_scores_gemma":[0.0000703047,0.9898149,0.0000202408,0.00009486624,0.0006058844,0.0068366765,0.000016827798,0.000078585064,0.0024617235],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99274606,0.0020932518,0.0027030124,0.0007601598,0.0010852299,0.00061228726],"domain_scores_gemma":[0.9623265,0.03293057,0.001490596,0.0018572374,0.0011917279,0.00020332252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005365957,0.00051367155,0.005842602,0.00017307865,0.00019232619,0.000059649432,0.0006900118,0.00035836725,0.00015832916],"category_scores_gemma":[0.0049263965,0.00023209766,0.0018075053,0.0006891861,0.0014900344,0.000115790426,0.00010556846,0.0009054644,0.000012427784],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015121818,0.00021777219,0.00007945372,0.58428025,0.0017986987,0.0000041578746,0.00013297398,5.7870545e-7,4.6646895e-7,0.000003368284,0.0041248216,0.40784526],"study_design_scores_gemma":[0.001075364,0.0010996126,0.0005648263,0.6094231,0.0092910305,0.0000579515,0.0000692247,0.000019374358,0.000003246111,0.0000012802611,0.3782329,0.00016207255],"about_ca_topic_score_codex":0.0031520505,"about_ca_topic_score_gemma":0.00030902796,"teacher_disagreement_score":0.40768316,"about_ca_system_score_codex":0.0006685755,"about_ca_system_score_gemma":0.005221067,"threshold_uncertainty_score":0.9464668},"labels":[],"label_agreement":null},{"id":"W2944198647","doi":"10.1158/1538-7445.am2008-lb-333","title":"Abstract LB-333: Antagonistic interaction effects of aspirin and folic acid on inflammatory markers","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aspirin; Placebo; Medicine; Gastroenterology; Internal medicine; Randomization; Randomized controlled trial; Pathology","score_opus":0.028807746503700667,"score_gpt":0.35109432121743434,"score_spread":0.3222865747137337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944198647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286014,0.003822467,0.000010666246,0.0000590715,0.0016127987,0.00025829233,0.0000137070565,0.0000066654397,0.0013561806],"genre_scores_gemma":[0.9890673,0.0072431345,0.000012866802,0.000063135965,0.002973883,0.00009302729,0.0000158871,0.000021006248,0.0005097425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989283,0.00008413083,0.00015633268,0.00029401568,0.00025242305,0.0002847605],"domain_scores_gemma":[0.9993837,0.000055953355,0.00005341496,0.0002671097,0.00012698803,0.000112826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025818622,0.000111941226,0.00015130432,0.00011297632,0.00012267058,0.000012594515,0.00012494702,0.000108501685,0.00003233252],"category_scores_gemma":[0.00014272478,0.00010686217,0.000054611137,0.000095907344,0.0002788735,0.0000065627346,0.00007907287,0.00023226441,0.000009131769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005513618,0.00003984724,0.0014974521,0.00025635108,0.000048320268,0.0000021690503,0.000101594596,0.000012867234,0.9714923,0.00003444975,0.0143845,0.011578787],"study_design_scores_gemma":[0.00091513066,0.00035175032,0.06533823,0.00013418727,0.000009985478,0.000016642247,0.00005309461,0.0000060944435,0.7136177,0.000024352043,0.21938547,0.00014737961],"about_ca_topic_score_codex":0.00026573424,"about_ca_topic_score_gemma":0.000098232704,"teacher_disagreement_score":0.2578746,"about_ca_system_score_codex":0.00004879619,"about_ca_system_score_gemma":0.00024783934,"threshold_uncertainty_score":0.4357713},"labels":[],"label_agreement":null},{"id":"W2944206845","doi":"10.1158/1538-7445.sabcs18-p5-13-04","title":"Abstract P5-13-04: Needle-to-knife wait time and impact on pCR in patients undergoing neoadjuvant chemotherapy for breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of British Columbia Hospital","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Cancer; Surgery; Neoadjuvant therapy; Surgical oncology; Radiation therapy; Cohort; Internal medicine; Oncology","score_opus":0.021452873576709344,"score_gpt":0.3513557132561609,"score_spread":0.32990283967945155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944206845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955047,0.00080251676,0.0000017314842,0.0015397556,0.00010694778,0.0010256724,0.0006319446,0.000009145684,0.00037760191],"genre_scores_gemma":[0.9975255,0.00067125243,0.000022252476,0.0003794813,0.00024987038,0.00036686554,0.00006149028,0.00005705317,0.0006662372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819964,0.00004231471,0.00018415015,0.0005984472,0.000318774,0.0006566705],"domain_scores_gemma":[0.99914765,0.00008668083,0.000049413153,0.00033063765,0.00022250469,0.0001630978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025052638,0.00024051155,0.0002723163,0.00015173045,0.00010613879,0.00004624754,0.00019533113,0.0001236384,0.0003284432],"category_scores_gemma":[0.000029453413,0.00019534836,0.00008041396,0.00020337284,0.000076419354,0.00001058268,0.000121240824,0.00017171731,0.000051424933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01004859,0.00056505925,0.7427509,0.00024929113,0.0006131158,0.000004093239,0.00065568014,0.0017449856,0.10799693,0.0000142388435,0.016856452,0.1185007],"study_design_scores_gemma":[0.0048309243,0.0007289677,0.9805163,0.00023232766,0.00000778357,0.0000013269528,0.0000671095,0.00003341109,0.012021063,0.00002978262,0.0012671789,0.00026378295],"about_ca_topic_score_codex":0.0017448035,"about_ca_topic_score_gemma":0.00080166885,"teacher_disagreement_score":0.23776548,"about_ca_system_score_codex":0.0004217239,"about_ca_system_score_gemma":0.0003246209,"threshold_uncertainty_score":0.7966075},"labels":[],"label_agreement":null},{"id":"W2944211448","doi":"10.1158/1538-7445.sabcs18-p4-13-06","title":"Abstract P4-13-06: Real-world experience using exemestane and everolimus in patients with hormone receptor positive/HER2 negative breast cancer with and without prior CDK4/6 inhibitor exposure","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Exemestane; Aromatase inhibitor; Internal medicine; Breast cancer; Discontinuation; Oncology; Lapatinib; Anastrozole; Everolimus; Cancer; Trastuzumab; Tamoxifen","score_opus":0.024729142544929347,"score_gpt":0.35337555918933505,"score_spread":0.3286464166444057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944211448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567324,0.0013809022,0.0000072983153,0.00037069284,0.0000592005,0.0021042074,0.0001700922,0.000039252525,0.00019510518],"genre_scores_gemma":[0.9973789,0.0006123264,0.00075757765,0.00012507335,0.00018935053,0.00036243125,0.0000138248015,0.00010703568,0.00045348614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967101,0.00011084881,0.0003288607,0.0009045557,0.0010931705,0.00085245323],"domain_scores_gemma":[0.99811506,0.00011454601,0.00016690533,0.00042452765,0.00080370024,0.00037525076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002865276,0.0003857566,0.0006112063,0.00037200685,0.00019179318,0.00007511911,0.00014431619,0.000111431335,0.00025874408],"category_scores_gemma":[0.000022173352,0.00028530485,0.000024430112,0.0009270581,0.00080899004,0.0006377018,0.00012255258,0.0007739522,0.000005138941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018112242,0.00017226687,0.93250906,0.0001978735,0.00012002836,0.000023915441,0.0049884873,0.000045992932,0.029741501,0.0000073000115,0.00001653718,0.014064795],"study_design_scores_gemma":[0.010662945,0.0009774036,0.979386,0.0022423828,0.000026249507,0.000024896874,0.0015856024,0.000027593409,0.0045231427,0.000010174579,0.00016140574,0.00037220283],"about_ca_topic_score_codex":0.0109037375,"about_ca_topic_score_gemma":0.0028503113,"teacher_disagreement_score":0.04687694,"about_ca_system_score_codex":0.0011290846,"about_ca_system_score_gemma":0.000673073,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2944217343","doi":"10.1158/1538-7445.sabcs18-gs6-03","title":"Abstract GS6-03: Symptoms and health-related quality of life on endocrine therapy alone (E) versus chemoendocrine therapy (C+E): TAILORx patient-reported outcomes results","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Endocrine system; Randomized controlled trial; Internal medicine; Conventional PCI; Physical therapy; Hormone; Myocardial infarction","score_opus":0.18310348887006425,"score_gpt":0.45823959047420265,"score_spread":0.2751361016041384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944217343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96646583,0.008495843,1.8150037e-7,0.017793948,0.0006305756,0.0030876172,0.00013955517,0.00010705975,0.0032793898],"genre_scores_gemma":[0.9814785,0.01591326,0.000010561872,0.000740826,0.000114010705,0.00026606984,0.00008587101,0.000073058516,0.0013178395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946528,0.00029655165,0.0014725968,0.0008850649,0.0016883869,0.0010046177],"domain_scores_gemma":[0.9960298,0.0010670577,0.0006130962,0.00084598735,0.0009991657,0.0004449153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015002079,0.0004091761,0.001292415,0.00046007047,0.00020494654,0.000027771206,0.00018352669,0.000111781585,0.000778299],"category_scores_gemma":[0.0008706551,0.00031663544,0.00019812239,0.00080451864,0.00047091892,0.00012584623,0.00014245333,0.0010623097,0.00007964644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19083768,0.0035754151,0.5072491,0.001023535,0.008141236,0.00017490998,0.00423667,0.000058079168,0.04872623,0.00020254152,0.02029575,0.21547882],"study_design_scores_gemma":[0.060236935,0.0072786473,0.9052104,0.00053163903,0.000023512437,0.000009559589,0.0007301944,0.0000077849945,0.019875443,0.000046839483,0.0056991954,0.00034988442],"about_ca_topic_score_codex":0.0076194215,"about_ca_topic_score_gemma":0.00017091198,"teacher_disagreement_score":0.39796123,"about_ca_system_score_codex":0.0006426005,"about_ca_system_score_gemma":0.000804931,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2944219604","doi":"10.1158/1538-7445.sabcs18-p6-16-03","title":"Abstract P6-16-03: The impact of ductal carcinoma in situ of the breast on health services utilization and general health and well-being of women","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Anxiety; Ductal carcinoma; Population; Cohort; Mastectomy; Mammography; Depression (economics); Breast-conserving surgery; Cancer; Gynecology; Internal medicine; Psychiatry","score_opus":0.09221219168877395,"score_gpt":0.44552265731786894,"score_spread":0.35331046562909496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944219604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940687,0.003250705,1.7912535e-7,0.0013880547,0.000024982224,0.000515368,0.000015048143,0.0000020087002,0.00073498883],"genre_scores_gemma":[0.9986722,0.0010539045,0.0000032799478,0.00017516085,0.000045042954,0.000010278425,0.000004283627,0.00000807284,0.000027786067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998592,0.00013888265,0.00026244347,0.00017178521,0.0004781115,0.0003567543],"domain_scores_gemma":[0.99925274,0.00007179147,0.00014439187,0.00024031616,0.00015500507,0.00013574211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001232926,0.00007722353,0.00028179766,0.000107481545,0.00006267611,0.000008669005,0.0001231162,0.000035566263,0.000057097415],"category_scores_gemma":[0.000018351036,0.00004385744,0.000031399777,0.0003988596,0.00014510563,0.00006631591,0.000076727556,0.00024489066,5.8514735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089541695,0.000041447845,0.9688073,0.0012323174,0.000026849413,0.0000015819387,0.012507111,0.00014807284,0.008934655,0.00013258637,0.00016225246,0.0071104206],"study_design_scores_gemma":[0.00071051356,0.00071869226,0.98968095,0.00088395155,0.0000017266021,0.000018596218,0.0052176644,0.00019218125,0.0024339526,0.00009209989,0.000018029192,0.000031663614],"about_ca_topic_score_codex":0.065861166,"about_ca_topic_score_gemma":0.00197573,"teacher_disagreement_score":0.063885435,"about_ca_system_score_codex":0.00061712763,"about_ca_system_score_gemma":0.0010433662,"threshold_uncertainty_score":0.94035935},"labels":[],"label_agreement":null},{"id":"W2944233167","doi":"10.1158/1538-7445.sabcs18-p1-08-12","title":"Abstract P1-08-12: Trends in incidence of bilateral breast cancer: A Population-based comparative study of the United States and Japan","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Incidence (geometry); Cancer; Ductal carcinoma; Population; Epidemiology; Cancer registry; Lobular carcinoma; Gynecology; Demography; Internal medicine","score_opus":0.04945638446521396,"score_gpt":0.3952243812844308,"score_spread":0.3457679968192169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944233167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865115,0.0004038061,1.4460085e-7,0.00030896292,0.000039542887,0.0003399463,0.00021026994,0.0000022239067,0.000043935863],"genre_scores_gemma":[0.99956536,0.00013956882,0.0000032202101,0.000019510248,0.000023397419,0.00011948784,0.000054638625,0.000009570732,0.00006525688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988853,0.00013933433,0.00020647807,0.00027304,0.00028400656,0.00021188894],"domain_scores_gemma":[0.99934137,0.00005577449,0.0000952542,0.00027587652,0.00019695066,0.000034746285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018935642,0.00011205728,0.00021536922,0.00018200684,0.00005941347,0.0000091551055,0.00017905152,0.00004560697,0.00007077367],"category_scores_gemma":[0.000007954963,0.00007919757,0.000030448242,0.0004898825,0.00016104453,0.00000580504,0.00012952513,0.00012991024,4.5635844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050064863,0.00020231135,0.97522897,0.000043478387,0.000084990985,4.6865424e-7,0.0013936233,0.003185728,0.018387688,0.0000032880594,0.00008376473,0.0008850371],"study_design_scores_gemma":[0.001426332,0.00018242252,0.9859693,0.00010388921,0.0000102347,6.358289e-7,0.0014368944,0.00012259615,0.010629715,0.000008130109,0.000034818495,0.0000750321],"about_ca_topic_score_codex":0.07449649,"about_ca_topic_score_gemma":0.033825994,"teacher_disagreement_score":0.0406705,"about_ca_system_score_codex":0.00009592966,"about_ca_system_score_gemma":0.00012295292,"threshold_uncertainty_score":0.98380417},"labels":[],"label_agreement":null},{"id":"W2944243263","doi":"10.1158/0008-5472.can-18-2529","title":"Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Saskatchewan; Vancouver Coastal Health","funders":"National Cancer Institute","keywords":"Prostate cancer; Androgen receptor; Internal medicine; Endocrinology; Cancer research; Cancer; Prostate; Scavenger receptor; Metastasis; Downregulation and upregulation; Cholesterol; Androgen; Cancer cell; LDL receptor; Biology; Androgen deprivation therapy; Medicine; Lipoprotein; Hormone; Biochemistry","score_opus":0.034858753797607445,"score_gpt":0.34893242363519905,"score_spread":0.3140736698375916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944243263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737699,0.021772254,0.00001862596,0.00036132042,0.0022381074,0.0014553872,0.00031219207,0.0000055205755,0.000066697976],"genre_scores_gemma":[0.981565,0.009044849,0.00013147424,0.00016388236,0.0027347964,0.0009461916,0.00006375932,0.000056368597,0.0052936967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808854,0.00013784488,0.0003474407,0.0005988444,0.0003147846,0.000512559],"domain_scores_gemma":[0.9989518,0.000025700514,0.00010851091,0.00045230988,0.00034925598,0.000112418296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006991223,0.00017667099,0.00033097243,0.00018741096,0.00005770791,0.00003349099,0.00022329322,0.00015298334,0.0001413252],"category_scores_gemma":[0.00003713276,0.00017181547,0.00010055267,0.00025590378,0.00017268705,0.00002291207,0.00015331525,0.00016091115,0.000006212473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007784465,0.000034053817,0.0070847725,0.00021077797,0.00007080903,1.8607473e-8,0.0005976815,0.000040407354,0.96639967,0.00002810559,0.007622252,0.017133016],"study_design_scores_gemma":[0.004335767,0.00023157267,0.023427306,0.00017020792,0.000032855613,0.0000020485127,0.00021583386,0.00008372774,0.5560025,0.00008728634,0.41511115,0.00029974946],"about_ca_topic_score_codex":0.00047855184,"about_ca_topic_score_gemma":0.00066343986,"teacher_disagreement_score":0.41039714,"about_ca_system_score_codex":0.00006845463,"about_ca_system_score_gemma":0.0003431616,"threshold_uncertainty_score":0.7006431},"labels":[],"label_agreement":null},{"id":"W2944261841","doi":"10.1158/1538-7445.sabcs18-p5-12-01","title":"Abstract P5-12-01: A novel gene expression signature prognostic for both locoregional and distant failure and predictive for adjuvant radiotherapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Clinical endpoint; Oncology; Gene signature; Internal medicine; Proportional hazards model; Breast cancer; Adjuvant radiotherapy; Classifier (UML); Radiation therapy; Clinical trial; Gene expression; Cancer; Gene; Artificial intelligence; Computer science","score_opus":0.02842056067629882,"score_gpt":0.3395157816291571,"score_spread":0.31109522095285824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944261841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96655923,0.02240253,0.0051319413,0.0012866465,0.000121229314,0.002974777,0.0014878914,0.000011419652,0.000024304432],"genre_scores_gemma":[0.993817,0.001469081,0.001964864,0.00007775774,0.00039345492,0.0018253712,0.0002204654,0.00003933295,0.00019270345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987443,0.000019918614,0.000113436545,0.0005543066,0.00019994297,0.00036809195],"domain_scores_gemma":[0.9993596,0.00012919787,0.000047343692,0.0001921382,0.0001728461,0.00009887589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001818545,0.00016660876,0.00018775636,0.000044323875,0.00017048849,0.00003410712,0.00010604594,0.00014373849,0.0000127599815],"category_scores_gemma":[0.000048360173,0.00012845946,0.00005124473,0.000046956153,0.0001907993,0.000008427405,0.00008457057,0.00012599128,2.5606641e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027555304,0.000097308526,0.011216691,0.00024399614,0.00019771847,0.0000013155103,0.000212323,0.000032540116,0.97682434,0.00004368233,0.005998686,0.0023758486],"study_design_scores_gemma":[0.01951292,0.0036883494,0.20989531,0.0008094469,0.00011066223,0.000039659157,0.001045235,0.0006224319,0.6499053,0.00067967095,0.112781376,0.0009096447],"about_ca_topic_score_codex":0.000027539458,"about_ca_topic_score_gemma":0.00005401536,"teacher_disagreement_score":0.32691905,"about_ca_system_score_codex":0.000071960036,"about_ca_system_score_gemma":0.00014745875,"threshold_uncertainty_score":0.52384245},"labels":[],"label_agreement":null},{"id":"W2944299841","doi":"10.1158/1538-7445.am10-ssy01-03","title":"Abstract SSY01-03: An RNAi screen identifies a heme biosynthetic mediator as a novel radiosensitizing target for head and neck cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Radioresistance; Cancer research; Cancer; In vivo; Medicine; Head and neck cancer; Cancer cell; Radiosensitizer; Radiation therapy; Druggability; Biology; Gene; Internal medicine","score_opus":0.057386924615972876,"score_gpt":0.4142350562435477,"score_spread":0.3568481316275748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944299841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944741,0.0025339308,0.00006256811,0.0011588193,0.00022855605,0.00068989024,0.0005191221,0.000019766383,0.0003132098],"genre_scores_gemma":[0.9950061,0.0011492515,0.00069782976,0.00013920516,0.0014844479,0.00043055663,0.00013918153,0.00007386019,0.0008795769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748874,0.00006854053,0.00024425995,0.00075689564,0.0005448983,0.0008966612],"domain_scores_gemma":[0.9983199,0.00011476089,0.000056626053,0.0005494137,0.00049698655,0.00046226193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009842257,0.00022098889,0.00024570664,0.00016688733,0.00042709452,0.00019012493,0.00040574942,0.00026481977,0.00035763107],"category_scores_gemma":[0.00047532903,0.000203801,0.000098964265,0.00019477117,0.0005080448,0.000027185217,0.00025144368,0.0005448477,0.000021252194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036746988,0.00009233719,0.0010270643,0.00010982506,0.00007914035,0.0000145260865,0.000098089746,0.0000057169186,0.98842645,0.000073518655,0.0029935462,0.006712315],"study_design_scores_gemma":[0.0011479896,0.0003743835,0.0027263688,0.00008757013,0.000012840475,0.000013039637,0.0002745282,0.0001914649,0.9457041,0.00016527915,0.048994236,0.00030817252],"about_ca_topic_score_codex":0.0029275536,"about_ca_topic_score_gemma":0.004228264,"teacher_disagreement_score":0.04600069,"about_ca_system_score_codex":0.000044332577,"about_ca_system_score_gemma":0.0006873464,"threshold_uncertainty_score":0.8310764},"labels":[],"label_agreement":null},{"id":"W2944307483","doi":"10.1158/1538-7445.am2008-2098","title":"Abstract 2098: The effect of in utero folic acid supplementation on colorectal cancer risk in the offspring in a chemical carcinogen rodent model","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Offspring; Azoxymethane; Medicine; Physiology; Colorectal cancer; In utero; Pregnancy; Weaning; Population; Internal medicine; Homocysteine; Endocrinology; Cancer; Fetus; Biology; Environmental health","score_opus":0.07333845561791501,"score_gpt":0.42336423803019674,"score_spread":0.3500257824122817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944307483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961765,0.0007750621,8.758278e-7,0.0011590366,0.000022847033,0.0014565705,0.00003781628,0.000004228573,0.00036707884],"genre_scores_gemma":[0.99668723,0.0019753503,0.0000059630565,0.000042042775,0.00008459391,0.0011218822,0.000013461611,0.00001838499,0.000051114977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997269,0.00040723034,0.0003134461,0.00030435278,0.0011206002,0.00058540783],"domain_scores_gemma":[0.99903625,0.00047536482,0.000041388546,0.00029811595,0.00008313825,0.0000657138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023309886,0.00012757504,0.00027472607,0.0003946845,0.00007798139,0.000014114657,0.00033798555,0.00009001134,0.000114077455],"category_scores_gemma":[0.0001985014,0.00007358005,0.00006633645,0.0008501555,0.00021201285,0.00006564346,0.00009738816,0.0012680853,0.000008763229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029940698,0.00019514606,0.67766905,0.00018609756,0.000030223597,0.00020936703,0.0055963793,0.0022639302,0.30374104,0.0000082946435,0.00076988916,0.0063365255],"study_design_scores_gemma":[0.0027689247,0.0004130843,0.5370173,0.00018947436,0.0000069679413,0.000006979981,0.00025689308,0.0050816243,0.45414984,0.000015763137,0.000031534775,0.00006162092],"about_ca_topic_score_codex":0.03465587,"about_ca_topic_score_gemma":0.013297546,"teacher_disagreement_score":0.15040879,"about_ca_system_score_codex":0.0007813903,"about_ca_system_score_gemma":0.00041298982,"threshold_uncertainty_score":0.97177243},"labels":[],"label_agreement":null},{"id":"W2944311490","doi":"10.1158/1538-7445.sabcs18-pd1-10","title":"Abstract PD1-10: Randomized phase II study comparing two different schedules of palbociclib plus second line endocrine therapy in women with estrogen receptor positive, HER2 negative advanced/metastatic breast cancer: CCTG MA38 (NCT02630693)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Université du Québec à Montréal; Ontario Institute for Cancer Research","funders":"","keywords":"Palbociclib; Medicine; Tolerability; Internal medicine; Oncology; Population; Breast cancer; Metastatic breast cancer; Tamoxifen; Cancer; Adverse effect","score_opus":0.04480513330979158,"score_gpt":0.4114934981525055,"score_spread":0.36668836484271394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944311490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98681104,0.0044394284,0.000030455,0.0007003764,0.00016432958,0.007101096,0.00047213488,0.000065108994,0.00021605178],"genre_scores_gemma":[0.99228424,0.0013663248,0.00046113512,0.00008518745,0.00019728031,0.004000933,0.000045542405,0.00015205452,0.0014073029],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945344,0.00064645254,0.0010406247,0.0010319821,0.0013818468,0.0013647117],"domain_scores_gemma":[0.99641216,0.0009001187,0.00046598088,0.0008079837,0.0009818212,0.000431936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011575861,0.0006438281,0.0025252358,0.00061594363,0.00019569756,0.000050679868,0.000476155,0.000063341286,0.0075263726],"category_scores_gemma":[0.00008017704,0.00046475016,0.00016689612,0.0010738805,0.0007782459,0.00040840183,0.00022851577,0.0011991701,0.000024005203],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.768616,0.0051160823,0.019360228,0.0006472517,0.0026654731,0.0001132938,0.008643947,0.0024678493,0.09285336,0.000062215186,0.000024793182,0.099429496],"study_design_scores_gemma":[0.84841585,0.009793452,0.04055681,0.0028944407,0.0001281551,0.000043396594,0.012579775,0.0005775742,0.08356029,0.0003270445,0.00030655105,0.00081668614],"about_ca_topic_score_codex":0.002305618,"about_ca_topic_score_gemma":0.00096372905,"teacher_disagreement_score":0.09861281,"about_ca_system_score_codex":0.0020243318,"about_ca_system_score_gemma":0.0010399708,"threshold_uncertainty_score":0.9997804},"labels":[],"label_agreement":null},{"id":"W2944312218","doi":"10.1158/1538-7445.sabcs18-es4-2","title":"Abstract ES4-2: Treatment morbidity and quality of life considerations","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Brachytherapy; Radiation therapy; Breast cancer; Cosmesis; Toxicity; Oncology; Cancer; Surgery; Internal medicine","score_opus":0.17650396638699706,"score_gpt":0.45148941075872057,"score_spread":0.2749854443717235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944312218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351007,0.0036494513,0.000002139519,0.00066866307,0.000059591985,0.000248851,0.00012439066,0.000004345734,0.0017324911],"genre_scores_gemma":[0.99758273,0.0017344102,0.000047753023,0.000045988632,0.000100460704,0.00010388584,0.000019524276,0.0000091757665,0.00035609613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99915093,0.00007923804,0.00014653741,0.00026290034,0.00017219722,0.00018817936],"domain_scores_gemma":[0.9993325,0.00009336372,0.000041056577,0.0002744444,0.00018343847,0.00007523148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023201643,0.00008549636,0.00016380666,0.00003356562,0.0000836008,0.000012767897,0.00004769206,0.000056459674,0.00022583676],"category_scores_gemma":[0.00010851126,0.00007078386,0.00004014901,0.000053843898,0.00018096597,0.000003178457,0.000076036886,0.00005926259,0.000012917428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031113607,0.00019991395,0.3443554,0.000112540336,0.0003451612,0.0000012104827,0.00026014211,0.000037893322,0.6491003,0.00084180577,0.0023543315,0.0020801437],"study_design_scores_gemma":[0.0014975399,0.00021862611,0.7764998,0.000020016347,0.000009922619,0.0000010427804,0.00025026355,0.0000014192873,0.21711291,0.00019374808,0.0040777884,0.00011693188],"about_ca_topic_score_codex":0.0038081857,"about_ca_topic_score_gemma":0.0014198566,"teacher_disagreement_score":0.43214437,"about_ca_system_score_codex":0.00006040031,"about_ca_system_score_gemma":0.00030254474,"threshold_uncertainty_score":0.5756863},"labels":[],"label_agreement":null},{"id":"W2944312379","doi":"10.1158/1538-7445.sabcs18-p1-11-17","title":"Abstract P1-11-17: Effects of depression, anxiety, and sexual functioning on quality of life among young breast cancer patients in Mexico","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Anxiety; Medicine; Depression (economics); Quality of life (healthcare); Breast cancer; Hospital Anxiety and Depression Scale; Cohort; Sexual function; Cancer; Psychiatry; Internal medicine","score_opus":0.03419657793134967,"score_gpt":0.3700256155891563,"score_spread":0.33582903765780664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944312379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636626,0.0013785742,0.0000013561405,0.00012667017,0.00041132778,0.00070997607,0.00008475406,0.000012255555,0.0009088168],"genre_scores_gemma":[0.9988078,0.00045000078,0.0000012915029,0.00007434229,0.000116185336,0.00014529328,0.000016216594,0.000025255373,0.00036363397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767756,0.00018185147,0.0003748433,0.0004097779,0.000990614,0.00036532898],"domain_scores_gemma":[0.9985296,0.00032096443,0.0001390317,0.00034377616,0.00043040604,0.00023623082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008355418,0.00014017173,0.00042916508,0.00024224147,0.000054023127,0.0000138464,0.000113982016,0.00013739252,0.0003902189],"category_scores_gemma":[0.00020627474,0.00011906894,0.000049874194,0.00046683123,0.00017725829,0.00011443696,0.00010575107,0.00047736755,0.000002659761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013985168,0.00018297612,0.97877455,0.0020440728,0.00004467748,0.00000188194,0.0014135356,0.00005803828,0.008607283,0.000008803304,0.00097390433,0.006491748],"study_design_scores_gemma":[0.0025181184,0.00017758671,0.98841447,0.0011314651,0.000012223473,5.77045e-7,0.0007382007,0.000017987379,0.0067755175,0.000007540604,0.00009924731,0.000107056396],"about_ca_topic_score_codex":0.09613648,"about_ca_topic_score_gemma":0.03471836,"teacher_disagreement_score":0.06141812,"about_ca_system_score_codex":0.00029895076,"about_ca_system_score_gemma":0.00042946517,"threshold_uncertainty_score":0.9828955},"labels":[],"label_agreement":null},{"id":"W2944327584","doi":"10.1158/1538-7445.sabcs18-p1-16-03","title":"Abstract P1-16-03: Phase II randomized clinical trial (RCT) of metformin (MET) vs placebo (PLAC) in combination with chemotherapy (CXT) in refractory locally advanced (LABC) or metastatic breast cancer (MBC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Vinorelbine; Taxane; Breast cancer; Anthracycline; Placebo; Cancer; Gastroenterology; Capecitabine; Progression-free survival; Oncology; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.0490663747175627,"score_gpt":0.4299014474251756,"score_spread":0.3808350727076129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944327584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96954024,0.026212873,0.00005749442,0.00010221372,0.00036314645,0.0033124622,0.000121085184,0.000009259772,0.0002812039],"genre_scores_gemma":[0.9371982,0.05966879,0.00017072752,0.0002123826,0.00025033948,0.00148205,0.000091487986,0.00006777497,0.000858254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99556565,0.0010128323,0.0011267425,0.0007924834,0.000782224,0.0007200778],"domain_scores_gemma":[0.9977894,0.0005523813,0.00039826147,0.00061040354,0.0004631018,0.00018649452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060378416,0.00032436187,0.0012697433,0.00033060336,0.00006401319,0.00003150414,0.00042125996,0.00026337904,0.0013191646],"category_scores_gemma":[0.0004777556,0.00023922049,0.00020627741,0.0006259621,0.00046382807,0.000046293324,0.000107074564,0.0006806059,0.000008539763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74311423,0.001564448,0.0003411268,0.000200836,0.000247411,0.000009570698,0.00017242294,0.00012587024,0.022612626,0.00004239204,0.00046731677,0.23110174],"study_design_scores_gemma":[0.8977249,0.0045349775,0.00051819725,0.00043328485,0.00005899719,0.0000035599364,0.0003153568,0.00017903816,0.06819849,0.000102805665,0.027485399,0.00044498724],"about_ca_topic_score_codex":0.0011144474,"about_ca_topic_score_gemma":0.0027990465,"teacher_disagreement_score":0.23065674,"about_ca_system_score_codex":0.0003060999,"about_ca_system_score_gemma":0.00217063,"threshold_uncertainty_score":0.9995938},"labels":[],"label_agreement":null},{"id":"W2944332420","doi":"10.1158/1538-7445.sabcs18-p3-12-05","title":"Abstract P3-12-05: Fractionation patterns in adjuvant breast radiotherapy in Ontario, Canada from 2009 to 2015","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Ductal carcinoma; Stage (stratigraphy); Cohort; Breast-conserving surgery; Retrospective cohort study; Logistic regression; Cancer; Adjuvant radiotherapy; Internal medicine; Mastectomy; Oncology; Surgery","score_opus":0.024116805317899368,"score_gpt":0.3362768517908379,"score_spread":0.3121600464729385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944332420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950022,0.0011487611,0.0000082178885,0.0025319455,0.0002756227,0.00037546564,0.00032175373,0.0000031434274,0.00033288074],"genre_scores_gemma":[0.9979503,0.00032142602,0.000030753625,0.00032798277,0.00018277409,0.00019079435,0.00018209075,0.000020472813,0.00079341664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985707,0.000057385376,0.00017121382,0.00043555629,0.00037746617,0.00038771154],"domain_scores_gemma":[0.99944854,0.000035662193,0.000031782474,0.0002807188,0.000111868525,0.00009145112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018557248,0.00013087646,0.00016887955,0.0001125517,0.00003831401,0.000019545852,0.00017897892,0.00008472775,0.0011440961],"category_scores_gemma":[0.000011865853,0.00012845476,0.00002509294,0.00013327219,0.000020969628,0.000008886404,0.000066822664,0.00026703766,0.000016697688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005413516,0.000080216174,0.9307495,0.000009633857,0.000058943915,0.000019744433,0.00025356965,0.00056718197,0.042940293,0.0000016149905,0.017625958,0.007151997],"study_design_scores_gemma":[0.0011089086,0.00005450591,0.963251,0.000067334884,0.0000015777656,0.0000023036023,0.00016990199,0.0000055249384,0.005625789,0.000010581594,0.02956875,0.0001338137],"about_ca_topic_score_codex":0.9951583,"about_ca_topic_score_gemma":0.9993374,"teacher_disagreement_score":0.037314504,"about_ca_system_score_codex":0.001977186,"about_ca_system_score_gemma":0.0015131356,"threshold_uncertainty_score":0.999769},"labels":[],"label_agreement":null},{"id":"W2944338381","doi":"10.1158/1538-7445.sabcs18-p6-18-15","title":"Abstract P6-18-15: Ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled safety analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Letrozole; Fulvestrant; Anastrozole; Internal medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Goserelin; Cancer; Placebo; Tamoxifen; Oncology; Gynecology; Pathology","score_opus":0.03212609355398043,"score_gpt":0.39309888290963524,"score_spread":0.3609727893556548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944338381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761034,0.0108198915,0.000040333587,0.006671712,0.00021700136,0.0025282847,0.0011212685,0.00013300455,0.0023650613],"genre_scores_gemma":[0.9759604,0.01794764,0.0004137555,0.00049517583,0.0004096788,0.0011003764,0.000150337,0.00014047006,0.0033821873],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99431604,0.00036673574,0.0007749698,0.0013233679,0.0016024569,0.0016164437],"domain_scores_gemma":[0.99629956,0.0005853753,0.00024782584,0.0010458941,0.0013410569,0.0004803089],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009317345,0.0005505413,0.0013565582,0.0011899092,0.00021735195,0.000070158625,0.00054203573,0.00019997543,0.01341924],"category_scores_gemma":[0.00009952738,0.00048616895,0.00037231404,0.004785461,0.00050000375,0.00057423284,0.00017785754,0.0016788385,0.00022277566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040235337,0.0007938255,0.11120532,0.00021311718,0.0041383626,0.00015827677,0.002851621,0.002932361,0.4556781,0.000092991686,0.0007226132,0.38097808],"study_design_scores_gemma":[0.014968804,0.0006700472,0.9254397,0.0006804619,0.00015905077,0.000026565765,0.0014891124,0.00014210473,0.0441278,0.00021091141,0.011430141,0.00065526454],"about_ca_topic_score_codex":0.012572095,"about_ca_topic_score_gemma":0.0024250213,"teacher_disagreement_score":0.81423444,"about_ca_system_score_codex":0.002896655,"about_ca_system_score_gemma":0.0010606996,"threshold_uncertainty_score":0.999759},"labels":[],"label_agreement":null},{"id":"W2944351912","doi":"10.1158/1538-7445.sabcs18-p1-06-02","title":"Abstract P1-06-02: Mismatch repair protein loss in breast cancer: Clinicopathological associations in a large British Columbia cohort","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MSH2; Medicine; Breast cancer; MSH6; Oncology; Internal medicine; Cancer; Tissue microarray; MLH1; Microsatellite instability; PMS2; Pathology; Colorectal cancer; DNA mismatch repair; Biology","score_opus":0.04645354312944214,"score_gpt":0.3947208722629305,"score_spread":0.34826732913348835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944351912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907957,0.0012212814,3.5685576e-7,0.0016649654,0.00027835596,0.0035414703,0.0005968975,0.00009162289,0.0018093485],"genre_scores_gemma":[0.9898138,0.0010164947,0.000082163715,0.0002460822,0.00025032743,0.0025360936,0.000054344957,0.000057556015,0.005943125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995501,0.00035843774,0.00071459095,0.0009139789,0.0012905707,0.0012214174],"domain_scores_gemma":[0.998277,0.00027736256,0.00012067643,0.0005485659,0.0005083668,0.00026800824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033887015,0.00017556894,0.00068747456,0.0001909896,0.000121283636,0.00012986347,0.00032530222,0.00044091966,0.007961624],"category_scores_gemma":[0.00053535786,0.00023097507,0.0001574858,0.0011941137,0.00019425868,0.000105786814,0.00021772244,0.0019048967,0.00016613252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020458877,0.0005008331,0.9832899,0.00023958599,0.00003095531,0.00043424932,0.00016954035,0.00002331292,0.0051926235,0.0000042929682,0.008275317,0.0016347882],"study_design_scores_gemma":[0.0026948056,0.0001941347,0.9923042,0.0011173752,0.000011715294,0.000042811207,0.00013901484,0.00008265292,0.00023733865,0.00012208793,0.0028231074,0.00023077136],"about_ca_topic_score_codex":0.088652454,"about_ca_topic_score_gemma":0.29158172,"teacher_disagreement_score":0.20292927,"about_ca_system_score_codex":0.002752134,"about_ca_system_score_gemma":0.0018368978,"threshold_uncertainty_score":0.99294525},"labels":[],"label_agreement":null},{"id":"W2944355422","doi":"10.1158/1538-7445.sabcs18-p3-13-11","title":"Abstract P3-13-11: The outcomes of ReFilx soft tissue filler as an immediate reconstruction technique for lumpectomy followed by radiotherapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Lumpectomy; Medicine; Radiation therapy; Soft tissue; Breast cancer; Mastectomy; Breast-conserving surgery; Adjuvant radiotherapy; Breast tissue; Surgery; Cancer; Nuclear medicine; Radiology; Internal medicine","score_opus":0.03667046520013666,"score_gpt":0.39569394324550666,"score_spread":0.35902347804537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944355422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933501,0.0005878873,0.00015823392,0.0021148706,0.0007672401,0.0023173846,0.000109334986,0.000042710853,0.00055224495],"genre_scores_gemma":[0.99288946,0.0003109023,0.0006613322,0.00007270247,0.00040423794,0.0006505362,0.000065430046,0.000052538828,0.0048928554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984042,0.00009182937,0.00032047395,0.00033483875,0.0004358566,0.00041277646],"domain_scores_gemma":[0.99875546,0.00025872813,0.00012324433,0.00042182824,0.00030862386,0.00013213082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009612794,0.00015363065,0.00038027889,0.00020668645,0.00013548294,0.000025950734,0.00019192426,0.00021383709,0.0014302717],"category_scores_gemma":[0.000041714415,0.00009883695,0.000113430135,0.00025688784,0.00026119407,0.00015715139,0.000020561949,0.00041572744,0.000023559618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010751237,0.00007925045,0.029705802,0.00020039291,0.00018672623,0.000002905721,0.00022944766,0.0000017614061,0.7193705,0.000072560135,0.0090601705,0.2400154],"study_design_scores_gemma":[0.00882903,0.0016631358,0.059843536,0.0005347678,0.00010398945,0.004351938,0.0014539863,0.000113985065,0.8748818,0.0009186717,0.046763767,0.00054138637],"about_ca_topic_score_codex":0.0013782411,"about_ca_topic_score_gemma":0.00014255999,"teacher_disagreement_score":0.23947401,"about_ca_system_score_codex":0.00018408234,"about_ca_system_score_gemma":0.0003462553,"threshold_uncertainty_score":0.9994826},"labels":[],"label_agreement":null},{"id":"W2944359344","doi":"10.1158/1538-7445.sabcs18-p3-11-03","title":"Abstract P3-11-03: Validation of CIN4 in the DBCG 89D clinical cohort","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Anthracycline; Internal medicine; Oncology; Medicine; Proportional hazards model; Cohort; Breast cancer; Hazard ratio; Cancer; Confidence interval","score_opus":0.07944753603182644,"score_gpt":0.44816090040583867,"score_spread":0.36871336437401225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944359344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470407,0.0008698828,0.000008899624,0.00043118847,0.00020803777,0.00040943365,0.000035719095,0.0000015519693,0.0033312237],"genre_scores_gemma":[0.9965663,0.0025079562,0.00002068463,0.00015426143,0.00032858964,0.00006161957,0.0000570371,0.000012358678,0.000291214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988029,0.00012629139,0.0002695032,0.00027168498,0.000289931,0.00023967863],"domain_scores_gemma":[0.9990877,0.00017206317,0.00005718555,0.0004569527,0.0001809907,0.000045143024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019052053,0.0000684243,0.00012959691,0.00005062668,0.00003174084,0.00002416929,0.00033097845,0.000121462974,0.00015871522],"category_scores_gemma":[0.00024470224,0.000054085223,0.00006619099,0.00015241456,0.000114730145,0.0000027689905,0.000105938634,0.00022328904,0.000042936594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002355353,0.00015888673,0.763959,0.00007949065,0.0000418757,0.0000044243366,0.0001113114,0.00039561058,0.21379499,0.00031484422,0.016530726,0.004373334],"study_design_scores_gemma":[0.0013721798,0.0005205108,0.69740653,0.00008461319,0.0000132477435,0.000002530046,0.00029532102,0.00005251075,0.18827318,0.00030993499,0.11145838,0.00021103797],"about_ca_topic_score_codex":0.0008085947,"about_ca_topic_score_gemma":0.00049855944,"teacher_disagreement_score":0.09492765,"about_ca_system_score_codex":0.000035230034,"about_ca_system_score_gemma":0.00033369943,"threshold_uncertainty_score":0.22055314},"labels":[],"label_agreement":null},{"id":"W2944375397","doi":"10.1158/1538-7445.sabcs18-p1-17-03","title":"Abstract P1-17-03: Statin use, site of recurrence, and survival among post-menopausal women taking bisphosphonates as adjuvant therapy for breast cancer (SWOG S0307)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Statin; Internal medicine; Hazard ratio; Bisphosphonate; Oncology; Breast cancer; Proportional hazards model; Adjuvant therapy; Zoledronic acid; Adjuvant; Cancer; Confidence interval; Osteoporosis","score_opus":0.031633340828053885,"score_gpt":0.35703862179782664,"score_spread":0.3254052809697727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944375397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834957,0.011221371,0.0000046739483,0.00015089169,0.0019217575,0.0008945661,0.0020581956,0.0000099894405,0.00024284821],"genre_scores_gemma":[0.9779164,0.016603203,0.000045466822,0.00012025894,0.0017629508,0.00052967254,0.00011410334,0.000058004356,0.0028499118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977361,0.00009510318,0.00031157388,0.0006390587,0.0004508769,0.00076727977],"domain_scores_gemma":[0.9983471,0.00012823773,0.00018520444,0.00039241122,0.0007351222,0.00021190559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000836708,0.00023570721,0.00037926168,0.0001281627,0.00012902058,0.00008511697,0.00026476485,0.00017277586,0.0006942951],"category_scores_gemma":[0.00009366683,0.0002085622,0.000057491638,0.00023372099,0.0003094211,0.000032034022,0.00015167311,0.00027360526,0.0000060738917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021513072,0.00007086842,0.041770075,0.00016828816,0.00015112234,2.910065e-7,0.0006855472,0.00004329494,0.8989351,0.00004868221,0.005393763,0.050581664],"study_design_scores_gemma":[0.0033619278,0.0011649363,0.6103236,0.00024265004,0.000017680386,0.000004545383,0.00094423594,0.00002017275,0.15629314,0.000093871866,0.2269943,0.00053892366],"about_ca_topic_score_codex":0.009434837,"about_ca_topic_score_gemma":0.0024028707,"teacher_disagreement_score":0.742642,"about_ca_system_score_codex":0.00009921106,"about_ca_system_score_gemma":0.00077516434,"threshold_uncertainty_score":0.99716145},"labels":[],"label_agreement":null},{"id":"W2944381671","doi":"10.1158/1538-7445.sabcs18-p4-09-02","title":"Abstract P4-09-02: Validation of iPrevent using the prospective family study cohort (ProF-SC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Ibis; Quartile; Cohort; Receiver operating characteristic; Breast cancer; Incidence (geometry); Demography; Cancer; Internal medicine; Confidence interval; Mathematics","score_opus":0.07162023648134797,"score_gpt":0.42971227399537226,"score_spread":0.3580920375140243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944381671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953432,0.00087842846,0.00007747184,0.00010142963,0.00023550096,0.001961917,0.000026947686,0.0000050942417,0.0013699753],"genre_scores_gemma":[0.9984618,0.000114992414,0.000062553445,0.000020614782,0.00021116149,0.0003536326,0.00001493069,0.000025944119,0.0007343778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839723,0.00017704576,0.00021797512,0.00040398346,0.00053596206,0.00026779572],"domain_scores_gemma":[0.9986809,0.000036084628,0.00008617791,0.0005868705,0.00057162106,0.000038359485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011862617,0.00010402986,0.00013184335,0.00006772762,0.0001279171,0.000031797972,0.00033784955,0.00007938841,0.0001355026],"category_scores_gemma":[0.00006422846,0.000081494276,0.000054578686,0.00029550213,0.00013926609,0.0000076110523,0.00018705252,0.00023286502,0.000018553897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008272166,0.00011889048,0.20101121,0.000025837595,0.00015289648,6.1723756e-7,0.00043431678,0.0017916809,0.7949374,0.000017910905,0.0005874659,0.0008391002],"study_design_scores_gemma":[0.00053914427,0.000299087,0.3159125,0.000029224806,0.00002169188,0.0000011228302,0.0016445149,0.000045548404,0.68002665,0.000096226846,0.0012694292,0.00011488119],"about_ca_topic_score_codex":0.0007489778,"about_ca_topic_score_gemma":0.00008015885,"teacher_disagreement_score":0.1149107,"about_ca_system_score_codex":0.00032243697,"about_ca_system_score_gemma":0.00076769583,"threshold_uncertainty_score":0.332324},"labels":[],"label_agreement":null},{"id":"W2944418782","doi":"10.1158/1538-7445.am2008-3839","title":"Abstract 3839: Is recent decline in breast cancer incidence equal across different US racial groups?","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Demography; Incidence (geometry); Medicine; Cancer; Epidemiology; Population; Quarter (Canadian coin); Gynecology; Internal medicine; Geography","score_opus":0.06702704243182409,"score_gpt":0.4211726302552994,"score_spread":0.35414558782347527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944418782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874791,0.009491667,0.000022343807,0.0017479258,0.00024628607,0.00029883668,0.0006122506,0.000009239774,0.00009233573],"genre_scores_gemma":[0.9471006,0.050409455,0.000016665483,0.00072574103,0.0011381732,0.00026134035,0.0000862455,0.0000295674,0.00023221463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976645,0.00010814147,0.00030217622,0.00058942294,0.0005849773,0.00075078564],"domain_scores_gemma":[0.9987562,0.000025377589,0.00005504988,0.00040510614,0.00044979082,0.00030852263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033939045,0.00018833575,0.00019570516,0.00007782373,0.00026058365,0.000044052962,0.00038891318,0.00018313859,0.00060724217],"category_scores_gemma":[0.0000759466,0.00018047265,0.0000832845,0.00024431196,0.00037197946,0.000009411993,0.00033874335,0.0003092757,0.000021235468],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024654977,0.0009197144,0.39973527,0.00015860211,0.00005677627,0.00009250501,0.00086407067,0.00009015943,0.5650616,0.000011034614,0.013982894,0.016561843],"study_design_scores_gemma":[0.0025206283,0.00012077812,0.8335761,0.00009587101,0.0000059442946,0.00001755297,0.00014292804,0.000016407483,0.1317638,0.00021120877,0.031184021,0.00034476808],"about_ca_topic_score_codex":0.0019213272,"about_ca_topic_score_gemma":0.0049913637,"teacher_disagreement_score":0.4338408,"about_ca_system_score_codex":0.00019851053,"about_ca_system_score_gemma":0.0005581116,"threshold_uncertainty_score":0.7359461},"labels":[],"label_agreement":null},{"id":"W2944432584","doi":"10.1158/1538-7445.sabcs18-p2-08-13","title":"Abstract P2-08-13: Survival in women with de novo metastatic breast cancer: Comparison of real-world evidence from publicly-funded Canadian province and the United States by insurance status","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Cohort; Breast cancer; Death certificate; Hazard ratio; Cancer; Epidemiology; Population; Demography; Proportional hazards model; Surveillance, Epidemiology, and End Results; Cancer registry; Family medicine; Internal medicine; Cause of death; Disease; Environmental health; Confidence interval","score_opus":0.07612721781407533,"score_gpt":0.33720284596468153,"score_spread":0.2610756281506062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944432584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274136,0.0073927576,0.000011845358,0.0029945653,0.00013153658,0.0008161841,0.004287001,0.000011668956,0.0016130668],"genre_scores_gemma":[0.98630315,0.012561683,0.00003108067,0.00022390512,0.000051985524,0.00028851876,0.000035011934,0.000043514123,0.00046113704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970765,0.0001249697,0.00074916234,0.0006261983,0.00017101344,0.0012521165],"domain_scores_gemma":[0.9976229,0.00079068413,0.0004109931,0.00051805866,0.00021878332,0.00043856286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002317875,0.00023741815,0.0008573041,0.00065183,0.00014459495,0.00022844749,0.0005720624,0.00008225018,0.0008261153],"category_scores_gemma":[0.00015601474,0.0002059748,0.000036708756,0.0010789878,0.0006040329,0.0006580125,0.0000893014,0.0006709121,0.000034854034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015554131,0.000054230084,0.98762244,0.0001333792,0.00010973144,0.0000041232934,0.002828111,0.0020106125,0.000045769197,0.0022216944,0.0008507332,0.0025637846],"study_design_scores_gemma":[0.0027835919,0.000102095095,0.9841894,0.00031731543,0.00000500354,6.8963226e-7,0.0013078778,0.0013663609,0.00011974464,0.002279362,0.0072230874,0.00030549386],"about_ca_topic_score_codex":0.97028446,"about_ca_topic_score_gemma":0.9129529,"teacher_disagreement_score":0.057331596,"about_ca_system_score_codex":0.002572415,"about_ca_system_score_gemma":0.0016625284,"threshold_uncertainty_score":0.90453833},"labels":[],"label_agreement":null},{"id":"W2944434572","doi":"10.1158/0008-5472.can-18-0189","title":"A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Myeloid leukemia; Antibody; Cancer research; Haematopoiesis; Epitope; Stem cell; Myeloid; Leukemia; T cell; Immunology; Immune system; Biology; Medicine; Cell biology","score_opus":0.029476369615721087,"score_gpt":0.37553475870149605,"score_spread":0.34605838908577496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944434572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918575,0.0003621971,0.00006447186,0.0013867517,0.00017574453,0.0015798147,0.000038046266,0.000019160509,0.004516268],"genre_scores_gemma":[0.98620766,0.00089202955,0.00026056689,0.00035057336,0.00022414255,0.00023561248,0.00011967393,0.000055188437,0.011654523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967031,0.0002933062,0.00035404766,0.00082631136,0.0008788015,0.00094441813],"domain_scores_gemma":[0.998275,0.000060932372,0.000041794465,0.0008398157,0.00044425903,0.00033819288],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011475381,0.00022030783,0.0002955944,0.0004441952,0.00010719649,0.00010615117,0.00062094175,0.0003058299,0.0009749563],"category_scores_gemma":[0.00021507077,0.00020251388,0.00009242371,0.0009966418,0.00010914175,0.000009544426,0.0003522462,0.00073706557,0.0017036563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010353993,0.000077197634,0.0008908808,0.000053854765,0.00004610556,0.000035664114,0.00013958337,0.0003632067,0.9890614,0.00008511736,0.0049149613,0.0032966149],"study_design_scores_gemma":[0.0014198087,0.0008474941,0.00505732,0.00012007764,0.0000030818167,0.0000026413418,0.000044896406,0.00042752243,0.88929284,0.000047774236,0.1024544,0.00028212267],"about_ca_topic_score_codex":0.00028439803,"about_ca_topic_score_gemma":0.00015652296,"teacher_disagreement_score":0.09976856,"about_ca_system_score_codex":0.0003612348,"about_ca_system_score_gemma":0.0007233123,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2944436740","doi":"10.1158/1538-7445.sabcs18-ot2-07-03","title":"Abstract OT2-07-03: Trastuzumab deruxtecan (DS-8201a) vs ado-trastuzumab emtansine (T-DM1) for subjects with HER2-positive, unresectable and/or metastatic breast cancer who previously received trastuzumab and a taxane: A phase 3, randomized study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Trastuzumab; Trastuzumab emtansine; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Antibody-drug conjugate; Population; Breast cancer; Cancer; Antibody; Immunology; Monoclonal antibody","score_opus":0.061201817016351676,"score_gpt":0.4287969098125477,"score_spread":0.367595092796196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944436740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600579,0.007433372,0.00014307119,0.0031981268,0.00020583092,0.026996424,0.0011347965,0.00015620209,0.0006742435],"genre_scores_gemma":[0.9739064,0.00686515,0.0005010337,0.0002411048,0.00044535234,0.011659885,0.00011336837,0.00038983315,0.005877904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98818946,0.0016797134,0.0013455916,0.0024925324,0.003234022,0.0030587066],"domain_scores_gemma":[0.99043196,0.0039140536,0.00040502506,0.0013313077,0.0023829618,0.0015346791],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006671468,0.0011009924,0.0033998883,0.0011273645,0.0007692787,0.00054426916,0.0007155894,0.00030048707,0.0033082967],"category_scores_gemma":[0.0011487615,0.0007938383,0.00029908036,0.001867568,0.0015790723,0.0006397345,0.00030987037,0.002177374,0.00005790012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85409534,0.0067043225,0.008849496,0.009737543,0.0052656536,0.0015542445,0.016663566,0.00011320079,0.020611849,0.00004991555,0.0071362774,0.069218576],"study_design_scores_gemma":[0.8576787,0.043279182,0.04197618,0.012847302,0.0026390508,0.0016085531,0.020324722,0.0028676842,0.009628211,0.00019077933,0.0042501246,0.0027094749],"about_ca_topic_score_codex":0.019346494,"about_ca_topic_score_gemma":0.014329076,"teacher_disagreement_score":0.066509105,"about_ca_system_score_codex":0.0026890566,"about_ca_system_score_gemma":0.0068794643,"threshold_uncertainty_score":0.9994513},"labels":[],"label_agreement":null},{"id":"W2944452750","doi":"10.1158/1538-7445.sabcs18-pd3-12","title":"Abstract PD3-12: Central nervous system as first site of relapse in patients with HER2 positive early breast cancer treated in the BCIRG-006 trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Breast cancer; Regimen; Oncology; Adjuvant; Population; Randomized controlled trial; Univariate analysis; Cancer; Multivariate analysis","score_opus":0.012394742471157356,"score_gpt":0.2921907497677226,"score_spread":0.27979600729656523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944452750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615383,0.0005367948,1.6086773e-7,0.000326206,0.00011680892,0.0014347574,0.0005341339,0.0000059765594,0.00089131674],"genre_scores_gemma":[0.9989783,0.00015818614,0.0000020690857,0.000029370976,0.00014525885,0.00041679826,0.00009858616,0.00003088883,0.00014053809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979123,0.00020001199,0.00026918386,0.0004791726,0.0005437929,0.00059555034],"domain_scores_gemma":[0.999109,0.000065788736,0.00010301535,0.00040507334,0.0002473887,0.000069715534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002792298,0.00020687324,0.00029626355,0.000113482616,0.000084157495,0.000030100438,0.0002664412,0.00013600796,0.00005690398],"category_scores_gemma":[0.000015818223,0.00014002704,0.00006752963,0.00037048245,0.00016346105,0.000014647863,0.00009721012,0.00028224062,0.000016109054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037896067,0.0004326705,0.9576368,0.000111148685,0.0001731843,0.000022951916,0.0010042705,0.0001850287,0.0012963592,0.000012793049,0.00028397102,0.0009448015],"study_design_scores_gemma":[0.019692888,0.00076554826,0.9762572,0.0003866296,0.000020007443,0.0000027773274,0.00033762748,0.0000022338397,0.0022644086,0.0000015572942,0.00011787541,0.00015121394],"about_ca_topic_score_codex":0.059049398,"about_ca_topic_score_gemma":0.015084656,"teacher_disagreement_score":0.043964744,"about_ca_system_score_codex":0.0004769428,"about_ca_system_score_gemma":0.00027439394,"threshold_uncertainty_score":0.94721645},"labels":[],"label_agreement":null},{"id":"W2944461353","doi":"10.1158/1538-7445.sabcs18-p6-18-14","title":"Abstract P6-18-14: Patient-reported outcomes with ribociclib-based therapy in hormone receptor-positive, HER2-negative advanced breast cancer: results from the phase III MONALEESA-2, -3, and -7 trials","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Goserelin; Fulvestrant; Anastrozole; Breast cancer; Clinical endpoint; Oncology; Cancer; Placebo; Aromatase inhibitor; Metastatic breast cancer; Progression-free survival; Palbociclib; Clinical trial; Chemotherapy; Estrogen receptor; Aromatase; Pathology","score_opus":0.07544344919931267,"score_gpt":0.4165428332646931,"score_spread":0.34109938406538043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944461353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97550267,0.005920408,0.000014957708,0.010336431,0.00019288911,0.0044165286,0.0032345692,0.00008062898,0.00030094516],"genre_scores_gemma":[0.99291044,0.0036033683,0.00033806197,0.0007610497,0.0002452615,0.0013225002,0.00022866779,0.00011679967,0.00047385332],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944504,0.00068419107,0.0011400618,0.0011758748,0.0015778738,0.00097162125],"domain_scores_gemma":[0.99324113,0.0037408378,0.00064793666,0.0009790645,0.0010523524,0.00033868037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019076798,0.00052919786,0.0013949652,0.00028098747,0.00025433162,0.00008530543,0.0003413646,0.00019708538,0.0010706523],"category_scores_gemma":[0.00048980303,0.00032084962,0.00016222028,0.0010026606,0.00073457806,0.0003814069,0.00008836481,0.0012662114,0.000018657358],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26216808,0.0012746926,0.081058815,0.00006677047,0.0015732896,0.00015757045,0.00602162,0.0006228414,0.17598172,0.00001454323,0.0010530263,0.47000703],"study_design_scores_gemma":[0.14363165,0.0024592325,0.79055935,0.0017838785,0.00009035809,0.000017455688,0.0031862569,0.000080608115,0.05187332,0.00022834212,0.0054059178,0.00068362174],"about_ca_topic_score_codex":0.021617627,"about_ca_topic_score_gemma":0.0017576466,"teacher_disagreement_score":0.70950055,"about_ca_system_score_codex":0.000974378,"about_ca_system_score_gemma":0.001360949,"threshold_uncertainty_score":0.99992436},"labels":[],"label_agreement":null},{"id":"W2944463051","doi":"10.1158/1538-7445.sabcs18-p6-19-01","title":"Abstract P6-19-01: Evaluation of multiple transcriptomic gene risk signatures in male breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Proportional hazards model; Hazard ratio; Cancer; Gene signature; Risk assessment; Subtyping; Gene; Confidence interval; Gene expression; Biology; Genetics","score_opus":0.05220204195692116,"score_gpt":0.3976965253514153,"score_spread":0.3454944833944942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944463051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851615,0.012252568,0.000018176703,0.00023288316,0.00030782024,0.0007963104,0.00057746255,0.0000052411037,0.0006480586],"genre_scores_gemma":[0.99620056,0.0023054762,0.00008831897,0.000046335736,0.00025337838,0.000522532,0.000059004084,0.00003504286,0.0004893647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977992,0.00027890253,0.00027096388,0.00049930526,0.0007551397,0.00039649976],"domain_scores_gemma":[0.99868625,0.000051278243,0.00009247299,0.0004709755,0.00061773136,0.000081299026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017418513,0.0001370699,0.00017089995,0.00019130656,0.0000639596,0.000019100145,0.00033762632,0.00021030802,0.00285493],"category_scores_gemma":[0.000114500086,0.00013701264,0.0000781418,0.00035596147,0.00014461312,0.0000106519,0.00006519316,0.00037296567,0.000018683804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000334602,0.00006127865,0.06607723,0.0000720294,0.000055728804,8.2861396e-7,0.00026376167,0.04046187,0.8798274,0.000002997389,0.0037834637,0.0090588005],"study_design_scores_gemma":[0.0023234508,0.00006534015,0.38292688,0.000070074195,0.000026492224,0.0000028766424,0.00023533833,0.0018316201,0.60918176,0.000078526886,0.0030571017,0.0002005369],"about_ca_topic_score_codex":0.0052241525,"about_ca_topic_score_gemma":0.008318564,"teacher_disagreement_score":0.31684965,"about_ca_system_score_codex":0.0005896572,"about_ca_system_score_gemma":0.001851051,"threshold_uncertainty_score":0.9980566},"labels":[],"label_agreement":null},{"id":"W2944539547","doi":"10.1158/0008-5472.sabcs12-p4-16-06","title":"Abstract P4-16-06: Radiotherapy to the Primary Tumor Is Associated with Improved Survival in Stage IV Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Surveillance, Epidemiology, and End Results; Retrospective cohort study; Univariate analysis; Radiation therapy; Proportional hazards model; Population; Hazard ratio; Cancer; Stage (stratigraphy); Epidemiology; External beam radiotherapy; Multivariate analysis; Oncology; Internal medicine; Surgery; Cancer registry; Confidence interval; Brachytherapy","score_opus":0.033043927656745166,"score_gpt":0.3540821383172141,"score_spread":0.3210382106604689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944539547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860699,0.0071077603,0.00001505881,0.00463012,0.0001653763,0.00067408796,0.0007223934,0.000014079999,0.00060117594],"genre_scores_gemma":[0.99445826,0.0010902144,0.000021145606,0.0011458389,0.000710071,0.0009587987,0.000055818888,0.000059734153,0.0015000986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978085,0.0001640336,0.00018223865,0.00044543343,0.00046642896,0.00093335396],"domain_scores_gemma":[0.9989802,0.000068816764,0.00006685703,0.000453231,0.00025246837,0.00017838285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007809302,0.00022980542,0.00025952648,0.00008094456,0.00020438248,0.000044599175,0.0003525801,0.00009206771,0.00033545823],"category_scores_gemma":[0.00003586413,0.00015359436,0.00005871984,0.0004288898,0.00018869231,0.000014168693,0.00016007049,0.00031963905,0.000011315525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023662362,0.00053333293,0.65489084,0.00008064066,0.0009819134,0.0000134482425,0.0016018789,0.00007702969,0.30067846,0.000014674049,0.027261185,0.0115003465],"study_design_scores_gemma":[0.0017982454,0.00010675479,0.9480587,0.000083966836,0.00001433711,0.000004755151,0.0003099594,0.0000034449126,0.023922894,0.0000023721054,0.025432775,0.00026175092],"about_ca_topic_score_codex":0.008275449,"about_ca_topic_score_gemma":0.012715305,"teacher_disagreement_score":0.2931679,"about_ca_system_score_codex":0.00092707475,"about_ca_system_score_gemma":0.0005187489,"threshold_uncertainty_score":0.9983285},"labels":[],"label_agreement":null},{"id":"W2944544993","doi":"10.1158/1538-7445.sabcs18-p3-12-02","title":"Abstract P3-12-02: Intraoperative radiotherapy outcomes in early-stage breast cancer: A study in elderly Canadian women","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Breast-conserving surgery; Radiation therapy; Intraoperative radiation therapy; Mastectomy; Cancer; Stage (stratigraphy); Surgery; Cohort; Internal medicine; Oncology","score_opus":0.028228268100631195,"score_gpt":0.3694098563659689,"score_spread":0.34118158826533773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944544993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499696,0.0011806061,3.483777e-7,0.0014106716,0.00016051094,0.0013188263,0.00034372395,0.000008081587,0.00058026565],"genre_scores_gemma":[0.99513656,0.0011213063,0.0000071801596,0.00017297118,0.00014084148,0.0017338803,0.000014167838,0.00004868969,0.0016243866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735886,0.00019839419,0.00027690103,0.00071283104,0.00037605487,0.0010769675],"domain_scores_gemma":[0.9990377,0.000045028784,0.000042971576,0.0004777914,0.00015283113,0.00024369216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056740374,0.00026841988,0.00040710246,0.0003735589,0.000112205504,0.000069090725,0.00039154929,0.00013959777,0.00071577705],"category_scores_gemma":[0.000019626275,0.00023855531,0.00005068637,0.00040131228,0.00013418678,0.000018515586,0.000098703866,0.00044195968,0.000027126349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054375466,0.00027398934,0.98055416,0.000025238316,0.00024845364,0.000054987573,0.0052662883,0.00019052262,0.007519953,0.0000070962897,0.00020146757,0.0051140683],"study_design_scores_gemma":[0.0032873526,0.00049873587,0.9885214,0.00004996273,0.0000029566847,0.0000018275414,0.0040873187,0.0000051710913,0.0012165635,0.0000075828693,0.002058058,0.00026305555],"about_ca_topic_score_codex":0.57007897,"about_ca_topic_score_gemma":0.8407146,"teacher_disagreement_score":0.2706356,"about_ca_system_score_codex":0.0020104859,"about_ca_system_score_gemma":0.0013791192,"threshold_uncertainty_score":0.9728003},"labels":[],"label_agreement":null},{"id":"W2944565413","doi":"10.1158/1538-7445.sabcs18-p1-16-05","title":"Abstract P1-16-05: Prognosis and survival in metastatic breast cancer – Ten years in review, a population-based analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Cohort; Internal medicine; Oncology; Cancer; Hormonal therapy; Systemic therapy; Population","score_opus":0.058699294286680234,"score_gpt":0.4305917263851753,"score_spread":0.37189243209849504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944565413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741677,0.019889768,0.0000067331557,0.004217606,0.00006616189,0.0013742001,0.00013272492,0.000022375842,0.00012274372],"genre_scores_gemma":[0.99441785,0.0038944536,0.00012371103,0.00036494038,0.000062143015,0.00080209324,0.000056633977,0.000040182334,0.0002380011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742556,0.0002002263,0.00041807722,0.00055160385,0.00083247427,0.00057206105],"domain_scores_gemma":[0.99887854,0.00024717845,0.000093587,0.0003874962,0.0002259388,0.00016728354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012378118,0.00018127722,0.0007291736,0.0009380693,0.000034004515,0.000026570353,0.00015417053,0.00006128664,0.0020534634],"category_scores_gemma":[0.00008314304,0.00016145893,0.00010114949,0.002953275,0.00010550696,0.00016135251,0.000048359532,0.000545936,0.0000173759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043640388,0.00011378416,0.9416494,0.0013175566,0.00023603874,0.000039327628,0.00011653702,0.0006304586,0.00072356453,0.0000111139725,0.00006608563,0.054659754],"study_design_scores_gemma":[0.001912698,0.00004618982,0.9940492,0.0024420065,0.00014167906,0.000003906388,0.0001486333,0.0002649342,0.00009374459,0.00004996705,0.0006832699,0.00016378425],"about_ca_topic_score_codex":0.028746285,"about_ca_topic_score_gemma":0.016460191,"teacher_disagreement_score":0.054495968,"about_ca_system_score_codex":0.0011282206,"about_ca_system_score_gemma":0.0005423374,"threshold_uncertainty_score":0.9988588},"labels":[],"label_agreement":null},{"id":"W2944568068","doi":"10.1158/1538-7445.sabcs18-p1-03-07","title":"Abstract P1-03-07: Breast cancer diagnosis is associated with relative left ventricular hypertrophy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Breast cancer; Ejection fraction; Diabetes mellitus; Cancer; Prospective cohort study; Cardiac magnetic resonance imaging; Magnetic resonance imaging; Radiology; Heart failure; Endocrinology","score_opus":0.03426821671327803,"score_gpt":0.3578905570587776,"score_spread":0.3236223403454996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944568068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978237,0.0059279655,0.0000030864333,0.007594687,0.00029463586,0.0007888714,0.00053577183,0.00007168219,0.0065463274],"genre_scores_gemma":[0.9936217,0.0015069712,0.000017361122,0.0006720186,0.00039166072,0.00039170968,0.000047413574,0.000068298315,0.003282833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719286,0.00010563299,0.00020883037,0.00051599665,0.001230551,0.0007461146],"domain_scores_gemma":[0.99744135,0.0008061619,0.0000764011,0.00046913067,0.00089179754,0.00031517626],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00049515994,0.00021000749,0.00045837686,0.00023219261,0.00016179295,0.00006800458,0.00014880368,0.00014702561,0.006035965],"category_scores_gemma":[0.00038116507,0.0001625729,0.00015835119,0.0006219635,0.00021689331,0.00015489805,0.00008198564,0.0009573339,0.00082833506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000310748,0.00023669265,0.9231966,0.000114953466,0.000528976,0.0005185251,0.0004206151,0.000072678726,0.00074570073,0.000025159832,0.071584016,0.0022453126],"study_design_scores_gemma":[0.002851176,0.00021839248,0.9695214,0.0016383831,0.0001973276,0.000063106025,0.00018910259,0.00004753925,0.0046898453,0.000044787976,0.02025684,0.00028210125],"about_ca_topic_score_codex":0.0030437035,"about_ca_topic_score_gemma":0.0000649909,"teacher_disagreement_score":0.051327176,"about_ca_system_score_codex":0.0009813666,"about_ca_system_score_gemma":0.000808686,"threshold_uncertainty_score":0.99994963},"labels":[],"label_agreement":null},{"id":"W2944583748","doi":"10.1158/1538-7445.sabcs18-gs3-02","title":"Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Université du Québec à Montréal","funders":"","keywords":"Palbociclib; Letrozole; Medicine; Oncology; Breast cancer; Internal medicine; Cancer; Metastatic breast cancer; Tamoxifen","score_opus":0.07886522984097512,"score_gpt":0.4758817732521635,"score_spread":0.3970165434111884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944583748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923299,0.0025806355,0.000025500356,0.0015892986,0.00006463347,0.003203893,0.0000138287905,0.000017586774,0.00017472699],"genre_scores_gemma":[0.99869907,0.0002045488,0.00013428285,0.00028008723,0.0001539724,0.00022044462,0.0000015093449,0.000035675115,0.00027043273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979646,0.00023816536,0.00027840948,0.00046882575,0.00066041254,0.00038955576],"domain_scores_gemma":[0.9983106,0.0005614605,0.00007350998,0.0004611882,0.0003612799,0.00023196192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009112315,0.00017197897,0.00056970585,0.00010441749,0.00011885589,0.000032168937,0.00014860569,0.000031778403,0.000058493268],"category_scores_gemma":[0.00010912438,0.00009710338,0.000032113625,0.00029417584,0.00059494475,0.00007643292,0.00015423787,0.0006276286,0.000012771585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043150727,0.00029518286,0.96561515,0.00032717167,0.0002721543,0.000024925943,0.004761864,0.000014131347,0.0077913115,0.000032911543,0.000095901356,0.016454233],"study_design_scores_gemma":[0.006917417,0.0030611018,0.97896105,0.0006881917,0.000041872874,0.000016028212,0.004628081,0.000020507301,0.004340665,0.000033105218,0.0011655575,0.00012639316],"about_ca_topic_score_codex":0.00036407312,"about_ca_topic_score_gemma":0.00039191477,"teacher_disagreement_score":0.016327841,"about_ca_system_score_codex":0.000053853848,"about_ca_system_score_gemma":0.0002455314,"threshold_uncertainty_score":0.3959761},"labels":[],"label_agreement":null},{"id":"W2944617781","doi":"10.1158/1538-7445.sabcs18-p5-07-04","title":"Abstract P5-07-04: Not presented","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; University of British Columbia; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Chatterjee; Medicine; Cancer; Eaves; Breast cancer; Internal medicine; Philosophy; History; Archaeology","score_opus":0.056671775062242864,"score_gpt":0.4000082597435993,"score_spread":0.34333648468135647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944617781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860627,0.0022489917,0.00000401355,0.0019769783,0.00024278378,0.0003559701,0.00006845573,0.000016353171,0.009023741],"genre_scores_gemma":[0.9915925,0.0008575439,0.000026079499,0.00015598325,0.00044503395,0.00021345308,0.000048737293,0.000030285319,0.0066303806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984728,0.000058581107,0.00012425912,0.000458412,0.00039555898,0.0004903521],"domain_scores_gemma":[0.99908715,0.000039388153,0.000029902867,0.00049673225,0.0002506763,0.00009612378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559347,0.00013144006,0.00013943654,0.000060712988,0.000112537324,0.00003152183,0.0002781643,0.00010197687,0.0007739378],"category_scores_gemma":[0.000058533216,0.0001154601,0.00006828148,0.00014156556,0.0001437363,0.000004808886,0.0002647031,0.00020451038,0.00076204893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006889918,0.00012668336,0.048833236,0.000097774115,0.00028143686,0.000011036627,0.00012760823,0.000052469615,0.8910509,0.000116381794,0.05160991,0.0070035956],"study_design_scores_gemma":[0.0015229456,0.00017282102,0.23235905,0.00006438118,0.000011247446,0.000004628496,0.00021484072,0.000005371564,0.52801234,0.00006364861,0.23731129,0.0002574197],"about_ca_topic_score_codex":0.0007665491,"about_ca_topic_score_gemma":0.00016696996,"teacher_disagreement_score":0.3630385,"about_ca_system_score_codex":0.00008991524,"about_ca_system_score_gemma":0.00020370811,"threshold_uncertainty_score":0.97948515},"labels":[],"label_agreement":null},{"id":"W2944621427","doi":"10.1158/1538-7445.sabcs18-p4-16-12","title":"Abstract P4-16-12: Does initial cardiac imaging impact clinical outcomes in patients with breast cancer?","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Ejection fraction; Internal medicine; Cardiac function curve; Cardiology; Stage (stratigraphy); Medical record; Cancer; Radiology; Heart failure","score_opus":0.04440893124589015,"score_gpt":0.4652725231513338,"score_spread":0.42086359190544365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944621427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297094,0.00044834398,9.857192e-7,0.0013128301,0.0009794302,0.00088645244,0.00057801115,0.000043522177,0.0027794957],"genre_scores_gemma":[0.9983677,0.0002202418,0.000013222711,0.00025451093,0.0006449482,0.00010911504,0.000054396514,0.000059311373,0.0002765488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969709,0.00016746495,0.00040615103,0.00052706373,0.0010942417,0.0008341648],"domain_scores_gemma":[0.9975475,0.0008490503,0.00007394977,0.00056474016,0.00059473905,0.00037003544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010963848,0.000226267,0.00071622914,0.0003118918,0.00007276718,0.000083560015,0.00016547638,0.000094018076,0.0010555286],"category_scores_gemma":[0.00035102334,0.00013949767,0.00026627933,0.00034872256,0.00026795827,0.00019364034,0.00012002152,0.0011451307,0.000112996495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011813581,0.00025640073,0.97315687,0.000089049485,0.0001765222,0.0000433444,0.00009271377,0.00002169775,0.000048487982,0.000003213592,0.004063183,0.020867158],"study_design_scores_gemma":[0.004590975,0.00014177054,0.9935783,0.00048262786,0.000047998605,0.000002311788,0.00011928807,0.000007581362,0.0001196605,0.0000147025385,0.0006984195,0.00019632404],"about_ca_topic_score_codex":0.015576225,"about_ca_topic_score_gemma":0.0003870539,"teacher_disagreement_score":0.020670833,"about_ca_system_score_codex":0.00091975986,"about_ca_system_score_gemma":0.0012597963,"threshold_uncertainty_score":0.99985766},"labels":[],"label_agreement":null},{"id":"W2944626596","doi":"10.1158/1538-7445.sabcs18-p6-18-05","title":"Abstract P6-18-05: First-line ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled efficacy analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Letrozole; Fulvestrant; Internal medicine; Anastrozole; Goserelin; Clinical endpoint; Breast cancer; Placebo; Cancer; Oncology; Palbociclib; Aromatase inhibitor; Metastatic breast cancer; Gastroenterology; Clinical trial; Estrogen receptor; Tamoxifen; Pathology","score_opus":0.04112823362356666,"score_gpt":0.40130150514590096,"score_spread":0.3601732715223343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944626596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97557974,0.009835265,0.00004051402,0.00983812,0.00023895157,0.0028071345,0.0006571993,0.00014902832,0.0008540767],"genre_scores_gemma":[0.9758398,0.018580783,0.0003517652,0.00047285232,0.0005308118,0.0012172752,0.00014265052,0.00015911715,0.0027049626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99420005,0.00029006987,0.0008037767,0.0014172123,0.0016163441,0.0016725445],"domain_scores_gemma":[0.9959563,0.0008567771,0.00027353133,0.0011303613,0.0012603857,0.0005226196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008239341,0.0006123773,0.001433778,0.0012885033,0.00024206242,0.000075475655,0.0005888096,0.00021185048,0.008769186],"category_scores_gemma":[0.00014588064,0.00053689873,0.00040982701,0.005049271,0.0005062198,0.0004891472,0.000190407,0.0017121217,0.00022899086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05013338,0.0020997936,0.09604461,0.00037151124,0.0058360407,0.00032239326,0.004007349,0.0120333,0.3310335,0.00006772743,0.0013327955,0.4967176],"study_design_scores_gemma":[0.023736151,0.0012008271,0.91321784,0.00096951466,0.00020771794,0.00003368587,0.0008135601,0.00027069898,0.04854522,0.00017561075,0.010057411,0.00077176356],"about_ca_topic_score_codex":0.011512117,"about_ca_topic_score_gemma":0.0029616673,"teacher_disagreement_score":0.81717324,"about_ca_system_score_codex":0.002410765,"about_ca_system_score_gemma":0.00084096723,"threshold_uncertainty_score":0.99970824},"labels":[],"label_agreement":null},{"id":"W2944630738","doi":"10.1158/1538-7445.sabcs18-p1-09-03","title":"Abstract P1-09-03: Withdrawn","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Cancer; Medicine; Breast cancer; Citation; Physiology; Gerontology; Gynecology; Library science; Internal medicine; Computer science","score_opus":0.07370384215184818,"score_gpt":0.44462985283243156,"score_spread":0.3709260106805834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944630738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589636,0.003819558,0.000016752323,0.003025737,0.00030093524,0.0007688081,0.000015763291,0.00009299182,0.032995865],"genre_scores_gemma":[0.9802437,0.0002527795,0.00022130871,0.00032309577,0.00054677407,0.0001775499,0.000008276581,0.000059943337,0.018166572],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977802,0.000040290743,0.00018079381,0.00042293323,0.0008966161,0.0006791414],"domain_scores_gemma":[0.9986259,0.00011976042,0.00003892588,0.00062245433,0.0003517745,0.00024119552],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00048039397,0.00014329562,0.00027636767,0.00020360104,0.00010433381,0.00003590992,0.00021827148,0.00009212019,0.008316664],"category_scores_gemma":[0.000052031966,0.00011914912,0.000070961854,0.0004806054,0.00025443273,0.0001603701,0.00008408049,0.0007436086,0.0027152505],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029662445,0.00023091743,0.056112573,0.00080355786,0.000269759,0.00015486869,0.0011928589,0.000116869574,0.70236576,0.0013138516,0.0069343685,0.22753839],"study_design_scores_gemma":[0.0052631223,0.0005747362,0.20392375,0.0009779929,0.000024218785,0.0000727085,0.0010491651,0.000035797842,0.112456314,0.0014749294,0.6737214,0.0004258827],"about_ca_topic_score_codex":0.00043507712,"about_ca_topic_score_gemma":0.000047067228,"teacher_disagreement_score":0.666787,"about_ca_system_score_codex":0.0005043678,"about_ca_system_score_gemma":0.00063422666,"threshold_uncertainty_score":0.99806124},"labels":[],"label_agreement":null},{"id":"W2944644749","doi":"10.1158/1538-7445.sabcs18-ot1-12-01","title":"Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health Research Institute; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University of British Columbia; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Clinical endpoint; Internal medicine; Cancer; Prospective cohort study; Oncology; Hormone therapy; Circulating tumor cell; Biomarker; Hormonal therapy; Adjuvant; Clinical trial; Metastasis","score_opus":0.044964765135876536,"score_gpt":0.34044800667881797,"score_spread":0.2954832415429414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944644749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958671,0.001908104,0.0000047821154,0.00020026333,0.000071441114,0.00043256223,0.0013688303,0.000004172621,0.00014274832],"genre_scores_gemma":[0.9955271,0.0039447634,0.000009440956,0.0000050942135,0.00004300074,0.00016015966,0.00017835824,0.000021487424,0.000110601046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855316,0.00014079716,0.00023324792,0.00036369413,0.00038549525,0.00032358916],"domain_scores_gemma":[0.9989519,0.00007423205,0.00020649459,0.00023959977,0.0004735618,0.00005421801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000322786,0.0001557574,0.0002648247,0.00010759906,0.00004169514,0.0000078996045,0.0001564602,0.00010518776,0.00009408143],"category_scores_gemma":[0.000065123335,0.00012319145,0.00005137399,0.00033187275,0.00018316024,0.000020890815,0.0000860703,0.00021064714,0.0000030065926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017830288,0.00025674907,0.54358625,0.000053980028,0.0004657118,0.0000010632082,0.001238141,0.00043614893,0.4491062,0.000005681775,0.00044089157,0.0026261855],"study_design_scores_gemma":[0.0011175454,0.00026967542,0.7800914,0.00026030096,0.000018293009,1.4440997e-7,0.00038950567,0.000004496406,0.21767254,0.000010658214,0.000050915794,0.00011453805],"about_ca_topic_score_codex":0.0068543255,"about_ca_topic_score_gemma":0.0044955034,"teacher_disagreement_score":0.23650514,"about_ca_system_score_codex":0.00024975062,"about_ca_system_score_gemma":0.0002928397,"threshold_uncertainty_score":0.99975914},"labels":[],"label_agreement":null},{"id":"W2944651921","doi":"10.1158/0008-5472.can-19-0119","title":"Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"Syros Pharmaceuticals","keywords":"Cyclin-dependent kinase 7; Cyclin-dependent kinase; Cancer research; Biology; CDK inhibitor; Cancer; Kinase; Ovarian cancer; Myeloid leukemia; Transcription factor; Cell cycle; Pharmacology; Cell biology; Gene; Biochemistry; Genetics; Cyclin-dependent kinase 2","score_opus":0.03227914873616353,"score_gpt":0.3508019022681425,"score_spread":0.318522753531979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944651921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970397,0.00095155824,0.00006971631,0.00026127198,0.00013091839,0.0007867995,0.0000685089,0.000009282481,0.0006822939],"genre_scores_gemma":[0.99740946,0.0010514929,0.000020439045,0.000025362644,0.00008409926,0.00005231629,0.000026228192,0.000023430006,0.0013071777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872756,0.00007622042,0.00020539256,0.00024064713,0.00053065445,0.00021950601],"domain_scores_gemma":[0.99913204,0.00004758649,0.00007566947,0.00024988232,0.00042588418,0.000068931055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031975986,0.00007784529,0.00025636458,0.00022301417,0.000022868988,0.000009134857,0.000060771825,0.00008226948,0.000091604365],"category_scores_gemma":[0.00006746372,0.00007052333,0.000044422635,0.00048213833,0.00015546607,0.000100467856,0.00007865811,0.00027729492,0.000008578046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005881152,0.00007192581,0.0098800715,0.0006307508,0.000062192645,0.0000040758846,0.00033571664,0.0000038148764,0.98567486,0.00017170655,0.00017166612,0.0024050837],"study_design_scores_gemma":[0.0014694785,0.00051746325,0.055189133,0.0007744658,0.000024324581,0.0000072772295,0.000063923566,0.00006849213,0.9404751,0.000025258429,0.0013179781,0.00006708693],"about_ca_topic_score_codex":0.00020359427,"about_ca_topic_score_gemma":0.00001312875,"teacher_disagreement_score":0.045309063,"about_ca_system_score_codex":0.00020400308,"about_ca_system_score_gemma":0.00052666425,"threshold_uncertainty_score":0.28758582},"labels":[],"label_agreement":null},{"id":"W2944712942","doi":"10.1158/1538-7445.sabcs18-p1-08-30","title":"Abstract P1-08-30: Triple negative breast cancer: Does ethnicity impact survival?","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Pacific islanders; Ethnic group; Internal medicine; Population; Oncology; Proportional hazards model; Cancer; Epidemiology; Surveillance, Epidemiology, and End Results; Demography; Survival analysis; Cancer registry","score_opus":0.04376793329850027,"score_gpt":0.40828539617764603,"score_spread":0.36451746287914577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944712942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902843,0.003024831,0.000004010381,0.0015256162,0.0006047054,0.00063661044,0.0014502683,0.000026724938,0.0024429092],"genre_scores_gemma":[0.99232787,0.004289062,0.000013923365,0.00009226746,0.0008427095,0.00040048314,0.000060068487,0.00005675178,0.0019168422],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99731135,0.00019276529,0.00023542704,0.0007752977,0.00060222956,0.0008829156],"domain_scores_gemma":[0.9984045,0.00010772872,0.00009272179,0.00064913795,0.00052883336,0.00021708694],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055011554,0.00030421506,0.00036330766,0.00010017858,0.00024665077,0.000063309504,0.00044149198,0.00019271244,0.0036303652],"category_scores_gemma":[0.0000706535,0.00021029473,0.00019128901,0.00034482626,0.00033085217,0.000015198385,0.0003353316,0.00043073308,0.00021155413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033574002,0.00043320312,0.45066577,0.00026894826,0.001850558,0.000023102326,0.0008887581,0.00040608866,0.4775549,0.00006768166,0.030157559,0.034326043],"study_design_scores_gemma":[0.0024831104,0.00018999846,0.8575162,0.0001179554,0.000029354658,0.000005866313,0.0005784769,0.000008155193,0.13233076,0.00014503876,0.0061685406,0.00042652065],"about_ca_topic_score_codex":0.02182014,"about_ca_topic_score_gemma":0.003967328,"teacher_disagreement_score":0.40685046,"about_ca_system_score_codex":0.0005066526,"about_ca_system_score_gemma":0.00076820736,"threshold_uncertainty_score":0.9972805},"labels":[],"label_agreement":null},{"id":"W2944717492","doi":"10.1158/1538-7445.sabcs18-ot1-06-01","title":"Abstract OT1-06-01: ANG1005 in leptomeningeal disease (ANGLeD) trial: A randomized, open-label, phase 3 study of ANG1005 compared with Physician's Best Choice in HER2-negative breast cancer patients with newly diagnosed leptomeningeal carcinomatosis and previously treated brain metastases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Capecitabine; Metastatic breast cancer; Cancer; Oncology; Eribulin; Chemotherapy; Phases of clinical research; Gastroenterology; Surgery","score_opus":0.05972211473529758,"score_gpt":0.40295973036431576,"score_spread":0.34323761562901817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944717492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97825444,0.0011551118,6.422066e-7,0.00050499,0.000033945926,0.0189313,0.0010276032,0.00002616267,0.000065804285],"genre_scores_gemma":[0.9928381,0.00016317803,0.00008883107,0.00008352102,0.000075931355,0.006279312,0.00024717377,0.00010392048,0.00012005713],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943492,0.0013880486,0.0008184527,0.0011212943,0.0013070651,0.0010159693],"domain_scores_gemma":[0.9961695,0.0016848317,0.0004032221,0.0006342457,0.0005230288,0.0005851892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015408879,0.00057569565,0.0022137705,0.0006967693,0.00012384485,0.00014179587,0.0003519368,0.00007600258,0.00023713749],"category_scores_gemma":[0.00019982185,0.00039186215,0.000086235465,0.0016699483,0.0004719383,0.00047082725,0.0002117867,0.00058973866,0.0000062302584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50394,0.018266996,0.47015977,0.0003430899,0.00093340565,0.0002777999,0.0025583813,0.00012468382,0.00010968535,0.0000033596345,0.00017139158,0.003111439],"study_design_scores_gemma":[0.6663479,0.006523126,0.32243857,0.0015387284,0.0005022981,0.0000019816648,0.0020292944,0.000110690846,0.00017438842,0.0000031419502,0.000025932104,0.00030393156],"about_ca_topic_score_codex":0.08655213,"about_ca_topic_score_gemma":0.027360938,"teacher_disagreement_score":0.16240792,"about_ca_system_score_codex":0.0008279906,"about_ca_system_score_gemma":0.0010223176,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W2944719495","doi":"10.1158/1538-7445.sabcs18-p6-13-05","title":"Abstract P6-13-05: Association between the <i>UGT2B17</i> gene deletion, exemestane metabolites and vasomotor QOL in women participating on the MAP3 prevention trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Exemestane; Metabolite; Internal medicine; Medicine; Aromatase inhibitor; Vasomotor; Oncology; Pharmacology; Endocrinology; Breast cancer; Cancer; Aromatase","score_opus":0.036589803727645295,"score_gpt":0.3596024911505195,"score_spread":0.3230126874228742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944719495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962248,0.0015500195,0.0000026757718,0.00083760894,0.00010769035,0.0010229658,0.000013257946,0.000005461901,0.00023552625],"genre_scores_gemma":[0.9968202,0.0009883462,0.000006610259,0.00008669947,0.00039615075,0.00068560353,0.000025477853,0.000016433662,0.00097446993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982746,0.00048524872,0.00020249186,0.00026531122,0.00035438655,0.0004179387],"domain_scores_gemma":[0.9992276,0.00027010692,0.0000910323,0.0002465461,0.00010444991,0.00006031043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027862138,0.00010024835,0.00013406463,0.0000432973,0.00015539835,0.00006098684,0.00016635362,0.00016520373,0.000054414464],"category_scores_gemma":[0.00031105062,0.00006113289,0.00004741578,0.00017818956,0.000053018317,0.0000073297847,0.00008003545,0.00039847536,0.000020160762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032546232,0.000116577045,0.024426308,0.000044902918,0.00030392726,0.0000025504642,0.00072136347,0.00008241575,0.95648265,0.00006879558,0.0018595037,0.01263637],"study_design_scores_gemma":[0.015721379,0.0022187068,0.119264185,0.00016862675,0.000068118636,0.0000018646201,0.00061016425,0.00008987177,0.83972067,0.00077635836,0.02096843,0.00039163095],"about_ca_topic_score_codex":0.00014053861,"about_ca_topic_score_gemma":0.000024443709,"teacher_disagreement_score":0.116762005,"about_ca_system_score_codex":0.00012635162,"about_ca_system_score_gemma":0.00012286156,"threshold_uncertainty_score":0.24929267},"labels":[],"label_agreement":null},{"id":"W2944776474","doi":"10.1158/1538-7445.sabcs18-ot3-04-02","title":"Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Trastuzumab; Pembrolizumab; Internal medicine; Oncology; Breast cancer; Pertuzumab; Regimen; Lapatinib; Taxane; Blockade; Metastatic breast cancer; Neoadjuvant therapy; Cancer; Immunotherapy; Receptor","score_opus":0.17144214421042142,"score_gpt":0.5137250226387211,"score_spread":0.3422828784282997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944776474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95632356,0.009226697,0.000013333249,0.0043054787,0.0005621564,0.018478857,0.00011203714,0.00016075825,0.010817107],"genre_scores_gemma":[0.96548235,0.011220661,0.00038233722,0.00084160594,0.0011831059,0.005539835,0.00017116361,0.00035022863,0.014828694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9900093,0.0017168493,0.0010288018,0.0015475267,0.0035921775,0.0021053643],"domain_scores_gemma":[0.9938608,0.0009451636,0.00025179097,0.002445937,0.0015549145,0.0009414385],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009044817,0.000627701,0.0021373737,0.00070566754,0.00066454115,0.0005587746,0.002171673,0.00039768906,0.025328975],"category_scores_gemma":[0.0003414705,0.00043682952,0.00022484365,0.0014921287,0.0010145096,0.00065880927,0.00045443478,0.0026077605,0.0004161763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7702948,0.0034998828,0.00011194999,0.00013500066,0.00062651874,0.00017127836,0.0013352876,0.000011962953,0.12437898,0.00014255191,0.0043208166,0.09497096],"study_design_scores_gemma":[0.8809517,0.025007268,0.00028696915,0.000542383,0.000032677428,0.000025572981,0.00031876168,0.00030795083,0.025976302,0.00020769598,0.065803245,0.0005394653],"about_ca_topic_score_codex":0.009574483,"about_ca_topic_score_gemma":0.0004145404,"teacher_disagreement_score":0.110656895,"about_ca_system_score_codex":0.0011720151,"about_ca_system_score_gemma":0.0059157982,"threshold_uncertainty_score":0.9998084},"labels":[],"label_agreement":null},{"id":"W2944795532","doi":"10.1158/1538-7445.sabcs18-ot3-04-03","title":"Abstract OT3-04-03: KEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab versus placebo in combination with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk early-stage ER+/HER2– breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Anthracycline; Chemotherapy; Pembrolizumab; Neoadjuvant therapy; Cancer; Placebo; Pathology; Immunotherapy","score_opus":0.035994479447603485,"score_gpt":0.37626037183514405,"score_spread":0.34026589238754057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944795532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888128,0.0035006623,0.000018927003,0.00044599638,0.00017369863,0.0066508013,0.00030294454,0.000014106245,0.00008005047],"genre_scores_gemma":[0.9861002,0.008973486,0.000029096866,0.00002612097,0.00015752857,0.0042690905,0.00007703265,0.00007367197,0.00029378955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973333,0.0002180711,0.00044413618,0.0008287285,0.00055474456,0.0006210304],"domain_scores_gemma":[0.9983413,0.00024430675,0.00025877616,0.0005269682,0.00051288423,0.00011573102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007780439,0.0003659398,0.00082330336,0.0002233677,0.00015566919,0.000049975773,0.00027466335,0.00012159854,0.00015324757],"category_scores_gemma":[0.000022224238,0.0002773938,0.0000975519,0.00030024044,0.000308629,0.000026987502,0.00010707495,0.0003129135,0.0000022540166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9403004,0.0017528584,0.022232812,0.0000865398,0.001168759,0.000008690246,0.0011408124,0.00020374206,0.009324618,0.000037314105,0.000098861965,0.02364458],"study_design_scores_gemma":[0.915234,0.0035084768,0.04945876,0.0001019465,0.00007332265,0.000003549719,0.00088991836,0.000046524598,0.030042464,0.000020307212,0.00030732973,0.00031339322],"about_ca_topic_score_codex":0.027252952,"about_ca_topic_score_gemma":0.0083079105,"teacher_disagreement_score":0.02722595,"about_ca_system_score_codex":0.0002169918,"about_ca_system_score_gemma":0.00035313997,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W2944808953","doi":"10.1158/1538-7445.am10-sy31-04","title":"Abstract SY31-04: Metabolic regulation of tumor cells survival","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Warburg effect; Glycolysis; Anaerobic glycolysis; Cancer cell; Cancer; Oxidative phosphorylation; Cancer research; Angiogenesis; Cell biology; Cell; Programmed cell death; Cell growth; Metabolic pathway; Biology; Downregulation and upregulation; Metabolism; Biochemistry; Chemistry; Apoptosis; Genetics","score_opus":0.03601683364735442,"score_gpt":0.3575787730086165,"score_spread":0.3215619393612621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944808953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905807,0.0039792527,0.000017998875,0.000106804655,0.002080975,0.00024068239,0.00008884867,0.000008269765,0.0028965047],"genre_scores_gemma":[0.9926943,0.0017768941,0.00013965032,0.000033738033,0.0031404498,0.00006923519,0.00004160664,0.000030397285,0.002073736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851245,0.00007590974,0.0002203307,0.00035373203,0.00043939732,0.00039819937],"domain_scores_gemma":[0.99879074,0.000028307482,0.000076927085,0.00053268013,0.0004320174,0.00013935009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008796405,0.00011956171,0.0002047759,0.00010750449,0.000090165006,0.00002544839,0.0003111705,0.00013432474,0.0004785483],"category_scores_gemma":[0.00011507172,0.0001130135,0.0001005647,0.00022174958,0.00024838123,0.000006818839,0.00011941073,0.0003548467,0.000023950483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010328296,0.000040415176,0.00030771093,0.00003807482,0.000031603933,4.1312566e-7,0.00003487389,0.000024405123,0.9841588,0.00040469883,0.0071296305,0.007726105],"study_design_scores_gemma":[0.00028722794,0.000024091692,0.023642348,0.0000067170445,0.0000073776064,0.000001179455,0.000024333485,0.0000036824138,0.6292741,0.00008218188,0.34656474,0.000082081395],"about_ca_topic_score_codex":0.00072562404,"about_ca_topic_score_gemma":0.0008359498,"teacher_disagreement_score":0.35488474,"about_ca_system_score_codex":0.000010896195,"about_ca_system_score_gemma":0.00040661683,"threshold_uncertainty_score":0.5239768},"labels":[],"label_agreement":null},{"id":"W2945067244","doi":"10.1158/0008-5472.can-18-2931","title":"Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mesenchymal stem cell; Stromal cell; Cancer research; Tumor microenvironment; Biology; Pathology; Cell biology; Tumor cells; Medicine","score_opus":0.042935135183095816,"score_gpt":0.3666930904844489,"score_spread":0.3237579553013531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945067244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076605,0.0054769097,0.000019201714,0.0017344006,0.00016332626,0.0011392616,0.000025060835,0.000014297682,0.0006615021],"genre_scores_gemma":[0.9931327,0.002994058,0.0003031279,0.00011507206,0.00014165971,0.00017568433,0.000017958933,0.000028258733,0.0030914496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979748,0.00018908124,0.00020463867,0.0004028491,0.00073969853,0.0004888945],"domain_scores_gemma":[0.9991117,0.00013254308,0.00007551731,0.0003966687,0.00007827833,0.00020528703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000512312,0.0001445752,0.00024256107,0.00014039669,0.0001689214,0.000059832917,0.00014776041,0.000027395492,0.00072783796],"category_scores_gemma":[0.000030323888,0.00008996484,0.000062311825,0.00027932675,0.0002295947,0.000082159786,0.00016007676,0.0004202767,0.00005727665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007688803,0.00033530686,0.12917908,0.0008219824,0.0001711351,0.00008121274,0.0013319551,0.000021696178,0.83892757,0.00020818468,0.007074322,0.021078674],"study_design_scores_gemma":[0.006932008,0.0017518245,0.42137256,0.00064651197,0.00034063443,0.00006700846,0.0033018594,0.00020784573,0.49231133,0.00022316349,0.07240767,0.0004376017],"about_ca_topic_score_codex":0.00023936361,"about_ca_topic_score_gemma":0.000026618289,"teacher_disagreement_score":0.34661624,"about_ca_system_score_codex":0.00016995128,"about_ca_system_score_gemma":0.00020946495,"threshold_uncertainty_score":0.7969315},"labels":[],"label_agreement":null},{"id":"W2945231194","doi":"10.1158/1538-7445.am2015-3448","title":"Abstract 3448: Overexpression of the steroid inactivating UGT2B28 enzyme is associated with high circulating androgens, tumor aggressiveness and adverse prostate cancer outcome","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Prostate cancer; Carcinogenesis; Cancer; Prostate; Dihydrotestosterone; Androgen; Cancer research; Internal medicine; Medicine; Intraepithelial neoplasia; Glucuronosyltransferase; Endocrinology; Biology; Enzyme; Hormone","score_opus":0.05329119090306114,"score_gpt":0.35154928210429454,"score_spread":0.29825809120123337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945231194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937957,0.005003889,0.0000025452325,0.00013844595,0.00026779887,0.00046799364,0.00020878158,0.000007864864,0.000106982436],"genre_scores_gemma":[0.9984092,0.0004322288,0.000022881932,0.00011882272,0.00037479695,0.00011857195,0.000019449744,0.000038907794,0.0004651499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980456,0.0001650682,0.0002713641,0.0004281803,0.0006442423,0.00044553194],"domain_scores_gemma":[0.9984926,0.000041567797,0.0002949906,0.000370258,0.0006403687,0.000160219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006498754,0.00017919547,0.00026881925,0.0000593441,0.00019811433,0.000030932442,0.00023638905,0.00012331984,0.000028630071],"category_scores_gemma":[0.00030681022,0.00012379144,0.00005571718,0.0002660909,0.00025366808,0.000019997364,0.00027898987,0.00034510807,5.20039e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037286727,0.000041732284,0.076875255,0.000114568094,0.00009915415,0.0000037961793,0.00050226646,0.00030937933,0.9183587,0.0000060140874,0.0009786871,0.0023375906],"study_design_scores_gemma":[0.0025064342,0.00012542763,0.1013838,0.00092492765,0.00003053142,0.000009067639,0.0007099555,0.00003387859,0.888292,0.00003363517,0.0056857844,0.00026456366],"about_ca_topic_score_codex":0.0022526814,"about_ca_topic_score_gemma":0.0003445665,"teacher_disagreement_score":0.030066688,"about_ca_system_score_codex":0.0001360292,"about_ca_system_score_gemma":0.0007524104,"threshold_uncertainty_score":0.5048069},"labels":[],"label_agreement":null},{"id":"W2945870927","doi":"10.1158/0008-5472.can-18-2414","title":"Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Oncolytic virus; Cancer cell; Pyruvate dehydrogenase complex; Biology; Pyruvate dehydrogenase kinase; Cancer research; PKM2; Metabolic pathway; Cell culture; Citric acid cycle; Cancer; Pyruvate kinase; Metabolism; Biochemistry; Glycolysis; Enzyme; Genetics","score_opus":0.04129191657484433,"score_gpt":0.39009177083976304,"score_spread":0.3487998542649187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945870927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950022,0.0030470085,0.000006962302,0.00021339623,0.00007156489,0.00071616215,0.00004677881,0.0000050702383,0.0008908532],"genre_scores_gemma":[0.9973651,0.001495482,0.000014168108,0.000051203027,0.00014904005,0.00009144789,0.000024826064,0.000028253271,0.00078047416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979143,0.00036202915,0.0002773576,0.0003588237,0.0006553309,0.0004321468],"domain_scores_gemma":[0.99851793,0.000109302724,0.000100222,0.00074181013,0.00044405504,0.00008669061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014390275,0.0001195355,0.00019754686,0.00013253889,0.00009321281,0.000016815302,0.000435026,0.00009384542,0.00027656366],"category_scores_gemma":[0.00017143467,0.00008926163,0.00010882411,0.0004888608,0.00049507484,0.0000064873248,0.00020764479,0.00026039276,0.000056376328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027400346,0.00011794703,0.00047923188,0.00011088856,0.000059375565,0.000003826882,0.0001005865,0.00016453529,0.9924603,0.00003980449,0.00046321956,0.0032602565],"study_design_scores_gemma":[0.0009922233,0.0019954266,0.0003256929,0.0000836959,0.0000061382257,0.0000011156133,0.00010050504,0.000030404242,0.9938309,0.00006130028,0.0024766976,0.00009590199],"about_ca_topic_score_codex":0.00026139175,"about_ca_topic_score_gemma":0.00027514636,"teacher_disagreement_score":0.0031643545,"about_ca_system_score_codex":0.000055340835,"about_ca_system_score_gemma":0.0006388043,"threshold_uncertainty_score":0.36399838},"labels":[],"label_agreement":null},{"id":"W2945912122","doi":"10.1158/1538-7445.am2017-1583","title":"Abstract 1583: Inhibition of proline isomerase Pin1 interrupts the function of the androgen receptor N-terminal domain and suppresses androgen-independent growth of prostate cancer cells","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Transactivation; PIN1; Androgen receptor; Prostate cancer; Peptidylprolyl isomerase; Cancer research; Dihydrotestosterone; Transcription factor; Androgen; Biology; Chemistry; Endocrinology; Cancer; Isomerase; Biochemistry; Gene; Genetics; Hormone","score_opus":0.03385072101828961,"score_gpt":0.3413013503711698,"score_spread":0.3074506293528802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945912122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958962,0.0025008612,0.000006580665,0.00030124641,0.00015512304,0.00057504873,0.0005040344,0.0000020733594,0.000058783196],"genre_scores_gemma":[0.99862057,0.0009323476,0.000012268604,0.000019292727,0.00013927091,0.00015354501,0.000018281675,0.00001713858,0.000087292516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873316,0.00013712005,0.00025652038,0.00027082526,0.0003874462,0.00021493333],"domain_scores_gemma":[0.9986316,0.00002941444,0.00027741314,0.00053908164,0.00045812424,0.00006436736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006164056,0.00011057478,0.0001491804,0.000038669503,0.0001871905,0.000028608527,0.00035021486,0.000088800436,0.00007711506],"category_scores_gemma":[0.00012661409,0.00007138549,0.00007384872,0.00007086877,0.00072166015,0.000012911332,0.00031871098,0.00017096709,5.6974346e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001001456,0.000090588626,0.016044136,0.0003538212,0.000072072755,0.000002213992,0.00021988087,0.000016484335,0.97953707,0.000013009986,0.0007986859,0.0018505529],"study_design_scores_gemma":[0.0007168018,0.00019537965,0.011865044,0.00025419498,0.000023368082,0.0000022518,0.00012308352,0.00000405103,0.98622423,0.00016359948,0.00035566045,0.00007231122],"about_ca_topic_score_codex":0.0005067103,"about_ca_topic_score_gemma":0.00018523107,"teacher_disagreement_score":0.006687157,"about_ca_system_score_codex":0.000027293563,"about_ca_system_score_gemma":0.0003111951,"threshold_uncertainty_score":0.29110157},"labels":[],"label_agreement":null},{"id":"W2946355903","doi":"10.1158/1538-7445.am2015-1860","title":"Abstract 1860: DNA-PK-mediated transcriptional regulation drives tumor progression and metastasis","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Metastasis; Cancer; Tumor progression; DNA; Cancer research; DNA damage; Transcriptional regulation; Biology; Medicine; Gene; Transcription factor; Genetics","score_opus":0.09939342321280618,"score_gpt":0.40941867513172314,"score_spread":0.31002525191891694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946355903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104285,0.006451559,0.00020957582,0.0008815492,0.00008524871,0.00025788113,0.0000657542,0.00001127568,0.0009943272],"genre_scores_gemma":[0.99764144,0.0006855565,0.00025493317,0.000045571516,0.00024298741,0.00023454677,0.000176043,0.000016513764,0.0007024012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886096,0.00008451598,0.0001365212,0.00031021677,0.00037093644,0.0002368615],"domain_scores_gemma":[0.99920994,0.000012990077,0.000037382444,0.00021016972,0.00035915006,0.00017036451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005501693,0.0000867073,0.00008444711,0.00007590814,0.00012863443,0.000051528626,0.0001212448,0.00006985793,0.00010728792],"category_scores_gemma":[0.00007810904,0.00007446345,0.0000307937,0.00015971115,0.00020083455,0.000011920582,0.000041325595,0.00012527753,0.000013621231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001665255,0.000045218647,0.00095562486,0.000022053606,0.000027982982,0.0000016319234,0.00009380997,0.00004476288,0.9754471,0.00019752166,0.008307718,0.014690029],"study_design_scores_gemma":[0.0015706699,0.0003285556,0.11096602,0.00007511516,0.000018795805,0.000011060552,0.00045086464,0.00020649155,0.4669709,0.00062744477,0.41847077,0.00030332064],"about_ca_topic_score_codex":0.00006922641,"about_ca_topic_score_gemma":0.00005964671,"teacher_disagreement_score":0.5084762,"about_ca_system_score_codex":0.00005108955,"about_ca_system_score_gemma":0.00031609822,"threshold_uncertainty_score":0.30365315},"labels":[],"label_agreement":null},{"id":"W2946356416","doi":"10.1158/0008-5472.can-18-1503","title":"Phosphorylation of SOCS1 Inhibits the SOCS1–p53 Tumor Suppressor Axis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Espace pour la vie; Université de Sherbrooke; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Suppressor of cytokine signaling 1; Proto-oncogene tyrosine-protein kinase Src; Phosphorylation; Src family kinase; Cancer research; Biology; SH2 domain; Suppressor of cytokine signalling; Tyrosine kinase; Tyrosine phosphorylation; Cell biology; Signal transduction; Chemistry; STAT3; SOCS3; Suppressor; Biochemistry; Gene","score_opus":0.07985022394261755,"score_gpt":0.4070547997562025,"score_spread":0.327204575813585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946356416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876076,0.00066814624,0.000015693104,0.0030071996,0.00024237898,0.00065449905,0.000038453138,0.000019643756,0.007746375],"genre_scores_gemma":[0.99677795,0.00009644782,0.000021300324,0.00015667046,0.00024925824,0.00009991367,0.000012746908,0.000021357957,0.0025643602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998611,0.00008470049,0.00021521893,0.00021015691,0.0005921157,0.00028684427],"domain_scores_gemma":[0.99849737,0.00042239166,0.00006456016,0.00039146244,0.00054841564,0.00007581442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006154748,0.0000796662,0.00018042285,0.00011978932,0.000120085075,0.000023112383,0.00014155699,0.000044606295,0.004778484],"category_scores_gemma":[0.0003625302,0.000053082826,0.00009493994,0.00036704473,0.0001436899,0.00007842697,0.000076848475,0.000513027,0.00025529135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024871877,0.00007035834,0.0027050395,0.00011847314,0.000041501946,0.000002732579,0.0006487914,0.000036573998,0.9776871,0.00047315288,0.015844572,0.0021229864],"study_design_scores_gemma":[0.0006294733,0.00026071703,0.005193111,0.00025497997,0.000014531541,0.000008445222,0.000458721,0.00031195313,0.9409208,0.0001256058,0.051765103,0.000056520686],"about_ca_topic_score_codex":0.0011645445,"about_ca_topic_score_gemma":0.00006018123,"teacher_disagreement_score":0.03676626,"about_ca_system_score_codex":0.0001409274,"about_ca_system_score_gemma":0.0003896713,"threshold_uncertainty_score":0.9961313},"labels":[],"label_agreement":null},{"id":"W2946814355","doi":"","title":"A biocomputational approach to the study of differential nature of E2 dependent breast cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Gene; Serial analysis of gene expression; Breast cancer; Biology; Context (archaeology); Microarray analysis techniques; Gene expression; Gene expression profiling; Cancer research; Genetics; Cancer","score_opus":0.02858493012690859,"score_gpt":0.3528788556480943,"score_spread":0.3242939255211857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946814355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715203,0.00031252802,0.0011543066,0.00017449072,0.00009177074,0.00047827684,0.000049935672,0.000001948722,0.0005847022],"genre_scores_gemma":[0.9988124,0.00001586482,0.000054317497,0.000016211765,0.0002514121,0.0001716718,0.000034393415,0.000008671997,0.0006351051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886733,0.0001390733,0.00015195756,0.00024426248,0.00045556595,0.00014178567],"domain_scores_gemma":[0.9993225,0.000010263197,0.0000501167,0.000278222,0.00030270324,0.00003619842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021379052,0.0000627217,0.00008069983,0.00007421155,0.00006554464,0.000012527447,0.00029696137,0.000078515324,0.000023689361],"category_scores_gemma":[0.0000069072544,0.000043156313,0.000033697455,0.00022540362,0.000057071633,0.0000013445419,0.00013248969,0.00015039238,0.0000014952933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015369791,0.00049254054,0.0011314604,0.00002018141,0.000023829587,1.0803882e-7,0.00011835377,0.0020509248,0.9854054,0.00011160095,0.009071643,0.0014202866],"study_design_scores_gemma":[0.00078745105,0.00024677778,0.058440033,0.0000136592125,0.000009300269,0.0000017866053,0.0010159167,0.00011574726,0.9349562,0.000044190972,0.004280313,0.00008861227],"about_ca_topic_score_codex":0.00025888506,"about_ca_topic_score_gemma":0.0000876381,"teacher_disagreement_score":0.057308573,"about_ca_system_score_codex":0.000019094536,"about_ca_system_score_gemma":0.00011928686,"threshold_uncertainty_score":0.17598633},"labels":[],"label_agreement":null},{"id":"W2949384952","doi":"10.1158/0008-5472.can-19-0989","title":"A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy","year":2019,"lang":"en","type":"review","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Tribute; Cancer; Cancer therapy; Medicine; Art; Internal medicine; Art history","score_opus":0.522667861932053,"score_gpt":0.6135850359263461,"score_spread":0.09091717399429311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949384952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016933146,0.977898,0.0000055468386,0.007186185,0.00087290583,0.011012308,0.00066378404,0.00009181956,0.0021001224],"genre_scores_gemma":[0.000030739353,0.9303817,0.000084455605,0.00047081895,0.0014808358,0.017173411,0.00016501549,0.00038544013,0.049827553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886168,0.0014503889,0.0012917687,0.001969482,0.0037861702,0.0028853747],"domain_scores_gemma":[0.99453527,0.00076978287,0.00017555301,0.00208374,0.0012765217,0.0011591184],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004565364,0.0008696228,0.0038702684,0.003198717,0.00016786816,0.00016576056,0.0014807802,0.0009544145,0.008277593],"category_scores_gemma":[0.0006305366,0.0006787317,0.00068143394,0.00690661,0.00028073695,0.00012732508,0.00066173583,0.0053166235,0.0021657888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004506358,0.00017126511,0.00008557341,0.018517295,0.00038029498,0.00024593557,0.00031498456,0.0000054538846,0.00011821798,0.000023933339,0.18603346,0.79365295],"study_design_scores_gemma":[0.0019224256,0.00059421547,0.00004820998,0.036171086,0.0001095185,0.0000241276,0.000047718415,0.000008760294,0.00011518371,0.000025308866,0.9603297,0.00060374866],"about_ca_topic_score_codex":0.0074509135,"about_ca_topic_score_gemma":0.0014502319,"teacher_disagreement_score":0.7930492,"about_ca_system_score_codex":0.008384349,"about_ca_system_score_gemma":0.017579354,"threshold_uncertainty_score":0.9995664},"labels":[],"label_agreement":null},{"id":"W2950286149","doi":"10.1158/0008-5472.can-17-0096","title":"Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Hospital for Sick Children; McGill University; Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; Lunenfeld-Tanenbaum Research Institute; Montreal Clinical Research Institute","funders":"","keywords":"Pharmacogenomics; Cancer; Drug; Taxonomy (biology); Medicine; Drug response; Computational biology; Biology; Internal medicine; Pharmacology; Ecology","score_opus":0.17665038217418094,"score_gpt":0.5009506009118767,"score_spread":0.32430021873769577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950286149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49839553,0.0009292135,0.46226168,0.020576457,0.00208832,0.0015748098,0.00018183848,0.00011243888,0.013879729],"genre_scores_gemma":[0.91693115,0.00046421753,0.063554585,0.0016686748,0.0012868807,0.0036922847,0.000005747082,0.0000548603,0.012341586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721545,0.00038957567,0.00021909125,0.0007067153,0.0007330344,0.00073615246],"domain_scores_gemma":[0.9973861,0.00037537309,0.0000918106,0.0010780147,0.0007298971,0.00033881835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020391096,0.00018004494,0.0002296469,0.00026290864,0.0009776604,0.00089805905,0.0031539872,0.000043403044,0.0002615594],"category_scores_gemma":[0.00024529116,0.00016104907,0.00008245192,0.00042188115,0.00017830316,0.0009330906,0.0022360145,0.00057319354,0.00021501497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026512175,0.00038088206,0.016347766,0.000117108844,0.0002805128,0.00008008157,0.019711982,0.038493168,0.01833236,0.05635315,0.2620255,0.58761233],"study_design_scores_gemma":[0.0011609189,0.00006269251,0.014112521,0.0001851999,0.000009869803,0.0000030818278,0.00040687367,0.08702909,0.064996965,0.0081446525,0.823267,0.0006211287],"about_ca_topic_score_codex":0.0019337753,"about_ca_topic_score_gemma":0.0017085472,"teacher_disagreement_score":0.58699125,"about_ca_system_score_codex":0.00066512916,"about_ca_system_score_gemma":0.001263565,"threshold_uncertainty_score":0.8660004},"labels":[],"label_agreement":null},{"id":"W2950449244","doi":"10.1158/0008-5472.can-19-0349","title":"Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Vector Institute; Université du Québec à Montréal; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Pharmacogenomics; Precision medicine; Computational biology; Concordance; Drug response; Medicine; Biomarker; Biomarker discovery; In vivo; Bioinformatics; Personalized medicine; Drug discovery; Oncology; Drug; Biology; Gene; Pharmacology; Genetics; Pathology; Proteomics","score_opus":0.027849415809988006,"score_gpt":0.37540030044539313,"score_spread":0.3475508846354051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950449244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995633,0.0022007711,0.000066513414,0.00007166326,0.00020548124,0.00027468306,0.00021685322,0.0000030513756,0.001327993],"genre_scores_gemma":[0.99641424,0.0027460807,0.00008887943,0.000116356336,0.000115153685,0.0000573432,0.0001281117,0.000017834607,0.00031599824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989019,0.00007679289,0.00019111185,0.00032183534,0.00022105663,0.00028732474],"domain_scores_gemma":[0.99900687,0.00005628506,0.00006910107,0.0003623477,0.00041369628,0.00009167317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002161925,0.000103180886,0.00021479232,0.0002392702,0.00004497867,0.000019165762,0.0002421956,0.00007674935,0.00033182837],"category_scores_gemma":[0.000068299036,0.000094397765,0.00015043754,0.0006429843,0.00012469823,0.000002548194,0.0002047161,0.00014286954,0.000017376657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019625641,0.000046307752,0.0081310775,0.0000144866935,0.0007434097,0.0000010226578,0.00030238277,0.0013973058,0.9834305,0.000099777775,0.0021502296,0.0034872212],"study_design_scores_gemma":[0.0004078027,0.00031325885,0.0014396469,0.000012042383,0.000113662754,3.2255252e-7,0.00047340945,0.00019679284,0.9547514,0.00003059153,0.042128213,0.00013286962],"about_ca_topic_score_codex":0.00036828517,"about_ca_topic_score_gemma":0.0003024889,"teacher_disagreement_score":0.039977983,"about_ca_system_score_codex":0.00006924512,"about_ca_system_score_gemma":0.00027259564,"threshold_uncertainty_score":0.38494292},"labels":[],"label_agreement":null},{"id":"W2951373147","doi":"10.1158/0008-5472.can-18-3622","title":"CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"Biology; Transcription factor; Immune system; Epigenetics; Cancer research; Follicular lymphoma; IRF4; CREB-binding protein; Cellular differentiation; Transcriptional regulation; Immunology; CREB; Lymphoma; Genetics; Gene","score_opus":0.029963617816206885,"score_gpt":0.30188646377734585,"score_spread":0.27192284596113897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951373147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896581,0.0026690322,0.0013832392,0.0009163761,0.0031358628,0.00042833821,0.000021207865,0.000016476864,0.001771339],"genre_scores_gemma":[0.97954595,0.00057825237,0.000021018885,0.00010915479,0.0000387718,0.00005644454,0.00004979011,0.000011771837,0.019588849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989483,0.00024420695,0.00020764052,0.00022909872,0.00013631853,0.00023444716],"domain_scores_gemma":[0.99940234,0.00012073642,0.00005727178,0.00020092327,0.0002065214,0.000012192954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037036973,0.00009717932,0.00014602656,0.000098286575,0.00021824383,0.000018693203,0.00015205951,0.00013926839,0.0073069986],"category_scores_gemma":[0.000008094467,0.00007073919,0.000074655254,0.00012809606,0.00027234756,0.00018409226,0.000030377143,0.0004326879,0.00024316489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026637278,0.000052927888,0.00018545186,0.00004477328,0.00008702067,9.467428e-8,0.0009302397,0.00001160207,0.97863203,0.015093886,0.004310677,0.00038490267],"study_design_scores_gemma":[0.0010585934,0.00019405567,0.044258885,0.000068299436,0.00001932338,0.0000055445157,0.0009071354,0.000035691923,0.91565275,0.0015678615,0.036130834,0.00010100684],"about_ca_topic_score_codex":0.00017483736,"about_ca_topic_score_gemma":0.000014624475,"teacher_disagreement_score":0.06297928,"about_ca_system_score_codex":0.00006161009,"about_ca_system_score_gemma":0.00008366728,"threshold_uncertainty_score":0.9936004},"labels":[],"label_agreement":null},{"id":"W2952076809","doi":"10.1158/0008-5472.can-17-0344","title":"Software for the Integration of Multiomics Experiments in Bioconductor","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Human Genome Research Institute; Research Foundation of The City University of New York","keywords":"Bioconductor; Computer science; Software; Visualization; Data integration; Data mining; Data science; Bioinformatics; Computational biology; Biology; Genetics; Operating system","score_opus":0.24461443685123643,"score_gpt":0.5000952341773651,"score_spread":0.2554807973261287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952076809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409807,0.001360148,0.0032248655,0.000553978,0.00020786953,0.00045403297,0.00002328222,0.0000017624781,0.00007600892],"genre_scores_gemma":[0.9975215,0.00052567717,0.00028521655,0.000022409018,0.00012459062,0.00057671877,0.00001633901,0.000007984227,0.0009195556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948245,0.000033266453,0.00009412302,0.00015938698,0.00011031057,0.00012043909],"domain_scores_gemma":[0.9992194,0.000019855794,0.000057987618,0.00044694432,0.00023409746,0.000021672056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031336548,0.000041622312,0.000049454415,0.000038592465,0.00017338466,0.000029781297,0.00033291502,0.00005783012,0.000015451862],"category_scores_gemma":[0.00037454686,0.00002926571,0.000025280924,0.000044014017,0.00013459058,0.0000042446563,0.000078605066,0.00006358585,8.6748474e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010231887,0.000018106191,0.001318546,0.00000957355,0.000006313631,3.4733816e-8,0.000093511655,0.000011960661,0.97728515,0.00007478916,0.0025134643,0.018566249],"study_design_scores_gemma":[0.00042228028,0.00004531166,0.007183762,0.000022218035,0.0000011909941,7.742678e-8,0.00027819342,0.000076411714,0.9692258,0.000059249905,0.022649992,0.000035475663],"about_ca_topic_score_codex":0.00017551468,"about_ca_topic_score_gemma":0.00014825625,"teacher_disagreement_score":0.020136528,"about_ca_system_score_codex":0.000028174456,"about_ca_system_score_gemma":0.00013524202,"threshold_uncertainty_score":0.13335522},"labels":[],"label_agreement":null},{"id":"W2953404073","doi":"10.1158/1538-7445.am2019-3904","title":"Abstract 3904: Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cisplatin; Medicine; Pharmacokinetics; Internal medicine; Oncology; Confidence interval; Adverse effect; Chemotherapy; Endocrinology; Urology","score_opus":0.09839875122151723,"score_gpt":0.43082938252517256,"score_spread":0.33243063130365536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953404073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069273,0.006914411,0.00000100921,0.0002722808,0.00014603825,0.0009862927,0.00024317579,0.000013751218,0.0007303042],"genre_scores_gemma":[0.9936006,0.0031457753,0.000013553841,0.00003456057,0.000106652136,0.00020238484,0.000028364742,0.000028002081,0.0028400735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984096,0.0000979715,0.00037393346,0.00028817548,0.0004505964,0.000379667],"domain_scores_gemma":[0.9990493,0.00019523132,0.000111112684,0.00021517318,0.0002966322,0.00013257388],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033640148,0.0001694407,0.0005039495,0.00019340216,0.000038598944,0.000009520352,0.000074375545,0.000098189725,0.003556965],"category_scores_gemma":[0.000015772275,0.00013687993,0.00009178297,0.00018507072,0.00013008768,0.000060802347,0.00005682064,0.00023244254,0.000010444659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022616785,0.0006404132,0.82232934,0.0010129107,0.0006896905,0.00010712643,0.0015093416,0.00047443522,0.15865394,0.0000054695747,0.00027163152,0.012044013],"study_design_scores_gemma":[0.0092411125,0.0022164523,0.92145336,0.00094217516,0.0002826985,0.000010143429,0.00017970424,0.0011594725,0.06426012,0.00003810205,0.00004689358,0.00016979886],"about_ca_topic_score_codex":0.00049302523,"about_ca_topic_score_gemma":0.00012265948,"teacher_disagreement_score":0.099123985,"about_ca_system_score_codex":0.00034675281,"about_ca_system_score_gemma":0.00022669963,"threshold_uncertainty_score":0.9973539},"labels":[],"label_agreement":null},{"id":"W2953410976","doi":"10.1158/1538-7445.am2019-ct083","title":"Abstract CT083: A Phase I/II study of aurora kinase A inhibitor, LY3295668 erbumine (AK-01): Safety as monotherapy in patients with locally advanced or metastatic solid tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Eli Lilly (Canada); McGill University Health Centre","funders":"","keywords":"Medicine; Mucositis; Tolerability; Adverse effect; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cohort; Phases of clinical research; Oncology; Gastroenterology; Surgery; Toxicity","score_opus":0.023067700423223855,"score_gpt":0.3738208185280846,"score_spread":0.3507531181048607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953410976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955802,0.0014098693,0.000014883971,0.00004787772,0.00030687478,0.0023827536,0.00010459126,0.000009205589,0.00014372113],"genre_scores_gemma":[0.99746233,0.00069376186,0.00009689754,0.000083671635,0.00025290903,0.0003537569,0.00006485724,0.00006736161,0.0009244625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724835,0.00016744592,0.00051069615,0.00069465785,0.00074442633,0.000634439],"domain_scores_gemma":[0.9984402,0.000041359,0.00016642077,0.00068999396,0.0004669715,0.00019504185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005438669,0.00027593912,0.000520726,0.00023644758,0.00010065057,0.000024548475,0.00037048958,0.00008937835,0.00030377333],"category_scores_gemma":[0.000100740486,0.00021412654,0.00007143001,0.00057915074,0.00015944707,0.000022703984,0.00016786453,0.00034978404,0.000010272751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08285777,0.009051212,0.006731187,0.000315109,0.00040558423,0.000040843097,0.0021575522,0.0016547864,0.82542443,0.000012265318,0.0009656265,0.07038363],"study_design_scores_gemma":[0.19583583,0.07983495,0.06784541,0.0010478011,0.00012696895,0.000008534966,0.006045191,0.00008895165,0.5481881,0.000060799764,0.099100985,0.0018164698],"about_ca_topic_score_codex":0.000980054,"about_ca_topic_score_gemma":0.0015745453,"teacher_disagreement_score":0.2772363,"about_ca_system_score_codex":0.00011126994,"about_ca_system_score_gemma":0.00097174844,"threshold_uncertainty_score":0.8731827},"labels":[],"label_agreement":null},{"id":"W2953411656","doi":"10.1158/1538-7445.am2019-ct139","title":"Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Afatinib; Internal medicine; Oncology; Concomitant; Cancer; Gastroenterology; Gefitinib; Epidermal growth factor receptor","score_opus":0.06733122609892622,"score_gpt":0.47997346237144645,"score_spread":0.4126422362725202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953411656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948807,0.00016798203,0.00004589218,0.00024815282,0.000035572702,0.003711821,0.000079146295,0.000017470426,0.0008133013],"genre_scores_gemma":[0.99796164,0.000023155948,0.00021921498,0.000043602446,0.00003538959,0.00118392,0.00013900806,0.00004106706,0.00035300638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979569,0.00006671855,0.0003619991,0.000433056,0.00079573685,0.0003856414],"domain_scores_gemma":[0.9981672,0.0002762347,0.00015287506,0.00043660527,0.00084413885,0.00012294234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034665508,0.00016507844,0.00042751772,0.0005403295,0.00016936086,0.000030090914,0.00013734684,0.00005727249,0.00042229434],"category_scores_gemma":[0.00009582982,0.00012667241,0.00009612852,0.0014514436,0.00005832932,0.00016637976,0.000032432654,0.0002672904,0.0000044110884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003448226,0.018244265,0.87631017,0.00028153308,0.005128458,0.000021004173,0.014684635,0.004911642,0.015871417,0.000050599774,0.00008502072,0.06096304],"study_design_scores_gemma":[0.06941134,0.022801457,0.8713878,0.00040221369,0.0007563313,5.316092e-7,0.0101332525,0.0005264602,0.02300861,0.00006242558,0.0011337195,0.00037585423],"about_ca_topic_score_codex":0.0047939816,"about_ca_topic_score_gemma":0.0010438486,"teacher_disagreement_score":0.06596311,"about_ca_system_score_codex":0.00042055195,"about_ca_system_score_gemma":0.00044231847,"threshold_uncertainty_score":0.7247098},"labels":[],"label_agreement":null},{"id":"W2953453625","doi":"10.1158/1538-7445.am2019-3084","title":"Abstract 3084: BI-907828: A novel, potent MDM2 inhibitor, inhibits GBM brain tumor stem cells <i>in vitro</i> and prolonged survival in orthotopic xenograft mouse models","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mdm2; Temozolomide; Cancer research; Cancer; Medicine; Cell culture; Biology; Glioma; Internal medicine; Genetics","score_opus":0.05203886776944241,"score_gpt":0.3210633849506434,"score_spread":0.269024517181201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953453625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912612,0.0024975375,0.000023988192,0.0014620632,0.00030577322,0.0033872232,0.00010467826,0.0000667765,0.000890801],"genre_scores_gemma":[0.9970089,0.00038027993,0.00009896055,0.00032645836,0.00016422194,0.00048756332,0.0000234195,0.00011807414,0.0013921253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99543905,0.00024580923,0.0006678282,0.0010478745,0.0013444218,0.0012550349],"domain_scores_gemma":[0.9982318,0.00020843589,0.000113460206,0.00073056755,0.00029497282,0.000420754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020035265,0.00036341068,0.0007228139,0.000883903,0.000078531455,0.00008284035,0.00025747638,0.0002905328,0.00006953793],"category_scores_gemma":[0.00006405629,0.00035120724,0.00011816693,0.0012239354,0.00021395799,0.00023462367,0.00027999043,0.001960315,0.000065245375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017067401,0.00038450095,0.0022564838,0.00064468617,0.000044794135,0.00034798574,0.00086433545,0.0009806461,0.9884461,0.000045222114,0.0003624113,0.0039160848],"study_design_scores_gemma":[0.010697186,0.00050783425,0.0028692496,0.0011483151,0.000017862087,0.000038769467,0.0005599407,0.002343902,0.9788101,0.000053185937,0.0024783055,0.00047538083],"about_ca_topic_score_codex":0.0025726638,"about_ca_topic_score_gemma":0.0019749473,"teacher_disagreement_score":0.009636041,"about_ca_system_score_codex":0.0009898832,"about_ca_system_score_gemma":0.0011838638,"threshold_uncertainty_score":0.99989396},"labels":[],"label_agreement":null},{"id":"W2953462291","doi":"10.1158/1538-7445.am2019-2727","title":"Abstract 2727: The premalignant state captured in the landscape of somatic mutations can reveal the cancer cell-of-origin","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Canada's Michael Smith Genome Sciences Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Somatic cell; Carcinogenesis; Cancer; Chromatin; Genetics; Cell of origin; Cell type; Epigenetics; Cancer cell; Genome; Ovarian cancer; Breast cancer; Cell; Cancer research; DNA; Gene","score_opus":0.03264801352798685,"score_gpt":0.3504157840829104,"score_spread":0.31776777055492356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953462291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895582,0.0065861326,0.000004721825,0.0014995815,0.00013566029,0.0006874137,0.00026113915,0.0000011490475,0.0012659942],"genre_scores_gemma":[0.9958918,0.0031854005,0.000008796644,0.00013666727,0.00011661444,0.00024192568,0.000027279566,0.000015385443,0.00037610397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876887,0.00014730728,0.0002499593,0.00021087826,0.00032723838,0.0002957782],"domain_scores_gemma":[0.9988336,0.00026802745,0.00010884547,0.00058310316,0.0001734182,0.00003299211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091622584,0.00009540713,0.00013208328,0.000032415533,0.00008600601,0.000028889377,0.00060958706,0.000055989174,0.00009671692],"category_scores_gemma":[0.00006503945,0.00004940709,0.00006233638,0.0001947521,0.00017805309,0.0000031940483,0.00010318032,0.00021673583,0.0000033783724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018955368,0.00013235782,0.035258383,0.00033320402,0.00010105291,0.0000044877006,0.0066193985,0.011249294,0.931483,0.0002932182,0.012255662,0.0020803998],"study_design_scores_gemma":[0.0022102708,0.000564811,0.1843499,0.00031458866,0.000067972745,0.0000063619477,0.010545014,0.00039552758,0.7747494,0.0017640945,0.024611117,0.00042094506],"about_ca_topic_score_codex":0.011409743,"about_ca_topic_score_gemma":0.015702335,"teacher_disagreement_score":0.15673359,"about_ca_system_score_codex":0.00005410818,"about_ca_system_score_gemma":0.00077038346,"threshold_uncertainty_score":0.99517334},"labels":[],"label_agreement":null},{"id":"W2953482371","doi":"10.1158/1538-7445.am2019-594","title":"Abstract 594: Associations of hemoglobin A1c with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort (CPS-II NC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Cohort; Internal medicine; Cancer; Endometrial cancer; Diabetes mellitus; Type 2 diabetes; Breast cancer; Oncology; Gynecology; Obstetrics; Endocrinology","score_opus":0.02630967365408702,"score_gpt":0.3537796676426477,"score_spread":0.32746999398856064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953482371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96251494,0.034829933,0.0000014174839,0.0000708505,0.00014919163,0.0017133264,0.0002980761,0.0000048374254,0.00041743083],"genre_scores_gemma":[0.97874266,0.019655284,0.0000109486145,0.000028785487,0.00013043378,0.0010078019,0.000101772006,0.000025264673,0.00029707738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975837,0.00042347264,0.00041055077,0.0004438266,0.00070016587,0.0004382977],"domain_scores_gemma":[0.9985673,0.000057945945,0.00029027052,0.00052508485,0.00050408347,0.000055313245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019597532,0.00015787367,0.00033975104,0.00013711993,0.00016183694,0.000015344713,0.0004115577,0.00016014754,0.0002703802],"category_scores_gemma":[0.000084495114,0.00011966709,0.00010081981,0.0006565591,0.00015488983,0.00001661219,0.00010955696,0.0003880652,0.0000026079815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019591583,0.0007998056,0.8969545,0.00018767122,0.0005934694,6.285456e-7,0.00096601027,0.0013698718,0.085759655,0.00001951259,0.0024978486,0.0106551135],"study_design_scores_gemma":[0.003923564,0.0015039602,0.85270566,0.00033316197,0.00014847785,1.9922415e-7,0.0013633516,0.000049725128,0.13242003,0.00020851503,0.007070314,0.0002730688],"about_ca_topic_score_codex":0.004867215,"about_ca_topic_score_gemma":0.007012362,"teacher_disagreement_score":0.046660367,"about_ca_system_score_codex":0.00025806302,"about_ca_system_score_gemma":0.00076112896,"threshold_uncertainty_score":0.7357806},"labels":[],"label_agreement":null},{"id":"W2953495104","doi":"10.1158/1538-7445.am2019-3114","title":"Abstract 3114: Correlation between response to atezolizumab and PD-L1 tumor expression in pediatric and young adult patients enrolled in the phase I/II iMATRIX-atezo study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Internal medicine; Oncology; Lymphoma; Progressive disease; Cancer; Immunotherapy; Disease; Pembrolizumab","score_opus":0.033792147924733146,"score_gpt":0.4051539350415538,"score_spread":0.37136178711682066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953495104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950357,0.00025471716,2.9208567e-7,0.0003793244,0.00004883187,0.0040947804,0.00003407992,0.000011835756,0.00014044438],"genre_scores_gemma":[0.99899197,0.00013573244,0.00000775111,0.000031011685,0.00006869419,0.00042816624,0.00001613346,0.000025221394,0.00029530327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968583,0.00066733215,0.00032761827,0.00050491304,0.0010769885,0.00056484825],"domain_scores_gemma":[0.9984766,0.0006419863,0.000052278894,0.00034071688,0.00022804081,0.00026034375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014758008,0.00016947537,0.00030904508,0.0008103167,0.00016720283,0.000060947666,0.00013586548,0.00005863156,0.00006385735],"category_scores_gemma":[0.00064897136,0.000112463385,0.000026197411,0.0008572291,0.000050917635,0.00016969629,0.00021377129,0.00066373864,0.00005371801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02036539,0.001313208,0.96681225,0.00009127724,0.0000151454105,0.00030355927,0.0029208274,0.0000036865918,0.005041034,5.1785184e-7,0.00020261576,0.0029304654],"study_design_scores_gemma":[0.02396439,0.00556563,0.9687321,0.00013768232,0.000016361091,0.000005118035,0.0006305132,0.00003583321,0.0007810575,0.000011594919,0.000027241545,0.00009244426],"about_ca_topic_score_codex":0.0007445121,"about_ca_topic_score_gemma":0.00016325417,"teacher_disagreement_score":0.004259976,"about_ca_system_score_codex":0.00027196613,"about_ca_system_score_gemma":0.0002350755,"threshold_uncertainty_score":0.45861238},"labels":[],"label_agreement":null},{"id":"W2953501806","doi":"10.1158/1538-7445.am2019-1500","title":"Abstract 1500: Mediators of CD8+ cytotoxic T lymphocyte infiltration in pancreatic cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Cytotoxic T cell; Pancreatic cancer; Chemokine; CCL5; CXCL9; CXCL10; Cancer research; CD8; Immune system; Immunotherapy; Immunology; Cancer immunotherapy; T cell; Medicine; Biology; Cancer; Internal medicine; IL-2 receptor","score_opus":0.04773726485834382,"score_gpt":0.3878654520946729,"score_spread":0.34012818723632904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953501806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886934,0.006939375,9.481094e-7,0.0005554033,0.0002734948,0.00091479684,0.000028800947,0.000018182895,0.0025755719],"genre_scores_gemma":[0.9910177,0.0072390866,0.000017142034,0.00014267948,0.00017980719,0.00028212674,0.000014123623,0.000029438286,0.0010778944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979639,0.00008165506,0.00040395083,0.0003097304,0.0007870353,0.00045375002],"domain_scores_gemma":[0.99900776,0.00018009364,0.00009417258,0.00038231455,0.00022399165,0.00011167587],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009018654,0.0001343398,0.00036586382,0.00042005366,0.000039110688,0.000016976506,0.00016750763,0.00013720538,0.0046276366],"category_scores_gemma":[0.00006934609,0.00011408544,0.00009056232,0.00091239356,0.0001900316,0.00012803671,0.000032740983,0.0003433739,0.000061834035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030994306,0.000089850524,0.19085479,0.0005640538,0.00010272266,0.000012999791,0.0006438705,0.000036493475,0.78842616,0.000029226576,0.0009663694,0.015174052],"study_design_scores_gemma":[0.006221998,0.0003484986,0.59681517,0.0014671749,0.000023072562,0.0000058616993,0.00052740885,0.000096763215,0.3882969,0.00005847086,0.005944383,0.00019427949],"about_ca_topic_score_codex":0.010672317,"about_ca_topic_score_gemma":0.0016850142,"teacher_disagreement_score":0.40596038,"about_ca_system_score_codex":0.0011282548,"about_ca_system_score_gemma":0.0017049368,"threshold_uncertainty_score":0.9962823},"labels":[],"label_agreement":null},{"id":"W2953512316","doi":"10.1158/1538-7445.am2019-ct188","title":"Abstract CT188: 5-year survival and other long-term outcomes from KEYNOTE-006 study of pembrolizumab (pembro) for ipilimumab (ipi)-naive advanced melanoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Discontinuation; Medicine; Family medicine; Internal medicine","score_opus":0.09129829141963566,"score_gpt":0.41869285483120017,"score_spread":0.3273945634115645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953512316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923188,0.0021756508,0.000007274864,0.00032126918,0.00043371352,0.003054645,0.00025993236,0.000034643228,0.0013940663],"genre_scores_gemma":[0.99721926,0.0002871198,0.00005052084,0.000110643996,0.00018555316,0.0003300763,0.000025326906,0.00007877594,0.0017127324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973303,0.00012158988,0.00046758645,0.0006444362,0.0008544791,0.00058161595],"domain_scores_gemma":[0.99803907,0.0006059843,0.0001427525,0.00070893596,0.00034325646,0.00015999608],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071326765,0.00026212604,0.00071678765,0.00024300322,0.00011529265,0.00004308325,0.00028612957,0.00015097503,0.0016971596],"category_scores_gemma":[0.00006237231,0.00020974298,0.0001631806,0.00028057196,0.00021562252,0.0001184777,0.000109799934,0.0003837852,0.00002821795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04018651,0.0007693136,0.8475492,0.00050101074,0.0010819149,0.000017036293,0.0021218313,0.000005225117,0.08361174,0.0000285064,0.00038488128,0.023742847],"study_design_scores_gemma":[0.034563992,0.0020970623,0.94703996,0.000287889,0.00008032335,0.0000021025282,0.0044991225,0.000009331653,0.009984246,0.000043015043,0.0011451277,0.00024780526],"about_ca_topic_score_codex":0.0047251717,"about_ca_topic_score_gemma":0.0010861106,"teacher_disagreement_score":0.09949081,"about_ca_system_score_codex":0.00027966997,"about_ca_system_score_gemma":0.00033546903,"threshold_uncertainty_score":0.9992154},"labels":[],"label_agreement":null},{"id":"W2953541197","doi":"10.1158/1538-7445.am2019-ct012","title":"Abstract CT012: Open-label, multicenter, Phase Ib study to assess safety, tolerability and efficacy of adavosertib monotherapy in patients with advanced solid tumors: Expansion cohorts","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Medicine; Tolerability; Nausea; Internal medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Breast cancer; Cancer; Metastatic breast cancer; Gastroenterology; Progressive disease; Chemotherapy; Surgery","score_opus":0.08270640598563027,"score_gpt":0.46787021229216635,"score_spread":0.38516380630653607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953541197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029714,0.00038054833,0.000026378935,0.00022393752,0.00008256066,0.0088450955,0.00004983468,0.000024400977,0.00007010332],"genre_scores_gemma":[0.99872667,0.0000809947,0.00046659057,0.0001123076,0.000034451958,0.00041437565,0.000019058834,0.00006970496,0.00007584873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966327,0.00021227759,0.0006317215,0.00085489365,0.0010394467,0.00062894943],"domain_scores_gemma":[0.997643,0.00029260264,0.00015566926,0.0008725238,0.0007247492,0.00031144702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009829456,0.00027688607,0.0008959692,0.0002857064,0.000089850044,0.000045403533,0.00039023274,0.0000565396,0.00025650417],"category_scores_gemma":[0.00012852486,0.0002204283,0.000023487333,0.00065610977,0.00016801119,0.0004338834,0.0002792318,0.0005213561,0.000008700663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1230488,0.015326385,0.6209832,0.00027446213,0.00013427809,0.000024331164,0.0031084232,0.0003862887,0.057864998,0.0000029734383,0.000009629161,0.17883627],"study_design_scores_gemma":[0.08103849,0.010491567,0.89339,0.0013225412,0.000014242274,8.737335e-7,0.0012606625,0.000040515388,0.011983981,0.000010612723,0.00020878096,0.00023774659],"about_ca_topic_score_codex":0.00091753044,"about_ca_topic_score_gemma":0.00051807554,"teacher_disagreement_score":0.27240682,"about_ca_system_score_codex":0.00061100285,"about_ca_system_score_gemma":0.00041304063,"threshold_uncertainty_score":0.8988805},"labels":[],"label_agreement":null},{"id":"W2953561286","doi":"10.1158/1538-7445.am2019-2623","title":"Abstract 2623: Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Allosteric regulation; GABAA receptor; Cancer research; Biology; Receptor; Benzodiazepine; Pharmacology; Chemistry; Internal medicine; Medicine; Biochemistry","score_opus":0.10302537942635526,"score_gpt":0.4076556902308134,"score_spread":0.3046303108044581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953561286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166787,0.00006569027,0.0000020087632,0.00079218403,0.00030256913,0.0013220871,0.00003198866,0.00005012766,0.0057654884],"genre_scores_gemma":[0.9972175,0.0003078298,0.000025884416,0.0004662887,0.00008756785,0.00027719428,0.0000012458981,0.0000611883,0.0015553191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943195,0.0009898546,0.00033415848,0.0013650771,0.0015848597,0.001406531],"domain_scores_gemma":[0.9972058,0.0017445694,0.0001295695,0.0003675215,0.000271785,0.00028074934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009411258,0.00030127287,0.00035302422,0.0008505344,0.00039472638,0.00016924566,0.0009903141,0.00011167628,0.0007719522],"category_scores_gemma":[0.00050790823,0.00024681547,0.000054991848,0.0026424716,0.0007564807,0.00083991897,0.00044756394,0.001749424,0.00027569436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004991403,0.00018709821,0.009638599,0.000058043453,0.0000046568184,0.0003087965,0.0013302723,0.0002831639,0.9866059,0.00006270139,0.000101787184,0.00091988454],"study_design_scores_gemma":[0.001027244,0.00086552073,0.028806373,0.00014848159,0.000001981923,0.000015515665,0.00051198277,0.0002469086,0.96783763,0.00006845032,0.00019695217,0.00027292914],"about_ca_topic_score_codex":0.00023556729,"about_ca_topic_score_gemma":0.000043258628,"teacher_disagreement_score":0.019167775,"about_ca_system_score_codex":0.00032667894,"about_ca_system_score_gemma":0.00062596047,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W2953565010","doi":"10.1158/1538-7445.am2019-3935","title":"Abstract 3935: PLK4 inhibition as a strategy for non-small cell lung cancer radiosensitization","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Clonogenic assay; Lung cancer; Cancer research; Radiosensitivity; Mitotic catastrophe; A549 cell; Cancer; Medicine; Cell cycle; Radiation sensitivity; Programmed cell death; Mitosis; Radiation therapy; Biology; Oncology; Cell; Apoptosis; Internal medicine; Cell biology; Biochemistry","score_opus":0.025990936824765314,"score_gpt":0.3494260875612759,"score_spread":0.3234351507365106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953565010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422246,0.0014752591,0.0005197533,0.00014843022,0.00018577445,0.0011050648,0.0001146916,0.000008855387,0.0022196905],"genre_scores_gemma":[0.9919625,0.0022571746,0.00007375257,0.00016559029,0.0004962147,0.00036874527,0.00033502135,0.000043765398,0.004297241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873877,0.000039072384,0.00016670716,0.00043441492,0.00018106852,0.00043998903],"domain_scores_gemma":[0.9991515,0.000023190987,0.00005601741,0.0002835896,0.00039048638,0.00009519998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031468578,0.00013231048,0.00013009796,0.00008086108,0.000109209046,0.000059054484,0.00013391045,0.00020621534,0.00016086274],"category_scores_gemma":[0.000019614405,0.000134661,0.00007767366,0.00013401883,0.00004612806,0.000007806857,0.00006670686,0.00019026166,0.00003128272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016304576,0.00004057646,0.00097525585,0.00028159408,0.000030699965,0.000001977255,0.0000741031,0.0010354433,0.98870957,0.000045592238,0.006973985,0.0016681417],"study_design_scores_gemma":[0.0010703129,0.00021387161,0.0012132428,0.000096526375,0.000013225492,0.0000020192865,0.00013598579,0.00093882164,0.9841112,0.000045157503,0.011952335,0.00020733502],"about_ca_topic_score_codex":0.00056882587,"about_ca_topic_score_gemma":0.00044200802,"teacher_disagreement_score":0.0049783504,"about_ca_system_score_codex":0.00011494808,"about_ca_system_score_gemma":0.0005961921,"threshold_uncertainty_score":0.5491316},"labels":[],"label_agreement":null},{"id":"W2953614966","doi":"","title":"Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paracellular transport; Transcellular; Nimesulide; Celecoxib; Oral mucosa; Pharmacology; Drug; Bioavailability; Medicine; Cancer; Pharmacokinetics; Diclofenac; Ibuprofen; Chemistry; Permeability (electromagnetism); Internal medicine; Pathology; Biochemistry","score_opus":0.032960375914414655,"score_gpt":0.39013634455945445,"score_spread":0.3571759686450398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953614966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962681,0.00024064613,0.00020996566,0.0007798092,0.00022408969,0.0013938588,0.000009771985,0.000033392927,0.0008403841],"genre_scores_gemma":[0.994791,0.00017950521,0.00039061793,0.000099269324,0.0015924436,0.0009860066,0.00001266165,0.000034951532,0.0019135829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983083,0.00005262242,0.0003069305,0.00029690797,0.0005593929,0.00047582434],"domain_scores_gemma":[0.9990232,0.00008483863,0.000080955775,0.0001985889,0.00044920447,0.00016321505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009756411,0.00013104778,0.00032809118,0.00019882518,0.000119968856,0.000014436127,0.00011179605,0.00015486451,0.00042057416],"category_scores_gemma":[0.000046997055,0.00011725745,0.00010958269,0.00027285822,0.000116108036,0.00008437843,0.000040322615,0.00033677966,0.000022607857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011484086,0.00013088297,0.016182166,0.0013807842,0.00010853027,0.0000024463175,0.00062121457,0.000055642093,0.87168956,0.00030225425,0.0068508005,0.10152732],"study_design_scores_gemma":[0.003599967,0.0002629218,0.033146743,0.00028240614,0.000055571563,0.0000027938402,0.000077902936,0.0010168394,0.9276231,0.000051321942,0.033718523,0.00016194803],"about_ca_topic_score_codex":0.00012090738,"about_ca_topic_score_gemma":0.00017952672,"teacher_disagreement_score":0.10136537,"about_ca_system_score_codex":0.00040822607,"about_ca_system_score_gemma":0.00056054286,"threshold_uncertainty_score":0.478162},"labels":[],"label_agreement":null},{"id":"W2953653332","doi":"10.1158/1538-7445.am2019-2720","title":"Abstract 2720: Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Protease; Proteolysis; In vivo; In vitro; Cancer cell; Biology; Synthetic lethality; Cancer; Mutant; Programmed cell death; Apoptosis; Cell biology; Cancer research; Biochemistry; Chemistry; Enzyme; Gene; Genetics","score_opus":0.04644365813195454,"score_gpt":0.3630070374939595,"score_spread":0.31656337936200496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953653332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673934,0.0043088803,0.0000054982397,0.00028691834,0.00043969083,0.0012614755,0.000211884,0.000021192727,0.0067251353],"genre_scores_gemma":[0.99325824,0.0013232122,0.000063988686,0.000121712605,0.001303868,0.0011275272,0.000110834386,0.00004236536,0.0026482742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759096,0.00026214664,0.00022381892,0.0006931002,0.00054801896,0.00068193336],"domain_scores_gemma":[0.9986859,0.000059355294,0.000088235516,0.0004729866,0.00050399615,0.00018951837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006026313,0.00019728193,0.00022049715,0.000070459784,0.00016015384,0.00006385054,0.0004275886,0.0003229832,0.001940508],"category_scores_gemma":[0.00013229303,0.00018003362,0.000109810266,0.0003236021,0.0001489673,0.000012065459,0.0002021452,0.00057426613,0.00031715195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036872696,0.000077637604,0.002374415,0.000112183676,0.00008167358,0.0000027966073,0.00019143989,0.000023461595,0.9895392,0.0000072032108,0.0056763375,0.0015449374],"study_design_scores_gemma":[0.0007789744,0.00022590639,0.0027307349,0.000040093528,0.000008677588,6.153094e-7,0.00013589158,0.000006564316,0.9554107,0.000043050026,0.04038455,0.00023420183],"about_ca_topic_score_codex":0.0037138555,"about_ca_topic_score_gemma":0.00073437445,"teacher_disagreement_score":0.034708213,"about_ca_system_score_codex":0.00017817708,"about_ca_system_score_gemma":0.00092059,"threshold_uncertainty_score":0.9989719},"labels":[],"label_agreement":null},{"id":"W2953673400","doi":"10.1158/1538-7445.am2019-2388","title":"Abstract 2388: In vitro assessment of tumor associated I.O. markers in cancer cell lines following Vicinium treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Cancer research; Cancer; Population; Biology; Cell; Immune system; Cancer cell; Immunology; Medicine","score_opus":0.03880193010095408,"score_gpt":0.4231564096446067,"score_spread":0.38435447954365265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953673400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913148,0.0038095084,5.4424765e-7,0.00011485238,0.00014305768,0.00084443705,0.00014336061,0.0000047144254,0.0036247133],"genre_scores_gemma":[0.9952549,0.0026277462,0.000031979198,0.0000248357,0.0000677866,0.0006534787,0.00011539627,0.000033990495,0.0011899167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977513,0.00017352524,0.0003126473,0.00051220873,0.0005297327,0.00072057784],"domain_scores_gemma":[0.999238,0.00006873993,0.00007733998,0.0003536755,0.00013532463,0.00012688396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062901486,0.00018599375,0.0003312088,0.00018703003,0.000041523643,0.000025459483,0.00024356057,0.00011337003,0.00025652198],"category_scores_gemma":[0.000037762016,0.00016537575,0.00013796234,0.00039106168,0.000057706977,0.000012348719,0.000120582175,0.00023720854,0.000008003691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172009,0.0005252258,0.19599718,0.00007094992,0.00012839415,0.000043612486,0.00005388201,0.00017672205,0.7998431,0.0000012201981,0.00019975932,0.002342771],"study_design_scores_gemma":[0.005343285,0.0007490811,0.20025532,0.0001785295,0.000010708369,3.5895462e-7,0.00034649487,0.00011469908,0.7912248,0.000010174473,0.0015624336,0.0002041488],"about_ca_topic_score_codex":0.041979704,"about_ca_topic_score_gemma":0.027973117,"teacher_disagreement_score":0.014006586,"about_ca_system_score_codex":0.0014801646,"about_ca_system_score_gemma":0.001306341,"threshold_uncertainty_score":0.98976386},"labels":[],"label_agreement":null},{"id":"W2953704454","doi":"10.1158/1538-7445.am2019-1805","title":"Abstract 1805: Integrative analysis of microRNAs in blastic plasmacytoid dendritic cell neoplasm","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"microRNA; Transcriptome; Biology; Computational biology; Gene expression profiling; Gene; Disease; Cancer research; Bioinformatics; Gene expression; Genetics; Medicine; Internal medicine","score_opus":0.03907003895030021,"score_gpt":0.4006090400353456,"score_spread":0.3615390010850454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953704454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448783,0.0011084985,0.000012214587,0.00033562823,0.00006654858,0.0010821975,0.00008636208,0.000015233612,0.012805499],"genre_scores_gemma":[0.99339,0.0005688975,0.000055238357,0.00004840061,0.000035427955,0.00014660304,0.000045726974,0.000040546358,0.005669119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965129,0.00023840247,0.0004970077,0.00061382976,0.001290186,0.0008476966],"domain_scores_gemma":[0.99698275,0.0011178332,0.00007688707,0.0005528425,0.0010248881,0.00024480635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086345413,0.00021803896,0.0008155891,0.0024123618,0.00006647247,0.00004135262,0.00034300634,0.00015268374,0.004298178],"category_scores_gemma":[0.0005272304,0.00018614982,0.00022879618,0.0039686863,0.0004076392,0.00008673679,0.00014929163,0.0010729076,0.00038770132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001580896,0.00060308096,0.3477373,0.00068000704,0.00077740307,0.0002964775,0.0027217302,0.0008212131,0.642499,0.00009699291,0.00069980044,0.0014860305],"study_design_scores_gemma":[0.008281995,0.001480815,0.3565289,0.0012932523,0.0004950985,0.000065432345,0.011705426,0.010376646,0.60706383,0.00023317517,0.0018135316,0.0006618682],"about_ca_topic_score_codex":0.0033920002,"about_ca_topic_score_gemma":0.0056452975,"teacher_disagreement_score":0.035435207,"about_ca_system_score_codex":0.00092907005,"about_ca_system_score_gemma":0.0015098343,"threshold_uncertainty_score":0.996612},"labels":[],"label_agreement":null},{"id":"W2953722762","doi":"10.1158/1538-7445.am2019-1449","title":"Abstract 1449: MG1 Maraba boost following adenovirus prime generates tumor antigen-specific T cells which are potentiated by anti-PD-1 antibody combination","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Interface Biologics (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; Antigen; Priming (agriculture); Antibody; Immunotherapy; Cancer research; Medicine; Oncolytic adenovirus; Immunology; Cancer immunotherapy; Combination therapy; Cancer; Biology; Pharmacology; Internal medicine","score_opus":0.028491927226995454,"score_gpt":0.35341544261664215,"score_spread":0.3249235153896467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953722762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823493,0.014627353,0.000033596018,0.00041922837,0.00047625176,0.0011498559,0.00022228352,0.00004252317,0.000679633],"genre_scores_gemma":[0.98988885,0.0068474356,0.000024531284,0.00012487949,0.00030561787,0.000101870035,0.0009087267,0.00013680838,0.0016613117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99541104,0.00043091475,0.0004363749,0.0011573863,0.0012712325,0.0012930454],"domain_scores_gemma":[0.9975443,0.000055491615,0.00015587822,0.0010055739,0.00094342284,0.00029531523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015763097,0.00037310526,0.00040873254,0.00031442853,0.00041449742,0.00031639845,0.00091168494,0.00030131335,0.0007334519],"category_scores_gemma":[0.00006533585,0.00037683337,0.00018794341,0.0009229035,0.00016952516,0.000036750604,0.00033039824,0.0007506094,0.00050907576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000979574,0.0002520214,0.01215188,0.00005834928,0.00017853487,0.000036900332,0.000031060237,0.00011785722,0.97323716,0.0000041051176,0.011871339,0.0010812136],"study_design_scores_gemma":[0.0016736288,0.0009695744,0.012681276,0.00009374477,0.0000054038464,0.000003511587,0.00010868945,0.00009213926,0.9613773,0.000012628936,0.02254628,0.0004358251],"about_ca_topic_score_codex":0.00028708202,"about_ca_topic_score_gemma":0.0001547626,"teacher_disagreement_score":0.011859867,"about_ca_system_score_codex":0.00020642857,"about_ca_system_score_gemma":0.0006092941,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W2953726607","doi":"10.1158/1538-7445.am2019-3829","title":"Abstract 3829: NEO1132 and NEO2734, novel dual bromodomain inhibitors of both BET and CREBBP/EP300, compared to single BET or CREBB/EP300 inhibitors in diffuse large B cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Bromodomain; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; CREB-binding protein; BET inhibitor; BRD4; Chromosomal translocation; Transcription factor; Biology; Chemistry; Molecular biology; Acetylation; CREB; Biochemistry; Immunology; Gene","score_opus":0.036618061565762625,"score_gpt":0.3262900807861814,"score_spread":0.28967201922041874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953726607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996388,0.0013336327,0.00003166892,0.0003123387,0.00019239569,0.0009326833,0.00023312517,0.000013396682,0.000562755],"genre_scores_gemma":[0.9978507,0.00022328032,0.000259583,0.00015427479,0.0002880237,0.00008453272,0.00008650362,0.000053812295,0.0009992829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973635,0.00013906264,0.0005057593,0.0007358217,0.0005438604,0.0007120116],"domain_scores_gemma":[0.99877226,0.00009549129,0.00012493423,0.00047308643,0.00018718519,0.0003470618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084614224,0.00027411003,0.00038833317,0.00034899564,0.00011697352,0.00009471644,0.00024775244,0.00027235333,0.00008598263],"category_scores_gemma":[0.00018387024,0.00024914625,0.00006426729,0.00048482176,0.0002364358,0.000030798932,0.0004891118,0.00025241383,0.000012487153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071414845,0.0009821936,0.009374686,0.00019429954,0.000022248742,0.000011192321,0.0003634266,0.000010983184,0.98091507,0.000028939243,0.0060602524,0.0013225432],"study_design_scores_gemma":[0.009714333,0.000790821,0.014513527,0.00026446834,0.000007579592,0.0000109540315,0.0007773612,0.00004833597,0.9257964,0.000020392532,0.047639284,0.00041656915],"about_ca_topic_score_codex":0.0008730775,"about_ca_topic_score_gemma":0.0009767943,"teacher_disagreement_score":0.055118714,"about_ca_system_score_codex":0.00012270326,"about_ca_system_score_gemma":0.0003375895,"threshold_uncertainty_score":0.99999607},"labels":[],"label_agreement":null},{"id":"W2953735966","doi":"10.1158/1538-7445.am2019-2296","title":"Abstract 2296: Validation of a novel one-step digital PCR platform with precision circulating cell-free DNA standards","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Innovative Microfluidic and Catalytic Techniques Innovation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centracare","funders":"","keywords":"Digital polymerase chain reaction; T790M; Liquid biopsy; Resistance mutation; Cancer; Cancer research; Medicine; Polymerase chain reaction; Biology; Epidermal growth factor receptor; Internal medicine; Reverse transcriptase; Genetics; Gene","score_opus":0.05655263355619434,"score_gpt":0.33487921297913453,"score_spread":0.2783265794229402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953735966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995899,0.00010402957,0.07717273,0.000019339745,0.000075809,0.00052274833,0.00026584466,0.00011087992,0.02213875],"genre_scores_gemma":[0.99875814,0.000016555701,0.0007787629,0.000004358818,0.00006346354,0.000050613016,0.0000828697,0.000047257738,0.00019798771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980474,0.0000057927577,0.0003436314,0.00022595815,0.0010480372,0.00032915443],"domain_scores_gemma":[0.9983731,0.00007915062,0.00007330712,0.00044678184,0.0009922499,0.00003544102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095116434,0.0001347806,0.00018909683,0.00028595873,0.00005856841,0.000074663876,0.00029818894,0.000105077714,0.00019105691],"category_scores_gemma":[0.00007265667,0.0001232273,0.000029019471,0.0009000674,0.00008600581,0.00047837602,0.00010072364,0.00040219384,0.00001005405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088587934,0.000050136045,0.0006703499,0.00042186934,0.0000337801,0.0000013309877,0.00026140944,0.0005244707,0.97868055,0.0012651454,0.0017217499,0.016280623],"study_design_scores_gemma":[0.0009561305,0.00012800217,0.0009836005,0.00042204908,0.000003786611,0.0000023044452,0.00019555274,0.00077706005,0.99347275,0.00021284897,0.0026713596,0.00017454299],"about_ca_topic_score_codex":0.000043107706,"about_ca_topic_score_gemma":0.0000011919631,"teacher_disagreement_score":0.099168256,"about_ca_system_score_codex":0.0006126564,"about_ca_system_score_gemma":0.0002285711,"threshold_uncertainty_score":0.5025064},"labels":[],"label_agreement":null},{"id":"W2953736933","doi":"10.1158/1538-7445.am2019-2747","title":"Abstract 2747: Loss of S100A10 gene suppresses mammary tumor progression in PyMT mouse tumor model","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"","keywords":"Breast cancer; Mammary tumor; Genetically modified mouse; Tumor progression; Cancer research; Cancer; Pathology; Biology; Medicine; Transgene; Internal medicine; Gene","score_opus":0.036505976508369564,"score_gpt":0.3757405312587706,"score_spread":0.33923455475040104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953736933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960207,0.002260058,0.000039275306,0.00014539243,0.000049324248,0.0005322354,0.00007044241,0.000008772057,0.00087384955],"genre_scores_gemma":[0.9972431,0.00052228,0.00038776282,0.000056921137,0.00011305491,0.00018499664,0.000042235835,0.00003366761,0.0014159749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840367,0.00006266827,0.00023632169,0.0004423026,0.0003817041,0.0004733144],"domain_scores_gemma":[0.9990505,0.000015833763,0.000065541804,0.0005413605,0.00022553711,0.000101206286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045240895,0.000136995,0.00019041481,0.00012588524,0.000044435106,0.00002879066,0.00045140632,0.00009996968,0.000119749166],"category_scores_gemma":[0.00005855419,0.00011889437,0.000067329216,0.00018461724,0.00013236901,0.000013139114,0.00032183566,0.00027618257,0.000019324856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027311753,0.00014141065,0.006212587,0.00019384676,0.000014602475,0.000027355341,0.000035973575,0.00079534133,0.9901333,0.000060518953,0.0010982715,0.0010136822],"study_design_scores_gemma":[0.0006388692,0.00019935904,0.0026898694,0.00011122546,0.0000014776277,0.0000045243655,0.000041821037,0.0005236394,0.9935126,0.00011283365,0.0020149846,0.00014882548],"about_ca_topic_score_codex":0.00021617896,"about_ca_topic_score_gemma":0.00008116719,"teacher_disagreement_score":0.0035227176,"about_ca_system_score_codex":0.000041687756,"about_ca_system_score_gemma":0.00047880242,"threshold_uncertainty_score":0.48483717},"labels":[],"label_agreement":null},{"id":"W2953737360","doi":"10.1158/1538-7445.am2019-5225","title":"Abstract 5225: Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; LNCaP; Androgen receptor; Androgen deprivation therapy; Cancer research; P-Chloroamphetamine; Gene knockdown; Corepressor; SOX2; Transcription factor; Biology; Downregulation and upregulation; Endocrinology; Gene silencing; Prostate; Cancer; Medicine; Internal medicine; Repressor; Receptor; Cell culture; Genetics","score_opus":0.043970121910423765,"score_gpt":0.3695935053490898,"score_spread":0.32562338343866604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953737360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872214,0.009503785,0.0000019623162,0.0009748411,0.00009775297,0.0016025085,0.00004122101,0.00003549714,0.000521016],"genre_scores_gemma":[0.99059206,0.005866864,0.00004824554,0.000030200516,0.00012495591,0.00040142037,0.00004966921,0.000040239065,0.0028463672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975191,0.00008416781,0.00027074802,0.00058732275,0.0007973565,0.0007413282],"domain_scores_gemma":[0.9990037,0.00012928639,0.000054422646,0.00026078403,0.0003030556,0.0002487557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047380792,0.00018921249,0.00031754977,0.00038633568,0.00014296464,0.00007805978,0.00013499062,0.00013174616,0.0013996544],"category_scores_gemma":[0.000058229492,0.00014450749,0.000047137808,0.0005281354,0.00020569746,0.00024024947,0.00017810802,0.00063052034,0.00007693622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011135782,0.00010885706,0.3657197,0.00055306836,0.000043665474,0.000096936186,0.0004323669,0.00006323007,0.62601966,0.000014780115,0.0005246895,0.0053094393],"study_design_scores_gemma":[0.003955082,0.00022679291,0.31067118,0.0012984617,0.000016159418,0.000005628053,0.00022908236,0.00038500116,0.68157333,0.0002424118,0.001213038,0.00018381822],"about_ca_topic_score_codex":0.0015719994,"about_ca_topic_score_gemma":0.00014216221,"teacher_disagreement_score":0.055553682,"about_ca_system_score_codex":0.00045575888,"about_ca_system_score_gemma":0.0004672628,"threshold_uncertainty_score":0.9995132},"labels":[],"label_agreement":null},{"id":"W2953773331","doi":"10.1158/1538-7445.am2019-lb-315","title":"Abstract LB-315: Overexpression of prolactin inducible protein (PIP) in 4T1 cells leads to delayed tumor onset and reduced tumor size in experimental model of mouse breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cancer research; Breast cancer; Cancer; Carcinogenesis; Biology; Immune system; Immunology; Medicine; Internal medicine","score_opus":0.030432991933538992,"score_gpt":0.3468080255661395,"score_spread":0.3163750336326005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953773331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638104,0.0016234556,9.777981e-7,0.00007704572,0.000090518326,0.0013496827,0.00035684387,0.0000037666946,0.00011666164],"genre_scores_gemma":[0.99787337,0.00021918169,0.00015328125,0.000048111295,0.00012378236,0.0005952699,0.0000096475405,0.00003858655,0.00093876047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807525,0.00011472694,0.00037075573,0.00056618254,0.0003908087,0.0004822885],"domain_scores_gemma":[0.9991208,0.000023528186,0.00011452897,0.00041742896,0.00017243614,0.00015127752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005739658,0.0001806951,0.00034278526,0.00018792623,0.00002951752,0.000016321654,0.0002593247,0.00012274097,0.00014180865],"category_scores_gemma":[0.000053678945,0.00017328702,0.000050746592,0.00027551522,0.00011553793,0.000019075447,0.0002367825,0.00032534785,0.0000025129966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037333653,0.0002267704,0.0017091834,0.00017916664,0.000013141452,0.0000011883319,0.00034265948,0.0013180189,0.99143434,0.0000035025573,0.0006580787,0.0003805968],"study_design_scores_gemma":[0.0017039452,0.00019739445,0.0075348755,0.0003127944,0.0000025923382,0.0000024890428,0.00029623447,0.00016428214,0.98939216,0.000008117368,0.00020200043,0.00018313403],"about_ca_topic_score_codex":0.004270331,"about_ca_topic_score_gemma":0.0007994659,"teacher_disagreement_score":0.0058256923,"about_ca_system_score_codex":0.0001350514,"about_ca_system_score_gemma":0.00081889913,"threshold_uncertainty_score":0.70664394},"labels":[],"label_agreement":null},{"id":"W2953939482","doi":"10.1158/1538-7445.am2019-ct190","title":"Abstract CT190: A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Regimen; Hypomethylating agent; Internal medicine; Cancer; Immune system; Breast cancer; Immune checkpoint; Oncology; Adverse effect; Immunology; Gastroenterology; Immunotherapy; Nivolumab; DNA methylation; Biology","score_opus":0.062445916746577027,"score_gpt":0.4374362417948338,"score_spread":0.3749903250482568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953939482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953173,0.0033178516,0.0000106644275,0.000036722307,0.0000751177,0.0007442876,0.000018842287,0.0000039682122,0.00047528703],"genre_scores_gemma":[0.99859506,0.0005934004,0.00013880956,0.000010716751,0.00005769443,0.000090875736,0.000021103107,0.000025351294,0.0004669737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821424,0.00019723014,0.00035973417,0.0004592728,0.00039178148,0.00037773533],"domain_scores_gemma":[0.99917644,0.00005161722,0.00010322234,0.00036630747,0.00020277881,0.00009962963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012904527,0.0001343943,0.0002582035,0.00018530592,0.00009125252,0.000022908833,0.00017771733,0.000089436355,0.000057319805],"category_scores_gemma":[0.00019795074,0.00012922905,0.000039815925,0.0003024293,0.000073305055,0.000009274287,0.00025145023,0.00023985782,0.0000033886504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030027778,0.0012542005,0.017292885,0.00006117283,0.00003933225,0.0000054427037,0.000508119,0.00040747318,0.9495066,0.0000041249596,0.000017752303,0.030602662],"study_design_scores_gemma":[0.015614634,0.0057360977,0.08326752,0.00009996426,0.000013619992,8.972499e-7,0.002151308,0.00032751038,0.89040184,0.00015325294,0.0019119317,0.00032143405],"about_ca_topic_score_codex":0.0005695026,"about_ca_topic_score_gemma":0.0004963426,"teacher_disagreement_score":0.06597463,"about_ca_system_score_codex":0.000047083748,"about_ca_system_score_gemma":0.00015395242,"threshold_uncertainty_score":0.52698076},"labels":[],"label_agreement":null},{"id":"W2953971302","doi":"10.1158/1538-7445.am2019-ct058","title":"Abstract CT058: Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; GiST; Tolerability; Pharmacokinetics; Concomitant; Retrospective cohort study; Internal medicine; Gastroenterology; Pharmacology; Drug; Oncology; Adverse effect; Stromal cell","score_opus":0.03439763882485165,"score_gpt":0.39508373206589376,"score_spread":0.3606860932410421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953971302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871565,0.00010554826,7.659351e-7,0.000048998358,0.000026629852,0.012407508,0.000044231783,0.0000077130035,0.0002021152],"genre_scores_gemma":[0.99858767,0.000004591548,0.00007286638,0.0000050241483,0.00002355051,0.0012370066,0.0000055589626,0.000034996134,0.000028759769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99571365,0.00048464703,0.00046926594,0.00049683504,0.0022457729,0.00058985135],"domain_scores_gemma":[0.997974,0.00027324373,0.00021615216,0.00039023295,0.0009846276,0.00016179275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016979076,0.0002240629,0.00047245662,0.00037003137,0.00004269543,0.000015904252,0.00017668145,0.00002564294,0.00008699252],"category_scores_gemma":[0.00087385386,0.00014821511,0.00004726503,0.00082610606,0.00033411523,0.000098528464,0.0001515757,0.0006712836,0.000002636436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006829244,0.0034095086,0.9496907,0.0007572655,0.00004965105,0.00006436192,0.00073693844,0.000107501975,0.03757714,0.000004060606,0.000005792228,0.00076783577],"study_design_scores_gemma":[0.03339086,0.0149416765,0.8894124,0.0041539175,0.000049553717,0.000012480192,0.00074778474,0.00020600532,0.05696801,0.000023942268,0.0000015089482,0.00009182766],"about_ca_topic_score_codex":0.0009979894,"about_ca_topic_score_gemma":0.00018362737,"teacher_disagreement_score":0.060278267,"about_ca_system_score_codex":0.00079359236,"about_ca_system_score_gemma":0.00081885525,"threshold_uncertainty_score":0.60440373},"labels":[],"label_agreement":null},{"id":"W2954013874","doi":"10.1158/1538-7445.am2019-3106","title":"Abstract 3106: Targeting vitamin D signalling in metastatic neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Calcipotriol; Medicine; Calcitriol receptor; Cancer research; Cancer; In vivo; Metastasis; Neuroblastoma; Internal medicine; Vitamin D and neurology; Cell culture; Oncology; Biology; Immunology; Genetics","score_opus":0.07118824826849475,"score_gpt":0.4107156806879149,"score_spread":0.3395274324194202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954013874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994239,0.00043673784,0.0000038940934,0.0007726645,0.000090463545,0.0010568403,0.0000109642715,0.00003996021,0.0033495014],"genre_scores_gemma":[0.99702984,0.00023054317,0.00014763187,0.000103791645,0.000089889785,0.00018121678,0.000012678814,0.000055009354,0.0021493987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967977,0.0001989198,0.00030290123,0.00053395575,0.0011440511,0.0010225105],"domain_scores_gemma":[0.99857104,0.0004984653,0.000040525334,0.00031713094,0.0002333833,0.0003394829],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010011655,0.00016971854,0.0003324932,0.0006034061,0.000087866094,0.000058772403,0.00020304711,0.000050079252,0.0019995237],"category_scores_gemma":[0.00027926237,0.00014420014,0.00008410012,0.000869994,0.00010392272,0.00016371337,0.00012662308,0.0010312296,0.0013036644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009937267,0.0004355373,0.020599196,0.0005511257,0.0000869645,0.0019518181,0.0001794884,0.00022279595,0.96692115,0.000057207817,0.0015413489,0.006459621],"study_design_scores_gemma":[0.015511267,0.0036000325,0.29530224,0.0021984365,0.00005025844,0.00010651416,0.001047702,0.002234321,0.6708084,0.00055718276,0.007893559,0.00069011486],"about_ca_topic_score_codex":0.00053091114,"about_ca_topic_score_gemma":0.000082525505,"teacher_disagreement_score":0.2961128,"about_ca_system_score_codex":0.0003642689,"about_ca_system_score_gemma":0.0005378965,"threshold_uncertainty_score":0.9994739},"labels":[],"label_agreement":null},{"id":"W2954022476","doi":"10.1158/1538-7445.am2019-3043","title":"Abstract 3043: Examination of NMT1 and NMT2 as independent prognostic markers and novel drug targets in adult acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myeloid leukemia; Viability assay; Biology; Context (archaeology); Peripheral blood mononuclear cell; Myeloid; Leukemia; Cancer research; Flow cytometry; Apoptosis; Molecular biology; Immunology; In vitro; Biochemistry","score_opus":0.014890549804510178,"score_gpt":0.3117854046629869,"score_spread":0.2968948548584767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954022476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295115,0.004919806,0.000008656075,0.000105874184,0.0002150556,0.00052937446,0.000045341938,0.0000034142254,0.0012213158],"genre_scores_gemma":[0.9897395,0.008381835,0.00004865324,0.00004905272,0.00019539444,0.000095736505,0.000036620364,0.000019705043,0.001433551],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986867,0.000062173654,0.00018711007,0.00040462817,0.0003372262,0.00032220327],"domain_scores_gemma":[0.99934494,0.00004092709,0.000059506594,0.00021073123,0.00024023525,0.00010365127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067638396,0.00011850262,0.00017151899,0.00013416739,0.000040175128,0.000027214832,0.0001376331,0.00013241556,0.00004855039],"category_scores_gemma":[0.00013092734,0.00011513008,0.000027823799,0.00014303361,0.0001475885,0.000012973595,0.00015700207,0.0002448311,0.000004165124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028832088,0.00003794744,0.0076907747,0.0001754038,0.000052262512,0.0000020583143,0.00029103833,0.000015824462,0.97149515,0.00009140712,0.00065451604,0.019205293],"study_design_scores_gemma":[0.0027244203,0.00022030114,0.6582831,0.00015279834,0.000020432133,0.000012946597,0.00061098335,0.00006774396,0.3260426,0.00006824237,0.011548277,0.00024815556],"about_ca_topic_score_codex":0.0011649397,"about_ca_topic_score_gemma":0.00070892816,"teacher_disagreement_score":0.6505923,"about_ca_system_score_codex":0.00007833971,"about_ca_system_score_gemma":0.00038870392,"threshold_uncertainty_score":0.46948683},"labels":[],"label_agreement":null},{"id":"W2954034891","doi":"10.1158/1538-7445.am2019-1667","title":"Abstract 1667: A robust human immune profiling assay using CyTOF technology and automated data analysis software","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Mass cytometry; Immune system; Software; Computer science; Computational biology; Immunology; Biology; Operating system","score_opus":0.11378775808116254,"score_gpt":0.3970572800362588,"score_spread":0.28326952195509625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954034891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959861,0.0022323793,0.0010797367,0.000072907525,0.00006476664,0.0002786861,0.000111786234,0.00006604084,0.000107565116],"genre_scores_gemma":[0.99648875,0.00018176666,0.0024690013,0.000014982241,0.00008552396,0.00001734995,0.00046630861,0.00003092242,0.00024540912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838954,0.00007795779,0.00022509934,0.00064594636,0.00023287005,0.0004285792],"domain_scores_gemma":[0.99867487,0.000023644283,0.00005819082,0.00095485605,0.0002168914,0.00007154414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008213562,0.00013755696,0.00024225286,0.00039897955,0.0002096394,0.00007067431,0.00056829926,0.00026007433,0.000076711374],"category_scores_gemma":[0.000103092025,0.00013226796,0.000052637948,0.0008455467,0.00020006463,0.000011176716,0.00043769885,0.00033719567,0.000005609001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045530625,0.00003682686,0.062236227,0.00007351925,0.000289292,0.000004833811,0.000014214515,0.00095154945,0.93531543,0.00001861085,0.000061708015,0.0009522451],"study_design_scores_gemma":[0.0014127195,0.00023599663,0.019557565,0.000124171,0.0002088935,0.000010740129,0.00027980612,0.02550721,0.9499767,0.00007495889,0.0020692768,0.00054197566],"about_ca_topic_score_codex":0.0006444643,"about_ca_topic_score_gemma":0.00023605862,"teacher_disagreement_score":0.04267866,"about_ca_system_score_codex":0.000049903843,"about_ca_system_score_gemma":0.00019771898,"threshold_uncertainty_score":0.5393731},"labels":[],"label_agreement":null},{"id":"W2954037869","doi":"10.1158/1538-7445.am2019-ct172","title":"Abstract CT172: Phase III METIS study: Tumor Treating Fields (150 kHz) and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Cancer; Oncology; Radiology; Internal medicine; Clinical trial; Radiation therapy","score_opus":0.06924136620697163,"score_gpt":0.41372294103764784,"score_spread":0.3444815748306762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954037869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859371,0.007267754,0.000052642066,0.0010608805,0.0005022237,0.0039060984,0.0010027445,0.000032517393,0.00023801487],"genre_scores_gemma":[0.99221975,0.0008207051,0.00058442826,0.00027052173,0.0011124671,0.001222974,0.00015183057,0.000072906936,0.0035443946],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970376,0.00022823036,0.0004961329,0.0008622807,0.00060209626,0.0007736774],"domain_scores_gemma":[0.9961774,0.0023888682,0.00014214862,0.00050218013,0.00028761942,0.0005017996],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016468692,0.00034490484,0.0008630515,0.0002651209,0.00026726408,0.00015461248,0.00014356256,0.00011144993,0.0034384758],"category_scores_gemma":[0.00036576876,0.0002528875,0.00014307094,0.0003233849,0.00011400098,0.00016194889,0.0001363226,0.0004446536,0.000009230032],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068801574,0.009880988,0.2479846,0.005982145,0.009357156,0.0031703403,0.015947903,0.00018609184,0.12736328,0.00008842152,0.23109142,0.28014606],"study_design_scores_gemma":[0.45513904,0.035075076,0.101406746,0.006321693,0.008343859,0.00013349263,0.03156519,0.008702691,0.20114248,0.0003730921,0.14732674,0.0044699046],"about_ca_topic_score_codex":0.016829373,"about_ca_topic_score_gemma":0.0014307257,"teacher_disagreement_score":0.38633746,"about_ca_system_score_codex":0.00027086202,"about_ca_system_score_gemma":0.00095718366,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W2954050745","doi":"10.1158/1538-7445.am2019-1138","title":"Abstract 1138: Non-invasive detection and quantification of tumor-associated macrophage density with magnetic particle imaging","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Characterization and Applications of Magnetic Nanoparticles","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Magnetic particle imaging; Breast cancer; Magnetic resonance imaging; In vivo; Cancer; Preclinical imaging; Medicine; Magnetic nanoparticles; Pathology; Cancer research; Chemistry; Nuclear medicine; Materials science; Biology; Internal medicine; Radiology; Nanoparticle; Nanotechnology","score_opus":0.017572833548570272,"score_gpt":0.27741660734208634,"score_spread":0.2598437737935161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954050745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988139,0.00029477305,0.00022101523,0.00009997472,0.000031379845,0.00032515515,0.000008917333,0.000048880043,0.00015595894],"genre_scores_gemma":[0.9996232,0.00016974202,0.00003534806,0.00000771379,0.000013455052,0.000066972505,0.0000036345155,0.00001712745,0.000062855535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928343,0.00002214012,0.00014250676,0.00015655324,0.00019912099,0.00019626258],"domain_scores_gemma":[0.9994618,0.000079752936,0.000031311232,0.00018249564,0.00018301002,0.00006158792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023100567,0.00006706488,0.00009536368,0.0000643634,0.000060868082,0.00004156051,0.000074763695,0.00002122894,0.0001399557],"category_scores_gemma":[0.00002994886,0.00006484174,0.000011621786,0.00033349326,0.00008527788,0.0000968694,0.000020993322,0.00012212456,0.00004118264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022786759,0.000022555449,0.017137159,0.00008646848,0.000005800971,0.0000012743725,0.00011061085,0.0005352653,0.97331125,0.00002594334,0.000020038337,0.0087208245],"study_design_scores_gemma":[0.00031273998,0.000033347205,0.30625942,0.000041905336,0.000004433797,0.0000014089456,0.000116059266,0.010173787,0.6829276,0.000026650412,0.00004150026,0.000061138286],"about_ca_topic_score_codex":0.00012961002,"about_ca_topic_score_gemma":0.00012532261,"teacher_disagreement_score":0.29038367,"about_ca_system_score_codex":0.000060929608,"about_ca_system_score_gemma":0.000032848013,"threshold_uncertainty_score":0.26441696},"labels":[],"label_agreement":null},{"id":"W2954122303","doi":"10.1158/1538-7445.am2019-1795","title":"Abstract 1795: MicroRNA sequence analysis reveals signatures of oral cancer lymph node metastasis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; University of British Columbia","funders":"","keywords":"microRNA; Medicine; Oncology; Lymph node; Cohort; Metastasis; Proportional hazards model; Cancer; Internal medicine; Biology; Gene; Genetics","score_opus":0.051463967603904745,"score_gpt":0.4023505242942147,"score_spread":0.35088655669030994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954122303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830262,0.013404737,0.00059284066,0.0005637928,0.00018748557,0.00068249967,0.00060120685,0.000015980204,0.00092523143],"genre_scores_gemma":[0.9920652,0.004433096,0.00037427523,0.00017090846,0.0001283349,0.00025165424,0.00014572972,0.000065594824,0.0023652161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961673,0.00032790622,0.00042852105,0.0009463643,0.0011775097,0.00095237914],"domain_scores_gemma":[0.9973725,0.00006125392,0.00015966798,0.0010957941,0.0010561165,0.00025466923],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014542334,0.00027173193,0.0005170649,0.0005777,0.00012363576,0.00006410777,0.0009194749,0.00036880377,0.001881773],"category_scores_gemma":[0.0001672908,0.00025896734,0.0003798355,0.0018172285,0.00029219472,0.000013753338,0.00042798248,0.0005992649,0.000056614397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003522581,0.00006548567,0.0018875668,0.00017775017,0.0014885096,0.000013436428,0.00003992478,0.0074893357,0.98243976,0.00005710583,0.0023987796,0.0035901137],"study_design_scores_gemma":[0.00075220043,0.00011787545,0.0048273285,0.00009420404,0.0001646751,0.00000214119,0.00008096596,0.00016150568,0.982629,0.00007377692,0.01078975,0.00030654954],"about_ca_topic_score_codex":0.004597153,"about_ca_topic_score_gemma":0.00062143715,"teacher_disagreement_score":0.009038965,"about_ca_system_score_codex":0.00030972608,"about_ca_system_score_gemma":0.0010546466,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2954161724","doi":"10.1158/1538-7445.am2019-lb-306","title":"Abstract LB-306: Long non-coding RNA NEAT1 promotes lung metastasis of soft tissue sarcoma by regulating RNA splicing pathways","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"KRAS; Metastasis; Cancer research; Lung; Sarcoma; RNA; Pathology; Primary tumor; Biology; Long non-coding RNA; Downregulation and upregulation; Medicine; Cancer; Gene; Internal medicine; Mutation; Genetics","score_opus":0.029812847484261457,"score_gpt":0.3497060923694167,"score_spread":0.31989324488515525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954161724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98028475,0.005617006,0.00962262,0.0002176933,0.00019313968,0.0014125854,0.00012402998,0.000026877477,0.0025012789],"genre_scores_gemma":[0.9967955,0.00067270396,0.00045442814,0.00003773032,0.00026624394,0.0001684166,0.0001268223,0.00012749297,0.0013507148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958777,0.00022104662,0.000525408,0.0009691105,0.00121229,0.0011944411],"domain_scores_gemma":[0.997796,0.00010902032,0.00019162244,0.0010028982,0.00062081136,0.0002796583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017484536,0.0003238011,0.000448588,0.0002893709,0.00026186625,0.00011556215,0.0007742943,0.0003471691,0.00051546854],"category_scores_gemma":[0.0002825778,0.00033143308,0.00017430754,0.0006525247,0.00019952485,0.00002595824,0.00067109626,0.00082750164,0.000033481163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018547934,0.00006696473,0.00017920483,0.0005087818,0.00018942519,0.000018089351,0.00014678862,0.00047211818,0.96254885,0.000042905467,0.001855785,0.033785593],"study_design_scores_gemma":[0.00091271626,0.00036408324,0.0002997175,0.00038674433,0.000022150902,0.000009326374,0.00016719286,0.0011866956,0.9941948,0.000048042093,0.0020786684,0.00032983284],"about_ca_topic_score_codex":0.0010361936,"about_ca_topic_score_gemma":0.00011248171,"teacher_disagreement_score":0.033455763,"about_ca_system_score_codex":0.00027912654,"about_ca_system_score_gemma":0.000622228,"threshold_uncertainty_score":0.99991375},"labels":[],"label_agreement":null},{"id":"W2954192475","doi":"10.1158/1538-7445.am2019-4604","title":"Abstract 4604: Kidney injury molecule-1 regulates metastasis in renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University","funders":"","keywords":"Extravasation; Medicine; Renal cell carcinoma; Metastasis; Pathology; Kidney; Cell; Cancer; Cancer research; Internal medicine; Biology","score_opus":0.02001092469339876,"score_gpt":0.3253774372877243,"score_spread":0.3053665125943255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954192475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630065,0.0030853706,0.0000019345337,0.00057473656,0.0001660411,0.00030529554,0.00006576343,0.00000714432,0.009493083],"genre_scores_gemma":[0.99304765,0.0012270304,0.000031323416,0.00023999438,0.00016928824,0.000080679,0.00007403599,0.000034178724,0.0050958134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815655,0.00011652247,0.00022290775,0.0005293029,0.0003831873,0.00059150317],"domain_scores_gemma":[0.99910897,0.000014727543,0.000048152287,0.00044845752,0.00015330175,0.00022639915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004913001,0.00016096729,0.00017970825,0.00017931599,0.000064553176,0.000036035686,0.0003599082,0.00022822486,0.000449139],"category_scores_gemma":[0.00003957741,0.00013706856,0.000101284946,0.0003808372,0.00013359016,0.0000073332158,0.00016772818,0.0004899692,0.00012724836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031971856,0.00003979527,0.0030584314,0.00009540677,0.000032840424,0.000017545164,0.00004309628,0.00016454946,0.9693598,0.00001396578,0.025137475,0.0017173699],"study_design_scores_gemma":[0.00065926963,0.00022100525,0.004422443,0.00006352373,0.0000058742608,0.0000025078618,0.000046834186,0.000014348899,0.9530954,0.00005250961,0.04122958,0.0001867024],"about_ca_topic_score_codex":0.00071008137,"about_ca_topic_score_gemma":0.000041930754,"teacher_disagreement_score":0.016264403,"about_ca_system_score_codex":0.00011792442,"about_ca_system_score_gemma":0.00059576356,"threshold_uncertainty_score":0.5589494},"labels":[],"label_agreement":null},{"id":"W2954195377","doi":"10.1158/1538-7445.am2019-3705","title":"Abstract 3705: Identification of frequent HER2 activating mutations in canine primary pulmonary adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Exome sequencing; Amplicon; Lung cancer; Biology; Copy-number variation; Adenocarcinoma; Cancer; Genetics; Cancer research; Medicine; Mutation; Pathology; Gene; Genome; Polymerase chain reaction","score_opus":0.1174650938242922,"score_gpt":0.45188697358361424,"score_spread":0.334421879759322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954195377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902384,0.0010494319,0.0000065644276,0.0017064897,0.00009731785,0.0012086377,0.000023540983,0.000019962072,0.005649642],"genre_scores_gemma":[0.99647677,0.00014604184,0.00017638989,0.000036118778,0.00010340477,0.0003268218,0.00006725068,0.00003371693,0.0026334976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974656,0.00019965332,0.00048740424,0.0004210051,0.0009048058,0.00052153505],"domain_scores_gemma":[0.9983669,0.00037783387,0.00010411852,0.00050450966,0.00050829886,0.00013833104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017454602,0.00010956055,0.000314386,0.0006442653,0.00007509975,0.000016502192,0.00025441457,0.00013331567,0.0011359329],"category_scores_gemma":[0.0002670652,0.00010778994,0.000055010616,0.00092820905,0.00024665802,0.00019729197,0.00014491918,0.00092340005,0.00013502635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003603073,0.00021509513,0.25075635,0.000595741,0.000027343642,0.00016422027,0.00034624527,0.00006395314,0.7400125,0.000026286467,0.0001314328,0.0073005254],"study_design_scores_gemma":[0.00082400115,0.00033118148,0.9636654,0.00030194962,0.0000056389013,0.00010287636,0.00083847373,0.00021982999,0.03333696,0.000093472,0.00019544095,0.00008472195],"about_ca_topic_score_codex":0.0025726608,"about_ca_topic_score_gemma":0.00014036855,"teacher_disagreement_score":0.7129091,"about_ca_system_score_codex":0.0011901495,"about_ca_system_score_gemma":0.0013155956,"threshold_uncertainty_score":0.99977714},"labels":[],"label_agreement":null},{"id":"W2954196736","doi":"10.1158/0008-5472.can-18-3038","title":"Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Montreal Clinical Research Institute; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cytarabine; Cancer research; Leukemia; Lymphoma; DNA damage; Biology; Myeloid leukemia; Myeloid; Cancer; Transcription factor; Immunology; Medicine; DNA; Genetics; Gene","score_opus":0.04924242315085141,"score_gpt":0.36694291613255137,"score_spread":0.31770049298169994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954196736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577975,0.0010469898,0.000014689256,0.0008497128,0.00002192447,0.0014960173,0.00004402172,0.00000864224,0.00073823665],"genre_scores_gemma":[0.9970758,0.0012098752,0.00012383702,0.000040204155,0.000045372275,0.00013236413,0.000010476147,0.000028270257,0.0013337968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975871,0.0003237468,0.00032880768,0.00033156705,0.00097243383,0.0004563627],"domain_scores_gemma":[0.99828565,0.00061341864,0.00006694891,0.00058951526,0.0002926323,0.00015182717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077009,0.00013693854,0.00040452078,0.00032260496,0.000038161288,0.000009272677,0.00022349691,0.00010943378,0.00012183562],"category_scores_gemma":[0.00020766145,0.000086424836,0.00007788449,0.00060557405,0.00040220126,0.00007373183,0.00021125819,0.00018396095,0.000009727422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01326727,0.0035388346,0.08201913,0.0013994911,0.0006058358,0.00008982206,0.0044867736,0.0019843779,0.85946465,0.0027842873,0.0014857769,0.028873745],"study_design_scores_gemma":[0.093546845,0.005908767,0.20148163,0.0025851082,0.00017129119,0.00014242234,0.0026293139,0.023187237,0.6632393,0.0031791562,0.0033587392,0.0005702197],"about_ca_topic_score_codex":0.014766515,"about_ca_topic_score_gemma":0.00041529362,"teacher_disagreement_score":0.19622537,"about_ca_system_score_codex":0.0018266295,"about_ca_system_score_gemma":0.0016585253,"threshold_uncertainty_score":0.9917942},"labels":[],"label_agreement":null},{"id":"W2954206125","doi":"10.1158/1538-7445.am2019-3046","title":"Abstract 3046: Targeting N-myristoylation in B cell lymphomas as a therapeutic strategy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphoma; Cancer research; B-cell lymphoma; Cell culture; Myristoylation; Medicine; Biology; Internal medicine; Biochemistry; Phosphorylation","score_opus":0.05769787597759461,"score_gpt":0.38896871894394547,"score_spread":0.33127084296635084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954206125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382998,0.008099285,0.000008351896,0.0005924365,0.00018990047,0.0009417076,0.0000053730632,0.00004435313,0.051818807],"genre_scores_gemma":[0.99657863,0.00062708487,0.000035560846,0.00013853186,0.00015644099,0.00011858157,0.000025694017,0.00005759656,0.002261887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767905,0.00011492725,0.0002935254,0.00045485856,0.0008225432,0.0006350832],"domain_scores_gemma":[0.99889135,0.00011373405,0.000061409184,0.0005304811,0.00024292927,0.00016008987],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00091865804,0.00014909302,0.00024678072,0.00034919556,0.00006858072,0.00004331465,0.0002121959,0.00018766074,0.0026621546],"category_scores_gemma":[0.00008883308,0.00014362049,0.00007539259,0.000724449,0.00007938701,0.00009998627,0.000076316785,0.00082715444,0.0010069151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005721146,0.00016046259,0.008903375,0.0003265962,0.00003567124,0.00015327687,0.00057162705,0.001136077,0.97218865,0.00026085,0.00146832,0.014222984],"study_design_scores_gemma":[0.01616327,0.0018835102,0.17513077,0.0016429448,0.00006910159,0.000062816085,0.003031556,0.0032532925,0.73433214,0.0036704806,0.059753958,0.0010061612],"about_ca_topic_score_codex":0.002425979,"about_ca_topic_score_gemma":0.00014071136,"teacher_disagreement_score":0.2378565,"about_ca_system_score_codex":0.0011556349,"about_ca_system_score_gemma":0.0014449692,"threshold_uncertainty_score":0.99977094},"labels":[],"label_agreement":null},{"id":"W2954258258","doi":"10.1158/1538-7445.am2019-3482","title":"Abstract 3482: ZBTB7A mediates the transcriptional repression activity of androgen receptor in prostate cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Biology; Cancer research; Androgen receptor; Zinc finger; PTEN; Transcription factor; Repressor; Cancer; Psychological repression; Tumor suppressor gene; Prostate; Gene; Genetics; Gene expression; PI3K/AKT/mTOR pathway; Carcinogenesis; Signal transduction","score_opus":0.07278021274602356,"score_gpt":0.41213069250007794,"score_spread":0.3393504797540544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954258258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832038,0.008332516,3.6358585e-7,0.004784519,0.00026201396,0.0019259336,0.00019895793,0.000016875298,0.0012750005],"genre_scores_gemma":[0.98146695,0.012018301,0.000012305514,0.000035108602,0.000165814,0.00072042044,0.000028342252,0.00003284024,0.0055198898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721086,0.00019335945,0.00027826376,0.00047045382,0.0011951379,0.00065190817],"domain_scores_gemma":[0.9985973,0.00030469653,0.00007445389,0.00044914577,0.00040044033,0.00017394716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012699051,0.00016109865,0.00034808478,0.0002591409,0.00010811482,0.000026903188,0.00025423145,0.0001087723,0.0030642983],"category_scores_gemma":[0.000049258324,0.00009694554,0.00010553076,0.0006960005,0.00035823867,0.0001711122,0.00008445765,0.00085540954,0.000080454876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034687817,0.00025368165,0.076130375,0.00053121476,0.000090751346,0.000018769671,0.0012675565,0.0000711447,0.8986639,0.000018852503,0.002525892,0.016959103],"study_design_scores_gemma":[0.0032583934,0.0002570397,0.1381654,0.0008020961,0.000015413982,0.0000017214097,0.00034292816,0.00007848902,0.8467647,0.00009832944,0.010092578,0.00012294747],"about_ca_topic_score_codex":0.0026674813,"about_ca_topic_score_gemma":0.00023550821,"teacher_disagreement_score":0.06203502,"about_ca_system_score_codex":0.00052569504,"about_ca_system_score_gemma":0.0013865543,"threshold_uncertainty_score":0.997847},"labels":[],"label_agreement":null},{"id":"W2954266854","doi":"10.1158/1538-7445.am2019-2872","title":"Abstract 2872: Acquisition of drug resistance mutations during chemotherapy treatment in pediatric acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Drug resistance; PMS2; Cancer research; MSH6; Biology; Acute lymphocytic leukemia; MSH2; Chemotherapy; Cancer; Gene signature; Germline mutation; Gene; Genetics; Leukemia; Medicine; Internal medicine; Mutation; DNA mismatch repair; DNA repair; Lymphoblastic Leukemia; Gene expression","score_opus":0.012654985742292747,"score_gpt":0.3171040664283662,"score_spread":0.30444908068607346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954266854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632347,0.0022413337,0.000007150253,0.00016219496,0.00009486172,0.00036117955,0.00008114551,0.000003958752,0.00072469946],"genre_scores_gemma":[0.9876654,0.009893435,0.000057577836,0.000022521492,0.00021201115,0.0001299467,0.000058111873,0.000023622244,0.0019373378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989602,0.000032204505,0.00020210043,0.00031425743,0.0001952601,0.00029600857],"domain_scores_gemma":[0.99937373,0.0000618719,0.000062278195,0.00030297585,0.00013688109,0.00006226098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016202773,0.00010574402,0.00014091902,0.00014131778,0.000050986306,0.000019491656,0.00015048518,0.00007452898,0.00010129126],"category_scores_gemma":[0.000021599952,0.00010668157,0.000057326935,0.00025179773,0.00005530858,0.000005124286,0.000044511482,0.00008092883,0.00001846293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007217885,0.0001135118,0.032364007,0.00017332079,0.000059987782,0.000011808215,0.00034405597,0.002007126,0.96274346,0.00006136765,0.00078253663,0.0006170308],"study_design_scores_gemma":[0.003518312,0.00017788066,0.26714233,0.00007171142,0.000020701664,0.0000018391626,0.00012797577,0.000033138753,0.7260133,0.00018152733,0.0024823959,0.00022889614],"about_ca_topic_score_codex":0.0003882242,"about_ca_topic_score_gemma":0.0009274579,"teacher_disagreement_score":0.23673017,"about_ca_system_score_codex":0.0005587967,"about_ca_system_score_gemma":0.00071044866,"threshold_uncertainty_score":0.4350348},"labels":[],"label_agreement":null},{"id":"W2954275934","doi":"10.1158/1538-7445.am2019-1184","title":"Abstract 1184: Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Immune system; Tumor microenvironment; Biology; Tumor-infiltrating lymphocytes; Cancer; Epigenetics; Cell type; Cancer research; Immunology; Cell; Immunotherapy; Genetics; Gene","score_opus":0.05782837659817464,"score_gpt":0.41904750903052923,"score_spread":0.3612191324323546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954275934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625534,0.00079732854,0.000089459914,0.0015313013,0.000039471324,0.00041548954,0.0000123779955,0.000012662053,0.0008465924],"genre_scores_gemma":[0.99860436,0.0001034041,0.00027054,0.000072979565,0.000049128073,0.00005561593,0.00002439666,0.000019979405,0.00079957827],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982291,0.00028799902,0.0002850859,0.00029093528,0.0006225327,0.00028437667],"domain_scores_gemma":[0.99798274,0.0010158506,0.000107427375,0.00030874752,0.0004887226,0.00009653318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011082629,0.00010595125,0.00042648189,0.00086351513,0.00004018356,0.000024598034,0.00013967333,0.000045597415,0.0014741635],"category_scores_gemma":[0.0005346435,0.00007916805,0.00008015126,0.0011790277,0.00019257613,0.00017661929,0.000052431074,0.00090211356,0.000016216603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03180594,0.00032223316,0.059014186,0.0004558006,0.0010877106,0.00025731273,0.00479386,0.025933977,0.8664385,0.00008427199,0.0012634994,0.008542677],"study_design_scores_gemma":[0.002877468,0.0007580308,0.95167065,0.0009595491,0.00012227161,0.0000046832915,0.004087923,0.0058631063,0.029053632,0.00008882942,0.0043367282,0.00017711631],"about_ca_topic_score_codex":0.0026638985,"about_ca_topic_score_gemma":0.00009600698,"teacher_disagreement_score":0.8926565,"about_ca_system_score_codex":0.00020510267,"about_ca_system_score_gemma":0.0002909603,"threshold_uncertainty_score":0.99943864},"labels":[],"label_agreement":null},{"id":"W2954364011","doi":"10.1158/1538-7445.am2019-ct225","title":"Abstract CT225: A Phase Ib/IIa randomized pilot study to investigate the safety and tolerability of autologous T-cells with enhanced T-cell receptors specific to NY-ESO-1/LAGE-1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Internal medicine; Oncology; Chemotherapy; Immunotherapy; Lung cancer; Phases of clinical research; Cancer; Adverse effect","score_opus":0.03804803893179919,"score_gpt":0.36638646646468603,"score_spread":0.32833842753288683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954364011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757411,0.0006507344,0.000064273845,0.0010409071,0.00014806079,0.021217428,0.000033145247,0.00003349245,0.0010708953],"genre_scores_gemma":[0.9915386,0.0010067889,0.00029293247,0.00014996418,0.000056845707,0.0025597578,0.000011755985,0.000112199625,0.004271176],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99332047,0.00133521,0.0011286244,0.0013221729,0.0016778406,0.0012156821],"domain_scores_gemma":[0.9952548,0.0018615242,0.00024769557,0.00118542,0.0008902792,0.0005602645],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060014087,0.0004919644,0.0017877956,0.0009106558,0.00014977377,0.00008122327,0.0005906956,0.00011115787,0.001729307],"category_scores_gemma":[0.00022683559,0.00031080277,0.0000721088,0.0027480787,0.0006102985,0.00017430501,0.00025496224,0.0015391263,0.0000230811],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4655147,0.002934172,0.017191272,0.0006918018,0.00008751083,0.00006880483,0.0086349435,0.0022591103,0.49849775,0.0000026476137,0.00017230646,0.003944984],"study_design_scores_gemma":[0.49492273,0.026739068,0.048834443,0.001829687,0.00008166566,0.000007087538,0.005665857,0.0007824368,0.41989905,0.000018884695,0.0004899922,0.00072909665],"about_ca_topic_score_codex":0.010246032,"about_ca_topic_score_gemma":0.01725044,"teacher_disagreement_score":0.078598686,"about_ca_system_score_codex":0.0015278684,"about_ca_system_score_gemma":0.0019611798,"threshold_uncertainty_score":0.99993443},"labels":[],"label_agreement":null},{"id":"W2954367118","doi":"10.1158/1538-7445.am2019-218","title":"Abstract 218: AVID100 is an anti-EGFR ADC that promotes DM1-meditated cytotoxicity on cancer cells but not on normal cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cytotoxicity; Cancer research; Epidermal growth factor receptor; EGFR inhibitors; Cytotoxic T cell; Antibody-drug conjugate; Cancer cell; Chemistry; Antibody; Cancer; In vivo; Cell culture; In vitro; Biology; Receptor; Monoclonal antibody; Immunology; Medicine; Internal medicine; Biochemistry","score_opus":0.1687449514968752,"score_gpt":0.4478875337279058,"score_spread":0.2791425822310306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954367118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789781,0.00052415056,0.0000017981725,0.0054370947,0.0013284783,0.003887981,0.0009934496,0.0001846135,0.008664313],"genre_scores_gemma":[0.9786894,0.002364584,0.000054997876,0.0020830396,0.0014487131,0.000863656,0.00007080992,0.00025038375,0.01417446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9889493,0.00051969476,0.00066968537,0.0018636219,0.005268823,0.0027288622],"domain_scores_gemma":[0.9945292,0.0007707264,0.00018289083,0.0020550145,0.0012377513,0.0012244356],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002921322,0.0006654312,0.0010119611,0.0009406669,0.00042615345,0.00026023207,0.0012572536,0.00059025333,0.021972157],"category_scores_gemma":[0.00018181134,0.0005676514,0.00023313661,0.0013199049,0.0007411454,0.00042924914,0.000340763,0.0040169572,0.0054645063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029816038,0.0010488832,0.009158114,0.001229752,0.00018172918,0.000372936,0.0011568132,0.00015584247,0.92798406,0.000022286435,0.04441983,0.011288129],"study_design_scores_gemma":[0.0032661478,0.0026492332,0.03842595,0.0015442453,0.000028556215,0.000007709183,0.00032715825,0.00042192306,0.93164426,0.000019096284,0.021098852,0.0005668395],"about_ca_topic_score_codex":0.012412319,"about_ca_topic_score_gemma":0.00052431994,"teacher_disagreement_score":0.029267834,"about_ca_system_score_codex":0.0026574954,"about_ca_system_score_gemma":0.003352351,"threshold_uncertainty_score":0.9996775},"labels":[],"label_agreement":null},{"id":"W2954375719","doi":"10.1158/1538-7445.am2019-3355","title":"Abstract 3355: Challenges in the implementation of molecular diagnostic testing for non-small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Dalhousie University; Canadian Electricity Association; Ottawa Hospital","funders":"","keywords":"Medicine; Lung cancer; Targeted therapy; Cancer; Mutation; Genetic testing; Oncology; Crizotinib; Computational biology; Bioinformatics; Internal medicine; Biology; Gene; Genetics","score_opus":0.06448811532661959,"score_gpt":0.39698081890411285,"score_spread":0.3324927035774933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954375719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98320365,0.014098425,0.000033513094,0.00044086433,0.00011683739,0.0012598775,0.00014483139,0.0000018274153,0.0007001458],"genre_scores_gemma":[0.99210197,0.006386487,0.00011686129,0.000092696086,0.00018907156,0.0010197408,0.000038557107,0.000025606063,0.000029005518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988588,0.000047883917,0.00020601261,0.00031771997,0.00019925863,0.00037032797],"domain_scores_gemma":[0.99877006,0.0005284882,0.000075748205,0.00031585552,0.00026810745,0.00004174564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069873885,0.000104390034,0.00012666748,0.00007018561,0.000047486898,0.000024131275,0.00031385972,0.00007654297,0.000045647263],"category_scores_gemma":[0.00018840277,0.000090590445,0.00005390264,0.00014826554,0.000042719,0.0000033895037,0.00009352762,0.00014201658,0.0000017116208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055767334,0.00006398854,0.047622055,0.0006178422,0.00003059488,0.0000036080805,0.00057296397,0.0010125068,0.9269138,0.00010438037,0.0013511641,0.02165136],"study_design_scores_gemma":[0.0017555776,0.00049435615,0.088652164,0.00016832679,0.000020769505,9.4087983e-7,0.0024552636,0.00011325584,0.8998931,0.00016270413,0.0060536144,0.00022995466],"about_ca_topic_score_codex":0.0017384982,"about_ca_topic_score_gemma":0.0025216718,"teacher_disagreement_score":0.041030105,"about_ca_system_score_codex":0.000069235495,"about_ca_system_score_gemma":0.00047169384,"threshold_uncertainty_score":0.36941713},"labels":[],"label_agreement":null},{"id":"W2954390247","doi":"10.1158/1538-7445.sabcs18-3880","title":"Abstract 3880: In vivo activities of TP-2846: a novel tetracycline antileukemia agent","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fractal Systems (Canada)","funders":"","keywords":"Bioavailability; In vivo; Pharmacokinetics; Pharmacology; Chemistry; Medicine; Biology; Biotechnology","score_opus":0.03397247291649929,"score_gpt":0.3622972008661655,"score_spread":0.3283247279496662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954390247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894731,0.0019199575,0.000030379153,0.000052275504,0.00014784526,0.00026791915,0.00004105284,0.000004648643,0.008062817],"genre_scores_gemma":[0.99302626,0.0018117793,0.00008793932,0.000034532306,0.00018592218,0.000063725965,0.000015983338,0.000026825079,0.004747034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849236,0.000046413195,0.00025236074,0.00039166232,0.0004016877,0.00041550564],"domain_scores_gemma":[0.9992516,0.000053882453,0.000070431954,0.00040739862,0.00014887354,0.00006783865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005722935,0.00013032311,0.00019840225,0.00013010077,0.000039294366,0.000021883901,0.0003573226,0.00018433302,0.000583334],"category_scores_gemma":[0.0000998719,0.000120848854,0.000072832554,0.00025632582,0.00018449589,0.000008879351,0.00016522685,0.0003390497,0.000018577555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017369846,0.000098196106,0.013666222,0.00031122824,0.000025127078,0.0000047486833,0.00009603367,0.00018826801,0.98289806,0.00003529043,0.0013208989,0.0011822048],"study_design_scores_gemma":[0.0007579818,0.00015124142,0.0050374423,0.00013696506,0.000002624538,0.0000029735206,0.00031893322,0.000030475569,0.9764554,0.00003070382,0.016937096,0.00013818668],"about_ca_topic_score_codex":0.00030859924,"about_ca_topic_score_gemma":0.00009151155,"teacher_disagreement_score":0.015616196,"about_ca_system_score_codex":0.000108742446,"about_ca_system_score_gemma":0.00062844256,"threshold_uncertainty_score":0.63870984},"labels":[],"label_agreement":null},{"id":"W2954440524","doi":"10.1158/1538-7445.am2019-2407","title":"Abstract 2407: Stage shifting by modifying the determinants of cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Cancer; Stage (stratigraphy); Breast cancer; Colorectal cancer; Disease; Asymptomatic; Lung cancer; Psychological intervention; Prospective cohort study; Cohort; Oncology; Internal medicine; Nursing","score_opus":0.09499960388610487,"score_gpt":0.42960772194060315,"score_spread":0.3346081180544983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954440524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913068,0.00066849607,0.000009473446,0.00038531606,0.00009596749,0.0006916711,0.0000653274,0.000011875405,0.006765072],"genre_scores_gemma":[0.99606097,0.00073487224,0.00002456973,0.0002030601,0.000047825604,0.00017264181,0.0000016090659,0.000031895786,0.0027225488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718124,0.00019956742,0.00028157778,0.00053237774,0.0010223854,0.0007828715],"domain_scores_gemma":[0.9988516,0.0003692493,0.00012332299,0.0004950669,0.000019018482,0.00014173353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022753347,0.00013103115,0.00017771653,0.0000444668,0.0002830272,0.00003550846,0.0005548095,0.00007088684,0.0130983],"category_scores_gemma":[0.000099184836,0.0000996481,0.000042967342,0.00033192668,0.00041778522,0.00023256088,0.000413013,0.0006258129,0.00064950285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027117037,0.000036344485,0.7415689,0.00010974432,0.000010259299,0.0000051001016,0.0010701189,0.0009010076,0.178724,0.00000505047,0.0010566956,0.07648563],"study_design_scores_gemma":[0.00070321135,0.00007946739,0.78102547,0.00031621096,0.000008666966,7.9435824e-7,0.0015749471,0.0023529897,0.17526363,0.000088189416,0.038247626,0.00033880028],"about_ca_topic_score_codex":0.018629426,"about_ca_topic_score_gemma":0.0020934616,"teacher_disagreement_score":0.076146826,"about_ca_system_score_codex":0.00067538273,"about_ca_system_score_gemma":0.00009212229,"threshold_uncertainty_score":0.9879056},"labels":[],"label_agreement":null},{"id":"W2954486272","doi":"10.1158/1538-7445.am2019-3141","title":"Abstract 3141: The relationship between BRAF/NRAS/KIT genomic driver mutations and anti-PD1 immunotherapy responses in patients with advanced melanoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Medicine; Melanoma; Immunotherapy; Oncology; Internal medicine; Cancer; Ipilimumab; Hazard ratio; Cancer research; KRAS; Confidence interval","score_opus":0.053841706845501124,"score_gpt":0.37446927507133493,"score_spread":0.3206275682258338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954486272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942942,0.0020218168,0.0000024945018,0.0017255025,0.000065776214,0.0014098539,0.00005587426,0.000020227122,0.00040424633],"genre_scores_gemma":[0.99800783,0.0003630605,0.00005134484,0.0001343695,0.000057946374,0.000120878,0.000043465723,0.000039458722,0.0011816206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982935,0.00018314504,0.00027276945,0.00034491275,0.0005073807,0.0003982868],"domain_scores_gemma":[0.9981707,0.001058727,0.00007851803,0.00044107114,0.00017559115,0.00007539999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077536464,0.00014904703,0.0002486302,0.0002992396,0.00022636804,0.000055034317,0.00017814411,0.000094383206,0.0003644549],"category_scores_gemma":[0.00008441348,0.00009999195,0.000047189493,0.0006014973,0.0003477274,0.00017626991,0.00003778537,0.0005600942,0.000041572406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049134763,0.000058348607,0.9690792,0.000045616627,0.000098068675,0.0000043690047,0.0007810258,0.000010664184,0.012043055,0.000029633038,0.00010714037,0.012829402],"study_design_scores_gemma":[0.0065656365,0.00044840318,0.98877907,0.00023552703,0.000012555501,0.0000019049035,0.00024861298,0.0000020852476,0.00075134274,0.00006965421,0.0027530158,0.00013217116],"about_ca_topic_score_codex":0.0005774627,"about_ca_topic_score_gemma":0.00014532602,"teacher_disagreement_score":0.019699892,"about_ca_system_score_codex":0.00035598865,"about_ca_system_score_gemma":0.00042885967,"threshold_uncertainty_score":0.40775532},"labels":[],"label_agreement":null},{"id":"W2954499677","doi":"10.1158/1538-7445.am2019-4191","title":"Abstract 4191: The worldwide female breast cancer incidence and survival, 2018","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Incidence (geometry); Population; Demography; Cancer registry; Epidemiology; International agency; Epidemiology of cancer; Relative survival; Gynecology; Internal medicine; Environmental health","score_opus":0.03831930373437544,"score_gpt":0.3703418126769209,"score_spread":0.3320225089425455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954499677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815148,0.014598145,0.0000042102233,0.0019634,0.00026292435,0.00031367512,0.00017094704,0.000006637582,0.0011652394],"genre_scores_gemma":[0.9853891,0.010525814,0.000011587246,0.0002704918,0.00065711874,0.00013343475,0.000020865005,0.000022173412,0.0029694277],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863505,0.000095724485,0.00012806515,0.00040319192,0.00034200886,0.0003959809],"domain_scores_gemma":[0.9990067,0.000045437184,0.000033441418,0.00047212394,0.00027535332,0.00016692602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004904382,0.000114260554,0.000106778825,0.00004515446,0.00018240265,0.00007678139,0.0003113768,0.000082284125,0.0006112311],"category_scores_gemma":[0.000041990894,0.00008797975,0.00004624003,0.0001441649,0.0003281324,0.0000070900674,0.0002011455,0.0001860587,0.000051529765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005153761,0.00009058207,0.29382282,0.00020383179,0.00006770756,0.000006002018,0.00011791974,0.00006266504,0.66000855,0.00008628871,0.038059376,0.006958856],"study_design_scores_gemma":[0.0012544898,0.00012285945,0.8178078,0.00015330489,0.000018611781,0.0000098902665,0.0005894609,0.000017378285,0.08148503,0.0003890668,0.09779054,0.00036154775],"about_ca_topic_score_codex":0.0014334554,"about_ca_topic_score_gemma":0.001272062,"teacher_disagreement_score":0.5785235,"about_ca_system_score_codex":0.000043076187,"about_ca_system_score_gemma":0.000354916,"threshold_uncertainty_score":0.66925514},"labels":[],"label_agreement":null},{"id":"W2954563397","doi":"10.1158/1538-7445.am2019-3288","title":"Abstract 3288: Ovarian cancer survivors' views of factors that influenced their exceptional survival: A qualitative study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Focus group; Medicine; Gerontology; Ovarian cancer; Grounded theory; Qualitative research; Cancer; Stage (stratigraphy); Disease; Survivorship curve; Oncology; Internal medicine; Biology","score_opus":0.26761899525592786,"score_gpt":0.5054854896449229,"score_spread":0.23786649438899504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954563397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907567,0.0015303334,0.0000032383957,0.0011172584,0.00046688606,0.0025654254,0.00036395132,0.000033449884,0.0031627624],"genre_scores_gemma":[0.99641716,0.0008910419,0.000020047304,0.00006219021,0.00016835317,0.0010641,0.00004412521,0.00005618458,0.0012767726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961028,0.0005734602,0.00048591156,0.00069391885,0.0015123053,0.0006316099],"domain_scores_gemma":[0.9971553,0.0009474674,0.0001878779,0.00070669,0.00072349055,0.00027918353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019813483,0.00030545314,0.0007927275,0.0003259368,0.00012883158,0.000044149398,0.0002898908,0.0001259969,0.0077826316],"category_scores_gemma":[0.00008085574,0.00021371503,0.0001999545,0.0007268464,0.00023227453,0.00017593394,0.00012346913,0.00057463226,0.000101462174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077793834,0.0015971726,0.92250586,0.00037099584,0.0010104385,0.000018321687,0.06267719,0.000033194483,0.006108632,0.00034310558,0.0009100877,0.0036470608],"study_design_scores_gemma":[0.0035271123,0.00076305255,0.9290724,0.00043795127,0.00006306975,6.415256e-7,0.053849414,0.000003528065,0.008334016,0.00017961107,0.003551052,0.00021815138],"about_ca_topic_score_codex":0.048202336,"about_ca_topic_score_gemma":0.011192152,"teacher_disagreement_score":0.037010185,"about_ca_system_score_codex":0.00075979414,"about_ca_system_score_gemma":0.0010619491,"threshold_uncertainty_score":0.99312437},"labels":[],"label_agreement":null},{"id":"W2954585443","doi":"10.1158/0008-5472.can-18-3215","title":"An <i>ERG</i> Enhancer–Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward Regulation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Israel Science Foundation; Israel Cancer Research Fund","keywords":"Erg; Enhancer; Cancer research; Biology; Molecular biology; Genetics; Biochemistry; Transcription factor; Gene","score_opus":0.010641913621750402,"score_gpt":0.2965933236577974,"score_spread":0.285951410036047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954585443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642783,0.00034884328,0.0014244508,0.0002033336,0.00027763384,0.00068384234,0.000044485074,0.000034647765,0.00055493804],"genre_scores_gemma":[0.98543024,0.00013364172,0.00015387333,0.00013991338,0.00031477725,0.00016543611,0.00069415197,0.000052466516,0.012915474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975678,0.00021137454,0.00030772146,0.00072085665,0.0006861215,0.00050614413],"domain_scores_gemma":[0.9983635,0.000010262975,0.00014479843,0.0007972031,0.0005113057,0.00017295215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050228107,0.00019912983,0.00018503459,0.00012263772,0.00018346035,0.00013434884,0.00035178108,0.00023171588,0.00052631897],"category_scores_gemma":[0.000025246707,0.00017750802,0.0000832265,0.0003109145,0.00018559599,0.000036266923,0.000081534934,0.00025511632,0.00007141075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044803988,0.000034932167,0.00059273996,0.00004018425,0.000049827406,0.0000044400335,0.00002015017,0.0014628693,0.9701601,0.0000064233373,0.026669404,0.0005108411],"study_design_scores_gemma":[0.001022509,0.00046816387,0.00057225255,0.000052005882,0.000012503483,0.000003826412,0.00005530357,0.001005974,0.9790695,0.000019742623,0.017467184,0.00025105706],"about_ca_topic_score_codex":0.0002734609,"about_ca_topic_score_gemma":0.00016107272,"teacher_disagreement_score":0.0123605365,"about_ca_system_score_codex":0.00026700884,"about_ca_system_score_gemma":0.00085583207,"threshold_uncertainty_score":0.7238567},"labels":[],"label_agreement":null},{"id":"W2954606475","doi":"10.1158/1538-7445.am2019-3480","title":"Abstract 3480: <i>TMEM30A</i> loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; CHOP; Population; Biology; Vincristine; Medicine; Oncology; Internal medicine; Immunology; Chemotherapy","score_opus":0.0441405401422112,"score_gpt":0.3386493642680522,"score_spread":0.294508824125841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954606475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926765,0.0024373895,0.000057899568,0.00010646976,0.0000775137,0.0004884232,0.000042716056,0.000006996486,0.004106106],"genre_scores_gemma":[0.9980919,0.0008211181,0.000070021575,0.000090845744,0.00006516726,0.00019286516,0.000037970418,0.000021714599,0.00060843973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861085,0.00016576394,0.00021445002,0.00041389003,0.00025019838,0.0003448524],"domain_scores_gemma":[0.9991676,0.00008574415,0.00004435712,0.00034141267,0.00027009656,0.00009077509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007265792,0.000117867465,0.0001598746,0.00008848298,0.00007556473,0.000031045096,0.00015508442,0.00015449764,0.00029378998],"category_scores_gemma":[0.000051468498,0.00011164246,0.000048032514,0.00019514094,0.0002263111,0.000012218738,0.00010538417,0.000115349794,0.000030613613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028690483,0.00019368016,0.042328194,0.00012146256,0.000022952736,0.000002103229,0.00013965197,0.00003672845,0.9489015,0.00014185022,0.00009678784,0.0077281883],"study_design_scores_gemma":[0.0018951345,0.00031660145,0.06859119,0.00003689345,0.0000068046397,0.0000023498794,0.00025944543,0.000030516207,0.92170906,0.0005048819,0.0064900583,0.00015705993],"about_ca_topic_score_codex":0.0003876243,"about_ca_topic_score_gemma":0.00010992398,"teacher_disagreement_score":0.027192436,"about_ca_system_score_codex":0.00006128784,"about_ca_system_score_gemma":0.00041001406,"threshold_uncertainty_score":0.45526475},"labels":[],"label_agreement":null},{"id":"W2954606714","doi":"10.1158/1538-7445.am2019-ct129","title":"Abstract CT129: Identifying molecular determinants of response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the SPARTAN study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Internal medicine; Oncology; Metastasis; Cancer; Proportional hazards model; Transcriptome; Biology; Gene; Gene expression","score_opus":0.07130469458714175,"score_gpt":0.4347156962361843,"score_spread":0.3634110016490425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954606714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921704,0.00048253883,4.1359507e-7,0.0006008201,0.000058232832,0.0064574615,0.000077203134,0.000008100432,0.00014483873],"genre_scores_gemma":[0.9976596,0.000107173204,0.00003226066,0.00005544644,0.000018277486,0.0015743743,0.000011742638,0.000046663507,0.0004944088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530363,0.0006386633,0.0005630586,0.00061193836,0.0020111657,0.0008715671],"domain_scores_gemma":[0.99824256,0.0003371206,0.000110692046,0.000668147,0.0004518106,0.0001896654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002982396,0.0002354553,0.00049839186,0.0007929897,0.00009521359,0.00007934087,0.00036731444,0.000057857655,0.00015970228],"category_scores_gemma":[0.00014809878,0.00015162976,0.0000520867,0.001721595,0.0001647578,0.00017880106,0.000105811094,0.00063270977,0.000035369852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023802752,0.0010983857,0.89411414,0.00046383444,0.000081152146,0.0007138404,0.008077349,0.0003246489,0.06733562,0.000002285328,0.000043737095,0.0039422703],"study_design_scores_gemma":[0.008327552,0.0029782706,0.96520144,0.0012137761,0.000029634468,0.0000019992403,0.0054810345,0.000029799447,0.01648532,0.000014452477,0.000073615796,0.00016312642],"about_ca_topic_score_codex":0.0060659493,"about_ca_topic_score_gemma":0.012210557,"teacher_disagreement_score":0.07108729,"about_ca_system_score_codex":0.00083969184,"about_ca_system_score_gemma":0.0012731518,"threshold_uncertainty_score":0.91699415},"labels":[],"label_agreement":null},{"id":"W2954612845","doi":"10.1158/1538-7445.am2019-3771","title":"Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Retinoblastoma; Point mutation; Genetics; Biology; Mutation; Cancer; Cancer research; Gene","score_opus":0.03935792307009964,"score_gpt":0.3889643744300937,"score_spread":0.349606451359994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954612845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944462,0.001205189,0.0000039574193,0.0007523433,0.00020506003,0.00053842156,0.000014672467,0.000026240446,0.0028078961],"genre_scores_gemma":[0.99657845,0.00024927285,0.000025688989,0.000024505522,0.00019591313,0.00007206201,0.000016451326,0.000018369137,0.0028192562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871397,0.000085604595,0.000121095356,0.00032095943,0.00039437783,0.00036398487],"domain_scores_gemma":[0.9993329,0.00009956337,0.00003055758,0.00021530462,0.00016333544,0.00015834942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019945989,0.0001042948,0.00020812877,0.00013567005,0.00012317432,0.000016950908,0.000071903945,0.00013599114,0.0013690941],"category_scores_gemma":[0.00004914917,0.00008330043,0.000049098773,0.00013675427,0.00019351878,0.00006469194,0.00008195712,0.00036811142,0.00033404015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014455401,0.00029940304,0.5687916,0.0002460791,0.00026613014,0.00019639105,0.00035685903,0.000005103019,0.41975954,0.00034254362,0.0017487771,0.0065420023],"study_design_scores_gemma":[0.002690772,0.0005876467,0.9442709,0.00017839311,0.000051198735,0.00002756661,0.00014114396,0.00003738295,0.04981808,0.00020532431,0.0018996364,0.00009196672],"about_ca_topic_score_codex":0.00028160503,"about_ca_topic_score_gemma":0.00007387215,"teacher_disagreement_score":0.37547925,"about_ca_system_score_codex":0.00028482635,"about_ca_system_score_gemma":0.00023014109,"threshold_uncertainty_score":0.9995438},"labels":[],"label_agreement":null},{"id":"W2954619918","doi":"10.1158/1538-7445.am2019-ct200","title":"Abstract CT200: IMpower130: Progression-free survival (PFS) and safety analysis from a randomized phase 3 study of carboplatin + nab-paclitaxel (CnP) with or without atezolizumab as first-line (1L) therapy in advanced non-squamous NSCLC","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Medicine; Atezolizumab; Internal medicine; Pemetrexed; Oncology; Population; Carboplatin; Progression-free survival; Docetaxel; Clinical endpoint; Paclitaxel; Bevacizumab; Randomized controlled trial; Chemotherapy; Cancer; Nivolumab; Cisplatin; Immunotherapy","score_opus":0.038004971061680104,"score_gpt":0.4185161436121033,"score_spread":0.3805111725504232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954619918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696756,0.0049052434,0.000015063718,0.0004823274,0.00011702882,0.006862683,0.00016858886,0.00003438414,0.00044712742],"genre_scores_gemma":[0.9944226,0.0038832084,0.00012192609,0.00004620028,0.00009260222,0.0008250889,0.00006222045,0.000071784285,0.00047437655],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99529314,0.0004691208,0.0009711574,0.00090708357,0.0016622695,0.0006972393],"domain_scores_gemma":[0.9962544,0.0014542463,0.00033595366,0.0012033831,0.00050642114,0.00024559617],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027127059,0.00041166367,0.0020810913,0.0007385832,0.00015121819,0.00005664191,0.00039625002,0.00018405291,0.0016591481],"category_scores_gemma":[0.00032295234,0.00025300955,0.00022681353,0.0021272711,0.00047460143,0.00017357475,0.00012861537,0.0007155285,0.000004896579],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84114736,0.0021805088,0.09255953,0.00015590218,0.002751713,0.0001284298,0.005468319,0.00009791929,0.0177181,0.0000012020756,0.000027533295,0.03776349],"study_design_scores_gemma":[0.8705794,0.011818207,0.102552645,0.0010844469,0.000466569,0.000007693653,0.0060601356,0.0010857763,0.005469583,0.00003116788,0.0003474673,0.0004968666],"about_ca_topic_score_codex":0.037077874,"about_ca_topic_score_gemma":0.02538874,"teacher_disagreement_score":0.037266623,"about_ca_system_score_codex":0.00039754895,"about_ca_system_score_gemma":0.0009219271,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W2954638822","doi":"10.1158/1538-7445.am2019-4664","title":"Abstract 4664: Massively parallel sequencing-based analysis of synchronous gastric cancer and lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Cancer; Lung cancer; Cancer research; Massive parallel sequencing; Exome sequencing; Mutation; Biology; Medicine; Internal medicine; Genetics; DNA sequencing; Gene","score_opus":0.0286701296333555,"score_gpt":0.3545196339120321,"score_spread":0.3258495042786766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954638822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763556,0.02166247,0.00016876166,0.00028516646,0.00015251264,0.00040137753,0.00060749217,0.00000578017,0.00036084722],"genre_scores_gemma":[0.98929024,0.009476993,0.00010503719,0.00016694186,0.00019061183,0.00028293562,0.00008771173,0.00003263146,0.0003668731],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982234,0.00004862551,0.00027347257,0.0005674308,0.0003658494,0.00052118656],"domain_scores_gemma":[0.9987026,0.000098581964,0.00013294493,0.00045125824,0.00044091317,0.00017371318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003541337,0.00018037346,0.0003472148,0.00032866542,0.00008951478,0.00004481536,0.00027865634,0.00015588063,0.0006903918],"category_scores_gemma":[0.000065735476,0.00017624507,0.00013712289,0.000711242,0.00018555827,0.0000060076486,0.00014342876,0.00023138392,0.00000357977],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036233556,0.000056732875,0.22572659,0.0003272816,0.0013514877,0.000008766019,0.00010017002,0.09384203,0.6694622,0.00005769021,0.0037663612,0.0049383296],"study_design_scores_gemma":[0.005622114,0.0009567667,0.5204337,0.0005885655,0.0018199654,0.0000040360924,0.0005420578,0.035270687,0.41159874,0.00006996821,0.021505661,0.0015876872],"about_ca_topic_score_codex":0.009220753,"about_ca_topic_score_gemma":0.0046639666,"teacher_disagreement_score":0.29470715,"about_ca_system_score_codex":0.00037065352,"about_ca_system_score_gemma":0.0018675091,"threshold_uncertainty_score":0.9973769},"labels":[],"label_agreement":null},{"id":"W2954640852","doi":"10.1158/1538-7445.am2019-570","title":"Abstract 570: A glioblastoma translational pipeline: discovery of novel tumor antigens that drive GBM recurrence","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Somatic evolution in cancer; Temozolomide; Transcriptome; Radiation therapy; Biology; Precision medicine; Brain tumor; Synthetic lethality; Cancer; Cancer research; Glioblastoma; Computational biology; Medicine; Gene; DNA repair; Genetics; Internal medicine; Pathology","score_opus":0.047688133819676216,"score_gpt":0.38219160928590484,"score_spread":0.3345034754662286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954640852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950577,0.0019482907,0.00020408256,0.00021972788,0.00012331571,0.00052274956,0.00064123445,0.000005552663,0.001277327],"genre_scores_gemma":[0.99736285,0.00084161013,0.0000839997,0.000026997632,0.00017925483,0.00010227964,0.00010786781,0.000024747109,0.0012703618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980259,0.000050223527,0.00018992492,0.00048751515,0.0007294975,0.0005169258],"domain_scores_gemma":[0.9990359,0.000053977557,0.000063472624,0.00040660315,0.00030915783,0.00013089662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003404719,0.00014554504,0.00018053452,0.0001310192,0.00007913443,0.00004627744,0.00033423945,0.00008002011,0.00025977878],"category_scores_gemma":[0.000054792585,0.00012928198,0.000120355864,0.00026238212,0.00022988976,0.000022168768,0.00012099437,0.0002556029,0.000040004386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011528521,0.0002697918,0.025316473,0.00012845958,0.00009949528,0.000010117397,0.000074859374,0.00009774369,0.9670033,0.00008805435,0.002703831,0.0030550293],"study_design_scores_gemma":[0.002321568,0.00058146234,0.031526987,0.00017877523,0.000007721396,0.000009457058,0.00011344981,0.000091547125,0.95503634,0.00007174573,0.009845605,0.00021531351],"about_ca_topic_score_codex":0.0006953837,"about_ca_topic_score_gemma":0.0007541229,"teacher_disagreement_score":0.011966925,"about_ca_system_score_codex":0.000060256556,"about_ca_system_score_gemma":0.0007909406,"threshold_uncertainty_score":0.52719665},"labels":[],"label_agreement":null},{"id":"W2954674887","doi":"10.1158/1538-7445.am2019-1470","title":"Abstract 1470: Development &amp; characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Oncolytic virus; Herpes simplex virus; Blockade; Immune system; Immune checkpoint; Immunotherapy; Antigen; Cancer immunotherapy; Medicine; Cancer research; Virology; Virus; Immunology; Biology; Receptor; Internal medicine","score_opus":0.08341549189432448,"score_gpt":0.3997466878874508,"score_spread":0.3163311959931263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954674887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978995,0.00031698012,0.000059781883,0.00016388035,0.0001066582,0.00065358763,0.000027458505,0.0000112642765,0.00076094095],"genre_scores_gemma":[0.9945852,0.00057438243,0.00010371166,0.00024543307,0.00018156425,0.0000704393,0.00027701232,0.000057461773,0.0039047892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803174,0.000079033955,0.00027374816,0.00040847217,0.000706937,0.0005000499],"domain_scores_gemma":[0.9987758,0.00004500667,0.0000820769,0.0006162669,0.00034160397,0.00013925237],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076547917,0.00016846703,0.00019810199,0.00019937148,0.00009341372,0.000039541683,0.0004213035,0.00016578774,0.001891492],"category_scores_gemma":[0.000046133046,0.00015595286,0.000063664054,0.00037893554,0.00008209998,0.000008747789,0.000073909934,0.0002260437,0.00028151582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063276244,0.00011759321,0.00025974787,0.00005158858,0.000059932485,8.6124055e-7,0.00011301433,0.00017652939,0.87443167,0.000003419427,0.0005134021,0.11794461],"study_design_scores_gemma":[0.0010674631,0.0011404284,0.004410729,0.000059315433,0.0000012657549,2.3395856e-7,0.00001266528,0.00004037745,0.802293,0.000011130678,0.19081664,0.00014675282],"about_ca_topic_score_codex":0.00019409967,"about_ca_topic_score_gemma":0.00040983007,"teacher_disagreement_score":0.19030324,"about_ca_system_score_codex":0.00018939187,"about_ca_system_score_gemma":0.0023070413,"threshold_uncertainty_score":0.99902093},"labels":[],"label_agreement":null},{"id":"W2954686273","doi":"10.1158/1538-7445.am2019-ct158","title":"Abstract CT158: ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Nivolumab; Oncology; Internal medicine; Chemotherapy; Debulking; PARP inhibitor; BRCA mutation; Cancer; Cancer research; Immunotherapy; Poly ADP ribose polymerase; Biology","score_opus":0.08737768898067304,"score_gpt":0.44119662403155485,"score_spread":0.3538189350508818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954686273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725346,0.0034591286,0.00018493879,0.0016421055,0.0007434973,0.018323248,0.0000754064,0.000087862216,0.002949242],"genre_scores_gemma":[0.986302,0.0005193494,0.00014526595,0.00039576154,0.00069767446,0.0094539635,0.00005060991,0.00017770029,0.0022576563],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9923061,0.0007436644,0.0018891628,0.0012240646,0.0024943142,0.0013426582],"domain_scores_gemma":[0.99548817,0.0014752903,0.000576189,0.0013235493,0.0007098212,0.00042700104],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006371867,0.0006240837,0.0031556683,0.0012401823,0.00021074229,0.000092104594,0.0006196982,0.0003752157,0.008477651],"category_scores_gemma":[0.00019491895,0.00053223246,0.0006860889,0.0012468265,0.0003406813,0.00028243856,0.00008459274,0.0017428041,0.000084193554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91917217,0.0034123228,0.0035983212,0.00028868072,0.0015096474,0.00009694825,0.005111808,0.0018140809,0.06076456,0.00004691368,0.00090142764,0.003283131],"study_design_scores_gemma":[0.9651235,0.001322955,0.0002586832,0.0013346958,0.0002014029,0.0000034430002,0.0016615109,0.0029727276,0.025851723,0.00009163693,0.0007034875,0.00047428507],"about_ca_topic_score_codex":0.018453747,"about_ca_topic_score_gemma":0.0034434167,"teacher_disagreement_score":0.04595129,"about_ca_system_score_codex":0.001741427,"about_ca_system_score_gemma":0.0026928284,"threshold_uncertainty_score":0.99971294},"labels":[],"label_agreement":null},{"id":"W2954693732","doi":"10.1158/1538-7445.am2019-ct006","title":"Abstract CT006: Clinical study of a personalized neoantigen cancer vaccine in treating patients with advanced malignant tumor","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Clinical trial; Cancer vaccine; Immunogenicity; Cancer immunotherapy; Oncology; Peptide vaccine; Immunotherapy; Internal medicine; Immunology; Immune system; Antigen; Epitope","score_opus":0.047097870459565684,"score_gpt":0.4056112250395573,"score_spread":0.3585133545799916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954693732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888583,0.009080644,4.2541672e-7,0.00005336869,0.00027315144,0.0015082305,0.00004017422,0.000015983655,0.00016974911],"genre_scores_gemma":[0.9965709,0.0008659335,0.000008710791,0.00003354568,0.000017694674,0.0002889882,0.000017005947,0.000034375626,0.0021628577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973656,0.00077715993,0.0006088524,0.00046833363,0.00017379712,0.0006062362],"domain_scores_gemma":[0.9984323,0.00055020564,0.0002029888,0.000425754,0.00036415271,0.000024614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00114086,0.0001899796,0.00059625035,0.0002676925,0.00012408436,0.0000129781965,0.0003650829,0.00011623294,0.0037051006],"category_scores_gemma":[0.000111423644,0.00013640836,0.00006841112,0.0005113048,0.00016813897,0.00012561982,0.000094594056,0.0006978486,0.000093758485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018863898,0.0014733131,0.78536123,0.000059320253,0.00031408024,0.000009326156,0.0019826037,0.000029102972,0.17058572,0.000007281209,0.000119177006,0.021194935],"study_design_scores_gemma":[0.021513049,0.003022201,0.94747776,0.0004835663,0.00001477498,0.0000015232669,0.0029808248,0.0000012085038,0.01940675,0.000002662455,0.0048962776,0.00019939525],"about_ca_topic_score_codex":0.0034179802,"about_ca_topic_score_gemma":0.00052951055,"teacher_disagreement_score":0.16211653,"about_ca_system_score_codex":0.00013765071,"about_ca_system_score_gemma":0.0004579977,"threshold_uncertainty_score":0.9972057},"labels":[],"label_agreement":null},{"id":"W2954735762","doi":"10.1158/1538-7445.am2019-3378","title":"Abstract 3378: Systematic pharmacogenomic analysis of large patient derived xenografts data","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pharmacogenomics; Computational biology; KEGG; Precision medicine; Medicine; Bioconductor; Personalized medicine; Drug response; Bioinformatics; Gene; Biology; Gene expression; Drug; Pharmacology; Genetics; Transcriptome; Pathology","score_opus":0.06195282922539227,"score_gpt":0.4057656652845563,"score_spread":0.3438128360591641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954735762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904392,0.007075395,0.000046795052,0.00004681601,0.0002184808,0.00061690406,0.0011805843,0.0000041228054,0.0003717071],"genre_scores_gemma":[0.9967262,0.0021817426,0.0000390777,0.00009209838,0.00012037985,0.00007427138,0.00064917566,0.00002359758,0.00009344897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983159,0.000095628515,0.00034872035,0.00048627928,0.00035158708,0.00040193854],"domain_scores_gemma":[0.99812233,0.000094168856,0.00013216349,0.0012552445,0.0002816881,0.00011442998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007472649,0.000121775265,0.0003448954,0.00022813957,0.00006141086,0.000033271255,0.0006866685,0.000083247876,0.00037374065],"category_scores_gemma":[0.00013129428,0.0001136638,0.00011741598,0.00048467773,0.00006341307,0.00000537364,0.0006439536,0.00013947164,0.00004254223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010500117,0.00009822219,0.004164122,0.0014741898,0.00123971,0.0000032386724,0.00010991512,0.00060775824,0.98958176,0.00002821255,0.0022851056,0.00030278222],"study_design_scores_gemma":[0.001901739,0.00041893742,0.012008318,0.00068910985,0.0010929351,0.0000022990728,0.00087791926,0.0019525613,0.955213,0.000022279079,0.02524104,0.00057985005],"about_ca_topic_score_codex":0.00033627704,"about_ca_topic_score_gemma":0.00034788286,"teacher_disagreement_score":0.034368727,"about_ca_system_score_codex":0.00006768204,"about_ca_system_score_gemma":0.00030467706,"threshold_uncertainty_score":0.46350753},"labels":[],"label_agreement":null},{"id":"W2954741075","doi":"10.1158/1538-7445.pedca19-pr17","title":"Abstract PR17: Immunogenomic landscape of pediatric solid malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer; Medicine; Synovial sarcoma; Cancer research; Sarcoma; Malignancy; Immunotherapy; Immunology; Biology; Pathology; Internal medicine","score_opus":0.0979179379956064,"score_gpt":0.39421207268108877,"score_spread":0.2962941346854824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954741075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972533,0.0220398,0.0000033654226,0.0029448755,0.00010287547,0.00037555417,0.000041863655,0.000029066376,0.00192961],"genre_scores_gemma":[0.98942304,0.009069357,0.000031638254,0.0002982776,0.00071449485,0.000055093653,0.000010178404,0.000026199246,0.0003717537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854666,0.000038489165,0.00028802425,0.00024584337,0.00050581415,0.0003751879],"domain_scores_gemma":[0.9992043,0.000074364965,0.000067981244,0.00024582946,0.00026100402,0.00014657198],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004389398,0.00010456225,0.0002645553,0.00014642552,0.00007540156,0.000018702201,0.00020248067,0.000077560675,0.002151631],"category_scores_gemma":[0.000076243035,0.00008695842,0.00012003088,0.0006441497,0.00014385596,0.00005317135,0.0000667069,0.0003183528,0.00007197968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003439982,0.00007093957,0.026564581,0.0006099905,0.00014885605,0.000032966607,0.0008977905,0.000006526282,0.94149,0.000014876169,0.021602204,0.005121286],"study_design_scores_gemma":[0.0066568647,0.0015502432,0.4659633,0.00027248394,0.000115568364,0.000014404856,0.001332441,0.00004387945,0.4698371,0.000045080797,0.05378412,0.00038449693],"about_ca_topic_score_codex":0.0002950543,"about_ca_topic_score_gemma":0.0000117746695,"teacher_disagreement_score":0.4716529,"about_ca_system_score_codex":0.000101633515,"about_ca_system_score_gemma":0.00073520886,"threshold_uncertainty_score":0.9987605},"labels":[],"label_agreement":null},{"id":"W2954741918","doi":"10.1158/1538-7445.am2019-3499","title":"Abstract 3499: Dianhydrogalactitol (VAL-083) in combination with AZD1775 increases survival in diffuse intrinsic pontine glioma (DIPG), in vivo","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Wee1; In vivo; Cancer research; Cell cycle checkpoint; Kinase; Cancer; Cell cycle; DNA damage; Chemistry; Cell culture; Pharmacology; Cell; Medicine; Biology; DNA; Cyclin-dependent kinase 1; Biochemistry; Internal medicine; Genetics","score_opus":0.032779860179668156,"score_gpt":0.35055338754524845,"score_spread":0.3177735273655803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954741918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381113,0.0007143786,1.6406328e-7,0.0016009044,0.000097430035,0.0014250566,0.000020547479,0.000022553966,0.0023078113],"genre_scores_gemma":[0.99874467,0.00038469845,0.000011853579,0.000030698597,0.00006913628,0.0005217191,0.000028783243,0.00004014886,0.00016828807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743855,0.00018698764,0.00035529543,0.0004969862,0.00086526,0.0006569346],"domain_scores_gemma":[0.99871147,0.00045148694,0.00006340948,0.00041547927,0.00017464893,0.0001835293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008653546,0.0002035808,0.00048518885,0.0013258873,0.00003675204,0.00005148129,0.00015245644,0.000119327306,0.00064602226],"category_scores_gemma":[0.00018557381,0.00016338291,0.000045904646,0.0016762923,0.00010000311,0.00021481236,0.0000851549,0.0005882551,0.00009440522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014153962,0.0042287186,0.9695325,0.00017987423,0.000038860533,0.0019371794,0.00028321383,0.00003474192,0.018673833,0.00017447148,0.00025846157,0.0032427602],"study_design_scores_gemma":[0.01963594,0.0005698468,0.9575111,0.00093970995,0.00001069042,0.000017771079,0.00031723792,0.00006478604,0.020222409,0.00006758797,0.00048018442,0.00016269794],"about_ca_topic_score_codex":0.043447103,"about_ca_topic_score_gemma":0.03713096,"teacher_disagreement_score":0.018220544,"about_ca_system_score_codex":0.001042727,"about_ca_system_score_gemma":0.00040342295,"threshold_uncertainty_score":0.9804389},"labels":[],"label_agreement":null},{"id":"W2954778422","doi":"10.1158/1538-7445.am2019-2198","title":"Abstract 2198: PBI-200: A novel, brain penetrant, next generation pan-TRK kinase inhibitor","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Cancer research; Kinase; Tyrosine kinase; Receptor tyrosine kinase; Anaplastic lymphoma kinase; Crizotinib; Biology; Medicine; Internal medicine; Signal transduction; Lung cancer; Receptor; Cell biology; Neurotrophin","score_opus":0.1588392718518351,"score_gpt":0.4169846002086986,"score_spread":0.2581453283568635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954778422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878906,0.002810862,0.00017931267,0.00503533,0.00075835205,0.0011609088,0.000047775156,0.000052308813,0.0020645245],"genre_scores_gemma":[0.9878961,0.0007669349,0.00019091721,0.0010723274,0.002387126,0.00021512082,0.000051515613,0.00006471392,0.0073552676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975495,0.00006616996,0.00027193176,0.0005333889,0.00093915605,0.0006398683],"domain_scores_gemma":[0.9986911,0.00010309083,0.00005239582,0.00054075697,0.0003568363,0.0002558114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001082519,0.00018121832,0.00030026934,0.0002581512,0.00014847922,0.0001227048,0.00017185142,0.00015959491,0.005705823],"category_scores_gemma":[0.000060097762,0.000159296,0.00010958471,0.0004955499,0.000081135004,0.00019680223,0.000052149575,0.00064933294,0.00045835477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036706898,0.00014687017,0.00036128535,0.00013755166,0.000044992852,0.000032240285,0.0003057966,0.0000140456405,0.95456076,0.0007108605,0.01276925,0.03054926],"study_design_scores_gemma":[0.0075150747,0.001247661,0.0110208215,0.0005321533,0.000023551222,0.00002967526,0.00045575906,0.0007806935,0.76229644,0.00027108932,0.21537594,0.000451165],"about_ca_topic_score_codex":0.0018825101,"about_ca_topic_score_gemma":0.00058731955,"teacher_disagreement_score":0.2026067,"about_ca_system_score_codex":0.00047902012,"about_ca_system_score_gemma":0.0008394639,"threshold_uncertainty_score":0.9952031},"labels":[],"label_agreement":null},{"id":"W2954779234","doi":"10.1158/1538-7445.am2019-lb-087","title":"Abstract LB-087: Discovery and development of first-in-class orally bioavailable USP19 inhibitors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Deubiquitinating enzyme; Drug discovery; Proteases; Pharmacology; Drug development; Computational biology; Ubiquitin; Kinase; Druggability; Drug; Biology; Bioinformatics; Biochemistry; Cancer research; Medicine; Enzyme; Gene","score_opus":0.04433416857709707,"score_gpt":0.3292489876439704,"score_spread":0.2849148190668733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954779234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949086,0.0019179257,0.000005515631,0.00012214683,0.00008370925,0.0003274536,0.000021350967,0.0000032119233,0.002610144],"genre_scores_gemma":[0.99708,0.00052868744,0.00016075964,0.000022346825,0.00007641666,0.000069703856,0.000023260576,0.000016451355,0.0020223395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988479,0.000038785256,0.00020122652,0.00032066638,0.00024988022,0.00034154562],"domain_scores_gemma":[0.9995273,0.000025199704,0.000041465315,0.00023316375,0.000101980884,0.00007093888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000604545,0.000097473625,0.00013395751,0.0000921855,0.00005797464,0.000033591266,0.00016855025,0.00011369145,0.00017435409],"category_scores_gemma":[0.00004207339,0.000088124245,0.000024454566,0.00013488201,0.00010797405,0.000010091779,0.00021551608,0.00017007394,0.00003673645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015882672,0.000046881705,0.06671155,0.00025559438,0.000020571068,0.0000026430791,0.00019328647,0.000014747646,0.92782193,0.000029215198,0.0012232501,0.0035214717],"study_design_scores_gemma":[0.00053262257,0.000111452166,0.013435476,0.00012339091,8.4798444e-7,8.7252266e-7,0.00015521691,0.0000047288263,0.90691817,0.000021013575,0.078573726,0.00012248986],"about_ca_topic_score_codex":0.00020863477,"about_ca_topic_score_gemma":0.00072957936,"teacher_disagreement_score":0.077350475,"about_ca_system_score_codex":0.000050254104,"about_ca_system_score_gemma":0.00042837753,"threshold_uncertainty_score":0.35936025},"labels":[],"label_agreement":null},{"id":"W2954811145","doi":"10.1158/1538-7445.am2019-ct183","title":"Abstract CT183: Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Cancer; Pancreatic cancer; Gastroenterology; Toxicity; Oncology","score_opus":0.051826628812253896,"score_gpt":0.4116926234289976,"score_spread":0.3598659946167437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954811145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966308,0.00009733132,8.006922e-7,0.00019076325,0.000020511561,0.0010770159,0.000033982153,0.00001810483,0.0019307006],"genre_scores_gemma":[0.99798864,0.000035912562,0.000015450301,0.000050942363,0.00003479246,0.00014566642,0.000035754856,0.000024458956,0.0016683715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765944,0.000076937926,0.00035337615,0.00038587386,0.0010902592,0.00043411867],"domain_scores_gemma":[0.9987012,0.000052381263,0.00009297724,0.0004544172,0.0005420646,0.00015694558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038782184,0.00014149683,0.00041584915,0.0004762343,0.00007677208,0.00001482873,0.00013436607,0.000054561326,0.0019427676],"category_scores_gemma":[0.00006699797,0.000108546046,0.000058188867,0.0009298873,0.00011370893,0.00014565712,0.0000766313,0.0003706893,0.000071499104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010417874,0.020092722,0.7467621,0.0008808488,0.00039452038,0.00025931012,0.0054989117,0.00043189267,0.19026864,0.000078532095,0.0024208098,0.022493819],"study_design_scores_gemma":[0.091126904,0.024487508,0.774147,0.005163118,0.00010359062,0.0000044536623,0.012106645,0.00014589891,0.088856734,0.000039769893,0.0032208806,0.00059750467],"about_ca_topic_score_codex":0.0007637464,"about_ca_topic_score_gemma":0.0007399612,"teacher_disagreement_score":0.1014119,"about_ca_system_score_codex":0.0002396949,"about_ca_system_score_gemma":0.0002479755,"threshold_uncertainty_score":0.9989696},"labels":[],"label_agreement":null},{"id":"W2954821948","doi":"","title":"STAT3 Ser-727 phosphorylation by CDK1 inhibits STAT3 function during cell cycle progression","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Phosphorylation; Cyclin-dependent kinase 1; Cyclin-dependent kinase; Molecular biology; Biology; Cell cycle; Transfection; Cell biology; Phosphorylation cascade; Cyclin B1; Protein phosphorylation; Cell culture; Biochemistry; Protein kinase A; Cell","score_opus":0.026285408200398305,"score_gpt":0.3667773465361794,"score_spread":0.34049193833578106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954821948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984005,0.009147038,0.00036862426,0.0015905784,0.00023021143,0.0012195199,0.00004984586,0.00016018731,0.0032290241],"genre_scores_gemma":[0.99200517,0.0013751064,0.00020608612,0.0001361128,0.0004705599,0.00033650987,0.00012421959,0.00009189527,0.005254353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967774,0.00014620734,0.0003365367,0.0006044522,0.0013353174,0.00080005673],"domain_scores_gemma":[0.9985663,0.000042965246,0.00009304848,0.00045951633,0.00047504425,0.00036309313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000624373,0.00020550773,0.000237597,0.00028240687,0.00032065497,0.0000625966,0.00012385439,0.00021053899,0.00095179107],"category_scores_gemma":[0.000066433066,0.0001982852,0.00007911152,0.00078721903,0.00013221077,0.00024233227,0.000120232406,0.0010028923,0.0003163245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014410403,0.00025943737,0.0010241261,0.00027907873,0.00004104383,0.000026340898,0.00060484494,0.0007226971,0.92295,0.000010557978,0.023409974,0.049230814],"study_design_scores_gemma":[0.003398955,0.0004733665,0.0025130021,0.00041873715,0.000032938104,0.000010828404,0.00019989756,0.0007754319,0.9074203,0.00003663632,0.08450257,0.0002173767],"about_ca_topic_score_codex":0.00027190306,"about_ca_topic_score_gemma":0.00012086996,"teacher_disagreement_score":0.061092597,"about_ca_system_score_codex":0.001525575,"about_ca_system_score_gemma":0.000568227,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W2954842563","doi":"10.1158/1538-7445.am2019-3854","title":"Abstract 3854: Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Sting; Stimulator of interferon genes; Innate immune system; Immune system; Medicine; Biology; Immunology; Cancer research; Cell biology","score_opus":0.06887248890523982,"score_gpt":0.3650036790657241,"score_spread":0.2961311901604843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954842563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780786,0.00014415235,0.00006464675,0.00025167354,0.00015077258,0.0005234867,0.00004607717,0.000013440288,0.0009978898],"genre_scores_gemma":[0.99701524,0.00008035102,0.000020783082,0.000029197237,0.000016407912,0.000049717084,0.000030030073,0.000022322067,0.002735936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986198,0.00020698611,0.00028818968,0.0003387541,0.00008613595,0.000460135],"domain_scores_gemma":[0.99914664,0.0002597167,0.0001309522,0.00025898297,0.00017934157,0.000024381796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007468615,0.00012836108,0.00030281974,0.00020707677,0.00008138961,0.000023111137,0.00027304728,0.00014210478,0.00041536742],"category_scores_gemma":[0.00012694132,0.00010746817,0.00005289684,0.00025264785,0.0002568103,0.000105266256,0.0001349439,0.00074376864,0.00018441543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032225514,0.00038153323,0.0063998173,0.000109241635,0.000054537053,0.000005615989,0.0002024858,0.000009696579,0.98748827,0.00001559239,0.000021119893,0.002089549],"study_design_scores_gemma":[0.0013452395,0.00031519323,0.3053939,0.0003177114,0.000003858282,0.0000070903466,0.00007178869,0.000027038564,0.6919308,4.823089e-7,0.00049511594,0.000091831374],"about_ca_topic_score_codex":0.0015069596,"about_ca_topic_score_gemma":0.00024689548,"teacher_disagreement_score":0.2989941,"about_ca_system_score_codex":0.0001190894,"about_ca_system_score_gemma":0.00033653385,"threshold_uncertainty_score":0.4547982},"labels":[],"label_agreement":null},{"id":"W2954848187","doi":"10.1158/1538-7445.am2019-ct116","title":"Abstract CT116: Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Radiation therapy; Tolerability; Regimen; Radiosensitizer; Oncology; Phases of clinical research; Cancer research; Internal medicine; Cancer; Combination therapy; Clinical trial; Adverse effect","score_opus":0.027644479719900993,"score_gpt":0.3683144988521224,"score_spread":0.34067001913222145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954848187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995188,0.00035618432,2.3633396e-7,0.00021495685,0.000056997873,0.003906807,0.000022047429,0.000022272741,0.00023250522],"genre_scores_gemma":[0.9988693,0.00029239277,0.000011595452,0.000023886447,0.00004544926,0.0006299247,0.000028174594,0.00004865836,0.000050599716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997456,0.00012676787,0.00029998066,0.00046921792,0.0011769835,0.00047101558],"domain_scores_gemma":[0.998528,0.00021305642,0.00012745682,0.00052265136,0.00042345063,0.00018535355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033990588,0.00021158368,0.00043984456,0.000605979,0.00008816973,0.000027387561,0.00013223676,0.000080919126,0.00045135446],"category_scores_gemma":[0.000037887963,0.00013864593,0.00004129448,0.0011769295,0.00007962255,0.00018604392,0.000037117257,0.00037558854,0.000036882113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010686736,0.015984742,0.9180648,0.00005474638,0.00033041005,0.00016832825,0.0018929292,0.0002262073,0.0026929232,0.0000023565663,0.00019893309,0.0496969],"study_design_scores_gemma":[0.074131936,0.0402751,0.86408335,0.000272094,0.000034922272,9.937353e-7,0.0005490342,0.000024101659,0.020148093,0.0000020859407,0.0003342419,0.00014402253],"about_ca_topic_score_codex":0.0039766394,"about_ca_topic_score_gemma":0.0012560908,"teacher_disagreement_score":0.0634452,"about_ca_system_score_codex":0.00039333015,"about_ca_system_score_gemma":0.00030361192,"threshold_uncertainty_score":0.6011515},"labels":[],"label_agreement":null},{"id":"W2954889722","doi":"","title":"Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Antibody; Epitope; Amino acid; Epithelial cell adhesion molecule; Biology; Immunohistochemistry; Recombinant DNA; Molecular biology; Cancer research; Pharmacology; Medicine; Immunology; Biochemistry","score_opus":0.12783204471652537,"score_gpt":0.46439084715537854,"score_spread":0.33655880243885317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954889722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992745,0.0029015448,0.00028830618,0.00011387024,0.001145608,0.0005461304,0.0001270821,0.00004604622,0.0020864308],"genre_scores_gemma":[0.9864874,0.002628569,0.0003566395,0.000032136075,0.000090358335,0.00010701032,0.000091645794,0.000034825756,0.010171452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968191,0.001092138,0.0006819505,0.0004961678,0.00015605839,0.00075460196],"domain_scores_gemma":[0.99839026,0.00034168042,0.00014829681,0.0007485323,0.0003013124,0.00006994429],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025173118,0.00017743597,0.00046494268,0.00020662899,0.0007499078,0.000020257556,0.0006867774,0.00035559083,0.004958044],"category_scores_gemma":[0.00014723513,0.00015597742,0.00015145082,0.00033861998,0.0012377572,0.00019462462,0.00024359347,0.0012696836,0.00026866107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030716552,0.00027193283,0.016113877,0.000023332346,0.00019194765,0.000012099681,0.00059070875,0.000010987621,0.9730168,0.0021830245,0.0016062328,0.005671902],"study_design_scores_gemma":[0.0042571947,0.0024001396,0.37363285,0.00019729082,0.000032860775,0.00006621251,0.00052097766,0.000026547466,0.5392376,0.00036379392,0.07880016,0.00046433334],"about_ca_topic_score_codex":0.00056094496,"about_ca_topic_score_gemma":0.00004657891,"teacher_disagreement_score":0.43377915,"about_ca_system_score_codex":0.00014400342,"about_ca_system_score_gemma":0.0009830764,"threshold_uncertainty_score":0.99595153},"labels":[],"label_agreement":null},{"id":"W2954917855","doi":"10.1158/1538-7445.am2019-ct043","title":"Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Pemetrexed; Medicine; Carboplatin; Internal medicine; Placebo; Oncology; Lung cancer; Randomization; Cisplatin; Clinical endpoint; Pembrolizumab; Randomized controlled trial; Chemotherapy; Cancer; Pathology","score_opus":0.07111186119183589,"score_gpt":0.3649071305933858,"score_spread":0.29379526940154993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954917855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848391,0.0007274012,0.00003373808,0.0008778966,0.00006812522,0.008791077,0.00391997,0.00014387684,0.0005988603],"genre_scores_gemma":[0.9920775,0.000087440836,0.0011404288,0.00033225553,0.00009360126,0.0012800073,0.001242459,0.00022944472,0.00351685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990527,0.001428186,0.0009687405,0.0018370572,0.00368115,0.0015578788],"domain_scores_gemma":[0.9898963,0.005392171,0.0005175257,0.0022984894,0.0012388671,0.0006566485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018076856,0.001051802,0.0018437576,0.00055285945,0.0006283185,0.0003377203,0.0006947619,0.00010904703,0.0022079602],"category_scores_gemma":[0.0006813553,0.00046148535,0.00023864317,0.0020348497,0.00077835575,0.0004985174,0.00024428626,0.0012429578,0.00020437119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14302997,0.008018001,0.7965907,0.0003920934,0.014718089,0.006033174,0.00456531,0.0012459736,0.00014352392,0.00003311891,0.00869846,0.016531613],"study_design_scores_gemma":[0.1032758,0.018773595,0.8618433,0.0009764929,0.0033868933,0.00006461984,0.0081317425,0.00014346768,0.0010424429,0.000007036087,0.0014802895,0.0008743164],"about_ca_topic_score_codex":0.056311663,"about_ca_topic_score_gemma":0.03167433,"teacher_disagreement_score":0.06525263,"about_ca_system_score_codex":0.0008657333,"about_ca_system_score_gemma":0.0015363483,"threshold_uncertainty_score":0.9997837},"labels":[],"label_agreement":null},{"id":"W2954931853","doi":"10.1158/1538-7445.am2019-2054","title":"Abstract 2054: A novel Bcl-2/Bcl-XL inhibitor APG-1252-12A as a potential therapeutic strategy for gastric carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Cancer; Apoptosis; In vivo; Cancer research; Cell cycle; Cell growth; Medicine; Flow cytometry; Western blot; Cell cycle checkpoint; Cancer cell; Cell; Internal medicine; Biology; Immunology; Biochemistry","score_opus":0.10751525757481271,"score_gpt":0.41735843676089557,"score_spread":0.30984317918608284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954931853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829813,0.006929612,0.00063807104,0.0022734236,0.00091209746,0.0032863847,0.0001565037,0.00007609145,0.0027464903],"genre_scores_gemma":[0.98608,0.0005850044,0.00014365258,0.0005026517,0.0016364147,0.0007215683,0.000042254906,0.00011299914,0.010175483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965842,0.000051374605,0.00038551167,0.00074652315,0.0011029323,0.0011295042],"domain_scores_gemma":[0.9980875,0.00013407678,0.00009718702,0.0006578636,0.00062991265,0.00039343972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008478076,0.000294385,0.00049946655,0.0004139421,0.00020458545,0.00013194322,0.0003232949,0.00022957257,0.0038169054],"category_scores_gemma":[0.000030820614,0.00025050965,0.00026307444,0.00062223425,0.00012435799,0.00015346064,0.00007907832,0.0007889818,0.00029474607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038942208,0.0004582005,0.0005350658,0.0005073438,0.00021963607,0.00005543249,0.00029452716,0.000079803125,0.9328233,0.0019130951,0.0030430136,0.056176346],"study_design_scores_gemma":[0.08503516,0.019386437,0.087979995,0.0019523309,0.0005102978,0.00061710045,0.005731523,0.004647943,0.4501927,0.011609501,0.3295644,0.0027726241],"about_ca_topic_score_codex":0.0018052756,"about_ca_topic_score_gemma":0.00013760172,"teacher_disagreement_score":0.4826306,"about_ca_system_score_codex":0.0005867664,"about_ca_system_score_gemma":0.0018357617,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W2954988217","doi":"10.1158/1538-7445.am2019-1473","title":"Abstract 1473: Dual oncolytic viral immunotherapy generates large polyfunctional tumour-specific CD8 + T cell responses that infiltrate immunosuppressive tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Interface Biologics (Canada)","funders":"","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Antigen; CD8; Cancer research; Immune system; T cell; Cytotoxic T cell; Immunology; Cancer; Medicine; Biology; In vitro","score_opus":0.04336569476906917,"score_gpt":0.3551836870709618,"score_spread":0.31181799230189267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954988217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768346,0.018875612,0.000013054464,0.00037852512,0.00041359177,0.00090670167,0.00034691402,0.000033843768,0.0021971483],"genre_scores_gemma":[0.9821986,0.0047319042,0.000035662604,0.00024969957,0.0007217304,0.00036171105,0.00026940028,0.00013648381,0.011294819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99514997,0.0006823294,0.00041281275,0.0009961011,0.0012867815,0.0014720227],"domain_scores_gemma":[0.9977895,0.00019232817,0.00013734189,0.0010542149,0.0005698061,0.0002567779],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018352033,0.000404664,0.0003810989,0.00036082143,0.00048067755,0.00026044558,0.0008275974,0.00029549334,0.003907247],"category_scores_gemma":[0.000050984003,0.0003785158,0.00023080493,0.00042064275,0.00038530343,0.000036091627,0.0003244773,0.0009944462,0.00069733884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012257742,0.00022663543,0.0029431349,0.000045270346,0.00013327054,0.00004319755,0.00013218068,0.00022504474,0.9736311,0.00003109247,0.009048411,0.0012829638],"study_design_scores_gemma":[0.0026561096,0.0023359882,0.009379436,0.000055904442,0.0000037892032,0.00001679218,0.0003369182,0.000020874004,0.93391085,0.00005906988,0.0507929,0.00043134866],"about_ca_topic_score_codex":0.00011572818,"about_ca_topic_score_gemma":0.000105214065,"teacher_disagreement_score":0.041744485,"about_ca_system_score_codex":0.00028883482,"about_ca_system_score_gemma":0.0014108351,"threshold_uncertainty_score":0.99986666},"labels":[],"label_agreement":null},{"id":"W2954991170","doi":"10.1158/1538-7445.am2019-2411","title":"Abstract 2411: A multidisciplinary approach for HCC risk prediction in patients with cirrhosis utilizing elastography, imaging, circulating tumor cells and genomics","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transient elastography; Internal medicine; Cohort; Cirrhosis; Liver disease; Hepatocellular carcinoma; Gastroenterology; Liver cancer; Oncology; Pathology; Liver fibrosis","score_opus":0.027429870433662084,"score_gpt":0.31689684317112454,"score_spread":0.28946697273746247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954991170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958429,0.00077338493,0.000017368515,0.000029037597,0.000047871363,0.0025723467,0.00033992602,0.000020038613,0.00035712981],"genre_scores_gemma":[0.9980889,0.0001530461,0.00078365265,0.000012846569,0.00005648153,0.0007359729,0.00011718404,0.000037592286,0.000014331752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847925,0.00004393319,0.00019789296,0.0004930431,0.0003757612,0.00041012827],"domain_scores_gemma":[0.9991935,0.00012508893,0.00007239908,0.0002393973,0.00019718554,0.00017242967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003623852,0.00013678244,0.00023111828,0.00027024848,0.00014915505,0.00004066233,0.000061546256,0.00003653728,0.000034442255],"category_scores_gemma":[0.000017491353,0.00011298055,0.00006438689,0.00024654838,0.00008515064,0.00012169041,0.00006747317,0.00026280282,0.000004444853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067420444,0.00065610354,0.99133873,0.00044213445,0.00010651884,0.0000065604536,0.00062500976,0.00021126172,0.0011297237,0.0000032205471,0.00006543968,0.00474111],"study_design_scores_gemma":[0.0052234763,0.00034207388,0.98835343,0.00030632614,0.000081000355,8.4805947e-7,0.0008343218,0.0040834635,0.0006160059,0.000014500042,0.000039917857,0.00010463138],"about_ca_topic_score_codex":0.00063729595,"about_ca_topic_score_gemma":0.00001695818,"teacher_disagreement_score":0.0046364786,"about_ca_system_score_codex":0.0003311148,"about_ca_system_score_gemma":0.00015434585,"threshold_uncertainty_score":0.4607213},"labels":[],"label_agreement":null},{"id":"W2955017401","doi":"10.1158/1538-7445.am2019-2619","title":"Abstract 2619: DNA damage agents promote TFEB function and induce pro-survival autophagy signals","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"TFEB; Autophagy; DNA damage; Cancer research; Biology; Cell biology; mTORC1; DNA; PI3K/AKT/mTOR pathway; Biochemistry; Signal transduction","score_opus":0.10367447670212596,"score_gpt":0.42256633888226797,"score_spread":0.318891862180142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955017401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890193,0.0013600657,0.0000054271304,0.0005593844,0.00031533604,0.0013113534,0.000019542784,0.000066680004,0.007342935],"genre_scores_gemma":[0.99247485,0.00029400544,0.000011900902,0.0002572725,0.00040124208,0.00015662382,0.000024489393,0.000043547905,0.006336046],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99784356,0.0001118821,0.00021234852,0.00046407568,0.0008467517,0.0005213519],"domain_scores_gemma":[0.9988784,0.000077370205,0.000053988282,0.00043097496,0.00024201843,0.00031720815],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085549185,0.00015856855,0.0002728256,0.00018376156,0.00013785392,0.0000613677,0.00014380304,0.00014441504,0.0048387214],"category_scores_gemma":[0.000060961498,0.00013293815,0.00006213154,0.0003383112,0.00013028989,0.00014836216,0.0000869708,0.0005826908,0.0004567409],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013954659,0.0003067649,0.011855132,0.00062688196,0.00027594855,0.00013198983,0.00057735987,0.0000070753,0.953309,0.00032418032,0.0025987718,0.028591458],"study_design_scores_gemma":[0.003918468,0.0008751329,0.8002854,0.0004239173,0.00005264082,0.000006915821,0.0002723611,0.00018756662,0.18013991,0.0014137409,0.012166424,0.00025749294],"about_ca_topic_score_codex":0.00015512377,"about_ca_topic_score_gemma":0.0000075648195,"teacher_disagreement_score":0.7884303,"about_ca_system_score_codex":0.00015520207,"about_ca_system_score_gemma":0.00047902783,"threshold_uncertainty_score":0.996071},"labels":[],"label_agreement":null},{"id":"W2955023061","doi":"10.1158/1538-7445.am2019-2683","title":"Abstract 2683: Biomarkers of glucose homeostasis and inflammation and risk of prostate cancer: A case-cohort study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Prostate cancer; Medicine; Internal medicine; Oncology; Cancer; Cohort; Body mass index; Prostate; Relative risk; Cohort study; Confidence interval","score_opus":0.01869767537551628,"score_gpt":0.3381213773193895,"score_spread":0.31942370194387326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955023061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97146684,0.026634758,9.370337e-7,0.000034473604,0.00042087087,0.0011206255,0.0002236015,0.0000032487937,0.000094666924],"genre_scores_gemma":[0.93131375,0.06782161,0.000017142904,0.0000025022064,0.00052430533,0.00017306037,0.000012368993,0.000016848118,0.00011838773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987445,0.00012557529,0.0002489826,0.0003603502,0.00027736454,0.00024324005],"domain_scores_gemma":[0.99910986,0.000038461778,0.00013330294,0.00031437553,0.00031309936,0.00009091814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009824174,0.00011233159,0.00023824188,0.00012909707,0.00006502391,0.00001881514,0.00009143872,0.00008346206,0.000042709453],"category_scores_gemma":[0.00007877543,0.00010161426,0.000036712216,0.00018717429,0.00020718011,0.000010458842,0.00013040329,0.0001362743,8.173674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052462873,0.000048497222,0.49106175,0.00024902963,0.00033145188,0.0000011002028,0.0006050197,0.000019404477,0.4305893,0.0000034278546,0.0006834579,0.075882934],"study_design_scores_gemma":[0.0021952896,0.0005048016,0.7015065,0.00007796868,0.00009583995,0.00001505878,0.001955212,0.00001952897,0.27490163,0.000018929428,0.018514568,0.00019466838],"about_ca_topic_score_codex":0.011203474,"about_ca_topic_score_gemma":0.0033742434,"teacher_disagreement_score":0.21044476,"about_ca_system_score_codex":0.000029478222,"about_ca_system_score_gemma":0.00024124768,"threshold_uncertainty_score":0.995381},"labels":[],"label_agreement":null},{"id":"W2955023428","doi":"10.1158/1538-7445.am2019-lb-097","title":"Abstract LB-097: Whole transcriptome dose response profiling enables characterization of efficacy, metabolism, side effects and cytotoxicity in a single comprehensive assay","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Computational biology; Fold change; Gene expression profiling; Computer science; Benchmark (surveying); Gene expression; Bioinformatics; Biology; Gene; Data mining; Genetics","score_opus":0.06381781574264134,"score_gpt":0.3779032728998042,"score_spread":0.31408545715716285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955023428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898109,0.00046230922,0.007827918,0.00047108677,0.00019460154,0.0010933047,0.000030011448,0.000037101432,0.000072767034],"genre_scores_gemma":[0.9962069,0.000036823287,0.0034613616,0.0000727319,0.00004289987,0.000088368564,0.000010429837,0.000019367171,0.00006111239],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99601,0.0017926118,0.0003596104,0.00058358215,0.00079392415,0.0004602866],"domain_scores_gemma":[0.995769,0.0032119686,0.000108855755,0.0004198744,0.0003747001,0.0001155665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030092108,0.00016748648,0.00038004247,0.0005722161,0.00007995808,0.00015812801,0.00053995673,0.00008814258,0.000007953027],"category_scores_gemma":[0.0004269412,0.00016348345,0.000059150887,0.0011477756,0.00014363608,0.00072356814,0.00026029235,0.00041223448,0.000012800245],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058533234,0.00015561472,0.0003921039,0.0003187653,0.000018171108,0.000015303143,0.0012422709,0.0034415529,0.9853746,0.00068630086,0.0000035218338,0.0077664135],"study_design_scores_gemma":[0.0010821158,0.000108630295,0.5085242,0.00023564298,0.000002947224,0.0000025927066,0.000042388376,0.010227555,0.47891462,0.00041648062,0.00029679466,0.00014608195],"about_ca_topic_score_codex":0.0001403782,"about_ca_topic_score_gemma":0.000009679207,"teacher_disagreement_score":0.50813204,"about_ca_system_score_codex":0.00018795299,"about_ca_system_score_gemma":0.000462701,"threshold_uncertainty_score":0.66666615},"labels":[],"label_agreement":null},{"id":"W2955033126","doi":"10.1158/1538-7445.am2019-ct014","title":"Abstract CT014: Initial results from the Phase I study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Interface Biologics (Canada); University of Toronto","funders":"","keywords":"Medicine; Tumor microenvironment; Cancer; Monoclonal antibody; Immunosuppression; Metastasis; Cytokine release syndrome; Cancer research; Cytokine; Antibody; Oncology; Immunotherapy; Immunology; Internal medicine","score_opus":0.08070228339118513,"score_gpt":0.4629608044383988,"score_spread":0.3822585210472137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955033126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693114,0.000057417263,0.0000013887241,0.0001826678,0.0001400245,0.0016616904,0.000367713,0.000015817881,0.0006421676],"genre_scores_gemma":[0.9993961,0.000019461411,0.000020095777,0.000041975974,0.00016285405,0.00006929224,0.00019788445,0.000030053,0.000062306375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976967,0.00012518985,0.0004961761,0.00041313737,0.0009030194,0.00036577447],"domain_scores_gemma":[0.99827325,0.0003873507,0.00014845359,0.00051519304,0.00058253686,0.00009318427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005299367,0.00014675598,0.000407956,0.00021062691,0.00010704058,0.000029651628,0.00022135153,0.00004571049,0.000657561],"category_scores_gemma":[0.00021165378,0.000094362294,0.00005281194,0.0004463755,0.00011461492,0.00013666696,0.00008719126,0.0007606388,0.000033390526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0454277,0.0103682345,0.38762748,0.00010188942,0.00037986683,0.00013809184,0.008850133,0.0005504691,0.53834057,0.000016988179,0.0010149612,0.0071835974],"study_design_scores_gemma":[0.049158,0.0058077998,0.8991025,0.0010602804,0.00003318828,0.0000013914545,0.0030507734,0.00015045011,0.04096807,0.000012985729,0.00048419862,0.0001703543],"about_ca_topic_score_codex":0.0049373084,"about_ca_topic_score_gemma":0.00048452817,"teacher_disagreement_score":0.511475,"about_ca_system_score_codex":0.00013562701,"about_ca_system_score_gemma":0.00038515474,"threshold_uncertainty_score":0.74637663},"labels":[],"label_agreement":null},{"id":"W2955102945","doi":"10.1158/1538-7445.am2019-3682","title":"Abstract 3682: Therapeutic targeting of stem cell self-renewal in childhood medulloblastoma: Strategies for blocking recurrence","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medulloblastoma; BMI1; Wnt signaling pathway; Stem cell; Neural stem cell; Cancer research; Carcinogenesis; Metastasis; Biology; Medicine; Internal medicine; Signal transduction; Cancer; Cell biology","score_opus":0.025448719082268135,"score_gpt":0.3364822494245678,"score_spread":0.31103353034229964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955102945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934476,0.005288013,0.00004224955,0.000034205437,0.00008976583,0.0006224349,0.000028108007,0.0000076163797,0.00044000323],"genre_scores_gemma":[0.99928504,0.00023128303,0.00013880686,0.000008769683,0.000115709416,0.000109719185,0.000030468032,0.00002339436,0.000056786666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987469,0.00007964815,0.00022753613,0.00034146378,0.00024277197,0.00036173427],"domain_scores_gemma":[0.99933666,0.00005439488,0.00008831181,0.0002494224,0.00021915694,0.00005206247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005850484,0.0001079634,0.00013489061,0.00009435777,0.000047162524,0.00002919449,0.00024995705,0.00011392009,0.000041114406],"category_scores_gemma":[0.000011834604,0.00010635151,0.00006207007,0.00017393302,0.00005188834,0.000009075397,0.00007791127,0.00014652628,0.000004585378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001062151,0.00009841248,0.004923914,0.00030003104,0.000028416272,4.58731e-7,0.00027574823,0.000738054,0.9911153,0.00006230159,0.00012900036,0.0022221634],"study_design_scores_gemma":[0.00094978267,0.00019904236,0.016423404,0.00014840873,0.000007555235,6.3499294e-7,0.0009044153,0.00013206575,0.9793975,0.00033044798,0.00133195,0.00017481232],"about_ca_topic_score_codex":0.00006283613,"about_ca_topic_score_gemma":0.000051430397,"teacher_disagreement_score":0.011717804,"about_ca_system_score_codex":0.00006728794,"about_ca_system_score_gemma":0.0006141148,"threshold_uncertainty_score":0.43368885},"labels":[],"label_agreement":null},{"id":"W2955107320","doi":"10.1158/1538-7445.am2019-1853","title":"Abstract 1853: Association of IDH genes with prostate cancer progression and their regulation by the androgen receptor","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"IDH1; Androgen receptor; Prostate cancer; Biology; Cancer research; Isocitrate dehydrogenase; Cancer; IDH2; Gene; Genetics; Mutation; Enzyme; Biochemistry","score_opus":0.035313064518755904,"score_gpt":0.385887786181679,"score_spread":0.35057472166292314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955107320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97269535,0.018479,7.748787e-7,0.006119891,0.000060874714,0.0018913497,0.00011711417,0.00001842244,0.0006172473],"genre_scores_gemma":[0.9787388,0.009665455,0.00001917056,0.000026708505,0.000111476125,0.00054552354,0.00007428861,0.00002999426,0.010788569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981369,0.00011989481,0.00017865338,0.0003112036,0.00082984363,0.00042353914],"domain_scores_gemma":[0.9986877,0.00016788581,0.00012193356,0.00025780336,0.0006520184,0.0001126769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009739911,0.00012872084,0.00023113274,0.000101540034,0.00016849875,0.000047123565,0.0001030557,0.00009653666,0.00046531443],"category_scores_gemma":[0.000031003136,0.00006328476,0.00003416456,0.00041983792,0.00019739493,0.00013066255,0.00006010776,0.0003435084,0.0000135831115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031467567,0.00010547554,0.37344712,0.00047258032,0.00025534045,0.0000017512385,0.0013785595,0.000010185555,0.48457673,0.000014388392,0.010606492,0.12598464],"study_design_scores_gemma":[0.0047268206,0.0009950296,0.14279766,0.0011423229,0.000041185915,0.0000041211993,0.0009748302,0.000121626574,0.79043305,0.000086127446,0.058490425,0.00018679418],"about_ca_topic_score_codex":0.0004753606,"about_ca_topic_score_gemma":0.00009032774,"teacher_disagreement_score":0.30585632,"about_ca_system_score_codex":0.00052299787,"about_ca_system_score_gemma":0.000550672,"threshold_uncertainty_score":0.5094867},"labels":[],"label_agreement":null},{"id":"W2955142030","doi":"10.1158/1538-7445.am2019-lb-288","title":"Abstract LB-288: CDC7 kinase inhibition by SRA141 induces a potentially novel caspase-dependent tumor cell apoptosis associated with altered DNA replication and cell cycle dynamics","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Control of chromosome duplication; DNA replication; S phase; DNA re-replication; Eukaryotic DNA replication; Biology; Minichromosome maintenance; Pre-replication complex; Origin recognition complex; DNA replication factor CDT1; Cell cycle; Replication factor C; Cell biology; Mitosis; DNA; Cancer research; Apoptosis; Genetics","score_opus":0.01533969940849665,"score_gpt":0.2842358806399598,"score_spread":0.26889618123146314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955142030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721855,0.00046475005,0.00027407083,0.00019175322,0.00006425617,0.00068495685,0.00045639128,0.00001775567,0.00062754087],"genre_scores_gemma":[0.997081,0.00047695954,0.00007641388,0.0001342562,0.00008475331,0.00014614477,0.0008682769,0.000055733657,0.0010764921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805665,0.000076504475,0.00023633041,0.00076954265,0.00038325446,0.00047773932],"domain_scores_gemma":[0.99877244,0.000026998323,0.00015641219,0.0005646573,0.00032557413,0.00015389027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051697955,0.00019873539,0.00018134747,0.000077120785,0.00015409572,0.00010557705,0.00019956104,0.000208427,0.000047584454],"category_scores_gemma":[0.00004068204,0.00019114355,0.000048504076,0.00018131183,0.00010432693,0.000018417853,0.0001639182,0.0003377894,0.000014504329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017088749,0.00026828857,0.00078943936,0.000087004984,0.000039486375,0.0000023239209,0.00003838353,0.0000672441,0.9967762,0.0000066956504,0.0011711176,0.0005828886],"study_design_scores_gemma":[0.0014465142,0.00033350784,0.002218089,0.000068804955,0.000021282762,0.0000034764942,0.0001720424,0.0003048321,0.99475515,0.000008986013,0.00040623918,0.0002610798],"about_ca_topic_score_codex":0.0007783537,"about_ca_topic_score_gemma":0.0005539316,"teacher_disagreement_score":0.0020210946,"about_ca_system_score_codex":0.00020443616,"about_ca_system_score_gemma":0.00025041148,"threshold_uncertainty_score":0.7794608},"labels":[],"label_agreement":null},{"id":"W2955174972","doi":"10.1158/1538-7445.am2019-2032","title":"Abstract 2032: Investigating the contribution of mTORC1-dependent signaling in the microenvironment to cancer onset in Li-Fraumeni syndrome","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"mTORC1; Carcinogenesis; Stromal cell; Cancer research; Paracrine signalling; Biology; Cancer; Phenotype; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Genetics; Gene","score_opus":0.050472617825991266,"score_gpt":0.36578337770117547,"score_spread":0.3153107598751842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955174972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830134,0.0034515513,0.000009992037,0.0056366716,0.00012460127,0.002231577,0.000047598216,0.000008007767,0.00018864483],"genre_scores_gemma":[0.9980916,0.00038004306,0.000018674664,0.00058483914,0.00006247087,0.00064441026,0.000011851599,0.000028734301,0.00017740966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971199,0.00032122724,0.00044358047,0.00039088094,0.0011081272,0.0006163045],"domain_scores_gemma":[0.9987938,0.00032074316,0.00009754177,0.00054798013,0.00011798437,0.00012199946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028193563,0.00015154568,0.0003096423,0.00025823782,0.0000786475,0.000029905266,0.00037239704,0.00011832373,0.00051694916],"category_scores_gemma":[0.00024937303,0.00010341712,0.00006602595,0.00073079113,0.00017044423,0.0000547489,0.00014006918,0.0011703465,0.00006910242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002556651,0.000110334615,0.051089697,0.00013294048,0.000051699448,0.000116561096,0.0027001349,0.008559831,0.93506616,0.00006204975,0.00064173585,0.0012131708],"study_design_scores_gemma":[0.005237264,0.0007390385,0.46519983,0.0045325765,0.000055203796,0.00009557677,0.0036263096,0.00033867036,0.5149334,0.00026928447,0.004599624,0.0003732531],"about_ca_topic_score_codex":0.008889936,"about_ca_topic_score_gemma":0.0027033174,"teacher_disagreement_score":0.4201328,"about_ca_system_score_codex":0.0016324666,"about_ca_system_score_gemma":0.00065498275,"threshold_uncertainty_score":0.99770993},"labels":[],"label_agreement":null},{"id":"W2955227933","doi":"10.1158/1538-7445.am2019-3123","title":"Abstract 3123: Targeting SHP2 and RAS MAPK pathway in neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; MAPK/ERK pathway; Neuroblastoma; PTPN11; Biology; Signal transduction; Protein tyrosine phosphatase; Effector; Cell growth; Apoptosis; Cell culture; Mutation; Immunology; Cell biology; Genetics; KRAS; Gene","score_opus":0.03312804763409139,"score_gpt":0.3684175530705048,"score_spread":0.3352895054364134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955227933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450463,0.0021929808,0.0000049570986,0.00031452836,0.00007305638,0.00030985576,0.000020059611,0.0000068840463,0.0025730429],"genre_scores_gemma":[0.99698055,0.00091019395,0.000026721744,0.00007338629,0.00021751721,0.00006781596,0.000024438747,0.000029610834,0.0016697797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982845,0.0001266233,0.00016100482,0.0004772581,0.00035731416,0.0005932605],"domain_scores_gemma":[0.999362,0.00007192558,0.00002313606,0.00028960803,0.000115636714,0.00013771362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076998334,0.000112437374,0.00012948041,0.00012549953,0.00008159241,0.000054247117,0.00023735149,0.00012229946,0.00037687208],"category_scores_gemma":[0.0001650519,0.00010420254,0.000037876427,0.00021318071,0.00012876505,0.000008073631,0.0003155261,0.00041339718,0.00010496163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013927132,0.00003215784,0.011559839,0.00007460855,0.000010157582,0.00003056975,0.000039072613,0.000029494113,0.9800125,0.000030876887,0.0021134617,0.005928037],"study_design_scores_gemma":[0.00077912316,0.000263804,0.021229006,0.000082387436,7.921796e-7,0.0000025362472,0.00025931332,0.00007364383,0.90785486,0.00006143612,0.069191456,0.00020162537],"about_ca_topic_score_codex":0.00033809553,"about_ca_topic_score_gemma":0.00014668962,"teacher_disagreement_score":0.07215758,"about_ca_system_score_codex":0.00003688382,"about_ca_system_score_gemma":0.00024310635,"threshold_uncertainty_score":0.42492563},"labels":[],"label_agreement":null},{"id":"W2955229867","doi":"10.1158/1538-7445.am2019-lb-269","title":"Abstract LB-269: Development of a vaccine model to track the CD8-specific response in Mauritius cynomolgus monkey","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"CTL*; Immune system; CD8; Cytotoxic T cell; Immunology; Immunotherapy; Cancer immunotherapy; Medicine; T cell; Biology; In vitro","score_opus":0.07295963913139998,"score_gpt":0.3669977844582566,"score_spread":0.2940381453268566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955229867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808995,0.01624355,0.000036435013,0.001190842,0.00022835431,0.0008979593,0.000026402084,0.000020000309,0.00045691853],"genre_scores_gemma":[0.98959225,0.0008368985,0.00009901309,0.00010686504,0.00001439319,0.00027005724,0.000009561514,0.000033137694,0.009037793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974595,0.00067765027,0.00054252555,0.00040452182,0.00016607085,0.00074973976],"domain_scores_gemma":[0.9982033,0.00077800784,0.000071899296,0.0006989619,0.00021687092,0.000030964828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0030795808,0.00018919379,0.00035172357,0.00046460278,0.00021187455,0.000025121768,0.0007476369,0.00020619722,0.0017281856],"category_scores_gemma":[0.000115368086,0.00014044171,0.00007861015,0.0005842937,0.00014218461,0.000094389616,0.0001798832,0.0008089206,0.0009894969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026669484,0.00016454792,0.00034443167,0.000033036977,0.000077919736,0.000006210601,0.0055168304,0.0005385298,0.9465145,0.0000998922,0.0022141791,0.017820477],"study_design_scores_gemma":[0.0029394086,0.0003710643,0.083751716,0.00027477075,0.000003168699,0.000013409064,0.001347481,0.000022035429,0.78772384,0.00008950782,0.12319659,0.0002670052],"about_ca_topic_score_codex":0.00025406876,"about_ca_topic_score_gemma":0.00009961203,"teacher_disagreement_score":0.15879062,"about_ca_system_score_codex":0.00030654733,"about_ca_system_score_gemma":0.0008527218,"threshold_uncertainty_score":0.99978834},"labels":[],"label_agreement":null},{"id":"W2955230553","doi":"10.1158/1538-7445.am2019-5151","title":"Abstract 5151: Deciphering the molecular mechanisms driving infiltrative histopathological type of colorectal cancer liver metastases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Colorectal cancer; Bevacizumab; Metastasis; Chemotherapy; Angiogenesis; Cancer; Oncology; Internal medicine; Liver cancer; Pathology","score_opus":0.04892145456917132,"score_gpt":0.3648889861899244,"score_spread":0.3159675316207531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955230553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97967947,0.017773375,0.00019271669,0.0000905268,0.0007689444,0.00044820862,0.000048625985,0.000008844149,0.000989295],"genre_scores_gemma":[0.99394345,0.0046529914,0.00027271657,0.000093071256,0.00033240297,0.00016159112,0.00001638218,0.000028727807,0.00049863826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983106,0.00018755496,0.0002080149,0.00042289056,0.00043196703,0.0004389669],"domain_scores_gemma":[0.99898505,0.00006753789,0.00008878021,0.0003611929,0.00040262914,0.000094792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007013982,0.0001608318,0.00024198473,0.00005810583,0.00011130067,0.000028874689,0.00040859083,0.00013860562,0.00068406994],"category_scores_gemma":[0.00016621756,0.00011758256,0.00011691538,0.00026593747,0.0002581915,0.0000091400825,0.00024496907,0.00033075814,0.00001799591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017983478,0.000041026477,0.0005387018,0.00003399328,0.00007118782,0.000005302255,0.00015270144,0.00036588442,0.9933662,0.00065592525,0.0010211297,0.0035681576],"study_design_scores_gemma":[0.00040481842,0.00031221405,0.010573932,0.000051543862,0.000027172915,0.000007864264,0.00025758502,0.000026362615,0.9438632,0.00015105287,0.044140287,0.00018396226],"about_ca_topic_score_codex":0.0005695842,"about_ca_topic_score_gemma":0.00039244007,"teacher_disagreement_score":0.04950295,"about_ca_system_score_codex":0.000074710944,"about_ca_system_score_gemma":0.0004510915,"threshold_uncertainty_score":0.7490086},"labels":[],"label_agreement":null},{"id":"W2955241001","doi":"10.1158/1538-7445.am2019-2405","title":"Abstract 2405: B7H4 as a T cell inhibitory regulator in bladder cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CD8; Cancer research; T cell; Transcriptome; Cytotoxic T cell; Cell growth; Biology; Cell; In vitro; Immunology; Medicine; Immune system; Gene expression; Gene; Genetics","score_opus":0.05003311348813792,"score_gpt":0.40121581435592696,"score_spread":0.351182700867789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955241001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625284,0.013368109,1.8155265e-7,0.0021237151,0.00053731346,0.0009697841,0.000019691332,0.00003558301,0.020417241],"genre_scores_gemma":[0.967476,0.0028931664,0.000012523904,0.00070477865,0.0004981343,0.00032787689,0.000007918667,0.000054331987,0.02802526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745786,0.00008014816,0.00032119316,0.000512803,0.0008991329,0.0007288535],"domain_scores_gemma":[0.99886566,0.0001085113,0.00005830516,0.0005374172,0.00023371023,0.00019637203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089957914,0.00017816295,0.00031816418,0.00038802772,0.00007283261,0.00004105521,0.0002144751,0.00019548682,0.016571859],"category_scores_gemma":[0.000028985187,0.0001537967,0.0001190388,0.00076211855,0.00021232365,0.00012883644,0.000075493655,0.0008190829,0.00054385734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004413342,0.00023423965,0.03478022,0.0005106996,0.00011316345,0.000093159404,0.00090032653,0.000018080913,0.8802554,0.000029316167,0.051469278,0.027182756],"study_design_scores_gemma":[0.009818855,0.0005841494,0.28281087,0.0014611678,0.000025300567,0.000015242226,0.001458397,0.000036424586,0.3914925,0.00012191285,0.31169623,0.00047896654],"about_ca_topic_score_codex":0.010763173,"about_ca_topic_score_gemma":0.001426581,"teacher_disagreement_score":0.48876294,"about_ca_system_score_codex":0.0010204568,"about_ca_system_score_gemma":0.0017461504,"threshold_uncertainty_score":0.9958242},"labels":[],"label_agreement":null},{"id":"W2955288059","doi":"10.1158/1538-7445.am2019-4450","title":"Abstract 4450: Novel transducer array layouts to optimize the treatment of multiple brain metastases with tumor treating fields","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Glioblastoma; Breast cancer; Melanoma; Head and neck; Nuclear medicine; Internal medicine; Surgery; Cancer research","score_opus":0.08927744508797383,"score_gpt":0.3951022567354356,"score_spread":0.3058248116474618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955288059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886487,0.0012492124,0.00023721466,0.006208861,0.0000604036,0.0020856224,0.00027160344,0.000021135245,0.0012172229],"genre_scores_gemma":[0.99389106,0.00009497289,0.0029534115,0.00032605114,0.00012300402,0.00053402456,0.000031170868,0.000039647457,0.0020066767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809116,0.000095493706,0.00025723325,0.0004108199,0.00064323214,0.0005020766],"domain_scores_gemma":[0.9979777,0.00093720696,0.000055547167,0.00060549716,0.000208031,0.00021603103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005244804,0.00021288371,0.0004558776,0.00014184354,0.00011854849,0.00003118278,0.0001427839,0.000042926105,0.0012642294],"category_scores_gemma":[0.00007393883,0.00010882069,0.00015391748,0.0004030381,0.000115194016,0.00005117737,0.000015231584,0.00020128829,0.000045669734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021725152,0.012773271,0.12077706,0.0013541806,0.0057154237,0.00067070633,0.025860962,0.014855389,0.5918313,0.0005791698,0.006636846,0.1972205],"study_design_scores_gemma":[0.035227746,0.020199038,0.106509924,0.0013614161,0.0007058864,0.00011495861,0.0070817075,0.0003241353,0.7239174,0.000026796644,0.10382015,0.00071083097],"about_ca_topic_score_codex":0.0038281288,"about_ca_topic_score_gemma":0.0007971507,"teacher_disagreement_score":0.19650967,"about_ca_system_score_codex":0.00024313614,"about_ca_system_score_gemma":0.00031718938,"threshold_uncertainty_score":0.99964875},"labels":[],"label_agreement":null},{"id":"W2955298108","doi":"10.1158/1538-7445.am2019-lb-187","title":"Abstract LB-187: Hsp90 inhibitor SNX-2112 enhances neoantigen presentation on the surface of tumor cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"MHC class I; Chemistry; Cancer research; Molecular biology; Cytotoxic T cell; Biology; Biochemistry; In vitro","score_opus":0.04411578129198945,"score_gpt":0.38420258803019736,"score_spread":0.3400868067382079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955298108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174863,0.000927882,0.0000112097005,0.00068876357,0.0001800574,0.0012156094,0.000064540225,0.000006193425,0.005157115],"genre_scores_gemma":[0.99416274,0.0005268874,0.0000376183,0.00006075014,0.00031794998,0.00013265514,0.000024146935,0.00003488181,0.004702392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973774,0.00032894203,0.00025436934,0.0004760268,0.00097498705,0.00058826106],"domain_scores_gemma":[0.9984535,0.00018517373,0.00006589699,0.0007159757,0.0004585056,0.000120934405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013970345,0.00014367784,0.00016821123,0.00008407154,0.00013704524,0.000055503086,0.0006091487,0.000119936034,0.0011064325],"category_scores_gemma":[0.0002091044,0.00010478156,0.00008305632,0.00032636378,0.00025128722,0.000010136068,0.00026027192,0.0004558674,0.0004122961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027740566,0.000065026354,0.00076109107,0.00011969182,0.000035733883,0.000003226414,0.00008960531,0.00029875932,0.9894016,0.000056748948,0.008248666,0.00064248056],"study_design_scores_gemma":[0.00029561602,0.00037281885,0.0016448669,0.000077411656,0.0000017563937,6.461439e-7,0.0002152719,0.00003034364,0.97771025,0.000035873338,0.019503122,0.000112053465],"about_ca_topic_score_codex":0.0007110471,"about_ca_topic_score_gemma":0.000089989,"teacher_disagreement_score":0.011691345,"about_ca_system_score_codex":0.00007755206,"about_ca_system_score_gemma":0.0005584841,"threshold_uncertainty_score":0.9998067},"labels":[],"label_agreement":null},{"id":"W2955306952","doi":"10.1158/1538-7445.am2019-142","title":"Abstract 142: The EGFR signaling modulates in mesenchymal stem cells the expression of microRNAs involved in the interaction with breast cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"microRNA; Mesenchymal stem cell; Microvesicles; Biology; Paracrine signalling; Cancer research; Transcriptome; Epidermal growth factor receptor; Breast cancer; Exosome; Cancer; Cell biology; Molecular biology; Gene expression; Gene; Receptor; Genetics","score_opus":0.028228920679733156,"score_gpt":0.3274466946471533,"score_spread":0.29921777396742016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955306952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953952,0.0019054089,0.00006527712,0.0010818028,0.00015072718,0.0011720107,0.00004823401,0.0000036695612,0.00017770675],"genre_scores_gemma":[0.9980185,0.0010817933,0.000013856127,0.00010257215,0.00014080349,0.0003424321,0.0000095130945,0.000038384493,0.00025215372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972355,0.000600302,0.0003075713,0.00048405124,0.0007881188,0.0005844526],"domain_scores_gemma":[0.99860144,0.0001875618,0.00011755824,0.0007281792,0.00031008688,0.000055167653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001790168,0.00018687495,0.00018885729,0.00015203678,0.00013100248,0.00008280571,0.0009048172,0.00017617397,0.0001800034],"category_scores_gemma":[0.000013391019,0.00009627961,0.000080096026,0.0006097537,0.0002311759,0.000018288789,0.00025743863,0.0010418684,0.000011945787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007134,0.0000656495,0.000527559,0.0000778122,0.000032583383,0.0000075784783,0.0007175683,0.016601516,0.97934264,0.000010403829,0.000505983,0.0013973285],"study_design_scores_gemma":[0.0006997793,0.00012688684,0.0011490202,0.0003615652,0.0000057563566,0.000005254687,0.0033288288,0.00031209004,0.99259394,0.000020580535,0.0012688574,0.00012745622],"about_ca_topic_score_codex":0.0040472164,"about_ca_topic_score_gemma":0.0024799583,"teacher_disagreement_score":0.016289426,"about_ca_system_score_codex":0.00020582315,"about_ca_system_score_gemma":0.00048116318,"threshold_uncertainty_score":0.61182076},"labels":[],"label_agreement":null},{"id":"W2955315677","doi":"10.1158/1538-7445.am2019-4706","title":"Abstract 4706: Temperature-dependent transcription artifacts and cell population biases in scRNAseq data are minimized by tissue dissociation at low temperatures","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Population; Gene expression; Cell; Dissociation (chemistry); Cytotoxic T cell; Cell culture; Gene; Chemistry; Biology; Cancer research; Molecular biology; Biophysics; Medicine; Biochemistry; In vitro; Genetics","score_opus":0.03952483381775539,"score_gpt":0.37168409332687213,"score_spread":0.33215925950911673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955315677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557745,0.0026584957,0.000010198744,0.0004875716,0.000044010176,0.00067868974,0.00045621226,0.000013586643,0.00007376469],"genre_scores_gemma":[0.9924121,0.0018720027,0.00006381944,0.000102841834,0.00007054274,0.00015340264,0.004118558,0.000021942486,0.0011848282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985859,0.00013056352,0.00019386398,0.00057982415,0.00021477789,0.00029509785],"domain_scores_gemma":[0.9992264,0.00002682132,0.000071263355,0.00051252823,0.00008377819,0.00007924505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047181192,0.00012814518,0.00014441476,0.00007240101,0.00012055037,0.00005653024,0.00024233981,0.00024480684,0.00008480898],"category_scores_gemma":[0.00006712882,0.00012019934,0.00002236371,0.00013158313,0.000052716452,0.00001435655,0.00014452811,0.00023550531,0.00001174468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115336894,0.00006748692,0.010016172,0.000043825687,0.000008919368,0.0000018041449,0.000020933563,0.000022567068,0.98121035,0.000004814721,0.008073421,0.00041435],"study_design_scores_gemma":[0.0006395929,0.000070759044,0.041032065,0.00006412117,0.0000052541022,0.0000018586342,0.000060735438,0.00003174435,0.95181274,0.000018130882,0.006103785,0.00015921824],"about_ca_topic_score_codex":0.0005002546,"about_ca_topic_score_gemma":0.0008441138,"teacher_disagreement_score":0.031015893,"about_ca_system_score_codex":0.00008319856,"about_ca_system_score_gemma":0.00005112523,"threshold_uncertainty_score":0.49015868},"labels":[],"label_agreement":null},{"id":"W2955350141","doi":"10.1158/1538-7445.am2019-1292","title":"Abstract 1292: A new generation of N-terminal domain androgen receptor inhibitors, with improved pharmaceutical properties, in castration-resistant prostate cancer models","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Androgen receptor; Prostate cancer; ADME; In vivo; Androgen; Potency; Chemistry; Pharmacology; Dihydrotestosterone; Cancer research; Cancer; In vitro; Pharmacokinetics; Biology; Medicine; Internal medicine; Biochemistry; Hormone; Genetics","score_opus":0.14067697070800234,"score_gpt":0.40492058545540405,"score_spread":0.2642436147474017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955350141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850658,0.008812672,0.0000033951974,0.0025434792,0.00010205606,0.0030639875,0.00008767412,0.000019959873,0.0003009577],"genre_scores_gemma":[0.9924351,0.0026115433,0.00024683203,0.00003690483,0.0003487224,0.00076900225,0.000071416056,0.000049788527,0.0034306797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971344,0.000115842464,0.00042738704,0.0005511451,0.0010331332,0.00073808705],"domain_scores_gemma":[0.9986928,0.000037932234,0.00008339994,0.00031936256,0.00051952904,0.00034694615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065786956,0.00021750943,0.0003904316,0.00031961888,0.000089378904,0.00006021217,0.00014495004,0.00012366129,0.000601666],"category_scores_gemma":[0.00001714343,0.00014810357,0.000057985435,0.0006314168,0.0002449009,0.00031682907,0.00006260993,0.00064559956,0.000015414826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00842746,0.00028389835,0.011011439,0.0007675232,0.0001234094,0.0000837891,0.0014381739,0.00028701982,0.9638167,0.000032669544,0.0012604572,0.012467461],"study_design_scores_gemma":[0.013498161,0.001712295,0.0034399503,0.0019915209,0.00004341046,0.000018277895,0.0006858743,0.0025095404,0.97240907,0.00008140801,0.0032703744,0.00034012596],"about_ca_topic_score_codex":0.005315199,"about_ca_topic_score_gemma":0.0018007848,"teacher_disagreement_score":0.012127334,"about_ca_system_score_codex":0.001018099,"about_ca_system_score_gemma":0.0046493206,"threshold_uncertainty_score":0.82476956},"labels":[],"label_agreement":null},{"id":"W2955367426","doi":"10.1158/1538-7445.am2019-967","title":"Abstract 967: Single-cell transcriptomics uncovers clonal heterogeneity linked to drug response and cellular phenotype in adult brain tumor stem cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Biology; Stem cell; Transcriptome; Population; Cancer research; Phenotype; Cancer stem cell; Genetics; Gene expression; Gene; Medicine","score_opus":0.032241810034037165,"score_gpt":0.29475414887603174,"score_spread":0.2625123388419946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955367426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969074,0.0008489436,0.000058530004,0.00066555646,0.00038490215,0.0007585763,0.00012839024,0.000014845611,0.00023283387],"genre_scores_gemma":[0.99729246,0.00014255878,0.00013440665,0.0007821462,0.00016399076,0.000052534822,0.000028241664,0.000066832225,0.0013368039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729246,0.00035672094,0.00035598056,0.0008120981,0.00044724927,0.0007354854],"domain_scores_gemma":[0.9987723,0.00014124284,0.000052385283,0.00048827002,0.00024025748,0.00030551042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012221155,0.00026703023,0.00029179946,0.00019341358,0.000101358244,0.00009370433,0.00040883498,0.00020085338,0.000053959455],"category_scores_gemma":[0.0000437884,0.00027701628,0.00010695586,0.0002998234,0.00014285528,0.000013678833,0.00011052051,0.00049704796,0.00005372402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041031674,0.00018710742,0.0068966816,0.00016173844,0.000023341907,0.000023048235,0.00044167548,0.00045805375,0.9857547,0.0000070142046,0.0010239211,0.00091954536],"study_design_scores_gemma":[0.0019673712,0.00044323498,0.0026812456,0.000078385456,0.000006045144,0.0000016798459,0.00026743446,0.00007000098,0.9799572,0.0000114006225,0.014177089,0.0003388696],"about_ca_topic_score_codex":0.0006626031,"about_ca_topic_score_gemma":0.0009766732,"teacher_disagreement_score":0.013153167,"about_ca_system_score_codex":0.00018756057,"about_ca_system_score_gemma":0.0003983367,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W2955414460","doi":"10.1158/1538-7445.am2019-1169","title":"Abstract 1169: Characterization of a small molecule inhibitor for GD3 synthase (ST8SIA1), a novel target in breast cancer stem-like cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"PI3K/AKT/mTOR pathway; Virtual screening; Cancer research; Protein kinase B; Metastasis; Chemistry; Protein Data Bank (RCSB PDB); Structural similarity; Small molecule; Cancer stem cell; Biology; Cancer; Stem cell; Computational biology; Cell biology; Biochemistry; Drug discovery; Signal transduction; Genetics","score_opus":0.044431328704136366,"score_gpt":0.384192596263569,"score_spread":0.33976126755943264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955414460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926958,0.00037534695,0.00013768325,0.0018954229,0.00033470476,0.0023704772,0.0018320904,0.000018415863,0.0003400263],"genre_scores_gemma":[0.9941784,0.00028397594,0.0002250954,0.00015021964,0.00020857126,0.0013860104,0.00017179304,0.00005293603,0.0033429884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983559,0.000029843919,0.00034023527,0.00039971256,0.00040872468,0.000465571],"domain_scores_gemma":[0.9988753,0.00008073902,0.000107077096,0.00030280405,0.0004747799,0.00015928553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003061583,0.00015394147,0.00033899987,0.0003031608,0.0000564976,0.000025919218,0.0001205967,0.000105874446,0.0005943649],"category_scores_gemma":[0.000011148215,0.00013163172,0.00008702973,0.00045350948,0.00008580847,0.00012088933,0.0000422628,0.00023782613,0.000022901355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008649474,0.0005476392,0.012312524,0.00094269123,0.0001243632,0.000009493112,0.0006181321,0.00007386516,0.9814128,0.00005641941,0.00039775652,0.0026393333],"study_design_scores_gemma":[0.01340234,0.00059035234,0.17225023,0.002632308,0.00015401533,0.000010884704,0.0006200568,0.0012407596,0.79630655,0.000029360337,0.012334797,0.0004283308],"about_ca_topic_score_codex":0.0021483516,"about_ca_topic_score_gemma":0.0002315102,"teacher_disagreement_score":0.18510626,"about_ca_system_score_codex":0.00066386303,"about_ca_system_score_gemma":0.0010900418,"threshold_uncertainty_score":0.6507879},"labels":[],"label_agreement":null},{"id":"W2955542325","doi":"10.1158/1538-7445.am2019-186","title":"Abstract 186: Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Angiogenesis; Prostate cancer; Neuroendocrine differentiation; EZH2; Cancer research; CREB; Enzalutamide; Cancer; Medicine; Androgen deprivation therapy; Biology; Androgen; Internal medicine; Androgen receptor; Epigenetics; Transcription factor; Genetics; Hormone","score_opus":0.060441497380012185,"score_gpt":0.3731030837646257,"score_spread":0.3126615863846135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955542325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893174,0.0044278805,0.0000023113453,0.0026345905,0.00009860327,0.0024314057,0.000059511378,0.000046746492,0.0009815119],"genre_scores_gemma":[0.992206,0.005047892,0.000042357173,0.00007109491,0.000114385315,0.00058048795,0.00013157379,0.00005181171,0.0017543935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973094,0.00012338591,0.00030659206,0.0006417565,0.0008193723,0.0007995011],"domain_scores_gemma":[0.99893284,0.00012753405,0.00006594119,0.00037307886,0.00031366388,0.00018691579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036856142,0.00021108436,0.00033726444,0.00037765843,0.00013977876,0.00008354168,0.00013321679,0.000057933248,0.0005388996],"category_scores_gemma":[0.00008391059,0.00016986245,0.000062943975,0.0008450862,0.00016727921,0.00031805702,0.00013282336,0.00045163409,0.00004479198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019804514,0.00024162354,0.65080833,0.0011153024,0.0001522969,0.00025653106,0.0013016975,0.000040374056,0.29895025,0.000115100156,0.00056962535,0.04446842],"study_design_scores_gemma":[0.005518123,0.000651746,0.64224577,0.00051313755,0.000019237263,0.000029438028,0.0003597339,0.00025803066,0.34613326,0.00043021166,0.0035887535,0.00025252465],"about_ca_topic_score_codex":0.0032348705,"about_ca_topic_score_gemma":0.00045416478,"teacher_disagreement_score":0.04718302,"about_ca_system_score_codex":0.00082954107,"about_ca_system_score_gemma":0.0007524766,"threshold_uncertainty_score":0.692679},"labels":[],"label_agreement":null},{"id":"W2955546107","doi":"10.1158/1538-7445.am2019-ct025","title":"Abstract CT025: Phase Ib study of adavosertib in combination with olaparib in patients with refractory solid tumors: Dose escalation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Neutropenia; Tolerability; Internal medicine; Nausea; Gastroenterology; Anemia; Vomiting; Toxicity; Refractory (planetary science); Adverse effect","score_opus":0.056301588110646575,"score_gpt":0.4262352520521331,"score_spread":0.3699336639414865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955546107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604475,0.000080029036,0.0000028385998,0.00012867937,0.000049532173,0.0027439245,0.000013518703,0.000016762368,0.0009199634],"genre_scores_gemma":[0.99933815,0.000023108765,0.000018066252,0.000034119545,0.000033834633,0.0003214837,0.000049663297,0.000036567228,0.0001449833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737084,0.00016990231,0.0004390479,0.00039364715,0.0012573014,0.000369267],"domain_scores_gemma":[0.9985802,0.00012277252,0.0001583988,0.00041824477,0.0006189251,0.00010141727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076076924,0.00014649647,0.00038137418,0.0006457693,0.000036930065,0.000016684206,0.00012481786,0.00007538391,0.00037118065],"category_scores_gemma":[0.000042318345,0.000115988645,0.000018201872,0.0009772416,0.00010577201,0.00029749813,0.000027031329,0.00065790635,0.000017440621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018722063,0.009351571,0.94978684,0.00022345751,0.000050091017,0.000026991975,0.0036188697,0.00035514648,0.011834351,0.000015592079,0.00011073574,0.00590431],"study_design_scores_gemma":[0.055078417,0.008995674,0.92768735,0.0011753383,0.000007752506,5.546258e-7,0.0012164019,0.000092418406,0.0054902527,0.000022289223,0.000101679325,0.00013188581],"about_ca_topic_score_codex":0.0013802812,"about_ca_topic_score_gemma":0.0010860804,"teacher_disagreement_score":0.036356356,"about_ca_system_score_codex":0.000927933,"about_ca_system_score_gemma":0.0005335725,"threshold_uncertainty_score":0.47298795},"labels":[],"label_agreement":null},{"id":"W2955549148","doi":"10.1158/1538-7445.am2019-3660","title":"Abstract 3660: A link between miRNAs and mRNA translation elongation: The let7-eEF2K axis in MYC-driven pediatric tumors adaptation to nutrient deprivation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"microRNA; Biology; Untranslated region; Translation (biology); Cancer research; Three prime untranslated region; Messenger RNA; Genetics; Gene","score_opus":0.06759038166692957,"score_gpt":0.3739284611035379,"score_spread":0.3063380794366083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955549148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333954,0.00092223176,0.00044784494,0.0040888647,0.000039285344,0.00095682754,0.000026216874,0.000006553135,0.00017264685],"genre_scores_gemma":[0.99759436,0.0009931608,0.00010582503,0.00004749774,0.0007368009,0.00019880556,0.00011135186,0.000020752255,0.00019147639],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830174,0.00016961993,0.00024155772,0.00040736265,0.00051494857,0.00036478485],"domain_scores_gemma":[0.9992023,0.00013635498,0.000046165584,0.0002923495,0.00020909701,0.00011374592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008439565,0.000110252106,0.00012246988,0.00020188531,0.0001425792,0.00006329803,0.00022925003,0.00012154762,0.000065151195],"category_scores_gemma":[0.00012632071,0.00008413362,0.000039662067,0.0005564654,0.000060078994,0.000018698413,0.00009167778,0.00032176796,0.00004608683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048285123,0.000060971703,0.23237553,0.0002182389,0.000045610235,0.000007911591,0.0018232059,0.002294713,0.60253584,0.00008526989,0.0005560372,0.1595138],"study_design_scores_gemma":[0.0021048386,0.00073342293,0.7659097,0.00015207345,0.000017632501,0.0000017984206,0.0011101861,0.0014402021,0.2036139,0.00036408976,0.024100209,0.00045195242],"about_ca_topic_score_codex":0.00054795406,"about_ca_topic_score_gemma":0.00034678174,"teacher_disagreement_score":0.53353417,"about_ca_system_score_codex":0.000078760335,"about_ca_system_score_gemma":0.00026444602,"threshold_uncertainty_score":0.34308693},"labels":[],"label_agreement":null},{"id":"W2955554680","doi":"10.1158/1538-7445.am2019-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Epigenetic therapy; Cancer research; Lung cancer; Cancer; Malignancy; Cell culture; Cell; Medicine; Chemistry; Biology; Oncology; Genetics; Internal medicine; DNA methylation; Gene expression","score_opus":0.08063073401355869,"score_gpt":0.44443369437175356,"score_spread":0.36380296035819487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955554680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96241885,0.021736009,0.000016681586,0.003849053,0.00026645738,0.004732596,0.00013065281,0.000046512614,0.0068031885],"genre_scores_gemma":[0.9804613,0.0053655882,0.00023880367,0.0002796713,0.0005472887,0.0021028358,0.000020409117,0.00009470965,0.010889369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963199,0.00012262198,0.00036520904,0.0007704448,0.00091392244,0.0015079078],"domain_scores_gemma":[0.9976226,0.0006195933,0.000059168524,0.0006186796,0.00071550166,0.00036445883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015936234,0.0002442922,0.0005776298,0.0005857229,0.00014849563,0.000054520646,0.00033800304,0.0001503983,0.0011164512],"category_scores_gemma":[0.0002360521,0.00021587459,0.00015486193,0.0008365075,0.00025139563,0.000083376704,0.00020201057,0.0009552189,0.00009660878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047873417,0.00039277851,0.49905595,0.008816345,0.00056742853,0.00027315205,0.0028634842,0.0007837763,0.37331063,0.00012738987,0.0853721,0.02364962],"study_design_scores_gemma":[0.02748403,0.0017559725,0.68338346,0.005255982,0.00016745753,0.000015340145,0.00274088,0.002949864,0.21053341,0.00038247617,0.0640018,0.0013292942],"about_ca_topic_score_codex":0.009888574,"about_ca_topic_score_gemma":0.0041617057,"teacher_disagreement_score":0.18432754,"about_ca_system_score_codex":0.0020041554,"about_ca_system_score_gemma":0.0019929504,"threshold_uncertainty_score":0.9997967},"labels":[],"label_agreement":null},{"id":"W2955570083","doi":"10.1158/1538-7445.am2019-883","title":"Abstract 883: PRDX4 as a novel target for pancreatic cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Occupational Cancer Research Centre; University Health Network","funders":"","keywords":"DNA damage; Pancreatic cancer; Biology; Small hairpin RNA; Reactive oxygen species; Programmed cell death; NOX4; Apoptosis; Molecular biology; NADPH oxidase; Cell growth; Cancer research; Cell biology; Cancer; Gene knockdown; Genetics; DNA","score_opus":0.05420367345978953,"score_gpt":0.42321120604813295,"score_spread":0.3690075325883434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955570083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98834896,0.003757108,0.000100068195,0.00039276955,0.00026947385,0.00080037577,0.00022464643,0.000008833396,0.0060977377],"genre_scores_gemma":[0.9836774,0.000938108,0.00018938344,0.0001756925,0.00050062744,0.00084703666,0.00014547638,0.000029232975,0.013497033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860376,0.000047285885,0.00014792904,0.00048832287,0.00018363108,0.00052905985],"domain_scores_gemma":[0.9991396,0.000054933113,0.0000488043,0.00035265074,0.00031601824,0.00008801388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040540533,0.00013742584,0.0001734496,0.000058296322,0.00012650112,0.000025069932,0.0003213643,0.00020885997,0.0008897559],"category_scores_gemma":[0.00013710496,0.00011535014,0.00008628659,0.0001204773,0.0001731241,0.000005432797,0.00011172642,0.00022024928,0.000086693064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049083604,0.0000485146,0.011373602,0.00011265258,0.00011768867,0.0000010554038,0.00003509846,0.000064181855,0.9753279,0.0002757046,0.010010751,0.0021420117],"study_design_scores_gemma":[0.0011155013,0.00046214246,0.016887732,0.00007132192,0.000008518892,0.0000020688417,0.00010554874,0.000024119494,0.7406539,0.00032359772,0.24013558,0.00020996893],"about_ca_topic_score_codex":0.00039443563,"about_ca_topic_score_gemma":0.00013300353,"teacher_disagreement_score":0.234674,"about_ca_system_score_codex":0.000050887007,"about_ca_system_score_gemma":0.00037321623,"threshold_uncertainty_score":0.97422034},"labels":[],"label_agreement":null},{"id":"W2955588652","doi":"","title":"Synthetic analogs of the marine natural product hemiasterlin: Optimization and discovery of E7974, a novel and potent antitumor agent","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Marine Sponges and Natural Products","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Stereochemistry; Quantitative structure–activity relationship; Natural product; Topoisomerase; Steric effects; Combinatorial chemistry; DNA; Biochemistry","score_opus":0.021652418969394606,"score_gpt":0.31380540950671176,"score_spread":0.29215299053731714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955588652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270695,0.005004969,0.000025592524,0.001806982,0.000064533095,0.00025616115,0.000016636333,0.0000013302642,0.000116816336],"genre_scores_gemma":[0.99563557,0.0019332936,0.00038113305,0.00002972436,0.00015147682,0.000008984962,0.000012741025,0.000008377641,0.0018386892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921286,0.000042260348,0.00013312792,0.00027063003,0.00018559546,0.00015551948],"domain_scores_gemma":[0.9994624,0.000009270825,0.00005453943,0.00026698792,0.00017677355,0.000030007808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002743714,0.000074816984,0.0001064513,0.000041393076,0.00005238918,0.000014460876,0.00012715055,0.000033715518,0.000010324522],"category_scores_gemma":[0.0001250513,0.000048692,0.00002796395,0.00013896325,0.00023001907,0.000008620349,0.00043758267,0.00013314071,9.0087454e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015420087,0.0000524959,0.0037969577,0.00018206728,0.000033775686,3.9949165e-7,0.00004120325,0.00094300375,0.97702855,0.00006718914,0.00024408521,0.017456073],"study_design_scores_gemma":[0.0004884624,0.00013582714,0.023388913,0.00006317648,0.000014867637,0.000019566785,0.00003096746,0.0009861294,0.97256166,0.000014881451,0.002194233,0.00010131269],"about_ca_topic_score_codex":0.00015419204,"about_ca_topic_score_gemma":0.00010248081,"teacher_disagreement_score":0.019591955,"about_ca_system_score_codex":0.000014445383,"about_ca_system_score_gemma":0.000070418864,"threshold_uncertainty_score":0.19856022},"labels":[],"label_agreement":null},{"id":"W2955663186","doi":"10.1158/1538-7445.am2019-5053","title":"Abstract 5053: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nodular sclerosis; Medicine; Cancer; Ethnic group; Population; Lymphoma; Pathology; Biopsy; Epstein–Barr virus; Oncology; Hodgkin lymphoma; Internal medicine; Virus; Immunology","score_opus":0.0668762382934313,"score_gpt":0.38447328217783366,"score_spread":0.31759704388440235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955663186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909087,0.0049608084,5.0102767e-7,0.0018261486,0.0001426177,0.0015470457,0.000063792424,0.00003730506,0.0005130698],"genre_scores_gemma":[0.99495476,0.002036332,0.000039415947,0.00033356773,0.00006280965,0.00067824754,0.000051520252,0.00003629183,0.0018070554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655265,0.0003020254,0.00054454803,0.00080877997,0.0009716648,0.0008203319],"domain_scores_gemma":[0.998435,0.00048063902,0.00011572946,0.00057438377,0.00014978054,0.0002444233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009982816,0.00026170872,0.0005884605,0.00039060164,0.00007385855,0.00003070236,0.0002486365,0.00026421717,0.0010500123],"category_scores_gemma":[0.00031708356,0.00022035072,0.00011372837,0.0007320192,0.00015264288,0.00015842963,0.000111942994,0.0004577483,0.00032311707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017758886,0.0013814856,0.92985404,0.00042287086,0.00003305625,0.00036222892,0.0005139823,0.000044626595,0.040170662,0.0000334776,0.0028003517,0.022607354],"study_design_scores_gemma":[0.0063927914,0.00042915528,0.9646384,0.00060198293,0.000014759627,0.00001101986,0.000074337,0.00046689447,0.026033591,0.00004154917,0.0010858953,0.00020961335],"about_ca_topic_score_codex":0.022621932,"about_ca_topic_score_gemma":0.00437188,"teacher_disagreement_score":0.034784395,"about_ca_system_score_codex":0.0036749013,"about_ca_system_score_gemma":0.00052040635,"threshold_uncertainty_score":0.99986315},"labels":[],"label_agreement":null},{"id":"W2955691720","doi":"10.1158/1538-7445.am2019-3647","title":"Abstract 3647: Single cell RNA sequencing reveals mitogenic and progenitor gene programs inBRAF-rearranged pilocytic astrocytomas","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Progenitor cell; Pilocytic astrocytoma; Cancer research; In situ hybridization; Astrocytoma; Glioma; Biology; RNA; Brain tumor; Molecular biology; Gene expression; Fusion gene; Progenitor; Gene; Stem cell; Pathology; Medicine; Cell biology; Genetics","score_opus":0.1063434149961675,"score_gpt":0.36521994589192447,"score_spread":0.25887653089575696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955691720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880524,0.007075228,6.092955e-7,0.00047515146,0.0001396287,0.0022840458,0.000015493755,0.00006531339,0.0018920788],"genre_scores_gemma":[0.9972409,0.00030914068,0.0005105769,0.00005309922,0.0003574729,0.00064027,0.000030411713,0.00006312765,0.0007950291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736017,0.00009323108,0.0002993854,0.0006021706,0.0008207606,0.0008243032],"domain_scores_gemma":[0.99853384,0.00012482666,0.00007687557,0.0004979489,0.00034631952,0.00042018533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000551098,0.00022641213,0.00039887064,0.0002414361,0.00015451944,0.000118205,0.00014707405,0.00012890977,0.00031374517],"category_scores_gemma":[0.000054110475,0.00018420552,0.00010912182,0.0004610728,0.000145324,0.00010941549,0.00010592625,0.00044334462,0.00026847722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025115593,0.00041185354,0.056191955,0.000453736,0.00013079614,0.00026175255,0.00026420996,0.0000030928695,0.92758495,0.00000829108,0.00047864811,0.01395955],"study_design_scores_gemma":[0.0042878496,0.0015562492,0.035535753,0.0005730577,0.00009557469,0.000083177925,0.00037417698,0.000019756355,0.9544215,0.000036674544,0.002786598,0.00022962772],"about_ca_topic_score_codex":0.00058281235,"about_ca_topic_score_gemma":0.00007211675,"teacher_disagreement_score":0.026836548,"about_ca_system_score_codex":0.0010749769,"about_ca_system_score_gemma":0.0005318749,"threshold_uncertainty_score":0.7511683},"labels":[],"label_agreement":null},{"id":"W2955790532","doi":"10.1158/1538-7445.am2019-2722","title":"Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Oncology; Medicine; Internal medicine; Disease; Serous fluid; Cancer; Serous carcinoma; Stage (stratigraphy); Bioinformatics; Biology","score_opus":0.0242349655774565,"score_gpt":0.34340977526843147,"score_spread":0.31917480969097495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955790532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905491,0.0066660834,0.00007930127,0.0007181307,0.00035113253,0.00093478395,0.00010844177,0.000008312275,0.000584718],"genre_scores_gemma":[0.99324983,0.0045495415,0.000014075205,0.00006518341,0.0002726215,0.00028824323,0.00005700986,0.000067239554,0.0014362393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722934,0.00027852628,0.0003232886,0.00062916323,0.0007219992,0.00081771094],"domain_scores_gemma":[0.9985189,0.00006594812,0.000086789325,0.0009075017,0.00028579202,0.00013505759],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011919899,0.00019928912,0.00026850513,0.00023826984,0.00009532483,0.00005235894,0.0008728374,0.00028001927,0.00129444],"category_scores_gemma":[0.000057214893,0.00016278643,0.00010696423,0.0005966807,0.0001951329,0.000008180785,0.00042113548,0.00075944397,0.00005721302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038591842,0.00007429603,0.0153333405,0.00015464872,0.00011795693,0.000019309331,0.000115619216,0.0026399323,0.9754255,0.00010873452,0.0005491488,0.005075599],"study_design_scores_gemma":[0.002054973,0.0002699866,0.26961032,0.00018412649,0.000012790798,0.0000085696465,0.00014616919,0.00008941967,0.7245574,0.00010988848,0.0026342738,0.0003220863],"about_ca_topic_score_codex":0.0111911995,"about_ca_topic_score_gemma":0.016260264,"teacher_disagreement_score":0.254277,"about_ca_system_score_codex":0.0002033198,"about_ca_system_score_gemma":0.0009114909,"threshold_uncertainty_score":0.99961853},"labels":[],"label_agreement":null},{"id":"W2955814637","doi":"10.1158/1538-7445.am2019-4805","title":"Abstract 4805: Cannabinoid WIN 55,212-2 induces endoplasmic reticulum stress in prostate cancer cells through CB1and CB2receptors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DU145; Cannabinoid receptor; AM251; Cannabinoid; Cannabinoid receptor type 2; Unfolded protein response; Cannabinoid Receptor Agonists; Apoptosis; Receptor; Prostate cancer; Cancer research; Endoplasmic reticulum; Chemistry; Endocrinology; Cancer; Biology; Cell biology; Internal medicine; Medicine; Antagonist; LNCaP; Biochemistry","score_opus":0.022133944610842025,"score_gpt":0.3430903066327961,"score_spread":0.3209563620219541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955814637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747414,0.0056144563,8.145028e-7,0.000546352,0.0006486035,0.0010035088,0.00052306254,0.000018044411,0.0041710017],"genre_scores_gemma":[0.9869403,0.0076149325,0.000026578771,0.00012818676,0.00034482597,0.00064394996,0.00013164959,0.00006889877,0.0041006715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663645,0.00019321262,0.00041223768,0.0009713126,0.00068023644,0.0011065573],"domain_scores_gemma":[0.99860525,0.000046935984,0.00011760586,0.0006471203,0.00030097255,0.0002820984],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039219146,0.00033440837,0.00033904077,0.00014935056,0.00014033043,0.00012010549,0.0005363596,0.00023731208,0.001149343],"category_scores_gemma":[0.00007568261,0.0003042842,0.00012290494,0.00041137257,0.0003219882,0.000030610874,0.00028290297,0.00062257325,0.00013557728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043543478,0.00017866827,0.06229464,0.00035043812,0.0000644428,0.000043460786,0.00044288335,0.0014256636,0.92016506,0.000036324196,0.013505892,0.001057103],"study_design_scores_gemma":[0.0015960617,0.00014849054,0.0071477527,0.0002836227,0.000011607458,0.000002408963,0.00088980404,0.000024775723,0.9695347,0.00006520911,0.019882068,0.00041349654],"about_ca_topic_score_codex":0.007601236,"about_ca_topic_score_gemma":0.0026325495,"teacher_disagreement_score":0.055146888,"about_ca_system_score_codex":0.0001708959,"about_ca_system_score_gemma":0.0009400576,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W2955828947","doi":"10.1158/1538-7445.pedca19-a45","title":"Abstract A45: Targeted drug therapies for osteosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PTEN; Medicine; Disease; Cancer; Cancer research; Somatic cell; Oncology; Bioinformatics; PI3K/AKT/mTOR pathway; Internal medicine; Biology; Genetics; Gene; Signal transduction","score_opus":0.05939502512736048,"score_gpt":0.36958254174747823,"score_spread":0.31018751662011773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955828947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749866,0.014293823,0.00020392417,0.008657353,0.0001781961,0.00056712696,0.00032818338,0.000014801977,0.0007700026],"genre_scores_gemma":[0.9944989,0.002095956,0.00026779214,0.001075846,0.0011885584,0.0002843546,0.00011303199,0.00003745256,0.00043808506],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989242,0.000029928367,0.0001345304,0.0003504619,0.00018199159,0.00037891918],"domain_scores_gemma":[0.9992549,0.00007561459,0.000029841387,0.00022315243,0.00024792625,0.00016860686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025109123,0.00010400032,0.00011397404,0.000030245355,0.00013743254,0.000056256045,0.00028943157,0.00007363543,0.00013281354],"category_scores_gemma":[0.00021974338,0.000100078985,0.00008149985,0.00011936067,0.000107089305,0.0000026570274,0.00012748493,0.00014694578,0.000020866546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033925645,0.000024532575,0.0005883004,0.00006440905,0.000055932232,0.0000026051002,0.0002963374,0.000057732133,0.8611026,0.00019656577,0.1281207,0.009151072],"study_design_scores_gemma":[0.0006410348,0.00020693161,0.0011494595,0.00000946236,0.0000045753313,4.2629785e-7,0.00022949207,0.00003135373,0.42762554,0.00022866197,0.5697339,0.00013915342],"about_ca_topic_score_codex":0.00013630475,"about_ca_topic_score_gemma":0.00014372432,"teacher_disagreement_score":0.44161323,"about_ca_system_score_codex":0.000032246317,"about_ca_system_score_gemma":0.00030565535,"threshold_uncertainty_score":0.40811026},"labels":[],"label_agreement":null},{"id":"W2955852486","doi":"10.1158/1538-7445.am2019-ct059","title":"Abstract CT059: A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Immunogenicity; Peptide vaccine; Capecitabine; Internal medicine; Cohort; Adjuvant; Phases of clinical research; Tolerability; Chemotherapy; Oncology; Gastroenterology; Cancer; Adverse effect; Immunology; Antibody; Epitope; Colorectal cancer","score_opus":0.0766206036349271,"score_gpt":0.46083766479900834,"score_spread":0.3842170611640812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955852486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186885,0.0005393977,0.0000011130065,0.0014976413,0.000033198703,0.0056862584,0.00023159651,0.000010930565,0.00013098732],"genre_scores_gemma":[0.99578637,0.00047667226,0.00031197938,0.00021988823,0.000050449627,0.00029586244,0.000014823851,0.00007641668,0.0027675678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955347,0.00070143986,0.0007168705,0.00087653555,0.0014162897,0.00075416965],"domain_scores_gemma":[0.99694335,0.0009879479,0.00026650293,0.00076260435,0.00070793513,0.00033164176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019218856,0.00038044693,0.0009454064,0.00017959574,0.00024332991,0.00011280223,0.00051916495,0.00011088341,0.000672647],"category_scores_gemma":[0.0001736997,0.00019375133,0.00004601286,0.0006383661,0.00044188244,0.00032149334,0.0005564806,0.0011655306,0.0000024090696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39632308,0.0026669747,0.5779548,0.00023057272,0.0003223399,0.000068797635,0.00090745615,0.000008029663,0.008179519,7.020733e-7,0.000046045338,0.013291655],"study_design_scores_gemma":[0.07702717,0.017254204,0.89964455,0.0019784844,0.00005796207,0.000013320325,0.001026339,0.00020431848,0.0018861786,0.0000012205584,0.0006420639,0.0002641791],"about_ca_topic_score_codex":0.0055004917,"about_ca_topic_score_gemma":0.009901581,"teacher_disagreement_score":0.32168972,"about_ca_system_score_codex":0.00027813477,"about_ca_system_score_gemma":0.0012245247,"threshold_uncertainty_score":0.83151346},"labels":[],"label_agreement":null},{"id":"W2955853802","doi":"10.1158/1538-7445.am2019-7","title":"Abstract 7: Discovery of OICR-10268: A potent and selective BCL6 inhibitor","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"BCL6; Lymphoma; Cancer; Cancer research; Germinal center; Medicine; Internal medicine; Immunology; B cell; Antibody","score_opus":0.05675449112698437,"score_gpt":0.4118218250370835,"score_spread":0.3550673339100991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955853802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98329216,0.0017568432,0.0000028005375,0.00096152775,0.00010951699,0.0010734433,0.000029047394,0.00001599055,0.012758657],"genre_scores_gemma":[0.97415483,0.0012004281,0.000023196011,0.00004891412,0.000303668,0.00009187597,0.000007100676,0.000039559705,0.024130413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975186,0.00010430101,0.00022319422,0.00041832944,0.001163449,0.0005721181],"domain_scores_gemma":[0.9985069,0.00029522114,0.000041519124,0.0004245432,0.0005326125,0.0001992115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010313983,0.000125908,0.00033896632,0.0003394229,0.00006413228,0.000049047867,0.000148826,0.00010931945,0.002094081],"category_scores_gemma":[0.00013411573,0.00010253396,0.000082362385,0.0005687984,0.0003160152,0.00016213306,0.00018087875,0.0008264016,0.000085572996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017562624,0.00014217108,0.02749771,0.00046658627,0.00011898681,0.000029627205,0.0004489046,0.0000032592275,0.94824797,0.00009543093,0.0026732092,0.018519886],"study_design_scores_gemma":[0.0034395584,0.001287845,0.21440443,0.0005854544,0.000018422406,0.000027132766,0.00076022453,0.000041000807,0.7661012,0.00025155384,0.012894474,0.0001887204],"about_ca_topic_score_codex":0.0017249091,"about_ca_topic_score_gemma":0.00009260899,"teacher_disagreement_score":0.18690673,"about_ca_system_score_codex":0.00042992373,"about_ca_system_score_gemma":0.0008015866,"threshold_uncertainty_score":0.99881816},"labels":[],"label_agreement":null},{"id":"W2955882985","doi":"10.1158/1538-7445.am2019-2593","title":"Abstract 2593: A double dose of DNA damage: Overcoming drug resistance using targeted oncolytic viruses","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Cancer; Cancer research; Biology; Small hairpin RNA; Ovarian cancer; Synthetic lethality; RNA interference; DNA repair; Virology; Virus; Gene; Medicine; RNA; Genetics","score_opus":0.07610690322166319,"score_gpt":0.415361316496627,"score_spread":0.3392544132749638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955882985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926997,0.0039098198,0.00000580155,0.00013184812,0.00012388913,0.00071345206,0.000047742054,0.000012681499,0.0023550605],"genre_scores_gemma":[0.9944891,0.00040721442,0.00014659158,0.00007840248,0.0002190098,0.00007065238,0.000021240478,0.00006800243,0.00449982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972246,0.00021734013,0.00033335327,0.00060171675,0.0008513321,0.0007716343],"domain_scores_gemma":[0.99817514,0.000085911604,0.00010808375,0.00093716825,0.0005174706,0.00017619616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015519805,0.00019463235,0.00028107676,0.00022166067,0.00016329579,0.00006137733,0.00067423616,0.00015522263,0.00064034754],"category_scores_gemma":[0.000088232126,0.0001935305,0.00011787082,0.0005497579,0.000287543,0.00001811854,0.0003060794,0.00046288493,0.000058803187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069246828,0.00008567412,0.0016791341,0.00021517486,0.000084897285,0.000008708978,0.00011951542,0.00034677147,0.9887157,0.000025787675,0.0013636174,0.00043032892],"study_design_scores_gemma":[0.0019620454,0.00029203165,0.0010320648,0.0001479097,0.0000063346506,8.7353635e-7,0.0001405207,0.000058340414,0.9843885,0.00005581437,0.011701005,0.00021460133],"about_ca_topic_score_codex":0.00067387935,"about_ca_topic_score_gemma":0.0018535188,"teacher_disagreement_score":0.010337387,"about_ca_system_score_codex":0.00023301634,"about_ca_system_score_gemma":0.0012443259,"threshold_uncertainty_score":0.78919446},"labels":[],"label_agreement":null},{"id":"W2955886650","doi":"10.1158/1538-7445.am2019-lb-225","title":"Abstract LB-225: RNA molecular signatures as predictive biomarkers of response to monotherapy pembrolizumab in patients with metastatic triple-negative breast cancer: KEYNOTE-086","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Triple-negative breast cancer; Breast cancer; Cohort; Tumor-infiltrating lymphocytes; Cancer; Gene signature; Gene expression; Immunotherapy; Gene; Biology","score_opus":0.017428781766807483,"score_gpt":0.35015654284941816,"score_spread":0.3327277610826107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955886650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911736,0.0018342135,0.000013315593,0.0019248804,0.00015392991,0.0037972233,0.00057995383,0.000028886416,0.0004939966],"genre_scores_gemma":[0.9978098,0.0004337953,0.00010953734,0.00042669536,0.000037180984,0.00059079984,0.000021587146,0.00008804923,0.00048253534],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9958346,0.0004915222,0.00052302994,0.00073782715,0.0016221707,0.0007908769],"domain_scores_gemma":[0.99751365,0.00045497122,0.00019079588,0.00064416585,0.0009027992,0.0002936059],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012798462,0.00034763748,0.00068296073,0.0010247432,0.000079148005,0.000037415193,0.0003676471,0.0001515114,0.0015252525],"category_scores_gemma":[0.0001545089,0.00027018637,0.00015555011,0.0019225097,0.00037523248,0.00018798118,0.000066532266,0.0006766712,0.000024163346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.639742,0.0005804304,0.036323696,0.00028391415,0.0015323065,0.000074302305,0.002087669,0.00046625838,0.29967293,0.000009795158,0.0008845996,0.01834207],"study_design_scores_gemma":[0.030532725,0.005070049,0.86318964,0.0015564619,0.000063178915,0.0000050625918,0.00082270964,0.00005106198,0.09781509,0.00005811747,0.00047698704,0.00035894607],"about_ca_topic_score_codex":0.009780382,"about_ca_topic_score_gemma":0.0003474838,"teacher_disagreement_score":0.8268659,"about_ca_system_score_codex":0.0014213521,"about_ca_system_score_gemma":0.0020356677,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2955899397","doi":"10.1158/1538-7445.am2019-ct019","title":"Abstract CT019: Population pharmacokinetics of an aurora kinase A inhibitor, LY3295668 erbumine (AK-01), in patients with locally advanced or metastatic solid tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacology; Population; Cmax; Aurora inhibitor; Pharmacodynamics; NONMEM; Dosing; Aurora A kinase; Kinase; Internal medicine; Oncology; Cancer; Chemistry; Cell cycle; Biochemistry","score_opus":0.019111248998705206,"score_gpt":0.35594819472829603,"score_spread":0.33683694572959083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955899397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986013,0.00020533097,0.00003521016,0.000023556848,0.000080629754,0.00089997344,0.000089234556,0.0000059371023,0.00005879745],"genre_scores_gemma":[0.99852675,0.00015368636,0.00045685485,0.000051752122,0.00006500013,0.000075969845,0.00041685908,0.000044543765,0.00020855367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983039,0.00009968725,0.0003376404,0.00042872247,0.00041193265,0.0004181188],"domain_scores_gemma":[0.9990149,0.000020217834,0.000114411945,0.00039541122,0.00033062842,0.00012440719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030933917,0.00016980797,0.00024846813,0.00016066094,0.000037383925,0.000020050295,0.00024317321,0.0000798769,0.00011132563],"category_scores_gemma":[0.000054540575,0.0001379145,0.000037880924,0.0003264826,0.000087095956,0.000020323427,0.00010300223,0.00023592592,0.000006076296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043263035,0.0005522506,0.0387824,0.00029912865,0.00005280863,0.00001326614,0.000086425796,0.0045428216,0.9408679,0.0000072213643,0.00012319475,0.010346294],"study_design_scores_gemma":[0.009701112,0.0038266855,0.16583622,0.00045552966,0.00002948306,0.0000025271054,0.00021829901,0.00081126904,0.81700754,0.000026343965,0.0015716477,0.00051335595],"about_ca_topic_score_codex":0.00036294464,"about_ca_topic_score_gemma":0.00078146916,"teacher_disagreement_score":0.12705381,"about_ca_system_score_codex":0.00008002073,"about_ca_system_score_gemma":0.00027880524,"threshold_uncertainty_score":0.562399},"labels":[],"label_agreement":null},{"id":"W2955918693","doi":"10.1158/1538-7445.am2019-1003","title":"Abstract 1003: Modulating estrogen related receptors (ERRs) activity in breast cancer using endogenous ligands","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University","funders":"","keywords":"Nuclear receptor; Receptor; Agonist; Estrogen receptor; Estrogen-related receptor alpha; Cancer research; Endogeny; Estrogen; Biology; Cancer; Orphan receptor; Endocrinology; Breast cancer; Internal medicine; Pharmacology; Medicine; Transcription factor; Biochemistry","score_opus":0.044115711774381075,"score_gpt":0.3553878380250305,"score_spread":0.31127212625064943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955918693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376893,0.004129622,0.00000170151,0.00015622425,0.00034550467,0.0005342589,0.000034015542,0.000019089768,0.0010106723],"genre_scores_gemma":[0.9975395,0.0015915796,0.00002546995,0.00001908735,0.00021158891,0.000072874616,0.00002439621,0.00006317607,0.00045233496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978088,0.00014437301,0.00024453228,0.00061378366,0.00039179943,0.00079670374],"domain_scores_gemma":[0.99911535,0.000038542858,0.00009030871,0.0004166094,0.00016578336,0.00017337971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007256556,0.00021655092,0.0002460043,0.0001780525,0.00015900322,0.000044389228,0.00028383677,0.0004207012,0.00026679682],"category_scores_gemma":[0.000033842716,0.00020404399,0.00010848551,0.0005189888,0.000118897886,0.000017375174,0.00019126241,0.0008067452,0.000046056066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028694834,0.00007297283,0.056646284,0.000058249378,0.00010131831,0.000021419675,0.0001116693,0.0041132057,0.9324564,0.000012608435,0.000095747244,0.0060232007],"study_design_scores_gemma":[0.0012984106,0.00014742406,0.015319872,0.00023277856,0.000014478804,0.000055941,0.00010060267,0.0012921364,0.980614,0.000023757979,0.0005454952,0.00035507325],"about_ca_topic_score_codex":0.003059174,"about_ca_topic_score_gemma":0.00006402244,"teacher_disagreement_score":0.04815765,"about_ca_system_score_codex":0.0003089465,"about_ca_system_score_gemma":0.0005782181,"threshold_uncertainty_score":0.83206725},"labels":[],"label_agreement":null},{"id":"W2955937053","doi":"10.1158/1538-7445.am2019-1424","title":"Abstract 1424: Preclinical development of TAC01-CD19, a CD19 specific T-cell Antigen Coupler (TAC) therapy for the treatment of CD19-positive B cell malignancies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CD19; Chimeric antigen receptor; T cell; Cancer research; Antigen; Medicine; Immunology; B cell; Antibody; Immune system","score_opus":0.17306072651144228,"score_gpt":0.4446102306505628,"score_spread":0.27154950413912055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955937053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97771245,0.013326788,0.00003858858,0.00064804766,0.00022430817,0.0057887887,0.00012694235,0.000018723127,0.00211536],"genre_scores_gemma":[0.9417369,0.035535574,0.0005008993,0.000043235654,0.00030911562,0.00089820364,0.000048544633,0.0000905446,0.020837005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958444,0.00017306386,0.0007824114,0.0006737158,0.0015906021,0.0009357686],"domain_scores_gemma":[0.9951721,0.002158481,0.00019896032,0.000992181,0.0012449156,0.0002333873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020404682,0.00030892258,0.0007728006,0.00028390827,0.00019998767,0.00003389026,0.0005158839,0.00020557907,0.0055702096],"category_scores_gemma":[0.000038118782,0.00019886155,0.00035244046,0.0005341141,0.00047441802,0.00006810359,0.000091146714,0.0004523883,0.0001167781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007128062,0.0018405805,0.01616927,0.00036918194,0.00039316693,0.0000102660615,0.0042455015,0.000023371847,0.9311309,0.000021369862,0.0017025757,0.036965784],"study_design_scores_gemma":[0.0061678686,0.0029042666,0.06374217,0.000195365,0.000018893355,0.0000019448821,0.0009847034,0.000046929017,0.79271984,0.000023432356,0.13302529,0.0001693081],"about_ca_topic_score_codex":0.000463028,"about_ca_topic_score_gemma":0.00008092799,"teacher_disagreement_score":0.13841105,"about_ca_system_score_codex":0.0007055361,"about_ca_system_score_gemma":0.0020507101,"threshold_uncertainty_score":0.99533886},"labels":[],"label_agreement":null},{"id":"W2955942151","doi":"10.1158/1538-7445.am2019-1990","title":"Abstract 1990: Cjc-1134-pc, a long-acting glp-1r agonist, effects in modulating pro-inflammatory cytokines in the tumor environment","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ConjuChem (Canada)","funders":"","keywords":"Medicine; Tumor necrosis factor alpha; Internal medicine; Inflammation; Cytokine; Endocrinology; Diabetes mellitus; Glycemic; Agonist; Type 2 diabetes; Cancer; Downregulation and upregulation; Immunology; Receptor; Biology","score_opus":0.024721209275260756,"score_gpt":0.3260037937106038,"score_spread":0.301282584435343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955942151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931504,0.003610335,0.000012932077,0.00017883121,0.0009332348,0.001097509,0.000010113269,0.000007298523,0.000999327],"genre_scores_gemma":[0.9946885,0.00059927336,0.00003626057,0.00011757558,0.0035270236,0.00059135194,0.000022117558,0.00003770817,0.0003802054],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977675,0.00024374409,0.0002929876,0.0005415469,0.0004823535,0.000671871],"domain_scores_gemma":[0.9991462,0.00010283402,0.00008211987,0.0005429279,0.0000459478,0.000079967525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014185469,0.00018951052,0.0002332563,0.000125214,0.00010687843,0.000065319575,0.00040523824,0.000119266006,0.00007770856],"category_scores_gemma":[0.00014106727,0.00015417788,0.00008040488,0.00019106947,0.00012411192,0.000013371517,0.00019249685,0.00052729633,0.000038102986],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023200068,0.000081612554,0.04884446,0.000373695,0.00002332925,0.000008843389,0.0005416041,0.0012176756,0.93366796,0.000043886408,0.000912847,0.014052062],"study_design_scores_gemma":[0.0033945965,0.00028760475,0.5095132,0.0004887893,0.0000133941,0.000017763992,0.0009364355,0.00036380542,0.19951163,0.00012442199,0.28469944,0.0006489106],"about_ca_topic_score_codex":0.0011046919,"about_ca_topic_score_gemma":0.0010997301,"teacher_disagreement_score":0.73415637,"about_ca_system_score_codex":0.00018180118,"about_ca_system_score_gemma":0.00028494286,"threshold_uncertainty_score":0.62871915},"labels":[],"label_agreement":null},{"id":"W2955954677","doi":"10.1158/1538-7445.am2019-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Cancer; Lung cancer; Cisplatin; Medicine; Viability assay; Cell culture; Cancer cell; Chemotherapy; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.08719973509604924,"score_gpt":0.4541016868402734,"score_spread":0.3669019517442242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955954677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96835095,0.012722924,0.000005020603,0.0022376005,0.0002955553,0.0020443953,0.000034009332,0.00009690826,0.014212661],"genre_scores_gemma":[0.9907132,0.0024172284,0.00019379,0.0002423281,0.0009848471,0.0011085866,0.000023926732,0.00011956234,0.0041965484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948934,0.00029291722,0.00053612,0.0009968253,0.0014135991,0.0018671732],"domain_scores_gemma":[0.9973603,0.0005460588,0.00011869426,0.00069477956,0.00080338476,0.0004768045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027701592,0.00032154206,0.00061836565,0.00061624835,0.0002859591,0.00012198564,0.0005085537,0.000182614,0.003187613],"category_scores_gemma":[0.00049236073,0.0002862703,0.00010715726,0.0012313765,0.00023092155,0.00037137727,0.00044365483,0.0022090357,0.00011873905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009940413,0.00034808295,0.3062997,0.003269775,0.00016996132,0.0002974849,0.0044615585,0.0005085869,0.66078806,0.000081819686,0.009165671,0.013615259],"study_design_scores_gemma":[0.0126047,0.0013347726,0.28640422,0.007374966,0.00006850157,0.000018091927,0.012444657,0.0047524404,0.6401257,0.00015144891,0.03314614,0.0015743502],"about_ca_topic_score_codex":0.015801862,"about_ca_topic_score_gemma":0.0020885153,"teacher_disagreement_score":0.023980467,"about_ca_system_score_codex":0.0024894406,"about_ca_system_score_gemma":0.0020451979,"threshold_uncertainty_score":0.99995893},"labels":[],"label_agreement":null},{"id":"W2955959842","doi":"10.1158/1538-7445.am2019-ct166","title":"Abstract CT166: A Phase I/II, open-label, two part study of GSK3359609 in combination with tremelimumab in participants with selected, advanced solid tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Tremelimumab; Medicine; Internal medicine; Oncology; Cancer; Ipilimumab; Immunotherapy; Pharmacology","score_opus":0.1232677421746893,"score_gpt":0.47346573222076316,"score_spread":0.3501979900460739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955959842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451256,0.00044055836,7.17196e-7,0.0003257459,0.00004479294,0.0040064757,0.000012380596,0.000016705875,0.0006400389],"genre_scores_gemma":[0.9982485,0.00015698609,0.000028474835,0.000051260136,0.000022580829,0.0008913974,0.000018066034,0.000041390096,0.00054133893],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971832,0.00018145413,0.00051228306,0.00051844044,0.0008833875,0.00072125485],"domain_scores_gemma":[0.9986611,0.0001116596,0.00014765888,0.00047919268,0.0004725799,0.00012783353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001292041,0.00019368267,0.00058825285,0.0004572764,0.00008055172,0.00003662227,0.00030675804,0.00005301598,0.00043180623],"category_scores_gemma":[0.000052456126,0.00014391077,0.000015178114,0.002171285,0.00015253312,0.00028074067,0.00008836851,0.00054966495,0.000007226841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20379099,0.033047717,0.26385626,0.00046974767,0.00046549056,0.00041460313,0.009657531,0.0003998166,0.41651398,0.000020397403,0.00042455268,0.07093892],"study_design_scores_gemma":[0.43017083,0.07965735,0.3894255,0.0053031174,0.000069029054,0.000021897058,0.011664966,0.00067899097,0.08136116,0.000030771742,0.00097236666,0.00064403575],"about_ca_topic_score_codex":0.0055236933,"about_ca_topic_score_gemma":0.020023497,"teacher_disagreement_score":0.3351528,"about_ca_system_score_codex":0.000581824,"about_ca_system_score_gemma":0.0012141258,"threshold_uncertainty_score":0.9978585},"labels":[],"label_agreement":null},{"id":"W2955993757","doi":"10.1158/1538-7445.am2019-2226","title":"Abstract 2226: Validation of a liquid biopsy tool to identify point mutations in pediatric brain tumor patients","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Liquid biopsy; Digital polymerase chain reaction; Pathological; Biopsy; Pathology; Brain biopsy; Oncology; Internal medicine; Cancer; Gene; Polymerase chain reaction","score_opus":0.02111178015196631,"score_gpt":0.36699471545214174,"score_spread":0.34588293530017544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955993757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998404,0.00021064872,0.000010956527,0.00034976128,0.00014560312,0.00044791924,0.000035487432,0.0000032136115,0.00039241224],"genre_scores_gemma":[0.9992387,0.00013704704,0.00003130503,0.000059218397,0.000092363305,0.00009177192,0.00007632535,0.000013789896,0.00025947572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989233,0.00005118247,0.00021770864,0.00026574588,0.00029459782,0.00024746868],"domain_scores_gemma":[0.99941266,0.000020626068,0.000052699437,0.00019489972,0.00025335446,0.00006577327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035928318,0.000073134426,0.00009465027,0.00020649827,0.000030357089,0.000015912578,0.00016733275,0.00008101138,0.00009795244],"category_scores_gemma":[0.00013836019,0.000066265544,0.000046381687,0.00045322228,0.00003483135,0.00000790011,0.00008039968,0.00016228016,0.00007114834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003509253,0.000083727624,0.022237118,0.00014022437,0.000017691113,0.000003189187,0.00017168895,0.0025953793,0.97295743,0.000018446413,0.00093753106,0.0004866606],"study_design_scores_gemma":[0.0011941753,0.00058256264,0.18848486,0.0001019236,0.000005926811,0.0000012271773,0.00009698956,0.0000039246765,0.80845696,0.00009540048,0.0008094669,0.00016661007],"about_ca_topic_score_codex":0.00034992865,"about_ca_topic_score_gemma":0.000029193985,"teacher_disagreement_score":0.16624774,"about_ca_system_score_codex":0.000105655316,"about_ca_system_score_gemma":0.0003450237,"threshold_uncertainty_score":0.27022305},"labels":[],"label_agreement":null},{"id":"W2956003558","doi":"10.1158/1538-7445.am2019-2779","title":"Abstract 2779: miR-142-3p as a regulator of RAC1 and a prognostic factor in melanoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Melanoma; RAC1; microRNA; Medicine; Cancer research; Metastasis; Gene expression; Microarray; Cancer; Oncology; Biology; Gene; Internal medicine; Genetics; Signal transduction","score_opus":0.02867707113358512,"score_gpt":0.35868151001586845,"score_spread":0.3300044388822833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956003558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955559,0.003261632,0.0000015420187,0.00010768664,0.000041133815,0.00055863534,0.000040444647,0.0000034439595,0.0004296116],"genre_scores_gemma":[0.9991264,0.00018608771,0.000031241558,0.000013194255,0.000064488304,0.000069905436,0.000026580743,0.00001812593,0.000463989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989549,0.00007110217,0.00016985658,0.00030933757,0.00023787128,0.00025696322],"domain_scores_gemma":[0.999383,0.000038867747,0.000049377315,0.00029386036,0.0001461145,0.00008882776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026674685,0.000086602435,0.0001283035,0.000100488054,0.000021858888,0.000016560138,0.0001386224,0.00011921999,0.00028305367],"category_scores_gemma":[0.00015622482,0.0000818727,0.00003456425,0.00014565948,0.00010284566,0.0000054067514,0.000110305016,0.00012036193,0.000024894543],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016203217,0.000039478546,0.10662976,0.00017355065,0.000021116237,0.000002999626,0.00006333492,0.0000069769662,0.89089984,0.000035701913,0.00032042104,0.0016447905],"study_design_scores_gemma":[0.00059167115,0.00015183848,0.5871309,0.00011204127,0.0000030072927,0.0000028185007,0.000043525124,0.000019287098,0.40788528,0.00008992392,0.0038726951,0.00009699595],"about_ca_topic_score_codex":0.00018912177,"about_ca_topic_score_gemma":0.00008640348,"teacher_disagreement_score":0.48301455,"about_ca_system_score_codex":0.000043522574,"about_ca_system_score_gemma":0.00029597158,"threshold_uncertainty_score":0.3338672},"labels":[],"label_agreement":null},{"id":"W2956006383","doi":"10.1158/1538-7445.am2019-2686","title":"Abstract 2686: Associations between a polygenic risk score and risk of multiple myeloma and its precursor","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Odds ratio; Single-nucleotide polymorphism; Medicine; Confidence interval; SNP; Logistic regression; Internal medicine; Oncology; Genetic association; Risk factor; Genotype; Genetics; Biology","score_opus":0.035339585337668775,"score_gpt":0.3199112044398151,"score_spread":0.2845716191021463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956006383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947435,0.0033280358,0.0000046361138,0.00005205289,0.00003341769,0.00027140428,0.0012698448,0.0000036780093,0.00029337613],"genre_scores_gemma":[0.9954085,0.00346699,0.000043817407,0.0000039035817,0.00012781032,0.000032573756,0.00006359292,0.00001266081,0.00084019324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991218,0.00010316228,0.00015622542,0.00023758557,0.00015457868,0.00022663346],"domain_scores_gemma":[0.9993815,0.00009486286,0.00009901754,0.00017328582,0.00017743051,0.00007389979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045900882,0.00007816457,0.00013071099,0.000054925862,0.00013648841,0.000024777935,0.00010548934,0.00010911309,0.000057089812],"category_scores_gemma":[0.00018764345,0.00007325553,0.000035540037,0.00008500562,0.00006392291,0.0000070004435,0.00013428788,0.00017484796,0.000009456227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030435816,0.000014884646,0.9020799,0.000042432883,0.00014018195,1.6116033e-7,0.00023191735,0.00001650955,0.09567598,0.000043664113,0.00012878577,0.0015951726],"study_design_scores_gemma":[0.00048661337,0.00012833076,0.9102352,0.000018355013,0.000025066316,5.9097596e-7,0.00015367562,0.00002276567,0.08776814,0.00010002652,0.0009744778,0.00008670294],"about_ca_topic_score_codex":0.00092995155,"about_ca_topic_score_gemma":0.00041381604,"teacher_disagreement_score":0.008155382,"about_ca_system_score_codex":0.000024846984,"about_ca_system_score_gemma":0.00013678959,"threshold_uncertainty_score":0.29872736},"labels":[],"label_agreement":null},{"id":"W2956014987","doi":"10.1158/1538-7445.am2019-lb-053","title":"Abstract LB-053: Familial studies identify variants in the E2A transcription factor as putative risk factors for lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Pedigree chart; Genetics; Gene; Allele; Genotype; Biology; Lung cancer; Cancer; Exome; Medicine; Exome sequencing; Oncology; Mutation","score_opus":0.11129736611801078,"score_gpt":0.4687711973594962,"score_spread":0.3574738312414854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956014987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897444,0.0073685716,0.00011153248,0.00034844008,0.00044241414,0.0011823856,0.000596766,0.000005605212,0.00019988418],"genre_scores_gemma":[0.98890436,0.008410563,0.000013229783,0.00006738796,0.00027370383,0.0011208646,0.00006829856,0.00002437015,0.001117245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983446,0.00018639979,0.00021776122,0.00046269564,0.00036959266,0.00041896405],"domain_scores_gemma":[0.9990501,0.00012768638,0.00007399715,0.0003323582,0.00036369156,0.00005216785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065928424,0.0001506619,0.00017119166,0.000091140406,0.00021571427,0.00006669188,0.0003621136,0.00012933029,0.00016824645],"category_scores_gemma":[0.0001553417,0.00010683717,0.00010347628,0.00022439395,0.00013189386,0.000018942357,0.000039872517,0.00030612273,0.000009576553],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035812624,0.00008214336,0.023654215,0.00015147426,0.00026907516,0.000001362351,0.0048572393,0.0008820491,0.9604133,0.00009942931,0.0042572436,0.0049743457],"study_design_scores_gemma":[0.0028649012,0.00053113763,0.7220953,0.0001715036,0.00007392467,0.0000012474376,0.019815123,0.0003489647,0.23205908,0.0006934426,0.0207592,0.0005861702],"about_ca_topic_score_codex":0.0028365436,"about_ca_topic_score_gemma":0.0015273985,"teacher_disagreement_score":0.7283542,"about_ca_system_score_codex":0.00018495182,"about_ca_system_score_gemma":0.00033643862,"threshold_uncertainty_score":0.43566933},"labels":[],"label_agreement":null},{"id":"W2956015136","doi":"10.1158/1538-7445.am2019-1583","title":"Abstract 1583: Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Carcinogenesis; Lung cancer; Single-nucleotide polymorphism; Biology; Cancer; Genetics; Gene; Genome-wide association study; Genotype; Cancer research; Oncology; Medicine","score_opus":0.021488582670899398,"score_gpt":0.3346408690526837,"score_spread":0.3131522863817843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956015136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97770566,0.020534338,0.000735816,0.0000861016,0.0002286578,0.00048763544,0.00001081061,0.0000075134944,0.00020348132],"genre_scores_gemma":[0.99029255,0.007972384,0.00036522333,0.00006569714,0.00017865711,0.00019352009,0.00008595491,0.000029931094,0.0008161036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981761,0.00006308116,0.0004744019,0.00048796693,0.00025492374,0.0005435125],"domain_scores_gemma":[0.9991439,0.00003446466,0.00013099973,0.0003413121,0.00017902513,0.00017028443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063226774,0.00019904127,0.00028261266,0.00028665335,0.000119846394,0.00007624884,0.0002388879,0.00028055356,0.0001746828],"category_scores_gemma":[0.00001314635,0.00018950625,0.0000825404,0.0006153498,0.000096454394,0.000013794167,0.00022456965,0.00032616802,0.000006068725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018336569,0.00006553934,0.59933674,0.00017630948,0.0010435698,0.000004850733,0.00030711017,0.17042746,0.15833728,0.000007696595,0.00058370916,0.069526374],"study_design_scores_gemma":[0.0016811594,0.000085474654,0.8711633,0.00024706413,0.00015172584,0.0000051597453,0.00032877334,0.09614056,0.01986772,0.000011724974,0.00961591,0.0007014046],"about_ca_topic_score_codex":0.00110403,"about_ca_topic_score_gemma":0.004381857,"teacher_disagreement_score":0.2718266,"about_ca_system_score_codex":0.00017929709,"about_ca_system_score_gemma":0.00031202356,"threshold_uncertainty_score":0.77278405},"labels":[],"label_agreement":null},{"id":"W2956056770","doi":"10.1158/1538-7445.am2019-596","title":"Abstract 596: Association between an empirically-derived inflammatory lifestyle score and incident colorectal cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Colorectal cancer; Hazard ratio; Cancer; Body mass index; Internal medicine; Cancer prevention; Confidence interval; Proportional hazards model; Cohort; Multivitamin; Oncology; Cohort study; Demography; Gerontology; Vitamin","score_opus":0.0729953072336627,"score_gpt":0.41122223332073987,"score_spread":0.33822692608707716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956056770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934265,0.0017178603,3.0464008e-7,0.0033077556,0.00011231388,0.0005938749,0.00007878281,0.000028430677,0.0007342003],"genre_scores_gemma":[0.9961629,0.0020974702,0.000016496124,0.00020726949,0.0008822024,0.00015111445,0.000043969445,0.000021171069,0.0004174448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982085,0.00006962427,0.00019523074,0.00030231616,0.0008172755,0.00040705575],"domain_scores_gemma":[0.99877775,0.00026320879,0.00006696084,0.00012631698,0.0005172844,0.00024848856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006704433,0.000104588195,0.0002588181,0.0000726494,0.00017721573,0.00004312541,0.00008424902,0.00012707435,0.00083557446],"category_scores_gemma":[0.00017080519,0.00009192728,0.000042459753,0.00018620565,0.00008829676,0.00012236882,0.00011593055,0.0005498284,0.000071590395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021922166,0.000055265173,0.95844656,0.0001570405,0.000111694295,0.000012220796,0.00023716615,0.0000020403875,0.03219799,0.000015873075,0.0067502945,0.0017946542],"study_design_scores_gemma":[0.0011987236,0.00027153888,0.9857075,0.00021708086,0.000023228531,0.0000010690393,0.0002496827,0.0000056820104,0.004872561,0.000086137974,0.007265331,0.000101468475],"about_ca_topic_score_codex":0.0019436567,"about_ca_topic_score_gemma":0.0012053299,"teacher_disagreement_score":0.027325429,"about_ca_system_score_codex":0.00091591146,"about_ca_system_score_gemma":0.0003847076,"threshold_uncertainty_score":0.9148954},"labels":[],"label_agreement":null},{"id":"W2956058071","doi":"10.1158/1538-7445.am2019-3808","title":"Abstract 3808: 225Ac-CD33 Radioimmunotherapy potently increases the sensitivity of resistant acute myeloid leukemia lines to the Bcl-2 inhibitor venetoclax by mediating a reduction in cellular Mcl-1 levels","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Venetoclax; Cytarabine; Medicine; Myeloid leukemia; CD33; Azacitidine; Leukemia; Myeloid; Internal medicine; Oncology; Cancer research; Immunology; Chronic lymphocytic leukemia; Stem cell; Chemistry; Biology; CD34","score_opus":0.05488437066301336,"score_gpt":0.3899085341727618,"score_spread":0.3350241635097484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956058071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878517,0.0025388123,0.000017079781,0.007974041,0.00007629593,0.0011734372,0.0001413542,0.000018625697,0.00020870248],"genre_scores_gemma":[0.997299,0.00073927763,0.000041529605,0.00017178842,0.00057185435,0.00026820952,0.000030944077,0.000027472403,0.0008498975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794316,0.0002469081,0.00036668967,0.00035140064,0.00067759084,0.00041426162],"domain_scores_gemma":[0.9983873,0.00055935566,0.00008802651,0.0005742042,0.00024807657,0.00014307002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021943592,0.00014542048,0.00027468687,0.00007498881,0.00018667562,0.00003251845,0.00021743018,0.00010588862,0.0001289238],"category_scores_gemma":[0.00023521128,0.00009239668,0.00008031955,0.00070298754,0.00024168077,0.00006514296,0.0000692414,0.00079632696,0.00002624892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069930527,0.000056712695,0.0003500527,0.00012588917,0.00006670041,0.000009390524,0.0003894444,0.0002760093,0.99191236,0.00001951731,0.0024895058,0.0036051131],"study_design_scores_gemma":[0.00088490185,0.00007415021,0.007861101,0.00025022824,0.000026885142,0.000015263166,0.00051581435,0.0004302969,0.9785633,0.000032186137,0.011239489,0.000106373205],"about_ca_topic_score_codex":0.0021487046,"about_ca_topic_score_gemma":0.000030820713,"teacher_disagreement_score":0.013349048,"about_ca_system_score_codex":0.0008444808,"about_ca_system_score_gemma":0.00075829437,"threshold_uncertainty_score":0.37678272},"labels":[],"label_agreement":null},{"id":"W2956067738","doi":"10.1158/1538-7445.am2019-ct073","title":"Abstract CT073: Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Oncology; Progression-free survival; Lung cancer; Cancer; Phases of clinical research; Surrogate endpoint; Immunotherapy; Clinical trial; Surgery; Chemotherapy","score_opus":0.057755507929358435,"score_gpt":0.43304730403021957,"score_spread":0.37529179610086116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956067738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944636,0.047117822,4.866672e-7,0.003547478,0.00017515416,0.0038114572,0.000458996,0.000028642311,0.00022400207],"genre_scores_gemma":[0.96233153,0.03433079,0.0001164759,0.00025343496,0.00029009065,0.0010352356,0.000026413054,0.00008472751,0.0015313089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955078,0.00022106418,0.00062996,0.0009566743,0.0016747983,0.001009729],"domain_scores_gemma":[0.99551016,0.0014681655,0.0002026647,0.00096999545,0.0016437249,0.00020530318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089140516,0.0004084299,0.0008817537,0.00028428,0.0001705095,0.000051253348,0.00044340896,0.00011505966,0.00027824155],"category_scores_gemma":[0.00052251446,0.00021691472,0.00008407814,0.0008652536,0.00081352744,0.0002115829,0.0004342882,0.0010758449,0.000010002102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11654747,0.0004143734,0.8357564,0.001126599,0.000879927,0.000069864145,0.0121865375,0.00019503663,0.0036525298,0.0000020119876,0.002274923,0.026894284],"study_design_scores_gemma":[0.03541546,0.001452706,0.94986856,0.002973914,0.00006162435,6.879661e-7,0.0022507068,0.000060566726,0.0060638404,0.00001758828,0.0015257152,0.00030861498],"about_ca_topic_score_codex":0.0077842707,"about_ca_topic_score_gemma":0.0065268157,"teacher_disagreement_score":0.11411214,"about_ca_system_score_codex":0.0006625132,"about_ca_system_score_gemma":0.001196712,"threshold_uncertainty_score":0.998823},"labels":[],"label_agreement":null},{"id":"W2956084983","doi":"10.1158/1538-7445.am2019-2684","title":"Abstract 2684: Identification of 14 novel genetic loci for testicular germ cell tumor susceptibility","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Genome-wide association study; Genetics; Seminoma; Cancer; Germ cell; Genotype; Genetic association; Gene; Single-nucleotide polymorphism","score_opus":0.06229372932254526,"score_gpt":0.403221227441834,"score_spread":0.3409274981192887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956084983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956596,0.001780325,0.000201434,0.00012515495,0.00007964465,0.0017638596,0.00019304197,0.000018312656,0.00017861734],"genre_scores_gemma":[0.99819213,0.000043094376,0.000462721,0.000021495573,0.00008060677,0.00023974139,0.00006690947,0.000027044309,0.00086626434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984368,0.000024749248,0.0002927779,0.000377352,0.00054089166,0.0003273991],"domain_scores_gemma":[0.9982236,0.00019643674,0.000110238165,0.0005628404,0.00073331257,0.00017358811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041419425,0.0001036467,0.00021540749,0.00009563466,0.000055795754,0.000020809608,0.00012128499,0.00004864623,0.0005155386],"category_scores_gemma":[0.00037978345,0.00008690914,0.00012396004,0.00021093675,0.000112431895,0.00003979758,0.00003842818,0.00013603436,0.0001102386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003036151,0.0011001057,0.24969965,0.0018959868,0.00008063958,0.000017475848,0.00005985072,0.000118398,0.74161196,0.000035924135,0.00046774538,0.0046086516],"study_design_scores_gemma":[0.0022470576,0.00029552044,0.89650553,0.00009777635,0.00009651682,0.0000036445736,0.00005964109,0.0004668916,0.09951187,0.00015124597,0.00048092098,0.0000833769],"about_ca_topic_score_codex":0.00045577664,"about_ca_topic_score_gemma":0.000020535106,"teacher_disagreement_score":0.6468059,"about_ca_system_score_codex":0.00022358623,"about_ca_system_score_gemma":0.0005232158,"threshold_uncertainty_score":0.56447864},"labels":[],"label_agreement":null},{"id":"W2956115901","doi":"10.1158/1538-7445.am2019-2799","title":"Abstract 2799: Targeting CXCR2-mediated neutrophil recruitment to lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"CXCL1; CXC chemokine receptors; Medicine; Immunotherapy; Cancer research; Immune system; Lung cancer; Chemokine; Tumor microenvironment; Immunology; Interleukin 8; Lung; A549 cell; Adenocarcinoma; Cancer; Oncology; Inflammation; Internal medicine; Chemokine receptor","score_opus":0.08263780513873482,"score_gpt":0.4114295928786815,"score_spread":0.3287917877399467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956115901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371147,0.046247188,0.000005664282,0.0029970598,0.004933608,0.002404886,0.0001362645,0.00011538013,0.0060452227],"genre_scores_gemma":[0.9692936,0.003115122,0.00003448826,0.00068625953,0.00030713915,0.0021594677,0.00010178151,0.00008868363,0.024213478],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671835,0.000327349,0.00043908795,0.00079233345,0.0002512382,0.0014716524],"domain_scores_gemma":[0.9981979,0.00042094826,0.0001008919,0.0006931842,0.0004833363,0.00010373496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012968504,0.00027966002,0.0004128491,0.0003347114,0.00032982283,0.00005329115,0.0007924548,0.00034096272,0.0337885],"category_scores_gemma":[0.00015171389,0.00025676304,0.00010682842,0.0007002786,0.00022916525,0.0001293284,0.00044138206,0.0014360248,0.0072724433],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035307725,0.000057476962,0.0051614027,0.00012863595,0.00017805099,0.000009269672,0.00065882615,0.00025534013,0.8287369,0.000058401554,0.1589801,0.0054225265],"study_design_scores_gemma":[0.0013993765,0.00014483486,0.009250371,0.00031728204,0.00001627787,0.0000027463382,0.00030386308,0.000009140932,0.3232837,0.000021267426,0.66487426,0.0003768699],"about_ca_topic_score_codex":0.0030988646,"about_ca_topic_score_gemma":0.0001691618,"teacher_disagreement_score":0.5058941,"about_ca_system_score_codex":0.0012492298,"about_ca_system_score_gemma":0.00073386496,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W2956118764","doi":"10.1158/1538-7445.am2019-300","title":"Abstract 300: A new combination therapy to treat metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Vinorelbine; Eribulin; Vinca alkaloid; Olaparib; Microtubule polymerization; Cancer research; Vinca; Mechanism of action; Tubulin; Medicine; Mitosis; Pharmacology; Microtubule; Breast cancer; Cancer; Chemistry; Poly ADP ribose polymerase; Metastatic breast cancer; Biology; Polymerase; Cell biology; Chemotherapy; Internal medicine; Biochemistry; Vincristine; In vitro; DNA; Cisplatin","score_opus":0.14919311792366122,"score_gpt":0.47943616552378726,"score_spread":0.330243047600126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956118764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96432346,0.0027066255,0.000035517907,0.024236431,0.00037458265,0.0019257483,0.00012473183,0.00008215191,0.0061907736],"genre_scores_gemma":[0.9712064,0.0026447007,0.00011111448,0.0021215333,0.00055325933,0.0007712346,0.000022658285,0.000074391646,0.022494676],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973022,0.00010669514,0.00028098185,0.000515206,0.001155645,0.00063931424],"domain_scores_gemma":[0.9981628,0.00016039802,0.000059456816,0.0005467541,0.00058054255,0.00049003353],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006122115,0.00019927676,0.00036721243,0.00041573748,0.00010835674,0.00007030736,0.00022499925,0.00007662918,0.023407804],"category_scores_gemma":[0.000025099407,0.00016673523,0.00010126315,0.00097648334,0.00008723797,0.00017789338,0.000040134826,0.0005012965,0.0012019079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004167989,0.00046996013,0.014945554,0.0003047506,0.0002363752,0.000039355942,0.0016079476,0.00016506159,0.6027063,0.00071692804,0.15827417,0.21636556],"study_design_scores_gemma":[0.0328421,0.0019948105,0.38297436,0.0022081118,0.000072848015,0.00011260712,0.0006774006,0.000111841815,0.34571704,0.0026047474,0.22975045,0.00093368505],"about_ca_topic_score_codex":0.005169843,"about_ca_topic_score_gemma":0.00015759049,"teacher_disagreement_score":0.3680288,"about_ca_system_score_codex":0.001201952,"about_ca_system_score_gemma":0.001438385,"threshold_uncertainty_score":0.9995758},"labels":[],"label_agreement":null},{"id":"W2956119141","doi":"10.1158/1538-7445.am2019-1639","title":"Abstract 1639: Predictive modeling of cancer-type in Li-Fraumeni syndrome","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Indel; Germline; Cancer; Germline mutation; Genetics; Copy-number variation; DNA methylation; Li–Fraumeni syndrome; Biology; Computational biology; Single-nucleotide polymorphism; Medicine; Oncology; Genome; Mutation; Gene; Genotype","score_opus":0.07574899750940903,"score_gpt":0.4109411252281755,"score_spread":0.3351921277187665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956119141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840017,0.008208733,0.000030499661,0.00051994,0.00041586003,0.0012240494,0.00004999496,0.00003805427,0.0055111637],"genre_scores_gemma":[0.9965832,0.0021243454,0.000047505546,0.000045415116,0.000103673265,0.00019754704,0.000015268111,0.0000650085,0.0008180076],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972535,0.00007630501,0.00041262782,0.000525447,0.001057553,0.00067460426],"domain_scores_gemma":[0.9984103,0.00008700877,0.000073600495,0.00058695645,0.00063284027,0.00020933578],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074409996,0.00017250094,0.00047319185,0.0005459417,0.00004199425,0.000014483022,0.00025259246,0.00022433916,0.0014403537],"category_scores_gemma":[0.00013217531,0.00016780756,0.00009215449,0.0011675186,0.00012939714,0.00010898068,0.0001344038,0.0012101827,0.00011914912],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004824629,0.00052631693,0.05931457,0.0022522393,0.00057241117,0.0006309302,0.0025396128,0.18050145,0.7370691,0.00021669663,0.0015183012,0.010033749],"study_design_scores_gemma":[0.031007094,0.008333041,0.2628904,0.025249507,0.00040378794,0.0002716168,0.004641771,0.35906407,0.2935729,0.0019639723,0.010396435,0.0022054056],"about_ca_topic_score_codex":0.008030858,"about_ca_topic_score_gemma":0.0006759414,"teacher_disagreement_score":0.44349617,"about_ca_system_score_codex":0.0011943048,"about_ca_system_score_gemma":0.001860852,"threshold_uncertainty_score":0.99947244},"labels":[],"label_agreement":null},{"id":"W2956136764","doi":"10.1158/1538-7445.am2019-1282","title":"Abstract 1282: Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cabozantinib; Erlotinib; Triple-negative breast cancer; Cancer research; Epidermal growth factor receptor; EGFR inhibitors; Kinome; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Cancer; Tyrosine kinase; Medicine; Pharmacology; Breast cancer; Kinase; Biology; Internal medicine; Receptor; Cell biology","score_opus":0.08987593085900725,"score_gpt":0.4458685232074839,"score_spread":0.35599259234847663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956136764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471924,0.0029958386,0.000011923306,0.042232625,0.00063255016,0.0023554575,0.00083279493,0.000028423752,0.0037180034],"genre_scores_gemma":[0.99104375,0.0006370551,0.000011371182,0.00060275674,0.00060273166,0.0008282515,0.000017423767,0.000028425122,0.0062282127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806696,0.00013446741,0.00025611883,0.00041598864,0.000439714,0.0006867382],"domain_scores_gemma":[0.9986882,0.00040711038,0.000052568703,0.00031338964,0.00031152807,0.0002271948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065576157,0.00016102959,0.0003160832,0.00028473334,0.00021922844,0.00004619848,0.00018088415,0.00008992687,0.0033961933],"category_scores_gemma":[0.0000793182,0.00011811432,0.00007276392,0.0010451967,0.0002023401,0.000100765385,0.000081770464,0.00067971676,0.000152676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025711035,0.0010844376,0.13194226,0.00059327687,0.00057221093,0.00029034785,0.006046355,0.00038136265,0.50905806,0.007944984,0.31306973,0.003305936],"study_design_scores_gemma":[0.029384177,0.00073022343,0.8241299,0.0026006163,0.00017381134,0.000021705002,0.0036278805,0.00011119512,0.08248848,0.0032473642,0.05276561,0.00071904465],"about_ca_topic_score_codex":0.0050039627,"about_ca_topic_score_gemma":0.015689718,"teacher_disagreement_score":0.6921876,"about_ca_system_score_codex":0.005485072,"about_ca_system_score_gemma":0.0011401155,"threshold_uncertainty_score":0.9983327},"labels":[],"label_agreement":null},{"id":"W2956141067","doi":"10.1158/1538-7445.am2020-3209","title":"Abstract 3209: The cBioPortal for Cancer Genomics","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Documentation; Visualization; Data science; Genomics; Container (type theory); World Wide Web; Computer science; Genome; Biology; Engineering; Data mining; Genetics","score_opus":0.08667336812473563,"score_gpt":0.3994388675947552,"score_spread":0.3127654994700196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956141067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692017,0.01341692,0.00036159405,0.014354106,0.0003623858,0.00079568056,0.00062629225,0.000010378064,0.0008709828],"genre_scores_gemma":[0.98551816,0.008810213,0.00008674733,0.0021268793,0.0024017359,0.00061132153,0.000059002232,0.000043454053,0.00034250092],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881446,0.000021842852,0.00016931612,0.00037626293,0.00019208858,0.000426042],"domain_scores_gemma":[0.99917114,0.00007075541,0.000047281326,0.00028730396,0.00025318874,0.0001703443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031574702,0.00011434645,0.00011756853,0.000020282858,0.00022610747,0.00007037123,0.00042227306,0.0000983432,0.00014447694],"category_scores_gemma":[0.00020079067,0.00009108542,0.00010153384,0.00012280703,0.00017016534,0.0000024947688,0.00017985681,0.00020556916,0.000015694268],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003661734,0.000026286492,0.00095591607,0.00007568597,0.00009721582,0.00000332705,0.00026169696,0.00082762865,0.86975896,0.0003247614,0.10770571,0.019596634],"study_design_scores_gemma":[0.00045783067,0.00015607652,0.0011335332,0.000011319837,0.000011931529,7.923933e-7,0.00017194731,0.00013311354,0.22201158,0.00013660295,0.77562535,0.0001499275],"about_ca_topic_score_codex":0.0004335259,"about_ca_topic_score_gemma":0.000554701,"teacher_disagreement_score":0.66791964,"about_ca_system_score_codex":0.000073229494,"about_ca_system_score_gemma":0.00072422996,"threshold_uncertainty_score":0.37143555},"labels":[],"label_agreement":null},{"id":"W2956582985","doi":"10.1158/0008-5472.can-18-1357","title":"ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto; Amgen (Canada); St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Temozolomide; Cancer research; Downregulation and upregulation; Carcinogenesis; Glioma; U87; Medicine; Cancer; Regulator; Tumor progression; Cytotoxic T cell; Chemotherapy; Biology; Internal medicine; In vitro; Gene","score_opus":0.05007405772271432,"score_gpt":0.423109570571338,"score_spread":0.3730355128486237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956582985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859076,0.004871234,0.0000010136037,0.008064395,0.000047677546,0.00069383765,0.000020787309,0.000010991799,0.00038243952],"genre_scores_gemma":[0.9977125,0.0004617841,0.0001285322,0.00015907301,0.000087692926,0.0005629171,0.0000018012332,0.000020137908,0.0008655443],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988135,0.000025527614,0.00012804611,0.00033226155,0.00030490817,0.0003957427],"domain_scores_gemma":[0.99905276,0.00036042507,0.000010408375,0.00023019283,0.00020961877,0.0001366051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029242566,0.00008578831,0.0002211797,0.00016860839,0.000054562646,0.000027277665,0.00005779118,0.00005564708,0.00033479292],"category_scores_gemma":[0.00015290453,0.00007015412,0.000040415347,0.00028373746,0.00012321574,0.000044624012,0.000039795166,0.000112757174,0.000036066973],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004194992,0.00097340613,0.644808,0.0025810786,0.00014771623,0.00033575742,0.00090659363,0.0000040100076,0.28289136,0.009057693,0.03437674,0.019722668],"study_design_scores_gemma":[0.0042093983,0.00090168795,0.24066788,0.00068069255,0.000029421524,0.000018549277,0.00035047205,0.00022520604,0.7405803,0.0015548534,0.01062449,0.00015702579],"about_ca_topic_score_codex":0.00018097144,"about_ca_topic_score_gemma":0.0001433717,"teacher_disagreement_score":0.45768896,"about_ca_system_score_codex":0.00018982195,"about_ca_system_score_gemma":0.00012109857,"threshold_uncertainty_score":0.36657476},"labels":[],"label_agreement":null},{"id":"W2960360023","doi":"10.1158/0008-5472.can-18-3594","title":"Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; Medical Research Council Canada; Cancer Research UK","keywords":"Telomerase; Oligonucleotide; Protein subunit; RNA; Telomere; DNA; Molecular biology; Cancer; Telomerase reverse transcriptase; DNA damage; Biology; Cancer research; Telomerase RNA component; Chemistry; Genetics; Gene","score_opus":0.036145881665339843,"score_gpt":0.34908147886717383,"score_spread":0.312935597201834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960360023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591506,0.007957651,0.0000013498916,0.0023274126,0.00033246836,0.0021067082,0.00016401312,0.00005847323,0.0011368549],"genre_scores_gemma":[0.9904016,0.006368306,0.00013707622,0.00059740007,0.00036616935,0.0002656445,0.000034926306,0.000117242154,0.0017116219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99455214,0.00071966083,0.00090666284,0.0010336887,0.0013660456,0.0014218092],"domain_scores_gemma":[0.99631125,0.0011865644,0.00025508332,0.0009114668,0.0008270759,0.0005085676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024674032,0.00050093763,0.0010286052,0.0009820474,0.0003561376,0.000107101376,0.00057092647,0.00027366553,0.0012175794],"category_scores_gemma":[0.00047347933,0.00038406072,0.00014545064,0.0026077265,0.0010181437,0.00038193932,0.00036713126,0.001929892,0.0000864556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088750944,0.0002607163,0.08133838,0.0006834173,0.00014360539,0.00018232787,0.0038420258,0.00006142309,0.89777726,0.000104537365,0.0022849678,0.012433831],"study_design_scores_gemma":[0.0035968383,0.00039550956,0.07182753,0.0015379159,0.000070380986,0.000020794412,0.003257798,0.00033018942,0.9152193,0.000055303222,0.0031807655,0.0005076858],"about_ca_topic_score_codex":0.00918175,"about_ca_topic_score_gemma":0.0009962614,"teacher_disagreement_score":0.017442035,"about_ca_system_score_codex":0.0005625897,"about_ca_system_score_gemma":0.0011334755,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W2962763649","doi":"","title":"Abstract #1291: Efficient knockdown of MMR proteins in human CRCcells using chained microRNA constructs","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Gene knockdown; MSH2; Microsatellite instability; KRAS; MLH1; MSH6; Cancer research; DNA mismatch repair; Biology; microRNA; Molecular biology; Mutation; Genetics; Cancer; Colorectal cancer; Gene; Allele","score_opus":0.1075476045321842,"score_gpt":0.4355502714724933,"score_spread":0.3280026669403091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962763649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265563,0.0011801622,0.000011483948,0.0004852405,0.00013564642,0.001479715,0.000017983892,0.000020040448,0.0040141097],"genre_scores_gemma":[0.99885523,0.00005093781,0.0005382617,0.000066588844,0.00015073713,0.00005124727,0.0000039228025,0.000025456395,0.00025759477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753696,0.000091336595,0.00043912514,0.00041793383,0.00084733916,0.00066732627],"domain_scores_gemma":[0.99873334,0.0000779491,0.00009630645,0.00043435043,0.00046648123,0.00019157722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007730934,0.00016923588,0.00039822437,0.00048531307,0.000096912656,0.000019827175,0.00023570284,0.00014736375,0.0008965461],"category_scores_gemma":[0.0001748197,0.0001547361,0.00007551458,0.0007924923,0.00040377426,0.00002441372,0.00007444195,0.0006844993,0.000010055966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035468728,0.00020095141,0.0036367942,0.00022032882,0.000018001989,0.000051858387,0.00046212893,0.00061792217,0.98986024,0.000049412003,0.00023045976,0.004297196],"study_design_scores_gemma":[0.0021024395,0.0006181199,0.07318845,0.0008846225,0.000011840239,0.000015846574,0.00017645843,0.00026468508,0.9220148,0.00013329345,0.0004271929,0.00016230368],"about_ca_topic_score_codex":0.0013155226,"about_ca_topic_score_gemma":0.00014840228,"teacher_disagreement_score":0.069551654,"about_ca_system_score_codex":0.00084376644,"about_ca_system_score_gemma":0.0009209244,"threshold_uncertainty_score":0.9816551},"labels":[],"label_agreement":null},{"id":"W2963412788","doi":"","title":"Role of promoter methylation in the induction of ABCB1 gene expression in anthracycline-resistant and paclitaxel-resistant breast tumor cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Epirubicin; Multiple drug resistance; Doxorubicin; Drug resistance; Biology; Cancer research; Cancer; Anthracycline; Cancer cell; Breast cancer; P-glycoprotein; Epigenetics; Gene expression; Cell culture; DNA methylation; Chemotherapy; Pharmacology; Gene; Genetics","score_opus":0.04659396711345784,"score_gpt":0.347088949658675,"score_spread":0.3004949825452171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963412788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961303,0.0024042197,0.000021546572,0.00041791057,0.000038291695,0.0007465969,0.00004588609,0.0000058294063,0.00018942768],"genre_scores_gemma":[0.99835575,0.0009425864,0.0004086064,0.000011735316,0.000066603614,0.000090633934,0.000013683319,0.000017339591,0.00009304106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979651,0.0002308764,0.0004653046,0.00028262066,0.00075446063,0.00030163195],"domain_scores_gemma":[0.99922633,0.000090257396,0.000106563064,0.00029835562,0.00021070497,0.000067781126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013995904,0.00011532606,0.0003276601,0.0003728781,0.000074180636,0.0000056890967,0.00012731455,0.000087825974,0.000055326775],"category_scores_gemma":[0.000033050608,0.00007536572,0.000049638344,0.00065618055,0.00029373154,0.00009472528,0.00002641768,0.00039535467,8.319588e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017469838,0.00027915186,0.00796616,0.00025192014,0.00000880519,0.000060773455,0.002931696,0.000011343427,0.9856292,0.000046918693,0.000021892403,0.0010451803],"study_design_scores_gemma":[0.0011425174,0.00017930845,0.22323497,0.00052186387,0.000009500121,0.00001362323,0.0016602187,0.000029817515,0.77267355,0.00032953397,0.00014176307,0.00006331932],"about_ca_topic_score_codex":0.00093945244,"about_ca_topic_score_gemma":0.00063469034,"teacher_disagreement_score":0.2152688,"about_ca_system_score_codex":0.00009626783,"about_ca_system_score_gemma":0.00022687209,"threshold_uncertainty_score":0.3073325},"labels":[],"label_agreement":null},{"id":"W2963854884","doi":"10.1158/0008-5472.can-19-0343","title":"IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Medical Research Council","keywords":"Bortezomib; Cancer research; Multiple myeloma; Downregulation and upregulation; Gene silencing; STAT3; Biology; Protein kinase B; Psychological repression; Effector; Signal transduction; Gene expression; Cell biology; Immunology; Gene; Biochemistry","score_opus":0.04029174501885144,"score_gpt":0.3656554818502967,"score_spread":0.32536373683144526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963854884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864164,0.011591761,0.0000888421,0.00035224366,0.000111142755,0.0009921188,0.00006780679,0.000015390038,0.0003642708],"genre_scores_gemma":[0.9962609,0.0005351195,0.0002570891,0.00006816651,0.00015341591,0.00030739993,0.00013314626,0.000039328952,0.0022454455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997995,0.00014946937,0.00021192242,0.0006365148,0.0004045025,0.00060256186],"domain_scores_gemma":[0.99884784,0.00005040889,0.000048349702,0.00072371506,0.00020444341,0.00012522083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661901,0.00014986828,0.00017430545,0.00011523849,0.00007421503,0.000041219933,0.00042273937,0.00015664917,0.0002465449],"category_scores_gemma":[0.00040668526,0.0001358179,0.000052705767,0.0003064707,0.00013672636,0.0000114219665,0.00050796603,0.00031768094,0.00015330527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004555925,0.000069095884,0.031016946,0.00010726608,0.000018758234,0.000012623699,0.000057802317,0.00008476356,0.9525099,0.000046740464,0.0032464191,0.012374112],"study_design_scores_gemma":[0.00096851634,0.00029580525,0.0063595,0.0001240133,0.0000020078712,0.00000340061,0.000046023244,0.00030173297,0.9760726,0.00017822294,0.015468358,0.0001797996],"about_ca_topic_score_codex":0.00089655933,"about_ca_topic_score_gemma":0.00031721682,"teacher_disagreement_score":0.024657445,"about_ca_system_score_codex":0.00009290414,"about_ca_system_score_gemma":0.00027466216,"threshold_uncertainty_score":0.55384934},"labels":[],"label_agreement":null},{"id":"W2964685394","doi":"10.1158/1538-7445.am2019-3698","title":"Abstract 3698: Conditionally reprogrammed cells from patient-derived xenograft to model neuroendocrine prostate cancer development","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Transdifferentiation; Prostate cancer; Cancer research; Transcriptome; Androgen receptor; LNCaP; Prostate; Biology; Cancer; Adenocarcinoma; In vivo; Progenitor cell; Stem cell; Gene; Cell biology; Gene expression; Genetics","score_opus":0.07155811418352288,"score_gpt":0.3941500161421357,"score_spread":0.3225919019586128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964685394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98694533,0.0018229835,0.000012437634,0.005402441,0.00030406594,0.003923687,0.00046696194,0.00010941127,0.001012687],"genre_scores_gemma":[0.9839502,0.0015561228,0.0009919312,0.0007476247,0.00018271014,0.0034048161,0.00042970796,0.000102968595,0.008633901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99503505,0.00009132993,0.00049732125,0.0010882624,0.0018563047,0.0014317043],"domain_scores_gemma":[0.9972494,0.00014943244,0.00008491702,0.0007048109,0.0009725514,0.0008388691],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032359094,0.00033161024,0.00048052325,0.0004260626,0.00026577702,0.00012739211,0.00032768425,0.000075510674,0.0030698548],"category_scores_gemma":[0.000053067004,0.0002704671,0.00011621486,0.00073789485,0.00019112673,0.00017466675,0.00033059553,0.00083256664,0.00087204075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038361633,0.00051030534,0.013321267,0.0003307112,0.00039013938,0.00041378158,0.0021692165,0.0013120978,0.8883485,0.000015901827,0.01405306,0.07529883],"study_design_scores_gemma":[0.00536219,0.00068172376,0.031952977,0.0007100548,0.000037750597,0.000006095269,0.0004903135,0.00051524426,0.894579,0.00019566313,0.06499016,0.00047884416],"about_ca_topic_score_codex":0.0018620265,"about_ca_topic_score_gemma":0.00034859992,"teacher_disagreement_score":0.07481999,"about_ca_system_score_codex":0.0011391714,"about_ca_system_score_gemma":0.0028155795,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W2967020362","doi":"","title":"Role of non-mutational mechanisms in cancer cell drug resistance","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"","keywords":"Biology; Cancer research; Cancer; Cancer cell; Breast cancer; DNA methylation; Estrogen receptor; Genetics; Gene; Gene expression","score_opus":0.030886394253582663,"score_gpt":0.3718731972009527,"score_spread":0.34098680294737005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967020362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950976,0.0056829615,0.00007510974,0.00025691546,0.000057731067,0.00033210902,0.00009200539,0.000004192642,0.003989193],"genre_scores_gemma":[0.98623985,0.0029664987,0.00032841816,0.000029771481,0.00012230742,0.00031580002,0.000039346338,0.000031771353,0.009926235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783605,0.00017169424,0.00023034589,0.00043020904,0.00077971193,0.000551985],"domain_scores_gemma":[0.9988884,0.000048247697,0.00004848111,0.00036803083,0.0005203496,0.00012653663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005490571,0.000119265,0.00016557705,0.00013773578,0.000100472316,0.000010744039,0.00045095762,0.00012043915,0.00041602054],"category_scores_gemma":[0.000079330115,0.00012013447,0.00005876111,0.000397003,0.00025583027,0.000009076717,0.00021129796,0.00030423442,0.00001708127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022480573,0.00009170863,0.0043514795,0.0000616886,0.000015040605,0.0000106943235,0.0003052727,0.000092360875,0.987551,0.00007900164,0.006883189,0.00033378787],"study_design_scores_gemma":[0.00056930457,0.000061543484,0.0074003055,0.00004102246,0.0000013944834,0.0000014621377,0.0002954093,0.00003754684,0.9835199,0.0004156171,0.0075271614,0.00012930403],"about_ca_topic_score_codex":0.003758122,"about_ca_topic_score_gemma":0.008460647,"teacher_disagreement_score":0.005937042,"about_ca_system_score_codex":0.00023131401,"about_ca_system_score_gemma":0.0012505136,"threshold_uncertainty_score":0.56811816},"labels":[],"label_agreement":null},{"id":"W2967026866","doi":"10.1158/0008-5472.can-19-0585","title":"Banding Together: A Systematic Comparison of The Cancer Genome Atlas and the Mitelman Databases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Atlas (anatomy); Cancer; Database; Genome; Medicine; Biology; Internal medicine; Genetics; Computer science; Anatomy; Gene","score_opus":0.06258615970504361,"score_gpt":0.392397605741044,"score_spread":0.3298114460360004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967026866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579601,0.03979007,0.000024064697,0.00057605514,0.00019724209,0.000897402,0.00010707087,0.0000020520686,0.00044588686],"genre_scores_gemma":[0.9944993,0.004183291,0.000014750049,0.00011747952,0.00017124857,0.00022091804,0.0000100532725,0.000017830565,0.00076509005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987716,0.00021606749,0.00022204734,0.00026571634,0.00027320342,0.00025137907],"domain_scores_gemma":[0.99883753,0.00023337758,0.00009789186,0.0006355652,0.00014720597,0.00004841427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007715162,0.00009544447,0.0002441579,0.000032622942,0.00014594712,0.000039032246,0.00042680805,0.000046874073,0.000058539736],"category_scores_gemma":[0.00020231643,0.00005343207,0.000066963126,0.00015435567,0.0003357966,0.000002855015,0.00046687786,0.00017074947,0.000005067798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005440196,0.00006338879,0.094326876,0.0054024253,0.00031009936,7.291148e-7,0.0014488415,0.0009766337,0.8897292,0.0032688235,0.0034932338,0.0004357542],"study_design_scores_gemma":[0.008108773,0.00055087445,0.022863016,0.005522353,0.00034425766,0.000017182978,0.0059475224,0.0019766954,0.82241046,0.00047270168,0.1308902,0.000895966],"about_ca_topic_score_codex":0.0014854699,"about_ca_topic_score_gemma":0.0013364176,"teacher_disagreement_score":0.12739697,"about_ca_system_score_codex":0.000051655654,"about_ca_system_score_gemma":0.00020690949,"threshold_uncertainty_score":0.22455959},"labels":[],"label_agreement":null},{"id":"W2967320821","doi":"","title":"VB1-008: Identification of a fully-human antibody specific for CD44E and CD44-isoform-3","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Gene isoform; Epitope; Antibody; Immunoprecipitation; Monoclonal antibody; Molecular biology; CD44; Flow cytometry; Peptide; Biology; Antigen; Peptide sequence; Immunohistochemistry; Exon; Chemistry; Cancer research; Biochemistry; Cell; Immunology; Gene","score_opus":0.04641912455652722,"score_gpt":0.42446428895604527,"score_spread":0.3780451643995181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967320821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365425,0.0022035537,0.0015916682,0.00033565148,0.000041572875,0.00075533346,0.00008772421,0.000007076757,0.0013231905],"genre_scores_gemma":[0.9902812,0.00043837915,0.00012458173,0.000010369973,0.00031730373,0.00022617227,0.00031292735,0.000021486307,0.008267527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985482,0.00008278054,0.00027165993,0.00036502225,0.00036983634,0.0003624877],"domain_scores_gemma":[0.99892765,0.000026500948,0.00006357505,0.00034427634,0.00056531176,0.000072712355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095532875,0.00009260517,0.0001226738,0.0001701971,0.00021825261,0.000059950096,0.00020902534,0.00011305485,0.0000920721],"category_scores_gemma":[0.000065256994,0.00008929594,0.000054288867,0.0002291191,0.00026978308,0.000007853426,0.00010970506,0.00012831799,0.000007228117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014475963,0.000057686106,0.0013867238,0.00008905501,0.0000133086705,7.2652483e-7,0.000020750103,0.000021998561,0.98248184,0.0013762935,0.01191716,0.0024896977],"study_design_scores_gemma":[0.0007987404,0.00025790243,0.014812796,0.000020436913,0.0000029274954,0.0000024904991,0.00005956233,0.00006377802,0.84268516,0.00080209516,0.14038084,0.00011323655],"about_ca_topic_score_codex":0.00033941763,"about_ca_topic_score_gemma":0.00021289299,"teacher_disagreement_score":0.13979666,"about_ca_system_score_codex":0.000033761135,"about_ca_system_score_gemma":0.00011307007,"threshold_uncertainty_score":0.3641383},"labels":[],"label_agreement":null},{"id":"W2967516433","doi":"","title":"Association of baseline fecal and plasma bile acids with colorectal adenoma recurrence and high-grade dysplasia in a phase III trial of colorectal adenoma recurrence","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Simon Fraser University; University of British Columbia","funders":"","keywords":"Ursodeoxycholic acid; Colorectal adenoma; Gastroenterology; Internal medicine; Colorectal cancer; Medicine; Adenoma; Bile acid; Dysplasia; Deoxycholic acid; Colonoscopy; Cancer","score_opus":0.023787982807968656,"score_gpt":0.3338685413773647,"score_spread":0.31008055856939604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967516433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965967,0.0009314275,0.00004455893,0.0005234285,0.00014640903,0.0013658543,0.00020046768,0.00001539351,0.00017575907],"genre_scores_gemma":[0.9981368,0.00064897805,0.0003841572,0.0000043486875,0.00015279536,0.00022433061,0.00007301537,0.00002123969,0.0003543349],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974181,0.00020712453,0.00052718644,0.00045521188,0.0009151622,0.0004771948],"domain_scores_gemma":[0.9987295,0.00040449481,0.00020503976,0.00015446547,0.00035211674,0.00015434824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014794342,0.00018551419,0.0006373096,0.00035451975,0.00008366975,0.000018183655,0.00012008908,0.00020165592,0.0000707991],"category_scores_gemma":[0.00017538332,0.00015010899,0.000044154152,0.00083953695,0.0004111151,0.00010667543,0.000036832786,0.0005482653,8.1158885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41407564,0.0042235665,0.21303816,0.0016657182,0.00030218635,0.00043446524,0.0024909026,0.000031067517,0.3395794,0.0011634935,0.0016080112,0.02138738],"study_design_scores_gemma":[0.32952222,0.0199252,0.1564297,0.0030394122,0.00033554118,0.000067322195,0.0010892088,0.00208862,0.4850055,0.0005232947,0.0012807123,0.0006932912],"about_ca_topic_score_codex":0.0010682489,"about_ca_topic_score_gemma":0.0036275436,"teacher_disagreement_score":0.1454261,"about_ca_system_score_codex":0.00027524141,"about_ca_system_score_gemma":0.00060137716,"threshold_uncertainty_score":0.61212665},"labels":[],"label_agreement":null},{"id":"W2967680982","doi":"10.1158/0008-5472.can-19-0860","title":"LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial metabolism and enzyme function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Ezrin; Cytoskeleton; Lysyl oxidase; Cell biology; Cell migration; Cancer research; Biology; Actin cytoskeleton; Phosphorylation; Focal adhesion; Chemistry; Cell; Biochemistry; Extracellular matrix","score_opus":0.014021441955405377,"score_gpt":0.28591509784440006,"score_spread":0.27189365588899467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967680982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821174,0.00081790733,0.00014557739,0.00008606275,0.00012238573,0.00037554232,0.000017257435,0.000004664134,0.00021883611],"genre_scores_gemma":[0.9979455,0.00025795397,0.00015615304,0.000037127196,0.00012310079,0.000014931859,0.000046484056,0.000016890403,0.0014018983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992666,0.000053548956,0.00011348043,0.00025520666,0.00014827712,0.00016287775],"domain_scores_gemma":[0.99949205,0.000005774775,0.000033036296,0.00019308852,0.00021588597,0.000060152506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029572184,0.00006571378,0.00008711372,0.00006621113,0.0000442236,0.000012549627,0.00008201311,0.00006279227,0.00012877853],"category_scores_gemma":[0.000058064605,0.000062280975,0.000016845504,0.00021511446,0.00003428998,0.000006640585,0.0001229755,0.00007095895,0.000031610885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112112604,0.000017687418,0.0024447308,0.000080295475,0.0000046473524,1.5926484e-7,0.000076258824,0.00007871611,0.99307287,0.000028272974,0.002306992,0.0017772532],"study_design_scores_gemma":[0.00028164266,0.00021053475,0.0058115222,0.000028979686,0.00000341553,9.4658446e-7,0.000035230943,0.000020746875,0.97428614,0.000028935321,0.019222539,0.00006939504],"about_ca_topic_score_codex":0.00011321782,"about_ca_topic_score_gemma":0.000024346451,"teacher_disagreement_score":0.018786762,"about_ca_system_score_codex":0.00001717789,"about_ca_system_score_gemma":0.000073518684,"threshold_uncertainty_score":0.25397444},"labels":[],"label_agreement":null},{"id":"W2967695014","doi":"","title":"In vitro screening of anticancer drug penetration into tumor tissue: taxanes","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Paclitaxel; Docetaxel; Penetration (warfare); Spheroid; Tissue culture; Drug; In vitro; Cell; Cell culture; Pharmacology; Biology; Chemistry; Cancer research; Chemotherapy; Internal medicine; Medicine; Biochemistry","score_opus":0.07811166090812563,"score_gpt":0.490811470373672,"score_spread":0.4126998094655464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967695014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234695,0.005671517,0.000013063591,0.009538166,0.00010119096,0.00050590205,0.000009092461,0.000013382272,0.0018007085],"genre_scores_gemma":[0.99352527,0.00071014324,0.0006944691,0.0003342607,0.00064675807,0.0002035061,0.0000126866835,0.000017013732,0.0038558675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986955,0.00009537097,0.00021636474,0.00023370025,0.00042814607,0.00033090462],"domain_scores_gemma":[0.999397,0.000114041366,0.000043525844,0.00015745025,0.00018592145,0.00010209253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004696804,0.00008873061,0.0002386081,0.00029431484,0.000055512195,0.000009270444,0.00009574414,0.00003767403,0.0019452344],"category_scores_gemma":[0.000038979182,0.000080135505,0.000033354292,0.0005036821,0.0001664099,0.00012528544,0.00004146255,0.00029597312,0.000029484921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001812707,0.00021478362,0.010947434,0.00016913518,0.000044261167,0.000059122154,0.0012979299,0.000063524836,0.9079665,0.00004736837,0.010316651,0.06706059],"study_design_scores_gemma":[0.0024397208,0.00018425318,0.0100156935,0.00010467262,0.0000261564,0.000008396655,0.00015346712,0.00030282207,0.91334075,0.00006119956,0.07328035,0.00008251632],"about_ca_topic_score_codex":0.004922212,"about_ca_topic_score_gemma":0.0016920756,"teacher_disagreement_score":0.066978075,"about_ca_system_score_codex":0.0003614555,"about_ca_system_score_gemma":0.00034871334,"threshold_uncertainty_score":0.9989671},"labels":[],"label_agreement":null},{"id":"W2967836332","doi":"","title":"The influence of the proton pump inhibitor pantoprazole on the distribution of doxorubicin in solid tumors with and without expression of P-glycoprotein","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Doxorubicin; Chemistry; Pharmacology; Cancer cell; P-glycoprotein; Penetration (warfare); Cancer research; Drug; Drug resistance; Cancer; Biology; Multiple drug resistance; Medicine; Chemotherapy; Biochemistry; Internal medicine","score_opus":0.03159754889633729,"score_gpt":0.3325593660493045,"score_spread":0.30096181715296716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967836332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668896,0.00023828083,0.0000071079917,0.00095929,0.000013924521,0.00198731,0.000018893357,0.0000037647198,0.00008245133],"genre_scores_gemma":[0.9989998,0.00036207403,0.000007177716,0.000011740837,0.000022957813,0.00037549247,0.0000019901531,0.000010396396,0.00020840256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983863,0.00013059983,0.00027700924,0.00016191733,0.0008065016,0.00023764676],"domain_scores_gemma":[0.9990745,0.00009458307,0.00012787092,0.00038136385,0.00027901938,0.000042626965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008610599,0.000088629495,0.0002207711,0.000046296595,0.0001792819,0.000003973709,0.00019058262,0.000049712886,0.000006773356],"category_scores_gemma":[0.00010562637,0.000034160086,0.000031958007,0.00043254707,0.0009373522,0.000038664373,0.000044485434,0.00038878463,2.8263645e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025266237,0.000102800084,0.09334418,0.00035449007,0.000011085835,0.0000059209783,0.0011219415,0.0001422569,0.9017261,0.00035631043,0.000032672186,0.00027561156],"study_design_scores_gemma":[0.00069497986,0.00027819697,0.17320582,0.0022230246,0.0000050712647,0.0000035703358,0.00042402153,0.000014725929,0.82287306,0.00008906199,0.00015494651,0.000033537817],"about_ca_topic_score_codex":0.00049440155,"about_ca_topic_score_gemma":0.00019300418,"teacher_disagreement_score":0.07986164,"about_ca_system_score_codex":0.00005766163,"about_ca_system_score_gemma":0.00033990465,"threshold_uncertainty_score":0.34537134},"labels":[],"label_agreement":null},{"id":"W2967961786","doi":"","title":"Type I collagenase expression and activity in the osteoblastic stromal cells of giant cell tumor of bone","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Stromal cell; Collagenase; Giant cell; Type I collagen; Giant-cell tumor of bone; Osteoclast; Pathology; Matrix metalloproteinase; Chemistry; Biology; Cell biology; Cancer research; Medicine; In vitro; Biochemistry","score_opus":0.058720153651511786,"score_gpt":0.388244674050788,"score_spread":0.3295245203992762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967961786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975395,0.001245754,0.0000015691534,0.0001076448,0.000029088098,0.0004411267,0.000018110815,0.0000022390434,0.0006149526],"genre_scores_gemma":[0.9995234,0.00015827695,0.000050593346,0.000011602603,0.000025414443,0.000022675356,0.0000011866179,0.000008665844,0.00019815809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895334,0.00009665307,0.00015404631,0.00014685754,0.00041544263,0.00023363908],"domain_scores_gemma":[0.99917257,0.00037101423,0.000054773118,0.00019800996,0.00012654935,0.000077072116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080054894,0.00006419832,0.00020086239,0.00012761238,0.0000334132,0.000004534819,0.000054917655,0.000028270924,0.00007810076],"category_scores_gemma":[0.00006195997,0.000040126713,0.000023721552,0.00034208075,0.00014344738,0.000019645973,0.000049021426,0.00017779508,0.0000031608824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009900016,0.000560487,0.0226643,0.00026124617,0.0000072694384,0.00025016454,0.00040371987,0.0000026317812,0.9734731,0.0000057451243,0.00037355997,0.0010078291],"study_design_scores_gemma":[0.0012634689,0.00065381976,0.22701022,0.0002279552,0.000012159309,0.000004761616,0.00035199968,0.000012278559,0.77036834,0.000007204718,0.000061278384,0.000026497955],"about_ca_topic_score_codex":0.00077357056,"about_ca_topic_score_gemma":0.00018691148,"teacher_disagreement_score":0.20434591,"about_ca_system_score_codex":0.0000663442,"about_ca_system_score_gemma":0.00015381894,"threshold_uncertainty_score":0.16363199},"labels":[],"label_agreement":null},{"id":"W2968003329","doi":"","title":"High-throughput screening of interacting proteins and their modulators in living cells","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Protein-fragment complementation assay; Computational biology; Förster resonance energy transfer; High-throughput screening; Bimolecular fluorescence complementation; Protein–protein interaction; Drug discovery; Biology; Target protein; Screening techniques; In vivo; ORFS; Throughput; Proteome; Complementation; Bioinformatics; Cell biology; Genetics; Computer science; Gene; Fluorescence; Physics","score_opus":0.041826355425950805,"score_gpt":0.3216142804892359,"score_spread":0.2797879250632851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968003329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966377,0.0010171324,0.0018552319,0.00005074111,0.000054426706,0.00018891416,0.0000072671874,0.0000023887628,0.00018618867],"genre_scores_gemma":[0.9976832,0.0007698708,0.0011996077,0.000021286896,0.00012911987,0.00002733392,0.0000040705936,0.000012232983,0.000153275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992399,0.00005699806,0.00018156134,0.00016733412,0.00009884469,0.00025535258],"domain_scores_gemma":[0.9996077,0.000045564386,0.000049697315,0.0001742226,0.00007461159,0.000048222642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046354998,0.00007549856,0.00011715216,0.00006875996,0.00008525129,0.00001149318,0.00012487841,0.00008150597,0.000013506417],"category_scores_gemma":[0.000047281723,0.00006505691,0.000024752642,0.00012259845,0.00013302288,0.000006273558,0.00024148352,0.00021722505,7.618252e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006543302,0.00003291561,0.006410618,0.00008933515,0.000037295747,0.0000028829315,0.001922325,0.0019700793,0.9689838,0.000052764757,0.0006616272,0.019770907],"study_design_scores_gemma":[0.00057661446,0.00027159814,0.00663308,0.0004568342,0.0000021874746,0.00001400972,0.0013022601,0.0052811853,0.98163563,0.000150197,0.0034280368,0.00024838568],"about_ca_topic_score_codex":0.00057402696,"about_ca_topic_score_gemma":0.00014481923,"teacher_disagreement_score":0.019522522,"about_ca_system_score_codex":0.000018594656,"about_ca_system_score_gemma":0.00007519817,"threshold_uncertainty_score":0.2652944},"labels":[],"label_agreement":null},{"id":"W2968099311","doi":"","title":"Transcription is required for active DNA demethylation","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"DNA demethylation; Biology; RNA polymerase II; Molecular biology; Chromatin; DNA methylation; Transcription (linguistics); Epigenetics of physical exercise; Histone methylation; Promoter; DNA; Genetics; Gene; Gene expression","score_opus":0.10332414065135147,"score_gpt":0.436078306370745,"score_spread":0.33275416571939354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968099311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95626557,0.0020841467,0.039669715,0.0003375289,0.0001967639,0.00045485873,0.00004041374,0.000006878274,0.0009441191],"genre_scores_gemma":[0.99647516,0.00076586613,0.0006265675,0.000067697496,0.0006692738,0.00010832152,0.00010845827,0.000021447577,0.0011572012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989393,0.000059079015,0.0001495566,0.00028867956,0.00023556495,0.0003278183],"domain_scores_gemma":[0.9991122,0.000043034288,0.000034782053,0.0001890862,0.0005420648,0.00007882008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012373617,0.000074038064,0.00007031229,0.00009241451,0.00015381101,0.000020210759,0.00010686572,0.00015105821,0.000037419464],"category_scores_gemma":[0.0001506902,0.00007534634,0.00006178112,0.00016565355,0.00006632381,0.000005458026,0.000022258566,0.00009186239,0.0000050313542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033871256,0.000018257355,0.00025473218,0.000015013439,0.000023555538,1.8021646e-7,0.00016214937,0.000012589524,0.9422884,0.000096971,0.0008151506,0.05597429],"study_design_scores_gemma":[0.00040800482,0.0002184067,0.003703375,0.0000066334724,0.0000060582506,9.464558e-8,0.00008408079,0.00003116314,0.898836,0.0011776421,0.09544631,0.00008221984],"about_ca_topic_score_codex":0.000055799184,"about_ca_topic_score_gemma":0.00016382651,"teacher_disagreement_score":0.094631165,"about_ca_system_score_codex":0.000063091364,"about_ca_system_score_gemma":0.00010170435,"threshold_uncertainty_score":0.30725345},"labels":[],"label_agreement":null},{"id":"W2968107447","doi":"","title":"A prospective study of BRAF and K-ras mutations in colorectal polyps: location, histologic subtype and clinical relevance","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hyperplastic Polyp; Microsatellite instability; Colorectal cancer; Medicine; Cancer research; Cancer; V600E; Mutation; Internal medicine; Pathology; Oncology; Biology; Colonoscopy; Genetics; Gene; Allele; Microsatellite","score_opus":0.07646650152082791,"score_gpt":0.4464260161942186,"score_spread":0.3699595146733907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968107447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936557,0.003847651,0.000005504285,0.00035917715,0.000090289075,0.0014049048,0.000005439882,0.000014163898,0.00061716355],"genre_scores_gemma":[0.99889076,0.00029308043,0.00014180949,0.00001706307,0.00008062676,0.000291392,0.0000027648543,0.000014718441,0.00026781333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839276,0.00021073749,0.00036272052,0.00040205015,0.00038490028,0.00024681978],"domain_scores_gemma":[0.9985893,0.0005509382,0.000069750684,0.00016630639,0.0005444367,0.000079287565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007119785,0.000092719616,0.00028768188,0.00020268341,0.000073437295,0.000011135337,0.00007255251,0.00009297293,0.000037363472],"category_scores_gemma":[0.0009695539,0.00008236639,0.00001669726,0.00072887156,0.0006509575,0.000040422357,0.00007457656,0.0004317342,0.0000024271526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076568674,0.0005438535,0.9914587,0.00007117223,0.000025256964,0.000019291374,0.00085502065,0.000024614857,0.003880625,0.000107018466,0.00027919144,0.0019695316],"study_design_scores_gemma":[0.002370733,0.0024712435,0.99108684,0.0000724484,0.0000238801,0.000011882395,0.0009904058,0.00008963386,0.0020145406,0.0007066238,0.00008881233,0.00007295502],"about_ca_topic_score_codex":0.0048284656,"about_ca_topic_score_gemma":0.01351263,"teacher_disagreement_score":0.008684165,"about_ca_system_score_codex":0.00035806166,"about_ca_system_score_gemma":0.000531523,"threshold_uncertainty_score":0.7540365},"labels":[],"label_agreement":null},{"id":"W2968350637","doi":"","title":"Soluble human plasminogen kringle 5 domain acts as a 2-pronged anti-cancer agent inhibiting both endothelial cells and tumor-associated macrophages","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Angiostatin; Angiogenesis; Cancer research; Kringle domain; Glioma; Biology; Cancer; Cancer cell; In vitro; In vivo; Umbilical vein; Endothelial stem cell; Immunology; Recombinant DNA; Gene; Biochemistry","score_opus":0.03945830204918946,"score_gpt":0.3694441434798333,"score_spread":0.3299858414306438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968350637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329585,0.0036630083,0.0000024658002,0.00030513812,0.00007805652,0.0006426589,0.0003325576,0.000024763953,0.0016554788],"genre_scores_gemma":[0.9900611,0.0025764445,0.00007180293,0.00013087022,0.0006224656,0.0004952602,0.00008894137,0.00006560828,0.0058874856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970205,0.0002270773,0.00024528932,0.0007200871,0.00065732776,0.0011297116],"domain_scores_gemma":[0.99900794,0.000032405125,0.00008437753,0.0003184677,0.00018949788,0.00036732294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006233698,0.00024804875,0.00025517266,0.00014343372,0.0005952357,0.0001725697,0.00030242687,0.00013304122,0.0004110803],"category_scores_gemma":[0.00006518159,0.00023824656,0.000089655914,0.00021663366,0.00030058142,0.000019000823,0.00045992807,0.00037234122,0.000043712334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021145339,0.00019217275,0.0035957464,0.000050067094,0.00019257488,0.000049845195,0.00016828738,0.00003553422,0.9883867,0.000022182341,0.0040215794,0.0030738497],"study_design_scores_gemma":[0.0022269702,0.00041895456,0.0007520861,0.00007887222,0.000012666217,0.0000057245115,0.00010864026,0.000011094521,0.95820606,0.00005550658,0.03788682,0.00023661183],"about_ca_topic_score_codex":0.0031369843,"about_ca_topic_score_gemma":0.0044536414,"teacher_disagreement_score":0.03386524,"about_ca_system_score_codex":0.0004050821,"about_ca_system_score_gemma":0.0004982247,"threshold_uncertainty_score":0.9715413},"labels":[],"label_agreement":null},{"id":"W2968384833","doi":"","title":"Comprehensive serial analysis of gene expression of the cervical epithelium transcriptome","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Biopsy; Cervical cancer; Gene; Biology; Serial analysis of gene expression; Gene expression; Pathology; Epithelium; SAGE; Cancer; Medicine; Genetics","score_opus":0.1104203998658603,"score_gpt":0.44329663565297683,"score_spread":0.33287623578711656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968384833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233454,0.0017069576,0.00020864424,0.0009018341,0.00015334797,0.0005380036,0.00010327358,0.000010596527,0.0040427875],"genre_scores_gemma":[0.9986846,0.00030623467,0.00010620977,0.00010143576,0.0002808226,0.000031118834,0.000013503889,0.00001895535,0.00045712345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966433,0.00022133447,0.00044072198,0.00031206454,0.0018262804,0.00055631285],"domain_scores_gemma":[0.997129,0.00034989647,0.00006281462,0.0006404406,0.0015607127,0.000257111],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011926602,0.00011247952,0.00054439,0.00058720616,0.0001093957,0.000009015204,0.00040564834,0.00013725327,0.0054766624],"category_scores_gemma":[0.0001110623,0.00007135039,0.0003655084,0.0032468014,0.0006169123,0.00003813698,0.00014481923,0.00063112326,0.000005273496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031285807,0.00017041709,0.019753098,0.00039336472,0.00036495863,0.000008568234,0.0007529038,0.00005852992,0.96920854,0.00009152375,0.0004146639,0.005654842],"study_design_scores_gemma":[0.0009734469,0.00015446878,0.40646908,0.00003707988,0.00017046121,0.0000011693799,0.0002947572,0.00004910796,0.5895979,0.000037294976,0.002167572,0.000047651232],"about_ca_topic_score_codex":0.0013462944,"about_ca_topic_score_gemma":0.00036548203,"teacher_disagreement_score":0.38671598,"about_ca_system_score_codex":0.00019469061,"about_ca_system_score_gemma":0.00041057667,"threshold_uncertainty_score":0.9954325},"labels":[],"label_agreement":null},{"id":"W2968430536","doi":"10.1158/0008-5472.can-18-2086","title":"ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"KEAP1; Gene knockdown; Insulin-like growth factor 1 receptor; Cancer research; Biology; Mutant; Cell growth; Cancer; Cancer cell; Cell culture; Cell biology; Growth factor; Receptor; Gene; Genetics; Transcription factor","score_opus":0.04033217365814307,"score_gpt":0.3719049768874503,"score_spread":0.3315728032293072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968430536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903814,0.007707763,0.0000966167,0.00042323326,0.00015530524,0.00082200434,0.00018269007,0.0000057114407,0.00022525899],"genre_scores_gemma":[0.99608326,0.0019774616,0.000089621964,0.0001265769,0.00037251753,0.0004925241,0.00004124468,0.000036368117,0.0007804078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983186,0.00008569917,0.00020995624,0.00060194684,0.00023151905,0.000552239],"domain_scores_gemma":[0.9991859,0.000053840184,0.00006638566,0.00025622884,0.0003150588,0.00012258418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000497133,0.00015256144,0.00022054744,0.0000911057,0.00008519983,0.000045088193,0.00026418065,0.0001540067,0.00007522491],"category_scores_gemma":[0.00012134038,0.00014850189,0.000054596705,0.00012144628,0.0001226919,0.000007903527,0.00021464459,0.00022080101,0.0000029809678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032888923,0.000027736252,0.043994945,0.00024228466,0.000046270674,0.00000252126,0.00013286844,0.00006871428,0.9537204,0.000045047604,0.00096345873,0.0004268895],"study_design_scores_gemma":[0.0013214046,0.00011091055,0.002938959,0.0001610997,0.000008354027,0.000001227793,0.0003380202,0.0001350765,0.9920139,0.00034297648,0.00240829,0.0002198205],"about_ca_topic_score_codex":0.00041290434,"about_ca_topic_score_gemma":0.00054017606,"teacher_disagreement_score":0.041055985,"about_ca_system_score_codex":0.00014341231,"about_ca_system_score_gemma":0.00023098433,"threshold_uncertainty_score":0.6055731},"labels":[],"label_agreement":null},{"id":"W2968445195","doi":"","title":"Soluble glypican 3 inhibits the growth of hepatocellular carcinoma","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Glypican 3; Wnt signaling pathway; Frizzled; HCCS; Cancer research; Biology; Cell growth; In vivo; Fibroblast growth factor; Signal transduction; Cell biology; Receptor; Internal medicine; Hepatocellular carcinoma; Medicine; Biochemistry","score_opus":0.06663387907928711,"score_gpt":0.3385442625653381,"score_spread":0.271910383486051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968445195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924411,0.0043481314,0.000086459535,0.00088465697,0.000077283985,0.00051377993,0.000031053667,0.0000066069333,0.0016109137],"genre_scores_gemma":[0.9932824,0.0018277369,0.00005011857,0.000083989704,0.00031371013,0.0002731538,0.00002516999,0.000030726063,0.0041129906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976963,0.00026161247,0.00022429983,0.0004092158,0.0007440898,0.00066452916],"domain_scores_gemma":[0.9984357,0.00004130024,0.000045882265,0.00065216253,0.00068976096,0.00013518902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007983224,0.00013641026,0.0001703442,0.00011810476,0.00040194896,0.00001921271,0.000730476,0.00013162583,0.00011395279],"category_scores_gemma":[0.00018679106,0.00009887987,0.00010312855,0.0005219787,0.0009409008,0.000005659045,0.00043799667,0.00040188894,0.000017779905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025736412,0.000066731685,0.06548992,0.00006436159,0.000040815925,0.000020710788,0.00015189197,0.0000051823695,0.9144718,0.0002797018,0.018371403,0.0007801268],"study_design_scores_gemma":[0.0005174159,0.0003550019,0.0055552004,0.000018488454,0.0000034112481,0.000022131355,0.00007436339,0.000071814364,0.9640857,0.00009965225,0.029071975,0.00012482997],"about_ca_topic_score_codex":0.002820681,"about_ca_topic_score_gemma":0.00018074477,"teacher_disagreement_score":0.059934717,"about_ca_system_score_codex":0.0000529267,"about_ca_system_score_gemma":0.0008413921,"threshold_uncertainty_score":0.42640448},"labels":[],"label_agreement":null},{"id":"W2968500109","doi":"","title":"Characterization of novel germ line p53 mutations associated with pediatric adrenocortical cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Adrenocortical carcinoma; Biology; Mutant; Mutagenesis; Mutation; Cancer research; Transfection; Point mutation; Geldanamycin; Wild type; Genetics; Cell culture; Cell biology; Gene; Hsp90; Heat shock protein; Endocrinology","score_opus":0.06105994802210105,"score_gpt":0.3816599804467296,"score_spread":0.32060003242462853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968500109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487066,0.00048021693,0.0034706974,0.00046303147,0.000055687804,0.0002766571,0.00025902718,0.0000085482825,0.000115497605],"genre_scores_gemma":[0.996918,0.0011893926,0.00008496852,0.000046626003,0.0003283526,0.00040900373,0.00034381848,0.000023987006,0.0006558427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895006,0.000035046167,0.00018095624,0.00026686807,0.00030371433,0.0002633797],"domain_scores_gemma":[0.9989145,0.000012363428,0.00008373991,0.00022999579,0.00067603984,0.00008337028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018812329,0.000086563865,0.00010793132,0.000096022595,0.00011347002,0.000019271594,0.00015689062,0.000101338956,0.00009748213],"category_scores_gemma":[0.00008194593,0.000075378695,0.00003388846,0.0005289195,0.00015021805,0.0000073841575,0.000042542077,0.00014650138,0.0000025377688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007070931,0.00019537253,0.003557953,0.000019109182,0.0000443062,7.2294216e-7,0.000061874045,0.0010179027,0.9940613,0.00022172836,0.00005877615,0.00069024094],"study_design_scores_gemma":[0.0028408237,0.0005518063,0.1855736,0.000094835916,0.0000746924,0.000002776554,0.00006707062,0.00011255452,0.8081567,0.00007063478,0.002149747,0.00030473838],"about_ca_topic_score_codex":0.00026243276,"about_ca_topic_score_gemma":0.00042345675,"teacher_disagreement_score":0.18590458,"about_ca_system_score_codex":0.00011196374,"about_ca_system_score_gemma":0.0008832525,"threshold_uncertainty_score":0.30738539},"labels":[],"label_agreement":null},{"id":"W2968779769","doi":"","title":"Cadherin-cadherin engagement promotes cell survival via Rac/Cdc42 and Stat3","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cadherin; STAT3; Cell biology; RAC1; Biology; CDC42; STAT protein; Cell; Cancer research; Signal transduction; Chemistry; Biochemistry","score_opus":0.10705199982136712,"score_gpt":0.3982838495275752,"score_spread":0.2912318497062081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968779769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932945,0.0027139464,0.00016254987,0.0003248721,0.00014124847,0.00060897897,0.000051439973,0.000018230894,0.002684242],"genre_scores_gemma":[0.985003,0.004225488,0.00017787727,0.00003586607,0.00034444663,0.00021759061,0.00004943523,0.000059616144,0.009886713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99683213,0.00055381004,0.00021634287,0.00068012904,0.0008071143,0.00091046473],"domain_scores_gemma":[0.9986052,0.00007452217,0.000037068537,0.0005626964,0.00039198817,0.0003285349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012230739,0.00020489159,0.00020408296,0.00012579588,0.00035253452,0.000058053414,0.00043428064,0.00017435262,0.00046108343],"category_scores_gemma":[0.00016921561,0.00019263667,0.00005951306,0.00028221175,0.00050460204,0.00000994731,0.00070760504,0.0006447287,0.00008466133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017423276,0.0001058629,0.016903799,0.00010361915,0.000046333193,0.000047421177,0.00029358623,0.00000781216,0.97252053,0.000008545071,0.0064853905,0.0033028906],"study_design_scores_gemma":[0.0008458535,0.00058479264,0.00964852,0.000015472797,0.0000038316803,0.0000129303,0.0001943969,0.00003575272,0.8861758,0.00003294197,0.102186084,0.00026360742],"about_ca_topic_score_codex":0.00120206,"about_ca_topic_score_gemma":0.00026367232,"teacher_disagreement_score":0.095700696,"about_ca_system_score_codex":0.0001225561,"about_ca_system_score_gemma":0.0005517067,"threshold_uncertainty_score":0.7855496},"labels":[],"label_agreement":null},{"id":"W2968792535","doi":"","title":"Additive effect of selenium and bicalutamide in human prostate cancer cells in vitro","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Bicalutamide; Prostate cancer; LNCaP; Propidium iodide; Apoptosis; Cancer; Selenium; Cancer research; Medicine; Malignancy; Oncology; Flow cytometry; Internal medicine; Endocrinology; Programmed cell death; Biology; Chemistry; Immunology; Androgen receptor; Biochemistry","score_opus":0.03184120861314017,"score_gpt":0.38420939560847156,"score_spread":0.3523681869953314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968792535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957465,0.0019574198,1.9898359e-7,0.0002584142,0.00017610336,0.0011243764,0.00013612845,0.000020923902,0.0005799468],"genre_scores_gemma":[0.9987117,0.000102978185,0.0000103034245,0.000017718883,0.00020942718,0.0007222975,0.000014424977,0.000023900835,0.00018726882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702173,0.0010371959,0.00037242015,0.0004578894,0.00042108778,0.0006896623],"domain_scores_gemma":[0.99876994,0.0007909038,0.000070466296,0.00017934907,0.00011613712,0.00007319955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014544538,0.00015482245,0.0004084987,0.00031589676,0.00007145605,0.00002852814,0.00019518353,0.00016382836,0.00009427359],"category_scores_gemma":[0.00009448265,0.00012013006,0.000036198384,0.0008107091,0.00038755286,0.00007073329,0.0000925048,0.00060690986,0.0000066006583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011646576,0.00004775534,0.06774771,0.00020177946,0.0000050885124,0.000005896178,0.00022426576,0.000053585838,0.9264221,0.000011587828,0.0008962691,0.0032192587],"study_design_scores_gemma":[0.0012215273,0.00030200757,0.07773747,0.00025114886,0.000003410955,6.9565243e-7,0.00005466307,0.000060648475,0.9190713,0.00015411172,0.0010184189,0.00012457752],"about_ca_topic_score_codex":0.044193007,"about_ca_topic_score_gemma":0.0038330364,"teacher_disagreement_score":0.040359974,"about_ca_system_score_codex":0.0006538335,"about_ca_system_score_gemma":0.000044343702,"threshold_uncertainty_score":0.9621718},"labels":[],"label_agreement":null},{"id":"W2968892642","doi":"","title":"Whole genome tiling-resolution array CGH identifies distinct DNA amplifications under vincristine selection of ovarian cancer cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Biology; Genome; Gene; clone (Java method); Drug resistance; Gene duplication; Vincristine; genomic DNA; Genetics; Molecular biology; Cancer research; Chemotherapy","score_opus":0.03808665449810182,"score_gpt":0.3354418257734009,"score_spread":0.2973551712752991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968892642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139297,0.0012075194,0.0049365726,0.0010026238,0.00014489457,0.00025732745,0.000362461,0.000014702677,0.0006809212],"genre_scores_gemma":[0.99104947,0.0004119394,0.0003346047,0.0000342784,0.0007642193,0.000205082,0.00021803292,0.000023097493,0.006959289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986671,0.00011427302,0.00027875355,0.00033895625,0.00025126123,0.00034961945],"domain_scores_gemma":[0.999018,0.000020243035,0.00009250203,0.00029413102,0.0004947949,0.00008028754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038963382,0.000117642616,0.00012849832,0.00010512065,0.0003159883,0.000050734852,0.00022504044,0.00011084927,0.00048341122],"category_scores_gemma":[0.00003346723,0.000118938944,0.00006415877,0.00026336673,0.00016943653,0.00001265534,0.000078557576,0.00015956676,0.000031308435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047526053,0.000063757005,0.00073114724,0.00003988728,0.000054437034,1.2378024e-7,0.00015286592,0.0030780018,0.99393797,0.00029572786,0.0013075563,0.00029101854],"study_design_scores_gemma":[0.00029854756,0.000069400645,0.020201828,0.0000222521,0.000022185666,0.0000024354244,0.00028734645,0.00012562617,0.91586876,0.00015489281,0.06279025,0.0001564499],"about_ca_topic_score_codex":0.0013305238,"about_ca_topic_score_gemma":0.0020092067,"teacher_disagreement_score":0.078069165,"about_ca_system_score_codex":0.00018559079,"about_ca_system_score_gemma":0.00037177093,"threshold_uncertainty_score":0.5293014},"labels":[],"label_agreement":null},{"id":"W2968995118","doi":"","title":"Abstract #4925: Unique role for the Rb LxCxE binding domain in lung development","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoblastoma protein; Ectopic expression; Retinoblastoma; Biology; Null allele; Carcinogenesis; Molecular biology; Genetics; Cell biology; Apoptosis; Allele; Cell cycle; Gene","score_opus":0.053637722253372586,"score_gpt":0.39395085293688753,"score_spread":0.34031313068351493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968995118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843406,0.010870127,0.0000777968,0.0020338227,0.0002280994,0.0006506387,0.000011323437,0.000022625565,0.0017649333],"genre_scores_gemma":[0.9923962,0.0003914493,0.000052070263,0.00013777021,0.000032039075,0.00026484486,0.000016482234,0.000011969403,0.006697227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986654,0.00021315743,0.00022362635,0.00021609713,0.000061072686,0.00062063994],"domain_scores_gemma":[0.99909705,0.00054067164,0.0000320932,0.00021193536,0.00010061264,0.00001764095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001609435,0.00010585336,0.00014647363,0.00022758105,0.0003765676,0.000031779222,0.0003901287,0.00014557586,0.00062063616],"category_scores_gemma":[0.00011620997,0.00007401634,0.000047123824,0.00021416131,0.00013845984,0.000057090343,0.00006609317,0.0005887879,0.00015444355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010996072,0.00006160725,0.00029441397,0.00001881025,0.000055724406,0.000004682644,0.0016748686,0.00000596879,0.95019054,0.0011326658,0.008057537,0.037403587],"study_design_scores_gemma":[0.00096444646,0.00011954307,0.021822387,0.00013276974,0.0000026129323,0.0000063909897,0.0015461063,0.0000032093333,0.67968726,0.0002543812,0.29533467,0.00012620693],"about_ca_topic_score_codex":0.00019384359,"about_ca_topic_score_gemma":0.00020816513,"teacher_disagreement_score":0.28727713,"about_ca_system_score_codex":0.00033650544,"about_ca_system_score_gemma":0.00041785243,"threshold_uncertainty_score":0.6795531},"labels":[],"label_agreement":null},{"id":"W2969441845","doi":"10.1158/0008-5472.can-19-0815","title":"ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Prostate Cancer Canada; National Cancer Institute; Government of Canada; Congressionally Directed Medical Research Programs; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"Androgen receptor; Prostate cancer; Psychological repression; Cancer research; Biology; Prostate; Internal medicine; Cancer; Endocrinology; Medicine; Genetics; Gene; Gene expression","score_opus":0.07559345992792177,"score_gpt":0.41638582505105604,"score_spread":0.34079236512313427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969441845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752174,0.008049604,2.7516487e-7,0.013381639,0.00027940393,0.0020272192,0.000112193855,0.000010777241,0.0009214793],"genre_scores_gemma":[0.98346204,0.00538356,0.000004992926,0.000060275815,0.00013899733,0.00083501684,0.000009940398,0.000023355624,0.010081821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739647,0.00035022714,0.00020132647,0.00036156355,0.0011744377,0.00051594817],"domain_scores_gemma":[0.9987589,0.00022477805,0.00005736421,0.0005151032,0.00034081787,0.00010301546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011177381,0.00012261853,0.0002499024,0.00013923501,0.00014833357,0.000020417598,0.0003189314,0.00007823367,0.001730478],"category_scores_gemma":[0.00008518197,0.000058098685,0.00010447739,0.0008607273,0.00043893428,0.000111448,0.00013442563,0.00078265707,0.000028496994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026838395,0.00017742082,0.38853684,0.00031557397,0.00008799093,0.000005551311,0.0018167819,0.00005132603,0.5887141,0.00007347969,0.0029903953,0.014546713],"study_design_scores_gemma":[0.0040572654,0.00026333664,0.3691359,0.0010565583,0.000024336758,0.0000037858265,0.00048434985,0.0001721377,0.60271007,0.00026855743,0.02169883,0.00012488138],"about_ca_topic_score_codex":0.0019456877,"about_ca_topic_score_gemma":0.00051495695,"teacher_disagreement_score":0.019400936,"about_ca_system_score_codex":0.0004861856,"about_ca_system_score_gemma":0.0012276354,"threshold_uncertainty_score":0.9991821},"labels":[],"label_agreement":null},{"id":"W2971671150","doi":"10.1158/0008-5472.can-19-0803","title":"Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Hepatocellular carcinoma; Medicine; Liver transplantation; Cirrhosis; Intensive care medicine; Cancer; Systemic therapy; Liver cancer; Transplantation; Oncology; Internal medicine","score_opus":0.17492790156558238,"score_gpt":0.3629639126661068,"score_spread":0.1880360111005244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971671150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96918315,0.019424226,0.0000024079848,0.0010825894,0.000107286316,0.0011477291,0.000005421531,0.000039429397,0.009007754],"genre_scores_gemma":[0.99016994,0.00680058,0.000079559555,0.00020920634,0.00008162611,0.00022660007,0.000031737207,0.000037771326,0.002362998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980957,0.00013631814,0.00018908991,0.00042639076,0.00060007983,0.0005524251],"domain_scores_gemma":[0.9990519,0.0000704072,0.000027686714,0.00031925226,0.0002924357,0.00023828671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025508,0.00017223005,0.00027223304,0.00020848332,0.00013805204,0.00008515231,0.00011085604,0.0001099475,0.00069854356],"category_scores_gemma":[0.000014028905,0.00013880515,0.000050200193,0.00041178952,0.00012187249,0.000081694576,0.00009200214,0.00035608688,0.00025494854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015964774,0.0000636452,0.9010929,0.00015628335,0.00010208849,0.00012641515,0.0004865153,2.4737164e-7,0.032093413,0.00021729195,0.0002048743,0.06529671],"study_design_scores_gemma":[0.006147495,0.0011431688,0.57096267,0.00046084006,0.00012441227,0.000048876365,0.0026000435,0.0021613934,0.13455302,0.0005547573,0.28058317,0.0006601309],"about_ca_topic_score_codex":0.00012994121,"about_ca_topic_score_gemma":0.000011083541,"teacher_disagreement_score":0.3301302,"about_ca_system_score_codex":0.00026991262,"about_ca_system_score_gemma":0.0008257141,"threshold_uncertainty_score":0.7648562},"labels":[],"label_agreement":null},{"id":"W2972659374","doi":"10.1158/0008-5472.can-19-0274","title":"Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"Canadian Institutes of Health Research; Government of Canada; Ontario Institute for Cancer Research; Canadian Blood Services","keywords":"Aryl hydrocarbon receptor; Haematopoiesis; Stem cell; Myeloid leukemia; Cancer research; Signal transduction; Progenitor cell; Cell biology; Leukemia; Downregulation and upregulation; Myeloid; Biology; Immunology; Gene; Transcription factor; Biochemistry","score_opus":0.0498136568298746,"score_gpt":0.37421210590182136,"score_spread":0.32439844907194676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972659374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658015,0.0009422332,0.000043916683,0.0018073496,0.00024238192,0.00186549,0.000042866275,0.00015487234,0.029099392],"genre_scores_gemma":[0.8710502,0.00081350416,0.00027320042,0.00037424432,0.0005740371,0.00036056832,0.000042143867,0.0001454467,0.12636667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993687,0.00038685845,0.0005543798,0.0011631213,0.0021758997,0.002032781],"domain_scores_gemma":[0.99629635,0.00042868988,0.00011511266,0.0013896504,0.0010488424,0.0007213625],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019532978,0.00037955458,0.00074004236,0.00065135874,0.00044574283,0.00016813337,0.00097484747,0.00031931367,0.0028712112],"category_scores_gemma":[0.00006324339,0.00032299198,0.00022862859,0.0012865297,0.0005753079,0.00027807237,0.0006561193,0.002605448,0.0021390684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074194936,0.00008483622,0.008056661,0.00057302497,0.00021546867,0.00044560654,0.0013061131,0.000052589305,0.94825757,0.0004777066,0.035617072,0.0041714106],"study_design_scores_gemma":[0.009586651,0.0018324014,0.011757542,0.0012320579,0.00012737133,0.000101672435,0.004557625,0.0009162248,0.91090876,0.00035511158,0.05774718,0.0008774275],"about_ca_topic_score_codex":0.00081144733,"about_ca_topic_score_gemma":0.00003396945,"teacher_disagreement_score":0.097267285,"about_ca_system_score_codex":0.0042250124,"about_ca_system_score_gemma":0.003077532,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W2973058185","doi":"10.1158/1538-7445.am2018-2432","title":"Abstract 2432: The genomic consequences of tumor hypoxia in human cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Hypoxia (environmental); Cancer; Prostate; Tumor microenvironment; Precision medicine; Disease; Medicine; Oncology; Prostatectomy; Biomarker; Copy-number variation; Biology; Cancer research; Internal medicine; Gene; Pathology; Genome; Genetics","score_opus":0.05462840323320203,"score_gpt":0.39372508007488655,"score_spread":0.33909667684168454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973058185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925168,0.0025773267,0.000049469505,0.00047103086,0.00014762147,0.0005342599,0.000041919186,0.0000061745723,0.0036554025],"genre_scores_gemma":[0.9980393,0.00058944616,0.00003442236,0.00012384182,0.00040604908,0.0002263211,0.000012672671,0.000035150428,0.0005328167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977623,0.00022823176,0.0002943209,0.00047752156,0.0005694049,0.0006682169],"domain_scores_gemma":[0.99868983,0.000043099823,0.00007766899,0.00062892307,0.00044969536,0.000110796456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001356578,0.00014121711,0.00017376414,0.0001926737,0.00022811434,0.0000383406,0.0007943515,0.00012852141,0.00051003887],"category_scores_gemma":[0.0001671042,0.00011476337,0.00007471878,0.00049725355,0.001729723,0.000005103266,0.00029664277,0.00048716087,0.000025373925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017258864,0.000021069556,0.00015151,0.000032680335,0.000041885054,0.000011763434,0.000118954835,0.0001284598,0.99517953,0.00028140176,0.0026858777,0.0011742798],"study_design_scores_gemma":[0.00049493724,0.00033913337,0.0027816126,0.00006802746,0.0000038563016,0.0000067314027,0.00024530434,0.000016340986,0.9813482,0.00044065987,0.014122923,0.00013224072],"about_ca_topic_score_codex":0.0072963424,"about_ca_topic_score_gemma":0.006326118,"teacher_disagreement_score":0.013831296,"about_ca_system_score_codex":0.00031789255,"about_ca_system_score_gemma":0.0015775175,"threshold_uncertainty_score":0.9993141},"labels":[],"label_agreement":null},{"id":"W2973878336","doi":"","title":"Abstract #3129: Vascular endothelial growth factor receptor 1 expressing tumor side-population cells are involved in the formation of \\#8220;tumor initiating niche\\#8221; in vivo","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Matrigel; Homeobox protein NANOG; Population; Biology; Stromal cell; Stem cell; Angiogenesis; Cell biology; Cancer research; Chemistry; Embryonic stem cell; Medicine; Induced pluripotent stem cell","score_opus":0.04717459110523238,"score_gpt":0.3344958594220582,"score_spread":0.2873212683168258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973878336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617124,0.0024350018,0.000036073052,0.00014240055,0.00024622437,0.0005567841,0.00010315571,0.0000073410683,0.00030175855],"genre_scores_gemma":[0.997516,0.0011175661,0.00011354955,0.0001955567,0.00085591915,0.00011329455,0.000044950935,0.000021178355,0.000022034792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978829,0.00031570843,0.00046292838,0.0003470559,0.00052502536,0.0004663794],"domain_scores_gemma":[0.9990848,0.00008722652,0.00020739884,0.0003389693,0.00021559527,0.00006605692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010066488,0.00016663253,0.00025141894,0.00021511683,0.000105991385,0.000059417467,0.0003383871,0.00011385757,0.000053345095],"category_scores_gemma":[0.00041178652,0.00014250966,0.00010231587,0.00036297002,0.00007093997,0.000045757686,0.000058785383,0.00038288537,0.0000027123936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014287453,0.00007566218,0.0021788296,0.000111503796,0.000007066919,0.0000024277883,0.0008245705,0.00014522637,0.9931166,0.00001531335,0.00062694174,0.002752992],"study_design_scores_gemma":[0.0010924252,0.000087016335,0.043983713,0.00022642405,0.00000570086,0.0000012191836,0.0010447132,0.00007746357,0.94629204,0.00015858351,0.0068459297,0.00018478895],"about_ca_topic_score_codex":0.0012853526,"about_ca_topic_score_gemma":0.0015418668,"teacher_disagreement_score":0.046824567,"about_ca_system_score_codex":0.00011386816,"about_ca_system_score_gemma":0.00018734697,"threshold_uncertainty_score":0.5811375},"labels":[],"label_agreement":null},{"id":"W2974376001","doi":"10.1158/0008-5472.can-18-3029","title":"Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"mTORC1; PTEN; Biology; Cancer research; Chromosome instability; Unfolded protein response; Ovarian cancer; Carcinogenesis; Proteasome; Cancer; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction; Genetics; Chromosome","score_opus":0.02459114106865675,"score_gpt":0.3424777985314327,"score_spread":0.31788665746277595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974376001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970212,0.00035837592,0.000062731844,0.00053579133,0.00004943319,0.0011548422,0.0001328339,0.0000047679446,0.0006800176],"genre_scores_gemma":[0.99895614,0.000098839846,0.000033404092,0.00008736701,0.00012999262,0.0004017774,0.000058892452,0.000015413236,0.0002181902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853283,0.00015005446,0.0001530908,0.0004925449,0.00026370323,0.00040779205],"domain_scores_gemma":[0.99925286,0.000027195976,0.000027470398,0.0003714788,0.00016814802,0.00015283904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026407457,0.00011486039,0.00014537161,0.000053073993,0.00006653566,0.00004277468,0.00017067962,0.00011356907,0.00008282537],"category_scores_gemma":[0.00016288512,0.00010560352,0.000029793719,0.00019425811,0.000108537686,0.000013349137,0.0002197272,0.0001845791,0.000010235656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005743915,0.000070409726,0.38580102,0.00012653037,0.000012111504,0.000008264535,0.00015337087,0.00006838939,0.61241925,0.00021731501,0.00016375196,0.00038522377],"study_design_scores_gemma":[0.0016307482,0.0003210405,0.14695336,0.0000964942,0.000002936964,0.0000019530762,0.00019381277,0.000052099982,0.8474152,0.00016288199,0.0029874078,0.00018208942],"about_ca_topic_score_codex":0.0012627997,"about_ca_topic_score_gemma":0.00029898353,"teacher_disagreement_score":0.23884767,"about_ca_system_score_codex":0.00010117076,"about_ca_system_score_gemma":0.00026866703,"threshold_uncertainty_score":0.43063867},"labels":[],"label_agreement":null},{"id":"W2974873440","doi":"","title":"PTEN (phosphatase and tensin homologue deleted on chromosome 10) gain-of-function analysis in LNCaP prostate cancer cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"PTEN; LNCaP; Cancer research; Tensin; Protein kinase B; PI3K/AKT/mTOR pathway; Prostate cancer; Biology; Androgen receptor; Cancer; Cell biology; Signal transduction","score_opus":0.03286161005410629,"score_gpt":0.35326038487729056,"score_spread":0.32039877482318424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974873440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863388,0.012187303,0.00003548494,0.0004848798,0.00009597244,0.00037255432,0.00030652736,0.000009539821,0.00016893497],"genre_scores_gemma":[0.9942981,0.0032720852,0.00009263954,0.0002306897,0.0002857707,0.00025963402,0.00015968914,0.000032380198,0.0013690131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979565,0.00019333157,0.00029450736,0.00063447293,0.00039081374,0.0005303809],"domain_scores_gemma":[0.9988962,0.0000550665,0.00009157112,0.00046348193,0.0003589712,0.00013470197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065754727,0.00018266003,0.00028726595,0.00035375933,0.000088603505,0.00002866209,0.00022121237,0.00019025951,0.00038490834],"category_scores_gemma":[0.000079851,0.00017225726,0.00008246838,0.00092261756,0.000282317,0.0000098736145,0.00012857343,0.00030590547,0.0000154894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011679298,0.00011136422,0.004864558,0.000067742054,0.00036437708,0.000018545488,0.0001312509,0.013525523,0.9506936,0.00001414379,0.010313344,0.018727643],"study_design_scores_gemma":[0.0010945968,0.00050449505,0.0041747065,0.00008203009,0.000085106294,0.0000013000994,0.000049154485,0.001156889,0.95926213,0.00002285468,0.033316992,0.0002497515],"about_ca_topic_score_codex":0.0017650434,"about_ca_topic_score_gemma":0.0025211787,"teacher_disagreement_score":0.023003649,"about_ca_system_score_codex":0.00022832159,"about_ca_system_score_gemma":0.0003479252,"threshold_uncertainty_score":0.70244473},"labels":[],"label_agreement":null},{"id":"W2976071796","doi":"10.1158/1538-7445.am2018-1646","title":"Abstract 1646: Discovery and characterization of BAY-6035, a novel benzodiazepine-based SMYD3 inhibitor","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"","keywords":"Kinase; Methyltransferase; Drug discovery; Protein kinase domain; Chemistry; Cancer research; Biology; Cell biology; Methylation; Biochemistry; Gene; Mutant","score_opus":0.04798337157261758,"score_gpt":0.3655660300952497,"score_spread":0.3175826585226321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976071796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680996,0.00061125326,0.0017352405,0.00018914838,0.00011209803,0.00018861334,0.00011809099,0.0000034858904,0.00023213784],"genre_scores_gemma":[0.99826294,0.00048266558,0.00015748583,0.000038848993,0.0006162926,0.00003368891,0.00015875511,0.000018273582,0.00023107372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907887,0.00003877679,0.0001681723,0.0002724261,0.00022811601,0.00021366667],"domain_scores_gemma":[0.9992776,0.00002077466,0.00006332407,0.00022858747,0.00034032442,0.000069422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040226505,0.00008360509,0.00009623833,0.00008599024,0.000083728875,0.000041178293,0.00010144127,0.00011085082,0.000037511127],"category_scores_gemma":[0.0000897077,0.00007895587,0.000030710875,0.00014726246,0.00023627363,0.000009102116,0.0000767764,0.00009056798,0.0000030823503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011599253,0.000046400208,0.004326946,0.000040983556,0.000013422493,2.6267938e-7,0.000032781714,0.000004871411,0.9922142,0.000024730718,0.0000486373,0.0031307796],"study_design_scores_gemma":[0.0003982371,0.00024312166,0.068011634,0.000040978448,0.000003673567,1.3700236e-7,0.0000103512675,0.000051874504,0.9256281,0.000022465567,0.0055058585,0.0000835557],"about_ca_topic_score_codex":0.00008285916,"about_ca_topic_score_gemma":0.000097301134,"teacher_disagreement_score":0.06658608,"about_ca_system_score_codex":0.00001968648,"about_ca_system_score_gemma":0.00020124827,"threshold_uncertainty_score":0.3219727},"labels":[],"label_agreement":null},{"id":"W2976231686","doi":"10.1158/0008-5472.can-19-0179","title":"Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"National Cancer Institute; Government of Canada; Canadian Institutes of Health Research; V Foundation for Cancer Research","keywords":"Radiation therapy; Radiosensitivity; Ionizing radiation; Radiobiology; Computational biology; Medicine; Biology; Internal medicine; Irradiation","score_opus":0.033715194980608564,"score_gpt":0.37152251994237634,"score_spread":0.3378073249617678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976231686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97774297,0.011009768,0.009717502,0.0003452099,0.00024103235,0.0006625146,0.0001852295,0.0000063380694,0.00008943804],"genre_scores_gemma":[0.99112326,0.00526667,0.0018238312,0.00034864244,0.0003120524,0.00015496746,0.000067702524,0.000051728497,0.0008511465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810207,0.0001952181,0.00022059256,0.000624963,0.00027769135,0.0005794404],"domain_scores_gemma":[0.9988224,0.0000959482,0.000021475045,0.00076111103,0.00013581662,0.00016323676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013796288,0.00013824456,0.00018304997,0.00020125415,0.0000757295,0.000037183705,0.00037536563,0.00008288895,0.00013709154],"category_scores_gemma":[0.00018629445,0.00014595174,0.00005502308,0.00030082595,0.000032353593,0.0000075899616,0.00026598954,0.00020509269,0.00005928128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00345266,0.000053020667,0.0023177639,0.000017187665,0.000010352012,0.000005759999,0.00021449868,0.085016556,0.9064553,0.000022572127,0.0010670316,0.0013673088],"study_design_scores_gemma":[0.0030317153,0.0009796004,0.0012127046,0.00017768788,0.0000049582595,0.0000044326976,0.0004893772,0.029344128,0.5840657,0.00006627522,0.3800639,0.0005595658],"about_ca_topic_score_codex":0.00028500796,"about_ca_topic_score_gemma":0.0005838789,"teacher_disagreement_score":0.37899688,"about_ca_system_score_codex":0.00025704288,"about_ca_system_score_gemma":0.00040712112,"threshold_uncertainty_score":0.5951739},"labels":[],"label_agreement":null},{"id":"W2977642107","doi":"10.1158/0008-5472.can-19-1847","title":"Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk","year":2019,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Center for Advancing Translational Sciences; Cancer Australia; National Institutes of Health; National Cancer Institute; National Health and Medical Research Council; National Breast Cancer Foundation","keywords":"Breast cancer; Medicine; Prospective cohort study; Cohort; Family history; Cancer; Cohort study; Oncology; Gynecology; Internal medicine","score_opus":0.025227240004036384,"score_gpt":0.34920626960876955,"score_spread":0.3239790296047332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977642107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92131466,0.00016140782,0.0000046514315,0.009381522,0.000212477,0.009327824,0.059553456,0.000038086608,0.0000058986425],"genre_scores_gemma":[0.9650457,0.0049853334,0.000014356065,0.0014030434,0.0026126541,0.023804769,0.00032710712,0.00023148219,0.0015755867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932477,0.00072735583,0.0005652264,0.0016981945,0.0018670786,0.001894471],"domain_scores_gemma":[0.99392074,0.0012569585,0.000856454,0.0007267848,0.0028926528,0.0003463918],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010125047,0.0006812846,0.0020622185,0.00050166715,0.00038529048,0.000059375896,0.00034338437,0.0006867804,0.00035675682],"category_scores_gemma":[0.0003414024,0.0005600262,0.0001659607,0.0012811203,0.00040445366,0.000115066854,0.0001688605,0.0029806586,0.0000018382103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021357337,0.000913422,0.88071114,0.00073250895,0.0035768847,0.000019919029,0.005466916,0.00011450875,0.0008246688,1.8066835e-7,0.06863092,0.017651606],"study_design_scores_gemma":[0.01566223,0.0025161025,0.9766118,0.0007379573,0.0008236589,0.00001031934,0.00040451455,0.0010210593,0.00025916277,0.000023475586,0.001340942,0.00058879616],"about_ca_topic_score_codex":0.21907198,"about_ca_topic_score_gemma":0.022089293,"teacher_disagreement_score":0.1969827,"about_ca_system_score_codex":0.0140660275,"about_ca_system_score_gemma":0.003832946,"threshold_uncertainty_score":0.9996851},"labels":[],"label_agreement":null},{"id":"W2977710785","doi":"10.1158/0008-5472.can-19-1982","title":"MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"National Cancer Institute; National Institutes of Health; National Research Foundation of Korea; Ulsan National Institute of Science and Technology","keywords":"Cancer; Programmed cell death; Cancer research; Apoptosis; Biology; Medicine; Genetics","score_opus":0.07206351326378002,"score_gpt":0.42257754021877475,"score_spread":0.35051402695499473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977710785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882822,0.007082875,0.000014168913,0.00069545425,0.000221513,0.0007775318,0.000024293253,0.000011526942,0.0028904607],"genre_scores_gemma":[0.99090624,0.0008861984,0.000080484584,0.0002991566,0.0002741648,0.00017147073,0.000008955903,0.000024488245,0.0073488387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985748,0.00009433303,0.00019012703,0.00025513023,0.00056331145,0.00032229218],"domain_scores_gemma":[0.9992562,0.00006401634,0.000043871307,0.00034088173,0.00020413364,0.000090880145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022201666,0.000088724126,0.00022957579,0.00020819386,0.000028416189,0.000008285978,0.00012364378,0.00009378327,0.008122135],"category_scores_gemma":[0.000009576572,0.00007412954,0.00006715038,0.0004065651,0.00006433955,0.00006183369,0.000028557532,0.00027888184,0.00007499021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017651326,0.0002526697,0.10564936,0.00031609164,0.000073699935,0.0000087028275,0.0013376086,0.00008537853,0.8834768,0.0003066424,0.002996689,0.003731242],"study_design_scores_gemma":[0.005046577,0.00040812677,0.17270577,0.00035848728,0.000025328989,9.971567e-7,0.00016142958,0.00089108135,0.8041747,0.002680159,0.01340454,0.00014279723],"about_ca_topic_score_codex":0.0012725178,"about_ca_topic_score_gemma":0.000041484313,"teacher_disagreement_score":0.07930208,"about_ca_system_score_codex":0.0002407295,"about_ca_system_score_gemma":0.0006607893,"threshold_uncertainty_score":0.99278456},"labels":[],"label_agreement":null},{"id":"W2978091090","doi":"","title":"Synthesis and characterization of the biological activity of the cisplatin analogs cis-PtCl2(dexrazoxane) and cis-PtCl2(levrazoxane) of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186).","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Topoisomerase; Chemistry; Cisplatin; Pharmacology; Stereochemistry; Biochemistry; Enzyme; Biology; Cancer; Medicine; Internal medicine; Chemotherapy; Anthracycline","score_opus":0.04383893967705684,"score_gpt":0.3139513286882184,"score_spread":0.2701123890111616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978091090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596703,0.0013169794,0.000053400854,0.0014351647,0.00016783939,0.00074875413,0.00023754366,0.000005143912,0.000068147136],"genre_scores_gemma":[0.9964516,0.003012743,0.000023452923,0.0001154323,0.00011601975,0.000078480705,0.000007798337,0.000029186403,0.00016526725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782455,0.00034057416,0.00040186773,0.00053607475,0.0004854675,0.0004114954],"domain_scores_gemma":[0.99845356,0.00010957925,0.00031960767,0.0007411345,0.0002650173,0.00011107806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081921957,0.00025802592,0.00039129297,0.00008927946,0.0004061118,0.000029651714,0.0004981456,0.00029140702,0.000029231913],"category_scores_gemma":[0.00018874758,0.00014997096,0.00014783921,0.00049806485,0.0012328207,0.000016917435,0.00093307137,0.0003637564,2.0337873e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027526185,0.00010740415,0.005136804,0.000118258264,0.00008805349,5.830838e-7,0.00029764324,0.000014162467,0.98500156,0.00041569595,0.000015506033,0.008529085],"study_design_scores_gemma":[0.00071735954,0.00035953982,0.05217002,0.00019145878,0.00004663288,0.000016733382,0.00012301824,0.000014610265,0.9447291,0.0005592279,0.0009071385,0.00016519208],"about_ca_topic_score_codex":0.0005510394,"about_ca_topic_score_gemma":0.00039153447,"teacher_disagreement_score":0.047033217,"about_ca_system_score_codex":0.0000666959,"about_ca_system_score_gemma":0.00029184244,"threshold_uncertainty_score":0.6115638},"labels":[],"label_agreement":null},{"id":"W2978484378","doi":"10.1158/1538-7445.am2018-3502","title":"Abstract 3502: Chemoproteomics provide insights into cell surface reprogramming during KRAS-mediated transformation","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"KRAS; Cell; Cancer research; Biology; Mutant; Reprogramming; Cancer cell; Cell biology; Proteome; Downregulation and upregulation; Cancer; Colorectal cancer; Bioinformatics; Genetics; Gene","score_opus":0.027866929173403096,"score_gpt":0.35802653028696396,"score_spread":0.33015960111356085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978484378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949272,0.0018828246,0.000090385365,0.0002179538,0.000075248165,0.0008692136,0.000017437362,0.00002828912,0.0018914136],"genre_scores_gemma":[0.9965958,0.0017374026,0.00023413645,0.000023946704,0.00043767437,0.00026084168,0.0001499298,0.000041059273,0.000519226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979127,0.00007875534,0.00023720604,0.000544332,0.0005385942,0.00068840367],"domain_scores_gemma":[0.9987505,0.000019878678,0.00005431856,0.00047097163,0.00045350206,0.0002508093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003945064,0.00017097432,0.00014121208,0.00010695309,0.00040966558,0.00010716821,0.0003111577,0.00016579399,0.00009732412],"category_scores_gemma":[0.00008781092,0.00015738554,0.000071350245,0.00037005244,0.00032245563,0.000025518262,0.00013522379,0.0003226724,0.00012124111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005744349,0.00009441276,0.000991814,0.00017407715,0.000050445575,0.000011167815,0.0006615041,0.000016143285,0.9923355,0.00000510841,0.00042024622,0.0046651205],"study_design_scores_gemma":[0.0012617785,0.00033501207,0.001546049,0.000045665176,0.0000044185385,0.0000022301726,0.00015481695,0.000033440538,0.9726153,0.00007660953,0.023757227,0.00016746233],"about_ca_topic_score_codex":0.002693297,"about_ca_topic_score_gemma":0.0023746053,"teacher_disagreement_score":0.02333698,"about_ca_system_score_codex":0.00025935093,"about_ca_system_score_gemma":0.00047655552,"threshold_uncertainty_score":0.64179957},"labels":[],"label_agreement":null},{"id":"W2978592473","doi":"10.1158/1538-7445.am2015-1846","title":"Abstract 1846: Catalytic topoisomerase II inhibitors suppress the androgen receptor signaling and prostate cancer progression","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Androgen receptor; Prostate cancer; LNCaP; Cancer research; Androgen; Cell growth; Androgen Receptor Antagonists; Biology; Internal medicine; Cancer; Chemistry; Endocrinology; Medicine; Biochemistry; Hormone","score_opus":0.0919581761973258,"score_gpt":0.4281808869955901,"score_spread":0.33622271079826427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978592473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474346,0.0353047,2.46147e-7,0.014158743,0.00027100235,0.0020222503,0.00010143722,0.00005601395,0.000651026],"genre_scores_gemma":[0.98736036,0.0049957293,0.000031298598,0.00009933614,0.0007083485,0.0014518357,0.000074001495,0.000058417798,0.0052206577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996537,0.00015769889,0.00030385435,0.000576791,0.0014870885,0.00093751005],"domain_scores_gemma":[0.9977966,0.00015609401,0.00007168568,0.00043771023,0.0008293715,0.00070853153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015746604,0.00023886231,0.00032172078,0.0002308142,0.00067748263,0.00014802387,0.00023961565,0.00012884907,0.00029727645],"category_scores_gemma":[0.0001784991,0.00013839429,0.000067679146,0.00068047014,0.00072234747,0.00023834666,0.00035879784,0.00088659313,0.00003926193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010385251,0.0009885007,0.12803146,0.0018517342,0.0008109603,0.00060432835,0.025381435,0.00009072517,0.41123533,0.00007141623,0.16892184,0.25162703],"study_design_scores_gemma":[0.009105236,0.0016316466,0.00567664,0.0023065088,0.00012728845,0.000046307516,0.005107698,0.00013310311,0.8360151,0.00027401056,0.1390328,0.0005436295],"about_ca_topic_score_codex":0.0017724633,"about_ca_topic_score_gemma":0.00011681963,"teacher_disagreement_score":0.4247798,"about_ca_system_score_codex":0.00070922106,"about_ca_system_score_gemma":0.0016203669,"threshold_uncertainty_score":0.5643555},"labels":[],"label_agreement":null},{"id":"W2978711591","doi":"10.1158/0008-5472.sabcs-09-4151","title":"Amplification of the Prolactin Receptor Gene in Mammary Lobular Neoplasia.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Invasive lobular carcinoma; Lobular carcinoma; Biology; Tissue microarray; Gene duplication; Prolactin receptor; Pathology; Cancer; Carcinoma; Ductal carcinoma; Comparative genomic hybridization; Polymerase chain reaction; Microarray; Amplicon; Breast cancer; Gene; Genome; Medicine; Genetics; Prolactin; Gene expression; Invasive ductal carcinoma; Endocrinology","score_opus":0.06634162620224955,"score_gpt":0.37770554709260007,"score_spread":0.31136392089035053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978711591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796775,0.001089618,0.00003494564,0.017420419,0.000047750294,0.0004790737,0.000004125515,0.000008501428,0.001238064],"genre_scores_gemma":[0.9979153,0.00019785984,0.00020277177,0.00018286952,0.00010052732,0.000056019475,0.0000043645214,0.0000069446724,0.0013333232],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99895793,0.00011163665,0.00014652492,0.00016890315,0.00039571367,0.00021927027],"domain_scores_gemma":[0.99925977,0.00002930007,0.000029315363,0.00042902364,0.00018717743,0.00006542633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005340656,0.000051791918,0.00011539566,0.00011778512,0.00004997383,0.000008441837,0.00017020358,0.00006148424,0.00013199872],"category_scores_gemma":[0.000077553814,0.000034861343,0.000038418868,0.00064992346,0.00006575091,0.00003938321,0.000038244376,0.0003418179,0.000014778999],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000517309,0.00020066151,0.02350487,0.00006871386,0.000009550616,0.000008938144,0.0003523279,0.000006036057,0.90446484,0.00133233,0.004931562,0.06460285],"study_design_scores_gemma":[0.0005558009,0.000109803615,0.86484486,0.00012736347,0.000004345823,0.000013378396,0.00008786659,0.000037383023,0.12767428,0.00027926572,0.006225699,0.000039983282],"about_ca_topic_score_codex":0.00014866483,"about_ca_topic_score_gemma":0.000019950747,"teacher_disagreement_score":0.84133995,"about_ca_system_score_codex":0.0001745641,"about_ca_system_score_gemma":0.00042169963,"threshold_uncertainty_score":0.14850478},"labels":[],"label_agreement":null},{"id":"W2979579934","doi":"10.1158/0008-5472.can-19-1961","title":"Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern Alberta Institute of Technology; Alberta Cancer Foundation; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Downregulation and upregulation; Wee1; Cancer; Biology; Cancer research; Cell cycle; Genetics; Gene; Cyclin-dependent kinase 1","score_opus":0.021067084947624954,"score_gpt":0.3901589490972172,"score_spread":0.3690918641495923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979579934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963987,0.0020780112,0.0004925626,0.00016400006,0.000099590165,0.00036644685,0.000040916675,0.00000346919,0.00035629587],"genre_scores_gemma":[0.9970584,0.00027147736,0.00028784556,0.000011407217,0.00009879709,0.00007012284,0.000014010781,0.0000149321895,0.0021730321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991656,0.000035035388,0.00015550437,0.00021586593,0.00023671724,0.0001912895],"domain_scores_gemma":[0.9993589,0.000012016423,0.0000362927,0.00026360017,0.00027926947,0.00004991074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023605772,0.00006506637,0.00010917149,0.0000717888,0.000019739347,0.000005638793,0.00010389564,0.00007059724,0.000100538535],"category_scores_gemma":[0.000025347366,0.00006548405,0.000035127283,0.0002088634,0.000046507517,0.0000028610327,0.00007458945,0.000044191023,0.000004798675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001192838,0.000015655687,0.0011078208,0.00020456333,0.000016177308,1.5118152e-7,0.00012591486,0.002087313,0.99400204,0.000029116922,0.0012469671,0.001044996],"study_design_scores_gemma":[0.00022918536,0.00011256359,0.004681106,0.00014388999,0.000003425041,8.50957e-8,0.00004586918,0.000040842682,0.99016285,0.000030614065,0.004480433,0.000069126174],"about_ca_topic_score_codex":0.00014883988,"about_ca_topic_score_gemma":0.00026646833,"teacher_disagreement_score":0.0038391806,"about_ca_system_score_codex":0.000030149457,"about_ca_system_score_gemma":0.00010355849,"threshold_uncertainty_score":0.2670362},"labels":[],"label_agreement":null},{"id":"W2979840360","doi":"10.1158/0008-5472.can-19-1840","title":"Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Centre hospitalier universitaire de Québec; Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; Canadian Institutes of Health Research; lékařská fakulta Univerzity Karlovy; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Fondazione Italiana per la Ricerca sul Cancro; Medical Research Council; Uppsala Universitet; National Institute of General Medical Sciences; Institut National Du Cancer; Aalborg Universitetshospital; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Associazione Italiana per la Ricerca sul Cancro; KWF Kankerbestrijding; Lietuvos Mokslo Taryba; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Cancer Association of South Africa; Karolinska Institutet; Linköpings Universitet; Hungarian Scientific Research Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Seoul National University; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; U.S. Department of Defense; Cancer Research UK; Government of Canada; National Cancer Institute; Liga Portuguesa Contra o Cancro; Hospital de Câncer de Barretos; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Aalborg Universitet; Genome Canada; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; Clalit Health Services; Deutsches Krebsforschungszentrum; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; NRG Oncology; Fondation du cancer du sein du Québec; Memorial Sloan-Kettering Cancer Center; QIMR Berghofer Medical Research Institute; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; European Social Fund; University of Chicago; Cancer Research Institute; Kansas Bioscience Authority; Instituto de Salud Carlos III; Ohio State University; National Health and Medical Research Council; Jewish General Hospital; Fisher Center for Alzheimer's Research Foundation; Cancer Australia; Georgetown University; College of Medicine, Seoul National University; Susan G. Komen for the Cure; Beth Israel Deaconess Medical Center; Istituto Oncologico Veneto; Umeå Universitet; Royal Marsden NHS Foundation Trust","keywords":"Prostate cancer; Cancer; Oncology; Medicine; BRCA2 Protein; Gynecology; Prostate; Internal medicine; Biology; Genetics; Gene; Mutation","score_opus":0.011506237353643414,"score_gpt":0.3197608896350697,"score_spread":0.3082546522814263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979840360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859795,0.012791391,0.000008646346,0.00033860424,0.00007034364,0.00048922375,0.00013082562,0.0000031125066,0.0001883258],"genre_scores_gemma":[0.9816511,0.016594313,0.00009804361,0.000052744974,0.00007633368,0.0002686792,0.000013888693,0.000025291592,0.001219577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872375,0.00016606097,0.00015434413,0.00039167426,0.0002598464,0.00030433753],"domain_scores_gemma":[0.99928313,0.000052347663,0.00013060453,0.00022926612,0.00024802078,0.00005665005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006259448,0.0001027289,0.00015863066,0.00009618052,0.000063898486,0.00002596408,0.000116150746,0.00011097748,0.000032614753],"category_scores_gemma":[0.00004334365,0.0000917975,0.000015939764,0.00021216794,0.00015606465,0.000008578255,0.00013244215,0.00021415653,0.0000022396155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003809901,0.00001717853,0.5954096,0.00009222787,0.000075998956,0.0000013261639,0.00044287744,0.00055125926,0.39774117,0.000008175281,0.0005939188,0.004685312],"study_design_scores_gemma":[0.005085959,0.0005341777,0.5062172,0.00030786928,0.00004471847,0.000006249046,0.0006991747,0.000098470504,0.4469003,0.00023441389,0.039475515,0.0003959733],"about_ca_topic_score_codex":0.0009853061,"about_ca_topic_score_gemma":0.0027923107,"teacher_disagreement_score":0.08919241,"about_ca_system_score_codex":0.00032055387,"about_ca_system_score_gemma":0.00054052466,"threshold_uncertainty_score":0.37433934},"labels":[],"label_agreement":null},{"id":"W2979900366","doi":"10.1158/1538-7445.am2018-229","title":"Abstract 229: Genome-wide association study by colorectal carcinoma subtype","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Genome-wide association study; Microsatellite instability; Genetics; Biology; Population; Genetic association; Colorectal cancer; Odds ratio; Population stratification; Oncology; Microsatellite; Single-nucleotide polymorphism; Bioinformatics; Genotype; Medicine; Cancer; Internal medicine; Allele; Gene","score_opus":0.06414100747145512,"score_gpt":0.395860142772181,"score_spread":0.3317191353007259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979900366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656255,0.00089405105,0.000002223183,0.0012938294,0.00060974667,0.0014569967,0.000045639044,0.000060832346,0.009074148],"genre_scores_gemma":[0.99310786,0.000084561616,0.00002544323,0.00024722007,0.00094046147,0.00037075847,0.000022500075,0.0000564729,0.0051447153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965777,0.00018427255,0.00029837716,0.00055790326,0.0015480779,0.0008336791],"domain_scores_gemma":[0.99744165,0.00050006364,0.00009353173,0.00041032129,0.0012567323,0.00029768987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015390568,0.00018214056,0.00031797471,0.00020607981,0.00027552023,0.00006502722,0.0002815523,0.00018624027,0.0042430917],"category_scores_gemma":[0.0011922427,0.00016785445,0.00006854143,0.00072748744,0.00022848973,0.00006732562,0.00015150057,0.00075176364,0.0005703869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006604218,0.00026627022,0.828213,0.000036850197,0.000107892396,0.000023134899,0.001059252,7.612413e-7,0.100169435,9.762316e-7,0.06861485,0.0008471702],"study_design_scores_gemma":[0.0014183545,0.0023799615,0.9219404,0.000023011797,0.000034283505,0.0000015343222,0.00055063755,0.0000064522596,0.052366372,0.000027504151,0.02109104,0.00016045859],"about_ca_topic_score_codex":0.001947034,"about_ca_topic_score_gemma":0.0011187403,"teacher_disagreement_score":0.093727395,"about_ca_system_score_codex":0.0029591732,"about_ca_system_score_gemma":0.0009332877,"threshold_uncertainty_score":0.99666715},"labels":[],"label_agreement":null},{"id":"W2982006614","doi":"10.1158/0008-5472.can-19-0729","title":"A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer Cells","year":2019,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Cancer cell; Cancer; Acquired resistance; Kinase; Cancer research; Biology; Receptor tyrosine kinase; Drug resistance; Cell culture; Tyrosine kinase; Signal transduction; Cell biology; Genetics","score_opus":0.04447817416959338,"score_gpt":0.3423194134676556,"score_spread":0.2978412392980622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982006614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512756,0.0013570683,0.0004168883,0.041221675,0.00055833126,0.0032048777,0.0016735167,0.000029483535,0.00026255345],"genre_scores_gemma":[0.95431364,0.0005430444,0.001345979,0.015672274,0.0033132308,0.002620258,0.0012774153,0.0003970736,0.02051709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.993835,0.0008843506,0.00070042524,0.0015102506,0.0016157075,0.0014542914],"domain_scores_gemma":[0.99729186,0.0001572337,0.00025357155,0.0010057287,0.0011099301,0.00018168823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001209759,0.00048803317,0.0006759618,0.0008108399,0.0001227941,0.000083528925,0.0006423534,0.0012307871,0.00032837392],"category_scores_gemma":[0.00036385827,0.00051791256,0.0001937576,0.0013995186,0.0002489139,0.000017978218,0.0006253373,0.0012664644,0.00014799066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072451046,0.000064453045,0.000112532725,0.00092223636,0.000056127086,0.000045700097,0.000022771472,0.000023738852,0.6501782,0.000008975499,0.34768757,0.00015319033],"study_design_scores_gemma":[0.00093906175,0.00068519195,0.00028431034,0.001179062,0.000013365132,0.0000024535066,0.00001548027,0.0000086527025,0.8728096,0.00013664633,0.12346886,0.00045735078],"about_ca_topic_score_codex":0.0016751837,"about_ca_topic_score_gemma":0.0029335883,"teacher_disagreement_score":0.22421871,"about_ca_system_score_codex":0.0013781338,"about_ca_system_score_gemma":0.0013252221,"threshold_uncertainty_score":0.99972725},"labels":[],"label_agreement":null},{"id":"W298423539","doi":"","title":"Targeting Prostate Cancer for Gene Therapy Utilizing Lentivirus and Oncolytic VSV Virus","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of British Columbia","funders":"","keywords":"Oncolytic virus; Prostate cancer; PTEN; Prostate; Cancer research; Virus; Vesicular stomatitis virus; Biology; Cancer; Cancer cell; Pathology; Medicine; Virology; Internal medicine; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.08248236621720723,"score_gpt":0.4320591573060336,"score_spread":0.3495767910888264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W298423539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478935,0.049147658,0.00006352791,0.0011185069,0.000097323624,0.0013212018,0.000113993476,0.000020322237,0.00022396274],"genre_scores_gemma":[0.94674385,0.049430497,0.00017682753,0.0005031502,0.00070286804,0.00087810884,0.00005100546,0.000060397822,0.0014533179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974043,0.0002279909,0.00023328772,0.0006955511,0.000471176,0.0009677361],"domain_scores_gemma":[0.9988575,0.000058728947,0.00005524589,0.00038267087,0.00044347826,0.00020237615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001433495,0.00021193686,0.00021705094,0.00014619017,0.0004249748,0.000114657494,0.00035012726,0.00015030065,0.00008186066],"category_scores_gemma":[0.00010406771,0.00019510441,0.00008009679,0.00029011825,0.00022174255,0.0000122675065,0.000111322646,0.0003182151,0.0000063871275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040851813,0.00006264517,0.000407015,0.000027516762,0.00006454745,0.0000037377845,0.00016217,0.00008625271,0.86814076,0.000013028557,0.0027386192,0.1242085],"study_design_scores_gemma":[0.0017105947,0.0026545625,0.0003142193,0.00003444993,0.0000050834024,0.0000017473434,0.00009473227,0.00018917368,0.9408385,0.00023728913,0.053679872,0.00023975156],"about_ca_topic_score_codex":0.0002657605,"about_ca_topic_score_gemma":0.0003469641,"teacher_disagreement_score":0.12396875,"about_ca_system_score_codex":0.00013818237,"about_ca_system_score_gemma":0.0006176031,"threshold_uncertainty_score":0.7956127},"labels":[],"label_agreement":null},{"id":"W2985039935","doi":"10.1158/0008-5472.can-18-3985","title":"Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institute on Aging; National Institutes of Health; National Natural Science Foundation of China","keywords":"ATP synthase; Trastuzumab; Oligomycin; Biology; Gene knockdown; Cancer research; Drug resistance; Pharmacology; Biochemistry; Cancer; Enzyme; Apoptosis; ATPase; Microbiology; Genetics; Breast cancer","score_opus":0.05766053273698057,"score_gpt":0.4023698686295897,"score_spread":0.3447093358926091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985039935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96628094,0.00044067553,0.000065771615,0.028722893,0.000036479873,0.00094925886,0.000081047736,0.00009083989,0.0033320847],"genre_scores_gemma":[0.97703606,0.00004873669,0.00026599146,0.0020965298,0.0002092927,0.00039011045,0.000042228374,0.00003128099,0.019879756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974484,0.00024917367,0.00028017987,0.00059649214,0.00087277126,0.00055297767],"domain_scores_gemma":[0.9979168,0.00017805547,0.00003170251,0.0006442856,0.0007434512,0.00048570387],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010521122,0.00015829214,0.00034816776,0.00042563136,0.00018424286,0.00007187517,0.0001221257,0.0000912298,0.006322337],"category_scores_gemma":[0.00045553525,0.00013482041,0.00012205414,0.0014054548,0.000119295226,0.00011312902,0.000087324726,0.00025466437,0.0013102858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014952517,0.00019915028,0.0064333817,0.00022769487,0.00007813262,0.00003645983,0.0016676774,0.000031548123,0.96088815,0.000155866,0.026686374,0.0021003042],"study_design_scores_gemma":[0.0018741405,0.00060455484,0.032011688,0.0024565158,0.000030559106,0.0000034360137,0.0018121563,0.00004395113,0.87881655,0.00037002028,0.081594765,0.00038165235],"about_ca_topic_score_codex":0.00046303048,"about_ca_topic_score_gemma":0.0004613764,"teacher_disagreement_score":0.082071595,"about_ca_system_score_codex":0.0005059099,"about_ca_system_score_gemma":0.00023335782,"threshold_uncertainty_score":0.9994673},"labels":[],"label_agreement":null},{"id":"W2988353924","doi":"10.1158/0008-5472.can-19-1108","title":"CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"Government of Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"CD44; Cancer research; Triple-negative breast cancer; Carcinogenesis; Regulator; Lung cancer; Biology; Small hairpin RNA; PD-L1; Breast cancer; Cancer; Downregulation and upregulation; Gene knockdown; Immune system; Medicine; Immunology; Cell; Oncology; Immunotherapy; Internal medicine; Cell culture; Gene","score_opus":0.033775768281425686,"score_gpt":0.35367727695887174,"score_spread":0.31990150867744604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988353924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806082,0.016340915,0.0000011104141,0.0012871166,0.00017393446,0.0008929442,0.0000144271025,0.000021480386,0.00065982423],"genre_scores_gemma":[0.9953586,0.0027106942,0.000008126157,0.00017277128,0.00014825883,0.00014220909,0.000005836425,0.000022956398,0.0014305458],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985614,0.00009306455,0.00016799447,0.0003907914,0.00039728716,0.0003894943],"domain_scores_gemma":[0.9994395,0.00006978145,0.00003494438,0.0001899858,0.00013528933,0.00013053023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005987479,0.00011986183,0.00021495516,0.0002590821,0.00008755212,0.00003928745,0.000063102176,0.000075592645,0.0006041661],"category_scores_gemma":[0.00002366306,0.00009715409,0.000026208141,0.0004219262,0.00011333633,0.00015161451,0.00007586452,0.0003861282,0.000011014512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007942745,0.00004107101,0.12050799,0.00067326945,0.000053256797,0.000025601945,0.00053588074,0.0000020546781,0.837178,0.000029324528,0.001978899,0.031031922],"study_design_scores_gemma":[0.011301561,0.00097560626,0.8519269,0.0036430813,0.000039417646,0.000198149,0.001193963,0.00066711893,0.119226225,0.000092651644,0.010328771,0.00040653246],"about_ca_topic_score_codex":0.0017346015,"about_ca_topic_score_gemma":0.00022473482,"teacher_disagreement_score":0.7314189,"about_ca_system_score_codex":0.0005232942,"about_ca_system_score_gemma":0.00039810996,"threshold_uncertainty_score":0.6615195},"labels":[],"label_agreement":null},{"id":"W2990808969","doi":"","title":"Stromal mast cells as a favorable prognostic marker in early breast cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Tissue microarray; Oncology; Stromal cell; Internal medicine; Lymph node; Immunohistochemistry; Antibody; Adjuvant; Mast cell; Pathology; Cohort; Cancer; Immunology","score_opus":0.07651018433685033,"score_gpt":0.4339942106875084,"score_spread":0.357484026350658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990808969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97823256,0.0022952934,0.000009452249,0.0084158,0.00029382174,0.0022494101,0.00018727865,0.000081946826,0.008234421],"genre_scores_gemma":[0.98595065,0.0014196818,0.00015904372,0.00027019688,0.00069795985,0.0021572437,0.0000109409575,0.00013403333,0.0092002405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934709,0.0003222563,0.0004825063,0.0009772055,0.0025769996,0.0021701504],"domain_scores_gemma":[0.9972228,0.00021403829,0.000056461733,0.00080505485,0.00087264006,0.0008290391],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018813764,0.00031916494,0.0005412097,0.00082367344,0.00021775514,0.00017159822,0.00059176615,0.0002604811,0.0066696843],"category_scores_gemma":[0.00023339184,0.00029181765,0.00012282196,0.0023445615,0.00059953704,0.00024068386,0.00033317602,0.0022689293,0.0010716283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052335146,0.0014409474,0.76292807,0.0020321116,0.00028974714,0.0037292459,0.0032566683,0.0008222303,0.17204024,0.0007848234,0.018081972,0.029360404],"study_design_scores_gemma":[0.011358768,0.0018238284,0.91126496,0.0055437493,0.00006454632,0.00028399462,0.0012718557,0.00013238474,0.045991484,0.0013486131,0.02006398,0.00085185614],"about_ca_topic_score_codex":0.055358674,"about_ca_topic_score_gemma":0.0049202535,"teacher_disagreement_score":0.14833684,"about_ca_system_score_codex":0.003675806,"about_ca_system_score_gemma":0.0068394085,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W2994722079","doi":"10.1158/1538-7445.panca19-b56","title":"Abstract B56: Endogenous retrovirus transcript levels are associated with immunogenic signatures in multiple metastatic cancer types","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Pancreas Centre (Canada)","funders":"","keywords":"Biology; Endogenous retrovirus; Pancreatic cancer; Cancer; Colorectal cancer; Cancer research; Metastatic breast cancer; Immunotherapy; Metastasis; Immunogenicity; Immunology; Breast cancer; Gene; Immune system; Genetics; Genome","score_opus":0.08248257307342638,"score_gpt":0.33670556513577526,"score_spread":0.2542229920623489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994722079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97321266,0.024570728,0.000005693739,0.00014362996,0.00020045943,0.0006182119,0.0006581891,0.000009837877,0.00058057444],"genre_scores_gemma":[0.99571246,0.0028041606,0.000022570477,0.00016899768,0.00012694894,0.0002618056,0.00006762079,0.00005924745,0.0007761765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980707,0.00011182944,0.00023667657,0.00051965483,0.00039802503,0.00066309585],"domain_scores_gemma":[0.9989229,0.00015810001,0.000094195166,0.00041168305,0.00030285816,0.00011030878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048059536,0.00020445463,0.00028585098,0.00013215517,0.00010426819,0.000060214545,0.0003590839,0.00015984352,0.00044867466],"category_scores_gemma":[0.00022972269,0.00018212025,0.00008354848,0.00034367596,0.00013032772,0.000008502156,0.000062472565,0.00046957325,0.000020069067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053723226,0.000114482085,0.023381673,0.000066638604,0.00023562984,0.000037853246,0.00020300975,0.0042701075,0.96915835,0.00000985771,0.00090972165,0.0010754267],"study_design_scores_gemma":[0.004079051,0.00063125126,0.12351728,0.00033017306,0.0000496373,0.0000038625935,0.000414976,0.00007857453,0.8566231,0.00006571172,0.013624082,0.0005822997],"about_ca_topic_score_codex":0.0035458107,"about_ca_topic_score_gemma":0.014859333,"teacher_disagreement_score":0.11253527,"about_ca_system_score_codex":0.00030094493,"about_ca_system_score_gemma":0.00077595643,"threshold_uncertainty_score":0.82918566},"labels":[],"label_agreement":null},{"id":"W2994737273","doi":"10.1158/1538-7445.panca19-a40","title":"Abstract A40: Genomic characterization of locally advanced pancreatic adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; McGill University Health Centre; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Internal medicine; FOLFIRINOX; CDKN2A; KRAS; Medicine; Adenocarcinoma; Oncology; Pancreatic cancer; Gastroenterology; Cancer","score_opus":0.05843046041801011,"score_gpt":0.3995905127521549,"score_spread":0.3411600523341448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994737273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887646,0.0010971507,0.000045142504,0.0006804218,0.0001087002,0.0014437828,0.000027479613,0.000026685073,0.0078060455],"genre_scores_gemma":[0.99082947,0.001524332,0.00014865742,0.00008631308,0.00016595468,0.00019800595,0.000055783028,0.00003884718,0.006952617],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976294,0.00013073732,0.00040266718,0.00039274758,0.0008259626,0.00061848527],"domain_scores_gemma":[0.9981855,0.00026873584,0.00009976771,0.000569225,0.0006387889,0.00023793959],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009779022,0.00014066523,0.0006037294,0.00033900078,0.00007850104,0.000015380172,0.00023975791,0.0001590157,0.0039962577],"category_scores_gemma":[0.00016631148,0.000120403085,0.000085111365,0.0004941997,0.00028428354,0.000111011934,0.000108908614,0.0005726096,0.00064507744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085101323,0.0000926765,0.39673987,0.0005146699,0.0000823135,0.000021055004,0.0001827605,0.0000034605544,0.59753567,0.0001287325,0.00009320383,0.0037545827],"study_design_scores_gemma":[0.0022022887,0.000692303,0.97089046,0.00045633735,0.000043992106,0.00001430278,0.00017396097,0.00025966277,0.02374172,0.00007418105,0.0013406831,0.000110103174],"about_ca_topic_score_codex":0.00026179737,"about_ca_topic_score_gemma":0.0000129639975,"teacher_disagreement_score":0.57415056,"about_ca_system_score_codex":0.00038913553,"about_ca_system_score_gemma":0.0014733265,"threshold_uncertainty_score":0.9969142},"labels":[],"label_agreement":null},{"id":"W2994749165","doi":"","title":"Enzymatic activity of prostate-specific antigen (PSA) in prostate cancer and human bone-metastasizing prostate cancer LNCaP cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Prostate cancer; Medicine; Prostate-specific antigen; Cancer; Prostate; PCA3; LNCaP; Prostatic acid phosphatase; Metastasis; Prostatectomy; Pathology; Internal medicine; Oncology","score_opus":0.0973781258124653,"score_gpt":0.4251718904687259,"score_spread":0.3277937646562606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994749165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463661,0.04343532,8.627372e-7,0.004845551,0.00014147983,0.004184094,0.00043520835,0.000059988342,0.0005314501],"genre_scores_gemma":[0.93235624,0.057737675,0.00014107309,0.00006486258,0.00030541298,0.0024749944,0.000037631602,0.00012127844,0.006760858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942414,0.000371853,0.0007729402,0.0011246656,0.001667923,0.0018211772],"domain_scores_gemma":[0.99750406,0.0001910512,0.00024179036,0.00070251105,0.00080125214,0.0005593232],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018418976,0.0004889504,0.0010275057,0.0010309699,0.00041373912,0.0001401568,0.0003044815,0.00017140212,0.00063592],"category_scores_gemma":[0.000047408303,0.00040310743,0.00013500154,0.0016618978,0.0010203902,0.0005389467,0.00033976187,0.0013570118,0.000025597328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037785706,0.0006849244,0.10700555,0.0022709745,0.0002908044,0.00023007693,0.0064427364,0.0001680261,0.768848,0.000064983644,0.0034696609,0.10674569],"study_design_scores_gemma":[0.0107772015,0.0010987617,0.08675095,0.0030666674,0.000092585884,0.000015263633,0.0011433992,0.0002753534,0.86036086,0.00014288744,0.03559004,0.00068604574],"about_ca_topic_score_codex":0.009220288,"about_ca_topic_score_gemma":0.003784856,"teacher_disagreement_score":0.10605964,"about_ca_system_score_codex":0.0017421612,"about_ca_system_score_gemma":0.0016599041,"threshold_uncertainty_score":0.9998421},"labels":[],"label_agreement":null},{"id":"W2994935974","doi":"10.1158/1538-7445.panca19-b46","title":"Abstract B46: Targeting pancreatic cancer organoids with dual BET and CBP/P300 inhibitor NEO2734","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"BET inhibitor; Bromodomain; BRD4; Cancer research; Biomarker; Pancreatic cancer; Histone deacetylase inhibitor; Cancer; Medicine; Pharmacology; Biology; Gene; Internal medicine; Epigenetics; Histone; Genetics; Histone deacetylase","score_opus":0.02052365006212125,"score_gpt":0.3271277593844102,"score_spread":0.30660410932228893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994935974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933244,0.0040084124,0.0000112591515,0.0007583057,0.00014767506,0.00046344724,0.000038486596,0.000015126069,0.001232911],"genre_scores_gemma":[0.993908,0.0010790752,0.00010742054,0.00014738849,0.0007257768,0.00016900517,0.00006227631,0.00004044852,0.0037606128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842674,0.00007810046,0.00017597004,0.00047028367,0.00039449742,0.00045441542],"domain_scores_gemma":[0.99921525,0.00002627544,0.000056287496,0.00028389617,0.00025804923,0.00016027543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004335096,0.00015602195,0.00016393609,0.00008168591,0.0001502384,0.00007963671,0.00014503062,0.00013966399,0.0006096925],"category_scores_gemma":[0.00007825908,0.00012519141,0.000030134763,0.00022310657,0.00017265089,0.000014688209,0.00014661693,0.0003062242,0.000042274456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018849272,0.000023908751,0.022282524,0.000108648965,0.000047709334,0.0000048002694,0.000078321515,0.00001834171,0.9636827,0.000034530698,0.010772358,0.0027576678],"study_design_scores_gemma":[0.000947447,0.00032602326,0.007987553,0.00014729504,0.000009034167,0.0000046419054,0.00024210765,0.000023858584,0.92931557,0.000016130341,0.060723025,0.00025731724],"about_ca_topic_score_codex":0.0007041625,"about_ca_topic_score_gemma":0.00019269911,"teacher_disagreement_score":0.049950667,"about_ca_system_score_codex":0.00006662821,"about_ca_system_score_gemma":0.00039598564,"threshold_uncertainty_score":0.66757053},"labels":[],"label_agreement":null},{"id":"W2995361078","doi":"10.1158/1538-7445.panca19-c57","title":"Abstract C57: Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Medicine; Oncology; Chemotherapy; Organoid; Internal medicine; Malignancy; Cancer; Cancer research; Biology","score_opus":0.09068682066675557,"score_gpt":0.4678894139888519,"score_spread":0.3772025933220964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995361078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981882,0.0015613756,0.0000039567985,0.0066822963,0.00017215198,0.002348793,0.00001790646,0.000042286334,0.007289279],"genre_scores_gemma":[0.9782229,0.0016204807,0.00016764353,0.00066880696,0.00023503091,0.0008388935,0.000013431023,0.00006016951,0.018172622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660033,0.00023471394,0.00041998248,0.00058071455,0.0011261939,0.0010380868],"domain_scores_gemma":[0.9979707,0.0005861369,0.00005068865,0.0006353955,0.00040048338,0.0003566192],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023226037,0.00019360356,0.0007122962,0.0007438893,0.0001268839,0.00005902308,0.00035015008,0.00019684875,0.0066263475],"category_scores_gemma":[0.0003283018,0.00016519785,0.00007027116,0.0013122836,0.00022250564,0.00011996607,0.00013244568,0.0010533476,0.0007870609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002234553,0.00013564723,0.68835324,0.0004746536,0.00009773292,0.000080874386,0.0011873755,0.000017714738,0.30016997,0.000078719655,0.00466438,0.0025051],"study_design_scores_gemma":[0.0039683217,0.0005127064,0.89454556,0.0012941186,0.000031572457,0.000010208869,0.0022020703,0.00020777671,0.09160283,0.00033814402,0.0050143786,0.00027230484],"about_ca_topic_score_codex":0.005455024,"about_ca_topic_score_gemma":0.0018478053,"teacher_disagreement_score":0.20856714,"about_ca_system_score_codex":0.0011992106,"about_ca_system_score_gemma":0.0017568376,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W2995391509","doi":"","title":"Personal financial conflicts of interest among authors of cancer clinical trials and editorials: scope and relationship to study funding","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Conflict of interest; Clinical trial; Logistic regression; Medicine; Pharmaceutical industry; Family medicine; Internal medicine; Business; Finance; Pharmacology","score_opus":0.9491359451290349,"score_gpt":0.7745228724883092,"score_spread":0.17461307264072568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995391509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919255,0.0034490135,0.000010656089,0.0013449884,0.0043127844,0.0013518658,0.00015526779,0.00001248584,0.00017039408],"genre_scores_gemma":[0.99385625,0.000896175,0.00001898039,0.00019003451,0.0046473425,0.00011826193,0.000002299729,0.000015416144,0.00025522808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929538,0.0044334647,0.0012158329,0.00042581285,0.0003570915,0.0006140154],"domain_scores_gemma":[0.98901826,0.009165088,0.00025429533,0.00012919978,0.0005167073,0.0009164763],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04372517,0.00015157662,0.00067190634,0.00027160815,0.00034239917,0.000018991705,0.00021094947,0.00066798314,0.0006867622],"category_scores_gemma":[0.0097012585,0.00013717581,0.000066885,0.0005057389,0.00086479954,0.000098616154,0.00022542846,0.0029094392,0.0000036018682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003375712,0.00032175815,0.94488037,0.00023754721,0.00016212698,0.000020357442,0.0041579055,0.000005292898,0.007230389,0.0008052268,0.004607796,0.034195498],"study_design_scores_gemma":[0.0043949843,0.001152861,0.9234036,0.00037408157,0.00022115455,0.0000019066435,0.0025759637,0.00009126027,0.03477938,0.00033718927,0.032424778,0.00024282104],"about_ca_topic_score_codex":0.000666944,"about_ca_topic_score_gemma":0.0012576478,"teacher_disagreement_score":0.034023914,"about_ca_system_score_codex":0.00011240404,"about_ca_system_score_gemma":0.00048265737,"threshold_uncertainty_score":0.9993909},"labels":[],"label_agreement":null},{"id":"W2995775886","doi":"10.1158/1538-7445.panca19-a61","title":"Abstract A61: Tandem duplicator phenotype: A potentially targetable genomic subgroup in pancreas cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Kingston General Hospital; Princess Margaret Cancer Centre; University Health Network; Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Medicine; Internal medicine; Oncology; Etiology; Breast cancer; Genome; Pancreatic cancer; Ovarian cancer; Cancer research; Gene; Biology; Genetics","score_opus":0.023323040777524076,"score_gpt":0.32854942700271167,"score_spread":0.3052263862251876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995775886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798357,0.015705721,0.000027900307,0.00038576734,0.00040242984,0.00061625964,0.00012777836,0.00001044366,0.0028880243],"genre_scores_gemma":[0.98677695,0.009152186,0.00009006043,0.00028105706,0.00069969066,0.00035695397,0.00007699099,0.00006348988,0.0025026412],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978382,0.00005916514,0.00028307864,0.0006840322,0.00033969042,0.00079583516],"domain_scores_gemma":[0.99886835,0.00004934294,0.00007038025,0.00059584173,0.00022144326,0.00019464745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061747414,0.0001946965,0.00025683845,0.00013435222,0.00009738198,0.00008178182,0.0004780883,0.00021001861,0.0016913981],"category_scores_gemma":[0.00007396,0.00020055719,0.00009236254,0.00029176375,0.00010724499,0.000008602192,0.0002856086,0.00038140954,0.00024177205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026090053,0.000081575934,0.05855131,0.0000629936,0.000057228357,0.000009209509,0.000047135483,0.00070993777,0.92696553,0.00016371287,0.009613131,0.0034773303],"study_design_scores_gemma":[0.0030588733,0.00030596645,0.30492863,0.00014110674,0.000025535994,0.000004380316,0.00015632375,0.000113848335,0.19891104,0.0004775512,0.4910875,0.0007892294],"about_ca_topic_score_codex":0.0061112703,"about_ca_topic_score_gemma":0.004790897,"teacher_disagreement_score":0.72805446,"about_ca_system_score_codex":0.0003189421,"about_ca_system_score_gemma":0.0011136243,"threshold_uncertainty_score":0.9992212},"labels":[],"label_agreement":null},{"id":"W2995905315","doi":"10.1158/1538-7445.panca19-b57","title":"Abstract B57: Early-onset pancreatic ductal adenocarcinomas are characterized by a distinct mutational landscape","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Canada's Michael Smith Genome Sciences Centre; Pancreas Centre (Canada); Spinal Cord Injury BC","funders":"","keywords":"Pancreatic cancer; FOLFIRINOX; KRAS; Oncology; Medicine; Internal medicine; Cancer; Transcriptome; Survival analysis; Pancreatic ductal adenocarcinoma; Adenocarcinoma; Biology; Gene; Gene expression; Oxaliplatin; Colorectal cancer; Genetics","score_opus":0.05723868573112222,"score_gpt":0.39010428263006364,"score_spread":0.3328655968989414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995905315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743284,0.0020999792,0.000009383491,0.001519997,0.00011808003,0.001609096,0.0002890596,0.00005539825,0.006866159],"genre_scores_gemma":[0.979437,0.00029022456,0.00005043844,0.00012342443,0.00038989817,0.00076808204,0.0002444323,0.000051409876,0.0186451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646485,0.0002351619,0.0003829757,0.0005925329,0.0013744191,0.00095008145],"domain_scores_gemma":[0.9976552,0.0007366108,0.00010669488,0.0005027703,0.0005241605,0.00047455094],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011112962,0.00022390267,0.00070509175,0.0002941847,0.00020796152,0.00007491942,0.00028465863,0.00018306443,0.009934663],"category_scores_gemma":[0.00029779156,0.00018391406,0.00012098436,0.0005061698,0.0003577924,0.00013835778,0.0001289462,0.0010412002,0.001960191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015310413,0.00021089653,0.9673319,0.00041360265,0.00021345161,0.00032465282,0.00032109427,2.2297615e-7,0.021321105,0.000011476436,0.0077048815,0.00061570294],"study_design_scores_gemma":[0.00326097,0.0004282285,0.9909346,0.00027961825,0.000055526565,0.00012048954,0.00023405855,0.000060520557,0.0009479917,0.0001009646,0.0033917306,0.00018531234],"about_ca_topic_score_codex":0.0005758505,"about_ca_topic_score_gemma":0.00003500858,"teacher_disagreement_score":0.023602717,"about_ca_system_score_codex":0.0003454886,"about_ca_system_score_gemma":0.0011330965,"threshold_uncertainty_score":0.9988169},"labels":[],"label_agreement":null},{"id":"W2996501216","doi":"10.1158/1538-7445.panca19-a24","title":"Abstract A24: Gene expression along the glycolysis-cholesterol synthesis axis and outcome in pancreatic cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Ontario Institute for Cancer Research; University Health Network; Spinal Cord Injury BC; Pancreas Centre (Canada)","funders":"","keywords":"Glycolysis; Cancer research; Biology; Anaerobic glycolysis; Pancreatic cancer; KRAS; Cancer; Tumor progression; Internal medicine; Endocrinology; Medicine; Metabolism; Genetics; Colorectal cancer","score_opus":0.03951463656392001,"score_gpt":0.35961820016338086,"score_spread":0.32010356359946085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996501216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255026,0.014926484,0.000005795649,0.00050974847,0.0010837166,0.000531139,0.000049683727,0.000006817409,0.00033634287],"genre_scores_gemma":[0.9859141,0.008885761,0.000026402207,0.00018198759,0.0026363877,0.00076270325,0.000008464598,0.000034068737,0.0015501148],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99814457,0.00017016035,0.00027134264,0.00052663765,0.00037576084,0.0005115269],"domain_scores_gemma":[0.9989983,0.00011457483,0.000062019106,0.00059215416,0.000114033435,0.00011891544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075071794,0.000169811,0.00027007353,0.00010680816,0.00012572612,0.00006864309,0.0003430813,0.00015519958,0.00035699416],"category_scores_gemma":[0.00013395396,0.00012154069,0.000075212825,0.00019940326,0.00016370765,0.000012289338,0.00021710577,0.0003245314,0.00002136131],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017673527,0.000024890713,0.18140803,0.00009179104,0.000034515742,3.4121584e-7,0.00015767656,0.000075667114,0.807863,0.000004949141,0.0033689316,0.0067934818],"study_design_scores_gemma":[0.0010131794,0.000057435904,0.4631289,0.00021814147,0.00002803524,0.000004539479,0.00041919423,0.000019359704,0.40497044,0.00002027969,0.12983336,0.00028714916],"about_ca_topic_score_codex":0.004964893,"about_ca_topic_score_gemma":0.003331116,"teacher_disagreement_score":0.40289253,"about_ca_system_score_codex":0.000081848906,"about_ca_system_score_gemma":0.0002145255,"threshold_uncertainty_score":0.75054663},"labels":[],"label_agreement":null},{"id":"W2998936402","doi":"10.1158/0008-5472.can-19-2039","title":"Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; Social Sciences and Humanities Research Council of Canada; National Institutes of Health; National Cancer Institute; Melanoma Research Alliance","keywords":"Melanoma; Tumor microenvironment; Biomarker; Immune system; Transcriptome; Computational biology; Cancer research; Medicine; Biology; Immunology; Genetics; Gene; Gene expression","score_opus":0.07578532127632648,"score_gpt":0.35455211334266906,"score_spread":0.2787667920663426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998936402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9189607,0.07118205,0.0001166546,0.008589972,0.00006191815,0.0008410383,0.00016297275,0.000014300153,0.00007041098],"genre_scores_gemma":[0.9935685,0.0051934887,0.0003397741,0.00042714202,0.000051715448,0.000087555316,0.00014628458,0.000025775342,0.00015981152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881184,0.00005905379,0.00023682394,0.00037263738,0.000274776,0.0002448972],"domain_scores_gemma":[0.99941385,0.00011054716,0.000060874136,0.00026251187,0.00007652508,0.00007567689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060301827,0.00010933261,0.0002617985,0.00011934987,0.00013662918,0.000057290676,0.00016506233,0.0000330289,0.000026967216],"category_scores_gemma":[0.000046577738,0.00009583902,0.000040278428,0.00018063099,0.0003413427,0.00015555127,0.00014779034,0.00015494823,3.9333997e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003081871,0.000045322977,0.010959752,0.001452255,0.00012822969,0.0000070127226,0.0007037447,1.1361776e-7,0.9409334,0.00001752596,0.0018071091,0.04086365],"study_design_scores_gemma":[0.012289367,0.0006428789,0.5759783,0.0015094295,0.00022227081,0.000084280735,0.0016866685,0.0007874853,0.38180637,0.00027185027,0.024386114,0.00033498267],"about_ca_topic_score_codex":0.00046265172,"about_ca_topic_score_gemma":0.000038849827,"teacher_disagreement_score":0.56501853,"about_ca_system_score_codex":0.000085793814,"about_ca_system_score_gemma":0.00013819843,"threshold_uncertainty_score":0.3908202},"labels":[],"label_agreement":null},{"id":"W2999401147","doi":"10.1158/0008-5472.can-19-2080","title":"Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Desmoplasia; Pancreatic cancer; Immune system; Cancer; Biology; Cancer research; Medicine; Pathology; Immunology; Internal medicine","score_opus":0.09124923583697828,"score_gpt":0.4199457631409499,"score_spread":0.3286965273039716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999401147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774494,0.009492178,0.0000108222275,0.008997147,0.000046449033,0.0013169185,0.000019755245,0.00003640861,0.0026308892],"genre_scores_gemma":[0.9937044,0.0032743667,0.00029190743,0.00033206068,0.0002212726,0.00084876566,0.000011395192,0.000040495168,0.0012753622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972427,0.00036664508,0.00034847125,0.00053511927,0.00069344294,0.00081363664],"domain_scores_gemma":[0.99848944,0.0004135298,0.00005096313,0.00028390315,0.00025044597,0.0005117127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080340623,0.00018295275,0.0006659468,0.00021868781,0.00017815633,0.00003714503,0.00020531223,0.00013418267,0.0019258551],"category_scores_gemma":[0.0005569966,0.00014526171,0.000048824128,0.0006911927,0.00047957755,0.00009860795,0.00025152304,0.0010302849,0.00005971685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013621371,0.00014862909,0.48935997,0.0009842492,0.00005780192,0.0003643256,0.0024215735,0.0000023286434,0.5006701,0.00002698068,0.0023553905,0.0022465524],"study_design_scores_gemma":[0.0076285983,0.001537173,0.7264331,0.001485817,0.00012554687,0.000044051263,0.0017270328,0.0035626434,0.2539862,0.00023116628,0.0028976644,0.00034097667],"about_ca_topic_score_codex":0.0022482688,"about_ca_topic_score_gemma":0.00019671195,"teacher_disagreement_score":0.24668385,"about_ca_system_score_codex":0.0002965838,"about_ca_system_score_gemma":0.0012368337,"threshold_uncertainty_score":0.99898654},"labels":[],"label_agreement":null},{"id":"W3000562243","doi":"10.1158/0008-5472.can-19-2850","title":"The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Cancer Council Victoria; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; U.S. Department of Defense; World Health Organization; European Commission; National Institute of Environmental Health Sciences; Institut National de la Santé et de la Recherche Médicale; Medical Research Council; Swedish Cancer Foundation; National Institutes of Health; U.S. Department of Health and Human Services; Office of Dietary Supplements; Ligue Contre le Cancer; National Institute for Health and Care Research; National Health and Medical Research Council; American Cancer Society; Cancer Research UK","keywords":"Ovarian cancer; Cancer; Medicine; Cohort; Oncology; Gynecology; Internal medicine","score_opus":0.043778426467996866,"score_gpt":0.38139175511517,"score_spread":0.33761332864717314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000562243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813053,0.0049258834,0.000011559904,0.0101984395,0.00005040893,0.0015388838,0.0015223878,0.000022036262,0.00042509293],"genre_scores_gemma":[0.9890966,0.007237984,0.00009170917,0.0010999113,0.00059853046,0.0016839935,0.0000971401,0.0000542574,0.000039904888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99446666,0.0018841212,0.0006577003,0.0007784971,0.0015736262,0.0006393996],"domain_scores_gemma":[0.9954222,0.0016162683,0.00034672036,0.0015087837,0.00064728525,0.00045875786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022393416,0.0003230761,0.0008277195,0.00013541631,0.0004195352,0.00009814654,0.00083014753,0.0001360918,0.001880748],"category_scores_gemma":[0.0003191974,0.00015569768,0.00021842287,0.0022304298,0.0010412954,0.00017513144,0.00013663397,0.00084188004,0.0000073748774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029696904,0.00056632014,0.9839959,0.000050857794,0.0038680304,0.000061023653,0.0030175743,0.0006929069,0.00020208053,0.0003769343,0.0011732862,0.0030254049],"study_design_scores_gemma":[0.002792045,0.0004151377,0.98610204,0.00024153857,0.003007374,0.0000030076665,0.0030590014,0.0011069328,0.0010149237,0.000104533174,0.0019671742,0.00018630207],"about_ca_topic_score_codex":0.55006504,"about_ca_topic_score_gemma":0.11534305,"teacher_disagreement_score":0.43472198,"about_ca_system_score_codex":0.0004423264,"about_ca_system_score_gemma":0.0023018995,"threshold_uncertainty_score":0.99903166},"labels":[],"label_agreement":null},{"id":"W3001714370","doi":"10.1158/0008-5472.can-19-1704","title":"The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma","year":2020,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"National Cancer Institute","keywords":"BAP1; Cancer research; Deubiquitinating enzyme; Pancreatic Intraepithelial Neoplasia; Pancreatic cancer; Hippo signaling pathway; Suppressor; Biology; Adenocarcinoma; Tumor suppressor gene; SKP2; Ubiquitin; Cancer; Carcinogenesis; Ubiquitin ligase; Medicine; Pancreatic ductal adenocarcinoma; Internal medicine; Signal transduction; Cell biology; Melanoma; Gene; Genetics","score_opus":0.030769348118237234,"score_gpt":0.3040814355350087,"score_spread":0.2733120874167715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001714370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50596476,0.025985762,0.0000030841607,0.4657839,0.0003873262,0.0011464423,0.0002531885,0.000013756939,0.0004618093],"genre_scores_gemma":[0.6807069,0.009620463,0.00003897643,0.26410568,0.017124416,0.003005144,0.0014892288,0.00038364253,0.02352553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967327,0.0006964661,0.0003296344,0.0007418598,0.00055298524,0.00094636425],"domain_scores_gemma":[0.99834055,0.0002217264,0.0000940855,0.0010668114,0.0001960211,0.00008079064],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005812994,0.0003096036,0.00029178167,0.00007170808,0.00040265813,0.00018638624,0.0014454335,0.00041156833,0.00006590471],"category_scores_gemma":[0.00025799748,0.00018829224,0.00017004363,0.0002774384,0.0005852325,0.0000036776005,0.0006446503,0.002363066,0.000041792533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092779854,0.0000098701275,0.0007368245,0.00011755906,0.00009963821,0.00024922407,0.000102973914,0.0000039031925,0.1898949,0.000017504655,0.8084209,0.00025394425],"study_design_scores_gemma":[0.00029586625,0.00013701647,0.0006351056,0.000087757166,0.000017813929,0.00003749452,0.00012812576,0.000032283027,0.106514014,0.00022629286,0.8916244,0.000263835],"about_ca_topic_score_codex":0.0004120243,"about_ca_topic_score_gemma":0.0004231393,"teacher_disagreement_score":0.20167819,"about_ca_system_score_codex":0.000119483884,"about_ca_system_score_gemma":0.0007143352,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W3003267918","doi":"","title":"The thrombin cleavage domain of osteopontin is important for mediating growth and adhesive properties of human breast cancer cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Osteopontin; Thrombin; Chemistry; Cleavage (geology); Cell growth; Cancer research; Biology; Molecular biology; Immunology; Platelet; Biochemistry","score_opus":0.0508015043628209,"score_gpt":0.3645598750914389,"score_spread":0.313758370728618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003267918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019165,0.015941259,0.0000010419276,0.002006907,0.000042511805,0.0010599827,0.00011695736,0.0000070543706,0.00063262274],"genre_scores_gemma":[0.99717593,0.0016473581,0.000036624024,0.000037945203,0.00018849796,0.0003921984,0.0000019920421,0.000020051262,0.0004993853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985811,0.000059502625,0.0003576862,0.00020087564,0.0004724227,0.00032840003],"domain_scores_gemma":[0.9991502,0.00012052144,0.00013098838,0.0001645124,0.0003854229,0.000048364793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067740976,0.00009885426,0.00030458948,0.000062756844,0.00030063113,0.000015318174,0.00009570738,0.000049771737,0.000020688152],"category_scores_gemma":[0.000042711923,0.000059281538,0.00006011198,0.00017524374,0.00068846694,0.000044115506,0.000116346135,0.00017008951,4.8384817e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040238182,0.000049258728,0.015082259,0.0008285795,0.00007256477,0.000003337118,0.0013555968,6.5611665e-8,0.97559226,0.00037659585,0.005582467,0.00065462367],"study_design_scores_gemma":[0.0010924422,0.00027924048,0.017016038,0.00040190044,0.000029110797,0.0000039210345,0.0034377708,0.0000031555662,0.9766312,0.000938936,0.00010081658,0.00006542391],"about_ca_topic_score_codex":0.010909104,"about_ca_topic_score_gemma":0.0010656848,"teacher_disagreement_score":0.016984284,"about_ca_system_score_codex":0.000059479655,"about_ca_system_score_gemma":0.00015508292,"threshold_uncertainty_score":0.99567735},"labels":[],"label_agreement":null},{"id":"W3003960114","doi":"","title":"Hypoxia-Inducible Factor 1 is required for hypoxia-induced resistance to doxorubicin in breast carcinoma cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Smoothened; Cyclopamine; Patched; Cancer research; Hedgehog signaling pathway; GLI1; Biology; Hedgehog; GLI2; Molecular biology; Signal transduction; Cell biology","score_opus":0.08499094368648552,"score_gpt":0.36471501088601754,"score_spread":0.279724067199532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003960114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935337,0.0015522181,0.00010474524,0.0020683128,0.00020813684,0.0010104753,0.00050238596,0.000017675162,0.0010024089],"genre_scores_gemma":[0.991903,0.000053359065,0.0003463463,0.00026039494,0.0007144564,0.0007268268,0.000033408294,0.00006800623,0.0058941673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970497,0.00015265509,0.00036752512,0.00094564696,0.00045453227,0.0010299359],"domain_scores_gemma":[0.9984807,0.00008738281,0.00005717401,0.0006881442,0.00051327446,0.00017333323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007008818,0.00025031433,0.0003105421,0.00025730536,0.00022836334,0.00005998146,0.0004832406,0.00022147984,0.000027057575],"category_scores_gemma":[0.000119652956,0.00025212555,0.00010786753,0.0005962044,0.000113901624,0.000008167691,0.00023602643,0.00024058137,0.000036718626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003680121,0.00013989271,0.0014278789,0.00007862019,0.000027004327,0.000009640129,0.00020336863,0.000015431815,0.9585148,0.000034792745,0.038658608,0.00052196445],"study_design_scores_gemma":[0.0015733817,0.00018640963,0.008023416,0.00007066495,0.0000049039854,0.0000015273895,0.00016006491,0.0000061686246,0.95885503,0.00013556154,0.030690141,0.00029272295],"about_ca_topic_score_codex":0.0013110142,"about_ca_topic_score_gemma":0.0022239496,"teacher_disagreement_score":0.0079684695,"about_ca_system_score_codex":0.00025615445,"about_ca_system_score_gemma":0.00044835565,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W3004486659","doi":"","title":"Clustering of anthracycline-containing lysosomes in drug-resistant MCF-7 cells in response to tesmilifene","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Doxorubicin; Epirubicin; Cytotoxicity; Anthracycline; Cancer research; Cytoplasm; Biology; Daunorubicin; Cancer cell; Clonogenic assay; Pharmacology; Cancer; Chemotherapy; Medicine; Apoptosis; In vitro; Cell biology; Internal medicine; Biochemistry; Breast cancer","score_opus":0.11304269958126131,"score_gpt":0.4622375099017531,"score_spread":0.3491948103204918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004486659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945514,0.0015332858,0.0000035749783,0.0024577351,0.00012665421,0.0007152503,0.000020837004,0.000012464527,0.00057879655],"genre_scores_gemma":[0.99483174,0.0010567455,0.00020806253,0.00017632541,0.00012150019,0.00026233186,0.0000032752,0.000023328597,0.0033167044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798566,0.00032759956,0.00038579985,0.00033649156,0.00041445668,0.0005499903],"domain_scores_gemma":[0.9987343,0.00065126794,0.00003856094,0.00025012778,0.00014438092,0.0001813851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012887658,0.00012406654,0.00041616306,0.00089012826,0.00006138937,0.0000045553525,0.00014378916,0.00006474377,0.00042170682],"category_scores_gemma":[0.00016844457,0.00011585858,0.00005114044,0.0010487546,0.00017249148,0.00005294407,0.00012303852,0.0003986876,0.00002398907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03481778,0.00034302814,0.09576514,0.00013400045,0.000032409767,0.0010296479,0.0050441273,0.00056592305,0.8589143,0.000003289381,0.0019996988,0.0013506532],"study_design_scores_gemma":[0.014257914,0.0020129858,0.42000258,0.0010985709,0.000024626219,0.000028523531,0.0014705582,0.00046471006,0.54823124,0.00002506898,0.012095389,0.00028783854],"about_ca_topic_score_codex":0.00854115,"about_ca_topic_score_gemma":0.006959251,"teacher_disagreement_score":0.32423744,"about_ca_system_score_codex":0.0007726681,"about_ca_system_score_gemma":0.00065427227,"threshold_uncertainty_score":0.99806106},"labels":[],"label_agreement":null},{"id":"W3005550822","doi":"10.1158/1538-7445.sabcs19-p6-08-18","title":"Abstract P6-08-18: Breast cancer in Li-Fraumeni syndrome and risk-reduction mastectomy in <i>TP53</i> p.R337H carriers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Penetrance; Genetic counseling; Cancer; Mastectomy; Oncology; Cohort; Population; Internal medicine; Genetic testing; Li–Fraumeni syndrome; Gynecology; Mutation; Germline mutation; Genetics; Environmental health; Biology","score_opus":0.05052030731082404,"score_gpt":0.35888273063938114,"score_spread":0.3083624233285571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005550822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824922,0.008216037,0.000007774186,0.006637642,0.00026518316,0.001181206,0.00026576887,0.00006231298,0.0008718559],"genre_scores_gemma":[0.9917776,0.0069807493,0.000028666445,0.0001555476,0.00030323208,0.00049631385,0.000014848392,0.00008307255,0.00015999077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967729,0.00019768722,0.000435541,0.0008348967,0.00087462866,0.0008843626],"domain_scores_gemma":[0.9986589,0.00006288925,0.00009403062,0.00037817744,0.00022175579,0.00058427243],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007431206,0.00026332735,0.0004990446,0.00052823283,0.00011145527,0.000054530217,0.00020210686,0.00026653416,0.0015041027],"category_scores_gemma":[0.00015603394,0.00026731633,0.000079394435,0.0018042194,0.000311143,0.00019208717,0.00015055815,0.002159677,0.00005322713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067131487,0.00040889537,0.19394375,0.0024045596,0.00057908567,0.004251836,0.011356047,0.005354366,0.6186532,0.000035939975,0.013765959,0.14253326],"study_design_scores_gemma":[0.015896084,0.0009035606,0.92433584,0.0031003875,0.00016236004,0.0010215068,0.0033156576,0.0015004753,0.035079263,0.00012489862,0.013546005,0.001013951],"about_ca_topic_score_codex":0.020417443,"about_ca_topic_score_gemma":0.0032889924,"teacher_disagreement_score":0.7303921,"about_ca_system_score_codex":0.0014815505,"about_ca_system_score_gemma":0.001213624,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W3005593524","doi":"10.1158/1538-7445.sabcs19-p1-19-05","title":"Abstract P1-19-05: Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"PTEN; Fulvestrant; Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Cancer; Oncology; Protein kinase B; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Palbociclib; Biology; Signal transduction","score_opus":0.06564374856405158,"score_gpt":0.378004243818123,"score_spread":0.3123604952540714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005593524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908038,0.0031175811,0.00009839202,0.004765372,0.000108560926,0.0006326494,0.00023414724,0.000016797174,0.0002227047],"genre_scores_gemma":[0.9974486,0.001030981,0.000072623574,0.00055984943,0.00021001349,0.00047971032,0.000063653875,0.00005826507,0.00007630934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730915,0.0001967256,0.00037032625,0.0007323122,0.00066093565,0.0007305497],"domain_scores_gemma":[0.9989747,0.000056708763,0.00008666715,0.00034395728,0.00025296723,0.0002850256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006659748,0.00024039243,0.00029832855,0.00017752947,0.00008209862,0.000060212973,0.0004413344,0.00013305874,0.00042894616],"category_scores_gemma":[0.000100445286,0.00021544658,0.000055951154,0.0007619824,0.00024377722,0.000020719017,0.000110930094,0.00062095746,0.0000135554765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016010674,0.00021847234,0.015282513,0.00030388316,0.00009942972,0.00023084479,0.0005506434,0.005050646,0.9677028,0.000052494794,0.0025185703,0.0063886223],"study_design_scores_gemma":[0.0115822,0.0015996451,0.11319668,0.0010357205,0.000056561934,0.0000697846,0.0014084249,0.0018827205,0.85224473,0.00033755405,0.015252483,0.0013334934],"about_ca_topic_score_codex":0.005510835,"about_ca_topic_score_gemma":0.0074350066,"teacher_disagreement_score":0.11545808,"about_ca_system_score_codex":0.00039471738,"about_ca_system_score_gemma":0.001384269,"threshold_uncertainty_score":0.8785656},"labels":[],"label_agreement":null},{"id":"W3005596322","doi":"10.1158/1538-7445.sabcs19-p1-17-17","title":"Abstract P1-17-17: Real-word implementation of <i>p</i>atient <i>r</i>eport <i>o</i>utcomes: Sustainability constraints and impact on patients health outcomes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Distress; Anxiety; Quality of life (healthcare); Patient experience; Dashboard; Family medicine; Health care; Nursing; Psychiatry; Database; Clinical psychology","score_opus":0.08030590734604155,"score_gpt":0.47621835952026964,"score_spread":0.3959124521742281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005596322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861989,0.00023666753,0.000005202337,0.009903382,0.00012888992,0.001805159,0.0004405225,0.00003871676,0.0012425635],"genre_scores_gemma":[0.99695635,0.0005339708,0.000010211544,0.0019963821,0.000092420814,0.00014254604,0.00013927835,0.000033506803,0.000095359705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658525,0.00017016691,0.00068624504,0.00056424603,0.0012852264,0.0007088482],"domain_scores_gemma":[0.99754405,0.0002564954,0.00023253381,0.0004081316,0.00088105106,0.00067775225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010048844,0.0002497182,0.00067997904,0.0001771956,0.00014793538,0.000032750588,0.0001455127,0.00008413883,0.00091017433],"category_scores_gemma":[0.00019053485,0.00019449616,0.00017404207,0.0005432117,0.0003990348,0.000114247225,0.00010841713,0.00053364143,0.000003581031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008308096,0.00019920719,0.9079712,0.0009836996,0.00011787218,0.000015654596,0.0049988427,0.000009787626,0.00018436211,0.000053234064,0.014266653,0.07036868],"study_design_scores_gemma":[0.0027152114,0.0018511403,0.9834847,0.00013265903,0.000022917959,0.0000012657003,0.007574704,0.0000026302505,0.0013065196,0.00006551298,0.0026795107,0.00016325506],"about_ca_topic_score_codex":0.020830873,"about_ca_topic_score_gemma":0.0023185199,"teacher_disagreement_score":0.07551347,"about_ca_system_score_codex":0.0012437386,"about_ca_system_score_gemma":0.0023874706,"threshold_uncertainty_score":0.9965771},"labels":[],"label_agreement":null},{"id":"W3005632677","doi":"10.1158/1538-7445.sabcs19-p3-08-52","title":"Abstract P3-08-52: Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Trastuzumab emtansine; Medicine; Metastatic breast cancer; Toxicity; Trastuzumab; Internal medicine; Oncology; Cancer; Antibody-drug conjugate; Breast cancer; Antibody; Immunology; Monoclonal antibody","score_opus":0.13632153337005212,"score_gpt":0.44626065717162655,"score_spread":0.3099391238015744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005632677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97086686,0.010622084,0.000019596078,0.014061363,0.00018502247,0.002162202,0.0012070527,0.0000903443,0.0007854591],"genre_scores_gemma":[0.99424165,0.0027319782,0.000081851314,0.00044658018,0.00054466235,0.0011160792,0.000017657216,0.00014038922,0.00067916507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9924448,0.0010303581,0.0011054522,0.0009362603,0.0029887056,0.0014943881],"domain_scores_gemma":[0.9960474,0.0010484817,0.0001744154,0.0007686761,0.0011009848,0.0008600459],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039544334,0.000388083,0.0011459275,0.00082887796,0.00013515208,0.00007189255,0.00072376407,0.00014446584,0.005113899],"category_scores_gemma":[0.0014536752,0.00034462838,0.00019069537,0.00257686,0.00085102674,0.00022609891,0.00025131847,0.0018847965,0.00012341522],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06463379,0.0008336449,0.040917054,0.016973801,0.0006918339,0.0044617937,0.009556429,0.0013642509,0.8073823,0.000090378904,0.034859072,0.018235693],"study_design_scores_gemma":[0.026641823,0.010078587,0.676255,0.0343973,0.00033951545,0.0015020866,0.028374415,0.0053622085,0.19693868,0.00024522826,0.017671317,0.0021938402],"about_ca_topic_score_codex":0.0070902514,"about_ca_topic_score_gemma":0.0010309208,"teacher_disagreement_score":0.63533795,"about_ca_system_score_codex":0.0025030691,"about_ca_system_score_gemma":0.0077217575,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W3005655675","doi":"10.1158/1538-7445.sabcs19-p5-12-06","title":"Abstract P5-12-06: Non-adherence to endocrine therapy is associated with a significant increased risk of local recurrence in women ≥65 years with stage T1N0 breast cancer treated with adjuvant endocrine therapy alone after breast-conserving surgery","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Population; Oncology; Internal medicine; Cancer registry; Mastectomy; Cohort; Anastrozole; Adjuvant therapy; Stage (stratigraphy); Gynecology; Breast-conserving surgery; Cancer; Tamoxifen","score_opus":0.06328383393888584,"score_gpt":0.3574040293898377,"score_spread":0.2941201954509518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005655675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897118,0.0017157308,0.000018134622,0.0037977125,0.00002169517,0.0026968096,0.0019029548,0.00007549861,0.000059649705],"genre_scores_gemma":[0.98890215,0.006332699,0.000058249214,0.0010518618,0.00013428726,0.003188779,0.000037965594,0.00013204422,0.00016196197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938872,0.0004741511,0.00080416497,0.0011965762,0.0018234861,0.0018144575],"domain_scores_gemma":[0.99577475,0.00079860137,0.00039723385,0.0006936477,0.0012947908,0.0010410049],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011903961,0.000603042,0.001606642,0.00054715446,0.0001437087,0.000050076043,0.00038089245,0.0001032215,0.0016176383],"category_scores_gemma":[0.00011665759,0.00041174077,0.00008956976,0.0026236165,0.00070094335,0.00019004998,0.00013390511,0.001279024,0.000018275457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0754663,0.0006831135,0.8642472,0.0005580709,0.0007988835,0.0018280202,0.0037013507,0.0000868191,0.003968373,3.3171636e-7,0.00071150926,0.047950022],"study_design_scores_gemma":[0.009691896,0.0026129102,0.9771326,0.0036190285,0.000041765503,0.00007975179,0.0015219902,0.00011475616,0.0044102482,0.0000013069372,0.00029800125,0.00047574175],"about_ca_topic_score_codex":0.09497859,"about_ca_topic_score_gemma":0.009095937,"teacher_disagreement_score":0.1128854,"about_ca_system_score_codex":0.0011362155,"about_ca_system_score_gemma":0.0032919233,"threshold_uncertainty_score":0.99983346},"labels":[],"label_agreement":null},{"id":"W3005672197","doi":"10.1158/1538-7445.sabcs19-p3-11-09","title":"Abstract P3-11-09: <i>ARISTACAT - Ar</i>omatase <i>i</i>nhibition plus minus <i>s</i>araca<i>t</i>inib as <i>a</i>dvanced breast <i>ca</i>ncer <i>t</i>herapy: A randomised phase II study of aromatase inhibition plus/minus the Src-inhibitor AZD0530 in post-menopausal women with advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Internal medicine; Placebo; Breast cancer; Oncology; Cancer; Pathology","score_opus":0.013877885950985483,"score_gpt":0.3165793258862445,"score_spread":0.302701439935259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005672197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830135,0.0047325236,0.000017221164,0.0021504273,0.00022229053,0.0054454957,0.004188759,0.00007813673,0.00015163439],"genre_scores_gemma":[0.9906807,0.0016210189,0.000035374596,0.0014620925,0.0007191476,0.0039571435,0.0012185287,0.00019873498,0.00010728865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.992638,0.00084427296,0.0012759098,0.0018156518,0.0016596897,0.0017664874],"domain_scores_gemma":[0.99629396,0.00021225362,0.0006055406,0.001160174,0.00086197077,0.00086608727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013092441,0.00094016164,0.0011480699,0.00028196114,0.0007860389,0.00016863197,0.0008228072,0.0005030724,0.00026674615],"category_scores_gemma":[0.000117359465,0.0007211788,0.0001723894,0.0015965955,0.00080412807,0.00015334059,0.0005093362,0.001513204,0.000031555417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10501222,0.0021854807,0.000067699075,0.00029828545,0.00038528154,0.00045791114,0.0033385048,0.002205433,0.8713733,0.00000423613,0.010244978,0.0044266963],"study_design_scores_gemma":[0.16937809,0.023178358,0.000848057,0.0010752715,0.00029416202,0.00041919912,0.008421159,0.00019794666,0.78704756,0.000029573943,0.0072093033,0.0019013109],"about_ca_topic_score_codex":0.0019402463,"about_ca_topic_score_gemma":0.0008161576,"teacher_disagreement_score":0.0843257,"about_ca_system_score_codex":0.0006514063,"about_ca_system_score_gemma":0.0017604567,"threshold_uncertainty_score":0.99952394},"labels":[],"label_agreement":null},{"id":"W3005686174","doi":"10.1158/1538-7445.sabcs19-p1-11-01","title":"Abstract P1-11-01: Effect of aerobic and resistance exercise on Reynolds risk score in overweight or obese breast cancer survivors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Overweight; Framingham Risk Score; Aerobic exercise; Internal medicine; Cancer; Physical therapy; Insulin resistance; Obesity; Disease","score_opus":0.042995736194362144,"score_gpt":0.37169260514456204,"score_spread":0.3286968689501999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005686174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791336,0.01710202,8.0339447e-7,0.0017041093,0.00015054428,0.0013502588,0.00022594149,0.000029219662,0.0003035198],"genre_scores_gemma":[0.95074207,0.04825565,0.00001054367,0.0000894731,0.00029854808,0.00023178615,0.000010588452,0.000050997223,0.00031036919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679923,0.00035994552,0.00040015925,0.00063110207,0.0011026625,0.00070692395],"domain_scores_gemma":[0.9980964,0.00048951776,0.0000966227,0.00051263074,0.00017712769,0.0006276975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016600799,0.00024243229,0.0008240512,0.00029050902,0.00012978152,0.000021812797,0.0001787806,0.00019977533,0.000460946],"category_scores_gemma":[0.0003506088,0.00016438327,0.00017144268,0.001068805,0.00028476756,0.00008564343,0.000084348445,0.0010498789,0.000014096087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030335708,0.00014810068,0.91097015,0.008415845,0.00017461304,0.0005076371,0.001347245,0.00007240958,0.0035562937,0.000017673014,0.008037673,0.036416627],"study_design_scores_gemma":[0.0046009636,0.0005557861,0.9713026,0.0041244077,0.0000960387,0.000007964451,0.00015531758,0.000021760881,0.011286473,0.000009094115,0.007610863,0.00022872805],"about_ca_topic_score_codex":0.029445654,"about_ca_topic_score_gemma":0.030581437,"teacher_disagreement_score":0.06033243,"about_ca_system_score_codex":0.0004111916,"about_ca_system_score_gemma":0.0008001923,"threshold_uncertainty_score":0.98710793},"labels":[],"label_agreement":null},{"id":"W3005694533","doi":"10.1158/1538-7445.sabcs19-p4-12-24","title":"Abstract P4-12-24: Evaluation of partial breast irradiation suitability in early stage breast cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Breast cancer; Stage (stratigraphy); Radiation therapy; Radiology; Ductal carcinoma; Cancer; Breast-conserving surgery; Surgical margin; Nuclear medicine; Mastectomy; Internal medicine; Metastasis","score_opus":0.08920534092164813,"score_gpt":0.397728866215431,"score_spread":0.3085235252937829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005694533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956732,0.0006444278,0.000002199923,0.001428071,0.00012537884,0.00066448195,0.0012770243,0.0000072262774,0.00017803686],"genre_scores_gemma":[0.9986556,0.00026289193,0.0000060788993,0.000050629187,0.00032335188,0.00053773273,0.0001241582,0.000022980217,0.000016544729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976153,0.0002604412,0.0003022161,0.0005183584,0.00089611387,0.00040759385],"domain_scores_gemma":[0.9986021,0.000030157269,0.0001040003,0.00026087865,0.00087143574,0.00013143229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007539667,0.00015402559,0.00020117813,0.00006764363,0.00008211669,0.000021110556,0.00019981527,0.00011199948,0.00032802587],"category_scores_gemma":[0.00013281647,0.00014836456,0.0000642216,0.00029297685,0.00017157044,0.00001928269,0.00013943753,0.00019891282,0.000008582971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009298913,0.0002416919,0.95043427,0.000090907204,0.00008729972,7.3321763e-7,0.00066746684,0.00054845517,0.032359935,0.0000061360906,0.00045100893,0.01418223],"study_design_scores_gemma":[0.0019872922,0.000101744765,0.97910947,0.00003557238,0.000022385431,3.129799e-7,0.000098399054,0.00009627536,0.018152323,0.000013660753,0.00025590355,0.00012665593],"about_ca_topic_score_codex":0.008788878,"about_ca_topic_score_gemma":0.0029014163,"teacher_disagreement_score":0.028675232,"about_ca_system_score_codex":0.00039399805,"about_ca_system_score_gemma":0.00062490645,"threshold_uncertainty_score":0.9978117},"labels":[],"label_agreement":null},{"id":"W3005705527","doi":"10.1158/1538-7445.sabcs19-ot1-08-04","title":"Abstract OT1-08-04: A first-in-human phase Ia dose escalation study of GDC-0077, a p110a-selective and mutant-degrading PI3K inhibitor, in patients with <i>PIK3CA</i>-mutant solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Palbociclib; Breast cancer; Cancer; Pharmacodynamics; Metastatic breast cancer; Phases of clinical research; Internal medicine; Adverse effect; Pharmacokinetics; Pharmacology; Oncology; Toxicity","score_opus":0.0470059046040869,"score_gpt":0.3988687330718152,"score_spread":0.3518628284677283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005705527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964173,0.00037753888,0.0000130760645,0.0004135531,0.000032065018,0.0025898525,0.000038201528,0.000035970967,0.00008246776],"genre_scores_gemma":[0.9992924,0.000034538283,0.000037015947,0.000054885302,0.00014079455,0.00034922332,0.000015095242,0.00006758429,0.000008484552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685705,0.00013971915,0.0005745491,0.000705726,0.0010439111,0.00067903136],"domain_scores_gemma":[0.99864715,0.00016122857,0.0001775135,0.00028576897,0.0004319133,0.00029639638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046742096,0.00027976854,0.0006627971,0.00050334027,0.00014021789,0.000032772183,0.00016164678,0.000083400504,0.00008362304],"category_scores_gemma":[0.00016287748,0.00023789301,0.000037942275,0.0015148959,0.00024712953,0.00029784182,0.00010085769,0.00091653,0.0000029194778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030147092,0.0050387345,0.7494486,0.0008277988,0.00026893002,0.00044254088,0.04330603,0.00063109264,0.1483102,0.000019577757,0.000042668726,0.021516742],"study_design_scores_gemma":[0.056193847,0.015119419,0.87345064,0.0019358111,0.000058115067,0.000009970941,0.006702651,0.00044658326,0.045306187,0.00017317403,0.00012262785,0.00048097657],"about_ca_topic_score_codex":0.0015216324,"about_ca_topic_score_gemma":0.002312833,"teacher_disagreement_score":0.12400204,"about_ca_system_score_codex":0.00083728577,"about_ca_system_score_gemma":0.000412215,"threshold_uncertainty_score":0.9700995},"labels":[],"label_agreement":null},{"id":"W3005787166","doi":"10.1158/1538-7445.sabcs19-pd2-03","title":"Abstract PD2-03: CDK4/6 inhibitor-resistant ER+ breast cancer cell lines are hypersensitive to TTK inhibition","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Palbociclib; Cancer research; Cell cycle; Cyclin-dependent kinase 4; Growth inhibition; Breast cancer; Cancer; Cytotoxicity; Biology; Estrogen receptor; Cell growth; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Cyclin-dependent kinase 2; In vitro; Genetics","score_opus":0.07521458282039346,"score_gpt":0.38430360908024463,"score_spread":0.3090890262598512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005787166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93430233,0.0047983634,0.00004992063,0.055523735,0.0003161676,0.0013845086,0.0010718923,0.00019784964,0.002355254],"genre_scores_gemma":[0.98995066,0.00074093364,0.0002206239,0.004068183,0.003538585,0.00053212,0.000036295045,0.00013608388,0.0007765433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960869,0.00011864646,0.00044232642,0.00096035015,0.0013569015,0.0010349007],"domain_scores_gemma":[0.9967487,0.00014551506,0.00013551766,0.00045952472,0.0015255483,0.0009852094],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035876065,0.00037874104,0.0005947082,0.00020919974,0.00029111735,0.00007951747,0.0001957638,0.000180761,0.0021056344],"category_scores_gemma":[0.00013132316,0.00034383096,0.00015505911,0.0011001911,0.00031331638,0.0003158634,0.00020604522,0.0009580763,0.00041267893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061464966,0.0001729767,0.0014096143,0.00067912677,0.00011279311,0.00039482914,0.002346132,0.00027649786,0.96266145,0.000031457137,0.010497864,0.015270781],"study_design_scores_gemma":[0.006868578,0.0009000591,0.12990719,0.0034963281,0.00011330773,0.00008744312,0.013533954,0.000106511034,0.75963587,0.00012541073,0.08409105,0.0011342796],"about_ca_topic_score_codex":0.0024107627,"about_ca_topic_score_gemma":0.0009964122,"teacher_disagreement_score":0.20302555,"about_ca_system_score_codex":0.001632359,"about_ca_system_score_gemma":0.00087513705,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W3005826492","doi":"10.1158/1538-7445.sabcs19-p2-11-03","title":"Abstract P2-11-03: Predictive significance of an optimized immunohistochemical panel for basal-like breast cancer on the CCTG MA.12 phase III randomized clinical trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Tamoxifen; Breast cancer; Oncology; Internal medicine; Tissue microarray; Immunohistochemistry; Medicine; Predictive marker; Estrogen receptor; Cancer","score_opus":0.1370041976967586,"score_gpt":0.4459869923489128,"score_spread":0.3089827946521542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005826492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773087,0.0022939087,0.0007467935,0.0098035,0.0006518366,0.0065322123,0.0022896235,0.00003529263,0.00033815234],"genre_scores_gemma":[0.98777324,0.0016751436,0.00018259011,0.0006280932,0.0020278085,0.0073041725,0.00020146456,0.00006788542,0.00013962077],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99612975,0.0008236663,0.0008394242,0.0009503509,0.0006271508,0.00062964606],"domain_scores_gemma":[0.996779,0.0013435225,0.00032158202,0.0006444472,0.0006322345,0.00027917788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023507085,0.0003391024,0.0009767814,0.00005016974,0.00027017706,0.000037579706,0.0006814081,0.0002684338,0.0002858372],"category_scores_gemma":[0.00093663647,0.0002349488,0.00050837797,0.00019798013,0.0013742219,0.000013597031,0.00020859369,0.0004903326,0.0000048406637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9038942,0.0008503222,0.00003617991,0.000064348445,0.00097576965,0.000004204859,0.0003557561,0.0001933532,0.07920657,0.000041169125,0.010968159,0.0034099638],"study_design_scores_gemma":[0.8923065,0.0023327642,0.0004955302,0.00013057003,0.00031345693,0.0000024071717,0.0006624207,0.0012666838,0.098182425,0.000097073236,0.0037443768,0.00046576522],"about_ca_topic_score_codex":0.0008125208,"about_ca_topic_score_gemma":0.00007714694,"teacher_disagreement_score":0.018975854,"about_ca_system_score_codex":0.00016725737,"about_ca_system_score_gemma":0.00084618124,"threshold_uncertainty_score":0.9580934},"labels":[],"label_agreement":null},{"id":"W3005827157","doi":"10.1158/1538-7445.sabcs19-p3-06-10","title":"Abstract P3-06-10: Temozolomide &amp; vorinostat as a targeted therapy strategy for triple negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Temozolomide; Triple-negative breast cancer; Vorinostat; Cancer research; PARP inhibitor; Breast cancer; Medicine; Cisplatin; Combination therapy; Decitabine; Oncology; Cancer; Internal medicine; Chemotherapy; DNA methylation; Histone deacetylase; Biology; Glioma; Histone; Poly ADP ribose polymerase; DNA","score_opus":0.10171294337917446,"score_gpt":0.42342487257336875,"score_spread":0.3217119291941943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005827157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862512,0.0048653977,0.00006557345,0.0044041136,0.00013266089,0.001710816,0.0015254552,0.000036862646,0.0010079265],"genre_scores_gemma":[0.98161966,0.0029557617,0.0001307551,0.0004541399,0.0017139859,0.001769292,0.00039022227,0.00011522656,0.010850976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99662536,0.00024722714,0.0003481422,0.0009484141,0.0007626902,0.0010681377],"domain_scores_gemma":[0.99761564,0.00013062236,0.00008937668,0.0004908491,0.0011319288,0.00054157665],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006524331,0.00029190234,0.00031872073,0.00012804876,0.00035372184,0.00011559889,0.00062643195,0.00027406748,0.002488911],"category_scores_gemma":[0.0004589506,0.0002703761,0.00018954944,0.00056636566,0.0004048655,0.000018336854,0.00018677796,0.0006112059,0.0002809872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037309858,0.000085562315,0.00024650083,0.00008563498,0.00014887103,0.000010300333,0.0003080087,0.00018071136,0.7822866,0.000014571693,0.19806442,0.014837846],"study_design_scores_gemma":[0.0026512954,0.00072314794,0.0017388511,0.000039674233,0.0000061541305,0.0000059694876,0.00023961603,0.00007427358,0.7324391,0.00007200302,0.2616524,0.00035752731],"about_ca_topic_score_codex":0.0028054651,"about_ca_topic_score_gemma":0.0010905485,"teacher_disagreement_score":0.063587986,"about_ca_system_score_codex":0.0002149785,"about_ca_system_score_gemma":0.0020538804,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W3005879958","doi":"10.1158/1538-7445.sabcs19-p1-19-06","title":"Abstract P1-19-06: Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2− advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Letrozole; Tamoxifen; Anastrozole; Internal medicine; Breast cancer; Oncology; Population; Quality of life (healthcare); Cancer; Palbociclib; Metastatic breast cancer; Gynecology; Confidence interval; Nursing","score_opus":0.09963595940985603,"score_gpt":0.39932718149679064,"score_spread":0.2996912220869346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005879958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977972,0.002422907,0.000010894703,0.014725704,0.00024713334,0.0041132267,0.00036849166,0.00007359104,0.00006606755],"genre_scores_gemma":[0.9965048,0.0004990333,0.00016315613,0.00062595255,0.00061123364,0.0013057964,0.00008193659,0.000120033095,0.00008805564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949075,0.00026550563,0.0008203518,0.0009852138,0.0021128177,0.00090861815],"domain_scores_gemma":[0.9969375,0.00054601434,0.00045716445,0.00087517744,0.00082875765,0.00035538553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004782009,0.00043084144,0.0009650453,0.00018043665,0.00020632373,0.00003800214,0.00049384777,0.00010479867,0.0006059307],"category_scores_gemma":[0.00038966376,0.00027812237,0.00014554992,0.0017676314,0.0005289486,0.00035135826,0.00026755684,0.0012770777,0.00000634011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16240463,0.00065538066,0.68678015,0.00008601873,0.00053987803,0.000049788796,0.002383306,0.00072407816,0.003018588,0.00000487939,0.00035568772,0.1429976],"study_design_scores_gemma":[0.08410944,0.0010238743,0.905658,0.00060126104,0.00004267219,0.0000025659392,0.00049535313,0.000007825285,0.003552541,0.000082573235,0.00410143,0.00032246643],"about_ca_topic_score_codex":0.0052317153,"about_ca_topic_score_gemma":0.0006284327,"teacher_disagreement_score":0.21887782,"about_ca_system_score_codex":0.0011168539,"about_ca_system_score_gemma":0.001331255,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W3005905875","doi":"10.1158/1538-7445.sabcs19-p6-13-02","title":"Abstract P6-13-02: Subcutaneous trastuzumab for the treatment of HER2+ breast cancer in Canada: A cost-minimization study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Roche (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Health care; Clinical trial; Cancer; Drug; Intensive care medicine; Pharmacology","score_opus":0.16501558405181768,"score_gpt":0.4549794697304116,"score_spread":0.2899638856785939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005905875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96570027,0.003919451,0.000014992237,0.020709664,0.00020034732,0.008162822,0.0010633968,0.000020881818,0.00020817317],"genre_scores_gemma":[0.98995405,0.0042845546,0.000010461087,0.00017985622,0.00050256384,0.004675283,0.000018038514,0.000072162446,0.00030303723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99616474,0.00018676663,0.0005322314,0.0005983406,0.0016159121,0.0009020356],"domain_scores_gemma":[0.9973736,0.0008545158,0.000087661785,0.0004995863,0.0007817289,0.00040292545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005559686,0.00023415107,0.00056523073,0.00016784038,0.0001703594,0.000036715646,0.0003965536,0.00007969145,0.0017384262],"category_scores_gemma":[0.00016723387,0.00016477816,0.00009586018,0.0011400804,0.00018584728,0.000054323456,0.00005659145,0.0005010345,0.0000072875177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.017816765,0.0028249891,0.2796374,0.0014605215,0.001031075,0.0012180434,0.020354547,0.0086976485,0.008473087,0.000015901653,0.021613969,0.636856],"study_design_scores_gemma":[0.017989863,0.010291244,0.8794374,0.00073532475,0.00027091685,0.00007776408,0.023530837,0.010391682,0.012492142,0.000019204805,0.0441312,0.00063241716],"about_ca_topic_score_codex":0.9223114,"about_ca_topic_score_gemma":0.9563795,"teacher_disagreement_score":0.6362236,"about_ca_system_score_codex":0.0076830843,"about_ca_system_score_gemma":0.014250693,"threshold_uncertainty_score":0.9991741},"labels":[],"label_agreement":null},{"id":"W3005908190","doi":"10.1158/1538-7445.sabcs19-gs1-01","title":"Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Clinical endpoint; Oncology; Pertuzumab; Breast cancer; Neratinib; Regimen; Palbociclib; Cancer; Clinical trial; Colorectal cancer","score_opus":0.048273422772037035,"score_gpt":0.38689826831232316,"score_spread":0.3386248455402861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005908190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97958714,0.0011285057,0.000030116522,0.012430813,0.000026269545,0.0045059104,0.0020331338,0.000056061337,0.0002020247],"genre_scores_gemma":[0.99476993,0.0003532458,0.00056229305,0.0010125181,0.00012772933,0.0021945091,0.00033863928,0.00011198587,0.00052916893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735355,0.00017557805,0.00027120428,0.00081387453,0.0006579921,0.00072776753],"domain_scores_gemma":[0.99788535,0.0005273722,0.000140339,0.00020758067,0.0005968092,0.00064254267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002721095,0.00043024815,0.0007943251,0.00016603226,0.00026695733,0.000082460436,0.00011150288,0.00006578412,0.00065556297],"category_scores_gemma":[0.00003875676,0.00026971806,0.0000406587,0.0005801526,0.0006553788,0.00020312492,0.000048839753,0.00045630307,0.0000024002925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3019784,0.0023688902,0.6533894,0.0021541447,0.005572942,0.00016922655,0.005171208,0.0000627164,0.0036904614,0.000042659853,0.014340174,0.011059762],"study_design_scores_gemma":[0.09657167,0.04139098,0.84716165,0.0013888885,0.0023910915,0.00010351459,0.0012550028,0.0002693046,0.005508694,0.00001496523,0.0031177811,0.0008264399],"about_ca_topic_score_codex":0.0025844679,"about_ca_topic_score_gemma":0.0030089177,"teacher_disagreement_score":0.20540674,"about_ca_system_score_codex":0.0003359008,"about_ca_system_score_gemma":0.0009111232,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W3005908275","doi":"10.1158/1538-7445.sabcs19-p4-09-09","title":"Abstract P4-09-09: Characteristics of stage 1 to 3 breast cancer patients with amplification of centromere of chromosome 17","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Breast cancer; Biology; Internal medicine; Chromosome; Medicine; Cancer; Genetics; Gene","score_opus":0.028654490511600187,"score_gpt":0.3046157314366322,"score_spread":0.275961240925032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005908275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953375,0.00013607884,0.000044202578,0.00033665213,0.000029599187,0.00028035938,0.003701448,0.0000023455896,0.00013181662],"genre_scores_gemma":[0.9991673,0.0001912714,0.00007154528,0.000029083234,0.00011215773,0.000053431744,0.00018725505,0.000016585636,0.00017131818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989523,0.000033900593,0.00028340664,0.00022062218,0.00030004146,0.00020972415],"domain_scores_gemma":[0.99873054,0.000011387949,0.00016848401,0.00023014462,0.0007491524,0.00011030095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105474086,0.00009135606,0.00018965919,0.00004688609,0.00003832269,0.000008650664,0.00021924265,0.00006156433,0.0003806558],"category_scores_gemma":[0.000029089733,0.00008033639,0.000037688682,0.00019356086,0.00011072574,0.0000064033916,0.00009459748,0.00008818233,0.000002809128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005021761,0.00013567103,0.1124147,0.00038948806,0.00008766133,3.9442028e-7,0.0004611788,0.00012595898,0.88337106,0.000076377146,0.00037209567,0.0020632448],"study_design_scores_gemma":[0.00046189502,0.00032883137,0.6659206,0.00006940609,0.00001068845,2.3203987e-7,0.00015998229,0.000003897927,0.33094862,0.0000024562323,0.0020006928,0.00009267076],"about_ca_topic_score_codex":0.0006019592,"about_ca_topic_score_gemma":0.000050899194,"teacher_disagreement_score":0.5535059,"about_ca_system_score_codex":0.00003867009,"about_ca_system_score_gemma":0.00030005677,"threshold_uncertainty_score":0.4167914},"labels":[],"label_agreement":null},{"id":"W3005918636","doi":"10.1158/1538-7445.sabcs19-p3-08-48","title":"Abstract P3-08-48: Adiposity, comorbidities, and function in patients with early breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Adipose tissue; Body mass index; Cancer; Internal medicine; Chemotherapy; Body surface area","score_opus":0.06294545102257085,"score_gpt":0.3519752532015175,"score_spread":0.2890298021789467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005918636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947269,0.0010944802,0.0000034390307,0.0027795802,0.000109105225,0.0005286998,0.000208524,0.000026368045,0.00052291073],"genre_scores_gemma":[0.9984625,0.00047140388,0.000004818796,0.00039481395,0.0003147208,0.00010442625,0.00002522321,0.000030963703,0.00019113431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841917,0.000034476427,0.00015750667,0.00034666812,0.0006463655,0.00039580578],"domain_scores_gemma":[0.9992008,0.00003101897,0.000036512618,0.00015487193,0.00025344986,0.00032332196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014411958,0.00012890229,0.0002363352,0.00012980585,0.00009564972,0.00005229604,0.00008184151,0.00007527253,0.0013082317],"category_scores_gemma":[0.000012171929,0.00010167955,0.000025640113,0.00044980098,0.00017317322,0.00015725064,0.00006814433,0.0006251553,0.000026182115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003765735,0.000078489466,0.96358293,0.00017992125,0.00006249106,0.000017663997,0.0005929838,0.000008018184,0.0005187587,0.000013203062,0.007056622,0.02412321],"study_design_scores_gemma":[0.0029340754,0.0004908758,0.99041367,0.00023519227,0.000026759002,0.000001328611,0.00009644174,0.000015961843,0.00019496815,0.000009461658,0.0054647224,0.000116517585],"about_ca_topic_score_codex":0.023939746,"about_ca_topic_score_gemma":0.0032056994,"teacher_disagreement_score":0.026830792,"about_ca_system_score_codex":0.00035561822,"about_ca_system_score_gemma":0.0003910618,"threshold_uncertainty_score":0.9996047},"labels":[],"label_agreement":null},{"id":"W3005965296","doi":"10.1158/1538-7445.sabcs19-p2-08-23","title":"Abstract P2-08-23: A population-based study examining the epidemiology, treatment patterns and resource utilization by stage in Ontario patients with HER2+ breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Cohort; Epidemiology; Population; Health care; Cancer; Cancer registry; Internal medicine; Disease; Oncology; Demography; Gerontology; Environmental health","score_opus":0.1886495615662797,"score_gpt":0.4197485354254959,"score_spread":0.23109897385921618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005965296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396473,0.00059327215,0.000050292085,0.003270452,0.000022621289,0.0018114634,0.0002304754,0.00003007774,0.00002659261],"genre_scores_gemma":[0.99794745,0.00003976632,0.00002508126,0.00069792947,0.00008066477,0.00076916703,0.00017036969,0.00004621544,0.00022334231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978149,0.00033763752,0.00033346907,0.00058121706,0.00043609293,0.0004967169],"domain_scores_gemma":[0.99876386,0.00042011452,0.00012188193,0.00031413793,0.00016843619,0.0002115866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043142,0.00022133217,0.00040003494,0.00010317841,0.00018273982,0.000024834702,0.0001284754,0.00006718587,0.00056026067],"category_scores_gemma":[0.00007288474,0.00014067192,0.0000242906,0.0003487932,0.000119908014,0.00010424255,0.000047255056,0.0005139439,0.0000025829675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021328665,0.00029804607,0.9666872,0.00005793458,0.00008948429,0.0000102423555,0.0033306507,0.0011180729,0.00005696768,0.0000016037678,0.000050792016,0.026166162],"study_design_scores_gemma":[0.0051239464,0.0009232798,0.98951787,0.00023475452,0.000028172532,7.689193e-7,0.0018486616,0.00013343227,0.000045466157,0.0000033568745,0.0020085254,0.0001317915],"about_ca_topic_score_codex":0.2807229,"about_ca_topic_score_gemma":0.35339835,"teacher_disagreement_score":0.07267546,"about_ca_system_score_codex":0.0018330128,"about_ca_system_score_gemma":0.000504158,"threshold_uncertainty_score":0.72406685},"labels":[],"label_agreement":null},{"id":"W3006070395","doi":"10.1158/1538-7445.sabcs19-p2-11-10","title":"Abstract P2-11-10: Estrogen drives the therapeutic hormonal response in ER+ breast cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Medicine; Estrogen; Breast cancer; Internal medicine; Estrogen receptor; Endocrinology; Concordance; Cancer; Oncology; Apoptosis; Menopause; Transcriptome; Estrogen receptor alpha; Cancer research; Gene expression; Biology; Gene","score_opus":0.037649745634480807,"score_gpt":0.3551057349982283,"score_spread":0.31745598936374747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006070395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97949183,0.012801361,0.000005737563,0.0067911088,0.000054533022,0.00035819729,0.00004424356,0.00001257401,0.00044040658],"genre_scores_gemma":[0.99735063,0.001332822,0.00000998155,0.00041896448,0.00033334058,0.00014946608,0.000023349845,0.000034267956,0.0003472029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980507,0.0004164441,0.00017822784,0.00042372235,0.00037781594,0.0005530958],"domain_scores_gemma":[0.9992366,0.00011012847,0.000039355862,0.00030877077,0.00011097929,0.00019418313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079878274,0.00016020711,0.0001399492,0.000060489674,0.00016970685,0.000051731844,0.00048201403,0.0001885332,0.0001822871],"category_scores_gemma":[0.000094883384,0.00011363021,0.00009289996,0.00038352233,0.0003344557,0.000006359356,0.00016102847,0.0005401651,0.000060729366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042259884,0.000031989835,0.0025539023,0.000020527183,0.00010418006,0.00004124035,0.00036435836,0.00049320486,0.98075175,0.000058390517,0.0062001827,0.0051542977],"study_design_scores_gemma":[0.0036542462,0.0021272756,0.13976625,0.00014678962,0.000046757243,0.00008390075,0.0016574081,0.0005545544,0.69886094,0.00014781926,0.15209977,0.0008542797],"about_ca_topic_score_codex":0.00033876993,"about_ca_topic_score_gemma":0.00008242237,"teacher_disagreement_score":0.28189078,"about_ca_system_score_codex":0.0001202472,"about_ca_system_score_gemma":0.00086148246,"threshold_uncertainty_score":0.46337056},"labels":[],"label_agreement":null},{"id":"W3006071177","doi":"10.1158/1538-7445.sabcs19-p4-10-20","title":"Abstract P4-10-20: Protein quantitation assays for AKT and PTEN to better understand sensitivity and resistance of breast cancer patients to treatment with AKT inhibitor capivasertib","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"PTEN; Fulvestrant; Breast cancer; Context (archaeology); PI3K/AKT/mTOR pathway; Medicine; Protein kinase B; Cancer research; Oncology; Cancer; Internal medicine; Population; Biology; Estrogen receptor; Signal transduction; Genetics","score_opus":0.05697374921549083,"score_gpt":0.35069392414751976,"score_spread":0.29372017493202895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006071177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991781,0.0006158906,0.00037627053,0.004701365,0.000028861774,0.0013741237,0.0010661454,0.0000069660514,0.000049377824],"genre_scores_gemma":[0.9981398,0.00005805781,0.0005810452,0.00025186152,0.00023050768,0.00046681153,0.00004607069,0.000036901532,0.00018896506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847174,0.000083230116,0.0001828426,0.000570404,0.00034129713,0.00035047953],"domain_scores_gemma":[0.99891555,0.000052822976,0.00006634704,0.00019387767,0.000515172,0.00025625655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026093156,0.00017322408,0.00021242585,0.00006195333,0.00011599911,0.000044706867,0.000078529716,0.00009422751,0.000021337528],"category_scores_gemma":[0.000068316534,0.00014757457,0.0000311562,0.00017993922,0.0001303712,0.000013272476,0.00007296526,0.000087735716,0.000001435563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039443094,0.0000758532,0.0064080013,0.00026968203,0.00010146766,0.000003823442,0.00050913595,0.00006670346,0.9827082,0.000011499533,0.003214624,0.0026866687],"study_design_scores_gemma":[0.0021991944,0.002571322,0.012748776,0.00033765586,0.00002846722,8.2946525e-7,0.00021012613,0.00002806928,0.974555,0.000027598784,0.006996167,0.00029675118],"about_ca_topic_score_codex":0.0006921527,"about_ca_topic_score_gemma":0.004885872,"teacher_disagreement_score":0.008153189,"about_ca_system_score_codex":0.0002126052,"about_ca_system_score_gemma":0.00029825192,"threshold_uncertainty_score":0.6017916},"labels":[],"label_agreement":null},{"id":"W3006105063","doi":"10.1158/1538-7445.sabcs19-p4-10-29","title":"Abstract P4-10-29: Identifying novel molecular markers of response to trastuzumab in metastatic breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; McMaster University; Ontario Institute for Cancer Research; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Interquartile range; Internal medicine; Breast cancer; Metastatic breast cancer; Cancer; Proportional hazards model; Cohort; Retrospective cohort study","score_opus":0.12124993240982997,"score_gpt":0.450419966527099,"score_spread":0.32917003411726903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006105063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97795904,0.0027212233,0.0010296131,0.016529005,0.0000812713,0.0011107452,0.00027303508,0.00004127379,0.00025479292],"genre_scores_gemma":[0.9968744,0.00012378597,0.0012270623,0.00076114334,0.00011503874,0.0005126592,0.00000648533,0.00008856374,0.0002908421],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965788,0.00020286947,0.0005223439,0.00063964725,0.0012616845,0.0007946591],"domain_scores_gemma":[0.9981048,0.00029613683,0.00010041041,0.00043269977,0.0005374366,0.0005285333],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012502484,0.00024356725,0.0005830238,0.0005237639,0.00006589133,0.000031486197,0.00036715,0.00007067706,0.002798118],"category_scores_gemma":[0.00043674256,0.00023569557,0.0001225803,0.0018693374,0.000251959,0.00018216604,0.00015481154,0.0006952922,0.000048550806],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032680444,0.00015459572,0.0012714196,0.00065749424,0.0002093726,0.0002282004,0.0019559034,0.001233402,0.93758106,0.000029117116,0.0004158305,0.023583129],"study_design_scores_gemma":[0.016396211,0.001375178,0.50854737,0.0042087045,0.00016235004,0.00011867134,0.0058033494,0.00050277886,0.4449353,0.00017373524,0.016854985,0.0009213894],"about_ca_topic_score_codex":0.001979669,"about_ca_topic_score_gemma":0.00025017274,"teacher_disagreement_score":0.50727594,"about_ca_system_score_codex":0.0011172709,"about_ca_system_score_gemma":0.001424346,"threshold_uncertainty_score":0.99811345},"labels":[],"label_agreement":null},{"id":"W3006113638","doi":"10.1158/1538-7445.sabcs19-p2-13-16","title":"Abstract P2-13-16: A multidisciplinary approach to implement personalized multifaceted care plans in standard breast cancer care: A quality improvement project","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Multidisciplinary approach; Shared care; Workflow; Cancer; Quality management; Health care; Collaborative Care; Nursing; Medical emergency; Family medicine; Primary care; Internal medicine; Database; Operations management","score_opus":0.27900016627866875,"score_gpt":0.513558349529831,"score_spread":0.2345581832511623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006113638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804947,0.0035033764,0.00014207354,0.005681427,0.000098937395,0.00469001,0.0035958856,0.00008824545,0.0017053935],"genre_scores_gemma":[0.9944756,0.0003334001,0.00057738565,0.00076337904,0.00040422552,0.0030819187,0.00018555105,0.00005900983,0.00011952236],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99444604,0.0002091084,0.0006713092,0.0011660765,0.0022193666,0.0012881237],"domain_scores_gemma":[0.9975622,0.00007395225,0.00010571309,0.0004855098,0.0010709428,0.0007016544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009885983,0.00036544848,0.00072664855,0.00027907992,0.0002852394,0.00009393247,0.0004360751,0.00015678699,0.000560727],"category_scores_gemma":[0.00011324145,0.00031628573,0.00018250626,0.0012853212,0.00014716251,0.00015229826,0.0003540429,0.0010620442,0.000017349585],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049900644,0.0005517653,0.2667032,0.008583141,0.0006040267,0.00042881942,0.30661786,0.002026308,0.08956996,0.00011377718,0.012404219,0.2624963],"study_design_scores_gemma":[0.023320828,0.0030656203,0.33349225,0.0025654275,0.00013914777,0.000022906737,0.5912007,0.0006865503,0.01988742,0.000010267333,0.024164077,0.001444822],"about_ca_topic_score_codex":0.0776178,"about_ca_topic_score_gemma":0.014544421,"teacher_disagreement_score":0.28458282,"about_ca_system_score_codex":0.0052897898,"about_ca_system_score_gemma":0.0031109592,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W3006137009","doi":"10.1158/1538-7445.sabcs19-es2-1","title":"Abstract ES2-1: Guiding decisions to omit radiotherapy after breast-conserving surgery for DCIS. Can genomic biomarkers help?","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast-conserving surgery; Medicine; Breast cancer; Radiation therapy; Ductal carcinoma; Oncology; Internal medicine; Cancer; General surgery; Mastectomy","score_opus":0.10950508050425398,"score_gpt":0.3802514741012207,"score_spread":0.27074639359696673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006137009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96732956,0.00749392,0.0006915793,0.022817135,0.00021188018,0.000724953,0.00063314504,0.00002388055,0.000073949646],"genre_scores_gemma":[0.9932571,0.0016676189,0.0008135801,0.0018850875,0.0009669692,0.0011937118,0.00005727043,0.00007838057,0.00008025881],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978944,0.000080965656,0.0002784005,0.00072208693,0.00029502338,0.0007291302],"domain_scores_gemma":[0.9985756,0.00030379914,0.00004909677,0.00040537387,0.00029337476,0.0003727214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005144651,0.00022955352,0.0002952895,0.00014164335,0.00027454874,0.00007763008,0.0003418588,0.00011583132,0.00015583646],"category_scores_gemma":[0.00029983334,0.00021837835,0.00019764145,0.00033548463,0.00013060437,0.0000065021377,0.00024569425,0.000101600635,0.000017482751],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039093774,0.000059194772,0.038390677,0.000091303846,0.0007747804,0.000026455416,0.00053995143,0.00007260571,0.7978098,0.0000053836116,0.09871413,0.05960635],"study_design_scores_gemma":[0.0035143842,0.00042700444,0.51902884,0.0004820554,0.00009224079,0.000047040627,0.0011442779,0.00006461001,0.22401088,0.00010819985,0.24972756,0.0013528925],"about_ca_topic_score_codex":0.0008868247,"about_ca_topic_score_gemma":0.00080780196,"teacher_disagreement_score":0.5737989,"about_ca_system_score_codex":0.0002886888,"about_ca_system_score_gemma":0.00056212454,"threshold_uncertainty_score":0.8905211},"labels":[],"label_agreement":null},{"id":"W3006142632","doi":"10.1158/1538-7445.sabcs19-p2-18-01","title":"Abstract P2-18-01: Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Internal medicine; Oncology; Adverse effect; Population; Breast-conserving surgery; Cohort; Cancer; Stage (stratigraphy); Radiation therapy; Adjuvant therapy; Cancer registry; Gynecology; Mastectomy","score_opus":0.04345817036291234,"score_gpt":0.3305445766456449,"score_spread":0.2870864062827326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006142632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909997,0.002140337,0.000037302398,0.0045437827,0.00001063901,0.000828516,0.0013852188,0.0000379985,0.000016488433],"genre_scores_gemma":[0.99462444,0.0027726828,0.00009055573,0.0004808708,0.00013697537,0.0010745095,0.0006775791,0.00008743841,0.000054963348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689656,0.00036489413,0.00034075245,0.0009159515,0.0007071185,0.000774697],"domain_scores_gemma":[0.9984487,0.00015327334,0.00021824807,0.00042802966,0.0004872567,0.00026443775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037544587,0.00040154046,0.00068607245,0.0002961016,0.00017098182,0.00010297137,0.00020929793,0.00010138111,0.0002934315],"category_scores_gemma":[0.00002010508,0.000277644,0.000090746486,0.0019657305,0.00020719957,0.000047822014,0.000047840498,0.00029020407,0.0000022400848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062822185,0.00053072633,0.8728027,0.000037335594,0.0028409497,0.00009451415,0.0009337377,0.0031865817,0.040437914,6.53712e-7,0.0001613385,0.016151402],"study_design_scores_gemma":[0.006180451,0.0009927638,0.9733311,0.000112000744,0.000067038614,0.000007675617,0.0003537106,0.00006300988,0.018398073,0.0000010230737,0.00010675837,0.00038638234],"about_ca_topic_score_codex":0.06882126,"about_ca_topic_score_gemma":0.012713731,"teacher_disagreement_score":0.10052845,"about_ca_system_score_codex":0.0007401667,"about_ca_system_score_gemma":0.0009617852,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W3006147702","doi":"10.1158/1538-7445.sabcs19-p1-19-10","title":"Abstract P1-19-10: Safety and efficacy of abemaciclib plus endocrine therapy (ET) in elderly patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+, HER2-) advanced breast cancer: An age-specific subgroup analysis of MONARCH 2 and 3 trials","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Internal medicine; Fulvestrant; Breast cancer; Letrozole; Anastrozole; Oncology; Metastatic breast cancer; Placebo; Tolerability; Adverse effect; Cancer; Tamoxifen; Pathology","score_opus":0.07795745802238126,"score_gpt":0.39759211947698336,"score_spread":0.3196346614546021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006147702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986449,0.006685913,0.000044624652,0.0018049615,0.000033840937,0.002291267,0.002590389,0.000039625884,0.000060374394],"genre_scores_gemma":[0.98138565,0.017102586,0.00048316104,0.00009482146,0.00018111468,0.00027184232,0.0003361193,0.000096119504,0.000048561153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99464715,0.00095745164,0.0012258599,0.0011083423,0.0012789917,0.00078223407],"domain_scores_gemma":[0.99577075,0.0014503584,0.0005784313,0.0004716167,0.0010960805,0.0006327772],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010553185,0.0004964029,0.002186894,0.000771704,0.00017530253,0.000042978896,0.00030976685,0.0001370951,0.0016040601],"category_scores_gemma":[0.00028564388,0.00039520793,0.00018007896,0.002294869,0.0011189174,0.00050357543,0.000125693,0.0008438066,0.0000015367148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16770923,0.0011837819,0.17039102,0.00057100377,0.003310665,0.00005774184,0.013784127,0.00057831843,0.28366065,0.00011572104,0.0000953652,0.35854235],"study_design_scores_gemma":[0.024648454,0.0031285905,0.94808173,0.00036865685,0.00014155624,0.0000024170981,0.0009505365,0.00002800955,0.021657297,0.000024825882,0.00058589235,0.00038201694],"about_ca_topic_score_codex":0.004089509,"about_ca_topic_score_gemma":0.0006207783,"teacher_disagreement_score":0.7776907,"about_ca_system_score_codex":0.0007006781,"about_ca_system_score_gemma":0.00047935074,"threshold_uncertainty_score":0.99985},"labels":[],"label_agreement":null},{"id":"W3006168572","doi":"10.1158/1538-7445.sabcs19-p4-01-12","title":"Abstract P4-01-12: The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Circulating tumor cell; Medicine; Breast cancer; Concordance; Chemotherapy; Oncology; Internal medicine; Neoadjuvant therapy; Cancer; Intraclass correlation; Metastasis","score_opus":0.04330005366249979,"score_gpt":0.344908189678758,"score_spread":0.30160813601625824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006168572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98571575,0.00045111345,0.0000044845633,0.012395339,0.00008227044,0.00079985627,0.00015666941,0.000016940518,0.0003775735],"genre_scores_gemma":[0.9977647,0.00044620977,0.00004434545,0.0012005654,0.00022956787,0.00013436016,0.000006525875,0.000049396564,0.00012434389],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973363,0.00023054454,0.00037467558,0.00037511432,0.0011419314,0.00054141],"domain_scores_gemma":[0.9983895,0.00052542874,0.00023536684,0.00024446993,0.00041824972,0.0001869884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001348935,0.00015975584,0.00037671698,0.00013336615,0.00011190614,0.000037455764,0.00017889266,0.00004837008,0.00057650264],"category_scores_gemma":[0.00019629402,0.00011048781,0.00007955583,0.0007977852,0.00010103256,0.00009051774,0.00005480648,0.0006247971,0.0000090444455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021619184,0.00038791908,0.47459593,0.00095759565,0.00027487558,0.000115351795,0.0052839383,0.0014958531,0.4763628,0.000009712067,0.0041812835,0.014715534],"study_design_scores_gemma":[0.008006796,0.00059745467,0.89715415,0.0012211935,0.00005458881,0.0000056431136,0.0011173851,0.00022321475,0.08822426,0.000010046854,0.0031604464,0.00022481216],"about_ca_topic_score_codex":0.00347266,"about_ca_topic_score_gemma":0.0010865555,"teacher_disagreement_score":0.42255822,"about_ca_system_score_codex":0.0012379786,"about_ca_system_score_gemma":0.001489908,"threshold_uncertainty_score":0.63123},"labels":[],"label_agreement":null},{"id":"W3006188747","doi":"10.1158/1538-7445.sabcs19-p3-10-07","title":"Abstract P3-10-07: Receptor-mediated chemotherapy using a new Docetaxel-peptide conjugate for Sortilin-positive triple-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Internalization; Cancer research; Docetaxel; Flow cytometry; Triple-negative breast cancer; Cancer; Breast cancer; Nude mouse; Clonogenic assay; Biology; Conjugate; Cancer cell; Paclitaxel; In vitro; Peptide; Molecular biology; Cell; Medicine; Internal medicine; Biochemistry","score_opus":0.07602323043770456,"score_gpt":0.40753736125687284,"score_spread":0.33151413081916825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006188747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950613,0.0043527083,0.00040008762,0.0072705233,0.00019207594,0.0027883637,0.0048633656,0.000043877182,0.0005828707],"genre_scores_gemma":[0.986591,0.0044038882,0.00054348167,0.0010870388,0.002198731,0.0009095971,0.00053793995,0.00014083825,0.0035875216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970103,0.00013041002,0.000326035,0.00089788414,0.0005959554,0.0010394405],"domain_scores_gemma":[0.9979203,0.00010987398,0.00012312792,0.0003275144,0.000769494,0.00074973307],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003296451,0.00031771197,0.0003612405,0.00009588012,0.0002971939,0.00011878051,0.0004150004,0.000198495,0.0026014305],"category_scores_gemma":[0.0002383798,0.0002939738,0.00020578915,0.00044427215,0.00030356387,0.000024896299,0.00015087471,0.00038603612,0.000096782314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012115273,0.00013870464,0.0010704882,0.00011961629,0.0008103231,0.000015656586,0.0004177997,0.00013952627,0.8869084,0.0000073847173,0.08346786,0.014788928],"study_design_scores_gemma":[0.011352771,0.001242933,0.0029649197,0.00020448446,0.000040431274,0.0000072614084,0.00029473015,0.00047448222,0.92307335,0.00011591402,0.05962289,0.0006058132],"about_ca_topic_score_codex":0.007875685,"about_ca_topic_score_gemma":0.0013539349,"teacher_disagreement_score":0.036164936,"about_ca_system_score_codex":0.00039684764,"about_ca_system_score_gemma":0.0023958504,"threshold_uncertainty_score":0.99995124},"labels":[],"label_agreement":null},{"id":"W3006363508","doi":"10.1158/1538-7445.sabcs19-ot3-09-01","title":"Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Mastectomy; Cohort; Ductal carcinoma; Breast-conserving surgery; Cancer registry; Prospective cohort study; Gynecology; Cancer","score_opus":0.1042511513432157,"score_gpt":0.40666343630857293,"score_spread":0.3024122849653572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006363508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848967,0.005164596,0.00012719278,0.0055448245,0.000099283854,0.0018943774,0.0006648341,0.000016611437,0.001591577],"genre_scores_gemma":[0.9960035,0.0017047258,0.00031565156,0.00015413342,0.00021438008,0.0010887892,0.000061016675,0.000029336677,0.00042844636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986229,0.000039007184,0.000186516,0.0005084946,0.00028171824,0.0003613663],"domain_scores_gemma":[0.99920744,0.00004472203,0.00005641322,0.00033579132,0.00020419691,0.00015141474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014581851,0.00013782924,0.00018228627,0.00005954468,0.0000690318,0.000022566386,0.00021349214,0.00006254701,0.000037619233],"category_scores_gemma":[0.00014586581,0.00012949378,0.00008511683,0.00025338595,0.00017321801,0.000007954234,0.00022861706,0.00013181182,0.0000062384165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04121749,0.001994092,0.45470318,0.0046923985,0.0031190938,0.00038691948,0.0023854997,0.0009275457,0.20929454,0.0022425042,0.18124121,0.09779552],"study_design_scores_gemma":[0.0059315325,0.00071184686,0.7149416,0.00033797222,0.00011274875,0.0000012481388,0.000793385,0.0000638617,0.11637492,0.0006266327,0.15954255,0.00056170253],"about_ca_topic_score_codex":0.000300242,"about_ca_topic_score_gemma":0.0002881376,"teacher_disagreement_score":0.2602384,"about_ca_system_score_codex":0.00015986538,"about_ca_system_score_gemma":0.00020238307,"threshold_uncertainty_score":0.5280603},"labels":[],"label_agreement":null},{"id":"W3006642698","doi":"10.1158/1538-7445.sabcs19-p1-15-09","title":"Abstract P1-15-09: What are the outcomes of importance for patient education in breast cancer?","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psychological intervention; Breast cancer; Qualitative research; Family medicine; Population; Focus group; Nursing; Cancer; Consistency (knowledge bases); Patient education; Internal medicine","score_opus":0.09836756802210798,"score_gpt":0.36236592382629534,"score_spread":0.26399835580418735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006642698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416872,0.021989306,0.00002025556,0.032357346,0.00062271353,0.00085630047,0.000904898,0.000010353454,0.001551623],"genre_scores_gemma":[0.9907685,0.0062765107,0.00002735754,0.0017276424,0.00031753094,0.0006653493,0.000009104051,0.000031719366,0.00017626856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983411,0.00001589643,0.0006776362,0.00042080303,0.000084723055,0.00045986386],"domain_scores_gemma":[0.9987867,0.00014234257,0.00043706346,0.00031738402,0.00018031389,0.00013623784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005995951,0.0001433375,0.00045225283,0.00015299584,0.00011037924,0.00011350026,0.0004288549,0.000094476716,0.00070530135],"category_scores_gemma":[0.00017789997,0.00012890811,0.000120376826,0.00035543164,0.00015409687,0.00059543067,0.00007368023,0.0003118922,0.000042382737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025262576,0.00015242146,0.8542959,0.00022856788,0.00007520101,0.0000011845774,0.0019147112,0.00033347995,0.00011489815,0.012992988,0.023249112,0.106388904],"study_design_scores_gemma":[0.0006472653,0.00007874192,0.92874986,0.00018293131,0.0000047722415,5.447709e-7,0.0031836894,0.0001831476,0.00057884183,0.008729207,0.057374492,0.00028649648],"about_ca_topic_score_codex":0.00333675,"about_ca_topic_score_gemma":0.0018585734,"teacher_disagreement_score":0.10610241,"about_ca_system_score_codex":0.00045653322,"about_ca_system_score_gemma":0.0006048208,"threshold_uncertainty_score":0.77225554},"labels":[],"label_agreement":null},{"id":"W3007141125","doi":"10.1158/1538-7445.sabcs19-ot1-08-08","title":"Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Tolerability; Internal medicine; Taxane; Oncology; Metastatic breast cancer; Cohort; Triple-negative breast cancer; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Clinical trial; Adverse effect; Immunotherapy","score_opus":0.05992016180778357,"score_gpt":0.40329152375285165,"score_spread":0.34337136194506807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007141125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862238,0.0011201437,0.000005390354,0.0015881222,0.000103356295,0.007830806,0.0030907087,0.000025025274,0.000012626753],"genre_scores_gemma":[0.9953014,0.0004158766,0.00005769002,0.00021394514,0.000079297184,0.0036300805,0.00013919862,0.00009813629,0.00006432205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951421,0.0005215309,0.0009037547,0.0010164264,0.0015338933,0.00088230346],"domain_scores_gemma":[0.9969817,0.00060655497,0.00043287643,0.00029361525,0.0011844306,0.0005008383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037041996,0.000598604,0.0013395905,0.0006938346,0.0001286994,0.000056849105,0.00025228882,0.000080484584,0.0009114341],"category_scores_gemma":[0.000087706874,0.00041713155,0.000085668966,0.0014134477,0.00041591906,0.0003588799,0.00009505608,0.0009223596,0.0000034983975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07189591,0.017163906,0.8694117,0.0006432175,0.001515518,0.00010420146,0.009560316,0.0002435339,0.00074566924,0.0000011037463,0.00022791442,0.028487032],"study_design_scores_gemma":[0.17687535,0.0076957387,0.81053185,0.0007447702,0.0003469658,0.0000018941018,0.002146976,0.00066467485,0.0006026321,0.0000041427593,0.00003337609,0.00035161627],"about_ca_topic_score_codex":0.028443038,"about_ca_topic_score_gemma":0.021507122,"teacher_disagreement_score":0.10497945,"about_ca_system_score_codex":0.0015489352,"about_ca_system_score_gemma":0.0008124439,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W3007802601","doi":"","title":"Males have a worse prognosis than females in chronic lymphocytic leukemia and this may be related to IgVH gene usage and mutational status.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Incidence (geometry); Population; Cancer registry; CD38; Cancer; Relative survival; Leukemia; Oncology; Biology; Genetics","score_opus":0.10856324353903613,"score_gpt":0.4088365153981463,"score_spread":0.3002732718591102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007802601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478013,0.010704272,0.0000038553253,0.0013530396,0.000040706316,0.0017482039,0.000056349792,0.000055317916,0.0012581054],"genre_scores_gemma":[0.98010755,0.009166411,0.0004326064,0.00015810659,0.00014037109,0.0008561587,0.000050992494,0.00007575031,0.009012081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952628,0.00032138458,0.00048128565,0.00092223147,0.0015634682,0.0014488423],"domain_scores_gemma":[0.99762267,0.0006501781,0.000054210454,0.00046555622,0.0003803305,0.00082704844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001306825,0.00028703708,0.0005042203,0.0009027147,0.00033534536,0.000075348675,0.00022565627,0.0002447968,0.00066942343],"category_scores_gemma":[0.0006314822,0.000258634,0.00006157961,0.0011975782,0.0012512685,0.00019099217,0.00043454202,0.000763702,0.000076981385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009488895,0.00045080108,0.7229226,0.005796592,0.0012176279,0.02233998,0.054421492,0.004049311,0.11742223,0.0013627139,0.020141637,0.040386107],"study_design_scores_gemma":[0.08817275,0.0037143133,0.69770837,0.0041843685,0.00016805434,0.0062858206,0.0039463714,0.07679606,0.09453412,0.0005963209,0.022011759,0.0018817203],"about_ca_topic_score_codex":0.01789621,"about_ca_topic_score_gemma":0.0034334594,"teacher_disagreement_score":0.07868385,"about_ca_system_score_codex":0.10286837,"about_ca_system_score_gemma":0.059169266,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W3009044127","doi":"10.1158/1538-7445.sabcs19-p1-10-08","title":"Abstract P1-10-08: Assessing immune biomarkers of response to anthracyclines in breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Tumor microenvironment; Immunotherapy; Internal medicine; Chemotherapy; Trastuzumab; Tumor-infiltrating lymphocytes; Immune system; Triple-negative breast cancer; Tissue microarray; Cancer; Immunology","score_opus":0.10412821195878418,"score_gpt":0.45845928599160013,"score_spread":0.35433107403281594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009044127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94214916,0.0052352636,0.000005400525,0.051096395,0.0001622316,0.0006389475,0.00014116698,0.000032612705,0.00053884304],"genre_scores_gemma":[0.9968511,0.0015255591,0.000095803895,0.0006638416,0.0002710812,0.00017265009,0.000008856725,0.000049129376,0.00036201565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99724096,0.00024163477,0.00059547747,0.00048907695,0.0008102576,0.00062259316],"domain_scores_gemma":[0.9984541,0.00034775084,0.00010612605,0.00038710714,0.00039564443,0.00030929476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018851816,0.00019305504,0.00048452444,0.00048399516,0.000102436454,0.00005339841,0.00030200576,0.00013138418,0.0041732118],"category_scores_gemma":[0.00031304266,0.0001688897,0.00014180296,0.0020870552,0.00034860586,0.0001805771,0.00011737358,0.00046534097,0.00003323591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051756512,0.00014639499,0.016792744,0.0003302007,0.0001590857,0.00008366036,0.0007992105,0.000021888654,0.8704169,0.0000014390814,0.0077263247,0.051765632],"study_design_scores_gemma":[0.0041694087,0.00035287076,0.8150082,0.0016988672,0.00002160592,0.000013013684,0.0013692944,0.000070646405,0.15905568,0.000004965701,0.017997056,0.00023836805],"about_ca_topic_score_codex":0.0057142465,"about_ca_topic_score_gemma":0.00024511674,"teacher_disagreement_score":0.7982155,"about_ca_system_score_codex":0.00055077305,"about_ca_system_score_gemma":0.0014056428,"threshold_uncertainty_score":0.9967371},"labels":[],"label_agreement":null},{"id":"W3009236223","doi":"10.1158/1538-7445.sabcs19-p6-05-05","title":"Abstract P6-05-05: The estrogen switch: Estrogen receptor alpha levels determine the proliferative response to estrogen","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of Alberta","funders":"","keywords":"Estrogen; Estrogen receptor alpha; Chromatin; Chromatin immunoprecipitation; Estrogen receptor; Cancer research; Biology; Estrogen receptor beta; Breast cancer; Molecular biology; Internal medicine; Cancer; Endocrinology; DNA; Medicine; Gene expression; Gene; Promoter; Genetics","score_opus":0.07531147079304255,"score_gpt":0.3783676131335623,"score_spread":0.30305614234051975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009236223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96775675,0.0049346937,0.000057898782,0.024910286,0.00018029823,0.0017409251,0.00016748141,0.000036489768,0.00021520504],"genre_scores_gemma":[0.9948929,0.00036814014,0.0001645152,0.0017426582,0.0011277687,0.0006764138,0.00004658621,0.00009064815,0.0008903505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959999,0.0010470627,0.0003777555,0.0008260749,0.0007486739,0.0010005388],"domain_scores_gemma":[0.9978075,0.00029614786,0.000101024445,0.00084429927,0.00039537586,0.0005556462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019912317,0.00036367282,0.0002850054,0.000072147566,0.00065749435,0.00017128025,0.0012347562,0.00030033692,0.0001581783],"category_scores_gemma":[0.0009294764,0.00021962654,0.00022479154,0.0006416504,0.00040820162,0.000014506262,0.00057777856,0.00096725696,0.0003156029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002804442,0.000050144594,0.00046121387,0.000023863731,0.00028028915,0.000050604696,0.0010968971,0.00016427063,0.962041,0.00007215405,0.025753878,0.0072012097],"study_design_scores_gemma":[0.0007841276,0.001358927,0.0010521688,0.000041285166,0.00003248972,0.000035489178,0.0004596138,0.00005765554,0.86198723,0.00002483659,0.13386813,0.0002980273],"about_ca_topic_score_codex":0.00010844742,"about_ca_topic_score_gemma":0.000018384262,"teacher_disagreement_score":0.10811425,"about_ca_system_score_codex":0.00011112893,"about_ca_system_score_gemma":0.0011836556,"threshold_uncertainty_score":0.89561105},"labels":[],"label_agreement":null},{"id":"W3009580144","doi":"10.1158/1538-7445.sabcs19-p4-07-02","title":"Abstract P4-07-02: Clinicopathological features and BRCA 1/2 status in a large prospective cohort of young women with breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Biomarker; Internal medicine; Prospective cohort study; Cancer; Cohort; BRCA mutation; Disease; Gynecology; Pathology; Biology","score_opus":0.028793261531042048,"score_gpt":0.37605361464011966,"score_spread":0.3472603531090776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009580144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939942,0.0034590792,0.000012511643,0.00073421083,0.000044088192,0.00056339847,0.00052226125,0.000008216103,0.000662081],"genre_scores_gemma":[0.9959803,0.002584523,0.00007938386,0.00018075704,0.00021978567,0.00078942534,0.000019762787,0.000027569355,0.0001184497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998179,0.000093177114,0.00021144052,0.0005863661,0.00035233144,0.000577637],"domain_scores_gemma":[0.9991432,0.000032262356,0.000068521535,0.00022572388,0.00034459235,0.00018571607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005301562,0.00014140522,0.0002346389,0.000063370746,0.00007521061,0.000030540603,0.00018898344,0.00015222986,0.00033803954],"category_scores_gemma":[0.000116999865,0.00011551851,0.000024602383,0.00034278992,0.0003569601,0.000009525886,0.00019040985,0.0004382915,0.0000032712671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017536294,0.00008343653,0.85323703,0.000094920135,0.000071960014,0.000023922647,0.0014358681,0.00010492089,0.13954338,0.00002326589,0.0014656443,0.0021620188],"study_design_scores_gemma":[0.0012154344,0.00040251116,0.9689045,0.000046937028,0.0000071157924,0.000014529487,0.000830217,0.0000073834017,0.027466452,0.00003969056,0.00091735704,0.00014786875],"about_ca_topic_score_codex":0.0006242172,"about_ca_topic_score_gemma":0.0016655924,"teacher_disagreement_score":0.11566747,"about_ca_system_score_codex":0.00032998566,"about_ca_system_score_gemma":0.0009969522,"threshold_uncertainty_score":0.4710708},"labels":[],"label_agreement":null},{"id":"W3009743700","doi":"10.1158/1538-7445.sabcs19-pd8-05","title":"Abstract PD8-05: Single-cell analysis of breast cancer metastasis using patient-derived xenograft model reveals clonal relationship between primary tumor and its metastases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Metastasis; Breast cancer; Cancer; Cancer research; Transcriptome; Somatic evolution in cancer; Primary tumor; Biology; Circulating tumor cell; Cancer cell; Metastatic breast cancer; Mammary tumor; Oncology; Medicine; Genetics; Gene; Gene expression","score_opus":0.14772122166400317,"score_gpt":0.36707977608959685,"score_spread":0.21935855442559368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009743700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819656,0.010232372,0.00029811932,0.00044440554,0.000026963426,0.00030460328,0.0066587394,0.00000642967,0.00006276703],"genre_scores_gemma":[0.9973931,0.0010392923,0.0006808465,0.00027127398,0.00017481208,0.000054521937,0.00033414867,0.000038002487,0.000014050047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803,0.00013210313,0.00043146004,0.00055187714,0.0004371338,0.00041744788],"domain_scores_gemma":[0.9985409,0.00020225588,0.0002031993,0.00026786939,0.0004875957,0.0002981966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036160884,0.00019800804,0.00044015437,0.00022982524,0.00016507693,0.000053092033,0.00022370045,0.00009931383,0.000061754],"category_scores_gemma":[0.00019776779,0.00020061545,0.00017755879,0.000785761,0.00015910898,0.000016198419,0.00029458074,0.00024358685,0.0000011492084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024636532,0.0000713671,0.03703453,0.00020136326,0.00067718857,0.000005284201,0.00015597147,0.0153326085,0.9443365,0.000016945627,0.0006666003,0.0012552894],"study_design_scores_gemma":[0.0015404812,0.00044940336,0.13380937,0.00011188508,0.0023715699,0.0000037056489,0.0002860216,0.005023543,0.85433036,0.0001026636,0.0012419039,0.0007290959],"about_ca_topic_score_codex":0.00043835805,"about_ca_topic_score_gemma":0.00011118802,"teacher_disagreement_score":0.09677484,"about_ca_system_score_codex":0.00011777196,"about_ca_system_score_gemma":0.00056000723,"threshold_uncertainty_score":0.8180861},"labels":[],"label_agreement":null},{"id":"W3009814258","doi":"10.1158/1538-7445.sabcs19-p6-03-21","title":"Abstract P6-03-21: Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Taxane; Paclitaxel; Docetaxel; Cancer research; Cancer; Protein kinase B; PI3K/AKT/mTOR pathway; Breast cancer; Medicine; Biology; Pharmacology; Signal transduction; Internal medicine; Genetics","score_opus":0.16886145998551766,"score_gpt":0.47063370405509486,"score_spread":0.3017722440695772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009814258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827699,0.004357133,0.000144905,0.010592126,0.00015257276,0.0009273386,0.00023915671,0.000027129348,0.0007897126],"genre_scores_gemma":[0.99518114,0.0028435423,0.00017724436,0.00012521546,0.00021567555,0.00038545064,0.000020480311,0.000035005218,0.0010162644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973278,0.00012440013,0.0007909267,0.00054063986,0.0007726133,0.00044363027],"domain_scores_gemma":[0.9983576,0.00024430957,0.00028716552,0.0003494087,0.00054117147,0.00022032566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008371803,0.00016253853,0.00057576003,0.00017805719,0.000052558185,0.0000118775515,0.0002930619,0.00014588797,0.00094201794],"category_scores_gemma":[0.000107040774,0.00015664358,0.00011353983,0.00087028457,0.00029874712,0.00016253394,0.00008744144,0.00036065077,0.000008555587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005119576,0.00042590793,0.0072821695,0.0013673705,0.00015306615,0.000037385336,0.0012559829,0.0005095642,0.9760975,0.00055023714,0.004154177,0.0030470563],"study_design_scores_gemma":[0.006729127,0.00030561065,0.24756444,0.0016180435,0.00016107492,0.00000403134,0.0004388912,0.0019129319,0.73770726,0.002768852,0.0004735371,0.00031620776],"about_ca_topic_score_codex":0.00093356706,"about_ca_topic_score_gemma":0.0016750451,"teacher_disagreement_score":0.24028227,"about_ca_system_score_codex":0.0004386441,"about_ca_system_score_gemma":0.0007919791,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W3009870983","doi":"10.1158/1538-7445.sabcs19-p1-03-11","title":"Abstract P1-03-11: In vivo rapid discovery of tumor suppressors in breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Cancer; Biology; Cancer research; Suppressor; Breast cancer; Tumor suppressor gene; Epigenetics; Mammary tumor; Gene; Mutation; Cancer cell; Genetics; Carcinogenesis","score_opus":0.028312452657892426,"score_gpt":0.375782520404754,"score_spread":0.34747006774686157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009870983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995151,0.0031558704,0.000022887703,0.00093507307,0.000064997206,0.00017558996,0.00020186987,0.0000034762554,0.00028924242],"genre_scores_gemma":[0.9980742,0.0014021643,0.000016630722,0.000077356955,0.00021075016,0.00009358703,0.000008841515,0.000021534279,0.00009498242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988683,0.00004007033,0.00020245259,0.00031041872,0.00021985565,0.00035889487],"domain_scores_gemma":[0.9996223,0.000019886875,0.000024078532,0.00019082798,0.000056859495,0.00008604958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022240786,0.00010155475,0.00015874549,0.000085552056,0.000016956003,0.00001746704,0.00024044266,0.00006815115,0.00029868446],"category_scores_gemma":[0.00004287686,0.000099817196,0.00004605377,0.00028262145,0.000084845095,0.0000070518854,0.00013547683,0.00021256595,0.0000020944356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014366626,0.000033683078,0.03101488,0.0001595077,0.000011988281,0.000013996406,0.0001700043,0.003897129,0.9610213,0.000006418493,0.0027127566,0.0008146568],"study_design_scores_gemma":[0.0006127212,0.000050148843,0.07182303,0.00009719144,0.0000021378005,0.00000176924,0.00025316802,0.00016031261,0.9215719,0.000005232474,0.0052894047,0.00013297296],"about_ca_topic_score_codex":0.0022338042,"about_ca_topic_score_gemma":0.0021336237,"teacher_disagreement_score":0.04080815,"about_ca_system_score_codex":0.000043699514,"about_ca_system_score_gemma":0.00020188154,"threshold_uncertainty_score":0.4070427},"labels":[],"label_agreement":null},{"id":"W3009871790","doi":"10.1158/1538-7445.sabcs19-p3-02-02","title":"Abstract P3-02-02: CD68-positive crown-like structures of the breast are independently associated with adverse survival: A retrospective analysis of cases from a prospective cohort","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; University of Toronto; Statistics Canada","funders":"","keywords":"Medicine; Breast cancer; Adipose tissue; Prospective cohort study; Internal medicine; CD68; Pathology; Oncology; Cancer; Immunohistochemistry","score_opus":0.04640937811753297,"score_gpt":0.3555336227860033,"score_spread":0.3091242446684703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009871790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914763,0.00030140977,0.000010448225,0.00042200537,0.00008108007,0.0011541209,0.0059590237,0.000026209647,0.00056942704],"genre_scores_gemma":[0.9994288,0.00006437002,0.0000056835083,0.00006595608,0.00012271489,0.00008381037,0.00008264885,0.00004068979,0.000105320665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964258,0.00019442957,0.00038629546,0.0006459211,0.0019241077,0.00042345407],"domain_scores_gemma":[0.99667287,0.00035613347,0.0004290067,0.00047060073,0.0018296328,0.00024177521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037641288,0.0002423549,0.0009700657,0.00028418063,0.00015494578,0.000024605963,0.00030824947,0.00015915558,0.0008894675],"category_scores_gemma":[0.00046188632,0.00015874782,0.00031323405,0.0030396173,0.00065905834,0.00010319149,0.00016076295,0.00095630635,0.0000016088046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032169202,0.00015010651,0.98131365,0.000048353413,0.0072070896,0.00012773172,0.0027342932,0.00020025593,0.004593801,0.000041077827,0.00025511326,0.00011163515],"study_design_scores_gemma":[0.0016391579,0.0003915796,0.9846759,0.00031559696,0.0014916352,0.0000045138113,0.0032535333,0.00006255088,0.007944402,0.000058551,0.000006998565,0.00015560412],"about_ca_topic_score_codex":0.052172065,"about_ca_topic_score_gemma":0.031207943,"teacher_disagreement_score":0.020964121,"about_ca_system_score_codex":0.0013035358,"about_ca_system_score_gemma":0.00093635067,"threshold_uncertainty_score":0.98647},"labels":[],"label_agreement":null},{"id":"W3009891869","doi":"10.1158/1538-7445.sabcs19-gs4-01","title":"Abstract GS4-01: Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor+ breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Clinical endpoint; Statistical significance; Breast cancer; Oncology; Placebo; Tamoxifen; Hormonal therapy; Randomized controlled trial; Cancer; Gastroenterology; Pathology","score_opus":0.09348842831903145,"score_gpt":0.4190237873823928,"score_spread":0.3255353590633614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009891869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674463,0.0058664656,0.000041402633,0.00789256,0.00015551358,0.015957857,0.0022980347,0.00015795614,0.00018389184],"genre_scores_gemma":[0.9802397,0.007363395,0.0005800985,0.00092664064,0.001878732,0.0082702,0.00037167955,0.0002762556,0.00009328394],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98923606,0.0018617782,0.0024358067,0.0020531528,0.002561277,0.0018519189],"domain_scores_gemma":[0.99302596,0.0017402571,0.0011665873,0.0013851125,0.0014055484,0.0012765449],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003400692,0.0010501936,0.0050441395,0.0005357411,0.0002289234,0.000121576144,0.0008168154,0.00037334996,0.00083611725],"category_scores_gemma":[0.00021415182,0.0006345237,0.00026379805,0.0011804751,0.0022461123,0.00058400707,0.00014646932,0.0027546866,0.000016645208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9303123,0.0035478105,0.0014951584,0.00008600487,0.0029081758,0.0006092613,0.0036214504,0.00031531465,0.010736118,0.000010812082,0.00040813698,0.045949474],"study_design_scores_gemma":[0.9388886,0.03936064,0.012245902,0.0009854964,0.00018125647,0.000062473046,0.002397907,0.00032614497,0.0028837498,0.000034136785,0.001885753,0.00074795925],"about_ca_topic_score_codex":0.012562699,"about_ca_topic_score_gemma":0.0027909747,"teacher_disagreement_score":0.045201518,"about_ca_system_score_codex":0.0014281526,"about_ca_system_score_gemma":0.004652076,"threshold_uncertainty_score":0.9996106},"labels":[],"label_agreement":null},{"id":"W3009969158","doi":"10.1158/1538-7445.sabcs19-pd4-02","title":"Abstract PD4-02: Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Toxicity; Internal medicine; Cancer; Clinical trial; Gastroenterology; Oncology; Breast cancer","score_opus":0.12462465475548473,"score_gpt":0.4319854546255928,"score_spread":0.30736079987010806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009969158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936337,0.0005139465,0.000024097975,0.0005751189,0.00022992025,0.004238754,0.0006082707,0.000020118223,0.00015606957],"genre_scores_gemma":[0.99534523,0.00008557424,0.00023744663,0.00018902321,0.0007161578,0.0030418294,0.00025658018,0.000072687486,0.000055449338],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99576735,0.00020650626,0.00094346306,0.0010405092,0.0008224642,0.0012196879],"domain_scores_gemma":[0.99801266,0.00030431384,0.0002799725,0.00043236854,0.00046099443,0.0005096945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026874808,0.0003600163,0.00076493755,0.0001903223,0.00024378877,0.00007694314,0.0005292492,0.00030107604,0.0002069865],"category_scores_gemma":[0.0037106292,0.00031681234,0.00022585977,0.0006195277,0.0002304825,0.000028475499,0.00013140071,0.00049558,0.000002589871],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38259405,0.0008051476,0.0017180935,0.0002462981,0.0001170765,0.000009689654,0.0006310984,0.0005981833,0.60827166,0.000011274068,0.0009970496,0.004000357],"study_design_scores_gemma":[0.80487466,0.01355591,0.0031936786,0.00033720714,0.000083484716,7.840094e-7,0.0015545805,0.0012698801,0.16328056,0.000043975477,0.010594384,0.0012108668],"about_ca_topic_score_codex":0.0076367008,"about_ca_topic_score_gemma":0.046578158,"teacher_disagreement_score":0.4449911,"about_ca_system_score_codex":0.0006558341,"about_ca_system_score_gemma":0.0031950534,"threshold_uncertainty_score":0.9999284},"labels":[],"label_agreement":null},{"id":"W3010027759","doi":"10.1158/1538-7445.sabcs19-p1-19-16","title":"Abstract P1-19-16: Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2–negative advanced breast cancer: An updated analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Palbociclib; Fulvestrant; Letrozole; Medicine; Internal medicine; Breast cancer; Cancer; Adverse effect; Oncology; Placebo; Metastatic breast cancer; Gynecology; Gastroenterology; Estrogen receptor; Tamoxifen; Pathology","score_opus":0.04543092689725916,"score_gpt":0.3934009876766021,"score_spread":0.34797006077934295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010027759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98399085,0.0015017312,0.0015859121,0.005876603,0.00003887989,0.002556836,0.004302535,0.00009883359,0.000047793743],"genre_scores_gemma":[0.9923069,0.0019663011,0.00048527814,0.00035265155,0.00019572912,0.00095913635,0.003529893,0.00011317407,0.00009092445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99510396,0.0004469365,0.00096363836,0.0012351144,0.0012420947,0.0010082473],"domain_scores_gemma":[0.9956978,0.00042654143,0.0005302416,0.00059661857,0.0021107513,0.0006380761],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057442207,0.00051997846,0.0017481971,0.0015858293,0.00029240426,0.00005254203,0.00047438222,0.00015907132,0.0037429773],"category_scores_gemma":[0.00010699581,0.00044472402,0.00041230588,0.0078100245,0.0005913151,0.00069407845,0.00008124393,0.0008112977,0.0000031386685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0652649,0.0013204871,0.40309462,0.00029560097,0.019631514,0.000039093287,0.004431346,0.0024999564,0.39241943,0.00014421226,0.00014251047,0.11071635],"study_design_scores_gemma":[0.015060784,0.0016983665,0.9044274,0.0001368495,0.0012420662,0.0000021440726,0.0007570737,0.00040316378,0.07564925,0.000043242253,0.000114829,0.0004648008],"about_ca_topic_score_codex":0.003735833,"about_ca_topic_score_gemma":0.0032709753,"teacher_disagreement_score":0.5013328,"about_ca_system_score_codex":0.0018237237,"about_ca_system_score_gemma":0.00064903765,"threshold_uncertainty_score":0.99980044},"labels":[],"label_agreement":null},{"id":"W3010231504","doi":"10.1158/1538-7445.sabcs19-pd3-03","title":"Abstract PD3-03: Impact of the breast cancer polygenic risk score on preventive endocrine therapy adherence and endocrine therapy usage on quality of life - The Genetic Risk Estimate (GENRE) trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Breast cancer; Odds ratio; Internal medicine; Risk assessment; Gynecology; Single-nucleotide polymorphism; Cancer; Oncology; Genotype; Genetics","score_opus":0.10024070028930741,"score_gpt":0.44625950180848895,"score_spread":0.3460188015191815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010231504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458034,0.011020444,0.0000111800855,0.00087773503,0.00015605311,0.0015340223,0.0017139442,0.0000071508834,0.00009912013],"genre_scores_gemma":[0.9709178,0.027852263,0.000023377608,0.00014769252,0.0004976342,0.0004318514,0.000010913208,0.000042224023,0.00007623637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968221,0.0009526254,0.00049779884,0.0005993615,0.0006716973,0.00045637143],"domain_scores_gemma":[0.9979405,0.00028219266,0.0004451071,0.0008146185,0.0003563544,0.00016124705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074979267,0.0002692976,0.0003426559,0.00005540277,0.00024610636,0.000037642585,0.0007226063,0.000088734225,0.0004958485],"category_scores_gemma":[0.0004085177,0.00015546045,0.00028161478,0.00041361887,0.0006739316,0.000008569156,0.00019787073,0.0005897569,0.000004545549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06842722,0.0004610503,0.19879879,0.00011062734,0.0015136772,0.0000026741263,0.0011208452,0.0077585354,0.60977507,0.000019924182,0.0030361153,0.108975455],"study_design_scores_gemma":[0.0110261375,0.002246618,0.7604665,0.000067250556,0.000026503514,0.0000024607812,0.000097997974,0.0000774241,0.22520392,0.00010367286,0.00047663736,0.00020485179],"about_ca_topic_score_codex":0.010222163,"about_ca_topic_score_gemma":0.0007016926,"teacher_disagreement_score":0.56166774,"about_ca_system_score_codex":0.00015757151,"about_ca_system_score_gemma":0.0017300746,"threshold_uncertainty_score":0.9963688},"labels":[],"label_agreement":null},{"id":"W3010482441","doi":"10.1158/0008-5472.can-19-3158","title":"NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors","year":2020,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Medical Research Council; Rosetrees Trust; Cancer Research UK","keywords":"Immunotherapy; Cancer immunotherapy; Cancer research; Cytotoxic T cell; CD8; Immune system; Tumor microenvironment; T cell; Biology; Immunology; Medicine; In vitro","score_opus":0.028890560935031482,"score_gpt":0.30416703827953234,"score_spread":0.27527647734450084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010482441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.336866,0.18525364,0.00005763249,0.44947597,0.0070729745,0.0034091144,0.015848305,0.00078197493,0.0012344006],"genre_scores_gemma":[0.32841334,0.05651814,0.0000611204,0.45969877,0.006112998,0.0038756717,0.0748956,0.0015980701,0.068826295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99234056,0.0020489448,0.0010316491,0.0017246734,0.0006711498,0.002183034],"domain_scores_gemma":[0.9962047,0.0014015819,0.00066497,0.00095492345,0.00069015304,0.00008372503],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00066363945,0.0009295846,0.0013057481,0.00050031475,0.0010299238,0.00018408966,0.0013416371,0.0027098432,0.0142624015],"category_scores_gemma":[0.00022388232,0.0009472181,0.00040000767,0.0010268654,0.0009610713,0.0002475958,0.00083562435,0.009673583,0.001880428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002681998,0.00006306339,0.00007037559,0.00012308777,0.00034996183,0.0000976833,0.00038898963,0.0000049626356,0.49479365,2.50564e-7,0.50328267,0.0005571263],"study_design_scores_gemma":[0.0026404026,0.0001992462,0.000047670997,0.0012997367,0.00005308518,0.0000028619581,0.00009718286,0.0000086133805,0.443884,0.000109147266,0.55095184,0.00070625695],"about_ca_topic_score_codex":0.022766016,"about_ca_topic_score_gemma":0.00028348318,"teacher_disagreement_score":0.12873548,"about_ca_system_score_codex":0.0026342226,"about_ca_system_score_gemma":0.0014225203,"threshold_uncertainty_score":0.99929786},"labels":[],"label_agreement":null},{"id":"W3010489206","doi":"","title":"A pharmaceutical approach to achieve synergy in vivo: A fixed ratio formulation of Irinotecan and Floxuridine for treatment of colorectal cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Irinotecan; Floxuridine; In vivo; Pharmacology; Colorectal cancer; Drug; Chemistry; Cancer; Medicine; Internal medicine; Fluorouracil; Biology","score_opus":0.08043896976769893,"score_gpt":0.4147457075727549,"score_spread":0.334306737805056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010489206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317276,0.0013357695,0.0040427125,0.0002828176,0.000046283818,0.00086651614,0.00015088623,0.0000021103297,0.00010014881],"genre_scores_gemma":[0.9966432,0.0013641758,0.0007986334,0.00003011129,0.00008837418,0.00094077113,0.000021433656,0.000016054819,0.000097248965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991614,0.000029927756,0.00016554038,0.00025325103,0.00014518862,0.00024469584],"domain_scores_gemma":[0.99960434,0.000016747032,0.0000332148,0.00011381685,0.00015060444,0.00008129828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001750904,0.00009140347,0.00017592337,0.00009737357,0.00003652557,0.0000069381535,0.00007674398,0.00007821392,0.0000082185115],"category_scores_gemma":[0.000013025888,0.000082014434,0.000044612018,0.0001676453,0.000057023706,0.000003196528,0.000041424715,0.000035897472,6.435918e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019985575,0.00023496272,0.0000913055,0.00007061488,0.000055377455,2.6832302e-7,0.00037693002,0.0025794564,0.9845077,0.0015278242,0.000019535606,0.008537514],"study_design_scores_gemma":[0.0026025514,0.0022016282,0.00017363483,0.000027837961,0.0000129268765,0.0000010601625,0.000070034854,0.0007061108,0.9893049,0.00023521145,0.00458167,0.00008243217],"about_ca_topic_score_codex":0.0010643426,"about_ca_topic_score_gemma":0.0014445101,"teacher_disagreement_score":0.008455082,"about_ca_system_score_codex":0.00016942185,"about_ca_system_score_gemma":0.00032336896,"threshold_uncertainty_score":0.33444515},"labels":[],"label_agreement":null},{"id":"W3010522503","doi":"10.1158/1538-7445.sabcs19-ot1-08-07","title":"Abstract OT1-08-07: CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"","keywords":"Capecitabine; Medicine; Taxane; Regimen; Internal medicine; Metastatic breast cancer; Clinical endpoint; Chemotherapy; Oncology; Dosing; Phases of clinical research; Chemotherapy regimen; Breast cancer; Cancer; Clinical trial","score_opus":0.10674752161737866,"score_gpt":0.4428524557434013,"score_spread":0.33610493412602266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010522503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906592,0.00082348706,0.0000016477617,0.002207771,0.000062024876,0.0051819594,0.0009679951,0.000017704922,0.00007822537],"genre_scores_gemma":[0.9973601,0.00029715107,0.00006778777,0.00015937151,0.000103523984,0.0015919522,0.00010070956,0.000054725406,0.0002646883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965528,0.00032656526,0.0006915073,0.00063896005,0.0011849421,0.0006051721],"domain_scores_gemma":[0.99706656,0.00037982123,0.0003687558,0.00031950048,0.0015065784,0.00035880186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048719317,0.00030313514,0.000997171,0.00035308162,0.00006429423,0.000016409278,0.00025411576,0.00006676451,0.0020341794],"category_scores_gemma":[0.00025016698,0.00023993662,0.00009074491,0.0007739187,0.0002837923,0.00014724869,0.000102393795,0.00060798926,0.000009550948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23308393,0.0479645,0.4878934,0.0038869914,0.0038653775,0.0005413158,0.043031607,0.00087787013,0.13801432,0.0000040459195,0.004125798,0.036710866],"study_design_scores_gemma":[0.19637752,0.014247987,0.7636381,0.0014869996,0.00062583684,0.0000053568547,0.0042029787,0.0018789236,0.016857043,0.0000015698462,0.00029544698,0.00038225087],"about_ca_topic_score_codex":0.010948805,"about_ca_topic_score_gemma":0.0033871145,"teacher_disagreement_score":0.2757447,"about_ca_system_score_codex":0.0008566277,"about_ca_system_score_gemma":0.0010359761,"threshold_uncertainty_score":0.9988781},"labels":[],"label_agreement":null},{"id":"W3010523936","doi":"10.1158/1538-7445.sabcs19-p4-10-03","title":"Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Context (archaeology); Oncology; Cancer; Medicine; Internal medicine; Targeted therapy; Clinical trial; Bioinformatics; Biology","score_opus":0.0960737207936746,"score_gpt":0.39746308239274675,"score_spread":0.30138936159907215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010523936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876707,0.0029972116,0.0007840569,0.0062071974,0.00016798287,0.00074959476,0.0006306629,0.0000060410857,0.00078652764],"genre_scores_gemma":[0.99747187,0.00023217274,0.00030606808,0.0003102768,0.000704896,0.00031336164,0.000086469365,0.000028437265,0.0005464413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989281,0.00010073654,0.00018215031,0.00027462843,0.00023636644,0.00027800922],"domain_scores_gemma":[0.99879104,0.00016542165,0.00008702259,0.0003052083,0.0005881439,0.000063149724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003270425,0.00009938514,0.00011434213,0.000035384215,0.00034600563,0.000037768266,0.0003781888,0.00007063781,0.00047394927],"category_scores_gemma":[0.00007279541,0.000069622125,0.00008285689,0.0002503226,0.0002961247,0.000006572662,0.00011875951,0.00018459724,0.000008172471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027288994,0.000013441601,0.0005099839,0.000079953454,0.0001278003,6.6112614e-7,0.00037897442,0.02920584,0.9328238,0.00002672812,0.035219003,0.0013409336],"study_design_scores_gemma":[0.002347039,0.0003612171,0.017635923,0.00007642888,0.00011596291,0.00005757402,0.0069074593,0.010733646,0.56320935,0.00016537843,0.39794883,0.00044118532],"about_ca_topic_score_codex":0.0005990857,"about_ca_topic_score_gemma":0.00028079684,"teacher_disagreement_score":0.36961445,"about_ca_system_score_codex":0.00024070706,"about_ca_system_score_gemma":0.0014053986,"threshold_uncertainty_score":0.5189412},"labels":[],"label_agreement":null},{"id":"W3010553242","doi":"10.1158/1538-7445.sabcs19-ot3-17-01","title":"Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Population; Randomized controlled trial; Chemotherapy; Cancer; Lymph node; Gynecology","score_opus":0.08665620771487301,"score_gpt":0.4397613743258074,"score_spread":0.3531051666109344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010553242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945326,0.0015530367,0.00016346206,0.002595962,0.00009548509,0.0051983823,0.0007798205,0.000016152237,0.00014442128],"genre_scores_gemma":[0.9937063,0.00190393,0.0002465282,0.00016602052,0.00026861893,0.0036329087,0.000024907871,0.00003449494,0.000016287542],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99665904,0.0011333,0.00048628822,0.00084054674,0.00044996812,0.00043087397],"domain_scores_gemma":[0.9966531,0.0020200948,0.00012758818,0.00037456257,0.00061337417,0.00021128215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022625069,0.00025151452,0.00073724694,0.00006411792,0.00017489644,0.000041367355,0.00031048642,0.00017350476,0.000055154374],"category_scores_gemma":[0.0012446379,0.00016966207,0.00017281798,0.0004808038,0.0006482565,0.000013365128,0.00028299214,0.0004093986,0.0000017137338],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78562826,0.0004469004,0.03698839,0.00003022092,0.00036862108,0.0000073218644,0.0007399837,0.000080486556,0.16808051,0.000004241994,0.0005558325,0.0070692515],"study_design_scores_gemma":[0.2641698,0.00040208775,0.51438934,0.00019285455,0.00004266084,0.0000020426075,0.000093321156,0.00004340471,0.22032444,0.000050075385,0.00010842196,0.00018156279],"about_ca_topic_score_codex":0.0012732006,"about_ca_topic_score_gemma":0.00022818791,"teacher_disagreement_score":0.52145845,"about_ca_system_score_codex":0.00014037943,"about_ca_system_score_gemma":0.00046492857,"threshold_uncertainty_score":0.69186187},"labels":[],"label_agreement":null},{"id":"W3010996890","doi":"10.1158/0008-5472.can-19-3819","title":"Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> Mutations","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Michael Smith Health Research BC; National Center for Advancing Translational Sciences; Lung Cancer Research Foundation; AstraZeneca","keywords":"Osimertinib; Afatinib; Erlotinib; Lung cancer; Cancer research; Drug resistance; Context (archaeology); Medicine; Mutation; Tyrosine-kinase inhibitor; Biology; Epidermal growth factor receptor; Pharmacology; Cancer; Oncology; Genetics; Internal medicine; Gene","score_opus":0.07865828639649587,"score_gpt":0.4131990002546753,"score_spread":0.33454071385817946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010996890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428284,0.0032622323,0.00023120901,0.046707027,0.00004381738,0.0007529141,0.00021646424,0.00004234854,0.0059155435],"genre_scores_gemma":[0.9959111,0.00091507635,0.00044318783,0.00032820203,0.00019192063,0.00007910394,0.00004275219,0.000019652472,0.0020689548],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987229,0.00009488842,0.00020074668,0.00031020748,0.0004182196,0.0002530313],"domain_scores_gemma":[0.9988507,0.00024222564,0.000048707967,0.00019756498,0.0004191065,0.00024172071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028146073,0.000095940144,0.00023887532,0.00006644861,0.00018791159,0.000017045424,0.000048768416,0.000036368925,0.00019720486],"category_scores_gemma":[0.00019383284,0.00008344092,0.00004663448,0.00045981957,0.0002609459,0.00006998151,0.000055003213,0.00024493088,0.00001350523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008040698,0.0024233616,0.280025,0.006247611,0.0023421866,0.0011582368,0.050232857,0.0009943872,0.24266867,0.0073962267,0.36079624,0.037674513],"study_design_scores_gemma":[0.0132349515,0.0011075413,0.12485351,0.0010477513,0.0006837047,0.000027338792,0.004981233,0.002190047,0.31352827,0.0013403201,0.5362866,0.0007187511],"about_ca_topic_score_codex":0.0007003761,"about_ca_topic_score_gemma":0.0019974068,"teacher_disagreement_score":0.17549035,"about_ca_system_score_codex":0.00014131832,"about_ca_system_score_gemma":0.00027496766,"threshold_uncertainty_score":0.3402622},"labels":[],"label_agreement":null},{"id":"W3011445145","doi":"10.1158/0008-5472.can-18-2098","title":"The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment","year":2020,"lang":"en","type":"review","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Kidney Foundation of Canada; Fondation de l’Hôpital Maisonneuve-Rosemont; Canadian Institutes of Health Research; Canadian Society of Nephrology; Cancer Research Society","keywords":"Extracellular matrix; Matricellular protein; Cell biology; Tumor microenvironment; Carcinogenesis; Metastasis; Cancer; Biology; Signal transduction; Matrix (chemical analysis); Cancer cell; Cancer research; Chemistry; Genetics","score_opus":0.10615315235467589,"score_gpt":0.43613419668518777,"score_spread":0.3299810443305119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011445145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041018322,0.9932255,0.0000012401708,0.0025728212,0.00013557618,0.003414977,0.000050685205,0.000009464583,0.00017955298],"genre_scores_gemma":[0.00025290422,0.99427325,0.00004213533,0.000018573688,0.0004607918,0.001310587,0.0000021024578,0.00004224777,0.003597425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976993,0.00028773068,0.00043134228,0.0004149055,0.00078265235,0.00038403747],"domain_scores_gemma":[0.9988925,0.00013117885,0.00018937943,0.00060085516,0.000079496596,0.0001066072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054953713,0.0002217673,0.00082182465,0.00006535825,0.0005147698,0.000032159067,0.0003633548,0.00013296466,0.00005438539],"category_scores_gemma":[0.000104131424,0.00010679303,0.0002318222,0.0005214378,0.0007333733,0.000021741413,0.00092349824,0.0010741326,0.000014754459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010852561,0.000022353523,0.00018529019,0.04395172,0.000539016,0.000048225058,0.00016337847,3.8745188e-7,0.0006130942,0.00016139066,0.0063050077,0.9479016],"study_design_scores_gemma":[0.00019802614,0.000059005662,0.00019169881,0.0112638455,0.00032195487,0.00003484766,0.0000753523,6.7777825e-7,0.00042756766,0.000058414862,0.98727214,0.000096445125],"about_ca_topic_score_codex":0.0008256761,"about_ca_topic_score_gemma":0.000067868845,"teacher_disagreement_score":0.98096716,"about_ca_system_score_codex":0.0005506098,"about_ca_system_score_gemma":0.0006003654,"threshold_uncertainty_score":0.46666312},"labels":[],"label_agreement":null},{"id":"W3011518098","doi":"10.1158/1538-7445.sabcs19-p5-02-01","title":"Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital; University of Ottawa; University of Alberta; Ontario Institute for Cancer Research; Queen's University; McMaster University; Juravinski Hospital; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Reproducibility; Protocol (science); Cancer; Medical physics; Core biopsy; Biomarker; Biopsy; Guideline; Pathology; Internal medicine; Statistics; Mathematics","score_opus":0.12751611688142872,"score_gpt":0.5013966937374744,"score_spread":0.3738805768560457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011518098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697118,0.0000046001887,0.0006095997,0.0010949128,0.00006190985,0.028249921,0.000008779719,0.000098265526,0.00016024266],"genre_scores_gemma":[0.984557,0.0000015830176,0.0005141841,0.00004269076,0.0006270447,0.014157323,0.000056077293,0.0000304123,0.000013698797],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981894,0.00007152955,0.00031402486,0.00039635695,0.0007389346,0.00028975424],"domain_scores_gemma":[0.9990861,0.00012610665,0.000074154996,0.00014524526,0.0002338072,0.00033460656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085304095,0.000106736436,0.00021850204,0.00015864022,0.00011107413,0.00021326847,0.0001890076,0.000050211765,0.00007372272],"category_scores_gemma":[0.0010554038,0.00009211816,0.000038941398,0.00024189397,0.00014141561,0.00032934838,0.00009773648,0.00046731232,0.0000014101511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047804574,0.002485142,0.71670985,0.0013812922,0.0004532334,0.00024244218,0.0026914903,0.0014554134,0.04161078,0.00027259337,0.00041704864,0.22750029],"study_design_scores_gemma":[0.00640529,0.002916537,0.3306357,0.0005711497,0.00006238063,0.00001784652,0.00096006674,0.65612006,0.0010258214,0.0000804615,0.0010161003,0.00018860197],"about_ca_topic_score_codex":0.000078432844,"about_ca_topic_score_gemma":0.0000031203087,"teacher_disagreement_score":0.65466464,"about_ca_system_score_codex":0.00008175762,"about_ca_system_score_gemma":0.00015573078,"threshold_uncertainty_score":0.37564698},"labels":[],"label_agreement":null},{"id":"W3011615132","doi":"","title":"Exposure to titanium dioxide, carbon black and cosmetic talc and risk of lung cancer: results from two case-control studies in Montreal","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Population; Cancer; Environmental health; Context (archaeology); Odds ratio; Talc; Case-control study; Relative risk; Toxicology; Internal medicine; Biology; Confidence interval","score_opus":0.034813470939974604,"score_gpt":0.39500012000129203,"score_spread":0.3601866490613174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011615132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97475505,0.023730759,0.000030526655,0.00014830809,0.00006497509,0.00048274465,0.0006607663,0.0000025305212,0.0001243245],"genre_scores_gemma":[0.9882902,0.011196395,0.000066618915,0.00003181034,0.00022398283,0.000054480926,0.000007860001,0.000014225028,0.000114426504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99856377,0.00012328685,0.00026349202,0.00045300473,0.0002308711,0.0003655731],"domain_scores_gemma":[0.999124,0.00017853394,0.000057626163,0.0002720865,0.00022901603,0.00013877642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011088498,0.00012640747,0.0002458042,0.00011363808,0.000062339044,0.000014486452,0.000087152395,0.000110518136,0.0000036828558],"category_scores_gemma":[0.0001813664,0.000115597475,0.000031029176,0.00017902072,0.00022585223,0.0000029637192,0.00017713237,0.00023258982,1.9395569e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018887338,0.000038478815,0.319708,0.00008090419,0.0004221834,0.000268903,0.0013281096,0.00056467316,0.66760135,0.000006823583,0.00039419357,0.0076976395],"study_design_scores_gemma":[0.0068469397,0.00088658783,0.57998204,0.00019285391,0.00015082407,0.000027315586,0.0036466022,0.00042915586,0.4070732,0.00009889688,0.00030985975,0.00035569977],"about_ca_topic_score_codex":0.05794726,"about_ca_topic_score_gemma":0.18525021,"teacher_disagreement_score":0.26052815,"about_ca_system_score_codex":0.000107953376,"about_ca_system_score_gemma":0.000088595996,"threshold_uncertainty_score":0.94832593},"labels":[],"label_agreement":null},{"id":"W3011656614","doi":"","title":"Mammalian Target of Rapamycin Inhibition Synergistically Increases Cytotoxicity of Vinorelbine in Breast Cancer Cells.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Vinorelbine; RPTOR; Chemistry; Kinase; Cancer research; Phosphorylation; Pharmacology; Signal transduction; Biology; Cell biology; Biochemistry","score_opus":0.03415952101981392,"score_gpt":0.38252770423928323,"score_spread":0.34836818321946933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011656614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941053,0.0014385128,0.000008929986,0.0015437977,0.00007379829,0.00055668666,0.0006171307,0.00001413154,0.001641717],"genre_scores_gemma":[0.9974235,0.00087473297,0.000096026335,0.00007330586,0.00032949384,0.00025846963,0.000067579276,0.000023993009,0.00085285114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981261,0.00017593207,0.00042858624,0.00030018782,0.00052690244,0.00044227514],"domain_scores_gemma":[0.9989499,0.00016150612,0.000095104944,0.00020699501,0.0004534964,0.00013304083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044349403,0.00014403886,0.00044943232,0.00041379198,0.000040902414,0.0000054322654,0.0000947631,0.00011539128,0.0033040491],"category_scores_gemma":[0.000024223866,0.00012665635,0.00008363777,0.000774957,0.00043413654,0.000056764027,0.00006615899,0.00032888446,0.0000065285744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025034861,0.0011402922,0.15842985,0.0004903134,0.000048004204,0.00009540532,0.000053385527,0.00019061418,0.82787305,0.00024147845,0.008476786,0.00045734813],"study_design_scores_gemma":[0.0032881787,0.00031163509,0.28012377,0.00034125545,0.0000505234,0.0000108900595,0.000032195974,0.00006780986,0.7149807,0.00024640086,0.00044854227,0.00009808839],"about_ca_topic_score_codex":0.06170004,"about_ca_topic_score_gemma":0.0038034678,"teacher_disagreement_score":0.121693924,"about_ca_system_score_codex":0.00055185513,"about_ca_system_score_gemma":0.0007171813,"threshold_uncertainty_score":0.99760705},"labels":[],"label_agreement":null},{"id":"W3011824971","doi":"10.1158/1538-7445.sabcs19-p6-10-12","title":"Abstract P6-10-12: Texture heterogeneity of breast tumour in magnetic resonance imaging can be explained by differentially regulated genes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Magnetic resonance imaging; Breast cancer; False discovery rate; Breast MRI; Tumour heterogeneity; Medicine; Multiple comparisons problem; Cancer; Pathology; Radiology; Gene; Biology; Mammography; Internal medicine; Genetics","score_opus":0.03404167046317556,"score_gpt":0.3504769301410093,"score_spread":0.3164352596778337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011824971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95729816,0.011167285,0.000022926202,0.030657835,0.00005915302,0.0003826337,0.00010073941,0.000040963034,0.00027033204],"genre_scores_gemma":[0.9978374,0.00061847677,0.000087450826,0.00061290985,0.0002433606,0.00004756819,0.00006704029,0.00005281831,0.00043292326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973965,0.00017382414,0.0004231189,0.0005240098,0.00085149327,0.00063104095],"domain_scores_gemma":[0.99885917,0.00011259308,0.00008012999,0.00029828874,0.0002248887,0.00042491476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005895129,0.00019622296,0.00044740454,0.00017279634,0.0000941549,0.000042029507,0.00032637364,0.00008623151,0.00087628997],"category_scores_gemma":[0.00033374285,0.0001727021,0.00008618605,0.00050130556,0.00033057356,0.000058950514,0.00014510176,0.0010109588,0.000005116941],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061625685,0.00011137086,0.05845163,0.00033048703,0.000018872546,0.00020245777,0.0006313024,0.00003718238,0.8436178,0.000009104707,0.013803273,0.08217024],"study_design_scores_gemma":[0.0069327145,0.00038977992,0.8215806,0.0013975333,0.000054497323,0.000106749154,0.00043338767,0.019245595,0.12965119,0.000059224087,0.019634683,0.0005140568],"about_ca_topic_score_codex":0.0022703079,"about_ca_topic_score_gemma":0.00025663967,"teacher_disagreement_score":0.76312894,"about_ca_system_score_codex":0.00017088614,"about_ca_system_score_gemma":0.0003474367,"threshold_uncertainty_score":0.95947605},"labels":[],"label_agreement":null},{"id":"W3011905462","doi":"","title":"The role of GATA4 and GATA6 as putative tumor suppressors and co-modulators in astrocytes","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Cancer research; Glioma; Western blot; GATA6; GATA4; Tumor suppressor gene; p14arf; Carcinogenesis; Astrocytoma; Gene expression; Gene; Pathology; Medicine; Genetics","score_opus":0.03149870062007718,"score_gpt":0.41779847364988115,"score_spread":0.38629977302980395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011905462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793256,0.010223957,3.0609291e-7,0.00044855115,0.000011957538,0.00037027738,0.000018611512,0.000003890028,0.0009898938],"genre_scores_gemma":[0.99891746,0.0008705979,0.000026654676,0.000017524704,0.00002862286,0.00007296277,0.0000040309474,0.000009553979,0.000052579817],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998992,0.000055016142,0.00013606859,0.00017772298,0.000332377,0.00030679072],"domain_scores_gemma":[0.99905926,0.0005366393,0.000026472382,0.00013543277,0.000110257686,0.00013193482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007043653,0.000069273745,0.00015194157,0.00014199439,0.00009222743,0.000019589668,0.000051147283,0.000026092252,0.000031829033],"category_scores_gemma":[0.00016154638,0.000043860615,0.00001645178,0.00020519755,0.00035780514,0.000036744485,0.000054323373,0.00017294884,0.000003549732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009371063,0.0001842361,0.90824217,0.00007200007,0.00009859126,0.00020666354,0.0019719915,0.0000044954086,0.047835723,0.0015650928,0.00032034318,0.038561568],"study_design_scores_gemma":[0.0013686672,0.00032293057,0.41035074,0.000102459315,0.000010618978,0.000017764667,0.0031531788,0.0000330736,0.5810179,0.00049126626,0.0030915483,0.000039852865],"about_ca_topic_score_codex":0.0014907639,"about_ca_topic_score_gemma":0.00036399753,"teacher_disagreement_score":0.53318214,"about_ca_system_score_codex":0.00008766858,"about_ca_system_score_gemma":0.000092668226,"threshold_uncertainty_score":0.22535989},"labels":[],"label_agreement":null},{"id":"W3012088777","doi":"10.1158/0008-5472.can-19-1372","title":"CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; University of Kent; Cancer Research UK; Wellcome Trust","keywords":"Colorectal cancer; Cancer research; DNA damage; Biology; DNA polymerase; Cancer; Aphidicolin; DNA replication; Polymerase; DNA repair; Lung cancer; Cell cycle; Small interfering RNA; Genetics; DNA; Medicine; Cell culture; Internal medicine","score_opus":0.025676021620959322,"score_gpt":0.32514958687640955,"score_spread":0.2994735652554502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012088777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975152,0.0011398196,0.00011549034,0.0005528593,0.000033463926,0.00029622528,0.000059683513,0.000007405666,0.00027985958],"genre_scores_gemma":[0.99910337,0.00026264985,0.000033599576,0.00022415533,0.00012738792,0.00012710429,0.00001639463,0.000024240318,0.00008108285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878794,0.00010636685,0.00014715378,0.0003897245,0.00029189885,0.0002768889],"domain_scores_gemma":[0.99956185,0.000013031237,0.00003719747,0.00012703058,0.0001388601,0.00012201579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021653606,0.00010476612,0.00013851443,0.00006128035,0.00005979489,0.00001713273,0.00008523122,0.00011671559,0.000104691724],"category_scores_gemma":[0.000017268727,0.00009679577,0.000028328792,0.00020850504,0.00022639509,0.000006446627,0.00011428748,0.00019436644,0.0000015838482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079069415,0.000037635553,0.0016560545,0.00009896197,0.000029690358,0.000015258216,0.00018189337,0.000017044922,0.9959437,0.000068816604,0.0005286191,0.00063160976],"study_design_scores_gemma":[0.0007036091,0.0007723145,0.0015939742,0.00007376845,0.00001088305,0.0000022912088,0.00012421183,0.000091716705,0.99621993,0.000027762708,0.00026892908,0.000110604],"about_ca_topic_score_codex":0.000506792,"about_ca_topic_score_gemma":0.00021245888,"teacher_disagreement_score":0.0015881924,"about_ca_system_score_codex":0.00005067786,"about_ca_system_score_gemma":0.0002012339,"threshold_uncertainty_score":0.3947217},"labels":[],"label_agreement":null},{"id":"W3012129470","doi":"10.1158/1538-7445.sabcs19-ot1-07-01","title":"Abstract OT1-07-01: [Fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) vs ado-trastuzumab emtansine (T-DM1) in subjects with HER2-positive, unresectable and/or metastatic breast cancer who previously received trastuzumab and a taxane: A phase 3, randomized trial (DESTINY-Breast03)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Trastuzumab; Trastuzumab emtansine; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Lapatinib; Antibody-drug conjugate; Phases of clinical research; Cancer; Breast cancer; Antibody; Clinical trial; Immunology; Monoclonal antibody","score_opus":0.08177458749404355,"score_gpt":0.4152758576420249,"score_spread":0.33350127014798137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012129470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95901906,0.010102485,0.00013958437,0.013704883,0.00017314948,0.014941326,0.00096267887,0.00020818,0.00074864493],"genre_scores_gemma":[0.9779148,0.011929146,0.0005450649,0.0006111107,0.00090781535,0.0066070515,0.00012978236,0.00037712976,0.0009780618],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9859886,0.0026097442,0.0017709978,0.0026775412,0.003638732,0.0033143917],"domain_scores_gemma":[0.9913041,0.0033147684,0.0004623315,0.0009913356,0.0014139992,0.0025134697],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054121944,0.0012487264,0.003821257,0.001171023,0.00056544284,0.0005634276,0.0007987932,0.00041995005,0.0037605267],"category_scores_gemma":[0.0026375833,0.00094966835,0.0003123417,0.003218833,0.0024917193,0.000700537,0.00038401227,0.0036989702,0.000049844657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92763984,0.0018307397,0.0011895071,0.0037191396,0.00118456,0.0031786968,0.0066753756,0.00008331627,0.009810969,0.000023354345,0.0030631134,0.0416014],"study_design_scores_gemma":[0.9517777,0.015022817,0.009037315,0.007918765,0.0008975428,0.0013315425,0.0029166723,0.0024652854,0.0053075543,0.000098233235,0.0016939102,0.0015326709],"about_ca_topic_score_codex":0.027676718,"about_ca_topic_score_gemma":0.016268367,"teacher_disagreement_score":0.040068727,"about_ca_system_score_codex":0.0028213863,"about_ca_system_score_gemma":0.009834454,"threshold_uncertainty_score":0.9992954},"labels":[],"label_agreement":null},{"id":"W3012444842","doi":"10.1158/0008-5472.can-19-3133","title":"Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster Institute for Research on Aging, McMaster University; National Cancer Institute; National Institutes of Health; Ministry of Education; Ministry of Science and Technology; National Natural Science Foundation of China; Breast Cancer Research Foundation","keywords":"PD-L1; Glycosylation; Immunotherapy; Cancer immunotherapy; T cell; Cancer research; Immune system; CD28; Monoclonal antibody; Receptor; T-cell receptor; Antibody; Biology; Chemistry; Cell biology; Immunology; Biochemistry","score_opus":0.0902434383197313,"score_gpt":0.36288744514962173,"score_spread":0.27264400682989043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012444842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536325,0.005365278,0.000058914324,0.0035608185,0.001942541,0.00023922457,0.000006354714,0.0001050792,0.0033585215],"genre_scores_gemma":[0.99414223,0.0006512073,0.0000069289085,0.00049301307,0.00012050276,0.000040902836,0.00009247815,0.000017205322,0.004435545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985353,0.00046718496,0.00021925868,0.00026200013,0.00008180712,0.00043448748],"domain_scores_gemma":[0.9993418,0.00009578034,0.000053694002,0.00016412094,0.0003029762,0.000041656735],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004705473,0.00010719897,0.0001617489,0.00010819704,0.00041144728,0.00003968812,0.00026379738,0.00013958242,0.0078059575],"category_scores_gemma":[0.00034110632,0.00009527244,0.000056357487,0.0003982982,0.0001618779,0.00015181799,0.0001670546,0.0012172498,0.0031219881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003983998,0.000040127165,0.00020753875,0.000020178835,0.000064834516,0.000004659602,0.0005757912,0.000015234485,0.92338103,0.0000630305,0.07291018,0.0023189727],"study_design_scores_gemma":[0.00058766396,0.00020694146,0.0008076253,0.000030244259,0.0000062528507,0.0000059543104,0.001195291,0.000027869788,0.69044477,0.000010817703,0.30656227,0.00011428674],"about_ca_topic_score_codex":0.00089391746,"about_ca_topic_score_gemma":0.0000052924115,"teacher_disagreement_score":0.2336521,"about_ca_system_score_codex":0.0001112752,"about_ca_system_score_gemma":0.00014175104,"threshold_uncertainty_score":0.9976542},"labels":[],"label_agreement":null},{"id":"W3013025151","doi":"10.1158/1538-7445.sabcs19-p2-12-15","title":"Abstract P2-12-15: Efficacy of Lymphdiaral™ in breast cancer patients with lymphedema","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; London Health Sciences Centre","funders":"","keywords":"Lymphedema; Medicine; Breast cancer; Randomized controlled trial; Quality of life (healthcare); Cancer; Psychosocial; Surgery; Internal medicine","score_opus":0.06198841094094878,"score_gpt":0.3780482001074602,"score_spread":0.31605978916651145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013025151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243534,0.0013974303,0.0000012680224,0.002747132,0.00006117678,0.0008177186,0.00016576663,0.000025846119,0.0023482973],"genre_scores_gemma":[0.9987392,0.00018414197,0.000011132165,0.00041402548,0.0002850749,0.00018569473,0.000022249438,0.000036122332,0.0001223836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976159,0.00008445438,0.00034775538,0.00038567322,0.0010828387,0.00048341765],"domain_scores_gemma":[0.9985501,0.00018263943,0.00008284821,0.00027844842,0.0004387726,0.0004671907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022556914,0.00015396268,0.0004111977,0.0001615986,0.000053049884,0.00001986714,0.00019339853,0.00007435142,0.0015868648],"category_scores_gemma":[0.00015487755,0.00011100431,0.00006791176,0.00065863086,0.00020352674,0.00010122448,0.00006767279,0.0000401306,0.0000527369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031262161,0.0005303049,0.98294294,0.0009722444,0.00008577082,0.0000533283,0.0006745224,0.00003873164,0.0017467781,0.000021126696,0.003910996,0.005897038],"study_design_scores_gemma":[0.008894141,0.000174821,0.9878003,0.0011097384,0.000033284236,0.0000025431275,0.0002147671,0.000027993221,0.0011839882,0.000005385617,0.0004309201,0.0001220991],"about_ca_topic_score_codex":0.0024941133,"about_ca_topic_score_gemma":0.000106921085,"teacher_disagreement_score":0.006303811,"about_ca_system_score_codex":0.0004458572,"about_ca_system_score_gemma":0.0016550319,"threshold_uncertainty_score":0.9993258},"labels":[],"label_agreement":null},{"id":"W3013041600","doi":"10.1158/1538-7445.sabcs19-pd2-10","title":"Abstract PD2-10: Predicting sensitivity to CDK4/6 inhibition in ER+/HER2- breast cancer cell lines","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Palbociclib; Growth inhibition; Cancer research; Cell cycle; Cell growth; Cell culture; Biology; Cancer; Oncology; Metastatic breast cancer; Medicine; Internal medicine; Breast cancer; Genetics","score_opus":0.07894707575200022,"score_gpt":0.40755050504777635,"score_spread":0.32860342929577613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013041600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677968,0.0017162309,0.00010818535,0.027382182,0.00014623538,0.0010041452,0.00031404285,0.00013386772,0.0013983183],"genre_scores_gemma":[0.99472076,0.0004431218,0.00019264242,0.001603407,0.0019821527,0.00041702666,0.000022375563,0.00008516979,0.00053333363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968922,0.00015978208,0.00038131452,0.00073897437,0.0009482567,0.00087946595],"domain_scores_gemma":[0.9981338,0.00020292048,0.00007784058,0.00033157607,0.00066295493,0.0005909279],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000766309,0.00025582843,0.0004379247,0.00019173008,0.00014682134,0.000048316717,0.00010495494,0.00014315445,0.0023764828],"category_scores_gemma":[0.00018290234,0.00024600214,0.00008165978,0.0011022639,0.00016656134,0.00030857263,0.00017486657,0.00092352997,0.00015341045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039367853,0.00021581289,0.021409394,0.00086585607,0.00005657916,0.00044918258,0.0033605054,0.0025130094,0.897564,0.000011175143,0.0033894675,0.06622825],"study_design_scores_gemma":[0.0065439497,0.00058724533,0.56204605,0.0031245488,0.000049099,0.00012098373,0.0036337858,0.001533076,0.4013757,0.0000896838,0.020080967,0.0008149188],"about_ca_topic_score_codex":0.008251705,"about_ca_topic_score_gemma":0.0039495816,"teacher_disagreement_score":0.54063666,"about_ca_system_score_codex":0.0012824489,"about_ca_system_score_gemma":0.0007242735,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W3013121057","doi":"10.1158/1538-7445.sabcs19-p5-08-19","title":"Abstract P5-08-19: The risk of breast, ovarian and endometrial cancer in obese women submitted to bariatric surgery: A meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endometrial cancer; Meta-analysis; Breast cancer; Gynecology; Relative risk; Ovarian cancer; Obesity; Incidence (geometry); Obstetrics; Cancer; Oncology; Internal medicine; Confidence interval","score_opus":0.16930420214018307,"score_gpt":0.41393238290120105,"score_spread":0.24462818076101797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013121057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741526,0.0088149365,0.000018481278,0.014924581,0.000079486876,0.00096557464,0.00091711665,0.000017723636,0.00010947829],"genre_scores_gemma":[0.9944616,0.003810361,0.000013966142,0.0004166291,0.00044298792,0.00067863683,0.0000084773565,0.000031037696,0.00013631943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965305,0.00044047734,0.00058573403,0.00059914513,0.001127989,0.00071618997],"domain_scores_gemma":[0.9967654,0.001482808,0.00015868126,0.0004926675,0.00034928453,0.00075117033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034294734,0.00021307172,0.001492298,0.0013447878,0.00012098383,0.0000627813,0.00026225817,0.00011072279,0.006173131],"category_scores_gemma":[0.0013985675,0.0001352073,0.0006017497,0.008892746,0.00017183149,0.00008087369,0.00016805463,0.0008184566,0.0000116304145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0106743025,0.0002797732,0.8475864,0.0005148552,0.08512143,0.00015692417,0.010481377,0.0013891589,0.006879882,0.000050172683,0.010844996,0.026020715],"study_design_scores_gemma":[0.0022692778,0.00017286505,0.9741543,0.000019216217,0.015305457,0.0000030515614,0.0009228056,0.00016935408,0.00069380197,0.000044525197,0.0060224705,0.0002228772],"about_ca_topic_score_codex":0.09816338,"about_ca_topic_score_gemma":0.007009844,"teacher_disagreement_score":0.12656789,"about_ca_system_score_codex":0.00051380054,"about_ca_system_score_gemma":0.0011576021,"threshold_uncertainty_score":0.99473536},"labels":[],"label_agreement":null},{"id":"W3013129387","doi":"10.1158/1538-7445.sabcs19-p5-14-11","title":"Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Internal medicine; Cohort; Breast cancer; Population; Cardiomyopathy; Logistic regression; Retrospective cohort study; Heart failure; Cancer; Oncology; Chemotherapy","score_opus":0.029849707587027322,"score_gpt":0.3457613972866761,"score_spread":0.3159116896996488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013129387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925968,0.00061175314,0.0000023637695,0.0034316042,0.00032834747,0.0016042704,0.00053614826,0.000069592774,0.00081911066],"genre_scores_gemma":[0.9952916,0.0023417517,0.000025540327,0.00014096258,0.0011127553,0.0006232353,0.000061034953,0.00008267133,0.000320454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969974,0.00012756312,0.00035671273,0.0006926114,0.001075454,0.00075022987],"domain_scores_gemma":[0.9984381,0.00011275531,0.00008023273,0.000328082,0.00061418023,0.00042660497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037308288,0.0002820523,0.00064810866,0.00017368891,0.00015389394,0.00005038251,0.00016360955,0.00018502353,0.00014561557],"category_scores_gemma":[0.000065325636,0.0002131626,0.00016898746,0.000893937,0.00014670675,0.00026739697,0.000050524508,0.00086660864,0.000012984884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002633134,0.000114191775,0.3653216,0.00033540462,0.00026068094,0.00002820781,0.0019521416,0.00009948333,0.56734747,0.0000028773286,0.00034727922,0.06155753],"study_design_scores_gemma":[0.0035920278,0.00028556774,0.4747308,0.00070920115,0.000052317173,7.351276e-7,0.00117362,0.000010549311,0.5160566,0.000002992252,0.0031232415,0.00026237036],"about_ca_topic_score_codex":0.0034165583,"about_ca_topic_score_gemma":0.00025953454,"teacher_disagreement_score":0.10940919,"about_ca_system_score_codex":0.0015877765,"about_ca_system_score_gemma":0.00063853886,"threshold_uncertainty_score":0.86925185},"labels":[],"label_agreement":null},{"id":"W3013133228","doi":"10.1158/1538-7445.sabcs19-p1-20-09","title":"Abstract P1-20-09: Does a single-dose of pre-operative prophylactic antibiotic reduce surgical site infection following wire-localized lumpectomy?","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Lumpectomy; Medicine; Perioperative; Surgery; Antibiotics; Clindamycin; Antibiotic prophylaxis; Randomized controlled trial; Prospective cohort study; Surgical wound; Breast surgery; Mastectomy; Breast cancer; Internal medicine; Cancer","score_opus":0.06414999251999348,"score_gpt":0.3886839123257547,"score_spread":0.32453391980576124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013133228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959374,0.0003864444,0.000015125571,0.0014402933,0.00037307403,0.0009076063,0.000023142236,0.000073863135,0.00084305217],"genre_scores_gemma":[0.998708,0.00007118989,0.0000891745,0.000016218539,0.00068068935,0.000030029452,0.000025982343,0.00003250994,0.00034622298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788415,0.00021021892,0.00036772256,0.00043712088,0.0006675441,0.00043326494],"domain_scores_gemma":[0.9989843,0.00015869713,0.00009685772,0.00019004289,0.00027653563,0.00029359543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045292728,0.00017269893,0.00045524514,0.00020758985,0.00016847992,0.000052813768,0.0000817783,0.00016468305,0.00030271526],"category_scores_gemma":[0.00011592398,0.00011913028,0.00017425638,0.00074545544,0.00029404936,0.00022225328,0.00006164169,0.00072745763,0.000033679815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043344595,0.0002775972,0.024779135,0.0010681388,0.0002268463,0.00030867738,0.0017162854,0.00002519021,0.8763868,0.000015881082,0.0001231803,0.09073781],"study_design_scores_gemma":[0.008611039,0.0017159767,0.06247756,0.0017281285,0.00023139731,0.0025678535,0.00061724766,0.00079503225,0.9189681,0.00004642224,0.0017921773,0.00044908444],"about_ca_topic_score_codex":0.0010451351,"about_ca_topic_score_gemma":0.000116651216,"teacher_disagreement_score":0.09028873,"about_ca_system_score_codex":0.00024479406,"about_ca_system_score_gemma":0.0005291079,"threshold_uncertainty_score":0.48579916},"labels":[],"label_agreement":null},{"id":"W3013217853","doi":"10.1158/1538-7445.sabcs19-p3-11-10","title":"Abstract P3-11-10: Health-related quality of life (HRQoL) in monarcHER: Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in HR+, HER2+ advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Fulvestrant; Trastuzumab; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Quality of life (healthcare); Tamoxifen; Nursing","score_opus":0.1312244441150667,"score_gpt":0.44956472524661995,"score_spread":0.3183402811315532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013217853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97276604,0.014321448,0.00007895077,0.008639814,0.000113398346,0.0028828043,0.0009154551,0.00009714729,0.00018493886],"genre_scores_gemma":[0.99529904,0.0025284186,0.00069608825,0.00026637438,0.00016415022,0.00067593134,0.00005371875,0.00019310902,0.00012316629],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.992781,0.00048800473,0.0018360497,0.0012018504,0.002236285,0.0014568064],"domain_scores_gemma":[0.99633247,0.00047982697,0.00062907225,0.00074581744,0.0009851614,0.00082765904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012103209,0.0006200169,0.0026709575,0.00049018336,0.00012042753,0.000025747262,0.0005197978,0.00028844504,0.0025640675],"category_scores_gemma":[0.00019674803,0.00050300045,0.0001957318,0.0026090853,0.0010319637,0.00033842953,0.0000905822,0.0016511793,0.0000062090694],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.71902287,0.0006137931,0.027887916,0.007939058,0.0006707172,0.00020151846,0.040645532,0.01303371,0.015491516,0.00006223025,0.00012310626,0.17430802],"study_design_scores_gemma":[0.3185347,0.02573662,0.50268126,0.015678262,0.00015442008,0.00010626426,0.09807881,0.0018152244,0.029369965,0.00013918408,0.0049011963,0.00280406],"about_ca_topic_score_codex":0.015792226,"about_ca_topic_score_gemma":0.030462228,"teacher_disagreement_score":0.47479337,"about_ca_system_score_codex":0.005626875,"about_ca_system_score_gemma":0.013179413,"threshold_uncertainty_score":0.99974215},"labels":[],"label_agreement":null},{"id":"W3013282680","doi":"10.1158/1538-7445.sabcs19-pd8-01","title":"Abstract PD8-01: The metastatic breast cancer project: Generating the clinical and genomic landscape of metastatic breast cancer through patient-partnered research","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Metastatic breast cancer; Biobank; Internal medicine; Oncology; Family medicine; Bioinformatics; Biology","score_opus":0.17360834925484442,"score_gpt":0.45577411837824233,"score_spread":0.2821657691233979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013282680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95991945,0.022653898,0.00002565452,0.013430766,0.00022257333,0.00131892,0.002187955,0.000008640448,0.0002321248],"genre_scores_gemma":[0.9719927,0.024532618,0.0001684829,0.0009995704,0.0012474714,0.0008513621,0.000047139678,0.00006914769,0.00009153678],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960325,0.0008010593,0.000694826,0.0008057524,0.0008140028,0.00085190794],"domain_scores_gemma":[0.9974532,0.00060958904,0.00021088996,0.00065951265,0.00084959576,0.00021718763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020843777,0.00026796287,0.00042001985,0.00006855879,0.0005896496,0.00018127194,0.0007394573,0.00011032655,0.00030502392],"category_scores_gemma":[0.00036286717,0.00016940925,0.0001576073,0.00062729506,0.0011832286,0.000018431638,0.00075068645,0.0009234164,0.000008702081],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003875637,0.0006027696,0.047799546,0.0011481973,0.0023473497,0.00006175916,0.007809629,0.0055267643,0.61111337,0.00068341993,0.21887118,0.10016041],"study_design_scores_gemma":[0.0196478,0.005016604,0.29082856,0.0016088069,0.0015468718,0.00043580294,0.039111223,0.015577873,0.18099883,0.0019576135,0.43903053,0.004239491],"about_ca_topic_score_codex":0.0068582823,"about_ca_topic_score_gemma":0.0028117977,"teacher_disagreement_score":0.4301145,"about_ca_system_score_codex":0.000084488165,"about_ca_system_score_gemma":0.0021951615,"threshold_uncertainty_score":0.99975514},"labels":[],"label_agreement":null},{"id":"W3013354254","doi":"10.1158/1538-7445.sabcs19-p5-07-07","title":"Abstract P5-07-07: A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumor dormancy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Decile; Breast cancer; Medicine; Internal medicine; Cancer; Mortality rate; Oncology; Demography; Statistics","score_opus":0.08504087643962845,"score_gpt":0.3658680522708321,"score_spread":0.28082717583120365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013354254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900914,0.00109379,0.00000699834,0.0047757,0.00004328373,0.00056877406,0.0030137964,0.000026165151,0.00038008686],"genre_scores_gemma":[0.9970816,0.00020491873,0.000026534037,0.00051535043,0.0005247038,0.00061732356,0.00048073387,0.00005309949,0.0004957402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778986,0.00011733666,0.00026801685,0.000721596,0.00048690927,0.00061626214],"domain_scores_gemma":[0.9987986,0.00005349179,0.00007988249,0.0003077603,0.00030345205,0.00045677766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022389922,0.00025688796,0.00027943894,0.000060020706,0.00033472676,0.00006561408,0.00025751963,0.000112677124,0.00039411717],"category_scores_gemma":[0.00009244359,0.00024143292,0.000058254296,0.0002719707,0.0001875545,0.000018548917,0.00031597615,0.00025859362,0.00005737906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001449578,0.0000531327,0.9509768,0.00007208315,0.00017173753,0.0000039415636,0.00033015112,0.00002926617,0.0067057125,0.0000034951852,0.04114125,0.00036746223],"study_design_scores_gemma":[0.0010255174,0.00012719979,0.9857539,0.000052979027,0.000042745833,6.884124e-7,0.000061275125,0.00001105155,0.008887439,0.000015199183,0.0037510565,0.0002709701],"about_ca_topic_score_codex":0.007489328,"about_ca_topic_score_gemma":0.0005747118,"teacher_disagreement_score":0.037390195,"about_ca_system_score_codex":0.00021428539,"about_ca_system_score_gemma":0.00026521485,"threshold_uncertainty_score":0.9991199},"labels":[],"label_agreement":null},{"id":"W3013419627","doi":"10.1158/1538-7445.sabcs19-p5-02-04","title":"Abstract P5-02-04: Upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast to reduce inter-observer variability: The DCISion study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Ductal carcinoma; Concordance; Intraclass correlation; Radiology; Oncology; Internal medicine; Pathology; Cancer","score_opus":0.08109260586593608,"score_gpt":0.43570941266165214,"score_spread":0.35461680679571606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013419627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734287,0.000110514084,0.00007307315,0.024039447,0.00015696825,0.0012213698,0.000010590394,0.000009263392,0.00095003133],"genre_scores_gemma":[0.9991774,0.000013774648,0.00011720156,0.00034922073,0.00016412606,0.000095835756,0.0000020119605,0.000016930007,0.00006348919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971611,0.0006542269,0.00045496091,0.0004127707,0.0009949106,0.00032205155],"domain_scores_gemma":[0.99856055,0.00035219974,0.00008755829,0.00055086345,0.0002502998,0.00019850722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036065895,0.0001199275,0.00037903077,0.00008221568,0.00008266143,0.000017269782,0.0005495838,0.000057069577,0.00023574101],"category_scores_gemma":[0.0014533947,0.000064359774,0.000093715564,0.00056364626,0.00034043036,0.00003536054,0.0004889306,0.0014084135,0.0000026206965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005489441,0.0007859058,0.75233716,0.00018223174,0.000032008586,0.0001980877,0.0043664854,0.00022160506,0.226104,0.000060397764,0.0015488684,0.013614325],"study_design_scores_gemma":[0.00096604764,0.0005566024,0.9939661,0.00015862971,0.000022479051,0.00003166579,0.0012851264,0.0010390365,0.001582183,0.000042996584,0.00028770577,0.00006142072],"about_ca_topic_score_codex":0.0015230547,"about_ca_topic_score_gemma":0.00007463081,"teacher_disagreement_score":0.24162897,"about_ca_system_score_codex":0.00038267937,"about_ca_system_score_gemma":0.0004648297,"threshold_uncertainty_score":0.6118934},"labels":[],"label_agreement":null},{"id":"W3013492464","doi":"","title":"Sub-megabase resolution array CGH profiling of small cell lung cancer cell lines.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Biology; Copy number analysis; Genome; Human genome; Carcinogenesis; Lung cancer; Genetics; Computational biology; Cancer; Cancer research; Copy-number variation; Gene; Pathology; Medicine","score_opus":0.039453289802668115,"score_gpt":0.3606775967532673,"score_spread":0.3212243069505992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013492464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032504,0.013240216,0.0018741697,0.00036549327,0.00012578793,0.0008561284,0.00008485822,0.000013974952,0.003114355],"genre_scores_gemma":[0.9911178,0.0045942934,0.0010024164,0.000048133556,0.00042983887,0.00043121332,0.00009193494,0.00004367624,0.0022407032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977517,0.00016944918,0.00028977633,0.0005190759,0.00060068816,0.0006693006],"domain_scores_gemma":[0.99832183,0.000022622311,0.00008065753,0.000497708,0.00086840376,0.0002087709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082963513,0.00016168466,0.0001723372,0.00013952819,0.00018906835,0.000035696732,0.00036992112,0.00021136065,0.00016264469],"category_scores_gemma":[0.00011668434,0.00015471359,0.00010027205,0.0004251192,0.00019708488,0.000010212933,0.00016945576,0.0004005444,0.000015183943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027371268,0.00012808465,0.0013910445,0.0003435158,0.00001845978,0.0000052615555,0.00008893925,0.0028993597,0.9932664,0.000044921428,0.00091039203,0.0006299348],"study_design_scores_gemma":[0.0012310538,0.00019589455,0.00037179742,0.000083057115,0.0000073781143,0.000001178379,0.00010886748,0.00016460217,0.9930143,0.000036313155,0.004619475,0.00016611748],"about_ca_topic_score_codex":0.0035996644,"about_ca_topic_score_gemma":0.0017879211,"teacher_disagreement_score":0.010792773,"about_ca_system_score_codex":0.0002708024,"about_ca_system_score_gemma":0.0013731581,"threshold_uncertainty_score":0.6309037},"labels":[],"label_agreement":null},{"id":"W3013534107","doi":"10.1158/1538-7445.sabcs19-p6-16-01","title":"Abstract P6-16-01: Refined local recurrence risk estimates based on a multigene expression assay combined with clinicopathological features significantly impacts radiotherapy recommendation in patients with low/intermediate risk DCIS treated with breast-conserving surgery","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta; McMaster University; University of Toronto; Western University; Juravinski Cancer Centre; Trillium Health Centre; Royal Victoria Regional Health Centre; University of Ottawa; Health Sciences Centre; Ottawa Hospital; University of Calgary; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Radiation therapy; Oncology; Radiation oncologist; Cohort; Cancer; Gynecology","score_opus":0.026702329163997635,"score_gpt":0.32346463272879383,"score_spread":0.2967623035647962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013534107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685514,0.0002735817,0.000694288,0.00068500906,0.000037721406,0.0007980145,0.00059379434,0.000041752577,0.000020685138],"genre_scores_gemma":[0.99722695,0.00074018765,0.00049535034,0.00021709099,0.00009003229,0.0003756805,0.0007841524,0.00006654482,0.000004004576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671364,0.0007144159,0.0003650391,0.0010084672,0.0005243556,0.00067408464],"domain_scores_gemma":[0.9979358,0.00069073006,0.00032435812,0.00041702445,0.0003515784,0.00028054568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076845236,0.00043028346,0.0005261927,0.00016602645,0.00025141414,0.00006879242,0.0002428861,0.00019545817,0.00008493456],"category_scores_gemma":[0.00041236856,0.00026800306,0.00007345703,0.00051441113,0.00040266005,0.000025177329,0.000072028306,0.0006523766,0.0000034622678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057938643,0.0006716249,0.90127254,0.0000797993,0.00013055903,0.000042187257,0.00015353273,0.0014194323,0.005437406,7.101573e-8,0.0010329236,0.031821292],"study_design_scores_gemma":[0.0069739344,0.0036026808,0.94856894,0.0007528394,0.000037320617,0.0000025994168,0.00010695696,0.0004974837,0.039065145,0.0000017192864,0.000029792158,0.00036059672],"about_ca_topic_score_codex":0.0012295344,"about_ca_topic_score_gemma":0.0013400307,"teacher_disagreement_score":0.050964706,"about_ca_system_score_codex":0.0003077243,"about_ca_system_score_gemma":0.00038480296,"threshold_uncertainty_score":0.99997723},"labels":[],"label_agreement":null},{"id":"W3013546657","doi":"10.1158/1538-7445.sabcs19-p3-11-01","title":"Abstract P3-11-01: An updated systematic review and meta-analysis of the safety and efficacy of phosphoinositide 3-kinase inhibitors (PI3Ki) in advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Mount Sinai Hospital; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Meta-analysis; Oncology; Subgroup analysis; Breast cancer; Odds ratio; Randomized controlled trial; Cochrane Library; Confidence interval; Cancer","score_opus":0.07118330192338554,"score_gpt":0.40109474195991385,"score_spread":0.3299114400365283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013546657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7359572,0.24724884,0.00001041904,0.012498174,0.000026309435,0.0033671446,0.00082553294,0.000025291616,0.00004108567],"genre_scores_gemma":[0.9909502,0.007728117,0.000058507354,0.0008345512,0.000027785803,0.0002810004,0.000022209355,0.000037849073,0.000059760507],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9969415,0.00038055793,0.0009278301,0.0005546966,0.0008044515,0.00039097745],"domain_scores_gemma":[0.9979193,0.00024918976,0.0003742563,0.0006761127,0.00050080806,0.00028028706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010059918,0.0002581171,0.0024304253,0.0002447291,0.000080956444,0.000014086285,0.00027797432,0.00007620445,0.0008121901],"category_scores_gemma":[0.00020480782,0.00016338014,0.0003206066,0.0026029677,0.0004730816,0.00019590017,0.00015819707,0.00046047868,7.880381e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013854148,0.0012303015,0.04120283,0.55480754,0.1545678,0.00014945079,0.009051062,0.004400491,0.20845667,0.00043019533,0.00066957826,0.011179938],"study_design_scores_gemma":[0.012073465,0.00075023697,0.45225507,0.033796247,0.4109944,0.00006698373,0.003033873,0.0006570036,0.084285334,0.0000695753,0.00077160273,0.0012462137],"about_ca_topic_score_codex":0.0021303673,"about_ca_topic_score_gemma":0.0012300253,"teacher_disagreement_score":0.5210113,"about_ca_system_score_codex":0.00023042069,"about_ca_system_score_gemma":0.0003232703,"threshold_uncertainty_score":0.8892912},"labels":[],"label_agreement":null},{"id":"W3013563715","doi":"10.1158/1538-7445.sabcs19-p2-04-05","title":"Abstract P2-04-05: Loss of Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Conditional gene knockout; Cancer research; Biology; Protein kinase B; Carcinogenesis; Oncogene; Mammary tumor; Knockout mouse; Breast cancer; Progenitor cell; Cancer; Stem cell; Cell biology; Signal transduction; Phenotype; Receptor; Genetics; Cell cycle","score_opus":0.06490426113467603,"score_gpt":0.3622567748435156,"score_spread":0.2973525137088396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013563715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551327,0.004941153,0.000019082672,0.004682571,0.00037264123,0.0013198141,0.00040072366,0.00005960041,0.0026911686],"genre_scores_gemma":[0.9970693,0.00087340095,0.000044923458,0.0009829209,0.00036613454,0.00022092191,0.000050133007,0.00010714077,0.0002851336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959901,0.00024020016,0.0005732984,0.00082836393,0.0014278977,0.00094013946],"domain_scores_gemma":[0.99778336,0.00015218815,0.00015376313,0.0005620801,0.0007212482,0.00062738435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007117753,0.00031469698,0.000669963,0.00040778943,0.000098285826,0.000038334405,0.00041341543,0.00028555698,0.0007031678],"category_scores_gemma":[0.00009894719,0.00031042213,0.00016057529,0.0018738976,0.00052186614,0.00015444928,0.00022340388,0.0016717127,0.00009601095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094130915,0.00072296156,0.013222298,0.003232342,0.00079778896,0.0042062537,0.010913823,0.0013265067,0.8622888,0.00019599411,0.021655409,0.07202476],"study_design_scores_gemma":[0.029775457,0.005508587,0.23362906,0.014505112,0.00045843064,0.00025573722,0.011607836,0.0014168704,0.6631344,0.0002638417,0.03679675,0.00264793],"about_ca_topic_score_codex":0.014011718,"about_ca_topic_score_gemma":0.0019387045,"teacher_disagreement_score":0.22040676,"about_ca_system_score_codex":0.0018688175,"about_ca_system_score_gemma":0.003403574,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W3013585111","doi":"10.1158/1538-7445.sabcs19-p1-19-36","title":"Abstract P1-19-36: Exploratory analysis of TreatER+ight; a Canadian prospective real-world observational study in HR+ advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; Novartis (Canada); BC Cancer Agency; Kingston General Hospital; Ottawa Hospital; Jewish General Hospital; Saskatchewan Cancer Agency; Lions Gate Hospital; London Health Sciences Centre; Grand River Hospital; Quebec Breast Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Observational study; Breast cancer; Combination therapy; Prospective cohort study; Cancer; Palbociclib; Oncology; Metastatic breast cancer","score_opus":0.20963694267995425,"score_gpt":0.458363410279256,"score_spread":0.24872646759930173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013585111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881834,0.001251533,0.000005329432,0.0065945657,0.0000754058,0.0019006551,0.0008863964,0.00005198984,0.0010507313],"genre_scores_gemma":[0.99613684,0.00034604987,0.00007658555,0.0005060112,0.00028759806,0.002008549,0.00006331741,0.00006878288,0.00050629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962723,0.00016990596,0.00061976205,0.000884151,0.0011951705,0.000858694],"domain_scores_gemma":[0.99730307,0.0001506492,0.00015963634,0.0005332323,0.0010079101,0.00084548385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055767695,0.00030532156,0.0009236043,0.0016532957,0.00016125095,0.000029724884,0.0003517005,0.000089816436,0.0027481453],"category_scores_gemma":[0.00010345731,0.00028297884,0.00015984382,0.0070768604,0.00030064394,0.00036527365,0.0000830752,0.0007656423,0.000013499491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040201466,0.00032215583,0.96428365,0.00015638939,0.0015122574,0.00019439087,0.008259877,0.0030794963,0.0068237646,0.00009989507,0.0002598537,0.010988134],"study_design_scores_gemma":[0.0031113646,0.00023818205,0.9891056,0.00018993259,0.00024228869,0.0000013144191,0.0038799227,0.00017556449,0.0013564057,0.00006166068,0.0013955763,0.000242178],"about_ca_topic_score_codex":0.34952587,"about_ca_topic_score_gemma":0.8286124,"teacher_disagreement_score":0.47908652,"about_ca_system_score_codex":0.0039545475,"about_ca_system_score_gemma":0.004338785,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W3013587102","doi":"10.1158/1538-7445.sabcs19-p4-10-11","title":"Abstract P4-10-11: PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Hazard ratio; Oncology; Randomized controlled trial; Breast cancer; Cancer; Meta-analysis; Internal medicine; Pharmacology; Bioinformatics; Cancer research; Phosphorylation; Confidence interval; Signal transduction; Biology; Genetics","score_opus":0.20661264422578995,"score_gpt":0.4406368692390121,"score_spread":0.23402422501322212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013587102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9241227,0.05841069,0.00026746627,0.009948337,0.000107722335,0.003320543,0.0031696889,0.00006823834,0.000584611],"genre_scores_gemma":[0.9957444,0.00089244836,0.0005936426,0.00038966502,0.00054461823,0.0010880568,0.00014436075,0.00007068554,0.0005321045],"study_design_codex":"meta_analysis","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99288636,0.0014537843,0.0018750657,0.0006964622,0.002348971,0.0007393641],"domain_scores_gemma":[0.98768264,0.008574933,0.0009918698,0.00083066133,0.0014788698,0.00044101162],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00798032,0.00033878424,0.005454403,0.0004112367,0.00013452013,0.000040241783,0.0005199867,0.00014422645,0.01857991],"category_scores_gemma":[0.008584638,0.00019697228,0.002766185,0.001994965,0.0007599458,0.00014282891,0.00018946227,0.00055689603,0.000017414679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2808578,0.00031733757,0.0006810519,0.00058398343,0.36544126,0.000038223305,0.022090271,0.00192472,0.314939,0.0005064959,0.0019725207,0.010647306],"study_design_scores_gemma":[0.22098778,0.00093930046,0.0026606012,0.00033522001,0.27895927,0.0000017304619,0.01030862,0.0017256805,0.43385646,0.0036647846,0.04571607,0.0008444859],"about_ca_topic_score_codex":0.008904525,"about_ca_topic_score_gemma":0.00020065125,"teacher_disagreement_score":0.11891746,"about_ca_system_score_codex":0.00023929072,"about_ca_system_score_gemma":0.0011169028,"threshold_uncertainty_score":0.99976647},"labels":[],"label_agreement":null},{"id":"W3013591492","doi":"10.1158/1538-7445.sabcs19-p5-06-02","title":"Abstract P5-06-02: Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Proportional hazards model; Chemotherapy; Neoadjuvant therapy; Cancer; Hormonal therapy; Gastroenterology; Confidence interval","score_opus":0.06312469433361909,"score_gpt":0.36158999774526696,"score_spread":0.2984653034116479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013591492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783654,0.011571327,0.000014252287,0.008384336,0.00007329099,0.000748979,0.00073912676,0.000025566482,0.000077672135],"genre_scores_gemma":[0.9884246,0.00996719,0.0000996915,0.00062079396,0.00029027043,0.00044749782,0.000039647006,0.00006572196,0.000044567005],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99742013,0.0003329938,0.00030628862,0.0008094859,0.00049177685,0.00063929334],"domain_scores_gemma":[0.998851,0.00011946833,0.00012587245,0.00032335494,0.00037112634,0.00020914733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053148746,0.00032498257,0.0004951241,0.00008137815,0.00027058268,0.000057491423,0.0003313508,0.00017689251,0.00009991706],"category_scores_gemma":[0.000055023145,0.00027403564,0.00017525606,0.00035904848,0.000436883,0.0000166965,0.00021912252,0.00030748738,0.0000069193306],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006636501,0.00015472937,0.09738165,0.000069548165,0.00069901417,0.00008749692,0.0022606258,0.000031471594,0.8718931,0.000006353421,0.0009795696,0.01979991],"study_design_scores_gemma":[0.0034403915,0.00064664305,0.8031522,0.00017409201,0.000024633611,0.000014742883,0.00040837625,0.000012875845,0.18951872,0.00001881078,0.0022672794,0.00032121802],"about_ca_topic_score_codex":0.0022146266,"about_ca_topic_score_gemma":0.00012233706,"teacher_disagreement_score":0.70577055,"about_ca_system_score_codex":0.00014793726,"about_ca_system_score_gemma":0.00039710858,"threshold_uncertainty_score":0.9999712},"labels":[],"label_agreement":null},{"id":"W3013605142","doi":"10.1158/1538-7445.sabcs19-p4-10-09","title":"Abstract P4-10-09: Association between pertuzumab (P) induced diarrhea and skin rash and survival outcomes in patients (pts) with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Rash; Internal medicine; Pertuzumab; Cohort; Diarrhea; Adverse effect; Lapatinib; Breast cancer; Cleopatra; Metastatic breast cancer; Oncology; Cancer; Gastroenterology; Trastuzumab","score_opus":0.07070611037285134,"score_gpt":0.38938700910059765,"score_spread":0.3186808987277463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013605142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881783,0.00038899793,1.7927354e-7,0.00896881,0.00004762215,0.0019101091,0.00023507787,0.000008822281,0.00026205252],"genre_scores_gemma":[0.9986142,0.0003602127,0.0000038920602,0.00014160307,0.00013939546,0.0006347134,0.000021946216,0.000020692587,0.000063337066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976293,0.00037696672,0.00029139704,0.0004016271,0.0008722522,0.00042846124],"domain_scores_gemma":[0.99859107,0.0008453149,0.00008941061,0.00011073923,0.00022552302,0.0001379732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007990294,0.00019522313,0.0006351018,0.0001317996,0.00014505933,0.00006543286,0.00008962151,0.000068970934,0.00008716961],"category_scores_gemma":[0.00023495461,0.00011707533,0.000044350094,0.000494546,0.00009290183,0.00011000409,0.00006997685,0.00052533916,0.0000021915475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013408878,0.00026356574,0.9630554,0.00007287941,0.00041248283,0.000026482305,0.0055563017,0.0000010263869,0.00002964495,0.0000022617817,0.000090535264,0.01708055],"study_design_scores_gemma":[0.04309547,0.0016334788,0.9538514,0.00011055721,0.00010595985,3.8473436e-7,0.0009628734,0.0000069038133,0.000073583404,0.000009091487,0.00003506739,0.00011521253],"about_ca_topic_score_codex":0.012485571,"about_ca_topic_score_gemma":0.010714249,"teacher_disagreement_score":0.02968659,"about_ca_system_score_codex":0.0009558566,"about_ca_system_score_gemma":0.00034201957,"threshold_uncertainty_score":0.9940904},"labels":[],"label_agreement":null},{"id":"W3013615718","doi":"10.1158/1538-7445.sabcs19-p6-08-31","title":"Abstract P6-08-31: BRCA1 interacting protein C-terminal helicase 1 (BRIP1) as a cancer susceptibility gene","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Medicine; Ovarian cancer; Mutation; Oncology; Genetics; Internal medicine; Genetic testing; Gene; Biology","score_opus":0.09219792752257998,"score_gpt":0.43238150631789835,"score_spread":0.34018357879531835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013615718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901154,0.0027047305,0.00007632636,0.0048443675,0.0002303321,0.0008702002,0.00016772644,0.00003230852,0.0009586069],"genre_scores_gemma":[0.99404186,0.0003782079,0.00055203907,0.0007173618,0.0017554123,0.0011121373,0.000072935116,0.00006408049,0.0013059917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714786,0.00017307847,0.00037563842,0.0010097426,0.0005644938,0.0007291963],"domain_scores_gemma":[0.9982426,0.000049878323,0.00011477946,0.00061645516,0.00061474275,0.00036150275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006526128,0.00024303864,0.00022813557,0.0000797665,0.00028027434,0.00012850198,0.00058813376,0.00020139133,0.0016490074],"category_scores_gemma":[0.00066978694,0.00024863405,0.00013070958,0.00042887457,0.00030582107,0.000018659313,0.00044683597,0.0007122013,0.0001903141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358719,0.000058572703,0.0007655459,0.00015994304,0.00008295382,0.00006284521,0.0005640024,0.00019434399,0.9713585,0.000006325287,0.011712784,0.014498311],"study_design_scores_gemma":[0.0006472769,0.0002830099,0.0012352102,0.000098012504,0.000012112816,0.00002135893,0.00040689172,0.000088988076,0.9328402,0.000045917954,0.0640219,0.00029911633],"about_ca_topic_score_codex":0.0020591961,"about_ca_topic_score_gemma":0.0011076579,"teacher_disagreement_score":0.05230912,"about_ca_system_score_codex":0.00058546884,"about_ca_system_score_gemma":0.0022404979,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W3013630572","doi":"10.1158/1538-7445.sabcs19-p4-12-07","title":"Abstract P4-12-07: Single pre-operative radiation therapy (SPORT) trial for low risk breast cancer: A phase 1 study comparing pathological findings in immediate versus delayed surgery","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Breast cancer; Pathological; Radiation therapy; Cancer; Biopsy; Oncology; Internal medicine; Breast-conserving surgery; Tumor-infiltrating lymphocytes; Surgery; Pathology; Immunotherapy; Mastectomy","score_opus":0.19918085724024265,"score_gpt":0.4565327531834848,"score_spread":0.25735189594324215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013630572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039507,0.0021981793,0.000011766537,0.0017227618,0.00057132595,0.0047061504,0.00031188526,0.000052961044,0.000029891786],"genre_scores_gemma":[0.9922097,0.004097129,0.0000094650695,0.00018548439,0.0010630772,0.0022675025,0.00009864908,0.00004627855,0.00002275574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970229,0.00023432708,0.0006515672,0.00068083534,0.00071280386,0.0006975617],"domain_scores_gemma":[0.99837846,0.0007098477,0.00016743828,0.00024792925,0.00023910857,0.00025719847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019775103,0.00025775694,0.00071621523,0.00024783824,0.00024341598,0.000094122,0.00019828229,0.00015633626,0.00052563817],"category_scores_gemma":[0.00022972676,0.00021075587,0.00021681824,0.0006628434,0.00018791706,0.00018167037,0.00004391115,0.0007140945,0.000007003207],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8129962,0.002214884,0.07384981,0.000065553,0.00047882955,0.00010539243,0.00540712,0.000073689895,0.025395239,9.1307345e-7,0.0016975849,0.07771479],"study_design_scores_gemma":[0.49464345,0.015546002,0.46899366,0.0002668523,0.00011863205,0.000006221231,0.00249208,0.001270631,0.013546434,0.00000808311,0.0025124715,0.00059546717],"about_ca_topic_score_codex":0.0050505074,"about_ca_topic_score_gemma":0.00096520287,"teacher_disagreement_score":0.39514384,"about_ca_system_score_codex":0.00096438115,"about_ca_system_score_gemma":0.0009698001,"threshold_uncertainty_score":0.85943747},"labels":[],"label_agreement":null},{"id":"W3013639522","doi":"10.1158/1538-7445.sabcs19-p4-15-01","title":"Abstract P4-15-01: Fragility index of trials supporting approval of breast cancer drugs","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Clinical trial; Clinical endpoint; Cancer; Internal medicine","score_opus":0.6765800397192301,"score_gpt":0.5785032675198416,"score_spread":0.09807677219938848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013639522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419945,0.0032388945,0.00021820852,0.047696393,0.00034120036,0.0012480303,0.002802467,0.000027782615,0.0024325203],"genre_scores_gemma":[0.9969234,0.00042722424,0.0001334766,0.0012440596,0.00080714055,0.00028011322,0.000018093115,0.00003975508,0.00012676675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99081224,0.0008773577,0.0064087026,0.0007510065,0.00043127505,0.00071941805],"domain_scores_gemma":[0.99276954,0.0022476816,0.003618999,0.00055181986,0.00043231694,0.00037965857],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.056511313,0.00018957007,0.0019260859,0.0003523533,0.0001444921,0.000047610643,0.0006074792,0.00020796875,0.006782445],"category_scores_gemma":[0.008895534,0.00022023625,0.00026614702,0.0006553719,0.00030536487,0.00035756364,0.0001605458,0.0005930721,0.00020392874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013354968,0.00054019154,0.8325441,0.013482872,0.00089803553,0.0000047894728,0.024202418,0.002503525,0.003604784,0.023631856,0.08478389,0.012468059],"study_design_scores_gemma":[0.0072199106,0.00034050416,0.9005395,0.0011440456,0.000044235072,0.0000037271259,0.011054674,0.008529914,0.0060079833,0.018606858,0.045149542,0.0013590712],"about_ca_topic_score_codex":0.024753863,"about_ca_topic_score_gemma":0.00033932042,"teacher_disagreement_score":0.06799545,"about_ca_system_score_codex":0.0006586671,"about_ca_system_score_gemma":0.0013412101,"threshold_uncertainty_score":0.99945295},"labels":[],"label_agreement":null},{"id":"W3013661685","doi":"10.1158/1538-7445.sabcs19-p2-18-02","title":"Abstract P2-18-02: Fractures in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG S0307 trial (ClinicalTrials.gov Identifier: NCT00127205)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Cancer; Zoledronic acid; Oncology; Randomized controlled trial; Adverse effect; Tamoxifen; Surgery","score_opus":0.10327840464670068,"score_gpt":0.45861384327917715,"score_spread":0.35533543863247646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013661685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94606966,0.0033639544,4.6265572e-7,0.044518366,0.0007047833,0.0036365231,0.0015647411,0.000036342542,0.0001051678],"genre_scores_gemma":[0.9888182,0.003726093,0.000023487142,0.0024781367,0.0007831057,0.003222552,0.000018053148,0.00008283858,0.00084748375],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9945257,0.0005150585,0.0010428766,0.00091638014,0.0017134126,0.0012866226],"domain_scores_gemma":[0.99655586,0.00069125026,0.0003511907,0.0006927949,0.0005672048,0.0011416785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018061196,0.00038274442,0.0010782392,0.0002163988,0.00024377805,0.00007512357,0.00048540387,0.00020015765,0.009099831],"category_scores_gemma":[0.0006621287,0.00023738224,0.00015786981,0.0015727188,0.00030010453,0.00019045296,0.00024016971,0.001159562,0.00005916947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55076003,0.003752747,0.11662359,0.0020532506,0.0022968722,0.00046278577,0.004314178,0.0008146703,0.00805649,0.000030020103,0.067688674,0.24314667],"study_design_scores_gemma":[0.04761977,0.0015277901,0.91048205,0.0031868806,0.0002502684,0.00002962821,0.0005843151,0.000007143253,0.021861464,0.00012837743,0.013895004,0.00042730966],"about_ca_topic_score_codex":0.08286537,"about_ca_topic_score_gemma":0.012633656,"teacher_disagreement_score":0.79385847,"about_ca_system_score_codex":0.0012106339,"about_ca_system_score_gemma":0.0043026586,"threshold_uncertainty_score":0.991806},"labels":[],"label_agreement":null},{"id":"W3013704572","doi":"10.1158/1538-7445.sabcs19-pd4-01","title":"Abstract PD4-01: First-line veliparib plus carboplatin/paclitaxel in patients with HER2-negative advanced/metastatic g<i>BRCA</i>-associated breast cancer: Planned subgroup analysis from the phase 3 BROCADE3 trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Veliparib; Medicine; Internal medicine; Metastatic breast cancer; Carboplatin; PARP inhibitor; Placebo; Breast cancer; Hazard ratio; Population; Oncology; Clinical endpoint; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Confidence interval; Pathology; Cisplatin","score_opus":0.06192788902987865,"score_gpt":0.3858429995150197,"score_spread":0.32391511048514104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013704572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97974163,0.0018951005,0.00011700556,0.009719476,0.00016683867,0.0032082438,0.0049609127,0.0001019128,0.00008887143],"genre_scores_gemma":[0.9956532,0.0004688863,0.00016197936,0.000921022,0.00059136935,0.0012925976,0.0006870403,0.00012403177,0.000099839766],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9940756,0.00041594225,0.0008965442,0.0011943582,0.0021363327,0.0012812001],"domain_scores_gemma":[0.9959055,0.0014415722,0.00045214695,0.00072046404,0.0008791482,0.00060113316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006568893,0.0005748168,0.0014112374,0.0003504583,0.00038509924,0.00009743234,0.00061266223,0.00017805379,0.001217667],"category_scores_gemma":[0.000647392,0.00040850943,0.00025302882,0.0043713534,0.0005758779,0.00039038406,0.00016193395,0.0018182448,0.000025676623],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69775,0.0027669915,0.20426567,0.00032960865,0.008551061,0.00025124243,0.012385001,0.023681251,0.0010430632,0.000015480391,0.0012813351,0.04767935],"study_design_scores_gemma":[0.30576926,0.004281536,0.6787453,0.0012306193,0.0013598293,0.000001950824,0.0026349179,0.0023446546,0.0010712418,0.00022689636,0.0014423523,0.00089142343],"about_ca_topic_score_codex":0.019670775,"about_ca_topic_score_gemma":0.023444546,"teacher_disagreement_score":0.47447965,"about_ca_system_score_codex":0.0022186413,"about_ca_system_score_gemma":0.0012696042,"threshold_uncertainty_score":0.9998367},"labels":[],"label_agreement":null},{"id":"W3013712040","doi":"10.1158/1538-7445.sabcs19-gs5-05","title":"Abstract GS5-05: Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Biopsy; Breast cancer; Clinical endpoint; Stage (stratigraphy); Radiology; Mammography; Surrogate endpoint; Primary tumor; Breast MRI; Cancer; Clinical trial; Internal medicine; Oncology; Nuclear medicine; Metastasis","score_opus":0.23631811823399917,"score_gpt":0.4518731586365466,"score_spread":0.21555504040254742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013712040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953589,0.0004466494,0.0000108027,0.0017170472,0.000038444057,0.0015857457,0.000830122,0.0000096843405,0.0000026017854],"genre_scores_gemma":[0.9988423,0.00012966538,0.00021390321,0.00021771863,0.000064023625,0.00041089574,0.000092296694,0.000027489026,0.0000017077729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99420035,0.0026511578,0.0012382661,0.00084087456,0.0005478994,0.00052146486],"domain_scores_gemma":[0.99552226,0.0026274791,0.0005398762,0.00070296944,0.00045877794,0.00014864282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040181815,0.0003219288,0.0013414371,0.0003458895,0.00011354338,0.000021657297,0.00036748458,0.0001293635,0.00003113559],"category_scores_gemma":[0.0021832814,0.00020669053,0.0003268814,0.0012960716,0.0008054117,0.000023732762,0.00033667934,0.00029308972,3.2386941e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36853483,0.0013124257,0.5723995,0.000048515572,0.00044064576,0.000029978402,0.0013176062,0.00009285337,0.053320706,7.264476e-8,0.000013555564,0.0024893384],"study_design_scores_gemma":[0.023551546,0.0050831377,0.96634674,0.00021460604,0.0001312313,0.0000022571753,0.00084413815,0.00005388947,0.0035661203,0.0000022660859,0.00002627054,0.00017779357],"about_ca_topic_score_codex":0.0005127232,"about_ca_topic_score_gemma":0.00026814485,"teacher_disagreement_score":0.39394727,"about_ca_system_score_codex":0.00030745016,"about_ca_system_score_gemma":0.0008036741,"threshold_uncertainty_score":0.8428595},"labels":[],"label_agreement":null},{"id":"W3013722198","doi":"10.1158/1538-7445.sabcs19-p3-08-73","title":"Abstract P3-08-73: Muscle measures, body composition, and function in patients with early breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sarcopenia; Breast cancer; Sarcopenic obesity; Skeletal muscle; Cancer; Lean body mass; Body mass index; Internal medicine; Physical therapy; Body weight","score_opus":0.09491439309018287,"score_gpt":0.3928388126616879,"score_spread":0.29792441957150506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013722198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842753,0.0007560903,0.000015996548,0.013817794,0.000061642175,0.00059209834,0.000063984146,0.000031632328,0.00038545343],"genre_scores_gemma":[0.9978172,0.00032461682,0.00003297754,0.0013381735,0.00027382813,0.00012854999,0.00002606951,0.00002152245,0.000037021633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985043,0.00006241075,0.00017513169,0.00028349366,0.00063158036,0.000343117],"domain_scores_gemma":[0.9990412,0.0000298028,0.000032384592,0.00011060079,0.0004510024,0.0003350105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027562556,0.000087997076,0.00017412564,0.00014185048,0.00014423377,0.000034899433,0.00005009243,0.000057522513,0.0005780874],"category_scores_gemma":[0.000012229761,0.000074676085,0.000014961083,0.0004118192,0.00009781453,0.00011963073,0.00002580061,0.00056035153,0.000023314722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045207436,0.000222842,0.95581543,0.00068260165,0.00003048631,0.000020229587,0.00056916807,0.000008140838,0.008785573,0.000041169114,0.006218345,0.023085281],"study_design_scores_gemma":[0.003970074,0.0003081296,0.9891129,0.00053426344,0.000010094344,0.0000013865048,0.00006822813,0.000030064484,0.00022360853,0.000017252014,0.0056458837,0.00007810711],"about_ca_topic_score_codex":0.0020563493,"about_ca_topic_score_gemma":0.00026295864,"teacher_disagreement_score":0.03329749,"about_ca_system_score_codex":0.00026566113,"about_ca_system_score_gemma":0.00026164693,"threshold_uncertainty_score":0.6329652},"labels":[],"label_agreement":null},{"id":"W3013726931","doi":"10.1158/1538-7445.sabcs19-pd6-1","title":"Abstract PD6-1: BREAST-Q satisfaction and quality of life outcomes in young women undergoing mastectomy and reconstruction for breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Psychosocial; Quality of life (healthcare); Breast reconstruction; Cohort; Patient satisfaction; Prospective cohort study; Cancer; Gynecology; Internal medicine; Surgery","score_opus":0.1024491328604542,"score_gpt":0.39538417642405904,"score_spread":0.29293504356360484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013726931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955326,0.00032976337,0.000019203713,0.0030083344,0.00017573564,0.0005473666,0.00029513802,0.00001996403,0.00007192465],"genre_scores_gemma":[0.99902016,0.0004347133,0.00009274117,0.000029073859,0.00021831051,0.0001418776,0.000004008083,0.000016412238,0.000042700583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986903,0.00007452947,0.00035081457,0.0003016111,0.00026604361,0.00031669642],"domain_scores_gemma":[0.99915016,0.00021434714,0.00010781103,0.00008743462,0.00019509078,0.000245143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669165,0.00011347873,0.00038516975,0.00018934789,0.00008986443,0.000026465741,0.000031098454,0.000112007394,0.00021682316],"category_scores_gemma":[0.00007363883,0.000096963144,0.000035326648,0.000236787,0.00020458201,0.00019862481,0.000033239336,0.00031908526,8.692465e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013345534,0.000011487049,0.71058583,0.00090079615,0.00006495856,6.2581654e-7,0.00043659905,0.0000029202522,0.011321472,0.00003068479,0.00001858627,0.2752915],"study_design_scores_gemma":[0.002912251,0.00006493287,0.9929412,0.00025859123,0.0000121966095,0.0008905615,0.0021842811,0.000068326524,0.0004638359,0.00010248741,0.0000050137655,0.00009630198],"about_ca_topic_score_codex":0.005231094,"about_ca_topic_score_gemma":0.004874232,"teacher_disagreement_score":0.2823554,"about_ca_system_score_codex":0.00026660482,"about_ca_system_score_gemma":0.0004084315,"threshold_uncertainty_score":0.7907885},"labels":[],"label_agreement":null},{"id":"W3013767050","doi":"10.1158/1538-7445.sabcs19-pd2-08","title":"Abstract PD2-08: Gene expression analysis and association with treatment response in postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer in the MONALEESA-3 study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Medicine; Breast cancer; Estrogen receptor; Internal medicine; Oncology; Cancer; Hazard ratio; Lapatinib; Cancer research; Progression-free survival; Metastatic breast cancer; Endocrinology; Trastuzumab; Confidence interval; Chemotherapy","score_opus":0.023338589891249647,"score_gpt":0.3491227203401349,"score_spread":0.32578413044888527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013767050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129725,0.0009742023,0.000012178395,0.004732564,0.0000122126185,0.002469488,0.00045628138,0.000020851909,0.000024946607],"genre_scores_gemma":[0.9973578,0.00053156633,0.00022585545,0.00017485033,0.00008336937,0.0014722993,0.00004334569,0.000044131848,0.00006679253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963536,0.00073097885,0.00030800098,0.0007077351,0.0013375649,0.0005620665],"domain_scores_gemma":[0.9981876,0.00058799237,0.00017472997,0.0003050997,0.00054656575,0.00019801126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007196618,0.00029226692,0.0005476186,0.00037569483,0.00016035378,0.00004689541,0.00015742778,0.000081750346,0.00012498052],"category_scores_gemma":[0.0000891561,0.00017470172,0.0000365755,0.0023278059,0.00014715674,0.0002718141,0.000054614655,0.0005828591,0.0000037271368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103197336,0.0010453563,0.8188128,0.000019802123,0.00074954424,0.00008762973,0.014033889,0.0011114839,0.049859226,4.0857194e-7,0.000015874783,0.011066635],"study_design_scores_gemma":[0.012323001,0.0051008533,0.9699569,0.0001839811,0.00016345149,0.0000016155361,0.0053321975,0.000020269632,0.0066730585,0.0000038578173,0.0000483175,0.0001925139],"about_ca_topic_score_codex":0.0031492133,"about_ca_topic_score_gemma":0.002719827,"teacher_disagreement_score":0.15114407,"about_ca_system_score_codex":0.002608773,"about_ca_system_score_gemma":0.00042780684,"threshold_uncertainty_score":0.71241295},"labels":[],"label_agreement":null},{"id":"W3013769352","doi":"10.1158/1538-7445.sabcs19-p3-08-22","title":"Abstract P3-08-22: The mutational landscape of cancer driver genes in matched primary ductal carcinoma <i>in situ</i> and recurrent ductal carcinoma <i>in situ</i> or recurrent invasive cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Ductal carcinoma; Medicine; Breast cancer; Oncology; Radiation therapy; Mastectomy; Cancer; Internal medicine; Breast-conserving surgery; Carcinoma","score_opus":0.037254551072187336,"score_gpt":0.31956651078084425,"score_spread":0.2823119597086569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013769352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641529,0.032236047,0.0000015039576,0.0017489002,0.00025583484,0.00071550714,0.0003642846,0.0000037691445,0.0005212524],"genre_scores_gemma":[0.9837342,0.014771943,0.000031106785,0.00037864066,0.00047026234,0.000389544,0.00015490336,0.000037707552,0.000031706193],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99755794,0.00014941789,0.00049541314,0.00072887784,0.0004601303,0.00060823426],"domain_scores_gemma":[0.9989583,0.00020709714,0.00013300814,0.00028783228,0.00022087035,0.00019289716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041436686,0.00026248506,0.0003803802,0.00015496736,0.0000810118,0.000045555826,0.00039656195,0.00016195935,0.000101508405],"category_scores_gemma":[0.00015839995,0.00022026338,0.00008051703,0.00053091766,0.00032077014,0.000017905233,0.00035662486,0.00051726267,0.000003069143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028054877,0.00012682234,0.32100546,0.00049507624,0.00006242838,0.00028348103,0.002278452,0.002169656,0.65939784,0.0000310412,0.004142243,0.007201993],"study_design_scores_gemma":[0.0042682844,0.00063742144,0.7196246,0.00025717227,0.00002844316,0.000021803446,0.0019308998,0.00018537289,0.2696413,0.000074531614,0.0027932783,0.0005369319],"about_ca_topic_score_codex":0.0047509903,"about_ca_topic_score_gemma":0.048003964,"teacher_disagreement_score":0.3986191,"about_ca_system_score_codex":0.00043603848,"about_ca_system_score_gemma":0.0026894931,"threshold_uncertainty_score":0.9693675},"labels":[],"label_agreement":null},{"id":"W3013771809","doi":"10.1158/1538-7445.sabcs19-pd10-06","title":"Abstract PD10-06: Clinical benefit of breast cancer drugs approved by the United States Food and Drug Administration","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Food and drug administration; Breast cancer; Clinical Oncology; Cancer; Clinical research; Internal medicine; Drug; Oncology; Cancer drugs; Quality of life (healthcare); Family medicine; Pharmacology","score_opus":0.5006780609041618,"score_gpt":0.5301298673329642,"score_spread":0.029451806428802407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013771809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79052615,0.0036088114,0.000031779713,0.202271,0.00011281249,0.0006353543,0.002527657,0.000017810473,0.00026864387],"genre_scores_gemma":[0.9898703,0.0033497144,0.000042704636,0.0055579077,0.00043701212,0.00025705926,0.00012888049,0.000031402597,0.00032502945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959724,0.00037499066,0.0024270194,0.00057454396,0.00022143441,0.00042964047],"domain_scores_gemma":[0.9962825,0.0018215751,0.00094209984,0.00036412987,0.0002702782,0.00031941762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013304575,0.00014714115,0.00060969114,0.00015006539,0.0002362498,0.000112662165,0.00039904352,0.000120098106,0.00052145903],"category_scores_gemma":[0.0010190259,0.00014382832,0.00007995918,0.00045676596,0.0003509078,0.00023827126,0.00009800706,0.0005252122,0.00011311752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006320801,0.0004225448,0.19643867,0.0025738643,0.0006273286,0.0000013464463,0.019397795,0.0007747904,0.00014040967,0.037658032,0.7353018,0.006031316],"study_design_scores_gemma":[0.006557438,0.0009906046,0.28369957,0.0006234768,0.00004578325,0.000005887223,0.027959922,0.022133922,0.0009137832,0.018993814,0.6366812,0.0013945706],"about_ca_topic_score_codex":0.008404724,"about_ca_topic_score_gemma":0.0008846978,"teacher_disagreement_score":0.19934416,"about_ca_system_score_codex":0.00025977442,"about_ca_system_score_gemma":0.00042885786,"threshold_uncertainty_score":0.9981984},"labels":[],"label_agreement":null},{"id":"W3013777135","doi":"10.1158/1538-7445.sabcs19-pd5-03","title":"Abstract PD5-03: Relationship between tumor-infiltrating lymphocytes (TILs) and outcomes in the KEYNOTE-119 study of pembrolizumab vs chemotherapy for previously treated metastatic triple-negative breast cancer (mTNBC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Taxane; Oncology; Gemcitabine; Vinorelbine; Tumor-infiltrating lymphocytes; Capecitabine; Breast cancer; Triple-negative breast cancer; Anthracycline; Chemotherapy; Eribulin; Metastatic breast cancer; Cancer; Immunotherapy; Colorectal cancer; Cisplatin","score_opus":0.1464990798915513,"score_gpt":0.4320991207423987,"score_spread":0.2856000408508474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013777135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862524,0.001483155,0.0000064179667,0.0075079603,0.000030051026,0.004329527,0.00027592562,0.000026960905,0.00008758673],"genre_scores_gemma":[0.99750483,0.00034796534,0.00005449509,0.000529755,0.00014535885,0.0012423052,0.000017764893,0.000048213322,0.00010931845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972341,0.00037764362,0.0006639471,0.00048288231,0.00072712224,0.0005142939],"domain_scores_gemma":[0.99651706,0.002483359,0.00022207259,0.0003206503,0.00031280724,0.00014404536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014012717,0.00026093857,0.00072942354,0.0002298128,0.00022558955,0.00006790623,0.00028593457,0.00006793061,0.00016220583],"category_scores_gemma":[0.0005270293,0.00017359733,0.0001319155,0.0010514912,0.00027053137,0.00015562683,0.00003415815,0.00046301924,0.0000018231731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014466753,0.00036388543,0.95118773,0.0006662508,0.00065480225,0.000018157754,0.018030848,0.000014775644,0.0031974772,0.0000117193595,0.000565336,0.010822268],"study_design_scores_gemma":[0.020920437,0.0014538467,0.96611714,0.00032253857,0.00014292523,0.000008540852,0.0073289825,0.00009709433,0.003243189,0.00006448593,0.00012604786,0.00017474031],"about_ca_topic_score_codex":0.008873901,"about_ca_topic_score_gemma":0.001266241,"teacher_disagreement_score":0.014929446,"about_ca_system_score_codex":0.00045938417,"about_ca_system_score_gemma":0.0007384952,"threshold_uncertainty_score":0.9977261},"labels":[],"label_agreement":null},{"id":"W3013804677","doi":"10.1158/1538-7445.sabcs19-p2-08-01","title":"Abstract P2-08-01: Alcohol and tobacco use in relation to mammographic density in 23,456 women","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Menarche; Mammography; Body mass index; Population; Cohort; Menopause; Gynecology; Family history; Hormone replacement therapy (female-to-male); Cancer; Digital mammography; Breast cancer screening; Internal medicine; Oncology; Obstetrics; Demography; Environmental health","score_opus":0.15476260527837593,"score_gpt":0.4136148345836343,"score_spread":0.25885222930525836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013804677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434453,0.00036789363,0.0000026789014,0.004299241,0.000047891725,0.00067171216,0.000015935238,0.000019929284,0.00023016428],"genre_scores_gemma":[0.9982228,0.0007418795,0.000027865199,0.0005794656,0.0001285751,0.0001327131,0.00000824698,0.0000206636,0.00013775498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837804,0.000059494785,0.0002271817,0.00039761054,0.00044970235,0.0004879692],"domain_scores_gemma":[0.9991674,0.00011075864,0.000024097753,0.00020259568,0.00009180648,0.00040333765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005296234,0.000106250794,0.00025080203,0.0004178478,0.00004915981,0.00005116909,0.00008259183,0.00010246572,0.00024442113],"category_scores_gemma":[0.00027679812,0.000100378486,0.000029234583,0.0011987655,0.00008014831,0.00016209303,0.00009470647,0.00070324383,0.000041299827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010318974,0.00003961058,0.97241217,0.000079133824,0.000013843014,0.00011438614,0.0028256811,0.00003739307,0.013436631,0.000023850349,0.0015454254,0.00844],"study_design_scores_gemma":[0.0013827442,0.00016154663,0.9915387,0.00014900116,0.0000031195516,0.0000019436584,0.0004801489,0.000035246692,0.00083081424,0.00004528884,0.005271324,0.00010013728],"about_ca_topic_score_codex":0.0075622573,"about_ca_topic_score_gemma":0.008538467,"teacher_disagreement_score":0.019126538,"about_ca_system_score_codex":0.00052355736,"about_ca_system_score_gemma":0.00022338421,"threshold_uncertainty_score":0.99904644},"labels":[],"label_agreement":null},{"id":"W3013807346","doi":"10.1158/1538-7445.sabcs19-p4-15-05","title":"Abstract P4-15-05: Participation of emerging regions in practice-changing breast cancer trials over the last three decades","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Clinical trial; Latin Americans; Medicine; Population; Clinical Practice; Demography; Incidence (geometry); Cancer; Family medicine; Geography; Political science; Environmental health; Pathology; Internal medicine; Sociology","score_opus":0.4486394229350884,"score_gpt":0.5505040190837452,"score_spread":0.10186459614865684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013807346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94190866,0.004332424,0.0001441865,0.051436063,0.00013488156,0.00084753276,0.00005695517,0.00002711176,0.0011121726],"genre_scores_gemma":[0.99621534,0.0012422657,0.000057458354,0.0012919642,0.0007977509,0.00033405525,0.000005315976,0.000024814399,0.000031011827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969836,0.00031021782,0.00058624434,0.00034881165,0.0011263341,0.0006447749],"domain_scores_gemma":[0.99775773,0.00096016907,0.00023620375,0.00028808526,0.00054078357,0.00021703342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003731238,0.00014018959,0.00044389218,0.00023180593,0.00018879735,0.00005002498,0.00024347114,0.000092664784,0.00070875883],"category_scores_gemma":[0.0025995474,0.00009950416,0.000118701886,0.0016131294,0.00018389615,0.00034926497,0.00012649367,0.00074184145,0.000013512811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012975288,0.00046213286,0.5289714,0.0014782131,0.0011432994,0.00079132704,0.033525284,0.0092156045,0.1625661,0.0056536533,0.055995557,0.18722215],"study_design_scores_gemma":[0.0051167947,0.00045893702,0.9228405,0.004084283,0.0004251312,0.000056194895,0.01670849,0.0029980908,0.024038225,0.0005129271,0.022291075,0.00046937924],"about_ca_topic_score_codex":0.007425941,"about_ca_topic_score_gemma":0.0046043973,"teacher_disagreement_score":0.39386907,"about_ca_system_score_codex":0.0003353342,"about_ca_system_score_gemma":0.00071052666,"threshold_uncertainty_score":0.9991837},"labels":[],"label_agreement":null},{"id":"W3013831414","doi":"10.1158/1538-7445.sabcs19-p5-08-08","title":"Abstract P5-08-08: Risk reducing mastectomy in average and high risk patients with locally advanced triple negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Mastectomy; Internal medicine; Chemotherapy; Cancer; Oncology; Disease; Surgery","score_opus":0.017069581201442467,"score_gpt":0.31320017346109835,"score_spread":0.2961305922596559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013831414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957447,0.0014104807,0.00018911259,0.00063673215,0.00011297493,0.00077582744,0.0009456263,0.000013681825,0.0001708579],"genre_scores_gemma":[0.9955967,0.0028046458,0.00050730095,0.00012864434,0.00027721623,0.00046820482,0.000054418877,0.00005562143,0.000107229695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776155,0.00020437154,0.0002605087,0.0007943462,0.00044579385,0.0005334527],"domain_scores_gemma":[0.9987753,0.000058563393,0.00014327512,0.00032637283,0.00048109048,0.00021541295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032743215,0.00021617989,0.00022753868,0.00010423046,0.00021017565,0.00005888179,0.00026442177,0.00013994938,0.00029598156],"category_scores_gemma":[0.00020275061,0.00019314371,0.000036722035,0.00055732095,0.000269533,0.000023867324,0.00019460486,0.000663249,0.000011121252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008708956,0.00025468416,0.49269193,0.0003243454,0.0005013987,0.00003471187,0.0033541159,0.058370322,0.08842059,0.000012037321,0.005288455,0.34203845],"study_design_scores_gemma":[0.009878791,0.00067836914,0.8888232,0.00026236734,0.00003458041,0.0000026876858,0.0006182841,0.00048285912,0.09495756,0.000099330646,0.0035817202,0.00058025814],"about_ca_topic_score_codex":0.00463126,"about_ca_topic_score_gemma":0.0026026573,"teacher_disagreement_score":0.39613125,"about_ca_system_score_codex":0.00036852807,"about_ca_system_score_gemma":0.0008250098,"threshold_uncertainty_score":0.7876172},"labels":[],"label_agreement":null},{"id":"W3013854659","doi":"10.1158/1538-7445.sabcs19-p2-12-07","title":"Abstract P2-12-07: Vaginal and sexual health of hormone-receptor positive breast cancer survivors on oral endocrine therapy: A cross-sectional study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Letrozole; Cancer; Gynecology; Quality of life (healthcare); Exemestane; Population; Outpatient clinic; Reproductive health; Anastrozole; Internal medicine; Oncology; Obstetrics; Nursing","score_opus":0.11799883760796649,"score_gpt":0.44448202598615577,"score_spread":0.3264831883781893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013854659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98568004,0.0040813084,0.0000029487887,0.0071468637,0.00031607668,0.0011858441,0.001263918,0.000042910997,0.00028007777],"genre_scores_gemma":[0.9961853,0.0013835244,0.00000465798,0.00079973467,0.00087436265,0.00028417172,0.000049155442,0.00005282829,0.00036629048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965562,0.00026032122,0.00041176518,0.0007017846,0.0014151256,0.0006547732],"domain_scores_gemma":[0.9982325,0.00017304292,0.00010819709,0.00026706763,0.0006502531,0.0005689393],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081937603,0.00024958915,0.00051554263,0.0001836987,0.00023999307,0.00007433473,0.00019313076,0.000075575146,0.0012769949],"category_scores_gemma":[0.000036603305,0.00021167769,0.00007695144,0.000530146,0.00035773832,0.00012118576,0.000108283355,0.0009255406,0.000022600529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013673335,0.0006878675,0.9403241,0.00024751085,0.00037628206,0.000052875286,0.0072787916,0.00002492811,0.011815374,0.000036649686,0.0035874557,0.021894813],"study_design_scores_gemma":[0.0038087822,0.0042666113,0.9854349,0.00006093497,0.000009962753,0.000015778798,0.0029731211,0.0000151202175,0.0011918502,0.0000058005558,0.0020395182,0.00017764898],"about_ca_topic_score_codex":0.11870544,"about_ca_topic_score_gemma":0.018816585,"teacher_disagreement_score":0.099888854,"about_ca_system_score_codex":0.000543956,"about_ca_system_score_gemma":0.0012535454,"threshold_uncertainty_score":0.999636},"labels":[],"label_agreement":null},{"id":"W3013855196","doi":"10.1158/1538-7445.sabcs19-pd5-06","title":"Abstract PD5-06: Digital spatial mapping of the immune landscape of triple negative breast cancer reveals novel features of immune-tumor cell interaction","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Immune system; Tumor-infiltrating lymphocytes; CD8; Stroma; Stromal cell; Medicine; Tumor microenvironment; Cancer research; T cell; Oncology; Pathology; Biology; Cancer; Internal medicine; Immunohistochemistry; Immunology","score_opus":0.04873867938235124,"score_gpt":0.34768320448471385,"score_spread":0.2989445251023626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013855196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804855,0.0049228515,0.000017110246,0.0031922294,0.00029548974,0.0008255296,0.00085276633,0.000011341773,0.0018341416],"genre_scores_gemma":[0.9983656,0.0005874131,0.000017836985,0.000078847275,0.0002382389,0.00005951112,0.00001793145,0.000027475142,0.0006071665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804556,0.0000631401,0.0006294694,0.00026088522,0.0007027188,0.000298222],"domain_scores_gemma":[0.998387,0.0001703576,0.00044487015,0.00033462304,0.0005826889,0.000080497375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041246557,0.00015523308,0.0004861541,0.00014561122,0.000074518946,0.000022188417,0.0003162581,0.000078475176,0.00069480203],"category_scores_gemma":[0.00014741026,0.00010809476,0.00027546487,0.0007891966,0.0003447633,0.00014977173,0.00013315314,0.0005502519,0.0000023117477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007153872,0.00018593651,0.008378693,0.00093216123,0.00026017096,0.0000026638331,0.002008131,0.000018779598,0.9678398,0.000004756337,0.0020003729,0.011214708],"study_design_scores_gemma":[0.0031017573,0.00019010002,0.4371948,0.0011073782,0.000027228307,0.000008608153,0.0019484619,0.000034156583,0.55547416,0.000007093642,0.0008150978,0.00009117614],"about_ca_topic_score_codex":0.00986733,"about_ca_topic_score_gemma":0.00013435783,"teacher_disagreement_score":0.42881608,"about_ca_system_score_codex":0.00018005796,"about_ca_system_score_gemma":0.0006318932,"threshold_uncertainty_score":0.99672604},"labels":[],"label_agreement":null},{"id":"W3013899227","doi":"10.1158/1538-7445.sabcs19-p4-14-09","title":"Abstract P4-14-09: Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Triple-negative breast cancer; Breast cancer; Taxane; Anthracycline; Chemotherapy; Confidence interval; Meta-analysis; Cancer; Surgery","score_opus":0.22982111868810523,"score_gpt":0.4780810175425407,"score_spread":0.24825989885443545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013899227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93374586,0.003816985,0.00001643969,0.05792267,0.00007953401,0.0016029893,0.0010176633,0.00006658302,0.0017312915],"genre_scores_gemma":[0.99200565,0.0007855531,0.00006669005,0.0025197645,0.00034831392,0.0013027255,0.000045724308,0.000048719918,0.0028768817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719226,0.00021683634,0.00039925822,0.00068588014,0.00080857065,0.00069719873],"domain_scores_gemma":[0.9984476,0.0003383119,0.00011141619,0.00032333357,0.00034045023,0.00043887275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005435567,0.0002718922,0.001175152,0.00050068623,0.00011229927,0.000046405312,0.00024221021,0.00013818571,0.03492806],"category_scores_gemma":[0.000045248333,0.00021702616,0.00066313153,0.002852709,0.00021374985,0.0001032317,0.000044794375,0.000867767,0.00007440956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052188437,0.0032838448,0.4119424,0.0014079046,0.30011117,0.0019616163,0.019099763,0.008662784,0.11704862,0.0001093481,0.059152044,0.025032064],"study_design_scores_gemma":[0.04329338,0.0017667125,0.7132626,0.00008558218,0.056218803,0.000005446187,0.0006568258,0.004427622,0.14429376,0.000087330925,0.034807898,0.001094016],"about_ca_topic_score_codex":0.031289335,"about_ca_topic_score_gemma":0.0062811677,"teacher_disagreement_score":0.30132023,"about_ca_system_score_codex":0.00072518,"about_ca_system_score_gemma":0.0011200324,"threshold_uncertainty_score":0.9751614},"labels":[],"label_agreement":null},{"id":"W3013900427","doi":"10.1158/1538-7445.sabcs19-p1-19-03","title":"Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cohort; Metastatic breast cancer; Oncology; Breast cancer; Regimen; PARP inhibitor; Avelumab; Cancer; Immunotherapy; Pembrolizumab; Poly ADP ribose polymerase","score_opus":0.16122024825631753,"score_gpt":0.47931689957853846,"score_spread":0.3180966513222209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013900427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97671145,0.0031763555,0.00002179711,0.010252972,0.00040750357,0.0028888737,0.0049788714,0.00014690116,0.0014152466],"genre_scores_gemma":[0.9931789,0.0023872857,0.000098347264,0.0008830493,0.0013902298,0.0013823517,0.00022416544,0.00012356715,0.00033209196],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99364406,0.00031891387,0.0012348786,0.001356878,0.0024531032,0.0009921519],"domain_scores_gemma":[0.99581945,0.0005557681,0.00039134378,0.00105241,0.0011209869,0.0010600325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010586428,0.00043084662,0.0011263805,0.00029258148,0.00026122926,0.00005878665,0.00055784587,0.00021895958,0.0035881756],"category_scores_gemma":[0.0004513991,0.0004003851,0.0001743381,0.001365091,0.0004761235,0.00024600484,0.0002218337,0.001435136,0.00011327468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1676855,0.013003948,0.014444756,0.0013767213,0.0030388366,0.002669818,0.06289142,0.0033943383,0.4926737,0.000050142044,0.1464773,0.09229353],"study_design_scores_gemma":[0.45303497,0.010434585,0.1465093,0.0060310625,0.00078046817,0.00012013267,0.02827246,0.0031180119,0.2831065,0.00050022337,0.06530174,0.0027905265],"about_ca_topic_score_codex":0.015907455,"about_ca_topic_score_gemma":0.0015256293,"teacher_disagreement_score":0.28534946,"about_ca_system_score_codex":0.0014961576,"about_ca_system_score_gemma":0.0026894202,"threshold_uncertainty_score":0.9998448},"labels":[],"label_agreement":null},{"id":"W3013990084","doi":"10.1158/1538-7445.sabcs19-p5-12-05","title":"Abstract P5-12-05: Clinical outcomes in early breast cancer patients on adjuvant tamoxifen: Impact of CYP2D6 genotype and observed endoxifen concentrations","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Internal medicine; CYP2D6; Adjuvant therapy; Hormonal therapy; Cancer; Pharmacogenomics; Genotype; Pharmacology","score_opus":0.08389931081199875,"score_gpt":0.41448070110808566,"score_spread":0.3305813902960869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013990084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729085,0.0011801212,7.926916e-7,0.0005184882,0.00009191657,0.000459704,0.00032936133,0.000005899672,0.00012286808],"genre_scores_gemma":[0.99747545,0.0020733762,0.00000810402,0.00011548811,0.0001456738,0.000054299613,0.00005415811,0.000023456101,0.000050013336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842316,0.0001829664,0.0003362363,0.0003933528,0.00028379774,0.00038047333],"domain_scores_gemma":[0.9991666,0.00008945557,0.000084939675,0.00019770632,0.00019313545,0.0002681719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027205973,0.00015132817,0.000281205,0.00004687293,0.00006112017,0.000022663622,0.00018887025,0.0002190635,0.00005533926],"category_scores_gemma":[0.0001686024,0.00011583128,0.0001354312,0.00015449659,0.0002040749,0.000008915821,0.00010725396,0.00047135766,0.000008010271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094101275,0.00019608285,0.87490726,0.000029033205,0.00017571417,0.000009962777,0.00017374355,0.000105437386,0.11955603,0.000007745179,0.0012283551,0.0026696469],"study_design_scores_gemma":[0.0018764634,0.0012408952,0.97695476,0.00004779677,0.000011753739,6.4849297e-7,0.000018235025,0.00003237292,0.019552365,0.0000063830385,0.00013509725,0.00012323103],"about_ca_topic_score_codex":0.0014769287,"about_ca_topic_score_gemma":0.0001947064,"teacher_disagreement_score":0.102047525,"about_ca_system_score_codex":0.00006715465,"about_ca_system_score_gemma":0.00041851337,"threshold_uncertainty_score":0.47234628},"labels":[],"label_agreement":null},{"id":"W3014011642","doi":"10.1158/1538-7445.sabcs19-p1-19-46","title":"Abstract P1-19-46: A phase Ib dose escalation study evaluating the mutant selective PI3K-alpha inhibitor GDC-0077 (G) in combination with letrozole (L) with and without palbociclib (P) in patients with <i>PIK3CA</i>-mutant HR+/HER2- breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Palbociclib; Medicine; Letrozole; Breast cancer; Pharmacodynamics; Cancer; Pharmacokinetics; Pharmacology; Metastatic breast cancer; Combination therapy; PI3K/AKT/mTOR pathway; Internal medicine; Chemistry; Signal transduction; Tamoxifen","score_opus":0.057163889637291375,"score_gpt":0.41684407488504693,"score_spread":0.3596801852477556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014011642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910077,0.00045891805,0.00006608725,0.0029367069,0.00003614783,0.005284391,0.00008962051,0.000058490932,0.000061933606],"genre_scores_gemma":[0.9975563,0.000049555867,0.00010525048,0.0003050473,0.00019586063,0.0016217801,0.00002899106,0.000114511466,0.000022649254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99521434,0.00043410473,0.0005107512,0.000966076,0.002045343,0.00082938554],"domain_scores_gemma":[0.9977713,0.0002196662,0.0002666242,0.00038497697,0.0010179156,0.000339467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011364629,0.00042418795,0.00062488194,0.00032389053,0.0003048115,0.00010679811,0.00021550895,0.00009875916,0.00011696774],"category_scores_gemma":[0.00011650622,0.0002609482,0.000028774697,0.002245168,0.00048821484,0.00052264216,0.00009690307,0.0013692536,0.0000027998196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053869274,0.00203448,0.86466205,0.00022086862,0.00024318682,0.00006729672,0.013827002,0.0012019719,0.010455334,0.0000075254825,0.00001795046,0.05339304],"study_design_scores_gemma":[0.059777144,0.011457678,0.91623145,0.0012757566,0.00011035097,0.000021653535,0.006495438,0.001702289,0.0024392668,0.000031536136,0.00004561733,0.00041180354],"about_ca_topic_score_codex":0.0036193714,"about_ca_topic_score_gemma":0.0073152683,"teacher_disagreement_score":0.05298124,"about_ca_system_score_codex":0.0015055737,"about_ca_system_score_gemma":0.0013760488,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W3014049252","doi":"10.1158/1538-7445.sabcs19-p2-11-02","title":"Abstract P2-11-02: Breast Cancer Index predicts benefit from extended endocrine therapy in HR+ breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Oncology; Internal medicine; Adjuvant therapy; Cancer; Endocrine system; Retrospective cohort study; Stage (stratigraphy); Gynecology; Hormone","score_opus":0.04579644409668298,"score_gpt":0.3626223422223657,"score_spread":0.31682589812568274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014049252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95762295,0.018042406,0.0000067278393,0.01734692,0.00028394698,0.0006779688,0.0056760525,0.00004609876,0.00029693663],"genre_scores_gemma":[0.9713596,0.023106769,0.00001504804,0.0010695154,0.0022925972,0.0016512558,0.00018556026,0.00010109329,0.00021856926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963241,0.000116414965,0.00041205817,0.0012301116,0.00079983746,0.0011174397],"domain_scores_gemma":[0.9983525,0.00006167789,0.00011590143,0.00057306385,0.0004928188,0.00040403783],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019038595,0.0004545872,0.00048336698,0.00013536113,0.00021466428,0.00007934483,0.0006602405,0.00021908598,0.0024989215],"category_scores_gemma":[0.000029014967,0.00040578307,0.0001423972,0.0006027119,0.00033902167,0.000028115857,0.0004288512,0.00056709384,0.000026952875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054523693,0.0004596757,0.63129747,0.00011560182,0.00076797546,0.00011526239,0.00089930947,0.0007408061,0.21915391,0.000025763491,0.018052615,0.12291924],"study_design_scores_gemma":[0.004060315,0.00011122507,0.942636,0.00019044332,0.000022621947,0.000013159454,0.00026468563,0.000042553267,0.041746717,0.00007827675,0.010404316,0.00042969864],"about_ca_topic_score_codex":0.05533919,"about_ca_topic_score_gemma":0.025924627,"teacher_disagreement_score":0.3113385,"about_ca_system_score_codex":0.00046285326,"about_ca_system_score_gemma":0.00081494317,"threshold_uncertainty_score":0.9998394},"labels":[],"label_agreement":null},{"id":"W3014082077","doi":"10.1158/1538-7445.sabcs19-p3-07-08","title":"Abstract P3-07-08: Comparison of MammaTyper® RT-qPCR based subtyping with simulated breast cancer prognostic signatures","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Subtyping; Breast cancer; Oncology; Pairwise comparison; Internal medicine; Cancer; Medicine; Artificial intelligence; Computer science","score_opus":0.053044156291189956,"score_gpt":0.3979662930775171,"score_spread":0.3449221367863271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014082077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922225,0.0023446546,0.0017115482,0.0025530958,0.000017182709,0.00066436164,0.00018290606,0.000034530694,0.00026925356],"genre_scores_gemma":[0.99868125,0.00017531992,0.00032297987,0.0002883137,0.00013448781,0.00020250723,0.00012073224,0.000034407494,0.000040016566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986409,0.0000825626,0.00021593767,0.0004495236,0.00025263897,0.00035843055],"domain_scores_gemma":[0.9990054,0.000036435547,0.00009128568,0.00031318676,0.0004063673,0.00014736694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018309981,0.00015201344,0.00020627072,0.000050948864,0.000119433724,0.000021098718,0.00034237452,0.000209848,0.0002836827],"category_scores_gemma":[0.000047718386,0.00012545474,0.00006017469,0.0003012964,0.00025627014,0.0000033744877,0.000101943566,0.00036867254,0.000008979239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005024072,0.00008599529,0.020272842,0.00012552872,0.00007341203,0.000004341518,0.000033097567,0.0046825684,0.9688088,0.00004659746,0.0028858474,0.0024785222],"study_design_scores_gemma":[0.00082537497,0.0005212417,0.029153077,0.00018251064,0.00003554591,0.0000025308566,0.00007986158,0.0032384822,0.94996357,0.0000212348,0.01565036,0.0003261906],"about_ca_topic_score_codex":0.0002647083,"about_ca_topic_score_gemma":0.00009522305,"teacher_disagreement_score":0.01884525,"about_ca_system_score_codex":0.000029342897,"about_ca_system_score_gemma":0.00037706163,"threshold_uncertainty_score":0.5115896},"labels":[],"label_agreement":null},{"id":"W3014446514","doi":"","title":"Induction of an anti-angiogenesis factor, Thrombospondin 1 (TSP-1), by a novel histone deacetylase inhibitor, MGCD0103, in human cancer cells in vitro and in vivo","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angiogenesis; Cancer research; Thrombospondin 1; Histone deacetylase inhibitor; Cancer; Peripheral blood mononuclear cell; Medicine; In vitro; Histone deacetylase; Biology; Internal medicine; Histone; Biochemistry","score_opus":0.05304892397541062,"score_gpt":0.3840525661258173,"score_spread":0.3310036421504067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014446514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994771,0.0039421734,0.0000054296734,0.00010763035,0.00010719828,0.0006186056,0.00037967533,0.000007805421,0.000060467184],"genre_scores_gemma":[0.9966355,0.0021205791,0.00006712458,0.000020848844,0.00015170132,0.00030437126,0.00006730639,0.00006226365,0.00057028607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967404,0.0003802288,0.0005267896,0.0008532196,0.0006828172,0.00081651995],"domain_scores_gemma":[0.9989491,0.000040784093,0.000090340676,0.00048036105,0.00021978906,0.00021960626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008250285,0.00025612643,0.00044278553,0.0009010227,0.00013973017,0.0000189934,0.00034065288,0.00038649826,0.00009677257],"category_scores_gemma":[0.000087578264,0.00028313135,0.000066869594,0.0011166688,0.00067230756,0.000037564452,0.00023322468,0.0006083233,0.0000020689442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040375767,0.00054497924,0.0049996134,0.000081776234,0.000016821834,0.000035652956,0.0006714899,0.000092946124,0.9911732,0.0000015324633,0.0014617298,0.00051651447],"study_design_scores_gemma":[0.0020720132,0.00020853219,0.0075970227,0.00008563962,0.0000025871732,0.000008303695,0.00017646348,0.000043538745,0.9880106,0.000003173541,0.0015209968,0.00027113457],"about_ca_topic_score_codex":0.021786492,"about_ca_topic_score_gemma":0.009811064,"teacher_disagreement_score":0.011975427,"about_ca_system_score_codex":0.0007253967,"about_ca_system_score_gemma":0.00062699785,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W3015602128","doi":"10.1158/0008-5472.can-19-3068","title":"Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute; National Institutes of Health; CANDU Owners Group; Cancer Prevention and Research Institute of Texas","keywords":"Neuroblastoma; ATRX; Telomere; Biology; Cancer research; Oncology; Cancer; Internal medicine; Exome sequencing; Medicine; Gene; Cell culture; Genetics; Mutation","score_opus":0.16799035952288258,"score_gpt":0.4605438150124882,"score_spread":0.29255345548960565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015602128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809392,0.00018939713,0.00009623813,0.016623313,0.00015547831,0.0010126237,0.00007035206,0.000088225934,0.0008251517],"genre_scores_gemma":[0.99521285,0.0010488344,0.00052909064,0.0015893166,0.00027602474,0.00024119334,0.0000093812505,0.000069948204,0.0010233785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955711,0.00061583915,0.00061691337,0.00085066905,0.0012063795,0.001139113],"domain_scores_gemma":[0.99762076,0.00048386914,0.000075646334,0.0005071717,0.0003036398,0.0010089038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001092984,0.00022410566,0.0005950603,0.00029058353,0.00013155083,0.00004402155,0.00035854158,0.00013531305,0.0006931428],"category_scores_gemma":[0.0021464892,0.00017803372,0.00016104613,0.0013105375,0.00029015227,0.00010106931,0.00035219084,0.0021280346,0.0010184427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010683047,0.0015636948,0.84805363,0.00062673487,0.0003267511,0.012170632,0.00025006296,0.000056297744,0.03295839,0.004972649,0.025713235,0.06262489],"study_design_scores_gemma":[0.022350555,0.010694327,0.9242388,0.00041486908,0.00007792654,0.00009316031,0.00021742948,0.00087732525,0.026096255,0.0034706735,0.010947543,0.00052113127],"about_ca_topic_score_codex":0.00079452124,"about_ca_topic_score_gemma":0.00025593163,"teacher_disagreement_score":0.07618518,"about_ca_system_score_codex":0.00025277713,"about_ca_system_score_gemma":0.000506237,"threshold_uncertainty_score":0.9997594},"labels":[],"label_agreement":null},{"id":"W3017340444","doi":"10.1158/1538-7445.mvc2020-b10","title":"Abstract B10: Antibacterial defense and metastatic progression—lessons from head and neck cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Malignancy; Head and neck cancer; Disease; Metastasis; Radiation therapy; Cancer; Head and neck squamous-cell carcinoma; Defensin; Cancer research; Oncology; Primary tumor; Internal medicine; Gene; Biology","score_opus":0.10075687160867057,"score_gpt":0.40321477081069756,"score_spread":0.302457899202027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017340444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168117,0.012325122,0.000006141615,0.004744402,0.00021613837,0.00026937804,0.0005743245,0.00003214838,0.00015115176],"genre_scores_gemma":[0.99528784,0.0036524502,0.000086722255,0.00030012798,0.00017577407,0.000056224886,0.00005196528,0.000022283499,0.0003665944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987656,0.00014963056,0.00016483426,0.00040954346,0.00006490232,0.00044549984],"domain_scores_gemma":[0.99948025,0.00018337058,0.00005334598,0.000121812714,0.0000789816,0.00008221315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016503828,0.00014870742,0.00028888992,0.000052047308,0.00032640214,0.00008729443,0.00013039423,0.00011267014,0.0017957819],"category_scores_gemma":[0.00006306058,0.00012051914,0.0000348398,0.00011440861,0.00060493685,0.00014314427,0.00020823951,0.00051490625,0.00005760102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006389308,0.00004067065,0.0036665483,0.00009208364,0.00015621899,0.000020623787,0.0011662055,0.0000012343562,0.9560677,0.00014258252,0.011093135,0.026914062],"study_design_scores_gemma":[0.005894602,0.00064679986,0.1582795,0.0010955024,0.00013005854,0.000028981234,0.0020173085,0.000015295649,0.67064136,0.00048858457,0.1599787,0.0007833232],"about_ca_topic_score_codex":0.004104343,"about_ca_topic_score_gemma":0.00042463225,"teacher_disagreement_score":0.28542635,"about_ca_system_score_codex":0.000029428458,"about_ca_system_score_gemma":0.0001709015,"threshold_uncertainty_score":0.9991167},"labels":[],"label_agreement":null},{"id":"W3021378100","doi":"10.1158/0008-5472.can-19-2270","title":"HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canadian Institutes of Health Research; Austrian Science Fund; European Commission","keywords":"Ubiquitin ligase; Carcinogenesis; GTPase; Cell biology; Ubiquitin; Mutation; Biology; DNA ligase; Cancer research; Homeostasis; Chemistry; Genetics; Cancer; DNA","score_opus":0.09764941686605956,"score_gpt":0.3882792780975191,"score_spread":0.29062986123145956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021378100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844264,0.010103193,0.0006678078,0.0023556997,0.00011492075,0.0009315447,0.0000646145,0.000050967938,0.0012848714],"genre_scores_gemma":[0.997667,0.0009442012,0.00011555426,0.0004473008,0.00030851076,0.00018873604,0.00003777748,0.000052263298,0.00023861989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976873,0.00017248053,0.000298735,0.0004112353,0.0010006174,0.00042964687],"domain_scores_gemma":[0.99872845,0.00006324253,0.00006716204,0.0003469531,0.00046156766,0.0003326342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036137842,0.00013512975,0.00031638125,0.00019385775,0.00008375578,0.000012274979,0.00012657334,0.00012723553,0.0004213403],"category_scores_gemma":[0.0002228011,0.00013343626,0.00012598034,0.0009185631,0.00017173158,0.00006639637,0.00014133957,0.00046496594,0.00005185214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061233813,0.00008025346,0.0034301996,0.00063753384,0.000098115976,0.00010714295,0.0004758702,0.00007977026,0.97610295,0.000027170498,0.012063763,0.0062848995],"study_design_scores_gemma":[0.0021221892,0.00050425815,0.008778436,0.0005562992,0.00009510432,0.000009764192,0.00015306212,0.00066667283,0.98160756,0.000044717985,0.00531693,0.00014501132],"about_ca_topic_score_codex":0.0008056886,"about_ca_topic_score_gemma":0.000028661898,"teacher_disagreement_score":0.013240656,"about_ca_system_score_codex":0.0003955728,"about_ca_system_score_gemma":0.0007298656,"threshold_uncertainty_score":0.5441373},"labels":[],"label_agreement":null},{"id":"W30224377","doi":"10.1158/0008-5472.can-18-0730","title":"Tracking eye movements to uncover the nature of visual-linguistic interaction in static and dynamic scenes","year":2008,"lang":"en","type":"dissertation","venue":"Cancer Research","topic":"Gaze Tracking and Assistive Technology","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Concordia University; Georgia Clinical and Translational Science Alliance","keywords":"Verb; Noun; Linguistics; Psychology; Sentence; Transitive relation; Referent; Artificial intelligence; Natural language processing; Cognitive psychology; Computer science; Mathematics","score_opus":0.0382799008484128,"score_gpt":0.44783255596385724,"score_spread":0.4095526551154444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30224377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966406,0.0011894273,0.00048737112,0.0003577172,0.0006217852,0.0003718515,0.0000075806342,0.000030296642,0.00029335555],"genre_scores_gemma":[0.9980552,0.0005528309,0.00018327514,0.000051256528,0.000030842013,0.000113500435,0.000018478886,0.000017283075,0.000977296],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982576,0.0001469633,0.0002586112,0.0004548443,0.0005486254,0.0003333879],"domain_scores_gemma":[0.99883425,0.00026167484,0.00011243931,0.00031465566,0.0004340447,0.000042919728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048397115,0.00014873406,0.00022959997,0.0006353086,0.00014028492,0.00007947951,0.00066433114,0.00020820979,0.0000070573597],"category_scores_gemma":[0.00045905076,0.00011809598,0.000031205072,0.00090383645,0.00008536456,0.000093607974,0.00012386196,0.0012802166,0.000004894273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000812024,0.0008783072,0.03559694,0.0034177543,0.00036759596,0.00034311146,0.04235862,0.0013780636,0.08767114,0.010480435,0.0016213025,0.8150747],"study_design_scores_gemma":[0.0016090896,0.0010233608,0.8920415,0.0076049,0.000030691426,0.000012154504,0.0062166695,0.024484908,0.048894413,0.011531304,0.005425328,0.0011256912],"about_ca_topic_score_codex":0.0007149488,"about_ca_topic_score_gemma":0.0026331244,"teacher_disagreement_score":0.85644454,"about_ca_system_score_codex":0.00028731773,"about_ca_system_score_gemma":0.0002663996,"threshold_uncertainty_score":0.5561975},"labels":[],"label_agreement":null},{"id":"W3022518620","doi":"10.1158/0008-5472.can-19-3278","title":"A Premalignant Cell-Based Model for Functionalization and Classification of <i>PTEN</i> Variants","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Simons Foundation","keywords":"PTEN; Cancer research; Medicine; Biology; Genetics; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.13420843975594432,"score_gpt":0.38034955607960996,"score_spread":0.24614111632366564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022518620","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45502642,0.0026620834,0.5385694,0.0019531453,0.00009884703,0.0009168373,0.0002914465,0.000015346532,0.00046647008],"genre_scores_gemma":[0.998085,0.00015214263,0.00065068767,0.00027485722,0.00017378564,0.00028867202,0.000099103956,0.00002090252,0.00025480648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908775,0.000054978194,0.00014400991,0.0003137136,0.00022614247,0.00017341784],"domain_scores_gemma":[0.9992453,0.000030484105,0.000056950554,0.00015770143,0.00042826668,0.00008129621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030281185,0.00007033252,0.00008776789,0.0000338086,0.00006979206,0.00001469877,0.00011887314,0.00009153174,0.00001795424],"category_scores_gemma":[0.000114813585,0.00006914443,0.00003339319,0.00013133393,0.00009336536,0.000004085526,0.00004067918,0.00006596249,0.0000011883034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039600008,0.000025731322,0.0005279452,0.00019160521,0.000014663336,1.1821261e-7,0.00006617969,0.012480675,0.9791884,0.00015222043,0.0064925887,0.0004639022],"study_design_scores_gemma":[0.0007943015,0.00025670725,0.00028115808,0.000028738243,0.0000122379015,2.174729e-7,0.000024128482,0.2905961,0.70223016,0.00014352742,0.005540094,0.00009264637],"about_ca_topic_score_codex":0.000012257131,"about_ca_topic_score_gemma":0.000012963881,"teacher_disagreement_score":0.54305863,"about_ca_system_score_codex":0.000029611068,"about_ca_system_score_gemma":0.00046859015,"threshold_uncertainty_score":0.2819628},"labels":[],"label_agreement":null},{"id":"W3022545044","doi":"10.1158/0008-5472.can-19-1523","title":"Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Pancreatic Cancer Research Fund; Terry Fox Research Institute; Gerald O. Mann Charitable Foundation; National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Sidney Kimmel Foundation for Cancer Research; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation; Government of Ontario; American Cancer Society","keywords":"Organoid; Pancreatic cancer; Cancer; Oncology; Internal medicine; Medicine; Outcome (game theory); Biology; Genetics","score_opus":0.2578945060778915,"score_gpt":0.5142480315451997,"score_spread":0.2563535254673082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022545044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471384,0.00065179804,0.00001407884,0.003482144,0.000015894499,0.0006393216,0.000045780922,0.000009447454,0.00042767532],"genre_scores_gemma":[0.9978154,0.0010839396,0.000027742512,0.0003799028,0.000083565385,0.00007730094,0.00001376558,0.000025760108,0.0004926642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973667,0.0004133124,0.00065070245,0.0003628518,0.0007895981,0.0004168329],"domain_scores_gemma":[0.9981298,0.0006779452,0.00013427352,0.00025416663,0.0005133956,0.00029043554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015981693,0.00012119809,0.00097607047,0.00018001863,0.00005582497,0.0000066147736,0.00017347312,0.00018674467,0.0009083985],"category_scores_gemma":[0.00087560556,0.000088957415,0.00005386659,0.00072631775,0.0008609197,0.000042343876,0.00016064184,0.00080039055,0.0000044452286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058764743,0.00021663857,0.98938715,0.0005613444,0.00022868626,0.00008655287,0.0012788213,5.804997e-7,0.0053752526,0.000011427402,0.00055050774,0.0017153568],"study_design_scores_gemma":[0.0049049756,0.0019787757,0.986307,0.00090578647,0.00012624104,0.0000027845495,0.00041024236,0.00024394438,0.0049321423,0.000033936274,0.00006429851,0.0000898648],"about_ca_topic_score_codex":0.004872129,"about_ca_topic_score_gemma":0.0015532261,"teacher_disagreement_score":0.0043173283,"about_ca_system_score_codex":0.00020471532,"about_ca_system_score_gemma":0.0008610661,"threshold_uncertainty_score":0.9946326},"labels":[],"label_agreement":null},{"id":"W3022851003","doi":"10.1158/1538-7445.mvc2020-pr04","title":"Abstract PR04: Potential of metformin to modify the gut microbiota and prevent inflammation in nondiabetic people with HIV","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Université Laval; McGill University Health Centre","funders":"","keywords":"Metformin; Gut flora; Inflammation; Medicine; Population; Internal medicine; Diabetes mellitus; Polycystic ovary; Viral load; Immunology; Endocrinology; Gastroenterology; Physiology; Insulin resistance; Human immunodeficiency virus (HIV)","score_opus":0.0240665718193564,"score_gpt":0.3345573427422998,"score_spread":0.3104907709229434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022851003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941227,0.00063023437,0.00005313557,0.004559775,0.000012661944,0.00053394755,0.000029915596,0.0000017989377,0.000055871475],"genre_scores_gemma":[0.9991943,0.00031957604,0.00010644344,0.0001045691,0.00008990339,0.000056407665,0.000023705074,0.000010581614,0.0000944878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921584,0.000058172456,0.0001457579,0.00021534903,0.00012363376,0.00024125095],"domain_scores_gemma":[0.9996137,0.000010878173,0.00003428237,0.00015553593,0.00009734684,0.00008822741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003121094,0.000069799935,0.00010533828,0.000047729805,0.000054575525,0.000017922297,0.00015336745,0.00006105965,0.000029125666],"category_scores_gemma":[0.000029705174,0.000049292477,0.000017613349,0.00019737575,0.00006607996,0.0000037231562,0.00012117466,0.00016034297,0.0000055913183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017619663,0.000017265875,0.0013537977,0.00015865054,0.000012452601,0.000001366459,0.0006402535,0.00024185916,0.9950852,0.0000083004825,0.0010545453,0.0012501081],"study_design_scores_gemma":[0.0007925837,0.00045580335,0.15482341,0.00008885835,0.00000830968,0.000005166781,0.0004868247,0.00006685074,0.8372809,0.000013063994,0.0058475644,0.00013060459],"about_ca_topic_score_codex":0.0002748944,"about_ca_topic_score_gemma":0.000794696,"teacher_disagreement_score":0.15780425,"about_ca_system_score_codex":0.000025261379,"about_ca_system_score_gemma":0.00023322643,"threshold_uncertainty_score":0.20100889},"labels":[],"label_agreement":null},{"id":"W3023886569","doi":"10.1158/1538-7445.mvc2020-ia05","title":"Abstract IA05: Microbiota, metabolites, and antitumor immunity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Microbiome; Cancer; Colorectal cancer; Blockade; Immunotherapy; Immune checkpoint; Immunology; Immunity; Cancer immunotherapy; Gut flora; Biology; Cancer research; Medicine; Bioinformatics; Internal medicine; Receptor","score_opus":0.07459605332937051,"score_gpt":0.3981814161017625,"score_spread":0.32358536277239197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023886569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808585,0.015371905,0.000008757323,0.0027726656,0.000053653515,0.00019856406,0.000086596854,0.00000919542,0.00064013054],"genre_scores_gemma":[0.9932028,0.0051006386,0.00012827314,0.0008118713,0.00031823374,0.00001655202,0.000057261066,0.000019205034,0.00034517943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989583,0.00008625723,0.0001312434,0.0003246999,0.000108532964,0.00039099876],"domain_scores_gemma":[0.9993826,0.000013344026,0.000026167327,0.00022157596,0.00014155434,0.00021475888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003489681,0.000098764845,0.00013242684,0.000037636735,0.00018590956,0.000047323847,0.00020897562,0.000095440155,0.00016591678],"category_scores_gemma":[0.000074043244,0.000092366725,0.000037157897,0.00015460457,0.0001836366,0.000003825828,0.00022228165,0.0003347855,0.000042459364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007717637,0.000019661033,0.001383238,0.000106649626,0.000021920358,0.000003886827,0.000100817146,7.243205e-7,0.9807734,0.000050901603,0.016163042,0.0012985849],"study_design_scores_gemma":[0.00043097363,0.00011934394,0.045622904,0.000018469078,0.0000049271002,0.0000061010564,0.000109564,0.0000020618154,0.64146036,0.000013753588,0.3120794,0.00013215376],"about_ca_topic_score_codex":0.0004326624,"about_ca_topic_score_gemma":0.0000687953,"teacher_disagreement_score":0.33931306,"about_ca_system_score_codex":0.00001695737,"about_ca_system_score_gemma":0.00028066064,"threshold_uncertainty_score":0.37666056},"labels":[],"label_agreement":null},{"id":"W3026891970","doi":"","title":"Spinal astrogliosis in an animal model of cancer-induced bone pain","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Osteolysis; Prostate cancer; Nociception; Bone cancer; Bone pain; Cancer; Pathology; Astrogliosis; Spinal cord; Anesthesia; Internal medicine; Central nervous system; Surgery","score_opus":0.15291075882829644,"score_gpt":0.45915972053075366,"score_spread":0.3062489617024572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026891970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977013,0.0008905366,0.00009642507,0.0006315648,0.00001949275,0.00037655386,0.000026471957,0.000015198033,0.00024244437],"genre_scores_gemma":[0.9983714,0.00006982599,0.0007440263,0.000050011105,0.00013627273,0.0002899131,0.0000093211465,0.00002345655,0.00030576997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982586,0.00017462796,0.00021849146,0.0002934073,0.0005788941,0.00047600755],"domain_scores_gemma":[0.9993358,0.000028951617,0.000037983762,0.00024964803,0.00021461329,0.00013299323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398352,0.00010676872,0.00026277074,0.00028981033,0.000055257755,0.00001156529,0.00009944683,0.00008106672,0.00011589542],"category_scores_gemma":[0.00004098807,0.00009378969,0.000047680627,0.00042620918,0.00005898395,0.00007240241,0.00003857675,0.00028572424,0.00000396389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010926545,0.00050593546,0.09419408,0.000117013726,0.000026310227,0.00006672159,0.000064802996,0.0002628628,0.88622594,0.00069359294,0.00019557933,0.016554492],"study_design_scores_gemma":[0.0077986303,0.006255251,0.20965795,0.0012221629,0.00007360729,0.0000057608695,0.0003457951,0.06877821,0.70287573,0.0024773143,0.00016561481,0.00034399546],"about_ca_topic_score_codex":0.017105525,"about_ca_topic_score_gemma":0.0038936243,"teacher_disagreement_score":0.18335025,"about_ca_system_score_codex":0.00042418498,"about_ca_system_score_gemma":0.00049353816,"threshold_uncertainty_score":0.98943967},"labels":[],"label_agreement":null},{"id":"W3029150605","doi":"10.1158/1538-7445.am2019-630","title":"Abstract 630: Smoking is associated with risks of molecular subtypes of colorectal cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Government of Newfoundland and Labrador; Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"Colorectal cancer; Internal medicine; Medicine; Microsatellite instability; KRAS; Quartile; Oncology; Cancer; Allele; Genetics; Biology; Confidence interval; Microsatellite; Gene","score_opus":0.046200992327070194,"score_gpt":0.3775343968243963,"score_spread":0.3313334044973261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029150605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900212,0.007043772,0.000006056412,0.00006558776,0.00078929943,0.0003148526,0.00019961873,0.0000051906286,0.0015544149],"genre_scores_gemma":[0.9968201,0.0017235974,0.000016049427,0.000048466998,0.00068097713,0.000077654004,0.000031064978,0.00003326084,0.0005688534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984572,0.00007579593,0.00021454498,0.0003518177,0.00050804415,0.00039258524],"domain_scores_gemma":[0.99882275,0.000033953092,0.00014048778,0.0003034778,0.00061900436,0.00008034754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047656219,0.00013075012,0.00028482892,0.00009432796,0.000042664873,0.000012210045,0.0002650631,0.00017255182,0.0004888596],"category_scores_gemma":[0.00007577974,0.00011437494,0.00009220191,0.0002908481,0.00023193062,0.000005736901,0.00009859208,0.00023793051,0.0000029768757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043482007,0.00005366861,0.04511607,0.000089264024,0.00025400706,3.0961198e-7,0.00015296356,0.00022490887,0.94717306,0.000029197325,0.0046435157,0.0018282274],"study_design_scores_gemma":[0.0009992106,0.00024825003,0.07080103,0.0001494008,0.000027266131,7.387956e-7,0.000117043375,0.000008774944,0.90612423,0.000021116804,0.021355545,0.000147373],"about_ca_topic_score_codex":0.0035935286,"about_ca_topic_score_gemma":0.0010340931,"teacher_disagreement_score":0.04104879,"about_ca_system_score_codex":0.00006666646,"about_ca_system_score_gemma":0.000675101,"threshold_uncertainty_score":0.54323643},"labels":[],"label_agreement":null},{"id":"W3029298233","doi":"10.1158/1538-7445.am2019-3649","title":"Abstract 3649: Allelic imbalance in <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Allele; Biology; Gene; Genetics; Single-nucleotide polymorphism; Leukemia; Genome; Genotype","score_opus":0.032075461796071125,"score_gpt":0.36594052922144577,"score_spread":0.33386506742537464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029298233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97518843,0.0013222627,0.000018496978,0.0018968976,0.00031818994,0.0018740979,0.000052746844,0.00010898898,0.019219901],"genre_scores_gemma":[0.9872337,0.0018251566,0.00014231139,0.00056555285,0.00044412544,0.00054501026,0.00004759834,0.00012686008,0.009069714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99342245,0.00021965275,0.00065883034,0.0010954263,0.0025447968,0.0020588185],"domain_scores_gemma":[0.99644667,0.00086268823,0.00009483536,0.0012759554,0.0006501987,0.0006696464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019076079,0.0003887985,0.00081378553,0.00093113736,0.00014268114,0.00010918318,0.000789,0.00037940784,0.0029878614],"category_scores_gemma":[0.00053292554,0.00033693624,0.00017234303,0.0019002722,0.00045333843,0.00027440186,0.00042665304,0.0018262329,0.0034099598],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0056659137,0.0003875923,0.12683894,0.0013181005,0.0005051562,0.0024786296,0.0012845068,0.00048644777,0.8131711,0.00031253966,0.040275525,0.0072755315],"study_design_scores_gemma":[0.038128965,0.0017547103,0.80303013,0.0038616725,0.00012434817,0.0005196716,0.0009397239,0.008141124,0.07053191,0.0004874953,0.07099209,0.0014881613],"about_ca_topic_score_codex":0.0046040528,"about_ca_topic_score_gemma":0.00047690736,"teacher_disagreement_score":0.7426392,"about_ca_system_score_codex":0.008246808,"about_ca_system_score_gemma":0.0072126486,"threshold_uncertainty_score":0.99990827},"labels":[],"label_agreement":null},{"id":"W3032944184","doi":"","title":"Phosphodiesterase inhibition as an approach to increase chemosensitivity of prostate cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DU145; Clonogenic assay; Prostate cancer; Zaprinast; Hypoxia (environmental); Phosphodiesterase; Cancer research; Cancer cell; Pharmacology; Cancer; Cell culture; Biology; Chemistry; Medicine; Internal medicine; Enzyme; Biochemistry; LNCaP","score_opus":0.048650991443875684,"score_gpt":0.35556141622616155,"score_spread":0.30691042478228586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032944184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970604,0.00045190373,0.000101525235,0.00019109748,0.00009307625,0.00044572714,0.000066200926,0.0000133969725,0.0015766482],"genre_scores_gemma":[0.9955083,0.00057422556,0.00016875398,0.00029744094,0.00021848288,0.00027412383,0.00016876266,0.000023213826,0.0027666788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985825,0.00016861763,0.00017268927,0.0004171792,0.00035445977,0.0003045701],"domain_scores_gemma":[0.9988774,0.000011568694,0.000049296,0.00033204874,0.00051006104,0.00021961283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041276985,0.00012234315,0.00014617274,0.00009557311,0.00019878823,0.000015500242,0.000088037785,0.00010480059,0.000051305615],"category_scores_gemma":[0.00008401382,0.00011338935,0.000046789475,0.0003010539,0.00022643387,0.000015044586,0.00011411655,0.00014086728,0.000009902837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012171688,0.00024705686,0.00550609,0.00005752336,0.000028130065,0.0000076132733,0.000719196,0.00040715432,0.98224384,0.000046525045,0.0061047133,0.003415017],"study_design_scores_gemma":[0.00065879844,0.00026680573,0.012636676,0.00003707204,0.000005241338,0.000022130034,0.00016106338,0.00007079308,0.97717214,0.00003524243,0.008777239,0.0001567998],"about_ca_topic_score_codex":0.002448223,"about_ca_topic_score_gemma":0.00021718987,"teacher_disagreement_score":0.007130586,"about_ca_system_score_codex":0.00007818396,"about_ca_system_score_gemma":0.00037261253,"threshold_uncertainty_score":0.46238837},"labels":[],"label_agreement":null},{"id":"W3033104501","doi":"10.1158/0008-5472.can-20-0233","title":"p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Enzalutamide; SUMO protein; Cancer research; Ubiquitin ligase; Androgen receptor; Chemistry; Biology; Ubiquitin; Cancer; Biochemistry","score_opus":0.09812964589445748,"score_gpt":0.4549123753982027,"score_spread":0.3567827295037452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033104501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601912,0.028041415,0.000006507712,0.00921306,0.00005571773,0.0020472382,0.00031524998,0.000030449275,0.00009917697],"genre_scores_gemma":[0.9707451,0.025842357,0.000021656362,0.000087178996,0.00010164235,0.0008836185,0.000109978784,0.000036825906,0.0021716561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970322,0.0003681529,0.00035760584,0.0005899349,0.0010312947,0.00062081206],"domain_scores_gemma":[0.99856,0.00019406395,0.00013316455,0.00017760553,0.0005301927,0.00040495294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008518533,0.0002050699,0.0004379636,0.00028245596,0.00012358614,0.000029879238,0.00014631392,0.00011795206,0.00031986437],"category_scores_gemma":[0.00045498685,0.0001764628,0.000045576784,0.0011510875,0.00022400316,0.00035784958,0.00014090861,0.0006439849,0.00001662226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031908434,0.0002720477,0.013297875,0.0012064032,0.00009199534,0.000034420194,0.0016874671,0.000008830036,0.95232505,0.0000049153423,0.002039305,0.025840852],"study_design_scores_gemma":[0.0041104984,0.0006518706,0.010834702,0.000549385,0.000033060376,0.0000011503237,0.00022250804,0.0007261078,0.9812616,0.000011169773,0.0014441367,0.00015380194],"about_ca_topic_score_codex":0.001121209,"about_ca_topic_score_gemma":0.0003365224,"teacher_disagreement_score":0.028936563,"about_ca_system_score_codex":0.00068844605,"about_ca_system_score_gemma":0.000978171,"threshold_uncertainty_score":0.7195944},"labels":[],"label_agreement":null},{"id":"W3033322560","doi":"10.1158/0008-5472.can-19-2373","title":"The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Kom op tegen Kanker; Vlaamse Liga Tegen Kanker; Vlaamse regering; Universiteit Gent; Stichting Tegen Kanker; Fonds Wetenschappelijk Onderzoek; European Hematology Association","keywords":"Melanoma; Ectopic expression; Cancer research; Mesenchymal stem cell; Epithelial–mesenchymal transition; Transcription factor; Biology; In vivo; Phenotype; Metastasis; Cancer; Cell biology; Cell culture; Gene; Genetics","score_opus":0.1634758341936226,"score_gpt":0.3733494961353122,"score_spread":0.2098736619416896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033322560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654383,0.0062517114,0.00012715436,0.0053494964,0.00008743174,0.0011387181,0.000077139695,0.000023119788,0.0004013675],"genre_scores_gemma":[0.9969903,0.0017486457,0.00039254714,0.0002636026,0.00019342912,0.0001389292,0.000042062926,0.00002799314,0.00020249502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981723,0.00027404432,0.00026781863,0.000330949,0.0006350874,0.00031980427],"domain_scores_gemma":[0.99891144,0.00016597084,0.000066879824,0.000236813,0.00037305892,0.00024583732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050084793,0.00012432151,0.00030010164,0.00007772998,0.00023382471,0.000085037944,0.000119367105,0.00004420855,0.00019440119],"category_scores_gemma":[0.00014734133,0.000084156374,0.000052679698,0.0003435768,0.00024323768,0.00022933187,0.000044936096,0.0003174716,0.000002957916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009967696,0.000084775704,0.0027445992,0.0011177582,0.0001111442,0.000009716632,0.0059688143,0.0000052498626,0.9380589,0.00006744047,0.0010252438,0.049809597],"study_design_scores_gemma":[0.0030541443,0.002183706,0.018691428,0.0003496282,0.00023011457,0.000014615055,0.0020351585,0.00056877243,0.9482188,0.00018297734,0.024224468,0.00024615778],"about_ca_topic_score_codex":0.00019646654,"about_ca_topic_score_gemma":0.00029973043,"teacher_disagreement_score":0.04956344,"about_ca_system_score_codex":0.000102515405,"about_ca_system_score_gemma":0.0007425621,"threshold_uncertainty_score":0.34317973},"labels":[],"label_agreement":null},{"id":"W3033322989","doi":"10.1158/1538-7445.camodels2020-a35","title":"Abstract A35: From map to model: Genetic evolution of diffuse intrinsic pontine glioma provides the framework for accurate tumor modeling","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"OLIG2; Nestin; Glioma; Biology; Cancer research; Tumor initiation; Progenitor cell; Epigenetics; Panobinostat; Neural stem cell; Carcinogenesis; Pathology; Cancer; Oligodendrocyte; Histone; Stem cell; Genetics; Medicine; Central nervous system; Myelin; Neuroscience; Gene","score_opus":0.12164649325174887,"score_gpt":0.4009334279689837,"score_spread":0.2792869347172348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033322989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96215594,0.0032573955,0.012743955,0.019783434,0.000059219914,0.001819723,0.00013917287,0.000028682425,0.000012493442],"genre_scores_gemma":[0.9924354,0.000076919525,0.0056529236,0.00025322317,0.0004183131,0.0011024796,0.00001243077,0.000038971903,0.0000093140725],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983287,0.00004079368,0.00030179243,0.00038713237,0.0005364551,0.0004051241],"domain_scores_gemma":[0.9985276,0.00032420616,0.00006016636,0.00037345666,0.00045991328,0.00025464132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022818193,0.00013984268,0.00028306706,0.0001232611,0.00012809486,0.00004390338,0.00022198878,0.00006433136,0.000057425463],"category_scores_gemma":[0.00058739533,0.00009312008,0.00010102877,0.00044138194,0.0000625524,0.000053468833,0.00011924026,0.00028725207,0.00002438183],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011038939,0.00214936,0.01800354,0.0018943483,0.0010917743,0.00035100023,0.006901837,0.23529683,0.6648509,0.006281327,0.013067637,0.039072543],"study_design_scores_gemma":[0.0064877877,0.0016486744,0.02724368,0.0016630245,0.0003167478,0.0000057045177,0.0013027734,0.81662244,0.11805686,0.025446925,0.00079334853,0.00041203294],"about_ca_topic_score_codex":0.0014725305,"about_ca_topic_score_gemma":0.0000952734,"teacher_disagreement_score":0.5813256,"about_ca_system_score_codex":0.00026104192,"about_ca_system_score_gemma":0.0003509059,"threshold_uncertainty_score":0.37973264},"labels":[],"label_agreement":null},{"id":"W3033443199","doi":"10.1158/1538-7445.camodels2020-b27","title":"Abstract B27: Modeling the impact of miR-200s on mammary tumor initiation and progression in vitro and in vivo","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"microRNA; Mesenchymal stem cell; Phenotype; Cell culture; Biology; Cancer research; Messenger RNA; In vivo; Cell biology; Gene; Genetics","score_opus":0.05495696754831394,"score_gpt":0.40302696969717583,"score_spread":0.3480700021488619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033443199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955435,0.002752122,0.00019999176,0.00075065275,0.000010339136,0.00048111333,0.000024511563,0.0000030849783,0.00023470589],"genre_scores_gemma":[0.99844027,0.0012476867,0.000044836946,0.000066384964,0.000058044567,0.00010517796,0.000011416861,0.000018132761,0.000008028358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987156,0.00015325665,0.00017419731,0.0003326978,0.00031534638,0.00030890704],"domain_scores_gemma":[0.999542,0.00003263856,0.000033600216,0.00018560936,0.00010445757,0.00010170182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005848804,0.00009890528,0.00012437232,0.00013124294,0.000048981638,0.000033070093,0.00016803038,0.00009872959,0.000016819766],"category_scores_gemma":[0.00017965968,0.000074744414,0.00003269484,0.00029836086,0.00008576547,0.000008963383,0.0002026549,0.00043087828,6.302604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012010207,0.000031917505,0.00014915211,0.00006428283,0.000013172062,0.000017836439,0.00016233974,0.0034376394,0.9910504,0.000009088662,0.000103298495,0.0037598484],"study_design_scores_gemma":[0.0009290201,0.00040997806,0.0014792341,0.00014159868,0.0000015642028,0.0000038233215,0.00010067297,0.028259499,0.9683896,0.00011114909,0.000074569114,0.00009929831],"about_ca_topic_score_codex":0.00048538097,"about_ca_topic_score_gemma":0.00008783428,"teacher_disagreement_score":0.024821859,"about_ca_system_score_codex":0.00008423685,"about_ca_system_score_gemma":0.000337614,"threshold_uncertainty_score":0.30479887},"labels":[],"label_agreement":null},{"id":"W3033914773","doi":"10.1158/1538-7445.camodels2020-a26","title":"Abstract A26: Modeling the ovarian cancer immune response and tumor microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TIGIT; Tumor microenvironment; Cancer research; Ovarian cancer; Immunotherapy; CD8; Immune system; T cell; Cancer; Medicine; Immune checkpoint; Immunology; Biology; Internal medicine","score_opus":0.07200832441248828,"score_gpt":0.347205243082211,"score_spread":0.27519691866972273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033914773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8924247,0.084514804,0.000045049856,0.021648696,0.0004719714,0.0005313746,0.000063988235,0.000037843434,0.000261585],"genre_scores_gemma":[0.9924656,0.004321836,0.000021323765,0.0010985838,0.00014632857,0.00038544546,0.000008458168,0.000047342637,0.0015050939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764144,0.0005813152,0.00033167438,0.0005295628,0.00014862914,0.0007673702],"domain_scores_gemma":[0.9989306,0.00036494227,0.0000686466,0.00047738416,0.000095837946,0.00006264065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014753466,0.00020338185,0.00026630305,0.00007493757,0.00062808295,0.00005774675,0.00060985866,0.00014293793,0.0036026477],"category_scores_gemma":[0.0001590819,0.0001520694,0.00007131059,0.00024467663,0.00072546786,0.00008847486,0.00048456184,0.0013449448,0.00041284037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025474778,0.00002626527,0.0002571626,0.000051441406,0.00013777745,0.00001641253,0.002032045,0.00057065923,0.9855124,0.000041165968,0.0045173196,0.0042898757],"study_design_scores_gemma":[0.0033278223,0.00027394807,0.019838126,0.0002682149,0.000058342866,0.000035742705,0.0025198497,0.00055756996,0.67076004,0.00013917181,0.30165568,0.000565476],"about_ca_topic_score_codex":0.0024274944,"about_ca_topic_score_gemma":0.00004944616,"teacher_disagreement_score":0.31475234,"about_ca_system_score_codex":0.00030928903,"about_ca_system_score_gemma":0.00037918804,"threshold_uncertainty_score":0.9973082},"labels":[],"label_agreement":null},{"id":"W3033947641","doi":"","title":"Identification of novel regions of genomic copy number alteration in mantle cell lymphoma by array comparative genomic hybridization to a 97,299 element whole genome DNA array","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Comparative genomic hybridization; Biology; Mantle cell lymphoma; Genome; Genetics; Bacterial artificial chromosome; Copy number analysis; Metaphase; Chromosome; Gene duplication; genomic DNA; Computational biology; Copy-number variation; Molecular biology; DNA; Gene; Lymphoma","score_opus":0.03613251875224729,"score_gpt":0.3303751998248434,"score_spread":0.29424268107259616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033947641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777236,0.00032900085,0.02035422,0.00023254233,0.000056178495,0.0005676839,0.00045488117,0.0000033907593,0.00027852575],"genre_scores_gemma":[0.99753994,0.00019634065,0.0005262643,0.000033512097,0.00008272986,0.00020283573,0.00053277996,0.000018734847,0.00086685026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985929,0.0000821216,0.00048696127,0.00034175906,0.00022438269,0.00027183676],"domain_scores_gemma":[0.99911284,0.000010945143,0.00016873366,0.00031942688,0.0003186731,0.00006937456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000393786,0.00012018062,0.00018334019,0.00012307326,0.00009800829,0.000029479694,0.00023380562,0.00007105427,0.00004587621],"category_scores_gemma":[0.000011710972,0.00013233488,0.000048073984,0.00022997658,0.00009224029,0.000013909872,0.00006156339,0.00006610227,0.000037300666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008746843,0.00028573468,0.000841561,0.000050059305,0.000026383417,2.1775055e-7,0.001500711,0.0077160406,0.98895824,0.0002643549,0.00023935245,0.000029867606],"study_design_scores_gemma":[0.0012503876,0.000134908,0.004120457,0.00002245669,0.000007693959,0.0000018122998,0.0007591597,0.000023602406,0.9892862,0.00010413969,0.004159416,0.00012977031],"about_ca_topic_score_codex":0.00055743026,"about_ca_topic_score_gemma":0.0002449782,"teacher_disagreement_score":0.019827956,"about_ca_system_score_codex":0.00032637798,"about_ca_system_score_gemma":0.0003895611,"threshold_uncertainty_score":0.539646},"labels":[],"label_agreement":null},{"id":"W3035682484","doi":"10.1158/0008-5472.can-19-3599","title":"Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan–Targeting Antibodies without the Need for Immune Effector Cells or Complement","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Medical Research Council; Medical Research Council Canada","keywords":"Avidity; Antibody-dependent cell-mediated cytotoxicity; Effector; Biology; Monoclonal antibody; Antibody; Proinflammatory cytokine; Fragment crystallizable region; Glycan; Immune system; Cytotoxicity; Cell biology; Molecular biology; Immunology; In vitro; Biochemistry; Glycoprotein; Inflammation","score_opus":0.10392378078081145,"score_gpt":0.3992927390557757,"score_spread":0.2953689582749643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035682484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93608505,0.021198556,0.00021773824,0.03771935,0.0002864622,0.003454809,0.000311015,0.00009311054,0.00063389004],"genre_scores_gemma":[0.9825957,0.005585509,0.00014306545,0.0006239471,0.0015741797,0.001122033,0.000093570874,0.00009108456,0.008170923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967607,0.00025155864,0.00040326364,0.00050384225,0.0009917034,0.0010889177],"domain_scores_gemma":[0.99762857,0.001261565,0.00008859442,0.0003363721,0.00040955527,0.0002753386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001302824,0.00028282736,0.0004938857,0.000092009584,0.0011373287,0.00013607247,0.000573373,0.00007463619,0.00040550224],"category_scores_gemma":[0.00019543488,0.0001440668,0.000187627,0.0005256303,0.0003123494,0.00006726358,0.00031689467,0.0008701522,0.000026075983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017221016,0.000055060947,0.0038463788,0.0016482332,0.00021895902,0.000023748198,0.001727851,0.0003008196,0.8769269,0.00004187297,0.11210563,0.0013824533],"study_design_scores_gemma":[0.0014868669,0.0006426786,0.00055003463,0.00049261964,0.00006785174,0.0000031216305,0.0010849623,0.0060547804,0.5259987,0.000006428348,0.46335974,0.00025222843],"about_ca_topic_score_codex":0.0045592953,"about_ca_topic_score_gemma":0.00015137464,"teacher_disagreement_score":0.3512541,"about_ca_system_score_codex":0.00023535182,"about_ca_system_score_gemma":0.00029715346,"threshold_uncertainty_score":0.87475276},"labels":[],"label_agreement":null},{"id":"W3036784533","doi":"10.1158/0008-5472.can-20-0093","title":"A Novel Locus Predicts Spermatogenic Recovery among Childhood Cancer Survivors Exposed to Alkylating Agents","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Azoospermia; Oligospermia; Spermatogenesis; Male infertility; Medicine; Sperm; Internal medicine; Testicular cancer; Cohort; Infertility; Locus (genetics); Semen analysis; Oncology; Cancer; Gynecology; Biology; Genetics; Andrology; Pregnancy","score_opus":0.14666981533282383,"score_gpt":0.4039515239904989,"score_spread":0.2572817086576751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036784533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96770126,0.0022742087,0.0003055223,0.023959402,0.00069062965,0.0024921978,0.00036214828,0.00027621645,0.0019384206],"genre_scores_gemma":[0.98508257,0.0007539161,0.00033564222,0.009095566,0.002823063,0.0007265835,0.00005482759,0.00020147965,0.0009263469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929956,0.00033524918,0.0009325534,0.001368978,0.002784695,0.0015829325],"domain_scores_gemma":[0.9958883,0.0003796103,0.00019115338,0.000906998,0.0006651319,0.0019688178],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016305173,0.0004769414,0.00091796584,0.0004205652,0.00038548923,0.0001540862,0.00075114635,0.00026048726,0.0020196897],"category_scores_gemma":[0.0016611761,0.00048256727,0.00030493917,0.002291271,0.00026898173,0.0003390577,0.0006243122,0.0015082706,0.00030394734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042505297,0.001614285,0.40480062,0.0035009105,0.0024531735,0.00044128703,0.083164595,0.0031476656,0.31037235,0.0000711566,0.13781738,0.04836602],"study_design_scores_gemma":[0.017802019,0.0034212396,0.704235,0.0072776456,0.00044473025,0.00008126428,0.009447002,0.0014557582,0.1844928,0.00011459767,0.06843553,0.0027924157],"about_ca_topic_score_codex":0.017654879,"about_ca_topic_score_gemma":0.008377698,"teacher_disagreement_score":0.29943436,"about_ca_system_score_codex":0.00090517674,"about_ca_system_score_gemma":0.0018324299,"threshold_uncertainty_score":0.9997626},"labels":[],"label_agreement":null},{"id":"W3037455779","doi":"10.1158/0008-5472.can-19-3822","title":"<i>NRAS</i> Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Neuroblastoma; Neuroblastoma RAS viral oncogene homolog; Cancer research; Trametinib; MAPK/ERK pathway; Vemurafenib; KRAS; PTPN11; Anaplastic lymphoma kinase; Targeted therapy; Medicine; Crizotinib; Biology; Kinase; Cancer; Internal medicine; Cell culture; Lung cancer; Melanoma; Genetics","score_opus":0.06303302831595037,"score_gpt":0.3695045378502346,"score_spread":0.30647150953428426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037455779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97474474,0.000335487,0.000018423523,0.02305396,0.00010374789,0.0013654049,0.000039305436,0.00006010046,0.0002788412],"genre_scores_gemma":[0.99718976,0.0001913966,0.000043878354,0.0016981992,0.0003006721,0.00029826304,0.000012416173,0.000047434572,0.00021800764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964982,0.00075219607,0.00024855087,0.0005098177,0.0010709864,0.0009202281],"domain_scores_gemma":[0.99809885,0.0006810313,0.000037157497,0.00028374855,0.00037400008,0.00052521523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007867375,0.00018598374,0.0002755776,0.00022712794,0.00024439063,0.0000965067,0.00014945384,0.000056744164,0.00008426224],"category_scores_gemma":[0.0011329661,0.00012902898,0.00006874772,0.0011863818,0.00018386595,0.00014028787,0.0002554636,0.0007686535,0.00012719592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001837184,0.00029561066,0.016187593,0.00015881748,0.000048002315,0.0011253793,0.0027339943,0.00004234464,0.9454793,0.000047383928,0.0073772664,0.024667166],"study_design_scores_gemma":[0.005057973,0.0031787786,0.07804429,0.00031479134,0.0000114028635,0.000027418497,0.0012221412,0.0011002041,0.8811338,0.00010295959,0.029520366,0.00028587264],"about_ca_topic_score_codex":0.00056887086,"about_ca_topic_score_gemma":0.00046174467,"teacher_disagreement_score":0.06434545,"about_ca_system_score_codex":0.00025513518,"about_ca_system_score_gemma":0.00044127193,"threshold_uncertainty_score":0.52616495},"labels":[],"label_agreement":null},{"id":"W3038493324","doi":"","title":"Plk1 - A novel therapeutic target for nasopharyngeal carcinoma","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; PLK1; Biology; Cyclin B1; Cancer research; Cell cycle; Viability assay; Mitosis; Small interfering RNA; Population; Cell cycle checkpoint; Apoptosis; Cyclin-dependent kinase 1; Cell culture; Medicine; Cell biology; Internal medicine; Transfection; Radiation therapy; Biochemistry; Genetics","score_opus":0.1250746203713338,"score_gpt":0.42728822723840787,"score_spread":0.3022136068670741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038493324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471846,0.01692337,0.019256702,0.003306606,0.0007852251,0.0031468025,0.00013940419,0.00013238747,0.00912486],"genre_scores_gemma":[0.9934572,0.00010303703,0.0013510312,0.00058083696,0.0009018483,0.00040333834,0.000040939307,0.00008739888,0.003074373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747026,0.000035221547,0.00025525896,0.00046538288,0.0007824824,0.0009914151],"domain_scores_gemma":[0.9983519,0.00021774211,0.000038898135,0.00046992462,0.0005742922,0.00034726493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014503547,0.0001613305,0.00027938987,0.0003414922,0.00018982074,0.000026619602,0.00020854975,0.0001775899,0.00037021615],"category_scores_gemma":[0.00013544167,0.00014843364,0.00015025756,0.0006318204,0.00020285313,0.000051444902,0.000072983355,0.0006759122,0.000048024867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028044248,0.00024291033,0.002714038,0.00029811412,0.0001857779,0.00012643164,0.00044230005,0.000019169871,0.95733184,0.00148329,0.0085619865,0.025789706],"study_design_scores_gemma":[0.009667986,0.0018957279,0.021273477,0.00022052521,0.00009541583,0.00010491357,0.00026868613,0.00061590964,0.6119665,0.0005078709,0.3530173,0.00036570893],"about_ca_topic_score_codex":0.00039704153,"about_ca_topic_score_gemma":0.000117620264,"teacher_disagreement_score":0.34536538,"about_ca_system_score_codex":0.0008019183,"about_ca_system_score_gemma":0.0010350783,"threshold_uncertainty_score":0.60529476},"labels":[],"label_agreement":null},{"id":"W3039302117","doi":"10.1158/0008-5472.can-20-0106","title":"Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; ADA Foundation; National Cancer Institute; National Institutes of Health; Université de Montréal; Novartis; American Diabetes Association","keywords":"Cyclin D1; Medicine; Internal medicine; Endocrinology; Hyperinsulinemia; Metformin; Cancer; Diabetes mellitus; Type 2 diabetes; Cancer research; Cell cycle; Insulin resistance","score_opus":0.05712041998364088,"score_gpt":0.3447255597384407,"score_spread":0.28760513975479984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039302117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459155,0.052397322,0.00001595579,0.00042576948,0.00023508295,0.0003569139,0.00010795091,0.000023267214,0.0005222142],"genre_scores_gemma":[0.9839846,0.011717082,0.000029245653,0.0028995115,0.00067144923,0.00008357785,0.000055978766,0.000041583036,0.0005169797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756867,0.00031930758,0.00019558019,0.0006393007,0.0004953662,0.0007817912],"domain_scores_gemma":[0.9984838,0.000038882048,0.000060909322,0.00031999368,0.00068436895,0.00041204362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055049895,0.00018039325,0.00027136103,0.00007453617,0.00019245945,0.00005296957,0.0003663963,0.00015780068,0.00019091064],"category_scores_gemma":[0.0008138978,0.00017689848,0.000089361165,0.000725189,0.00013684815,0.000006275805,0.00031579135,0.0003437715,0.00021031249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003688551,0.00023699274,0.027683694,0.0001942153,0.00018608803,0.000059219656,0.0013353708,0.00025473902,0.8006615,0.00006969852,0.13058697,0.03836267],"study_design_scores_gemma":[0.0007917536,0.00072799093,0.029744873,0.00012410094,0.00003106719,6.0484126e-7,0.0005606562,0.00012647254,0.7537179,0.000030497931,0.2136016,0.000542487],"about_ca_topic_score_codex":0.00012082296,"about_ca_topic_score_gemma":0.00018325385,"teacher_disagreement_score":0.08301463,"about_ca_system_score_codex":0.00009761955,"about_ca_system_score_gemma":0.00036542577,"threshold_uncertainty_score":0.7213711},"labels":[],"label_agreement":null},{"id":"W3041030570","doi":"10.1158/0008-5472.can-20-1127","title":"Physical Activity Does Not Lower the Risk of Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute","keywords":"Mendelian randomization; Observational study; Causality (physics); Lung cancer; Physical activity; Medicine; Oncology; Cancer; Mendelian inheritance; Internal medicine; Physical therapy; Biology; Genetics; Gene; Genetic variants; Genotype","score_opus":0.051940512496426186,"score_gpt":0.41635379166508074,"score_spread":0.36441327916865457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041030570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99121636,0.0005201533,0.00016373953,0.0074631716,0.00009638905,0.00017422128,0.0001381169,0.0000033399542,0.00022450357],"genre_scores_gemma":[0.9969294,0.001475895,0.0000226271,0.00025147691,0.00071019505,0.00012261671,0.0000038695234,0.0000110004585,0.00047289624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884087,0.00036405766,0.00008618012,0.00025308272,0.00018768299,0.00026815583],"domain_scores_gemma":[0.99933034,0.000110437395,0.0000673498,0.00023370086,0.00018636903,0.00007179935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045902331,0.000072050825,0.00013971115,0.0000124431035,0.0001282072,0.00000786751,0.00024872913,0.00007954262,0.00008644099],"category_scores_gemma":[0.00045312548,0.000041740765,0.0000881431,0.00013665367,0.00020256931,0.0000016721093,0.00018402861,0.00026116692,0.000004089384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002181902,0.000061942425,0.09562418,0.000033200144,0.00018981737,5.384445e-7,0.0002977388,0.0006890649,0.8728586,0.000043333508,0.022603983,0.0073794317],"study_design_scores_gemma":[0.0005508542,0.0003132894,0.21119684,0.00001544457,0.00006168318,2.6833706e-7,0.00016741802,0.004304463,0.7543522,0.00013862015,0.028702416,0.0001964918],"about_ca_topic_score_codex":0.000997872,"about_ca_topic_score_gemma":0.00030100136,"teacher_disagreement_score":0.11850637,"about_ca_system_score_codex":0.000027729828,"about_ca_system_score_gemma":0.00019210888,"threshold_uncertainty_score":0.1702139},"labels":[],"label_agreement":null},{"id":"W3041197210","doi":"","title":"The Atkins style high fat-low carbohydrate diet inhibits proliferation of prostate cancer in a xenograft model","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; LNCaP; Endocrinology; Carbohydrate; Internal medicine; Insulin; Prostate; Cancer; Medicine; Matrigel; Angiogenesis","score_opus":0.04992809116960529,"score_gpt":0.38432447635654576,"score_spread":0.3343963851869405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041197210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97732145,0.0068103983,0.000003158164,0.012982956,0.00011196843,0.0011774153,0.000059192174,0.0000205352,0.0015129144],"genre_scores_gemma":[0.97795767,0.011661922,0.00005322827,0.0001365101,0.00038686168,0.0013292154,0.0000065659965,0.000024081846,0.00844396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980445,0.000099711615,0.00031501323,0.0002746441,0.00068686984,0.0005792602],"domain_scores_gemma":[0.99886465,0.000064369946,0.000060529153,0.00027964727,0.00062460254,0.00010620039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007272268,0.00013336257,0.00030091434,0.00019390119,0.00019691949,0.00003240096,0.00013289636,0.00006226261,0.00003685925],"category_scores_gemma":[0.0001259936,0.00008755357,0.0000507112,0.0006653564,0.00027268057,0.00012216262,0.00011794769,0.00042090224,0.000010271441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011459502,0.0013351389,0.06090917,0.0016212658,0.00063426455,0.000032856275,0.056334272,0.030294705,0.6192967,0.0056170523,0.055490844,0.15697417],"study_design_scores_gemma":[0.016391668,0.0017610642,0.13074902,0.0031450253,0.00026297313,0.0000015640729,0.0036169095,0.06794604,0.6032312,0.0022227387,0.1695943,0.001077531],"about_ca_topic_score_codex":0.0015434973,"about_ca_topic_score_gemma":0.008211263,"teacher_disagreement_score":0.15589663,"about_ca_system_score_codex":0.00023800002,"about_ca_system_score_gemma":0.00056308665,"threshold_uncertainty_score":0.4582078},"labels":[],"label_agreement":null},{"id":"W3041532210","doi":"10.1158/0008-5472.can-20-0447","title":"Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Center for Chronic Disease Prevention and Health Promotion; Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Council Victoria; National Institute of Environmental Health Sciences; Ministerio de Ciencia y Tecnología; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Ministero della Salute; Grantová Agentura České Republiky; European Cooperation in Science and Technology; Ministerstvo Zdravotnictví Ceské Republiky; California Department of Public Health; Pancreatic Cancer Action Network; U.S. Department of Defense; World Health Organization; National Institutes of Health; U.S. Department of Health and Human Services; Lustgarten Foundation; National Human Genome Research Institute; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública","keywords":"Inflammatory bowel disease; Pancreatitis; Ulcerative colitis; Genome-wide association study; Medicine; Disease; Genetic predisposition; Genetic association; Primary sclerosing cholangitis; Internal medicine; Gastroenterology; Biology; Genotype; Single-nucleotide polymorphism; Gene; Genetics","score_opus":0.0744868467072635,"score_gpt":0.37650344149860127,"score_spread":0.3020165947913378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041532210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838896,0.0071601835,0.000023571816,0.002244753,0.00004035287,0.001773498,0.0002632187,0.000050846338,0.00005459546],"genre_scores_gemma":[0.9978414,0.0007234764,0.00012008283,0.000166493,0.0005219558,0.0003051108,0.00008360545,0.000024606446,0.00021322905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971332,0.0006513989,0.00027330412,0.0007981167,0.00061334186,0.00053067214],"domain_scores_gemma":[0.9979255,0.0005402638,0.00007417998,0.0007108348,0.00022809178,0.00052108127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008536047,0.00016536888,0.00036840525,0.000097715776,0.00023690175,0.000037645998,0.0002698306,0.00006831249,0.00018143597],"category_scores_gemma":[0.0035164866,0.0001477159,0.000031957054,0.00033018034,0.00014766373,0.000092348826,0.0005570463,0.00053254166,0.00010833073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004530072,0.00019511257,0.9948076,0.0001518338,0.00024577117,0.0005975851,0.0009545026,0.000006984094,0.0010320724,0.0000015813789,0.0008090174,0.0007449129],"study_design_scores_gemma":[0.0017209299,0.002157074,0.99473536,0.00006212909,0.0004256494,0.000013220515,0.00040335793,0.000046895646,0.000060204122,0.000038513725,0.00022035516,0.00011628773],"about_ca_topic_score_codex":0.0005513373,"about_ca_topic_score_gemma":0.00056841696,"teacher_disagreement_score":0.009452459,"about_ca_system_score_codex":0.0011714768,"about_ca_system_score_gemma":0.00080918823,"threshold_uncertainty_score":0.60236794},"labels":[],"label_agreement":null},{"id":"W3041613483","doi":"10.1158/0008-5472.can-20-0104","title":"The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Michael Smith Health Research BC","funders":"","keywords":"Biology; Genetics; Transcription factor; Missense mutation; Germline mutation; Point mutation; Somatic cell; Mutation; Molecular biology; Immunoprecipitation; Chromatin immunoprecipitation; Cell biology; Gene; Gene expression; Promoter","score_opus":0.16922309238578007,"score_gpt":0.4280849093084536,"score_spread":0.2588618169226735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041613483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277264,0.0025025785,0.000038678652,0.06513465,0.00025200844,0.00088391424,0.00003162725,0.000048526454,0.0033815997],"genre_scores_gemma":[0.99527645,0.0025322104,0.00005467756,0.00048806312,0.00070891454,0.00037197606,0.000016076763,0.0000273636,0.0005242843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982163,0.00012183554,0.00018609359,0.0003645721,0.00064236234,0.00046883646],"domain_scores_gemma":[0.9989275,0.00029146936,0.0000404801,0.00027344289,0.00018861129,0.00027854877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051333033,0.00010842019,0.0001710621,0.000056163324,0.00040718593,0.00009760263,0.00015197249,0.000048151946,0.00037593077],"category_scores_gemma":[0.00015366243,0.0000727834,0.000082558836,0.0004856456,0.00014941656,0.00006158717,0.00007116711,0.00038405025,0.00025498445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037822425,0.00067716243,0.097214155,0.0006713451,0.001187654,0.002138679,0.009107076,0.00012353803,0.07324946,0.008754658,0.19925947,0.60383457],"study_design_scores_gemma":[0.009540359,0.003163422,0.1620856,0.00079733826,0.00028255917,0.000055793407,0.005455184,0.0012952496,0.24860923,0.0009265536,0.567141,0.0006477066],"about_ca_topic_score_codex":0.00018101347,"about_ca_topic_score_gemma":0.00008094591,"teacher_disagreement_score":0.60318685,"about_ca_system_score_codex":0.0006006364,"about_ca_system_score_gemma":0.00040106452,"threshold_uncertainty_score":0.41161785},"labels":[],"label_agreement":null},{"id":"W3041675387","doi":"","title":"The pro-cell death Bcl-2 family member, BNIP3 is mutated in breast tumors and this mutation increases resistance to hypoxia-induced cell death in breast cancer cell lines","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Biology; Cancer research; Programmed cell death; Breast cancer; Missense mutation; Mutation; Nonsense mutation; Gene; Molecular biology; Cancer; Apoptosis; Genetics","score_opus":0.03531103678156038,"score_gpt":0.327340931588527,"score_spread":0.2920298948069666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041675387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703011,0.022846395,0.0000013820988,0.0017085443,0.00017051061,0.00094631006,0.00030191088,0.000039195653,0.0036846611],"genre_scores_gemma":[0.97222054,0.0032820457,0.000015939768,0.00023303018,0.000063768915,0.0006078235,0.00004148469,0.000052767624,0.023482578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99637073,0.001067361,0.00058340945,0.0006918129,0.00020428022,0.0010823974],"domain_scores_gemma":[0.9983544,0.0005694437,0.00012475827,0.00043519758,0.00044312928,0.00007311939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010437241,0.00033620532,0.00041523145,0.00039927586,0.00043846513,0.0001087371,0.0004953478,0.00026794148,0.00040114403],"category_scores_gemma":[0.000051602576,0.0002608502,0.00006790185,0.0007290647,0.00025063072,0.00018966541,0.00021909106,0.0008063972,0.00012662455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045452076,0.00036124387,0.010528589,0.00012814536,0.000024476254,0.00006054329,0.0009326063,0.000020128628,0.9711103,0.00005290906,0.010946412,0.0012894575],"study_design_scores_gemma":[0.003446809,0.0002044629,0.20503224,0.0004873167,0.00001935465,0.00006524356,0.0016908009,0.000032725427,0.7815644,0.000092904214,0.006905968,0.00045776877],"about_ca_topic_score_codex":0.114692435,"about_ca_topic_score_gemma":0.021462766,"teacher_disagreement_score":0.19450365,"about_ca_system_score_codex":0.0006838958,"about_ca_system_score_gemma":0.00076558103,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W3041899188","doi":"10.1158/0008-5472.can-19-2888","title":"Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Naito Foundation; Princess Takamatsu Cancer Research Fund; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Japan Agency for Medical Research and Development","keywords":"KEAP1; Cancer research; Tumor microenvironment; Gene knockdown; Transcription factor; Tumor progression; Cancer; KRAS; Biology; Immune system; Immunology; Cell culture; Gene; Colorectal cancer; Genetics","score_opus":0.05596733446016541,"score_gpt":0.3573987546116955,"score_spread":0.3014314201515301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041899188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978458,0.00055005774,0.000047606423,0.0008618762,0.000021706992,0.00037546142,0.00005646979,0.0000029776422,0.00023802028],"genre_scores_gemma":[0.9990821,0.00042056662,0.000087880246,0.00006789746,0.00014151538,0.00005506994,0.00006696131,0.000017348013,0.000060652765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883735,0.00014127285,0.0002092395,0.00028737797,0.00028859894,0.00023615338],"domain_scores_gemma":[0.9993896,0.000028184164,0.00012598884,0.00025081867,0.0001252952,0.00008013201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019145072,0.000098075885,0.00013828505,0.00003070435,0.00007138732,0.000008140481,0.00030865494,0.00007713535,0.000040069877],"category_scores_gemma":[0.00014355239,0.00007203786,0.000054952292,0.00018258345,0.0003619105,0.0000046554624,0.0002395329,0.00017639333,0.0000024409628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043989104,0.000055782773,0.0029115889,0.00006488914,0.000033610944,7.5218037e-7,0.00020075959,0.00003584004,0.99336284,0.000014714137,0.0014378956,0.0014414052],"study_design_scores_gemma":[0.00034604818,0.00029987132,0.0052789287,0.0000644974,0.000004213441,5.594367e-7,0.00034846377,0.000010614897,0.99025935,0.000021358166,0.0032937648,0.00007235268],"about_ca_topic_score_codex":0.00007665895,"about_ca_topic_score_gemma":0.000002794435,"teacher_disagreement_score":0.0031035433,"about_ca_system_score_codex":0.000029228417,"about_ca_system_score_gemma":0.00013139319,"threshold_uncertainty_score":0.29376188},"labels":[],"label_agreement":null},{"id":"W3042041751","doi":"10.1158/0008-5472.can-20-0788","title":"Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Université du Québec à Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Cancer research; Immunosurveillance; Microvesicles; CD8; Gelsolin; Biology; Cytotoxic T cell; Immune system; Cancer; Medicine; Immunology; Internal medicine; Cell biology; In vitro; microRNA","score_opus":0.03661197214953109,"score_gpt":0.3248031838206396,"score_spread":0.2881912116711085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042041751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989319,0.004635021,0.00013385984,0.0049756635,0.00012487872,0.00054653455,0.000024276396,0.000013037866,0.00022769919],"genre_scores_gemma":[0.9966393,0.00072043046,0.00016469044,0.0003615195,0.00060371606,0.00027876327,0.000029318628,0.00003657613,0.0011656831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982943,0.00012804585,0.00019578835,0.0006953575,0.00029786132,0.00038863503],"domain_scores_gemma":[0.9991917,0.000011935817,0.000038265047,0.00026869448,0.00021971189,0.00026971224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038206438,0.00014023688,0.00013686712,0.000079919686,0.00009916612,0.00004384997,0.00015931028,0.00012805965,0.00007465177],"category_scores_gemma":[0.0002176494,0.00014884053,0.000028428767,0.00040388323,0.00013859129,0.000011520513,0.00018753724,0.00025958192,0.000017903136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011218117,0.000040915693,0.002379816,0.00014267462,0.000015038282,0.0000063363104,0.00021130999,0.00046511658,0.98746985,0.000053351472,0.0058139972,0.0022797557],"study_design_scores_gemma":[0.0008167955,0.00015051472,0.004046889,0.00006340098,0.000008467857,0.000001321888,0.00012828608,0.00012773101,0.9859104,0.00012140045,0.008445098,0.00017965934],"about_ca_topic_score_codex":0.00013036023,"about_ca_topic_score_gemma":0.00043129438,"teacher_disagreement_score":0.0073202737,"about_ca_system_score_codex":0.00008450131,"about_ca_system_score_gemma":0.00029327863,"threshold_uncertainty_score":0.60695404},"labels":[],"label_agreement":null},{"id":"W3042494942","doi":"10.1158/1538-7445.pedca19-b52","title":"Abstract B52: Ewing sarcoma: A case study of clonal aneuploidy and DNA damage repair in pediatric cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Carcinogenesis; Cancer research; Aneuploidy; Embryonic stem cell; Cancer; Molecular biology; Genetics; Cell biology; Chromosome; Gene","score_opus":0.15212615162088622,"score_gpt":0.4353680762682835,"score_spread":0.2832419246473973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042494942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885905,0.0086471075,6.419083e-8,0.001525602,0.00003561332,0.0010165267,0.000041972613,0.000029862307,0.0001127702],"genre_scores_gemma":[0.9977226,0.0013360432,0.000024212737,0.00012639226,0.00029771737,0.00044151756,0.000003057878,0.00002744632,0.000020970328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998111,0.00011864615,0.0003229997,0.0004585434,0.00060125196,0.0003875286],"domain_scores_gemma":[0.99895287,0.0002965306,0.00005155111,0.00024892995,0.00016547002,0.0002846235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046442388,0.0001403732,0.00036672503,0.0002519708,0.00008821207,0.000013916329,0.00008331599,0.00005899828,0.00025144345],"category_scores_gemma":[0.00013010752,0.00011750353,0.00005853723,0.0007747321,0.00007735146,0.00007272064,0.00013849202,0.00046736762,0.000004876518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003076919,0.0014152766,0.9663962,0.00048519633,0.000090982045,0.02035761,0.0042573605,0.00001428824,0.001532829,0.000004292475,0.0015447435,0.0035934916],"study_design_scores_gemma":[0.0048243897,0.0008698095,0.9876922,0.000103621955,0.00010287934,0.00011796813,0.0046285624,0.000105598396,0.0011985629,0.0000051622833,0.00023962131,0.000111625865],"about_ca_topic_score_codex":0.017311184,"about_ca_topic_score_gemma":0.004487849,"teacher_disagreement_score":0.021295961,"about_ca_system_score_codex":0.00021196055,"about_ca_system_score_gemma":0.00035828183,"threshold_uncertainty_score":0.9892326},"labels":[],"label_agreement":null},{"id":"W3042503188","doi":"10.1158/1538-7445.pedca19-ia10","title":"Abstract IA10: Activating innate and adaptive immunity to improve outcome for “cold” tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunotherapy; Adjuvant; Neuroblastoma; Immune system; Acquired immune system; Melanoma; Immunology; Cancer research; Biology","score_opus":0.19653844542905002,"score_gpt":0.46361946075663385,"score_spread":0.2670810153275838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042503188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898549,0.00013931423,0.00003619348,0.007138477,0.00003131157,0.0019324005,0.00010046847,0.000038050362,0.0007288974],"genre_scores_gemma":[0.99757284,0.000034171855,0.00035870445,0.0005802955,0.00017805911,0.0006824229,0.0000052939276,0.00003889621,0.00054934324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981463,0.00006810772,0.00019832718,0.00040140445,0.0005394972,0.00064638286],"domain_scores_gemma":[0.9982534,0.0003851944,0.000033954842,0.00021720641,0.0003815785,0.0007286383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043659343,0.00013596688,0.00026994836,0.00015193611,0.00023935713,0.00005262524,0.00014477108,0.00004767635,0.000096826574],"category_scores_gemma":[0.0010419757,0.00011176082,0.000056412406,0.00042511956,0.00011170583,0.0001086456,0.00023025961,0.00066831394,0.00004727552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041339477,0.00014926269,0.0067664664,0.0005349973,0.00016710511,0.0001919115,0.0007825087,0.0000049447667,0.9516684,0.00015455193,0.001695514,0.033750426],"study_design_scores_gemma":[0.0069000884,0.006564763,0.1378062,0.00033480805,0.000024424866,0.000008324214,0.0011888717,0.00033551524,0.83986455,0.00015353819,0.0065221014,0.00029678963],"about_ca_topic_score_codex":0.0006061929,"about_ca_topic_score_gemma":0.000029110428,"teacher_disagreement_score":0.13103974,"about_ca_system_score_codex":0.0002365051,"about_ca_system_score_gemma":0.00034988325,"threshold_uncertainty_score":0.4557474},"labels":[],"label_agreement":null},{"id":"W3042613214","doi":"10.1158/1538-7445.pedca19-b62","title":"Abstract B62: The need to improve exercise prescriptions to support care in pediatric oncology","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cardiorespiratory fitness; Medicine; Physical fitness; Physical therapy","score_opus":0.12031125525527056,"score_gpt":0.4545475419869995,"score_spread":0.3342362867317289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042613214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8413116,0.001621057,0.000009720608,0.1492353,0.00041505272,0.0028771171,0.00010887255,0.000063991625,0.0043572905],"genre_scores_gemma":[0.9872097,0.00055561634,0.00013643398,0.0083229905,0.0018716666,0.001193068,0.000018990839,0.000049325776,0.0006422163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694115,0.00014868606,0.00046117976,0.000618865,0.0010434443,0.0007866979],"domain_scores_gemma":[0.99767816,0.0002783109,0.000047358302,0.0006037104,0.00048066868,0.0009117839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011930418,0.00017325686,0.00043172535,0.00033747905,0.00015294005,0.000048339603,0.0005321002,0.00013681935,0.0009753346],"category_scores_gemma":[0.0009122327,0.0001412482,0.00009741286,0.0016943563,0.000087639484,0.0000798684,0.00036235794,0.0011390061,0.0005633905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055474536,0.00047191084,0.050308336,0.002328447,0.00007803716,0.0003479203,0.1730815,0.00025935224,0.024186438,0.00011614619,0.63581085,0.10746361],"study_design_scores_gemma":[0.005631214,0.00612358,0.44277927,0.00043348563,0.00014728731,0.000008648128,0.041583713,0.000023080887,0.009616389,0.00010303,0.49286857,0.0006817372],"about_ca_topic_score_codex":0.0060370686,"about_ca_topic_score_gemma":0.0072402214,"teacher_disagreement_score":0.39247093,"about_ca_system_score_codex":0.00087224256,"about_ca_system_score_gemma":0.0024495774,"threshold_uncertainty_score":0.9999379},"labels":[],"label_agreement":null},{"id":"W3043005157","doi":"10.1158/1538-7445.pedca19-ia16","title":"Abstract IA16: Accelerating innovation for children with cancer in the new regulatory environment","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blinatumomab; Drug development; Marketing authorization; Pediatric cancer; Pediatric oncology; Waiver; Orphan drug; Cancer; Milestone; Disease; Oncology; Intensive care medicine; Internal medicine; Drug; Lymphoblastic Leukemia; Leukemia; Pharmacology; Bioinformatics","score_opus":0.3324064938822954,"score_gpt":0.499763722472177,"score_spread":0.1673572285898816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043005157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86597043,0.0028349531,0.00004133159,0.12910448,0.00002061773,0.0011127074,0.00001575219,0.000009182307,0.00089054403],"genre_scores_gemma":[0.9944707,0.0010990665,0.00011165509,0.0031064064,0.00074431975,0.0003236347,0.0000078591775,0.000012762891,0.00012357575],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891526,0.000039757047,0.00014089399,0.00020052775,0.0004379248,0.00026564184],"domain_scores_gemma":[0.99956334,0.00015467669,0.000040656676,0.00010415088,0.00006086028,0.00007631005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006167731,0.0000691399,0.00011207752,0.000036761085,0.00014536543,0.000033254346,0.00011067639,0.000030656134,0.000595161],"category_scores_gemma":[0.0001230392,0.00004122104,0.000015791471,0.00040550283,0.00006583893,0.00008908403,0.000040008777,0.00046502298,0.0000074880413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043210466,0.00024280691,0.17499366,0.0005071663,0.0005291263,0.00002625431,0.0077990466,0.0009009969,0.08587091,0.001541458,0.12516236,0.5981052],"study_design_scores_gemma":[0.0031375182,0.0004409753,0.77665466,0.00014411446,0.000050016988,0.0000030363829,0.00092394656,0.00022767555,0.0135446945,0.00011346128,0.20461139,0.0001485184],"about_ca_topic_score_codex":0.0005423098,"about_ca_topic_score_gemma":0.0000917194,"teacher_disagreement_score":0.601661,"about_ca_system_score_codex":0.0001358993,"about_ca_system_score_gemma":0.00023423776,"threshold_uncertainty_score":0.6516596},"labels":[],"label_agreement":null},{"id":"W3043179762","doi":"10.1158/1538-7445.pedca19-pr15","title":"Abstract PR15: Acting at a distance: Medulloblastoma-secreted ligands disrupt normal neural stem cell function","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Neurosphere; Neural stem cell; Subventricular zone; Neurogenesis; Biology; Medulloblastoma; Stem cell; Cell biology; Precursor cell; Astrocyte; Glial fibrillary acidic protein; Neuroscience; Cancer research; Immunology; Cellular differentiation; Cell; Adult stem cell; Biochemistry; Immunohistochemistry; Central nervous system","score_opus":0.07827822864304358,"score_gpt":0.3643831469567267,"score_spread":0.2861049183136831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043179762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910111,0.0019297797,0.000010401745,0.0039548045,0.00017892277,0.0006288366,0.00004238918,0.0000868196,0.0021569647],"genre_scores_gemma":[0.9980407,0.00018245284,0.000007938472,0.00026784596,0.0005192534,0.0003157716,0.000045025376,0.000045817385,0.00057523564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976559,0.000046384703,0.00026240147,0.00049035717,0.0008955896,0.0006493666],"domain_scores_gemma":[0.9987047,0.00016373002,0.00007484649,0.0002709657,0.00022881235,0.00055699394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023987047,0.00018999209,0.00028719715,0.00010460051,0.00031059928,0.00006743567,0.00012523615,0.00009936367,0.00089113816],"category_scores_gemma":[0.000043398668,0.00015198521,0.00012479517,0.00059126026,0.00009647993,0.00013621364,0.00013907965,0.0005419136,0.00019268402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069891466,0.0005562416,0.1755387,0.0013280923,0.00030324055,0.0013803776,0.0032210196,0.00019079146,0.73631346,0.00003898415,0.018057413,0.05608252],"study_design_scores_gemma":[0.0076755392,0.0023465683,0.26613092,0.00044522708,0.00018992332,0.00003177408,0.002335878,0.0021858574,0.6830206,0.000007822784,0.035193592,0.00043627564],"about_ca_topic_score_codex":0.0001787896,"about_ca_topic_score_gemma":0.00012472883,"teacher_disagreement_score":0.09059223,"about_ca_system_score_codex":0.00054577703,"about_ca_system_score_gemma":0.00018760814,"threshold_uncertainty_score":0.97573376},"labels":[],"label_agreement":null},{"id":"W3043185138","doi":"10.1158/1538-7445.pedca19-pr03","title":"Abstract PR03: Sex ratio disparities and the risk of childhood cancer: Evaluating the mediating effect of birth defects among 15,000 childhood cancer cases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Cancer registry; Demography; Population; Birth weight; Gestational age; Obstetrics; Pregnancy; Internal medicine; Environmental health; Genetics","score_opus":0.052984267115974176,"score_gpt":0.4005290675358097,"score_spread":0.3475448004198355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043185138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636392,0.031133452,0.0000023586194,0.0020422626,0.00014942489,0.0022025364,0.0006233116,0.000030064302,0.00017741506],"genre_scores_gemma":[0.98171437,0.016182216,0.000005994648,0.00016842835,0.000867738,0.0009368076,0.000012261623,0.00005747842,0.000054685475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961864,0.000769755,0.00058804394,0.0004881852,0.0013722363,0.0005954258],"domain_scores_gemma":[0.99497753,0.0035824187,0.00041503235,0.00044234443,0.0003337419,0.0002489529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027582296,0.00029159465,0.00081808993,0.00011483584,0.00049690343,0.0000696897,0.00032476673,0.00011056032,0.00042346824],"category_scores_gemma":[0.0026001034,0.00015502697,0.00020840226,0.0006896253,0.0012074425,0.00013056568,0.0002110189,0.001237382,0.0000013208186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014255566,0.000059265472,0.9285623,0.0013051487,0.00063479017,0.000009785672,0.015224622,0.0011975851,0.0055242702,0.000029007091,0.00068758836,0.045340125],"study_design_scores_gemma":[0.005307405,0.0010882788,0.94612056,0.00092831114,0.0004458465,0.000005408061,0.0016068972,0.0014496917,0.042682223,0.00003579361,0.00013693579,0.0001926377],"about_ca_topic_score_codex":0.08201478,"about_ca_topic_score_gemma":0.0048586708,"teacher_disagreement_score":0.077156104,"about_ca_system_score_codex":0.00017991613,"about_ca_system_score_gemma":0.0009600091,"threshold_uncertainty_score":0.9240982},"labels":[],"label_agreement":null},{"id":"W3043576037","doi":"","title":"Inhibition of growth and metastasis of breast carcinoma by tranilast","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tranilast; Cancer research; Metastasis; Medicine; Desmoplasia; Cancer; Pancreatic cancer; Pathology; Pharmacology; Internal medicine","score_opus":0.0231096678794913,"score_gpt":0.30622844784153536,"score_spread":0.28311877996204404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043576037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937234,0.0055296435,0.000014785353,0.000077182696,0.000012899533,0.000110145185,0.00010273523,0.000001722828,0.00042747264],"genre_scores_gemma":[0.9971719,0.002622499,0.000025874182,0.0000070741835,0.00003159019,0.00001567661,0.00003256852,0.000009919864,0.00008290288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993279,0.00008641795,0.00010693104,0.00015625672,0.0001686336,0.000153866],"domain_scores_gemma":[0.99965674,0.000012434304,0.000028976758,0.00010601211,0.00013382103,0.00006199975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012554006,0.0000583493,0.00010561705,0.000052245774,0.00005213191,0.0000021672786,0.000055794088,0.000085678206,0.000011600597],"category_scores_gemma":[0.000016416298,0.00005042482,0.000037699625,0.00013575288,0.0003099543,0.00000268014,0.00004454271,0.00010625518,6.0399015e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014575168,0.00004111562,0.0037838796,0.000069685964,0.00003787773,0.0000035442827,0.00008231117,6.90674e-7,0.99346805,0.000026832357,0.0016862706,0.00065399136],"study_design_scores_gemma":[0.00045421734,0.00030096454,0.004145826,0.000016804026,0.0000082857905,0.000038851536,0.000040951763,0.000002466755,0.99479616,0.000012006419,0.0001356683,0.000047790472],"about_ca_topic_score_codex":0.00021552262,"about_ca_topic_score_gemma":0.0000037442026,"teacher_disagreement_score":0.003448482,"about_ca_system_score_codex":0.000007189114,"about_ca_system_score_gemma":0.00008635238,"threshold_uncertainty_score":0.20562646},"labels":[],"label_agreement":null},{"id":"W3043577596","doi":"10.1158/1538-7445.pedca19-pr11","title":"Abstract PR11: EP300 controls the oncogenic enhancer landscape of high-risk neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Histone acetyltransferase; Acetylation; Enhancer; Cancer research; Cereblon; Histone; CREB-binding protein; Neuroblastoma; P300-CBP Transcription Factors; Cell biology; Genetics; Gene; Transcription factor; Ubiquitin; Histone Acetyltransferases; Cell culture; Ubiquitin ligase","score_opus":0.05843736545061853,"score_gpt":0.38056194756839223,"score_spread":0.32212458211777373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043577596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844234,0.0014911776,0.000010556288,0.011104522,0.00006499206,0.0011906127,0.00012651444,0.00004452723,0.0015437263],"genre_scores_gemma":[0.9971276,0.0011135655,0.000021437538,0.00037994262,0.0004263645,0.00029328707,0.000009690219,0.000048399415,0.0005796976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685323,0.0002820094,0.00032264635,0.00048260507,0.0013347481,0.0007247472],"domain_scores_gemma":[0.9977561,0.0006452062,0.00010291527,0.000532078,0.0004584337,0.000505235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050871196,0.0001814572,0.0004047638,0.0001340912,0.00019687918,0.000041867937,0.00038230617,0.0000770706,0.001918965],"category_scores_gemma":[0.0006406863,0.000112620124,0.00014016588,0.0007427678,0.00035479566,0.00008388603,0.00017719826,0.0010836242,0.00038333694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009079761,0.000561044,0.011953075,0.00058466225,0.0010049546,0.0007116711,0.00058713835,0.000103414604,0.8924479,0.00014161837,0.044867713,0.037957065],"study_design_scores_gemma":[0.012347989,0.00671744,0.2430447,0.0002757336,0.00023793377,0.000039942788,0.0003220147,0.00038314107,0.7170018,0.00019984713,0.019138059,0.00029140332],"about_ca_topic_score_codex":0.0009265454,"about_ca_topic_score_gemma":0.000117876065,"teacher_disagreement_score":0.23109162,"about_ca_system_score_codex":0.00009454525,"about_ca_system_score_gemma":0.0006927663,"threshold_uncertainty_score":0.9989934},"labels":[],"label_agreement":null},{"id":"W3043591634","doi":"10.1158/1538-7445.pedca19-ia19","title":"Abstract IA19: Genomic analysis of osteosarcoma: Insights into tumor evolution and therapy response","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Cancer; Copy-number variation; Metastasis; Genome; Disease; Medicine; Computational biology; Precision medicine; Targeted therapy; Primary tumor; Genomics; Cancer research; Bioinformatics; Biology; Gene; Internal medicine; Genetics; Pathology","score_opus":0.038037026279458916,"score_gpt":0.34820878707034947,"score_spread":0.31017176079089054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043591634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97046435,0.028434642,0.00007158813,0.00068341126,0.000032759915,0.00018492666,0.00004613054,0.000004049861,0.00007815329],"genre_scores_gemma":[0.9933396,0.0061122878,0.000057145975,0.00021633967,0.00016025425,0.00004010832,0.00003227746,0.000016700002,0.000025291985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989366,0.00011404721,0.00018914341,0.00035402036,0.00019630043,0.00020987795],"domain_scores_gemma":[0.9992217,0.00009398596,0.00005812173,0.00026156724,0.00020877541,0.00015584708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003517506,0.00009724928,0.00018753506,0.00017238299,0.000089884146,0.000026478541,0.00019290544,0.00007037422,0.00004650086],"category_scores_gemma":[0.00020973381,0.00009265075,0.00008182809,0.00051231176,0.00018674291,0.0000035356077,0.00016037807,0.00013344026,0.0000037001323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019527421,0.000027288937,0.0051433234,0.00002151687,0.00025626548,0.000005104145,0.00046872965,0.000318133,0.9884116,0.000059693353,0.0005552263,0.0027804004],"study_design_scores_gemma":[0.001707737,0.0012026499,0.3450037,0.000020897214,0.00011255683,0.0000013414463,0.0005596337,0.0006758277,0.5738556,0.00028636106,0.07623645,0.0003372788],"about_ca_topic_score_codex":0.0007244417,"about_ca_topic_score_gemma":0.00032832776,"teacher_disagreement_score":0.414556,"about_ca_system_score_codex":0.000068731715,"about_ca_system_score_gemma":0.00040021958,"threshold_uncertainty_score":0.3778188},"labels":[],"label_agreement":null},{"id":"W3043655441","doi":"10.1158/1538-7445.pedca19-pr13","title":"Abstract PR13: Surgical excision of the primary tumor in osteosarcoma model results in enhanced metastatic growth by modulating the lung immune microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Metastasis; Gefitinib; Osteosarcoma; Primary tumor; Immune system; Perioperative; Lung; Context (archaeology); Cancer research; Tumor microenvironment; Pathology; Internal medicine; Cancer; Immunology; Surgery; Epidermal growth factor receptor; Biology","score_opus":0.03384800647165747,"score_gpt":0.3420559408693693,"score_spread":0.3082079343977118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043655441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911973,0.0055370587,0.000021944505,0.001939864,0.0000140295415,0.00078628765,0.00015094363,0.000002172832,0.00035038608],"genre_scores_gemma":[0.9982224,0.0012055985,0.00004727478,0.00006788467,0.000035075038,0.00022896063,0.000058393445,0.000020365596,0.00011405391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978392,0.00028420554,0.00038890663,0.00042401312,0.0005913283,0.00047233337],"domain_scores_gemma":[0.99929875,0.000092214876,0.00008381418,0.0003753015,0.000057459005,0.00009243527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007589955,0.00013255973,0.0001975258,0.00004541714,0.0000908717,0.000022351758,0.0004889041,0.00004512702,0.00001622827],"category_scores_gemma":[0.00016859344,0.00008406341,0.00008471959,0.00033310417,0.00021880117,0.000008896358,0.00046771325,0.00041406564,0.0000023070236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015819788,0.0001410821,0.0018269428,0.000100886355,0.000035787325,0.000021697573,0.00029165516,0.0022898708,0.9909577,0.0000049486307,0.00081574946,0.0019317401],"study_design_scores_gemma":[0.0040002237,0.00023217603,0.022839563,0.0001540468,0.0000062676027,0.0000029777975,0.0001506887,0.0027881898,0.96915835,0.00008221118,0.00044494963,0.00014038049],"about_ca_topic_score_codex":0.0014859907,"about_ca_topic_score_gemma":0.00035070695,"teacher_disagreement_score":0.021799337,"about_ca_system_score_codex":0.00020284689,"about_ca_system_score_gemma":0.00027472957,"threshold_uncertainty_score":0.34280065},"labels":[],"label_agreement":null},{"id":"W3043773677","doi":"10.1158/1538-7445.pedca19-pr07","title":"Abstract PR07: GD2 is a macrophage checkpoint molecule and combined GD2/CD47 blockade results in synergistic effects and tumor clearance in xenograft models of neuroblastoma and osteosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD47; Blockade; Medicine; Cancer research; Antibody; Neuroblastoma; Monoclonal antibody; Osteosarcoma; Phagocytosis; Immunotherapy; In vivo; Radioimmunotherapy; Macrophage; Cancer; Pharmacology; Immunology; In vitro; Internal medicine; Chemistry; Cell culture; Receptor; Biology; Biochemistry","score_opus":0.04383254322733609,"score_gpt":0.3449037828000689,"score_spread":0.3010712395727328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043773677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992797,0.0022136762,0.0000023074365,0.003149798,0.000014391458,0.0013971425,0.00007574671,0.00002151897,0.00032840902],"genre_scores_gemma":[0.99843174,0.0009658042,0.00006452005,0.00021361398,0.00002878787,0.00016003523,0.0000052015266,0.00004705469,0.00008324487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971568,0.00023159376,0.0004384051,0.00074601645,0.0007059868,0.0007211995],"domain_scores_gemma":[0.99849147,0.00041655824,0.00007320276,0.00029590284,0.00013126491,0.00059158663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042666701,0.0002415999,0.0005406161,0.0003830493,0.000073070805,0.00004855338,0.00014084428,0.000080403486,0.000015740354],"category_scores_gemma":[0.00050872157,0.00021801495,0.00004000762,0.0007745824,0.00048626796,0.00012388418,0.00029193665,0.0008436864,0.000005200666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029422142,0.0008541366,0.008268116,0.0061926446,0.00012668806,0.011152202,0.00280785,0.00010049703,0.93217206,0.000065894325,0.00042764284,0.008410135],"study_design_scores_gemma":[0.029738633,0.007125799,0.45353225,0.0022503124,0.000038457118,0.000092852744,0.00018911855,0.01540055,0.49077144,0.00038891935,0.00010064192,0.00037099732],"about_ca_topic_score_codex":0.001038549,"about_ca_topic_score_gemma":0.00023146563,"teacher_disagreement_score":0.44526416,"about_ca_system_score_codex":0.0000930391,"about_ca_system_score_gemma":0.00022204401,"threshold_uncertainty_score":0.8890391},"labels":[],"label_agreement":null},{"id":"W3043910646","doi":"","title":"A tumor model of ascites fluid production: Intrahepatic injection of the rabbit with rabbit VX2 tumor cells","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ascites; Effusion; Pathology; In vivo; Fibrin; Pleural effusion; Abdominal cavity; Medicine; Liver tumor; Lung; Biology; Internal medicine; Anatomy; Immunology; Surgery","score_opus":0.06375789499112638,"score_gpt":0.3735489634528237,"score_spread":0.3097910684616973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043910646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200565,0.0006300772,0.00010710292,0.003460852,0.000078757825,0.0013798377,0.000015838092,0.000018998227,0.0023028662],"genre_scores_gemma":[0.9912436,0.00023444952,0.0011109628,0.000098298326,0.00037537835,0.00033019396,0.0000023293326,0.000029429768,0.006575361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971826,0.00027165518,0.00041433,0.0003667728,0.0012606923,0.0005039448],"domain_scores_gemma":[0.99772346,0.00021095916,0.00013197085,0.0006579974,0.0011202714,0.0001553267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015526738,0.00014469655,0.0005185965,0.000288806,0.0001774412,0.000010874411,0.00028567403,0.00006719205,0.00037740916],"category_scores_gemma":[0.00048118486,0.00008834739,0.00008465457,0.0010249091,0.0010495303,0.00010931115,0.00012065213,0.0006621984,0.000018575436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031528042,0.0007647713,0.12076504,0.0013495438,0.0003016713,0.000014373916,0.002192602,0.004449391,0.8507827,0.00033025653,0.012532724,0.0033641027],"study_design_scores_gemma":[0.0026290468,0.0017577894,0.019587172,0.0010744239,0.00020343206,0.00013931298,0.000710028,0.02474504,0.9475272,0.00035710042,0.0010910085,0.00017843135],"about_ca_topic_score_codex":0.0005833283,"about_ca_topic_score_gemma":0.0002762811,"teacher_disagreement_score":0.10117787,"about_ca_system_score_codex":0.00040502916,"about_ca_system_score_gemma":0.0022662224,"threshold_uncertainty_score":0.41323656},"labels":[],"label_agreement":null},{"id":"W3044281570","doi":"10.1158/1538-7445.pedca19-ia02","title":"Abstract IA02: Novel strategies for early cancer detection and prevention: The Li-Fraumeni syndrome story","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Germline; Cancer; Germline mutation; Epigenome; Medicine; Mutation; Genetics; Cancer research; Biology; Internal medicine; Gene; DNA methylation","score_opus":0.13521962117453043,"score_gpt":0.4074796587114322,"score_spread":0.27226003753690176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044281570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756165,0.0087467395,0.0027918175,0.0099733155,0.00028589607,0.0019011024,0.00007195102,0.00007380516,0.00053888344],"genre_scores_gemma":[0.996573,0.00071459456,0.0000792858,0.0002602637,0.0004252054,0.0012493193,0.000005504673,0.000051075138,0.00064177834],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998318,0.00006347023,0.00019024238,0.0004308,0.0005647034,0.0004327651],"domain_scores_gemma":[0.9989897,0.00012628618,0.00006188872,0.00026567394,0.00032683936,0.00022962606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056614855,0.00014737937,0.00022085689,0.00009763559,0.00032764277,0.00010212665,0.00015518382,0.00013883554,0.00023733197],"category_scores_gemma":[0.00011500358,0.00011711905,0.000097017284,0.00040741748,0.00024523505,0.00016285127,0.00007327024,0.00089068094,0.000015341939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001655167,0.00008638845,0.00026969827,0.001107234,0.00044746892,0.000061956634,0.0030991593,0.00029686862,0.9265799,0.00034071872,0.0044597215,0.06159571],"study_design_scores_gemma":[0.02519632,0.011132419,0.30186832,0.003515355,0.0009556855,0.00045718203,0.012227974,0.0036538239,0.23068962,0.0030133987,0.40547913,0.0018107961],"about_ca_topic_score_codex":0.0010532988,"about_ca_topic_score_gemma":0.0006810093,"teacher_disagreement_score":0.6958903,"about_ca_system_score_codex":0.0003658941,"about_ca_system_score_gemma":0.0011011238,"threshold_uncertainty_score":0.47759765},"labels":[],"label_agreement":null},{"id":"W3044435499","doi":"10.1158/1538-7445.pedca19-pr08","title":"Abstract PR08: Lactate dehydrogenase A is a pharmacologically tractable EWS-FLI1 transcriptional target that regulates the glycolytic dependence of Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glycolysis; Lactate dehydrogenase A; Gene knockdown; Cancer research; Lactate dehydrogenase; Cell culture; Cancer cell; Cancer; Chemistry; Biology; Apoptosis; Cell biology; Biochemistry; Enzyme; Genetics","score_opus":0.09187766296466274,"score_gpt":0.3626608364504153,"score_spread":0.27078317348575254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044435499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97470814,0.01973801,0.00008004793,0.003801271,0.00023056948,0.0005857176,0.00018053043,0.000015144864,0.0006605514],"genre_scores_gemma":[0.99214816,0.0047492604,0.0001432178,0.001153291,0.0009619125,0.00020019393,0.000026304398,0.000030027362,0.0005876223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778026,0.00014930603,0.000286168,0.0005162057,0.0006716731,0.00059636275],"domain_scores_gemma":[0.99903077,0.00006958383,0.000094926,0.0002991219,0.00025750193,0.00024812206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071152404,0.000189004,0.00025377894,0.00004911659,0.00022127536,0.000056738027,0.00061267655,0.00014441779,0.0006289217],"category_scores_gemma":[0.00010841492,0.00014152958,0.0001872662,0.00029848932,0.00032161825,0.000021315764,0.00012772281,0.0004477265,0.000015893738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079113955,0.000076783035,0.00020406273,0.00010131215,0.00011729405,0.0000073876363,0.0005235571,0.0001917495,0.98456997,0.00003709561,0.01046126,0.0029184197],"study_design_scores_gemma":[0.00089917565,0.000147369,0.0021993644,0.000026495285,0.000026823383,0.0000088217985,0.00018954229,0.00017128508,0.8065574,0.00012079596,0.18949929,0.00015365153],"about_ca_topic_score_codex":0.00021598268,"about_ca_topic_score_gemma":0.000050911116,"teacher_disagreement_score":0.17903802,"about_ca_system_score_codex":0.000041963365,"about_ca_system_score_gemma":0.00061596616,"threshold_uncertainty_score":0.68862516},"labels":[],"label_agreement":null},{"id":"W3045186535","doi":"10.1158/1538-7445.pedca19-ia15","title":"Abstract IA15: Tissue-agnostic development of TRK inhibitors for pediatric cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trk receptor; Medicine; Tropomyosin receptor kinase A; Neurotrophin; Cancer; ROS1; Tropomyosin receptor kinase B; Cancer research; Internal medicine; Tropomyosin receptor kinase C; Targeted therapy; Oncology; Receptor; Neurotrophic factors; Growth factor; Adenocarcinoma; Platelet-derived growth factor receptor","score_opus":0.15935606098097121,"score_gpt":0.44711296711193876,"score_spread":0.28775690613096755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045186535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783033,0.014971011,0.000017184733,0.004957979,0.0001402541,0.0012454209,0.00006384991,0.000024941342,0.00027604474],"genre_scores_gemma":[0.99465305,0.0018066557,0.0008212572,0.00017760729,0.00069429877,0.0016507583,0.000021592296,0.00003495362,0.00013982723],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982631,0.000022688317,0.00033546868,0.0003375041,0.00061851315,0.00042271687],"domain_scores_gemma":[0.9987123,0.0003791157,0.00006470532,0.00016054128,0.00037378716,0.00030957267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026926651,0.00013159824,0.00030917418,0.00014222473,0.000112884205,0.000014016975,0.00011921541,0.00007243365,0.0008273578],"category_scores_gemma":[0.0002720878,0.00010651751,0.00007412694,0.00048521333,0.000059290283,0.00003752205,0.000059998623,0.0002053617,0.000054049167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013221685,0.0013762697,0.45319298,0.0045164293,0.0005117899,0.00017102763,0.005484381,0.00009594221,0.048758138,0.00010760369,0.12858868,0.3558746],"study_design_scores_gemma":[0.0043412577,0.0006360231,0.3500204,0.00045178278,0.00019273297,0.0000020376183,0.00031927502,0.000025846473,0.5241294,0.000042600346,0.11957253,0.00026608905],"about_ca_topic_score_codex":0.00030636386,"about_ca_topic_score_gemma":0.000107650056,"teacher_disagreement_score":0.47537127,"about_ca_system_score_codex":0.00030481414,"about_ca_system_score_gemma":0.0011883518,"threshold_uncertainty_score":0.9058988},"labels":[],"label_agreement":null},{"id":"W3045287847","doi":"10.1158/1538-7445.pedca19-ia23","title":"Abstract IA23: Lessons from a rare childhood cancer syndrome on replication repair deficiency and hypermutation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Biology; Genetics; Cancer; Carcinogenesis; DNA mismatch repair; Cancer research; Germline; Germline mutation; DNA repair; Mutation; Gene","score_opus":0.13312755316281324,"score_gpt":0.4276906524545066,"score_spread":0.29456309929169333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045287847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736852,0.005123613,0.000007854364,0.018575126,0.00012922465,0.00088042516,0.00017187145,0.00012710571,0.0012995751],"genre_scores_gemma":[0.9962366,0.0015127456,0.00016084415,0.0010128905,0.00027830538,0.0005722033,0.00004941078,0.00004550327,0.00013144685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99755085,0.000078250625,0.00025181146,0.00088582555,0.00083155604,0.00040171505],"domain_scores_gemma":[0.9985752,0.0002039971,0.00006609901,0.0005395785,0.00028235736,0.00033278196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031810658,0.00016394471,0.0002658696,0.00012414064,0.00018770358,0.00004044717,0.00016226055,0.0001356282,0.0010131028],"category_scores_gemma":[0.000615501,0.00014772908,0.000069155925,0.00056747155,0.00016752182,0.000073454474,0.000090490714,0.0006566612,0.00007091659],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002805559,0.0007398436,0.12830095,0.0012995878,0.00042211983,0.0004160928,0.013455139,0.00067764096,0.5960836,0.00043353418,0.03402104,0.22134492],"study_design_scores_gemma":[0.0012252477,0.0008034164,0.96581954,0.0004279013,0.000053071213,0.000023786657,0.00044022917,0.0002658372,0.02663605,0.00028462164,0.0038033267,0.00021697838],"about_ca_topic_score_codex":0.0016284606,"about_ca_topic_score_gemma":0.00014588342,"teacher_disagreement_score":0.8375186,"about_ca_system_score_codex":0.00045022857,"about_ca_system_score_gemma":0.00067538384,"threshold_uncertainty_score":0.9999001},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W3045469676","doi":"10.1158/1538-7445.pedca19-pr05","title":"Abstract PR05: T-cell receptor (TCR)-based immunotherapy in pediatric malignancy: Addressing the challenge of early metastasis and low immunogenicity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"T-cell receptor; Cancer research; Metastasis; Immunotherapy; Biology; Immunogenicity; CD8; T cell; Cancer; Cancer immunotherapy; Immunology; Immune system; Genetics","score_opus":0.16093607519239192,"score_gpt":0.4025395723156677,"score_spread":0.2416034971232758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045469676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550092,0.0337118,0.0000058178025,0.00849451,0.000053947853,0.0013440021,0.000053768992,0.00002601256,0.0013009319],"genre_scores_gemma":[0.9806942,0.0181162,0.00007431882,0.00020323714,0.00031594315,0.00023574363,0.000008904872,0.00007484107,0.00027666165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963665,0.00048297032,0.00050078897,0.00055476656,0.001335053,0.0007599029],"domain_scores_gemma":[0.9979851,0.0006031589,0.000121456214,0.00061910576,0.0004233688,0.0002477619],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022723572,0.00022462643,0.00051913026,0.00035580955,0.00016156802,0.000069715104,0.00047581198,0.00015338953,0.0041157342],"category_scores_gemma":[0.00018737228,0.00016742534,0.00015972563,0.0013902624,0.0004139777,0.00010867163,0.000144116,0.0013982136,0.0000320732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047565848,0.0003589036,0.01715311,0.0013792639,0.000109659384,0.000049210492,0.0027206887,0.000026594642,0.9353967,0.000016267853,0.00070201285,0.037331033],"study_design_scores_gemma":[0.015813863,0.0031676306,0.10225791,0.00093791564,0.000090317575,0.0000044562453,0.0010153563,0.0005360982,0.86413586,0.00011967906,0.0112782605,0.00064262515],"about_ca_topic_score_codex":0.0015859581,"about_ca_topic_score_gemma":0.00006971249,"teacher_disagreement_score":0.08510479,"about_ca_system_score_codex":0.0002550306,"about_ca_system_score_gemma":0.0011046717,"threshold_uncertainty_score":0.99679464},"labels":[],"label_agreement":null},{"id":"W3045804715","doi":"10.1158/1538-7445.pedca19-ia20","title":"Abstract IA20: Neuronal activity promotes proliferation of normal and neoplastic glial cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioma; Biology; Neuroscience; Neurotrophic factors; Premovement neuronal activity; Cell biology; Cancer research; Receptor","score_opus":0.08143590818180353,"score_gpt":0.37442853212083516,"score_spread":0.29299262393903164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045804715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523795,0.00015611715,0.0000042155375,0.0038655964,0.00003775804,0.00046560017,0.000027332802,0.000010324635,0.00019513788],"genre_scores_gemma":[0.99952143,0.0000770674,0.00002987962,0.0000490986,0.00020797245,0.00008181074,0.0000042561564,0.000009812794,0.000018648007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999096,0.000036743557,0.00009794295,0.00019443447,0.0003836844,0.00019124738],"domain_scores_gemma":[0.99946713,0.00011210291,0.000027153867,0.000080030186,0.00013840674,0.00017516741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011846495,0.000068355075,0.00014638467,0.000052752777,0.000057148278,0.000020030715,0.000035707777,0.00003743018,0.00020216682],"category_scores_gemma":[0.00009702495,0.000054090542,0.000027377982,0.00015020357,0.000088307286,0.00006440822,0.000041845364,0.0002043706,0.000014238585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086516415,0.0003208273,0.042745225,0.00041394163,0.00004727456,0.00006526222,0.00036770795,0.000026150816,0.9413759,0.000029716246,0.000846647,0.012896167],"study_design_scores_gemma":[0.0011132337,0.00070917956,0.27659056,0.000054423497,0.000019548488,0.0000043574346,0.000016239104,0.00038661386,0.72083634,0.000007733993,0.00022238106,0.000039429706],"about_ca_topic_score_codex":0.00017487751,"about_ca_topic_score_gemma":0.000033190405,"teacher_disagreement_score":0.23384532,"about_ca_system_score_codex":0.00004078052,"about_ca_system_score_gemma":0.00022372487,"threshold_uncertainty_score":0.22135848},"labels":[],"label_agreement":null},{"id":"W3046047132","doi":"10.1158/1538-7445.pedca19-ia22","title":"Abstract IA22: Tumor cells highjack diverse cellular processes to maintain redox balance","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxidative stress; Metastasis; Anoikis; Cancer research; Cancer; Biology; Medicine; Sarcoma; Bioinformatics; Pathology; Internal medicine","score_opus":0.050439641340378975,"score_gpt":0.3665043086282038,"score_spread":0.31606466728782484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046047132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915678,0.0023916266,0.000087258995,0.0035612131,0.00009214716,0.0007823556,0.00040969142,0.000026947144,0.0010809605],"genre_scores_gemma":[0.99623895,0.0007466825,0.00013722811,0.00071728334,0.0007457803,0.00034465105,0.00009351314,0.00004410241,0.00093180145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975325,0.00008489105,0.00017500902,0.00072642905,0.00064646517,0.00083473395],"domain_scores_gemma":[0.9984675,0.000030653977,0.000035963993,0.00039215424,0.00038586816,0.00068783376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027826588,0.00018886045,0.00018193034,0.00007375739,0.0001960668,0.00009621554,0.0005587937,0.00007797577,0.0005516937],"category_scores_gemma":[0.000252023,0.00017585019,0.000069405025,0.0005578847,0.0001537127,0.000010024781,0.00042099043,0.000298135,0.000489939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007547586,0.000082312115,0.0013793348,0.0002350981,0.000073767405,0.00018012086,0.00012790559,0.00010292193,0.9159666,0.000019212253,0.07964994,0.0014280658],"study_design_scores_gemma":[0.00065624376,0.00046790982,0.00040023148,0.000041917745,0.000004972321,0.0000012839222,0.00017077912,0.000007682846,0.7882246,0.000036876263,0.20981091,0.00017658892],"about_ca_topic_score_codex":0.000877102,"about_ca_topic_score_gemma":0.0003908526,"teacher_disagreement_score":0.13016096,"about_ca_system_score_codex":0.00013902178,"about_ca_system_score_gemma":0.00081251806,"threshold_uncertainty_score":0.71709627},"labels":[],"label_agreement":null},{"id":"W3046101679","doi":"10.1158/1538-7445.pedca19-a10","title":"Abstract A10: Constitutive HIF activity enhances T-cell antitumor immunity and memory T-cell formation in the murine adoptive cell therapy model","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adoptive cell transfer; Cytotoxic T cell; CD8; Cancer research; T cell; Biology; Melanoma; Pathology; Chemistry; In vitro; Medicine; Immunology; Immune system","score_opus":0.08150301861523336,"score_gpt":0.37191336293973076,"score_spread":0.2904103443244974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046101679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863479,0.004745295,0.0001463687,0.0008815733,0.000022972823,0.0008793093,0.000071943665,0.000009131542,0.0068954746],"genre_scores_gemma":[0.9889988,0.010087027,0.00004845206,0.00033220896,0.00012971822,0.00018407029,0.000037338352,0.000022280405,0.00016011634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997859,0.0004911568,0.00018671916,0.0004349373,0.00051278545,0.00051540957],"domain_scores_gemma":[0.99906695,0.00009220608,0.00007347036,0.00039071598,0.00024095876,0.00013572503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140969,0.0001933629,0.00018756089,0.00009305177,0.0002985149,0.00008210638,0.0005461111,0.00012650284,0.0000669753],"category_scores_gemma":[0.000041913438,0.00015138161,0.00006056146,0.0003512004,0.00051476667,0.00003562106,0.00019763198,0.00078830763,0.000017420305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031805579,0.0002139714,0.000059271275,0.00009768088,0.000013711006,0.000011903722,0.001427761,0.0006765416,0.9899374,0.000005335748,0.00065698085,0.0037188465],"study_design_scores_gemma":[0.0016198894,0.0011526418,0.00029458254,0.000013640438,0.0000027066455,0.0000014533266,0.0010763657,0.0011163288,0.9938714,0.000048959148,0.0006305527,0.0001714703],"about_ca_topic_score_codex":0.0003331757,"about_ca_topic_score_gemma":0.00035066655,"teacher_disagreement_score":0.0067353584,"about_ca_system_score_codex":0.000071770606,"about_ca_system_score_gemma":0.00052607997,"threshold_uncertainty_score":0.6173163},"labels":[],"label_agreement":null},{"id":"W3046179605","doi":"10.1158/1538-7445.pedca19-ia24","title":"Abstract IA24: The lifetime impact of cancer and cancer therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Quality of life (healthcare); Population; Disease; Pediatrics; Malignancy; Gerontology; Intensive care medicine; Environmental health; Internal medicine","score_opus":0.16850653275024025,"score_gpt":0.5000093033093006,"score_spread":0.33150277055906036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046179605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87068456,0.06106077,0.0000019087272,0.066278756,0.000106755484,0.0008736957,0.00020213722,0.00004092324,0.00075046724],"genre_scores_gemma":[0.95724523,0.03769593,0.000014719147,0.0027931093,0.0014886705,0.00032494907,0.0000071054915,0.00006150909,0.0003687681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996964,0.00019073681,0.0004349243,0.0005150701,0.0012516832,0.00064359646],"domain_scores_gemma":[0.9978908,0.00041440548,0.00014266194,0.0005054072,0.0005197883,0.00052699214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011043515,0.0002407885,0.0005598035,0.00011019761,0.00018934972,0.000053380907,0.000383926,0.00012378584,0.003793566],"category_scores_gemma":[0.00025034277,0.00015249696,0.00021282851,0.00077036966,0.0006188897,0.00011170361,0.00014871728,0.0009743826,0.000022560196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062905787,0.00034595802,0.4248546,0.0014338178,0.0023830072,0.00004600618,0.027103852,0.00031124565,0.159048,0.00012361784,0.17987798,0.19818133],"study_design_scores_gemma":[0.0041835997,0.0009898597,0.9064671,0.00070681015,0.00007464752,0.0000056197864,0.0010096313,0.00014249301,0.028684113,0.00011694314,0.057262763,0.00035642114],"about_ca_topic_score_codex":0.06369313,"about_ca_topic_score_gemma":0.0014575468,"teacher_disagreement_score":0.4816125,"about_ca_system_score_codex":0.0003423106,"about_ca_system_score_gemma":0.0021169325,"threshold_uncertainty_score":0.9971171},"labels":[],"label_agreement":null},{"id":"W3046204049","doi":"10.1158/1538-7445.pedca19-ia28","title":"Abstract IA28: Tumor uniformity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Transcriptome; Citation; Computational biology; Medicine; Pediatric cancer; Cancer research; Tumor cells; Biology; Gene; Library science; Genetics; Computer science; Gene expression; Internal medicine","score_opus":0.06688277803913363,"score_gpt":0.37472728793407195,"score_spread":0.30784450989493833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046204049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989861,0.0019778006,0.00012311844,0.0024900842,0.00012122018,0.0001930102,0.00010931915,0.00001097752,0.00511344],"genre_scores_gemma":[0.99628186,0.00095433067,0.00011696107,0.001322515,0.0010382606,0.000055892466,0.000031107014,0.000023234166,0.00017580845],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989664,0.000025198779,0.0001206141,0.00031805856,0.00022242853,0.0003473091],"domain_scores_gemma":[0.9992916,0.000028815995,0.000025440339,0.00023831947,0.00017872856,0.00023710991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022097002,0.00008746922,0.00009257512,0.000026075424,0.00010294575,0.000044515473,0.00028395792,0.000060702587,0.00026013402],"category_scores_gemma":[0.00028303327,0.00008653634,0.00005287746,0.00015743554,0.00011088705,0.0000023297791,0.00021397947,0.0002210691,0.000101460624],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002283844,0.000035726363,0.0023873316,0.00006554224,0.00003403729,0.000024027955,0.00007022234,0.00019101119,0.89422435,0.00057420344,0.09499354,0.0071716034],"study_design_scores_gemma":[0.00047477067,0.0002300806,0.0053110537,0.000013169564,0.0000044097433,0.0000022526717,0.00008151575,0.00003727485,0.4106531,0.00021547552,0.58279854,0.00017833368],"about_ca_topic_score_codex":0.0002197076,"about_ca_topic_score_gemma":0.00009844939,"teacher_disagreement_score":0.487805,"about_ca_system_score_codex":0.000042463304,"about_ca_system_score_gemma":0.00041526151,"threshold_uncertainty_score":0.35288495},"labels":[],"label_agreement":null},{"id":"W3046467059","doi":"10.1158/1538-7445.pedca19-pr09","title":"Abstract PR09: <i>STAG2</i> mutations alter topologic organization of the genome and cis-mediated interactions","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chromatin; Cohesin; Genetics; Biology; PAX3; Gene; Establishment of sister chromatid cohesion; Transcription factor; CTCF; Cell biology; Enhancer; Cancer research","score_opus":0.05665004466280099,"score_gpt":0.3665293071731054,"score_spread":0.3098792625103044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046467059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299926,0.000612245,0.00024984512,0.0051663285,0.000053824075,0.0002013258,0.000080766564,0.0000055140426,0.0006308956],"genre_scores_gemma":[0.9984777,0.00064852677,0.000026727601,0.00029569268,0.00013105069,0.00004774948,0.00007129627,0.000010933477,0.00029033006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994054,0.000048759786,0.00011783259,0.00018208058,0.00012403505,0.000121888756],"domain_scores_gemma":[0.99939895,0.000020805088,0.000044212553,0.00017655159,0.00030164947,0.000057840225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009641543,0.000050928527,0.00005583924,0.000024063296,0.0001431085,0.000020884556,0.00015618613,0.00004325786,0.00024742834],"category_scores_gemma":[0.00017155465,0.00003840538,0.00002084055,0.00032520565,0.00017347586,0.0000045699276,0.000094059535,0.00013009226,0.000008230196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000129012,0.000013843213,0.002258744,0.000018282357,0.000017608232,2.0908004e-7,0.0001985033,0.00011567282,0.99533355,0.00009253116,0.0015167608,0.00042139125],"study_design_scores_gemma":[0.0004857255,0.00012843325,0.08995586,0.000020908077,0.000016703347,0.000003506158,0.0008451701,0.00007250329,0.8374439,0.00009342543,0.070773035,0.00016086458],"about_ca_topic_score_codex":0.000069336624,"about_ca_topic_score_gemma":0.000042410124,"teacher_disagreement_score":0.1578897,"about_ca_system_score_codex":0.00002180932,"about_ca_system_score_gemma":0.00016006884,"threshold_uncertainty_score":0.27091667},"labels":[],"label_agreement":null},{"id":"W3046932746","doi":"10.1158/1538-7445.pedca19-a23","title":"Abstract A23: Novel approaches to Ewing sarcoma therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PARP1; DNA damage; Cancer research; Synthetic lethality; FLI1; Biology; Sarcoma; Cancer; Pediatric cancer; DNA repair; DNA; Chromosomal translocation; Medicine; Gene; Genetics; Poly ADP ribose polymerase; Pathology","score_opus":0.2969357991154682,"score_gpt":0.4314839166845446,"score_spread":0.13454811756907642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046932746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98656803,0.0030667677,0.005862542,0.0028431932,0.000057813184,0.00025254034,0.000015956892,0.000015010454,0.0013181698],"genre_scores_gemma":[0.997834,0.00032468408,0.0005732648,0.00037256716,0.0006488827,0.00008276028,0.0000120962195,0.000027011203,0.00012472046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902946,0.000015362972,0.00009535065,0.00031943942,0.00020962875,0.00033074155],"domain_scores_gemma":[0.9995255,0.000011916268,0.000008665523,0.00020531319,0.0000501843,0.00019841142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021354399,0.000090711634,0.00008381265,0.00003576153,0.00006816497,0.000036081557,0.0002515013,0.00006606079,0.000057089797],"category_scores_gemma":[0.000056782395,0.00008578693,0.00004360607,0.00018268592,0.00003409366,0.0000018594081,0.00012740062,0.0001717603,0.000024560835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006842866,0.000023034756,0.00033118378,0.000023043345,0.000023639255,0.0000014810216,0.0002528741,0.0012050177,0.98036075,0.00002488271,0.0023460123,0.0153396595],"study_design_scores_gemma":[0.0003807723,0.00014375297,0.0041859904,0.000010644636,0.0000010009692,9.942963e-7,0.00013787884,0.0000940092,0.8808372,0.0000058570586,0.11407758,0.00012431382],"about_ca_topic_score_codex":0.000042407813,"about_ca_topic_score_gemma":0.000011795901,"teacher_disagreement_score":0.11173157,"about_ca_system_score_codex":0.000015870532,"about_ca_system_score_gemma":0.000081413054,"threshold_uncertainty_score":0.34982896},"labels":[],"label_agreement":null},{"id":"W3046935819","doi":"10.1158/1538-7445.pedca19-a54","title":"Abstract A54: Parallel targeting of RAF/MEK/ERK pathway in RAS-mutant embryonal rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Neuroblastoma RAS viral oncogene homolog; Embryonal rhabdomyosarcoma; MAPK/ERK pathway; MEK inhibitor; Cancer research; HRAS; Rhabdomyosarcoma; PI3K/AKT/mTOR pathway; Cancer; Mutant; Biology; Targeted therapy; Medicine; Signal transduction; KRAS; Cell biology; Pathology; Genetics; Sarcoma","score_opus":0.11375136288366705,"score_gpt":0.3972506261201197,"score_spread":0.28349926323645264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046935819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801807,0.008167619,0.000006059041,0.009058754,0.000061447296,0.0006873162,0.00004970387,0.000026819982,0.001761589],"genre_scores_gemma":[0.99779356,0.0008555431,0.00034100033,0.00031225686,0.00028717035,0.00028476794,0.00002962614,0.000035617573,0.000060441504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974526,0.000119543016,0.00046079844,0.00044321967,0.00090845523,0.00061536435],"domain_scores_gemma":[0.9987067,0.00038462607,0.00007599879,0.00026077544,0.00023200498,0.00033988475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066222803,0.00017158338,0.0004692867,0.00018191866,0.000076703225,0.000021121536,0.00020148982,0.000099457735,0.0014039086],"category_scores_gemma":[0.00036443135,0.00013890215,0.00013508648,0.0006174022,0.00016250239,0.000066925306,0.000126885,0.0006089146,0.00009900098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030543376,0.0024554748,0.49883538,0.0011510463,0.0003617248,0.0034826358,0.0029778758,0.00023582178,0.4179118,0.0010491598,0.015264743,0.05321999],"study_design_scores_gemma":[0.012231389,0.0011761484,0.6350113,0.0012556176,0.00004420264,0.000024823694,0.0019267331,0.00050639006,0.31925377,0.0004138182,0.027700912,0.0004548685],"about_ca_topic_score_codex":0.0008599153,"about_ca_topic_score_gemma":0.00007905314,"teacher_disagreement_score":0.13617593,"about_ca_system_score_codex":0.0002758787,"about_ca_system_score_gemma":0.00061824825,"threshold_uncertainty_score":0.9995089},"labels":[],"label_agreement":null},{"id":"W3046944317","doi":"10.1158/1538-7445.pedca19-b70","title":"Abstract B70: Clonal evolution of chemotherapy-resistant rhabdomyosarcoma via multifocal genomic analysis of pretreatment and treatment-resistant autopsy specimens","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Loss of heterozygosity; Biology; Pathology; Biopsy; Autopsy; Cancer research; Germline mutation; Alveolar rhabdomyosarcoma; Mutation; Medicine; Sarcoma; Genetics; Gene","score_opus":0.0643189981676233,"score_gpt":0.36894653949573686,"score_spread":0.30462754132811354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046944317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865183,0.009993065,0.00002735288,0.0018157184,0.000022713588,0.00095323066,0.0003481085,0.000022519846,0.00029895408],"genre_scores_gemma":[0.9974448,0.0015654039,0.00050297624,0.000038814247,0.00009696442,0.00018860695,0.000058114536,0.000033505752,0.00007083211],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975995,0.000104797175,0.0005431082,0.0005757631,0.0007308677,0.00044597962],"domain_scores_gemma":[0.99850327,0.00027415188,0.00016622491,0.0004244272,0.00027396114,0.00035793745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024786868,0.00025991432,0.00087046245,0.0004483866,0.00010066663,0.000017239772,0.0001182884,0.000106280546,0.00089370017],"category_scores_gemma":[0.00003771211,0.00019720297,0.00034442203,0.0010111401,0.00033224415,0.000046390414,0.000059704962,0.0001445098,0.000007430682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005838495,0.0022238668,0.30169865,0.00021274017,0.0075452933,0.00018000328,0.0014582685,0.00009289778,0.65173256,0.0002196189,0.00020230842,0.028595308],"study_design_scores_gemma":[0.0048594973,0.0018519724,0.9088994,0.0000978692,0.0013950361,0.0000029596222,0.0004284515,0.0012394364,0.08032622,0.000028761187,0.000731393,0.00013899044],"about_ca_topic_score_codex":0.0044278093,"about_ca_topic_score_gemma":0.0007545495,"teacher_disagreement_score":0.60720074,"about_ca_system_score_codex":0.0013357518,"about_ca_system_score_gemma":0.00043877726,"threshold_uncertainty_score":0.978539},"labels":[],"label_agreement":null},{"id":"W3046959938","doi":"10.1158/1538-7445.pedca19-a67","title":"Abstract A67: Improving tissue allocation for research in pediatric solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical physics; Tissue Donation; Tissue bank; Patient care; Pathology; Surgery; Nursing","score_opus":0.7524942848113819,"score_gpt":0.6929308620380319,"score_spread":0.05956342277335003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046959938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87565386,0.0025723218,0.00019446822,0.110792965,0.00018836379,0.004324182,0.000036208326,0.00008579068,0.0061518215],"genre_scores_gemma":[0.9904711,0.0029458965,0.0005270444,0.0004386823,0.0025934835,0.0012496682,0.000022622686,0.00008377256,0.0016676999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9924847,0.00041026683,0.00075035176,0.0010196327,0.0037188837,0.00161619],"domain_scores_gemma":[0.9808973,0.013990582,0.00007142758,0.0006721734,0.0034770756,0.0008914608],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024163611,0.00015864518,0.0004260072,0.00079548743,0.0003181146,0.00012398355,0.00076721556,0.00046864912,0.0004089844],"category_scores_gemma":[0.041131377,0.0001503973,0.00008804687,0.0026719472,0.00052471115,0.0001594495,0.00050197565,0.0072432347,0.00033386692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009031143,0.0014749167,0.06945795,0.033397026,0.00012319678,0.0009968709,0.006560794,0.00032933714,0.61770177,0.016565656,0.045665413,0.19869593],"study_design_scores_gemma":[0.024018982,0.016319945,0.3088366,0.0049595637,0.00011713063,0.000027664579,0.008408993,0.011866074,0.47128615,0.0964413,0.05554269,0.0021748862],"about_ca_topic_score_codex":0.0014491397,"about_ca_topic_score_gemma":0.00085681357,"teacher_disagreement_score":0.23937868,"about_ca_system_score_codex":0.0008550904,"about_ca_system_score_gemma":0.0054629464,"threshold_uncertainty_score":0.9950471},"labels":[],"label_agreement":null},{"id":"W3046964403","doi":"10.1158/1538-7445.pedca19-a41","title":"Abstract A41: Novel mithramycin analogues with improved pharmacologic profile and efficacy in ETS transcription factor-driven tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ETS transcription factor family; FLI1; Transcription factor; Biology; Cancer research; Chromosomal translocation; Carcinogenesis; Fusion gene; Gene silencing; Sarcoma; Promoter; Gene; Molecular biology; Gene expression; Genetics; Medicine; Pathology","score_opus":0.08136347541052871,"score_gpt":0.3676678332200451,"score_spread":0.28630435780951635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046964403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745345,0.0006600631,0.00009624639,0.00093988836,0.000028032646,0.000603705,0.000060757153,0.000013369016,0.00014449513],"genre_scores_gemma":[0.9988876,0.00031595744,0.00013269352,0.00020822026,0.00015793325,0.0001378907,0.00007435442,0.000016462729,0.00006887728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989487,0.000059527512,0.00014579021,0.0003795448,0.00018362959,0.00028279834],"domain_scores_gemma":[0.99960124,0.000013568426,0.000035739402,0.00010323291,0.00010241192,0.00014377465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001486646,0.00011292959,0.0001204767,0.00006400251,0.0000661563,0.000035663565,0.00014018994,0.00009308066,0.00009235054],"category_scores_gemma":[0.000061870334,0.00009090047,0.00002592146,0.00021566244,0.00013598474,0.000011700933,0.00004611584,0.0002960168,0.0000047444946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036442402,0.00007253825,0.0011913959,0.000048314618,0.000017407789,0.0000044743083,0.00017128367,0.00002563783,0.994228,0.000005186051,0.00044945802,0.0034218677],"study_design_scores_gemma":[0.0019334578,0.0005314483,0.057630464,0.000038175218,0.0000032467044,0.0000014703194,0.0001313909,0.00025015709,0.9355939,0.0000021188957,0.003738244,0.0001459015],"about_ca_topic_score_codex":0.00015092107,"about_ca_topic_score_gemma":0.00015147697,"teacher_disagreement_score":0.058634087,"about_ca_system_score_codex":0.000035745514,"about_ca_system_score_gemma":0.00016514689,"threshold_uncertainty_score":0.37068135},"labels":[],"label_agreement":null},{"id":"W3046965403","doi":"","title":"The combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of Chronic Myelogenous Leukemia","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada","funders":"","keywords":"Imatinib; Chronic myelogenous leukemia; Cancer research; Apoptosis; breakpoint cluster region; Imatinib mesylate; ABL; Tyrosine kinase; DNA damage; Leukemia; Biology; Chemistry; Cell biology; Immunology; Signal transduction; DNA; Receptor; Biochemistry","score_opus":0.09225582972052165,"score_gpt":0.40192676211249106,"score_spread":0.3096709323919694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046965403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93053347,0.05447185,0.007152367,0.0013985309,0.00034462922,0.0050683115,0.000085050255,0.000094864685,0.00085094717],"genre_scores_gemma":[0.9896169,0.0042150375,0.0018807078,0.00006596138,0.0007968308,0.00076238584,0.00009642347,0.000099795216,0.0024659648],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99645287,0.00018178295,0.00060710596,0.0005362088,0.0008670719,0.0013549866],"domain_scores_gemma":[0.9960086,0.0020430246,0.00018356195,0.0008265922,0.0006675125,0.00027075698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022167207,0.00029098373,0.00048069295,0.00010925763,0.0010987775,0.00006017586,0.00035693153,0.00015259064,0.000081077305],"category_scores_gemma":[0.00033113052,0.00016671368,0.00023086455,0.00038714334,0.0007073478,0.0000739336,0.000084390536,0.00037724528,0.000007271389],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009412571,0.0025368193,0.0005264969,0.0004449788,0.0022804746,0.00021667466,0.021510186,0.085333034,0.57863003,0.0009327614,0.008495683,0.2896803],"study_design_scores_gemma":[0.024467327,0.0071229218,0.00018373349,0.00024797648,0.00041124324,0.000033910044,0.0038306625,0.47953963,0.46301323,0.0001984976,0.02052932,0.00042155935],"about_ca_topic_score_codex":0.0013103852,"about_ca_topic_score_gemma":0.00046796538,"teacher_disagreement_score":0.39420658,"about_ca_system_score_codex":0.011077913,"about_ca_system_score_gemma":0.0033859257,"threshold_uncertainty_score":0.9927184},"labels":[],"label_agreement":null},{"id":"W3046970531","doi":"10.1158/1538-7445.pedca19-b57","title":"Abstract B57: A combination of IL7Rα and NRAS mutations sheds light on the oncogenesis of T-cell acute lymphoblastic leukemia in a murine model","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Interleukin-7 receptor; KRAS; Cancer research; Leukemia; Immunology; Medicine; Biology; Cancer; T cell; Internal medicine; IL-2 receptor; Colorectal cancer; Immune system","score_opus":0.057191940591034336,"score_gpt":0.35775061475604714,"score_spread":0.3005586741650128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046970531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988194,0.00020304005,0.00017724022,0.0067590913,0.000018933857,0.0008819175,0.000066762674,0.000015205843,0.0036837982],"genre_scores_gemma":[0.99848956,0.00056817336,0.00012938648,0.00020844598,0.000053186817,0.00020943655,0.00001524166,0.00003965182,0.0002868974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997291,0.00014319879,0.00045998636,0.00038973152,0.0012728741,0.00044316213],"domain_scores_gemma":[0.9976606,0.0010346699,0.0001056664,0.0003606703,0.0005895767,0.00024885344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007828319,0.00016389567,0.0003976522,0.00041260576,0.000089379406,0.00001882748,0.0002993051,0.00012648104,0.00019824096],"category_scores_gemma":[0.00071138615,0.0001193033,0.00007102815,0.0012339994,0.00041927843,0.00008060502,0.00018986409,0.0004956946,0.00001980669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021979013,0.0003279999,0.0012666141,0.0010123765,0.00015512701,0.000106503445,0.003830052,0.0040521994,0.982415,0.0010561014,0.0021121593,0.0014679589],"study_design_scores_gemma":[0.010046125,0.0015158483,0.013316736,0.000666549,0.000118839394,0.000014711116,0.00096268713,0.1939757,0.7784084,0.0005668552,0.00018822847,0.00021932066],"about_ca_topic_score_codex":0.0007085877,"about_ca_topic_score_gemma":0.00005621859,"teacher_disagreement_score":0.20400661,"about_ca_system_score_codex":0.0017511977,"about_ca_system_score_gemma":0.003998073,"threshold_uncertainty_score":0.709241},"labels":[],"label_agreement":null},{"id":"W3046977721","doi":"10.1158/1538-7445.pedca19-a21","title":"Abstract A21: Time-to-event Bayesian optimal interval design to accelerate phase I pediatric oncology trials","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bayesian probability; Medicine; Maximum tolerated dose; Event (particle physics); Interval (graph theory); Accrual; Confidence interval; Clinical trial; Computer science; Oncology; Internal medicine; Statistics; Artificial intelligence; Mathematics","score_opus":0.8968177525830496,"score_gpt":0.72093317679735,"score_spread":0.1758845757856996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046977721","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031858478,0.00013379757,0.9280596,0.029595839,0.0007839929,0.006064,0.00054359337,0.00017066723,0.0027900524],"genre_scores_gemma":[0.05780321,0.00012923058,0.9299438,0.002461679,0.0060929866,0.0016421527,0.0000032601636,0.00016279664,0.0017609015],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9880386,0.0068449816,0.0019310651,0.0009396568,0.0011653932,0.0010803188],"domain_scores_gemma":[0.9105026,0.086603664,0.00027376355,0.0005219269,0.0005431153,0.0015549446],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.029385626,0.0002925839,0.0015884865,0.0002872323,0.000158702,0.00016147642,0.001047665,0.00028559545,0.0264753],"category_scores_gemma":[0.23977792,0.00024709955,0.00025911097,0.0012373459,0.00012624201,0.000079319136,0.0005569191,0.0011563322,0.004084078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014133727,0.0012941658,0.000013957914,0.000518141,0.00029805693,0.00032954843,0.0015692051,0.0007086014,0.035770986,0.0016547552,0.6542891,0.2894197],"study_design_scores_gemma":[0.048395924,0.050061632,0.0003187129,0.0010687654,0.0013073253,0.000020339907,0.0009941785,0.014092249,0.2955474,0.28895488,0.29473662,0.004501992],"about_ca_topic_score_codex":0.0000240674,"about_ca_topic_score_gemma":0.0000022616205,"teacher_disagreement_score":0.35955253,"about_ca_system_score_codex":0.0004846574,"about_ca_system_score_gemma":0.0010505235,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W3046979613","doi":"10.1158/1538-7445.pedca19-a40","title":"Abstract A40: Integration of high-throughput drug screening on patient-derived organdies into pediatric precision medicine programs: The future is now!","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Precision medicine; Internal medicine; Personalized medicine; Exome; Exome sequencing; Clinical trial; Bioinformatics; Computational biology; Cancer research; Gene; Biology; Mutation; Pathology; Genetics","score_opus":0.07594266452080835,"score_gpt":0.39631075193002807,"score_spread":0.32036808740921974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046979613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542173,0.0022565413,0.000046651243,0.04167964,0.00012337186,0.0013910523,0.000018982762,0.00004333738,0.00022313124],"genre_scores_gemma":[0.99430525,0.0034781236,0.00018767387,0.00047040966,0.0011550845,0.0001894641,0.000049279377,0.000038909508,0.00012578536],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967291,0.00019705025,0.00035343925,0.00047052713,0.0017871652,0.00046274494],"domain_scores_gemma":[0.9981164,0.00033521184,0.00011160028,0.0003984918,0.00071338017,0.000324944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042330357,0.00019826273,0.0003418538,0.00022597125,0.00026835344,0.000036926802,0.0002619911,0.00007792707,0.0005658662],"category_scores_gemma":[0.00040847214,0.00010829375,0.00007853126,0.0011557402,0.00031386994,0.0001286944,0.00016542783,0.00089219806,0.00007615282],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00995809,0.0008014529,0.0114773195,0.0011709671,0.00039239196,0.00027335307,0.028094033,0.000019844956,0.18188545,0.000099872916,0.117463246,0.648364],"study_design_scores_gemma":[0.013518758,0.02089408,0.12203385,0.0024176477,0.000277748,0.000017782724,0.016822616,0.0002610346,0.7973573,0.000991358,0.02486458,0.0005432384],"about_ca_topic_score_codex":0.00087160006,"about_ca_topic_score_gemma":0.00019719847,"teacher_disagreement_score":0.6478207,"about_ca_system_score_codex":0.00015558804,"about_ca_system_score_gemma":0.00029378678,"threshold_uncertainty_score":0.6195838},"labels":[],"label_agreement":null},{"id":"W3046981872","doi":"10.1158/1538-7445.pedca19-ia03","title":"Abstract IA03: Medulloblastoma predisposition according to molecular subgroup: The usual suspects and beyond","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic predisposition; Germline; Cancer; Medulloblastoma; Malignancy; Genetics; Medicine; Germline mutation; Biology; Gene; Mutation","score_opus":0.05333533399325049,"score_gpt":0.3855145634255731,"score_spread":0.33217922943232264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046981872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952385,0.0015018601,0.000013770517,0.044051778,0.00004502527,0.0007301612,0.000017156406,0.00002632892,0.0012288904],"genre_scores_gemma":[0.99781984,0.00014733427,0.000056706685,0.0013920064,0.00024883111,0.00028444693,0.000010039318,0.000022677012,0.000018116445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858814,0.0000510064,0.00012024445,0.00031972578,0.0005667907,0.00035411614],"domain_scores_gemma":[0.9991391,0.000129866,0.000018560206,0.00018937634,0.0001486467,0.00037446036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025140625,0.000105236875,0.00015766462,0.00008686753,0.00016612475,0.00007804624,0.00010370054,0.00004597901,0.00013698555],"category_scores_gemma":[0.00013886976,0.00007113964,0.0000449426,0.0004225464,0.00008372043,0.000055691766,0.00012042833,0.000269322,0.000054762957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093885517,0.00023958205,0.0354444,0.00021241403,0.00025207494,0.00136514,0.0023898832,0.000058619215,0.9181688,0.0017712915,0.0133348,0.025824144],"study_design_scores_gemma":[0.003423167,0.0020341577,0.2854463,0.00034765396,0.00013448746,0.00007037816,0.0037006198,0.00023645001,0.6986672,0.00037851147,0.0052926796,0.00026838775],"about_ca_topic_score_codex":0.00023552985,"about_ca_topic_score_gemma":0.000048768667,"teacher_disagreement_score":0.25000188,"about_ca_system_score_codex":0.00015204931,"about_ca_system_score_gemma":0.00010465335,"threshold_uncertainty_score":0.29009905},"labels":[],"label_agreement":null},{"id":"W3046994859","doi":"10.1158/1538-7445.pedca19-b10","title":"Abstract B10: Rhabdomyosarcoma requires MYC family genomic events to pathogenically subvert core-regulatory circuitry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Enhancer; Cancer research; Chromatin immunoprecipitation; Rhabdomyosarcoma; Carcinogenesis; Transcription factor; Pediatric cancer; Gene; CRISPR; Genetics; Cancer; Computational biology; Gene expression; Promoter; Sarcoma; Medicine; Pathology","score_opus":0.18554069032200468,"score_gpt":0.4148541279067773,"score_spread":0.2293134375847726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046994859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821166,0.0066197673,0.0000065318295,0.007845854,0.00016933559,0.0012621881,0.000099367244,0.000088666246,0.0017917124],"genre_scores_gemma":[0.99339205,0.0007955363,0.00014938251,0.004123407,0.0006833071,0.0005320797,0.00003403799,0.0000806003,0.00020962028],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965046,0.00009991307,0.00046219447,0.00079586654,0.0012626037,0.00087482407],"domain_scores_gemma":[0.99754435,0.00025062135,0.000059917395,0.0006888451,0.0003327306,0.0011235519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005809693,0.00026189853,0.0005162655,0.00018838853,0.00019997953,0.000042905776,0.0004147076,0.00015310996,0.0007792984],"category_scores_gemma":[0.00026774438,0.00022808141,0.0002279336,0.0005712679,0.00014689597,0.00007944061,0.00026688632,0.0005642867,0.0010381613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009163852,0.00054483785,0.22223023,0.00022045831,0.00029933464,0.0010213868,0.00052509265,0.000017301441,0.6870658,0.00029450635,0.03268145,0.05418322],"study_design_scores_gemma":[0.0019924152,0.00045530297,0.9625331,0.00025263152,0.00005560525,0.000016383594,0.00017270603,0.00001598296,0.012067809,0.00013879323,0.02207162,0.00022760652],"about_ca_topic_score_codex":0.0005142634,"about_ca_topic_score_gemma":0.00003693142,"teacher_disagreement_score":0.7403029,"about_ca_system_score_codex":0.0007645851,"about_ca_system_score_gemma":0.00088888017,"threshold_uncertainty_score":0.99973965},"labels":[],"label_agreement":null},{"id":"W3047000763","doi":"10.1158/1538-7445.pedca19-b60","title":"Abstract B60: Exposure assessment among an adult population on radiation therapy, chemotherapy, and other cancer therapies in childhood","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Logistic regression; Intraclass correlation; Cancer; Population; Kappa; Adverse effect; Internal medicine; Clinical psychology; Psychometrics; Environmental health","score_opus":0.08887978191870256,"score_gpt":0.4377163528887358,"score_spread":0.34883657097003323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047000763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703137,0.0031009505,0.0000048674824,0.024575375,0.00010751029,0.0013230545,0.000047622427,0.00008167644,0.00044524382],"genre_scores_gemma":[0.98568445,0.0044257613,0.00005929461,0.008205212,0.001068447,0.00038633993,0.000036495596,0.00008950407,0.000044474462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969167,0.0003491943,0.00043660856,0.00068555376,0.0011220961,0.0004898536],"domain_scores_gemma":[0.99881476,0.00014318008,0.00013116724,0.00038449102,0.00018771243,0.0003386736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096024445,0.0002598077,0.00042935155,0.00024095368,0.00015247789,0.000102994585,0.00018960309,0.00017903249,0.0007921155],"category_scores_gemma":[0.00008257412,0.0002282607,0.000069972826,0.0005396371,0.00013994132,0.00026966314,0.00003131592,0.0008650866,0.0000064381297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008801106,0.00039731132,0.8494562,0.00015372898,0.00013488406,0.0000072488097,0.021498175,0.00008182222,0.003941965,0.00016447385,0.00056575576,0.12271833],"study_design_scores_gemma":[0.0042850007,0.00079282897,0.98873633,0.00036639217,0.000007708904,8.751993e-7,0.0013443115,0.00013152372,0.0018772772,0.00014241971,0.0020841858,0.00023114707],"about_ca_topic_score_codex":0.019040152,"about_ca_topic_score_gemma":0.0043876707,"teacher_disagreement_score":0.13928014,"about_ca_system_score_codex":0.00041626833,"about_ca_system_score_gemma":0.0003562245,"threshold_uncertainty_score":0.98749214},"labels":[],"label_agreement":null},{"id":"W3047005388","doi":"10.1158/1538-7445.pedca19-b56","title":"Abstract B56: A CRISPR/Cas9 domain screen identifies a small motif in the PAX3-FOXO1 transactivation domain relevant for tumor maintenance in alveolar rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Druggability; Alveolar rhabdomyosarcoma; Transcription factor; Biology; Transactivation; Fusion protein; Carcinogenesis; Computational biology; Genetics; Cancer research; Rhabdomyosarcoma; Gene; Medicine; Recombinant DNA","score_opus":0.07660945267326966,"score_gpt":0.3620230747456486,"score_spread":0.28541362207237897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047005388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97753125,0.0018861109,0.007625253,0.011193932,0.000047838188,0.001306441,0.00013828068,0.00000863828,0.0002622638],"genre_scores_gemma":[0.99610436,0.00062050717,0.00067870104,0.0006704113,0.0002508735,0.0014669815,0.00006934399,0.000030991054,0.00010783591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783164,0.00026084125,0.00037168278,0.00059628853,0.00035145198,0.0005881167],"domain_scores_gemma":[0.999077,0.0001075847,0.00007706206,0.00043964302,0.00020223862,0.000096446754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016466642,0.00017152565,0.00019818915,0.0001164114,0.00016867611,0.00010057091,0.00062082143,0.00011918394,0.0000403603],"category_scores_gemma":[0.00020414156,0.00013774073,0.000113319475,0.00050913787,0.0001871807,0.000018020592,0.000054428645,0.00043378543,0.000006837262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009805688,0.00012213773,0.0012096376,0.00016125738,0.000033357464,0.000029004956,0.0017561682,0.00021244054,0.98397833,0.0006816796,0.0050215153,0.005813899],"study_design_scores_gemma":[0.009408827,0.0011924936,0.10733416,0.00060872704,0.000028484032,0.000025709944,0.018208047,0.0007993321,0.5744555,0.010561014,0.27616575,0.0012119872],"about_ca_topic_score_codex":0.000920595,"about_ca_topic_score_gemma":0.0026796772,"teacher_disagreement_score":0.40952286,"about_ca_system_score_codex":0.000118825796,"about_ca_system_score_gemma":0.00031527298,"threshold_uncertainty_score":0.5616904},"labels":[],"label_agreement":null},{"id":"W3047006373","doi":"10.1158/1538-7445.pedca19-b41","title":"Abstract B41: Genomic landscape of somatic mutations in osteosarcomas","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetics; Missense mutation; Biology; Gene; Frameshift mutation; Osteosarcoma; Population; Context (archaeology); Cancer; Germline mutation; Nonsynonymous substitution; Mutation; Cancer research; Genome; Medicine","score_opus":0.12681968197751586,"score_gpt":0.4149783313878412,"score_spread":0.2881586494103253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047006373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859841,0.004072085,9.249863e-7,0.007205414,0.000018533567,0.0004381089,0.000019875504,0.000012279746,0.0022486625],"genre_scores_gemma":[0.9991391,0.00032023073,0.00009178958,0.00012038128,0.0000746102,0.00018652252,0.00001788751,0.000014736975,0.0000347978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990274,0.00004089226,0.00020646205,0.00017406461,0.00031938116,0.00023183267],"domain_scores_gemma":[0.99939036,0.00019896172,0.000029195851,0.00015947715,0.000080324964,0.0001416838],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017668946,0.00006573424,0.00020631817,0.00014661025,0.000032015098,0.000009977087,0.000083376006,0.00003653097,0.0010231904],"category_scores_gemma":[0.00009409157,0.000054302753,0.000050974664,0.0003433615,0.00006362767,0.00003077526,0.000039882616,0.00020364611,0.000106189655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002146254,0.0005424415,0.9108971,0.0005419146,0.00010721743,0.00035755837,0.0025644316,0.000086413245,0.05789897,0.00019996712,0.0020251358,0.02456425],"study_design_scores_gemma":[0.0020749762,0.00018318037,0.9772417,0.00017445056,0.000022397886,0.0000045944357,0.0007647468,0.00016544572,0.018300729,0.00013749962,0.0008724641,0.00005784753],"about_ca_topic_score_codex":0.00040612387,"about_ca_topic_score_gemma":0.00011820735,"teacher_disagreement_score":0.06634459,"about_ca_system_score_codex":0.00011303009,"about_ca_system_score_gemma":0.00027636893,"threshold_uncertainty_score":0.99989},"labels":[],"label_agreement":null},{"id":"W3047010288","doi":"10.1158/1538-7445.pedca19-a58","title":"Abstract A58: Curation of pediatric cancer variants within the Clinical Genome Resource (ClinGen)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric cancer; Cancer; Medicine; Internal medicine","score_opus":0.13784855010553732,"score_gpt":0.4355653418474983,"score_spread":0.297716791741961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047010288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858404,0.008683518,0.00003159979,0.0018073155,0.00012805047,0.00025943984,0.00013963816,0.0000047324984,0.0003616916],"genre_scores_gemma":[0.99311423,0.0039923848,0.00002496758,0.00041078482,0.002180662,0.00005606088,0.000044193304,0.00002108991,0.00015564289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986642,0.00015661174,0.00032526374,0.000344734,0.00027457153,0.00023461353],"domain_scores_gemma":[0.99914527,0.000052092226,0.0001180984,0.00028712867,0.00023648409,0.00016091413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075161434,0.00008893869,0.00012788647,0.000028604554,0.00013108739,0.000028869561,0.0003867783,0.00010991941,0.00011808988],"category_scores_gemma":[0.00029472416,0.000064781154,0.000093470146,0.00021017386,0.00014333002,0.000004278056,0.00017425652,0.00027084848,0.000014130362],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013075558,0.00021944045,0.02745836,0.00028581635,0.00029236925,0.000025654945,0.00082534575,0.0038130565,0.9340254,0.0001970197,0.027103312,0.00444669],"study_design_scores_gemma":[0.0042785993,0.0018995106,0.51507616,0.000088580535,0.00030218903,0.000007043872,0.001976166,0.00085611636,0.12826702,0.0004763409,0.3455519,0.0012203731],"about_ca_topic_score_codex":0.00014910186,"about_ca_topic_score_gemma":0.00007496115,"teacher_disagreement_score":0.80575836,"about_ca_system_score_codex":0.000017175873,"about_ca_system_score_gemma":0.00066532556,"threshold_uncertainty_score":0.2641699},"labels":[],"label_agreement":null},{"id":"W3047011607","doi":"10.1158/1538-7445.pedca19-a03","title":"Abstract A03: Prevalence and spectrum of germline mutations in children with high-risk cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Germline mutation; Cancer; CHEK2; Genetics; Biology; Oncology; Medicine; Somatic cell; Internal medicine; Mutation; Bioinformatics; Cancer research; Gene","score_opus":0.027996885519739702,"score_gpt":0.35309471334265824,"score_spread":0.3250978278229185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047011607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925319,0.0052265795,0.00005001006,0.0014257438,0.000023224267,0.0003603084,0.0002970011,0.0000053438175,0.000079864],"genre_scores_gemma":[0.9940169,0.0051132976,0.00023493158,0.000067833396,0.00021955647,0.00020572335,0.000031917683,0.000022303413,0.000087552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988824,0.00006517113,0.00016685168,0.00038608906,0.00024834627,0.0002511223],"domain_scores_gemma":[0.9994694,0.000023234088,0.000066123386,0.00020987378,0.00013882267,0.000092518196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018107732,0.00009634898,0.00011973793,0.00007064253,0.00006424171,0.000016350677,0.00019070295,0.00007062051,0.00019548305],"category_scores_gemma":[0.00007478849,0.000087637694,0.000019424077,0.00035477238,0.00028541626,0.00000694121,0.00009522141,0.00025576696,0.0000025615914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002670398,0.000052331165,0.7770654,0.00016447142,0.00015088322,0.0000028155907,0.0004960495,0.005147863,0.20997293,0.00005127223,0.001151312,0.0054776166],"study_design_scores_gemma":[0.00076496444,0.00021716527,0.7634186,0.00005276798,0.000017412694,0.0000023474372,0.00005943196,0.000042504103,0.23474646,0.00008603921,0.0004707659,0.000121510995],"about_ca_topic_score_codex":0.0023425077,"about_ca_topic_score_gemma":0.0019772975,"teacher_disagreement_score":0.024773533,"about_ca_system_score_codex":0.00008033948,"about_ca_system_score_gemma":0.00059304415,"threshold_uncertainty_score":0.35737616},"labels":[],"label_agreement":null},{"id":"W3047019788","doi":"10.1158/1538-7445.pedca19-a13","title":"Abstract A13: Immunogenomic approaches to optimize immunotherapeutic targeting of neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Antigen; Immunotherapy; Medicine; Cancer research; Cancer; Neuroblastoma; Lymphoma; Cancer immunotherapy; Immunology; T cell; Immune system; Internal medicine; Cell culture; Biology","score_opus":0.3185861517142442,"score_gpt":0.3984366831874055,"score_spread":0.07985053147316129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047019788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797738,0.00346221,0.000069049434,0.010865704,0.00007338723,0.0014262685,0.000023538665,0.00006061914,0.0042454163],"genre_scores_gemma":[0.9959628,0.0006895461,0.0006707115,0.0005343428,0.000407157,0.00021168585,0.000010508783,0.00010898347,0.0014042509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968348,0.00019743266,0.00045353943,0.0005605626,0.0011128802,0.00084074325],"domain_scores_gemma":[0.9983474,0.00028674968,0.00006424247,0.0005480641,0.0003031759,0.00045036437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001234034,0.00019868414,0.0004772521,0.0002964814,0.00013490878,0.000054148568,0.0005443618,0.00010683665,0.006771125],"category_scores_gemma":[0.00024300454,0.00018337258,0.00017657489,0.0010904408,0.00027584966,0.000073419396,0.00028837303,0.0010371448,0.00024335603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037463114,0.000101757,0.00047228398,0.0003498821,0.00017618375,0.000034135835,0.0017463547,0.00064956624,0.9677105,0.00003564875,0.001423916,0.023553455],"study_design_scores_gemma":[0.0031936478,0.0016123002,0.009926693,0.0002490238,0.000031005762,0.000014056089,0.001205822,0.0009772663,0.9398367,0.000038518232,0.042590085,0.000324873],"about_ca_topic_score_codex":0.00049112574,"about_ca_topic_score_gemma":0.0000069203443,"teacher_disagreement_score":0.04116617,"about_ca_system_score_codex":0.0003171577,"about_ca_system_score_gemma":0.00066576066,"threshold_uncertainty_score":0.9941368},"labels":[],"label_agreement":null},{"id":"W3047022674","doi":"10.1158/1538-7445.pedca19-a11","title":"Abstract A11: A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; KRAS; Targeted therapy; CD19; Cancer; Cancer research; Immunology; Colorectal cancer","score_opus":0.05515896922623703,"score_gpt":0.37477869149320675,"score_spread":0.3196197222669697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047022674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902455,0.0054240786,0.000040938216,0.001226783,0.00007306532,0.0022433957,0.00034136997,0.00007887998,0.00032596817],"genre_scores_gemma":[0.9831109,0.013017495,0.0001372075,0.00049918983,0.00027648185,0.0003020273,0.00005026277,0.00010007575,0.0025063641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99464166,0.00088356424,0.0006696745,0.001082448,0.0018013784,0.0009212466],"domain_scores_gemma":[0.9936765,0.0027123673,0.00018543315,0.00082035246,0.0015056381,0.0010997448],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011900712,0.000409469,0.0011203702,0.0016935904,0.00017156452,0.00006610209,0.0005167959,0.0002776471,0.0011329101],"category_scores_gemma":[0.00061436463,0.0003399612,0.00031950558,0.0042431024,0.0004335844,0.00013271866,0.00029612184,0.0014373848,0.000054059903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055194147,0.00021826038,0.0076548923,0.00033068008,0.001170432,0.00018888662,0.01061992,0.0005405868,0.9167748,8.5651163e-7,0.005653921,0.0016526323],"study_design_scores_gemma":[0.023009887,0.010826404,0.42209938,0.00027262428,0.0016060622,0.000009928044,0.0041127605,0.007524667,0.51763433,0.000010716291,0.012058854,0.0008343685],"about_ca_topic_score_codex":0.0014598094,"about_ca_topic_score_gemma":0.000079826554,"teacher_disagreement_score":0.41444448,"about_ca_system_score_codex":0.0015400869,"about_ca_system_score_gemma":0.003035907,"threshold_uncertainty_score":0.9999052},"labels":[],"label_agreement":null},{"id":"W3047026715","doi":"10.1158/1538-7445.pedca19-ia11","title":"Abstract IA11: Overcoming immune evasion in pediatric brain tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Cytotoxic T cell; Immune system; Major histocompatibility complex; Tumor necrosis factor alpha; MHC class I; Antigen; Cancer research; Immunotherapy; Cancer; Immune checkpoint; Immunology; Biology; In vitro; Genetics","score_opus":0.11104773815042568,"score_gpt":0.4177270401436291,"score_spread":0.3066793019932034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047026715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703082,0.0047583184,6.201857e-7,0.02281235,0.00004448877,0.00046747914,0.0000065142244,0.000023301813,0.0015787455],"genre_scores_gemma":[0.9979597,0.0009780398,0.000027150114,0.00041891364,0.00036878593,0.00015652408,0.000009853205,0.00002318427,0.00005788271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843246,0.000059949893,0.00022304658,0.00030532226,0.00056416565,0.00041508797],"domain_scores_gemma":[0.9991957,0.00024842305,0.000029570501,0.0001937439,0.00009398216,0.00023858606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048567812,0.00009975841,0.00023008794,0.00023442587,0.00006849455,0.000026130605,0.00010849231,0.000057350273,0.0006499143],"category_scores_gemma":[0.00039166442,0.00008281315,0.00006827951,0.0008087452,0.00003714616,0.0000622108,0.000088457484,0.00046323746,0.00019349997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007357623,0.00068643235,0.74867284,0.0007374702,0.000052604704,0.0025769505,0.001590306,0.00009259606,0.19880706,0.00014912483,0.020964535,0.024934335],"study_design_scores_gemma":[0.0030654704,0.00028192528,0.9606751,0.0001944668,0.000015659614,0.0000061905644,0.00020128518,0.00010443294,0.032200605,0.00004401464,0.0031049994,0.00010583095],"about_ca_topic_score_codex":0.0010349161,"about_ca_topic_score_gemma":0.00007082971,"teacher_disagreement_score":0.21200229,"about_ca_system_score_codex":0.00031130473,"about_ca_system_score_gemma":0.00025607584,"threshold_uncertainty_score":0.71161056},"labels":[],"label_agreement":null},{"id":"W3047029284","doi":"10.1158/1538-7445.pedca19-pr10","title":"Abstract PR10: Disruption of IL6-mediated paracrine signaling to prevent pulmonary metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paracrine signalling; Autocrine signalling; Lung; Cancer research; Interleukin 8; Biology; Metastasis; Cell; Cell biology; Medicine; Receptor; Immunology; Cytokine; Internal medicine; Cancer","score_opus":0.17516783554921048,"score_gpt":0.445102872119146,"score_spread":0.26993503656993556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047029284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840386,0.00045402112,0.00013060859,0.009080978,0.00008318261,0.00066999206,0.0001378141,0.00004276016,0.0009967785],"genre_scores_gemma":[0.99845254,0.00017432387,0.00020932805,0.00031216707,0.00041052257,0.0001645938,0.000065686676,0.000028969327,0.0001818516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982217,0.00007837647,0.0003669532,0.00032294562,0.0006705389,0.00033951795],"domain_scores_gemma":[0.99865764,0.00019380767,0.00006673065,0.00021709867,0.00046966455,0.00039504064],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005121972,0.0001147689,0.00028746985,0.0001964652,0.000082745355,0.000018913395,0.0001301827,0.00004729012,0.0025043665],"category_scores_gemma":[0.00053824065,0.00009854744,0.00011811524,0.0007450766,0.000059475664,0.000089217814,0.00008804714,0.00047972862,0.00015039227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000617085,0.00026770224,0.00070723303,0.00031385815,0.000082536724,0.000063312924,0.00048872805,0.00027173027,0.98594487,0.000025035413,0.0028160862,0.008401812],"study_design_scores_gemma":[0.00037884605,0.000884173,0.007086423,0.00053669326,0.00006116936,0.000012557176,0.00055195054,0.0005881153,0.9585977,0.000027667456,0.031131819,0.00014288239],"about_ca_topic_score_codex":0.00043463556,"about_ca_topic_score_gemma":0.000014837891,"teacher_disagreement_score":0.028315732,"about_ca_system_score_codex":0.00014117947,"about_ca_system_score_gemma":0.00025241636,"threshold_uncertainty_score":0.9984075},"labels":[],"label_agreement":null},{"id":"W3047029549","doi":"10.1158/1538-7445.pedca19-a55","title":"Abstract A55: Defining the transcriptional regulation of pediatric AML as a new strategy to find potential druggable vulnerabilities","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enhancer; Biology; Cancer research; Druggability; Chromatin; Gene; Chromatin immunoprecipitation; Genetics; Computational biology; Transcription factor; Gene expression; Promoter","score_opus":0.04575410099614812,"score_gpt":0.3447168534992638,"score_spread":0.29896275250311566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047029549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122775,0.004589836,0.0005031816,0.0016286651,0.00006287791,0.00020789847,0.000025772457,0.0000061893807,0.0017478156],"genre_scores_gemma":[0.9963006,0.00049001066,0.000102339356,0.00016234368,0.0009044335,0.00004511652,0.000042887616,0.000015982598,0.0019363149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987565,0.00008081791,0.00019466995,0.00029313366,0.0004127841,0.00026207478],"domain_scores_gemma":[0.99935496,0.000033595945,0.00004083,0.00017784133,0.0002307655,0.00016203248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003578829,0.00009143081,0.00009803919,0.000039343355,0.00014212867,0.00004716706,0.00028966836,0.000096695956,0.000518803],"category_scores_gemma":[0.0002466726,0.000073451476,0.00006408771,0.0002634842,0.0000991105,0.000007756132,0.00006296948,0.00022461424,0.000025552143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025533393,0.000014965192,0.00032874683,0.000113468675,0.000021808804,0.0000012277818,0.00042279065,0.0075913183,0.97633016,0.0007019168,0.011542162,0.0026761238],"study_design_scores_gemma":[0.00064502686,0.00069553143,0.007555444,0.000022934864,0.000024205423,0.000004007737,0.0010603482,0.000108746965,0.9700971,0.0015923606,0.017986134,0.00020815195],"about_ca_topic_score_codex":0.00026996332,"about_ca_topic_score_gemma":0.000014209814,"teacher_disagreement_score":0.0074825715,"about_ca_system_score_codex":0.000026010814,"about_ca_system_score_gemma":0.0012941702,"threshold_uncertainty_score":0.56805295},"labels":[],"label_agreement":null},{"id":"W3047035583","doi":"10.1158/1538-7445.pedca19-b44","title":"Abstract B44: Role of EMT transcription factors in the metastatic potential of osteosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Metastasis; Cancer research; Circulating tumor cell; Primary tumor; Glioma; Biology; Cell culture; Sarcoma; Pathology; Medicine; Cancer; Internal medicine","score_opus":0.12940165960735445,"score_gpt":0.3990962979497544,"score_spread":0.26969463834239993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047035583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275476,0.003058249,0.000015902026,0.0027910846,0.000042160234,0.00048394027,0.00008157016,0.000004925059,0.00076742034],"genre_scores_gemma":[0.99917597,0.0005401526,0.00004088205,0.000078787954,0.00007375422,0.000036279675,0.000014113105,0.000013085227,0.000026968604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984243,0.00012551084,0.00028853022,0.0001745403,0.0007400565,0.00024706946],"domain_scores_gemma":[0.9994221,0.00008259295,0.00005531959,0.00018890612,0.00015358125,0.00009755181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057250797,0.00008094416,0.00028210453,0.00013005125,0.000027991546,0.000008363605,0.0001752618,0.000032134223,0.0007023067],"category_scores_gemma":[0.000062764826,0.000053852928,0.000121563804,0.00055529893,0.00013816736,0.00005315783,0.000020359652,0.0003582264,0.0000044021026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005902416,0.0001401659,0.0021960153,0.00057577604,0.00006137829,0.000020361731,0.004929804,0.00006110159,0.9756862,0.00009919436,0.00036827126,0.015271499],"study_design_scores_gemma":[0.0025396883,0.00078667206,0.0813266,0.00019931744,0.00013878988,0.000004718907,0.015644975,0.000082688835,0.88811266,0.0002046781,0.010849605,0.00010962445],"about_ca_topic_score_codex":0.00257359,"about_ca_topic_score_gemma":0.00021769543,"teacher_disagreement_score":0.08757354,"about_ca_system_score_codex":0.00005267603,"about_ca_system_score_gemma":0.00026222217,"threshold_uncertainty_score":0.76897657},"labels":[],"label_agreement":null},{"id":"W3047040853","doi":"10.1158/1538-7445.pedca19-b17","title":"Abstract B17: A <i>C19MC</i>-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs—a lethal brain tumor","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Enhancer; Cancer research; microRNA; Carcinogenesis; Embryonic stem cell; Downregulation and upregulation; Neuroblastoma; Chromatin; Epigenomics; Cell biology; Gene; Transcription factor; DNA methylation; Genetics; Gene expression; Cell culture","score_opus":0.08457749333775737,"score_gpt":0.38822749196323564,"score_spread":0.30364999862547826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047040853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863703,0.0070426255,0.00033175087,0.0042746277,0.00009466891,0.00061528187,0.00019844847,0.000018336012,0.0010539342],"genre_scores_gemma":[0.99735767,0.00062811153,0.000025668027,0.00082246226,0.00038418095,0.00023746678,0.00015097625,0.000056571782,0.0003369203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968942,0.0004173227,0.0004292715,0.00093849027,0.0005886905,0.0007320656],"domain_scores_gemma":[0.9987347,0.0001509529,0.00008086775,0.0005056029,0.00021696898,0.0003109094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001103896,0.0002536539,0.00030049693,0.00007407229,0.00016328707,0.00007823814,0.0005073605,0.00022157679,0.00069535064],"category_scores_gemma":[0.00037191284,0.00025294325,0.00015151525,0.00042818245,0.0002908537,0.000011708164,0.00018429445,0.0006765848,0.000047786176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023571728,0.00009578118,0.012702455,0.00008013764,0.000055768127,0.000008994873,0.0005565024,0.0000738703,0.97511196,0.000008791684,0.0043163504,0.0067536533],"study_design_scores_gemma":[0.0014059163,0.0005032457,0.01781196,0.00003459808,0.000012688029,0.0000012545304,0.00020336767,0.0002677927,0.9147315,0.00042313497,0.064183146,0.00042136307],"about_ca_topic_score_codex":0.00080543646,"about_ca_topic_score_gemma":0.00046009492,"teacher_disagreement_score":0.060380448,"about_ca_system_score_codex":0.00021238487,"about_ca_system_score_gemma":0.0006208165,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W3047046898","doi":"10.1158/1538-7445.pedca19-a09","title":"Abstract A09: Glypican-2 targeted CAR T cells designed to effectively eradicate endogenous site density solid tumors in the absence of toxicity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; In vivo; Cancer research; Antigen; Single-chain variable fragment; In vitro; Pediatric cancer; Biology; Cell culture; Chemistry; Molecular biology; Cancer; Antibody; Immunology; Biochemistry; Monoclonal antibody","score_opus":0.10088848235893828,"score_gpt":0.3809940487510608,"score_spread":0.28010556639212253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047046898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273187,0.0004626696,0.000053624768,0.0029765395,0.00004412887,0.002759958,0.00006364338,0.000034533237,0.0008730521],"genre_scores_gemma":[0.9981004,0.00024094968,0.000095516334,0.00083625293,0.00024632568,0.00026745314,0.0000085420015,0.000048202248,0.00015636245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953249,0.00076964824,0.0004351519,0.000666022,0.00177802,0.0010262753],"domain_scores_gemma":[0.99714005,0.0009930289,0.00007648665,0.0006429603,0.0005656562,0.00058184494],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027391897,0.00022961793,0.0006142497,0.00027185574,0.00017137406,0.000046186862,0.00069446757,0.00012183096,0.0012043536],"category_scores_gemma":[0.00076409255,0.00017665193,0.00014641823,0.0019784153,0.00042803533,0.00007106023,0.00020602912,0.0013438906,0.00016469846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003228531,0.00018758517,0.006283913,0.0003181361,0.00006506591,0.00057754456,0.006057398,0.00017198318,0.9793849,0.000010745494,0.0012065725,0.0025075988],"study_design_scores_gemma":[0.0012747139,0.001134382,0.086437166,0.0001368692,0.000009797397,0.00001650948,0.00041825537,0.00010952094,0.9096164,0.000025967156,0.00067017245,0.00015021306],"about_ca_topic_score_codex":0.00411174,"about_ca_topic_score_gemma":0.0005267641,"teacher_disagreement_score":0.08015325,"about_ca_system_score_codex":0.0005981926,"about_ca_system_score_gemma":0.0009968296,"threshold_uncertainty_score":0.99970865},"labels":[],"label_agreement":null},{"id":"W3047053717","doi":"10.1158/1538-7445.pedca19-b23","title":"Abstract B23: EWS-FLI1 partners with EWSR1 to regulate transcription in Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FLI1; Sarcoma; Transcription factor; Pediatric cancer; Transcription (linguistics); Cancer research; Biology; Ewing's sarcoma; Cancer; Gene; Medicine; Genetics; Pathology","score_opus":0.20587371299008142,"score_gpt":0.4475229030928435,"score_spread":0.24164919010276206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047053717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96256703,0.0013226565,0.000008672253,0.032885745,0.000031255302,0.0008367439,0.000008830386,0.000037635662,0.0023014192],"genre_scores_gemma":[0.9975945,0.00030516007,0.00017446122,0.0010587007,0.0001758155,0.0004403724,0.000012723438,0.0000335465,0.00020474348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814194,0.00006023784,0.00020537575,0.00041591452,0.0006498789,0.0005266731],"domain_scores_gemma":[0.9991193,0.00007609111,0.000019973908,0.00024126419,0.00012015221,0.0004232522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003377767,0.00013684807,0.0002696119,0.0001875882,0.00007658773,0.000041178675,0.00011452938,0.000061014594,0.00045190097],"category_scores_gemma":[0.000052863266,0.000103088474,0.00005582183,0.0007658004,0.00006833461,0.00009452327,0.00002922536,0.0003820033,0.00012316318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070234896,0.0011276304,0.41825464,0.00069984497,0.0003365192,0.0030050771,0.011803794,0.00056326634,0.28223756,0.0005017121,0.022285389,0.2521611],"study_design_scores_gemma":[0.0050685015,0.001062124,0.8576341,0.00086763204,0.000041837393,0.000014418642,0.0010280041,0.00009139762,0.07915042,0.000051268646,0.054753862,0.00023638029],"about_ca_topic_score_codex":0.0010919456,"about_ca_topic_score_gemma":0.0005973215,"teacher_disagreement_score":0.4393795,"about_ca_system_score_codex":0.00038907252,"about_ca_system_score_gemma":0.0002325754,"threshold_uncertainty_score":0.49479985},"labels":[],"label_agreement":null},{"id":"W3047056701","doi":"10.1158/1538-7445.pedca19-b13","title":"Abstract B13: Leveraging cloud-based computational resources for gene fusion discovery with potential clinical implications for pediatric solid tumor patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusion gene; Computational biology; Transcriptome; Gene; Bioinformatics; Cancer; Computer science; Medicine; Biology; Genetics; Gene expression","score_opus":0.0642910645119543,"score_gpt":0.39192305765540303,"score_spread":0.3276319931434487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047056701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95324266,0.00035295193,0.042134643,0.0020826661,0.00013780805,0.0008376754,0.0011951503,0.000007201706,0.000009269702],"genre_scores_gemma":[0.9941867,0.00014674761,0.0019414342,0.0006978349,0.0018212238,0.00040087674,0.0007564465,0.000035683795,0.000013036928],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99873364,0.000030305167,0.0002622987,0.0004630638,0.0001929474,0.00031772163],"domain_scores_gemma":[0.99883604,0.00018892459,0.00009685267,0.00017080127,0.00054274325,0.00016464091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027600207,0.00011002925,0.00013880401,0.00004368111,0.00026211824,0.00008815411,0.00021876257,0.00007374912,0.0000052875394],"category_scores_gemma":[0.00025941382,0.000101920275,0.00010909198,0.00011860469,0.000093271425,0.0000061589917,0.00009865499,0.00013850743,0.0000016227101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01448007,0.0014781457,0.2555071,0.0011292291,0.00036221527,0.000008372852,0.00033814742,0.4192816,0.23232143,0.00049733854,0.063028865,0.01156748],"study_design_scores_gemma":[0.027059399,0.009927037,0.8420353,0.00012443628,0.00026755955,0.0000037436123,0.00019101905,0.007303409,0.05956702,0.002999402,0.04897796,0.001543704],"about_ca_topic_score_codex":0.00003840688,"about_ca_topic_score_gemma":0.000022064778,"teacher_disagreement_score":0.5865282,"about_ca_system_score_codex":0.000058750175,"about_ca_system_score_gemma":0.0009015591,"threshold_uncertainty_score":0.4156188},"labels":[],"label_agreement":null},{"id":"W3047058424","doi":"10.1158/1538-7445.pedca19-b51","title":"Abstract B51: Adaptation to oncogene-induced metabolic stress by MondoA (MLXIP) drives common acute lymphoblastic leukemia (cALL) malignancy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Cancer research; Downregulation and upregulation; Gene knockdown; Transcription factor; Biology; Chemistry; Cell biology; Biochemistry; Gene","score_opus":0.049408809045592125,"score_gpt":0.35436115507312704,"score_spread":0.3049523460275349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047058424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993025,0.003184831,0.00050016167,0.0018591468,0.00014044189,0.00055753585,0.00018768352,0.00002881255,0.0005164076],"genre_scores_gemma":[0.99588823,0.001541408,0.00018148251,0.00080891163,0.00051559677,0.00028775758,0.00022390294,0.000045154895,0.00050757633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799985,0.00014789049,0.00028190707,0.0005699729,0.0005162361,0.0004841654],"domain_scores_gemma":[0.9988959,0.00002651973,0.00007111185,0.00033782521,0.0002545591,0.0004140719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020535923,0.0001967114,0.00021613382,0.00008240722,0.000172811,0.000085241765,0.00044100522,0.0001739875,0.00009983588],"category_scores_gemma":[0.00015222021,0.00019166719,0.000083048915,0.00038579057,0.00007430244,0.000015855401,0.00021033805,0.00024378784,0.00008425781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020645885,0.000030040785,0.00017293461,0.000024629819,0.00007849361,0.000007850743,0.00022721622,0.00021701609,0.963617,0.000035436024,0.019140147,0.016242731],"study_design_scores_gemma":[0.0006099749,0.00028714482,0.00090085814,0.000045577337,0.000011855821,0.0000011311749,0.00015414333,0.00016656716,0.9458682,0.000014046918,0.051723085,0.00021743639],"about_ca_topic_score_codex":0.0006544925,"about_ca_topic_score_gemma":0.00017607519,"teacher_disagreement_score":0.03258294,"about_ca_system_score_codex":0.00012981278,"about_ca_system_score_gemma":0.0005217675,"threshold_uncertainty_score":0.7815961},"labels":[],"label_agreement":null},{"id":"W3047061532","doi":"10.1158/1538-7445.pedca19-b21","title":"Abstract B21: Childhood Cancer Molecular Map (C2M2) to define medulloblastoma heterogeneity and predict treatment response","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Biology; Computational biology; Transcriptome; Cancer; Gene; Context (archaeology); Genetics; Bioinformatics; Gene expression","score_opus":0.050389032928735804,"score_gpt":0.39036818613045643,"score_spread":0.3399791532017206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047061532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822448,0.0073796,0.00005768127,0.009011147,0.000049054113,0.00072293996,0.00038657224,0.000023057952,0.00012517328],"genre_scores_gemma":[0.9957074,0.0021015268,0.00009264413,0.00070355466,0.00043212585,0.0006209688,0.000044506003,0.000058215363,0.00023909075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973171,0.0002854297,0.00021751164,0.00083555456,0.0005840485,0.0007604096],"domain_scores_gemma":[0.99845517,0.000062119216,0.000032700256,0.00045347234,0.00020786912,0.00078867475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045163042,0.00024591922,0.00024191443,0.000101618745,0.00020593025,0.00007797002,0.0003438239,0.00015781872,0.00022393819],"category_scores_gemma":[0.0002660092,0.00021583104,0.00010415445,0.0002960051,0.00019236188,0.0000074552213,0.00041036378,0.00026037783,0.00006773408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025907422,0.00011001499,0.0030510263,0.000052329782,0.0001752215,0.000095757234,0.00015656256,0.00015029666,0.97845703,0.0000052569253,0.004273087,0.010882701],"study_design_scores_gemma":[0.000998131,0.0016966182,0.017578894,0.000052653744,0.000014264669,0.0000032552434,0.00008194089,0.000027263848,0.901104,0.00000707758,0.07820464,0.00023131008],"about_ca_topic_score_codex":0.0005623532,"about_ca_topic_score_gemma":0.0003893668,"teacher_disagreement_score":0.07735306,"about_ca_system_score_codex":0.00014184539,"about_ca_system_score_gemma":0.00067552854,"threshold_uncertainty_score":0.88013345},"labels":[],"label_agreement":null},{"id":"W3047066179","doi":"10.1158/1538-7445.pedca19-a75","title":"Abstract A75: Mithramycin evicts SWI/SNF from chromatin to induce epigenetic reprogramming in rhabdoid tumor","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reprogramming; SWI/SNF; Cancer; Chromatin; Epigenetics; Pediatric cancer; Biology; Cancer research; Genetics; Chromatin remodeling; Gene","score_opus":0.09006199949493038,"score_gpt":0.3950800974642148,"score_spread":0.3050180979692844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047066179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906808,0.0052591343,0.00013116044,0.0026565609,0.00010586666,0.00051039655,0.000052919353,0.000027313301,0.0005758478],"genre_scores_gemma":[0.996159,0.00037762854,0.0010175596,0.0010800825,0.00088558585,0.00026612496,0.00005577489,0.000054664197,0.000103560946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974245,0.0001346264,0.00037867663,0.0008747054,0.0005227113,0.00066479424],"domain_scores_gemma":[0.99877685,0.000051028954,0.000063575324,0.0005397702,0.00019581216,0.0003729508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059206755,0.00019939197,0.0002506023,0.00008781179,0.00010481336,0.00011695306,0.0005268596,0.00016571872,0.00022368168],"category_scores_gemma":[0.0005894439,0.00020273837,0.00007902475,0.0005389122,0.000081694954,0.000008469579,0.0003045497,0.0005107011,0.00010973968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001706603,0.000046241366,0.0020779606,0.00008305437,0.000026037866,0.000030026575,0.00056257535,0.00092382875,0.9500813,0.000002184287,0.003508465,0.04248765],"study_design_scores_gemma":[0.0010024045,0.0003621089,0.017511142,0.0003454361,0.00000732182,0.0000025267946,0.0005787903,0.00047668815,0.94864506,0.00007885573,0.030591803,0.00039787666],"about_ca_topic_score_codex":0.003016569,"about_ca_topic_score_gemma":0.0010279102,"teacher_disagreement_score":0.042089775,"about_ca_system_score_codex":0.00014102514,"about_ca_system_score_gemma":0.00049441296,"threshold_uncertainty_score":0.82674307},"labels":[],"label_agreement":null},{"id":"W3047067051","doi":"10.1158/1538-7445.pedca19-b19","title":"Abstract B19: Identification of physiologically relevant EWS-FLI1 target genes in Ewing’s sarcoma via CRISPRa screening","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ewing's sarcoma; Biology; Gene; Sarcoma; Fusion gene; CD44; Pediatric cancer; Computational biology; Cancer research; Cancer; Genetics; Cell; Medicine; Pathology","score_opus":0.05857783347540065,"score_gpt":0.4087653837980935,"score_spread":0.3501875503226929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047067051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98011255,0.00479014,0.014096634,0.00057793176,0.000055374265,0.00022221298,0.000021594611,0.000010498062,0.000113058595],"genre_scores_gemma":[0.9976519,0.0010237973,0.0008581736,0.000063725325,0.00024031305,0.000052356663,0.000042860112,0.000019450332,0.000047440662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986915,0.000062632396,0.00030640405,0.00036506553,0.0002563624,0.0003180093],"domain_scores_gemma":[0.9994215,0.000025756906,0.000053140095,0.00024082608,0.00015846072,0.000100335594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045717647,0.00010457613,0.00015311329,0.00006448534,0.000049154783,0.000018459683,0.00028750912,0.00010767716,0.000060810493],"category_scores_gemma":[0.00016318931,0.0000998655,0.00006051433,0.00023972886,0.00008143462,0.0000053177514,0.00015215171,0.00022812033,0.000007969203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010962052,0.000025645764,0.0018743386,0.00009310775,0.00001788385,0.000004203015,0.000111074085,0.0047747786,0.9831505,0.000007896724,0.0004944316,0.009336563],"study_design_scores_gemma":[0.00028004125,0.00012981631,0.05082018,0.00002782424,0.0000025890542,8.3056557e-7,0.00011932968,0.0012712775,0.9431995,0.000052644464,0.0039785933,0.0001173747],"about_ca_topic_score_codex":0.00012281626,"about_ca_topic_score_gemma":0.000020745367,"teacher_disagreement_score":0.04894584,"about_ca_system_score_codex":0.000018863835,"about_ca_system_score_gemma":0.00007094707,"threshold_uncertainty_score":0.4072397},"labels":[],"label_agreement":null},{"id":"W3047075782","doi":"10.1158/1538-7445.pedca19-b03","title":"Abstract B03: Methods for integrated analysis of RNA and DNA sequencing in pediatric cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Genetics; Computational biology; DNA sequencing; Copy-number variation; Gene; Germline; Genome; Structural variation; Somatic cell; Cancer genome sequencing; Reference genome","score_opus":0.0935835763362398,"score_gpt":0.4468526433262994,"score_spread":0.3532690669900596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047075782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107915,0.005976347,0.00202831,0.00028112956,0.000045180503,0.00024672414,0.00016095607,0.000002640771,0.00017957004],"genre_scores_gemma":[0.99076456,0.0066880947,0.0020416945,0.00013625111,0.00017592391,0.00010069582,0.00005790786,0.000015366308,0.00001949998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903417,0.00006317527,0.0002127022,0.00032858824,0.0001042455,0.00025715094],"domain_scores_gemma":[0.99926305,0.000163185,0.000056815792,0.00015039643,0.00024806673,0.000118460855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063790055,0.00008568483,0.00022670785,0.00020934561,0.00003739185,0.000021313475,0.00015627065,0.00008867249,0.00002663437],"category_scores_gemma":[0.0006213112,0.00008491324,0.00007359139,0.0009138662,0.00007677871,0.0000030393476,0.000088871944,0.00014297794,2.5246712e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025165555,0.000008168444,0.008493649,0.0001457894,0.00021740998,0.000001733037,0.00033772123,0.0046505774,0.971833,0.000049767867,0.0009392227,0.0130712995],"study_design_scores_gemma":[0.0015237933,0.0005541913,0.021480152,0.000034760324,0.0003816594,4.1921703e-7,0.00094005826,0.014176264,0.9421125,0.00017759303,0.018220915,0.00039770885],"about_ca_topic_score_codex":0.0022124248,"about_ca_topic_score_gemma":0.0015848372,"teacher_disagreement_score":0.029720522,"about_ca_system_score_codex":0.00019963724,"about_ca_system_score_gemma":0.00097173185,"threshold_uncertainty_score":0.34626615},"labels":[],"label_agreement":null},{"id":"W3047087162","doi":"10.1158/1538-7445.pedca19-b68","title":"Abstract B68: Spatial and temporal conditions for Smarcb1 deletion determines mouse AT/RT (atypical teratoid/rhabdoid tumor) subtype","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SMARCB1; Biology; Conditional gene knockout; SMARCA4; Immunohistochemistry; Phenotype; Atypical teratoid rhabdoid tumor; Pathology; Stem cell; Nestin; Neural stem cell; Cancer research; Medicine; Cell biology; Gene; Gene expression; Immunology; Genetics","score_opus":0.061625210060393495,"score_gpt":0.3748079887419755,"score_spread":0.313182778681582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047087162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679834,0.0008604873,0.00047871988,0.0011174629,0.00006754908,0.00034879538,0.00023181432,0.00001730237,0.00007955683],"genre_scores_gemma":[0.9976497,0.00023262818,0.00017119857,0.00034598287,0.0007551484,0.00021741475,0.00028527222,0.00002945071,0.00031319974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988724,0.000045202316,0.000178424,0.0003957254,0.00019857883,0.00030969962],"domain_scores_gemma":[0.9993528,0.00003155053,0.00004141349,0.00017021882,0.0002207061,0.00018329958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018805367,0.00011815839,0.00013285904,0.00003285266,0.00022761746,0.00004717703,0.00013408544,0.00010168052,0.000110549685],"category_scores_gemma":[0.0001405116,0.000112448986,0.000060969734,0.00007264931,0.0001638696,0.000005634871,0.00011662102,0.00015476329,0.0000107510505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006536411,0.000023913997,0.0039259912,0.000119702316,0.00002291712,0.0000042693355,0.00005516495,0.000045405042,0.9807854,0.000010901577,0.012070746,0.0022819177],"study_design_scores_gemma":[0.0017593589,0.0006802913,0.0068955724,0.000055525754,0.000016322068,0.0000151263985,0.00008509664,0.003393354,0.9261095,0.00011669862,0.060524702,0.0003484588],"about_ca_topic_score_codex":0.00022755531,"about_ca_topic_score_gemma":0.0004833205,"teacher_disagreement_score":0.054675937,"about_ca_system_score_codex":0.00005402006,"about_ca_system_score_gemma":0.00022920969,"threshold_uncertainty_score":0.45855364},"labels":[],"label_agreement":null},{"id":"W3047089095","doi":"10.1158/1538-7445.pedca19-b49","title":"Abstract B49: Modeling a pathogenic <i>SAMD9</i> mutation in human induced pluripotent stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Induced pluripotent stem cell; Cancer research; Biology; Myeloid; Stem cell; Haematopoiesis; Chromosome 7 (human); Progenitor cell; Genetics; Embryonic stem cell; Gene; Chromosome","score_opus":0.2254322174262751,"score_gpt":0.4319023045431385,"score_spread":0.2064700871168634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047089095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333584,0.00080232584,0.00004360998,0.0028831533,0.00006878511,0.0013575921,0.000015730106,0.00006203374,0.0014309402],"genre_scores_gemma":[0.99753183,0.00038457348,0.000030243553,0.0003535807,0.00047172356,0.00030598207,0.000017910064,0.00007760776,0.0008265587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962261,0.00022288381,0.00045628127,0.0006489229,0.0015815469,0.0008642643],"domain_scores_gemma":[0.9984821,0.00011399094,0.00004480643,0.00041367588,0.0004379228,0.00050748675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012333066,0.00018637668,0.00036742486,0.0003848887,0.00015129324,0.00008018822,0.00031060062,0.00017130349,0.001971613],"category_scores_gemma":[0.000058425354,0.00018056699,0.00012263289,0.0011126007,0.00008514272,0.00012477247,0.00015852951,0.0016539524,0.0001507424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000635143,0.000106016654,0.00042633628,0.00030455572,0.000040522846,0.00043322542,0.0016448253,0.0020503933,0.9711281,0.000017230672,0.00029152274,0.022922147],"study_design_scores_gemma":[0.005802334,0.0009941149,0.0013804418,0.00051135675,0.000023056453,0.00001595007,0.0030562067,0.02761181,0.95772743,0.00015427379,0.0023252773,0.00039772966],"about_ca_topic_score_codex":0.0018817848,"about_ca_topic_score_gemma":0.00028552717,"teacher_disagreement_score":0.025561418,"about_ca_system_score_codex":0.00083595165,"about_ca_system_score_gemma":0.00077441527,"threshold_uncertainty_score":0.9989407},"labels":[],"label_agreement":null},{"id":"W3047113143","doi":"10.1158/1538-7445.pedca19-a02","title":"Abstract A02: Pediatric ovarian cancer in the United States: Incidence trends over four decades","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Ovarian cancer; Epidemiology; Germ cell tumors; Cancer; Pacific islanders; Demography; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.1579987691427776,"score_gpt":0.4452591722806307,"score_spread":0.2872604031378531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047113143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923866,0.004532908,0.0000052564737,0.06938219,0.00011577804,0.0005531894,0.0001389799,0.00003811368,0.0013676379],"genre_scores_gemma":[0.9800516,0.014240312,0.000026622509,0.0034959796,0.0010755145,0.0008318813,0.00004267741,0.000038320628,0.00019710908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971571,0.00018797159,0.0003247384,0.0005331354,0.0011102952,0.000686754],"domain_scores_gemma":[0.99855876,0.00044468432,0.0000685353,0.00039772768,0.00020397619,0.00032633386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007439247,0.0002053089,0.0003061999,0.0004945259,0.00015736138,0.00010206667,0.00037431216,0.000109504996,0.003559595],"category_scores_gemma":[0.00014563427,0.0001376095,0.0000927541,0.0034804158,0.000118899334,0.0001229327,0.0000914261,0.0009108845,0.00005899389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010713617,0.00052316574,0.8319461,0.0005409296,0.00023634554,0.0015897144,0.009368455,0.0012811524,0.00057490775,0.00043858425,0.10988064,0.042548656],"study_design_scores_gemma":[0.002802767,0.0003252781,0.9508347,0.00019232299,0.00008963894,0.000006154322,0.00064573064,0.00038025132,0.00044042643,0.000095164214,0.044008236,0.00017934454],"about_ca_topic_score_codex":0.01702917,"about_ca_topic_score_gemma":0.0020647496,"teacher_disagreement_score":0.1188886,"about_ca_system_score_codex":0.000653103,"about_ca_system_score_gemma":0.00079520245,"threshold_uncertainty_score":0.9973513},"labels":[],"label_agreement":null},{"id":"W3047119549","doi":"10.1158/1538-7445.pedca19-ia17","title":"Abstract IA17: From functional genomics to new targets in pediatric oncology","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Pediatric cancer; Medicine; CRISPR; Neuroblastoma; Targeted therapy; Pediatric oncology; Genomics; Computational biology; Genome; Bioinformatics; Cancer research; Oncology; Biology; Internal medicine; Genetics; Gene; Cell culture","score_opus":0.16958964799974638,"score_gpt":0.4375053799117293,"score_spread":0.2679157319119829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047119549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97535545,0.000999002,0.000035999514,0.020417228,0.000116173986,0.0006224551,0.000046670113,0.000025795562,0.0023812125],"genre_scores_gemma":[0.99436766,0.0008413685,0.00035544098,0.0014349904,0.0018131897,0.0001238036,0.000039872237,0.000031412797,0.0009922619],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99808013,0.000056288998,0.00018732973,0.0004380392,0.0006563826,0.00058181887],"domain_scores_gemma":[0.9983663,0.00023385379,0.000018995259,0.00017668711,0.00013800601,0.001066178],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019346949,0.00010523638,0.00022421416,0.00026611253,0.00005752154,0.000020701671,0.00014849952,0.000080827864,0.0031454568],"category_scores_gemma":[0.00031996754,0.00009497951,0.000048664406,0.0007024157,0.000039968163,0.00005319965,0.00015014077,0.00072854303,0.0017532569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013348315,0.00095491856,0.11794401,0.00021114711,0.00021544563,0.0049565085,0.0019665519,0.0003790601,0.25782752,0.000066272325,0.50621057,0.09591966],"study_design_scores_gemma":[0.0072262753,0.0022918775,0.8122031,0.00003966857,0.000026392656,0.000008187208,0.00013622796,0.00006013971,0.02350242,0.00055973965,0.15374531,0.00020068714],"about_ca_topic_score_codex":0.002268925,"about_ca_topic_score_gemma":0.00055370375,"teacher_disagreement_score":0.69425905,"about_ca_system_score_codex":0.000781126,"about_ca_system_score_gemma":0.0026094536,"threshold_uncertainty_score":0.999024},"labels":[],"label_agreement":null},{"id":"W3047123472","doi":"10.1158/1538-7445.pedca19-a48","title":"Abstract A48: YB-1-based oncolytic virotherapy in combination with CDK4/6-inhibitors against Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Cancer research; Immune checkpoint; Immune system; Retinoblastoma; Retinoblastoma protein; Viral replication; Biology; Cell cycle; Oncolytic adenovirus; Medicine; Immunotherapy; Virology; Immunology; Cancer; Virus; Internal medicine","score_opus":0.09914652753803432,"score_gpt":0.4084362448651844,"score_spread":0.30928971732715005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047123472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603965,0.0005894513,0.000047739417,0.015616321,0.00005919236,0.001896655,0.00000964018,0.00008411852,0.005657248],"genre_scores_gemma":[0.9964626,0.00031461698,0.00010454173,0.0013076303,0.00041531504,0.0003799351,0.000030006298,0.000105912535,0.00087943196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99597585,0.00025568946,0.0003604991,0.00061477994,0.0019118777,0.0008813245],"domain_scores_gemma":[0.99821687,0.00039275436,0.00005680805,0.00043716966,0.00040528507,0.00049113255],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013303264,0.00022279787,0.0004176582,0.0005475292,0.00015498858,0.00009881482,0.00030811218,0.0001466843,0.0025107393],"category_scores_gemma":[0.0001805341,0.00019171108,0.00009547941,0.0018070705,0.0003209777,0.00014794224,0.000058397494,0.0015008848,0.00010765707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049770395,0.00048069452,0.04073488,0.00043650935,0.0000746796,0.0005268778,0.0010532627,0.00031692444,0.8639596,0.000038047656,0.0017820073,0.08561945],"study_design_scores_gemma":[0.03669285,0.005912045,0.1424008,0.0023949728,0.000026412705,0.000012282969,0.0015743094,0.008496913,0.7260236,0.00011532297,0.07550546,0.000845041],"about_ca_topic_score_codex":0.000827223,"about_ca_topic_score_gemma":0.0003574585,"teacher_disagreement_score":0.13793604,"about_ca_system_score_codex":0.0010799419,"about_ca_system_score_gemma":0.0016043107,"threshold_uncertainty_score":0.9984011},"labels":[],"label_agreement":null},{"id":"W3047128548","doi":"10.1158/1538-7445.pedca19-b27","title":"Abstract B27: A link between small noncoding RNAs and mRNA translation elongation: The let7-eEF2K axis in pediatric tumor adaptation to nutrient deprivation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"microRNA; Biology; Translation (biology); Messenger RNA; Cancer research; Untranslated region; Downregulation and upregulation; Neuroblastoma; Small nucleolar RNA; Cell culture; Genetics; Non-coding RNA; Gene","score_opus":0.14323350415088887,"score_gpt":0.3656346269054032,"score_spread":0.22240112275451435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047128548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97447956,0.0015905849,0.007565952,0.01559045,0.000034089986,0.00058271457,0.000018572851,0.000007475294,0.00013062292],"genre_scores_gemma":[0.9966046,0.001329031,0.00030391477,0.00020058265,0.0011895078,0.0002696838,0.00005757024,0.000015492278,0.000029585264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99888086,0.00009109166,0.00022515906,0.00034284635,0.00024347253,0.00021657234],"domain_scores_gemma":[0.9994364,0.00005874398,0.0000531744,0.0001705337,0.00017572584,0.000105438936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054756936,0.000088018045,0.0000889275,0.00009312122,0.00016259354,0.00006563085,0.00017362459,0.00006951318,0.000015545262],"category_scores_gemma":[0.00012306742,0.00007030815,0.00002727289,0.00051702623,0.000039691397,0.000011918058,0.00004582661,0.00022043147,0.000007981846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005267209,0.000046238092,0.046177864,0.0002516404,0.000045019016,0.000004772099,0.0057654204,0.0061705564,0.51020247,0.0002786672,0.0011145406,0.4294161],"study_design_scores_gemma":[0.0023595532,0.0007177151,0.66654795,0.000109197164,0.00004584685,0.000002332905,0.001631308,0.003349482,0.24311274,0.00039776263,0.08112027,0.00060582405],"about_ca_topic_score_codex":0.00018640509,"about_ca_topic_score_gemma":0.00030988303,"teacher_disagreement_score":0.6203701,"about_ca_system_score_codex":0.00006239492,"about_ca_system_score_gemma":0.00020094062,"threshold_uncertainty_score":0.28670833},"labels":[],"label_agreement":null},{"id":"W3047130338","doi":"10.1158/1538-7445.pedca19-b18","title":"Abstract B18: MEG3 and MEG8 aberrant methylation associated with worst prognosis in an infant with neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; MEG3; Epigenetics; Biology; Copy-number variation; DNA methylation; Cancer; Disease; Methylation; Stage (stratigraphy); Pediatric cancer; Primary tumor; Oncology; Bioinformatics; Cancer research; Gene; Genetics; Internal medicine; Medicine; RNA; Gene expression; Genome; Metastasis; Long non-coding RNA","score_opus":0.10171849824437246,"score_gpt":0.391256980663956,"score_spread":0.2895384824195835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047130338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326175,0.00018813067,0.0000031108507,0.0047611212,0.000008626805,0.0012544794,0.000022146975,0.000059008216,0.00044162205],"genre_scores_gemma":[0.99904656,0.0001434773,0.00006730991,0.00016041826,0.00006039769,0.0003663538,0.000027974904,0.000053098032,0.00007438219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972184,0.00022659013,0.00020079415,0.00057721615,0.0011171493,0.00065988424],"domain_scores_gemma":[0.99855065,0.00021237842,0.000053676085,0.00019611325,0.0003466299,0.00064056105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004230046,0.0001884775,0.0003255207,0.00027063832,0.0001295183,0.000088958106,0.00011820786,0.00007259808,0.00012783158],"category_scores_gemma":[0.0002323427,0.00012758648,0.000023935829,0.0012007639,0.00024754697,0.00026613832,0.000066480636,0.00080457487,0.000012844923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017791718,0.0017154035,0.7561507,0.00052664115,0.0005467675,0.005765595,0.0029723183,0.00015577338,0.19351558,0.00004001566,0.0007362142,0.020083241],"study_design_scores_gemma":[0.0062596183,0.007224094,0.9451812,0.00053777563,0.00003997885,0.000023967921,0.00019856678,0.00062930596,0.039491765,0.000014536085,0.00021909187,0.00018012674],"about_ca_topic_score_codex":0.0005312778,"about_ca_topic_score_gemma":0.0025685998,"teacher_disagreement_score":0.18903044,"about_ca_system_score_codex":0.00019704798,"about_ca_system_score_gemma":0.00047443158,"threshold_uncertainty_score":0.52028257},"labels":[],"label_agreement":null},{"id":"W3047153750","doi":"10.1158/1538-7445.pedca19-a01","title":"Abstract A01: Novel childhood genitourinary manifestations of <i>DICER1</i> syndrome","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; McGill University; SickKids Foundation; University of Toronto; Montreal Children's Hospital; Jewish General Hospital","funders":"","keywords":"Sanger sequencing; Germline; Sarcoma; Pathology; Genitourinary system; Endometrial stromal sarcoma; Germline mutation; Biology; Wilms' tumor; Cancer research; Embryonal rhabdomyosarcoma; Medicine; Mutation; Rhabdomyosarcoma; Internal medicine; Genetics; Gene","score_opus":0.1332716866907248,"score_gpt":0.40407906850213665,"score_spread":0.27080738181141184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047153750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778351,0.001656242,0.00001881062,0.009364012,0.000057218556,0.00064618373,0.00014127229,0.00004766341,0.010233453],"genre_scores_gemma":[0.9982507,0.00036049288,0.0002943384,0.00032191112,0.00018994822,0.00014653342,0.0000128299625,0.00003443691,0.00038879263],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817866,0.000033500786,0.00031573288,0.00028527188,0.00079890224,0.00038793654],"domain_scores_gemma":[0.9987415,0.00024890117,0.000052927557,0.00026474678,0.00039450877,0.00029743568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028348406,0.00012331933,0.00031164353,0.00013626748,0.00011711639,0.000014512445,0.00018300973,0.000057983456,0.001069017],"category_scores_gemma":[0.00047788423,0.000112294714,0.00009320608,0.000574586,0.00021134308,0.000077145836,0.00017129142,0.0004903858,0.00023278745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010743464,0.0030229033,0.058364466,0.0078883525,0.0025164452,0.006383496,0.029991247,0.00008609642,0.80767393,0.00062805944,0.04450886,0.03786179],"study_design_scores_gemma":[0.0021045126,0.00064237136,0.98430693,0.00038926606,0.000096877695,0.00030629223,0.0024391143,0.000043233915,0.004121663,0.000099959114,0.005252755,0.00019700159],"about_ca_topic_score_codex":0.000258835,"about_ca_topic_score_gemma":0.000034615834,"teacher_disagreement_score":0.9259425,"about_ca_system_score_codex":0.00009940217,"about_ca_system_score_gemma":0.00048565594,"threshold_uncertainty_score":0.99984413},"labels":[],"label_agreement":null},{"id":"W3047155545","doi":"10.1158/1538-7445.pedca19-a22","title":"Abstract A22: YAP1 knockout in vitro models of medulloblastoma showed improved response to sonidegib","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Propidium iodide; Cancer research; Medulloblastoma; Cell growth; Biology; YAP1; Apoptosis; Cell culture; Molecular biology; Internal medicine; Medicine; Programmed cell death; Genetics","score_opus":0.046194195735284826,"score_gpt":0.402369820234393,"score_spread":0.35617562449910817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047155545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951283,0.0011685637,0.0015289361,0.0015352165,0.00004772779,0.00031805693,0.000042457956,0.00000892996,0.00022185664],"genre_scores_gemma":[0.9988277,0.00014224356,0.0004350697,0.00014007218,0.00013748594,0.000102971346,0.0000070044425,0.000029000346,0.00017843318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986876,0.000077726116,0.0002148384,0.00036606716,0.0002458322,0.00040791024],"domain_scores_gemma":[0.9992801,0.00004326363,0.000021487574,0.00028458465,0.00014729433,0.00022326804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005712655,0.000113638205,0.00016638826,0.00010574462,0.000028792407,0.000015457224,0.00029854474,0.0001081055,0.0000366162],"category_scores_gemma":[0.00028675533,0.00011715374,0.000058181326,0.00029913255,0.00005317759,0.0000037132406,0.0002028604,0.00022069948,0.0000071538616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034181296,0.00002105694,0.00003243979,0.00005420472,0.000016646429,0.0000054959646,0.00035581348,0.0066560004,0.9842474,0.0000026937842,0.0006761569,0.004513956],"study_design_scores_gemma":[0.00052671693,0.00025676037,0.0012471011,0.00003006215,0.0000020503958,7.5605175e-7,0.00017540486,0.0019186365,0.9919539,0.00001557327,0.0037489007,0.00012411008],"about_ca_topic_score_codex":0.00017214265,"about_ca_topic_score_gemma":0.000103422084,"teacher_disagreement_score":0.0077065215,"about_ca_system_score_codex":0.00004434619,"about_ca_system_score_gemma":0.00026866674,"threshold_uncertainty_score":0.4777391},"labels":[],"label_agreement":null},{"id":"W3047156703","doi":"10.1158/1538-7445.pedca19-ia09","title":"Abstract IA09: Immunotherapeutic approaches for pediatric solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chimeric antigen receptor; Immunotherapy; Rhabdomyosarcoma; Neuroblastoma; Transplantation; Oncology; Immune system; Chemotherapy; Cytokine release syndrome; Immunology; Cancer research; Sarcoma; Internal medicine; Pathology; Biology; Cell culture","score_opus":0.3021584727594122,"score_gpt":0.45402061226202023,"score_spread":0.15186213950260802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047156703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96273,0.008286015,0.0001592721,0.017943164,0.00012918781,0.0033682312,0.000060793205,0.00014231038,0.0071810284],"genre_scores_gemma":[0.9884568,0.001671615,0.00014573512,0.0006566545,0.0024207789,0.0010553641,0.000028336768,0.00012266797,0.005442061],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996798,0.00010318379,0.00033667558,0.00058817235,0.0011533399,0.0010206753],"domain_scores_gemma":[0.9981872,0.0004052455,0.00004973438,0.00046178797,0.00040209203,0.00049394666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012513518,0.00019284971,0.00041753647,0.00028277855,0.00022065907,0.000088553876,0.0004209603,0.00013357807,0.005624422],"category_scores_gemma":[0.00027531607,0.00016899823,0.00020839724,0.0009899145,0.00022555109,0.00008859712,0.00011951991,0.0010259193,0.00022444518],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007214164,0.00042296518,0.008961471,0.0029733677,0.0004211496,0.000106322026,0.0030221571,0.00010446117,0.80073404,0.00036539012,0.024011841,0.15166265],"study_design_scores_gemma":[0.021503009,0.0065733283,0.07584174,0.00041439626,0.00028983736,0.00006710873,0.0040569864,0.005552669,0.43642598,0.0016333826,0.4459773,0.0016642545],"about_ca_topic_score_codex":0.0001582612,"about_ca_topic_score_gemma":0.000011001862,"teacher_disagreement_score":0.42196548,"about_ca_system_score_codex":0.00033748557,"about_ca_system_score_gemma":0.0011516298,"threshold_uncertainty_score":0.99528456},"labels":[],"label_agreement":null},{"id":"W3047160360","doi":"10.1158/1538-7445.pedca19-a49","title":"Abstract A49: Combined targeting of the p53 and pRb pathway in neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; CDKN2A; Mdm2; Cancer research; Neuroblastoma; Biology; Cell cycle; Cyclin D1; Cancer; Mutation; Cell culture; Medicine; Genetics; Gene","score_opus":0.0770797733286501,"score_gpt":0.37652207456817754,"score_spread":0.2994423012395274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047160360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897871,0.00035553475,3.433123e-7,0.007967065,0.00002895996,0.0006485247,0.000016572485,0.00001394207,0.0011819828],"genre_scores_gemma":[0.9993093,0.00013118461,0.000013971308,0.0002181251,0.000059358208,0.0000633319,0.000002078849,0.000021355014,0.00018130724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829453,0.00014582009,0.00019656104,0.00028018115,0.0006647399,0.00041819492],"domain_scores_gemma":[0.99916595,0.0001929253,0.00003588721,0.00019823019,0.00014748695,0.00025952538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031473357,0.0000934788,0.00019962851,0.00010055571,0.000081239865,0.000018248757,0.0001633917,0.00004008821,0.00016217295],"category_scores_gemma":[0.00055999274,0.000062142404,0.00004522169,0.0006202373,0.00023653018,0.0000541831,0.0002202029,0.0006403239,0.000017017908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019021791,0.00028607325,0.060100645,0.00067222054,0.00005182258,0.00047463248,0.00068739173,0.000015253906,0.9249924,0.00011193064,0.0030707729,0.0076347115],"study_design_scores_gemma":[0.004447196,0.0013479054,0.46652618,0.0003538758,0.000005687921,0.000009536939,0.00022181594,0.00021116428,0.5241508,0.00011002341,0.0025193603,0.00009645368],"about_ca_topic_score_codex":0.00027053393,"about_ca_topic_score_gemma":0.000063623695,"teacher_disagreement_score":0.40642554,"about_ca_system_score_codex":0.00006719271,"about_ca_system_score_gemma":0.00036174277,"threshold_uncertainty_score":0.27819243},"labels":[],"label_agreement":null},{"id":"W3047171961","doi":"10.1158/1538-7445.pedca19-b29","title":"Abstract B29: Validation of a model of pediatric leukemia based on pluripotent stem cells using mass cytometry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Induced pluripotent stem cell; Myeloid leukemia; Biology; Cancer research; Lineage markers; Stem cell; Progenitor cell; Bone marrow; Myeloid; Mass cytometry; Leukemia; Immunology; Cell biology; Embryonic stem cell; Phenotype; Genetics; Gene","score_opus":0.12444906871308475,"score_gpt":0.36928180100767927,"score_spread":0.2448327322945945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047171961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935123,0.00043987122,0.004899433,0.00013754414,0.000042815107,0.00043069132,0.00016788089,0.0000067729256,0.00036274004],"genre_scores_gemma":[0.9986592,0.00045339466,0.00041523133,0.00004222711,0.00022039008,0.00002965983,0.000025962248,0.000038710492,0.00011522702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997394,0.0001729176,0.00036415193,0.00048596243,0.0011303496,0.00045259236],"domain_scores_gemma":[0.99864936,0.00006584897,0.000106819476,0.00042601384,0.0005363868,0.00021555596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008072085,0.00014979712,0.0002326354,0.00028836922,0.00006788795,0.00002007647,0.00046338706,0.00017833216,0.00005806192],"category_scores_gemma":[0.00007495531,0.00014700515,0.00012388018,0.0006725891,0.000121718855,0.000007506039,0.00017031677,0.00034425472,0.000010964966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037429846,0.000042988264,0.000693752,0.0004425012,0.000022406142,0.0000032795197,0.000026561878,0.23192619,0.7658275,0.0000024092801,0.0004091142,0.00022904141],"study_design_scores_gemma":[0.00058068754,0.0002610562,0.00012016873,0.000033001183,0.000011805476,1.4676675e-7,0.00003849421,0.11159687,0.88716406,0.000005962147,0.000075204836,0.000112552756],"about_ca_topic_score_codex":0.00008595716,"about_ca_topic_score_gemma":0.0000015282217,"teacher_disagreement_score":0.121336594,"about_ca_system_score_codex":0.00020884344,"about_ca_system_score_gemma":0.001325238,"threshold_uncertainty_score":0.5994696},"labels":[],"label_agreement":null},{"id":"W3047190724","doi":"10.1158/1538-7445.pedca19-ia31","title":"Abstract IA31: Stalled developmental programs at the root of K27M mutant gliomas and other pediatric brain tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Progenitor cell; OLIG2; PRC2; Lineage (genetic); Progenitor; Neuroscience; Wnt signaling pathway; Neural stem cell; Cellular differentiation; Epigenetics; Cancer research; Stem cell; Cell biology; Genetics; Central nervous system; EZH2; Oligodendrocyte; Myelin","score_opus":0.06355479748055734,"score_gpt":0.3565387594744608,"score_spread":0.2929839619939034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047190724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444944,0.0034797362,0.000011580897,0.0010648222,0.000022637514,0.00029189524,0.000032323896,0.000008719976,0.000638829],"genre_scores_gemma":[0.99887156,0.00021827038,0.000048615748,0.00016539312,0.00024988025,0.00007290121,0.000015001296,0.000023502187,0.00033487205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988695,0.00005828662,0.00017843946,0.00029469054,0.00032200292,0.0002771203],"domain_scores_gemma":[0.99957293,0.000026582335,0.000049717983,0.00014403182,0.000095752745,0.00011097136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038016707,0.00009959816,0.0001124381,0.000026487442,0.00011873322,0.000025289992,0.00019702614,0.0000670666,0.0001556803],"category_scores_gemma":[0.00008205117,0.00007098285,0.000043759217,0.0002071858,0.00017376099,0.0000022362144,0.00023034036,0.00014476712,0.000007617092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002532092,0.000032214677,0.01153572,0.00015600973,0.000046195404,0.0000060244506,0.00056626875,0.00005313159,0.9751046,0.00000783686,0.004454109,0.007784716],"study_design_scores_gemma":[0.0018746135,0.00054905657,0.010408811,0.00007461263,0.000018720557,0.000024651841,0.0011537793,0.00020356316,0.91700727,0.000052945295,0.06825268,0.00037928202],"about_ca_topic_score_codex":0.00020386296,"about_ca_topic_score_gemma":0.00035308563,"teacher_disagreement_score":0.06379858,"about_ca_system_score_codex":0.000049311144,"about_ca_system_score_gemma":0.00032573738,"threshold_uncertainty_score":0.28945968},"labels":[],"label_agreement":null},{"id":"W3047199953","doi":"10.1158/1538-7445.pedca19-pr14","title":"Abstract PR14: Ewing sarcoma cells exploit the IL1RAP-CTH axis to drive oxidative stress adaptation and lung metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastasis; Cancer research; Anoikis; Oxidative stress; Cancer; Lung cancer; Medicine; Biology; Pathology; Cell biology; Internal medicine","score_opus":0.08096699722359395,"score_gpt":0.35787108170289805,"score_spread":0.2769040844793041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047199953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98231786,0.012531905,0.0010333159,0.002515253,0.00027879063,0.0007017527,0.00022688518,0.000012802166,0.00038145372],"genre_scores_gemma":[0.99230313,0.004957863,0.00027102235,0.0005632078,0.0013308728,0.00025506635,0.00003674841,0.000032217464,0.00024986462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983072,0.00016229242,0.00017779366,0.00051819853,0.00040276325,0.00043174357],"domain_scores_gemma":[0.9990575,0.00006218159,0.000051365183,0.00029316804,0.00027209453,0.00026371007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041653018,0.00015682701,0.00017727255,0.000062065585,0.00023888635,0.00009723413,0.0003130887,0.00008124324,0.00009237594],"category_scores_gemma":[0.00013596062,0.00012519376,0.00006735721,0.00029890108,0.00015073761,0.000014976982,0.0002600794,0.00028479905,0.000013844996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021550612,0.00002209921,0.00010945101,0.00006327705,0.00012786675,0.0000022703687,0.0033741465,0.0003207484,0.9288151,0.00004132797,0.013402347,0.053505823],"study_design_scores_gemma":[0.00047191954,0.00016128249,0.0016607571,0.00003610849,0.00003200597,0.0000010067145,0.004094638,0.0001277099,0.8400113,0.000022645758,0.15319131,0.00018931332],"about_ca_topic_score_codex":0.00063947245,"about_ca_topic_score_gemma":0.0004215905,"teacher_disagreement_score":0.13978897,"about_ca_system_score_codex":0.000042369917,"about_ca_system_score_gemma":0.00023749856,"threshold_uncertainty_score":0.51052535},"labels":[],"label_agreement":null},{"id":"W3047205060","doi":"10.1158/1538-7445.pedca19-b01","title":"Abstract B01: Alternative splicing as a therapeutic vulnerability in pediatric rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA splicing; Alternative splicing; Pediatric cancer; Biology; splice; Rhabdomyosarcoma; Cancer research; Splice site mutation; Carcinogenesis; Cancer; Gene isoform; Computational biology; Genetics; Medicine; Gene; RNA; Sarcoma; Pathology","score_opus":0.10893555181514414,"score_gpt":0.42602128696249325,"score_spread":0.3170857351473491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047205060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910974,0.0036015126,0.0001475773,0.0025376186,0.000054495747,0.00030334963,0.000013883085,0.000007854774,0.002236301],"genre_scores_gemma":[0.9962406,0.002230146,0.000026255964,0.00042501223,0.00064623915,0.00023212697,0.000011875263,0.000019754556,0.00016800278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859744,0.00013368735,0.00018033001,0.00046008232,0.0002828501,0.00034560866],"domain_scores_gemma":[0.9993366,0.000036869696,0.00003766389,0.00029392968,0.00016476019,0.00013020237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048155666,0.00010211791,0.00011373918,0.00006717211,0.000095431926,0.000037700054,0.0003277644,0.00008273418,0.00020417171],"category_scores_gemma":[0.00012111677,0.00009514767,0.00005058795,0.00038992253,0.00009292632,0.0000063858865,0.000108206325,0.00035954363,0.00004817232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032815643,0.00010535179,0.037540432,0.000093113995,0.000026563877,0.000011864723,0.00053582987,0.0005832159,0.93723804,0.0003617961,0.0013814375,0.021794224],"study_design_scores_gemma":[0.0025250597,0.00077709975,0.27692738,0.000046453588,0.000019847525,0.0000048452816,0.00077668694,0.000585263,0.6713647,0.002090204,0.04420446,0.00067801314],"about_ca_topic_score_codex":0.0007744408,"about_ca_topic_score_gemma":0.00016197078,"teacher_disagreement_score":0.2658733,"about_ca_system_score_codex":0.000083494575,"about_ca_system_score_gemma":0.00034506392,"threshold_uncertainty_score":0.38800094},"labels":[],"label_agreement":null},{"id":"W3047207404","doi":"10.1158/1538-7445.pedca19-ia27","title":"Abstract IA27: Patient-derived organoids in pediatric cancer research","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Organoid; Cancer; Medicine; Wilms' tumor; Cancer research; Translational research; Pediatric cancer; Oncology; Biology; Internal medicine; Pathology; Neuroscience","score_opus":0.06788979712148496,"score_gpt":0.3908271450122118,"score_spread":0.3229373478907268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047207404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806399,0.01257899,0.0000028970678,0.0038876329,0.0001821906,0.0004095004,0.00003670395,0.000013738593,0.0022484607],"genre_scores_gemma":[0.9701524,0.027654592,0.000012796399,0.00031702995,0.0011369569,0.00030251683,0.000026862086,0.000045909008,0.0003509596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970688,0.0002584514,0.00027750368,0.0006748362,0.0008099895,0.0009103714],"domain_scores_gemma":[0.99877787,0.00004703548,0.000043318232,0.00029900705,0.00048711573,0.00034568028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061703543,0.00016018075,0.00018041838,0.00020823136,0.00019348355,0.000055835677,0.0004899695,0.00029074852,0.00046487994],"category_scores_gemma":[0.00022870731,0.00013923256,0.00007136302,0.001330189,0.00024738448,0.000009158674,0.00033455054,0.001185896,0.000106790845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041037175,0.00004637057,0.006246624,0.00014658156,0.000034810597,0.00004405856,0.00049598387,0.00043758567,0.9545833,0.000010644412,0.029801648,0.0077420147],"study_design_scores_gemma":[0.0012143565,0.00056615594,0.010568401,0.000083183106,0.000008413004,0.000002008925,0.00057014584,0.000024891644,0.9208906,0.0000684847,0.06565756,0.00034575583],"about_ca_topic_score_codex":0.0012683389,"about_ca_topic_score_gemma":0.00039998707,"teacher_disagreement_score":0.035855915,"about_ca_system_score_codex":0.00019652995,"about_ca_system_score_gemma":0.001165173,"threshold_uncertainty_score":0.56777394},"labels":[],"label_agreement":null},{"id":"W3047209647","doi":"10.1158/1538-7445.pedca19-a08","title":"Abstract A08: Development of FGFR4-specific chimeric antibody receptor (CAR) T cell and bispecific T cell engager (BiTE) for rhabdomyosarcoma (RMS) immunotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Monoclonal antibody; In vivo; Immunotherapy; In vitro; Alveolar rhabdomyosarcoma; Antibody; T cell; Medicine; Molecular biology; Biology; Immunology; Rhabdomyosarcoma; Immune system; Pathology; Biochemistry; Sarcoma","score_opus":0.11237093703901149,"score_gpt":0.3963435076616698,"score_spread":0.28397257062265835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047209647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97526234,0.016207205,0.0003426914,0.0016281764,0.00018326608,0.0027664665,0.00008648656,0.00006742252,0.0034559376],"genre_scores_gemma":[0.9745788,0.013737001,0.004689406,0.00019682368,0.0008077708,0.00053554185,0.00014590238,0.00022365635,0.0050850976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954906,0.000247453,0.00074081443,0.00092971674,0.0014705992,0.0011207822],"domain_scores_gemma":[0.99714637,0.0007144695,0.000150603,0.0006544747,0.0007454678,0.0005886164],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019535727,0.00036448552,0.00074599695,0.00048232285,0.00039817183,0.00009967737,0.0005145424,0.00021298349,0.009215525],"category_scores_gemma":[0.00007991163,0.00032851342,0.0002077506,0.0011371432,0.00049944536,0.00012365481,0.00019619949,0.0013231926,0.0001388671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003419837,0.00040793084,0.0013674693,0.0010361802,0.00012050018,0.00001752732,0.003800258,0.0000027023689,0.9213904,0.000016134194,0.008245844,0.06017519],"study_design_scores_gemma":[0.0034099484,0.00061715493,0.0043247505,0.000111690104,0.0000070145397,0.0000023750267,0.00085105526,0.000020617386,0.63612366,0.000010053082,0.35430092,0.00022075846],"about_ca_topic_score_codex":0.0001229627,"about_ca_topic_score_gemma":0.000008214091,"teacher_disagreement_score":0.34605506,"about_ca_system_score_codex":0.00038950617,"about_ca_system_score_gemma":0.0011015418,"threshold_uncertainty_score":0.9999167},"labels":[],"label_agreement":null},{"id":"W3047210705","doi":"10.1158/1538-7445.pedca19-pr04","title":"Abstract PR04: Locoregionally administered B7H3-targeting CAR T cells mediate potent antitumor effects in atypical teratoid/rhabdoid tumor","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Cancer research; Immune system; Brain tumor; Immunology; Pharmacology; Pathology; Medulloblastoma","score_opus":0.07927072980989242,"score_gpt":0.39065753962015737,"score_spread":0.31138680981026495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047210705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850265,0.0018350119,0.0000142129875,0.008993185,0.00024295552,0.0024725173,0.000039040682,0.000085665815,0.0012909446],"genre_scores_gemma":[0.99487007,0.00057317864,0.00022146055,0.0013343475,0.0013337553,0.0004973734,0.000052720716,0.00011976796,0.0009973081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941732,0.0004465594,0.00063065597,0.0010048001,0.002234128,0.0015106288],"domain_scores_gemma":[0.99699694,0.0007118742,0.00009125356,0.00052567414,0.0005192883,0.001154993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016615106,0.0003457956,0.00072927796,0.00042773137,0.00017487627,0.00012490846,0.000571158,0.00017391713,0.002605751],"category_scores_gemma":[0.0008425158,0.00030598082,0.00020925363,0.0011994233,0.00044070405,0.00013643003,0.00034146704,0.0022780597,0.0004795641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004861899,0.00026972155,0.013572226,0.0013712154,0.000083093226,0.004735413,0.00087529107,0.00003506155,0.96014667,0.000028600749,0.008737765,0.0052830297],"study_design_scores_gemma":[0.007855556,0.0019484696,0.075445615,0.0011944309,0.000029795356,0.0000606043,0.0004974732,0.000913759,0.86602724,0.00008537939,0.045333013,0.000608668],"about_ca_topic_score_codex":0.0003178057,"about_ca_topic_score_gemma":0.0000851175,"teacher_disagreement_score":0.094119444,"about_ca_system_score_codex":0.00072597456,"about_ca_system_score_gemma":0.0017275214,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W3047221384","doi":"10.1158/1538-7445.pedca19-a32","title":"Abstract A32: Selective inhibition of AuroraA by LY3295668 erbumine in neuroblastoma models induces apoptosis through a combination of S-phase DNA damage and mitotic arrest","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer research; Mitosis; DNA damage; Apoptosis; Cell cycle; Cell biology; Molecular biology; Genetics; DNA","score_opus":0.043954780241225996,"score_gpt":0.34686703346022585,"score_spread":0.30291225321899984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047221384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981599,0.00048733933,0.00022016904,0.00052006193,0.000022287655,0.00032749254,0.00012384416,0.000003705557,0.00013518806],"genre_scores_gemma":[0.9987736,0.0008643022,0.0000472884,0.0000882552,0.000038530245,0.00004634211,0.00010982976,0.000018336277,0.000013521321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989535,0.00009997546,0.00024018016,0.00031698914,0.00017967942,0.00020967334],"domain_scores_gemma":[0.9994575,0.000030552183,0.00008964417,0.00013534186,0.00022255287,0.00006444645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001741774,0.00010601652,0.00017554982,0.000071480965,0.00003736195,0.000013231606,0.0001122261,0.00011917399,0.000006912715],"category_scores_gemma":[0.00008116529,0.000111414585,0.000033077875,0.00032245854,0.00017440954,0.000021389907,0.000105666666,0.00021136533,4.7904496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028869548,0.00024176172,0.0001001276,0.00017874564,0.000023461218,0.000001306585,0.00046459984,0.00015757316,0.99668807,0.00007657807,0.0013381686,0.0004409284],"study_design_scores_gemma":[0.0013911824,0.00066654943,0.000479374,0.00007161007,0.0000072779053,4.056464e-7,0.00019007825,0.00069472985,0.99604553,0.0002535445,0.000105522864,0.00009416938],"about_ca_topic_score_codex":0.00033111242,"about_ca_topic_score_gemma":0.00011805572,"teacher_disagreement_score":0.0012326457,"about_ca_system_score_codex":0.000028879289,"about_ca_system_score_gemma":0.00012735132,"threshold_uncertainty_score":0.45433548},"labels":[],"label_agreement":null},{"id":"W3047222590","doi":"10.1158/1538-7445.pedca19-a46","title":"Abstract A46: Charting the synthetic lethality landscape in pediatric cancer to advance whole-exome precision-based treatments","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Synthetic lethality; Cancer; Exome; Gene; Pediatric cancer; Computational biology; CRISPR; Exome sequencing; RNA interference; Biology; Medicine; Bioinformatics; Genetics; Phenotype; DNA repair","score_opus":0.09483826355882806,"score_gpt":0.435269265275793,"score_spread":0.34043100171696494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047222590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96514785,0.0020257367,0.000008869953,0.030126028,0.00007367489,0.0016721627,0.000111757734,0.000045500296,0.000788409],"genre_scores_gemma":[0.9962093,0.0006294262,0.000038073722,0.0008454755,0.00038544938,0.0013687818,0.000011933831,0.000047994577,0.00046352594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963979,0.00024945912,0.00033303248,0.0007018623,0.0013466881,0.0009710194],"domain_scores_gemma":[0.9977857,0.0006968284,0.00005762315,0.0005058812,0.0002575633,0.00069642754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006931543,0.00021859672,0.00034312456,0.00027731524,0.00021914803,0.00006544608,0.00035724282,0.00006993964,0.000827272],"category_scores_gemma":[0.00088072167,0.00014413804,0.000097942924,0.0015967553,0.00009640391,0.00010025585,0.00014889613,0.0007994999,0.00045741486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008528706,0.001688856,0.7413831,0.0013875443,0.00023994946,0.0021866744,0.001961861,0.0025774704,0.0877077,0.000014542123,0.010659205,0.14166442],"study_design_scores_gemma":[0.006290696,0.0013903352,0.94939214,0.0005544813,0.00007084261,0.0000050096883,0.0002216768,0.0011068868,0.032833267,0.000046869118,0.007781393,0.00030642375],"about_ca_topic_score_codex":0.0007803375,"about_ca_topic_score_gemma":0.00031618666,"teacher_disagreement_score":0.20800903,"about_ca_system_score_codex":0.00044929012,"about_ca_system_score_gemma":0.0007688072,"threshold_uncertainty_score":0.9058049},"labels":[],"label_agreement":null},{"id":"W3047227463","doi":"10.1158/1538-7445.pedca19-b30","title":"Abstract B30: ARID1A is a haploinsufficient tumor suppressor for N-Myc transformation of neural crest cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Carcinogenesis; Cancer research; ARID1A; Neuroblastoma; Haploinsufficiency; Loss of heterozygosity; Suppressor; Neural crest; Tumor suppressor gene; Chromatin remodeling; Cancer; Chromatin; Molecular biology; Gene; Genetics; Mutation; Phenotype; Cell culture; Allele","score_opus":0.1305740287140764,"score_gpt":0.41762425627024075,"score_spread":0.2870502275561644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047227463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869944,0.0002921543,0.000049625025,0.0074698087,0.00006254213,0.0018532091,0.0004858215,0.00003274536,0.001054668],"genre_scores_gemma":[0.99856704,0.00009826596,0.00006422078,0.00048083783,0.00014163107,0.00036068485,0.000029426652,0.00003483808,0.00022304594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769765,0.000053109634,0.0003075042,0.0003415613,0.0009800055,0.00062015594],"domain_scores_gemma":[0.9985606,0.00019519095,0.0000504157,0.00023970359,0.00047927274,0.0004748037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027160865,0.00013824213,0.00028833852,0.00017650939,0.00012653333,0.000039590937,0.0001937712,0.0000474756,0.00060060015],"category_scores_gemma":[0.00012797616,0.00011247282,0.00014948956,0.0004189703,0.00017712494,0.00012710526,0.000046604204,0.00040015025,0.0000792377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041136937,0.00042017226,0.0001812297,0.0014999658,0.0000981459,0.000106864725,0.0018159652,0.0000986575,0.9721958,0.000052196807,0.016471852,0.002945461],"study_design_scores_gemma":[0.0039247978,0.0023041295,0.004339425,0.0001324786,0.000030223013,0.000005924307,0.00032752135,0.003777411,0.97259074,0.00002361048,0.012444719,0.00009901191],"about_ca_topic_score_codex":0.00024796865,"about_ca_topic_score_gemma":0.000014281251,"teacher_disagreement_score":0.0098676225,"about_ca_system_score_codex":0.00011595518,"about_ca_system_score_gemma":0.0004467291,"threshold_uncertainty_score":0.65761507},"labels":[],"label_agreement":null},{"id":"W3047230158","doi":"10.1158/1538-7445.pedca19-a31","title":"Abstract A31: Podxl as therapeutic target for metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Cancer research; Cancer; Medicine; Podocalyxin; Biology; Pathology; Internal medicine; Kidney","score_opus":0.1350725069005645,"score_gpt":0.44218121563763546,"score_spread":0.30710870873707097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047230158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524117,0.009081888,0.0027719487,0.02425511,0.00015204264,0.0022967337,0.0003114255,0.000044971486,0.008674176],"genre_scores_gemma":[0.99511313,0.00048324995,0.0003970362,0.00090015103,0.0005175572,0.00050618994,0.00010673191,0.000038563427,0.0019373985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830204,0.00010192261,0.00015558506,0.0004410358,0.00047241533,0.00052702834],"domain_scores_gemma":[0.99894935,0.00004423492,0.000027628192,0.0002786933,0.00042852946,0.00027155757],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006057885,0.00011646457,0.00013108182,0.00006807939,0.00019192521,0.000072991905,0.00037310325,0.00011414807,0.0012771024],"category_scores_gemma":[0.00037060547,0.00010423257,0.000108403,0.0002730894,0.00012423436,0.000005667226,0.00013290229,0.00026025466,0.00017013817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063433236,0.000039095376,0.00019045157,0.000090360205,0.00009652387,0.000004503035,0.00007139394,0.00006803637,0.95316625,0.0003617301,0.020635072,0.02464225],"study_design_scores_gemma":[0.0004992701,0.00041040083,0.0002837042,0.0000055350724,0.0000031969807,8.9579237e-7,0.000080379985,0.0000671827,0.49558973,0.00031201929,0.50265044,0.00009726007],"about_ca_topic_score_codex":0.00012024702,"about_ca_topic_score_gemma":0.000028072915,"teacher_disagreement_score":0.48201534,"about_ca_system_score_codex":0.00003375644,"about_ca_system_score_gemma":0.0004296236,"threshold_uncertainty_score":0.9996359},"labels":[],"label_agreement":null},{"id":"W3047230848","doi":"10.1158/1538-7445.pedca19-a26","title":"Abstract A26: Characterization and development of a GPC2 ADC for neuroblastoma and other cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroblastoma; Flow cytometry; Cancer research; Biology; Immunohistochemistry; Tissue microarray; Apoptosis; Cancer; Pathology; Molecular biology; Medicine; Cell culture; Immunology","score_opus":0.14243602597518332,"score_gpt":0.4128089626927205,"score_spread":0.27037293671753715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047230848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972145,0.00017675076,0.0001006273,0.0014624795,0.000017768169,0.0008222699,0.000073307965,0.000015490807,0.00011681972],"genre_scores_gemma":[0.99869764,0.00016696754,0.0002918694,0.00030568498,0.00007850688,0.00024154031,0.000013341179,0.00002820116,0.00017627933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888283,0.000027699416,0.0001600177,0.00028019713,0.00034792442,0.00030132994],"domain_scores_gemma":[0.999313,0.000080310085,0.000036433434,0.00009092226,0.00016898407,0.00031035204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001531228,0.00009026381,0.00017761106,0.00010439216,0.00009686473,0.000020753683,0.00005260123,0.00003630226,0.00010832334],"category_scores_gemma":[0.00009712779,0.00007604635,0.00001805124,0.00017525864,0.00013468992,0.000056464345,0.00006174804,0.0001567308,0.0000057114516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020485353,0.00005927068,0.0066947835,0.00093131437,0.00009961701,0.000023043462,0.0012277303,7.9648316e-7,0.91225946,0.000022447843,0.00035098556,0.07628203],"study_design_scores_gemma":[0.006210405,0.001949498,0.2961343,0.00041580293,0.000025781903,0.00001427547,0.00025695917,0.0003220522,0.6168029,0.00001379367,0.07765991,0.00019437616],"about_ca_topic_score_codex":0.00006775662,"about_ca_topic_score_gemma":0.000040929248,"teacher_disagreement_score":0.2954566,"about_ca_system_score_codex":0.0000890444,"about_ca_system_score_gemma":0.00058619166,"threshold_uncertainty_score":0.310108},"labels":[],"label_agreement":null},{"id":"W3047232895","doi":"10.1158/1538-7445.pedca19-b32","title":"Abstract B32: ASAP1 regulates differentiation in myoblasts and PAX-FOXO1 fusion-negative rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Differentiation therapy; Rhabdomyosarcoma; Biology; C2C12; Metastasis; Cell biology; Myogenesis; Cancer; Myocyte; Medicine; Sarcoma; Acute promyelocytic leukemia; Pathology; Cell culture; Genetics","score_opus":0.08708556344944476,"score_gpt":0.38838606640525886,"score_spread":0.3013005029558141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047232895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816837,0.002756043,0.0000018021138,0.014256829,0.000036798087,0.00063964486,0.000018062578,0.000026550024,0.0005805764],"genre_scores_gemma":[0.9976435,0.0015173198,0.00007452373,0.0002610762,0.00014762561,0.00023727756,0.000018405124,0.000022674096,0.000077632205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984196,0.00009146403,0.00021466814,0.00039384948,0.00051585294,0.00036460484],"domain_scores_gemma":[0.99898046,0.0003924449,0.000039495157,0.00017570863,0.00014806922,0.00026382576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022877878,0.0001349953,0.00026942865,0.00016306198,0.00010092053,0.000044368207,0.00007751251,0.00008087758,0.0005864393],"category_scores_gemma":[0.00025932264,0.00010607539,0.000047240574,0.00041867106,0.00012557884,0.00008507033,0.00010799822,0.00036778738,0.000048095815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094723253,0.00059567526,0.8307862,0.00033141553,0.00014371422,0.00037624803,0.0031852913,0.000007573351,0.062449586,0.00025907607,0.0039130943,0.09700486],"study_design_scores_gemma":[0.0023162311,0.00022912689,0.94583154,0.00031098528,0.000016677228,0.0000040138034,0.00034845262,0.00020519765,0.049654517,0.00041461948,0.00057529047,0.00009336819],"about_ca_topic_score_codex":0.0008761976,"about_ca_topic_score_gemma":0.00031031785,"teacher_disagreement_score":0.11504529,"about_ca_system_score_codex":0.00021596673,"about_ca_system_score_gemma":0.00013291776,"threshold_uncertainty_score":0.6421099},"labels":[],"label_agreement":null},{"id":"W3047235899","doi":"10.1158/1538-7445.pedca19-b46","title":"Abstract B46: CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb Repressive complex 2 via a H3K27M-like mechanism","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PRC2; Histone H3; Histone; Fusion protein; Epigenetics; DNA methylation; Methylation; EZH2; Fusion gene; Methionine; Biology; Gene; Chemistry; Cell biology; Molecular biology; Genetics; Gene expression; Amino acid; Recombinant DNA","score_opus":0.23980868894620103,"score_gpt":0.4056006710918198,"score_spread":0.16579198214561877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047235899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266326,0.0019086752,0.0038254578,0.00034240462,0.00011827062,0.00051924767,0.00019180178,0.00001705121,0.00041380955],"genre_scores_gemma":[0.9975969,0.0012107036,0.00037017776,0.00007373518,0.00032299178,0.00007445417,0.00026607467,0.000043393444,0.000041540858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773085,0.00032670805,0.00025820662,0.0007011667,0.00054864836,0.0004344049],"domain_scores_gemma":[0.99842745,0.000058877245,0.00017752849,0.0006511976,0.00042597644,0.0002589681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007355551,0.00018977564,0.0002665097,0.000104298,0.0002004378,0.000045007528,0.00039830207,0.00022888687,0.00016513243],"category_scores_gemma":[0.00013791857,0.00019103412,0.00009565983,0.00028340632,0.00014872567,0.000021890082,0.00025439018,0.00031409043,0.0000084778385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029907815,0.00010732254,0.0005349418,0.000058385773,0.0000813135,0.0000065342815,0.0004535289,0.00018825597,0.9902335,0.000035877092,0.0000834969,0.007917761],"study_design_scores_gemma":[0.00051545154,0.00047379694,0.004125453,0.000009323887,0.000016397315,0.000001802828,0.00009924108,0.00039531337,0.99262863,0.0004865872,0.0010574074,0.00019062062],"about_ca_topic_score_codex":0.0023568245,"about_ca_topic_score_gemma":0.00021415947,"teacher_disagreement_score":0.00772714,"about_ca_system_score_codex":0.000063067666,"about_ca_system_score_gemma":0.00031733562,"threshold_uncertainty_score":0.7790146},"labels":[],"label_agreement":null},{"id":"W3047239617","doi":"10.1158/1538-7445.pedca19-a68","title":"Abstract A68: Optical coherence tomography improves subclinical retinoblastoma management","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Retinoblastoma; Optical coherence tomography; Subclinical infection; Ophthalmology; Fundus (uterus); Radiology; Pathology","score_opus":0.10477229565407324,"score_gpt":0.4477727302115678,"score_spread":0.34300043455749457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047239617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96399134,0.0007273577,0.000013480909,0.012465715,0.00010114024,0.0007204323,0.000007375666,0.000065584216,0.021907551],"genre_scores_gemma":[0.99709374,0.00032102098,0.0006498399,0.0008265517,0.00025728042,0.00019410177,0.000010275874,0.000019593735,0.0006275814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820995,0.000069164686,0.0002234579,0.0004537972,0.0005686015,0.0004750252],"domain_scores_gemma":[0.9989323,0.00016428683,0.000027662085,0.00027744504,0.00015021666,0.0004480975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040318322,0.0001184619,0.0002488347,0.00009287919,0.000113611604,0.00002327664,0.00018098265,0.00013889275,0.0008046665],"category_scores_gemma":[0.00012762261,0.0000958763,0.000118876065,0.00045287312,0.0003953083,0.000046837486,0.0001487291,0.0006886416,0.00048228554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013589811,0.0031084912,0.42968646,0.0023531727,0.0030785922,0.013042921,0.00088824733,0.000006550445,0.10570647,0.0047713844,0.061410844,0.36235705],"study_design_scores_gemma":[0.005852421,0.0034133282,0.92249703,0.00029356897,0.00019192125,0.000019732059,0.0003414521,0.000048532354,0.03191227,0.00042114136,0.03475418,0.00025443954],"about_ca_topic_score_codex":0.000029566414,"about_ca_topic_score_gemma":0.000010419319,"teacher_disagreement_score":0.49281055,"about_ca_system_score_codex":0.000092987895,"about_ca_system_score_gemma":0.00016680083,"threshold_uncertainty_score":0.8810534},"labels":[],"label_agreement":null},{"id":"W3047241938","doi":"10.1158/1538-7445.pedca19-ia05","title":"Abstract IA05: Circulating tumor DNA as a tool for prognostication, translational discovery, and early cancer detection","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Liquid biopsy; Somatic cell; Circulating tumor DNA; Oncology; Internal medicine; Cancer research; Bioinformatics; Computational biology; Biology; Gene; Genetics","score_opus":0.047220596450140866,"score_gpt":0.3595539037925309,"score_spread":0.31233330734239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047241938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927293,0.0021613636,0.0019373731,0.0020606327,0.00008324554,0.0007103876,0.00020400333,0.000008533049,0.00010515215],"genre_scores_gemma":[0.9972876,0.000492862,0.0001494712,0.0002845816,0.00090900576,0.00074682344,0.000041242773,0.000028781482,0.000059683804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989172,0.00002311438,0.00017725381,0.00040063553,0.00020557478,0.00027619384],"domain_scores_gemma":[0.9993449,0.000103636994,0.000048603648,0.00012187063,0.0002664394,0.00011456867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020907055,0.00010222209,0.00010291753,0.000034552868,0.00018658904,0.00012433203,0.00011073102,0.00006802141,0.000027988262],"category_scores_gemma":[0.00044177522,0.00010675848,0.00005183806,0.00012529084,0.00009504676,0.000013829935,0.00004976686,0.00012868918,0.0000028717504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035436405,0.00002195168,0.009281997,0.0001354277,0.000050678333,0.0000018926389,0.000250709,0.00026024407,0.9699578,0.00035718383,0.00054046366,0.018787265],"study_design_scores_gemma":[0.002169884,0.0007876519,0.15155984,0.00010590206,0.00005202924,0.000008212642,0.0001657275,0.0009791788,0.7897368,0.0014638931,0.05243479,0.00053610245],"about_ca_topic_score_codex":0.00042848318,"about_ca_topic_score_gemma":0.00023616501,"teacher_disagreement_score":0.18022104,"about_ca_system_score_codex":0.000040616884,"about_ca_system_score_gemma":0.00046524,"threshold_uncertainty_score":0.43534848},"labels":[],"label_agreement":null},{"id":"W3047245360","doi":"10.1158/1538-7445.pedca19-b24","title":"Abstract B24: Dysregulated Transcription Drives Splicing Defect in Ewing Sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA splicing; Biology; RNA polymerase II; Alternative splicing; Phenotype; Pediatric cancer; Transcription (linguistics); Genetics; Cell biology; Cancer; RNA; Gene; Gene isoform; Gene expression; Promoter","score_opus":0.08672364914761188,"score_gpt":0.3787164289620253,"score_spread":0.2919927798144134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047245360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356556,0.0035566774,0.00024204754,0.0014454103,0.00003932191,0.00021790105,0.000011365252,0.000011748988,0.0009099961],"genre_scores_gemma":[0.9982308,0.000995966,0.00004850049,0.00016301949,0.00024756798,0.000097481614,0.000040752784,0.00002119191,0.00015468034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888206,0.00007810786,0.00015954702,0.0003584991,0.00020293456,0.00031885545],"domain_scores_gemma":[0.9995647,0.0000108250315,0.000023367693,0.00020273191,0.00009614809,0.00010219463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029460122,0.00008843835,0.00009960168,0.000068420166,0.00009792766,0.000039345003,0.00019848754,0.00009623148,0.000120669014],"category_scores_gemma":[0.0000436378,0.00008817617,0.0000656309,0.00032192605,0.00007652301,0.000007653343,0.000040085026,0.00023843317,0.00001686966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000979786,0.000020117079,0.0019503224,0.00003673287,0.000018113311,0.0000036239915,0.00026491258,0.00045078385,0.9834848,0.00005298431,0.0011713508,0.012448273],"study_design_scores_gemma":[0.0008976327,0.00016573726,0.07033282,0.00007028382,0.000006715079,0.0000016693149,0.00035853937,0.0003902153,0.890655,0.00007634378,0.036824435,0.0002206208],"about_ca_topic_score_codex":0.00031151678,"about_ca_topic_score_gemma":0.00020133515,"teacher_disagreement_score":0.09282982,"about_ca_system_score_codex":0.000062170824,"about_ca_system_score_gemma":0.00013982155,"threshold_uncertainty_score":0.359572},"labels":[],"label_agreement":null},{"id":"W3047248304","doi":"10.1158/1538-7445.pedca19-a37","title":"Abstract A37: Unique gene fusions inform targeted therapeutic strategies across extremely rare, non-CNS pediatric solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Fusion gene; Medicine; Cancer; Biology; Gene; Internal medicine; Genetics","score_opus":0.05576901238559525,"score_gpt":0.3817108859885395,"score_spread":0.32594187360294424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047248304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98866224,0.006743276,0.0001785993,0.0010131053,0.0001511121,0.00040336535,0.00011562535,0.000031264983,0.0027013998],"genre_scores_gemma":[0.98582983,0.011871699,0.000033699635,0.0004567089,0.00090000377,0.00013958539,0.000118968484,0.00004312772,0.0006063658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979102,0.000060547613,0.00030944232,0.0004763106,0.0004547335,0.0007887602],"domain_scores_gemma":[0.99888927,0.000023822846,0.00008387694,0.00031587883,0.000344657,0.00034249263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030855383,0.00021962106,0.00021626877,0.000070759685,0.00034609606,0.00012174906,0.0005120128,0.0002791338,0.00026045842],"category_scores_gemma":[0.00004490861,0.00017864093,0.00013002827,0.000597437,0.00022400668,0.00001957117,0.00024262487,0.00068570685,0.0000573798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031036438,0.00003389602,0.00080514216,0.00012468672,0.000104333725,0.00003924423,0.00065407855,0.0016597643,0.98743385,0.000025225976,0.005183371,0.0036260427],"study_design_scores_gemma":[0.0014570516,0.00076910615,0.018809408,0.000059009348,0.000030031622,0.000013319899,0.002265621,0.00022887868,0.93933004,0.00020592425,0.036178056,0.0006535304],"about_ca_topic_score_codex":0.00037406475,"about_ca_topic_score_gemma":0.00011221426,"teacher_disagreement_score":0.048103787,"about_ca_system_score_codex":0.000074394426,"about_ca_system_score_gemma":0.0014162145,"threshold_uncertainty_score":0.7284765},"labels":[],"label_agreement":null},{"id":"W3047252135","doi":"10.1158/1538-7445.pedca19-b12","title":"Abstract B12: PAX3 translocations co-opt super enhancers and intrinsically disordered fusion partners in rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enhancer; CTCF; PAX3; Alveolar rhabdomyosarcoma; Fusion gene; Biology; Cohesin; Genetics; Chromosomal translocation; Transcription factor; Computational biology; Fusion transcript; Chromatin; Cancer research; Gene; Rhabdomyosarcoma; Medicine; Sarcoma","score_opus":0.09029470034075517,"score_gpt":0.3680409796434182,"score_spread":0.27774627930266305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047252135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96242243,0.00054217316,0.0000025390873,0.035706695,0.000024930678,0.00031364016,0.000063188905,0.000023436109,0.0009009516],"genre_scores_gemma":[0.9983501,0.0010097816,0.00002541277,0.00022285189,0.00018339175,0.000111509435,0.00004283502,0.0000013862361,0.000052734013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987554,0.00009165968,0.0001823302,0.0003340721,0.00030123125,0.00033532083],"domain_scores_gemma":[0.9994062,0.00024326357,0.000013656283,0.000047108933,0.000079414065,0.00021034169],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021326938,0.00009266115,0.00012915747,0.000020172458,0.00023509796,0.000066326415,0.00019166652,0.00007409723,0.0017168834],"category_scores_gemma":[0.000079318284,0.00004290825,0.00003610904,0.00059229013,0.0001488471,0.00008125134,0.00005410467,0.00027192177,0.000039825496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071986375,0.000073363524,0.012033479,0.000018299204,0.0000075621815,0.0000037252787,0.0011465735,0.000023234788,0.8952298,0.0002593858,0.00061476784,0.09051782],"study_design_scores_gemma":[0.000796353,0.00037249035,0.9164733,0.00006235134,0.00000652666,0.0000015939852,0.0017449266,0.00028211297,0.02374762,0.0009026925,0.055306982,0.000303033],"about_ca_topic_score_codex":0.0011742264,"about_ca_topic_score_gemma":0.005557511,"teacher_disagreement_score":0.90443987,"about_ca_system_score_codex":0.00004122935,"about_ca_system_score_gemma":0.0000614973,"threshold_uncertainty_score":0.9991957},"labels":[],"label_agreement":null},{"id":"W3047253554","doi":"10.1158/1538-7445.pedca19-a60","title":"Abstract A60: Transcriptional profile of CD56negCD16pos Natural Killer cells within endemic Burkitt lymphoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perforin; Biology; Immunosurveillance; Interleukin 21; Immunology; CD16; NK-92; Lymphokine-activated killer cell; Lymphoma; Natural killer cell; Interleukin 12; Cancer research; Virology; CD8; Cytotoxic T cell; Immune system; CD3; Genetics","score_opus":0.054577857414948396,"score_gpt":0.3273331956808409,"score_spread":0.2727553382658925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047253554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778656,0.0065248427,0.000028180353,0.0016424455,0.008740586,0.00049149647,0.000027245043,0.00007698827,0.0046026125],"genre_scores_gemma":[0.97653806,0.00022983765,0.000018882458,0.0003187223,0.00012895442,0.00007477261,0.00010347839,0.00002128176,0.022566011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985839,0.00019833462,0.00035681544,0.00032799292,0.00015035947,0.00038255582],"domain_scores_gemma":[0.99923354,0.00012083204,0.00009242457,0.00017476521,0.00033385897,0.000044572735],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034391083,0.00013824132,0.00021926413,0.00013596444,0.00017477639,0.00001679036,0.00026816205,0.00019870777,0.0140599],"category_scores_gemma":[0.00007708227,0.00012142642,0.00011749154,0.00027728936,0.00020215246,0.00015692186,0.000050257906,0.00074149057,0.0014113312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009929376,0.00007372032,0.00009697297,0.00007119954,0.00010507289,0.0000025318209,0.0010837473,0.000017264656,0.90204066,0.00031755262,0.09324808,0.0019502885],"study_design_scores_gemma":[0.0011933196,0.00016438843,0.0029250742,0.00004644727,0.000009393011,0.000008496675,0.0006234693,0.000032241467,0.8140639,0.000017172715,0.18079504,0.00012106855],"about_ca_topic_score_codex":0.00036897697,"about_ca_topic_score_gemma":0.0000125156375,"teacher_disagreement_score":0.08797674,"about_ca_system_score_codex":0.00013677203,"about_ca_system_score_gemma":0.00029886706,"threshold_uncertainty_score":0.99936616},"labels":[],"label_agreement":null},{"id":"W3047254663","doi":"10.1158/1538-7445.pedca19-a43","title":"Abstract A43: Effects of transcriptional dysregulation on the DNA damage response in Ewing’s sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA damage; FLI1; Gene knockdown; Cancer research; Biology; Sarcoma; DNA repair; DNA; Transcription factor; Molecular biology; Cell biology; Genetics; Cell culture; Medicine; Gene; Pathology","score_opus":0.12130013534749597,"score_gpt":0.3997153031449108,"score_spread":0.2784151677974149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047254663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96531475,0.00092607643,0.0000016146573,0.0324844,0.00003733562,0.00068641495,0.000009747292,0.000010580957,0.00052906055],"genre_scores_gemma":[0.99888927,0.00009957786,0.000012538985,0.0005955465,0.00009426605,0.00023359174,0.0000064559335,0.00001480866,0.000053958996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851215,0.00027510416,0.00016613657,0.00020524068,0.00062003447,0.00022135985],"domain_scores_gemma":[0.998212,0.001368765,0.000025147569,0.00020210592,0.00009068699,0.00010132581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068301667,0.00008239428,0.0001665649,0.00012998671,0.000058434813,0.00001261443,0.00010093259,0.00004882226,0.00033953227],"category_scores_gemma":[0.0004434357,0.000054434975,0.00006656464,0.0003962569,0.00010566452,0.00003734127,0.000019132644,0.00030125494,0.0000295784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012444155,0.00095387484,0.06258859,0.0004361369,0.00011753247,0.00043325414,0.002605668,0.00007131801,0.9006407,0.0026067942,0.0038939614,0.013208011],"study_design_scores_gemma":[0.0015964654,0.00050021644,0.85273564,0.00032614276,0.000010484225,9.124997e-7,0.00009591845,0.00005967284,0.1433664,0.00008936831,0.0011806948,0.000038102462],"about_ca_topic_score_codex":0.00013904282,"about_ca_topic_score_gemma":0.000016271024,"teacher_disagreement_score":0.790147,"about_ca_system_score_codex":0.00020189398,"about_ca_system_score_gemma":0.00019807632,"threshold_uncertainty_score":0.37176403},"labels":[],"label_agreement":null},{"id":"W3047263629","doi":"10.1158/1538-7445.pedca19-b50","title":"Abstract B50: Targeting EWS/FLI fusion oncoprotein stability/degradation in Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcription factor; Fusion protein; Cancer research; Carcinogenesis; Biology; Druggability; Protein degradation; Computational biology; Cancer; Genetics; Cell biology; Gene","score_opus":0.09127641192772956,"score_gpt":0.3712006484416381,"score_spread":0.2799242365139085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047263629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993294,0.0014286666,0.00018609017,0.0032937229,0.00008126496,0.0005323257,0.000015499054,0.000018258823,0.0011501586],"genre_scores_gemma":[0.99825686,0.0003049437,0.00030194691,0.0002306154,0.0004867883,0.00013044594,0.00013216543,0.000023525425,0.0001326947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982264,0.0001976683,0.00028880368,0.00047668384,0.00041656874,0.00039388117],"domain_scores_gemma":[0.9993572,0.000026145224,0.00005577718,0.00023036258,0.00017488177,0.00015558387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009815954,0.00011943229,0.00012752057,0.00008083789,0.00013951596,0.00005486036,0.00025135657,0.0001356545,0.0003232063],"category_scores_gemma":[0.0006931464,0.00011775522,0.0000525738,0.00038723712,0.000090026595,0.000016756445,0.0001989411,0.0004062099,0.000035623383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013898895,0.00003535668,0.0029799852,0.000062646155,0.0000054366233,0.000004137288,0.00016190458,0.00002389813,0.9771537,0.000025404766,0.0032210373,0.0161875],"study_design_scores_gemma":[0.0005009837,0.00013821681,0.0027898091,0.00005045019,9.904995e-7,3.4681813e-7,0.00034684245,0.00014471583,0.9537127,0.00004265894,0.04213086,0.00014142714],"about_ca_topic_score_codex":0.0004859548,"about_ca_topic_score_gemma":0.00017038245,"teacher_disagreement_score":0.038909823,"about_ca_system_score_codex":0.00011285494,"about_ca_system_score_gemma":0.0002702922,"threshold_uncertainty_score":0.48019186},"labels":[],"label_agreement":null},{"id":"W3047268757","doi":"10.1158/1538-7445.pedca19-a42","title":"Abstract A42: EphB2 a potential therapeutic target for pediatric medulloblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Erythropoietin-producing hepatocellular (Eph) receptor; Cancer research; Downregulation and upregulation; Receptor; Cancer; Medicine; Radiation therapy; Pediatric cancer; Small hairpin RNA; Flow cytometry; Biology; Oncology; Cell culture; Internal medicine; Immunology; Gene; Receptor tyrosine kinase; Genetics; Gene knockdown","score_opus":0.07170493754058471,"score_gpt":0.4032688553866594,"score_spread":0.3315639178460747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047268757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575985,0.006690617,0.0021865722,0.0039186454,0.00010980911,0.0006859217,0.00018358033,0.000021746533,0.00044325335],"genre_scores_gemma":[0.9946065,0.0012051566,0.00015725479,0.00036517816,0.0026587965,0.00036807635,0.00008516377,0.00005044832,0.0005034027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979693,0.00009569663,0.00018103825,0.000530271,0.0005139644,0.000709693],"domain_scores_gemma":[0.9989929,0.000053725056,0.000034958488,0.00027103667,0.00032688768,0.00032046225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004385323,0.00014468584,0.000151521,0.00007479619,0.00022497347,0.000065390996,0.00046270964,0.00015506241,0.0005130112],"category_scores_gemma":[0.00019105326,0.00013136618,0.00014449736,0.00029113315,0.0001315393,0.000006328515,0.00020224134,0.00030985466,0.00008496368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076751015,0.00006271965,0.00071943866,0.00015916738,0.000095592004,0.000018012543,0.000057212503,0.00011890303,0.962874,0.00003616044,0.027364658,0.0077266167],"study_design_scores_gemma":[0.0017558952,0.0015350032,0.0016708925,0.000014300936,0.00002780139,0.0000026076752,0.0002461985,0.0005389391,0.7704018,0.00028555936,0.22311257,0.00040842977],"about_ca_topic_score_codex":0.000044031684,"about_ca_topic_score_gemma":0.000011179031,"teacher_disagreement_score":0.19574791,"about_ca_system_score_codex":0.000032286618,"about_ca_system_score_gemma":0.0005452829,"threshold_uncertainty_score":0.56171125},"labels":[],"label_agreement":null},{"id":"W3047269236","doi":"10.1158/1538-7445.pedca19-a65","title":"Abstract A65: Alveolar soft part sarcoma in children and adolescents: A single-institute retrospective analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alveolar soft part sarcoma; Sarcoma; Retrospective cohort study; Head and neck; Soft tissue; Single Center; Soft tissue sarcoma; Surgery; Chemotherapy; Progressive disease; Pathology","score_opus":0.06840670930888404,"score_gpt":0.3726456551651798,"score_spread":0.30423894585629574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047269236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960936,0.0048108976,0.0000063737994,0.004566946,0.000027062355,0.00061839336,0.00005692497,0.000031313793,0.00027274227],"genre_scores_gemma":[0.9979991,0.0010598052,0.000037634116,0.00044875577,0.00023826584,0.00012442034,0.000045472418,0.00002032946,0.000026256756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810594,0.00006518436,0.00023015896,0.00055779016,0.0005932884,0.00044763327],"domain_scores_gemma":[0.9991558,0.000040921223,0.000038341208,0.00026439174,0.00015606706,0.00034445472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028736223,0.0001515365,0.00042126214,0.0003129644,0.00009665855,0.00005491655,0.000110846835,0.000078931036,0.0002588604],"category_scores_gemma":[0.0001866545,0.00012911524,0.00012168498,0.0013947005,0.00019384132,0.0001156542,0.00010081241,0.00048991345,0.000037220692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019366072,0.00048312586,0.987512,0.0000462868,0.00064913026,0.00019844378,0.00025342446,0.000011774357,0.0008754563,0.0000262786,0.00089553127,0.0088548865],"study_design_scores_gemma":[0.0021278965,0.0002028912,0.9945982,0.00023886996,0.00022120324,0.0000060706634,0.000060282637,0.00004646671,0.0014787419,0.000027395035,0.0008823985,0.00010955953],"about_ca_topic_score_codex":0.0015647766,"about_ca_topic_score_gemma":0.000652114,"teacher_disagreement_score":0.008745328,"about_ca_system_score_codex":0.00046483858,"about_ca_system_score_gemma":0.00014961722,"threshold_uncertainty_score":0.5265167},"labels":[],"label_agreement":null},{"id":"W3047276503","doi":"10.1158/1538-7445.pedca19-ia30","title":"Abstract IA30: Using single-cell, high-dimensional approaches to unravel tumor heterogeneity in pediatric cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mass cytometry; Bone marrow; Cancer; Leukemia; B cell; Oncology; Immunology; Cancer research; Internal medicine; Antibody; Biology; Phenotype","score_opus":0.4101916416728193,"score_gpt":0.4161850809966296,"score_spread":0.005993439323810301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047276503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98977953,0.0024117583,0.000019536656,0.0054633943,0.00014401622,0.0013879666,0.00006445495,0.000045892048,0.00068343757],"genre_scores_gemma":[0.99587715,0.00021058443,0.0004564315,0.0008344467,0.0016068773,0.000304265,0.000015613894,0.000103268896,0.0005913654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527115,0.00022378525,0.00043941732,0.00093796774,0.0018949073,0.0012327785],"domain_scores_gemma":[0.9979594,0.00023096542,0.00005920992,0.0004576413,0.00033384384,0.0009589462],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011272009,0.00027097456,0.0005086248,0.0005964487,0.00016771336,0.0000849629,0.0003917117,0.00013925048,0.0044354727],"category_scores_gemma":[0.00020734157,0.00025434163,0.00012315375,0.0021483912,0.00017711849,0.00011505261,0.00038273673,0.001368363,0.00014721883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021487053,0.0004589585,0.05056583,0.00079050043,0.000053132615,0.00037510908,0.0006133015,0.0039194394,0.9324367,0.000013102566,0.002753415,0.0058718123],"study_design_scores_gemma":[0.0071332036,0.0012957703,0.15466589,0.0004136628,0.00007639503,0.00003285897,0.00035789656,0.0047895187,0.824271,0.000062297455,0.0060068583,0.0008945923],"about_ca_topic_score_codex":0.005731104,"about_ca_topic_score_gemma":0.00088723784,"teacher_disagreement_score":0.10816564,"about_ca_system_score_codex":0.0014370969,"about_ca_system_score_gemma":0.0017901246,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W3047285039","doi":"10.1158/1538-7445.pedca19-b55","title":"Abstract B55: MYCN promotes m6a-dependent translation of eEF2K mRNA during adaptation to ER stress","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Unfolded protein response; Neuroblastoma; Tunicamycin; Protein biosynthesis; Translation (biology); EIF4EBP1; Integrated stress response; Cycloheximide; Biology; Messenger RNA; Gene; Cell biology; Cancer research; Molecular biology; Genetics; Cell culture","score_opus":0.15637359321971467,"score_gpt":0.4210944747920114,"score_spread":0.26472088157229673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047285039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287885,0.00034361583,0.000038129707,0.004581676,0.000030016452,0.0011456602,0.00008218741,0.000034241864,0.0008656193],"genre_scores_gemma":[0.9989441,0.00017707862,0.0001673484,0.0000415695,0.00016056724,0.00016413341,0.000020210344,0.000030532556,0.00029445242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977197,0.0000810517,0.00022901864,0.00035076242,0.0011846508,0.00043481358],"domain_scores_gemma":[0.9988574,0.00009744559,0.000035908768,0.00020117576,0.00034624667,0.0004618515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002129081,0.00011098319,0.00020061787,0.00020943426,0.00009209961,0.000027972723,0.00013035862,0.000051395207,0.00056943466],"category_scores_gemma":[0.00017338328,0.000096166026,0.000058779162,0.0004853182,0.000060763065,0.00012208591,0.000050425584,0.0003773802,0.000109539484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027588368,0.0002915916,0.0048091854,0.001018734,0.0001289567,0.00025211868,0.002701581,0.00035419338,0.9537902,0.000011415988,0.00024812293,0.033635084],"study_design_scores_gemma":[0.0025645196,0.0009962732,0.10139517,0.00037553895,0.00001985174,0.0000045751844,0.00041190075,0.0003208513,0.8934973,0.000025147563,0.0002894762,0.0000994094],"about_ca_topic_score_codex":0.0004890612,"about_ca_topic_score_gemma":0.00019944496,"teacher_disagreement_score":0.09658598,"about_ca_system_score_codex":0.0001538337,"about_ca_system_score_gemma":0.00030990381,"threshold_uncertainty_score":0.62349105},"labels":[],"label_agreement":null},{"id":"W3047293352","doi":"10.1158/1538-7445.pedca19-a59","title":"Abstract A59: Sequencing identifies diagnostically relevant alterations in pediatric solid tumor patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric cancer; DNA sequencing; Medicine; Osteosarcoma; Sarcoma; Medical diagnosis; Cancer; Oncology; Bioinformatics; Internal medicine; Genetics; Gene; Biology; Pathology","score_opus":0.10690951072500504,"score_gpt":0.4106831136488964,"score_spread":0.3037736029238914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047293352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009866,0.0018164634,0.0000038157787,0.0067280964,0.000096203825,0.0007023103,0.000032968095,0.000029420673,0.00049206085],"genre_scores_gemma":[0.99701643,0.0014021124,0.00007048922,0.0005668955,0.00037210993,0.00048615015,0.000033037388,0.000025016181,0.000027776046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998142,0.000057452526,0.0003191208,0.00036759936,0.0006687813,0.0004450668],"domain_scores_gemma":[0.9987102,0.00045033783,0.000037872363,0.0001920591,0.00030873698,0.00030079042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024532282,0.000117400006,0.00022970124,0.00019779656,0.00011583182,0.0000694161,0.00011112666,0.000042985517,0.00035911694],"category_scores_gemma":[0.0014351577,0.00009878724,0.00006133935,0.0005584487,0.00006354282,0.00010955543,0.00008411687,0.00042960307,0.0002623323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016916878,0.00062426017,0.98719263,0.00037437514,0.000039456656,0.0011393707,0.0014081082,0.00016690191,0.0025753172,0.00016263936,0.004184458,0.0019633067],"study_design_scores_gemma":[0.0018844346,0.00025111876,0.98700774,0.00026624944,0.000037129892,0.0000026350406,0.00019401242,0.000063845306,0.009797998,0.00020401958,0.000176748,0.00011408624],"about_ca_topic_score_codex":0.00073755917,"about_ca_topic_score_gemma":0.000263753,"teacher_disagreement_score":0.007222681,"about_ca_system_score_codex":0.0006839525,"about_ca_system_score_gemma":0.0007661189,"threshold_uncertainty_score":0.40284267},"labels":[],"label_agreement":null},{"id":"W3047298366","doi":"10.1158/1538-7445.pedca19-a64","title":"Abstract A64: Functional genomics of metastatic Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Insertional mutagenesis; FLI1; Biology; Cancer research; Metastasis; Fusion gene; Primary tumor; Sarcoma; ETS transcription factor family; Transcription factor; Transduction (biophysics); Functional genomics; Gene; Genetics; Genomics; Genome; Cancer; Medicine; Pathology","score_opus":0.27628650196824484,"score_gpt":0.4311567399186237,"score_spread":0.15487023795037885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047298366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861304,0.0048682243,0.000022543516,0.007092072,0.000050882005,0.00031699194,0.00003154563,0.00001514796,0.0014721773],"genre_scores_gemma":[0.9984577,0.00046266062,0.00030013474,0.00036802134,0.00020318774,0.000098146316,0.0000177056,0.000018523024,0.00007393503],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988122,0.000036286525,0.00018486909,0.00020682877,0.000513464,0.00024636448],"domain_scores_gemma":[0.9992008,0.00021403328,0.000032478612,0.00015648644,0.00019742407,0.00019874668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000246685,0.00007563353,0.00021436653,0.000084166044,0.00006116664,0.000012462552,0.00007208179,0.00002489322,0.0016304392],"category_scores_gemma":[0.000117733514,0.00006127279,0.0000846957,0.00026612025,0.00008852283,0.000037012807,0.000052692012,0.00023069179,0.00010787229],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00236012,0.0018784552,0.27389356,0.0016663821,0.001812152,0.0010259236,0.0025705907,0.00033563797,0.46918884,0.002248501,0.05162051,0.19139934],"study_design_scores_gemma":[0.0046161027,0.00064092595,0.7424437,0.00025591246,0.00017470027,0.000025406582,0.0009421347,0.00028992558,0.20829503,0.00035553525,0.041777365,0.00018327955],"about_ca_topic_score_codex":0.00023490936,"about_ca_topic_score_gemma":0.000011116604,"teacher_disagreement_score":0.46855012,"about_ca_system_score_codex":0.00019154466,"about_ca_system_score_gemma":0.00037978825,"threshold_uncertainty_score":0.9992822},"labels":[],"label_agreement":null},{"id":"W3047299246","doi":"10.1158/1538-7445.pedca19-ia04","title":"Abstract IA04: New approaches to study cancer predisposition syndromes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychosocial; Cancer; Medical diagnosis; Family medicine; Clinical trial; MEDLINE; Psychiatry; Pathology; Internal medicine","score_opus":0.4870980218394449,"score_gpt":0.4735744961807096,"score_spread":0.01352352565873527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047299246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8701451,0.0024097667,0.00006128098,0.12348875,0.000199597,0.0023857232,0.00006005097,0.00013966655,0.0011100632],"genre_scores_gemma":[0.99309784,0.00017374234,0.00020058834,0.0026768337,0.0021947988,0.000689608,0.000018553701,0.00007296045,0.0008750913],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9960047,0.00021904333,0.0004391609,0.0008486399,0.0017765866,0.000711841],"domain_scores_gemma":[0.99779284,0.00016460218,0.00006499232,0.0005398661,0.00016888381,0.001268845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010190818,0.0002409063,0.0005222174,0.00020291828,0.00020211858,0.00009774837,0.00039814465,0.00010569926,0.0020881344],"category_scores_gemma":[0.0002944945,0.00022559564,0.00011203212,0.0011323154,0.000094956944,0.00016422664,0.00023865992,0.0008628999,0.00028913832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008920437,0.0037004175,0.22119579,0.0038119627,0.0027082402,0.0007355063,0.17987306,0.001003088,0.027868386,0.0005716626,0.38508445,0.164527],"study_design_scores_gemma":[0.0066500087,0.003725389,0.92480654,0.0011269615,0.00023347713,0.000020324149,0.01240929,0.000098619006,0.022768067,0.0002845379,0.027074723,0.0008020552],"about_ca_topic_score_codex":0.009578535,"about_ca_topic_score_gemma":0.0013085182,"teacher_disagreement_score":0.7036108,"about_ca_system_score_codex":0.00046453354,"about_ca_system_score_gemma":0.0012922694,"threshold_uncertainty_score":0.9988241},"labels":[],"label_agreement":null},{"id":"W3047301471","doi":"10.1158/1538-7445.pedca19-a34","title":"Abstract A34: Hypoxia signaling pathway is frequently involved in pediatric osteosarcoma microenvironment, as diagnostic and prognostic biomarkers, but also as new therapeutic targets","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypoxia (environmental); Osteosarcoma; PI3K/AKT/mTOR pathway; Cancer research; Medicine; Autophagy; Signal transduction; Tumor microenvironment; Cancer; Stromal cell; Biology; Internal medicine; Apoptosis; Chemistry; Cell biology","score_opus":0.04013945347838324,"score_gpt":0.3088842102212721,"score_spread":0.2687447567428889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047301471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8465403,0.1498006,0.00001817,0.0023659568,0.00021440354,0.00081898534,0.00008555826,0.000014691799,0.00014134496],"genre_scores_gemma":[0.95308965,0.04230401,0.00008739364,0.0019592147,0.0018744237,0.00020055608,0.00007981906,0.00007100291,0.0003338986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971938,0.00019393135,0.00037596893,0.0009057015,0.00049633277,0.00083427405],"domain_scores_gemma":[0.9985962,0.00021236151,0.00010056223,0.00035273738,0.00008398019,0.0006541883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004514871,0.00031088653,0.00031126456,0.00015558481,0.00014885131,0.00010542351,0.0004018754,0.00023871483,0.0003651759],"category_scores_gemma":[0.00071278826,0.00031108485,0.00010589423,0.00037884744,0.00020489868,0.000018759853,0.00027278182,0.0004541721,0.00008736782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002776916,0.000081363505,0.021246461,0.00016285515,0.00009481093,0.00003960923,0.0004717683,0.000012576778,0.9554529,0.0000111759155,0.008683051,0.013465744],"study_design_scores_gemma":[0.0033656342,0.0007969609,0.048606098,0.00011299349,0.000094220115,0.000015592805,0.00054657005,0.000015609226,0.76385725,0.0006259637,0.1811953,0.00076783565],"about_ca_topic_score_codex":0.0019280986,"about_ca_topic_score_gemma":0.00029274123,"teacher_disagreement_score":0.19159567,"about_ca_system_score_codex":0.00007814368,"about_ca_system_score_gemma":0.0010249707,"threshold_uncertainty_score":0.99993414},"labels":[],"label_agreement":null},{"id":"W3047302402","doi":"10.1158/1538-7445.pedca19-a50","title":"Abstract A50: Targeted therapies for children and young adults with cancer: Single-patient use (SPU) experience at three large pediatric cancer programs","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Pediatric cancer; Clinical trial; Single Center; Malignancy; Pediatric oncology; Expanded access; Internal medicine; Oncology","score_opus":0.16296940530062415,"score_gpt":0.43231045057910505,"score_spread":0.2693410452784809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047302402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93777925,0.053029813,0.000009713697,0.0064875036,0.00011716345,0.0021887193,0.00028134245,0.00005516095,0.00005133408],"genre_scores_gemma":[0.97100914,0.025284186,0.00012416829,0.0006291404,0.00071383454,0.0020897465,0.000032207325,0.000045140365,0.00007245762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975825,0.000048060396,0.00022831964,0.0005935473,0.00072801777,0.0008195407],"domain_scores_gemma":[0.99861455,0.00021313078,0.00010390331,0.00017590827,0.00044363656,0.00044884242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020107183,0.00021924236,0.0003218766,0.000054158812,0.00049009814,0.00010816275,0.00014923383,0.00007563665,0.00047282624],"category_scores_gemma":[0.00015992935,0.00015015672,0.00005461999,0.00049931934,0.00023563832,0.0002813603,0.00018420808,0.00046718793,0.000004198318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075108875,0.00026159195,0.8964136,0.0004993749,0.00031759692,0.000025468353,0.011622764,0.0000057473985,0.0030167436,0.000008572293,0.0037506944,0.07656695],"study_design_scores_gemma":[0.0087819835,0.0034863113,0.8584532,0.0004957987,0.00030620492,0.000014255065,0.0026673998,0.00037146363,0.009965319,0.000011855035,0.11478886,0.0006573179],"about_ca_topic_score_codex":0.006026193,"about_ca_topic_score_gemma":0.0056966273,"teacher_disagreement_score":0.11103816,"about_ca_system_score_codex":0.00026709118,"about_ca_system_score_gemma":0.00020500367,"threshold_uncertainty_score":0.91098416},"labels":[],"label_agreement":null},{"id":"W3047311809","doi":"10.1158/1538-7445.pedca19-ia26","title":"Abstract IA26: The need for evidence-based survivorship care","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survivorship curve; Medicine; Psychosocial; Psychological intervention; Cancer; Quality of life (healthcare); Multidisciplinary approach; Health care; Guideline; Cancer survivorship; Family medicine; Disease; Gerontology; Nursing; Psychiatry; Pathology; Internal medicine","score_opus":0.37547346851289665,"score_gpt":0.4869988608700374,"score_spread":0.11152539235714076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047311809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6514212,0.016261218,0.00021113224,0.32757312,0.00037212085,0.0028477602,0.00012234977,0.00014780732,0.0010433244],"genre_scores_gemma":[0.98503864,0.0003035253,0.00013902126,0.011116361,0.0023217278,0.00074980356,0.000031909647,0.000069099624,0.00022993627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632865,0.00036041898,0.0003980467,0.000591735,0.0015572765,0.0007638627],"domain_scores_gemma":[0.9947885,0.0028405162,0.00008457658,0.0006996448,0.0010642573,0.0005224768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024654355,0.00020627829,0.00040506868,0.00011194371,0.00037542346,0.000108047476,0.0006024236,0.00013493313,0.0006627128],"category_scores_gemma":[0.0034931814,0.00015021862,0.00024537768,0.0008251189,0.0003430928,0.00013635533,0.00010615884,0.00094579905,0.000110384375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02662583,0.00054792623,0.12969351,0.029121095,0.0010075397,0.000183706,0.094946004,0.0008482194,0.086268015,0.002295215,0.547178,0.08128497],"study_design_scores_gemma":[0.015465086,0.004927726,0.22282691,0.009309686,0.00041116212,0.000010042766,0.057639077,0.001124063,0.18035935,0.0007812016,0.5054358,0.0017098717],"about_ca_topic_score_codex":0.005413687,"about_ca_topic_score_gemma":0.0017590828,"teacher_disagreement_score":0.33361745,"about_ca_system_score_codex":0.00038265332,"about_ca_system_score_gemma":0.0021211829,"threshold_uncertainty_score":0.81839114},"labels":[],"label_agreement":null},{"id":"W3047312634","doi":"10.1158/1538-7445.pedca19-b04","title":"Abstract B04: Three distinct subgroups of Wilms’ tumors with novel molecular features and important clinical implications are defined by genome-wide DNA methylation profiles","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"DNA methylation; Methylation; Epigenetics; Cohort; Wilms' tumor; Biology; Cancer; Gene; Oncology; Genome; Genetics; Bioinformatics; Medicine; Internal medicine; Gene expression","score_opus":0.04352354114065894,"score_gpt":0.34853935728892016,"score_spread":0.30501581614826123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047312634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876765,0.007217737,0.0005711553,0.0036553666,0.000017036315,0.0003879029,0.00028165983,0.000009138081,0.00018351566],"genre_scores_gemma":[0.99813104,0.0010961457,0.00015161857,0.00013943567,0.0000979009,0.00010466194,0.00021200647,0.000027124519,0.00004008231],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859655,0.000050650866,0.00032463617,0.00046754748,0.00028569525,0.0002749055],"domain_scores_gemma":[0.9990789,0.00005676622,0.00017140292,0.00024720625,0.00024182162,0.0002038695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003546384,0.00013927271,0.00021341041,0.000035029727,0.000099510304,0.000026596823,0.0002201463,0.00016115718,0.000011991653],"category_scores_gemma":[0.00019512684,0.00010290545,0.00006781575,0.00023966245,0.00035447074,0.000006101574,0.0001037368,0.0003504015,8.0946444e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034287397,0.000052042153,0.09777201,0.000094756,0.0001401232,0.000005337796,0.0000252362,0.00005536283,0.8990537,0.00008648761,0.0015715206,0.00080053305],"study_design_scores_gemma":[0.0008396746,0.00050615694,0.639605,0.000066421744,0.000033559052,0.0000067148367,0.000065527274,0.000014553013,0.3560066,0.00015006885,0.002497983,0.0002077676],"about_ca_topic_score_codex":0.00015592971,"about_ca_topic_score_gemma":0.00018432803,"teacher_disagreement_score":0.54304713,"about_ca_system_score_codex":0.000025186391,"about_ca_system_score_gemma":0.00026320433,"threshold_uncertainty_score":0.41963625},"labels":[],"label_agreement":null},{"id":"W3047338102","doi":"10.1158/1538-7445.pedca19-a70","title":"Abstract A70: Aqueous humor is superior to blood as a liquid biopsy for retinoblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoblastoma; Medicine; Liquid biopsy; Biopsy; Cancer; Pathology; Internal medicine; Chemistry","score_opus":0.09596430396411823,"score_gpt":0.4458081419773217,"score_spread":0.3498438380132035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047338102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576193,0.0010164459,0.000005621191,0.03800592,0.00010118974,0.0013768718,0.00008664395,0.000053440515,0.0017345612],"genre_scores_gemma":[0.99234265,0.00011412601,0.00040443594,0.003432072,0.000502553,0.0007598433,0.000016696304,0.00004350949,0.0023841395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835354,0.00004232629,0.00018099698,0.00046555078,0.00040044755,0.0005571521],"domain_scores_gemma":[0.99873996,0.0001230393,0.000021948757,0.00027629978,0.00029422902,0.0005445073],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025565017,0.00013597787,0.0002845401,0.000111431604,0.00018169598,0.000022720858,0.00016098385,0.00014077546,0.002073987],"category_scores_gemma":[0.00041153588,0.000116058436,0.00011107394,0.0003649365,0.00012497751,0.00003838501,0.00008838445,0.00035349737,0.0009253543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026100872,0.001150718,0.008935282,0.0010044164,0.0012580104,0.0049631875,0.0076740086,0.000002727906,0.87756985,0.00015340073,0.052702222,0.018485282],"study_design_scores_gemma":[0.008531983,0.01814414,0.00930636,0.0003351961,0.00025434958,0.00020954102,0.0007183369,0.00001757353,0.78085893,0.00008701622,0.18121885,0.0003177267],"about_ca_topic_score_codex":0.00024343104,"about_ca_topic_score_gemma":0.000026501526,"teacher_disagreement_score":0.12851663,"about_ca_system_score_codex":0.0001468074,"about_ca_system_score_gemma":0.00067010935,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W3047338291","doi":"10.1158/1538-7445.pedca19-a38","title":"Abstract A38: Validation of potential therapies for treatment of fatal pediatric brain tumors DIPG and AT/RT using a novel rapid intracranial model in zebrafish","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Glioma; Medicine; Atypical teratoid rhabdoid tumor; Cisplatin; Apoptosis; Pathology; Biology; Internal medicine; Medulloblastoma; Chemotherapy","score_opus":0.09994247141706654,"score_gpt":0.369490882238782,"score_spread":0.2695484108217155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047338291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460715,0.0033924785,0.00062763056,0.000594829,0.000061170605,0.00044856573,0.0002483033,0.0000061550036,0.000013736611],"genre_scores_gemma":[0.9991751,0.00043289587,0.00014461645,0.000018631807,0.00004868409,0.000046694036,0.000034094646,0.00001408496,0.00008520318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990639,0.00012437662,0.00028706985,0.00020487697,0.00005971301,0.000260049],"domain_scores_gemma":[0.999493,0.0001954829,0.00008037231,0.00009510077,0.00011628835,0.0000197465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002966397,0.00010008372,0.00026303972,0.00017997132,0.00008045198,0.0000085033025,0.00010616446,0.00009125643,0.00017440695],"category_scores_gemma":[0.00009101425,0.000086421445,0.00006592685,0.00014428825,0.00019096807,0.000069717105,0.000058372632,0.00010316418,0.0000021470448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004878775,0.00015967655,0.00035027976,0.00010234223,0.00007025189,0.0000017323131,0.0024621177,0.00041604007,0.9889921,0.00003227758,0.00009782053,0.0024366132],"study_design_scores_gemma":[0.0049869446,0.0013959315,0.0054411483,0.000037684767,0.00002500956,0.000008838161,0.00055993476,0.001829947,0.9853123,0.000029753122,0.0002544175,0.00011813704],"about_ca_topic_score_codex":0.0004341553,"about_ca_topic_score_gemma":0.000025664238,"teacher_disagreement_score":0.0050908686,"about_ca_system_score_codex":0.00010596184,"about_ca_system_score_gemma":0.00023020463,"threshold_uncertainty_score":0.35241643},"labels":[],"label_agreement":null},{"id":"W3047350363","doi":"10.1158/1538-7445.pedca19-a36","title":"Abstract A36: Targeting anaplastic lymphoma kinase in neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anaplastic lymphoma kinase; Neuroblastoma; Crizotinib; Cancer research; Neural crest; Tyrosine kinase; Cancer; Carcinogenesis; Receptor tyrosine kinase; ALK inhibitor; Population; Biology; Medicine; Kinase; Lung cancer; Signal transduction; Internal medicine; Genetics; Embryo","score_opus":0.08672634435975647,"score_gpt":0.39709273167098896,"score_spread":0.3103663873112325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047350363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905289,0.0005193747,0.000003830327,0.005826846,0.00006338723,0.000630237,0.000022221375,0.00007017415,0.0023350548],"genre_scores_gemma":[0.99839026,0.00026895633,0.000052461808,0.00052050187,0.0002927159,0.00016740555,0.000013515603,0.000054637192,0.00023956799],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99693304,0.00015024925,0.00028053272,0.00058931997,0.0010477921,0.0009990821],"domain_scores_gemma":[0.99837327,0.0003062381,0.00003279935,0.00025077604,0.00020846176,0.00082843343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033075208,0.00017995949,0.0002948342,0.0003403907,0.00013188891,0.000058737245,0.00022437617,0.00007328858,0.00096082425],"category_scores_gemma":[0.0009835033,0.00015864032,0.00007866966,0.001237678,0.0001769815,0.0001296269,0.00018240622,0.0006529357,0.000648774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010246348,0.0013170438,0.03282601,0.0013291971,0.00016236793,0.025542352,0.0008423191,0.00021893119,0.8180535,0.00012088055,0.03236782,0.07697325],"study_design_scores_gemma":[0.021144701,0.0068967915,0.61616576,0.0010542276,0.000039690363,0.00009562423,0.00072555774,0.0027709783,0.31655523,0.00017594834,0.03369813,0.00067739096],"about_ca_topic_score_codex":0.00037563834,"about_ca_topic_score_gemma":0.00010371729,"teacher_disagreement_score":0.58333975,"about_ca_system_score_codex":0.00034350288,"about_ca_system_score_gemma":0.000684075,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W3047361797","doi":"10.1158/1538-7445.pedca19-b72","title":"Abstract B72: Dissecting the heterogeneity of metastatic neuroblastoma cells by single-cell RNA-seq","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bone marrow; Biology; Gene; Neuroblastoma; Transcriptome; Cancer research; Population; Metastasis; Cell; Gene expression; Intracardiac injection; In vivo; Cancer; Pathology; Cell culture; Medicine; Genetics; Internal medicine; Immunology","score_opus":0.1438687945158045,"score_gpt":0.3997206664131861,"score_spread":0.25585187189738157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047361797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936837,0.0007547249,0.000017237076,0.0030718409,0.000074701136,0.00082036504,0.00009918824,0.000036502435,0.0014417554],"genre_scores_gemma":[0.99873257,0.0001923681,0.000049213722,0.0003098847,0.00012598086,0.000093645845,0.00000946989,0.00005398842,0.00043290635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969529,0.00028002865,0.00032089357,0.00046756008,0.0012495194,0.0007291302],"domain_scores_gemma":[0.9979446,0.0005968648,0.000091126174,0.00042190327,0.0004067571,0.0005387413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460203,0.00018668691,0.00032896208,0.00010099169,0.00020309979,0.00005666907,0.0003518776,0.00004136847,0.00043038194],"category_scores_gemma":[0.00041188323,0.0001252344,0.0001468344,0.00069741055,0.0003274733,0.00008885479,0.00020110453,0.00081728096,0.00013057739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006360332,0.00041977444,0.00039839337,0.0004369728,0.000109130415,0.00028791433,0.00022777254,0.000024143681,0.98450017,0.0000022533416,0.009673112,0.0032843081],"study_design_scores_gemma":[0.0013434286,0.0013278782,0.0011458326,0.000078157296,0.00003520129,0.000010198308,0.00017850594,0.00009585129,0.9935356,0.000010525999,0.0021539142,0.00008493871],"about_ca_topic_score_codex":0.0003468903,"about_ca_topic_score_gemma":0.00004408446,"teacher_disagreement_score":0.009035376,"about_ca_system_score_codex":0.0001265909,"about_ca_system_score_gemma":0.0002941995,"threshold_uncertainty_score":0.510691},"labels":[],"label_agreement":null},{"id":"W3047362268","doi":"10.1158/1538-7445.pedca19-b06","title":"Abstract B06: Candidate differentiation stall in epithelial mesenchymal transition in H3K27M diffuse midline glioma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; Glioma; Biology; Epithelial–mesenchymal transition; Cancer research; Gene; Pathology; Medicine; Transition (genetics); Genetics","score_opus":0.035251983453925516,"score_gpt":0.34759094433535315,"score_spread":0.31233896088142765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047362268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941488,0.0008813851,0.001254112,0.0026243315,0.00008903933,0.0006717692,0.00015092177,0.000013721428,0.00016590497],"genre_scores_gemma":[0.99779075,0.001019929,0.00003389026,0.00016011017,0.00036193745,0.00023713193,0.0002909484,0.000049402253,0.000055875986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972202,0.0002928681,0.0003535113,0.0006887817,0.00070476474,0.0007398657],"domain_scores_gemma":[0.99917334,0.000027218932,0.000044916877,0.000316702,0.00018835517,0.00024947833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006116601,0.0001925057,0.00022348414,0.0003239561,0.00007608178,0.000062030784,0.00035431495,0.00027199154,0.00028292992],"category_scores_gemma":[0.00018814976,0.0002019262,0.00008322318,0.00077866163,0.000114484705,0.00001519084,0.0001634872,0.0007420735,0.000025656589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011486934,0.00015224495,0.00012172668,0.00009336383,0.000026902668,0.00010902166,0.00045587312,0.0010696943,0.9941558,0.0000257569,0.0003357746,0.002305126],"study_design_scores_gemma":[0.0038311896,0.00039122763,0.0074669123,0.000089221445,0.000005503479,0.000004074314,0.00019022253,0.0020636648,0.98335814,0.000109206776,0.0022172031,0.00027341704],"about_ca_topic_score_codex":0.0019580962,"about_ca_topic_score_gemma":0.0040922365,"teacher_disagreement_score":0.0107976645,"about_ca_system_score_codex":0.00024423,"about_ca_system_score_gemma":0.00045152003,"threshold_uncertainty_score":0.82343113},"labels":[],"label_agreement":null},{"id":"W3047376330","doi":"10.1158/1538-7445.pedca19-b36","title":"Abstract B36: A novel model of osteosarcomagenesis reveals dysregulation of oxidative phosphorylation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Cancer research; Mesenchymal stem cell; Induced pluripotent stem cell; Transcriptome; Cell biology; Autophagy; Biology; Osteoblast; Downregulation and upregulation; Medicine; Bioinformatics; Gene; Genetics; Apoptosis; Gene expression; In vitro","score_opus":0.13321387434098855,"score_gpt":0.3841243599179906,"score_spread":0.250910485577002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047376330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888245,0.0011069129,0.008376368,0.0005004197,0.000015432868,0.0002470808,0.00019161747,0.0000036307792,0.0007340345],"genre_scores_gemma":[0.9978584,0.00037242295,0.0012288764,0.000037803875,0.00007783855,0.00007016721,0.000067860856,0.000014901335,0.00027170978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990587,0.00003444238,0.00023040478,0.0002411655,0.00028646708,0.00014880195],"domain_scores_gemma":[0.99901116,0.000016205155,0.0001140912,0.00024230909,0.00055069,0.00006553221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029086063,0.00007016133,0.00012133502,0.00004624818,0.000046899113,0.0000072633857,0.00017811813,0.00008130494,0.00007874869],"category_scores_gemma":[0.00009354177,0.00006932905,0.000054308442,0.00023917768,0.00012458416,0.000007318325,0.00006372649,0.00007905763,0.0000029846547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017768347,0.000038009257,0.0005714453,0.00007201444,0.000028330975,6.081855e-8,0.00016887719,0.009391164,0.9849418,0.00028720018,0.0010429539,0.003280459],"study_design_scores_gemma":[0.0003439746,0.00010297523,0.008460251,0.000024574663,0.000007064023,1.0620542e-7,0.00010373805,0.0033220246,0.9868946,0.00011904335,0.0005497646,0.000071884766],"about_ca_topic_score_codex":0.000105179606,"about_ca_topic_score_gemma":0.000013670783,"teacher_disagreement_score":0.0090339165,"about_ca_system_score_codex":0.000027949589,"about_ca_system_score_gemma":0.00023270705,"threshold_uncertainty_score":0.28271565},"labels":[],"label_agreement":null},{"id":"W3047386356","doi":"10.1158/1538-7445.pedca19-b59","title":"Abstract B59: Cardiometabolic complications after pediatric cancer: Associations with chemotherapeutic agents and body-mass-index fluctuations","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Body mass index; Obesity; Internal medicine; Cancer; Childhood obesity; Insulin resistance; Metabolic syndrome; Pediatrics; Overweight","score_opus":0.10904025590824913,"score_gpt":0.42345873355975205,"score_spread":0.31441847765150294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047386356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9237629,0.0062562777,0.00023118108,0.06614546,0.00010057568,0.0013135015,0.00049550657,0.00012881772,0.0015657721],"genre_scores_gemma":[0.9896784,0.0036981297,0.00014183095,0.0038108812,0.0012171767,0.0010448119,0.000057153706,0.00007111175,0.00028049963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969779,0.00014792189,0.0003906302,0.0006198833,0.001261265,0.00060238724],"domain_scores_gemma":[0.9978686,0.00026948928,0.00012633855,0.0004671176,0.00067345676,0.0005949917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005435842,0.00022435086,0.0004864176,0.00031131945,0.00035856603,0.00010834034,0.00021951298,0.00011797947,0.000633456],"category_scores_gemma":[0.00019057505,0.00020922565,0.000100619545,0.0017417382,0.00022093821,0.00016941613,0.0000785757,0.00075218256,0.00007223643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003775769,0.00021275113,0.97218895,0.00076258637,0.000816891,0.000016031081,0.0044170674,0.0001466205,0.0033141908,0.00013035536,0.0125614675,0.0050555174],"study_design_scores_gemma":[0.0015489814,0.00008962066,0.9817795,0.00008376268,0.00020442044,0.000002930261,0.00033062111,0.00018410222,0.00025185858,0.00007051553,0.0152301015,0.00022359093],"about_ca_topic_score_codex":0.0024195923,"about_ca_topic_score_gemma":0.000497853,"teacher_disagreement_score":0.065915495,"about_ca_system_score_codex":0.00040507325,"about_ca_system_score_gemma":0.0014678973,"threshold_uncertainty_score":0.8531974},"labels":[],"label_agreement":null},{"id":"W3047405871","doi":"10.1158/1538-7445.pedca19-a62","title":"Abstract A62: A cerebral organoid model of pediatric glioma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ATRX; Organoid; Biology; Epigenetics; Induced pluripotent stem cell; Cancer research; Embryonic stem cell; Glioma; Cancer; Brain tumor; Pathology; Cell biology; Medicine; Mutation; Genetics; Gene","score_opus":0.0812892223524317,"score_gpt":0.36418012490106594,"score_spread":0.28289090254863425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047405871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941377,0.001736511,0.00014618541,0.0017052655,0.000033406966,0.00028887767,0.00009782162,0.000011157212,0.0018430522],"genre_scores_gemma":[0.99763805,0.00085935945,0.00013743491,0.00008900104,0.0006073552,0.000053937667,0.000029515002,0.000037871876,0.00054748566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792516,0.000088899505,0.00022517478,0.0004692926,0.0007322683,0.000559211],"domain_scores_gemma":[0.998857,0.00002499425,0.000047803896,0.00035947643,0.00041358933,0.00029713544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004403164,0.00012240905,0.00016194895,0.00012511402,0.0000856926,0.00002591691,0.00059729075,0.00020918513,0.00027177276],"category_scores_gemma":[0.00022213241,0.000117016934,0.000084895226,0.0005627199,0.00015040275,0.000006021689,0.00045354987,0.00048727053,0.000080365884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022824791,0.000047062465,0.002079368,0.00020012519,0.000030099261,0.000010062764,0.000080854654,0.0008979119,0.9806231,0.000030061976,0.015410017,0.00036305079],"study_design_scores_gemma":[0.0006324472,0.00022447562,0.0009522725,0.000008300303,0.000006884851,0.0000015421172,0.00005315159,0.0014840846,0.99491984,0.00007511584,0.0014887674,0.00015315086],"about_ca_topic_score_codex":0.00008192663,"about_ca_topic_score_gemma":0.00001689352,"teacher_disagreement_score":0.0142966695,"about_ca_system_score_codex":0.000038461647,"about_ca_system_score_gemma":0.00070752983,"threshold_uncertainty_score":0.47718123},"labels":[],"label_agreement":null},{"id":"W3047406596","doi":"10.1158/1538-7445.pedca19-a29","title":"Abstract A29: Respective role of TEAD and Smad signaling in YAP-mediated osteosarcoma tumor growth and lung metastatic development","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hippo signaling pathway; Cancer research; Osteosarcoma; Biology; Cell growth; SMAD; Context (archaeology); Gene signature; Metastasis; Cell; In vivo; Signal transduction; Cell biology; Gene; Cancer; Gene expression; Genetics","score_opus":0.0432882462142608,"score_gpt":0.33689530175750376,"score_spread":0.29360705554324296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047406596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927194,0.006556468,0.000015173386,0.00020353029,0.000011992477,0.00024884925,0.000031746815,0.0000063831535,0.00020646861],"genre_scores_gemma":[0.9992224,0.00019651958,0.00034819308,0.00006194104,0.00005435131,0.00006374422,0.000021268726,0.000019196057,0.000012398569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986894,0.0001342629,0.00023679055,0.00037647417,0.0002529612,0.0003100996],"domain_scores_gemma":[0.99945706,0.00009188004,0.000051825875,0.00009770218,0.00013803407,0.00016352224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056078326,0.000116812,0.00018923664,0.000101523176,0.00007565883,0.000024367693,0.00012699167,0.00005394617,0.000020864853],"category_scores_gemma":[0.00033319474,0.000110050314,0.00002128158,0.00023323475,0.00014599887,0.0000056378635,0.0001367302,0.00024783166,0.0000023558755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022968158,0.000026551435,0.010750544,0.00016468015,0.000047225752,0.00002188648,0.0014612827,0.000013476379,0.98609775,0.000022217391,0.000016696331,0.0011479801],"study_design_scores_gemma":[0.0006704824,0.00018017476,0.00885418,0.00009483069,0.0000062621866,0.000002947295,0.0010458076,0.00008767708,0.98851556,0.00008322872,0.0003277217,0.00013110781],"about_ca_topic_score_codex":0.00026087507,"about_ca_topic_score_gemma":0.000087726556,"teacher_disagreement_score":0.0065029995,"about_ca_system_score_codex":0.000028999466,"about_ca_system_score_gemma":0.000362688,"threshold_uncertainty_score":0.44877216},"labels":[],"label_agreement":null},{"id":"W3047410483","doi":"10.1158/1538-7445.pedca19-b67","title":"Abstract B67: EGFR as a target in pediatric solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidermal growth factor receptor; Desmoplastic small-round-cell tumor; Cancer research; Immunohistochemistry; Cancer; Epitope; Tissue microarray; Monoclonal antibody; Malignancy; Medicine; Biology; Pathology; Antibody; Immunology; Internal medicine","score_opus":0.11407814438250664,"score_gpt":0.4558578506241235,"score_spread":0.34177970624161685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047410483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515718,0.0023974653,0.0000033129318,0.013679603,0.000076580065,0.0010321337,0.000012502835,0.0000632239,0.031163383],"genre_scores_gemma":[0.9883005,0.0024572979,0.00005876785,0.0008258115,0.0015984286,0.0002854079,0.000015460024,0.00007507674,0.0063832626],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99608004,0.00016897866,0.00036178305,0.0005955006,0.0016949672,0.0010987057],"domain_scores_gemma":[0.9981866,0.00025801978,0.000037219066,0.00041070703,0.0003542608,0.0007531904],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013640282,0.00017316708,0.0004132842,0.0005221062,0.00009689969,0.00006384728,0.00040486787,0.00013389044,0.027396334],"category_scores_gemma":[0.00078136637,0.00015960618,0.00011055197,0.0020396588,0.00017841537,0.00010561967,0.00021341733,0.001907064,0.0014347631],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005354759,0.00051754515,0.17342296,0.0017095698,0.00010700963,0.0039939047,0.0042000073,0.00013958014,0.72267693,0.000209216,0.06337759,0.024290932],"study_design_scores_gemma":[0.014657892,0.003830603,0.43669343,0.00057306886,0.000049150105,0.00009887874,0.0023623814,0.0013201528,0.26894268,0.0015707371,0.26873562,0.0011654026],"about_ca_topic_score_codex":0.001795425,"about_ca_topic_score_gemma":0.00012654973,"teacher_disagreement_score":0.45373425,"about_ca_system_score_codex":0.0006013034,"about_ca_system_score_gemma":0.001986265,"threshold_uncertainty_score":0.99934274},"labels":[],"label_agreement":null},{"id":"W3047411356","doi":"10.1158/1538-7445.pedca19-a27","title":"Abstract A27: An apoptosis-based screen for targeted agents in rhabdomyosarcoma reveals potential combination therapies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apoptosis; Staurosporine; Rhabdomyosarcoma; Cancer research; High-throughput screening; Cell culture; Medicine; Pharmacology; Chemistry; Biology; Bioinformatics; Enzyme; Biochemistry; Pathology; Sarcoma; Genetics","score_opus":0.09069016641687697,"score_gpt":0.3960005971374764,"score_spread":0.3053104307205994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047411356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939465,0.0004968264,0.0007639343,0.003771006,0.000066785804,0.0007673731,0.00008218589,0.000013290163,0.00009211233],"genre_scores_gemma":[0.99779516,0.000079794256,0.0003296224,0.0006308003,0.00026217196,0.0002808071,0.000503358,0.000023030545,0.00009526363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876845,0.00014419251,0.00018381792,0.00033354198,0.0002795944,0.0002904025],"domain_scores_gemma":[0.9994009,0.000015118394,0.00004572839,0.00018471722,0.0002270823,0.00012642542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048973825,0.00009645774,0.0001078692,0.0000836236,0.00010834936,0.00004983073,0.00025118,0.000116444535,0.00011480091],"category_scores_gemma":[0.00015533574,0.00009506023,0.000055105043,0.00019449984,0.00007786702,0.000012574971,0.00004545341,0.00015055834,0.000005929164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045414767,0.00009009798,0.0010070982,0.000042679672,0.000016482529,8.636085e-7,0.0000567853,0.000087043925,0.9855628,0.00005256276,0.007835447,0.0047939774],"study_design_scores_gemma":[0.0018695544,0.0005337307,0.01222819,0.000025971161,0.0000025571615,1.14148534e-7,0.000102807135,0.0006726401,0.9723383,0.00016073693,0.011918431,0.0001469374],"about_ca_topic_score_codex":0.00014229312,"about_ca_topic_score_gemma":0.000039442966,"teacher_disagreement_score":0.013224484,"about_ca_system_score_codex":0.000039900668,"about_ca_system_score_gemma":0.00016371271,"threshold_uncertainty_score":0.38764438},"labels":[],"label_agreement":null},{"id":"W3047412501","doi":"10.1158/1538-7445.pedca19-b45","title":"Abstract B45: Therapeutic potential of splicing in RMS: SRSF2 binding modulation controls MDM2 alternative splicing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minigene; RNA splicing; Alternative splicing; Splicing factor; Biology; Exon; Exonic splicing enhancer; Genetics; Mdm2; Cell biology; Cancer research; Gene; RNA","score_opus":0.0691222251706888,"score_gpt":0.3936719226216246,"score_spread":0.32454969745093576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047412501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645215,0.0008787164,0.0011348833,0.000705144,0.00004991681,0.00046190532,0.000021107919,0.0000071944983,0.000288969],"genre_scores_gemma":[0.9986962,0.0005002274,0.000050348834,0.00010947086,0.00038438343,0.00006017412,0.000025697896,0.00002992266,0.00014354747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979745,0.00016048057,0.0003092218,0.00043587538,0.00055210333,0.0005678229],"domain_scores_gemma":[0.9992338,0.00005861688,0.00008504202,0.00022587519,0.00023440726,0.00016228884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008161784,0.00013317708,0.00022405953,0.00017874836,0.00010611435,0.000046872145,0.00033330143,0.000112353264,0.00006517643],"category_scores_gemma":[0.00018954925,0.00012602929,0.00008004102,0.00036954967,0.00012329847,0.00001615667,0.00016307861,0.00042420797,0.000011037321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004431378,0.000027959244,0.005217449,0.00007613356,0.000057368816,0.000014323212,0.00017376839,0.006054031,0.97839344,0.00006137604,0.000068127476,0.009412917],"study_design_scores_gemma":[0.001803596,0.00039307165,0.01894703,0.00016186215,0.000006344578,0.0000021392773,0.00055885984,0.018614177,0.95886993,0.000115538176,0.0003236034,0.00020383527],"about_ca_topic_score_codex":0.0016165416,"about_ca_topic_score_gemma":0.00019029355,"teacher_disagreement_score":0.019523464,"about_ca_system_score_codex":0.000093769246,"about_ca_system_score_gemma":0.00021004087,"threshold_uncertainty_score":0.5139325},"labels":[],"label_agreement":null},{"id":"W3047421844","doi":"10.1158/1538-7445.pedca19-a16","title":"Abstract A16: Genomic and immunologic characterization of a cohort of INI1-deficient pediatric cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SMARCB1; Medicine; Epithelioid sarcoma; Immunohistochemistry; Oncology; Cohort; Cancer; DNA sequencing; Internal medicine; Pathology; Gene; Biology; Genetics; Gene expression","score_opus":0.04452950193678767,"score_gpt":0.3370361737203091,"score_spread":0.2925066717835214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047421844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953212,0.0040355567,0.000046358655,0.00014397423,0.00004335787,0.00019134098,0.00007142215,0.0000042673128,0.00014248208],"genre_scores_gemma":[0.99011916,0.009551652,0.000019724464,0.000044448934,0.00015156298,0.00003520245,0.000033008062,0.00001198863,0.000033245713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991687,0.00003660527,0.00020123206,0.00023862267,0.00018460014,0.00017022518],"domain_scores_gemma":[0.9995067,0.000008179939,0.00009149201,0.00015026168,0.0001867443,0.000056633806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000239565,0.00007044819,0.00013644078,0.000045795172,0.000037996062,0.00000749783,0.0001370726,0.00008518133,0.000040567902],"category_scores_gemma":[0.000051572355,0.000066267465,0.000033992415,0.00017226169,0.00011253004,0.0000025824509,0.000105306746,0.000122008256,0.0000012897681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011387673,0.000012291896,0.01574718,0.00016593754,0.000024120714,4.1275206e-7,0.00013280798,0.00035893027,0.98150903,0.000004758152,0.00010482683,0.0018258195],"study_design_scores_gemma":[0.0006893805,0.00043921176,0.35974318,0.000041417326,0.000029345134,0.0000014910124,0.00015809324,0.0005357472,0.636056,0.000010907546,0.0021199144,0.00017531462],"about_ca_topic_score_codex":0.00024808713,"about_ca_topic_score_gemma":0.000007213731,"teacher_disagreement_score":0.34545305,"about_ca_system_score_codex":0.00004557289,"about_ca_system_score_gemma":0.00037785282,"threshold_uncertainty_score":0.2702309},"labels":[],"label_agreement":null},{"id":"W3047431181","doi":"10.1158/1538-7445.pedca19-b02","title":"Abstract B02: 5-Hydroxymethylcytosine profiles in circulating cell-free DNA are biomarkers of disease burden in children with neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Medicine; Biomarker; Pediatric cancer; Bone marrow; Epigenetics; Disease; Cell-free fetal DNA; Oncology; Cancer; Pathology; Internal medicine; Cancer research; Gene; Biology; Genetics","score_opus":0.0441606395533976,"score_gpt":0.34010845130936124,"score_spread":0.29594781175596363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047431181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288636,0.00052044913,0.0000011009398,0.004410039,0.000010393854,0.0016078198,0.00011653869,0.00003112365,0.0004161806],"genre_scores_gemma":[0.999258,0.00013018379,0.00005740925,0.00007241049,0.0001075043,0.00023782699,0.000027083606,0.00006135752,0.000048237172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686265,0.00019959215,0.00035223053,0.00062841724,0.0011930888,0.0007639997],"domain_scores_gemma":[0.9983953,0.00015790164,0.00009506653,0.0005102728,0.00018141633,0.00066001265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003295434,0.00021493513,0.00040280502,0.0005582032,0.00006158748,0.000029176746,0.00035284812,0.00006158439,0.00017103231],"category_scores_gemma":[0.0004930386,0.00017539202,0.00007056685,0.0016297078,0.00027107328,0.00012978792,0.00023855703,0.0007169323,0.000020491141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043786666,0.00046802676,0.7662836,0.00084316777,0.00012235789,0.0016215974,0.0002535165,0.00030150753,0.2233485,0.00000378866,0.00046548824,0.0019098023],"study_design_scores_gemma":[0.006279772,0.00075761374,0.91776353,0.0007095571,0.000018852092,0.00000826625,0.00016381351,0.00031451817,0.07380482,0.000020474607,0.000020396383,0.00013841003],"about_ca_topic_score_codex":0.0013332553,"about_ca_topic_score_gemma":0.00017266457,"teacher_disagreement_score":0.15147993,"about_ca_system_score_codex":0.00022336672,"about_ca_system_score_gemma":0.0007120302,"threshold_uncertainty_score":0.7152279},"labels":[],"label_agreement":null},{"id":"W3047434078","doi":"10.1158/1538-7445.pedca19-b14","title":"Abstract B14: Pinpointing the origins of pediatric brain tumors using single-cell transcriptomic analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Hospital for Sick Children; McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Biology; Transcriptome; Medulloblastoma; Wnt signaling pathway; Cell type; Forebrain; Carcinogenesis; Embryonic stem cell; Cell; Cancer research; Neuroscience; Genetics; Gene; Central nervous system; Gene expression","score_opus":0.10294928996514875,"score_gpt":0.3732713470249165,"score_spread":0.27032205705976775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047434078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469703,0.0029798106,0.0009657387,0.0008313655,0.00004369646,0.00014482647,0.000033193166,0.00000874357,0.00029561977],"genre_scores_gemma":[0.9986308,0.0002739884,0.00013913287,0.00019447875,0.00064943876,0.000012370354,0.00001549784,0.000023867522,0.000060389753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985884,0.00010721287,0.00026823833,0.0003452954,0.0003546483,0.00033623405],"domain_scores_gemma":[0.9992914,0.000047722213,0.00008961577,0.0002810996,0.0001892652,0.00010085826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005442449,0.0001118791,0.00018516692,0.00009418123,0.00013851048,0.000034963283,0.00034507632,0.00007709,0.00009713003],"category_scores_gemma":[0.000099599565,0.0000891347,0.00019239914,0.0008930725,0.000112162365,0.000004163889,0.00007224279,0.00025322565,0.0000036122526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005422448,0.000028664062,0.0021354423,0.00011605843,0.00010343684,0.00000165256,0.00030349178,0.008856569,0.9869664,0.0000064760584,0.00081709714,0.00061051483],"study_design_scores_gemma":[0.00068080775,0.0001806731,0.0014530907,0.000028326322,0.00022799036,0.0000013952546,0.00062711706,0.010162475,0.9816604,0.00001987251,0.004698933,0.00025889464],"about_ca_topic_score_codex":0.0008067358,"about_ca_topic_score_gemma":0.00009463672,"teacher_disagreement_score":0.005305947,"about_ca_system_score_codex":0.00009398939,"about_ca_system_score_gemma":0.0003832819,"threshold_uncertainty_score":0.36348075},"labels":[],"label_agreement":null},{"id":"W3047435965","doi":"10.1158/1538-7445.pedca19-a17","title":"Abstract A17: HHLA2 is a new immune checkpoint expressed in pediatric Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immune checkpoint; Lymphoma; Immune system; Oncology; Immunohistochemistry; Internal medicine; CD30; Cancer research; Immunology; Immunotherapy","score_opus":0.11008399795338839,"score_gpt":0.3954945733747507,"score_spread":0.2854105754213623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047435965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95572484,0.012253975,0.0000021396236,0.027447665,0.000078312005,0.00072836987,0.00002795322,0.000047559122,0.0036891866],"genre_scores_gemma":[0.99010444,0.0069672335,0.00009634417,0.0008115363,0.0008651395,0.00032419479,0.000015839381,0.000040732222,0.0007745598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975325,0.00006161634,0.00039175936,0.00054406933,0.0008136774,0.0006563699],"domain_scores_gemma":[0.9986673,0.0001563093,0.000057653375,0.00040599026,0.00014143361,0.0005713114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000350092,0.00019221284,0.0004000216,0.00023515474,0.0000737327,0.000057465248,0.00022739764,0.00012178182,0.002215092],"category_scores_gemma":[0.00020596418,0.0001601614,0.00014723481,0.00096840237,0.000060355836,0.00009305321,0.0001486315,0.0002675285,0.00059060776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003571295,0.0027208526,0.37084213,0.0014879537,0.0003467591,0.003388008,0.01024629,0.000031299845,0.11571874,0.00014874508,0.18120311,0.31029484],"study_design_scores_gemma":[0.010335117,0.0004389949,0.80746365,0.00020225486,0.000047496767,0.000007342316,0.00023182185,0.000048034555,0.14985915,0.000103467886,0.031053739,0.00020891715],"about_ca_topic_score_codex":0.0062678247,"about_ca_topic_score_gemma":0.00008718246,"teacher_disagreement_score":0.43662155,"about_ca_system_score_codex":0.0007329873,"about_ca_system_score_gemma":0.0016043507,"threshold_uncertainty_score":0.99869704},"labels":[],"label_agreement":null},{"id":"W3047444557","doi":"10.1158/1538-7445.pedca19-pr01","title":"Abstract PR01: Three-hit model of Wilms’ tumor formation reveals immunogenic transcriptional subtypes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Wilms' tumor; microRNA; Cancer research; Gene; Drosha; Chromatin remodeling; Loss of heterozygosity; Mutation; Transcriptome; Genetics; Chromatin; Gene expression; RNA; RNA interference; Allele","score_opus":0.07799964653136852,"score_gpt":0.3387483783430958,"score_spread":0.26074873181172725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047444557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114764,0.0057572643,0.0006249909,0.0011072471,0.000046536934,0.00022755716,0.00008716887,0.000007341575,0.0009942706],"genre_scores_gemma":[0.997521,0.0016835172,0.000079052195,0.0001617985,0.00016636876,0.000058862624,0.00007516555,0.000015508242,0.00023873404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989533,0.000033538905,0.00021571142,0.00021688822,0.00033053797,0.0002500314],"domain_scores_gemma":[0.99946624,0.000008083942,0.000057007124,0.00014603576,0.00022472351,0.00009788065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023494114,0.00008765912,0.00011858453,0.00003868813,0.00007857761,0.000013721004,0.00022698633,0.00009779178,0.00008799678],"category_scores_gemma":[0.00003150958,0.00007454185,0.00009711762,0.00015921984,0.00012740935,0.000010760746,0.000042214273,0.00023040108,0.000012799836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040611878,0.000016227536,0.00015784854,0.00014365104,0.000057298465,0.0000012248121,0.00011063233,0.0049039614,0.99021405,0.000120823366,0.002719293,0.0011488529],"study_design_scores_gemma":[0.00071131473,0.00024794432,0.0015899757,0.000087253306,0.000014987146,0.000003554239,0.0000831602,0.0027653174,0.9892043,0.0005758141,0.004553128,0.0001632457],"about_ca_topic_score_codex":0.00006376099,"about_ca_topic_score_gemma":0.00002962462,"teacher_disagreement_score":0.00637337,"about_ca_system_score_codex":0.000040907715,"about_ca_system_score_gemma":0.00030485637,"threshold_uncertainty_score":0.30397287},"labels":[],"label_agreement":null},{"id":"W3047450785","doi":"10.1158/1538-7445.pedca19-a56","title":"Abstract A56: Effect of chemotherapy on gut microbiota and microbiota-derived metabolites in children with cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université de Montréal","funders":"","keywords":"Gut flora; Cancer; Medicine; Chemotherapy; Pediatric cancer; Immunology; Antibiotics; Oncology; Bioinformatics; Internal medicine; Biology; Microbiology","score_opus":0.0215380944013853,"score_gpt":0.3538162741770322,"score_spread":0.3322781797756469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047450785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905004,0.0072976085,0.000001245099,0.001284524,0.000021970169,0.0006560187,0.00015819022,0.000005989702,0.00007403862],"genre_scores_gemma":[0.9939875,0.005019677,0.000050028382,0.00056102243,0.00016355842,0.000062191044,0.00005222293,0.000037336453,0.000066478075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860173,0.00012838467,0.00018906643,0.0005085184,0.00013250617,0.00043978935],"domain_scores_gemma":[0.99943614,0.000028440336,0.00006288126,0.00023771988,0.00009389938,0.00014089672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030775534,0.00019046383,0.0003101263,0.00008859424,0.000065829074,0.000024547518,0.00022152756,0.00014461244,0.00012496952],"category_scores_gemma":[0.000025857304,0.00014635794,0.0000472795,0.00025552165,0.00023961457,0.000004334938,0.00008143449,0.00033008956,0.0000049072864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009791985,0.000037547277,0.055051878,0.00016236,0.000103093356,0.0000012841518,0.00014125668,0.000012325217,0.9393069,0.0000031047596,0.0019755147,0.0022255538],"study_design_scores_gemma":[0.0016285593,0.0005630461,0.2719254,0.00007770483,0.000007645381,0.0000027415213,0.000014287139,8.375778e-7,0.722989,7.614799e-7,0.002669661,0.00012035775],"about_ca_topic_score_codex":0.0010488717,"about_ca_topic_score_gemma":0.0002760499,"teacher_disagreement_score":0.21687351,"about_ca_system_score_codex":0.00003989849,"about_ca_system_score_gemma":0.0002548033,"threshold_uncertainty_score":0.5968303},"labels":[],"label_agreement":null},{"id":"W3047453056","doi":"10.1158/1538-7445.pedca19-b43","title":"Abstract B43: The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Embryonal rhabdomyosarcoma; Cancer research; Sarcoma; Biology; In vivo; Pediatric cancer; Immunohistochemistry; Cancer; Cell migration; Soft tissue sarcoma; PAX3; Pathology; Cell growth; Transcription factor; Cell; Medicine; Genetics","score_opus":0.13574342329437047,"score_gpt":0.4276992223133152,"score_spread":0.29195579901894475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047453056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.891599,0.010321243,9.670878e-7,0.095127404,0.000045693334,0.001413849,0.000108398235,0.000010405553,0.001373036],"genre_scores_gemma":[0.9932693,0.0025778408,0.000080151796,0.0025825188,0.00029548,0.0010137762,0.000015349937,0.000023491704,0.0001420558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976428,0.00013010412,0.0003785506,0.00037872934,0.0009685733,0.00050120143],"domain_scores_gemma":[0.9985322,0.00049595477,0.00005386527,0.0005321704,0.00015323945,0.00023257128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054101116,0.00017634648,0.00035342886,0.00011065946,0.0001232527,0.000032945412,0.00031225017,0.000057847992,0.0014205021],"category_scores_gemma":[0.00009496111,0.00008536569,0.00017209773,0.00073485746,0.00014927013,0.000032123517,0.000051901006,0.00027373838,0.00009770062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026690334,0.0058482853,0.75017905,0.00026575272,0.00080553564,0.0031284862,0.03967198,0.000044506352,0.018521443,0.00086236565,0.08695889,0.09104465],"study_design_scores_gemma":[0.0032416598,0.0027171988,0.733834,0.00015206965,0.00006801048,0.000031577758,0.0029249825,0.000072585965,0.04460683,0.00023877546,0.21195264,0.00015963757],"about_ca_topic_score_codex":0.002613751,"about_ca_topic_score_gemma":0.00028297404,"teacher_disagreement_score":0.12499374,"about_ca_system_score_codex":0.00032689655,"about_ca_system_score_gemma":0.0004004905,"threshold_uncertainty_score":0.99949235},"labels":[],"label_agreement":null},{"id":"W3047456958","doi":"10.1158/1538-7445.pedca19-b07","title":"Abstract B07: Prospective germline next-generation sequencing in pediatric patients with neuroblastoma identifies frequent alterations in genes involved in DNA damage repair","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germline; Genetics; Biology; CHEK2; Genetic testing; Cancer; BAP1; Pediatric cancer; Germline mutation; PALB2; Bioinformatics; Medicine; Gene; Mutation","score_opus":0.12351217207062722,"score_gpt":0.35831404769877573,"score_spread":0.23480187562814853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047456958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655795,0.0002753996,0.0000029082512,0.0008901614,0.000048086058,0.0020124773,0.000029300816,0.000050395323,0.00013330717],"genre_scores_gemma":[0.99833286,0.00030598656,0.00008228374,0.00012762331,0.00025319186,0.0006943666,0.00008753093,0.0000449621,0.000071182716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689364,0.0002719729,0.00046741407,0.00071366056,0.0009851638,0.00066812604],"domain_scores_gemma":[0.9988297,0.00012910542,0.00006620277,0.0002901506,0.00039561235,0.0002891809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041044262,0.00020753185,0.0003182473,0.00086010405,0.000109638655,0.00010336383,0.00014856155,0.000075476455,0.0000960589],"category_scores_gemma":[0.00038150602,0.00017926445,0.0000514316,0.0019544556,0.00010492114,0.0005083903,0.00010680763,0.0008604134,0.00003133711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011868001,0.0004844987,0.85087246,0.0003210286,0.00002810994,0.0013827046,0.0012579737,0.0016295798,0.14221725,0.000014064824,0.00025577555,0.0003497277],"study_design_scores_gemma":[0.004488521,0.0009092953,0.96722555,0.00018390892,0.000010563009,0.0000014092084,0.00020569032,0.0026449398,0.024139056,0.000026741129,0.000012783843,0.00015151195],"about_ca_topic_score_codex":0.0019001386,"about_ca_topic_score_gemma":0.020092366,"teacher_disagreement_score":0.118078195,"about_ca_system_score_codex":0.0014335279,"about_ca_system_score_gemma":0.0011359141,"threshold_uncertainty_score":0.99778837},"labels":[],"label_agreement":null},{"id":"W3047462357","doi":"10.1158/1538-7445.pedca19-b66","title":"Abstract B66: Nutritional intakes are associated with HDL-cholesterol levels in survivors of childhood acute lymphoblastic leukemia","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Dyslipidemia; Medicine; Cholesterol; Population; Internal medicine; Micronutrient; Body mass index; Logistic regression; Lipid profile; Endocrinology; Pediatrics; Environmental health; Obesity; Pathology","score_opus":0.13105633680010836,"score_gpt":0.4037496080602151,"score_spread":0.27269327126010673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047462357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891445,0.00036808246,0.000012688572,0.009152738,0.000041267074,0.0005633024,0.00022128051,0.00003482406,0.0004613005],"genre_scores_gemma":[0.9980925,0.00025417175,0.000058423866,0.0011479766,0.00017824903,0.00012097523,0.000049185564,0.000030215238,0.00006834762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979026,0.000114376824,0.0003628126,0.00031645762,0.0008401343,0.00046365155],"domain_scores_gemma":[0.99872226,0.00027314937,0.000107157255,0.00014637236,0.00043021992,0.0003208583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052114396,0.00012614485,0.0003855344,0.0002633955,0.000087400025,0.000020536827,0.00013939208,0.00011160808,0.00043862927],"category_scores_gemma":[0.0002926501,0.00011170029,0.000046254176,0.0008302443,0.00018121958,0.00008892009,0.000039734063,0.00074025214,0.00002085493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035030185,0.0017390532,0.92043084,0.0043821256,0.0005764519,0.0008059211,0.0055406694,0.00021896746,0.047658358,0.00023788116,0.009278284,0.0056284186],"study_design_scores_gemma":[0.0055963728,0.00032718547,0.98401165,0.00315283,0.000017784043,0.000009440255,0.00055026734,0.00007851421,0.0057119904,0.000086983244,0.00035015514,0.00010681037],"about_ca_topic_score_codex":0.0006104858,"about_ca_topic_score_gemma":0.0009958094,"teacher_disagreement_score":0.06358081,"about_ca_system_score_codex":0.00083192636,"about_ca_system_score_gemma":0.0011840562,"threshold_uncertainty_score":0.4802683},"labels":[],"label_agreement":null},{"id":"W3047477991","doi":"10.1158/1538-7445.pedca19-a63","title":"Abstract A63: Overcoming challenges in health care with machine learning: Innovation from retinoblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Esri (Canada); Hospital for Sick Children","funders":"","keywords":"Retinoblastoma; Timeline; Medicine; Health care; Electronic health record; Medical physics; Disease; Family medicine; Artificial intelligence; Computer science; Pathology; Statistics","score_opus":0.18792875659455896,"score_gpt":0.42011930780015244,"score_spread":0.23219055120559348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047477991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8994063,0.03564539,0.0000035783273,0.061716024,0.000028854343,0.0005445798,0.000017233015,0.00006664905,0.0025714005],"genre_scores_gemma":[0.99328,0.0055181454,0.0003067957,0.00037659437,0.00031098313,0.00006760412,0.000044340868,0.00003519083,0.000060375165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782485,0.00016757546,0.00031166608,0.00046478456,0.00078958063,0.00044152705],"domain_scores_gemma":[0.99897856,0.00018608854,0.00009667817,0.00020055397,0.00039622822,0.00014187378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068101834,0.00014169917,0.00037775902,0.00023682084,0.00014796978,0.000024199013,0.0001281663,0.00007629497,0.000105456966],"category_scores_gemma":[0.0005611082,0.000118866235,0.000024143741,0.00073442387,0.00011978177,0.00007729041,0.0001140519,0.0013976753,0.000024240018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009464692,0.00030158504,0.50715727,0.012151287,0.0003524181,0.0008427196,0.2100783,0.00022795238,0.052786615,0.00075220474,0.0049995766,0.2008854],"study_design_scores_gemma":[0.0057042716,0.003254145,0.86140317,0.0052054464,0.000017796327,0.000010931441,0.040374927,0.00026394048,0.014377311,0.00009897114,0.06883849,0.00045059214],"about_ca_topic_score_codex":0.0028082922,"about_ca_topic_score_gemma":0.0020860909,"teacher_disagreement_score":0.3542459,"about_ca_system_score_codex":0.00045453364,"about_ca_system_score_gemma":0.00042266762,"threshold_uncertainty_score":0.6072281},"labels":[],"label_agreement":null},{"id":"W3047479028","doi":"10.1158/1538-7445.pedca19-b22","title":"Abstract B22: Cell state and lineage specification are controlled by epigenetic landscapes regulating the core transcriptional regulatory circuitry in pediatric neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Neuroblastoma; Transcription factor; Enhancer; Cancer research; Cell biology; GATA3; Chromatin; Gene; Genetics; Cell culture","score_opus":0.07203216526159331,"score_gpt":0.33686443525143167,"score_spread":0.26483226998983833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047479028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895112,0.0048854426,0.0000071437066,0.0038408781,0.000033375996,0.0012250033,0.00007141014,0.000023984503,0.00040156126],"genre_scores_gemma":[0.99607825,0.002558885,0.000009917421,0.0001864703,0.00028821424,0.00021470143,0.000021842661,0.00003767058,0.00060406956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975709,0.00019683849,0.00034996305,0.00048215914,0.00088579615,0.0005143509],"domain_scores_gemma":[0.99870527,0.0004179733,0.0000921957,0.00024397753,0.0001883836,0.00035217564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004999516,0.0001654263,0.0003147262,0.00017664683,0.00018376943,0.00006320076,0.0001623307,0.00006389316,0.00021697946],"category_scores_gemma":[0.0001646473,0.00011982158,0.00006999581,0.0005425212,0.00014023439,0.000076564145,0.00004510054,0.000755373,0.000038948278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007139827,0.0005700677,0.14252003,0.0011256671,0.00009680886,0.00045811053,0.0013654642,0.00032480538,0.8313683,0.000023547449,0.010304214,0.0047031543],"study_design_scores_gemma":[0.011626799,0.00049943186,0.96418005,0.00008987865,0.000034150788,0.0000103675375,0.0002317213,0.0012561854,0.021120053,0.00005585681,0.0007495916,0.0001458986],"about_ca_topic_score_codex":0.000046224362,"about_ca_topic_score_gemma":0.000067079185,"teacher_disagreement_score":0.82166004,"about_ca_system_score_codex":0.00010534208,"about_ca_system_score_gemma":0.00027382706,"threshold_uncertainty_score":0.48861822},"labels":[],"label_agreement":null},{"id":"W3047481795","doi":"10.1158/1538-7445.pedca19-b47","title":"Abstract B47: Overexpression of <i>TLX3</i> or <i>HOXA9</i> in association mutant <i>IL7R</i>α are sufficient to generate T-ALL in vivo","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interleukin-7 receptor; Cell culture; Mutant; Leukemia; Flow cytometry; Cancer research; In vivo; Biology; Molecular biology; T cell; Immunology; Gene; Genetics; IL-2 receptor","score_opus":0.10893035518877109,"score_gpt":0.40776543124914816,"score_spread":0.29883507606037707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047481795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859865,0.00028878884,0.000016806454,0.010668422,0.000074298165,0.0013115491,0.00012796561,0.000029748251,0.0014959339],"genre_scores_gemma":[0.9957057,0.0004927813,0.000111225316,0.0021345543,0.00027178208,0.00025691846,0.000011198455,0.000057022015,0.0009588185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99480337,0.00028174592,0.00069717626,0.0007009516,0.002396954,0.0011198005],"domain_scores_gemma":[0.9975689,0.0006357118,0.00016005551,0.00041447638,0.00061843195,0.0006024184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018796077,0.00021875996,0.0005986343,0.000514535,0.000057647052,0.000045262892,0.00041471276,0.00024923825,0.00079038576],"category_scores_gemma":[0.0023517255,0.0001761312,0.000078792844,0.0023321772,0.000087219276,0.00012356673,0.0003818373,0.001104103,0.00009520779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003355041,0.0003623547,0.03673442,0.0006506765,0.00003544293,0.0003871738,0.0022084147,0.001353388,0.9118266,0.000018091027,0.04263962,0.0004287664],"study_design_scores_gemma":[0.008929992,0.00096083456,0.053100325,0.0028846466,0.000017720848,0.000007563121,0.0015159141,0.0029954955,0.9017111,0.000021780725,0.027485395,0.0003692061],"about_ca_topic_score_codex":0.0023090856,"about_ca_topic_score_gemma":0.0007263414,"teacher_disagreement_score":0.016365906,"about_ca_system_score_codex":0.0048004407,"about_ca_system_score_gemma":0.0023780891,"threshold_uncertainty_score":0.99902},"labels":[],"label_agreement":null},{"id":"W3047482662","doi":"10.1158/1538-7445.pedca19-b71","title":"Abstract B71: Molecular heterogeneity and novel oncogenic fusions in <i>RELA-</i> and <i>YAP1-</i>negative supratentorial ependymoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ependymoma; Sanger sequencing; Biology; DNA methylation; Breast cancer; Methylation; Molecular biology; Cancer research; Cancer; Genetics; DNA sequencing; Gene; Pathology; Medicine; Gene expression","score_opus":0.10742123577248829,"score_gpt":0.4048815800097469,"score_spread":0.2974603442372586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047482662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896947,0.0029847422,0.000005107072,0.0060437564,0.00007689934,0.00072006526,0.00007753797,0.000016695893,0.00038046058],"genre_scores_gemma":[0.9980553,0.00096327066,0.00009537829,0.00043148219,0.00018714445,0.00022009811,0.00001265417,0.000024475308,0.0000102462855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983498,0.00006801396,0.00020489242,0.00048418777,0.00048202826,0.00041106204],"domain_scores_gemma":[0.9990019,0.00018652316,0.00003206491,0.00017695373,0.00014066015,0.00046186836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027912608,0.00015268833,0.0002940135,0.00011857721,0.00010891842,0.00005009337,0.00007562115,0.00009780553,0.00010101087],"category_scores_gemma":[0.00020422044,0.00012813948,0.000053441952,0.00039888496,0.0001742177,0.00007227162,0.00017025674,0.00042333026,0.000020013693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081453443,0.00050719676,0.052781075,0.00015535869,0.00016853947,0.0017237916,0.00075505656,0.000014842782,0.93802196,0.00034337706,0.0011283174,0.0035859568],"study_design_scores_gemma":[0.014195454,0.0011579721,0.23930766,0.00033806852,0.000103764876,0.000100954945,0.00045139316,0.00015188236,0.7389724,0.00022552152,0.004668845,0.00032608243],"about_ca_topic_score_codex":0.0013902709,"about_ca_topic_score_gemma":0.00046354704,"teacher_disagreement_score":0.19904955,"about_ca_system_score_codex":0.00014754894,"about_ca_system_score_gemma":0.00023056583,"threshold_uncertainty_score":0.5225376},"labels":[],"label_agreement":null},{"id":"W3047513087","doi":"10.1158/1538-7445.pedca19-a28","title":"Abstract A28: Targeted sequencing in 388 patients with high-risk or recurrent/refractory pediatric extracranial solid malignancies: An interim report from the GAIN Consortium/iCat2 Study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interim analysis; Oncology; Internal medicine; Targeted therapy; Rhabdomyosarcoma; Interim; Clinical trial; Pediatric cancer; Cancer; Sarcoma; Pathology","score_opus":0.10068745256830881,"score_gpt":0.397874006606786,"score_spread":0.2971865540384772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047513087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959862,0.00032934503,0.000006827168,0.00038077612,0.00014058246,0.0026987707,0.00032636037,0.00006686409,0.00006423706],"genre_scores_gemma":[0.99808496,0.00035343756,0.00006473677,0.00012814383,0.0005730289,0.0004935637,0.00015165166,0.000074995965,0.000075487675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948855,0.000704086,0.0006396953,0.0009985354,0.0018348827,0.00093731744],"domain_scores_gemma":[0.997043,0.0006655853,0.00022037573,0.0007630372,0.0006236945,0.0006842824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009353915,0.0003073358,0.0005109674,0.00023359299,0.00026658102,0.00010867281,0.00045777005,0.0000963331,0.0009932186],"category_scores_gemma":[0.0017010006,0.0001825786,0.00006432493,0.0011065736,0.00023620993,0.00027642737,0.00020522095,0.0016785722,0.000079846635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014047755,0.0021244148,0.9543306,0.0001187446,0.00025225367,0.010249293,0.0036527049,0.000029042416,0.0074010827,6.9041545e-7,0.0017051328,0.006088288],"study_design_scores_gemma":[0.007956842,0.0072927205,0.979512,0.00016841563,0.0000984793,0.000011748144,0.0023101487,0.00006094161,0.0021398468,0.000014971626,0.00020149794,0.00023240059],"about_ca_topic_score_codex":0.008271838,"about_ca_topic_score_gemma":0.0028359212,"teacher_disagreement_score":0.025181388,"about_ca_system_score_codex":0.0008732256,"about_ca_system_score_gemma":0.002449853,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W3047515618","doi":"10.1158/1538-7445.pedca19-b28","title":"Abstract B28: A cross-species enhancer activity analysis approach to identify the Ewing sarcoma cell of origin","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; FLI1; Zebrafish; Biology; Cancer research; Neural crest; Ewing's sarcoma; Enhancer; Mesenchymal stem cell; Progenitor cell; Cell; Stem cell; Transcription factor; Pathology; Medicine; Cell biology; Genetics; Embryo; Gene","score_opus":0.23133581350816076,"score_gpt":0.48096873060276996,"score_spread":0.2496329170946092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047515618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863923,0.0020018972,0.000109869965,0.0035967147,0.000038218433,0.0006762201,0.000050516348,0.000021526532,0.007112718],"genre_scores_gemma":[0.9981543,0.0003640284,0.00011951615,0.0002026431,0.0002483251,0.00039022902,0.000009777312,0.000022230835,0.0004889812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768555,0.0001116513,0.00024562087,0.0004781217,0.0010204284,0.00045865396],"domain_scores_gemma":[0.9984723,0.00033277602,0.00006673691,0.0005130258,0.0003344986,0.00028066136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064146897,0.00015025746,0.000439206,0.00022280314,0.00018927669,0.00010247463,0.00031054707,0.00006556034,0.00079070433],"category_scores_gemma":[0.0001337572,0.00009768367,0.00027543583,0.0020631056,0.00020119338,0.00008593532,0.00017167538,0.00043858946,0.00007336038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011199942,0.0014780377,0.56395215,0.00052222854,0.001800148,0.00007408759,0.005194114,0.00051854976,0.405817,0.00015370465,0.0063129324,0.013057082],"study_design_scores_gemma":[0.0006189653,0.00011360824,0.75775045,0.00003399708,0.00020045368,6.626933e-7,0.0003552481,0.000083017774,0.2357704,0.000008190332,0.004984379,0.0000806053],"about_ca_topic_score_codex":0.0015677622,"about_ca_topic_score_gemma":0.00007682677,"teacher_disagreement_score":0.19379833,"about_ca_system_score_codex":0.00028861038,"about_ca_system_score_gemma":0.00024810294,"threshold_uncertainty_score":0.8657658},"labels":[],"label_agreement":null},{"id":"W3047517029","doi":"10.1158/1538-7445.pedca19-ia29","title":"Abstract IA29: Developmental and oncogenic programs in pediatric brain tumors dissected by single-cell RNA-sequencing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric cancer; Progenitor cell; Biology; Cancer; Neural stem cell; RNA; Cell; Stem cell; Cancer research; Neuroscience; Genetics; Gene","score_opus":0.1328079856959487,"score_gpt":0.35909531473528017,"score_spread":0.22628732903933146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047517029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905729,0.0035900774,5.672896e-7,0.004163828,0.000020478727,0.0007729328,0.0000119963115,0.00003671347,0.0008304547],"genre_scores_gemma":[0.9986654,0.00044912234,0.00013159377,0.00018964359,0.00012413165,0.0002798728,0.000048432612,0.000031920747,0.00007989799],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824995,0.000055221426,0.00024773588,0.00042228197,0.000506168,0.00051864027],"domain_scores_gemma":[0.9992336,0.00014369636,0.000038144044,0.00009709621,0.00008805082,0.00039942228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002729486,0.00014617914,0.00023782828,0.00016445643,0.00008407695,0.000058531896,0.00009383302,0.000068158566,0.00015604158],"category_scores_gemma":[0.00015472055,0.00012500717,0.0000391002,0.0008571554,0.00007649005,0.00006928214,0.00008043887,0.00039859215,0.000037078655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001954675,0.0005786899,0.36204976,0.0004111979,0.000034213557,0.00095674203,0.0018876743,0.0000019947292,0.6051338,0.0000038016456,0.0054675206,0.02327918],"study_design_scores_gemma":[0.0109758545,0.0018483181,0.4928379,0.00059414917,0.00007615226,0.00007531339,0.00393301,0.00009380636,0.484557,0.000034510707,0.0043489076,0.00062507536],"about_ca_topic_score_codex":0.0007839219,"about_ca_topic_score_gemma":0.00019749397,"teacher_disagreement_score":0.13078813,"about_ca_system_score_codex":0.00078441715,"about_ca_system_score_gemma":0.0005825746,"threshold_uncertainty_score":0.50976443},"labels":[],"label_agreement":null},{"id":"W3047518314","doi":"10.1158/1538-7445.pedca19-b48","title":"Abstract B48: A LIN28B-PDZ kinase axis promotes neuroblastoma metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Metastasis; Cancer research; Small hairpin RNA; Gene knockdown; Biology; microRNA; Cancer; Kinase; Downregulation and upregulation; Apoptosis; Cell biology; Cell culture; Gene; Genetics","score_opus":0.1585132769561963,"score_gpt":0.4313398011238319,"score_spread":0.27282652416763564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047518314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725956,0.0009052937,0.0000066792654,0.021768274,0.00006531123,0.0013060523,0.000112327965,0.00015701607,0.0030834954],"genre_scores_gemma":[0.9966127,0.0004925032,0.00017627818,0.0007976069,0.00042330954,0.00040244087,0.0000218109,0.00008574677,0.0009875478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592924,0.00021721852,0.00030655495,0.00080232776,0.0016126937,0.00113197],"domain_scores_gemma":[0.9972471,0.00027722097,0.00004855001,0.00052964553,0.00051813835,0.001379329],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042594477,0.00026243835,0.00042311885,0.00030627547,0.0002529314,0.00011353505,0.00034289085,0.00009183073,0.0027546072],"category_scores_gemma":[0.0009427694,0.0002127995,0.0001908814,0.0012661831,0.00031227985,0.00017304011,0.00028201033,0.0012023542,0.0014018981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056798663,0.0014564057,0.003978743,0.0016247244,0.00077293644,0.011163698,0.0008263912,0.000014750992,0.8156143,0.00015667443,0.047146965,0.111564554],"study_design_scores_gemma":[0.0071499557,0.007093184,0.044589005,0.0004741791,0.00013165096,0.00012486054,0.0002656351,0.0003206837,0.8606749,0.00018711036,0.07849238,0.00049645867],"about_ca_topic_score_codex":0.0003592507,"about_ca_topic_score_gemma":0.000046771824,"teacher_disagreement_score":0.11106809,"about_ca_system_score_codex":0.0002087586,"about_ca_system_score_gemma":0.00080224685,"threshold_uncertainty_score":0.99937564},"labels":[],"label_agreement":null},{"id":"W3047522715","doi":"10.1158/1538-7445.pedca19-a18","title":"Abstract A18: Characterization of checkpoint inhibitors in the tumor microenvironment (TME) and peripheral blood in endemic Burkitt Lymphoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TIGIT; Tumor microenvironment; Immune checkpoint; Immunology; Peripheral blood mononuclear cell; Cytotoxic T cell; Immune system; CD8; Cancer research; T cell; Biology; Medicine; Immunotherapy; In vitro","score_opus":0.041106052142593254,"score_gpt":0.3220867497399568,"score_spread":0.28098069759736355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047522715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917619,0.0022780148,6.1842445e-7,0.005212304,0.000038987433,0.0005871043,0.000012739763,0.0000052628857,0.000103034494],"genre_scores_gemma":[0.9961579,0.0028904942,0.000008093833,0.00066259765,0.0001352578,0.00008273825,0.000014635689,0.000014961015,0.00003334463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986993,0.00009853073,0.00031689653,0.00024269383,0.0003777348,0.00026484183],"domain_scores_gemma":[0.99965286,0.000040567702,0.00005765971,0.00015207368,0.00003115581,0.000065675886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006444023,0.000098064294,0.0001939042,0.00010217432,0.00003476697,0.000017571425,0.0001171225,0.000052515894,0.00025064065],"category_scores_gemma":[0.000038457878,0.00007295352,0.00003903192,0.0004149256,0.00017695696,0.00006011952,0.00004390965,0.0002531812,0.0000021605804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015631531,0.00014228915,0.043458063,0.00018185766,0.000024527528,0.000052135638,0.0036239102,0.0000011734343,0.94120336,0.0000035778096,0.000059518687,0.009686447],"study_design_scores_gemma":[0.003478508,0.0003550447,0.7435367,0.00027822322,0.000009005286,0.000016709166,0.0009611616,0.000030387993,0.24700578,0.000005187374,0.004243535,0.0000797186],"about_ca_topic_score_codex":0.0008644373,"about_ca_topic_score_gemma":0.00006732539,"teacher_disagreement_score":0.70007867,"about_ca_system_score_codex":0.00022605364,"about_ca_system_score_gemma":0.00020666464,"threshold_uncertainty_score":0.2974958},"labels":[],"label_agreement":null},{"id":"W3047532876","doi":"10.1158/1538-7445.pedca19-a19","title":"Abstract A19: Immunologic dysfunctions of NSG mice confer higher engraftment levels of xenograft Ewing sarcoma metastasis in the PuMA model compared to NOD-SCID mice","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nod; Puma; Sarcoma; Metastasis; Cancer research; Medicine; Pathology; Cancer; Immunology; Biology; Internal medicine; Apoptosis","score_opus":0.3034319770245302,"score_gpt":0.43762971159918485,"score_spread":0.13419773457465467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047532876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788513,0.0016647825,0.00023349331,0.015665052,0.00004413892,0.0016193229,0.00015522668,0.000023209368,0.0017434353],"genre_scores_gemma":[0.9975249,0.0001707922,0.0007638915,0.00067614723,0.00006065559,0.00030156464,0.00002009746,0.000037740658,0.00044419835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959598,0.00044202473,0.000633609,0.0005225674,0.0017079501,0.00073405745],"domain_scores_gemma":[0.99752456,0.00060651207,0.00009390229,0.00062245975,0.000865587,0.0002869644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015811638,0.00021107103,0.0005860713,0.00040246657,0.00013467419,0.000039587987,0.00074503047,0.00011113732,0.0017041344],"category_scores_gemma":[0.00040840803,0.00015475425,0.00017343092,0.0017471634,0.0003663137,0.00007646365,0.0003864646,0.0010841446,0.00011154901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011494844,0.00042227044,0.0008009239,0.00040119863,0.00019614745,0.000055538574,0.0024465376,0.0015528525,0.9865091,0.0002091339,0.0027569297,0.00349991],"study_design_scores_gemma":[0.0052843154,0.0013896422,0.10678175,0.000565548,0.0001266051,0.000010789999,0.0055243564,0.004178664,0.86161506,0.0002268368,0.013898145,0.00039827166],"about_ca_topic_score_codex":0.0017148072,"about_ca_topic_score_gemma":0.00015029468,"teacher_disagreement_score":0.124894,"about_ca_system_score_codex":0.00033110997,"about_ca_system_score_gemma":0.00059971056,"threshold_uncertainty_score":0.99920845},"labels":[],"label_agreement":null},{"id":"W3047534042","doi":"10.1158/1538-7445.pedca19-b34","title":"Abstract B34: Cord blood CD34+ HSPCs: An in vitro model system for characterizing NUP98 fusions","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haematopoiesis; Cancer research; Progenitor cell; CD34; Biology; Myeloid; Fusion gene; Molecular biology; Stem cell; Cell biology; Gene; Genetics","score_opus":0.17175552406438538,"score_gpt":0.42925918511824873,"score_spread":0.25750366105386335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047534042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847741,0.0004556088,0.00024412439,0.010049975,0.00008467363,0.0024523395,0.00031610962,0.0001423995,0.001480676],"genre_scores_gemma":[0.99499565,0.00030374844,0.0009994331,0.00066131,0.0009469627,0.0013294822,0.00015384943,0.00011305221,0.0004965232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99611557,0.00015475154,0.00048794408,0.0008155082,0.0011398863,0.0012863342],"domain_scores_gemma":[0.9974322,0.00031924745,0.000068118636,0.00062748865,0.00062632404,0.0009266265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015192989,0.00023555761,0.0005636075,0.00042639545,0.0002718397,0.00009820897,0.0005753344,0.00022699244,0.00015673357],"category_scores_gemma":[0.00054520543,0.00021577885,0.00012736753,0.0009113763,0.00017696146,0.0002514276,0.0002803632,0.0015983757,0.00009767191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046723806,0.00016626451,0.0003695998,0.001406673,0.00006510274,0.00025740504,0.0009521721,0.00006244097,0.98006904,0.00011076118,0.0020324073,0.009835764],"study_design_scores_gemma":[0.013444029,0.001883476,0.0043273135,0.0013580511,0.000108628956,0.00006828168,0.004452617,0.19554152,0.768491,0.00008053629,0.009552672,0.00069184456],"about_ca_topic_score_codex":0.00090525317,"about_ca_topic_score_gemma":0.0000814444,"teacher_disagreement_score":0.211578,"about_ca_system_score_codex":0.0012163679,"about_ca_system_score_gemma":0.0023334762,"threshold_uncertainty_score":0.87992066},"labels":[],"label_agreement":null},{"id":"W3047535567","doi":"10.1158/1538-7445.pedca19-a15","title":"Abstract A15: Improving immune recognition of shared tumor-associated antigens in pediatric tumors using a multimodal oncolytic virus","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Immune system; Virus; Immunotherapy; Immunology; Antigen; Virology; Cancer research; Medicine; Immune checkpoint; Biology","score_opus":0.08851622916072041,"score_gpt":0.3834152318789799,"score_spread":0.29489900271825953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047535567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676627,0.002109102,0.000011703527,0.00013316417,0.00004275812,0.0006228404,0.00020611528,0.000013562016,0.00009445652],"genre_scores_gemma":[0.9985691,0.0006993697,0.00009782689,0.00005792294,0.0003049621,0.00008127503,0.00011234634,0.000058397443,0.000018815967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997338,0.00030397618,0.00046408048,0.0005522845,0.00061302807,0.00072863157],"domain_scores_gemma":[0.9988109,0.000064709144,0.00015576567,0.00028850255,0.00048145276,0.00019868575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012211403,0.00017828398,0.00029503752,0.00026180304,0.00011826695,0.000041745963,0.00041912208,0.00015667385,0.00020013948],"category_scores_gemma":[0.00070730346,0.00019481803,0.00011302825,0.0009762864,0.00013494234,0.000015065806,0.00023494283,0.0005873575,0.000021021451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020499204,0.0001421991,0.0056921793,0.00017081779,0.000034506753,0.000038938302,0.00020621187,0.000440461,0.9867485,1.4134424e-7,0.00005804217,0.0044180914],"study_design_scores_gemma":[0.0019322129,0.0015218862,0.019986397,0.00009279281,0.000011281619,0.0000018473307,0.0001831928,0.0026472127,0.9733111,0.000014677544,0.00003194786,0.00026541678],"about_ca_topic_score_codex":0.0024152477,"about_ca_topic_score_gemma":0.001249018,"teacher_disagreement_score":0.014294216,"about_ca_system_score_codex":0.00024809767,"about_ca_system_score_gemma":0.001272632,"threshold_uncertainty_score":0.79444486},"labels":[],"label_agreement":null},{"id":"W3047541112","doi":"10.1158/1538-7445.pedca19-b63","title":"Abstract B63: Survivorship, vision, and eye salvage following pars plana vitrectomy for residual active or recurrent retinoblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Retinoblastoma; Vitrectomy; Pars plana; Chemotherapy; Surgery; Survivorship curve; Visual acuity; Internal medicine; Cancer","score_opus":0.1166065889947241,"score_gpt":0.4633809408629525,"score_spread":0.3467743518682284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047541112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873205,0.0012602975,0.0000069610187,0.008976739,0.00017858134,0.0011601952,0.00010554552,0.000047434467,0.00094377104],"genre_scores_gemma":[0.9978757,0.0003134045,0.000222208,0.0002715239,0.00033794547,0.00029486654,0.000061487866,0.000037451096,0.00058544124],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981181,0.00017292147,0.00020564202,0.00052022765,0.00046640818,0.0005167002],"domain_scores_gemma":[0.99851084,0.00071507914,0.000047858375,0.00019278514,0.00015811503,0.0003753082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061906147,0.00016806362,0.00036105845,0.00010908983,0.000268084,0.000030761134,0.000112076224,0.0001640846,0.00027059202],"category_scores_gemma":[0.0007312478,0.00012278544,0.000096587966,0.00028018636,0.00014602463,0.00008519467,0.0000887432,0.0005394991,0.000037571263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12167097,0.0017595027,0.27599928,0.0030263634,0.0055491915,0.006493755,0.013239918,0.0000067439155,0.06572583,0.00023466983,0.12132463,0.38496915],"study_design_scores_gemma":[0.027614946,0.015106195,0.691925,0.002021595,0.00077475683,0.0000344799,0.0035949058,0.00015843612,0.113777414,0.0005661682,0.14353812,0.000887972],"about_ca_topic_score_codex":0.00025217564,"about_ca_topic_score_gemma":0.00070198305,"teacher_disagreement_score":0.41592574,"about_ca_system_score_codex":0.00021487982,"about_ca_system_score_gemma":0.00044809998,"threshold_uncertainty_score":0.50070447},"labels":[],"label_agreement":null},{"id":"W3047545536","doi":"10.1158/1538-7445.pedca19-a47","title":"Abstract A47: BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; BMI1; Cancer research; Alveolar rhabdomyosarcoma; Fusion gene; Biology; Epigenome; FOXM1; Apoptosis; Cell cycle; Medicine; Cell culture; Gene; DNA methylation; Genetics; Gene expression; Pathology; Sarcoma","score_opus":0.11311763526783461,"score_gpt":0.40861042744185466,"score_spread":0.29549279217402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047545536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883738,0.0032290495,0.0008402989,0.004628324,0.00006684409,0.00042103915,0.000098337005,0.000009860651,0.0023324247],"genre_scores_gemma":[0.9980347,0.0006207771,0.00008502491,0.00058857416,0.00024837584,0.00025088977,0.000037984402,0.00001569434,0.00011798838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986423,0.00009083158,0.00018951626,0.00047321914,0.00025752714,0.00034660712],"domain_scores_gemma":[0.9992392,0.00004997691,0.00003276104,0.0003105963,0.00022932417,0.00013814804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043415517,0.00011269316,0.00013117112,0.000050512164,0.00013824609,0.000042532607,0.00029442293,0.00010930011,0.00022926882],"category_scores_gemma":[0.00012709685,0.000102921265,0.000056120207,0.00031320532,0.00031223087,0.000007217175,0.00012427202,0.00033928436,0.000023348111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021491431,0.00010236929,0.004114805,0.000029911116,0.000025968546,0.000003861849,0.00016340963,0.00013349163,0.982403,0.0006201445,0.0009502399,0.011237905],"study_design_scores_gemma":[0.0022138574,0.000406681,0.1372486,0.00009229012,0.000011042038,0.000005570486,0.0006377216,0.00037855504,0.7929476,0.0004624601,0.065110214,0.0004854336],"about_ca_topic_score_codex":0.00037825637,"about_ca_topic_score_gemma":0.00023390839,"teacher_disagreement_score":0.1894554,"about_ca_system_score_codex":0.00007803939,"about_ca_system_score_gemma":0.0005081053,"threshold_uncertainty_score":0.41970074},"labels":[],"label_agreement":null},{"id":"W3047545981","doi":"10.1158/1538-7445.pedca19-b73","title":"Abstract B73: Second-generation molecular subgrouping of medulloblastoma: An international meta-analysis of Group 3 and Group 4 subtypes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Concordance; Meta-analysis; Medulloblastoma; Biology; Computational biology; Oncology; Bioinformatics; Internal medicine; Medicine; Genetics","score_opus":0.1857289733834188,"score_gpt":0.41742458827806844,"score_spread":0.23169561489464965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047545981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936752,0.0040524537,0.000035689485,0.0016849961,0.000023949086,0.0002352458,0.0000913626,0.0000075856938,0.00019353331],"genre_scores_gemma":[0.99898696,0.000317763,0.00024835402,0.00013189545,0.000065035165,0.00009050153,0.00013859446,0.000012791827,0.000008085883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985608,0.00008126643,0.0002802576,0.00031020466,0.00061196607,0.00015550606],"domain_scores_gemma":[0.9991836,0.00008195914,0.000089347726,0.00020122675,0.00028172857,0.00016213828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041712297,0.00009641755,0.0005107176,0.00033799282,0.00003524861,0.000021967966,0.00010631686,0.00005092325,0.0015952772],"category_scores_gemma":[0.000070581475,0.000076250864,0.00025209677,0.00059124205,0.000098448014,0.000119300086,0.000053086656,0.00013043343,0.0000018259763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016740985,0.0003027529,0.022982987,0.00011486326,0.03753151,0.00005851661,0.00040219343,0.00015335379,0.9353523,0.0013782515,0.0001271646,0.0014286751],"study_design_scores_gemma":[0.0020690558,0.0010836816,0.31092864,0.000028021626,0.033931408,0.0000049640935,0.00032872797,0.0037073572,0.6468488,0.00006967153,0.00080682547,0.00019286544],"about_ca_topic_score_codex":0.0005808408,"about_ca_topic_score_gemma":0.0006990645,"teacher_disagreement_score":0.28850353,"about_ca_system_score_codex":0.000053513413,"about_ca_system_score_gemma":0.000047039757,"threshold_uncertainty_score":0.9993174},"labels":[],"label_agreement":null},{"id":"W3047558026","doi":"10.1158/1538-7445.pedca19-b76","title":"Abstract B76: Characterizing vascular invasion in hepatoblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatoblastoma; Intrahepatic Cholangiocarcinoma; Medicine; Pathology; Metastasis; Malignancy; Primary tumor; Liver tumor; Cancer; Cancer research; Hepatocellular carcinoma; Internal medicine","score_opus":0.26997515851602766,"score_gpt":0.37353949620138654,"score_spread":0.10356433768535889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047558026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896682,0.0018461186,0.0000029376406,0.0066005033,0.00004062753,0.0006436782,0.0000066987177,0.000045936424,0.0011452899],"genre_scores_gemma":[0.9976836,0.0010643611,0.000048321504,0.0005676789,0.00030030528,0.0002041683,0.000028737079,0.000032643882,0.00007021524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825925,0.00009615305,0.0002107226,0.00037908554,0.0005888669,0.00046589656],"domain_scores_gemma":[0.9992269,0.00006994045,0.000024403525,0.00022255881,0.000119259734,0.00033690824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005129146,0.00012410643,0.000265255,0.00018717904,0.0000770051,0.000035699966,0.000121011486,0.00010024968,0.0009562205],"category_scores_gemma":[0.00012719174,0.00010817279,0.00010523236,0.00065753923,0.00006357852,0.000106941865,0.00008659582,0.0005577663,0.00035880366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027506312,0.00009208226,0.7541097,0.00027527442,0.000044963177,0.0007333263,0.0009571984,6.0275113e-7,0.22849284,0.000015111773,0.00064981694,0.014354022],"study_design_scores_gemma":[0.0034415147,0.0006609123,0.6561755,0.0007239403,0.000039616338,0.000009068164,0.00036919973,0.001420195,0.28582254,0.0000260377,0.051030498,0.00028096684],"about_ca_topic_score_codex":0.0005041246,"about_ca_topic_score_gemma":0.000052530097,"teacher_disagreement_score":0.09793419,"about_ca_system_score_codex":0.00021908393,"about_ca_system_score_gemma":0.00028610934,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W3047560020","doi":"10.1158/1538-7445.pedca19-pr02","title":"Abstract PR02: Generation of the first genetically defined tumorigenic model of Ewing sarcoma expressing EWS-FLI1","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"HOTAIR; Small hairpin RNA; Cancer research; Gene knockdown; Carcinogenesis; Biology; Mesenchymal stem cell; Cell culture; Cell growth; Telomerase reverse transcriptase; Embryonic stem cell; FLI1; Cell biology; Cancer; Downregulation and upregulation; Telomerase; Transcription factor; Genetics; Long non-coding RNA; Gene","score_opus":0.11423633089897495,"score_gpt":0.3567062041776462,"score_spread":0.24246987327867126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047560020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98315424,0.002642152,0.011474994,0.0014051503,0.000085796426,0.000586337,0.000059273763,0.000008219944,0.00058383116],"genre_scores_gemma":[0.9980411,0.0005051951,0.0007605017,0.00015386238,0.00028605273,0.00009568183,0.000019575993,0.00004637794,0.00009168336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977092,0.0001279947,0.00037451435,0.0004666328,0.00085101934,0.00047060958],"domain_scores_gemma":[0.9986102,0.000026841708,0.000109550616,0.00057264534,0.0005295818,0.00015120067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005099637,0.0001495631,0.00020016072,0.00007229269,0.00018945092,0.000034263467,0.0006705406,0.00017931362,0.00007404306],"category_scores_gemma":[0.00034980287,0.00012664411,0.0001557398,0.0003952737,0.00026485696,0.000007653722,0.0005142915,0.00041453473,0.000003813743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016199067,0.000036172623,0.000058335918,0.00013878387,0.000049702594,0.0000015383699,0.00016508174,0.020651562,0.97520655,0.000121172634,0.0013059765,0.0021031015],"study_design_scores_gemma":[0.00050694874,0.00015959276,0.00024223578,0.00007131215,0.000011184521,0.0000014167615,0.000035117304,0.0209648,0.9764115,0.00007554099,0.0013990507,0.00012127661],"about_ca_topic_score_codex":0.00013162084,"about_ca_topic_score_gemma":0.00012415634,"teacher_disagreement_score":0.0148868235,"about_ca_system_score_codex":0.000081631966,"about_ca_system_score_gemma":0.00093297404,"threshold_uncertainty_score":0.5164397},"labels":[],"label_agreement":null},{"id":"W3047563634","doi":"10.1158/1538-7445.pedca19-b08","title":"Abstract B08: Beyond synthetic lethality: Multiple mechanisms can explain genetic interactions within childhood cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Synthetic lethality; Cancer; Gene; Genetics; Biology; Cancer cell; Mutation; Computational biology; DNA repair","score_opus":0.05132567977518505,"score_gpt":0.35326560265178936,"score_spread":0.3019399228766043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047563634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988012,0.0050172727,0.00049198396,0.0042602704,0.00040204072,0.00061930873,0.00070802146,0.000035390964,0.00045371373],"genre_scores_gemma":[0.9946605,0.0014595641,0.00046972802,0.0012579347,0.0010217852,0.00059489853,0.00014341969,0.000066816385,0.00032534476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765956,0.00018654298,0.00032090495,0.00076679996,0.00048036306,0.00058580865],"domain_scores_gemma":[0.9984829,0.000048212958,0.00008033777,0.00048748706,0.00032806242,0.0005730102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026506238,0.00023152008,0.00020595068,0.00009323232,0.00031401316,0.000091110145,0.00042126342,0.00014173909,0.00069101556],"category_scores_gemma":[0.00029669475,0.00024101752,0.000130686,0.0002490699,0.00020518845,0.000008169937,0.00020454136,0.00039816735,0.00003596718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027157637,0.00023396817,0.0019676033,0.00014703292,0.00012574182,0.000023669414,0.0008251643,0.0006780522,0.98231846,0.00008356731,0.00960665,0.0037185191],"study_design_scores_gemma":[0.0018456946,0.00035580012,0.012365509,0.00012868721,0.000058035817,0.000010753826,0.0014734841,0.00021300977,0.95690125,0.0015887675,0.024465494,0.0005935008],"about_ca_topic_score_codex":0.0010712367,"about_ca_topic_score_gemma":0.002715432,"teacher_disagreement_score":0.02541719,"about_ca_system_score_codex":0.00010277203,"about_ca_system_score_gemma":0.0006873371,"threshold_uncertainty_score":0.98284096},"labels":[],"label_agreement":null},{"id":"W3047568984","doi":"10.1158/1538-7445.pedca19-b25","title":"Abstract B25: HNRNPH1-dependent splicing of the fusion oncogene <i>EWS-FLI1</i> reveals a targetable RNA G-quadruplex interaction","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exon; RNA; Biology; RNA splicing; Transcription (linguistics); Fusion protein; Alternative splicing; Telomere; Ribonucleoprotein; RNA-binding protein; Messenger RNA; Molecular biology; Cell biology; Genetics; Gene","score_opus":0.14045057276669162,"score_gpt":0.4213511612875352,"score_spread":0.28090058852084354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047568984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97711945,0.003223616,0.000007071997,0.01443596,0.00019204587,0.00088893657,0.0000309998,0.000024850846,0.004077075],"genre_scores_gemma":[0.9960246,0.0019314019,0.000061439416,0.000804966,0.00039626448,0.00019271587,0.0000105099325,0.000032158627,0.0005459068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775994,0.000113712005,0.0003653656,0.00037612818,0.00097221404,0.00041262357],"domain_scores_gemma":[0.9987014,0.00020095795,0.00012549938,0.00042582946,0.00031411552,0.00023217616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005807866,0.0001470857,0.00033615285,0.0000929261,0.0001797065,0.000030700612,0.00021706156,0.00007796552,0.0012776016],"category_scores_gemma":[0.00019397511,0.00009568829,0.00016190503,0.0005120663,0.00008119367,0.000096476346,0.00020489341,0.00053490326,0.00009797716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052000117,0.00037898202,0.032690845,0.00030504263,0.00013317277,0.00006982573,0.0008561383,0.00013013452,0.9336849,0.0000510792,0.010289717,0.020890158],"study_design_scores_gemma":[0.0019831469,0.00031350635,0.07143093,0.0008026035,0.00008745311,0.00001616203,0.0007126831,0.00015006443,0.9075012,0.00007567933,0.01679327,0.000133296],"about_ca_topic_score_codex":0.002545273,"about_ca_topic_score_gemma":0.00014249794,"teacher_disagreement_score":0.038740087,"about_ca_system_score_codex":0.00044402096,"about_ca_system_score_gemma":0.0002881495,"threshold_uncertainty_score":0.99963534},"labels":[],"label_agreement":null},{"id":"W3047570049","doi":"10.1158/1538-7445.pedca19-a57","title":"Abstract A57: Feasibility of physical activity in children with cancer: A multidisciplinary program in the context of the VIE study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Context (archaeology); Medicine; Psychological intervention; Multidisciplinary approach; Intervention (counseling); Cancer; Physical activity; Physical therapy; Pediatric oncology; Nursing; Internal medicine","score_opus":0.16555719935132035,"score_gpt":0.48877832108439995,"score_spread":0.3232211217330796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047570049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196644,0.0003604286,2.410358e-7,0.011038987,0.000021462016,0.0063878447,0.00008234066,0.000015647922,0.00012658528],"genre_scores_gemma":[0.99879706,0.000039169554,0.0000070008077,0.00012384025,0.00016790841,0.00083352736,0.0000022721188,0.000022536342,0.00000670566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963172,0.00087480695,0.00035184552,0.00050877774,0.0015325737,0.00041479451],"domain_scores_gemma":[0.9983222,0.00041883346,0.00015947041,0.0007432584,0.00023182345,0.00012441784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018763593,0.00017581969,0.00060809596,0.00008355086,0.00007757229,0.000014136144,0.0005988127,0.00007615934,0.000029177045],"category_scores_gemma":[0.00031007256,0.00009706157,0.00011889486,0.001455096,0.0006722651,0.000089560504,0.00026172076,0.0016877326,0.0000012559618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022006126,0.0051186983,0.9390175,0.00035086344,0.0001065191,0.0000066406365,0.038981948,0.0000346965,0.0025037068,0.000008927552,0.00007703546,0.011592877],"study_design_scores_gemma":[0.003734534,0.0016561121,0.9790604,0.00040329475,0.00002998674,0.0000011093306,0.010909265,0.00008703746,0.0039929543,0.000016219901,0.000016469932,0.00009258982],"about_ca_topic_score_codex":0.03589766,"about_ca_topic_score_gemma":0.03397334,"teacher_disagreement_score":0.04004295,"about_ca_system_score_codex":0.0003013985,"about_ca_system_score_gemma":0.0012590124,"threshold_uncertainty_score":0.98365414},"labels":[],"label_agreement":null},{"id":"W3047583852","doi":"10.1158/1538-7445.pedca19-pr16","title":"Abstract PR16: Comprehensive transcriptomic characterization of 1,400 sarcomas for diagnosis and immune contexture","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Transcriptome; Computational biology; RNA-Seq; Biology; RNA; Fusion gene; Gene; Gene expression; Bioinformatics; Pathology; Medicine; Genetics","score_opus":0.1497444050228511,"score_gpt":0.40160285104030474,"score_spread":0.25185844601745366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047583852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727996,0.011310199,0.000016309172,0.013869919,0.00004875181,0.0015575358,0.00032208842,0.000018201245,0.000057421006],"genre_scores_gemma":[0.9933542,0.00482849,0.000052124808,0.0004650092,0.00014150774,0.0009662602,0.00013848516,0.0000265502,0.000027355802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892473,0.00004028144,0.0002385307,0.00027101915,0.00027521345,0.00025022274],"domain_scores_gemma":[0.99901736,0.00024547687,0.000055685858,0.00014844464,0.00036348504,0.00016954988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001078811,0.00011598065,0.00036135103,0.00007909918,0.000079890786,0.000019351712,0.00007312927,0.000075368895,0.00019771578],"category_scores_gemma":[0.000060356255,0.000095622076,0.000093441835,0.00018764412,0.00013912494,0.00006147419,0.000025462296,0.00018889959,0.0000052125743],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012348513,0.00037019124,0.068976715,0.0011236108,0.00027054828,0.00002874923,0.0016871839,9.61365e-7,0.8595138,0.00018390805,0.001323434,0.065286055],"study_design_scores_gemma":[0.0037194104,0.0005585471,0.6346873,0.0003411505,0.000079771984,0.0000036031936,0.00027381632,0.000050461345,0.33790734,0.00003431473,0.02224808,0.000096193704],"about_ca_topic_score_codex":0.000157376,"about_ca_topic_score_gemma":0.0000116299925,"teacher_disagreement_score":0.5657106,"about_ca_system_score_codex":0.00007014599,"about_ca_system_score_gemma":0.0001151902,"threshold_uncertainty_score":0.38993552},"labels":[],"label_agreement":null},{"id":"W3047584058","doi":"10.1158/1538-7445.pedca19-a33","title":"Abstract A33: HIF2 in pediatric high-grade glioma and its targeting","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenetics; Biomarker; Cancer research; Biology; Histone; Pediatric cancer; Medicine; Bioinformatics; Cancer; Oncology; Gene; Genetics","score_opus":0.04835794206433006,"score_gpt":0.35402043601966054,"score_spread":0.30566249395533046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047584058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488116,0.04886775,0.0000040025734,0.0015105236,0.00028685742,0.00021261787,0.000030421954,0.000009252381,0.00026697808],"genre_scores_gemma":[0.97518295,0.019902546,0.00003937659,0.0001710644,0.004443939,0.00006849655,0.00002367487,0.000025725436,0.00014224104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985733,0.000072683026,0.00017548715,0.00044671327,0.00027304032,0.00045876415],"domain_scores_gemma":[0.99947673,0.000023488361,0.000035054596,0.00013682454,0.00011039641,0.0002175311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038555087,0.00011605103,0.00015290425,0.00009969715,0.00008008954,0.00003757082,0.00020561946,0.00012630294,0.00008883535],"category_scores_gemma":[0.00022359283,0.00011552046,0.000037106474,0.00039441095,0.00005304675,0.000007105882,0.00018493705,0.00031811645,0.000017716371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010893158,0.000025532632,0.0017890278,0.00012695669,0.000011554513,0.0000111334375,0.0001534293,0.00003036942,0.97883373,0.000058328893,0.015588809,0.0032622113],"study_design_scores_gemma":[0.0023028564,0.00020291308,0.06568524,0.000025578905,0.000016967895,0.0000051935745,0.00020553955,0.000046454494,0.6598739,0.000105361156,0.27110595,0.00042404165],"about_ca_topic_score_codex":0.0002662903,"about_ca_topic_score_gemma":0.00011840845,"teacher_disagreement_score":0.3189598,"about_ca_system_score_codex":0.000026201687,"about_ca_system_score_gemma":0.00023602025,"threshold_uncertainty_score":0.47107878},"labels":[],"label_agreement":null},{"id":"W3047585484","doi":"10.1158/1538-7445.pedca19-a35","title":"Abstract A35: P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vincristine; Neuroblastoma; Crizotinib; Etoposide; Doxorubicin; Cancer research; Medicine; Drug resistance; P-glycoprotein; Anaplastic lymphoma kinase; Gene knockdown; Multiple drug resistance; Pharmacology; Oncology; Chemotherapy; Internal medicine; Biology; Lung cancer; Cell culture; Cyclophosphamide","score_opus":0.06580783660990208,"score_gpt":0.36725919133652274,"score_spread":0.30145135472662066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047585484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656218,0.00013006391,0.00007085418,0.031138433,0.0001260261,0.0023911847,0.000254953,0.000059268183,0.00020738626],"genre_scores_gemma":[0.99398965,0.00047958601,0.0003669779,0.0012042021,0.0005572489,0.0013512605,0.000027658776,0.000076309036,0.0019471061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967435,0.00013783733,0.00036947615,0.0007547403,0.0012248497,0.0007696074],"domain_scores_gemma":[0.9984891,0.00015292961,0.000099002464,0.00030084193,0.0005106619,0.00044748627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048249186,0.00021824281,0.00034178465,0.00032356847,0.00020551187,0.000059754722,0.00019818998,0.0001445401,0.0006000797],"category_scores_gemma":[0.0004043547,0.00020403789,0.00013979257,0.0007608812,0.00017068512,0.0001680119,0.00007125239,0.00095639203,0.00011448297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019155294,0.00063424406,0.0010590577,0.0008410573,0.0002276306,0.0004449203,0.00046669686,0.000007968514,0.9286355,0.001551635,0.031182224,0.015793798],"study_design_scores_gemma":[0.0108312005,0.0016400978,0.020212743,0.00033324727,0.000017143653,0.00000821216,0.00012050198,0.00011337616,0.95575655,0.00231807,0.008444211,0.00020465392],"about_ca_topic_score_codex":0.00091674685,"about_ca_topic_score_gemma":0.00027109176,"teacher_disagreement_score":0.029934231,"about_ca_system_score_codex":0.00040758212,"about_ca_system_score_gemma":0.00061129156,"threshold_uncertainty_score":0.83204234},"labels":[],"label_agreement":null},{"id":"W3047591876","doi":"10.1158/1538-7445.pedca19-b16","title":"Abstract B16: <i>MECOM</i> dysregulation is associated with poor outcome in pediatric therapy-related myeloid neoplasms","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid; Medicine; Cancer research; Fusion gene; Biology; Oncology; Genetics; Gene","score_opus":0.08531234762386512,"score_gpt":0.3783933516594323,"score_spread":0.29308100403556714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047591876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667267,0.0012557688,0.0000060120465,0.027363593,0.000065625245,0.0014830938,0.000044812346,0.00013052943,0.002923829],"genre_scores_gemma":[0.993966,0.0013034164,0.000045303696,0.0017330054,0.00035630248,0.00022184153,0.00008912549,0.00011325929,0.002171772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952092,0.0002818018,0.00062716566,0.00077704166,0.0019365966,0.0011681494],"domain_scores_gemma":[0.9976311,0.00052926637,0.00013353492,0.00043120075,0.00068628346,0.00058862515],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001633808,0.00029495536,0.00059394294,0.00061047444,0.00017907193,0.00008613664,0.00042598197,0.00034633887,0.002110004],"category_scores_gemma":[0.0007223253,0.00023474764,0.00011038274,0.0037219278,0.00022351957,0.00024248725,0.00014658603,0.0023837537,0.0003926829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003932243,0.00041677206,0.9079451,0.00036587132,0.00033572066,0.0008800223,0.0036779973,0.00029446164,0.030925099,0.000051479346,0.03666368,0.014511575],"study_design_scores_gemma":[0.014653089,0.0012238664,0.9645934,0.00020936824,0.00005115332,0.00001840945,0.00042569582,0.0021380035,0.011345954,0.000095557385,0.004741503,0.000503974],"about_ca_topic_score_codex":0.00086402777,"about_ca_topic_score_gemma":0.0002543656,"teacher_disagreement_score":0.056648348,"about_ca_system_score_codex":0.001558442,"about_ca_system_score_gemma":0.0017605758,"threshold_uncertainty_score":0.9999178},"labels":[],"label_agreement":null},{"id":"W3047592794","doi":"10.1158/1538-7445.pedca19-ia13","title":"Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Medicine; Cancer research; Panobinostat; Pediatric cancer; Cancer; Targeted therapy; Pharmacology; Oncology; Histone; Internal medicine; Biology; Histone deacetylase","score_opus":0.060040064020927375,"score_gpt":0.3746137212664933,"score_spread":0.3145736572455659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047592794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846294,0.0055090324,0.000037848582,0.008140166,0.000013198589,0.0013829509,0.00005599304,0.000042976764,0.00018842811],"genre_scores_gemma":[0.9972519,0.001037763,0.00020277404,0.00088447804,0.00014492396,0.00022149037,0.000010851407,0.000060180366,0.00018559356],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981263,0.00008294802,0.0001560397,0.00050023064,0.00067289826,0.00046155826],"domain_scores_gemma":[0.9988372,0.00022097773,0.000039085564,0.00021230572,0.00023465807,0.00045581246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002558424,0.00017853694,0.0002865727,0.00015464993,0.00015464562,0.000039264174,0.000102094025,0.000059618313,0.00016618],"category_scores_gemma":[0.0002387357,0.00011383371,0.000028776572,0.00027382688,0.0004968014,0.00008611795,0.0000781327,0.00034551774,0.000006149839],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058568423,0.00013671159,0.020027924,0.0003574648,0.00040341372,0.0002015646,0.001053269,0.0000029207051,0.94332415,0.00010202881,0.004994276,0.023539439],"study_design_scores_gemma":[0.016869774,0.019248342,0.7075107,0.0010247501,0.00012864459,0.00015362361,0.0004845526,0.00008979185,0.22879696,0.00034114288,0.024933148,0.00041852886],"about_ca_topic_score_codex":0.0001666364,"about_ca_topic_score_gemma":0.00002352872,"teacher_disagreement_score":0.7145272,"about_ca_system_score_codex":0.00004076806,"about_ca_system_score_gemma":0.00015392445,"threshold_uncertainty_score":0.46420038},"labels":[],"label_agreement":null},{"id":"W3047594115","doi":"10.1158/1538-7445.pedca19-b54","title":"Abstract B54: Enhancer reprogramming by ASPSCR1-TFE3 in alveolar soft part sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alveolar soft part sarcoma; Biology; TFEB; Enhancer; Epigenetics; H3K4me3; Gene; Phenotype; Reprogramming; Cancer research; Basic helix-loop-helix leucine zipper transcription factors; Genetics; Transcription factor; Cell biology; DNA-binding protein; Gene expression; Promoter; Sarcoma; Medicine; Pathology","score_opus":0.05477278328385826,"score_gpt":0.3701689522890445,"score_spread":0.31539616900518624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047594115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756388,0.018720128,0.00016038406,0.0030483284,0.00018336481,0.00041557738,0.00012530592,0.00001735475,0.001690732],"genre_scores_gemma":[0.99221194,0.00516478,0.00010432184,0.0008170011,0.00090726843,0.00024106493,0.00012897141,0.000048455073,0.0003762162],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794513,0.00006878131,0.00028149458,0.00069343206,0.00034432122,0.0006668148],"domain_scores_gemma":[0.9990349,0.000065500004,0.000052897773,0.0004086708,0.00016254665,0.000275495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054031605,0.00016402072,0.00019525544,0.000052750845,0.00010767955,0.000088687346,0.00039411697,0.00017475778,0.00030908178],"category_scores_gemma":[0.0004338419,0.00017574766,0.00008292211,0.00030677454,0.0001554324,0.000006792713,0.00027741594,0.00044031764,0.00006222047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023318785,0.00008209123,0.0056055603,0.00006909285,0.00003802621,0.000025742173,0.00015936182,0.000101417834,0.8338797,0.00003386138,0.109017104,0.050754838],"study_design_scores_gemma":[0.0005862455,0.00019936048,0.0010023887,0.00003516753,0.0000039773076,0.0000010638691,0.00011084125,0.000032442942,0.3454296,0.000053402433,0.6523417,0.00020377181],"about_ca_topic_score_codex":0.00088548247,"about_ca_topic_score_gemma":0.0006767029,"teacher_disagreement_score":0.54332465,"about_ca_system_score_codex":0.000111155074,"about_ca_system_score_gemma":0.0004036183,"threshold_uncertainty_score":0.71667814},"labels":[],"label_agreement":null},{"id":"W3047600203","doi":"10.1158/1538-7445.pedca19-a44","title":"Abstract A44: Comparative gene expression analysis for identification and prioritization of therapeutic targets in a cohort of childhood cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Cohort; Oncology; PI3K/AKT/mTOR pathway; Internal medicine; Bioinformatics; Biology; Signal transduction; Genetics","score_opus":0.05656914037018653,"score_gpt":0.38281214499898764,"score_spread":0.3262430046288011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047600203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98980165,0.0058817663,0.0034588573,0.00012461176,0.000020339357,0.00048006608,0.00020174641,0.0000012169419,0.000029720868],"genre_scores_gemma":[0.99651223,0.0029304363,0.00016189781,0.000026628917,0.000066864646,0.00012202421,0.00016506377,0.000007254544,0.000007579387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992602,0.00003387773,0.00021224492,0.0002366015,0.00013719118,0.000119871096],"domain_scores_gemma":[0.999442,0.00004338215,0.00009297382,0.00012438401,0.00024958298,0.0000477234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024067641,0.000057703794,0.00017090503,0.00008659979,0.000031439376,0.000009681588,0.0000925049,0.00005371825,0.000011001433],"category_scores_gemma":[0.000065665234,0.000058653102,0.000042724187,0.00029629708,0.00008187411,0.0000038552384,0.00004043933,0.00005595043,1.2511434e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017647313,0.0000301855,0.044056922,0.00006223858,0.00013143904,1.2541088e-7,0.0006592784,0.004228158,0.9497423,0.000023007924,0.00017275455,0.0007171164],"study_design_scores_gemma":[0.0003861714,0.00009754987,0.22143592,0.000014479592,0.000032314667,4.301211e-8,0.00017447557,0.00049279997,0.77700025,0.000050006816,0.0002636415,0.000052373034],"about_ca_topic_score_codex":0.00026093636,"about_ca_topic_score_gemma":0.00032946898,"teacher_disagreement_score":0.177379,"about_ca_system_score_codex":0.00004107118,"about_ca_system_score_gemma":0.00021705599,"threshold_uncertainty_score":0.23918042},"labels":[],"label_agreement":null},{"id":"W3047602186","doi":"10.1158/1538-7445.pedca19-ia01","title":"Abstract IA01: Pediatric neuro-oncology: What’s next?","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Bioinformatics; Medical physics; Internal medicine; Biology","score_opus":0.19918608849677588,"score_gpt":0.4492434152564978,"score_spread":0.2500573267597219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047602186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91427046,0.013869714,6.3924443e-7,0.06924171,0.00025377783,0.0005416824,0.00000617974,0.000052367683,0.0017634763],"genre_scores_gemma":[0.97355187,0.02226161,0.000034339322,0.0024497602,0.0013334814,0.00027908484,0.00001012004,0.000029072551,0.000050686547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983108,0.000068100555,0.00017884892,0.00038150078,0.00058278174,0.00047798053],"domain_scores_gemma":[0.99867254,0.00031015414,0.00003314895,0.00024213834,0.00022457232,0.0005174314],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002612356,0.00011441195,0.00024436475,0.00014419998,0.00011382554,0.00015351051,0.0001443176,0.00009128463,0.0016828969],"category_scores_gemma":[0.00027192605,0.000091399124,0.00008761491,0.00065248157,0.00007905416,0.00028422376,0.00009812679,0.00054235925,0.00086203346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011467465,0.0014621268,0.12159418,0.00073351077,0.00024131307,0.00648022,0.0020582462,0.000043618587,0.15569758,0.00029406222,0.3711415,0.33910692],"study_design_scores_gemma":[0.0073798867,0.0028282502,0.25332028,0.00016326732,0.00022479352,0.00005050091,0.0023587001,0.000119245065,0.046301577,0.0001267767,0.6867711,0.0003556462],"about_ca_topic_score_codex":0.0001678443,"about_ca_topic_score_gemma":0.000018844436,"teacher_disagreement_score":0.33875126,"about_ca_system_score_codex":0.00024773533,"about_ca_system_score_gemma":0.0005908104,"threshold_uncertainty_score":0.9999159},"labels":[],"label_agreement":null},{"id":"W3047616895","doi":"10.1158/1538-7445.pedca19-a53","title":"Abstract A53: Synergistic interaction of HDACi and PLK1i in Group 3 <i>MYC</i>-amplified medulloblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Medulloblastoma; Combination therapy; Cell culture; Cell cycle; Histone deacetylase inhibitor; Histone deacetylase; Cell; Biology; Histone; Pharmacology; Gene; Genetics","score_opus":0.06398248237271388,"score_gpt":0.39106994053472033,"score_spread":0.32708745816200646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047616895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574196,0.0011386948,0.000059735936,0.00064768584,0.00007982724,0.00027589215,0.00003445418,0.0000063125453,0.002015438],"genre_scores_gemma":[0.99866706,0.00053638173,0.00003694869,0.0000686763,0.0002789576,0.00009746105,0.0000347602,0.000027973583,0.00025177954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827933,0.00015642619,0.0002728852,0.0004596328,0.0004335353,0.0003982008],"domain_scores_gemma":[0.99924165,0.000080310514,0.000050836243,0.00024518205,0.00017097872,0.00021106539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049688853,0.00012033367,0.00018613807,0.000150514,0.00006348496,0.000026754491,0.00023688709,0.00013886139,0.00021247641],"category_scores_gemma":[0.0004683608,0.00012259459,0.000045579603,0.00036107787,0.00029431455,0.000008240987,0.00023141649,0.0004649077,0.000047073703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058279175,0.000054873362,0.00046063642,0.00018007017,0.000021327069,0.00001520747,0.00020063936,0.00007039967,0.98926586,0.000042900185,0.0068773045,0.0022280167],"study_design_scores_gemma":[0.00083747203,0.0004578914,0.0020364784,0.00011284716,0.0000031818888,0.0000044003286,0.00033433829,0.00014613915,0.96746296,0.000016741438,0.028424036,0.00016353268],"about_ca_topic_score_codex":0.00053535186,"about_ca_topic_score_gemma":0.0004394862,"teacher_disagreement_score":0.021802891,"about_ca_system_score_codex":0.000087691114,"about_ca_system_score_gemma":0.00019410373,"threshold_uncertainty_score":0.4999262},"labels":[],"label_agreement":null},{"id":"W3047620687","doi":"10.1158/1538-7445.pedca19-a20","title":"Abstract A20: Single-cell immune TCR repertoire profiling in the context of immunotherapy by using three 10x Genomics libraries","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"T-cell receptor; Biology; Immune system; Gene expression profiling; Repertoire; Gene; T cell; Computational biology; Gene expression; Molecular biology; Immunology; Genetics","score_opus":0.08904234849044668,"score_gpt":0.3164002338438021,"score_spread":0.22735788535335544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047620687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759686,0.022151297,0.00023419669,0.00072373496,0.0000699833,0.00039841753,0.000056503366,0.0000067361334,0.000390508],"genre_scores_gemma":[0.99768394,0.0013978344,0.00020361535,0.00037800323,0.00017256553,0.000028591745,0.00005371939,0.00004111273,0.000040640774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985762,0.000116202726,0.00033975314,0.00033663167,0.0002659247,0.00036524984],"domain_scores_gemma":[0.9993365,0.000055408575,0.00008205198,0.0003467306,0.00012378534,0.00005553552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044087294,0.00014725307,0.00020862992,0.000040739513,0.00013816186,0.000073186035,0.0005586796,0.00015440588,0.00003563236],"category_scores_gemma":[0.000053558397,0.00011934245,0.000094930794,0.00022505148,0.0002919015,0.0000116724805,0.00008201525,0.00037314705,0.0000017939966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005703913,0.000112720256,0.0023838144,0.00008585365,0.000029608784,0.0000038829025,0.0011786177,0.00007631715,0.989199,0.000018706214,0.000268291,0.0060727936],"study_design_scores_gemma":[0.00081915397,0.0002488525,0.00018791278,0.000042474432,0.000003335708,0.0000012932057,0.0011935123,0.00019479904,0.99055123,0.00003293158,0.00658579,0.00013873671],"about_ca_topic_score_codex":0.0007407467,"about_ca_topic_score_gemma":0.00010892436,"teacher_disagreement_score":0.021715295,"about_ca_system_score_codex":0.000048623937,"about_ca_system_score_gemma":0.00032363556,"threshold_uncertainty_score":0.48666438},"labels":[],"label_agreement":null},{"id":"W3047627967","doi":"10.1158/1538-7445.pedca19-b35","title":"Abstract B35: Liaison between <i>SNAI2</i> and <i>MYOD</i> enhances oncogenesis and suppresses differentiation in fusion-negative rhabdomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MyoD; Gene knockdown; Cancer research; Molecular biology; MyoD Protein; Transcription factor; Enhancer; Biology; Myogenesis; Chemistry; Cell biology; Myocyte; Genetics; Cell culture; Gene","score_opus":0.04401302179370022,"score_gpt":0.3542113554689621,"score_spread":0.3101983336752619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047627967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906278,0.0056422837,0.0004528823,0.0022863531,0.00004901565,0.00056898216,0.000089293375,0.000014343834,0.0002690138],"genre_scores_gemma":[0.9909219,0.008077869,0.00010492376,0.00016040722,0.00035493294,0.00019272034,0.00006388078,0.000042626863,0.00008074127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976048,0.00024515946,0.00026605107,0.0007626983,0.0005607631,0.0005605167],"domain_scores_gemma":[0.99901605,0.0001457211,0.00006162678,0.0002487512,0.00022274374,0.00030511964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004454919,0.00020656153,0.00026379904,0.00014656552,0.00017969674,0.00010695174,0.00027922823,0.00024110576,0.00007969637],"category_scores_gemma":[0.00034898808,0.00020409423,0.00004747376,0.00042253413,0.00026483973,0.000019387144,0.00050734996,0.00048717443,0.0000068338218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031194568,0.000030880034,0.0038675987,0.00016026804,0.00005566537,0.000011867675,0.00035603254,0.000013141192,0.97942966,0.000016611624,0.00093985215,0.014806479],"study_design_scores_gemma":[0.0010474205,0.0003461435,0.019849733,0.00008977165,0.000011976167,0.000002041319,0.00022949827,0.000058659076,0.97375643,0.0001655581,0.0042176996,0.00022507564],"about_ca_topic_score_codex":0.0006555609,"about_ca_topic_score_gemma":0.00057290716,"teacher_disagreement_score":0.015982132,"about_ca_system_score_codex":0.00006718992,"about_ca_system_score_gemma":0.000262319,"threshold_uncertainty_score":0.8322721},"labels":[],"label_agreement":null},{"id":"W3047655686","doi":"10.1158/1538-7445.pedca19-pr12","title":"Abstract PR12: IL6-mediated self-seeding functions to prevent osteosarcoma metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Primary tumor; Osteosarcoma; Circulating tumor cell; Cancer research; Tumor microenvironment; Chemotaxis; Medicine; Pathology; Tumor cells; Cancer; Immunology; Biology; Internal medicine; Receptor","score_opus":0.14649721693722775,"score_gpt":0.4150629780306347,"score_spread":0.2685657610934069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047655686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92879605,0.004246001,0.00013551736,0.052596007,0.0005014008,0.0024036507,0.00047878284,0.00031726473,0.010525303],"genre_scores_gemma":[0.9925073,0.0010150063,0.0008641242,0.0019310252,0.0011982954,0.0006273737,0.00007057628,0.000076208526,0.0017101319],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692976,0.00009641021,0.00036501396,0.0006403132,0.0011502904,0.000818234],"domain_scores_gemma":[0.99764663,0.00018442975,0.000053822332,0.00039344528,0.00051317934,0.0012085082],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008080075,0.00021133496,0.00042912934,0.00029184174,0.00023290416,0.00007809597,0.00024010976,0.00008834031,0.0040880083],"category_scores_gemma":[0.00039193206,0.00018542455,0.00018196122,0.0017075918,0.00007595737,0.000116168376,0.00021436799,0.0007624093,0.0013114086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014523009,0.00081385043,0.0030516938,0.0013591013,0.0010541982,0.00028947662,0.003691996,0.000093917566,0.52827615,0.00007470374,0.3416522,0.11819043],"study_design_scores_gemma":[0.0014503024,0.0007741156,0.005254604,0.00020673497,0.00020253813,0.000013616068,0.0012127154,0.000038142058,0.064551264,0.00000802869,0.9260188,0.00026918406],"about_ca_topic_score_codex":0.0006729661,"about_ca_topic_score_gemma":0.0001327042,"teacher_disagreement_score":0.58436656,"about_ca_system_score_codex":0.00053903606,"about_ca_system_score_gemma":0.0008454529,"threshold_uncertainty_score":0.9994662},"labels":[],"label_agreement":null},{"id":"W3047661378","doi":"10.1158/1538-7445.pedca19-ia21","title":"Abstract IA21: Blocking purine synthesis in cancer promotes response to immunotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer; Cancer immunotherapy; Purine; Transversion; Cancer research; Mutagenesis; Purine analogue; Nucleotide; Mutation; Biology; Genetics; Medicine; Gene; Biochemistry","score_opus":0.08735693364780281,"score_gpt":0.4168034415099978,"score_spread":0.329446507862195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047661378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489505,0.006810937,0.000054597385,0.007587864,0.000048922782,0.00036102138,0.000027373406,0.000008101764,0.0002061282],"genre_scores_gemma":[0.99610734,0.0025780722,0.00017132043,0.000211222,0.00030680394,0.00039479273,0.0000049341966,0.000033339784,0.00019217104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855727,0.00020205055,0.00018788199,0.00039787468,0.00028327634,0.00037163304],"domain_scores_gemma":[0.9993277,0.000091987895,0.000030735584,0.00024573485,0.0001572042,0.00014661101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009638446,0.0001088281,0.00012996941,0.000104391096,0.000078060795,0.000043250413,0.00025722446,0.00010106456,0.00023491457],"category_scores_gemma":[0.0006077114,0.00010618672,0.00004243289,0.00036677837,0.00004896854,0.0000034569123,0.000115945,0.00019741038,0.000016644286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012249494,0.000029903244,0.004130761,0.000024098059,0.000022865952,0.000005934758,0.00027741742,0.00039339229,0.9600751,0.0000020252533,0.000267648,0.03354594],"study_design_scores_gemma":[0.0002723536,0.00018899949,0.032944143,0.00004890654,0.0000016920932,1.3858266e-7,0.00004966174,0.00003097458,0.9260277,0.000021258185,0.040285073,0.00012909246],"about_ca_topic_score_codex":0.0006099119,"about_ca_topic_score_gemma":0.00033555884,"teacher_disagreement_score":0.040017426,"about_ca_system_score_codex":0.00007603132,"about_ca_system_score_gemma":0.00028154784,"threshold_uncertainty_score":0.43301687},"labels":[],"label_agreement":null},{"id":"W3047663499","doi":"10.1158/1538-7445.pedca19-a14","title":"Abstract A14: Exploiting DNA damage repair defects to enhance PD-L1 expression in Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Cancer research; Biology; DNA damage; Poly ADP ribose polymerase; Apoptosis; PARP inhibitor; Cell culture; DNA repair; Molecular biology; Polymerase; Genetics","score_opus":0.1526339092066052,"score_gpt":0.46741168541344963,"score_spread":0.31477777620684444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047663499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850971,0.0012662589,0.00016131089,0.0067530065,0.00013224082,0.0009410884,0.000016168204,0.00020855962,0.005424234],"genre_scores_gemma":[0.99391603,0.00028192962,0.0009926902,0.0028667657,0.0009280041,0.0006467504,0.00001021994,0.00007265955,0.00028494943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99667066,0.00021059449,0.00043707225,0.00076312094,0.0010711083,0.0008474448],"domain_scores_gemma":[0.9982403,0.00033382932,0.000065935514,0.0005091854,0.0002550992,0.0005956304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011315295,0.00019966153,0.00037204812,0.0003160805,0.00018067926,0.000049824986,0.0002740195,0.00012303436,0.0011980257],"category_scores_gemma":[0.00073574216,0.00019764384,0.000115046656,0.0011848229,0.00011181254,0.00023494619,0.00020209304,0.0010876692,0.000284337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009867577,0.000066882305,0.0051153507,0.00037176546,0.000014693481,0.00028497723,0.0029715926,0.000078400204,0.9710183,0.000021143,0.0146826375,0.0043874905],"study_design_scores_gemma":[0.0012723,0.00028036188,0.022579286,0.002313591,0.000004377649,0.0000040476507,0.00095935183,0.0000888693,0.9535988,0.00009164028,0.018590422,0.00021692997],"about_ca_topic_score_codex":0.00020205478,"about_ca_topic_score_gemma":0.000059177444,"teacher_disagreement_score":0.017463936,"about_ca_system_score_codex":0.00075923477,"about_ca_system_score_gemma":0.00046131137,"threshold_uncertainty_score":0.99971503},"labels":[],"label_agreement":null},{"id":"W3047755466","doi":"10.1158/1538-7445.pedca19-b26","title":"Abstract B26: Prometastatic effect of ICG-001, a β-catenin/CBP dependent transcription inhibitor, in osteosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Wnt signaling pathway; Medicine; Cancer research; Beta-catenin; Catenin; Population; Internal medicine; Oncology; Signal transduction; Biology; Cell biology","score_opus":0.056732981823866185,"score_gpt":0.35462700203891095,"score_spread":0.29789402021504474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047755466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529123,0.0026534717,0.00001743846,0.00051198533,0.000055114248,0.00081437576,0.00007296598,0.000008765086,0.00057467597],"genre_scores_gemma":[0.9989441,0.0002290324,0.00003676289,0.00005236858,0.00017286687,0.0003468116,0.00007469764,0.000025406765,0.00011792038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982828,0.00030329844,0.00025560433,0.00037588537,0.00039760594,0.00038482322],"domain_scores_gemma":[0.9994752,0.00003906091,0.00004857907,0.00018442661,0.000106029176,0.00014674556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008917873,0.00013507107,0.00021202628,0.000096926,0.000045002533,0.000021824479,0.000246318,0.00011870586,0.00023690559],"category_scores_gemma":[0.00014344818,0.000119198645,0.00007028167,0.00026248637,0.0001202242,0.0000070646684,0.000082116516,0.00033435292,0.000033906465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070449227,0.000070695445,0.001088145,0.0006146129,0.00002332034,0.000016492031,0.00028247616,0.000019898484,0.986962,0.000008651255,0.00046279814,0.009746412],"study_design_scores_gemma":[0.0015831615,0.001336986,0.0013491603,0.00006935066,0.0000071212053,0.000002644861,0.00007092095,0.00002197635,0.99336,0.000024355031,0.0020572657,0.00011709762],"about_ca_topic_score_codex":0.0002709894,"about_ca_topic_score_gemma":0.00014757027,"teacher_disagreement_score":0.009629314,"about_ca_system_score_codex":0.00004031806,"about_ca_system_score_gemma":0.00018972071,"threshold_uncertainty_score":0.48607796},"labels":[],"label_agreement":null},{"id":"W3047839049","doi":"10.1158/1538-7445.pedca19-b61","title":"Abstract B61: Improvement of physical activity training in childhood acute lymphoblastic leukemia survivors: New specific equation to predict the peak oxygen uptake from the six-minute walk test","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; VO2 max; Test (biology); Generalized estimating equation; Blood cancer; Physical therapy; Statistics; Mathematics; Cancer; Internal medicine","score_opus":0.16034222998192216,"score_gpt":0.393780793582678,"score_spread":0.23343856360075582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047839049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96162945,0.00023550927,0.00013712618,0.036010932,0.00010569241,0.0013543385,0.00013779772,0.000027925582,0.00036120773],"genre_scores_gemma":[0.99666387,0.00025795115,0.00005629833,0.00090714364,0.0018358652,0.00015688717,0.000023791717,0.000028519515,0.00006966002],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775124,0.00009872091,0.00030938504,0.00039736615,0.00094474567,0.0004985422],"domain_scores_gemma":[0.9979404,0.0011345497,0.000085995576,0.00035424402,0.00014230127,0.0003425164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008317445,0.0001467295,0.00031459163,0.00008547959,0.00022785211,0.000040365012,0.00032033422,0.00006039633,0.00020025813],"category_scores_gemma":[0.00044281132,0.000095280964,0.00007837495,0.00070211984,0.00010763032,0.00008411662,0.00015060557,0.0007825132,0.00003363688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001719405,0.00050185155,0.0049809227,0.000335577,0.00017481322,0.00004301315,0.07209247,0.0003546966,0.5910936,0.00014554324,0.012024851,0.31653327],"study_design_scores_gemma":[0.0037002733,0.0009452367,0.9538255,0.0009199327,0.00004293542,0.0000017318943,0.0037816677,0.0035996744,0.02166937,0.00030822572,0.011040222,0.00016526657],"about_ca_topic_score_codex":0.004769441,"about_ca_topic_score_gemma":0.0010322012,"teacher_disagreement_score":0.94884455,"about_ca_system_score_codex":0.00073156116,"about_ca_system_score_gemma":0.001784867,"threshold_uncertainty_score":0.721},"labels":[],"label_agreement":null},{"id":"W3047846091","doi":"10.1158/1538-7445.pedca19-a25","title":"Abstract A25: Evaluation of Drug Disposition in Supratentorial Ependymoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Pharmacology; Medicine; Therapeutic index; Dosing; Pharmacokinetics; Drug delivery; Cancer research; Chemistry","score_opus":0.19716522679862147,"score_gpt":0.47470476414622614,"score_spread":0.27753953734760467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047846091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183476,0.00092928606,4.1682026e-7,0.0054120673,0.00011087881,0.00065169734,0.000016741133,0.0000065815366,0.0010375576],"genre_scores_gemma":[0.9992148,0.00010300745,0.000010111319,0.00003369081,0.00033266458,0.00024701457,0.00003665721,0.000009140285,0.000012863114],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983174,0.00011718292,0.00016774976,0.00018563228,0.0010294414,0.00018256309],"domain_scores_gemma":[0.9992494,0.00007275343,0.00002913739,0.000115672665,0.00041832027,0.000114746115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000920167,0.000055550117,0.00014346706,0.000112399546,0.000027257605,0.00001128422,0.000051532483,0.000036403406,0.001047194],"category_scores_gemma":[0.00018935968,0.000046002955,0.000038621598,0.00037395215,0.000039409617,0.000059642236,0.000024268578,0.00016814494,0.000053441963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003542022,0.0019295968,0.23887949,0.00066345104,0.00022516891,0.0005306479,0.005392433,0.0006694464,0.6533931,0.00080497225,0.020731108,0.07323858],"study_design_scores_gemma":[0.0076272083,0.00033199426,0.6804123,0.0003124317,0.000079648824,0.0000031253821,0.0004338821,0.0010184059,0.30879268,0.00022741072,0.00068028836,0.00008060823],"about_ca_topic_score_codex":0.0011655032,"about_ca_topic_score_gemma":0.00022752887,"teacher_disagreement_score":0.44153282,"about_ca_system_score_codex":0.00032632163,"about_ca_system_score_gemma":0.00032904005,"threshold_uncertainty_score":0.999866},"labels":[],"label_agreement":null},{"id":"W3047853280","doi":"10.1158/1538-7445.pedca19-a24","title":"Abstract A24: Identifying BRCAness in osteosarcoma with DNA-methylation profiling and gene expression signatures","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Loss of heterozygosity; Biology; Synthetic lethality; DNA methylation; Genome instability; Genetics; Cancer research; Gene; Molecular biology; Allele; DNA; Gene expression; DNA repair; DNA damage","score_opus":0.053559953106763904,"score_gpt":0.35967217436557664,"score_spread":0.3061122212588127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047853280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922554,0.0065696957,0.00017102278,0.0004961073,0.000040906056,0.00029967746,0.000026897958,0.0000059297467,0.00013439644],"genre_scores_gemma":[0.9977447,0.0011061344,0.00046423275,0.00012353521,0.00037448766,0.000083216575,0.000058174246,0.00002394788,0.000021564081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989231,0.000050498984,0.00013548872,0.00038932337,0.00022875558,0.00027279518],"domain_scores_gemma":[0.99952,0.00004695978,0.000038334918,0.00015368433,0.000119610064,0.00012141949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024200827,0.00009942631,0.00010750185,0.00006269927,0.000092283604,0.000071387054,0.00013766947,0.00010296818,0.000017305885],"category_scores_gemma":[0.00011618812,0.000089647576,0.000017693961,0.00017706436,0.000081384045,0.000007943537,0.00015539602,0.0002440146,0.0000017067971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026233934,0.0000132183095,0.0067557567,0.00008672983,0.000008658065,0.000017666885,0.00018825028,0.00061932136,0.9889186,0.00001561512,0.00024714047,0.002866693],"study_design_scores_gemma":[0.00063342496,0.00011938485,0.013373477,0.00006777175,0.0000029215453,0.0000016219674,0.00026588785,0.000068224006,0.98380804,0.000048122165,0.0014843313,0.00012681287],"about_ca_topic_score_codex":0.00014274534,"about_ca_topic_score_gemma":0.00016655846,"teacher_disagreement_score":0.0066177207,"about_ca_system_score_codex":0.00003873199,"about_ca_system_score_gemma":0.00019532224,"threshold_uncertainty_score":0.3655722},"labels":[],"label_agreement":null},{"id":"W3047969091","doi":"10.1158/1538-7445.pedca19-b42","title":"Abstract B42: Mutant RAS represses CASZ1, a novel regulator of MYOD and MYOG, to inhibit embryonal rhabdomyosarcoma differentiation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MyoD; Myogenesis; MYF5; Enhancer; Myogenic regulatory factors; Biology; Transcription factor; Myogenin; Cell biology; MyoD Protein; Cellular differentiation; Cancer research; Molecular biology; Myocyte; Genetics; Gene","score_opus":0.05148252507054291,"score_gpt":0.35021822938500424,"score_spread":0.29873570431446134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047969091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950909,0.0014548992,0.0004929402,0.002225473,0.000079414385,0.0004421865,0.00010761362,0.000011345709,0.00009519743],"genre_scores_gemma":[0.99871683,0.0002880152,0.00015237517,0.000087774155,0.00042974995,0.00007696142,0.00006330841,0.000030848787,0.00015411328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983763,0.00005344981,0.00028282485,0.00053292734,0.00044640683,0.00030806335],"domain_scores_gemma":[0.99901855,0.000029511426,0.000076320786,0.00031353944,0.00034007526,0.00022202801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024969902,0.00013873674,0.00018685058,0.0000946544,0.00009017893,0.000036475263,0.00017172271,0.00016411803,0.000099160905],"category_scores_gemma":[0.00023419024,0.00013894937,0.00005741551,0.000315338,0.00013454435,0.000009397723,0.00024232663,0.0001861393,0.0000050819203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004896458,0.000045615365,0.001101263,0.00012169056,0.00006201101,0.0000016741951,0.00023175533,0.0005201536,0.9915005,0.00005299846,0.0018986337,0.0039740517],"study_design_scores_gemma":[0.00080440444,0.00027426478,0.047955908,0.00008317206,0.000013279927,0.0000056545937,0.00007268763,0.0002516601,0.9454833,0.0000391483,0.0048593683,0.00015713427],"about_ca_topic_score_codex":0.00024950653,"about_ca_topic_score_gemma":0.00017159553,"teacher_disagreement_score":0.046854645,"about_ca_system_score_codex":0.0000650769,"about_ca_system_score_gemma":0.00026935924,"threshold_uncertainty_score":0.56661904},"labels":[],"label_agreement":null},{"id":"W3048036485","doi":"10.1158/1538-7445.pedca19-b74","title":"Abstract B74: Investigating the role of tumor:bone microenvironment crosstalk in Ewing sarcoma progression","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Cancer research; Tumor microenvironment; Metastasis; Medicine; Wnt signaling pathway; Angiogenesis; Tumor progression; Ewing's sarcoma; Crosstalk; Biology; Pathology; Cancer; Immunology; Internal medicine; Cell biology; Signal transduction","score_opus":0.09859623654936583,"score_gpt":0.4248860469714638,"score_spread":0.326289810422098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048036485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984389,0.0075289533,2.8146786e-7,0.0066675115,0.000016660511,0.00073853927,0.000009260524,0.000011082511,0.000638689],"genre_scores_gemma":[0.99892914,0.00018511394,0.00016860571,0.00042775724,0.0000625737,0.00016310829,0.0000065225563,0.000018845572,0.000038325205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842566,0.00008260551,0.0002777369,0.00023500396,0.00054657244,0.00043244584],"domain_scores_gemma":[0.99933195,0.00009410837,0.00006610698,0.00019399589,0.00004300864,0.00027081207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004778919,0.00008811835,0.00019831149,0.000059383157,0.00013209872,0.000014360418,0.000096790856,0.000039172188,0.00011697334],"category_scores_gemma":[0.00014635398,0.000058391022,0.000035469136,0.00030798122,0.000250818,0.000045182518,0.000105605744,0.0005415967,0.000026717666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036080187,0.00019890745,0.5046929,0.00046392734,0.00002331675,0.00013909742,0.0026080583,0.000011379425,0.41975802,0.000021573622,0.00025406294,0.07146797],"study_design_scores_gemma":[0.002459342,0.00045011638,0.6619492,0.0011146229,0.000012640419,0.000013057526,0.0012423353,0.00023457212,0.32472202,0.00020483929,0.007507226,0.000090005444],"about_ca_topic_score_codex":0.0013703527,"about_ca_topic_score_gemma":0.00007786951,"teacher_disagreement_score":0.15725634,"about_ca_system_score_codex":0.00021638104,"about_ca_system_score_gemma":0.00034120097,"threshold_uncertainty_score":0.23811169},"labels":[],"label_agreement":null},{"id":"W3048040101","doi":"10.1158/1538-7445.pedca19-a04","title":"Abstract A04: Childhood cancer incidence among specific Asian and Pacific Islander populations in the U.S.","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pacific islanders; Demography; Incidence (geometry); Medicine; Rate ratio; Epidemiology; Confidence interval; Population; Ethnic group; Internal medicine","score_opus":0.11877088428077964,"score_gpt":0.4042256676866003,"score_spread":0.28545478340582064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048040101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378568,0.0024044206,0.00002134784,0.05187327,0.0000694196,0.0011070692,0.000038300474,0.000031137704,0.0065982393],"genre_scores_gemma":[0.99569494,0.0023759448,0.000053125805,0.00049570325,0.0006723765,0.00036018735,0.00001694879,0.000037689344,0.00029306975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688023,0.00019356083,0.0003006051,0.0005373102,0.001371492,0.00071680977],"domain_scores_gemma":[0.9986904,0.00027386838,0.000043551932,0.00041528995,0.00022160583,0.00035527634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092546374,0.00016697917,0.0002708526,0.00023936313,0.00025376183,0.00013198111,0.00038011148,0.00012972971,0.0010225972],"category_scores_gemma":[0.00035642378,0.00011563153,0.000051228937,0.0013296317,0.000496202,0.00018367663,0.00016753499,0.0013775345,0.00007656374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065716595,0.00028549245,0.7784748,0.00046830162,0.00010906011,0.0009421782,0.028469304,0.000108127584,0.0110736145,0.0007225059,0.14167294,0.037016496],"study_design_scores_gemma":[0.0015689319,0.0001109143,0.9853377,0.0002480814,0.000011417011,0.000023216784,0.0033727023,0.00032401265,0.00037875507,0.00023833831,0.008252015,0.00013393204],"about_ca_topic_score_codex":0.0027746568,"about_ca_topic_score_gemma":0.0013784206,"teacher_disagreement_score":0.20686287,"about_ca_system_score_codex":0.00069993787,"about_ca_system_score_gemma":0.0010911033,"threshold_uncertainty_score":0.9998906},"labels":[],"label_agreement":null},{"id":"W3048066516","doi":"10.1158/1538-7445.pedca19-b39","title":"Abstract B39: Modulation of insulin receptor alternative splicing to develop cancer therapeutics","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alternative splicing; Gene isoform; Exon; Biology; Cancer research; RNA splicing; Cancer; Insulin receptor; Cancer cell; Rhabdomyosarcoma; Angiogenesis; Insulin; Sarcoma; Endocrinology; Gene; Medicine; RNA; Insulin resistance; Genetics; Pathology","score_opus":0.14848633667340277,"score_gpt":0.4289123884060879,"score_spread":0.28042605173268514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048066516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925122,0.0016039349,0.0015642483,0.0034636937,0.00009261728,0.00030431803,0.00008907315,0.00000619027,0.000363726],"genre_scores_gemma":[0.9954287,0.0026562808,0.00039843438,0.0005452786,0.00047476892,0.0002012103,0.000031261494,0.0000233706,0.00024071534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989165,0.00005161291,0.00019359596,0.00031960232,0.00028703504,0.0002316441],"domain_scores_gemma":[0.99880207,0.000015503225,0.00006032926,0.00020906271,0.0007963634,0.00011667576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023646893,0.000090018155,0.000109998226,0.00005292974,0.00007832949,0.000019328196,0.00025736907,0.00007542934,0.00017764133],"category_scores_gemma":[0.00008256093,0.000085185755,0.000028705741,0.0005013925,0.00006537511,0.000005612033,0.000099020624,0.00015236848,0.000020216408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015695154,0.000017812403,0.001111212,0.000030336205,0.000051187166,2.3089228e-7,0.00055874814,0.0030690108,0.93985665,0.000068194306,0.0019867527,0.05309289],"study_design_scores_gemma":[0.0002997683,0.00012498203,0.017193882,0.000045262022,0.000004607106,1.16798084e-7,0.00018793443,0.0003586296,0.9047026,0.000029197914,0.076920755,0.0001322568],"about_ca_topic_score_codex":0.00067111506,"about_ca_topic_score_gemma":0.000114778944,"teacher_disagreement_score":0.074934,"about_ca_system_score_codex":0.0000838178,"about_ca_system_score_gemma":0.00044296036,"threshold_uncertainty_score":0.34737742},"labels":[],"label_agreement":null},{"id":"W3048096837","doi":"10.1158/1538-7445.pedca19-a39","title":"Abstract A39: Molecular characterization of ETMRs reveals role for R-loop mediated genomic instability and new treatment options","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Genome instability; Transcriptome; Germline; microRNA; Somatic cell; Cancer research; Genetics; DNA methylation; Gene; DNA damage; DNA; Gene expression","score_opus":0.08892611573984846,"score_gpt":0.375265180412793,"score_spread":0.28633906467294457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048096837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947315,0.0021413956,0.0006198309,0.0015703199,0.000018747276,0.0005530551,0.00028593,0.0000051220395,0.00007409581],"genre_scores_gemma":[0.995787,0.0030756,0.00013813382,0.00008475503,0.000120012504,0.0002656981,0.00033086032,0.000016034723,0.00018186128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992192,0.000044097513,0.00016777834,0.00029030457,0.00010673178,0.0001719338],"domain_scores_gemma":[0.99939924,0.000015935364,0.000052217674,0.00020793591,0.00018004244,0.00014465333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015940286,0.0000786119,0.00011594511,0.000031464668,0.00006701505,0.000018061786,0.00010427426,0.000077099285,0.000050652416],"category_scores_gemma":[0.00007692166,0.000073592964,0.00004464732,0.00011925297,0.000079431906,0.00000524183,0.000039089075,0.00005392291,0.0000023649102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012645416,0.000032573807,0.0007491441,0.000037249625,0.00003686238,1.9522378e-7,0.000108540575,0.000033954486,0.9899243,0.000082317136,0.00011619322,0.008752224],"study_design_scores_gemma":[0.00083666237,0.00037678762,0.03773654,0.0000131374245,0.00001573358,3.596662e-7,0.000088063956,0.00011948556,0.9332272,0.00009668305,0.027375454,0.000113920854],"about_ca_topic_score_codex":0.0001588216,"about_ca_topic_score_gemma":0.00002479527,"teacher_disagreement_score":0.05669712,"about_ca_system_score_codex":0.000055388737,"about_ca_system_score_gemma":0.000349935,"threshold_uncertainty_score":0.3001034},"labels":[],"label_agreement":null},{"id":"W3048110418","doi":"10.1158/1538-7445.pedca19-pr06","title":"Abstract PR06: The immunogenomic landscape of pediatric primary solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Cancer research; Tumor microenvironment; Immunotherapy; Immune checkpoint; CD8; Medicine; Pediatric cancer; Oncology; Cancer; Biology; Immunology; Internal medicine","score_opus":0.050209583159429305,"score_gpt":0.3556082680728142,"score_spread":0.3053986849133849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048110418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652095,0.010801467,0.00002485539,0.0007356987,0.000053457785,0.00017021375,0.00003200859,0.000006968774,0.0016544098],"genre_scores_gemma":[0.9953456,0.0031949522,0.000024906292,0.00020567121,0.00097381417,0.000042818767,0.000025731719,0.000020287605,0.00016620879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899316,0.000054699412,0.00018898731,0.00023648389,0.00026937062,0.00025732096],"domain_scores_gemma":[0.9994153,0.000024590803,0.000058004374,0.0002783422,0.00015120125,0.00007260963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036679677,0.00008206307,0.00012082408,0.000026223443,0.00009386623,0.000018522034,0.00037855085,0.00006405453,0.00012659132],"category_scores_gemma":[0.00006382857,0.00005983395,0.00007147552,0.00018436748,0.00009344718,0.0000021618991,0.00016589178,0.00021991035,0.000018671726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014882555,0.000020330555,0.0012481994,0.00013538361,0.00003415272,0.0000017217158,0.00017660279,0.00064880843,0.97922367,0.0000049118767,0.015479588,0.0028777826],"study_design_scores_gemma":[0.0010610771,0.00043177116,0.01846698,0.000041734012,0.000028736576,0.00000493008,0.00042052483,0.0002836098,0.9609525,0.00006131861,0.0179582,0.00028858875],"about_ca_topic_score_codex":0.00006904531,"about_ca_topic_score_gemma":0.000008144414,"teacher_disagreement_score":0.018271161,"about_ca_system_score_codex":0.00002506725,"about_ca_system_score_gemma":0.00051479205,"threshold_uncertainty_score":0.24399577},"labels":[],"label_agreement":null},{"id":"W3048125984","doi":"10.1158/1538-7445.pedca19-a05","title":"Abstract A05: Incidence and trends in head and neck cancer among United States’ pediatric, adolescent, and young adult population","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Population; Cancer; Head and neck cancer; Epidemiology; Young adult; Demography; Head and neck; Pediatrics; Surgery; Gerontology; Internal medicine; Environmental health","score_opus":0.08988312083530937,"score_gpt":0.42452755001612025,"score_spread":0.3346444291808109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048125984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218536,0.010889703,7.869583e-7,0.0063399975,0.000053257132,0.00028220992,0.000042474305,0.000025622325,0.00018055827],"genre_scores_gemma":[0.9561765,0.042762063,0.00001576513,0.0004785668,0.00029040157,0.000086489774,0.000029506817,0.000021194428,0.00013950744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984354,0.000061458246,0.00024046063,0.00043114534,0.00041027545,0.00042129986],"domain_scores_gemma":[0.9992271,0.00006124846,0.000044171225,0.0001068432,0.0002163252,0.000344323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025427298,0.00014604472,0.00031657997,0.00036400955,0.00014353983,0.000045039866,0.000052959313,0.00008133305,0.00006222424],"category_scores_gemma":[0.00013216367,0.00012864222,0.000016734153,0.001000023,0.00016813366,0.00015876,0.0001165467,0.0005621298,0.0000011935077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000382603,0.000023575973,0.97289723,0.0005428523,0.00001471211,0.000046497644,0.003014387,0.000008804775,0.00034752162,0.000007422234,0.0021478417,0.020566558],"study_design_scores_gemma":[0.0017958948,0.00019784774,0.9955768,0.00044355137,0.000020566958,0.00000308248,0.0004898852,0.0007458769,0.00009042964,0.000012283091,0.00049743685,0.00012632426],"about_ca_topic_score_codex":0.04149298,"about_ca_topic_score_gemma":0.020729365,"teacher_disagreement_score":0.031872362,"about_ca_system_score_codex":0.00018299933,"about_ca_system_score_gemma":0.00008733184,"threshold_uncertainty_score":0.99713975},"labels":[],"label_agreement":null},{"id":"W3048148439","doi":"10.1158/1538-7445.pedca19-b37","title":"Abstract B37: Menin and EWS/FLI1 activate serine biosynthesis via ATF4 in Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene knockdown; Cancer research; FLI1; Transcription factor; Biology; ATF4; Oncogene; Cancer; Genetics; Gene; Cell cycle","score_opus":0.060659818170031125,"score_gpt":0.3554778057143165,"score_spread":0.29481798754428534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048148439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218243,0.003907484,0.00005666764,0.0029823938,0.000052568834,0.00020682186,0.000057183275,0.0000070819765,0.0005473865],"genre_scores_gemma":[0.99562436,0.0033492458,0.00011004876,0.0003546439,0.00038913713,0.000053689113,0.000021226615,0.000030414414,0.000067223824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877393,0.000048620524,0.00016662842,0.00042644917,0.00018382861,0.00040055206],"domain_scores_gemma":[0.99941576,0.00007267853,0.000031559615,0.00021226329,0.00007330345,0.00019446935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026835024,0.00012482567,0.00015484488,0.00006664875,0.00008050226,0.000051212308,0.00020344103,0.00010479771,0.000097566095],"category_scores_gemma":[0.00020350069,0.00012750486,0.000037191614,0.00020828439,0.00010670997,0.0000058891083,0.0002897379,0.00024195075,0.000010335572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021558379,0.000025140593,0.003538789,0.000049150276,0.000026386731,0.000020611562,0.00014671178,0.00007523115,0.9679358,0.000021869424,0.0016422217,0.026302481],"study_design_scores_gemma":[0.00063917326,0.00017720982,0.018728202,0.000044417477,0.000004549196,0.000002779478,0.00010692495,0.00010567719,0.9278345,0.00008060518,0.052076355,0.00019960433],"about_ca_topic_score_codex":0.00074235944,"about_ca_topic_score_gemma":0.00035979677,"teacher_disagreement_score":0.05043413,"about_ca_system_score_codex":0.0000638616,"about_ca_system_score_gemma":0.00016409262,"threshold_uncertainty_score":0.5199497},"labels":[],"label_agreement":null},{"id":"W3048161488","doi":"10.1158/1538-7445.pedca19-b15","title":"Abstract B15: Genomic classification and prognosis in rhabdomyosarcoma: A report from the Children’s Oncology Group, the Institute of Cancer Research, and the National Cancer Institute","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"HRAS; Neuroblastoma RAS viral oncogene homolog; KRAS; Medicine; Rhabdomyosarcoma; Oncology; Internal medicine; Cancer; Population; Sarcoma; Pathology; Colorectal cancer","score_opus":0.22716460640979258,"score_gpt":0.46096183185233747,"score_spread":0.2337972254425449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048161488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82786936,0.02196924,8.169026e-7,0.14751627,0.00010795721,0.0020493472,0.00011717636,0.000009516053,0.0003603326],"genre_scores_gemma":[0.9763534,0.017627586,0.000038763133,0.00076314085,0.00067028234,0.004452149,0.000044763656,0.000020490863,0.000029403642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971625,0.00035405648,0.0004686706,0.0005539112,0.0010662616,0.00039456924],"domain_scores_gemma":[0.99767137,0.0011903982,0.00015432216,0.0002975671,0.00053837296,0.00014797543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024301421,0.00015721541,0.0003664403,0.0001244343,0.000441406,0.000071392285,0.00033192406,0.00011457086,0.00008296316],"category_scores_gemma":[0.0006560204,0.00007825729,0.00006239159,0.00068157195,0.002604319,0.00013834711,0.00027375977,0.0010036534,0.0000041042467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018766469,0.00042069034,0.9286885,0.00007437157,0.0005255637,0.00010976541,0.0032275962,0.000031329553,0.0053764028,0.0025541757,0.00653912,0.050575823],"study_design_scores_gemma":[0.0037646587,0.000121974,0.97161144,0.0001996423,0.00006272835,0.000025161744,0.00037357566,0.00010253042,0.00086882134,0.00069502427,0.022098964,0.000075487296],"about_ca_topic_score_codex":0.060908362,"about_ca_topic_score_gemma":0.024621138,"teacher_disagreement_score":0.14848407,"about_ca_system_score_codex":0.0007838249,"about_ca_system_score_gemma":0.001584565,"threshold_uncertainty_score":0.993177},"labels":[],"label_agreement":null},{"id":"W3048224515","doi":"10.1158/1538-7445.pedca19-a06","title":"Abstract A06: The added value of examining germline variants in a precision cancer therapy study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Genetics; Germline mutation; Exome sequencing; Cancer; Biology; Genomics; Single-nucleotide polymorphism; Gene; Medicine; Bioinformatics; Computational biology; Genome; Mutation; Genotype","score_opus":0.13591671399824984,"score_gpt":0.42491056155221124,"score_spread":0.2889938475539614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048224515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144745,0.0065258,0.000020569067,0.0008364237,0.00010986034,0.0006920071,0.000073022085,0.0000032880314,0.00029155437],"genre_scores_gemma":[0.99142444,0.007445682,0.000023897337,0.0002847907,0.000470055,0.00025708103,0.000010554294,0.000025493864,0.00005801165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985395,0.0001531309,0.00026844686,0.0003855312,0.0003480113,0.00030536353],"domain_scores_gemma":[0.99914,0.00015439809,0.00006897139,0.00035408774,0.00019280231,0.00008969792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008210552,0.000113401,0.00017520794,0.00005202672,0.00007477218,0.00003100326,0.000428595,0.000078968005,0.00015777898],"category_scores_gemma":[0.0003107796,0.000084831554,0.000040005525,0.00033546746,0.000095442294,0.0000036962472,0.00022453349,0.00027331006,0.0000033306592],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001077264,0.00027476373,0.033859145,0.000031393174,0.000096515556,0.00001380436,0.0020130596,0.0021960945,0.92114836,0.000026576769,0.0037892617,0.03547374],"study_design_scores_gemma":[0.0052120998,0.0023635998,0.6317449,0.00014677359,0.00001798726,0.0000012574852,0.0023177937,0.00055729836,0.33285064,0.0001246391,0.024278225,0.00038475377],"about_ca_topic_score_codex":0.0025456883,"about_ca_topic_score_gemma":0.0010194767,"teacher_disagreement_score":0.5978858,"about_ca_system_score_codex":0.00004946139,"about_ca_system_score_gemma":0.0005036874,"threshold_uncertainty_score":0.3848336},"labels":[],"label_agreement":null},{"id":"W3048255749","doi":"10.1158/1538-7445.pedca19-b69","title":"Abstract B69: Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Langerhans cell histiocytosis; Biology; Lineage markers; Chromatin; Epigenomics; Phenotype; Cancer research; Genetics; Pathology; Gene expression; Gene; Disease; DNA methylation; Medicine","score_opus":0.15463643192026325,"score_gpt":0.3464227155194194,"score_spread":0.19178628359915614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048255749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770964,0.002805698,0.000011596148,0.001449905,0.000025794365,0.00039664173,0.000033086948,0.000022890757,0.018158024],"genre_scores_gemma":[0.9970214,0.00073440705,0.00094274303,0.00026204338,0.000059006597,0.000075785116,0.000032116237,0.000031322306,0.0008412194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986504,0.000033893255,0.00020874196,0.00035558376,0.0003266048,0.0004248145],"domain_scores_gemma":[0.9994235,0.00008196436,0.000029328841,0.0001033382,0.00007158373,0.00029027188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020078346,0.00013077362,0.00023426257,0.00016056917,0.00010428517,0.00003032914,0.0000834859,0.00007051071,0.00031901477],"category_scores_gemma":[0.00006773275,0.00012350827,0.000031349013,0.0003533951,0.00011732586,0.000052502044,0.000074583135,0.00034941247,0.00009451028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016397411,0.0011720587,0.1431769,0.0021404503,0.000143193,0.00223494,0.019494772,0.00006727525,0.7480163,0.00008988916,0.0052776127,0.076546885],"study_design_scores_gemma":[0.04075634,0.0033878381,0.15633215,0.0017900949,0.00026944999,0.00011957314,0.01576922,0.0012906749,0.6165741,0.00050933467,0.16114981,0.0020513718],"about_ca_topic_score_codex":0.0015245695,"about_ca_topic_score_gemma":0.0003264999,"teacher_disagreement_score":0.1558722,"about_ca_system_score_codex":0.0014572535,"about_ca_system_score_gemma":0.00084354886,"threshold_uncertainty_score":0.50365216},"labels":[],"label_agreement":null},{"id":"W3048257712","doi":"10.1158/1538-7445.pedca19-a51","title":"Abstract A51: Advances in the etiology and therapeutics of a lethal childhood cancer, fibrolamellar hepatocellular carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatocellular carcinoma; Cancer research; Cancer; Liver cancer; Biology; Liver disease; Medicine; Genetics; Biochemistry","score_opus":0.05908905223741158,"score_gpt":0.35542572280864587,"score_spread":0.2963366705712343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048257712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648853,0.031844195,0.000048935664,0.002367753,0.00010662051,0.0002851774,0.000037811216,0.0000031160068,0.00042108292],"genre_scores_gemma":[0.9849501,0.013769307,0.000035678633,0.0007069925,0.00038930922,0.00009001465,0.000018726749,0.000012359755,0.000027467047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987971,0.00027470928,0.00017392282,0.00031971972,0.00017112763,0.00026339124],"domain_scores_gemma":[0.99953556,0.000060990766,0.00004691123,0.00020313573,0.00009390511,0.000059499704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036097612,0.00009871385,0.00015424157,0.000042285254,0.00006496704,0.000010825679,0.00024150057,0.00014950214,0.00009187703],"category_scores_gemma":[0.00006718136,0.00007395152,0.000041405478,0.00018445113,0.0002495686,0.0000044772055,0.00007916317,0.0003249806,0.0000029715557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003437313,0.0000385334,0.06581191,0.00007978898,0.000020466592,0.000014006957,0.001053831,0.000050900217,0.9268025,0.00016516888,0.00057128334,0.005047883],"study_design_scores_gemma":[0.0025667173,0.0018078864,0.08426667,0.00005772526,0.000027814005,0.00003600202,0.0016881222,0.0001711713,0.5525207,0.0003763626,0.35609975,0.00038105488],"about_ca_topic_score_codex":0.00016924567,"about_ca_topic_score_gemma":0.00014678875,"teacher_disagreement_score":0.37428176,"about_ca_system_score_codex":0.000010181912,"about_ca_system_score_gemma":0.00017884288,"threshold_uncertainty_score":0.30156556},"labels":[],"label_agreement":null},{"id":"W3048409093","doi":"10.1158/1538-7445.pedca19-b78","title":"Abstract B78: Role of noradrenergic core regulatory circuitry transcription factors in neuroblastoma cell identity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; GATA3; Neuroblastoma; Transcription factor; Cancer research; Mesenchymal stem cell; Phenotype; Cell biology; Cell culture; Genetics; Gene","score_opus":0.10599274135817181,"score_gpt":0.3765124697445919,"score_spread":0.2705197283864201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048409093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967868,0.00080085796,0.0000020641228,0.0003651982,0.00005309993,0.00056641654,0.00005190295,0.000036168356,0.0013374944],"genre_scores_gemma":[0.9992088,0.00033094484,0.000006521273,0.000065905166,0.00009517915,0.00005470294,0.000022676779,0.000041155577,0.00017410895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725455,0.00011453042,0.00032222574,0.0004656498,0.0012563297,0.0005867379],"domain_scores_gemma":[0.99880266,0.00009247905,0.000057642184,0.00032032572,0.00022556962,0.0005013314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002599677,0.00016598581,0.00034002875,0.00035097724,0.000073428186,0.000025254709,0.00025232474,0.00010299483,0.0005939828],"category_scores_gemma":[0.000093139104,0.00015110617,0.0001279443,0.0009616346,0.00021819516,0.0002513111,0.00007026679,0.00079373334,0.000055576606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006807983,0.00034104608,0.057891473,0.0004693362,0.000029955894,0.00023609576,0.0005097189,0.000046558896,0.9382741,0.000056507615,0.00040580423,0.001058615],"study_design_scores_gemma":[0.0017763661,0.0005879192,0.47616076,0.000112010406,0.000012271677,0.0000031425368,0.00031265375,0.000064293956,0.5204605,0.00012873037,0.00029600298,0.000085368214],"about_ca_topic_score_codex":0.0009367885,"about_ca_topic_score_gemma":0.00026757055,"teacher_disagreement_score":0.4182693,"about_ca_system_score_codex":0.00023473901,"about_ca_system_score_gemma":0.0005010973,"threshold_uncertainty_score":0.6503695},"labels":[],"label_agreement":null},{"id":"W3048429360","doi":"10.1158/1538-7445.pedca19-b09","title":"Abstract B09: Epigenetic changes mediated by H3.3 G34R mutation in a CRISPR-edited pediatric glioblastoma cell line","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Epigenome; CRISPR; Carcinogenesis; Biology; Epigenetics; Histone; Mutation; Genetics; Histone H3; Cancer research; DNA methylation; Methylation; Transcriptome; Epigenomics; Gene; Gene expression","score_opus":0.02845150336223706,"score_gpt":0.3752640989198378,"score_spread":0.34681259555760074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048429360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836632,0.013302314,0.0007586806,0.0015898633,0.00011765213,0.00033703516,0.00009028523,0.000023044122,0.00011790633],"genre_scores_gemma":[0.99341834,0.0050413283,0.000053296364,0.00017512115,0.0008823049,0.00014341556,0.00013097207,0.000042978307,0.00011225582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842745,0.00006736521,0.0002110871,0.00045399443,0.0003473464,0.0004927699],"domain_scores_gemma":[0.9993247,0.000049237373,0.000038956194,0.00019939736,0.00015862688,0.00022909908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027915358,0.00015758535,0.00015035536,0.00015301867,0.000053838492,0.000030777206,0.00024329532,0.00017485007,0.00013599049],"category_scores_gemma":[0.00020500917,0.00016579404,0.00003886247,0.0006343809,0.000047985297,0.0000036722847,0.000111053276,0.00032566275,0.00003970042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001295151,0.00004782984,0.00077744515,0.00016857048,0.00001017107,0.000022070311,0.00021430978,0.001828075,0.9841955,2.8396906e-7,0.011270277,0.0013359861],"study_design_scores_gemma":[0.0009480024,0.00061675254,0.0041826842,0.000015037517,0.000008775186,0.0000011136723,0.00015202675,0.0010028754,0.97940975,0.000004055977,0.013426041,0.00023290211],"about_ca_topic_score_codex":0.00015045471,"about_ca_topic_score_gemma":0.00031266487,"teacher_disagreement_score":0.0097551085,"about_ca_system_score_codex":0.000040523595,"about_ca_system_score_gemma":0.00013716499,"threshold_uncertainty_score":0.67608845},"labels":[],"label_agreement":null},{"id":"W3048583768","doi":"10.1158/1538-7445.pedca19-a77","title":"Abstract A77: Targeting lymphocyte exclusion in metastatic osteosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteosarcoma; Cancer; Context (archaeology); Tumor-infiltrating lymphocytes; Immune system; Immune checkpoint; Disease; Extravasation; Cancer research; Immunotherapy; Immunology; Pathology; Oncology; Internal medicine; Biology","score_opus":0.13009418898882158,"score_gpt":0.4229033758782355,"score_spread":0.29280918688941393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048583768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97339946,0.012870689,0.000010969492,0.010870119,0.00010396384,0.0005830112,0.000013025718,0.000040692576,0.0021080447],"genre_scores_gemma":[0.9955752,0.0023423224,0.00017694582,0.0012475506,0.00025537374,0.00009907317,0.00001555177,0.000031777727,0.00025624406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804854,0.0001138244,0.0003080223,0.0003453518,0.0006737359,0.0005104922],"domain_scores_gemma":[0.9992889,0.00014081107,0.00003905981,0.00018679704,0.00013214622,0.0002122673],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009873608,0.000120199715,0.00025876146,0.00017567296,0.00011011043,0.00003446964,0.0001734073,0.000054913806,0.0018952667],"category_scores_gemma":[0.0001959922,0.000101299804,0.00008421804,0.00089373614,0.0001353268,0.000093160466,0.00010434913,0.0004502177,0.00009468487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006101552,0.00009889183,0.004954518,0.0005396876,0.00008454908,0.00045896939,0.0020712076,0.000016599095,0.8368529,0.000015504198,0.009385838,0.13941975],"study_design_scores_gemma":[0.028173799,0.0017864201,0.116747536,0.0020498065,0.000064810585,0.00005683816,0.005759371,0.0020771325,0.45026204,0.00024096586,0.39193037,0.0008508882],"about_ca_topic_score_codex":0.0017960203,"about_ca_topic_score_gemma":0.00011825808,"teacher_disagreement_score":0.3865909,"about_ca_system_score_codex":0.0005844995,"about_ca_system_score_gemma":0.00071815355,"threshold_uncertainty_score":0.9990171},"labels":[],"label_agreement":null},{"id":"W3048704933","doi":"10.1158/1538-7445.pedca19-ia18","title":"Abstract IA18: Clinically relevant mutational signatures in childhood cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Childhood cancer; Cancer; Context (archaeology); Medicine; Genetics; Mutation; Bioinformatics; Computational biology; Oncology; Biology; Gene","score_opus":0.1322538952585828,"score_gpt":0.4744016249731278,"score_spread":0.342147729714545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048704933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8857624,0.0066288426,0.0000117980735,0.1024445,0.0002971673,0.0010420773,0.00014063403,0.00010346139,0.003569123],"genre_scores_gemma":[0.9846581,0.0015292616,0.00025115316,0.010615328,0.0021727395,0.00033926373,0.000036264915,0.000070603244,0.0003272428],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99522454,0.00028468156,0.00088200415,0.0008393413,0.001965413,0.0008040065],"domain_scores_gemma":[0.99737734,0.0009212765,0.00013640936,0.0004014184,0.0004917427,0.0006717939],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019154208,0.00024038089,0.0005864067,0.00024375785,0.00013486083,0.000059405775,0.0004188682,0.0002457256,0.004934643],"category_scores_gemma":[0.002135455,0.00022430373,0.00017519959,0.0010455475,0.00030070322,0.00015072167,0.00016728477,0.0023662806,0.00017063672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012792213,0.0036512,0.30181012,0.004605136,0.0014133952,0.0023803841,0.05734439,0.005943352,0.052120566,0.002222955,0.44644862,0.10926768],"study_design_scores_gemma":[0.005691504,0.0006808163,0.95467275,0.0013862248,0.000039721406,0.0000072969497,0.0014015978,0.000227861,0.0037014277,0.00081784517,0.030897692,0.0004752884],"about_ca_topic_score_codex":0.0032114522,"about_ca_topic_score_gemma":0.0018216032,"teacher_disagreement_score":0.6528626,"about_ca_system_score_codex":0.00044304982,"about_ca_system_score_gemma":0.0029023336,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W3048770784","doi":"10.1158/1538-7445.pedca19-ia06","title":"Abstract IA06: New strategies for multidimensional molecular characterization and follow-up of high-risk pediatric cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Pediatric cancer; Cancer; Tumor progression; Neuroblastoma; Internal medicine; Exome sequencing; Rhabdomyosarcoma; Primary tumor; Circulating tumor cell; Germline; Disease; Sarcoma; Bioinformatics; Pathology; Biology; Mutation; Genetics; Gene; Metastasis","score_opus":0.06052285287936354,"score_gpt":0.3653793873091559,"score_spread":0.3048565344297924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048770784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942502,0.001988304,0.00032414426,0.002450234,0.000081203645,0.00070992985,0.00016541977,0.000013739777,0.00001685359],"genre_scores_gemma":[0.9971917,0.0017197058,0.0004191689,0.00009602833,0.00026269726,0.00015877078,0.000089684036,0.00002102164,0.000041174764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989284,0.000025941868,0.00017063846,0.00026811936,0.00037428964,0.00023257647],"domain_scores_gemma":[0.99920523,0.00010794208,0.00006819835,0.0001138644,0.0002596288,0.00024516165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000130147,0.00009791229,0.00021971432,0.000104255996,0.000067774155,0.000017595006,0.00004300337,0.00005754711,0.00011293874],"category_scores_gemma":[0.000105653366,0.00008189885,0.000055878496,0.00026794744,0.00004886212,0.0000743832,0.000030583957,0.00013899372,0.0000042801335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001892158,0.0001557048,0.067676194,0.0008851984,0.00032231677,0.00007778893,0.0012444389,0.00025436838,0.8897756,0.0021615569,0.0051525035,0.030402213],"study_design_scores_gemma":[0.018254828,0.0019412097,0.6836984,0.00022595312,0.00045315275,0.0000041996414,0.0006745768,0.0007308015,0.28871095,0.0005375913,0.0044545494,0.00031374747],"about_ca_topic_score_codex":0.0030558882,"about_ca_topic_score_gemma":0.00006583401,"teacher_disagreement_score":0.6160222,"about_ca_system_score_codex":0.00010617187,"about_ca_system_score_gemma":0.00093147974,"threshold_uncertainty_score":0.4619609},"labels":[],"label_agreement":null},{"id":"W3048870789","doi":"10.1158/1538-7445.pedca19-b40","title":"Abstract B40: EWS-FLI1 orchestrates Ewing sarcoma plasticity through a post-translational modification cascade regulating FOXM1 stability","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Sarcoma; FOXM1; Biology; Transcription factor; Cell biology; FLI1; Epithelial–mesenchymal transition; Metastasis; Chemistry; Genetics; Pathology; Medicine; Cancer; Gene","score_opus":0.16563139289558318,"score_gpt":0.4079788515644058,"score_spread":0.2423474586688226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048870789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366105,0.0014917246,0.00157979,0.0019266392,0.000041617463,0.00041930762,0.00020933361,0.000030945484,0.0006395888],"genre_scores_gemma":[0.9984966,0.000093277464,0.00038443395,0.0001752705,0.00044638678,0.000107975684,0.00024685598,0.00003473505,0.000014485887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782145,0.00017804562,0.0003013873,0.00064677635,0.00058609893,0.00046626196],"domain_scores_gemma":[0.9988172,0.00013643235,0.00006970124,0.0003185228,0.00045367493,0.0002044804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039497396,0.00016748329,0.0001557035,0.00003407932,0.00026900377,0.00008436721,0.00035136798,0.00016049572,0.00022394596],"category_scores_gemma":[0.000989538,0.00017369802,0.00011254238,0.0002676452,0.00027522945,0.00002597644,0.00013107964,0.00037093315,0.000017080116],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029391758,0.00006953396,0.007061405,0.00016204237,0.00005291979,0.0000045567704,0.0004934779,0.0009208148,0.9883654,0.00021508597,0.0003229993,0.002037845],"study_design_scores_gemma":[0.0006242346,0.00012472308,0.12692468,0.000053604632,0.00001724018,0.0000043191517,0.0005130132,0.001108279,0.8676966,0.00060665584,0.0020429664,0.00028370775],"about_ca_topic_score_codex":0.00042282563,"about_ca_topic_score_gemma":0.00012288142,"teacher_disagreement_score":0.12066883,"about_ca_system_score_codex":0.00008768999,"about_ca_system_score_gemma":0.00060111,"threshold_uncertainty_score":0.70831996},"labels":[],"label_agreement":null},{"id":"W3048913754","doi":"10.1158/1538-7445.pedca19-a30","title":"Abstract A30: Alisertib acts synergistically with sonidegib by modulating primary cilia assembly in a pediatric RELA ependymoma cell line","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Smoothened; Cilium; Ciliogenesis; GLI1; Cyclopamine; Hedgehog signaling pathway; GLI2; Biology; Cancer research; Cell biology; Signal transduction","score_opus":0.05756154453365862,"score_gpt":0.3402292569346398,"score_spread":0.28266771240098115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048913754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139434,0.0037934922,0.00023563494,0.0013530647,0.000039228195,0.00033845022,0.00005384432,0.00002346084,0.0027684919],"genre_scores_gemma":[0.99729276,0.00083444326,0.0003536695,0.00035097852,0.0005245543,0.00011899537,0.000074609,0.000059792368,0.00039017756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975069,0.00014062058,0.00032715415,0.0007177835,0.00058684027,0.0007206681],"domain_scores_gemma":[0.99891686,0.00011491517,0.00007678249,0.00031345832,0.00029934032,0.00027864252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006310934,0.0002199542,0.00026921774,0.000079421356,0.00014119344,0.000057863548,0.00037650517,0.00018379962,0.000027288916],"category_scores_gemma":[0.0005406152,0.00019635061,0.000052719774,0.0004841759,0.00012577491,0.000009379551,0.00029490844,0.000582735,0.000024150879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004113621,0.000101870915,0.0060393983,0.00035858827,0.000032535638,0.00017713371,0.00022074358,0.0013088211,0.98445684,0.000007668088,0.0061827316,0.00070231565],"study_design_scores_gemma":[0.0029480513,0.0015877663,0.030821823,0.00017283413,0.00004298469,0.000008078887,0.00031413054,0.0006910631,0.9511892,0.00002832816,0.01131986,0.00087585096],"about_ca_topic_score_codex":0.00018075245,"about_ca_topic_score_gemma":0.00016255277,"teacher_disagreement_score":0.033267602,"about_ca_system_score_codex":0.00010159058,"about_ca_system_score_gemma":0.0006460605,"threshold_uncertainty_score":0.8006945},"labels":[],"label_agreement":null},{"id":"W3048992533","doi":"10.1158/1538-7445.am2020-6442","title":"Abstract 6442: Investigation of custom biomarkers on circulating tumor cells from clinical samples using RarePlex® Developer Kits","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Saint Vincent University","funders":"","keywords":"Circulating tumor cell; Biomarker; Prostate cancer; Breast cancer; Medicine; Cancer; Cancer biomarkers; Cancer research; Oncology; Computational biology; Internal medicine; Biology; Metastasis","score_opus":0.48807296344019163,"score_gpt":0.48649962543129527,"score_spread":0.0015733380088963633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048992533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963015,0.0007259121,0.000057090583,0.0014980198,0.00022533936,0.0004702892,0.00015932803,0.000026375079,0.0005361546],"genre_scores_gemma":[0.9950768,0.00022090142,0.0029656517,0.000944155,0.0006653038,0.000020858044,0.00004687138,0.00004146157,0.00001800612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748456,0.00019347288,0.00060511654,0.00052815233,0.0008100316,0.0003786736],"domain_scores_gemma":[0.99816304,0.0005495956,0.00016063162,0.00029921162,0.00038272428,0.0004448161],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001091533,0.00014712066,0.00043606802,0.00014154449,0.000104600884,0.000029537934,0.00015710421,0.00009141402,0.0010534705],"category_scores_gemma":[0.00066741713,0.00013027947,0.0001339651,0.0006507186,0.0002991879,0.00007809555,0.00009332716,0.0005417865,0.000044409022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073523005,0.000045543857,0.045775775,0.00034864154,0.0002050422,0.000060999733,0.0008175253,0.0001480446,0.92214763,0.000017630864,0.0038408986,0.025857007],"study_design_scores_gemma":[0.0025487377,0.00028771837,0.15993378,0.0012373038,0.00011962892,0.0000028608995,0.0009016332,0.0006566877,0.8208843,0.00011215758,0.01303295,0.00028227252],"about_ca_topic_score_codex":0.0045076124,"about_ca_topic_score_gemma":0.000066435445,"teacher_disagreement_score":0.114158,"about_ca_system_score_codex":0.00024583796,"about_ca_system_score_gemma":0.0014188447,"threshold_uncertainty_score":0.9998597},"labels":[],"label_agreement":null},{"id":"W3048997450","doi":"10.1158/1538-7445.am2020-5489","title":"Abstract 5489: The cost of delaying therapy for advanced non-small cell lung cancer (NSCLC): a population kinetics assessment","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Placebo; Subgroup analysis; Population; Internal medicine; Lung cancer; Oncology; Survival analysis; Surgery; Confidence interval; Pathology","score_opus":0.0680414398346201,"score_gpt":0.46058110527279855,"score_spread":0.3925396654381784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048997450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96648926,0.0037147598,0.008672819,0.017881796,0.00018277214,0.0021927946,0.000025195217,0.00002273662,0.0008178603],"genre_scores_gemma":[0.9933624,0.002326669,0.0019118624,0.0011207924,0.00048420148,0.00058998284,0.00002874248,0.000046197056,0.00012914857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984041,0.00006381366,0.0002936568,0.0002877414,0.0005528196,0.0003978776],"domain_scores_gemma":[0.9987824,0.00033845007,0.00011426099,0.0002244384,0.00034317403,0.00019730916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007360483,0.0001217871,0.00026286935,0.00007089957,0.00015986935,0.00003454937,0.00022633112,0.00006158834,0.00014907547],"category_scores_gemma":[0.00018413718,0.00008430428,0.00009282957,0.0003072993,0.000098009135,0.000043519754,0.000053590877,0.00075588125,0.0000010211052],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084601896,0.0001677891,0.083579704,0.0012387164,0.00013795492,0.000011401485,0.0016203345,0.00993144,0.5952956,0.00008738639,0.005346402,0.30173722],"study_design_scores_gemma":[0.015965268,0.0015211034,0.48359704,0.001939818,0.00019733502,0.000004787331,0.0014653623,0.36552435,0.080270275,0.00014440606,0.048793633,0.0005766304],"about_ca_topic_score_codex":0.0008859796,"about_ca_topic_score_gemma":0.00002562783,"teacher_disagreement_score":0.5150254,"about_ca_system_score_codex":0.0002259943,"about_ca_system_score_gemma":0.0004166625,"threshold_uncertainty_score":0.34378287},"labels":[],"label_agreement":null},{"id":"W3049208831","doi":"10.1158/0008-5472.can-20-0168","title":"Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research","funders":"City of Seattle; National Cancer Institute; National Heart, Lung, and Blood Institute; NIH Clinical Center; Health and Medical Research Fund; Australian Institute of Health and Welfare, Australian Government; World Cancer Research Fund; Cancerfonden; Canadian Institutes of Health Research; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Cancer Council Victoria; Deutsche Krebshilfe; NordForsk; Vetenskapsrådet; Kræftens Bekæmpelse; Svenska Forskningsrådet Formas; World Health Organization; Uehara Memorial Foundation; Seattle Children’s Hospital; Västerbotten Läns Landsting; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; Institut National de la Santé et de la Recherche Médicale; Bundesministerium für Bildung und Forschung; Centre International de Recherche sur le Cancer; Mayo Clinic; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Colorectal cancer; KRAS; Internal medicine; Microsatellite instability; Medicine; Oncology; Cancer; Confidence interval; Biology; Genetics; Allele; Microsatellite; Gene","score_opus":0.09317095272828328,"score_gpt":0.41135914229523457,"score_spread":0.3181881895669513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049208831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95535207,0.043222345,0.000007807726,0.0005918381,0.00004231051,0.00053632905,0.0001385546,0.0000071917816,0.00010156875],"genre_scores_gemma":[0.99063575,0.008627176,0.00043492074,0.000076837474,0.000038948318,0.00012379038,0.000003501495,0.00002195453,0.000037093687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815094,0.00015524708,0.0003750099,0.00040288828,0.0006211419,0.00029475187],"domain_scores_gemma":[0.99835676,0.0003379488,0.0001294384,0.00020636572,0.00074770575,0.00022178184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004953923,0.00014719545,0.00087801646,0.00040177247,0.000045034678,0.000006269541,0.00013026489,0.00007801546,0.000156423],"category_scores_gemma":[0.00078283745,0.00012474218,0.00010182338,0.0018581386,0.00044004634,0.000032453194,0.00031826628,0.00028667395,6.7448644e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018255512,0.000039796927,0.4675216,0.0012377371,0.006459812,0.0000103101065,0.004211982,0.00087279454,0.5088481,0.0000061987694,0.00025470476,0.00871145],"study_design_scores_gemma":[0.0013855809,0.0020090824,0.40281865,0.0006269035,0.0043431963,0.0000014365044,0.003871885,0.00082932715,0.5836011,0.00004987576,0.00025889062,0.00020406979],"about_ca_topic_score_codex":0.0032923627,"about_ca_topic_score_gemma":0.0010716558,"teacher_disagreement_score":0.07475302,"about_ca_system_score_codex":0.00013314991,"about_ca_system_score_gemma":0.00031698507,"threshold_uncertainty_score":0.50868386},"labels":[],"label_agreement":null},{"id":"W3049279502","doi":"10.1158/1538-7445.am2020-6540","title":"Abstract 6540: Regression of metastatic cancer and abscopal effects following <i>in situ</i> vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brantford Energy (Canada)","funders":"","keywords":"Medicine; Pembrolizumab; Ipilimumab; Nivolumab; Internal medicine; Cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Prostate cancer; Immunotherapy; Melanoma; Gastroenterology; Surgery; Chemotherapy; Phases of clinical research; Cancer research","score_opus":0.06748114986850805,"score_gpt":0.3563037795644071,"score_spread":0.28882262969589906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049279502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96348315,0.034093466,0.0000031051093,0.0015263868,0.000031751188,0.00071766425,0.000023797804,0.000014024657,0.00010664592],"genre_scores_gemma":[0.99695593,0.0024309442,0.00011272099,0.000088030836,0.000042534077,0.00025410016,0.00001681114,0.000027069626,0.000071881426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854475,0.00016939393,0.00025362812,0.0003425206,0.0003739133,0.0003157879],"domain_scores_gemma":[0.9992961,0.00022293754,0.00006174897,0.0001198946,0.00008343742,0.00021585944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044160237,0.00016904774,0.00045413955,0.00013618986,0.000099255434,0.00004140809,0.00005000678,0.00005300676,0.00010257835],"category_scores_gemma":[0.00006039724,0.00012762666,0.0000759172,0.00043605382,0.00007466496,0.00015856989,0.000046477762,0.00032602865,0.0000015100879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015332227,0.00016360545,0.33963308,0.0018304196,0.0001582625,0.009055352,0.0021597226,9.942962e-7,0.62172973,0.0000058947894,0.00056031055,0.02316939],"study_design_scores_gemma":[0.0097843185,0.00143383,0.036181122,0.0009788634,0.0002705278,0.0002815882,0.00090019143,0.000712646,0.9485384,0.000044387147,0.00056107674,0.000313001],"about_ca_topic_score_codex":0.0012075831,"about_ca_topic_score_gemma":0.00014132912,"teacher_disagreement_score":0.3268087,"about_ca_system_score_codex":0.00010922857,"about_ca_system_score_gemma":0.00017139656,"threshold_uncertainty_score":0.52044636},"labels":[],"label_agreement":null},{"id":"W3049330696","doi":"10.1158/1538-7445.am2020-ct302","title":"Abstract CT302: Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"TIGIT; Atezolizumab; Medicine; Tolerability; Oncology; Pharmacodynamics; Antibody; Internal medicine; Pharmacokinetics; Pharmacology; Cancer; Immunotherapy; Immunology; Adverse effect; Nivolumab","score_opus":0.04779853249571873,"score_gpt":0.4007939234105441,"score_spread":0.35299539091482535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049330696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968371,0.00020664999,0.0000016103322,0.00060610694,0.000025567262,0.0021596476,0.000010461789,0.000010669853,0.00014219419],"genre_scores_gemma":[0.9997031,0.00007233834,0.000006918256,0.00006296263,0.000015383408,0.00007652799,0.000020052188,0.000023256458,0.000019425452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.00010695059,0.00030903486,0.00032363314,0.00076239475,0.00027404845],"domain_scores_gemma":[0.99932194,0.000043248638,0.000118430326,0.00021606167,0.00022107922,0.00007926721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026406613,0.00012904147,0.0002898881,0.0001808301,0.000073688185,0.000027721135,0.00011441567,0.000042120242,0.00004867797],"category_scores_gemma":[0.000048753816,0.00008472198,0.00002170612,0.0009978373,0.00017635993,0.000129324,0.000046551148,0.0003180166,0.0000011261689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043960504,0.004851563,0.8190553,0.00029557972,0.00011299946,0.00005741587,0.0061944574,0.00022886864,0.07092463,0.0000030429173,0.00003674998,0.05427884],"study_design_scores_gemma":[0.036556173,0.006912069,0.9453232,0.0006995643,0.000013494957,0.0000014526046,0.0012502547,0.00011409111,0.00897637,0.0000051985407,0.000045912144,0.000102182355],"about_ca_topic_score_codex":0.0012130226,"about_ca_topic_score_gemma":0.0006694372,"teacher_disagreement_score":0.1262679,"about_ca_system_score_codex":0.00030721596,"about_ca_system_score_gemma":0.00027982547,"threshold_uncertainty_score":0.34548622},"labels":[],"label_agreement":null},{"id":"W3049682127","doi":"10.1158/1538-7445.am2020-sy09-03","title":"Abstract SY09-03: PROFYLEing Cancer for KiCS: The Canadian Pediatric Precision Oncology Initiative","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Hospital for Sick Children; Children's Hospital of Eastern Ontario; Montreal Children's Hospital; BC Cancer Agency","funders":"","keywords":"Cancer; Medicine; Citation; Pediatric oncology; Pediatric cancer; Gerontology; Oncology; Internal medicine; Family medicine; Library science; Computer science","score_opus":0.13752039659287865,"score_gpt":0.4322523954130915,"score_spread":0.29473199882021284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049682127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93672705,0.017606221,0.00018294631,0.035377726,0.0008473738,0.0025671269,0.0011954139,0.000016401671,0.0054797432],"genre_scores_gemma":[0.9855751,0.00716812,0.00009942312,0.0025521656,0.003177988,0.001164771,0.0000756893,0.00004174255,0.00014499894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836767,0.000084754036,0.0002123584,0.00046001974,0.00025722102,0.0006179619],"domain_scores_gemma":[0.9984702,0.00025617614,0.00007218672,0.00025679352,0.00057473633,0.00036991498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061396847,0.00013811272,0.0001573525,0.00007630657,0.0004966094,0.00009089081,0.00046161882,0.0002053687,0.00013637789],"category_scores_gemma":[0.00078808784,0.0001128576,0.00008161046,0.00028280754,0.00013999682,0.000005612292,0.00016993386,0.00038604432,0.000024203178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019492832,0.00015048996,0.018522589,0.0005578755,0.00037522326,0.000053863354,0.0040491363,0.0033675109,0.2202002,0.0013164111,0.647254,0.10220341],"study_design_scores_gemma":[0.0010524635,0.00072500645,0.00704273,0.0000277419,0.000039230188,0.0000015726029,0.00041732835,0.00020753815,0.045769267,0.00036493212,0.94405204,0.00030016643],"about_ca_topic_score_codex":0.036226153,"about_ca_topic_score_gemma":0.25278664,"teacher_disagreement_score":0.29679802,"about_ca_system_score_codex":0.0004407783,"about_ca_system_score_gemma":0.0052164434,"threshold_uncertainty_score":0.9701917},"labels":[],"label_agreement":null},{"id":"W3053707155","doi":"10.1158/1538-7445.am2020-6408","title":"Abstract 6408: E3<i>scan</i>™ ligand binding assay platform for targeted protein degradation and PROTAC discovery","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Drug discovery; Ubiquitin ligase; Computational biology; Protein degradation; Cereblon; Mdm2; Neddylation; Ubiquitin; Biology; Bioinformatics; Chemistry; Biochemistry","score_opus":0.0657233218218696,"score_gpt":0.35122747354687944,"score_spread":0.28550415172500987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3053707155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381894,0.0009850422,0.0008264228,0.0020188221,0.000053241394,0.0018442005,0.00012172587,0.000016906057,0.0003147202],"genre_scores_gemma":[0.9960682,0.00018570122,0.0003308391,0.00014164424,0.0004865873,0.0010087877,0.00026342625,0.000031071377,0.0014837723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987209,0.000042733205,0.00018879566,0.00041992828,0.0002803103,0.00034737686],"domain_scores_gemma":[0.9994259,0.00002514136,0.00006263648,0.0001607436,0.00016433075,0.00016126444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578141,0.00012739451,0.0001213359,0.00006250929,0.00021929326,0.00014886686,0.00016192136,0.00013297195,0.000021166456],"category_scores_gemma":[0.00044866255,0.000114052404,0.00004866213,0.0001855157,0.00010255657,0.000037122,0.00011054364,0.00020794543,0.00000610454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027820974,0.000017253273,0.0002511243,0.00013241435,0.0000250206,9.5090076e-7,0.00004529909,0.0000034692432,0.9866013,0.00012601029,0.005707153,0.006811782],"study_design_scores_gemma":[0.0006397887,0.000258789,0.00035372513,0.000051790237,0.0000034239306,7.052556e-7,0.000097122975,0.000061082355,0.95219606,0.00007273499,0.046117693,0.00014706486],"about_ca_topic_score_codex":0.000055137305,"about_ca_topic_score_gemma":0.000039587372,"teacher_disagreement_score":0.04041054,"about_ca_system_score_codex":0.0000479557,"about_ca_system_score_gemma":0.0002774434,"threshold_uncertainty_score":0.4650922},"labels":[],"label_agreement":null},{"id":"W3067522129","doi":"","title":"Determination of bioavailable drug levels from liposomal doxorubicin in murine orthotopic breast tumors","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Liposome; Pharmacology; Doxorubicin; Bioavailability; Drug; Medicine; Chemistry; Chemotherapy; Breast cancer; Cancer; Internal medicine; Biochemistry","score_opus":0.09625662723819724,"score_gpt":0.4345616201300872,"score_spread":0.33830499289189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3067522129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951376,0.00037921566,0.000035967514,0.00247289,0.000017393848,0.00033485715,0.00007860932,0.000015251712,0.0015282427],"genre_scores_gemma":[0.9979298,0.00008062897,0.0003674193,0.00004835551,0.00016648625,0.00014168046,0.000021302152,0.000011672565,0.0012326553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888563,0.000031873304,0.00022532632,0.00024051196,0.00034860245,0.00026806825],"domain_scores_gemma":[0.9993533,0.00007836464,0.000030864692,0.00024300154,0.00015423498,0.00014024276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025174004,0.0000756663,0.00017695548,0.00010489533,0.00004674917,0.000008750166,0.00012765835,0.000052215444,0.00079259416],"category_scores_gemma":[0.000049933275,0.00006921096,0.000033893368,0.00052769884,0.00018254598,0.000057216028,0.000043262226,0.00036381674,0.0000314734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014147941,0.00023906761,0.01747056,0.00018065923,0.0000098622295,0.000049696613,0.00019925435,0.000025794796,0.9750517,0.00020865559,0.00007957725,0.00634369],"study_design_scores_gemma":[0.0017207135,0.000029091305,0.073941536,0.00032675694,0.000010131009,0.000017587037,0.00008689133,0.00010066695,0.92220813,0.00074715685,0.00074344396,0.0000678683],"about_ca_topic_score_codex":0.0020547225,"about_ca_topic_score_gemma":0.00012997912,"teacher_disagreement_score":0.05647098,"about_ca_system_score_codex":0.00025192412,"about_ca_system_score_gemma":0.0003224204,"threshold_uncertainty_score":0.86783504},"labels":[],"label_agreement":null},{"id":"W3073513887","doi":"10.1158/1538-7445.am2020-6361","title":"Abstract 6361: Identification of mitochondrial RNA polymerase inhibitors via deep convolutional neural networks: A therapeutic strategy for cancer metabolism","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Myeloid leukemia; Mitochondrion; Cancer; Mitochondrial DNA; Cancer research; Polymerase; Molecular biology; Gene; Biochemistry; Genetics","score_opus":0.07023404594498803,"score_gpt":0.39399039760235305,"score_spread":0.32375635165736505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3073513887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566845,0.028545866,0.011138328,0.0018158557,0.00041865263,0.0010037215,0.00033557136,0.000013855153,0.000043611886],"genre_scores_gemma":[0.9948981,0.0010934224,0.000029314288,0.00015698858,0.0028656593,0.00059789815,0.00017961829,0.000039378097,0.00013966688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978948,0.00014834593,0.00038437394,0.00050539005,0.00051697384,0.0005500826],"domain_scores_gemma":[0.9987694,0.00007888037,0.00011582227,0.0002609815,0.00054421177,0.00023070506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031948593,0.00016088672,0.00021304081,0.000075648546,0.00018629113,0.00005533049,0.00036822687,0.00016967172,0.00022800399],"category_scores_gemma":[0.000106663116,0.00015049915,0.00016483637,0.00031517143,0.0003038046,0.000016678428,0.000108429136,0.00029992615,0.0000045682223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009779662,0.000058383037,0.00014183532,0.000077789766,0.00014127603,0.000002055896,0.000052327265,0.0045822747,0.96495813,0.0000701899,0.0016320253,0.02730577],"study_design_scores_gemma":[0.001194606,0.0002234967,0.0011671563,0.000017844955,0.000031072428,6.136924e-7,0.00014474688,0.021001473,0.9705677,0.00007861056,0.005365301,0.00020740007],"about_ca_topic_score_codex":0.0005174906,"about_ca_topic_score_gemma":0.00013355928,"teacher_disagreement_score":0.038213518,"about_ca_system_score_codex":0.000044404766,"about_ca_system_score_gemma":0.0004577731,"threshold_uncertainty_score":0.61371773},"labels":[],"label_agreement":null},{"id":"W3074819526","doi":"10.1158/1538-7445.am2020-6600","title":"Abstract 6600: Rapid generation of TCR-engineered T lymphocytes by linking the single cell transcriptome to its corresponding T cell receptor in antigen specific T cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"T-cell receptor; Biology; clone (Java method); Transcriptome; CD8; T cell; Cytotoxic T cell; Molecular biology; Cell biology; Population; Cell; Antigen; Immunology; In vitro; Gene expression; Gene; Immune system; Genetics","score_opus":0.1487216237679269,"score_gpt":0.3563254740094948,"score_spread":0.2076038502415679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3074819526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219144,0.010615277,0.00013587846,0.0028304001,0.00030831224,0.0017109565,0.00009941316,0.00003798154,0.0020703648],"genre_scores_gemma":[0.9895003,0.0061332383,0.00016981621,0.00025564746,0.0008012304,0.00013273959,0.000061831015,0.00009595055,0.0028492364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99622774,0.00031536873,0.0005474984,0.00061627873,0.0014235023,0.00086963514],"domain_scores_gemma":[0.99821126,0.0004196791,0.00007030097,0.00045199474,0.0004288844,0.00041790484],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017142916,0.00023916234,0.00044538316,0.0004915319,0.00014951319,0.0001115748,0.0005399792,0.00016871227,0.0060101114],"category_scores_gemma":[0.00009678512,0.00020166354,0.00013297485,0.001966845,0.00012853158,0.00012728698,0.00009419277,0.00090837164,0.00020302644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012424388,0.00017951154,0.00015422674,0.00033616376,0.00002272183,0.000022967404,0.004438683,0.00066827063,0.95968765,0.0000028537877,0.024261156,0.008983379],"study_design_scores_gemma":[0.0016702939,0.00048590865,0.00019356982,0.0001665615,0.000004600833,9.4119747e-7,0.0006058609,0.0006189385,0.89437574,0.0000014079244,0.10171214,0.00016404816],"about_ca_topic_score_codex":0.00018211146,"about_ca_topic_score_gemma":0.000019277992,"teacher_disagreement_score":0.077450976,"about_ca_system_score_codex":0.00081185484,"about_ca_system_score_gemma":0.00054096064,"threshold_uncertainty_score":0.99489856},"labels":[],"label_agreement":null},{"id":"W3080386471","doi":"10.1158/1538-7445.am2020-6417","title":"Abstract 6417: LY3410738, a novel inhibitor of mutant IDH1 is more effective than Ivosidenib and potentiates antileukemic activity of standard chemotherapy in preclinical models of acute myeloid leukemia (AML)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Isocitrate dehydrogenase; IDH1; Cancer research; Cytarabine; Myeloid; Chemistry; Pharmacology; Mutant; Medicine; Enzyme; Biochemistry","score_opus":0.06601102206621924,"score_gpt":0.40557041916179626,"score_spread":0.33955939709557703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080386471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218494,0.0011942298,0.00023607304,0.0029955027,0.00003917072,0.0022973279,0.00089391496,0.000024940098,0.00013392816],"genre_scores_gemma":[0.99532074,0.0036932202,0.00038980038,0.00014285762,0.00015887513,0.00015438678,0.0000136385825,0.00008609122,0.000040364477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99527127,0.00022797617,0.0008993454,0.00089368783,0.0018964342,0.00081130397],"domain_scores_gemma":[0.9965886,0.00091405254,0.00033282948,0.00062239997,0.0010900563,0.00045205565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018451276,0.00034688582,0.0014475328,0.00052725355,0.00006532356,0.000022780507,0.00046653496,0.0003964886,0.00013060364],"category_scores_gemma":[0.0005352502,0.00029964212,0.00025464114,0.0013461564,0.0012967398,0.00032510728,0.00041198617,0.0017854661,0.0000024720669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019497367,0.0002604788,0.012114354,0.0019010641,0.00065161916,0.00006970657,0.0035594897,0.00011907828,0.95299095,0.000022263637,0.0007107038,0.008102935],"study_design_scores_gemma":[0.009913638,0.0017163525,0.070050694,0.001174631,0.00008775013,0.000014679207,0.0004395679,0.0064546843,0.9097356,0.00015733264,0.00004343813,0.00021159205],"about_ca_topic_score_codex":0.0036861405,"about_ca_topic_score_gemma":0.000061756946,"teacher_disagreement_score":0.05793634,"about_ca_system_score_codex":0.001467278,"about_ca_system_score_gemma":0.0037630412,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W3080467329","doi":"10.1158/1538-7445.am2020-6494","title":"Abstract 6494: Personalize My Treatment (PMT): A pan-Canadian initiative integrating precision oncology across Canada - PMT-001 pilot project","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Precision medicine; Oncology; Breast cancer; Clinical trial; Internal medicine; Cancer; Lung cancer; Family medicine; Medical physics; Pathology","score_opus":0.14955288604845854,"score_gpt":0.42892116593444274,"score_spread":0.2793682798859842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080467329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397976,0.0035621168,0.000014849521,0.0039070984,0.0002531422,0.00095119444,0.0018392763,0.000009395184,0.0054831402],"genre_scores_gemma":[0.9933882,0.0028840844,0.00009953469,0.0016177509,0.00084982865,0.00044445292,0.00034212592,0.000044666445,0.00032935786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977351,0.00014466523,0.0002719076,0.00064166606,0.0003453864,0.0008613186],"domain_scores_gemma":[0.9985565,0.00019679572,0.00007896943,0.000282838,0.0003945365,0.0004903598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034653785,0.0002318725,0.00026458025,0.00004366858,0.0003685649,0.00009729164,0.00035122194,0.00015119853,0.00022850076],"category_scores_gemma":[0.00054314715,0.00020895265,0.000068255285,0.00026922632,0.00016529502,0.000007079328,0.00017010554,0.00037062945,0.00001904532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028230664,0.0005023979,0.0057828217,0.00018784398,0.000631898,0.00060307153,0.008904017,0.00025735406,0.3054793,0.0001371056,0.24645789,0.42823327],"study_design_scores_gemma":[0.001789682,0.0030974464,0.0024734747,0.000050436523,0.000014688133,0.000008053254,0.0035232054,0.00009494466,0.04403984,0.000019183402,0.9445511,0.0003379175],"about_ca_topic_score_codex":0.9553066,"about_ca_topic_score_gemma":0.99176645,"teacher_disagreement_score":0.69809324,"about_ca_system_score_codex":0.0019958736,"about_ca_system_score_gemma":0.0125791775,"threshold_uncertainty_score":0.99301857},"labels":[],"label_agreement":null},{"id":"W3081001765","doi":"10.1158/1538-7445.am2020-6362","title":"Abstract 6362: TH1901, a novel curcumin-peptide conjugate for the treatment of Sortilin-positive (SORT1+) cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Université du Québec à Montréal","funders":"","keywords":"Curcumin; Cancer cell; Cancer; Apoptosis; Cancer research; Chemistry; Internalization; Cell; Pharmacology; Cell growth; Biochemistry; Biology; Medicine; Internal medicine","score_opus":0.10432823011271009,"score_gpt":0.4264096768238154,"score_spread":0.32208144671110533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081001765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96222436,0.009240836,0.0040888395,0.01872436,0.000129939,0.0025279098,0.0024899999,0.000017709232,0.00055606896],"genre_scores_gemma":[0.9922926,0.003186161,0.00014012199,0.00038967008,0.0007591432,0.0024679757,0.00013331181,0.000032542943,0.00059848255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856555,0.000025465491,0.0002511687,0.0004488659,0.00031073252,0.000398193],"domain_scores_gemma":[0.99879974,0.00017178578,0.00008305715,0.00036424695,0.00038369614,0.00019750191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019624195,0.00014633362,0.00018439683,0.00002914328,0.00017109864,0.000021946084,0.00035411958,0.00010452948,0.00018004232],"category_scores_gemma":[0.000094933406,0.0001019417,0.00014155767,0.00024381555,0.00047169183,0.0000034303666,0.000083061,0.00012511517,0.000010816045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037959052,0.00020076497,0.00031142734,0.00005212119,0.0002078368,9.4837236e-7,0.00034898493,0.00004875607,0.9748968,0.00018463354,0.0074679065,0.015900226],"study_design_scores_gemma":[0.0008926818,0.00047579256,0.0023941002,0.000019450683,0.00003339618,6.267761e-7,0.00017164189,0.00014997665,0.6998931,0.00003712715,0.29582962,0.000102431935],"about_ca_topic_score_codex":0.0009041222,"about_ca_topic_score_gemma":0.00037690558,"teacher_disagreement_score":0.28836173,"about_ca_system_score_codex":0.000089060275,"about_ca_system_score_gemma":0.00048574948,"threshold_uncertainty_score":0.41570622},"labels":[],"label_agreement":null},{"id":"W3081564540","doi":"10.1158/1538-7445.am2020-2335","title":"Abstract 2335: Heterozygous <i>PALB2</i> mutations cause replication stress and DNA repair defects in carrier derived lymphoblastoid cell lines","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"PALB2; DNA repair; Biology; Genetics; Mutation; DNA damage; Population; Breast cancer; Cancer research; Cancer; Medicine; DNA; Gene; Germline mutation","score_opus":0.03770342055582075,"score_gpt":0.3565645035725092,"score_spread":0.3188610830166884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081564540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961181,0.0015745823,0.00025608053,0.001020102,0.000015181735,0.0005221326,0.00012449053,0.000042290998,0.0003269837],"genre_scores_gemma":[0.99677473,0.0013424577,0.000330743,0.00044693114,0.00012410322,0.00064543163,0.0002209664,0.00002762636,0.00008698427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861425,0.00009567035,0.0002071379,0.000648509,0.0001350119,0.00029941578],"domain_scores_gemma":[0.99910235,0.000026806561,0.000054248736,0.00049008813,0.0001683126,0.00015818013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002049814,0.00012848315,0.0001236243,0.000058124486,0.00013640437,0.000026577738,0.00019344431,0.00017971607,0.000012603367],"category_scores_gemma":[0.00012613134,0.00013020953,0.00005492105,0.00024381278,0.000194533,0.0000052805335,0.00016355324,0.00019873309,0.0000042234938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052262538,0.00004016114,0.004055212,0.000063899875,0.00001458439,0.00000845748,0.000096370335,0.00006575765,0.99310917,0.000022806591,0.0019183754,0.00055293465],"study_design_scores_gemma":[0.00037560487,0.00014615947,0.008395255,0.00002478576,0.000007556284,0.000003851111,0.00008394643,0.00007470522,0.9789288,0.000043524044,0.011762648,0.00015313727],"about_ca_topic_score_codex":0.00020572219,"about_ca_topic_score_gemma":0.00037113694,"teacher_disagreement_score":0.014180351,"about_ca_system_score_codex":0.000036536596,"about_ca_system_score_gemma":0.00016223888,"threshold_uncertainty_score":0.5309791},"labels":[],"label_agreement":null},{"id":"W3081566255","doi":"10.1158/1538-7445.am2020-1200","title":"Abstract 1200: Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Pancreatic cancer; Genome-wide association study; Biology; Oncology; Biomarker; Disease; Cancer; Genetic association; Internal medicine; Medicine; Genetics; Gene; Bioinformatics; Genotype; Single-nucleotide polymorphism","score_opus":0.09543256340267416,"score_gpt":0.3950035635257004,"score_spread":0.29957100012302623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081566255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319197,0.0026777154,0.000041719784,0.009257625,0.000017849266,0.0018296149,0.00046171868,0.000077348224,0.0024444193],"genre_scores_gemma":[0.9960324,0.0010922024,0.0011189213,0.000113128146,0.0006999742,0.00037517239,0.00008513244,0.000043853328,0.00043917217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965838,0.00042365215,0.00044107795,0.0005917492,0.0011225685,0.0008371256],"domain_scores_gemma":[0.9974404,0.0006942186,0.000097008604,0.0003206269,0.0004986101,0.00094916153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012992044,0.00019088795,0.00062042574,0.00020706387,0.00037422328,0.00006230252,0.00022343693,0.00026606023,0.00086737407],"category_scores_gemma":[0.0028001391,0.00016603722,0.000079592,0.0007621715,0.00066767103,0.00007587569,0.00018497053,0.0012014229,0.000077130026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003254477,0.000109536886,0.963749,0.00020970854,0.001091315,0.0001643372,0.0005097441,3.2505636e-7,0.030279236,0.0000392673,0.0022070785,0.0013150366],"study_design_scores_gemma":[0.00263138,0.0010143738,0.9921751,0.00013967014,0.0005403124,0.000011012078,0.00018612573,0.00018580054,0.0024993264,0.00018590191,0.00028499792,0.00014598518],"about_ca_topic_score_codex":0.0012081121,"about_ca_topic_score_gemma":0.000037451457,"teacher_disagreement_score":0.028426146,"about_ca_system_score_codex":0.00021213364,"about_ca_system_score_gemma":0.0013275916,"threshold_uncertainty_score":0.94971377},"labels":[],"label_agreement":null},{"id":"W3081569869","doi":"10.1158/1538-7445.am2020-ct207","title":"Abstract CT207: A phase II trial using grape seed extract for prostate cancer patients with non-metastatic PSA progression after local therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuts composition and effects","field":"Nursing","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Grape seed extract; Urology; Androgen deprivation therapy; Prostate-specific antigen; Prostate; Cancer; Doubling time; Clinical trial; Internal medicine; Phases of clinical research; Oncology; Surgery; Pathology","score_opus":0.08586198240494596,"score_gpt":0.4537298808054445,"score_spread":0.36786789840049855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081569869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078053,0.0006274714,0.00040089976,0.0018643104,0.00048758625,0.005605585,0.00015924188,0.000058993322,0.000015380665],"genre_scores_gemma":[0.9960027,0.000035967558,0.00036030362,0.0005092429,0.0004713656,0.0024602825,0.000052897394,0.00008689945,0.000020367514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99728817,0.00019173326,0.0003099571,0.0005571153,0.00088557805,0.0007674219],"domain_scores_gemma":[0.9987,0.0001533776,0.00012456517,0.00020428518,0.00047358306,0.00034418062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042919326,0.00025388217,0.00033087438,0.00016665594,0.00048584936,0.00015648558,0.00019156736,0.00007427887,0.00024098576],"category_scores_gemma":[0.00003589288,0.0001859655,0.00010378865,0.0005617347,0.00020953623,0.00030340737,0.00005075846,0.00050076423,0.000008989451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58014286,0.0023171671,0.0020380998,0.000570153,0.00013953006,0.000040568462,0.004262716,0.00031967225,0.09991377,7.539937e-7,0.0015979335,0.30865678],"study_design_scores_gemma":[0.58518994,0.073236436,0.019529874,0.004155845,0.00023161495,0.000004256059,0.000564917,0.043498784,0.25525498,0.00013593017,0.01633977,0.001857688],"about_ca_topic_score_codex":0.00022169879,"about_ca_topic_score_gemma":0.00003601557,"teacher_disagreement_score":0.3067991,"about_ca_system_score_codex":0.00033727082,"about_ca_system_score_gemma":0.00030244424,"threshold_uncertainty_score":0.7583453},"labels":[],"label_agreement":null},{"id":"W3081590106","doi":"10.1158/1538-7445.am2020-ct162","title":"Abstract CT162: The phase 1b PORTIA study: Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Pembrolizumab; Adverse effect; Cohort; Internal medicine; Neutropenia; Refractory (planetary science); Clinical trial; Oncology; Cancer; Toxicity; Immunotherapy","score_opus":0.04802705472500542,"score_gpt":0.3721562432470194,"score_spread":0.324129188522014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081590106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302036,0.0012249874,0.000004120096,0.0007866097,0.000043441632,0.003063335,0.00010082666,0.00002796629,0.001728344],"genre_scores_gemma":[0.9975155,0.00070195884,0.000006802879,0.00016185711,0.00014395014,0.00012275581,0.000039352497,0.00008920353,0.0012186317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954651,0.0003936274,0.0005811591,0.0006898255,0.00196887,0.00090143754],"domain_scores_gemma":[0.9975781,0.0005382593,0.00014071654,0.00078009424,0.00045619844,0.0005066666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013546534,0.00026858205,0.0006090986,0.00027649727,0.00020698215,0.00004907363,0.00043878207,0.00012768226,0.0014466109],"category_scores_gemma":[0.0003119912,0.00018305075,0.00008301752,0.0010455718,0.0004235027,0.00012912098,0.00030953292,0.0010847497,0.00003233962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25656277,0.12273,0.3442613,0.0015384933,0.0008965229,0.0012469585,0.030131727,0.000027127104,0.06279632,0.00003403267,0.004952691,0.17482206],"study_design_scores_gemma":[0.30567247,0.005787075,0.6713499,0.00017178108,0.000056448054,0.000003147897,0.001548035,0.00012954383,0.0029847727,0.0000033264548,0.012055681,0.0002378541],"about_ca_topic_score_codex":0.0010218493,"about_ca_topic_score_gemma":0.00028310576,"teacher_disagreement_score":0.3270886,"about_ca_system_score_codex":0.00063306605,"about_ca_system_score_gemma":0.0011789206,"threshold_uncertainty_score":0.9994662},"labels":[],"label_agreement":null},{"id":"W3081601616","doi":"10.1158/1538-7445.am2020-1096","title":"Abstract 1096: Harmonization standards from the Variant Interpretation for Cancer Consortium","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Harmonization; Precision medicine; Cancer; Computational biology; Computer science; Biology; Genetics","score_opus":0.05516288501767114,"score_gpt":0.386566722652286,"score_spread":0.33140383763461484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081601616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107705,0.016237382,0.038289372,0.024561903,0.0007764468,0.0014274194,0.007247897,0.000021504744,0.0006675992],"genre_scores_gemma":[0.9922555,0.0038170957,0.00012466173,0.001728021,0.0013215573,0.0003923948,0.0002635997,0.000027641694,0.00006952225],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989607,0.00004566909,0.00015960162,0.00032491158,0.0002671892,0.00024196244],"domain_scores_gemma":[0.9989024,0.00014444096,0.00005238481,0.00020070304,0.000600209,0.00009990285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035170565,0.00008982345,0.000096147254,0.000014701636,0.00016184304,0.00009535909,0.00024769406,0.00007986902,0.00021819917],"category_scores_gemma":[0.0006685824,0.000072757895,0.00005360535,0.000114571274,0.00010111345,0.0000045296506,0.00010111225,0.00014330709,0.000004810729],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015240659,0.000032136046,0.0018576601,0.00006818919,0.00017765754,0.0000037721163,0.0010398725,0.0025257487,0.75762933,0.00039705075,0.19673038,0.038014106],"study_design_scores_gemma":[0.0011252931,0.00025097866,0.004080624,0.0000606241,0.000035309706,4.370861e-7,0.00035168199,0.0022984857,0.30548143,0.00042545944,0.68566805,0.0002215827],"about_ca_topic_score_codex":0.0010576729,"about_ca_topic_score_gemma":0.00094118406,"teacher_disagreement_score":0.4889377,"about_ca_system_score_codex":0.0001064693,"about_ca_system_score_gemma":0.0008565176,"threshold_uncertainty_score":0.2966981},"labels":[],"label_agreement":null},{"id":"W3081645843","doi":"10.1158/1538-7445.am2020-3401","title":"Abstract 3401: Targeting lysosomal homeostasis in ovarian cancer through drug repurposing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Autophagy; Drug repositioning; Ovarian cancer; Pharmacology; Biology; Drug; PI3K/AKT/mTOR pathway; Cancer; Cancer research; Cell biology; Signal transduction; Apoptosis; Biochemistry; Genetics","score_opus":0.10644783419795278,"score_gpt":0.42873847055609354,"score_spread":0.32229063635814076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081645843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94806343,0.030221757,0.000014275507,0.01751921,0.00014903847,0.00062199304,0.000041867548,0.00006597984,0.0033024664],"genre_scores_gemma":[0.98995036,0.006149542,0.00018317,0.0020327095,0.0011038476,0.00024561275,0.000020270427,0.000056081986,0.0002584313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751717,0.00012309579,0.0003408594,0.0005323299,0.0007612163,0.0007253213],"domain_scores_gemma":[0.9990021,0.00012276703,0.00006022905,0.000285693,0.00020030627,0.0003288816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005250243,0.00016892733,0.00034327037,0.00012363757,0.0001863952,0.000055600434,0.00022634746,0.00009733562,0.003219048],"category_scores_gemma":[0.00019231132,0.00015320437,0.00010145352,0.0009316517,0.00015401408,0.00021021292,0.000099853554,0.0008941486,0.000076647135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006272232,0.0007408216,0.10276567,0.0023326029,0.0007468876,0.0040077846,0.035422098,0.00051762804,0.6502449,0.0011131819,0.082403705,0.11343251],"study_design_scores_gemma":[0.009840273,0.0003541002,0.17921524,0.0023271625,0.00010573721,0.000012332324,0.0054763933,0.0005687245,0.6560482,0.0015328716,0.14361233,0.00090669293],"about_ca_topic_score_codex":0.0043978654,"about_ca_topic_score_gemma":0.00011681507,"teacher_disagreement_score":0.11252582,"about_ca_system_score_codex":0.00040131315,"about_ca_system_score_gemma":0.0008540508,"threshold_uncertainty_score":0.99769217},"labels":[],"label_agreement":null},{"id":"W3081724831","doi":"10.1158/1538-7445.am2020-3553","title":"Abstract 3553: Three-dimensional (3D) telomere signatures of sporadic pediatric papillary thyroid carcinoma (PTC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Telomere; Carcinogenesis; Thyroid carcinoma; Thyroid cancer; Population; Medicine; Pathology; Cancer; Thyroid; Papillary thyroid cancer; Fluorescence in situ hybridization; Internal medicine; Cancer research; Gastroenterology; Biology; Endocrinology; Genetics; Gene","score_opus":0.06843838726263057,"score_gpt":0.3506661436871674,"score_spread":0.28222775642453685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081724831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9090407,0.081868365,9.094126e-7,0.0068983748,0.00013000166,0.00072732085,0.00012372066,0.000045480425,0.0011651629],"genre_scores_gemma":[0.9946299,0.0030258638,0.000097415614,0.00064209633,0.0012232424,0.00018622946,0.000042849457,0.00005707576,0.00009532188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969735,0.00006074124,0.00039243163,0.0006015629,0.0013557081,0.0006160191],"domain_scores_gemma":[0.99824786,0.00024345519,0.00011118292,0.00042112637,0.00043327507,0.0005430697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032706923,0.00024449822,0.00051711506,0.00024019362,0.00013969341,0.000021314227,0.0002483072,0.00016632068,0.0019329892],"category_scores_gemma":[0.00010439605,0.00019372144,0.00018316165,0.0008896576,0.00020060575,0.0000838637,0.00014964149,0.00079672533,0.00010931779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023317568,0.0008807956,0.7530258,0.001825435,0.00042879928,0.0014509024,0.0006107189,0.00038972643,0.055272944,0.00033432324,0.16781747,0.015631303],"study_design_scores_gemma":[0.0038137853,0.0017324693,0.95491457,0.00019222898,0.00018970679,0.0000137376355,0.0001055614,0.000099037636,0.032496717,0.00014846645,0.005991471,0.0003022191],"about_ca_topic_score_codex":0.001333307,"about_ca_topic_score_gemma":0.00010849378,"teacher_disagreement_score":0.20188878,"about_ca_system_score_codex":0.00029742578,"about_ca_system_score_gemma":0.0011726744,"threshold_uncertainty_score":0.9989794},"labels":[],"label_agreement":null},{"id":"W3081757084","doi":"10.1158/1538-7445.am2020-5636","title":"Abstract 5636: Restoration of tumor immunosurveillance in tasmanian devil facial tumor disease","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Biology; ErbB; Cancer research; Cancer; Population; Receptor tyrosine kinase; Immunology; Medicine; Kinase; Genetics","score_opus":0.15718547287613374,"score_gpt":0.45202469810441054,"score_spread":0.29483922522827677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081757084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882567,0.0013961303,0.000004651719,0.008170833,0.00007906721,0.00089451054,0.000078232355,0.000029639177,0.0010902586],"genre_scores_gemma":[0.9987193,0.00017201468,0.00008624936,0.00027185716,0.00030586633,0.0002302781,0.000026539417,0.00003142857,0.00015648606],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99726284,0.00030869182,0.0004032479,0.0004429444,0.0009858238,0.0005964417],"domain_scores_gemma":[0.99846655,0.00017907914,0.00007154827,0.00037233596,0.00044219993,0.00046831137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012281926,0.00013265538,0.00037900262,0.00028690812,0.00009614555,0.000022809134,0.00032517195,0.000056690427,0.0008802937],"category_scores_gemma":[0.0014264451,0.00012656592,0.00006798764,0.00096928334,0.0004317043,0.0001331461,0.00018809372,0.0008934713,0.00014845634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011335041,0.00035592803,0.3533754,0.0013937477,0.00004540207,0.003749174,0.0009168031,0.00007107901,0.61720335,0.0000671542,0.0059695477,0.0055173286],"study_design_scores_gemma":[0.0023829674,0.0011524793,0.9776351,0.0002686541,0.0000068545564,0.00003192036,0.00029606835,0.00035319384,0.0041080434,0.000038546194,0.013574443,0.00015176355],"about_ca_topic_score_codex":0.0006179323,"about_ca_topic_score_gemma":0.00025461122,"teacher_disagreement_score":0.62425965,"about_ca_system_score_codex":0.00046213358,"about_ca_system_score_gemma":0.002006525,"threshold_uncertainty_score":0.96385986},"labels":[],"label_agreement":null},{"id":"W3081770373","doi":"10.1158/1538-7445.am2020-4655","title":"Abstract 4655: Social jetlag and lung cancer incidence in the Alberta's Tomorrow Project: A prospective cohort study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Saskatchewan","funders":"","keywords":"Medicine; Lung cancer; Demography; Body mass index; Prospective cohort study; Hazard ratio; Cohort; Population; Proportional hazards model; Cohort study; Cancer; Internal medicine; Gerontology; Environmental health; Confidence interval","score_opus":0.07266577756178332,"score_gpt":0.4532639362894136,"score_spread":0.38059815872763025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081770373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827471,0.003840313,9.650742e-7,0.006613076,0.00007003855,0.0054069893,0.000013569294,0.000017088145,0.0012909104],"genre_scores_gemma":[0.9951803,0.0013288502,0.0000030639521,0.0004859498,0.00072502816,0.0021049795,0.000003657332,0.00002354002,0.00014462163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972347,0.00028886858,0.0002325278,0.0005117773,0.0011835601,0.00054859096],"domain_scores_gemma":[0.9990852,0.00021051083,0.00003860782,0.00022760876,0.00025203376,0.00018607496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016611456,0.00014218643,0.0003863998,0.00012265188,0.0002861072,0.000054414166,0.00018221357,0.00008817423,0.00011983764],"category_scores_gemma":[0.0004080695,0.00009315011,0.00008422484,0.0009615492,0.00018501861,0.00008809035,0.000101411824,0.0011316522,0.0000070945575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051930186,0.000113723676,0.960739,0.00029064892,0.00017380777,0.00015245796,0.031358216,0.0000025894567,0.00023309544,0.000013896235,0.0036677422,0.0027355119],"study_design_scores_gemma":[0.0015698065,0.00020086736,0.9899776,0.00008630244,0.00008350824,0.000008460347,0.006162984,0.000057057376,0.0001280818,0.000006648056,0.0016155903,0.0001030905],"about_ca_topic_score_codex":0.10247615,"about_ca_topic_score_gemma":0.031673238,"teacher_disagreement_score":0.07080291,"about_ca_system_score_codex":0.0004932993,"about_ca_system_score_gemma":0.0015031972,"threshold_uncertainty_score":0.9859962},"labels":[],"label_agreement":null},{"id":"W3081787367","doi":"10.1158/1538-7445.am2020-ct221","title":"Abstract CT221: Nivolumab (NIVO) + ipilimumab (IPI) as first-line (1L) treatment for patients with advanced non-small cell lung cancer (NSCLC) with brain metastases: Results from CheckMate 227","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Ipilimumab; Oncology; Lung cancer; Brain metastasis; Asymptomatic; Cancer; Performance status; Gastroenterology; Immunotherapy; Metastasis","score_opus":0.053857589937074755,"score_gpt":0.3624827389685978,"score_spread":0.30862514903152305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081787367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97253484,0.0035021969,0.00019102654,0.009488414,0.00012474341,0.0063567576,0.0069842115,0.00010225378,0.0007155783],"genre_scores_gemma":[0.9871657,0.0014746619,0.0030824875,0.00088716956,0.00053863827,0.003398325,0.0020768174,0.00020739622,0.0011688194],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99528503,0.00011045484,0.0006304079,0.0015126269,0.0012077166,0.0012537604],"domain_scores_gemma":[0.9963461,0.0007446871,0.00028685897,0.0009157219,0.00090442394,0.00080222136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004059852,0.00066262996,0.0009990649,0.00019632472,0.00042199486,0.00011113748,0.00032965696,0.00014491023,0.0007021235],"category_scores_gemma":[0.00018579914,0.0004413119,0.00023171096,0.00071567204,0.00021591586,0.00022146836,0.000113341615,0.00051099394,0.00006247461],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50378644,0.019090982,0.07169019,0.0074195378,0.015176151,0.003143037,0.017766675,0.014083705,0.012550732,0.0000886258,0.06797941,0.2672245],"study_design_scores_gemma":[0.4797234,0.073957965,0.08058051,0.007204734,0.0050527994,0.000015942886,0.0033782385,0.004553464,0.13265117,0.00012138371,0.20927003,0.003490383],"about_ca_topic_score_codex":0.012266202,"about_ca_topic_score_gemma":0.004258005,"teacher_disagreement_score":0.2637341,"about_ca_system_score_codex":0.0013808245,"about_ca_system_score_gemma":0.0017270321,"threshold_uncertainty_score":0.99980384},"labels":[],"label_agreement":null},{"id":"W3081837099","doi":"10.1158/1538-7445.am2020-3784","title":"Abstract 3784: The metabolic enzyme Hexokinase 2 localizes to the nucleus and regulates stemness in AML through a kinase independent mechanism","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Stem cell; Biology; Clonogenic assay; Cancer stem cell; Pyruvate kinase; Cell biology; Cancer research; Molecular biology; Biochemistry; Glycolysis; Cell; Enzyme","score_opus":0.051958531945169105,"score_gpt":0.3452780633169133,"score_spread":0.2933195313717442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081837099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432965,0.04486568,0.00011995395,0.010115054,0.00037611465,0.00085991324,0.00008803915,0.0000125800125,0.00026616247],"genre_scores_gemma":[0.9832833,0.012185997,0.00003760393,0.002113302,0.0015917239,0.00039980188,0.000011378674,0.000039099494,0.00033779567],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997845,0.00025062167,0.00024052615,0.0005850657,0.000502434,0.0005763357],"domain_scores_gemma":[0.9989891,0.000051647272,0.000047673777,0.0005396558,0.00016283017,0.00020910802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008519926,0.00019819368,0.00024257317,0.00005130527,0.00025527642,0.00012882096,0.0006087056,0.0001381272,0.00009845307],"category_scores_gemma":[0.00017793001,0.00012594218,0.000074906195,0.0004150046,0.00019325785,0.0000127043895,0.0005135415,0.0004420915,0.000021258937],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007109024,0.00007659146,0.0001575762,0.00009447154,0.00011879844,0.000021373384,0.0031222934,0.00040229896,0.94934565,0.0050300094,0.015475457,0.025444573],"study_design_scores_gemma":[0.0006840567,0.00009692801,0.0035521346,0.000028334138,0.000016125647,0.0000056039617,0.0009573817,0.000032831627,0.36811042,0.0005425192,0.62580246,0.00017123295],"about_ca_topic_score_codex":0.0022915783,"about_ca_topic_score_gemma":0.0017280028,"teacher_disagreement_score":0.610327,"about_ca_system_score_codex":0.00003359239,"about_ca_system_score_gemma":0.00026988954,"threshold_uncertainty_score":0.51357734},"labels":[],"label_agreement":null},{"id":"W3081856157","doi":"10.1158/1538-7445.am2020-829","title":"Abstract 829: Global tumor transcriptional activity reveals aggressiveness across multiple cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Prostate cancer; Cancer; Biology; Epigenetics; Gene; Somatic cell; Genome; Cancer research; Computational biology; Gene expression; Genetics","score_opus":0.07450202248969799,"score_gpt":0.40433818227298207,"score_spread":0.32983615978328407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081856157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350096,0.0100493785,0.00016932734,0.0013364977,0.002690897,0.00040130346,0.0014135146,0.000023994467,0.00041410315],"genre_scores_gemma":[0.9820692,0.0028959303,0.000028760087,0.000616115,0.013752865,0.00027181653,0.00006198592,0.00003187334,0.00027146097],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759793,0.00013733242,0.00020582015,0.00069904875,0.000576791,0.000783077],"domain_scores_gemma":[0.9988157,0.0000285848,0.00007852831,0.00032778588,0.00034097073,0.0004084344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042991652,0.0002057951,0.00026409986,0.000021501579,0.00028422067,0.0000737425,0.00045266663,0.00014764388,0.00020905354],"category_scores_gemma":[0.00023316966,0.00020527322,0.00016182706,0.0003215304,0.00033305783,0.000016236036,0.00015118612,0.00035968696,0.000028040697],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011986076,0.000040887266,0.0053760507,0.00012756453,0.00007045376,0.0000020525788,0.00017960057,0.0002574433,0.9327086,0.00003645174,0.05101259,0.008989664],"study_design_scores_gemma":[0.0018819221,0.00013927449,0.09649598,0.00007315673,0.000011546,0.0000068584873,0.00024368647,0.000036174348,0.13937889,0.000049118185,0.7613366,0.000346759],"about_ca_topic_score_codex":0.0021375201,"about_ca_topic_score_gemma":0.001597909,"teacher_disagreement_score":0.7933297,"about_ca_system_score_codex":0.0002589881,"about_ca_system_score_gemma":0.0010781187,"threshold_uncertainty_score":0.8370799},"labels":[],"label_agreement":null},{"id":"W3081861280","doi":"10.1158/1538-7445.am2020-ct169","title":"Abstract CT169: A phase Ia study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in patients with locally advanced or metastatic solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chills; Immunotherapy; Internal medicine; Adverse effect; Cancer; Immune system; Oncology; Nausea; Gastroenterology; Immunology","score_opus":0.11949571553765717,"score_gpt":0.4719475528965949,"score_spread":0.3524518373589377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081861280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911308,0.0009493834,0.00004106336,0.0012894452,0.00007950189,0.006261659,0.000090995,0.00006689596,0.000090209505],"genre_scores_gemma":[0.9968113,0.0003266084,0.00048501615,0.0010915474,0.00012996572,0.00081178953,0.00006490638,0.00012018792,0.00015869492],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950203,0.0004361808,0.0007647259,0.0009139039,0.001928035,0.00093689235],"domain_scores_gemma":[0.99795693,0.0001242992,0.00014347627,0.0006130426,0.0006090916,0.000553132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016455953,0.00038693697,0.0008324168,0.00049560826,0.00018034075,0.00012946189,0.0005212384,0.000052431755,0.00268327],"category_scores_gemma":[0.00011566778,0.00027215792,0.000090422196,0.0022732678,0.00019482842,0.0002883752,0.00008677248,0.00066478585,0.00007576087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45685247,0.010094373,0.07644871,0.00032294012,0.0012338617,0.00090846966,0.026610723,0.00043158044,0.10929341,0.000002684913,0.0015625935,0.3162382],"study_design_scores_gemma":[0.13479318,0.04358104,0.7949696,0.00093450426,0.0000844429,0.0000075530356,0.0068353224,0.000114154325,0.0090062795,0.000014185907,0.008848874,0.00081087195],"about_ca_topic_score_codex":0.00068552204,"about_ca_topic_score_gemma":0.0007620878,"teacher_disagreement_score":0.7185209,"about_ca_system_score_codex":0.00051549514,"about_ca_system_score_gemma":0.0013419619,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W3081888797","doi":"10.1158/1538-7445.am2020-3331","title":"Abstract 3331: Role of innate immune cells in the development of vessel co-opting CRC liver metastases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Stromal cell; Medicine; Angiogenesis; Pathology; Colorectal cancer; Immune system; Bevacizumab; Innate immune system; Immunohistochemistry; Infiltration (HVAC); Cancer research; Chemotherapy; Cancer; Immunology; Internal medicine","score_opus":0.13104497694854572,"score_gpt":0.40105833304479155,"score_spread":0.2700133560962458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081888797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014413,0.0064515052,0.0000040774166,0.0009898382,0.000017712033,0.00041760434,0.00003510465,0.0000057392303,0.0019343067],"genre_scores_gemma":[0.9984368,0.00084455224,0.00037697155,0.000107308144,0.00005611757,0.00013349886,0.000008539838,0.000015289903,0.000020895895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982459,0.000110897025,0.0004173449,0.00020153714,0.0007254425,0.00029887343],"domain_scores_gemma":[0.9992315,0.00015926297,0.00009185737,0.0001973987,0.00024055126,0.000079395664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012679502,0.00009208083,0.00029528746,0.00011289912,0.00006195477,0.0000128419415,0.0002650083,0.00004322418,0.0006090783],"category_scores_gemma":[0.0000886485,0.00006425457,0.000061538376,0.00054975715,0.0001375894,0.000052821586,0.000084758496,0.00038818017,0.000016592981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003798299,0.00023473414,0.0048032156,0.00087816565,0.00010160802,0.000012350856,0.01411105,0.00004398946,0.9218849,0.000043200987,0.0014167778,0.0560902],"study_design_scores_gemma":[0.00059902517,0.00014936275,0.0512889,0.00028212657,0.00001636859,4.5997862e-7,0.00501965,0.000050396702,0.929104,0.0000067764618,0.013419089,0.000063879415],"about_ca_topic_score_codex":0.00066713383,"about_ca_topic_score_gemma":0.000044306507,"teacher_disagreement_score":0.05602632,"about_ca_system_score_codex":0.00008730058,"about_ca_system_score_gemma":0.0005727802,"threshold_uncertainty_score":0.666898},"labels":[],"label_agreement":null},{"id":"W3081911417","doi":"10.1158/1538-7445.am2020-ct288","title":"Abstract CT288: Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with inoperable stage I/IIA non-small-cell lung cancer (NSCLC): KEYNOTE-867","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Clinical endpoint; Internal medicine; Oncology; Placebo; Lung cancer; Stage (stratigraphy); non-small cell lung cancer (NSCLC); Radiation therapy; Cancer; Randomized controlled trial; Pathology; Immunotherapy","score_opus":0.03283083314242326,"score_gpt":0.38228448949498695,"score_spread":0.3494536563525637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081911417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782987,0.0024940278,0.00002607872,0.0005381537,0.00007359054,0.01790717,0.00006832998,0.000037852074,0.0005560593],"genre_scores_gemma":[0.98922837,0.0015390653,0.00006804311,0.0002510803,0.00016620723,0.00764907,0.00002013479,0.00014076316,0.0009372568],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99522614,0.0004762527,0.0008268936,0.00097119587,0.0015816598,0.00091784034],"domain_scores_gemma":[0.99714744,0.0006130765,0.0003533004,0.0006695173,0.0007074388,0.0005092116],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089121144,0.0005298338,0.0023492316,0.00036936754,0.00016457828,0.00009851185,0.000328748,0.00011819197,0.0016297017],"category_scores_gemma":[0.000080148035,0.00030196764,0.00014250442,0.0009151802,0.00021371384,0.00022029992,0.00007229927,0.00086699275,0.000007447765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62550145,0.005543057,0.35966557,0.00087415177,0.001841979,0.00020802529,0.004748002,0.00042946445,0.00036482525,9.764153e-7,0.0002938913,0.0005286178],"study_design_scores_gemma":[0.95254755,0.010632272,0.02980248,0.0012470203,0.00077657634,0.0000014740589,0.000996055,0.0016661293,0.0018212909,2.5976945e-7,0.00013115379,0.00037774458],"about_ca_topic_score_codex":0.009376744,"about_ca_topic_score_gemma":0.0024875375,"teacher_disagreement_score":0.3298631,"about_ca_system_score_codex":0.0017281459,"about_ca_system_score_gemma":0.0024808412,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W3081986849","doi":"10.1158/0008-5472.can-20-1387","title":"Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; National Institute for Health and Care Research; Ontario Ministry of Economic Development and Innovation; UCLH Biomedical Research Centre; Cancer Research UK; Sarcoma UK; Bone Cancer Research Trust; European Federation of Pharmaceutical Industries and Associations; Fondation Leducq; Merck KGaA; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Pfizer; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; European Commission; Chordoma Foundation; NIHR Oxford Biomedical Research Centre; Wellcome Trust; Medical Research Council; Ministero dello Sviluppo Economico; National Institute on Handicapped Research","keywords":"Brachyury; H3K4me3; Biology; Cancer research; Demethylating agent; Histone; Epigenetics; Chordoma; Cell biology; Genetics; Embryonic stem cell; Gene expression; DNA methylation; DNA; Mesoderm; Gene","score_opus":0.046154494143849936,"score_gpt":0.37971739271078475,"score_spread":0.33356289856693483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081986849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883481,0.007828307,0.001390611,0.00094148726,0.00003699393,0.00055718696,0.000058467904,0.000015428399,0.0008234142],"genre_scores_gemma":[0.99632734,0.002465374,0.00031523168,0.00013102003,0.00021878272,0.00015053558,0.000058124915,0.000047967565,0.00028561658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796015,0.0002556799,0.00022502197,0.000573192,0.00052761065,0.00045834002],"domain_scores_gemma":[0.9989665,0.00005065925,0.000066609704,0.0002924338,0.0003670803,0.00025671767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004516539,0.0001601252,0.0002079463,0.00013138466,0.00013203101,0.000032472544,0.0002084891,0.00020010956,0.00012088641],"category_scores_gemma":[0.00039473528,0.00016171127,0.000065373526,0.00039661385,0.00027136164,0.000010746053,0.00040106877,0.00042704408,0.000006515289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003869459,0.00006787704,0.000118567914,0.00023944459,0.000040380273,0.000012465011,0.00014658933,0.00002829512,0.99370867,0.0000816595,0.001460862,0.003708244],"study_design_scores_gemma":[0.0007492619,0.0009829877,0.00014590939,0.000050283274,0.00001088896,0.0000043565747,0.0001379237,0.00009824263,0.99111354,0.0001595658,0.00638984,0.00015716931],"about_ca_topic_score_codex":0.00035858297,"about_ca_topic_score_gemma":0.000043797918,"teacher_disagreement_score":0.007979244,"about_ca_system_score_codex":0.00009377162,"about_ca_system_score_gemma":0.00041740687,"threshold_uncertainty_score":0.65943944},"labels":[],"label_agreement":null},{"id":"W3082081828","doi":"10.1158/1538-7445.am2020-2355","title":"Abstract 2355: Folate and folic acid intake in relation to molecular subtypes of colorectal cancer; a pooled analysis of 7542 cases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Newfoundland and Labrador; Memorial University of Newfoundland; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Colorectal cancer; Medicine; Oncology; Internal medicine; Odds ratio; Thymidylate synthase; Methylenetetrahydrofolate reductase; KRAS; Epidemiology; Cancer; Genetics; Biology; Genotype; Fluorouracil","score_opus":0.07218742358189911,"score_gpt":0.41484850993907696,"score_spread":0.34266108635717785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082081828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939992,0.0033023865,0.000006786345,0.0017591593,0.000012127794,0.00053662545,0.0000815689,0.000008458749,0.00029369586],"genre_scores_gemma":[0.998734,0.00094123615,0.000045071127,0.000081680715,0.00002769917,0.00009033806,0.000022672299,0.000017634255,0.000039679413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981843,0.00010464461,0.00033501902,0.0003309732,0.00069355645,0.0003514609],"domain_scores_gemma":[0.9989476,0.00016676623,0.00005567391,0.000173733,0.00039562472,0.00026057282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054785854,0.00010348771,0.0004769744,0.0009219123,0.000034434754,0.000013507824,0.00012641726,0.00009919591,0.00041043098],"category_scores_gemma":[0.00052157353,0.0000922821,0.00008324679,0.0032280718,0.00013920241,0.000069423724,0.00011301719,0.00039986902,0.0000056997537],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019153085,0.000070614406,0.10017955,0.00030518172,0.0007405875,0.00017950023,0.0012976296,0.00027986572,0.88735235,0.00004420807,0.00015485942,0.0074803466],"study_design_scores_gemma":[0.0009773618,0.0009662821,0.63290244,0.00017263943,0.00027513038,0.0000024253327,0.0003303129,0.0014845083,0.3626359,0.000017094746,0.00014459835,0.00009126911],"about_ca_topic_score_codex":0.009825659,"about_ca_topic_score_gemma":0.0031025368,"teacher_disagreement_score":0.5327229,"about_ca_system_score_codex":0.0001728924,"about_ca_system_score_gemma":0.0004398842,"threshold_uncertainty_score":0.996768},"labels":[],"label_agreement":null},{"id":"W3082091318","doi":"10.1158/1538-7445.am2020-3509","title":"Abstract 3509: Racial variation in molecularly-defined prostate cancer subtypes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; DECIPHER; Cancer; Oncology; Internal medicine; Biomarker; Medicine; Logistic regression; Prostate; Bioinformatics; Biology; Genetics","score_opus":0.08798550149882475,"score_gpt":0.42135064695053664,"score_spread":0.3333651454517119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082091318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546078,0.007963534,0.000012292097,0.03318381,0.00012987548,0.0015091357,0.000076161225,0.00006461874,0.002452769],"genre_scores_gemma":[0.9919119,0.0045205588,0.00006533859,0.00049782335,0.0005226775,0.00091870426,0.000048555365,0.00005154967,0.0014629028],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970836,0.0001330263,0.00030256758,0.00057975797,0.0010810173,0.00082004326],"domain_scores_gemma":[0.9987223,0.00010008046,0.000049455517,0.00024955775,0.00047191663,0.0004066522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006155862,0.00018230842,0.00033120092,0.00029426804,0.00014301759,0.000082146464,0.00019445377,0.00013457598,0.0014822964],"category_scores_gemma":[0.0002690521,0.00015111636,0.0000784615,0.0013020242,0.00017475749,0.00017939063,0.00011123393,0.00091973046,0.00016008054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011633262,0.0005159955,0.13391656,0.0013421495,0.0003226559,0.0013176032,0.013315662,0.00022115304,0.79404014,0.0003738959,0.008234547,0.03476638],"study_design_scores_gemma":[0.01618705,0.0015949832,0.7843762,0.0009709349,0.00008462105,0.0000067466085,0.0006821809,0.0010199758,0.15611398,0.0007595277,0.037532266,0.00067152386],"about_ca_topic_score_codex":0.0033626333,"about_ca_topic_score_gemma":0.00047254964,"teacher_disagreement_score":0.65045965,"about_ca_system_score_codex":0.0007568724,"about_ca_system_score_gemma":0.0017946521,"threshold_uncertainty_score":0.9994305},"labels":[],"label_agreement":null},{"id":"W3082120606","doi":"10.1158/1538-7445.am2020-1998","title":"Abstract 1998: Predictive and prognostic role of T- and B-cell receptor repertoire in HER2-positive breast cancer: An analysis of the NeoALTTO clinical trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Oncology; Breast cancer; Internal medicine; T-cell receptor; Proportional hazards model; Hazard ratio; Biology; Univariate analysis; Medicine; Cancer; Multivariate analysis; Immunology; Immune system; T cell; Confidence interval","score_opus":0.03728976721493562,"score_gpt":0.37636144244776676,"score_spread":0.33907167523283116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082120606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439156,0.0033607231,0.000002745883,0.00055393355,0.000049226674,0.0005350716,0.0010208734,0.0000016766267,0.000084205996],"genre_scores_gemma":[0.9934426,0.006051057,0.000019345916,0.000083351515,0.00025631892,0.00008478414,0.000037588117,0.0000131998695,0.000011785017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863935,0.00018144834,0.00034472227,0.00042177938,0.0002116974,0.00020098474],"domain_scores_gemma":[0.999157,0.0001423687,0.00012455159,0.00023457485,0.00018988915,0.00015161962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046994386,0.000098098935,0.00028679735,0.000062504456,0.00005273545,0.0000174397,0.00019247235,0.00013074368,0.000020199675],"category_scores_gemma":[0.00024438943,0.00007868283,0.00008719466,0.00038840566,0.00038951842,0.000005504603,0.00021552667,0.00023439726,1.8799847e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023217747,0.00049078127,0.54622567,0.0001248693,0.00056040206,0.0000030274684,0.0014696432,0.0007585332,0.40454626,0.000025389114,0.0005142354,0.022063471],"study_design_scores_gemma":[0.0110076545,0.0026849592,0.899253,0.00013693387,0.0003480025,0.0000011198795,0.0015234499,0.0025771991,0.080470406,0.000045931225,0.0016972648,0.0002540373],"about_ca_topic_score_codex":0.0027417531,"about_ca_topic_score_gemma":0.0020805188,"teacher_disagreement_score":0.3530274,"about_ca_system_score_codex":0.000036164267,"about_ca_system_score_gemma":0.00044193878,"threshold_uncertainty_score":0.41447288},"labels":[],"label_agreement":null},{"id":"W3082141982","doi":"10.1158/1538-7445.am2020-1459","title":"Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Biology; Cancer research; Ovarian cancer; Clear cell carcinoma; Mitochondrion; ARID1A; Clear cell; Ovary; Ovarian carcinoma; Chromatin remodeling; Cancer; Carcinoma; Chromatin; Endocrinology; Cell biology; Mutation; Genetics; Gene","score_opus":0.04069521490920025,"score_gpt":0.3450263755501812,"score_spread":0.3043311606409809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082141982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917477,0.005571295,0.00047559652,0.00045352036,0.0001748566,0.00037148004,0.00012832192,0.000015499407,0.0010617366],"genre_scores_gemma":[0.99783766,0.0011717309,0.00013973708,0.00014759068,0.00027941252,0.00012497784,0.000097812896,0.000027910784,0.00017314334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982729,0.00009698541,0.0002797696,0.00051333656,0.0004410256,0.00039599434],"domain_scores_gemma":[0.9989669,0.000059470338,0.00012349107,0.00019708276,0.0005019456,0.00015113487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033505145,0.00015031511,0.00019303923,0.000049525097,0.00014031831,0.000022616618,0.00023717272,0.0001615299,0.00016973694],"category_scores_gemma":[0.00025227154,0.00014355216,0.0000877912,0.00040359134,0.00018804354,0.0000068432255,0.00010506079,0.00032530222,0.000012183328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021928287,0.000030302099,0.0005506201,0.0000641552,0.000055322216,8.5683996e-7,0.00043558524,0.005375881,0.9562777,0.00000501737,0.033244368,0.003740879],"study_design_scores_gemma":[0.00047181398,0.00034828286,0.00039937886,0.000051405692,0.000008907963,3.5702098e-7,0.0005610798,0.0010202024,0.984932,0.000035433477,0.0120019885,0.0001691288],"about_ca_topic_score_codex":0.0009294541,"about_ca_topic_score_gemma":0.00010612845,"teacher_disagreement_score":0.028654289,"about_ca_system_score_codex":0.00030147776,"about_ca_system_score_gemma":0.0006775487,"threshold_uncertainty_score":0.5853887},"labels":[],"label_agreement":null},{"id":"W3082177126","doi":"10.1158/1538-7445.am2020-6455","title":"Abstract 6455: Characterization of extracellular vesicles derived from uveal melanoma cell lines","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Microvesicles; Exosome; CD63; Melanoma; Cell culture; Cell biology; Extracellular vesicle; Proteome; Cell; Biology; Blot; Basigin; Cancer research; Chemistry; Bioinformatics; microRNA; Biochemistry","score_opus":0.044615041405061916,"score_gpt":0.3231516919736889,"score_spread":0.27853665056862703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082177126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926695,0.005448104,0.00046440904,0.00055110565,0.00007951169,0.0002782359,0.00028146253,0.000015981048,0.00021166183],"genre_scores_gemma":[0.997213,0.00082900695,0.00023484392,0.000097602715,0.00076770684,0.000048429945,0.00054794055,0.00004614851,0.00021529655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836576,0.0001360795,0.0003042726,0.00047981393,0.0003806337,0.00033344998],"domain_scores_gemma":[0.9989669,0.0000325546,0.00011497946,0.00038471888,0.0002562543,0.0002446114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022338003,0.00015122439,0.00017630648,0.00004558908,0.000082132516,0.00003478504,0.00043356937,0.00016302223,0.00036490083],"category_scores_gemma":[0.00011622049,0.00015597149,0.00009259215,0.0001841702,0.00019469844,0.0000107802425,0.00019739722,0.00021745941,0.000044065127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030560617,0.000089550165,0.002487601,0.00010889509,0.000036777023,0.000019342835,0.000184589,0.00002252772,0.99348503,0.000009827782,0.00042509593,0.00282517],"study_design_scores_gemma":[0.00047958337,0.0001272117,0.019810563,0.000026741078,0.000012666066,2.9415622e-7,0.00008960773,0.00009137696,0.9733575,0.000032804404,0.0058169877,0.00015463523],"about_ca_topic_score_codex":0.00009342261,"about_ca_topic_score_gemma":0.000011973334,"teacher_disagreement_score":0.02012749,"about_ca_system_score_codex":0.000022390157,"about_ca_system_score_gemma":0.00024364646,"threshold_uncertainty_score":0.6360333},"labels":[],"label_agreement":null},{"id":"W3082180012","doi":"10.1158/1538-7445.am2020-6507","title":"Abstract 6507: Inhibition of the translation initiation factor eIF4A1 enhances tumor cell radiosensitivity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"EIF4G; EIF4E; Radiosensitivity; Biology; EIF4A1; Initiation factor; eIF4A; Gene knockdown; Radioresistance; EIF4EBP1; Molecular biology; Protein biosynthesis; Clonogenic assay; Cancer research; Cell culture; Cell biology; Messenger RNA; Translation (biology); Gene; Medicine; Genetics","score_opus":0.0934166624120492,"score_gpt":0.36052464247715443,"score_spread":0.2671079800651052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082180012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959353,0.00080614997,0.00036663873,0.0013856024,0.00006287231,0.00025804254,0.00009930224,0.0000047577846,0.0010812883],"genre_scores_gemma":[0.99902976,0.00039699546,0.000030759435,0.00014144344,0.00026013373,0.000050405724,0.000031259144,0.0000109183065,0.00004831736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991066,0.00011000642,0.00014748858,0.00021888597,0.0002660502,0.00015096963],"domain_scores_gemma":[0.9994692,0.000021641104,0.00007275483,0.00018102488,0.00020345909,0.000051928197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018703792,0.00006699058,0.00007560299,0.000024460427,0.000109692075,0.000017846587,0.00011117597,0.000058243077,0.00007964576],"category_scores_gemma":[0.000048772275,0.000053501957,0.000060146005,0.00021177255,0.000113749076,0.000009633069,0.000028775925,0.00015250826,0.000005909453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062872954,0.000023414124,0.00041388423,0.000053809134,0.0000067677124,3.5368194e-7,0.00020292871,0.00007934225,0.9944148,0.000014849493,0.0006754281,0.0040515224],"study_design_scores_gemma":[0.00023313527,0.00005778034,0.021386126,0.000018075207,0.0000033222573,2.8467923e-7,0.000087548855,0.000050309805,0.9738292,0.000023077217,0.004250119,0.00006103576],"about_ca_topic_score_codex":0.00008100212,"about_ca_topic_score_gemma":0.000060179882,"teacher_disagreement_score":0.02097224,"about_ca_system_score_codex":0.00002856657,"about_ca_system_score_gemma":0.00022709854,"threshold_uncertainty_score":0.21817465},"labels":[],"label_agreement":null},{"id":"W3082202404","doi":"10.1158/1538-7445.am2020-4911","title":"Abstract 4911: Characterizing the role of podocalyxin's cytoplasmic tail domain in collective tumor invasion","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Cancer research; Biology; Ezrin; Epithelial–mesenchymal transition; Cancer; Cell; Cell biology; Cytoskeleton; Metastasis; Endocrinology; Kidney","score_opus":0.04412752897029882,"score_gpt":0.33674679097660803,"score_spread":0.2926192620063092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082202404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937005,0.0008013544,0.000010206362,0.0024450906,0.00002562968,0.00066742266,0.000033361262,0.0000049147175,0.0023115403],"genre_scores_gemma":[0.998908,0.0002327706,0.00003202979,0.0002122713,0.00015961635,0.0002535508,0.000022392633,0.000019754369,0.0001596027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983329,0.00024096217,0.00021831733,0.00034231757,0.00047220543,0.00039328178],"domain_scores_gemma":[0.9992526,0.000070902635,0.0000551567,0.00025434414,0.00024214297,0.00012486105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077130104,0.00010149451,0.00014798263,0.000105820895,0.00013128459,0.000036658323,0.0003886034,0.00008409689,0.00022456149],"category_scores_gemma":[0.0003876031,0.00007880234,0.000057447745,0.0006016601,0.00019709714,0.000007675454,0.00025742353,0.0004551839,0.000031469586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055872183,0.000035947487,0.006013037,0.000037854385,0.000016108996,0.000008207006,0.00046076567,0.000026318532,0.9896754,0.00005449735,0.0005589516,0.0025542143],"study_design_scores_gemma":[0.00059311074,0.00021496543,0.022252651,0.000041126244,0.0000011161958,0.0000023277962,0.0007323192,0.00009362597,0.9276048,0.0002017546,0.048169088,0.000093117174],"about_ca_topic_score_codex":0.0003968748,"about_ca_topic_score_gemma":0.00031751025,"teacher_disagreement_score":0.062070575,"about_ca_system_score_codex":0.00009107588,"about_ca_system_score_gemma":0.00064197154,"threshold_uncertainty_score":0.3213466},"labels":[],"label_agreement":null},{"id":"W3082295976","doi":"10.1158/1538-7445.am2020-3795","title":"Abstract 3795: Investigate the mechanism of actions of flavonoid dimers in reversing doxorubicin resistance in breast cancer stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cancer stem cell; Cancer cell; CD44; Chemistry; Cancer; Cancer research; Abcg2; Drug resistance; Radioresistance; Stem cell; Metastasis; Flavonoid; ATP-binding cassette transporter; Pharmacology; Biochemistry; Biology; Cell biology; Radiation therapy; Medicine; Cell; Transporter; Antioxidant; Internal medicine; Genetics","score_opus":0.07371116694719927,"score_gpt":0.36189100182502615,"score_spread":0.2881798348778269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082295976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931357,0.0019502966,0.000010760963,0.0038248503,0.00006713181,0.00024926738,0.00016917575,0.0000020792604,0.0005907452],"genre_scores_gemma":[0.99726456,0.0022833492,0.00002472035,0.00010186684,0.00006569012,0.00004984422,0.0000064845676,0.000010764711,0.00019270206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878013,0.00023768317,0.0002448355,0.00029496555,0.000166715,0.0002756561],"domain_scores_gemma":[0.9994366,0.000050601167,0.000094235285,0.00021548555,0.0001356247,0.00006742953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044074573,0.00009478972,0.00017396004,0.00007133546,0.00006619921,0.0000054155503,0.0003050722,0.00012725845,0.000045520388],"category_scores_gemma":[0.000028428383,0.00007535807,0.000044871314,0.00041555482,0.0004943417,0.000007206965,0.00011020793,0.0003605832,0.0000014484874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038075628,0.0000199486,0.0037210437,0.000107662694,0.000026679409,0.0000030343742,0.00042512623,0.00019744123,0.9937768,0.0002146425,0.00076129264,0.00036560054],"study_design_scores_gemma":[0.000357676,0.000040404368,0.015385198,0.00016079332,0.0000038101887,2.406354e-7,0.0007713832,0.0000107957085,0.98211545,0.00013690614,0.0009421721,0.000075192664],"about_ca_topic_score_codex":0.0012856077,"about_ca_topic_score_gemma":0.003142776,"teacher_disagreement_score":0.011664154,"about_ca_system_score_codex":0.000055642267,"about_ca_system_score_gemma":0.0002662618,"threshold_uncertainty_score":0.30730128},"labels":[],"label_agreement":null},{"id":"W3082336104","doi":"10.1158/1538-7445.am2020-3559","title":"Abstract 3559: Protein secretion rates of VEGF and CA9 in normoxia and hypoxia","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hypoxia (environmental); Secretion; Protein disulfide-isomerase; Cell biology; Angiogenesis; Downregulation and upregulation; Biochemistry; Secretory protein; Chemistry; Tumor hypoxia; Endoplasmic reticulum; Biology; Internal medicine; Cancer research; Oxygen; Medicine","score_opus":0.052715253633346705,"score_gpt":0.36113797983371604,"score_spread":0.3084227262003693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082336104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823885,0.016279122,0.000008800632,0.0006215144,0.0000519391,0.00032123094,0.000029153578,0.0000030842905,0.0002966728],"genre_scores_gemma":[0.9935752,0.0055808723,0.000056599878,0.00006863076,0.0004614551,0.000084791296,0.000016183287,0.0000139442445,0.00014233131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909574,0.00005851588,0.00014528708,0.00029842375,0.00016866926,0.00023338675],"domain_scores_gemma":[0.99959654,0.000012717167,0.000034337663,0.00012580589,0.000105615516,0.00012499427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030820185,0.0000851962,0.00014315896,0.000053093223,0.000040745406,0.000019603007,0.000092276816,0.000099039215,0.000033845045],"category_scores_gemma":[0.00011472883,0.00008183239,0.000021449996,0.00015442044,0.00018157475,0.000006144248,0.00011377041,0.00017921568,0.0000015739446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022664198,0.000012564244,0.0017118868,0.00015602894,0.0000116361925,0.0000012744067,0.00022370393,0.000004178405,0.98796636,0.000040322546,0.0007586461,0.008886759],"study_design_scores_gemma":[0.001150145,0.00024382712,0.08369164,0.0000791613,0.0000054810453,0.0000025421036,0.00026839232,0.000039110724,0.847942,0.00012312092,0.06628909,0.00016551562],"about_ca_topic_score_codex":0.00068287645,"about_ca_topic_score_gemma":0.00039731283,"teacher_disagreement_score":0.1400244,"about_ca_system_score_codex":0.000013586924,"about_ca_system_score_gemma":0.00017526178,"threshold_uncertainty_score":0.3337028},"labels":[],"label_agreement":null},{"id":"W3082345860","doi":"10.1158/1538-7445.am2020-3689","title":"Abstract 3689: Mutation spectrum of MEF cells transformed by overexpression of novel activating KRAS mutation candidates in lung adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"KRAS; Carcinogenesis; Cancer research; Mutation; Mutant; Cancer; Lung cancer; Adenocarcinoma; Biology; Gene; Molecular biology; Medicine; Genetics; Pathology","score_opus":0.04348335068321347,"score_gpt":0.3594082440592621,"score_spread":0.3159248933760486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082345860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964637,0.0014356137,0.0009233213,0.0004404042,0.000021167887,0.0003032378,0.00013912478,0.000003120475,0.0002702888],"genre_scores_gemma":[0.99915934,0.00039338355,0.00009729756,0.000023175704,0.00006433504,0.00006997266,0.0001264591,0.000016564674,0.000049490664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891907,0.000045152254,0.0002739784,0.00026702665,0.00028280096,0.00021199169],"domain_scores_gemma":[0.99951863,0.00003361005,0.000108192704,0.00014580082,0.00012795173,0.00006581416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019018592,0.00008585961,0.00013153278,0.00006970106,0.00004579216,0.000011689745,0.00015925404,0.000094974035,0.0000852058],"category_scores_gemma":[0.000055152235,0.0000834415,0.000040570943,0.00026371615,0.000082105376,0.00001460082,0.000028565997,0.00016041801,8.072738e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024660528,0.000061720384,0.0012602552,0.00019773439,0.000018512206,6.7847986e-7,0.0005660815,0.0010695357,0.9944322,0.000015097543,0.0008006342,0.0013309087],"study_design_scores_gemma":[0.0008084525,0.00012323244,0.009023502,0.000094376446,0.0000034489299,3.9987816e-7,0.00041932776,0.0011851735,0.9879623,0.00001329565,0.0002853273,0.00008113892],"about_ca_topic_score_codex":0.0009298723,"about_ca_topic_score_gemma":0.000070826,"teacher_disagreement_score":0.0077632456,"about_ca_system_score_codex":0.00006394798,"about_ca_system_score_gemma":0.00024358607,"threshold_uncertainty_score":0.34026453},"labels":[],"label_agreement":null},{"id":"W3082354092","doi":"10.1158/1538-7445.am2020-1417","title":"Abstract 1417: Development of a miRNA-based prediction tool to discriminate cutaneous blastic plasmacytoid dendritic cell neoplasm from cutaneous myeloid sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"microRNA; Gene expression profiling; Myeloid; Profiling (computer programming); Computational biology; Myeloid sarcoma; Linear discriminant analysis; Phenotype; Medicine; Bioinformatics; Biology; Artificial intelligence; Cancer research; Gene; Computer science; Gene expression; Genetics","score_opus":0.06399025801758933,"score_gpt":0.35128390985901625,"score_spread":0.2872936518414269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082354092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916768,0.0006992302,0.00046877738,0.002756496,0.00015453233,0.0023172835,0.00054754043,0.00012167495,0.0012576735],"genre_scores_gemma":[0.9953629,0.00015876222,0.002513849,0.00044242296,0.00027733334,0.00050364883,0.00015545127,0.00013718614,0.00044846174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936261,0.00021435843,0.0009266349,0.0011558137,0.0027427124,0.0013343616],"domain_scores_gemma":[0.99608505,0.0009310655,0.000117841126,0.0006305787,0.0011530565,0.0010824231],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000367856,0.0004493893,0.0007697447,0.00056022697,0.00037341076,0.00012915135,0.00060907024,0.00022567986,0.0019875476],"category_scores_gemma":[0.0011804624,0.000432868,0.00017509762,0.00115961,0.00036954362,0.00009346832,0.00031679677,0.0011145385,0.00061535445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009146573,0.00087165856,0.00947749,0.0016546644,0.00025659538,0.0038124872,0.0077790893,0.0017739712,0.91906214,0.000009808315,0.0037407156,0.042414833],"study_design_scores_gemma":[0.0057859924,0.0028665487,0.0066984748,0.0014861294,0.00013777195,0.00058301276,0.0028830348,0.008673918,0.95457494,0.00009481766,0.015357682,0.0008576803],"about_ca_topic_score_codex":0.0006550976,"about_ca_topic_score_gemma":0.00047239798,"teacher_disagreement_score":0.04155715,"about_ca_system_score_codex":0.0012804966,"about_ca_system_score_gemma":0.003961397,"threshold_uncertainty_score":0.9998123},"labels":[],"label_agreement":null},{"id":"W3082386323","doi":"10.1158/1538-7445.am2020-549","title":"Abstract 549: Genome-wide CRISPR-Cas9 screen and RNAseq analysis identify new candidate synthetic lethality partners to PARP inhibitor in triple-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Synthetic lethality; Olaparib; Triple-negative breast cancer; Biology; PARP inhibitor; Cancer research; Genome editing; Cancer; Breast cancer; Genetics; DNA repair; Gene; Poly ADP ribose polymerase; Polymerase","score_opus":0.04823621442026489,"score_gpt":0.4320396808816556,"score_spread":0.38380346646139074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082386323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106455,0.0026648026,0.0012468402,0.0039640567,0.00006185884,0.00046200852,0.00038222966,0.000012094719,0.00014156154],"genre_scores_gemma":[0.99749523,0.0012431456,0.00009441931,0.0002854383,0.00040820078,0.00012710133,0.0000461225,0.000031357908,0.00026899253],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99789536,0.000112329835,0.00030433264,0.00072392105,0.00037153697,0.00059249037],"domain_scores_gemma":[0.9988135,0.00005438091,0.00004423584,0.0003339775,0.00015576936,0.00059809966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048317423,0.00020693269,0.0003170636,0.00021133144,0.00009410553,0.00009034987,0.00027842686,0.00012765522,0.00030008916],"category_scores_gemma":[0.00023392717,0.00020675569,0.000100551384,0.000955488,0.00011133307,0.000010323782,0.0002531791,0.00033564624,0.000011452292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009806528,0.00006365177,0.07046457,0.0002016652,0.00080783246,0.00006194819,0.001758667,0.017722929,0.8873219,0.000005843278,0.011233308,0.009377063],"study_design_scores_gemma":[0.0014342411,0.00017414113,0.6655864,0.000094790616,0.00014250453,0.0000035713751,0.00075607013,0.00031953523,0.3212069,0.000026159752,0.009681554,0.00057409273],"about_ca_topic_score_codex":0.015090797,"about_ca_topic_score_gemma":0.01166281,"teacher_disagreement_score":0.59512186,"about_ca_system_score_codex":0.00011512387,"about_ca_system_score_gemma":0.0003882347,"threshold_uncertainty_score":0.9914678},"labels":[],"label_agreement":null},{"id":"W3082443445","doi":"10.1158/1538-7445.am2020-1061","title":"Abstract 1061: Increasing potency of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Ovarian cancer; Doxorubicin; Pharmacology; Cancer research; Cancer cell; Cytotoxic T cell; Cancer; Medicine; Chemistry; Internal medicine; In vitro; Chemotherapy; Biochemistry","score_opus":0.07960139887220102,"score_gpt":0.37479184534952875,"score_spread":0.29519044647732773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082443445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7826296,0.20510454,0.0011425749,0.0040100617,0.0022706795,0.002866879,0.0014203707,0.000027877311,0.000527395],"genre_scores_gemma":[0.7727368,0.20988551,0.0010356817,0.0004557088,0.0133762825,0.0015230313,0.0002002058,0.00009759669,0.00068920775],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749655,0.00016031189,0.00048673298,0.0006549013,0.0005587228,0.0006427675],"domain_scores_gemma":[0.99832326,0.00015461643,0.00023214071,0.0004991914,0.0005710913,0.00021972333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047644376,0.00028733283,0.0005185882,0.000059479422,0.00017725246,0.000027952241,0.0004758494,0.00021509362,0.00051577116],"category_scores_gemma":[0.0001523407,0.00020446168,0.00026935517,0.00053136784,0.00038220483,0.000015950238,0.00006853786,0.00020905312,0.0000014676724],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038814738,0.00022931119,0.0013055042,0.00016540586,0.00061866554,7.112233e-8,0.0032721306,0.0005774369,0.8817975,0.000040374918,0.028550994,0.07956112],"study_design_scores_gemma":[0.0036008589,0.0005233363,0.0032725234,0.000057499758,0.000065778695,3.4128252e-7,0.00077701063,0.0002155961,0.4078738,0.000032847365,0.58332396,0.00025643967],"about_ca_topic_score_codex":0.037272625,"about_ca_topic_score_gemma":0.0007214195,"teacher_disagreement_score":0.554773,"about_ca_system_score_codex":0.00014966077,"about_ca_system_score_gemma":0.0022929662,"threshold_uncertainty_score":0.96913826},"labels":[],"label_agreement":null},{"id":"W3082501668","doi":"10.1158/1538-7445.am2020-ct273","title":"Abstract CT273: Phase 2 trial of dianhydrogalactitol (VAL-083) in patients with newly diagnosed MGMT-unmethylated glioblastoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Radiosensitizer; Oncology; Regimen; Radiation therapy; Internal medicine; Cancer research; Cancer; Methyltransferase; Chemoradiotherapy; DNA repair; Biology; Adverse effect; DNA","score_opus":0.05428933571141433,"score_gpt":0.39113893744301337,"score_spread":0.33684960173159906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082501668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484813,0.0002327461,9.89922e-7,0.0020755553,0.000085527274,0.002185891,0.00009195419,0.000028791801,0.00045043405],"genre_scores_gemma":[0.99897224,0.00018051117,0.000031225947,0.00009107586,0.00017791202,0.00044951375,0.000040074658,0.000042016363,0.000015407926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997424,0.000117676915,0.00039446895,0.00044938564,0.0010942245,0.00052026386],"domain_scores_gemma":[0.99847645,0.00030971674,0.00010586465,0.00034072017,0.00034646966,0.00042077087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028976946,0.00019263299,0.000503271,0.00035914232,0.00005799277,0.000026944163,0.00015290186,0.00011083519,0.00059650827],"category_scores_gemma":[0.00037824933,0.00014453291,0.00009467545,0.001259731,0.00015240905,0.00011909532,0.0000585941,0.00047766775,0.00005175417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44822496,0.018971894,0.42563805,0.0006081186,0.00077548967,0.00225414,0.0022744604,0.0001946516,0.022490874,0.000029109853,0.0080993185,0.07043892],"study_design_scores_gemma":[0.5760561,0.021031315,0.27413085,0.0006551441,0.000119506214,0.0000011872277,0.00021493794,0.00009217967,0.12386383,0.0000122114625,0.0035233025,0.00029938566],"about_ca_topic_score_codex":0.0012297314,"about_ca_topic_score_gemma":0.00026362506,"teacher_disagreement_score":0.1515072,"about_ca_system_score_codex":0.00028922866,"about_ca_system_score_gemma":0.00043788675,"threshold_uncertainty_score":0.6531347},"labels":[],"label_agreement":null},{"id":"W3082507722","doi":"10.1158/1538-7445.am2020-1141","title":"Abstract 1141: Is periodontal disease associated with increased risk of colorectal cancer? A meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Colorectal cancer; Fusobacterium nucleatum; Internal medicine; Cancer; Relative risk; Confidence interval; Subgroup analysis; Periodontitis; Publication bias; Oncology","score_opus":0.1308793442211438,"score_gpt":0.4022472990065166,"score_spread":0.2713679547853728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082507722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809345,0.0061470415,0.0000067385245,0.0011298863,0.000042210868,0.0005434093,0.010817696,0.000045277557,0.00033321785],"genre_scores_gemma":[0.9979963,0.00042583628,0.000018368692,0.00015956661,0.00008594765,0.00040365141,0.00019395535,0.000041199983,0.0006752089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600804,0.00096758676,0.00042486447,0.00077528204,0.0010313132,0.00079289166],"domain_scores_gemma":[0.99736625,0.00048416614,0.00021588565,0.00040151877,0.0008927212,0.0006394464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011358776,0.00026773743,0.001137049,0.00031210252,0.00039007378,0.00012225888,0.0006900667,0.00019888929,0.03144801],"category_scores_gemma":[0.0006729199,0.0002034305,0.0009008065,0.002449253,0.00081243494,0.0001700207,0.00023982105,0.0012008145,0.0001469982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031239558,0.00022212656,0.8599206,0.00014260178,0.10171258,0.0004042623,0.0008391851,0.0002217495,0.02577859,0.000013481114,0.0073992983,0.0002215559],"study_design_scores_gemma":[0.0012578673,0.00026565345,0.9554423,0.00002312902,0.024027502,0.0000015739326,0.0003272997,0.00029709234,0.017078565,0.000014805999,0.00093421055,0.00032997242],"about_ca_topic_score_codex":0.027327638,"about_ca_topic_score_gemma":0.03680043,"teacher_disagreement_score":0.09552171,"about_ca_system_score_codex":0.0002626947,"about_ca_system_score_gemma":0.0010813513,"threshold_uncertainty_score":0.9807755},"labels":[],"label_agreement":null},{"id":"W3082682241","doi":"10.1158/1538-7445.am2020-1680","title":"Abstract 1680: Assessment of statistical power in one mouse per treatment design for preclinical anticancer agent PDX large scale drug screens","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cancer; In vivo; False positive paradox; Lung cancer; Drug; Oncology; Pharmacology; Internal medicine; Biology; Computer science; Machine learning","score_opus":0.3029285319059805,"score_gpt":0.5175469428655607,"score_spread":0.21461841095958017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082682241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95405275,0.0024478417,0.022323284,0.011829394,0.00016721508,0.005242445,0.0022590007,0.00004283672,0.0016352104],"genre_scores_gemma":[0.9784933,0.0022604764,0.016818643,0.0003829683,0.00024581765,0.00077360735,0.00005923642,0.00005418392,0.00091181544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699485,0.00019611795,0.0005651029,0.0006053324,0.00089987495,0.0007387455],"domain_scores_gemma":[0.9979813,0.00071197806,0.00007598902,0.00036108482,0.00034806677,0.00052155415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014434024,0.00018927599,0.0006897772,0.00013443684,0.0000738349,0.000025703317,0.0001512783,0.00009063998,0.0035023226],"category_scores_gemma":[0.0002076693,0.00015655319,0.00016011068,0.0002937689,0.00021856536,0.000054551434,0.00008174673,0.00044095935,0.000022219901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052973922,0.023021806,0.10737677,0.0060162693,0.0028253293,0.00046309186,0.012780793,0.0018370353,0.5482057,0.0036270316,0.13701831,0.10385397],"study_design_scores_gemma":[0.08587165,0.016370725,0.28801617,0.0016057603,0.0009926562,0.0000073752185,0.005193819,0.0065600956,0.33973002,0.00036201472,0.2538358,0.0014539299],"about_ca_topic_score_codex":0.0008619524,"about_ca_topic_score_gemma":0.00048159296,"teacher_disagreement_score":0.20847566,"about_ca_system_score_codex":0.0007717141,"about_ca_system_score_gemma":0.0015494943,"threshold_uncertainty_score":0.9974086},"labels":[],"label_agreement":null},{"id":"W3082742154","doi":"10.1158/1538-7445.am2020-3222","title":"Abstract 3222: The Virtual Molecular Tumor Board of the Variant Interpretation for Cancer Consortium: A systematic gateway connecting cancer genome interpretation and progress in genomic knowledgebases in cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Harmonization; Context (archaeology); Precision medicine; Personalized medicine; Interpretation (philosophy); Medicine; Bioinformatics; Computer science; Biology; Pathology","score_opus":0.04652983227197934,"score_gpt":0.37830021205670594,"score_spread":0.3317703797847266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082742154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601392,0.035997164,0.00026419494,0.002080827,0.00015459352,0.0012396363,0.000102827726,0.000007103776,0.000014410769],"genre_scores_gemma":[0.996532,0.0007427993,0.000043174565,0.00026723338,0.000101336365,0.0022641104,0.0000070410547,0.000024267625,0.000018000881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982896,0.00030920724,0.00043353144,0.00040366958,0.00021958351,0.0003444289],"domain_scores_gemma":[0.9991063,0.00022202027,0.0001865978,0.00020122735,0.00021433682,0.000069538284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006898346,0.00015063322,0.00030899027,0.00007226647,0.000090977665,0.000043143267,0.0003678213,0.00010544608,0.000026478489],"category_scores_gemma":[0.0006257735,0.000097078446,0.00006860938,0.000287627,0.0004176598,0.000008003478,0.00019176025,0.00028405848,5.1924997e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015858869,0.00009687678,0.02043521,0.008798407,0.00030407385,0.000015954738,0.01200598,0.0030208866,0.92194694,0.00009292264,0.00019816647,0.031498693],"study_design_scores_gemma":[0.009325086,0.0024338046,0.14360918,0.029946469,0.00044145552,0.000029975059,0.028134158,0.075017706,0.7046613,0.00041881207,0.004152154,0.0018299032],"about_ca_topic_score_codex":0.001371496,"about_ca_topic_score_gemma":0.005437793,"teacher_disagreement_score":0.21728563,"about_ca_system_score_codex":0.00015611561,"about_ca_system_score_gemma":0.0005295622,"threshold_uncertainty_score":0.3958744},"labels":[],"label_agreement":null},{"id":"W3082763273","doi":"10.1158/1538-7445.am2020-2012","title":"Abstract 2012: Recurrent rearrangements of NAALADL2 in prostate, breast, cervical, head and neck and lung squamous cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prostate cancer; Prostate; Fusion gene; Medicine; Head and neck squamous-cell carcinoma; Cancer; Gene duplication; Comparative genomic hybridization; Breast cancer; Oncology; Cancer research; PCA3; Lung cancer; Fluorescence in situ hybridization; Internal medicine; Gene; Head and neck cancer; Biology; Genetics; Genome; Chromosome","score_opus":0.04630680729067415,"score_gpt":0.342354763304201,"score_spread":0.29604795601352685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082763273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843698,0.013257255,0.0000012331552,0.00067106175,0.000024492207,0.0004581386,0.00013187263,0.000003489226,0.0010826667],"genre_scores_gemma":[0.9984496,0.0010961014,0.000038579765,0.000070999966,0.0001003677,0.00008087395,0.00003037256,0.0000168416,0.000116237985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988774,0.00008438157,0.00017104654,0.0003539132,0.00020174684,0.00031152685],"domain_scores_gemma":[0.99950993,0.000017240982,0.000037222533,0.00015132573,0.000104706975,0.0001795646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026927455,0.00010285293,0.00013717095,0.000048252918,0.000048684065,0.000022803111,0.00012166524,0.000077867175,0.000087719956],"category_scores_gemma":[0.00003105204,0.000097520264,0.000021890583,0.00013981646,0.00012313845,0.000006867582,0.00020794875,0.00022816184,0.0000026452103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083768007,0.00010286736,0.11054658,0.0011665857,0.0000104456585,0.000017242977,0.00061264355,0.0000035680655,0.8734952,0.000008495376,0.004491937,0.00870676],"study_design_scores_gemma":[0.0033092573,0.0011702036,0.33420882,0.00013941809,0.000009091581,0.000010770281,0.0003124756,0.00010486578,0.6477115,0.000043705244,0.012677743,0.00030215425],"about_ca_topic_score_codex":0.0003520117,"about_ca_topic_score_gemma":0.00012127144,"teacher_disagreement_score":0.22578369,"about_ca_system_score_codex":0.000020107262,"about_ca_system_score_gemma":0.00012697688,"threshold_uncertainty_score":0.39767608},"labels":[],"label_agreement":null},{"id":"W3082806608","doi":"10.1158/1538-7445.am2020-2035","title":"Abstract 2035: Listen to the patients: Assessing the prognostic value of pre-treatment health-related quality of life in 1L DLBCL patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Quality of life (healthcare); Proportional hazards model; Hazard ratio; Oncology; International Prognostic Index; Diffuse large B-cell lymphoma; Progression-free survival; Lymphoma; Overall survival; Confidence interval","score_opus":0.1607710881039595,"score_gpt":0.46707680202327406,"score_spread":0.3063057139193146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082806608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779537,0.0018125243,6.633181e-7,0.01704089,0.000066916225,0.002665383,0.00007702993,0.000009571777,0.0003733763],"genre_scores_gemma":[0.99857295,0.0002479401,0.000019262205,0.0005248248,0.000046682144,0.0004931029,0.000045284953,0.000017276774,0.000032696054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971815,0.0004644536,0.000741047,0.000303417,0.00093029876,0.00037929477],"domain_scores_gemma":[0.9979483,0.00073517964,0.00022620913,0.00037658325,0.00044933223,0.00026441118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008784853,0.0001366386,0.00045684175,0.00007539505,0.00011743168,0.000024629659,0.00019493671,0.000055326756,0.000068976035],"category_scores_gemma":[0.0013199148,0.000069282534,0.00009613927,0.00064275216,0.00012534525,0.000057961544,0.000108956294,0.000194774,0.000011538029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038115543,0.0023288028,0.9672425,0.00027082663,0.00014273706,0.0000028929064,0.0035393804,0.00011058038,0.000050367365,0.00004941379,0.0011687629,0.02471263],"study_design_scores_gemma":[0.004016641,0.0013848775,0.9923998,0.00045795096,0.000023840481,9.618835e-8,0.00036604644,0.00004542905,0.0005815746,0.000013920673,0.00065574876,0.0000540444],"about_ca_topic_score_codex":0.015175682,"about_ca_topic_score_gemma":0.00044146483,"teacher_disagreement_score":0.025157379,"about_ca_system_score_codex":0.00081847125,"about_ca_system_score_gemma":0.0012584081,"threshold_uncertainty_score":0.99138236},"labels":[],"label_agreement":null},{"id":"W3082840399","doi":"10.1158/1538-7445.am2020-ct109","title":"Abstract CT109: A phase I/Ib study evaluating GDC-0077 plus fulvestrant in patients with <i>PIK3CA</i>-mutant, hormone receptor-positive/HER2-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Adverse effect; Breast cancer; Pharmacokinetics; Pharmacodynamics; Internal medicine; Cancer; Cmax; Dysgeusia; Oncology; Pharmacology; Estrogen receptor; Gastroenterology","score_opus":0.08345085841686188,"score_gpt":0.4375639325702059,"score_spread":0.35411307415334403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082840399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894586,0.0011121215,0.000045438297,0.0033862973,0.00010216978,0.0046659783,0.0008544743,0.00010394217,0.00027095884],"genre_scores_gemma":[0.99702173,0.0002010174,0.00028760944,0.00047055242,0.0006073094,0.0011167148,0.000058403577,0.00015835173,0.00007828974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99379194,0.0004247115,0.00068470737,0.0012582309,0.002535667,0.0013047323],"domain_scores_gemma":[0.99668014,0.00032539418,0.00023896387,0.00054754235,0.0014940439,0.0007139143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095221587,0.0005296465,0.00091041374,0.00031810888,0.00030163245,0.000087557775,0.00042634516,0.00013838398,0.0015884407],"category_scores_gemma":[0.00020851754,0.0004317038,0.00009596142,0.001999248,0.0005233398,0.00048116688,0.00017648685,0.001765272,0.00005748856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19053428,0.008055026,0.24744466,0.0008114331,0.00207841,0.00078625133,0.058849305,0.0025554358,0.1705143,0.000018862815,0.0013057478,0.31704628],"study_design_scores_gemma":[0.073155984,0.010986438,0.89344275,0.0017135609,0.00016471284,0.000014198657,0.009677316,0.00038485913,0.009282675,0.000036861435,0.000299088,0.0008415508],"about_ca_topic_score_codex":0.0057702516,"about_ca_topic_score_gemma":0.0010000663,"teacher_disagreement_score":0.6459981,"about_ca_system_score_codex":0.0023285884,"about_ca_system_score_gemma":0.0020457383,"threshold_uncertainty_score":0.9998135},"labels":[],"label_agreement":null},{"id":"W3082884553","doi":"10.1158/1538-7445.am2020-30","title":"Abstract 30: Cross-cancer cross-tissue transcriptome-wide association study (TWAS) of 11 cancers identifies 56 novel genes","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genome-wide association study; Cancer; Bonferroni correction; Biology; Transcriptome; Gene; Genetic association; Computational biology; Genetics; Gene expression; Single-nucleotide polymorphism; Genotype","score_opus":0.14331148119992534,"score_gpt":0.4835798738863838,"score_spread":0.3402683926864585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082884553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731726,0.005266904,0.000014622329,0.0042507853,0.00036854783,0.001632234,0.00035869717,0.00006705065,0.0007238748],"genre_scores_gemma":[0.9887561,0.0023335326,0.000016749897,0.0002887229,0.00089104415,0.0005308512,0.000028749115,0.00008025496,0.0070739454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99420464,0.0001385532,0.00072732475,0.00081038376,0.0029996452,0.0011194341],"domain_scores_gemma":[0.99608505,0.00048118806,0.00017326612,0.0004976875,0.0022652126,0.0004976145],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019263406,0.00027890215,0.00067830266,0.00034189338,0.0003662374,0.00029840102,0.00058445614,0.00025043925,0.0049727308],"category_scores_gemma":[0.0011520649,0.00025326086,0.00021738619,0.001436529,0.00046880668,0.00042208633,0.00017022292,0.001070587,0.00014445276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006594746,0.00032875926,0.61095756,0.00076065515,0.00038005976,0.000055441156,0.0027849593,0.00020681878,0.37350845,0.0000052522146,0.007659676,0.0026928724],"study_design_scores_gemma":[0.0042042015,0.0007185142,0.7594833,0.00020412201,0.00008117734,6.574104e-7,0.001492001,0.00006459875,0.21074481,0.000009891534,0.02274707,0.0002496967],"about_ca_topic_score_codex":0.02143925,"about_ca_topic_score_gemma":0.0031024325,"teacher_disagreement_score":0.16276363,"about_ca_system_score_codex":0.0016048993,"about_ca_system_score_gemma":0.0017985812,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W3082886874","doi":"10.1158/1538-7445.am2020-5769","title":"Abstract 5769: Opioid prescription characteristics associated with frequent emergency department use among hospitalized cancer patients: a comparative cohort study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Emergency department; Medical prescription; Cancer; Emergency medicine; Prospective cohort study; Cohort; Cohort study; Logistic regression; Internal medicine; Psychiatry","score_opus":0.09875157855196227,"score_gpt":0.386210620149576,"score_spread":0.28745904159761376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082886874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336755,0.00034306664,0.0000089511,0.0003252834,0.0005144414,0.004439056,0.00060860836,0.00009050616,0.00030252425],"genre_scores_gemma":[0.9948995,0.0007050677,0.0000036648792,0.00014409624,0.00029202626,0.0029869121,0.0004777577,0.000056192057,0.0004347566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962129,0.0002606531,0.00050877006,0.0007016947,0.0016810647,0.00063491333],"domain_scores_gemma":[0.9971772,0.00006719974,0.0002042407,0.00035172392,0.0016835227,0.0005161156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039896814,0.00029540353,0.00063155516,0.00011379719,0.0002224653,0.000097836004,0.0002020175,0.00010565522,0.0015679774],"category_scores_gemma":[0.00019564456,0.0002411447,0.000096754426,0.00073927635,0.00016099901,0.00028478276,0.00010162281,0.00070857565,0.000022300881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012888388,0.0010189579,0.9815732,0.00012080413,0.0007396447,0.000050919283,0.008609004,0.000007620939,0.0003913919,0.000003932532,0.005923808,0.00027186773],"study_design_scores_gemma":[0.0025175714,0.0016841376,0.99193126,0.00027875308,0.00020999016,1.4582626e-7,0.0011373723,0.000048150585,0.00040880882,0.0000030654342,0.0015144706,0.0002662621],"about_ca_topic_score_codex":0.012106585,"about_ca_topic_score_gemma":0.011843658,"teacher_disagreement_score":0.010358063,"about_ca_system_score_codex":0.0012531116,"about_ca_system_score_gemma":0.0004732879,"threshold_uncertainty_score":0.9993447},"labels":[],"label_agreement":null},{"id":"W3082897678","doi":"10.1158/1538-7445.am2020-2102","title":"Abstract 2102: Interpretable machine learning for perturbation biology","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Artificial intelligence; Machine learning; Computer science; Systems biology; Deep learning; Computational biology; Biology","score_opus":0.17293622892817503,"score_gpt":0.4679638168406103,"score_spread":0.2950275879124352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082897678","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05093598,0.0010098997,0.93266755,0.012938047,0.00023414554,0.0003473878,0.000013865543,0.00011021093,0.0017429201],"genre_scores_gemma":[0.98241943,0.00006040748,0.016295891,0.00045088434,0.00024439627,0.00015286145,0.00001747167,0.000013000896,0.00034567024],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985993,0.00025020388,0.00015639482,0.00040806324,0.00025466486,0.00033135814],"domain_scores_gemma":[0.9982853,0.0011248719,0.000040684205,0.00015893055,0.00027273071,0.00011746318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010597851,0.00007922592,0.00012428427,0.00010639217,0.00018421076,0.00014522867,0.00069188996,0.000044030665,0.00009971912],"category_scores_gemma":[0.0009626631,0.0000733237,0.00005345571,0.00048121833,0.000056880377,0.00031169635,0.00032574843,0.000378795,0.000040130686],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028483392,0.00007561763,0.0012741319,0.00028680204,0.00008985619,0.000007983193,0.005156633,0.12603106,0.13197272,0.1957088,0.0059021,0.53320944],"study_design_scores_gemma":[0.00033928396,0.00019489013,0.0008883233,0.000024306866,0.0000016966243,9.71934e-7,0.000030320274,0.90017647,0.009087482,0.023861824,0.06526128,0.000133135],"about_ca_topic_score_codex":0.00011030121,"about_ca_topic_score_gemma":0.0000071617665,"teacher_disagreement_score":0.93148345,"about_ca_system_score_codex":0.00011225976,"about_ca_system_score_gemma":0.00026748172,"threshold_uncertainty_score":0.2990054},"labels":[],"label_agreement":null},{"id":"W3083004448","doi":"10.1158/1538-7445.am2020-5231","title":"Abstract 5231: Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Cancer research; Brain tumor; Medicine; O-6-methylguanine-DNA methyltransferase; Methyltransferase; In vivo; Glioma; Oncology; Internal medicine; Chemotherapy; Biology; Pathology; DNA; Methylation","score_opus":0.1527323420709229,"score_gpt":0.3783925297844439,"score_spread":0.22566018771352098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083004448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863217,0.008428947,8.5680284e-7,0.0030560375,0.00004729793,0.0011460409,0.000013936313,0.000030624342,0.00095458276],"genre_scores_gemma":[0.99741906,0.0014681896,0.00002749442,0.00008288803,0.00019677731,0.0005539062,0.000015763642,0.000048517788,0.00018743105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978589,0.00008668847,0.00024702598,0.0006075702,0.00060577854,0.00059405307],"domain_scores_gemma":[0.9988014,0.00019922027,0.00005006897,0.00030303805,0.0000788405,0.0005674361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099818215,0.00026495158,0.00046136972,0.0002053531,0.00007976772,0.000038244216,0.00008929725,0.000069530215,0.00061121397],"category_scores_gemma":[0.000028607212,0.00018196642,0.00006724243,0.00023742318,0.00019900245,0.00006687404,0.000055860673,0.00034074087,0.000044823315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032891307,0.005331335,0.86396766,0.0006439586,0.0007647631,0.0067158234,0.005035846,0.00025065994,0.028965494,0.00014772033,0.004207251,0.08068035],"study_design_scores_gemma":[0.00784558,0.0020137322,0.97411937,0.00038754332,0.000080829486,0.000021507076,0.00038787356,0.00007487222,0.009327423,0.0000033964652,0.0055473666,0.00019048442],"about_ca_topic_score_codex":0.0019985037,"about_ca_topic_score_gemma":0.0012602974,"teacher_disagreement_score":0.11015172,"about_ca_system_score_codex":0.002384165,"about_ca_system_score_gemma":0.00044430012,"threshold_uncertainty_score":0.74203753},"labels":[],"label_agreement":null},{"id":"W3083023269","doi":"10.1158/1538-7445.am2020-2298","title":"Abstract 2298: Is smoking a risk factor for second primary lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Prostate cancer; Cancer; Cohort; Prospective cohort study; Risk factor","score_opus":0.13318791249727896,"score_gpt":0.431848614623794,"score_spread":0.298660702126515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083023269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96688884,0.012507495,0.00008294663,0.007624002,0.00035572262,0.0018613966,0.0034487161,0.00008862977,0.0071422434],"genre_scores_gemma":[0.9826706,0.0027267372,0.00015247721,0.009233885,0.0017527654,0.00082956086,0.000053303993,0.00009616623,0.0024845148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720824,0.00006403748,0.00036861282,0.0007174267,0.0007880873,0.0008535714],"domain_scores_gemma":[0.99815947,0.0003311952,0.000108847584,0.00037761443,0.00043213446,0.0005907196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044209926,0.00023552445,0.00049440545,0.00016100123,0.00031207464,0.00007460038,0.0002951899,0.00017419769,0.036093067],"category_scores_gemma":[0.00013487427,0.00021300693,0.00022229581,0.00041902246,0.00015916613,0.00022090702,0.00011939906,0.001175184,0.000027644186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004225024,0.000099189274,0.11361348,0.006571442,0.0011136362,0.00008724832,0.008873508,0.000044729502,0.19682007,0.000024405654,0.3966741,0.27185318],"study_design_scores_gemma":[0.0072003403,0.0004681742,0.20321903,0.00045522835,0.00015769871,0.0000043448035,0.00041087106,0.0011103849,0.11191416,0.000032686872,0.6744735,0.00055356545],"about_ca_topic_score_codex":0.0007487529,"about_ca_topic_score_gemma":0.00019635275,"teacher_disagreement_score":0.27779943,"about_ca_system_score_codex":0.001131021,"about_ca_system_score_gemma":0.0022753866,"threshold_uncertainty_score":0.9647881},"labels":[],"label_agreement":null},{"id":"W3083023402","doi":"10.1158/1538-7445.am2020-3021","title":"Abstract 3021: Integrated pharmacokinetic (PK)/pharmacodynamic (PD) modeling leveraging PK, biomarker, and safety data to support dose and schedule selection for the BET inhibitor BMS-986158","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pharmacology; Pharmacodynamics; Pharmacokinetics; Cmax; Dosing; Medicine; Population; Biomarker; Chemistry","score_opus":0.18862865616449656,"score_gpt":0.42875532570818004,"score_spread":0.24012666954368347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083023402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98271364,0.0023559055,0.007766113,0.005346536,0.0001627082,0.0012242829,0.0003410069,0.00002488949,0.00006489991],"genre_scores_gemma":[0.99613446,0.0015749285,0.00045353288,0.00061625004,0.00047683812,0.00017045284,0.00042372604,0.000035191122,0.00011462761],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99839795,0.000090872956,0.00024745637,0.0006393158,0.00024675165,0.0003776807],"domain_scores_gemma":[0.9991625,0.00005162913,0.00004210045,0.00025930692,0.00024811114,0.00023636677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008948131,0.00016286108,0.00013370492,0.00007946188,0.0003282104,0.000120656485,0.00035055235,0.000089814945,0.00007741568],"category_scores_gemma":[0.0002436965,0.00013258145,0.000030089308,0.00031852504,0.000101155005,0.00002883782,0.00044732637,0.0003087224,0.0000051133243],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082545687,0.000017455994,0.00022041578,0.000085207874,0.00006895557,0.0000010182196,0.000079698795,0.00048269404,0.946344,0.0000042091615,0.010233893,0.041636966],"study_design_scores_gemma":[0.002674106,0.0003806419,0.0007362617,0.000078032215,0.00004666068,0.000009395557,0.00035327108,0.43442258,0.4200255,0.000015505708,0.14087828,0.00037979268],"about_ca_topic_score_codex":0.00020257378,"about_ca_topic_score_gemma":0.00007463251,"teacher_disagreement_score":0.52631855,"about_ca_system_score_codex":0.000049809903,"about_ca_system_score_gemma":0.0002807969,"threshold_uncertainty_score":0.5406515},"labels":[],"label_agreement":null},{"id":"W3083034293","doi":"10.1158/1538-7445.am2020-741","title":"Abstract 741: Molecular and clinicopathological characteristics of Chinese non-small cell lung cancers with <i>ROS1</i> gene fusions identified by next-generation sequencing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"ROS1; Crizotinib; Lung cancer; Medicine; Adenocarcinoma; Cancer research; Exon; Oncology; Fusion gene; Internal medicine; Targeted therapy; Cancer; Gene; Biology; Genetics","score_opus":0.09718839445636361,"score_gpt":0.39495905719508195,"score_spread":0.29777066273871833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083034293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435323,0.0026413056,0.00049064145,0.0010278422,0.00007301654,0.0007425848,0.00020956076,0.000021461241,0.0004403631],"genre_scores_gemma":[0.9968496,0.0012772558,0.0005708636,0.0004862539,0.00020964243,0.00018410716,0.00020863235,0.000032019867,0.00018162811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984923,0.000056362143,0.00031010038,0.00042223642,0.00040836766,0.00031062643],"domain_scores_gemma":[0.9989637,0.00006562959,0.0001091031,0.00021492824,0.00034141456,0.0003052149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023566128,0.00015815905,0.00032641218,0.00006934712,0.00017969192,0.000055457527,0.00009710685,0.00009035629,0.000112352136],"category_scores_gemma":[0.0000754116,0.0001152571,0.00004952287,0.0003588092,0.00016171813,0.000087520326,0.000062326486,0.0003632383,0.0000043135947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020152782,0.00006134281,0.048911165,0.00029151866,0.000048566417,0.0001620511,0.001338617,0.0000499155,0.9467012,0.0000049401006,0.00078060105,0.0014485328],"study_design_scores_gemma":[0.009351706,0.0023836072,0.18853767,0.0006290601,0.00067006145,0.000046220506,0.001507503,0.006053114,0.78903633,0.000033900924,0.0010419412,0.00070885755],"about_ca_topic_score_codex":0.0007826547,"about_ca_topic_score_gemma":0.00008393758,"teacher_disagreement_score":0.15766487,"about_ca_system_score_codex":0.0003487665,"about_ca_system_score_gemma":0.0010236283,"threshold_uncertainty_score":0.4700048},"labels":[],"label_agreement":null},{"id":"W3083034993","doi":"10.1158/1538-7445.am2020-2083","title":"Abstract 2083: Alternative splicing regulation by the androgen receptor in prostate cancer cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Alternative splicing; RNA splicing; Androgen receptor; Biology; Transcriptome; LNCaP; Splicing factor; Gene; Gene expression; Cancer research; Prostate cancer; Cell biology; RNA; Cancer; Exon; Genetics","score_opus":0.09723422705816151,"score_gpt":0.4210208239302919,"score_spread":0.3237865968721304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083034993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94978154,0.0083066635,0.0000034621255,0.03800623,0.00012466687,0.0019037959,0.0001755148,0.0000323403,0.0016657837],"genre_scores_gemma":[0.98357385,0.009208039,0.00001887882,0.00047167146,0.0004919995,0.00086066313,0.00006391864,0.000047146877,0.005263827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973975,0.00015528958,0.0002695239,0.0005017686,0.0009723441,0.0007035869],"domain_scores_gemma":[0.9988868,0.0001602471,0.00006160397,0.00025788732,0.00033996082,0.0002934638],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006972097,0.00016679788,0.00025909804,0.00013300426,0.00020072822,0.000072647104,0.0002455475,0.000070323746,0.0017254269],"category_scores_gemma":[0.00006950471,0.00010827094,0.00006027489,0.0009275408,0.00027069045,0.00015095559,0.0001171707,0.000863661,0.00012641565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002512988,0.000113652604,0.01640601,0.0003236478,0.00014870695,0.00007463741,0.00543865,0.00026371365,0.82198286,0.000028653469,0.11903478,0.0336717],"study_design_scores_gemma":[0.0038139855,0.00034202766,0.008878439,0.0004983284,0.00002026987,0.000002156922,0.001045508,0.00076761167,0.915671,0.00010950757,0.0686486,0.00020255518],"about_ca_topic_score_codex":0.0048060426,"about_ca_topic_score_gemma":0.00022398078,"teacher_disagreement_score":0.09368815,"about_ca_system_score_codex":0.0008548941,"about_ca_system_score_gemma":0.0006639768,"threshold_uncertainty_score":0.9991871},"labels":[],"label_agreement":null},{"id":"W3083042226","doi":"10.1158/1538-7445.am2020-1324","title":"Abstract 1324: Genomic and clinical characteristics of MET exon14 alterations in 26,391 Chinese cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Cancer; KRAS; Lung cancer; Medicine; Internal medicine; CDKN2A; Crizotinib; STK11; Oncology; Exon; ROS1; Population; Carcinogenesis; Cancer research; Gene; Genetics; Biology; Adenocarcinoma; Colorectal cancer","score_opus":0.10764201669093068,"score_gpt":0.5053879675990613,"score_spread":0.3977459509081307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083042226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995241,0.0008441579,0.0000038854228,0.0024089154,0.00013904469,0.00064000953,0.00028288472,0.000014199627,0.0004259216],"genre_scores_gemma":[0.99678105,0.0020840364,0.00009238993,0.0003176369,0.00031360163,0.00017602304,0.00006427532,0.000026858392,0.00014410407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865264,0.00006600879,0.00043163108,0.00029582463,0.00030800886,0.00024587533],"domain_scores_gemma":[0.99906033,0.00015429452,0.00007943828,0.00015691579,0.00030514627,0.00024386658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023332192,0.000105898,0.00033098343,0.00011195019,0.00006877012,0.000021711368,0.00008119965,0.00006701478,0.00037779985],"category_scores_gemma":[0.0002444329,0.00008344529,0.000052613377,0.0003299934,0.0001445285,0.00007682965,0.00006309743,0.00035904066,0.00001558912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000333461,0.0003007422,0.9748725,0.0001794663,0.00013931164,0.00001623672,0.0011440766,0.000005456715,0.0027856326,0.00002632625,0.00070895394,0.01948782],"study_design_scores_gemma":[0.002333464,0.00034057812,0.99511486,0.00012240153,0.000054927503,4.1852857e-7,0.000073541036,0.000105230945,0.00017539848,0.00002563687,0.0015838825,0.000069649024],"about_ca_topic_score_codex":0.0015012084,"about_ca_topic_score_gemma":0.00043678668,"teacher_disagreement_score":0.020242356,"about_ca_system_score_codex":0.00022027038,"about_ca_system_score_gemma":0.0006131907,"threshold_uncertainty_score":0.41366434},"labels":[],"label_agreement":null},{"id":"W3083055113","doi":"10.1158/1538-7445.am2020-ct301","title":"Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Atezolizumab; Medicine; Immunotherapy; Internal medicine; Adverse effect; Pembrolizumab; Oncology; Cancer; Melanoma; Immune system; Gastroenterology; Immunology; Cancer research","score_opus":0.07132464025938938,"score_gpt":0.40666812662263774,"score_spread":0.33534348636324834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083055113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928363,0.0020775688,0.000051569055,0.00037137113,0.000074876014,0.004451739,0.000056203316,0.000050294562,0.000030110754],"genre_scores_gemma":[0.9981661,0.0003066612,0.00010404544,0.00020540292,0.0000119563865,0.00079754076,0.00012470335,0.000087313405,0.0001962662],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99547696,0.0016629497,0.00071313005,0.0007666822,0.00042205045,0.00095822115],"domain_scores_gemma":[0.9985406,0.0002605141,0.00017556833,0.0004825576,0.00045451065,0.00008627732],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001485661,0.00038938157,0.0007622894,0.0007030998,0.00025059516,0.00009425053,0.00068551744,0.000089418994,0.0012990051],"category_scores_gemma":[0.00011692247,0.0002767984,0.00004370018,0.0017918235,0.00027133117,0.00037539183,0.00009377961,0.00086601137,0.00014498178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46075177,0.012095842,0.037944626,0.000104154584,0.00082546053,0.0002877106,0.042277984,0.001280791,0.2669763,0.000025080586,0.00018408032,0.17724621],"study_design_scores_gemma":[0.15536667,0.04619025,0.74026155,0.00069001154,0.00003033188,0.000010037756,0.007820789,0.000025058253,0.045795895,0.000034875284,0.0028883703,0.00088615326],"about_ca_topic_score_codex":0.00064507575,"about_ca_topic_score_gemma":0.00070715207,"teacher_disagreement_score":0.70231694,"about_ca_system_score_codex":0.00033383307,"about_ca_system_score_gemma":0.00082987593,"threshold_uncertainty_score":0.9999684},"labels":[],"label_agreement":null},{"id":"W3083062597","doi":"10.1158/1538-7445.am2020-4899","title":"Abstract 4899: Investigating mutation co-operativity in early tumorigenesis of low-grade serous ovarian carcinoma with organoid model system and single-cell RNA sequencing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Organoid; Neuroblastoma RAS viral oncogene homolog; KRAS; Carcinogenesis; Biology; Serous fluid; Cancer research; Ovarian carcinoma; Serous carcinoma; Ovarian cancer; Mutation; Gene; Genetics; Cancer","score_opus":0.06275420631186224,"score_gpt":0.3019909241421818,"score_spread":0.23923671783031958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083062597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979013,0.0008891567,0.00040182503,0.00014341857,0.00001781022,0.00031245378,0.00008116807,0.00000675622,0.00024610705],"genre_scores_gemma":[0.9990339,0.000096990334,0.00056735356,0.00006559768,0.00011789792,0.0000467459,0.00002724382,0.000032648808,0.0000115884695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987713,0.000074866206,0.00023016735,0.00038965695,0.00024438289,0.0002896071],"domain_scores_gemma":[0.9993293,0.000047286936,0.00008190316,0.00017960524,0.00019049952,0.00017139886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002909634,0.0001299119,0.00018781137,0.00006294018,0.00009112621,0.000054985172,0.00013493496,0.00009048664,0.000002772428],"category_scores_gemma":[0.000093046205,0.00012687291,0.000021182606,0.00021959365,0.0001420511,0.000010579643,0.00007905136,0.00019606188,0.0000010002439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009350906,0.000021891994,0.015903402,0.0004949328,0.000011374752,0.000029749535,0.0012598597,0.013629908,0.96823806,0.000028376478,0.0000312235,0.00025770479],"study_design_scores_gemma":[0.00076964084,0.000325026,0.005966369,0.00011697233,0.000007234295,0.000005139666,0.00079590763,0.007882152,0.9839551,0.000011344753,0.000009399167,0.0001557327],"about_ca_topic_score_codex":0.0022614943,"about_ca_topic_score_gemma":0.00061645283,"teacher_disagreement_score":0.015717013,"about_ca_system_score_codex":0.00019323156,"about_ca_system_score_gemma":0.00086236856,"threshold_uncertainty_score":0.5173727},"labels":[],"label_agreement":null},{"id":"W3083066627","doi":"10.1158/1538-7445.am2020-5730","title":"Abstract 5730: A new polyphenol prebiotic isolated from <i>Myrciaria dubia</i> improves gut microbiota composition and increases anti-PD-1 efficacy in murine cancer models","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Computer Research Institute of Montréal","funders":"","keywords":"Akkermansia; Gut flora; Prebiotic; Biology; Feces; Akkermansia muciniphila; Microbiology; Antibiotics; Immunology; Biochemistry; Lactobacillus","score_opus":0.048306523557373963,"score_gpt":0.3509937508628041,"score_spread":0.30268722730543013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083066627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849023,0.011144816,0.00004974055,0.0027586094,0.00006444176,0.00064000074,0.00035378904,0.000020549525,0.00006575251],"genre_scores_gemma":[0.99323034,0.004905429,0.0001569264,0.00080215494,0.00047482285,0.000028063647,0.00028553145,0.00004372507,0.000072981566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808556,0.00012120941,0.0003167111,0.0007148944,0.00016706435,0.0005945824],"domain_scores_gemma":[0.99911493,0.000041935815,0.00007502467,0.0002878246,0.00012006245,0.00036022838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016726747,0.00022250206,0.00029987143,0.00008631086,0.00014431482,0.000094602154,0.00028114545,0.00024340481,0.00011288399],"category_scores_gemma":[0.000032895958,0.00022153986,0.000055191525,0.00027865375,0.00014711489,0.000018259007,0.00027578705,0.00045820075,0.000012125746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000663403,0.00014519786,0.0015521611,0.00013001628,0.00006198812,0.000010561264,0.00031712325,0.00017195124,0.9904778,0.000008414356,0.004711267,0.0017501428],"study_design_scores_gemma":[0.00857127,0.00075175334,0.28296405,0.0008077233,0.00006972098,0.000014759274,0.00021932057,0.0019639418,0.6980182,0.00012910848,0.0054823738,0.0010077909],"about_ca_topic_score_codex":0.03600538,"about_ca_topic_score_gemma":0.001929762,"teacher_disagreement_score":0.29245958,"about_ca_system_score_codex":0.00009374154,"about_ca_system_score_gemma":0.00074553257,"threshold_uncertainty_score":0.9704139},"labels":[],"label_agreement":null},{"id":"W3083070660","doi":"10.1158/1538-7445.am2020-ct147","title":"Abstract CT147: Phase 1 dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Internal medicine; Tumor microenvironment; Adverse effect; Oncology; Radioimmunotherapy; Cancer; Monoclonal antibody; Antibody; Immunology; Toxicity","score_opus":0.08106162704801605,"score_gpt":0.45675539334713555,"score_spread":0.3756937662991195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083070660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962676,0.00023828872,0.000015622054,0.00084455527,0.00003208244,0.0016992748,0.000060715123,0.000033097724,0.0008087694],"genre_scores_gemma":[0.99888426,0.00020495665,0.00013019622,0.00008561066,0.00015534874,0.000107114756,0.00015015945,0.000064330285,0.00021802842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996366,0.00014364898,0.0004885295,0.00054230663,0.001757289,0.00070217665],"domain_scores_gemma":[0.99814737,0.00015365762,0.00010942733,0.00038663443,0.00082698,0.00037594722],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068718824,0.0001963804,0.0005753187,0.0004148662,0.00008688198,0.000031985324,0.00026354883,0.000096450894,0.0034660168],"category_scores_gemma":[0.0002471336,0.00016537591,0.000082427265,0.001300017,0.00032395057,0.00019770986,0.00011727389,0.00093834574,0.00003379328],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016419305,0.0010262763,0.14875111,0.00043002752,0.00008792774,0.00009633386,0.0008655145,0.00013433454,0.8071239,0.000016689532,0.00024381673,0.024804758],"study_design_scores_gemma":[0.036132555,0.0038272033,0.7899482,0.0007540844,0.000019760211,0.000002284125,0.00025619369,0.00095344003,0.16669658,0.000030086796,0.0011006185,0.0002790042],"about_ca_topic_score_codex":0.00038759547,"about_ca_topic_score_gemma":0.000053993324,"teacher_disagreement_score":0.6411971,"about_ca_system_score_codex":0.00033063683,"about_ca_system_score_gemma":0.0007785924,"threshold_uncertainty_score":0.9974449},"labels":[],"label_agreement":null},{"id":"W3083072407","doi":"10.1158/1538-7445.am2020-520","title":"Abstract 520: Therapeutic antibodies against parathyroid hormone-related peptide (PTHrP) inhibit the growth of established skeletal metastasis in mice transplanted with human triple negative breast cancer cell lines","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Bone metastasis; Metastasis; Monoclonal antibody; Parathyroid hormone-related protein; Triple-negative breast cancer; Cancer; Cell culture; Parathyroid hormone; Antibody; Medicine; Internal medicine; Breast cancer; Biology; Immunology","score_opus":0.056324982375668894,"score_gpt":0.36443614281271236,"score_spread":0.30811116043704345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083072407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792886,0.0121710915,0.0000017633282,0.0053226254,0.000023603405,0.0014781281,0.00051208265,0.000035616897,0.0011664893],"genre_scores_gemma":[0.9885706,0.010388161,0.000023190778,0.00034240118,0.000063738175,0.00029558846,0.00008853615,0.00005255232,0.00017523688],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99736804,0.0002458978,0.0005355941,0.00048639343,0.00066299224,0.0007010596],"domain_scores_gemma":[0.9985562,0.0002261476,0.0001609162,0.00023810433,0.0005130533,0.00030555227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045753433,0.00028525596,0.000605769,0.00016909768,0.00023637731,0.000033766017,0.00021741028,0.00011835437,0.00014426402],"category_scores_gemma":[0.00003087263,0.00017392411,0.00010863829,0.0012136176,0.00045476627,0.00021717588,0.000034397377,0.0009009777,0.000009713167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01452288,0.0017512823,0.07135192,0.0026514838,0.0017396699,0.0006361886,0.020020682,0.00013648628,0.8761514,0.0000868743,0.0026296617,0.008321485],"study_design_scores_gemma":[0.020331305,0.0016644399,0.79450905,0.0012399242,0.00042100647,0.000027157557,0.0033651642,0.00023127603,0.1775194,0.000080688435,0.00016386683,0.0004467257],"about_ca_topic_score_codex":0.029378083,"about_ca_topic_score_gemma":0.00975616,"teacher_disagreement_score":0.7231571,"about_ca_system_score_codex":0.0002529414,"about_ca_system_score_gemma":0.0007825865,"threshold_uncertainty_score":0.97708535},"labels":[],"label_agreement":null},{"id":"W3083088832","doi":"10.1158/1538-7445.am2020-lb-108","title":"Abstract LB-108: A potent and selective small molecule degrader of STAT5 for the treatment of hematological malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre; University of Toronto","funders":"","keywords":"STAT5; Western blot; STAT protein; Chemistry; Small molecule; Gene isoform; Cancer research; STAT3; Phosphorylation; Molecular biology; Biochemistry; Biology; Gene","score_opus":0.11368475942509207,"score_gpt":0.3718578193550152,"score_spread":0.2581730599299231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083088832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895228,0.0073759574,0.0005645646,0.0017719072,0.00001536704,0.0005961584,0.000060837592,0.0000028386667,0.00008957558],"genre_scores_gemma":[0.9971491,0.0022009253,0.00018350367,0.00006322518,0.000056373345,0.00023215225,0.000012332908,0.00000779195,0.000094556795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993602,0.00003981845,0.00012916097,0.00018669109,0.00012243015,0.0001616681],"domain_scores_gemma":[0.99953014,0.000054086366,0.000044160217,0.00010988865,0.0002033466,0.000058396563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115403156,0.00006930876,0.000117736876,0.000018322793,0.000059045396,0.000008425158,0.00009585266,0.000057685535,0.000012490028],"category_scores_gemma":[0.00010268871,0.000043137115,0.000057017223,0.00008755367,0.00018743073,0.0000015939629,0.00003513206,0.000048253256,4.0639782e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003523271,0.00008898488,0.0006238312,0.000074867225,0.000079795216,0.0000010688312,0.00028015889,0.000014261423,0.9923077,0.0002056677,0.0013486558,0.0046226326],"study_design_scores_gemma":[0.0004857927,0.001143307,0.0014472037,0.000011071086,0.000007849268,9.721721e-7,0.0003045571,0.00004081213,0.988503,0.00004499022,0.007963647,0.00004681773],"about_ca_topic_score_codex":0.000091449525,"about_ca_topic_score_gemma":0.000031142034,"teacher_disagreement_score":0.0076263454,"about_ca_system_score_codex":0.000017127386,"about_ca_system_score_gemma":0.000121353834,"threshold_uncertainty_score":0.17590806},"labels":[],"label_agreement":null},{"id":"W3083093525","doi":"10.1158/1538-7445.am2020-ct161","title":"Abstract CT161: Phase I clinical trials of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada); Princess Margaret Cancer Centre; Welichem Biotech (Canada); Spinal Cord Injury BC","funders":"","keywords":"Tolerability; Medicine; Response Evaluation Criteria in Solid Tumors; Nausea; Adverse effect; Pharmacokinetics; Internal medicine; Oncology; Pharmacology; Vomiting; Cancer; Discontinuation; Clinical trial; Phases of clinical research","score_opus":0.1466887722011047,"score_gpt":0.4786759782495269,"score_spread":0.3319872060484222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083093525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846077,0.00028072498,0.000063515174,0.00020711296,0.00007925994,0.00049669156,0.0001844009,0.0000043092855,0.00022321955],"genre_scores_gemma":[0.99919873,0.00015450464,0.000064559674,0.000120297525,0.00023206988,0.000054635446,0.00012708461,0.000019007015,0.000029080493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980131,0.00022940952,0.0007911653,0.00035246235,0.00036823703,0.0002456675],"domain_scores_gemma":[0.9988913,0.000085947555,0.0002562521,0.00022324864,0.0003872919,0.00015594327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015333401,0.00010793921,0.0004027222,0.00008426448,0.000024671,0.0000070274145,0.00013005409,0.00012264862,0.00010695918],"category_scores_gemma":[0.001403008,0.00008959627,0.00010747222,0.00028423304,0.00019659291,0.000009228793,0.00007039282,0.00028009008,0.0000021715555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059614577,0.0007543312,0.0073959907,0.00010097115,0.00003899622,0.000002062283,0.00006066858,0.00011111635,0.98055893,0.00000884635,0.0017042244,0.003302422],"study_design_scores_gemma":[0.01197373,0.0037925113,0.009025146,0.0001828256,0.000009936987,1.908745e-7,0.000108505265,0.000038993625,0.9729601,0.000004721015,0.0017714094,0.00013189002],"about_ca_topic_score_codex":0.000055531844,"about_ca_topic_score_gemma":0.00005118552,"teacher_disagreement_score":0.007598774,"about_ca_system_score_codex":0.000030954485,"about_ca_system_score_gemma":0.00042311996,"threshold_uncertainty_score":0.365363},"labels":[],"label_agreement":null},{"id":"W3083093551","doi":"10.1158/1538-7445.am2020-472","title":"Abstract 472: What electric field strength is necessary for maximum tumor-treating fields efficacy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Electron Microscopy Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Amplitude; Electric field; Flux (metallurgy); Materials science; Physics; Optics","score_opus":0.03845171654927734,"score_gpt":0.42651886696621866,"score_spread":0.3880671504169413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083093551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569469,0.0066470345,0.022556983,0.012010459,0.00004179349,0.00097366277,0.00003993455,0.000056751465,0.0007264704],"genre_scores_gemma":[0.9918681,0.0031324637,0.0013312134,0.0024286336,0.00046057993,0.00045793937,0.000051761548,0.000031850945,0.00023747777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988183,0.00002274463,0.00015357978,0.00042300366,0.00013720986,0.0004451822],"domain_scores_gemma":[0.9993451,0.00009212176,0.000044559583,0.00025750854,0.00014364773,0.00011706253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014776924,0.00011715066,0.0001153864,0.000034790002,0.00019751287,0.00007974563,0.00030177415,0.00011261963,0.00011213188],"category_scores_gemma":[0.00012208558,0.00011604808,0.00007467974,0.00024323633,0.000027397378,0.0000124174985,0.00009098992,0.00031259464,0.0000066329026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015338289,0.000031818134,0.00006023941,0.000044253436,0.000017296685,9.895552e-7,0.00004636232,0.000014654671,0.9005099,0.000052193227,0.03756658,0.061502345],"study_design_scores_gemma":[0.0002555671,0.00046569202,0.000033328815,0.000025132602,0.0000044101544,9.1665635e-7,0.000087793225,0.00007284007,0.91201717,0.00036751138,0.086546555,0.00012306536],"about_ca_topic_score_codex":0.000044647677,"about_ca_topic_score_gemma":0.000012594953,"teacher_disagreement_score":0.06137928,"about_ca_system_score_codex":0.00002961745,"about_ca_system_score_gemma":0.000155034,"threshold_uncertainty_score":0.47323036},"labels":[],"label_agreement":null},{"id":"W3083097298","doi":"10.1158/1538-7445.am2020-5156","title":"Abstract 5156: Targeting N-myristoylation in B-cell lymphomas as a therapeutic strategy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myristoylation; Cancer research; Cell growth; Signal transduction; MAPK/ERK pathway; Cell culture; MCL1; B cell; Biology; Lymphoma; breakpoint cluster region; Apoptosis; Ibrutinib; Cell; CHOP; Viability assay; Kinase; Cell biology; Receptor; Immunology; Leukemia; Phosphorylation; Chronic lymphocytic leukemia; Downregulation and upregulation; Biochemistry; Antibody","score_opus":0.08314408908031433,"score_gpt":0.372667622264723,"score_spread":0.28952353318440865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083097298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766853,0.0061661736,0.000024997922,0.0010715057,0.00003653098,0.00030422767,0.000012552594,0.000012491092,0.015686257],"genre_scores_gemma":[0.9981497,0.000606372,0.00004077085,0.00041090688,0.0003575848,0.00010347723,0.000045901077,0.000025028694,0.00026027247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987066,0.00013033484,0.00016776344,0.00035607893,0.00026049127,0.00037873295],"domain_scores_gemma":[0.99950117,0.000023781571,0.000036708705,0.00020374755,0.000106125975,0.0001284792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048019562,0.0001032817,0.000099637015,0.000048866816,0.000086325905,0.0000448006,0.0002926375,0.00012813286,0.00038953617],"category_scores_gemma":[0.0001176692,0.00010205949,0.00004278981,0.00023083686,0.00006771804,0.000005544983,0.00012031559,0.00026220674,0.00010319942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017465618,0.000036018097,0.0013816,0.00006814531,0.00000866224,0.000011998968,0.00025950186,0.00017228365,0.9900819,0.00008514396,0.001703298,0.0060167904],"study_design_scores_gemma":[0.00074590667,0.00029046417,0.00166046,0.000020634214,0.0000020122263,0.0000011200866,0.0003739723,0.0001392558,0.9578804,0.00048242576,0.03824244,0.0001609268],"about_ca_topic_score_codex":0.00030363808,"about_ca_topic_score_gemma":0.000047659873,"teacher_disagreement_score":0.036539145,"about_ca_system_score_codex":0.000052664956,"about_ca_system_score_gemma":0.00040763078,"threshold_uncertainty_score":0.4265148},"labels":[],"label_agreement":null},{"id":"W3083099135","doi":"10.1158/1538-7445.am2020-6559","title":"Abstract 6559: Novel anti-myeloma potential of CAPE analogs: Downregulation of IKZF1-IRF4-MYC axis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Université de Moncton; University of New Brunswick","funders":"","keywords":"IRF4; Cancer research; Cyclin D1; Multiple myeloma; Transcription factor; Biology; Plasma cell; Chromosomal translocation; Molecular biology; Immunology; Cancer; Genetics; Cell cycle","score_opus":0.054708050145159004,"score_gpt":0.3346324765064247,"score_spread":0.2799244263612657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083099135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948572,0.00264909,0.00047997074,0.0006629116,0.00026293032,0.0003244871,0.00026613497,0.000024630952,0.0004726344],"genre_scores_gemma":[0.99899083,0.00032476414,0.00011671634,0.000048719085,0.000079318655,0.000023786424,0.0000725577,0.000022062708,0.00032126083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998476,0.00012523327,0.00043371058,0.00034186238,0.00017376897,0.00044938247],"domain_scores_gemma":[0.9990072,0.00008684117,0.0001616546,0.00031995572,0.00037759004,0.000046763198],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049799064,0.00014162659,0.00036882018,0.00017896281,0.00014003235,0.000011939386,0.0004069269,0.00026143962,0.0032901638],"category_scores_gemma":[0.000118200434,0.00012975842,0.00013055722,0.0004463492,0.000396778,0.000114625065,0.000172648,0.0004965793,0.000120790966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030716864,0.00011239945,0.00024145759,0.0001136343,0.00015110688,0.0000033761817,0.000482614,0.00013095717,0.98985136,0.00093256147,0.0013048459,0.006368511],"study_design_scores_gemma":[0.0012070261,0.00032176977,0.10081072,0.000070772425,0.000018657825,0.0000047161584,0.00042057925,0.00003446268,0.8925421,0.000092348164,0.0043457844,0.0001310556],"about_ca_topic_score_codex":0.0009938079,"about_ca_topic_score_gemma":0.00003585757,"teacher_disagreement_score":0.10056926,"about_ca_system_score_codex":0.000052634707,"about_ca_system_score_gemma":0.00026353708,"threshold_uncertainty_score":0.99762094},"labels":[],"label_agreement":null},{"id":"W3083100836","doi":"10.1158/1538-7445.am2020-278","title":"Abstract 278: Deciphering circular RNA axes in early-onset breast cancer using a breast epithelial risk-progression 3D culture model","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Downregulation and upregulation; Circular RNA; microRNA; Microarray; In silico; Breast cancer; Cancer research; Microarray analysis techniques; Biology; Cancer; In vivo; Cell biology; Molecular biology; Gene expression; Gene; Genetics","score_opus":0.054225162382179656,"score_gpt":0.3872729645446015,"score_spread":0.3330478021624218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083100836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915726,0.0078791175,0.00033413144,0.00038186944,0.000089723144,0.00035151275,0.0016884897,0.000024747531,0.00009317641],"genre_scores_gemma":[0.9959158,0.0025380747,0.0003852553,0.00014407458,0.00072029774,0.00012600374,0.000057248835,0.000079129386,0.0000341711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972355,0.00020672436,0.0002973693,0.0008400536,0.00067455735,0.00074581464],"domain_scores_gemma":[0.9986384,0.00001703206,0.00010376747,0.0004828022,0.00036742608,0.00039056127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035501333,0.00026439922,0.00025491178,0.0000769293,0.00023808311,0.000112551286,0.0004994496,0.0002696263,0.00014595539],"category_scores_gemma":[0.00016113145,0.00025395612,0.00015296023,0.0004474009,0.00022656532,0.000022565944,0.00043561266,0.00066002784,0.00001438785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005536706,0.00009670557,0.08191951,0.00015736031,0.00009862544,0.000095711024,0.0003374334,0.021822529,0.8827313,0.0000018435925,0.0006165288,0.011568738],"study_design_scores_gemma":[0.0051704836,0.0001997058,0.32160664,0.0015321741,0.00016560889,0.00022887826,0.0006702194,0.045660086,0.6185784,0.00039678326,0.0038735115,0.0019175335],"about_ca_topic_score_codex":0.0015107812,"about_ca_topic_score_gemma":0.0003265197,"teacher_disagreement_score":0.26415294,"about_ca_system_score_codex":0.00023484892,"about_ca_system_score_gemma":0.0009577642,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W3083103851","doi":"10.1158/1538-7445.am2020-1203","title":"Abstract 1203: Identification of 22 novel loci associated with susceptibility to testicular germ cell tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Genome-wide association study; Testicular Germ Cell Tumor; 1000 Genomes Project; Testicular cancer; Cancer; Genetic association; Genetics; Seminoma; Odds ratio; Oncology; Biology; Medicine; Genotype; Single-nucleotide polymorphism; Internal medicine; Gene","score_opus":0.08700751687244823,"score_gpt":0.39026300219196924,"score_spread":0.303255485319521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083103851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969233,0.00033921032,0.00011094319,0.001298812,0.000013713681,0.00084923644,0.00017928494,0.0000369089,0.00024858143],"genre_scores_gemma":[0.99934524,0.000011424687,0.00009127836,0.000104096565,0.000052403277,0.00009584479,0.00008957645,0.000025713796,0.00018439694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981936,0.000043127486,0.0002578168,0.00038338214,0.00081152585,0.00031049945],"domain_scores_gemma":[0.99829125,0.00013250136,0.00009896514,0.00032585344,0.0007127458,0.00043867758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035085555,0.00011173984,0.00023545965,0.000072724026,0.000069198795,0.000023924924,0.000121877674,0.00004677768,0.00031403708],"category_scores_gemma":[0.0012494005,0.00008741282,0.00006495647,0.00066195783,0.000120790086,0.00004517893,0.00005091802,0.00021274116,0.000058588623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006641265,0.0015996153,0.39330956,0.00060227804,0.00020307339,0.00017512884,0.00045009286,0.00036037626,0.5990634,0.000020840176,0.0017851732,0.0017663621],"study_design_scores_gemma":[0.0015003087,0.0005223834,0.93041277,0.00016177387,0.000096987,0.000001256096,0.00014717573,0.00016864273,0.06678058,0.000015757465,0.000102977225,0.00008941457],"about_ca_topic_score_codex":0.0005996462,"about_ca_topic_score_gemma":0.000051388284,"teacher_disagreement_score":0.5371032,"about_ca_system_score_codex":0.0002982546,"about_ca_system_score_gemma":0.00056367635,"threshold_uncertainty_score":0.35645917},"labels":[],"label_agreement":null},{"id":"W3083110487","doi":"10.1158/1538-7445.am2020-917","title":"Abstract 917: Functional blocking of CD5 on T cells to enhance the efficacy of therapeutic PD-1 blockade in treatment of mouse 4T1 breast tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Cytotoxic T cell; CD8; Cancer research; T cell; Blockade; CD5; Ex vivo; In vivo; Biology; Immune system; Immunology; Medicine; Antibody; Receptor; Internal medicine; In vitro","score_opus":0.09600337573824338,"score_gpt":0.40060629083581495,"score_spread":0.30460291509757154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083110487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267465,0.0014659547,0.000004756007,0.0046998803,0.000052274572,0.000757204,0.00006548225,0.0000071627796,0.0002726612],"genre_scores_gemma":[0.99864537,0.0005411597,0.0000107472,0.00020512717,0.00014024696,0.000079026606,0.0000039338975,0.000020500693,0.00035392147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983157,0.000086185995,0.0003857314,0.00026365684,0.0006668091,0.0002819328],"domain_scores_gemma":[0.99895364,0.00035910457,0.00010149275,0.0003121499,0.00017700481,0.000096613025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036346182,0.00012709541,0.0003362705,0.00016576519,0.000041328713,0.000005938189,0.00016770366,0.000051754272,0.00055017194],"category_scores_gemma":[0.000029873767,0.000083443985,0.000129125,0.0006961905,0.00022561487,0.000019742716,0.000027004153,0.00020969825,0.000008438167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013750494,0.0005498302,0.002027228,0.00015615641,0.0001749856,0.0000070554693,0.0018506615,0.00051752495,0.94272506,0.000009765656,0.00025535043,0.03797588],"study_design_scores_gemma":[0.002080061,0.0014597564,0.08811349,0.0003308792,0.000018045195,0.0000023547527,0.000396672,0.000028539207,0.906154,0.000003590938,0.001347141,0.00006549611],"about_ca_topic_score_codex":0.0016817143,"about_ca_topic_score_gemma":0.00010933346,"teacher_disagreement_score":0.08608626,"about_ca_system_score_codex":0.0002842374,"about_ca_system_score_gemma":0.00045397965,"threshold_uncertainty_score":0.6023997},"labels":[],"label_agreement":null},{"id":"W3083114613","doi":"10.1158/1538-7445.am2020-1112","title":"Abstract 1112: Feasibility of real-time personalized patient-derived Tumorgraft® models for guiding systemic treatment in recurrent and/or metastatic head and neck cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Regimen; Drug response; Internal medicine; Head and neck cancer; Oncology; Progressive disease; Cancer; Biopsy; Head and neck; Basal cell; Disease; Surgery; Drug; Pharmacology","score_opus":0.16846234231048327,"score_gpt":0.42398639003082045,"score_spread":0.2555240477203372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083114613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901606,0.0064677927,0.000007861248,0.00019713928,0.000025736552,0.0022081633,0.00089394813,0.000006358801,0.00003243469],"genre_scores_gemma":[0.98871917,0.009492848,0.00012560956,0.000020349149,0.000043640735,0.001383039,0.00013169093,0.000029721305,0.000053913234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980029,0.0001666184,0.00034485757,0.0006306362,0.00035361713,0.0005013654],"domain_scores_gemma":[0.99902946,0.00007811537,0.00009436817,0.00020395331,0.00030274768,0.00029138525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002324379,0.00020294546,0.0003830663,0.00008411815,0.00009755739,0.000032368436,0.00012298586,0.000060291844,0.00004070919],"category_scores_gemma":[0.00014182151,0.00015851967,0.000078284545,0.00018429875,0.00017415875,0.000016582908,0.00012881127,0.000082378836,9.267762e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015539384,0.00089954335,0.037547458,0.0016298498,0.00047084855,0.000022542363,0.003133875,0.00016277787,0.9123776,0.000015020003,0.0006690103,0.027532104],"study_design_scores_gemma":[0.070610076,0.040725116,0.038477354,0.003085708,0.00030886897,0.000018854058,0.0034953773,0.007681016,0.83127713,0.00053711707,0.0019725214,0.0018108492],"about_ca_topic_score_codex":0.005596775,"about_ca_topic_score_gemma":0.0015443773,"teacher_disagreement_score":0.08110044,"about_ca_system_score_codex":0.00036336668,"about_ca_system_score_gemma":0.00057859544,"threshold_uncertainty_score":0.8460687},"labels":[],"label_agreement":null},{"id":"W3083124224","doi":"10.1158/1538-7445.am2020-4108","title":"Abstract 4108: The use of conditionally reprogrammed cells for high throughput screening for novel drug combinations to treat drug resistant triple negative breast cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Carboplatin; Triple-negative breast cancer; Paclitaxel; Cancer research; Breast cancer; Medicine; Drug; Drug resistance; Cancer; Oncology; Chemotherapy; Pharmacology; Internal medicine; Cisplatin; Biology; Genetics","score_opus":0.24355266399996264,"score_gpt":0.41662239043589194,"score_spread":0.1730697264359293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083124224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6860922,0.0017839362,0.020142084,0.22545479,0.0007939363,0.02414283,0.04077024,0.00016398785,0.0006559925],"genre_scores_gemma":[0.9808877,0.00023760193,0.010227109,0.0014551383,0.0004771878,0.0032951802,0.00029084843,0.00007376772,0.0030554305],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975552,0.00006655708,0.000449199,0.00057977636,0.00076916604,0.0005800756],"domain_scores_gemma":[0.9960398,0.0014856617,0.00015712474,0.00041285699,0.0015448089,0.00035975635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079855236,0.0001918172,0.0004575837,0.0001408448,0.00038816544,0.00008392556,0.0002596647,0.000052925796,0.00022674425],"category_scores_gemma":[0.00050757115,0.0001454691,0.00022484103,0.00081018376,0.00032095148,0.00014351867,0.000083665436,0.0003197744,0.000003571842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018859785,0.00064693147,0.00013501046,0.0018010886,0.00079045864,0.000012360905,0.0071783997,0.0023870114,0.2992388,0.0045425314,0.6203661,0.04404149],"study_design_scores_gemma":[0.024014348,0.0014371133,0.0065549733,0.0009839614,0.0005523588,0.0000060103575,0.0060451827,0.0005709998,0.6559113,0.0006808454,0.3026591,0.00058375683],"about_ca_topic_score_codex":0.017130919,"about_ca_topic_score_gemma":0.0027276524,"teacher_disagreement_score":0.35667253,"about_ca_system_score_codex":0.0005434014,"about_ca_system_score_gemma":0.0012720388,"threshold_uncertainty_score":0.9894141},"labels":[],"label_agreement":null},{"id":"W3083124691","doi":"10.1158/1538-7445.am2020-6710","title":"Abstract 6710: AVID200, a first-in-class selective TGF-beta 1 and -beta 3 inhibitor, sensitizes tumors to immune checkpoint blockade therapies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"In vivo; Cancer research; TGF beta signaling pathway; Cancer immunotherapy; Immunotherapy; Blockade; Medicine; Transforming growth factor beta; Ectodomain; Immune checkpoint; Immune system; Tumor microenvironment; Cancer; Pharmacology; Immunology; Biology; Receptor; Internal medicine","score_opus":0.06202703810496706,"score_gpt":0.3577934308272735,"score_spread":0.2957663927223064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083124691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9377783,0.009890851,0.000004477996,0.049013503,0.00011201545,0.0010971101,0.000057195324,0.000050788876,0.0019957507],"genre_scores_gemma":[0.9951803,0.00250039,0.00013849443,0.0006668321,0.0006905508,0.00021570336,0.000008457433,0.000063214524,0.00053606444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971751,0.00010448423,0.00042613567,0.00070887536,0.0007636613,0.00082176],"domain_scores_gemma":[0.998447,0.00020597398,0.00006193866,0.00033986726,0.00035410514,0.0005911137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007628887,0.0002630107,0.00062833255,0.00029221253,0.00017484669,0.00008177783,0.00016169241,0.000107564425,0.00049277046],"category_scores_gemma":[0.00015092063,0.00022954351,0.00012361044,0.0011055609,0.00023959596,0.00009332738,0.00020653474,0.0009577067,0.00007960974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025231573,0.00016205346,0.0040876246,0.0007765365,0.00024955443,0.00046442816,0.011543816,0.00006554819,0.9587037,0.00004008911,0.0051049655,0.016278552],"study_design_scores_gemma":[0.003828974,0.0009299788,0.08046116,0.0008695083,0.000060053793,0.000037724825,0.003129648,0.000055214598,0.8421088,0.000057947615,0.06803349,0.00042754126],"about_ca_topic_score_codex":0.004290855,"about_ca_topic_score_gemma":0.0014017251,"teacher_disagreement_score":0.11659491,"about_ca_system_score_codex":0.00046757466,"about_ca_system_score_gemma":0.00059055514,"threshold_uncertainty_score":0.9360513},"labels":[],"label_agreement":null},{"id":"W3083156486","doi":"10.1158/1538-7445.am2020-5049","title":"Abstract 5049: Development of huPBMC-NCG mice to study xenogenic graft versus host disease (GVHD)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Graft-versus-host disease; Medicine; Immunology; Peripheral blood mononuclear cell; Transplantation; Flow cytometry; Leukemia; Stem cell; Cancer research; Biology; Internal medicine","score_opus":0.2869972821785014,"score_gpt":0.48372473059883797,"score_spread":0.19672744842033657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083156486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859155,0.0013923371,0.000017492588,0.0037151338,0.00014539895,0.0027804151,0.00003120804,0.00004439698,0.003282088],"genre_scores_gemma":[0.9977039,0.00008909348,0.00029995103,0.0001402337,0.00028377402,0.0004819481,0.000014032981,0.00006127833,0.00092580635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945171,0.00022006597,0.0005417278,0.00077708723,0.0029580968,0.0009859622],"domain_scores_gemma":[0.9960379,0.0003417326,0.000058678266,0.00060615846,0.00087514136,0.0020803658],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015625689,0.00022611399,0.00045280624,0.00032399734,0.00024078184,0.00004705435,0.00053932116,0.000074219635,0.004685],"category_scores_gemma":[0.0014570312,0.00020059763,0.00010376387,0.0015534059,0.00016662573,0.00007206669,0.0006204669,0.00081234355,0.0009395169],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03338108,0.0029210541,0.06660435,0.0031447918,0.0012374311,0.0023489913,0.01971524,0.000047000314,0.7798321,0.000050663155,0.013917256,0.07680004],"study_design_scores_gemma":[0.007910841,0.002491535,0.7615412,0.0002450671,0.00008963833,0.0000018479815,0.004881444,0.000034540364,0.19206707,0.0000074521463,0.03029078,0.00043860334],"about_ca_topic_score_codex":0.00039138293,"about_ca_topic_score_gemma":0.00017476064,"teacher_disagreement_score":0.6949368,"about_ca_system_score_codex":0.000583376,"about_ca_system_score_gemma":0.00282838,"threshold_uncertainty_score":0.99983835},"labels":[],"label_agreement":null},{"id":"W3083163488","doi":"10.1158/1538-7445.am2020-3396","title":"Abstract 3396: Multiethnic genome-wide meta-analysis of 34,329 cases and 35,732 controls identifies cross-ancestry loci for lung cancer susceptibility","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genome-wide association study; Lung cancer susceptibility; Lung cancer; Imputation (statistics); Genetic association; Population; Biology; 1000 Genomes Project; Genetics; Cancer; Oncology; Medicine; Single-nucleotide polymorphism; Genotype; Gene; Environmental health","score_opus":0.23926247004437026,"score_gpt":0.4803124642270481,"score_spread":0.24104999418267783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083163488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9179504,0.07860137,0.00035174313,0.00096172374,0.000040969408,0.00069499237,0.0013378145,0.000008087867,0.000052912244],"genre_scores_gemma":[0.9923083,0.005100521,0.00006849098,0.00022466265,0.00020404678,0.0011054085,0.00016327275,0.000026116339,0.0007991862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788606,0.00011251145,0.00045048178,0.0007600169,0.00036078738,0.0004301701],"domain_scores_gemma":[0.99804944,0.00023889489,0.00017390586,0.00054442865,0.0008017449,0.00019161013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076896645,0.00019042192,0.0006246962,0.00010002694,0.0002163255,0.00010147193,0.00035669122,0.0001635351,0.00059980765],"category_scores_gemma":[0.00047152242,0.0001636589,0.0005457968,0.00046707084,0.0005224035,0.000017834553,0.00013698285,0.00021583331,0.0000010541083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005630161,0.000067399604,0.06397689,0.00045354565,0.025508918,0.000003222497,0.00022978985,0.003904282,0.9021936,0.000016480426,0.0023872613,0.0006955768],"study_design_scores_gemma":[0.0028486769,0.0004892828,0.36315304,0.000023649434,0.03120338,0.0000013562554,0.0010941549,0.002177839,0.5732143,0.00007117801,0.02476751,0.00095564825],"about_ca_topic_score_codex":0.0020629452,"about_ca_topic_score_gemma":0.003956896,"teacher_disagreement_score":0.32897934,"about_ca_system_score_codex":0.00008176399,"about_ca_system_score_gemma":0.0003562721,"threshold_uncertainty_score":0.6673816},"labels":[],"label_agreement":null},{"id":"W3083171017","doi":"10.1158/1538-7445.am2020-685","title":"Abstract 685: Sortilin receptor-mediated novel cancer therapy: A targeted approach to inhibit vasculogenic mimicry in ovarian and breast cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Vasculogenic mimicry; Ovarian cancer; Cancer research; Doxorubicin; Matrigel; Triple-negative breast cancer; Cancer; Breast cancer; Docetaxel; Cancer cell; Cancer stem cell; Medicine; Biology; Chemistry; Internal medicine; Metastasis; Chemotherapy; Angiogenesis","score_opus":0.05204581272193721,"score_gpt":0.32774772273463615,"score_spread":0.27570191001269895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083171017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694731,0.024306543,0.00007982932,0.0025732978,0.0011311903,0.0011074569,0.0007332267,0.000024411216,0.00057090004],"genre_scores_gemma":[0.9675002,0.02089352,0.00024271247,0.0018769803,0.0077578463,0.0010913315,0.00021828421,0.00009287137,0.00032624343],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972908,0.00011669559,0.00034955595,0.0009769882,0.0004424381,0.0008235601],"domain_scores_gemma":[0.9987608,0.000025614534,0.00006590757,0.0003585519,0.00026193104,0.0005271469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005837934,0.00027902788,0.00036333123,0.00016950331,0.000121899226,0.000060797473,0.0003793752,0.00026473205,0.00026382742],"category_scores_gemma":[0.00011279147,0.00026904282,0.000101037665,0.00079770916,0.0002085598,0.0000141818855,0.00021431723,0.0005410449,0.000013355373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761246,0.0000826663,0.0017599097,0.00007816508,0.00011635724,2.7237624e-7,0.00083681697,0.00039742579,0.9485631,0.000010568814,0.03994264,0.007135928],"study_design_scores_gemma":[0.005440286,0.0002676515,0.049215052,0.00012270789,0.000018853727,0.00000846746,0.00094408775,0.00019018853,0.1914204,0.0000100739,0.7514846,0.00087764685],"about_ca_topic_score_codex":0.008560578,"about_ca_topic_score_gemma":0.002545721,"teacher_disagreement_score":0.7571427,"about_ca_system_score_codex":0.00022684658,"about_ca_system_score_gemma":0.0014129515,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W3083171877","doi":"10.1158/1538-7445.am2020-5465","title":"Abstract 5465: HRDetect as a predictive score of platinum response in advanced PDAC","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"PALB2; CHEK2; Medicine; Indel; Internal medicine; Oncology; Germline; Population; Germline mutation; Mutation; Genetics; Gene; Biology","score_opus":0.04655848575234597,"score_gpt":0.3757191651520273,"score_spread":0.32916067939968136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083171877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953699,0.0021556353,0.000037104655,0.0008309846,0.00006177884,0.00036993678,0.00017559274,0.0000054051316,0.0009936515],"genre_scores_gemma":[0.998143,0.0011326746,0.0000696945,0.00019879744,0.00019079611,0.00012416487,0.000021713679,0.000025472576,0.0000936575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869144,0.00009725583,0.00022061665,0.00038395394,0.00027265542,0.00033408843],"domain_scores_gemma":[0.9991686,0.00015038972,0.000056881385,0.00026448083,0.00021035047,0.00014931033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046333263,0.000107839034,0.0001639721,0.00008059465,0.000042722775,0.000014828058,0.00026264455,0.00011550782,0.00010825642],"category_scores_gemma":[0.0013318907,0.00011224072,0.00005610191,0.00029573735,0.00015243303,0.0000040779696,0.00019773407,0.0002765659,0.000013431156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012784992,0.000035571706,0.002137958,0.00005693302,0.000024498204,0.000020687437,0.00034584224,0.0018722845,0.97757953,0.000020996535,0.001461325,0.0036594043],"study_design_scores_gemma":[0.0016392098,0.0025011557,0.030366564,0.00011191055,0.000004865332,0.0000017876965,0.00043804257,0.00010788894,0.94658965,0.00016851076,0.017883696,0.00018671317],"about_ca_topic_score_codex":0.0002624703,"about_ca_topic_score_gemma":0.00018423656,"teacher_disagreement_score":0.03098985,"about_ca_system_score_codex":0.00007991689,"about_ca_system_score_gemma":0.00079300354,"threshold_uncertainty_score":0.45770437},"labels":[],"label_agreement":null},{"id":"W3083172821","doi":"10.1158/1538-7445.am2020-5246","title":"Abstract 5246: Disulfiram anticancer metabolite, dithiocarb-copper complex, demonstrates anti-neoplastic activity against hypermutated colorectal cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Irinotecan; Cancer research; Cancer; KRAS; Medicine; In vivo; Microsatellite instability; Apoptosis; Cancer cell; Biology; Internal medicine; Biochemistry","score_opus":0.058211679812737664,"score_gpt":0.35541628330652714,"score_spread":0.29720460349378947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083172821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98751664,0.005074538,0.00007167842,0.0010914279,0.0027316452,0.0007041075,0.00068632094,0.0000681582,0.0020554874],"genre_scores_gemma":[0.98099416,0.0072094277,0.00007436927,0.0006549128,0.010318346,0.00028035804,0.00020509971,0.000097206896,0.00016609034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961821,0.00026316996,0.00039514978,0.001132026,0.0008033994,0.0012241731],"domain_scores_gemma":[0.99812704,0.00011128062,0.00013169486,0.00046721494,0.0004954219,0.00066734327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048596994,0.00043575847,0.0006236381,0.00012690188,0.0003983859,0.00015595704,0.0006141131,0.00029020183,0.00022764869],"category_scores_gemma":[0.00036652014,0.000412424,0.00022761674,0.0007694035,0.00083020196,0.0000334964,0.000296622,0.0007813157,0.000056117493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007445185,0.00008595762,0.0046137837,0.0001228452,0.00024581436,0.0000033361816,0.00019377291,0.0009961522,0.9543825,0.000034771096,0.030409174,0.008167403],"study_design_scores_gemma":[0.0025816432,0.00035768174,0.13042794,0.00007512762,0.000091763475,0.000009347064,0.00036698725,0.0008170162,0.46495882,0.000023744276,0.3993883,0.0009016037],"about_ca_topic_score_codex":0.0013576909,"about_ca_topic_score_gemma":0.0008543101,"teacher_disagreement_score":0.48942366,"about_ca_system_score_codex":0.00020795072,"about_ca_system_score_gemma":0.0017848323,"threshold_uncertainty_score":0.99983275},"labels":[],"label_agreement":null},{"id":"W3083202954","doi":"10.1158/1538-7445.am2020-1194","title":"Abstract 1194: Cross-cancer GWAS meta-analysis of more than 370,000 cases and 530,000 controls identifies multiple novel cancer risk regions","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genome-wide association study; Cancer; Meta-analysis; Colorectal cancer; Prostate cancer; Breast cancer; Oncology; Biology; Medicine; Internal medicine; Genetics; Single-nucleotide polymorphism; Genotype","score_opus":0.2032077128479647,"score_gpt":0.455281033930309,"score_spread":0.25207332108234426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083202954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96155226,0.028843671,0.00018648992,0.0035165958,0.00006716573,0.0003564064,0.005419293,0.000009406605,0.000048736558],"genre_scores_gemma":[0.9883967,0.009493389,0.000090389454,0.00037001277,0.00024155155,0.000607994,0.00011331789,0.000028532237,0.0006581209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976524,0.00022760166,0.0005051134,0.00070726086,0.00036284543,0.0005447406],"domain_scores_gemma":[0.99794334,0.00040598548,0.00027150963,0.0004581002,0.0006900548,0.00023100563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085672166,0.00022105874,0.000844025,0.00015315025,0.0002884103,0.00006262453,0.00033837877,0.00023999624,0.0005896658],"category_scores_gemma":[0.0014993638,0.00018412375,0.0005236492,0.0005679798,0.0005634616,0.000011310429,0.00022441501,0.0003209563,0.0000024625106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033018284,0.00010446638,0.5752342,0.000097611504,0.054393742,0.000005546972,0.0006352176,0.023978468,0.33722174,0.000032818654,0.007444508,0.0005215187],"study_design_scores_gemma":[0.0014005345,0.00026224888,0.9285433,0.000013709051,0.01614869,0.0000019630832,0.00076290825,0.0018747944,0.03905413,0.000054598793,0.011445491,0.0004376207],"about_ca_topic_score_codex":0.019728487,"about_ca_topic_score_gemma":0.016225396,"teacher_disagreement_score":0.35330912,"about_ca_system_score_codex":0.00005070442,"about_ca_system_score_gemma":0.00022933554,"threshold_uncertainty_score":0.98679924},"labels":[],"label_agreement":null},{"id":"W3083211751","doi":"10.1158/1538-7445.am2020-3438","title":"Abstract 3438: Hypoxia inhibits BMP4-induced astrocytic differentiation in glioma stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hypoxia (environmental); Biology; Stem cell; Cellular differentiation; Cell biology; Cancer research; Neural stem cell; Glial fibrillary acidic protein; Epigenetics; Immunology; Chemistry; Genetics; Immunohistochemistry","score_opus":0.06586998332408771,"score_gpt":0.33977651571499085,"score_spread":0.2739065323909031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083211751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541825,0.0027170132,0.000040074487,0.00043741547,0.0005315371,0.00040811417,0.00003944251,0.000015381058,0.00039275916],"genre_scores_gemma":[0.99645865,0.0009079575,0.000020591408,0.00015553016,0.0019910056,0.00013292991,0.0000311785,0.00003861662,0.000263511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800515,0.00012695549,0.00027497983,0.00056719297,0.000452158,0.0005735627],"domain_scores_gemma":[0.9991778,0.000023530487,0.0000632425,0.00030174854,0.00018122507,0.00025243615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003234959,0.00017432119,0.00022047621,0.00013043894,0.000086651555,0.00006387901,0.00030811015,0.0001881746,0.000107031214],"category_scores_gemma":[0.000048602567,0.00017525243,0.000086004104,0.00043301733,0.00006542509,0.000011072847,0.00018402748,0.0004019965,0.00006117154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023568641,0.000043412114,0.0002307898,0.00007582043,0.000024182855,0.0000051024813,0.00019872609,0.000056418245,0.9838068,0.000015888936,0.0030340338,0.012273124],"study_design_scores_gemma":[0.0011987257,0.0001481607,0.007452082,0.000035209887,0.0000072516427,0.0000019307224,0.0001345312,0.000045796613,0.9660225,0.0000132095975,0.024753448,0.00018715124],"about_ca_topic_score_codex":0.0002102432,"about_ca_topic_score_gemma":0.00027832607,"teacher_disagreement_score":0.021719413,"about_ca_system_score_codex":0.00009586867,"about_ca_system_score_gemma":0.00038627535,"threshold_uncertainty_score":0.7146586},"labels":[],"label_agreement":null},{"id":"W3083234180","doi":"10.1158/1538-7445.am2020-4325","title":"Abstract 4325: A Phase II exploratory study to identify biomarkers prognostic of clinical response to regorafenib in patients with metastatic colorectal cancer who have failed first-line therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Moncton Hospital; St Mary's Hospital Centre; Hôpital Maisonneuve-Rosemont; McGill University Health Centre","funders":"","keywords":"Regorafenib; Medicine; Bevacizumab; Colorectal cancer; Oncology; Irinotecan; Internal medicine; Cancer; Oxaliplatin; Chemotherapy","score_opus":0.19532489753110302,"score_gpt":0.5069603624864915,"score_spread":0.3116354649553884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083234180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576164,0.0009152316,0.0000034689597,0.005727259,0.00009809901,0.0072113974,0.00022065925,0.000028382423,0.00003386135],"genre_scores_gemma":[0.9957683,0.00028858753,0.00004821992,0.00028303423,0.00010424764,0.0033612547,0.000013414549,0.0000581072,0.000074808115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582165,0.000540972,0.0008480761,0.0008478622,0.0013217499,0.00061968813],"domain_scores_gemma":[0.99714893,0.00073845265,0.00015034695,0.0003403575,0.0009967375,0.000625203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017505592,0.00030527578,0.0010457449,0.0004205272,0.00019950402,0.000033377662,0.00025090954,0.00005463971,0.0003121964],"category_scores_gemma":[0.0015529457,0.00021735262,0.00011406291,0.0015790112,0.0002260511,0.00012120805,0.00025210733,0.00047622636,0.000012858027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.262809,0.0065759597,0.6867138,0.00012987849,0.0012044825,0.00025984232,0.020533256,0.000051909192,0.001132424,2.3476309e-7,0.0023564228,0.018232804],"study_design_scores_gemma":[0.027780766,0.053278904,0.9111164,0.00047415897,0.000101394995,2.3123285e-7,0.0045462954,0.000028373548,0.0014229474,0.0000017355445,0.0010365965,0.00021216705],"about_ca_topic_score_codex":0.00113996,"about_ca_topic_score_gemma":0.006773661,"teacher_disagreement_score":0.23502824,"about_ca_system_score_codex":0.00051364425,"about_ca_system_score_gemma":0.0010955394,"threshold_uncertainty_score":0.88633823},"labels":[],"label_agreement":null},{"id":"W3083237575","doi":"10.1158/1538-7445.am2020-3517","title":"Abstract 3517: A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec","funders":"","keywords":"Prostate cancer; Family history; Allele; Population; Medicine; Genotype; Internal medicine; Genetics; Allele frequency; Genome-wide association study; Demography; Oncology; Cancer; Gynecology; Biology; Single-nucleotide polymorphism; Gene","score_opus":0.11476872701665779,"score_gpt":0.43060013953468307,"score_spread":0.31583141251802527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083237575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735678,0.0064526987,0.000014564582,0.015424828,0.000085659376,0.0019098532,0.0005828785,0.000021127364,0.0019406319],"genre_scores_gemma":[0.9939373,0.003865931,0.00007586189,0.00012835966,0.00019484138,0.0006135725,0.000023967203,0.000038004324,0.0011221245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711716,0.000100327605,0.000550345,0.0005085762,0.0009300684,0.0007935236],"domain_scores_gemma":[0.9983942,0.00018103342,0.00010011491,0.0003042364,0.0006067067,0.00041373906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007330124,0.00018702731,0.0006486235,0.00034825524,0.000072939656,0.000016748749,0.00027658025,0.00010489147,0.0005110251],"category_scores_gemma":[0.00023351327,0.00014978088,0.000086775166,0.0014451153,0.0003277689,0.00008094562,0.00036449535,0.0005367844,0.000012637925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019702338,0.00033139822,0.1093486,0.0026896922,0.00033578262,0.0004648278,0.005718241,0.0011842342,0.83686006,0.000031749743,0.00486957,0.01846349],"study_design_scores_gemma":[0.01845108,0.002838273,0.3258248,0.0037641749,0.0000976979,0.000008624955,0.0032545598,0.0035415394,0.63030756,0.00011510838,0.011297851,0.00049870904],"about_ca_topic_score_codex":0.0061117634,"about_ca_topic_score_gemma":0.0012574401,"teacher_disagreement_score":0.2164762,"about_ca_system_score_codex":0.0009323712,"about_ca_system_score_gemma":0.0013435448,"threshold_uncertainty_score":0.9239199},"labels":[],"label_agreement":null},{"id":"W3083244525","doi":"10.1158/1538-7445.am2020-3875","title":"Abstract 3875: Investigating tumor-immune interactions in adult sarcomas of the extremities","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Sarcoma; Immunotherapy; Medicine; Tumor-infiltrating lymphocytes; Immune system; Cancer research; Cancer; Metastasis; Primary tumor; Chemotherapy; Pathology; Oncology; Immunology; Internal medicine","score_opus":0.17864376716445324,"score_gpt":0.42121556766248697,"score_spread":0.24257180049803373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083244525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752035,0.002191177,3.0719477e-7,0.019243646,0.00006199597,0.00037349248,0.000010619645,0.000012791286,0.0029024463],"genre_scores_gemma":[0.9988074,0.0001928247,0.000050646893,0.0005215449,0.000112191374,0.00020097758,0.0000026289551,0.000015283733,0.00009655456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880135,0.000083553714,0.00026372552,0.00018359812,0.00042332287,0.00024445972],"domain_scores_gemma":[0.9990879,0.00030213097,0.00005670423,0.00023843384,0.00020388662,0.00011091785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019779315,0.00008158212,0.0001984189,0.00008597062,0.000082477214,0.000015443085,0.00014937087,0.000019899013,0.00033653085],"category_scores_gemma":[0.00064632855,0.000054888435,0.000080715094,0.0005169115,0.00021418942,0.00005741758,0.00011131285,0.00052812166,0.000016730783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090907124,0.0002489724,0.88258785,0.00026850888,0.000064214546,0.00007347006,0.002933459,0.000025977268,0.10031124,0.0005751643,0.0025917757,0.010228452],"study_design_scores_gemma":[0.0009815593,0.00005751139,0.8781246,0.0010590239,0.000014678427,0.000007716473,0.0022184048,0.000084806095,0.1155466,0.00015861238,0.0016880456,0.000058423964],"about_ca_topic_score_codex":0.003460336,"about_ca_topic_score_gemma":0.0004889002,"teacher_disagreement_score":0.023603823,"about_ca_system_score_codex":0.00020051836,"about_ca_system_score_gemma":0.00029426155,"threshold_uncertainty_score":0.5231016},"labels":[],"label_agreement":null},{"id":"W3083249075","doi":"10.1158/1538-7445.am2020-lb-079","title":"Abstract LB-079: Microbubble mediated focused ultrasound therapy enhances the antitumor potency and durability of anti-PD-L1 checkpoint blockade","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Blockade; Paclitaxel; Immune checkpoint; Immunotherapy; Cancer research; Toxicity; Breast cancer; Triple-negative breast cancer; Cancer; Pharmacology; Internal medicine; Receptor","score_opus":0.05455394360473243,"score_gpt":0.3141290801629285,"score_spread":0.2595751365581961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083249075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912861,0.004745284,0.000047977486,0.0024833353,0.000045045093,0.0004886068,0.00010225977,0.000089956564,0.0007114484],"genre_scores_gemma":[0.9914942,0.0080345925,0.000077157594,0.000052175124,0.0001478596,0.00012735139,0.000008881935,0.0000325047,0.000025318706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867845,0.000057532627,0.00028405394,0.00028353307,0.0003241627,0.0003722497],"domain_scores_gemma":[0.9988629,0.0004886074,0.000038902992,0.00031791397,0.00015335888,0.00013831221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042691556,0.00014904997,0.00024110102,0.000049736213,0.00019105998,0.0000659221,0.00037079467,0.00007670446,0.00043610347],"category_scores_gemma":[0.00013887665,0.00010594793,0.000060231145,0.0005081546,0.00039090068,0.00009717195,0.000031873074,0.00045710788,0.000028802624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025900823,0.000036787234,0.002235402,0.00011784852,0.000056178742,0.0000011644341,0.0011677771,0.000102233054,0.99439216,0.000027339238,0.00036713545,0.0014700966],"study_design_scores_gemma":[0.0005424028,0.000055371776,0.09723387,0.000039407576,0.0000090719805,0.0000036361935,0.00038990757,0.00020591947,0.89086103,0.00022947631,0.010242561,0.00018735224],"about_ca_topic_score_codex":0.0004040342,"about_ca_topic_score_gemma":0.000082347906,"teacher_disagreement_score":0.103531115,"about_ca_system_score_codex":0.000044446442,"about_ca_system_score_gemma":0.000113147085,"threshold_uncertainty_score":0.4775027},"labels":[],"label_agreement":null},{"id":"W3083253396","doi":"10.1158/1538-7445.am2020-lb-258","title":"Abstract LB-258: Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score &amp;lt;1, 1-19, and ≥20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Proportional hazards model; Population; Cetuximab; Oncology; Progression-free survival; Post-hoc analysis; Head and neck cancer; Confidence interval; Subgroup analysis; Urology; Overall survival; Gastroenterology; Nuclear medicine; Cancer; Immunotherapy","score_opus":0.08650490551771019,"score_gpt":0.37831657496832594,"score_spread":0.29181166945061576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083253396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636846,0.03010942,0.00001905635,0.004429528,0.0000401395,0.001203709,0.00037167064,0.000019679752,0.00012220151],"genre_scores_gemma":[0.9942867,0.004741659,0.00008696903,0.00025984473,0.000055288845,0.00009540212,0.00019850844,0.000042135525,0.00023348877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970906,0.00021502395,0.00062380993,0.00075746846,0.0007076423,0.0006054946],"domain_scores_gemma":[0.99799716,0.00073211076,0.00015794687,0.00035975841,0.00024488568,0.00050810544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065968465,0.00031711537,0.0009054442,0.00050230656,0.00016514552,0.0000619431,0.00017500325,0.00012273075,0.0003304756],"category_scores_gemma":[0.00025620358,0.00025964525,0.00014407223,0.001734486,0.0005538968,0.000108527885,0.00014436447,0.0006276289,0.0000025102458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28682724,0.0031418903,0.44196817,0.009281895,0.0024912837,0.0006297133,0.015713004,0.00008764121,0.19465983,0.000025737772,0.012096503,0.03307708],"study_design_scores_gemma":[0.05150313,0.007863675,0.9139217,0.0006996754,0.0010976485,0.000033250966,0.00075367215,0.001686093,0.017596437,0.000032933112,0.00415404,0.0006577356],"about_ca_topic_score_codex":0.006450509,"about_ca_topic_score_gemma":0.006104924,"teacher_disagreement_score":0.4719535,"about_ca_system_score_codex":0.00030025156,"about_ca_system_score_gemma":0.00036470033,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W3083266489","doi":"10.1158/1538-7445.am2020-6528","title":"Abstract 6528: Anti-PD-1 induces the endocytosis of the co-receptor from the surface of T-cells: Nivolumab is more effective than Pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Internalization; Endocytosis; Nivolumab; Pembrolizumab; Cell biology; Receptor; Cancer research; Biology; Chemistry; Molecular biology; Immunotherapy; Immune system; Immunology; Biochemistry","score_opus":0.06894999887386426,"score_gpt":0.38273960844279653,"score_spread":0.31378960956893226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083266489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690669,0.007201962,0.0000011994703,0.020677421,0.00020082704,0.0014464431,0.0007554627,0.000014801134,0.00063497043],"genre_scores_gemma":[0.9964902,0.0020555863,0.0000068526506,0.0008539062,0.00028606303,0.0000862541,0.000011056736,0.000033910637,0.0001762169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973857,0.00038829184,0.00033802254,0.0003586494,0.0011373945,0.0003919683],"domain_scores_gemma":[0.9976092,0.0010789223,0.00018686577,0.0007092948,0.00032237222,0.000093354705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007475314,0.00018514103,0.00039446395,0.00003480667,0.00027091656,0.000034320346,0.00084115815,0.000114944116,0.0013927951],"category_scores_gemma":[0.00015215672,0.00008756627,0.00028474018,0.0007921964,0.0012001308,0.00006354881,0.00016321888,0.0008187305,0.000028868804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00375627,0.00008634788,0.012213981,0.00015930951,0.00058830495,0.0000022898955,0.009232719,0.00001234501,0.92035306,0.0000044929507,0.047677543,0.0059133274],"study_design_scores_gemma":[0.0023036909,0.0002641326,0.1445977,0.0003274246,0.000057142082,0.0000011292933,0.003532432,0.000020801233,0.8370313,0.000007909535,0.011766778,0.0000895475],"about_ca_topic_score_codex":0.015248394,"about_ca_topic_score_gemma":0.00012987078,"teacher_disagreement_score":0.1323837,"about_ca_system_score_codex":0.00019966839,"about_ca_system_score_gemma":0.000673001,"threshold_uncertainty_score":0.99952006},"labels":[],"label_agreement":null},{"id":"W3083272402","doi":"10.1158/1538-7445.am2020-1968","title":"Abstract 1968: Early on-treatment genomic instability level in cell free DNA as a predictive and prognostic marker in metastatic breast cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Liquid biopsy; Cancer; Genome instability; Cell-free fetal DNA; Clinical trial; Cohort; Chemotherapy; Biopsy; DNA; Biology","score_opus":0.04822272783659429,"score_gpt":0.3281204859413821,"score_spread":0.2798977581047878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083272402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941952,0.0014291242,0.0000025596657,0.0007464808,0.000064549946,0.0010962139,0.0020589542,0.0000043648624,0.00040254148],"genre_scores_gemma":[0.99662364,0.0022235953,0.000025674932,0.00020927837,0.00011775452,0.0006599604,0.000057360674,0.000034444503,0.00004830582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981794,0.00011500606,0.00027556534,0.0006664684,0.00027579378,0.00048779298],"domain_scores_gemma":[0.9991129,0.00013029025,0.00005626066,0.00030607608,0.0001567391,0.00023773566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024152554,0.00021086368,0.00023752205,0.000101593716,0.000059954797,0.00005075521,0.00023999109,0.00009392343,0.00008887564],"category_scores_gemma":[0.00023753023,0.00019232911,0.000048024503,0.00022877616,0.00015749566,0.000008569401,0.00025644846,0.00026587766,0.000011193668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032753814,0.00092010165,0.9153135,0.00019285895,0.00009626442,0.000043460364,0.001271891,0.000579008,0.068988055,0.000013883408,0.00079712365,0.008508513],"study_design_scores_gemma":[0.0030746986,0.0013060545,0.98034966,0.00006463369,0.000014152831,7.2288776e-7,0.00013161315,0.000069071364,0.013683205,0.000106684114,0.0009955503,0.00020394231],"about_ca_topic_score_codex":0.008020289,"about_ca_topic_score_gemma":0.005976239,"teacher_disagreement_score":0.065036215,"about_ca_system_score_codex":0.0005307939,"about_ca_system_score_gemma":0.00086062436,"threshold_uncertainty_score":0.9985854},"labels":[],"label_agreement":null},{"id":"W3083277479","doi":"10.1158/1538-7445.am2020-6472","title":"Abstract 6472: Clonal lineage and somatic hypermutation analysis of chronic lymphocytic leukemia by long-amplicon IGH chain sequencing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Sanger sequencing; Biology; Somatic hypermutation; Amplicon; Genetics; IGHV@; Gene; DNA sequencing; Molecular biology; Multiplex ligation-dependent probe amplification; Multiplex; Immunoglobulin heavy chain; Polymerase chain reaction; Chronic lymphocytic leukemia; Antibody; B cell; Exon; Leukemia","score_opus":0.053324087669243216,"score_gpt":0.36568904103399097,"score_spread":0.31236495336474773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083277479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521273,0.0029310891,0.00091475627,0.0002503093,0.000015363412,0.00032948883,0.000090162546,0.00000977231,0.00024634105],"genre_scores_gemma":[0.9981998,0.00087139755,0.000039495655,0.000080558944,0.00015280457,0.00007805065,0.000290024,0.000020218675,0.000267643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828637,0.00012486354,0.00027590088,0.00042599143,0.0005202879,0.0003665823],"domain_scores_gemma":[0.99914384,0.000060218154,0.00007461051,0.00024022031,0.00027042037,0.00021069458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000525413,0.00012245665,0.00022758551,0.00019318293,0.00011584028,0.000049999726,0.00021052561,0.00013557066,0.0002791251],"category_scores_gemma":[0.00024324202,0.00011827691,0.00008475295,0.00077747647,0.00019086551,0.00001014556,0.00013053208,0.00022180277,0.0000112559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011202296,0.000008479064,0.0014910229,0.00023277226,0.00021467287,0.0000054845827,0.0001422307,0.004864338,0.9893168,0.000017779164,0.00046108192,0.0031333012],"study_design_scores_gemma":[0.0010614727,0.00035304588,0.009054144,0.000049446986,0.00006762052,0.0000028269917,0.00015462072,0.0665168,0.9211635,0.000013549192,0.0013677068,0.00019528928],"about_ca_topic_score_codex":0.000969774,"about_ca_topic_score_gemma":0.00036038164,"teacher_disagreement_score":0.06815334,"about_ca_system_score_codex":0.0009241292,"about_ca_system_score_gemma":0.0018875625,"threshold_uncertainty_score":0.48231924},"labels":[],"label_agreement":null},{"id":"W3083285942","doi":"10.1158/1538-7445.am2020-4069","title":"Abstract 4069: Selective ablation of solid tumors using a p53-targeted FAST-LNP gene therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer research; Programmed cell death; Tumor suppressor gene; Biology; Viability assay; Apoptosis; Transcription factor; PI3K/AKT/mTOR pathway; Cancer; Gene; Carcinogenesis; Genetics","score_opus":0.09255436987757736,"score_gpt":0.42391369066114404,"score_spread":0.33135932078356667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083285942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950693,0.0035655168,0.0001302135,0.00025211184,0.000028546903,0.0004710713,0.00018254454,0.0000090635585,0.00029158668],"genre_scores_gemma":[0.99777466,0.0014301199,0.00011014799,0.000074958545,0.00032319498,0.00009055779,0.00008690301,0.000032327378,0.00007713163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833536,0.000110655135,0.00019434364,0.00040934005,0.00047579315,0.00047450984],"domain_scores_gemma":[0.99902004,0.000019793712,0.000067153494,0.00021908243,0.00046206726,0.00021188977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023909286,0.00013103973,0.00018148636,0.00008672241,0.00012771571,0.00002264467,0.00021893732,0.00009131958,0.00015054208],"category_scores_gemma":[0.00009357488,0.00012036804,0.0000839815,0.00042415125,0.00015028068,0.000009295343,0.00010200945,0.0002306652,0.000010448309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009617784,0.00006963814,0.00266089,0.000032730437,0.00017483038,0.000010841202,0.00024587434,0.00047553756,0.9885877,0.0000029627472,0.000938088,0.0058391267],"study_design_scores_gemma":[0.0010460932,0.00057981105,0.007054269,0.000021854326,0.00000415652,0.0000020800196,0.000077892444,0.000248571,0.98936117,0.000042151456,0.0014511159,0.0001108635],"about_ca_topic_score_codex":0.0016365205,"about_ca_topic_score_gemma":0.00015440832,"teacher_disagreement_score":0.0057282634,"about_ca_system_score_codex":0.00013454082,"about_ca_system_score_gemma":0.00078092737,"threshold_uncertainty_score":0.4908466},"labels":[],"label_agreement":null},{"id":"W3083288058","doi":"10.1158/1538-7445.am2020-34","title":"Abstract 34: Predictors of discordance between image-based and manual scoring of immunohistochemical stains in ovarian cancer tissue microarrays","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tissue microarray; Immunohistochemistry; Medicine; Pathology; Stain; Ovarian cancer; Pathological; Cancer; Staining; Internal medicine","score_opus":0.06864075886924989,"score_gpt":0.41343063580473555,"score_spread":0.3447898769354857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083288058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902,0.004478562,0.000029672543,0.0049339053,0.000057697558,0.00074572937,0.00033386826,0.000011115183,0.00038948364],"genre_scores_gemma":[0.9980868,0.0008570794,0.0003899201,0.000048136117,0.00027089077,0.00025512124,0.000025502393,0.00003322685,0.00003330452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981098,0.000057948466,0.00043965917,0.00044031988,0.0005376214,0.0004146295],"domain_scores_gemma":[0.9989847,0.00018211866,0.00010893775,0.00027956255,0.00019371677,0.00025097962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003225986,0.00016410707,0.00052856776,0.00017073295,0.00004440645,0.000014235493,0.00016414808,0.00008622049,0.00027339708],"category_scores_gemma":[0.00009442445,0.00014795223,0.000058809554,0.00048589366,0.00042066074,0.000071679526,0.0000916336,0.000455832,0.0000022942183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007335992,0.00016196488,0.46117783,0.0012135516,0.0001333296,0.000068873625,0.0007175048,0.000019560011,0.53099614,0.000040009738,0.0004928964,0.00424474],"study_design_scores_gemma":[0.002768295,0.00042334976,0.47205687,0.0009743548,0.00005522238,7.3697026e-7,0.0002044689,0.00001317055,0.5226371,0.000011958724,0.0007508495,0.00010357851],"about_ca_topic_score_codex":0.0061494866,"about_ca_topic_score_gemma":0.00015852062,"teacher_disagreement_score":0.010879038,"about_ca_system_score_codex":0.00045396847,"about_ca_system_score_gemma":0.0008619557,"threshold_uncertainty_score":0.92962253},"labels":[],"label_agreement":null},{"id":"W3083291269","doi":"10.1158/1538-7445.am2020-2206","title":"Abstract 2206: Degradation of hyaluronan in the tumor microenvironment enhances oncolytic reovirus and anti-PD-L1 therapy in a murine syngeneic breast tumor model","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Tumor microenvironment; Oncolytic virus; Cancer research; Immunotherapy; Cytotoxic T cell; CD8; Medicine; Immune system; Combination therapy; Immune checkpoint; Cancer immunotherapy; Immunology; Chemistry; Internal medicine; In vitro","score_opus":0.055249925882906774,"score_gpt":0.36047762468686206,"score_spread":0.3052276988039553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083291269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928988,0.0052339616,0.000006895814,0.001026884,0.0000089518235,0.0006145061,0.00009804269,0.0000021940964,0.00010972886],"genre_scores_gemma":[0.99434066,0.0050195367,0.000035333374,0.00018154971,0.000060061328,0.0002702391,0.00003258491,0.000017404229,0.00004265637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846274,0.00013918935,0.00021522924,0.00040206988,0.0003956929,0.00038509353],"domain_scores_gemma":[0.9995328,0.000030827436,0.000050770286,0.00024169924,0.000041838397,0.00010201698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004318897,0.00012904496,0.00016986091,0.00008527852,0.000058267324,0.000029618644,0.00028049466,0.00003770389,0.000036749407],"category_scores_gemma":[0.00003182556,0.00009633898,0.000039124494,0.00023861823,0.0002021989,0.000010772191,0.0001128718,0.00022884109,0.0000038930175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000923629,0.00022942039,0.011364865,0.00008019546,0.000032309734,0.00003741282,0.00025589258,0.00036918293,0.9729102,0.0000056657555,0.00019964934,0.013591539],"study_design_scores_gemma":[0.003042086,0.0011168346,0.19443578,0.000108372056,0.0000059554964,0.00001962124,0.0003941393,0.0005611069,0.7990242,0.00006111878,0.0010289953,0.00020174879],"about_ca_topic_score_codex":0.0021541037,"about_ca_topic_score_gemma":0.0016924172,"teacher_disagreement_score":0.18307091,"about_ca_system_score_codex":0.00010240446,"about_ca_system_score_gemma":0.0003092664,"threshold_uncertainty_score":0.39285898},"labels":[],"label_agreement":null},{"id":"W3083298312","doi":"10.1158/1538-7445.am2020-3211","title":"Abstract 3211: Evolution of the CIViC knowledgebase for community driven curation of clinical variants in cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Data curation; Annotation; Interoperability; World Wide Web; Computer science; Digital curation; Bottleneck; Data science; Artificial intelligence","score_opus":0.18442790462321274,"score_gpt":0.47563897931398846,"score_spread":0.29121107469077573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083298312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632573,0.001574272,0.00030158364,0.00070092035,0.00018475542,0.00043426894,0.00026890347,0.0000013489904,0.00020822897],"genre_scores_gemma":[0.9984229,0.000983356,0.000049444214,0.00006598859,0.00030659957,0.00011336876,0.000020958945,0.000011324221,0.000026026208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989655,0.0002206891,0.00034132408,0.00016203838,0.00014375187,0.00016666844],"domain_scores_gemma":[0.9989446,0.00020161038,0.0001180887,0.00028264173,0.0003916743,0.00006142946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008492295,0.000060900424,0.00015830804,0.000028858707,0.000073353425,0.0000062386275,0.0003110703,0.000107554224,0.000030571064],"category_scores_gemma":[0.001171551,0.000051680378,0.00008713787,0.0002011045,0.00017956037,0.0000042360903,0.00018061405,0.00029300316,8.165193e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080945826,0.00029197102,0.08556379,0.00037067718,0.00005689417,3.4386628e-7,0.00047583305,0.002012543,0.89324033,0.00038650804,0.008671304,0.008120354],"study_design_scores_gemma":[0.0035497588,0.0009758711,0.58719707,0.00030699972,0.000033463748,3.228843e-7,0.0006375252,0.0033022284,0.3858019,0.0008886295,0.017070815,0.00023541681],"about_ca_topic_score_codex":0.0022276428,"about_ca_topic_score_gemma":0.009101872,"teacher_disagreement_score":0.5074384,"about_ca_system_score_codex":0.000075582255,"about_ca_system_score_gemma":0.0010232204,"threshold_uncertainty_score":0.50790584},"labels":[],"label_agreement":null},{"id":"W3083302085","doi":"10.1158/1538-7445.am2020-5724","title":"Abstract 5724: Revelation of shared transcriptional gradients in glioblastoma tumors and cultured glioma stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Glioma; Transcriptome; Stem cell; Cancer research; Biology; Glioblastoma; Cancer stem cell; Brain tumor; Neurosphere; Astrocyte; Pathology; Cellular differentiation; Neuroscience; Medicine; Gene; Cell biology; Genetics; Gene expression; Adult stem cell; Central nervous system","score_opus":0.04492883170594925,"score_gpt":0.32661048118575103,"score_spread":0.2816816494798018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083302085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977696,0.001477568,0.000032887598,0.00025087118,0.00002502236,0.00026884806,0.000120170065,0.0000039888064,0.000051044815],"genre_scores_gemma":[0.9996222,0.00009045757,0.000052253163,0.000020117917,0.00008429579,0.000035272344,0.000039512903,0.000012206361,0.000043677985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990426,0.000067508176,0.00018778216,0.0002752343,0.00024934008,0.00017757506],"domain_scores_gemma":[0.99958706,0.000008672885,0.000045143777,0.00010525032,0.0001472213,0.00010664122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018216539,0.00007618899,0.00009781614,0.00007325206,0.000035434517,0.000015645495,0.00011170293,0.000083437204,0.000060409686],"category_scores_gemma":[0.000021110898,0.00007698659,0.00003461543,0.00024605595,0.00008715518,0.000009093319,0.00004119071,0.000104779094,0.0000035693054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039250107,0.000027371405,0.0013694984,0.00013542057,0.000014757343,0.00000485876,0.00025354497,0.00018008168,0.99613756,0.000030475925,0.00086887745,0.0005850565],"study_design_scores_gemma":[0.00071629946,0.00012457422,0.07973611,0.00007736661,0.000003494415,0.0000015737236,0.000098840974,0.00015060563,0.9178001,0.000031298674,0.0011707265,0.00008900533],"about_ca_topic_score_codex":0.000041204054,"about_ca_topic_score_gemma":0.00005418841,"teacher_disagreement_score":0.078366615,"about_ca_system_score_codex":0.000039839742,"about_ca_system_score_gemma":0.00011035486,"threshold_uncertainty_score":0.3139422},"labels":[],"label_agreement":null},{"id":"W3083311387","doi":"10.1158/1538-7445.am2020-5425","title":"Abstract 5425: Novel molecular subtypes identified in prostate cancer: Results from the SPARTAN study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Gene signature; Medicine; Oncology; Internal medicine; Cancer; Androgen deprivation therapy; Prostate; Hormonal therapy; Gene expression; Biology; Gene; Genetics","score_opus":0.15897740021073345,"score_gpt":0.4424666324182094,"score_spread":0.2834892322074759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083311387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521474,0.0064381515,0.0000016961461,0.03675398,0.0001394684,0.0029956324,0.0005499464,0.000049046008,0.0009246693],"genre_scores_gemma":[0.9944203,0.0023327412,0.000014121733,0.0004630857,0.0004162403,0.0009373096,0.00010763247,0.00005598246,0.0012525787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960136,0.00020871412,0.00047953674,0.00087497965,0.0015397903,0.0008833972],"domain_scores_gemma":[0.99807245,0.0003898408,0.00007464036,0.00063239294,0.00043809778,0.0003926012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012617718,0.00023299703,0.000404216,0.00015153411,0.00022411029,0.0001530263,0.0004963752,0.00008013086,0.00039236486],"category_scores_gemma":[0.00046490887,0.00015297197,0.00008754266,0.0013392221,0.00029365337,0.00013054522,0.00026382957,0.0012767788,0.00011216419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03008369,0.0019922678,0.4014424,0.000326095,0.0010156587,0.003484658,0.028317088,0.0004062243,0.49300942,0.000085596526,0.022379339,0.017457576],"study_design_scores_gemma":[0.028710986,0.0013222131,0.8272572,0.00082890963,0.00012209431,0.0000030733843,0.009573151,0.00025063613,0.11340872,0.00020362061,0.01783627,0.00048308566],"about_ca_topic_score_codex":0.02546844,"about_ca_topic_score_gemma":0.0059933737,"teacher_disagreement_score":0.42581484,"about_ca_system_score_codex":0.00048141196,"about_ca_system_score_gemma":0.0012829145,"threshold_uncertainty_score":0.98102105},"labels":[],"label_agreement":null},{"id":"W3083312313","doi":"10.1158/1538-7445.am2020-507","title":"Abstract 507: Repurposing of FDA approved drugs for treatment of metastatic HNSCC","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Repurposing; Medicine; Malignancy; Cancer; Metastasis; Disease; Drug repositioning; Drug discovery; Cancer research; Drug; Oncology; Bioinformatics; Internal medicine; Pharmacology; Biology","score_opus":0.1097385413920946,"score_gpt":0.40790241230853935,"score_spread":0.29816387091644475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083312313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902534,0.007117048,0.0003765465,0.0006382551,0.000067060006,0.00065911823,0.00036549254,0.0000029885766,0.0005201237],"genre_scores_gemma":[0.9955105,0.0030134255,0.00081455114,0.00006365217,0.00021626326,0.00018512593,0.00006531115,0.000022149958,0.000109019034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991061,0.000025814483,0.00022353067,0.0002617056,0.00015888666,0.00022395902],"domain_scores_gemma":[0.99922025,0.00010014715,0.00008284713,0.00023375609,0.00026442308,0.00009855319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017726672,0.00008762473,0.00020413964,0.000035309356,0.00004070169,0.000011172676,0.00014225,0.00004502827,0.000026033365],"category_scores_gemma":[0.00016970947,0.0000801144,0.00010852612,0.00011048967,0.000109249966,0.0000018245107,0.000052281157,0.00003499877,0.0000010801812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005825885,0.00010342953,0.0001700261,0.00023502568,0.000121212404,0.0000011014965,0.0004690242,0.0002482289,0.9755529,0.00012123403,0.002327493,0.020067716],"study_design_scores_gemma":[0.0011644522,0.0010822807,0.00014562737,0.000021514845,0.000025360156,3.104087e-7,0.00027771477,0.00010211378,0.9207073,0.00010089479,0.07629242,0.00008002645],"about_ca_topic_score_codex":0.00036298973,"about_ca_topic_score_gemma":0.00005815146,"teacher_disagreement_score":0.07396492,"about_ca_system_score_codex":0.0000503137,"about_ca_system_score_gemma":0.0003885465,"threshold_uncertainty_score":0.32669702},"labels":[],"label_agreement":null},{"id":"W3083327241","doi":"10.1158/1538-7445.am2020-4344","title":"Abstract 4344: Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Clinical trial; Population; Cancer; Family medicine; Internal medicine; Oncology; Environmental health","score_opus":0.4936007258666017,"score_gpt":0.6107604516564021,"score_spread":0.11715972578980044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083327241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97366667,0.007604178,0.00016338582,0.014268397,0.0007097892,0.00090407656,0.0023435075,0.000008393376,0.000331612],"genre_scores_gemma":[0.9890077,0.0053407485,0.000043529733,0.0022955055,0.0025443665,0.00053962215,0.000084899104,0.000026737933,0.000116871044],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689007,0.00067624485,0.0007576758,0.00057075254,0.0007020891,0.00040319606],"domain_scores_gemma":[0.9976132,0.0007980242,0.00018432792,0.00022586653,0.0008363722,0.00034224635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030433347,0.00017177199,0.00049069856,0.000049370392,0.00018255253,0.000064029766,0.0006094608,0.00013297361,0.0003798247],"category_scores_gemma":[0.003237005,0.00013584553,0.00018919396,0.00034965648,0.0006391528,0.000009242485,0.00034696565,0.0004165574,0.000012356312],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005717429,0.00017170192,0.010020544,0.00008954273,0.0004809662,0.0000041517073,0.0004927699,0.0062446245,0.7449305,0.0002786584,0.21882254,0.012746555],"study_design_scores_gemma":[0.002713869,0.00018084422,0.014986187,0.00007136691,0.00005767064,7.142014e-7,0.00024206743,0.0004009074,0.377451,0.00006746841,0.60355014,0.00027777647],"about_ca_topic_score_codex":0.0020006625,"about_ca_topic_score_gemma":0.0011793259,"teacher_disagreement_score":0.3847276,"about_ca_system_score_codex":0.00011640653,"about_ca_system_score_gemma":0.0014997076,"threshold_uncertainty_score":0.553962},"labels":[],"label_agreement":null},{"id":"W3083337094","doi":"10.1158/1538-7445.am2020-4652","title":"Abstract 4652: Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Odds ratio; KRAS; Colorectal cancer; Internal medicine; Quartile; Confidence interval; Medicine; Oncology; Microsatellite instability; Cancer; Biology; Genetics; Allele; Microsatellite; Gene","score_opus":0.029702988723565808,"score_gpt":0.3392967148064809,"score_spread":0.3095937260829151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083337094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782143,0.0207949,0.000032290267,0.00023486423,0.000017092863,0.00023161143,0.0003702849,0.000003255595,0.00010138742],"genre_scores_gemma":[0.9921762,0.0073297704,0.0001803064,0.00008240016,0.00008934988,0.00006012306,0.00004123183,0.000015794258,0.00002483179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988726,0.00008526712,0.00019831097,0.0003796127,0.00022918775,0.00023507001],"domain_scores_gemma":[0.9991959,0.000029405077,0.000063909705,0.00017263378,0.0002750773,0.00026309604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021451981,0.00010906554,0.0002446224,0.00011750291,0.000059389477,0.000017821361,0.00013407366,0.00008412234,0.0000780591],"category_scores_gemma":[0.00015383733,0.00010833262,0.00008304301,0.00041014684,0.00016628014,0.0000046293003,0.00017502537,0.00011492961,9.105495e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007167808,0.000042227774,0.1400241,0.00022072316,0.0007552675,0.000004241689,0.00016779598,0.00044127897,0.85415405,0.0000031791703,0.0003911949,0.0030791617],"study_design_scores_gemma":[0.00085450587,0.0004127762,0.2355574,0.00005665997,0.0005406173,4.928329e-7,0.00043034455,0.000111825866,0.76053673,0.000060949467,0.0012446669,0.00019304572],"about_ca_topic_score_codex":0.0014461416,"about_ca_topic_score_gemma":0.00052204076,"teacher_disagreement_score":0.095533304,"about_ca_system_score_codex":0.000016567177,"about_ca_system_score_gemma":0.00017794954,"threshold_uncertainty_score":0.4417676},"labels":[],"label_agreement":null},{"id":"W3083338392","doi":"10.1158/1538-7445.am2020-5089","title":"Abstract 5089: The origin and contribution of the tumor stroma in colorectal cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Stromal cell; Cancer research; Stroma; Mesenchyme; Biology; Colorectal cancer; Mesenchymal stem cell; Bone marrow; Tumor microenvironment; Cancer; Lineage (genetic); Tumor progression; Cell biology; Immunology; Gene; Immunohistochemistry; Genetics; Tumor cells","score_opus":0.08650820001402454,"score_gpt":0.41283971051250723,"score_spread":0.3263315104984827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083338392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791775,0.0047184015,0.0000012487492,0.014885025,0.00010062637,0.0006486386,0.00008356954,0.0000056366935,0.0003793649],"genre_scores_gemma":[0.998125,0.0010354554,0.0000044103053,0.00036140822,0.00022649932,0.00015829476,0.000002156336,0.000010239671,0.000076535835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988362,0.00008494092,0.00016799582,0.00018992629,0.0004420117,0.0002789146],"domain_scores_gemma":[0.999404,0.0001232125,0.000047275964,0.00012921587,0.00018796686,0.00010831581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050316664,0.00007209156,0.00019669486,0.000037805294,0.00008091896,0.000015785477,0.00013449583,0.000031903917,0.00050324545],"category_scores_gemma":[0.00018171684,0.00003934866,0.000048168524,0.00051214296,0.00028632267,0.000032511936,0.00008374754,0.00047800635,0.0000032516805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001645437,0.0000683339,0.19469611,0.00029691015,0.00008570791,0.000031193948,0.0011629816,0.000043196662,0.77902925,0.0004509525,0.0099421665,0.012547744],"study_design_scores_gemma":[0.002283949,0.00020311173,0.642636,0.00026501124,0.000038607835,0.0000059463573,0.000539115,0.000085754655,0.3092227,0.000053019103,0.04458808,0.00007867594],"about_ca_topic_score_codex":0.0056156237,"about_ca_topic_score_gemma":0.0029867527,"teacher_disagreement_score":0.46980655,"about_ca_system_score_codex":0.00021447433,"about_ca_system_score_gemma":0.00066407974,"threshold_uncertainty_score":0.848918},"labels":[],"label_agreement":null},{"id":"W3083339796","doi":"10.1158/1538-7445.am2020-5393","title":"Abstract 5393: Association of heat shock proteins as chaperone for STING: A potential link in a key immune activation mechanism revealed by the novel anti-cancer agent PV-10","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Sting; Immune system; Western blot; THP1 cell line; Cytokine; Heat shock protein; Cancer research; Cell culture; Medicine; Biology; Chemistry; Molecular biology; Immunology; Biochemistry; Gene","score_opus":0.06485820800207646,"score_gpt":0.35635676419954304,"score_spread":0.29149855619746656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083339796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780415,0.0025937175,0.0006401056,0.016355695,0.00021658749,0.00181841,0.000193477,0.00002446927,0.00011598049],"genre_scores_gemma":[0.99209344,0.00068173965,0.000017175324,0.00022822095,0.0001033661,0.0008133961,0.000086227956,0.000028603063,0.0059478558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981623,0.0003426592,0.0004387656,0.00033300713,0.00018127685,0.0005419852],"domain_scores_gemma":[0.99887186,0.00030487534,0.00017145289,0.00020463245,0.0004189576,0.00002821649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013001292,0.0001548927,0.00033175354,0.00012363392,0.0002419707,0.000031295287,0.00036224525,0.00028141736,0.0012298719],"category_scores_gemma":[0.0008399784,0.00012308104,0.000110236986,0.00030304719,0.00010580349,0.000112480084,0.00013476935,0.0007120316,0.000058599824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027489297,0.00014483936,0.00004768709,0.00010161881,0.000173488,5.2270997e-7,0.00123456,0.00004568267,0.9903608,0.00019817801,0.00287017,0.002073556],"study_design_scores_gemma":[0.0026453773,0.0005251858,0.0026320387,0.00018484966,0.000015085883,0.0000012857597,0.0004908109,0.00011188532,0.9782546,0.000043150172,0.014963737,0.00013198184],"about_ca_topic_score_codex":0.001848184,"about_ca_topic_score_gemma":0.000054785756,"teacher_disagreement_score":0.016127475,"about_ca_system_score_codex":0.00043513475,"about_ca_system_score_gemma":0.0003897179,"threshold_uncertainty_score":0.99968314},"labels":[],"label_agreement":null},{"id":"W3083341879","doi":"10.1158/1538-7445.am2020-6316","title":"Abstract 6316: High throughput small molecule screening with synthetic 3D lung-mimetic hydrogels in the rare lung cancer lymphangioleiomyomatosis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Canada; Ottawa Hospital","funders":"","keywords":"Lymphangioleiomyomatosis; Cancer research; mTORC1; Viability assay; Cytotoxicity; Cell culture; Lung cancer; Cancer cell; Cell; Biology; Cancer; Cell biology; Pathology; Medicine; Biochemistry; Tuberous sclerosis; Internal medicine; Protein kinase B; Signal transduction; In vitro","score_opus":0.11743911137573275,"score_gpt":0.3836898054415954,"score_spread":0.26625069406586266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083341879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95631516,0.009852073,0.00045162716,0.028813355,0.000046649842,0.0024997257,0.00007345363,0.00011792125,0.0018300167],"genre_scores_gemma":[0.9939769,0.00069087534,0.00065342744,0.0020119168,0.00044056732,0.0018440086,0.000026188467,0.0001479328,0.00020818411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936666,0.00062294456,0.0005023905,0.0010814404,0.0024180503,0.0017085789],"domain_scores_gemma":[0.9969907,0.0008475309,0.00009375695,0.0009995804,0.0005183426,0.00055008003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015351896,0.00040110532,0.00066097395,0.00042214486,0.00040660356,0.00022651353,0.0011188119,0.00017851833,0.0017514216],"category_scores_gemma":[0.00037530487,0.00027753005,0.0001533745,0.0027588778,0.0005801243,0.00017260612,0.0003958685,0.0013737709,0.00008343891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009324488,0.0018919286,0.46526408,0.009903476,0.002896167,0.005955254,0.028732114,0.008646564,0.3430223,0.0011685976,0.06702697,0.056168053],"study_design_scores_gemma":[0.028959678,0.0035413671,0.6191772,0.021029262,0.001095791,0.00045925588,0.009502023,0.06502307,0.23431975,0.00014710899,0.013181866,0.003563588],"about_ca_topic_score_codex":0.009918288,"about_ca_topic_score_gemma":0.0008769455,"teacher_disagreement_score":0.15391314,"about_ca_system_score_codex":0.0007817974,"about_ca_system_score_gemma":0.0011302112,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W3083344415","doi":"10.1158/1538-7445.am2020-2307","title":"Abstract 2307: Clinicopathological analysis of oral lichenoid mucositis with dysplasia","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Occupational Cancer Research Centre; University of British Columbia","funders":"","keywords":"Medicine; Pathology; Dysplasia; Mucositis; Leukoplakia; Epithelial dysplasia; Atypia; Cancer; Lesion; Internal medicine; Radiation therapy","score_opus":0.23402247859959951,"score_gpt":0.5071119109104687,"score_spread":0.2730894323108692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083344415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955107,0.0007433098,0.000043489443,0.0017623757,0.00006897981,0.0002702526,0.00019465455,0.000041577412,0.0013646715],"genre_scores_gemma":[0.9986853,0.00016704424,0.00031369354,0.0003475392,0.000078608544,0.000103760955,0.000044388406,0.000015464555,0.0002441875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978462,0.0003133692,0.00034777544,0.00047586646,0.000530552,0.00048622573],"domain_scores_gemma":[0.9987955,0.00025543646,0.00010062158,0.0003140067,0.00025341226,0.0002810122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007025231,0.00012943294,0.0004795196,0.00018823,0.0001499798,0.000019122184,0.0002593813,0.00017696925,0.0024930753],"category_scores_gemma":[0.00010715722,0.000094939656,0.00012236004,0.001506503,0.00036257115,0.00006418097,0.00010187571,0.0006548945,0.0003888165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002174337,0.00048191106,0.9695181,0.00025039364,0.0008817211,0.0044547967,0.00079511356,0.0002440879,0.00360676,0.0004897145,0.0039089536,0.0131940935],"study_design_scores_gemma":[0.0009879818,0.0009629729,0.99225974,0.00003099515,0.00033888905,0.000013241805,0.00017397449,0.00009520829,0.0034025032,0.000046613462,0.0015693026,0.0001186042],"about_ca_topic_score_codex":0.0005369476,"about_ca_topic_score_gemma":0.0010306777,"teacher_disagreement_score":0.022741595,"about_ca_system_score_codex":0.000101603924,"about_ca_system_score_gemma":0.00022619384,"threshold_uncertainty_score":0.9984188},"labels":[],"label_agreement":null},{"id":"W3083362003","doi":"10.1158/1538-7445.am2020-ct289","title":"Abstract CT289: Pembrolizumab plus lenvatinib vs docetaxel in patients with previously treated metastatic non-small-cell lung cancer (NSCLC) and PD after platinum-doublet chemotherapy and immunotherapy: Phase 3, randomized, open-label LEAP-008 trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Docetaxel; Internal medicine; Oncology; Chemotherapy; Tolerability; Lung cancer; Cancer; Immunotherapy; Adverse effect; Thyroid cancer","score_opus":0.060631510661958425,"score_gpt":0.38275793540181857,"score_spread":0.32212642473986014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083362003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688058,0.016293997,0.00002346512,0.002159724,0.00008600656,0.012055108,0.00014574567,0.000036506077,0.00039362934],"genre_scores_gemma":[0.980024,0.012937393,0.00023224174,0.001678786,0.00018716857,0.003971965,0.000070636735,0.00015274542,0.0007450974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99591774,0.00040368355,0.0008957514,0.0010047979,0.0008525448,0.0009255075],"domain_scores_gemma":[0.9981234,0.00038067927,0.00029088336,0.00047228046,0.00034183025,0.0003909026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015314958,0.00055124174,0.0016434412,0.00030597716,0.00020590627,0.00031706158,0.0003902322,0.00016880147,0.0012147685],"category_scores_gemma":[0.000066771354,0.00040061076,0.000110781926,0.00086184,0.00059094426,0.00037106764,0.00014085532,0.00086152676,0.000004624862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9556159,0.0010882276,0.006118136,0.00078702014,0.0010180507,0.00007164347,0.0045900103,0.0000048663833,0.0060703787,0.000001489878,0.0009711385,0.023663176],"study_design_scores_gemma":[0.9827843,0.003925844,0.0062349723,0.0010825539,0.00021319624,0.0000047051226,0.00017333675,0.0005951933,0.0031915877,0.0000047694734,0.0012940022,0.0004955624],"about_ca_topic_score_codex":0.0060487953,"about_ca_topic_score_gemma":0.0004707068,"teacher_disagreement_score":0.027168415,"about_ca_system_score_codex":0.0005283102,"about_ca_system_score_gemma":0.0014304587,"threshold_uncertainty_score":0.99984455},"labels":[],"label_agreement":null},{"id":"W3083368494","doi":"10.1158/1538-7445.am2020-5413","title":"Abstract 5413: Terry Fox PRecision Oncology For Young peopLE (PROFYLE): A Canadian precision medicine program for children, adolescents and young adults with hard-to-treat cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of Ottawa; McGill University Health Centre; Izaak Walton Killam Health Centre; University of Alberta; University of Calgary; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University; BC Children's Hospital; University of Toronto; BC Cancer Agency; SickKids Foundation; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Precision medicine; Medicine; Cancer; Oncology; Personalized medicine; Internal medicine; Family medicine; Bioinformatics; Pathology","score_opus":0.031540717433492876,"score_gpt":0.3667420782877112,"score_spread":0.33520136085421837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083368494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840843,0.004391606,0.0003413477,0.0040560854,0.0002724468,0.005617324,0.0010280026,0.000016788323,0.00019206338],"genre_scores_gemma":[0.98999757,0.0029801165,0.0007068042,0.0005062501,0.0010809898,0.0041334364,0.00035442202,0.000075355005,0.00016503276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976657,0.00004166857,0.00028583387,0.0008909049,0.0003224589,0.0007934341],"domain_scores_gemma":[0.99815667,0.00007594057,0.00008042399,0.00031993614,0.00065180176,0.00071521575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040266901,0.00024624306,0.00033497004,0.00013875379,0.00029321757,0.00007185673,0.00033893512,0.0002306468,0.00003929044],"category_scores_gemma":[0.00045094296,0.00020550776,0.00006405341,0.0002601612,0.00013681142,0.000009947266,0.0001499453,0.0002316023,0.000002592551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014812071,0.00026308096,0.14736243,0.0009794176,0.00021098313,0.000011490757,0.0032410058,0.00019884993,0.11363995,0.000018187608,0.13930902,0.57995355],"study_design_scores_gemma":[0.017525304,0.018711293,0.6913763,0.0020232585,0.00021347648,0.000036882466,0.0011505474,0.00060329464,0.051403735,0.00008386734,0.21562131,0.0012506844],"about_ca_topic_score_codex":0.07813386,"about_ca_topic_score_gemma":0.47716644,"teacher_disagreement_score":0.57870287,"about_ca_system_score_codex":0.00033005307,"about_ca_system_score_gemma":0.0012845573,"threshold_uncertainty_score":0.9280049},"labels":[],"label_agreement":null},{"id":"W3083376441","doi":"10.1158/1538-7445.am2020-1008","title":"Abstract 1008: Characterizing the post-translational regulation of programmed death-ligand 1 (PD-L1) in triple-negative breast cancer: Role of EphA3/Fes/Fer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Receptor tyrosine kinase; Cancer research; Triple-negative breast cancer; Immune checkpoint; Immunotherapy; Kinase; Cancer immunotherapy; PD-L1; Cancer; Immune system; Tyrosine kinase; Biology; Downregulation and upregulation; Cancer cell; Breast cancer; Cell biology; Signal transduction; Immunology; Biochemistry; Gene","score_opus":0.07469745203307526,"score_gpt":0.37562422982766425,"score_spread":0.300926777794589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083376441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96734,0.0018303491,0.000002441262,0.028698906,0.00005306972,0.0013388935,0.00024687732,0.00001600361,0.0004734741],"genre_scores_gemma":[0.9979702,0.00071476836,0.00005268055,0.00028247244,0.00030021573,0.0005511382,0.000045349152,0.000031378066,0.000051758412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99761754,0.00012948016,0.00051837997,0.00035819458,0.0009614425,0.00041493645],"domain_scores_gemma":[0.9983821,0.00018134761,0.00016627478,0.00022402163,0.0008853182,0.0001609727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065876805,0.00015644074,0.00040854627,0.00016877883,0.00009315936,0.000024207195,0.00021435134,0.00010814371,0.00078010524],"category_scores_gemma":[0.00011056701,0.00011522126,0.00012352204,0.0008794925,0.00025921382,0.00017053708,0.00004971458,0.0005219384,0.000004382352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042446177,0.00022203132,0.22365564,0.0005374635,0.00015644755,0.0000035899122,0.0058091762,0.000039114457,0.6786441,0.00022142967,0.00024244834,0.08622392],"study_design_scores_gemma":[0.0015579106,0.00019329958,0.77542573,0.0004446079,0.00003265326,0.0000025561267,0.00072583725,0.00025242675,0.22037803,0.000077356635,0.0008211517,0.00008844058],"about_ca_topic_score_codex":0.0046285703,"about_ca_topic_score_gemma":0.0005398829,"teacher_disagreement_score":0.5517701,"about_ca_system_score_codex":0.00018208724,"about_ca_system_score_gemma":0.00088433997,"threshold_uncertainty_score":0.85416055},"labels":[],"label_agreement":null},{"id":"W3083383019","doi":"10.1158/1538-7445.am2020-1766","title":"Abstract 1766: Targeting epigenetic regulation in clear cell renal cell carcinoma reveals PRMT1 as a novel target","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Epigenetics; Biology; Clear cell renal cell carcinoma; Cell growth; Cancer research; Viability assay; Cell; Cancer; Genetics; Gene; Renal cell carcinoma; Medicine; Internal medicine","score_opus":0.037638057430025504,"score_gpt":0.3254346745756286,"score_spread":0.28779661714560306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083383019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907133,0.0044328975,0.00050431374,0.0011400105,0.000115282426,0.0006528415,0.000037743048,0.000017138571,0.0023864745],"genre_scores_gemma":[0.9965551,0.00030714087,0.000648357,0.00013860891,0.0009622349,0.000107809334,0.00019284373,0.00006857297,0.0010193675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997438,0.00016038009,0.00043351983,0.00076809217,0.0005499027,0.000650066],"domain_scores_gemma":[0.9989334,0.000035225403,0.0001344561,0.00036495147,0.00028614065,0.00024584067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007253443,0.00020595752,0.00021048776,0.00014019212,0.0001410109,0.000053502074,0.0003224328,0.000304571,0.00037118015],"category_scores_gemma":[0.00016147499,0.00022961499,0.00009369215,0.0005667638,0.00011087111,0.00001338486,0.00019283257,0.00048629206,0.00007930263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043127855,0.000057047077,0.0020449746,0.00014044326,0.00000940709,0.0000058297337,0.0002756253,0.011607329,0.9774261,0.000007903635,0.007462946,0.0005310788],"study_design_scores_gemma":[0.0011533659,0.0003780099,0.024971537,0.000042861495,0.000006823905,0.00000164985,0.00012324082,0.0011409575,0.9523638,0.00009040354,0.01945687,0.00027050293],"about_ca_topic_score_codex":0.00048966135,"about_ca_topic_score_gemma":0.00007871722,"teacher_disagreement_score":0.02506236,"about_ca_system_score_codex":0.00021595051,"about_ca_system_score_gemma":0.00056647975,"threshold_uncertainty_score":0.9363428},"labels":[],"label_agreement":null},{"id":"W3083386940","doi":"10.1158/1538-7445.am2020-896","title":"Abstract 896: Enhanced sensitivity detection of replication competent lentivirus by qPCR","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Lentivirus; Amplicon; Retrovirus; Vesicular stomatitis virus; Biology; Virology; Genetic enhancement; Plasmid; Chimeric antigen receptor; Virus; Gene; Computational biology; Polymerase chain reaction; Genetics; Cancer; Viral disease","score_opus":0.06549577759062106,"score_gpt":0.3892408387869539,"score_spread":0.32374506119633284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083386940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957308,0.0013175914,0.001131291,0.0008223299,0.0000386178,0.0004019339,0.00008071838,0.000014520341,0.00046215314],"genre_scores_gemma":[0.9982543,0.0010345563,0.000015586724,0.00013112352,0.00021525961,0.00010714317,0.0000671552,0.000027987076,0.00014688414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805737,0.00029538845,0.00020088289,0.0005718028,0.0005125943,0.0003619928],"domain_scores_gemma":[0.99874926,0.00004306059,0.00006984126,0.0005554033,0.00042784482,0.00015458102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010279679,0.00011014222,0.00014781208,0.00005485961,0.00011218166,0.00002187162,0.00020772761,0.00011659053,0.00008232749],"category_scores_gemma":[0.00023069413,0.00011399892,0.000074030846,0.00030631517,0.00019410164,0.0000063910697,0.00013290232,0.00030227232,0.0000354083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019464999,0.00005469843,0.00009667537,0.000054294786,0.00004484409,0.000001319576,0.000056500645,0.00006218378,0.95115256,0.00000191489,0.0013343127,0.045194197],"study_design_scores_gemma":[0.00042633,0.0010379247,0.0007692749,0.000013266606,0.0000029856494,6.101213e-7,0.000049662085,0.000094660674,0.9909122,0.000009895907,0.006577647,0.000105537954],"about_ca_topic_score_codex":0.00023735646,"about_ca_topic_score_gemma":0.0003555084,"teacher_disagreement_score":0.04508866,"about_ca_system_score_codex":0.0000695544,"about_ca_system_score_gemma":0.00020181401,"threshold_uncertainty_score":0.4648741},"labels":[],"label_agreement":null},{"id":"W3083401631","doi":"10.1158/1538-7445.am2020-3233","title":"Abstract 3233: Reduced inflammatory cytokine production by CAR-modified Th1/Tc1-polarized T-Rapa cells is not sufficient to reduce monocyte-driven production of IL-6","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytokine; Immunology; Biology; Chimeric antigen receptor; T cell; Interleukin 12; Interleukin 21; Cancer research; Cytotoxic T cell; Immune system; In vitro","score_opus":0.10256261673285785,"score_gpt":0.3899393690030996,"score_spread":0.28737675227024173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083401631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95359135,0.00041826445,0.000015201423,0.04016238,0.0005880656,0.0040705386,0.00010889667,0.000121053075,0.0009242425],"genre_scores_gemma":[0.98813915,0.00078011333,0.00011613798,0.00043673927,0.0016577278,0.0005648031,0.000053196665,0.00013170006,0.008120438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938073,0.0003547822,0.00083250954,0.0014713204,0.0024259135,0.001108146],"domain_scores_gemma":[0.99534935,0.00011991313,0.00019582175,0.001231406,0.002276354,0.00082713016],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002024559,0.00036407844,0.0007376212,0.0006260842,0.0002587648,0.000079848425,0.00051784894,0.00024715494,0.0010994859],"category_scores_gemma":[0.0010784132,0.00034891133,0.0002124655,0.002004544,0.0004591732,0.00022179961,0.0002729085,0.0015775876,0.00015977472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008158417,0.00031667363,0.00015232437,0.00076747034,0.0001696407,0.000021208745,0.0042620623,0.00038128797,0.89617634,0.000010161648,0.08519019,0.0043942393],"study_design_scores_gemma":[0.0017024161,0.00078602805,0.0013695862,0.0002482268,0.000039034112,0.000008645474,0.0007520408,0.00017892105,0.9557223,0.000008706761,0.038902298,0.0002818076],"about_ca_topic_score_codex":0.0009994173,"about_ca_topic_score_gemma":0.000027774477,"teacher_disagreement_score":0.059545964,"about_ca_system_score_codex":0.0011414398,"about_ca_system_score_gemma":0.0014123799,"threshold_uncertainty_score":0.9998963},"labels":[],"label_agreement":null},{"id":"W3083404349","doi":"10.1158/1538-7445.am2020-4623","title":"Abstract 4623: External validation of the BOADICEA model for predicting ovarian cancer risk: The Breast Cancer Family Registry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Ovarian cancer; Breast cancer; Medicine; Cancer registry; Cohort; Cancer; Oncology; Family history; Prospective cohort study; Gynecology; Cohort study; Internal medicine","score_opus":0.07384159484820926,"score_gpt":0.3827778595031088,"score_spread":0.30893626465489954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083404349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782384,0.0045118,0.0040475377,0.009324663,0.0003633159,0.0008919805,0.0022734215,0.000012320235,0.00033656138],"genre_scores_gemma":[0.99417317,0.0020298813,0.0002164964,0.000544578,0.0013670571,0.0011603975,0.000020783376,0.000047244983,0.00044040888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981257,0.00013552672,0.0003050947,0.00048299445,0.0005373815,0.0004133442],"domain_scores_gemma":[0.9983852,0.00006743481,0.00024090557,0.0005622078,0.0006398426,0.00010444038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070845574,0.00015472848,0.00014741272,0.000030079776,0.00042831857,0.000059516322,0.00081428204,0.00015174867,0.00007691247],"category_scores_gemma":[0.00019416733,0.00010727632,0.00013804172,0.0003101424,0.00032314454,0.000012778292,0.00024084462,0.00045968711,0.000001566624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051274424,0.000029852199,0.026053382,0.00017203928,0.0001986958,4.361848e-7,0.00094342267,0.11675648,0.8121832,0.00004897172,0.030223647,0.012877137],"study_design_scores_gemma":[0.0023261055,0.0001305823,0.10553986,0.00041680416,0.00019140847,0.000007976811,0.0011426116,0.062468316,0.8093049,0.0006778459,0.017277308,0.000516287],"about_ca_topic_score_codex":0.0027599533,"about_ca_topic_score_gemma":0.00053228025,"teacher_disagreement_score":0.079486474,"about_ca_system_score_codex":0.00026134704,"about_ca_system_score_gemma":0.0021214208,"threshold_uncertainty_score":0.43746012},"labels":[],"label_agreement":null},{"id":"W3083419119","doi":"10.1158/1538-7445.am2020-1869","title":"Abstract 1869: Methylation signatures associated with T790M status in progressive NSCLC","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"T790M; Medicine; DNA methylation; Oncology; Methylation; Internal medicine; Bioinformatics; Cancer; Biology; Genetics; DNA; Adenocarcinoma; Gene; Gene expression","score_opus":0.07790474931393125,"score_gpt":0.4618267536533595,"score_spread":0.38392200433942825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083419119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98034877,0.0051273284,0.000011859982,0.0067478223,0.000038291233,0.0012569333,0.00007448126,0.000058229314,0.006336304],"genre_scores_gemma":[0.9985059,0.00014384865,0.000073649986,0.00029427718,0.00012030347,0.0003874636,0.00013214041,0.000026875341,0.00031552647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842983,0.00007738935,0.00014717971,0.00029409918,0.00061665283,0.00043484799],"domain_scores_gemma":[0.9990539,0.00015332388,0.000052336196,0.0001219439,0.0003777057,0.00024079875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019818058,0.00010370535,0.0001908926,0.0001396312,0.00009105213,0.000037371105,0.0000641735,0.00008205572,0.00053667167],"category_scores_gemma":[0.0003119053,0.00007469842,0.00002985315,0.00081673526,0.00009902114,0.000108346365,0.000023358489,0.0005207699,0.000019620418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009115902,0.0024045126,0.5459195,0.0011247509,0.0033234525,0.0036153411,0.03873403,0.0028298276,0.09580019,0.001325087,0.034665357,0.2611421],"study_design_scores_gemma":[0.008340369,0.0013330483,0.9669453,0.0010051326,0.00013607749,0.0000018043835,0.0015021465,0.00037412887,0.013479373,0.00019449623,0.0064342055,0.0002539419],"about_ca_topic_score_codex":0.0006999506,"about_ca_topic_score_gemma":0.00038140462,"teacher_disagreement_score":0.4210258,"about_ca_system_score_codex":0.0006688055,"about_ca_system_score_gemma":0.0011001629,"threshold_uncertainty_score":0.5876178},"labels":[],"label_agreement":null},{"id":"W3083420153","doi":"10.1158/1538-7445.am2020-5833","title":"Abstract 5833: Senescence is a central response to chemotherapy in ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Espace pour la vie; Université de Montréal","funders":"","keywords":"Senescence; Chemotherapy; Context (archaeology); Cancer research; Medicine; Cancer; DNA damage; Carboplatin; Ovarian cancer; Biology; Oncology; Internal medicine; Cisplatin; Genetics","score_opus":0.06116905777116554,"score_gpt":0.4193508444882746,"score_spread":0.35818178671710904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083420153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97221106,0.0017225681,0.000037988873,0.024856754,0.000060798557,0.0006409953,0.00018640983,0.000009671967,0.00027374088],"genre_scores_gemma":[0.9937543,0.001966373,0.000057384415,0.002627278,0.00041431017,0.00046413016,0.000016188562,0.00003913135,0.00066089636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975258,0.00016049792,0.00017929375,0.0006646473,0.00053074746,0.0009390004],"domain_scores_gemma":[0.99884397,0.000029917865,0.00002380944,0.00034749453,0.00016513419,0.0005896921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000429297,0.00016407108,0.0001700245,0.00011271175,0.000098391094,0.00006617121,0.00041370065,0.000112733294,0.0010122084],"category_scores_gemma":[0.00015638245,0.00015807302,0.00006858982,0.0006377761,0.00010349172,0.000008136042,0.00017576115,0.00031935278,0.00007049662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087180305,0.000078433965,0.01703753,0.000039415234,0.000057335987,0.00006268637,0.0007817281,0.00005601885,0.9395998,0.0000039100973,0.024433622,0.0091314865],"study_design_scores_gemma":[0.0023174533,0.00047250508,0.11291248,0.000077662284,0.0000024528802,0.0000016355523,0.00012364639,0.000019618989,0.74544644,0.000017428803,0.1383817,0.00022692648],"about_ca_topic_score_codex":0.0059310887,"about_ca_topic_score_gemma":0.0025954342,"teacher_disagreement_score":0.19415332,"about_ca_system_score_codex":0.00028872106,"about_ca_system_score_gemma":0.0011105937,"threshold_uncertainty_score":0.999901},"labels":[],"label_agreement":null},{"id":"W3083422982","doi":"10.1158/1538-7445.am2020-3935","title":"Abstract 3935: Runt related transcription factor-1 (runx1) plays a central role in vessel co-option of colorectal cancer liver metastases","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University Health Centre; McGill University","funders":"","keywords":"RUNX1; Colorectal cancer; Angiogenesis; Metastasis; Cancer research; Transcription factor; Liver cancer; Medicine; Cancer; Cancer cell; Transforming growth factor; Gene knockdown; Transforming growth factor beta; Pathology; Internal medicine; Biology; Cell culture","score_opus":0.05653761840472124,"score_gpt":0.3865931099863259,"score_spread":0.33005549158160463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083422982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912674,0.0037567115,0.0000440756,0.003700446,0.000104686915,0.0005239725,0.000111877765,0.000034725,0.00045613773],"genre_scores_gemma":[0.9961482,0.0032167349,0.00008255265,0.00016488715,0.00015792431,0.0000817751,0.0000640345,0.000032036958,0.000051824783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978538,0.00015892346,0.00038243877,0.0003499867,0.00072699715,0.0005278487],"domain_scores_gemma":[0.9992016,0.000121665376,0.00007915353,0.000112484726,0.00014613781,0.0003389424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005263446,0.00014042131,0.00037725075,0.00020215403,0.000073140945,0.000023972032,0.0001465225,0.00011540486,0.0013970841],"category_scores_gemma":[0.00028151917,0.00012407146,0.00009549567,0.0004929048,0.00022297255,0.00012925148,0.000026336122,0.0012473756,0.000015332675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011517714,0.00017517571,0.03723481,0.00048338692,0.00012223974,0.000122030775,0.005637259,0.0013045574,0.9344667,0.00010730734,0.0013008093,0.017893905],"study_design_scores_gemma":[0.0052184165,0.0005930328,0.7894245,0.00087265304,0.00009003141,0.000014719379,0.0011093583,0.03182433,0.1595111,0.00006439524,0.010986444,0.0002910292],"about_ca_topic_score_codex":0.0047963345,"about_ca_topic_score_gemma":0.00011545531,"teacher_disagreement_score":0.77495563,"about_ca_system_score_codex":0.00036693682,"about_ca_system_score_gemma":0.00049377506,"threshold_uncertainty_score":0.9995158},"labels":[],"label_agreement":null},{"id":"W3083440288","doi":"10.1158/1538-7445.am2020-ct272","title":"Abstract CT272: Phase 2 study of dianhydrogalactitol (VAL-083) in patients with MGMT-unmethylated, bevacizumab-naïve glioblastoma in the recurrent or adjuvant setting","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Phases of clinical research; Cancer; Radiation therapy; Cancer research; Clinical trial; Chemotherapy","score_opus":0.07203583874636765,"score_gpt":0.4184064016721624,"score_spread":0.34637056292579477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083440288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946121,0.0003693117,1.9522535e-7,0.001912475,0.000045478366,0.0028656689,0.000043800137,0.000013615254,0.00013735927],"genre_scores_gemma":[0.9990355,0.00012392543,0.000011556545,0.000073992014,0.0000704679,0.00063305366,0.000016337794,0.00003048569,0.0000046783275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969673,0.0002949,0.00045256922,0.00047644207,0.0012799738,0.0005287853],"domain_scores_gemma":[0.9986639,0.00039360177,0.000114499286,0.00038701782,0.0002446293,0.00019636228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006787267,0.00020125664,0.0004424333,0.00036548902,0.00008206907,0.000033324686,0.00023681881,0.000063972635,0.00021506408],"category_scores_gemma":[0.00030916388,0.00011326104,0.000050064504,0.001574314,0.00008715008,0.000105027815,0.00008849134,0.00073050964,0.000022017583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018032499,0.016407875,0.8594048,0.000340584,0.0002395219,0.0018894298,0.019202735,0.00012712763,0.00088039436,0.0000030948956,0.0010007255,0.08247122],"study_design_scores_gemma":[0.044932734,0.020119382,0.9157222,0.0009210402,0.00008921733,0.0000040950144,0.009095221,0.00015318445,0.008102305,0.000004525144,0.0006495804,0.00020651701],"about_ca_topic_score_codex":0.0016226831,"about_ca_topic_score_gemma":0.002727978,"teacher_disagreement_score":0.0822647,"about_ca_system_score_codex":0.00037489808,"about_ca_system_score_gemma":0.00031329982,"threshold_uncertainty_score":0.46186513},"labels":[],"label_agreement":null},{"id":"W3083440507","doi":"10.1158/1538-7445.am2020-1887","title":"Abstract 1887: Tumor-stroma interactions mediated by Semaphorin 6A as a determinant of drug resistance in BRAF-mut melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Semaphorin; Melanoma; Cancer research; Stroma; RHOA; Cell culture; Actin cytoskeleton; Biology; Cell; Cell biology; Cytoskeleton; Signal transduction; Immunology; Receptor; Genetics","score_opus":0.09261882626044156,"score_gpt":0.3887582903634843,"score_spread":0.29613946410304276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083440507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924975,0.00061703165,0.000005070643,0.0039806166,0.000112623755,0.00036332503,0.00013209805,0.000037736292,0.0022539785],"genre_scores_gemma":[0.9979364,0.00034824625,0.000019656438,0.0006641682,0.00009669313,0.0001400819,0.0000039986253,0.000034458095,0.00075628527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697757,0.00033114586,0.00049236236,0.0006703669,0.00090227515,0.0006262761],"domain_scores_gemma":[0.9980392,0.0011636532,0.0001500658,0.00027384335,0.000114613926,0.00025861646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049349904,0.00017069212,0.00030516612,0.00018728632,0.00016097448,0.00005213367,0.00064158684,0.00004302656,0.00056713435],"category_scores_gemma":[0.001432984,0.00016505217,0.00007578283,0.0011578468,0.00026880408,0.00028037993,0.00017379955,0.0008880258,0.0001377597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043876056,0.00007259097,0.001317969,0.000111273424,0.000003746442,0.0003979819,0.0008335573,0.000010151711,0.98689437,0.000107139975,0.009468567,0.00034388748],"study_design_scores_gemma":[0.00053434557,0.00009726844,0.002360549,0.0002699954,0.0000026549928,0.000007107227,0.0002193471,0.000083781735,0.9692485,0.00013218819,0.026877912,0.00016638807],"about_ca_topic_score_codex":0.0007099873,"about_ca_topic_score_gemma":0.00083163707,"teacher_disagreement_score":0.017645912,"about_ca_system_score_codex":0.00017636524,"about_ca_system_score_gemma":0.0003791279,"threshold_uncertainty_score":0.6730632},"labels":[],"label_agreement":null},{"id":"W3083445513","doi":"10.1158/1538-7445.am2020-3491","title":"Abstract 3491: COX-2 inhibitor use and risk of skin cancer: three prospective cohort studies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Skin cancer; Internal medicine; Prospective cohort study; Cancer; Confidence interval; Oncology; Melanoma; Relative risk; Cohort; Basal cell carcinoma; Incidence (geometry); Basal cell; Cancer research","score_opus":0.08770271116284245,"score_gpt":0.37661962489656703,"score_spread":0.2889169137337246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083445513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867074,0.012013065,0.000014442955,0.000220455,0.000088760906,0.000495429,0.00024213128,0.0000073422184,0.00021099692],"genre_scores_gemma":[0.9820142,0.01700692,0.000060233375,0.000053719923,0.00049742975,0.00023379081,0.00001013015,0.000019370536,0.00010423721],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880207,0.00006793365,0.00016753783,0.00041236394,0.00027486586,0.00027524607],"domain_scores_gemma":[0.99908614,0.00005269176,0.00006811879,0.0002074792,0.00045041073,0.00013515048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285809,0.000117389725,0.00020998449,0.000033750086,0.00011159393,0.00002421983,0.00013821351,0.00009457063,0.000034126333],"category_scores_gemma":[0.00037415477,0.000099155695,0.000045707195,0.00014139223,0.00031531067,0.000007671342,0.00023456351,0.00023945508,0.0000038842168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002975097,0.00002532822,0.53364766,0.00014299055,0.00042787616,0.0000066900834,0.00037991808,0.000014747496,0.45512024,0.000052463118,0.007091369,0.002793219],"study_design_scores_gemma":[0.0006362605,0.00043020997,0.28039572,0.000056343666,0.0000382894,9.876454e-7,0.0002824136,0.00001582939,0.7072768,0.00009279761,0.010626124,0.00014822758],"about_ca_topic_score_codex":0.0014324064,"about_ca_topic_score_gemma":0.0017675381,"teacher_disagreement_score":0.25325194,"about_ca_system_score_codex":0.00004051867,"about_ca_system_score_gemma":0.00022461372,"threshold_uncertainty_score":0.40434518},"labels":[],"label_agreement":null},{"id":"W3083450039","doi":"10.1158/1538-7445.am2020-2910","title":"Abstract 2910: A novel Sortilin-targeted docetaxel peptide conjugate (TH1902), for the treatment of Sortilin-positive (SORT1+) triple-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Breast cancer; Docetaxel; Cancer; Medicine; Estrogen receptor; Tamoxifen; Gene silencing; Internal medicine; Oncology; Biology","score_opus":0.08099407502260804,"score_gpt":0.3754409065356007,"score_spread":0.29444683151299267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083450039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698975,0.007211458,0.00053019583,0.0044840984,0.00018331315,0.0031715997,0.0068111755,0.00002186733,0.00059654174],"genre_scores_gemma":[0.99186146,0.004028066,0.0001504604,0.00033508238,0.00081501825,0.001907783,0.00013496922,0.00005445941,0.0007127279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978168,0.00009848448,0.00039611716,0.00063989795,0.0004008296,0.0006478646],"domain_scores_gemma":[0.998212,0.0002169626,0.00017822895,0.00038135183,0.00076225697,0.00024920842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037158915,0.00027477022,0.00035285007,0.000052224706,0.00028267383,0.000043487897,0.00039529128,0.00016373426,0.00039539422],"category_scores_gemma":[0.00016698234,0.00019603116,0.00027173923,0.00026900944,0.0004252422,0.000010032215,0.00009310051,0.00023855534,0.00001109614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003713737,0.00028113165,0.0006379474,0.00012152788,0.0005360044,0.0000044319722,0.0012504543,0.0002349058,0.97902113,0.00005840155,0.00207843,0.012061912],"study_design_scores_gemma":[0.0030974522,0.0011748396,0.008201024,0.00005909152,0.00006190481,0.000003300362,0.0005256458,0.00039244234,0.97220904,0.000054305463,0.01398837,0.0002326177],"about_ca_topic_score_codex":0.0014179554,"about_ca_topic_score_gemma":0.0006528026,"teacher_disagreement_score":0.014871683,"about_ca_system_score_codex":0.000122061014,"about_ca_system_score_gemma":0.0008320188,"threshold_uncertainty_score":0.79939187},"labels":[],"label_agreement":null},{"id":"W3083451341","doi":"10.1158/1538-7445.am2020-5895","title":"Abstract 5895: Whole-genome characterization of lung adenocarcinomas lacking alterations in RTK/RAS/RAF/MAPK pathway","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of Toronto","funders":"","keywords":"KRAS; Biology; Cancer research; Oncogene; Transcriptome; Receptor tyrosine kinase; MAPK/ERK pathway; Gene; Genetics; Mutation; Kinase; Cell cycle; Gene expression","score_opus":0.09326818636019134,"score_gpt":0.4143546089192447,"score_spread":0.32108642255905334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083451341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879007,0.0009830269,0.00011067202,0.007586643,0.00008014423,0.00089956535,0.00030696302,0.000031177722,0.0021011147],"genre_scores_gemma":[0.9976145,0.00019920872,0.000060064984,0.00029384278,0.0003323745,0.0002591656,0.00047872524,0.000032334116,0.0007297969],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845916,0.00006482952,0.00033963393,0.00032794298,0.00046299238,0.00034541302],"domain_scores_gemma":[0.9991328,0.000058671125,0.00007481187,0.0002198576,0.00031521925,0.00019862318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022211713,0.000119466364,0.00025467182,0.00023768976,0.000114427596,0.00004018468,0.000116419666,0.000072419694,0.00053366914],"category_scores_gemma":[0.00007987889,0.00010961452,0.000057769637,0.00074152905,0.00008084649,0.00019456029,0.000051189516,0.0003514496,0.000042639975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019565939,0.00014998733,0.029338578,0.0004141871,0.000090228285,0.00006855316,0.005719029,0.00006940367,0.9607156,0.000328201,0.00017273382,0.0027378495],"study_design_scores_gemma":[0.0031041203,0.0003584634,0.925704,0.0005077445,0.00007249298,0.0000047516137,0.00067446416,0.0007022216,0.05338284,0.000051581635,0.015223881,0.00021345295],"about_ca_topic_score_codex":0.00043977177,"about_ca_topic_score_gemma":0.000096160074,"teacher_disagreement_score":0.9073327,"about_ca_system_score_codex":0.00042141665,"about_ca_system_score_gemma":0.00078506605,"threshold_uncertainty_score":0.5843303},"labels":[],"label_agreement":null},{"id":"W3083461068","doi":"10.1158/1538-7445.am2020-2034","title":"Abstract 2034: The young-onset colorectal cancer community speaks out about financial and emotional health","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Medicine; Colorectal cancer; Quarter (Canadian coin); Disease; Cancer; Young adult; Gerontology; Family medicine; Psychiatry; Internal medicine","score_opus":0.1736380524403509,"score_gpt":0.37835224995340305,"score_spread":0.20471419751305214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083461068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376113,0.01744108,0.000083161736,0.032910194,0.00072596414,0.00057599414,0.0020296134,0.000036992587,0.008585692],"genre_scores_gemma":[0.9860272,0.008502251,0.000025783513,0.0036291925,0.0010651412,0.0001833554,0.0000250487,0.00004004881,0.00050198776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978081,0.00012623034,0.00063784706,0.00047118092,0.00013709985,0.00081953296],"domain_scores_gemma":[0.9986247,0.0002181866,0.0002872026,0.0003213056,0.00014145947,0.00040718605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002169075,0.0002196811,0.0005268,0.00012712996,0.0011179139,0.00022455124,0.00063621625,0.00015243894,0.0014916144],"category_scores_gemma":[0.00054527924,0.00021006768,0.00010969201,0.00031304968,0.0006190477,0.00032209934,0.00027079193,0.001606376,0.00035480107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009985057,0.00031102516,0.44014373,0.0006789823,0.00026135685,0.00002031294,0.031544756,0.00031676368,0.00034003338,0.06497234,0.41909465,0.04131754],"study_design_scores_gemma":[0.00090322935,0.00024009089,0.8644227,0.00009979124,0.0000032187015,0.000004315171,0.0003782748,0.00021164193,0.00015300358,0.007845224,0.12539357,0.0003449632],"about_ca_topic_score_codex":0.019190036,"about_ca_topic_score_gemma":0.0087843565,"teacher_disagreement_score":0.42427894,"about_ca_system_score_codex":0.0006089878,"about_ca_system_score_gemma":0.00085030287,"threshold_uncertainty_score":0.9994212},"labels":[],"label_agreement":null},{"id":"W3083461696","doi":"10.1158/1538-7445.am2020-4163","title":"Abstract 4163: Clinical proteomics for patient stratification - a GCLP quantitative mass spectrometry workflow for multiplexed measurement of protein biomarkers in FFPE tissues","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Biomarker; Biomarker discovery; Quantitative proteomics; Proteomics; Selected reaction monitoring; Multiplex; Repeatability; Computational biology; Mass spectrometry; Chemistry; Biology; Chromatography; Bioinformatics; Tandem mass spectrometry; Biochemistry","score_opus":0.2425054858616976,"score_gpt":0.4720913003550647,"score_spread":0.2295858144933671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083461696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82171524,0.000979085,0.15912826,0.004114887,0.000031439933,0.012747245,0.000828721,0.000106545354,0.0003485644],"genre_scores_gemma":[0.64603233,0.000091889655,0.34275118,0.000010081843,0.00007011155,0.010954765,0.000043786833,0.000032079508,0.000013793883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780667,0.000049839593,0.0007321945,0.0005484058,0.0004728956,0.00039001493],"domain_scores_gemma":[0.9982497,0.00028685096,0.0002748429,0.00032592085,0.0007312007,0.0001314738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012025074,0.00015205996,0.00030349163,0.000099109275,0.00010209528,0.000032751504,0.00032746774,0.00015903384,0.00005397546],"category_scores_gemma":[0.0010753389,0.00015341923,0.000121973666,0.00042374505,0.00017309806,0.00008455687,0.0000474276,0.0003874838,0.0000020643404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660604,0.00018776536,0.0003526345,0.00066563446,0.0000673029,4.9962085e-7,0.00020665502,0.000060997034,0.98384446,0.0015195896,0.00023762473,0.011390805],"study_design_scores_gemma":[0.0009949597,0.00035880238,0.00011894433,0.00028213143,0.0000076190518,6.149937e-8,0.0004573469,0.0018915767,0.9868855,0.007192241,0.0016425686,0.00016823589],"about_ca_topic_score_codex":0.00009398194,"about_ca_topic_score_gemma":0.000061139384,"teacher_disagreement_score":0.18362293,"about_ca_system_score_codex":0.00035967794,"about_ca_system_score_gemma":0.0003449382,"threshold_uncertainty_score":0.62562543},"labels":[],"label_agreement":null},{"id":"W3083470695","doi":"10.1158/1538-7445.am2020-4550","title":"Abstract 4550: Increased IL-27 is associated with poor prognosis in renal cell carcinoma and supports use of SRF388, a first-in-class IL-27p28 blocking antibody, to counteract IL-27-mediated immunosuppression in this setting","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Glycoprotein 130; Cancer research; Cytokine; Antibody; Immune system; Biology; Immunology; Medicine; Interleukin 6","score_opus":0.04198249141507971,"score_gpt":0.3361593111368219,"score_spread":0.2941768197217422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083470695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903805,0.0010111112,5.891948e-7,0.006098086,0.000065291315,0.0017576679,0.0005006404,0.00002976189,0.00015630062],"genre_scores_gemma":[0.9979507,0.00068650465,0.000054849872,0.00068574125,0.00006711906,0.0001570377,0.00018201907,0.00007288661,0.00014319642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591887,0.00030179264,0.00085798744,0.0007962123,0.0011473922,0.0009777739],"domain_scores_gemma":[0.9978588,0.0008549291,0.00025913017,0.0003083859,0.00038965972,0.00032907302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015649273,0.000347741,0.00076851394,0.00078360725,0.00010542525,0.0000971886,0.0002540546,0.00026017643,0.00063966255],"category_scores_gemma":[0.0006355376,0.00029897355,0.00009412158,0.002107334,0.00019461485,0.0003090461,0.00018174158,0.0011125598,0.0000064589917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007845529,0.00031266696,0.5145766,0.0004398194,0.00007581439,0.00074173725,0.0042913537,0.000018273426,0.46684504,1.1328328e-7,0.0040037874,0.00084924226],"study_design_scores_gemma":[0.009137513,0.0012545238,0.7768126,0.005127238,0.000039570336,0.000015750022,0.0008022823,0.0012394873,0.20071235,0.0000011734924,0.0044577005,0.00039977045],"about_ca_topic_score_codex":0.030928966,"about_ca_topic_score_gemma":0.005283015,"teacher_disagreement_score":0.26613268,"about_ca_system_score_codex":0.0010218187,"about_ca_system_score_gemma":0.0010279266,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W3083471085","doi":"10.1158/1538-7445.am2020-5144","title":"Abstract 5144: Exploring the potential of a novel multiplex proteomics technology to identify personalized biomarkers of tumor burden in ovarian cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Multiplex; Personalized medicine; Medicine; Ovarian cancer; Oncology; Proteomics; Cancer; Serous carcinoma; Precision medicine; Bioinformatics; Serous fluid; Internal medicine; Multiplex polymerase chain reaction; Computational biology; Biology; Pathology; Polymerase chain reaction; Gene; Genetics","score_opus":0.09880996523975247,"score_gpt":0.4118981859577296,"score_spread":0.31308822071797715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083471085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370074,0.00010577418,0.0015695125,0.0031434812,0.000020171212,0.0010527822,0.0002830608,0.00003247831,0.000091989874],"genre_scores_gemma":[0.98906004,0.00013694486,0.006497879,0.000025896437,0.000082805316,0.0041273786,0.000008673436,0.00003396822,0.000026409994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998427,0.000015977563,0.00039965456,0.000376591,0.00041188582,0.00036893235],"domain_scores_gemma":[0.9989972,0.00005465845,0.00015204232,0.00033622255,0.00036271193,0.000097176344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024078536,0.00012845264,0.00023430963,0.00017119343,0.00009382283,0.000016618565,0.00069929165,0.0000840649,0.00020778507],"category_scores_gemma":[0.00022010205,0.00011279297,0.00006579791,0.0009194824,0.00027053937,0.00007895262,0.00032261896,0.0005071243,0.0000023347366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003387927,0.00008364517,0.0030493224,0.00022250567,0.000036345395,0.0000018027508,0.00054821756,0.00045918796,0.99256134,0.00018815485,0.000057544024,0.0024531218],"study_design_scores_gemma":[0.0012098878,0.00003432934,0.003386205,0.00025600867,0.000007406279,3.9350354e-7,0.0009715896,0.0005332314,0.99248254,0.00023897352,0.0007444967,0.0001349293],"about_ca_topic_score_codex":0.0027084013,"about_ca_topic_score_gemma":0.000087555134,"teacher_disagreement_score":0.0049283663,"about_ca_system_score_codex":0.00021297061,"about_ca_system_score_gemma":0.00021050127,"threshold_uncertainty_score":0.4599564},"labels":[],"label_agreement":null},{"id":"W3083497692","doi":"10.1158/1538-7445.am2020-3541","title":"Abstract 3541: Biallelic alterations in BRCA2, ATM, or CDK12 in metastatic prostate cancer via circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; BRCA2 Protein; Loss of heterozygosity; Genome instability; Biology; Mutation; Germline mutation; DNA repair; COLD-PCR; PARP inhibitor; Prostate cancer; Germline; Cancer; DNA damage; Somatic cell; Microsatellite instability; Genetics; Molecular biology; Point mutation; Poly ADP ribose polymerase; Gene; Allele; Polymerase; DNA; Microsatellite","score_opus":0.09412821861311031,"score_gpt":0.39848508716662356,"score_spread":0.30435686855351324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083497692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316835,0.0029051087,0.00005818381,0.002622977,0.00011266489,0.00068412285,0.00015806558,0.000007958665,0.00028259007],"genre_scores_gemma":[0.99580324,0.0019706208,0.00014980808,0.00080032955,0.00040368212,0.0006200186,0.00007156754,0.000043226064,0.00013749576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811214,0.00010078593,0.0003833587,0.0005444152,0.00028232104,0.00057695433],"domain_scores_gemma":[0.99922484,0.00009623814,0.00006904851,0.0002561232,0.00016177869,0.00019199551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042609108,0.00016510936,0.00022779431,0.00012337817,0.0001004779,0.00008654855,0.00025924575,0.00006276832,0.00028072402],"category_scores_gemma":[0.00041225745,0.00015827315,0.0000541072,0.0005659973,0.0001008653,0.000011225741,0.0001755723,0.00035897136,0.000018157112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006455088,0.00012427145,0.011192309,0.0002491082,0.00005858159,0.00020107417,0.0013301577,0.012827271,0.9599121,0.000055286004,0.0026221732,0.010782119],"study_design_scores_gemma":[0.013987025,0.0018412534,0.11984506,0.0011115683,0.00007678405,0.00004122087,0.0027528806,0.015582653,0.7203395,0.0010934613,0.12075676,0.002571871],"about_ca_topic_score_codex":0.005015435,"about_ca_topic_score_gemma":0.021501405,"teacher_disagreement_score":0.23957267,"about_ca_system_score_codex":0.00021153565,"about_ca_system_score_gemma":0.0012426733,"threshold_uncertainty_score":0.9963536},"labels":[],"label_agreement":null},{"id":"W3083498943","doi":"10.1158/1538-7445.am2020-ct150","title":"Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Rash; Cancer; Renal cell carcinoma; Lung cancer; Melanoma; Oncology; Gastroenterology; Immunotherapy; Cancer research","score_opus":0.0506028019822661,"score_gpt":0.3909846976816892,"score_spread":0.3403818956994231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083498943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513507,0.00030742493,4.8013385e-7,0.0012927458,0.00005429243,0.0027554536,0.000033923116,0.000027896107,0.00039268844],"genre_scores_gemma":[0.9990995,0.000079053934,0.0000070695714,0.00015730981,0.000072366,0.0003911224,0.000018486264,0.000053581796,0.00012149681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680924,0.00026975758,0.0005861698,0.0005518641,0.0011257688,0.0006571778],"domain_scores_gemma":[0.9986184,0.00011892446,0.00015561336,0.0005156009,0.00041616408,0.00017528253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057027227,0.00023704312,0.0005317881,0.00025170937,0.00026388225,0.000033064152,0.00043496565,0.000078578574,0.00032210542],"category_scores_gemma":[0.0001915914,0.00016426675,0.0000744403,0.0024295982,0.00030514132,0.000112642134,0.00010990112,0.0011732758,0.0000043309597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114469305,0.012560744,0.65085083,0.0013185289,0.00052409625,0.0003037173,0.02932851,0.0006562257,0.16758645,0.000008714531,0.0018224777,0.02057043],"study_design_scores_gemma":[0.06188169,0.008737002,0.9081069,0.00084319717,0.00002945342,0.0000027368499,0.0033562838,0.00007971215,0.015318777,0.000004089424,0.0013845913,0.00025552162],"about_ca_topic_score_codex":0.003674715,"about_ca_topic_score_gemma":0.00638533,"teacher_disagreement_score":0.25725615,"about_ca_system_score_codex":0.0006884276,"about_ca_system_score_gemma":0.0007780663,"threshold_uncertainty_score":0.66986036},"labels":[],"label_agreement":null},{"id":"W3083506489","doi":"10.1158/1538-7445.am2020-1621","title":"Abstract 1621: Contactin 1 (CNTN1) promotes prostate cancer tumorigenesis in transgenic models","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University","funders":"","keywords":"Tramp; Prostate cancer; Cancer research; Carcinogenesis; PTEN; Genetically modified mouse; Transgene; Cre recombinase; Metastasis; Cancer; Medicine; Biology; Internal medicine; Apoptosis; Genetics; Gene","score_opus":0.2011238224896096,"score_gpt":0.4413270813062213,"score_spread":0.24020325881661167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083506489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517217,0.013297075,0.0000061277583,0.02847626,0.000102804246,0.0027341149,0.00017051207,0.0000940555,0.0033973032],"genre_scores_gemma":[0.9844692,0.009725936,0.0000476904,0.00033142808,0.00040471257,0.0021626775,0.000042957516,0.00009065622,0.0027247916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959853,0.0001563966,0.00044514847,0.000835725,0.0012798787,0.0012975145],"domain_scores_gemma":[0.9982391,0.00015910085,0.00005645751,0.00035184145,0.00048416277,0.0007093336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007156948,0.00029027511,0.0005605489,0.000340785,0.00018770988,0.00008254328,0.00031962644,0.00015097848,0.0015938429],"category_scores_gemma":[0.00008767198,0.00023161333,0.0001441667,0.0014373974,0.00027837843,0.0003024906,0.000094411706,0.0012083711,0.000091431844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01904102,0.0012091646,0.087618396,0.004638495,0.00077733485,0.0019249154,0.015917914,0.00084228435,0.7536478,0.00041466719,0.012982434,0.10098559],"study_design_scores_gemma":[0.024233747,0.0026627819,0.08373029,0.002701299,0.00016788447,0.000019178084,0.0034358993,0.0042889155,0.8474507,0.0015006016,0.028506266,0.0013024323],"about_ca_topic_score_codex":0.0033380247,"about_ca_topic_score_gemma":0.0011043228,"teacher_disagreement_score":0.09968315,"about_ca_system_score_codex":0.000963788,"about_ca_system_score_gemma":0.0023500903,"threshold_uncertainty_score":0.99931884},"labels":[],"label_agreement":null},{"id":"W3083509257","doi":"10.1158/1538-7445.am2020-4375","title":"Abstract 4375: Inhibition of triple negative breast cancer cell progression using estrogen related receptor alpha endogenous ligands","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Estrogen receptor; Cancer research; Receptor; Agonist; Estrogen-related receptor alpha; Estrogen; Estrogen receptor alpha; Cancer; Endogeny; Internal medicine; Estrogen receptor beta; Endocrinology; Medicine; Biology; Pharmacology; Oncology","score_opus":0.05086883794200459,"score_gpt":0.3546389060941128,"score_spread":0.3037700681521082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083509257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373693,0.014388117,0.0000064052433,0.00036735626,0.00013357704,0.0006237216,0.00019981967,0.000018875548,0.00052522344],"genre_scores_gemma":[0.9949293,0.0042728614,0.00010169596,0.000039477844,0.000316413,0.00009515509,0.00009994962,0.00004923933,0.00009590259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982308,0.00012891203,0.00030226816,0.0004655251,0.00040679274,0.00046570945],"domain_scores_gemma":[0.99899626,0.000022742952,0.00015336898,0.0002103752,0.0003646901,0.00025256633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031473502,0.0001834503,0.00022199292,0.000054444365,0.00017787334,0.000024474039,0.00018260484,0.00032164782,0.00024328381],"category_scores_gemma":[0.000052133608,0.0001598705,0.000120823956,0.0004073377,0.00020752047,0.000015425205,0.00015102475,0.00043914147,0.000014529964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080364785,0.00010689933,0.00071349734,0.0001356563,0.00010647729,0.000016162816,0.0004198153,0.00014526039,0.9923311,0.000009982319,0.0012243026,0.0039871833],"study_design_scores_gemma":[0.0012915886,0.00045711326,0.00021866511,0.00017145253,0.00002564271,0.000012229089,0.0002153257,0.00013259053,0.9967032,0.000010392315,0.00059138227,0.0001704109],"about_ca_topic_score_codex":0.0006557633,"about_ca_topic_score_gemma":0.000011475258,"teacher_disagreement_score":0.011192401,"about_ca_system_score_codex":0.00012888646,"about_ca_system_score_gemma":0.000555365,"threshold_uncertainty_score":0.651933},"labels":[],"label_agreement":null},{"id":"W3083529479","doi":"10.1158/1538-7445.am2020-5853","title":"Abstract 5853: Identification of <i>TSC1</i> and <i>TSC2</i> as potential determinants of sensitivity to trastuzumab emtansine","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Genomics","funders":"","keywords":"Trastuzumab emtansine; CRISPR; Biology; Computational biology; Gene; Cas9; Trastuzumab; Genetics; Cancer; Breast cancer","score_opus":0.07742955374148075,"score_gpt":0.42380785332929677,"score_spread":0.346378299587816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083529479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043226,0.0006182868,0.000042078496,0.007654461,0.000048769012,0.0005416598,0.00016423076,0.000011237883,0.0004870082],"genre_scores_gemma":[0.99778503,0.0007792929,0.00006600556,0.00024590726,0.00021462982,0.000022440925,0.000011507789,0.000020647061,0.00085455674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763346,0.00012136549,0.00039482792,0.00037527367,0.0010847178,0.00039036755],"domain_scores_gemma":[0.9983756,0.00020394033,0.00008340713,0.00022334301,0.0006828218,0.0004308773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087905175,0.00012392848,0.0004047357,0.00016638316,0.00009242414,0.00001997327,0.00012513383,0.00007782689,0.00016801825],"category_scores_gemma":[0.000454404,0.000106783846,0.000080762286,0.00053484313,0.00035339504,0.00008008354,0.00017267544,0.0003944123,0.00003948516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021774713,0.00008462821,0.005768209,0.0010408381,0.00004150971,0.00020564541,0.0005529369,0.00001859321,0.96846735,0.000048035647,0.0020022818,0.019592484],"study_design_scores_gemma":[0.0007909618,0.0007526187,0.13917015,0.00025615378,0.000026727113,0.00005123863,0.0002632033,0.00049083197,0.8559625,0.00003853218,0.0020814494,0.00011559858],"about_ca_topic_score_codex":0.0015899435,"about_ca_topic_score_gemma":0.00012427113,"teacher_disagreement_score":0.13340195,"about_ca_system_score_codex":0.00004832659,"about_ca_system_score_gemma":0.0004878564,"threshold_uncertainty_score":0.4354519},"labels":[],"label_agreement":null},{"id":"W3083541285","doi":"10.1158/1538-7445.am2020-776","title":"Abstract 776: Androgen receptor (AR) and non-AR aberrations associated with outcomes in metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) plus androgen deprivation therapy (ADT) in TITAN","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Androgen receptor; Internal medicine; Progression-free survival; Medicine; Oncology; Urology; Proportional hazards model; LNCaP; Overall survival; Cancer","score_opus":0.08397157565865523,"score_gpt":0.37833558719738425,"score_spread":0.29436401153872904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083541285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989198,0.0012510129,0.0000051993047,0.0057217563,0.000017397246,0.0032071872,0.00028474958,0.000042283737,0.00027240068],"genre_scores_gemma":[0.994119,0.0032306812,0.00009874596,0.00018892527,0.000047854723,0.0013451058,0.00033890293,0.00006767851,0.00056310825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970318,0.00022417841,0.000402754,0.00067845517,0.0009171414,0.0007456365],"domain_scores_gemma":[0.9984381,0.00026353853,0.000120553465,0.00022876379,0.00060842425,0.0003405744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056555384,0.00031437282,0.0006358882,0.00042192146,0.0002013377,0.00010760452,0.00011176858,0.00011034776,0.00015383423],"category_scores_gemma":[0.00013751305,0.00021639938,0.000042265878,0.0016926815,0.00034731283,0.00034554713,0.000038584767,0.00070694875,0.000010298615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00746456,0.00037364507,0.94301885,0.0001830364,0.00089292653,0.0007092849,0.009111469,0.0005183808,0.03136291,0.000013158126,0.0003004857,0.0060512912],"study_design_scores_gemma":[0.023135345,0.0020763816,0.9178549,0.0009870606,0.00009526299,0.000013518187,0.0033427305,0.0015677924,0.050213177,0.000029741155,0.00022030978,0.00046377344],"about_ca_topic_score_codex":0.0052778036,"about_ca_topic_score_gemma":0.01326307,"teacher_disagreement_score":0.025163945,"about_ca_system_score_codex":0.0013037847,"about_ca_system_score_gemma":0.0018412261,"threshold_uncertainty_score":0.88245106},"labels":[],"label_agreement":null},{"id":"W3083557162","doi":"10.1158/1538-7445.am2020-1782","title":"Abstract 1782: N-myristoyltransferase proteins in breast cancer: Prognostic relevance and validation as a new drug target","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Immunohistochemistry; Cancer; Biology; Antibody; Cancer research; Apoptosis; Monoclonal antibody; Hazard ratio; Internal medicine; Oncology; Medicine; Immunology; Biochemistry","score_opus":0.03915082027005959,"score_gpt":0.3696220976885585,"score_spread":0.3304712774184989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083557162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561703,0.0017836445,0.0015507187,0.037445314,0.000012617207,0.0012946661,0.00032145166,0.00017188117,0.0012494023],"genre_scores_gemma":[0.98876625,0.0036484667,0.0038841122,0.00020016482,0.00028123477,0.0026403978,0.000032886004,0.00005042831,0.00049606775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983536,0.000024789388,0.00026279516,0.00055111555,0.00037549954,0.00043220163],"domain_scores_gemma":[0.99906963,0.00011285946,0.00005132651,0.00025356817,0.00014104143,0.00037159852],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019574292,0.0001609575,0.00018546032,0.000061743645,0.00015424217,0.00006962076,0.00028964164,0.00009482768,0.0009898443],"category_scores_gemma":[0.00015565217,0.00016757859,0.000032554526,0.0004627896,0.0001269323,0.00018317506,0.000074027346,0.0008031424,0.000020662386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003528508,0.000096715776,0.012079008,0.00069585926,0.000017674518,0.000026375797,0.001037739,0.0004122794,0.95430434,0.0008503032,0.0037221038,0.026404733],"study_design_scores_gemma":[0.0008720325,0.00003138922,0.0014731153,0.0005179673,0.000008331738,0.00000776022,0.00016364384,0.0002968272,0.9658053,0.009589409,0.020875024,0.00035922407],"about_ca_topic_score_codex":0.003858348,"about_ca_topic_score_gemma":0.000149861,"teacher_disagreement_score":0.03724515,"about_ca_system_score_codex":0.00025073718,"about_ca_system_score_gemma":0.0006759988,"threshold_uncertainty_score":0.9999234},"labels":[],"label_agreement":null},{"id":"W3083561833","doi":"10.1158/1538-7445.am2020-1644","title":"Abstract 1644: Detection and quantification of lymphedema using optical coherence tomography lymphangiography","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphatic system; Lymphedema; Medicine; Optical coherence tomography; Lymphatic vessel; Pathology; Lymphangiogenesis; Radiology; Cancer; Metastasis","score_opus":0.1017371641526965,"score_gpt":0.35851377035747267,"score_spread":0.25677660620477616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083561833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830002,0.0018497589,0.013359777,0.00016356993,0.000047808397,0.00043969598,0.000027422368,0.00015486611,0.0009568987],"genre_scores_gemma":[0.9982897,0.00029308556,0.0011430939,0.000012461972,0.00007262711,0.0001582062,0.0000029298485,0.000026907443,9.587643e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986753,0.000034748544,0.0002632096,0.00029783952,0.00039103668,0.00033786858],"domain_scores_gemma":[0.99911904,0.00015215501,0.00003135073,0.00023045126,0.00023130365,0.00023566833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028157598,0.00012443778,0.00017149583,0.00032763794,0.0001128707,0.00005545268,0.00020809112,0.00010791033,0.00007089369],"category_scores_gemma":[0.000046721667,0.00013237653,0.000086652035,0.0022824483,0.00038754352,0.00015650489,0.000041440493,0.00013720717,0.00000942038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028993676,0.00002603676,0.0033477831,0.0002639465,0.00005566975,0.0000010117859,0.0001525417,0.00190119,0.9747441,0.00094387017,0.000042555155,0.018492296],"study_design_scores_gemma":[0.0006536787,0.00017173454,0.10632118,0.00018196713,0.0000648605,0.000004345854,0.000486504,0.055408552,0.834168,0.0013110769,0.0007231382,0.00050494354],"about_ca_topic_score_codex":0.0001244835,"about_ca_topic_score_gemma":0.000024155184,"teacher_disagreement_score":0.14057608,"about_ca_system_score_codex":0.000044678443,"about_ca_system_score_gemma":0.00004239945,"threshold_uncertainty_score":0.53981584},"labels":[],"label_agreement":null},{"id":"W3083563724","doi":"10.1158/1538-7445.am2020-lb-397","title":"Abstract LB-397: Pembrolizumab plus pemetrexed and platinum vs placebo plus pemetrexed and platinum as first-line therapy for metastatic nonsquamous NSCLC: analysis of KEYNOTE-189 by <i>STK11</i> and <i>KEAP1</i> status","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Pembrolizumab; Pemetrexed; STK11; Medicine; Internal medicine; Oncology; Gemcitabine; Chemotherapy; Cancer; Immunotherapy; KRAS","score_opus":0.045915212090327555,"score_gpt":0.35125639281028437,"score_spread":0.3053411807199568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083563724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96887356,0.024658805,0.00055302464,0.001179908,0.00006168117,0.0013850074,0.0030253378,0.000014195636,0.00024849243],"genre_scores_gemma":[0.9736988,0.024000956,0.00039087614,0.00052656746,0.00016949442,0.00032557332,0.0005969397,0.00007329063,0.0002174824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971394,0.00010155292,0.00054375734,0.00095476414,0.0004903767,0.00077017676],"domain_scores_gemma":[0.9976904,0.00076218235,0.00022375947,0.00042009435,0.00038322154,0.00052034174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056508614,0.0003779582,0.0007781403,0.0002603532,0.0002765425,0.00014757407,0.00026395105,0.00019087284,0.000097727236],"category_scores_gemma":[0.00066351786,0.00036415804,0.00015794722,0.00069918163,0.0004281594,0.000018399822,0.0002985935,0.00032011906,0.000001501837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049553465,0.00043235914,0.010311917,0.0016626725,0.00559349,0.000052216932,0.004533432,0.0054043955,0.83907676,0.00021273068,0.039368223,0.04379835],"study_design_scores_gemma":[0.09577822,0.014873876,0.01782782,0.0002936649,0.0028805488,0.000036649,0.003787,0.037152454,0.59019756,0.00060548465,0.2330587,0.0035079855],"about_ca_topic_score_codex":0.0020066265,"about_ca_topic_score_gemma":0.0018313755,"teacher_disagreement_score":0.24887915,"about_ca_system_score_codex":0.00011532334,"about_ca_system_score_gemma":0.0006529159,"threshold_uncertainty_score":0.999881},"labels":[],"label_agreement":null},{"id":"W3083563767","doi":"10.1158/1538-7445.am2020-lb-038","title":"Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"","keywords":"SMARCA4; SWI/SNF; Biology; Chromatin remodeling; Protein subunit; Cancer research; Immunoprecipitation; Genetics; Chromatin; Cell culture; Gene","score_opus":0.1082155874982815,"score_gpt":0.326545219815976,"score_spread":0.2183296323176945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083563767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633247,0.0009819893,0.000057041085,0.0009959915,0.0000951317,0.0006463337,0.00013469861,0.0000039880283,0.00075237826],"genre_scores_gemma":[0.9988587,0.000020273568,0.000056032583,0.00007918858,0.00015092148,0.00009882722,0.00004358872,0.000022159036,0.0006702991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984721,0.00014529013,0.0003426967,0.0003568125,0.00042365157,0.00025942948],"domain_scores_gemma":[0.9989998,0.000034588942,0.00012857454,0.0004365443,0.00033213358,0.0000683748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024667362,0.00013184673,0.00016654404,0.0000378414,0.00013465769,0.000013659523,0.0004639288,0.000092985385,0.00010950017],"category_scores_gemma":[0.0001675134,0.00008861736,0.000099152,0.0004086721,0.00024654123,0.0000040979994,0.00033022458,0.0004541299,0.0000032238122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003535417,0.000119875534,0.0027783131,0.00016585823,0.000014500041,4.4662838e-7,0.00013855723,0.0004937082,0.99262166,0.000017543147,0.003099603,0.00019638486],"study_design_scores_gemma":[0.0008678979,0.00016643548,0.05545084,0.00016104798,0.000008767999,0.0000018899369,0.00017235716,0.00042575665,0.9377815,0.000040083054,0.0047917296,0.0001316865],"about_ca_topic_score_codex":0.0013946824,"about_ca_topic_score_gemma":0.0004729167,"teacher_disagreement_score":0.054840162,"about_ca_system_score_codex":0.00010573548,"about_ca_system_score_gemma":0.0006485069,"threshold_uncertainty_score":0.3613711},"labels":[],"label_agreement":null},{"id":"W3083564788","doi":"10.1158/1538-7445.am2020-1984","title":"Abstract 1984: Investigating circulating tumor DNA as a biomarker of cancer progression and recurrence in sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Digital polymerase chain reaction; Sarcoma; Medicine; Cancer; Circulating tumor DNA; Liquid biopsy; Oncology; Biopsy; Circulating tumor cell; Internal medicine; Biomarker; Soft tissue sarcoma; Pathology; Polymerase chain reaction; Biology; Gene; Genetics; Metastasis","score_opus":0.08996162890328466,"score_gpt":0.41773772918233165,"score_spread":0.327776100279047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083564788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98771524,0.010408401,0.0000044509516,0.0009911273,0.000052313266,0.00029743955,0.000047323127,0.0000042047814,0.00047951468],"genre_scores_gemma":[0.9977321,0.0015269921,0.00017039916,0.00023178112,0.00016664255,0.00012819722,0.000015020263,0.000020541198,0.000008322052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987076,0.000063434854,0.0002516658,0.000401883,0.00025222066,0.00032319105],"domain_scores_gemma":[0.99933887,0.00007093208,0.00009292435,0.00016307343,0.00015405893,0.00018015926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000384082,0.000110073524,0.00015526084,0.00006263616,0.00007087578,0.000032929376,0.00017603255,0.000073689516,0.00004871845],"category_scores_gemma":[0.0007321461,0.00010852497,0.000030734733,0.00030675644,0.00023289079,0.000005738715,0.00025511958,0.00022288157,0.0000017756813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093485054,0.000021084765,0.06399127,0.00020869663,0.000014842302,0.000012553762,0.00029505783,0.0000449389,0.8971584,0.000039647723,0.0005503944,0.03756962],"study_design_scores_gemma":[0.0012528158,0.00035446425,0.15159604,0.0008943138,0.000009488829,0.0000058291985,0.00037053076,0.0011480018,0.83734995,0.00035706555,0.0063248742,0.00033661307],"about_ca_topic_score_codex":0.001391736,"about_ca_topic_score_gemma":0.0004969052,"teacher_disagreement_score":0.08760476,"about_ca_system_score_codex":0.000048642363,"about_ca_system_score_gemma":0.0005786662,"threshold_uncertainty_score":0.442552},"labels":[],"label_agreement":null},{"id":"W3083569853","doi":"10.1158/1538-7445.am2020-276","title":"Abstract 276: Mir-139 regulates autophagy in prostate cancer cells through Beclin-1 and mTOR signaling proteins","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"LNCaP; DU145; Prostate cancer; Cancer research; Autophagy; PI3K/AKT/mTOR pathway; Downregulation and upregulation; microRNA; Cancer cell; Cancer; Biology; Medicine; Cell biology; Signal transduction; Internal medicine; Apoptosis; Biochemistry; Gene","score_opus":0.0925193703593268,"score_gpt":0.41202558521414895,"score_spread":0.31950621485482217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083569853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97126746,0.018034484,0.0000037432555,0.008518724,0.00008468406,0.0016045707,0.0000739882,0.00006600219,0.00034631434],"genre_scores_gemma":[0.9923476,0.0043075294,0.00019201796,0.0010658882,0.000543278,0.0006516889,0.000012227485,0.000058161422,0.0008216102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770415,0.00009880554,0.0003362065,0.00057465484,0.0006271861,0.00065900903],"domain_scores_gemma":[0.9989664,0.000117315925,0.00006580878,0.00029528138,0.00020034278,0.00035483626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041004305,0.00020105613,0.0003771274,0.00010697418,0.00014004803,0.00006015376,0.00020442877,0.00011186217,0.0014873147],"category_scores_gemma":[0.00009447423,0.00017059267,0.00006777625,0.0005332888,0.00026037148,0.00017746544,0.00012480163,0.00071817904,0.000047119996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015766176,0.00015955922,0.003632491,0.0009468988,0.000126075,0.0005054268,0.0051468625,0.000106380045,0.9767048,0.00006779759,0.003319583,0.007707515],"study_design_scores_gemma":[0.0027216654,0.00031429404,0.017732808,0.0006604062,0.000024265259,0.0000027030358,0.00045868923,0.00029034715,0.9666583,0.0007458933,0.010168945,0.00022170898],"about_ca_topic_score_codex":0.0021303555,"about_ca_topic_score_gemma":0.00009885737,"teacher_disagreement_score":0.021080108,"about_ca_system_score_codex":0.00021852838,"about_ca_system_score_gemma":0.00078263244,"threshold_uncertainty_score":0.9994255},"labels":[],"label_agreement":null},{"id":"W3083578333","doi":"10.1158/1538-7445.am2020-5228","title":"Abstract 5228: Small molecule activation of the LKB1 tumor suppressor","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Kinase; Small molecule; Trimer; Suppressor; Dasatinib; Cell biology; Immunoprecipitation; HEK 293 cells; Biochemistry; Biology; Chemistry; Signal transduction; Dimer; Receptor; Tyrosine kinase","score_opus":0.1166573664394056,"score_gpt":0.37661492147802716,"score_spread":0.25995755503862156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083578333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98104674,0.0005305718,0.0000671673,0.01200429,0.00010023267,0.0008114577,0.000031551328,0.00003307602,0.00537493],"genre_scores_gemma":[0.99852645,0.000052058716,0.000045537126,0.0007448497,0.00022503886,0.00010480004,0.0000082679835,0.000038655842,0.00025435534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829435,0.00009062889,0.00021958127,0.00030125983,0.00074371306,0.00035047167],"domain_scores_gemma":[0.9988343,0.00008226984,0.000075396194,0.00043361355,0.00038599886,0.00018841792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002817909,0.00010556256,0.00019832271,0.00007832812,0.00008675329,0.000016681608,0.00028203335,0.00007822659,0.0006559939],"category_scores_gemma":[0.0006143731,0.00007922256,0.000113750415,0.000696499,0.00018773573,0.000041005376,0.00015325705,0.0007870567,0.00004149544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038898602,0.00005177732,0.00036023918,0.00025422734,0.000051618594,0.000021871678,0.00042680514,0.000118547694,0.9902092,0.000094304676,0.00713959,0.0008828383],"study_design_scores_gemma":[0.000977705,0.00014938446,0.010196904,0.00026432183,0.000019991363,0.0000039600127,0.00011605312,0.00015676446,0.9799937,0.000030853207,0.008016922,0.00007342385],"about_ca_topic_score_codex":0.0005097034,"about_ca_topic_score_gemma":0.000029867871,"teacher_disagreement_score":0.017479714,"about_ca_system_score_codex":0.00022431042,"about_ca_system_score_gemma":0.0007913826,"threshold_uncertainty_score":0.7182673},"labels":[],"label_agreement":null},{"id":"W3083579627","doi":"10.1158/1538-7445.am2020-lb-307","title":"Abstract LB-307: Translational and mechanistic implications of osteosarcoma genomics: A TARGET report","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"CDKN2A; PDGFRA; Biology; PTEN; Transcriptome; Cancer research; Copy-number variation; Synthetic lethality; Cancer; Genome instability; DNA methylation; ARID1A; Targeted therapy; Genetics; Gene; Mutation; Genome; DNA repair; Gene expression; DNA damage; DNA; PI3K/AKT/mTOR pathway; Stromal cell","score_opus":0.05930441921192003,"score_gpt":0.3658195407416472,"score_spread":0.30651512152972715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083579627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985503,0.0040430343,0.0023214966,0.005706461,0.00005632109,0.0003552881,0.00054283725,0.000006346336,0.0014651978],"genre_scores_gemma":[0.9972568,0.0010150395,0.0009196536,0.00019558756,0.0003018235,0.000074617405,0.00016410358,0.000019079247,0.000053297554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909467,0.000022485105,0.00021605512,0.00031477018,0.00015121627,0.00020083757],"domain_scores_gemma":[0.99929947,0.000050943192,0.00005695291,0.00021832356,0.00022331715,0.0001510145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002391836,0.00007845773,0.00011421818,0.000035563397,0.000083546096,0.000021373033,0.0001541709,0.00007329781,0.00010093461],"category_scores_gemma":[0.0001635658,0.00008410919,0.00004331843,0.000109456094,0.00012443928,0.0000025841596,0.00009654499,0.000120034085,0.000003750571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092325616,0.000022824586,0.0021082463,0.000058014557,0.000036662947,0.000007735093,0.00011159932,0.00012251879,0.9913792,0.0013420482,0.0025563596,0.0021624905],"study_design_scores_gemma":[0.0011979224,0.0004792332,0.038675424,0.000031357296,0.000030561314,0.000050729086,0.00019111921,0.00020056826,0.728931,0.0073843375,0.22245975,0.00036796488],"about_ca_topic_score_codex":0.00010655705,"about_ca_topic_score_gemma":0.00006966771,"teacher_disagreement_score":0.26244813,"about_ca_system_score_codex":0.00002266507,"about_ca_system_score_gemma":0.0004937219,"threshold_uncertainty_score":0.34298733},"labels":[],"label_agreement":null},{"id":"W3083585700","doi":"10.1158/1538-7445.am2020-707","title":"Abstract 707: Combinatorial assessment of ctDNA release and mutational burden predicts clinical outcome from anti-PD-(L)1 therapies in non-small-cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Concordance; Circulating tumor DNA; Cancer","score_opus":0.06136508772903712,"score_gpt":0.4249599041672914,"score_spread":0.3635948164382543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083585700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262226,0.0045426055,0.000051193863,0.0012689637,0.00037482404,0.0004098359,0.00046951266,0.0000038450057,0.0002569724],"genre_scores_gemma":[0.9921606,0.006025425,0.00015295827,0.00021404159,0.0011799027,0.00011109975,0.000106203064,0.000025624327,0.000024106956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837166,0.00009994427,0.0004421204,0.00046086404,0.00033454943,0.0002908859],"domain_scores_gemma":[0.9990331,0.00022300698,0.000108820605,0.00021207235,0.00022141424,0.00020159333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005157826,0.0001333606,0.0002774131,0.000049256767,0.000056643017,0.000042465857,0.00026261635,0.00017099633,0.00011079306],"category_scores_gemma":[0.00018588797,0.00013238018,0.000068734,0.00012876577,0.00018276759,0.0000056326658,0.00023580411,0.00038225562,0.0000012144022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040754382,0.00017301715,0.787783,0.00022503038,0.00015201228,0.000029266106,0.00048225536,0.0012162275,0.20324562,0.00010072147,0.0037806213,0.0024046688],"study_design_scores_gemma":[0.0056140423,0.0004480943,0.9550849,0.00011534601,0.000040298248,4.180445e-7,0.00036048374,0.0025542076,0.030422937,0.00021188687,0.004842897,0.00030449682],"about_ca_topic_score_codex":0.0032549542,"about_ca_topic_score_gemma":0.00041156728,"teacher_disagreement_score":0.17282268,"about_ca_system_score_codex":0.00007167407,"about_ca_system_score_gemma":0.0009258677,"threshold_uncertainty_score":0.5398307},"labels":[],"label_agreement":null},{"id":"W3083608894","doi":"10.1158/1538-7445.am2020-3731","title":"Abstract 3731: Targeting the isocitrate dehydrogenase 1 (IDH1) metabolic enzyme in prostate cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Cell growth; PI3K/AKT/mTOR pathway; Cancer research; Prostate cancer; Biology; Anabolism; Cancer cell; Enzyme; Chemistry; Cancer; Biochemistry; Cell biology; Signal transduction; Mutant; Genetics","score_opus":0.10888073083183997,"score_gpt":0.4228358465801656,"score_spread":0.31395511574832563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083608894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8857392,0.06291203,0.0000011360842,0.047124032,0.00011550067,0.0018874897,0.00010941668,0.00006668235,0.0020445161],"genre_scores_gemma":[0.9757107,0.017752321,0.000029336286,0.0013303405,0.00080367527,0.0016865847,0.000039393883,0.00007522489,0.002572432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960234,0.00026900723,0.00042949268,0.00067378127,0.0012491713,0.001355148],"domain_scores_gemma":[0.9983388,0.00023174533,0.000073317926,0.00036112103,0.00043373107,0.0005612502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014483706,0.00026394703,0.00045811382,0.00028050682,0.00036102903,0.00012057855,0.00041274691,0.00008653864,0.0021612148],"category_scores_gemma":[0.0002386408,0.00016694095,0.00014411393,0.0022263082,0.00045253072,0.00018836134,0.00020455511,0.0016834699,0.00018926527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005130148,0.00040992454,0.0956657,0.0012383804,0.0007014034,0.0017309301,0.012756815,0.0007973219,0.7704693,0.0003992728,0.08060677,0.030094037],"study_design_scores_gemma":[0.008300811,0.00039582787,0.03136377,0.0006544443,0.000105050356,0.000009451812,0.0029596994,0.0014485138,0.72357965,0.00035020828,0.23024905,0.0005835517],"about_ca_topic_score_codex":0.0038456025,"about_ca_topic_score_gemma":0.0009968408,"teacher_disagreement_score":0.14964227,"about_ca_system_score_codex":0.00050976913,"about_ca_system_score_gemma":0.0018514993,"threshold_uncertainty_score":0.9987509},"labels":[],"label_agreement":null},{"id":"W3083627375","doi":"10.1158/1538-7445.am2020-770","title":"Abstract 770: Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: a first-in-human pilot study","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Chemotherapy; Prospective cohort study; Radiation therapy; Cancer; Cohort","score_opus":0.09347021977223609,"score_gpt":0.41238189214990706,"score_spread":0.318911672377671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083627375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874455,0.00020446246,0.00010436736,0.00024604774,0.00001998639,0.0005373719,0.00007307593,0.0000026042137,0.00006755211],"genre_scores_gemma":[0.99945325,0.00012787273,0.000037677935,0.000045164445,0.000092642265,0.00018997502,0.000022358441,0.00001374633,0.000017344088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872965,0.00012018736,0.0002907509,0.0003998324,0.00023552761,0.00022406367],"domain_scores_gemma":[0.9990599,0.000089884794,0.00008660746,0.00031717512,0.00032245799,0.0001239471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046630763,0.00010904498,0.00029934561,0.00017960706,0.000047836354,0.000012895142,0.00012731196,0.000028463419,0.00003337361],"category_scores_gemma":[0.00027404155,0.0001091273,0.0000697999,0.0008854611,0.0000422217,0.0000034794339,0.000103804836,0.00008233921,0.0000026602472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004411907,0.0004685091,0.018313995,0.000047909536,0.00031603558,0.000010493671,0.0011872295,0.0056443913,0.97238636,0.000004951116,0.00008986997,0.001089069],"study_design_scores_gemma":[0.0006185295,0.006142568,0.11478412,0.000026194135,0.000092734044,1.1774275e-7,0.0010859256,0.00010585711,0.8768643,0.000008543423,0.00014217636,0.00012890207],"about_ca_topic_score_codex":0.009527766,"about_ca_topic_score_gemma":0.026711214,"teacher_disagreement_score":0.096470125,"about_ca_system_score_codex":0.00014789292,"about_ca_system_score_gemma":0.00025846483,"threshold_uncertainty_score":0.99706787},"labels":[],"label_agreement":null},{"id":"W3083636513","doi":"10.1158/1538-7445.am2020-6080","title":"Abstract 6080: IL1RAP augments Cysteine metabolism and drives oxidative stress adaptation and lung metastasis in Ewing sarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Oxidative stress; Cancer research; Metastasis; Biology; Medicine; Cancer; Biochemistry; Internal medicine","score_opus":0.12985878875365464,"score_gpt":0.4004193794735103,"score_spread":0.27056059071985566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083636513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771599,0.016665062,0.000037230322,0.0049749957,0.000039786144,0.00062535924,0.00006298802,0.00002035993,0.0004142744],"genre_scores_gemma":[0.99412936,0.004795915,0.00036563326,0.00023183419,0.00015374161,0.00023297622,0.00001942054,0.000026086074,0.00004503831],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99819964,0.00013819883,0.00025227098,0.0004537127,0.0005731801,0.00038297946],"domain_scores_gemma":[0.9992383,0.000108588116,0.00005327256,0.00013639474,0.00018088554,0.00028255887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044604248,0.0001494856,0.00036012073,0.00021141864,0.00011364118,0.00007128483,0.000091138005,0.00006357398,0.0002357948],"category_scores_gemma":[0.0001301106,0.00012919419,0.0000367605,0.00052148366,0.00016638036,0.00023843804,0.00012679098,0.00043596965,0.000003350203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021227526,0.00035516758,0.12086388,0.0025779011,0.00092664285,0.00018581442,0.029004142,0.00012329473,0.41417262,0.00065373676,0.0017959046,0.42721814],"study_design_scores_gemma":[0.008960511,0.00084293797,0.6961439,0.0014747996,0.00032532425,0.000008802001,0.014411025,0.0065795425,0.26500136,0.00013000506,0.0055685444,0.0005531993],"about_ca_topic_score_codex":0.0012189323,"about_ca_topic_score_gemma":0.00021100898,"teacher_disagreement_score":0.5752801,"about_ca_system_score_codex":0.00011432544,"about_ca_system_score_gemma":0.00015315421,"threshold_uncertainty_score":0.5268386},"labels":[],"label_agreement":null},{"id":"W3083638783","doi":"10.1158/1538-7445.am2020-4361","title":"Abstract 4361: A systematic study of the impact of estrogens and selective estrogen receptor modulators on prostate cancer cell proliferation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Estrogen receptor; LNCaP; Cancer research; DU145; Prostate cancer; Estrogen; Selective estrogen receptor modulator; Androgen receptor; Cell growth; Oncogene; Receptor; Estrogen receptor alpha; Cancer; Cell; Biology; Internal medicine; Endocrinology; Cell cycle; Breast cancer; Medicine; Biochemistry","score_opus":0.0727677534753255,"score_gpt":0.4143117050873933,"score_spread":0.3415439516120678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083638783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014866,0.0027992064,2.6253306e-7,0.00057201454,0.00003058535,0.006150828,0.0001344532,0.000014018181,0.00014998896],"genre_scores_gemma":[0.9979509,0.0007567888,0.0000055830724,0.000012981846,0.00008522003,0.0009623612,0.0000062470062,0.00003458418,0.00018533015],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975191,0.00028700015,0.0003788646,0.00038459964,0.0010277621,0.00040267708],"domain_scores_gemma":[0.99838406,0.0001287405,0.00016718106,0.00032486956,0.0007494219,0.00024570705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004939921,0.00018193558,0.00050498644,0.00011255969,0.00014140368,0.000025685353,0.00016771065,0.00006834124,0.00010094003],"category_scores_gemma":[0.0001548428,0.00010048644,0.00011809179,0.0007862397,0.00017870257,0.00008558152,0.00009278568,0.0004434582,0.0000037826833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067402404,0.0018144891,0.6428771,0.015625684,0.0015190684,0.000017308575,0.028478505,0.0011791434,0.29940358,0.000015266734,0.001461686,0.00086795114],"study_design_scores_gemma":[0.010088226,0.014345818,0.25304064,0.0052066147,0.00032551965,0.000004399439,0.009487715,0.0013344785,0.7058197,0.000034054974,0.000010002151,0.0003028205],"about_ca_topic_score_codex":0.0042349356,"about_ca_topic_score_gemma":0.00010156445,"teacher_disagreement_score":0.40641615,"about_ca_system_score_codex":0.0007450824,"about_ca_system_score_gemma":0.001303488,"threshold_uncertainty_score":0.6401984},"labels":[],"label_agreement":null},{"id":"W3083639628","doi":"10.1158/1538-7445.am2020-3537","title":"Abstract 3537: Evaluation of genomic instability using microsatellite instability, ploidy status, and p53 expression in archival paraffin embedded tissue from primary ovarian cancer specimens","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Microsatellite instability; Loss of heterozygosity; Genome instability; Biology; Cancer; Ovarian cancer; Immunohistochemistry; Ploidy; Pathology; Aneuploidy; Cancer research; Microsatellite; Medicine; DNA; Genetics; Gene; DNA damage; Chromosome","score_opus":0.0978412802431278,"score_gpt":0.3923966122814426,"score_spread":0.29455533203831485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083639628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878114,0.00998141,0.000036153622,0.00019101826,0.000102756305,0.0008481744,0.00081428076,0.0000050844133,0.00020972421],"genre_scores_gemma":[0.9933371,0.0048459163,0.0010591091,0.0000845297,0.0003264616,0.00009213603,0.00021657386,0.000034043962,0.0000041354688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975682,0.00027258781,0.00044685163,0.00073302456,0.00050747884,0.0004718727],"domain_scores_gemma":[0.99880314,0.00011781241,0.00011994811,0.00041984266,0.0003056411,0.00023361568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009864889,0.00018593413,0.0002983319,0.00008387986,0.000085590575,0.00005069061,0.00023288006,0.00013601012,0.00019874299],"category_scores_gemma":[0.00025824274,0.00019637622,0.000045990248,0.00018645816,0.00027662146,0.000014212808,0.0004480477,0.0003289778,0.0000019843085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056303665,0.00010436436,0.028460532,0.00012383788,0.000027729668,0.0000021178414,0.001166831,0.002245312,0.9510108,0.000004784132,0.00006767421,0.016222987],"study_design_scores_gemma":[0.0015177059,0.00010497011,0.346891,0.00007725574,0.000021612874,3.1567035e-7,0.00023504862,0.0006158901,0.6472996,0.0002444578,0.0027886692,0.00020349986],"about_ca_topic_score_codex":0.0071596256,"about_ca_topic_score_gemma":0.0033901683,"teacher_disagreement_score":0.31843045,"about_ca_system_score_codex":0.00045456656,"about_ca_system_score_gemma":0.0017837165,"threshold_uncertainty_score":0.99945176},"labels":[],"label_agreement":null},{"id":"W3083643318","doi":"10.1158/1538-7445.am2020-3497","title":"Abstract 3497: The physical activity paradox in lung cancer: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Research","topic":"Physical Activity and Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Saskatchewan","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Odds ratio; Confidence interval; Prospective cohort study; Cohort study; Systematic review; Relative risk; Internal medicine; MEDLINE; Physical therapy; Environmental health; Oncology","score_opus":0.4673136870656671,"score_gpt":0.5891492881863574,"score_spread":0.12183560112069025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083643318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008564492,0.9833922,0.0000012123794,0.009462048,0.000013304057,0.0066596875,0.00022408366,0.000019135734,0.00014272581],"genre_scores_gemma":[0.004091078,0.98743135,0.0000014173268,0.0003297167,0.00021990792,0.0075949132,0.000010777374,0.00004377641,0.00027705892],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951855,0.001634932,0.0005817748,0.0008084128,0.0011490565,0.00064030837],"domain_scores_gemma":[0.9962723,0.0019506599,0.0003581132,0.0008758509,0.00016079009,0.00038223606],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019781387,0.00044102376,0.012108356,0.000271236,0.00017115846,0.000059164093,0.00042609338,0.0001631116,0.00025454134],"category_scores_gemma":[0.0004156834,0.00022135141,0.0020524643,0.0031627498,0.00023377815,0.00008038302,0.00020938469,0.0031533996,0.000034123135],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014294441,0.00025265175,8.533767e-7,0.9342155,0.050138276,0.00004113768,0.000102125836,4.948958e-7,8.25999e-7,0.000050664108,0.0004642758,0.014718913],"study_design_scores_gemma":[0.00014814353,0.00007417225,0.000030878928,0.108184606,0.8472097,0.000007582542,0.000012431504,0.00008731434,0.0000018682471,0.000029901981,0.043933522,0.00027990245],"about_ca_topic_score_codex":0.0026337428,"about_ca_topic_score_gemma":0.00050806644,"teacher_disagreement_score":0.8260309,"about_ca_system_score_codex":0.0008555971,"about_ca_system_score_gemma":0.0017931763,"threshold_uncertainty_score":0.99914634},"labels":[],"label_agreement":null},{"id":"W3083646126","doi":"10.1158/1538-7445.am2020-2162","title":"Abstract 2162: KIM–1 mediatesimmune evasioninrenal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Immune system; Cancer research; Tumor microenvironment; CD8; Immunotherapy; T cell; Biology; Cytotoxic T cell; Immunology; In vitro","score_opus":0.1489772875883832,"score_gpt":0.3872222499104864,"score_spread":0.23824496232210324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083646126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622277,0.009423141,0.0000036788272,0.010219026,0.00012374103,0.0007407841,0.000026345097,0.000069357375,0.017166229],"genre_scores_gemma":[0.9961744,0.00053040107,0.00011568078,0.00049302547,0.00083624496,0.00019925526,0.000052621504,0.000064921354,0.0015334731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967698,0.00011752122,0.0003329988,0.0005908919,0.001399214,0.0007895632],"domain_scores_gemma":[0.997957,0.00020910785,0.00005763515,0.00049817195,0.00042699047,0.00085110153],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00048058722,0.00022768826,0.00039191576,0.00017268871,0.00018016557,0.00004939232,0.00029795978,0.00013268518,0.0035617105],"category_scores_gemma":[0.0001667245,0.00018128101,0.00016201772,0.0006510279,0.00020613805,0.0000839378,0.00018617389,0.0009503737,0.0012686746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016926134,0.00034073874,0.044336203,0.0009695606,0.00009707029,0.0022572624,0.0014793557,0.000030317065,0.89078194,0.000045660472,0.050301082,0.007668208],"study_design_scores_gemma":[0.0031161602,0.0010085588,0.2647296,0.00010594088,0.00006194376,0.000021648577,0.00035882564,0.00006537297,0.7125393,0.000030591167,0.017745225,0.00021681638],"about_ca_topic_score_codex":0.0007302065,"about_ca_topic_score_gemma":0.000016284634,"teacher_disagreement_score":0.2203934,"about_ca_system_score_codex":0.00051654584,"about_ca_system_score_gemma":0.0009560729,"threshold_uncertainty_score":0.999509},"labels":[],"label_agreement":null},{"id":"W3083654999","doi":"10.1158/1538-7445.am2020-3215","title":"Abstract 3215: ClinGen somatic cancer working group: Disseminating standardized cancer molecular diagnostic data and evidence through global collaboration and expert curation","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Context (archaeology); Precision medicine; Computational biology; Medicine; Genetics; Bioinformatics; Biology","score_opus":0.12249242459524387,"score_gpt":0.4575415373378594,"score_spread":0.3350491127426155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083654999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8215623,0.16947584,0.0019241646,0.005591428,0.00018855173,0.00061688514,0.000571422,0.000014874236,0.00005453441],"genre_scores_gemma":[0.8910519,0.10656787,0.0005989415,0.00063304225,0.00062551146,0.00034460833,0.00014048447,0.000031459524,0.0000062002505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978713,0.00011878399,0.0003179148,0.00082775386,0.0004502428,0.00041400787],"domain_scores_gemma":[0.99859357,0.0003361252,0.00013011922,0.0004239619,0.00031018181,0.00020604733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004990279,0.00020444886,0.00023674707,0.000024414267,0.0002766756,0.00030100901,0.00036199985,0.00013832205,0.00003515377],"category_scores_gemma":[0.0022949958,0.00020749036,0.00002707524,0.0003533337,0.0001953924,0.00006570777,0.0006093386,0.00020323842,9.623344e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005980654,0.00004737342,0.027707351,0.0005145447,0.00019658024,0.000036504112,0.0018762419,0.0007370918,0.87960416,0.00022530285,0.009000768,0.079455994],"study_design_scores_gemma":[0.010242105,0.0020515944,0.049283322,0.011139694,0.0006031173,0.000027439717,0.010362689,0.021641392,0.6658443,0.0025381672,0.22206238,0.0042037596],"about_ca_topic_score_codex":0.0017159819,"about_ca_topic_score_gemma":0.0024683278,"teacher_disagreement_score":0.21375984,"about_ca_system_score_codex":0.00019795321,"about_ca_system_score_gemma":0.00060678425,"threshold_uncertainty_score":0.84612113},"labels":[],"label_agreement":null},{"id":"W3083655400","doi":"10.1158/1538-7445.am2020-3535","title":"Abstract 3535: Whole genome sequencing of single circulating tumor cells from localized high-risk prostate cancer patients: Laser microdissection and 3Dtelomere profile","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Prostate cancer; Circulating tumor cell; Laser capture microdissection; Prostate; Cancer; Indel; Biology; Oncology; Computational biology; Internal medicine; Medicine; Gene; Single-nucleotide polymorphism; Genetics; Metastasis; Genotype","score_opus":0.026443507599600905,"score_gpt":0.2889850143765425,"score_spread":0.2625415067769416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083655400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318475,0.002888137,0.000030264182,0.00015820547,0.00012971302,0.0005025813,0.0030337072,0.000009013,0.00006365355],"genre_scores_gemma":[0.9971815,0.001457454,0.00021923012,0.0001376214,0.00038945378,0.000117671065,0.0004085356,0.000044243283,0.00004431329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847794,0.00006995659,0.00031753557,0.000524846,0.00024807002,0.00036165488],"domain_scores_gemma":[0.999004,0.000060720722,0.0001771775,0.00020663059,0.0003758154,0.00017567707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018877306,0.00015592972,0.0002138357,0.000047777103,0.00014140856,0.000059783775,0.00014950596,0.00009118079,0.00013080458],"category_scores_gemma":[0.00019517995,0.00015872749,0.00004966128,0.00019529597,0.00014550165,0.000010529002,0.00014806286,0.00023391252,0.0000073747724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002520465,0.00004539551,0.009629088,0.00014102727,0.00005901176,0.0000046890077,0.0004978489,0.001381946,0.984273,9.792201e-7,0.0006731303,0.0030418166],"study_design_scores_gemma":[0.0011165673,0.0003142855,0.009016651,0.00007850271,0.000023293518,3.2706544e-7,0.00032664608,0.00010511406,0.97987664,0.00003520395,0.008898305,0.00020846965],"about_ca_topic_score_codex":0.006952619,"about_ca_topic_score_gemma":0.00061622827,"teacher_disagreement_score":0.008225175,"about_ca_system_score_codex":0.00017297092,"about_ca_system_score_gemma":0.00036147423,"threshold_uncertainty_score":0.9996602},"labels":[],"label_agreement":null},{"id":"W3083661584","doi":"10.1158/1538-7445.am2020-158","title":"Abstract 158: Custom primer design pipeline and analysis workflow for targeted methylation sequencing using NGS Ion AmpliSeq technology","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Amplicon; Ion semiconductor sequencing; Computational biology; Bisulfite sequencing; Illumina Methylation Assay; Primer (cosmetics); DNA methylation; Biology; Methylation; Pipeline (software); In silico; Genetics; Computer science; DNA sequencing; Polymerase chain reaction; DNA; Gene; Chemistry; Operating system","score_opus":0.14689535808815496,"score_gpt":0.40725647485930094,"score_spread":0.260361116771146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083661584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7027935,0.0057640434,0.29018176,0.0007676354,0.000029911937,0.00040675944,0.000024007859,0.000013220294,0.000019151006],"genre_scores_gemma":[0.98005986,0.0007974604,0.018529307,0.00007325,0.000265355,0.000058752637,0.00014255365,0.000026515738,0.000046954843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868274,0.000099384306,0.00022254976,0.00046843672,0.00020541459,0.00032148368],"domain_scores_gemma":[0.9991134,0.000059466558,0.00008023769,0.00020309034,0.00042752628,0.00011629625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078845484,0.00011989297,0.00018213734,0.00025035272,0.0001641459,0.000045660177,0.00013287048,0.00022774773,0.000024101055],"category_scores_gemma":[0.00037287406,0.00011917465,0.000067609806,0.00089505437,0.00010305892,0.000007881458,0.0000873321,0.00017941366,0.0000019450324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013207566,0.0000075254275,0.0012557532,0.000027418278,0.00013013624,7.9655547e-7,0.00006364175,0.01256685,0.97652656,0.000012563551,0.000106217965,0.009170446],"study_design_scores_gemma":[0.00032602853,0.0001239876,0.00061888894,0.000010901578,0.00009424814,2.1075898e-7,0.000052770065,0.02146827,0.9728149,0.00041127537,0.0039351634,0.0001433071],"about_ca_topic_score_codex":0.00010118394,"about_ca_topic_score_gemma":0.000024895937,"teacher_disagreement_score":0.27726635,"about_ca_system_score_codex":0.00007590043,"about_ca_system_score_gemma":0.00022245637,"threshold_uncertainty_score":0.48598012},"labels":[],"label_agreement":null},{"id":"W3083677935","doi":"10.1158/1538-7445.am2020-384","title":"Abstract 384: T cell infiltration into tumors induced by DPX-Survivac combination immunotherapy demonstrated by PET/MRI imaging in an orthotopic ovarian cancer model","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Carleton University; Nova Scotia Health Authority; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Ovarian cancer; Medicine; Immunotherapy; CD8; Cancer research; Cytotoxic T cell; In vivo; Cancer; Immune system; Pathology; In vitro; Internal medicine; Immunology; Biology","score_opus":0.03973437556436236,"score_gpt":0.3757003716542016,"score_spread":0.33596599608983924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083677935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945142,0.0021838448,0.00022741067,0.0017947766,0.000039480565,0.0006872748,0.00015803316,0.000019814355,0.00037513685],"genre_scores_gemma":[0.9963967,0.0017801417,0.00005635662,0.0002577014,0.00008692989,0.00053691794,0.000733727,0.00004849808,0.00010302771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977517,0.0002039816,0.00029520228,0.0006486684,0.00050932186,0.00059109286],"domain_scores_gemma":[0.99903524,0.000016774613,0.000075327815,0.00031318163,0.00027899578,0.0002804958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036967205,0.00021158266,0.00018962834,0.00011009627,0.00019308516,0.00014431393,0.00036792192,0.00009890045,0.00013990149],"category_scores_gemma":[0.000029823857,0.00021919057,0.00005042274,0.00043175594,0.000108711574,0.000052950483,0.000079988924,0.00045095803,0.0000075759444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041949505,0.00019920919,0.015831143,0.000043258126,0.000027655473,0.000012566096,0.0002743254,0.00031771362,0.9718911,0.000009477482,0.0024780196,0.008496009],"study_design_scores_gemma":[0.0038346215,0.0004785975,0.0077318773,0.0000493475,0.0000054239827,0.0000013840455,0.0002728027,0.00659529,0.97888005,0.00014212921,0.0016341839,0.000374272],"about_ca_topic_score_codex":0.014226549,"about_ca_topic_score_gemma":0.004613853,"teacher_disagreement_score":0.009612696,"about_ca_system_score_codex":0.00029497908,"about_ca_system_score_gemma":0.00093680405,"threshold_uncertainty_score":0.9923378},"labels":[],"label_agreement":null},{"id":"W3083690848","doi":"10.1158/1538-7445.am2020-29","title":"Abstract 29: Integrating computational epigenetic and statistical approaches to investigate how genome-wide transcription factor (TF)-DNA bindings affect breast cancer risk","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Genome-wide association study; Breast cancer; FOXA1; Epigenetics; Computational biology; Biology; Context (archaeology); Genetics; Genetic association; Bioinformatics; Cancer; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.11848966441014253,"score_gpt":0.33486061948002,"score_spread":0.21637095506987747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083690848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860613,0.0019679836,0.003961099,0.0048848754,0.000054599128,0.00053586264,0.0024817192,0.00001611479,0.00003644333],"genre_scores_gemma":[0.99661493,0.00102493,0.000906968,0.00039668934,0.00047674228,0.00020469727,0.00030357318,0.000038043625,0.000033404143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998183,0.00018908897,0.00018626158,0.00063014013,0.00037637088,0.00043514933],"domain_scores_gemma":[0.99886984,0.00007226532,0.00005225283,0.00014421815,0.00018557935,0.00067587366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024441726,0.00019536742,0.00018014395,0.00008914501,0.00023191993,0.00015477846,0.00018214194,0.00011142222,0.00010914756],"category_scores_gemma":[0.00022300276,0.00019004401,0.000055683067,0.00020366018,0.00029540065,0.0000109911725,0.00008195786,0.00027614788,0.000007543784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070322293,0.00010463822,0.09276392,0.00052591646,0.00014614129,0.000009595139,0.0014082697,0.0015818315,0.88930094,0.00008657777,0.003859779,0.009509135],"study_design_scores_gemma":[0.0019064425,0.0006432318,0.88762885,0.00012835441,0.00006413053,0.000005747794,0.0009876832,0.0013934005,0.10105687,0.001303204,0.0041984506,0.0006836602],"about_ca_topic_score_codex":0.00021394315,"about_ca_topic_score_gemma":0.00018851618,"teacher_disagreement_score":0.7948649,"about_ca_system_score_codex":0.00007260127,"about_ca_system_score_gemma":0.00033515695,"threshold_uncertainty_score":0.77497697},"labels":[],"label_agreement":null},{"id":"W3083695050","doi":"10.1158/1538-7445.am2020-904","title":"Abstract 904: Stimulation and expansion of oncogene-reactive tumor infiltrating T cells through combined Ad-HER2Δ16 vaccination and anti-PD1 enable anti-tumor responses against established HER2 BC","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Immune system; Cancer research; clone (Java method); Vaccination; CD8; Tumor progression; Tumor antigen; Antigen; Tumor-infiltrating lymphocytes; Immunology; T cell; Medicine; Immunotherapy; Cancer; Biology; Internal medicine","score_opus":0.05151613807065108,"score_gpt":0.34553927776168236,"score_spread":0.2940231396910313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083695050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98796505,0.0100292275,0.000029607701,0.0006134594,0.00017700018,0.00074758934,0.00006731143,0.000047950136,0.00032279],"genre_scores_gemma":[0.9969149,0.0023421205,0.00008456806,0.00018658393,0.00003349744,0.00005724971,0.000055327087,0.000039006347,0.00028669875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976147,0.00070999167,0.00050143653,0.00050131424,0.00016768982,0.0005048968],"domain_scores_gemma":[0.997964,0.00103802,0.00025399943,0.00027106208,0.00042568427,0.000047225534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009383511,0.00024213169,0.00048533798,0.00020386207,0.00046961376,0.000079653306,0.00021104648,0.00017701207,0.00037442578],"category_scores_gemma":[0.0005203044,0.00022247397,0.00006009824,0.000480398,0.00032596657,0.00061571534,0.00014248127,0.00060217746,0.000020377554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004458131,0.00010313309,0.0025385206,0.000186315,0.000119708806,0.000014822933,0.0031709224,0.000084086074,0.981857,0.000020665408,0.00053526345,0.0069114487],"study_design_scores_gemma":[0.0029035255,0.0006206603,0.055246666,0.00020134886,0.000017945782,0.000008605959,0.0020810557,0.0000852497,0.934675,0.00004247516,0.0038976683,0.00021984518],"about_ca_topic_score_codex":0.0009293887,"about_ca_topic_score_gemma":0.00001832847,"teacher_disagreement_score":0.052708145,"about_ca_system_score_codex":0.00009454667,"about_ca_system_score_gemma":0.0004205798,"threshold_uncertainty_score":0.9072225},"labels":[],"label_agreement":null},{"id":"W3083697290","doi":"10.1158/1538-7445.am2020-6321","title":"Abstract 6321: BEND3 modulates sensitivity to the UBA1 inhibitor TAK-243 by regulating expression of the multidrug transporter BCRP","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Knockout mouse; Biology; Gene knockout; ATP-binding cassette transporter; Ubiquitin; Abcg2; Cancer research; Cell biology; Molecular biology; Genetics; Gene; Transporter","score_opus":0.047927151086864295,"score_gpt":0.32745588601317666,"score_spread":0.27952873492631236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083697290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324626,0.0006008751,0.00012986905,0.004876892,0.00006989209,0.00053958874,0.00027124226,0.000008212035,0.0002571531],"genre_scores_gemma":[0.9986623,0.000056216508,0.00009616749,0.00037582603,0.0004524367,0.00007213544,0.0000342221,0.000024169824,0.00022654892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985095,0.00022567948,0.0001894906,0.0003544681,0.00039823752,0.00032260414],"domain_scores_gemma":[0.9992222,0.000050722792,0.000058037836,0.0003838887,0.0001543302,0.0001307934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006466525,0.00011995798,0.00012517076,0.00001640644,0.00021264907,0.000024625693,0.00029120586,0.00010794558,0.00007636727],"category_scores_gemma":[0.00016921943,0.00007331204,0.00009212627,0.00018087353,0.00013877537,0.0000055299233,0.00019768237,0.0003147136,0.000006946816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012193451,0.000020530731,0.0007305628,0.000055570526,0.000011680878,0.000001298157,0.00072058366,0.000343842,0.9833171,0.0000036209506,0.010229193,0.0044440767],"study_design_scores_gemma":[0.00023032648,0.000064276865,0.0026402373,0.00008050755,0.000003265036,7.181261e-7,0.00017553537,0.00012286741,0.96914923,0.00000956344,0.02742974,0.00009372505],"about_ca_topic_score_codex":0.00021659897,"about_ca_topic_score_gemma":0.00009579279,"teacher_disagreement_score":0.017200546,"about_ca_system_score_codex":0.00001806078,"about_ca_system_score_gemma":0.00010014972,"threshold_uncertainty_score":0.29895782},"labels":[],"label_agreement":null},{"id":"W3083711044","doi":"10.1158/1538-7445.am2020-779","title":"Abstract 779: A phase I study of BI 754111, an anti-LAG-3 monoclonal antibody (mAb), in combination with BI 754091, an anti-PD-1 mAb: Biomarker analyses from the microsatellite stable metastatic colorectal cancer (MSS mCRC) cohort","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); University of Alberta","funders":"","keywords":"Medicine; Immune checkpoint; Monoclonal antibody; Immune system; Biomarker; Peripheral blood mononuclear cell; CD8; Antibody; Oncology; Tumor microenvironment; Immunotherapy; T cell; Internal medicine; Cancer research; Immunology; Biology; In vitro","score_opus":0.1651016991836861,"score_gpt":0.47874438294533583,"score_spread":0.3136426837616497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083711044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890608,0.0055578975,0.000017835559,0.0013083651,0.00013361729,0.0029648596,0.00083901495,0.00005090009,0.000066668195],"genre_scores_gemma":[0.9962219,0.0022796395,0.000099558165,0.00026090338,0.00013134643,0.0003611984,0.0005256928,0.00008677777,0.000032995278],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99500364,0.0007531197,0.0008334417,0.0010177152,0.0015737921,0.00081829156],"domain_scores_gemma":[0.9976511,0.00035305734,0.0002986626,0.0006602284,0.00068348733,0.00035345438],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016890771,0.00042008678,0.000979373,0.00045890873,0.0003340101,0.0001817515,0.0005834212,0.00012317921,0.0013839912],"category_scores_gemma":[0.000073935524,0.00028933972,0.00013063564,0.0027653878,0.00073631515,0.00051394687,0.0001069617,0.00072216726,0.0000056817653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014568885,0.0032933427,0.29742396,0.00014833776,0.0013590157,0.00020465089,0.003752976,0.00010378227,0.6702744,0.0000026519963,0.0002817933,0.008586193],"study_design_scores_gemma":[0.018467141,0.0043070223,0.81411636,0.00039061045,0.00037314452,0.000008939097,0.008102791,0.0021648363,0.15122217,0.000014151802,0.00044068502,0.00039215796],"about_ca_topic_score_codex":0.077190615,"about_ca_topic_score_gemma":0.009106574,"teacher_disagreement_score":0.5190522,"about_ca_system_score_codex":0.00044855222,"about_ca_system_score_gemma":0.0012544942,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W3083714561","doi":"10.1158/1538-7445.am2020-243","title":"Abstract 243: Integration of transcriptome and metabolome provides unique insights to pathways associated with obese breast cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Metabolome; Transcriptome; Biology; Pyrimidine metabolism; Metabolomics; Metabolic pathway; Bioinformatics; Endocrinology; Metabolism; Biochemistry; Gene expression; Gene; Purine","score_opus":0.042913843277891245,"score_gpt":0.3158634087345963,"score_spread":0.272949565456705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083714561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933372,0.004472893,0.00004834629,0.0006518063,0.00013464282,0.00060403085,0.00059719436,0.000011742359,0.00014211789],"genre_scores_gemma":[0.9959033,0.0028865503,0.000037111513,0.00028852,0.0003739801,0.00026788388,0.00010373377,0.00003145608,0.00010744969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852675,0.000117382486,0.00021343913,0.0004279538,0.0003924037,0.00032208717],"domain_scores_gemma":[0.9987435,0.000019463474,0.00007109803,0.00017115251,0.0007327144,0.00026212324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021583866,0.00016172549,0.0002543669,0.000093340605,0.00008436012,0.000034142908,0.00018929907,0.00012831089,0.000042083662],"category_scores_gemma":[0.00012530517,0.00012638405,0.000047310885,0.00041228824,0.00015341945,0.000018333007,0.000066281995,0.00023226633,0.0000013282321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006242986,0.00008965127,0.0021672137,0.000077656325,0.000095851916,7.5408184e-7,0.0013128758,0.000024630934,0.98378175,0.000048764476,0.0013996352,0.010376937],"study_design_scores_gemma":[0.002464199,0.00092520035,0.224916,0.00028518552,0.0000592573,0.0000011863909,0.0004462269,0.000024844805,0.7246534,0.000053979813,0.045762077,0.0004084414],"about_ca_topic_score_codex":0.0008288483,"about_ca_topic_score_gemma":0.0018006081,"teacher_disagreement_score":0.25912833,"about_ca_system_score_codex":0.000053800468,"about_ca_system_score_gemma":0.0004472595,"threshold_uncertainty_score":0.51537925},"labels":[],"label_agreement":null},{"id":"W3083715659","doi":"10.1158/1538-7445.am2020-1953","title":"Abstract 1953: Pre-clinical development of the second-generation N-terminal domain androgen receptor inhibitor, EPI-7386, for the treatment of prostate cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Androgen receptor; LNCaP; Prostate cancer; Cancer research; Cancer; Chemistry; Computational biology; Biology; Pharmacology; Genetics","score_opus":0.18562171698225297,"score_gpt":0.460539999905851,"score_spread":0.274918282923598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083715659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787524,0.008465533,0.000009554403,0.008201897,0.00028826634,0.0038488384,0.00034119905,0.000011246615,0.000081068894],"genre_scores_gemma":[0.9864921,0.005198082,0.00038009975,0.00011614288,0.0011066796,0.002886891,0.00006962988,0.00004240541,0.0037079875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974371,0.00016991237,0.0006499783,0.00043012292,0.00082093064,0.0004919101],"domain_scores_gemma":[0.998295,0.00034900583,0.00017423762,0.0003674756,0.0005848613,0.00022942443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009271784,0.0001848986,0.00041595896,0.00005253129,0.00032064927,0.000026125954,0.00025848506,0.000111860034,0.0009382528],"category_scores_gemma":[0.00008412056,0.00009382984,0.00021366865,0.00040389207,0.0004937291,0.00006112427,0.0000836812,0.00032936662,0.00000812018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013137863,0.001553267,0.07381884,0.0018957554,0.0017388816,0.00002131114,0.02584761,0.00004609828,0.42762136,0.000034224617,0.035580292,0.41870448],"study_design_scores_gemma":[0.005552452,0.0017906134,0.026000433,0.00025600265,0.000068479254,0.0000016837657,0.0004962633,0.000084488376,0.7345276,0.00002090211,0.23107672,0.00012437288],"about_ca_topic_score_codex":0.00019961684,"about_ca_topic_score_gemma":0.00078516616,"teacher_disagreement_score":0.4185801,"about_ca_system_score_codex":0.0005520993,"about_ca_system_score_gemma":0.0027122481,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W3083723887","doi":"10.1158/1538-7445.am2020-978","title":"Abstract 978: Monocyte-derived macrophages contribute to the inflammation-induced survival of experimental micrometastases in the lung","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto; University of British Columbia","funders":"","keywords":"Inflammation; Extravasation; Cancer research; Melanoma; Medicine; Lung; Metastasis; CD11c; Monocyte; Immunology; Tumor microenvironment; Pathology; Biology; Cancer; Internal medicine; Tumor cells","score_opus":0.10961423753870707,"score_gpt":0.41656794793144397,"score_spread":0.3069537103927369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083723887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967234,0.006138142,0.000006532703,0.025114115,0.0000897255,0.0011442918,0.00007326253,0.000010436357,0.00018949255],"genre_scores_gemma":[0.99840915,0.00035964831,0.000012939688,0.0006490371,0.00026077445,0.0002474602,0.000013937642,0.00001504569,0.00003197808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833566,0.00022827103,0.00028589892,0.00021474878,0.00061439927,0.00032102782],"domain_scores_gemma":[0.9991226,0.0003018561,0.000053717762,0.0002809464,0.00015318852,0.00008769597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011022391,0.000107912165,0.00022500547,0.00009542962,0.00011688131,0.000046079986,0.00034620918,0.0000432094,0.00047353204],"category_scores_gemma":[0.00015972834,0.00006290056,0.00008196602,0.00071520195,0.00013241649,0.000056117246,0.00007504096,0.0003316135,0.000016720109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029172238,0.00004760846,0.0009307041,0.000063798274,0.00009558117,0.000029828936,0.004643173,0.000009096746,0.98378116,0.00001810885,0.0041529997,0.0033107416],"study_design_scores_gemma":[0.002102192,0.00029237755,0.05753629,0.00009885917,0.000011084794,0.0000027691613,0.0049890927,0.000023930434,0.9280558,0.0000026441467,0.0068100044,0.00007493278],"about_ca_topic_score_codex":0.0018929563,"about_ca_topic_score_gemma":0.00021054976,"teacher_disagreement_score":0.056605585,"about_ca_system_score_codex":0.00019489053,"about_ca_system_score_gemma":0.000299194,"threshold_uncertainty_score":0.51848435},"labels":[],"label_agreement":null},{"id":"W3083727132","doi":"10.1158/1538-7445.am2020-5887","title":"Abstract 5887: Clonal heterogeneity and evolution of multifocal lung cancers revealed by whole exome sequencing to facilitate molecular diagnosis of multiple primary lung cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Atypical adenomatous hyperplasia; Adenocarcinoma; Lung cancer; Medicine; Lung; Exome sequencing; Pathology; Stage (stratigraphy); Adenocarcinoma of the lung; Oncology; Cancer; Internal medicine; Biology; Mutation","score_opus":0.07729295988666274,"score_gpt":0.36707239386204227,"score_spread":0.28977943397537953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083727132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97479403,0.01930895,0.00013154375,0.0028125085,0.00008099049,0.001569139,0.0011650579,0.000027036018,0.00011073221],"genre_scores_gemma":[0.99587053,0.0021913538,0.00030967017,0.00032298322,0.00008724361,0.0010724494,0.0000654579,0.000042802374,0.0000375181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693793,0.00013822594,0.00053280976,0.0007338629,0.0010341393,0.00062305166],"domain_scores_gemma":[0.9981019,0.00028142205,0.00013725046,0.0003610181,0.0004872426,0.0006311889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004916786,0.00025733045,0.00065973884,0.00017909617,0.00011469859,0.000018977911,0.0001875933,0.00012367043,0.00008030766],"category_scores_gemma":[0.00024715875,0.00024117688,0.0001515433,0.00062193983,0.0002975024,0.00012675048,0.00016372728,0.00039040003,0.0000043906007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010821614,0.0000996697,0.6208161,0.0027555737,0.00044387218,0.00006120776,0.0013878103,0.0024871926,0.35793114,0.0000067815186,0.010176014,0.0027524882],"study_design_scores_gemma":[0.007013451,0.0013301559,0.5484149,0.0024898732,0.0003000948,0.0000062522577,0.0007915774,0.0033164541,0.43322226,0.00001210341,0.0026010727,0.00050182076],"about_ca_topic_score_codex":0.03257961,"about_ca_topic_score_gemma":0.0016293556,"teacher_disagreement_score":0.07529113,"about_ca_system_score_codex":0.008455366,"about_ca_system_score_gemma":0.0018557615,"threshold_uncertainty_score":0.995351},"labels":[],"label_agreement":null},{"id":"W3083730531","doi":"10.1158/1538-7445.am2020-1369","title":"Abstract 1369: Dianhydrogalactitol (VAL-083) synergizes with topoisomerase inhibitors to overcome homologous recombination repair activity in glioblastoma and prostate cancer cells","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Propidium iodide; Cancer research; DNA repair; Cell cycle; Molecular biology; Biology; Cancer cell; DNA damage; Cancer; Chemistry; DNA; Apoptosis; Programmed cell death; Genetics","score_opus":0.01829799740755562,"score_gpt":0.31230392745852364,"score_spread":0.29400593005096803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083730531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963468,0.00056913117,0.0000074960385,0.0019097251,0.00012836218,0.00083158567,0.00005321929,0.000045095076,0.000108628636],"genre_scores_gemma":[0.99779904,0.0007195722,0.0001039381,0.00019131874,0.00017629682,0.0005379647,0.0000060576913,0.000046739275,0.0004190673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798846,0.00015448828,0.00018628994,0.0007472121,0.00039627074,0.0005272994],"domain_scores_gemma":[0.9991193,0.000041559553,0.0000620046,0.0002960302,0.0001698432,0.0003112902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004194988,0.00020064416,0.00021864737,0.00015292007,0.000106604064,0.00005707764,0.00017419226,0.00015478,0.00005547252],"category_scores_gemma":[0.00010752144,0.00018548148,0.000050335162,0.0004912463,0.000120307435,0.00002797989,0.00022678507,0.00037832305,0.000012462218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013792572,0.000088134184,0.0026883055,0.00013440152,0.00004072323,0.00008023244,0.0004862648,0.0003264747,0.98544234,0.0000061713413,0.0017652124,0.0075624604],"study_design_scores_gemma":[0.00086878985,0.0011925811,0.0054787975,0.000092902854,0.0000065510035,0.000004074183,0.00015216084,0.00007757224,0.9881905,0.000022013443,0.003669381,0.00024467724],"about_ca_topic_score_codex":0.0015570725,"about_ca_topic_score_gemma":0.002115067,"teacher_disagreement_score":0.0073177833,"about_ca_system_score_codex":0.0001990457,"about_ca_system_score_gemma":0.00032656253,"threshold_uncertainty_score":0.7563715},"labels":[],"label_agreement":null},{"id":"W3083735926","doi":"10.1158/1538-7445.am2020-4130","title":"Abstract 4130: Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Mitosis; Mitotic catastrophe; Cancer research; Cell cycle; Kinase; Cell growth; Apoptosis; Cell biology","score_opus":0.10802873920770342,"score_gpt":0.45531401868136095,"score_spread":0.3472852794736575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083735926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892185,0.002634621,4.0044944e-7,0.006400409,0.00009080596,0.0011349897,0.00010565996,0.0000058266737,0.00040880288],"genre_scores_gemma":[0.99726635,0.0018066594,0.000018907516,0.00013216965,0.0002437931,0.00019824177,0.000017864912,0.000014159865,0.00030182564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985612,0.00007629566,0.00038501227,0.00022755329,0.0004632929,0.00028664773],"domain_scores_gemma":[0.9991312,0.0002489014,0.00009780934,0.00026347474,0.00014955025,0.00010904363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027678284,0.00012297992,0.0004001547,0.00015108766,0.000025596875,0.0000036494484,0.0001636442,0.00004199464,0.0007960354],"category_scores_gemma":[0.000021142252,0.000079600766,0.000119592034,0.0004761864,0.0002504073,0.000026995507,0.0000443206,0.00017047668,0.000004540792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052535525,0.0034804135,0.014913741,0.00084477867,0.00023088258,0.00012652305,0.008019541,0.0000129555365,0.9168484,0.000034321954,0.003692711,0.046542186],"study_design_scores_gemma":[0.011157157,0.006883176,0.07089372,0.0001245198,0.00006744443,0.0000019230008,0.00074048224,0.000015821692,0.87734294,0.000014394203,0.03268313,0.000075302545],"about_ca_topic_score_codex":0.0049572727,"about_ca_topic_score_gemma":0.00030087566,"teacher_disagreement_score":0.055979975,"about_ca_system_score_codex":0.00024222134,"about_ca_system_score_gemma":0.00041301217,"threshold_uncertainty_score":0.8716029},"labels":[],"label_agreement":null},{"id":"W3083740962","doi":"10.1158/1538-7445.am2020-1583","title":"Abstract 1583: The tumor immune microenvironment in early breast cancer progression","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Ductal carcinoma; Mass cytometry; Immune system; Breast cancer; Cancer research; Cancer; Tumor progression; Pathology; Medicine; Biology; Immunology; Internal medicine; Phenotype","score_opus":0.04268127745866636,"score_gpt":0.33783850620904887,"score_spread":0.2951572287503825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083740962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799145,0.005537269,0.000008080755,0.0057841395,0.000086910506,0.0003446726,0.00005689001,0.0000056640088,0.00018489639],"genre_scores_gemma":[0.9971715,0.0016945509,0.000016842556,0.00039158348,0.0003886679,0.00018534005,0.000013431893,0.000025651038,0.000112412294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987514,0.000081684775,0.00016992172,0.0003344134,0.0002768269,0.00038574118],"domain_scores_gemma":[0.9995761,0.00001182715,0.000032589196,0.00022615664,0.000048657745,0.000104689425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026460353,0.00011101123,0.00010882427,0.000024483536,0.00011615069,0.00004297861,0.00035443026,0.000069172616,0.00020553454],"category_scores_gemma":[0.000014850995,0.00007896191,0.000055625598,0.00015029086,0.00018894904,0.000004297746,0.00012584773,0.00036972787,0.000021014383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038712114,0.00005923475,0.023128737,0.00003849534,0.000017636894,0.00001070974,0.00024802276,0.000065984204,0.9650116,0.0000028249087,0.00086769793,0.010161918],"study_design_scores_gemma":[0.00082720723,0.00017020633,0.29710624,0.000105635314,0.000005118952,0.000003726749,0.00013234172,0.00004282617,0.6774089,0.0000079566935,0.02401591,0.00017398364],"about_ca_topic_score_codex":0.0012604933,"about_ca_topic_score_gemma":0.00021608664,"teacher_disagreement_score":0.28760275,"about_ca_system_score_codex":0.00006629174,"about_ca_system_score_gemma":0.00015508554,"threshold_uncertainty_score":0.3219973},"labels":[],"label_agreement":null},{"id":"W3083742534","doi":"10.1158/1538-7445.am2020-5774","title":"Abstract 5774: Indo-Canadian parternship for oral cancer screening in rural India","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kelowna General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cancer; Socioeconomic status; Family medicine; Environmental health; Population; Internal medicine","score_opus":0.32819243010348353,"score_gpt":0.5141447116891581,"score_spread":0.18595228158567456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083742534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907576,0.0014705954,0.0000098253795,0.0054114647,0.00031236207,0.000875616,0.00046356829,0.000028502713,0.0006704585],"genre_scores_gemma":[0.9968225,0.00011302099,0.00008320422,0.00090099213,0.0004292757,0.0012037006,0.00005033051,0.00003252126,0.00036447012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978014,0.00016480881,0.0002678025,0.0003696853,0.00031570258,0.0010805691],"domain_scores_gemma":[0.9988405,0.00019655025,0.000045651293,0.00018313747,0.00012391697,0.0006102536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066188315,0.0001438227,0.000246346,0.00020933672,0.00028326194,0.000054188204,0.0002866873,0.00020950547,0.0014710319],"category_scores_gemma":[0.000104294806,0.00013914383,0.000061020426,0.0004429856,0.000117496216,0.00013453807,0.000054483633,0.0008008764,0.00031808042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045940894,0.000044103625,0.9449611,0.00020777363,0.000042556352,0.0006322458,0.00085658295,0.000035380006,0.00016260962,0.00026300424,0.008638359,0.04369692],"study_design_scores_gemma":[0.002219092,0.00018882047,0.9824162,0.00016254555,0.000009292678,0.000004628442,0.00049678073,0.00009936875,0.00095631235,0.0002887829,0.01297777,0.00018038797],"about_ca_topic_score_codex":0.14147992,"about_ca_topic_score_gemma":0.42228326,"teacher_disagreement_score":0.28080332,"about_ca_system_score_codex":0.0004465822,"about_ca_system_score_gemma":0.000988832,"threshold_uncertainty_score":0.99944174},"labels":[],"label_agreement":null},{"id":"W3083758578","doi":"10.1158/1538-7445.am2020-2015","title":"Abstract 2015: A transcriptionally enhanced biosensor to detect and monitor biopsy-dissociated primary prostate cancer single cell drug responses by bioluminescence microscopy","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Enzalutamide; Prostate cancer; LNCaP; Androgen receptor; Cancer research; PCA3; Cell culture; Cancer cell; Cancer; Cell; Circulating tumor cell; Prostate; Biology; Medicine; Chemistry; Internal medicine; Metastasis; Biochemistry","score_opus":0.04859452136934901,"score_gpt":0.3828039818549057,"score_spread":0.3342094604855567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083758578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482579,0.021680456,0.000010057009,0.026081465,0.0001387778,0.0021574253,0.001324866,0.00010983776,0.00023917986],"genre_scores_gemma":[0.9786592,0.008684219,0.0004680396,0.00073640334,0.00031365443,0.0009168393,0.00011314253,0.000093557166,0.010014905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961871,0.00020223112,0.00040918385,0.0009822601,0.0010766874,0.0011425387],"domain_scores_gemma":[0.9976042,0.00022366228,0.00008051727,0.00029560446,0.0007843018,0.0010117118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005337622,0.00034727593,0.0005142455,0.00028826416,0.00035657125,0.00016136773,0.00028055406,0.00015397041,0.0003013045],"category_scores_gemma":[0.00015678898,0.0002917107,0.00010174303,0.0012366131,0.0004860981,0.00017881242,0.00012305184,0.0007193409,0.00007831957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093144635,0.00016861591,0.002341143,0.0007454597,0.00010029591,0.00008373979,0.0021178436,0.0000013966193,0.9478902,3.0174726e-7,0.03071589,0.006520619],"study_design_scores_gemma":[0.0032265321,0.0007748909,0.018206654,0.00050166063,0.000038140257,0.0000034790698,0.00042821147,0.0000043926507,0.9646574,0.000006982071,0.011836748,0.0003148823],"about_ca_topic_score_codex":0.0014515446,"about_ca_topic_score_gemma":0.000084228326,"teacher_disagreement_score":0.030401304,"about_ca_system_score_codex":0.0009144494,"about_ca_system_score_gemma":0.001160551,"threshold_uncertainty_score":0.9999535},"labels":[],"label_agreement":null},{"id":"W3087035662","doi":"10.1158/0008-5472.can-19-3981","title":"Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific Chemotherapies","year":2020,"lang":"en","type":"review","venue":"Cancer Research","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland; Marshall Aid Commemoration Commission; National Cancer Institute; Health Research Board","keywords":"Goldilocks principle; Cancer; Intensive care medicine; Dosing; Disease; Medicine; Chemotherapy; Schedule; Bioinformatics; Biology; Internal medicine; Computer science","score_opus":0.13396557117334237,"score_gpt":0.44036551887937336,"score_spread":0.30639994770603096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087035662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093711645,0.98903686,0.0004363405,0.0015649449,0.00018142039,0.0071364557,0.00042959777,0.00008998765,0.00018728994],"genre_scores_gemma":[0.00084529276,0.9902002,0.0013850356,0.000041716034,0.00054805225,0.006288755,0.00005191029,0.00018407914,0.00045496182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995813,0.0011542618,0.0004844374,0.0009860784,0.00057283475,0.0009893462],"domain_scores_gemma":[0.99144965,0.0071137976,0.00026140074,0.0005304859,0.00036388967,0.0002807749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013752539,0.00052568404,0.0019989077,0.00038087444,0.00032870687,0.00012089621,0.0005192779,0.00050169195,0.00009589732],"category_scores_gemma":[0.0021889443,0.00039873796,0.0003291439,0.0005900082,0.0007170758,0.000069005844,0.00045054487,0.001449191,0.000021405833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091857,0.000099050405,0.000017094691,0.057469983,0.00054726587,0.000030303863,0.001407522,1.0169644e-7,0.000047481324,0.042672936,0.01216576,0.88545066],"study_design_scores_gemma":[0.00054054306,0.00058953266,0.0000073965102,0.0056671253,0.00016960339,0.000035440098,0.00039316664,0.000022426757,0.00007779807,0.072793305,0.91921914,0.00048451626],"about_ca_topic_score_codex":0.000039399114,"about_ca_topic_score_gemma":0.00007140901,"teacher_disagreement_score":0.9070534,"about_ca_system_score_codex":0.0016966085,"about_ca_system_score_gemma":0.0007162276,"threshold_uncertainty_score":0.99984646},"labels":[],"label_agreement":null},{"id":"W3087210672","doi":"10.1158/0008-5472.can-20-0624","title":"Cancers from Novel <i>Pole</i> -Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade","year":2020,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; University of Toronto","funders":"National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Stand Up To Cancer; National Institutes of Health","keywords":"Biology; Carcinogenesis; Cancer research; Phenotype; Cancer; Mutagenesis; Mutation; Genetics; Blockade; Immunotherapy; Gene; Receptor","score_opus":0.036109221897172694,"score_gpt":0.2932745242812809,"score_spread":0.25716530238410823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087210672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61836225,0.09481647,0.00040005,0.2781112,0.0007604013,0.0017478757,0.005473507,0.00006880679,0.00025947747],"genre_scores_gemma":[0.5018466,0.11432096,0.000772944,0.34440005,0.02121465,0.0026079277,0.01087515,0.0009223307,0.0030393612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99579537,0.00016449542,0.00062948145,0.0016080319,0.00080928573,0.0009933608],"domain_scores_gemma":[0.997791,0.00019130613,0.00021769857,0.0010167436,0.0003844139,0.00039882964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017921519,0.0006298667,0.00070901425,0.00021143853,0.0003274173,0.00020803319,0.0008477835,0.0009875915,0.000055897588],"category_scores_gemma":[0.00023281605,0.0006299067,0.00021330507,0.00035364466,0.0005625684,0.0000131612105,0.000982649,0.0018166229,0.000019702415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026083298,0.00003159658,0.000014808983,0.00018357678,0.0003411856,0.00014289583,0.00037652557,0.0002980318,0.88267004,0.0000042504776,0.114968486,0.0007077465],"study_design_scores_gemma":[0.00095048896,0.00018364651,0.000005506651,0.00009412965,0.000064265405,0.000004027211,0.00007172701,0.0006684156,0.5514176,0.00019190657,0.44578782,0.0005604982],"about_ca_topic_score_codex":0.031552188,"about_ca_topic_score_gemma":0.0020141832,"teacher_disagreement_score":0.3312525,"about_ca_system_score_codex":0.0006004312,"about_ca_system_score_gemma":0.0027871917,"threshold_uncertainty_score":0.99961525},"labels":[],"label_agreement":null},{"id":"W3089607491","doi":"10.1158/1538-7445.mel2019-a18","title":"Abstract A18: Ccn1 expression by fibroblasts is required for melanoma metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University","funders":"","keywords":"Cancer research; Metastasis; CYR61; Melanoma; Extracellular matrix; Tumor microenvironment; Tumor progression; Pathology; Biology; Matricellular protein; Cancer; CTGF; Medicine; Growth factor; Cell biology","score_opus":0.11527156109701055,"score_gpt":0.4150525667375126,"score_spread":0.2997810056405021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089607491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854386,0.0049416865,0.00085651636,0.005909589,0.00007051557,0.0010817009,0.00097771,0.000026192052,0.00069748214],"genre_scores_gemma":[0.99670017,0.00037017337,0.00020098926,0.00027729422,0.00046681965,0.0005436122,0.00017628506,0.00006366195,0.0012010189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997499,0.00015258303,0.00021836757,0.000790683,0.00059987634,0.00073949987],"domain_scores_gemma":[0.9985417,0.00012403385,0.00004972364,0.00043074563,0.00046676648,0.00038700504],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005408716,0.00018503008,0.00021185387,0.00007565498,0.00022203212,0.00008130147,0.0005637515,0.00017107937,0.0009185528],"category_scores_gemma":[0.00063624536,0.00017454254,0.00013117817,0.00028906012,0.00017171325,0.0000130359385,0.00039348684,0.00030210364,0.00007758416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057167606,0.000028123442,0.00028064428,0.000115760806,0.00005814024,0.0000031008442,0.00012210298,0.00000226933,0.7707777,0.000008700838,0.22241764,0.0056141494],"study_design_scores_gemma":[0.0006434694,0.00043359626,0.00030685394,0.000026639636,0.0000043039995,6.3673923e-7,0.00008781838,0.0000152659,0.74875265,0.000043579854,0.24953769,0.00014749027],"about_ca_topic_score_codex":0.00012643843,"about_ca_topic_score_gemma":0.000023016348,"teacher_disagreement_score":0.02712005,"about_ca_system_score_codex":0.00007777299,"about_ca_system_score_gemma":0.0002773502,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W3090341601","doi":"10.1158/1538-7445.mel2019-b11","title":"Abstract B11: Prognostic biomarkers in stage II-III melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Melanoma; Medicine; Immune system; CD68; CD8; Immunotherapy; Population; Cancer research; Oncology; Immunology; Pathology; Internal medicine; Immunohistochemistry","score_opus":0.07477771625519929,"score_gpt":0.36674315381217376,"score_spread":0.29196543755697446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090341601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654692,0.028535275,0.0000047088647,0.003093172,0.00024311253,0.00055360096,0.00004043944,0.000055117434,0.0020054148],"genre_scores_gemma":[0.993808,0.0012337604,0.00000715951,0.00025347542,0.000040483097,0.00018586997,0.000030788062,0.000027229655,0.004413267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980501,0.00040690627,0.00030783284,0.00038681668,0.00010273623,0.00074561767],"domain_scores_gemma":[0.9991216,0.00041329284,0.000051141436,0.00026902615,0.000102465456,0.00004246093],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081697805,0.000159873,0.00026088444,0.00023516393,0.00032073335,0.00002998941,0.00046874848,0.00021577884,0.0069640675],"category_scores_gemma":[0.00031812745,0.00014256033,0.00007268319,0.0006261527,0.00042559998,0.00012258271,0.0001880817,0.0008479142,0.000541648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033889466,0.00011314606,0.0050267177,0.000053371343,0.00024284856,0.00004815245,0.0021601124,0.000005115733,0.966928,0.000117288946,0.0077261515,0.014190131],"study_design_scores_gemma":[0.0044838456,0.0008868713,0.06774325,0.00018666085,0.000009128273,0.0000093264125,0.0016447596,0.0000057040616,0.5312121,0.00004021491,0.39342424,0.00035391276],"about_ca_topic_score_codex":0.0013722052,"about_ca_topic_score_gemma":0.000098564335,"teacher_disagreement_score":0.4357159,"about_ca_system_score_codex":0.00012571372,"about_ca_system_score_gemma":0.00041737553,"threshold_uncertainty_score":0.9939437},"labels":[],"label_agreement":null},{"id":"W3092753222","doi":"","title":"MMR variants & HNPCC susceptibility","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"MLH1; Biology; DNA mismatch repair; Genetics; Lynch syndrome; Germline mutation; Gene; Germline; Missense mutation; Phenotype; Mutagenesis; Mutation; Colorectal cancer; Cancer research; Cancer","score_opus":0.09918285890962324,"score_gpt":0.43751504459706975,"score_spread":0.3383321856874465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092753222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610826,0.0012944235,0.0000315512,0.0016566188,0.0003711284,0.0006075195,0.000020219166,0.00006202836,0.03487391],"genre_scores_gemma":[0.988209,0.0001056617,0.00030598007,0.00012795652,0.0008012191,0.00018306152,0.000010937921,0.000032731954,0.0102234585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975439,0.00013899943,0.00022062699,0.00047736883,0.00095838326,0.000660755],"domain_scores_gemma":[0.9985358,0.00014504275,0.000025412084,0.00058851356,0.0005216752,0.00018353004],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090602745,0.00012368248,0.00022480285,0.00015555628,0.00013852275,0.00003327903,0.00019776044,0.00012522818,0.0051764348],"category_scores_gemma":[0.00021799743,0.00010659043,0.000071803806,0.00061740266,0.0003402834,0.00004270519,0.00012278023,0.00056972523,0.00027401478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008357029,0.0003467075,0.23243198,0.00027935507,0.000054822398,0.000104163446,0.00018335262,0.000054988064,0.6270691,0.00063306297,0.12354999,0.014456738],"study_design_scores_gemma":[0.002017325,0.0006831551,0.7483086,0.00015524286,0.00003155731,0.000029681396,0.00011654316,0.00009640122,0.17083627,0.0036313082,0.07382764,0.00026628905],"about_ca_topic_score_codex":0.004077178,"about_ca_topic_score_gemma":0.0013075421,"teacher_disagreement_score":0.5158766,"about_ca_system_score_codex":0.0007588416,"about_ca_system_score_gemma":0.000759469,"threshold_uncertainty_score":0.99573296},"labels":[],"label_agreement":null},{"id":"W3092806394","doi":"10.1158/0008-5472.can-19-4036","title":"Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Tumor microenvironment; Cancer research; Immune system; Innate immune system; Immunology; Biology; Cancer; Hsp90 inhibitor; Heat shock protein; Medicine; Hsp90","score_opus":0.02129564951906584,"score_gpt":0.30267605887919546,"score_spread":0.28138040936012965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092806394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97914594,0.013323204,0.00000532549,0.0054011866,0.0012936532,0.00050758244,0.000018845087,0.00002767897,0.00027656753],"genre_scores_gemma":[0.9864323,0.00092360866,0.0000096605145,0.00008143125,0.000057812413,0.00016957849,0.00004069473,0.000020311809,0.012264576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858963,0.00030810083,0.00027605516,0.00035476242,0.00010596017,0.00036546605],"domain_scores_gemma":[0.9995042,0.00006327977,0.000050594383,0.00016121588,0.00018139528,0.000039276867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023575666,0.0001395766,0.00023113302,0.00015150913,0.00012665306,0.000015811096,0.00014307328,0.0001468797,0.001099183],"category_scores_gemma":[0.00004840987,0.000119624434,0.000042938,0.00032526083,0.00011657937,0.0001865052,0.00009765241,0.0007745169,0.000036030062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017844163,0.00005315399,0.0007699837,0.00017927318,0.000019964407,0.0000022453773,0.0010277379,0.000021228218,0.968273,0.000025211913,0.027325891,0.0005178993],"study_design_scores_gemma":[0.0015203522,0.00007435834,0.010940098,0.00037041985,0.0000057882016,0.0000031064135,0.0005411591,0.000075078344,0.9601189,0.000009787784,0.02618517,0.00015581794],"about_ca_topic_score_codex":0.0011182696,"about_ca_topic_score_gemma":0.00026592016,"teacher_disagreement_score":0.012399595,"about_ca_system_score_codex":0.00016137824,"about_ca_system_score_gemma":0.00011218995,"threshold_uncertainty_score":0.999814},"labels":[],"label_agreement":null},{"id":"W3092841805","doi":"10.1158/0008-5472.can-20-0957","title":"The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Duke-NUS Medical School; Medical Research Council; National Medical Research Council; National Research Foundation Singapore; National Research Foundation","keywords":"Wnt signaling pathway; Missense mutation; Biology; Frameshift mutation; Mutation; Cancer research; Genetics; Cell biology; Signal transduction; Gene","score_opus":0.03530456705697052,"score_gpt":0.3174099141225577,"score_spread":0.2821053470655872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092841805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356246,0.0005029775,0.00082096126,0.004457173,0.00010861646,0.0003261419,0.000058158035,0.000008243798,0.00015525844],"genre_scores_gemma":[0.99905694,0.00012173206,0.000027346314,0.00012198615,0.00036456002,0.00009658066,0.00013059253,0.000012193419,0.000068101086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989642,0.00015107378,0.00013704032,0.00022605315,0.000332583,0.00018907995],"domain_scores_gemma":[0.99924755,0.000046047287,0.000040143263,0.00014581889,0.00041237663,0.00010806062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023542889,0.0000622604,0.000064126805,0.00003639623,0.0001775023,0.00001875548,0.00004744303,0.00006970336,0.00003673436],"category_scores_gemma":[0.0002265983,0.000052670614,0.000040359086,0.00028892164,0.00010172693,0.0000041953494,0.00010233181,0.00012045518,0.000011977127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031538715,0.000012597022,0.00031865464,0.000012315083,0.000029521574,7.870699e-7,0.00019970449,0.008848506,0.974559,0.000034495664,0.009860417,0.0058086226],"study_design_scores_gemma":[0.00035100116,0.0003169642,0.006913495,0.0000195824,0.000006698251,0.0000022919155,0.00023999054,0.0005567964,0.97912025,0.00004497178,0.012357083,0.00007085062],"about_ca_topic_score_codex":0.000051041163,"about_ca_topic_score_gemma":0.00022057403,"teacher_disagreement_score":0.008291709,"about_ca_system_score_codex":0.000041779505,"about_ca_system_score_gemma":0.00025473916,"threshold_uncertainty_score":0.21478452},"labels":[],"label_agreement":null},{"id":"W3094554399","doi":"10.1158/0008-5472.can-19-3923","title":"Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Ontario Brain Institute; University of Calgary","funders":"Government of Canada; Stand Up To Cancer; Genome Canada; Canadian Institutes of Health Research; American Association for Cancer Research","keywords":"Glutaminase; Glutamine; Vulnerability (computing); Biology; Cell; Amino acid; Internal medicine; Biochemistry; Cancer research; Endocrinology; Cell biology; Medicine; Computer science","score_opus":0.0645071775150792,"score_gpt":0.3539717765481716,"score_spread":0.2894645990330924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094554399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788738,0.012316447,0.00042701545,0.0066871685,0.00033485075,0.00081650325,0.00018315836,0.000022779284,0.0003382842],"genre_scores_gemma":[0.9907704,0.0012231747,0.00009112026,0.004116399,0.001708877,0.00048383858,0.000026990048,0.000043776316,0.0015354399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958126,0.0016776159,0.0003173815,0.0008446001,0.00071610167,0.00063168525],"domain_scores_gemma":[0.9981682,0.00025401032,0.00010400282,0.00092108233,0.00032626893,0.00022648858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022732534,0.00023166214,0.0002724171,0.000049173013,0.00036638472,0.000086096166,0.00071265723,0.00014103734,0.00009236723],"category_scores_gemma":[0.0009924783,0.00017713722,0.00013995239,0.00053313107,0.0002976256,0.000017019873,0.00032495183,0.00059645047,0.00005477527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023988679,0.000060251292,0.00016066506,0.00005321392,0.000024989507,0.000006457627,0.0009168059,0.00007112714,0.9721388,0.000185329,0.013000597,0.010982857],"study_design_scores_gemma":[0.00056266325,0.00026395553,0.002438685,0.000014306035,0.000008662684,0.0000034845687,0.0003374328,0.00001321818,0.6472429,0.00008217488,0.34888333,0.00014918175],"about_ca_topic_score_codex":0.0002166866,"about_ca_topic_score_gemma":0.0001150778,"teacher_disagreement_score":0.33588272,"about_ca_system_score_codex":0.00007615086,"about_ca_system_score_gemma":0.0007255985,"threshold_uncertainty_score":0.72234464},"labels":[],"label_agreement":null},{"id":"W3095131201","doi":"","title":"TGF-β induced activation of ERK regulates Smad degradation","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"MAPK/ERK pathway; SMAD; Phosphorylation; Cell biology; Kinase; Signal transduction; Smad2 Protein; Biology; Protein kinase A; Chemistry; Molecular biology; Cancer research","score_opus":0.061075162736344606,"score_gpt":0.383423178890362,"score_spread":0.32234801615401737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095131201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837995,0.0007193949,0.00011149499,0.00011095931,0.000039691247,0.00015224557,0.000009853382,0.000008817024,0.00046761308],"genre_scores_gemma":[0.9984007,0.00003092098,0.00011936257,0.000012975314,0.00027409484,0.000061625564,0.00015206162,0.000015833128,0.00093243027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907744,0.000088946275,0.00014386281,0.0002159546,0.00027697347,0.00019682119],"domain_scores_gemma":[0.9993272,0.00002720231,0.000051754614,0.00025118256,0.00030514091,0.00003753121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024759938,0.00006626815,0.00007129394,0.00008275664,0.000077142846,0.000016609245,0.00015745647,0.00009431183,0.0000488411],"category_scores_gemma":[0.00012738963,0.00006526908,0.000033246608,0.00019198984,0.000083823834,0.0000047807457,0.00006168273,0.000086489286,0.000004825155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009122877,0.000047325902,0.0031434682,0.000030379646,0.000014090767,2.83084e-7,0.000012724911,0.00016883033,0.9894466,0.00009790192,0.0033060715,0.0036411362],"study_design_scores_gemma":[0.00022043125,0.00007075167,0.018370163,0.000034459514,0.0000032808537,2.6465995e-7,0.000024474872,0.000016473901,0.976656,0.00023371281,0.004301818,0.00006816528],"about_ca_topic_score_codex":0.0005651572,"about_ca_topic_score_gemma":0.00008193686,"teacher_disagreement_score":0.015226695,"about_ca_system_score_codex":0.000042696687,"about_ca_system_score_gemma":0.00023364754,"threshold_uncertainty_score":0.26615956},"labels":[],"label_agreement":null},{"id":"W3095170121","doi":"10.1158/1538-7445.tumhet2020-ia21","title":"Abstract IA21: Stem cells play a role in human leukemia from origin to relapse","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Leukemia; Stem cell; Cancer research; Cancer; Cancer stem cell; Somatic evolution in cancer; Immunology; Genetics","score_opus":0.05299002597872241,"score_gpt":0.35745698291045386,"score_spread":0.3044669569317314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095170121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952489,0.0016516256,0.000019095714,0.00088693254,0.0001108579,0.0003144714,0.00024194663,0.00000838851,0.0015177594],"genre_scores_gemma":[0.9970817,0.00058393914,0.00006841293,0.0009217227,0.0007591397,0.00012854351,0.000052892472,0.000036592748,0.00036705076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850094,0.00004973692,0.00021280478,0.0005395519,0.00025872185,0.00043824146],"domain_scores_gemma":[0.9991653,0.000051257022,0.000030624517,0.000342069,0.00009598976,0.0003147831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023231177,0.00013089858,0.00016141868,0.000065874156,0.00008188487,0.00006407511,0.0003950524,0.00014138865,0.00018676936],"category_scores_gemma":[0.000047286263,0.00013992605,0.000051436542,0.00024099952,0.000056246554,0.000003300037,0.00027491126,0.0003399773,0.000114218645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017451766,0.000021143916,0.0019205943,0.00001545696,0.000018014858,0.000024413222,0.000388211,0.0011618624,0.9637653,0.00006296503,0.03066697,0.0017805055],"study_design_scores_gemma":[0.00066246407,0.00020998345,0.0024103282,0.000030358087,0.0000033990716,2.2848077e-7,0.00021297963,0.000027985554,0.7678178,0.00011344855,0.22831914,0.00019188145],"about_ca_topic_score_codex":0.004085706,"about_ca_topic_score_gemma":0.0021408068,"teacher_disagreement_score":0.19765216,"about_ca_system_score_codex":0.00026368164,"about_ca_system_score_gemma":0.00053872366,"threshold_uncertainty_score":0.61763924},"labels":[],"label_agreement":null},{"id":"W3095277969","doi":"10.1158/1538-7445.tumhet2020-po-069","title":"Abstract PO-069: Characterizing cell-to-cell heterogeneity and chromosome instability induced by <i>USP22</i> deficiency in colorectal cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Chromosome instability; Biology; Cancer research; Cancer; Mitosis; Gene silencing; Cell cycle; Molecular biology; Genetics; Chromosome; Gene","score_opus":0.056391156758584755,"score_gpt":0.33991949103831226,"score_spread":0.2835283342797275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095277969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942784,0.0029680522,0.0000043769487,0.00088358263,0.00007012887,0.00068605086,0.0002962231,0.000013593388,0.00079961814],"genre_scores_gemma":[0.9979429,0.0007229895,0.000021057313,0.0006445521,0.00019472104,0.0003737735,0.00004732962,0.000031480584,0.000021200913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791336,0.00016118141,0.0002470387,0.00073744805,0.00031155665,0.0006294426],"domain_scores_gemma":[0.9992211,0.000027881093,0.000052107906,0.00020920298,0.00012226893,0.0003674778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005388367,0.00018857556,0.00021257828,0.000056330533,0.00014294933,0.00006442754,0.000318825,0.0001902762,0.000106877684],"category_scores_gemma":[0.00008021287,0.00019122902,0.000046678186,0.00034875018,0.00012032738,0.000012633425,0.00035595158,0.00046845013,0.000017968427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022927824,0.000089150686,0.014038557,0.00018135144,0.000005269237,0.0000047798194,0.0003393411,0.0000052010128,0.9826983,9.696221e-7,0.00049492234,0.0019128508],"study_design_scores_gemma":[0.000573463,0.00043806774,0.01604448,0.000027637067,0.0000022545619,8.0671583e-7,0.000080052945,0.00000935211,0.9779916,0.0000037593206,0.0046124933,0.00021603711],"about_ca_topic_score_codex":0.0006253254,"about_ca_topic_score_gemma":0.0005479395,"teacher_disagreement_score":0.004706733,"about_ca_system_score_codex":0.00010468334,"about_ca_system_score_gemma":0.00038495645,"threshold_uncertainty_score":0.7798093},"labels":[],"label_agreement":null},{"id":"W3095491069","doi":"10.1158/1538-7445.tumhet2020-po-084","title":"Abstract PO-084: Protein marker heterogeneity in breast cancer subtypes measured using immunofluorescence protein multiplexing and quantitative, single cell image analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Estrogen receptor; Tissue microarray; Breast cancer; Immunofluorescence; Biology; Progesterone receptor; Immunohistochemistry; Cancer research; Tumor microenvironment; Pathology; Multiplex; Cancer; Antibody; Medicine; Immunology; Tumor cells; Bioinformatics","score_opus":0.08240081245470463,"score_gpt":0.38849497466201816,"score_spread":0.30609416220731356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095491069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291164,0.0016107279,0.0036742152,0.0008027432,0.000006139783,0.0007616568,0.00017462314,0.000021189138,0.000037053927],"genre_scores_gemma":[0.9865408,0.00024127374,0.012817182,0.000045559773,0.000056794255,0.00021818311,0.000027879589,0.000029482006,0.000022872384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838555,0.00013175904,0.0002316725,0.0005972073,0.0002560665,0.00039772602],"domain_scores_gemma":[0.999168,0.000014152821,0.000089547735,0.00028730647,0.0003158866,0.00012515357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036513302,0.00016430701,0.00020454888,0.00010958607,0.0001701627,0.00006765501,0.00020822157,0.000115451905,0.000022355513],"category_scores_gemma":[0.00006701391,0.00016003611,0.00007310628,0.0007107073,0.00025238201,0.0000173303,0.00019583154,0.000279657,0.0000014464812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028935616,0.00006039295,0.0052011893,0.000078253426,0.00005605995,0.000004864536,0.00004786375,0.00018944414,0.993079,0.000007196502,0.000027535296,0.0009588416],"study_design_scores_gemma":[0.000273794,0.000055745953,0.015042674,0.00008601364,0.000016249898,0.0000011364077,0.00007346891,0.0012103834,0.98271126,0.00003110381,0.00029919387,0.00019900636],"about_ca_topic_score_codex":0.0016786365,"about_ca_topic_score_gemma":0.00064661255,"teacher_disagreement_score":0.010367773,"about_ca_system_score_codex":0.00010267732,"about_ca_system_score_gemma":0.00015170951,"threshold_uncertainty_score":0.65260834},"labels":[],"label_agreement":null},{"id":"W3095666270","doi":"10.1158/1538-7445.tumhet2020-po-071","title":"Abstract PO-071: MYC influences metastatic heterogeneity in pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Genetic heterogeneity; Cancer; Medicine; Tumor heterogeneity; Metastasis; Phenotype; Tumor progression; Epigenetics; Internal medicine; Cancer research; Oncology; Biology; Gene; Genetics","score_opus":0.23075524081227436,"score_gpt":0.5002228309575567,"score_spread":0.2694675901452823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095666270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97845984,0.0068504983,0.00001272255,0.010274467,0.000060984858,0.0011036103,0.00004744255,0.000045240333,0.0031451762],"genre_scores_gemma":[0.9925787,0.004133719,0.00022614558,0.0012341121,0.00031958244,0.00096080726,0.000011896907,0.000037342612,0.00049772346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962477,0.0003604299,0.0005036391,0.00061405695,0.0012318951,0.0010422819],"domain_scores_gemma":[0.9978482,0.0006337539,0.00006960507,0.00037487008,0.00039105155,0.0006824974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014103745,0.00021557862,0.00081375067,0.00031152624,0.00016324903,0.000049891816,0.00036522734,0.00012916067,0.0038513965],"category_scores_gemma":[0.0010029045,0.00017344882,0.0001046742,0.001241354,0.0005459042,0.0001527614,0.00016355503,0.0012050985,0.0003176404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010292993,0.00020063003,0.9481243,0.0009804514,0.0002968669,0.00055446173,0.0013664527,0.00006262431,0.037124977,0.00006486787,0.0041672075,0.006027894],"study_design_scores_gemma":[0.003190961,0.000659129,0.97764915,0.00064318144,0.00013390812,0.000016595313,0.0009010917,0.0007769746,0.010660269,0.00026613465,0.0048404313,0.00026219964],"about_ca_topic_score_codex":0.0072603864,"about_ca_topic_score_gemma":0.0018787656,"teacher_disagreement_score":0.029524859,"about_ca_system_score_codex":0.0005552974,"about_ca_system_score_gemma":0.0021332372,"threshold_uncertainty_score":0.99935037},"labels":[],"label_agreement":null},{"id":"W3095801959","doi":"10.1158/1538-7445.tumhet2020-po-004","title":"Abstract PO-004: Intra-individual heterogeneity of prostate cancer gene expression signatures of luminal and basal subtypes: Implications for selection of biopsy cores for genomic testing","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"","keywords":"Prostate cancer; Biopsy; Medicine; Microarray; Cancer; Oncology; Overdiagnosis; Basal (medicine); Biomarker; Gene expression; Liquid biopsy; Internal medicine; Pathology; Cancer research; Gene; Biology; Genetics","score_opus":0.07535196285180075,"score_gpt":0.3970447858566326,"score_spread":0.3216928230048319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095801959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219143,0.0015172168,0.0036891792,0.00033030382,0.0000109379935,0.0009052092,0.0013435738,0.000005757283,0.0000064060364],"genre_scores_gemma":[0.9907618,0.00036530753,0.007708595,0.000032040647,0.000108863984,0.0008497862,0.00015168858,0.00001670001,0.0000052166456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991825,0.000031863172,0.00022680723,0.00029846918,0.00007750867,0.00018281862],"domain_scores_gemma":[0.999116,0.00005871448,0.00014456281,0.00013843921,0.000482667,0.000059634658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024375263,0.00008466168,0.00014902113,0.0000445166,0.00008963711,0.00000605483,0.00016553093,0.00012610453,0.000004162263],"category_scores_gemma":[0.00012390476,0.00007851918,0.000053492044,0.00013341778,0.00019978383,0.0000032205573,0.00008646287,0.00008632859,3.238185e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026256018,0.000031078376,0.020607503,0.00022237684,0.00004384529,3.4905312e-8,0.000036647623,0.00007188891,0.9755395,0.00003524532,0.0005640564,0.002585232],"study_design_scores_gemma":[0.00028430004,0.00039993532,0.04121899,0.000029399092,0.000017923894,8.618136e-7,0.000017596998,0.000049047452,0.9573903,0.00015134068,0.00037117256,0.00006911152],"about_ca_topic_score_codex":0.000110969144,"about_ca_topic_score_gemma":0.00003561549,"teacher_disagreement_score":0.020611484,"about_ca_system_score_codex":0.000013198041,"about_ca_system_score_gemma":0.00020927368,"threshold_uncertainty_score":0.32019192},"labels":[],"label_agreement":null},{"id":"W3095945573","doi":"10.1158/1538-7445.tumhet2020-po-002","title":"Abstract PO-002: Revealing tumour spatial heterogeneity in breast cancer and the impact on clinical management","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Lumpectomy; Tissue microarray; Medicine; Multiplex; Targeted therapy; Pathology; Computational biology; Oncology; Cancer; Biology; Internal medicine; Immunohistochemistry; Bioinformatics; Mastectomy","score_opus":0.09486343455098203,"score_gpt":0.4923034138679561,"score_spread":0.39743997931697406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095945573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91648704,0.0008283352,0.000032026728,0.08116755,0.000097731485,0.0005028985,0.000016969105,0.000017380056,0.0008500574],"genre_scores_gemma":[0.9925296,0.0037787254,0.000034740144,0.0025436752,0.0009521411,0.00007597447,0.0000040325904,0.00002549354,0.000055658937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799925,0.0002560657,0.0003349515,0.00039662313,0.00057706604,0.00043602113],"domain_scores_gemma":[0.9989879,0.00031727614,0.000054494936,0.00020136233,0.00007162272,0.00036732745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026711796,0.000128642,0.0003495936,0.00009094807,0.00011522807,0.00005758211,0.00018614535,0.000059771693,0.0002395182],"category_scores_gemma":[0.00025970023,0.00007489801,0.00010428044,0.0002630013,0.00036329788,0.000034072043,0.00014738429,0.0016043839,0.000015560474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009478849,0.0002564972,0.5446361,0.00058639346,0.00041603227,0.0007438925,0.00079463277,0.0017419818,0.0026602591,0.00021835341,0.015459134,0.42300788],"study_design_scores_gemma":[0.0056533134,0.00015054477,0.9807642,0.0005240881,0.000028713352,0.000017396402,0.000102319194,0.011341044,0.00018753773,0.00006612045,0.001057125,0.000107571024],"about_ca_topic_score_codex":0.0069322977,"about_ca_topic_score_gemma":0.000071457696,"teacher_disagreement_score":0.43612814,"about_ca_system_score_codex":0.00018415485,"about_ca_system_score_gemma":0.00016685002,"threshold_uncertainty_score":0.99968064},"labels":[],"label_agreement":null},{"id":"W3096190465","doi":"10.1158/1538-7445.tumhet2020-po-080","title":"Abstract PO-080: Predicting relapse in patients with triple negative breast cancer (TNBC) using a deep-learning approach","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Cohort; Triple-negative breast cancer; Breast cancer; Medicine; Tumor-infiltrating lymphocytes; Oncology; Internal medicine; Cancer; Artificial intelligence; Machine learning; Computer science; Immunotherapy","score_opus":0.0651865803646133,"score_gpt":0.3564657935200026,"score_spread":0.2912792131553893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096190465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541235,0.00115051,0.000048892092,0.0010968723,0.000079541394,0.001180879,0.000054525626,0.0000548423,0.00092160853],"genre_scores_gemma":[0.99837154,0.00031062405,0.00027338404,0.00027980452,0.00032667548,0.00020636158,0.000025662632,0.000068089736,0.00013786329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971827,0.00017843666,0.0003530445,0.00058523274,0.0009847889,0.00071577827],"domain_scores_gemma":[0.99887246,0.000097826174,0.00012652589,0.0002108606,0.00041189813,0.00028042519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006277328,0.00021580982,0.00037774967,0.00023621025,0.00024842215,0.00006205816,0.00018880841,0.00012996695,0.00059572415],"category_scores_gemma":[0.00013816866,0.00017318854,0.00007597025,0.0015108567,0.00024172234,0.00022567064,0.00008528822,0.001332795,0.000005710199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02668566,0.00033397306,0.90883875,0.000562637,0.0003579103,0.000061992076,0.007464498,0.0017473093,0.007660287,0.0000028846216,0.00035482907,0.045929253],"study_design_scores_gemma":[0.013101838,0.0006252369,0.97587496,0.0010436982,0.000047503214,0.000009009182,0.002515417,0.0045884303,0.0013337156,0.000004049717,0.0005550534,0.00030109275],"about_ca_topic_score_codex":0.0076516303,"about_ca_topic_score_gemma":0.00030050505,"teacher_disagreement_score":0.06703619,"about_ca_system_score_codex":0.0010385677,"about_ca_system_score_gemma":0.00075111055,"threshold_uncertainty_score":0.9989565},"labels":[],"label_agreement":null},{"id":"W3096247510","doi":"10.1158/0008-5472.can-20-1287","title":"Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; Fondation du cancer des Cèdres; Fondation de l'Hôpital Général de Montréal; Broad Institute; McGill University","keywords":"Chromatin; Biology; BRD4; Bromodomain; Transcription factor; YAP1; Cancer research; Chromatin immunoprecipitation; Cell biology; Hippo signaling pathway; RNA polymerase II; Acetylation; Gene; Genetics; Gene expression; Promoter; Signal transduction","score_opus":0.1456731154830737,"score_gpt":0.40444631568634315,"score_spread":0.25877320020326944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096247510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517965,0.0012430234,0.00010437425,0.0020597943,0.00006676754,0.00066483766,0.00007544464,0.00002053483,0.0005855628],"genre_scores_gemma":[0.9975683,0.0003786672,0.00006229082,0.00016873574,0.0007355487,0.00043178862,0.000113755996,0.00004510236,0.0004958108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709773,0.00027716308,0.0002738283,0.00065197423,0.0008870744,0.0008122438],"domain_scores_gemma":[0.9992076,0.0000178442,0.000032962253,0.00021631023,0.00023460861,0.00029067014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060389965,0.00016963156,0.00019354478,0.00012577174,0.00015601947,0.00009367981,0.0005903541,0.00016969936,0.0005105071],"category_scores_gemma":[0.00011439372,0.00016933924,0.00008540027,0.0004227825,0.00028282747,0.000012223717,0.0002200389,0.000604744,0.00004009352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018762455,0.000052752534,0.008053818,0.000114981485,0.000037761787,0.00001951785,0.00043548786,0.00019962637,0.9854535,0.000083812716,0.0009187058,0.0044424427],"study_design_scores_gemma":[0.0028928253,0.0013703771,0.013748915,0.00020486412,0.000007701315,0.0000061159303,0.001073778,0.00051942025,0.92978626,0.00014850902,0.049657173,0.00058404217],"about_ca_topic_score_codex":0.0022975614,"about_ca_topic_score_gemma":0.00274246,"teacher_disagreement_score":0.055667188,"about_ca_system_score_codex":0.00035096536,"about_ca_system_score_gemma":0.0008874673,"threshold_uncertainty_score":0.6905454},"labels":[],"label_agreement":null},{"id":"W3097641122","doi":"10.1158/1538-7445.tumhet2020-po-065","title":"Abstract PO-065: Utilization of optimized extracellular matrix substratum for inclusive capture of circulating tumor cells in stage IV colorectal cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Trillium Health Centre; University of Waterloo","funders":"","keywords":"Circulating tumor cell; Metastasis; Colorectal cancer; Extracellular matrix; Population; Cancer research; Fibronectin; Cancer; Cancer cell; Cell; Cancer stem cell; Epithelial–mesenchymal transition; Mesenchymal stem cell; Biology; Stem cell; Medicine; Cell biology; Internal medicine; Genetics","score_opus":0.10309108196893524,"score_gpt":0.4194274190461048,"score_spread":0.31633633707716957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097641122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838552,0.011645149,0.0003253269,0.0007645684,0.00015090342,0.0019851895,0.0008993614,0.000016461792,0.00035785756],"genre_scores_gemma":[0.99728787,0.0008697024,0.0008138264,0.00004448478,0.0001975896,0.00029351405,0.000065908505,0.000052696934,0.00037438195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976098,0.000089828,0.0006275472,0.0004390686,0.0007284898,0.0005052592],"domain_scores_gemma":[0.9983373,0.00022083246,0.00026248844,0.00020234796,0.00074554945,0.00023142406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007754869,0.00018197739,0.0006467329,0.00022912356,0.00006827389,0.000015718631,0.00018676833,0.00012538479,0.0011489396],"category_scores_gemma":[0.00022062712,0.00017252551,0.00016642292,0.0008781477,0.00018555815,0.00009133163,0.000089435576,0.00050435826,0.0000019002124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029083113,0.00013499464,0.0019756816,0.0030939884,0.00009039595,0.000070184535,0.0026559124,0.0067747463,0.9791519,0.00009195843,0.00079135835,0.002260568],"study_design_scores_gemma":[0.005333721,0.00030503786,0.0029338521,0.0005961616,0.00008170315,0.0000022024806,0.0027739177,0.0039529405,0.98075485,0.000024781937,0.003045642,0.0001951735],"about_ca_topic_score_codex":0.004930004,"about_ca_topic_score_gemma":0.0007529835,"teacher_disagreement_score":0.013432714,"about_ca_system_score_codex":0.0003944759,"about_ca_system_score_gemma":0.0014811214,"threshold_uncertainty_score":0.99976414},"labels":[],"label_agreement":null},{"id":"W3097759449","doi":"10.1158/1538-7445.tumhet2020-po-049","title":"Abstract PO-049: Exploiting tumor acidic microenvironment for improved therapeutics","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Tumor microenvironment; Cancer research; Antibody; Tumor progression; Tumor hypoxia; Immune system; Cancer; Chemistry; Medicine; Immunology; Tumor cells; Internal medicine; Radiation therapy","score_opus":0.08455431797527364,"score_gpt":0.3656363877435302,"score_spread":0.28108206976825656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097759449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699612,0.022110963,0.0009117335,0.004946719,0.0005387178,0.0009774924,0.00022154697,0.000021251522,0.00031033676],"genre_scores_gemma":[0.9837242,0.00728625,0.0003995339,0.002660925,0.0046888785,0.00053100905,0.00007861562,0.00006952692,0.0005610787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998512,0.00004404953,0.00019328925,0.00048289733,0.00020091707,0.0005667913],"domain_scores_gemma":[0.99933845,0.000025296767,0.00005540932,0.0002826532,0.00009879366,0.00019937979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032531962,0.00014894857,0.00016685616,0.000032571763,0.00016646206,0.000048021328,0.00030679948,0.00008889371,0.00009176598],"category_scores_gemma":[0.000066788285,0.00014381619,0.000117455784,0.00009953586,0.00017991554,0.000005307161,0.00014988623,0.00023589938,0.00001627718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027989768,0.00002782054,0.000052645162,0.000068074994,0.000056973826,7.2148055e-7,0.00013295143,0.000012743956,0.9673006,0.000011696841,0.0070004514,0.025055408],"study_design_scores_gemma":[0.0005964936,0.00015904685,0.0002482324,0.000009903852,0.000010262933,0.0000011635262,0.0002328152,0.000023969658,0.52594894,0.000021339489,0.47263515,0.00011269349],"about_ca_topic_score_codex":0.00007040894,"about_ca_topic_score_gemma":0.000035667355,"teacher_disagreement_score":0.4656347,"about_ca_system_score_codex":0.000052441617,"about_ca_system_score_gemma":0.0002225089,"threshold_uncertainty_score":0.58646536},"labels":[],"label_agreement":null},{"id":"W3098348738","doi":"","title":"Effect of testosterone on the mitochondrial aspartate aminotransferase in prostate cancer cell lines","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"LNCaP; Prostate cancer; Testosterone (patch); Endocrinology; Androgen; Internal medicine; Biology; Mitochondrion; Prostate; Chemistry; Biochemistry; Cancer; Hormone; Medicine","score_opus":0.024885008858930125,"score_gpt":0.35084621587107917,"score_spread":0.32596120701214903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098348738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887346,0.0071170568,0.000006256638,0.0007382482,0.0021325264,0.0008595914,0.00009908635,0.0000050522203,0.00030759248],"genre_scores_gemma":[0.98467124,0.008181264,0.00001329369,0.00012522399,0.004979946,0.00089469017,0.000019949674,0.000032916287,0.0010814797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983565,0.00026857038,0.00021225076,0.00037263107,0.00033939414,0.00045064854],"domain_scores_gemma":[0.9992656,0.000084647014,0.00003784303,0.00038311182,0.00014424816,0.00008453425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005589746,0.00015994147,0.00021431822,0.000062842206,0.000079678444,0.000021032805,0.00027777345,0.0000896711,0.00005707812],"category_scores_gemma":[0.000092174945,0.000108638735,0.00007719554,0.00022348548,0.00022597543,0.000005532463,0.00006366653,0.0002730053,0.000007245586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016266843,0.00007093498,0.00046561868,0.00012165545,0.000019868081,6.001178e-7,0.00027677877,0.00092126825,0.9881323,0.000026592235,0.003466769,0.0048709256],"study_design_scores_gemma":[0.0025762336,0.00095529953,0.0006273149,0.000113535636,0.000011115287,7.1796813e-7,0.00004384037,0.0000024191643,0.9508926,0.00003145043,0.044626042,0.00011939051],"about_ca_topic_score_codex":0.004958586,"about_ca_topic_score_gemma":0.0062361113,"teacher_disagreement_score":0.041159272,"about_ca_system_score_codex":0.000091589936,"about_ca_system_score_gemma":0.00041107487,"threshold_uncertainty_score":0.74959314},"labels":[],"label_agreement":null},{"id":"W3099837445","doi":"10.1158/1538-7445.panca20-po-005","title":"Abstract PO-005: GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Oncology; Internal medicine; Pancreatic cancer; Capecitabine; Folinic acid; Proportional hazards model; Hazard ratio; Cancer; Pathology; Fluorouracil; Confidence interval; Colorectal cancer","score_opus":0.22332617395140278,"score_gpt":0.48132406689415114,"score_spread":0.25799789294274833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099837445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528969,0.010518507,0.000013424741,0.031238882,0.00013132386,0.0020350108,0.00089946075,0.00003712421,0.0022293527],"genre_scores_gemma":[0.98626584,0.009099683,0.000092960785,0.00038582506,0.0018416541,0.0011003835,0.00007451302,0.000040604496,0.0010985379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943973,0.0013695889,0.0009953254,0.00069998973,0.0017919714,0.000745837],"domain_scores_gemma":[0.9905651,0.0073495144,0.0002397528,0.0006816145,0.0006500083,0.00051400403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046849935,0.00022362178,0.0011261412,0.00013752814,0.00022804303,0.00004947919,0.00038688802,0.0002822151,0.0049731242],"category_scores_gemma":[0.007591399,0.00013314413,0.00021940675,0.0008015593,0.0006181355,0.00010739498,0.0002319849,0.0012956945,0.00010809606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1161313,0.00060682226,0.5988903,0.0012046192,0.0011850401,0.0008073485,0.010221201,0.000017257875,0.12321311,0.00005153386,0.12959018,0.018081307],"study_design_scores_gemma":[0.028577017,0.0043496867,0.6873723,0.0073646987,0.0011410093,0.000028563129,0.0031204605,0.0010462241,0.18759203,0.0007964279,0.07796556,0.0006459708],"about_ca_topic_score_codex":0.008964991,"about_ca_topic_score_gemma":0.0003401101,"teacher_disagreement_score":0.08848207,"about_ca_system_score_codex":0.0002834868,"about_ca_system_score_gemma":0.0015764254,"threshold_uncertainty_score":0.9976344},"labels":[],"label_agreement":null},{"id":"W3100278440","doi":"10.1158/1538-7445.panca20-po-053","title":"Abstract PO-053: MYC Influences metastatic heterogeneity in pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Metastasis; Cancer; Genetic heterogeneity; Primary tumor; Epigenetics; Circulating tumor cell; Cancer research; Medicine; Somatic evolution in cancer; Phenotype; Biology; Oncology; Gene; Internal medicine; Genetics","score_opus":0.09113140396234004,"score_gpt":0.4083232977529198,"score_spread":0.31719189379057977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100278440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846984,0.012689148,0.00002442239,0.0014979221,0.00010625184,0.0003429634,0.00016806346,0.00000839271,0.00046443814],"genre_scores_gemma":[0.9898604,0.0081141405,0.00008054811,0.0010565263,0.00041682977,0.00033316104,0.00003364487,0.000030991974,0.000073754585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982374,0.00009612265,0.00027154345,0.00052075327,0.0003358107,0.00053838635],"domain_scores_gemma":[0.9991511,0.0000798753,0.000055322555,0.00029132346,0.00017272303,0.0002496505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003723036,0.00016237785,0.00022794925,0.00007535625,0.00009218749,0.000069629044,0.00037916028,0.00008591459,0.0003242571],"category_scores_gemma":[0.0003313222,0.00015703373,0.00007340613,0.00035668697,0.00016837534,0.0000075143003,0.00021089247,0.00029531054,0.000044509186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039024442,0.000086871216,0.10160546,0.0002496485,0.00014181646,0.00005136064,0.00030478547,0.0036659115,0.87586373,0.000052798354,0.010488591,0.0070988066],"study_design_scores_gemma":[0.0021009194,0.0005821068,0.16400671,0.00018905553,0.00004709368,0.000004465385,0.000435982,0.00025682044,0.7345005,0.0003204857,0.09685394,0.0007018613],"about_ca_topic_score_codex":0.0031910392,"about_ca_topic_score_gemma":0.0048453314,"teacher_disagreement_score":0.14136316,"about_ca_system_score_codex":0.000109900866,"about_ca_system_score_gemma":0.00065655797,"threshold_uncertainty_score":0.64036494},"labels":[],"label_agreement":null},{"id":"W3100315745","doi":"10.1158/1538-7445.panca20-ia-08","title":"Abstract IA-08: Clinical advances in pancreas adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreas; Medicine; Adenocarcinoma; Internal medicine; General surgery; Oncology; Cancer","score_opus":0.26288539433661035,"score_gpt":0.5566341167765619,"score_spread":0.2937487224399516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100315745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9373496,0.02096723,0.0000146314505,0.016232431,0.00009852482,0.00078315305,0.000013590956,0.000043326923,0.024497481],"genre_scores_gemma":[0.9805146,0.016005307,0.00023454145,0.0010045354,0.0010937852,0.0002351997,0.000010577727,0.00003085363,0.0008705941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966289,0.0003756904,0.00056751916,0.00059991534,0.0009624895,0.00086550176],"domain_scores_gemma":[0.9975175,0.00097121514,0.000052585845,0.00036493526,0.00032656756,0.0007671996],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023608806,0.00014700305,0.0007084833,0.0001996965,0.00010623281,0.000024387075,0.0003210401,0.00022303103,0.0028981075],"category_scores_gemma":[0.0020276078,0.00012131907,0.0001157698,0.0008261403,0.0006218951,0.00015477878,0.00016925535,0.0018382645,0.00083315425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017306537,0.00019030819,0.96171707,0.00030538905,0.000050983213,0.0006337328,0.00031732096,0.000002090878,0.0013885135,0.00023154929,0.008503488,0.024928903],"study_design_scores_gemma":[0.0031603607,0.00086884445,0.9434574,0.00022776244,0.000025973419,0.000013930177,0.00048480585,0.00022236616,0.0003939664,0.00027699448,0.050737984,0.00012961483],"about_ca_topic_score_codex":0.00045318625,"about_ca_topic_score_gemma":0.00017227321,"teacher_disagreement_score":0.043164976,"about_ca_system_score_codex":0.0002521939,"about_ca_system_score_gemma":0.0015881087,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W3100824124","doi":"10.1158/1538-7445.panca20-po-038","title":"Abstract PO-038: Activation of Kras and loss of <i>Pten</i> induces pancreatic ductal adenocarcinoma from pancreatic acinar cells in mice","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PTEN; KRAS; Carcinogenesis; Cancer research; Context (archaeology); Mucin; Biology; Immunohistochemistry; Acinus; Acinar cell; Pancreas; Pathology; Pancreatic cancer; Adenocarcinoma; Cancer; Endocrinology; Medicine; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology","score_opus":0.09407689761402352,"score_gpt":0.3854863355650046,"score_spread":0.29140943795098107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100824124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234504,0.002990911,0.000010714996,0.002523652,0.000028912624,0.0008881007,0.000083963314,0.000013241626,0.0011154694],"genre_scores_gemma":[0.99702525,0.0021225838,0.00027002898,0.00011651341,0.00019751614,0.00010212666,0.00002670814,0.00003059927,0.00010865857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99727505,0.00027146118,0.00058417977,0.0004755503,0.0008776344,0.000516097],"domain_scores_gemma":[0.9976688,0.0011649259,0.00015953276,0.00029758032,0.0003905506,0.0003186212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078579696,0.0001851906,0.0009148539,0.0002955565,0.0000660183,0.000014710313,0.0002353193,0.00021478474,0.0005225709],"category_scores_gemma":[0.00067067624,0.00016117391,0.00006503035,0.0007758869,0.00066244014,0.00015215621,0.00015046222,0.0007927287,0.00002086583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013186827,0.00014417956,0.4663955,0.0007860183,0.0001395764,0.000086245076,0.0023320122,0.0000028017064,0.52771753,0.000022663262,0.00033334747,0.000721411],"study_design_scores_gemma":[0.0024807951,0.0006469184,0.71575904,0.0007669226,0.00011028791,0.0000075220305,0.0020935389,0.00017571301,0.27750546,0.0002847256,0.00004761486,0.00012146739],"about_ca_topic_score_codex":0.008388916,"about_ca_topic_score_gemma":0.000083219915,"teacher_disagreement_score":0.25021207,"about_ca_system_score_codex":0.00019621794,"about_ca_system_score_gemma":0.0009429209,"threshold_uncertainty_score":0.9982143},"labels":[],"label_agreement":null},{"id":"W3100879804","doi":"10.1158/1538-7445.panca20-po-057","title":"Abstract PO-057: Collateral amplification of the PTHrP gene drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"KRAS; Metastasis; Cancer research; Cancer; Biology; Medicine; Internal medicine; Colorectal cancer","score_opus":0.16959075952600056,"score_gpt":0.4412288106841118,"score_spread":0.27163805115811124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100879804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668984,0.011658688,0.000010969913,0.020215964,0.000030011519,0.0009894266,0.000064935404,0.000011106228,0.00012049893],"genre_scores_gemma":[0.9945343,0.0043450617,0.000121811114,0.0005953884,0.000069420785,0.00015116,0.0000049290475,0.000015330883,0.00016257624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986299,0.00016802947,0.00023708584,0.00031240913,0.00036545465,0.00028709316],"domain_scores_gemma":[0.99904376,0.00016237632,0.000071147064,0.00023089407,0.00015297208,0.00033887418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030644718,0.00010869306,0.00030021436,0.00004529856,0.00015410403,0.000021689133,0.00007686468,0.000055900204,0.00012656742],"category_scores_gemma":[0.00010986063,0.00006853487,0.00003769264,0.0003532708,0.00022681529,0.000057078796,0.00005087693,0.00025646904,0.0000019783492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091321,0.00009301552,0.7952804,0.0012963468,0.00031187938,0.0000051807397,0.002197108,0.000001934455,0.14887121,0.00012951669,0.0005893966,0.050310824],"study_design_scores_gemma":[0.0014001325,0.00019723605,0.9663527,0.00014294768,0.0001183836,0.000004097373,0.00009868494,0.00002126149,0.030460114,0.0008732121,0.00026906715,0.00006216083],"about_ca_topic_score_codex":0.008552933,"about_ca_topic_score_gemma":0.00020676713,"teacher_disagreement_score":0.17107233,"about_ca_system_score_codex":0.00010335607,"about_ca_system_score_gemma":0.00057770486,"threshold_uncertainty_score":0.9980492},"labels":[],"label_agreement":null},{"id":"W3102944279","doi":"10.1158/1538-7445.panca20-pr-002","title":"Abstract PR-002: Stromal phenotypic heterogeneity fosters pancreatic cancer progression","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Stroma; Stromal cell; Pancreatic cancer; Cancer research; Tumour heterogeneity; Biology; Tumor microenvironment; KRAS; Desmoplasia; Cancer; Pathology; Immunohistochemistry; Medicine; Colorectal cancer; Genetics","score_opus":0.1909641840084778,"score_gpt":0.4876420761931037,"score_spread":0.29667789218462587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102944279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750927,0.0052408506,0.000028580283,0.013744297,0.0001129282,0.001617458,0.000054264216,0.00009820387,0.004010689],"genre_scores_gemma":[0.9943894,0.0017303432,0.00043188737,0.0006428894,0.0009864327,0.0010719758,0.000027438953,0.000059781814,0.000659857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959817,0.00027816274,0.00040808925,0.0007066071,0.0014716063,0.0011538249],"domain_scores_gemma":[0.99767303,0.00030642084,0.00008517608,0.00045929552,0.0005042675,0.0009718235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088931556,0.0002462802,0.000693534,0.00017336496,0.00032717016,0.00006199289,0.00036298827,0.00022278512,0.0033017676],"category_scores_gemma":[0.00046596117,0.0001926058,0.00013477581,0.00068044185,0.00054925034,0.00013338472,0.00026325494,0.0012246972,0.0003137051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004130315,0.00038135238,0.7353131,0.0016171999,0.0005517972,0.00042135268,0.0013307419,0.000015202086,0.18090762,0.000085828775,0.014933781,0.060311694],"study_design_scores_gemma":[0.007386354,0.002507057,0.91185445,0.0016982062,0.00036536276,0.000037287533,0.0008550107,0.001646912,0.05395182,0.00014637758,0.01896723,0.0005839072],"about_ca_topic_score_codex":0.0007796852,"about_ca_topic_score_gemma":0.0001455689,"teacher_disagreement_score":0.17654136,"about_ca_system_score_codex":0.0005806518,"about_ca_system_score_gemma":0.0017831099,"threshold_uncertainty_score":0.9976094},"labels":[],"label_agreement":null},{"id":"W3103947124","doi":"10.1158/1538-7445.panca20-pr-009","title":"Abstract PR-009: Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Vancouver General Hospital; Pancreas Centre (Canada); Spinal Cord Injury BC","funders":"","keywords":"Transcriptome; Biology; Proteome; Gene expression profiling; Computational biology; Gene expression; Subgroup analysis; Oncology; PDX1; Microarray analysis techniques; Gene; Cohort; Cancer research; Internal medicine; Bioinformatics; Genetics; Medicine; Meta-analysis","score_opus":0.10401002787543503,"score_gpt":0.3942140073785972,"score_spread":0.2902039795031621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103947124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808922,0.0003021457,0.00001991712,0.016507402,0.00003983966,0.0017189423,0.000044611723,0.00005944566,0.00041549842],"genre_scores_gemma":[0.99654603,0.0022076352,0.00007349277,0.00022456594,0.00016394128,0.000355498,0.000040981307,0.000044439254,0.0003433954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772054,0.00013772679,0.00034848397,0.00046886914,0.0008286348,0.0004957264],"domain_scores_gemma":[0.99875116,0.00011454868,0.00008829516,0.00028292302,0.0003655204,0.0003975679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017148601,0.00014712424,0.0003332358,0.0002091389,0.000090657144,0.000038232105,0.00016997353,0.000010220349,0.00027407162],"category_scores_gemma":[0.00044656836,0.0001308051,0.000046831934,0.00065732526,0.00031856398,0.00023341358,0.00007430348,0.0006125651,0.000028559942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009836921,0.00007549118,0.014345509,0.0012855786,0.000026051732,0.00025859365,0.000116410614,0.0000014418599,0.9777702,0.00011423511,0.00019216773,0.0048306277],"study_design_scores_gemma":[0.0019351561,0.0010164643,0.35198152,0.00026730905,0.000031489042,0.00015991415,0.00014746132,0.0006152318,0.6357158,0.00006060218,0.00792711,0.00014194733],"about_ca_topic_score_codex":0.00009444755,"about_ca_topic_score_gemma":0.000008098443,"teacher_disagreement_score":0.34205443,"about_ca_system_score_codex":0.00007140711,"about_ca_system_score_gemma":0.0003103729,"threshold_uncertainty_score":0.5334077},"labels":[],"label_agreement":null},{"id":"W3105381078","doi":"","title":"Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Biological Sciences; Biotechnology Research Institute","funders":"","keywords":"Internalization; Endocytosis; Tyrosine kinase; Epidermal growth factor receptor; Epidermal growth factor; Monoclonal antibody; Receptor; Cell biology; Chemistry; Molecular biology; Cell surface receptor; Biology; Cancer research; Antibody; Biochemistry; Immunology","score_opus":0.03620473210396714,"score_gpt":0.4083207034210947,"score_spread":0.3721159713171276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105381078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896087,0.0023486493,0.0000022356503,0.0035224948,0.00021258096,0.0008871795,0.00006962735,0.00002802792,0.003320506],"genre_scores_gemma":[0.9935618,0.0010196021,0.000059737224,0.00008485697,0.0008869693,0.00010010783,0.000029703013,0.000043705786,0.0042135236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961393,0.0005037808,0.00041936227,0.0005156662,0.0015656917,0.0008561969],"domain_scores_gemma":[0.99780685,0.0011423841,0.00010993618,0.0004009387,0.00033468322,0.0002052042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017939876,0.00025009678,0.0005340643,0.00028490098,0.000504713,0.000059556674,0.00032595877,0.00013476609,0.0003508167],"category_scores_gemma":[0.00040446338,0.00015138561,0.00020264694,0.0007466746,0.0006633758,0.00006842063,0.00033916868,0.001007983,0.000058385434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001268062,0.00011129446,0.22740743,0.0006179052,0.00008373909,0.000014233058,0.00009236082,0.000018550621,0.7522289,0.00039594015,0.004865667,0.012895878],"study_design_scores_gemma":[0.0014427431,0.0011555078,0.049664307,0.0009632459,0.00003158044,0.000019243436,0.00003983828,0.00014750718,0.9307,0.000053471394,0.015621025,0.00016151123],"about_ca_topic_score_codex":0.0026252125,"about_ca_topic_score_gemma":0.000037557977,"teacher_disagreement_score":0.17847107,"about_ca_system_score_codex":0.00016801481,"about_ca_system_score_gemma":0.00028377227,"threshold_uncertainty_score":0.6173326},"labels":[],"label_agreement":null},{"id":"W3106260045","doi":"10.1158/1538-7445.panca20-po-044","title":"Abstract PO-044: ATG4B loss reduces pancreatic cancer cell viability and enhances the utilization of survival-promoting GABARAP-L2","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Viability assay; Autophagy; Pancreatic cancer; Cell culture; Cancer research; Cancer cell; Cell growth; Cancer; Chemistry; Biology; Apoptosis; Medicine; Internal medicine; Biochemistry","score_opus":0.1335718949243083,"score_gpt":0.43370964650820965,"score_spread":0.3001377515839013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106260045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97655356,0.017713206,0.000011407434,0.00354995,0.00008017041,0.0006560627,0.000048063055,0.000027761535,0.0013598228],"genre_scores_gemma":[0.988738,0.010425104,0.000013038282,0.00013030785,0.00033404282,0.00013710867,0.000008865569,0.000023307943,0.00019024739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998165,0.00021188772,0.00028227127,0.0003664617,0.0006360921,0.00033827944],"domain_scores_gemma":[0.99874866,0.00033564557,0.00009749704,0.00027537718,0.00033582223,0.00020702125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085948,0.00013156711,0.0003047574,0.000034270943,0.00018080173,0.000029704815,0.00018904786,0.00006985726,0.0013517227],"category_scores_gemma":[0.00021080973,0.00008842582,0.00006436798,0.00038955314,0.00045417016,0.00011433662,0.0000701175,0.00030684337,0.0000088317465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009989758,0.00021030116,0.0338148,0.0020083503,0.0001829806,0.000016716933,0.007347346,0.000016322205,0.9303869,0.00008168085,0.00065209024,0.02428354],"study_design_scores_gemma":[0.0007698384,0.00019860023,0.107315026,0.00027773314,0.00005196893,7.389428e-7,0.0014596715,0.00022050492,0.8884393,0.00020427938,0.0009566904,0.0001056281],"about_ca_topic_score_codex":0.0015003018,"about_ca_topic_score_gemma":0.00007969922,"teacher_disagreement_score":0.07350022,"about_ca_system_score_codex":0.00010258538,"about_ca_system_score_gemma":0.00047058394,"threshold_uncertainty_score":0.9995612},"labels":[],"label_agreement":null},{"id":"W3106821130","doi":"10.1158/1538-7445.epimetab20-po-051","title":"Abstract PO-051: Metabolic alterations reveal epigenetic vulnerabilities in breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Epigenetics; Breast cancer; Cancer; Cancer research; Biology; DNA methylation; Epigenetic therapy; Chromatin; Cancer epigenetics; Cancer cell; Chromatin remodeling; Histone; Medicine; Bioinformatics; Genetics; Histone methyltransferase; DNA; Gene; Gene expression","score_opus":0.05186866660508613,"score_gpt":0.37155105323022686,"score_spread":0.3196823866251407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106821130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536606,0.033562817,0.000038941915,0.00851489,0.0020619773,0.0005260026,0.00071005477,0.00001988391,0.00090481376],"genre_scores_gemma":[0.96518123,0.013422314,0.00005192518,0.0009860477,0.01831453,0.00067541987,0.00007625393,0.000047762336,0.0012445328],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978142,0.00019666263,0.00032399478,0.00061696983,0.0003979181,0.0006502861],"domain_scores_gemma":[0.99895227,0.000033225624,0.000047553916,0.00038073317,0.00029956148,0.00028664892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004685707,0.0001913162,0.00028285876,0.00011525485,0.0001658135,0.00007363686,0.00036480025,0.00014439406,0.0008248922],"category_scores_gemma":[0.00011148422,0.00018671642,0.00010394065,0.00043041672,0.00023138568,0.000013592548,0.00015985574,0.00045082465,0.000030124404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029684277,0.000074232965,0.00944898,0.00013047513,0.00007161039,8.365912e-7,0.0008557305,0.0010184193,0.84320647,0.00019401764,0.1287057,0.01599671],"study_design_scores_gemma":[0.0011251526,0.000083195955,0.09501321,0.00005936861,0.000019172536,0.0000050990852,0.00044045615,0.00003064658,0.10793384,0.00012841035,0.7947912,0.0003702054],"about_ca_topic_score_codex":0.00339077,"about_ca_topic_score_gemma":0.0030411875,"teacher_disagreement_score":0.7352726,"about_ca_system_score_codex":0.000073098665,"about_ca_system_score_gemma":0.00089779735,"threshold_uncertainty_score":0.90319914},"labels":[],"label_agreement":null},{"id":"W3107391416","doi":"10.1158/0008-5472.can-20-1965","title":"KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Amgen (Canada); University of Toronto","funders":"National Key Research and Development Program of China; Canadian Institutes of Health Research; National Natural Science Foundation of China; Shandong University","keywords":"Enzalutamide; Prostate cancer; Cancer; Oncology; Medicine; Cancer research; Internal medicine; Androgen receptor","score_opus":0.07888420955720794,"score_gpt":0.41474316714508785,"score_spread":0.3358589575878799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107391416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942686,0.027391747,0.000015901032,0.026864307,0.000051144863,0.0021048505,0.00031675413,0.000032340602,0.00053694856],"genre_scores_gemma":[0.98625416,0.01044448,0.000068130525,0.0005013518,0.00009599013,0.00088444434,0.000059952006,0.000038809376,0.0016526694],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974475,0.0001895732,0.00038093567,0.00053843664,0.00076646346,0.0006771127],"domain_scores_gemma":[0.9979662,0.00028440368,0.000056036297,0.00024228649,0.0010251687,0.00042595546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069578923,0.0001640692,0.00045198912,0.00036033124,0.000090421614,0.000035551006,0.00015305626,0.0000840814,0.00021160259],"category_scores_gemma":[0.0010302002,0.00013572029,0.000029994995,0.0025861182,0.00034919332,0.00010901287,0.00014638908,0.00046988323,0.000013055083],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01318327,0.0001850908,0.5295366,0.0024009023,0.00019600875,0.00017304865,0.007700538,0.000098545905,0.42626962,0.000497874,0.0143578965,0.005400622],"study_design_scores_gemma":[0.02000272,0.001635073,0.33033216,0.0040024356,0.00009393462,0.0000023148455,0.0035422903,0.00061528117,0.53584933,0.00094630494,0.102362916,0.00061524607],"about_ca_topic_score_codex":0.0012181915,"about_ca_topic_score_gemma":0.0023254305,"teacher_disagreement_score":0.19920442,"about_ca_system_score_codex":0.00069128646,"about_ca_system_score_gemma":0.0013830446,"threshold_uncertainty_score":0.55345124},"labels":[],"label_agreement":null},{"id":"W3107924164","doi":"","title":"DNA Demethylase transforms normal cells into highly invasive and metastatic cancer cells: Identification and characterization of novel metastatic cancer targets, therapeutic intervention for these targets, and signaling pathways leading to DNA demethylation","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; DNA methylation; Biology; Demethylating agent; Ectopic expression; DNA demethylation; Carcinogenesis; Cell culture; Cancer; Cancer cell; Gene knockdown; Metastasis; Molecular biology; Gene expression; Gene; Genetics","score_opus":0.0787249978234601,"score_gpt":0.35781669297233565,"score_spread":0.27909169514887555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107924164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180643,0.012989982,0.0672278,0.00017538694,0.00014367123,0.001127715,0.000262257,0.0000069077128,0.0000019735241],"genre_scores_gemma":[0.980662,0.016607232,0.0015351279,0.000045063614,0.000113758826,0.00071978394,0.00019447638,0.000043344768,0.0000792028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811494,0.0002016757,0.0004972234,0.00053172954,0.00031079777,0.00034361603],"domain_scores_gemma":[0.9987097,0.00013559285,0.00021724455,0.00017300062,0.00061258447,0.00015190167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011792682,0.00020995594,0.0002856654,0.00025280952,0.0002685371,0.00006829071,0.000120800316,0.000097275944,0.00001381386],"category_scores_gemma":[0.00010861704,0.00019721067,0.00006571624,0.00027235196,0.00018251906,0.000069113776,0.00006905619,0.0001298723,4.6208442e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023261865,0.00007172784,0.0005022522,0.0005118705,0.00015749148,6.2524896e-7,0.0023107897,0.00037871808,0.97237766,0.000036611214,0.0000066286757,0.023413034],"study_design_scores_gemma":[0.0010354425,0.00036297154,0.0023027223,0.00010190738,0.00010069139,8.333316e-7,0.0002892933,0.0011957672,0.9936108,0.00023203106,0.00055173645,0.00021581426],"about_ca_topic_score_codex":0.0005361894,"about_ca_topic_score_gemma":0.000602293,"teacher_disagreement_score":0.06569268,"about_ca_system_score_codex":0.000075053475,"about_ca_system_score_gemma":0.00018401071,"threshold_uncertainty_score":0.8042018},"labels":[],"label_agreement":null},{"id":"W3108450721","doi":"10.1158/1538-7445.epimetab20-po-040","title":"Abstract PO-040: The role of mTOR in epigenetic regulation in cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PI3K/AKT/mTOR pathway; mTORC1; Epigenetics; Biology; Cancer research; H3K4me3; Histone; Mechanistic target of rapamycin; Histone H3; Methylation; Histone methylation; Histone methyltransferase; Cell biology; DNA methylation; Biochemistry; Signal transduction; Gene expression; Gene; Promoter","score_opus":0.0630443730385752,"score_gpt":0.3901539824734314,"score_spread":0.32710960943485623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108450721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803711,0.017436378,0.000027848777,0.0010348557,0.000035747875,0.00026143517,0.0000147474975,0.0000017739719,0.00081608613],"genre_scores_gemma":[0.9965278,0.003009799,0.00002312384,0.00004370384,0.00019894843,0.00010267415,0.000014322901,0.000013957808,0.000065697546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989546,0.000120266064,0.00021197226,0.00024076231,0.00024210136,0.00023027728],"domain_scores_gemma":[0.9995493,0.00003306882,0.00004737332,0.00019431977,0.0001215516,0.00005434065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004927163,0.00006910179,0.000097005366,0.00006173385,0.000033543136,0.00001213724,0.00019855672,0.00009456575,0.00013010498],"category_scores_gemma":[0.00012033205,0.000057228644,0.000031235242,0.0003322711,0.00008559178,0.0000030118892,0.00007881174,0.00018084224,0.0000037635132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008632821,0.000021517337,0.03779718,0.00002226115,0.0000072455314,5.6845363e-7,0.00028809256,0.0036946347,0.9375389,0.00003429833,0.000076040014,0.020432927],"study_design_scores_gemma":[0.00024255704,0.00006965029,0.21885172,0.000022326461,0.0000015551757,3.56627e-8,0.00012785231,0.00032390354,0.77131826,0.0004644372,0.008518092,0.000059608486],"about_ca_topic_score_codex":0.0016583191,"about_ca_topic_score_gemma":0.0025630358,"teacher_disagreement_score":0.18105453,"about_ca_system_score_codex":0.000045056924,"about_ca_system_score_gemma":0.00021412286,"threshold_uncertainty_score":0.25068936},"labels":[],"label_agreement":null},{"id":"W3108620446","doi":"10.1158/0008-5472.can-20-1876","title":"Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"New Jersey Commission on Cancer Research; Susan G. Komen; National Cancer Institute; Rutgers Cancer Institute of New Jersey; American Cancer Society; U.S. Department of Defense","keywords":"Colorectal cancer; Cancer research; Metastasis; Medicine; Lung; Wnt signaling pathway; In vivo; Cancer; Lung cancer; Oncology; Biology; Internal medicine; Signal transduction; Genetics","score_opus":0.0930725144396463,"score_gpt":0.4532038766076852,"score_spread":0.36013136216803887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108620446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8928739,0.10165463,0.00006027389,0.0045732646,0.000057726218,0.0006157112,0.000038548005,0.00002223491,0.000103734135],"genre_scores_gemma":[0.98657084,0.012305393,0.00038082147,0.00021287391,0.00017878365,0.00025493515,0.0000037210639,0.000029326067,0.0000633149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986569,0.000108396736,0.00017487172,0.00031866317,0.00043909802,0.00030205084],"domain_scores_gemma":[0.99933016,0.000093055765,0.000051008312,0.00009830253,0.00021298471,0.0002145083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040203403,0.00011603733,0.000335562,0.00007624868,0.00010361759,0.000030173818,0.00007329472,0.000056081622,0.0006788827],"category_scores_gemma":[0.000050009974,0.000086990316,0.000040343348,0.00033782714,0.0001952433,0.00007612248,0.00010217108,0.00028342448,5.0178596e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013317649,0.000039081682,0.009086433,0.0008658793,0.0003342989,0.000015488346,0.001824426,0.0000036931986,0.8992854,0.00035935975,0.0007411461,0.08611307],"study_design_scores_gemma":[0.0021712983,0.0009725163,0.0047874395,0.00033799815,0.00018114463,0.0000066409907,0.00074247475,0.0012028067,0.9773379,0.00015671909,0.0119388765,0.00016416048],"about_ca_topic_score_codex":0.0004160801,"about_ca_topic_score_gemma":0.00004016843,"teacher_disagreement_score":0.09369695,"about_ca_system_score_codex":0.00005573478,"about_ca_system_score_gemma":0.00022929873,"threshold_uncertainty_score":0.7433289},"labels":[],"label_agreement":null},{"id":"W3108919388","doi":"10.1158/1538-7445.epimetab20-po-002","title":"Abstract PO-002: Epigenetic regulation of metabolic pathways in response of breast cancer cells to stilbenoids","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epigenetics; DNA methylation; Resveratrol; CpG site; Biology; Methylation; Cancer epigenetics; Cancer; Cancer research; Gene; Genetics; Molecular biology; Gene expression; Biochemistry","score_opus":0.062117094275914705,"score_gpt":0.3606688919898294,"score_spread":0.29855179771391466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108919388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351114,0.004154379,0.00011784279,0.0013048426,0.000048337017,0.00033853462,0.00038514886,0.0000030193585,0.00013676831],"genre_scores_gemma":[0.9975216,0.00178059,0.000079702055,0.00008809919,0.00014907752,0.00017399703,0.000013083006,0.000021335913,0.00017255399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985565,0.00017030479,0.00031076072,0.00035029807,0.00033335132,0.00027876828],"domain_scores_gemma":[0.99899286,0.000031198455,0.00007890294,0.00035753124,0.0003933614,0.00014612214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005962519,0.00010126496,0.00019357087,0.0001350703,0.000036158082,0.000010344876,0.00028967205,0.000101167956,0.00032101516],"category_scores_gemma":[0.00007939543,0.00009977671,0.00005694951,0.00058044627,0.00011397052,0.000005312716,0.00009912313,0.00013632831,0.000008235333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013488084,0.000046826073,0.0017635988,0.00006276275,0.000021478863,7.210472e-7,0.0003200852,0.0031019968,0.984258,0.00005553344,0.00087082275,0.008149359],"study_design_scores_gemma":[0.00027572416,0.00009140213,0.29578224,0.00003419736,0.0000042746196,2.2956104e-7,0.00008440926,0.00003073355,0.70004433,0.000015619262,0.0035628944,0.000073936884],"about_ca_topic_score_codex":0.00089040777,"about_ca_topic_score_gemma":0.00019162867,"teacher_disagreement_score":0.29401866,"about_ca_system_score_codex":0.000041046547,"about_ca_system_score_gemma":0.00058903533,"threshold_uncertainty_score":0.40687764},"labels":[],"label_agreement":null},{"id":"W3109285551","doi":"10.1158/1538-7445.epimetab20-po-053","title":"Abstract PO-053: Investigating intra-tumour metabolic heterogeneity in triple-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Cancer; Breast cancer; GLUT1; Population; Biology; Cancer cell; Epigenetics; Glutamine; Glutaminolysis; Glucose uptake; Medicine; Genetics; Gene; Endocrinology","score_opus":0.07259362344737223,"score_gpt":0.37841676082097253,"score_spread":0.3058231373736003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109285551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97772247,0.01718496,0.000020010886,0.0031093112,0.0005649922,0.00055122434,0.00039357226,0.00002108483,0.0004323823],"genre_scores_gemma":[0.98578435,0.007947079,0.00011568461,0.0012313637,0.004241445,0.00043305376,0.00003612431,0.00005757826,0.00015330467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971895,0.000265463,0.00038332574,0.00080010324,0.00052607915,0.000835489],"domain_scores_gemma":[0.9987045,0.000039952072,0.00010413476,0.00033330522,0.00033496722,0.00048313104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006722471,0.00026506928,0.00039128563,0.00012830812,0.0001656514,0.00007764182,0.0004977949,0.00020235752,0.00030758567],"category_scores_gemma":[0.0003810807,0.00025875279,0.00013217519,0.000734956,0.00032516467,0.00002109631,0.00027370595,0.0007220793,0.000024055853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027847567,0.000046578534,0.005906983,0.00009134984,0.00009220677,0.000005605172,0.00052319467,0.00021648727,0.96106845,0.000049855815,0.008810395,0.022910422],"study_design_scores_gemma":[0.0019960552,0.00007713646,0.1259952,0.000088413675,0.000021871969,0.0000086131,0.00028970183,0.00006469228,0.82009923,0.00012227659,0.050820563,0.00041623367],"about_ca_topic_score_codex":0.004809974,"about_ca_topic_score_gemma":0.004934774,"teacher_disagreement_score":0.14096922,"about_ca_system_score_codex":0.00009706011,"about_ca_system_score_gemma":0.001054372,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W3109554415","doi":"10.1158/0008-5472.can-20-0271","title":"Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Society for the Promotion of Science","keywords":"Biology; Mammary gland; Mammary tumor; Cancer research; Cell growth; Internal medicine; Mutant; Endocrinology; Cancer; Breast cancer; Genetics; Gene; Medicine","score_opus":0.11001332117408621,"score_gpt":0.38056039936162406,"score_spread":0.27054707818753787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109554415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959713,0.002125662,0.00004415501,0.0013763843,0.000008651489,0.00033210558,0.000012777185,0.0000032338407,0.00012569057],"genre_scores_gemma":[0.9987539,0.0007395071,0.0002365386,0.00015320051,0.00003397397,0.000053151016,0.0000060943885,0.0000059124923,0.000017724935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908996,0.00006558444,0.00020943194,0.00010972682,0.00036878165,0.00015649419],"domain_scores_gemma":[0.99962646,0.000044464687,0.000043109303,0.000112952235,0.00010240431,0.000070611735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004520167,0.00005220964,0.0001614934,0.00008487173,0.000030309733,0.000008479796,0.00010056986,0.0000210204,0.00003057208],"category_scores_gemma":[0.000040851915,0.000034771405,0.000021213242,0.00027835232,0.00007807821,0.000051855186,0.00006578937,0.0001517137,9.949201e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020754326,0.00027275155,0.01569369,0.0052665817,0.00015704997,0.00021301168,0.057839185,0.00007632717,0.73155934,0.00008142755,0.0023967866,0.18436842],"study_design_scores_gemma":[0.0014687909,0.00031058,0.005484746,0.00013440239,0.000012970454,0.00003393745,0.0017807857,0.00008844168,0.98370767,0.000019663054,0.0068927146,0.00006529233],"about_ca_topic_score_codex":0.00021908221,"about_ca_topic_score_gemma":0.00018010807,"teacher_disagreement_score":0.25214833,"about_ca_system_score_codex":0.00005955702,"about_ca_system_score_gemma":0.0002506164,"threshold_uncertainty_score":0.14179367},"labels":[],"label_agreement":null},{"id":"W3111663680","doi":"","title":"Coordination of fatty acid synthesis and cell proliferation by transcription factor Sp1 in MCF-7 human breast cancer cells","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cell growth; Cell cycle; Sp1 transcription factor; Biology; Transfection; Transcription factor; Cancer cell; Cyclin D1; Fatty acid synthase; G1 phase; Cell; Cancer research; Cell biology; Cell cycle checkpoint; Cell culture; Promoter; Gene expression; Fatty acid; Cancer; Biochemistry; Gene","score_opus":0.027205219783740582,"score_gpt":0.3366368673002615,"score_spread":0.3094316475165209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111663680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942003,0.0038382395,0.00033253815,0.00019821739,0.00053101283,0.00038151335,0.000335845,0.000004740252,0.00017760269],"genre_scores_gemma":[0.9950427,0.0025551836,0.000024722593,0.000028726561,0.001441732,0.00014304294,0.000033916156,0.000019644447,0.0007103327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875736,0.00010207036,0.00022711488,0.00032076385,0.00027367895,0.00031903645],"domain_scores_gemma":[0.9994409,0.00001638812,0.000057275185,0.00016110686,0.00023499518,0.00008931641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005817938,0.0001110943,0.00015736195,0.00014345387,0.00008473542,0.000022424234,0.00011274101,0.00015505421,0.00009811253],"category_scores_gemma":[0.000016926733,0.00011044215,0.00003830952,0.0001936403,0.00012857154,0.000013631502,0.000029053526,0.00015934641,9.035698e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019533082,0.00006836746,0.0055939285,0.00012393716,0.000011189072,6.260597e-8,0.00020785877,0.000007720294,0.977014,0.000011759937,0.0047395974,0.012026266],"study_design_scores_gemma":[0.00056608854,0.000056952784,0.020041378,0.00003503041,0.000007339005,7.498396e-7,0.00013168702,0.000011811076,0.96081406,0.000009289765,0.018213486,0.00011211891],"about_ca_topic_score_codex":0.0019597472,"about_ca_topic_score_gemma":0.0034258298,"teacher_disagreement_score":0.016199913,"about_ca_system_score_codex":0.000097208365,"about_ca_system_score_gemma":0.00013608589,"threshold_uncertainty_score":0.45037004},"labels":[],"label_agreement":null},{"id":"W3112053934","doi":"10.1158/0008-5472.can-20-2675","title":"Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cardiomyopathy; Genetic genealogy; Population; Internal medicine; Cancer; Heart failure","score_opus":0.06624746435578537,"score_gpt":0.3385654209479206,"score_spread":0.2723179565921352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112053934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928276,0.0028832864,0.000026188727,0.001354165,0.00008008777,0.0009273277,0.00007207988,0.000066178014,0.0017630704],"genre_scores_gemma":[0.9968197,0.002216879,0.000026556962,0.00022802177,0.00027324917,0.00019814231,0.000019546982,0.000061650004,0.00015629554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974785,0.00028356636,0.0002951163,0.0004606678,0.0009844953,0.00049766054],"domain_scores_gemma":[0.998609,0.000103095605,0.00013054821,0.00030867464,0.00053806324,0.00031059515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004921981,0.00018858933,0.00052027026,0.00013418254,0.000120332305,0.000023744893,0.00019739156,0.00019229868,0.00030576962],"category_scores_gemma":[0.00014416348,0.00015619252,0.0001289818,0.0015882804,0.000361165,0.0000867739,0.000038951264,0.0007063396,0.0000041928165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001003405,0.00031679627,0.39142987,0.00020022769,0.001973046,0.00012572916,0.012056034,0.0007502707,0.5573586,0.00001915008,0.00056316744,0.034203697],"study_design_scores_gemma":[0.0036053348,0.00067786564,0.77665746,0.00049513864,0.000075434145,0.0000062451286,0.00062209606,0.00017578495,0.2171275,0.000049718547,0.00029496851,0.00021246259],"about_ca_topic_score_codex":0.0034631544,"about_ca_topic_score_gemma":0.00046763348,"teacher_disagreement_score":0.38522756,"about_ca_system_score_codex":0.00026977473,"about_ca_system_score_gemma":0.00090924464,"threshold_uncertainty_score":0.6369346},"labels":[],"label_agreement":null},{"id":"W3113432048","doi":"10.1158/0008-5472.can-20-2121","title":"Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ste. Anne's Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Cyclin-dependent kinase 6; Biology; Cancer research; Metastasis; Cancer; DNA repair; Tumor progression; Cell cycle; Kinase; Cyclin-dependent kinase; Cell biology; Genetics; DNA","score_opus":0.0540760209616148,"score_gpt":0.39717524057498826,"score_spread":0.3430992196133735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113432048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989128,0.006134547,0.00009994102,0.0035396619,0.00003492016,0.0008395365,0.00006790268,0.000060893108,0.00009462558],"genre_scores_gemma":[0.998088,0.00081949745,0.0001719771,0.0000864482,0.00024089274,0.00042590578,0.00004565455,0.00003011002,0.00009150016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814844,0.000101993086,0.00028793112,0.00051218754,0.00056148146,0.00038798276],"domain_scores_gemma":[0.99913055,0.00004519467,0.000094534014,0.00032521193,0.00019964406,0.00020483955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019511509,0.00011845409,0.00026964908,0.000101694946,0.000064618645,0.000011351387,0.00009269912,0.00009237032,0.0002655291],"category_scores_gemma":[0.00010987512,0.0001038803,0.000042355477,0.0004502714,0.00019584558,0.0001183576,0.000081330516,0.000327482,0.0000014533615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001951305,0.000075902484,0.06762702,0.00031488852,0.000030905736,0.0000028532534,0.0018181925,0.000020440097,0.84275633,0.00010837363,0.00047752762,0.084816255],"study_design_scores_gemma":[0.0030594554,0.00043015095,0.35114205,0.00074393983,0.000024126823,0.0000034168963,0.0004561012,0.003417158,0.6333556,0.00033349777,0.0068734577,0.00016100741],"about_ca_topic_score_codex":0.0005370704,"about_ca_topic_score_gemma":0.00010363894,"teacher_disagreement_score":0.28351504,"about_ca_system_score_codex":0.0003337925,"about_ca_system_score_gemma":0.00026628398,"threshold_uncertainty_score":0.42361155},"labels":[],"label_agreement":null},{"id":"W3115565159","doi":"","title":"SAGE analysis of human metastatic and non-metastatic prostate cancer xenograft sublines from a single patient.","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"UniGene; Prostate cancer; Metastasis; Cancer; Serial analysis of gene expression; Prostate; Cancer research; Biology; Gene; Stromal cell; Primary tumor; Tumor progression; Pathology; Medicine; Gene expression profiling; Transcriptome; Gene expression; Genetics","score_opus":0.04564294365610181,"score_gpt":0.41604991071031816,"score_spread":0.37040696705421633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115565159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913889,0.00385422,0.0036602954,0.00013591173,0.000015053264,0.00042844057,0.00039483828,0.000008615272,0.000113714865],"genre_scores_gemma":[0.9964142,0.001004236,0.00159408,0.00008793603,0.000036478606,0.00028379084,0.00036993457,0.000019646603,0.00018971921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986388,0.00009453458,0.0002945305,0.00041487854,0.0002118393,0.00034543587],"domain_scores_gemma":[0.9990964,0.000041454095,0.000106643565,0.00038250876,0.0002642414,0.000108754546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048550343,0.00012633714,0.0002470288,0.00027781184,0.00012809187,0.000023049735,0.00018056255,0.00006652086,0.000085386324],"category_scores_gemma":[0.00003844933,0.000111874535,0.00009234034,0.000790477,0.00032011967,0.000003942289,0.0001606117,0.00013532846,6.7555635e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005955205,0.00010307055,0.011204095,0.000023736613,0.00057306595,0.000003968103,0.00014849674,0.000017223605,0.9744251,0.000024961537,0.0003327527,0.0130840195],"study_design_scores_gemma":[0.00036316842,0.00043607672,0.012534167,0.000035156714,0.00031439777,7.2647583e-7,0.0002529232,0.00007699396,0.97985274,0.00024430087,0.0057130875,0.00017629053],"about_ca_topic_score_codex":0.002898684,"about_ca_topic_score_gemma":0.0035198792,"teacher_disagreement_score":0.012907729,"about_ca_system_score_codex":0.000027734437,"about_ca_system_score_gemma":0.00007481211,"threshold_uncertainty_score":0.4562111},"labels":[],"label_agreement":null},{"id":"W3116079182","doi":"","title":"Chromosomal aberrations in breast cancer tumors using cDNA microarray CGH.","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Comparative genomic hybridization; Complementary DNA; Copy number analysis; Microarray; Biology; Breast cancer; Cancer; Tissue microarray; Molecular biology; Bioconductor; Copy-number variation; Genetics; Pathology; Chromosome; Gene; Gene expression; Medicine; Genome","score_opus":0.04013777938733512,"score_gpt":0.35488746499582036,"score_spread":0.31474968560848526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116079182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474615,0.0018843383,0.00003244738,0.0019978439,0.00009482775,0.00019187974,0.00019377997,0.0000074502004,0.00085125666],"genre_scores_gemma":[0.9958291,0.00046349238,0.0003054213,0.00014200833,0.0009828747,0.00016695556,0.000036521677,0.000025504754,0.0020480899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986426,0.00010418322,0.00022020264,0.0003411782,0.00020145898,0.0004903821],"domain_scores_gemma":[0.999391,0.000009351089,0.000038326394,0.00027000153,0.00019503762,0.00009623983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002751983,0.000122062374,0.00012259444,0.0001221323,0.00021480609,0.0000548495,0.00023467623,0.00010815459,0.00066781486],"category_scores_gemma":[0.000012964632,0.00012286378,0.000050342467,0.00026609388,0.00013597604,0.000013370151,0.00012515455,0.00021549717,0.000020785445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050900322,0.000073107585,0.026832627,0.000023477081,0.00002970875,0.000003786937,0.000341275,0.0044217594,0.9641667,0.0001431846,0.002419955,0.0014935135],"study_design_scores_gemma":[0.0023287362,0.00015643622,0.119666204,0.00026703728,0.000027469741,0.00017438605,0.0017851493,0.0020598895,0.78112817,0.000119233104,0.091357276,0.0009300111],"about_ca_topic_score_codex":0.002536746,"about_ca_topic_score_gemma":0.0030858687,"teacher_disagreement_score":0.18303853,"about_ca_system_score_codex":0.0002576109,"about_ca_system_score_gemma":0.00070603605,"threshold_uncertainty_score":0.7312105},"labels":[],"label_agreement":null},{"id":"W3120238974","doi":"10.1158/0008-5472.can-20-2222","title":"Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Ovarian Cancer Canada; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canada Foundation for Innovation","keywords":"KRAS; CDKN2A; Selumetinib; Cancer research; Neuroblastoma RAS viral oncogene homolog; Targeted therapy; MEK inhibitor; Medicine; Synthetic lethality; Cancer; Biology; Mutation; Gene; Internal medicine; Kinase; Genetics; DNA repair; MAPK/ERK pathway","score_opus":0.05249500699688612,"score_gpt":0.36017261681159723,"score_spread":0.3076776098147111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120238974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962274,0.0008627601,0.000078813,0.0019274127,0.0002094483,0.00047841787,0.00018076219,0.0000098199025,0.000025194187],"genre_scores_gemma":[0.99892235,0.0006074161,0.000080679114,0.000037906633,0.00012963459,0.000060885104,0.00006882038,0.000019414008,0.00007288069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982417,0.00037382616,0.00029537943,0.0003740867,0.00046501466,0.000249983],"domain_scores_gemma":[0.9986105,0.00014058842,0.000090123474,0.00034715317,0.00069675257,0.00011488242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000650631,0.0001172995,0.00034853638,0.0001390457,0.00009178867,0.000026453488,0.00003854782,0.000092934184,0.00009499622],"category_scores_gemma":[0.00007819887,0.000106472486,0.0000812133,0.00040953775,0.00031719627,0.000067467794,0.00008139062,0.00017784003,0.0000011709442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039677252,0.0004338469,0.11443757,0.00065867923,0.00027160137,0.00009874905,0.0004917733,0.0000048213897,0.87369764,0.000050083545,0.000020806432,0.009437633],"study_design_scores_gemma":[0.0012493455,0.00008746085,0.46656305,0.00013980037,0.00006445841,0.000018864708,0.00015078516,0.00024709676,0.53137124,0.000031344895,0.000026126567,0.000050452007],"about_ca_topic_score_codex":0.0012570021,"about_ca_topic_score_gemma":0.00026292627,"teacher_disagreement_score":0.35212547,"about_ca_system_score_codex":0.00021373114,"about_ca_system_score_gemma":0.00052324415,"threshold_uncertainty_score":0.4341822},"labels":[],"label_agreement":null},{"id":"W3120533655","doi":"10.1158/0008-5472.can-20-2571","title":"Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"review","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute","keywords":"Leukemia; Haematopoiesis; Cancer research; Epigenetics; Immunotherapy; Stem cell; Biology; Cancer; Acute leukemia; Immunology; Medicine; Immune system; Cell biology; Genetics; Gene","score_opus":0.09428769550823791,"score_gpt":0.4300560703652312,"score_spread":0.3357683748569933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120533655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053241965,0.9923661,0.00007321782,0.00009014624,0.0006387564,0.0029673362,0.00024911383,0.00013058048,0.0029523692],"genre_scores_gemma":[0.00017674018,0.987889,0.0006326445,0.00012786909,0.0017927802,0.0022521706,0.00056295644,0.00048729213,0.0060785627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9867744,0.0018888396,0.0020803085,0.0022631753,0.0035694116,0.0034238638],"domain_scores_gemma":[0.9913802,0.0042831046,0.0004119762,0.0016075715,0.0012958344,0.0010212748],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0040646726,0.0011014194,0.0046482515,0.0023377135,0.00041449646,0.00030828465,0.0013508716,0.0014341773,0.0017011965],"category_scores_gemma":[0.002732533,0.0009599729,0.00087717274,0.005520661,0.000666194,0.00022861653,0.0017087747,0.0060497024,0.0010906861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00020870629,0.00018090608,0.00003167605,0.07010402,0.0016666385,0.017278524,0.0005190008,0.00015639234,0.0013226087,0.00013413434,0.054420512,0.8539769],"study_design_scores_gemma":[0.002888791,0.0002373505,0.0000035954029,0.0877727,0.00087567413,0.00054614077,0.00030982724,0.0010621255,0.00042772098,0.00001828446,0.9049186,0.0009391933],"about_ca_topic_score_codex":0.0015132511,"about_ca_topic_score_gemma":0.000059321646,"teacher_disagreement_score":0.8530377,"about_ca_system_score_codex":0.061099835,"about_ca_system_score_gemma":0.0771036,"threshold_uncertainty_score":0.9998622},"labels":[],"label_agreement":null},{"id":"W3120640760","doi":"10.1158/0008-5472.can-20-3708","title":"Next-Generation Profiling of Medulloblastoma: Old Drugs Are an Elegant Weapon in a Civilized Age","year":2021,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Profiling (computer programming); Medicine; Pathology; Computer science; Programming language","score_opus":0.17075829202292614,"score_gpt":0.4070534444660893,"score_spread":0.23629515244316318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120640760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8556327,0.0055620866,8.6240595e-7,0.13678941,0.00023570319,0.0013919738,0.00008168177,0.000022522536,0.00028304258],"genre_scores_gemma":[0.95154727,0.0024503737,0.00035002758,0.032864578,0.0049339524,0.0031239653,0.0023936806,0.00017736058,0.0021588053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960729,0.0005359064,0.00048733936,0.00077977375,0.0014272005,0.00069689867],"domain_scores_gemma":[0.998178,0.00018271625,0.00014953554,0.0007420452,0.0006001969,0.00014748177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073968474,0.0002859269,0.00083690975,0.0007693647,0.00007793167,0.00008474512,0.00020357696,0.00054170226,0.00041652858],"category_scores_gemma":[0.00019566421,0.00024289917,0.00016264868,0.0008600557,0.0001367842,0.000104603336,0.000106627806,0.001929561,0.000013326292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042601975,0.0012609869,0.00689436,0.0033174918,0.00043785985,0.020602642,0.0014805166,0.000034070366,0.5219424,0.000058098853,0.4374532,0.0060923984],"study_design_scores_gemma":[0.008265121,0.001032444,0.0029913837,0.0072766086,0.00024828513,0.000059352566,0.0013381707,0.0005810925,0.8674245,0.00006437794,0.11009463,0.00062405714],"about_ca_topic_score_codex":0.0021192841,"about_ca_topic_score_gemma":0.0020534357,"teacher_disagreement_score":0.34548214,"about_ca_system_score_codex":0.0008922348,"about_ca_system_score_gemma":0.00091783673,"threshold_uncertainty_score":0.9905141},"labels":[],"label_agreement":null},{"id":"W3121973936","doi":"10.1158/0008-5472.can-20-1822","title":"3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Centre for the Replacement, Refinement and Reduction of Animals in Research; King's College London; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; BC Cancer Agency; Breast Cancer Now; Medical Research Council; Barts Charity; Pfizer","keywords":"Triple-negative breast cancer; Breast cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.03677260844504455,"score_gpt":0.362714778354144,"score_spread":0.32594216990909947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121973936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808518,0.013417326,0.0001493661,0.0012944666,0.00062744966,0.00040582998,0.0010498498,0.000008109378,0.0021957844],"genre_scores_gemma":[0.96855825,0.02006614,0.00027434833,0.0007718399,0.001486059,0.0005239448,0.0002974683,0.00006718717,0.007954757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997701,0.00016931635,0.0002724892,0.0007322186,0.00043805366,0.00068695756],"domain_scores_gemma":[0.9981903,0.00009437516,0.00010665726,0.0004314695,0.0009643735,0.0002128447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037600967,0.00019778164,0.00023955623,0.00014461913,0.00021696903,0.00011550937,0.0002724261,0.00020277397,0.002085677],"category_scores_gemma":[0.00040379353,0.00021426337,0.00010761582,0.0005086147,0.00024887643,0.000013145378,0.00044984993,0.00044160674,0.000065240376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012928742,0.0002772397,0.024999468,0.00007939755,0.00033423796,0.00031214496,0.00038718226,0.004511977,0.88207316,0.00055737206,0.077140674,0.008034244],"study_design_scores_gemma":[0.00566406,0.00024588342,0.12928142,0.0003029104,0.00006063885,0.00014084177,0.0011666735,0.00038739498,0.6861981,0.002009432,0.1736052,0.0009374255],"about_ca_topic_score_codex":0.004664363,"about_ca_topic_score_gemma":0.009515778,"teacher_disagreement_score":0.19587506,"about_ca_system_score_codex":0.0004953105,"about_ca_system_score_gemma":0.0030098804,"threshold_uncertainty_score":0.99882656},"labels":[],"label_agreement":null},{"id":"W3122107622","doi":"10.1158/0008-5472.can-20-1237","title":"Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Center for Advancing Translational Sciences; Medical Research Council; Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; National Institutes of Health; Medical Research and Materiel Command; Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología; Princess Margaret Hospital Foundation; Universidad de Oviedo; Vanderbilt University; Moffitt Cancer Center; Herlev Hospital; Norges Forskningsråd; Vanderbilt University Medical Center; Cancer Care Ontario; National Center for Research Resources; Georgia Clinical and Translational Science Alliance; National Cancer Institute; Sundhed og Sygdom, Det Frie Forskningsråd; World Health Organization; Roy Castle Lung Cancer Foundation; U.S. Department of Defense","keywords":"Lung cancer; Absolute risk reduction; Cancer; Medicine; Oncology; Statistics; Internal medicine; Mathematics; Confidence interval","score_opus":0.06646280740802088,"score_gpt":0.46487277598174803,"score_spread":0.3984099685737271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122107622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97171533,0.008208678,0.009022111,0.005883201,0.00036546,0.00033466882,0.000051882755,0.00008892872,0.004329765],"genre_scores_gemma":[0.98832875,0.0041840817,0.0025072682,0.001271511,0.00073324266,0.00019331223,0.000018746388,0.00008504272,0.0026780525],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99657536,0.0005320629,0.00027282603,0.000629285,0.0011975126,0.0007929568],"domain_scores_gemma":[0.99804485,0.0004458505,0.00009275021,0.0005743053,0.00039582024,0.00044642904],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018796051,0.00018646274,0.0003557593,0.00028795327,0.00048334003,0.00015626069,0.00019608346,0.00012722719,0.0009399387],"category_scores_gemma":[0.001341203,0.00016342111,0.00017191305,0.00067829463,0.0002170532,0.000110493995,0.0000811875,0.0028233936,0.000016925163],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009297312,0.0007207401,0.16710655,0.0011232158,0.000720265,0.0010179857,0.0015519198,0.37134486,0.090572536,0.00016427324,0.056010067,0.30873784],"study_design_scores_gemma":[0.0018826849,0.000058056085,0.02895004,0.00070029043,0.00014536861,0.0000075240764,0.00010908501,0.96257377,0.0027071587,0.000098787525,0.002584863,0.00018238022],"about_ca_topic_score_codex":0.0027116742,"about_ca_topic_score_gemma":0.00014832725,"teacher_disagreement_score":0.5912289,"about_ca_system_score_codex":0.00079666707,"about_ca_system_score_gemma":0.0032494008,"threshold_uncertainty_score":0.99997336},"labels":[],"label_agreement":null},{"id":"W3122363717","doi":"","title":"Regulation of E2F1 phosphorylation, subcellular distribution and stability in keratinocytes.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"E2F1; Phosphorylation; Biology; Cell biology; Keratinocyte; Kinase; Cell cycle; Biochemistry; Cell; In vitro","score_opus":0.07493787278120903,"score_gpt":0.3492213573993787,"score_spread":0.27428348461816965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122363717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434364,0.003885092,0.00038449603,0.00039136587,0.000043330525,0.0005855667,0.00003511237,0.000015456126,0.00031591367],"genre_scores_gemma":[0.99867165,0.000902682,0.00007203012,0.000008754513,0.000044644574,0.000065276254,0.00011519668,0.000012640306,0.00010715181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858534,0.00012551878,0.00026603797,0.00026948622,0.00051819585,0.00023541956],"domain_scores_gemma":[0.9990473,0.00006676039,0.00004566344,0.00028196818,0.0004641473,0.00009418211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070797466,0.00007565326,0.00018964506,0.000113822796,0.0000869162,0.0000056435097,0.000045148212,0.00010446457,0.00020758],"category_scores_gemma":[0.00029188654,0.00007623699,0.000031340696,0.0006257427,0.0003316599,0.00006573859,0.000041003,0.00033383828,0.00000396623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006617978,0.0001314848,0.14868851,0.00020535888,0.000020597989,0.00002763917,0.00090170885,0.00009860773,0.8439294,0.00046788657,0.0009932367,0.003873743],"study_design_scores_gemma":[0.0012866056,0.00013349789,0.42926574,0.00011287175,0.000007671151,0.000014053936,0.000057726018,0.0008632226,0.5667398,0.00020590801,0.0012481578,0.0000647394],"about_ca_topic_score_codex":0.0010258879,"about_ca_topic_score_gemma":0.0001909662,"teacher_disagreement_score":0.2805772,"about_ca_system_score_codex":0.0005804131,"about_ca_system_score_gemma":0.0004897203,"threshold_uncertainty_score":0.31088543},"labels":[],"label_agreement":null},{"id":"W3123853262","doi":"10.1158/0008-5472.can-20-3108","title":"Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers","year":2021,"lang":"en","type":"review","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute of General Medical Sciences; Cancer Research UK; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medulloblastoma; Transcription factor; Neuroblastoma; Pediatric cancer; Biology; N-Myc; Cancer research; Bioinformatics; Computational biology; Gene; Medicine; Cancer; Genetics","score_opus":0.16587872954468452,"score_gpt":0.49643616907874516,"score_spread":0.33055743953406064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123853262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012314831,0.98070186,0.0000037284324,0.00034856852,0.0002932317,0.0050958088,0.00056651933,0.000086710024,0.00058873993],"genre_scores_gemma":[0.010194872,0.9839886,0.000021194732,0.00010546086,0.0007222314,0.002235007,0.0001750973,0.00021889262,0.002338633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928666,0.0012447621,0.0006803687,0.0011941134,0.0021558716,0.0018583348],"domain_scores_gemma":[0.9962157,0.0008175496,0.00014306567,0.0013266088,0.00046536385,0.0010317117],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000896064,0.00069894874,0.0020466011,0.0007718334,0.00065283926,0.00032238642,0.0007383819,0.00028193707,0.0014036886],"category_scores_gemma":[0.00043243097,0.00043178504,0.00128421,0.0022101288,0.00021176887,0.0001588331,0.00030322096,0.0027335968,0.00028255195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010247527,0.00020176673,0.00003263455,0.006237442,0.0016447282,0.00048084726,0.0007427078,0.0000082480165,0.00064674346,0.000008076648,0.0053266995,0.98456764],"study_design_scores_gemma":[0.0010426396,0.0005980774,0.00024396168,0.029330561,0.0006898645,0.00022899114,0.00017428836,0.0000033011218,0.00042542332,0.0000084502735,0.9668437,0.0004107133],"about_ca_topic_score_codex":0.002618528,"about_ca_topic_score_gemma":0.00046735822,"teacher_disagreement_score":0.9841569,"about_ca_system_score_codex":0.007887311,"about_ca_system_score_gemma":0.010086922,"threshold_uncertainty_score":0.9998134},"labels":[],"label_agreement":null},{"id":"W3126439695","doi":"10.1158/0008-5472.can-20-2489","title":"Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"National Institute of Neurological Disorders and Stroke; Innovative Medicines Initiative; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Wellcome Trust; Novartis Pharma; Ontario Genomics Institute; China Scholarship Council; National Institutes of Health; Ontario Genomics; Florida Department of Health; Mayo Clinic; Pfizer; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA","keywords":"SOX2; Reprogramming; Biology; Transcriptome; Transcription factor; Cancer research; Tumor microenvironment; Immune system; Immunology; Stem cell; Cell biology; Genetics; Gene expression; Gene","score_opus":0.05354059156191435,"score_gpt":0.3556553722922861,"score_spread":0.3021147807303718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126439695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938638,0.0049347444,0.00010810591,0.00030519126,0.00018012084,0.000341325,0.000021463215,0.000011393108,0.00023384271],"genre_scores_gemma":[0.9974017,0.0011493867,0.00013177718,0.00004911325,0.00012365512,0.00014301404,0.00006455701,0.000024524721,0.0009122521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981899,0.00028014675,0.00024156422,0.00053862395,0.00033769797,0.00041203448],"domain_scores_gemma":[0.99933803,0.000019445963,0.000040372888,0.00028813956,0.00021050904,0.00010350214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004810138,0.00013277745,0.00014499985,0.00010345826,0.00014874327,0.00010050868,0.00015039623,0.0001685568,0.00007297208],"category_scores_gemma":[0.00012853944,0.00013120116,0.0000559073,0.00028973358,0.00012368537,0.00001751284,0.000082618906,0.00040983167,0.000002697593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005496067,0.000047741178,0.001618294,0.000054513315,0.00001913706,0.000016221356,0.0006707401,0.000009503376,0.9875892,0.000018110706,0.00012023198,0.009781371],"study_design_scores_gemma":[0.00063924247,0.000097488846,0.0016799592,0.000087570035,0.0000041456515,0.000005650412,0.0018150125,0.00001393964,0.9897111,0.000037030866,0.00576082,0.00014804264],"about_ca_topic_score_codex":0.00041117024,"about_ca_topic_score_gemma":0.00031272593,"teacher_disagreement_score":0.009633329,"about_ca_system_score_codex":0.0000722174,"about_ca_system_score_gemma":0.00019827817,"threshold_uncertainty_score":0.5350228},"labels":[],"label_agreement":null},{"id":"W3126741775","doi":"10.1158/0008-5472.can-20-3892","title":"Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Cancer research; Epithelial–mesenchymal transition; ADAM10; Pancreatic cancer; Medicine; Fibrosis; Cancer; Metastasis; Radiation therapy; Stromal cell; Pathology; Biology; Internal medicine; Metalloproteinase; Matrix metalloproteinase; Disintegrin","score_opus":0.05039197099669572,"score_gpt":0.4051473477458818,"score_spread":0.35475537674918606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126741775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719062,0.021203252,0.0000431933,0.0050410386,0.00006508203,0.0007170522,0.000107317435,0.000011179839,0.0009056787],"genre_scores_gemma":[0.9413504,0.054199487,0.0002768471,0.00014770417,0.00019625247,0.0005337121,0.00004934171,0.00002178407,0.0032244525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99782693,0.00042354414,0.00031030175,0.00038759573,0.00063702493,0.00041460613],"domain_scores_gemma":[0.9987969,0.00027017907,0.000045222612,0.0002459557,0.0004495517,0.00019220477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008314507,0.00011592428,0.00045026527,0.00022788437,0.00010453793,0.00001832238,0.00007301055,0.00015280608,0.0008650387],"category_scores_gemma":[0.00019517352,0.00010433853,0.00004041155,0.00085361983,0.00024635802,0.00012136572,0.000028658207,0.00037352936,0.000004440891],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017867623,0.00024692024,0.095368095,0.00040450066,0.000121733065,0.000022004879,0.00357477,0.0000110494475,0.8676549,0.00015781911,0.008237801,0.0224136],"study_design_scores_gemma":[0.006263449,0.0008779708,0.6880576,0.001369818,0.00007092532,0.0000121274325,0.0022965397,0.00025972835,0.2841239,0.00056486286,0.015854133,0.00024897885],"about_ca_topic_score_codex":0.004062291,"about_ca_topic_score_gemma":0.002655913,"teacher_disagreement_score":0.59268945,"about_ca_system_score_codex":0.00046050266,"about_ca_system_score_gemma":0.0010509639,"threshold_uncertainty_score":0.9471567},"labels":[],"label_agreement":null},{"id":"W3127162284","doi":"10.1158/0008-5472.can-20-3267","title":"Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Center for Chronic Disease Prevention and Health Promotion; National Heart, Lung, and Blood Institute; National Health and Medical Research Council; Centers for Disease Control and Prevention; Division of Cancer Epidemiology and Genetics, National Cancer Institute; University of California, San Francisco; Ministero della Salute; Lustgarten Foundation; California Department of Public Health; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; Grantová Agentura České Republiky; European Cooperation in Science and Technology; Ministerio de Ciencia y Tecnología; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; Medical Research Council; Pancreatic Cancer Action Network; Patient-Centered Outcomes Research Institute; Ministerstvo Zdravotnictví Ceské Republiky; American Cancer Society; State of Connecticut Department of Public Health; Kaiser Permanente; U.S. Department of Defense; World Health Organization; Geoffrey Beene Foundation; Cancer Council Victoria; Yale University; National Institutes of Health; Promises for Purple; U.S. Department of Health and Human Services","keywords":"Expression quantitative trait loci; Quantitative trait locus; Pancreatic cancer; Genotype; Colocalization; Linkage disequilibrium; Allele; Locus (genetics); SNP","score_opus":0.15149679739840988,"score_gpt":0.4764570425719832,"score_spread":0.3249602451735733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127162284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95506406,0.009885178,0.00004688673,0.005631365,0.00018071919,0.0005628919,0.0000649338,0.000060930757,0.028503034],"genre_scores_gemma":[0.94267696,0.022889886,0.0001734955,0.000524023,0.0008369345,0.00088090944,0.000026844178,0.00005398629,0.031936936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958499,0.0006483369,0.00031776953,0.00063703745,0.0014891131,0.0010578489],"domain_scores_gemma":[0.99678063,0.0009574937,0.00006172816,0.0007367356,0.0010378651,0.00042551523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015028123,0.00019933241,0.00065375114,0.00029780716,0.0004978298,0.00006499794,0.0002246366,0.00022048737,0.0060826996],"category_scores_gemma":[0.0014399454,0.00016351197,0.00013102966,0.0009572426,0.00049950497,0.00006830284,0.00019002859,0.001626541,0.0002631619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012591624,0.0004682865,0.88998884,0.00059285463,0.0009473778,0.0011133789,0.0013307374,0.00009768037,0.014294497,0.0015393464,0.052571338,0.035796493],"study_design_scores_gemma":[0.010697923,0.00210722,0.7452058,0.0032420056,0.0010507656,0.0001603317,0.004383109,0.0033018682,0.092418574,0.0047810785,0.13173425,0.0009170563],"about_ca_topic_score_codex":0.0045121037,"about_ca_topic_score_gemma":0.0005781669,"teacher_disagreement_score":0.14478302,"about_ca_system_score_codex":0.001056191,"about_ca_system_score_gemma":0.0028169665,"threshold_uncertainty_score":0.9948259},"labels":[],"label_agreement":null},{"id":"W3129132895","doi":"10.1158/0008-5472.can-20-2511","title":"ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Interreg; National Cancer Institute; Cancer Council South Australia; Medical Research Council; North Dakota Department of Agriculture; Fondation contre le Cancer; Vlaamse regering; KU Leuven; Fonds Wetenschappelijk Onderzoek; Prostate Cancer Foundation of Australia; National Health and Medical Research Council; Commonwealth Scientific and Industrial Research Organisation; Queen's University Belfast; National Institutes of Health; Queen's University; Department of Health and Aged Care, Australian Government; U.S. Department of Defense; European Commission; Prostate Cancer Foundation; Movember Foundation; Australian Government; Dana-Farber Cancer Institute","keywords":"Prostate cancer; Metastasis; Cancer research; Cancer; Androgen receptor; Lipidome; Cancer cell; Prostate; Fatty acid metabolism; Lipid metabolism; Biology; Fatty acid; Chemistry; Internal medicine; Endocrinology; Biochemistry; Medicine","score_opus":0.03641418879254042,"score_gpt":0.39576320595851444,"score_spread":0.359349017165974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129132895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8972008,0.09554085,0.000043105843,0.0039987736,0.0016918876,0.00030147095,0.00024662307,0.000009155379,0.00096728373],"genre_scores_gemma":[0.919652,0.0629898,0.00040607303,0.0014152819,0.0072997096,0.00084389164,0.00006250332,0.000058355523,0.007272399],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808496,0.00016298796,0.00018165098,0.0006002426,0.0003061052,0.00066405366],"domain_scores_gemma":[0.99899334,0.000025761829,0.00001732126,0.00033940646,0.0004109146,0.00021324363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044712395,0.0001372324,0.00020545255,0.00007805384,0.0001300016,0.00007302558,0.00014299623,0.000117408184,0.000514536],"category_scores_gemma":[0.00026312633,0.0001362288,0.00004938871,0.00033027478,0.00027529025,0.000010879898,0.00024737176,0.00034102015,0.000008681927],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020596271,0.00006864175,0.013820085,0.00014538603,0.00003152585,0.0000065895065,0.00030559232,0.000009206066,0.91002434,0.00019953492,0.06655739,0.008625712],"study_design_scores_gemma":[0.0007001539,0.00004423858,0.0057030735,0.000053294687,0.000007259533,0.000009221942,0.00024587172,0.000014993769,0.49376607,0.00016968184,0.4991322,0.0001539654],"about_ca_topic_score_codex":0.001423564,"about_ca_topic_score_gemma":0.0042185313,"teacher_disagreement_score":0.4325748,"about_ca_system_score_codex":0.00007054205,"about_ca_system_score_gemma":0.0010341918,"threshold_uncertainty_score":0.5633808},"labels":[],"label_agreement":null},{"id":"W3129273253","doi":"10.1158/1538-7445.sabcs20-ps9-71","title":"Abstract PS9-71: The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Montreal Cognitive Assessment; Oncology; Internal medicine; Cancer; Verbal memory; Cognition; Population; Adjuvant; Aromatase; Anastrozole; Aromatase inhibitor; Adjuvant therapy; Psychiatry; Disease; Dementia","score_opus":0.029933487607746875,"score_gpt":0.3673990927094161,"score_spread":0.33746560510166923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129273253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993284,0.003780075,0.0000027171607,0.0018056033,0.00018260664,0.001652352,0.0018187568,0.000025128984,0.00079990504],"genre_scores_gemma":[0.9970755,0.00081245444,0.000003826312,0.00015401086,0.00034501596,0.001209259,0.00008087309,0.0000568479,0.00026220735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996786,0.00044230514,0.00034419936,0.00057528005,0.0010510538,0.0008011438],"domain_scores_gemma":[0.9972873,0.0010714304,0.00012590137,0.00028153454,0.0010248525,0.00020898151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008826155,0.00029381367,0.0005679797,0.00034161017,0.00032071274,0.00003190484,0.00009673633,0.00010889837,0.00075035484],"category_scores_gemma":[0.00026335003,0.00019197067,0.00006113405,0.0016070532,0.0007301113,0.00012989536,0.00013638436,0.001167527,0.00003223039],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11526242,0.0018760031,0.16697434,0.0012717135,0.0045082862,0.0015262004,0.009002196,0.00063216285,0.62231576,0.000015077346,0.01255743,0.064058416],"study_design_scores_gemma":[0.012293725,0.007933792,0.80790967,0.008705273,0.0003702992,0.00014136963,0.012935762,0.000027540531,0.14901978,0.000011426582,0.00022790239,0.00042344636],"about_ca_topic_score_codex":0.0027697165,"about_ca_topic_score_gemma":0.0005898435,"teacher_disagreement_score":0.64093536,"about_ca_system_score_codex":0.0022106923,"about_ca_system_score_gemma":0.0011503204,"threshold_uncertainty_score":0.82158595},"labels":[],"label_agreement":null},{"id":"W3129284683","doi":"10.1158/1538-7445.sabcs20-ps18-06","title":"Abstract PS18-06: Proteomic analysis of breast cancer formalin-fixed paraffin-embedded clinical specimens identifies biologically-important subtypes with distinct clinical outcomes","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Centre for Advancing Health Outcomes","funders":"","keywords":"Breast cancer; Multiplex; Proteomics; Biomarker discovery; Oncology; Cancer; Biomarker; Fold change; Medicine; Internal medicine; Computational biology; Biology; Pathology; Bioinformatics; Cancer research; Gene expression; Gene; Genetics","score_opus":0.10837667249053547,"score_gpt":0.47533726798496395,"score_spread":0.3669605954944285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129284683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954955,0.00039699726,0.0005669755,0.0012325095,0.0000441435,0.00048638496,0.0011453658,0.00010973592,0.0005223794],"genre_scores_gemma":[0.98882204,0.0030731398,0.005125121,0.000060367864,0.00024461673,0.0011171007,0.00023272935,0.000044053584,0.0012808443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958621,0.00014646038,0.0016425131,0.0009906845,0.0006672007,0.0006909961],"domain_scores_gemma":[0.99613565,0.0007819873,0.0006118928,0.0011501269,0.0010357703,0.00028454544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016838319,0.00029735925,0.0010804594,0.0001589012,0.0002418868,0.000084666484,0.00066558743,0.00034515923,0.0035753644],"category_scores_gemma":[0.00034835874,0.00021675015,0.00049763906,0.0011714658,0.000910696,0.00012297608,0.00033971612,0.001199539,0.000019324385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004709112,0.0005392926,0.8657841,0.00012839655,0.0016601529,0.000049574854,0.000034213237,0.00007024405,0.1281194,0.0008036484,0.00044554606,0.0018945144],"study_design_scores_gemma":[0.000992093,0.00007465465,0.80584246,0.0001805055,0.00051378197,0.000007261112,0.00016534716,0.0002003078,0.18908635,0.0013375073,0.0011351522,0.00046454728],"about_ca_topic_score_codex":0.00048101952,"about_ca_topic_score_gemma":0.0014524834,"teacher_disagreement_score":0.060966957,"about_ca_system_score_codex":0.0001792665,"about_ca_system_score_gemma":0.00078459154,"threshold_uncertainty_score":0.9973355},"labels":[],"label_agreement":null},{"id":"W3129286763","doi":"10.1158/1538-7445.sabcs20-ot-30-01","title":"Abstract OT-30-01: KEYLYNK-009: A phase 2/3, open-label, randomized study of pembrolizumab plus olaparib vs pembrolizumab plus chemotherapy after induction with first-line pembrolizumab plus chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Olaparib; Internal medicine; Chemotherapy; Gemcitabine; Atezolizumab; PARP inhibitor; Carboplatin; Cancer; Immunotherapy; Cisplatin","score_opus":0.07989167611688573,"score_gpt":0.41428373338485575,"score_spread":0.33439205726797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129286763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781826,0.0023985882,0.00020787006,0.0029856646,0.00036870426,0.014825257,0.0005742699,0.00009235927,0.00036469573],"genre_scores_gemma":[0.9787925,0.0055397917,0.00032372237,0.00086780655,0.0003680883,0.012164438,0.00017174052,0.00032925644,0.0014426884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9893611,0.0013908885,0.0020356851,0.0021162354,0.003335125,0.0017609877],"domain_scores_gemma":[0.99249417,0.0006945172,0.000881409,0.0015721496,0.0036457083,0.0007120287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019617896,0.0011661403,0.0036983814,0.0010457399,0.00046495476,0.00033039812,0.0008928426,0.00032900926,0.008502541],"category_scores_gemma":[0.00027180754,0.0008347822,0.00021067869,0.0035389243,0.0011044225,0.00097123487,0.00025661965,0.0021890248,0.000026290452],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9524135,0.013182088,0.001568356,0.0012118622,0.0026071598,0.0005407911,0.011042004,0.001803999,0.00058600167,0.000014649663,0.0012544992,0.013775104],"study_design_scores_gemma":[0.9573155,0.011714975,0.015179115,0.0049359775,0.00043912252,0.00011978072,0.0022874135,0.0015105004,0.004649753,0.00006535693,0.0007035924,0.0010788887],"about_ca_topic_score_codex":0.0099760825,"about_ca_topic_score_gemma":0.011767551,"teacher_disagreement_score":0.013610759,"about_ca_system_score_codex":0.006685438,"about_ca_system_score_gemma":0.0121333,"threshold_uncertainty_score":0.9994103},"labels":[],"label_agreement":null},{"id":"W3129484121","doi":"10.1158/1538-7445.sabcs20-ps15-07","title":"Abstract PS15-07: Deep inspiration breath-hold in right-sided breast irradiation: Quantifying the benefit","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interquartile range; Nuclear medicine; Breast cancer; Radiation therapy; Dosimetry; Radiation treatment planning; Left breast; Radiology; Cancer; Surgery; Internal medicine","score_opus":0.07558037128014865,"score_gpt":0.38224641814986854,"score_spread":0.3066660468697199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129484121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98405707,0.008547254,0.000015014262,0.0049385233,0.00017781022,0.00024769938,0.000058228718,0.000012129733,0.0019462439],"genre_scores_gemma":[0.9968911,0.0015612833,0.00003503759,0.00021812107,0.0005321034,0.0003084796,0.00013405448,0.000025784397,0.0002940412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99836344,0.00011201664,0.0002220484,0.00048553414,0.00037818775,0.00043876548],"domain_scores_gemma":[0.9989922,0.000081602004,0.00005182972,0.0004421882,0.00036317835,0.00006899697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040319556,0.00015326553,0.000151888,0.00007271484,0.0003258398,0.000087178894,0.0002248605,0.00012269268,0.00026099378],"category_scores_gemma":[0.000087389715,0.00012073366,0.000069175985,0.00040488632,0.00013921894,0.000013751942,0.00016933425,0.0002747739,0.000046432287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074268895,0.0005765684,0.23292585,0.00018764962,0.0005503621,0.00023170946,0.001859619,0.002121443,0.68099684,0.0026209645,0.005209086,0.07197725],"study_design_scores_gemma":[0.0011581025,0.00004390853,0.90017116,0.000102399994,0.000016105922,0.000051323397,0.0005316241,0.00005910843,0.090375856,0.00031530787,0.0069537675,0.00022131417],"about_ca_topic_score_codex":0.0014647823,"about_ca_topic_score_gemma":0.012486629,"teacher_disagreement_score":0.6672453,"about_ca_system_score_codex":0.00021354845,"about_ca_system_score_gemma":0.00033151673,"threshold_uncertainty_score":0.6967832},"labels":[],"label_agreement":null},{"id":"W3129522204","doi":"10.1158/1538-7445.sabcs20-ps4-48","title":"Abstract PS4-48: Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Cancer research; Cancer; Oncology; Proteomics; Cyclin-dependent kinase; Drug resistance; Internal medicine; Bioinformatics; Biology; Cell cycle","score_opus":0.10881384647906636,"score_gpt":0.38783894327230517,"score_spread":0.27902509679323884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129522204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98423797,0.0061371396,0.00069922913,0.0006879971,0.000060305727,0.007845654,0.00029721728,0.000017005512,0.000017495986],"genre_scores_gemma":[0.9587729,0.00008081429,0.034951873,0.00002476088,0.00019299187,0.0056852587,0.000027182488,0.000074608586,0.00018960993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967136,0.00020682884,0.00077802414,0.00062346424,0.0010238701,0.0006542178],"domain_scores_gemma":[0.99704367,0.00019095966,0.00030209892,0.0004997513,0.001838623,0.00012487448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011893935,0.00025936076,0.0006331058,0.00025751215,0.00022613263,0.000020097543,0.00027581002,0.00012188753,0.000055074743],"category_scores_gemma":[0.00020825813,0.00020240727,0.00008952639,0.001376049,0.00033269424,0.00013050617,0.00015373368,0.00063432456,4.808672e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010100733,0.0013389109,0.0024758514,0.0008359963,0.00038773162,0.00001060164,0.012040606,0.0005851301,0.9633444,0.00000832068,0.00006894441,0.008802764],"study_design_scores_gemma":[0.009659833,0.00021744451,0.10625069,0.0018637436,0.00005599281,0.0000065340014,0.019979844,0.0004046236,0.86089,0.000033905853,0.00031187935,0.00032554506],"about_ca_topic_score_codex":0.0021602022,"about_ca_topic_score_gemma":0.0019220498,"teacher_disagreement_score":0.10377484,"about_ca_system_score_codex":0.0014022655,"about_ca_system_score_gemma":0.002523954,"threshold_uncertainty_score":0.8253929},"labels":[],"label_agreement":null},{"id":"W3129561386","doi":"10.1158/1538-7445.sabcs20-gs3-00","title":"Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) &amp;lt; 25: SWOG S1007 (RxPonder)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Randomized controlled trial; Gynecology; Proportional hazards model; Clinical endpoint; Sentinel lymph node; Cancer","score_opus":0.041482988315018746,"score_gpt":0.38740851471987764,"score_spread":0.3459255264048589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129561386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805946,0.006529773,0.000057625995,0.001963431,0.0001297271,0.0026091372,0.007886508,0.000013574937,0.00021565736],"genre_scores_gemma":[0.9473147,0.04962702,0.00038964825,0.00014018717,0.0002888071,0.000935774,0.0011268555,0.00007615754,0.000100844234],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948548,0.00109591,0.0009354371,0.0014306498,0.00096207845,0.00072109536],"domain_scores_gemma":[0.995897,0.0010723172,0.0004973599,0.0006269905,0.0016580025,0.00024830713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013580789,0.00054327643,0.0013928248,0.0001310995,0.00022061825,0.000067815025,0.00029051772,0.00016104418,0.00017345305],"category_scores_gemma":[0.00037824176,0.00039559248,0.00018045772,0.0005357054,0.0014260041,0.000041562875,0.00019481732,0.0006694152,0.0000020149816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95004225,0.0020674448,0.010280111,0.000030956027,0.0019763457,0.000049297338,0.0015514393,0.000021333335,0.0037158905,0.000007992626,0.0012113397,0.029045613],"study_design_scores_gemma":[0.8212497,0.0036207326,0.12706845,0.0011307667,0.00009812005,0.000008767319,0.00036446968,0.0000050704257,0.044670053,0.000039403054,0.0012021238,0.00054231106],"about_ca_topic_score_codex":0.021568542,"about_ca_topic_score_gemma":0.0130619425,"teacher_disagreement_score":0.1287925,"about_ca_system_score_codex":0.0004115125,"about_ca_system_score_gemma":0.0014376701,"threshold_uncertainty_score":0.9998496},"labels":[],"label_agreement":null},{"id":"W3129622461","doi":"10.1158/1538-7445.sabcs20-pd13-02","title":"Abstract PD13-02: Site of recurrence after neoadjuvant therapy: A multi-center pooled analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Oncology; Incidence (geometry); Population; Confidence interval; Breast cancer; Disease; Cancer; Cohort","score_opus":0.061897343098025547,"score_gpt":0.43709237074682133,"score_spread":0.3751950276487958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129622461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856626,0.008990255,0.00041078427,0.0039899102,0.00012190883,0.00019686666,0.0000347542,0.000018196526,0.0005747377],"genre_scores_gemma":[0.99361175,0.0035700072,0.00078302366,0.0005004426,0.0001630893,0.000068563895,0.000046490644,0.000023120321,0.0012335163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979312,0.0001621524,0.0003025441,0.00040520984,0.0007557037,0.00044322194],"domain_scores_gemma":[0.99847203,0.00015034227,0.00006171642,0.00046813543,0.0006003191,0.0002474771],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009445901,0.00012066307,0.00041438016,0.0003382284,0.000065925014,0.00003869309,0.00013361062,0.000073446055,0.0022796814],"category_scores_gemma":[0.00044911224,0.00009535816,0.00022217349,0.0012190517,0.00022110887,0.000055491706,0.00009818871,0.0009111391,0.00003593551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010122728,0.0014333253,0.52112615,0.00042792328,0.0023214037,0.0012035492,0.0022685553,0.00015274143,0.22421426,0.000022119417,0.0032551622,0.24256252],"study_design_scores_gemma":[0.0068871127,0.00018849061,0.917043,0.000983878,0.0004221525,0.000030192372,0.0002813158,0.009656159,0.028194735,0.000041446303,0.035972428,0.00029912035],"about_ca_topic_score_codex":0.00059506955,"about_ca_topic_score_gemma":0.000100655685,"teacher_disagreement_score":0.3959168,"about_ca_system_score_codex":0.00010756106,"about_ca_system_score_gemma":0.0004053324,"threshold_uncertainty_score":0.9986324},"labels":[],"label_agreement":null},{"id":"W3129720267","doi":"10.1158/1538-7445.sabcs20-ps7-01","title":"Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Cohort; Intensive care unit; Proportional hazards model; Lung cancer; Internal medicine; Emergency medicine","score_opus":0.15628966459425542,"score_gpt":0.47875458353223216,"score_spread":0.32246491893797674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129720267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870794,0.00076807284,0.0000014337674,0.009450125,0.00013968232,0.0016951105,0.00083124335,0.00001390657,0.000021051772],"genre_scores_gemma":[0.9918936,0.004762022,0.0000028953734,0.0027623724,0.00012621246,0.000343953,0.000042280742,0.000027971113,0.00003869325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976838,0.00023718075,0.00038326788,0.0004914578,0.00077785243,0.0004264329],"domain_scores_gemma":[0.9975566,0.00087381067,0.00014635136,0.00037734702,0.0007778807,0.0002680038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066849653,0.00018902202,0.0005616219,0.00016231781,0.0001789532,0.000053243515,0.000083893734,0.00010392425,0.00024107243],"category_scores_gemma":[0.0008774951,0.00012757115,0.000029063616,0.00048341407,0.0003421912,0.00011609921,0.00012800141,0.00063395145,0.0000015683581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011625701,0.0003355145,0.990003,0.00051201467,0.00024973834,0.00005765607,0.0019306057,0.000002510114,0.001106868,0.000002981358,0.0006699664,0.003966578],"study_design_scores_gemma":[0.0036996694,0.00024130984,0.9936358,0.00036330955,0.00009299223,0.0000034560417,0.00037286026,0.0000032074593,0.0008755693,0.000013519179,0.000570968,0.00012738723],"about_ca_topic_score_codex":0.41927084,"about_ca_topic_score_gemma":0.27249777,"teacher_disagreement_score":0.14677307,"about_ca_system_score_codex":0.0009144832,"about_ca_system_score_gemma":0.004419773,"threshold_uncertainty_score":0.78404874},"labels":[],"label_agreement":null},{"id":"W3129726308","doi":"10.1158/1538-7445.sabcs20-ps8-14","title":"Abstract PS8-14: Pathogenic variants in hereditary cancer syndrome genes are prevalent among breast cancer patients not meeting various ex-U.S. genetic testing guidelines","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic testing; Medicine; Breast cancer; Cancer; Cohort; Population; Oncology; Family medicine; Ethnic group; Internal medicine; Gynecology; Environmental health","score_opus":0.06855184286792146,"score_gpt":0.3702021272790683,"score_spread":0.30165028441114683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129726308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654683,0.030456446,0.0000141631335,0.00084871455,0.0012429077,0.0006495219,0.0011354442,0.0000273684,0.00015714754],"genre_scores_gemma":[0.9874207,0.007665237,0.0009069355,0.00030768587,0.0015174033,0.0013421084,0.000117261276,0.00013589257,0.0005868089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528164,0.00034384333,0.000848051,0.0013777146,0.0010084487,0.0011403346],"domain_scores_gemma":[0.9956861,0.00009975139,0.00027235955,0.0007961339,0.0028824594,0.00026317014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000855198,0.00040380814,0.00041739148,0.0002204466,0.0003114649,0.00012297549,0.0006353009,0.0003531069,0.00059237314],"category_scores_gemma":[0.0005368071,0.00042843117,0.00013398826,0.0009776,0.00028820266,0.0000295345,0.0006283066,0.00058935554,0.000017316237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014856634,0.0002724369,0.5989187,0.00049427303,0.00027128903,0.00050261087,0.00021982426,0.022124922,0.33052123,0.0000010601605,0.0053292797,0.041195814],"study_design_scores_gemma":[0.0011996519,0.00007334445,0.95417213,0.0010419923,0.000048958627,0.0000902621,0.00022426507,0.0003646306,0.04096067,0.000030196197,0.001236465,0.00055740296],"about_ca_topic_score_codex":0.0059327385,"about_ca_topic_score_gemma":0.011616757,"teacher_disagreement_score":0.35525346,"about_ca_system_score_codex":0.0010588832,"about_ca_system_score_gemma":0.0029370312,"threshold_uncertainty_score":0.9998168},"labels":[],"label_agreement":null},{"id":"W3129754483","doi":"10.1158/1538-7445.sabcs20-pd1-02","title":"Abstract PD1-02: A phase I/Ib study evaluating GDC-0077 + palbociclib (palbo) + fulvestrant in patients (pts) with <i>PIK3CA</i>-mutant (mut), hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2- mBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Palbociclib; Phases of clinical research; Breast cancer; Oncology; Progressive disease; Cancer; Pharmacology; Chemotherapy; Gastroenterology; Metastatic breast cancer; Tamoxifen","score_opus":0.07982276108933845,"score_gpt":0.4456599860075646,"score_spread":0.3658372249182262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129754483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878162,0.003423708,0.000059591457,0.0021738247,0.00023563586,0.004503892,0.0012274159,0.00010921111,0.00045050352],"genre_scores_gemma":[0.9936608,0.0008943562,0.00096669124,0.00032932247,0.00043033148,0.002775509,0.00016550375,0.0002571883,0.00052031066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98994523,0.001232504,0.0012079178,0.0018982358,0.0036800192,0.0020360877],"domain_scores_gemma":[0.9936707,0.0008209297,0.00043105075,0.001134926,0.0031707783,0.00077158376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022065814,0.00084883143,0.001469899,0.00056113803,0.0005006903,0.00018618918,0.0005288016,0.00017966404,0.00315458],"category_scores_gemma":[0.0004150563,0.0007094271,0.00020061314,0.0029758164,0.00077097653,0.000665637,0.0002712724,0.002290051,0.000082552295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060780704,0.023956003,0.1345821,0.0013111121,0.0045200232,0.0033157703,0.031682145,0.0012743549,0.31554168,0.000042048378,0.0009449061,0.42204913],"study_design_scores_gemma":[0.10118425,0.013845286,0.7835203,0.0056576817,0.0007661844,0.0001840171,0.025843998,0.00023570305,0.06552742,0.00029367593,0.0009638802,0.0019776374],"about_ca_topic_score_codex":0.008438341,"about_ca_topic_score_gemma":0.005087265,"teacher_disagreement_score":0.6489382,"about_ca_system_score_codex":0.003248918,"about_ca_system_score_gemma":0.0035951498,"threshold_uncertainty_score":0.9995357},"labels":[],"label_agreement":null},{"id":"W3129851337","doi":"10.1158/1538-7445.sabcs20-ot-13-02","title":"Abstract OT-13-02: Bracelet-1 (pre0113): A study to assess overall response rate by inducing an inflammatory phenotype in metastatic breast cancer with the oncolytic reovirus pelareorep in combination with anti-PD-L1 avelumab and paclitaxel","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Immune system; Oncolytic virus; CD8; Biomarker; Oncology; Internal medicine; Cancer; Immune checkpoint; Paclitaxel; Immunology; Cancer research; Immunotherapy; Biology","score_opus":0.04729007422189422,"score_gpt":0.3885531600493882,"score_spread":0.341263085827494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129851337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516577,0.0014615256,0.000011145547,0.0016498729,0.000023376817,0.0015418446,0.00009503552,0.000009482491,0.000041927484],"genre_scores_gemma":[0.9982562,0.00033520025,0.000022645636,0.00024630543,0.00005122306,0.0007373685,0.0000322105,0.00007320185,0.00024566782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99429595,0.0029123472,0.0003232188,0.00089899893,0.0008204866,0.00074898265],"domain_scores_gemma":[0.99802923,0.00027363183,0.00009055512,0.0007708255,0.0006015591,0.00023417233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005690376,0.0002690124,0.000331975,0.0002860693,0.00021952424,0.0002237097,0.00041271013,0.000092865426,0.00008939165],"category_scores_gemma":[0.00023098776,0.00020475173,0.00002645513,0.000923365,0.00023612732,0.00005114041,0.00023939439,0.0007977124,0.0000042760507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035578277,0.00087777764,0.038712166,0.000097778975,0.00016699357,0.00031403065,0.0025266076,0.0013842579,0.9154846,0.000004504456,0.00024645263,0.004606563],"study_design_scores_gemma":[0.008565622,0.0063104336,0.79969966,0.00035651884,0.00002697155,0.000028625924,0.006667371,0.00016525299,0.17720558,0.000029618677,0.00037952806,0.0005648447],"about_ca_topic_score_codex":0.0036657916,"about_ca_topic_score_gemma":0.06659658,"teacher_disagreement_score":0.76098746,"about_ca_system_score_codex":0.00044084832,"about_ca_system_score_gemma":0.0025155116,"threshold_uncertainty_score":0.9504356},"labels":[],"label_agreement":null},{"id":"W3129853752","doi":"10.1158/1538-7445.sabcs20-pd12-06","title":"Abstract PD12-06: Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Docetaxel; Internal medicine; Oncology; Breast cancer; Clinical endpoint; Gynecology; Neoadjuvant therapy; Amenorrhea; Cancer; Clinical trial; Pregnancy","score_opus":0.047104629111357835,"score_gpt":0.3732314727476038,"score_spread":0.326126843636246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129853752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337376,0.007153433,0.000021264277,0.0034239513,0.00016756028,0.0015233235,0.00028564985,0.000031438012,0.004019645],"genre_scores_gemma":[0.99258006,0.0020575651,0.00007263206,0.00023457651,0.0005132273,0.0013145913,0.00040473073,0.00009723205,0.0027253898],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957919,0.00031980526,0.00050743367,0.0012594055,0.0009752708,0.001146151],"domain_scores_gemma":[0.9977982,0.0002039627,0.00016288791,0.001125426,0.0004972837,0.00021220958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042702025,0.0005952193,0.0006781742,0.0001550014,0.0005001138,0.000158758,0.0004882863,0.00024616366,0.0004841623],"category_scores_gemma":[0.000085659085,0.00036077455,0.0001840307,0.000850444,0.00059010816,0.000024820532,0.00016480996,0.00060382707,0.000037105285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6010741,0.02126663,0.011371566,0.00053122087,0.0129627455,0.012093484,0.032928996,0.0019206672,0.13519464,0.00031514122,0.03095943,0.13938136],"study_design_scores_gemma":[0.68342555,0.033001456,0.015855853,0.0016077028,0.001082471,0.0012053646,0.017564809,0.00037320124,0.14103767,0.00015801158,0.10129398,0.0033939464],"about_ca_topic_score_codex":0.0042617717,"about_ca_topic_score_gemma":0.0051850285,"teacher_disagreement_score":0.13598742,"about_ca_system_score_codex":0.0010994889,"about_ca_system_score_gemma":0.0024615638,"threshold_uncertainty_score":0.9998844},"labels":[],"label_agreement":null},{"id":"W3129869730","doi":"10.1158/1538-7445.sabcs20-pd4-02","title":"Abstract PD4-02: Sentinel node biopsy should not be routine in older patients with ER positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Breast cancer; Sentinel lymph node; Population; Adjuvant therapy; Oncology; Internal medicine; Cancer; Biopsy; Proportional hazards model; Sentinel node","score_opus":0.03885314930624802,"score_gpt":0.3626948859155488,"score_spread":0.3238417366093008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129869730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987728,0.0013009475,0.000005517202,0.008597177,0.000113244976,0.00030523978,0.0011269661,0.000011303279,0.0008115885],"genre_scores_gemma":[0.9967349,0.00053492887,0.00004416575,0.00085360714,0.00031580607,0.00039653172,0.00036883657,0.000056274963,0.0006949025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753934,0.000101698824,0.00021960677,0.0007734974,0.00063865545,0.00072721404],"domain_scores_gemma":[0.9984316,0.000038684546,0.00006135909,0.00042965,0.00089913385,0.00013957487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019374656,0.0002617796,0.00026178322,0.00010003073,0.00016699654,0.000051626423,0.00020325645,0.0001513401,0.00050628063],"category_scores_gemma":[0.000035609235,0.0002180714,0.00007130158,0.00046657826,0.00023875531,0.000013159847,0.00030020342,0.00035340895,0.000011729601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014262609,0.0006842339,0.9143829,0.000087558496,0.0004286428,0.00011062279,0.00030826664,0.000121431294,0.07422187,0.000018194529,0.0052280575,0.0029820043],"study_design_scores_gemma":[0.0027335237,0.00002803617,0.92082256,0.00018103003,0.000023739067,0.000010554302,0.00015769181,0.0000025396027,0.07490171,0.000003172707,0.0008881929,0.0002472302],"about_ca_topic_score_codex":0.003219532,"about_ca_topic_score_gemma":0.0022903362,"teacher_disagreement_score":0.009006931,"about_ca_system_score_codex":0.00029678192,"about_ca_system_score_gemma":0.0005465301,"threshold_uncertainty_score":0.8892693},"labels":[],"label_agreement":null},{"id":"W3129910830","doi":"10.1158/1538-7445.sabcs20-ps5-46","title":"Abstract PS5-46: Introduction and clinical validation of metrology standards for immunohistochemistry (IHC); New tool for standardization of estrogen receptor (ER) IHC assay in breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Estrogen receptor; Immunohistochemistry; Gold standard (test); Traceability; Estrogen; Analyte; Breast cancer; Tissue microarray; Cancer; Medicine; Pathology; Computer science; Internal medicine; Chemistry; Chromatography","score_opus":0.03729494128024711,"score_gpt":0.4340086360876938,"score_spread":0.39671369480744667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129910830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816044,0.0066269585,0.005213067,0.0026551513,0.0003489018,0.0006052688,0.002919171,0.000004975875,0.000022096905],"genre_scores_gemma":[0.99181986,0.004583426,0.0013694628,0.000018215991,0.0010837079,0.00036801532,0.0005854284,0.000030552386,0.00014133188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832624,0.00012642318,0.00047124102,0.00048789053,0.00030938597,0.00027882832],"domain_scores_gemma":[0.9977049,0.00014205444,0.00017925823,0.0002823044,0.0016346661,0.0000567926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014406419,0.00013180563,0.00034060658,0.00007208901,0.000073718,0.000016457985,0.000107431086,0.00019631846,0.00011184475],"category_scores_gemma":[0.0006995058,0.00013390719,0.000110347195,0.00020387422,0.00022499727,0.000014665755,0.000087681976,0.00013214175,1.293939e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041807694,0.00015422679,0.029351814,0.00039109477,0.00045048114,4.303575e-7,0.0000881628,0.00023815347,0.9165769,0.00007508691,0.013164515,0.035328344],"study_design_scores_gemma":[0.0034590983,0.00024768844,0.017070038,0.000091244154,0.00007656771,0.000004096047,0.00021381889,0.0000121181865,0.96597105,0.0001528657,0.012552479,0.00014895906],"about_ca_topic_score_codex":0.00034916218,"about_ca_topic_score_gemma":0.000108557164,"teacher_disagreement_score":0.0493941,"about_ca_system_score_codex":0.0003436772,"about_ca_system_score_gemma":0.0017953779,"threshold_uncertainty_score":0.54605764},"labels":[],"label_agreement":null},{"id":"W3129923342","doi":"10.1158/1538-7445.sabcs20-pd14-07","title":"Abstract PD14-07: Association between biomarkers and response to pembrolizumab in patients with metastatic triple-negative breast cancer (mTNBC): Exploratory analysis from KEYNOTE-086","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cohort; Triple-negative breast cancer; Breast cancer; Biomarker; Cancer; Immunotherapy; Biology","score_opus":0.04501016533167566,"score_gpt":0.3672172241175309,"score_spread":0.3222070587858552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129923342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161243,0.0012830687,0.000013468119,0.0043703257,0.000085431704,0.00083245116,0.0017235498,0.000022827557,0.00005646618],"genre_scores_gemma":[0.9979689,0.0004762791,0.00011903792,0.00031245136,0.00010315165,0.00037745346,0.00016200489,0.000043217166,0.00043746884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605656,0.0007785447,0.0004572535,0.0007232698,0.0013435283,0.0006408553],"domain_scores_gemma":[0.99711144,0.000998745,0.00016324129,0.00043324317,0.0009638171,0.00032954302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016991491,0.00024709743,0.0006781629,0.0008969222,0.00016299431,0.000104429564,0.00014726202,0.00013005723,0.0014272237],"category_scores_gemma":[0.00042711024,0.00021148044,0.00012703473,0.0036122466,0.00014906436,0.00022986475,0.00008512306,0.0005089403,0.00001827965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07189955,0.00022093565,0.89014477,0.000074592266,0.0065487456,0.000073225776,0.0026130574,0.0000226959,0.007540643,4.0568162e-7,0.0016914534,0.019169925],"study_design_scores_gemma":[0.0115481885,0.00025308479,0.9800428,0.00036859667,0.00057588174,5.2886605e-7,0.001616452,0.000011441286,0.004721027,0.000014866946,0.00060767314,0.00023941703],"about_ca_topic_score_codex":0.016057497,"about_ca_topic_score_gemma":0.008096356,"teacher_disagreement_score":0.089898065,"about_ca_system_score_codex":0.0032096123,"about_ca_system_score_gemma":0.001694189,"threshold_uncertainty_score":0.9994856},"labels":[],"label_agreement":null},{"id":"W3129977606","doi":"10.1158/1538-7445.sabcs20-ps3-17","title":"Abstract PS3-17: Patient and provider determinants of breast cancer screening among Ontario women age 40-49: A population based retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Cohort; Breast cancer; Retrospective cohort study; Population; Family medicine; Mammography; Cohort study; Cancer; Guideline; Health care; Breast cancer screening; Internal medicine; Pathology; Environmental health","score_opus":0.09556096845013255,"score_gpt":0.40957922909370975,"score_spread":0.3140182606435772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129977606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748206,0.00036893465,0.0000046340137,0.00013583114,0.00007848069,0.0013501219,0.00007004687,0.000020788159,0.0004891281],"genre_scores_gemma":[0.99840564,0.000040779174,0.00007667646,0.00010085683,0.00011076448,0.000632479,0.000018932871,0.000029391898,0.0005845085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664104,0.00013339335,0.00044211885,0.0006515787,0.0014976069,0.0006342679],"domain_scores_gemma":[0.99806416,0.000071764785,0.00015666067,0.00040651645,0.0010026641,0.00029822573],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095435244,0.00019316051,0.0005576234,0.00018898207,0.00021560922,0.000072865594,0.000114041075,0.00010272945,0.001081349],"category_scores_gemma":[0.00014776911,0.0001755948,0.0000657675,0.0005685421,0.00015095857,0.00024438003,0.0001417381,0.00062888896,0.000001521656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080518686,0.00016987536,0.9841949,0.00012681093,0.00011812484,0.00049653626,0.0028084083,0.000077090684,0.0012165442,7.3493953e-7,0.0002103369,0.009775478],"study_design_scores_gemma":[0.0014137853,0.00044466424,0.992876,0.0009308269,0.000055121014,0.000015740929,0.0027263756,0.00010409991,0.0011839254,0.0000147990295,0.00007136848,0.00016329257],"about_ca_topic_score_codex":0.36582458,"about_ca_topic_score_gemma":0.32600206,"teacher_disagreement_score":0.03982254,"about_ca_system_score_codex":0.0027400309,"about_ca_system_score_gemma":0.0013059533,"threshold_uncertainty_score":0.9998318},"labels":[],"label_agreement":null},{"id":"W3130041405","doi":"10.1158/1538-7445.sabcs20-ps9-49","title":"Abstract PS9-49: Comparison of the quality of life (QOL) of patients with an arm vein port (TIVAD) versus a peripherally inserted central catheter (PICC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Peripherally inserted central catheter; Quality of life (healthcare); Psychosocial; Port (circuit theory); Cancer; Catheter; Cohort; Prospective cohort study; Colorectal cancer; Venous access; Surgery; Internal medicine; Nursing","score_opus":0.2210392679162135,"score_gpt":0.49983291161513643,"score_spread":0.2787936436989229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130041405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972273,0.00025191522,0.000004996539,0.0003891367,0.00026181515,0.00066831394,0.00020444322,0.000009327389,0.0009827596],"genre_scores_gemma":[0.99944013,0.000062013714,0.000044843895,0.000059338403,0.00008003695,0.000055965647,0.00006356027,0.000026802272,0.00016731996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605995,0.00092269445,0.0008728069,0.00032499604,0.0011257987,0.0006937237],"domain_scores_gemma":[0.9966964,0.00038304934,0.00047280517,0.00072787754,0.0014751959,0.00024468542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082435086,0.00014448,0.0006210377,0.00007740026,0.0003030462,0.000008148981,0.00041512898,0.00015341605,0.0013071223],"category_scores_gemma":[0.00032093603,0.000097946744,0.0001751485,0.00053913577,0.00030397583,0.000090089285,0.00017171778,0.00079836446,0.00000381724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052167536,0.0028489698,0.9615699,0.00074227527,0.00024975874,0.000001262432,0.018071655,0.00008599758,0.008654202,0.00013840519,0.0006799365,0.0017408861],"study_design_scores_gemma":[0.0031770233,0.00062030705,0.9855095,0.00024117349,0.000033718166,2.6130834e-8,0.0045981836,0.00003975939,0.005027029,0.000032928987,0.0006024305,0.00011792701],"about_ca_topic_score_codex":0.008002414,"about_ca_topic_score_gemma":0.008427078,"teacher_disagreement_score":0.023939596,"about_ca_system_score_codex":0.00032040942,"about_ca_system_score_gemma":0.0025363285,"threshold_uncertainty_score":0.99960583},"labels":[],"label_agreement":null},{"id":"W3130048594","doi":"10.1158/1538-7445.sabcs20-pd1-05","title":"Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant for <i>HER2</i>-mutant, hormone receptor-positive, metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Neratinib; Medicine; Fulvestrant; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Population; Cancer; Estrogen receptor","score_opus":0.06149143344151323,"score_gpt":0.40938022759496856,"score_spread":0.3478887941534553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130048594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481121,0.010271217,0.00009444539,0.014802116,0.00058662455,0.003934314,0.022062585,0.0000517915,0.000084814856],"genre_scores_gemma":[0.9864882,0.0055679656,0.0003659766,0.00047286882,0.0014145866,0.0045582894,0.00049326004,0.00017395055,0.00046487697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99424595,0.00040496158,0.0011575308,0.0012167448,0.0015865351,0.0013882965],"domain_scores_gemma":[0.9954897,0.0015127242,0.0003108562,0.0008512366,0.0014178362,0.00041763106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014743609,0.00057868386,0.001361304,0.00025546522,0.0003544316,0.0001244556,0.0005444265,0.00021708121,0.0034169052],"category_scores_gemma":[0.00020928822,0.00044795996,0.0003552223,0.0016365161,0.0008028166,0.00040771702,0.00012631495,0.0014147748,0.000011238202],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17663613,0.0029898202,0.019868389,0.0005343219,0.0024037324,0.0003175645,0.0023777625,0.00036988655,0.6967809,0.00008911116,0.009424356,0.08820798],"study_design_scores_gemma":[0.30807862,0.0025477412,0.44832075,0.0063080927,0.0013846146,0.0003005224,0.0051605897,0.0005481493,0.20574988,0.0005451615,0.01925851,0.0017973698],"about_ca_topic_score_codex":0.01999763,"about_ca_topic_score_gemma":0.00867145,"teacher_disagreement_score":0.49103105,"about_ca_system_score_codex":0.001702981,"about_ca_system_score_gemma":0.004219898,"threshold_uncertainty_score":0.9997972},"labels":[],"label_agreement":null},{"id":"W3130050547","doi":"","title":"Upregulation of STAT1 transcription activator by an androgen agonist in prostate cancer cells affects intracellular cholesterol esterification","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Sterol O-acyltransferase; Endocrinology; Internal medicine; Androgen; Androgen receptor; Cholesteryl ester; Chemistry; Agonist; Cholesterol; Prostate cancer; Biology; Medicine; Receptor; Cancer; Lipoprotein; Hormone","score_opus":0.026693255499963785,"score_gpt":0.3462429509296385,"score_spread":0.31954969542967476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130050547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933498,0.003965263,0.00062194886,0.00010987129,0.0009601209,0.0008027023,0.00013895026,0.000007968241,0.00004339825],"genre_scores_gemma":[0.9945387,0.0027232484,0.000041555926,0.0000304646,0.0015068415,0.00030229625,0.00020967663,0.000033309774,0.0006138608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835896,0.00017311852,0.00025259398,0.000428824,0.00033052725,0.00045595932],"domain_scores_gemma":[0.9992478,0.000011720368,0.00009099368,0.0003237864,0.00018182053,0.00014387297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010061966,0.00013518917,0.00016895728,0.00013039142,0.00007171691,0.0000357483,0.00017473767,0.00014233196,0.000022309228],"category_scores_gemma":[0.000012610613,0.00014058081,0.000042200303,0.00027082767,0.00015892155,0.000029998275,0.000025929274,0.00018533813,0.0000010086076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063947623,0.00010440192,0.0025242718,0.00009947433,0.000017364697,1.2990833e-7,0.0006297374,0.00016691309,0.9553894,0.000008805463,0.0016118467,0.03880822],"study_design_scores_gemma":[0.00085439597,0.00014344086,0.013620711,0.000036731424,0.000007762613,6.7383513e-7,0.00016376188,0.00003331075,0.88726187,0.000010884967,0.097738065,0.00012837829],"about_ca_topic_score_codex":0.0013704997,"about_ca_topic_score_gemma":0.0027138658,"teacher_disagreement_score":0.09612622,"about_ca_system_score_codex":0.00016151795,"about_ca_system_score_gemma":0.00032260502,"threshold_uncertainty_score":0.5732719},"labels":[],"label_agreement":null},{"id":"W3130050803","doi":"10.1158/1538-7445.sabcs20-ps1-06","title":"Abstract PS1-06: High-risk breast cancer in oldest old: Exploring the effect of different treatments on outcomes","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Population; Disease; Internal medicine; Proportional hazards model; Cancer; Cancer registry; Comorbidity; National Death Index; Retrospective cohort study; Observational study; Oncology; Demography; Hazard ratio; Confidence interval; Environmental health","score_opus":0.04449857296616774,"score_gpt":0.37205541370370865,"score_spread":0.3275568407375409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130050803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540746,0.0022046706,4.6574422e-7,0.0011926956,0.00024169176,0.00036367925,0.00045906892,0.000007412853,0.00012288062],"genre_scores_gemma":[0.99040985,0.007181615,0.0000028401316,0.000033643886,0.00021008441,0.0016025541,0.00004283708,0.000035182133,0.0004813837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980018,0.00030544976,0.00022241948,0.00051921245,0.00045393317,0.00049715355],"domain_scores_gemma":[0.9988943,0.00024469997,0.00007088734,0.0005736675,0.00013780392,0.00007867353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027426996,0.0002534013,0.00035501728,0.000086216074,0.00016927405,0.000025883633,0.00024905303,0.000075799486,0.00011896498],"category_scores_gemma":[0.000078285935,0.00015192162,0.00013156292,0.0002786991,0.00017236224,0.00000690803,0.00022246632,0.000288656,0.000011062262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005521641,0.00021863745,0.9214549,0.00007904687,0.00060288614,0.000025591653,0.00016197487,0.00018327766,0.039943404,0.000022539325,0.00033836567,0.036417235],"study_design_scores_gemma":[0.0016113381,0.00016517074,0.7278592,0.00013214583,0.000038400656,0.0000018715749,0.00007805512,7.095971e-7,0.26987237,0.000015451731,0.00012749486,0.00009778819],"about_ca_topic_score_codex":0.006239404,"about_ca_topic_score_gemma":0.0041913628,"teacher_disagreement_score":0.22992896,"about_ca_system_score_codex":0.00032498533,"about_ca_system_score_gemma":0.00012892288,"threshold_uncertainty_score":0.94321537},"labels":[],"label_agreement":null},{"id":"W3130116683","doi":"10.1158/1538-7445.sabcs20-pd5-05","title":"Abstract PD5-05: Including a 21-gene assay recurrence score in multivariable predictive model generation improves prediction of local recurrence after breast conserving surgery for ductal carcinoma-in-situ","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Population; Ductal carcinoma; Hazard ratio; Akaike information criterion; Internal medicine; Breast-conserving surgery; Oncology; Mastectomy; Bootstrapping (finance); Cancer; Confidence interval; Statistics; Mathematics","score_opus":0.08903768823683507,"score_gpt":0.3491897003635756,"score_spread":0.26015201212674055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130116683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048376,0.004484875,0.003119181,0.00022268793,0.0002495221,0.00048554246,0.00088617,0.0000065245267,0.00006171571],"genre_scores_gemma":[0.99687624,0.00081378105,0.0004069714,0.00001919429,0.0002733863,0.0012017533,0.0003563678,0.000024981859,0.000027349524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792826,0.00015862222,0.00039140973,0.00070577645,0.00031898342,0.00049695384],"domain_scores_gemma":[0.9986417,0.00015998301,0.00009843817,0.0003014851,0.00072092935,0.00007741408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009107475,0.000188313,0.000288926,0.00016784815,0.00011216253,0.000025953179,0.00013479215,0.00016962811,0.000008183126],"category_scores_gemma":[0.0002786101,0.00019635579,0.00008150885,0.00038277477,0.0002189196,0.000034059118,0.0002488449,0.0002503372,4.3024258e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010948577,0.00019825259,0.10974571,0.0002489083,0.000069486756,0.000021170214,0.00036884937,0.0027365203,0.8783449,0.0000078506355,0.00055330456,0.006610219],"study_design_scores_gemma":[0.0011110011,0.000077071556,0.3064686,0.00047681434,0.000018054356,0.000024723917,0.00038526577,0.014190511,0.6769598,0.000073220705,0.000024282424,0.0001906345],"about_ca_topic_score_codex":0.00090622687,"about_ca_topic_score_gemma":0.0024436025,"teacher_disagreement_score":0.20138505,"about_ca_system_score_codex":0.00041992226,"about_ca_system_score_gemma":0.001331954,"threshold_uncertainty_score":0.8007157},"labels":[],"label_agreement":null},{"id":"W3130130649","doi":"10.1158/1538-7445.sabcs20-ot-09-04","title":"Abstract OT-09-04: Analysis of genomic alterations in cell free DNA and gut bacterial diversity in metastatic breast cancer (MBC) patients on endocrine therapy: A pilot study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Endocrine system; Medicine; Fulvestrant; Breast cancer; Aromatase inhibitor; Metastatic breast cancer; Internal medicine; Oncology; Cancer; Discontinuation; Estrogen receptor; Aromatase; Hormone","score_opus":0.1525101546569416,"score_gpt":0.3916189974157762,"score_spread":0.23910884275883462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130130649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964019,0.0014111751,3.302576e-7,0.00033739503,0.000077698714,0.0007066767,0.00077666744,0.0000036896438,0.0002844551],"genre_scores_gemma":[0.99802995,0.0015536016,0.000010373418,0.000043208798,0.000060348444,0.00015388927,0.000043878405,0.000012814243,0.000091939866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792856,0.00032350846,0.00035892933,0.0004287881,0.0006193313,0.00034089558],"domain_scores_gemma":[0.9988906,0.00014203163,0.00007205683,0.0003957212,0.0003919004,0.00010770727],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005575293,0.00014738106,0.0005973372,0.00066855125,0.00014147256,0.000027769502,0.00012504891,0.000015181444,0.001346762],"category_scores_gemma":[0.000064469874,0.00012410307,0.00007070477,0.001043043,0.00009854,0.00006533987,0.0004571374,0.00028541076,0.0000026493076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024854518,0.0039908974,0.9101645,0.00014278214,0.0011373999,0.00025024675,0.0028819565,0.00007012841,0.07245514,0.000008420264,0.0002569621,0.006156132],"study_design_scores_gemma":[0.0058700233,0.0008675108,0.98826355,0.000061492115,0.00027179407,9.260482e-7,0.0013228407,0.000017883594,0.0031742605,0.000012410134,0.000044148765,0.00009313663],"about_ca_topic_score_codex":0.020903578,"about_ca_topic_score_gemma":0.04043709,"teacher_disagreement_score":0.07809909,"about_ca_system_score_codex":0.00033462158,"about_ca_system_score_gemma":0.00029245816,"threshold_uncertainty_score":0.99956614},"labels":[],"label_agreement":null},{"id":"W3130146550","doi":"10.1158/1538-7445.sabcs20-ps11-03","title":"Abstract PS11-03: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: A subgroup analysis of germline <i>BRCA1</i> or <i>BRCA2</i> mutations from the phase 3 BROCADE3 trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Veliparib; Carboplatin; Internal medicine; Hazard ratio; Breast cancer; Metastatic breast cancer; Oncology; Neutropenia; Paclitaxel; Chemotherapy; Gastroenterology; Cancer; Confidence interval; Cisplatin","score_opus":0.06069596838321386,"score_gpt":0.4208892218136763,"score_spread":0.36019325343046243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130146550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882719,0.0015152651,0.00016173796,0.0016408061,0.000093504146,0.0021751665,0.0060283053,0.000015530275,0.000097820724],"genre_scores_gemma":[0.996114,0.0017309322,0.00047585642,0.0002560023,0.00013252684,0.0005553239,0.0004914399,0.000053345982,0.00019058582],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99568045,0.0004994251,0.0011270525,0.0007187458,0.0014306842,0.0005436407],"domain_scores_gemma":[0.99341744,0.0036690175,0.0004674723,0.0006749416,0.0015187677,0.00025238635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078312284,0.00031032966,0.0012677137,0.0003991117,0.0001616194,0.000034260713,0.00024464197,0.00011065997,0.0018327931],"category_scores_gemma":[0.0006805766,0.00019680413,0.0001707441,0.0039215204,0.00083527697,0.00019185245,0.00008684894,0.00075453153,0.0000019765118],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89767015,0.0041211434,0.022335745,0.00057587866,0.008126252,0.00016234974,0.007939565,0.01090511,0.012062341,0.000051828527,0.00054100616,0.03550864],"study_design_scores_gemma":[0.46728295,0.0035197553,0.4985768,0.003029569,0.002857473,0.000009866464,0.003510784,0.0015044989,0.018241726,0.00007627359,0.00079542707,0.00059488363],"about_ca_topic_score_codex":0.009464671,"about_ca_topic_score_gemma":0.0217411,"teacher_disagreement_score":0.47624105,"about_ca_system_score_codex":0.0007709438,"about_ca_system_score_gemma":0.003523091,"threshold_uncertainty_score":0.99907964},"labels":[],"label_agreement":null},{"id":"W3130191307","doi":"10.1158/1538-7445.sabcs20-gs4-07","title":"Abstract GS4-07: Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, residual cancer burden class and neo-bioscore","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Neoadjuvant therapy; Context (archaeology); Internal medicine; Oncology; Stage (stratigraphy); Cancer; Disease; Minimal residual disease","score_opus":0.08316496431492273,"score_gpt":0.4301714130888664,"score_spread":0.3470064487739437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130191307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94169736,0.053209905,0.000008090556,0.0040370654,0.00013508351,0.0003556611,0.0002484776,0.000023965018,0.00028438645],"genre_scores_gemma":[0.9887578,0.008579551,0.00012811185,0.00016462331,0.0011533785,0.0007256929,0.00012185407,0.00006631696,0.00030271022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972511,0.00020519007,0.00031332352,0.0009051017,0.0005425154,0.0007827543],"domain_scores_gemma":[0.9986881,0.00008225575,0.00009694356,0.0004468625,0.00048651107,0.00019931993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036422486,0.00030443698,0.0004094565,0.00010477176,0.00033781535,0.00024218681,0.00024154256,0.000204863,0.00022297286],"category_scores_gemma":[0.00004907723,0.00027511045,0.00008458346,0.00028758976,0.00038711188,0.000022266448,0.00042014927,0.00046251778,0.000009534929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032228735,0.00009732653,0.80027896,0.00012480482,0.0006254509,0.00006825459,0.0007385339,0.00001789182,0.10008525,0.0000059531,0.0056126337,0.09202267],"study_design_scores_gemma":[0.0014818473,0.00010742591,0.7582792,0.0002820441,0.000056872985,0.0000047266144,0.0011480004,0.000011308096,0.20583372,0.000042448683,0.032385737,0.00036663754],"about_ca_topic_score_codex":0.0025419956,"about_ca_topic_score_gemma":0.0012146392,"teacher_disagreement_score":0.10574847,"about_ca_system_score_codex":0.00025061198,"about_ca_system_score_gemma":0.0008892514,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W3130193359","doi":"10.1158/1538-7445.sabcs20-ps18-31","title":"Abstract PS18-31: Identification of cell surface proteins in triple negative breast cancer for the development of novel targeted therapies","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Cell growth; Cancer; Cell; Breast cancer; Biology; Metastasis; Carcinogenesis; Computational biology; Chemistry; Biochemistry; Genetics","score_opus":0.06850067671040198,"score_gpt":0.3792216653388592,"score_spread":0.3107209886284572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130193359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990608,0.004937161,0.0026306733,0.0005940194,0.00006647036,0.0007228104,0.00036961734,0.0000016903602,0.00006960399],"genre_scores_gemma":[0.99541146,0.0012206135,0.0012841745,0.000009974223,0.000048752398,0.0007997424,0.00004245929,0.000013453839,0.0011693643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899685,0.000041022056,0.0003053628,0.00024460448,0.00021956078,0.0001926047],"domain_scores_gemma":[0.99868983,0.00004855555,0.0001226329,0.0002874261,0.0008253522,0.00002621661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061164604,0.00007386565,0.00011072334,0.00003749552,0.000102856284,0.00001607993,0.00021842807,0.0000660915,0.000053010375],"category_scores_gemma":[0.000049258677,0.00005787251,0.00004009665,0.00030572293,0.0001261515,0.000006027069,0.000050636147,0.00010050899,4.4522758e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015734253,0.00015106432,0.00043647687,0.00010097027,0.00005117146,6.827542e-8,0.00071169966,0.000817772,0.99376184,0.000026277225,0.00031789238,0.0034674036],"study_design_scores_gemma":[0.00063624396,0.000017890103,0.054830983,0.0000355718,0.00000395333,1.7784957e-7,0.000984374,0.000097190765,0.94181097,0.000020280902,0.0014987385,0.00006365016],"about_ca_topic_score_codex":0.000577008,"about_ca_topic_score_gemma":0.0016074609,"teacher_disagreement_score":0.054394506,"about_ca_system_score_codex":0.00008123596,"about_ca_system_score_gemma":0.0013973998,"threshold_uncertainty_score":0.24789274},"labels":[],"label_agreement":null},{"id":"W3130243682","doi":"10.1158/1538-7445.sabcs20-pd13-09","title":"Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neratinib; Lapatinib; Metastatic breast cancer; Capecitabine; Clinical endpoint; Internal medicine; Oncology; Cancer; Breast cancer; Phases of clinical research; Gastroenterology; Randomized controlled trial; Trastuzumab; Clinical trial; Colorectal cancer","score_opus":0.05039416918420588,"score_gpt":0.4159013622418695,"score_spread":0.36550719305766366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130243682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828384,0.0006461716,0.0000025894785,0.0018547712,0.00014605503,0.0017679784,0.012701637,0.000011533069,0.00003084931],"genre_scores_gemma":[0.9981856,0.00009614467,0.000028029695,0.00010969909,0.00017803653,0.00042201715,0.000805565,0.000040493996,0.0001344197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967299,0.00057206507,0.0004272137,0.0004928615,0.0011625604,0.00061538856],"domain_scores_gemma":[0.9976684,0.0008489205,0.00011746547,0.00046598964,0.0004660769,0.0004331655],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053607195,0.00026577993,0.00061069435,0.00010759692,0.00015989515,0.0000516648,0.0001365178,0.0000421719,0.0012528991],"category_scores_gemma":[0.00021243254,0.00014057735,0.00024899,0.00045561558,0.00015192207,0.00008606983,0.00006762169,0.00042875428,0.000010888821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16508786,0.0071218875,0.809082,0.00034915537,0.0024331382,0.002180723,0.00088946335,0.00089702685,0.00074482395,0.000050726307,0.0022450094,0.008918218],"study_design_scores_gemma":[0.06735218,0.0012773806,0.9283366,0.0011009462,0.00033129266,0.000005470873,0.000255004,0.00014922864,0.0010066114,0.0000032711127,0.0000377589,0.00014425606],"about_ca_topic_score_codex":0.017225185,"about_ca_topic_score_gemma":0.0015557486,"teacher_disagreement_score":0.11925464,"about_ca_system_score_codex":0.0017151334,"about_ca_system_score_gemma":0.0016088111,"threshold_uncertainty_score":0.9996601},"labels":[],"label_agreement":null},{"id":"W3130256579","doi":"10.1158/1538-7445.sabcs20-sp87","title":"Abstract SP087: Epigenetic therapy against high-risk breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Epigenetics; Oncology; Internal medicine; Cancer; Disease; Adjuvant therapy; Chemotherapy; Epigenetic therapy; Hormonal therapy; Bioinformatics; DNA methylation; Gene; Biology","score_opus":0.04586144509366474,"score_gpt":0.3801195846881927,"score_spread":0.33425813959452794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130256579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95474184,0.042726487,0.0000879333,0.00068380235,0.0003112595,0.00019793843,0.0002539992,0.00001060065,0.000986164],"genre_scores_gemma":[0.874275,0.1231866,0.00009653264,0.00012529838,0.0009130339,0.00014652163,0.00011754618,0.000043626682,0.0010957955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980069,0.00022410066,0.00022021102,0.00057670654,0.00044392902,0.0005281607],"domain_scores_gemma":[0.9984646,0.00003993829,0.00006790766,0.00056288345,0.00068699644,0.00017767116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005696211,0.00016305967,0.00015734206,0.00007050069,0.00024056775,0.00008131031,0.00025721814,0.0001918745,0.00079188065],"category_scores_gemma":[0.000073537696,0.0001538215,0.00009368643,0.00031331903,0.00013909837,0.0000045064994,0.00014050382,0.00033189342,0.000034146382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008001362,0.00006598711,0.014616573,0.000016257703,0.00008526948,0.000010893302,0.000036825375,0.0006928717,0.8510481,0.000016611204,0.0012069008,0.1321237],"study_design_scores_gemma":[0.0005727172,0.00006099033,0.1647852,0.000025884678,0.000005806611,0.0000010770775,0.000043477456,0.000012766158,0.7911935,0.00025226918,0.042862512,0.00018379191],"about_ca_topic_score_codex":0.001263555,"about_ca_topic_score_gemma":0.0011402846,"teacher_disagreement_score":0.15016863,"about_ca_system_score_codex":0.00007614598,"about_ca_system_score_gemma":0.0007114178,"threshold_uncertainty_score":0.86705375},"labels":[],"label_agreement":null},{"id":"W3130290520","doi":"10.1158/1538-7445.sabcs20-ps7-39","title":"Abstract PS7-39: Survival differences in chinese versus white women with breast cancer in the United States: A SEER-based analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Oncology; Proportional hazards model; Lumpectomy; Internal medicine; Cancer; Gynecology; Marital status; Epidemiology; Mastectomy; Demography; Population; Confidence interval","score_opus":0.08157588526435801,"score_gpt":0.4147916751229225,"score_spread":0.3332157898585645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130290520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922272,0.0005449294,0.000006985671,0.0060539534,0.00009782551,0.00033930692,0.00036963244,0.00001680334,0.00034335812],"genre_scores_gemma":[0.997682,0.0011174858,0.0000048189004,0.00019775545,0.00013873805,0.00049199606,0.00011734923,0.000025105715,0.00022475021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699587,0.0003006204,0.00028235384,0.00048737793,0.0011648522,0.00076895516],"domain_scores_gemma":[0.9983296,0.0004616976,0.000057027202,0.0005039979,0.00044020673,0.00020750856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009601398,0.00021111606,0.00052902487,0.0008980729,0.00009858859,0.00010410169,0.0002673861,0.00008449477,0.0029743426],"category_scores_gemma":[0.00006966323,0.00012326826,0.000076527656,0.00802382,0.00022804317,0.00007918134,0.000049662718,0.0009246225,0.0000049263467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050668023,0.0002596933,0.9826898,0.00012470293,0.00040158603,0.0003255671,0.004706684,0.0038993703,0.0002812623,0.000004159209,0.0001112418,0.0021291142],"study_design_scores_gemma":[0.003946787,0.00016962466,0.9860647,0.00018434541,0.00006734644,0.0000019438137,0.0075984127,0.0012557573,0.000035062683,0.000010841022,0.0005088834,0.00015631467],"about_ca_topic_score_codex":0.06927825,"about_ca_topic_score_gemma":0.17829485,"teacher_disagreement_score":0.109016605,"about_ca_system_score_codex":0.0010839636,"about_ca_system_score_gemma":0.0015435325,"threshold_uncertainty_score":0.9979371},"labels":[],"label_agreement":null},{"id":"W3130306790","doi":"10.1158/1538-7445.sabcs20-pd3-08","title":"Abstract PD3-08: Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): Outcomes by hormone receptor status","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Metastatic breast cancer; Pertuzumab; Oncology; Trastuzumab; Placebo; Breast cancer; Regimen; Progression-free survival; Neratinib; Cancer; Chemotherapy; Colorectal cancer; Pathology","score_opus":0.022968683255123783,"score_gpt":0.35649628121608185,"score_spread":0.33352759796095804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130306790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98451495,0.004218753,0.00041254482,0.004675151,0.000087580374,0.003682079,0.0022512367,0.000048634385,0.00010907915],"genre_scores_gemma":[0.98785055,0.0016904618,0.003276305,0.00032027447,0.00005481799,0.0039495747,0.00058189,0.00016250841,0.0021136398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960814,0.00017496501,0.0004695838,0.00090834993,0.0011635784,0.0012020873],"domain_scores_gemma":[0.9962441,0.00080517697,0.00018547343,0.00039954035,0.0019471857,0.0004185655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041153413,0.00042948307,0.0008385863,0.00026718335,0.00023412732,0.00008536715,0.00015875166,0.0000996495,0.00066318526],"category_scores_gemma":[0.00019485952,0.00030445476,0.000050346684,0.0011001757,0.00042906485,0.0005001904,0.00006902812,0.0006878142,0.0000050197473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29292637,0.0075417953,0.3538521,0.002375686,0.0022658014,0.00020839168,0.00555739,0.00071699376,0.033961125,0.00010965909,0.0040195254,0.29646516],"study_design_scores_gemma":[0.08700212,0.007051147,0.8787103,0.0023846112,0.00017061799,0.00003529611,0.005419095,0.00009465665,0.010666272,0.00009133993,0.0074964636,0.0008780545],"about_ca_topic_score_codex":0.0017121912,"about_ca_topic_score_gemma":0.004481012,"teacher_disagreement_score":0.52485824,"about_ca_system_score_codex":0.0019439379,"about_ca_system_score_gemma":0.002202412,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W3130310298","doi":"10.1158/1538-7445.sabcs20-ps10-54","title":"Abstract PS10-54: Single-centre retrospective study of treatment choices and outcomes of metastatic breast cancer post-progression on the CDK4/6 inhibitor palbobiclib","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Palbociclib; Metastatic breast cancer; Breast cancer; Internal medicine; Oncology; Cancer; Primary tumor; Population; Fulvestrant; Surgery; Metastasis; Tamoxifen","score_opus":0.08547221319040686,"score_gpt":0.4308914046703316,"score_spread":0.3454191914799247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130310298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886636,0.004085472,4.859321e-7,0.0052030464,0.00012436745,0.0014119874,0.0003284237,0.000019536834,0.00016305101],"genre_scores_gemma":[0.99828416,0.00043388119,0.000044684613,0.00009048415,0.00014241638,0.0003461762,0.000007971767,0.00004481269,0.0006054347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740195,0.0002477185,0.0003965092,0.00051997515,0.0010009651,0.0004328904],"domain_scores_gemma":[0.99738187,0.00046042236,0.00021129638,0.00055609277,0.0012363291,0.0001539714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003603136,0.00024978715,0.00066407514,0.00016715728,0.00016503528,0.000029060966,0.0001385073,0.000053247357,0.0008828429],"category_scores_gemma":[0.00016544099,0.0001448646,0.00010214117,0.00056500605,0.0003943428,0.000109285254,0.000109530265,0.00035828477,0.0000031460913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038018404,0.005054964,0.63290346,0.00045400372,0.0018801981,0.00012686999,0.009667104,0.00004357054,0.2574615,0.000110672576,0.000101184836,0.08839464],"study_design_scores_gemma":[0.0054059913,0.0024278387,0.880695,0.000995449,0.00016058434,0.000014289097,0.012836737,0.0000067893643,0.096823424,0.000082625826,0.00039771444,0.0001535554],"about_ca_topic_score_codex":0.0019496595,"about_ca_topic_score_gemma":0.002161591,"teacher_disagreement_score":0.24779154,"about_ca_system_score_codex":0.00099266,"about_ca_system_score_gemma":0.0005980851,"threshold_uncertainty_score":0.9666511},"labels":[],"label_agreement":null},{"id":"W3130327672","doi":"10.1158/1538-7445.sabcs20-ps5-12","title":"Abstract PS5-12: Preliminary correlative analysis of clinical outcomes with <i>PIK3CA</i> mutation (mut) status from a phase I/Ib study of GDC-0077 in patients (pts) with hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2- mBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Fulvestrant; Medicine; Letrozole; Internal medicine; Palbociclib; Oncology; Cancer; Breast cancer; Estrogen receptor; Tamoxifen","score_opus":0.06948872393345283,"score_gpt":0.4526514672675588,"score_spread":0.38316274333410594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130327672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926915,0.0009329535,0.00020149861,0.00027124607,0.000083631996,0.0022588628,0.0034061307,0.000024949557,0.0001292044],"genre_scores_gemma":[0.9968963,0.0005097624,0.001074523,0.000072061965,0.000059887323,0.00061956415,0.00050915446,0.000091651455,0.00016707167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934495,0.0010601691,0.0013950622,0.0011234101,0.0021979294,0.0007739458],"domain_scores_gemma":[0.99279416,0.0021069853,0.0008726305,0.00076827814,0.0030790067,0.000378949],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008875223,0.00046433875,0.002046827,0.0007550576,0.000118989374,0.000027824502,0.00024885475,0.0001355489,0.0011422886],"category_scores_gemma":[0.00037150795,0.0003497618,0.00022155765,0.0034223446,0.00084575976,0.00042593083,0.00013405604,0.001187591,0.00000561411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062896125,0.0117806,0.8479089,0.00014099124,0.012299168,0.000276515,0.017609745,0.0029524993,0.0010834521,0.0000036321285,0.0000672444,0.042981133],"study_design_scores_gemma":[0.033498265,0.007998224,0.9328558,0.0008011096,0.002115757,0.0000030341873,0.02013425,0.00017156743,0.0020515865,0.000026521337,0.00002331271,0.00032060008],"about_ca_topic_score_codex":0.032463904,"about_ca_topic_score_gemma":0.017106198,"teacher_disagreement_score":0.08494688,"about_ca_system_score_codex":0.001026265,"about_ca_system_score_gemma":0.0019275581,"threshold_uncertainty_score":0.99989545},"labels":[],"label_agreement":null},{"id":"W3130387627","doi":"10.1158/1538-7445.sabcs20-pd14-03","title":"Abstract PD14-03: Molecular mechanism of ipatasertib (IPAT) and its combination with atezolizumab (atezo) in patients (pts) with locally advanced/metastatic triple-negative breast cancer (aTNBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Paclitaxel; Breast cancer; Oncology; Cohort; Internal medicine; Immunohistochemistry; Cancer; Cyclin D1; Chemotherapy; Immune checkpoint; Triple-negative breast cancer; Cyclophosphamide; Cancer research; Cell cycle; Immunotherapy; Nivolumab","score_opus":0.028021584279272475,"score_gpt":0.346558188338385,"score_spread":0.3185366040591125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130387627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939471,0.0030398099,0.00004241159,0.0008927292,0.00006207526,0.0013640012,0.00038738828,0.000015796679,0.00024871159],"genre_scores_gemma":[0.9968448,0.0020592608,0.00013581754,0.00015223857,0.000015866983,0.00039926192,0.00009168997,0.00005259745,0.000248425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972502,0.0001739445,0.00039680462,0.0005532695,0.0010892573,0.0005364961],"domain_scores_gemma":[0.9978593,0.00010157265,0.0001591511,0.0003218282,0.001378681,0.00017944135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004227912,0.00024734263,0.00048389312,0.00030663205,0.00009563959,0.000033316275,0.00013720966,0.00008298145,0.00045651986],"category_scores_gemma":[0.00006193906,0.0001902532,0.000048956714,0.0011910293,0.0002423758,0.00020605871,0.00006373842,0.0004604855,0.0000040457157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17454073,0.0051346724,0.048551492,0.0064458936,0.002970521,0.002196291,0.004909697,0.0007198493,0.3811108,0.0021812427,0.00078423903,0.37045458],"study_design_scores_gemma":[0.059037287,0.0036553475,0.4020622,0.0064433054,0.00015725521,0.00006452404,0.0014585688,0.00039725853,0.5253048,0.0006450595,0.00015801753,0.0006163682],"about_ca_topic_score_codex":0.0018876607,"about_ca_topic_score_gemma":0.0012815895,"teacher_disagreement_score":0.36983824,"about_ca_system_score_codex":0.0006533757,"about_ca_system_score_gemma":0.0013916256,"threshold_uncertainty_score":0.77583},"labels":[],"label_agreement":null},{"id":"W3130435961","doi":"10.1158/1538-7445.sabcs20-ps10-05","title":"Abstract PS10-05: Ribociclib + letrozole in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) advanced breast cancer (ABC): Expanded safety analysis of the phase IIIb CompLEEment-1 trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Letrozole; Clinical endpoint; Internal medicine; Discontinuation; Breast cancer; Adverse effect; Population; Goserelin; Metastatic breast cancer; Phases of clinical research; Oncology; Cancer; Clinical trial; Gastroenterology; Surgery; Tamoxifen","score_opus":0.04300735938034665,"score_gpt":0.39475965956004255,"score_spread":0.3517523001796959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130435961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888598,0.0009163095,0.000049346043,0.0019350043,0.0002456361,0.0024832506,0.0051843775,0.000042000494,0.0002842931],"genre_scores_gemma":[0.99698216,0.00047183354,0.00020102468,0.00019883492,0.00029916083,0.000714837,0.000649173,0.00009781945,0.0003851722],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99389714,0.00071063306,0.0010459248,0.001079041,0.0021201486,0.0011471385],"domain_scores_gemma":[0.9952194,0.00045149162,0.0005394824,0.00089981913,0.0025256579,0.0003641412],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006122468,0.0005139977,0.0014138393,0.0006196365,0.0004954206,0.000049018734,0.0004991338,0.00018702996,0.00552473],"category_scores_gemma":[0.00022312516,0.00038293874,0.0003872331,0.0042248755,0.0009614087,0.0004770316,0.00026432017,0.0012910743,0.0000075287003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4001861,0.006580491,0.23116933,0.00038918876,0.010104039,0.00006181087,0.006893412,0.000888191,0.24234104,0.00019047954,0.0012473741,0.099948555],"study_design_scores_gemma":[0.12627411,0.0012789445,0.8098493,0.00064212165,0.00041146507,0.0000020497205,0.0014425573,0.00002256813,0.058774143,0.000049315244,0.0007599919,0.00049341813],"about_ca_topic_score_codex":0.003468128,"about_ca_topic_score_gemma":0.0025855475,"teacher_disagreement_score":0.57868,"about_ca_system_score_codex":0.0026850277,"about_ca_system_score_gemma":0.0011923754,"threshold_uncertainty_score":0.99986225},"labels":[],"label_agreement":null},{"id":"W3130516758","doi":"10.1158/1538-7445.sabcs20-pd12-01","title":"Abstract PD12-01: Evaluation of sleep problems and their association with febrile neutropenia, leucopenia and infections in women receiving adjuvant chemotherapy for breast cancer in the Canadian Cancer Trials Group MA.21 trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University; Dalhousie University; Université Laval","funders":"","keywords":"Medicine; Leukopenia; Breast cancer; Internal medicine; Febrile neutropenia; Neutropenia; Cancer; Chemotherapy; Clinical endpoint; Sleep disorder; Oncology; Clinical trial; Insomnia; Psychiatry","score_opus":0.11104536688349853,"score_gpt":0.41180840114597816,"score_spread":0.30076303426247963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130516758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815339,0.0030865765,0.000004524145,0.009988624,0.00022420126,0.004385631,0.00037680817,0.0000084691765,0.00039127594],"genre_scores_gemma":[0.98563355,0.0041572545,0.000009836571,0.0002479676,0.00044063354,0.009301831,0.000018999532,0.000036302303,0.00015365113],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99694014,0.0008091389,0.00051308586,0.00045452503,0.00067846413,0.00060463377],"domain_scores_gemma":[0.99777794,0.00066000834,0.00021776243,0.00025242407,0.0009139878,0.00017785789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008461031,0.00018370041,0.0006301601,0.00037368815,0.0003099654,0.00013410291,0.00009922866,0.0001544608,0.00083880016],"category_scores_gemma":[0.00034158645,0.00012749294,0.000060917286,0.0010682464,0.00011187982,0.00022138073,0.000026751917,0.0005865657,6.4032326e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0247725,0.00080230966,0.38547903,0.0008766198,0.0009136401,0.000013997138,0.01769178,0.0022072294,0.0757379,0.00015350827,0.002424205,0.48892727],"study_design_scores_gemma":[0.06218039,0.0006553102,0.92122763,0.0011017194,0.00016678998,0.000030328514,0.0022027374,0.00047617132,0.0032797554,0.00030393634,0.008092697,0.00028254063],"about_ca_topic_score_codex":0.2730826,"about_ca_topic_score_gemma":0.88725555,"teacher_disagreement_score":0.614173,"about_ca_system_score_codex":0.003969982,"about_ca_system_score_gemma":0.003921055,"threshold_uncertainty_score":0.9998536},"labels":[],"label_agreement":null},{"id":"W3130546611","doi":"10.1158/1538-7445.sabcs20-pd12-10","title":"Abstract PD12-10: Patient reported outcomes and health care utilization of UPMC breast cancer survivorship clinic patients","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survivorship curve; Medicine; Breast cancer; Cancer; Population; Cancer survivor; Family medicine; Health care; Cancer survivorship; Gerontology; Internal medicine","score_opus":0.18089192216943012,"score_gpt":0.4710592021674199,"score_spread":0.2901672799979898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130546611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258984,0.0115223285,0.0000012892552,0.0026354366,0.00066721404,0.0006139433,0.0005000177,0.000030108451,0.0014398071],"genre_scores_gemma":[0.99427015,0.003404705,0.0000070315673,0.00043261648,0.00009586348,0.00022920578,0.00031226827,0.000045054276,0.0012030913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966782,0.00027382837,0.0006658527,0.0005675911,0.0012942435,0.00052030646],"domain_scores_gemma":[0.9967307,0.00014594478,0.0002528048,0.0005569614,0.001986783,0.00032679367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073105807,0.00017979323,0.0005231602,0.00020637724,0.00021595902,0.000027666265,0.00010670318,0.00010653097,0.0069950647],"category_scores_gemma":[0.00016036836,0.00016432405,0.0001210902,0.0008035831,0.00014832107,0.000084470565,0.00017285059,0.00049369584,0.000005468282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047953444,0.00022774935,0.91739625,0.0010619573,0.00012552389,0.00003218197,0.004412118,0.0000043025357,0.00011826097,0.000015103074,0.0044775824,0.07164944],"study_design_scores_gemma":[0.0014653249,0.00028495913,0.9815529,0.00035383602,0.00003306983,0.0000070553315,0.0054112766,0.0000022040833,0.0011431358,0.000013314392,0.009584793,0.00014811904],"about_ca_topic_score_codex":0.03746036,"about_ca_topic_score_gemma":0.030919712,"teacher_disagreement_score":0.07150132,"about_ca_system_score_codex":0.0008379183,"about_ca_system_score_gemma":0.002390456,"threshold_uncertainty_score":0.9939127},"labels":[],"label_agreement":null},{"id":"W3130563236","doi":"10.1158/1538-7445.sabcs20-ps10-11","title":"Abstract PS10-11: Associations with response to poly(ADP-ribose) polymerase (PARP) inhibitors in patients with BRCA mutated metastatic breast cancer: Results of a meta-regression analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; BRCA mutation; Oncology; Internal medicine; Breast cancer; Metastatic breast cancer; Chemotherapy; Cancer; Meta-analysis","score_opus":0.06755840244320246,"score_gpt":0.41028482165536156,"score_spread":0.3427264192121591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130563236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794289,0.0016469423,0.000030186113,0.012807693,0.00007107044,0.0010742617,0.00478806,0.00004114461,0.00011175296],"genre_scores_gemma":[0.9971082,0.00013776775,0.00033050432,0.0003076879,0.00010068721,0.00076329295,0.00040956735,0.00007185995,0.00077044097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938513,0.0009993747,0.0009186049,0.00092085457,0.002467221,0.0008426194],"domain_scores_gemma":[0.9947948,0.00079725304,0.00040450782,0.00090482435,0.0025698591,0.0005287585],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020106107,0.00038063247,0.0012803596,0.0017556179,0.00020000702,0.000061931925,0.00022709841,0.00012405867,0.0011059064],"category_scores_gemma":[0.00047135644,0.00026055978,0.0002646421,0.008867092,0.00027285374,0.00023383058,0.000089009074,0.0006586823,0.000009672905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14648218,0.004215419,0.685174,0.00040780436,0.023745647,0.0009022122,0.005876412,0.006128583,0.11015876,0.000019498799,0.009459604,0.00742991],"study_design_scores_gemma":[0.016115578,0.0007340048,0.83566463,0.0011469487,0.0024017878,0.000008391519,0.0005871568,0.000038252947,0.14213853,0.000011495639,0.0007607606,0.0003925019],"about_ca_topic_score_codex":0.01336757,"about_ca_topic_score_gemma":0.011580533,"teacher_disagreement_score":0.15049063,"about_ca_system_score_codex":0.0017208441,"about_ca_system_score_gemma":0.003206648,"threshold_uncertainty_score":0.9999847},"labels":[],"label_agreement":null},{"id":"W3130574885","doi":"10.1158/1538-7445.sabcs20-ps1-50","title":"Abstract PS1-50: Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Oncology; Systemic therapy; Metastatic breast cancer; Population; Subgroup analysis; Randomization; Cancer; Randomized controlled trial; Meta-analysis; Confidence interval","score_opus":0.1415803323186085,"score_gpt":0.43723766392116015,"score_spread":0.29565733160255164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130574885","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26511356,0.72415894,0.000020100126,0.009614217,0.000021754517,0.00041124847,0.00054673944,0.000006474899,0.000106924235],"genre_scores_gemma":[0.74742305,0.25002795,0.000059997317,0.00082170113,0.00006563711,0.0011877815,0.00005885684,0.000020446427,0.00033458552],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9980323,0.00030191406,0.00026624257,0.0005916463,0.00034828697,0.00045962408],"domain_scores_gemma":[0.998924,0.000063839834,0.00006792239,0.00041631784,0.00041071823,0.00011719261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065044465,0.00020045915,0.00073422625,0.0001226881,0.00010311485,0.000034722674,0.00018500657,0.00006231628,0.0007998436],"category_scores_gemma":[0.000033959914,0.00015619055,0.00030809978,0.00073561975,0.00017067327,0.0000070001565,0.00013217458,0.00020307301,0.0000047633603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012978663,0.0013471846,0.1782055,0.007389568,0.54217166,0.0008365935,0.00087015773,0.0013153316,0.21802461,0.0003300278,0.02303967,0.025171848],"study_design_scores_gemma":[0.008989059,0.0003682673,0.65026915,0.0010129699,0.21863548,0.0018667055,0.0015496492,0.000027650309,0.07495803,0.0005563154,0.039199475,0.0025672808],"about_ca_topic_score_codex":0.0025774918,"about_ca_topic_score_gemma":0.003649001,"teacher_disagreement_score":0.4823095,"about_ca_system_score_codex":0.00019140291,"about_ca_system_score_gemma":0.0006623712,"threshold_uncertainty_score":0.87577266},"labels":[],"label_agreement":null},{"id":"W3130576199","doi":"10.1158/1538-7445.sabcs20-gs3-01","title":"Abstract GS3-01: Additional efficacy endpoints from the phase 3 KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy as first-line therapy for locally recurrent inoperable or metastatic triple-negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Taxane; Carboplatin; Pembrolizumab; Chemotherapy; Internal medicine; Oncology; Interim analysis; Clinical endpoint; Chemotherapy regimen; Paclitaxel; Premedication; Progression-free survival; Triple-negative breast cancer; Metastatic breast cancer; Phases of clinical research; Clinical trial; Breast cancer; Cancer; Surgery; Cisplatin","score_opus":0.10626608274781106,"score_gpt":0.4343006938422686,"score_spread":0.32803461109445753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130576199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640752,0.006622677,0.000090188376,0.011784318,0.00050078053,0.0076470473,0.009060797,0.00006111463,0.00015784508],"genre_scores_gemma":[0.96445966,0.021436842,0.00022720553,0.002996022,0.0012449375,0.0055598756,0.0009011841,0.0001977135,0.002976555],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946754,0.00045439007,0.0010093757,0.0010962691,0.0017930606,0.0009714859],"domain_scores_gemma":[0.9936756,0.0031330257,0.00036522912,0.0009917421,0.001528525,0.00030586458],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012426282,0.0005738971,0.001176685,0.00022914619,0.00059801195,0.0001405063,0.0006496959,0.00017956232,0.06247949],"category_scores_gemma":[0.0003858952,0.0003785188,0.0004102079,0.0012893035,0.0005666702,0.00020307876,0.00008408192,0.0009665572,0.000021639715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6374625,0.0078093586,0.00014426628,0.00031181276,0.005007999,0.00014154534,0.010943737,0.000293347,0.016746886,0.000010862582,0.07927403,0.24185365],"study_design_scores_gemma":[0.6410541,0.018100394,0.043135073,0.003693096,0.0004363559,0.00016602356,0.012592104,0.0019863658,0.12957117,0.00038073247,0.14731269,0.0015718837],"about_ca_topic_score_codex":0.006688496,"about_ca_topic_score_gemma":0.0049616466,"teacher_disagreement_score":0.24028176,"about_ca_system_score_codex":0.0017148997,"about_ca_system_score_gemma":0.0069361734,"threshold_uncertainty_score":0.99992603},"labels":[],"label_agreement":null},{"id":"W3130640576","doi":"10.1158/1538-7445.sabcs20-sp112","title":"Abstract SP112: Spatial variance signatures/Intra-tumor zonation in TNBC","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Multiplex; Biology; Breast cancer; Cell; Cancer; Triple-negative breast cancer; Cancer research; Computational biology; Genetics","score_opus":0.04222704835314198,"score_gpt":0.3462402317221729,"score_spread":0.30401318336903094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130640576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234104,0.0030542272,0.0006471738,0.000724494,0.0004043074,0.00018476578,0.00003801117,0.000008787963,0.0025971844],"genre_scores_gemma":[0.99737614,0.0006023127,0.00014384191,0.000249908,0.00061584037,0.0000577395,0.00009693481,0.000024032848,0.0008332705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985487,0.00011435343,0.00018172465,0.00042961183,0.00032745095,0.00039816592],"domain_scores_gemma":[0.99928814,0.000032226595,0.000027822956,0.00027572224,0.00028844856,0.00008762112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004211216,0.00010904938,0.00012179233,0.000069213114,0.00008613279,0.000054805583,0.00021157281,0.00015453376,0.00032179648],"category_scores_gemma":[0.00017066093,0.000114097726,0.00005418292,0.00025845005,0.000088852656,0.00000585555,0.00006338001,0.00042469506,0.00001731805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001612986,0.00010409918,0.0015237378,0.00004495569,0.000016295868,0.00010447928,0.000056782064,0.00032613857,0.9877626,0.000118470794,0.0013869903,0.008394183],"study_design_scores_gemma":[0.00092827575,0.000089221925,0.025144793,0.00006682386,0.0000034069208,0.0000053490726,0.00006276862,0.00019072299,0.93685544,0.00028238836,0.036168978,0.00020183131],"about_ca_topic_score_codex":0.0010951619,"about_ca_topic_score_gemma":0.004368608,"teacher_disagreement_score":0.05090713,"about_ca_system_score_codex":0.00008579789,"about_ca_system_score_gemma":0.0005953237,"threshold_uncertainty_score":0.46527705},"labels":[],"label_agreement":null},{"id":"W3130664242","doi":"10.1158/1538-7445.sabcs20-ot-32-02","title":"Abstract OT-32-02: Irene study: Phase 2 study of incmga00012 (retifanlimab)and the oncolytic virus pelareorep in metastatic triple negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Triple-negative breast cancer; Breast cancer; Chemotherapy; Internal medicine; Taxane; Metastatic breast cancer; Oncology; Cancer; Tumor microenvironment; Clinical trial; Phases of clinical research; Immunotherapy; Cancer research","score_opus":0.06885363079924274,"score_gpt":0.4511108196795613,"score_spread":0.38225718888031857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130664242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891841,0.0073830015,0.0000023802531,0.0005880133,0.000079532714,0.0022998212,0.00025052542,0.000006270496,0.00020640124],"genre_scores_gemma":[0.99545527,0.002420903,0.000008121671,0.000068266076,0.00015574305,0.0014299857,0.000020321519,0.000053283402,0.0003881072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950962,0.0018111115,0.00053353887,0.000798436,0.00105719,0.00070350623],"domain_scores_gemma":[0.9977551,0.00025996173,0.00012652886,0.00087993365,0.00079314044,0.00018531599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031516578,0.00025913244,0.00052697456,0.00022655891,0.00023858102,0.000081686776,0.0005691975,0.00008626448,0.00062448985],"category_scores_gemma":[0.0003578421,0.00019777822,0.00009296225,0.001059226,0.0006564026,0.000015764517,0.0005056534,0.0006950457,0.0000067401297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05009898,0.0098385,0.011984695,0.00022477566,0.0015518846,0.00034741242,0.009790381,0.0005673668,0.83305424,0.000018973064,0.0006681632,0.08185463],"study_design_scores_gemma":[0.08708162,0.014429094,0.05530272,0.0002603695,0.00021748633,0.00003658402,0.044362303,0.000374518,0.79599077,0.00038053398,0.000736359,0.0008276229],"about_ca_topic_score_codex":0.011609768,"about_ca_topic_score_gemma":0.07383764,"teacher_disagreement_score":0.081027,"about_ca_system_score_codex":0.00021882255,"about_ca_system_score_gemma":0.0016015,"threshold_uncertainty_score":0.994972},"labels":[],"label_agreement":null},{"id":"W3130697901","doi":"10.1158/1538-7445.sabcs20-ps10-33","title":"Abstract PS10-33: Analysis of factors associated with pathological complete response (pCR) in patients with HER2+ breast cancer receiving neoadjuvant chemotherapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Epirubicin; Oncology; Anthracycline; Taxane; Trastuzumab; Docetaxel; Cyclophosphamide; Chemotherapy; Cancer; Immunohistochemistry","score_opus":0.04863190583447462,"score_gpt":0.3485122363574448,"score_spread":0.2998803305229702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130697901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971279,0.0005808962,0.000007922068,0.00058363524,0.000026946605,0.0002310321,0.0013857462,0.000009336836,0.000046587775],"genre_scores_gemma":[0.9989224,0.000370659,0.00002840096,0.00007381948,0.000030035748,0.00012579035,0.00033684564,0.00003377949,0.00007824437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976178,0.00037156238,0.0002610833,0.0006266064,0.0005903656,0.0005326278],"domain_scores_gemma":[0.99836075,0.00016099392,0.0001368636,0.00040895556,0.0008315572,0.000100876736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046014844,0.00023131218,0.000495218,0.00020863228,0.00012117321,0.000026418904,0.00020226867,0.00013992687,0.0002573506],"category_scores_gemma":[0.00012366488,0.00016437516,0.00010073997,0.0014376823,0.00031056907,0.000009126788,0.00011479936,0.00026217033,6.2991796e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004972923,0.00044035792,0.9616257,0.00001546071,0.0017550186,0.000024036664,0.00032984628,0.00043546333,0.028674623,0.0000011008351,0.00010750722,0.0016179513],"study_design_scores_gemma":[0.0025525095,0.00024724234,0.985075,0.00015543817,0.000115389346,6.450003e-7,0.0002650351,0.000005797923,0.011263031,0.0000025407903,0.00012018025,0.00019719046],"about_ca_topic_score_codex":0.0013287936,"about_ca_topic_score_gemma":0.0074499687,"teacher_disagreement_score":0.02344929,"about_ca_system_score_codex":0.00036552132,"about_ca_system_score_gemma":0.00045878044,"threshold_uncertainty_score":0.67030245},"labels":[],"label_agreement":null},{"id":"W3130745660","doi":"10.1158/1538-7445.sabcs20-ps14-07","title":"Abstract PS14-07: Ribociclib + letrozole in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) advanced breast cancer (ABC) and central nervous system metastases: Subgroup analysis of the phase IIIb CompLEEment-1 trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Letrozole; Goserelin; Metastatic breast cancer; Tolerability; Oncology; Cancer; Population; Adverse effect; Tamoxifen","score_opus":0.03512929365736709,"score_gpt":0.36558569335040264,"score_spread":0.33045639969303553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130745660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98844415,0.0019535972,0.00004318444,0.00076660526,0.00021507755,0.0024188063,0.006016886,0.000041451298,0.000100231],"genre_scores_gemma":[0.99788684,0.00030753983,0.00018520208,0.00009049815,0.00024939014,0.0006182885,0.00046835298,0.00008608161,0.00010779642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943888,0.0008103529,0.00091653643,0.0010250137,0.0016668366,0.001192436],"domain_scores_gemma":[0.9962884,0.00036312008,0.00050824566,0.00070664694,0.0017093465,0.0004242246],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000520196,0.000495925,0.0014112048,0.00052559644,0.00043175856,0.000075723954,0.00039085068,0.00014545493,0.0014558324],"category_scores_gemma":[0.00013290865,0.00036513177,0.0002916956,0.0029207787,0.0008753813,0.0004669665,0.00024504247,0.0009936423,0.000004152464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30133003,0.006311573,0.39551237,0.0017678264,0.017604832,0.00015005487,0.008956777,0.0011745079,0.18225817,0.00059415447,0.0007437561,0.08359596],"study_design_scores_gemma":[0.08533453,0.0011805173,0.88635737,0.0008756565,0.00074296,0.000005005796,0.0031588639,0.000051174018,0.021581572,0.000013520034,0.00025388013,0.0004449389],"about_ca_topic_score_codex":0.0061717113,"about_ca_topic_score_gemma":0.0022849806,"teacher_disagreement_score":0.49084502,"about_ca_system_score_codex":0.002413776,"about_ca_system_score_gemma":0.00083286996,"threshold_uncertainty_score":0.9998801},"labels":[],"label_agreement":null},{"id":"W3130789118","doi":"10.1158/1538-7445.sabcs20-pd10-06","title":"Abstract PD10-06: Clinical behavior and outcomes of <i>BRCA</i>-mutated breast cancer in young patients according to type of <i>BRCA</i> mutation and hormone receptor status: Results from an international cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Oncology; Internal medicine; Cancer; Hormone receptor; Proportional hazards model; BRCA mutation; Gynecology; Confidence interval","score_opus":0.05242469912368318,"score_gpt":0.44256180850329363,"score_spread":0.39013710937961044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130789118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959279,0.00047754086,0.0000029563648,0.00017555598,0.00034670488,0.0006514998,0.0023608487,0.0000045326933,0.000052495827],"genre_scores_gemma":[0.99682796,0.0018630617,0.00020658247,0.00003532013,0.000112083006,0.00017969859,0.0006970265,0.00002642329,0.000051861356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776536,0.00021857799,0.0006283653,0.0006437501,0.00048520655,0.0002587097],"domain_scores_gemma":[0.9979979,0.00010268925,0.00016075997,0.00034274644,0.001254937,0.00014100896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007749774,0.00013619172,0.00028714232,0.00013084573,0.000052309806,0.000038979113,0.00019052485,0.00012872258,0.0000434666],"category_scores_gemma":[0.00044898494,0.00013769191,0.00003196962,0.00034573235,0.0001501188,0.00003113363,0.00025282206,0.00022883886,0.0000011973951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080621766,0.0004286825,0.8652994,0.000009026183,0.00013083997,0.0000052562677,0.0005858284,0.00007784681,0.12421496,5.9640996e-7,0.00024649277,0.008194875],"study_design_scores_gemma":[0.002638085,0.00029546503,0.97306764,0.000041006315,0.0000303734,0.0000010652803,0.0015930999,0.000012527736,0.022085436,0.0000048043003,0.000105582825,0.0001249406],"about_ca_topic_score_codex":0.0051583652,"about_ca_topic_score_gemma":0.004907995,"teacher_disagreement_score":0.10776824,"about_ca_system_score_codex":0.00019547864,"about_ca_system_score_gemma":0.0005847946,"threshold_uncertainty_score":0.779794},"labels":[],"label_agreement":null},{"id":"W3130800072","doi":"10.1158/1538-7445.sabcs20-pd12-09","title":"Abstract PD12-09: Patient-reported outcomes of adolescents and young adults with breast cancer treated with curative intent","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Logistic regression; Medical record; Cancer; Anxiety; Depression (economics); Stage (stratigraphy); Young adult; Internal medicine; Pediatrics; Psychiatry","score_opus":0.048444590024174866,"score_gpt":0.37767699591888354,"score_spread":0.3292324058947087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130800072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964922,0.0012664559,0.000003657098,0.0009129945,0.0000686664,0.0006609228,0.00022496222,0.000022120596,0.00034801068],"genre_scores_gemma":[0.9978235,0.0013103349,0.000016645165,0.00006329695,0.000046971752,0.000182517,0.000030174591,0.000038795904,0.0004877631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978506,0.000048845195,0.00030798023,0.00047952324,0.0008771683,0.00043589767],"domain_scores_gemma":[0.9975336,0.000034406872,0.00014461427,0.00033697806,0.0016710043,0.00027940178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011056355,0.00020504661,0.0004696768,0.0001520516,0.0000924566,0.000030204816,0.00006790244,0.00007255393,0.00041535936],"category_scores_gemma":[0.00003846101,0.00012637791,0.00005201584,0.00057435426,0.00034443458,0.000117753014,0.00006409274,0.00046789736,0.000001965474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046533123,0.00025607753,0.9661017,0.00034122835,0.0004463831,0.00036636036,0.0016174975,0.000006074353,0.0047113462,0.0000033706879,0.00033385653,0.021162778],"study_design_scores_gemma":[0.004001992,0.00043627582,0.9721748,0.002749617,0.000091937734,0.000106768224,0.0027961347,0.000013711507,0.017266482,0.0000016900387,0.00020698192,0.00015360133],"about_ca_topic_score_codex":0.026168544,"about_ca_topic_score_gemma":0.009143196,"teacher_disagreement_score":0.021009177,"about_ca_system_score_codex":0.00036635084,"about_ca_system_score_gemma":0.0009167695,"threshold_uncertainty_score":0.9803163},"labels":[],"label_agreement":null},{"id":"W3130823265","doi":"10.1158/1538-7445.sabcs20-gs4-01","title":"Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Regimen; Internal medicine; Breast cancer; Chemotherapy; Cancer; Oncology; Chemotherapy regimen; Fluorouracil; Gastroenterology; Urology; Colorectal cancer","score_opus":0.08037823029429043,"score_gpt":0.4083962176252598,"score_spread":0.3280179873309694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130823265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834962,0.0058688982,7.1456714e-7,0.001458703,0.00023442591,0.0039123064,0.0047123176,0.00002427709,0.00029216317],"genre_scores_gemma":[0.99426776,0.0020587659,0.00012937615,0.000039073628,0.00022625706,0.0013606228,0.0008520611,0.000090276095,0.0009758286],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99453986,0.0005743692,0.0012560353,0.0011063035,0.0015644135,0.00095903716],"domain_scores_gemma":[0.99505764,0.00086963794,0.0005563163,0.0008815711,0.0021760364,0.0004588229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081064715,0.00047831566,0.0017356953,0.0004928915,0.000107488544,0.000028185907,0.00031664871,0.00014274011,0.0022516875],"category_scores_gemma":[0.0004572876,0.00039402593,0.00013844686,0.0015652274,0.0004212861,0.00019791123,0.000168139,0.0009282964,0.000009128836],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5672352,0.040961716,0.041862026,0.0008394369,0.006289034,0.0011428907,0.020642152,0.00026638596,0.2793362,0.0000019983643,0.012485345,0.028937645],"study_design_scores_gemma":[0.44030935,0.01765167,0.49394503,0.0020153308,0.0013173148,0.000008940122,0.0076901955,0.00013791086,0.035680927,0.0000068614077,0.00060028804,0.00063619367],"about_ca_topic_score_codex":0.063831575,"about_ca_topic_score_gemma":0.028431328,"teacher_disagreement_score":0.452083,"about_ca_system_score_codex":0.0017655365,"about_ca_system_score_gemma":0.0022947462,"threshold_uncertainty_score":0.99985117},"labels":[],"label_agreement":null},{"id":"W3130876934","doi":"10.1158/1538-7445.sabcs20-ps2-27","title":"Abstract PS2-27: Benefits of a rapid diagnostic centre for breast cancer care during the COVID-19 pandemic","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Referral; Malignancy; Retrospective cohort study; Cancer; Internal medicine; Pediatrics; Radiology; Disease; Family medicine","score_opus":0.21545643707746082,"score_gpt":0.5040283179643178,"score_spread":0.288571880886857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130876934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90131575,0.040319066,0.0000035519354,0.054746076,0.00026640366,0.001326796,0.0018503579,0.000038287733,0.0001337156],"genre_scores_gemma":[0.97768533,0.01815113,0.000008127136,0.0021382049,0.0008398186,0.00032328747,0.00003984992,0.000042331074,0.0007719133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975106,0.00012646444,0.00032341955,0.00044119646,0.00077281386,0.0008254873],"domain_scores_gemma":[0.9947523,0.0025835354,0.00008236898,0.0005376025,0.0013871233,0.00065707957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006442,0.00016107301,0.00036316158,0.00015694201,0.00035576147,0.000033595476,0.00021665117,0.00013949188,0.0018557553],"category_scores_gemma":[0.0031699063,0.0001183345,0.00014431283,0.0005864512,0.00018470049,0.000060514703,0.00012090538,0.0006127335,0.000009901622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023287,0.00019694722,0.7612298,0.021556865,0.0002774092,0.0001998584,0.011692013,0.0007263743,0.022656182,0.00014158715,0.017451039,0.16154324],"study_design_scores_gemma":[0.003661502,0.00013076307,0.90920943,0.0015412545,0.00008395265,0.00010577511,0.0040301005,0.0000093440885,0.007995066,0.00005550272,0.072984666,0.00019265445],"about_ca_topic_score_codex":0.010051757,"about_ca_topic_score_gemma":0.016442617,"teacher_disagreement_score":0.16135058,"about_ca_system_score_codex":0.0019523368,"about_ca_system_score_gemma":0.008169355,"threshold_uncertainty_score":0.9990567},"labels":[],"label_agreement":null},{"id":"W3130950208","doi":"10.1158/1538-7445.sabcs20-ps7-19","title":"Abstract PS7-19: Pre/perimenopausal (preMeno) women receiving palbociclib (PAL) for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) in a real-world setting: Treatment patterns from POLARIS","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anastrozole; Palbociclib; Exemestane; Letrozole; Breast cancer; Internal medicine; Cancer; Fulvestrant; Gynecology; Oncology; Metastatic breast cancer; Tamoxifen","score_opus":0.0535790946027976,"score_gpt":0.4034126591646535,"score_spread":0.34983356456185594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130950208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976561,0.0032314775,0.00008740551,0.0059256614,0.00037980804,0.0035045506,0.009660068,0.0001984877,0.00045154063],"genre_scores_gemma":[0.9800336,0.004405329,0.0020336395,0.00040805896,0.0015786758,0.0075982856,0.00071507506,0.00032823725,0.0028991413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9922172,0.00067815976,0.0011704215,0.0020866152,0.0013646093,0.0024829947],"domain_scores_gemma":[0.99445784,0.0015333145,0.0004596191,0.0009852074,0.0015266652,0.0010373589],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083472976,0.0009105551,0.0015145444,0.000615567,0.0007080283,0.00017680445,0.00048759088,0.00033994814,0.0062752194],"category_scores_gemma":[0.00040125946,0.0008711087,0.00025732617,0.0012533736,0.00044292578,0.00076289923,0.00028111413,0.0014422669,0.00003228787],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01209414,0.0011948826,0.11593768,0.00047235127,0.0015561443,0.000169001,0.02521061,0.000064554355,0.74508876,0.00007399307,0.0007401913,0.097397685],"study_design_scores_gemma":[0.012692183,0.0013632883,0.7422492,0.0016893473,0.00007631985,0.000012734487,0.005379768,0.000020027948,0.23209357,0.0005850055,0.002925032,0.0009135367],"about_ca_topic_score_codex":0.060238685,"about_ca_topic_score_gemma":0.01664582,"teacher_disagreement_score":0.62631154,"about_ca_system_score_codex":0.014317796,"about_ca_system_score_gemma":0.0025396158,"threshold_uncertainty_score":0.999374},"labels":[],"label_agreement":null},{"id":"W3131019385","doi":"10.1158/0008-5472.can-20-1613","title":"A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; National Institutes of Health","keywords":"Alveolar rhabdomyosarcoma; FOXO1; Cancer research; PAX3; Transcription factor; Fusion gene; Rhabdomyosarcoma; Biology; Medicine; Gene; Genetics; Pathology; Sarcoma","score_opus":0.07963867810012622,"score_gpt":0.39449776084216304,"score_spread":0.31485908274203683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131019385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652726,0.0044210604,0.00036616746,0.006168856,0.00023172161,0.0014520478,0.00032210982,0.00003483543,0.00047591768],"genre_scores_gemma":[0.99482876,0.0021872604,0.00057782204,0.00015994247,0.00017559726,0.0015811021,0.0001326707,0.000025333435,0.0003315234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972618,0.00017615124,0.0003395795,0.0005410546,0.0012517452,0.0004296352],"domain_scores_gemma":[0.99795896,0.00012742366,0.00006541003,0.00029568493,0.0012590213,0.00029350675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020291528,0.00019302293,0.00038194284,0.00030873468,0.0001937302,0.000031369047,0.0001024856,0.00013897341,0.0029822795],"category_scores_gemma":[0.000102588245,0.00016112508,0.00016351929,0.0008040404,0.00017639896,0.00014772218,0.00004794045,0.0003668618,0.000023024802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012603637,0.0016536844,0.07172437,0.00025841096,0.0002770559,0.00016067253,0.0021795034,0.00013366883,0.8837546,0.0003880021,0.00091611745,0.037293565],"study_design_scores_gemma":[0.0035387657,0.0005416736,0.19279726,0.0015323869,0.0001033471,0.00003222897,0.00066540315,0.000087015986,0.7890207,0.00017865573,0.011305062,0.00019750254],"about_ca_topic_score_codex":0.0016210579,"about_ca_topic_score_gemma":0.0006869989,"teacher_disagreement_score":0.12107289,"about_ca_system_score_codex":0.0008229737,"about_ca_system_score_gemma":0.001455117,"threshold_uncertainty_score":0.99792916},"labels":[],"label_agreement":null},{"id":"W3131021926","doi":"10.1158/1538-7445.sabcs20-ps13-29","title":"Abstract PS13-29: Four cycles of docetaxel-cyclophosphamide versus anthracycline-taxane adjuvant chemotherapy in node negative, HER2-negative breast cancer: A real-world comparison","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Taxane; Medicine; Docetaxel; Regimen; Oncology; Internal medicine; Anthracycline; Breast cancer; Cyclophosphamide; Chemotherapy; Cancer","score_opus":0.06213674412197129,"score_gpt":0.41477461655051573,"score_spread":0.35263787242854444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131021926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525923,0.006154868,0.000006321024,0.004488096,0.00032614463,0.00047785175,0.00077871693,0.000020291294,0.002488492],"genre_scores_gemma":[0.9697017,0.028333677,0.00037796661,0.00012205722,0.00042587562,0.00045190533,0.00007555117,0.00007100311,0.00044023184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670064,0.00024421123,0.0005971795,0.00093269703,0.0006748857,0.0008503719],"domain_scores_gemma":[0.99777013,0.00031006086,0.00026516913,0.0006502861,0.0008210043,0.00018334472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039123025,0.00038874795,0.0007322855,0.0001945758,0.00018985268,0.00004060136,0.0004117672,0.00017608628,0.00049570936],"category_scores_gemma":[0.00016916072,0.00037335482,0.00017575269,0.0009844226,0.0006389768,0.000021146063,0.00029400722,0.0005310271,0.000009939057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01485846,0.0017578528,0.65830195,0.00051116047,0.0017630667,0.00021026703,0.00174847,0.001731048,0.23963767,0.00008232859,0.011312707,0.06808502],"study_design_scores_gemma":[0.005333771,0.00009443955,0.6050154,0.00032579596,0.00002728803,0.0000037853727,0.0009881796,0.000019773242,0.3865276,0.00009341513,0.001285895,0.00028468552],"about_ca_topic_score_codex":0.045046467,"about_ca_topic_score_gemma":0.09055745,"teacher_disagreement_score":0.14688994,"about_ca_system_score_codex":0.00053198554,"about_ca_system_score_gemma":0.0010343187,"threshold_uncertainty_score":0.99987185},"labels":[],"label_agreement":null},{"id":"W3131078121","doi":"10.1158/1538-7445.sabcs20-pd2-07","title":"Abstract PD2-07: Alpelisib + letrozole in patients with <i>PIK3CA-</i>mutated, hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) previously treated with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + fulvestrant: BYLieve study results","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Letrozole; Cohort; Medicine; Fulvestrant; Internal medicine; Oncology; Breast cancer; Clinical endpoint; Cancer; Gynecology; Clinical trial; Estrogen receptor; Aromatase","score_opus":0.02330723514965225,"score_gpt":0.33720449396616314,"score_spread":0.31389725881651087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131078121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984753,0.0016505627,0.000011445083,0.0015266354,0.00018143065,0.006219672,0.0048557175,0.00020561823,0.00059587636],"genre_scores_gemma":[0.9940321,0.000572697,0.00034845024,0.00020250528,0.00052985305,0.0022671293,0.00081063964,0.0003544774,0.0008821646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9894094,0.0009188697,0.0014628791,0.0025940253,0.0032075956,0.002407246],"domain_scores_gemma":[0.99246806,0.00046203536,0.00062198454,0.0012374407,0.004155494,0.0010549623],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007818726,0.0012091198,0.0017167107,0.00070963986,0.0006506703,0.00020951754,0.00060260814,0.00035126333,0.0013325678],"category_scores_gemma":[0.0002613997,0.0009673232,0.00020860955,0.0024848168,0.0009552364,0.0011602903,0.00027522023,0.0026660399,0.00008587512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23534095,0.017528754,0.5130695,0.0008605627,0.0038753632,0.0033380783,0.021129582,0.0014970554,0.15747362,0.000023573604,0.0012781044,0.04458485],"study_design_scores_gemma":[0.06605369,0.0070348987,0.8333573,0.0030508924,0.00020348027,0.000053274634,0.0055900067,0.000009101493,0.082986206,0.000017622135,0.00027675612,0.0013668054],"about_ca_topic_score_codex":0.010331624,"about_ca_topic_score_gemma":0.006866797,"teacher_disagreement_score":0.32028776,"about_ca_system_score_codex":0.0039416337,"about_ca_system_score_gemma":0.0021655587,"threshold_uncertainty_score":0.99988204},"labels":[],"label_agreement":null},{"id":"W3131204198","doi":"10.1158/1538-7445.sabcs20-ps4-27","title":"Abstract PS4-27: A prospective multicenter study evaluating the impact of the 21-Gene Breast Recurrence Score® upon physician treatment decision and cost in lymph node-positive breast cancer patients in Quebec","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; Université Laval; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Prospective cohort study; Clinical endpoint; Oncology; Cohort; Lymph node; Chemotherapy; Cancer; Cohort study; Observational study; Clinical trial","score_opus":0.04165953741964125,"score_gpt":0.41564278841052155,"score_spread":0.3739832509908803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131204198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544615,0.0015708392,7.1679807e-7,0.00038111923,0.00009630073,0.0016337375,0.0008274391,0.0000022197269,0.000041482555],"genre_scores_gemma":[0.99809974,0.0007467847,0.0000075956373,0.000030944804,0.00010412678,0.00092473265,0.00003102685,0.000023267155,0.00003177415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773693,0.00040094162,0.00028319418,0.0006408759,0.00048596095,0.0004520699],"domain_scores_gemma":[0.9985721,0.00013306394,0.00012052967,0.0004284911,0.000683323,0.00006245209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036291222,0.00024586456,0.00028107528,0.00006923494,0.00018910177,0.000048873782,0.00022418167,0.00006537514,0.000016143098],"category_scores_gemma":[0.00008226202,0.00014323356,0.00009968485,0.00052373856,0.00022563449,0.000018467692,0.00035047426,0.00019396837,0.0000011110137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018041432,0.0015406086,0.89984584,0.000013640924,0.0002296672,0.0000057887664,0.0022322792,0.0004248401,0.025306089,4.866739e-7,0.000035223595,0.06856142],"study_design_scores_gemma":[0.00432385,0.00027789097,0.9731592,0.0004222323,0.000028575107,0.0000028099366,0.0010755504,0.000058822294,0.020509573,0.000010548827,0.000001970473,0.00012895859],"about_ca_topic_score_codex":0.14597435,"about_ca_topic_score_gemma":0.13615607,"teacher_disagreement_score":0.07331341,"about_ca_system_score_codex":0.0017034303,"about_ca_system_score_gemma":0.00082934706,"threshold_uncertainty_score":0.87960684},"labels":[],"label_agreement":null},{"id":"W3131211776","doi":"10.1158/1538-7445.sabcs20-ot-28-01","title":"Abstract OT-28-01: HER2CLIMB-02: A randomized, double-blind, phase 3 study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Taxane; Capecitabine; Metastatic breast cancer; Internal medicine; Oncology; Placebo; Nausea; Gastroenterology; Breast cancer; Trastuzumab; Phases of clinical research; Cancer; Surgery; Clinical trial; Colorectal cancer; Pathology","score_opus":0.1485206845789407,"score_gpt":0.4857765730134932,"score_spread":0.3372558884345525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131211776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708546,0.007678579,0.0012255735,0.0028431062,0.00033894574,0.015823744,0.0006634279,0.00012261127,0.00044940412],"genre_scores_gemma":[0.9660773,0.0012097438,0.0021203184,0.00024344267,0.00050513237,0.021192051,0.000069552465,0.00026210814,0.008320299],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934338,0.0005053278,0.0011727632,0.0013245387,0.0020146072,0.0015490085],"domain_scores_gemma":[0.9922964,0.002087468,0.0004568094,0.0012590557,0.0032771046,0.0006231596],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002283467,0.0006358415,0.0022939285,0.00048707126,0.00038286718,0.000112978545,0.0005398244,0.00014619404,0.0061279493],"category_scores_gemma":[0.00053698453,0.000408372,0.000265983,0.0023162828,0.0008106649,0.0004520295,0.0001856857,0.0010709921,0.000015183015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92621094,0.004648824,0.00026257537,0.0023105964,0.0026074292,0.00051175314,0.0025147414,0.001652837,0.011469545,0.00004138429,0.00042448094,0.047344897],"study_design_scores_gemma":[0.93313926,0.0043282807,0.00022036156,0.002881852,0.0007499559,0.0003300779,0.016961806,0.00023402981,0.036579326,0.000109377615,0.0038535537,0.0006121118],"about_ca_topic_score_codex":0.0038196389,"about_ca_topic_score_gemma":0.015992666,"teacher_disagreement_score":0.046732787,"about_ca_system_score_codex":0.0010092964,"about_ca_system_score_gemma":0.0073188157,"threshold_uncertainty_score":0.9998368},"labels":[],"label_agreement":null},{"id":"W3131282401","doi":"10.1158/1538-7445.sabcs20-ps7-17","title":"Abstract PS7-17: Exploring global clinical trial enrollment opportunities in high breast cancer mortality regions","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Cancer; Incidence (geometry); Mortality rate; Cancer registry; Demography; Internal medicine; Oncology","score_opus":0.8244581893782873,"score_gpt":0.5944368311054251,"score_spread":0.2300213582728622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131282401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779765,0.0028667916,0.0000061080464,0.012075723,0.001059155,0.0006255318,0.0002557922,0.000048195114,0.005086192],"genre_scores_gemma":[0.9849521,0.009914251,0.00005156985,0.0008410553,0.002227199,0.00093270856,0.000040975632,0.000023243474,0.0010169107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560165,0.00032843783,0.0008232718,0.00072282355,0.0015866654,0.00093713356],"domain_scores_gemma":[0.99766964,0.00020467446,0.00010276477,0.0006687728,0.00078237924,0.00057178055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024532466,0.00021235658,0.0006153392,0.00012500875,0.00018968173,0.000093646784,0.00028086774,0.00018451335,0.0022199706],"category_scores_gemma":[0.00032215437,0.00019871599,0.00021997417,0.00085247523,0.00034819095,0.00031608093,0.00024531494,0.0010866182,0.000023605557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04534411,0.0012683929,0.74828947,0.00042432421,0.0006178415,0.008207583,0.000511234,0.0002765879,0.00074621226,0.0047073937,0.062449858,0.12715699],"study_design_scores_gemma":[0.027088793,0.0004162872,0.9479198,0.0014808279,0.00008549206,0.00007740747,0.0034299507,0.000019725849,0.00043023328,0.0008500532,0.01787108,0.00033035863],"about_ca_topic_score_codex":0.022326058,"about_ca_topic_score_gemma":0.010902551,"teacher_disagreement_score":0.19963032,"about_ca_system_score_codex":0.0016279852,"about_ca_system_score_gemma":0.0044852076,"threshold_uncertainty_score":0.99869215},"labels":[],"label_agreement":null},{"id":"W3131295993","doi":"10.1158/1538-7445.sabcs20-ps11-20","title":"Abstract PS11-20: Radiation therapy (RT) induced toxicity in advanced breast cancer (ABC) patients treated with CDK4/6 inhibitors (CDK4/6is)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Palbociclib; Common Terminology Criteria for Adverse Events; Toxicity; Adverse effect; Cancer; Internal medicine; Radiation therapy; Breast cancer; Oncology; Surgery; Metastatic breast cancer","score_opus":0.045906522525190764,"score_gpt":0.3821999245497152,"score_spread":0.3362934020245244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131295993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076533,0.0040612984,0.000007126236,0.0026162032,0.0002403705,0.0014304003,0.00024024658,0.00010856105,0.0005304533],"genre_scores_gemma":[0.99419445,0.0028079092,0.0000843088,0.00044559993,0.00053568085,0.001124109,0.00015521196,0.000139358,0.0005133545],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99550587,0.00024756845,0.00055833993,0.0010350917,0.0014906806,0.0011624338],"domain_scores_gemma":[0.99697775,0.00017172738,0.00019040209,0.00073104736,0.0015153723,0.00041369727],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004348798,0.00044319234,0.0006787744,0.0005095495,0.00024746166,0.00007172677,0.0002558825,0.00025162092,0.0014094607],"category_scores_gemma":[0.000095787975,0.00037024522,0.00011230964,0.0023341107,0.00027215367,0.0005693372,0.00008613009,0.0012074669,0.000030273437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055750185,0.00070256134,0.3233881,0.00013566022,0.00018155103,0.00013471881,0.00071106554,0.00027470686,0.2783296,0.000010402261,0.00018212791,0.3903745],"study_design_scores_gemma":[0.011224708,0.00043312335,0.70723575,0.00091316976,0.000018261722,0.000021138036,0.00030266377,0.000024009008,0.27568048,0.000051756895,0.0036954854,0.00039946174],"about_ca_topic_score_codex":0.002774464,"about_ca_topic_score_gemma":0.0028048402,"teacher_disagreement_score":0.38997504,"about_ca_system_score_codex":0.0026960208,"about_ca_system_score_gemma":0.0018224884,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W3131366900","doi":"10.1158/1538-7445.sabcs20-pd13-04","title":"Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Quality of life (healthcare); Visual analogue scale; Internal medicine; Metastatic breast cancer; Breast cancer; Oncology; Trastuzumab; Placebo; Cancer; Physical therapy; Colorectal cancer; Alternative medicine; Nursing; Pathology","score_opus":0.08995328600110802,"score_gpt":0.4578494692486977,"score_spread":0.36789618324758966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131366900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153477,0.002987099,0.000007859612,0.002543172,0.000019619829,0.0009443748,0.0018732167,0.000012111259,0.00007777737],"genre_scores_gemma":[0.99896806,0.00025364917,0.00021913956,0.00014640056,0.000019553281,0.00017964416,0.00007537258,0.000052867515,0.0000853176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660355,0.00053699524,0.00063724676,0.0005089841,0.0011003516,0.0006129016],"domain_scores_gemma":[0.9968968,0.0006740057,0.000410186,0.00046844303,0.001201455,0.0003491319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009869718,0.00024975327,0.0010580227,0.00030139653,0.00007221194,0.000013941059,0.00011166961,0.00005026581,0.0009010313],"category_scores_gemma":[0.00026772934,0.000170884,0.00006917209,0.0012402707,0.0004818355,0.00021162115,0.00005122045,0.0006122696,0.00000119251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051589552,0.002736231,0.8493803,0.0026719794,0.002646994,0.000040206654,0.004419778,0.002039604,0.006275617,0.000103038954,0.00030476248,0.077791914],"study_design_scores_gemma":[0.008791031,0.0014055462,0.98334974,0.0015489812,0.000031067793,0.0000068188465,0.0011748709,0.0000048416114,0.0034140928,0.00008484598,0.000030733452,0.00015740188],"about_ca_topic_score_codex":0.049736105,"about_ca_topic_score_gemma":0.007451818,"teacher_disagreement_score":0.13396946,"about_ca_system_score_codex":0.00097187737,"about_ca_system_score_gemma":0.0048339902,"threshold_uncertainty_score":0.98656607},"labels":[],"label_agreement":null},{"id":"W3131590360","doi":"10.1158/1538-7445.sabcs20-sp97","title":"Abstract SP097: Local Regional Management Following Neoadjuvant Chemotherapy: Minding the Knowledge Gaps","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Neoadjuvant therapy; Internal medicine; Lumpectomy; Chemotherapy; Trastuzumab; Axillary lymph nodes; Inflammatory breast cancer; Mastectomy; Triple-negative breast cancer; Cancer; Lymph node","score_opus":0.05690804329228461,"score_gpt":0.3937545534740899,"score_spread":0.3368465101818053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131590360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8971975,0.06544083,0.00027201712,0.011995238,0.0006440712,0.0005374888,0.000030867035,0.000027329892,0.023854697],"genre_scores_gemma":[0.9912705,0.0040181796,0.000102201935,0.00027922977,0.00055636803,0.0002729739,0.000044287623,0.000034276545,0.003421991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983844,0.000095353076,0.0001464085,0.00048860005,0.0003759313,0.0005093185],"domain_scores_gemma":[0.9992171,0.000051316507,0.000028550603,0.00045556782,0.00016786746,0.00007959382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034852934,0.000156434,0.00014152855,0.000048658414,0.00039508138,0.000052861225,0.00029106956,0.00007808261,0.00017084574],"category_scores_gemma":[0.00001862305,0.00011863243,0.00014806751,0.0002834942,0.00022003536,0.0000044451144,0.00031733743,0.00021067096,0.000044115575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008405712,0.0008163617,0.010041918,0.0004226715,0.0041251318,0.0008173071,0.0024274474,0.00016539638,0.28192037,0.0019496925,0.18486305,0.5116101],"study_design_scores_gemma":[0.0025674703,0.00007708971,0.054715898,0.00032925876,0.00006471371,0.000043105818,0.00416221,0.000011602973,0.22220913,0.00039683733,0.7150188,0.00040386792],"about_ca_topic_score_codex":0.000112261325,"about_ca_topic_score_gemma":0.00033277445,"teacher_disagreement_score":0.5301558,"about_ca_system_score_codex":0.00019675671,"about_ca_system_score_gemma":0.00024927012,"threshold_uncertainty_score":0.483769},"labels":[],"label_agreement":null},{"id":"W3131599386","doi":"10.1158/1538-7445.sabcs20-ps7-05","title":"Abstract PS7-05: Estrogen-based hormone replacement therapy [E-HRT] reduces all-cause, breast cancer, and Alzheimer's dementia mortality","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Hormone replacement therapy (female-to-male); Dementia; Population; Estrogen; Cause of death; Mortality rate; Cancer; Internal medicine; Hormone therapy; Gynecology; Demography; Gerontology; Disease; Environmental health","score_opus":0.16894475701031575,"score_gpt":0.4526925573810967,"score_spread":0.28374780037078096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131599386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7681728,0.2259131,0.0000037052619,0.0045750123,0.00023099489,0.0007065213,0.00017224412,0.00004199664,0.0001836014],"genre_scores_gemma":[0.901314,0.097006164,0.000060112365,0.0005041417,0.00052407244,0.00037652996,0.00009916783,0.000047521105,0.0000682849],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964002,0.00021310954,0.00039893287,0.00075123605,0.0013530003,0.0008835231],"domain_scores_gemma":[0.9977001,0.000098218996,0.00008000237,0.00076419656,0.00064386067,0.0007136334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014349011,0.00024279644,0.0004789527,0.00015694731,0.0002907125,0.00007935706,0.00013715595,0.00015911672,0.0008693561],"category_scores_gemma":[0.00004856999,0.00020113902,0.0002157965,0.0004806936,0.00026415425,0.00008732596,0.00008076621,0.00069229095,0.000013110915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970433,0.0015558301,0.31595516,0.00096704013,0.045652293,0.0018260222,0.00084595795,0.00019313769,0.21534134,0.000104170074,0.07129558,0.33729303],"study_design_scores_gemma":[0.008102219,0.00035155422,0.78227645,0.00030461635,0.0012043107,0.00012767287,0.0004891609,0.000062807056,0.1409265,0.000024594145,0.065723486,0.00040665086],"about_ca_topic_score_codex":0.009107256,"about_ca_topic_score_gemma":0.00064493355,"teacher_disagreement_score":0.46632126,"about_ca_system_score_codex":0.00027634052,"about_ca_system_score_gemma":0.002823892,"threshold_uncertainty_score":0.9974912},"labels":[],"label_agreement":null},{"id":"W3131616921","doi":"10.1158/1538-7445.sabcs20-ps9-47","title":"Abstract PS9-47: A scoping review characterizing “choosing wisely” recommendations for breast cancer management","year":2021,"lang":"en","type":"review","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Psychological intervention; MEDLINE; Inclusion (mineral); Family medicine; Cancer; Internal medicine; Nursing; Psychology","score_opus":0.8173357431975284,"score_gpt":0.6528125250343196,"score_spread":0.1645232181632088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131616921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000357373,0.93812853,0.00013880407,0.046260834,0.0013821145,0.008154805,0.005003286,0.00005348837,0.00087457435],"genre_scores_gemma":[0.0000022002982,0.973601,0.00087478175,0.004543314,0.001589547,0.017298076,0.0006450677,0.00018626075,0.0012597629],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892103,0.0008956472,0.0066200253,0.0016601232,0.00031532897,0.0012985602],"domain_scores_gemma":[0.9924643,0.002088276,0.003383818,0.0011959171,0.00048286872,0.00038483617],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.029040413,0.0005470378,0.0045446577,0.0009915502,0.0007819923,0.00043762554,0.00091039774,0.000340271,0.005753741],"category_scores_gemma":[0.0013576545,0.00066450366,0.0007652154,0.0010907504,0.000107143016,0.00058652624,0.00031931108,0.0010048627,0.00093199936],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000340849,0.000059157697,0.000014111307,0.47256222,0.00042537518,0.0000032767512,0.00010522974,0.0000014456097,9.344473e-8,0.0038457902,0.08940066,0.43357924],"study_design_scores_gemma":[0.00017097096,0.000006740776,0.000019899077,0.40264,0.00007281863,0.000005910607,0.00006590906,0.0000050916083,1.1604903e-7,0.00012587545,0.59651726,0.00036936093],"about_ca_topic_score_codex":0.00079382746,"about_ca_topic_score_gemma":0.00020306493,"teacher_disagreement_score":0.5071166,"about_ca_system_score_codex":0.004384646,"about_ca_system_score_gemma":0.0023253155,"threshold_uncertainty_score":0.99984586},"labels":[],"label_agreement":null},{"id":"W3131625996","doi":"10.1158/1538-7445.sabcs20-ps7-30","title":"Abstract PS7-30: Differential efficacy, safety and tolerability of low-dose versus standard dose tamoxifen as breast cancer prophylaxis: A network meta-analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Hazard ratio; Tolerability; Placebo; Internal medicine; Meta-analysis; Dosing; Adverse effect; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.05085474341550628,"score_gpt":0.3800101312835951,"score_spread":0.32915538786808884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131625996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97605145,0.022210551,0.000018209961,0.00036612875,0.00014809016,0.0004201444,0.0004525688,0.000009334217,0.0003235113],"genre_scores_gemma":[0.995146,0.0038925745,0.000033752185,0.000020067535,0.00030339736,0.00010975741,0.00010621941,0.000028599849,0.0003596675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972194,0.00044712282,0.00039538706,0.00074097695,0.00062234607,0.00057477393],"domain_scores_gemma":[0.99820733,0.00012611876,0.00011490227,0.00065612537,0.0006339518,0.00026159498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000735052,0.00023975443,0.00077266473,0.00007732608,0.00020970216,0.00006566902,0.0002465915,0.00030674247,0.00160623],"category_scores_gemma":[0.00012367353,0.00018667014,0.00057886954,0.00068673625,0.00038774902,0.000007458211,0.00033801998,0.0005266882,0.000006111098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042777803,0.00086982036,0.006341008,0.00068044313,0.13979259,0.00016649048,0.00039407128,0.007909769,0.77748907,0.00012849705,0.0017813275,0.021669095],"study_design_scores_gemma":[0.015411896,0.0034018955,0.19204561,0.00015168454,0.03810024,0.000034046694,0.00029682496,0.0002261702,0.74303645,0.00018842718,0.0055458364,0.0015608901],"about_ca_topic_score_codex":0.0007388064,"about_ca_topic_score_gemma":0.0003710919,"teacher_disagreement_score":0.1857046,"about_ca_system_score_codex":0.0001006766,"about_ca_system_score_gemma":0.00082468195,"threshold_uncertainty_score":0.99930644},"labels":[],"label_agreement":null},{"id":"W3131777052","doi":"10.1158/1538-7445.sabcs20-ps18-25","title":"Abstract PS18-25: Concordance of immunohistochemical assays between peri-operative and post-operative breast tumor specimens: A prospective observational study of 18 cases","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Statistics Canada","funders":"","keywords":"Medicine; Breast cancer; Biopsy; Immunohistochemistry; Concordance; Core biopsy; Biomarker; Cancer; Prospective cohort study; Histopathology; H&E stain; Pathology; Internal medicine","score_opus":0.174949610998236,"score_gpt":0.4699988086108637,"score_spread":0.2950491976126277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131777052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196285,0.0038708472,7.531028e-7,0.0008917266,0.00003907196,0.0014001834,0.0007960071,0.0000084667845,0.0010300823],"genre_scores_gemma":[0.99832094,0.00024865192,0.00010105161,0.000044399665,0.000182692,0.0006727595,0.00006882761,0.000023626453,0.00033703717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783546,0.00013724185,0.0004300857,0.00052231626,0.0007853433,0.00028955308],"domain_scores_gemma":[0.9964315,0.0006035293,0.00011379027,0.00031631664,0.0023925805,0.00014227023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027481394,0.00018546941,0.000636915,0.00010073403,0.00014137077,0.000027528244,0.000090628884,0.000049112165,0.0011039594],"category_scores_gemma":[0.000283555,0.00015444108,0.000066475375,0.0004250389,0.0004628937,0.000104564715,0.00013819423,0.00039710428,0.000003845889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011353388,0.0022821967,0.68301356,0.00021368223,0.00090264395,0.00043794862,0.0051156096,0.000004785407,0.30462682,0.0003168905,0.00075235066,0.0011981546],"study_design_scores_gemma":[0.003370779,0.0019744805,0.8712678,0.0004332436,0.00009742999,0.000075318596,0.00649931,0.000002960529,0.11604666,0.000026487887,0.00009179337,0.00011373021],"about_ca_topic_score_codex":0.0035160773,"about_ca_topic_score_gemma":0.000579736,"teacher_disagreement_score":0.18858017,"about_ca_system_score_codex":0.0007637135,"about_ca_system_score_gemma":0.00147179,"threshold_uncertainty_score":0.99980915},"labels":[],"label_agreement":null},{"id":"W3131883755","doi":"10.1158/1538-7445.sabcs20-ps9-55","title":"Abstract PS9-55: Subcutaneous fixed-dose combination of pertuzumab and trastuzumab for the treatment of metastatic breast cancer in Canada - a budget impact analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Roche (Canada)","funders":"","keywords":"Medicine; Pertuzumab; Metastatic breast cancer; Trastuzumab; Breast cancer; Taxane; Pharmacokinetics; Cancer; Internal medicine; Oncology","score_opus":0.057394691934636026,"score_gpt":0.345171524895353,"score_spread":0.287776832960717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131883755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96794766,0.024395563,0.000054272743,0.0011164618,0.000121930076,0.00046988676,0.005656344,0.0000022816141,0.00023558426],"genre_scores_gemma":[0.9853342,0.014064812,0.000020339225,0.000025072624,0.000040718143,0.00023972211,0.000025855064,0.00002016902,0.00022912143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998419,0.00003116653,0.0006503847,0.00036389835,0.000103629056,0.00043196004],"domain_scores_gemma":[0.9984813,0.0005394527,0.00029352627,0.0003196225,0.00026203098,0.00010411674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046132758,0.00015978023,0.0007462914,0.00033349186,0.00009573905,0.000039942275,0.00018107971,0.000049295017,0.000941002],"category_scores_gemma":[0.00008068878,0.00013561652,0.00019571064,0.00078852545,0.00013568094,0.00013265279,0.000025024121,0.0001272609,0.0000014361635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026804027,0.0016917858,0.72241527,0.0008126115,0.0072341664,0.00010723866,0.005980804,0.031257443,0.0013155402,0.01051616,0.0022300072,0.21375857],"study_design_scores_gemma":[0.0027772766,0.00038869272,0.9816881,0.000055386234,0.00016876216,0.000011107339,0.0009470999,0.008327667,0.0012257855,0.0022159454,0.001920308,0.0002738812],"about_ca_topic_score_codex":0.88578176,"about_ca_topic_score_gemma":0.8711202,"teacher_disagreement_score":0.2592728,"about_ca_system_score_codex":0.003175992,"about_ca_system_score_gemma":0.002334661,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W3131891501","doi":"10.1158/1538-7445.sabcs20-ps13-20","title":"Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"","keywords":"Neratinib; Medicine; Loperamide; Tolerability; Diarrhea; Internal medicine; Breast cancer; Oncology; Trastuzumab; Metastatic breast cancer; Gastroenterology; Cancer; Adverse effect","score_opus":0.039339813526386457,"score_gpt":0.36887368654988506,"score_spread":0.3295338730234986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131891501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391265,0.0017163754,0.000014970211,0.012135237,0.00022392784,0.00086249574,0.00016462874,0.000050913583,0.000918825],"genre_scores_gemma":[0.9955925,0.00083423615,0.0000221037,0.00033073753,0.0003143494,0.00026133112,0.00004662224,0.00003965309,0.0025584626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712324,0.00025799152,0.00044235773,0.0006900179,0.00072058407,0.00076581916],"domain_scores_gemma":[0.99847686,0.00035533082,0.00010578111,0.0002975226,0.00051206007,0.0002524508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001186418,0.0002325657,0.0005204935,0.00026203142,0.00021941877,0.00019746833,0.0001145192,0.00012784003,0.0006844634],"category_scores_gemma":[0.00022872053,0.00021941146,0.000095851174,0.0008866959,0.00022603825,0.00029553127,0.00012951093,0.0007959406,0.0000053521803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009715467,0.00024329963,0.917877,0.00037992495,0.00033235023,0.00021487061,0.0011788418,0.0003467614,0.055409063,0.00013375128,0.0008771401,0.022035414],"study_design_scores_gemma":[0.0034942692,0.000074250966,0.98947877,0.0004547755,0.000048167145,0.000004566296,0.00045844598,0.00065904745,0.004887068,0.00007002249,0.00017513156,0.00019548656],"about_ca_topic_score_codex":0.01106102,"about_ca_topic_score_gemma":0.0073467297,"teacher_disagreement_score":0.07160173,"about_ca_system_score_codex":0.0010478955,"about_ca_system_score_gemma":0.00066452863,"threshold_uncertainty_score":0.9955244},"labels":[],"label_agreement":null},{"id":"W3131900383","doi":"10.1158/1538-7445.sabcs20-gs1-02","title":"Abstract GS1-02: Phase III study of palbociclib combined with endocrine therapy (ET) in patients with hormone-receptor-positive (HR+), HER2-negative primary breast cancerand with high relapse risk after neoadjuvant chemotherapy (NACT): First results from PENELOPE-B","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Palbociclib; Medicine; Oncology; Breast cancer; Internal medicine; Clinical endpoint; Neoadjuvant therapy; Taxane; Chemotherapy; Cancer; Metastatic breast cancer; Randomized controlled trial","score_opus":0.015045762838866125,"score_gpt":0.31623281666239944,"score_spread":0.30118705382353333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131900383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000394,0.0015609883,0.00001911539,0.0014020725,0.00006208503,0.0041404804,0.0025681783,0.000055135213,0.00018802892],"genre_scores_gemma":[0.99402964,0.0025272742,0.0005992558,0.00027339344,0.000155906,0.0013548255,0.0005779062,0.00020450604,0.00027729786],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9941835,0.00048619072,0.00082784216,0.0014349318,0.0020657743,0.0010018],"domain_scores_gemma":[0.99522465,0.0007285168,0.0005099519,0.001138299,0.002015557,0.00038301825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052922574,0.00069029606,0.0013779812,0.0003259988,0.00024043133,0.000075157535,0.0003370526,0.00012858259,0.00059070665],"category_scores_gemma":[0.000048800728,0.00046998562,0.000083226325,0.0014535569,0.00069282425,0.00050202274,0.00011317129,0.0015189671,0.000005910802],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7647334,0.009692059,0.16939853,0.0000912739,0.0021325422,0.0007701449,0.020020543,0.00036520997,0.0026577634,0.00000276867,0.00015736243,0.029978449],"study_design_scores_gemma":[0.21673515,0.01255266,0.749694,0.0014396504,0.000080924896,0.0000122103265,0.0029368412,0.000003889113,0.015746271,0.000022260734,0.0002925967,0.00048354108],"about_ca_topic_score_codex":0.03289821,"about_ca_topic_score_gemma":0.022994325,"teacher_disagreement_score":0.58029544,"about_ca_system_score_codex":0.0014286423,"about_ca_system_score_gemma":0.0017031926,"threshold_uncertainty_score":0.9997752},"labels":[],"label_agreement":null},{"id":"W3131964219","doi":"10.1158/1538-7445.sabcs20-ps17-31","title":"Abstract PS17-31: Investigating the estrogen receptor Y537S mutation in transgenic models of luminal B breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Estrogen receptor; Mutant; Cancer; Cancer research; Estrogen receptor alpha; Context (archaeology); Biology; Metastatic breast cancer; Fulvestrant; Mutation; Progesterone receptor; Estrogen; Internal medicine; Endocrinology; Medicine; Genetics; Gene","score_opus":0.11769280712546626,"score_gpt":0.42336265375022286,"score_spread":0.3056698466247566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131964219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821659,0.008572586,0.00007829614,0.007918033,0.0001377659,0.000536442,0.00015223591,0.000023721943,0.00041504673],"genre_scores_gemma":[0.9970515,0.00084795564,0.00052716536,0.00018873128,0.00044888526,0.00049304747,0.00002663933,0.00004826084,0.00036784785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975368,0.00016137697,0.00042389904,0.00042151933,0.0008858657,0.0005705446],"domain_scores_gemma":[0.9983403,0.00020776727,0.0001021783,0.00040874246,0.000770886,0.00017011934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007361798,0.00016790043,0.00033594773,0.00016727355,0.00012776018,0.000024804249,0.0002254532,0.00010148078,0.0008841359],"category_scores_gemma":[0.00008711487,0.00013394994,0.00010072414,0.0011197657,0.0005091844,0.00023599023,0.000053589163,0.00081238005,0.00000942326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093590305,0.00018076351,0.013381183,0.0007556959,0.00022194392,0.00006519393,0.006088673,0.009245171,0.8226677,0.0005789037,0.00043744288,0.14544141],"study_design_scores_gemma":[0.007465633,0.0002452371,0.18521677,0.0046876045,0.00013220163,0.00028066672,0.011522333,0.0027803862,0.7763286,0.007512519,0.0031908895,0.0006371086],"about_ca_topic_score_codex":0.0029142934,"about_ca_topic_score_gemma":0.0010951507,"teacher_disagreement_score":0.17183559,"about_ca_system_score_codex":0.0007161427,"about_ca_system_score_gemma":0.0024818073,"threshold_uncertainty_score":0.9680668},"labels":[],"label_agreement":null},{"id":"W3131992475","doi":"10.1158/1538-7445.sabcs20-pd12-04","title":"Abstract PD12-04: Long-term risks of cerebrovascular accidents (CVAs) in patients with breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Interquartile range; Internal medicine; Stage (stratigraphy); Radiation therapy; Hormonal therapy; Population; Cancer; Oncology; Cancer registry; Heart failure; Coronary artery disease; Adjuvant therapy","score_opus":0.08238123266807812,"score_gpt":0.41363778017281044,"score_spread":0.3312565475047323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131992475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977228,0.0007174382,0.0000065933073,0.00039024086,0.000082132785,0.0005771516,0.000066439214,0.000012771437,0.00042440378],"genre_scores_gemma":[0.9983643,0.0008921742,0.000017137963,0.000098783836,0.00017254826,0.000116458345,0.000062420375,0.00003630705,0.00023983156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977209,0.000092271126,0.0002530303,0.00038675236,0.00112876,0.00041826145],"domain_scores_gemma":[0.99834675,0.00004737509,0.00006567941,0.00045310726,0.0009269865,0.00016013163],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039134236,0.00013539162,0.00035186662,0.00019589193,0.00005955846,0.000026552116,0.00013377483,0.00013440859,0.0014953183],"category_scores_gemma":[0.00004596375,0.000117169526,0.000106222484,0.00069943565,0.00012608436,0.00014559731,0.000060608687,0.00057113793,0.0000119378965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048796335,0.0002997112,0.9190769,0.00035862412,0.00023357212,0.00004149036,0.00023058592,0.0000356367,0.053807613,0.0000038168087,0.0001771549,0.02524694],"study_design_scores_gemma":[0.0036354626,0.000058124537,0.7699727,0.0008749454,0.000026885378,0.00000646427,0.000054064447,0.0000015200103,0.22522514,0.000009037564,0.00004599346,0.00008971177],"about_ca_topic_score_codex":0.0026449827,"about_ca_topic_score_gemma":0.0019149786,"teacher_disagreement_score":0.17141752,"about_ca_system_score_codex":0.00056613126,"about_ca_system_score_gemma":0.0008314157,"threshold_uncertainty_score":0.9994174},"labels":[],"label_agreement":null},{"id":"W3132215221","doi":"10.1158/1538-7445.sabcs20-ps6-07","title":"Abstract PS6-07: Comparison of breast cancer staging models in patients after neoadjuvant chemotherapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Lymph node; Oncology; Internal medicine; TNM staging system; Neoadjuvant therapy; Cancer staging; Anthracycline; Chemotherapy; Receiver operating characteristic; AJCC staging system; Surgery; Staging system","score_opus":0.04524926419537834,"score_gpt":0.3920567981011136,"score_spread":0.34680753390573527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132215221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109864,0.007061689,0.000015105685,0.00081153883,0.00011217113,0.00020511624,0.00033275405,0.000005190309,0.0003577907],"genre_scores_gemma":[0.9970992,0.0020637934,0.000053140724,0.000111255256,0.00014363872,0.0002997101,0.000055335873,0.000033683387,0.00014019525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982985,0.00007465426,0.00027062246,0.0004628501,0.00042613107,0.0004672017],"domain_scores_gemma":[0.9989353,0.000019962521,0.00006413576,0.0003566538,0.00054506346,0.00007891517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632629,0.00016225153,0.0002793602,0.000081044214,0.000061849736,0.000020079713,0.00017407155,0.00009903645,0.00031798455],"category_scores_gemma":[0.000012458565,0.00015368742,0.00007086055,0.00025030394,0.00014911135,0.000010814725,0.00017922693,0.00021461745,0.0000049648124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012940055,0.00063092756,0.9220281,0.00012900958,0.000199523,0.000009811755,0.0009706897,0.0010894806,0.037355393,0.000011480816,0.0019029946,0.03437855],"study_design_scores_gemma":[0.0020708602,0.000051515268,0.8927897,0.00019409572,0.000008811667,5.131275e-7,0.0003442957,0.000050537754,0.10342787,0.000067959554,0.0008203657,0.00017342994],"about_ca_topic_score_codex":0.0015386607,"about_ca_topic_score_gemma":0.0014665001,"teacher_disagreement_score":0.06607249,"about_ca_system_score_codex":0.00021085411,"about_ca_system_score_gemma":0.00038564194,"threshold_uncertainty_score":0.6267191},"labels":[],"label_agreement":null},{"id":"W3132303491","doi":"10.1158/1538-7445.sabcs20-ps6-02","title":"Abstract PS6-02: Spatially defined immune-related proteins and outcome in triple negative breast cancer in the FinXX trial and Mayo Clinic cohort","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Oncology; Cohort; Tumor-infiltrating lymphocytes; Immune system; Internal medicine; CD8; Proportional hazards model; Cancer; Immunology","score_opus":0.08142677421550706,"score_gpt":0.4232534601446759,"score_spread":0.34182668592916887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132303491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630614,0.008794278,5.297099e-7,0.010854606,0.00024236231,0.0028456082,0.000110867455,0.000012904715,0.0008327294],"genre_scores_gemma":[0.98931974,0.0077466373,0.00001968848,0.0002834346,0.00015041606,0.0010555387,0.00001764593,0.000027757125,0.0013791415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723023,0.00043498963,0.0007128132,0.0004942596,0.0006141512,0.00051353435],"domain_scores_gemma":[0.9987339,0.00047965793,0.000107740874,0.00036779567,0.00021466598,0.00009625012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002889921,0.00018690541,0.00049952755,0.00023451951,0.00013620623,0.00008141197,0.00016380603,0.00019261034,0.0018669016],"category_scores_gemma":[0.00036474154,0.00013338708,0.00009208896,0.0010128147,0.00040932492,0.000103757084,0.00008753688,0.0010787273,0.0000070913275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16785419,0.00088826584,0.6552087,0.00063454383,0.00058590283,0.0007546695,0.0048124488,0.000007903724,0.051792122,0.000061814004,0.0011356691,0.11626377],"study_design_scores_gemma":[0.049835134,0.0003332607,0.9461822,0.00044182778,0.000031965752,0.00004122418,0.00064082054,0.000028093746,0.0016202789,0.0001125502,0.0005733465,0.0001593014],"about_ca_topic_score_codex":0.026076376,"about_ca_topic_score_gemma":0.016446033,"teacher_disagreement_score":0.29097348,"about_ca_system_score_codex":0.00040516554,"about_ca_system_score_gemma":0.0013694736,"threshold_uncertainty_score":0.99904555},"labels":[],"label_agreement":null},{"id":"W3132319387","doi":"10.1158/1538-7445.sabcs20-ps11-11","title":"Abstract PS11-11: Targeted safety events from a phase I/Ib study evaluating GDC-0077 alone and in combination with endocrine therapy (ET) ± palbociclib (palbo) in patients (pts) with <i>PIK3CA</i>-mutant (mut), hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2- mBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Rash; Neutropenia; Internal medicine; Fulvestrant; Adverse effect; Dysgeusia; Gastroenterology; Letrozole; Maculopapular rash; Surgery; Breast cancer; Toxicity; Cancer; Estrogen receptor; Tamoxifen","score_opus":0.049800809997383504,"score_gpt":0.4119863499116258,"score_spread":0.3621855399142423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132319387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873985,0.003437529,0.00005826656,0.0020950146,0.0000789691,0.0044245576,0.0010714887,0.000051007988,0.000043338165],"genre_scores_gemma":[0.9939315,0.0021914297,0.00093517045,0.00024623054,0.000096050026,0.0018718175,0.00047168488,0.00016261278,0.00009351007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929256,0.0013846763,0.000871784,0.0013786368,0.0023188079,0.0011205159],"domain_scores_gemma":[0.9961203,0.00076461607,0.00036389023,0.00061450835,0.0017724638,0.0003642268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014355885,0.0006205143,0.0011513152,0.00048732597,0.00025849888,0.00008621193,0.0002582633,0.00009681586,0.00090113876],"category_scores_gemma":[0.00019750658,0.0004924481,0.00006604809,0.0021674142,0.0003804192,0.00063665013,0.00015715354,0.0013153057,0.0000065412914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09088978,0.015120414,0.61922747,0.0002234868,0.0017583285,0.00079508644,0.017470434,0.0006240062,0.11176803,0.000010872175,0.00005532421,0.14205675],"study_design_scores_gemma":[0.09851531,0.0047763376,0.86904514,0.0017891444,0.00010794152,0.00002391682,0.005301229,0.0001425742,0.019506909,0.00015595062,0.000095050265,0.0005405289],"about_ca_topic_score_codex":0.022150131,"about_ca_topic_score_gemma":0.021460382,"teacher_disagreement_score":0.24981762,"about_ca_system_score_codex":0.0021393115,"about_ca_system_score_gemma":0.0015417585,"threshold_uncertainty_score":0.9997527},"labels":[],"label_agreement":null},{"id":"W3132362195","doi":"10.1158/1538-7445.sabcs20-ps10-14","title":"Abstract PS10-14: Efficacy and safety of palbociclib (PAL) in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with preexisting conditions: A post hoc analysis of PALOMA-2","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Adverse effect; Breast cancer; Cancer; Placebo; Palbociclib; Estrogen receptor; Oncology; Gastroenterology; Metastatic breast cancer; Toxicity; Pathology","score_opus":0.027895225363218656,"score_gpt":0.36227043587781,"score_spread":0.33437521051459135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132362195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914299,0.0012512116,0.000023080867,0.00057180825,0.000033819924,0.0013944011,0.0050669326,0.00003125573,0.00019758566],"genre_scores_gemma":[0.99701303,0.0006311422,0.0010563714,0.00006231019,0.00007608276,0.00039386598,0.0005816899,0.000088453824,0.000097031705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995852,0.0003721536,0.0007933709,0.00094883144,0.0012407601,0.0007928831],"domain_scores_gemma":[0.99402165,0.0008106961,0.00052558584,0.000518918,0.003783561,0.00033961347],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037418114,0.00042433437,0.0012223161,0.00068300305,0.00025041692,0.00002985165,0.00022169658,0.00015531995,0.0016537266],"category_scores_gemma":[0.000275563,0.00034873202,0.00013668314,0.002823471,0.0011928923,0.00040567943,0.00012826279,0.00077719026,0.0000025612412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03658844,0.0012971393,0.8148007,0.000948887,0.0054057976,0.00007001428,0.0065750014,0.00074113585,0.09243541,0.0002280648,0.000027939663,0.04088148],"study_design_scores_gemma":[0.012249249,0.0015742182,0.93539953,0.002540017,0.00035216054,0.000008975106,0.0021460736,0.000010442819,0.04529103,0.00002813831,0.000042588315,0.00035754777],"about_ca_topic_score_codex":0.0030851348,"about_ca_topic_score_gemma":0.002746425,"teacher_disagreement_score":0.120598875,"about_ca_system_score_codex":0.0010251001,"about_ca_system_score_gemma":0.0010688399,"threshold_uncertainty_score":0.99989647},"labels":[],"label_agreement":null},{"id":"W3132423864","doi":"10.1158/1538-7445.sabcs20-ps14-13","title":"Abstract PS14-13: National comprehensive cancer network (NCCN) recommendations for drugs without US food and drug administration (FDA) approval in metastatic breast cancer: A cross-sectional study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Cancer; Breast cancer; Confidence interval; Odds ratio; Oncology; Food and drug administration; Drug; Gynecology; Pharmacology","score_opus":0.13906231479616854,"score_gpt":0.48505789769048585,"score_spread":0.3459955828943173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132423864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98257256,0.0047086137,0.000113938506,0.007871807,0.0005168333,0.0024436354,0.0015863522,0.000048821836,0.00013741611],"genre_scores_gemma":[0.9899178,0.00065313425,0.0010575978,0.00045023265,0.0011653799,0.005726731,0.0002397747,0.00007316643,0.0007161621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962,0.0002473952,0.000640932,0.00090772886,0.0012526475,0.0007512847],"domain_scores_gemma":[0.99596983,0.000620952,0.00018618163,0.00029278192,0.0026739356,0.000256314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010573813,0.00029813166,0.00052296073,0.00027212786,0.0005268069,0.00018393745,0.0001671538,0.000091010304,0.00072064955],"category_scores_gemma":[0.00010586787,0.00030107604,0.0001018886,0.0009566137,0.00034007008,0.00038417755,0.00010959247,0.00080129923,0.0000039950287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066428874,0.0014323053,0.9411146,0.0008125891,0.0012902032,0.00004309551,0.002842224,0.006298299,0.003220056,0.0005065182,0.0025667155,0.033230484],"study_design_scores_gemma":[0.008840928,0.00036684744,0.9747452,0.00043680766,0.00007427949,0.00011163536,0.0028904183,0.0005217389,0.0010336973,0.0014319702,0.009181521,0.00036493587],"about_ca_topic_score_codex":0.002158523,"about_ca_topic_score_gemma":0.015414804,"teacher_disagreement_score":0.033630595,"about_ca_system_score_codex":0.0014993764,"about_ca_system_score_gemma":0.0040478697,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W3132544023","doi":"10.1158/1538-7445.sabcs20-ps1-61","title":"Abstract PS1-61: Clinical and patient reported outcomes in oncoplastic breast conservation surgery from a single surgeon's practice in a busy community hospital in Canada","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oncoplastic Surgery; Breast surgery; Mastectomy; Breast cancer; Breast-conserving surgery; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.11527046777547945,"score_gpt":0.3950542488178506,"score_spread":0.27978378104237117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132544023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257624,0.00034880804,4.0452883e-7,0.006129103,0.0005101388,0.00028017547,0.00006979698,0.000007200284,0.00007810237],"genre_scores_gemma":[0.99948335,0.0001454056,0.000039656985,0.00013311746,0.000045088844,0.000039814528,0.000087316585,0.000012345533,0.0000139039985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734676,0.0008263754,0.0007501843,0.00027089464,0.0004588008,0.0003470078],"domain_scores_gemma":[0.9928088,0.0062694754,0.00015366868,0.0002522428,0.00035997943,0.0001558369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001575084,0.00010937514,0.00047414494,0.00022399415,0.0000744198,0.000037821974,0.00004457965,0.00012162683,0.00006867207],"category_scores_gemma":[0.002755104,0.00010239636,0.00003609745,0.00057119457,0.0001828175,0.00016660763,0.00007190361,0.0013889677,0.0000011670352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051209866,0.000503645,0.8969823,0.000049791015,0.000039177816,0.001817079,0.00037435858,0.0000027198926,0.00012642126,0.000001022713,0.0004513648,0.09913999],"study_design_scores_gemma":[0.0013465587,0.000041831674,0.9903266,0.0006336677,0.000010575436,0.0017496344,0.005425419,0.000035748722,0.00012635956,0.000030290306,0.00017223656,0.000101117206],"about_ca_topic_score_codex":0.9737634,"about_ca_topic_score_gemma":0.9840834,"teacher_disagreement_score":0.09903887,"about_ca_system_score_codex":0.0009182086,"about_ca_system_score_gemma":0.0076182066,"threshold_uncertainty_score":0.99800766},"labels":[],"label_agreement":null},{"id":"W3132547876","doi":"10.1158/1538-7445.sabcs20-ps12-28","title":"Abstract PS12-28: Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab, and a taxane as first-line therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Taxane; Medicine; Triple-negative breast cancer; Internal medicine; Oncology; Metastatic breast cancer; Phases of clinical research; Chemotherapy; Population; Breast cancer; Cancer; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Immunotherapy; Pembrolizumab","score_opus":0.159363250679661,"score_gpt":0.5174108302588322,"score_spread":0.35804757957917116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132547876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764498,0.0115808295,0.00052564114,0.0036390685,0.00020745523,0.0058523226,0.0016436052,0.000054850294,0.00004641594],"genre_scores_gemma":[0.98910093,0.0038895553,0.00087956066,0.0002539302,0.00022699115,0.0047607035,0.00017271945,0.000119172844,0.0005964499],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99524,0.00038824938,0.0009063256,0.0010059273,0.0015679516,0.0008915842],"domain_scores_gemma":[0.99406344,0.0010937095,0.00043039152,0.0006797753,0.0033744413,0.00035822528],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017300153,0.00043470325,0.00103311,0.00039564192,0.0004011291,0.00006571679,0.00026476115,0.000104926796,0.0009832811],"category_scores_gemma":[0.0010621098,0.00038608807,0.0001602789,0.0013083717,0.00040541674,0.00038781465,0.00012537019,0.0006734577,0.000006141269],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05358638,0.008349481,0.002499994,0.0014484775,0.0012532958,0.00025249805,0.0064433264,0.000562357,0.08296684,0.00007003617,0.00033930325,0.842228],"study_design_scores_gemma":[0.53088355,0.042820748,0.10277728,0.0074001327,0.0007913897,0.0004627479,0.032468308,0.00761193,0.2604142,0.008157253,0.004159576,0.0020528582],"about_ca_topic_score_codex":0.0017758633,"about_ca_topic_score_gemma":0.0012216102,"teacher_disagreement_score":0.84017515,"about_ca_system_score_codex":0.00078069326,"about_ca_system_score_gemma":0.0023348394,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W3132562669","doi":"10.1158/0008-5472.can-20-2642","title":"Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced <i>N</i>-glycosylation Abundance and Branching","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Breast Cancer Research Foundation","keywords":"Fluvastatin; Breast cancer; Cancer research; Golgi apparatus; Glycosylation; Metastasis; Cancer; Biology; Medicine; Endoplasmic reticulum; Internal medicine; Cell biology; Biochemistry","score_opus":0.02940166865155256,"score_gpt":0.34073408175165104,"score_spread":0.31133241310009846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132562669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96404195,0.029993432,0.0005459026,0.0016299771,0.002556661,0.00030622887,0.0003956082,0.000020866499,0.00050938054],"genre_scores_gemma":[0.9717085,0.017631846,0.00017835545,0.00032572958,0.008289635,0.00031505327,0.0001616282,0.000052687905,0.0013366101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997746,0.00029836394,0.00025215425,0.00070619537,0.00046591548,0.00053139025],"domain_scores_gemma":[0.9986761,0.000027094728,0.00007419646,0.00039142085,0.0006376305,0.00019355754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068294606,0.00019108495,0.00024112906,0.000100965066,0.00031485077,0.000102764,0.00012564943,0.00015231743,0.00022555316],"category_scores_gemma":[0.00007313391,0.00019449377,0.000092459086,0.00040360438,0.00018801348,0.000027203972,0.00019544663,0.00032327868,0.0000071837007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018543054,0.0000344219,0.00036884384,0.00008365743,0.00006705595,0.0000011852435,0.00013508715,0.000078884164,0.90658396,0.00008744842,0.004777902,0.08759612],"study_design_scores_gemma":[0.0010219889,0.000043291504,0.007173602,0.00011274671,0.000029237244,0.000057247566,0.00007805001,0.00006869687,0.713759,0.00026938753,0.2771098,0.00027691724],"about_ca_topic_score_codex":0.001111576,"about_ca_topic_score_gemma":0.0022564356,"teacher_disagreement_score":0.2723319,"about_ca_system_score_codex":0.00011067401,"about_ca_system_score_gemma":0.0006842158,"threshold_uncertainty_score":0.7931226},"labels":[],"label_agreement":null},{"id":"W3132582124","doi":"10.1158/1538-7445.sabcs20-gs2-04","title":"Abstract GS2-04: A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (BIG 3-07/TROG 07.01)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Randomization; Hazard ratio; Clinical endpoint; Ductal carcinoma; Breast cancer; Breast-conserving surgery; Radiation therapy; Randomized controlled trial; Dose fractionation; Urology; Internal medicine; Oncology; Nuclear medicine; Mastectomy; Cancer; Confidence interval","score_opus":0.024002234046238972,"score_gpt":0.3533530926034828,"score_spread":0.32935085855724383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132582124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949616,0.0037345653,0.000006631669,0.0003259458,0.00008350765,0.0007223653,0.000074608775,0.0000023383923,0.00008840717],"genre_scores_gemma":[0.9980442,0.0014436599,0.000012715441,0.000006582581,0.00010472794,0.0003277126,0.000027729639,0.0000145782915,0.000018082586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839056,0.00039917245,0.00032816222,0.00033632744,0.00034317304,0.00020261442],"domain_scores_gemma":[0.99912447,0.0001602073,0.0001547294,0.00025978984,0.00026566716,0.00003512353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007045664,0.000119969736,0.00033078255,0.00012248573,0.00010265315,0.000014754945,0.0001112977,0.000079620026,0.000026182019],"category_scores_gemma":[0.00027439595,0.0000946812,0.000067277615,0.0003569669,0.00021511067,0.000011990673,0.00013762648,0.00020889436,8.8958234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04346966,0.0029875478,0.4820206,0.00018012698,0.00057935494,0.000025171556,0.0028841158,0.000609167,0.43002257,0.00003074137,0.000080309524,0.03711065],"study_design_scores_gemma":[0.090771236,0.000092519054,0.7319023,0.00006243271,0.00003770166,0.0000063598313,0.0021942356,0.000048991198,0.17473564,0.000052313837,0.000013129071,0.00008311277],"about_ca_topic_score_codex":0.00507301,"about_ca_topic_score_gemma":0.0063751135,"teacher_disagreement_score":0.25528693,"about_ca_system_score_codex":0.00011507703,"about_ca_system_score_gemma":0.00030574697,"threshold_uncertainty_score":0.76689076},"labels":[],"label_agreement":null},{"id":"W3132602666","doi":"10.1158/1538-7445.sabcs20-ps1-57","title":"Abstract PS1-57: Mastectomy versus breast conserving surgery for the management of locally advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Mastectomy; Radiation therapy; Neoadjuvant therapy; Inflammatory breast cancer; Retrospective cohort study; Cancer; Surgery; General surgery; Internal medicine","score_opus":0.06038524808092775,"score_gpt":0.38189475216859986,"score_spread":0.3215095040876721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132602666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93439245,0.04662665,0.0003676843,0.011705905,0.0014663695,0.0014132798,0.002339819,0.000032797296,0.0016550733],"genre_scores_gemma":[0.9874886,0.009942884,0.00016469359,0.00008848188,0.00035078597,0.0013544327,0.00006263286,0.000044356213,0.0005031058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816865,0.00006652998,0.00025676165,0.00052175066,0.00041044632,0.0005758895],"domain_scores_gemma":[0.99807334,0.0003027583,0.00009019504,0.0005736829,0.00087252015,0.00008750373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004135472,0.0001935521,0.00025391797,0.00005181884,0.00027176156,0.00003438088,0.00030804056,0.000083615465,0.0002861637],"category_scores_gemma":[0.000029639406,0.00015281496,0.00017547476,0.000333314,0.0002884528,0.000008663377,0.0003585081,0.00015231104,0.000004509326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018187327,0.0006231116,0.026179694,0.0031789516,0.0084275305,0.00013648985,0.00026546503,0.0015932911,0.20355076,0.00048690382,0.035407793,0.7019627],"study_design_scores_gemma":[0.011589878,0.00017455337,0.64244235,0.0020367906,0.00046524222,0.00011242717,0.005188165,0.00005594512,0.27077687,0.00012449923,0.0660656,0.00096770044],"about_ca_topic_score_codex":0.0006619156,"about_ca_topic_score_gemma":0.0012654158,"teacher_disagreement_score":0.70099497,"about_ca_system_score_codex":0.00016455851,"about_ca_system_score_gemma":0.0006202351,"threshold_uncertainty_score":0.6231613},"labels":[],"label_agreement":null},{"id":"W3132700492","doi":"10.1158/1538-7445.sabcs20-pd2-04","title":"Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Anastrozole; Oncology; Tamoxifen; Hazard ratio; Placebo; Randomized controlled trial; Progression-free survival; Goserelin; Breast cancer; Chemotherapy; Gynecology; Cancer; Confidence interval; Pathology","score_opus":0.04548641285416216,"score_gpt":0.3831915911177023,"score_spread":0.33770517826354013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132700492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97398114,0.0014520298,0.00001950444,0.003874824,0.00019844166,0.003986511,0.016093645,0.00012213484,0.00027179185],"genre_scores_gemma":[0.9897844,0.002641441,0.000436387,0.00027186956,0.0008125776,0.0010989856,0.0031795416,0.00024175775,0.0015330066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9926095,0.0010157417,0.0011089017,0.0015359103,0.0023911914,0.0013387327],"domain_scores_gemma":[0.99251616,0.0013403117,0.0007095658,0.001099228,0.003793888,0.00054082676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000545991,0.00083575514,0.0014437723,0.00020689059,0.00053057505,0.00011422022,0.0005767991,0.00019499093,0.0047983937],"category_scores_gemma":[0.00025504697,0.00049954845,0.00017359824,0.0013175082,0.0011415381,0.0007632026,0.00018073707,0.001515997,0.000011013807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71170163,0.0027997182,0.0035125378,0.00004508739,0.0020362015,0.00010669242,0.0024721643,0.000055223354,0.25789618,0.000028927565,0.0009541477,0.018391483],"study_design_scores_gemma":[0.39738294,0.00911347,0.35705268,0.00088949956,0.0001568099,0.00001590127,0.00091311405,0.000009779624,0.2308801,0.00003576185,0.0027712404,0.0007786866],"about_ca_topic_score_codex":0.01599763,"about_ca_topic_score_gemma":0.0017163034,"teacher_disagreement_score":0.35354015,"about_ca_system_score_codex":0.0012442063,"about_ca_system_score_gemma":0.0023304445,"threshold_uncertainty_score":0.9997456},"labels":[],"label_agreement":null},{"id":"W3132704529","doi":"10.1158/1538-7445.sabcs20-ps14-18","title":"Abstract PS14-18: A physician survey evaluating real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Denosumab; Medicine; Breast cancer; Family medicine; Internal medicine; Oncology; Cancer; Osteoporosis","score_opus":0.23245557062307864,"score_gpt":0.5178051184319206,"score_spread":0.2853495478088419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132704529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618065,0.0010785145,0.000004906968,0.00058447337,0.00004462989,0.0006305031,0.0012427354,0.000011005495,0.00022257229],"genre_scores_gemma":[0.997766,0.00092575816,0.00033022158,0.00019248379,0.00005752314,0.00017793303,0.00044474896,0.000034177996,0.00007115994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702513,0.0005663987,0.0003863212,0.0004531119,0.0010625067,0.0005065113],"domain_scores_gemma":[0.99775803,0.0004705657,0.00019484365,0.0002829698,0.0010514145,0.000242157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013968695,0.00016263511,0.00044429966,0.00020949467,0.000117787575,0.000039951403,0.00004891268,0.00005969311,0.0002707392],"category_scores_gemma":[0.00029174675,0.00013762398,0.000033464454,0.0006469553,0.00007728343,0.0002600966,0.00007518816,0.00042327348,0.0000024857095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002131389,0.00074803486,0.92675644,0.00042743227,0.00020049025,0.000083619234,0.0003619205,0.000029253353,0.0005231744,0.0000014075995,0.000100987614,0.06863582],"study_design_scores_gemma":[0.004364198,0.00016998933,0.992601,0.0014761337,0.00010642741,0.0000024103247,0.00013304275,0.00010696976,0.0009012196,0.000009188207,0.000024143304,0.00010527358],"about_ca_topic_score_codex":0.31178,"about_ca_topic_score_gemma":0.089773394,"teacher_disagreement_score":0.22200662,"about_ca_system_score_codex":0.0007236453,"about_ca_system_score_gemma":0.0014614079,"threshold_uncertainty_score":0.9268359},"labels":[],"label_agreement":null},{"id":"W3132797257","doi":"10.1158/1538-7445.sabcs20-ps8-02","title":"Abstract PS8-02: Influence of a breast cancer polygenic risk score on adherence to preventive endocrine therapy in high risk women at 1 and 2 year follow-up: The genetic risk estimate (GENRE) trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Breast cancer; Framingham Risk Score; Risk assessment; Single-nucleotide polymorphism; Absolute risk reduction; Family history; Genetic testing; Demography; Internal medicine; Gynecology; Confidence interval; Cancer; Genetics; Genotype; Disease","score_opus":0.031103990061292493,"score_gpt":0.37588652577167936,"score_spread":0.34478253571038686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132797257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243885,0.004968317,0.000006699625,0.00019987123,0.00019340627,0.000992402,0.0011603478,0.0000060475118,0.000034050434],"genre_scores_gemma":[0.9719102,0.025594683,0.00010205539,0.000058815633,0.00022775261,0.001483442,0.000013719811,0.000039248753,0.0005701239],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99735755,0.00051264744,0.00035559532,0.00071448163,0.000479186,0.0005805324],"domain_scores_gemma":[0.9983928,0.00015745928,0.00019136697,0.00070638774,0.00040027505,0.00015168384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075093616,0.00020856228,0.00025590602,0.000097190954,0.000215156,0.000045249875,0.00041709092,0.00011060091,0.00042377037],"category_scores_gemma":[0.00037957582,0.00016809814,0.000078571895,0.0005531349,0.00030364064,0.000009190049,0.00034608957,0.0004631297,0.000016771506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044644218,0.00032502768,0.36091134,0.00011401651,0.0007753689,0.00003370935,0.0034195038,0.02493882,0.42060372,0.000015986367,0.002116269,0.14210202],"study_design_scores_gemma":[0.0118253995,0.0010725934,0.8111989,0.0001254948,0.000026455215,0.0000066862494,0.00028428776,0.00002114465,0.17400712,0.00027690802,0.00091104745,0.00024399314],"about_ca_topic_score_codex":0.010284808,"about_ca_topic_score_gemma":0.009005586,"teacher_disagreement_score":0.45028755,"about_ca_system_score_codex":0.00049289514,"about_ca_system_score_gemma":0.0012311991,"threshold_uncertainty_score":0.99630576},"labels":[],"label_agreement":null},{"id":"W3133034676","doi":"10.1158/1538-7445.sabcs20-ps4-26","title":"Abstract PS4-26: Impact of TAILORx data on chemotherapy prescribing in British Columbia","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cohort; Internal medicine; Retrospective cohort study; Cancer; Oncology","score_opus":0.16549578978122634,"score_gpt":0.4498005009759668,"score_spread":0.28430471119474043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133034676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924209,0.0024734135,0.000001148198,0.00095236924,0.00008478086,0.00040595434,0.00031494605,0.000019595165,0.0033269078],"genre_scores_gemma":[0.99389815,0.0033774711,0.00006836351,0.0005108891,0.00024146355,0.000037358146,0.00015299431,0.000045015076,0.0016682972],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979939,0.00008937068,0.00029365992,0.0005154006,0.0006247341,0.00048296087],"domain_scores_gemma":[0.9984023,0.00015772856,0.000045646702,0.00094343105,0.00027836705,0.00017253481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007753955,0.00008342745,0.00034957528,0.00009341908,0.000066638575,0.00011157089,0.0003333769,0.00009555975,0.00887562],"category_scores_gemma":[0.00025126088,0.00011450692,0.00008675901,0.0005247328,0.00015898953,0.00017741222,0.00014794573,0.00069912954,0.000013198363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007875938,0.0005042526,0.26412156,0.00056023145,0.00024990042,0.0008572643,0.00037508883,0.00007357323,0.15892273,0.0000017693213,0.32764286,0.24590318],"study_design_scores_gemma":[0.004369494,0.00036324523,0.9649567,0.0010787968,0.000009929988,0.000027109998,0.0002678656,0.00021741052,0.009212184,0.00003735681,0.019295715,0.00016419268],"about_ca_topic_score_codex":0.10937484,"about_ca_topic_score_gemma":0.08380659,"teacher_disagreement_score":0.70083517,"about_ca_system_score_codex":0.00069151743,"about_ca_system_score_gemma":0.0021972146,"threshold_uncertainty_score":0.9920304},"labels":[],"label_agreement":null},{"id":"W3133096119","doi":"10.1158/1538-7445.sabcs20-ps7-47","title":"Abstract PS7-47: Real-world treatment patterns in older patients with stage I-III breast cancer: A population-based study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Interquartile range; Breast cancer; Cancer registry; Stage (stratigraphy); Internal medicine; Proportional hazards model; Radiation therapy; Cancer; Comorbidity; Population; Logistic regression; Hazard ratio; Confidence interval","score_opus":0.06104834497759498,"score_gpt":0.4074367634052676,"score_spread":0.3463884184276726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133096119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953348,0.00017316967,0.0000016497542,0.00096098054,0.00012150505,0.0018389231,0.0006599816,0.000033840985,0.0008751533],"genre_scores_gemma":[0.99462336,0.00026612997,0.000016100435,0.0002637355,0.00017816824,0.0009926573,0.0004443046,0.000056828965,0.00315871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970772,0.0001670948,0.00038416722,0.00069511717,0.0010198657,0.00065650675],"domain_scores_gemma":[0.9983936,0.00013603792,0.000079869285,0.0006072726,0.0004966592,0.00028653842],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027072933,0.00024824834,0.00048367167,0.00041134632,0.0001545971,0.000058003152,0.00012769423,0.00006411608,0.0069846264],"category_scores_gemma":[0.000012478564,0.00019416836,0.00007432756,0.0008487798,0.00004771179,0.0001386381,0.000045237943,0.0004650343,0.000012220542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017586562,0.0017516066,0.9750935,0.00019731591,0.00015083521,0.00036858814,0.0007313917,0.00037443574,0.00012364348,0.0000023875364,0.00023421267,0.019213414],"study_design_scores_gemma":[0.014245396,0.000438638,0.9827118,0.00040131444,0.00003937569,7.4620016e-7,0.0006763124,0.000065229986,0.0004626771,9.737489e-7,0.0007613892,0.00019615496],"about_ca_topic_score_codex":0.17829026,"about_ca_topic_score_gemma":0.29522866,"teacher_disagreement_score":0.11693841,"about_ca_system_score_codex":0.0037127165,"about_ca_system_score_gemma":0.0026105845,"threshold_uncertainty_score":0.9939231},"labels":[],"label_agreement":null},{"id":"W3133115881","doi":"10.1158/1538-7445.sabcs20-gs4-09","title":"Abstract GS4-09: Correlative studies of the breast cancer index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine benefit: A trans-aTTom study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Biomarker; Breast cancer; Medicine; Tamoxifen; Estrogen receptor; Internal medicine; Oncology; Tissue microarray; Cancer; Androgen receptor; Progesterone receptor; Immunohistochemistry; Proportional hazards model; Prostate cancer; Biology","score_opus":0.061793716062174646,"score_gpt":0.39552783726584323,"score_spread":0.3337341212036686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133115881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655137,0.030150138,0.00003133769,0.0012619975,0.00016975978,0.0010712275,0.0017345331,0.000005348812,0.00006192508],"genre_scores_gemma":[0.9898121,0.008572489,0.00002453746,0.000027263965,0.0001538633,0.000962515,0.00002654876,0.000023732136,0.00039696606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844533,0.00010148804,0.00030231322,0.0004915653,0.00035854417,0.0003007473],"domain_scores_gemma":[0.99836606,0.0001224441,0.00011973792,0.00030983533,0.0010187603,0.0000631351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024278647,0.0001920828,0.0003455245,0.000060036444,0.00023580484,0.000015929409,0.00012347258,0.00007240083,0.00002535271],"category_scores_gemma":[0.0000923195,0.00014066792,0.00007539076,0.00023140978,0.0005305393,0.000017043061,0.00021238948,0.00017750994,1.17830155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003837757,0.0013800532,0.61471957,0.0011374727,0.0051454213,0.000012175302,0.006833182,0.00029929169,0.31613287,0.00020891958,0.0019326092,0.04836069],"study_design_scores_gemma":[0.0034713454,0.0003527946,0.90813726,0.00020845266,0.0001546411,0.000015926289,0.004957274,0.00002565453,0.08184286,0.0001852001,0.00052249205,0.00012609168],"about_ca_topic_score_codex":0.0006418236,"about_ca_topic_score_gemma":0.0023534442,"teacher_disagreement_score":0.29341772,"about_ca_system_score_codex":0.00009279063,"about_ca_system_score_gemma":0.0003101032,"threshold_uncertainty_score":0.5736272},"labels":[],"label_agreement":null},{"id":"W3133383562","doi":"10.1158/1538-7445.sabcs20-ps10-37","title":"Abstract PS10-37: Real-world experience of patients treated for HER2-positive metastatic breast cancer at the centre hospitalier universitaire de Quebec: A retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Lapatinib; Metastatic breast cancer; Pertuzumab; Trastuzumab emtansine; Trastuzumab; Internal medicine; Breast cancer; Cancer; Retrospective cohort study; Oncology; Population; Cohort; Progression-free survival; Chemotherapy","score_opus":0.026404129970632552,"score_gpt":0.3778593476893832,"score_spread":0.3514552177187506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133383562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927371,0.0006311535,0.000008673063,0.0017193903,0.00010295003,0.002896848,0.0013644672,0.000031765467,0.0005076384],"genre_scores_gemma":[0.9854919,0.00034011566,0.000042751213,0.00007186116,0.00010400061,0.00083586253,0.00008963764,0.00006241186,0.01296149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692696,0.00024296157,0.00032409286,0.0007033623,0.001058636,0.0007439888],"domain_scores_gemma":[0.996078,0.00028073427,0.00017254936,0.00060435425,0.0026378252,0.00022651446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040229547,0.00026185127,0.0005682027,0.00013248208,0.00038965806,0.00003177487,0.00025553902,0.00005591661,0.001611021],"category_scores_gemma":[0.000092207396,0.00020059301,0.00015305827,0.00113447,0.0006080936,0.00020463901,0.00017611374,0.00038231752,0.0000052874952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027084725,0.00085911585,0.97422105,0.00011747789,0.0009369907,0.0001046181,0.009941854,0.000038624203,0.0034032655,0.00005718987,0.000983152,0.0066281958],"study_design_scores_gemma":[0.0031720977,0.00029270095,0.9625114,0.00032713116,0.00021506124,0.0000052330033,0.016183125,0.000011436331,0.016392734,0.000038905033,0.00066536345,0.00018479362],"about_ca_topic_score_codex":0.050465137,"about_ca_topic_score_gemma":0.08415988,"teacher_disagreement_score":0.03369474,"about_ca_system_score_codex":0.00604288,"about_ca_system_score_gemma":0.0012378267,"threshold_uncertainty_score":0.9993016},"labels":[],"label_agreement":null},{"id":"W3134068090","doi":"10.1158/1538-7445.tme21-po028","title":"Abstract PO028: Embryonic protein NODAL as a potential modulator of the tumour microenvironment: Breast cancer secretome reprogramming and fibroblast activation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; University of Alberta; Queen's University; Western University","funders":"","keywords":"Stromal cell; Tumor microenvironment; NODAL; Nodal signaling; Cancer research; Biology; Cancer-Associated Fibroblasts; Mesenchymal stem cell; Metastasis; Chemokine; Embryonic stem cell; Cell biology; Immunology; Cancer; Immune system","score_opus":0.02696345726068132,"score_gpt":0.33406281755805806,"score_spread":0.3070993602973767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134068090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076074,0.002009398,0.000014913994,0.0060598324,0.00006408667,0.00080811296,0.00011162474,0.000012547009,0.00015876537],"genre_scores_gemma":[0.9961501,0.00061929383,0.00013141044,0.000075459364,0.00031525988,0.00023997705,0.0000117916825,0.000038166094,0.0024185714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792045,0.0000964871,0.00024022421,0.00048852625,0.0007911609,0.00046317297],"domain_scores_gemma":[0.99897426,0.000026340762,0.00010982632,0.00044379392,0.00026121023,0.00018453784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037831767,0.00014830464,0.00026414584,0.00009290251,0.00019255806,0.000052271927,0.00012710897,0.00008720305,0.001216492],"category_scores_gemma":[0.00005437139,0.00011442523,0.00012157581,0.00046643644,0.00028345888,0.00010246092,0.00022095197,0.00052877696,0.000007398222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004392838,0.00010286492,0.001380862,0.0005280369,0.00009991648,0.000030293199,0.00018581764,0.00005553585,0.96899813,0.000029250736,0.00022534459,0.027924677],"study_design_scores_gemma":[0.0012834996,0.00007432654,0.12620124,0.001417762,0.000044338132,0.000099774945,0.0004884754,0.00003160543,0.8665899,0.00005848928,0.0035872557,0.00012330091],"about_ca_topic_score_codex":0.0033373758,"about_ca_topic_score_gemma":0.0001829063,"teacher_disagreement_score":0.12482038,"about_ca_system_score_codex":0.00042171645,"about_ca_system_score_gemma":0.0009834486,"threshold_uncertainty_score":0.99969655},"labels":[],"label_agreement":null},{"id":"W3134083417","doi":"10.1158/1538-7445.tme21-po006","title":"Abstract PO006: Heating up the fight against cancer using 3D bioprinting","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Tumor microenvironment; Immune system; Cancer-Associated Fibroblasts; Immunotherapy; Cancer research; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Cancer; Medicine; Biology; Immunology; Internal medicine","score_opus":0.2134307626132334,"score_gpt":0.4741941833476058,"score_spread":0.2607634207343724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134083417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657851,0.019003544,0.000031674226,0.005012736,0.00073741976,0.0004774316,0.000044904114,0.00003600004,0.008871202],"genre_scores_gemma":[0.9839115,0.006188535,0.00055796717,0.001762101,0.0018084645,0.0002607802,0.000016299593,0.000067134446,0.0054271775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974896,0.00011255205,0.00030450424,0.00047150487,0.00085343217,0.00076845236],"domain_scores_gemma":[0.9982714,0.00019423758,0.000070704875,0.0005335577,0.00071778113,0.00021232304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010381772,0.00015909618,0.00029725334,0.00012358213,0.0005327033,0.0001266699,0.00018378184,0.000083298044,0.003192595],"category_scores_gemma":[0.00023838678,0.00011475922,0.00013573056,0.0009417927,0.00016338845,0.000085199186,0.00021647722,0.0009057973,0.000034449142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011189417,0.00006675564,0.007524538,0.0005011274,0.00019777099,0.00020868279,0.000805799,0.000553769,0.72087103,0.00005568669,0.0070789657,0.262024],"study_design_scores_gemma":[0.0016120953,0.00003862384,0.007971715,0.0018534188,0.00011072304,0.000045867608,0.0023315684,0.00088821416,0.57338727,0.000040637256,0.41140005,0.00031984498],"about_ca_topic_score_codex":0.0064659463,"about_ca_topic_score_gemma":0.00091980986,"teacher_disagreement_score":0.40432107,"about_ca_system_score_codex":0.0006640752,"about_ca_system_score_gemma":0.0019137835,"threshold_uncertainty_score":0.99771863},"labels":[],"label_agreement":null},{"id":"W3135029913","doi":"10.1158/1538-7445.tme21-ia018","title":"Abstract IA018: Linking obesity-associated inflammation with cancer metastasis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Metastasis; Lung cancer; Cancer; Population; Neutrophilia; Breast cancer; Internal medicine; Extravasation; Cancer research; Oncology; Immunology; Pathology","score_opus":0.0671288972967473,"score_gpt":0.35445828528104883,"score_spread":0.2873293879843015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135029913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914563,0.0053516636,0.00005852718,0.0013508716,0.00030218434,0.00026468793,0.000106454216,0.00006290708,0.0010464455],"genre_scores_gemma":[0.99361765,0.0014323385,0.00005240623,0.00012107456,0.00012422714,0.0002497442,0.00021345979,0.000033723816,0.0041553965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796915,0.0004758834,0.000232614,0.00046527333,0.00018795139,0.000669138],"domain_scores_gemma":[0.9984315,0.00020205992,0.000092309936,0.00031251344,0.00091348944,0.000048097965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007439955,0.00017703736,0.00029851295,0.00017830604,0.000508512,0.0000686176,0.00024482232,0.00020263725,0.0047211004],"category_scores_gemma":[0.00009921567,0.00014539756,0.0000661318,0.0007212697,0.0001954088,0.00018644883,0.0001462285,0.0008758761,0.00036402902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012327581,0.000080473794,0.0017495997,0.000052011237,0.00043580827,0.00008808367,0.0003903509,0.000043312903,0.98157656,0.0009374229,0.0009596123,0.013563512],"study_design_scores_gemma":[0.0010103374,0.00008578167,0.009471154,0.00029361786,0.000041583447,0.000007821918,0.00035658176,0.000001421134,0.9699219,0.00034840035,0.018272867,0.00018854193],"about_ca_topic_score_codex":0.00090305554,"about_ca_topic_score_gemma":0.0023673903,"teacher_disagreement_score":0.017313255,"about_ca_system_score_codex":0.0003327348,"about_ca_system_score_gemma":0.0007007759,"threshold_uncertainty_score":0.9961887},"labels":[],"label_agreement":null},{"id":"W3135048636","doi":"10.1158/1538-7445.tme21-lt021","title":"Abstract LT021: Targeting AXL favors an anti-tumorigenic tumor microenvironment that enhances immunotherapy responses by decreasing HIF-1a levels in cancer cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Tumor microenvironment; Cancer research; Metastasis; Immunotherapy; Angiogenesis; Immune system; Metastatic breast cancer; Cancer; Breast cancer; Tumor hypoxia; Receptor tyrosine kinase; AXL receptor tyrosine kinase; Biology; Hypoxia (environmental); Medicine; Immunology; Internal medicine; Receptor; Chemistry; Radiation therapy; JAK-STAT signaling pathway","score_opus":0.07506359404709063,"score_gpt":0.37584883698319593,"score_spread":0.3007852429361053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135048636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8878931,0.11053198,0.000014825365,0.00041835837,0.0005270646,0.00034873257,0.00015597572,0.000028138102,0.00008185655],"genre_scores_gemma":[0.982585,0.014792776,0.00006226482,0.00012663248,0.000081180966,0.00018166236,0.000119497425,0.000056647288,0.0019943225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99629927,0.0011423202,0.00051018654,0.0007583231,0.00022437081,0.0010655499],"domain_scores_gemma":[0.998817,0.00032195868,0.00017569179,0.0004900242,0.00012952772,0.000065797445],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014710694,0.00029015308,0.00046978393,0.00023538004,0.0005488163,0.000109461704,0.0004436491,0.00019990225,0.0050760983],"category_scores_gemma":[0.00005899751,0.00027844188,0.000117710886,0.0004428921,0.00043324364,0.00037455728,0.00014234534,0.0007954772,0.00010828013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042633305,0.0002611664,0.0067098136,0.0000402067,0.00010564091,0.00002751436,0.00077861355,0.000045778666,0.97815126,0.000008220732,0.001190409,0.012255032],"study_design_scores_gemma":[0.0010250557,0.00008407346,0.11119117,0.00021114468,0.000007891204,0.000010651345,0.00096175965,0.0000046522778,0.864181,0.000037486338,0.022015058,0.00027005188],"about_ca_topic_score_codex":0.0038692735,"about_ca_topic_score_gemma":0.00044333615,"teacher_disagreement_score":0.113970265,"about_ca_system_score_codex":0.0007689932,"about_ca_system_score_gemma":0.0006712429,"threshold_uncertainty_score":0.9999668},"labels":[],"label_agreement":null},{"id":"W3135230498","doi":"10.1158/1538-7445.tme21-lt015","title":"Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer <i>via</i> targeting lysyl oxidase (LOX)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial metabolism and enzyme function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Lysyl oxidase; Cancer research; Doxorubicin; Triple-negative breast cancer; Kinome; Biology; Breast cancer; Chemistry; Cancer; Medicine; Chemotherapy; Kinase; Extracellular matrix; Cell biology; Internal medicine","score_opus":0.022564782379979557,"score_gpt":0.3277638275673069,"score_spread":0.3051990451873273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135230498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280364,0.013424376,0.00008849537,0.0018153522,0.00041367268,0.00025823314,0.00025475727,0.00001200234,0.00092946895],"genre_scores_gemma":[0.9860419,0.0070792367,0.00032607198,0.00058853684,0.0011358341,0.00017342424,0.00007749232,0.00004955721,0.004527918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808836,0.00018091661,0.0002655068,0.0005873332,0.00029743003,0.00058047083],"domain_scores_gemma":[0.99903077,0.000037224592,0.000067899564,0.00033092758,0.000416456,0.00011669462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006747911,0.0001679442,0.00021495728,0.0000850669,0.00016945708,0.000049450155,0.00020346798,0.00016527585,0.00068086956],"category_scores_gemma":[0.0001596833,0.0001714074,0.0000815538,0.0005327689,0.00010861011,0.000017578182,0.000112105074,0.00039351653,0.000012902745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057067873,0.00006631418,0.0009472508,0.00007289495,0.000032655775,0.000016980728,0.00016561736,0.000045730758,0.9492061,0.00001641635,0.044871226,0.003988129],"study_design_scores_gemma":[0.0014482896,0.000015172284,0.012450259,0.00012420399,0.0000049650807,0.0000037823215,0.00017558722,0.0000074481777,0.8847301,0.00011290577,0.10070881,0.00021844925],"about_ca_topic_score_codex":0.001976338,"about_ca_topic_score_gemma":0.004947476,"teacher_disagreement_score":0.064475976,"about_ca_system_score_codex":0.00015154875,"about_ca_system_score_gemma":0.00050149835,"threshold_uncertainty_score":0.74550444},"labels":[],"label_agreement":null},{"id":"W3135366498","doi":"","title":"Functional requirement for RGD and PKD domains of GPNMB in breast cancer metastasis","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Metastasis; Medicine; Ectopic expression; Cancer research; Cancer; CA15-3; Melanoma; CA 15-3; Metastatic breast cancer; Oncology; Cancer cell; Lung cancer; Internal medicine; Biology; Cell culture","score_opus":0.18850154997160457,"score_gpt":0.44254127189447473,"score_spread":0.25403972192287017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135366498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903006,0.0009289697,0.00012357872,0.008841185,0.000019019346,0.00031826622,0.00028005926,0.000008014685,0.00045087282],"genre_scores_gemma":[0.9958918,0.0013505287,0.00012947431,0.00024207153,0.00016722463,0.00036034462,0.000025566593,0.000011266429,0.0018217036],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987479,0.000052861553,0.00020650821,0.00022240091,0.0005075082,0.00026282662],"domain_scores_gemma":[0.99924546,0.000073124334,0.000033812008,0.00013724182,0.00038216516,0.00012818218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004965848,0.0000706785,0.0002250546,0.00033511277,0.00010183317,0.000005754008,0.000039353446,0.000039794377,0.0015845313],"category_scores_gemma":[0.000041155337,0.000059011294,0.00007416128,0.0004823949,0.00024204799,0.000059811824,0.0000345229,0.00015501316,0.000004075471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043667015,0.0010068483,0.23473975,0.001321572,0.00084480003,0.00014173394,0.0013053085,0.00016536827,0.5886018,0.0019251968,0.13928981,0.0262911],"study_design_scores_gemma":[0.017348954,0.00061364565,0.7918099,0.0026988569,0.0002453127,0.00019957796,0.0016754753,0.0009644109,0.15347528,0.000793658,0.029690538,0.00048434254],"about_ca_topic_score_codex":0.0013584022,"about_ca_topic_score_gemma":0.00048479481,"teacher_disagreement_score":0.5570702,"about_ca_system_score_codex":0.00025623935,"about_ca_system_score_gemma":0.00039501663,"threshold_uncertainty_score":0.99932814},"labels":[],"label_agreement":null},{"id":"W3135432136","doi":"","title":"Enhanced liposomal retention of irinotecan is correlated to increases in plasma irinotecan AUC and improved efficacy against a model of colorectal cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Irinotecan; Liposome; Chemistry; Pharmacology; Colorectal cancer; Cancer; Biochemistry; Internal medicine; Medicine","score_opus":0.039394804187186355,"score_gpt":0.3324298527779297,"score_spread":0.29303504859074336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135432136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800813,0.00032655953,0.000054197135,0.00032884348,0.00007095911,0.0008621526,0.00024231679,0.0000346226,0.00007224277],"genre_scores_gemma":[0.998811,0.000192962,0.0004736684,0.00005446551,0.00005300476,0.00026585406,0.000004212785,0.00003084019,0.000113997055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973339,0.00021877914,0.0005681336,0.00056618644,0.0006479057,0.0006650878],"domain_scores_gemma":[0.9985443,0.00023305228,0.00015016261,0.00032462238,0.00050046836,0.0002473949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008619042,0.00018246565,0.00039506055,0.000415633,0.000091374735,0.000036762274,0.00035494572,0.00013582275,0.0002184878],"category_scores_gemma":[0.00028589476,0.00018116826,0.000053781547,0.00089617627,0.00038143873,0.00023780964,0.0002811388,0.0002977186,0.000017864577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020445317,0.0003377828,0.0006337987,0.000093220915,0.000013059357,0.0000025713396,0.00096715824,0.020236444,0.9644317,0.000019728335,0.000118572956,0.011101403],"study_design_scores_gemma":[0.0018472737,0.00042039022,0.0030396818,0.00029027543,0.000011681932,6.817523e-7,0.00009065518,0.08490977,0.9091962,0.00001299405,0.000012976104,0.0001674162],"about_ca_topic_score_codex":0.0077348948,"about_ca_topic_score_gemma":0.004496735,"teacher_disagreement_score":0.06467332,"about_ca_system_score_codex":0.0005430162,"about_ca_system_score_gemma":0.0007642465,"threshold_uncertainty_score":0.9988727},"labels":[],"label_agreement":null},{"id":"W3135598154","doi":"10.1158/1538-7445.tme21-po052","title":"Abstract PO052: Uncovering the evolution of Glioblastoma proteome landscape from primary to the recurrent stage for development of novel diagnostic and predictive biomarkers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Hospital for Sick Children; University of Calgary; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"Proteome; Glioblastoma; Biology; Phenotype; Gene expression profiling; Cancer research; Computational biology; Proteomics; Microarray; Bioinformatics; Gene; Oncology; Medicine; Gene expression; Genetics","score_opus":0.05675914001222882,"score_gpt":0.35904307818084447,"score_spread":0.30228393816861565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135598154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894657,0.005455787,0.0010456182,0.0016544606,0.00010579736,0.0016804956,0.0004563247,0.000005954211,0.00012987116],"genre_scores_gemma":[0.99743456,0.00033270838,0.0006812166,0.00003583433,0.00010844489,0.0013192223,0.00002206835,0.000015385212,0.00005058093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986033,0.00004641251,0.00026509375,0.00026744543,0.0005713152,0.0002464287],"domain_scores_gemma":[0.9984128,0.0006501008,0.00007552451,0.00024979893,0.00052611384,0.000085656495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075125333,0.00009178058,0.00020305303,0.00008270607,0.00013513828,0.000017567578,0.00013221792,0.000044798355,0.000072080824],"category_scores_gemma":[0.00054574775,0.00005538593,0.000048612215,0.00042705573,0.00011459405,0.00004112212,0.0001627877,0.0001809962,7.5994205e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01014755,0.0010516326,0.061781008,0.0035885118,0.0014809334,0.000009177486,0.011004133,0.00060895353,0.7557636,0.00010264072,0.0068804403,0.1475814],"study_design_scores_gemma":[0.001972064,0.00072863884,0.7221518,0.0017840223,0.00006868073,0.0000015993446,0.0038037137,0.0002585463,0.26081815,0.000025485697,0.008273371,0.00011388],"about_ca_topic_score_codex":0.0003632759,"about_ca_topic_score_gemma":0.00049763307,"teacher_disagreement_score":0.6603708,"about_ca_system_score_codex":0.0004196873,"about_ca_system_score_gemma":0.001257113,"threshold_uncertainty_score":0.22585727},"labels":[],"label_agreement":null},{"id":"W3135965150","doi":"","title":"Mouse models of insulin resistance and IGF-1 deficiency in colon carcinogenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hyperinsulinemia; Insulin resistance; Endocrinology; Internal medicine; Insulin; Knockout mouse; Colorectal cancer; Medicine; Cancer; Receptor","score_opus":0.0469602636538027,"score_gpt":0.3556939473467054,"score_spread":0.3087336836929027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135965150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585181,0.038666286,0.00019219212,0.00007023042,0.00032853958,0.00021987542,0.00003909731,0.0000035149346,0.0019622042],"genre_scores_gemma":[0.9879577,0.008985946,0.00013511037,0.000038778613,0.00092859456,0.00004871717,0.000007726566,0.00001763594,0.001879758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867594,0.00007716978,0.00022003615,0.00033876667,0.00027467115,0.00041339497],"domain_scores_gemma":[0.99932235,0.000031632626,0.000039424627,0.00028850092,0.00021927585,0.00009881572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010805969,0.00009097999,0.00016001418,0.0001575143,0.000059372665,0.00000996025,0.0001852935,0.000121672805,0.000012105199],"category_scores_gemma":[0.00008195626,0.0000915378,0.00003351234,0.0003202693,0.0002338044,0.0000056251592,0.00011796346,0.00014240807,8.131485e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075632805,0.000052246007,0.0029946684,0.0000945446,0.000007863271,4.143313e-7,0.00028213585,0.00013270634,0.9871247,0.0005470969,0.0033517005,0.004655589],"study_design_scores_gemma":[0.00154285,0.00016620025,0.020774147,0.00005662823,0.000008372076,0.000002088961,0.00045741475,0.000034943652,0.8388669,0.0005374613,0.13731015,0.00024286765],"about_ca_topic_score_codex":0.0011166385,"about_ca_topic_score_gemma":0.010099394,"teacher_disagreement_score":0.14825784,"about_ca_system_score_codex":0.00005953308,"about_ca_system_score_gemma":0.00030130416,"threshold_uncertainty_score":0.5635699},"labels":[],"label_agreement":null},{"id":"W3136856529","doi":"10.1158/1538-7445.sabcs20-pd3-03","title":"Abstract PD3-03: Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Neratinib; Medicine; Oncology; Breast cancer; Internal medicine; Trastuzumab; Hazard ratio; Placebo; Stage (stratigraphy); Cancer; Confidence interval; Pathology","score_opus":0.04989331607234977,"score_gpt":0.4014012699091703,"score_spread":0.35150795383682054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136856529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924301,0.0015167537,0.00007973093,0.0013234881,0.00017278192,0.0022139258,0.0020817027,0.00001904443,0.00016247317],"genre_scores_gemma":[0.9974646,0.00030780025,0.000115927534,0.00011683846,0.0005077472,0.00053703063,0.00037495245,0.000050359326,0.0005247752],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954515,0.0010216071,0.0006989431,0.0006946639,0.0014882071,0.00064508594],"domain_scores_gemma":[0.99543047,0.0020200503,0.00029269207,0.0006969258,0.0013584158,0.00020143099],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012445445,0.00030011588,0.0014822041,0.00024011747,0.0001416727,0.00007457191,0.0002888818,0.000116211035,0.0025632796],"category_scores_gemma":[0.0003571397,0.00019789145,0.00033562645,0.0014672392,0.0006668738,0.00016576481,0.0000985641,0.00086616987,0.000005287855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91062444,0.0014136229,0.06791645,0.00003695741,0.0029849575,0.00009270987,0.0014227935,0.0006495906,0.0026729954,0.000034486235,0.000058935813,0.012092031],"study_design_scores_gemma":[0.51139784,0.00028138646,0.4849312,0.00029746586,0.000389467,5.359977e-7,0.0001702392,0.000056570258,0.0021563303,0.000019624418,0.00015040039,0.00014895815],"about_ca_topic_score_codex":0.025758555,"about_ca_topic_score_gemma":0.0048241457,"teacher_disagreement_score":0.41701475,"about_ca_system_score_codex":0.00044439425,"about_ca_system_score_gemma":0.0012697257,"threshold_uncertainty_score":0.99834853},"labels":[],"label_agreement":null},{"id":"W3137173878","doi":"","title":"Transillumination breast spectroscopy (TiBS) as biomarker for breast cancer risk assessment.","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Transillumination; Mammography; Biomarker; Cancer; Breast tissue; Oncology; Internal medicine; Pathology; Radiology; Biology","score_opus":0.05775162085625667,"score_gpt":0.4490521966802276,"score_spread":0.39130057582397093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137173878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721109,0.0015890204,0.00065820594,0.012189469,0.0005072114,0.0021390703,0.0015230831,0.00012695987,0.009156046],"genre_scores_gemma":[0.9888613,0.005379679,0.00079079834,0.0003762924,0.0011760143,0.0012770775,0.00007572955,0.000094763374,0.0019683228],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964494,0.00022695768,0.0003650223,0.0005989909,0.001408929,0.00095069397],"domain_scores_gemma":[0.99726033,0.00024895405,0.00010091069,0.00053877715,0.0014651852,0.00038582744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013781268,0.0002559047,0.00045320974,0.0006911019,0.0005521148,0.000027669254,0.0002674796,0.00019067111,0.0052733794],"category_scores_gemma":[0.00010460252,0.00021478251,0.00020777663,0.0012931079,0.00084129925,0.00017816067,0.000036295165,0.00088758406,0.000034519737],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045999037,0.00055849133,0.16743279,0.0005743775,0.00081065536,0.00021180169,0.0014871907,0.000007049996,0.6835589,0.00042610263,0.07691176,0.06342101],"study_design_scores_gemma":[0.008896263,0.00082192867,0.945887,0.0007654933,0.0002654694,0.0011553839,0.00061143836,0.0011567695,0.028590048,0.00066377514,0.010767517,0.00041890587],"about_ca_topic_score_codex":0.001995568,"about_ca_topic_score_gemma":0.00013319458,"teacher_disagreement_score":0.77845424,"about_ca_system_score_codex":0.0008225826,"about_ca_system_score_gemma":0.001767275,"threshold_uncertainty_score":0.9956359},"labels":[],"label_agreement":null},{"id":"W3138025188","doi":"10.1158/0008-5472.can-20-3348","title":"The Landscape of the Heritable Cancer Genome","year":2021,"lang":"en","type":"letter","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia Graduate School; University of British Columbia; Cancer Research UK","keywords":"Cancer; Genome; Biology; Genetics; Evolutionary biology; Computational biology; Gene","score_opus":0.05187474536256996,"score_gpt":0.3690926799973182,"score_spread":0.31721793463474823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138025188","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04838268,0.16513771,0.000012882274,0.77685905,0.002455417,0.0009502442,0.0008163496,0.000009968203,0.005375687],"genre_scores_gemma":[0.10036159,0.12009338,0.00015608036,0.30536115,0.043582603,0.007954195,0.0011316511,0.00059128285,0.42076805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974546,0.00040999075,0.0002495483,0.0005211152,0.00074074965,0.0006239833],"domain_scores_gemma":[0.99756336,0.00009230512,0.00012016568,0.0013447133,0.0008414996,0.000037942926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005836321,0.00018667724,0.00020156002,0.000046868132,0.00044159184,0.00009022575,0.0012860086,0.0005030618,0.00046779425],"category_scores_gemma":[0.00013394546,0.00011673534,0.00017672368,0.0004750004,0.00054503675,0.0000021710102,0.00068738876,0.0014234696,0.000007750475],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018242985,0.000006158201,0.00020685903,0.000105656545,0.00018580825,0.0000054950465,0.000056706005,0.000131691,0.08516739,0.0000057276784,0.9129729,0.0011373541],"study_design_scores_gemma":[0.00014611857,0.000031761134,0.00025331762,0.00006910279,0.000020525495,0.000004074608,0.00009773383,0.0000030237918,0.06508655,0.000047849815,0.934104,0.00013592893],"about_ca_topic_score_codex":0.00055162265,"about_ca_topic_score_gemma":0.0010529031,"teacher_disagreement_score":0.47149792,"about_ca_system_score_codex":0.0002900827,"about_ca_system_score_gemma":0.0035767548,"threshold_uncertainty_score":0.634501},"labels":[],"label_agreement":null},{"id":"W3140079447","doi":"10.1158/1538-7445.am2013-sy05-01","title":"Abstract SY05-01: Genetic and non-genetic mechanisms contribute to long-term clonal growth dynamics and therapy resistance.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer stem cell; Biology; Somatic evolution in cancer; Genetic heterogeneity; Stem cell; Epigenetics; Cancer; Cancer research; Genetics; Gene; Phenotype","score_opus":0.016759217795566415,"score_gpt":0.30982742409465275,"score_spread":0.2930682062990863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140079447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852923,0.010624091,0.0015533749,0.001150849,0.00013291705,0.0008536649,0.00017638528,0.0000070952456,0.00020931214],"genre_scores_gemma":[0.9697511,0.0276798,0.00080626016,0.00043167424,0.00029095786,0.00040259265,0.000051958206,0.0000469906,0.00053865806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982126,0.000046794634,0.00022813433,0.0006010409,0.00030407117,0.0006073706],"domain_scores_gemma":[0.9987412,0.00007316975,0.000047463447,0.00037057287,0.000390041,0.00037754598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002566669,0.00020439802,0.00020428635,0.00010093391,0.00022058834,0.00019685201,0.0002681958,0.00016686074,0.00010934453],"category_scores_gemma":[0.00008389656,0.00019779407,0.000042827134,0.00014977294,0.00019565836,0.00000657313,0.0002654339,0.00020516619,0.000018719626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000459173,0.00009111546,0.036436755,0.00017852474,0.00015170185,0.000041288356,0.0001156329,0.000035905687,0.9185933,0.0005921687,0.008072288,0.03523215],"study_design_scores_gemma":[0.0017013869,0.000586861,0.8841568,0.00009188642,0.000013925688,0.000013823787,0.000051307008,0.00007592887,0.10884362,0.0025023425,0.0014789975,0.00048307344],"about_ca_topic_score_codex":0.00058586407,"about_ca_topic_score_gemma":0.0016132467,"teacher_disagreement_score":0.8477201,"about_ca_system_score_codex":0.00009755028,"about_ca_system_score_gemma":0.00024811644,"threshold_uncertainty_score":0.8065808},"labels":[],"label_agreement":null},{"id":"W3141144532","doi":"10.1158/0008-5472.can-20-2701","title":"Mesothelin-Specific CAR T Cells Target Ovarian Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Vetenskapsrådet; Karolinska Institutet; Cancerfonden; Barncancerfonden; Memorial Sloan-Kettering Cancer Center","keywords":"Mesothelin; Ovarian cancer; Cancer research; CD28; Tumor microenvironment; T cell; Cytotoxic T cell; CD8; Immune system; Medicine; Ovarian tumor; Antigen; Cancer; Immunology; Biology; Internal medicine; In vitro","score_opus":0.11573063686289073,"score_gpt":0.42826269920093607,"score_spread":0.3125320623380453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141144532","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84718186,0.060743935,0.00018627064,0.023855474,0.0018873457,0.0022836833,0.00038086588,0.00021905321,0.06326152],"genre_scores_gemma":[0.4381789,0.054320566,0.0014588002,0.0014565504,0.005779876,0.0015034775,0.00011255688,0.0003491544,0.49684012],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948698,0.00048610457,0.0003487742,0.00088161445,0.0020533996,0.0013602553],"domain_scores_gemma":[0.9961857,0.00028333787,0.000037953872,0.0011669268,0.0016798249,0.00064623094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014868658,0.00023763135,0.00049829314,0.00036536163,0.00029487436,0.00013905863,0.00040398247,0.00021764918,0.15238012],"category_scores_gemma":[0.000103321785,0.00021883234,0.00020454777,0.0016594967,0.0003981451,0.00009203733,0.0002870471,0.0015954382,0.000746611],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052824087,0.00014687174,0.0016521143,0.0001635762,0.00017003062,0.0006994711,0.00054286525,0.000033803695,0.88268524,0.00035915984,0.093205556,0.01981304],"study_design_scores_gemma":[0.0011873599,0.00007613437,0.0007641304,0.00011899769,0.000009531316,0.000018652874,0.00026119026,0.0000367727,0.48130193,0.00015945439,0.51593524,0.00013057425],"about_ca_topic_score_codex":0.0017163517,"about_ca_topic_score_gemma":0.00043381882,"teacher_disagreement_score":0.4335786,"about_ca_system_score_codex":0.00126385,"about_ca_system_score_gemma":0.0030618208,"threshold_uncertainty_score":0.95964223},"labels":[],"label_agreement":null},{"id":"W3142133875","doi":"10.1158/1538-7445.am2019-1023","title":"Abstract 1023: Combining all-trans retinoic acid therapy with androgen receptor N-terminal domain inhibitors for the treatment of castration-resistant prostate cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Androgen receptor; Transactivation; Prostate cancer; LNCaP; Cancer research; Bicalutamide; Androgen deprivation therapy; Biology; Chemistry; Cancer; Transcription factor; Biochemistry; Genetics; Gene","score_opus":0.0765473766767302,"score_gpt":0.40273880725303324,"score_spread":0.32619143057630307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142133875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767263,0.0131715005,0.0000028230586,0.0039596525,0.00016134443,0.0053188773,0.0002589967,0.000025073414,0.0003754266],"genre_scores_gemma":[0.97383434,0.01817974,0.00012356043,0.000036573787,0.00026368754,0.0033206856,0.00010082406,0.000067367815,0.00407322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727285,0.000099248995,0.0003539843,0.000506072,0.0009728438,0.00079499016],"domain_scores_gemma":[0.99824727,0.00033080167,0.00011446364,0.0004804313,0.0006141996,0.00021285909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006576988,0.0002642222,0.000435638,0.0001818908,0.00027564736,0.000065446926,0.0001968026,0.000103097154,0.0010198209],"category_scores_gemma":[0.00000992288,0.00014080839,0.00015254566,0.00044611603,0.00044174877,0.00010858136,0.000017476928,0.00026944047,0.00001802858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033259418,0.0008563728,0.03740257,0.000594805,0.0013065578,0.00007959348,0.0071246373,0.000047982354,0.87254435,0.000052676678,0.0023309474,0.044400074],"study_design_scores_gemma":[0.01978671,0.012826501,0.0123856375,0.00092155824,0.00011616238,0.000014492602,0.0030246163,0.000034617482,0.8579753,0.0000693875,0.092540115,0.00030489557],"about_ca_topic_score_codex":0.0014301294,"about_ca_topic_score_gemma":0.00052376726,"teacher_disagreement_score":0.09020917,"about_ca_system_score_codex":0.0007536402,"about_ca_system_score_gemma":0.0015124248,"threshold_uncertainty_score":0.99989337},"labels":[],"label_agreement":null},{"id":"W3144969879","doi":"","title":"Prostate cancer: MMP2, MMP9, MMP14, TIMP2 and disease-free survival","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"MMP2; Gelatinase A; Cancer; Matrix metalloproteinase; MMP9; Stromal cell; Cancer research; Gelatinase; TIMP1; Medicine; Oncology; Internal medicine; Biology; Metastasis; Downregulation and upregulation; Gene expression","score_opus":0.034467207274068344,"score_gpt":0.353072396997592,"score_spread":0.3186051897235237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144969879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97762454,0.016097363,0.000097364835,0.004087673,0.00029637676,0.0006302511,0.00028590523,0.000023083978,0.00085744733],"genre_scores_gemma":[0.9893709,0.006291842,0.00008876434,0.00028078156,0.00081016513,0.0005474018,0.000049608447,0.00004231229,0.0025182446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982645,0.000094364266,0.0001391768,0.00051167054,0.00043081178,0.00055949774],"domain_scores_gemma":[0.9987546,0.000009842313,0.00003073989,0.0005344229,0.00023344312,0.00043692224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323364,0.00015104687,0.00013262634,0.00006499803,0.0002212246,0.00006924102,0.0003322877,0.000103294944,0.000076173084],"category_scores_gemma":[0.0001974093,0.000138427,0.000051519743,0.00016671272,0.00020430612,0.000010303778,0.00041354465,0.00023609682,0.000016823504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050018413,0.00006824199,0.0014435303,0.00010550263,0.000054115288,0.000034074557,0.00008853175,0.00006217156,0.97961086,0.0014144306,0.011966291,0.0046520852],"study_design_scores_gemma":[0.002119276,0.00037233674,0.00097481627,0.0001336115,0.000016548789,0.0000038864064,0.000076262586,0.000010071056,0.91172355,0.011468401,0.072767876,0.00033335947],"about_ca_topic_score_codex":0.00078945106,"about_ca_topic_score_gemma":0.00035782944,"teacher_disagreement_score":0.067887284,"about_ca_system_score_codex":0.00008979697,"about_ca_system_score_gemma":0.00088321016,"threshold_uncertainty_score":0.56448895},"labels":[],"label_agreement":null},{"id":"W3146562435","doi":"10.1158/1538-7445.am2019-923","title":"Abstract 923: FOXA1 chromatin binding is regulated by LSD1-mediated methylation in prostate cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"FOXA1; Coactivator; Prostate cancer; Chromatin; Androgen receptor; Cancer research; Histone; Enhancer; Pioneer factor; Transcription factor; Androgen deprivation therapy; Chemistry; Cancer; Medicine; Internal medicine; Breast cancer; Biochemistry","score_opus":0.05501616584590622,"score_gpt":0.41185329665783543,"score_spread":0.3568371308119292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146562435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345983,0.00707298,4.8988665e-7,0.00424868,0.00024401073,0.0026892372,0.00035030363,0.00007082024,0.0018636743],"genre_scores_gemma":[0.9686596,0.0071899053,0.000026345453,0.0001283531,0.00012780813,0.00076769694,0.00032077896,0.00008488085,0.022694655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592525,0.00018255653,0.00047469416,0.0007577084,0.00143217,0.0012275958],"domain_scores_gemma":[0.9982713,0.0002755313,0.00011186618,0.0005005091,0.00049292255,0.00034788763],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013383996,0.00027249122,0.0004932807,0.00073637697,0.00015158701,0.00009215848,0.0002460617,0.00021357354,0.0052791415],"category_scores_gemma":[0.00007580625,0.00022305206,0.00009113428,0.0019004261,0.00020485357,0.00027536278,0.00011847911,0.0010824447,0.00080851663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001039992,0.00016291645,0.034741607,0.00055180566,0.00012597472,0.00007306515,0.0013804617,0.000033024808,0.9290676,0.00000325215,0.024369422,0.008450857],"study_design_scores_gemma":[0.0069750776,0.0003900813,0.039694466,0.0012665085,0.000024293604,0.000002699117,0.0005003082,0.0006332666,0.93362856,0.000060893708,0.016492,0.00033183873],"about_ca_topic_score_codex":0.004993774,"about_ca_topic_score_gemma":0.00020883507,"teacher_disagreement_score":0.02083098,"about_ca_system_score_codex":0.0020443967,"about_ca_system_score_gemma":0.0013061591,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W3146910991","doi":"10.1158/1538-7445.am2019-lb-024","title":"Abstract LB-024: Inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1): evidence for impaired vitamin D signaling in an MMTV-PYMT mouse model of breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Calcitriol receptor; Transfection; Biology; Cancer cell; Vitamin D and neurology; Estrogen receptor; Molecular biology; Internal medicine; Cancer research; Endocrinology; Cell culture; Chemistry; Cancer; Breast cancer; Medicine","score_opus":0.1510003120780131,"score_gpt":0.43970933623980785,"score_spread":0.2887090241617948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146910991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934494,0.0011385785,0.00005991806,0.0014778583,0.00010552709,0.0031713487,0.00052145176,0.00002463985,0.00005126764],"genre_scores_gemma":[0.9965069,0.0008496169,0.00019979315,0.000049514958,0.00018302855,0.0008186277,0.000016577975,0.000079678524,0.001296221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99530053,0.00030102947,0.000778307,0.0007461185,0.0018721863,0.001001831],"domain_scores_gemma":[0.9955821,0.0010564727,0.000284347,0.0010702136,0.0017584583,0.0002483999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031027803,0.00030106772,0.0007596704,0.00064182264,0.00017875816,0.00003207017,0.00072829827,0.00021212186,0.00020047057],"category_scores_gemma":[0.0010765078,0.00022311028,0.00021214804,0.0011788883,0.00057891913,0.00058260706,0.00037682967,0.0008849938,0.000006276853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008584928,0.0003863312,0.066165425,0.0018902296,0.000115912226,0.000003959445,0.00136507,0.011198622,0.91555005,0.000031254564,0.0003800386,0.0020545975],"study_design_scores_gemma":[0.0026846344,0.00044854195,0.27749276,0.0022363558,0.00003928239,0.000003046725,0.0008616907,0.02751378,0.6883846,0.000119574404,0.000008793068,0.00020696552],"about_ca_topic_score_codex":0.004662724,"about_ca_topic_score_gemma":0.0012528262,"teacher_disagreement_score":0.22716549,"about_ca_system_score_codex":0.0013697875,"about_ca_system_score_gemma":0.0018289733,"threshold_uncertainty_score":0.90981734},"labels":[],"label_agreement":null},{"id":"W3147172847","doi":"10.1158/0008-5472.sabcs13-bs01-1","title":"Abstract BS01-1: Genetic and non-genetic mechanisms contribute to longterm clonal growth dynamics and therapy resistance","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Somatic evolution in cancer; Genetic heterogeneity; Biology; Cancer stem cell; Epigenetics; Stem cell; Genetics; Gene; Cancer; Leukemia; Tumor progression; Cancer research; Phenotype","score_opus":0.015195418799716075,"score_gpt":0.30444499254895036,"score_spread":0.28924957374923427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147172847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875715,0.008097789,0.0016813518,0.0013590455,0.00011642902,0.00073534733,0.00018246763,0.0000062858185,0.00024979893],"genre_scores_gemma":[0.97609854,0.020470457,0.0015921221,0.00054716977,0.00025501588,0.00035944144,0.000033197513,0.000041655665,0.0006024035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983786,0.00004144609,0.00020605601,0.00056091935,0.0002681582,0.00054486847],"domain_scores_gemma":[0.99882036,0.00006673477,0.00004340193,0.00034143115,0.00039603974,0.00033201167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024142719,0.00018264122,0.00018104454,0.00008635287,0.00018092363,0.0001708389,0.00024431423,0.000141665,0.00006801153],"category_scores_gemma":[0.000088122746,0.00017801463,0.00003571476,0.0001371516,0.00017804113,0.0000058947116,0.0002402497,0.00018202388,0.000016317836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035550634,0.00006391618,0.007317517,0.00011220654,0.000104693965,0.00002506153,0.00014938069,0.000047100417,0.94714326,0.00066862727,0.010836848,0.03317589],"study_design_scores_gemma":[0.0031527837,0.0011135557,0.7242105,0.00014886449,0.000021558984,0.00002289546,0.00021377273,0.00038631458,0.24968512,0.008639454,0.011445423,0.0009597752],"about_ca_topic_score_codex":0.00081433204,"about_ca_topic_score_gemma":0.0013321006,"teacher_disagreement_score":0.71689296,"about_ca_system_score_codex":0.00007630615,"about_ca_system_score_gemma":0.000202878,"threshold_uncertainty_score":0.7259226},"labels":[],"label_agreement":null},{"id":"W3154563477","doi":"10.1158/0008-5472.can-20-3979","title":"mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Renal cell carcinoma; TSC1; MAPK/ERK pathway; Cell growth; Biology; Clear cell; Cell biology; Kinase; Medicine; Signal transduction; Pathology","score_opus":0.09248545803040284,"score_gpt":0.36988556457392086,"score_spread":0.277400106543518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154563477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884341,0.0047464785,0.000030435438,0.0012611523,0.00004212512,0.00033127159,0.0000074875147,0.00002138833,0.005125608],"genre_scores_gemma":[0.9922516,0.0001274969,0.00076134916,0.00012337307,0.00013515941,0.00020990863,0.000094300565,0.000030020623,0.00626684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817955,0.000113568305,0.00021057935,0.00041503567,0.0006468028,0.00043446544],"domain_scores_gemma":[0.99879473,0.00017811378,0.000041903462,0.00021772661,0.00053142663,0.00023608029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003874894,0.00013784833,0.00021095396,0.00012648734,0.00023728698,0.0000585797,0.000064175445,0.000078287114,0.00032312228],"category_scores_gemma":[0.00012763262,0.00012224217,0.000031697644,0.00037703742,0.000089042966,0.00009143911,0.00013834663,0.00037002005,0.000022887043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016873005,0.00016532087,0.026160873,0.00037565056,0.00005635175,0.0004146727,0.0010814923,0.0000014560515,0.940752,0.000024306626,0.011102059,0.019697065],"study_design_scores_gemma":[0.0012765974,0.00018440546,0.048758905,0.00015128279,0.000016375188,0.0000348195,0.00045347877,0.000014088752,0.9337139,0.000020905614,0.015265689,0.0001095372],"about_ca_topic_score_codex":0.0002161751,"about_ca_topic_score_gemma":0.000023209363,"teacher_disagreement_score":0.022598032,"about_ca_system_score_codex":0.0007175798,"about_ca_system_score_gemma":0.0009965334,"threshold_uncertainty_score":0.4984891},"labels":[],"label_agreement":null},{"id":"W3160177048","doi":"","title":"Acquired resistance to reoviral oncolysis","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University","funders":"","keywords":"Oncolytic virus; Fibrosarcoma; HT1080; Virology; Biology; Virus; Cell culture; Viral replication; Genetics","score_opus":0.05590546603344061,"score_gpt":0.42508376249034735,"score_spread":0.36917829645690675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160177048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802919,0.0037825694,0.00006499335,0.00725719,0.00006387382,0.00048480165,0.00003762637,0.000021130902,0.007995917],"genre_scores_gemma":[0.9533906,0.0008074013,0.00047264824,0.00085048855,0.0013102806,0.00047373484,0.000024614264,0.000052512143,0.042617727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972484,0.0003084392,0.0001982359,0.000621427,0.000778188,0.0008453214],"domain_scores_gemma":[0.99833304,0.000031377265,0.000024455874,0.0008466756,0.00043563996,0.00032879523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012957931,0.00014532327,0.00015615868,0.00020299504,0.00025055488,0.00006909717,0.0007102789,0.00013316036,0.00050588825],"category_scores_gemma":[0.00019031171,0.00014427926,0.000086055654,0.0006917871,0.00018567206,0.0000068030176,0.00030638467,0.000202674,0.00041917383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033705945,0.000051530475,0.00016864348,0.000013350337,0.00004511442,0.000004972936,0.000099964156,0.00017481126,0.89038277,0.000029961138,0.07661567,0.029042615],"study_design_scores_gemma":[0.00035746538,0.0006231516,0.00011896536,0.000014836198,0.0000020506855,5.905393e-7,0.000036201902,0.0000064350743,0.58336425,0.00002619407,0.41532615,0.00012370343],"about_ca_topic_score_codex":0.000063532294,"about_ca_topic_score_gemma":0.0054737898,"teacher_disagreement_score":0.3387105,"about_ca_system_score_codex":0.00026106217,"about_ca_system_score_gemma":0.00054810575,"threshold_uncertainty_score":0.58835375},"labels":[],"label_agreement":null},{"id":"W3160252189","doi":"","title":"SBEM protein expression correlates with estrogen receptor and tumor grade in breast cancer.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Breast cancer; Cancer; MUC1; Cancer research; Internal medicine; Biology; Oncology; Pathology; Medicine","score_opus":0.02345348582139748,"score_gpt":0.3400593762650442,"score_spread":0.3166058904436467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160252189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948293,0.0021768839,0.000029407081,0.0019143893,0.000024426054,0.0008212252,0.000057009,0.000010610378,0.00013677414],"genre_scores_gemma":[0.9971783,0.000645245,0.0002569014,0.000045120938,0.00014052447,0.00095638057,0.000027234833,0.000031616528,0.0007186721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982792,0.00013130158,0.00014578225,0.00047191756,0.00045243968,0.0005193447],"domain_scores_gemma":[0.99928397,0.000010371241,0.000033584907,0.00026591631,0.00021215944,0.00019398122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037656914,0.00013731331,0.0001304989,0.00014226146,0.00015265137,0.000057157045,0.0002099668,0.00010684331,0.00019708187],"category_scores_gemma":[0.00004361567,0.00010886189,0.000023377055,0.00036771488,0.00025918722,0.000011870525,0.00016844532,0.000398599,0.00001416665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006651896,0.00007241868,0.016120244,0.000055599023,0.000013024777,0.000018021105,0.000080666425,0.00021982656,0.98026186,0.00009857379,0.00047463068,0.0019199178],"study_design_scores_gemma":[0.0020519407,0.00030160617,0.0062483624,0.00037206395,0.0000017611891,0.000026604894,0.00018331774,0.00001918155,0.9840705,0.00013197775,0.0063991505,0.00019356058],"about_ca_topic_score_codex":0.0016151686,"about_ca_topic_score_gemma":0.0007044801,"teacher_disagreement_score":0.009871882,"about_ca_system_score_codex":0.00013617658,"about_ca_system_score_gemma":0.00057264435,"threshold_uncertainty_score":0.4439259},"labels":[],"label_agreement":null},{"id":"W3162344820","doi":"10.1158/0008-5472.can-20-1799","title":"Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Cancer Research Society; National Institute of Diabetes and Digestive and Kidney Diseases; W. M. Keck Foundation","keywords":"Metastasis; Breast cancer; Phenotype; Cancer; Breast cancer metastasis; Medicine; Oncology; Biology; Internal medicine; Cancer metastasis; Cancer research; Genetics; Gene","score_opus":0.09832218918011627,"score_gpt":0.4206923945828093,"score_spread":0.32237020540269307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162344820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96523273,0.030514276,0.000026349871,0.0023709424,0.00020179679,0.00026339755,0.0005269035,0.000013932761,0.0008496473],"genre_scores_gemma":[0.97864246,0.019065946,0.00036945543,0.0002253682,0.00025760828,0.00011396028,0.000009486015,0.000031594467,0.0012841187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981197,0.00014857374,0.00023597406,0.00042683881,0.0006218751,0.0004470218],"domain_scores_gemma":[0.9983772,0.000080249025,0.000049124104,0.00041965087,0.0007835137,0.0002902591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049836485,0.00013029146,0.00042074567,0.00014190399,0.00009420466,0.000025121564,0.00009342133,0.00006626033,0.002373052],"category_scores_gemma":[0.000030440293,0.000112825954,0.000111162626,0.00066693506,0.0002740992,0.000058390182,0.00016868758,0.00032367476,0.000011085197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037694033,0.0001632744,0.010141841,0.0008134031,0.00034675383,0.00006856542,0.00018389193,0.000013043462,0.8722229,0.00010595948,0.004238598,0.11132482],"study_design_scores_gemma":[0.0011815567,0.00006711474,0.021853741,0.00021047119,0.00016695303,0.000050927025,0.00021356138,0.000008830623,0.9497812,0.00004711901,0.026303502,0.00011502035],"about_ca_topic_score_codex":0.0026314245,"about_ca_topic_score_gemma":0.001284515,"teacher_disagreement_score":0.1112098,"about_ca_system_score_codex":0.0001879165,"about_ca_system_score_gemma":0.0009301354,"threshold_uncertainty_score":0.9985389},"labels":[],"label_agreement":null},{"id":"W3162982128","doi":"10.1158/0008-5472.can-20-3694","title":"SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Beatson Institute for Cancer Research; CRUK and EPSRC Cancer Imaging Centre in Cambridge and Manchester; Ligue Contre le Cancer; European Commission; Cancer Research UK","keywords":"Prostate cancer; Androgen deprivation therapy; mTORC1; Cancer research; Androgen receptor; Amino acid transporter; PI3K/AKT/mTOR pathway; Regulator; Prostate; Cancer; Androgen; Medicine; Transporter; Internal medicine; Biology; Signal transduction; Hormone; Cell biology; Biochemistry; Gene","score_opus":0.09149100848381074,"score_gpt":0.4304945983274098,"score_spread":0.3390035898435991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162982128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801571,0.004601438,0.0000010425379,0.010999066,0.00013160058,0.0010559325,0.00007874147,0.000049509803,0.0029255685],"genre_scores_gemma":[0.97449243,0.0041302983,0.000054947137,0.000111886984,0.00028879568,0.0011627259,0.00020734148,0.000047789876,0.019503787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966667,0.00024308905,0.00033264668,0.00058755884,0.0013184189,0.0008515608],"domain_scores_gemma":[0.99748176,0.00024332816,0.00005158951,0.0003907771,0.0015549335,0.00027761134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007925398,0.00018304071,0.00032283316,0.00040836076,0.00020366066,0.00009703651,0.00012392063,0.00014578085,0.0018191384],"category_scores_gemma":[0.00042359656,0.00015254634,0.00006729117,0.001870425,0.00022534562,0.0002157471,0.00009494633,0.0007447061,0.0000544249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020179779,0.00023731713,0.043611236,0.0003434283,0.00011569225,0.00029175443,0.0010098586,0.000044362445,0.9396818,0.000091408336,0.004743807,0.007811354],"study_design_scores_gemma":[0.005263382,0.00030315295,0.18993534,0.0011202998,0.000024285444,0.000007946544,0.000986021,0.00014701081,0.78845876,0.00034286105,0.013169023,0.000241908],"about_ca_topic_score_codex":0.004205585,"about_ca_topic_score_gemma":0.004245532,"teacher_disagreement_score":0.15122303,"about_ca_system_score_codex":0.002047526,"about_ca_system_score_gemma":0.005014188,"threshold_uncertainty_score":0.99909335},"labels":[],"label_agreement":null},{"id":"W3163276458","doi":"10.1158/0008-5472.can-20-3143","title":"The MNK1/2–eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Queen's University; Université de Montréal; McGill University Health Centre; Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Vlaamse regering; Vetenskapsrådet; Réseau de cancérologie Rossy; Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Cancer research; Stromal cell; Tumor microenvironment; Immune system; Metastasis; Immunotherapy; Medicine; Breast cancer; Cancer; Biology; Immunology; Oncology; Internal medicine","score_opus":0.03248068759400755,"score_gpt":0.3533564660349124,"score_spread":0.3208757784409048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163276458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91737884,0.06580311,0.0000037612372,0.011005385,0.0039351,0.0002932479,0.00005578737,0.000028492961,0.0014962939],"genre_scores_gemma":[0.9401207,0.016929958,0.000002137704,0.00012592768,0.000055194774,0.0002114876,0.00006908194,0.000018853741,0.042466648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980226,0.00068470783,0.0002793354,0.00035333954,0.00010240353,0.000557596],"domain_scores_gemma":[0.9989203,0.00028125587,0.000053225856,0.0003488241,0.00036371496,0.000032666903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008174741,0.0001271637,0.0001996832,0.00013396746,0.0005487275,0.00007709562,0.0001541397,0.00014381227,0.010365159],"category_scores_gemma":[0.00011180971,0.000091023154,0.0000618495,0.00037433897,0.00028443558,0.00016583479,0.0002360205,0.00082703825,0.00015954321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080415595,0.000089466375,0.006952767,0.000034477016,0.00013495922,0.000026118341,0.00044743894,0.0000038958474,0.8840709,0.00018120503,0.07287684,0.03437781],"study_design_scores_gemma":[0.0009628653,0.000059175323,0.08023301,0.00015271557,0.00001667907,0.00017483404,0.0015988769,0.00000627357,0.46701387,0.000056914287,0.4495808,0.00014400572],"about_ca_topic_score_codex":0.0030109033,"about_ca_topic_score_gemma":0.0013106656,"teacher_disagreement_score":0.417057,"about_ca_system_score_codex":0.00018060779,"about_ca_system_score_gemma":0.00031643987,"threshold_uncertainty_score":0.9905395},"labels":[],"label_agreement":null},{"id":"W3168115304","doi":"10.1158/0008-5472.can-21-0950","title":"NCI Imaging Data Commons","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Documentation; Cloud computing; Data science; Commons; Computer science; Cyberinfrastructure; Political science","score_opus":0.1610928151742399,"score_gpt":0.5090268107221984,"score_spread":0.34793399554795845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168115304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6455831,0.02590715,0.0024120722,0.25923193,0.00096661947,0.00048311244,0.00008521774,0.00020011832,0.06513072],"genre_scores_gemma":[0.986322,0.0011875676,0.0016760082,0.0022374787,0.0009405856,0.000028487068,0.00022997124,0.00004497631,0.0073329583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824876,0.00015271315,0.00013953925,0.0003907144,0.0006296517,0.000438629],"domain_scores_gemma":[0.9981949,0.00019912074,0.000016455595,0.0010258392,0.00030040898,0.0002633228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012660355,0.00006977051,0.00017269237,0.00009853734,0.00018873948,0.00007266958,0.00035318098,0.000029080535,0.0011717957],"category_scores_gemma":[0.0013909863,0.00006169522,0.00003134816,0.00045138478,0.00022678997,0.000087052154,0.0006132647,0.0010910775,0.00008192176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006315513,0.00015738746,0.11263826,0.0002275526,0.000097412405,0.0021163484,0.00028106148,0.000014526024,0.086109094,0.0011571796,0.50817615,0.28896186],"study_design_scores_gemma":[0.0014063822,0.000026257963,0.021626715,0.00042518033,0.000041951593,0.0003257175,0.00041988486,0.015784157,0.005413319,0.00046100456,0.9539195,0.00014994951],"about_ca_topic_score_codex":0.00047616157,"about_ca_topic_score_gemma":0.000048824742,"teacher_disagreement_score":0.44574332,"about_ca_system_score_codex":0.00011822393,"about_ca_system_score_gemma":0.0007905946,"threshold_uncertainty_score":0.99974126},"labels":[],"label_agreement":null},{"id":"W3173760515","doi":"10.1158/1538-7445.am2021-ct038","title":"Abstract CT038: Kinetics of radiographic response for tebentafusp (tebe) in previously treated metastatic uveal melanoma (mUM) patients (pts) achieving prolonged survival","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Internal medicine; Post-hoc analysis; Progressive disease; Interim analysis; Gastroenterology; Progression-free survival; Phases of clinical research; Nuclear medicine; Melanoma; Overall survival; Oncology; Surgery; Clinical trial; Disease; Cancer research","score_opus":0.0802007319790216,"score_gpt":0.41318754142414255,"score_spread":0.33298680944512093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173760515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945572,0.002333476,0.0000061950577,0.0006901992,0.00011125924,0.0019603414,0.000101123085,0.00001785154,0.00022233029],"genre_scores_gemma":[0.997975,0.0003833215,0.00034965205,0.000029340028,0.00004160154,0.0005210381,0.00015159152,0.000041823932,0.00050662237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707526,0.00080519816,0.00046384564,0.00045446024,0.0005809238,0.00062029914],"domain_scores_gemma":[0.9977756,0.0008947074,0.00010879392,0.00041159504,0.00062533055,0.00018394868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014226972,0.00018515802,0.00059676217,0.0005020823,0.000078267265,0.00001615608,0.00014233873,0.00014118062,0.00017764635],"category_scores_gemma":[0.0009964888,0.00016104785,0.0001712363,0.0009805558,0.00023206348,0.00006663325,0.00006890468,0.00042456144,0.000008008493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01521108,0.003152857,0.8950666,0.00076214137,0.0007713633,0.0006754739,0.0006744352,0.000013161954,0.07091616,0.000029255843,0.0002542222,0.012473225],"study_design_scores_gemma":[0.0126318075,0.0030153324,0.92244095,0.0004405264,0.00019982501,0.00001148421,0.00019121505,0.000017775488,0.059557926,0.00006345541,0.0012856103,0.00014410092],"about_ca_topic_score_codex":0.00034270657,"about_ca_topic_score_gemma":0.0008956175,"teacher_disagreement_score":0.027374322,"about_ca_system_score_codex":0.00040967183,"about_ca_system_score_gemma":0.00057758315,"threshold_uncertainty_score":0.65673405},"labels":[],"label_agreement":null},{"id":"W3174572714","doi":"10.1158/1538-7445.am2021-ct207","title":"Abstract CT207: Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Tolerability; Oncology; Adverse effect; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical trial; Phases of clinical research","score_opus":0.0641380885522939,"score_gpt":0.44568319175312987,"score_spread":0.38154510320083596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174572714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664795,0.00038043724,0.0000016860597,0.00029385733,0.000019489604,0.002363939,0.000016338638,0.0000085509855,0.0002677322],"genre_scores_gemma":[0.99821967,0.00023824885,0.000047801215,0.000036577665,0.000009181522,0.0010466045,0.00002106842,0.000032450134,0.0003483902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978302,0.00010549423,0.00040873684,0.00042776167,0.00081469055,0.000413121],"domain_scores_gemma":[0.9989034,0.00015780015,0.00009257256,0.0002584689,0.0005053028,0.00008247009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002978489,0.00018454697,0.0006064394,0.0003743376,0.0000822201,0.000018679,0.00009520486,0.000027172688,0.00032409155],"category_scores_gemma":[0.00008548471,0.00011331305,0.000021845648,0.0012700054,0.00012042076,0.0001213202,0.00004140465,0.00032325098,0.0000015470737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11034932,0.03481343,0.79206926,0.00069172715,0.0005871223,0.0038000112,0.015944755,0.0011024653,0.0006922002,0.000018936204,0.0000557776,0.03987499],"study_design_scores_gemma":[0.089725405,0.029517282,0.86776644,0.0013440894,0.000034665714,0.0000034211741,0.008831553,0.000037738224,0.0024708176,0.000031327643,0.00006701337,0.00017022966],"about_ca_topic_score_codex":0.004108663,"about_ca_topic_score_gemma":0.10135991,"teacher_disagreement_score":0.09725125,"about_ca_system_score_codex":0.0008407134,"about_ca_system_score_gemma":0.0008504203,"threshold_uncertainty_score":0.91503793},"labels":[],"label_agreement":null},{"id":"W3174592879","doi":"10.1158/0008-5472.can-21-1258","title":"Effects of Exercise on Cancer Treatment Efficacy: A Systematic Review of Preclinical and Clinical Studies","year":2021,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Foothills Medical Centre; University of Toronto; Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"Canada Research Chairs; Canadian Cancer Society","keywords":"Medicine; Cancer; Clinical efficacy; Tamoxifen; Oncology; Chemotherapy; Internal medicine; Clinical trial; Cancer treatment; Breast cancer","score_opus":0.39818469433594755,"score_gpt":0.6206040535838336,"score_spread":0.22241935924788608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174592879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025231583,0.99050766,1.3961328e-7,0.00016053389,0.0005661575,0.008346598,0.00009451857,0.0000137836705,0.000058311583],"genre_scores_gemma":[0.000055734745,0.99282646,0.000004780887,0.000058285957,0.0002907633,0.005405564,0.000023080698,0.00006918854,0.0012661677],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933377,0.0022504572,0.0020588844,0.0008159146,0.0011234055,0.00041367277],"domain_scores_gemma":[0.98870957,0.0082633095,0.00063604844,0.0010243983,0.0010703211,0.0002963335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002768955,0.00045029866,0.00989115,0.00024737293,0.000050463164,0.000010416724,0.00024710858,0.00035319154,0.00008092869],"category_scores_gemma":[0.0034952,0.0002727054,0.0013759763,0.00084517186,0.0005449867,0.000018414441,0.00021906834,0.0008698775,0.0000082949055],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008465613,0.00036468115,0.000016690341,0.7199096,0.002138409,0.000057823203,0.00015165776,1.33494344e-8,2.4007167e-7,0.000010494118,0.0008698123,0.27639592],"study_design_scores_gemma":[0.00092997035,0.001282982,0.00001068623,0.917856,0.014096343,0.0000069191656,0.00007187067,1.3919313e-7,0.00003018508,0.0000015667889,0.065547414,0.0001659208],"about_ca_topic_score_codex":0.00044315067,"about_ca_topic_score_gemma":0.00016311574,"teacher_disagreement_score":0.27623,"about_ca_system_score_codex":0.00076783734,"about_ca_system_score_gemma":0.0027781152,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W3174628921","doi":"10.1158/1538-7445.am2021-lb077","title":"Abstract LB077: Adrenergic signaling induces neuroendocrine differentiation of prostate adenocarcinoma cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"DU145; Prostate cancer; Neuroendocrine differentiation; LNCaP; Synaptophysin; Chromogranin A; Cancer research; Prostate; Cancer; Cancer cell; Biology; Endocrinology; Medicine; Internal medicine; Immunohistochemistry","score_opus":0.06362105093122483,"score_gpt":0.3600445014234532,"score_spread":0.29642345049222835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174628921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848421,0.013146277,0.000002586504,0.0009576447,0.00023583612,0.0003510805,0.000025185242,0.000026953981,0.00041229825],"genre_scores_gemma":[0.9914246,0.004807491,0.000023783126,0.000061164035,0.00047462096,0.000093589864,0.0000438173,0.000041280244,0.003029607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976496,0.0002112845,0.00038672998,0.00040911988,0.00081365125,0.00052962435],"domain_scores_gemma":[0.9983973,0.00023456964,0.00010792497,0.00044260456,0.000648452,0.0001691357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029454113,0.0001610825,0.00038432024,0.00027340953,0.00012540084,0.00004924961,0.00015633923,0.000052095715,0.0010004047],"category_scores_gemma":[0.00015321471,0.00014650718,0.00013351908,0.00062158797,0.00018429018,0.00010512137,0.00008888191,0.00052803836,0.00002089921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012188278,0.00019979809,0.009033374,0.00064835977,0.000075503405,0.00044270037,0.0004053504,0.000085947235,0.9773399,0.00002574886,0.0010506979,0.0094737895],"study_design_scores_gemma":[0.0011599333,0.00020706079,0.16167046,0.00040720313,0.000038105005,0.000059186477,0.00042667153,0.00003104142,0.8331083,0.000027212955,0.002756703,0.00010810113],"about_ca_topic_score_codex":0.0006991281,"about_ca_topic_score_gemma":0.000050528644,"teacher_disagreement_score":0.15263708,"about_ca_system_score_codex":0.00016135765,"about_ca_system_score_gemma":0.0010426491,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W3175510465","doi":"","title":"Effects of brilliant green on human erythroleukemic K562 and breast adenocarcinoma MCF7 cell growth and on inhibition of human topoisomerase IIα","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"K562 cells; Topoisomerase; Sulforhodamine B; Molecular biology; Growth inhibition; Chemistry; Etoposide; Apoptosis; Flow cytometry; DNA synthesis; Annexin; DNA; Cell culture; Biochemistry; Biology; In vitro; Cytotoxicity","score_opus":0.03662564262484367,"score_gpt":0.3281743930582514,"score_spread":0.2915487504334077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175510465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689513,0.0023870026,0.0000065532345,0.00010237489,0.000027965913,0.00028347576,0.00005424935,0.0000035115127,0.00023974032],"genre_scores_gemma":[0.9967673,0.0026705884,0.00000537643,0.00010141438,0.00013909995,0.000042633,0.000021750157,0.000023814022,0.0002280226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998914,0.000086942724,0.00015908749,0.00033858846,0.00025751282,0.00024388237],"domain_scores_gemma":[0.9994686,0.000024025916,0.00006431244,0.0002105898,0.00011362295,0.00011881919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014787637,0.00012621708,0.00018175102,0.00011700811,0.00016918033,0.0000073519514,0.000087552544,0.000109748,0.000011231465],"category_scores_gemma":[0.0000070947594,0.0001193718,0.000043624343,0.000096800395,0.00028768412,0.0000038657945,0.00009632352,0.0001580121,6.55051e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000238608,0.00007107204,0.0011387769,0.00029769284,0.000026667953,0.000012554014,0.00019028875,0.0000010978177,0.99653995,0.0006490354,0.000116649215,0.00071759184],"study_design_scores_gemma":[0.001429757,0.0020398397,0.013703004,0.0001216589,0.000012147396,0.000015987589,0.00004692515,0.0000024094036,0.9820882,0.0003395296,0.00008428962,0.000116268064],"about_ca_topic_score_codex":0.0012518393,"about_ca_topic_score_gemma":0.00008395133,"teacher_disagreement_score":0.014451782,"about_ca_system_score_codex":0.000038285056,"about_ca_system_score_gemma":0.00009735342,"threshold_uncertainty_score":0.48678407},"labels":[],"label_agreement":null},{"id":"W3175859892","doi":"10.1158/1538-7445.am2021-ct154","title":"Abstract CT154: Isatuximab (Isa) plus atezolizumab (Atezo) in patients (pts) with advanced malignancies: Results from a Phase 1/2 open-label multicenter study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cancer","score_opus":0.13706679409820502,"score_gpt":0.4601622671213244,"score_spread":0.32309547302311936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175859892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990368,0.0007647213,0.0000026184864,0.0006153974,0.00012233588,0.004800177,0.0012491039,0.000041912575,0.0020356996],"genre_scores_gemma":[0.9945806,0.00036514335,0.0005108765,0.00011483533,0.00009751288,0.0013022663,0.00088808144,0.00008982125,0.0020508473],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938168,0.00042496074,0.00069859345,0.001426616,0.0021813011,0.0014517166],"domain_scores_gemma":[0.9959849,0.00046468276,0.00012818718,0.0012943482,0.0014352406,0.0006926332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007870778,0.00039188148,0.00079447665,0.00036972846,0.00028129126,0.00026248785,0.0006197578,0.00013485472,0.00081096333],"category_scores_gemma":[0.0010505652,0.00030525058,0.00005595929,0.001219045,0.00022730872,0.0004747117,0.00068665546,0.001071115,0.00022298636],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30162537,0.093463965,0.324179,0.00049882126,0.0019848829,0.021606648,0.011216349,0.000098976,0.01943347,0.000012314339,0.0050735185,0.22080669],"study_design_scores_gemma":[0.51393944,0.0066164606,0.4555894,0.0015885639,0.00006944954,0.000004635704,0.004226418,0.00042830218,0.014121704,0.000018456823,0.0029382613,0.00045887884],"about_ca_topic_score_codex":0.011905979,"about_ca_topic_score_gemma":0.0058752187,"teacher_disagreement_score":0.2203478,"about_ca_system_score_codex":0.0019961628,"about_ca_system_score_gemma":0.002213851,"threshold_uncertainty_score":0.99994},"labels":[],"label_agreement":null},{"id":"W3176859254","doi":"10.1158/1538-7445.am2021-lb040","title":"Abstract LB040: Targeting CD38 and PD-1 with isatuximab (Isa) plus cemiplimab (Cemi) in patients (pts) with advanced malignancies: Results from a Phase 1/2 open-label, multicenter study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Tolerability; Oncology; Internal medicine; Immune checkpoint; Interim analysis; Adverse effect; Immunotherapy; Cancer; Clinical trial","score_opus":0.08120297173712268,"score_gpt":0.41291577264296403,"score_spread":0.3317128009058413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176859254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929626,0.0025555945,0.00000489276,0.0006153721,0.00009878609,0.0026018785,0.00040363593,0.000028431059,0.0007287947],"genre_scores_gemma":[0.9970493,0.0006386713,0.00064754166,0.0002936557,0.000087281034,0.00042901107,0.00024189975,0.00007114087,0.00054151955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962843,0.00020376561,0.0005603461,0.0010726517,0.0010755352,0.0008034155],"domain_scores_gemma":[0.9978983,0.00031106788,0.00015841024,0.0006656392,0.00072223425,0.0002443925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009453287,0.0003098929,0.000599645,0.00019065698,0.00024326629,0.00020260602,0.00031269746,0.00010363599,0.00030641307],"category_scores_gemma":[0.00025398342,0.00023074589,0.000027619142,0.0009153664,0.00028068558,0.0003721861,0.00029530912,0.00075461325,0.000008131939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5545125,0.018286278,0.17156953,0.0005309279,0.0012359162,0.0025199181,0.019222217,0.000053551463,0.1493818,0.000002853955,0.004611489,0.078073025],"study_design_scores_gemma":[0.6163391,0.012876183,0.29843858,0.005228966,0.00014980155,0.000011222936,0.025081469,0.00022535247,0.03077105,0.000008244495,0.009912087,0.0009579799],"about_ca_topic_score_codex":0.0049654823,"about_ca_topic_score_gemma":0.002893065,"teacher_disagreement_score":0.12686904,"about_ca_system_score_codex":0.0008938852,"about_ca_system_score_gemma":0.0011785876,"threshold_uncertainty_score":0.94095445},"labels":[],"label_agreement":null},{"id":"W3176900519","doi":"10.1158/1538-7445.am2021-2620","title":"Abstract 2620: Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Regimen; Oncology; Survival analysis; Pemetrexed; Internal medicine; KRAS; Colorectal cancer; FOLFOX; Cohort; Log-rank test; Cancer; Chemotherapy; Oxaliplatin","score_opus":0.16160553190674054,"score_gpt":0.48129034993289493,"score_spread":0.3196848180261544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176900519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98741007,0.0005923336,0.000017082972,0.0024507148,0.00047276096,0.00067339325,0.00016295155,0.000054622156,0.008166084],"genre_scores_gemma":[0.99323255,0.00048536778,0.0008008856,0.000092798706,0.00035850634,0.00010215324,0.00089679006,0.000060241215,0.003970699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975403,0.00011282558,0.00043522214,0.000724546,0.00060140446,0.00058572274],"domain_scores_gemma":[0.9980309,0.00027632964,0.00006355551,0.0009727605,0.00038155934,0.00027488355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019464,0.00018864899,0.00037642758,0.00038203667,0.0001640976,0.00011873266,0.00027481388,0.00007617426,0.0006816203],"category_scores_gemma":[0.0002982091,0.00018132439,0.00003916491,0.00069726864,0.00007300577,0.00025138137,0.0003086602,0.000503227,0.00011810085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008988069,0.00043550198,0.647783,0.0004230326,0.00042779563,0.00057596085,0.0036145253,0.0061525838,0.3291056,0.0014459363,0.0024243162,0.0067129396],"study_design_scores_gemma":[0.0027532694,0.00009505494,0.97652656,0.00047083877,0.000085152235,0.000008237675,0.0004532918,0.00080486416,0.014757869,0.00028110915,0.0035005843,0.0002631407],"about_ca_topic_score_codex":0.019368306,"about_ca_topic_score_gemma":0.05391405,"teacher_disagreement_score":0.32874358,"about_ca_system_score_codex":0.0017180037,"about_ca_system_score_gemma":0.0023296848,"threshold_uncertainty_score":0.9871618},"labels":[],"label_agreement":null},{"id":"W3176982346","doi":"10.1158/0008-5472.can-20-3956","title":"Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"Norges Forskningsråd; Kreftforeningen","keywords":"Prostate cancer; Reprogramming; Disease; Cancer; Medicine; Oncology; Cancer research; Internal medicine; Biology; Genetics; Gene","score_opus":0.03221806916325126,"score_gpt":0.37992778283312095,"score_spread":0.3477097136698697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176982346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.922306,0.075531766,0.00000504178,0.0006331172,0.00048429583,0.00044527528,0.00021736123,0.000017592,0.0003595635],"genre_scores_gemma":[0.9622234,0.033111177,0.00013338658,0.000046826768,0.0014127716,0.0007144721,0.00023661283,0.00004765055,0.0020736707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770015,0.00020900043,0.00025889374,0.00065642624,0.00059374096,0.0005817714],"domain_scores_gemma":[0.9982372,0.000025587013,0.00009618761,0.00061236223,0.0007289213,0.0002997301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003608598,0.00015527372,0.0002297802,0.000084634914,0.00011880268,0.000043373206,0.00023563123,0.00011939387,0.00009627449],"category_scores_gemma":[0.00031151585,0.00014937833,0.000100827565,0.00044336967,0.00030235827,0.000007778707,0.00030802246,0.00025910887,0.0000021953442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005162788,0.00023179651,0.026672514,0.00030876082,0.000102998965,0.000011730696,0.00023596676,0.000103560094,0.89438826,0.000023443186,0.0007813893,0.07662329],"study_design_scores_gemma":[0.001095627,0.0001152587,0.013438073,0.00045063646,0.00004066436,0.0000011361219,0.00026024407,0.000071753115,0.86092174,0.000088335466,0.1232678,0.0002487045],"about_ca_topic_score_codex":0.00045209628,"about_ca_topic_score_gemma":0.00056922645,"teacher_disagreement_score":0.122486405,"about_ca_system_score_codex":0.00005241452,"about_ca_system_score_gemma":0.0012971264,"threshold_uncertainty_score":0.6091472},"labels":[],"label_agreement":null},{"id":"W3177309704","doi":"10.1158/0008-5472.can-20-3761","title":"<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"PARP1; DNA repair; Biology; Cancer research; Synthetic lethality; Mutation; Homologous recombination; DNA damage; PARP inhibitor; DNA methylation; Molecular biology; Poly ADP ribose polymerase; Genetics; DNA; Gene; Polymerase; Gene expression","score_opus":0.022015136461871636,"score_gpt":0.3333466836415265,"score_spread":0.31133154717965483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177309704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958092,0.003187046,0.000107127526,0.00023578147,0.00011591606,0.00022262063,0.000034551947,0.000005393643,0.00028236717],"genre_scores_gemma":[0.99661815,0.0024490764,0.00019604994,0.00010020475,0.000140932,0.000038084785,0.000024303486,0.000013490855,0.0004196951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881655,0.0002697381,0.00012261048,0.00035783963,0.0002280238,0.00020526223],"domain_scores_gemma":[0.99922216,0.00013912447,0.000026056394,0.00022825571,0.00024035282,0.00014404766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000550024,0.00008710417,0.000118995296,0.000051038052,0.000107066546,0.000018304223,0.000029354387,0.000084602696,0.0000048166676],"category_scores_gemma":[0.00022295475,0.000086773325,0.000038177237,0.00016975409,0.00008727948,0.000002716069,0.00018118953,0.000108124674,0.0000021321518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047076875,0.000022032307,0.0024927075,0.000077689736,0.000023661878,0.000015210528,0.00010963226,0.00015671775,0.9901361,0.000018649456,0.00092264597,0.0059779105],"study_design_scores_gemma":[0.00024688712,0.00022427469,0.0051603694,0.00004984788,0.000009440264,0.0000011647363,0.00004868437,0.00003507849,0.9850048,0.000058149355,0.009070738,0.000090567926],"about_ca_topic_score_codex":0.00013329613,"about_ca_topic_score_gemma":0.0002152341,"teacher_disagreement_score":0.008148092,"about_ca_system_score_codex":0.000040555024,"about_ca_system_score_gemma":0.00017791774,"threshold_uncertainty_score":0.35385135},"labels":[],"label_agreement":null},{"id":"W3177544322","doi":"10.1158/1538-7445.am2021-1767","title":"Abstract 1767: Peripheral blood neutrophil-to-lymphocyte ratio (NLR), a predictor of poor survival in cancer patients, was positively associated with the percentage of circulating low-density neutrophil fraction","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer; Medicine; Neutrophil to lymphocyte ratio; Immunophenotyping; Internal medicine; Gastroenterology; Lymphocyte; Immunology; Colorectal cancer; Circulating tumor cell; Metastasis; Flow cytometry","score_opus":0.03089608981531661,"score_gpt":0.3275454602981292,"score_spread":0.2966493704828126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177544322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703807,0.000575345,0.000003888699,0.00078267255,0.00013804703,0.0009303874,0.00027388104,0.000024014096,0.00023371316],"genre_scores_gemma":[0.99903566,0.00017504343,0.000023903225,0.0001232525,0.00018075205,0.00025346613,0.00008195735,0.000054648015,0.00007134159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965202,0.0004295032,0.0005143804,0.0005111143,0.0014510166,0.00057375996],"domain_scores_gemma":[0.99713457,0.0002741156,0.00024512882,0.0003745275,0.0017547918,0.00021688292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007500121,0.00022371844,0.00050907093,0.00021148863,0.0001964491,0.000038414724,0.00020386298,0.00014714563,0.00040577337],"category_scores_gemma":[0.00037499642,0.00017836176,0.00013323607,0.00084491115,0.0003175796,0.00015568122,0.00015100208,0.0005813874,0.0000017479424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024304774,0.00078237074,0.6683885,0.0004607672,0.0004026106,0.0001865872,0.00082950847,0.0002102894,0.3255073,0.0000094517145,0.000091295624,0.0007008648],"study_design_scores_gemma":[0.0039041692,0.0002457422,0.9168623,0.0011508622,0.00014897855,0.0000031411507,0.00070929294,0.00022376167,0.07657636,0.0000033280571,0.000022324552,0.00014970942],"about_ca_topic_score_codex":0.0023905581,"about_ca_topic_score_gemma":0.0012127297,"teacher_disagreement_score":0.24893095,"about_ca_system_score_codex":0.0014166348,"about_ca_system_score_gemma":0.001871778,"threshold_uncertainty_score":0.72733814},"labels":[],"label_agreement":null},{"id":"W3177690237","doi":"10.1158/1538-7445.am2021-98","title":"Abstract 98: Personalized therapy choice integrating genome and expression data in advanced cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Transcriptome; Clinical trial; Genome; Medicine; Precision medicine; Oncology; Personalized medicine; Disease; Cancer; Whole genome sequencing; Bioinformatics; Internal medicine; Computational biology; Gene; Biology; Genetics; Gene expression; Pathology","score_opus":0.08308389317216579,"score_gpt":0.41825873298374977,"score_spread":0.33517483981158397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177690237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95374894,0.044444997,0.000027757998,0.00040381515,0.00009542345,0.00018585504,0.00015349119,0.0000040787895,0.00093562173],"genre_scores_gemma":[0.9344693,0.06379674,0.00054446195,0.00023979259,0.0002464005,0.00008458525,0.00027411137,0.000027281056,0.00031732625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862874,0.000059660677,0.00016252254,0.0005959954,0.00021148587,0.000341616],"domain_scores_gemma":[0.9989779,0.000099752586,0.000038497215,0.00059684954,0.0001795829,0.00010742622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004050871,0.00011697889,0.0001453678,0.000053659565,0.000111333124,0.000050799365,0.00032053443,0.00009465408,0.00020394521],"category_scores_gemma":[0.00038182794,0.00011320654,0.000024092633,0.0001550059,0.00013122926,0.000010441218,0.0004296273,0.00026772733,0.000002151145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015182154,0.000021331354,0.0036860032,0.000022775528,0.000016659953,0.000014670229,0.00012808891,0.000107049,0.98194104,0.00003743851,0.00047854657,0.013394581],"study_design_scores_gemma":[0.0030930864,0.00015804624,0.042520665,0.00022204449,0.0000039206707,0.000007064288,0.0013611302,0.00013571259,0.47981524,0.000136587,0.4721293,0.00041722725],"about_ca_topic_score_codex":0.0014324822,"about_ca_topic_score_gemma":0.004456952,"teacher_disagreement_score":0.5021258,"about_ca_system_score_codex":0.00011688521,"about_ca_system_score_gemma":0.0006957136,"threshold_uncertainty_score":0.46164286},"labels":[],"label_agreement":null},{"id":"W3177707721","doi":"10.1158/1538-7445.am2021-2056","title":"Abstract 2056: The genomic landscape of carriers of rare variants in FANCI, a new candidate ovarian cancer predisposing gene","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"MSH6; Genetics; Biology; MSH2; MLH1; PMS2; Candidate gene; DNA repair; Population; Gene; DNA mismatch repair; Medicine","score_opus":0.03430300859636045,"score_gpt":0.3601482021135574,"score_spread":0.325845193517197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177707721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775635,0.019977622,0.00009887889,0.00079455547,0.00025430782,0.0002737787,0.0003522555,0.0000028099867,0.0006823194],"genre_scores_gemma":[0.99557287,0.002915008,0.0002727687,0.000066343506,0.00035208743,0.00011081449,0.00006761906,0.000029820923,0.00061268965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984472,0.00013795242,0.00031228334,0.00038808378,0.00032867704,0.0003858138],"domain_scores_gemma":[0.9988234,0.000040583676,0.0001017943,0.0005617609,0.0003779225,0.000094555995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000509947,0.00011915334,0.00019827625,0.00009806114,0.00008324113,0.000027712042,0.00037788865,0.00013422873,0.0005030005],"category_scores_gemma":[0.00012595329,0.00010378074,0.00006784451,0.0005140568,0.0001707488,0.000006897344,0.00020163346,0.00025833477,0.00000143867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019389305,0.00002506952,0.015200741,0.000080707025,0.00012758978,0.000012944216,0.0008182099,0.0035248331,0.9686621,0.000022688819,0.0057119206,0.0056193173],"study_design_scores_gemma":[0.0011026728,0.000048578062,0.08782096,0.00012856637,0.000021083517,0.000007736544,0.0007703513,0.00008187491,0.90096456,0.000106786014,0.008798884,0.0001479172],"about_ca_topic_score_codex":0.0061503435,"about_ca_topic_score_gemma":0.007201779,"teacher_disagreement_score":0.07262022,"about_ca_system_score_codex":0.0001910445,"about_ca_system_score_gemma":0.005052452,"threshold_uncertainty_score":0.92975205},"labels":[],"label_agreement":null},{"id":"W3177739324","doi":"10.1158/1538-7445.am2021-672","title":"Abstract 672: Prognostic significance of urokinase plasminogen activator system in a naturally occurring model of osteosarcoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Urokinase receptor; Osteosarcoma; Internal medicine; Proportional hazards model; Clinical significance; Carboplatin; Metastasis; Oncology; Plasminogen activator; Log-rank test; Cancer; Gastroenterology; Chemotherapy; Pathology; Cisplatin","score_opus":0.13725823352178482,"score_gpt":0.4282735526450222,"score_spread":0.2910153191232374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177739324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951737,0.0016265763,0.000018944691,0.0003177375,0.00006677049,0.0011597822,0.00009005337,0.0000236918,0.0015227634],"genre_scores_gemma":[0.9982567,0.00007672137,0.0008195154,0.000018032304,0.000063410465,0.00040883414,0.000009796818,0.000037687587,0.00030930995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967194,0.0002934651,0.00054537616,0.0005171733,0.0011969402,0.00072762254],"domain_scores_gemma":[0.99717724,0.0007366536,0.00011598339,0.0005797138,0.001153687,0.0002366972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013038239,0.00016221513,0.00060430664,0.00048116414,0.000062580744,0.000013640806,0.00035576208,0.00019263524,0.00012155885],"category_scores_gemma":[0.0010403149,0.00015346475,0.00010226465,0.001081842,0.000398793,0.0001253185,0.00030589759,0.0011268043,0.00001120425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016312326,0.0003653972,0.051008828,0.0043535484,0.00008099438,0.0015873787,0.00048295915,0.000427408,0.93778914,0.000116194555,0.00013360656,0.0020233009],"study_design_scores_gemma":[0.0044577727,0.0013472387,0.099020764,0.004660552,0.000043633783,0.00044654362,0.0026855082,0.008941126,0.8778175,0.00005694602,0.00023355386,0.00028887478],"about_ca_topic_score_codex":0.00037663867,"about_ca_topic_score_gemma":0.000112080575,"teacher_disagreement_score":0.059971668,"about_ca_system_score_codex":0.0007753,"about_ca_system_score_gemma":0.0037463135,"threshold_uncertainty_score":0.6645799},"labels":[],"label_agreement":null},{"id":"W3177742807","doi":"10.1158/1538-7445.am2021-ct002","title":"Abstract CT002: Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Interim analysis; Population; Internal medicine; Randomized controlled trial; Ipilimumab; Intention-to-treat analysis; Oncology; Randomization; Progression-free survival; Surgery; Cancer; Chemotherapy; Immunotherapy","score_opus":0.15393485208103255,"score_gpt":0.4672737265675273,"score_spread":0.3133388744864948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177742807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908817,0.0021698477,0.00001075557,0.0031607752,0.00014700656,0.0017164337,0.000013018846,0.00002276799,0.0018777027],"genre_scores_gemma":[0.997456,0.00025597226,0.00026080504,0.00017001705,0.0002513448,0.0007405286,0.00008966709,0.00002714967,0.0007484765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99769783,0.00045928132,0.0003776562,0.00040757668,0.0005706554,0.00048700065],"domain_scores_gemma":[0.99796706,0.0010663284,0.00007242173,0.00030218923,0.00022596991,0.00036601722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012983648,0.00016721882,0.0008769664,0.00022249589,0.00014765323,0.00003541175,0.000105192164,0.00008375262,0.0007701339],"category_scores_gemma":[0.0012957155,0.00012191513,0.000105001556,0.0005859033,0.00039941256,0.00009196374,0.00006422847,0.00072142784,0.00005297354],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93972653,0.0032184038,0.042762518,0.00036822198,0.0013199023,0.00560569,0.0004832063,0.000082655,0.001973787,0.0001124182,0.00093452894,0.0034121082],"study_design_scores_gemma":[0.98301136,0.0009015987,0.0032557386,0.00041124443,0.00024302799,0.00003371298,0.00009592061,0.00021305808,0.009005677,0.000112976006,0.0025945765,0.00012107886],"about_ca_topic_score_codex":0.0018948631,"about_ca_topic_score_gemma":0.0067139454,"teacher_disagreement_score":0.04328483,"about_ca_system_score_codex":0.00039084104,"about_ca_system_score_gemma":0.0016723693,"threshold_uncertainty_score":0.84324265},"labels":[],"label_agreement":null},{"id":"W3177752528","doi":"10.1158/1538-7445.am2021-1031","title":"Abstract 1031: Translatome and protein synthesis machinery remodeling by rocaglates drives antitumor activity","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bioinformatics Solutions (Canada)","funders":"","keywords":"Protein biosynthesis; Translation (biology); Proteome; Biology; eIF2; Cancer research; Cancer; Initiation factor; Cell biology; Bioinformatics; Messenger RNA; Biochemistry; Genetics; Gene","score_opus":0.031722390926843515,"score_gpt":0.34464124565964976,"score_spread":0.31291885473280623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177752528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718572,0.025806103,0.00012391226,0.0007821377,0.00042047407,0.00022564728,0.0001167541,0.000013336876,0.00065444876],"genre_scores_gemma":[0.9872678,0.008227502,0.000134278,0.00004405477,0.0024631014,0.00016205548,0.000023115357,0.00003454781,0.001643582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984451,0.00013085578,0.00014521799,0.0005481489,0.0002894305,0.0004412502],"domain_scores_gemma":[0.9992694,0.000037803256,0.000033386197,0.00032452345,0.00018049752,0.00015436785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044700553,0.0001519081,0.00021279234,0.000060826645,0.00018989686,0.000079884696,0.00015723736,0.0001391667,0.00010517197],"category_scores_gemma":[0.00014081436,0.0001468088,0.00007549901,0.00016335833,0.0001711686,0.0000135749815,0.000101548794,0.00030333776,0.000004073336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013215981,0.000047407688,0.00027093026,0.00011478582,0.00004506244,0.0000010336179,0.000063948886,0.00001541807,0.9620825,0.000014325231,0.005466768,0.03174566],"study_design_scores_gemma":[0.0002986472,0.00002540053,0.00168528,0.00007796563,0.000010460261,0.000007340164,0.000081264974,0.000056938443,0.8332966,0.00005021741,0.16423273,0.00017716558],"about_ca_topic_score_codex":0.0005190513,"about_ca_topic_score_gemma":0.00029380055,"teacher_disagreement_score":0.15876596,"about_ca_system_score_codex":0.000028427343,"about_ca_system_score_gemma":0.0003977239,"threshold_uncertainty_score":0.59866893},"labels":[],"label_agreement":null},{"id":"W3177787770","doi":"10.1158/1538-7445.am2021-2863","title":"Abstract 2863: Cancer extracellular vesicles induce lymph node metastasis via neutrophil extracellular traps","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Neutrophil extracellular traps; Cancer; Lymphatic system; Cancer research; Cancer cell; Medicine; Melanoma; Extracellular; Immune system; Lymph; Immunology; Pathology; Biology; Inflammation; Cell biology; Internal medicine","score_opus":0.05449822785152119,"score_gpt":0.35965699869294265,"score_spread":0.30515877084142146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177787770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8171503,0.17925103,0.0006877604,0.0012252565,0.00040160108,0.00038373028,0.00023700892,0.000046530033,0.00061677664],"genre_scores_gemma":[0.98255175,0.00943536,0.0006682414,0.00021787453,0.0012718124,0.00051087065,0.00029826316,0.00018820034,0.004857633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945151,0.00058439246,0.00066199445,0.0015649912,0.0012032839,0.0014702246],"domain_scores_gemma":[0.9964649,0.00009085446,0.00017323358,0.0016823646,0.0008995889,0.0006890769],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012879664,0.0005072013,0.00046330417,0.00020466205,0.00049292005,0.00021562114,0.0010087282,0.0004704977,0.001924374],"category_scores_gemma":[0.00025733243,0.00054495235,0.00039838927,0.0008215165,0.0005784713,0.000036043348,0.0005240736,0.0008144716,0.00014343797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002269655,0.00041494693,0.0017182456,0.0002484033,0.00031399334,0.00063374976,0.00008586679,0.0005451358,0.9623537,0.00015219803,0.0037720418,0.029534727],"study_design_scores_gemma":[0.0010727291,0.000052791413,0.004880652,0.00011860274,0.00008735813,0.00003662332,0.00022548351,0.000075129625,0.9048466,0.00030897855,0.08769884,0.0005962043],"about_ca_topic_score_codex":0.00053127937,"about_ca_topic_score_gemma":0.0001580747,"teacher_disagreement_score":0.16981567,"about_ca_system_score_codex":0.00028829,"about_ca_system_score_gemma":0.0016591059,"threshold_uncertainty_score":0.9997002},"labels":[],"label_agreement":null},{"id":"W3177818426","doi":"10.1158/1538-7445.am2021-284","title":"Abstract 284: Design, synthesis and biological evaluation of novel water-soluble salts of the antimitotic prodrugs 4-(3-alkyl-2-oxoimidazolidin-1-yl)-<i>N</i>-phenylbenzenesulfonamides selectively bioactivated by cytochrome p450 1A1 in breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemical Synthesis and Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Chemistry; Prodrug; Solubility; Sulforhodamine B; Aqueous solution; Context (archaeology); Alkyl; Salt (chemistry); Combinatorial chemistry; Stereochemistry; In vitro; Cytotoxicity; Biochemistry; Organic chemistry","score_opus":0.07286993358995593,"score_gpt":0.3455121928686281,"score_spread":0.2726422592786722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177818426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694246,0.001774964,0.000027179622,0.0006019141,0.000026704321,0.00038271965,0.00019055062,0.0000038671164,0.00004964489],"genre_scores_gemma":[0.9976222,0.0020029875,0.00006700644,0.000020973406,0.000058004465,0.00014421092,0.000023647712,0.00002255165,0.000038421415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752563,0.00044885933,0.0003836153,0.000592384,0.0006017284,0.00044778464],"domain_scores_gemma":[0.9983268,0.00020373268,0.00012451953,0.00034584914,0.00091411365,0.00008501831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015518251,0.00018732286,0.00036572968,0.00008363042,0.00010056875,0.000028679371,0.0002961355,0.00021635857,0.00018357388],"category_scores_gemma":[0.00034636637,0.00012209959,0.00011425987,0.00057759316,0.00034136092,0.000011526679,0.000237106,0.00021678161,7.2379805e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020652315,0.00033022257,0.002676835,0.000093934235,0.00014699812,7.355897e-7,0.000060191564,0.00064650207,0.9930368,0.0000018025877,0.00017176032,0.0026276854],"study_design_scores_gemma":[0.0005086923,0.000026277516,0.036171637,0.00018145566,0.000053473657,0.0000027240205,0.000120529134,0.0004594726,0.9622347,0.000032235825,0.000054824144,0.00015399732],"about_ca_topic_score_codex":0.0015052955,"about_ca_topic_score_gemma":0.00014984669,"teacher_disagreement_score":0.033494804,"about_ca_system_score_codex":0.00014937013,"about_ca_system_score_gemma":0.0005239073,"threshold_uncertainty_score":0.49790767},"labels":[],"label_agreement":null},{"id":"W3177842341","doi":"10.1158/1538-7445.am2021-817","title":"Abstract 817: Probing the diabetes - colorectal cancer link using gene - environment interaction analyses","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Colorectal cancer; Odds ratio; Confidence interval; Oncology; Internal medicine; Medicine; Type 2 diabetes; Genome-wide association study; Logistic regression; Allele; Cancer; Diabetes mellitus; Genetics; Biology; Gene; Genotype; Single-nucleotide polymorphism; Endocrinology","score_opus":0.13711990398958082,"score_gpt":0.4442337061343164,"score_spread":0.3071138021447356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177842341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924169,0.005308214,0.00011878442,0.0016221681,0.00017788864,0.00015072597,0.000028226228,0.0000037343389,0.0001733246],"genre_scores_gemma":[0.9951346,0.0031481918,0.00026646495,0.0001409908,0.00068132015,0.00017585505,0.00006452016,0.000016705693,0.00037135257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998642,0.00026479393,0.00018685327,0.00033446023,0.00018155403,0.00039031374],"domain_scores_gemma":[0.9994034,0.00008086686,0.000074486656,0.00022733597,0.00015499661,0.000058902035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000606692,0.00009532714,0.00012945756,0.000036684174,0.00029418615,0.000037986378,0.0001498047,0.00011998063,0.00031672607],"category_scores_gemma":[0.00016849513,0.00007387487,0.00007777991,0.00014031067,0.00012500369,0.0000040920936,0.0001838071,0.00025402504,0.000009943568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013048504,0.000020883066,0.020139495,0.000009863176,0.0001303377,0.0000016631893,0.00005647626,0.00949817,0.96487087,0.0000026265297,0.00074753305,0.00450903],"study_design_scores_gemma":[0.00016979061,0.000049069113,0.06726753,0.000024218107,0.000027553056,0.0000025490833,0.0002496031,0.0010625491,0.9156982,0.00005476391,0.015270916,0.00012326187],"about_ca_topic_score_codex":0.00052436726,"about_ca_topic_score_gemma":0.00026122446,"teacher_disagreement_score":0.049172677,"about_ca_system_score_codex":0.00018043502,"about_ca_system_score_gemma":0.00030863212,"threshold_uncertainty_score":0.34679285},"labels":[],"label_agreement":null},{"id":"W3177859492","doi":"10.1158/1538-7445.am2021-359","title":"Abstract 359: Molecular signatures associated with long-term response to apalutamide (APA) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in TITAN","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure","funders":"","keywords":"Quartile; Prostate cancer; Internal medicine; Medicine; Cohort; Oncology; Population; Proportional hazards model; Androgen deprivation therapy; Hazard ratio; Placebo; Cancer; Pathology","score_opus":0.038756578742328615,"score_gpt":0.38618270671746224,"score_spread":0.3474261279751336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177859492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284613,0.0015077266,0.000003481203,0.0026119694,0.000043379292,0.0024394146,0.00022332011,0.000025407115,0.00029915402],"genre_scores_gemma":[0.99617517,0.00032603872,0.000068175505,0.00021208974,0.000029008637,0.0010856926,0.00022916944,0.00007789055,0.0017967462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99539196,0.0006437201,0.00036064463,0.0008002715,0.0016942824,0.0011090939],"domain_scores_gemma":[0.99715227,0.0004047823,0.000080159945,0.00040759906,0.0015552205,0.00039999213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011382285,0.00030228164,0.00053678994,0.00072968606,0.00012645965,0.00010686275,0.0001494054,0.00011388505,0.00021291751],"category_scores_gemma":[0.0005108417,0.00022616488,0.000051534847,0.002471794,0.00025909746,0.00018916768,0.000088043875,0.0010908785,0.000017583357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051416136,0.001616457,0.7626473,0.00043356398,0.00079619617,0.02078532,0.004341561,0.0018231046,0.14832723,0.000015468995,0.00035001655,0.00744766],"study_design_scores_gemma":[0.009529673,0.0013435944,0.9062132,0.00249181,0.000050274255,0.000006923229,0.000574017,0.000019455676,0.07945323,0.000013085598,0.000038093905,0.00026661012],"about_ca_topic_score_codex":0.0014486639,"about_ca_topic_score_gemma":0.018167833,"teacher_disagreement_score":0.14356595,"about_ca_system_score_codex":0.0028701415,"about_ca_system_score_gemma":0.0037538703,"threshold_uncertainty_score":0.99974805},"labels":[],"label_agreement":null},{"id":"W3177908368","doi":"10.1158/1538-7445.am2021-928","title":"Abstract 928: Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft model of hepatocellular carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glypican 3; Biodistribution; In vivo; Radioimmunotherapy; Antibody; Hepatocellular carcinoma; Cancer research; Medicine; Flow cytometry; Cancer; Monoclonal antibody; Chemistry; Immunology; Internal medicine; Biology","score_opus":0.14298177898607028,"score_gpt":0.4160329136280503,"score_spread":0.27305113464198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177908368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836483,0.01119148,0.0000035801404,0.0024787185,0.00007781026,0.00070859364,0.00008874834,0.000023497629,0.0017792559],"genre_scores_gemma":[0.99193895,0.002997962,0.00030984468,0.00011814052,0.00044546433,0.00021143327,0.000101622085,0.00004946112,0.0038271043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99606293,0.00029667324,0.0005210834,0.0006666414,0.0014956956,0.00095694454],"domain_scores_gemma":[0.99759936,0.00016807603,0.000070202695,0.000621553,0.0010874155,0.00045340645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009922206,0.00023675921,0.00058150536,0.00042715378,0.0001505906,0.000048845224,0.00042160653,0.0001417235,0.0015246023],"category_scores_gemma":[0.00012761269,0.00019578022,0.00016696301,0.0010287006,0.0004148327,0.00015283354,0.00017362865,0.0010784311,0.00002309712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015071811,0.00037851374,0.15032649,0.00032678852,0.00007120439,0.0009558497,0.00092851825,0.00013254666,0.8363639,0.00019420637,0.00046336732,0.008351406],"study_design_scores_gemma":[0.00226149,0.0006533773,0.1408431,0.00031235226,0.000013079582,0.00003355314,0.00090912374,0.012172163,0.8371116,0.00056055334,0.004829801,0.00029984818],"about_ca_topic_score_codex":0.005595831,"about_ca_topic_score_gemma":0.00042669816,"teacher_disagreement_score":0.012039617,"about_ca_system_score_codex":0.00020033539,"about_ca_system_score_gemma":0.0022920305,"threshold_uncertainty_score":0.99938816},"labels":[],"label_agreement":null},{"id":"W3177950975","doi":"10.1158/1538-7445.am2021-1802","title":"Abstract 1802: CD39 inhibition shapes the transcriptional landscape of myeloid cells and induces proinflammatory states in the CT26 syngeneic tumor model","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Adenosine; Proinflammatory cytokine; Cancer research; Immune system; Transcriptome; Tumor microenvironment; T cell; Biology; Extracellular; Chemistry; Cell biology; Immunology; Inflammation; Biochemistry; Gene expression","score_opus":0.04039076693485977,"score_gpt":0.32039422298192044,"score_spread":0.2800034560470607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177950975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98514766,0.013684651,0.000023260025,0.0007237546,0.000015146129,0.00014621884,0.000047384434,0.0000018105886,0.00021011294],"genre_scores_gemma":[0.9976701,0.0017926729,0.00002262923,0.00012333298,0.00015454578,0.00008012568,0.00003850335,0.00000893023,0.000109168344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911726,0.000110582834,0.0001472901,0.00019271624,0.0002495133,0.00018263543],"domain_scores_gemma":[0.99962914,0.000052320334,0.00003064986,0.00012057936,0.00014003269,0.000027254358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056575844,0.00007136345,0.00007752329,0.000038498394,0.000091532755,0.00003227764,0.00012279778,0.00004938752,0.00005113258],"category_scores_gemma":[0.00001901473,0.000045279485,0.000031387317,0.00012610551,0.00012202175,0.0000065722757,0.000046739257,0.00019797316,9.673008e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054259923,0.000030675626,0.0003712838,0.00006995645,0.000018035018,0.000011069424,0.0004656476,0.0035206638,0.9934296,0.000087718225,0.001710989,0.00023008228],"study_design_scores_gemma":[0.00036391895,0.000051833125,0.006301309,0.00006860525,0.000008407637,0.000011338873,0.0015651037,0.00073367293,0.98882663,0.00050109864,0.0014755629,0.00009253102],"about_ca_topic_score_codex":0.000058396814,"about_ca_topic_score_gemma":0.00008854962,"teacher_disagreement_score":0.01252243,"about_ca_system_score_codex":0.000008940613,"about_ca_system_score_gemma":0.00029418105,"threshold_uncertainty_score":0.18464439},"labels":[],"label_agreement":null},{"id":"W3177956740","doi":"10.1158/1538-7445.am2021-980","title":"Abstract 980: Preclinical evaluation of mps1 inhibition in uterine leiomyosarcoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"DAPI; Propidium iodide; Mitosis; Spindle checkpoint; Biology; Cell cycle; BUB1; Apoptosis; Cancer research; Molecular biology; Spindle apparatus; Cell; Cell biology; Kinetochore; Programmed cell death; Cell division; Chromosome; Genetics","score_opus":0.3293847875283459,"score_gpt":0.551754839741068,"score_spread":0.2223700522127221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177956740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988631,0.0048914887,0.0000012218451,0.0037030405,0.00006771317,0.00047226195,0.000016062308,0.0000075560893,0.002209672],"genre_scores_gemma":[0.9981425,0.0010266777,0.000082182625,0.00006545582,0.00012179248,0.00038342518,0.00005246784,0.000011862251,0.00011367374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979492,0.00022273259,0.0003048043,0.00026628963,0.0010266053,0.00023037549],"domain_scores_gemma":[0.9985025,0.00025165308,0.00003812788,0.0002866647,0.0008337925,0.00008729499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00182942,0.00006823452,0.00021710098,0.00016707068,0.000028119814,0.000011812319,0.000031795866,0.000072297094,0.0024001454],"category_scores_gemma":[0.00049742265,0.000059806946,0.000065395456,0.00045890128,0.00007663253,0.00005361777,0.000058797083,0.00026133234,0.000033564957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006412239,0.0041120374,0.45863557,0.0005358577,0.0001614455,0.0010713232,0.00042095428,0.000119213,0.1541613,0.0003812464,0.0035913712,0.37616846],"study_design_scores_gemma":[0.0033626633,0.00012947904,0.79666275,0.0004934602,0.000030864692,0.000019066723,0.00009632222,0.00018772903,0.19688201,0.00047949437,0.0016075972,0.000048565744],"about_ca_topic_score_codex":0.0004580589,"about_ca_topic_score_gemma":0.00051764457,"teacher_disagreement_score":0.3761199,"about_ca_system_score_codex":0.00040822668,"about_ca_system_score_gemma":0.0008118994,"threshold_uncertainty_score":0.9985118},"labels":[],"label_agreement":null},{"id":"W3177975628","doi":"10.1158/1538-7445.am2021-1949","title":"Abstract 1949: Caspase 3 plays a requisite role in regulating survival of human breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apoptosis; Caspase 3; Cell culture; Cancer research; Gene knockdown; In vitro; Caspase; Biology; Caspase 8; Cancer cell; Cell; Cancer; Small hairpin RNA; Molecular biology; Cell biology; Programmed cell death; Biochemistry","score_opus":0.06424251582887369,"score_gpt":0.3985769405082259,"score_spread":0.3343344246793522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177975628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875781,0.0044110944,0.000004408531,0.00094375014,0.00021946993,0.00046134385,0.00025267008,0.000030383506,0.0060987566],"genre_scores_gemma":[0.9976178,0.0005281073,0.000054365373,0.000060086848,0.00038806323,0.00015043514,0.000042394586,0.000074465526,0.0010842801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966677,0.00020712394,0.0005306811,0.0006227013,0.001170785,0.0008010506],"domain_scores_gemma":[0.99790835,0.00013940038,0.00012188951,0.0007124252,0.000829577,0.00028834454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010506182,0.00020013518,0.0005211289,0.00037856915,0.00012849749,0.00003427357,0.00019968809,0.00021234644,0.0023221131],"category_scores_gemma":[0.00011296083,0.00021006759,0.00013954642,0.0012946988,0.00021608206,0.00009269536,0.00020426419,0.0011719771,0.000024421064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037084948,0.00017660155,0.008411175,0.00041713234,0.0000887501,0.00075432897,0.00067331863,0.0005666956,0.9832353,0.000115879484,0.00097241154,0.0042175497],"study_design_scores_gemma":[0.0032381867,0.00012087726,0.106494516,0.0021151386,0.000042304382,0.0000654448,0.00083554036,0.00019104547,0.88571084,0.00011303512,0.0008143455,0.00025871745],"about_ca_topic_score_codex":0.016337859,"about_ca_topic_score_gemma":0.012101768,"teacher_disagreement_score":0.09808335,"about_ca_system_score_codex":0.0011068739,"about_ca_system_score_gemma":0.0018783543,"threshold_uncertainty_score":0.9985899},"labels":[],"label_agreement":null},{"id":"W3178030326","doi":"10.1158/1538-7445.am2021-886","title":"Abstract 886: Prediction of outcome in Li-Fraumeni Syndrome: Development of an integrative function-based prognostic model","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Penetrance; Germline; Germline mutation; Medicine; Oncology; Internal medicine; Cohort; Li–Fraumeni syndrome; Cancer; Genetics; Mutation; Biology; Phenotype; Gene","score_opus":0.10121722102003783,"score_gpt":0.39438617262743864,"score_spread":0.2931689516074008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178030326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465835,0.00067884306,0.0029630137,0.00017209115,0.00013614459,0.0006894086,0.00006711128,0.00002360253,0.0006114553],"genre_scores_gemma":[0.99763876,0.000033878252,0.0015745809,0.000024752984,0.000022383934,0.0003276676,0.00011178773,0.000030785304,0.0002354052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771154,0.00010196941,0.0005819191,0.00037456653,0.0009053626,0.00032467247],"domain_scores_gemma":[0.9984014,0.000110785106,0.00009689907,0.000367991,0.00087232166,0.00015057775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000749399,0.00013474737,0.0003720207,0.00042403853,0.0000509375,0.000009172012,0.00010845757,0.00014811278,0.0002622607],"category_scores_gemma":[0.00040826405,0.00012364409,0.00006857319,0.0009261432,0.00014443096,0.00008039458,0.000049576673,0.00067926553,0.0000059839344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019890117,0.0018948403,0.06776722,0.0021376545,0.00035970475,0.00041810074,0.0033746238,0.029649394,0.8657127,0.00017152273,0.0002485849,0.026276635],"study_design_scores_gemma":[0.0050932863,0.0010656166,0.35412362,0.0032101448,0.00009207795,0.000022632312,0.0016016249,0.032402884,0.6016502,0.00020485302,0.0002993786,0.00023368381],"about_ca_topic_score_codex":0.0002167735,"about_ca_topic_score_gemma":0.00065722835,"teacher_disagreement_score":0.28635642,"about_ca_system_score_codex":0.0008093283,"about_ca_system_score_gemma":0.0040472997,"threshold_uncertainty_score":0.7179736},"labels":[],"label_agreement":null},{"id":"W3178035954","doi":"10.1158/1538-7445.am2021-2619","title":"Abstract 2619: Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cancer; Disease; Internal medicine; Colorectal cancer; Lung cancer; Stage (stratigraphy); Oncology; Medical physics","score_opus":0.1850372014363198,"score_gpt":0.5244202844852826,"score_spread":0.33938308304896275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178035954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8975485,0.01200461,0.000027392667,0.031767387,0.0004625124,0.0011028765,0.00019094991,0.000051521092,0.05684428],"genre_scores_gemma":[0.9860496,0.009703179,0.0011534655,0.0010461655,0.0005087101,0.00017701068,0.00027583807,0.000033280157,0.0010527844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972473,0.00045180562,0.00027806408,0.0005555152,0.0009141072,0.0005532128],"domain_scores_gemma":[0.99781674,0.0007551038,0.000055586195,0.0008550623,0.00039248713,0.00012499839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037391747,0.00012151441,0.00024849095,0.00025381235,0.00020489494,0.00013162143,0.00062723004,0.000049731,0.00032526543],"category_scores_gemma":[0.0022539592,0.00008574384,0.000030099407,0.0025864386,0.00027800465,0.00013922586,0.00032153967,0.0018257488,0.000038506238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000988677,0.00089139823,0.1442809,0.0013807487,0.00032340913,0.008129049,0.016334333,0.00012163302,0.06947379,0.0048589697,0.38878176,0.36443534],"study_design_scores_gemma":[0.005630263,0.00026910688,0.18984076,0.0032653725,0.00010657781,0.00018986824,0.012707591,0.008095814,0.008097645,0.00079827145,0.7703454,0.0006533215],"about_ca_topic_score_codex":0.0032018453,"about_ca_topic_score_gemma":0.001142465,"teacher_disagreement_score":0.38156366,"about_ca_system_score_codex":0.00021594492,"about_ca_system_score_gemma":0.002901217,"threshold_uncertainty_score":0.79320717},"labels":[],"label_agreement":null},{"id":"W3178063948","doi":"10.1158/1538-7445.am2021-288","title":"Abstract 288: Revisiting small molecules that influence the nuclear translocation of thioredoxin-1, prohibitin, and galectin-3 for cancer chemotherapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tubulin; Thioredoxin; Prohibitin; Biology; Biochemistry; Cytosol; Cell biology; Chemistry; Molecular biology; Microtubule; Mitochondrion; Enzyme","score_opus":0.05929036235076225,"score_gpt":0.3718263202884778,"score_spread":0.31253595793771555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178063948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787819,0.01695321,0.00037085643,0.0031159227,0.00002983069,0.00043672352,0.000042276424,0.0000054732764,0.00026380148],"genre_scores_gemma":[0.98169166,0.016754428,0.00036921975,0.000258558,0.00017681309,0.0003748972,0.000016168497,0.000028234203,0.0003300187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990021,0.00008364491,0.00016340955,0.00032910405,0.00017799751,0.00024372655],"domain_scores_gemma":[0.9989145,0.000055936853,0.00007392147,0.000305767,0.00060252845,0.000047339727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006000423,0.00009258348,0.00011189597,0.000028556997,0.0002146857,0.000054806842,0.00018158753,0.00008267365,0.000041759515],"category_scores_gemma":[0.00008877529,0.00007468768,0.000055632034,0.00016617741,0.00019357337,0.000006719346,0.00003706266,0.00014516017,6.309032e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011490646,0.00001692963,0.00042395858,0.00014647748,0.000037767346,4.1559215e-7,0.00025800502,0.00011709747,0.94942194,0.00028701412,0.00025365088,0.04892181],"study_design_scores_gemma":[0.00044239382,0.000049971455,0.01251259,0.00015812901,0.000009708609,0.0000032883054,0.00050477515,0.000092795926,0.9548649,0.00011934404,0.031128248,0.00011384162],"about_ca_topic_score_codex":0.00025792068,"about_ca_topic_score_gemma":0.00024579986,"teacher_disagreement_score":0.048807967,"about_ca_system_score_codex":0.000030761945,"about_ca_system_score_gemma":0.00034132216,"threshold_uncertainty_score":0.30456752},"labels":[],"label_agreement":null},{"id":"W3178090164","doi":"10.1158/1538-7445.am2021-lb182","title":"Abstract LB182: Vaccination by liposomes and synthetic short peptide eradicated HPV-associated tumor","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Epitope; Peptide vaccine; Adjuvant; Immunogenicity; Liposome; Immunization; Virology; Peptide; Vaccination; Immune system; Antigen; Biology; Medicine; Cancer research; Immunology; Biochemistry","score_opus":0.03388764964836241,"score_gpt":0.3435267438659098,"score_spread":0.30963909421754743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178090164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9197868,0.07724073,0.0000025409158,0.0012402834,0.00023031182,0.00021866948,0.00007715511,0.000058724632,0.0011447497],"genre_scores_gemma":[0.97987217,0.005741413,0.0000036810318,0.00013280037,0.000019748073,0.00011098962,0.00016139232,0.000030804767,0.013926974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980076,0.000636925,0.0002615774,0.0003898035,0.00011598422,0.00058813504],"domain_scores_gemma":[0.99872714,0.00055041374,0.000048717535,0.000298183,0.00034128167,0.000034239813],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008307678,0.00015764369,0.00026457597,0.00016523362,0.00045622245,0.00006986597,0.00021776286,0.00019691202,0.005050188],"category_scores_gemma":[0.0004123817,0.00014768793,0.00006246363,0.00040692417,0.00023014998,0.00012885549,0.00009918027,0.00067822845,0.00017601343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032449837,0.0001686297,0.0010100104,0.000027917224,0.0002594739,0.00001955935,0.00034894864,6.0945825e-7,0.954785,0.000052462332,0.018494269,0.02450866],"study_design_scores_gemma":[0.00092825975,0.000121785684,0.101473704,0.00009109822,0.000017306364,0.00004678107,0.0003857036,0.0000018558591,0.82472646,0.000059817656,0.07195823,0.00018899239],"about_ca_topic_score_codex":0.0004528311,"about_ca_topic_score_gemma":0.000071772934,"teacher_disagreement_score":0.1300585,"about_ca_system_score_codex":0.00019721134,"about_ca_system_score_gemma":0.00035202043,"threshold_uncertainty_score":0.9958593},"labels":[],"label_agreement":null},{"id":"W3178128501","doi":"10.1158/1538-7445.am2021-ct003","title":"Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Oncology; Internal medicine; Nivolumab; Lung cancer; Clinical endpoint; non-small cell lung cancer (NSCLC); Neoadjuvant therapy; Chemotherapy; Clinical trial; Cancer; Immunotherapy; Breast cancer","score_opus":0.0873477316640326,"score_gpt":0.43491273243975653,"score_spread":0.34756500077572394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178128501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96484417,0.013979528,0.000021650645,0.007396125,0.00061618094,0.0061721057,0.00023475377,0.000053417927,0.0066820863],"genre_scores_gemma":[0.9481524,0.017860651,0.00020492071,0.0017412378,0.002144495,0.0072497656,0.00024173592,0.00020494414,0.022199815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950836,0.00021668366,0.00082333904,0.0011205843,0.0011637874,0.0015920409],"domain_scores_gemma":[0.9971753,0.00051820726,0.00021720094,0.0011778619,0.00063186634,0.00027961165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002110049,0.0005321576,0.0009244921,0.0003058574,0.0004595397,0.0002567969,0.0005933995,0.0003507082,0.0038018988],"category_scores_gemma":[0.00010771227,0.00039618948,0.00047562367,0.0012774451,0.00027141318,0.00017531046,0.00008646454,0.00089514663,0.00003072837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3309132,0.003338118,0.00091965374,0.0010542156,0.0007692404,0.00043531312,0.006155229,0.000030164827,0.5315332,0.000018283721,0.039594963,0.08523844],"study_design_scores_gemma":[0.26804474,0.0029871627,0.0012607556,0.00096211996,0.00012789125,0.0000333665,0.0014793938,0.0004193219,0.60900176,0.000052171366,0.115115896,0.0005154278],"about_ca_topic_score_codex":0.013916891,"about_ca_topic_score_gemma":0.0031207108,"teacher_disagreement_score":0.08472301,"about_ca_system_score_codex":0.002741146,"about_ca_system_score_gemma":0.0051769237,"threshold_uncertainty_score":0.999849},"labels":[],"label_agreement":null},{"id":"W3178154076","doi":"10.1158/1538-7445.am2021-3","title":"Abstract 3: Deep learning-based integration of esophageal cancer morphology with genomics","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Esophageal cancer; Stromal cell; Cancer; Adenocarcinoma; Deep learning; Convolutional neural network; Medicine; Oncology; Artificial intelligence; Cancer research; Internal medicine; Pathology; Computer science","score_opus":0.06681386995785399,"score_gpt":0.41259433780970967,"score_spread":0.3457804678518557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178154076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97255886,0.023263585,0.00025264127,0.0022294342,0.00006503472,0.00053590245,0.00004128801,0.000031763702,0.0010214688],"genre_scores_gemma":[0.9951355,0.0020675857,0.00043008916,0.00012691935,0.00019390867,0.00046162025,0.00010029302,0.000044142173,0.0014399624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763,0.00017771777,0.00024705112,0.00045206374,0.0008853682,0.0006077698],"domain_scores_gemma":[0.9977519,0.0001969473,0.00007340288,0.00037275042,0.0013020391,0.0003029933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047119573,0.0001606445,0.00036350815,0.00024071649,0.00014815813,0.00002948257,0.00013526372,0.00011236106,0.0032126373],"category_scores_gemma":[0.00015781248,0.00012362328,0.00008740051,0.000691133,0.00036810877,0.00006537334,0.000057993522,0.0009394153,0.00003514678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011250304,0.0017424537,0.31389776,0.0018353941,0.0011552318,0.008909276,0.0014998537,0.010543981,0.46487314,0.00064455206,0.0020355831,0.18161249],"study_design_scores_gemma":[0.0048159,0.0015644596,0.20966274,0.00039717474,0.00007624843,0.000049162867,0.00046942962,0.00065436214,0.7805203,0.000079443234,0.0015463526,0.00016439336],"about_ca_topic_score_codex":0.0025994678,"about_ca_topic_score_gemma":0.0021801502,"teacher_disagreement_score":0.3156472,"about_ca_system_score_codex":0.0009854443,"about_ca_system_score_gemma":0.0031562047,"threshold_uncertainty_score":0.99769855},"labels":[],"label_agreement":null},{"id":"W3178156393","doi":"10.1158/1538-7445.am2021-ct258","title":"Abstract CT258: EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide +/- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Clinical endpoint; Internal medicine; Oncology; Radiation therapy; Randomized controlled trial; Surgery","score_opus":0.03709922039226152,"score_gpt":0.36965132366278314,"score_spread":0.33255210327052165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178156393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040705,0.0036238353,0.0000055624573,0.0022671665,0.00012943588,0.002482159,0.000017161388,0.000020750509,0.001046867],"genre_scores_gemma":[0.9951256,0.0027612895,0.000056830377,0.000135593,0.00024791504,0.001487738,0.000019473235,0.000030218907,0.00013532396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997325,0.00040949727,0.00060455065,0.00042223104,0.000780005,0.00045874022],"domain_scores_gemma":[0.9962551,0.0026860388,0.00017449858,0.00037516,0.00034105906,0.00016815348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011365392,0.0002001123,0.0009282008,0.0003275791,0.00008330331,0.000053128348,0.00011089406,0.00012672885,0.00054780435],"category_scores_gemma":[0.0011010204,0.00014132359,0.00021350487,0.00072146446,0.00016669225,0.000093785406,0.000038078262,0.00047107632,0.000008383787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9063281,0.0019904838,0.019441674,0.00014578774,0.00052005274,0.003506804,0.0011307443,0.000114781324,0.020431325,0.00010049018,0.0009896617,0.0453001],"study_design_scores_gemma":[0.7673801,0.0018425782,0.009567136,0.00050652435,0.000055140335,0.000028036062,0.0004299559,0.00011506329,0.21973126,0.00005454066,0.0001610153,0.0001286467],"about_ca_topic_score_codex":0.0038428681,"about_ca_topic_score_gemma":0.0017004044,"teacher_disagreement_score":0.19929993,"about_ca_system_score_codex":0.00031090973,"about_ca_system_score_gemma":0.0009424548,"threshold_uncertainty_score":0.5998073},"labels":[],"label_agreement":null},{"id":"W3178156522","doi":"10.1158/1538-7445.am2021-1788","title":"Abstract 1788: Increasing the therapeutic index of IL12 by engineering for tumor specific protease activation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Potency; Chemistry; Proteases; Antibody; Cancer research; Immunotherapy; Tumor microenvironment; Cytokine; Antigen; Cytotoxicity; Molecular biology; Cancer immunotherapy; In vitro; Immune system; Immunology; Biochemistry; Biology; Enzyme","score_opus":0.09670404060589026,"score_gpt":0.4044964865205174,"score_spread":0.3077924459146271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178156522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989237,0.0038039205,0.00023623466,0.005076779,0.00005157362,0.00096748554,0.000051868345,0.000012931029,0.00056219124],"genre_scores_gemma":[0.9972838,0.0004356636,0.00012161843,0.00011046251,0.0003479577,0.00033547496,0.00003436882,0.000027167187,0.0013034483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829465,0.00008893589,0.00020732917,0.00023561329,0.0007503949,0.00042309286],"domain_scores_gemma":[0.99821854,0.0007351545,0.000039715917,0.00025840037,0.0006225011,0.00012571897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010365759,0.00010049828,0.00019160975,0.00010410442,0.00016407321,0.00003985927,0.00015337417,0.000048742077,0.00044932895],"category_scores_gemma":[0.00031945467,0.00006844614,0.00008630148,0.00044199816,0.00014330202,0.00006377758,0.00007092288,0.00053636095,0.000007698571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013300462,0.000115844916,0.003964204,0.00059497403,0.00008772332,0.000016802183,0.00015508792,0.000027751927,0.9717965,0.00041644456,0.0030192214,0.018475363],"study_design_scores_gemma":[0.0009165373,0.00014340536,0.05843662,0.0004359268,0.000009791348,0.000023592316,0.00032366219,0.00070965756,0.8108635,0.00023005718,0.12779438,0.00011285565],"about_ca_topic_score_codex":0.00064270437,"about_ca_topic_score_gemma":0.000008018426,"teacher_disagreement_score":0.16093303,"about_ca_system_score_codex":0.00014809261,"about_ca_system_score_gemma":0.00052243995,"threshold_uncertainty_score":0.49198368},"labels":[],"label_agreement":null},{"id":"W3178182026","doi":"10.1158/1538-7445.am2021-2045","title":"Abstract 2045: Aneuploidy, immunohistochemical overexpression of MSH-2, P53, P21^WAF1/CIP1, P16^INK4A, and correlation to epithelial ovarian carcinoma patient prognosis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Aneuploidy; Immunohistochemistry; Immunostaining; Biology; Ovarian carcinoma; Carcinoma; Survival analysis; Cancer; Internal medicine; Ovarian cancer; Cancer research; Oncology; Medicine; Gene; Genetics","score_opus":0.04768662578894174,"score_gpt":0.368647710198386,"score_spread":0.32096108440944426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178182026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996615,0.0035155928,0.000010897821,0.0034451536,0.00021176712,0.0010486173,0.0001696133,0.000022002476,0.0016101996],"genre_scores_gemma":[0.9975723,0.0005354792,0.00047807902,0.00015341658,0.00023715195,0.00057500764,0.0000891242,0.000040956937,0.00031849468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743116,0.00010973737,0.00043817319,0.0006243176,0.0009043134,0.0004923097],"domain_scores_gemma":[0.9981023,0.00020772766,0.0000992492,0.0004984338,0.00070825993,0.00038400074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003027497,0.000204705,0.0004164998,0.00019622297,0.00016452823,0.00004263314,0.00010655814,0.00017298882,0.0010896561],"category_scores_gemma":[0.00020779755,0.0001788572,0.00010929677,0.00048673304,0.0001562783,0.00009527576,0.00021480075,0.00045987175,0.000032092623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013265358,0.0010355699,0.11439292,0.0004990368,0.00017157583,0.00019813231,0.0016311706,0.000024865505,0.8301644,0.00017260537,0.011980484,0.038402725],"study_design_scores_gemma":[0.0025068638,0.00066303543,0.4232439,0.0011586475,0.00007588544,0.00003119145,0.00025562505,0.000036160876,0.56457734,0.00007142221,0.007194592,0.00018531864],"about_ca_topic_score_codex":0.0013941103,"about_ca_topic_score_gemma":0.000044007837,"teacher_disagreement_score":0.30885097,"about_ca_system_score_codex":0.0006654841,"about_ca_system_score_gemma":0.00074439053,"threshold_uncertainty_score":0.9998235},"labels":[],"label_agreement":null},{"id":"W3178189790","doi":"10.1158/1538-7445.am2021-ct219","title":"Abstract CT219: Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Tolerability; T-cell receptor; Oncology; CD8; Internal medicine; T cell; Immunology; Tumor microenvironment; Cancer; Adverse effect; Antigen; Immune system","score_opus":0.1512024054731531,"score_gpt":0.4203069724784636,"score_spread":0.2691045670053105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178189790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613869,0.00042428178,0.000032532425,0.0012714685,0.00007952919,0.035796598,0.000091614354,0.0000082901215,0.00090875156],"genre_scores_gemma":[0.9660466,0.00087818113,0.0002768666,0.00023719957,0.0004041824,0.029315453,0.00004793935,0.00008619865,0.0027074348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967941,0.00038649925,0.00047683858,0.0006621587,0.0010163804,0.00066402723],"domain_scores_gemma":[0.99776655,0.00031274676,0.00009180491,0.0005881526,0.0009172153,0.0003235259],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013120946,0.00023135882,0.0004301088,0.00027983479,0.00017960051,0.00017600194,0.0002074233,0.00012800178,0.0029969013],"category_scores_gemma":[0.000047722002,0.00016503414,0.000044740766,0.0008072697,0.00019418234,0.00016364011,0.00024089133,0.00088598375,0.0000044629514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008389062,0.00090922724,0.043921597,0.0007947953,0.00007814039,0.0000832272,0.0014036719,0.000039108887,0.8746709,0.0000042570255,0.0035335654,0.06617244],"study_design_scores_gemma":[0.040077433,0.0024227528,0.15164596,0.0013548037,0.000045911023,0.000009557675,0.0010518499,0.0012044056,0.75179356,0.000009407007,0.049857654,0.0005267115],"about_ca_topic_score_codex":0.0008443763,"about_ca_topic_score_gemma":0.0019931376,"teacher_disagreement_score":0.12287735,"about_ca_system_score_codex":0.00055773125,"about_ca_system_score_gemma":0.0009708978,"threshold_uncertainty_score":0.9979145},"labels":[],"label_agreement":null},{"id":"W3178251946","doi":"10.1158/1538-7445.am2021-ng16","title":"Abstract NG16: Concomitant reduction of PTPN1/PTPN2 activity synergistically enhanced antitumoral effector function of CD8 T cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre","funders":"","keywords":"Cytotoxic T cell; CD8; Immune system; Immunology; T cell; Proinflammatory cytokine; Acquired immune system; Biology; ZAP70; Cancer research; Interleukin 21; Inflammation","score_opus":0.032938460161926815,"score_gpt":0.35426503520413455,"score_spread":0.32132657504220774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178251946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934279,0.0044427756,0.00093715294,0.000072232644,0.00034338672,0.000273574,0.00021159723,0.000006883176,0.00028453846],"genre_scores_gemma":[0.9984786,0.0007278094,0.0001701316,0.0000070310593,0.00021837451,0.00006856192,0.0000845787,0.000019566567,0.00022534943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985425,0.00017884541,0.0002256864,0.00038634118,0.0003715952,0.0002950171],"domain_scores_gemma":[0.9986289,0.00006084637,0.00011300634,0.00044053147,0.0006703585,0.00008631353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047223945,0.00011550795,0.00022691123,0.000053498152,0.00006160398,0.00001554666,0.00016153492,0.00012465255,0.00018784498],"category_scores_gemma":[0.00036871945,0.000114397866,0.00008682409,0.0002501611,0.00031317218,0.000009623919,0.00014858354,0.00021459117,0.000008054098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088645855,0.0001490311,0.00007205489,0.00029057593,0.0000641128,0.000005617489,0.000008270674,0.00008050717,0.9915339,0.00021314778,0.0014056996,0.005290646],"study_design_scores_gemma":[0.0004892229,0.00045086563,0.0053255805,0.00010642116,0.000015793556,0.00000199298,0.000024378414,0.0000063387033,0.9924865,0.00005733962,0.00092995254,0.00010565701],"about_ca_topic_score_codex":0.000290353,"about_ca_topic_score_gemma":0.000046890087,"teacher_disagreement_score":0.0052535255,"about_ca_system_score_codex":0.000060085837,"about_ca_system_score_gemma":0.00056285755,"threshold_uncertainty_score":0.46650097},"labels":[],"label_agreement":null},{"id":"W3178284704","doi":"10.1158/1538-7445.am2021-2084","title":"Abstract 2084: Single-cell multimodal glioma analyses reveal epigenetic regulators of cellular plasticity and environmental stress response","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Epigenetics; DNA methylation; Biology; Genome instability; Histone; Transcriptome; Glioma; DNA damage; Phenotypic plasticity; Methylation; Cancer research; Genetics; DNA; Gene expression; Gene","score_opus":0.05601531629359195,"score_gpt":0.3585569670394099,"score_spread":0.30254165074581796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178284704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599386,0.013244265,0.00023725687,0.00004082366,0.000051257688,0.00013860258,0.0001938689,0.0000031352079,0.0000969012],"genre_scores_gemma":[0.99815625,0.00088819343,0.0002838861,0.0000047156864,0.00011645877,0.000016828166,0.00010642862,0.000025035282,0.00040219622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982311,0.00033474166,0.00026403953,0.00045699877,0.00039287473,0.00032024205],"domain_scores_gemma":[0.99918354,0.00013311567,0.000081120954,0.00032053626,0.00012960228,0.00015207616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046741543,0.00013578258,0.00017179786,0.00010394219,0.00011323338,0.000029860064,0.00013748197,0.00016479875,0.000100914076],"category_scores_gemma":[0.00019103987,0.00013947948,0.00006908485,0.00016722953,0.0002826324,0.000004383968,0.00020050279,0.00015766264,0.000002500541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043535448,0.00017310449,0.0052896873,0.000060737333,0.0000431503,0.000025917345,0.00006709572,0.000854099,0.991927,0.0000011291381,0.00004562101,0.0010770506],"study_design_scores_gemma":[0.00048309905,0.00024095454,0.03947201,0.0000281006,0.000017173164,0.0000012571305,0.00020324519,0.00008856079,0.9588201,0.000025891844,0.00048535483,0.00013422074],"about_ca_topic_score_codex":0.00012577722,"about_ca_topic_score_gemma":0.00004531395,"teacher_disagreement_score":0.034182325,"about_ca_system_score_codex":0.000050849103,"about_ca_system_score_gemma":0.0001807657,"threshold_uncertainty_score":0.56878084},"labels":[],"label_agreement":null},{"id":"W3178309154","doi":"10.1158/1538-7445.am2021-1005","title":"Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Zymeworks (Canada)","funders":"","keywords":"Pertuzumab; Antibody; Antibody-dependent cell-mediated cytotoxicity; Cancer research; Trastuzumab; Internalization; Humanized antibody; Cancer; Medicine; Epidermal growth factor receptor; Receptor; Immunology; Breast cancer; Monoclonal antibody; Internal medicine","score_opus":0.1126481908267863,"score_gpt":0.44191571172493754,"score_spread":0.32926752089815126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178309154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907115,0.0019431824,0.000072513656,0.0045066327,0.00013394521,0.00048133885,0.000069900176,0.00001563752,0.0020653405],"genre_scores_gemma":[0.9902546,0.0076399883,0.00009745752,0.00008548202,0.00016873717,0.000068401,0.000026209545,0.000030246436,0.0016289179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971931,0.000336155,0.00028587,0.0005002155,0.0010109312,0.000673734],"domain_scores_gemma":[0.9984323,0.0003606579,0.00008239608,0.0004592772,0.00046690565,0.00019846107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013654764,0.00017229932,0.00040788483,0.00026363687,0.00030357557,0.00008529003,0.00020273261,0.00010617527,0.00078677834],"category_scores_gemma":[0.00018343506,0.00012538454,0.000075769945,0.0009369138,0.00047547204,0.00021248187,0.00024937445,0.0011780217,0.000011052768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006463473,0.00013328092,0.009707018,0.0006320919,0.000055464494,0.00031328734,0.00020313812,0.000031521526,0.9786636,0.00062835624,0.00069083145,0.008295028],"study_design_scores_gemma":[0.00071461574,0.00010891728,0.23978518,0.0006837903,0.0000110043575,0.00006041449,0.0010041388,0.00028047597,0.74994826,0.00046742446,0.006806007,0.00012978139],"about_ca_topic_score_codex":0.015147024,"about_ca_topic_score_gemma":0.0026586826,"teacher_disagreement_score":0.23007816,"about_ca_system_score_codex":0.00037717045,"about_ca_system_score_gemma":0.0015327267,"threshold_uncertainty_score":0.9914112},"labels":[],"label_agreement":null},{"id":"W3178411050","doi":"10.1158/1538-7445.am2021-3062","title":"Abstract 3062: Proton irradiation sensitizes cancer cell lines with acquired radioresistance by exploiting differentially dysregulated DNA damage response (DDR) pathways","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Radioresistance; Cancer research; DNA repair; DNA damage; Cancer; PI3K/AKT/mTOR pathway; Biology; Chemistry; Molecular biology; Cell culture; DNA; Signal transduction; Genetics","score_opus":0.049795631493980426,"score_gpt":0.3506515579875446,"score_spread":0.3008559264935642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178411050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869472,0.008255246,0.000046181252,0.0025918162,0.0001391076,0.0012067222,0.0001620814,0.00012427468,0.00052741676],"genre_scores_gemma":[0.99260056,0.0022367595,0.00012273922,0.0003432911,0.00047294222,0.0006153354,0.00017775508,0.00008904104,0.003341605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99661326,0.0005372539,0.0004180538,0.0006605164,0.0010906386,0.0006802856],"domain_scores_gemma":[0.99757993,0.00044233454,0.0001680617,0.00056685787,0.0009181065,0.0003247319],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009948136,0.00026502085,0.00041897318,0.00018070475,0.00037251206,0.00015355177,0.0001581237,0.00019366317,0.0011778635],"category_scores_gemma":[0.00023957156,0.00022863345,0.000087781875,0.0008779894,0.00019831286,0.000289283,0.00004188113,0.00040151304,0.000016780306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008632522,0.00020912245,0.0029389146,0.00043185594,0.00012535613,0.00023875691,0.00082810153,0.00008083633,0.97842354,0.000015581578,0.0050810925,0.0029943355],"study_design_scores_gemma":[0.0032887252,0.00023578807,0.105173,0.0005571124,0.000039616258,0.000009182787,0.00068185176,0.00036789099,0.88541687,0.000026646898,0.003940026,0.0002633118],"about_ca_topic_score_codex":0.0004182788,"about_ca_topic_score_gemma":0.00028471282,"teacher_disagreement_score":0.10223409,"about_ca_system_score_codex":0.00074766594,"about_ca_system_score_gemma":0.0015415477,"threshold_uncertainty_score":0.9997352},"labels":[],"label_agreement":null},{"id":"W3178431638","doi":"10.1158/1538-7445.am2021-3111","title":"Abstract 3111: Notch3 functions as a tumor suppressor in ER-positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Involution (esoterism); Mammary gland; Breast cancer; Cancer research; Biology; Knockout mouse; Estrogen receptor; Carcinogenesis; Internal medicine; Population; Endocrinology; Cancer; Pathology; Medicine; Receptor","score_opus":0.06870134995112472,"score_gpt":0.41768528292480617,"score_spread":0.34898393297368147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178431638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959296,0.0069921897,0.0000067077835,0.013503065,0.0005379355,0.00062805973,0.0010178692,0.00003624203,0.017981915],"genre_scores_gemma":[0.98297274,0.0015847291,0.00004676698,0.00082238426,0.0007915652,0.0007691125,0.000060120834,0.000052634583,0.012899935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973328,0.00011936571,0.00029258194,0.00061358884,0.00084547576,0.0007962005],"domain_scores_gemma":[0.99808735,0.0001720095,0.000045075987,0.0004667896,0.0008501518,0.00037862483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048559892,0.00018027675,0.00039099227,0.00029013737,0.00016510068,0.000071031405,0.00013896184,0.00008676177,0.020691881],"category_scores_gemma":[0.000121326586,0.0001662341,0.00014181709,0.0012187904,0.00019763115,0.00013161692,0.0001358481,0.0009779525,0.00028347562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033024903,0.0011340212,0.019776499,0.000862659,0.00046563082,0.0040687704,0.0015414548,0.00016129615,0.7914685,0.00023355312,0.105897374,0.07108773],"study_design_scores_gemma":[0.0058629746,0.00023238911,0.37690508,0.0019801825,0.00017153214,0.0005177554,0.002919267,0.000028419661,0.39043647,0.00015114654,0.22028004,0.00051472685],"about_ca_topic_score_codex":0.022004342,"about_ca_topic_score_gemma":0.011138314,"teacher_disagreement_score":0.40103203,"about_ca_system_score_codex":0.001002094,"about_ca_system_score_gemma":0.00313244,"threshold_uncertainty_score":0.9845082},"labels":[],"label_agreement":null},{"id":"W3178434086","doi":"10.1158/1538-7445.am2021-231","title":"Abstract 231: Evaluation of pharmacologic mechanisms to overcome IgG1 antibody (Ab) resistance via quantitative systems pharmacology (QSP) modeling of antibody-dependent cell mediated cytotoxicity (ADCC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Ofatumumab; Chemistry; Antibody; CD16; Cancer research; Immunology; CD20; Antigen; Biology; Monoclonal antibody","score_opus":0.17861966911601887,"score_gpt":0.5009678893107882,"score_spread":0.3223482201947693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178434086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799374,0.0102571305,0.002906508,0.0012404401,0.0005247776,0.002179873,0.0004733716,0.00003202107,0.0024484976],"genre_scores_gemma":[0.99378747,0.003745361,0.0005536938,0.00012781311,0.00020686832,0.00028797975,0.00021579734,0.000050496707,0.0010244983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99178714,0.0013459303,0.0010046079,0.0008447686,0.0040212288,0.0009963295],"domain_scores_gemma":[0.9918566,0.00091807876,0.0002606119,0.0004463084,0.0060257297,0.0004926796],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005771182,0.00031522603,0.00097091316,0.0006397956,0.00022745124,0.000032353753,0.00047191058,0.00023705742,0.002047601],"category_scores_gemma":[0.0005211734,0.00027949535,0.00020174914,0.0014774341,0.00028444215,0.00016248459,0.00036285553,0.0010335044,0.000083666804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030521695,0.0007252803,0.0005064131,0.0020472433,0.0003449854,0.00021784898,0.00042392127,0.010699826,0.9806907,0.00044967802,0.0007014186,0.00014051775],"study_design_scores_gemma":[0.0032538387,0.00066237495,0.0025149777,0.0006301822,0.0001964937,0.00001462257,0.00088457507,0.09796509,0.8928813,0.00044433904,0.0002710728,0.00028116666],"about_ca_topic_score_codex":0.002038083,"about_ca_topic_score_gemma":0.00018858428,"teacher_disagreement_score":0.087809436,"about_ca_system_score_codex":0.00074005564,"about_ca_system_score_gemma":0.0023074648,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W3178451727","doi":"10.1158/1538-7445.am2021-644","title":"Abstract 644: Tumor circadian dysfunction is associated with improved survival in breast cancer patients on neoadjuvant chemotherapy (NAC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Circadian rhythm; Breast cancer; Internal medicine; Medicine; Oncology; Hazard ratio; Cancer; Carcinogenesis; Circadian clock; Chemotherapy; CLOCK; Transcriptome; Cancer research; Biology; Gene expression; Gene; Confidence interval","score_opus":0.03146483072348167,"score_gpt":0.32352160136320307,"score_spread":0.2920567706397214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178451727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266267,0.000055771914,0.000004983133,0.0032987762,0.00015615272,0.0006272348,0.00018279333,0.000023477482,0.0029881652],"genre_scores_gemma":[0.9965963,0.0004503633,0.000009651587,0.0018309597,0.00008342885,0.00028195416,0.00003436285,0.00006020337,0.00065278925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629813,0.0003095102,0.00027793212,0.0009425025,0.0011802263,0.0009916939],"domain_scores_gemma":[0.99896306,0.00017788232,0.00010641153,0.00037257638,0.00007868204,0.0003013824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00106979,0.00022045245,0.00025607363,0.000110767054,0.00025598757,0.00006357805,0.00022994792,0.00010785031,0.0104056485],"category_scores_gemma":[0.00009776997,0.00020437279,0.000043753727,0.0008412668,0.00025187372,0.00024752642,0.000109304216,0.00089728227,0.00026901925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036279112,0.0006624975,0.89699024,0.000027504404,0.00004700565,0.00008815928,0.0010159204,0.0002948159,0.028879909,0.000002139674,0.0011350639,0.07049395],"study_design_scores_gemma":[0.0022179638,0.0001238715,0.9844168,0.00023433946,0.0000043847976,0.0000012618631,0.00023163014,0.00022126871,0.010711605,0.000024882027,0.0015692578,0.00024272976],"about_ca_topic_score_codex":0.018157339,"about_ca_topic_score_gemma":0.014649529,"teacher_disagreement_score":0.087426566,"about_ca_system_score_codex":0.0043062298,"about_ca_system_score_gemma":0.00032845116,"threshold_uncertainty_score":0.99951607},"labels":[],"label_agreement":null},{"id":"W3178463110","doi":"10.1158/1538-7445.am2021-lb133","title":"Abstract LB133: Targetting IL-6/gp130 signalling axis attenuates acquired drug resistance in medulloblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medulloblastoma; Cancer research; Paracrine signalling; Drug resistance; Tumor microenvironment; Leukemia inhibitory factor; Cell culture; Biology; Cytokine; Cancer; Oncostatin M; Medicine; Pharmacology; Immunology; Interleukin 6; Internal medicine; Receptor","score_opus":0.03983578419956487,"score_gpt":0.3433190937504416,"score_spread":0.30348330955087677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178463110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8943616,0.09664587,0.00001669945,0.0031828573,0.0013460533,0.00034306693,0.00006641176,0.00007648733,0.003960949],"genre_scores_gemma":[0.97208714,0.002062315,0.00022647185,0.00016938956,0.00017272068,0.00027180198,0.00008379333,0.00006576827,0.02486057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99627566,0.00066280464,0.0005789423,0.00084045914,0.00025773275,0.0013843771],"domain_scores_gemma":[0.99761564,0.0009700595,0.00012119703,0.0006154879,0.0006229082,0.00005471697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002027906,0.00026375742,0.00044628655,0.00029051505,0.00044709028,0.00007415683,0.00068317936,0.00030364102,0.0050141294],"category_scores_gemma":[0.0005621168,0.00027638412,0.00012009071,0.0010143674,0.0005626931,0.00019314013,0.00036890447,0.0012266182,0.00079256576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003197038,0.00009485493,0.0018444634,0.00017647592,0.00010858745,0.00017139863,0.0016841118,0.0000634544,0.9662032,0.00017904262,0.025966896,0.0031877905],"study_design_scores_gemma":[0.0010894003,0.000017995737,0.002661597,0.00061490305,0.000007932566,0.000007687199,0.0011182181,0.0000029740702,0.8387161,0.0006124698,0.15485115,0.0002995765],"about_ca_topic_score_codex":0.00069934106,"about_ca_topic_score_gemma":0.0029095255,"teacher_disagreement_score":0.12888426,"about_ca_system_score_codex":0.0007228568,"about_ca_system_score_gemma":0.00094097794,"threshold_uncertainty_score":0.99998546},"labels":[],"label_agreement":null},{"id":"W3178468434","doi":"10.1158/1538-7445.am2021-lb065","title":"Abstract LB065: Prostate cancer molecular immunophenotypes in biopsies with high vs average radiation sensitivity as predicted by post-operative radiation therapy outcomes (PORTOS) scores","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Radiation therapy; Biopsy; Oncology; Prostate biopsy; Internal medicine; Cancer; Gene signature; Pathology; Prostate; Biology; Gene expression; Gene","score_opus":0.020428050638043524,"score_gpt":0.36549042134474274,"score_spread":0.3450623707066992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178468434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674494,0.018170854,0.0000041164453,0.0113372635,0.00012742396,0.0019014586,0.00067942165,0.00006146523,0.00026855015],"genre_scores_gemma":[0.9649171,0.029888215,0.000027497255,0.00046639092,0.0001022781,0.0009766604,0.0010982583,0.00006995186,0.0024536154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99629575,0.0004582838,0.0003556315,0.0007305261,0.001329051,0.0008307734],"domain_scores_gemma":[0.99763894,0.00024572306,0.000099613695,0.00044163424,0.0013333844,0.00024072267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072828855,0.00032128041,0.00053688674,0.0003856437,0.0002648886,0.00016359333,0.00011535554,0.00016512211,0.00074651133],"category_scores_gemma":[0.00022446821,0.00023248488,0.00008056218,0.0011391225,0.00034733073,0.00037132367,0.00007204858,0.0008355706,0.000019290033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008877076,0.0006245445,0.3296601,0.00024587027,0.0008186087,0.0017303468,0.0036817694,0.00064399483,0.609145,0.00006340553,0.0010823879,0.043426927],"study_design_scores_gemma":[0.006039248,0.0006423525,0.51238817,0.00030630262,0.000022456952,0.000011683493,0.00037788675,0.00006689712,0.4787973,0.00004320269,0.0010804571,0.00022405366],"about_ca_topic_score_codex":0.015685283,"about_ca_topic_score_gemma":0.0011789942,"teacher_disagreement_score":0.18272807,"about_ca_system_score_codex":0.0011634862,"about_ca_system_score_gemma":0.0030582654,"threshold_uncertainty_score":0.99086934},"labels":[],"label_agreement":null},{"id":"W3178481827","doi":"10.1158/1538-7445.am2021-3024","title":"Abstract 3024: Targeting the RNA binding protein LIN28B in Group 3 medulloblastoma decreases proliferation and promotes apoptosis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Biology; Cancer research; Cell growth; RNA-binding protein; Downregulation and upregulation; PARP1; microRNA; Apoptosis; RNA; Cell biology; Genetics; Gene; Signal transduction; Poly ADP ribose polymerase","score_opus":0.02800091437121601,"score_gpt":0.33971498263904054,"score_spread":0.31171406826782455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178481827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929117,0.0041370117,0.00022351023,0.0013801847,0.00006107207,0.0009916617,0.00001631335,0.000012394764,0.0002661655],"genre_scores_gemma":[0.9965646,0.0012034173,0.00030093893,0.000047299312,0.00028446858,0.0009832243,0.00008421416,0.00004567357,0.00048615868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974656,0.0004022279,0.00025183207,0.0006226414,0.00061561615,0.000642069],"domain_scores_gemma":[0.9989925,0.00006191913,0.00005130235,0.0003597529,0.00038129886,0.00015325363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014673665,0.00016262803,0.00015093396,0.0001498952,0.000320865,0.00019000612,0.0002593277,0.00020147488,0.00010882556],"category_scores_gemma":[0.001075603,0.00013658681,0.000056476307,0.00058099226,0.00018051498,0.0000140657185,0.00037536165,0.00062740425,0.000008789949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014026058,0.000065338434,0.00013891282,0.00010376082,0.000040373056,0.000020474463,0.00009091823,0.000034242585,0.99242157,0.00011031944,0.0004013679,0.006432448],"study_design_scores_gemma":[0.00050491875,0.00015438383,0.0002182617,0.00019715866,0.000004638238,0.000008694764,0.00036862429,0.00012151555,0.99535424,0.0001267544,0.0027851446,0.00015564746],"about_ca_topic_score_codex":0.00030332778,"about_ca_topic_score_gemma":0.00082547317,"teacher_disagreement_score":0.0062768003,"about_ca_system_score_codex":0.00013943632,"about_ca_system_score_gemma":0.00066828215,"threshold_uncertainty_score":0.55698484},"labels":[],"label_agreement":null},{"id":"W3178496778","doi":"10.1158/1538-7445.am2021-749","title":"Abstract 749: Plasma insulin-like growth factor 1-related biomarkers and risk of lethal prostate cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Prostate cancer; Medicine; Internal medicine; Oncology; Cancer; Prostate; Odds ratio; Prospective cohort study; Confidence interval; Quartile","score_opus":0.04499320205276038,"score_gpt":0.3498958988861105,"score_spread":0.30490269683335014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178496778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821181,0.012421192,0.0000011496385,0.0013706733,0.0004111373,0.00067784655,0.00050280517,0.000057005695,0.0024400777],"genre_scores_gemma":[0.9661542,0.031878076,0.000071686074,0.00006105562,0.00013309285,0.00013440824,0.000057401074,0.000063333,0.0014467097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964102,0.0002526444,0.0006461779,0.0007332295,0.001095154,0.0008626148],"domain_scores_gemma":[0.9970293,0.00032616802,0.00019107368,0.00047511252,0.0014354546,0.00054289756],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007509462,0.00030662472,0.0006111873,0.00043944817,0.00023315218,0.00005367689,0.00019401686,0.0003156194,0.001212666],"category_scores_gemma":[0.0007245933,0.00026295858,0.00015885044,0.0013055519,0.00063633145,0.00022525432,0.0002032067,0.0013145199,0.000037354883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020826017,0.00039498348,0.6615724,0.0012532094,0.0017806423,0.0005254129,0.0031265686,0.0000078248095,0.28606853,0.000112846705,0.010622535,0.03245244],"study_design_scores_gemma":[0.004544426,0.00036506754,0.7895909,0.0005145101,0.00015585644,0.000040301587,0.00077292527,0.000088651184,0.19628777,0.0002115795,0.0070855203,0.00034252356],"about_ca_topic_score_codex":0.0055454182,"about_ca_topic_score_gemma":0.00030899933,"teacher_disagreement_score":0.12801847,"about_ca_system_score_codex":0.00032760136,"about_ca_system_score_gemma":0.0015624786,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W3178543062","doi":"10.1158/1538-7445.am2021-2114","title":"Abstract 2114: Horvath clock as a predictor of cancer risk in LFS patients","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"dNaM; Epigenetics; DNA methylation; Cancer; Oncology; Medicine; Disease; Biomarker; Age of onset; Germline mutation; Genetics; Internal medicine; Biology; Mutation; Gene; Gene expression","score_opus":0.034754282212877206,"score_gpt":0.39408195170693544,"score_spread":0.35932766949405825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178543062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837836,0.014252271,0.000009194809,0.00006959668,0.0001301233,0.0001812303,0.00015391542,0.000002362116,0.0014177087],"genre_scores_gemma":[0.98364925,0.015333998,0.00004475124,0.000018648378,0.0001733437,0.00009819869,0.00008016753,0.000017922492,0.00058369146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986845,0.00012745157,0.00021578428,0.00032305592,0.00036204624,0.00028711406],"domain_scores_gemma":[0.9989911,0.000030705978,0.00006790889,0.0002940551,0.0005326912,0.00008357805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038223172,0.00008367096,0.000120702556,0.00006895759,0.0000494663,0.000015683336,0.00014843281,0.00013226361,0.00018932107],"category_scores_gemma":[0.0003281811,0.00008239912,0.000049634604,0.00025469158,0.00007676068,0.0000032004723,0.0001286195,0.00021725218,0.0000062491163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010072839,0.000115572046,0.47766513,0.000042687858,0.00003655906,0.0000034001107,0.00007927266,0.00021528642,0.51153225,0.00002461788,0.00037189169,0.009812624],"study_design_scores_gemma":[0.0005298843,0.000105363986,0.39540184,0.000036241134,0.0000042641504,3.5448718e-8,0.00003549287,0.000011050292,0.59222865,0.00019661544,0.01138245,0.00006810811],"about_ca_topic_score_codex":0.0024227253,"about_ca_topic_score_gemma":0.0025983825,"teacher_disagreement_score":0.08226328,"about_ca_system_score_codex":0.00006104691,"about_ca_system_score_gemma":0.00054863875,"threshold_uncertainty_score":0.3662452},"labels":[],"label_agreement":null},{"id":"W3178565027","doi":"10.1158/1538-7445.am2021-2539","title":"Abstract 2539: DNA content and chromatin texture measurement to predict malignant transformation in low-grade oral dysplasia","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Cancer; Malignant transformation; Dysplasia; Medicine; Malignancy; Biopsy; Lesion; Pathology; Internal medicine","score_opus":0.18708858202534753,"score_gpt":0.42397558468632335,"score_spread":0.23688700266097582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178565027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928727,0.0021984514,0.00003383449,0.003090317,0.00023487836,0.0008592951,0.000104702296,0.000025032039,0.00058074656],"genre_scores_gemma":[0.9986395,0.00027191854,0.000054517917,0.00015591334,0.00006334178,0.0004444989,0.000028756938,0.00001537618,0.00032613674],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99765897,0.00028719593,0.00035333814,0.00036763048,0.00077300204,0.0005598578],"domain_scores_gemma":[0.99917674,0.000057906956,0.000035597088,0.00023117791,0.00026789797,0.00023067211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012791039,0.00013717814,0.00023247945,0.00014752797,0.00017181368,0.000050719085,0.00010839776,0.00015139564,0.00040226476],"category_scores_gemma":[0.00008143522,0.00011723148,0.000036530775,0.00033320568,0.00007359059,0.00012803783,0.000048738922,0.00045151808,0.00016054309],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033108266,0.0032102664,0.22458644,0.0070846416,0.00045176514,0.012221748,0.014710146,0.0003113943,0.55818415,0.0027176882,0.01383666,0.15937428],"study_design_scores_gemma":[0.0026736842,0.00021423798,0.9083025,0.0009045066,0.000013948936,0.00007809008,0.0008467767,0.000059300175,0.084731854,0.00016418741,0.0018576154,0.00015329366],"about_ca_topic_score_codex":0.00075387326,"about_ca_topic_score_gemma":0.009702124,"teacher_disagreement_score":0.68371606,"about_ca_system_score_codex":0.00066965574,"about_ca_system_score_gemma":0.00041011683,"threshold_uncertainty_score":0.54140127},"labels":[],"label_agreement":null},{"id":"W3178613530","doi":"10.1158/1538-7445.am2021-1377","title":"Abstract 1377: Volume scanning, a rational approach to covalent PI3Kα inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"PI3K/AKT/mTOR pathway; Chemistry; Covalent bond; Selectivity; Rational design; Combinatorial chemistry; Biochemistry; Kinase; Target protein; Stereochemistry; Biophysics; Nanotechnology; Signal transduction; Biology; Materials science; Organic chemistry","score_opus":0.1462639111395096,"score_gpt":0.4690487802446619,"score_spread":0.3227848691051523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178613530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366109,0.003614795,0.00004301626,0.012160356,0.0005100099,0.0007838063,0.000052756797,0.00004648012,0.0461779],"genre_scores_gemma":[0.95088273,0.00029312965,0.00037499482,0.00091648457,0.0014924296,0.00071440765,0.00012062584,0.000030347093,0.045174826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980498,0.00008207809,0.00019761978,0.00044223928,0.0007300369,0.00049820717],"domain_scores_gemma":[0.99872285,0.0000699172,0.00002470007,0.00024237233,0.0005690767,0.0003710997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043249642,0.00012137686,0.00022508172,0.0001950569,0.00016935731,0.000044216595,0.00009961101,0.00008173732,0.005098759],"category_scores_gemma":[0.000083512874,0.00011276423,0.00008685215,0.00066650705,0.00011557981,0.000058386486,0.000103007245,0.00045679428,0.00031323018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007994953,0.0010574604,0.02807632,0.00028509728,0.00026695224,0.00029457672,0.0011783672,0.00024570053,0.15742695,0.0003320298,0.79968816,0.01034891],"study_design_scores_gemma":[0.0038298175,0.00046599391,0.117076576,0.000218778,0.00008037439,0.00008022486,0.0005104016,0.00015022002,0.098709024,0.00008821663,0.7785248,0.00026555295],"about_ca_topic_score_codex":0.00048392662,"about_ca_topic_score_gemma":0.000082435625,"teacher_disagreement_score":0.089000255,"about_ca_system_score_codex":0.0007353844,"about_ca_system_score_gemma":0.0017798676,"threshold_uncertainty_score":0.9958107},"labels":[],"label_agreement":null},{"id":"W3178620716","doi":"10.1158/1538-7445.am2021-2698","title":"Abstract 2698: Spatial gene expression profiling in breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Lumpectomy; Immune system; Transcriptome; Cancer research; Cancer; Medicine; Gene expression profiling; Pathology; Biology; Internal medicine; Immunology; Mastectomy; Gene; Gene expression","score_opus":0.05469841785174891,"score_gpt":0.36249813646543666,"score_spread":0.30779971861368777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178620716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504596,0.0032940947,0.00013252847,0.00047028458,0.000282866,0.00015693453,0.00010497178,0.000007452408,0.00050491706],"genre_scores_gemma":[0.9958436,0.0023513704,0.0002032318,0.00009748334,0.00076074124,0.00013155495,0.000089577676,0.000029475592,0.0004930025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985396,0.00009569226,0.00017993031,0.0004503324,0.000298344,0.0004360698],"domain_scores_gemma":[0.9992903,0.000015018924,0.000025608239,0.0002826815,0.00028086247,0.00010552896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030039897,0.00011345021,0.00012898345,0.00006105452,0.00010142284,0.00004361812,0.00019200561,0.00016131067,0.00045291396],"category_scores_gemma":[0.000034111035,0.00010916084,0.000055143642,0.0001941804,0.00008211755,0.0000054359116,0.00011113586,0.00032671637,0.000008770786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021871587,0.00008467465,0.03341751,0.000055848966,0.000012623895,0.0000323802,0.000047247242,0.00019255116,0.9585125,0.000004045866,0.00074132835,0.00668056],"study_design_scores_gemma":[0.00060735765,0.000021728496,0.022558413,0.00009884013,0.0000022923393,0.000006193815,0.000056723962,0.00003827788,0.9737663,0.000021739696,0.0026885094,0.0001336056],"about_ca_topic_score_codex":0.0020782899,"about_ca_topic_score_gemma":0.0022087886,"teacher_disagreement_score":0.015253805,"about_ca_system_score_codex":0.00008690274,"about_ca_system_score_gemma":0.00065803825,"threshold_uncertainty_score":0.49590904},"labels":[],"label_agreement":null},{"id":"W3178630184","doi":"10.1158/1538-7445.am2021-ct023","title":"Abstract CT023: PATHFINDER: Interim analysis of avapritinib (ava) in patients (pts) with advanced systemic mastocytosis (AdvSM)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Systemic mastocytosis; Internal medicine; Interim analysis; Midostaurin; Bristol-Myers; Clinical endpoint; Myeloproliferative neoplasm; Gastroenterology; Phases of clinical research; Surgery; Clinical trial; Leukemia; Myelofibrosis; Bone marrow","score_opus":0.0374080084587002,"score_gpt":0.33427813533468587,"score_spread":0.2968701268759857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178630184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930941,0.0043397574,0.000021823002,0.00006489375,0.0001294223,0.00025950477,0.00019100793,0.000012560943,0.0018869325],"genre_scores_gemma":[0.9969917,0.0006281544,0.000026580541,0.000019363852,0.000010872176,0.000114043934,0.00023687683,0.000019586385,0.0019528558],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981524,0.00028873034,0.00041829233,0.00045823396,0.00016397279,0.000518401],"domain_scores_gemma":[0.9986377,0.00015942937,0.00011993213,0.00044559405,0.00059707015,0.000040281455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050797185,0.0001463295,0.00053405866,0.0005701257,0.00009130848,0.000015843418,0.00025691694,0.00015851624,0.0033896803],"category_scores_gemma":[0.00007668189,0.00012786473,0.00010273421,0.0013749662,0.0002549048,0.00006834051,0.00013942338,0.00051773235,0.00006145368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001256137,0.000791298,0.19343528,0.00048396995,0.0013812355,0.00005553491,0.0012152403,0.0003188466,0.7637866,0.00017411682,0.0006029725,0.036498744],"study_design_scores_gemma":[0.008482146,0.0010110213,0.6749291,0.0012632771,0.00033607913,0.000009241148,0.003551823,0.000018066754,0.29613698,0.000018021148,0.013687676,0.00055658305],"about_ca_topic_score_codex":0.00084818405,"about_ca_topic_score_gemma":0.002284808,"teacher_disagreement_score":0.4814938,"about_ca_system_score_codex":0.00024246432,"about_ca_system_score_gemma":0.00027068018,"threshold_uncertainty_score":0.99752134},"labels":[],"label_agreement":null},{"id":"W3178688808","doi":"10.1158/1538-7445.am2021-1066","title":"Abstract 1066: Pre-clinical combination of a PARP inhibitor, talazoparib, and carboplatin in triple-negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Carboplatin; Triple-negative breast cancer; PARP inhibitor; Medicine; Breast cancer; Cancer research; Cancer; Combination therapy; Internal medicine; Oncology; Chemotherapy; Poly ADP ribose polymerase; Biology; Cisplatin; DNA","score_opus":0.11768069951727021,"score_gpt":0.4877386973206827,"score_spread":0.3700579978034125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178688808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897021,0.0034758868,0.0000051206634,0.0040122666,0.00031261484,0.0007590446,0.0002050638,0.000019972696,0.0015078989],"genre_scores_gemma":[0.99411756,0.0040649907,0.00007152909,0.00016630141,0.00035063864,0.000445421,0.000024621533,0.000031971213,0.00072694756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971727,0.00036794168,0.00067564484,0.0005244912,0.00083158264,0.00042761743],"domain_scores_gemma":[0.99767214,0.00062755734,0.00015101516,0.0003352199,0.0009900038,0.00022405747],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001468403,0.00015686819,0.0005192787,0.00025917313,0.00007380179,0.000028223218,0.00009823875,0.00019938474,0.0015209314],"category_scores_gemma":[0.00042233468,0.00015246606,0.000082419254,0.0009418925,0.0005352949,0.00014524908,0.00009129322,0.00097309734,0.000006707061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074366364,0.0021760913,0.6212182,0.0014575222,0.00042519352,0.00035186083,0.004432003,0.00007911844,0.26618674,0.0010732859,0.016004156,0.0791592],"study_design_scores_gemma":[0.009805186,0.00023323744,0.87062347,0.0014492505,0.000021764476,0.000031538908,0.00044432178,0.00016147122,0.11530786,0.000857959,0.0009000508,0.00016386465],"about_ca_topic_score_codex":0.004416351,"about_ca_topic_score_gemma":0.0024145832,"teacher_disagreement_score":0.24940531,"about_ca_system_score_codex":0.0007310282,"about_ca_system_score_gemma":0.0018123911,"threshold_uncertainty_score":0.9993918},"labels":[],"label_agreement":null},{"id":"W3178720883","doi":"10.1158/1538-7445.am2021-280","title":"Abstract 280: Sub-30-nm capsules for drug delivery","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nanocarriers; Cancer; Drug delivery; Cancer research; Ovarian cancer; Prostate cancer; Drug; Internal medicine; Pharmacology; Nanotechnology; Materials science","score_opus":0.056626407332501336,"score_gpt":0.3397605476002239,"score_spread":0.28313414026772254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178720883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812889,0.014479968,0.00040034714,0.00019382413,0.0008243653,0.00037682755,0.00023771373,0.00017766135,0.0020203881],"genre_scores_gemma":[0.9937353,0.004090619,0.00025786445,0.000045424084,0.0005594578,0.0003386419,0.00003970872,0.00010225971,0.0008307392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982623,0.000015445,0.0002127915,0.00027034132,0.0004550554,0.0007840912],"domain_scores_gemma":[0.99872464,0.0002748355,0.000015110419,0.00036938017,0.00044364194,0.0001723643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041597197,0.00015364264,0.00019559532,0.00012376287,0.0001571722,0.0000985515,0.00027388535,0.0000959828,0.00069615897],"category_scores_gemma":[0.000076179895,0.0001596941,0.0000959003,0.00035686846,0.00008125267,0.00017087611,0.00006311316,0.00043013634,0.00016503439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042048476,0.000023982511,0.00012522464,0.0005473647,0.00011812914,0.000054770244,0.0003306685,0.0031509616,0.92259353,0.00021751209,0.044858478,0.027937315],"study_design_scores_gemma":[0.0006959854,0.000018186132,0.00067183364,0.00013894026,0.000012157029,0.0000030118254,0.00022145467,0.0010326565,0.8971278,0.001730982,0.09808692,0.00026003734],"about_ca_topic_score_codex":0.00018377091,"about_ca_topic_score_gemma":0.0005901254,"teacher_disagreement_score":0.053228445,"about_ca_system_score_codex":0.00056196196,"about_ca_system_score_gemma":0.00040303468,"threshold_uncertainty_score":0.76224524},"labels":[],"label_agreement":null},{"id":"W3178736812","doi":"10.1158/1538-7445.am2021-2974","title":"Abstract 2974: Loss of <i>TSC1</i> or <i>TSC2</i> drives lineage infidelity and hamartoma formation in a renal organoid model of angiomyolipoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Ottawa Hospital","funders":"","keywords":"TSC1; Angiomyolipoma; Biology; TSC2; Organoid; mTORC1; Induced pluripotent stem cell; Lineage markers; Pathology; Cancer research; Cell biology; Kidney; Stem cell; PI3K/AKT/mTOR pathway; Progenitor cell; Genetics; Medicine; Gene; Signal transduction; Embryonic stem cell","score_opus":0.0958769667578749,"score_gpt":0.38242890406790514,"score_spread":0.28655193731003026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178736812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956688,0.0020760437,0.000102986676,0.00060149434,0.000019573583,0.00045210813,0.00007752279,0.000010979795,0.0009904797],"genre_scores_gemma":[0.9971283,0.0012142353,0.0009183136,0.000053464308,0.000056283006,0.000065975204,0.000039419876,0.000021186363,0.0005028226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997954,0.00010831547,0.0005465368,0.0003056402,0.0007262501,0.00035925081],"domain_scores_gemma":[0.99835443,0.00018238573,0.000114221264,0.00040924578,0.000771956,0.00016775471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005917866,0.00014194331,0.00043568877,0.00027112124,0.00004422274,0.000016420743,0.0001003802,0.00009613832,0.00015885885],"category_scores_gemma":[0.00021119078,0.00011232054,0.00007780899,0.00068791857,0.00025843072,0.00018900828,0.00014326841,0.00033988358,0.000003548895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015086139,0.00030582186,0.012778577,0.0012804692,0.000057990095,0.0005151702,0.0014626961,0.00025513605,0.97907454,0.000073521725,0.0005618312,0.0021256502],"study_design_scores_gemma":[0.0024571754,0.00028587517,0.03807253,0.0005534155,0.000029574214,0.0000964624,0.00029913036,0.0019750998,0.95588905,0.000095093754,0.0001536299,0.00009293813],"about_ca_topic_score_codex":0.00058191107,"about_ca_topic_score_gemma":0.0008441861,"teacher_disagreement_score":0.025293952,"about_ca_system_score_codex":0.00025209127,"about_ca_system_score_gemma":0.000898401,"threshold_uncertainty_score":0.45802984},"labels":[],"label_agreement":null},{"id":"W3178794077","doi":"10.1158/1538-7445.am2021-2472","title":"Abstract 2472: Effective ER antagonists resist conformational restrictions imposed by somatic mutation but do not correlate with effects on receptor stability in live cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Estrogen receptor; Receptor; Estrogen receptor alpha; Mutant; Biology; Mutation; Cancer research; Cell biology; Chemistry; Genetics; Cancer; Breast cancer","score_opus":0.01284090760516128,"score_gpt":0.3075583302617151,"score_spread":0.2947174226565538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178794077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650633,0.0012003605,0.000022884664,0.00026619382,0.0001820208,0.000984186,0.00014022013,0.00001456958,0.00068324886],"genre_scores_gemma":[0.99795115,0.0007398721,0.000068364716,0.000059024343,0.00009380196,0.00041666868,0.0003988612,0.00002788617,0.0002443789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978676,0.0004944599,0.00025329704,0.00048157317,0.00047440937,0.00042868665],"domain_scores_gemma":[0.99862516,0.0004496861,0.00008752199,0.00033091815,0.00035846047,0.00014823275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005943056,0.00018707186,0.00019540967,0.000106177875,0.00023721094,0.00006445349,0.00013370962,0.00026941518,0.000080224054],"category_scores_gemma":[0.00024029413,0.00016038027,0.00006651685,0.0003736867,0.00017321031,0.000017745877,0.00006218467,0.00066190865,0.00008777395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012258169,0.00019115534,0.0008594933,0.00019938071,0.00010362474,0.000055693676,0.00023473868,0.00023796584,0.99193877,0.000018577373,0.002732561,0.0022022366],"study_design_scores_gemma":[0.0017066369,0.0007327365,0.016923537,0.00022231898,0.000014173451,0.000009205159,0.00022401652,0.00006080396,0.97929585,0.00002554516,0.0005955882,0.00018959331],"about_ca_topic_score_codex":0.0002640533,"about_ca_topic_score_gemma":0.0000879596,"teacher_disagreement_score":0.016064044,"about_ca_system_score_codex":0.00028277253,"about_ca_system_score_gemma":0.00060717284,"threshold_uncertainty_score":0.6540117},"labels":[],"label_agreement":null},{"id":"W3178814489","doi":"10.1158/1538-7445.am2021-1737","title":"Abstract 1737: Understanding the geometry and valency of bispecific antibodies in the optimization of tumor-dependent activation of 4-1BB","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody; Bispecific antibody; Antigen; Epitope; Potency; Cancer research; Chemistry; T cell; Immunology; Molecular biology; Medicine; Biology; In vitro; Biochemistry; Monoclonal antibody; Immune system","score_opus":0.1756450794103638,"score_gpt":0.4195745582058641,"score_spread":0.24392947879550028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178814489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908485,0.0032333802,0.00017319969,0.0025735572,0.000029316781,0.00030125654,0.000026051439,0.0000020447005,0.00281272],"genre_scores_gemma":[0.9935905,0.0059839357,0.00007149569,0.000022550952,0.000053487187,0.000013581632,0.000010388981,0.000008016573,0.00024608758],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815494,0.00018525118,0.00029654222,0.00016507946,0.0009807118,0.00021747613],"domain_scores_gemma":[0.9984624,0.0007741337,0.000086761465,0.00022736572,0.0004138345,0.000035511108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013868843,0.00006999699,0.00021445012,0.00026896235,0.00009388651,0.000014516201,0.00014948029,0.000040856954,0.00030079027],"category_scores_gemma":[0.0003002473,0.000040618437,0.00004755688,0.00084598246,0.00044633268,0.0000650616,0.00009773735,0.00037314306,5.888983e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020518308,0.00072213664,0.3264115,0.005108488,0.00028329765,0.00010665607,0.0074280393,0.004482193,0.63069195,0.015298125,0.0010705189,0.0063452586],"study_design_scores_gemma":[0.0014172107,0.00036435496,0.6096951,0.001552162,0.000029663357,0.00003563628,0.02582273,0.0009855067,0.35756397,0.0021039299,0.00030109452,0.00012867973],"about_ca_topic_score_codex":0.00073103135,"about_ca_topic_score_gemma":0.00007546197,"teacher_disagreement_score":0.2832836,"about_ca_system_score_codex":0.00009456473,"about_ca_system_score_gemma":0.00030570873,"threshold_uncertainty_score":0.32934424},"labels":[],"label_agreement":null},{"id":"W3178821569","doi":"10.1158/1538-7445.am2021-2726","title":"Abstract 2726: Characterization of immune microenvironment and heterogeneity in breast cancer subtypes","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Tumor microenvironment; Biology; Immune system; Breast cancer; Cancer research; Context (archaeology); Tumor progression; Immunology; Cancer; Genetics","score_opus":0.02518071033300133,"score_gpt":0.2964461163041518,"score_spread":0.27126540597115045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178821569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339825,0.0058218255,0.00002267198,0.00016561072,0.0001527561,0.00014257124,0.00023231421,0.000016387557,0.00004758984],"genre_scores_gemma":[0.9812099,0.018535286,0.000017425367,0.0000106855505,0.000059198966,0.00006882843,0.000023158434,0.000030564235,0.000045003027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905074,0.000018804994,0.00022779126,0.0001732382,0.00023518119,0.00029427718],"domain_scores_gemma":[0.9996288,0.000028133476,0.00002490723,0.00019363171,0.00006686036,0.00005767108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019400078,0.000097447766,0.00017176919,0.000100925936,0.000032716973,0.000022012411,0.00009726943,0.00006628838,0.00031566466],"category_scores_gemma":[0.0000053824087,0.000101875485,0.00002715212,0.00026597848,0.00008180767,0.000122024736,0.000059309255,0.00023088693,0.000005192579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003583973,0.00002257956,0.02437016,0.00025429242,0.000033161712,0.00001053819,0.00014811754,0.00049315294,0.9652927,0.0000067661013,0.000012820097,0.009319882],"study_design_scores_gemma":[0.0002464354,0.000004903345,0.41130218,0.00012170832,0.000002946188,0.0000029881326,0.000019948504,0.00011491713,0.58756894,0.000015954178,0.0005300742,0.000069016496],"about_ca_topic_score_codex":0.00037017636,"about_ca_topic_score_gemma":0.00038558056,"teacher_disagreement_score":0.38693202,"about_ca_system_score_codex":0.00033518736,"about_ca_system_score_gemma":0.00008555485,"threshold_uncertainty_score":0.41543618},"labels":[],"label_agreement":null},{"id":"W3178830572","doi":"10.1158/1538-7445.am2021-2528","title":"Abstract 2528: Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; McMaster University; Western University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Rurality; Socioeconomic status; Quality of life (healthcare); Oncology; Cancer; Internal medicine; Gerontology; Demography; Rural area; Environmental health; Population; Pathology","score_opus":0.10763562150603093,"score_gpt":0.41365781251754286,"score_spread":0.30602219101151196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178830572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179673,0.0013088041,0.0000037876246,0.0041641537,0.00003950812,0.0007062716,0.00006246417,0.00003604783,0.0018822077],"genre_scores_gemma":[0.99813163,0.00067129865,0.00003560905,0.00028889487,0.000047250727,0.0003048676,0.000069815585,0.000032772794,0.00041784724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974695,0.00014430676,0.0004146016,0.00057036383,0.00078398566,0.0006172444],"domain_scores_gemma":[0.9983346,0.00016913208,0.0001774292,0.00032211383,0.0007812263,0.00021549003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008683796,0.0002015994,0.0004686407,0.00013856989,0.00015802357,0.00008979714,0.00008997971,0.000118179814,0.00038399693],"category_scores_gemma":[0.00024538513,0.00015204567,0.00003919857,0.0005318506,0.00019475777,0.00028371418,0.000080421625,0.00061829446,0.000004141752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011581014,0.000081119324,0.98691875,0.000078024575,0.0002510454,0.00029332488,0.000975897,0.00014110813,0.002229762,0.0000262178,0.00035255292,0.0074940976],"study_design_scores_gemma":[0.0038543823,0.00022468502,0.98906636,0.0006372991,0.000048617785,0.000013137178,0.0019199682,0.00012456009,0.0036352465,0.0001649078,0.00011148709,0.00019932158],"about_ca_topic_score_codex":0.009527281,"about_ca_topic_score_gemma":0.014848892,"teacher_disagreement_score":0.007294776,"about_ca_system_score_codex":0.0011006827,"about_ca_system_score_gemma":0.0016609265,"threshold_uncertainty_score":0.99706835},"labels":[],"label_agreement":null},{"id":"W3178864027","doi":"10.1158/1538-7445.am2021-lb098","title":"Abstract LB098: Vulnerability of <i>MTAP</i>-deleted nasopharyngeal carcinoma to MAT2A inhibition","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CDKN2A; Cancer research; Biology; Synthetic lethality; Cancer; Nasopharyngeal carcinoma; Gene; Copy-number variation; Genetics; Medicine; Genome; Internal medicine; Radiation therapy; DNA repair","score_opus":0.044686760134907196,"score_gpt":0.3708842069069306,"score_spread":0.3261974467720234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178864027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951297,0.0022614284,0.000093678034,0.0009421021,0.00018463559,0.0003228325,0.000097734504,0.000010253477,0.0009576053],"genre_scores_gemma":[0.99817926,0.00019017991,0.00012673634,0.00008622702,0.00044029034,0.00011541826,0.00021945467,0.000027800605,0.00061462325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998217,0.00016511093,0.00027949899,0.00051325903,0.00045219914,0.00037292237],"domain_scores_gemma":[0.9983412,0.000029616229,0.000053411954,0.0005370562,0.00088312547,0.00015561492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005589061,0.00011959262,0.0001682672,0.000095576004,0.00010106795,0.000024182697,0.00013648221,0.00018583228,0.00034610697],"category_scores_gemma":[0.00018144291,0.00013148533,0.00008897495,0.00050622266,0.00012368987,0.0000069006205,0.00018657531,0.00024893132,0.000020921849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024654463,0.00006003599,0.0016393602,0.00009809005,0.000028565188,0.000007718209,0.000061261824,0.0006753862,0.9833705,0.000028940147,0.007741959,0.0060416376],"study_design_scores_gemma":[0.00049440144,0.0001403932,0.039571162,0.00004717262,0.000006364319,0.0000064125884,0.00005475878,0.000023199165,0.9515817,0.00009501942,0.007853996,0.00012540795],"about_ca_topic_score_codex":0.00041279706,"about_ca_topic_score_gemma":0.0005180842,"teacher_disagreement_score":0.037931804,"about_ca_system_score_codex":0.00017502804,"about_ca_system_score_gemma":0.00068403257,"threshold_uncertainty_score":0.5361816},"labels":[],"label_agreement":null},{"id":"W3178882790","doi":"10.1158/1538-7445.am2021-286","title":"Abstract 286: Conception and preparation of new potent antimicrotubule agents","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Chemistry; Moiety; In vitro; Cancer research; Stereochemistry; Carcinogen; Pharmacology; Biochemistry; Medicine","score_opus":0.17432258615767393,"score_gpt":0.44021049810041174,"score_spread":0.2658879119427378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178882790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.000670988,0.00000615921,0.00039471377,0.00001904107,0.00004100038,0.000023374821,0.000007780847,0.004927197],"genre_scores_gemma":[0.9973634,0.0009088483,0.000042732503,0.000013681454,0.0001302344,0.000010500681,0.000010384256,0.0000036088645,0.0015166312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934715,0.000028166138,0.00009970186,0.00019060393,0.0001924714,0.0001419081],"domain_scores_gemma":[0.9995952,0.0000677776,0.000032304535,0.000121271594,0.00012188278,0.000061546285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001749613,0.0000453277,0.00009580114,0.0000133113745,0.000051560713,0.000023943348,0.00005953789,0.0000719115,0.0033664375],"category_scores_gemma":[0.00011108914,0.000035984463,0.000027262375,0.000073187526,0.00009516086,0.000046334106,0.00006315759,0.00012513477,0.000007303613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005286864,0.000054834913,0.0043732664,0.00006191747,0.000012175874,0.0000035963722,0.00005282037,0.0000034454492,0.94368553,0.00001785561,0.0023791245,0.049302556],"study_design_scores_gemma":[0.00014876068,0.00001374874,0.037243664,0.000056320143,0.0000025742424,0.0000012256319,0.00008245123,0.000019701869,0.9562719,0.00016837982,0.005949568,0.000041726093],"about_ca_topic_score_codex":0.00037229984,"about_ca_topic_score_gemma":0.000032072574,"teacher_disagreement_score":0.04926083,"about_ca_system_score_codex":0.000051074996,"about_ca_system_score_gemma":0.00011521307,"threshold_uncertainty_score":0.99754465},"labels":[],"label_agreement":null},{"id":"W3178905652","doi":"10.1158/1538-7445.am2021-1251","title":"Abstract 1251: Dithiocarb-copper complex, CuET, demonstrates anti-neoplastic activity in mouse model of prostate cancer and prevents recurrence of tumors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prostate cancer; Cancer; Metastasis; Medicine; Cancer research; Cancer cell; Apoptosis; PTEN; Prostate; In vivo; Oncology; Internal medicine; Biology; PI3K/AKT/mTOR pathway","score_opus":0.058430706166172935,"score_gpt":0.36660627797802037,"score_spread":0.3081755718118474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178905652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931952,0.005363239,0.000017635866,0.00008355994,0.00032163772,0.00028808767,0.000571798,0.0000032417086,0.00015561661],"genre_scores_gemma":[0.9847006,0.014155085,0.00009195642,0.00001397488,0.00035822758,0.000118581505,0.000024400992,0.000020662139,0.0005165198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984409,0.00010841547,0.0002752473,0.000450966,0.0003272693,0.00039716103],"domain_scores_gemma":[0.9991115,0.000044371103,0.00010436818,0.00029604151,0.0003318569,0.00011191116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038076568,0.00014736879,0.00032558333,0.00009468051,0.000054062068,0.000016625649,0.00017506613,0.000106814674,0.000024998822],"category_scores_gemma":[0.00012872572,0.00014556409,0.000055788536,0.00023536095,0.00036377812,0.0000145855,0.00018144473,0.00027656884,4.3852995e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002228672,0.0001311356,0.026199196,0.00037717988,0.00003705897,4.5282798e-7,0.00016705661,0.0020241945,0.9647089,0.000019168478,0.0008691719,0.0052435724],"study_design_scores_gemma":[0.0008581021,0.00006938325,0.049894057,0.00024316506,0.000010835512,0.0000018652734,0.00012615445,0.00071696664,0.94671875,0.000076960394,0.0011117493,0.00017202555],"about_ca_topic_score_codex":0.0014807828,"about_ca_topic_score_gemma":0.0023550915,"teacher_disagreement_score":0.023694862,"about_ca_system_score_codex":0.00004509094,"about_ca_system_score_gemma":0.0012167639,"threshold_uncertainty_score":0.5935931},"labels":[],"label_agreement":null},{"id":"W3178981676","doi":"10.1158/1538-7445.am2021-2897","title":"Abstract 2897: The metastatic potential of high-grade serous ovarian cancer cells along disease progression","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Serous fluid; Ovarian cancer; Metastasis; Medicine; Cancer; Cancer research; Extracellular matrix; Pathology; Fibronectin; Disease; Cell migration; Cell; Internal medicine; Biology; Cell biology","score_opus":0.0405173715859188,"score_gpt":0.40119169990784925,"score_spread":0.36067432832193047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178981676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804516,0.016216002,0.00004544943,0.001964868,0.0002108953,0.00053463643,0.00047106316,0.0000071882637,0.000098319506],"genre_scores_gemma":[0.992838,0.0050966023,0.00008577453,0.000061333,0.00032498717,0.0005420889,0.00016246435,0.00003436373,0.0008543358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757075,0.0002753228,0.00022101348,0.00049598544,0.0008265339,0.0006103665],"domain_scores_gemma":[0.99851257,0.000039696733,0.00006939135,0.0006184122,0.00046333717,0.00029659297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040175905,0.00015692611,0.00018024955,0.00006237205,0.00024979253,0.000075925745,0.00036410365,0.0000624124,0.00046800668],"category_scores_gemma":[0.00007724574,0.00011072681,0.0001277457,0.0003384766,0.00030145704,0.000009306882,0.00031118802,0.00029266576,0.000013572866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000749976,0.00036694898,0.002182807,0.0002162588,0.00039741752,0.00033885296,0.00005338665,0.00045367048,0.968836,0.000051188334,0.0056485618,0.020704916],"study_design_scores_gemma":[0.0014569206,0.00014395491,0.027801065,0.00013063973,0.000056362696,0.0000060721572,0.00010815623,0.000024000037,0.9622716,0.0002846204,0.0075636567,0.00015297673],"about_ca_topic_score_codex":0.0063105617,"about_ca_topic_score_gemma":0.0024832091,"teacher_disagreement_score":0.025618259,"about_ca_system_score_codex":0.00010427329,"about_ca_system_score_gemma":0.0016807236,"threshold_uncertainty_score":0.9539724},"labels":[],"label_agreement":null},{"id":"W3178993652","doi":"10.1158/1538-7445.am2021-291","title":"Abstract 291: Development of optimized chemical probes targeting PI3Ka to deconvolute the role of class I PI3Ks isoforms in insulin signaling","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"PI3K/AKT/mTOR pathway; Gene isoform; Protein kinase B; Chemistry; Kinase; Chemical biology; Insulin receptor; Computational biology; Biochemistry; Cancer; Biology; Cancer research; Signal transduction; Insulin; Genetics; Gene","score_opus":0.04895795836441566,"score_gpt":0.36564777589518077,"score_spread":0.3166898175307651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178993652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947618,0.0010608931,0.00003081513,0.00049350737,0.0000073584583,0.000138397,0.000024709812,0.000011270152,0.0034712057],"genre_scores_gemma":[0.9962697,0.00007619436,0.0028771465,0.000015005223,0.0000783566,0.00040463454,0.000033756103,0.000017137616,0.00022809401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983459,0.000018584698,0.00053232367,0.0003080372,0.00041534178,0.0003798074],"domain_scores_gemma":[0.9987635,0.00036769174,0.00009579548,0.0003204399,0.0003529764,0.000099613404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069099513,0.00010806094,0.00022364088,0.000042070908,0.00010716322,0.000022308352,0.00042945298,0.000109245135,0.0010589607],"category_scores_gemma":[0.00038431448,0.0000896619,0.00005893332,0.00048710583,0.00011398888,0.000046261885,0.00027192148,0.0005132337,0.00000815137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083335646,0.0001337143,0.00055577053,0.00025457214,0.000027919155,0.0000017591661,0.0015096144,0.00053366716,0.9899305,0.00005319528,0.00009252746,0.0068233954],"study_design_scores_gemma":[0.00038738424,0.000002329991,0.000103216276,0.0002763747,0.0000031143784,7.9492423e-7,0.0026092494,0.00015837923,0.9899023,0.00030025782,0.006157467,0.00009912559],"about_ca_topic_score_codex":0.0000967695,"about_ca_topic_score_gemma":0.000032810596,"teacher_disagreement_score":0.00672427,"about_ca_system_score_codex":0.00020826927,"about_ca_system_score_gemma":0.0007702117,"threshold_uncertainty_score":0.9998542},"labels":[],"label_agreement":null},{"id":"W3179030148","doi":"10.1158/1538-7445.am2021-208","title":"Abstract 208: Development of Evidence Statement curation algorithms to aid cancer variant interpretation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Data curation; Statement (logic); Computer science; Interpretation (philosophy); Clinical trial; Evidence-based medicine; Prioritization; Data science; Medicine; Alternative medicine; Pathology; Management science; Political science","score_opus":0.14811633396612187,"score_gpt":0.4561982996584764,"score_spread":0.3080819656923546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179030148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421426,0.0068849735,0.016497677,0.0013706636,0.00039615514,0.00038031823,0.00009592625,0.0000044292888,0.00015557893],"genre_scores_gemma":[0.98829955,0.0052268454,0.0050895154,0.00017209881,0.00024172133,0.000381035,0.0000774444,0.000018943185,0.0004928632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986433,0.000054588865,0.00031285168,0.00035840875,0.0003610061,0.0002698828],"domain_scores_gemma":[0.99868464,0.00005606563,0.000065744825,0.0002611144,0.00081614585,0.0001162971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057002914,0.00009273779,0.00011411242,0.000062239866,0.000089709356,0.000045138997,0.00016693327,0.00006016756,0.00021225981],"category_scores_gemma":[0.0002876034,0.000086371845,0.00003390757,0.0002136874,0.000040056915,0.000010036553,0.00019630554,0.000106143816,0.00001261527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017581442,0.000054294414,0.00049109216,0.00009733705,0.00005915863,0.000007965317,0.00070977415,0.0019722464,0.87583876,0.000035694702,0.0040221005,0.11653575],"study_design_scores_gemma":[0.0002484186,0.00010131116,0.005410071,0.00029035544,0.0000069573907,0.0000011885243,0.00019037262,0.000123554,0.9335283,0.000051143656,0.059912737,0.00013559866],"about_ca_topic_score_codex":0.00048094912,"about_ca_topic_score_gemma":0.0020608515,"teacher_disagreement_score":0.11640015,"about_ca_system_score_codex":0.00024611678,"about_ca_system_score_gemma":0.002029595,"threshold_uncertainty_score":0.3600414},"labels":[],"label_agreement":null},{"id":"W3179037057","doi":"10.1158/1538-7445.am2021-3153","title":"Abstract 3153: Targeting the stress response kinase GCN2 to restore immunity in the tumor microenvironment","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Integrated stress response; Tumor microenvironment; Immune system; Cancer research; Kinase; Biology; T cell; Cancer cell; Cancer; Cell biology; Chemistry; Immunology; Biochemistry; Translation (biology)","score_opus":0.05067173055874241,"score_gpt":0.3612885193697223,"score_spread":0.31061678881097987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179037057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95848495,0.029450001,0.0000022681004,0.010194366,0.00061225164,0.00058977294,0.000081870174,0.000015227182,0.0005693183],"genre_scores_gemma":[0.99345934,0.0007523363,0.00002111992,0.0009780244,0.00009284402,0.0005082346,0.000038725557,0.0000316035,0.0041177594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994596,0.003438076,0.00035265912,0.0004565579,0.00022699194,0.0009297072],"domain_scores_gemma":[0.9967429,0.001814585,0.00006456948,0.0011886996,0.00015582521,0.00003341088],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005381886,0.00018656134,0.00021595313,0.00013178961,0.0007741105,0.00007427638,0.0012481853,0.00013374301,0.0023613295],"category_scores_gemma":[0.0009669366,0.00012253896,0.0000834347,0.0006281591,0.00061968045,0.00006211776,0.00062777154,0.002111534,0.00065006764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00136724,0.00016331467,0.002181815,0.000034808432,0.000042665495,0.00019272465,0.004563626,0.000116556,0.95877385,0.00004869674,0.030800184,0.0017145203],"study_design_scores_gemma":[0.0006297379,0.000082377854,0.11926223,0.00015848121,0.0000067183123,0.000022197699,0.009125683,4.9325484e-7,0.5741879,0.000035973844,0.2963343,0.00015391037],"about_ca_topic_score_codex":0.0023889951,"about_ca_topic_score_gemma":0.0009393401,"teacher_disagreement_score":0.38458598,"about_ca_system_score_codex":0.0006419726,"about_ca_system_score_gemma":0.0005811456,"threshold_uncertainty_score":0.99855065},"labels":[],"label_agreement":null},{"id":"W3179094822","doi":"10.1158/1538-7445.am2021-457","title":"Abstract 457: A comparison of IDH1 R132H [H09] and [IHC132] antibodies on diffuse gliomas","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"IDH1; Oligodendroglioma; Astrocytoma; Immunohistochemistry; Pathology; IDH2; Glioma; Monoclonal antibody; Medicine; Biology; Cancer research; Antibody; Mutation; Immunology; Genetics","score_opus":0.15448556800396449,"score_gpt":0.480764247139875,"score_spread":0.32627867913591047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179094822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98235816,0.011453796,3.9172733e-7,0.0024001629,0.00007260008,0.00026729557,0.000033014916,0.000015191154,0.0033994126],"genre_scores_gemma":[0.9971754,0.0023256026,0.000051321596,0.000055743578,0.00009661148,0.00007631339,0.000017024682,0.000018815363,0.00018317722],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839234,0.00005839172,0.00021723856,0.00031785687,0.00068038015,0.00033376747],"domain_scores_gemma":[0.9987676,0.00027638517,0.000042522533,0.0003427683,0.000389261,0.00018142334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023346177,0.000117592106,0.00037648604,0.00021414648,0.00010643356,0.000035026726,0.000064443644,0.00007640222,0.00035391224],"category_scores_gemma":[0.00017443759,0.00009113175,0.00006715898,0.00037881677,0.00019720722,0.000036612164,0.000087113425,0.00030152735,0.00003132917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045231605,0.0031580778,0.48142478,0.00065521983,0.00034075967,0.0010444795,0.0011126483,0.000007994016,0.46930364,0.0010842494,0.015095787,0.026320046],"study_design_scores_gemma":[0.0024482259,0.00037747843,0.44084993,0.00054251356,0.000040288505,0.000014765533,0.00061490515,0.000022662216,0.5503642,0.00011265992,0.004533076,0.000079332516],"about_ca_topic_score_codex":0.00069718825,"about_ca_topic_score_gemma":0.00028933838,"teacher_disagreement_score":0.08106053,"about_ca_system_score_codex":0.00011899189,"about_ca_system_score_gemma":0.00021516746,"threshold_uncertainty_score":0.38750908},"labels":[],"label_agreement":null},{"id":"W3179095419","doi":"10.1158/1538-7445.am2021-3091","title":"Abstract 3091: Relevance of iNOS expression in bladder cancer stem cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation and Economic Development Trois Rivières; Université du Québec à Trois-Rivières","funders":"","keywords":"Homeobox protein NANOG; Cancer stem cell; Nitric oxide synthase; Cancer research; Cancer; Bladder cancer; Medicine; CD44; Pharmacology; Nitric oxide; Biology; Cell; Induced pluripotent stem cell; Internal medicine; Gene; Embryonic stem cell","score_opus":0.04978842742104913,"score_gpt":0.3725734861766841,"score_spread":0.322785058755635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179095419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92367977,0.074003614,0.000021207929,0.0002180772,0.0008622166,0.00022214648,0.00009435014,0.0000052426117,0.00089339283],"genre_scores_gemma":[0.9394499,0.052531525,0.0000925577,0.00008650234,0.0011951241,0.00022275982,0.000017452701,0.00003533578,0.0063688545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815094,0.00013719941,0.00028586894,0.0005135282,0.00043054196,0.0004819131],"domain_scores_gemma":[0.9988104,0.000042827305,0.000073608586,0.0005118529,0.0004413539,0.00011991874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000411477,0.00013553521,0.00023380027,0.00009106883,0.000060341,0.000020975087,0.0002710556,0.00018612578,0.00038849583],"category_scores_gemma":[0.000058599268,0.00013209396,0.00008257111,0.00035728863,0.00018405866,0.0000087697645,0.00021460386,0.0003495348,0.0000091379015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013631073,0.000073006355,0.0005990706,0.00011993506,0.000024088791,0.000006652932,0.00013151855,0.00024224223,0.96086264,0.000015965594,0.017001867,0.020786732],"study_design_scores_gemma":[0.00053759327,0.000025416513,0.003039741,0.00013628957,0.0000039548345,0.0000010396838,0.00016798156,0.000003393599,0.7634179,0.000025182693,0.23252866,0.000112852584],"about_ca_topic_score_codex":0.0005694837,"about_ca_topic_score_gemma":0.0013793486,"teacher_disagreement_score":0.21552679,"about_ca_system_score_codex":0.00007195884,"about_ca_system_score_gemma":0.0009753583,"threshold_uncertainty_score":0.53866357},"labels":[],"label_agreement":null},{"id":"W3179168710","doi":"10.1158/1538-7445.am2021-ct252","title":"Abstract CT252: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ruxolitinib Plus Parsaclisib in Patients with JAK- and PI3K-Inhibitor Treatment-Naïve Myelofibrosis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Gastroenterology; Placebo; International Prognostic Scoring System; Polycythemia vera; Randomization; Anemia; Randomized controlled trial; Surgery; Bone marrow; Myelodysplastic syndromes; Pathology","score_opus":0.08149661003398903,"score_gpt":0.41382205842461756,"score_spread":0.3323254483906285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179168710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588395,0.001724224,0.0000011539188,0.00044871765,0.00006927748,0.010845875,0.00009892022,0.000018105118,0.0009098033],"genre_scores_gemma":[0.9906363,0.0009267111,0.00005931137,0.000033058368,0.00012833021,0.007515948,0.00009920191,0.000049216374,0.00055194466],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961386,0.00052967307,0.00078046275,0.00078685675,0.0011159014,0.0006485478],"domain_scores_gemma":[0.9966955,0.0013218023,0.00018911042,0.0004983729,0.00093908666,0.00035611153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089420367,0.0003780664,0.0019586263,0.00041799774,0.0001613912,0.00008425528,0.000088159024,0.00012228072,0.0004822071],"category_scores_gemma":[0.0002523629,0.00024050378,0.00016751171,0.000609411,0.00025847138,0.00012954346,0.00007874163,0.00035661954,0.000010447613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85227823,0.011565437,0.12719405,0.00014274818,0.0015874723,0.00028000734,0.0029037131,0.000025705545,0.00026402314,0.00004462504,0.00010075442,0.0036132182],"study_design_scores_gemma":[0.95851046,0.0058446033,0.022763021,0.0005504054,0.00047767695,0.0000036629656,0.0016262195,0.000037380036,0.009881003,0.000012006811,0.0000998222,0.00019374753],"about_ca_topic_score_codex":0.0020062025,"about_ca_topic_score_gemma":0.0018667959,"teacher_disagreement_score":0.1062322,"about_ca_system_score_codex":0.0006951799,"about_ca_system_score_gemma":0.0011162605,"threshold_uncertainty_score":0.980746},"labels":[],"label_agreement":null},{"id":"W3179219421","doi":"10.1158/1538-7445.am2021-1546","title":"Abstract 1546: Defining the immune microenvironment in Ewing's sarcoma to potentiate IL1RAP-targeted CAR-T immunotherapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chimeric antigen receptor; Stromal cell; Cancer research; T cell; Tumor microenvironment; Medicine; Immunotherapy; Immune system; Cytokine; Biology; Immunology","score_opus":0.04865885854201953,"score_gpt":0.37405951825854866,"score_spread":0.32540065971652915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179219421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94469666,0.039021853,0.000012015923,0.011743748,0.00019950034,0.001150575,0.000028125502,0.000034635304,0.003112887],"genre_scores_gemma":[0.98015404,0.007393302,0.00020088113,0.00081345206,0.00021303335,0.0004908091,0.000045815454,0.000116319956,0.010572361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995227,0.00047610537,0.00053374533,0.0007274852,0.0016178042,0.0014178875],"domain_scores_gemma":[0.9976659,0.00038196892,0.000052588493,0.0012892074,0.00031084788,0.00029949512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026430131,0.00026243972,0.0004814617,0.00044658405,0.00034452026,0.00015161461,0.00057101937,0.0001479845,0.018073408],"category_scores_gemma":[0.00020426742,0.00021000554,0.00021856584,0.0015465883,0.0002961643,0.00008673573,0.00040112436,0.0017656869,0.0004448167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010831215,0.0002307429,0.006159012,0.00007179126,0.00017901206,0.0005317456,0.0013964842,0.000082362436,0.91880774,0.00005101051,0.0012279546,0.070179015],"study_design_scores_gemma":[0.0028074437,0.00023559378,0.29181537,0.0003650798,0.000011211165,0.000054860204,0.001436034,0.000024782763,0.6204072,0.00008445749,0.0825265,0.00023145213],"about_ca_topic_score_codex":0.0034380183,"about_ca_topic_score_gemma":0.0005119882,"teacher_disagreement_score":0.29840052,"about_ca_system_score_codex":0.001299368,"about_ca_system_score_gemma":0.0009861608,"threshold_uncertainty_score":0.9828242},"labels":[],"label_agreement":null},{"id":"W3179219574","doi":"10.1158/1538-7445.am2021-954","title":"Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD47; Cancer research; Lymphoma; Immune system; Phagocytosis; Antibody; Innate immune system; Immune checkpoint; Antibody-dependent cell-mediated cytotoxicity; Immunology; Cytotoxicity; In vivo; Monoclonal antibody; Chemistry; Biology; Immunotherapy; In vitro; Biochemistry","score_opus":0.15170617068020367,"score_gpt":0.4726794218566161,"score_spread":0.3209732511764124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179219574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775554,0.01015284,0.000052929227,0.00040302327,0.0006621819,0.0003757246,0.00015004822,0.00003095751,0.00041677695],"genre_scores_gemma":[0.98919535,0.007811024,0.000015827127,0.000063217296,0.00007104683,0.000034386714,0.00020833361,0.00003182516,0.0025689881],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9957247,0.0013136506,0.0013294466,0.00071329344,0.00021053138,0.00070837105],"domain_scores_gemma":[0.99762946,0.0008187175,0.00023219126,0.000735721,0.00051451323,0.000069422946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020776978,0.0002064599,0.00083315175,0.00023535013,0.00013260609,0.00003220648,0.0004479702,0.00064652285,0.0014536778],"category_scores_gemma":[0.00030672402,0.00018613186,0.00029290645,0.00056487194,0.0006705435,0.00016317189,0.00034732203,0.00086850923,0.00012837676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00114867,0.0026094797,0.08523435,0.00017222473,0.00054114754,0.000055149307,0.0005753226,0.00012345744,0.87608606,0.0003911258,0.0035161043,0.029546918],"study_design_scores_gemma":[0.0049304613,0.00021293042,0.82433075,0.00024992105,0.000023287244,0.0000058734836,0.00007619675,0.000303739,0.16491097,0.00016000736,0.0046003195,0.00019553765],"about_ca_topic_score_codex":0.0010389352,"about_ca_topic_score_gemma":0.00016018341,"teacher_disagreement_score":0.7390964,"about_ca_system_score_codex":0.00011671779,"about_ca_system_score_gemma":0.00083285896,"threshold_uncertainty_score":0.99945915},"labels":[],"label_agreement":null},{"id":"W3179222450","doi":"10.1158/1538-7445.am2021-2627","title":"Abstract 2627: Socioeconomic status and utilization of major surgical procedures in the United States, Canada, and Australia","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Residence; Demography; Socioeconomic status; Population; Australian population; Per capita; Census; Geography; Gerontology; Environmental health","score_opus":0.2145200230231602,"score_gpt":0.46128245157457665,"score_spread":0.24676242855141645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179222450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450225,0.003168252,3.2930112e-7,0.0019580384,0.000018289034,0.00017908947,0.000042398722,0.0000024176848,0.00012891732],"genre_scores_gemma":[0.9964515,0.0030286228,0.000010187775,0.00017400611,0.00003846497,0.000023790737,0.000050202678,0.000005428457,0.00021779495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998964,0.000076465854,0.00016451979,0.00017459985,0.0003309036,0.00028950223],"domain_scores_gemma":[0.99938947,0.00015372944,0.00002815273,0.00010905097,0.00021694422,0.00010262502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047018807,0.000060269147,0.00013816965,0.00007685738,0.00005949584,0.000026573614,0.000052920874,0.00004375378,0.00026342893],"category_scores_gemma":[0.00010315643,0.00004557671,0.000010796401,0.0002748909,0.00015340323,0.000047317815,0.00003379116,0.0002705575,6.3693915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005507388,0.00004802642,0.9773656,0.0007969091,0.000054742002,0.0005236233,0.0022085255,0.00015573962,0.0016478889,0.00072907755,0.013151946,0.0027671678],"study_design_scores_gemma":[0.0010253437,0.00006814978,0.98084646,0.00021836141,0.000012088968,0.000039731694,0.004864582,0.000089314955,0.002145141,0.00020580535,0.010418127,0.00006690659],"about_ca_topic_score_codex":0.78545994,"about_ca_topic_score_gemma":0.8176144,"teacher_disagreement_score":0.03215447,"about_ca_system_score_codex":0.0002299603,"about_ca_system_score_gemma":0.0017574851,"threshold_uncertainty_score":0.31177032},"labels":[],"label_agreement":null},{"id":"W3179257080","doi":"10.1158/1538-7445.am2021-2255","title":"Abstract 2255: The impact of primary immunodeficiency informed molecular landscape on the biology and prognosis of refractory malignancies","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Primary immunodeficiency; Biology; Transcriptome; Cancer; Immune system; Gene; Immunodeficiency; Computational biology; Gene expression; Immunology; Genetics","score_opus":0.05223443136007342,"score_gpt":0.3876361111715848,"score_spread":0.33540167981151137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179257080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793344,0.01728138,0.000008996309,0.00043744463,0.000020681337,0.00017863761,0.000059071353,0.0000016011206,0.0026777738],"genre_scores_gemma":[0.99269587,0.0069495095,0.000011803958,0.000048922073,0.00002807874,0.00011556092,0.000028785138,0.000008471782,0.00011301152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991925,0.00010595362,0.00017915397,0.00015581034,0.00016502615,0.00020155082],"domain_scores_gemma":[0.99901277,0.00009083794,0.00008201901,0.00042688198,0.00036172956,0.000025751935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004485102,0.000076576805,0.00011298363,0.000038996033,0.00009777027,0.000016103835,0.00023976756,0.00007568772,0.000088259396],"category_scores_gemma":[0.00014779248,0.000040707997,0.00008010172,0.00021025828,0.000382692,0.0000034282318,0.00011898975,0.0001523652,0.000001057728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007465012,0.0000568001,0.0044345264,0.000034653865,0.00006343071,5.5253196e-7,0.000115849085,0.000041709096,0.98911214,0.0005076862,0.0009347794,0.0046232073],"study_design_scores_gemma":[0.00025018863,0.0003645317,0.1438919,0.00005392862,0.000007691969,0.000002933031,0.0005566185,0.00000642609,0.84941053,0.00014084585,0.005233661,0.00008075179],"about_ca_topic_score_codex":0.00022941148,"about_ca_topic_score_gemma":0.000015523956,"teacher_disagreement_score":0.13970163,"about_ca_system_score_codex":0.00003159794,"about_ca_system_score_gemma":0.00079453766,"threshold_uncertainty_score":0.1660024},"labels":[],"label_agreement":null},{"id":"W3179328724","doi":"10.1158/1538-7445.am2021-314","title":"Abstract 314: Highly polymeric grape seed proanthocyanidins: A call for establishing the safe dose","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Grape seed extract; Proanthocyanidin; Catechin; Histopathology; H&E stain; Alanine transaminase; Chemistry; Feces; Staining; Pathology; Biology; Medicine; Biochemistry; Internal medicine; Polyphenol; Microbiology; Antioxidant","score_opus":0.10034658521987772,"score_gpt":0.4183696718664966,"score_spread":0.3180230866466189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179328724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594596,0.012818028,0.00005585411,0.022020115,0.00044954897,0.0015079664,0.000057491252,0.00006999283,0.0035614094],"genre_scores_gemma":[0.99163026,0.00061225105,0.00020063238,0.00069374475,0.0010152753,0.00070301554,0.000031092033,0.00005480325,0.0050589456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976625,0.00013875894,0.00022310282,0.00043212372,0.00071618875,0.00082737056],"domain_scores_gemma":[0.9978978,0.0008012564,0.000047458063,0.0005539068,0.00043907532,0.00026047154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011771615,0.0001534971,0.00028392414,0.000116630195,0.00040019993,0.00018401182,0.00025308164,0.00010774367,0.00024460955],"category_scores_gemma":[0.000885746,0.00010161436,0.00013585134,0.0007830594,0.00017371183,0.00013819899,0.00013020824,0.0007001153,0.000039427818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012151714,0.00031009896,0.0032372652,0.0011310035,0.00024156,0.00039225144,0.002252346,0.000014282688,0.86529744,0.0009835312,0.046420578,0.07850445],"study_design_scores_gemma":[0.00804933,0.0011130028,0.23606688,0.0015707838,0.00020415914,0.00016335685,0.0033346487,0.0005644225,0.43149734,0.0006956989,0.3160875,0.00065286],"about_ca_topic_score_codex":0.0021662642,"about_ca_topic_score_gemma":0.0003377077,"teacher_disagreement_score":0.4338001,"about_ca_system_score_codex":0.00024543027,"about_ca_system_score_gemma":0.0013216248,"threshold_uncertainty_score":0.41437134},"labels":[],"label_agreement":null},{"id":"W3179352926","doi":"10.1158/1538-7445.am2021-2689","title":"Abstract 2689: Investigating the molecular mechanisms linking disrupted growth homeostasis to tumourigenesis in Li-Fraumeni Syndrome","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"mTORC1; Cancer; Cellular stress response; Carcinogenesis; Cancer research; Unfolded protein response; Medicine; Biology; Bioinformatics; PI3K/AKT/mTOR pathway; Genetics; Internal medicine; Gene; Fight-or-flight response; Signal transduction","score_opus":0.06223044705945931,"score_gpt":0.3716575250500113,"score_spread":0.309427077990552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179352926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131007,0.005569122,0.0006678496,0.010299976,0.00021930743,0.0010858901,0.0000332824,0.00007513601,0.0007393885],"genre_scores_gemma":[0.99595845,0.00049830525,0.0012259026,0.0012942951,0.000106877895,0.00057263806,0.000038227605,0.00011494269,0.00019036431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99577373,0.00034225223,0.00048843364,0.00080593233,0.0015379835,0.0010516606],"domain_scores_gemma":[0.9976358,0.00025135718,0.000074895965,0.00084413966,0.00069111935,0.00050273025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016248531,0.0002677214,0.00045411353,0.0005156692,0.0002832541,0.00013710835,0.00041823598,0.0002102189,0.00038337611],"category_scores_gemma":[0.0012446949,0.00023143066,0.00015769435,0.0032601943,0.00016879862,0.000087973756,0.0004240201,0.0014702546,0.00011284582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009057389,0.0001243532,0.0006706833,0.00035119243,0.00013783493,0.005441681,0.001182972,0.0005041857,0.98123163,0.0014930145,0.0003456827,0.008426174],"study_design_scores_gemma":[0.0014543707,0.0002509932,0.029251691,0.0024256415,0.00007041378,0.00034278882,0.0011427783,0.00019007223,0.9602886,0.002942223,0.0012393113,0.00040113353],"about_ca_topic_score_codex":0.0017108626,"about_ca_topic_score_gemma":0.00062904233,"teacher_disagreement_score":0.028581008,"about_ca_system_score_codex":0.0010568394,"about_ca_system_score_gemma":0.0016750161,"threshold_uncertainty_score":0.94374686},"labels":[],"label_agreement":null},{"id":"W3179417079","doi":"10.1158/1538-7445.am2021-1412","title":"Abstract 1412: Whole exome sequencing reveals PI3K-ATK pathway alterations are frequent in relapsed small cell-lung cancer after chemoradiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Exome sequencing; Lung cancer; Copy-number variation; Cancer; Oncology; Primary tumor; Medicine; Chemotherapy; Exome; Internal medicine; Cancer research; Biology; Gene; Mutation; Genetics; Genome; Metastasis","score_opus":0.08756969921773325,"score_gpt":0.40525648446732193,"score_spread":0.3176867852495887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179417079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494287,0.034295287,0.000020013234,0.011466664,0.0003103984,0.0014560198,0.00026172673,0.00006562654,0.0026955823],"genre_scores_gemma":[0.98148745,0.004153711,0.00020696364,0.0005946526,0.00084523886,0.003773013,0.00007691047,0.00008636343,0.008775679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953318,0.0003375208,0.00062571495,0.00094755075,0.0014555082,0.0013018816],"domain_scores_gemma":[0.9968417,0.00032058812,0.00013387718,0.000804785,0.0014701876,0.0004288403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001542381,0.00030545142,0.0006060392,0.000538399,0.00032120178,0.00016769233,0.00025932773,0.00019979228,0.0014871892],"category_scores_gemma":[0.0007307723,0.00029114564,0.00014760513,0.001567337,0.00021069696,0.0002285056,0.00025924915,0.001608026,0.00008518587],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005504025,0.00033863293,0.1854625,0.00400285,0.00025027373,0.002823057,0.005455479,0.0009851917,0.7786334,0.000055731554,0.018066084,0.003376392],"study_design_scores_gemma":[0.008416824,0.00028711816,0.558314,0.008491548,0.00012678142,0.000037146896,0.004485471,0.0009521765,0.40179235,0.00047177493,0.015579761,0.0010450486],"about_ca_topic_score_codex":0.0038585071,"about_ca_topic_score_gemma":0.009238935,"teacher_disagreement_score":0.37684104,"about_ca_system_score_codex":0.006748592,"about_ca_system_score_gemma":0.004503379,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W3179446910","doi":"10.1158/1538-7445.am2021-3131","title":"Abstract 3131: Tumour spatial heterogeneity in breast cancer and the impact on clinical management","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Lumpectomy; Computational biology; Targeted therapy; Tissue microarray; Medicine; Pathology; Oncology; Biology; Cancer; Immunohistochemistry; Internal medicine; Mastectomy","score_opus":0.07406126000756398,"score_gpt":0.5000764452879315,"score_spread":0.4260151852803675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179446910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641176,0.0011754857,0.000010560679,0.03234183,0.00016797111,0.00031428668,0.000017974395,0.000010692831,0.0018435973],"genre_scores_gemma":[0.9916315,0.0065106526,0.0000277494,0.00079621765,0.00054136594,0.0000887301,0.0000065374134,0.000019877389,0.0003773669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981113,0.00028912496,0.00027171406,0.0003641678,0.0005515061,0.000412189],"domain_scores_gemma":[0.998993,0.00034354778,0.00003704252,0.00028033604,0.00011654438,0.00022953191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025976351,0.00010957508,0.00030206481,0.00009939044,0.0001068005,0.000062418774,0.00012811867,0.000058209658,0.0004880252],"category_scores_gemma":[0.00019305346,0.00006363746,0.000103884726,0.00025309305,0.00039405236,0.00002805841,0.00014769392,0.0013591169,0.000017450035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036974617,0.00043446492,0.57298,0.00027119755,0.00036962272,0.0015307879,0.00020074994,0.00042209824,0.0028271785,0.00031812798,0.010982847,0.40596548],"study_design_scores_gemma":[0.004627171,0.000056883797,0.9906047,0.0003981087,0.000020858311,0.000049331335,0.00007750543,0.002244764,0.0003166902,0.00010849214,0.0014210348,0.000074479794],"about_ca_topic_score_codex":0.0060594627,"about_ca_topic_score_gemma":0.00028824544,"teacher_disagreement_score":0.41762468,"about_ca_system_score_codex":0.00023305033,"about_ca_system_score_gemma":0.00031476642,"threshold_uncertainty_score":0.91601354},"labels":[],"label_agreement":null},{"id":"W3179498946","doi":"10.1158/1538-7445.am2021-ct191","title":"Abstract CT191: A window-of-opportunity study with atezolizumab and the oncolytic virus pelareorep in early breast cancer (AWARE-1)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Oncology; Cohort; Internal medicine; Breast cancer; Letrozole; Trastuzumab; Clinical endpoint; Cancer; Oncolytic virus; Immunotherapy; Pembrolizumab; Clinical trial; Tamoxifen","score_opus":0.052229394919889295,"score_gpt":0.3907557235460781,"score_spread":0.3385263286261888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179498946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933173,0.0040226695,0.0000021983515,0.0012243203,0.000035352237,0.00090563716,0.00013983321,0.000005830505,0.00034682744],"genre_scores_gemma":[0.9957525,0.003014332,0.000003712952,0.000105211104,0.00014210257,0.0005255285,0.0000143763955,0.000042696098,0.00039951454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99700713,0.00070924766,0.00028767853,0.000588592,0.0007976939,0.0006096756],"domain_scores_gemma":[0.9981671,0.00011512802,0.000072691866,0.000739518,0.00068742316,0.00021815248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017444015,0.00018954113,0.00031371025,0.00013645548,0.00018164248,0.0000741299,0.00042235997,0.00011326526,0.00027796545],"category_scores_gemma":[0.000099438126,0.0001332407,0.00005988689,0.0006363955,0.00079487666,0.000009494045,0.00033219054,0.0006409026,0.000003626339],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07235998,0.001401929,0.17946553,0.0002896395,0.0009547116,0.0006658895,0.003046155,0.0004087381,0.67370373,0.000044300985,0.00087434624,0.06678508],"study_design_scores_gemma":[0.019695913,0.0055685146,0.5173586,0.0003585352,0.00006285951,0.00008878295,0.004418676,0.00006433604,0.45028394,0.00019205445,0.0012570975,0.00065066485],"about_ca_topic_score_codex":0.0087626595,"about_ca_topic_score_gemma":0.03793673,"teacher_disagreement_score":0.3378931,"about_ca_system_score_codex":0.00014652431,"about_ca_system_score_gemma":0.0021547657,"threshold_uncertainty_score":0.9978381},"labels":[],"label_agreement":null},{"id":"W3179535367","doi":"10.1158/1538-7445.am2021-2686","title":"Abstract 2686: Preventive effects of saffron in a colitis mouse model","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Saffron Plant Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Colitis; Inflammatory bowel disease; Gastroenterology; Inflammation; Crocus sativus; Internal medicine; Colorectal cancer; Ulcerative colitis; Cancer; Immunology; Pharmacology; Disease; Traditional medicine","score_opus":0.08085149054792656,"score_gpt":0.45054727824874174,"score_spread":0.3696957877008152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179535367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887942,0.004999856,0.000019615076,0.0012275442,0.00004230341,0.0008546354,0.000083079525,0.000016833495,0.0039618956],"genre_scores_gemma":[0.98191696,0.0049486607,0.00018376973,0.000043457392,0.000068780246,0.000433668,0.000019564523,0.000022991078,0.012362119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742895,0.00019575954,0.00024771923,0.00037702132,0.0010857611,0.00066480367],"domain_scores_gemma":[0.99806476,0.00068781857,0.000034621444,0.00036138066,0.0006718204,0.00017962421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000766961,0.000116986506,0.0004014651,0.00032454892,0.000059526406,0.000014437115,0.00014331173,0.00008834194,0.00021026892],"category_scores_gemma":[0.001312822,0.00010621917,0.0000779307,0.0006204321,0.00024358569,0.00007488681,0.00024287612,0.00069376436,0.000025228415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001414244,0.00089322473,0.014658356,0.005222754,0.0002856442,0.0015449764,0.0018991902,0.00017349145,0.94837254,0.0007456055,0.016244568,0.00854542],"study_design_scores_gemma":[0.002704016,0.00023498917,0.13457023,0.0016264269,0.000017497303,0.000009231471,0.0004858527,0.00049637584,0.858526,0.0005969706,0.00060362346,0.00012882697],"about_ca_topic_score_codex":0.0012260218,"about_ca_topic_score_gemma":0.001358787,"teacher_disagreement_score":0.11991187,"about_ca_system_score_codex":0.0005009309,"about_ca_system_score_gemma":0.0014146084,"threshold_uncertainty_score":0.43314922},"labels":[],"label_agreement":null},{"id":"W3179541608","doi":"10.1158/1538-7445.am2021-432","title":"Abstract 432: Sarcopenia predicts dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Gemcitabine; Sarcopenia; Pancreatic cancer; Toxicity; Internal medicine; Cancer; Chemotherapy; Urology; Hazard ratio; Gastroenterology; Oncology; Surgery; Confidence interval","score_opus":0.1094588359426785,"score_gpt":0.41066246760563846,"score_spread":0.30120363166295994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179541608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452205,0.016737057,0.0000038688836,0.0038825527,0.00007519867,0.0014137392,0.00020393253,0.00006016277,0.0031014278],"genre_scores_gemma":[0.98793656,0.0064116684,0.00026399843,0.00029284818,0.0002470228,0.002464392,0.000095893585,0.00008284014,0.0022047567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960966,0.00021812358,0.00050714647,0.00086372945,0.001222447,0.0010919325],"domain_scores_gemma":[0.997593,0.000519524,0.00010527332,0.0006366156,0.00069556345,0.00045002156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006949541,0.00034056348,0.0008556859,0.0003287329,0.00019709724,0.00011095809,0.00016954583,0.00009733412,0.0026426956],"category_scores_gemma":[0.00027668767,0.00026012253,0.00011844584,0.0015795801,0.0002418963,0.00018855986,0.00012158615,0.000757742,0.0000468754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059903483,0.0029249513,0.83569854,0.0035262578,0.0025506613,0.0125629585,0.0027863127,0.0017893199,0.067618124,0.00025204537,0.007677929,0.056622528],"study_design_scores_gemma":[0.017027408,0.0009921679,0.8706516,0.005657415,0.0005045861,0.00011338032,0.0014398481,0.00048303878,0.09916633,0.000076053904,0.003390895,0.00049726316],"about_ca_topic_score_codex":0.020045483,"about_ca_topic_score_gemma":0.02102522,"teacher_disagreement_score":0.056125265,"about_ca_system_score_codex":0.003022275,"about_ca_system_score_gemma":0.0030342722,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W3179554841","doi":"10.1158/0008-5472.can-21-1040","title":"Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Medicine; Radiofrequency ablation; Indocyanine green; Ablation; Radiology; Pathology; Ex vivo; In vivo; Nuclear medicine; Internal medicine; Biology","score_opus":0.03741590745553266,"score_gpt":0.3423717073094008,"score_spread":0.30495579985386817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179554841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919729,0.0037733535,0.0035745976,0.000022035967,0.0001538464,0.0001308464,0.000039397208,0.000044345717,0.00028866983],"genre_scores_gemma":[0.99928623,0.00024047587,0.00029638415,0.000005900808,0.00005701435,0.00003317542,0.000014031766,0.000027812348,0.000038946735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987579,0.00006278116,0.00032859223,0.00019052855,0.00041132836,0.00024885373],"domain_scores_gemma":[0.99923307,0.00009824586,0.00003807461,0.00013203498,0.00043353115,0.00006505175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038607075,0.00009856178,0.00019888255,0.0001510684,0.00005755202,0.000025704894,0.000086119115,0.00004510563,0.00014844362],"category_scores_gemma":[0.00020625068,0.00009553266,0.00004651414,0.00044925787,0.00021179675,0.00014029363,0.00008581559,0.00022950352,0.0000018191527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001160019,0.000053542833,0.0020365217,0.0005035787,0.000030481675,0.00007752706,0.00019957122,0.0007093429,0.98861337,0.0010244099,0.000030535113,0.006605148],"study_design_scores_gemma":[0.00075061247,0.00016949639,0.014250729,0.00040127058,0.00001997754,0.000084458574,0.0004512704,0.007936909,0.97477865,0.0006720459,0.0003224386,0.00016214183],"about_ca_topic_score_codex":0.00002381529,"about_ca_topic_score_gemma":0.000058155994,"teacher_disagreement_score":0.01383469,"about_ca_system_score_codex":0.00017293141,"about_ca_system_score_gemma":0.00011845436,"threshold_uncertainty_score":0.38957086},"labels":[],"label_agreement":null},{"id":"W3179561240","doi":"10.1158/1538-7445.am2021-1879","title":"Abstract 1879: CIT-801: a bifunctional anti-PD1xIL15 agent demonstrated synergy and enhanced in vivo anti-tumor efficacy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Bifunctional; Cancer research; In vivo; Antibody; Chemistry; Population; Cytotoxicity; Cytokine; Immune system; Interleukin 2; In vitro; Immunology; Pharmacology; Biology; Medicine; Biochemistry","score_opus":0.044019226908825544,"score_gpt":0.3419651759107868,"score_spread":0.29794594900196125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179561240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878937,0.0044717668,0.00003582308,0.00049180177,0.0022349863,0.00021600907,0.000015126709,0.000048292175,0.004592472],"genre_scores_gemma":[0.98741406,0.0014764166,0.0000070707815,0.00016041574,0.00007431897,0.00008226548,0.00008232009,0.000022174241,0.010680951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980672,0.00033698938,0.00035824746,0.00053216313,0.00012458478,0.00058078906],"domain_scores_gemma":[0.99901307,0.00027176735,0.00007057072,0.0002598796,0.00033390705,0.0000508074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048030788,0.00017506715,0.00028671735,0.00033871995,0.0002975921,0.000066491695,0.00013539295,0.00020154686,0.015389468],"category_scores_gemma":[0.00021569742,0.00016962255,0.00007178604,0.00056332635,0.0002843851,0.00016818018,0.00011098108,0.0009325002,0.00048099374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034345442,0.00025052496,0.0009533898,0.00003537628,0.00010416472,0.000059824193,0.00013149937,0.000041488664,0.9846054,0.00017113356,0.01052223,0.0027815343],"study_design_scores_gemma":[0.0018486714,0.0001117791,0.09156292,0.00015438875,0.000009652309,0.00008683675,0.0006268617,0.000014516537,0.8235146,0.000021957545,0.08185397,0.00019388799],"about_ca_topic_score_codex":0.0007182776,"about_ca_topic_score_gemma":0.000219875,"teacher_disagreement_score":0.16109082,"about_ca_system_score_codex":0.0002064842,"about_ca_system_score_gemma":0.0004698615,"threshold_uncertainty_score":0.9855106},"labels":[],"label_agreement":null},{"id":"W3179579574","doi":"10.1158/1538-7445.am2021-2587","title":"Abstract 2587: Investigating the impact of chemotherapy on gut microbiota and microbiota-derived metabolites and their link to inflammation and cardiometabolic disorders in children with cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hypertriglyceridemia; Internal medicine; Metabolic syndrome; Overweight; Gastroenterology; Inflammation; Gut flora; Systemic inflammation; Obesity; Endocrinology; Population; Immunology; Triglyceride; Cholesterol","score_opus":0.020565350984615864,"score_gpt":0.34769235842256757,"score_spread":0.3271270074379517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179579574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417175,0.013227924,0.0000020661992,0.001943562,0.00001220733,0.0004926804,0.000119834396,0.0000027920196,0.000027173885],"genre_scores_gemma":[0.9864797,0.013079849,0.00007603135,0.000115650204,0.00011394952,0.00005014492,0.00003573947,0.0000230148,0.000025927773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998927,0.00012620294,0.00016861882,0.000377015,0.00007814584,0.00032300266],"domain_scores_gemma":[0.99943,0.000034281522,0.000057313424,0.00023884718,0.00013354782,0.000106021536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036731796,0.00016086634,0.00023673428,0.00011660527,0.00012273066,0.000058829817,0.00010318532,0.00009645472,0.0000131268],"category_scores_gemma":[0.000044034074,0.00010311557,0.000035091765,0.00033281045,0.0002818848,0.000007677687,0.00010859497,0.00023435756,2.7770784e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007177831,0.000012312461,0.07912011,0.0000438616,0.00012914099,1.3925779e-7,0.0007112638,0.000063742234,0.9014461,0.0000050689614,0.00009091641,0.018305538],"study_design_scores_gemma":[0.000522767,0.00007842865,0.6003514,0.00006376394,0.000004576249,0.000005202072,0.00012363239,0.0000027120207,0.39833102,0.0000122404335,0.0004215463,0.00008270641],"about_ca_topic_score_codex":0.0034629896,"about_ca_topic_score_gemma":0.0023638415,"teacher_disagreement_score":0.5212313,"about_ca_system_score_codex":0.000034870798,"about_ca_system_score_gemma":0.0003814158,"threshold_uncertainty_score":0.5235027},"labels":[],"label_agreement":null},{"id":"W3179701978","doi":"10.1158/1538-7445.am2021-2813","title":"Abstract 2813: A multiplexed, multispectral approach to analyzing the immune microenvironment of oral potentially malignant lesions","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"West Fraser (Canada); Fraser Institute; Dalhousie University; University of British Columbia","funders":"","keywords":"Immunohistochemistry; Immunostaining; Staining; Pathology; H&E stain; Immune system; Tumor microenvironment; Medicine; Antibody; Biology; Immunology","score_opus":0.0977807220864716,"score_gpt":0.3823993234959176,"score_spread":0.284618601409446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179701978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97657174,0.015391088,0.0007531586,0.004211621,0.00016352013,0.0010245803,0.00010686764,0.000016531154,0.0017608835],"genre_scores_gemma":[0.9879235,0.003095743,0.0061923135,0.00010587155,0.0001351841,0.0001752251,0.000029469182,0.000035169516,0.002307534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773353,0.00012925228,0.00036957208,0.00045017633,0.00070833793,0.0006091193],"domain_scores_gemma":[0.9987085,0.00007638175,0.000060409224,0.00066810026,0.00023859575,0.00024802095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090191374,0.00014737836,0.00037391673,0.00015165212,0.00020588697,0.000037765134,0.00023963623,0.00005999877,0.00077800633],"category_scores_gemma":[0.00009720053,0.000102799066,0.00022508854,0.0006377119,0.00020995531,0.000038467344,0.00024992798,0.00049476634,0.00003119385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028684767,0.00040670583,0.0009126605,0.00017011046,0.00018855216,0.00006711468,0.000526394,0.00041477513,0.9552447,0.00008249596,0.0011419193,0.040557697],"study_design_scores_gemma":[0.0017761238,0.00012940918,0.07261696,0.00030071763,0.00012448947,0.000039301955,0.001684354,0.000059247795,0.88841474,0.000013701725,0.034674432,0.00016651099],"about_ca_topic_score_codex":0.0038244592,"about_ca_topic_score_gemma":0.00039328993,"teacher_disagreement_score":0.07170429,"about_ca_system_score_codex":0.0003139449,"about_ca_system_score_gemma":0.000538442,"threshold_uncertainty_score":0.8518624},"labels":[],"label_agreement":null},{"id":"W3179731920","doi":"10.1158/1538-7445.am2021-881","title":"Abstract 881: Benchmarking genome-wide polygenic risk score development techniques in colorectal cancer risk prediction","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Genome-wide association study; Colorectal cancer; Population; Framingham Risk Score; Risk assessment; Cancer; Internal medicine; Genetics; Genotype; Biology; Computer science; Environmental health; Single-nucleotide polymorphism; Gene","score_opus":0.027733719364783086,"score_gpt":0.3338067512056877,"score_spread":0.3060730318409046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179731920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148,0.017075486,0.00010234832,0.0000770276,0.00016222644,0.00036898247,0.00030877814,0.000019742482,0.00040541586],"genre_scores_gemma":[0.9632394,0.034438517,0.00047740116,0.000050985982,0.0006762329,0.00061446195,0.00031835795,0.000031110467,0.00015358198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980231,0.00019236293,0.00029898054,0.0005902931,0.000379111,0.00051616505],"domain_scores_gemma":[0.9990375,0.000033755412,0.00007855301,0.00026213564,0.00040077005,0.0001873081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062918774,0.00015598857,0.00014575492,0.00014890557,0.00026826287,0.000056183777,0.00019830209,0.00018492753,0.00029015925],"category_scores_gemma":[0.00019427884,0.00016984285,0.000072905044,0.0003155654,0.0001335443,0.000007649052,0.00018336103,0.00037286538,0.000006028698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025012076,0.00012768958,0.5285258,0.00007518706,0.00006383552,0.000018846755,0.00014778123,0.000103372615,0.45196578,0.000001272501,0.0014955184,0.017224781],"study_design_scores_gemma":[0.00037273436,0.000059500886,0.50548095,0.00006742268,0.000009355214,0.000001349291,0.00009047637,0.0000072609555,0.47955197,0.00006679394,0.014161151,0.00013102578],"about_ca_topic_score_codex":0.0008418919,"about_ca_topic_score_gemma":0.0050127436,"teacher_disagreement_score":0.027586203,"about_ca_system_score_codex":0.0003090714,"about_ca_system_score_gemma":0.0015598414,"threshold_uncertainty_score":0.69259906},"labels":[],"label_agreement":null},{"id":"W3179855712","doi":"10.1158/1538-7445.am2021-260","title":"Abstract 260: Application of integrated analysis of whole genome sequencing and RNA sequencing to personalized therapy decision making in pediatric and young adult cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Transcriptome; Germline; Cancer; Somatic cell; Genome; Personalized medicine; Biology; Pediatric cancer; Germline mutation; Disease; Computational biology; Genomics; Gene; Mutation; Bioinformatics; Medicine; Genetics; Internal medicine; Gene expression","score_opus":0.06991204936496943,"score_gpt":0.4135214151309767,"score_spread":0.34360936576600726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179855712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983685,0.0154083185,0.000095911026,0.0002673487,0.000014495159,0.00040066685,0.000070626185,0.0000050605777,0.000052553227],"genre_scores_gemma":[0.9867626,0.012357887,0.0005241659,0.00004761349,0.000033981036,0.00022195633,0.000025971112,0.000013521658,0.000012340236],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859554,0.000060271886,0.00030438261,0.00035678665,0.0004489176,0.00023412958],"domain_scores_gemma":[0.9987041,0.00017911829,0.00008258273,0.00020376414,0.0007317419,0.00009872153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050018134,0.00010230585,0.00039129614,0.0008008301,0.000055050725,0.000021859592,0.000056505563,0.00006225545,0.00010744586],"category_scores_gemma":[0.00013513626,0.00008407355,0.000057154884,0.0024809947,0.00005774454,0.000051947165,0.00004602453,0.00017194728,6.3047105e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020954013,0.000050040377,0.42657557,0.00010577126,0.0002043414,0.000039611838,0.0019967072,0.0003883706,0.5325911,0.000019221012,0.0000104219935,0.037809264],"study_design_scores_gemma":[0.00173454,0.00009363082,0.9440562,0.00041802917,0.00020961836,0.000006039941,0.0023585742,0.001991469,0.04893306,0.000045539004,0.00005125642,0.00010206082],"about_ca_topic_score_codex":0.012053308,"about_ca_topic_score_gemma":0.006974858,"teacher_disagreement_score":0.5174806,"about_ca_system_score_codex":0.0007742764,"about_ca_system_score_gemma":0.00052458025,"threshold_uncertainty_score":0.9945255},"labels":[],"label_agreement":null},{"id":"W3179957602","doi":"10.1158/1538-7445.am2021-1013","title":"Abstract 1013: Mechanistic role of nelfinavir as drug-repurposing strategy against high-grade serous ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nelfinavir; Medicine; Drug; Pharmacology; Toxicity; Cisplatin; Debulking; Ovarian cancer; Auranofin; Cancer cell; Cancer; Clonogenic assay; Drug repositioning; Cancer research; Oncology; Chemotherapy; Internal medicine; Cell; Biology; Immunology","score_opus":0.044366665636527865,"score_gpt":0.3648101227556639,"score_spread":0.320443457119136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179957602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604026,0.032018334,0.000006449936,0.0010618558,0.00029801694,0.000504536,0.00057290884,0.00004637657,0.005088934],"genre_scores_gemma":[0.98757255,0.0041536763,0.000035600235,0.00007432289,0.00009422997,0.00038482586,0.0003259215,0.000041581705,0.007317291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969984,0.00051156257,0.00035750406,0.0006166444,0.0002947628,0.0012211056],"domain_scores_gemma":[0.9982353,0.0003034829,0.000087150955,0.00056898507,0.00061652286,0.00018857759],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006279077,0.00022835034,0.0004086356,0.00021497489,0.00044301216,0.000068433896,0.00040626872,0.00022876247,0.0062456303],"category_scores_gemma":[0.00019562177,0.0002068666,0.00011433234,0.000592935,0.0003688936,0.00010862675,0.00022933703,0.00094812975,0.0010167706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027165847,0.00039485117,0.00053619954,0.000106638865,0.0004967372,0.00032448958,0.0004035884,0.00011987339,0.93194866,0.0026939441,0.004251099,0.058452263],"study_design_scores_gemma":[0.0021078829,0.00020939024,0.0044966466,0.00025154732,0.000036314246,0.000029102257,0.0013473424,0.0000047678127,0.95478916,0.002264917,0.034228478,0.0002344496],"about_ca_topic_score_codex":0.021978578,"about_ca_topic_score_gemma":0.0033933208,"teacher_disagreement_score":0.058217812,"about_ca_system_score_codex":0.0004933504,"about_ca_system_score_gemma":0.00302167,"threshold_uncertainty_score":0.99976104},"labels":[],"label_agreement":null},{"id":"W3179962123","doi":"10.1158/1538-7445.am2021-2441","title":"Abstract 2441: Polysome profiling suggests VHL-dependent translational control in clear cell renal cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Polysome; Clear cell renal cell carcinoma; Cancer research; Translational regulation; PI3K/AKT/mTOR pathway; Translational efficiency; Biology; Renal cell carcinoma; Metastasis; Kidney cancer; Tumor progression; Medicine; Gene; Cancer; Bioinformatics; Oncology; Internal medicine; Messenger RNA; Translation (biology); Genetics; Signal transduction; RNA; Ribosome","score_opus":0.06386902647025752,"score_gpt":0.35858021079437696,"score_spread":0.29471118432411947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179962123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97783375,0.008865738,0.00001562365,0.0020540676,0.00012193669,0.0009831582,0.00009205578,0.000029109371,0.010004566],"genre_scores_gemma":[0.9952033,0.00022633847,0.00021665948,0.00013487296,0.00039667683,0.0002598646,0.00009895681,0.00006299375,0.0034002964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603355,0.0002654334,0.00049189175,0.00074257585,0.0015513854,0.00091514154],"domain_scores_gemma":[0.9981632,0.000312098,0.00006538615,0.00050553156,0.0005452981,0.00040843934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008829689,0.00024820317,0.00044749616,0.0003688668,0.00013563216,0.00006321235,0.00018667823,0.00018849438,0.0015586778],"category_scores_gemma":[0.000051772404,0.00022721184,0.00017066457,0.0005912166,0.00012666492,0.00011371827,0.000057427256,0.0011500239,0.00019104958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015477601,0.0006046997,0.14158158,0.00046176175,0.0000400306,0.0035715697,0.0003657535,0.00028486055,0.8498815,0.00004019229,0.00042857006,0.0011917815],"study_design_scores_gemma":[0.0066233906,0.0003072978,0.3038825,0.0001200433,0.000039741124,0.00003488945,0.0003135183,0.00018060772,0.6877741,0.00005328822,0.00048693098,0.0001836824],"about_ca_topic_score_codex":0.0010553107,"about_ca_topic_score_gemma":0.00045688017,"teacher_disagreement_score":0.16230093,"about_ca_system_score_codex":0.00085615565,"about_ca_system_score_gemma":0.0021121774,"threshold_uncertainty_score":0.999354},"labels":[],"label_agreement":null},{"id":"W3180085542","doi":"10.1158/1538-7445.am2021-lb246","title":"Abstract LB246: E-cadherin loss drives Id2-dependent dampening of cell cycle progression and predicts increased susceptibility to CDK4/6 inhibition in lobular breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Cadherin; Cell cycle; Downregulation and upregulation; Biology; Internal medicine; Oncology; Medicine; Cell; Genetics","score_opus":0.04310286532256443,"score_gpt":0.39259825218129485,"score_spread":0.34949538685873044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180085542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996739,0.0008073927,0.000018842928,0.0009382876,0.00008879661,0.00060483976,0.00019754222,0.000022625438,0.00058267725],"genre_scores_gemma":[0.9988901,0.00036536015,0.00013559256,0.000051111892,0.00018525205,0.0001866116,0.00003898354,0.000026249181,0.00012072296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978947,0.00014629854,0.00037251215,0.0005037176,0.00068183074,0.00040092695],"domain_scores_gemma":[0.99860436,0.00011233616,0.000073340576,0.0003185035,0.00060692325,0.00028451337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000748896,0.00013804696,0.00029902236,0.00023646177,0.000105026535,0.00004182879,0.0000644781,0.00010127499,0.0016105919],"category_scores_gemma":[0.0001593379,0.00012626838,0.000055574626,0.0005295227,0.0001440636,0.00014976061,0.00017425082,0.0005921346,0.00000887481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007459043,0.00039774587,0.08089091,0.0005260545,0.000019550562,0.00019359805,0.0007210338,0.0001254077,0.91232914,0.000008805857,0.00023920924,0.0038026273],"study_design_scores_gemma":[0.0013232487,0.00020361588,0.2922307,0.0019546484,0.000013989596,0.00003684667,0.0005525037,0.00013390639,0.7032303,0.00003425143,0.00018699346,0.000098977616],"about_ca_topic_score_codex":0.0050009023,"about_ca_topic_score_gemma":0.002788893,"teacher_disagreement_score":0.21133979,"about_ca_system_score_codex":0.000411046,"about_ca_system_score_gemma":0.00068828306,"threshold_uncertainty_score":0.9993021},"labels":[],"label_agreement":null},{"id":"W3180090815","doi":"10.1158/1538-7445.am2021-1193","title":"Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; GATA6; Tissue microarray; Pancreatic cancer; Oncology; Immunohistochemistry; Cancer; Pathology; Internal medicine; Biology; Gene expression","score_opus":0.1730998958327343,"score_gpt":0.4629723126219339,"score_spread":0.2898724167891996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180090815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903418,0.0051128697,0.00005570809,0.0020193723,0.000074266216,0.00091725535,0.0010018768,0.000009549431,0.00046730583],"genre_scores_gemma":[0.99479,0.0014404021,0.0000387255,0.00006905433,0.00019272974,0.0016249829,0.00037794426,0.000028293269,0.0014378349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969025,0.00046693668,0.0006238567,0.00042199166,0.0010909094,0.0004937595],"domain_scores_gemma":[0.9914271,0.006785073,0.00020785167,0.000570856,0.000916341,0.0000927558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038641826,0.00015556836,0.00097300595,0.00012558611,0.00010017334,0.000065705906,0.00018781447,0.00019481209,0.0014408714],"category_scores_gemma":[0.00440571,0.00010023756,0.00016850224,0.00044192057,0.0002901544,0.00011626825,0.000050999377,0.0005078433,0.00000509215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007593846,0.00064471824,0.5758435,0.0005535528,0.0005650648,0.0001448149,0.0014319092,0.000004885014,0.40093628,0.0000098495375,0.009091157,0.0031804333],"study_design_scores_gemma":[0.004333224,0.00015017703,0.8575398,0.0035186664,0.00023198985,0.0000045966026,0.0016758163,0.00013015803,0.13091582,0.00030741436,0.0009661181,0.00022623],"about_ca_topic_score_codex":0.001965851,"about_ca_topic_score_gemma":0.00026315582,"teacher_disagreement_score":0.2816963,"about_ca_system_score_codex":0.00044655253,"about_ca_system_score_gemma":0.0022371353,"threshold_uncertainty_score":0.99947196},"labels":[],"label_agreement":null},{"id":"W3180099680","doi":"10.1158/1538-7445.am2021-2035","title":"Abstract 2035: Alterations in nuclear DNA organization in sporadic pediatric Papillary Thyroid Carcinoma (PTC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pathology; Thyroid carcinoma; DNA; Metastasis; Chromatin; Papillary thyroid cancer; Nuclear DNA; Malignancy; Medicine; Cancer; Cancer research; Thyroid; Internal medicine; Biology; Genetics; Gene","score_opus":0.0461966073388341,"score_gpt":0.3514555787552649,"score_spread":0.30525897141643077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180099680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98189825,0.011686584,5.871518e-7,0.004300571,0.000120316436,0.00044357489,0.000024497445,0.000024623452,0.0015009781],"genre_scores_gemma":[0.98755115,0.011173892,0.00003605413,0.00021187121,0.0004141961,0.000122398,0.000108477856,0.000048610484,0.0003333383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981873,0.0000998026,0.0003079511,0.0004392784,0.0005122087,0.0004534424],"domain_scores_gemma":[0.998881,0.00009774943,0.00003836496,0.00036353085,0.00044715972,0.00017221444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031960077,0.00013175332,0.00025588457,0.0004234614,0.000107965316,0.000058135418,0.00010126647,0.00010249644,0.0020194857],"category_scores_gemma":[0.00018481516,0.00012822931,0.000038206326,0.0025895506,0.00004879896,0.00012931631,0.000073707786,0.00047306018,0.00013768129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009902864,0.00069720624,0.9666023,0.00020196155,0.00002363321,0.0016996523,0.0010496938,0.00009020574,0.016837196,0.00034695596,0.010426082,0.0019260403],"study_design_scores_gemma":[0.0021359364,0.00012509173,0.9861524,0.00012228514,0.000020343405,0.000019837331,0.0004388319,0.000022884655,0.008996558,0.00006404793,0.001780635,0.000121141224],"about_ca_topic_score_codex":0.0020642865,"about_ca_topic_score_gemma":0.0017135374,"teacher_disagreement_score":0.019550063,"about_ca_system_score_codex":0.0011218819,"about_ca_system_score_gemma":0.0013487494,"threshold_uncertainty_score":0.9988928},"labels":[],"label_agreement":null},{"id":"W3180158371","doi":"10.1158/1538-7445.am2021-206","title":"Abstract 206: CIViC knowledgebase adapts to field experts and community input","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Crowdsourcing; Documentation; Relevance (law); Field (mathematics); Interpretation (philosophy); Political science; Public relations; Law; Computer science","score_opus":0.07710663477485513,"score_gpt":0.40596240045744725,"score_spread":0.3288557656825921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180158371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851832,0.008227629,0.000060712697,0.0013903636,0.00017103799,0.00014211876,0.000045870405,0.000005066182,0.004774003],"genre_scores_gemma":[0.99386084,0.0032957082,0.000101251004,0.0010044018,0.0004108131,0.000094723866,0.000036054513,0.000018953962,0.0011772406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990089,0.00014410682,0.00011653237,0.00026387715,0.00014969395,0.00031687607],"domain_scores_gemma":[0.99875134,0.00019454781,0.0000149286125,0.000491143,0.00033066978,0.00021738917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042437867,0.00009414809,0.00010796155,0.000049536473,0.00026698102,0.00006673933,0.00019043051,0.00010353072,0.00021230268],"category_scores_gemma":[0.000747009,0.00009960563,0.00003383305,0.00015503215,0.00006817458,0.0000026591613,0.0005217556,0.0003329954,0.000015999172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013699794,0.00014209047,0.0017592901,0.00007050963,0.000034493103,0.000030551688,0.00053087197,0.000028436654,0.8274858,0.00006200165,0.14110442,0.028614534],"study_design_scores_gemma":[0.0004031309,0.00028960253,0.0045512156,0.00006345996,0.0000041256803,0.0000068179943,0.0006461915,0.000005517997,0.6683264,0.00014872756,0.3253796,0.00017523672],"about_ca_topic_score_codex":0.0011387897,"about_ca_topic_score_gemma":0.0071392613,"teacher_disagreement_score":0.18427518,"about_ca_system_score_codex":0.000046672125,"about_ca_system_score_gemma":0.00042398935,"threshold_uncertainty_score":0.40618},"labels":[],"label_agreement":null},{"id":"W3180224129","doi":"10.1158/1538-7445.am2021-2039","title":"Abstract 2039: The role of HORMAD1 in DNA damage repair in squamous cell carcinomas","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Genome instability; Biology; DNA repair; Homologous recombination; Centrosome; Cancer research; DNA damage; Chromosome instability; Meiosis; Cancer; RAD51; Gene knockdown; Genetics; Cell biology; Gene; Cell cycle; DNA; Chromosome","score_opus":0.024719078344313746,"score_gpt":0.3252078075701713,"score_spread":0.30048872922585756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180224129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869431,0.006410476,9.234034e-7,0.0001605737,0.00004883986,0.00021177265,0.000029566607,0.00000608636,0.006188609],"genre_scores_gemma":[0.99832445,0.00030256103,0.000048717975,0.000043192664,0.000078535035,0.00009377087,0.00002116728,0.000020324416,0.0010673003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852437,0.00021593455,0.0002156667,0.0003487696,0.00030129295,0.0003939683],"domain_scores_gemma":[0.9990865,0.0000494139,0.000034267658,0.00060902024,0.00016254002,0.000058231846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091142784,0.00009117696,0.00012768505,0.00008313552,0.000038414924,0.000011051424,0.00030833078,0.00012710114,0.00012043097],"category_scores_gemma":[0.00014846932,0.00007834361,0.000074978336,0.00034448027,0.000105373845,0.000004177214,0.0002877393,0.00033408467,0.0000087961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006908769,0.00011175183,0.007055227,0.000049764232,0.0000053645254,0.00005703742,0.00018185696,0.00007291756,0.99089617,0.00006356365,0.00077733694,0.00065992714],"study_design_scores_gemma":[0.00039017832,0.00008064745,0.028805317,0.000018123437,0.0000018424156,0.0000022407992,0.0008565425,0.000053429896,0.95949686,0.00019656202,0.010017174,0.0000810847],"about_ca_topic_score_codex":0.0011726872,"about_ca_topic_score_gemma":0.0030865339,"teacher_disagreement_score":0.03139931,"about_ca_system_score_codex":0.00007518424,"about_ca_system_score_gemma":0.00052903034,"threshold_uncertainty_score":0.31947598},"labels":[],"label_agreement":null},{"id":"W3180398641","doi":"10.1158/1538-7445.am2021-2311","title":"Abstract 2311: Identification of therapeutic targets in HNSCC","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Disease; Metastasis; Malignancy; Cancer; Biology; Computational biology; Cancer cell; Cancer research; Bioinformatics; Medicine; Internal medicine; Genetics","score_opus":0.053117363192103806,"score_gpt":0.39540756243871783,"score_spread":0.342290199246614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180398641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810645,0.017253986,0.00009861103,0.00036639924,0.00013947154,0.00011575454,0.000048069283,0.0000017330677,0.00091148255],"genre_scores_gemma":[0.9934339,0.005801391,0.000024744919,0.00006398981,0.00013118438,0.000051973944,0.00005875134,0.000012106128,0.00042195208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991679,0.00004573215,0.00018510125,0.00022956221,0.00017052135,0.00020115242],"domain_scores_gemma":[0.9993141,0.000035615994,0.00003712159,0.00028944184,0.00028353248,0.00004018589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003869667,0.00005240803,0.00008251255,0.00005668504,0.00003153055,0.000019812958,0.00013872485,0.00007108647,0.00011004025],"category_scores_gemma":[0.00014618025,0.000056428962,0.000036676698,0.00019440931,0.00007395441,0.000002068539,0.00008001189,0.000116318246,0.000008529012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004266722,0.000058257745,0.00261335,0.00003587703,0.000015596572,0.0000054285842,0.000059724538,0.00016212513,0.98696166,0.0002455812,0.0012139372,0.008585768],"study_design_scores_gemma":[0.00028401922,0.00003003816,0.03898227,0.000016886173,0.000002283985,9.664441e-7,0.00011075557,0.000014256938,0.9369895,0.0005266086,0.022978678,0.00006374252],"about_ca_topic_score_codex":0.0001826517,"about_ca_topic_score_gemma":0.00068129884,"teacher_disagreement_score":0.04997219,"about_ca_system_score_codex":0.00004837242,"about_ca_system_score_gemma":0.00043579933,"threshold_uncertainty_score":0.23011063},"labels":[],"label_agreement":null},{"id":"W3180413371","doi":"10.1158/1538-7445.am2021-1520","title":"Abstract 1520: Targetable immunogenic tumor specific antigens can be identified in non-coding regions of the genome","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cytotoxic T cell; Biology; Major histocompatibility complex; CD8; Human leukocyte antigen; Antigen; Cancer immunotherapy; T cell; MHC class I; Immunotherapy; Immunogenicity; Immunology; Cancer research; Immune system; Computational biology; Genetics; In vitro","score_opus":0.06882251920545758,"score_gpt":0.34234047386214117,"score_spread":0.2735179546566836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180413371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.936776,0.0598546,0.000007406529,0.001194031,0.0007551478,0.00036809166,0.00008704876,0.000012761144,0.0009449308],"genre_scores_gemma":[0.97881216,0.007486068,0.000007868771,0.000088915236,0.000039090995,0.00007777805,0.000038743605,0.00003109823,0.013418276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975697,0.0006262114,0.0004695354,0.0003873254,0.0001497524,0.0007975176],"domain_scores_gemma":[0.9983551,0.00031745693,0.00011868078,0.0008732057,0.00031478534,0.000020796691],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012012536,0.00016754333,0.0003615649,0.00026018676,0.0005033246,0.000044305863,0.00071502826,0.0001566354,0.0029773952],"category_scores_gemma":[0.0001517655,0.00013714179,0.00019027884,0.0010462528,0.0006093577,0.00009624559,0.00027571482,0.0009884288,0.0000928215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037914712,0.0001197334,0.000837888,0.000045967226,0.00015055791,0.000034629218,0.0012282948,0.000017549273,0.9947074,0.00030278333,0.0017346279,0.00044141285],"study_design_scores_gemma":[0.0010849462,0.000030194591,0.116447955,0.0001562801,0.000006238203,0.00003806923,0.0012063,3.4348156e-7,0.82809377,0.00009175772,0.052710533,0.00013359297],"about_ca_topic_score_codex":0.002338655,"about_ca_topic_score_gemma":0.0007114012,"teacher_disagreement_score":0.16661361,"about_ca_system_score_codex":0.00024800413,"about_ca_system_score_gemma":0.00090725545,"threshold_uncertainty_score":0.99793404},"labels":[],"label_agreement":null},{"id":"W3180418576","doi":"10.1158/1538-7445.am2021-lb034","title":"Abstract LB034: Analysis of PD-L1 IHC tests using NIST SRM 1934-traceable reference materials: A new paradigm for development of predictive IHC biomarkers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Immunohistochemistry; Gold standard (test); Detection limit; NIST; Chemistry; Medicine; Pathology; Internal medicine; Computer science; Chromatography","score_opus":0.21920378215054082,"score_gpt":0.46282798124992763,"score_spread":0.24362419909938682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180418576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269545,0.004564278,0.0003851373,0.00035890634,0.00015220509,0.0007507941,0.00040133396,0.00001776513,0.00067413884],"genre_scores_gemma":[0.9941363,0.00083243684,0.0035046316,0.00003783739,0.00010367448,0.00013547414,0.00018828799,0.00003466382,0.001026715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727505,0.000100925296,0.0007551588,0.0005117253,0.0008062434,0.00055087416],"domain_scores_gemma":[0.9979923,0.00030426594,0.00025213868,0.00050588965,0.0007505142,0.00019488759],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013689722,0.00019435825,0.000718588,0.0005730485,0.00016829524,0.0000438221,0.0002242731,0.00015833059,0.0014997447],"category_scores_gemma":[0.00020215285,0.00017521673,0.00019237488,0.0020602203,0.00029876342,0.000102767124,0.0000827804,0.00018813583,0.0000027711508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007784599,0.00021948884,0.0036727532,0.0007535503,0.0048184874,0.000016961954,0.0009130076,0.00005092603,0.96922946,0.000023824738,0.001368776,0.011148159],"study_design_scores_gemma":[0.0024128666,0.00024426397,0.16104789,0.0009250938,0.0006129857,0.0000060698344,0.0007310708,0.00015423242,0.8200299,0.00005551678,0.013580426,0.00019965578],"about_ca_topic_score_codex":0.0040402254,"about_ca_topic_score_gemma":0.0010935769,"teacher_disagreement_score":0.15737514,"about_ca_system_score_codex":0.0007286102,"about_ca_system_score_gemma":0.0049304105,"threshold_uncertainty_score":0.999413},"labels":[],"label_agreement":null},{"id":"W3180422433","doi":"10.1158/1538-7445.am2021-lb090","title":"Abstract LB090: Associations of somatically mutated genes and pathways with colorectal cancer specific survival in 4,500 colorectal cancer patients","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Colorectal cancer; Hazard ratio; Microsatellite instability; Cancer; Proportional hazards model; Biology; Oncology; Internal medicine; Gene; Population; Genetics; Cancer research; Confidence interval; Medicine; Allele; Microsatellite","score_opus":0.08293319762128186,"score_gpt":0.37058699434627207,"score_spread":0.2876537967249902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180422433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912059,0.00478617,0.000002033169,0.00042169832,0.0005375624,0.0010591128,0.00068414037,0.00003357967,0.0012698559],"genre_scores_gemma":[0.99467635,0.0037802488,0.00017887767,0.000039509323,0.00024141252,0.0007976838,0.000093089875,0.00007286577,0.000119988195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960904,0.00024584378,0.0005955834,0.0007045305,0.0015213834,0.000842236],"domain_scores_gemma":[0.99597144,0.0005612292,0.0001707062,0.00025021122,0.0027308504,0.00031553526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005925416,0.000290459,0.0007163832,0.00029711696,0.00016064754,0.00005439964,0.00019502472,0.00024385244,0.0016302438],"category_scores_gemma":[0.000478232,0.0002541235,0.00008029053,0.0014071373,0.00054449134,0.00010535643,0.00017420683,0.00078602805,0.0000080954605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094781496,0.0004441939,0.7323133,0.00027177457,0.00020410925,0.00007390565,0.0010221895,0.000147935,0.25731114,0.000036966994,0.0005826597,0.006643999],"study_design_scores_gemma":[0.0026204905,0.0004729598,0.7730933,0.0004210181,0.000038196733,0.0000029992082,0.0003981273,0.000060037306,0.22232224,0.00006132689,0.00029123705,0.000218065],"about_ca_topic_score_codex":0.0034172074,"about_ca_topic_score_gemma":0.0201879,"teacher_disagreement_score":0.040780004,"about_ca_system_score_codex":0.0015390151,"about_ca_system_score_gemma":0.0031489804,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W3180494678","doi":"10.1158/1538-7445.am2021-2155","title":"Abstract 2155: BRCAness in HGSC cancer initiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Laser capture microdissection; Biology; Transcriptome; Ovarian cancer; Cancer research; Luteal phase; Cancer; Follicular phase; Gene; Molecular biology; Oncology; Genetics; Medicine; Gene expression","score_opus":0.17637926582773106,"score_gpt":0.48719499126831317,"score_spread":0.3108157254405821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180494678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559782,0.0104910685,0.0000022661047,0.021303134,0.00031293317,0.0004187881,0.000053662967,0.000022825203,0.011417083],"genre_scores_gemma":[0.988539,0.008037287,0.000034981073,0.00061002246,0.00046247905,0.00096857676,0.00004165703,0.000027611826,0.001278421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821883,0.00007976153,0.00021960522,0.00041075042,0.0006058643,0.00046515846],"domain_scores_gemma":[0.99886996,0.00014166594,0.000031398362,0.00032225627,0.00046421244,0.00017050553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000384549,0.00011117458,0.00024792756,0.00019214173,0.00008051555,0.000047286256,0.00007800787,0.00009245541,0.0057404153],"category_scores_gemma":[0.00009326247,0.00010132494,0.00005728863,0.00081184274,0.00007106815,0.00009657665,0.000053810523,0.00044394436,0.000089389476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005509578,0.0014555213,0.73147315,0.0009113086,0.0003059973,0.0037120131,0.0014389519,0.00022212864,0.02486841,0.0012750975,0.035406828,0.19837965],"study_design_scores_gemma":[0.0029720217,0.00008071348,0.8850209,0.0009371799,0.00003094665,0.00001469453,0.0003472866,0.00002691296,0.06741806,0.00024509925,0.042761397,0.0001447565],"about_ca_topic_score_codex":0.0049666623,"about_ca_topic_score_gemma":0.005645458,"teacher_disagreement_score":0.1982349,"about_ca_system_score_codex":0.0012998857,"about_ca_system_score_gemma":0.0020328008,"threshold_uncertainty_score":0.99516845},"labels":[],"label_agreement":null},{"id":"W3180501931","doi":"10.1158/1538-7445.am2021-2874","title":"Abstract 2874: Understanding small cell lung cancer metastasis using circulating tumor cell (CTC)-derived tumor explant (CDX) models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pathology; Metastasis; Medicine; Tropism; Parenchyma; Lung; Brain metastasis; Primary tumor; Cancer; Ex vivo; Lung cancer; Cancer research; Biology; In vivo; Internal medicine; Immunology","score_opus":0.3469073019242359,"score_gpt":0.45201999508232604,"score_spread":0.10511269315809013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180501931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94568247,0.037926976,0.001411921,0.0014132989,0.00043462144,0.0016536354,0.00027446364,0.00014118664,0.011061407],"genre_scores_gemma":[0.9922102,0.0037171615,0.0013258043,0.00030343857,0.00073204725,0.0006066246,0.000032815224,0.0001916487,0.00088022713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99278706,0.00041951667,0.00073586364,0.0013763928,0.0024033585,0.0022778246],"domain_scores_gemma":[0.99610114,0.0006543311,0.00021949691,0.000930765,0.0013261576,0.0007680815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017402645,0.0005207907,0.0009985635,0.000619028,0.0010200873,0.00032489307,0.0004878951,0.00012147932,0.0014450317],"category_scores_gemma":[0.00030151833,0.00048848847,0.00031875525,0.0016389538,0.00041967302,0.00042449444,0.00078705774,0.0018437976,0.000021854925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005513042,0.0003176424,0.0054391893,0.006033578,0.00071419217,0.0043043895,0.0032049306,0.009133893,0.9652456,0.0003103316,0.004144315,0.0006006549],"study_design_scores_gemma":[0.007665924,0.0002506859,0.002076816,0.005508446,0.00078836683,0.00023605551,0.03130304,0.048543796,0.8991987,0.0011537726,0.0017316684,0.0015427433],"about_ca_topic_score_codex":0.006656926,"about_ca_topic_score_gemma":0.001293451,"teacher_disagreement_score":0.06604689,"about_ca_system_score_codex":0.0070243008,"about_ca_system_score_gemma":0.0053967717,"threshold_uncertainty_score":0.99995786},"labels":[],"label_agreement":null},{"id":"W3180519390","doi":"10.1158/1538-7445.am2021-1676","title":"Abstract 1676: A comprehensive whole blood CyTOF immune monitoring panel with expanded surface and intracellular markers using the Maxpar Direct Immune Profiling Assay","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Mass cytometry; Immune system; Multiplex; Immunology; Antibody; Whole blood; Biology; Medicine; Bioinformatics; Phenotype","score_opus":0.08232898409758506,"score_gpt":0.33403635348912314,"score_spread":0.2517073693915381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180519390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97124135,0.027773572,0.000114021954,0.00016108269,0.00015692522,0.00033335495,0.000025838048,0.000012534559,0.00018129771],"genre_scores_gemma":[0.99591076,0.0024657047,0.00085341296,0.000012993346,0.00022972707,0.000032394564,0.00003864195,0.00004929687,0.00040708258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811184,0.00026838106,0.00023807489,0.00049644825,0.00036340696,0.0005218186],"domain_scores_gemma":[0.998818,0.00009977321,0.00006538085,0.00046683144,0.0004490466,0.00010098387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056167494,0.00020015611,0.00024658834,0.000034400175,0.00040729332,0.00014602917,0.00023651197,0.00014332724,0.00001694802],"category_scores_gemma":[0.00005763791,0.00015476046,0.00007129625,0.000236291,0.00029505038,0.0000112444695,0.00016814833,0.00047710788,0.0000012624507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034888534,0.000068680136,0.0074798893,0.00011162526,0.00023170865,0.00006517836,0.0001674609,0.0009056921,0.9896602,0.000002063223,0.000011306893,0.0009472888],"study_design_scores_gemma":[0.0009142649,0.00011019967,0.005051074,0.0001802978,0.00004232674,0.000033641736,0.0015005714,0.00018492155,0.990825,0.000005502777,0.0009440523,0.00020814012],"about_ca_topic_score_codex":0.0007262699,"about_ca_topic_score_gemma":0.000045540037,"teacher_disagreement_score":0.025307868,"about_ca_system_score_codex":0.000048173897,"about_ca_system_score_gemma":0.00037136255,"threshold_uncertainty_score":0.6310949},"labels":[],"label_agreement":null},{"id":"W3180549194","doi":"10.1158/1538-7445.am2021-2407","title":"Abstract 2407: Serine and threonine phosphorylation marks proteins for degradation by ClpXP","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Phosphorylation; Biochemistry; Biology; Serine; Protease; Threonine; Phosphatase; Casein; Arginine; Amino acid; Molecular biology; Enzyme","score_opus":0.04102618336899519,"score_gpt":0.3913401635929476,"score_spread":0.35031398022395244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180549194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848626,0.011865748,0.0005240229,0.0011453511,0.00004649652,0.00073610985,0.00026455912,0.000007353055,0.0005477118],"genre_scores_gemma":[0.9884034,0.0037330203,0.0003856898,0.000041622578,0.00017503044,0.00085468433,0.0010145041,0.000023956109,0.0053681294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988879,0.000042068976,0.000107094915,0.00037083353,0.0002509181,0.00034118313],"domain_scores_gemma":[0.99926746,0.000023400253,0.000024551775,0.00021477135,0.00034693675,0.00012287249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028133087,0.00009047295,0.00008835869,0.000034932327,0.00016606555,0.00006616853,0.00008133038,0.000082886014,0.00012468507],"category_scores_gemma":[0.00011634109,0.00008637064,0.000035476354,0.00013442116,0.0000789601,0.000006932018,0.000092374496,0.0001242097,0.0000035611763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042394287,0.00007471608,0.0024260308,0.00008842646,0.00005963527,0.0000051657144,0.000014044904,0.000004476739,0.9418126,0.000043027503,0.013706144,0.04134182],"study_design_scores_gemma":[0.0011512821,0.0002513771,0.005521971,0.000022107948,0.000005189805,0.0000037298055,0.00003135019,0.000025883654,0.890456,0.00016873042,0.1022637,0.000098643766],"about_ca_topic_score_codex":0.000799861,"about_ca_topic_score_gemma":0.0021144834,"teacher_disagreement_score":0.08855755,"about_ca_system_score_codex":0.0000808757,"about_ca_system_score_gemma":0.0003404911,"threshold_uncertainty_score":0.35220924},"labels":[],"label_agreement":null},{"id":"W3180572238","doi":"10.1158/1538-7445.am2021-1218","title":"Abstract 1218: Targeting B-RAF and checkpoint inhibitor resistant melanoma with RSK inhibitor PMD-026 in pre-clinical models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Public Health Inspectors","funders":"","keywords":"Melanoma; Cancer research; Cancer; Kinase; Medicine; MEK inhibitor; Metastasis; Targeted therapy; MAPK/ERK pathway; Mucosal melanoma; Vemurafenib; Immunotherapy; Biology; Internal medicine; Metastatic melanoma","score_opus":0.06307485076322,"score_gpt":0.3681155071778808,"score_spread":0.30504065641466077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180572238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024045,0.007134362,0.000051147363,0.00044867297,0.00014862677,0.0003167589,0.000048230388,0.000011457381,0.0016002943],"genre_scores_gemma":[0.9956578,0.0015891483,0.00056261435,0.00007802102,0.0008069672,0.00013415854,0.00007775073,0.00004296629,0.0010505858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974371,0.00025708333,0.00046295355,0.0008026871,0.00042902847,0.00061111705],"domain_scores_gemma":[0.9988284,0.000078798126,0.00007563865,0.00043965149,0.0003251202,0.00025238632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013980793,0.00019214512,0.00028412443,0.00008436697,0.00013175208,0.000079611294,0.00019114946,0.00026997778,0.00008001034],"category_scores_gemma":[0.00027361544,0.00016529948,0.00008183583,0.00023316378,0.00024140184,0.000014902613,0.00033377056,0.00057895255,0.000007823463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011203736,0.00015537055,0.007560151,0.00017361263,0.00006223249,0.00025413436,0.00027018946,0.00006479388,0.98439276,0.00011658097,0.0039000758,0.0019296964],"study_design_scores_gemma":[0.0027936115,0.0009719905,0.030327283,0.00040067453,0.000015032509,0.000026327207,0.0007075449,0.00017129075,0.941606,0.00044232406,0.022045633,0.00049232796],"about_ca_topic_score_codex":0.00040131292,"about_ca_topic_score_gemma":0.0015489683,"teacher_disagreement_score":0.042786825,"about_ca_system_score_codex":0.000065549924,"about_ca_system_score_gemma":0.0008231093,"threshold_uncertainty_score":0.6740717},"labels":[],"label_agreement":null},{"id":"W3180575562","doi":"10.1158/1538-7445.am2021-1427","title":"Abstract 1427: Sensitizing HL60 acute myeloid leukemia cells to decitabine with pterostilbene","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Decitabine; Myeloid leukemia; Pterostilbene; HL60; Leukemia; Medicine; Cancer research; DNA demethylation; Azacitidine; Demethylating agent; Hypomethylating agent; Cell culture; Pharmacology; Cell growth; DNA methylation; Gene expression; Chemistry; Biology; Internal medicine; Gene; Biochemistry; Resveratrol; Genetics","score_opus":0.035945366416243046,"score_gpt":0.3590123343916237,"score_spread":0.3230669679753807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180575562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462044,0.0021748971,0.00078289484,0.00044666606,0.00012975498,0.00018997485,0.000046517347,0.000008620972,0.0016002051],"genre_scores_gemma":[0.99377614,0.0018466248,0.0015205613,0.00018407255,0.00041644013,0.000048859765,0.00009154429,0.00003912209,0.0020766368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983948,0.00007603261,0.0001611281,0.0005082501,0.00039291222,0.00046689392],"domain_scores_gemma":[0.9986528,0.000036397974,0.000030726987,0.00045154526,0.0006087624,0.00021976387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040448343,0.00013417163,0.0001380585,0.00007196379,0.00014786515,0.00008480093,0.00015386812,0.000118313,0.000096762975],"category_scores_gemma":[0.00006454617,0.00012329048,0.000044479675,0.00030770866,0.00006739988,0.0000044316107,0.0001904129,0.00021820953,0.000043237735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012611094,0.000016704951,0.0004401356,0.00001802889,0.00006787283,0.00007648772,0.000068170215,0.0009242185,0.9897697,0.000009567029,0.0009076964,0.0075753136],"study_design_scores_gemma":[0.00036159894,0.00017900225,0.0061090197,0.000039631457,0.00001067369,0.0000049060727,0.00007877751,0.000013965912,0.9607671,0.000028598988,0.03224445,0.00016226427],"about_ca_topic_score_codex":0.00016014864,"about_ca_topic_score_gemma":0.00045622306,"teacher_disagreement_score":0.031336755,"about_ca_system_score_codex":0.00012063171,"about_ca_system_score_gemma":0.000609278,"threshold_uncertainty_score":0.5027639},"labels":[],"label_agreement":null},{"id":"W3180593037","doi":"10.1158/1538-7445.am2021-1183","title":"Abstract 1183: Targeting the DNA repair pathway with BOLD-100 in <i>BRAF</i> mutant colorectal cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Colorectal cancer; Unfolded protein response; KRAS; Cancer research; Biology; Cancer; CHOP; Apoptosis; Molecular biology; Genetics","score_opus":0.02127018847791949,"score_gpt":0.32838669969387696,"score_spread":0.30711651121595746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180593037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878093,0.008708414,0.000003948039,0.0006318539,0.00012804152,0.0002627043,0.00011015945,0.000015222177,0.002330355],"genre_scores_gemma":[0.9962009,0.002207797,0.000029547484,0.00022158281,0.0003344109,0.00044254554,0.00006152872,0.00003259452,0.00046909458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980652,0.0001709598,0.00020570177,0.0005377614,0.0004311713,0.0005892062],"domain_scores_gemma":[0.9990933,0.000051328858,0.00004747937,0.000361374,0.00028901012,0.00015748621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004544875,0.0001546923,0.00015518183,0.000039689967,0.00019593685,0.00006302057,0.0002470112,0.00010311828,0.00030072016],"category_scores_gemma":[0.00016440314,0.00010473672,0.0000897171,0.00033852557,0.00024247139,0.000006681191,0.00019431346,0.00037615202,0.000007095172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031009867,0.00012938966,0.017380439,0.00008358358,0.000063195504,0.00035153082,0.00020868341,0.0005487868,0.97330827,0.000058876394,0.006213588,0.0013435556],"study_design_scores_gemma":[0.00079566013,0.0001249708,0.00918485,0.00012656664,0.000008412639,0.000011889723,0.00083013996,0.00006655012,0.96181977,0.000022798846,0.026806533,0.00020183802],"about_ca_topic_score_codex":0.0010732114,"about_ca_topic_score_gemma":0.0032261238,"teacher_disagreement_score":0.020592947,"about_ca_system_score_codex":0.000090575566,"about_ca_system_score_gemma":0.001278493,"threshold_uncertainty_score":0.42710394},"labels":[],"label_agreement":null},{"id":"W3180697236","doi":"10.1158/1538-7445.am2021-1401","title":"Abstract 1401: MYC mediates retinoic acid resistance by suppressing cellular retinoic acid-binding protein (CRABP2) transcription in HER2-enriched breast cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer research; Retinoic acid; Breast cancer; Transcription factor; Acute promyelocytic leukemia; Promyelocytic leukemia protein; Biology; Gene; Medicine; Cancer; Internal medicine; Genetics","score_opus":0.0220402658785659,"score_gpt":0.30951924665438124,"score_spread":0.28747898077581535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180697236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95833397,0.037643705,0.000119046446,0.00086540583,0.0002183143,0.0005190231,0.00014341566,0.000033701086,0.0021233968],"genre_scores_gemma":[0.98847187,0.003877328,0.00022386495,0.000057159737,0.00045000605,0.0004889479,0.00056814105,0.00009629851,0.005766362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956199,0.00049722585,0.0005726796,0.0012174114,0.0009184545,0.0011743561],"domain_scores_gemma":[0.99829936,0.000036870257,0.00015781421,0.0007073126,0.00054069073,0.00025796113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013165855,0.0003751253,0.00038582852,0.0001634615,0.00035538274,0.00021504147,0.0006392036,0.0005048313,0.00037955347],"category_scores_gemma":[0.00033388074,0.00039550406,0.00014568437,0.00085534336,0.00042123572,0.000041378404,0.00016367996,0.0010114352,0.000019827421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000389053,0.00007319544,0.0009464814,0.00062337756,0.00004587019,0.000111002155,0.00025355464,0.00002265487,0.9920741,0.000017347977,0.004262373,0.001181006],"study_design_scores_gemma":[0.0010135865,0.00006434112,0.00033156623,0.00050653744,0.0000136461695,0.000012537138,0.00068696996,0.000012022807,0.98351073,0.0001266271,0.0132816285,0.00043979217],"about_ca_topic_score_codex":0.0002825838,"about_ca_topic_score_gemma":0.0007613488,"teacher_disagreement_score":0.033766378,"about_ca_system_score_codex":0.00066209224,"about_ca_system_score_gemma":0.0015880287,"threshold_uncertainty_score":0.9998497},"labels":[],"label_agreement":null},{"id":"W3180806010","doi":"10.1158/1538-7445.am2021-lb155","title":"Abstract LB155: Combination of IGF-1R targeted alpha therapy with checkpoint inhibitors results in synergistic efficacy in a syngeneic colorectal tumor model","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"General Fusion (Canada)","funders":"","keywords":"Medicine; Cancer research; Immunotherapy; Combination therapy; Colorectal cancer; CD8; Antigen; Radiation therapy; Monoclonal antibody; Radioimmunotherapy; Cytotoxic T cell; Immunology; Immune system; Cancer; Pharmacology; Antibody; Internal medicine; Chemistry; In vitro","score_opus":0.0394900178038754,"score_gpt":0.364728935574213,"score_spread":0.3252389177703376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180806010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953458,0.0031678183,0.0000068728427,0.00025258397,0.000031535736,0.0005634118,0.00010593775,0.000005306682,0.00052078435],"genre_scores_gemma":[0.9977935,0.0013841278,0.0000497376,0.000015631138,0.00004987983,0.00026546782,0.00023073012,0.00002991201,0.00018100144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978661,0.00017731618,0.0003507793,0.00053557596,0.0005416421,0.0005286149],"domain_scores_gemma":[0.9990045,0.00007130099,0.00007479509,0.000328939,0.00039264627,0.0001278327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006136971,0.00015643275,0.00023528792,0.00022755354,0.000051098494,0.00002945635,0.00019545076,0.00009771148,0.00002798395],"category_scores_gemma":[0.00031516788,0.00013645322,0.000062610765,0.0006863261,0.0001955654,0.000010069986,0.00010889453,0.0003276261,0.0000037857553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005445552,0.0011299988,0.0037304554,0.00006638242,0.00008347913,0.00019969042,0.00020863979,0.0030935195,0.9829441,0.000020589441,0.0003222062,0.0027554128],"study_design_scores_gemma":[0.007859748,0.0008133567,0.03463984,0.00017398322,0.000002981611,0.0000039803854,0.00010272457,0.00046737114,0.95555687,0.0000661024,0.00016312284,0.00014994403],"about_ca_topic_score_codex":0.00238759,"about_ca_topic_score_gemma":0.011473124,"teacher_disagreement_score":0.030909382,"about_ca_system_score_codex":0.00030421044,"about_ca_system_score_gemma":0.0016401364,"threshold_uncertainty_score":0.64022726},"labels":[],"label_agreement":null},{"id":"W3180848797","doi":"10.1158/1538-7445.am2021-2512","title":"Abstract 2512: BRCA1 and BRCA2 mutations and its clinical relevance among egyptian breast cancer women","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Frameshift mutation; Breast cancer; Exon; Cancer; Genetics; Biology; Gene; Mutation; Medicine; Cancer research; Oncology; Molecular biology","score_opus":0.061420598404149235,"score_gpt":0.43293924448588794,"score_spread":0.3715186460817387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180848797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036444,0.01582914,0.000015678248,0.0024635475,0.00025109205,0.00023394798,0.00028114923,0.00001282293,0.00054816314],"genre_scores_gemma":[0.97722995,0.01886119,0.000110533125,0.00026150717,0.00065813033,0.0004684837,0.000041953735,0.000041251344,0.0023269919],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978993,0.00018027585,0.0003048977,0.00075964176,0.00031866357,0.00053721404],"domain_scores_gemma":[0.9984539,0.00012018392,0.00006819115,0.00038204968,0.00068007776,0.00029556436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075734576,0.00015383959,0.00019538005,0.0000717348,0.00027644742,0.000105619,0.00018763317,0.0002114499,0.00047314228],"category_scores_gemma":[0.0003289781,0.00016141389,0.000045684024,0.00031941303,0.00050210307,0.000018931063,0.00027289792,0.00044586105,0.000011636163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004346909,0.00025986007,0.14411685,0.0004506279,0.0006946698,0.000118590535,0.0019020451,0.0005035382,0.6526383,0.0002756961,0.023033008,0.1755721],"study_design_scores_gemma":[0.0018082048,0.00014124761,0.83840847,0.00017711254,0.00002979962,0.000079891455,0.0015249953,0.00016521601,0.08829808,0.00045035232,0.06839737,0.00051927444],"about_ca_topic_score_codex":0.00020441724,"about_ca_topic_score_gemma":0.0010816553,"teacher_disagreement_score":0.6942916,"about_ca_system_score_codex":0.00025530902,"about_ca_system_score_gemma":0.0013716042,"threshold_uncertainty_score":0.6582268},"labels":[],"label_agreement":null},{"id":"W3180942646","doi":"10.1158/1538-7445.am2021-885","title":"Abstract 885: A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Ovarian cancer; Breast cancer; Family history; Oncology; Medicine; Internal medicine; Cancer; Genetic testing","score_opus":0.047720358522960186,"score_gpt":0.3516867823459148,"score_spread":0.3039664238229546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180942646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785704,0.015215846,0.0012504153,0.00032939253,0.00037813262,0.0009341169,0.0028135187,0.000017706214,0.0004904414],"genre_scores_gemma":[0.9753013,0.007073763,0.0031891798,0.00016843564,0.000915695,0.0038976602,0.00028441116,0.0000887466,0.009080798],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980302,0.00014204842,0.00031737288,0.0005868235,0.0004879265,0.00043561668],"domain_scores_gemma":[0.997989,0.000103516206,0.00015863303,0.0005606252,0.0010970506,0.00009119473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068371446,0.00016512666,0.00024495437,0.000108813125,0.000099555655,0.00002510731,0.00024918056,0.00017771976,0.0003434625],"category_scores_gemma":[0.00021348037,0.00014181426,0.00007883831,0.0003221698,0.00027874613,0.000012405042,0.00009734144,0.00025831032,0.0000027027452],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002141474,0.00020559397,0.033580344,0.00060216896,0.0008968459,0.000011544334,0.0008148867,0.0017415769,0.8376665,0.000046463654,0.09176737,0.030525222],"study_design_scores_gemma":[0.0058055585,0.0010807631,0.1543388,0.0006182663,0.00031494128,0.00007191228,0.0010020032,0.00023468431,0.22902572,0.00019632342,0.60667944,0.00063156884],"about_ca_topic_score_codex":0.0009758819,"about_ca_topic_score_gemma":0.0006214501,"teacher_disagreement_score":0.6086408,"about_ca_system_score_codex":0.0010116033,"about_ca_system_score_gemma":0.00808837,"threshold_uncertainty_score":0.9975349},"labels":[],"label_agreement":null},{"id":"W3180955020","doi":"10.1158/1538-7445.am2021-1932","title":"Abstract 1932: Talazoparib interacts with oncolytic reovirus to enhance death-inducing signaling complex (DISC)-mediated apoptosis and immune response","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Cancer research; Paracrine signalling; Immune system; PARP1; Apoptosis; Medicine; Oncolytic adenovirus; Chemokine; Autocrine signalling; Cytokine; PARP inhibitor; In vivo; Immunosurveillance; Poly ADP ribose polymerase; Immunology; Biology; Internal medicine; Receptor","score_opus":0.06543128242452048,"score_gpt":0.41475166378155376,"score_spread":0.34932038135703325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180955020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945845,0.0026193848,0.00005738451,0.0016230753,0.00005705493,0.0005206548,0.000061323495,0.000019474392,0.00045715176],"genre_scores_gemma":[0.9971269,0.0005788322,0.00028791357,0.0003313213,0.00020695219,0.00026777358,0.0000985961,0.00007648237,0.0010252808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964907,0.0006244571,0.00033015537,0.0009031936,0.00072688394,0.00092458946],"domain_scores_gemma":[0.99766004,0.00034338507,0.000066909706,0.0007629236,0.0007436074,0.00042313247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002034235,0.00025069667,0.00030711538,0.00022209887,0.00034943878,0.00019009133,0.00041312285,0.00015396248,0.000348872],"category_scores_gemma":[0.0008151148,0.00023511832,0.00006364323,0.00069588405,0.00020951811,0.00001599122,0.0004502131,0.00062641315,0.000060802267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014976255,0.00009156702,0.00018536756,0.00006085207,0.00012614562,0.00007272158,0.0002957289,0.00024475757,0.97704667,0.0000023445305,0.0004773638,0.0064202347],"study_design_scores_gemma":[0.00073221145,0.0018466921,0.003048504,0.0002330606,0.000008325946,0.00001530771,0.0003672364,0.000026493937,0.98924565,0.000010306396,0.004174523,0.0002917111],"about_ca_topic_score_codex":0.00041993323,"about_ca_topic_score_gemma":0.0007252128,"teacher_disagreement_score":0.014244043,"about_ca_system_score_codex":0.0002516647,"about_ca_system_score_gemma":0.0013839913,"threshold_uncertainty_score":0.9587847},"labels":[],"label_agreement":null},{"id":"W3180960802","doi":"10.1158/1538-7445.am2021-563","title":"Abstract 563: cfDNA-based analysis of minimal residual disease and T-cell receptor clonality as predictors of relapse in stage 3 NSCLC treated with chemoradiotherapy and durvalumab","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Oncology; Medicine; Internal medicine; Immunotherapy; Stage (stratigraphy); T-cell receptor; Minimal residual disease; Chemoradiotherapy; Adjuvant; Cancer; Immunology; T cell; Immune system; Nivolumab; Biology","score_opus":0.020575920053231434,"score_gpt":0.3268703039137077,"score_spread":0.30629438386047625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180960802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925915,0.006029411,0.00000419396,0.00019807939,0.000013348607,0.00018412666,0.00084392005,0.00000200922,0.0001334012],"genre_scores_gemma":[0.99537235,0.003894402,0.0001009312,0.000033560293,0.000048831218,0.000037809747,0.0002480699,0.000017932456,0.0002461127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875104,0.00010773133,0.00023723523,0.000413683,0.00026852576,0.00022180662],"domain_scores_gemma":[0.9990287,0.000109675275,0.00008376245,0.0003325571,0.00027774862,0.00016759135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003784317,0.000115659546,0.0002849618,0.00015529314,0.000036141977,0.00001964692,0.00009447395,0.00009009176,0.00011814362],"category_scores_gemma":[0.0001522137,0.00010830585,0.000054337204,0.0004997776,0.00032979104,0.0000040470154,0.00005949798,0.00012396893,1.6168256e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003005573,0.00020731878,0.37909615,0.00018422632,0.0003056329,0.00002509625,0.00008602243,0.00042580874,0.6160224,0.00001157818,0.000303603,0.0003265844],"study_design_scores_gemma":[0.00232221,0.00039449512,0.3627936,0.000058380516,0.0001285511,3.5205224e-7,0.00016216515,0.000080080405,0.633003,0.000005690865,0.0009132197,0.00013828414],"about_ca_topic_score_codex":0.0013814428,"about_ca_topic_score_gemma":0.0014579487,"teacher_disagreement_score":0.01698056,"about_ca_system_score_codex":0.000055083277,"about_ca_system_score_gemma":0.00094249734,"threshold_uncertainty_score":0.44165844},"labels":[],"label_agreement":null},{"id":"W3181005086","doi":"10.1158/1538-7445.am2021-1483","title":"Abstract 1483: Examining the role of genome editing enzymes in anti tumor immunity","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"APOBEC; Biology; MHC class I; Immunogenicity; CTL*; DNA; Major histocompatibility complex; Genome; Genetics; Gene; Immune system; CD8","score_opus":0.11270783103410754,"score_gpt":0.4121810240990429,"score_spread":0.29947319306493536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181005086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96447927,0.019267304,8.8693963e-7,0.0007353949,0.000051234623,0.00030982454,0.000028378568,0.0000120722425,0.0151156355],"genre_scores_gemma":[0.99757695,0.0011472444,0.000027373168,0.00006693217,0.00046171664,0.00008594726,0.0000117868385,0.000028263945,0.0005937574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997438,0.0002614482,0.00033765344,0.00029091386,0.0009957735,0.00067618466],"domain_scores_gemma":[0.998071,0.00056722737,0.000052420124,0.00055234623,0.0006152332,0.00014173579],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027047666,0.00010628194,0.00032537826,0.00028181582,0.00021312294,0.000057672547,0.00030484115,0.00006882097,0.0024116472],"category_scores_gemma":[0.0007775613,0.000079866106,0.00006792974,0.0011017512,0.000313853,0.000089213696,0.00033338438,0.0014701638,0.00004945123],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016754451,0.0001912328,0.073779605,0.00027940588,0.00006398683,0.00034697753,0.0015527132,0.000029243583,0.89688456,0.00047630427,0.00029221497,0.025936222],"study_design_scores_gemma":[0.00082057697,0.00008859874,0.59018224,0.00038727128,0.000007786055,0.000025086072,0.007509077,0.00008980303,0.3696045,0.00017878521,0.031007834,0.00009845212],"about_ca_topic_score_codex":0.005235532,"about_ca_topic_score_gemma":0.0009862734,"teacher_disagreement_score":0.52728003,"about_ca_system_score_codex":0.0002573373,"about_ca_system_score_gemma":0.0012936051,"threshold_uncertainty_score":0.9985003},"labels":[],"label_agreement":null},{"id":"W3181014127","doi":"10.1158/1538-7445.am2021-2426","title":"Abstract 2426: Effects of MEN2 mutations on RET receptor localization and function","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Receptor; Cell biology; Biology; Proto-Oncogene Proteins c-ret; Receptor tyrosine kinase; Mutant; Signal transduction; Mutation; Genetics; Germline mutation; Gene","score_opus":0.0213259779168203,"score_gpt":0.34182315183097894,"score_spread":0.32049717391415866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181014127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629474,0.0018029002,0.0009304335,0.00013550663,0.00012337798,0.00014420418,0.000019956939,0.0000034014176,0.0005454888],"genre_scores_gemma":[0.99647015,0.002330928,0.00004618449,0.00008169501,0.00011278911,0.000046550515,0.0001989244,0.000011267461,0.00070150243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939346,0.00006687365,0.000086051274,0.00019748998,0.00013134183,0.0001247799],"domain_scores_gemma":[0.9995049,0.000033478802,0.000023802737,0.00015693343,0.00023877919,0.00004206286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014153287,0.00005046172,0.00006197718,0.000039815335,0.000069491914,0.000013845998,0.00004209987,0.00008433873,0.000054241398],"category_scores_gemma":[0.00013441607,0.000050196875,0.00002159349,0.00012748588,0.000066837674,0.0000026146643,0.000040875857,0.00009084366,0.0000052056976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006829807,0.000039548668,0.00045413227,0.00012568662,0.000027303882,0.0000012371682,0.00003772235,0.000095651034,0.98854005,0.00017432649,0.0042295814,0.0062064584],"study_design_scores_gemma":[0.00029261777,0.0001779347,0.0021629191,0.00006284429,0.0000067036462,7.8206983e-7,0.000057588953,0.000034674275,0.97137034,0.000088635024,0.025691964,0.00005302175],"about_ca_topic_score_codex":0.00003964665,"about_ca_topic_score_gemma":0.00006978379,"teacher_disagreement_score":0.021462383,"about_ca_system_score_codex":0.000022554668,"about_ca_system_score_gemma":0.00013294865,"threshold_uncertainty_score":0.20469691},"labels":[],"label_agreement":null},{"id":"W3181071769","doi":"10.1158/1538-7445.am2021-1165","title":"Abstract 1165: Complementary diagnostics for precision targeting of cellular pathways","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PI3K/AKT/mTOR pathway; Computational biology; Precision medicine; MAPK/ERK pathway; Transcriptome; Biological pathway; Cancer research; Medicine; Bioinformatics; Signal transduction; Biology; Gene; Genetics; Gene expression","score_opus":0.0666923984987266,"score_gpt":0.3623847471270701,"score_spread":0.2956923486283435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181071769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97552747,0.012394598,0.009516989,0.00026579533,0.00030390295,0.0004852587,0.00046184513,0.000004695365,0.0010394335],"genre_scores_gemma":[0.9934661,0.0026968282,0.0024170515,0.00007927991,0.0004269631,0.00006887988,0.0006690961,0.000018069677,0.00015777077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.000035619978,0.00025776483,0.00019680976,0.00020195922,0.00030998103],"domain_scores_gemma":[0.99908614,0.00011413203,0.000060059836,0.00025157197,0.00041760106,0.000070492075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066462054,0.00007658197,0.00011714153,0.00002853783,0.000112836395,0.000021053573,0.00017959642,0.00008837116,0.00013171902],"category_scores_gemma":[0.00016226797,0.00007446708,0.00007282083,0.00008951751,0.00006864357,0.0000027262092,0.0002117469,0.000130972,0.0000032179819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063581974,0.00004574205,0.00030032056,0.00014959977,0.000040042472,0.0000029009902,0.000085309104,0.00017269875,0.9365114,0.00024117196,0.048160236,0.014226979],"study_design_scores_gemma":[0.00048554095,0.00013088137,0.00029076115,0.000058153884,0.0000065456934,6.932034e-7,0.00034677022,0.00029568322,0.87718076,0.00093172194,0.120167196,0.0001052979],"about_ca_topic_score_codex":0.00003236849,"about_ca_topic_score_gemma":0.000040534323,"teacher_disagreement_score":0.07200696,"about_ca_system_score_codex":0.000024329815,"about_ca_system_score_gemma":0.0002343672,"threshold_uncertainty_score":0.30366793},"labels":[],"label_agreement":null},{"id":"W3181160016","doi":"10.1158/1538-7445.am2021-lb187","title":"Abstract LB187: EGFR signaling and pharmacology in oncology revealed with an innovative RTK biosensor technology","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Epiregulin; Epidermal growth factor receptor; Receptor tyrosine kinase; Cancer research; Internalization; Signal transduction; MAPK/ERK pathway; Endosome; ERBB3; Angiogenesis; Chemistry; Receptor; Cell biology; Pharmacology; Biology; Biochemistry","score_opus":0.1160522961399389,"score_gpt":0.4934628462371796,"score_spread":0.3774105500972407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181160016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347175,0.000674255,0.0053438237,0.009296732,0.00015005129,0.00027162378,0.0000062393933,0.000054581542,0.0007309525],"genre_scores_gemma":[0.9584514,0.00011265536,0.04074154,0.0003576511,0.00009551366,0.00014705234,0.0000038935605,0.000014058604,0.00007623612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973402,0.00077127,0.00026214134,0.0007114009,0.0003778352,0.000537156],"domain_scores_gemma":[0.997464,0.0010513471,0.0000703633,0.00030042292,0.0010090119,0.00010485389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017562987,0.00012751672,0.0002686998,0.00077271584,0.00013656335,0.000084010004,0.00056166766,0.00013409382,0.000076105134],"category_scores_gemma":[0.00020083299,0.00011921959,0.000012727294,0.004211182,0.00040043454,0.00037548182,0.00050065696,0.00085480843,0.000007976255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031827402,0.00040987955,0.005059982,0.00011405641,0.00009195452,0.0021742969,0.002489387,0.006929304,0.73970544,0.035685506,0.00034422605,0.20667772],"study_design_scores_gemma":[0.0053729545,0.0017327144,0.043501478,0.0003145427,0.000011640282,0.00037697656,0.002157247,0.024187878,0.86707217,0.03765665,0.01676166,0.00085411186],"about_ca_topic_score_codex":0.00012871552,"about_ca_topic_score_gemma":0.00025909356,"teacher_disagreement_score":0.2058236,"about_ca_system_score_codex":0.00043238685,"about_ca_system_score_gemma":0.002135347,"threshold_uncertainty_score":0.48616338},"labels":[],"label_agreement":null},{"id":"W3181165699","doi":"10.1158/1538-7445.am2021-285","title":"Abstract 285: Development of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as new antimitotic cytochrome P450 1A1-activated prodrugs selective toward breast cancers: Evaluation of branched alkyl chains","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Prodrug; Chemistry; Cancer cell; Pharmacology; Sulforhodamine B; Cell cycle; Cancer research; Cancer; Biochemistry; Stereochemistry; In vitro; Cell; Cytotoxicity; Biology; Medicine; Internal medicine","score_opus":0.13779680643842696,"score_gpt":0.41936854793341427,"score_spread":0.2815717414949873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181165699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821664,0.0012461859,0.000021961827,0.0008515129,0.00003570596,0.0004820395,0.00019822546,0.000055588833,0.008892164],"genre_scores_gemma":[0.99726313,0.0002786726,0.00021834704,0.000019144838,0.00030927893,0.0005489932,0.00024910015,0.000051860883,0.0010614415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99580276,0.00008862276,0.0007576081,0.0008343993,0.0018182002,0.00069838885],"domain_scores_gemma":[0.99534774,0.0003074628,0.00034275363,0.0006831831,0.0029691665,0.00034970956],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009717969,0.0003152366,0.0005216434,0.00013009628,0.00024753195,0.000053159347,0.0005170495,0.00025518678,0.00433096],"category_scores_gemma":[0.00064918934,0.00033826154,0.00013468326,0.0013611371,0.00023327062,0.00020704971,0.00019905172,0.00065207033,0.00002255743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023446843,0.0003065319,0.00020467311,0.0008528895,0.00031907216,0.0000050241015,0.0029498476,0.00066445244,0.9717642,0.000075194854,0.0006247259,0.021998921],"study_design_scores_gemma":[0.001527447,0.000014405873,0.0051770015,0.000669928,0.00006791846,0.000020546075,0.0017241678,0.00020219,0.9890028,0.00044019884,0.0008349611,0.0003183832],"about_ca_topic_score_codex":0.0012913152,"about_ca_topic_score_gemma":0.0002698329,"teacher_disagreement_score":0.021680538,"about_ca_system_score_codex":0.0017113509,"about_ca_system_score_gemma":0.014058238,"threshold_uncertainty_score":0.99990696},"labels":[],"label_agreement":null},{"id":"W3181215270","doi":"10.1158/1538-7445.am2021-lb104","title":"Abstract LB104: Dose-Finding/Expansion Phase Ib Study to Evaluate the Safety and Activity of BET Inhibitor RO6870810 (RO) and Atezolizumab (A) in Patients (pts) with Advanced Ovarian Cancer (OC) or Triple Negative Breast Cancer (TNBC)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Adverse effect; Atezolizumab; Internal medicine; Febrile neutropenia; Triple-negative breast cancer; Oncology; Cancer; Gastroenterology; Breast cancer; Chemotherapy; Immunotherapy","score_opus":0.04197000312876247,"score_gpt":0.3989249781194998,"score_spread":0.3569549749907373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181215270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961684,0.0005788171,0.000010039758,0.0010091697,0.00011780709,0.0016217318,0.00043192902,0.0000052098344,0.00005693583],"genre_scores_gemma":[0.99791723,0.001107093,0.00003061693,0.00006829196,0.0001181247,0.00040898976,0.000027601352,0.000028924263,0.00029312746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775606,0.00033851338,0.00028194554,0.0006431776,0.0005778763,0.00040244623],"domain_scores_gemma":[0.9986642,0.00005909234,0.000100389814,0.00036226044,0.0006437711,0.00017026092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006483755,0.00020833309,0.0002904603,0.00011405293,0.00022997645,0.00005187163,0.00016869136,0.00009288038,0.0001369777],"category_scores_gemma":[0.00018823682,0.00014032793,0.000030537183,0.00057895074,0.00019746045,0.000034177927,0.00026892728,0.00033647523,7.8231346e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0332029,0.0017415736,0.043996606,0.00016786063,0.0002544262,0.000027368671,0.0030156437,0.00018247018,0.6496993,0.000009668327,0.00066171755,0.26704052],"study_design_scores_gemma":[0.016034758,0.001753127,0.5002626,0.00029553313,0.00002638127,0.0000028781303,0.0012893912,0.000045271692,0.47912756,0.000008970785,0.0008765934,0.00027691518],"about_ca_topic_score_codex":0.003778446,"about_ca_topic_score_gemma":0.012935071,"teacher_disagreement_score":0.45626605,"about_ca_system_score_codex":0.00021706286,"about_ca_system_score_gemma":0.00089072745,"threshold_uncertainty_score":0.72180736},"labels":[],"label_agreement":null},{"id":"W3181217566","doi":"10.1158/1538-7445.am2021-449","title":"Abstract 449: A standard operating procedure for the curation of gene fusions","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fusion gene; Interpretation (philosophy); Computational biology; Interoperability; Set (abstract data type); Gene; Biology; Computer science; Bioinformatics; Data science; Genetics; World Wide Web","score_opus":0.10215346907557346,"score_gpt":0.44957096225736637,"score_spread":0.34741749318179294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181217566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894853,0.011873719,0.0041069426,0.004231247,0.00012135272,0.00029531517,0.0001301605,0.0000065745717,0.00028614805],"genre_scores_gemma":[0.99627125,0.0010044575,0.0015582943,0.00007635527,0.00026689784,0.00017678473,0.00004539237,0.000008229107,0.00059236446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993221,0.000036997004,0.00010837132,0.00016912285,0.00018928775,0.0001740879],"domain_scores_gemma":[0.9992187,0.00008548864,0.000023547263,0.00017830779,0.0004594946,0.00003448095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046099361,0.000044415443,0.0000696627,0.0000145315,0.00019252017,0.000022317749,0.00013215904,0.000084086634,0.000054936572],"category_scores_gemma":[0.0009293254,0.000029288718,0.000039667913,0.0001143336,0.00014748072,0.0000017076694,0.00006666562,0.00011596749,6.885653e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053547923,0.000014769203,0.00018720541,0.000053827334,0.000026927955,0.0000011163575,0.000107447464,0.00003522917,0.9651019,0.00005842771,0.006765402,0.027594225],"study_design_scores_gemma":[0.00028269365,0.00014140322,0.0012362131,0.000039931052,0.0000053170643,0.0000028842298,0.00081739225,0.00007183456,0.92656237,0.000070514216,0.07072132,0.000048108217],"about_ca_topic_score_codex":0.000028719258,"about_ca_topic_score_gemma":0.0001500557,"teacher_disagreement_score":0.06395592,"about_ca_system_score_codex":0.000014294699,"about_ca_system_score_gemma":0.00060980354,"threshold_uncertainty_score":0.1480729},"labels":[],"label_agreement":null},{"id":"W3181260058","doi":"10.1158/1538-7445.am2021-2694","title":"Abstract 2694: An anatomic proteomic atlas of human glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Glioblastoma; Laser capture microdissection; Tumor microenvironment; Brain tumor; Biology; Proteomics; Cancer research; Neuroscience; Computational biology; Bioinformatics; Medicine; Pathology; Tumor cells; Gene; Genetics","score_opus":0.09091469914617191,"score_gpt":0.43979124290910143,"score_spread":0.34887654376292954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181260058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389,0.0013338674,0.0000011918322,0.0009845006,0.00007491663,0.00049508497,0.000024639447,0.000033224624,0.003162609],"genre_scores_gemma":[0.99776435,0.00041462254,0.00006957265,0.00007643797,0.00031768726,0.0003071498,0.00001733967,0.000040964307,0.0009918894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997883,0.00010816404,0.0003010888,0.00044161774,0.0007828896,0.000483244],"domain_scores_gemma":[0.9982837,0.000033629116,0.00006017496,0.00057539257,0.0007838531,0.0002632761],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005678409,0.0001259673,0.0003388421,0.00021157507,0.00014463931,0.00003712948,0.00020068507,0.00011441955,0.003400209],"category_scores_gemma":[0.00006758451,0.00011411164,0.000110328474,0.0006575038,0.00024219614,0.00011006901,0.00010306212,0.0005474135,0.000047700378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034303582,0.00036775568,0.015370459,0.0004574172,0.000078032346,0.000088986504,0.00028143494,0.0000038657804,0.96845216,0.0003038919,0.0039331377,0.010319807],"study_design_scores_gemma":[0.0010926598,0.0007399804,0.09198661,0.0003911332,0.00002309569,0.000013434587,0.000373583,0.000019357001,0.9022979,0.0001355538,0.0028128698,0.00011382221],"about_ca_topic_score_codex":0.0009433173,"about_ca_topic_score_gemma":0.00050390925,"teacher_disagreement_score":0.07661615,"about_ca_system_score_codex":0.00030633376,"about_ca_system_score_gemma":0.0010457647,"threshold_uncertainty_score":0.9975108},"labels":[],"label_agreement":null},{"id":"W3181286681","doi":"10.1158/1538-7445.am2021-1014","title":"Abstract 1014: Repurposing the anti-rheumatic gold compound auranofin for high-grade serous ovarian cancer therapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; XIAP; Medicine; Ovarian cancer; Cancer cell; Pharmacology; Cancer; Carboplatin; Toxicity; Cancer research; Chemotherapy; Apoptosis; Internal medicine; Cisplatin; Programmed cell death; Chemistry; Rheumatoid arthritis; Biochemistry; Caspase","score_opus":0.13400099358864123,"score_gpt":0.42569535341642206,"score_spread":0.2916943598277808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181286681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321224,0.0327099,0.00033956644,0.03063872,0.00090861943,0.0021526022,0.0000997868,0.000084032166,0.0009443614],"genre_scores_gemma":[0.97537786,0.015562662,0.0003991924,0.0018400324,0.0010752856,0.0013430219,0.000041627954,0.00010653678,0.0042537767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972828,0.00015511694,0.00039105816,0.0005887945,0.0007611068,0.00082113186],"domain_scores_gemma":[0.9976911,0.0004338151,0.00010376441,0.0008153244,0.00075354293,0.0002024665],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011156487,0.0002399519,0.00050552713,0.00013241691,0.00048768928,0.00022527236,0.00031274572,0.00014273303,0.0017441381],"category_scores_gemma":[0.0000616784,0.00016884586,0.00018190032,0.00067463034,0.00019803114,0.00011063941,0.00006483789,0.00067000155,0.000016312204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011721998,0.000430542,0.0008457644,0.00081448985,0.000920585,0.00022708972,0.001986329,0.0001240024,0.7968972,0.010395578,0.03091353,0.15527269],"study_design_scores_gemma":[0.015140104,0.00071901974,0.03079712,0.0021577056,0.00012349989,0.00014928162,0.0013195067,0.00049546827,0.55010575,0.01725732,0.381006,0.00072923437],"about_ca_topic_score_codex":0.005616527,"about_ca_topic_score_gemma":0.0010683595,"teacher_disagreement_score":0.35009247,"about_ca_system_score_codex":0.00055594154,"about_ca_system_score_gemma":0.0014621634,"threshold_uncertainty_score":0.9991684},"labels":[],"label_agreement":null},{"id":"W3181289099","doi":"10.1158/1538-7445.am2021-1647","title":"Abstract 1647: CAPTIV-8: A prospective trial of atezolizumab using a multivariate model incorporating whole genome and transcriptome analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Pancreas Centre (Canada); Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Medicine; Atezolizumab; Oncology; Cohort; Context (archaeology); Internal medicine; Disease; Cancer; Clinical trial; Immunotherapy; Pembrolizumab; Biology","score_opus":0.127506638324887,"score_gpt":0.4230340859456433,"score_spread":0.2955274476207563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181289099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944703,0.0030927772,0.00065038254,0.0003568666,0.000050468145,0.00076848315,0.00015151934,0.000016138738,0.00044309197],"genre_scores_gemma":[0.9979406,0.00031894151,0.0010246241,0.00003191397,0.000124614,0.00010180169,0.000027220201,0.000026745838,0.000403531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803203,0.00011557358,0.00040909174,0.00045546427,0.0006204605,0.00036738848],"domain_scores_gemma":[0.9987311,0.00007201604,0.00011675811,0.00032084732,0.00062788965,0.0001313888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008722007,0.00014685065,0.0005278365,0.00041570843,0.00016114833,0.000047355028,0.00008889533,0.0001125612,0.00014462246],"category_scores_gemma":[0.00007655853,0.00013144921,0.000208215,0.0017090548,0.00029382313,0.0001202988,0.00005315486,0.0003972672,0.0000010266509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03605999,0.0002067925,0.0010533849,0.00018687647,0.001468845,0.00005512782,0.0020021359,0.0011365635,0.9559576,0.000036372083,0.00000765795,0.0018286478],"study_design_scores_gemma":[0.31683698,0.0032028346,0.15024394,0.0016418784,0.0036611692,0.0000944881,0.00792619,0.16345401,0.34848687,0.0021222548,0.00082340674,0.0015059776],"about_ca_topic_score_codex":0.0034846328,"about_ca_topic_score_gemma":0.0004433059,"teacher_disagreement_score":0.60747075,"about_ca_system_score_codex":0.00049891364,"about_ca_system_score_gemma":0.0013535608,"threshold_uncertainty_score":0.53603435},"labels":[],"label_agreement":null},{"id":"W3181312404","doi":"10.1158/1538-7445.am2021-lb094","title":"Abstract LB094: KisoBody: Development and pre-clinical assessment of a novel multispecific antibody platform","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Monoclonal antibody; Antibody; Cancer; Computational biology; Pharmacokinetics; Cancer research; Biology; Pharmacology; Medicine; Immunology; Internal medicine","score_opus":0.2984530107632288,"score_gpt":0.5658075367731463,"score_spread":0.26735452600991755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181312404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873389,0.0027159667,0.000098856675,0.0013291971,0.00013998128,0.00046423095,0.000052277403,0.000015599378,0.0078449985],"genre_scores_gemma":[0.9803385,0.0047603305,0.007002891,0.00008647077,0.0003268955,0.00007799976,0.00010387212,0.000029254292,0.007273764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99664706,0.00006910266,0.0006327042,0.00053788314,0.0014242987,0.0006889568],"domain_scores_gemma":[0.9976696,0.00058847695,0.00007323957,0.00035754708,0.0008786237,0.00043251895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019060033,0.00016211566,0.00049565616,0.00019778292,0.00020685901,0.000046453624,0.00017724131,0.00014637118,0.0014567432],"category_scores_gemma":[0.00023294988,0.00012991099,0.00010598138,0.00044002078,0.00047659167,0.000082835344,0.00042350337,0.0010462246,0.000022808135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012996845,0.0023563427,0.37052166,0.002008948,0.000625424,0.00062141684,0.0007225138,0.000007746094,0.4852357,0.002276831,0.0033204828,0.13100325],"study_design_scores_gemma":[0.0021064943,0.00022376327,0.87757343,0.00050409016,0.000012745057,0.000048704078,0.00024294193,0.0003251661,0.033221666,0.000027122978,0.08557332,0.00014054734],"about_ca_topic_score_codex":0.00042806522,"about_ca_topic_score_gemma":0.00017256495,"teacher_disagreement_score":0.50705177,"about_ca_system_score_codex":0.00016638308,"about_ca_system_score_gemma":0.0025502741,"threshold_uncertainty_score":0.99945605},"labels":[],"label_agreement":null},{"id":"W3181315038","doi":"10.1158/1538-7445.am2021-2450","title":"Abstract 2450: A systemic approach to decipher the interactome of RET receptor isoforms","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Interactome; SH2 domain; Biology; Gene isoform; GRB2; Phosphotyrosine-binding domain; Protein–protein interaction; Computational biology; Alternative splicing; Receptor tyrosine kinase; Signal transducing adaptor protein; Cell biology; Signal transduction; Gene; Genetics","score_opus":0.07408504518549167,"score_gpt":0.39389567368591966,"score_spread":0.31981062850042796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181315038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596454,0.0040427577,0.00042185278,0.00068484264,0.00014135968,0.00029166232,0.000056105986,0.0000042090446,0.008392686],"genre_scores_gemma":[0.9931351,0.0010549326,0.00017786528,0.00012095716,0.00025580177,0.00037656704,0.00004588423,0.000018976923,0.004813905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884176,0.000085841464,0.00019404534,0.00031438077,0.00029268485,0.00027128274],"domain_scores_gemma":[0.9986807,0.000025858299,0.000043284137,0.00063322426,0.0005332839,0.000083660816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053487386,0.00007999621,0.0001127403,0.00004208545,0.00009943841,0.00003995341,0.0003722299,0.000083971456,0.00023461603],"category_scores_gemma":[0.000137134,0.000054658387,0.00006689873,0.00034619775,0.000097108,0.000004147096,0.00016681945,0.00019393774,0.000034260796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079267586,0.000055834746,0.0002950764,0.000067332614,0.000045757926,5.640641e-7,0.00025139019,0.000106080864,0.96909815,0.00018601409,0.024412269,0.0054022814],"study_design_scores_gemma":[0.00031562874,0.000093136165,0.0036000356,0.00013659107,0.000006870033,0.000013391476,0.002298744,0.000018793085,0.7695422,0.000037207574,0.22377789,0.00015948899],"about_ca_topic_score_codex":0.00010821172,"about_ca_topic_score_gemma":0.00003953584,"teacher_disagreement_score":0.1995559,"about_ca_system_score_codex":0.00007053372,"about_ca_system_score_gemma":0.00039656818,"threshold_uncertainty_score":0.2568881},"labels":[],"label_agreement":null},{"id":"W3181341608","doi":"10.1158/1538-7445.am2021-1741","title":"Abstract 1741: Reduced PTPN1/PTPN2 activity synergistically enhanced anti-tumoraleffector functionof CD8 T cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cytotoxic T cell; CD8; Immunology; Immune system; Biology; Acquired immune system; Proinflammatory cytokine; T cell; Cancer research; Inflammation","score_opus":0.041101523947490524,"score_gpt":0.366830617948242,"score_spread":0.3257290940007515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181341608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900782,0.006544951,0.0006429766,0.00046455592,0.00048264908,0.0004121793,0.0002184347,0.00003110125,0.0011249481],"genre_scores_gemma":[0.9956747,0.0010501374,0.00021171568,0.00009368376,0.0006776399,0.0003064275,0.00016001839,0.000049739963,0.0017758923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750084,0.00024610545,0.00021370777,0.00082040334,0.0005137993,0.0007051652],"domain_scores_gemma":[0.9981377,0.000102677775,0.0000682307,0.0008162698,0.0006258216,0.0002493066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053895405,0.00021607727,0.000253771,0.00006642739,0.00022540879,0.000106216714,0.00034479503,0.00019186884,0.00079091365],"category_scores_gemma":[0.00068249856,0.00021732255,0.00011836342,0.000372517,0.00027782406,0.000013400177,0.00035653473,0.0004471129,0.00012784671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027106967,0.00014126711,0.000056091892,0.000119178905,0.00007454459,0.000053511176,0.0000073268393,0.00012462921,0.9821939,0.00011019917,0.0111593995,0.005688878],"study_design_scores_gemma":[0.00049383513,0.00016479292,0.0056767804,0.0000670882,0.000013319189,0.000004968562,0.000014180592,0.000012441567,0.97950786,0.00005241551,0.013748597,0.00024372707],"about_ca_topic_score_codex":0.00024682193,"about_ca_topic_score_gemma":0.00009630918,"teacher_disagreement_score":0.0056206887,"about_ca_system_score_codex":0.0001239611,"about_ca_system_score_gemma":0.0009541804,"threshold_uncertainty_score":0.8862156},"labels":[],"label_agreement":null},{"id":"W3181354435","doi":"10.1158/1538-7445.am2021-827","title":"Abstract 827: Transcriptome-wide association study of endometrial cancer risk","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Endometrial cancer; Genome-wide association study; Biology; Cancer; Oncology; Transcriptome; Genetics; Bioinformatics; Genotype; Internal medicine; Gene; Single-nucleotide polymorphism; Medicine; Gene expression","score_opus":0.11749389682926102,"score_gpt":0.44433942245734004,"score_spread":0.326845525628079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181354435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870813,0.006841563,0.0000030310646,0.0013804802,0.0007092789,0.00094786065,0.0001905536,0.000029334837,0.0028166168],"genre_scores_gemma":[0.9897088,0.005854006,0.000019382152,0.000110052264,0.00075013685,0.00048603426,0.000019748288,0.000031656815,0.0030201862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614424,0.00037898863,0.00047939073,0.00047078275,0.001962472,0.0005641565],"domain_scores_gemma":[0.99624014,0.0016880761,0.00016580234,0.00037242865,0.0012740064,0.00025953082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013611596,0.00015947787,0.00059872936,0.00044889428,0.00015642459,0.000036380792,0.00015488817,0.00014041115,0.00484252],"category_scores_gemma":[0.00329895,0.00013269049,0.00019047281,0.0028399006,0.00005383438,0.00009287981,0.000059129958,0.00075896527,0.00003647744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025589752,0.0023563257,0.93969226,0.00020302866,0.0012677422,0.00012738374,0.0010122367,0.000022926324,0.023306787,0.000008075253,0.0034029596,0.026041308],"study_design_scores_gemma":[0.025517358,0.0014433446,0.89431864,0.00019994235,0.00045064266,9.1224456e-7,0.0016677631,0.000002306019,0.06389815,0.00013620155,0.012188548,0.00017617039],"about_ca_topic_score_codex":0.013454107,"about_ca_topic_score_gemma":0.0025482539,"teacher_disagreement_score":0.045373593,"about_ca_system_score_codex":0.0015061614,"about_ca_system_score_gemma":0.00093963963,"threshold_uncertainty_score":0.99606717},"labels":[],"label_agreement":null},{"id":"W3181380383","doi":"10.1158/1538-7445.am2021-1359","title":"Abstract 1359: Evaluation of the therapeutic potential of AIMZ-938 as a new cytochrome p450 1A1-selective prodrug for the treatment of breast cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval","funders":"","keywords":"Prodrug; Medicine; Therapeutic index; Pharmacology; Toxicity; Cytochrome P450; Chemotherapy; Internal medicine; Cancer research; Drug; Metabolism","score_opus":0.3088135265142726,"score_gpt":0.5661243054341547,"score_spread":0.25731077891988213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181380383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862915,0.007905491,0.00001657386,0.0027138905,0.00025545724,0.0017042032,0.00021546807,0.0000049489604,0.00089242635],"genre_scores_gemma":[0.99549764,0.0027529248,0.000007693164,0.00006887544,0.00022074231,0.00055148377,0.000008238371,0.000013540085,0.0008788657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983759,0.00032814892,0.00026691926,0.0002215922,0.00052566576,0.00028176446],"domain_scores_gemma":[0.9976393,0.00075160793,0.00014749396,0.00026723612,0.0011063066,0.00008803474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088553183,0.00010690397,0.00021432342,0.00005132723,0.00018828404,0.000008687177,0.00023493203,0.000118699405,0.0016133393],"category_scores_gemma":[0.00016897991,0.00006396653,0.00018366115,0.00045523976,0.00037246014,0.0000435228,0.0000373464,0.00032210772,0.0000024199098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084090675,0.000374163,0.00022942286,0.000061446175,0.0005950534,5.95056e-7,0.00097002677,0.001829135,0.87823117,0.0001693732,0.0015035262,0.115195185],"study_design_scores_gemma":[0.002096526,0.00022389232,0.014135408,0.000043567918,0.00039135327,0.000007979399,0.0005519748,0.000941071,0.9619572,0.0012594672,0.018324492,0.000067057015],"about_ca_topic_score_codex":0.002528679,"about_ca_topic_score_gemma":0.0005004471,"teacher_disagreement_score":0.11512813,"about_ca_system_score_codex":0.00067007594,"about_ca_system_score_gemma":0.0041229776,"threshold_uncertainty_score":0.99929935},"labels":[],"label_agreement":null},{"id":"W3181382552","doi":"10.1158/1538-7445.am2021-1045","title":"Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Vinorelbine; Ovarian cancer; Cancer research; Paclitaxel; Biology; Microtubule; Cancer; Medicine; Internal medicine; Pathology; Oncology; Cell biology; Chemotherapy; Cisplatin","score_opus":0.019209612000402193,"score_gpt":0.3094141540266082,"score_spread":0.29020454202620605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181382552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936787,0.005326349,0.0001386422,0.00015097563,0.000062839026,0.00021334227,0.00022188271,0.0000039205493,0.0002033746],"genre_scores_gemma":[0.99124503,0.007593237,0.000279384,0.000010192042,0.0001221475,0.00007304937,0.00009147316,0.000030318117,0.00055518217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985883,0.00011336555,0.000252426,0.0004028877,0.00024853082,0.00039449293],"domain_scores_gemma":[0.9991212,0.000031270607,0.000115449235,0.00026499468,0.00037156005,0.000095556796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018600278,0.00016720286,0.00025481833,0.00006283362,0.00011919467,0.00003472687,0.0001402744,0.00013409943,0.00011741321],"category_scores_gemma":[0.000017076547,0.00014076509,0.00006711538,0.0001201198,0.00023131109,0.000007061591,0.00013283118,0.00014003513,5.9426037e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006315282,0.00024105559,0.0008789563,0.00016926718,0.00021786052,0.00002390365,0.000103282866,0.0010745669,0.99198633,0.000048347265,0.000097974844,0.004526911],"study_design_scores_gemma":[0.0016421528,0.0005076945,0.0019169836,0.0000709954,0.00003855362,0.000007626181,0.0008666769,0.000041857602,0.9941152,0.000032010303,0.0006140942,0.00014616807],"about_ca_topic_score_codex":0.0044899634,"about_ca_topic_score_gemma":0.0026532528,"teacher_disagreement_score":0.0043807426,"about_ca_system_score_codex":0.000075673925,"about_ca_system_score_gemma":0.0008343511,"threshold_uncertainty_score":0.6787512},"labels":[],"label_agreement":null},{"id":"W3181405059","doi":"10.1158/1538-7445.am2021-2500","title":"Abstract 2500: The Forkhead-like protein Dach1 governs sensitivity to WEE1 kinase and PARP inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Ku70; DNA repair; Genetics; Chromatin; Molecular biology; Cancer research; Gene","score_opus":0.09128255855732804,"score_gpt":0.38987828999796825,"score_spread":0.2985957314406402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181405059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778498,0.0021814404,0.000005570261,0.015654916,0.00009329405,0.0013116391,0.000041532436,0.00002361169,0.002838196],"genre_scores_gemma":[0.99336857,0.00012502729,0.00008446938,0.00032898915,0.00041324153,0.0003868383,0.000013895916,0.000032934804,0.005246045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975839,0.00024011104,0.00018147191,0.000490354,0.0009407885,0.0005633463],"domain_scores_gemma":[0.99834836,0.00025497976,0.00002978474,0.00059362286,0.00037323625,0.00040004373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010412432,0.00015977467,0.00024681154,0.000075507465,0.00023142144,0.0000782948,0.000072473245,0.000082520026,0.00023008109],"category_scores_gemma":[0.00031014805,0.000107822736,0.000075799486,0.00045470396,0.00017765195,0.00006092469,0.00023060429,0.00060065876,0.000092808536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070356426,0.0002838326,0.013517833,0.0004262087,0.00014095123,0.0042279838,0.0010316249,0.000012964244,0.9288289,0.0001959377,0.018821152,0.031809065],"study_design_scores_gemma":[0.001075297,0.00035665397,0.25500816,0.000461232,0.000037066147,0.000103824415,0.0008844061,0.000018273417,0.7066431,0.000068863716,0.03518067,0.00016245131],"about_ca_topic_score_codex":0.0030115247,"about_ca_topic_score_gemma":0.0014589546,"teacher_disagreement_score":0.24149033,"about_ca_system_score_codex":0.0006300365,"about_ca_system_score_gemma":0.0006001383,"threshold_uncertainty_score":0.45525447},"labels":[],"label_agreement":null},{"id":"W3181444527","doi":"10.1158/1538-7445.am2021-878","title":"Abstract 878: Contraceptive use and ovarian cancer risk in <i>BRCA1</i> and <i>BRCA2</i> mutation carriers: A prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Prospective cohort study; Hazard ratio; BRCA mutation; Gynecology; Proportional hazards model; Cancer; Obstetrics; Population; Cohort; Cohort study; Oncology; Confidence interval; Internal medicine; Environmental health","score_opus":0.04850396754944766,"score_gpt":0.38610273117359967,"score_spread":0.337598763624152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181444527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861286,0.008354039,0.000003393111,0.0015612742,0.00011953133,0.0030614943,0.00020399204,0.000023606377,0.0005440534],"genre_scores_gemma":[0.98740107,0.008969321,0.000068529705,0.00014618678,0.00018527314,0.0028988107,0.000017797336,0.000039664388,0.00027334414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997341,0.00027429647,0.0003075198,0.00091113924,0.00065515214,0.0005109168],"domain_scores_gemma":[0.998139,0.0003992282,0.00008339347,0.00035527992,0.00072021125,0.0003028588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087606435,0.00022084346,0.00049959467,0.00018886794,0.00022228781,0.00019147579,0.000055102017,0.000111329544,0.00031853482],"category_scores_gemma":[0.0003474321,0.00019554782,0.000044328768,0.0006470563,0.00024711012,0.00027881638,0.000091340604,0.00071023026,0.000005197859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060805486,0.0006746896,0.9809058,0.000080995494,0.0007014552,0.0011343256,0.0051208716,0.000017063076,0.00079103885,0.000074249794,0.0005310009,0.009360464],"study_design_scores_gemma":[0.008021534,0.00044333917,0.98268217,0.00032912404,0.00022039891,0.000023060966,0.0040732916,0.000026689775,0.0032182492,0.0001507111,0.00063698756,0.0001744322],"about_ca_topic_score_codex":0.030707955,"about_ca_topic_score_gemma":0.026022248,"teacher_disagreement_score":0.009186032,"about_ca_system_score_codex":0.0011489718,"about_ca_system_score_gemma":0.0010067079,"threshold_uncertainty_score":0.9917503},"labels":[],"label_agreement":null},{"id":"W3181477033","doi":"10.1158/1538-7445.am2021-lb018","title":"Abstract LB018: Cloud-based biological domain knowledge derived gene expression classifier to predict the cancer clinical outcome","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brantford Energy (Canada)","funders":"","keywords":"Radiation therapy; Gene; Gene expression; Bioinformatics; Medicine; Cancer; Signal transduction; Computational biology; Oncology; Cancer research; Biology; Internal medicine; Genetics","score_opus":0.23126440430392511,"score_gpt":0.5231201485028837,"score_spread":0.29185574419895854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181477033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94736874,0.0035118852,0.0014950975,0.044024274,0.0012305016,0.0006240884,0.000028748573,0.00007275245,0.0016438911],"genre_scores_gemma":[0.9877504,0.0010686892,0.0022343837,0.0039507607,0.0030432132,0.000445674,0.000033914825,0.00005352418,0.0014194312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960552,0.0008319603,0.00064748985,0.00080514594,0.0008157381,0.00084450917],"domain_scores_gemma":[0.9965574,0.0012822954,0.00007871212,0.0007814725,0.00054213766,0.000757978],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004204567,0.00021157865,0.0005201798,0.00012572153,0.0003938094,0.00008693886,0.0005036673,0.0002584902,0.0022853233],"category_scores_gemma":[0.0030298112,0.0001249827,0.00023798188,0.0006227267,0.0006367177,0.000035753375,0.00037081254,0.0024104035,0.00012239987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000806069,0.00047895472,0.28724793,0.00016445178,0.00012109914,0.0004320619,0.0003648249,0.00016231922,0.5880924,0.00009398616,0.07706734,0.04496857],"study_design_scores_gemma":[0.0045070155,0.00040307405,0.50705457,0.0010021023,0.00005811165,0.000029310431,0.00042206066,0.0014826966,0.07726927,0.00022944379,0.4071578,0.00038451434],"about_ca_topic_score_codex":0.00021509868,"about_ca_topic_score_gemma":0.00006277798,"teacher_disagreement_score":0.51082313,"about_ca_system_score_codex":0.0003527371,"about_ca_system_score_gemma":0.0015619345,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W3181502328","doi":"10.1158/1538-7445.am2021-lb105","title":"Abstract LB105: In vivo CAR T therapy: targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Cytotoxic T cell; CD8; Ex vivo; Biology; Transduction (biophysics); T cell; Cancer research; Gene delivery; Viral vector; Cell therapy; CD19; In vivo; Genetic enhancement; Cell biology; Immunology; Antigen; Immune system; In vitro; Stem cell; Biochemistry; Gene; Genetics; Recombinant DNA","score_opus":0.12560361493496577,"score_gpt":0.4004026008070786,"score_spread":0.2747989858721128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181502328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832042,0.013470727,0.0000015044008,0.00067741843,0.00008851773,0.0012752401,0.00015079914,0.00001659019,0.0011150349],"genre_scores_gemma":[0.9875097,0.010834245,0.00019143267,0.00006621621,0.00024201254,0.00022257093,0.00003544127,0.00007317888,0.00082516746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952454,0.0006256141,0.00086816255,0.00081090926,0.0014644027,0.0009855274],"domain_scores_gemma":[0.9976175,0.00039913217,0.00011033778,0.0008524292,0.0007880781,0.0002325437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028932863,0.00022504554,0.00063057133,0.0014647635,0.00006596311,0.000041356143,0.00033839507,0.00019431819,0.0035747313],"category_scores_gemma":[0.00028272375,0.00022996348,0.000115807234,0.0033821666,0.0002743287,0.00014416855,0.00013729413,0.0012699955,0.000010519547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004547,0.0003951308,0.014773329,0.00016034169,0.000049784365,0.0012473279,0.0024114053,0.00042134977,0.97066706,0.000008357386,0.0005530046,0.0047658808],"study_design_scores_gemma":[0.0071415515,0.000189509,0.055491056,0.00063696713,0.0000041699013,0.000030119263,0.0010696176,0.00073396886,0.92666113,0.000049299117,0.007785339,0.00020727348],"about_ca_topic_score_codex":0.017352229,"about_ca_topic_score_gemma":0.007192439,"teacher_disagreement_score":0.04400596,"about_ca_system_score_codex":0.0023871805,"about_ca_system_score_gemma":0.002843282,"threshold_uncertainty_score":0.99733615},"labels":[],"label_agreement":null},{"id":"W3181542836","doi":"10.1158/1538-7445.am2021-924","title":"Abstract 924: PROTECT, a novel antibody platform for integrating tumor-specific immune modulation and enhancing the therapeutic window of targeted multispecific biologics","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody; Cancer research; Antigen; Immune system; Tumor microenvironment; Chemistry; Immunology; Biology","score_opus":0.13827831713167282,"score_gpt":0.4220520339317984,"score_spread":0.2837737168001256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181542836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981045,0.013031007,0.002069239,0.0017175017,0.00011811262,0.0016196348,0.00007840625,0.000019123006,0.00030198816],"genre_scores_gemma":[0.9954576,0.0017678643,0.0014840364,0.000048760197,0.00029319138,0.00025834178,0.00009924809,0.000028893972,0.0005620484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978562,0.00007966648,0.00046181056,0.0004079079,0.0006285005,0.0005658953],"domain_scores_gemma":[0.9975309,0.00089359994,0.00010822127,0.00033030333,0.0010300607,0.000106921616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015341286,0.00017101112,0.00037794848,0.00016074741,0.00042880565,0.00006662778,0.00018576106,0.00009865028,0.00019331415],"category_scores_gemma":[0.00038084676,0.00010509023,0.00012478902,0.0005591245,0.00042984297,0.00009086358,0.00014279269,0.00079315004,0.000004545911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083646376,0.000112811686,0.0020042425,0.0004189946,0.00009553951,0.00001554511,0.0005281829,0.000020043824,0.96188855,0.0012150625,0.000039766972,0.03282482],"study_design_scores_gemma":[0.0017328673,0.00044958043,0.20431407,0.00066578813,0.000014621305,0.000060532795,0.0021739588,0.0032595336,0.7785623,0.00072905346,0.007854066,0.00018361206],"about_ca_topic_score_codex":0.00050233124,"about_ca_topic_score_gemma":0.0001095559,"teacher_disagreement_score":0.20230983,"about_ca_system_score_codex":0.00013104761,"about_ca_system_score_gemma":0.0004438392,"threshold_uncertainty_score":0.4285455},"labels":[],"label_agreement":null},{"id":"W3181574734","doi":"10.1158/1538-7445.am2021-2415","title":"Abstract 2415: The role of GTSF1 as a regulator of retrotransposons and its impact on carcinogenesis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Retrotransposon; Biology; Carcinogenesis; DNA methylation; Gene knockdown; Germline; Genetics; Genome instability; Gene silencing; Cancer research; RNA interference; Cancer; Gene expression; Gene; RNA; Transposable element; Genome; DNA; DNA damage","score_opus":0.052396275496124634,"score_gpt":0.35144027044921294,"score_spread":0.2990439949530883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181574734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929217,0.003619014,1.3534492e-8,0.00225712,0.000016141714,0.00012773523,0.00020246278,0.000003514905,0.0008522914],"genre_scores_gemma":[0.99924123,0.00048476434,0.0000018943919,0.000014090438,0.00008585544,0.000020622358,0.0000073170604,7.307485e-7,0.00014346399],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991479,0.000084157,0.000114617775,0.00015890594,0.00031700803,0.00017741439],"domain_scores_gemma":[0.9993253,0.00026440102,0.000023876664,0.00006979583,0.00024681792,0.00006982687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022289495,0.000056641817,0.00010854649,0.0000103176435,0.0001320302,0.00001441658,0.00014304402,0.00004728099,0.0012524055],"category_scores_gemma":[0.000064125255,0.000018213987,0.00006764554,0.00040685834,0.00007614718,0.000020620679,0.000041040665,0.00010565986,0.0000054736315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043360058,0.000040257786,0.01090399,0.000009899305,0.000019437808,0.0000011797092,0.00012316246,0.00001141641,0.97695065,0.0008920954,0.000030396835,0.01097414],"study_design_scores_gemma":[0.000046048277,0.00012756123,0.5251585,0.000026900221,0.0000042854826,0.0000016378045,0.00018999547,0.000011492574,0.4727736,0.0007166349,0.00091519137,0.000028112589],"about_ca_topic_score_codex":0.0012295174,"about_ca_topic_score_gemma":0.0008662314,"teacher_disagreement_score":0.5142545,"about_ca_system_score_codex":0.000022045257,"about_ca_system_score_gemma":0.00008473256,"threshold_uncertainty_score":0.9996606},"labels":[],"label_agreement":null},{"id":"W3181654390","doi":"10.1158/1538-7445.am2021-857","title":"Abstract 857: Evaluating the relationship between arsenic exposure and cancer risk in Canada","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fluoride Effects and Removal","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer; Public Health Ontario; University of Toronto","funders":"","keywords":"Quartile; Medicine; Arsenic; Environmental health; Population; Cancer; Breast cancer; Risk assessment; Internal medicine; Confidence interval; Chemistry","score_opus":0.1223247175551724,"score_gpt":0.40675578942473606,"score_spread":0.2844310718695637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181654390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942712,0.0029057849,7.148115e-7,0.0015835305,0.00011486009,0.0001974924,0.000023361066,0.0000036332237,0.00089941674],"genre_scores_gemma":[0.9987404,0.0003596026,0.000029476649,0.00004031359,0.00013347248,0.000065501445,0.0000022504857,0.000010425107,0.0006186052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811167,0.00037574262,0.00015036493,0.00028419986,0.000710621,0.00036742652],"domain_scores_gemma":[0.99813837,0.0014866414,0.00003535774,0.00022294334,0.000023216287,0.00009349219],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016375554,0.00007370362,0.000099177785,0.000021704189,0.0003378379,0.00004230492,0.00016218073,0.000041465315,0.0013210977],"category_scores_gemma":[0.0005739265,0.000050961004,0.000017070557,0.0004646529,0.0001281166,0.000075495154,0.00017701778,0.0007135479,0.00002058747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007810749,0.0000033982865,0.9440206,0.000013246778,0.000005864794,0.000018566026,0.00020870284,0.0023048674,0.0027340688,0.000009409087,0.0009620449,0.049711417],"study_design_scores_gemma":[0.00020951343,0.000016588923,0.9968508,0.000049472026,0.0000053489935,0.0000013240988,0.0002516858,0.00033666572,0.0008682865,0.00032089715,0.0010190841,0.00007033233],"about_ca_topic_score_codex":0.94326514,"about_ca_topic_score_gemma":0.9704445,"teacher_disagreement_score":0.052830197,"about_ca_system_score_codex":0.0011876449,"about_ca_system_score_gemma":0.0010001381,"threshold_uncertainty_score":0.9995918},"labels":[],"label_agreement":null},{"id":"W3181675264","doi":"10.1158/1538-7445.am2021-ct004","title":"Abstract CT004: Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915)","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Ipilimumab; Oncology; Stage (stratigraphy); Adjuvant; Gastroenterology; Cancer; Immunotherapy","score_opus":0.03971357376249071,"score_gpt":0.33448434079264733,"score_spread":0.2947707670301566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181675264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991075,0.0027064034,0.000006822087,0.0017035275,0.0001061466,0.002031209,0.00012750905,0.000103530736,0.0021398438],"genre_scores_gemma":[0.9910362,0.0022213655,0.00017327577,0.00036348548,0.000101570164,0.000484608,0.00023862059,0.00016736817,0.0052135033],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99453294,0.00032649448,0.000567969,0.0011037523,0.0021138028,0.001355018],"domain_scores_gemma":[0.99658465,0.00017638535,0.00019303692,0.0012211488,0.0014575134,0.00036723723],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087749085,0.0005066632,0.00091285736,0.00050866354,0.0003061638,0.00014595037,0.00040546898,0.0002248926,0.0022366717],"category_scores_gemma":[0.000048545982,0.00034151305,0.00010180971,0.0023570901,0.0006763293,0.00029564457,0.000100351084,0.0012922413,0.000028939938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5334687,0.0036946598,0.34208584,0.00087601907,0.0018351559,0.0028475209,0.0027356953,0.000072544186,0.07192889,0.000031628242,0.0036715209,0.036751803],"study_design_scores_gemma":[0.09814668,0.0152991535,0.8108694,0.0024135143,0.000052231197,0.0000486613,0.0012698532,0.000049860017,0.061296895,0.000012881036,0.009816079,0.0007247878],"about_ca_topic_score_codex":0.006672069,"about_ca_topic_score_gemma":0.014770716,"teacher_disagreement_score":0.46878356,"about_ca_system_score_codex":0.0012819677,"about_ca_system_score_gemma":0.0027531944,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W3181748785","doi":"10.1158/1538-7445.am2021-2591","title":"Abstract 2591: Characterizing the metabolic landscape of dermal fibroblasts in Li-Fraumeni Syndrome for the prediction of cancer risk and drug response","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cancer; Disease; Sarcoma; Medicine; Phenotype; Cancer research; Li–Fraumeni syndrome; Biology; Germline; Internal medicine; Oncology; Germline mutation; Bioinformatics; Pathology; Mutation; Gene; Genetics","score_opus":0.03852979015618025,"score_gpt":0.3502919240687254,"score_spread":0.31176213391254515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181748785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9591398,0.035983656,0.000021783006,0.0033553347,0.00015283708,0.00087420514,0.00042411406,0.000009719303,0.00003851361],"genre_scores_gemma":[0.98684454,0.0121712675,0.000027885848,0.00005204649,0.00011062406,0.00050920574,0.000012851617,0.000031553707,0.00024002403],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99814975,0.0003097231,0.00035155137,0.00029561666,0.0005295056,0.00036384555],"domain_scores_gemma":[0.9979968,0.00094964495,0.00013160067,0.00044135883,0.00039880697,0.00008180373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018405981,0.00011768085,0.0003181092,0.0001924298,0.0001350668,0.00002144822,0.00015148432,0.00009291722,0.00016356715],"category_scores_gemma":[0.00057552767,0.00007751005,0.000094842726,0.0006609761,0.000233188,0.00007108149,0.00011334943,0.0006407456,0.0000011785542],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044741756,0.00009356115,0.024221173,0.00047852282,0.0003382275,0.00005664546,0.0027640325,0.00035113058,0.94817346,0.00002994964,0.001010706,0.018008389],"study_design_scores_gemma":[0.002119354,0.00013287425,0.7142171,0.0007386688,0.000119862096,0.000045604844,0.00068466685,0.0006001148,0.2717882,0.000023725375,0.009461927,0.00006788351],"about_ca_topic_score_codex":0.0016943987,"about_ca_topic_score_gemma":0.0009889606,"teacher_disagreement_score":0.68999594,"about_ca_system_score_codex":0.00011735946,"about_ca_system_score_gemma":0.0009932399,"threshold_uncertainty_score":0.31607682},"labels":[],"label_agreement":null},{"id":"W3181779104","doi":"10.1158/1538-7445.am2021-125","title":"Abstract 125: First report of a full spectrum of de novo induced human breast cancer subtypes generated from oncogene-transduced freshly isolated normal human mammary cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Biology; Cancer research; Cancer; Matrigel; Breast cancer; Pathology; Angiogenesis; Medicine","score_opus":0.03788982313077589,"score_gpt":0.36266008202939787,"score_spread":0.324770258898622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181779104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445754,0.002689522,0.000026914331,0.0004250921,0.00010276379,0.00034062134,0.0013457428,0.000013094615,0.0005987279],"genre_scores_gemma":[0.99633604,0.0015335863,0.00007014566,0.000026109874,0.000382043,0.00015373074,0.00075421843,0.00005572106,0.0006883916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707824,0.00017379303,0.0005402262,0.0007441387,0.00065947016,0.0008041607],"domain_scores_gemma":[0.99782836,0.00002974812,0.00018110071,0.00084611255,0.0008115596,0.00030310755],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004079163,0.00025251665,0.00039790416,0.0001643828,0.00023742918,0.000052387513,0.0004888593,0.0002827147,0.0011424612],"category_scores_gemma":[0.000028518463,0.00025630547,0.00018559143,0.00052886107,0.00021234884,0.00001812636,0.00026037046,0.0004274333,0.0000058558335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007028196,0.00035848425,0.011191183,0.00014175788,0.00062712,0.0008127405,0.00011573132,0.00007447596,0.98416954,0.00000947664,0.001232168,0.0005644817],"study_design_scores_gemma":[0.0016471758,0.00035640688,0.031055864,0.00013237503,0.000032755805,0.00008074516,0.0000396025,0.000010477179,0.9654239,0.000059443653,0.00093848177,0.0002228023],"about_ca_topic_score_codex":0.04058372,"about_ca_topic_score_gemma":0.07220641,"teacher_disagreement_score":0.031622685,"about_ca_system_score_codex":0.00027366646,"about_ca_system_score_gemma":0.002225238,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W3181844394","doi":"10.1158/1538-7445.am2021-3147","title":"Abstract 3147: Stereotactic image-guided epigenome profiling reveals a neural stem cell evolutionary origin of diffuse gliomas","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lineage (genetic); Glioma; White matter; Biology; Epigenome; Pathology; Brain tumor; Biopsy; Evolutionary biology; DNA methylation; Magnetic resonance imaging; Medicine; Cancer research; Gene; Radiology; Genetics","score_opus":0.08187370815978155,"score_gpt":0.4166930715948029,"score_spread":0.33481936343502133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181844394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98621905,0.0068493243,0.00006374817,0.003252829,0.00026049765,0.00046657192,0.000022625642,0.00004362051,0.0028217412],"genre_scores_gemma":[0.99296504,0.0005747115,0.0014214145,0.00016433546,0.00042901462,0.0000746119,0.000030628,0.000055061675,0.0042851954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701107,0.00027492328,0.0005108233,0.0004895031,0.0010402541,0.00067341275],"domain_scores_gemma":[0.9977331,0.00039678073,0.00012654332,0.00054385356,0.00082894356,0.00037076618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012219764,0.00016868369,0.0004447173,0.00029719234,0.00016874932,0.000052166768,0.00023069709,0.00009367982,0.000552506],"category_scores_gemma":[0.00044535252,0.0001495276,0.0001393983,0.00079045846,0.00024364905,0.00013947644,0.0001694014,0.0012733368,0.000039978415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018921377,0.00034361955,0.035653245,0.0017027745,0.00008749922,0.0012905961,0.0004021343,0.000039723247,0.9512728,0.00014174457,0.0039361017,0.004940555],"study_design_scores_gemma":[0.019104764,0.0010661121,0.37419727,0.0040630647,0.00042227522,0.0011495188,0.0030070317,0.022767844,0.54416275,0.0020799548,0.02649187,0.0014875218],"about_ca_topic_score_codex":0.00028480025,"about_ca_topic_score_gemma":0.0000036237914,"teacher_disagreement_score":0.40711004,"about_ca_system_score_codex":0.0003996971,"about_ca_system_score_gemma":0.0011042177,"threshold_uncertainty_score":0.6097558},"labels":[],"label_agreement":null},{"id":"W3181852565","doi":"10.1158/1538-7445.am2021-1222","title":"Abstract 1222: Validating the WD repeat protein CDC40 as a potential therapeutic target for lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cell cycle; Cancer research; Carcinogenesis; Cell cycle checkpoint; RNA splicing; Gene knockdown; Alternative splicing; Small hairpin RNA; Cancer; Lung cancer; Spliceosome; Synthetic lethality; Cell growth; Cancer cell; Cell biology; Apoptosis; Messenger RNA; Genetics; RNA; DNA repair; Medicine; Gene; Oncology","score_opus":0.059344429730200224,"score_gpt":0.42140426402615616,"score_spread":0.36205983429595595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181852565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524546,0.036469184,0.0022314638,0.0055460287,0.00027616366,0.0012058218,0.00014387057,0.000015304977,0.001657508],"genre_scores_gemma":[0.9838383,0.0013425425,0.00025529592,0.0002761383,0.00094677997,0.0031527278,0.00008989243,0.000042232186,0.010056083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983368,0.00014520437,0.00019448793,0.0004949926,0.00034785326,0.0004806841],"domain_scores_gemma":[0.9986,0.000030894214,0.000063148254,0.00058811775,0.0006369319,0.00008091462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068711856,0.00012732855,0.00011640402,0.000032692038,0.0004953107,0.00013879065,0.00034724866,0.00011895159,0.0006147715],"category_scores_gemma":[0.00012771151,0.000097202086,0.0001198602,0.00021180799,0.00013707159,0.0000072428024,0.0001203878,0.00026236277,0.000005707395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012236863,0.000037572492,0.00016965227,0.00007731685,0.00011503498,0.000004274537,0.00007000275,0.00049172685,0.9760031,0.00034452876,0.0066361064,0.015928322],"study_design_scores_gemma":[0.0004894567,0.00007323539,0.0006197951,0.0000645965,0.000019877076,0.0000051218553,0.0002729765,0.0003455071,0.86867094,0.00040535696,0.12886655,0.00016655886],"about_ca_topic_score_codex":0.00049333443,"about_ca_topic_score_gemma":0.00015913713,"teacher_disagreement_score":0.12223045,"about_ca_system_score_codex":0.0000997669,"about_ca_system_score_gemma":0.0011228052,"threshold_uncertainty_score":0.6731317},"labels":[],"label_agreement":null},{"id":"W3181895160","doi":"10.1158/1538-7445.am2021-1708","title":"Abstract 1708: Improving genotype specific chemotherapy response in ovarian cancer via cGAS-STING pathway activation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario; University of Ottawa; Queen's University","funders":"","keywords":"Cancer research; Immune system; PTEN; Tumor microenvironment; Biology; Immune checkpoint; Ovarian cancer; CXCL10; Chemokine; CD8; Immunology; Immunotherapy; Cancer; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.060980450235424845,"score_gpt":0.36013798734740643,"score_spread":0.29915753711198156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181895160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457533,0.011698767,0.00013054303,0.0019463626,0.00058974844,0.0002970945,0.000027385277,0.000036838937,0.0006979285],"genre_scores_gemma":[0.99199504,0.0014470378,0.000039737217,0.00017346277,0.00013241688,0.00015647197,0.000034521472,0.00004499396,0.005976321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972263,0.0009844567,0.00035514377,0.0005179237,0.00012973754,0.0007864653],"domain_scores_gemma":[0.99838275,0.0006374214,0.00008558646,0.00043154054,0.00042656643,0.000036113277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018191636,0.00018617878,0.00026846325,0.00037837288,0.000303584,0.000071451665,0.00029551992,0.00029006467,0.005321929],"category_scores_gemma":[0.00041791867,0.00018061187,0.00007675145,0.00073307776,0.00019087859,0.00017569841,0.00013245054,0.0011419123,0.00027691855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008171561,0.000089626905,0.00046281994,0.00004108403,0.000053726817,0.000049033384,0.0012362376,0.000017135104,0.9229616,0.00006458842,0.00073315616,0.06611944],"study_design_scores_gemma":[0.00141085,0.000111885325,0.062478915,0.00027490171,0.0000017586871,0.0000168151,0.00052432576,0.0000063196967,0.89902824,0.000046195164,0.035919882,0.00017991668],"about_ca_topic_score_codex":0.0021172394,"about_ca_topic_score_gemma":0.00030453817,"teacher_disagreement_score":0.06593952,"about_ca_system_score_codex":0.0007282567,"about_ca_system_score_gemma":0.0011163147,"threshold_uncertainty_score":0.99558735},"labels":[],"label_agreement":null},{"id":"W3181900713","doi":"10.1158/1538-7445.am2021-lb130","title":"Abstract LB130: Combination of IGF-1R targeted alpha therapy with Olaparib results in synergistic efficacy against colorectal and lung cancer xenografts","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"General Fusion (Canada)","funders":"","keywords":"Olaparib; Cancer research; Medicine; PARP inhibitor; Poly ADP ribose polymerase; Cancer; DNA repair; Apoptosis; Targeted therapy; DNA damage; Biology; Polymerase; Internal medicine; DNA","score_opus":0.06077148724054904,"score_gpt":0.4142986896277987,"score_spread":0.35352720238724966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181900713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791386,0.015025989,0.000009281015,0.00269023,0.00018107708,0.0009357742,0.00013722829,0.00003598593,0.0018458392],"genre_scores_gemma":[0.9885222,0.0101616625,0.00006697909,0.00017498186,0.00018724061,0.00037262452,0.00013042615,0.000049490023,0.00033441678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723834,0.0002244239,0.00048258252,0.0005674996,0.0009416168,0.000545546],"domain_scores_gemma":[0.99775416,0.0005066705,0.00014351419,0.00036039765,0.0010301126,0.00020512678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008564993,0.0002037848,0.00046347096,0.0003650496,0.0001208186,0.00004418476,0.00013257068,0.00014869856,0.00027793783],"category_scores_gemma":[0.00025087714,0.0001766756,0.000054117867,0.0013260324,0.0004709266,0.00012646611,0.000047416517,0.00071480364,0.0000032774756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01722352,0.0013256944,0.038537163,0.0006804848,0.00047913147,0.00047470455,0.003302975,0.0007088613,0.9059408,0.0002530806,0.0059741805,0.025099441],"study_design_scores_gemma":[0.030581338,0.0008629215,0.35784584,0.002589449,0.000032169995,0.000014372286,0.0004184815,0.0005588736,0.6030962,0.00006235634,0.0035993562,0.00033866163],"about_ca_topic_score_codex":0.0013772651,"about_ca_topic_score_gemma":0.0015062506,"teacher_disagreement_score":0.31930867,"about_ca_system_score_codex":0.00073360075,"about_ca_system_score_gemma":0.0016978917,"threshold_uncertainty_score":0.7204622},"labels":[],"label_agreement":null},{"id":"W3182028798","doi":"10.1158/1538-7445.am2021-2602","title":"Abstract 2602: Leveraging cell-free methylome markers for early cancer detection","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Wilfrid Laurier University; University of Waterloo; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Context (archaeology); DNA methylation; Epigenetics; Biomarker; Oncology; Population; Medicine; Stage (stratigraphy); Internal medicine; Bioinformatics; Biology; Genetics; Gene","score_opus":0.05008971120894964,"score_gpt":0.36601146608499185,"score_spread":0.31592175487604224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182028798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489505,0.010784642,0.0010419001,0.0006601211,0.00060316187,0.00035529403,0.00025618987,0.000010039192,0.0013936309],"genre_scores_gemma":[0.9891024,0.006586278,0.00024874756,0.00020482195,0.0009892781,0.0006182684,0.000049672835,0.00005135929,0.0021491302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984845,0.000056933244,0.00018910236,0.0004576404,0.00027194392,0.00053989905],"domain_scores_gemma":[0.9985654,0.0001198464,0.000049523806,0.0005349171,0.000580241,0.00015011535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005170625,0.00013681728,0.00014449906,0.00007644578,0.0002304782,0.00010481931,0.0003001216,0.00014869671,0.00017779367],"category_scores_gemma":[0.00030915326,0.00015119181,0.00011953931,0.0002200786,0.00008314174,0.000005880863,0.00024557134,0.00023781748,0.000007278605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025077607,0.000033819488,0.0007798803,0.000097393735,0.000063974534,0.000006675253,0.00006337961,0.0002479746,0.9647354,0.000014463965,0.01108772,0.022618547],"study_design_scores_gemma":[0.0009605067,0.00011557019,0.0059398855,0.000034714045,0.00001580847,0.0000017455652,0.00019678248,0.000025768326,0.8866325,0.00029373297,0.10559172,0.00019126444],"about_ca_topic_score_codex":0.001673651,"about_ca_topic_score_gemma":0.0017937325,"teacher_disagreement_score":0.094504,"about_ca_system_score_codex":0.00019727228,"about_ca_system_score_gemma":0.0007917478,"threshold_uncertainty_score":0.61654234},"labels":[],"label_agreement":null},{"id":"W3182080430","doi":"10.1158/1538-7445.am2021-1778","title":"Abstract 1778: Bacterial regulation of innate and adaptive tumor immunity in metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Inflammation; Tumor microenvironment; Immune system; Acquired immune system; Breast cancer; Immunology; Cancer; Microbiome; Innate immune system; Cancer research; Metastatic breast cancer; Tumor progression; Medicine; Biology; Internal medicine; Bioinformatics","score_opus":0.053159723280216675,"score_gpt":0.38862050097267703,"score_spread":0.33546077769246035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182080430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953566,0.0034490537,0.000003105867,0.00021444223,0.000049456812,0.00022284448,0.00042585403,0.0000021878504,0.00027641366],"genre_scores_gemma":[0.9974418,0.0019073656,0.000046838093,0.000013882207,0.000093569506,0.00016743471,0.000094100535,0.000015296262,0.00021970311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987025,0.00020479258,0.00017445002,0.00029674207,0.000291932,0.00032956825],"domain_scores_gemma":[0.99918056,0.000032742922,0.00004618314,0.00024297199,0.00039823866,0.00009932749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037845442,0.00009637017,0.00016210412,0.00009871068,0.000067630564,0.00002817896,0.00010957436,0.000044212906,0.0005155877],"category_scores_gemma":[0.00006721066,0.00009110522,0.000036162135,0.0002917697,0.0001928617,0.000011562648,0.00018043676,0.00019647446,0.000002311467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011381912,0.00012546284,0.0072720344,0.000084766325,0.0001129891,0.000030137977,0.00008764092,0.000029233079,0.9783297,0.000036132784,0.00036719342,0.012386491],"study_design_scores_gemma":[0.0016340679,0.00013534816,0.3754426,0.00012084576,0.00000864589,0.000015061713,0.00018708539,0.000018509,0.62117034,0.00021847956,0.00094334973,0.0001056747],"about_ca_topic_score_codex":0.009818295,"about_ca_topic_score_gemma":0.012195536,"teacher_disagreement_score":0.36817056,"about_ca_system_score_codex":0.00012592674,"about_ca_system_score_gemma":0.000859707,"threshold_uncertainty_score":0.9967754},"labels":[],"label_agreement":null},{"id":"W3182272247","doi":"10.1158/1538-7445.am2021-3001","title":"Abstract 3001: Multicellular structures of serous ovarian cancer nature isolated from pleural effusions are sufficient to recreate peritoneal carcinomatosis in immunosuppressed mice","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Histopathology; Pleural effusion; Ovarian cancer; Pathology; Ascites; Peritoneal cavity; Pleural cavity; Serous fluid; Abdominal cavity; Peritoneum; Lymph node; Cancer; Internal medicine; Surgery","score_opus":0.0496943983288677,"score_gpt":0.3814572876618752,"score_spread":0.3317628893330075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182272247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732185,0.018669765,0.0000027307537,0.0053362753,0.00047113234,0.0010733308,0.0010295665,0.000029851193,0.00016883311],"genre_scores_gemma":[0.9965113,0.0016033471,0.00033622424,0.00027052464,0.0002486909,0.0005654878,0.00017696735,0.00006387246,0.00022359147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996734,0.00022800257,0.0005254564,0.0008581218,0.00088886236,0.0007655079],"domain_scores_gemma":[0.99752796,0.00032232975,0.00012119653,0.00077835703,0.00086367776,0.00038648365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026951075,0.00030361587,0.0007044462,0.0003346611,0.00018110582,0.00007297796,0.000289489,0.0002944303,0.0023394178],"category_scores_gemma":[0.00018540285,0.00026529253,0.00014475452,0.0012049382,0.00012274315,0.000073831805,0.000228863,0.0012100168,0.000015300902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032509814,0.0013871252,0.25860742,0.0005127539,0.00068016845,0.0020154805,0.0051728287,0.001455774,0.72182786,0.000058894915,0.0023493106,0.0026813955],"study_design_scores_gemma":[0.0035351843,0.00021371938,0.72479075,0.0012995503,0.000110800735,0.000010070559,0.0013732313,0.00027761725,0.26706463,0.000022217568,0.0010893565,0.00021286508],"about_ca_topic_score_codex":0.06694491,"about_ca_topic_score_gemma":0.010680403,"teacher_disagreement_score":0.46618333,"about_ca_system_score_codex":0.0010162517,"about_ca_system_score_gemma":0.0011365871,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W3182291201","doi":"10.1158/1538-7445.am2021-2886","title":"Abstract 2886: The mechanistic effect of DHA on FABP7 associated membrane lipid order &amp; nanodomain distribution in glioblastoma migration","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Docosahexaenoic acid; Arachidonic acid; Lipid signaling; Chemistry; Biochemistry; Biology; Cell biology; Polyunsaturated fatty acid; Fatty acid; Receptor","score_opus":0.027614231117211993,"score_gpt":0.36221266112897466,"score_spread":0.33459843001176265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182291201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735475,0.0002760613,0.00001810432,0.0010316343,0.00027618927,0.0007454269,0.00008252455,0.000022440134,0.00019284752],"genre_scores_gemma":[0.9988743,0.00016957957,0.0000028454697,0.000043973534,0.00019837831,0.0002135792,0.00018669324,0.000019701278,0.00029092442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972677,0.0007797991,0.0002914091,0.00028858057,0.000932909,0.00043960873],"domain_scores_gemma":[0.99768883,0.0012996414,0.00008399013,0.00035131926,0.00046697713,0.0001092194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030617933,0.00014895744,0.00035250775,0.00013202903,0.00013786474,0.000024240855,0.00011024709,0.00016612996,0.00042418277],"category_scores_gemma":[0.0037849364,0.00010086821,0.00008272711,0.0010748117,0.00011090356,0.000043392985,0.000045179288,0.00066334114,0.00008474225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030312832,0.0003044309,0.007491029,0.00091764994,0.000120845434,0.0002099377,0.0004923031,0.00013423811,0.9774601,0.0003977035,0.005921011,0.0035194806],"study_design_scores_gemma":[0.0030696862,0.0010082835,0.033347946,0.0010068992,0.00004745662,0.000009060471,0.00007287383,0.00019470183,0.957105,0.000052097912,0.0039463574,0.00013968309],"about_ca_topic_score_codex":0.0004139276,"about_ca_topic_score_gemma":0.002711886,"teacher_disagreement_score":0.025856918,"about_ca_system_score_codex":0.00057794416,"about_ca_system_score_gemma":0.0004780203,"threshold_uncertainty_score":0.4644504},"labels":[],"label_agreement":null},{"id":"W3182312709","doi":"10.1158/1538-7445.am2021-517","title":"Abstract 517: Tebentafusp induces transient systemic inflammation and modifies the micro-environment to sensitize uveal melanoma tumors to cytotoxic CD8 cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; CD8; Immune system; Chemokine; Cytotoxic T cell; Immunohistochemistry; Inflammation; CD3; T cell; Immunology; CXCL9; Cancer research; Internal medicine; Biology; CXCL10","score_opus":0.04375356368309628,"score_gpt":0.34301753497194143,"score_spread":0.29926397128884513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182312709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054617,0.000837867,0.000010702805,0.0068831965,0.00009537108,0.0011433525,0.000022763277,0.000014054013,0.00044652095],"genre_scores_gemma":[0.9979445,0.0003194534,0.00009392899,0.00020012337,0.00015044177,0.0002668469,0.0000150048045,0.000018440596,0.0009912718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998413,0.00018198675,0.00021460085,0.00036131113,0.00045768305,0.0003713773],"domain_scores_gemma":[0.99920326,0.00012880584,0.00002875924,0.00030261997,0.00009949469,0.00023704986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048971124,0.00013154323,0.00023437211,0.000119304175,0.00022321913,0.000042489057,0.00007969172,0.00009140752,0.00018034628],"category_scores_gemma":[0.000032478776,0.00009444252,0.000046044614,0.00020258331,0.00010893595,0.00004459553,0.00008561375,0.00031506657,0.00025063378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022785696,0.00007326403,0.0020239835,0.00013663044,0.00011729195,0.0005613026,0.0026430662,0.00016963587,0.98862374,0.000015822312,0.00039713198,0.0050102756],"study_design_scores_gemma":[0.0010449315,0.00032404903,0.07721404,0.00034179701,0.00005361124,0.00014573113,0.0027981456,0.000009653116,0.9161295,0.000019592619,0.0018081751,0.00011075329],"about_ca_topic_score_codex":0.00025944258,"about_ca_topic_score_gemma":0.000118563825,"teacher_disagreement_score":0.07519006,"about_ca_system_score_codex":0.0004642316,"about_ca_system_score_gemma":0.0002923533,"threshold_uncertainty_score":0.38512543},"labels":[],"label_agreement":null},{"id":"W3182363921","doi":"10.1158/1538-7445.am2021-1313","title":"Abstract 1313: TH1902, a docetaxel peptide-drug conjugate, shows pre-clinical efficacy in several Sortilin-positive (SORT1+) cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Cancer research; Internalization; Pharmacology; Cytotoxic T cell; Medicine; In vitro; Cancer; Intracellular; Pancreatic cancer; Internal medicine; Chemistry; Receptor; Biochemistry","score_opus":0.06582039717045288,"score_gpt":0.4277971464615576,"score_spread":0.3619767492911047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182363921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127614,0.0034585851,0.00001924869,0.00050262315,0.00035415826,0.00038711802,0.00012484196,0.000012059563,0.003865233],"genre_scores_gemma":[0.98459643,0.0040968657,0.00005443311,0.0004864869,0.00062419655,0.000121327554,0.00015235296,0.00003687147,0.00983104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697036,0.00034718018,0.0005353204,0.00091678265,0.00045177428,0.0007785667],"domain_scores_gemma":[0.99835855,0.00013554891,0.00008321406,0.0005893473,0.0005939439,0.00023937532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095854636,0.00022925915,0.00034126698,0.000096521224,0.00012693355,0.00009271111,0.00044366182,0.00024933086,0.0006628076],"category_scores_gemma":[0.00032602242,0.00022549844,0.0002049572,0.00029623724,0.00032857023,0.000016547294,0.00033376768,0.00083447807,0.000088654946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024450745,0.00070497295,0.04111052,0.00012483005,0.0004402897,0.000576397,0.00074762094,0.0022288284,0.85207504,0.00003766447,0.088805996,0.010702786],"study_design_scores_gemma":[0.003298306,0.0005211383,0.2715456,0.00036822396,0.000026719004,0.000026630843,0.0007061554,0.0001817815,0.6981145,0.00009019342,0.024457386,0.0006633547],"about_ca_topic_score_codex":0.0020879945,"about_ca_topic_score_gemma":0.009905605,"teacher_disagreement_score":0.23043507,"about_ca_system_score_codex":0.00017988135,"about_ca_system_score_gemma":0.0021016437,"threshold_uncertainty_score":0.91955596},"labels":[],"label_agreement":null},{"id":"W3182365975","doi":"10.1158/1538-7445.am2021-1927","title":"Abstract 1927: Cancer cells induce apoptosis in hepatocytes as one of the mechanisms to displace hepatocytes in vessel co-opted colorectal cancer liver metastases","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Cancer cell; Apoptosis; Colorectal cancer; Cancer research; Liver cancer; Biology; Pathology; Medicine; Hepatocellular carcinoma; Internal medicine; Biochemistry","score_opus":0.042494887379638094,"score_gpt":0.3570364523240334,"score_spread":0.31454156494439534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182365975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812413,0.014745134,0.000010237936,0.00062242884,0.0015689066,0.00084523816,0.00069787673,0.0000073014808,0.00026158322],"genre_scores_gemma":[0.977196,0.019017927,0.000090438705,0.00031352087,0.001244298,0.0014086043,0.000041820964,0.000051313826,0.0006360868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697506,0.00037469037,0.00043104248,0.0007534874,0.0006961243,0.0007696203],"domain_scores_gemma":[0.9985776,0.000115903786,0.00011455851,0.00052385783,0.00045986293,0.00020823925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071863405,0.0002683188,0.0004760662,0.00019042514,0.00012048622,0.000051143914,0.00056398433,0.00023544894,0.0009158857],"category_scores_gemma":[0.00023511844,0.00023772087,0.00014641414,0.00090944336,0.00022036217,0.000018279741,0.0003978752,0.00052623206,0.000013628974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000587914,0.00022541395,0.0049926676,0.00015295646,0.000108535176,0.0000018709253,0.00044168645,0.00046518087,0.9824954,0.000110151675,0.007526368,0.0028918094],"study_design_scores_gemma":[0.0009743856,0.00008991525,0.015369847,0.00029141424,0.000026880969,0.000001420194,0.0004021376,0.000020020389,0.9486828,0.000055736844,0.03381945,0.0002659914],"about_ca_topic_score_codex":0.046476666,"about_ca_topic_score_gemma":0.041217916,"teacher_disagreement_score":0.033812642,"about_ca_system_score_codex":0.0003502882,"about_ca_system_score_gemma":0.002335976,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W3182554615","doi":"10.1158/1538-7445.am2021-2496","title":"Abstract 2496: CD82 regulation of c-Met in metastatic prostate cells","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Cancer research; Tetraspanin; Prostate cancer; Prostate; Biology; Cancer; Metastasis suppressor; Medicine; Cell; Internal medicine","score_opus":0.12321089482797858,"score_gpt":0.4537991853095187,"score_spread":0.3305882904815401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182554615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883446,0.0050192103,0.0000035460246,0.0016544921,0.00009082958,0.00079954363,0.000060130515,0.000014366187,0.004013276],"genre_scores_gemma":[0.98598695,0.0028925992,0.00031625276,0.00002979049,0.00006919988,0.00021256645,0.00007844506,0.000027782544,0.010386389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760634,0.00017178548,0.00033794402,0.00036579807,0.00096496503,0.0005531733],"domain_scores_gemma":[0.9984227,0.00019873117,0.00005183051,0.00038417132,0.00077201985,0.00017054386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010464485,0.000114196606,0.00033381145,0.00039263253,0.00006216144,0.000027393506,0.00010271853,0.000059193826,0.0019315183],"category_scores_gemma":[0.00014230683,0.00009332276,0.000074952,0.0012736768,0.00022397032,0.00011358626,0.00008661272,0.0004893986,0.00006803055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094256987,0.00036847405,0.012529425,0.0009654458,0.00010622379,0.00044618556,0.00079779973,0.00008365375,0.96329045,0.00015228604,0.0028006427,0.017516833],"study_design_scores_gemma":[0.0031594646,0.00023816431,0.09243517,0.00056417333,0.000021516931,0.000007972626,0.0006496902,0.000052245046,0.89817107,0.00069791893,0.003908393,0.00009424491],"about_ca_topic_score_codex":0.0005940991,"about_ca_topic_score_gemma":0.00020628235,"teacher_disagreement_score":0.07990575,"about_ca_system_score_codex":0.0004416171,"about_ca_system_score_gemma":0.0016557523,"threshold_uncertainty_score":0.9989809},"labels":[],"label_agreement":null},{"id":"W3182585765","doi":"10.1158/1538-7445.am2021-1779","title":"Abstract 1779: Dietary supplementation of haskap berry anthocyanin and probiotics attenuate the severity of DSS-induced acute colitis in Balb/c mice","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Moringa oleifera research and applications","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Anthocyanin; Colitis; Colorectal cancer; Berry; Probiotic; Medicine; Polyphenol; Food science; Cancer; Pharmacology; Chemistry; Gastroenterology; Internal medicine; Biochemistry; Biology; Botany; Antioxidant","score_opus":0.12087838029274217,"score_gpt":0.3951887776818151,"score_spread":0.2743103973890729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182585765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292326,0.00019204259,3.5974648e-7,0.0059085106,0.00001579798,0.00038480054,0.00034935787,0.0000038711305,0.00022200338],"genre_scores_gemma":[0.9984461,0.0010748574,0.00004364953,0.000027043367,0.00005369077,0.000086271175,0.00007400582,9.832439e-7,0.00019339635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987468,0.0001644391,0.00020920279,0.00021910592,0.00036528325,0.00029517288],"domain_scores_gemma":[0.9991874,0.0003209095,0.000050009803,0.00008001079,0.00028740955,0.00007424456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006596401,0.000063273226,0.00013091002,0.000018625005,0.00015122782,0.000033774315,0.00020664955,0.000044854827,0.00033406305],"category_scores_gemma":[0.00006089998,0.000027462456,0.00003141696,0.0005813694,0.00017708074,0.00007690048,0.00015677072,0.00025947712,0.0000024034816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075395146,0.000102222635,0.010933539,0.000056660967,0.000020007126,0.000006565311,0.00022295663,0.0000021563606,0.9608108,0.00017339196,0.00052131695,0.02707501],"study_design_scores_gemma":[0.0001534428,0.000109763576,0.67922115,0.000049215,0.000003889666,0.000002483766,0.00094307493,0.000031564017,0.31864226,0.00023565147,0.0005587769,0.00004875074],"about_ca_topic_score_codex":0.004887192,"about_ca_topic_score_gemma":0.011912302,"teacher_disagreement_score":0.6682876,"about_ca_system_score_codex":0.00004826513,"about_ca_system_score_gemma":0.00009419235,"threshold_uncertainty_score":0.7388005},"labels":[],"label_agreement":null},{"id":"W3182606016","doi":"10.1158/1538-7445.am2021-2562","title":"Abstract 2562: EGCG targeting of adipogenesis reveals a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Paracrine signalling; Adipogenesis; Cancer research; Triple-negative breast cancer; Biology; Autocrine signalling; Gene silencing; Endocrinology; Internal medicine; Cell biology; Adipose tissue; Medicine; Breast cancer; Cancer; Biochemistry; Receptor","score_opus":0.02664341388316217,"score_gpt":0.3369156546753517,"score_spread":0.3102722407921895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182606016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407325,0.053331625,0.000043116248,0.00027161866,0.0014599246,0.000561005,0.0030213557,0.000007701563,0.0005711959],"genre_scores_gemma":[0.96672875,0.028329868,0.00012196129,0.00012616938,0.0032694503,0.0002587784,0.00016066043,0.000049714276,0.0009546389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997326,0.0003351627,0.0005740894,0.0005808704,0.00055545627,0.0006284293],"domain_scores_gemma":[0.9967325,0.00022313568,0.0003013733,0.00047051173,0.002049545,0.00022295538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007565951,0.00022480672,0.0005522145,0.000089525325,0.00009856956,0.000017586039,0.00032829086,0.00018584992,0.000940853],"category_scores_gemma":[0.0006358585,0.00021836013,0.00020461345,0.00047139765,0.00029575208,0.000014267645,0.00016045161,0.00026631483,0.0000071475265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001121242,0.00015756386,0.0028963962,0.00037375133,0.00031541532,0.0000018549157,0.00026530054,0.00008242645,0.97765493,0.000017519751,0.014657177,0.0024564336],"study_design_scores_gemma":[0.0033927588,0.00014253792,0.017745925,0.00014157583,0.0000867105,0.000003544472,0.00074692105,0.000008013851,0.95778316,0.00006745882,0.019619936,0.00026147265],"about_ca_topic_score_codex":0.0068048853,"about_ca_topic_score_gemma":0.0033329157,"teacher_disagreement_score":0.0259963,"about_ca_system_score_codex":0.00014606347,"about_ca_system_score_gemma":0.002686597,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W3182627936","doi":"10.1158/1538-7445.am2021-636","title":"Abstract 636: PROFYLE: The pan-Canadian precision oncology program for children, adolescents and young adults with hard-to-treat cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario; Centre Hospitalier Universitaire Sainte-Justine; Spinal Cord Injury BC; Izaak Walton Killam Health Centre; University of Alberta; BC Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; McGill University Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Cancer; Internal medicine; Pediatric cancer; Disease; Precision medicine; Referral; Family medicine; Pathology","score_opus":0.05163802828367076,"score_gpt":0.420830563730656,"score_spread":0.36919253544698527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182627936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847363,0.0018692382,0.0000019625938,0.006377308,0.0000917507,0.0060445443,0.00021805166,0.000032683787,0.0006281316],"genre_scores_gemma":[0.98977196,0.001368676,0.00020892554,0.00028416037,0.00026718125,0.0052719475,0.00006211634,0.000056860394,0.0027081883],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971058,0.00013776292,0.00018219724,0.0006869633,0.00078921724,0.0010981116],"domain_scores_gemma":[0.99749947,0.00012285911,0.000034313198,0.00046113995,0.00094862835,0.0009335971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038143186,0.00019464838,0.00028670984,0.00022883427,0.000450783,0.00012085158,0.00019566633,0.00011117882,0.00021834414],"category_scores_gemma":[0.0002261774,0.000119264725,0.00005731436,0.0006472526,0.00023739891,0.000082088474,0.000111209105,0.0006279107,0.00003745711],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056700306,0.0007165721,0.21429056,0.00050014124,0.00023623536,0.00060882047,0.0005127189,0.0000024902738,0.0056337337,0.000009647888,0.019259047,0.75256],"study_design_scores_gemma":[0.0060399794,0.0027859698,0.95569265,0.0014459469,0.00006499497,0.00013535182,0.00022394634,0.000018008564,0.018503096,0.0000176818,0.014915051,0.00015732826],"about_ca_topic_score_codex":0.046399396,"about_ca_topic_score_gemma":0.22494605,"teacher_disagreement_score":0.75240266,"about_ca_system_score_codex":0.0008263003,"about_ca_system_score_gemma":0.003528382,"threshold_uncertainty_score":0.9599507},"labels":[],"label_agreement":null},{"id":"W3182650514","doi":"10.1158/1538-7445.am2021-630","title":"Abstract 630: Response to nivolumab in a pediatric chordoma with overexpression of brachyury","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Brachyury; Immune checkpoint; Cancer research; Biology; Chordoma; Nivolumab; Immune system; Medicine; Immunology; Genetics; Immunotherapy; Pathology","score_opus":0.03141744483885674,"score_gpt":0.37676225115481193,"score_spread":0.3453448063159552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182650514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965407,0.0023660345,0.000033155127,0.00026680258,0.00003248282,0.00014329396,0.000022385022,0.0000042189713,0.0005909031],"genre_scores_gemma":[0.99774545,0.00063899026,0.00024348054,0.000051888415,0.00018143997,0.00006957597,0.000012332629,0.000020813133,0.0010360541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986633,0.00015039885,0.0001690118,0.00035775383,0.0003645079,0.00029502917],"domain_scores_gemma":[0.9991304,0.000048025053,0.000033658245,0.00038366523,0.00030584174,0.000098372286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059595425,0.00008448997,0.00012460588,0.00011014965,0.00004637301,0.000017525386,0.00016755424,0.000096933574,0.00010993679],"category_scores_gemma":[0.00023310001,0.00007545455,0.00003565709,0.00044842498,0.00004630602,0.0000036097297,0.00014239686,0.00019498782,0.0000055037076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023904976,0.00006907693,0.00800659,0.00009349179,0.000008415414,0.000017350416,0.000110194174,0.00058981526,0.9838022,0.0000016270251,0.0025041965,0.002406543],"study_design_scores_gemma":[0.0012866365,0.00035430232,0.07778945,0.00025807926,0.000004004678,0.000007729744,0.00021203526,0.000040408013,0.91508156,0.000024081955,0.0047784513,0.00016325501],"about_ca_topic_score_codex":0.00026874754,"about_ca_topic_score_gemma":0.000342891,"teacher_disagreement_score":0.06978286,"about_ca_system_score_codex":0.000072857794,"about_ca_system_score_gemma":0.00097407587,"threshold_uncertainty_score":0.3076947},"labels":[],"label_agreement":null},{"id":"W3182666754","doi":"10.1158/1538-7445.am2021-ct006","title":"Abstract CT006: Phase 2 study of pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): KEYNOTE-629","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Tolerability; Discontinuation; Pembrolizumab; Internal medicine; Clinical endpoint; Oncology; Clinical trial; Adverse effect; Surgery; Cancer; Immunotherapy","score_opus":0.09035054185042334,"score_gpt":0.4364000889593772,"score_spread":0.34604954710895386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182666754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863185,0.0081605315,0.00008659669,0.0003684827,0.0003680605,0.0029880651,0.00024179168,0.000043476248,0.001424487],"genre_scores_gemma":[0.99375147,0.00076608604,0.00028297983,0.00011073382,0.00018589736,0.00081331935,0.000068594236,0.00009839514,0.0039225137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959891,0.00032469837,0.0007826101,0.00081237574,0.0012009622,0.0008902625],"domain_scores_gemma":[0.9962017,0.0011584132,0.00020015627,0.0008672907,0.0012662847,0.00030617],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084970606,0.00033235765,0.00076221593,0.0003351628,0.0002297769,0.00006203401,0.0003551438,0.00012943476,0.0017578397],"category_scores_gemma":[0.00044941896,0.0002765791,0.00025550986,0.0010452308,0.00029433603,0.00010647791,0.00011211525,0.00068262895,0.000012898916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17642374,0.010611606,0.00068190874,0.0040507037,0.00039902198,0.0031582215,0.00287295,0.00006764078,0.4799593,0.000012050831,0.007368584,0.31439427],"study_design_scores_gemma":[0.23674887,0.05012764,0.007927537,0.0014077005,0.00075496733,0.00096056494,0.020678217,0.00076752476,0.6054769,0.00011544442,0.07367701,0.00135762],"about_ca_topic_score_codex":0.0005769238,"about_ca_topic_score_gemma":0.0006870866,"teacher_disagreement_score":0.31303665,"about_ca_system_score_codex":0.0006039213,"about_ca_system_score_gemma":0.0032533468,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W3182715522","doi":"10.1158/1538-7445.am2021-17","title":"Abstract 17: Proteogenomic characterization of pancreatic ductal adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Proteomics; Biology; Glycoproteomics; Proteogenomics; Pancreatic cancer; Cancer research; Phosphoproteomics; Cancer; KRAS; Kinome; Transcriptome; Shotgun proteomics; Proteome; CDKN2A; Computational biology; Gene; Bioinformatics; Kinase; Genetics; Gene expression; Colorectal cancer; Protein phosphorylation; Protein kinase A","score_opus":0.10178470800259051,"score_gpt":0.41806078832167143,"score_spread":0.31627608031908094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182715522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890317,0.0017601975,0.00002542725,0.0016988884,0.00006430857,0.0008197166,0.000042008272,0.000019571553,0.006538218],"genre_scores_gemma":[0.9884802,0.0013764326,0.00022040251,0.00006856619,0.0003427527,0.0003123036,0.00010341379,0.000028669376,0.009067267],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978439,0.00017888691,0.0003504586,0.0003573847,0.00074831635,0.0005210058],"domain_scores_gemma":[0.99812716,0.00017218718,0.00007049336,0.0004590897,0.00094461965,0.00022647473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008249272,0.00011389386,0.00048421815,0.00021854653,0.00012178277,0.00002020263,0.00014330469,0.00013947849,0.004406409],"category_scores_gemma":[0.00037282117,0.000101290716,0.000083874336,0.0005913512,0.00034046549,0.000076739896,0.000111015106,0.0005283363,0.00011141325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029407357,0.00015283807,0.29978272,0.00039584577,0.00012915254,0.00026481348,0.0002350948,2.6481842e-7,0.69741905,0.00011246513,0.0004011401,0.000812515],"study_design_scores_gemma":[0.0010460526,0.00022353164,0.855926,0.00027671698,0.00006589003,0.000097002994,0.00018207922,0.00004203091,0.14091784,0.00009304466,0.0010498641,0.000079992555],"about_ca_topic_score_codex":0.0002196844,"about_ca_topic_score_gemma":0.000022254508,"teacher_disagreement_score":0.5565012,"about_ca_system_score_codex":0.00030200707,"about_ca_system_score_gemma":0.0025133428,"threshold_uncertainty_score":0.9965037},"labels":[],"label_agreement":null},{"id":"W3182768394","doi":"10.1158/1538-7445.am2021-1032","title":"Abstract 1032: Super-resolution imaging studies of zanidatamab: Providing insights into its bispecific mode of action","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Zymeworks (Canada)","funders":"","keywords":"Pertuzumab; Trastuzumab; Epitope; Antibody; Cancer research; Effector; Receptor; Antibody-dependent cell-mediated cytotoxicity; Cancer; Medicine; Chemistry; Biology; Breast cancer; Computational biology; Monoclonal antibody; Cell biology; Immunology; Internal medicine","score_opus":0.2639422503680773,"score_gpt":0.5102448635905408,"score_spread":0.2463026132224635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182768394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623065,0.03312202,0.00001720872,0.0026244707,0.00016802775,0.0003485786,0.000027546228,0.000016212944,0.0013694089],"genre_scores_gemma":[0.9795699,0.017825179,0.00015131455,0.000023714812,0.00031379447,0.00006066911,0.000043479788,0.000022870128,0.001989094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972975,0.00016266202,0.0004172148,0.00039618355,0.0012780073,0.00044840318],"domain_scores_gemma":[0.9967913,0.00033712506,0.000076827106,0.000336175,0.002304221,0.00015433732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005451701,0.00013723344,0.0004098601,0.00039783202,0.00022038042,0.000021290149,0.00017236701,0.00006735439,0.0003225619],"category_scores_gemma":[0.00053935265,0.00011139848,0.000106413965,0.000809373,0.00041084082,0.00023412425,0.00028166568,0.0005672746,0.00002606543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068974553,0.00018153054,0.0042969775,0.0025461921,0.00016764371,0.00009998616,0.0017731914,0.000044084005,0.97104734,0.0008436174,0.002846877,0.015462796],"study_design_scores_gemma":[0.00067637686,0.00013917928,0.011502487,0.0010674786,0.000023198087,0.000015891686,0.0031916418,0.00090990093,0.9667448,0.0004847297,0.015131969,0.000112349655],"about_ca_topic_score_codex":0.0015873794,"about_ca_topic_score_gemma":0.00050060696,"teacher_disagreement_score":0.017263358,"about_ca_system_score_codex":0.0003490458,"about_ca_system_score_gemma":0.00086279615,"threshold_uncertainty_score":0.45426983},"labels":[],"label_agreement":null},{"id":"W3182795002","doi":"10.1158/1538-7445.am2021-3098","title":"Abstract 3098: Leukemia stem cells demonstrate enhanced DNA damage repair and chemoresistance in AML","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"DNA repair; Stem cell; DNA damage; Biology; Cancer research; Myeloid leukemia; RAD51; Leukemia; Cancer stem cell; Molecular biology; DNA; Cell biology; Immunology; Genetics","score_opus":0.03841850347981069,"score_gpt":0.34493718538312096,"score_spread":0.3065186819033103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182795002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903019,0.006097164,0.00004107581,0.00018522286,0.000086642045,0.00016550397,0.00003040723,0.000011602366,0.0030804898],"genre_scores_gemma":[0.9892599,0.0056322915,0.00012358473,0.000082598184,0.000161637,0.00016106082,0.000020565749,0.000022239146,0.004536123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850816,0.00009425041,0.00020752064,0.0005617578,0.00022890452,0.0003994146],"domain_scores_gemma":[0.9990776,0.000025498659,0.00004088572,0.0004981533,0.00024369088,0.00011414234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043804062,0.00011912947,0.0001409701,0.000055372988,0.00011467895,0.000053288786,0.00017547187,0.00013546755,0.000083957064],"category_scores_gemma":[0.000025023308,0.00012336226,0.000051004125,0.00029650112,0.00019406698,0.000008633159,0.000115622264,0.00027033963,0.000008750114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072109164,0.000026610465,0.0006263749,0.00007480898,0.000018635466,0.000024997917,0.000053368265,0.00004908394,0.9903947,0.000063451786,0.0030842104,0.005511638],"study_design_scores_gemma":[0.0004169488,0.000028679833,0.01902178,0.000061302606,0.0000030263595,0.0000018359032,0.00029690514,0.000025087258,0.9657933,0.00004819144,0.014160399,0.00014251615],"about_ca_topic_score_codex":0.0001652278,"about_ca_topic_score_gemma":0.0012322265,"teacher_disagreement_score":0.024601383,"about_ca_system_score_codex":0.00016194313,"about_ca_system_score_gemma":0.0008979022,"threshold_uncertainty_score":0.5030567},"labels":[],"label_agreement":null},{"id":"W3182868687","doi":"10.1158/1538-7445.am2021-1485","title":"Abstract 1485: Tumors with homologous recombination repair deficiency signatures associate with an RNAseq profile profile suggestive of T cell-inflammation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; McGill University; Concordia University; McGill University Health Centre","funders":"","keywords":"Immune system; Immune checkpoint; Biology; Inflammation; Cancer research; Cancer; Ovarian cancer; Pancreatic cancer; Carcinogenesis; Transcriptome; Immunology; Chemokine; Immunotherapy; Gene; Genetics; Gene expression","score_opus":0.029867818748172723,"score_gpt":0.3420742597793572,"score_spread":0.31220644103118445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182868687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111474,0.0014577295,0.000011321746,0.0005491524,0.00006207184,0.0009721566,0.00006470844,0.00007733229,0.005690776],"genre_scores_gemma":[0.9957059,0.00021862358,0.00078442146,0.000031400155,0.00009484656,0.00031935688,0.00018308533,0.000038254624,0.0026240803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976411,0.0002116899,0.00029739304,0.00045972658,0.00095268514,0.00043740362],"domain_scores_gemma":[0.997621,0.00014466436,0.00019840138,0.00037823876,0.0015429421,0.00011477971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010409091,0.00016108387,0.00029377037,0.00021501485,0.00019335453,0.000035208195,0.00012603725,0.0001350359,0.00080982153],"category_scores_gemma":[0.00011876434,0.00011865973,0.00007070927,0.0009999153,0.000293777,0.00020127383,0.000029987872,0.0005453929,0.000007421952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011691738,0.000959212,0.010848879,0.0012755184,0.00025906778,0.00061202724,0.002088524,0.000081805774,0.9395873,0.00013236993,0.0026638308,0.029799737],"study_design_scores_gemma":[0.0027415568,0.0027467022,0.1577143,0.00069783535,0.00004311039,0.000034867502,0.0014961216,0.0000976712,0.8339377,0.000055731598,0.0002444516,0.0001899546],"about_ca_topic_score_codex":0.0008812172,"about_ca_topic_score_gemma":0.00051777647,"teacher_disagreement_score":0.14686543,"about_ca_system_score_codex":0.00056011707,"about_ca_system_score_gemma":0.0020663724,"threshold_uncertainty_score":0.88669777},"labels":[],"label_agreement":null},{"id":"W3182886812","doi":"10.1158/1538-7445.am2021-1439","title":"Abstract 1439: Increasing potency of anticancer drugs through SORT1+ technology: A new targeted approach for the treatment of ovarian and endometrial cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Ovarian cancer; Docetaxel; Cancer research; Cancer; Endometrial cancer; Medicine; Internal medicine; Targeted therapy; Oncology; Biology; Pharmacology","score_opus":0.05477818262834891,"score_gpt":0.3822192688047638,"score_spread":0.3274410861764149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182886812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649598,0.031595163,0.0014353368,0.0007452935,0.00005846272,0.0007047504,0.00008834315,0.0000049875107,0.00040784592],"genre_scores_gemma":[0.9771118,0.018608084,0.0030227203,0.000016099317,0.0002883856,0.00019961095,0.000034330995,0.00002144007,0.00069752027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998482,0.000088237975,0.00023561636,0.00038430752,0.00035673138,0.00045314693],"domain_scores_gemma":[0.9987965,0.00020507886,0.00007514925,0.00040986552,0.00042089963,0.00009249226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005917985,0.000120983044,0.0002596475,0.00012492556,0.00016627136,0.000024349882,0.00022266361,0.00014451778,0.000035485733],"category_scores_gemma":[0.00052011496,0.000087083914,0.00009901438,0.0006341562,0.0004156341,0.000007044367,0.00009727501,0.0001448126,1.8642633e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010376523,0.00009270185,0.0015318034,0.00008997074,0.00028084352,0.000002579444,0.0002153308,0.0000847798,0.94516915,0.00020658434,0.0003266277,0.050961964],"study_design_scores_gemma":[0.0028841808,0.00068280334,0.0014544625,0.000043958928,0.00003118711,0.000005397764,0.0012772732,0.00017189422,0.9841099,0.0002701784,0.008957957,0.00011081925],"about_ca_topic_score_codex":0.008549006,"about_ca_topic_score_gemma":0.0002576549,"teacher_disagreement_score":0.050851148,"about_ca_system_score_codex":0.00012302306,"about_ca_system_score_gemma":0.0016764156,"threshold_uncertainty_score":0.99805313},"labels":[],"label_agreement":null},{"id":"W3182894010","doi":"10.1158/1538-7445.am2021-1518","title":"Abstract 1518: Dose optimization and radiation dosimetry of CD45-targeting 225Actinium-armed antibody as a conditioning agent for adoptive cell therapy","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Bone marrow; Immune system; Stem cell; Adoptive cell transfer; Antibody; Total body irradiation; Haematopoiesis; Immunology; White blood cell; Transplantation; Chemotherapy; Radioimmunotherapy; Dosimetry; Cancer research; T cell; Nuclear medicine; Internal medicine; Cyclophosphamide; Biology; Monoclonal antibody","score_opus":0.04023117044653529,"score_gpt":0.4184501450814923,"score_spread":0.378218974634957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182894010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852704,0.012736198,0.00069634075,0.00011976172,0.00007061035,0.00056025514,0.00014144226,0.000005312972,0.00039969836],"genre_scores_gemma":[0.98274785,0.014986507,0.00046353467,0.000045625828,0.00017144925,0.00019647172,0.0011070096,0.000023826145,0.00025774125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987283,0.000104054634,0.00016970448,0.00036034538,0.0002832613,0.00035437153],"domain_scores_gemma":[0.999129,0.00008082398,0.0000799889,0.00016905346,0.00043404792,0.00010706722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039787713,0.000102848164,0.0001315295,0.00008792462,0.00018782688,0.00005627411,0.00008424503,0.00009393118,0.00017809328],"category_scores_gemma":[0.00016406058,0.00010119641,0.00006149099,0.00020927879,0.00010157298,0.000013733674,0.00006698502,0.00013144292,0.000001994733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006026806,0.00014237879,0.0020512382,0.00009611865,0.000121822755,0.000007897519,0.0001487894,0.0011663027,0.98716325,0.000010282592,0.001086823,0.0074024047],"study_design_scores_gemma":[0.0023166335,0.0003873519,0.0024768277,0.000034443012,0.000007936282,0.0000019240974,0.00036141276,0.00019869927,0.9904883,0.000026592237,0.0036002842,0.00009960457],"about_ca_topic_score_codex":0.00036052807,"about_ca_topic_score_gemma":0.000027338325,"teacher_disagreement_score":0.0073028,"about_ca_system_score_codex":0.00008341128,"about_ca_system_score_gemma":0.00058159785,"threshold_uncertainty_score":0.41266698},"labels":[],"label_agreement":null},{"id":"W3182903048","doi":"10.1158/1538-7445.am2021-3116","title":"Abstract 3116: Designing a model system for the study of CD44-Ezrin interactions in breast cancer progression and drug resistance","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"CD44; Cancer research; Triple-negative breast cancer; Cancer stem cell; Cancer; Biology; Ezrin; Context (archaeology); Lymph node; Breast cancer; Medicine; Immunology; Cell; Internal medicine","score_opus":0.14543016180970988,"score_gpt":0.47280340245000724,"score_spread":0.3273732406402974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182903048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817033,0.012207001,0.0001978887,0.0034048352,0.00015271091,0.001825274,0.00010517937,0.000015709566,0.00038809577],"genre_scores_gemma":[0.9946455,0.0013077137,0.00032266462,0.000021090547,0.00012020893,0.0018446633,0.000003053807,0.000025862291,0.0017092472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984208,0.000112432666,0.0002989481,0.00035647344,0.0004836899,0.0003277089],"domain_scores_gemma":[0.99852574,0.00035538795,0.00007904803,0.00032567812,0.0006132822,0.00010085572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010022002,0.00010679262,0.00028847787,0.00014651896,0.00018705064,0.000038407437,0.00010652898,0.000026765281,0.00005585972],"category_scores_gemma":[0.00005550319,0.00007481752,0.000050065064,0.0005348176,0.00009062523,0.00007875041,0.00008807944,0.0003999959,5.279809e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013167356,0.0031889407,0.0538309,0.012392432,0.0010231503,0.00033856198,0.025109285,0.0062502376,0.6334179,0.00042940164,0.022342555,0.22850926],"study_design_scores_gemma":[0.039983213,0.0006477595,0.16483928,0.042926893,0.0014065908,0.00020969134,0.22245444,0.015415739,0.48175704,0.00025557398,0.028630856,0.001472908],"about_ca_topic_score_codex":0.0024080034,"about_ca_topic_score_gemma":0.014074786,"teacher_disagreement_score":0.22703636,"about_ca_system_score_codex":0.0004563422,"about_ca_system_score_gemma":0.0008213427,"threshold_uncertainty_score":0.7854061},"labels":[],"label_agreement":null},{"id":"W3182946075","doi":"10.1158/1538-7445.am2021-441","title":"Abstract 441: Potential implications of population kinetic characteristics of PD-1/PDL-1 monoclonals combined with chemotherapy in lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Chemotherapy; Lung cancer; Medicine; Internal medicine; Oncology; Population; Cancer","score_opus":0.04466715355760361,"score_gpt":0.4010688425013572,"score_spread":0.3564016889437536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182946075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931244,0.0025125626,0.000024830946,0.0033874337,0.00007110763,0.0005485377,0.000116312054,0.000009027219,0.000205768],"genre_scores_gemma":[0.9954329,0.0036248674,0.00010387084,0.00011672654,0.0000929725,0.0001767976,0.000113075,0.000027536224,0.00031125286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985073,0.000059706235,0.00042862524,0.00025684453,0.000467691,0.00027979593],"domain_scores_gemma":[0.99870986,0.000069910544,0.00014933854,0.000353914,0.0006461732,0.000070832684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034064258,0.00011057419,0.00035900887,0.00020631829,0.000045175373,0.0000127183785,0.00011298605,0.000089067034,0.0012799116],"category_scores_gemma":[0.000029944784,0.00009575015,0.00007230969,0.0008008432,0.00015825969,0.000053684384,0.0000244937,0.00025565748,6.449189e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006163899,0.0003569955,0.27682695,0.00069228833,0.00022392576,0.000016264457,0.0002754054,0.000048042566,0.68482965,0.0000832548,0.00049675925,0.02998655],"study_design_scores_gemma":[0.0029476439,0.00018194367,0.9296412,0.0006217513,0.000028896176,0.000005654185,0.000066184126,0.0000997895,0.06595726,0.00004349689,0.00031948718,0.000086677435],"about_ca_topic_score_codex":0.005333021,"about_ca_topic_score_gemma":0.0009374214,"teacher_disagreement_score":0.65281427,"about_ca_system_score_codex":0.00031114757,"about_ca_system_score_gemma":0.00067274924,"threshold_uncertainty_score":0.9996331},"labels":[],"label_agreement":null},{"id":"W3182949005","doi":"10.1158/1538-7445.am2021-855","title":"Abstract 855: Is shift-work associated with increased risk of gastric cancer? A meta-analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Confidence interval; Cancer; Publication bias; Cochrane Library; Subgroup analysis; Shift work; Relative risk; Sample size determination; Internal medicine; Random effects model; Oncology; Statistics; Mathematics","score_opus":0.13699303352808426,"score_gpt":0.42125723994190045,"score_spread":0.2842642064138162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182949005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585036,0.038685817,0.000033415552,0.0011931738,0.00003996508,0.00044859017,0.0005624254,0.000026302212,0.0005067198],"genre_scores_gemma":[0.9921915,0.0065564974,0.000060923117,0.0002013015,0.00011905745,0.00022617992,0.00008290577,0.000034738263,0.00052689406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958852,0.0005872806,0.0004142917,0.00054102595,0.0018679821,0.0007042286],"domain_scores_gemma":[0.9966229,0.00053416734,0.00018309646,0.0008168274,0.0013179928,0.00052501017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002286097,0.00019234215,0.0014933137,0.000535348,0.00017920425,0.000027311693,0.00015047812,0.0001608423,0.005343514],"category_scores_gemma":[0.0006962895,0.00013010873,0.0015273175,0.006101916,0.00017841546,0.000046856665,0.00006175112,0.0009608215,0.000014411138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085233833,0.00031096305,0.62666684,0.00032541866,0.36324966,0.0003534475,0.00065231405,0.00043695007,0.0003776352,0.0000046138516,0.003930608,0.002839183],"study_design_scores_gemma":[0.00144541,0.00010133725,0.8820984,0.00007670124,0.109353684,0.0000027185117,0.00016809623,0.000014364961,0.004756274,0.000013834455,0.0018268256,0.00014239369],"about_ca_topic_score_codex":0.04381363,"about_ca_topic_score_gemma":0.0072359336,"teacher_disagreement_score":0.2554315,"about_ca_system_score_codex":0.00052242185,"about_ca_system_score_gemma":0.0029512497,"threshold_uncertainty_score":0.9955657},"labels":[],"label_agreement":null},{"id":"W3182960513","doi":"10.1158/1538-7445.am2021-lb189","title":"Abstract LB189: Three-dimensional genome organization maps in normal haematopoietic stem cells and acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Government of Newfoundland and Labrador; Memorial University of Newfoundland","funders":"","keywords":"Myeloid leukemia; Haematopoiesis; Biology; Cancer research; Stem cell; Epigenetics; Leukemia; Myeloid; Acute leukemia; Chromatin; Myelopoiesis; Oncogene; Cancer; Genetics; Gene; Cell cycle","score_opus":0.027036544946669582,"score_gpt":0.3116109471167089,"score_spread":0.2845744021700393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182960513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993621,0.005610754,0.00010897033,0.00018070775,0.00008822303,0.00015077788,0.00004339065,0.0000047759177,0.00019138072],"genre_scores_gemma":[0.9964265,0.002368666,0.00016581021,0.000044035558,0.00013973306,0.000020886828,0.00015772485,0.00002686267,0.00064973015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875796,0.0000760779,0.00018541393,0.0003749129,0.0003019706,0.00030369312],"domain_scores_gemma":[0.9992022,0.000023714952,0.000034919638,0.00023695535,0.00040256177,0.00009963946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004173081,0.000101140824,0.00011699248,0.000073732495,0.00010932957,0.00005443918,0.00010977802,0.00016602676,0.00012228968],"category_scores_gemma":[0.00002476561,0.00010457805,0.000022534987,0.00030889665,0.00008043865,0.000006714273,0.00020781223,0.0002202076,0.000018011353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026639238,0.000019151523,0.006507949,0.00003748618,0.000025315738,0.000034562974,0.000047676414,0.0007278669,0.99091566,0.000026805317,0.00013010458,0.0015007776],"study_design_scores_gemma":[0.000415613,0.000050909213,0.04839348,0.00002148674,0.0000063379807,0.00000619367,0.000037360605,0.00005108775,0.9476547,0.00014547586,0.0030869076,0.00013041541],"about_ca_topic_score_codex":0.00012478675,"about_ca_topic_score_gemma":0.00050365133,"teacher_disagreement_score":0.043260932,"about_ca_system_score_codex":0.00010047277,"about_ca_system_score_gemma":0.0005743363,"threshold_uncertainty_score":0.4264569},"labels":[],"label_agreement":null},{"id":"W3183031970","doi":"10.1158/1538-7445.am2021-307","title":"Abstract 307: Lymph node accumulation of theranostic lipid-based nanoparticles in healthy and diseased models: Preliminary results comparing nanoparticle morphology and targeting","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymph; Lymph node; Medicine; Pharmacokinetics; Biodistribution; Drug delivery; Pathology; Cancer research; Pharmacology; In vivo; Nanotechnology; Biology; Materials science","score_opus":0.1396922826419152,"score_gpt":0.3901859662413106,"score_spread":0.2504936835993954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183031970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945456,0.0035082877,0.000034896388,0.0013801234,0.000093880204,0.0003213547,0.000054360036,0.000037050882,0.00002448208],"genre_scores_gemma":[0.99910533,0.0001440752,0.0004540606,0.00011680258,0.000047656864,0.00008828349,0.000012596621,0.000025163075,0.0000060073116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701494,0.0005879847,0.000600117,0.0006140151,0.00050929515,0.00067365036],"domain_scores_gemma":[0.9978556,0.0011212395,0.00012580254,0.00035359102,0.0003152866,0.00022850427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018877179,0.00015070503,0.0003222744,0.00016977951,0.00020048754,0.00008839735,0.00017047115,0.00007881622,0.000055656874],"category_scores_gemma":[0.00063950964,0.00015073812,0.000027137661,0.0005039115,0.0003973232,0.000343056,0.00019057034,0.00018204536,0.000009005218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047391127,0.00023235226,0.023226138,0.0002498841,0.0000047720328,0.0000546891,0.0005222178,0.057937555,0.9123878,0.000062062536,0.00003478853,0.00054866227],"study_design_scores_gemma":[0.0033288705,0.00015832798,0.06696111,0.00023685768,0.000010364873,0.0000026196587,0.00027288194,0.11052023,0.81803256,0.00032418765,0.0000047506596,0.00014722972],"about_ca_topic_score_codex":0.0014701283,"about_ca_topic_score_gemma":0.0001840271,"teacher_disagreement_score":0.094355196,"about_ca_system_score_codex":0.00017956953,"about_ca_system_score_gemma":0.0005777579,"threshold_uncertainty_score":0.6146923},"labels":[],"label_agreement":null},{"id":"W3183048910","doi":"10.1158/1538-7445.am2021-3099","title":"Abstract 3099: The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal hematopoietic stem/progenitor cells to maintain stemness","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Stem cell; Cell biology; Biology; Progenitor cell; Clonogenic assay; Haematopoiesis; Mitochondrion; Neural stem cell; Cancer stem cell; Cancer research; Chemistry; Cell; Biochemistry","score_opus":0.030265343187783754,"score_gpt":0.3341348791851776,"score_spread":0.30386953599739386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183048910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548091,0.04014185,0.00006761437,0.0032240874,0.0006853828,0.00074676966,0.00012146994,0.000007410904,0.00019631197],"genre_scores_gemma":[0.98907703,0.0056656385,0.000049977774,0.0010933493,0.0016825758,0.00059733255,0.00001049547,0.000043237127,0.0017803848],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765474,0.00032333613,0.0002655135,0.0005661824,0.00047033155,0.0007198865],"domain_scores_gemma":[0.99858254,0.000070317044,0.00003527208,0.00074546103,0.0002829962,0.00028343563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011762142,0.00019352979,0.0002514393,0.000088674766,0.00025518888,0.00016103877,0.00053069985,0.000118890675,0.00013768343],"category_scores_gemma":[0.000083183215,0.00013210002,0.00008314458,0.00055363897,0.00015122133,0.000008097772,0.0005631255,0.00035425296,0.000052371768],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035270114,0.000096355296,0.00025866178,0.00010870566,0.00008694893,0.000037704594,0.0010895137,0.0004948959,0.9415993,0.0006708875,0.01784676,0.037357535],"study_design_scores_gemma":[0.0003380695,0.00004019654,0.0015852664,0.000028388258,0.000010793391,0.000014514635,0.0010346302,0.000006013168,0.4764372,0.000023081124,0.5203517,0.00013014322],"about_ca_topic_score_codex":0.0009599496,"about_ca_topic_score_gemma":0.002827366,"teacher_disagreement_score":0.50250494,"about_ca_system_score_codex":0.000052485673,"about_ca_system_score_gemma":0.0005151528,"threshold_uncertainty_score":0.53868824},"labels":[],"label_agreement":null},{"id":"W3183066110","doi":"10.1158/1538-7445.am2021-816","title":"Abstract 816: Genetic variants associated with C-reactive protein and colorectal cancer survival: Sex- and lifestyle factors- specific associations","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hazard ratio; Medicine; Single-nucleotide polymorphism; Colorectal cancer; Proportional hazards model; Internal medicine; Minor allele frequency; Oncology; Genome-wide association study; Interquartile range; Confidence interval; Cancer; Genetics; Genotype; Biology; Gene","score_opus":0.05068591735237741,"score_gpt":0.3429328351005763,"score_spread":0.2922469177481989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183066110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897152,0.007922267,0.000014643876,0.0002550709,0.00062882045,0.00042577804,0.0005032021,0.000013315232,0.00052171334],"genre_scores_gemma":[0.9916162,0.003761816,0.000035153596,0.000028737493,0.0024366248,0.00025934755,0.00013674336,0.000044810487,0.0016805904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809134,0.00023891564,0.00017307188,0.00058946846,0.00040638694,0.0005008394],"domain_scores_gemma":[0.99895275,0.00009529097,0.000086226566,0.00021057787,0.00045408154,0.00020106175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041168634,0.0001846331,0.000264027,0.00006290652,0.00027343325,0.000114913164,0.00011367693,0.00020130073,0.00010334234],"category_scores_gemma":[0.00024246496,0.0001687523,0.000039968134,0.0002752594,0.0002289118,0.000012592205,0.00013490778,0.0003429096,0.0000016122592],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110604924,0.00010119843,0.070916906,0.000026165402,0.0002814836,0.000002751558,0.000444408,0.000011650942,0.9234418,0.00004906049,0.0028878087,0.0017261092],"study_design_scores_gemma":[0.0010722936,0.00011970562,0.79730034,0.00006608422,0.00002629022,0.0000032888645,0.00035276773,0.0000044177696,0.16197224,0.00007677987,0.038743608,0.0002621887],"about_ca_topic_score_codex":0.001500755,"about_ca_topic_score_gemma":0.006464029,"teacher_disagreement_score":0.7614696,"about_ca_system_score_codex":0.00015208058,"about_ca_system_score_gemma":0.0009053632,"threshold_uncertainty_score":0.6881519},"labels":[],"label_agreement":null},{"id":"W3183091224","doi":"10.1158/1538-7445.am2021-2701","title":"Abstract 2701: Molecular profiling to assess the immune response to neoadjuvant SABR in early breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; Lawson Health Research Institute; Ontario Institute for Cancer Research","funders":"","keywords":"Tumor microenvironment; Immune system; Breast cancer; Cancer research; Medicine; Abscopal effect; Immune checkpoint; Gene expression profiling; Radiation therapy; Oncology; Immunology; Immunotherapy; Cancer; Biology; Internal medicine; Gene expression; Gene","score_opus":0.05173073731958699,"score_gpt":0.36450317789341063,"score_spread":0.31277244057382364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183091224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902275,0.0048624813,0.0003511157,0.002531487,0.0005607687,0.0008186713,0.00018540115,0.00009123471,0.00037133915],"genre_scores_gemma":[0.9976402,0.00032842802,0.00026755076,0.00017494916,0.00018428102,0.0009301109,0.000004723721,0.00011679385,0.0003529928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971582,0.00013365292,0.00038045418,0.00042382756,0.00086481625,0.0010390468],"domain_scores_gemma":[0.99818397,0.00032955487,0.000021408207,0.0007550234,0.00043117176,0.00027888952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015177953,0.00023293897,0.00029537742,0.00032028728,0.00013747961,0.00020095093,0.00063999044,0.00012047267,0.0003395656],"category_scores_gemma":[0.00021331837,0.00019998862,0.00008000022,0.0019389133,0.000060647468,0.00016781056,0.0002338879,0.0009728489,0.00013563865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006328659,0.00002116297,0.0010104029,0.000090363894,0.00005626908,0.00026072422,0.000885507,0.044018812,0.9425814,0.00007388696,0.00038000938,0.009988578],"study_design_scores_gemma":[0.0006648073,0.000050619565,0.09833176,0.00055349467,0.000008777065,0.000013606449,0.00043989808,0.00036703062,0.8919976,0.00013119928,0.007070488,0.00037075757],"about_ca_topic_score_codex":0.001736633,"about_ca_topic_score_gemma":0.0010592969,"teacher_disagreement_score":0.097321354,"about_ca_system_score_codex":0.0013897757,"about_ca_system_score_gemma":0.00077289244,"threshold_uncertainty_score":0.8155299},"labels":[],"label_agreement":null},{"id":"W3183093381","doi":"10.1158/1538-7445.am2021-2633","title":"Abstract 2633: Advancing childhood cancer research through young investigator and advocate collaboration","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Psychology; Public relations; Medical education; Political science","score_opus":0.12885641870264408,"score_gpt":0.47908927855597666,"score_spread":0.3502328598533326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183093381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9076856,0.03078272,0.000013150882,0.055749282,0.0005955906,0.0011562769,0.00012291846,0.00010771965,0.0037867394],"genre_scores_gemma":[0.974305,0.017172823,0.0007996737,0.002344369,0.0021528027,0.0007777769,0.00007745595,0.00013070495,0.0022394462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926872,0.0009227268,0.0006807406,0.0012337255,0.0029746322,0.0015009529],"domain_scores_gemma":[0.993757,0.0007903014,0.0001240648,0.0009704707,0.003341809,0.0010163637],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047377246,0.00031329383,0.0006467531,0.0003752748,0.0008714361,0.000303563,0.00031230238,0.00026923156,0.0010509243],"category_scores_gemma":[0.0045536193,0.00031804448,0.00009296597,0.0030232142,0.00087606156,0.00063373207,0.00042516054,0.0022433368,0.000084685846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001280576,0.0011559097,0.094734244,0.0048187254,0.0009064673,0.00091442274,0.06525785,0.00012568734,0.5536157,0.0035474468,0.25127304,0.022369955],"study_design_scores_gemma":[0.0075700753,0.0006938942,0.35659066,0.0064907125,0.00013856585,0.00017523707,0.036785454,0.000062848565,0.41819334,0.006457558,0.16566078,0.0011808616],"about_ca_topic_score_codex":0.011979617,"about_ca_topic_score_gemma":0.01472807,"teacher_disagreement_score":0.26185644,"about_ca_system_score_codex":0.0013294028,"about_ca_system_score_gemma":0.011532883,"threshold_uncertainty_score":0.99992716},"labels":[],"label_agreement":null},{"id":"W3183098828","doi":"10.1158/1538-7445.am2021-2861","title":"Abstract 2861: Collateral amplification KRAS-PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"KRAS; Metastasis; Cancer research; Cancer; Biology; Medicine; Internal medicine; Oncology; Colorectal cancer","score_opus":0.1470310524776631,"score_gpt":0.46037814632856544,"score_spread":0.3133470938509023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183098828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95761144,0.03093508,0.0000109925995,0.0100884205,0.00006108404,0.0007399119,0.00005244704,0.00002384935,0.0004768],"genre_scores_gemma":[0.9825385,0.014940314,0.00023092747,0.00042570077,0.00010121654,0.00032949285,0.000023883817,0.000023288343,0.0013866443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981233,0.00021649928,0.00026223809,0.00050699833,0.00041532962,0.0004756676],"domain_scores_gemma":[0.9985523,0.0002804052,0.000052235962,0.0003175654,0.0002958154,0.00050164136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004716052,0.00014922564,0.0003744174,0.000102169375,0.00024590068,0.000070744536,0.00004927516,0.00008864042,0.00047575284],"category_scores_gemma":[0.00013504954,0.00011937091,0.0000383193,0.00040976942,0.00018977688,0.000106663676,0.000046888854,0.00034708998,0.0000083052655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075452257,0.00024445684,0.7857959,0.0015933574,0.0004918059,0.00008260315,0.0012642407,8.734423e-7,0.06580703,0.0004182721,0.0013138773,0.14223303],"study_design_scores_gemma":[0.0021760538,0.00016138163,0.98088694,0.0003086409,0.00015770916,0.000029926274,0.00017454868,0.000014136872,0.011302934,0.0031207637,0.0015437717,0.00012317115],"about_ca_topic_score_codex":0.00951715,"about_ca_topic_score_gemma":0.00083379005,"teacher_disagreement_score":0.19509102,"about_ca_system_score_codex":0.00024323982,"about_ca_system_score_gemma":0.0011421146,"threshold_uncertainty_score":0.99707854},"labels":[],"label_agreement":null},{"id":"W3183131990","doi":"10.1158/1538-7445.am2021-ct172","title":"Abstract CT172: Phase 2 clinical trial of dianhydrogalactitol (VAL-083) in patients with newly diagnosed MGMT-unmethylated GBM","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Radiosensitizer; Oncology; Radiation therapy; Regimen; Internal medicine; Cancer research; Phases of clinical research; Methyltransferase; Chemoradiotherapy; Clinical trial; Biology; Adverse effect; DNA","score_opus":0.1234724709484172,"score_gpt":0.4875924216043667,"score_spread":0.3641199506559495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183131990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566704,0.0005103765,7.800964e-7,0.0010022551,0.00025612474,0.0014675927,0.000046737707,0.000016525764,0.0010325729],"genre_scores_gemma":[0.9981596,0.00090821827,0.00008329032,0.00005698646,0.00022308968,0.00035526653,0.000088494024,0.00003577857,0.00008926332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969311,0.000303223,0.0006438742,0.00052574143,0.0010694988,0.00052661233],"domain_scores_gemma":[0.99737257,0.000934192,0.00012550228,0.00057413423,0.00065701874,0.0003366131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089636847,0.00017240974,0.0006201721,0.00030288883,0.00006003137,0.000030243087,0.00012562331,0.00016891502,0.0007867664],"category_scores_gemma":[0.000998632,0.000130083,0.00015386067,0.0010248229,0.00020738746,0.00009545743,0.00007158242,0.00065522135,0.000042458385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06983984,0.02259744,0.8187649,0.00015246207,0.0004623262,0.002189491,0.00021749106,0.000020613017,0.0021313739,0.000023230834,0.0027524221,0.080848396],"study_design_scores_gemma":[0.3449086,0.0043687546,0.6229639,0.00050529797,0.0000895504,0.000001500677,0.00009454166,0.000011154468,0.024227414,0.00002224585,0.002658684,0.00014835257],"about_ca_topic_score_codex":0.0011944986,"about_ca_topic_score_gemma":0.0004903078,"teacher_disagreement_score":0.27506876,"about_ca_system_score_codex":0.000296275,"about_ca_system_score_gemma":0.0010760999,"threshold_uncertainty_score":0.86145407},"labels":[],"label_agreement":null},{"id":"W3183135849","doi":"10.1158/1538-7445.am2021-1356","title":"Abstract 1356: Meta-analysis and lack of independence assumption: Application in biomarker discovery","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sample size determination; Computer science; Meta-analysis; False discovery rate; Independence (probability theory); Pharmacogenomics; Biomarker discovery; Identification (biology); Breast cancer; Data mining; Computational biology; Data science; Econometrics; Statistics; Bioinformatics; Cancer; Medicine; Biology; Mathematics; Pathology; Proteomics; Internal medicine","score_opus":0.22468834575018895,"score_gpt":0.46322061260200875,"score_spread":0.2385322668518198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183135849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601216,0.009975673,0.0021464662,0.00089828356,0.00002212785,0.00015314082,0.00003521781,0.000002123687,0.00075482373],"genre_scores_gemma":[0.99646217,0.0018354161,0.000066474844,0.000047556994,0.000029691322,0.00018951044,0.00006547594,0.0000060642847,0.0012976343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886346,0.00012515108,0.0001834414,0.00037748078,0.00030934092,0.00014109764],"domain_scores_gemma":[0.99922633,0.00002229002,0.000060759263,0.00038375353,0.00026125685,0.000045605917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005820911,0.00006550172,0.00018781384,0.00014892996,0.000035669134,0.000030923937,0.000118576085,0.00010413102,0.00017127096],"category_scores_gemma":[0.000052250856,0.00005766784,0.000119750664,0.00068046787,0.00009010525,0.000009597242,0.00009718111,0.00011883825,0.0000027766223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004224696,0.00004026501,0.010511016,0.000031955777,0.0015865387,0.0000011577267,0.000021321523,0.00006527106,0.9849836,0.00008641489,0.0003770315,0.0022531424],"study_design_scores_gemma":[0.00020441425,0.000014835351,0.20977318,0.000004900564,0.000804316,8.4839417e-7,0.00014334176,0.000042249256,0.78361225,0.00015037092,0.0051601087,0.00008916781],"about_ca_topic_score_codex":0.00025646057,"about_ca_topic_score_gemma":0.0009711441,"teacher_disagreement_score":0.20137139,"about_ca_system_score_codex":0.000024376526,"about_ca_system_score_gemma":0.00018652863,"threshold_uncertainty_score":0.23516262},"labels":[],"label_agreement":null},{"id":"W3183730523","doi":"10.1158/0008-5472.can-21-0463","title":"Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Social Fund; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Agencia Estatal de Investigación; Instituto de Salud Carlos III; Cummings Foundation; Cumming School of Medicine, University of Calgary; Gobierno de Navarra; National Institutes of Health; Ministerio de Economía y Competitividad; Ministerio de Ciencia, Innovación y Universidades; University of Sussex; Natural Sciences and Engineering Research Council of Canada; European Commission; National Cancer Institute; Universidad de Navarra","keywords":"Hepatocellular carcinoma; Ligation; DNA; Biology; RNA; Molecular biology; Genetics; Cancer research; Gene","score_opus":0.04257501145060937,"score_gpt":0.34829746011366547,"score_spread":0.3057224486630561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183730523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048847,0.0050370875,0.0023300592,0.00025840837,0.00010711724,0.00067230547,0.00002266362,0.00000770163,0.0010761587],"genre_scores_gemma":[0.99801725,0.00064521475,0.000087206776,0.000015745129,0.00015966651,0.00019882622,0.00008368823,0.00004215507,0.0007502662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730664,0.00026043327,0.00034306187,0.0006469894,0.0007742467,0.00066863676],"domain_scores_gemma":[0.9984724,0.00003266823,0.00006361638,0.00055399415,0.00072157226,0.00015576147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010685433,0.00016030353,0.00023233387,0.00024564838,0.0001209412,0.00005392265,0.000360385,0.00025733327,0.00012858179],"category_scores_gemma":[0.00015299447,0.00017498464,0.00010367122,0.0009614957,0.00018893837,0.000009827014,0.00031391354,0.00048315368,0.000007444117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028523276,0.00012023106,0.0038605437,0.00018744158,0.00003067072,0.00011291842,0.00016282409,0.00019610867,0.99307895,0.00007219611,0.00010358952,0.0017893165],"study_design_scores_gemma":[0.0017783655,0.0002241882,0.0010400512,0.00015771153,0.000007345153,0.000015587791,0.00013288751,0.0007111688,0.9951744,0.000058997728,0.00052992447,0.00016939269],"about_ca_topic_score_codex":0.0008003056,"about_ca_topic_score_gemma":0.0007977568,"teacher_disagreement_score":0.007528733,"about_ca_system_score_codex":0.00019521549,"about_ca_system_score_gemma":0.0013835278,"threshold_uncertainty_score":0.71356666},"labels":[],"label_agreement":null},{"id":"W3183913095","doi":"10.1158/0008-5472.can-20-1518","title":"Modeling High-Grade Serous Ovarian Carcinoma Using a Combination of <i>In Vivo</i> Fallopian Tube Electroporation and CRISPR-Cas9–Mediated Genome Editing","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Montreal Neurological Institute and Hospital; Montreal Children's Hospital; BC Cancer Agency; University of British Columbia; McGill University; McGill Genome Centre; McGill University Health Centre","funders":"Cancer Research Society","keywords":"Ovarian cancer; CRISPR; Ovarian carcinoma; Serous fluid; Cancer research; Biology; Cancer; BRCA mutation; Medicine; Pathology; Gene; Genetics","score_opus":0.03134777162215207,"score_gpt":0.3554774778367069,"score_spread":0.32412970621455484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183913095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98431265,0.0026073535,0.012627135,0.00017881197,0.000060379898,0.00015143782,0.000018719495,0.0000049819264,0.000038552298],"genre_scores_gemma":[0.9985778,0.00046864516,0.00056712015,0.000021177138,0.00018753888,0.000021750862,0.00009482711,0.00002183838,0.000039331448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988931,0.000092998256,0.00020072075,0.00029688384,0.00021174163,0.00030454592],"domain_scores_gemma":[0.9994492,0.0000127146905,0.000025213476,0.00016887786,0.0002804961,0.000063479194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032814321,0.00009223034,0.00013155055,0.00010946292,0.000073491654,0.000028716246,0.00007865114,0.00010597714,0.000011976007],"category_scores_gemma":[0.00008486208,0.00010742045,0.000023667215,0.0003023384,0.000037729173,0.0000073517635,0.000089180416,0.00017434436,1.9758075e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021953785,0.000025679796,0.002086518,0.00007299889,0.000013774409,0.000010053948,0.00013534576,0.023325404,0.97407216,0.000074806776,0.000016144308,0.00014515803],"study_design_scores_gemma":[0.00075953617,0.00009865371,0.0019317502,0.000033129712,0.000008167297,0.0000130954095,0.00032553426,0.09874357,0.8977079,0.00008537473,0.00016488021,0.00012840048],"about_ca_topic_score_codex":0.0010887317,"about_ca_topic_score_gemma":0.0007298579,"teacher_disagreement_score":0.07636426,"about_ca_system_score_codex":0.00007251534,"about_ca_system_score_gemma":0.00021292492,"threshold_uncertainty_score":0.4380479},"labels":[],"label_agreement":null},{"id":"W3184904659","doi":"10.1158/0008-5472.can-21-0774","title":"Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Cancer Council Tasmania; Cancer Council Victoria; Cancer Council South Australia; Victorian Cancer Agency; Entertainment Industry Foundation; Stand Up To Cancer; Medical Research Council; Peter MacCallum Foundation; AstraZeneca Australia; Medical Research and Materiel Command; Eisai; Ovarian Cancer Research Fund; Cancer Australia; National Cancer Institute; Australian Cancer Research Foundation; Mayo Foundation for Medical Education and Research; State Government of Victoria; Australian Government; Cancer Council NSW; Ovarian Cancer Australia; National Breast Cancer Foundation; Clovis Oncology; Sierra Oncology; National Ovarian Cancer Coalition; American Association for Cancer Research; National Health and Medical Research Council; Cancer Research Institute; AstraZeneca; Ovarian Cancer Research Fund Alliance; National Institutes of Health","keywords":"Serous fluid; PARP inhibitor; Ovarian carcinoma; Methylation; Cancer research; Medicine; Ovarian cancer; Oncology; Internal medicine; Biology; Poly ADP ribose polymerase; Cancer; Gene; Genetics; Polymerase","score_opus":0.09252431265740614,"score_gpt":0.4020122372412097,"score_spread":0.3094879245838036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184904659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97018266,0.007583152,0.00007068926,0.019248309,0.0005039541,0.00096460595,0.00009059058,0.00008546796,0.0012705481],"genre_scores_gemma":[0.99021447,0.0009255889,0.0008723296,0.00076247606,0.0011084041,0.00080515095,0.00009037954,0.0000848488,0.0051363776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99568886,0.00068033545,0.0005502816,0.0008629998,0.0013131355,0.0009043979],"domain_scores_gemma":[0.997651,0.00025347588,0.000096434764,0.00085247454,0.0008465987,0.00030002365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011067792,0.00025485066,0.0005084376,0.00039027093,0.00020289242,0.00009215384,0.00020839449,0.0002418644,0.0008556135],"category_scores_gemma":[0.0002411217,0.00025509368,0.00009948566,0.0019119773,0.00033625614,0.00025583326,0.00011682785,0.0006911419,0.00006959417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002371279,0.000587249,0.058548387,0.00085993053,0.0001463013,0.002440632,0.0031973268,0.000035310783,0.90854913,0.0021196527,0.019141547,0.0020032784],"study_design_scores_gemma":[0.0072520175,0.00019122007,0.08660529,0.0010179234,0.000031458443,0.00005981634,0.0003059607,0.000020847794,0.8572535,0.0035578883,0.043328863,0.00037524497],"about_ca_topic_score_codex":0.0009868202,"about_ca_topic_score_gemma":0.0030219483,"teacher_disagreement_score":0.05129563,"about_ca_system_score_codex":0.0016159557,"about_ca_system_score_gemma":0.0017709775,"threshold_uncertainty_score":0.9999901},"labels":[],"label_agreement":null},{"id":"W3194406004","doi":"","title":"In vivo synergy between oncolytic reovirus and gemcitibane in ras-mutated human HCT116 xenografts","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Gemcitabine; In vivo; Combination therapy; Cytotoxic T cell; Virology; Medicine; Internal medicine; Cancer research; Chemotherapy; Virus; Immunology; Biology; In vitro","score_opus":0.058492003335117754,"score_gpt":0.4361381971881448,"score_spread":0.377646193853027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194406004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480414,0.0025546872,0.000011047954,0.00036540235,0.000047048892,0.00048690077,0.000026668049,0.000010313441,0.0016937677],"genre_scores_gemma":[0.9961429,0.0011025954,0.00001934387,0.00013635957,0.00046011058,0.00011442008,0.00003124269,0.000052323936,0.0019407086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969512,0.00037208377,0.00036626158,0.00063828356,0.00056602363,0.0011061508],"domain_scores_gemma":[0.99894345,0.000114106886,0.0000392604,0.00046427659,0.00017932785,0.00025957788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003201495,0.00018703932,0.00026297857,0.00063483894,0.00013928923,0.000049617567,0.00040980245,0.00025953073,0.00020807103],"category_scores_gemma":[0.00012627461,0.00019358721,0.00004259149,0.0009216984,0.00039818577,0.000010922162,0.0002720938,0.000619371,0.0000141983655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013294287,0.00007116768,0.020237818,0.00004475168,0.000034997993,0.00014094758,0.0001476817,0.000027992668,0.9696124,0.000022762755,0.0012956003,0.0070344377],"study_design_scores_gemma":[0.0021256022,0.0015764394,0.01213564,0.00007557491,0.0000033528195,0.0000048641996,0.00013613685,0.0000087733015,0.9658644,0.0002353191,0.017569145,0.00026475493],"about_ca_topic_score_codex":0.0027194223,"about_ca_topic_score_gemma":0.024457285,"teacher_disagreement_score":0.021737862,"about_ca_system_score_codex":0.0002969097,"about_ca_system_score_gemma":0.00035479825,"threshold_uncertainty_score":0.99334383},"labels":[],"label_agreement":null},{"id":"W3195572553","doi":"10.1158/0008-5472.can-21-0839","title":"Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Israel Science Foundation; National Institutes of Health; Emerson Collective; Israel Cancer Association; Israel Cancer Research Fund","keywords":"Eosinophil; Tumor microenvironment; Immunology; Immune system; Cancer research; Immunity; CD8; Biology; Medicine","score_opus":0.08190139313986122,"score_gpt":0.42740978935514595,"score_spread":0.34550839621528473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195572553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95990354,0.021995757,0.00003317513,0.007853268,0.00025159318,0.00044300494,0.00008124687,0.00008027788,0.009358159],"genre_scores_gemma":[0.9817802,0.007922505,0.00022964754,0.00065573346,0.00018991824,0.00014966057,0.00014687974,0.000045786186,0.008879695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969075,0.00035292545,0.0003361518,0.0005237742,0.0010302266,0.00084944896],"domain_scores_gemma":[0.99757534,0.00025682346,0.000049356495,0.00079645857,0.0009568379,0.00036517196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009712023,0.00019515042,0.00050482043,0.0002300873,0.00030905998,0.0000865698,0.00026015265,0.00011545744,0.0040302915],"category_scores_gemma":[0.00089731335,0.00017417285,0.00014878513,0.0013872975,0.00037899704,0.00012981852,0.00019256964,0.0006355403,0.00030579028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006131224,0.0011552917,0.0049782773,0.00073546654,0.00057745544,0.002447105,0.0010026485,0.0000055510523,0.92854196,0.0012779004,0.024054931,0.034610305],"study_design_scores_gemma":[0.007484294,0.00075024326,0.046417113,0.0010812656,0.00017868126,0.000484918,0.002518838,0.00015374343,0.7598677,0.0016350015,0.17868549,0.0007426764],"about_ca_topic_score_codex":0.0006476161,"about_ca_topic_score_gemma":0.00013201013,"teacher_disagreement_score":0.1686742,"about_ca_system_score_codex":0.00041012155,"about_ca_system_score_gemma":0.0021936372,"threshold_uncertainty_score":0.9968802},"labels":[],"label_agreement":null},{"id":"W3200163524","doi":"10.1158/0008-5472.can-21-0761","title":"Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"National Cancer Institute","keywords":"Thyroid carcinoma; Transcriptome; Gene; Fusion gene; Exome sequencing; Exome; Gene expression; Thyroid; Candidate gene; Gene expression profiling","score_opus":0.06028638502116663,"score_gpt":0.3454165414276917,"score_spread":0.28513015640652506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200163524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92834735,0.069526345,0.0000044525996,0.0011954133,0.00010005519,0.00036276111,0.00020724225,0.00001178902,0.00024457494],"genre_scores_gemma":[0.9589422,0.03983175,0.00004285777,0.00007238234,0.0005078146,0.00019324664,0.00005968864,0.000024602736,0.0003254678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837786,0.00015973982,0.00021468758,0.0003818756,0.00050352066,0.00036231425],"domain_scores_gemma":[0.9987245,0.0002459417,0.000058968977,0.00051102135,0.00026171142,0.00019782095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027118906,0.0001366331,0.00026611536,0.000106571235,0.00025468765,0.000022817549,0.00012900318,0.00006508145,0.0007556708],"category_scores_gemma":[0.00006277137,0.00008715402,0.000098509474,0.0003540891,0.00010121566,0.00003204216,0.00040216313,0.00028785603,0.000012819429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015258732,0.00020874519,0.85729766,0.00015015547,0.00006748768,0.00023722994,0.00040213906,0.000004156896,0.13219419,0.000017189086,0.0059187165,0.0033497303],"study_design_scores_gemma":[0.002105959,0.0003472119,0.903137,0.000082621584,0.00019096695,0.000044832006,0.00074303115,0.000010504302,0.09208627,0.000028137289,0.0011196325,0.000103795755],"about_ca_topic_score_codex":0.00065412,"about_ca_topic_score_gemma":0.00030158344,"teacher_disagreement_score":0.04583937,"about_ca_system_score_codex":0.00016609699,"about_ca_system_score_gemma":0.0005393113,"threshold_uncertainty_score":0.8274065},"labels":[],"label_agreement":null},{"id":"W3201978388","doi":"","title":"Diosgenin inhibits growth and induces apoptosis in HCT-116 human colon adenocarcinoma cells by modulating the cholesterol biosynthetic pathway","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Diosgenin; Apoptosis; Pharmacology; Fluvastatin; Chemistry; Mechanism of action; Biology; Cancer research; Endocrinology; Internal medicine; Biochemistry; Medicine; Simvastatin; In vitro","score_opus":0.02634427616283212,"score_gpt":0.30166236075249003,"score_spread":0.2753180845896579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201978388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950804,0.003494124,0.0000023264747,0.00060607155,0.000028751367,0.00027991782,0.000047667665,0.0000057314187,0.00045501278],"genre_scores_gemma":[0.998957,0.00037106845,0.000006058716,0.00006386581,0.00020890897,0.0001720069,0.000019405023,0.000018012559,0.00018367595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986231,0.00015820871,0.000167869,0.00038385123,0.0002316508,0.00043536036],"domain_scores_gemma":[0.99962234,0.000051907256,0.00004230618,0.00017334623,0.00005877774,0.000051332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030574188,0.00013973266,0.00014268965,0.000043605705,0.00032709714,0.000064139895,0.00019649981,0.00012314311,0.000005264074],"category_scores_gemma":[0.000030536492,0.000101209705,0.000037059202,0.00018161826,0.00036245445,0.00000651147,0.00029500644,0.00028995576,0.0000010675401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002776427,0.00005102667,0.00661852,0.000031039737,0.000013696912,4.9636833e-7,0.00008368533,0.0000022415795,0.9914179,0.000017464534,0.001111262,0.00062489224],"study_design_scores_gemma":[0.000321615,0.00014699802,0.004906019,0.000038155045,0.000003200796,8.64967e-7,0.0002320841,0.0000044733397,0.99339265,0.000114553295,0.0007084332,0.00013095935],"about_ca_topic_score_codex":0.0019793003,"about_ca_topic_score_gemma":0.0004014513,"teacher_disagreement_score":0.0038766006,"about_ca_system_score_codex":0.000043161624,"about_ca_system_score_gemma":0.00003362541,"threshold_uncertainty_score":0.4127212},"labels":[],"label_agreement":null},{"id":"W3206895537","doi":"","title":"The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Cancer; Doxorubicin; Internal medicine; Urology; Oncology; Surgery","score_opus":0.07046813172707168,"score_gpt":0.45713557103825403,"score_spread":0.38666743931118236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206895537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808608,0.011001004,3.4598617e-7,0.0056932713,0.0003049814,0.0011412452,0.000033557968,0.0000139649355,0.00095079036],"genre_scores_gemma":[0.98592395,0.011628268,0.0000132400455,0.00009233166,0.00044168008,0.0004331169,0.0000043540695,0.000027799988,0.0014352505],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980978,0.00015686266,0.00031622598,0.0002866051,0.00056222564,0.0005802975],"domain_scores_gemma":[0.9983965,0.0008674038,0.00008309391,0.00030429312,0.0002051938,0.00014347768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119863,0.00014982882,0.0004504862,0.0003098298,0.00010316182,0.000009279599,0.0002088796,0.00009867247,0.00035262285],"category_scores_gemma":[0.000080826576,0.0001018799,0.00009984012,0.0007370865,0.00039249,0.000047844896,0.00005543374,0.0006029413,0.000011696113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010591618,0.0016504624,0.032924112,0.0013904022,0.00031839107,0.00013313685,0.0063291206,0.00023132698,0.4221361,0.00028494978,0.015145903,0.50886446],"study_design_scores_gemma":[0.017918518,0.0015125755,0.3401976,0.0051907585,0.00020716515,0.000018382128,0.00045613272,0.00012459555,0.61137694,0.00003328513,0.022719253,0.00024478228],"about_ca_topic_score_codex":0.0028057331,"about_ca_topic_score_gemma":0.0011744916,"teacher_disagreement_score":0.50861967,"about_ca_system_score_codex":0.00042314103,"about_ca_system_score_gemma":0.00066286046,"threshold_uncertainty_score":0.42414477},"labels":[],"label_agreement":null},{"id":"W3207148993","doi":"","title":"DNA palindromes: The role of repair functions","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Palindrome; Biology; Genetics; Palindromic sequence; DNA; DNA replication; Genome; Breakpoint; Chromosome; Computational biology; Gene","score_opus":0.03208274521916133,"score_gpt":0.3481826997936727,"score_spread":0.3160999545745114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207148993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927109,0.0026839927,0.00010926514,0.0003714505,0.00009858171,0.00022259106,0.00002276348,0.000018331397,0.0037621446],"genre_scores_gemma":[0.99707294,0.00024871962,0.000111577836,0.000048600807,0.00017594926,0.00014453073,0.000013077466,0.000016050548,0.002168544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990586,0.00008187841,0.000110849156,0.00022472187,0.0002732357,0.00025072278],"domain_scores_gemma":[0.9991988,0.0000148742265,0.000024390607,0.00051345356,0.00019326131,0.00005524331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050098443,0.00006230411,0.000068944406,0.000041306484,0.00012321724,0.000009410548,0.00024797482,0.00007964398,0.00009097365],"category_scores_gemma":[0.00009970855,0.000045256227,0.000088808076,0.00019872106,0.00016980352,0.0000019128668,0.00015261698,0.00014678124,0.000030232364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041524956,0.000038648846,0.00025849813,0.000010511461,0.00004774437,0.0000017510125,0.00008480906,0.00013560972,0.9958068,0.0010362709,0.0011704824,0.0013673239],"study_design_scores_gemma":[0.00022662808,0.00021271776,0.00025857997,0.000015825988,0.0000055352975,0.000005989116,0.00056538073,0.0000056083845,0.9047069,0.0019831755,0.09195873,0.000054933487],"about_ca_topic_score_codex":0.0002569619,"about_ca_topic_score_gemma":0.00016999613,"teacher_disagreement_score":0.091099925,"about_ca_system_score_codex":0.000041694708,"about_ca_system_score_gemma":0.000307361,"threshold_uncertainty_score":0.18454954},"labels":[],"label_agreement":null},{"id":"W3207313894","doi":"10.1158/0008-5472.can-21-2056","title":"Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; University of Toronto; Government of Ontario; Prostate Cancer Foundation; Ontario Institute for Cancer Research; Movember Foundation; Princess Margaret Cancer Foundation","keywords":"Genome; Prostate cancer; Chromatin; Gene; Prostate; Chromoplexy; Concordance; Genome instability","score_opus":0.018245369796316597,"score_gpt":0.29296036292208494,"score_spread":0.27471499312576836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207313894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803615,0.0004939267,0.00006938872,0.00014213273,0.000054834472,0.00013327342,0.00004391589,0.0000013846461,0.0010250247],"genre_scores_gemma":[0.9978337,0.0007719178,0.0002985489,0.000030818173,0.000045517627,0.000008282505,0.00005310222,0.000014574699,0.00094352185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925065,0.00007912841,0.00014894285,0.00016747483,0.00020042957,0.00015337119],"domain_scores_gemma":[0.9991392,0.000008559352,0.00006875916,0.00029918936,0.00045562006,0.000028668084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002419247,0.000050728446,0.00009221942,0.000025166442,0.00006557332,0.0000083805635,0.00020024205,0.000047565576,0.00003374606],"category_scores_gemma":[0.00006901129,0.000043144304,0.00003707914,0.00025018246,0.00013528936,0.0000018673261,0.00030058576,0.00008948374,0.0000010500872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014312828,0.000019463674,0.006280742,0.00010143919,0.000020391566,0.0000014218652,0.00019256576,0.00034716015,0.9924388,0.00005588531,0.000104931234,0.0004229111],"study_design_scores_gemma":[0.00026065417,0.000052939024,0.02419494,0.000050771596,0.000005473956,0.0000042504416,0.0002083302,0.00007084123,0.9736165,0.000085536034,0.0013871689,0.00006262784],"about_ca_topic_score_codex":0.000026661537,"about_ca_topic_score_gemma":0.000034298177,"teacher_disagreement_score":0.018822309,"about_ca_system_score_codex":0.00006520156,"about_ca_system_score_gemma":0.00059761177,"threshold_uncertainty_score":0.17593737},"labels":[],"label_agreement":null},{"id":"W3208414451","doi":"10.1158/0008-5472.can-21-1079","title":"Heterogeneity of Circulating Tumor Cell–Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Hospital; Sunnybrook Health Science Centre; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Breast cancer; Immune system; Circulating tumor cell; Primary tumor; Breast carcinoma; Cancer; Metastatic breast cancer; Genetic heterogeneity","score_opus":0.06206170035291685,"score_gpt":0.3758840776408584,"score_spread":0.31382237728794155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208414451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98242563,0.010360881,8.5783915e-7,0.006435572,0.00004917974,0.00038778002,0.00019841213,0.000008059633,0.00013360527],"genre_scores_gemma":[0.9968188,0.0018881456,0.00000880856,0.00014858563,0.000073579016,0.00012680159,0.00000849819,0.000027612428,0.0008992071],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99792176,0.000497049,0.00024106864,0.00029681195,0.0006067724,0.00043651],"domain_scores_gemma":[0.9984795,0.00034910114,0.00014691752,0.00022905278,0.00069806253,0.00009739753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022150301,0.00011004646,0.00032656206,0.000120954326,0.00013346769,0.000029320905,0.00008753033,0.00006300769,0.00016450445],"category_scores_gemma":[0.000207568,0.00008193153,0.00005655858,0.00082127517,0.00007352105,0.00004874795,0.000102393074,0.00046878346,0.0000021952462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011993685,0.00008730707,0.12985617,0.00014423627,0.00011168334,0.000068672496,0.00075593655,0.00006241741,0.86693025,0.0000033717727,0.00014058483,0.00064001593],"study_design_scores_gemma":[0.0020023766,0.000069480324,0.7507449,0.00029940286,0.00005556635,0.000017752594,0.00063255546,0.000081238046,0.2455476,0.0000016395041,0.00046041873,0.00008709635],"about_ca_topic_score_codex":0.0028661091,"about_ca_topic_score_gemma":0.0027057,"teacher_disagreement_score":0.62138265,"about_ca_system_score_codex":0.0014792994,"about_ca_system_score_gemma":0.0014393515,"threshold_uncertainty_score":0.43327188},"labels":[],"label_agreement":null},{"id":"W3211267133","doi":"","title":"Post-translational modification of β-catenin by O-glycosylation regulates its nuclear localization and transcriptional activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Adherens junction; Wnt signaling pathway; Glycosylation; Signal transduction; Cell biology; Chemistry; Catenin; Biology; Molecular biology; Biochemistry; Cell; Cadherin","score_opus":0.04081914702367088,"score_gpt":0.3547188824231417,"score_spread":0.3138997353994708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211267133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917957,0.0018675304,0.0028519232,0.0025404347,0.000020246614,0.00039626387,0.00018291447,0.000010612869,0.00033434128],"genre_scores_gemma":[0.99751556,0.00079668086,0.00014878668,0.00004161728,0.0001234497,0.000050112314,0.00035938044,0.000021364645,0.00094307115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985589,0.00016637829,0.00018269132,0.00032419548,0.0005346455,0.00023319085],"domain_scores_gemma":[0.99895114,0.000020821375,0.00005009393,0.00015456,0.0007268719,0.00009654456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005063945,0.000095971314,0.00009563993,0.00013711925,0.00018219797,0.000034070876,0.00012845268,0.00015025682,0.00027415625],"category_scores_gemma":[0.000079748854,0.00009874219,0.000038588416,0.00022272226,0.00017299836,0.000033105265,0.000033990273,0.00015645205,0.000013610512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004141833,0.00007816941,0.00030424364,0.00003742023,0.0000200966,7.818486e-8,0.00013114573,0.0011448257,0.9794193,0.001236252,0.0006881845,0.016526112],"study_design_scores_gemma":[0.000700526,0.00016584505,0.009923133,0.00001925401,0.000004904179,0.0000024914889,0.000030430872,0.011820795,0.9422605,0.00009263594,0.034851212,0.0001282983],"about_ca_topic_score_codex":0.00016001226,"about_ca_topic_score_gemma":0.00010669411,"teacher_disagreement_score":0.037158813,"about_ca_system_score_codex":0.000040727857,"about_ca_system_score_gemma":0.00013520395,"threshold_uncertainty_score":0.40265894},"labels":[],"label_agreement":null},{"id":"W3211446739","doi":"10.1158/1538-7445.panca21-po-103","title":"Abstract PO-103: Cellular origin influences immune microenvironment in a pancreatic cancer mouse model with loss of Pten and activation of Kras","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immune system; PTEN; Tumor microenvironment; Cancer research; Carcinogenesis; Pancreatic cancer; KRAS; Pancreatic Intraepithelial Neoplasia; Population; Biology; Cancer; Immunology; Pathology; Medicine; PI3K/AKT/mTOR pathway; Pancreatic ductal adenocarcinoma; Internal medicine; Signal transduction; Cell biology; Colorectal cancer","score_opus":0.06881260336608822,"score_gpt":0.3949343919889631,"score_spread":0.3261217886228749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211446739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419796,0.0037225096,0.00005724252,0.0009678093,0.0000074860086,0.00052337046,0.000031173633,0.000004546186,0.00048790508],"genre_scores_gemma":[0.99014086,0.0074500563,0.00045338104,0.000028016046,0.000028168703,0.0002326566,0.00001217678,0.00001935734,0.0016353446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807703,0.0001241157,0.00037460672,0.0003144303,0.00070963707,0.00040015476],"domain_scores_gemma":[0.9988955,0.00023979525,0.00010013481,0.00032859342,0.0003092993,0.00012665945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006913882,0.00012325242,0.0005641906,0.00022994459,0.000053713342,0.000009129365,0.000114389215,0.00010738194,0.00041176935],"category_scores_gemma":[0.00011793308,0.000096111944,0.000034214616,0.0004172939,0.00064005377,0.00009324456,0.000089824374,0.0004477874,0.000002317606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072864885,0.00019913983,0.39341614,0.0006300545,0.000120784345,0.00004085323,0.0006741013,0.00046536498,0.6027513,0.000038438415,0.00002628035,0.00090889557],"study_design_scores_gemma":[0.0024241589,0.00025656284,0.34304425,0.0010725969,0.0000650826,0.000005456669,0.000871297,0.0014185724,0.6505625,0.00010781419,0.00007076173,0.00010092834],"about_ca_topic_score_codex":0.006190632,"about_ca_topic_score_gemma":0.00036501707,"teacher_disagreement_score":0.050371908,"about_ca_system_score_codex":0.0003716412,"about_ca_system_score_gemma":0.0015675494,"threshold_uncertainty_score":0.9358425},"labels":[],"label_agreement":null},{"id":"W3211461828","doi":"10.1158/1538-7445.panca21-po-021","title":"Abstract PO-021: Targeting the mitochondrial pyruvate complex to alter metabolic programming in pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada); University of British Columbia","funders":"","keywords":"Glycolysis; Cancer research; Biology; Transcriptome; Warburg effect; Mitochondrion; Internal medicine; Endocrinology; Medicine; Cell biology; Biochemistry; Gene expression; Metabolism; Gene","score_opus":0.05827439749783252,"score_gpt":0.3850064537207525,"score_spread":0.32673205622291995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211461828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954393,0.04062109,0.000080888145,0.0021527836,0.0014144472,0.00077457534,0.00006983787,0.000013910041,0.00047942155],"genre_scores_gemma":[0.97322565,0.010644605,0.0010335054,0.0010632579,0.009280517,0.0018929499,0.0001229184,0.00008502019,0.002651593],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997227,0.00026826022,0.000345008,0.00068051415,0.00052329566,0.00095591805],"domain_scores_gemma":[0.998689,0.000056991084,0.000061029514,0.0005508972,0.0004284837,0.0002135931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007301305,0.0002126309,0.00032172218,0.000113024274,0.00025443768,0.00014842572,0.00044907653,0.00013031173,0.00051447237],"category_scores_gemma":[0.00033263938,0.00017124545,0.00013052473,0.00069940306,0.00016020416,0.00001020602,0.00033744526,0.00046953268,0.000025547239],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016893208,0.000049347676,0.00093078864,0.000049383973,0.00007971326,0.000008603998,0.00035909592,0.00019564072,0.9436864,0.00006227998,0.017827353,0.036582448],"study_design_scores_gemma":[0.0006224613,0.00002719535,0.008854713,0.00005711181,0.000018149254,0.0000026017035,0.0003266352,0.000008612368,0.31324995,0.00005034182,0.6765911,0.00019112362],"about_ca_topic_score_codex":0.0037041912,"about_ca_topic_score_gemma":0.006707572,"teacher_disagreement_score":0.65876377,"about_ca_system_score_codex":0.00008435608,"about_ca_system_score_gemma":0.00084333366,"threshold_uncertainty_score":0.69831866},"labels":[],"label_agreement":null},{"id":"W3212214778","doi":"10.1158/1538-7445.panca21-ia-003","title":"Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pancreatic cancer; Cancer research; Biology; Epigenomics; Cancer; Carcinogenesis; Proteogenomics; Adenocarcinoma; Tumor microenvironment; Computational biology; DNA methylation; Genomics; Gene; Genome; Genetics; Gene expression; Tumor cells","score_opus":0.1148256809657899,"score_gpt":0.4461626039202047,"score_spread":0.33133692295441475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212214778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836833,0.00438153,0.000025726007,0.002346643,0.00009236793,0.0008877188,0.00006509563,0.000023538052,0.008494095],"genre_scores_gemma":[0.99070114,0.0017287275,0.0005159187,0.00006837246,0.0003169682,0.00042558994,0.00008144145,0.000034996294,0.0061268564],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976076,0.00020589492,0.00039665922,0.0003962342,0.00077981537,0.0006138198],"domain_scores_gemma":[0.99782157,0.00029383673,0.00007214292,0.00057111296,0.00094961614,0.0002916974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007920462,0.00013051994,0.0005464036,0.00025854446,0.00017883886,0.000024585781,0.00018421169,0.00014826108,0.004951277],"category_scores_gemma":[0.0007285208,0.000116717005,0.00010360919,0.0007679719,0.00046452825,0.00007859757,0.00014500476,0.0006376337,0.00016714328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002180893,0.00026637412,0.45407397,0.00052863784,0.00022654016,0.00042547128,0.0003670854,8.236475e-7,0.5419197,0.00040489063,0.0007062052,0.00086218846],"study_design_scores_gemma":[0.0012859259,0.00024895562,0.93684626,0.000325647,0.00009897343,0.00012415438,0.00038946173,0.000049634575,0.059068322,0.00020034931,0.0012563324,0.000105996834],"about_ca_topic_score_codex":0.0003326914,"about_ca_topic_score_gemma":0.000034974764,"teacher_disagreement_score":0.4828514,"about_ca_system_score_codex":0.00033245757,"about_ca_system_score_gemma":0.00351348,"threshold_uncertainty_score":0.9959583},"labels":[],"label_agreement":null},{"id":"W3212357316","doi":"10.1158/1538-7445.panca21-po-107","title":"Abstract PO-107: Fibroblast differentiation trajectories elicit regional tissue states in pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Tumor microenvironment; Stromal cell; Phenotype; Cellular differentiation; Cancer-Associated Fibroblasts; Cancer; Transcriptome; Pancreatic cancer; Fibroblast; Immune system; Stem cell; Tumor progression; Cancer research; Pathology; Immunology; Cell biology; Cell culture; Genetics; Medicine; Gene; Gene expression","score_opus":0.03739748938343958,"score_gpt":0.3584242068142077,"score_spread":0.32102671743076816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212357316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774034,0.010411985,0.000058993504,0.000948702,0.00016560766,0.00019157183,0.0001896693,0.000006358282,0.0002867945],"genre_scores_gemma":[0.9809539,0.016409976,0.000049506893,0.00015495598,0.0006148185,0.00025773246,0.00037532204,0.000031386942,0.001152418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985246,0.0000736805,0.0002184952,0.0004332277,0.00030702437,0.0004429363],"domain_scores_gemma":[0.999114,0.00009785558,0.000045706372,0.00029433722,0.00033874187,0.0001094098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018396896,0.00013767842,0.00016909868,0.000082410705,0.00010351481,0.0000805843,0.00016913579,0.00012446556,0.00052082585],"category_scores_gemma":[0.00013356599,0.0001424897,0.000047696314,0.00027496024,0.00010537298,0.0000066451034,0.000118277254,0.00022459167,0.000010965069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017050431,0.00008976243,0.016112592,0.00012511954,0.000056680517,0.00002242049,0.00023250478,0.0011694995,0.96142447,0.00013042009,0.015466401,0.004999611],"study_design_scores_gemma":[0.0008254697,0.00012447592,0.1446283,0.00021816291,0.000011077565,0.000003996073,0.0003548838,0.00004591819,0.79625726,0.0005597432,0.056697425,0.000273281],"about_ca_topic_score_codex":0.003482986,"about_ca_topic_score_gemma":0.016445255,"teacher_disagreement_score":0.16516721,"about_ca_system_score_codex":0.00018901806,"about_ca_system_score_gemma":0.00076907873,"threshold_uncertainty_score":0.91768384},"labels":[],"label_agreement":null},{"id":"W3212434637","doi":"10.1158/1538-7445.panca21-po-077","title":"Abstract PO-077: Establishment of a novel living biobank of patient-derived pancreatic cancer organoids with genomic and drug response characterization","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Medicine; KRAS; Pancreatic cancer; Irinotecan; Oncology; Internal medicine; Trametinib; Erlotinib; Oxaliplatin; Cancer; Colorectal cancer; Biology; Kinase","score_opus":0.04602365213740525,"score_gpt":0.36668082850770045,"score_spread":0.3206571763702952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212434637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954823,0.002091219,0.000045991317,0.0012310456,0.000046218254,0.0008022677,0.0001244558,0.000012564824,0.00016390161],"genre_scores_gemma":[0.99432546,0.0039198827,0.0005101453,0.000058715206,0.0000728598,0.00028914,0.00002942783,0.000036370267,0.0007579962],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99762756,0.00029196232,0.00043123448,0.00039690154,0.00077204173,0.00048028163],"domain_scores_gemma":[0.99721307,0.00080226915,0.00016634609,0.00040524045,0.0011853643,0.00022770464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011438511,0.00015461733,0.0006179094,0.00031480333,0.000115603674,0.00002599895,0.00011953412,0.000102723294,0.00096070714],"category_scores_gemma":[0.00069202547,0.00012476408,0.000041909196,0.0007165919,0.00050465384,0.000107479485,0.0001751481,0.00038199202,0.0000027679466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002733165,0.00043107834,0.18430062,0.0008128337,0.00019445922,0.00004311491,0.0028278714,0.000003410465,0.8059101,0.0000124439275,0.00006777693,0.0026630922],"study_design_scores_gemma":[0.0020416696,0.0005742021,0.70802253,0.0019932934,0.00011119194,0.00002631083,0.0017683298,0.000085237494,0.2849311,0.0000044536805,0.00032407563,0.000117641175],"about_ca_topic_score_codex":0.0015967733,"about_ca_topic_score_gemma":0.0002220555,"teacher_disagreement_score":0.5237219,"about_ca_system_score_codex":0.00039433865,"about_ca_system_score_gemma":0.003296379,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W3212668399","doi":"10.1158/0008-5472.can-20-2426","title":"Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Lenvatinib; Signal transduction; Tyrosine kinase; Receptor tyrosine kinase; Cancer; Fibroblast growth factor receptor; Kinase; Cancer cell; Monoclonal antibody","score_opus":0.031164425192960206,"score_gpt":0.3637609272757074,"score_spread":0.3325965020827472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212668399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985238,0.00026105915,0.000056442543,0.00042764907,0.000028094739,0.00043249415,0.00007358513,0.0000039899987,0.00019290755],"genre_scores_gemma":[0.9993063,0.00017703287,0.00016836228,0.000023571174,0.0000501472,0.00007101172,0.000020484678,0.000025511032,0.00015755766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979533,0.00037294067,0.0002361277,0.0004263937,0.00057015393,0.0004410749],"domain_scores_gemma":[0.99848825,0.0001800634,0.000093238275,0.00045583642,0.0007105836,0.00007205937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135459,0.00013148464,0.00026279147,0.00014806261,0.00008500658,0.000026039595,0.00024649058,0.000064704625,0.000044516444],"category_scores_gemma":[0.00034177955,0.00010047368,0.000049079666,0.00081591954,0.00037487553,0.000014378256,0.00031510976,0.00035212914,0.000003130661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007130044,0.0001500851,0.009783588,0.0002647252,0.00003552689,0.000018531367,0.00019426706,0.00021418897,0.98808837,0.000020166211,0.00021209182,0.00030546446],"study_design_scores_gemma":[0.00036483738,0.0004579762,0.01760936,0.0003835267,0.0000028823747,0.0000023294124,0.00029856805,0.00001138424,0.98058426,0.000021072827,0.00015475453,0.00010905333],"about_ca_topic_score_codex":0.000605369,"about_ca_topic_score_gemma":0.00033010752,"teacher_disagreement_score":0.007825772,"about_ca_system_score_codex":0.000049995717,"about_ca_system_score_gemma":0.0005811539,"threshold_uncertainty_score":0.40971977},"labels":[],"label_agreement":null},{"id":"W3213285951","doi":"10.1158/1538-7445.panca21-po-117","title":"Abstract PO-117: The role of Hippo signaling in stromal-epithelial interactions in acinar-to-ductal metaplasia and pancreatic cancer initiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill Genome Centre; McGill University Health Centre","funders":"","keywords":"Cancer research; Stromal cell; Pancreatic cancer; Biology; Hippo signaling pathway; Ductal cells; Epithelial–mesenchymal transition; Pathology; Metaplasia; Stroma; Cancer; Medicine; Signal transduction; Cell biology; Immunology; Immunohistochemistry; Metastasis","score_opus":0.09243021442796145,"score_gpt":0.4490863032952405,"score_spread":0.35665608886727906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213285951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051356,0.0031257332,0.0000051746297,0.0032902274,0.00006202667,0.0006170839,0.000044981807,0.0000066669604,0.0023345626],"genre_scores_gemma":[0.9974033,0.0012805156,0.0001336054,0.000076061544,0.00015574103,0.0005020761,0.000012885061,0.000018127015,0.0004176526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978933,0.0003606351,0.0003855749,0.0003147692,0.00056124455,0.00048447846],"domain_scores_gemma":[0.9982078,0.0009249876,0.00005621926,0.00025252198,0.00040170466,0.00015675942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013306751,0.000114144845,0.00043718462,0.00041768167,0.00010345104,0.000028290533,0.00012686125,0.00007475922,0.0030925456],"category_scores_gemma":[0.00077489705,0.00008779733,0.00004569127,0.0009144664,0.00020242206,0.00011555969,0.00011975642,0.0007643274,0.000009012861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006924889,0.00019774913,0.5338461,0.00016934928,0.00010919968,0.00015156224,0.0028662013,0.000060439303,0.45358104,0.00019422262,0.000092564616,0.008039118],"study_design_scores_gemma":[0.0018214117,0.00021842313,0.88613,0.00089553854,0.000077242796,0.00004462003,0.0075834715,0.00043839283,0.10080988,0.00080051384,0.0010639715,0.0001165665],"about_ca_topic_score_codex":0.0060046776,"about_ca_topic_score_gemma":0.00794788,"teacher_disagreement_score":0.35277113,"about_ca_system_score_codex":0.00047714246,"about_ca_system_score_gemma":0.0014751898,"threshold_uncertainty_score":0.99781877},"labels":[],"label_agreement":null},{"id":"W3213350334","doi":"10.1158/1538-7445.panca21-po-056","title":"Abstract PO-056: Insulin receptor signaling in pancreatic acinar cells contributes to pancreatic cancer development","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hyperinsulinemia; Endocrinology; Internal medicine; Pancreatic Intraepithelial Neoplasia; Pancreas; Pancreatic cancer; Insulin; Insulin receptor; Acinar cell; Biology; Medicine; Cancer; Insulin resistance","score_opus":0.09595841723444971,"score_gpt":0.4263724117532333,"score_spread":0.3304139945187836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213350334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97825277,0.011363301,0.000067663444,0.006056989,0.0002214608,0.001599253,0.000048942587,0.000047873862,0.002341721],"genre_scores_gemma":[0.9798542,0.005248761,0.0023469802,0.0007500524,0.00036224735,0.0021725267,0.00005534775,0.000071094735,0.00913875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949933,0.00045838344,0.0008229018,0.0008651466,0.0012919435,0.0015682966],"domain_scores_gemma":[0.99604756,0.0012783858,0.000081034,0.00059636973,0.0013207054,0.00067592156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026830097,0.00031473287,0.0011595433,0.0006894194,0.0003126337,0.000090552516,0.0003424254,0.0002944364,0.0055930465],"category_scores_gemma":[0.0013846349,0.00028302707,0.0001000239,0.0020824529,0.00025041474,0.00010142419,0.00028237965,0.0012801115,0.000713791],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001491254,0.0005734947,0.29293114,0.0009952933,0.00047880883,0.0007220428,0.0020940707,0.00008193789,0.6757629,0.0000819311,0.009866699,0.014920462],"study_design_scores_gemma":[0.005147677,0.000336843,0.31601232,0.0044616046,0.00012919636,0.000015341098,0.0022745302,0.00008232393,0.6266273,0.00018532453,0.044254623,0.0004728735],"about_ca_topic_score_codex":0.0025209014,"about_ca_topic_score_gemma":0.0013541683,"teacher_disagreement_score":0.04913554,"about_ca_system_score_codex":0.00266631,"about_ca_system_score_gemma":0.007426291,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W3213536910","doi":"10.1158/1538-7445.panca21-pr-010","title":"Abstract PR-010: Collateral amplification of the <i>KRAS</i> linked gene <i>PTHLH</i> governs pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"KRAS; Metastasis; Cancer research; Biology; Cancer; Medicine; Internal medicine; Colorectal cancer","score_opus":0.12013840211400073,"score_gpt":0.4232188595747039,"score_spread":0.30308045746070317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213536910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690739,0.019006884,0.0000075188927,0.010351951,0.00007674547,0.00097585696,0.00016298491,0.000012278071,0.00033189481],"genre_scores_gemma":[0.9863427,0.011342406,0.00017145845,0.00075744156,0.00008201878,0.00024106597,0.000018258772,0.000022285647,0.0010223227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980493,0.0002613235,0.00032798699,0.00041463034,0.0005494817,0.00039726004],"domain_scores_gemma":[0.9985114,0.00027239468,0.00010365089,0.00044376872,0.0003562755,0.0003125485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054799486,0.00014468552,0.0003865181,0.000045455014,0.00020581068,0.00003651736,0.00008396778,0.00009508412,0.00016299119],"category_scores_gemma":[0.0001539317,0.000097015385,0.000058095284,0.0005025032,0.00022179777,0.000067593624,0.000077409946,0.00037230444,0.0000021803041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085719133,0.00029825178,0.6435963,0.0018339081,0.0005040883,0.000021365613,0.0010026568,0.0000027940073,0.31996474,0.00018596005,0.0017310735,0.030001683],"study_design_scores_gemma":[0.0023909374,0.00012429238,0.91806847,0.00034401953,0.00022937023,0.000024467703,0.00009632671,0.000013861966,0.07583697,0.0013139229,0.0014546491,0.000102723934],"about_ca_topic_score_codex":0.014834545,"about_ca_topic_score_gemma":0.0010998086,"teacher_disagreement_score":0.27447215,"about_ca_system_score_codex":0.00023718641,"about_ca_system_score_gemma":0.0013492048,"threshold_uncertainty_score":0.99172574},"labels":[],"label_agreement":null},{"id":"W3213921154","doi":"10.1158/1538-7445.panca21-po-039","title":"Abstract PO-039: Antiproliferative activity of inhibitors of RAD51, singly and in combination with chemotherapy drugs, against pancreatic cancer cell lines","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ontario Institute for Cancer Research; London Health Sciences Centre","funders":"","keywords":"Pancreatic cancer; RAD51; Cancer research; Cancer; Cancer cell; Chemotherapy; Cytotoxicity; Pharmacology; Chemistry; Homologous recombination; Medicine; Biology; Biochemistry; In vitro; Internal medicine; DNA","score_opus":0.02663913916150233,"score_gpt":0.34038804274839124,"score_spread":0.3137489035868889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213921154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363667,0.0053920103,0.000039045142,0.00029339932,0.000049114195,0.00024966476,0.000042332777,0.000002237259,0.00029552146],"genre_scores_gemma":[0.98605406,0.013489327,0.000077590186,0.000054978438,0.00007335637,0.00006096458,0.000018024833,0.000021451322,0.00015024673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901277,0.000079142665,0.00016198309,0.00028551667,0.00024951674,0.0002110934],"domain_scores_gemma":[0.99923545,0.00003024899,0.000094306226,0.00019034717,0.0003991238,0.000050510298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027146348,0.00011012321,0.00021399285,0.00005783269,0.000042638483,0.000015318868,0.000079951154,0.00009323893,0.00002191621],"category_scores_gemma":[0.000013463637,0.00009866353,0.00003241587,0.00022331567,0.00014902816,0.000009337809,0.0000492836,0.00013790271,9.730766e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006150934,0.00018679409,0.0023999948,0.00018918548,0.000052092128,0.0000024556655,0.00042034758,0.000054213677,0.97977716,0.000020065878,0.000029527891,0.016253056],"study_design_scores_gemma":[0.0015828559,0.00024294062,0.005539625,0.00017229764,0.0000073704273,6.3141715e-7,0.0003741203,0.000042309992,0.9914334,0.000053640895,0.00044642776,0.00010437347],"about_ca_topic_score_codex":0.000938248,"about_ca_topic_score_gemma":0.0013964545,"teacher_disagreement_score":0.016148683,"about_ca_system_score_codex":0.00007187544,"about_ca_system_score_gemma":0.0005622402,"threshold_uncertainty_score":0.4023382},"labels":[],"label_agreement":null},{"id":"W3214083702","doi":"10.1158/0008-5472.can-21-3360","title":"HER3 Is an Actionable Target in Advanced Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Wellcome Trust Centre for Mitochondrial Research; Daiichi Sankyo Company; Imperial Experimental Cancer Medicine Centre; Stand Up To Cancer; National Institute for Health and Care Research; Prostate Cancer UK; Mark Foundation For Cancer Research; National Institutes of Health; Prostate Cancer Foundation; Cancer Research UK; Academy of Medical Sciences; Wellcome Trust; Chordoma Foundation","keywords":"Prostate cancer; Prostate; Cancer; PCA3; ErbB; Antibody; Immunotherapy","score_opus":0.15372566243138425,"score_gpt":0.5247178831692222,"score_spread":0.37099222073783794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214083702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560919,0.012336384,0.000007075186,0.021463271,0.00039781045,0.001249143,0.00014314508,0.0000741915,0.008237113],"genre_scores_gemma":[0.8896722,0.014862399,0.00095762353,0.0016658636,0.0008890477,0.003664875,0.00008493955,0.00016206644,0.08804095],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99487096,0.00040143487,0.00037675814,0.0009866032,0.0018995142,0.0014647457],"domain_scores_gemma":[0.9967391,0.0001336782,0.000042027845,0.00090603577,0.0015755888,0.000603588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014027142,0.0002145026,0.00044200377,0.00044420833,0.00022464294,0.000105370505,0.00032280275,0.00017857576,0.019092312],"category_scores_gemma":[0.00034156404,0.00020965407,0.00008198742,0.0024447853,0.00027720496,0.00035873163,0.00023596098,0.0016965041,0.00020809381],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00295891,0.001084365,0.2759699,0.0019109822,0.00019192684,0.00216361,0.0055766627,0.00092242257,0.4405973,0.00034391994,0.116266795,0.15201324],"study_design_scores_gemma":[0.0037945705,0.0004672678,0.03423371,0.0009882633,0.00001253871,0.00003780718,0.0023757287,0.000540673,0.38592523,0.0012519143,0.5699959,0.0003764109],"about_ca_topic_score_codex":0.0051440336,"about_ca_topic_score_gemma":0.00389355,"teacher_disagreement_score":0.45372906,"about_ca_system_score_codex":0.002379015,"about_ca_system_score_gemma":0.0066741966,"threshold_uncertainty_score":0.99895704},"labels":[],"label_agreement":null},{"id":"W3214094257","doi":"10.1158/1538-7445.am2014-2998","title":"Abstract 2998: Akt-activated endothelium constitute the niche for residual disease and resistance to bevacizumab in ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Bevacizumab; Medicine; Ovarian cancer; Minimal residual disease; Cancer research; Cancer; Protein kinase B; Vascular endothelial growth factor; Oncology; Internal medicine; Immunology; Bone marrow; Biology; Chemotherapy; Signal transduction; VEGF receptors; Cell biology","score_opus":0.04881782900273999,"score_gpt":0.3892126993242034,"score_spread":0.34039487032146337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214094257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986961,0.0019428483,0.00012368958,0.007740746,0.00013508456,0.0014104389,0.0004566553,0.000010365485,0.0012191402],"genre_scores_gemma":[0.99411374,0.00052350643,0.0000985318,0.00028244263,0.0004896176,0.0014379236,0.000046079913,0.000044130335,0.0029640477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974614,0.00028037673,0.00023644938,0.0006882946,0.00050689356,0.0008266225],"domain_scores_gemma":[0.9982858,0.00025799847,0.000042892727,0.0006611113,0.0003937898,0.00035845715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014154352,0.0001856862,0.00019119214,0.00014554476,0.00026543805,0.00011509924,0.00054483576,0.00013284263,0.00010715125],"category_scores_gemma":[0.0013569981,0.00014581882,0.000050117345,0.00031386744,0.0004306594,0.000010011925,0.0002986726,0.00042004185,0.000010032429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027976371,0.00004704647,0.008085903,0.00014782425,0.00005642646,0.000007015924,0.00011756649,0.000052300922,0.9632443,0.0006570566,0.022308946,0.0024779448],"study_design_scores_gemma":[0.002122254,0.00018840223,0.070538566,0.00017758699,0.000012357265,0.0000011983929,0.00014808316,0.000019104746,0.6773419,0.00071928237,0.2483695,0.00036180354],"about_ca_topic_score_codex":0.0015714484,"about_ca_topic_score_gemma":0.009433689,"teacher_disagreement_score":0.28590247,"about_ca_system_score_codex":0.00017958925,"about_ca_system_score_gemma":0.0009886121,"threshold_uncertainty_score":0.5946319},"labels":[],"label_agreement":null},{"id":"W3215256792","doi":"10.1158/0008-5472.can-21-1903","title":"Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas; World Health Organization","keywords":"Lung cancer; Medicine; Cancer; Oncology; Haematopoiesis; Lung; Internal medicine; Cancer research; Biology; Genetics; Stem cell","score_opus":0.033512044909596514,"score_gpt":0.3795939166029421,"score_spread":0.3460818716933456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215256792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917348,0.0030431286,0.000019595791,0.0022556859,0.0000998304,0.0014105357,0.0009732451,0.000061372935,0.00040178935],"genre_scores_gemma":[0.9928971,0.0010811214,0.00007291786,0.00013756615,0.00016195235,0.0015685316,0.00032880987,0.00012500251,0.0036269808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942402,0.00054510124,0.0003911389,0.0008713854,0.0025791468,0.0013729836],"domain_scores_gemma":[0.9951517,0.0006279098,0.0001802654,0.00057962537,0.0029621422,0.0004983736],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067525695,0.00033676127,0.00066283194,0.0005677654,0.00044979126,0.00010491797,0.00030534304,0.00022912861,0.0026648042],"category_scores_gemma":[0.0009021344,0.0002511398,0.00008686141,0.0033068126,0.00044172787,0.00025119339,0.00020607906,0.0021060256,0.000008185795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008650921,0.00033296872,0.98586035,0.00031452844,0.0008359165,0.00026253643,0.001385908,0.0007906483,0.00023244576,0.00001402505,0.008679677,0.00042589166],"study_design_scores_gemma":[0.0064705084,0.00017148751,0.98416257,0.0020171134,0.0001979328,0.0000024573105,0.0012454569,0.0012336733,0.0037659365,0.000010446699,0.00039363885,0.00032878297],"about_ca_topic_score_codex":0.017925082,"about_ca_topic_score_gemma":0.029692475,"teacher_disagreement_score":0.011767392,"about_ca_system_score_codex":0.0074817445,"about_ca_system_score_gemma":0.0070490185,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W3215602595","doi":"10.1158/1538-7445.am2019-1011","title":"Abstract 1011: Prolactin-induced EDD E3 ubiquitin ligase regulates pro/anti-apoptotic gene expression, and stimulates TORC1 signaling and drug resistance in breast cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; Ubiquitin ligase; Apoptosis; Cell cycle; Cancer cell; Transfection; Cancer research; Cell biology; Molecular biology; Ubiquitin; Cancer; Cell culture; Gene; Biochemistry","score_opus":0.02785394132044355,"score_gpt":0.3190318135144298,"score_spread":0.2911778721939862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215602595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068964,0.0073755123,0.0000015419591,0.0005281729,0.00009625721,0.0010234569,0.00008683388,0.000017015936,0.0001815457],"genre_scores_gemma":[0.99662507,0.0013159906,0.0001942632,0.00006886606,0.00029197955,0.00029249288,0.000021427455,0.000055454926,0.0011344707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975892,0.00019562652,0.00031728004,0.0008440662,0.0003586354,0.0006952306],"domain_scores_gemma":[0.9988898,0.000094366704,0.00010731067,0.00041324212,0.00027026556,0.0002249945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010023607,0.00025744585,0.00029415175,0.00013173274,0.00017397446,0.0001236612,0.00025069437,0.00020802439,0.00019702195],"category_scores_gemma":[0.000054959113,0.0002342207,0.00004324161,0.00021079653,0.00015194506,0.000026010941,0.00026460786,0.00044875327,0.000009996396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006107706,0.000051129813,0.0076612593,0.00043961374,0.000023770266,0.00001193028,0.00036520374,0.00009833794,0.98947436,0.000007082165,0.00051195064,0.0007446201],"study_design_scores_gemma":[0.0009626005,0.00005520142,0.012231408,0.0005618529,0.000006451793,0.000005286023,0.0001570218,0.00003651571,0.9850111,0.00010991409,0.00056473253,0.00029788524],"about_ca_topic_score_codex":0.0003412777,"about_ca_topic_score_gemma":0.00020614616,"teacher_disagreement_score":0.006059522,"about_ca_system_score_codex":0.000077574114,"about_ca_system_score_gemma":0.000314616,"threshold_uncertainty_score":0.95512426},"labels":[],"label_agreement":null},{"id":"W4205712587","doi":"10.1158/1538-7445.sabcs20-ot-18-01","title":"Abstract OT-18-01: The metastatic breast cancer project: Generating the clinical and genomic landscape of metastatic breast cancer through patient-partnered research","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Biobank; Cancer; Internal medicine; Oncology; Medical record; Exome sequencing; Family medicine; Bioinformatics; Biology; Genetics; Gene","score_opus":0.16634082187777954,"score_gpt":0.46644219581220303,"score_spread":0.3001013739344235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205712587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484744,0.042566128,0.000018535686,0.0053033577,0.00034444095,0.00093937153,0.0019466426,0.0000066082102,0.00040051728],"genre_scores_gemma":[0.9568063,0.040147442,0.00020099623,0.0004929702,0.0009891484,0.00089444354,0.0000671161,0.00006899435,0.0003325704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956643,0.0010210723,0.0007107259,0.00084542215,0.000846519,0.00091198424],"domain_scores_gemma":[0.9966599,0.0006550443,0.00020143202,0.0009235604,0.0013969884,0.00016308503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025767935,0.0002674153,0.00042724772,0.000084966545,0.00067288795,0.00021948399,0.0006046915,0.00012378549,0.0005301198],"category_scores_gemma":[0.00038593626,0.00017470807,0.00017466077,0.0006827933,0.001161816,0.000018390427,0.0008052432,0.00089469313,0.000006593319],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019407494,0.0008658655,0.045883637,0.0009439949,0.0024058789,0.00012430946,0.0034143075,0.00359107,0.67724746,0.0007157354,0.15390827,0.10895871],"study_design_scores_gemma":[0.014867819,0.0019749997,0.32758358,0.0020771772,0.0012882823,0.0010014278,0.032621462,0.004614091,0.2911929,0.0028129537,0.31670904,0.0032562972],"about_ca_topic_score_codex":0.0079188235,"about_ca_topic_score_gemma":0.0075897938,"teacher_disagreement_score":0.38605458,"about_ca_system_score_codex":0.00011666453,"about_ca_system_score_gemma":0.0036494178,"threshold_uncertainty_score":0.9986875},"labels":[],"label_agreement":null},{"id":"W4207082851","doi":"10.1158/0008-5472.can-21-0218","title":"Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Laboratoire d'Excellence EpiGenMed; European Research Council; Institut National Du Cancer; Institut Universitaire de France; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; European Commission; Agence Nationale de la Recherche; Centre National de la Recherche Scientifique; CNIB","keywords":"Iron homeostasis; Lymphoma; Homeostasis; Diffuse large B-cell lymphoma; Cell; Tumor cells","score_opus":0.026880388551431704,"score_gpt":0.32122336189947137,"score_spread":0.29434297334803966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207082851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981581,0.013587216,0.000038978564,0.0008446395,0.00009343718,0.00062815053,0.00004772046,0.00003093556,0.0031479276],"genre_scores_gemma":[0.9949544,0.00069480843,0.00011992124,0.00026601195,0.0001298613,0.00052201864,0.00007263508,0.000054234635,0.0031861023],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724984,0.00030602302,0.00021037926,0.00044320239,0.0009245533,0.00086600374],"domain_scores_gemma":[0.9992396,0.0000719168,0.00004078827,0.00037837654,0.0000785199,0.00019077201],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011596716,0.00014717708,0.00027347598,0.00043680766,0.00035694163,0.00002513574,0.00022795025,0.000046516725,0.0016998878],"category_scores_gemma":[0.00004611193,0.00012949081,0.000047216523,0.0009610697,0.00010952613,0.00007341521,0.00027809455,0.0005433697,0.0000454012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013373778,0.04028561,0.4974101,0.0041338783,0.00009911314,0.0038971016,0.025138592,0.0016290554,0.250776,0.0022436513,0.08501094,0.07600219],"study_design_scores_gemma":[0.14845113,0.0021070174,0.04768212,0.00019994284,0.00014670266,0.000029557095,0.059703577,0.0008532884,0.043258082,0.00019688567,0.6959868,0.001384899],"about_ca_topic_score_codex":0.0015852266,"about_ca_topic_score_gemma":0.00011252634,"teacher_disagreement_score":0.61097586,"about_ca_system_score_codex":0.0004744134,"about_ca_system_score_gemma":0.0005914922,"threshold_uncertainty_score":0.9992127},"labels":[],"label_agreement":null},{"id":"W4214489112","doi":"10.1158/0008-5472.can-06-0561","title":"Patterns of Known and Novel Small RNAs in Human Cervical Cancer","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"microRNA; Cervical cancer; Cancer; Biology; Cervix; Cervical carcinoma; Computational biology; Cancer research; Bioinformatics; Gene; Genetics","score_opus":0.05994981475423369,"score_gpt":0.402283929519764,"score_spread":0.34233411476553033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214489112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888325,0.0034000329,0.006282716,0.00022611364,0.000086491214,0.00041667646,0.00006191942,0.000006012132,0.00068756676],"genre_scores_gemma":[0.99712056,0.0012785757,0.00009192032,0.00007165119,0.00026614068,0.00012689104,0.000025214402,0.000043458258,0.00097560725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997855,0.00009860848,0.0002949936,0.00052642985,0.00048801818,0.0007369291],"domain_scores_gemma":[0.99897367,0.000037232472,0.000047002835,0.0003972242,0.00033784503,0.00020700306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013433355,0.00014556937,0.00019761772,0.00030247666,0.00008886949,0.000024469255,0.0003559519,0.0002628955,0.00021572542],"category_scores_gemma":[0.000084702944,0.00014845049,0.000056146848,0.0003798591,0.00016830629,0.0000038886024,0.000442044,0.0005448422,0.000001948816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020886541,0.00009252058,0.004543406,0.000120364406,0.00004019399,0.000015142674,0.000084765205,0.000058320107,0.98508096,0.0005285867,0.00018050698,0.009046357],"study_design_scores_gemma":[0.0012850531,0.00027763896,0.014770642,0.0001370095,0.0000054225247,0.000005728679,0.00013918766,0.000030729556,0.97137386,0.00008908349,0.011713088,0.00017258465],"about_ca_topic_score_codex":0.006954785,"about_ca_topic_score_gemma":0.026748743,"teacher_disagreement_score":0.019793957,"about_ca_system_score_codex":0.00016071243,"about_ca_system_score_gemma":0.00033471698,"threshold_uncertainty_score":0.999658},"labels":[],"label_agreement":null},{"id":"W4220665593","doi":"10.1158/1538-7445.sabcs21-p4-11-08","title":"Abstract P4-11-08: Impact of ovarian stimulation for fertility preservation in young women with breast cancer: Updated survival and pregnancy outcomes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pacific Centre for Reproductive Medicine; Sunnybrook Health Science Centre; Credit Valley Hospital; William Osler Health System; Trillium Health Centre; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Fertility preservation; Breast cancer; Pregnancy; Cohort; Internal medicine; Proportional hazards model; Gynecology; Cancer; Fertility; Oncology; Obstetrics; Population","score_opus":0.08721699922186664,"score_gpt":0.42314899177719706,"score_spread":0.3359319925553304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220665593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967155,0.0003787505,0.000013733317,0.0007583589,0.000059077393,0.0015282587,0.00046282518,0.000013362236,0.000070167844],"genre_scores_gemma":[0.99888235,0.000028273482,0.000016431823,0.0000049397886,0.000023776069,0.0007698427,0.00009058663,0.000013449273,0.00017036051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983791,0.00022123627,0.00025190576,0.00042338794,0.0003616736,0.0003626959],"domain_scores_gemma":[0.9988884,0.00013061556,0.00008004331,0.0003329218,0.00048070142,0.000087327375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015473552,0.000107811094,0.00031841936,0.00014667599,0.00015674737,0.000009051896,0.000101002224,0.000060048733,0.0006084443],"category_scores_gemma":[0.00015858251,0.00007924753,0.000034097888,0.00042245333,0.00019011038,0.00017045492,0.0000822162,0.00032879502,2.1118316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020083621,0.0002248767,0.96454,0.00018414551,0.000116476345,0.0000021645549,0.0007261547,0.0004197274,0.011250221,0.000012769339,0.000029993356,0.0024098367],"study_design_scores_gemma":[0.0025364528,0.00048735618,0.99551713,0.00007179157,0.000011544166,0.0000015065106,0.00024697455,0.00033731438,0.000490126,0.00021404268,0.000014220883,0.0000715369],"about_ca_topic_score_codex":0.013915946,"about_ca_topic_score_gemma":0.0018072175,"teacher_disagreement_score":0.03097712,"about_ca_system_score_codex":0.0009245099,"about_ca_system_score_gemma":0.0006406745,"threshold_uncertainty_score":0.99265045},"labels":[],"label_agreement":null},{"id":"W4220673029","doi":"10.1158/1538-7445.sabcs21-pd14-08","title":"Abstract PD14-08: Effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: Individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Lobular carcinoma; Ductal carcinoma; Invasive lobular carcinoma; Oncology; Internal medicine; Aromatase; Cancer; Selective estrogen receptor modulator; Gynecology; Pathology; Invasive ductal carcinoma","score_opus":0.06216226501604589,"score_gpt":0.33503667363920847,"score_spread":0.2728744086231626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220673029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936641,0.0035468936,0.0000020799343,0.000018872206,0.000039412927,0.000632829,0.002070065,0.0000035532103,0.000022186814],"genre_scores_gemma":[0.9986601,0.00004625304,0.00004658963,0.000006823139,0.000012581788,0.00050521275,0.00069284695,0.000022770557,0.0000068087047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99722946,0.000643536,0.00026839031,0.00062541594,0.0005688011,0.0006644164],"domain_scores_gemma":[0.99879414,0.000094855524,0.000118881064,0.00064772286,0.000101345904,0.00024304667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001220117,0.00018406143,0.0006287184,0.00033846239,0.00009207401,0.000014030391,0.0003822736,0.00007877306,0.00007826112],"category_scores_gemma":[0.00004479075,0.00014512964,0.00005379885,0.00087835256,0.00031100304,0.000011623113,0.00076983473,0.00035813433,3.8146428e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04996701,0.0010034485,0.08090464,0.00042740008,0.03503935,0.00054079527,0.0073898104,0.018930873,0.8047052,0.0000085017755,0.00032405567,0.00075888174],"study_design_scores_gemma":[0.009821401,0.015436256,0.7032386,0.0000373395,0.00835966,0.000032200343,0.009555465,0.00007610948,0.25111172,0.000008723865,0.0014962809,0.00082623673],"about_ca_topic_score_codex":0.0012622433,"about_ca_topic_score_gemma":0.00020091202,"teacher_disagreement_score":0.62233394,"about_ca_system_score_codex":0.00029408495,"about_ca_system_score_gemma":0.0004179778,"threshold_uncertainty_score":0.5918215},"labels":[],"label_agreement":null},{"id":"W4220673086","doi":"10.1158/1538-7445.sabcs21-p5-13-25","title":"Abstract P5-13-25: <i>PIK3CA</i> registry: A noninterventional, descriptive, retrospective cohort study of <i>PIK3CA</i> mutations in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Population; Metastatic breast cancer; Cohort; Clinical endpoint; Clinical trial; Breast cancer; Cancer; Gynecology; Estrogen receptor","score_opus":0.028842267968597714,"score_gpt":0.3440795251232873,"score_spread":0.3152372571546896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220673086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855511,0.0007611051,0.00002077846,0.0007931713,0.00025692998,0.005734753,0.0061317375,0.00008975068,0.0006606482],"genre_scores_gemma":[0.991293,0.00016220959,0.00021762853,0.00009857456,0.00019813569,0.0065817437,0.0004625145,0.0001893292,0.00079684315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922314,0.0007936625,0.0010743155,0.0015525649,0.003147449,0.0012006034],"domain_scores_gemma":[0.99441594,0.00031742605,0.00076732354,0.0008067778,0.0033012708,0.0003912734],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092069275,0.0006291747,0.0012674776,0.0007672325,0.000933039,0.000057523994,0.00063733547,0.00013647048,0.003335125],"category_scores_gemma":[0.00020190897,0.0006034528,0.0002192152,0.002565391,0.0010476485,0.00072876015,0.00041377125,0.0022928312,0.000013624164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015399027,0.005535221,0.94737124,0.00017930756,0.0013458708,0.000058664533,0.008134374,0.00042688698,0.016899452,0.00009393803,0.0014548094,0.003101175],"study_design_scores_gemma":[0.014908497,0.0045581725,0.966324,0.0006053681,0.00010287579,0.000010526839,0.009603992,0.000004907634,0.002938427,0.000143193,0.00024134803,0.00055873644],"about_ca_topic_score_codex":0.016736425,"about_ca_topic_score_gemma":0.0029799899,"teacher_disagreement_score":0.018952683,"about_ca_system_score_codex":0.0072859,"about_ca_system_score_gemma":0.0010757627,"threshold_uncertainty_score":0.99964166},"labels":[],"label_agreement":null},{"id":"W4220678222","doi":"10.1158/1538-7445.sabcs21-p3-19-11","title":"Abstract P3-19-11: Long-term outcomes of primary and secondary angiosarcomas of the breast: A 20-year single-center experience","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Mastectomy; Angiosarcoma; Sarcoma; Single Center; Population; Primary tumor; Cancer registry; Cancer; Surgery; Oncology; Internal medicine; Metastasis; Pathology","score_opus":0.06934855285491447,"score_gpt":0.35627242545633026,"score_spread":0.2869238726014158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220678222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935992,0.0027829364,0.0000016878466,0.0017493211,0.00010152835,0.000494281,0.00015787373,0.000010877679,0.0011023164],"genre_scores_gemma":[0.99848944,0.00006676394,0.000028407905,0.00020640688,0.00005742368,0.000106114014,0.00001567254,0.000025309013,0.0010044908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979668,0.00013422247,0.00027915265,0.00028598096,0.00097366725,0.00036012576],"domain_scores_gemma":[0.99901414,0.00009735549,0.000089729925,0.00051076664,0.00014589376,0.00014210404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005209296,0.00011929306,0.00035032965,0.00015786255,0.00019816661,0.000014418163,0.0003202779,0.000036596546,0.00129586],"category_scores_gemma":[0.000042658918,0.00008443058,0.0002025973,0.00038099434,0.00046781712,0.00007038715,0.0006001456,0.0004453703,0.0000014792146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019929855,0.00040455037,0.9245242,0.00039901285,0.00008019042,0.000070858245,0.0011279305,0.0000014903641,0.06800977,0.00005611236,0.0011652343,0.003961335],"study_design_scores_gemma":[0.0017295264,0.00016960569,0.9887161,0.00015607516,0.000020343845,0.00022109327,0.0006455079,0.0000028125985,0.005728595,0.000020512416,0.002499634,0.00009016242],"about_ca_topic_score_codex":0.00029643564,"about_ca_topic_score_gemma":0.000061154184,"teacher_disagreement_score":0.064191915,"about_ca_system_score_codex":0.00019585146,"about_ca_system_score_gemma":0.00043089854,"threshold_uncertainty_score":0.9996171},"labels":[],"label_agreement":null},{"id":"W4220682552","doi":"10.1158/1538-7445.sabcs21-p1-18-11","title":"Abstract P1-18-11: Analysis of first-line (1L) patients (pts) with de novo disease vs late relapse and all pts with vs without prior chemotherapy (CT) in the MONALEESA-3 (ML-3) trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Internal medicine; Adjuvant; Population; Cancer; Breast cancer; Fulvestrant; Placebo; Oncology; Nuclear medicine; Tamoxifen; Pathology","score_opus":0.05174704060359159,"score_gpt":0.38079660490958755,"score_spread":0.32904956430599597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220682552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347466,0.0011166369,0.000023054927,0.0031730344,0.000032277905,0.0019052601,0.00020395491,0.000024197194,0.000046946265],"genre_scores_gemma":[0.9971157,0.00044438083,0.00014219909,0.00057193596,0.00011213668,0.001098766,0.00007083247,0.000070824906,0.00037323966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964775,0.00025239366,0.00038771244,0.0005960704,0.0016376218,0.0006486879],"domain_scores_gemma":[0.9982106,0.0003177456,0.00019517684,0.00070268725,0.00029379848,0.00028000545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011266944,0.000261609,0.00062955485,0.0005447016,0.0002498296,0.00003279768,0.0003730865,0.00003911704,0.00071687397],"category_scores_gemma":[0.00009446546,0.00017069589,0.00009939622,0.0018275278,0.0004504429,0.00013629312,0.000106844884,0.00078785187,8.807991e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2703381,0.0013411863,0.7063866,0.0002487299,0.0015075793,0.00027122852,0.00351819,0.0057936604,0.0004602605,0.000014694152,0.00012040442,0.009999352],"study_design_scores_gemma":[0.09035951,0.003570436,0.88486403,0.00034032806,0.00085185905,0.000017285927,0.000768327,0.00095181464,0.00032742816,0.00009314595,0.017498175,0.00035767345],"about_ca_topic_score_codex":0.0017360669,"about_ca_topic_score_gemma":0.003752914,"teacher_disagreement_score":0.1799786,"about_ca_system_score_codex":0.00073119707,"about_ca_system_score_gemma":0.0006848069,"threshold_uncertainty_score":0.7849267},"labels":[],"label_agreement":null},{"id":"W4220682758","doi":"10.1158/1538-7445.sabcs21-p3-17-02","title":"Abstract P3-17-02: Knowledge is power: Designing an educational program to support black breast cancer patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Outreach; Breast cancer; Medicine; Health care; Health equity; Family medicine; Cancer; Gerontology; Nursing; Public health; Internal medicine; Political science","score_opus":0.2011292490547806,"score_gpt":0.5115752495430823,"score_spread":0.31044600048830173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220682758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771804,0.00055135845,0.0000047647927,0.008797824,0.00039929553,0.0016602761,0.00047158182,0.000072462004,0.010862039],"genre_scores_gemma":[0.9890968,0.000060553026,0.00020659353,0.0015392081,0.00055535755,0.0024872208,0.00012944789,0.000053944445,0.0058708778],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9960943,0.00013539175,0.0003467391,0.0007027045,0.0017390953,0.0009817603],"domain_scores_gemma":[0.99741566,0.00008007112,0.00007130859,0.00044525607,0.0012413248,0.00074637146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001063011,0.000206234,0.00028331607,0.00035033713,0.0006090292,0.00010111082,0.0004946974,0.000070592854,0.029387703],"category_scores_gemma":[0.00006696405,0.00020584778,0.00009786042,0.0012159686,0.00017009245,0.0002525496,0.0003314827,0.0008956533,0.00024575702],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015530935,0.0015288183,0.22382075,0.00014808784,0.00011261981,0.000040771276,0.0058768303,0.00017431026,0.0037682706,0.000065167624,0.6247625,0.13814881],"study_design_scores_gemma":[0.0021909908,0.0047935895,0.7626985,0.00043091585,0.00005654631,0.000045973462,0.0032612681,0.00012317061,0.002427482,0.00013840006,0.2232437,0.00058950053],"about_ca_topic_score_codex":0.0026525385,"about_ca_topic_score_gemma":0.0003697409,"teacher_disagreement_score":0.5388777,"about_ca_system_score_codex":0.002090987,"about_ca_system_score_gemma":0.0037412925,"threshold_uncertainty_score":0.97149956},"labels":[],"label_agreement":null},{"id":"W4220683438","doi":"10.1158/1538-7445.sabcs21-p2-06-03","title":"Abstract P2-06-03: Obesity is associated with DNA damage in the breast epithelium of BRCA1 and BRCA2 mutation carriers: A role for estrogens &amp; strategies for prevention","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Aromatase; Breast cancer; Internal medicine; Endocrinology; Estrogen; Cancer research; Biology; DNA damage; Carcinogenesis; Estrogen receptor; Cancer; Medicine; DNA; Genetics","score_opus":0.03582186595310973,"score_gpt":0.3532125263163675,"score_spread":0.3173906603632578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220683438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958102,0.0011681794,0.00014246609,0.00023904826,0.00001487461,0.0008496962,0.0017201073,0.000003063672,0.00005236213],"genre_scores_gemma":[0.99805003,0.00009241992,0.00007106358,0.000041306754,0.00006576567,0.0007852505,0.0007595573,0.000014082114,0.000120509365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99902546,0.00013790838,0.00013236569,0.00024815765,0.0002300082,0.00022609727],"domain_scores_gemma":[0.9993345,0.00005188263,0.000065677996,0.0001827561,0.00031707913,0.000048105278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064037275,0.00007722373,0.00009607177,0.000058038353,0.0002161904,0.000039842493,0.00014564474,0.000050681712,0.000025819621],"category_scores_gemma":[0.00006666704,0.000068023124,0.00004912354,0.00014555204,0.00011965204,0.0000084968415,0.00004392225,0.00009027621,1.6914868e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030639488,0.001099418,0.032190274,0.0005959,0.00031087876,0.0000052032574,0.004273375,0.00086805626,0.94811356,0.00035656703,0.007180605,0.001942217],"study_design_scores_gemma":[0.01739425,0.00489862,0.58883107,0.00028470732,0.00028286016,0.000044854325,0.06335773,0.00058319577,0.27540556,0.030541478,0.017374055,0.0010016314],"about_ca_topic_score_codex":0.0002331999,"about_ca_topic_score_gemma":0.0015681707,"teacher_disagreement_score":0.67270803,"about_ca_system_score_codex":0.00005200702,"about_ca_system_score_gemma":0.00041726904,"threshold_uncertainty_score":0.27739024},"labels":[],"label_agreement":null},{"id":"W4220700535","doi":"10.1158/1538-7445.sabcs21-ot1-12-04","title":"Abstract OT1-12-04: A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP compared with ddAC-THP in patients with high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Pertuzumab; Breast cancer; Gastroenterology; Cancer","score_opus":0.03987498572126909,"score_gpt":0.36814914918136726,"score_spread":0.3282741634600982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220700535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851549,0.0007733487,0.000026848078,0.00043810823,0.00012669942,0.0035035661,0.009858081,0.000019816927,0.00009859849],"genre_scores_gemma":[0.9937263,0.00041749596,0.00014202726,0.00009277373,0.0001305086,0.004382243,0.0005910818,0.00013052793,0.00038701674],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99557227,0.0005403857,0.00054056244,0.0011748859,0.0011650628,0.0010068206],"domain_scores_gemma":[0.9980251,0.00012229812,0.00039372276,0.00070968014,0.00049761025,0.00025158946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005571374,0.0005307143,0.0008052069,0.00020576466,0.00049020344,0.00009699079,0.0008893397,0.00012444297,0.0004309928],"category_scores_gemma":[0.00002414169,0.00040322394,0.00007541997,0.0007385068,0.0004866423,0.000039291866,0.0004705379,0.00066117966,0.0000019613715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7353181,0.0131608145,0.18936071,0.00011171768,0.0023851157,0.00013932232,0.0018697431,0.0009900007,0.020624382,0.000009333533,0.0036135518,0.0324172],"study_design_scores_gemma":[0.49456543,0.025366113,0.44404083,0.00043726075,0.00023342772,0.000022939446,0.0011680848,0.000036706722,0.030416222,0.000018530725,0.0023888533,0.0013055988],"about_ca_topic_score_codex":0.07483371,"about_ca_topic_score_gemma":0.018968217,"teacher_disagreement_score":0.25468013,"about_ca_system_score_codex":0.0008713304,"about_ca_system_score_gemma":0.0015836816,"threshold_uncertainty_score":0.999842},"labels":[],"label_agreement":null},{"id":"W4220707985","doi":"10.1158/1538-7445.sabcs21-ot2-24-02","title":"Abstract OT2-24-02: ZEST: Randomized phase III study evaluating efficacy and safety of niraparib in patients with HER2-negative BRCA-mutated or triple-negative breast cancer with detectable circulating tumor DNA after definitive therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Triple-negative breast cancer; Cancer; Chemotherapy","score_opus":0.07882265798531476,"score_gpt":0.42161315977992964,"score_spread":0.3427905017946149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220707985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685384,0.0005420461,0.000013854159,0.00024408179,0.00008684002,0.0113097,0.00069192174,0.00004267858,0.00021506366],"genre_scores_gemma":[0.98930436,0.00015665512,0.00014871439,0.00018609726,0.000081399914,0.009876717,0.00003529802,0.00011395049,0.00009677728],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928717,0.0020028523,0.0009998573,0.00097106403,0.0023015563,0.000852972],"domain_scores_gemma":[0.9946084,0.0025580737,0.0005836718,0.00044333225,0.0015549298,0.00025160538],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003649599,0.00045663762,0.0014632705,0.00061112497,0.0005271944,0.00005542631,0.0002155239,0.0000693671,0.0032582541],"category_scores_gemma":[0.00044670366,0.00031855152,0.00009111521,0.0022127605,0.00085855764,0.00027071935,0.0001331201,0.0014341645,0.0000016173677],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9113379,0.0028707234,0.048938725,0.00012981507,0.0011551615,0.00017888536,0.02049387,0.0009535201,0.0034756272,0.0000028296656,0.000025886917,0.010437051],"study_design_scores_gemma":[0.716274,0.007749123,0.2569768,0.0013672394,0.00015073888,0.000025993537,0.007787316,0.00034151497,0.008844617,0.000050195194,0.0000070408646,0.00042535513],"about_ca_topic_score_codex":0.008186072,"about_ca_topic_score_gemma":0.0014097025,"teacher_disagreement_score":0.20803809,"about_ca_system_score_codex":0.0016579282,"about_ca_system_score_gemma":0.0024117937,"threshold_uncertainty_score":0.9999266},"labels":[],"label_agreement":null},{"id":"W4220713221","doi":"10.1158/1538-7445.sabcs21-p1-18-05","title":"Abstract P1-18-05: Early changes in circulating tumor DNA and its effect on clinical outcomes in patients with advanced breast cancer receiving the CDK4/6 inhibitor palbociclib: Genotyping results from POLARIS","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Medicine; Oncology; Internal medicine; Breast cancer; Cancer; Genotyping; Metastatic breast cancer; Genotype; Gene; Genetics; Biology","score_opus":0.06046124020476749,"score_gpt":0.3998349772114765,"score_spread":0.339373737006709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220713221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921611,0.0014765889,6.0232e-7,0.0032961548,0.0003592832,0.0019348514,0.000665445,0.000050170987,0.00005583217],"genre_scores_gemma":[0.9977231,0.00013875934,0.0000344267,0.00050365395,0.00039926582,0.0009936936,0.00003180456,0.000105771236,0.00006952062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99532586,0.0007404321,0.0006594141,0.0009912138,0.0013555248,0.00092754763],"domain_scores_gemma":[0.9965827,0.0021716654,0.0002728173,0.0005414151,0.00022010122,0.0002113023],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023696423,0.00033952316,0.00072859105,0.00038351014,0.00043688837,0.000058962887,0.00032352455,0.00009544671,0.00023428015],"category_scores_gemma":[0.0006541573,0.000242043,0.00007388831,0.00093952764,0.00022100232,0.00021924407,0.0003254549,0.0023392201,0.000004445982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013767566,0.00020293111,0.8821059,0.000084191575,0.00012273318,0.00009128808,0.002246563,0.0002912823,0.005285304,0.0000028289817,0.00002082438,0.09577862],"study_design_scores_gemma":[0.011523192,0.0011742722,0.9839232,0.001215735,0.000019110767,0.0000047295744,0.00055004406,0.00005768899,0.001022632,0.000019734372,0.00022320182,0.00026648145],"about_ca_topic_score_codex":0.0056204624,"about_ca_topic_score_gemma":0.003223131,"teacher_disagreement_score":0.10181731,"about_ca_system_score_codex":0.0013434072,"about_ca_system_score_gemma":0.0003938959,"threshold_uncertainty_score":0.99996245},"labels":[],"label_agreement":null},{"id":"W4220714022","doi":"10.1158/1538-7445.sabcs21-p5-17-05","title":"Abstract P5-17-05: A phase I/Ib study of inavolisib (GDC-0077) in combination with fulvestrant in patients (pts) with <i>PIK3CA</i>-mutated hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fulvestrant; Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Oncology; Cancer; Combination therapy; Phases of clinical research; Chemotherapy; Tamoxifen","score_opus":0.03702796251358815,"score_gpt":0.38047729758949195,"score_spread":0.3434493350759038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220714022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926511,0.00060325826,0.00001941563,0.00081497856,0.00007174717,0.0047997655,0.0008469396,0.000042886953,0.00014992824],"genre_scores_gemma":[0.995659,0.00014766061,0.00014114553,0.00009726762,0.000044124008,0.0034691775,0.00016343192,0.00012351717,0.00015465888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941124,0.0007491037,0.0007684721,0.0009339733,0.0024622544,0.000973835],"domain_scores_gemma":[0.9972701,0.00031571757,0.0003778552,0.00053869624,0.0012331728,0.00026444724],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011362222,0.00045414164,0.00094924355,0.0010049968,0.00024807532,0.00003679157,0.0003880574,0.00006600882,0.0009611892],"category_scores_gemma":[0.000053620966,0.00037575926,0.000057030084,0.0035524445,0.00052873336,0.00045411935,0.0001634622,0.0016587514,0.000003157633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28493676,0.079072446,0.37770993,0.0010185441,0.0026316673,0.0017298949,0.07713936,0.021250045,0.034089457,0.00006655589,0.0013787171,0.11897665],"study_design_scores_gemma":[0.11438126,0.022135062,0.83055985,0.001304154,0.00014751185,0.000044970966,0.025393203,0.00020568665,0.004892346,0.00007898236,0.00021443574,0.0006425073],"about_ca_topic_score_codex":0.02728062,"about_ca_topic_score_gemma":0.008312696,"teacher_disagreement_score":0.45284995,"about_ca_system_score_codex":0.003199042,"about_ca_system_score_gemma":0.0013262664,"threshold_uncertainty_score":0.9999521},"labels":[],"label_agreement":null},{"id":"W4220714882","doi":"10.1158/1538-7445.sabcs21-p4-07-04","title":"Abstract P4-07-04: Bc cancer ipsilateral breast tumor recurrence (BCC IBTR) nomogram","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Nomogram; Breast cancer; Oncology; Internal medicine; Lymphovascular invasion; Mastectomy; Radiation therapy; Population; Hormonal therapy; Breast-conserving surgery; Cancer; Ductal carcinoma; Cohort; Metastasis","score_opus":0.0477364499658457,"score_gpt":0.38294713065385544,"score_spread":0.33521068068800974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220714882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836837,0.009188464,0.00000393423,0.0028391609,0.00072991126,0.00050966366,0.001300635,0.000036512865,0.0017080404],"genre_scores_gemma":[0.99277794,0.0013835042,0.000035944744,0.00028057751,0.0008376817,0.0028130389,0.00015925075,0.000058415313,0.0016536141],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969579,0.00019109242,0.00026504853,0.00086334173,0.00076705375,0.0009555735],"domain_scores_gemma":[0.99874586,0.000040781422,0.00008935355,0.00059314613,0.00032579422,0.0002050396],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050779176,0.00027831792,0.0002613789,0.00012752843,0.0008121783,0.000071167844,0.000643425,0.000070499904,0.0029690117],"category_scores_gemma":[0.000034240613,0.00027095267,0.00013829177,0.00043231912,0.00033830552,0.0000120854265,0.0008800568,0.0006268102,0.00007883988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043105865,0.0013885939,0.27959204,0.00040399784,0.0013703787,0.0003614973,0.0014523633,0.0014876643,0.33242682,0.0001886578,0.20028095,0.17673646],"study_design_scores_gemma":[0.0035835402,0.0007267708,0.47035182,0.00020061519,0.0000806665,0.0002373952,0.0010384616,0.000036588008,0.07327444,0.00027608642,0.4488907,0.0013029354],"about_ca_topic_score_codex":0.008667873,"about_ca_topic_score_gemma":0.00120966,"teacher_disagreement_score":0.25915238,"about_ca_system_score_codex":0.0005325174,"about_ca_system_score_gemma":0.0007433869,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W4220719444","doi":"10.1158/1538-7445.sabcs21-pd2-05","title":"Abstract PD2-05: Genomic profiling of PAM50-based intrinsic subtypes in HR+/HER2- advanced breast cancer (ABC) across the MONALEESA (ML) studies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Indel; Medicine; Oncology; False discovery rate; Exact test; Internal medicine; Breast cancer; Logistic regression; Multiple comparisons problem; Gene; Cancer; Bioinformatics; Biology; Genetics; Single-nucleotide polymorphism; Genotype","score_opus":0.08569701664852465,"score_gpt":0.4448074994330611,"score_spread":0.35911048278453644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220719444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95300007,0.037911322,0.0000068423838,0.0064693093,0.0003743175,0.0015377263,0.0005626391,0.000054922966,0.00008287719],"genre_scores_gemma":[0.9931498,0.0022252933,0.00016886916,0.00041313746,0.00034805856,0.003189644,0.000020434316,0.00009932081,0.00038542334],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958366,0.00030613068,0.00062256295,0.00072449207,0.0013833888,0.0011268393],"domain_scores_gemma":[0.9974649,0.0005979681,0.00023677188,0.00077112287,0.0007773809,0.00015188698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018831263,0.00031669738,0.000697537,0.00031623908,0.00060500967,0.00002551111,0.0006301856,0.00007506697,0.0008368205],"category_scores_gemma":[0.00014890493,0.00024543586,0.00015139986,0.0014905118,0.00100097,0.00015911006,0.00048255504,0.0016083905,0.000008357244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018646857,0.0007125485,0.15225981,0.0019255385,0.00082042126,0.0002669705,0.008952126,0.047691315,0.46546304,0.00023641625,0.0005398096,0.30248514],"study_design_scores_gemma":[0.011876828,0.00080615876,0.79592156,0.0014814679,0.00009107736,0.000111049456,0.03592975,0.00034017573,0.13181771,0.0009759137,0.019809665,0.000838641],"about_ca_topic_score_codex":0.00230842,"about_ca_topic_score_gemma":0.0016357359,"teacher_disagreement_score":0.64366174,"about_ca_system_score_codex":0.0027164249,"about_ca_system_score_gemma":0.0017147613,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W4220729116","doi":"10.1158/1538-7445.sabcs21-ot2-11-05","title":"Abstract OT2-11-05: SERENA-6: A Phase III study to assess the efficacy and safety of AZD9833 (camizestrant) compared with aromatase inhibitors when given in combination with palbociclib or abemaciclib in patients with HR+/HER2- metastatic breast cancer with detectable <i>ESR1</i>m who have not experienced disease progression on first-line therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Metastatic breast cancer; Cancer; Oncology; Breast cancer; Aromatase inhibitor; Aromatase; Estrogen receptor; Fulvestrant; Cancer research","score_opus":0.061133145485971666,"score_gpt":0.4015729937799294,"score_spread":0.34043984829395774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220729116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884363,0.00023082654,0.00003718413,0.0015889762,0.000024928804,0.009077579,0.0005600829,0.000036888443,0.000007263597],"genre_scores_gemma":[0.9937757,0.000057829133,0.00014718756,0.00013528284,0.000030374598,0.005609354,0.000093116934,0.00010599001,0.000045120596],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950516,0.00049942045,0.0005761858,0.0009099012,0.002216613,0.000746262],"domain_scores_gemma":[0.99765974,0.00045736475,0.00031671376,0.0006908473,0.00050036557,0.00037497544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082944025,0.0004661326,0.0008528636,0.00045374307,0.0004850019,0.00007073532,0.00036243538,0.000031478863,0.00020961485],"category_scores_gemma":[0.00003473227,0.0002473764,0.000030246825,0.0014517849,0.00052689563,0.0003310262,0.00012837828,0.00074027356,3.7048088e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54406345,0.010533551,0.39535627,0.00031733577,0.00030577497,0.00036061916,0.018463567,0.010701611,0.000661135,0.0000026959356,0.000036978985,0.019196995],"study_design_scores_gemma":[0.14758043,0.019544438,0.8121471,0.003740319,0.0001020815,0.000019335579,0.012229669,0.00035232407,0.0035788005,0.000006714266,0.0001884736,0.0005103305],"about_ca_topic_score_codex":0.002906113,"about_ca_topic_score_gemma":0.009669812,"teacher_disagreement_score":0.4167908,"about_ca_system_score_codex":0.0008114482,"about_ca_system_score_gemma":0.00090971554,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W4220731244","doi":"10.1158/1538-7445.sabcs21-pd1-08","title":"Abstract PD1-08: <i>Esr1</i> mutant breast cancers show elevated basal cytokeratins and immune activation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Estrogen receptor alpha; Biology; Estrogen receptor; Cancer research; Progesterone receptor; Mutant; Chromatin; Molecular biology; Cell biology; Breast cancer; Cancer; Gene; Genetics","score_opus":0.019497404167717183,"score_gpt":0.30531783506479315,"score_spread":0.285820430897076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220731244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972045,0.00064970873,0.000028544602,0.00066311617,0.00011410072,0.00027528813,0.00035210594,0.000009415832,0.0007032548],"genre_scores_gemma":[0.99779236,0.00066659,0.000039169412,0.00014498494,0.0001609874,0.00022339619,0.00029478373,0.00003379728,0.0006439497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861205,0.000095618474,0.00018426978,0.0003719452,0.00034169652,0.00039443822],"domain_scores_gemma":[0.9993652,0.000020119525,0.0000641482,0.0002945027,0.00015750041,0.00009852111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004661583,0.00012582047,0.00012331846,0.00006529953,0.0004962167,0.000069574795,0.00024268145,0.000069930735,0.00034171145],"category_scores_gemma":[0.00002307344,0.00013361387,0.000040759187,0.00019459098,0.00012238885,0.000006403628,0.0003498758,0.00037038437,0.000003212854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018783666,0.000038699654,0.00039787724,0.00002694757,0.000046603174,0.0000047328094,0.00009177801,0.0012709992,0.99340767,0.000056211364,0.0017541167,0.0027165196],"study_design_scores_gemma":[0.002517665,0.0007887216,0.025796602,0.000050274906,0.00001776635,0.000062886524,0.0017836282,0.0034331493,0.91128397,0.00028495654,0.05329307,0.0006873273],"about_ca_topic_score_codex":0.0017713013,"about_ca_topic_score_gemma":0.00035571182,"teacher_disagreement_score":0.08212373,"about_ca_system_score_codex":0.0003028376,"about_ca_system_score_gemma":0.000574611,"threshold_uncertainty_score":0.54486156},"labels":[],"label_agreement":null},{"id":"W4220734028","doi":"10.1158/1538-7445.sabcs21-p1-18-25","title":"Abstract P1-18-25: Real-world quality of life (QoL) in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced breast cancer (ABC) treated with palbociclib: A patient-reported outcome (PRO) analysis from POLARIS","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Medicine; Cancer; Internal medicine; Oncology; Quality of life (healthcare); Breast cancer; Metastatic breast cancer; Stage (stratigraphy); Disease; Cohort; Gynecology","score_opus":0.06712141622283398,"score_gpt":0.3906830873880279,"score_spread":0.32356167116519396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220734028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560345,0.00063331967,0.000017524575,0.0008123421,0.00007794481,0.002866984,0.009542668,0.00012910223,0.00031664106],"genre_scores_gemma":[0.9952106,0.00017606924,0.00046799163,0.0001733592,0.00012576427,0.002051045,0.0012270261,0.00020131185,0.00036684689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99060214,0.0011835217,0.0018710833,0.0016840021,0.0032714228,0.0013878365],"domain_scores_gemma":[0.9935759,0.00074119243,0.0014899212,0.0011367622,0.0023564952,0.0006997338],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085691706,0.00076734973,0.0022197112,0.0017859284,0.0006172447,0.00005009765,0.000522652,0.00017861325,0.0073302994],"category_scores_gemma":[0.00024382953,0.0006276986,0.0003198264,0.007244298,0.00089251867,0.0005879827,0.00031161137,0.0020545486,0.0000064719497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039228592,0.0013823854,0.9304577,0.00012983801,0.00432208,0.00004100278,0.0033131444,0.00038705338,0.0130191455,0.00001592625,0.00011352882,0.007589565],"study_design_scores_gemma":[0.013796323,0.0015914767,0.97530836,0.00026895327,0.0003777777,0.0000010522392,0.0024678162,0.000009699407,0.0053387284,0.000025039113,0.00011639727,0.00069834996],"about_ca_topic_score_codex":0.20246415,"about_ca_topic_score_gemma":0.018567426,"teacher_disagreement_score":0.18389672,"about_ca_system_score_codex":0.0044170297,"about_ca_system_score_gemma":0.0012435153,"threshold_uncertainty_score":0.99961746},"labels":[],"label_agreement":null},{"id":"W4220741531","doi":"10.1158/1538-7445.sabcs21-p5-13-26","title":"Abstract P5-13-26: The future of HER2-positive breast cancer patients might be written in miRNAs: An exploratory analysis from the NeoALTTO study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Breast cancer; Internal medicine; microRNA; Pathological; Proportional hazards model; Multivariate analysis; Neoadjuvant therapy; Univariate analysis; Stage (stratigraphy); Cancer; Gene; Biology","score_opus":0.023749706163928207,"score_gpt":0.34116933187143206,"score_spread":0.31741962570750387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220741531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918855,0.004469857,0.0000011610252,0.0012172579,0.00010318069,0.00071621715,0.0015828139,0.0000043815107,0.000019658692],"genre_scores_gemma":[0.9980955,0.0002489489,0.0000021461688,0.00016525034,0.00035320726,0.00074408797,0.00032779397,0.00002705905,0.00003596753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746585,0.00088811154,0.0002423481,0.0004421284,0.00067275105,0.00028883986],"domain_scores_gemma":[0.99877113,0.000053539734,0.000107952954,0.0006410061,0.00034923115,0.0000771403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007218736,0.00013270337,0.00017192992,0.000104676954,0.00030023546,0.000033666725,0.0006442209,0.0000606809,0.00049933564],"category_scores_gemma":[0.000014908008,0.0000889519,0.00010348816,0.00081938994,0.0001441529,0.0000112666685,0.00036762585,0.00035314859,0.0000012623686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013692544,0.0015711791,0.7797058,0.000021007672,0.0013474277,0.00001399689,0.007317741,0.0034668674,0.18948878,0.0000044727485,0.008150076,0.00754337],"study_design_scores_gemma":[0.0006274197,0.00014143092,0.9796097,0.000010491787,0.000090720925,2.1558539e-7,0.009463606,0.000032235424,0.0075906473,0.000012146268,0.0023061521,0.00011520037],"about_ca_topic_score_codex":0.008496022,"about_ca_topic_score_gemma":0.026040882,"teacher_disagreement_score":0.1999039,"about_ca_system_score_codex":0.00020981478,"about_ca_system_score_gemma":0.0003279356,"threshold_uncertainty_score":0.9981065},"labels":[],"label_agreement":null},{"id":"W4220746904","doi":"10.1158/1538-7445.sabcs21-es8-4","title":"Abstract ES8-4: Axillary management in upfront surgery - staging, local control or both?","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Axilla; Breast cancer; Axillary Lymph Node Dissection; Lymphedema; Sentinel lymph node; Sentinel node; Mastectomy; Surgery; Stage (stratigraphy); Cancer; Internal medicine","score_opus":0.05041575626098258,"score_gpt":0.3701679831953249,"score_spread":0.3197522269343423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220746904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023206,0.01269699,0.00018459995,0.002408435,0.00044135377,0.00084419607,0.0002577148,0.000026575579,0.0029080492],"genre_scores_gemma":[0.9944895,0.0020131194,0.000019615753,0.00029898318,0.00015100217,0.0015499803,0.00006296546,0.000033094224,0.0013817657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979642,0.00018167321,0.00021414821,0.0004961927,0.00052998605,0.0006137759],"domain_scores_gemma":[0.99937135,0.00007339009,0.000041176907,0.00036676045,0.00006256083,0.000084787345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007980217,0.00015065978,0.00020878488,0.00017652429,0.0002702721,0.000023534729,0.00025943344,0.000044790773,0.0006670897],"category_scores_gemma":[0.000023178227,0.00013650356,0.000074680094,0.00028638064,0.00016997631,0.0000045688407,0.00045225854,0.00027899505,0.000011862779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0126693295,0.0016124784,0.2866613,0.00059265003,0.0022890647,0.0028262432,0.0007853782,0.008656544,0.020206297,0.00025750697,0.34962156,0.31382164],"study_design_scores_gemma":[0.005472922,0.00036237197,0.43582007,0.00009892054,0.00004524831,0.000028408584,0.004687024,0.00008284934,0.008131044,0.00015383626,0.54440624,0.0007110644],"about_ca_topic_score_codex":0.0014493427,"about_ca_topic_score_gemma":0.0005868125,"teacher_disagreement_score":0.3131106,"about_ca_system_score_codex":0.0005197722,"about_ca_system_score_gemma":0.00033099315,"threshold_uncertainty_score":0.7304165},"labels":[],"label_agreement":null},{"id":"W4220749248","doi":"10.1158/1538-7445.sabcs21-ot1-01-01","title":"Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Lakeridge Health; Markham Stouffville Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Radiation therapy; Clinical endpoint; Breast cancer; Quality of life (healthcare); Cancer; Oncology; Clinical trial; Internal medicine","score_opus":0.03259851394639791,"score_gpt":0.34762006522641514,"score_spread":0.31502155128001724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220749248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927502,0.0030250482,0.0000028651139,0.0010272628,0.00011583088,0.0027236242,0.00026899658,0.0000060073376,0.00008016283],"genre_scores_gemma":[0.9953078,0.00071497745,0.000046849822,0.00007914379,0.00021457936,0.003444907,0.0000345221,0.000037464157,0.000119776254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975287,0.00063198473,0.00037474354,0.00040824423,0.0006323,0.0004240849],"domain_scores_gemma":[0.99895,0.00029904107,0.00021706702,0.00032704975,0.00013413625,0.0000727229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00129203,0.00019306196,0.0004615294,0.00011432122,0.0002562969,0.00003490214,0.00025023782,0.000040147293,0.00019692199],"category_scores_gemma":[0.0001480524,0.000129017,0.00007492975,0.0003158437,0.0004958881,0.000012134329,0.00021792478,0.00037313125,2.524345e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.955741,0.00032443076,0.029744772,0.00010786776,0.0006104228,0.000005579089,0.0018983672,0.00027407016,0.0059365947,0.000023368522,0.0004153127,0.0049182205],"study_design_scores_gemma":[0.93393475,0.00097584125,0.060902745,0.00011990121,0.00005398343,0.00000305305,0.00049192033,0.000029542682,0.0023691747,0.000029941873,0.0008607448,0.0002283941],"about_ca_topic_score_codex":0.008734411,"about_ca_topic_score_gemma":0.0008760654,"teacher_disagreement_score":0.031157972,"about_ca_system_score_codex":0.00024530833,"about_ca_system_score_gemma":0.00042985482,"threshold_uncertainty_score":0.9978665},"labels":[],"label_agreement":null},{"id":"W4220750659","doi":"10.1158/1538-7445.sabcs21-p4-12-12","title":"Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Breast cancer; Cohort; Family medicine; Cancer; Declaration; Health care; Disease; Internal medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.3795168443750717,"score_gpt":0.6209774067916722,"score_spread":0.24146056241660052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220750659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864351,0.0072767762,0.0000037082311,0.0046586315,0.00019120678,0.000962155,0.00008292782,0.000018943536,0.00037054124],"genre_scores_gemma":[0.9965461,0.0013938303,0.0000046827477,0.0009930355,0.00020866083,0.00074076065,0.0000024553779,0.000021897022,0.00008861447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974022,0.00031681647,0.0002516439,0.00036507126,0.0011415277,0.0005227287],"domain_scores_gemma":[0.9967562,0.002161089,0.000111705594,0.00052011845,0.00015087238,0.00029999705],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009986474,0.0001577631,0.0002805007,0.00017858279,0.0013312639,0.000070353235,0.00029091662,0.000057459994,0.0012919757],"category_scores_gemma":[0.0008840073,0.0000770864,0.00013864052,0.00045545163,0.00032476475,0.00006883104,0.00020709756,0.00067044445,9.720701e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011345849,0.00012545889,0.6669626,0.00027146286,0.00010940619,0.00005862259,0.09205312,0.0029313162,0.0035151101,0.000010981937,0.002771419,0.23005587],"study_design_scores_gemma":[0.001922804,0.0015214933,0.9027221,0.0006835755,0.00004111374,0.000055946974,0.07586919,0.000157255,0.0006121402,0.00018701275,0.016053123,0.00017420761],"about_ca_topic_score_codex":0.048383523,"about_ca_topic_score_gemma":0.004928749,"teacher_disagreement_score":0.2357595,"about_ca_system_score_codex":0.006347911,"about_ca_system_score_gemma":0.008360512,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4220767373","doi":"10.1158/1538-7445.sabcs21-pd10-09","title":"Abstract PD10-09: Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines- or taxane-based treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Medicine; Immune system; Oncology; Breast cancer; Paclitaxel; Internal medicine; Doxorubicin; Cyclophosphamide; Chemotherapy; Carboplatin; Cancer; Immune checkpoint; Cancer research; Immunotherapy; Immunology; Cisplatin","score_opus":0.16828568174729894,"score_gpt":0.42076595494338925,"score_spread":0.25248027319609034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220767373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896733,0.008733882,0.000011599701,0.0005611427,0.000048785318,0.0006432646,0.00027343773,0.000008474976,0.000046086552],"genre_scores_gemma":[0.99784267,0.0015753405,0.00006956377,0.000021009468,0.000026894628,0.0002016053,0.000092181486,0.000013529045,0.0001572199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854577,0.00012959153,0.00039196873,0.0002494257,0.0004497312,0.00023352267],"domain_scores_gemma":[0.9993379,0.00015362231,0.00015014879,0.00024437442,0.000050677747,0.00006328423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004682107,0.00011087027,0.00035628976,0.000117255724,0.00013824382,0.0000062865693,0.00009301955,0.000053293574,0.0011688276],"category_scores_gemma":[0.000017877155,0.000078003846,0.00008202463,0.00022619503,0.00035178152,0.000022719163,0.000053072734,0.00018881971,0.0000010244548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010706932,0.0008234253,0.04747424,0.00007907874,0.000095654315,0.0000071620816,0.0003497541,0.00007808012,0.8824904,0.0000025978438,0.00030611746,0.057586573],"study_design_scores_gemma":[0.004883651,0.0061303885,0.4079646,0.00008716965,0.000021526856,0.000003123254,0.00072895904,0.00025113326,0.57420266,0.0000075401936,0.00561607,0.000103188344],"about_ca_topic_score_codex":0.0025215282,"about_ca_topic_score_gemma":0.000022699604,"teacher_disagreement_score":0.36049035,"about_ca_system_score_codex":0.0004359342,"about_ca_system_score_gemma":0.00020810934,"threshold_uncertainty_score":0.99974424},"labels":[],"label_agreement":null},{"id":"W4220770704","doi":"10.1158/1538-7445.sabcs21-ot1-07-01","title":"Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Magnetic resonance imaging; Oncology; Cancer; Population; Internal medicine; Breast cancer; Quality of life (healthcare); Anxiety; Radiology; Psychiatry","score_opus":0.10828456778191527,"score_gpt":0.4043935584884237,"score_spread":0.2961089907065084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220770704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98088497,0.0009177462,0.00007922329,0.0017564261,0.0003245206,0.008381016,0.0073995898,0.00016507186,0.000091451366],"genre_scores_gemma":[0.9866243,0.00008474253,0.00090294814,0.00014032742,0.0001658471,0.010231821,0.00040470395,0.00014815651,0.0012971659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936915,0.0012297967,0.000571814,0.0011154626,0.002143724,0.0012476818],"domain_scores_gemma":[0.9947467,0.0028228592,0.00028216175,0.0007152617,0.00095009664,0.000482912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025607757,0.0004909334,0.0009948476,0.00046873992,0.0009909297,0.000121841185,0.00038614077,0.000029692634,0.0054654786],"category_scores_gemma":[0.00056594814,0.00035311378,0.00015902575,0.0017791167,0.00030665594,0.0002275372,0.00026811293,0.0008123151,0.000008841751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32398647,0.021781994,0.5095514,0.0011589576,0.01832009,0.0013420067,0.0037699388,0.0056666047,0.00027329315,0.000047563677,0.064511016,0.04959065],"study_design_scores_gemma":[0.076187536,0.037037384,0.87206185,0.00031841843,0.00086949905,0.00001841932,0.0067447443,0.00062472164,0.00031016878,0.00001783472,0.0050549363,0.0007544924],"about_ca_topic_score_codex":0.02444504,"about_ca_topic_score_gemma":0.017195726,"teacher_disagreement_score":0.36251044,"about_ca_system_score_codex":0.0013517066,"about_ca_system_score_gemma":0.0013490058,"threshold_uncertainty_score":0.99989206},"labels":[],"label_agreement":null},{"id":"W4220772552","doi":"10.1158/1538-7445.sabcs21-p1-08-09","title":"Abstract P1-08-09: High mid-treatment RNA disruption in patients with HER2-negative breast cancer predicts survival benefit after neoadjuvant chemotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Sudbury","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Chemotherapy; Oncology; RNA; Cancer; Neoadjuvant therapy; Bevacizumab; Gastroenterology; Biology","score_opus":0.019810858390760466,"score_gpt":0.3194976044248395,"score_spread":0.299686746034079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220772552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958748,0.0007945192,0.000007920344,0.0008838091,0.00017926536,0.0007126112,0.0013645585,0.0000092161745,0.00017329979],"genre_scores_gemma":[0.99362206,0.0015115277,0.000021039808,0.000076807875,0.00024255189,0.003194822,0.00024845934,0.000048528484,0.001034223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979698,0.00011021052,0.00020727403,0.0005962098,0.0006195102,0.000496979],"domain_scores_gemma":[0.9990831,0.000017437409,0.00007697312,0.00043704564,0.00026150938,0.00012391592],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023795609,0.00020078997,0.00018790184,0.00011181337,0.00023496381,0.000042935433,0.00024633162,0.00007894854,0.0014270125],"category_scores_gemma":[0.000005148822,0.00016613044,0.00005730222,0.00033718342,0.00014135565,0.0000139627155,0.00011241352,0.00026019602,0.0000066698203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016372442,0.0026514125,0.689675,0.00010205351,0.00062151015,0.00003346954,0.001470624,0.010756609,0.078011036,0.00006234761,0.0017126156,0.19853093],"study_design_scores_gemma":[0.0034836312,0.00062056683,0.9725595,0.000043347736,0.000010696348,9.118349e-7,0.00020082852,0.000014976702,0.017434143,0.000036798036,0.005361162,0.00023340799],"about_ca_topic_score_codex":0.008669621,"about_ca_topic_score_gemma":0.004189772,"teacher_disagreement_score":0.28288457,"about_ca_system_score_codex":0.0008348912,"about_ca_system_score_gemma":0.00039318585,"threshold_uncertainty_score":0.9994858},"labels":[],"label_agreement":null},{"id":"W4220775282","doi":"10.1158/1538-7445.sabcs21-p1-18-29","title":"Abstract P1-18-29: Male patients with hormone receptor positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) receiving palbociclib in the real-world: patient characteristics, treatment patterns, and outcomes from the POLARIS study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Internal medicine; Breast cancer; Oncology; Cancer; Neutropenia; Metastatic breast cancer; Tamoxifen; Gynecology; Chemotherapy","score_opus":0.0380005638176461,"score_gpt":0.35891615054231046,"score_spread":0.32091558672466436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220775282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97972584,0.00064632524,0.0000019504862,0.0048669353,0.00022975504,0.004732837,0.009640424,0.00004917093,0.00010678865],"genre_scores_gemma":[0.99301916,0.001020999,0.00006014478,0.00055187254,0.00030436553,0.0042183213,0.00039388065,0.00013485174,0.0002963976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939756,0.0012918166,0.0007243211,0.0011172628,0.0018331164,0.0010578886],"domain_scores_gemma":[0.9965221,0.0013934155,0.00043291523,0.0008175134,0.0005644461,0.00026955374],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006426198,0.00061117706,0.0008905748,0.0002953374,0.0012927689,0.00013417778,0.0005358876,0.000077429875,0.0041690296],"category_scores_gemma":[0.00010783913,0.00036437743,0.00011865815,0.0008520159,0.00044916678,0.0003614641,0.0003587304,0.0015183993,0.000009052026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050805877,0.0015621942,0.89235973,0.000031385087,0.00059466803,0.00005602227,0.02489357,0.0000067914184,0.0012124149,0.0000062626923,0.00023449732,0.07396187],"study_design_scores_gemma":[0.0073483996,0.0022880586,0.97046125,0.00025171574,0.000088691944,0.000004216573,0.018029356,0.000001979318,0.00045816702,0.00002016258,0.0006433178,0.000404698],"about_ca_topic_score_codex":0.07741856,"about_ca_topic_score_gemma":0.01180495,"teacher_disagreement_score":0.07810149,"about_ca_system_score_codex":0.0032818215,"about_ca_system_score_gemma":0.00040872014,"threshold_uncertainty_score":0.9998808},"labels":[],"label_agreement":null},{"id":"W4220798168","doi":"10.1158/1538-7445.sabcs21-p4-12-03","title":"Abstract P4-12-03: Assessment of quality of life (QoL) in patients with metastatic breast cancer (MBC) in clinical practice: A real-world multi-country survey","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical Practice; Family medicine; Breast cancer; Likert scale; Metastatic breast cancer; Clinical Oncology; Cancer; Internal medicine; Nursing; Psychology","score_opus":0.2609319230496844,"score_gpt":0.49285624731695754,"score_spread":0.23192432426727316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220798168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874813,0.00093365856,0.00001898812,0.00047372165,0.00031249618,0.00083880115,0.0053667678,0.000006327652,0.003301091],"genre_scores_gemma":[0.99738014,0.0013811984,0.0002993797,0.00019485915,0.000056929268,0.00040374874,0.00005971482,0.000043793625,0.00018025344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534035,0.00057598506,0.0023799997,0.0006819971,0.00036382204,0.0006578621],"domain_scores_gemma":[0.99625725,0.001199591,0.0014056943,0.0005648816,0.0003838863,0.00018870739],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013927456,0.00020323189,0.0012039569,0.0007382394,0.00010063013,0.00003766444,0.00053961424,0.0000801577,0.0013752785],"category_scores_gemma":[0.0011099321,0.00022077977,0.00010426884,0.0012161117,0.00030861684,0.00051613816,0.00025393892,0.0011896564,0.000008388883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016984559,0.0017646205,0.98917073,0.00017989556,0.0001326332,0.0000037747745,0.00023146527,0.0019401485,0.0000045495535,0.0030117563,0.0004448475,0.0014171425],"study_design_scores_gemma":[0.0046101217,0.00021696623,0.99286383,0.00006564087,0.000005387978,1.3925568e-7,0.0001804943,0.00023117385,0.0000033361036,0.00022353108,0.0013612424,0.0002381183],"about_ca_topic_score_codex":0.30225927,"about_ca_topic_score_gemma":0.124879874,"teacher_disagreement_score":0.1773794,"about_ca_system_score_codex":0.0018351863,"about_ca_system_score_gemma":0.0018950728,"threshold_uncertainty_score":0.9995376},"labels":[],"label_agreement":null},{"id":"W4220799525","doi":"10.1158/1538-7445.sabcs21-gs1-02","title":"Abstract GS1-02: Final results of KEYNOTE-355: Randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Carboplatin; Pembrolizumab; Internal medicine; Taxane; Hazard ratio; Population; Oncology; Placebo; Chemotherapy; Breast cancer; Clinical endpoint; Cancer; Confidence interval; Clinical trial; Cisplatin; Pathology","score_opus":0.1262927204348393,"score_gpt":0.45418967136191757,"score_spread":0.32789695092707827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220799525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96917444,0.00358739,0.00024284092,0.0028605857,0.0002840511,0.021393511,0.0022377016,0.00007533148,0.00014416089],"genre_scores_gemma":[0.97698516,0.0020826447,0.00038251258,0.00022238956,0.00026445038,0.01644774,0.00013063248,0.00018543402,0.0032990365],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99290794,0.0008699847,0.0017454905,0.0011480558,0.0021498566,0.0011786538],"domain_scores_gemma":[0.9939176,0.0016911651,0.0009143498,0.0009803864,0.0021449924,0.0003515392],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039067436,0.0006102091,0.0024354546,0.00077557936,0.00044314563,0.000043568572,0.0007166004,0.00011029112,0.003982546],"category_scores_gemma":[0.00033373706,0.0004670956,0.0003975518,0.0019071177,0.0007633756,0.00024609556,0.00015682768,0.0011711118,0.000003143559],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90060246,0.0059038103,0.00007593008,0.00090854446,0.0025356617,0.000043206965,0.009969128,0.0020632348,0.005382361,0.000017801707,0.001529416,0.070968464],"study_design_scores_gemma":[0.94874775,0.009857583,0.0003060969,0.0007111226,0.00041923407,0.000066121225,0.004632633,0.00080929237,0.031282745,0.00012076498,0.0025976347,0.00044898893],"about_ca_topic_score_codex":0.0068490375,"about_ca_topic_score_gemma":0.0011270134,"teacher_disagreement_score":0.07051947,"about_ca_system_score_codex":0.0017737026,"about_ca_system_score_gemma":0.003694498,"threshold_uncertainty_score":0.9997781},"labels":[],"label_agreement":null},{"id":"W4220802109","doi":"10.1158/1538-7445.sabcs21-p3-19-23","title":"Abstract P3-19-23: Radiation-induced sarcomas of the breast: A 20-year single-centre experience","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Sarcoma; Breast cancer; Leiomyosarcoma; Incidence (geometry); Cancer registry; Radiation therapy; Cancer; Radiology; Internal medicine; Pathology","score_opus":0.07411770985528067,"score_gpt":0.36349382026888966,"score_spread":0.289376110413609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220802109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888789,0.0015414777,0.0000011465576,0.0061579086,0.00017884462,0.0005649355,0.00005626334,0.000016524356,0.002603979],"genre_scores_gemma":[0.9963402,0.00003142715,0.000016420596,0.00017533882,0.0002000698,0.000089261215,0.000011512654,0.000025476855,0.0031103066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976107,0.00018531272,0.00021601205,0.00028639188,0.0012729167,0.00042870457],"domain_scores_gemma":[0.9989349,0.00009193307,0.000068505426,0.000544428,0.0001854108,0.00017481277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005672595,0.000100155696,0.00019716288,0.00013358855,0.00033859682,0.000021628583,0.0003706243,0.00003622473,0.003368747],"category_scores_gemma":[0.00012639276,0.00007549612,0.00017504228,0.0008041126,0.00015449339,0.00005406683,0.00027949113,0.0005668501,0.00003531448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058885786,0.0010102335,0.15177317,0.0002581465,0.0001501401,0.00017071655,0.00826567,0.000105857405,0.78674644,0.0007359436,0.030162714,0.020032082],"study_design_scores_gemma":[0.008883713,0.0009322227,0.4842768,0.0006321481,0.00010282534,0.00047161998,0.023683188,0.00037902925,0.19267489,0.00046022714,0.28680173,0.00070160284],"about_ca_topic_score_codex":0.0005570798,"about_ca_topic_score_gemma":0.00005071665,"teacher_disagreement_score":0.59407157,"about_ca_system_score_codex":0.0004246995,"about_ca_system_score_gemma":0.0006456754,"threshold_uncertainty_score":0.9975423},"labels":[],"label_agreement":null},{"id":"W4220811973","doi":"10.1158/1538-7445.sabcs21-p2-13-07","title":"Abstract P2-13-07: Zanidatamab (ZW25), a HER2-targeted bispecific antibody, in combination with chemotherapy (chemo) for HER2-positive breast cancer (BC): Results from a phase 1 study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); Jewish General Hospital; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pertuzumab; Vinorelbine; Capecitabine; Trastuzumab; Internal medicine; Tolerability; Oncology; Breast cancer; Metastatic breast cancer; Response Evaluation Criteria in Solid Tumors; Cancer; Toxicity; Phases of clinical research; Chemotherapy; Adverse effect; Cisplatin","score_opus":0.08425191162979943,"score_gpt":0.4665428208257864,"score_spread":0.38229090919598696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220811973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96657795,0.0011130361,0.000034657867,0.012815759,0.0002859313,0.008376871,0.010034752,0.000105919986,0.00065513595],"genre_scores_gemma":[0.9875562,0.00085394393,0.000119557226,0.00028180264,0.0005728163,0.0070807273,0.0019925656,0.00022308757,0.0013192554],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9916975,0.0006982792,0.0008617348,0.0017576233,0.0033877182,0.0015971324],"domain_scores_gemma":[0.9957692,0.0008432333,0.00023430966,0.0012603435,0.0014074354,0.00048545448],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036274013,0.00048399603,0.00089345337,0.0009637432,0.00069302256,0.00018961712,0.0008857398,0.00017101901,0.0060141706],"category_scores_gemma":[0.0002107065,0.0004483366,0.00014082152,0.002794608,0.0004467537,0.00027658363,0.0003527938,0.0024103972,0.000046418903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27657586,0.041555602,0.16677529,0.0011542314,0.0023587176,0.002942831,0.03188609,0.0006758716,0.20976281,0.000094192554,0.091893464,0.17432503],"study_design_scores_gemma":[0.1462672,0.013316491,0.73746276,0.0017114842,0.00013751705,0.000066028144,0.0193458,0.0021262432,0.036346573,0.00022599557,0.041636154,0.0013577485],"about_ca_topic_score_codex":0.104792655,"about_ca_topic_score_gemma":0.009836237,"teacher_disagreement_score":0.5706875,"about_ca_system_score_codex":0.004618765,"about_ca_system_score_gemma":0.0033979777,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W4220819104","doi":"10.1158/1538-7445.sabcs21-p3-16-02","title":"Abstract P3-16-02: Enhancing impact and efficiency of financial support for cancer through use of AI: A nascent initiative of Indian cancer society","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Beneficiary; Medicine; Concordance; Cancer; Interim; Finance; Business; Internal medicine; Political science","score_opus":0.15098781707139572,"score_gpt":0.3973384918118526,"score_spread":0.24635067474045688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220819104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97967696,0.008779901,0.00033000726,0.0004745515,0.00042696,0.00093247433,0.008723879,0.000008488503,0.000646782],"genre_scores_gemma":[0.9924195,0.0059248027,0.00013130295,0.0003068651,0.00018491132,0.0007188493,0.000025074298,0.000048199385,0.00024048929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972976,0.00003818336,0.0011263525,0.00056867255,0.00020529542,0.00076391886],"domain_scores_gemma":[0.99787724,0.0003227846,0.0008827732,0.00034682688,0.00043061894,0.00013974284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014485919,0.00023644461,0.00093557814,0.00029864075,0.00029680345,0.00003611174,0.0003899206,0.00014718705,0.0023162828],"category_scores_gemma":[0.00031084713,0.00026494887,0.00036246525,0.0006406625,0.00050512434,0.00055431615,0.00022001233,0.0006043624,0.0000021326346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004244822,0.0020423417,0.7136551,0.006574609,0.0017585938,0.000014489661,0.07906366,0.01802752,0.02495372,0.03644254,0.073309556,0.03991303],"study_design_scores_gemma":[0.01042381,0.0054291836,0.5921167,0.0011616009,0.00011883695,0.000007728229,0.0038603214,0.0013173944,0.18806867,0.03087685,0.16431352,0.0023053652],"about_ca_topic_score_codex":0.03148548,"about_ca_topic_score_gemma":0.0015907986,"teacher_disagreement_score":0.16311496,"about_ca_system_score_codex":0.0013709846,"about_ca_system_score_gemma":0.0022236838,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W4220820471","doi":"10.1158/1538-7445.sabcs21-p3-12-11","title":"Abstract P3-12-11: Survival differences in Filipino versus white women with breast cancer in the United States: A SEER-based analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Hazard ratio; Marital status; Proportional hazards model; Epidemiology; Surveillance, Epidemiology, and End Results; Cancer; Internal medicine; Oncology; Mastectomy; Retrospective cohort study; Stage (stratigraphy); Demography; Gynecology; Obstetrics; Cancer registry; Population; Confidence interval","score_opus":0.19512785279715927,"score_gpt":0.4262165138722753,"score_spread":0.23108866107511605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220820471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211574,0.00029911226,0.000008613472,0.006095623,0.00008714423,0.00050991453,0.00040949753,0.000021220956,0.00045314076],"genre_scores_gemma":[0.9973442,0.00019053952,0.000009590557,0.00046360292,0.00009576079,0.0015624603,0.000103693805,0.00001998591,0.00021019622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955947,0.00055291946,0.00030923582,0.0005056607,0.0020830117,0.0009545203],"domain_scores_gemma":[0.9985419,0.00045178502,0.000076431475,0.00046903075,0.00027432622,0.00018653068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022314934,0.00019549849,0.00045551555,0.001128714,0.000268328,0.000081407794,0.00054966996,0.00005365965,0.004772152],"category_scores_gemma":[0.00005291528,0.00013350057,0.000067749446,0.0068569407,0.00022876394,0.00010119515,0.000113699665,0.0011554585,0.0000035300302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00973716,0.00016959154,0.94343704,0.00007686305,0.00025722844,0.00031198777,0.005176835,0.038426355,0.00011306432,0.00001108538,0.00068724324,0.0015955268],"study_design_scores_gemma":[0.0034729757,0.0005385212,0.9548452,0.0001467136,0.00007320079,0.000003338628,0.034957595,0.004094188,0.00001503302,0.000011043699,0.0016629614,0.0001792267],"about_ca_topic_score_codex":0.09910069,"about_ca_topic_score_gemma":0.113097385,"teacher_disagreement_score":0.034332167,"about_ca_system_score_codex":0.0021419425,"about_ca_system_score_gemma":0.0013145155,"threshold_uncertainty_score":0.9961376},"labels":[],"label_agreement":null},{"id":"W4220826119","doi":"10.1158/1538-7445.sabcs21-p1-03-02","title":"Abstract P1-03-02: Clip placement after ultrasound guided biopsy in the setting of neoadjuvant chemotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Biopsy; CLIPS; Cancer; Breast cancer; Mastectomy; Surgery; Nat; Radiology; General surgery; Internal medicine","score_opus":0.04094693481910658,"score_gpt":0.38347765825812064,"score_spread":0.34253072343901403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220826119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271435,0.0034891977,0.0000036254748,0.0021885452,0.000091464695,0.00041514417,0.0001341061,0.0000043425853,0.00095925457],"genre_scores_gemma":[0.9972884,0.00066679943,0.000050849743,0.00034604553,0.00017260965,0.0012411845,0.000046558314,0.00002244768,0.0001650821],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825424,0.0002058981,0.00023396625,0.00035333633,0.0005353479,0.0004171971],"domain_scores_gemma":[0.9992986,0.0000966423,0.00006607127,0.00041475863,0.000089125664,0.000034839202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010934387,0.00013060623,0.00015132179,0.00008065755,0.00019966376,0.000019283529,0.000370881,0.000043502016,0.00050847227],"category_scores_gemma":[0.000045425444,0.000100801866,0.00007087068,0.00030453195,0.00015063732,0.000003287023,0.00021385496,0.000264603,0.0000042283373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002549735,0.00071557064,0.18711025,0.0001537305,0.0004087877,0.00005886758,0.0068187285,0.00131838,0.7525676,0.00004768405,0.03883541,0.00941527],"study_design_scores_gemma":[0.0043712202,0.00053387164,0.75092745,0.000089774614,0.000025289868,0.00008070042,0.009732233,0.000010657675,0.18894587,0.00016576158,0.04467535,0.00044182246],"about_ca_topic_score_codex":0.0010953436,"about_ca_topic_score_gemma":0.00031806325,"teacher_disagreement_score":0.5638172,"about_ca_system_score_codex":0.00018733079,"about_ca_system_score_gemma":0.0001912569,"threshold_uncertainty_score":0.5567415},"labels":[],"label_agreement":null},{"id":"W4220833656","doi":"10.1158/1538-7445.sabcs21-p4-10-01","title":"Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Palbociclib; Breast cancer; Clinical endpoint; Quality of life (healthcare); Internal medicine; Adjuvant; Cancer; Randomized controlled trial; Interim analysis; Adjuvant therapy; Oncology; Metastatic breast cancer","score_opus":0.07693271054620061,"score_gpt":0.42274366292314197,"score_spread":0.34581095237694137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220833656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574257,0.006339484,0.0000030303777,0.0042670597,0.00008363792,0.003082484,0.00027181,0.000013892637,0.00019605384],"genre_scores_gemma":[0.99369377,0.0031212033,0.000026977614,0.00022605775,0.0001734063,0.0025833282,0.00001079929,0.000039618386,0.00012483331],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948854,0.0015750967,0.00084410043,0.0004733232,0.0016353576,0.0005867458],"domain_scores_gemma":[0.9972234,0.0014479787,0.0003100697,0.0005593106,0.00032216377,0.00013711577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004823742,0.00023386505,0.0012780001,0.0003236414,0.00011112184,0.000017810406,0.00037262673,0.000057471563,0.0012970705],"category_scores_gemma":[0.00022110964,0.00015061,0.00013146491,0.0010124524,0.00087332336,0.00012730072,0.00014039883,0.0010201954,5.83759e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92105585,0.0005913534,0.05016932,0.00026335032,0.00023484541,0.00003590445,0.004063926,0.00013481549,0.006317263,0.00010153125,0.000068293215,0.01696357],"study_design_scores_gemma":[0.60110056,0.0007572378,0.3946906,0.00019749394,0.000016675394,0.000015779135,0.0013507926,0.000018294364,0.0008765665,0.0002674695,0.000552077,0.00015645943],"about_ca_topic_score_codex":0.037440065,"about_ca_topic_score_gemma":0.0031766267,"teacher_disagreement_score":0.34452128,"about_ca_system_score_codex":0.00040977515,"about_ca_system_score_gemma":0.0013036891,"threshold_uncertainty_score":0.9996159},"labels":[],"label_agreement":null},{"id":"W4220834516","doi":"10.1158/1538-7445.sabcs21-p1-08-01","title":"Abstract P1-08-01: Validation of automated Ki67 analysis to predict Oncotype DX recurrence score in early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Stage (stratigraphy); Oncology; Correlation; Cohort; Cancer; Pathological; Pathology; Biology","score_opus":0.05082725623250592,"score_gpt":0.3927816609717089,"score_spread":0.341954404739203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220834516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616253,0.0010944554,0.000009564851,0.00051910116,0.00013187372,0.00042432192,0.0014301427,0.000026462123,0.00020153915],"genre_scores_gemma":[0.99788326,0.0004987144,0.000030658597,0.000040386218,0.0000988786,0.0010160526,0.00021973129,0.000024134079,0.00018820903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977904,0.00019661224,0.0002940937,0.00058376475,0.0006673907,0.00046775318],"domain_scores_gemma":[0.99900085,0.00003740592,0.000102420534,0.0004515451,0.00029186442,0.00011588735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059617776,0.00016293125,0.00027793227,0.00041987168,0.00019339526,0.00002705641,0.00039198986,0.000071008195,0.0008334783],"category_scores_gemma":[0.000051717296,0.00016489548,0.00010038245,0.001963,0.00012850124,0.000012339059,0.00044177665,0.0002759048,0.00000578342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013125701,0.00029656664,0.8286137,0.00009499907,0.0009838183,0.000016191992,0.0010404089,0.02463409,0.13486071,0.0000075699713,0.003847521,0.0042918334],"study_design_scores_gemma":[0.00062985334,0.0001733847,0.94525373,0.00005188357,0.0000725942,0.0000015249949,0.00036334706,0.00012996695,0.05194339,0.0000038990606,0.0012018146,0.00017460226],"about_ca_topic_score_codex":0.017504191,"about_ca_topic_score_gemma":0.0056628203,"teacher_disagreement_score":0.11664002,"about_ca_system_score_codex":0.0005014671,"about_ca_system_score_gemma":0.0005329441,"threshold_uncertainty_score":0.98903835},"labels":[],"label_agreement":null},{"id":"W4220840510","doi":"10.1158/1538-7445.sabcs21-p1-18-08","title":"Abstract P1-18-08: Effect of duration of prior cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy (≤6 mo or &amp;gt;6 mo) on alpelisib benefit in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), <i>PIK3CA</i>-mutated advanced breast cancer (ABC) from BYLieve","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Letrozole; Internal medicine; Cohort; Population; Aromatase inhibitor; Oncology; Gastroenterology; Cancer; Breast cancer; Tamoxifen","score_opus":0.028843720760742365,"score_gpt":0.34747679407936316,"score_spread":0.3186330733186208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220840510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432857,0.0014615444,0.000013298616,0.0005377414,0.00025153952,0.004837456,0.008405619,0.00007829031,0.00008595612],"genre_scores_gemma":[0.9946194,0.00090804684,0.0002925384,0.00013610315,0.0003130959,0.0024587906,0.0008020615,0.00022330301,0.00024663063],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9924237,0.00084823056,0.0012969954,0.0013902445,0.0029284568,0.0011123704],"domain_scores_gemma":[0.99521196,0.001180612,0.0009380499,0.00068751234,0.0015910445,0.00039083103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008640073,0.0007724357,0.0014877316,0.0007269929,0.00045525143,0.000041199317,0.0005608839,0.00023863382,0.004353371],"category_scores_gemma":[0.00023697874,0.00059987325,0.00021115188,0.0015879816,0.00063351786,0.0005671212,0.00024567384,0.0017750125,0.00001709773],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1922168,0.0022905488,0.04547438,0.00031110266,0.0008240541,0.000033793694,0.0045128143,0.0017196534,0.6236684,0.000013381983,0.00030521108,0.12862986],"study_design_scores_gemma":[0.029391918,0.00757267,0.5289239,0.0013090238,0.00005871015,0.000003480629,0.0005460039,0.00001623729,0.43129686,0.0000604436,0.00020913057,0.00061162363],"about_ca_topic_score_codex":0.008841119,"about_ca_topic_score_gemma":0.0010214077,"teacher_disagreement_score":0.48344952,"about_ca_system_score_codex":0.0032240152,"about_ca_system_score_gemma":0.00067854265,"threshold_uncertainty_score":0.9996453},"labels":[],"label_agreement":null},{"id":"W4220847446","doi":"10.1158/1538-7445.sabcs21-p2-08-01","title":"Abstract P2-08-01: Validation of a 16-gene genomic signature to identify early-stage invasive breast cancer patients who may omit radiotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Breast-conserving surgery; Tamoxifen; Oncology; Internal medicine; Stage (stratigraphy); Adjuvant radiotherapy; Randomized controlled trial; Cancer; Adjuvant; Clinical trial; Mastectomy","score_opus":0.031003631448057168,"score_gpt":0.36624428922328583,"score_spread":0.33524065777522866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220847446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910309,0.0038246252,0.00001197021,0.0010237535,0.00027309518,0.00080457114,0.002871004,0.000009115977,0.00015097426],"genre_scores_gemma":[0.9949977,0.001705233,0.000033216445,0.00024813102,0.00034804328,0.0012736341,0.00027019402,0.000060182207,0.001063663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99763346,0.0002038159,0.00027970245,0.0006462636,0.000705272,0.00053150003],"domain_scores_gemma":[0.9987733,0.000043244072,0.00013925918,0.0004612169,0.00043733558,0.00014565045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036387338,0.00022396009,0.00027800177,0.00019227025,0.00035160428,0.000041363543,0.000489158,0.00010720589,0.0014384197],"category_scores_gemma":[0.000031918247,0.0002260371,0.000118824304,0.00042516392,0.00013340532,0.000012840534,0.00046977316,0.00033209298,0.000012091706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00147738,0.00023404481,0.13951938,0.00008658795,0.00049430545,0.000006562096,0.0009026645,0.0013629274,0.8395918,0.000008326059,0.012997379,0.0033186255],"study_design_scores_gemma":[0.0015009686,0.0002550943,0.54542065,0.000039002825,0.000019709418,0.0000019863455,0.00021755972,7.358411e-7,0.44399732,0.000013471696,0.008310431,0.00022303325],"about_ca_topic_score_codex":0.004516765,"about_ca_topic_score_gemma":0.00060003804,"teacher_disagreement_score":0.40590128,"about_ca_system_score_codex":0.0009735875,"about_ca_system_score_gemma":0.00053337443,"threshold_uncertainty_score":0.9994744},"labels":[],"label_agreement":null},{"id":"W4220849940","doi":"10.1158/1538-7445.sabcs21-ot1-19-01","title":"Abstract OT1-19-01: The metastatic breast cancer project: Generating the clinical and genomic landscape of metastatic breast cancer through patient-partnered research","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Biobank; Cancer; Internal medicine; Oncology; genomic DNA; Family medicine; Bioinformatics; DNA; Genetics; Biology","score_opus":0.14641124231549915,"score_gpt":0.4570803367954893,"score_spread":0.31066909447999014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220849940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96199787,0.026987804,0.000011548652,0.0053896075,0.00037805169,0.0014428326,0.0035666663,0.000007884784,0.0002177319],"genre_scores_gemma":[0.9787754,0.01676952,0.00010850716,0.00060282135,0.00076217466,0.0025643695,0.00007575055,0.000072828625,0.00026867515],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995099,0.0013856479,0.00069740566,0.00081422523,0.0010761812,0.0009275533],"domain_scores_gemma":[0.9973078,0.0007735839,0.00024034864,0.0008519199,0.0006624242,0.00016394087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039409245,0.000259295,0.00039387238,0.00012610608,0.0012232776,0.00015485809,0.0008637958,0.00007484169,0.0006931849],"category_scores_gemma":[0.0002636384,0.00017421415,0.00016542284,0.000745684,0.0011037139,0.000015399213,0.0013367569,0.0011817787,0.0000034998009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005173915,0.0013873714,0.06580415,0.0009502887,0.003015896,0.00010355825,0.009704931,0.023343809,0.4580163,0.0012000465,0.3232638,0.10803594],"study_design_scores_gemma":[0.015278229,0.0041358112,0.19809172,0.0005929879,0.0010639344,0.0009426604,0.051066216,0.0073918686,0.048659433,0.0029303525,0.6666365,0.0032102778],"about_ca_topic_score_codex":0.015768968,"about_ca_topic_score_gemma":0.004515608,"teacher_disagreement_score":0.40935686,"about_ca_system_score_codex":0.00021260505,"about_ca_system_score_gemma":0.0031797136,"threshold_uncertainty_score":0.9907851},"labels":[],"label_agreement":null},{"id":"W4220851987","doi":"10.1158/1538-7445.sabcs21-ot2-03-01","title":"Abstract OT2-03-01: RNA disruption assay (RDA) - Breast cancer response evaluation for individualized therapy (brevity/brevity-02)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Internal medicine; Stage (stratigraphy); Clinical trial; Cancer; Biopsy; Surgery","score_opus":0.11935197367561821,"score_gpt":0.4604645255189903,"score_spread":0.3411125518433721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220851987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96814734,0.018276157,0.000053822645,0.00766704,0.00047253212,0.0022241815,0.0028333315,0.000031240583,0.00029437215],"genre_scores_gemma":[0.9797312,0.004623647,0.000070667025,0.00034756004,0.00073615776,0.013332257,0.00053472165,0.00007384496,0.0005499571],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995255,0.0015511665,0.00032605158,0.0008344348,0.0013203179,0.00071302766],"domain_scores_gemma":[0.99812174,0.00028736,0.00016587849,0.0006051318,0.0006794503,0.00014041303],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059748115,0.000283355,0.00031459183,0.00019098054,0.0010331675,0.00007850728,0.00045400416,0.0001296827,0.0016312631],"category_scores_gemma":[0.00026299717,0.0002662766,0.00019929965,0.00045680584,0.00021159937,0.0000199823,0.0003621948,0.00039321097,0.000012165135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02410208,0.0005876749,0.010515103,0.00013177117,0.000908375,0.0000071493882,0.0007859458,0.0006294483,0.6477353,0.000047739606,0.04436204,0.2701874],"study_design_scores_gemma":[0.012851615,0.0009931165,0.5390063,0.00014595567,0.00018821764,0.000036393943,0.0010070831,0.00011842074,0.09916081,0.0005306302,0.34500274,0.0009587058],"about_ca_topic_score_codex":0.0010858469,"about_ca_topic_score_gemma":0.00036584935,"teacher_disagreement_score":0.54857445,"about_ca_system_score_codex":0.0010067124,"about_ca_system_score_gemma":0.0012030139,"threshold_uncertainty_score":0.99997896},"labels":[],"label_agreement":null},{"id":"W4220870634","doi":"10.1158/1538-7445.sabcs21-ot2-11-06","title":"Abstract OT2-11-06: SERENA-4: A Phase III comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive/HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Breast cancer; Internal medicine; Anastrozole; Cancer; Oncology; Letrozole; Aromatase inhibitor; Estrogen receptor; Tamoxifen; Pharmacology; Metastatic breast cancer","score_opus":0.062136053726374436,"score_gpt":0.41991301954510485,"score_spread":0.3577769658187304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220870634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625297,0.0026262298,0.00065092853,0.0015170696,0.00036732896,0.014635491,0.01749407,0.00013020803,0.000048973452],"genre_scores_gemma":[0.97073257,0.0004830959,0.00091964466,0.00010287122,0.00031276842,0.024904743,0.0012276989,0.00027575044,0.0010408725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932403,0.0003426325,0.0011748315,0.0015945764,0.0018418375,0.0018058254],"domain_scores_gemma":[0.99342084,0.0016120134,0.0008881116,0.0010240481,0.0021796487,0.0008753582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005140124,0.0008583432,0.0020022441,0.000428088,0.000973881,0.00006027488,0.0005947318,0.00014448013,0.000341806],"category_scores_gemma":[0.00018211514,0.00074660685,0.00045961916,0.0007654745,0.00067409285,0.0004534125,0.0001758693,0.00074397685,0.0000030938866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76001376,0.004501785,0.018330216,0.0032646395,0.002790119,0.000071348884,0.010855427,0.04936475,0.0125114,0.00007677409,0.0008147333,0.13740508],"study_design_scores_gemma":[0.7683812,0.036472477,0.07767586,0.0106606735,0.0026969037,0.00003651586,0.0307045,0.011196697,0.045326587,0.00013183868,0.013497667,0.0032190937],"about_ca_topic_score_codex":0.002629724,"about_ca_topic_score_gemma":0.0019538698,"teacher_disagreement_score":0.13418598,"about_ca_system_score_codex":0.008041063,"about_ca_system_score_gemma":0.0036850632,"threshold_uncertainty_score":0.9994985},"labels":[],"label_agreement":null},{"id":"W4220871268","doi":"10.1158/1538-7445.sabcs21-p1-10-03","title":"Abstract P1-10-03: Estrogen and breast cancer benefits: Emerging hormone replacement therapy breast cancer paradigms","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Hormone replacement therapy (female-to-male); Breast cancer; Gynecology; Oncology; Internal medicine; Relative risk; Cancer; Confidence interval; Estrogen; Progestin; Hormone therapy; Randomized controlled trial","score_opus":0.026683943217616506,"score_gpt":0.3439873309701537,"score_spread":0.3173033877525372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220871268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88019866,0.115397856,0.0000011343543,0.0023844333,0.00019790804,0.00053931243,0.00091215235,0.000023504717,0.0003450412],"genre_scores_gemma":[0.933168,0.06303388,0.00000911899,0.00021432815,0.0005646871,0.0015913346,0.000111439665,0.000075052994,0.0012321846],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971971,0.00019795726,0.0002754985,0.00080202176,0.0006727768,0.00085465645],"domain_scores_gemma":[0.99891037,0.000027202386,0.00010180979,0.0004977066,0.00017645648,0.00028646126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007022139,0.0002844769,0.00024782232,0.00013846498,0.00073766056,0.000079909805,0.00040487695,0.00015614482,0.0016310939],"category_scores_gemma":[0.000007049174,0.0002572669,0.000108285654,0.0003741056,0.00020800004,0.000014738668,0.00044353653,0.0006607445,0.000010258394],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048800134,0.0002720447,0.014732773,0.00006609142,0.000778359,0.000039637765,0.00033732655,0.0021486622,0.8359831,0.00009255405,0.037188746,0.10348069],"study_design_scores_gemma":[0.015815988,0.003187912,0.18679388,0.00038015214,0.00017741516,0.0008621481,0.0018310839,0.00058692554,0.34605578,0.000118262025,0.44143537,0.002755112],"about_ca_topic_score_codex":0.0027452633,"about_ca_topic_score_gemma":0.0000817763,"teacher_disagreement_score":0.48992732,"about_ca_system_score_codex":0.00028455668,"about_ca_system_score_gemma":0.0005189758,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W4220872739","doi":"10.1158/1538-7445.sabcs21-ot1-11-02","title":"Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Evening; Clinical endpoint; Breast cancer; Morning; Internal medicine; Cancer; Clinical trial; Oncology; Adverse effect","score_opus":0.2686467496825231,"score_gpt":0.5216192358242293,"score_spread":0.2529724861417062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220872739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854107,0.00504455,3.016894e-7,0.0012303862,0.00021550778,0.007894316,0.000017612676,0.00001840062,0.0001682633],"genre_scores_gemma":[0.9962564,0.00042470318,0.000022126746,0.00010749547,0.000266745,0.0026661255,0.000007858575,0.000024892566,0.00022362142],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967504,0.0012030709,0.00037172073,0.00044194804,0.00081637356,0.00041647226],"domain_scores_gemma":[0.99538285,0.0038748977,0.00016776925,0.00026702537,0.00018297718,0.00012451402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030801103,0.000182765,0.0005440171,0.00011927315,0.00049383956,0.000027134645,0.00013923783,0.000027292203,0.0007263048],"category_scores_gemma":[0.00053995504,0.00012819906,0.000067581386,0.00026422896,0.00012117389,0.00005441024,0.00016993827,0.00069446757,0.0000020561047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7013908,0.0026434907,0.017984703,0.0010968829,0.0007296158,0.00013976119,0.014380519,0.00036537024,0.13464744,0.000014754704,0.00045875506,0.12614788],"study_design_scores_gemma":[0.8221901,0.02642576,0.11252544,0.0006132886,0.00040226936,0.000038618586,0.002321011,0.006976811,0.025765669,0.000038632512,0.0023599372,0.00034244463],"about_ca_topic_score_codex":0.00049541827,"about_ca_topic_score_gemma":0.00006728222,"teacher_disagreement_score":0.12580544,"about_ca_system_score_codex":0.0003570309,"about_ca_system_score_gemma":0.00035107275,"threshold_uncertainty_score":0.7952528},"labels":[],"label_agreement":null},{"id":"W4220876924","doi":"10.1158/1538-7445.sabcs21-p5-18-02","title":"Abstract P5-18-02: Final findings from the CONTROL trial of diarrheal prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"","keywords":"Neratinib; Loperamide; Medicine; Internal medicine; Diarrhea; Oncology; Metastatic breast cancer; Breast cancer; Gastroenterology; Cancer; Trastuzumab","score_opus":0.059989679698916235,"score_gpt":0.35446006608337843,"score_spread":0.2944703863844622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220876924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926265,0.00006854244,0.0000015962277,0.0028672365,0.00021250444,0.0031366302,0.0009772814,0.00001767875,0.00009201447],"genre_scores_gemma":[0.997792,0.00003525774,0.0000066156304,0.00021141786,0.0002097826,0.0010363513,0.00008480633,0.000028153923,0.0005956343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967032,0.00044028545,0.0004849308,0.00049438555,0.0013938724,0.00048329326],"domain_scores_gemma":[0.9983903,0.0007077187,0.00016880457,0.00034878615,0.00025600102,0.00012837982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001378241,0.0001997823,0.0004952854,0.0001744764,0.00034710168,0.00007200408,0.00019921824,0.00006771535,0.0029191605],"category_scores_gemma":[0.00028858354,0.000126915,0.00006642531,0.0007722709,0.00020824179,0.00012394546,0.00011295839,0.001003599,0.0000014430764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10067272,0.00065032486,0.8879263,0.00006250769,0.00011655644,0.000015856847,0.0007370726,0.00032820806,0.00006502734,0.0000105783165,0.0011715799,0.008243254],"study_design_scores_gemma":[0.065888934,0.0029452129,0.9303044,0.000115060706,0.00003449715,2.0674267e-7,0.00016200589,0.00018157857,0.00004450171,0.0000104983665,0.00019437181,0.000118751275],"about_ca_topic_score_codex":0.019541275,"about_ca_topic_score_gemma":0.005127495,"teacher_disagreement_score":0.042378075,"about_ca_system_score_codex":0.0008155666,"about_ca_system_score_gemma":0.0006116282,"threshold_uncertainty_score":0.9979923},"labels":[],"label_agreement":null},{"id":"W4220883416","doi":"10.1158/1538-7445.sabcs21-p4-12-11","title":"Abstract P4-12-11: Eq-5d-5l utility scores for patients with breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Children's Hospital of Eastern Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University Health Network; University of Toronto","funders":"","keywords":"EQ-5D; Medicine; Visual analogue scale; Breast cancer; Anxiety; Depression (economics); Quality of life (healthcare); Reimbursement; Metastatic breast cancer; Cancer; Physical therapy; Hospital Anxiety and Depression Scale; Disease; Health care; Internal medicine; Psychiatry; Health related quality of life","score_opus":0.5195523338642936,"score_gpt":0.4946422369932038,"score_spread":0.02491009687108975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220883416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644032,0.0015561415,0.00008434401,0.019623121,0.0007427914,0.0025008067,0.009949383,0.00004700849,0.0010931806],"genre_scores_gemma":[0.9906906,0.000114151764,0.00014463089,0.0018698552,0.0005112257,0.0052896976,0.00013113683,0.00006996368,0.0011787509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547666,0.00034397992,0.001824562,0.00092591526,0.00044407469,0.0009848269],"domain_scores_gemma":[0.9967702,0.0010265048,0.0008199068,0.00070365856,0.00037617443,0.00030358144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014400272,0.0002093163,0.0007187746,0.00044541218,0.0010758885,0.00012800778,0.00065218017,0.00008887466,0.01004364],"category_scores_gemma":[0.00075054704,0.00023951012,0.000117516436,0.0004314331,0.0002080108,0.0004240906,0.00022003263,0.0005278132,0.00019784505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034644332,0.0003199778,0.8832803,0.000577246,0.0000999752,9.292192e-7,0.0009864415,0.00048955117,0.000003900156,0.005689633,0.10689049,0.0013151596],"study_design_scores_gemma":[0.001997055,0.00016550993,0.8308175,0.00007642745,0.000005154171,0.0000010176968,0.0005480783,0.00055731984,0.000009207127,0.0031618932,0.1623118,0.00034902367],"about_ca_topic_score_codex":0.019843126,"about_ca_topic_score_gemma":0.0050412263,"teacher_disagreement_score":0.05542132,"about_ca_system_score_codex":0.002474187,"about_ca_system_score_gemma":0.0010249224,"threshold_uncertainty_score":0.9908613},"labels":[],"label_agreement":null},{"id":"W4220884345","doi":"10.1158/1538-7445.sabcs21-p5-16-11","title":"Abstract P5-16-11: Ipatasertib (ipat) in combination with palbociclib (palbo) and fulvestrant (fulv) in patients (pts) with hormone receptor-positive (HR+) HER2-negative advanced breast cancer (aBC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Palbociclib; Medicine; Breast cancer; Fulvestrant; Internal medicine; Cancer; Oncology; Aromatase inhibitor; Tamoxifen; Pharmacology; Metastatic breast cancer","score_opus":0.021763398283629904,"score_gpt":0.333341173949691,"score_spread":0.3115777756660611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220884345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918811,0.0014278764,0.000014087753,0.0027293765,0.000080839694,0.0024979953,0.0011160253,0.00004869995,0.00020402341],"genre_scores_gemma":[0.9952004,0.0007129211,0.00019918679,0.00023405142,0.00007357278,0.0029716496,0.00027213138,0.00011662288,0.00021944856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99543554,0.0003496278,0.0004908787,0.0010077769,0.001652415,0.0010637471],"domain_scores_gemma":[0.99808115,0.00026344226,0.0002146046,0.00045127762,0.000668954,0.00032056822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067624875,0.00042511846,0.0006558651,0.00061641855,0.00036786363,0.00004867589,0.00027683185,0.00010367401,0.0006367594],"category_scores_gemma":[0.000047284124,0.00036038982,0.00004322584,0.0018492086,0.00065637974,0.0005706508,0.00018245091,0.0015438234,0.000005289515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06312507,0.0025598612,0.74375445,0.000419018,0.0003097127,0.00024388278,0.010074151,0.0018556287,0.010879632,0.00014203394,0.00040829257,0.16622825],"study_design_scores_gemma":[0.024840565,0.0026860475,0.96216214,0.0010421715,0.000029137225,0.000028803539,0.0043264027,0.000041293686,0.0031786403,0.0002074161,0.00097057637,0.00048677996],"about_ca_topic_score_codex":0.014338842,"about_ca_topic_score_gemma":0.012435172,"teacher_disagreement_score":0.21840769,"about_ca_system_score_codex":0.003932191,"about_ca_system_score_gemma":0.0009246245,"threshold_uncertainty_score":0.9998915},"labels":[],"label_agreement":null},{"id":"W4220885597","doi":"10.1158/1538-7445.sabcs21-pd5-06","title":"Abstract PD5-06: Safety of assisted reproductive technologies (ART) following treatment completion in young women with germline <i>BRCA</i> pathogenic variants having a pregnancy after breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Intracytoplasmic sperm injection; Assisted reproductive technology; Breast cancer; Infertility; Fertility preservation; Population; Gynecology; Retrospective cohort study; In vitro fertilisation; Cancer; Obstetrics; Oncology; Fertility; Internal medicine; Biology","score_opus":0.04828632299476925,"score_gpt":0.35460601250735474,"score_spread":0.3063196895125855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220885597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077016,0.005148107,0.0000072341477,0.001755565,0.0001392984,0.0014808526,0.00030931243,0.00006811213,0.00032134829],"genre_scores_gemma":[0.9940808,0.00048040127,0.000074878924,0.000011798764,0.00007533551,0.004418033,0.000046977453,0.00002851097,0.000783288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704665,0.0003236465,0.00041400024,0.0010128524,0.00057283964,0.0006300041],"domain_scores_gemma":[0.9985758,0.00007415503,0.00013051627,0.00086350075,0.00028842158,0.00006759142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001390039,0.00020760401,0.0005484003,0.00029781842,0.00025136324,0.000009565069,0.00017943754,0.00010267924,0.00052161235],"category_scores_gemma":[0.00012239812,0.00015885831,0.0000849353,0.0009625485,0.00044309706,0.00011035112,0.00020809995,0.000710735,0.0000036227586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031036146,0.0011441975,0.71954525,0.00020848152,0.00048892305,0.00036828854,0.0024408656,0.00006389142,0.21195461,0.000008515321,0.00006916015,0.0326717],"study_design_scores_gemma":[0.0022831764,0.00069318566,0.99088496,0.0004976546,0.00004382984,0.00007723885,0.001744481,0.0000094050465,0.0032127586,0.000060498434,0.00034419735,0.0001486131],"about_ca_topic_score_codex":0.0012498477,"about_ca_topic_score_gemma":0.0006689189,"teacher_disagreement_score":0.27133974,"about_ca_system_score_codex":0.0030980464,"about_ca_system_score_gemma":0.0006755018,"threshold_uncertainty_score":0.8101284},"labels":[],"label_agreement":null},{"id":"W4220892713","doi":"10.1158/1538-7445.sabcs21-p1-09-04","title":"Abstract P1-09-04: Flaxseed &amp; breast cancer: A systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Internal medicine; Placebo; Cancer; Clinical trial; Oncology; Meta-analysis; Relative risk; Confidence interval; Pathology; Alternative medicine","score_opus":0.24364249884582184,"score_gpt":0.5309520993828485,"score_spread":0.28730960053702664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220892713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013039241,0.9812557,3.9427786e-7,0.0011388239,0.0004080035,0.014033806,0.001037371,0.00010455966,0.0020083142],"genre_scores_gemma":[0.000010205158,0.96418315,0.0000076154333,0.00019521159,0.0010610304,0.024122888,0.00038130907,0.00028001438,0.009758545],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889007,0.0021280064,0.001563923,0.001361323,0.004128006,0.0019179909],"domain_scores_gemma":[0.9940306,0.0015142459,0.0004977773,0.0023106504,0.00065174076,0.000995004],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006910177,0.00081968366,0.0063941134,0.0010011117,0.0006153496,0.00014341845,0.001472321,0.00041591414,0.019393988],"category_scores_gemma":[0.00095168926,0.00053993147,0.0014988799,0.0031013829,0.0004077699,0.00010829718,0.0007981061,0.005428037,0.0012816122],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040625328,0.0001625526,0.0000025824302,0.78938717,0.00094617263,0.0003353758,0.000022145945,1.9663044e-7,0.000012362532,0.000011865542,0.02649163,0.18258733],"study_design_scores_gemma":[0.00022169645,0.00006860774,0.0000050468384,0.47485155,0.0014231812,0.00040568222,0.000010401842,5.024616e-7,0.0000010546752,0.000003086219,0.5227414,0.00026780766],"about_ca_topic_score_codex":0.0018173978,"about_ca_topic_score_gemma":0.0001331215,"teacher_disagreement_score":0.49624977,"about_ca_system_score_codex":0.003761242,"about_ca_system_score_gemma":0.008645412,"threshold_uncertainty_score":0.9997052},"labels":[],"label_agreement":null},{"id":"W4220900778","doi":"10.1158/1538-7445.sabcs21-p1-18-03","title":"Abstract P1-18-03: Alpelisib + fulvestrant in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), <i>PIK3CA</i>-mutated advanced breast cancer (ABC) previously treated with cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + aromatase inhibitor (AI): 18-month follow-up of BYLieve Cohort A","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Rash; Internal medicine; Maculopapular rash; Letrozole; Clinical endpoint; Cohort; Oncology; Cancer; Hazard ratio; Breast cancer; Adverse effect; Confidence interval; Clinical trial; Estrogen receptor; Tamoxifen","score_opus":0.02095730569695405,"score_gpt":0.3205103256317687,"score_spread":0.29955301993481465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220900778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756997,0.00176156,0.000013089134,0.00082659815,0.00029148432,0.008000292,0.012964591,0.0001994234,0.0002432572],"genre_scores_gemma":[0.990268,0.0005061963,0.00033489053,0.000230071,0.00036319735,0.005417103,0.001995559,0.00040223118,0.00048273164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98882276,0.0009497318,0.0016823094,0.002271456,0.003995155,0.0022785973],"domain_scores_gemma":[0.9938414,0.00045842453,0.0009774852,0.0011982583,0.0024940749,0.001030333],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010111047,0.0012521251,0.0020879472,0.001041295,0.00080857024,0.00010293377,0.00077972544,0.00030920774,0.0035745907],"category_scores_gemma":[0.00016605688,0.0010451173,0.0002802589,0.0027981517,0.001371632,0.0010839863,0.00041496436,0.002987154,0.000022569446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23034817,0.007281109,0.45213273,0.001194067,0.003092885,0.0009555421,0.0074374126,0.0015784798,0.26825225,0.000022485641,0.004446244,0.023258623],"study_design_scores_gemma":[0.0613809,0.009856927,0.75107574,0.0032612246,0.00034498723,0.00006363081,0.0027510459,0.000024690506,0.16895851,0.00003725624,0.00050489506,0.0017401786],"about_ca_topic_score_codex":0.015687486,"about_ca_topic_score_gemma":0.0026119787,"teacher_disagreement_score":0.29894304,"about_ca_system_score_codex":0.0054098247,"about_ca_system_score_gemma":0.0022337341,"threshold_uncertainty_score":0.999313},"labels":[],"label_agreement":null},{"id":"W4220902905","doi":"10.1158/1538-7445.sabcs21-p5-13-10","title":"Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; Queen's University","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Biomarker; Gastroenterology; Urology","score_opus":0.07302284824606578,"score_gpt":0.4411081391265313,"score_spread":0.3680852908804655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220902905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844482,0.0006113017,0.000011219612,0.0020695506,0.0005213123,0.009224975,0.0029713307,0.000045071836,0.00009702653],"genre_scores_gemma":[0.9794329,0.00025622375,0.00013599804,0.0000886457,0.00017246319,0.018473553,0.00022031192,0.00011452459,0.0011053752],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99416745,0.0008277157,0.0013613931,0.0007716832,0.0017651174,0.00110664],"domain_scores_gemma":[0.9964744,0.0016299069,0.0004179012,0.00053803035,0.0006799317,0.000259867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032085157,0.00037907303,0.0018310419,0.0010217662,0.00016347656,0.000025459636,0.0004463067,0.000102994105,0.0032439684],"category_scores_gemma":[0.0010898623,0.00032753666,0.0003242439,0.0014473639,0.0004348678,0.00021324606,0.00018768015,0.0010291113,0.000005176815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9557629,0.0037038834,0.00303588,0.0005215841,0.0005763029,0.000046964757,0.0018079515,0.0008134795,0.012598996,0.000025291656,0.00050655456,0.020600189],"study_design_scores_gemma":[0.97986406,0.0015399975,0.008665775,0.00043062377,0.00011573496,0.000006169655,0.000769052,0.0007709518,0.005856599,0.00043710542,0.0012341709,0.000309745],"about_ca_topic_score_codex":0.00319095,"about_ca_topic_score_gemma":0.00067670643,"teacher_disagreement_score":0.024101151,"about_ca_system_score_codex":0.0018979323,"about_ca_system_score_gemma":0.0018087605,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W4220923359","doi":"10.1158/1538-7445.sabcs21-p3-03-20","title":"Abstract P3-03-20: The association of preoperative MRI with surgical decision-making in patients with early-stage breast cancer: A multi-institutional analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Mastectomy; Breast MRI; Stage (stratigraphy); Cohort; Cancer; Retrospective cohort study; Breast surgery; Surgery; Internal medicine; Mammography","score_opus":0.017406511115963252,"score_gpt":0.34133965851962556,"score_spread":0.3239331474036623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220923359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972646,0.00045269539,0.000059865117,0.00038889446,0.000031773638,0.0004084187,0.0012640092,0.0000037481896,0.00012597721],"genre_scores_gemma":[0.9987593,0.00012854036,0.000091000315,0.000020598047,0.000052655578,0.0006933699,0.000088390814,0.000013543388,0.00015259112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799967,0.00018862466,0.00018424848,0.00039243538,0.0009112776,0.0003237329],"domain_scores_gemma":[0.9989662,0.0001331228,0.00012168115,0.00024107064,0.0004972522,0.000040640964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004863342,0.00013748827,0.00022064382,0.00015387677,0.00042084913,0.000025909821,0.00023226638,0.00004711199,0.00022924335],"category_scores_gemma":[0.000028242624,0.00008387415,0.00006869142,0.0009863066,0.00018467303,0.00001158433,0.00022278388,0.000291882,9.924605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027382264,0.0002655031,0.9627625,0.000009401003,0.0009819303,0.000009947749,0.00039377162,0.031492714,0.000108676606,0.000014791706,0.000103152684,0.0011194169],"study_design_scores_gemma":[0.0021788809,0.0001729099,0.9960639,0.00004472933,0.00007169399,0.000001091118,0.0002608675,0.000076451346,0.0002689664,0.0000023338205,0.0007491392,0.000109038716],"about_ca_topic_score_codex":0.0029398568,"about_ca_topic_score_gemma":0.012489238,"teacher_disagreement_score":0.03330143,"about_ca_system_score_codex":0.00077174004,"about_ca_system_score_gemma":0.0005598003,"threshold_uncertainty_score":0.69692874},"labels":[],"label_agreement":null},{"id":"W4220929390","doi":"10.1158/1538-7445.sabcs21-p2-01-02","title":"Abstract P2-01-02: A whole blood assay to identify breast cancer: Interim analysis of the international identify breast cancer (IDBC) study evidence supporting the Syantra DX breast cancer test","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Breast cancer; Medicine; Cancer; Mammography; Internal medicine; Oncology; Blood test; Asymptomatic; Interim analysis; Interim; Clinical trial","score_opus":0.07178420171157927,"score_gpt":0.44811904367409483,"score_spread":0.37633484196251554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220929390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696518,0.002054337,0.000023090226,0.02077258,0.0010046702,0.0010518602,0.005319972,0.000019737121,0.00010193251],"genre_scores_gemma":[0.9920236,0.0013132658,0.0000037679297,0.00054644654,0.00072191865,0.0034048278,0.00006512381,0.000059838414,0.0018612321],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99456185,0.0006171902,0.0008120889,0.0011683778,0.0020576278,0.0007828467],"domain_scores_gemma":[0.9965788,0.00015754656,0.00055169297,0.0012886085,0.0011821325,0.00024122765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027587602,0.00033790185,0.0004205498,0.00041733307,0.0008751584,0.0002969146,0.0027073855,0.00011758799,0.0058373176],"category_scores_gemma":[0.00018923615,0.00024864727,0.00035676616,0.0023588233,0.00029099113,0.000049928818,0.0018396453,0.0008484992,0.0000088599545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035194802,0.00042332333,0.24926187,0.000045854933,0.0011200143,0.0000061688297,0.0007122107,0.0024518496,0.7228132,0.0000036438466,0.014663975,0.008145974],"study_design_scores_gemma":[0.0006444776,0.00009087098,0.9353311,0.00027007627,0.00051326444,0.000033700933,0.004187655,0.00022485848,0.054021053,0.0000072063885,0.0043473546,0.00032839645],"about_ca_topic_score_codex":0.01747963,"about_ca_topic_score_gemma":0.011231238,"teacher_disagreement_score":0.68606925,"about_ca_system_score_codex":0.00069550663,"about_ca_system_score_gemma":0.0016079212,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W4220930047","doi":"10.1158/1538-7445.sabcs21-p3-22-01","title":"Abstract P3-22-01: The past and present of breast cancer resources: A re-evaluation of the quality of online resources in breast cancer after eight years","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Readability; Breast cancer; Medicine; Descriptive statistics; Quality (philosophy); Cancer; Computer science; Internal medicine; Statistics; Mathematics","score_opus":0.18844832893703617,"score_gpt":0.552361561670203,"score_spread":0.36391323273316684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220930047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97657055,0.0025091406,4.2786849e-7,0.0134144295,0.00020742888,0.0017719257,0.004955384,0.0000064338487,0.0005642637],"genre_scores_gemma":[0.9965163,0.000545604,0.0000069036337,0.0005058966,0.00024251072,0.0019003556,0.0000148344,0.000016080352,0.00025151772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9902473,0.004873692,0.0017623538,0.00031364817,0.002277467,0.00052552903],"domain_scores_gemma":[0.9959959,0.0009458346,0.0009360987,0.0007419733,0.0012682194,0.000112013775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016198209,0.00012866386,0.00036938302,0.00022533636,0.00053515757,0.000013214403,0.0006206837,0.000110297515,0.007907896],"category_scores_gemma":[0.00021481737,0.000080438076,0.00007581106,0.0011346666,0.00050086627,0.0002749624,0.0006843821,0.0014802888,0.0000014582395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023022266,0.0002433475,0.9251172,0.0022697088,0.00003760068,3.184779e-7,0.042168777,0.0007061403,0.000414278,0.0000332707,0.0043776548,0.022329466],"study_design_scores_gemma":[0.0010524127,0.000021603733,0.9740964,0.00066924037,0.000013385784,4.729841e-7,0.010635806,0.00072387065,0.00003101863,0.00011803008,0.0125622405,0.000075496624],"about_ca_topic_score_codex":0.07250663,"about_ca_topic_score_gemma":0.013152038,"teacher_disagreement_score":0.059354596,"about_ca_system_score_codex":0.0008372065,"about_ca_system_score_gemma":0.0019934895,"threshold_uncertainty_score":0.992999},"labels":[],"label_agreement":null},{"id":"W4220954053","doi":"10.1158/1538-7445.sabcs21-p5-18-04","title":"Abstract P5-18-04: Combination plinabulin+pegfilgrastim (Plin+Peg) had better toxicity management and health related quality-of-life (HrQoL) compared to Peg alone in early-stage breast cancer (BC) patients (pts) treated with taxotere, doxorubicin and cyclophosphamide (TAC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Neutropenia; Cardiotoxicity; Internal medicine; Heart failure; Anthracycline; Toxicity; Surgery; Cancer; Breast cancer","score_opus":0.09027019231753095,"score_gpt":0.3950600458236136,"score_spread":0.3047898535060827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220954053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057424,0.00057437166,0.000018876972,0.004927658,0.00011251403,0.0027843888,0.00048935344,0.000051367504,0.0004672043],"genre_scores_gemma":[0.9961191,0.0006640552,0.00007507082,0.0005881508,0.00003848063,0.0012727494,0.00014640014,0.000060480612,0.0010355253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959984,0.0003917574,0.0008535752,0.00081241794,0.0011766515,0.0007671986],"domain_scores_gemma":[0.99823284,0.00012304111,0.00027926828,0.00044772757,0.00039082023,0.00052629644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013608176,0.000306179,0.0007976698,0.0006571869,0.0005147271,0.000057589634,0.00019477024,0.000085360894,0.00077718805],"category_scores_gemma":[0.000022994405,0.00028491282,0.00005571613,0.0015104891,0.00024818684,0.00015861858,0.00031746464,0.0009922946,0.000006891274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003936232,0.00096299825,0.9822357,0.00077623373,0.00022422573,0.000059498736,0.0009781528,0.0006466772,0.0010186799,0.00010014381,0.0020477592,0.0070136883],"study_design_scores_gemma":[0.009534149,0.0009910055,0.98625934,0.00044284278,0.000038890346,0.000007892026,0.00068434776,0.00009271029,0.00087077415,0.000045251847,0.0007609265,0.00027186045],"about_ca_topic_score_codex":0.10531572,"about_ca_topic_score_gemma":0.008800599,"teacher_disagreement_score":0.09651512,"about_ca_system_score_codex":0.0015309852,"about_ca_system_score_gemma":0.0004058796,"threshold_uncertainty_score":0.9999603},"labels":[],"label_agreement":null},{"id":"W4220956892","doi":"10.1158/1538-7445.sabcs21-p4-10-22","title":"Abstract P4-10-22: Patient reported symptoms and functional status in breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Children's Hospital of Eastern Ontario; University of Toronto; University Health Network; St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Logistic regression; Comorbidity; Internal medicine; Metastatic breast cancer; Physical therapy; Pediatrics","score_opus":0.07170124349806363,"score_gpt":0.3907391592256297,"score_spread":0.31903791572756607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220956892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863092,0.0070099183,1.8932923e-7,0.003987622,0.00023212361,0.0006172081,0.00031837847,0.000021428013,0.0015039336],"genre_scores_gemma":[0.9932304,0.0022920214,0.0000037995635,0.00025964342,0.00016120977,0.0030836512,0.00006289145,0.000026923804,0.0008794772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976587,0.0000685188,0.0002758453,0.00046126897,0.0009954856,0.000540154],"domain_scores_gemma":[0.999109,0.000102195234,0.00006223705,0.00026499125,0.00021131839,0.00025024448],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000355075,0.0001238839,0.00022655216,0.0002748556,0.00022920879,0.000028527797,0.00004064433,0.000037261074,0.023371281],"category_scores_gemma":[0.000022748956,0.00011011687,0.000050678445,0.0005414476,0.00010975307,0.000057015164,0.00016144523,0.00050400425,0.000009780544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001981573,0.0008581511,0.8132833,0.000119264245,0.000253702,0.0006019847,0.00052350544,0.0003019895,0.0030266126,0.00006352716,0.06445889,0.114527486],"study_design_scores_gemma":[0.0023923686,0.00028456983,0.94047207,0.00011814336,0.000026717595,0.00007358599,0.00032316922,0.000027407115,0.000528807,0.000043798504,0.05560387,0.00010552266],"about_ca_topic_score_codex":0.02185557,"about_ca_topic_score_gemma":0.001232792,"teacher_disagreement_score":0.12718873,"about_ca_system_score_codex":0.0024047971,"about_ca_system_score_gemma":0.0011372239,"threshold_uncertainty_score":0.984658},"labels":[],"label_agreement":null},{"id":"W4220961745","doi":"10.1158/1538-7445.sabcs21-p5-13-36","title":"Abstract P5-13-36: Germline <i>BRCA</i>1/2 and other predisposition genes in high-risk early-stage HR+/HER2- breast cancer (BC) patients treated with endocrine therapy (ET) with or without palbociclib: A secondary analysis from the PENELOPE-B study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CHEK2; Medicine; Oncology; Internal medicine; Breast cancer; PALB2; Cancer; Germline; Hazard ratio; Germline mutation; Genetics; Mutation; Biology; Gene; Confidence interval","score_opus":0.03400871225458401,"score_gpt":0.3600987525816422,"score_spread":0.3260900403270582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220961745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907588,0.0022017285,0.000015486368,0.00091080624,0.00004123241,0.003040965,0.00290075,0.00007793443,0.00005230671],"genre_scores_gemma":[0.9930078,0.001365347,0.00007633718,0.00046945544,0.00020581069,0.0037593895,0.00018186828,0.00016224473,0.00077179587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538165,0.0007815801,0.00047105865,0.0010529903,0.0015382401,0.0007744911],"domain_scores_gemma":[0.9978896,0.00033459533,0.00027426603,0.0008187839,0.00045646654,0.00022632776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007160738,0.0004647946,0.0008214943,0.00045125087,0.0005502923,0.00011662205,0.00038160838,0.00005978176,0.0042232135],"category_scores_gemma":[0.000012512113,0.00026603183,0.00008083436,0.0023236617,0.00040466493,0.0002891895,0.0001930996,0.0013083688,0.000002904945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03962599,0.0010666839,0.92213976,0.00003574793,0.0023967258,0.00014313134,0.004971493,0.0014211565,0.00059299066,0.000001326069,0.000036820904,0.027568176],"study_design_scores_gemma":[0.018253436,0.0022823163,0.97300005,0.00014747451,0.00039309677,0.000013937736,0.0034933786,0.00009503257,0.00059949054,0.000009580911,0.00136775,0.00034445658],"about_ca_topic_score_codex":0.29716343,"about_ca_topic_score_gemma":0.13728786,"teacher_disagreement_score":0.15987557,"about_ca_system_score_codex":0.00072853174,"about_ca_system_score_gemma":0.0007880806,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W4220967821","doi":"10.1158/1538-7445.sabcs21-p4-12-01","title":"Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"","keywords":"Medicine; Palbociclib; Adjuvant; Internal medicine; Pill; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Pharmacology","score_opus":0.1864431683296825,"score_gpt":0.4594538310750189,"score_spread":0.2730106627453364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220967821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877977,0.0026993433,0.000016987657,0.003875998,0.00011943497,0.0036366154,0.00003832651,0.000061739935,0.0017538941],"genre_scores_gemma":[0.9903112,0.00072490243,0.00016611209,0.00075411913,0.000490003,0.0061046067,0.00001657477,0.000084722924,0.0013477574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99559826,0.00039777788,0.00032489546,0.0006317472,0.0021194192,0.00092789275],"domain_scores_gemma":[0.9983091,0.00042999172,0.000116955285,0.00081539364,0.00016403491,0.00016457678],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001063922,0.00028213684,0.0005134281,0.0002414124,0.00040774693,0.000060068836,0.00062555785,0.00003981493,0.0036518164],"category_scores_gemma":[0.000051659703,0.00014244001,0.000059216112,0.0011728201,0.00050244917,0.00014404864,0.000116561765,0.0017006507,0.000011177258],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8147645,0.0011558381,0.04115462,0.00016256409,0.00031102222,0.0017670406,0.0066712457,0.00041215908,0.016237434,0.00014028007,0.00066855515,0.11655472],"study_design_scores_gemma":[0.50894755,0.05224785,0.1348424,0.0011646702,0.00009969589,0.0014236607,0.026780939,0.00010400575,0.017005548,0.00059293624,0.25538394,0.0014067905],"about_ca_topic_score_codex":0.0022489242,"about_ca_topic_score_gemma":0.0031735187,"teacher_disagreement_score":0.30581695,"about_ca_system_score_codex":0.00046902453,"about_ca_system_score_gemma":0.0017579399,"threshold_uncertainty_score":0.99725896},"labels":[],"label_agreement":null},{"id":"W4220973733","doi":"10.1158/1538-7445.sabcs21-p1-18-17","title":"Abstract P1-18-17: Phase I study of cfi-402257, an oral ttk inhibitor, in patients with advanced solid tumors with breast cancer expansion cohorts","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; Breast cancer; Cancer; Internal medicine; Oncology; Fulvestrant; Response Evaluation Criteria in Solid Tumors; Triple-negative breast cancer; Chemotherapy; Progressive disease; Adverse effect; Estrogen receptor","score_opus":0.024611612887634214,"score_gpt":0.36918062786544525,"score_spread":0.34456901497781106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220973733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753463,0.0003985869,0.000002924821,0.00004900488,0.00011004092,0.0011455736,0.00067928474,0.00000688208,0.00007309285],"genre_scores_gemma":[0.9984458,0.00015500809,0.000021777141,0.000060287013,0.00011671503,0.00085513573,0.00022399251,0.000057618792,0.00006367658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757904,0.00013255222,0.00031641623,0.0006502905,0.00079403544,0.0005276582],"domain_scores_gemma":[0.9986908,0.000024251985,0.00013618267,0.0005369082,0.00043012286,0.0001817652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039709616,0.00020776254,0.00031603753,0.00017629158,0.00022016541,0.00003031094,0.00032914974,0.00005449341,0.0003047845],"category_scores_gemma":[0.00001917676,0.0001815274,0.000030235133,0.00045276177,0.00015293543,0.00001766163,0.0002975488,0.00039470795,4.858483e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024736932,0.010713193,0.71069396,0.00011872976,0.00022009676,0.00012804227,0.0016535543,0.04819955,0.16219749,0.0000051856223,0.0033315672,0.038001698],"study_design_scores_gemma":[0.0333252,0.028251523,0.85897124,0.0002516644,0.000060510203,0.000010783005,0.006405296,0.00012780956,0.06808328,0.000016749767,0.0034805224,0.0010154579],"about_ca_topic_score_codex":0.0040352046,"about_ca_topic_score_gemma":0.0071911793,"teacher_disagreement_score":0.14827724,"about_ca_system_score_codex":0.00029029735,"about_ca_system_score_gemma":0.0009967594,"threshold_uncertainty_score":0.74024725},"labels":[],"label_agreement":null},{"id":"W4220978230","doi":"10.1158/1538-7445.sabcs21-p4-10-15","title":"Abstract P4-10-15: Whole-body vibration combined with physical exercise to treat aromatase inhibitor-induced musculoskeletal symptoms in breast cancer women: Results of a pilot randomized controlled study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Physical therapy; Whole body vibration; Randomized controlled trial; WOMAC; Cancer; Aromatase inhibitor; Osteoarthritis; Internal medicine; Physical medicine and rehabilitation; Tamoxifen; Alternative medicine; Pathology","score_opus":0.028336843282527033,"score_gpt":0.3870256262619594,"score_spread":0.35868878297943235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220978230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98482704,0.0001947348,2.4638223e-7,0.0029582584,0.00014855457,0.010848032,0.00066164776,0.00004303214,0.0003184689],"genre_scores_gemma":[0.9679171,0.000056376546,0.0000022746297,0.000079305304,0.0002878256,0.030274233,0.00015259156,0.00005425008,0.0011760668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954526,0.0009615185,0.0007430982,0.00071824057,0.0013852272,0.00073933933],"domain_scores_gemma":[0.9978633,0.0007231504,0.00021372036,0.00046395947,0.00036343196,0.00037246113],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001979587,0.0003422345,0.002013336,0.000718077,0.00021534863,0.00003425928,0.0002279945,0.000050155602,0.0012484026],"category_scores_gemma":[0.000079665806,0.00024645252,0.00019657714,0.0013199818,0.00019734041,0.00013147917,0.0001718654,0.00066821155,0.000015306803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78817993,0.0073936665,0.00084903504,0.00014621919,0.00052640814,0.0001957368,0.003612074,0.00023321857,0.19466393,0.000004818453,0.0026276836,0.0015672756],"study_design_scores_gemma":[0.95090216,0.016237333,0.020641223,0.0002843955,0.0004937535,0.000007999737,0.0021443681,0.00020527332,0.008684048,0.000018131897,0.00007761767,0.00030369693],"about_ca_topic_score_codex":0.006336328,"about_ca_topic_score_gemma":0.0005418328,"teacher_disagreement_score":0.18597987,"about_ca_system_score_codex":0.0019686366,"about_ca_system_score_gemma":0.0011574846,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W4220983579","doi":"10.1158/1538-7445.sabcs21-p5-02-01","title":"Abstract P5-02-01: A FACS-free purification method to study estrogen signaling, organoid formation, and metabolic reprogramming in mammary epithelial cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Organoid; Cell biology; Biology; Warburg effect; Matrigel; Reprogramming; Estrogen receptor; Flow cytometry; Cell; Metabolism; Molecular biology; Glycolysis; Endocrinology; Biochemistry; Breast cancer; Cancer","score_opus":0.07927431138580993,"score_gpt":0.4115245471433436,"score_spread":0.33225023575753365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220983579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989108,0.004540579,0.0014653851,0.0018468046,0.00011573665,0.002606121,0.00009333131,0.000042930318,0.00018109384],"genre_scores_gemma":[0.98710966,0.0004849045,0.009313684,0.0001798166,0.00019880304,0.0022314428,0.000025947016,0.000044875473,0.0004108491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996947,0.00045144168,0.00044747812,0.00058380427,0.0010320459,0.0005382212],"domain_scores_gemma":[0.9985676,0.00012183761,0.00008823229,0.0007222062,0.00023105755,0.00026908077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004446391,0.00015655904,0.00036358312,0.00058470777,0.0003192496,0.00008762398,0.00035872046,0.00004263979,0.0006584806],"category_scores_gemma":[0.00014725828,0.00015298532,0.00006231355,0.0013604834,0.000039083963,0.00015895031,0.0004616753,0.000659429,0.000012876697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062085764,0.0005293856,0.0025012523,0.00015881323,0.000110189925,0.00010821953,0.0071095293,0.00019275096,0.62554574,0.00015379183,0.00093349087,0.362036],"study_design_scores_gemma":[0.0041537085,0.00075826753,0.013100762,0.00004152427,0.00011014699,0.000037365113,0.009007618,0.000056312376,0.8325772,0.00033602622,0.13953651,0.0002845378],"about_ca_topic_score_codex":0.003291841,"about_ca_topic_score_gemma":0.0002551418,"teacher_disagreement_score":0.36175144,"about_ca_system_score_codex":0.00037442904,"about_ca_system_score_gemma":0.00042844057,"threshold_uncertainty_score":0.72099006},"labels":[],"label_agreement":null},{"id":"W4220987969","doi":"10.1158/1538-7445.sabcs21-ot1-14-01","title":"Abstract OT1-14-01: Zanidatamab in combination with ALX148 in advanced human epidermal growth factor receptor 2 (HER2)-expressing cancers, including breast cancer: A phase 1b/2, multicenter, open-label, dose-finding and cohort-expansion study (ZWI-ZW25-204)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Breast cancer; Cancer; Trastuzumab; Antibody; Metastatic breast cancer; Combination therapy; Oncology; Cancer research; Phases of clinical research; Immune system; CD47; Internal medicine; Chemotherapy; Immunology","score_opus":0.14462866124921506,"score_gpt":0.4732179216635033,"score_spread":0.32858926041428826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220987969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098724,0.0015484509,0.0000026646212,0.0019406213,0.00018037124,0.0044278363,0.0005744859,0.000039236704,0.0002990933],"genre_scores_gemma":[0.9949811,0.0013255212,0.00011495731,0.00012702403,0.0001517589,0.002435589,0.00022618624,0.00009450546,0.00054333656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937863,0.000803584,0.0007612288,0.0012377098,0.002079311,0.001331911],"domain_scores_gemma":[0.99803394,0.00042209777,0.00022927046,0.00044389375,0.00043173955,0.00043905483],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022749116,0.00041991757,0.0008439585,0.0010263666,0.0012125109,0.00024439004,0.0007164338,0.00010371529,0.0015427474],"category_scores_gemma":[0.00013625143,0.00037441944,0.000040360126,0.0016198826,0.00030872988,0.00081639964,0.0014956576,0.0023001418,0.0000053633894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017367058,0.007862578,0.6882003,0.0007327553,0.00023561079,0.000800212,0.0057533304,0.000120735865,0.22756882,0.00004111446,0.00085108145,0.050466415],"study_design_scores_gemma":[0.08710691,0.0045916624,0.88384336,0.0022840335,0.000054605727,0.000063491025,0.007853891,0.0014102657,0.009385662,0.000037751022,0.0025060074,0.000862341],"about_ca_topic_score_codex":0.0765665,"about_ca_topic_score_gemma":0.013310565,"teacher_disagreement_score":0.21818316,"about_ca_system_score_codex":0.003481307,"about_ca_system_score_gemma":0.0012084396,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W4220990421","doi":"10.1158/1538-7445.sabcs21-es13-3","title":"Abstract ES13-3: Novel epigenomic targets in TNBC","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epigenomics; Triple-negative breast cancer; Epigenetics; Breast cancer; Cancer; Triple negative; Cancer research; Medicine; Bioinformatics; Epigenesis; Computational biology; Oncology; Biology; DNA methylation; Genetics; Internal medicine; Gene","score_opus":0.07074015856699441,"score_gpt":0.3973169133295152,"score_spread":0.3265767547625208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220990421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881317,0.009010313,0.00008780151,0.00030432112,0.0001664106,0.00021277937,0.000058144175,0.000003863257,0.002024664],"genre_scores_gemma":[0.99713176,0.001212445,0.00008790499,0.00004827433,0.00018882198,0.00024268375,0.00008175509,0.000022283066,0.0009840388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987584,0.00008979131,0.00015622182,0.00032637303,0.00030353444,0.0003656951],"domain_scores_gemma":[0.99953157,0.000028446062,0.00003072177,0.0002648562,0.00007575858,0.00006864922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010049582,0.000075505646,0.00008164808,0.00012441186,0.0001895073,0.000019096859,0.00026054136,0.000055377463,0.0004930935],"category_scores_gemma":[0.0000764328,0.00008407747,0.000038832233,0.0002162627,0.000055392135,0.0000020333277,0.00029091857,0.0003047658,0.000012989029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063880005,0.0000709179,0.0029942247,0.000010312426,0.000010509268,0.000005799975,0.00007161864,0.0028378586,0.99027234,0.000045785608,0.0007906001,0.002826167],"study_design_scores_gemma":[0.0006880353,0.00019748542,0.052596956,0.0000064333376,0.0000017633422,7.550965e-7,0.00017906564,0.000044520908,0.7500066,0.00036770062,0.1957265,0.00018418967],"about_ca_topic_score_codex":0.00061235536,"about_ca_topic_score_gemma":0.00050924777,"teacher_disagreement_score":0.24026573,"about_ca_system_score_codex":0.00013865603,"about_ca_system_score_gemma":0.0003412103,"threshold_uncertainty_score":0.53990287},"labels":[],"label_agreement":null},{"id":"W4220991301","doi":"10.1158/1538-7445.sabcs21-gs1-01","title":"Abstract GS1-01: KEYNOTE-522 study of neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Carboplatin; Placebo; Internal medicine; Oncology; Pembrolizumab; Epirubicin; Stage (stratigraphy); Chemotherapy; Cyclophosphamide; Cisplatin; Cancer; Pathology; Immunotherapy","score_opus":0.07198443318772366,"score_gpt":0.4048215236955636,"score_spread":0.33283709050783994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220991301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864732,0.0034671917,0.00008559595,0.0024197958,0.00040948397,0.0055901404,0.0011642273,0.000105888634,0.00028448124],"genre_scores_gemma":[0.99248916,0.0016070846,0.000052755877,0.0003698986,0.00028540965,0.0014355548,0.00013177306,0.00020763672,0.0034207457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9926275,0.00095927954,0.0010306386,0.0013696392,0.002600159,0.0014128009],"domain_scores_gemma":[0.995938,0.0011387574,0.00043818893,0.0015634692,0.00050163065,0.00041992252],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00445983,0.00066265155,0.001580483,0.00063646043,0.0008920843,0.0001262795,0.0007093015,0.00022549693,0.001645322],"category_scores_gemma":[0.0002084786,0.0006174691,0.0004942601,0.0011759376,0.0005337767,0.00022703139,0.00042407008,0.0011410277,0.0000028803197],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40835702,0.0032940605,0.023269318,0.0007196835,0.0024304937,0.0002547602,0.0054377527,0.00015206123,0.5149112,0.00001396285,0.02888037,0.012279337],"study_design_scores_gemma":[0.32084897,0.02834861,0.44178903,0.0005468267,0.0006674665,0.00013834791,0.01840625,0.0019337749,0.13075341,0.00010059955,0.054090176,0.0023765403],"about_ca_topic_score_codex":0.013903177,"about_ca_topic_score_gemma":0.00327965,"teacher_disagreement_score":0.4185197,"about_ca_system_score_codex":0.0012233306,"about_ca_system_score_gemma":0.0010230996,"threshold_uncertainty_score":0.99962765},"labels":[],"label_agreement":null},{"id":"W4220992683","doi":"10.1158/1538-7445.sabcs21-p5-13-03","title":"Abstract P5-13-03: Alpelisib + endocrine therapy (ET) in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), <i>PIK3CA</i>-mutated advanced breast cancer (ABC) previously treated with cyclin-dependent kinase 4/6 inhibitor (CDK4/6i): Biomarker analyses from the Phase II BYLieve study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Cohort; Letrozole; Breast cancer; Oncology; Hazard ratio; Cancer; Clinical endpoint; Progression-free survival; Estrogen receptor; Confidence interval; Aromatase; Clinical trial; Chemotherapy","score_opus":0.05369898673042435,"score_gpt":0.40153964004033166,"score_spread":0.3478406533099073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220992683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786032,0.0038738053,0.00001005571,0.0021746685,0.00016122952,0.008491617,0.006384647,0.0001818741,0.00011892557],"genre_scores_gemma":[0.9895932,0.0010459181,0.00013776925,0.00049519684,0.00031808042,0.006484421,0.001225153,0.00032544826,0.00037478187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898271,0.0019014355,0.001170183,0.0020546368,0.0032546874,0.0017919383],"domain_scores_gemma":[0.99470353,0.0008749891,0.00069230737,0.0012080878,0.0019176183,0.00060345116],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008924664,0.0011129811,0.0014876268,0.0006694332,0.0016478931,0.00014854371,0.0008869832,0.00013230389,0.003832078],"category_scores_gemma":[0.00012329144,0.0007320744,0.00021299381,0.0029175682,0.0009923375,0.000834865,0.00051720213,0.0024786585,0.000015324416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21901345,0.021406692,0.35030606,0.00009526564,0.005459756,0.00068720244,0.018684408,0.0010241513,0.2839743,0.0000049777927,0.0014335271,0.09791022],"study_design_scores_gemma":[0.08333506,0.014198046,0.8421112,0.0006719864,0.00023144227,0.000018263865,0.007903687,0.00001918476,0.049839817,0.000022409764,0.0005457181,0.0011031961],"about_ca_topic_score_codex":0.046280004,"about_ca_topic_score_gemma":0.005667158,"teacher_disagreement_score":0.49180514,"about_ca_system_score_codex":0.0035892553,"about_ca_system_score_gemma":0.0011718667,"threshold_uncertainty_score":0.9998227},"labels":[],"label_agreement":null},{"id":"W4221000688","doi":"10.1158/1538-7445.sabcs21-p3-18-04","title":"Abstract P3-18-04: Evaluating <b>de</b>-escalation of <b>b</b>reast <b>r</b>adiation (<b>DEBRA</b>) following lumpectomy for breast conservative treatment of stage 1, hr+, HER2-, RS ≤18 breast cancer: NRG-BR007 a phase III trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Tamoxifen; Oncology; Radiation therapy; Internal medicine; Stage (stratigraphy); Aromatase inhibitor; Breast-conserving surgery; Cancer; Mastectomy; Gynecology","score_opus":0.12485161086553026,"score_gpt":0.47297774146934857,"score_spread":0.3481261306038183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221000688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858058,0.002630972,0.00018246665,0.00082381314,0.00037404415,0.002783472,0.0071147066,0.000027081633,0.000257644],"genre_scores_gemma":[0.9921196,0.0005457526,0.00020629977,0.00003793106,0.0006115825,0.005379467,0.0005400218,0.000087134016,0.00047219484],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961097,0.00047178386,0.00076016487,0.00084298226,0.0010023762,0.000812956],"domain_scores_gemma":[0.9976322,0.00030088634,0.0005318627,0.00053683587,0.0008161999,0.0001820123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013893879,0.00038095258,0.00069147506,0.0002700189,0.00065226236,0.000036675418,0.00034194434,0.00014897258,0.0007140392],"category_scores_gemma":[0.00010151105,0.00038883695,0.00043615545,0.00060821563,0.00028067242,0.000034255343,0.00019822014,0.00022326682,0.0000012203935],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15587239,0.004055519,0.021857334,0.0004344015,0.0028793546,0.000020263204,0.003437861,0.0036892379,0.63747025,0.0001178925,0.0019994762,0.16816604],"study_design_scores_gemma":[0.455672,0.01902954,0.16845573,0.00073049,0.0014065034,0.00008813054,0.012979109,0.0045975493,0.3265231,0.00045680048,0.007901998,0.0021590625],"about_ca_topic_score_codex":0.009364923,"about_ca_topic_score_gemma":0.0008401974,"teacher_disagreement_score":0.31094712,"about_ca_system_score_codex":0.0015585583,"about_ca_system_score_gemma":0.0021559852,"threshold_uncertainty_score":0.99985635},"labels":[],"label_agreement":null},{"id":"W4221004188","doi":"10.1158/1538-7445.sabcs21-ot2-25-01","title":"Abstract OT2-25-01: Irene study: Phase 2 study of Incmga00012 and the oncolytic virus pelareorep in metastatic triple negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Breast cancer; Triple-negative breast cancer; Tumor microenvironment; Metastatic breast cancer; Cancer; Internal medicine; Oncology; Immunotherapy; CD8; Cancer research; Immune system; Immunology","score_opus":0.06852457087173387,"score_gpt":0.44466513314767286,"score_spread":0.376140562275939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221004188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920939,0.0035622718,9.568805e-7,0.00042874928,0.00007789589,0.0032606616,0.00041345443,0.0000059927156,0.00015607485],"genre_scores_gemma":[0.9948979,0.00071107957,0.0000030501287,0.00006556599,0.00010666493,0.003822351,0.00001795001,0.000047673115,0.0003277577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99494606,0.0021210166,0.00045398716,0.00066374906,0.0011995438,0.0006156166],"domain_scores_gemma":[0.9984868,0.00024324392,0.00013088564,0.00070611807,0.00029085943,0.00014210533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004329621,0.00021439385,0.0004221981,0.00029948447,0.0004426366,0.000050701412,0.0007204116,0.000042180232,0.0010145723],"category_scores_gemma":[0.00015259522,0.00016752897,0.00007003933,0.001033703,0.0005155894,0.000011922748,0.0007765526,0.0008076426,0.0000025924824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14361759,0.019268107,0.02684338,0.0002196654,0.0022685383,0.00029366586,0.025589405,0.0039538164,0.677371,0.000027400527,0.0027083864,0.097839005],"study_design_scores_gemma":[0.24987668,0.08638515,0.15100166,0.00017263659,0.0004315248,0.00007615115,0.19429067,0.0015788628,0.30846632,0.0008809389,0.004791563,0.0020478508],"about_ca_topic_score_codex":0.021134969,"about_ca_topic_score_gemma":0.041289218,"teacher_disagreement_score":0.36890474,"about_ca_system_score_codex":0.0003139452,"about_ca_system_score_gemma":0.0010281908,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W4221005563","doi":"10.1158/1538-7445.sabcs21-p2-11-08","title":"Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Neoadjuvant therapy; Pandemic; Cancer; Population; Stage (stratigraphy); Internal medicine; Oncology; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.0783945053906604,"score_gpt":0.47417430679031014,"score_spread":0.39577980139964974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221005563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944168,0.0032164396,0.000011224078,0.00006796614,0.000018675197,0.00034036458,0.0018530404,0.0000028947425,0.00007264201],"genre_scores_gemma":[0.9971013,0.0023882154,0.000026458863,0.000027805108,0.000013894962,0.00012452855,0.0002949338,0.000012301723,0.000010556055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822044,0.00034422002,0.00030682713,0.00033892554,0.000563387,0.00022620134],"domain_scores_gemma":[0.9986638,0.00019448923,0.00023181926,0.00034739217,0.00047162423,0.0000909076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005004202,0.00012629134,0.0003594142,0.00017621316,0.00015171277,0.000005501748,0.00018297855,0.000049528604,0.00013602164],"category_scores_gemma":[0.00011703415,0.0001061108,0.00018957112,0.00037121322,0.00019641744,0.0000036542456,0.00026137594,0.00014232368,6.753364e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001712201,0.00029102655,0.91125274,0.00021828891,0.0016769224,8.05861e-7,0.0011967756,0.0035092374,0.07561456,0.000009167565,0.00008947341,0.00442881],"study_design_scores_gemma":[0.0023590133,0.0016656995,0.98254806,0.000019989262,0.00006628283,2.3146148e-7,0.0017412442,0.000010274622,0.011391424,0.000012005239,0.0000901006,0.00009568923],"about_ca_topic_score_codex":0.017119283,"about_ca_topic_score_gemma":0.0034024199,"teacher_disagreement_score":0.07129531,"about_ca_system_score_codex":0.00053054397,"about_ca_system_score_gemma":0.0012822429,"threshold_uncertainty_score":0.9894258},"labels":[],"label_agreement":null},{"id":"W4221013240","doi":"10.1158/1538-7445.sabcs21-pd13-05","title":"Abstract PD13-05: Alpelisib + fulvestrant in patients with <i>PIK3CA</i>-mutated, HR+, HER2— advanced breast cancer (ABC) who received chemotherapy or endocrine therapy (ET) as immediate prior treatment: BYLieve Cohort C primary results and exploratory biomarker analyses","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Cohort; Letrozole; Oncology; Clinical endpoint; Breast cancer; Cancer; Metastatic breast cancer; Palbociclib; Clinical trial; Tamoxifen","score_opus":0.06264451628072079,"score_gpt":0.4018803996710633,"score_spread":0.3392358833903425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221013240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98080397,0.008921751,0.0000031671211,0.0044255126,0.0001837952,0.0036991928,0.0014407139,0.00012269574,0.0003991901],"genre_scores_gemma":[0.9594129,0.032228008,0.00024291432,0.001466144,0.00017375332,0.004499974,0.00047998477,0.00025988612,0.0012364521],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99379647,0.0005054808,0.0008566523,0.0015518668,0.0019015792,0.0013879358],"domain_scores_gemma":[0.99707586,0.00039420626,0.00035653813,0.0009325587,0.00071393745,0.0005269204],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082582084,0.00074099295,0.0012006825,0.00074003683,0.00052649394,0.000086620086,0.00039572886,0.00011610848,0.0010708636],"category_scores_gemma":[0.000049080394,0.0005307124,0.00013618499,0.0018915802,0.0007104851,0.0006471352,0.00015603962,0.0010503022,0.0000067491665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2412988,0.0025478324,0.117960796,0.0002476465,0.0017943474,0.000845234,0.004023244,0.00079487805,0.04476993,0.0000030501346,0.00051182794,0.5852024],"study_design_scores_gemma":[0.064594984,0.0034801953,0.900712,0.00066673633,0.00008768478,0.00010513332,0.0018173762,0.000025802157,0.0107876295,0.00002918083,0.01695094,0.0007423185],"about_ca_topic_score_codex":0.004772349,"about_ca_topic_score_gemma":0.0009514683,"teacher_disagreement_score":0.7827512,"about_ca_system_score_codex":0.0031022609,"about_ca_system_score_gemma":0.0024615822,"threshold_uncertainty_score":0.9998423},"labels":[],"label_agreement":null},{"id":"W4221038606","doi":"10.1158/1538-7445.sabcs21-pd10-05","title":"Abstract PD10-05: Activity of atezolizumab (atezo) plus paclitaxel (pac) in metastatic triple-negative breast cancer (mTNBC) according to Burstein molecular subtype: Analysis of the IMpassion131 trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Oncology; Internal medicine; Triple-negative breast cancer; Taxane; Clinical endpoint; Breast cancer; Population; Progression-free survival; Paclitaxel; Adjuvant; Cancer; Randomized controlled trial; Chemotherapy; Immunotherapy; Nivolumab","score_opus":0.08240046586389813,"score_gpt":0.4384546055163097,"score_spread":0.3560541396524116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221038606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113,0.0010189853,0.00011067202,0.0036190492,0.00029839843,0.0024527635,0.0012339758,0.00001920018,0.0001169435],"genre_scores_gemma":[0.99737936,0.00009860799,0.00008409336,0.000104517945,0.00008845009,0.0018428488,0.00001228455,0.00006189353,0.00032796312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994838,0.0008564268,0.0007048966,0.0006836469,0.002100423,0.0008166242],"domain_scores_gemma":[0.9971921,0.00057456066,0.00042873542,0.0009368005,0.0006212101,0.0002466168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018209848,0.00030027181,0.0012453693,0.0013837762,0.00024661815,0.000021125361,0.0006521174,0.00007239978,0.0014500826],"category_scores_gemma":[0.0004781017,0.000231004,0.00045358678,0.007427371,0.00037945554,0.00018056257,0.00055027264,0.0011598764,0.0000020623975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20586778,0.0010947449,0.012277806,0.0005850623,0.0050902446,0.0001597734,0.0059122555,0.056087706,0.6317598,0.00020083194,0.00029557067,0.08066838],"study_design_scores_gemma":[0.10313149,0.0023397023,0.57223713,0.0012805836,0.0024216422,0.00004492801,0.018826472,0.0025969588,0.2942352,0.0010132923,0.0008352571,0.0010373568],"about_ca_topic_score_codex":0.030161329,"about_ca_topic_score_gemma":0.0019321705,"teacher_disagreement_score":0.5599593,"about_ca_system_score_codex":0.0035419657,"about_ca_system_score_gemma":0.0025956393,"threshold_uncertainty_score":0.9994627},"labels":[],"label_agreement":null},{"id":"W4221038695","doi":"10.1158/1538-7445.sabcs21-pd7-07","title":"Abstract PD7-07: Surgical management and contralateral breast cancer risk in women with a history of radiation therapy for Hodgkin lymphoma: Results from a population-based cohort","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Population; Cohort; Cumulative incidence; Cancer; Incidence (geometry); Retrospective cohort study; Surgery; Oncology; Internal medicine","score_opus":0.017587551216228674,"score_gpt":0.3030637881315245,"score_spread":0.28547623691529583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221038695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905352,0.0055806157,0.000002943924,0.0004126629,0.00006823223,0.0007355856,0.0025830837,0.0000051028096,0.00007655454],"genre_scores_gemma":[0.99362946,0.0023780458,0.00002834278,0.000047915368,0.000093653514,0.0032819542,0.00033198597,0.000018234881,0.00019043685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866104,0.00013092082,0.00019694497,0.00041754442,0.00029686364,0.00029669932],"domain_scores_gemma":[0.9994983,0.00006757682,0.00010127976,0.00019832692,0.00007999869,0.00005452442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043992858,0.00011726811,0.00018560055,0.00009416667,0.000104782055,0.000008449251,0.00010511822,0.0000419526,0.000107404114],"category_scores_gemma":[0.000007232802,0.000103351376,0.000028667268,0.000104557,0.000095059,0.0000053410454,0.000055662626,0.000083130646,1.7434292e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04031201,0.0003193662,0.88055634,0.000050125564,0.0005639776,0.0000172403,0.0006464863,0.0018990821,0.0013563344,0.000008942466,0.0028898257,0.071380265],"study_design_scores_gemma":[0.0111616375,0.0001955283,0.97786766,0.000022969047,0.000014204881,0.0000011759064,0.00010222638,0.000058360176,0.00047098333,0.000025457646,0.009964873,0.00011491486],"about_ca_topic_score_codex":0.026115496,"about_ca_topic_score_gemma":0.00097284623,"teacher_disagreement_score":0.097311325,"about_ca_system_score_codex":0.0014778656,"about_ca_system_score_gemma":0.0003232278,"threshold_uncertainty_score":0.9803697},"labels":[],"label_agreement":null},{"id":"W4221044842","doi":"10.1158/1538-7445.sabcs21-pd8-01","title":"Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Oncology; Gastroenterology; Cancer; Breast cancer","score_opus":0.05967525828412634,"score_gpt":0.4021295240335063,"score_spread":0.34245426574938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221044842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304134,0.0012533425,0.000004683864,0.002000345,0.00009450311,0.0022341476,0.0011756406,0.00002318759,0.00017282972],"genre_scores_gemma":[0.9956803,0.00076262327,0.00004950977,0.00021555222,0.00015790416,0.0014634074,0.000115773204,0.0000930148,0.0014619328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923838,0.0007088453,0.00080769125,0.001004301,0.0038150987,0.0012802712],"domain_scores_gemma":[0.9976905,0.00029903068,0.00021174662,0.00071998406,0.0007020259,0.00037669696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016936577,0.00046138305,0.0013482653,0.0012307534,0.00037114305,0.000072674695,0.00061286904,0.00007325259,0.019281978],"category_scores_gemma":[0.00002827014,0.000350596,0.00029826554,0.002839572,0.00038117313,0.00019858801,0.00027823274,0.0015074599,0.000012582927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06614285,0.021380758,0.8768939,0.0005759775,0.005177879,0.000582207,0.00584149,0.0006493271,0.0019270997,0.000009340016,0.0008926652,0.019926533],"study_design_scores_gemma":[0.025809182,0.005478722,0.9633618,0.00013947736,0.00032094656,0.000008679261,0.0021874541,0.0003449766,0.00035294658,0.00002617666,0.0015831518,0.0003864946],"about_ca_topic_score_codex":0.030467281,"about_ca_topic_score_gemma":0.0060463957,"teacher_disagreement_score":0.08646792,"about_ca_system_score_codex":0.0011457071,"about_ca_system_score_gemma":0.0012292209,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W4221046989","doi":"10.1158/1538-7445.sabcs21-es9-1","title":"Abstract ES9-1: Local therapy of the primary tumor in de novo Stage IV breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Breast cancer; Randomization; Context (archaeology); Clinical trial; Metastatic breast cancer; Cancer; Internal medicine; Radiation therapy; Randomized controlled trial; Surgery; Oncology; Primary tumor; Quality of life (healthcare); Metastasis","score_opus":0.036271400163727416,"score_gpt":0.36204085423999566,"score_spread":0.32576945407626823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221046989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916954,0.0054144654,0.0000035113542,0.0013423678,0.00011108675,0.00031258116,0.00049708295,0.0000045120532,0.00061900925],"genre_scores_gemma":[0.99634224,0.0017845628,0.000006670974,0.00034975447,0.00013047492,0.00090339186,0.0000135279515,0.00002678364,0.00044260008],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844325,0.00018210082,0.000161387,0.00032157672,0.00045297094,0.00043871682],"domain_scores_gemma":[0.9993772,0.000029349028,0.000056005905,0.00037194075,0.00011549912,0.000050042803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047107515,0.000119358956,0.00015272609,0.0000621702,0.00021045415,0.000008737206,0.00043739518,0.000038148064,0.000567071],"category_scores_gemma":[0.000010249028,0.00009157908,0.000069377165,0.00034277642,0.00032877258,0.0000035468456,0.0004701142,0.0003410038,0.0000012009192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022680738,0.0004397294,0.4675195,0.00011328511,0.00020489679,0.000028705497,0.0005190644,0.003094949,0.4722776,0.000030552383,0.0037177014,0.04978594],"study_design_scores_gemma":[0.0014466041,0.00008527126,0.8898708,0.00003529434,0.0000034666652,0.000016063075,0.00038868404,0.000008026275,0.09484121,0.00001868395,0.013165563,0.000120303615],"about_ca_topic_score_codex":0.0055256807,"about_ca_topic_score_gemma":0.0016349603,"teacher_disagreement_score":0.42235136,"about_ca_system_score_codex":0.00068878935,"about_ca_system_score_gemma":0.0011307714,"threshold_uncertainty_score":0.8353213},"labels":[],"label_agreement":null},{"id":"W4221056009","doi":"10.1158/1538-7445.sabcs21-gs1-08","title":"Abstract GS1-08: CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Statistics Canada; Juravinski Cancer Centre; University of British Columbia; McMaster University; Queen's University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Metformin; Breast cancer; Placebo; Internal medicine; Cancer; Randomized controlled trial; Oncology; Clinical trial; Diabetes mellitus; Endocrinology; Insulin; Pathology","score_opus":0.18884914232113492,"score_gpt":0.5005900067145773,"score_spread":0.3117408643934424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221056009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97404176,0.0021867636,0.00001296194,0.0015814869,0.00095578405,0.01793836,0.0020780682,0.000029261568,0.0011755604],"genre_scores_gemma":[0.9903512,0.0021064822,0.000016804874,0.00008101256,0.00076419866,0.0048058443,0.0001486063,0.0000707463,0.0016551099],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98197645,0.006503719,0.0056836805,0.0011511731,0.003605235,0.0010797417],"domain_scores_gemma":[0.98000723,0.014878648,0.0023349053,0.0014431985,0.0008477974,0.00048820235],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.056993235,0.00051469356,0.00754909,0.0016492226,0.000306166,0.00006355104,0.00086067966,0.00033312783,0.0033490332],"category_scores_gemma":[0.004988432,0.0003298822,0.0030667032,0.003937612,0.0011596322,0.00015979548,0.00051046786,0.002799552,0.0000058778874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9729634,0.0031805637,0.0011283415,0.00016347077,0.005865681,0.00006123715,0.0012387924,0.0012640919,0.0012412093,0.00003408012,0.0029932447,0.009865885],"study_design_scores_gemma":[0.9837982,0.0017463543,0.0059036263,0.0002848033,0.0037249771,0.000006814951,0.0004171189,0.0008445784,0.0011604988,0.000014590296,0.0017916653,0.0003067511],"about_ca_topic_score_codex":0.06753797,"about_ca_topic_score_gemma":0.005970797,"teacher_disagreement_score":0.061567172,"about_ca_system_score_codex":0.0014016604,"about_ca_system_score_gemma":0.0055985833,"threshold_uncertainty_score":0.9999153},"labels":[],"label_agreement":null},{"id":"W4221062043","doi":"10.1158/1538-7445.sabcs21-gs2-07","title":"Abstract GS2-07: Updated results from a phase 3 randomized clinical trial in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) ≤ 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): SWOG S1007 (RxPONDER)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Taxane; Medicine; Post-hoc analysis; Internal medicine; Oncology; Breast cancer; Clinical trial; Cancer","score_opus":0.08411709192082865,"score_gpt":0.44281978933278765,"score_spread":0.358702697411959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221062043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96366364,0.004429146,0.00021610617,0.014863486,0.00027351378,0.012834055,0.0033512304,0.00015096916,0.00021785818],"genre_scores_gemma":[0.9750325,0.009546396,0.000919818,0.0015306487,0.0005960805,0.011300002,0.0004068489,0.00025594843,0.0004117555],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98634917,0.0054926323,0.0018985289,0.0022342093,0.00226281,0.0017626623],"domain_scores_gemma":[0.9887128,0.0073337005,0.0007974976,0.000952008,0.0012898096,0.0009141932],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008422742,0.00093902973,0.0036379148,0.0006476146,0.0005959822,0.00015693618,0.0005986177,0.00014947203,0.0024786384],"category_scores_gemma":[0.0010857391,0.0006694745,0.00034146666,0.0021309566,0.0025558823,0.00046743272,0.00027066647,0.0022887536,0.000025522748],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9275772,0.002222504,0.0008631721,0.000029677427,0.0023653796,0.000388196,0.006809665,0.00025020682,0.004421177,0.000048183214,0.00041387376,0.054610748],"study_design_scores_gemma":[0.9690314,0.0031075166,0.014964788,0.0012958903,0.00022119917,0.00007399097,0.001993194,0.00026978934,0.00722828,0.0002697584,0.0007330731,0.0008111222],"about_ca_topic_score_codex":0.03481241,"about_ca_topic_score_gemma":0.0014118693,"teacher_disagreement_score":0.05379963,"about_ca_system_score_codex":0.0018108842,"about_ca_system_score_gemma":0.0028140943,"threshold_uncertainty_score":0.9995757},"labels":[],"label_agreement":null},{"id":"W4221068889","doi":"10.1158/1538-7445.sabcs21-p4-12-04","title":"Abstract P4-12-04: Healthcare utilization and symptoms among hospitalized patients with breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Nausea; Constipation; Cancer; Cohort; Internal medicine; Pediatrics; Emergency medicine","score_opus":0.05843556415484868,"score_gpt":0.39435043695212024,"score_spread":0.33591487279727156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221068889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895388,0.0039812573,5.167901e-7,0.004102414,0.00013620815,0.0013829846,0.00056804257,0.000034443303,0.00025535273],"genre_scores_gemma":[0.9944517,0.0017862228,0.0000050580657,0.00024219381,0.000121608726,0.0029006996,0.0001447429,0.000044448178,0.0003033204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977705,0.00008047802,0.00018124079,0.0004580825,0.0010475466,0.00046218035],"domain_scores_gemma":[0.9989319,0.000047948302,0.000067272726,0.00028109428,0.0003899654,0.0002818206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022178232,0.00014964583,0.00025665743,0.0001734461,0.00043956898,0.000043568387,0.0000889962,0.000042683547,0.0023281819],"category_scores_gemma":[0.000009840886,0.00011766899,0.000040023217,0.00042416237,0.00017030387,0.00010341139,0.00012374774,0.0003901932,0.0000032137123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007864681,0.00034814677,0.9448379,0.00019669355,0.00012958562,0.000027187194,0.00040048757,0.000021933576,0.000019777064,0.00004119163,0.0026978052,0.050492767],"study_design_scores_gemma":[0.003866839,0.000779115,0.99006164,0.0002539382,0.000043623855,0.000004477715,0.00015671628,0.000018732053,0.000113607246,0.000017007485,0.0045626117,0.000121676334],"about_ca_topic_score_codex":0.021394487,"about_ca_topic_score_gemma":0.0029797652,"teacher_disagreement_score":0.05037109,"about_ca_system_score_codex":0.0013544387,"about_ca_system_score_gemma":0.0005436065,"threshold_uncertainty_score":0.99858385},"labels":[],"label_agreement":null},{"id":"W4221068906","doi":"10.1158/1538-7445.sabcs21-p5-16-10","title":"Abstract P5-16-10: RLY-2608: The first allosteric mutant- and isoform-selective inhibitor of PI3Kα, is efficacious as a single agent and drives regressions in combination with standard of care therapies in <i>PIK3CA</i> mutant breast cancer models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Fulvestrant; PI3K/AKT/mTOR pathway; Allosteric regulation; Mutant; Pharmacology; Kinase; Cancer research; Estrogen receptor; Cancer; Chemistry; Breast cancer; Biology; Medicine; Receptor; Internal medicine; Signal transduction; Biochemistry","score_opus":0.030474278015578764,"score_gpt":0.33826035101037627,"score_spread":0.3077860729947975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221068906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794878,0.014276038,0.000013466615,0.0041686995,0.000039015024,0.0013658506,0.0004775513,0.000014133453,0.0001574924],"genre_scores_gemma":[0.9970653,0.0018746922,0.000034008757,0.0001157132,0.00003214385,0.00075742527,0.000009738374,0.00004780175,0.00006320005],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757,0.00014983575,0.00037832558,0.0004554105,0.00099733,0.0004491028],"domain_scores_gemma":[0.9986358,0.00022442492,0.000192053,0.0003133837,0.0005364225,0.00009787112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040426542,0.00022258789,0.0005159195,0.00038391727,0.00027051542,0.000024769015,0.0001806145,0.00006624779,0.00020682902],"category_scores_gemma":[0.000025106083,0.00015534993,0.00004276572,0.0009549862,0.0006754475,0.00020488905,0.00020458212,0.0006250648,2.151109e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06797569,0.0017518575,0.06807985,0.0025731793,0.0006977007,0.00020925333,0.3723898,0.005806835,0.22743255,0.00034753443,0.00027318433,0.25246257],"study_design_scores_gemma":[0.04963822,0.019008042,0.28937972,0.012785067,0.0002467805,0.00054860476,0.3012314,0.0013243634,0.31107455,0.005431622,0.007750957,0.0015806777],"about_ca_topic_score_codex":0.0052217576,"about_ca_topic_score_gemma":0.007807564,"teacher_disagreement_score":0.25088188,"about_ca_system_score_codex":0.0016231283,"about_ca_system_score_gemma":0.0006979418,"threshold_uncertainty_score":0.78937703},"labels":[],"label_agreement":null},{"id":"W4221076958","doi":"10.1158/1538-7445.sabcs21-ms1-1","title":"Abstract MS1-1: CRISPR screens to identify novel DNA repair defects synthetic lethal therapies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"CRISPR; Synthetic lethality; Computational biology; DNA repair; Biology; Context (archaeology); Cancer; Chromatin; Genetics; Cancer research; DNA; Gene","score_opus":0.05246282546040411,"score_gpt":0.43554529167164674,"score_spread":0.38308246621124264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221076958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927824,0.0039022274,0.0012074828,0.0004796211,0.00026146,0.00034718472,0.00008169606,0.00003742965,0.0009004948],"genre_scores_gemma":[0.99757385,0.00016312485,0.00022907564,0.00016129256,0.00031733525,0.00040380462,0.000023431236,0.000046758574,0.0010813342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821067,0.00007756875,0.0001619916,0.0004958358,0.0005124145,0.00054150727],"domain_scores_gemma":[0.9991204,0.00004102216,0.000020603507,0.00052598177,0.00013042956,0.00016153454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008423092,0.00013797425,0.00012706098,0.00013990185,0.00032644797,0.000039607432,0.00039126087,0.00006456605,0.00037879185],"category_scores_gemma":[0.00012785352,0.0001458937,0.00012222822,0.00028559368,0.00007331351,0.000002967622,0.00049989787,0.0003540555,0.000021551703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086197884,0.000054733642,0.00041791573,0.000038012604,0.000057183654,0.000013382125,0.00019620688,0.0027558699,0.98452,0.000043198306,0.010488505,0.0013287737],"study_design_scores_gemma":[0.00045568956,0.00038450063,0.024371877,0.000031419742,0.000011507822,0.000024890394,0.0009065517,0.000052690477,0.7508784,0.00003525225,0.22251633,0.000330915],"about_ca_topic_score_codex":0.0003591396,"about_ca_topic_score_gemma":0.00014659674,"teacher_disagreement_score":0.23364164,"about_ca_system_score_codex":0.000085731765,"about_ca_system_score_gemma":0.00015664523,"threshold_uncertainty_score":0.59493726},"labels":[],"label_agreement":null},{"id":"W4221083544","doi":"10.1158/1538-7445.sabcs21-pd15-05","title":"Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Letrozole; Aromatase inhibitor; Medicine; Internal medicine; Tamoxifen; Oncology; Breast cancer; Clinical endpoint; Proportional hazards model; Cancer; Aromatase; Gynecology; Randomized controlled trial","score_opus":0.03682718754772205,"score_gpt":0.4001597617387765,"score_spread":0.3633325741910544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221083544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103457,0.002504898,0.000029346704,0.00013570358,0.00033609616,0.0009450732,0.004931611,0.000006383504,0.00007629167],"genre_scores_gemma":[0.9972742,0.0006199138,0.00043440342,0.000014505894,0.00027286087,0.00079696457,0.0004992911,0.000035436216,0.000052376305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980391,0.00022875122,0.00039502513,0.0004532102,0.0004643832,0.0004194939],"domain_scores_gemma":[0.9990287,0.0000710195,0.0002115845,0.00027978633,0.00029436444,0.000114542534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088185695,0.00015624959,0.00027598022,0.00018783512,0.0001970234,0.0000097248985,0.00024155989,0.00021534285,0.00014562451],"category_scores_gemma":[0.000029837563,0.00015028236,0.00012023403,0.0002954554,0.00016129763,0.000013542028,0.00028117004,0.00046609505,3.8254282e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001974345,0.00042424642,0.0037615907,0.00013071045,0.000110642664,0.0000076130073,0.0001213783,0.0028500333,0.9841754,0.00002213538,0.001709157,0.0047127525],"study_design_scores_gemma":[0.0020955908,0.0012430187,0.017694158,0.0002532184,0.000029709123,0.000015880529,0.00035568117,0.0005707996,0.976501,0.000040385916,0.0010559096,0.00014468461],"about_ca_topic_score_codex":0.00064288406,"about_ca_topic_score_gemma":0.000029810239,"teacher_disagreement_score":0.013932568,"about_ca_system_score_codex":0.0005877878,"about_ca_system_score_gemma":0.0010738763,"threshold_uncertainty_score":0.6128337},"labels":[],"label_agreement":null},{"id":"W4221087847","doi":"10.1158/1538-7445.sabcs21-ot1-06-01","title":"Abstract OT1-06-01: A randomised trial comparing continuation or de-escalation of bone modifying agents (BMA) in patients treated for over 2 years for bone metastases from either breast or castration-resistant prostate cancer (REaCT-HOLD BMA)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Clinical endpoint; Denosumab; Randomized controlled trial; Internal medicine; Oncology; Clinical trial; Cancer; Surgery; Osteoporosis","score_opus":0.16422922007885143,"score_gpt":0.4298036303402548,"score_spread":0.2655744102614034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221087847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852614,0.00069877424,0.000021590995,0.00025473387,0.00011912358,0.010017018,0.003572252,0.000025690155,0.00002945687],"genre_scores_gemma":[0.9861136,0.00021757255,0.00012596969,0.000024634344,0.00017563476,0.010246487,0.0018407605,0.00007153802,0.0011837897],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964996,0.00030646275,0.0007630327,0.0005537083,0.0011493271,0.00072787993],"domain_scores_gemma":[0.99800915,0.00070172624,0.0003065719,0.0002763117,0.0005178769,0.00018838624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017505625,0.00023289381,0.000758375,0.00051624334,0.0002630625,0.00006855348,0.0001337047,0.0000913958,0.0009127343],"category_scores_gemma":[0.00031663693,0.00018292143,0.00017717347,0.0006755173,0.00012244511,0.00020988935,0.00007623115,0.0003843902,0.0000014656389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8785362,0.0013477278,0.042603046,0.00044569388,0.0005176343,0.000052941967,0.0019447345,0.0007363478,0.06022513,0.000005109259,0.0027617821,0.010823626],"study_design_scores_gemma":[0.5544168,0.0026491124,0.42068452,0.0006801389,0.00031419154,0.0000024585015,0.0008010863,0.0061717303,0.012858951,0.00006253412,0.001016902,0.00034160638],"about_ca_topic_score_codex":0.00922429,"about_ca_topic_score_gemma":0.0028157607,"teacher_disagreement_score":0.37808144,"about_ca_system_score_codex":0.0017363703,"about_ca_system_score_gemma":0.0014152873,"threshold_uncertainty_score":0.99938005},"labels":[],"label_agreement":null},{"id":"W4221089121","doi":"10.1158/1538-7445.sabcs21-p5-14-11","title":"Abstract P5-14-11: Retrospective analysis of VES13 questionnaire prior oncology consultation in the Senior Women’s Breast Cancer Clinic at tertiary care center, what have we learned?","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Referral; Breast cancer; Geriatric oncology; Family medicine; Medical record; Cancer; Descriptive statistics; Retrospective cohort study; Disease; Internal medicine","score_opus":0.05324888019399778,"score_gpt":0.4335206540575492,"score_spread":0.38027177386355143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221089121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657257,0.0051767523,7.4061995e-7,0.026814008,0.0003280686,0.0011789518,0.0005460229,0.000023976201,0.00020573738],"genre_scores_gemma":[0.9896005,0.0056756698,0.000007769908,0.00049885386,0.00015522508,0.0019116908,0.00014155573,0.00003325915,0.0019754907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959279,0.00083786383,0.0005624823,0.00062312227,0.0013958252,0.00065285986],"domain_scores_gemma":[0.9975921,0.0005128356,0.00022224839,0.00058108295,0.0009312873,0.00016043728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017753874,0.00018517904,0.0005694139,0.00078132295,0.00033397492,0.000044461514,0.00037849133,0.00013647148,0.0042445646],"category_scores_gemma":[0.00033783566,0.00015138547,0.00016408061,0.0017143105,0.00045537011,0.00022050305,0.00026152533,0.0013208017,0.000016455877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016460214,0.0005148276,0.84673744,0.00038451207,0.0006858269,0.00019973259,0.08927424,0.00047118915,0.0021000032,0.000008887143,0.005002257,0.05297503],"study_design_scores_gemma":[0.003244106,0.00034755736,0.91134125,0.00044200846,0.00018529649,0.000032233846,0.07876761,0.00015218696,0.00036378633,0.000022637652,0.004966529,0.00013480349],"about_ca_topic_score_codex":0.007403352,"about_ca_topic_score_gemma":0.038368065,"teacher_disagreement_score":0.06460377,"about_ca_system_score_codex":0.010638259,"about_ca_system_score_gemma":0.0015707796,"threshold_uncertainty_score":0.9992064},"labels":[],"label_agreement":null},{"id":"W4221090420","doi":"10.1158/1538-7445.sabcs21-p5-16-13","title":"Abstract P5-16-13: Safety and efficacy of INT230-6, a potential first-in-class intratumoral therapy, in monotherapy and in combination with pembrolizumab: Results from the IT-01 study [KEYNOTE-A10] in subjects with locally advanced, unresectable and metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Dosing; Breast cancer; Response Evaluation Criteria in Solid Tumors; Internal medicine; Tolerability; Oncology; Cancer; Phases of clinical research; Adverse effect; Clinical trial; Immunotherapy","score_opus":0.027447146859004182,"score_gpt":0.33030144978083276,"score_spread":0.3028543029218286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221090420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867387,0.0061226576,0.0000038446774,0.004161469,0.000038099424,0.0027176435,0.0001628025,0.000007853323,0.00004695977],"genre_scores_gemma":[0.99155444,0.0076016965,0.000017522301,0.00014239557,0.000023378881,0.00055581494,0.000023703054,0.000039414706,0.00004162096],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99703026,0.0004985157,0.00055433303,0.00063034805,0.00077854417,0.00050798047],"domain_scores_gemma":[0.9987282,0.00059677806,0.00014515457,0.00032345526,0.00012128984,0.00008509708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017830576,0.00024322636,0.0005445969,0.0004706791,0.00015793207,0.000056181936,0.00019310288,0.000051730243,0.00012665897],"category_scores_gemma":[0.000040996918,0.00016777084,0.000022782766,0.0014477661,0.00043940503,0.00019274846,0.00009931562,0.00094491296,9.48128e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5588911,0.0020207062,0.3403313,0.00015148656,0.00026318012,0.00038520145,0.014042341,0.004127465,0.0066631227,0.00000821216,0.0000698217,0.073046096],"study_design_scores_gemma":[0.08484596,0.0027518296,0.9026381,0.00070904114,0.000014806215,0.000030971292,0.007619373,0.0006438701,0.00038357457,0.000038545117,0.00013473164,0.00018922686],"about_ca_topic_score_codex":0.12044922,"about_ca_topic_score_gemma":0.31574827,"teacher_disagreement_score":0.5623068,"about_ca_system_score_codex":0.00083178916,"about_ca_system_score_gemma":0.00076982036,"threshold_uncertainty_score":0.8854078},"labels":[],"label_agreement":null},{"id":"W4221099817","doi":"10.1158/1538-7445.sabcs21-ot2-21-01","title":"Abstract OT2-21-01: A randomized, multicenter pragmatic trial comparing bone pain from a single dose of pegfilgrastim to 5 doses of daily filgrastim in breast cancer patients receiving neoadjuvant/adjuvant chemotherapy (REaCT-5G)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Breast cancer; Bone pain; Chemotherapy; Neutropenia; Febrile neutropenia; Randomized controlled trial; Surgery; Multicenter trial; Oncology; Internal medicine; Cancer; Multicenter study","score_opus":0.04701009547556543,"score_gpt":0.364894265693216,"score_spread":0.31788417021765053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221099817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191296,0.0008858263,0.000044399527,0.0014680548,0.000490292,0.0041677207,0.0005154016,0.0000329236,0.00048240865],"genre_scores_gemma":[0.9958766,0.00031680573,0.00018955162,0.00023554549,0.0002608076,0.002820865,0.000090492606,0.00007582559,0.00013350064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950937,0.00093512796,0.0012067367,0.0006310896,0.00141085,0.0007225106],"domain_scores_gemma":[0.99691314,0.0013879944,0.00041798135,0.0005142508,0.00047983817,0.00028679002],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00278999,0.00030593318,0.0015485073,0.00071923016,0.00020614173,0.00004112003,0.00034342782,0.00008646918,0.0031645645],"category_scores_gemma":[0.0005661925,0.00027510943,0.00028268123,0.0011883477,0.00025833686,0.00014487203,0.00022419613,0.0009632506,0.000007724955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.706602,0.004745306,0.08074081,0.0006248151,0.00050052383,0.000043537628,0.0059260507,0.0020419278,0.14683725,0.000006852425,0.005217342,0.046713635],"study_design_scores_gemma":[0.77499056,0.0017357157,0.20244482,0.0034435259,0.00022343226,0.000008534965,0.0018485618,0.0014892184,0.011611738,0.00009392975,0.0015593111,0.00055066246],"about_ca_topic_score_codex":0.026772993,"about_ca_topic_score_gemma":0.0026224412,"teacher_disagreement_score":0.1352255,"about_ca_system_score_codex":0.0011560133,"about_ca_system_score_gemma":0.0006896872,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W4221100020","doi":"10.1158/1538-7445.sabcs21-p5-06-11","title":"Abstract P5-06-11: <i>Secreted frizzled related protein 1</i>: From lobular involution to breast osteoimmunological disorder","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cancer research; Carcinogenesis; Wnt signaling pathway; Biology; Frizzled; Breast cancer; Pathology; Signal transduction; Internal medicine; Cancer; Medicine; Cell biology","score_opus":0.0529610139223877,"score_gpt":0.353672970010342,"score_spread":0.30071195608795426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221100020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247576,0.006323851,0.000011576812,0.007427451,0.00011119053,0.0021787286,0.00019332331,0.00012526436,0.0011528837],"genre_scores_gemma":[0.9936303,0.00009522111,0.00006350522,0.00025301674,0.00012076474,0.0022302407,0.00018211348,0.00003986657,0.003384974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969407,0.00027866662,0.00035421766,0.00058702065,0.0011914733,0.0006479349],"domain_scores_gemma":[0.99888915,0.00008368135,0.000058112306,0.00047868682,0.0002815112,0.00020886495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069598923,0.00018710879,0.00037159116,0.00021612052,0.0007587345,0.000035219164,0.00025722227,0.00012621017,0.0045334585],"category_scores_gemma":[0.00019477178,0.00016214915,0.000103949234,0.00105235,0.00023987124,0.00008204356,0.0007944262,0.0012697122,0.00036654118],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032524923,0.00059170555,0.030660722,0.00012019055,0.0003393774,0.0004383892,0.0012684163,0.000051493247,0.9365051,0.000316529,0.013531581,0.012924004],"study_design_scores_gemma":[0.01067474,0.0021854471,0.80072546,0.00084798405,0.000115720024,0.0001375022,0.009838255,0.00014815532,0.033395544,0.0031578506,0.13775112,0.0010222457],"about_ca_topic_score_codex":0.010064882,"about_ca_topic_score_gemma":0.00032988287,"teacher_disagreement_score":0.90310955,"about_ca_system_score_codex":0.00061935803,"about_ca_system_score_gemma":0.00020595656,"threshold_uncertainty_score":0.9965272},"labels":[],"label_agreement":null},{"id":"W4221101062","doi":"10.1158/1538-7445.sabcs21-p3-09-18","title":"Abstract P3-09-18: The association between genomic alterations and body mass index in patients with early breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Body mass index; Breast cancer; Internal medicine; Overweight; Logistic regression; Oncology; Cancer; Cohort","score_opus":0.04281519725770174,"score_gpt":0.3663726919007705,"score_spread":0.32355749464306877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221101062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995727,0.00027127712,0.0000026034002,0.002229081,0.000087613924,0.0007569586,0.0006052812,0.000011712467,0.00030847496],"genre_scores_gemma":[0.9982648,0.00014028577,0.0000024671322,0.000090277594,0.0002611957,0.00052749,0.000046869667,0.000026490901,0.0006401141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981435,0.00011196842,0.0001853976,0.000273164,0.0008872394,0.00039873022],"domain_scores_gemma":[0.9992726,0.00012431735,0.00007787609,0.000207084,0.00020647762,0.00011168754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006169342,0.0001006083,0.00018509914,0.00018735998,0.0003899217,0.00007067934,0.00012957587,0.00004794728,0.0011652212],"category_scores_gemma":[0.000016958127,0.00007289716,0.000027143764,0.0004834791,0.000072928924,0.00010062999,0.00009439239,0.0009043914,0.0000050173626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038562296,0.00004591606,0.99203235,0.0000203133,0.0000877944,0.0000031262598,0.00047317112,0.00010410434,0.00041210666,0.0000070582796,0.0015460015,0.0048824376],"study_design_scores_gemma":[0.0017703554,0.00016107436,0.9940094,0.000037786707,0.000025320298,4.784514e-7,0.00015958244,0.00002801781,0.00003342315,0.000024586669,0.0036640628,0.00008594252],"about_ca_topic_score_codex":0.021276126,"about_ca_topic_score_gemma":0.0021681767,"teacher_disagreement_score":0.019107949,"about_ca_system_score_codex":0.0021930307,"about_ca_system_score_gemma":0.00055746303,"threshold_uncertainty_score":0.9997479},"labels":[],"label_agreement":null},{"id":"W4221104500","doi":"10.1158/1538-7445.sabcs21-pd15-01","title":"Abstract PD15-01: Impact of <i>ESR1</i> mutations on endocrine therapy (ET) plus alpelisib benefit in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), <i>PIK3CA</i>-mutated, advanced breast cancer (ABC) who progressed on or after prior cyclin-dependent kinase inhibitor (CDK4/6i) therapy in the BYLieve trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Internal medicine; Fulvestrant; Oncology; Clinical endpoint; Hazard ratio; Progression-free survival; Clinical trial; Cancer; Estrogen receptor; Confidence interval; Breast cancer; Chemotherapy","score_opus":0.03477374645994236,"score_gpt":0.380465132983951,"score_spread":0.34569138652400866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221104500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98091173,0.0012751712,0.0000017493402,0.0024932332,0.00021600525,0.010299069,0.00463446,0.00006307619,0.00010551194],"genre_scores_gemma":[0.9844691,0.001589244,0.000084646475,0.0007225854,0.00040428666,0.01197755,0.00036273288,0.00023093002,0.0001589294],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9917757,0.0011844583,0.0011716649,0.0013590942,0.003038868,0.001470236],"domain_scores_gemma":[0.9958424,0.0012142587,0.00063273247,0.0008755479,0.0010913814,0.00034369208],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010218406,0.0008660675,0.0012631282,0.00089884194,0.0005031937,0.00010184012,0.0007248403,0.0001630496,0.0025181277],"category_scores_gemma":[0.00014471222,0.00055472524,0.00030804658,0.0021224916,0.0006627527,0.0005814531,0.00016278397,0.0026505494,0.000010042269],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8530101,0.0070142183,0.02100305,0.000100909456,0.0007441139,0.00024191877,0.013686916,0.0038707799,0.028954394,0.000028851317,0.0002550352,0.07108968],"study_design_scores_gemma":[0.18504576,0.027490726,0.74930835,0.0010718221,0.000032484983,0.000013709818,0.0020559027,0.00001434481,0.033733882,0.00009072225,0.00032106097,0.0008212306],"about_ca_topic_score_codex":0.005949234,"about_ca_topic_score_gemma":0.0012355885,"teacher_disagreement_score":0.7283053,"about_ca_system_score_codex":0.0047261687,"about_ca_system_score_gemma":0.0018994948,"threshold_uncertainty_score":0.9996904},"labels":[],"label_agreement":null},{"id":"W4221105522","doi":"10.1158/1538-7445.sabcs21-ot2-11-09","title":"Abstract OT2-11-09: Lidera breast cancer: A phase III adjuvant study of giredestrant (GDC-9545) vs physician’s choice of endocrine therapy (ET) in patients (pts) with estrogen receptor-positive, HER2-negative early breast cancer (ER+/HER2- EBC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Anastrozole; Tolerability; Internal medicine; Fulvestrant; Breast cancer; Oncology; Estrogen receptor; Cancer; Adverse effect","score_opus":0.0176347581674941,"score_gpt":0.3443360846957387,"score_spread":0.3267013265282446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221105522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934129,0.002070402,0.0000012063613,0.0003726738,0.00010694216,0.0021188078,0.0018185948,0.000013574334,0.00008490824],"genre_scores_gemma":[0.9958688,0.0020190754,0.000010034159,0.0000730092,0.0001578913,0.0015054331,0.00013562135,0.00009424778,0.0001359092],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959977,0.000667708,0.0005571849,0.00086676015,0.0010922755,0.0008183178],"domain_scores_gemma":[0.9981072,0.0000892107,0.00034370346,0.00053513155,0.0007091121,0.00021563211],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043545305,0.0004174416,0.0006490543,0.00022719252,0.00025864656,0.000033980064,0.0005695948,0.00012225936,0.00023609864],"category_scores_gemma":[0.000015592279,0.00035128658,0.00014749898,0.0008053718,0.00033048345,0.000034429417,0.00026528246,0.000871989,0.0000016917722],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032089796,0.01188732,0.3002431,0.00017963792,0.0017370962,0.0000872877,0.0038544785,0.0029098936,0.60027575,0.000015238297,0.0009709625,0.045749415],"study_design_scores_gemma":[0.031060532,0.01012038,0.6049705,0.0004270547,0.000081311875,0.000014512787,0.0016200006,0.000036196507,0.3503649,0.000007726502,0.0006430372,0.00065386563],"about_ca_topic_score_codex":0.06348599,"about_ca_topic_score_gemma":0.0026389458,"teacher_disagreement_score":0.30472738,"about_ca_system_score_codex":0.00039650634,"about_ca_system_score_gemma":0.00096255477,"threshold_uncertainty_score":0.9998939},"labels":[],"label_agreement":null},{"id":"W4221106342","doi":"10.1158/1538-7445.sabcs21-p1-12-03","title":"Abstract P1-12-03: Metaplastic carcinoma of the breast: A single-center 18-year series of 73 cases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Metaplastic carcinoma; Adenosquamous carcinoma; Triple-negative breast cancer; Breast cancer; Lumpectomy; Oncology; Internal medicine; Mastectomy; Radiation therapy; Cancer; Breast carcinoma; Population; Single Center; Chemotherapy; Adenocarcinoma","score_opus":0.13182278070949882,"score_gpt":0.35500969931622917,"score_spread":0.22318691860673034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221106342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341065,0.0009520145,5.903049e-7,0.0013196856,0.00017942162,0.00043336896,0.00045055494,0.000010209353,0.0032435262],"genre_scores_gemma":[0.99770224,0.000022633125,0.000019044486,0.00004504692,0.00011753824,0.00014459687,0.0000101677615,0.000029584015,0.0019091521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978173,0.00019227095,0.00029102675,0.0002563316,0.0010544363,0.00038864266],"domain_scores_gemma":[0.99872714,0.0001947548,0.00009301946,0.0005497014,0.0003099906,0.00012541321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005240194,0.00011799057,0.00030850375,0.00019210672,0.00024075528,0.000011761159,0.0003024334,0.000042525982,0.005176477],"category_scores_gemma":[0.0001042212,0.000082963365,0.00016735216,0.0005710744,0.00043288653,0.000059395206,0.00041189583,0.00054999336,0.000008092843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005103205,0.0019099389,0.5090436,0.0014148928,0.00033135075,0.0004580874,0.0017574704,0.00007122915,0.44966164,0.0008505657,0.02280712,0.006590938],"study_design_scores_gemma":[0.002115466,0.00095200376,0.94324774,0.0002778311,0.000099932724,0.0017787039,0.0032518993,0.000015849815,0.037989244,0.00006444931,0.010061062,0.00014582361],"about_ca_topic_score_codex":0.0014413564,"about_ca_topic_score_gemma":0.00015492902,"teacher_disagreement_score":0.43420416,"about_ca_system_score_codex":0.0002640413,"about_ca_system_score_gemma":0.00071621954,"threshold_uncertainty_score":0.9957329},"labels":[],"label_agreement":null},{"id":"W4221119482","doi":"10.1158/1538-7445.sabcs21-pd13-06","title":"Abstract PD13-06: Neoadjuvant giredestrant (GDC-9545) + palbociclib versus anastrozole + palbociclib in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer: Primary analysis of the randomized, open-label, phase II coopERA breast cancer study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Anastrozole; Palbociclib; Medicine; Breast cancer; Estrogen receptor; Internal medicine; Oncology; Clinical endpoint; Cancer; Estrogen; Aromatase inhibitor; Tamoxifen; Metastatic breast cancer; Randomized controlled trial","score_opus":0.04047341895383786,"score_gpt":0.38535084469638503,"score_spread":0.34487742574254715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221119482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977898,0.0019318641,0.0000042573283,0.0038638795,0.00021716271,0.00725124,0.008550876,0.000073209885,0.00020953728],"genre_scores_gemma":[0.98734057,0.00081716647,0.00007791978,0.00029457622,0.00018131403,0.010208274,0.00022137685,0.0001906266,0.0006681474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904983,0.0018793148,0.0013131124,0.0016065963,0.0028028672,0.0018997855],"domain_scores_gemma":[0.9951998,0.0007683386,0.00068984204,0.0013484673,0.0013766179,0.00061695004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024798526,0.0008274516,0.0027473595,0.0009994105,0.0012151902,0.00015527658,0.0016543169,0.0001485501,0.004658124],"category_scores_gemma":[0.00006791495,0.0005965365,0.00021639068,0.007535209,0.0015389692,0.00058924203,0.0012237207,0.0020652006,0.000005674179],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7757715,0.0097709,0.10041278,0.00015782307,0.015036322,0.00032188467,0.012555891,0.0072972034,0.03885184,0.000036179732,0.00024316942,0.03954451],"study_design_scores_gemma":[0.5252948,0.007711211,0.4476213,0.0007305355,0.0023305016,0.00006655743,0.011949826,0.00035293752,0.002546329,0.000024268562,0.0003925134,0.0009792899],"about_ca_topic_score_codex":0.07362477,"about_ca_topic_score_gemma":0.006190606,"teacher_disagreement_score":0.3472085,"about_ca_system_score_codex":0.005988935,"about_ca_system_score_gemma":0.0041645095,"threshold_uncertainty_score":0.99964863},"labels":[],"label_agreement":null},{"id":"W4221120760","doi":"10.1158/1538-7445.sabcs21-p2-03-04","title":"Abstract P2-03-04: Characteristics and clinical differences of breast cancer patients with negative or low HER2 expression","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Algoma University; Sault Area Hospital","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Cancer; Trastuzumab; Stage (stratigraphy); Biology","score_opus":0.13593175903646715,"score_gpt":0.479460287434435,"score_spread":0.3435285283979678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221120760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532056,0.0003225463,0.0000017586394,0.0013094465,0.00022823205,0.001198514,0.0012626625,0.00002333511,0.00033292393],"genre_scores_gemma":[0.99578786,0.0017448689,0.000054634525,0.000111561545,0.0003431975,0.0007696369,0.0000343704,0.00005844006,0.0010954413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509233,0.00048515073,0.00057562534,0.00067189144,0.0024451362,0.0007298712],"domain_scores_gemma":[0.99695724,0.00085082307,0.00019739964,0.00048447668,0.0010342693,0.00047580493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013338998,0.00021731036,0.0006346691,0.00025975332,0.00037618334,0.000048107653,0.00039504914,0.00011099393,0.008358863],"category_scores_gemma":[0.00036539766,0.0001451247,0.00006858774,0.0007278939,0.0009606063,0.00011326195,0.00055358186,0.0017674409,0.000010220269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092995055,0.0009194599,0.9409123,0.00073578826,0.00014304192,0.00008138204,0.00075254904,0.0000021221056,0.0033155233,0.000006496502,0.004449966,0.039381832],"study_design_scores_gemma":[0.0029975066,0.0016653707,0.9900446,0.0010267452,0.000028048746,0.000007540739,0.00059704075,0.00004115795,0.0020483031,0.00002027379,0.0013473124,0.00017613344],"about_ca_topic_score_codex":0.002540885,"about_ca_topic_score_gemma":0.00030800077,"teacher_disagreement_score":0.04913223,"about_ca_system_score_codex":0.00060757605,"about_ca_system_score_gemma":0.0021673676,"threshold_uncertainty_score":0.99254763},"labels":[],"label_agreement":null},{"id":"W4221133846","doi":"10.1158/1538-7445.sabcs21-p5-13-17","title":"Abstract P5-13-17: PD-L1 expression in breast to brain metastases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Oncology; Cancer; Immunotherapy; Progesterone receptor; Internal medicine; Estrogen receptor; Triple-negative breast cancer; Tissue microarray; Biomarker; Hormone receptor; Pathology; Biology","score_opus":0.09781286746448095,"score_gpt":0.44162251449385465,"score_spread":0.34380964702937367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221133846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96552914,0.002098075,0.000011899687,0.028247893,0.00012934364,0.0011052852,0.00061305467,0.00003579261,0.0022294885],"genre_scores_gemma":[0.992973,0.000085210035,0.00029016673,0.0013835335,0.00017687396,0.0013869028,0.000110059074,0.00003892255,0.0035552953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997096,0.00035081126,0.0002518008,0.00049214653,0.0011597752,0.0006494819],"domain_scores_gemma":[0.99869823,0.00031054145,0.000032951448,0.0004931442,0.00011121749,0.00035393005],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018673594,0.00015069748,0.00030092828,0.0004778822,0.00027290106,0.000034012824,0.00021286584,0.000033882672,0.01183741],"category_scores_gemma":[0.00012171769,0.00012451358,0.00009327409,0.000919411,0.00006884591,0.000065925684,0.0003753496,0.00069177034,0.000094205185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004568682,0.002132083,0.017722216,0.00027893268,0.00020157211,0.0030256014,0.0015215715,0.0015151341,0.18299684,0.00022405606,0.6976258,0.088187516],"study_design_scores_gemma":[0.007843199,0.0015012722,0.3089761,0.00058633107,0.00005729001,0.00029582763,0.00406615,0.000047665435,0.03577386,0.0003535764,0.6400193,0.00047940845],"about_ca_topic_score_codex":0.0025222441,"about_ca_topic_score_gemma":0.00029699167,"teacher_disagreement_score":0.2912539,"about_ca_system_score_codex":0.00073655363,"about_ca_system_score_gemma":0.00044086957,"threshold_uncertainty_score":0.9890659},"labels":[],"label_agreement":null},{"id":"W4225377920","doi":"10.1158/0008-5472.can-22-0855","title":"No Back-up Plan: Loss of Isozyme Diversity as a Promising Therapeutic Strategy for Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Isozyme; Cancer; Cancer cell; Enzyme; Cancer treatment","score_opus":0.10304780340742026,"score_gpt":0.39203762050059826,"score_spread":0.288989817093178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225377920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97460055,0.0204617,0.00007123029,0.00026982612,0.0014105254,0.0009145409,0.0006776105,0.000007946167,0.001586054],"genre_scores_gemma":[0.9747369,0.0035488317,0.000029716315,0.00022043345,0.0014004546,0.0005954942,0.00007418688,0.000034319695,0.019359617],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983519,0.0001510805,0.00015887017,0.00041773068,0.0004395447,0.00048089135],"domain_scores_gemma":[0.9991019,0.000030426781,0.000069609654,0.00031926378,0.0003749312,0.00010388303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055093813,0.00012451586,0.00020055841,0.00007788192,0.0004946204,0.00002150283,0.00044466392,0.00008057175,0.0012536737],"category_scores_gemma":[0.000032129497,0.00012634881,0.00011620413,0.00020443564,0.00018509706,0.000006128642,0.0006300029,0.00025168026,0.0000076221986],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027639885,0.00012387254,0.0017987043,0.00025285565,0.0002665603,0.000002077222,0.0005373715,0.00048645455,0.9317293,0.00033710417,0.040097408,0.0216043],"study_design_scores_gemma":[0.0017498522,0.00064656604,0.0006039509,0.00002178836,0.00003240488,0.0000058663895,0.00046802135,0.000050363185,0.14831921,0.00032271407,0.8475617,0.00021751582],"about_ca_topic_score_codex":0.0025756024,"about_ca_topic_score_gemma":0.0005060025,"teacher_disagreement_score":0.80746436,"about_ca_system_score_codex":0.000118592274,"about_ca_system_score_gemma":0.00096965604,"threshold_uncertainty_score":0.9996593},"labels":[],"label_agreement":null},{"id":"W4226488147","doi":"10.1158/0008-5472.can-21-3863","title":"The Genetic Evolution of Metastasis","year":2022,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"European Society for Medical Oncology","keywords":"Metastasis; Biology; Selection (genetic algorithm); Evolutionary biology; Cancer; Primary tumor; Computational biology; Genetics; Computer science","score_opus":0.12277634147822489,"score_gpt":0.44155985657918084,"score_spread":0.3187835151009559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226488147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105422994,0.9981508,0.000028605433,0.000025475367,0.00032200958,0.0005304057,0.00033752387,0.000002236936,0.00049750594],"genre_scores_gemma":[0.00009639005,0.99755555,0.000030495508,0.0000061897163,0.0004228296,0.00093601696,0.00008448152,0.000047011006,0.00082101085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813974,0.00038674247,0.00033464388,0.00036948847,0.00039988002,0.0003694883],"domain_scores_gemma":[0.99863166,0.00026896683,0.0001481106,0.0007316904,0.0001497988,0.000069786765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085088075,0.000158493,0.000393681,0.00010280737,0.000310799,0.000032976415,0.0007213593,0.00012798012,0.0001618984],"category_scores_gemma":[0.00032842977,0.000116392206,0.00029459083,0.00038911775,0.00024152872,6.6266557e-7,0.0006414021,0.00037269472,0.000008567583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017004435,0.000018268518,0.0000032497207,0.0013206493,0.00018764936,0.0000019707177,0.0000058912406,0.000015902915,0.00015453306,0.00027439467,0.012893954,0.9851065],"study_design_scores_gemma":[0.000069829824,0.00013370924,0.000003094135,0.00020549833,0.00011232451,0.0000053794197,0.000030368785,8.02292e-7,0.00014183362,0.00008157808,0.9990981,0.000117454154],"about_ca_topic_score_codex":0.0003435633,"about_ca_topic_score_gemma":0.00019908312,"teacher_disagreement_score":0.98620415,"about_ca_system_score_codex":0.00033757713,"about_ca_system_score_gemma":0.0021855792,"threshold_uncertainty_score":0.47463363},"labels":[],"label_agreement":null},{"id":"W4229579388","doi":"10.1158/1538-7445.am2019-3725","title":"Abstract 3725: Numerical simulation of tumor treating fields effects on cell structures: Mechanism and signaling pathway candidates","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiphysics; Microtubule; Physics; Chemistry; Biophysics; Finite element method; Biology; Cell biology","score_opus":0.045573523384454716,"score_gpt":0.3502357463525717,"score_spread":0.304662222968117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229579388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990616,0.00003283987,0.00007318131,0.000036300706,0.00016839431,0.00029780425,0.0000071495865,0.00002496569,0.00029780503],"genre_scores_gemma":[0.99965936,0.000016808033,0.000014387804,0.000107874446,0.000055570792,0.000016920543,3.3054954e-7,0.000015722018,0.000113040056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998633,0.000077027325,0.00013377042,0.0003671017,0.00046644927,0.00032263243],"domain_scores_gemma":[0.9982722,0.0014086874,0.00004617556,0.00015950987,0.000029853676,0.00008357737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019186494,0.00010248865,0.00014295346,0.00013834545,0.00011735071,0.00004900203,0.00016794521,0.000039723673,0.00005528304],"category_scores_gemma":[0.00030298284,0.000083425475,0.00002699288,0.00030645562,0.000043071115,0.00012828756,0.000058412752,0.00033823264,0.000010480401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037837464,0.000010417764,0.00012552996,0.00015413365,5.6549e-7,0.000017730152,0.00013163511,0.021718396,0.9759986,0.00037851703,0.0000029955272,0.0014236621],"study_design_scores_gemma":[0.00022183084,0.0002686955,0.00028369477,0.00008648656,0.0000011167955,0.0000013231872,0.000019176648,0.02258173,0.9759028,0.0005240411,0.000027565518,0.000081572754],"about_ca_topic_score_codex":0.000068130044,"about_ca_topic_score_gemma":0.0000011703603,"teacher_disagreement_score":0.0013420893,"about_ca_system_score_codex":0.000037541096,"about_ca_system_score_gemma":0.00005020562,"threshold_uncertainty_score":0.3401992},"labels":[],"label_agreement":null},{"id":"W4229735891","doi":"10.1158/1538-7445.am2019-3088","title":"Abstract 3088: Farnesyl/geranylgeranyl transferase dual inhibitor thwarts mutant KRas-driven patient-derived pancreatic tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"KRAS; Farnesyltransferase; Cancer research; Pancreatic cancer; Cancer; Prenylation; Carcinogenesis; PI3K/AKT/mTOR pathway; Protein kinase B; EGFR inhibitors; Biology; Medicine; Apoptosis; Epidermal growth factor receptor; Colorectal cancer; Internal medicine; Biochemistry","score_opus":0.03989486226974744,"score_gpt":0.351024661300706,"score_spread":0.31112979903095855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229735891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125236,0.002437222,0.00003585881,0.001872207,0.0004930161,0.0023830193,0.00015676941,0.00019042855,0.001179116],"genre_scores_gemma":[0.9968466,0.000362134,0.00017950516,0.0004550197,0.0006993566,0.0006592327,0.00005610647,0.00016309864,0.0005789574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99504817,0.0002003653,0.00065051345,0.0009746266,0.0017108155,0.0014154991],"domain_scores_gemma":[0.99730515,0.00038484496,0.00010845351,0.00091765064,0.00067071425,0.0006132075],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004893797,0.0004606097,0.0008461752,0.00042319528,0.0002695231,0.00008792316,0.00027802997,0.00020082224,0.0043351003],"category_scores_gemma":[0.0001247732,0.00039523348,0.0002369682,0.000804354,0.0004614687,0.00035795098,0.00009619682,0.0012758157,0.00061706605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028926872,0.00028334136,0.0050342176,0.0005403906,0.00022737758,0.00046775994,0.0030571811,0.00020488535,0.9514222,0.00008420757,0.00025345694,0.03553228],"study_design_scores_gemma":[0.01239565,0.0020562445,0.039251823,0.0028602097,0.00011927066,0.0002906142,0.0041709724,0.00019421118,0.9027935,0.00043448547,0.03430641,0.0011265724],"about_ca_topic_score_codex":0.000621546,"about_ca_topic_score_gemma":0.00008992602,"teacher_disagreement_score":0.048628677,"about_ca_system_score_codex":0.0008340911,"about_ca_system_score_gemma":0.0010588306,"threshold_uncertainty_score":0.99985},"labels":[],"label_agreement":null},{"id":"W4229958567","doi":"10.1158/1538-7445.am2019-2851","title":"Abstract 2851: The effects of nidogen-1 on proliferation and migration in claudin-low mammary tumor cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Flow cytometry; Metastasis; Cancer research; Annexin; Cancer; Claudin; Laminin; Cell growth; Biology; Cancer cell; Cell cycle; Cell migration; Apoptosis; Pathology; Cell; Cell biology; Immunology; Medicine; Tight junction; Extracellular matrix","score_opus":0.02972485496965457,"score_gpt":0.3465827919254634,"score_spread":0.3168579369558088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229958567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432284,0.0012911573,0.0000012032446,0.0022150418,0.0001179267,0.0013862617,0.0000040719747,0.000007753046,0.0006537668],"genre_scores_gemma":[0.9974222,0.0014593026,0.0000125728675,0.0002548058,0.00011389778,0.00036589155,0.0000042231127,0.000013323506,0.00035377184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988219,0.0000932096,0.00016691857,0.00023091603,0.00046430438,0.00022271054],"domain_scores_gemma":[0.9993206,0.00022349301,0.000042768454,0.00021719556,0.00013799644,0.000057904745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004909613,0.00008122931,0.00017136429,0.00014238009,0.000044441753,0.00002709429,0.00008873647,0.0000533249,0.00008206156],"category_scores_gemma":[0.00007013052,0.00005361135,0.000032281125,0.00027984974,0.00006760721,0.00007554974,0.00003412377,0.0003393714,0.000022204471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051869,0.00016618303,0.063811354,0.0016391064,0.000025895359,0.000010801207,0.0005910124,0.0000218217,0.9158123,0.00018327925,0.0038402765,0.013379272],"study_design_scores_gemma":[0.0010503887,0.0006422912,0.2684098,0.00078982714,0.0000076014103,0.0000013472243,0.00008392774,0.0002035603,0.7276348,0.000041347255,0.0010742447,0.000060883827],"about_ca_topic_score_codex":0.00035093585,"about_ca_topic_score_gemma":0.00017490632,"teacher_disagreement_score":0.20459843,"about_ca_system_score_codex":0.00013710615,"about_ca_system_score_gemma":0.00021618085,"threshold_uncertainty_score":0.21862073},"labels":[],"label_agreement":null},{"id":"W4229991244","doi":"10.1158/1538-7445.compsysbio-pr14","title":"Abstract PR14: Integrative functional genomics of breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Synthetic lethality; Druggability; Small hairpin RNA; Breast cancer; Cancer; Biology; Epigenetics; Somatic cell; Cancer research; Gene; Genomics; Computational biology; Copy-number variation; Functional genomics; Drug discovery; Genetics; Genome; Bioinformatics; Gene knockdown; DNA repair","score_opus":0.11672014230483745,"score_gpt":0.4073725236033889,"score_spread":0.2906523812985514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229991244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110794,0.0029486653,0.00032427232,0.0010552605,0.0003536597,0.00021053632,0.00015835236,0.0000068682093,0.0038344455],"genre_scores_gemma":[0.99570155,0.000855211,0.000049343078,0.000067256326,0.0005587245,0.0002057758,0.000050993218,0.000016546659,0.0024945685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893713,0.00006702198,0.0001546569,0.00028011858,0.0003482232,0.00021287036],"domain_scores_gemma":[0.99865454,0.000010268781,0.000064948224,0.00025958722,0.00086871977,0.0001419045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003870711,0.00008818103,0.00009834298,0.000082895,0.00005628077,0.000016497723,0.00019382309,0.00010075816,0.0004105067],"category_scores_gemma":[0.00004678111,0.00007219734,0.00004620599,0.0001919879,0.00017031544,0.000005460151,0.00009041978,0.00017559069,0.000016664288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036099504,0.00004301895,0.0017089169,0.000016002316,0.000031756972,3.442856e-7,0.00014880917,0.00020485226,0.89629936,0.0001065508,0.09421945,0.0068599205],"study_design_scores_gemma":[0.00073076505,0.000100662626,0.042813197,0.000054886583,0.0000061506735,0.000003815406,0.0011708655,0.00003277823,0.80715567,0.00022247942,0.14756086,0.0001478922],"about_ca_topic_score_codex":0.00036414745,"about_ca_topic_score_gemma":0.00020779428,"teacher_disagreement_score":0.08914373,"about_ca_system_score_codex":0.000150132,"about_ca_system_score_gemma":0.0011969815,"threshold_uncertainty_score":0.44947606},"labels":[],"label_agreement":null},{"id":"W4230033833","doi":"10.1158/1538-7445.am2021-207","title":"Abstract 207: The cBioPortal for Cancer Genomics","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Visualization; Genomics; Computer science; World Wide Web; Data visualization; Data science; Data mining; Genome; Biology; Genetics","score_opus":0.09070789689338121,"score_gpt":0.47488212390527046,"score_spread":0.38417422701188925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230033833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9084045,0.013775496,0.00032987958,0.071934536,0.00066047185,0.00057574565,0.000039572,0.00003080911,0.0042489558],"genre_scores_gemma":[0.9782936,0.0061773374,0.00058232597,0.0023692288,0.002048646,0.0004801379,0.00003141912,0.000055442426,0.00996188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986002,0.000041158037,0.00017669455,0.0002782102,0.0004391089,0.00046463308],"domain_scores_gemma":[0.9987872,0.0002657583,0.000033966393,0.00030954025,0.000422194,0.00018130637],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010420963,0.00008359081,0.00018158813,0.00005433142,0.00027548897,0.00006273895,0.0001659468,0.000059989125,0.0011440263],"category_scores_gemma":[0.00056294136,0.000056588753,0.00010091751,0.00023819631,0.00023028658,0.00003073565,0.000073000636,0.0008217102,0.000018795663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035497904,0.00018111442,0.014974714,0.00068874244,0.00038758316,0.0003532328,0.0011186827,0.00036406607,0.374772,0.0018843327,0.15715007,0.44777045],"study_design_scores_gemma":[0.0013668457,0.000058301903,0.020083508,0.0002777706,0.00005401341,0.000046710025,0.00053626666,0.002923488,0.025116686,0.00065742433,0.9487395,0.0001394338],"about_ca_topic_score_codex":0.0007353653,"about_ca_topic_score_gemma":0.00012810578,"teacher_disagreement_score":0.7915895,"about_ca_system_score_codex":0.00023974288,"about_ca_system_score_gemma":0.0013687169,"threshold_uncertainty_score":0.9997691},"labels":[],"label_agreement":null},{"id":"W4230043107","doi":"10.1158/1538-7445.am2019-2465","title":"Abstract 2465: Genomic harmonization of the Data Resource Center for Gabriella Miller Kids First Pediatric Research Program","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Workflow; Harmonization; Computer science; Ensembl; Data science; Resource (disambiguation); World Wide Web; Genomics; Database; Genome; Biology; Genetics","score_opus":0.10289464049746498,"score_gpt":0.40633358084187415,"score_spread":0.30343894034440916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230043107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018145,0.0018279109,0.000051004197,0.0020361806,0.00027512555,0.0028271687,0.0006307091,0.000010253437,0.0021601962],"genre_scores_gemma":[0.98926944,0.004149728,0.00037897093,0.00008074507,0.00093211496,0.00024219407,0.0007433809,0.00004878996,0.004154645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99657714,0.00019355425,0.0004130843,0.00057839765,0.0013130087,0.00092482625],"domain_scores_gemma":[0.9968697,0.00019334292,0.00008940108,0.0016050858,0.0010325836,0.00020991676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003519614,0.00014578542,0.00017787871,0.00019859019,0.00031149373,0.000098200704,0.002084489,0.0002606064,0.00015742853],"category_scores_gemma":[0.00090069533,0.00010549321,0.00009689116,0.00059630227,0.000573783,0.000010696811,0.0018197452,0.000531957,0.000060260678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011145797,0.0007232551,0.062816784,0.0027959722,0.0001771055,0.0000017188379,0.00052526727,0.000115047056,0.3271029,0.000052540225,0.54236597,0.062208883],"study_design_scores_gemma":[0.0013017067,0.00061492523,0.01935435,0.000077399876,0.000010022719,0.0000016429893,0.00033489225,0.0006592851,0.05774422,0.000052549178,0.9196512,0.00019779417],"about_ca_topic_score_codex":0.0001579847,"about_ca_topic_score_gemma":0.0001515995,"teacher_disagreement_score":0.37728527,"about_ca_system_score_codex":0.000090428766,"about_ca_system_score_gemma":0.0008514469,"threshold_uncertainty_score":0.4301888},"labels":[],"label_agreement":null},{"id":"W4230368187","doi":"10.1158/1538-7445.am2019-4646","title":"Abstract 4646: Loss of nuclear HoxA10 is associated with proliferation of testicular germ cell tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medicinal Plant Pharmacodynamics Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Seminoma; Biology; Cancer research; Cell growth; Cancer; Cell cycle; Flow cytometry; Transcription factor; Molecular biology; Genetics; Gene","score_opus":0.1473468825253232,"score_gpt":0.49062041419434466,"score_spread":0.34327353166902147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230368187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800975,0.0003587741,0.0000023017433,0.00060474616,0.00015852078,0.0011819595,0.00030790924,0.000025681495,0.009350354],"genre_scores_gemma":[0.9970453,0.00043208912,0.000020915166,0.00025181303,0.0000894573,0.00006147837,0.000046653615,0.000047512796,0.0020047831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99639803,0.00063236326,0.00048130902,0.0004066915,0.0013260181,0.0007556072],"domain_scores_gemma":[0.99668634,0.001236635,0.00026987554,0.0003170849,0.0011804696,0.0003095904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033543718,0.0001946928,0.0004469778,0.0003693224,0.00013685723,0.000018244245,0.0005585871,0.0002756862,0.009580316],"category_scores_gemma":[0.00030944843,0.00016294407,0.00007218237,0.00079031085,0.0006233459,0.000138713,0.00013290418,0.0019547024,0.00023972018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021833738,0.0006794277,0.09274902,0.0011252195,0.00029871217,0.00016332374,0.0012239608,0.0011064357,0.89037156,0.00030777373,0.009025728,0.00076548266],"study_design_scores_gemma":[0.007812392,0.0017602174,0.039260887,0.0007699605,0.00015285931,0.000028687457,0.00047097265,0.023424888,0.91118854,0.00016671758,0.014411582,0.0005523169],"about_ca_topic_score_codex":0.00021086544,"about_ca_topic_score_gemma":0.000019918534,"teacher_disagreement_score":0.053488135,"about_ca_system_score_codex":0.00026103485,"about_ca_system_score_gemma":0.0008517162,"threshold_uncertainty_score":0.9913251},"labels":[],"label_agreement":null},{"id":"W4230516262","doi":"10.1158/1538-7445.am2019-sy28-03","title":"Abstract SY28-03: Extending the paradigm of hormonal dependency of cancer to account for effects of lifestyle on risk and prognosis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Prostate cancer; Hormone; Medicine; Breast cancer; Cancer cell; Oncology; Internal medicine; Hormonal therapy; Bioinformatics; Biology","score_opus":0.024820972435549055,"score_gpt":0.36799855390348,"score_spread":0.343177581467931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230516262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8526585,0.14607614,0.000010003634,0.000040722633,0.00013084165,0.0008427589,0.00015252056,0.0000014238669,0.00008706387],"genre_scores_gemma":[0.9421624,0.056905728,0.000029380002,0.00004187329,0.00018533584,0.00057988404,0.000005532882,0.000018828945,0.000071057024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987701,0.000075584925,0.00020724673,0.00029215484,0.00035189107,0.0003030167],"domain_scores_gemma":[0.99906844,0.00019814823,0.00012446503,0.00030401768,0.00023069803,0.00007420741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006825605,0.00010613707,0.0002312601,0.00007364232,0.000053773867,0.000010638406,0.00025773566,0.00009110066,0.000044399672],"category_scores_gemma":[0.00017539767,0.00007556863,0.00007923591,0.00014117933,0.000122010046,0.0000052142063,0.00008951415,0.0001384901,0.0000017501154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064195174,0.00010679116,0.047427654,0.001161245,0.00020281572,3.2929432e-7,0.00020632075,0.00015247542,0.7568506,0.00041467845,0.0013216145,0.19151354],"study_design_scores_gemma":[0.00064517534,0.0005604961,0.081948325,0.00021765813,0.000033625896,1.5887727e-7,0.000051071904,0.000012894014,0.8935345,0.00015907729,0.022739552,0.00009746805],"about_ca_topic_score_codex":0.0007838667,"about_ca_topic_score_gemma":0.00018060177,"teacher_disagreement_score":0.19141607,"about_ca_system_score_codex":0.000026353471,"about_ca_system_score_gemma":0.00024413665,"threshold_uncertainty_score":0.30815992},"labels":[],"label_agreement":null},{"id":"W4230839613","doi":"10.1158/1538-7445.am2019-4550","title":"Abstract 4550: Correlations between tumor mutation burden, inflammatory profile and histological characteristics of tumor microenvironment in early-stage squamous cell lung carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Tumor microenvironment; Immunotherapy; CD8; Lung cancer; Immune system; Cancer; Tumor-infiltrating lymphocytes; Immunohistochemistry; Medicine; Cancer research; Pathology; Biology; Immunology; Internal medicine","score_opus":0.02931991368300928,"score_gpt":0.31356870054116265,"score_spread":0.28424878685815336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230839613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649924,0.0014601017,0.0000033365948,0.00020150763,0.00007895008,0.0011734248,0.00011010324,0.000011236627,0.00046209124],"genre_scores_gemma":[0.9983344,0.00008806663,0.000036210284,0.000026742146,0.00009537237,0.000119312615,0.00005147566,0.000022194508,0.0012261906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984734,0.00008477379,0.00040836004,0.00029850815,0.0004046971,0.00033024515],"domain_scores_gemma":[0.99923766,0.00018930342,0.0001427705,0.00024326725,0.0000851625,0.000101828235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005092673,0.00012449814,0.00029940958,0.00022251571,0.000060281294,0.000015650958,0.0000990772,0.00008059877,0.0009931988],"category_scores_gemma":[0.000042179414,0.00011339523,0.000049967002,0.00018528428,0.0002487364,0.00007117439,0.00005730275,0.00046573454,0.000028947334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008115882,0.00006263313,0.819255,0.0006147348,0.000015145329,0.00009731018,0.0008782428,0.000005025013,0.17672059,0.000004602557,0.00015503439,0.0013801155],"study_design_scores_gemma":[0.002040463,0.00031268486,0.9784691,0.00013786589,0.000018292492,0.0000069942002,0.00034006446,0.000110739325,0.017213343,0.0000030120113,0.0012391851,0.000108258224],"about_ca_topic_score_codex":0.0013592511,"about_ca_topic_score_gemma":0.00002524764,"teacher_disagreement_score":0.15950724,"about_ca_system_score_codex":0.0006062834,"about_ca_system_score_gemma":0.00030412906,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W4230897189","doi":"10.1158/1538-7445.am2019-4023","title":"Abstract 4023: Co-occurring mutations in recurrent/persistent head and neck squamous cell carcinoma (HNSCC) patients","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rogue Research (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; ERCC1; Head and neck cancer; Cohort; Microsatellite instability; Cancer; Targeted therapy; Biomarker; Stage (stratigraphy); Gene; Allele; DNA repair","score_opus":0.09279130613187583,"score_gpt":0.40882257895887053,"score_spread":0.3160312728269947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230897189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998786,0.0040956154,9.7044506e-8,0.00041854777,0.00022588644,0.0008423343,0.000051337804,0.00001719526,0.014361106],"genre_scores_gemma":[0.9986937,0.00028657753,0.000014821085,0.00011185531,0.00009093466,0.0001502019,0.000025260395,0.000023957822,0.000602664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981326,0.000056590285,0.0002532895,0.00041021322,0.0005663507,0.0005809633],"domain_scores_gemma":[0.99909055,0.0001580833,0.000036164245,0.0002451538,0.00024522044,0.00022484962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032006152,0.00013910024,0.00031152763,0.0002814545,0.00014120282,0.000028223798,0.00009607284,0.00007253172,0.00031337686],"category_scores_gemma":[0.0000879928,0.0001256851,0.00006504491,0.00034794284,0.00011795011,0.00009067471,0.00008325232,0.00056293345,0.00011133824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003505785,0.00028651152,0.98419535,0.0007060774,0.000013833762,0.000023955918,0.0023241304,0.000010947577,0.0020280688,0.000007574987,0.002721104,0.0073318738],"study_design_scores_gemma":[0.0052518295,0.0010452523,0.9812206,0.00038806538,0.000014295168,0.0000019408817,0.0010920586,0.000072440474,0.002053508,0.000010022647,0.008692267,0.00015771354],"about_ca_topic_score_codex":0.0015525604,"about_ca_topic_score_gemma":0.000540722,"teacher_disagreement_score":0.018705847,"about_ca_system_score_codex":0.00055999355,"about_ca_system_score_gemma":0.00032156782,"threshold_uncertainty_score":0.51252896},"labels":[],"label_agreement":null},{"id":"W4231618358","doi":"10.1158/1538-7445.am2019-3666","title":"Abstract 3666: The genomic landscape and clonal evolution of tumours arising in <i>TP53</i> mutation carriers","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germline; Biology; Context (archaeology); Genetics; Germline mutation; Cancer; Mutation; Carcinogenesis; Cancer research; Somatic cell; Genome; Gene","score_opus":0.026967270937135367,"score_gpt":0.3425018829852227,"score_spread":0.31553461204808736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231618358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905949,0.0060541313,0.000016282369,0.000760651,0.00012451228,0.00056817563,0.000014577127,0.000008763965,0.0018579584],"genre_scores_gemma":[0.99943537,0.00026195825,0.000020511385,0.00003235706,0.00009222786,0.0000340949,0.000009963571,0.000019138048,0.000094376155],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878305,0.00007514362,0.00018503334,0.00022336187,0.00045281398,0.00028060284],"domain_scores_gemma":[0.99941534,0.000100309604,0.000052792002,0.00021651508,0.00014020815,0.000074857664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008207321,0.000074220705,0.00015688674,0.00021900224,0.00005364341,0.000015256597,0.00008189179,0.00008160985,0.000119762386],"category_scores_gemma":[0.00007946938,0.000059422928,0.00003619867,0.00038073384,0.00014226811,0.0000457873,0.000044058535,0.0005443792,0.000014902789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006924835,0.000037007132,0.1278852,0.00025088454,0.000045047855,0.000042319087,0.00161373,0.0018172093,0.86161435,0.00031067446,0.00085384713,0.004837228],"study_design_scores_gemma":[0.0035692148,0.00029325488,0.9442159,0.00059592584,0.000037593032,0.000054403667,0.0029010563,0.0017401134,0.044706117,0.00038009803,0.0013509268,0.00015540735],"about_ca_topic_score_codex":0.0018293376,"about_ca_topic_score_gemma":0.00039322177,"teacher_disagreement_score":0.81690824,"about_ca_system_score_codex":0.0005524808,"about_ca_system_score_gemma":0.00073423056,"threshold_uncertainty_score":0.27654234},"labels":[],"label_agreement":null},{"id":"W4232014388","doi":"10.1158/1538-7445.am2019-1598","title":"Abstract 1598: Deep targeted sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"MSH6; Microsatellite instability; MSH2; Colorectal cancer; MLH1; Genetics; Biology; Cancer; Germline mutation; Exome sequencing; Lynch syndrome; KRAS; Indel; Germline; Oncology; Internal medicine; DNA mismatch repair; Medicine; Mutation; Microsatellite; Single-nucleotide polymorphism; Gene; Genotype","score_opus":0.08823094661494049,"score_gpt":0.4280170890612386,"score_spread":0.3397861424462981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232014388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957573,0.001700625,0.0000067664987,0.00006077563,0.00016175368,0.0019795075,0.00019420029,0.000017743936,0.0001213382],"genre_scores_gemma":[0.99849916,0.0004549091,0.0006919707,0.000024347646,0.00005534255,0.00017761755,0.0000068332097,0.00004747833,0.00004235768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972389,0.0002896416,0.0005353797,0.00050599355,0.0009887364,0.000441377],"domain_scores_gemma":[0.99715143,0.0009234009,0.00023788337,0.00037543869,0.0010290566,0.0002827996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009182662,0.0001874519,0.0006126661,0.0002428152,0.000088494904,0.0000174366,0.00018474182,0.00013498396,0.0005879114],"category_scores_gemma":[0.0010338735,0.00014885594,0.00007760996,0.000690085,0.00025190736,0.000040865507,0.0001297528,0.00054501503,0.0000049971113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055302744,0.0002000874,0.86289203,0.00009824052,0.000409853,0.000026425716,0.0014817637,0.0008690467,0.13212788,0.0000010971693,0.000051626917,0.0012888922],"study_design_scores_gemma":[0.0011125372,0.003016637,0.8280814,0.00010693095,0.00012319804,0.0000024756866,0.0017880976,0.000046397614,0.16556108,0.0000074037484,0.000026387135,0.00012741369],"about_ca_topic_score_codex":0.013142454,"about_ca_topic_score_gemma":0.004615901,"teacher_disagreement_score":0.034810618,"about_ca_system_score_codex":0.0004301789,"about_ca_system_score_gemma":0.0012461884,"threshold_uncertainty_score":0.9934291},"labels":[],"label_agreement":null},{"id":"W4232017003","doi":"10.1158/1538-7445.am2019-3743","title":"Abstract 3743: Neutrophil extracellular traps and their implication with radioresistance in muscle invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Radioresistance; Neutrophil extracellular traps; HMGB1; Tumor microenvironment; Cancer research; Cancer; Inflammation; Bladder cancer; Medicine; Metastasis; Tumor progression; Context (archaeology); Immunology; Radiation therapy; Immune system; Biology; Internal medicine","score_opus":0.034067086795659736,"score_gpt":0.30396225595145765,"score_spread":0.2698951691557979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232017003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749992,0.022986349,0.000018870005,0.00057262345,0.00010103025,0.0007662783,0.00006967751,0.000025111454,0.00046084242],"genre_scores_gemma":[0.9933042,0.0041850307,0.00002131447,0.00007451564,0.000046811598,0.00044407733,0.000027901839,0.000038276325,0.0018579008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818933,0.00022016482,0.00022169395,0.0006124175,0.00008896792,0.0006674355],"domain_scores_gemma":[0.9990343,0.00021229811,0.000071523915,0.00040232195,0.00022297869,0.00005657788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046572447,0.00021636569,0.00030141536,0.00023218867,0.00020614406,0.00003737907,0.00028631667,0.00017564358,0.0016450257],"category_scores_gemma":[0.000017313218,0.00015961834,0.00003746649,0.00045206663,0.000492204,0.00021248132,0.00007632824,0.00071586994,0.00014290851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034454072,0.00006776845,0.0026599925,0.000085463784,0.00007471796,0.000014241928,0.000977534,0.00001705659,0.982732,0.0010970124,0.00031242397,0.011617273],"study_design_scores_gemma":[0.0018568572,0.00025510587,0.12577926,0.00025360478,0.000008267938,0.000010406256,0.0009805316,0.0000013245254,0.85750204,0.000772256,0.012325819,0.0002545442],"about_ca_topic_score_codex":0.0012067537,"about_ca_topic_score_gemma":0.0020608956,"teacher_disagreement_score":0.12522994,"about_ca_system_score_codex":0.00022125545,"about_ca_system_score_gemma":0.0003135669,"threshold_uncertainty_score":0.9992676},"labels":[],"label_agreement":null},{"id":"W4232358903","doi":"10.1158/1538-7445.am2019-1556","title":"Abstract 1556: Preclinical development of antibody drug conjugates targetting EGFRvIII","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Antibody; Antibody-drug conjugate; Cancer research; In vivo; Epidermal growth factor receptor; Conjugate; Cancer; Chemistry; Monoclonal antibody; Molecular biology; Medicine; Biology; Immunology; Internal medicine; Genetics","score_opus":0.1575404227938784,"score_gpt":0.5331337627656179,"score_spread":0.3755933399717395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232358903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97822255,0.003437479,0.000009217192,0.0019151096,0.00032488944,0.0014341999,0.000021803658,0.000053546955,0.014581221],"genre_scores_gemma":[0.99125063,0.00075346336,0.0013763739,0.00010847117,0.00038708744,0.00017955154,0.000038578983,0.00007274189,0.005833068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947712,0.00021404706,0.0008435281,0.0007106579,0.0023206568,0.0011399146],"domain_scores_gemma":[0.9965875,0.0009092262,0.00012552523,0.0007851718,0.0011375899,0.0004549711],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005353857,0.00021055662,0.0006208322,0.00039156774,0.00017184214,0.000048965165,0.0005458275,0.00017690271,0.007109741],"category_scores_gemma":[0.00080333214,0.00018135697,0.00012897575,0.00076744263,0.00042688937,0.00012165115,0.0003940092,0.0015663531,0.0011158976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000986347,0.00043064982,0.22609544,0.0033764686,0.00024864968,0.00006647607,0.0023248815,0.000020257785,0.7124685,0.00017739757,0.014413305,0.039391637],"study_design_scores_gemma":[0.0033353325,0.00040248394,0.15926215,0.00313956,0.000020106076,0.000010032941,0.0012472548,0.00014911202,0.64527655,0.00013988519,0.18662025,0.00039729232],"about_ca_topic_score_codex":0.00059730734,"about_ca_topic_score_gemma":0.0000872513,"teacher_disagreement_score":0.17220694,"about_ca_system_score_codex":0.0005726268,"about_ca_system_score_gemma":0.004110252,"threshold_uncertainty_score":0.99966186},"labels":[],"label_agreement":null},{"id":"W4232375200","doi":"10.1158/1538-7445.transcagen-a2-11","title":"Abstract A2-11: PLZF, a tumor suppressor genetically lost in metastatic castration resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Gene knockdown; Enzalutamide; Cancer research; Cancer; LNCaP; Suppressor; Androgen; Medicine; Biology; Androgen receptor; Internal medicine; Gene; Genetics; Hormone","score_opus":0.12344612421085763,"score_gpt":0.42362044191053555,"score_spread":0.30017431769967795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232375200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97596186,0.011417898,0.0000057837306,0.008550786,0.00009116882,0.0030401684,0.00042819537,0.000021757822,0.0004824031],"genre_scores_gemma":[0.9927391,0.0030135254,0.0005596263,0.00021506588,0.0001501717,0.0015513839,0.000055679717,0.00006322173,0.0016522477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955625,0.00024278555,0.00066364114,0.00068082,0.0019430596,0.000907218],"domain_scores_gemma":[0.9969338,0.00019826714,0.00013106101,0.0005730849,0.0015063442,0.0006574299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016952625,0.000257628,0.00054414384,0.00063006644,0.00009240352,0.00006777658,0.00030201828,0.0000864527,0.0004305617],"category_scores_gemma":[0.00039667732,0.00020644983,0.00008061074,0.0015222812,0.00030130398,0.00018370137,0.00009584624,0.00045003463,0.000038685375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029560609,0.0008976147,0.06799807,0.0012246299,0.00031077216,0.0006499248,0.009925947,0.00012091797,0.86284745,0.000121058845,0.01984096,0.0065020435],"study_design_scores_gemma":[0.010370229,0.0011656353,0.08294197,0.0011071415,0.000042181393,0.0000066242087,0.0015089926,0.00007466603,0.8883485,0.0005626547,0.013544193,0.00032721876],"about_ca_topic_score_codex":0.0027171562,"about_ca_topic_score_gemma":0.0056547904,"teacher_disagreement_score":0.025501035,"about_ca_system_score_codex":0.0011649798,"about_ca_system_score_gemma":0.0037509378,"threshold_uncertainty_score":0.84187794},"labels":[],"label_agreement":null},{"id":"W4232583537","doi":"10.1158/1538-7445.am2019-1730","title":"Abstract 1730: <i>DACH1</i> gene deletion extends portraits of human prostate cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; PTEN; Tramp; Cancer; Chromoplexy; Cancer research; Metastasis; Biology; TMPRSS2; Population; Genetics; Prostate; Medicine; Disease; PCA3; Pathology; PI3K/AKT/mTOR pathway","score_opus":0.07678466906530115,"score_gpt":0.43913796638237185,"score_spread":0.36235329731707067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232583537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755957,0.009542796,8.175319e-7,0.0013458888,0.00018199293,0.0016368666,0.00015910323,0.000048072514,0.00952492],"genre_scores_gemma":[0.9709756,0.0053768936,0.00003595492,0.00008453658,0.0003158342,0.00062051794,0.00013759009,0.00006669044,0.022386432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964302,0.00008844789,0.00042401103,0.00059916737,0.0014989374,0.0009592043],"domain_scores_gemma":[0.9978422,0.000076060154,0.0001114297,0.00056622626,0.0010609162,0.0003431792],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010126211,0.00021851572,0.00046673982,0.00041051782,0.0001793376,0.000039846123,0.000252977,0.0001518695,0.0047804727],"category_scores_gemma":[0.000033837827,0.00017226554,0.0001420069,0.0008024724,0.00035376707,0.00017010554,0.0001259741,0.00077218754,0.00014991335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011011987,0.00027868044,0.08955181,0.00091511547,0.00019005145,0.00008974928,0.00048793497,0.00002401079,0.88153416,0.00011688221,0.006965993,0.018744446],"study_design_scores_gemma":[0.0054081683,0.0011359104,0.2878323,0.0009502565,0.00005561489,0.0000144627,0.00029624967,0.000024382183,0.69251335,0.00025605073,0.011224658,0.0002886023],"about_ca_topic_score_codex":0.0025310046,"about_ca_topic_score_gemma":0.00015697851,"teacher_disagreement_score":0.19828047,"about_ca_system_score_codex":0.00064651103,"about_ca_system_score_gemma":0.001140352,"threshold_uncertainty_score":0.9961293},"labels":[],"label_agreement":null},{"id":"W4232931847","doi":"10.1158/1538-7445.am2019-1508","title":"Abstract 1508: Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; University of Toronto; McGill University","funders":"","keywords":"Neutrophil extracellular traps; Neutrophil elastase; Cancer research; Cancer; Tumor microenvironment; Metastasis; Medicine; Ex vivo; Tumor progression; Primary tumor; Population; Immunology; Immune system; In vivo; Inflammation; Internal medicine; Biology","score_opus":0.03105584402049991,"score_gpt":0.2972740943088286,"score_spread":0.2662182502883287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232931847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527336,0.010722553,0.00002987414,0.0003927723,0.00034369415,0.0014451499,0.000038084927,0.00009102295,0.001663496],"genre_scores_gemma":[0.99376833,0.00017755151,0.00015489465,0.000101126556,0.00009623316,0.0003616447,0.000090520494,0.00008368068,0.005165997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664694,0.0005899072,0.00033861538,0.00086190493,0.0002751115,0.001287543],"domain_scores_gemma":[0.99848956,0.00033138544,0.00013092294,0.0006348275,0.0003090393,0.000104238665],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013173469,0.00035333025,0.0005949003,0.00034904212,0.00041667433,0.00007197895,0.00057735114,0.00023456143,0.002180528],"category_scores_gemma":[0.00004342781,0.0002697227,0.00011059879,0.00069814,0.0003066679,0.00034263855,0.00019583531,0.001565056,0.001653939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040194113,0.00019152193,0.00067926897,0.0004336125,0.00027488463,0.00017547116,0.00036654962,0.000015537029,0.988729,0.0007711561,0.0004999714,0.007461082],"study_design_scores_gemma":[0.0018179413,0.0007393628,0.0051759654,0.00034870804,0.00003682982,0.000042217653,0.00019018266,0.0000010132703,0.9760789,0.00016819366,0.015058203,0.00034246407],"about_ca_topic_score_codex":0.0003344792,"about_ca_topic_score_gemma":0.000017952323,"teacher_disagreement_score":0.0145582305,"about_ca_system_score_codex":0.00023969993,"about_ca_system_score_gemma":0.00048250062,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W4233339371","doi":"10.1158/1538-7445.am2019-3450","title":"Abstract 3450: Impact of BRCA1 on glucocorticoid signaling in fallopian tube epithelial cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Glucocorticoid receptor; Cancer research; Ovarian cancer; Biology; Cell culture; Cancer cell; microRNA; Cancer; Glucocorticoid; Molecular biology; Endocrinology; Gene; Genetics","score_opus":0.06260917361986063,"score_gpt":0.4152076054125848,"score_spread":0.35259843179272415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233339371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901744,0.00049209705,4.781414e-7,0.0005354025,0.00019098633,0.0011220574,0.000064209744,0.000011039564,0.0074093146],"genre_scores_gemma":[0.9983572,0.00053389923,0.000021029331,0.000070580965,0.00018517852,0.00011395941,0.000010581536,0.000035962523,0.00067161274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979217,0.00006819949,0.00032526758,0.00041322166,0.000714333,0.000557289],"domain_scores_gemma":[0.99881625,0.00028024122,0.000063986,0.00047844584,0.0001799465,0.0001811537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005343128,0.00016026267,0.00042663448,0.00033361287,0.000027740612,0.000023450713,0.00014521841,0.00010269153,0.003227747],"category_scores_gemma":[0.000037687416,0.00012133955,0.00018172646,0.00044075688,0.00006776843,0.000059596005,0.000043754368,0.0004927075,0.00044695695],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015665534,0.0008625051,0.27721027,0.0004196837,0.00026385448,0.00014868744,0.00049146864,0.0031996935,0.7023344,0.00022325107,0.0006859702,0.012593641],"study_design_scores_gemma":[0.004427222,0.0018061923,0.61755264,0.0009191149,0.000020618338,0.0000022276065,0.00010439205,0.00009044058,0.37391013,0.000058729816,0.0009723492,0.00013594425],"about_ca_topic_score_codex":0.0053291023,"about_ca_topic_score_gemma":0.00017317165,"teacher_disagreement_score":0.34034237,"about_ca_system_score_codex":0.0011629693,"about_ca_system_score_gemma":0.001017457,"threshold_uncertainty_score":0.99768347},"labels":[],"label_agreement":null},{"id":"W4233680495","doi":"10.1158/1538-7445.am2019-4576","title":"Abstract 4576: Study of the immune contexture in advanced pancreatic neuroendocrine tumors reveals tumor-associated macrophages as promoters of poor survival","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Biology; Immune system; Cancer research; CD68; CD8; Tumor-infiltrating lymphocytes; ATRX; Pathology; Immunohistochemistry; Medicine; Immunology; Gene","score_opus":0.034988830512816246,"score_gpt":0.3900782055281366,"score_spread":0.35508937501532034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233680495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101925,0.0013139269,3.1196432e-8,0.0012202372,0.00020138465,0.0053416146,0.00006251692,0.00003091415,0.0008101237],"genre_scores_gemma":[0.99596334,0.00022611624,0.0000063822354,0.000052757438,0.000034995846,0.00033041573,0.000007547656,0.00008205994,0.0032964007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99389815,0.0009907566,0.0009811074,0.0006904435,0.0023167722,0.0011227833],"domain_scores_gemma":[0.9966548,0.0008374187,0.0003862604,0.0011159214,0.00079249014,0.00021312197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010805066,0.00031038787,0.0011709111,0.00048583004,0.000093279035,0.000023719931,0.0008580071,0.000015104341,0.0005427117],"category_scores_gemma":[0.0029204697,0.00022048103,0.00017407899,0.0019041586,0.000413513,0.00018204575,0.0004682615,0.0015790098,0.000028750797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028370703,0.0016976015,0.34200746,0.0010785196,0.00013924809,0.002677827,0.0003711562,0.00011828856,0.6481198,0.000028851988,0.00012427129,0.0007998757],"study_design_scores_gemma":[0.008429743,0.003564087,0.7499453,0.0015735299,0.00003118439,0.000120995246,0.0038769864,0.000015881495,0.2320353,0.00011524424,0.00011083353,0.00018092048],"about_ca_topic_score_codex":0.0043464056,"about_ca_topic_score_gemma":0.00086128246,"teacher_disagreement_score":0.41608453,"about_ca_system_score_codex":0.00035386413,"about_ca_system_score_gemma":0.00064512214,"threshold_uncertainty_score":0.89909554},"labels":[],"label_agreement":null},{"id":"W4234581092","doi":"10.1158/1538-7445.am2014-659","title":"Abstract 659: Integrated therapeutic antibody development at the National Research Council of Canada","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Antibody; Biomanufacturing; Antibody Repertoire; Monoclonal antibody; Computational biology; Medicine; Immunology; Biology; Biotechnology","score_opus":0.28732471470045146,"score_gpt":0.4637272266095531,"score_spread":0.17640251190910167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234581092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9075008,0.002441034,0.0000074249006,0.0129483,0.00012833801,0.00064582046,0.000059187005,0.000013136065,0.076255955],"genre_scores_gemma":[0.95362926,0.00035712318,0.000040678235,0.00039940837,0.0002954073,0.00014034142,0.000036918245,0.000027427453,0.04507342],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98549926,0.00045542832,0.00039256198,0.00039547193,0.012262958,0.0009943267],"domain_scores_gemma":[0.98490256,0.001705483,0.000052192783,0.00032406184,0.012714272,0.0003014144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015721664,0.00015773383,0.000291107,0.00020453529,0.00084068597,0.000037963357,0.0005060956,0.00009451036,0.0028195921],"category_scores_gemma":[0.002186267,0.00009384503,0.00006233053,0.0009841609,0.0008956368,0.00004355782,0.00030491714,0.0013137576,0.00011227699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0034630457,0.00039280203,0.016069375,0.0010035773,0.0005858989,0.000062645566,0.0019324311,0.000089730216,0.4908985,0.003652565,0.43907872,0.04277071],"study_design_scores_gemma":[0.0005412259,0.00013454216,0.08285721,0.00021252298,0.000004138737,0.000013955762,0.00023808524,0.0001712944,0.06193547,0.00028101314,0.85350114,0.000109430104],"about_ca_topic_score_codex":0.29545882,"about_ca_topic_score_gemma":0.3737805,"teacher_disagreement_score":0.42896304,"about_ca_system_score_codex":0.008388815,"about_ca_system_score_gemma":0.049121026,"threshold_uncertainty_score":0.99809194},"labels":[],"label_agreement":null},{"id":"W4234685159","doi":"10.1158/1538-7445.am2019-579","title":"Abstract 579: Immune features and neoantigen recognition in mismatch repair-proficient colorectal cancer liver metastases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Institute for Research in Immunology and Cancer; Université de Montréal; Jewish General Hospital","funders":"","keywords":"Immune system; Immunotherapy; CD8; Colorectal cancer; Cancer research; Antigen; Tumor-infiltrating lymphocytes; Biology; Cancer; Immunology; Medicine; Internal medicine","score_opus":0.0614319214106752,"score_gpt":0.38043770882940686,"score_spread":0.31900578741873165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234685159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488361,0.04723996,2.9948333e-7,0.0011029319,0.00027018046,0.0011975198,0.0001036546,0.000045772398,0.0012035889],"genre_scores_gemma":[0.9806347,0.016755974,0.00006232164,0.00018877316,0.00014064906,0.00034344033,0.000049136786,0.00003316086,0.0017918602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979598,0.0001292384,0.00029468906,0.00048217928,0.00059101864,0.00054306275],"domain_scores_gemma":[0.99915344,0.00015736498,0.00006315728,0.00025604144,0.00024956156,0.000120462435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011936758,0.00016910583,0.00033759678,0.0003251151,0.000107906555,0.000048139816,0.000112267146,0.00013567685,0.003545146],"category_scores_gemma":[0.00005645326,0.00013982832,0.00011941095,0.0005893551,0.00022889413,0.00012482035,0.00007340845,0.00058109727,0.00007583292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009365221,0.00022461927,0.043342695,0.00079230726,0.00032418533,0.00014937359,0.0014909937,0.00000717454,0.8352442,0.0000120844825,0.009410736,0.09963644],"study_design_scores_gemma":[0.0037010552,0.0004806409,0.761696,0.0010867947,0.000041098574,0.000050656887,0.0011069194,0.000052408013,0.22135803,0.000030307716,0.010137913,0.0002582102],"about_ca_topic_score_codex":0.01686775,"about_ca_topic_score_gemma":0.0016886293,"teacher_disagreement_score":0.7183533,"about_ca_system_score_codex":0.00046583332,"about_ca_system_score_gemma":0.00047846042,"threshold_uncertainty_score":0.9973658},"labels":[],"label_agreement":null},{"id":"W4234935132","doi":"10.1158/1538-7445.am2019-2554","title":"Abstract 2554: Branched chain amino acid transaminase 1 in claudin-low breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Medicine; Population; Cell culture; Metastatic breast cancer; Small hairpin RNA; Oncology; Internal medicine; Gene knockdown; Biology; Genetics","score_opus":0.05593705074826207,"score_gpt":0.38523222698703335,"score_spread":0.3292951762387713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234935132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98223734,0.0050617578,0.0000035933958,0.007418016,0.00034525356,0.001347234,0.00017218971,0.000053377305,0.0033612547],"genre_scores_gemma":[0.9911635,0.0034401831,0.000020509035,0.00060377776,0.00050649565,0.0011877152,0.000021466867,0.000078101824,0.0029782627],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964489,0.00012296031,0.0004209679,0.0007646273,0.0011205092,0.0011220621],"domain_scores_gemma":[0.99848366,0.000096044794,0.000062730694,0.0006124713,0.0003687457,0.00037634224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010353684,0.00027138204,0.00057520944,0.00045071734,0.00009736855,0.00005806266,0.00033623303,0.00023377305,0.012096197],"category_scores_gemma":[0.000031996024,0.00023700553,0.00016469517,0.0011288783,0.00021853925,0.00018620024,0.00006450557,0.0011992654,0.00034098478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026427128,0.0007196807,0.27713165,0.0020673026,0.00016223015,0.00013740876,0.001518632,0.000078701276,0.5395837,0.00011193169,0.008591447,0.16725458],"study_design_scores_gemma":[0.0055603115,0.00029135507,0.84194326,0.0020321445,0.000032766482,0.000020605738,0.00063489407,0.00019761818,0.13936156,0.000031840285,0.009482616,0.00041102243],"about_ca_topic_score_codex":0.004610943,"about_ca_topic_score_gemma":0.0020293058,"teacher_disagreement_score":0.5648116,"about_ca_system_score_codex":0.0009917438,"about_ca_system_score_gemma":0.00095284136,"threshold_uncertainty_score":0.9888069},"labels":[],"label_agreement":null},{"id":"W4235059002","doi":"10.1158/1538-7445.am2013-2004","title":"Abstract 2004: International Cancer Genome Consortium (ICGC).","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Biology; Computational biology; Library science; Genetics; Computer science; Gene","score_opus":0.04574030055709758,"score_gpt":0.3770965824445834,"score_spread":0.3313562818874858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235059002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785503,0.009251418,0.000044973156,0.0025914628,0.00070874224,0.0003851704,0.00022840369,0.000010727123,0.008228782],"genre_scores_gemma":[0.98298484,0.009795026,0.000062491476,0.00057238934,0.0015374158,0.0006359805,0.00010311033,0.00003352005,0.004275197],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985869,0.000027706794,0.00019222706,0.00040421775,0.0003216537,0.00046727344],"domain_scores_gemma":[0.99883014,0.000029328736,0.00004773486,0.0003517039,0.00056018523,0.00018089318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024279415,0.00012315068,0.00011065535,0.00008691617,0.00011443107,0.00011987198,0.00044889376,0.00011978307,0.0043378617],"category_scores_gemma":[0.00011550992,0.00012142888,0.00006454149,0.00011512318,0.0001840337,0.000007696885,0.00023565449,0.00023204199,0.0002671845],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004895597,0.000045818313,0.004603819,0.000018437744,0.00008320736,0.000004400037,0.000038292743,0.00037440672,0.8782781,0.000096789896,0.10884163,0.007566189],"study_design_scores_gemma":[0.0007337008,0.0000943156,0.053816844,0.000030160247,0.000007600865,0.0000037637137,0.00011344514,0.000041322168,0.13448822,0.00034340195,0.8100192,0.0003080235],"about_ca_topic_score_codex":0.0035321817,"about_ca_topic_score_gemma":0.0006345113,"teacher_disagreement_score":0.74378985,"about_ca_system_score_codex":0.00016136296,"about_ca_system_score_gemma":0.000504478,"threshold_uncertainty_score":0.9965723},"labels":[],"label_agreement":null},{"id":"W4235161998","doi":"10.1158/1538-7445.am2019-443","title":"Abstract 443: Blood-based genotyping and clinical outcomes in patients with advanced breast cancer receiving the CDK4/6 inhibitor palbociclib in real-world settings: Results from POLARIS","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Oncology; Medicine; Genotyping; Breast cancer; Internal medicine; Cancer; Circulating tumor cell; Copy-number variation; Metastatic breast cancer; Genotype; Gene; Biology; Genetics; Metastasis","score_opus":0.034679735385543656,"score_gpt":0.39399517430360664,"score_spread":0.359315438918063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235161998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049443,0.0009267264,0.0000015464074,0.0058126263,0.000230737,0.0017805193,0.0004810024,0.000051295054,0.00022111458],"genre_scores_gemma":[0.997574,0.0005229892,0.0003995236,0.00058501726,0.0002885249,0.0002298856,0.000043590153,0.00009598745,0.00026051755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995742,0.00032125704,0.0009013708,0.001035848,0.0010460766,0.0009534006],"domain_scores_gemma":[0.9963755,0.0018400088,0.0002827393,0.00082651863,0.00043125704,0.00024400183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017391193,0.00033983157,0.00076739595,0.000421137,0.0001501556,0.000068732224,0.0003225568,0.00017268822,0.00022895147],"category_scores_gemma":[0.00035607987,0.0002316546,0.00008716052,0.0010440125,0.00040947346,0.0003123509,0.00015926783,0.001856482,0.000013488213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092234835,0.000289839,0.95033616,0.00010519837,0.00014156524,0.000021735757,0.00062331697,0.00015704695,0.0011201239,0.0000043381983,0.00003711039,0.037940063],"study_design_scores_gemma":[0.018662652,0.00022249424,0.9767304,0.00249589,0.000032650492,8.031597e-7,0.00033429288,0.0000511286,0.00053050247,0.00004157947,0.0006230446,0.00027454912],"about_ca_topic_score_codex":0.018332567,"about_ca_topic_score_gemma":0.020681633,"teacher_disagreement_score":0.037665516,"about_ca_system_score_codex":0.0008077129,"about_ca_system_score_gemma":0.00082982157,"threshold_uncertainty_score":0.9971884},"labels":[],"label_agreement":null},{"id":"W4235182644","doi":"10.1158/1538-7445.am2019-2506","title":"Abstract 2506: Exploring the complex etiology of oncogenic fusions in childhood cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children","funders":"","keywords":"Biology; Carcinogenesis; Genome; Fusion gene; Genetics; Cancer; Sarcoma; Gene; Cancer research; Chromoplexy; Pathology; Medicine","score_opus":0.2702841410612657,"score_gpt":0.45941199987855824,"score_spread":0.18912785881729255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235182644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886953,0.004135119,9.131356e-8,0.0045123785,0.00014232649,0.000726855,0.000025510579,0.000008580924,0.0017538024],"genre_scores_gemma":[0.9935618,0.0050168126,0.0000147002975,0.00015416574,0.000131851,0.000956768,0.0000090730355,0.000016635042,0.00013820361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874735,0.00007970206,0.00020734817,0.00023336508,0.00036328967,0.00036894382],"domain_scores_gemma":[0.99904615,0.00034152795,0.000036240875,0.00037087992,0.00012713487,0.00007806151],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041394497,0.00008598481,0.00025652556,0.00016222647,0.00006585652,0.0000066400053,0.0001567212,0.000044099837,0.0034677512],"category_scores_gemma":[0.00005122525,0.000053917523,0.00007514811,0.0003769738,0.00012009166,0.000034764867,0.0000974084,0.00039328446,0.00010237523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018877788,0.0007311016,0.8750774,0.00010526959,0.00016220436,0.000042246837,0.0015327389,0.00010828099,0.055242803,0.00043631438,0.002317631,0.06405521],"study_design_scores_gemma":[0.0014207087,0.00011681841,0.98255694,0.0002549586,0.000014697772,0.000004098579,0.0004724413,0.000010045894,0.009157978,0.000066389985,0.0058756922,0.000049224327],"about_ca_topic_score_codex":0.0059306426,"about_ca_topic_score_gemma":0.0016705253,"teacher_disagreement_score":0.10747953,"about_ca_system_score_codex":0.00029030975,"about_ca_system_score_gemma":0.00036483022,"threshold_uncertainty_score":0.9974432},"labels":[],"label_agreement":null},{"id":"W4235819024","doi":"10.1158/1538-7445.am2019-3809","title":"Abstract 3809: Modulation of MRP1 activity reverses chemotherapy resistance in adult cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Efflux; Glutathione; Cancer cell; Cancer research; Pharmacology; Intracellular; Ovarian cancer; Multiple drug resistance; Chemotherapy; Biology; Lung cancer; Cancer; Drug resistance; Biochemistry; Internal medicine; Medicine; Enzyme","score_opus":0.040590403649946136,"score_gpt":0.37563871281532624,"score_spread":0.3350483091653801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235819024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923038,0.0007224759,0.000021754036,0.0013782409,0.00022927001,0.00085897226,0.00004064327,0.000020793084,0.0044240914],"genre_scores_gemma":[0.98746544,0.003111791,0.00019289201,0.00007917717,0.00011339849,0.00010794754,0.000006262289,0.000034952947,0.008888153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804294,0.000048417423,0.00026342715,0.00039348655,0.00081032224,0.0004413823],"domain_scores_gemma":[0.9988959,0.000070269154,0.00009031767,0.0004147666,0.00042291541,0.00010587097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000551328,0.00013905557,0.00037442226,0.00024218421,0.000043620938,0.000010256939,0.00015582916,0.00014189901,0.0013706387],"category_scores_gemma":[0.00001787107,0.00012078913,0.0000861779,0.0006153862,0.00011440308,0.00013156755,0.000014549021,0.0004821921,0.00002773393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020801146,0.00016322195,0.018574525,0.0010640273,0.000035692712,0.000016774487,0.00054627715,0.000115703006,0.9725776,0.00021003827,0.0008615487,0.003754482],"study_design_scores_gemma":[0.0021761018,0.00006223077,0.32410336,0.0012914819,0.0000088558,2.7057004e-7,0.0001642821,0.00007709092,0.66922367,0.00022015313,0.002531247,0.00014125972],"about_ca_topic_score_codex":0.0026552344,"about_ca_topic_score_gemma":0.0049349447,"teacher_disagreement_score":0.30552882,"about_ca_system_score_codex":0.00038591854,"about_ca_system_score_gemma":0.00047380253,"threshold_uncertainty_score":0.99954224},"labels":[],"label_agreement":null},{"id":"W4235969444","doi":"10.1158/1538-7445.am2019-ct122","title":"Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Medicine; Ototoxicity; Cisplatin; Randomized controlled trial; Head and neck cancer; Radiation therapy; Oncology; Chemoradiotherapy; Mucositis; Head and neck squamous-cell carcinoma; Internal medicine; Cancer; Chemotherapy; Surgery","score_opus":0.06144599019396137,"score_gpt":0.4278888982429266,"score_spread":0.36644290804896523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235969444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888993,0.004111893,0.00008883225,0.0006113277,0.00007155573,0.005852295,0.000090228554,0.0000022075642,0.00028173372],"genre_scores_gemma":[0.9980085,0.0008233015,0.00038847435,0.000028199946,0.000024186973,0.0006247284,0.0000099990375,0.00001625148,0.00007639289],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981421,0.0003723502,0.0004847672,0.00025947802,0.0004802151,0.00026103941],"domain_scores_gemma":[0.9970076,0.0021229691,0.00023626944,0.00036880065,0.00020871825,0.00005563187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010318134,0.00016379128,0.0008558654,0.00009115965,0.000043837998,0.000008717525,0.00014082529,0.000049167404,0.00006187128],"category_scores_gemma":[0.00007126854,0.000082443796,0.00024014368,0.0002115506,0.00032709536,0.000038739454,0.000024419507,0.00017456614,2.1653958e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22819127,0.018143088,0.31830224,0.009602511,0.0016973314,0.00006186388,0.037208408,0.0023342029,0.23693654,0.003805139,0.00028346168,0.14343396],"study_design_scores_gemma":[0.50684667,0.011231973,0.2295768,0.0011323624,0.00019865192,0.000008254507,0.0029889853,0.0036860052,0.24363041,0.00020548458,0.0002993124,0.00019507422],"about_ca_topic_score_codex":0.00082603615,"about_ca_topic_score_gemma":0.00030969866,"teacher_disagreement_score":0.2786554,"about_ca_system_score_codex":0.0003890737,"about_ca_system_score_gemma":0.00059506926,"threshold_uncertainty_score":0.33619604},"labels":[],"label_agreement":null},{"id":"W4236428559","doi":"10.1158/1538-7445.am2014-lb-320","title":"Abstract LB-320: Systemic tumor-stroma interactions are prognostic indicators of breast tumor invasiveness","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Stromal cell; Stroma; Tumor microenvironment; Biology; Metastasis; Tumor progression; Cancer research; Primary tumor; Breast cancer; Cancer; Pathology; Breast tumor; Immunohistochemistry; Medicine; Immunology; Tumor cells; Genetics","score_opus":0.05169697122896268,"score_gpt":0.37220383042202937,"score_spread":0.3205068591930667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236428559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953424,0.0008120731,0.000015221533,0.00097579224,0.0002702926,0.0009001955,0.00010784933,0.000055055436,0.0015211238],"genre_scores_gemma":[0.9980999,0.000113158116,0.000025456824,0.00011274536,0.00045448897,0.0009400839,0.000017688111,0.000056384495,0.00018009389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972528,0.00019822048,0.0004894651,0.0004897322,0.0009639681,0.00060578104],"domain_scores_gemma":[0.9977962,0.00034234382,0.00025777728,0.0005511209,0.0007005832,0.00035200964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008675609,0.00020255383,0.00053847337,0.0006047741,0.00017554748,0.000048395035,0.00033877487,0.00006712806,0.00094459794],"category_scores_gemma":[0.00041048464,0.00017114439,0.0001501483,0.0009980496,0.00033402315,0.00013564185,0.0001305262,0.00076231366,0.00010059514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054100744,0.0004949378,0.8868238,0.0035368777,0.00021156049,0.00007726239,0.0003391535,0.000023137052,0.094171524,0.00022301108,0.0038958755,0.009661867],"study_design_scores_gemma":[0.0013386476,0.00039849625,0.93790996,0.0062042624,0.00010078336,0.00031801066,0.0015139492,0.000046135236,0.048676163,0.00003446741,0.0032243778,0.0002347616],"about_ca_topic_score_codex":0.0007959051,"about_ca_topic_score_gemma":0.00013973162,"teacher_disagreement_score":0.05108616,"about_ca_system_score_codex":0.00046224435,"about_ca_system_score_gemma":0.0007375231,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4236827015","doi":"10.1158/1538-7445.am2019-2272","title":"Abstract 2272: Exploratory analysis of T cell repertoire dynamics upon systemic treatment with the oncolytic virus pelareorep in combination with pembrolizumab and chemotherapy in patients with advanced pancreatic adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Pembrolizumab; Medicine; Gemcitabine; Chemotherapy; Cancer research; Internal medicine; Immunotherapy; Oncology; Immunology; Cancer","score_opus":0.012136128788053098,"score_gpt":0.2903457425220445,"score_spread":0.2782096137339914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236827015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664325,0.0016770073,0.0000068557006,0.00008380508,0.000006728729,0.0014580985,0.00003668122,0.000004382662,0.00008320118],"genre_scores_gemma":[0.99827313,0.0010271231,0.000012763474,0.00001850117,0.000008525746,0.00039147568,0.00010864704,0.00004462249,0.000115179944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979966,0.00025279901,0.00022693168,0.00053335464,0.0005868942,0.00040341454],"domain_scores_gemma":[0.99877155,0.00006958514,0.000120808276,0.00065092434,0.00031191346,0.00007519776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045443026,0.00020632349,0.0003783984,0.0003943397,0.000063938,0.000028161347,0.00023121768,0.00009587332,0.000023603008],"category_scores_gemma":[0.0000068725885,0.00012606311,0.00003902281,0.001017945,0.00018192586,0.000017777827,0.00003989878,0.00022452862,0.0000013664835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03995726,0.0006470122,0.8286333,0.00021867499,0.00058434356,0.000014693697,0.0011633211,0.0047736983,0.117206655,0.0000050212966,0.0000035909484,0.0067924326],"study_design_scores_gemma":[0.025775474,0.035708457,0.7915656,0.00045205568,0.0001663178,0.0000032332684,0.003362773,0.0027174868,0.13970895,0.0000053927583,0.00003319296,0.0005010471],"about_ca_topic_score_codex":0.00061378314,"about_ca_topic_score_gemma":0.014974096,"teacher_disagreement_score":0.037067685,"about_ca_system_score_codex":0.00064734725,"about_ca_system_score_gemma":0.00052529696,"threshold_uncertainty_score":0.8355897},"labels":[],"label_agreement":null},{"id":"W4236986578","doi":"10.1158/1538-7445.sabcs16-ot2-01-01","title":"Abstract OT2-01-01: SANDPIPER: Phase III study of the PI3-kinase inhibitor taselisib (GDC-0032) plus fulvestrant in patients with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer enriched for patients with <i>PIK3CA-</i>mutant tumors","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Calgary","funders":"","keywords":"Fulvestrant; Metastatic breast cancer; Medicine; Internal medicine; Estrogen receptor; Cancer; Aromatase inhibitor; Breast cancer; Oncology; Estrogen; Placebo; PI3K/AKT/mTOR pathway; Endocrinology; Cancer research; Aromatase; Biology; Pathology; Apoptosis; Biochemistry","score_opus":0.029655723474470718,"score_gpt":0.3682503041920291,"score_spread":0.3385945807175584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236986578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849516,0.00026431138,0.00005562265,0.00051090063,0.00018599848,0.011099363,0.0028618528,0.00003506762,0.000035292644],"genre_scores_gemma":[0.99538213,0.00007575689,0.00048387027,0.00009800621,0.00015186059,0.0034243022,0.00009525343,0.00017419884,0.000114644194],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9940724,0.00029878222,0.0009160822,0.0011643734,0.0022692555,0.0012791489],"domain_scores_gemma":[0.99466395,0.00041147016,0.0008479825,0.0014047192,0.0022098692,0.000462009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006535408,0.0006841174,0.0012694142,0.00030883081,0.000813359,0.00010700598,0.00086232624,0.00010870788,0.00033252581],"category_scores_gemma":[0.00029164003,0.00040163053,0.00013428368,0.0008426287,0.0012224959,0.00068723137,0.00022198488,0.0009690504,0.0000029567846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48658562,0.018022088,0.37377858,0.0012984949,0.0025783752,0.00020412591,0.010720789,0.0017901569,0.014303641,0.00002277561,0.00024797203,0.09044739],"study_design_scores_gemma":[0.19419792,0.013623812,0.7604734,0.004271916,0.0004104157,0.000008915224,0.0061097783,0.00005431722,0.01971378,0.00004177807,0.00022990978,0.0008640976],"about_ca_topic_score_codex":0.0051278304,"about_ca_topic_score_gemma":0.0047370717,"teacher_disagreement_score":0.3866948,"about_ca_system_score_codex":0.0016795407,"about_ca_system_score_gemma":0.0025436108,"threshold_uncertainty_score":0.99984354},"labels":[],"label_agreement":null},{"id":"W4237012958","doi":"10.1158/1538-7445.am2019-910","title":"Abstract 910: The cBioPortal for cancer genomics","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"World Wide Web; Visualization; Computer science; Download; Software; Genomics; Data science; Genome; Biology; Data mining; Genetics; Operating system","score_opus":0.04797229819333007,"score_gpt":0.389642651865596,"score_spread":0.34167035367226595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237012958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671454,0.008310456,0.00005516626,0.0014513724,0.00063533254,0.0008206414,0.00031971023,0.000005414561,0.0016873738],"genre_scores_gemma":[0.98749506,0.0072403476,0.00005489376,0.0004743785,0.0011510423,0.00059396663,0.000058228045,0.000042479838,0.0028895775],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987713,0.000020854677,0.00016248919,0.00037226622,0.00020207455,0.00047098973],"domain_scores_gemma":[0.9990147,0.000089364556,0.000050286235,0.00047791936,0.00027657705,0.00009120164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005090176,0.00011452231,0.000120069875,0.00003743173,0.00016823346,0.00006832065,0.00040809065,0.000113490634,0.0002974444],"category_scores_gemma":[0.00007743456,0.000089229856,0.0001027901,0.00009887756,0.00013089151,0.0000028484537,0.00016233986,0.00019118725,0.000045268727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027543597,0.000036671216,0.004388785,0.000074123396,0.00009528527,0.0000013474457,0.00009504013,0.00079534,0.93776196,0.0006108579,0.039891295,0.015973885],"study_design_scores_gemma":[0.0006011117,0.00015036663,0.004320747,0.000023303555,0.000010059191,0.0000014577873,0.00015874587,0.000071173556,0.20846103,0.00028097822,0.7857428,0.00017820965],"about_ca_topic_score_codex":0.00078637165,"about_ca_topic_score_gemma":0.00095961103,"teacher_disagreement_score":0.7458515,"about_ca_system_score_codex":0.0001149826,"about_ca_system_score_gemma":0.0007270919,"threshold_uncertainty_score":0.36386877},"labels":[],"label_agreement":null},{"id":"W4237140976","doi":"10.1158/1538-7445.am2019-74","title":"Abstract 74: Heterogeneity response to afatinib in gastric cancer patient with uncommon EGFR mutations","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Afatinib; Cancer; Cancer research; Medicine; Epidermal growth factor receptor; Mutation; EGFR inhibitors; Lung cancer; Gene; Oncology; Internal medicine; Biology; Genetics; Erlotinib","score_opus":0.035465198019335405,"score_gpt":0.37049657775233646,"score_spread":0.33503137973300107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237140976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965818,0.0010514633,0.00001944017,0.00080988824,0.00014182692,0.00066805957,0.0001967193,0.000005609218,0.0005252253],"genre_scores_gemma":[0.9982172,0.00041431602,0.00013409053,0.00027534948,0.00011640425,0.0005307394,0.000043303524,0.0000332053,0.00023535598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984035,0.0001177056,0.00019927864,0.00046362114,0.00032952565,0.00048635242],"domain_scores_gemma":[0.99896616,0.00011183547,0.000045589706,0.00045042264,0.00024121907,0.00018477073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044768967,0.00013661939,0.00014689514,0.00018815124,0.00007612805,0.00004936501,0.00023182575,0.00008884068,0.00015879194],"category_scores_gemma":[0.00012251295,0.00012633481,0.000039426428,0.00042615994,0.00006733823,0.000005031971,0.00016559727,0.00023034588,0.0000502785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041099135,0.00014446263,0.088621296,0.000046311652,0.0000470773,0.000029801688,0.0003177864,0.021124855,0.8714644,0.00001564114,0.0031346914,0.01094378],"study_design_scores_gemma":[0.00257971,0.0024666796,0.34872758,0.00024729845,0.000012028937,0.000011140122,0.00058293267,0.0000633962,0.53960997,0.000042409192,0.10507909,0.0005777189],"about_ca_topic_score_codex":0.00234774,"about_ca_topic_score_gemma":0.00982058,"teacher_disagreement_score":0.3318544,"about_ca_system_score_codex":0.00031391357,"about_ca_system_score_gemma":0.0008033698,"threshold_uncertainty_score":0.54801136},"labels":[],"label_agreement":null},{"id":"W4237219642","doi":"10.1158/1538-7445.am2019-2891","title":"Abstract 2891: Landscape of infiltrating immune repertoire in pediatric solid tumors","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Immunotherapy; Tumor microenvironment; Immune checkpoint; Cancer immunotherapy; Biology; Cancer; Repertoire; T-cell receptor; Immunology; T cell; Computational biology; Cancer research; Medicine; Genetics","score_opus":0.03025689914606765,"score_gpt":0.3637490819094387,"score_spread":0.33349218276337106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237219642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892264,0.005147644,0.0000028074446,0.00015160302,0.00007114627,0.00019547174,0.000011846799,0.0000033282142,0.0051897694],"genre_scores_gemma":[0.99644554,0.002130881,0.000024037105,0.000014337368,0.000184332,0.000079383375,0.000023179395,0.000015215309,0.0010831029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998954,0.00004575613,0.0002483221,0.00026229286,0.0002199099,0.00026973948],"domain_scores_gemma":[0.99931115,0.000020631533,0.0000675526,0.00038780796,0.00017011618,0.000042740074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050343154,0.00007216394,0.00013049656,0.000121492594,0.000042096934,0.00001692241,0.00022949361,0.000084571046,0.0002445802],"category_scores_gemma":[0.000067222485,0.00006678549,0.00004566295,0.00031058022,0.000047953414,0.0000058634255,0.00007517674,0.0002016037,0.000018902505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006039185,0.000038606617,0.08713264,0.000092700706,0.00000819363,0.0000015715779,0.000092998176,0.0004020144,0.9088463,0.000038731992,0.0007320625,0.0025537717],"study_design_scores_gemma":[0.0009849286,0.00024394628,0.3929306,0.00010414068,0.0000046460887,0.0000031906604,0.00081817445,0.00010650631,0.5996645,0.0000615821,0.004833114,0.00024468967],"about_ca_topic_score_codex":0.0003121177,"about_ca_topic_score_gemma":0.00011836059,"teacher_disagreement_score":0.30918184,"about_ca_system_score_codex":0.000029272634,"about_ca_system_score_gemma":0.0003427494,"threshold_uncertainty_score":0.27234334},"labels":[],"label_agreement":null},{"id":"W4237506889","doi":"10.1158/1538-7445.am2019-2908","title":"Abstract 2908: Mesothelioma phylogeny reveal MTAP as a solitary clonal deletion, exposing vulnerability to the PRMT5 perturbagen, quinacrine","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Mesothelioma; Somatic evolution in cancer; Biology; Exome sequencing; Somatic cell; Copy number analysis; Exome; Oncology; Pathology; Cancer research; Medicine; Internal medicine; Cancer; Genetics; Copy-number variation; Mutation; Genome","score_opus":0.052876720153644856,"score_gpt":0.4030645692534043,"score_spread":0.3501878490997594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237506889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827057,0.0020423187,0.000005683567,0.010726754,0.00014795002,0.0010507923,0.00009780276,0.000027188673,0.0031958027],"genre_scores_gemma":[0.99234533,0.00010607607,0.00009489283,0.0017807416,0.0006586305,0.0002727644,0.000064688385,0.00002943706,0.0046474203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757093,0.00012186458,0.0002421839,0.0004610156,0.0010809699,0.00052303454],"domain_scores_gemma":[0.99874854,0.00020676969,0.00002998139,0.0005119468,0.00017383153,0.00032893574],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00084891886,0.00015140776,0.00019766873,0.00011041113,0.00026962263,0.000033745426,0.00023306026,0.00005962193,0.004536266],"category_scores_gemma":[0.00019494184,0.000101606674,0.00011336051,0.00031149443,0.00018318174,0.00009139448,0.00016763266,0.00041664336,0.0014764721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057927896,0.000998725,0.4006412,0.0007711516,0.00023389822,0.00012038496,0.0011517056,0.0004289279,0.48647785,0.0006307277,0.07722679,0.025525846],"study_design_scores_gemma":[0.0006282661,0.0004459628,0.9504423,0.000157402,0.000022744749,0.000025351717,0.0003381634,0.000035783585,0.008039319,0.0004254034,0.0392969,0.00014237408],"about_ca_topic_score_codex":0.0013140314,"about_ca_topic_score_gemma":0.00006368949,"teacher_disagreement_score":0.5498011,"about_ca_system_score_codex":0.00054498593,"about_ca_system_score_gemma":0.0003164156,"threshold_uncertainty_score":0.999301},"labels":[],"label_agreement":null},{"id":"W4237513022","doi":"10.1158/1538-7445.sabcs18-p5-18-10","title":"Abstract P5-18-10: BHLHE40-AS1 is an enhancer associated long noncoding RNA critical to breast cancer progression","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Ductal carcinoma; Cancer; Biomarker; Long non-coding RNA; Medicine; Cancer research; Overdiagnosis; Tumor progression; Oncology; Internal medicine; Biology; RNA; Gene","score_opus":0.05406486171203709,"score_gpt":0.45563484286908,"score_spread":0.4015699811570429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237513022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812664,0.00320326,0.00046311898,0.00285242,0.00064364815,0.0015079981,0.0004251619,0.000060600894,0.002717152],"genre_scores_gemma":[0.99004614,0.00090997625,0.00011365369,0.00041399887,0.0008472683,0.0008057401,0.000116833355,0.00015551069,0.0065908926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942543,0.0003799288,0.00042663264,0.001460589,0.0017434276,0.0017351552],"domain_scores_gemma":[0.9963336,0.00008710124,0.00008511528,0.0010610638,0.0016219242,0.0008112123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016565674,0.00037770916,0.00038806963,0.0003273459,0.00037005314,0.0002620557,0.0009327163,0.0006445888,0.012692595],"category_scores_gemma":[0.00040731096,0.00037267405,0.00017681903,0.00087594736,0.00023400808,0.000042001673,0.0006854293,0.0011551264,0.0005276789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008160689,0.00021646573,0.00048665653,0.00013284855,0.0001273047,0.000033564676,0.000162691,0.00016442571,0.95639807,0.000029511391,0.016599324,0.024833046],"study_design_scores_gemma":[0.001186386,0.0007778384,0.0053901016,0.0006579505,0.000022155782,0.000013058913,0.0001647312,0.0002521292,0.97618824,0.000049268627,0.014682362,0.00061576726],"about_ca_topic_score_codex":0.0010517178,"about_ca_topic_score_gemma":0.0007339262,"teacher_disagreement_score":0.024217278,"about_ca_system_score_codex":0.00081750355,"about_ca_system_score_gemma":0.0014205498,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W4237744731","doi":"10.1158/1538-7445.am2019-3110","title":"Abstract 3110: Shorter naïve T cell telomere length is associated with thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study (CCSS)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Oncology; Population; Thyroid cancer; Cancer","score_opus":0.049421221381520004,"score_gpt":0.34588681910158653,"score_spread":0.29646559772006653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237744731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665345,0.004116651,0.0000011251304,0.0027888278,0.00047334871,0.0034898955,0.0003948795,0.00011453496,0.0019672995],"genre_scores_gemma":[0.9898139,0.00120119,0.000011441205,0.00068169716,0.00053094624,0.00063640194,0.00010901988,0.00014081123,0.0068745967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933083,0.00037263412,0.0007451276,0.0013994278,0.0027692975,0.0014051908],"domain_scores_gemma":[0.9958301,0.0006781366,0.0002935964,0.0017376093,0.0009875445,0.00047299615],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019153475,0.00051764876,0.00089972327,0.0002269316,0.0004124584,0.00017612318,0.00071764225,0.00024296541,0.0032255067],"category_scores_gemma":[0.00019101762,0.00031775955,0.00018653946,0.0011633538,0.000267835,0.00021073979,0.0002210926,0.0017712653,0.00028616982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008596507,0.0014853118,0.9364539,0.000097634096,0.0010497916,0.0022899187,0.01116459,0.00002523165,0.029496692,0.000004230091,0.013713805,0.003359277],"study_design_scores_gemma":[0.0039792773,0.00081361487,0.9626506,0.0007503857,0.00020293106,0.000060291626,0.0068910522,0.00002810513,0.019922007,0.000018906445,0.0041472847,0.0005355504],"about_ca_topic_score_codex":0.043708958,"about_ca_topic_score_gemma":0.01796361,"teacher_disagreement_score":0.026196724,"about_ca_system_score_codex":0.0008586336,"about_ca_system_score_gemma":0.002326851,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W4237871758","doi":"10.1158/1538-7445.am2019-3778","title":"Abstract 3778: Uncovering the role of glioma stem cells in glioblastoma chemo-resistance and recurrence","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University; McGill Genome Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"SOX2; Cancer stem cell; Stem cell; Cancer research; Glioma; Neural stem cell; Biology; Progenitor cell; Stem cell marker; Population; Cancer; Oncology; Medicine; Genetics; Gene; Embryonic stem cell","score_opus":0.015344286615657446,"score_gpt":0.3058285859602209,"score_spread":0.29048429934456343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237871758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914493,0.0075965105,0.0000019714203,0.000045789813,0.000044568973,0.00027410858,0.00002492134,0.0000022522397,0.0005605673],"genre_scores_gemma":[0.99936706,0.00030725083,0.0000106435655,0.0000056874624,0.00004952499,0.00003389642,0.0000020694713,0.000011326975,0.00021251389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991116,0.000057325113,0.00013693923,0.00025304666,0.00022041197,0.00022068495],"domain_scores_gemma":[0.99944973,0.000034508226,0.000049659728,0.00031234455,0.000110290704,0.0000434674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039737788,0.00007202679,0.00008680668,0.000055701184,0.000033589993,0.000019338693,0.00020689183,0.000067189925,0.000036587167],"category_scores_gemma":[0.000016782335,0.000060080783,0.000025397707,0.00020973472,0.00011416611,0.0000058947994,0.00013304017,0.00012458411,0.0000077414115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019970447,0.00001499931,0.0035962323,0.00010210006,0.000009090191,0.000001155298,0.00005914875,0.00011592409,0.992309,0.00003596471,0.00017535091,0.0033813776],"study_design_scores_gemma":[0.00023954187,0.000037820544,0.0129446555,0.00010559295,0.000001389134,7.2985154e-7,0.0001431223,0.00002840396,0.97928363,0.00009954626,0.007048985,0.00006657708],"about_ca_topic_score_codex":0.000091294336,"about_ca_topic_score_gemma":0.00026409878,"teacher_disagreement_score":0.013025316,"about_ca_system_score_codex":0.000049119473,"about_ca_system_score_gemma":0.00014175876,"threshold_uncertainty_score":0.24500231},"labels":[],"label_agreement":null},{"id":"W4238086529","doi":"10.1158/1538-7445.am2019-2777","title":"Abstract 2777: LOXL4-expressing neutrophils are found in colorectal cancer liver metastases resistant to anti-angiogenic therapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Colorectal cancer; Immunostaining; Pathological; Metastasis; Biomarker; Pathology; Angiogenesis; Bevacizumab; Cancer; Cancer research; Oncology; Immunohistochemistry; Internal medicine; Chemotherapy; Biology","score_opus":0.06946924270353733,"score_gpt":0.3855045357878939,"score_spread":0.31603529308435657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238086529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448283,0.05355147,0.0000074033037,0.00027120858,0.00024558965,0.00069924316,0.00016431617,0.000010916396,0.00022158737],"genre_scores_gemma":[0.9883637,0.009678174,0.00005331688,0.00032029668,0.00054951175,0.00044878744,0.000029074889,0.00006538948,0.0004917463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974598,0.00017582424,0.0002920721,0.00077199365,0.000503435,0.00079686486],"domain_scores_gemma":[0.9988365,0.00005123335,0.000089626184,0.00045408873,0.00037837157,0.00019017565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006444503,0.00024554506,0.00033167217,0.00021539775,0.00014586565,0.00011058431,0.0004666861,0.0001792881,0.0007584127],"category_scores_gemma":[0.000044677985,0.00021671664,0.00017406004,0.00057776616,0.000115690586,0.000015793406,0.000216504,0.00023676304,0.00007605766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008669138,0.00008384603,0.023244293,0.00006759986,0.00011652496,0.000028673132,0.00011817641,0.0008813464,0.9648456,0.00001318171,0.00572868,0.0040051504],"study_design_scores_gemma":[0.0010423334,0.00030986048,0.28698954,0.0002661213,0.000011017376,0.0000027922504,0.00028878593,0.000013847273,0.65305805,0.000014082624,0.057606265,0.00039729575],"about_ca_topic_score_codex":0.0018454537,"about_ca_topic_score_gemma":0.002485372,"teacher_disagreement_score":0.31178755,"about_ca_system_score_codex":0.00022977669,"about_ca_system_score_gemma":0.00052105647,"threshold_uncertainty_score":0.88374484},"labels":[],"label_agreement":null},{"id":"W4238275106","doi":"10.1158/1538-7445.am2019-4531","title":"Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"","keywords":"Hazard ratio; Medicine; Internal medicine; Regorafenib; Quartile; Placebo; Oncology; Proportional hazards model; Confidence interval; Cancer; Randomized controlled trial; Progression-free survival; Colorectal cancer; Chemotherapy; Pathology","score_opus":0.08155113361549109,"score_gpt":0.43438610555701135,"score_spread":0.35283497194152025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238275106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96419877,0.0040369374,0.000021961578,0.000106898464,0.0019048643,0.029444015,0.00022423611,0.000018149343,0.000044140932],"genre_scores_gemma":[0.9826344,0.00041487717,0.00005018731,0.000005368371,0.0012999921,0.014690491,0.00012439169,0.00007694208,0.000703335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930141,0.0018064794,0.0018112613,0.0011708911,0.0011320019,0.0010652803],"domain_scores_gemma":[0.99557287,0.0018294161,0.0008141567,0.00092758227,0.0006640853,0.00019187834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011970586,0.0005372723,0.0020874185,0.00054945657,0.00023963834,0.00013289573,0.0010119687,0.00018664612,0.00009815373],"category_scores_gemma":[0.0047352184,0.0003495682,0.00038911618,0.00077474077,0.00034066933,0.00005725872,0.00035152276,0.0009512344,0.0000010705218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67700994,0.004675094,0.015724918,0.00020918756,0.0004061731,0.000002953524,0.0020310192,0.0002772443,0.29654235,0.000007133713,0.00062988576,0.0024841013],"study_design_scores_gemma":[0.95164186,0.005226348,0.002938056,0.00061439874,0.00022481129,0.0000023437203,0.017538441,0.00008449935,0.020714972,0.000041372936,0.00053217047,0.0004407491],"about_ca_topic_score_codex":0.004570353,"about_ca_topic_score_gemma":0.012156707,"teacher_disagreement_score":0.27582738,"about_ca_system_score_codex":0.0002301624,"about_ca_system_score_gemma":0.0010188866,"threshold_uncertainty_score":0.99989563},"labels":[],"label_agreement":null},{"id":"W4238704533","doi":"10.1158/1538-7445.am2019-ct115","title":"Abstract CT115: Phase II study of dianhydrogalactitol (VAL-083) in patients with MGMT-unmethylated, bevacizumab-naïve recurrent glioblastoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Internal medicine; Phases of clinical research; Clinical trial; In vivo; Cancer research; Radiation therapy; Chemotherapy; Biology","score_opus":0.036422004630993265,"score_gpt":0.39673721453913513,"score_spread":0.36031520990814186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238704533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539244,0.00033778377,7.319408e-8,0.00023509003,0.00015445927,0.003258984,0.000045880995,0.000020210191,0.00055505807],"genre_scores_gemma":[0.9991647,0.00011000045,0.000009006264,0.000010789896,0.00004939777,0.0004710734,0.000023100145,0.000042814874,0.00011913349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969113,0.00012685051,0.00040921118,0.0005606632,0.0013909591,0.00060101954],"domain_scores_gemma":[0.99833,0.0001612038,0.00012145796,0.00064374076,0.00049484643,0.00024873952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044658972,0.00022748411,0.00052571646,0.0007005112,0.00009602569,0.000022493281,0.00017845952,0.00009329885,0.00080177496],"category_scores_gemma":[0.00007065396,0.00015098782,0.000069436916,0.0010542874,0.00008837361,0.00013853332,0.00013110634,0.00056648237,0.00011562775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013542875,0.033340402,0.88688016,0.00024846118,0.00042915475,0.00026213028,0.0025474592,0.000061651976,0.0027087503,0.000006922296,0.0007062928,0.059265725],"study_design_scores_gemma":[0.06380488,0.058406904,0.8471305,0.0010034004,0.0001037621,0.0000026494067,0.0013158777,0.000033933782,0.026616955,0.000010039402,0.0013017255,0.00026939053],"about_ca_topic_score_codex":0.0016207708,"about_ca_topic_score_gemma":0.0011932185,"teacher_disagreement_score":0.058996335,"about_ca_system_score_codex":0.0006313597,"about_ca_system_score_gemma":0.00028573637,"threshold_uncertainty_score":0.87788737},"labels":[],"label_agreement":null},{"id":"W4239119746","doi":"10.1158/1538-7445.am2019-655","title":"Abstract 655: Clinicopathological and genetic features of colorectal cancer in Algerian patients","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colorectal cancer; Lynch syndrome; MSH6; Internal medicine; Familial adenomatous polyposis; MLH1; Cancer; MSH2; Oncology; Family history; Population; Gastroenterology; Gynecology; DNA mismatch repair","score_opus":0.05427711005426862,"score_gpt":0.41434488301728967,"score_spread":0.36006777296302106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239119746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930354,0.003294518,1.6357147e-7,0.00029432346,0.00039924443,0.0010694203,0.00005836781,0.000012356166,0.0018362108],"genre_scores_gemma":[0.99744314,0.001734855,0.00013373286,0.00007575102,0.0000903006,0.00022064382,0.0000056828485,0.000027737964,0.00026818019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978879,0.00011450984,0.000343048,0.00047601014,0.0006824015,0.00049610133],"domain_scores_gemma":[0.9989448,0.00023426092,0.000072068724,0.00024544218,0.00033032545,0.00017306699],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004165158,0.00014902845,0.000409575,0.00022775955,0.000034063607,0.000015241079,0.00016861774,0.00020777651,0.0017871212],"category_scores_gemma":[0.00023808917,0.00012082941,0.000055347282,0.00040059304,0.0003429518,0.000035322082,0.00015788889,0.0006796337,0.000021551241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010388708,0.0001358709,0.8713696,0.00023164203,0.0000153826,0.00002504693,0.0003110103,0.000026341266,0.10018929,0.000005743384,0.00046633632,0.026184862],"study_design_scores_gemma":[0.0018698182,0.0009339983,0.9697967,0.00026565016,0.000009463828,0.000005288419,0.00009406858,0.0000132501655,0.026500441,0.000061460916,0.00033701558,0.00011282503],"about_ca_topic_score_codex":0.00073337887,"about_ca_topic_score_gemma":0.0006334001,"teacher_disagreement_score":0.09842712,"about_ca_system_score_codex":0.0003010032,"about_ca_system_score_gemma":0.00046088177,"threshold_uncertainty_score":0.99912536},"labels":[],"label_agreement":null},{"id":"W4239923498","doi":"10.1158/1538-7445.am2019-1739","title":"Abstract 1739: Diminished <i>SKP1</i> or <i>CUL1</i> expression induces chromosome instability in high-grade serous ovarian cancer precursor cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cancer research; Ubiquitin ligase; Genome instability; Cyclin D; Cyclin D2; Biology; Cell cycle; Cancer; Cyclin; Medicine; DNA damage; Ubiquitin; Genetics; Gene; DNA","score_opus":0.052307170073927926,"score_gpt":0.34921726391626495,"score_spread":0.296910093842337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239923498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387896,0.001916378,0.000002692507,0.0004394252,0.0005140194,0.0013323207,0.00027825558,0.000026424997,0.0016115181],"genre_scores_gemma":[0.9946698,0.0017120296,0.00011628525,0.00021356532,0.00049723324,0.0009335528,0.000079451485,0.00006116145,0.0017169554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967462,0.00034082631,0.00039773568,0.0009830968,0.0006188092,0.00091332523],"domain_scores_gemma":[0.9985069,0.00009410016,0.000110428125,0.0008227032,0.00021506194,0.0002507876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010142071,0.00029235447,0.000352529,0.00012759304,0.00014325128,0.00009307909,0.00067213416,0.00042546025,0.001538734],"category_scores_gemma":[0.00010382667,0.0002393554,0.0000889413,0.00044265366,0.00019697826,0.000028554607,0.0004013301,0.00075607107,0.00009140184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075341185,0.00022394839,0.00510152,0.00029407413,0.000025473835,0.000016282409,0.00029268675,0.00008200875,0.9885102,0.000012021109,0.002128452,0.0025599208],"study_design_scores_gemma":[0.0015767801,0.000303284,0.0070237876,0.00025475447,0.000004479556,0.0000023423088,0.00016790259,0.0000044150574,0.965677,0.000080845566,0.024576245,0.0003281406],"about_ca_topic_score_codex":0.00195745,"about_ca_topic_score_gemma":0.0011055635,"teacher_disagreement_score":0.022833176,"about_ca_system_score_codex":0.00018962917,"about_ca_system_score_gemma":0.0009574751,"threshold_uncertainty_score":0.999374},"labels":[],"label_agreement":null},{"id":"W4239971652","doi":"10.1158/1538-7445.am2019-841","title":"Abstract 841: Meningioma subgroups associated with functional genomic elements defined by DNA methylation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; DNA methylation; Methylation; Enhancer; Biology; Epigenetics; Cancer; Cancer research; Genetics; Gene; Medicine; Gene expression; Pathology","score_opus":0.039316498569122664,"score_gpt":0.3325657183498284,"score_spread":0.2932492197807057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239971652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501574,0.0019324732,0.00023658607,0.00011846673,0.00011243116,0.00031828668,0.000054513614,0.000010072059,0.0022014074],"genre_scores_gemma":[0.99647874,0.00023571496,0.00008407863,0.000027179489,0.00012885692,0.00007905189,0.0008727509,0.000028754934,0.0020648595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984641,0.00011074476,0.00019452484,0.00039191384,0.00047048958,0.00036819596],"domain_scores_gemma":[0.9992178,0.00005490671,0.0000899692,0.00024444342,0.00030443064,0.000088418004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086352596,0.00012136694,0.0001128768,0.00008008246,0.00012634488,0.000046750913,0.00013797288,0.00014167238,0.00038780406],"category_scores_gemma":[0.00008243041,0.00011101494,0.000042804077,0.00020107212,0.000054444845,0.0000072946823,0.00006724783,0.00016953395,0.000050897626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014552887,0.00004996297,0.028497823,0.000008880181,0.000107078245,6.27413e-7,0.000016803697,0.00019608017,0.96803063,0.000036770354,0.0013898263,0.0015199708],"study_design_scores_gemma":[0.001178094,0.0003893269,0.16868381,0.000020018802,0.000012270733,3.1209677e-7,0.00002851485,0.00006719648,0.8158307,0.00021813338,0.013368533,0.0002030962],"about_ca_topic_score_codex":0.000091580325,"about_ca_topic_score_gemma":0.00011591743,"teacher_disagreement_score":0.15219995,"about_ca_system_score_codex":0.00013570143,"about_ca_system_score_gemma":0.00018969484,"threshold_uncertainty_score":0.45270577},"labels":[],"label_agreement":null},{"id":"W4240152671","doi":"10.1158/1538-7445.pedca17-b30","title":"Abstract B30: Dianhydrogalactitol (VAL-083) has the potential to overcome major challenges in the treatment of DIPG","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Delmar (Canada)","funders":"","keywords":"Temozolomide; Cancer research; Medicine; DNA repair; Topoisomerase; Etoposide; Glioma; DNA damage; Methyltransferase; Cancer; Chemotherapy; Pharmacology; Biology; Internal medicine; In vitro; DNA; Genetics","score_opus":0.197862116008028,"score_gpt":0.43685459962824347,"score_spread":0.23899248362021547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240152671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442627,0.008758459,3.3669514e-7,0.043032277,0.00014527202,0.0012072672,0.000023063718,0.0000089214645,0.0025617473],"genre_scores_gemma":[0.9924318,0.005775132,0.0000116695455,0.000114310875,0.0006121084,0.0008753122,0.0000038593607,0.000018943676,0.00015686137],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816304,0.00013164505,0.00019892862,0.00030064283,0.00074790866,0.00045783725],"domain_scores_gemma":[0.9987569,0.0002728039,0.000034629076,0.0006360754,0.00017681635,0.00012280299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005475224,0.0001383495,0.0002447751,0.00018609752,0.00019748871,0.00004455564,0.00022725044,0.00006254218,0.00039953936],"category_scores_gemma":[0.000046923076,0.00006620973,0.0001081614,0.00036616647,0.00037796,0.00004168766,0.00004229548,0.00016533327,0.0001756839],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051002363,0.018998945,0.057435833,0.00052800326,0.0018994277,0.0025412063,0.08404739,0.00005644285,0.16712752,0.0023950331,0.034650654,0.6252193],"study_design_scores_gemma":[0.0037292733,0.0035363054,0.8367501,0.0002303941,0.00009243627,0.00002370589,0.0035869514,0.000012994678,0.052425377,0.00026901418,0.09921904,0.00012439009],"about_ca_topic_score_codex":0.004685552,"about_ca_topic_score_gemma":0.0026429957,"teacher_disagreement_score":0.7793143,"about_ca_system_score_codex":0.00036778575,"about_ca_system_score_gemma":0.00020129573,"threshold_uncertainty_score":0.7083184},"labels":[],"label_agreement":null},{"id":"W4240295576","doi":"10.1158/1538-7445.sabcs16-p4-03-08","title":"Abstract P4-03-08: Mechanisms of CD8+ T cell immunosuppression in triple negative breast cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"Triple-negative breast cancer; Stromal cell; Cytotoxic T cell; CD8; Cancer research; Estrogen receptor; Stroma; Breast cancer; T cell; Immune system; Tumor microenvironment; Medicine; Cancer; Biology; Pathology; Immunology; Internal medicine; Immunohistochemistry","score_opus":0.06673681666675702,"score_gpt":0.4107836348163933,"score_spread":0.3440468181496363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240295576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593396,0.0031814894,0.000008667814,0.0028444934,0.00051077455,0.0009543521,0.0002457446,0.00001797064,0.0063025462],"genre_scores_gemma":[0.9928611,0.0039178375,0.000064278276,0.00008266825,0.00017588011,0.000277143,0.000007987347,0.00003790637,0.0025752313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977313,0.00009800571,0.00038675175,0.00040595906,0.0007929773,0.000584966],"domain_scores_gemma":[0.99829775,0.000108501285,0.00021880843,0.00084954774,0.00038580684,0.00013956707],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010518583,0.00017923169,0.00041303967,0.00028506655,0.00031711627,0.00006432376,0.00051943364,0.00017369779,0.004527134],"category_scores_gemma":[0.000079842815,0.00014418659,0.00013624252,0.0002854113,0.0004438871,0.0002220343,0.00016800479,0.0006639382,0.000029083021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007253273,0.00022672296,0.0049177976,0.0003257588,0.00008299056,0.00004107177,0.00058182667,0.0000045019765,0.95210844,0.000034973902,0.0034762977,0.030946353],"study_design_scores_gemma":[0.005822875,0.00017555509,0.32062456,0.0012024238,0.000015644338,0.0000063591187,0.0003971612,0.000026652195,0.6701329,0.00043463212,0.001013598,0.00014765667],"about_ca_topic_score_codex":0.03949201,"about_ca_topic_score_gemma":0.0020513753,"teacher_disagreement_score":0.31570676,"about_ca_system_score_codex":0.00056651776,"about_ca_system_score_gemma":0.00091468316,"threshold_uncertainty_score":0.9963829},"labels":[],"label_agreement":null},{"id":"W4240999353","doi":"10.1158/1538-7445.transcagen-a2-63","title":"Abstract A2-63: Airway gene-coexpression network rewiring in the presence of bronchial dysplasia and lung cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Carcinogenesis; Cancer; Context (archaeology); Biomarker; Lung; Disease; Pathology; Dysplasia; Medicine; Lung cancer screening; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.03842579179467311,"score_gpt":0.3575759887272576,"score_spread":0.3191501969325845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240999353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807324,0.016814206,0.00012401612,0.000285316,0.00019123808,0.0003463044,0.000017830042,0.0000026579683,0.0014860264],"genre_scores_gemma":[0.99687535,0.0019192671,0.00015296906,0.00007243019,0.0006765365,0.000103530176,0.000013177602,0.000012692584,0.00017406548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872667,0.00010581909,0.0002255463,0.00021975188,0.0003139266,0.0004082642],"domain_scores_gemma":[0.9993394,0.000050319995,0.00006931328,0.00031507635,0.00012674318,0.000099168494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013290257,0.00010077853,0.00012536629,0.000038100887,0.00009214326,0.00003828403,0.00034796188,0.00013506011,0.00002045019],"category_scores_gemma":[0.000054232165,0.000073144605,0.000028292603,0.00016606643,0.00017255048,0.000008999734,0.00024947623,0.00031090836,0.0000010057115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013112305,0.00011499189,0.05371448,0.0004941443,0.00015161168,0.000016478558,0.0045985742,0.03437165,0.57869893,0.00033985244,0.27732024,0.048867837],"study_design_scores_gemma":[0.011107694,0.0016312075,0.1172933,0.003188901,0.00011497755,0.000059533362,0.004645269,0.03643552,0.6191988,0.0035334998,0.20054735,0.0022439377],"about_ca_topic_score_codex":0.00053265644,"about_ca_topic_score_gemma":0.0007135805,"teacher_disagreement_score":0.0767729,"about_ca_system_score_codex":0.000040242285,"about_ca_system_score_gemma":0.0002798643,"threshold_uncertainty_score":0.29827505},"labels":[],"label_agreement":null},{"id":"W4241191707","doi":"10.1158/1538-7445.am2019-3015","title":"Abstract 3015: IMiDs and BET inhibitors target distinct pathways of <i>MYC</i> dysregulation by super-enhancers in multiple myeloma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"BRD4; Enhancer; Transcription factor; Cancer research; Cell culture; BET inhibitor; Biology; Locus (genetics); Chromosomal translocation; Gene; Genetics; Bromodomain; Histone","score_opus":0.02452024358211144,"score_gpt":0.30147357166491023,"score_spread":0.2769533280827988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241191707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629474,0.0018720936,0.000018097824,0.00015975157,0.00012319801,0.00043681168,0.00012125608,0.000006868182,0.00096716685],"genre_scores_gemma":[0.9986302,0.00023034394,0.0000569069,0.00002141066,0.000121447294,0.0000777415,0.00022945396,0.000021234204,0.0006112189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866176,0.000084139865,0.00025524816,0.0003714209,0.00031827847,0.00030916661],"domain_scores_gemma":[0.9994145,0.000036063764,0.000059592363,0.00025585399,0.00014335525,0.00009063385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050980906,0.000119361444,0.00015404398,0.00009812605,0.000057335506,0.000023338232,0.00014696008,0.00015290544,0.00015041858],"category_scores_gemma":[0.000120631354,0.000114819224,0.000039989933,0.00020628468,0.00018098381,0.000016637387,0.00011421777,0.00019344164,0.000008634113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012890513,0.00003757557,0.06726533,0.00006976342,0.000009429304,4.4292204e-7,0.00007259178,0.000022212153,0.92194104,0.000015241789,0.007478325,0.002959159],"study_design_scores_gemma":[0.00078997505,0.00015500133,0.032451585,0.00006320581,0.0000012281664,4.391246e-7,0.0001338651,0.00006460957,0.94974685,0.000052481748,0.016405711,0.00013505096],"about_ca_topic_score_codex":0.00038461204,"about_ca_topic_score_gemma":0.0001514606,"teacher_disagreement_score":0.034813747,"about_ca_system_score_codex":0.000067466965,"about_ca_system_score_gemma":0.00015631557,"threshold_uncertainty_score":0.46821922},"labels":[],"label_agreement":null},{"id":"W4241230740","doi":"10.1158/1538-7445.am2019-86","title":"Abstract 86: Pre-existing neurovascular inflammation increases the occurrence of brain metastases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Inflammation; Medicine; Cell adhesion molecule; VCAM-1; Pathology; Metastasis; Cancer; Cancer research; Immunology; Internal medicine; ICAM-1","score_opus":0.09944576953226728,"score_gpt":0.4261208096186832,"score_spread":0.3266750400864159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241230740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940391,0.0022370035,0.0000146849425,0.0018254966,0.00006041782,0.00092739396,0.00011353303,0.000018289957,0.0007640513],"genre_scores_gemma":[0.9989905,0.00023767259,0.00009805314,0.00009113015,0.0001180266,0.000116046314,0.00006331136,0.0000126084915,0.00027267114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99807113,0.00028985323,0.00025260198,0.00026114823,0.0008166702,0.00030857648],"domain_scores_gemma":[0.99792343,0.0010365335,0.000087895336,0.00054228655,0.00031233806,0.00009751079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019200181,0.0001097951,0.00023956114,0.00012239235,0.00010591727,0.000030400815,0.00016754516,0.00003308418,0.00085244904],"category_scores_gemma":[0.0009289287,0.000068060355,0.000118184886,0.00039380172,0.00016679209,0.00009024907,0.00009210113,0.0003161426,0.000058913927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024019878,0.0013822735,0.19487415,0.0052217674,0.0018660973,0.0003385206,0.0019389561,0.0017914742,0.29164103,0.005169538,0.02828502,0.46508917],"study_design_scores_gemma":[0.0058375155,0.0015454248,0.6873439,0.0015933478,0.00039152696,0.00007905372,0.0011563443,0.00048043823,0.19261242,0.0005152034,0.108053185,0.00039160883],"about_ca_topic_score_codex":0.0022700822,"about_ca_topic_score_gemma":0.000060830298,"teacher_disagreement_score":0.49246976,"about_ca_system_score_codex":0.00007948139,"about_ca_system_score_gemma":0.00031970412,"threshold_uncertainty_score":0.9333719},"labels":[],"label_agreement":null},{"id":"W4241532973","doi":"10.1158/1538-7445.am2019-2988","title":"Abstract 2988: Quantifying the Uptake of Metal Based Cancer Therapy Drugs Using Single Cell ICP-MS","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Analytical chemistry methods development","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal","funders":"","keywords":"Population; Cancer; Cancer cell; Cell; Drug; Cancer therapy; Drug discovery; Chemistry; Computational biology; Cancer research; Biology; Medicine; Bioinformatics; Pharmacology; Internal medicine; Biochemistry","score_opus":0.2807754935051227,"score_gpt":0.45817153537864463,"score_spread":0.17739604187352193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241532973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782724,0.0024809232,0.00018443745,0.00028458645,0.000108405744,0.00019700089,0.00003862058,0.000027497501,0.018406134],"genre_scores_gemma":[0.994019,0.0002640246,0.0021715902,0.00005945622,0.0001751818,0.000070974536,0.0000073694196,0.000058848007,0.0031735578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704397,0.00008484607,0.00046050805,0.0005104834,0.0011952404,0.00070497365],"domain_scores_gemma":[0.9979071,0.00067283737,0.00015798735,0.00070586964,0.00040947372,0.0001467476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017399684,0.0002233043,0.00035425255,0.000071335475,0.00017170735,0.00006877401,0.00071764446,0.00016297497,0.01742187],"category_scores_gemma":[0.00011179185,0.00016324641,0.00016878138,0.00048618522,0.00028537892,0.0000805622,0.00014658009,0.0008062109,0.000044830555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000136599,0.00010665708,0.0016473802,0.00048212017,0.00008689914,0.0000037511752,0.00029697068,0.00039882903,0.98804873,0.00001189021,0.00011252855,0.008667649],"study_design_scores_gemma":[0.0006312937,0.0000105391,0.0003622563,0.00020348761,0.000016196622,5.185945e-7,0.00059695856,0.0019783145,0.98395157,0.00004095965,0.012011191,0.00019670668],"about_ca_topic_score_codex":0.0012985356,"about_ca_topic_score_gemma":0.00001819644,"teacher_disagreement_score":0.017377038,"about_ca_system_score_codex":0.0006438182,"about_ca_system_score_gemma":0.0010848658,"threshold_uncertainty_score":0.98347634},"labels":[],"label_agreement":null},{"id":"W4241698753","doi":"10.1158/1538-7445.am10-3400","title":"Abstract 3400: Recurrent focal copy-number changes and loss-of-heterozygosity implicate two non-coding RNAs and one tumor-suppressor gene at chromosome 3q13.31 in osteosarcoma","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Loss of heterozygosity; Biology; Osteosarcoma; Cancer research; Tumor suppressor gene; Locus (genetics); Gene; Fluorescence in situ hybridization; Genetics; Allele; Chromosome; Carcinogenesis","score_opus":0.05379501154448146,"score_gpt":0.38088975738907344,"score_spread":0.32709474584459197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241698753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968263,0.0016009884,0.000019074396,0.0006266058,0.00010826242,0.00038417676,0.00013430452,0.0000047446824,0.00029557364],"genre_scores_gemma":[0.9959663,0.003087373,0.00011741274,0.000029961051,0.00029180676,0.00027312007,0.000041820305,0.000023738085,0.00016848043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985828,0.000048453116,0.00020545653,0.0005157994,0.00021393743,0.00043356055],"domain_scores_gemma":[0.9991399,0.00003379457,0.00007409974,0.0004272449,0.00015721857,0.00016774096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040519403,0.00015147607,0.00021516268,0.00007618385,0.00015016807,0.00004382695,0.00021337043,0.000119915996,0.00009882005],"category_scores_gemma":[0.0000310881,0.00014382343,0.000035586094,0.0001353776,0.0004091453,0.00000981634,0.00030189182,0.0003166,0.000006357254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018078541,0.00006901975,0.016713107,0.000079160454,0.000023332179,0.0000060151383,0.00008734756,0.00000155492,0.97289544,0.000033176104,0.00020615573,0.009704882],"study_design_scores_gemma":[0.0009135061,0.00017268879,0.066819504,0.000047054047,0.000006744597,0.000025425094,0.000017854232,0.000033586948,0.92575073,0.00006599486,0.005983083,0.00016381768],"about_ca_topic_score_codex":0.000680425,"about_ca_topic_score_gemma":0.0032103474,"teacher_disagreement_score":0.050106395,"about_ca_system_score_codex":0.00007674884,"about_ca_system_score_gemma":0.00014529485,"threshold_uncertainty_score":0.5864949},"labels":[],"label_agreement":null},{"id":"W4241700116","doi":"10.1158/1538-7445.am2012-ct-04","title":"Abstract CT-04: A phase II study of neoadjuvant metformin in prostatic carcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metformin; Prostate cancer; Tolerability; Prostatectomy; Adverse effect; Internal medicine; Urology; Cancer; Diabetes mellitus; Prostate; Oncology; Insulin; Endocrinology","score_opus":0.0793018199902067,"score_gpt":0.4283110842525917,"score_spread":0.349009264262385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241700116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8659767,0.13285144,0.0000013619145,0.000011368055,0.00013886571,0.00064873457,0.00003578391,0.0000030825138,0.00033265224],"genre_scores_gemma":[0.9936582,0.0051815794,0.000019508221,0.000032159416,0.00030627154,0.00049006613,0.000020639543,0.000025058449,0.00026651076],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818987,0.00014007278,0.00030089807,0.0002957041,0.00042039683,0.000653056],"domain_scores_gemma":[0.9991513,0.000023886045,0.00006756039,0.000423966,0.00017023414,0.00016307634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011820914,0.0001338168,0.00024874767,0.00015273361,0.00008477246,0.000012342258,0.00026288506,0.00005445186,0.00021046509],"category_scores_gemma":[0.00010465659,0.00011646276,0.000049935945,0.00030189854,0.000107461834,0.000012557709,0.0001801967,0.0002395246,0.0000073135393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006009464,0.0039145937,0.038182247,0.00019891522,0.000106557054,0.000020108992,0.0039028178,0.000022969834,0.47444662,0.000040002647,0.003831716,0.4747325],"study_design_scores_gemma":[0.00819663,0.0028851258,0.032919813,0.00007004358,0.000032479948,0.000004186411,0.0043541547,0.000016250924,0.80384284,0.000049937633,0.14725682,0.00037169812],"about_ca_topic_score_codex":0.00114241,"about_ca_topic_score_gemma":0.00061407173,"teacher_disagreement_score":0.4743608,"about_ca_system_score_codex":0.000060288203,"about_ca_system_score_gemma":0.0002834459,"threshold_uncertainty_score":0.47492135},"labels":[],"label_agreement":null},{"id":"W4241766313","doi":"10.1158/1538-7445.compsysbio-b2-01","title":"Abstract B2-01: Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Biology; Proteome; Transcriptome; Lung cancer; Cancer research; Adenocarcinoma; Gene; Cancer; Serine hydroxymethyltransferase; DNA methylation; Genetics; Computational biology; Gene expression; Serine; Oncology; Medicine","score_opus":0.08329368526202459,"score_gpt":0.4634422628667166,"score_spread":0.380148577604692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241766313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841043,0.011714366,0.000013979673,0.0009848909,0.000049698334,0.002025691,0.00024663663,0.00004307007,0.0008173845],"genre_scores_gemma":[0.9961275,0.0008010893,0.00008166516,0.000046197903,0.00020048548,0.0007778999,0.000107963744,0.00005856547,0.0017986286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955515,0.00027097354,0.00044202828,0.00057857274,0.0021478655,0.0010090112],"domain_scores_gemma":[0.9956129,0.00025024902,0.00013073572,0.00065849174,0.0026396227,0.00070796924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002117131,0.0002791614,0.00095572375,0.0018606046,0.000104026796,0.00007791077,0.0004022697,0.0002172744,0.0016421563],"category_scores_gemma":[0.0007342004,0.00016894467,0.00023629748,0.0058036856,0.0004336616,0.0002026818,0.00011408758,0.0014064857,0.00001778927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008638598,0.00070778414,0.4400818,0.00118772,0.01426946,0.0004045738,0.001894044,0.0026664808,0.48868275,0.000050651444,0.034701794,0.006714327],"study_design_scores_gemma":[0.0030307039,0.00094714225,0.94888246,0.00090903224,0.0018666377,0.000008098965,0.00042372858,0.0027118267,0.03940156,0.00004034591,0.0014362866,0.00034220418],"about_ca_topic_score_codex":0.01823288,"about_ca_topic_score_gemma":0.0014054441,"teacher_disagreement_score":0.5088006,"about_ca_system_score_codex":0.0008863196,"about_ca_system_score_gemma":0.0037606212,"threshold_uncertainty_score":0.9992705},"labels":[],"label_agreement":null},{"id":"W4241843979","doi":"10.1158/1538-7445.pedca19-a52","title":"Abstract A52: Zero Childhood Cancer (ZERO): A comprehensive precision medicine platform for children with high-risk cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Pediatric cancer; Medicine; Oncology; Germline mutation; Sarcoma; Germline; Bioinformatics; Internal medicine; Genetics; Biology; Mutation; Gene; Pathology","score_opus":0.08207689061090008,"score_gpt":0.40095974194663264,"score_spread":0.3188828513357326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241843979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97729295,0.005536972,0.0000933532,0.010956797,0.00014614986,0.004539904,0.0010565787,0.0001146685,0.0002626139],"genre_scores_gemma":[0.9857801,0.008506198,0.00019523452,0.0009637281,0.0011227402,0.002596505,0.0001655876,0.00014337094,0.0005265253],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950291,0.00009240778,0.0004343796,0.0010862752,0.0020225951,0.0013352709],"domain_scores_gemma":[0.9963835,0.00052426034,0.00016312921,0.0005647985,0.00113343,0.0012308714],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030800223,0.00043558885,0.0007966425,0.00032342743,0.00050146953,0.00006213129,0.00042998785,0.0001621098,0.0018133201],"category_scores_gemma":[0.00030817988,0.00028848377,0.00013686351,0.0010058433,0.00052851374,0.00022553506,0.0001951906,0.001355374,0.00007682321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036125414,0.0016337943,0.15479599,0.0016127067,0.006226557,0.0006417259,0.0040675704,0.0010204719,0.06656785,0.0001759461,0.32160157,0.4055304],"study_design_scores_gemma":[0.029661877,0.009023388,0.89587843,0.002112863,0.0004268147,0.000045490353,0.0001977305,0.00012382463,0.048186816,0.00053555256,0.013256903,0.0005503124],"about_ca_topic_score_codex":0.014924457,"about_ca_topic_score_gemma":0.0013302343,"teacher_disagreement_score":0.74108243,"about_ca_system_score_codex":0.0006094012,"about_ca_system_score_gemma":0.0014229761,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W4242253935","doi":"10.1158/1538-7445.transcontrol16-a20","title":"Abstract A20: Baseline IL-17 receptor signaling is essential for controlling aberrant JNK-dependent cellular proliferation via maintenance of endogenous level of ubiquitin-editing enzyme A20","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Downregulation and upregulation; Gene knockdown; Biology; Cell growth; Signal transduction; Cancer research; Cell biology; Gene silencing; Small hairpin RNA; Cell culture; Biochemistry; Genetics","score_opus":0.145291793268657,"score_gpt":0.36838736700611296,"score_spread":0.22309557373745598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242253935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97396487,0.004513398,0.015307451,0.0011152215,0.0012708914,0.001659961,0.0016472156,0.000026733615,0.00049423095],"genre_scores_gemma":[0.99536663,0.00029012447,0.00016166606,0.000046985697,0.00033637174,0.00017815018,0.000096703625,0.000038656104,0.0034847083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752915,0.00027669192,0.0007636399,0.00042369976,0.00020493576,0.0008018931],"domain_scores_gemma":[0.9969998,0.0005959956,0.00055913377,0.0005321766,0.0012690149,0.000043895827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003311062,0.0002098241,0.00055832806,0.00019432437,0.0006864447,0.000056153887,0.0006163081,0.0002557673,0.0016772818],"category_scores_gemma":[0.0010327656,0.00018889915,0.00020130633,0.00005890494,0.0005187586,0.00016284501,0.00014712072,0.0005522317,0.000044279997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038969545,0.00014167557,0.000067164896,0.00028370574,0.00024289178,0.0000055277537,0.00090184767,0.00006609226,0.98671806,0.00010807119,0.0029999043,0.004568095],"study_design_scores_gemma":[0.0028130452,0.0003795016,0.000060899318,0.00045173225,0.000033917946,0.000010078499,0.0004913843,0.00022793327,0.99137056,0.00004893366,0.00394632,0.00016568995],"about_ca_topic_score_codex":0.0014075129,"about_ca_topic_score_gemma":0.00017177332,"teacher_disagreement_score":0.021401735,"about_ca_system_score_codex":0.00014894085,"about_ca_system_score_gemma":0.0004435408,"threshold_uncertainty_score":0.99923533},"labels":[],"label_agreement":null},{"id":"W4242608225","doi":"10.1158/1538-7445.am2019-3356","title":"Abstract 3356: Working together to put kids first: Outreach strategies driving collaborative research, data sharing and cross-disease analysis to accelerate discoveries in pediatric cancer and structural birth defects","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Outreach; Data sharing; Pediatric cancer; Resource (disambiguation); Medicine; Social media; Medical education; World Wide Web; Psychology; Computer science; Cancer; Political science; Alternative medicine; Pathology","score_opus":0.4717998377567976,"score_gpt":0.6149010002424645,"score_spread":0.1431011624856669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242608225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777735,0.0042816717,0.00000653155,0.004784364,0.00011850817,0.0018612676,0.0002314745,0.00003143588,0.00090739253],"genre_scores_gemma":[0.9896141,0.0071936143,0.00017230368,0.00012627058,0.00048337536,0.00040383576,0.000037793256,0.000072532755,0.0018961632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925538,0.00035138938,0.00061686005,0.0020902406,0.00283087,0.0015568453],"domain_scores_gemma":[0.9897741,0.005409644,0.00008158762,0.0017665358,0.0016563812,0.0013117519],"candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010524952,0.00031212086,0.0006976761,0.0018825671,0.0005794124,0.0017829362,0.0012657407,0.00027597393,0.0005254326],"category_scores_gemma":[0.0092020435,0.00026590555,0.00006227821,0.0065872003,0.0007090818,0.0008347175,0.0040391833,0.003598864,0.000028783918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013543733,0.000042514872,0.9892795,0.0010384092,0.00021383484,0.00010683359,0.0028492445,0.0020075229,0.0010682998,0.00058820413,0.00018589455,0.0012653888],"study_design_scores_gemma":[0.0010194033,0.0002244822,0.9906604,0.0008662712,0.000072923765,5.9600444e-7,0.0026155612,0.0011835402,0.00025165442,0.002376084,0.00041831596,0.00031074614],"about_ca_topic_score_codex":0.0076949825,"about_ca_topic_score_gemma":0.09744959,"teacher_disagreement_score":0.089754604,"about_ca_system_score_codex":0.0007267675,"about_ca_system_score_gemma":0.0033557797,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W4242650650","doi":"10.1158/1538-7445.sabcs18-p6-17-13","title":"Abstract P6-17-13: ZW49, a HER2 targeted biparatopic antibody drug conjugate for the treatment of HER2 expressing cancers","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Trastuzumab; Antibody-drug conjugate; Medicine; In vivo; Tolerability; Pertuzumab; Cancer; Breast cancer; Cancer research; Pharmacology; Lapatinib; Internalization; Antibody; Internal medicine; Monoclonal antibody; Immunology; Adverse effect; Biology; Receptor","score_opus":0.08880423222923725,"score_gpt":0.44730583470964513,"score_spread":0.35850160248040785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242650650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726087,0.017624976,0.000009180554,0.004040254,0.0002934549,0.0023265122,0.00019718173,0.000024648838,0.002875082],"genre_scores_gemma":[0.9544173,0.009090749,0.00008290729,0.000146618,0.0005766787,0.00053414045,0.00006828408,0.000046933976,0.035036374],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970904,0.000107183594,0.0003853655,0.00049454306,0.0009988394,0.0009236561],"domain_scores_gemma":[0.99755746,0.00091876596,0.000094690244,0.0005901738,0.00058061525,0.00025830494],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066653127,0.00023785493,0.0005373458,0.00020118424,0.00031222892,0.000060487015,0.00033671546,0.0000974583,0.0019545276],"category_scores_gemma":[0.000052647658,0.0001430479,0.00025465354,0.00043400025,0.00047731368,0.00009424908,0.000071568116,0.00039906017,0.0000873836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074851597,0.00077787566,0.06771493,0.0019530576,0.0012082207,0.000084481835,0.004811129,0.0005260727,0.8333936,0.00029511718,0.03407213,0.047678232],"study_design_scores_gemma":[0.0059454865,0.0021093579,0.08835337,0.0008906936,0.00009407084,0.000011434171,0.0015270666,0.0019798577,0.31992456,0.00018254017,0.57861286,0.00036865342],"about_ca_topic_score_codex":0.019599754,"about_ca_topic_score_gemma":0.00090638123,"teacher_disagreement_score":0.54454076,"about_ca_system_score_codex":0.00053239736,"about_ca_system_score_gemma":0.0011936428,"threshold_uncertainty_score":0.9989578},"labels":[],"label_agreement":null},{"id":"W4242653428","doi":"10.1158/1538-7445.am2019-4457","title":"Abstract 4457: Open science medicinal chemistry: Towards a treatment for DIPG","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Drug discovery; Disease; Medicine; Computational biology; Bioinformatics; Biology; Internal medicine","score_opus":0.2972832542674915,"score_gpt":0.5661887466311306,"score_spread":0.2689054923636391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242653428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91568553,0.0017208314,0.000011512438,0.017604627,0.00024672333,0.0013182706,0.000026045205,0.000025121519,0.06336131],"genre_scores_gemma":[0.97726893,0.00046849725,0.0002450588,0.0003748709,0.00036760664,0.00061599567,0.000010687428,0.000013828059,0.020634511],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808514,0.000019618019,0.00014445392,0.0004637017,0.0007034937,0.0005835952],"domain_scores_gemma":[0.9986717,0.0001800387,0.000027276883,0.00039192647,0.0004241672,0.00030488422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019200651,0.000103329105,0.00030195765,0.00007830816,0.00024122297,0.000046333415,0.00047708745,0.000052094692,0.001170647],"category_scores_gemma":[0.00069919915,0.00006782145,0.00004543943,0.00033502385,0.0010690626,0.00006533026,0.0002502095,0.00026882064,0.000082370374],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016283169,0.00054241234,0.036110267,0.0010235029,0.00023709367,0.00018515646,0.0023469885,0.000001882611,0.58876956,0.00020412442,0.046326797,0.3226239],"study_design_scores_gemma":[0.014860466,0.0028003387,0.12208162,0.0016433044,0.00014061504,0.000115222196,0.0027930911,0.00024836787,0.33911458,0.0007172933,0.5150389,0.0004461783],"about_ca_topic_score_codex":0.0009024009,"about_ca_topic_score_gemma":0.000014130829,"teacher_disagreement_score":0.46871212,"about_ca_system_score_codex":0.00045483626,"about_ca_system_score_gemma":0.0021132282,"threshold_uncertainty_score":0.9997424},"labels":[],"label_agreement":null},{"id":"W4242778004","doi":"10.1158/1538-7445.am2019-3134","title":"Abstract 3134: CCN3 is a prognostic biomarker and functional mediator of prostate cancer bone metastasis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Prostate cancer; Bone metastasis; Metastasis; Cancer research; Medicine; Tissue microarray; LNCaP; Cancer; Prostate; Internal medicine; Oncology","score_opus":0.06652728091872098,"score_gpt":0.38547693883577683,"score_spread":0.3189496579170559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242778004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533267,0.01210204,0.0000042881284,0.00082411536,0.00012505997,0.0008696034,0.00038212846,0.0000070685487,0.0003530197],"genre_scores_gemma":[0.99546796,0.0019605048,0.000022355629,0.000037780683,0.00013272757,0.0004480519,0.000047366808,0.00003705219,0.0018462114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977813,0.00013141157,0.00022525559,0.00058514293,0.0007327027,0.0005442335],"domain_scores_gemma":[0.99852914,0.00012754345,0.00006667505,0.00036453476,0.00071624666,0.00019587035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008434212,0.0001575503,0.00022441731,0.00020608444,0.000084073516,0.0000375683,0.00017391845,0.00012006163,0.0022884822],"category_scores_gemma":[0.0002896588,0.00014011511,0.000069857066,0.00036561186,0.00032423018,0.000012310043,0.0003069299,0.00027738506,0.000049084214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005298562,0.00005836273,0.1581902,0.00027683616,0.00019215989,0.000004869907,0.00011111091,0.0000025830545,0.8236779,0.000018976976,0.0050235903,0.011913539],"study_design_scores_gemma":[0.0011621044,0.00028805493,0.31156433,0.000087687615,0.00001843367,0.0000049937,0.000178658,0.000019114963,0.65395296,0.00006971307,0.03244371,0.0002102584],"about_ca_topic_score_codex":0.0007394951,"about_ca_topic_score_gemma":0.00019940182,"teacher_disagreement_score":0.16972496,"about_ca_system_score_codex":0.0000763747,"about_ca_system_score_gemma":0.0006376107,"threshold_uncertainty_score":0.99862355},"labels":[],"label_agreement":null},{"id":"W4243150102","doi":"10.1158/1538-7445.am2019-lb-148","title":"Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Gemcitabine; Cancer research; Immune system; Immune checkpoint; Cytotoxic T cell; Tumor microenvironment; Regimen; Lung cancer; Medicine; Blockade; Immunotherapy; Cancer; Pharmacology; Immunology; Biology; Oncology; Internal medicine; Receptor","score_opus":0.02671144682847327,"score_gpt":0.3339614798496113,"score_spread":0.307250033021138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243150102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97076964,0.023277914,4.5000112e-7,0.002891288,0.00007156986,0.0026596377,0.00002092834,0.000009950621,0.00029863865],"genre_scores_gemma":[0.9920857,0.0061882753,0.000031267988,0.000020512884,0.00006490034,0.0006918663,0.0000049306173,0.000038114507,0.00087444286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977172,0.00018771514,0.00035332868,0.00049274287,0.00062524516,0.0006237531],"domain_scores_gemma":[0.9987246,0.00033981656,0.00016082454,0.00048116155,0.00018045744,0.00011314653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069612876,0.00023439691,0.00043133943,0.0001770954,0.00038916548,0.00006157081,0.00016364225,0.00006417913,0.00007441529],"category_scores_gemma":[0.00006566351,0.000121587305,0.00004400311,0.0004982146,0.00060043205,0.00012967567,0.00024329504,0.00055042346,0.0000011772906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035290245,0.0003124275,0.5359415,0.0010976788,0.00013452931,0.00002448592,0.0019355601,0.00050181017,0.45699066,0.000022515454,0.0000547307,0.0026312314],"study_design_scores_gemma":[0.0044278633,0.00049615046,0.79016525,0.0031635254,0.00005125578,0.000012036231,0.0019518764,0.0012522482,0.19824506,0.000021375683,0.00006725749,0.00014610618],"about_ca_topic_score_codex":0.008752522,"about_ca_topic_score_gemma":0.0017185824,"teacher_disagreement_score":0.2587456,"about_ca_system_score_codex":0.001031366,"about_ca_system_score_gemma":0.0005831208,"threshold_uncertainty_score":0.9978483},"labels":[],"label_agreement":null},{"id":"W4243349520","doi":"10.1158/1538-7445.am2019-ct124","title":"Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nivolumab; Medicine; Oncology; Cancer; Internal medicine; Pharmacodynamics; Immune checkpoint; Lung cancer; Clinical trial; Surgery; Immunotherapy; Pharmacokinetics","score_opus":0.1854502117508664,"score_gpt":0.4969662274814304,"score_spread":0.311516015730564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243349520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899815,0.0008084367,5.7837826e-7,0.0007249567,0.000073777745,0.002011581,0.00003881415,0.0000126877585,0.006347695],"genre_scores_gemma":[0.9946584,0.0009174177,0.000036371697,0.000059740363,0.00008334874,0.00026131654,0.0000072632356,0.000022868204,0.0039532785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997176,0.000324404,0.00039971317,0.0004344098,0.00096330844,0.0007021914],"domain_scores_gemma":[0.9981185,0.0005335829,0.000074041534,0.00046805223,0.0004132472,0.00039254766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031676886,0.00014533274,0.00072936184,0.00036427288,0.000083626626,0.000016241582,0.00020346713,0.00015087819,0.003607979],"category_scores_gemma":[0.00050632376,0.00012264957,0.00004244666,0.0005763237,0.00042001446,0.00009980583,0.0001793201,0.0010712224,0.00002718102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010767448,0.00076322566,0.96578497,0.00035770654,0.00011779873,0.00011361829,0.0013085157,0.0000026975129,0.017922191,0.000024978763,0.0007874659,0.011740109],"study_design_scores_gemma":[0.0047725122,0.0011516811,0.9893847,0.0003135314,0.00003401251,0.000005630402,0.0022132343,0.000079307574,0.0014633501,0.00007164578,0.0004035401,0.000106830485],"about_ca_topic_score_codex":0.037992097,"about_ca_topic_score_gemma":0.009250451,"teacher_disagreement_score":0.028741647,"about_ca_system_score_codex":0.00044942214,"about_ca_system_score_gemma":0.0029877042,"threshold_uncertainty_score":0.99730283},"labels":[],"label_agreement":null},{"id":"W4243582178","doi":"10.1158/1538-7445.am2019-1873","title":"Abstract 1873: Water-pipe smoking induces epithelial-mesenchymal transition and enhances cell invasion of human breast cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epithelial–mesenchymal transition; Metastasis; Breast cancer; Cancer; Cancer research; Carcinogenesis; Cancer cell; Cell adhesion; Oncology; Cell; Medicine; Biology; Immunology; Internal medicine","score_opus":0.024374868721058266,"score_gpt":0.32942937097154806,"score_spread":0.3050545022504898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243582178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960397,0.0019416879,0.000071238355,0.00029914008,0.00020796011,0.0006145215,0.00017202424,0.000010931615,0.0006428232],"genre_scores_gemma":[0.9952022,0.003639942,0.00001886974,0.000044028722,0.00028743895,0.00013520654,0.000068584726,0.000054283057,0.0005494511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729145,0.00019171095,0.0003150782,0.0007039485,0.0007768233,0.0007210067],"domain_scores_gemma":[0.99883026,0.000026935273,0.0000781064,0.00044548025,0.00044062434,0.00017859208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090001,0.00021851543,0.0002678428,0.0002449069,0.00020306701,0.00006774194,0.00037621305,0.00032853626,0.00086366956],"category_scores_gemma":[0.000009534582,0.0001868112,0.00009620808,0.00024408191,0.0002607705,0.000022687524,0.00025193053,0.000564786,0.000021048758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002405564,0.000072643,0.000068398615,0.000365109,0.00005678922,0.000006159253,0.00037414712,0.00017521928,0.9951158,0.0000096043605,0.0001812468,0.0033342994],"study_design_scores_gemma":[0.0008873191,0.0003393484,0.0007920973,0.00022016499,0.000013392206,0.0000052150217,0.0003146381,0.000017406079,0.9963411,0.00006532982,0.0007736852,0.00023027875],"about_ca_topic_score_codex":0.002535075,"about_ca_topic_score_gemma":0.00033725638,"teacher_disagreement_score":0.0031040206,"about_ca_system_score_codex":0.000111792615,"about_ca_system_score_gemma":0.00034153112,"threshold_uncertainty_score":0.94565755},"labels":[],"label_agreement":null},{"id":"W4243667708","doi":"10.1158/0008-5472.can-03-3852","title":"Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Institute of Environmental Health Sciences","keywords":"DNA methylation; Tamoxifen; Methylation; Estrogen receptor; Estrogen receptor alpha; Biology; Breast cancer; Progesterone receptor; Internal medicine; Cancer research; Antiestrogen; Estrogen; Epigenetics; Cancer; Endocrinology; Gene; Medicine; Genetics; Gene expression","score_opus":0.02260002131992832,"score_gpt":0.3520918319834126,"score_spread":0.32949181066348426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243667708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372977,0.0031605768,0.00022546957,0.0022352813,0.000034910056,0.0003688071,0.00018264544,0.0000049142895,0.000057599827],"genre_scores_gemma":[0.9947429,0.0036732059,0.00053904316,0.000025376185,0.00013779869,0.00016458899,0.00003695481,0.000020402762,0.0006597596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998672,0.00020102217,0.00014497525,0.0002757704,0.00041263064,0.0002935816],"domain_scores_gemma":[0.9989923,0.000042876327,0.00007701388,0.00017265392,0.0005886197,0.00012654132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010739196,0.000086305285,0.00011011037,0.00010628073,0.00008473413,0.000027179556,0.00008186278,0.000111564725,0.000024536153],"category_scores_gemma":[0.00019033632,0.0000753785,0.000018706069,0.00029027188,0.000060618386,0.000006992677,0.0000694696,0.00010503534,0.0000025314534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019221597,0.000025848127,0.011360392,0.000015332242,0.000052240932,2.2935737e-7,0.0002898339,0.00044599903,0.98098534,0.00001564739,0.0002716549,0.004615293],"study_design_scores_gemma":[0.000743964,0.00047936747,0.17195627,0.000030723266,0.000009738349,2.0181712e-7,0.00008138911,0.0000022860877,0.82009786,0.000094387775,0.0064057624,0.00009807478],"about_ca_topic_score_codex":0.00076948875,"about_ca_topic_score_gemma":0.0004570351,"teacher_disagreement_score":0.16088752,"about_ca_system_score_codex":0.0002522835,"about_ca_system_score_gemma":0.00046149513,"threshold_uncertainty_score":0.3073846},"labels":[],"label_agreement":null},{"id":"W4243678380","doi":"10.1158/1538-7445.sabcs19-p2-08-08","title":"Abstract P2-08-08: A population-based study examining the epidemiology, treatment patterns and resource utilization by stage in Ontario patients with triple negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Triple-negative breast cancer; Stage (stratigraphy); Breast cancer; Population; Incidence (geometry); Health care; Cancer registry; Epidemiology; Cancer; Disease; Internal medicine; Oncology; Environmental health","score_opus":0.20374761579835007,"score_gpt":0.4044712027633965,"score_spread":0.2007235869650464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243678380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482656,0.0002590747,0.000012170721,0.0021653618,0.000028491186,0.0021738852,0.00040839714,0.000017233444,0.00010882826],"genre_scores_gemma":[0.99759245,0.0000633819,0.000013509648,0.0010361368,0.000060851395,0.00059652585,0.00028632052,0.000028363442,0.00032246712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791133,0.00041414116,0.00034300913,0.00053937366,0.00036999013,0.0004221506],"domain_scores_gemma":[0.998718,0.000559764,0.00011538879,0.0002495358,0.00014164411,0.00021562594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005647734,0.00019174888,0.00040025907,0.000106807995,0.00019687215,0.000026341178,0.00011089821,0.00006718391,0.0014334923],"category_scores_gemma":[0.0001204621,0.0001221009,0.000027702165,0.00030926272,0.00009739255,0.00010450876,0.000041116124,0.000529101,0.0000021749686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024736507,0.00022114835,0.97680366,0.00005660335,0.00009207089,0.0000099071885,0.005103594,0.0005013344,0.000037491645,7.6249165e-7,0.0004159232,0.014283831],"study_design_scores_gemma":[0.007727408,0.0011094806,0.9867329,0.00012610089,0.00003154533,2.8400635e-7,0.0021808571,0.0004429844,0.000054261836,0.0000011930506,0.0014753052,0.000117679556],"about_ca_topic_score_codex":0.43252978,"about_ca_topic_score_gemma":0.45248124,"teacher_disagreement_score":0.019951453,"about_ca_system_score_codex":0.0019220941,"about_ca_system_score_gemma":0.00090465345,"threshold_uncertainty_score":0.99947935},"labels":[],"label_agreement":null},{"id":"W4243831931","doi":"10.1158/1538-7445.am2011-2592","title":"Abstract 2592: Therapeutic testing of a novel inhibitor GAP-107B8 on ovarian cancer cells","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micropharma (Canada); University of Ottawa","funders":"","keywords":"Ovarian cancer; Cancer research; Medicine; Cancer; Cell cycle; Apoptosis; Oncogene; Cell growth; Kinase; Cancer cell; Oncology; Internal medicine; Biology; Cell biology","score_opus":0.226691963967695,"score_gpt":0.4188832162686021,"score_spread":0.19219125230090708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243831931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877361,0.0022014368,0.000029901388,0.00011167306,0.00017266885,0.0005228466,0.00022591544,0.000012225121,0.008987218],"genre_scores_gemma":[0.9975606,0.00067696435,0.00022470011,0.00007831611,0.0003745023,0.0003718007,0.000015536349,0.000044753215,0.0006528336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980132,0.00006790318,0.00021909902,0.0004904923,0.00054630946,0.0006630182],"domain_scores_gemma":[0.99877304,0.000056965073,0.000074211566,0.00048040124,0.00040741597,0.00020797629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042678678,0.00017455434,0.00017986858,0.00014263365,0.0001389098,0.000026994208,0.00035966162,0.00013231716,0.00044080857],"category_scores_gemma":[0.00007849775,0.00014962594,0.00008500998,0.00035225542,0.000246373,0.000007267586,0.00015427322,0.00032142104,0.000024778617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006938201,0.0004131949,0.0032813177,0.00007705283,0.00015922048,0.000011846417,0.00013413104,0.000022499122,0.97503203,0.00007028039,0.0012477142,0.018856913],"study_design_scores_gemma":[0.001412029,0.0007056416,0.009805072,0.00013994185,0.000010389398,0.0000018189357,0.000057927788,0.000013814224,0.9833669,0.00007754773,0.0042525004,0.0001564091],"about_ca_topic_score_codex":0.010705082,"about_ca_topic_score_gemma":0.0010947393,"teacher_disagreement_score":0.018700505,"about_ca_system_score_codex":0.0001399641,"about_ca_system_score_gemma":0.0007431104,"threshold_uncertainty_score":0.9958827},"labels":[],"label_agreement":null},{"id":"W4244011565","doi":"10.1158/0008-5472.can-18-3418","title":"Epigenetic Regulation of <i>NAMPT</i> by <i>NAMPT-AS</i> Drives Metastatic Progression in Triple-Negative Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Natural Science Foundation of Shandong Province; China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Triple-negative breast cancer; Epigenetics; Breast cancer; Cancer; Cancer research; Medicine; Triple negative; Epigenesis; Oncology; Biology; Internal medicine; DNA methylation; Genetics; Gene; Gene expression","score_opus":0.03325761628537665,"score_gpt":0.41746281091972287,"score_spread":0.3842051946343462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244011565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296267,0.009156678,0.000019555242,0.0036222674,0.00035948612,0.0021497414,0.00009288928,0.000022123726,0.0016146062],"genre_scores_gemma":[0.9899316,0.0035512738,0.00015655175,0.00024044856,0.00020823402,0.00043200413,0.000039924635,0.00004649448,0.0053935074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966908,0.00033133017,0.0005051877,0.00051077397,0.0013651802,0.00059669034],"domain_scores_gemma":[0.99829835,0.00028175794,0.0001501265,0.00045618034,0.0005762428,0.00023734069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010507528,0.00020541903,0.0006004683,0.00039993174,0.00007572891,0.000017559722,0.00020415484,0.00012004063,0.0028016034],"category_scores_gemma":[0.00014646519,0.00014712462,0.00008750341,0.0011443748,0.00041038447,0.00011636541,0.000084884734,0.00064843724,0.000041858064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002747241,0.00049581967,0.084788695,0.00094822963,0.0001808227,0.000031746546,0.0016506589,0.00017538446,0.84644866,0.000097479184,0.017349772,0.045085475],"study_design_scores_gemma":[0.026661346,0.0033979411,0.3004608,0.010238625,0.0002495516,0.00008004806,0.003651026,0.0026886014,0.637501,0.0014040116,0.012938009,0.00072902266],"about_ca_topic_score_codex":0.0025562404,"about_ca_topic_score_gemma":0.00021996038,"teacher_disagreement_score":0.21567209,"about_ca_system_score_codex":0.00036773886,"about_ca_system_score_gemma":0.00075323676,"threshold_uncertainty_score":0.99811},"labels":[],"label_agreement":null},{"id":"W4244036514","doi":"10.1158/1538-7445.am2019-1743","title":"Abstract 1743: Evaluating the effect of USP22 depletion on chromosome instability in colorectal cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Gene silencing; Chromosome instability; Colorectal cancer; Carcinogenesis; Genome instability; Cancer; Cancer research; Biology; Gene knockdown; Chromosome; Gene; Genetics; Molecular biology; DNA damage; DNA","score_opus":0.058732532005197444,"score_gpt":0.41353244386200866,"score_spread":0.3547999118568112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244036514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624074,0.0010262594,5.410999e-7,0.00013799655,0.00013936784,0.0010354107,0.00003442529,0.00000408262,0.0013811789],"genre_scores_gemma":[0.99896866,0.00017167888,0.000004728562,0.000023639166,0.00017362458,0.0005440789,0.000015374195,0.000015578995,0.000082638166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982667,0.00050555065,0.00017586786,0.00032518568,0.0004128111,0.00031391092],"domain_scores_gemma":[0.9993037,0.00019061574,0.00005605799,0.0002837843,0.00012380315,0.000042058986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026227417,0.00010139875,0.00015090861,0.00005413622,0.00006823882,0.000014704656,0.0002466686,0.00011680053,0.00040901045],"category_scores_gemma":[0.00033737285,0.00007021539,0.000059520567,0.00020702148,0.0001355409,0.000003862198,0.00011110533,0.00034802305,0.000019728677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00102901,0.000023509827,0.05181371,0.00013902398,0.0000146482735,6.3115255e-7,0.000076453696,0.00048422188,0.937171,0.0000121746425,0.00009612762,0.009139492],"study_design_scores_gemma":[0.000741089,0.0017799976,0.061548535,0.00009988753,0.0000025824058,5.535066e-7,0.000025705738,0.00008183426,0.93481565,0.000018388095,0.000809303,0.00007650312],"about_ca_topic_score_codex":0.001026219,"about_ca_topic_score_gemma":0.00070450176,"teacher_disagreement_score":0.009734824,"about_ca_system_score_codex":0.00014372935,"about_ca_system_score_gemma":0.00027262463,"threshold_uncertainty_score":0.44783774},"labels":[],"label_agreement":null},{"id":"W4244385207","doi":"10.1158/1538-7445.transcagen-a2-61","title":"Abstract A2-61: Functional enrichment and pathway analysis of the transcriptome related to lymphovascular invasion and recurrence in axillary-node negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Lymphovascular invasion; KEGG; Transcriptome; Breast cancer; Biology; Carcinogenesis; Gene expression profiling; Gene; Cancer; Gene expression; Cancer research; Computational biology; Genetics; Metastasis","score_opus":0.04809108672209739,"score_gpt":0.33591921135993685,"score_spread":0.28782812463783947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244385207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843825,0.009340624,0.00000766314,0.0014951004,0.00008961901,0.0002939848,0.0002306015,0.0000030688211,0.00010107026],"genre_scores_gemma":[0.997554,0.00199408,0.000017224598,0.0000789932,0.000031985393,0.00022200948,0.00002041894,0.000010814062,0.00007049438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851274,0.00013782558,0.00019570578,0.00043936184,0.00042756964,0.00028681563],"domain_scores_gemma":[0.99920017,0.00003517005,0.000047797083,0.00026219827,0.00032520518,0.00012948997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005464634,0.00013487352,0.00022225293,0.0001848983,0.00012029136,0.000020646587,0.00013275123,0.00008744174,0.00003727795],"category_scores_gemma":[0.00006572077,0.00009815385,0.000067282956,0.0009848402,0.0002919115,0.000009449803,0.00019774829,0.00013590745,8.274169e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011922912,0.00019683747,0.773918,0.00008615696,0.0020910644,0.0000075003827,0.0041123955,0.0027112605,0.19227508,0.00007073336,0.0011153682,0.022223344],"study_design_scores_gemma":[0.0011589436,0.00005094089,0.97769225,0.000087837536,0.000090277455,0.0000045461234,0.00053767837,0.000026124178,0.01961492,0.00007039418,0.00055091747,0.00011516645],"about_ca_topic_score_codex":0.0059788655,"about_ca_topic_score_gemma":0.0038891619,"teacher_disagreement_score":0.20377429,"about_ca_system_score_codex":0.00023214858,"about_ca_system_score_gemma":0.0004236674,"threshold_uncertainty_score":0.90382963},"labels":[],"label_agreement":null},{"id":"W4244827489","doi":"10.1158/1538-7445.am2019-463","title":"Abstract 463: Integrated digital pathology and transcriptome analysis identifies molecular mediators of T cell exclusion in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Ovarian cancer; Transcriptome; CD8; Cytotoxic T cell; Immunotherapy; Biology; Cancer research; Phenotype; Cancer immunotherapy; Cancer; Immune system; Pathology; Medicine; Immunology; Gene expression; In vitro; Gene; Genetics","score_opus":0.024170201862757118,"score_gpt":0.35169495756540664,"score_spread":0.3275247557026495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244827489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185485,0.006408417,0.000016599417,0.00041309505,0.00014311523,0.00043337612,0.00010310776,0.000010085243,0.0006173279],"genre_scores_gemma":[0.9959658,0.0032341406,0.000011917802,0.00006112735,0.000025220765,0.000064451895,0.000039990617,0.000019767504,0.0005775751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998365,0.00007677304,0.00034007375,0.00036564286,0.0004991844,0.0003533514],"domain_scores_gemma":[0.9992657,0.00007936924,0.000064584274,0.00027833148,0.00021115132,0.000100897545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061472686,0.00013100654,0.00042366458,0.00085706415,0.000033261054,0.000034473767,0.00013750937,0.00014221354,0.0021002044],"category_scores_gemma":[0.000028266173,0.00010737704,0.00013395792,0.0016290696,0.00026303946,0.00012491873,0.00004656021,0.0003774422,0.000008195519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014782666,0.00008713565,0.079102375,0.00025061998,0.00026981957,0.00010153656,0.0010815978,0.00001623814,0.9123476,0.000005817737,0.00009989762,0.005159052],"study_design_scores_gemma":[0.0052040773,0.00031497914,0.45224768,0.000472727,0.0001833585,0.000007720864,0.0018463503,0.000099744284,0.53765064,0.0000815609,0.0016449003,0.00024626206],"about_ca_topic_score_codex":0.00486425,"about_ca_topic_score_gemma":0.0010771194,"teacher_disagreement_score":0.374697,"about_ca_system_score_codex":0.0002311632,"about_ca_system_score_gemma":0.00036329913,"threshold_uncertainty_score":0.998812},"labels":[],"label_agreement":null},{"id":"W4245342009","doi":"10.1158/1538-7445.am2019-5253","title":"Abstract 5253: Regulation of estrogen related receptor α by ING4 and its potential role in breast cancer pathogenesis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Breast cancer; Cancer research; Gene knockdown; Cancer; Biology; Estrogen receptor; Nuclear receptor; Transcription factor; Gene; Genetics","score_opus":0.007754202976273864,"score_gpt":0.29419305199122914,"score_spread":0.28643884901495525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245342009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730683,0.025942137,5.269367e-7,0.00021948395,0.00010785876,0.0003446303,0.00012237573,0.000005809432,0.00018887527],"genre_scores_gemma":[0.9941354,0.004929263,0.000010094061,0.0000099599,0.000078620295,0.000058601196,0.0000906492,0.000027188657,0.0006602601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987413,0.000118571326,0.00020831253,0.00035703133,0.00025425182,0.0003205019],"domain_scores_gemma":[0.9994713,0.000014448894,0.00006875218,0.0001878692,0.00016460902,0.00009299794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040298305,0.000114564595,0.00015260623,0.00009862424,0.00004854013,0.000014519605,0.00013539476,0.0002887979,0.00022376118],"category_scores_gemma":[0.000017079814,0.0001070287,0.000046191428,0.00023821348,0.000069332746,0.0000100477555,0.000096144104,0.0002458854,0.0000176433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030816716,0.00004323591,0.015756972,0.000058664744,0.000054202697,0.0000014747183,0.00004656828,0.0002613596,0.9768221,0.00003590348,0.0006249412,0.0059864344],"study_design_scores_gemma":[0.0011163639,0.00017114608,0.061183896,0.00013353108,0.000011728759,0.000009458775,0.000075789496,0.00028550703,0.93516195,0.00003270494,0.0016361206,0.00018180875],"about_ca_topic_score_codex":0.0004011192,"about_ca_topic_score_gemma":0.00001211622,"teacher_disagreement_score":0.045426924,"about_ca_system_score_codex":0.000056617468,"about_ca_system_score_gemma":0.00017422017,"threshold_uncertainty_score":0.43645036},"labels":[],"label_agreement":null},{"id":"W4245781750","doi":"10.1158/1538-7445.tim2013-pr15","title":"Abstract PR15: Antitumor effect of metformin in breast cancer is associated with AMPK and FOXO3a activation","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lakehead University","funders":"","keywords":"Metformin; Medicine; Hyperinsulinemia; Internal medicine; Endocrinology; Breast cancer; Cancer; Insulin resistance; AMPK; Mammary tumor; Diabetes mellitus; Obesity; Biology","score_opus":0.019835771653664205,"score_gpt":0.3418937542700487,"score_spread":0.3220579826163845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245781750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753684,0.023725377,0.000002224189,0.00011211696,0.0000380179,0.00046451812,0.0000791598,0.000003951656,0.00020627539],"genre_scores_gemma":[0.98211974,0.016999222,0.000007238399,0.00007523335,0.00011151676,0.00046376427,0.00002487267,0.000021629454,0.00017679702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987534,0.00010732796,0.00015822634,0.00030355123,0.0003048046,0.00037264993],"domain_scores_gemma":[0.9993055,0.000050830244,0.00007797432,0.00019574392,0.00028507435,0.00008491384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057825056,0.00012555477,0.00022932731,0.000103481645,0.00005127296,0.000030118841,0.00013346545,0.000115695104,0.00035881624],"category_scores_gemma":[0.000071271555,0.00009411741,0.0000309213,0.00027560373,0.00015919913,0.000020255766,0.0000574332,0.00019138202,0.000002909329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036423508,0.000059768892,0.0691318,0.00020816745,0.0001346332,0.0000016243334,0.00013232492,0.000016498798,0.78362066,0.000008167085,0.0046777697,0.14164434],"study_design_scores_gemma":[0.0012415918,0.00018192458,0.2097374,0.0002064954,0.000011374023,0.0000010844739,0.000043467837,0.000017948565,0.7846839,0.000024917414,0.0037118339,0.00013804912],"about_ca_topic_score_codex":0.0034912536,"about_ca_topic_score_gemma":0.00051702507,"teacher_disagreement_score":0.1415063,"about_ca_system_score_codex":0.00007288409,"about_ca_system_score_gemma":0.00022226371,"threshold_uncertainty_score":0.5277754},"labels":[],"label_agreement":null},{"id":"W4245821900","doi":"10.1158/1538-7445.am2019-659","title":"Abstract 659: Expression patterns of NF-κB in inflammatory oral potentially malignant lesions","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Oral lichen planus; Medicine; Epithelial dysplasia; Cancer; Dysplasia; Malignant transformation; Immunohistochemistry; Pathology; Head and neck cancer; Oral mucosa; Immune system; Internal medicine; Oncology; Immunology","score_opus":0.09927405880531565,"score_gpt":0.44836749172988194,"score_spread":0.3490934329245663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245821900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974989,0.0005393696,0.000006974714,0.0001491432,0.00044138063,0.00052074424,0.00008639473,0.000017982735,0.0007390724],"genre_scores_gemma":[0.99723476,0.00019577565,0.000046497953,0.000025104922,0.000056541638,0.000120059834,0.000017151107,0.000020226396,0.002283903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979847,0.00027959852,0.00036312419,0.0003373821,0.000507107,0.0005280854],"domain_scores_gemma":[0.9990888,0.00013516132,0.00008400491,0.0004280845,0.00014185006,0.00012206529],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00087382965,0.00011279667,0.00023169364,0.00023575203,0.00009191052,0.000015186776,0.0002468712,0.00018920538,0.0027506282],"category_scores_gemma":[0.00003132015,0.00009313088,0.00006048891,0.00016491838,0.00007706381,0.00011791191,0.00017093483,0.00053478486,0.00082644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029650566,0.0002255092,0.8504177,0.00048014862,0.000014830605,0.0007190554,0.00024356172,0.000054762877,0.1402941,0.00026554873,0.0005741701,0.006414152],"study_design_scores_gemma":[0.0011620428,0.00010554614,0.9080392,0.0006244774,0.000003837736,0.000007756541,0.00022368625,0.0000056059375,0.088626236,0.00016809917,0.00093622814,0.00009728354],"about_ca_topic_score_codex":0.001818527,"about_ca_topic_score_gemma":0.001549128,"teacher_disagreement_score":0.057621546,"about_ca_system_score_codex":0.00020135917,"about_ca_system_score_gemma":0.0003527425,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W4246521993","doi":"10.1158/1538-7445.transcagen-a1-17","title":"Abstract A1-17: Genomic analysis of metachronous pancreatic ductal adenocarcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Pancreas; Adenocarcinoma; Copy number analysis; DNA sequencing; Pathology; Genome; Copy-number variation; Genetics; Medicine; Cancer; DNA; Gene","score_opus":0.189045452828816,"score_gpt":0.4633045814175539,"score_spread":0.2742591285887379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246521993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728372,0.009828866,0.000033474,0.00075864437,0.00006164966,0.00062071584,0.000048967508,0.00002669831,0.015783789],"genre_scores_gemma":[0.99339586,0.00073710835,0.0003894014,0.000059364043,0.0002671486,0.00018889175,0.00005366124,0.000030714236,0.004877852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966961,0.00025239732,0.00048653156,0.00046236868,0.0013193595,0.000783249],"domain_scores_gemma":[0.9970528,0.00045473853,0.00009946112,0.0007398135,0.0010030934,0.0006501049],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025112098,0.00017138787,0.001121239,0.0011875327,0.00010707457,0.00002313039,0.00033372204,0.00016706322,0.0025923122],"category_scores_gemma":[0.0005733648,0.00013942325,0.00023890675,0.002038141,0.000667197,0.000080626436,0.00016597159,0.0006614071,0.00016765551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010009544,0.00030468372,0.9554564,0.00018799528,0.0050249547,0.0002924959,0.0011620402,0.000075084485,0.027833166,0.0001640998,0.007728286,0.00076984346],"study_design_scores_gemma":[0.0018019223,0.0006464694,0.9900467,0.00006339795,0.0026108671,0.000028582941,0.0009822801,0.0010156574,0.0014157402,0.00013850466,0.0011156793,0.00013421137],"about_ca_topic_score_codex":0.004442879,"about_ca_topic_score_gemma":0.0003097275,"teacher_disagreement_score":0.03459029,"about_ca_system_score_codex":0.0008905104,"about_ca_system_score_gemma":0.0028487302,"threshold_uncertainty_score":0.99831945},"labels":[],"label_agreement":null},{"id":"W4247194577","doi":"10.1158/1538-7445.am2017-377","title":"Abstract 377: International Cancer Genome Consortium (ICGC)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Genomics; Cancer; Globe; Library science; Computational biology; Biology; Genetics; Computer science; Gene","score_opus":0.08232470423160727,"score_gpt":0.4283289756921895,"score_spread":0.3460042714605822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247194577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97417426,0.004292586,0.000028545277,0.0029294482,0.0011603114,0.00022189476,0.0003882939,0.000007492965,0.016797174],"genre_scores_gemma":[0.9796977,0.014067329,0.00004200648,0.0002591737,0.0020959228,0.00021220288,0.000064843785,0.000030300618,0.0035305123],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986483,0.000020531366,0.00016456429,0.00042373023,0.0003212083,0.0004216893],"domain_scores_gemma":[0.9985878,0.000021389707,0.00009361546,0.0007383786,0.00040234238,0.00015648939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003786392,0.00011807619,0.00011579389,0.00006166659,0.00042885527,0.0002530035,0.0009127287,0.00011989311,0.0008844148],"category_scores_gemma":[0.00028702532,0.00011956104,0.00007158272,0.00003405757,0.00033045487,0.000008171851,0.00049441465,0.00023552273,0.00006118718],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017991885,0.000051484883,0.015917372,0.00002563612,0.00012548643,0.000019445555,0.00004863423,0.00016977679,0.9426227,0.00032798335,0.029666683,0.010844853],"study_design_scores_gemma":[0.0007282522,0.00006484504,0.117733054,0.00003294576,0.00000805562,0.0000029019639,0.000045510467,0.000017425627,0.12936528,0.00020987556,0.751562,0.00022985502],"about_ca_topic_score_codex":0.002188204,"about_ca_topic_score_gemma":0.0016803968,"teacher_disagreement_score":0.81325746,"about_ca_system_score_codex":0.00013593848,"about_ca_system_score_gemma":0.0005752917,"threshold_uncertainty_score":0.9683722},"labels":[],"label_agreement":null},{"id":"W4247342915","doi":"10.1158/1538-7445.am2019-1815","title":"Abstract 1815: Transcriptomic profiling of VHL-dependent long noncoding RNAs in clear cell renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Clear cell renal cell carcinoma; Transcriptome; Carcinogenesis; Cancer research; Biology; Long non-coding RNA; Renal cell carcinoma; Cancer; Kidney cancer; Gene; RNA; Gene expression; Medicine; Genetics; Oncology","score_opus":0.0293937126757136,"score_gpt":0.3318588945291316,"score_spread":0.302465181853418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247342915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888403,0.0041171866,0.00050285034,0.00006905983,0.00020193121,0.0009905357,0.00004758644,0.000008915306,0.0052216686],"genre_scores_gemma":[0.99690676,0.00074225006,0.00013900967,0.0000248186,0.0001734446,0.00011865978,0.000046932182,0.00007960354,0.0017685158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668074,0.00022467636,0.000435979,0.00078501843,0.0009318661,0.0009417019],"domain_scores_gemma":[0.99866265,0.00003976438,0.00009354846,0.0006656415,0.0003447548,0.00019365834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013707569,0.00022004219,0.00029354147,0.00036853607,0.000080834994,0.00004680882,0.0006479119,0.0003361967,0.00038829877],"category_scores_gemma":[0.00004161694,0.00023293326,0.00014995015,0.00044403286,0.00012567846,0.000013231622,0.00025788855,0.0010069585,0.00007092873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007717405,0.00011911473,0.0018096439,0.00042948974,0.000020009462,0.000042708456,0.00014124309,0.0014046711,0.99388504,0.000014922473,0.00019760667,0.0011638172],"study_design_scores_gemma":[0.0019303873,0.00047672787,0.001999425,0.000105982246,0.000006480931,0.000004168468,0.00030507907,0.00023758771,0.99375945,0.000016616135,0.0009243039,0.00023378756],"about_ca_topic_score_codex":0.0012448767,"about_ca_topic_score_gemma":0.00058244687,"teacher_disagreement_score":0.0080665,"about_ca_system_score_codex":0.00031774156,"about_ca_system_score_gemma":0.0009693165,"threshold_uncertainty_score":0.9498743},"labels":[],"label_agreement":null},{"id":"W4247489084","doi":"10.1158/1538-7445.am2019-4671","title":"Abstract 4671: Novel biological roles of the atypical WNT ligand, Norrin, on glioblastoma stem cells segregate with ASCL1 expression","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Wnt signaling pathway; Biology; Cancer research; Frizzled; LRP5; AXIN2; Carcinogenesis; Catenin; Cancer stem cell; Stem cell; Cell biology; Cancer; Signal transduction; Genetics","score_opus":0.03117848632176423,"score_gpt":0.31159579515861635,"score_spread":0.2804173088368521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247489084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982518,0.000538325,0.000029366432,0.00020572037,0.00016507214,0.0005018118,0.000036805388,0.000008326615,0.0002627972],"genre_scores_gemma":[0.99856746,0.00019778179,0.000021265665,0.00003074448,0.00020302067,0.00005464707,0.000006439833,0.000024861825,0.00089375395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843395,0.0000915865,0.00019477269,0.00045527628,0.00047636003,0.00034803903],"domain_scores_gemma":[0.99901396,0.000046585432,0.000096327254,0.00053209433,0.00022585638,0.00008515157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031493604,0.00015026606,0.00016499577,0.00005872959,0.00009187431,0.000020153411,0.00035644122,0.00025478838,0.00007803915],"category_scores_gemma":[0.000015439238,0.000088638066,0.000086284344,0.00022456807,0.00021775367,0.0000049141927,0.00020581225,0.00034248977,0.00003089036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021372815,0.00007627775,0.0018923888,0.000034796903,0.000030709714,6.903404e-7,0.00004012648,0.003542212,0.9887502,0.000026000827,0.00061654224,0.0028527789],"study_design_scores_gemma":[0.000794141,0.00075487164,0.013810329,0.0002245447,0.000004102476,0.000002976608,0.00006872681,0.00004494358,0.9789654,0.000007845849,0.0051998487,0.00012228364],"about_ca_topic_score_codex":0.000037921218,"about_ca_topic_score_gemma":0.00016000168,"teacher_disagreement_score":0.01191794,"about_ca_system_score_codex":0.00008293741,"about_ca_system_score_gemma":0.00023065753,"threshold_uncertainty_score":0.36145553},"labels":[],"label_agreement":null},{"id":"W4247619157","doi":"10.1158/1538-7445.am2019-4223","title":"Abstract 4223: Conducting community oral cancer screening among South Asians in British Columbia","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Cancer; Areca; Stage (stratigraphy); Pathology; Internal medicine","score_opus":0.2746394019692752,"score_gpt":0.48039430356568913,"score_spread":0.2057549015964139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247619157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547625,0.00084803207,0.0000015415283,0.00010895215,0.0004947784,0.0007341088,0.00020157771,0.000055891265,0.0020788633],"genre_scores_gemma":[0.9929566,0.000073326526,0.000059814,0.00007708491,0.000112179914,0.0002997969,0.000028896935,0.000039250765,0.0063530626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969731,0.00089082116,0.00034474474,0.00038794745,0.00046985698,0.00093355763],"domain_scores_gemma":[0.998764,0.0002829138,0.00009656397,0.00046928113,0.00020320808,0.0001840814],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022229303,0.00011453468,0.0003320845,0.000100713354,0.0007156376,0.00024018074,0.00037331315,0.00024307847,0.0051202546],"category_scores_gemma":[0.00010367145,0.00017181806,0.00006193133,0.00047167522,0.0003148333,0.00024908545,0.00021540858,0.0025182255,0.0003363665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040507824,0.00010873381,0.98226,0.00019644636,0.000032452397,0.0004454739,0.0010139516,0.000050696566,0.0003248464,0.000002999203,0.0012785676,0.014245318],"study_design_scores_gemma":[0.0014419472,0.00007528393,0.99270713,0.00057301455,0.000007085341,0.000018316483,0.0043521,0.000023440527,0.00021837895,0.00007420086,0.00035186298,0.00015721623],"about_ca_topic_score_codex":0.72282386,"about_ca_topic_score_gemma":0.89414775,"teacher_disagreement_score":0.17132385,"about_ca_system_score_codex":0.00058169354,"about_ca_system_score_gemma":0.00038839187,"threshold_uncertainty_score":0.999783},"labels":[],"label_agreement":null},{"id":"W4247708146","doi":"10.1158/1538-7445.fbcr11-a3","title":"Abstract A3: p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Secretion; HMGB1; Biology; Senescence; Cell biology; Extracellular; Immunology; Inflammation; Biochemistry","score_opus":0.07090157318661089,"score_gpt":0.3842560539290987,"score_spread":0.3133544807424878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247708146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994459,0.003124163,0.00013821972,0.00020142859,0.00012639676,0.00037226497,0.00017149691,0.000005963509,0.0014010714],"genre_scores_gemma":[0.99540067,0.0028791924,0.00040772505,0.000029780655,0.00022751378,0.000056650282,0.000029594019,0.000028319786,0.0009405663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789673,0.00012751641,0.00029819962,0.000417044,0.00074465375,0.0005158747],"domain_scores_gemma":[0.998224,0.00003192291,0.00010184222,0.00060638937,0.0008357301,0.00020011733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064350385,0.000117403004,0.00017407144,0.00011933447,0.000053866224,0.000005866863,0.00041974566,0.00011267138,0.0009558871],"category_scores_gemma":[0.0003893989,0.000108719185,0.0000675655,0.0002447429,0.00032271692,0.000008463624,0.00020867276,0.00027274512,0.00001917939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005947376,0.0002052316,0.0030663314,0.00023229144,0.00006891057,0.000005974283,0.00064324494,0.000023747163,0.9769982,0.00009567404,0.002630055,0.015435577],"study_design_scores_gemma":[0.00039866762,0.00020111635,0.008518801,0.000035016084,0.0000055135365,0.0000014400981,0.00024453417,0.0000047843246,0.9843224,0.00017712299,0.0059876735,0.000102925274],"about_ca_topic_score_codex":0.0004885617,"about_ca_topic_score_gemma":0.00006285357,"teacher_disagreement_score":0.015332652,"about_ca_system_score_codex":0.000063649175,"about_ca_system_score_gemma":0.000702721,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W4247975540","doi":"10.1158/1538-7445.am2019-756","title":"Abstract 756: Whole exome sequencing identifies frequent mutations of PTPRB and KDR in secondary angiosarcoma","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McGill University","funders":"","keywords":"Angiosarcoma; Exome sequencing; Exome; Missense mutation; Cancer research; Cancer; Biology; Germline mutation; Medicine; Pathology; Mutation; Genetics; Gene","score_opus":0.06106046227219772,"score_gpt":0.3763264395938997,"score_spread":0.31526597732170203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247975540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897743,0.0056708003,0.00000234125,0.00092859514,0.00007402601,0.0004509216,0.000029646964,0.000013731216,0.003055639],"genre_scores_gemma":[0.99792254,0.00021467269,0.00007200772,0.00004984669,0.00007002758,0.000048619673,0.000025002957,0.000021646214,0.0015756475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985478,0.0000623472,0.00026576818,0.00027862558,0.0004865326,0.00035894723],"domain_scores_gemma":[0.9992461,0.000104770195,0.000043469357,0.00029939567,0.00018594867,0.000120312754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074594154,0.00009660149,0.0002726986,0.00039860466,0.00005903492,0.000031560125,0.0001082163,0.00006244849,0.0006630556],"category_scores_gemma":[0.00007144098,0.00008684074,0.00008514946,0.00040524607,0.00017692849,0.00015051545,0.00008153429,0.00044126334,0.000055956207],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000593841,0.00008047017,0.09534698,0.00092384143,0.000072170704,0.00024189985,0.0017873524,0.000024838986,0.8946914,0.0003370919,0.0006384218,0.0057961172],"study_design_scores_gemma":[0.0023056346,0.00019438389,0.89205736,0.0012100439,0.000022731658,0.00006409405,0.003892653,0.00010031355,0.09625258,0.001380268,0.0023341544,0.00018577947],"about_ca_topic_score_codex":0.0019513018,"about_ca_topic_score_gemma":0.0003797932,"teacher_disagreement_score":0.79843885,"about_ca_system_score_codex":0.00020600308,"about_ca_system_score_gemma":0.00048600047,"threshold_uncertainty_score":0.72599936},"labels":[],"label_agreement":null},{"id":"W4248046779","doi":"10.1158/0008-5472.can-17-3847","title":"Correction: Regulatory Aspects of Optical Methods and Exogenous Targets for Cancer Detection","year":2018,"lang":"en","type":"erratum","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cancer detection; Computational biology; Medicine; Cancer research; Computer science; Biology; Internal medicine","score_opus":0.053749065896837735,"score_gpt":0.3931398783614002,"score_spread":0.33939081246456243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248046779","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015644541,0.3768566,0.10324873,0.00021438916,0.42943195,0.0071866317,0.0012936039,0.0010835665,0.06503999],"genre_scores_gemma":[0.27052906,0.18785465,0.028185224,0.00017759575,0.0878078,0.0169716,0.00056101044,0.0037806388,0.40413243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758816,0.00007496382,0.00041777143,0.0005121325,0.0006260834,0.0007809068],"domain_scores_gemma":[0.99795353,0.00039838458,0.00008915265,0.0005112197,0.00083788525,0.00020981963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011169346,0.00034774636,0.00062427076,0.00046046296,0.00022347392,0.000055252414,0.00032316262,0.00077382923,0.00022275631],"category_scores_gemma":[0.0002522165,0.00035349128,0.00013176697,0.00052280654,0.00045186558,0.00012084653,0.00010072561,0.0013505899,0.000005382441],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026571716,0.000022833257,0.00000516686,0.002672579,0.0005204552,0.00000513695,0.00043541158,0.00042179495,0.21488425,0.000096107804,0.5814118,0.19925879],"study_design_scores_gemma":[0.00041689497,0.00030941944,0.00007672567,0.00054440164,0.00008920123,0.000009413167,0.00005031925,0.0047857235,0.43649107,0.0012797172,0.5555834,0.000363675],"about_ca_topic_score_codex":0.0003541536,"about_ca_topic_score_gemma":0.001706596,"teacher_disagreement_score":0.34162414,"about_ca_system_score_codex":0.0014453534,"about_ca_system_score_gemma":0.0007866981,"threshold_uncertainty_score":0.9998917},"labels":[],"label_agreement":null},{"id":"W4248072347","doi":"10.1158/1538-7445.am2019-3606","title":"Abstract 3606: Blockade of the PPARα metabolic checkpoint with TPST-1120 suppresses tumor growth and stimulates anti-tumor immunity","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Cancer research; Tumor microenvironment; Melanoma; Ovarian cancer; Immune checkpoint; Pancreatic cancer; Biology; Immune system; Cancer; Immunotherapy; Medicine; Immunology; Internal medicine","score_opus":0.02132642519155866,"score_gpt":0.3142128799654107,"score_spread":0.29288645477385206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248072347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97746575,0.020710442,0.0000024701797,0.00022984152,0.00030264969,0.00053948147,0.000101640835,0.00000810044,0.0006396396],"genre_scores_gemma":[0.99484825,0.0039605,0.00004034908,0.00006811723,0.0005120405,0.00007614667,0.000013354191,0.000038170994,0.00044306758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826026,0.00014205396,0.00023613204,0.00042498036,0.00043969956,0.00049690413],"domain_scores_gemma":[0.9986714,0.000057371253,0.00011257002,0.00069056347,0.00033986865,0.00012820041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004850469,0.00019764395,0.000334216,0.00008090189,0.00015520962,0.00004854473,0.0004937971,0.00008024423,0.00014087307],"category_scores_gemma":[0.00014251733,0.00013137423,0.000094768926,0.00028923008,0.00047974053,0.000012878662,0.00036783845,0.00040140757,0.0000053866697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026151992,0.000066555156,0.013968757,0.00019219363,0.000109358174,0.0000013180436,0.00009970589,0.000067823996,0.98430467,0.000061395105,0.00047586462,0.00039083397],"study_design_scores_gemma":[0.0009301886,0.00010859269,0.13906254,0.00006804375,0.000030392526,0.000013272881,0.0001601712,0.000007972975,0.8352216,0.000040581897,0.024196632,0.00016004956],"about_ca_topic_score_codex":0.0018038905,"about_ca_topic_score_gemma":0.00019266117,"teacher_disagreement_score":0.14908311,"about_ca_system_score_codex":0.000013852008,"about_ca_system_score_gemma":0.0004945955,"threshold_uncertainty_score":0.5357286},"labels":[],"label_agreement":null},{"id":"W4248240157","doi":"10.1158/1538-7445.am2019-3765","title":"Abstract 3765: Somatic JAK-STAT mutations in subtypes of aggressive B-cell lymphomas with DLBCL morphology","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC","funders":"","keywords":"BCL6; Cancer research; Diffuse large B-cell lymphoma; Lymphoma; Biology; Neuroblastoma RAS viral oncogene homolog; Phenotype; Gene; B cell; Immunology; Mutation; KRAS; Genetics; Germinal center; Antibody","score_opus":0.03930099950478923,"score_gpt":0.371593883685706,"score_spread":0.3322928841809168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248240157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898393,0.0022178842,6.492588e-7,0.0006769811,0.000051035047,0.0007717453,0.000030301153,0.000011715632,0.0064003714],"genre_scores_gemma":[0.99792993,0.00051571184,0.00011130497,0.00005016434,0.000029353405,0.0002979562,0.00003267646,0.0000232526,0.0010096733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.00006569626,0.0002303189,0.00028777073,0.00047017055,0.00038898273],"domain_scores_gemma":[0.99879843,0.00034025856,0.00014409644,0.00034226174,0.00025690466,0.00011803365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022094543,0.00011770372,0.00032515623,0.0002962963,0.00004027535,0.000012272195,0.00010620147,0.00007541687,0.0010615054],"category_scores_gemma":[0.000069876245,0.00008325933,0.00004718465,0.00042793064,0.00018958784,0.00006223864,0.00004034255,0.00015265221,0.00024542314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045933892,0.0015940473,0.9671379,0.00056577905,0.000119034274,0.0008793312,0.0011331146,0.00012765826,0.023336636,0.00020755723,0.0007268935,0.003712756],"study_design_scores_gemma":[0.0100328745,0.00066097797,0.88405067,0.0008173767,0.000042325577,0.000050154333,0.00093008124,0.000047368994,0.10277387,0.00016730049,0.0003137306,0.000113296934],"about_ca_topic_score_codex":0.0024118293,"about_ca_topic_score_gemma":0.0003150372,"teacher_disagreement_score":0.08308721,"about_ca_system_score_codex":0.00047599038,"about_ca_system_score_gemma":0.00089647085,"threshold_uncertainty_score":0.99985164},"labels":[],"label_agreement":null},{"id":"W4248494524","doi":"10.1158/1538-7445.am2019-2102","title":"Abstract 2102: Assessing glioma-protein inhibition in sunitinib-resistance using a 3-dimentional tissue-engineered renal cell carcinoma patient derived model","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Cancer research; Medicine; Renal cell carcinoma; Sonic hedgehog; Tyrosine-kinase inhibitor; Cancer; Extracellular matrix; Hedgehog signaling pathway; Pathology; Internal medicine; Biology; Signal transduction; Cell biology","score_opus":0.09287254474761449,"score_gpt":0.3697786240415342,"score_spread":0.27690607929391975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248494524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343455,0.0015729088,0.00018230708,0.00020980705,0.00006517815,0.0015597757,0.00003973009,0.00003332506,0.0029023928],"genre_scores_gemma":[0.99685824,0.000010304467,0.0019340406,0.000025155166,0.00009804635,0.00026835533,0.000091382775,0.00006613868,0.0006483417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967423,0.00015771214,0.000491532,0.00060388946,0.0012384821,0.0007660817],"domain_scores_gemma":[0.9986411,0.000092898474,0.000114008595,0.0004374722,0.0004594715,0.0002550775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005610731,0.00025989916,0.00037467206,0.0006404731,0.00014117733,0.00009299957,0.0000966114,0.00015455075,0.0005049456],"category_scores_gemma":[0.000039994065,0.00025323572,0.000097398566,0.00069641887,0.000106010746,0.00028653024,0.0001037683,0.00067742105,0.00006429954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047805373,0.00025847612,0.000079268844,0.00045195283,0.000019790918,0.0007031096,0.000288864,0.0036240432,0.9935954,0.000052947238,0.000095966425,0.0003521315],"study_design_scores_gemma":[0.0025724699,0.00017591631,0.010959904,0.00091230427,0.00002005106,0.00002254418,0.00026146506,0.00058239856,0.9840636,0.00015833312,0.000048677444,0.00022231897],"about_ca_topic_score_codex":0.0007473772,"about_ca_topic_score_gemma":0.000096949414,"teacher_disagreement_score":0.010880634,"about_ca_system_score_codex":0.0018731215,"about_ca_system_score_gemma":0.0010445066,"threshold_uncertainty_score":0.999992},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4248538276","doi":"10.1158/1538-7445.am2019-2998","title":"Abstract 2998: Co-targeting bulk tumor and CSCs in clinically translatable TNBC patient-derived xenografts via combination nanotherapy","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Medicine; Wnt signaling pathway; Cancer stem cell; Breast cancer; Cancer; Paclitaxel; Carcinogenesis; Internal medicine; Chemistry; Signal transduction","score_opus":0.031008361697552507,"score_gpt":0.388188903864401,"score_spread":0.3571805421668485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248538276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947014,0.0034565844,0.0000106068765,0.00024721725,0.00008663935,0.0007665449,0.00005228174,0.000008503144,0.00067025446],"genre_scores_gemma":[0.99702346,0.002193568,0.000065010405,0.00010614176,0.000082052225,0.0001920621,0.00014161222,0.000032508357,0.0001635681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980473,0.00014322787,0.0002870091,0.00049810536,0.00042800832,0.0005963282],"domain_scores_gemma":[0.99928296,0.00006301102,0.00005650768,0.00027005802,0.00016843117,0.00015901083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006686454,0.00014173253,0.0001829295,0.00012513339,0.00011138745,0.00007473783,0.00018503098,0.00010877269,0.00024183202],"category_scores_gemma":[0.00005387103,0.00013285488,0.000054869957,0.00019244409,0.00014282948,0.000016308033,0.00006673363,0.000313764,0.00003637744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091886654,0.00019890897,0.036969878,0.0000709073,0.000052145817,0.000021835618,0.00017567605,0.00001867246,0.94164693,0.0000059881095,0.0007188123,0.019201376],"study_design_scores_gemma":[0.0064406916,0.0023277197,0.029745629,0.00014518356,0.000005278041,0.0000060916027,0.00023072884,0.00009316996,0.9246619,0.00022089324,0.035736945,0.00038577488],"about_ca_topic_score_codex":0.0016250256,"about_ca_topic_score_gemma":0.00049139454,"teacher_disagreement_score":0.03501813,"about_ca_system_score_codex":0.00008958801,"about_ca_system_score_gemma":0.0002797463,"threshold_uncertainty_score":0.54176646},"labels":[],"label_agreement":null},{"id":"W4248542833","doi":"10.1158/0008-5472.sabcs10-p6-04-09","title":"Abstract P6-04-09: Single Cell Whole Genome Amplification for High Density SNP Analysis of Circulating Tumour Cells in Early Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Circulating tumor cell; Metastasis; Breast cancer; Population; Biology; Cancer research; Cancer; Primary tumor; Cancer cell; Metastatic breast cancer; CD44; Cytokeratin; Pathology; Cell; Medicine; Immunology; Immunohistochemistry; Genetics","score_opus":0.03827842908587853,"score_gpt":0.33343843633957393,"score_spread":0.2951600072536954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248542833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971542,0.00037889238,0.00025259148,0.00017239888,0.00016165504,0.00037691626,0.0014090355,0.000004162807,0.000090157664],"genre_scores_gemma":[0.99861056,0.00021758104,0.00021852109,0.000033310327,0.00034780588,0.00016243235,0.00024651887,0.000030392375,0.00013287838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850756,0.000034636043,0.00031170942,0.00047609195,0.00024293362,0.0004270751],"domain_scores_gemma":[0.9986486,0.000091530186,0.00014040087,0.00042910382,0.0005725748,0.00011780785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055763766,0.00013087477,0.0002484579,0.00025189892,0.00010334162,0.00005605287,0.00028214493,0.00016851274,0.000085858286],"category_scores_gemma":[0.00006691007,0.00014279183,0.000120665616,0.00053260964,0.00012150914,0.000007129058,0.00010722071,0.000261507,0.0000041620747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001070073,0.000115264396,0.01587648,0.00006359436,0.000089602436,0.0000014939296,0.00012473272,0.0028335056,0.9788857,0.000023718632,0.00017128806,0.0017075936],"study_design_scores_gemma":[0.0003999218,0.00005553017,0.39174023,0.000012248288,0.000060967155,4.127041e-7,0.00004866437,0.00014184855,0.6062452,0.000058601443,0.0010896558,0.00014671385],"about_ca_topic_score_codex":0.011801702,"about_ca_topic_score_gemma":0.014990122,"teacher_disagreement_score":0.37586376,"about_ca_system_score_codex":0.00013341388,"about_ca_system_score_gemma":0.00035707036,"threshold_uncertainty_score":0.9947788},"labels":[],"label_agreement":null},{"id":"W4248668221","doi":"10.1158/1538-7445.sabcs18-p6-18-34","title":"Abstract P6-18-34: Treat ER+ight Canadian prospective observational study in HR+ advanced breast cancer: <i>3rd interim analysis</i>","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lions Gate Hospital; Windsor Regional Hospital; Saskatchewan Cancer Agency; BC Cancer Agency; Kingston General Hospital; Ottawa Hospital; North York General Hospital","funders":"","keywords":"Medicine; Palbociclib; Exemestane; Fulvestrant; Letrozole; Everolimus; Internal medicine; Interim analysis; Breast cancer; Oncology; Adverse effect; Cancer; Anastrozole; Discontinuation; Metastatic breast cancer; Hazard ratio; Tamoxifen; Clinical trial; Confidence interval","score_opus":0.12552298573273044,"score_gpt":0.4553104924355075,"score_spread":0.329787506702777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248668221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98515487,0.0021038775,0.0000057797147,0.003918295,0.00026773408,0.0030722965,0.0005103005,0.0000650693,0.0049017947],"genre_scores_gemma":[0.9914081,0.0002672392,0.00007702036,0.0004147261,0.00036092996,0.0018789568,0.00008192987,0.000089449466,0.005421629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99548244,0.00016234092,0.00057496026,0.0011467701,0.0013182627,0.0013152245],"domain_scores_gemma":[0.99708754,0.00015393253,0.00013253366,0.0008879689,0.0011094327,0.00062860263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007620039,0.00040162564,0.0009044071,0.0014673948,0.00020488603,0.000078755766,0.00048243295,0.00015429297,0.008037632],"category_scores_gemma":[0.000057764995,0.0003638895,0.00018782426,0.0037530721,0.00024386426,0.000500283,0.00011547233,0.0011952012,0.0001463114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027853544,0.00045813288,0.9609344,0.00012511302,0.000896632,0.00015250026,0.0019184407,0.0013186747,0.010711609,0.0000905687,0.00037413582,0.020234447],"study_design_scores_gemma":[0.0046798093,0.00035087942,0.98502105,0.0003222284,0.0001382072,0.000014543928,0.0026104555,0.0000895429,0.0013591766,0.0001387399,0.0049192784,0.00035610955],"about_ca_topic_score_codex":0.30611086,"about_ca_topic_score_gemma":0.6109985,"teacher_disagreement_score":0.30488768,"about_ca_system_score_codex":0.0074242637,"about_ca_system_score_gemma":0.0034399424,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W4248714155","doi":"10.1158/1538-7445.am2019-3054","title":"Abstract 3054: Cell surface targets in head and neck cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Metastasis; Cancer research; Cancer; Malignancy; Cell; Cancer cell; Medicine; Head and neck squamous-cell carcinoma; Biology; Head and neck cancer; Pathology; Internal medicine; Genetics","score_opus":0.043923481691847545,"score_gpt":0.3852102028902809,"score_spread":0.34128672119843334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248714155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752837,0.0195457,0.0000049312953,0.00042320476,0.00011256604,0.00028066925,0.00003662453,0.0000040608174,0.004308573],"genre_scores_gemma":[0.9854337,0.008086364,0.00005540731,0.000084630396,0.00011812907,0.000104144594,0.000017441429,0.000020458256,0.0060797185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887985,0.00004414129,0.00012538048,0.0003873506,0.00019507704,0.00036820283],"domain_scores_gemma":[0.9994324,0.000013472622,0.000026617556,0.0003122851,0.00012581244,0.00008943816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030048646,0.00009309569,0.00010672609,0.000048257567,0.00005981048,0.000034787096,0.00017821524,0.00010718355,0.00059282355],"category_scores_gemma":[0.000010587144,0.0000880226,0.000025762412,0.00016390663,0.000077929384,0.0000064453143,0.00009293371,0.00022287428,0.0000519663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008225561,0.00004048115,0.047425196,0.000065453234,0.000009151095,0.0000017228234,0.000088628614,0.00058065547,0.9427316,0.000021193515,0.006524094,0.002429557],"study_design_scores_gemma":[0.0015330596,0.00015288214,0.19865847,0.00009648965,0.0000033271942,0.0000011718664,0.00027197986,0.00010422808,0.5748653,0.00007259191,0.22392212,0.00031841866],"about_ca_topic_score_codex":0.0023646846,"about_ca_topic_score_gemma":0.0013661769,"teacher_disagreement_score":0.36786634,"about_ca_system_score_codex":0.00007436348,"about_ca_system_score_gemma":0.0002916095,"threshold_uncertainty_score":0.6491002},"labels":[],"label_agreement":null},{"id":"W4248977310","doi":"10.1158/1538-7445.am2019-3461","title":"Abstract 3461: Characterizing the PTEN - p85alpha interaction","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"PTEN; Docking (animal); PI3K/AKT/mTOR pathway; Phosphatase; C2 domain; Binding site; Computational biology; Phosphatidylinositol; Protein kinase domain; Chemistry; Cell biology; Kinase; Cancer research; Biology; Biochemistry; Phosphorylation; Signal transduction; Gene; Mutant; Medicine","score_opus":0.07128664663999323,"score_gpt":0.4145289401213658,"score_spread":0.3432422934813726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248977310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911957,0.0013016019,0.000014415954,0.001291491,0.00082469283,0.0003186818,0.000019098998,0.00001388332,0.0050204564],"genre_scores_gemma":[0.9947448,0.00055271236,0.000012728112,0.00039590427,0.0010831186,0.00014747494,0.000035698948,0.000034531753,0.002993057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854743,0.00010050213,0.00015994548,0.00038943347,0.0003730313,0.00042963706],"domain_scores_gemma":[0.9990492,0.000059789592,0.000060547496,0.0005432715,0.00021392616,0.00007326795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007729089,0.000116981224,0.00010581413,0.000059727547,0.00014667478,0.00008874858,0.00045161223,0.00011906674,0.0009630173],"category_scores_gemma":[0.00007602466,0.00008842393,0.00007322747,0.00015851617,0.00010991278,0.000011433243,0.0001796322,0.00045617222,0.00032457808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014853256,0.000016784365,0.0021109055,0.000029569006,0.00004456682,0.0000019250765,0.00007849566,0.00003840848,0.9811674,0.000025239582,0.008158497,0.008179716],"study_design_scores_gemma":[0.00027762246,0.000106244435,0.00872287,0.000066407396,0.000003885363,0.0000049364235,0.00014007224,0.000031063995,0.62190324,0.000029852168,0.36858088,0.00013289381],"about_ca_topic_score_codex":0.00024734304,"about_ca_topic_score_gemma":0.00005318873,"teacher_disagreement_score":0.3604224,"about_ca_system_score_codex":0.00012038405,"about_ca_system_score_gemma":0.00022187653,"threshold_uncertainty_score":0.99995023},"labels":[],"label_agreement":null},{"id":"W4249219855","doi":"10.1158/1538-7445.am2019-4389","title":"Abstract 4389: Post-translational modifications of histone demethylase JMJD1A in prostate cancer cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Demethylase; Cancer research; Histone; Ubiquitin; Androgen receptor; Chemistry; Interactome; Cancer; EZH2; Chromatin immunoprecipitation; Biology; Medicine; Biochemistry; Internal medicine; DNA","score_opus":0.08258141192698826,"score_gpt":0.4642664800740971,"score_spread":0.38168506814710884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249219855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97849876,0.010283168,0.0000018178613,0.0060585355,0.0001514072,0.0018293334,0.00033471506,0.000020028556,0.002822264],"genre_scores_gemma":[0.98581684,0.004375918,0.000091257425,0.00005681804,0.000091853835,0.0006686639,0.00008316219,0.000038916594,0.008776587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972958,0.00010080907,0.0004012372,0.00046148835,0.0010891722,0.000651513],"domain_scores_gemma":[0.998113,0.00018285247,0.00007158532,0.00043023887,0.0009749251,0.00022744948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008113566,0.00015707871,0.00034174568,0.0006314196,0.000084314954,0.000019456005,0.00020766346,0.000101175785,0.0027786875],"category_scores_gemma":[0.00004367894,0.00013164843,0.00009425388,0.0009484258,0.00032036577,0.00015668482,0.000052519248,0.000708762,0.00017028816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017235334,0.0004248307,0.036154218,0.0007679001,0.000096887044,0.00003880301,0.0012247608,0.0003419624,0.9498285,0.00016896857,0.001126015,0.008103621],"study_design_scores_gemma":[0.00646312,0.00039465807,0.2500596,0.0009173111,0.000035795136,0.000003806432,0.0006428462,0.00026443996,0.73260564,0.0002540463,0.008087049,0.0002716825],"about_ca_topic_score_codex":0.0057252585,"about_ca_topic_score_gemma":0.00066716445,"teacher_disagreement_score":0.21722284,"about_ca_system_score_codex":0.0006799012,"about_ca_system_score_gemma":0.0023201248,"threshold_uncertainty_score":0.9981329},"labels":[],"label_agreement":null},{"id":"W4249289759","doi":"10.1158/1538-7445.am2019-623","title":"Abstract 623: Iron intake, oxidative stress-related genes, and breast cancer risk","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Odds ratio; Physiology; Internal medicine; Case-control study; Oncology; Cancer; Confidence interval; Population; Estrogen receptor; Gynecology; Environmental health","score_opus":0.0196767305648922,"score_gpt":0.32370622481704653,"score_spread":0.3040294942521543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249289759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98431206,0.013051518,0.0000064941382,0.00050319114,0.00016704104,0.00033634691,0.0009693299,0.000010173549,0.0006438328],"genre_scores_gemma":[0.9778277,0.020166645,0.000012829358,0.00005417244,0.00018465168,0.00008340856,0.000095330965,0.000033228993,0.0015420355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985426,0.000107686974,0.00016702816,0.00047538264,0.00026852262,0.00043878317],"domain_scores_gemma":[0.99928814,0.00002920484,0.000042545376,0.0003123677,0.00016722606,0.00016052827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029450562,0.00015740191,0.00015057025,0.000055298173,0.00013889688,0.00004374757,0.00019248777,0.00018019417,0.0013267712],"category_scores_gemma":[0.000010354978,0.00013793401,0.00005486257,0.00015461918,0.00017995558,0.000008876307,0.000096876465,0.0003891576,0.00006216383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030008223,0.000051321837,0.06624977,0.000072048744,0.00010369254,0.0000061890114,0.00015013383,0.0002126244,0.9058387,0.00006088845,0.0011698368,0.025784684],"study_design_scores_gemma":[0.0024466529,0.00041515334,0.36834827,0.00019716003,0.000044678975,0.0000247652,0.0004321622,0.000064875494,0.6070555,0.00013283177,0.02026607,0.00057191565],"about_ca_topic_score_codex":0.00448264,"about_ca_topic_score_gemma":0.00092106475,"teacher_disagreement_score":0.30209848,"about_ca_system_score_codex":0.000047949692,"about_ca_system_score_gemma":0.00021478174,"threshold_uncertainty_score":0.99958616},"labels":[],"label_agreement":null},{"id":"W4249406782","doi":"10.1158/1538-7445.am2019-sy26-02","title":"Abstract SY26-02: <i>Sherlock-Lung</i>: Tracing lung cancer mutational processes in never smokers","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Lung cancer; Medicine; Cancer; Carcinogenesis; Adenocarcinoma; Oncology; Etiology; Lung; Internal medicine; Bioinformatics; Biology","score_opus":0.026116504558112954,"score_gpt":0.3726034955646355,"score_spread":0.3464869910065226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249406782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98085374,0.015322403,0.000017891074,0.0006689384,0.00045065867,0.00052433193,0.00013194144,0.000008332584,0.0020217698],"genre_scores_gemma":[0.99271363,0.0044494336,0.000031974443,0.0003574618,0.0007203377,0.00037575507,0.00008585653,0.00004465442,0.0012208804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981761,0.00004076905,0.00024534593,0.00054394343,0.00041332768,0.0005805084],"domain_scores_gemma":[0.9990005,0.00011540655,0.000060349426,0.00029422672,0.00039885344,0.00013067233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040395145,0.00016556935,0.00017496469,0.00013440152,0.00009349855,0.00007972116,0.00030160125,0.00016379012,0.0005673429],"category_scores_gemma":[0.00016934091,0.00017070374,0.000056133777,0.00038277573,0.00010022057,0.0000191481,0.00012612823,0.00034829072,0.000021260857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089431636,0.00025463488,0.27850425,0.001989536,0.00025009498,0.000059946,0.0010165886,0.024285154,0.6255158,0.00017650488,0.062057715,0.0049954574],"study_design_scores_gemma":[0.0052833646,0.0003515307,0.14818178,0.0011333342,0.000053060812,0.000015720418,0.0010577361,0.001114948,0.67204106,0.00022291306,0.1690875,0.001457072],"about_ca_topic_score_codex":0.002408699,"about_ca_topic_score_gemma":0.0025748278,"teacher_disagreement_score":0.13032246,"about_ca_system_score_codex":0.00027613898,"about_ca_system_score_gemma":0.0017904598,"threshold_uncertainty_score":0.69610965},"labels":[],"label_agreement":null},{"id":"W4249493324","doi":"10.1158/1538-7445.am2019-2121","title":"Abstract 2121: Overcoming tamoxifen resistance and inhibiting metastatic recurrence in estrogen receptor-positive breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tamoxifen; Breast cancer; Cancer research; Medicine; Estrogen receptor; Cancer; Metastatic breast cancer; Internal medicine; Antiestrogen; Oncology","score_opus":0.025970153937163346,"score_gpt":0.3550966645469809,"score_spread":0.32912651060981757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249493324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865877,0.009994647,0.00009097983,0.0006959891,0.00015218699,0.0009456323,0.00032828352,0.000012342861,0.0011922292],"genre_scores_gemma":[0.994297,0.0034763745,0.00027386917,0.00009429297,0.00018944658,0.00039556302,0.000060730286,0.00006766892,0.0011450332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966849,0.00032006402,0.00034143118,0.0009518276,0.0007390211,0.0009627706],"domain_scores_gemma":[0.99870056,0.000105225714,0.00009785658,0.0004517969,0.0004139871,0.00023056881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013573034,0.0002491865,0.0002930657,0.00026099922,0.00015906883,0.000111450565,0.00038320126,0.00018597872,0.00047205988],"category_scores_gemma":[0.00017400162,0.0002636029,0.000072706185,0.00064439635,0.00022796002,0.000028725153,0.00041564228,0.0008644864,0.000039012994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006196832,0.000045051544,0.0015822387,0.00020554227,0.00007628972,0.000029124663,0.00018777576,0.00019097747,0.9870091,0.00020851856,0.001206623,0.008639074],"study_design_scores_gemma":[0.0022312372,0.00018908468,0.009037573,0.0015290639,0.00001554302,0.000031076863,0.0005485663,0.00013693859,0.97815853,0.00030916312,0.007192905,0.0006202939],"about_ca_topic_score_codex":0.0015005496,"about_ca_topic_score_gemma":0.0014948329,"teacher_disagreement_score":0.008850547,"about_ca_system_score_codex":0.00041138794,"about_ca_system_score_gemma":0.00078893156,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4249568651","doi":"10.1158/1538-7445.am2019-3284","title":"Abstract 3284: Adiposity, muscle mass and delays and dose reductions on adjuvant, taxane-based chemotherapy for breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Taxane; Breast cancer; Internal medicine; Chemotherapy; Cancer; Oncology; Body surface area; Anthracycline; Proportional hazards model; Body mass index; Urology; Surgery","score_opus":0.060546061042804064,"score_gpt":0.404986775186829,"score_spread":0.34444071414402494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249568651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767092,0.004591174,0.000004559952,0.01579568,0.00016868471,0.0016188053,0.0005237333,0.000026810978,0.0005613908],"genre_scores_gemma":[0.9921747,0.0047085555,0.00010416852,0.0005115445,0.00034759482,0.001192836,0.000020192205,0.000043601663,0.0008968213],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857044,0.000025093264,0.00014747877,0.0004821127,0.0003573244,0.000417546],"domain_scores_gemma":[0.9990045,0.00017317868,0.000044110388,0.00029195083,0.00023310588,0.00025319157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025811992,0.00015778256,0.00027639462,0.00016557194,0.00017702884,0.000055855737,0.0000665248,0.00008795254,0.001239572],"category_scores_gemma":[0.000011213133,0.00012934249,0.00006550997,0.00019143593,0.00015528049,0.00006380861,0.000022524373,0.00026070594,0.000014557525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005947976,0.0009269663,0.12975594,0.0013999034,0.0006743088,0.000041335294,0.0005114919,0.00015967975,0.21803415,0.00032647126,0.03327176,0.60895],"study_design_scores_gemma":[0.011541126,0.0010923442,0.9236775,0.00095454126,0.00012345197,0.000019444802,0.0001635237,0.00022855251,0.037225224,0.0001304506,0.024580304,0.00026352896],"about_ca_topic_score_codex":0.0032615522,"about_ca_topic_score_gemma":0.00055906904,"teacher_disagreement_score":0.79392153,"about_ca_system_score_codex":0.00047930737,"about_ca_system_score_gemma":0.00041542613,"threshold_uncertainty_score":0.9996734},"labels":[],"label_agreement":null},{"id":"W4249577962","doi":"10.1158/1538-7445.sabcs19-ot2-04-04","title":"Abstract OT2-04-04: Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase 2 trial","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pembrolizumab; Trastuzumab; Pertuzumab; Internal medicine; Breast cancer; Oncology; Neoadjuvant therapy; Clinical endpoint; Randomized controlled trial; Cancer; Metastatic breast cancer; Gastroenterology; Immunotherapy","score_opus":0.16369235837609136,"score_gpt":0.46420772914625336,"score_spread":0.300515370770162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249577962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596623,0.014355497,0.000052223324,0.01318906,0.00032248892,0.009608578,0.00011429219,0.0001685347,0.0025270265],"genre_scores_gemma":[0.974449,0.014803054,0.00033942887,0.004684283,0.0013761979,0.0025850807,0.00018540048,0.0002187015,0.0013589044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994553,0.0009128242,0.00085196225,0.0010467871,0.0015442279,0.0010911742],"domain_scores_gemma":[0.99704224,0.00042670057,0.00025328758,0.0009929254,0.0006321613,0.0006526887],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003108543,0.00050468335,0.0015482958,0.00025536364,0.00044778126,0.00043581118,0.0011871535,0.00025402277,0.008378677],"category_scores_gemma":[0.00014946837,0.0003430605,0.0002375865,0.001171009,0.0008692621,0.00048250007,0.000127156,0.0011973893,0.000057789024],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6939656,0.0013015908,0.000019299925,0.000056604753,0.00091315754,0.00012798168,0.0016201871,0.000003520884,0.20414975,0.000028885224,0.0037978946,0.09401551],"study_design_scores_gemma":[0.8926003,0.012752639,0.00025142022,0.00022668528,0.000052149768,0.000015993379,0.00039157365,0.00020644866,0.03221002,0.000056500296,0.060788557,0.00044770268],"about_ca_topic_score_codex":0.0061118607,"about_ca_topic_score_gemma":0.00021587852,"teacher_disagreement_score":0.1986347,"about_ca_system_score_codex":0.0004162005,"about_ca_system_score_gemma":0.002342827,"threshold_uncertainty_score":0.9999021},"labels":[],"label_agreement":null},{"id":"W4249649511","doi":"10.1158/1538-7445.am2019-1950","title":"Abstract 1950: Differential expression of MUC16 mucin (CA125) depending on the architecture of the tumors developed in an orthotopic mouse model of high-grade serous ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pathology; Serous fluid; Ovarian cancer; Pancreas; Histopathology; Stroma; Peritoneal cavity; Cancer; Ovary; Medicine; Immunohistochemistry; Biology; Anatomy; Internal medicine","score_opus":0.05325800276262018,"score_gpt":0.35743986483701873,"score_spread":0.30418186207439857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249649511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984664,0.0001805802,0.00002481727,0.00018213168,0.000051657888,0.0007556027,0.00022888955,0.0000023255648,0.000107642896],"genre_scores_gemma":[0.9990302,0.0002101816,0.000042751308,0.000017102042,0.000050974184,0.00018859135,0.000023341272,0.000026327727,0.0004105351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810386,0.00023169661,0.000275847,0.0003644216,0.0006166676,0.00040748145],"domain_scores_gemma":[0.9989219,0.000054407552,0.0001233667,0.00066312595,0.00015646918,0.000080778205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031320166,0.00014880477,0.00023561959,0.00012324352,0.0000760744,0.0000136003455,0.0005997004,0.000113096576,0.00019377856],"category_scores_gemma":[0.00005406384,0.00008684589,0.00008420062,0.00023721569,0.00017546945,0.000007563529,0.00026792026,0.00039314706,0.0000011274315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070011336,0.00016891534,0.023997212,0.000119226796,0.00004255769,0.0000013396344,0.0002613567,0.0049063247,0.9680188,0.00009047697,0.000049126396,0.0016445686],"study_design_scores_gemma":[0.0010916602,0.00018401847,0.03803871,0.00021619427,0.0000045004745,4.0987007e-7,0.00008129254,0.00015190455,0.9599658,0.00015159107,0.00002885174,0.00008504603],"about_ca_topic_score_codex":0.007670725,"about_ca_topic_score_gemma":0.01126803,"teacher_disagreement_score":0.0140414955,"about_ca_system_score_codex":0.000099551726,"about_ca_system_score_gemma":0.0006298049,"threshold_uncertainty_score":0.9989373},"labels":[],"label_agreement":null},{"id":"W4249719377","doi":"10.1158/1538-7445.am2019-lb-095","title":"Abstract LB-095: Aurora-A is elevated in cancer cells due to inactivation of EF1A2-PTEN-GSK3b regulated late S-G2 phase specific degradation pathway","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"PTEN; Mitosis; Cancer research; Protein kinase B; Ectopic expression; Phosphorylation; Gene knockdown; PLK1; Biology; PI3K/AKT/mTOR pathway; Cancer; Cell cycle; Signal transduction; Cell culture; Chemistry; Cell biology; Genetics","score_opus":0.04134245152881088,"score_gpt":0.35895112389727724,"score_spread":0.31760867236846635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249719377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751925,0.00058582943,0.00008645484,0.00031649944,0.00017157759,0.0007991638,0.0001897216,0.000008419252,0.00032306623],"genre_scores_gemma":[0.9960042,0.0012550856,0.000072168456,0.000111898364,0.00011769667,0.00010997276,0.00023361335,0.000039526098,0.00205583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822015,0.000103434686,0.00035674372,0.000529284,0.00034226148,0.00044812524],"domain_scores_gemma":[0.99879664,0.00002564841,0.00011359674,0.0004914906,0.0004648172,0.00010778689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005071742,0.00016735373,0.00023680467,0.0002557405,0.000052290543,0.000031250118,0.00027580088,0.00022655996,0.00046021884],"category_scores_gemma":[0.00003109281,0.00016778256,0.000060981576,0.0006260616,0.000061488136,0.000016176306,0.000105387495,0.0002833589,0.000047834965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005667803,0.00016515706,0.00049318984,0.00007968057,0.000034703302,0.0000045828715,0.00016433603,0.00047170484,0.98366535,0.000019909137,0.0025432587,0.011791374],"study_design_scores_gemma":[0.0012806646,0.000221318,0.0038218496,0.00012114128,0.0000035433807,7.044725e-7,0.000075051634,0.0001865155,0.97141856,0.000025685424,0.02266187,0.00018310075],"about_ca_topic_score_codex":0.0016141913,"about_ca_topic_score_gemma":0.00052041473,"teacher_disagreement_score":0.020118613,"about_ca_system_score_codex":0.00022384203,"about_ca_system_score_gemma":0.00037288462,"threshold_uncertainty_score":0.6841974},"labels":[],"label_agreement":null},{"id":"W4249868975","doi":"10.1158/1538-7445.am2016-130","title":"Abstract 130: International Cancer Genome Consortium (ICGC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Genomics; Cancer; Globe; Biology; Computational biology; Library science; Computer science; Genetics; Gene","score_opus":0.056590746118043184,"score_gpt":0.39141496150932853,"score_spread":0.3348242153912854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249868975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353887,0.004791794,0.0001584393,0.004037065,0.00082760793,0.0002144918,0.00071741786,0.000011369466,0.005702946],"genre_scores_gemma":[0.980317,0.013106697,0.0000350587,0.00032489092,0.0016723606,0.00023240816,0.00002981886,0.000031658852,0.0042500948],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986201,0.000029801166,0.00018047483,0.00042550155,0.00030202666,0.0004421189],"domain_scores_gemma":[0.998984,0.000050081926,0.00004772897,0.00036160822,0.0003982186,0.00015836499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003366854,0.00011607999,0.0001049286,0.00008110168,0.00010118998,0.000053447548,0.00044129227,0.00011240277,0.0020837456],"category_scores_gemma":[0.00018244378,0.00008993929,0.00006685864,0.000092397,0.0002322364,0.000005624315,0.00025678045,0.00013238858,0.00010458391],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001215436,0.00003040589,0.004456405,0.000010808931,0.00007152532,0.000008872362,0.000018929484,0.00003348748,0.9608746,0.0002294611,0.019553714,0.014590235],"study_design_scores_gemma":[0.00084609457,0.00007704465,0.029968183,0.000046076606,0.000005681622,0.0000029874336,0.00003153024,0.0000025269755,0.27652177,0.00022845512,0.6920601,0.00020952588],"about_ca_topic_score_codex":0.00047959207,"about_ca_topic_score_gemma":0.0006445679,"teacher_disagreement_score":0.6843528,"about_ca_system_score_codex":0.0002005126,"about_ca_system_score_gemma":0.00056243,"threshold_uncertainty_score":0.9988285},"labels":[],"label_agreement":null},{"id":"W4250015940","doi":"10.1158/1538-7445.am2016-lb-341","title":"Abstract LB-341: Evolving functional heterogeneity in B-acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Somatic evolution in cancer; clone (Java method); Biology; Cancer; SNP array; Leukemia; Cancer research; Acute lymphocytic leukemia; Exome sequencing; Genetics; Immunology; Oncology; Mutation; Medicine; Lymphoblastic Leukemia; Gene; Single-nucleotide polymorphism; Genotype","score_opus":0.042314030379522166,"score_gpt":0.34331473932390266,"score_spread":0.30100070894438047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250015940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996016,0.0019940836,0.00035057653,0.00030275443,0.00029376027,0.00015756166,0.00010539178,0.0000071278296,0.0007727325],"genre_scores_gemma":[0.99580723,0.0026880575,0.000043426055,0.000117942465,0.00053578697,0.00013988212,0.000024078581,0.000027987977,0.0006156081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985234,0.00004562699,0.00019200843,0.00044724194,0.0002865425,0.00050516106],"domain_scores_gemma":[0.99916315,0.00010878083,0.000035373316,0.00034519483,0.00020656596,0.00014095039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000396571,0.00012445846,0.00012102183,0.00010827977,0.00009737862,0.000041458294,0.00022333587,0.00013115963,0.00026999388],"category_scores_gemma":[0.00024130076,0.00010095637,0.000065480206,0.00015579487,0.00015949536,0.000006987727,0.00020840378,0.00013042415,0.000071286166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023089806,0.000030556792,0.013205468,0.000016770184,0.00004383369,0.000017548453,0.000011298989,0.0002532766,0.96931654,0.00006409951,0.010497308,0.006312415],"study_design_scores_gemma":[0.002230894,0.0002364681,0.2391203,0.00014700889,0.000010821058,0.000013879911,0.000027788326,0.00005521677,0.7128002,0.00036323874,0.04462545,0.000368728],"about_ca_topic_score_codex":0.00043084373,"about_ca_topic_score_gemma":0.0012473488,"teacher_disagreement_score":0.25651634,"about_ca_system_score_codex":0.00062743766,"about_ca_system_score_gemma":0.0009688713,"threshold_uncertainty_score":0.41168815},"labels":[],"label_agreement":null},{"id":"W4250484950","doi":"10.1158/1538-7445.am2019-3003","title":"Abstract 3003: Inhibiting the mitochondrial enzyme phosphatidylserine decarboxylase (PISD) reduces stemness and increases differentiation in acute myeloid leukemia (AML)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Brock University; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Clonogenic assay; Cancer research; Myeloid; Biology; Haematopoiesis; Cell growth; Leukemia; Stem cell; Progenitor cell; Cellular differentiation; Chemistry; Cell biology; Immunology; Cell; Biochemistry","score_opus":0.028784465769420748,"score_gpt":0.3506110704357492,"score_spread":0.32182660466632845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250484950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349874,0.004200812,0.0000029739983,0.0006020573,0.0002174358,0.0010483608,0.000028596562,0.000032842338,0.0003681729],"genre_scores_gemma":[0.9964182,0.0019039172,0.000020366046,0.00014318895,0.00049953815,0.00025694267,0.000040509436,0.000034451,0.0006828886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803185,0.00015017172,0.000301174,0.00040188583,0.0006453545,0.0004695766],"domain_scores_gemma":[0.9989122,0.0003296897,0.000082601626,0.00032538784,0.00016932384,0.00018075242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004784827,0.00017251319,0.00029782765,0.00018505128,0.00015791082,0.0000861874,0.00017609484,0.000106298285,0.000626029],"category_scores_gemma":[0.00011543454,0.000120578305,0.000059141286,0.00041159688,0.00017235297,0.00019739481,0.00011738344,0.00054878637,0.000027274747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003320287,0.00021932293,0.02824855,0.00037130644,0.00025103413,0.00015880517,0.0011207974,0.00004281711,0.9377685,0.00021955973,0.0006325865,0.027646396],"study_design_scores_gemma":[0.004975226,0.00021912681,0.30599442,0.00077407423,0.000054730943,0.000016401025,0.00077464076,0.00032493143,0.68577826,0.00037138103,0.0005049887,0.00021183607],"about_ca_topic_score_codex":0.0020306369,"about_ca_topic_score_gemma":0.00018491886,"teacher_disagreement_score":0.27774587,"about_ca_system_score_codex":0.00035507814,"about_ca_system_score_gemma":0.00058816286,"threshold_uncertainty_score":0.6854578},"labels":[],"label_agreement":null},{"id":"W4250636026","doi":"10.1158/1538-7445.am2019-2464","title":"Abstract 2464: Gabriella Miller Kids First Data Resource Center: Harmonizing clinical and genomic data to support childhood cancer and structural birth defect research","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Context (archaeology); Data sharing; Resource (disambiguation); Translational research; Medicine; Bioinformatics; Data science; Biology; Computer science; Pathology; Alternative medicine","score_opus":0.22431589813757333,"score_gpt":0.45172461555387816,"score_spread":0.22740871741630483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250636026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800253,0.014101765,0.0000021581604,0.0012902438,0.00019500752,0.000814112,0.0032493633,0.000010605591,0.00031142618],"genre_scores_gemma":[0.97945476,0.016770521,0.00012843472,0.00033732972,0.0010027153,0.000050053153,0.001477945,0.000060533028,0.0007177386],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962761,0.00027746055,0.00037474223,0.0016175933,0.0005918182,0.0008623015],"domain_scores_gemma":[0.9965705,0.00013224901,0.000049301358,0.0023065298,0.000279751,0.0006616604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023603323,0.00021208262,0.00026361647,0.00016228804,0.0003923319,0.00021721514,0.0014088837,0.00019718739,0.00030672908],"category_scores_gemma":[0.0003645567,0.00020357087,0.000049709797,0.00020833101,0.0005391583,0.00002430651,0.0039548697,0.0005768129,0.00003459778],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014190843,0.00016734749,0.6786688,0.00045139118,0.00024350925,0.000027410431,0.00027423017,0.000021558788,0.08741205,0.000009122557,0.20954241,0.021763092],"study_design_scores_gemma":[0.0025501414,0.0004648884,0.4349303,0.00013338147,0.000022327024,0.000015609061,0.00032762537,0.000071940434,0.0034599511,0.00003875472,0.5576065,0.00037856487],"about_ca_topic_score_codex":0.0010002361,"about_ca_topic_score_gemma":0.0015855688,"teacher_disagreement_score":0.3480641,"about_ca_system_score_codex":0.000052498854,"about_ca_system_score_gemma":0.0006688305,"threshold_uncertainty_score":0.83013797},"labels":[],"label_agreement":null},{"id":"W4250857274","doi":"10.1158/1538-7445.am2019-4051","title":"Abstract 4051: First step for development of checkpoint inhibitors immune monitoring panels in human whole blood and peripheral mononuclear cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Peripheral blood mononuclear cell; Immune system; Monoclonal antibody; Flow cytometry; Antibody; Immunotherapy; CD8; clone (Java method); Immunology; Medicine; Cancer immunotherapy; Cancer research; Biology; In vitro","score_opus":0.06484803613932401,"score_gpt":0.3703665553649097,"score_spread":0.3055185192255857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250857274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959323,0.0023709037,0.0000029275095,0.00022727104,0.00018682043,0.0010455835,0.000010173778,0.000011963229,0.00021206227],"genre_scores_gemma":[0.9978025,0.00039265412,0.00044638017,0.000007849796,0.00014761713,0.00017012848,0.0000050951103,0.000036329962,0.0009914611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984146,0.000024214563,0.00045248552,0.00030467295,0.00038056224,0.00042349647],"domain_scores_gemma":[0.9993847,0.00006834261,0.00007705882,0.00023938078,0.00014316615,0.00008733214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009241812,0.00013296928,0.0003112866,0.00018958328,0.00012838731,0.000030125972,0.00012370425,0.000102677295,0.00023418646],"category_scores_gemma":[0.000013318971,0.0001207502,0.00007493714,0.00021070433,0.00012290436,0.000079066136,0.00007482914,0.0003020732,0.0000047323633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011571605,0.00014658239,0.01655784,0.0008089454,0.00010127113,0.0000051112647,0.0028369091,0.000011342582,0.96781135,0.0000024547812,0.000048968555,0.010512059],"study_design_scores_gemma":[0.004411926,0.0003434425,0.17765604,0.0010188245,0.000009308446,0.0000015849582,0.0014001202,0.000010033855,0.80638176,0.000006025351,0.008630609,0.00013033018],"about_ca_topic_score_codex":0.0010676171,"about_ca_topic_score_gemma":0.000102335754,"teacher_disagreement_score":0.1614296,"about_ca_system_score_codex":0.00027974823,"about_ca_system_score_gemma":0.00028426087,"threshold_uncertainty_score":0.49240503},"labels":[],"label_agreement":null},{"id":"W4250917173","doi":"10.1158/1538-7445.am2015-2988","title":"Abstract 2988: International cancer genome consortium (ICGC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Globe; Genome; Library science; Identification (biology); Coding (social sciences); Biology; Computational biology; Genetics; Computer science; Sociology; Gene; Social science","score_opus":0.10527178139362929,"score_gpt":0.41649463496091244,"score_spread":0.31122285356728313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250917173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727564,0.0096818665,0.000060660233,0.001915196,0.00110964,0.00024198183,0.0003166121,0.00001182975,0.013905819],"genre_scores_gemma":[0.9878128,0.00657789,0.00006858684,0.00041112045,0.0020002746,0.0002407261,0.00012219732,0.000032808966,0.0027335992],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985601,0.000034091736,0.00018110717,0.00039418018,0.0004142052,0.00041633617],"domain_scores_gemma":[0.9986718,0.000023185145,0.00004736852,0.00033977762,0.0006458033,0.00027205286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050392764,0.00011749966,0.00011335557,0.00008527361,0.00007979168,0.00008135332,0.00044828537,0.000116716044,0.00049181527],"category_scores_gemma":[0.00021678185,0.00011830487,0.000055910197,0.00012697985,0.00018068468,0.000005301484,0.00028655783,0.00022304151,0.000086215645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037782363,0.00009591745,0.009050985,0.00002595835,0.00015048098,0.000023704331,0.00017781601,0.0013517932,0.8431812,0.00037102783,0.13777648,0.0074168374],"study_design_scores_gemma":[0.00086217065,0.00010485984,0.008016356,0.000018691422,0.0000068866125,0.000004164014,0.0001646593,0.000025627996,0.078562446,0.0002526947,0.9117696,0.00021180055],"about_ca_topic_score_codex":0.0013926482,"about_ca_topic_score_gemma":0.0008752056,"teacher_disagreement_score":0.77399313,"about_ca_system_score_codex":0.00024229911,"about_ca_system_score_gemma":0.0011020226,"threshold_uncertainty_score":0.5385032},"labels":[],"label_agreement":null},{"id":"W4251007774","doi":"10.1158/1538-7445.transcagen-a2-49","title":"Abstract A2-49: Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Proteome; Transcriptome; Lung cancer; Cancer research; Adenocarcinoma; Serine hydroxymethyltransferase; Gene; Cancer; DNA methylation; Genetics; Computational biology; Bioinformatics; Gene expression; Serine; Pathology; Medicine","score_opus":0.051057255105645336,"score_gpt":0.41854969130859193,"score_spread":0.3674924362029466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251007774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170257,0.01646505,0.00012981861,0.00025141786,0.000050341572,0.00071303314,0.00034409892,0.000010049638,0.0003336185],"genre_scores_gemma":[0.9967747,0.0010772725,0.000076392884,0.0000339109,0.00016966819,0.0009291399,0.00017862224,0.0000320322,0.00072826416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815106,0.00014766575,0.00026344234,0.0004614316,0.00052740757,0.00044896506],"domain_scores_gemma":[0.997736,0.000027152488,0.00013716862,0.00053902244,0.0013332424,0.00022741673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075241074,0.00018231838,0.00034455027,0.00035808622,0.00008142447,0.00005219913,0.00037614818,0.00015853395,0.00021966272],"category_scores_gemma":[0.00016144715,0.00012529662,0.00013914528,0.0015131707,0.00022784891,0.000012228901,0.00007025925,0.00032372592,0.0000027339977],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068083516,0.00009433651,0.03679197,0.00006708796,0.0021546455,0.000003825228,0.00017368812,0.009607594,0.9389388,0.000026775524,0.009900127,0.0015603184],"study_design_scores_gemma":[0.0016722946,0.0004844037,0.5301861,0.0002275334,0.001036971,0.000002330665,0.00033970925,0.0010015756,0.45317692,0.000064605396,0.011212928,0.00059465255],"about_ca_topic_score_codex":0.0037542211,"about_ca_topic_score_gemma":0.0008595335,"teacher_disagreement_score":0.49339414,"about_ca_system_score_codex":0.00018740671,"about_ca_system_score_gemma":0.001535173,"threshold_uncertainty_score":0.5675284},"labels":[],"label_agreement":null},{"id":"W4251722174","doi":"10.1158/1538-7445.am2014-4278","title":"Abstract 4278: International Cancer Genome Consortium (ICGC)","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Globe; Library science; Identification (biology); Biology; Computational biology; Computer science; Genetics; Gene","score_opus":0.047904543972154184,"score_gpt":0.386006713944055,"score_spread":0.3381021699719008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251722174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97811484,0.0038496596,0.00020274243,0.0024701855,0.0009489707,0.0002226286,0.00021814324,0.000012540992,0.013960301],"genre_scores_gemma":[0.98741126,0.0070849713,0.000064254054,0.0007254227,0.0022474173,0.00021867514,0.00010154988,0.000033414883,0.002113038],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859,0.000044023363,0.00018393087,0.00042278826,0.00033202014,0.00042724353],"domain_scores_gemma":[0.9989936,0.00004487375,0.000050245908,0.00037401635,0.00037630647,0.00016097701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049822574,0.00012026804,0.00011854248,0.00008431901,0.00012455901,0.000080275815,0.00045750107,0.00011746081,0.00090639445],"category_scores_gemma":[0.00021605578,0.00012130568,0.000067020825,0.00010630577,0.00018232904,0.000004181754,0.00024490527,0.00022743962,0.000073233496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013496784,0.000050601582,0.00419047,0.00002774117,0.000086423475,0.0000038147327,0.00004897425,0.00062870566,0.9439138,0.00060953264,0.038026355,0.012278609],"study_design_scores_gemma":[0.0005321784,0.0000823601,0.015378086,0.00002054411,0.0000059327294,0.0000020637087,0.000034412304,0.000051562023,0.09455112,0.0002207358,0.88893473,0.00018625971],"about_ca_topic_score_codex":0.0010722529,"about_ca_topic_score_gemma":0.0009505685,"teacher_disagreement_score":0.8509084,"about_ca_system_score_codex":0.00012966219,"about_ca_system_score_gemma":0.000381536,"threshold_uncertainty_score":0.9924384},"labels":[],"label_agreement":null},{"id":"W4251781653","doi":"10.1158/1538-7445.am2019-3383","title":"Abstract 3383: EPIC: MHC-I epitope prediction integrating mass spectrometry derived motifs and tissue-specific expression profiles","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epitope; Human leukocyte antigen; Computational biology; Major histocompatibility complex; Biology; Gene; Computer science; Antigen; Genetics","score_opus":0.0367652546446296,"score_gpt":0.32390352796563093,"score_spread":0.28713827332100134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251781653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920563,0.0042741206,0.00051093835,0.000130584,0.00016888914,0.00048893585,0.000032446525,0.000014265139,0.0023235297],"genre_scores_gemma":[0.99358493,0.0035157672,0.0016319895,0.000013637942,0.00030938434,0.000087279455,0.000106391366,0.000026523594,0.0007240987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987161,0.00005632683,0.0002417565,0.00033963815,0.00027221622,0.00037394976],"domain_scores_gemma":[0.99930286,0.000026466745,0.000068895424,0.00036595576,0.00014983176,0.000086013155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048788646,0.00014386946,0.00015240473,0.000108636355,0.00015337793,0.00011077838,0.00021507751,0.0001507279,0.0003794767],"category_scores_gemma":[0.00005609088,0.0001170054,0.00003671741,0.00015575219,0.00006695602,0.000022934826,0.00018316253,0.00033060974,0.000032205247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076212906,0.000019139165,0.0043091006,0.00011452826,0.000019084682,8.0513547e-7,0.00014451295,0.000020769863,0.9859681,0.000045960624,0.0015037155,0.0077780336],"study_design_scores_gemma":[0.00042683387,0.00024563496,0.01633079,0.00011266398,0.0000025120055,0.0000049200476,0.0009828742,0.00016970403,0.9707289,0.000069628106,0.010790178,0.00013540026],"about_ca_topic_score_codex":0.000043825195,"about_ca_topic_score_gemma":0.000004859171,"teacher_disagreement_score":0.015239275,"about_ca_system_score_codex":0.000052607407,"about_ca_system_score_gemma":0.000077149176,"threshold_uncertainty_score":0.47713417},"labels":[],"label_agreement":null},{"id":"W4252345694","doi":"10.1158/1538-7445.am2012-5063","title":"Abstract 5063: International Cancer Genome Consortium (ICGC)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Breast cancer; Genome; Medicine; Oncology; Biology; Family medicine; Internal medicine; Genetics; Gene","score_opus":0.07035793734801903,"score_gpt":0.40702398464447587,"score_spread":0.3366660472964568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252345694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719663,0.016193125,0.00004435757,0.0010182658,0.0012544639,0.00021317138,0.0003004594,0.000009755438,0.009000066],"genre_scores_gemma":[0.98236006,0.011507105,0.000057055833,0.00040685947,0.0033172646,0.0002540039,0.00010645948,0.0000332865,0.0019579283],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985599,0.00003293306,0.00017596614,0.00029831633,0.0003293382,0.0006035517],"domain_scores_gemma":[0.9990651,0.000031892843,0.0000475773,0.00032233892,0.0002982812,0.0002347905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048141382,0.00011989678,0.000107445565,0.0000824784,0.00011940382,0.00005724329,0.00037583092,0.00011988426,0.0014238121],"category_scores_gemma":[0.00012731968,0.000120181634,0.000068422334,0.000113307215,0.00016331764,0.000008400216,0.00025991956,0.00022865845,0.00009589189],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012920584,0.00009498518,0.027133334,0.00002490111,0.00011421299,0.0000033745055,0.00011305128,0.00014950497,0.930772,0.00036875243,0.03508355,0.006013106],"study_design_scores_gemma":[0.00042317194,0.00004509055,0.05616781,0.000016664722,0.000007945197,0.0000035741778,0.00008331041,0.000005427129,0.123899445,0.000050478757,0.81909966,0.00019743684],"about_ca_topic_score_codex":0.00077526877,"about_ca_topic_score_gemma":0.00031291007,"teacher_disagreement_score":0.80687255,"about_ca_system_score_codex":0.00017962001,"about_ca_system_score_gemma":0.00038596577,"threshold_uncertainty_score":0.999489},"labels":[],"label_agreement":null},{"id":"W4252633638","doi":"10.1158/1538-7445.am2019-1947","title":"Abstract 1947: Modelling of lipid-based nanoparticle pharmacokinetics and tumor accumulation using preclinical models of ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Ovarian cancer; Medicine; Cancer; Liposome; Cancer research; Pharmacology; Pathology; Chemistry; Internal medicine; Biochemistry","score_opus":0.2816095915094226,"score_gpt":0.4516564054579349,"score_spread":0.1700468139485123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252633638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969777,0.0006478246,0.0013265576,0.00011943097,0.00023065644,0.0005469615,0.00008499772,0.000022026285,0.000043862576],"genre_scores_gemma":[0.9980363,0.00006543464,0.0016637559,0.00003662926,0.00010637326,0.000040117873,0.0000016148819,0.00002994073,0.000019813424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974938,0.00021038268,0.0005771953,0.00042458126,0.000805933,0.00048811667],"domain_scores_gemma":[0.9981958,0.00048658764,0.00020482748,0.00036917877,0.0005886068,0.00015500127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017756749,0.00013181951,0.000317849,0.00015848453,0.000080910715,0.000045524564,0.00027291046,0.000067996094,0.0008584846],"category_scores_gemma":[0.000063277264,0.00012662128,0.00005166781,0.0004064056,0.0002818374,0.00035972724,0.00012444767,0.00021910992,0.000013752859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032506854,0.000068262,0.0023286901,0.00016725184,0.0000059160247,0.0000010548558,0.00009638927,0.47050166,0.5262395,0.000048306294,0.000012643723,0.00020524312],"study_design_scores_gemma":[0.00073198404,0.000045209174,0.0002842401,0.00014498689,0.000011972266,2.3244654e-7,0.000018090019,0.47254172,0.52599335,0.00014672348,0.000009957536,0.000071527385],"about_ca_topic_score_codex":0.0028597617,"about_ca_topic_score_gemma":0.000042236377,"teacher_disagreement_score":0.0028175253,"about_ca_system_score_codex":0.00014625462,"about_ca_system_score_gemma":0.00066830224,"threshold_uncertainty_score":0.93998045},"labels":[],"label_agreement":null},{"id":"W4252789837","doi":"10.1158/1538-7445.am2019-962","title":"Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Medicine; Decile; Prospective cohort study; Risk assessment; Relative risk; Cohort; Absolute risk reduction; Population; Demography; Cohort study; Framingham Risk Score; Cancer; Confidence interval; Internal medicine; Statistics; Environmental health; Disease; Mathematics","score_opus":0.036365416500723245,"score_gpt":0.3715962992051754,"score_spread":0.33523088270445217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252789837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101067,0.0071104653,0.000011286483,0.000041678843,0.000068432826,0.0006428033,0.0010715529,0.00000463713,0.000038499227],"genre_scores_gemma":[0.9695192,0.030058423,0.00003248398,0.000005809439,0.00010340864,0.00017741874,0.000036935,0.000019605544,0.00004673686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983733,0.00020630722,0.00029677735,0.00047445166,0.0003459567,0.00030316302],"domain_scores_gemma":[0.99896896,0.00008333666,0.00017284605,0.00023755143,0.00044829457,0.000089036424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007318202,0.00015314661,0.00025149257,0.00016039,0.00010457512,0.00002737625,0.00012477135,0.0001295146,0.000018967174],"category_scores_gemma":[0.00025151408,0.000135506,0.00004587696,0.00019625972,0.00043600198,0.000017094077,0.00012746514,0.00032112986,0.0000014043934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006578548,0.00008656928,0.97458297,0.00013913008,0.00010196569,9.71481e-7,0.00042512926,0.003897715,0.019796746,0.000018501352,0.00012619913,0.00016625445],"study_design_scores_gemma":[0.0011777752,0.00010798956,0.943848,0.00011961454,0.000029437038,4.03018e-7,0.00067094556,0.0005736583,0.051855776,0.0014572641,0.000007882319,0.00015124596],"about_ca_topic_score_codex":0.004446148,"about_ca_topic_score_gemma":0.005528398,"teacher_disagreement_score":0.03205903,"about_ca_system_score_codex":0.00017409562,"about_ca_system_score_gemma":0.00046413022,"threshold_uncertainty_score":0.6721275},"labels":[],"label_agreement":null},{"id":"W4253706262","doi":"10.1158/1538-7445.sabcs15-s1-05","title":"Abstract S1-05: Prophylactic beta blockade preserves left ventricular ejection fraction in HER2-overexpresssing breast cancer patients receiving trastuzumab: Primary results of the MANTICORE randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Alberta","funders":"","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Heart failure; Trastuzumab; Breast cancer; Ventricular remodeling; Asymptomatic; Perindopril; Cancer","score_opus":0.02689821192734731,"score_gpt":0.32848922755633936,"score_spread":0.30159101562899204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253706262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896,0.00036031587,0.000017166958,0.0020537789,0.00048352548,0.0068360907,0.000054115,0.000024022016,0.00057100476],"genre_scores_gemma":[0.9974927,0.0006580148,0.000009278195,0.00002948654,0.0006028265,0.000688027,0.000014802108,0.000036794896,0.00046810776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959994,0.0009254539,0.00084081583,0.0004554138,0.001334907,0.00044401083],"domain_scores_gemma":[0.99755186,0.0008769276,0.00046274712,0.00041060318,0.0005965367,0.00010134139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022857385,0.00020467276,0.0010246839,0.00028703094,0.00017440278,0.00004648563,0.00018334186,0.00022150489,0.00015044464],"category_scores_gemma":[0.0012199399,0.00011477164,0.0003987999,0.00042263436,0.000267298,0.00031182388,0.00005878385,0.00062807667,0.000003081303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61523324,0.0004115007,0.005731308,0.0002568433,0.00021530974,0.0000055839164,0.00019251813,0.000027342605,0.36975166,0.000001838211,0.0001713298,0.008001523],"study_design_scores_gemma":[0.66003954,0.00015886244,0.11823391,0.0019275825,0.000117842785,0.0000059224662,0.00005585001,0.00003199415,0.21917444,0.000054234897,0.000081178965,0.000118622454],"about_ca_topic_score_codex":0.0015209051,"about_ca_topic_score_gemma":0.00015178378,"teacher_disagreement_score":0.15057722,"about_ca_system_score_codex":0.0013599619,"about_ca_system_score_gemma":0.0006864377,"threshold_uncertainty_score":0.46802515},"labels":[],"label_agreement":null},{"id":"W4254237205","doi":"10.1158/1538-7445.am2019-4594","title":"Abstract 4594: Cytoplasmic LOXL2 regulates actin cytoskeletal organization in esophageal squamous cell carcinoma progression","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial metabolism and enzyme function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Gene knockdown; Actin cytoskeleton; Cytoskeleton; Cell migration; Plectin; Vimentin; Cancer research; Cell biology; Molecular biology; Cell; Intermediate filament; Cell culture; Genetics; Immunology; Immunohistochemistry","score_opus":0.014004592365439012,"score_gpt":0.30382345860892157,"score_spread":0.2898188662434826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254237205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710757,0.0013653393,0.0000085550855,0.00010113979,0.00033694514,0.00042632196,0.000023521483,0.000013159859,0.0006174726],"genre_scores_gemma":[0.99699605,0.00015219358,0.000027334512,0.000033400018,0.00039486357,0.00003229789,0.00019284696,0.000042137053,0.0021288907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853665,0.00010742462,0.0001915185,0.0004632869,0.00026251655,0.00043862336],"domain_scores_gemma":[0.99925476,0.000019927116,0.00005575862,0.00033217482,0.0002520427,0.00008530515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003942771,0.0001386015,0.000140596,0.00014056874,0.00008921112,0.000037572398,0.00021117995,0.0002162975,0.0005572792],"category_scores_gemma":[0.00009214768,0.00013031006,0.00003376747,0.00047818405,0.000060279435,0.000014576992,0.0001429735,0.0002979947,0.00018410149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015883775,0.00007070101,0.027788166,0.00010925209,0.00000290826,0.00000639958,0.000066045,0.00014218067,0.9653113,0.00000879812,0.0048471205,0.0014882899],"study_design_scores_gemma":[0.00083417265,0.0001406776,0.0830887,0.000019489613,0.0000030873891,0.0000039077654,0.00006366033,0.000015400481,0.909564,0.000008586883,0.0061223716,0.00013591441],"about_ca_topic_score_codex":0.00022444721,"about_ca_topic_score_gemma":0.00008199533,"teacher_disagreement_score":0.055747278,"about_ca_system_score_codex":0.00007919599,"about_ca_system_score_gemma":0.0002647243,"threshold_uncertainty_score":0.6101817},"labels":[],"label_agreement":null},{"id":"W4254343589","doi":"10.1158/1538-7445.am2019-4332","title":"Abstract 4332: Targeting MYC overexpressing leukemia with cardiac glycoside proscillaridin through downregulation of histone acetyltransferases","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University; Concordia University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Downregulation and upregulation; Cancer research; Histone Acetyltransferases; Histone acetyltransferase; Acetylation; Histone; Biology; Histone H3; HDAC3; Molecular biology; Histone deacetylase; Biochemistry; Gene","score_opus":0.027274995950676603,"score_gpt":0.3760061267141482,"score_spread":0.34873113076347156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254343589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244374,0.0035886336,0.00012283916,0.00011725567,0.00010918608,0.0008110052,0.000090693786,0.000017886488,0.00269873],"genre_scores_gemma":[0.9967187,0.00056639756,0.0004718021,0.00001682759,0.00033112866,0.00013460776,0.00017733964,0.00006707153,0.0015161431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701995,0.00021879913,0.00033294852,0.0006664465,0.0010711171,0.0006907255],"domain_scores_gemma":[0.99844366,0.00008683987,0.000092983595,0.0006197453,0.00063111336,0.00012567395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092383777,0.00021315984,0.00031764637,0.00012596798,0.00020793089,0.000051849587,0.00032734068,0.00022211709,0.0001656214],"category_scores_gemma":[0.00015795718,0.00019011513,0.00011602593,0.00039946663,0.00042837465,0.000032584947,0.00014493242,0.00048101725,0.000023735234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064475863,0.000041176063,0.0015008097,0.00028098637,0.00006281452,0.0000039785064,0.00032510987,0.0011160593,0.9907163,0.00003733139,0.0046123588,0.00065833586],"study_design_scores_gemma":[0.0007212691,0.0002959504,0.0020417066,0.00025463902,0.000007866871,0.0000021702097,0.00024100099,0.000024738238,0.9753388,0.000014922153,0.020828512,0.00022843746],"about_ca_topic_score_codex":0.0012591202,"about_ca_topic_score_gemma":0.00006630242,"teacher_disagreement_score":0.016216153,"about_ca_system_score_codex":0.0005092787,"about_ca_system_score_gemma":0.0012390852,"threshold_uncertainty_score":0.77526695},"labels":[],"label_agreement":null},{"id":"W4254376651","doi":"10.1158/1538-7445.am2019-3554","title":"Abstract 3554: miR-139 is associated with improved prognosis in patients with localized prostate cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Ontario Genomics; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Medicine; Biochemical recurrence; Prostatectomy; Proportional hazards model; Oncology; Hazard ratio; Internal medicine; microRNA; Metastasis; Cancer; Surgical margin; Lymph node; Survival analysis; Stage (stratigraphy); Biology; Gene; Confidence interval","score_opus":0.01758640556884581,"score_gpt":0.3274357980159776,"score_spread":0.3098493924471318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254376651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967203,0.0010607797,0.0000011785554,0.00015077146,0.00004488247,0.0015345815,0.00023014026,0.000013651602,0.00024372437],"genre_scores_gemma":[0.9977762,0.00016344205,0.000018257535,0.00012855274,0.00004462207,0.00084009307,0.00018878769,0.00006254748,0.00077750836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997856,0.0000979734,0.00018670328,0.0006252387,0.0005878119,0.00064627384],"domain_scores_gemma":[0.9987632,0.000023126904,0.000087715984,0.00040726826,0.00057103636,0.00014765184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029022462,0.00019402964,0.00021693649,0.000102555394,0.00006829224,0.000059824815,0.00029349135,0.00014002995,0.00036958946],"category_scores_gemma":[0.00008451141,0.00014998732,0.0000476696,0.0004204879,0.00018124978,0.000012149281,0.00012099901,0.00029288814,0.000014885004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001745036,0.00032112884,0.9412702,0.00009311252,0.00020200283,0.000007813767,0.00009614429,0.000078902,0.052755713,0.0000010975916,0.0015710944,0.0018577952],"study_design_scores_gemma":[0.006946925,0.00094846723,0.84704953,0.00045502334,0.000025510062,4.135627e-7,0.00008873208,0.000042838627,0.13924795,0.000010396319,0.00474875,0.0004354393],"about_ca_topic_score_codex":0.0010199089,"about_ca_topic_score_gemma":0.0016766213,"teacher_disagreement_score":0.09422061,"about_ca_system_score_codex":0.000238351,"about_ca_system_score_gemma":0.00069807324,"threshold_uncertainty_score":0.61163056},"labels":[],"label_agreement":null},{"id":"W4254394809","doi":"10.1158/1538-7445.compsysbio-b2-59","title":"Abstract B2-59: PhyloSpan: Using multi-mutation reads to resolve subclonal architectures from heterogeneous tumor samples","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Genetics; Indel; Germline mutation; Somatic cell; Germline; Computational biology; Mutation; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.13897145300526695,"score_gpt":0.4069566911741654,"score_spread":0.2679852381688984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254394809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340737,0.0035767318,0.001457759,0.00024995214,0.00026914856,0.00035674847,0.000588371,0.000011692011,0.000082246646],"genre_scores_gemma":[0.9919578,0.0001164412,0.005963704,0.00036189242,0.0011682279,0.000096200376,0.00021417356,0.000051510833,0.000070069225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816567,0.00008572401,0.00022686328,0.00056262536,0.00043822295,0.0005209087],"domain_scores_gemma":[0.9986113,0.000092195245,0.000057541238,0.00043716823,0.00041050164,0.0003913371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039336283,0.00017638969,0.00017516692,0.00011800102,0.00013737922,0.000101714024,0.00032651774,0.000109389934,0.00005071557],"category_scores_gemma":[0.0004923888,0.0001764512,0.00007618909,0.00016800953,0.00013264407,0.0000029355194,0.00026431496,0.00022745274,0.000026455431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006563269,0.000078756726,0.003679782,0.000019902573,0.000070250506,0.000065797634,0.00037487847,0.026381293,0.9613223,0.000009743829,0.0035142556,0.0038267206],"study_design_scores_gemma":[0.0013354,0.0004552817,0.015472478,0.000075211734,0.00002022649,0.000025385367,0.0002539889,0.00046116518,0.9498847,0.00048755851,0.03106813,0.00046046378],"about_ca_topic_score_codex":0.00797951,"about_ca_topic_score_gemma":0.003890212,"teacher_disagreement_score":0.027553875,"about_ca_system_score_codex":0.0002133658,"about_ca_system_score_gemma":0.0007258649,"threshold_uncertainty_score":0.9986264},"labels":[],"label_agreement":null},{"id":"W4254432607","doi":"10.1158/1538-7445.am2019-3724","title":"Abstract 3724: Molecular mechanisms of TTField action determined by measurements and modelling of electro-conductive properties of microtubules","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Communication and Nanonetworks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Microtubule; Tubulin; Electrical conductor; Mitosis; Materials science; Actin; Biophysics; Chemistry; Physics; Biology; Cell biology; Composite material","score_opus":0.1488635080853084,"score_gpt":0.3250860843798343,"score_spread":0.17622257629452587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254432607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985387,0.005206955,0.008782955,0.000017697677,0.000025631029,0.0002767168,0.0000037211028,0.000008922942,0.00029037462],"genre_scores_gemma":[0.9986597,0.00080864364,0.00045152978,0.000002886414,0.0000029784737,0.000028280594,0.00000214569,0.000015711426,0.000028140626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992739,0.000050114813,0.00017712868,0.000096955046,0.00025747478,0.0001444206],"domain_scores_gemma":[0.99947494,0.000018669914,0.000043142958,0.00022921358,0.00020678819,0.000027231894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030225233,0.00006506829,0.00014809042,0.00009273409,0.000016795906,0.000005675007,0.00014554975,0.00006474956,0.00002910646],"category_scores_gemma":[0.000009687282,0.000062259256,0.00002790107,0.00012572951,0.000046236535,0.00005526987,0.000034116205,0.00017834753,7.6177884e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047239162,0.000017074095,0.000023106048,0.00028216955,0.00005424378,1.0107895e-7,0.00012054648,0.012381159,0.9858672,0.000053487816,0.000029071078,0.0011245979],"study_design_scores_gemma":[0.0002067609,0.00004706007,0.000016755188,0.00015735177,0.0000054657867,2.8278697e-7,0.00007014485,0.013147741,0.9861035,0.00016542536,0.000026536498,0.000053004078],"about_ca_topic_score_codex":0.00019428277,"about_ca_topic_score_gemma":0.000009222478,"teacher_disagreement_score":0.013272658,"about_ca_system_score_codex":0.000037631267,"about_ca_system_score_gemma":0.000035879606,"threshold_uncertainty_score":0.2538859},"labels":[],"label_agreement":null},{"id":"W4254533543","doi":"10.1158/1538-7445.sabcs19-ot1-04-02","title":"Abstract OT1-04-02: POSITIVE: A study evaluating pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsive breast cancer who desire pregnancy (IBCSG 48-14/big 8-13)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pregnancy; Breast cancer; Cancer; Endocrine system; Gynecology; Obstetrics; Pediatrics; Internal medicine; Hormone","score_opus":0.18120374429398456,"score_gpt":0.4682109011937057,"score_spread":0.2870071568997211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254533543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805629,0.008296989,0.00005473776,0.00249434,0.000118018994,0.0071472293,0.0011514061,0.00006463632,0.0001096992],"genre_scores_gemma":[0.99276745,0.0020859237,0.00009520756,0.00016518227,0.00042860562,0.0037499384,0.000024532163,0.00013392798,0.00054925657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522555,0.0003217371,0.0008179382,0.0010734748,0.0013862387,0.001175054],"domain_scores_gemma":[0.9964315,0.00046975922,0.00031381415,0.0005402674,0.0014130778,0.00083155057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007399814,0.00046770496,0.0009763515,0.0002648664,0.00031432876,0.00008545006,0.00031908258,0.000059796203,0.00047560973],"category_scores_gemma":[0.0004843027,0.00035852322,0.00010253305,0.0006821821,0.00035778084,0.0002380586,0.00027243185,0.0008022764,0.0000020054338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0988512,0.00087535504,0.56415355,0.0026961192,0.0011704428,0.00042209637,0.014271959,0.00010640402,0.024981353,0.000028129696,0.00014575834,0.2922976],"study_design_scores_gemma":[0.019953532,0.0085733235,0.9550047,0.0074822716,0.00022228937,0.0000278872,0.0041183936,0.00034248526,0.0034805874,0.000025404726,0.00026555787,0.00050358265],"about_ca_topic_score_codex":0.0020587866,"about_ca_topic_score_gemma":0.000510207,"teacher_disagreement_score":0.3908511,"about_ca_system_score_codex":0.00087208464,"about_ca_system_score_gemma":0.0016149004,"threshold_uncertainty_score":0.9998867},"labels":[],"label_agreement":null},{"id":"W4254649859","doi":"10.1158/1538-7445.am2015-lb-307","title":"Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Serous fluid; Oncology; Internal medicine; Serous carcinoma; Ovarian carcinoma; Cancer; Adjuvant; Stage (stratigraphy); Surgery; Biology","score_opus":0.2839295482176014,"score_gpt":0.4612088933759195,"score_spread":0.1772793451583181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254649859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690568,0.0047197086,0.012264618,0.011751973,0.000050722596,0.0010995565,0.00024912128,0.000019433277,0.00078808866],"genre_scores_gemma":[0.99383074,0.00031041823,0.005022445,0.00007688339,0.00014782701,0.00044845522,0.00009442794,0.000022340755,0.000046456335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990413,0.000023387307,0.0001866589,0.0002482723,0.00026501258,0.00023537947],"domain_scores_gemma":[0.99866205,0.00015997398,0.00003952395,0.00019032384,0.00075892475,0.0001892234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043877217,0.000083246436,0.00018687904,0.00012968223,0.00010888989,0.0000255402,0.00006899062,0.000051172476,0.000021544229],"category_scores_gemma":[0.000037893897,0.00007205594,0.00004499541,0.00017173102,0.00007735044,0.00005639252,0.000029334666,0.00012907796,0.0000011841929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024155176,0.00085804204,0.5351252,0.00048285406,0.0007561056,0.000016508622,0.0021137653,0.057563175,0.0012712241,0.019132141,0.004094092,0.3761714],"study_design_scores_gemma":[0.013475027,0.0011295448,0.61637795,0.00035143938,0.00007955224,0.000029389414,0.0009481275,0.3510709,0.0006376582,0.014315229,0.0013309177,0.00025424745],"about_ca_topic_score_codex":0.001751778,"about_ca_topic_score_gemma":0.00011041368,"teacher_disagreement_score":0.37591717,"about_ca_system_score_codex":0.0002608251,"about_ca_system_score_gemma":0.00058708875,"threshold_uncertainty_score":0.29383558},"labels":[],"label_agreement":null},{"id":"W4254976957","doi":"10.1158/1538-7445.am2019-4529","title":"Abstract 4529: Mapping the protein interactome of mitochondrial intermembrane space proteases identifies a novel function for HTRA2","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Intermembrane space; Mitochondrial intermembrane space; Proteases; Biotinylation; Biology; Cell biology; Mitochondrion; Molecular biology; Biochemistry; Bacterial outer membrane; Gene; Enzyme","score_opus":0.07925075511544756,"score_gpt":0.3735900366515782,"score_spread":0.29433928153613065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254976957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900677,0.00064929755,0.0008900466,0.0018007867,0.00042439398,0.0051281573,0.000022989074,0.000017202225,0.0009993803],"genre_scores_gemma":[0.9918836,0.000030572322,0.00012503695,0.000041482894,0.00029958333,0.0010635243,0.000016900665,0.000026839416,0.006512475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853265,0.00004047823,0.00024073455,0.00029616337,0.0005612271,0.00032876423],"domain_scores_gemma":[0.9988792,0.00014285155,0.0000705694,0.0004218235,0.00041822353,0.000067340705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005537763,0.00011016807,0.00023098964,0.0001918411,0.00007707696,0.000049764156,0.00018417253,0.00006745865,0.00084384915],"category_scores_gemma":[0.00031476314,0.00007641459,0.0001858044,0.00028659028,0.00016547879,0.00008145763,0.00007490735,0.00033028235,0.00004072588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014244174,0.0001508722,0.00049562874,0.0015318363,0.00020570956,5.3522746e-7,0.00072333997,0.000022183012,0.98625827,0.00009295554,0.0014958973,0.0075983754],"study_design_scores_gemma":[0.015100695,0.0020781069,0.10800558,0.005227319,0.00016865642,0.000016164873,0.011204735,0.00046007652,0.7543127,0.000975783,0.101954855,0.00049532077],"about_ca_topic_score_codex":0.00062870525,"about_ca_topic_score_gemma":0.0001832288,"teacher_disagreement_score":0.23194554,"about_ca_system_score_codex":0.00007411493,"about_ca_system_score_gemma":0.00030211336,"threshold_uncertainty_score":0.9239556},"labels":[],"label_agreement":null},{"id":"W4255102952","doi":"10.1158/1538-7445.am2019-1051","title":"Abstract 1051: Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth upon bevacizumab-induced hypoxia, <i>in vivo</i>","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Bevacizumab; Temozolomide; Cancer research; In vivo; Medicine; Downregulation and upregulation; Glucose transporter; Brain tumor; Glioma; Pathology; Internal medicine; Chemistry; Chemotherapy; Biology","score_opus":0.02319639472760599,"score_gpt":0.32695285351328623,"score_spread":0.30375645878568025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255102952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848896,0.004434905,0.0000013325517,0.00043886705,0.0018877867,0.00078284065,0.000077046774,0.000028553257,0.0074590174],"genre_scores_gemma":[0.9912262,0.002240881,0.000025764104,0.00017856056,0.0026556752,0.0003219496,0.000018940476,0.0000855261,0.0032464822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965154,0.0001852214,0.00039544687,0.0009909228,0.0007677578,0.0011452701],"domain_scores_gemma":[0.9984194,0.00006517686,0.00011271167,0.0007500104,0.0003396919,0.00031300168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008803632,0.00032378387,0.0004024781,0.00032337988,0.00014986862,0.000106194966,0.00066317606,0.0002708067,0.00069095904],"category_scores_gemma":[0.00018217524,0.00032271462,0.00018331908,0.0005817434,0.00013277502,0.0000314628,0.0002691649,0.0006694052,0.0002565352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007066158,0.000109088105,0.00054189784,0.00009601808,0.00004794171,0.000014816099,0.000120387034,0.000026014068,0.9823232,0.00004894016,0.011691267,0.004273767],"study_design_scores_gemma":[0.0014981322,0.00031645902,0.0032804462,0.000091799964,0.000009530103,0.000016083743,0.00020423676,0.000010226703,0.8473611,0.000072739866,0.14678235,0.00035687868],"about_ca_topic_score_codex":0.0015922864,"about_ca_topic_score_gemma":0.0016875063,"teacher_disagreement_score":0.1350911,"about_ca_system_score_codex":0.00019821522,"about_ca_system_score_gemma":0.00089297263,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W4255521712","doi":"10.1158/1538-7445.am2019-3451","title":"Abstract 3451: Interpreting gene lists from -omics experiments","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene nomenclature; Gene; Relevance (law); Workflow; Computational biology; Function (biology); Resource (disambiguation); Similarity (geometry); Biology; Computer science; Biological network; Genetics; Database; Artificial intelligence; Taxonomy (biology)","score_opus":0.03629958494048452,"score_gpt":0.3720919691303676,"score_spread":0.33579238418988305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255521712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902516,0.0022910195,0.00015270669,0.000102108286,0.00036670757,0.00021941905,0.00005423592,0.0000069478515,0.0065552304],"genre_scores_gemma":[0.99716556,0.00050723297,0.00039110376,0.0002277553,0.00044377174,0.00003920168,0.00014992362,0.000024449057,0.0010509798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891895,0.00003190241,0.00018690145,0.0002788805,0.00020570554,0.0003776498],"domain_scores_gemma":[0.9993197,0.000022812654,0.00004793386,0.00041180474,0.00009689494,0.00010088278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003423136,0.00010501145,0.00011134566,0.00003741835,0.00007130565,0.00006523027,0.00033333458,0.00014969753,0.00038038724],"category_scores_gemma":[0.000020592004,0.000100180114,0.00005483355,0.0000660852,0.00006343817,0.00000493049,0.00030027961,0.00024954948,0.00018401581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010144497,0.000017787659,0.0016359505,0.000014917478,0.000048274862,0.0000014433011,0.00021455246,0.00009207116,0.9849398,0.000025942556,0.0057129283,0.0071948464],"study_design_scores_gemma":[0.00065727514,0.00011427173,0.002107406,0.0000724149,0.0000033947713,0.0000014908265,0.00031896832,0.0006712233,0.9313152,0.0002818961,0.064203,0.0002534725],"about_ca_topic_score_codex":0.00027865465,"about_ca_topic_score_gemma":0.00002736132,"teacher_disagreement_score":0.058490075,"about_ca_system_score_codex":0.000060734383,"about_ca_system_score_gemma":0.0001269041,"threshold_uncertainty_score":0.41649735},"labels":[],"label_agreement":null},{"id":"W4255743860","doi":"10.1158/1538-7445.am2016-134","title":"Abstract 134: Mutational landscape of breast cancers from PALB2 germline mutation carriers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"PALB2; Germline mutation; Breast cancer; Germline; Genetics; Biology; Exome; Loss of heterozygosity; Cancer research; Mutation; BRCA2 Protein; Cancer; Exome sequencing; Allele; Gene","score_opus":0.03153879368771195,"score_gpt":0.36538265132852393,"score_spread":0.333843857640812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255743860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377185,0.002089974,0.0004113988,0.0010441308,0.00025134333,0.00019975704,0.0014185277,0.000009431865,0.00080358406],"genre_scores_gemma":[0.9976091,0.0005356689,0.00023350933,0.00005643011,0.00062696845,0.00018059801,0.00024121629,0.000030835257,0.00048572346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998448,0.0000794981,0.00024929267,0.0004150716,0.00048668502,0.000321415],"domain_scores_gemma":[0.99872327,0.00009728809,0.000095437776,0.0003428964,0.00062756677,0.00011352827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003461375,0.00011938249,0.00013391757,0.000116076306,0.000094304756,0.000017647242,0.00025893448,0.00013366564,0.0013069514],"category_scores_gemma":[0.0001234212,0.00009580455,0.00006757692,0.00022970636,0.0003022235,0.000011092389,0.00007314003,0.00012039397,0.000024122823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002993976,0.000021777541,0.005506008,0.00002456913,0.00014784325,0.0000065965596,0.00019506282,0.00072572066,0.9491534,0.000047104113,0.009548683,0.034323838],"study_design_scores_gemma":[0.0023737254,0.0001590644,0.1252145,0.00015887599,0.000026183192,0.000016234197,0.000649511,0.000060953564,0.8519302,0.00085189485,0.01821218,0.00034668355],"about_ca_topic_score_codex":0.0013032287,"about_ca_topic_score_gemma":0.00096457,"teacher_disagreement_score":0.1197085,"about_ca_system_score_codex":0.00034956617,"about_ca_system_score_gemma":0.0016492519,"threshold_uncertainty_score":0.999606},"labels":[],"label_agreement":null},{"id":"W4255825421","doi":"10.1158/1538-7445.am2019-4603","title":"Abstract 4603: To analyse PIMT function in glioblastoma cell invasion","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Transfection; Gentamicin protection assay; Viability assay; Chemistry; Cell migration; Glioma; Cell culture; Cell; Cell biology; Molecular biology; Western blot; Biology; Cancer research; Gene; Biochemistry; Genetics","score_opus":0.03891754562893612,"score_gpt":0.36604283745601035,"score_spread":0.3271252918270742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255825421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956229,0.0013300972,0.00008342466,0.0001320058,0.00014011333,0.00029971017,0.0000058019045,0.000004286076,0.002381693],"genre_scores_gemma":[0.99790657,0.0004368743,0.00004093022,0.000060720824,0.0001633718,0.000052630567,0.000018328374,0.000017807964,0.0013027928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884254,0.000075090764,0.00014946159,0.00035918746,0.0002761586,0.00029758082],"domain_scores_gemma":[0.99936396,0.000020434645,0.000026282794,0.00032070765,0.0001639044,0.00010473426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006300248,0.00008139287,0.00008987684,0.00020604061,0.000043314052,0.000030572603,0.00014853166,0.000119186814,0.00024061897],"category_scores_gemma":[0.000050403407,0.00007940942,0.00003744365,0.00038604884,0.000020809599,0.000004337013,0.00011195817,0.00017483269,0.00021803811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002538264,0.000036235324,0.020031892,0.000023516877,0.0000063582065,0.0000013770464,0.000038763606,0.0012799795,0.9727515,0.0000049041882,0.0006015931,0.0049700625],"study_design_scores_gemma":[0.00036645873,0.00047833318,0.059127122,0.000020240535,0.0000021294757,9.6892585e-8,0.0000865396,0.000031152333,0.91965693,0.000075273885,0.020052416,0.00010332612],"about_ca_topic_score_codex":0.00035056533,"about_ca_topic_score_gemma":0.0010384832,"teacher_disagreement_score":0.05309458,"about_ca_system_score_codex":0.00006769458,"about_ca_system_score_gemma":0.0001397213,"threshold_uncertainty_score":0.32382223},"labels":[],"label_agreement":null},{"id":"W4256002320","doi":"10.1158/0008-5472.can-04-9999","title":"Message from the Editor-in-Chief","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Enthusiasm; Associate editor; Editor in chief; Editorial board; The Internet; Library science; Medical education; Medicine; Operations research; Computer science; Psychology; Management; World Wide Web; Engineering","score_opus":0.049564351297229116,"score_gpt":0.47946486669048577,"score_spread":0.42990051539325663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256002320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9151938,0.020000178,0.0002182424,0.04771549,0.004354919,0.0006486863,0.000024624776,0.000038885155,0.011805158],"genre_scores_gemma":[0.96055436,0.0073928647,0.0005601347,0.0026186146,0.02470776,0.00022507597,0.000007269171,0.000028170452,0.003905758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989767,0.00009121083,0.000099581106,0.00019362582,0.00033675684,0.00030211775],"domain_scores_gemma":[0.99912614,0.00043406404,0.0000138248815,0.00029275566,0.00006647784,0.00006675312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004943696,0.0000599413,0.000134248,0.00004784317,0.00013418873,0.000008180472,0.00018968999,0.00009365985,0.000828687],"category_scores_gemma":[0.00013769214,0.000035706216,0.000031087304,0.00025407452,0.00041590646,0.000034950495,0.000034305216,0.00074667257,0.00005763681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038619044,0.0009949122,0.17464644,0.000101124286,0.00032671788,0.0012146296,0.008563615,0.0008663997,0.060545843,0.009931119,0.6341266,0.10482068],"study_design_scores_gemma":[0.0037865976,0.00026825164,0.05391852,0.00022703769,0.000008539007,0.0000093336075,0.00046767414,0.000006198662,0.0064125694,0.01183314,0.92297,0.00009211268],"about_ca_topic_score_codex":0.001013433,"about_ca_topic_score_gemma":0.00070046436,"teacher_disagreement_score":0.2888434,"about_ca_system_score_codex":0.00047176666,"about_ca_system_score_gemma":0.00046035627,"threshold_uncertainty_score":0.9073541},"labels":[],"label_agreement":null},{"id":"W4256151041","doi":"10.1158/1538-7445.am2019-4915","title":"Abstract 4915: Optimal frequency of follow up scans on systemictherapy for advanced malignancies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Regimen; Nuclear medicine; Confidence interval; Progression-free survival; Surgery; Internal medicine; Overall survival","score_opus":0.038782092617401606,"score_gpt":0.3642403346600216,"score_spread":0.32545824204261997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256151041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931452,0.003839537,0.00014011505,0.00015292037,0.0005113189,0.0008225612,0.00037357165,0.0000055641285,0.0010092079],"genre_scores_gemma":[0.9953707,0.002042047,0.00032786792,0.00008753996,0.0002547223,0.00034156084,0.00006381065,0.000038651848,0.0014731154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870324,0.00002727115,0.0002226402,0.00038161586,0.0002558715,0.00040935958],"domain_scores_gemma":[0.9988585,0.00010504398,0.00007712624,0.0004554075,0.00042002613,0.00008390351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037796964,0.00012959089,0.00020162409,0.00007816212,0.000067975016,0.0000232224,0.00030677542,0.00012586181,0.00008606338],"category_scores_gemma":[0.00010953625,0.00012307758,0.00012068256,0.00011283413,0.00008767682,0.000004159935,0.000055230925,0.000120083285,0.00001519383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005984929,0.000037170044,0.0017808153,0.00019288836,0.000055440927,8.4638793e-7,0.00006754926,0.0013332262,0.989915,0.0009266706,0.0028110575,0.002280806],"study_design_scores_gemma":[0.0022165824,0.0011786289,0.0016106744,0.00023633633,0.0000074076092,0.0000013244273,0.00026062556,0.000031744745,0.96638507,0.0001869873,0.027657649,0.00022699959],"about_ca_topic_score_codex":0.00022307315,"about_ca_topic_score_gemma":0.00013525254,"teacher_disagreement_score":0.024846591,"about_ca_system_score_codex":0.00009602065,"about_ca_system_score_gemma":0.0004562784,"threshold_uncertainty_score":0.50189584},"labels":[],"label_agreement":null},{"id":"W4256178155","doi":"10.1158/1538-7445.am2018-4995","title":"Abstract 4995: Identity fraud: Lineage plasticity as a mechanism of anti-androgen resistance and target for therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Reprogramming; Biology; Enzalutamide; Cancer research; Transdifferentiation; Androgen receptor; EZH2; Prostate cancer; Epigenetics; Cancer; Cell biology; Cell; Stem cell; Genetics; Gene","score_opus":0.1007832456863494,"score_gpt":0.4513442733368875,"score_spread":0.3505610276505381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256178155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975426,0.0054909666,0.0003353351,0.0009714939,0.000113881266,0.00148265,0.00020872754,0.000027370756,0.0016153014],"genre_scores_gemma":[0.98977137,0.0055591017,0.00054464774,0.00006807533,0.00047779753,0.00031250858,0.000020724307,0.000037287995,0.003208517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977765,0.00006679768,0.00026108764,0.0004482391,0.0008378511,0.00060953177],"domain_scores_gemma":[0.9980466,0.0002775595,0.00006921155,0.00028746782,0.0010617689,0.00025741538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010308357,0.00015340874,0.00037249803,0.0002363818,0.00029608115,0.00005017836,0.00020312442,0.00013170186,0.0007338892],"category_scores_gemma":[0.00027256622,0.000117082316,0.00008564096,0.0004243777,0.0006638363,0.00017298799,0.00009799507,0.00033135992,0.000024973013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01297504,0.000674081,0.01013978,0.001711348,0.000737769,0.0001201149,0.0016294807,0.0000012832667,0.94905865,0.008027125,0.010380287,0.0045450167],"study_design_scores_gemma":[0.0051400447,0.0015258616,0.011291643,0.00034468982,0.000024772253,0.0000045547235,0.00018667588,0.00005645982,0.9584859,0.006711543,0.016078422,0.00014946223],"about_ca_topic_score_codex":0.0005522694,"about_ca_topic_score_gemma":0.00021636469,"teacher_disagreement_score":0.009427197,"about_ca_system_score_codex":0.00016918361,"about_ca_system_score_gemma":0.00070960505,"threshold_uncertainty_score":0.8035572},"labels":[],"label_agreement":null},{"id":"W4256353661","doi":"10.1158/1538-7445.am2019-4731","title":"Abstract 4731: Therapeutic targeting of RNA splicing through inhibition of protein arginine methylation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"RNA splicing; Splicing factor; Mutant; RNA-binding protein; Cancer research; Biology; Wild type; SR protein; Methylation; RNA; Alternative splicing; Cancer; Genetics; Molecular biology; Messenger RNA; Gene","score_opus":0.04091007175302925,"score_gpt":0.37009634878662123,"score_spread":0.329186277033592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256353661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943816,0.0032860797,0.0004987452,0.00016460754,0.00007233271,0.00059941947,0.000011807783,0.000005463583,0.0009799306],"genre_scores_gemma":[0.9988506,0.00028762512,0.00020602628,0.000008509696,0.00017523908,0.000052006264,0.00006846227,0.000022800801,0.0003287224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988163,0.00008937621,0.00027484263,0.00025473902,0.00034843409,0.00021630985],"domain_scores_gemma":[0.9991636,0.000022890204,0.0001611755,0.0002533797,0.00037316838,0.000025764572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006514062,0.00008546726,0.00014174038,0.000081029815,0.0000397001,0.0000075258417,0.000091778675,0.00013898584,0.00015523643],"category_scores_gemma":[0.000048869533,0.000083778534,0.000059464175,0.00027259495,0.000085533895,0.000011862962,0.00005661226,0.00016873935,0.0000067841243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016773585,0.000023531786,0.00045963048,0.00016449751,0.000039929884,1.3767726e-7,0.00012874392,0.0026809925,0.98981225,0.00014199877,0.00008654203,0.0062940116],"study_design_scores_gemma":[0.0004517026,0.0001720894,0.0031025528,0.00015843156,0.0000055971204,2.921167e-7,0.00009664958,0.0001504308,0.9941273,0.00033621,0.0013180344,0.00008074128],"about_ca_topic_score_codex":0.00039297796,"about_ca_topic_score_gemma":0.00003204351,"teacher_disagreement_score":0.00621327,"about_ca_system_score_codex":0.00007002834,"about_ca_system_score_gemma":0.00018523319,"threshold_uncertainty_score":0.34163895},"labels":[],"label_agreement":null},{"id":"W4256453127","doi":"10.1158/1538-7445.am10-2226","title":"Abstract 2226: International Cancer Genome Consortium (ICGC)","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; Government (linguistics); Library science; Medicine; Political science; Internal medicine","score_opus":0.06351124660776447,"score_gpt":0.41905995794064477,"score_spread":0.3555487113328803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256453127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843642,0.0017935097,0.000044565644,0.0019505995,0.00086184085,0.00019053895,0.0001517439,0.000011647529,0.010631352],"genre_scores_gemma":[0.9877714,0.0031448335,0.00007173614,0.00018835448,0.0015371708,0.00047289787,0.000080696795,0.000025587362,0.006707315],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872667,0.000026969547,0.00016076029,0.0003949024,0.00033680294,0.00035389472],"domain_scores_gemma":[0.99890053,0.0000107270325,0.00004484938,0.00044288594,0.00046886757,0.00013212385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039596658,0.00010038379,0.00008336504,0.00008292674,0.00015674719,0.00007297102,0.0005047945,0.00013818916,0.0032379127],"category_scores_gemma":[0.00006462254,0.000094519906,0.000058194077,0.00013297706,0.00024482125,0.000007174497,0.00013206844,0.0004214514,0.000076933866],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052373372,0.000036372236,0.0027963985,0.000009196835,0.000046968966,0.0000020610373,0.000028913624,0.000043508644,0.9774685,0.00030246063,0.011112648,0.008100597],"study_design_scores_gemma":[0.00031323705,0.000025469262,0.04193782,0.000008492495,0.0000037601806,0.0000028802406,0.000048446174,0.000013254435,0.22095944,0.00008124859,0.73646146,0.00014447318],"about_ca_topic_score_codex":0.00064279104,"about_ca_topic_score_gemma":0.0009874385,"teacher_disagreement_score":0.75650907,"about_ca_system_score_codex":0.00005873736,"about_ca_system_score_gemma":0.00048156423,"threshold_uncertainty_score":0.9976733},"labels":[],"label_agreement":null},{"id":"W4256531334","doi":"10.1158/1538-7445.am2018-494","title":"Abstract 494: Intravital discovery of miRNA drivers of human cancer cell directional invasion","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Invadopodia; microRNA; Cancer cell; Cancer; Metastasis; Cell biology; Cell; Pancreatic cancer; Biology; Cell migration; Cancer research; Pathology; Medicine; Gene; Biochemistry","score_opus":0.0483413214969391,"score_gpt":0.34725571943073386,"score_spread":0.29891439793379476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256531334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923537,0.0014076601,0.00006671256,0.000014976586,0.00062262116,0.00020259955,0.00019942802,0.000037191006,0.0050951466],"genre_scores_gemma":[0.99781454,0.0012147813,0.000055085,0.0000043864893,0.00038378095,0.000047053814,0.000010458906,0.000045399513,0.00042452163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851596,0.0000146124685,0.0002843885,0.00019242757,0.00061383453,0.00037878662],"domain_scores_gemma":[0.9992008,0.00008936848,0.000055615652,0.00025929374,0.00031367605,0.00008123902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025316805,0.00013166413,0.00021416217,0.00016187417,0.000096956785,0.000022423721,0.0002931069,0.000100958445,0.0008721224],"category_scores_gemma":[0.000016232121,0.00012658126,0.00007312635,0.00035017403,0.0004093639,0.00036779544,0.000069139314,0.00029960627,0.000013311848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060968345,0.000037830898,0.0021141719,0.00030889982,0.00006299249,0.0000020284099,0.00053006486,0.00042448202,0.9916094,0.00008977082,0.0024774175,0.0022820071],"study_design_scores_gemma":[0.00046239042,0.00013519645,0.0078277,0.00020977473,0.000010518051,4.1842873e-7,0.00017271427,0.00006314091,0.9893008,0.00031164824,0.0013696833,0.00013605706],"about_ca_topic_score_codex":0.003490566,"about_ca_topic_score_gemma":0.0024107404,"teacher_disagreement_score":0.0057135285,"about_ca_system_score_codex":0.0005971401,"about_ca_system_score_gemma":0.0002060022,"threshold_uncertainty_score":0.9549129},"labels":[],"label_agreement":null},{"id":"W4280498349","doi":"10.1158/0008-5472.can-21-2395","title":"Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; American Association for Cancer Research; Government of Ontario; Genentech; Stand Up To Cancer; Princess Margaret Cancer Foundation","keywords":"Interpretability; Pharmacogenomics; Machine learning; Artificial intelligence; Computer science; Pipeline (software); Computational biology; Gene expression profiling; Predictive modelling; Drug discovery; Precision medicine; Bioinformatics; Medicine; Biology; Gene expression; Gene; Pathology; Genetics","score_opus":0.02572384923362774,"score_gpt":0.3389749630961608,"score_spread":0.31325111386253307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280498349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686635,0.00081330794,0.00046502156,0.00046976446,0.0001819119,0.0008968399,0.000202614,0.00000857258,0.00009559491],"genre_scores_gemma":[0.995064,0.00010923462,0.000228985,0.0001053921,0.000097600256,0.0031437534,0.000169202,0.000030758565,0.0010510805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982318,0.00031597525,0.00014308866,0.0005176697,0.00041128905,0.0003801364],"domain_scores_gemma":[0.9992779,0.000027631208,0.000060019695,0.00032081673,0.0002313942,0.000082261104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006745781,0.00011357223,0.00011715567,0.00015423795,0.00027888073,0.000028460252,0.00019293075,0.000047335387,0.00010690426],"category_scores_gemma":[0.000043623295,0.00009841129,0.000039783623,0.00031821805,0.00008642977,0.000009448622,0.0002690735,0.00019314505,7.221294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023216433,0.00013339758,0.056668952,0.00003897926,0.000025641084,9.3067297e-7,0.00014685295,0.00080800446,0.9166703,0.0000040073874,0.017601531,0.0055797216],"study_design_scores_gemma":[0.0022659618,0.00033968466,0.028520912,0.00006664981,0.00000608464,5.170674e-7,0.00042465384,0.0002749471,0.9097505,0.000028306882,0.05808646,0.00023528191],"about_ca_topic_score_codex":0.0003968863,"about_ca_topic_score_gemma":0.00034747226,"teacher_disagreement_score":0.040484928,"about_ca_system_score_codex":0.00024214905,"about_ca_system_score_gemma":0.00045331035,"threshold_uncertainty_score":0.4013096},"labels":[],"label_agreement":null},{"id":"W4280576252","doi":"10.1158/1538-7445.evodyn22-b041","title":"Abstract B041: Mimicking tumor acidic and hypoxic microenvironment in vitro towards generation of more predictive screening platform for solid tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; National Research Council Canada","funders":"","keywords":"Transcriptome; Epigenome; Tumor microenvironment; Cancer research; Hypoxia (environmental); Biology; Tirapazamine; In vivo; A549 cell; Cancer cell; Cell culture; In vitro; Cancer; Gene expression; Chemistry; Gene; Biochemistry; Genetics; DNA methylation; Cytotoxicity","score_opus":0.0876341050865813,"score_gpt":0.36102340801538874,"score_spread":0.2733893029288074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280576252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962391,0.0012451077,0.0011508327,0.00024556898,0.00008794705,0.0007389241,0.00016712116,0.000031585016,0.00009377371],"genre_scores_gemma":[0.9977175,0.00021448077,0.0010284681,0.000015517264,0.00013406035,0.00078593654,0.000032489534,0.000046986195,0.000024536052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768734,0.000054296153,0.00033535436,0.00031691996,0.0009605711,0.0006455161],"domain_scores_gemma":[0.9993457,0.0002176751,0.000039355673,0.00019973298,0.000058284597,0.00013920513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018715485,0.0001269803,0.00022577346,0.0004345708,0.00019161585,0.000033386197,0.00030610748,0.000046727673,0.00016699806],"category_scores_gemma":[0.0001987486,0.0001374717,0.000043932265,0.00038249983,0.0002964774,0.0001077194,0.00035862773,0.0007706764,0.0000012223771],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018884467,0.00003330882,0.00040430584,0.0003021836,0.000035314457,0.000017228163,0.00071888877,0.024352435,0.9418272,0.0000064233354,0.0003643483,0.03174952],"study_design_scores_gemma":[0.0008345182,0.00012517696,0.015024308,0.00011692498,0.0000046660507,0.0000057012344,0.0011044064,0.17762315,0.80428493,0.000060385988,0.0006538147,0.00016204553],"about_ca_topic_score_codex":0.00030097843,"about_ca_topic_score_gemma":0.000016437862,"teacher_disagreement_score":0.15327072,"about_ca_system_score_codex":0.0007782052,"about_ca_system_score_gemma":0.00015732968,"threshold_uncertainty_score":0.5605933},"labels":[],"label_agreement":null},{"id":"W4282913459","doi":"10.1158/1538-7445.am2022-3625","title":"Abstract 3625: Clonal architecture and evolution of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prostate cancer; Somatic evolution in cancer; Biology; Deep sequencing; Metastasis; Cancer; DNA sequencing; Genome; Cancer research; Genetics; DNA; Gene","score_opus":0.023939588098384812,"score_gpt":0.31747376868677163,"score_spread":0.2935341805883868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728503,0.024572324,0.00008452643,0.00037842977,0.00011439003,0.00043099426,0.0013824843,0.0000056946237,0.00018083442],"genre_scores_gemma":[0.99560815,0.0028433695,0.000074433534,0.000046091583,0.0002692246,0.00052829337,0.00017741942,0.00003261799,0.00042039438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985221,0.00008741639,0.00021215375,0.00044025815,0.0003069941,0.0004310913],"domain_scores_gemma":[0.99928886,0.000041698426,0.0000855054,0.0002885917,0.00016678436,0.00012857674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032887355,0.00014932484,0.00017257294,0.00012435793,0.00032122713,0.00002729452,0.00018943103,0.00006370973,0.00013893735],"category_scores_gemma":[0.000032804837,0.00014499029,0.00006718171,0.00021106798,0.00019896496,0.0000038056817,0.00026654976,0.00024145005,0.0000013013647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059086457,0.00004147826,0.0022369882,0.00006577094,0.00008292877,0.0000101666765,0.00037813585,0.010291194,0.9784604,0.000040982497,0.0001643151,0.00763682],"study_design_scores_gemma":[0.0062478227,0.0061060553,0.073908746,0.00013699688,0.00014234388,0.00007007215,0.0030118718,0.00074139365,0.48111996,0.0029486376,0.4242216,0.0013444833],"about_ca_topic_score_codex":0.005203023,"about_ca_topic_score_gemma":0.0027150775,"teacher_disagreement_score":0.49734038,"about_ca_system_score_codex":0.0012096908,"about_ca_system_score_gemma":0.0012554884,"threshold_uncertainty_score":0.7865449},"labels":[],"label_agreement":null},{"id":"W4282913510","doi":"10.1158/1538-7445.am2022-3755","title":"Abstract 3755: DNA methylation patterns, but not genetic sequence alterations, are concordant across multiply sampled sites within individuals with unilateral and bilateral Wilms tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Wilms' tumor; DNA methylation; Biology; Methylation; Malignancy; Pathology; Epigenomics; Cancer research; Genetics; DNA; Medicine; Gene","score_opus":0.055043650003347794,"score_gpt":0.3618875400657644,"score_spread":0.30684389006241664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972806,0.0009080752,0.000038797465,0.0004206521,0.00009743157,0.0004720922,0.0007516917,0.000015909902,0.000014774566],"genre_scores_gemma":[0.9977221,0.00043195082,0.00018549126,0.00027942742,0.00015186903,0.0003678267,0.00036210008,0.00003716523,0.0004620579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997795,0.00024440448,0.00030233277,0.00059351407,0.00055188715,0.0005128479],"domain_scores_gemma":[0.99917144,0.000041447045,0.00015346229,0.00028697614,0.00018854007,0.00015813025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005762129,0.00020123215,0.00019939919,0.00009084798,0.00064890867,0.00014518549,0.00026432922,0.00009256836,0.00009325753],"category_scores_gemma":[0.00003356569,0.00016135894,0.000044533863,0.00023088323,0.00026181398,0.000018587127,0.00022440558,0.0005201457,0.0000025210686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034497204,0.00002766596,0.11172434,0.000069225935,0.00010930054,0.00006100916,0.0007421753,0.0077755433,0.877729,0.0000068970326,0.00014017406,0.0012697019],"study_design_scores_gemma":[0.00207213,0.0008425443,0.22914557,0.00015991318,0.000023122222,0.00012531008,0.0018640744,0.0006207998,0.7627423,0.000061940955,0.0018004222,0.000541915],"about_ca_topic_score_codex":0.0012010736,"about_ca_topic_score_gemma":0.00058394595,"teacher_disagreement_score":0.117421225,"about_ca_system_score_codex":0.00013396636,"about_ca_system_score_gemma":0.00031216696,"threshold_uncertainty_score":0.6580026},"labels":[],"label_agreement":null},{"id":"W4282913612","doi":"10.1158/1538-7445.am2022-5479","title":"Abstract 5479: Discovery and evaluation of GT19630, a c-Myc/GSPT1 cereblon E3 ligase modulator (CELMoD), for targeting Myc-driven blood cancers and small cell lung cancers (SCLC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Western blot; Biology; Cell growth; Cancer; Cell; Ubiquitin ligase; HL60; Molecular biology; Chemistry; Ubiquitin; Biochemistry; Gene; Genetics","score_opus":0.044180123399350416,"score_gpt":0.349968534002214,"score_spread":0.3057884106028636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865997,0.01113637,0.000040694737,0.00019655593,0.00015881627,0.0012229386,0.00035993734,0.000007368242,0.0002776358],"genre_scores_gemma":[0.9965729,0.0012792072,0.00017546737,0.000057665777,0.0002578999,0.0010482104,0.00017082182,0.000038249316,0.00039957304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795115,0.00020331246,0.00028159158,0.0005615756,0.0005937291,0.00040864744],"domain_scores_gemma":[0.99901927,0.000049154252,0.00015155747,0.000268619,0.00037127995,0.00014009816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014491825,0.00016153205,0.00018967767,0.0001269613,0.00036814,0.000058072594,0.00020026059,0.00009400016,0.00006642391],"category_scores_gemma":[0.00016151751,0.00016733838,0.000068658555,0.00018697853,0.00015999358,0.000021687669,0.00027381632,0.00025759512,2.3632568e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003063568,0.000048136382,0.0022345874,0.00027771943,0.00007980585,0.0000012878887,0.00025956504,0.0049157427,0.9856702,0.000031075833,0.0033194013,0.0028561247],"study_design_scores_gemma":[0.002532178,0.00044858313,0.0015205184,0.000065794215,0.00007989565,0.0000027024578,0.0008095435,0.006135398,0.98237616,0.000086872,0.0056711645,0.000271219],"about_ca_topic_score_codex":0.0022707405,"about_ca_topic_score_gemma":0.00041234688,"teacher_disagreement_score":0.009973222,"about_ca_system_score_codex":0.00037943685,"about_ca_system_score_gemma":0.0013922899,"threshold_uncertainty_score":0.6823861},"labels":[],"label_agreement":null},{"id":"W4282913754","doi":"10.1158/1538-7445.am2022-2058","title":"Abstract 2058: Effect of route of Bacillus-Calmette Guerin administration on systemic immune responses in a murine model of non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Ex vivo; Immune system; Systemic administration; Lymph; Bone marrow; Cancer; Spleen; Cystectomy; Lipopolysaccharide; Immunology; In vivo; Pathology; Cancer research; Internal medicine; Biology","score_opus":0.06863559493204169,"score_gpt":0.4017403420890373,"score_spread":0.3331047471569956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416524,0.0021834543,0.0000044217772,0.00029831182,0.00010298909,0.0015169036,0.0008089476,0.000009027571,0.00091068144],"genre_scores_gemma":[0.9968212,0.000738459,0.00001938381,0.000027790787,0.000054945293,0.0013817183,0.000031556112,0.000039692066,0.0008852559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713075,0.0003551123,0.00063600537,0.0003780762,0.001119902,0.0003801444],"domain_scores_gemma":[0.99838656,0.0004847058,0.00022309467,0.0005136845,0.00029174276,0.000100186575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001261647,0.00019389454,0.00069286715,0.0005103212,0.000074381045,0.000005440478,0.0002376221,0.00007976826,0.00075234607],"category_scores_gemma":[0.00018095913,0.00016704093,0.00014784755,0.00069599587,0.00018369449,0.00006757238,0.00013671984,0.0005381696,0.0000033195133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01864332,0.0005236981,0.013925576,0.0021582954,0.00029946154,0.0000757733,0.0010937934,0.006687463,0.9486724,0.000019016052,0.00035060127,0.0075505753],"study_design_scores_gemma":[0.007125882,0.0062206853,0.088234834,0.0015975815,0.0001099838,0.000010883835,0.0004337602,0.0007667842,0.89523834,0.000026890224,0.00006783945,0.00016652382],"about_ca_topic_score_codex":0.0077207694,"about_ca_topic_score_gemma":0.0007089146,"teacher_disagreement_score":0.07430926,"about_ca_system_score_codex":0.0007922164,"about_ca_system_score_gemma":0.0021031166,"threshold_uncertainty_score":0.9988869},"labels":[],"label_agreement":null},{"id":"W4282915077","doi":"10.1158/1538-7445.am2022-44","title":"Abstract 44: Evolution of large copy number variants in breast cancer through genetic network rewiring","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Concordia University; McGill University","funders":"","keywords":"Biology; Gene; Genetics; Gene dosage; Cancer; Comparative genomic hybridization; Copy-number variation; Breast cancer; Computational biology; Triple-negative breast cancer; Cancer research; Chromosome; Gene expression; Genome","score_opus":0.027871391856275993,"score_gpt":0.3654098225261914,"score_spread":0.3375384306699154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282915077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899806,0.007988337,0.00012186069,0.0004350771,0.00040955178,0.00029364513,0.0006459986,0.0000047419803,0.0011027178],"genre_scores_gemma":[0.9948686,0.003557073,0.00012024076,0.0001343212,0.00064010086,0.00037821115,0.000039812727,0.00003468205,0.00022697581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819523,0.0001218841,0.00027183667,0.0004101345,0.00038190107,0.0006190425],"domain_scores_gemma":[0.9992773,0.000042875337,0.0000818584,0.00036708388,0.00016003163,0.00007086489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062617764,0.00011741432,0.00017122277,0.00005145995,0.00021508281,0.000018644316,0.00032704906,0.000085038955,0.0012247763],"category_scores_gemma":[0.00003137343,0.00013484368,0.00006017331,0.00045174046,0.000087544926,0.0000056012846,0.00049750856,0.00035571828,0.000006521322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009894763,0.00034676035,0.57602274,0.00016174548,0.0001255049,0.0000414345,0.00033253877,0.06337425,0.28310114,0.0012900373,0.07152941,0.0026849485],"study_design_scores_gemma":[0.0031595617,0.00023818434,0.8364272,0.0001955482,0.000027220234,0.00004019573,0.0006375607,0.0004232859,0.024056075,0.0023294762,0.13185038,0.0006153089],"about_ca_topic_score_codex":0.0065472377,"about_ca_topic_score_gemma":0.001940577,"teacher_disagreement_score":0.26040444,"about_ca_system_score_codex":0.00048686084,"about_ca_system_score_gemma":0.0008397814,"threshold_uncertainty_score":0.99968827},"labels":[],"label_agreement":null},{"id":"W4282915239","doi":"10.1158/1538-7445.am2022-1437","title":"Abstract 1437: Ambient air pollution and risk of prostate cancer: The multiethnic cohort study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Cohort; Cancer registry; Demography; Population; Cohort study; Cancer; Environmental health; Epidemiology; Gerontology; Internal medicine","score_opus":0.0970464614742414,"score_gpt":0.4334819685201344,"score_spread":0.336435507045893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282915239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921272,0.00070033566,0.0000012458181,0.0050308527,0.000095443065,0.0016396636,0.00013092096,0.000011138449,0.00026322392],"genre_scores_gemma":[0.9957481,0.002419698,0.000007817868,0.00031390562,0.00003080524,0.0008604654,0.0000017807546,0.000009995626,0.0006074187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972663,0.0006915645,0.00021900397,0.00029206148,0.0010971491,0.00043394373],"domain_scores_gemma":[0.9993086,0.00013255172,0.00010528056,0.00028974927,0.000023754816,0.00014006604],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004985991,0.000076274264,0.00012923212,0.000042136195,0.0010101803,0.000012375848,0.00026080522,0.000021957154,0.0018325233],"category_scores_gemma":[0.00008154443,0.00005591121,0.000022851043,0.0004498359,0.00042322258,0.00009048458,0.0005014291,0.00065633695,0.000016759015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017589612,0.00019755622,0.9534093,0.000031220465,0.00002718134,0.0000023621983,0.008751892,0.009967743,0.0006168661,0.000005820692,0.009192951,0.017621199],"study_design_scores_gemma":[0.00037864182,0.00029780893,0.9835631,0.00000844951,0.000010648648,5.5541074e-7,0.0036222613,0.00023342803,0.00030054667,0.00009490288,0.01142672,0.00006293347],"about_ca_topic_score_codex":0.12635063,"about_ca_topic_score_gemma":0.012454418,"teacher_disagreement_score":0.113896206,"about_ca_system_score_codex":0.0008434908,"about_ca_system_score_gemma":0.00015188572,"threshold_uncertainty_score":0.99907994},"labels":[],"label_agreement":null},{"id":"W4282915372","doi":"10.1158/1538-7445.am2022-1079","title":"Abstract 1079: Anti-cancer efficacy of TH1902, a SORT1 docetaxel peptide-drug conjugate, against ovarian and endometrial cancers xenografts alone or in combination with carboplatin","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Ovarian cancer; Cancer research; Pharmacology; Carboplatin; Cancer; Peptide; Medicine; Apoptosis; Drug; Internal medicine; Chemotherapy; Cisplatin; Chemistry; Biochemistry","score_opus":0.06753017365991106,"score_gpt":0.38683840589362406,"score_spread":0.319308232233713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282915372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857284,0.004957156,0.0000013665278,0.0019528,0.00019345223,0.0027087291,0.00026801412,0.000036213194,0.0013094532],"genre_scores_gemma":[0.98988456,0.005720975,0.000051337673,0.00008244567,0.00020603498,0.0015732977,0.00012665064,0.000066876266,0.0022878184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561137,0.00033603975,0.00056131853,0.0006989784,0.0018787684,0.0009135142],"domain_scores_gemma":[0.99800056,0.0006167644,0.0001900883,0.0004116918,0.00046609054,0.00031480298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018468064,0.00027808908,0.0007487466,0.0012348011,0.00038434484,0.00004816282,0.00027187323,0.00008260938,0.001022093],"category_scores_gemma":[0.00022266195,0.0002080779,0.000083022125,0.0026788574,0.0006326712,0.00018171461,0.00025852915,0.0012388931,0.0000031332545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11128443,0.00421904,0.4846905,0.003404942,0.002306818,0.0027658204,0.0114506725,0.0055125356,0.3090538,0.0002262252,0.010379017,0.054706205],"study_design_scores_gemma":[0.17861716,0.006479692,0.62534666,0.002565519,0.00026802972,0.00006920324,0.007477138,0.0009059548,0.16427316,0.00009252397,0.012642953,0.001261993],"about_ca_topic_score_codex":0.014988858,"about_ca_topic_score_gemma":0.003093553,"teacher_disagreement_score":0.14478067,"about_ca_system_score_codex":0.0018335006,"about_ca_system_score_gemma":0.0036265776,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W4282915892","doi":"10.1158/1538-7445.am2022-ct250","title":"Abstract CT250: A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Melanoma; Immunotherapy; Cancer; Refractory (planetary science); Cytotoxic T cell; Cancer immunotherapy; Dosing; Oncology; Internal medicine; Immune system; Cancer research; Immunology; Biology; In vitro","score_opus":0.08198810902565855,"score_gpt":0.4348763330431794,"score_spread":0.35288822401752085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282915892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962431,0.0009772669,8.104608e-8,0.00030448477,0.00012482045,0.0019453712,0.00007977316,0.00001354678,0.0003115305],"genre_scores_gemma":[0.99705946,0.0001967415,0.0000031652671,0.00007758289,0.000055694807,0.0014695198,0.000022063752,0.00004131954,0.0010744247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717754,0.00018626699,0.00044295003,0.00043086795,0.0012684086,0.00049394945],"domain_scores_gemma":[0.9989856,0.0001222355,0.000120575,0.0004724129,0.00019940714,0.00009975208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010173162,0.00015218323,0.0003830729,0.00060320296,0.00020136249,0.000012412208,0.0002616428,0.00005167588,0.0070950813],"category_scores_gemma":[0.000038423954,0.000115748575,0.000043887616,0.0013178388,0.00015254336,0.00009125391,0.00010955586,0.00091773004,0.000001785033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11232865,0.014880062,0.82266206,0.0003926892,0.00029763862,0.00032709748,0.00872362,0.00014280347,0.010686701,0.0000020878813,0.0058699627,0.02368662],"study_design_scores_gemma":[0.059421673,0.012824817,0.9081195,0.00045497433,0.000023817433,0.000001206654,0.004175626,0.000009231234,0.00081367587,0.000003919166,0.0139484005,0.0002031388],"about_ca_topic_score_codex":0.028433114,"about_ca_topic_score_gemma":0.02904028,"teacher_disagreement_score":0.08545745,"about_ca_system_score_codex":0.0017685625,"about_ca_system_score_gemma":0.00089520775,"threshold_uncertainty_score":0.99381256},"labels":[],"label_agreement":null},{"id":"W4282916163","doi":"10.1158/1538-7445.am2022-3621","title":"Abstract 3621: 3D spatial sampling and integrated omics reveal sources and patterning of intratumoral heterogeneity in glioblastoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Chromatin; Biology; CTCF; Computational biology; Epigenomics; Exome sequencing; Context (archaeology); Deep sequencing; Exome; Brain tumor; Transcription factor; Cancer research; Genetics; Pathology; Phenotype; Enhancer; Genome; Medicine; DNA methylation; Gene; Gene expression","score_opus":0.040102402079705425,"score_gpt":0.37119748905158245,"score_spread":0.331095086971877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282916163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799037,0.0010031257,0.00056461204,0.00011714644,0.0000143932975,0.00019308752,0.000090219626,0.00000520009,0.000021852891],"genre_scores_gemma":[0.99898636,0.0003142475,0.00036474154,0.000045257166,0.000038107537,0.00017494457,0.00005006755,0.000011604152,0.000014661796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915123,0.000109322595,0.00015359887,0.00028170666,0.00010535013,0.0001988188],"domain_scores_gemma":[0.9996844,0.000017159751,0.00004690592,0.00015158996,0.00005427671,0.000045668803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047261812,0.00007490547,0.00010820634,0.000080501195,0.00012824414,0.000014102767,0.00013231981,0.00006591132,0.000018832276],"category_scores_gemma":[0.000028173974,0.000075768694,0.000018948025,0.000119579825,0.00017494943,0.0000019165464,0.0003443785,0.0003055417,1.1229541e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000135163,0.00002599272,0.046001066,0.000023833005,0.000011269201,0.000002901887,0.000051334944,0.000062020285,0.94280314,0.00002007135,0.000059678638,0.010803526],"study_design_scores_gemma":[0.0004940831,0.0005831861,0.05579967,0.000033258675,0.000004962228,0.000025083255,0.00028066238,0.00022407934,0.93588203,0.00013327603,0.006357082,0.00018259701],"about_ca_topic_score_codex":0.0012253018,"about_ca_topic_score_gemma":0.00071455457,"teacher_disagreement_score":0.010620929,"about_ca_system_score_codex":0.000027989994,"about_ca_system_score_gemma":0.00007816064,"threshold_uncertainty_score":0.30897576},"labels":[],"label_agreement":null},{"id":"W4282916472","doi":"10.1158/1538-7445.am2022-5176","title":"Abstract 5176: Tumor dynamic model-based decision support for phase Ib immunotherapy combination studies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Bevacizumab; Internal medicine; Carboplatin; Oncology; Clinical endpoint; Proportional hazards model; Cancer; Confidence interval; Urology; Nuclear medicine; Chemotherapy; Clinical trial","score_opus":0.06388238886099472,"score_gpt":0.4513000233609258,"score_spread":0.38741763449993105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282916472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363346,0.006486862,0.007400651,0.0005211741,0.00035707053,0.0007863627,0.00070499134,0.000009958161,0.00009947255],"genre_scores_gemma":[0.9946843,0.0016982225,0.0005998812,0.00044180494,0.00009252699,0.001610611,0.000379962,0.000043495664,0.00044923925],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998632,0.000043342432,0.00021447956,0.0003866443,0.00036066634,0.0003628819],"domain_scores_gemma":[0.9989519,0.00015390721,0.00006559833,0.000355714,0.00040550102,0.00006738017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086841953,0.00011952013,0.00015204669,0.00012006849,0.00046786744,0.000036849742,0.00030841152,0.00004085513,0.00012534898],"category_scores_gemma":[0.00016476265,0.0001260748,0.00009855703,0.00014854608,0.00010990786,0.0000037482291,0.00017067653,0.0001835347,0.0000028967888],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002974692,0.0005613089,0.00007787989,0.000077880715,0.00010984273,0.000008871105,0.00013948945,0.03840818,0.86996543,0.00020963029,0.03170956,0.05575721],"study_design_scores_gemma":[0.028341804,0.00861922,0.0006383047,0.00008302244,0.00005072672,0.000010454589,0.0013677089,0.13171777,0.40079764,0.010373828,0.41686925,0.001130288],"about_ca_topic_score_codex":0.0000393028,"about_ca_topic_score_gemma":0.00008596127,"teacher_disagreement_score":0.46916783,"about_ca_system_score_codex":0.00036712186,"about_ca_system_score_gemma":0.0008295385,"threshold_uncertainty_score":0.5141181},"labels":[],"label_agreement":null},{"id":"W4282916799","doi":"10.1158/1538-7445.am2022-2947","title":"Abstract 2947: Surveying the tumor suppressive genetic network underlying chr4p deletion in TNBC","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Concordia University","funders":"","keywords":"Triple-negative breast cancer; Biology; Breast cancer; Cancer research; Gene; CRISPR; Mutant; Cancer; PTEN; Genetics; Computational biology; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.07260991254797172,"score_gpt":0.3668695431478316,"score_spread":0.2942596305998599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282916799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991609,0.0059609516,0.0002876823,0.0005239156,0.00028718796,0.00043667163,0.000026552745,0.0000060433495,0.00086203415],"genre_scores_gemma":[0.99816257,0.00045603942,0.000080540995,0.00029813856,0.00035040587,0.00036658533,0.0000654771,0.000024113098,0.00019614495],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982338,0.00029253447,0.00024995464,0.00027487957,0.0003441902,0.0006046462],"domain_scores_gemma":[0.9993448,0.00006250515,0.00007410077,0.00037138193,0.00008205004,0.00006515074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017781229,0.00010989587,0.0001113869,0.000057305926,0.0005984151,0.00006769978,0.0004762918,0.000057535526,0.00022201348],"category_scores_gemma":[0.000031380638,0.00009388372,0.000054121552,0.00032880376,0.000114242095,0.0000042698052,0.00050752994,0.0006358253,0.000007479443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083130307,0.00017496053,0.021466391,0.0001864099,0.00017167453,0.00013721065,0.0018456742,0.5725809,0.20168856,0.0005299324,0.09865861,0.101728424],"study_design_scores_gemma":[0.004638827,0.0011662357,0.3650977,0.00027420293,0.00003687972,0.00020030954,0.0067934375,0.025382454,0.0110143935,0.007086866,0.57646483,0.0018438656],"about_ca_topic_score_codex":0.00050467224,"about_ca_topic_score_gemma":0.0006891365,"teacher_disagreement_score":0.5471984,"about_ca_system_score_codex":0.00013117047,"about_ca_system_score_gemma":0.00028379814,"threshold_uncertainty_score":0.46025854},"labels":[],"label_agreement":null},{"id":"W4282916804","doi":"10.1158/1538-7445.am2022-463","title":"Abstract 463: Highly accurate machine learning assessment of immune-related pathologic response criteria (irPRC) scoring in patients with non-small cell lung carcinoma (NSCLC) treated with neoadjuvant anti-PD-1-based therapies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Neoadjuvant therapy; Oncology; Digital pathology; Internal medicine; Radiology; Pathology; Cancer","score_opus":0.02415591630071456,"score_gpt":0.3482531996067472,"score_spread":0.32409728330603266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282916804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963426,0.001092102,0.000080931386,0.0008322744,0.00008244903,0.0011965482,0.000035664663,0.000059060236,0.00027839217],"genre_scores_gemma":[0.9985929,0.00007539206,0.00049911457,0.000073547344,0.000024333138,0.00027969305,0.00014193919,0.000097744756,0.00021534887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956564,0.0011039586,0.00063605024,0.0006597454,0.0011517826,0.00079207623],"domain_scores_gemma":[0.9981627,0.00045540702,0.0003163439,0.0005112878,0.00035659125,0.0001977038],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036380722,0.00031560936,0.000683824,0.0007895097,0.00043966144,0.00006396818,0.00036442734,0.00008374397,0.00040457485],"category_scores_gemma":[0.00016958668,0.00023100387,0.0000928779,0.0011328211,0.00029320226,0.00010158173,0.00019086267,0.0027078066,0.0000015207639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00678719,0.00052254286,0.8678591,0.00030751503,0.00008222001,0.0009174556,0.0009839113,0.01343039,0.107292056,0.0000023490577,0.000024904684,0.0017903463],"study_design_scores_gemma":[0.011306632,0.002764532,0.94596064,0.0007107806,0.000054209766,0.000011321474,0.00058319775,0.034564238,0.0036963604,0.0000021015444,0.00008696722,0.00025902322],"about_ca_topic_score_codex":0.0025744827,"about_ca_topic_score_gemma":0.000020491432,"teacher_disagreement_score":0.1035957,"about_ca_system_score_codex":0.00069351366,"about_ca_system_score_gemma":0.0010097366,"threshold_uncertainty_score":0.99959296},"labels":[],"label_agreement":null},{"id":"W4282917118","doi":"10.1158/1538-7445.am2022-124","title":"Abstract 124: PRDX4 links ER-specific redox vulnerability to innate immunity in pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Innate immune system; Downregulation and upregulation; Biology; Gene knockdown; Cancer research; Cell biology; Programmed cell death; TANK-binding kinase 1; Immunology; Immune system; Apoptosis; Kinase; Protein kinase A; Gene; Genetics","score_opus":0.08050445000509944,"score_gpt":0.39518053068792613,"score_spread":0.3146760806828267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282917118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97511077,0.018425837,0.0000026495516,0.0022942114,0.0009968271,0.0008372803,0.00020652775,0.00005314376,0.00207278],"genre_scores_gemma":[0.98633593,0.0012607864,0.0000069095336,0.00027787976,0.00005726117,0.002034276,0.0000496905,0.00003728312,0.009939987],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954302,0.0022193755,0.00050107844,0.0005826205,0.00021345104,0.0010532922],"domain_scores_gemma":[0.9982267,0.00060389173,0.00006949475,0.00080145645,0.00023365537,0.00006480094],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032200809,0.00021883966,0.00041996862,0.00058291457,0.00084117625,0.00004383932,0.00089736347,0.0002496092,0.025982657],"category_scores_gemma":[0.00030798983,0.00021146836,0.00008524787,0.0010258245,0.00038017964,0.00009857578,0.0008178612,0.0043377155,0.0005187871],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004265582,0.0003456945,0.00559135,0.000061404055,0.000097907716,0.000027654361,0.0027880326,0.00020304036,0.93687135,0.00019355178,0.028982501,0.020571942],"study_design_scores_gemma":[0.0016803454,0.000692981,0.19608217,0.00015365166,0.000007788756,0.000017710727,0.0022260407,0.0000030775882,0.23708305,0.00019583998,0.5614585,0.0003987998],"about_ca_topic_score_codex":0.012698134,"about_ca_topic_score_gemma":0.0013998497,"teacher_disagreement_score":0.6997883,"about_ca_system_score_codex":0.0015011468,"about_ca_system_score_gemma":0.00070246926,"threshold_uncertainty_score":0.9979593},"labels":[],"label_agreement":null},{"id":"W4282917431","doi":"10.1158/1538-7445.am2022-5271","title":"Abstract 5271: Correlative analysis of RNA biomarkers for adjuvant capecitabine benefit in the CIBOMA/2004-01phase III clinical trial of triple negative breast cancer patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Oncology; Breast cancer; Internal medicine; Triple-negative breast cancer; Biomarker; Clinical endpoint; Cancer; Clinical trial; Biology; Colorectal cancer","score_opus":0.0631960871830504,"score_gpt":0.41735933572427447,"score_spread":0.35416324854122405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282917431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891564,0.0012876985,0.000026273376,0.00025655402,0.00044363536,0.0014171994,0.0071923607,0.0000014188971,0.0002184533],"genre_scores_gemma":[0.99692273,0.001200409,0.000020453028,0.0000786084,0.00019265425,0.0010399184,0.00040740345,0.000019166153,0.00011863197],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977349,0.00023187135,0.00070887565,0.00044435792,0.0005238893,0.00035611258],"domain_scores_gemma":[0.99798983,0.0005851738,0.00033225908,0.0004063798,0.0006028113,0.00008351735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017580802,0.00013982633,0.00044995308,0.0002889443,0.00015236644,0.000013277212,0.00047568986,0.000096692915,0.00027085692],"category_scores_gemma":[0.00043573146,0.00011660957,0.0003404588,0.0010849222,0.0002830633,0.0000053270664,0.00021282856,0.00028992599,3.1723204e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4824088,0.011252293,0.15584983,0.00030721776,0.012238029,0.000018111641,0.0048308945,0.030120049,0.08481043,0.0005029817,0.07403096,0.14363042],"study_design_scores_gemma":[0.24063076,0.012807355,0.67331016,0.00015397815,0.0018678219,0.0000019014749,0.0071197147,0.003695523,0.03818874,0.00069784693,0.020367129,0.0011590588],"about_ca_topic_score_codex":0.0058499686,"about_ca_topic_score_gemma":0.0043434277,"teacher_disagreement_score":0.51746035,"about_ca_system_score_codex":0.00019633824,"about_ca_system_score_gemma":0.0006903575,"threshold_uncertainty_score":0.88434416},"labels":[],"label_agreement":null},{"id":"W4282917982","doi":"10.1158/1538-7445.am2022-1694","title":"Abstract 1694: Cytotoxic conditions alter cell free DNA concentration and fragment size in cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cytotoxic T cell; Apoptosis; Colorectal cancer; Cancer; Cancer research; Cell cycle; Programmed cell death; Biomarker; Lung cancer; Cancer cell; Medicine; Biology; Molecular biology; Immunology; Pathology; In vitro; Internal medicine; Biochemistry","score_opus":0.026273180518182216,"score_gpt":0.3418850516547897,"score_spread":0.3156118711366075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282917982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239695,0.004119266,0.0000065914287,0.0009256558,0.0002549462,0.00044413903,0.0009092485,0.0000041692756,0.0009390508],"genre_scores_gemma":[0.9917811,0.005947409,0.000026675785,0.0004524724,0.00025021815,0.0008983819,0.00007106804,0.000022537693,0.0005501089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867976,0.0000815144,0.00017998184,0.00038237363,0.0002928904,0.00038350606],"domain_scores_gemma":[0.99935246,0.000092890645,0.000045891014,0.00030757475,0.00008761354,0.00011360039],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033823497,0.00010644217,0.00011395269,0.00003996117,0.00023624807,0.000047188594,0.00023215575,0.00006249484,0.0011758839],"category_scores_gemma":[0.000045484103,0.00012055446,0.00003468536,0.00014969791,0.00012221995,0.000004822106,0.0003446445,0.00029465285,0.0000044546405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008251053,0.00009218483,0.0015617404,0.000033061995,0.0000133882995,0.0000105798,0.0001386927,0.0020032509,0.97009486,0.0000530363,0.02555094,0.00036576416],"study_design_scores_gemma":[0.0015366896,0.00023512251,0.009891191,0.00001870678,0.000007422894,0.0000016774943,0.00033132956,0.00006936066,0.93625075,0.00039234752,0.05105086,0.00021454104],"about_ca_topic_score_codex":0.0014469812,"about_ca_topic_score_gemma":0.001322756,"teacher_disagreement_score":0.0338441,"about_ca_system_score_codex":0.00027806812,"about_ca_system_score_gemma":0.0005096467,"threshold_uncertainty_score":0.9997372},"labels":[],"label_agreement":null},{"id":"W4282918027","doi":"10.1158/1538-7445.am2022-6402","title":"Abstract 6402: Associations of sodium glucose cotransporter-2 (SGLT2), metabolic disorders, and survival following incident epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Debulking; Internal medicine; Ovarian cancer; Oncology; Cancer; Proportional hazards model; Epithelial ovarian cancer","score_opus":0.043876754645389704,"score_gpt":0.36616549647099467,"score_spread":0.32228874182560496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282918027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489803,0.0114313,0.00013284206,0.0007318256,0.00070386386,0.00041385103,0.0014010944,0.00001054751,0.00027664946],"genre_scores_gemma":[0.9941543,0.004406491,0.000119194454,0.000076407654,0.0002785752,0.0005484708,0.00013759708,0.000043357104,0.00023564104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974994,0.00025685484,0.00032714952,0.00048709303,0.00091966684,0.00050984195],"domain_scores_gemma":[0.9991081,0.00005229875,0.00014113152,0.00038296916,0.00016730446,0.00014822058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001656083,0.00016358924,0.00030930206,0.0001434317,0.00041520855,0.00003250262,0.00041569353,0.000087187545,0.0006760648],"category_scores_gemma":[0.00009538593,0.00017688444,0.0001641174,0.00033768162,0.00010919888,0.000011925806,0.0003161031,0.00038534138,0.0000014826629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019525773,0.00010762407,0.011853473,0.00004077986,0.0003738734,0.0000058763517,0.00026076523,0.00013323424,0.9729132,0.00041686159,0.00066673016,0.013032294],"study_design_scores_gemma":[0.0025575745,0.00029280217,0.12221854,0.000027131893,0.00014461644,0.0000013351415,0.00073629565,0.000016094396,0.7627372,0.00087652757,0.10994791,0.00044395478],"about_ca_topic_score_codex":0.005961515,"about_ca_topic_score_gemma":0.005636769,"teacher_disagreement_score":0.21017602,"about_ca_system_score_codex":0.000119567194,"about_ca_system_score_gemma":0.0006988672,"threshold_uncertainty_score":0.90120673},"labels":[],"label_agreement":null},{"id":"W4282918103","doi":"10.1158/1538-7445.am2022-3832","title":"Abstract 3832: A tissue injury-like state in mouse with BMP signaling impaired Foxl1+ telocytes leads to abnormal ECM biodynamics and neoplasia initiation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Extracellular matrix; Biology; Stroma; Pathology; Tumor microenvironment; Cell biology; Cancer research; Immune system; Immunology; Medicine; Immunohistochemistry","score_opus":0.04614727355240336,"score_gpt":0.3793093290711303,"score_spread":0.3331620555187269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282918103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970134,0.00044245753,0.0000106656535,0.00067312084,0.00006199931,0.001252182,0.00018570328,0.00004895762,0.00031150272],"genre_scores_gemma":[0.997678,0.0001311762,0.00014430615,0.00016229719,0.000055531793,0.0010811044,0.000052239124,0.00004664264,0.00064871757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756724,0.00014980063,0.000274801,0.00047485915,0.0009061777,0.0006271543],"domain_scores_gemma":[0.99901146,0.000207342,0.000052909334,0.00024339359,0.00018475634,0.0003001176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007075931,0.00018232378,0.00031304135,0.00052242907,0.00022546068,0.00005782559,0.00013686536,0.000051079198,0.0005110048],"category_scores_gemma":[0.000067930436,0.00016244942,0.000026839029,0.0011454099,0.0001132458,0.00014632606,0.0002419528,0.0006864927,0.000015807731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03599993,0.0009177959,0.56673855,0.0005953517,0.00023966841,0.002572043,0.008480507,0.0058290903,0.26806918,0.00003980665,0.00072329224,0.10979481],"study_design_scores_gemma":[0.01890212,0.0250806,0.60559225,0.0008407733,0.00010540486,0.00028521908,0.0031559241,0.0017735232,0.33404258,0.0003625377,0.008415226,0.0014438124],"about_ca_topic_score_codex":0.0030138525,"about_ca_topic_score_gemma":0.0026446255,"teacher_disagreement_score":0.108351,"about_ca_system_score_codex":0.0016762838,"about_ca_system_score_gemma":0.0006825264,"threshold_uncertainty_score":0.6624495},"labels":[],"label_agreement":null},{"id":"W4282918625","doi":"10.1158/1538-7445.am2022-5942","title":"Abstract 5942: Vitamin D, calcium supplement use and the risk of breast cancer in <i>BRCA1</i> and <i>BRCA2</i> mutation carriers: A case-control study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Vitamin D and neurology; BRCA mutation; Odds ratio; Internal medicine; Cancer; Case-control study; Population; Oncology; Gynecology; Endocrinology; Environmental health","score_opus":0.02546259842696344,"score_gpt":0.34178258455138427,"score_spread":0.3163199861244208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282918625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884732,0.0058458024,0.000012040902,0.00053510896,0.00006587993,0.0010729192,0.003984671,0.0000027348713,0.000007677214],"genre_scores_gemma":[0.99726,0.0014527233,0.0000081286225,0.0000969699,0.00011759109,0.0009837996,0.000026384581,0.000018180293,0.000036229754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981384,0.0006069464,0.00023801399,0.00038034207,0.00034424744,0.00029204707],"domain_scores_gemma":[0.999219,0.000119789736,0.00007612941,0.00027490238,0.00019643939,0.0001137207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012830563,0.000115491035,0.00016524915,0.0000919735,0.00030799911,0.000051811865,0.00012658552,0.000039251194,0.00011204502],"category_scores_gemma":[0.00008603285,0.00009714025,0.000041945706,0.00016987068,0.00030299608,0.00000901553,0.00018601787,0.00023668475,1.3311679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008526883,0.00087307894,0.83750814,0.00024198176,0.0005655933,0.00038980093,0.0054044626,0.0024198391,0.13215664,0.00004065042,0.0043004854,0.0075724246],"study_design_scores_gemma":[0.03626829,0.0010622252,0.91106564,0.00005415982,0.0002835798,0.00023352333,0.030048408,0.00044827166,0.017131232,0.00026931582,0.0026304116,0.0005049588],"about_ca_topic_score_codex":0.01210095,"about_ca_topic_score_gemma":0.0071827727,"teacher_disagreement_score":0.1150254,"about_ca_system_score_codex":0.000082729224,"about_ca_system_score_gemma":0.00024093791,"threshold_uncertainty_score":0.99447757},"labels":[],"label_agreement":null},{"id":"W4282919264","doi":"10.1158/1538-7445.am2022-47","title":"Abstract 47: Identifying genetic vulnerabilities of chromosome 4p large copy number variants in triple negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Concordia University; McGill University","funders":"","keywords":"Biology; Triple-negative breast cancer; CRISPR; Gene; Copy-number variation; Genetics; Transcriptome; Cancer; Cancer research; Genome; Breast cancer; Gene expression","score_opus":0.039302414850280964,"score_gpt":0.3749897913780945,"score_spread":0.33568737652781355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282919264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276686,0.0031375377,0.000020287926,0.00023225474,0.00041380775,0.0004331504,0.0023608184,0.0000048243405,0.0006304869],"genre_scores_gemma":[0.9951644,0.0027896455,0.000055301294,0.00010485086,0.00034043947,0.0007992641,0.000059362865,0.00004011415,0.00064661686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978989,0.00019856925,0.0003441714,0.00048812982,0.00047900257,0.00059126975],"domain_scores_gemma":[0.9990341,0.00010348762,0.00009854785,0.00039619626,0.00026158307,0.00010610146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007457456,0.00014859716,0.00023974854,0.00012358846,0.00024833638,0.000039190418,0.000405785,0.00008323417,0.0039937436],"category_scores_gemma":[0.000121883124,0.00016593676,0.00008230731,0.00043062048,0.00017134803,0.000008148856,0.000540529,0.00042904547,0.000008304115],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001339643,0.00068954093,0.17406312,0.00043382763,0.00023301832,0.00007638517,0.0020311996,0.0057489467,0.78578734,0.00043341742,0.02341529,0.0057482407],"study_design_scores_gemma":[0.0075709564,0.0004916516,0.6055294,0.0002462861,0.000041615276,0.00006332314,0.0048865085,0.00029730858,0.35010585,0.0025015117,0.027250329,0.0010152282],"about_ca_topic_score_codex":0.008972361,"about_ca_topic_score_gemma":0.004499766,"teacher_disagreement_score":0.43568152,"about_ca_system_score_codex":0.0003797961,"about_ca_system_score_gemma":0.0010054822,"threshold_uncertainty_score":0.99762696},"labels":[],"label_agreement":null},{"id":"W4282921489","doi":"10.1158/1538-7445.am2022-2524","title":"Abstract 2524: Investigating the role of neutrophils in muscle-invasive bladder cancer and response to radiation therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Bladder cancer; Radioresistance; Neutrophil extracellular traps; Tumor microenvironment; Medicine; Cancer research; Radiation therapy; Immune system; Cancer; Cell culture; In vivo; Pathology; Immunology; Inflammation; Internal medicine; Biology","score_opus":0.04884545235644332,"score_gpt":0.3573919500036882,"score_spread":0.30854649764724484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282921489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414587,0.05368085,1.8926139e-7,0.0036132394,0.00031660573,0.0006448678,0.00006957497,0.000010896859,0.0002050972],"genre_scores_gemma":[0.99457264,0.003208565,0.0000052169603,0.00042267138,0.000049101858,0.0012479062,0.000007751033,0.000025313084,0.00046086244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977452,0.0010310905,0.00027096207,0.0003251873,0.00015965044,0.00046792146],"domain_scores_gemma":[0.9983221,0.0010791667,0.00009305722,0.0003434827,0.0001336539,0.000028529774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021451565,0.00011668345,0.00018894179,0.0002763312,0.0004300343,0.000017280121,0.00041881032,0.000083604806,0.0014555881],"category_scores_gemma":[0.00026353987,0.00009673841,0.000035443245,0.00063414953,0.0004177323,0.00006387885,0.00030504668,0.00094201317,0.000015129023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091467187,0.000032864984,0.0045343894,0.000011200658,0.000052588308,0.0000023228847,0.0077964803,0.0006899321,0.9295865,0.000067846755,0.0014902989,0.054820888],"study_design_scores_gemma":[0.0015360045,0.00030078585,0.2039305,0.00006358126,0.0000054638354,0.0000040902846,0.00506541,0.0000055963983,0.68236494,0.0005269047,0.10602591,0.00017080184],"about_ca_topic_score_codex":0.0062481915,"about_ca_topic_score_gemma":0.0004490263,"teacher_disagreement_score":0.24722157,"about_ca_system_score_codex":0.00045471717,"about_ca_system_score_gemma":0.0008545442,"threshold_uncertainty_score":0.99945724},"labels":[],"label_agreement":null},{"id":"W4282921591","doi":"10.1158/1538-7445.am2022-2996","title":"Abstract 2996: Pre-activation of autophagy impacts PARP inhibitor sensitivity of prostate cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal","funders":"","keywords":"Olaparib; LNCaP; Autophagy; Cancer research; Clonogenic assay; PARP inhibitor; Prostate cancer; Biology; Cancer; Cell biology; Cell culture; Poly ADP ribose polymerase; Apoptosis","score_opus":0.0761107896073613,"score_gpt":0.42853906030834416,"score_spread":0.35242827070098287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282921591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947487,0.0011065174,0.000014636874,0.0013353113,0.0003343895,0.001204578,0.0005963657,0.000035775818,0.0006237248],"genre_scores_gemma":[0.99715674,0.0007678587,0.00004457873,0.00014543333,0.00030375127,0.000725786,0.000032171687,0.000047834612,0.000775855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669063,0.00040012543,0.0004789839,0.00039118464,0.0015229145,0.0005161706],"domain_scores_gemma":[0.99797916,0.00034038568,0.00028330594,0.00044867018,0.00076079054,0.00018766563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020376425,0.00015965923,0.0004247161,0.000359285,0.00018659368,0.000012214353,0.00012050695,0.00007487366,0.0026377672],"category_scores_gemma":[0.00011260797,0.0001574436,0.000112424255,0.00092450617,0.00032012933,0.00015456443,0.00013833177,0.0008081603,0.000005200083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002542963,0.00030088477,0.0041494477,0.0006612384,0.000101423444,0.000024276163,0.0019203314,0.0018464891,0.97392356,0.00003261079,0.008095305,0.006401459],"study_design_scores_gemma":[0.0019037359,0.00043123215,0.04136176,0.00039619752,0.000015116277,0.0000059236313,0.0003348961,0.00014733657,0.9500283,0.00008524555,0.0051669437,0.00012328707],"about_ca_topic_score_codex":0.006479185,"about_ca_topic_score_gemma":0.00009925457,"teacher_disagreement_score":0.037212316,"about_ca_system_score_codex":0.0012956328,"about_ca_system_score_gemma":0.0019734045,"threshold_uncertainty_score":0.99827397},"labels":[],"label_agreement":null},{"id":"W4282922078","doi":"10.1158/1538-7445.am2022-4250","title":"Abstract 4250: Insights on genomic status and biomarker modulation using OncoPanel™ and BioMAP®platforms","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Trastuzumab; Medicine; Tumor microenvironment; Antibody-dependent cell-mediated cytotoxicity; Cancer research; Breast cancer; Cancer; Immune system; Immunology; Monoclonal antibody; Oncology; Antibody; Internal medicine","score_opus":0.19362200273439914,"score_gpt":0.4417882486844389,"score_spread":0.24816624595003975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282922078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931025,0.0041334215,0.0000015636764,0.0010332561,0.00009237447,0.00049609627,0.00008502389,0.000017219018,0.0010385554],"genre_scores_gemma":[0.9973378,0.001339254,0.00006373198,0.0001248661,0.00013170291,0.000068619534,0.00005909975,0.000022706361,0.0008521882],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997815,0.000068354704,0.00019737847,0.0004060892,0.00094340526,0.0005697644],"domain_scores_gemma":[0.9991264,0.00017987605,0.00003728758,0.00019759193,0.00012439543,0.00033446628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055403094,0.00013486299,0.00021035754,0.00049483706,0.0007049615,0.00005362983,0.000088610024,0.000055104338,0.00057099323],"category_scores_gemma":[0.000037806523,0.00010616394,0.00003700374,0.0004126615,0.0002864938,0.00009099128,0.00033134245,0.00060447666,0.000018498326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035421418,0.00018060279,0.045473468,0.00037093397,0.00014744695,0.00025206272,0.0010433083,0.00015740583,0.8812955,0.0013887617,0.0011311796,0.06501717],"study_design_scores_gemma":[0.002772385,0.001181129,0.9284154,0.00016430998,0.000023665601,0.00014343756,0.0009806438,0.00875676,0.009019614,0.0035987673,0.044577997,0.00036590116],"about_ca_topic_score_codex":0.0027025235,"about_ca_topic_score_gemma":0.00006518864,"teacher_disagreement_score":0.8829419,"about_ca_system_score_codex":0.00048239736,"about_ca_system_score_gemma":0.000463337,"threshold_uncertainty_score":0.6251975},"labels":[],"label_agreement":null},{"id":"W4282925834","doi":"10.1158/1538-7445.am2022-1506","title":"Abstract 1506: <i>APOBEC3A a</i> causative agent in cancer-related chromosomal instability and STING driven metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; Cancer; Chromosome instability; Cytidine deaminase; Pancreatic cancer; Downregulation and upregulation; Biology; Metastasis; Medicine; Genetics; Gene; Chromosome","score_opus":0.08661240975080152,"score_gpt":0.40021688492030927,"score_spread":0.31360447516950773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282925834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124116,0.0065306528,0.0000041194576,0.00069716753,0.00010873728,0.0004274546,0.00024567597,0.000010559356,0.0007344988],"genre_scores_gemma":[0.9962271,0.0019703566,0.00004424774,0.00006112758,0.00007526426,0.0012242147,0.000055461736,0.000022275613,0.00031995133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814683,0.00029182422,0.0002446166,0.00053716387,0.0003714146,0.00040812086],"domain_scores_gemma":[0.9993156,0.000036266807,0.00006734482,0.0003298044,0.00014637395,0.000104584724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008767362,0.00012232797,0.0001532709,0.00010439335,0.00037858207,0.000032476804,0.0002440727,0.000063414715,0.00059979694],"category_scores_gemma":[0.000058586636,0.00012601883,0.000045594523,0.00043558938,0.00017438557,0.0000087106655,0.00037798917,0.00047150627,0.00000244858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017319151,0.00027068867,0.032573875,0.000087774686,0.00014764072,0.000018825718,0.0012859945,0.004621453,0.93492943,0.00011931371,0.002118231,0.023653599],"study_design_scores_gemma":[0.0048953174,0.0010677739,0.3174714,0.00013625655,0.00007448223,0.00002400982,0.0063706283,0.0015461703,0.38430935,0.00047874884,0.2823809,0.0012449409],"about_ca_topic_score_codex":0.0038064495,"about_ca_topic_score_gemma":0.0014847947,"teacher_disagreement_score":0.5506201,"about_ca_system_score_codex":0.00045306954,"about_ca_system_score_gemma":0.00059329416,"threshold_uncertainty_score":0.6567356},"labels":[],"label_agreement":null},{"id":"W4282925868","doi":"10.1158/1538-7445.am2022-lb177","title":"Abstract LB177: Widespread hypertranscription in aggressive human cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Cancer; Disease; Phenotype; Biology; Gene; Medicine; Cancer research; Genetics; Oncology; Bioinformatics; Internal medicine","score_opus":0.06416241647401208,"score_gpt":0.3948246814013953,"score_spread":0.33066226492738326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282925868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852218,0.011596811,0.000005076419,0.0005907342,0.0003811381,0.00031527207,0.00023356776,0.0000067712012,0.0016488425],"genre_scores_gemma":[0.9936461,0.0034349423,0.000010426371,0.00028505462,0.00041139635,0.0011665344,0.00011276296,0.000034228477,0.00089858443],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984397,0.00010245341,0.00019169532,0.0004323371,0.00037190592,0.00046187255],"domain_scores_gemma":[0.9993556,0.000036720365,0.00006613303,0.0003177027,0.0001283032,0.00009552358],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004908312,0.000115588635,0.00012864171,0.00014761869,0.0003350033,0.00003844377,0.00034466665,0.00007139485,0.0010657347],"category_scores_gemma":[0.00007845542,0.00012939432,0.000061152205,0.00026984367,0.000115730494,0.000004291125,0.00025204042,0.0004421457,0.000006641345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018573418,0.00009348006,0.0062913042,0.000028212182,0.000024384013,0.000035712623,0.00017114638,0.0023137156,0.9628041,0.00018756241,0.021951491,0.005913188],"study_design_scores_gemma":[0.0027034776,0.000687666,0.0530775,0.00014060721,0.000016985106,0.000014156332,0.00087563583,0.000051009025,0.44238225,0.0011407385,0.49826658,0.000643408],"about_ca_topic_score_codex":0.006015573,"about_ca_topic_score_gemma":0.006170042,"teacher_disagreement_score":0.5204218,"about_ca_system_score_codex":0.00035183903,"about_ca_system_score_gemma":0.00047648334,"threshold_uncertainty_score":0.9998474},"labels":[],"label_agreement":null},{"id":"W4282926190","doi":"10.1158/1538-7445.am2022-lb560","title":"Abstract LB560: Engineering genetically-encoded synthetic biomarkers for breath-based cancer detection","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Chemical Sensor Technologies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Limonene; Cancer; Mevalonate pathway; HeLa; Carcinogen; Cancer cell; Chemistry; Enzyme; Biochemistry; Reductase; Cancer research; Molecular biology; Biology; Cell; Genetics; Chromatography","score_opus":0.03823218608877286,"score_gpt":0.3289175324730569,"score_spread":0.290685346384284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98409426,0.0028616607,0.010040341,0.00053532596,0.00041674273,0.00074744155,0.00021885683,0.0009483774,0.00013700443],"genre_scores_gemma":[0.9948289,0.00020696077,0.0009814297,0.000015862071,0.00008850652,0.0037393116,0.0000076115566,0.000091152826,0.00004027942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828374,0.000016587956,0.0002010219,0.00034422832,0.00044586425,0.00070852967],"domain_scores_gemma":[0.9991212,0.0003335887,0.000019588026,0.00032545472,0.0000991456,0.00010103806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019449077,0.00016998423,0.00017357826,0.00026619795,0.00023000785,0.000030315145,0.00038761177,0.00009835398,0.00033664503],"category_scores_gemma":[0.00017166503,0.00018762359,0.00007912792,0.00063212623,0.000105389125,0.000050145012,0.00009390029,0.0006602297,0.000005603375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042708478,0.000010163588,0.0000134700185,0.00012567706,0.000032665153,0.0000039166625,0.000016401955,0.3077216,0.6670539,0.000010706324,0.00021570567,0.02475313],"study_design_scores_gemma":[0.0003407807,0.000047201233,0.000116027,0.000035328932,0.000008700421,0.0000019270265,0.00006382493,0.092915505,0.88848364,0.00014017003,0.017629134,0.00021773075],"about_ca_topic_score_codex":0.00010735673,"about_ca_topic_score_gemma":0.000027485261,"teacher_disagreement_score":0.22142981,"about_ca_system_score_codex":0.0013624383,"about_ca_system_score_gemma":0.0000375466,"threshold_uncertainty_score":0.7651068},"labels":[],"label_agreement":null},{"id":"W4282926266","doi":"10.1158/1538-7445.am2022-3524","title":"Abstract 3524: Role of the gut microbiota in the development of immune-mediated diarrhea and colitis induced by immune checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Immune system; Microbiome; Colitis; Metagenomics; Biology; Gut flora; Enterococcus faecium; Immunology; Lactobacillus; Biomarker; Diarrhea; Feces; Microbiology; Bacteria; Internal medicine; Medicine; Bioinformatics; Biochemistry; Antibiotics","score_opus":0.023828575309323786,"score_gpt":0.3263904683308752,"score_spread":0.3025618930215514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929577,0.0056519695,1.5191563e-7,0.0005900799,0.00006381646,0.00046036087,0.000120133576,0.0000013723625,0.00015441848],"genre_scores_gemma":[0.99929243,0.00033750024,0.000012402613,0.00004470634,0.000023481804,0.00013096299,0.00007178786,0.000012852512,0.00007385344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985337,0.00025699954,0.0004242027,0.0002171948,0.00024337544,0.00032450588],"domain_scores_gemma":[0.9993982,0.000038818474,0.00012031338,0.00031495668,0.00009127171,0.00003647649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001519724,0.00009139423,0.00015032516,0.00006364129,0.0002331449,0.000010273105,0.00042893007,0.00007911842,0.000061818806],"category_scores_gemma":[0.00005672681,0.00006571649,0.000050314364,0.00030178085,0.00017182865,0.0000023988255,0.00047879832,0.00042647912,8.6173526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000965163,0.00008688917,0.0014129652,0.000065148386,0.000019281031,3.2197246e-7,0.0016496176,0.0000016257198,0.9952258,0.00000545032,0.0006000445,0.0008363772],"study_design_scores_gemma":[0.00038337024,0.00006875849,0.21936496,0.000031289273,0.0000015547679,0.0000019681736,0.0014579716,6.010943e-7,0.7666689,0.000007756687,0.011951677,0.00006118654],"about_ca_topic_score_codex":0.001709881,"about_ca_topic_score_gemma":0.00052072975,"teacher_disagreement_score":0.22855686,"about_ca_system_score_codex":0.0000962247,"about_ca_system_score_gemma":0.0007906997,"threshold_uncertainty_score":0.26798406},"labels":[],"label_agreement":null},{"id":"W4282926341","doi":"10.1158/1538-7445.am2022-ct223","title":"Abstract CT223: Updated efficacy and safety from the phase 3 CROWN study of first-line lorlatinib vs crizotinib in advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Crizotinib; Medicine; Internal medicine; ALK inhibitor; Lung cancer; Interim analysis; Oncology; Clinical endpoint; Progression-free survival; Anaplastic lymphoma kinase; Gastroenterology; Randomized controlled trial; Overall survival","score_opus":0.033986968074024,"score_gpt":0.4047510235122184,"score_spread":0.3707640554381944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888264,0.0036367578,0.000013266231,0.0014047436,0.00020545628,0.0037007413,0.0016564496,0.00002392037,0.000532269],"genre_scores_gemma":[0.99675685,0.0006668992,0.0000395761,0.00015695699,0.00015072024,0.0014849904,0.00031485016,0.000056412147,0.00037271573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972248,0.00023960716,0.0005413374,0.00067289633,0.0007572309,0.0005641408],"domain_scores_gemma":[0.99774045,0.0009972781,0.00017038826,0.0005318762,0.00034408012,0.00021592206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004768943,0.00026223937,0.0005168355,0.00024355146,0.0006250491,0.000038371007,0.00028494728,0.00005729304,0.001306863],"category_scores_gemma":[0.00010293016,0.00020197571,0.000062921245,0.0010241678,0.00017922114,0.00012505999,0.00026628425,0.0005825767,0.000003163225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1433046,0.040704362,0.4282618,0.0011948355,0.0036200187,0.0025563806,0.09811941,0.030928679,0.04298684,0.000047191385,0.009895535,0.19838038],"study_design_scores_gemma":[0.104782775,0.0060470724,0.86030364,0.0008156908,0.0006677303,0.0000056619488,0.012737824,0.0025455055,0.006995126,0.000015808153,0.004665401,0.00041778412],"about_ca_topic_score_codex":0.022806909,"about_ca_topic_score_gemma":0.008513739,"teacher_disagreement_score":0.43204185,"about_ca_system_score_codex":0.0011550917,"about_ca_system_score_gemma":0.0011091261,"threshold_uncertainty_score":0.9996061},"labels":[],"label_agreement":null},{"id":"W4282926424","doi":"10.1158/1538-7445.am2022-5935","title":"Abstract 5935: Malignant risk assessment of clinical and histological subtypes of lichenoid mucositis with dysplasia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Dalhousie University; University of British Columbia","funders":"","keywords":"Medicine; Oral lichen planus; Dysplasia; Pathology; Cancer; Biopsy; Mucositis; Leukoplakia; Dermatology; Internal medicine; Radiation therapy","score_opus":0.15168647138072264,"score_gpt":0.5140197423137364,"score_spread":0.3623332709330137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956978,0.0019514662,0.000009368292,0.0002972578,0.00017622157,0.00033473584,0.00029137966,0.000011486053,0.0012302891],"genre_scores_gemma":[0.99823684,0.00064990035,0.00042407512,0.0000258855,0.000041777155,0.00020356415,0.000012012615,0.000011851271,0.00039409322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974172,0.00084418495,0.00047045937,0.00036259854,0.00058283994,0.0003226796],"domain_scores_gemma":[0.9986212,0.0005596652,0.00022888745,0.00028818205,0.00017629836,0.00012572286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023147012,0.00009377238,0.0003890181,0.000096557545,0.00027776163,0.00000594816,0.00017737107,0.00009693098,0.0014166047],"category_scores_gemma":[0.000074457996,0.00007007845,0.000053575815,0.00020773093,0.0006359824,0.000036300877,0.00021667413,0.00089175237,0.000007845824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007884385,0.0005158114,0.9868864,0.00016804843,0.00009565758,0.0006556677,0.00009649501,0.000023727067,0.000464921,0.0009856179,0.00095241424,0.008366836],"study_design_scores_gemma":[0.0012118082,0.0015784691,0.99435705,0.000034302502,0.000034703422,0.00005760579,0.00019450596,0.000021966764,0.00078673754,0.00025795936,0.0013989753,0.00006592617],"about_ca_topic_score_codex":0.0017193941,"about_ca_topic_score_gemma":0.0005800953,"teacher_disagreement_score":0.00830091,"about_ca_system_score_codex":0.0001397867,"about_ca_system_score_gemma":0.00047828638,"threshold_uncertainty_score":0.9994962},"labels":[],"label_agreement":null},{"id":"W4282927325","doi":"10.1158/1538-7445.am2022-ct126","title":"Abstract CT126: A phase 2 trial of first-line AZD0171 + durvalumab and chemotherapy (CT) in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and CD8+ T cell infiltration","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Tumor microenvironment; Response Evaluation Criteria in Solid Tumors; CD8; Oncology; Cancer research; Immune system; Internal medicine; Immunotherapy; Phases of clinical research; Cancer; Chemotherapy; Immunology; Nivolumab","score_opus":0.0599190100686973,"score_gpt":0.38013565412632844,"score_spread":0.3202166440576311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944394,0.0015063137,0.0000033438553,0.0006120304,0.000043273383,0.0030496113,0.0000882171,0.0000124043445,0.00024536913],"genre_scores_gemma":[0.99757123,0.00084145076,0.000070604205,0.0000373861,0.00008722831,0.000626391,0.000076714845,0.000054126547,0.00063488685],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967327,0.00030299713,0.00045761387,0.00048112788,0.0015119608,0.00051359483],"domain_scores_gemma":[0.9986681,0.00035177259,0.00011745589,0.00039099998,0.00026143293,0.00021025562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001542973,0.0001900919,0.0005093466,0.0005414464,0.00019661794,0.000039015114,0.0001491945,0.000032880995,0.0035495067],"category_scores_gemma":[0.00012031119,0.00016373178,0.000048537982,0.00080148736,0.00033596123,0.0001282753,0.00011373178,0.00077942776,0.0000017529719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36542284,0.0057261656,0.5273042,0.001473424,0.00041828337,0.0003589366,0.0037592452,0.000091482805,0.06489185,0.00002056714,0.00064691715,0.029886086],"study_design_scores_gemma":[0.5290514,0.028464133,0.41785052,0.00030435613,0.000148949,0.00006384695,0.0018398347,0.00081788877,0.01826106,0.00017296306,0.0025195924,0.00050542527],"about_ca_topic_score_codex":0.0017615687,"about_ca_topic_score_gemma":0.00027126088,"teacher_disagreement_score":0.16362858,"about_ca_system_score_codex":0.00041866762,"about_ca_system_score_gemma":0.0005222133,"threshold_uncertainty_score":0.99736136},"labels":[],"label_agreement":null},{"id":"W4282927399","doi":"10.1158/1538-7445.am2022-lb519","title":"Abstract LB519: Bimodality of gene expression in cancer patients as interpretable biomarkers for drug sensitivity","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacogenomics; Interpretability; Machine learning; Computational biology; Medicine; Cancer; Artificial intelligence; Precision medicine; Bioinformatics; Computer science; Biology; Internal medicine; Pharmacology; Pathology","score_opus":0.07395173899285883,"score_gpt":0.43851790970438564,"score_spread":0.3645661707115268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807866,0.00032632644,0.01647954,0.0006728158,0.0004918659,0.0007116372,0.00024649588,0.000021202273,0.0002634832],"genre_scores_gemma":[0.993398,0.000023759756,0.005638756,0.00006683082,0.000035347108,0.0007242241,0.000015628893,0.000014266969,0.00008320122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996577,0.0010098758,0.00031956463,0.0005659165,0.0010759345,0.0004516906],"domain_scores_gemma":[0.9976854,0.0012912572,0.00011792485,0.00041374812,0.0003939486,0.00009773441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041745887,0.00011484718,0.0002175788,0.0003716846,0.00023352784,0.000056729437,0.000707515,0.000029687804,0.00012391126],"category_scores_gemma":[0.00030034193,0.00011833039,0.00008270525,0.0010242665,0.000096805554,0.00039406482,0.0009811312,0.00034929297,0.0000022369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018483356,0.0019128153,0.057654433,0.00065417925,0.0001487163,0.000042768814,0.008369753,0.2915762,0.4719907,0.002538499,0.011065094,0.1521985],"study_design_scores_gemma":[0.0025824553,0.00027560955,0.2214879,0.0002952467,0.00000660824,0.0000023689292,0.0004330053,0.16585417,0.5902197,0.01518185,0.003107778,0.0005533298],"about_ca_topic_score_codex":0.006251624,"about_ca_topic_score_gemma":0.00027554098,"teacher_disagreement_score":0.16383347,"about_ca_system_score_codex":0.00084545853,"about_ca_system_score_gemma":0.0010021171,"threshold_uncertainty_score":0.9450627},"labels":[],"label_agreement":null},{"id":"W4282927888","doi":"10.1158/1538-7445.am2022-5662","title":"Abstract 5662: Targeting N-myristoylation for therapy of adult acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; University Health Network; University of Alberta","funders":"","keywords":"Cancer research; Myristoylation; Cell culture; Biology; Cancer; Transcriptome; Apoptosis; Cell growth; Cell; Internal medicine; Phosphorylation; Medicine; Gene expression; Cell biology; Gene; Biochemistry; Genetics","score_opus":0.033683530208614185,"score_gpt":0.36205952773914624,"score_spread":0.32837599753053204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993287,0.004499375,0.00034322482,0.00015892535,0.00014979426,0.0003850236,0.000090452566,0.00000802545,0.0010781256],"genre_scores_gemma":[0.9937611,0.0035286478,0.00025274727,0.00007729749,0.0003161977,0.00064646726,0.00023736844,0.000030856118,0.0011493248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868524,0.00008295329,0.00020885895,0.00032020707,0.00038566085,0.00031705335],"domain_scores_gemma":[0.99911886,0.00004377511,0.00009204534,0.00023737636,0.00045936022,0.00004858568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006613828,0.00009488492,0.000117484946,0.00006573994,0.0003327902,0.000016923352,0.00034532143,0.0000767077,0.00017824525],"category_scores_gemma":[0.00011427962,0.00009318171,0.00008622077,0.0001894116,0.000110875044,0.0000046365667,0.00014320633,0.0002454235,0.000001612508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004797255,0.000025555006,0.0004965325,0.00006393674,0.000058677982,0.0000014534352,0.0001230407,0.0004858023,0.97911656,0.00009269275,0.011374252,0.007681771],"study_design_scores_gemma":[0.0006474048,0.00032642586,0.00021605902,0.000008480199,0.0000038326966,0.0000018001897,0.00029236157,0.00006857445,0.9012385,0.0002619182,0.096825436,0.00010922427],"about_ca_topic_score_codex":0.00011052623,"about_ca_topic_score_gemma":0.0000057630746,"teacher_disagreement_score":0.085451186,"about_ca_system_score_codex":0.00016681058,"about_ca_system_score_gemma":0.0006903358,"threshold_uncertainty_score":0.379984},"labels":[],"label_agreement":null},{"id":"W4282928261","doi":"10.1158/1538-7445.am2022-6090","title":"Abstract 6090: Disentangling subclonal dynamics in growing tumors using stochastic simulations and Bayesian neural networks","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Computer science; Bayesian probability; Curse of dimensionality; Artificial intelligence; Approximate Bayesian computation; Computational biology; Biology; Algorithm","score_opus":0.034094151815479146,"score_gpt":0.3530746443911234,"score_spread":0.31898049257564426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282928261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563223,0.0019019516,0.0017124182,0.00021027315,0.00016289034,0.00021001101,0.000131824,0.000004063387,0.00003430834],"genre_scores_gemma":[0.9992914,0.00006990465,0.00004810663,0.00008444649,0.00027274125,0.00004877068,0.00013289014,0.000028871389,0.000022832779],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988264,0.00006594977,0.0001735161,0.00032054444,0.00021959223,0.00039404182],"domain_scores_gemma":[0.9995449,0.00009796443,0.000035596884,0.0001663683,0.000055650486,0.00009947587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030287344,0.00009800667,0.000106726206,0.00012053132,0.000368928,0.00005260044,0.00015087149,0.000044724133,0.000049154874],"category_scores_gemma":[0.00007319258,0.00011844693,0.000034319986,0.00025366785,0.00009278903,0.0000068042173,0.00036500132,0.0003764901,1.2371146e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009634729,0.000028462255,0.018335193,0.000012297977,0.0000114564755,0.000022339902,0.000046388017,0.9631453,0.01659079,0.00017007379,0.000039584313,0.0015017756],"study_design_scores_gemma":[0.00046603652,0.00007333521,0.0034944387,0.000019715137,0.0000062769386,0.0000111553345,0.0005299936,0.99454397,0.00032820526,0.00022175812,0.00013524949,0.00016987725],"about_ca_topic_score_codex":0.0006461969,"about_ca_topic_score_gemma":0.0012798621,"teacher_disagreement_score":0.03139867,"about_ca_system_score_codex":0.00039944742,"about_ca_system_score_gemma":0.00019795315,"threshold_uncertainty_score":0.48301256},"labels":[],"label_agreement":null},{"id":"W4282928759","doi":"10.1158/1538-7445.am2022-5224","title":"Abstract 5224: The PRecision Oncology For Young peopLE (PROFYLE) Program: A national precision oncology program for children, adolescents and young adults with hard-to-cure cancer in Canada","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario; Centre Hospitalier Universitaire Sainte-Justine; Spinal Cord Injury BC; McGill University Health Centre; BC Children's Hospital; McGill University; University of Calgary; Children's Hospital of Eastern Ontario; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Cancer; Internal medicine; Precision medicine; Breast cancer; Family medicine; Pathology","score_opus":0.042367208048462994,"score_gpt":0.4199006589439091,"score_spread":0.3775334508954461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282928759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726181,0.0006339376,0.0000069695566,0.005648468,0.00023461033,0.01991175,0.00077920075,0.000032058124,0.0001349209],"genre_scores_gemma":[0.9421008,0.0003339511,0.00053268974,0.00014217949,0.00018852556,0.056096807,0.00014771029,0.000057300258,0.0003999875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957208,0.00026146852,0.00035086446,0.00080008066,0.0017889371,0.0010778282],"domain_scores_gemma":[0.99774396,0.00047997912,0.00010494602,0.00028633286,0.0009764681,0.0004082957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001208615,0.0002239074,0.0004139944,0.00032382467,0.0006635531,0.000057915484,0.0003542199,0.00008667833,0.00013434111],"category_scores_gemma":[0.0003365729,0.00015464073,0.000064443404,0.0008684487,0.00012651885,0.00008843248,0.00029136415,0.0009495135,0.0000018068131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.034152858,0.002272702,0.28334528,0.00045201537,0.00023193755,0.00009365021,0.0013443261,0.0002511609,0.00094548834,0.000013214875,0.02683741,0.65005994],"study_design_scores_gemma":[0.01343702,0.011947895,0.9453665,0.0005346381,0.000043247033,0.0001325578,0.000920317,0.0010086795,0.00060180674,0.0000551081,0.025741298,0.00021094465],"about_ca_topic_score_codex":0.3708861,"about_ca_topic_score_gemma":0.92922163,"teacher_disagreement_score":0.6620212,"about_ca_system_score_codex":0.006086181,"about_ca_system_score_gemma":0.011773784,"threshold_uncertainty_score":0.9977293},"labels":[],"label_agreement":null},{"id":"W4282928883","doi":"10.1158/1538-7445.am2022-6375","title":"Abstract 6375: Augmented intelligence to define drug targets associated with triple negative breast cancer (TNBC) metabolic reprogramming","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Warburg effect; Computational biology; Context (archaeology); Anaerobic glycolysis; Transcriptome; Gene; Biology; Cancer; Bioinformatics; Computer science; Cancer cell; Gene expression; Genetics","score_opus":0.03111238549343866,"score_gpt":0.33791515271762906,"score_spread":0.3068027672241904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282928883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876602,0.0062445602,0.0007879854,0.0020850636,0.00033246362,0.0012779933,0.0007667346,0.000033849796,0.00081111887],"genre_scores_gemma":[0.99545133,0.0006536403,0.00025249424,0.00038061314,0.00021317831,0.0011436524,0.00016609617,0.000041358973,0.0016976256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779576,0.00014337321,0.0002944124,0.00048782022,0.0005506136,0.00072804897],"domain_scores_gemma":[0.99883294,0.000041789583,0.00012048293,0.00040738314,0.00037542317,0.00022197768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011915307,0.00018780667,0.0002266855,0.00012377201,0.0005114726,0.000071362716,0.00047396377,0.000068097645,0.00058487203],"category_scores_gemma":[0.000076863194,0.00016772709,0.00007140666,0.00076810335,0.00013154875,0.00000882234,0.00051123736,0.00055468787,0.000010580522],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060914434,0.0011747973,0.009231241,0.0002034649,0.002701033,0.000116639756,0.0064896424,0.050275218,0.19212341,0.00092133373,0.119893625,0.61077815],"study_design_scores_gemma":[0.0052939653,0.0022741866,0.061071943,0.0005497486,0.0002190113,0.00008364158,0.01198272,0.003878371,0.42260674,0.0016277848,0.48714674,0.0032651713],"about_ca_topic_score_codex":0.002119842,"about_ca_topic_score_gemma":0.002160947,"teacher_disagreement_score":0.60751295,"about_ca_system_score_codex":0.00022827287,"about_ca_system_score_gemma":0.00047216497,"threshold_uncertainty_score":0.6839712},"labels":[],"label_agreement":null},{"id":"W4282929179","doi":"10.1158/1538-7445.am2022-2228","title":"Abstract 2228: A multi-omic perspective of how selection shapes blood cancer risk phenotypes in aging populations","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wilfrid Laurier University; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Disease; Cancer; Somatic cell; Genotyping; Selection (genetic algorithm); Genetics; Germline mutation; Linkage disequilibrium; Evolutionary biology; Genotype; Mutation; Single-nucleotide polymorphism; Medicine; Gene; Internal medicine","score_opus":0.05534268479949877,"score_gpt":0.38621851139920677,"score_spread":0.330875826599708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282929179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937976,0.0087552555,0.00006755594,0.0008347958,0.00012896811,0.00030510325,0.0003770623,0.000005827035,0.00014565364],"genre_scores_gemma":[0.995655,0.0031834797,0.0001546441,0.000038503684,0.00023728352,0.0004095816,0.00002889799,0.000026312275,0.00026629164],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987862,0.0001186637,0.00015008404,0.00037617347,0.00024909986,0.00031974955],"domain_scores_gemma":[0.99938005,0.00004330646,0.00009126596,0.00015498805,0.0002737438,0.000056653127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042461863,0.0001005317,0.00013329824,0.00019211335,0.00026216707,0.00002804407,0.00020075297,0.000055549932,0.00021454487],"category_scores_gemma":[0.00018963085,0.00011432602,0.00006213876,0.00039569233,0.000083150975,0.000005535242,0.0002046364,0.00039049078,9.4232763e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023287759,0.00031931774,0.13815834,0.00004938122,0.00013257415,0.000004840442,0.0010696023,0.0425503,0.81177473,0.0005159084,0.0017948723,0.0033972785],"study_design_scores_gemma":[0.0054209772,0.0008650735,0.569078,0.00012667142,0.00013485306,0.000010170203,0.008331158,0.004162063,0.38992482,0.0018539393,0.01920889,0.0008833703],"about_ca_topic_score_codex":0.023810398,"about_ca_topic_score_gemma":0.023508787,"teacher_disagreement_score":0.43091968,"about_ca_system_score_codex":0.00035887377,"about_ca_system_score_gemma":0.00055902713,"threshold_uncertainty_score":0.9943096},"labels":[],"label_agreement":null},{"id":"W4282929212","doi":"10.1158/1538-7445.am2022-2436","title":"Abstract 2436: CIRBP is a functional mediator of leptomeningeal metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Medicine; Pathology; Cell biology; Biology","score_opus":0.07097892391842514,"score_gpt":0.3758447443584623,"score_spread":0.3048658204400372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282929212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812956,0.014742177,0.000038467875,0.0005520832,0.0012092865,0.00021531468,0.00057346496,0.0000076134975,0.0013659816],"genre_scores_gemma":[0.9927001,0.0018467689,0.000054451197,0.00020060137,0.0018787186,0.00045769222,0.00016032529,0.000029062012,0.0026723011],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981111,0.00011599736,0.00020159892,0.0003777437,0.0008009138,0.00039258826],"domain_scores_gemma":[0.99918765,0.000029503277,0.00006676531,0.0003381247,0.0002476654,0.00013026626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008477792,0.00010571252,0.00017364587,0.00014827048,0.00023366854,0.000014602428,0.0002938274,0.00005995543,0.004722892],"category_scores_gemma":[0.00006239153,0.00010940295,0.0001289661,0.00033133346,0.00016478445,0.000004449139,0.0003424378,0.00033271973,0.000011301655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003222862,0.00007334357,0.00049116084,0.000038395534,0.00013319816,0.0000013514806,0.00016840799,0.00008558443,0.85811704,0.000064254535,0.13024479,0.01026021],"study_design_scores_gemma":[0.0005548331,0.0001272973,0.002877502,0.000003908806,0.000013986297,0.00000436186,0.00033475636,0.0000033930228,0.27789587,0.00005329094,0.7180273,0.000103523875],"about_ca_topic_score_codex":0.00031838162,"about_ca_topic_score_gemma":0.000054789034,"teacher_disagreement_score":0.5877825,"about_ca_system_score_codex":0.00007982197,"about_ca_system_score_gemma":0.0007683625,"threshold_uncertainty_score":0.9961869},"labels":[],"label_agreement":null},{"id":"W4282929594","doi":"10.1158/1538-7445.am2022-5333","title":"Abstract 5333: Pancreatic cancer enhances HER2 signaling through DUSP6 to circumvent therapeutic MAPK inhibition","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Cancer research; DUSP6; Trametinib; Downregulation and upregulation; Kinase; KRAS; PI3K/AKT/mTOR pathway; MEK inhibitor; Afatinib; Pancreatic cancer; Cancer; Chemistry; Medicine; Signal transduction; Phosphorylation; Internal medicine; Erlotinib; Phosphatase; Protein phosphatase 2; Epidermal growth factor receptor","score_opus":0.07713922568351408,"score_gpt":0.42108169229198356,"score_spread":0.3439424666084695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282929594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98328805,0.012734587,0.000104921186,0.0014952776,0.00021076188,0.0008988733,0.0002623463,0.000021512931,0.0009836415],"genre_scores_gemma":[0.9903656,0.0025551717,0.000034534558,0.0005452831,0.0005011676,0.0043146014,0.000138233,0.00005448811,0.0014908937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969111,0.00026265875,0.00024609646,0.0007122717,0.0009815735,0.00088629336],"domain_scores_gemma":[0.998964,0.000048127287,0.00005953769,0.0004528064,0.00024903237,0.00022650987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062762457,0.0002056393,0.00021081655,0.00013758952,0.0006988801,0.00009259485,0.00036492987,0.000071455645,0.0025865978],"category_scores_gemma":[0.00004154062,0.00020051301,0.000118430624,0.00056063366,0.00012783254,0.000015018047,0.00039992962,0.00045728608,0.000056918896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005743022,0.00018797294,0.0013326764,0.0000759689,0.00021855203,0.00004041414,0.00036479533,0.00086880836,0.98045397,0.00005719692,0.005293399,0.010531964],"study_design_scores_gemma":[0.0009275936,0.00078477414,0.0020462833,0.00008686531,0.000019588751,0.000007627439,0.0006300026,0.000006966945,0.8980572,0.00064932473,0.09649272,0.00029101642],"about_ca_topic_score_codex":0.008249013,"about_ca_topic_score_gemma":0.0016819987,"teacher_disagreement_score":0.09119932,"about_ca_system_score_codex":0.0006564501,"about_ca_system_score_gemma":0.00077460584,"threshold_uncertainty_score":0.99835515},"labels":[],"label_agreement":null},{"id":"W4282930742","doi":"10.1158/1538-7445.am2022-2148","title":"Abstract 2148: Pre-clinical models recapitulating the spectrum of response of BRCA associated pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Oncology; Pancreatic cancer; Cancer; Internal medicine; Cancer research; Clinical trial; PARP inhibitor; Disease; Biology; Poly ADP ribose polymerase; Gene; Genetics","score_opus":0.09176123865306204,"score_gpt":0.42031833902729593,"score_spread":0.3285571003742339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282930742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149126,0.006332714,0.000019265573,0.0006205484,0.00020757584,0.00038307917,0.0004530989,0.000004187373,0.0004882881],"genre_scores_gemma":[0.99487364,0.0037732304,0.00002423418,0.000108706314,0.0001979873,0.00025368505,0.000032040614,0.000030470203,0.00070601597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976615,0.00061736896,0.000485727,0.00033998006,0.00051949854,0.00037594797],"domain_scores_gemma":[0.99819636,0.000703454,0.00024219933,0.0005315228,0.00024871257,0.0000777215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003569697,0.0001092033,0.00025369087,0.000069907655,0.00022839494,0.000015459524,0.00049943535,0.00009261051,0.0004220086],"category_scores_gemma":[0.00089800754,0.000095083604,0.00014106264,0.00031314872,0.00027664323,0.0000035529358,0.00049688754,0.0004497232,8.180032e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068557616,0.00043218464,0.03735074,0.00013529976,0.0005022975,0.000009612589,0.0009858371,0.06561859,0.8634041,0.00037849124,0.021139624,0.003187471],"study_design_scores_gemma":[0.005817497,0.0042708693,0.3449773,0.00043831047,0.00021456767,0.000009287759,0.0021744883,0.007001052,0.5982736,0.005876468,0.029957423,0.0009891875],"about_ca_topic_score_codex":0.0027550496,"about_ca_topic_score_gemma":0.0009134384,"teacher_disagreement_score":0.30762655,"about_ca_system_score_codex":0.00017283039,"about_ca_system_score_gemma":0.001274429,"threshold_uncertainty_score":0.46206984},"labels":[],"label_agreement":null},{"id":"W4282931813","doi":"10.1158/1538-7445.am2022-2111","title":"Abstract 2111: Mobilization of memory natural killer cells in cancer immunotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Antigen; Recombination-activating gene; Immunology; Immunotherapy; Biology; Immune system; Memory T cell; Cancer immunotherapy; Cancer research; Immunization; T cell","score_opus":0.04183124188873127,"score_gpt":0.36812358293083897,"score_spread":0.3262923410421077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282931813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.895351,0.101133786,0.0000017729982,0.00030362737,0.0023851767,0.0004993783,0.000035761055,0.000034123834,0.0002553596],"genre_scores_gemma":[0.97844267,0.0073555605,0.0000042644074,0.000120868026,0.000026517371,0.0007099572,0.000032366726,0.000048580736,0.013259214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976682,0.00085862185,0.00040080966,0.00031842708,0.00018508872,0.0005688605],"domain_scores_gemma":[0.9989695,0.0003379151,0.00011459824,0.00039175735,0.00017401419,0.00001219147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001322886,0.00015230187,0.0003000246,0.0004929768,0.00031114873,0.000012448435,0.00053681247,0.00011581765,0.01105515],"category_scores_gemma":[0.000033451364,0.00014452467,0.00010002804,0.000751979,0.00036769916,0.000113268856,0.00016733722,0.0011312072,0.000033568416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026549234,0.00023938889,0.0005977136,0.00003648296,0.00012191662,0.0000045102433,0.0020621265,0.000705264,0.9609104,0.000051059564,0.005648362,0.026967853],"study_design_scores_gemma":[0.0026277495,0.00024390774,0.017458132,0.00006917839,0.0000040999807,0.0000059066815,0.0019034212,0.0000073854226,0.8072707,0.000055167253,0.17014524,0.00020910711],"about_ca_topic_score_codex":0.0058615874,"about_ca_topic_score_gemma":0.00018248009,"teacher_disagreement_score":0.16449687,"about_ca_system_score_codex":0.00045308762,"about_ca_system_score_gemma":0.00055033655,"threshold_uncertainty_score":0.98984885},"labels":[],"label_agreement":null},{"id":"W4282931903","doi":"10.1158/1538-7445.am2022-2734","title":"Abstract 2734: Integrating hybrid spatiotemporal models and multiscale data for the study of cancer progression in 3D cultures","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Cancer cell; Metastasis; Spatial analysis; Chemotaxis; Biology; Computational biology; Biological system; Computer science; Mathematics; Genetics; Statistics","score_opus":0.32925851244410764,"score_gpt":0.5371564345194854,"score_spread":0.20789792207537772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282931903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994643,0.0013782224,0.00025289622,0.0005810699,0.000056398338,0.0025766238,0.00037529063,0.000015805459,0.00012072709],"genre_scores_gemma":[0.9954371,0.00006424401,0.0016354128,0.00001092666,0.000053189447,0.0026554812,0.000019051118,0.000021972915,0.00010262205],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998076,0.00027418288,0.00038104525,0.00038749672,0.00056061393,0.00032061595],"domain_scores_gemma":[0.997398,0.00166654,0.00013349435,0.00061683415,0.00013908508,0.000046004072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002930685,0.00011437138,0.00026585412,0.000092397815,0.00033857688,0.000029047156,0.0007821872,0.000029085972,0.00015629554],"category_scores_gemma":[0.0007268746,0.00006895358,0.000021041584,0.00022131765,0.00018177848,0.00010906563,0.0010575582,0.00061529607,2.4740834e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055941683,0.017307073,0.18306181,0.011736303,0.0015016429,0.00021054139,0.11578046,0.0044323285,0.041158613,0.06048638,0.10131674,0.45741394],"study_design_scores_gemma":[0.010436615,0.0025199747,0.015854836,0.0015905902,0.00020438671,0.0000201932,0.07823151,0.5780933,0.012458009,0.296674,0.0028052581,0.0011113341],"about_ca_topic_score_codex":0.00247893,"about_ca_topic_score_gemma":0.0038465373,"teacher_disagreement_score":0.57366097,"about_ca_system_score_codex":0.000119006385,"about_ca_system_score_gemma":0.00013986389,"threshold_uncertainty_score":0.3747417},"labels":[],"label_agreement":null},{"id":"W4282932160","doi":"10.1158/1538-7445.am2022-3047","title":"Abstract 3047: Investigating the interaction between the microbiome and mutant p53 in Li-Fraumeni Syndrome","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Context (archaeology); Microbiome; Cancer; Germline mutation; Population; Medicine; Cancer research; Germline; Lung cancer; Immunology; Oncology; Biology; Mutation; Internal medicine; Bioinformatics; Gene; Genetics","score_opus":0.0679376028941715,"score_gpt":0.3999722759091164,"score_spread":0.3320346730149449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282932160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941413,0.0020615465,0.0000010583612,0.0029411418,0.00006218399,0.00046752364,0.00009635389,0.000004218145,0.00022466537],"genre_scores_gemma":[0.99847347,0.0003819453,0.000004954138,0.00011171949,0.00011601976,0.0005853193,0.000056975816,0.00001776939,0.0002518137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847704,0.00028783857,0.0001519325,0.00031714997,0.00034892213,0.00041710242],"domain_scores_gemma":[0.9994139,0.00010291651,0.000039408762,0.0003078596,0.000052509622,0.00008338696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010534663,0.000095403695,0.00009489599,0.000089607434,0.000568327,0.00008289648,0.00035527258,0.00003807409,0.00013481603],"category_scores_gemma":[0.00007819769,0.00006271326,0.00003598895,0.00036000667,0.00027626092,0.000007549882,0.00060441537,0.0006278102,0.00000689446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018526328,0.00007746003,0.052534256,0.000056555593,0.0001834489,0.00007213279,0.00070752617,0.00016208219,0.9227248,0.000025239826,0.0039166524,0.019354578],"study_design_scores_gemma":[0.003763193,0.001803721,0.34210178,0.0001785116,0.000035744917,0.00035768506,0.006338506,0.00010761455,0.38712975,0.0013147746,0.25623268,0.00063603744],"about_ca_topic_score_codex":0.0042860014,"about_ca_topic_score_gemma":0.0009967977,"teacher_disagreement_score":0.53559506,"about_ca_system_score_codex":0.00021612184,"about_ca_system_score_gemma":0.00026764415,"threshold_uncertainty_score":0.6479181},"labels":[],"label_agreement":null},{"id":"W4282932391","doi":"10.1158/1538-7445.am2022-273","title":"Abstract 273: Prostate cancer metastasis induces irregular bone formation associated to specific androgen dependent phenotypes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bone mineral; Extracellular matrix; Prostate cancer; Pathology; Trabecula (gastropod); Androgen receptor; Matrix (chemical analysis); Stromal cell; Fibril; Chemistry; Medicine; Osteoporosis; Cancer; Biology; Cell biology; Biophysics; Internal medicine","score_opus":0.12189096876564127,"score_gpt":0.4195824741293929,"score_spread":0.29769150536375166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282932391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821317,0.009400081,0.0000019472943,0.005555297,0.00021563988,0.0016251403,0.0004512349,0.000048995928,0.00056992203],"genre_scores_gemma":[0.9933967,0.001366802,0.00004241247,0.00033472004,0.000082203755,0.0023430763,0.00016368709,0.0000368717,0.002233536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704224,0.00018062092,0.00031500074,0.00036752608,0.0013696202,0.0007249922],"domain_scores_gemma":[0.9988433,0.000058836285,0.00008971897,0.0002811652,0.0003263793,0.0004005709],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011314283,0.00014431134,0.00030020814,0.00034051127,0.00059596135,0.00004593077,0.00012692579,0.00005195427,0.0022650417],"category_scores_gemma":[0.00005738262,0.00012887602,0.000060535927,0.00083612883,0.000042068048,0.00014246162,0.00014577628,0.00057297625,0.00010228525],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00819967,0.0028652316,0.04585235,0.0010931956,0.0015769212,0.0015697344,0.012617137,0.0010458784,0.12455227,0.00017594897,0.108645335,0.6918063],"study_design_scores_gemma":[0.01558048,0.0028731157,0.36263385,0.0006464977,0.00035241467,0.00012526094,0.0051253447,0.00010846528,0.22014502,0.00074538466,0.39068255,0.0009816253],"about_ca_topic_score_codex":0.004948362,"about_ca_topic_score_gemma":0.0011924179,"teacher_disagreement_score":0.6908247,"about_ca_system_score_codex":0.0021117232,"about_ca_system_score_gemma":0.0007228032,"threshold_uncertainty_score":0.99864703},"labels":[],"label_agreement":null},{"id":"W4282932782","doi":"10.1158/1538-7445.am2022-858","title":"Abstract 858: Development of ultrasensitive split luciferase biosensors monitoring activity of the merlin tumor suppressor","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Merlin (protein); Luciferase; Suppressor; Phosphorylation; Chemistry; Cancer; Cell biology; Biology; Biophysics; Cancer research; Biochemistry; Genetics; Transfection","score_opus":0.04294211249060236,"score_gpt":0.35039802643022383,"score_spread":0.30745591393962146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282932782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988586,0.00030746,0.0000066876846,0.00006615858,0.00013752414,0.0002833394,0.00016412268,0.0000025754712,0.00017353529],"genre_scores_gemma":[0.9993398,0.00007283254,0.000115944866,0.000012130596,0.00008500468,0.00009688494,0.000012171825,0.0000150991555,0.00025011887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986873,0.00016823223,0.00019143286,0.00026399846,0.00040914098,0.00027986974],"domain_scores_gemma":[0.9992547,0.000041224826,0.00009754529,0.00035030715,0.00020398798,0.000052205272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005666676,0.00009412874,0.0001356165,0.000057378893,0.00023757607,0.000006846572,0.00031208314,0.000041998945,0.00005951717],"category_scores_gemma":[0.000075214855,0.000079932375,0.000079395846,0.00019274274,0.00015336464,0.0000027806827,0.00038907773,0.00029694772,9.57123e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021599981,0.00010748317,0.0034519879,0.000066250876,0.00006146934,0.000002705964,0.00023143334,0.00021412676,0.9938485,0.000006805173,0.00021573772,0.00157748],"study_design_scores_gemma":[0.00022974572,0.000049476454,0.038704973,0.000023844319,0.0000054202555,0.0000024560657,0.00033336852,0.0000081227545,0.95821357,0.0000030508058,0.0023452458,0.00008075226],"about_ca_topic_score_codex":0.00027690452,"about_ca_topic_score_gemma":0.00006665646,"teacher_disagreement_score":0.035634976,"about_ca_system_score_codex":0.00009683752,"about_ca_system_score_gemma":0.00050714536,"threshold_uncertainty_score":0.32595477},"labels":[],"label_agreement":null},{"id":"W4282933010","doi":"10.1158/1538-7445.am2022-6084","title":"Abstract 6084: Recurrent genomic patterns of MPNST evolution correlate with clinical outcome","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chromothripsis; CDKN2A; BAP1; Comparative genomic hybridization; Biology; Malignant peripheral nerve sheath tumor; Chromosome instability; Cancer research; Copy number analysis; Genome instability; Sarcoma; Neurofibromatosis; Targeted therapy; Genetics; Copy-number variation; Genome; Chromosome; Cancer; Medicine; Pathology; Melanoma; Gene","score_opus":0.18545588829712495,"score_gpt":0.4585531442092565,"score_spread":0.2730972559121316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282933010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695385,0.00083434134,0.000010974244,0.0006880869,0.00036303786,0.00046779765,0.000134914,0.000021543035,0.00052546174],"genre_scores_gemma":[0.99877614,0.0001500665,0.000020067635,0.00005785256,0.00015069955,0.00014088136,0.000021794915,0.000027845796,0.00065465405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977528,0.0002232211,0.00048785904,0.00034163866,0.0008482865,0.0003461807],"domain_scores_gemma":[0.9989279,0.00020540871,0.00011847351,0.0003941341,0.00018092465,0.00017314992],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012125174,0.00009824616,0.00032367656,0.00017976275,0.00018378864,0.000012406957,0.00017231057,0.000040376908,0.0015097361],"category_scores_gemma":[0.0000802668,0.000078080455,0.000111726345,0.00027003395,0.00013963196,0.00003979389,0.00019828905,0.0009993131,0.000030501282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018599634,0.00037971494,0.97727317,0.00024056474,0.00006632818,0.00030723636,0.00009259105,0.00005408971,0.011516491,0.0002059117,0.00315428,0.00484968],"study_design_scores_gemma":[0.0014632246,0.0015979984,0.9892463,0.00012397644,0.000028642313,0.00008209134,0.00028588838,0.00005700748,0.00047106837,0.00001731224,0.006535881,0.00009060941],"about_ca_topic_score_codex":0.0005036439,"about_ca_topic_score_gemma":0.00004096126,"teacher_disagreement_score":0.01197315,"about_ca_system_score_codex":0.00035395595,"about_ca_system_score_gemma":0.00048919005,"threshold_uncertainty_score":0.999403},"labels":[],"label_agreement":null},{"id":"W4282933379","doi":"10.1158/1538-7445.am2022-3652","title":"Abstract 3652: Maternal body mass index, diabetes, and gestational weight gain and risk for pediatric cancer in offspring: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Cancer Research","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gestational diabetes; Meta-analysis; Body mass index; Cancer; Offspring; Pregnancy; Obesity; Pediatrics; Obstetrics; Internal medicine; Gestation","score_opus":0.13690167788870425,"score_gpt":0.44625090398161515,"score_spread":0.30934922609291093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282933379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056139164,0.98983145,0.000008970964,0.00039270543,0.000020959413,0.0073649557,0.0017635575,0.00001109463,0.00004489911],"genre_scores_gemma":[0.00046637314,0.9751568,0.00007634419,0.00007829055,0.000073597286,0.02242786,0.00022821485,0.00005798289,0.0014345335],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951816,0.0008122352,0.00096969545,0.00086131314,0.0014271169,0.00074799015],"domain_scores_gemma":[0.9966639,0.0018580782,0.00040192538,0.0003926953,0.00029465876,0.0003886954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046464466,0.0004006181,0.0038460428,0.0017055308,0.0002059177,0.00013471347,0.0002488244,0.000119554395,0.0015916404],"category_scores_gemma":[0.00076189346,0.0002903095,0.00051177316,0.0014618655,0.00012836218,0.00010792182,0.0002926899,0.0010190384,0.0000036800009],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001733898,0.00004265475,0.004142487,0.9528223,0.035264134,0.00002920122,0.000018514116,0.000007474932,4.102076e-7,0.000066815825,0.00051348336,0.0070751403],"study_design_scores_gemma":[0.0015339834,0.00026633416,0.018915104,0.031520683,0.82611203,0.0000071471845,0.000058622943,0.000361879,0.0000010057165,0.00033650926,0.12006266,0.0008240499],"about_ca_topic_score_codex":0.00063832826,"about_ca_topic_score_gemma":0.00019052133,"teacher_disagreement_score":0.92130166,"about_ca_system_score_codex":0.0005116204,"about_ca_system_score_gemma":0.00072560314,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W4282934146","doi":"10.1158/1538-7445.am2022-1155","title":"Abstract 1155: cBioPortal for cancer genomics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bioconductor; Genomics; Library science; Medicine; Data science; Computer science; Genome; Biology; Genetics","score_opus":0.05237915269810959,"score_gpt":0.3787754107327689,"score_spread":0.32639625803465927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282934146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862552,0.008080876,0.00046471934,0.00096551597,0.0006689876,0.0007438414,0.00072141725,0.000010558136,0.0020888292],"genre_scores_gemma":[0.99264646,0.0013890077,0.00019122001,0.00037706233,0.0007788858,0.0013604517,0.0001854231,0.000035061184,0.003036432],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988123,0.000026761776,0.00019328918,0.00026330404,0.0002323541,0.00047199227],"domain_scores_gemma":[0.99940884,0.000017865672,0.000058009457,0.00028466614,0.0001318289,0.00009877222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007180709,0.00009657546,0.00010832886,0.000054452263,0.0004519665,0.000035414636,0.00035696305,0.00007168551,0.00055049645],"category_scores_gemma":[0.000014779235,0.000099889476,0.00008847498,0.00011305779,0.00008862898,0.0000026954012,0.00032670924,0.0002856505,0.0000058830215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006015659,0.000098037934,0.0007221698,0.00013614591,0.00019840359,0.0000051339393,0.00034907766,0.006454992,0.7103291,0.0006692903,0.18844472,0.09199138],"study_design_scores_gemma":[0.0005808924,0.00020185292,0.00039284915,0.0000075759353,0.0000071984555,0.0000040483897,0.00037856487,0.0005516265,0.030636355,0.0005263778,0.96651113,0.00020154523],"about_ca_topic_score_codex":0.0002241746,"about_ca_topic_score_gemma":0.00019215676,"teacher_disagreement_score":0.7780664,"about_ca_system_score_codex":0.00014775821,"about_ca_system_score_gemma":0.00052687165,"threshold_uncertainty_score":0.602755},"labels":[],"label_agreement":null},{"id":"W4282934381","doi":"10.1158/1538-7445.am2022-126","title":"Abstract 126: Defining how oxidative stress drives the evolution of aggressive breast cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Breast cancer; Oxidative stress; Transcription factor; Cancer research; Metastasis; Malignancy; Medicine; Cancer; Disease; Biology; Bioinformatics; Immunology; Internal medicine; Gene; Genetics","score_opus":0.025941271835125367,"score_gpt":0.3343711659341407,"score_spread":0.30842989409901533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282934381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95763254,0.03843538,0.000043879645,0.0007554144,0.0007502217,0.00033904443,0.0010665822,0.0000072153207,0.00096970133],"genre_scores_gemma":[0.99476767,0.0028839,0.000018713423,0.00003864426,0.0008145441,0.00045773844,0.00007826004,0.000024612902,0.0009159263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818486,0.0002576403,0.00014571579,0.00038012472,0.00059554784,0.00043613123],"domain_scores_gemma":[0.9988713,0.00005574892,0.00024145895,0.0004121609,0.00033559074,0.000083688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057627354,0.0001261253,0.00015941194,0.00010019442,0.00049243396,0.000031561216,0.00050353934,0.00006196314,0.00021233936],"category_scores_gemma":[0.00013719684,0.00010408857,0.00009672367,0.00035666054,0.00041288172,0.000008456177,0.0004037982,0.00043553486,0.0000020212208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004560215,0.00006410108,0.002546375,0.000058490747,0.0001822499,0.0000033678439,0.0009894321,0.0024325284,0.94839644,0.00060741394,0.023336725,0.020926861],"study_design_scores_gemma":[0.002642772,0.00066422764,0.08073196,0.0002346682,0.000082165476,0.00006735224,0.03590487,0.00010258218,0.59511805,0.00045560292,0.2832617,0.00073409814],"about_ca_topic_score_codex":0.0034877707,"about_ca_topic_score_gemma":0.0011671301,"teacher_disagreement_score":0.3532784,"about_ca_system_score_codex":0.0003801066,"about_ca_system_score_gemma":0.0013757538,"threshold_uncertainty_score":0.5272489},"labels":[],"label_agreement":null},{"id":"W4282934638","doi":"10.1158/1538-7445.am2022-1121","title":"Abstract 1121: Identification and <i>in vivo</i> validation of unique anti-oncogenic properties and mechanisms involving protein kinase signalling and autophagy mediated by the investigational new agent PV-10","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Cancer research; Aurora kinase; Melanoma; Kinase; Aurora A kinase; Cancer; Metastasis; Medicine; Biology; Cell cycle; Internal medicine; Cell biology","score_opus":0.09095453036064802,"score_gpt":0.33697267184324453,"score_spread":0.24601814148259651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282934638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943135,0.0025785747,0.00002223892,0.0017359375,0.0000130491935,0.0012654728,0.000043590368,0.0000115384555,0.000016138303],"genre_scores_gemma":[0.9982122,0.00041444055,0.000042370448,0.000042630956,0.000018266122,0.00045940775,0.0000359882,0.000016676457,0.0007580159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824786,0.00027968112,0.00023136179,0.00029008422,0.00071571534,0.00023529102],"domain_scores_gemma":[0.99935454,0.00013684732,0.00007095874,0.00012961269,0.00014008235,0.0001679439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010508772,0.00009184834,0.00014197134,0.00019448414,0.0002573728,0.000056033183,0.00008543619,0.000032750668,0.0001854406],"category_scores_gemma":[0.0002409399,0.00007013951,0.000015002777,0.00035599718,0.00020637388,0.0001260273,0.00015026942,0.00033561836,0.0000011520431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021856563,0.00007032256,0.0008616958,0.00018385776,0.00003071294,0.000021526677,0.0003295831,0.000039954455,0.9971485,0.0001230829,0.0003378699,0.0006343361],"study_design_scores_gemma":[0.0010776394,0.00023716805,0.0056050895,0.00014282351,0.000010763202,0.0000110469555,0.00025664523,0.00071065954,0.9907249,0.0010292785,0.00013553243,0.000058445094],"about_ca_topic_score_codex":0.0009954997,"about_ca_topic_score_gemma":0.00004995636,"teacher_disagreement_score":0.0064235837,"about_ca_system_score_codex":0.00016140207,"about_ca_system_score_gemma":0.00054874195,"threshold_uncertainty_score":0.28602064},"labels":[],"label_agreement":null},{"id":"W4282934712","doi":"10.1158/1538-7445.am2022-1361","title":"Abstract 1361: Crosstalk between peripherally expanded T cells and Tfh-like cells in shaping effector functions of CD8 T cells in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Cytotoxic T cell; Ovarian cancer; Cancer research; CD8; Immune checkpoint; Immune system; Tumor microenvironment; Granzyme; Biology; Perforin; Immunology; T cell; Cancer; Immunotherapy","score_opus":0.07595620165777602,"score_gpt":0.38082194835241356,"score_spread":0.30486574669463756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282934712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990998,0.005356718,0.0000066415973,0.00052379275,0.0005116505,0.0011911992,0.0008574491,0.000019434041,0.0005350789],"genre_scores_gemma":[0.9951499,0.0013640788,0.000030268688,0.00015588722,0.00021286936,0.00071844447,0.000038662944,0.000052848,0.0022770157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970751,0.00026990072,0.0005368145,0.0005697828,0.00081883086,0.0007296121],"domain_scores_gemma":[0.9988908,0.00031139186,0.000109693756,0.00038082318,0.00013248625,0.00017480874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015918536,0.00021938271,0.00052066887,0.0005772686,0.00025864143,0.000054038188,0.00024448213,0.00012520033,0.0041810875],"category_scores_gemma":[0.000015637019,0.00021673381,0.00011499609,0.001199698,0.00032828722,0.00011995317,0.00019379401,0.001069376,0.000006798524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002512386,0.00017997879,0.05518584,0.0005120051,0.000117649724,0.00006349279,0.002147249,0.0002340647,0.9255147,0.0000011909192,0.0025757202,0.010955722],"study_design_scores_gemma":[0.011183415,0.00083177496,0.45168886,0.0009294917,0.000048855687,0.000005841921,0.0027786635,0.000092291266,0.4936672,0.000019715582,0.0382715,0.00048240024],"about_ca_topic_score_codex":0.030385064,"about_ca_topic_score_gemma":0.0055778758,"teacher_disagreement_score":0.4318475,"about_ca_system_score_codex":0.0013061982,"about_ca_system_score_gemma":0.0010964024,"threshold_uncertainty_score":0.99672925},"labels":[],"label_agreement":null},{"id":"W4282935129","doi":"10.1158/1538-7445.am2022-912","title":"Abstract 912: A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Nestin; Cancer research; Carcinogenesis; Glioma; Biology; Gene; Mutation; Genetics; Stem cell; Neural stem cell","score_opus":0.03667223026750355,"score_gpt":0.33212466035976335,"score_spread":0.2954524300922598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947215,0.0059209513,0.003469466,0.00018329569,0.00012398818,0.00049407606,0.00018142218,0.0000066344537,0.00014804196],"genre_scores_gemma":[0.9954227,0.001317428,0.0016173945,0.0000458358,0.0003969055,0.00042408,0.00016047532,0.000034155175,0.0005810344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845445,0.00008021582,0.00025925523,0.00038147657,0.00047355186,0.00035107002],"domain_scores_gemma":[0.99918085,0.000016606615,0.000058145637,0.00033060982,0.00033109065,0.000082673636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006424468,0.0001226609,0.00018513943,0.00013106853,0.00010615076,0.000017691591,0.00022903553,0.000085449006,0.00010816918],"category_scores_gemma":[0.000045628218,0.00012000313,0.00004484789,0.00032898074,0.000109106724,0.000008279049,0.00014387339,0.00022927474,8.471805e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003531082,0.00007594549,0.00042569233,0.000039965056,0.000023463543,0.0000010050798,0.0001127171,0.24233814,0.75446063,0.00015266187,0.0005731063,0.0014435934],"study_design_scores_gemma":[0.0041223043,0.00066259026,0.022650087,0.00007647878,0.000024124538,0.00002273503,0.00019739277,0.026722573,0.8950318,0.00027342458,0.049621955,0.00059453404],"about_ca_topic_score_codex":0.00020505277,"about_ca_topic_score_gemma":0.0002279257,"teacher_disagreement_score":0.21561556,"about_ca_system_score_codex":0.000089099565,"about_ca_system_score_gemma":0.00068005646,"threshold_uncertainty_score":0.48935857},"labels":[],"label_agreement":null},{"id":"W4282935937","doi":"10.1158/1538-7445.am2022-5984","title":"Abstract 5984: MT1-MMP cooperates with TGF-beta receptor-mediated signaling to trigger SNAIL and induce epithelial-to-mesenchymal-like transition in U87 glioblastoma cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Cancer research; Epithelial–mesenchymal transition; Snail; Biology; Signal transduction; Transforming growth factor beta; Gene silencing; Cell biology; Metastasis; Cancer; Gene; Biochemistry","score_opus":0.021174556594171806,"score_gpt":0.30429997903048134,"score_spread":0.28312542243630956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946552,0.0017977244,0.000033037344,0.0011261237,0.0011309141,0.00080301013,0.00031204944,0.000015195682,0.0001267742],"genre_scores_gemma":[0.9942107,0.000835616,0.00006416221,0.0006561319,0.0022032652,0.0007268957,0.000092139606,0.0000586618,0.001152403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975242,0.0002671442,0.000274231,0.00071942597,0.0005517107,0.0006632707],"domain_scores_gemma":[0.9989877,0.000063051775,0.000042749874,0.00032210714,0.0002693832,0.00031504952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010306988,0.0002167586,0.00028258737,0.00033667262,0.00027297306,0.00007333465,0.00028495071,0.0001216714,0.00050390465],"category_scores_gemma":[0.000047168363,0.00020645297,0.0000472992,0.000934888,0.00011649531,0.000013519336,0.00017399041,0.000529756,0.000025771993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018038775,0.00007913562,0.00013017993,0.00004322855,0.000035597204,0.000002559985,0.0011546074,0.0026978627,0.97241145,0.000005549008,0.01931289,0.002323039],"study_design_scores_gemma":[0.0014119713,0.00087248837,0.0010659024,0.000059071837,0.00000776504,0.000005681616,0.0008135812,0.000016850629,0.63459414,0.000003129474,0.36084116,0.00030825433],"about_ca_topic_score_codex":0.0012121508,"about_ca_topic_score_gemma":0.0011505538,"teacher_disagreement_score":0.34152827,"about_ca_system_score_codex":0.00014687749,"about_ca_system_score_gemma":0.0006366513,"threshold_uncertainty_score":0.8418908},"labels":[],"label_agreement":null},{"id":"W4282935984","doi":"10.1158/1538-7445.am2022-5469","title":"Abstract 5469: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Cancer research; Prostate cancer; FOXA1; SWI/SNF; Androgen receptor; Enhancer; Cancer; TMPRSS2; Enzalutamide; Biology; Cell growth; Chromatin remodeling; Chromatin; Transcription factor; Medicine; Internal medicine; Gene; Breast cancer; Genetics; Disease","score_opus":0.03884122648464811,"score_gpt":0.38558856639168204,"score_spread":0.34674733990703394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980283,0.017288657,0.000007441751,0.0005183309,0.00029703096,0.0004086862,0.00022231364,0.000025019974,0.0009495036],"genre_scores_gemma":[0.99155325,0.003570782,0.000051929044,0.00016502838,0.00048648752,0.0016896562,0.00016296234,0.000054536675,0.0022653698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747354,0.00019745991,0.0003210127,0.0006275228,0.00063882716,0.00074164924],"domain_scores_gemma":[0.9991848,0.000036879104,0.000080916056,0.00035658965,0.0002201574,0.00012064823],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095897744,0.00017238838,0.00018838177,0.00014372384,0.00039921567,0.000046115,0.00041477918,0.00008615746,0.0021075727],"category_scores_gemma":[0.00011194744,0.00017891827,0.00007769033,0.0005290165,0.00012380807,0.0000075556404,0.0004165434,0.0006539786,0.00001118326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033233143,0.00008637962,0.0031980167,0.00008634591,0.000035758916,0.00001837128,0.0003447014,0.009743465,0.9446405,0.000007083687,0.027424851,0.014082206],"study_design_scores_gemma":[0.00172246,0.00031055356,0.0046844217,0.0001616045,0.000009824503,0.0000053637204,0.0014043561,0.0007244088,0.7883089,0.00014444134,0.20197104,0.00055261457],"about_ca_topic_score_codex":0.0037271152,"about_ca_topic_score_gemma":0.0011224172,"teacher_disagreement_score":0.1745462,"about_ca_system_score_codex":0.00041874932,"about_ca_system_score_gemma":0.00095113856,"threshold_uncertainty_score":0.9988046},"labels":[],"label_agreement":null},{"id":"W4282936358","doi":"10.1158/1538-7445.am2022-1549","title":"Abstract 1549: The tumorigenesis model in DGCR8 associated schwannomatosis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"SMARCB1; Neurofibromatosis type 2; Schwannoma; Germline; Germline mutation; Cancer research; Exome sequencing; Somatic cell; Exome; Medicine; Biology; Mutation; Pathology; Genetics; Gene","score_opus":0.12359550208191666,"score_gpt":0.39646035976943766,"score_spread":0.272864857687521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282936358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888946,0.0013122052,0.0000010086417,0.0056222705,0.00011412491,0.0005892366,0.00011044576,0.00004989042,0.0033062585],"genre_scores_gemma":[0.99653924,0.0001458906,0.000014740079,0.00037751734,0.00007631007,0.0009652467,0.000018612322,0.00004549203,0.0018169568],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996984,0.00030929572,0.00032362694,0.00040202474,0.0013249675,0.00065608585],"domain_scores_gemma":[0.99880207,0.00030608996,0.00006156229,0.00050271617,0.00017877857,0.00014880835],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018552551,0.00013677718,0.00028595977,0.00032953214,0.0006605572,0.000058753154,0.00038022417,0.00004771887,0.001355026],"category_scores_gemma":[0.00026871145,0.000103767095,0.00011522535,0.0013178237,0.00014574859,0.000076048076,0.0003351668,0.001068298,0.000038072776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023265302,0.0027289458,0.2216207,0.0004682746,0.00034868394,0.0037414834,0.0033347562,0.013972674,0.52462083,0.0029325406,0.2154319,0.0084727],"study_design_scores_gemma":[0.007127934,0.0013724527,0.84629786,0.00055629876,0.0001128125,0.00033256196,0.0057881097,0.025227219,0.073530674,0.0022511485,0.036372986,0.0010299626],"about_ca_topic_score_codex":0.0012095014,"about_ca_topic_score_gemma":0.00011877392,"teacher_disagreement_score":0.6246772,"about_ca_system_score_codex":0.0006802598,"about_ca_system_score_gemma":0.00087867555,"threshold_uncertainty_score":0.99955785},"labels":[],"label_agreement":null},{"id":"W4282936376","doi":"10.1158/1538-7445.am2022-2902","title":"Abstract 2902: Development of PSB202, a bifunctional antibody pair that target CD20 and CD37, for the treatment of B-cell malignancies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cystic Fibrosis Canada","funders":"","keywords":"CD20; Antibody-dependent cell-mediated cytotoxicity; Obinutuzumab; Antibody; Monoclonal antibody; Radioimmunotherapy; Rituximab; Cancer research; B cell; Cell culture; Immunology; Non-Hodgkin's lymphoma; Lymphoma; Chemistry; Medicine; Biology","score_opus":0.14392422371653277,"score_gpt":0.4191626808209548,"score_spread":0.2752384571044221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282936376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983786,0.0120593365,0.00004178885,0.0022568528,0.00012509302,0.00096984016,0.0003069392,0.0000074224417,0.00044672954],"genre_scores_gemma":[0.98853105,0.0027425196,0.0007803594,0.0000397447,0.0001386544,0.0009071103,0.00009704824,0.000020384354,0.0067430967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978837,0.00007087488,0.00026718993,0.0002651676,0.0011015316,0.00041155296],"domain_scores_gemma":[0.9984427,0.0008613834,0.00006929839,0.00020257385,0.00030700493,0.00011701353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086074736,0.00012502486,0.00028646048,0.00018838026,0.00052217074,0.000011729213,0.00016341469,0.00003425381,0.0013403685],"category_scores_gemma":[0.00003558432,0.00007764903,0.00011651636,0.00028233745,0.0003398479,0.00002956703,0.00014351906,0.00021323904,0.0000035282665],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071051144,0.002428573,0.11416442,0.0020520487,0.00073825015,0.000047959256,0.00527684,0.00010869002,0.812233,0.0006354766,0.011073515,0.044136167],"study_design_scores_gemma":[0.002080568,0.0017787003,0.12470673,0.000072986855,0.000029084087,0.000012768438,0.0020052781,0.00016275929,0.32474402,0.0001251191,0.54416925,0.00011275217],"about_ca_topic_score_codex":0.00058737874,"about_ca_topic_score_gemma":0.00003941669,"teacher_disagreement_score":0.5330957,"about_ca_system_score_codex":0.00021137497,"about_ca_system_score_gemma":0.0010001998,"threshold_uncertainty_score":0.9995725},"labels":[],"label_agreement":null},{"id":"W4282936598","doi":"10.1158/1538-7445.am2022-5616","title":"Abstract 5616: Tumor-targeted immune activation via a site-specific TLR7-agonist antibody-drug conjugate","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Agonist; Immune system; Conjugate; Chemistry; Antibody; In vivo; Systemic administration; Pharmacology; Biology; Biochemistry; Immunology; Receptor","score_opus":0.08176485321994376,"score_gpt":0.4318421477716949,"score_spread":0.35007729455175113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282936598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827539,0.0018111767,0.00003828057,0.008764081,0.00008750766,0.0007138965,0.00010919588,0.000090015514,0.0056319693],"genre_scores_gemma":[0.99482185,0.000305526,0.000040457497,0.00031696708,0.00038488902,0.0007141705,0.00038467566,0.00003803728,0.0029934312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997773,0.000092590984,0.00030247655,0.00045283587,0.00084011996,0.0005389696],"domain_scores_gemma":[0.99875355,0.00018299378,0.0000689775,0.0004919229,0.00023812887,0.00026441898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077144697,0.00014318048,0.00023459138,0.00011242087,0.00086218654,0.000052762163,0.0002599025,0.00003897381,0.00830523],"category_scores_gemma":[0.000054195418,0.00014430346,0.00009360127,0.0008081637,0.00025582925,0.00007062826,0.00015483353,0.0014263827,0.00017692598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005370132,0.00023690349,0.00032588298,0.00013505467,0.000033030377,0.00006087314,0.00015914033,0.00008320137,0.9857193,0.00014812732,0.010891479,0.001669982],"study_design_scores_gemma":[0.0010284968,0.000047762485,0.006794097,0.00004291132,0.000012212618,0.0000270846,0.00022505729,0.00024525102,0.70897853,0.00013766778,0.2823182,0.00014274774],"about_ca_topic_score_codex":0.00031832492,"about_ca_topic_score_gemma":0.000002263758,"teacher_disagreement_score":0.2767408,"about_ca_system_score_codex":0.00059532985,"about_ca_system_score_gemma":0.00032923766,"threshold_uncertainty_score":0.99260134},"labels":[],"label_agreement":null},{"id":"W4282936736","doi":"10.1158/1538-7445.am2022-5990","title":"Abstract 5990: Targeted nanoparticles reduce tumor progression and lung metastasis by limiting DNA damage repair and immune suppression in metastatic triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Olaparib; Cancer research; PARP inhibitor; PARP1; Biology; Medicine; Poly ADP ribose polymerase; Biochemistry; Polymerase","score_opus":0.05990157005565653,"score_gpt":0.4212244016056191,"score_spread":0.36132283154996253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282936736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693365,0.024112241,0.0000012425985,0.0038666795,0.00013931582,0.0015631036,0.00076844805,0.00008522175,0.00012723778],"genre_scores_gemma":[0.99481547,0.0013769025,0.00032375357,0.00017207094,0.00008755398,0.0028574765,0.000052706528,0.000066795044,0.0002472827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596334,0.0008089948,0.00057483494,0.00075451884,0.0011287966,0.0007695039],"domain_scores_gemma":[0.99843955,0.00044147286,0.00019868866,0.00036329695,0.0002549757,0.00030200527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023318501,0.00025713112,0.0005296739,0.00041616714,0.00064460264,0.00006963763,0.00016374167,0.000045458753,0.0020400241],"category_scores_gemma":[0.00023376143,0.00022778034,0.00007575342,0.0010930155,0.00044347768,0.00031550892,0.00032770046,0.0010835328,0.0000017617316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029628961,0.0002849027,0.006678197,0.00046321694,0.00016530792,0.00019285244,0.0016776475,0.000033585882,0.96717685,0.00001953678,0.008911429,0.011433596],"study_design_scores_gemma":[0.00793347,0.00041357838,0.09728588,0.0014760856,0.0001047246,0.00014535648,0.0045609106,0.0014700836,0.8846984,0.00018635816,0.0013428377,0.00038231857],"about_ca_topic_score_codex":0.001720881,"about_ca_topic_score_gemma":0.000087734734,"teacher_disagreement_score":0.09060768,"about_ca_system_score_codex":0.0009169693,"about_ca_system_score_gemma":0.0005826221,"threshold_uncertainty_score":0.9988722},"labels":[],"label_agreement":null},{"id":"W4282937006","doi":"10.1158/1538-7445.am2022-3540","title":"Abstract 3540: Effect of route of Bacillus Calmette Guerin administration on the immune microenvironment and growth of bladder tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Tumor microenvironment; Urology; Immune system; CD8; Cancer; BCG vaccine; Internal medicine; Oncology; Cancer research; Immunology; Vaccination","score_opus":0.03728540451036644,"score_gpt":0.3463954640408511,"score_spread":0.30911005953048465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948365,0.0017084386,0.000001077464,0.001035914,0.000042143845,0.0007839487,0.00019829081,0.0000031531188,0.0013905171],"genre_scores_gemma":[0.9989319,0.00029035727,0.000006583746,0.000032028955,0.00003140756,0.00026108423,0.000014882688,0.000016155727,0.00041561152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984148,0.00020598671,0.00027397115,0.00019765372,0.00070662133,0.00020094261],"domain_scores_gemma":[0.9992446,0.00024318964,0.000102828286,0.00029228834,0.00005804944,0.000059088954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007711572,0.00010581104,0.0002967586,0.0001017558,0.000095408795,0.000003871095,0.00012458618,0.000027147467,0.0013748422],"category_scores_gemma":[0.000049924518,0.00007078499,0.00007654592,0.00020252734,0.00028386537,0.00002156267,0.00010038815,0.00030740758,0.0000031158195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008288477,0.0006421053,0.048391983,0.0010803585,0.00064215984,0.00006794195,0.0009889749,0.000041572166,0.9260689,0.00031717028,0.001145092,0.0123252785],"study_design_scores_gemma":[0.0016327171,0.003928694,0.19363417,0.00010893036,0.000056247096,0.000008725776,0.00015585087,0.000005672048,0.8000791,0.000031132553,0.00030988373,0.000048900565],"about_ca_topic_score_codex":0.0013826636,"about_ca_topic_score_gemma":0.000015737742,"teacher_disagreement_score":0.14524218,"about_ca_system_score_codex":0.00019084384,"about_ca_system_score_gemma":0.0002090112,"threshold_uncertainty_score":0.99953806},"labels":[],"label_agreement":null},{"id":"W4282937259","doi":"10.1158/1538-7445.am2022-lb559","title":"Abstract LB559: The X-linked gene for the helicase DDX3X is required for lymphoid differentiation and MYC-driven lymphomagenesis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Biology; Lymphoma; Carcinogenesis; Haematopoiesis; Germinal center; Cancer research; Allele; Gene; Molecular biology; Genetics; B cell; Stem cell; Immunology; Antibody","score_opus":0.08696704211220496,"score_gpt":0.3836821743408905,"score_spread":0.29671513222868556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803561,0.008737807,0.0020924797,0.006527186,0.00016989918,0.0013556349,0.0007116275,0.0000072274042,0.00004203933],"genre_scores_gemma":[0.9874337,0.0028579298,0.00008443867,0.0004461964,0.00049987977,0.006664632,0.00014938979,0.000029404235,0.0018344381],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988476,0.000081725884,0.00015455445,0.00035987797,0.0002510311,0.000305199],"domain_scores_gemma":[0.99902505,0.00013822141,0.00006286953,0.00048605233,0.00023397351,0.00005381199],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006249949,0.000097132186,0.00008780078,0.00003729511,0.0013033606,0.0000727703,0.0003705337,0.00005288516,0.00011693167],"category_scores_gemma":[0.000054359334,0.000065354725,0.0000942361,0.00014029504,0.00014373021,0.000004670488,0.00019118711,0.000075296484,0.0000015502869],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038347702,0.000042087457,0.00025069015,0.00003213456,0.00009676896,3.0230876e-7,0.00019138587,0.00020475531,0.9427957,0.00011159102,0.027120955,0.028770179],"study_design_scores_gemma":[0.002462906,0.00036947845,0.016580872,0.000009640419,0.00007166595,0.000013850309,0.0009406709,0.003782332,0.3999066,0.00043738706,0.5751474,0.00027720488],"about_ca_topic_score_codex":0.0001990768,"about_ca_topic_score_gemma":0.00005063767,"teacher_disagreement_score":0.54802644,"about_ca_system_score_codex":0.00011661857,"about_ca_system_score_gemma":0.00027554348,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W4282937497","doi":"10.1158/1538-7445.am2022-ct572","title":"Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvo Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Carboplatin; Pemetrexed; Internal medicine; Oncology; Trastuzumab; Tolerability; Durvalumab; Lapatinib; Cancer; Lung cancer; Chemotherapy; Cisplatin; Nivolumab; Breast cancer; Immunotherapy; Adverse effect","score_opus":0.0972688980441431,"score_gpt":0.4678346401220942,"score_spread":0.3705657420779511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849795,0.0052956203,0.000057497855,0.00040526257,0.00010387823,0.008754194,0.000106556115,0.000060485916,0.00023700848],"genre_scores_gemma":[0.99021214,0.000935613,0.0014399433,0.000050316023,0.00007482236,0.006576986,0.000051837356,0.0001384804,0.00051984726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99235004,0.001158603,0.0009749005,0.0014164606,0.0028112964,0.001288704],"domain_scores_gemma":[0.99640274,0.0015379346,0.00034365625,0.0005713032,0.0007612181,0.00038314748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043631154,0.0005440151,0.0010277919,0.0012993029,0.00087490736,0.00015783505,0.0003041365,0.00009589353,0.0004908875],"category_scores_gemma":[0.0009499247,0.00042894454,0.00005229169,0.0025705013,0.000354191,0.00044297663,0.0005361713,0.0019288006,0.0000011974113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07165383,0.01174888,0.40154552,0.0053130346,0.0005802676,0.0022876258,0.045265198,0.010665103,0.12255553,0.000006693798,0.00054924114,0.32782906],"study_design_scores_gemma":[0.14053726,0.021733133,0.72767687,0.003220845,0.0004225286,0.000080198,0.035963938,0.063612714,0.0055655614,0.000049814083,0.000059231068,0.0010778945],"about_ca_topic_score_codex":0.014016018,"about_ca_topic_score_gemma":0.029589709,"teacher_disagreement_score":0.32675117,"about_ca_system_score_codex":0.003291398,"about_ca_system_score_gemma":0.0032952772,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W4282937622","doi":"10.1158/1538-7445.am2022-2515","title":"Abstract 2515: Estrogen regulates the immune microenvironment of colorectal cancer liver metastases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Estrogen; Immune system; Cancer research; Medicine; Estrogen receptor; Cytokine; Cytotoxic T cell; Fulvestrant; Cancer; Internal medicine; Immunology; Biology; Breast cancer","score_opus":0.03926061580326935,"score_gpt":0.32649498190904785,"score_spread":0.2872343661057785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7797765,0.21740082,7.37867e-7,0.00073303835,0.00074915495,0.000552378,0.00045624695,0.000018065562,0.0003130745],"genre_scores_gemma":[0.9872142,0.0070209396,0.000016088488,0.00006435692,0.000046121957,0.0014058648,0.000071508795,0.000041137373,0.004119794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974422,0.0007320695,0.00039682334,0.00041409137,0.00027092354,0.00074387697],"domain_scores_gemma":[0.9986802,0.00043856763,0.00017486278,0.00056321966,0.00011844882,0.000024746392],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014747024,0.0001919716,0.00032874942,0.00014655072,0.0008948867,0.000016619551,0.0010134265,0.0000930716,0.030801732],"category_scores_gemma":[0.000040957486,0.0001489269,0.00016816102,0.00038495025,0.0013404954,0.00006251543,0.0009876807,0.0011767183,0.00014474835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006309008,0.00016052867,0.0008913762,0.000047155383,0.0004934509,0.000011774262,0.00086987304,0.0006405107,0.9718155,0.00020522208,0.015601953,0.008631744],"study_design_scores_gemma":[0.0006478444,0.00015424854,0.0105858175,0.000027410333,0.00004115301,0.000019751042,0.0009062229,0.0000024219444,0.7976802,0.00004631778,0.18975587,0.00013273381],"about_ca_topic_score_codex":0.0063465512,"about_ca_topic_score_gemma":0.000119267024,"teacher_disagreement_score":0.21037988,"about_ca_system_score_codex":0.00069499924,"about_ca_system_score_gemma":0.00044348536,"threshold_uncertainty_score":0.97008425},"labels":[],"label_agreement":null},{"id":"W4282938858","doi":"10.1158/1538-7445.am2022-5886","title":"Abstract 5886: Pre-treatment adiposity measured by computed tomography and survival of women with high-grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Serous fluid; Body mass index; Ovarian cancer; Internal medicine; Population; Proportional hazards model; Ascites; Oncology; Cancer; Confidence interval","score_opus":0.04544216654781944,"score_gpt":0.3415544304261457,"score_spread":0.29611226387832623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282938858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874556,0.007203092,0.0000054790257,0.0029659516,0.00016267123,0.0012776916,0.00072784297,0.000043395412,0.00015827602],"genre_scores_gemma":[0.9955125,0.0010826297,0.000095141004,0.00008326677,0.000120072546,0.0027431427,0.000066517576,0.000046946723,0.0002497914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691933,0.00023235798,0.00026501945,0.0006128463,0.0012245089,0.00074591587],"domain_scores_gemma":[0.9985553,0.00015482733,0.00010356491,0.00046503238,0.00027868175,0.00044258073],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065438583,0.00024632324,0.00058649475,0.00024298979,0.0003718271,0.00003848599,0.00016522944,0.00006445582,0.0010893525],"category_scores_gemma":[0.0000084015965,0.0001909821,0.00006441602,0.00083668303,0.00025188128,0.00006112175,0.000124374,0.00040892418,0.0000012472784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010072686,0.005555713,0.8909495,0.00074251735,0.0058230925,0.00045711565,0.0053428537,0.00063675095,0.031393792,0.0003050434,0.009288329,0.039432615],"study_design_scores_gemma":[0.009536867,0.004522488,0.9509409,0.00020379633,0.00023722215,0.000019413521,0.00047769118,0.000021768325,0.020803768,0.00006326863,0.012908583,0.00026421715],"about_ca_topic_score_codex":0.033859733,"about_ca_topic_score_gemma":0.0020935268,"teacher_disagreement_score":0.059991427,"about_ca_system_score_codex":0.0028705343,"about_ca_system_score_gemma":0.000956502,"threshold_uncertainty_score":0.9998238},"labels":[],"label_agreement":null},{"id":"W4282939251","doi":"10.1158/1538-7445.am2022-ct537","title":"Abstract CT537: A phase 2, multicenter, randomized, double-blind trial of maintenance therapy with FLT3 inhibitor gilteritinib (ASP2215) in patients with FLT3/ITD AML (GOSSAMER study)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Placebo; Surgery; Internal medicine; Randomization; Discontinuation; Intention-to-treat analysis; Hazard ratio; Randomized controlled trial; Confidence interval; Pathology","score_opus":0.08475048191245492,"score_gpt":0.4207714481141023,"score_spread":0.33602096620164734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97948486,0.00036541416,0.000008503132,0.0009407007,0.00020056794,0.018168394,0.00015405512,0.000035454552,0.0006420543],"genre_scores_gemma":[0.989413,0.0002783572,0.000097575496,0.00011688865,0.0003407611,0.008539455,0.000097622345,0.00013018804,0.0009861097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915988,0.0011658684,0.0009877987,0.0009752583,0.0039570155,0.001315288],"domain_scores_gemma":[0.996343,0.0006935105,0.00029597533,0.000987453,0.0012798879,0.00040016894],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052296235,0.00040684923,0.001393212,0.0010161885,0.00030953615,0.00007685192,0.0006761269,0.000104915714,0.0017466884],"category_scores_gemma":[0.00030160457,0.00027652193,0.00017230524,0.0018746015,0.0009792523,0.00023756975,0.0003756491,0.0023849548,0.000017054075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96709836,0.010728492,0.010181996,0.00015206526,0.00053988176,0.00040221112,0.0022302472,0.000048402715,0.0016781596,0.00001082382,0.0016476276,0.0052817264],"study_design_scores_gemma":[0.9771829,0.010950975,0.0032959275,0.00032420803,0.000051333085,0.000005746065,0.0025435607,0.000077434146,0.0032334365,0.0000049825976,0.0020352323,0.00029426618],"about_ca_topic_score_codex":0.0048524765,"about_ca_topic_score_gemma":0.00031187283,"teacher_disagreement_score":0.010084532,"about_ca_system_score_codex":0.0016682361,"about_ca_system_score_gemma":0.0024049708,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W4282939680","doi":"10.1158/1538-7445.am2022-6108","title":"Abstract 6108: <i>In vivo</i> CRISPR screens identified dual function of MEN1-MLL1 in regulating tumor-microenvironment interactions","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Biology; Epigenetics; Cancer research; In vivo; CRISPR; Tumor microenvironment; Chromatin; Gene knockout; Cancer; Cell biology; Genetics; Gene","score_opus":0.03642152940241653,"score_gpt":0.34522123141583333,"score_spread":0.3087997020134168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694,0.0010521058,0.0000327095,0.00023921319,0.00024937792,0.00028191778,0.00015089026,0.0000027493513,0.0010510474],"genre_scores_gemma":[0.99840033,0.00038806724,0.000034258785,0.00010321278,0.00014553861,0.00021994348,0.000053166732,0.00002215257,0.0006333432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985766,0.00010693736,0.00031290302,0.0003594951,0.00031168503,0.0003323845],"domain_scores_gemma":[0.9994477,0.00006115982,0.00008203625,0.0003001956,0.00005268993,0.00005621521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006909409,0.00009437166,0.00013226183,0.00018897657,0.0001306009,0.00002015498,0.00016323113,0.000033891043,0.0005595287],"category_scores_gemma":[0.00007158188,0.000114198294,0.00005535619,0.00025543722,0.00008581002,0.000006427938,0.00037856292,0.00035778063,0.0000029516357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036124117,0.00013706037,0.007264737,0.000028212333,0.000018810688,0.00001268752,0.00011012241,0.006768071,0.9768284,0.000059453647,0.007216583,0.0011946375],"study_design_scores_gemma":[0.001775019,0.0004272859,0.08581737,0.000089837326,0.0000129252185,0.000010700855,0.0026064715,0.00020069037,0.80583525,0.0002762256,0.102642514,0.00030573303],"about_ca_topic_score_codex":0.0029135551,"about_ca_topic_score_gemma":0.0050480426,"teacher_disagreement_score":0.17099315,"about_ca_system_score_codex":0.0003352268,"about_ca_system_score_gemma":0.00019605926,"threshold_uncertainty_score":0.6126447},"labels":[],"label_agreement":null},{"id":"W4282939729","doi":"10.1158/1538-7445.am2022-2060","title":"Abstract 2060: Treatment combination strategies to improve radiation efficacy in immunologically cold tumors <i>in vivo</i>","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Sting; Bladder cancer; In vivo; Radiation therapy; Immunotherapy; Cancer research; Immune system; Cancer; Internal medicine; Immunology; Biology","score_opus":0.05512858140882753,"score_gpt":0.3949893531006022,"score_spread":0.33986077169177464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940307,0.0011956093,0.0000012729199,0.0021477947,0.00014242326,0.0020233048,0.00008123125,0.00002948178,0.00497579],"genre_scores_gemma":[0.99504745,0.00042587964,0.000013710009,0.00016247606,0.00006259756,0.0028165295,0.000025355133,0.000022220504,0.0014237883],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99813783,0.00015606656,0.00026855213,0.0003950814,0.00057262485,0.00046984828],"domain_scores_gemma":[0.9993884,0.0001257402,0.000038134873,0.00025073905,0.0000864005,0.000110603905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047495,0.00013925882,0.00026266152,0.00041488,0.00014875586,0.00004424751,0.00013985309,0.000050032773,0.0011169377],"category_scores_gemma":[0.000040361665,0.00012265945,0.00005142525,0.0008277451,0.000051061572,0.00009802503,0.00007191029,0.00040693217,0.000026992942],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006295129,0.007260414,0.030594297,0.00012922425,0.00018018948,0.00076674577,0.004777124,0.0030115105,0.8433292,0.0021136238,0.0029434087,0.09859913],"study_design_scores_gemma":[0.02068672,0.0103057455,0.7707234,0.00017713237,0.00003186442,0.000010251662,0.003761362,0.00008621817,0.16568524,0.0005073378,0.027634807,0.00038989523],"about_ca_topic_score_codex":0.0076414957,"about_ca_topic_score_gemma":0.00065575365,"teacher_disagreement_score":0.7401291,"about_ca_system_score_codex":0.0032650253,"about_ca_system_score_gemma":0.0010024025,"threshold_uncertainty_score":0.99979615},"labels":[],"label_agreement":null},{"id":"W4282939738","doi":"10.1158/1538-7445.am2022-3813","title":"Abstract 3813: Unification of over 50 published single-cell RNA datasets covering over a 1000 patient samples with deep-learning reveals novel axes of tumor microenvironment variation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Centre for Phenogenomics","funders":"","keywords":"Computer science; Workflow; Ground truth; Artificial intelligence; Atlas (anatomy); Deep learning; Machine learning; Computational biology; Biology; Database","score_opus":0.03312181511764542,"score_gpt":0.2777606808536144,"score_spread":0.24463886573596896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702024,0.0006521595,0.001129046,0.000040284332,0.000060361497,0.0003341748,0.0006080537,0.0000048395545,0.00015082247],"genre_scores_gemma":[0.99812627,0.00014802978,0.0005042609,0.000037589863,0.000048171536,0.00008453343,0.0009515684,0.00003111516,0.00006845077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982849,0.00013015879,0.00033327242,0.00039848586,0.00056875544,0.00028444565],"domain_scores_gemma":[0.99914855,0.00005375354,0.0002450539,0.00037767825,0.00010753927,0.00006744778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005352038,0.00012803709,0.00017266018,0.00011019647,0.00016409335,0.000036105168,0.00026184408,0.00005130801,0.00032594457],"category_scores_gemma":[0.000053100724,0.00012572407,0.00005006863,0.00019056525,0.00011578269,0.00001894418,0.00018166953,0.00027097456,5.7217324e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055352616,0.00042608893,0.005091048,0.0001378843,0.000047088633,0.0000013379367,0.00030299765,0.006742787,0.9856969,0.00001802432,0.00022506271,0.00075725006],"study_design_scores_gemma":[0.0012147092,0.00088586856,0.046531644,0.000055605393,0.000021723325,0.0000025005386,0.00030821684,0.00021581813,0.93535364,0.0000103770935,0.015200713,0.00019917462],"about_ca_topic_score_codex":0.0015231078,"about_ca_topic_score_gemma":0.00009148929,"teacher_disagreement_score":0.050343256,"about_ca_system_score_codex":0.00016936744,"about_ca_system_score_gemma":0.00014476232,"threshold_uncertainty_score":0.51268786},"labels":[],"label_agreement":null},{"id":"W4282939778","doi":"10.1158/1538-7445.am2022-1058","title":"Abstract 1058: Evaluation of a novel class of bifunctional DNA alkylating agent and PARP inhibitor","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PARP1; Propidium iodide; Poly ADP ribose polymerase; DNA damage; Molecular biology; DNA repair; PARP inhibitor; Biology; Cancer research; Flow cytometry; DNA; Chemistry; Polymerase; Programmed cell death; Biochemistry; Apoptosis","score_opus":0.3031036381395359,"score_gpt":0.4876622091104945,"score_spread":0.18455857097095862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942988,0.0018898916,0.00003447123,0.0011409543,0.00022112214,0.0006302169,0.0001435804,0.000010704653,0.001630239],"genre_scores_gemma":[0.998628,0.00010711844,0.00012640808,0.000080579855,0.00025709343,0.0005769914,0.00003275122,0.000018928818,0.00017212133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672145,0.00017290772,0.0003474586,0.00025235835,0.0022839108,0.00022194516],"domain_scores_gemma":[0.9984545,0.00021679996,0.00014142357,0.00021574936,0.0008815594,0.000089979905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003590902,0.000078530255,0.00019996028,0.00028130226,0.00017390285,0.0000069461717,0.000074156625,0.00004082954,0.0035851733],"category_scores_gemma":[0.00020084968,0.000078336816,0.00005378651,0.0004957565,0.00022339287,0.000058519487,0.000097791715,0.0004060183,0.0000020347793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008162721,0.0003048536,0.0037301306,0.00023491142,0.00009832064,0.0000021937763,0.0008654772,0.0016592807,0.97158736,0.0002883812,0.0052455906,0.015167235],"study_design_scores_gemma":[0.026398247,0.0021760822,0.20815603,0.0011552189,0.00020222885,0.00006781998,0.0056125624,0.013418531,0.7120595,0.0016411591,0.028675325,0.0004373115],"about_ca_topic_score_codex":0.00024853516,"about_ca_topic_score_gemma":0.00001848495,"teacher_disagreement_score":0.2595279,"about_ca_system_score_codex":0.0007149169,"about_ca_system_score_gemma":0.0010535073,"threshold_uncertainty_score":0.99732566},"labels":[],"label_agreement":null},{"id":"W4282940254","doi":"10.1158/1538-7445.am2022-819","title":"Abstract 819: ERBB4 mediates IL10-induced growth of EGFR-independent colon tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ERBB4; Downregulation and upregulation; ErbB; Cancer research; Colorectal cancer; ERBB3; Biology; Medicine; Receptor; Cancer; Internal medicine; Epidermal growth factor receptor; Receptor tyrosine kinase; Gene; Genetics","score_opus":0.14543979386801828,"score_gpt":0.46036240678029816,"score_spread":0.31492261291227985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282940254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779117,0.001706908,0.000001490348,0.0075658676,0.00045350552,0.0016085082,0.00017258895,0.00007506778,0.010504361],"genre_scores_gemma":[0.99445045,0.0004649948,0.000044132496,0.00024206712,0.0006382399,0.0016680672,0.000045226076,0.00010660695,0.0023402087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9915198,0.0005253894,0.00064715423,0.00079139555,0.005133964,0.0013822638],"domain_scores_gemma":[0.99655104,0.0006470446,0.00014588569,0.00087098184,0.0011362421,0.00064879283],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047451607,0.0002520216,0.0006330049,0.00090060657,0.0004896671,0.000046297617,0.0009687916,0.000141523,0.013375256],"category_scores_gemma":[0.0009342805,0.0002427884,0.00018270484,0.0019038222,0.00042687912,0.00010848661,0.0009008404,0.0028563032,0.00015039851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027896112,0.00095820474,0.036766488,0.0018453792,0.00029854928,0.0012787217,0.002226171,0.00006170628,0.86121863,0.0009381372,0.07896559,0.012652808],"study_design_scores_gemma":[0.0064684716,0.0041275555,0.123755954,0.0007314485,0.000069773014,0.0001379878,0.0047602756,0.00019169267,0.82379127,0.0012384767,0.034019586,0.0007075002],"about_ca_topic_score_codex":0.0072425716,"about_ca_topic_score_gemma":0.0002764958,"teacher_disagreement_score":0.08698947,"about_ca_system_score_codex":0.0026623227,"about_ca_system_score_gemma":0.0043805493,"threshold_uncertainty_score":0.9994441},"labels":[],"label_agreement":null},{"id":"W4282940376","doi":"10.1158/1538-7445.am2022-5997","title":"Abstract 5997: The role of neutrophil extracellular trap-CCDC25-integrin linked kinase complex in pancreatic cancer progression and metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Spinal Cord Injury BC; Pancreas Centre (Canada)","funders":"","keywords":"Neutrophil extracellular traps; Metastasis; Cancer research; Integrin-linked kinase; Pancreatic cancer; Tumor microenvironment; Cancer; Biology; Pathology; Kinase; Immunology; Medicine; Cell biology; Inflammation; Protein kinase A","score_opus":0.07223978616198778,"score_gpt":0.36104403904406907,"score_spread":0.2888042528820813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282940376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419707,0.05546518,0.000003064574,0.0011809509,0.00013525168,0.0008304406,0.00022295414,0.00001885225,0.00017261953],"genre_scores_gemma":[0.9958648,0.0021833968,0.00002948303,0.000058096204,0.00004176635,0.0012630065,0.000054156015,0.000031675674,0.0004736288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971628,0.0011088736,0.00038789818,0.0004776353,0.0002284431,0.0006343353],"domain_scores_gemma":[0.998957,0.00031337148,0.00012934457,0.00040329076,0.00014887743,0.000048136568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014001369,0.00020620326,0.00041504658,0.00029870105,0.00057110237,0.000023247037,0.00051377923,0.00010139094,0.004143629],"category_scores_gemma":[0.000040351635,0.00014475762,0.00008456538,0.0006058852,0.00054289686,0.00007906238,0.00040184165,0.0013740034,0.000018315075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006079322,0.00020302682,0.0016658985,0.000058236645,0.00011882755,0.00003495701,0.0008864871,0.00005722436,0.9492733,0.0017366492,0.00027832214,0.045079138],"study_design_scores_gemma":[0.0019572452,0.0005318979,0.029920941,0.00016997052,0.000055347584,0.000020452739,0.0041511483,0.000037543225,0.9033768,0.001382585,0.058130704,0.00026533863],"about_ca_topic_score_codex":0.0029293462,"about_ca_topic_score_gemma":0.0003389469,"teacher_disagreement_score":0.057852384,"about_ca_system_score_codex":0.0001986555,"about_ca_system_score_gemma":0.0002580321,"threshold_uncertainty_score":0.99676675},"labels":[],"label_agreement":null},{"id":"W4282940543","doi":"10.1158/1538-7445.am2022-2293","title":"Abstract 2293: Evaluation of multiple myeloma research samples by analysis of B cell heavy and light chain receptors in a single NGS assay","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Molecular biology; Immunoglobulin light chain; Chronic lymphocytic leukemia; Biology; Immunoglobulin heavy chain; B cell; B-cell receptor; Plasma cell neoplasm; Antibody; Genetics; Multiple myeloma; Computational biology; Leukemia; Immunology","score_opus":0.0990063396041987,"score_gpt":0.4032455621753687,"score_spread":0.30423922257117003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282940543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937389,0.0037944952,0.000016878254,0.0005521226,0.000029279461,0.0007121901,0.00018569283,0.00000266783,0.0009677689],"genre_scores_gemma":[0.9981562,0.000354841,0.00005370065,0.000008653522,0.00003073647,0.00047186457,0.00025407868,0.000019548326,0.0006504036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994616,0.0018499591,0.00036921466,0.00050565094,0.0021669588,0.0004922186],"domain_scores_gemma":[0.9980143,0.0002319777,0.00008949205,0.0004258865,0.0011217515,0.00011661435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012407488,0.00010266731,0.00024672318,0.0010913288,0.00021270427,0.0000272503,0.00034664024,0.00010980688,0.0009856349],"category_scores_gemma":[0.0011144844,0.000105978506,0.00007926992,0.0024163492,0.0002569788,0.000008831533,0.0004363557,0.0004988415,0.0000016335348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045347924,0.00029728594,0.014790189,0.000067890505,0.0001001326,0.0000010209343,0.0004375905,0.00092120504,0.9699895,0.000010273655,0.0039492687,0.008982163],"study_design_scores_gemma":[0.0010433093,0.00046453436,0.014981006,0.000018932864,0.000021677153,3.5573075e-7,0.0015727258,0.0019150674,0.9618743,0.00004975484,0.017940605,0.00011774269],"about_ca_topic_score_codex":0.0033327513,"about_ca_topic_score_gemma":0.0028626185,"teacher_disagreement_score":0.013991337,"about_ca_system_score_codex":0.00030010138,"about_ca_system_score_gemma":0.0006018211,"threshold_uncertainty_score":0.9999276},"labels":[],"label_agreement":null},{"id":"W4282941071","doi":"10.1158/1538-7445.am2022-5729","title":"Abstract 5729: Dynamic phase separation of the androgen receptor and its coactivators to regulate gene expression","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Coactivator; Androgen receptor; Prostate cancer; Transcription factor; FOXA1; Biology; Cancer research; Nuclear receptor coactivator 3; Androgen; Transcription (linguistics); Cell biology; Gene; Cancer; Genetics; Endocrinology; Hormone","score_opus":0.07137576185562841,"score_gpt":0.4583538856016459,"score_spread":0.3869781237460175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282941071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919489,0.0030911942,0.0000023847351,0.0030685165,0.00012141771,0.0013285641,0.0001899832,0.00001382632,0.00023522013],"genre_scores_gemma":[0.9946873,0.0006776013,0.000024558847,0.000046188998,0.000057846646,0.00055429444,0.000042629337,0.000023497703,0.0038860494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802583,0.00017538966,0.00017747177,0.00031423592,0.00095704413,0.0003500454],"domain_scores_gemma":[0.9991466,0.00007186394,0.00004996917,0.00030801992,0.00022519493,0.0001983561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006746401,0.0000973426,0.00017842781,0.00019197424,0.0004501115,0.000017562003,0.00017359917,0.000041586507,0.00095091236],"category_scores_gemma":[0.000061776314,0.00006546982,0.000048669495,0.000657434,0.00010419656,0.000073131705,0.00032576526,0.0004242095,0.0000082308325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021150701,0.00017555365,0.0011005049,0.00009865611,0.000046397035,0.00001046863,0.00072456,0.000060464175,0.9865002,0.000011808437,0.003993507,0.005162811],"study_design_scores_gemma":[0.002558812,0.000558852,0.004395952,0.000117477044,0.0000128291085,0.000007687733,0.000369436,0.00015613588,0.9813848,0.000038759794,0.010322592,0.00007668006],"about_ca_topic_score_codex":0.00009691914,"about_ca_topic_score_gemma":0.000010008545,"teacher_disagreement_score":0.0063290857,"about_ca_system_score_codex":0.0005738257,"about_ca_system_score_gemma":0.00052037893,"threshold_uncertainty_score":0.99996233},"labels":[],"label_agreement":null},{"id":"W4282941222","doi":"10.1158/1538-7445.am2022-1877","title":"Abstract 1877: Measurement of cytosolic DNA sensing cGAS-STING pathway functional activity using <i>in vitro</i> phenotypic assay models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Sting; Stimulator of interferon genes; Cancer research; Cancer; Tumor microenvironment; Cancer immunotherapy; Innate immune system; Immune system; Immunotherapy; Medicine; Immune checkpoint; Biology; Interferon; Immunology; Internal medicine","score_opus":0.18466757667624076,"score_gpt":0.34982778327696484,"score_spread":0.16516020660072409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282941222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942596,0.0030109328,0.00048983085,0.00014773631,0.0005501337,0.00028789666,0.00007147584,0.00002441827,0.001157997],"genre_scores_gemma":[0.9994067,0.000028722803,0.000028250826,0.00003670407,0.00004413049,0.000042941116,0.000014119612,0.000027541017,0.00037087026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968499,0.0014038015,0.00033044783,0.00037311282,0.00036666324,0.0006761048],"domain_scores_gemma":[0.99890244,0.00032511537,0.00012134745,0.00029639486,0.00032829502,0.000026413054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037721305,0.00015625327,0.00031191818,0.0003992349,0.00057254825,0.00001785004,0.00023217856,0.000107505184,0.00075272133],"category_scores_gemma":[0.00018820066,0.00016069805,0.00010313529,0.00041493398,0.00022279032,0.00013353028,0.00033840927,0.0012337987,0.00001828654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030297304,0.00015498172,0.000044410266,0.000043724594,0.0000906922,0.0000088367415,0.00038723592,0.003339319,0.9774248,0.00007607518,0.00018817445,0.015211997],"study_design_scores_gemma":[0.0009612406,0.000096556694,0.0010831261,0.00008433791,0.000007689244,0.000027653316,0.0006289902,0.0009139279,0.99410975,0.00011183737,0.0018215876,0.00015330737],"about_ca_topic_score_codex":0.0022391647,"about_ca_topic_score_gemma":0.00011109684,"teacher_disagreement_score":0.016684923,"about_ca_system_score_codex":0.0011593647,"about_ca_system_score_gemma":0.0010160819,"threshold_uncertainty_score":0.8241771},"labels":[],"label_agreement":null},{"id":"W4282941260","doi":"10.1158/1538-7445.am2022-5725","title":"Abstract 5725: <i>HOXA9</i> demonstrates allelic imbalance in <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Biology; Allele; Genetics; Minor allele frequency; Leukemia; Gene; Single-nucleotide polymorphism; Allele frequency; Genotype","score_opus":0.02130108132594891,"score_gpt":0.32824672126624665,"score_spread":0.3069456399402977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282941260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154913,0.0057976176,0.000026642983,0.00055579166,0.00028299217,0.00049961155,0.00012145137,0.000023381892,0.0011433755],"genre_scores_gemma":[0.9955649,0.0019206046,0.00003993415,0.0001543175,0.00032991826,0.0007371669,0.00019727484,0.00005302227,0.0010028871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973746,0.00022203173,0.00033706933,0.0006634316,0.00066596473,0.0007369227],"domain_scores_gemma":[0.99904263,0.00005258758,0.000087165245,0.0005173533,0.00015763906,0.00014261043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008268545,0.00020169701,0.00021729303,0.00020936714,0.0003136006,0.000049443694,0.0004896036,0.00015841692,0.00033310193],"category_scores_gemma":[0.00006179056,0.00022319795,0.000094269366,0.00070963334,0.0001960689,0.00001113354,0.00036782524,0.0006045937,0.000024430485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053406035,0.00005201817,0.0057542403,0.000031711523,0.00008399741,0.00002476204,0.00011100832,0.015395781,0.9633403,0.000018956867,0.011651678,0.0030015125],"study_design_scores_gemma":[0.005800798,0.00091143104,0.13653702,0.00016368106,0.000049866925,0.00011751352,0.00057330815,0.0018933621,0.66013145,0.0003776745,0.19228387,0.0011600422],"about_ca_topic_score_codex":0.0012518569,"about_ca_topic_score_gemma":0.0013958474,"teacher_disagreement_score":0.30320883,"about_ca_system_score_codex":0.0009238429,"about_ca_system_score_gemma":0.0014514633,"threshold_uncertainty_score":0.9101748},"labels":[],"label_agreement":null},{"id":"W4282941936","doi":"10.1158/1538-7445.am2022-1794","title":"Abstract 1794: The combination of Talazoparib with anti-her2 drugs shows efficacy in drug resistant Her2+ and low Her2 PDX models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Breast cancer; PARP inhibitor; Cancer research; Cancer; Combination therapy; SKBR3; Internal medicine; Oncology; Poly ADP ribose polymerase; Biology; Polymerase; DNA","score_opus":0.060370640494501644,"score_gpt":0.3836592425164361,"score_spread":0.3232886020219345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282941936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871342,0.0022314112,0.000008254548,0.0054955003,0.000088637054,0.0012461537,0.00008323347,0.000027635708,0.0036849447],"genre_scores_gemma":[0.996993,0.0006868933,0.0000323567,0.00023451947,0.0000747267,0.0006327787,0.000022276516,0.00004755109,0.0012758817],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968739,0.00034237714,0.00037834694,0.00043811926,0.0014932209,0.00047401187],"domain_scores_gemma":[0.99852324,0.00038320746,0.00012405055,0.0005283021,0.000314869,0.00012636339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022305707,0.00016256886,0.00035449708,0.00029936322,0.00032289748,0.000040059265,0.0002787511,0.000051262323,0.00067015557],"category_scores_gemma":[0.000040332496,0.00012241643,0.000051388208,0.0009535045,0.00049636123,0.00014716403,0.00014592215,0.0010483715,0.0000033995545],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042307984,0.009467046,0.03945017,0.004530798,0.0011258448,0.00092761684,0.076976836,0.059491012,0.59285367,0.020291343,0.0911547,0.06142297],"study_design_scores_gemma":[0.081127584,0.00573533,0.46918505,0.006367006,0.00020388191,0.00017926481,0.038886502,0.019527417,0.29689595,0.015253655,0.06442963,0.0022087272],"about_ca_topic_score_codex":0.0037149463,"about_ca_topic_score_gemma":0.0007159264,"teacher_disagreement_score":0.4297349,"about_ca_system_score_codex":0.00076231523,"about_ca_system_score_gemma":0.00077756593,"threshold_uncertainty_score":0.73377335},"labels":[],"label_agreement":null},{"id":"W4282943420","doi":"10.1158/1538-7445.am2022-5291","title":"Abstract 5291: Characterizing the interplay between angiogenic and immunoactive factors of hepatocellular carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Angiogenesis; Context (archaeology); Liver cancer; Immune system; Immunohistochemistry; Cancer; Tumor microenvironment; Tumor progression; Oncology; Cancer research; Pathology; Internal medicine; Immunology; Biology","score_opus":0.04498319123374556,"score_gpt":0.3453641326443962,"score_spread":0.30038094141065064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282943420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839168,0.014884066,0.0000065856257,0.00014824094,0.000331024,0.00029754158,0.00026845423,0.000003887959,0.00014338696],"genre_scores_gemma":[0.99768984,0.0011382248,0.0000043631185,0.000034143366,0.00059918885,0.00014338057,0.00008719458,0.000024689203,0.00027897314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986698,0.00017420901,0.00017905074,0.00030777467,0.0003296641,0.00033948547],"domain_scores_gemma":[0.9993256,0.000054225187,0.00007899138,0.00035510518,0.00011147832,0.00007459763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063257955,0.00011661159,0.00017713677,0.00008769713,0.00032459167,0.000023832792,0.00035950076,0.000057633766,0.00015252118],"category_scores_gemma":[0.000030693285,0.00009387121,0.00010613464,0.00018613106,0.00022360076,0.000005976245,0.00051066576,0.00036128433,0.0000010477495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110694586,0.000017738193,0.062182073,0.000023003553,0.00010656248,9.81098e-7,0.0006722845,0.0000021079468,0.9325748,0.000012705698,0.0006398927,0.0036571529],"study_design_scores_gemma":[0.000349787,0.00016485933,0.2726093,0.00000964565,0.000022989556,0.0000038977814,0.0012530538,0.0000042136608,0.6036417,0.000023361219,0.121784,0.00013319276],"about_ca_topic_score_codex":0.0012161166,"about_ca_topic_score_gemma":0.000026993537,"teacher_disagreement_score":0.3289331,"about_ca_system_score_codex":0.00006063129,"about_ca_system_score_gemma":0.0002428545,"threshold_uncertainty_score":0.3827957},"labels":[],"label_agreement":null},{"id":"W4282943485","doi":"10.1158/1538-7445.am2022-2505","title":"Abstract 2505: Predicting prognosis in PFA ependymoma and group 3/4 medulloblastoma methylomes using interpretable epigenetic models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Waterloo","funders":"","keywords":"Computational biology; Epigenetics; CpG site; DNA methylation; Biology; Methylation; Oncology; Bioinformatics; Artificial intelligence; Computer science; Genetics; Gene; Medicine; Gene expression","score_opus":0.12121311631678684,"score_gpt":0.4038936476500564,"score_spread":0.2826805313332696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282943485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579544,0.010872031,0.000037135454,0.0009269167,0.00015690818,0.0011115675,0.00004434439,0.00004773993,0.0010079341],"genre_scores_gemma":[0.9963642,0.0008779355,0.0004070076,0.00012154873,0.00013388156,0.001852187,0.000009031593,0.000067385816,0.00016683672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965302,0.00030921446,0.00043729806,0.00069659983,0.0011655405,0.00086119934],"domain_scores_gemma":[0.9989979,0.00019420015,0.000082765306,0.00030038203,0.00016338682,0.00026131808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020616995,0.00020677007,0.00044189874,0.0005921031,0.00042823536,0.0000802831,0.0002636024,0.00008533101,0.0013241026],"category_scores_gemma":[0.000090329944,0.00020159261,0.0000889253,0.0010676425,0.00019452984,0.00022243659,0.0005899249,0.0011210634,0.000002856152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032700046,0.0016650681,0.47396794,0.0022263087,0.0007418369,0.00087929575,0.009712989,0.012190066,0.26348022,0.0005644617,0.0016276436,0.22967418],"study_design_scores_gemma":[0.015452692,0.007788059,0.46208933,0.005153601,0.0006328888,0.0009596777,0.028021054,0.293809,0.17099448,0.0045058606,0.008041354,0.002552013],"about_ca_topic_score_codex":0.004150949,"about_ca_topic_score_gemma":0.00042106444,"teacher_disagreement_score":0.28161892,"about_ca_system_score_codex":0.0009074082,"about_ca_system_score_gemma":0.0004707736,"threshold_uncertainty_score":0.99958885},"labels":[],"label_agreement":null},{"id":"W4282944143","doi":"10.1158/1538-7445.am2022-1296","title":"Abstract 1296: MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Chemoimmunotherapy; Cancer research; Medicine; MEK inhibitor; Cancer; Internal medicine; Oncology; Biology; Immunotherapy; Kinase; Cell biology; MAPK/ERK pathway","score_opus":0.06099132534059765,"score_gpt":0.4121338627770085,"score_spread":0.35114253743641083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282944143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667581,0.027239602,0.0000021221022,0.002883511,0.00020408587,0.0006414437,0.00017113252,0.000043563847,0.0020564555],"genre_scores_gemma":[0.9848505,0.006186616,0.000015284071,0.0010968787,0.00019050205,0.0012591848,0.000049995262,0.00005799141,0.0062930505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741024,0.00016176912,0.00030274317,0.0004588156,0.0010574968,0.0006089371],"domain_scores_gemma":[0.9991286,0.00012232222,0.00007381832,0.00040819595,0.00012604735,0.00014104496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000928718,0.00016115865,0.00029259457,0.00029266978,0.00032881775,0.000035679423,0.0001971794,0.000078906356,0.008644892],"category_scores_gemma":[0.000021298018,0.0001625391,0.000082684186,0.00088271813,0.00013817832,0.00013273569,0.0000880014,0.001142631,0.000022064356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015962292,0.00040010008,0.0017043051,0.00017217788,0.0000802243,0.00015832704,0.0015430234,0.00010173064,0.9389789,0.000077215765,0.04799696,0.007190801],"study_design_scores_gemma":[0.005272775,0.00019736217,0.029402709,0.0004938704,0.0000148254,0.000003449553,0.0012622954,0.000029308632,0.81805784,0.00078754977,0.14413354,0.0003445093],"about_ca_topic_score_codex":0.0029523768,"about_ca_topic_score_gemma":0.00028967016,"teacher_disagreement_score":0.1209211,"about_ca_system_score_codex":0.0015720975,"about_ca_system_score_gemma":0.0007889077,"threshold_uncertainty_score":0.99226135},"labels":[],"label_agreement":null},{"id":"W4282944250","doi":"10.1158/1538-7445.am2022-5046","title":"Abstract 5046: DeepTumour: Identify tumor origin from whole genome sequences","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Chromatin; Genome; Biology; Mutation; Genetics; Mutation rate; Epigenetics; Cancer; Lineage (genetic); Mutation Accumulation; DNA; Computational biology; Gene","score_opus":0.05862259529043245,"score_gpt":0.38440264581007316,"score_spread":0.3257800505196407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282944250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986462,0.009436821,0.000023565295,0.00063486025,0.00046439312,0.00025853704,0.0015261829,0.000012082427,0.0011815338],"genre_scores_gemma":[0.9954815,0.000913527,0.000089764355,0.00040766486,0.00094646023,0.00043550748,0.0005203303,0.000039541756,0.0011657183],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980557,0.000109767316,0.00021221444,0.0005602561,0.0005344673,0.00052760064],"domain_scores_gemma":[0.999065,0.00006615651,0.00006482592,0.00047983674,0.00015681339,0.00016736313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005998183,0.00013795623,0.00014818778,0.0000963919,0.00047158767,0.000111735484,0.00065443246,0.000051303778,0.0018430969],"category_scores_gemma":[0.000092392416,0.00015060787,0.000086643704,0.00024557623,0.00016779624,0.0000054143065,0.000638609,0.0004341596,0.00009512983],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010878474,0.000053971587,0.0025982172,0.00001354512,0.000048609945,0.00006150388,0.000100192214,0.0011381421,0.97689146,0.00008585799,0.017866928,0.0010328013],"study_design_scores_gemma":[0.00058624754,0.00022691525,0.018914599,0.0000112732,0.00001173515,0.000008246515,0.00065934734,0.000020699776,0.087023474,0.0010364059,0.8911896,0.00031145485],"about_ca_topic_score_codex":0.0035796165,"about_ca_topic_score_gemma":0.0007790005,"teacher_disagreement_score":0.88986796,"about_ca_system_score_codex":0.00026685363,"about_ca_system_score_gemma":0.000802157,"threshold_uncertainty_score":0.99906933},"labels":[],"label_agreement":null},{"id":"W4282944316","doi":"10.1158/1538-7445.am2022-5283","title":"Abstract 5283: Characterization of Gli activation by the estrogen receptor in breast cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Estrogen receptor; Cancer research; Biology; Hedgehog; Fulvestrant; Transcription factor; Gene knockdown; Androgen receptor; Steroid hormone receptor; Hedgehog signaling pathway; Signal transduction; Estrogen receptor alpha; Prostate cancer; Cell biology; Chemistry; Cancer; Breast cancer; Apoptosis; Biochemistry; Genetics","score_opus":0.039414690413992905,"score_gpt":0.3470549709498752,"score_spread":0.30764028053588227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282944316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694574,0.0005014854,0.000013533398,0.0014970365,0.00011209152,0.00026606137,0.0006045642,0.0000035132173,0.00005598826],"genre_scores_gemma":[0.99819815,0.0005924753,0.000004553667,0.00007850645,0.00015631065,0.000517083,0.00012649765,0.000017451634,0.00030895098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988888,0.00016300238,0.00015476896,0.00023179033,0.0003246677,0.0002369872],"domain_scores_gemma":[0.999532,0.000024641842,0.00006846927,0.00019375072,0.00015215168,0.000028985301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000552753,0.00007354144,0.00008968349,0.00005547248,0.00017548974,0.000011715045,0.00024413006,0.00004308088,0.0003046479],"category_scores_gemma":[0.000022389151,0.000062804516,0.000030400408,0.00029165903,0.000102399696,0.000004426322,0.00018553338,0.00022971554,0.000002065923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013625398,0.000048079775,0.0027310296,0.000022294977,0.000026456672,2.9737245e-7,0.0002068699,0.0001590347,0.9898171,0.0000065844592,0.0032693925,0.0035766345],"study_design_scores_gemma":[0.0001999334,0.000042985957,0.010562392,0.000016900665,0.0000017902873,4.1409186e-7,0.00021043816,0.0000097281945,0.96749383,0.000004422489,0.021391734,0.00006540723],"about_ca_topic_score_codex":0.00089470536,"about_ca_topic_score_gemma":0.000028242082,"teacher_disagreement_score":0.02232322,"about_ca_system_score_codex":0.00013674682,"about_ca_system_score_gemma":0.00024030604,"threshold_uncertainty_score":0.3335681},"labels":[],"label_agreement":null},{"id":"W4282944829","doi":"10.1158/1538-7445.am2022-5342","title":"Abstract 5342: Identifying therapeutic targets in combination with PARP inhibitors using a 63-gene signature in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Triple-negative breast cancer; Olaparib; Cancer research; Gene signature; Breast cancer; PARP inhibitor; Cancer; Carboplatin; Gene knockdown; DNA repair; Biology; Medicine; Gene; Internal medicine; Genetics; Gene expression; Poly ADP ribose polymerase; Chemotherapy; Cisplatin","score_opus":0.10838948347366295,"score_gpt":0.43063272836412786,"score_spread":0.3222432448904649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282944829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713636,0.0073495824,0.00004241216,0.0028074526,0.000396042,0.0018092163,0.00018825426,0.000041532938,0.0002291552],"genre_scores_gemma":[0.9964892,0.00057982584,0.00007712843,0.00040604116,0.00024534386,0.0018541688,0.000039026167,0.00007677137,0.00023248889],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996093,0.0004745867,0.00045074878,0.00062630576,0.001581683,0.0007736856],"domain_scores_gemma":[0.9987744,0.00020502832,0.00015783812,0.0003140958,0.0003952795,0.00015334583],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015848831,0.00023909418,0.0004167974,0.0010663988,0.00034896174,0.000055612647,0.00023278223,0.00012037262,0.0024260792],"category_scores_gemma":[0.00003476287,0.00022493966,0.00006745026,0.002732346,0.00023494655,0.00028929175,0.00011096307,0.0020942886,0.0000046845157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011035232,0.0014227881,0.12470443,0.00056335004,0.00031139082,0.00080580125,0.013012751,0.013887782,0.8106211,0.0001643488,0.0021588672,0.021312179],"study_design_scores_gemma":[0.046835653,0.0011780185,0.57350516,0.0041642534,0.00009109485,0.00026936806,0.012510319,0.0032609105,0.35033518,0.003853263,0.0025801724,0.0014165748],"about_ca_topic_score_codex":0.00709199,"about_ca_topic_score_gemma":0.0025798997,"teacher_disagreement_score":0.4602859,"about_ca_system_score_codex":0.005148028,"about_ca_system_score_gemma":0.001647963,"threshold_uncertainty_score":0.9995199},"labels":[],"label_agreement":null},{"id":"W4282945768","doi":"10.1158/1538-7445.am2022-3592","title":"Abstract 3592: Targeting SWI/SNF ATPases in enhancer-addicted human cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; SWI/SNF; Cancer research; Chromatin remodeling; Biology; Chromatin; FOXA1; Prostate cancer; Androgen receptor; Enhancer; Histone; Cell biology; Transcription factor; Cancer; Genetics; DNA; Gene","score_opus":0.053337455895271065,"score_gpt":0.4029769451519689,"score_spread":0.34963948925669786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900451,0.006561736,0.000010942323,0.00022542407,0.0002241205,0.00028055854,0.000100221616,0.000023622135,0.002528297],"genre_scores_gemma":[0.99619687,0.0007536093,0.000043057058,0.00012952375,0.00050923164,0.0007331849,0.00019359167,0.000047754944,0.001393169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976296,0.00019149054,0.0003065732,0.00058493944,0.0006099973,0.00067743147],"domain_scores_gemma":[0.99924195,0.000031654614,0.00007266927,0.0003804158,0.00015796743,0.00011531967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096763764,0.00015802347,0.00017834952,0.00015394796,0.00055033213,0.000039512423,0.0004640457,0.00008766793,0.0017619983],"category_scores_gemma":[0.0000920366,0.00017322048,0.00008124845,0.0004628004,0.00013673349,0.0000058855117,0.00037868138,0.00064191315,0.000009233348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012892272,0.000051605948,0.0012218825,0.000049701328,0.000027529688,0.000015252133,0.00019101254,0.0077437577,0.9642193,0.000017837601,0.022223936,0.0041092713],"study_design_scores_gemma":[0.00176015,0.00044474646,0.003959409,0.00012434693,0.000009003993,0.0000060265515,0.0019066542,0.00043095363,0.8445565,0.0002154784,0.1459997,0.0005870164],"about_ca_topic_score_codex":0.005627991,"about_ca_topic_score_gemma":0.0015864952,"teacher_disagreement_score":0.12377576,"about_ca_system_score_codex":0.00075167336,"about_ca_system_score_gemma":0.0008494763,"threshold_uncertainty_score":0.9991505},"labels":[],"label_agreement":null},{"id":"W4282946122","doi":"10.1158/1538-7445.am2022-6317","title":"Abstract 6317: Molecular subtyping in prostate cancer associate with outcomes to abiraterone and ipatasertib treatment from the phase III IPATential150 trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Cell cycle; Cancer research; Cancer; Transcriptome; Internal medicine; Prostate; Oncology; Medicine; Biology; Gene; Genetics; Gene expression","score_opus":0.10475146967943505,"score_gpt":0.44809907688356615,"score_spread":0.3433476072041311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452384,0.0057527004,0.0000014763134,0.014048831,0.00016365328,0.0044196164,0.00097147294,0.00003013565,0.00008829013],"genre_scores_gemma":[0.98767626,0.0016586389,0.000015528627,0.00037660764,0.00013807211,0.008068473,0.00023904159,0.000059152764,0.0017682199],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964109,0.00034836857,0.0003510618,0.00069243734,0.0012361879,0.0009610554],"domain_scores_gemma":[0.99871916,0.00023377444,0.000078035926,0.00046523032,0.00018000211,0.00032378663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000990134,0.0002697763,0.00052941474,0.00026400122,0.0005574612,0.000120559744,0.00024105055,0.00004849185,0.000849499],"category_scores_gemma":[0.00004701321,0.00015963354,0.00007777424,0.00079148664,0.00018937759,0.00010146289,0.00026845525,0.00071279536,0.0000105973195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5015539,0.0042302557,0.24461253,0.00017607781,0.0027763667,0.004696756,0.015676629,0.000796622,0.11618242,0.00004203209,0.004431191,0.10482522],"study_design_scores_gemma":[0.634242,0.015625373,0.21771887,0.00080020603,0.0004793939,0.000014655012,0.0067700935,0.00015699005,0.09275475,0.00021549455,0.030166723,0.0010554562],"about_ca_topic_score_codex":0.046070475,"about_ca_topic_score_gemma":0.0049587726,"teacher_disagreement_score":0.13268809,"about_ca_system_score_codex":0.0022235063,"about_ca_system_score_gemma":0.0014737275,"threshold_uncertainty_score":0.96028185},"labels":[],"label_agreement":null},{"id":"W4282946315","doi":"10.1158/1538-7445.am2022-ct012","title":"Abstract CT012: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment for resectable (IB-IIIA) non-small cell lung cancer (NSCLC): Event-free survival (EFS) results from the phase 3 CheckMate 816 trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Oncology; Lung cancer; Nivolumab; Population; Interim analysis; Neoadjuvant therapy; Randomized controlled trial; Odds ratio; Surrogate endpoint; Cancer; Breast cancer; Immunotherapy","score_opus":0.08247936788751797,"score_gpt":0.42005308205522157,"score_spread":0.3375737141677036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526472,0.008409088,0.000012529478,0.016940136,0.0015948892,0.010362535,0.006167863,0.00011003927,0.0037557236],"genre_scores_gemma":[0.948916,0.007966911,0.00014826981,0.0007539448,0.0036403735,0.02142316,0.001247563,0.00027961266,0.015624173],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99285924,0.00032775232,0.0010738255,0.0017398619,0.0021792955,0.0018199907],"domain_scores_gemma":[0.99454033,0.0015282226,0.00043918562,0.0023410243,0.0005889856,0.0005622197],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002360781,0.0007243273,0.001230546,0.00022651184,0.001434047,0.00024701405,0.0012119507,0.00023309485,0.0045735296],"category_scores_gemma":[0.00022227355,0.0005358702,0.0006157161,0.0008525503,0.00022751497,0.00016838082,0.0004921931,0.001118047,0.00004445595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55971366,0.009266468,0.0038250403,0.00056973624,0.0032099008,0.00042996235,0.008214465,0.0007258755,0.029675888,0.000052178973,0.3451692,0.0391476],"study_design_scores_gemma":[0.5917897,0.009137654,0.0028710156,0.0008955691,0.000723507,0.000010747267,0.0016130309,0.0011873348,0.2128129,0.00022191153,0.1778205,0.000916102],"about_ca_topic_score_codex":0.06695043,"about_ca_topic_score_gemma":0.0048780525,"teacher_disagreement_score":0.18313701,"about_ca_system_score_codex":0.0076893284,"about_ca_system_score_gemma":0.004663958,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W4282946667","doi":"10.1158/1538-7445.am2022-98","title":"Abstract 98: The role of HORMAD1 in transformation of keratinocytes following vemurafenib treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Business Development Bank of Canada; McGill University Health Centre","funders":"","keywords":"Vemurafenib; Trametinib; HaCaT; Cancer research; MAPK/ERK pathway; MEK inhibitor; Medicine; Melanoma; Cell growth; Kinase; Cell culture; Pharmacology; Biology; Metastatic melanoma; Cell biology","score_opus":0.04021768466794612,"score_gpt":0.3462389301832301,"score_spread":0.306021245515284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326426,0.003011169,0.0000032051223,0.000093649425,0.00004136591,0.00024183065,0.000041057014,0.0000013344376,0.0033021097],"genre_scores_gemma":[0.9993043,0.00027824522,0.000008659654,0.0000070025003,0.000034183606,0.00022974965,0.000041080013,0.0000059135623,0.000090851776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992848,0.00009398413,0.00015354545,0.000102385005,0.00021435008,0.00015090183],"domain_scores_gemma":[0.99972916,0.000022363625,0.00003148935,0.00016173799,0.000035519108,0.000019749374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041496285,0.000048724378,0.00008633977,0.000052821655,0.00008937925,0.000004788061,0.00014640512,0.000026391821,0.00007592359],"category_scores_gemma":[0.000012475193,0.00003627891,0.00006279576,0.0001233252,0.00003690995,0.0000031241343,0.00004478539,0.000092293805,7.165872e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115977964,0.000067349974,0.001831778,0.0000146291995,0.00002561401,0.0000013039518,0.0009279153,0.00031534352,0.982894,0.0001587384,0.00006109655,0.013586253],"study_design_scores_gemma":[0.0004313665,0.00038505654,0.0050607687,0.000007287019,0.0000035057,6.993167e-7,0.0016390777,0.000040949264,0.97743744,0.000092354676,0.014862695,0.000038801183],"about_ca_topic_score_codex":0.0008239983,"about_ca_topic_score_gemma":0.0002322982,"teacher_disagreement_score":0.014801598,"about_ca_system_score_codex":0.00005273319,"about_ca_system_score_gemma":0.00017620246,"threshold_uncertainty_score":0.1479411},"labels":[],"label_agreement":null},{"id":"W4282946835","doi":"10.1158/1538-7445.am2022-458","title":"Abstract 458: Development and validation of convolutional neural network to identify regions of interest in lumpectomy margins using optical coherence tomography","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Illumisonics (Canada)","funders":"","keywords":"Optical coherence tomography; Lumpectomy; Convolutional neural network; Medicine; Ductal carcinoma; Malignancy; Region of interest; Microcalcification; Artificial intelligence; Radiology; Computer science; Mammography; Breast cancer; Pathology; Mastectomy; Cancer; Internal medicine","score_opus":0.3006433052214918,"score_gpt":0.4634016532760785,"score_spread":0.16275834805458672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971045,0.00064115354,0.000046824935,0.0013358421,0.00012920395,0.0005654878,0.000024469518,0.000006280652,0.00014620277],"genre_scores_gemma":[0.9982624,0.000075007934,0.0011646966,0.00005488887,0.00007146709,0.00031945735,0.000014534051,0.000012959252,0.00002460233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998427,0.00010918367,0.00035131583,0.00026699965,0.0005287265,0.0003167968],"domain_scores_gemma":[0.99909645,0.00027147634,0.00006776185,0.00018165405,0.00024911063,0.00013356877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009333945,0.00007948969,0.00022544707,0.00042069366,0.00010803769,0.000011552166,0.00014972562,0.00003588001,0.00053208094],"category_scores_gemma":[0.00007143125,0.00008595413,0.000035821307,0.00112828,0.00020477627,0.000056457622,0.000275036,0.00041792975,0.0000010131023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009302474,0.000395414,0.87170124,0.00064116955,0.00012582635,0.00006410081,0.0016580352,0.009544701,0.10084473,0.0016486798,0.009271928,0.003173895],"study_design_scores_gemma":[0.00091887906,0.00019677368,0.9603353,0.0006164759,0.000016548982,0.000013480671,0.0005967148,0.00028929766,0.03478327,0.00021667645,0.0019045031,0.0001120369],"about_ca_topic_score_codex":0.0008845153,"about_ca_topic_score_gemma":0.0004292243,"teacher_disagreement_score":0.088634074,"about_ca_system_score_codex":0.0005212171,"about_ca_system_score_gemma":0.0006080453,"threshold_uncertainty_score":0.58259135},"labels":[],"label_agreement":null},{"id":"W4282946982","doi":"10.1158/1538-7445.am2022-ct240","title":"Abstract CT240: A first-in-human study of the dual A2A/A2B adenosine receptor antagonist M1069 in patients with advanced solid tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Internal medicine; Pharmacodynamics; Adenosine; Response Evaluation Criteria in Solid Tumors; Pharmacology; Oncology; Antagonist; Chemotherapy; Adverse effect; Phases of clinical research; Receptor","score_opus":0.022102500736720612,"score_gpt":0.3390637192212145,"score_spread":0.3169612184844939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982932,0.0005853483,3.5860126e-7,0.00015492272,0.000065140295,0.0007009171,0.000049252194,0.0000031045392,0.00014771422],"genre_scores_gemma":[0.999271,0.000025734596,0.0000060992747,0.000029674726,0.0000802805,0.0003035924,0.000043526696,0.000025901647,0.00021420006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825007,0.00018128606,0.0002733364,0.00036667645,0.0005628789,0.00036573719],"domain_scores_gemma":[0.99935204,0.00002500352,0.00008982778,0.0003703011,0.00012032196,0.000042485466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043160008,0.00012067863,0.0001770701,0.000109836554,0.00027647862,0.000014087819,0.00037770387,0.000037912705,0.00023733953],"category_scores_gemma":[0.00003390221,0.0000933875,0.00003288699,0.00045066696,0.000110165776,0.0000057233847,0.00040966005,0.0004294746,8.2892205e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022103845,0.0021455402,0.8601555,0.00007787034,0.00007519243,0.000029600113,0.0013338816,0.012494757,0.1156664,0.000010312446,0.00543974,0.00036079972],"study_design_scores_gemma":[0.008780623,0.0047047604,0.8986565,0.00018579418,0.00001302646,0.0000024534825,0.0048061665,0.000012773606,0.076438285,0.000019054256,0.0059796157,0.00040093967],"about_ca_topic_score_codex":0.0006359835,"about_ca_topic_score_gemma":0.00068527384,"teacher_disagreement_score":0.03922811,"about_ca_system_score_codex":0.00011952811,"about_ca_system_score_gemma":0.00019773442,"threshold_uncertainty_score":0.38082317},"labels":[],"label_agreement":null},{"id":"W4282947107","doi":"10.1158/1538-7445.am2022-lb001","title":"Abstract LB001: Identifying MAGE-A4-positive tumors for SPEAR T-cell therapies in HLA-A*02-eligible patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Human leukocyte antigen; Antigen; Medicine; Cancer; Oncology; Immunology; Cancer research; Internal medicine","score_opus":0.1094098929922035,"score_gpt":0.4386398053673828,"score_spread":0.3292299123751793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282947107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848276,0.002133846,0.000010850956,0.0011146623,0.00022455561,0.0029657597,0.00018348682,0.000041749405,0.0084975315],"genre_scores_gemma":[0.9755721,0.00062195904,0.00007623643,0.00020067809,0.00026550208,0.0019190374,0.00011984009,0.00011278703,0.021111833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952385,0.0003421785,0.00042748486,0.00069993647,0.0020543307,0.0012375938],"domain_scores_gemma":[0.9980046,0.0005315497,0.00007721628,0.00054384867,0.00058367685,0.0002590915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026955102,0.00021859306,0.00041856297,0.00093087595,0.0005322351,0.00011995671,0.0005103094,0.00007725938,0.011375091],"category_scores_gemma":[0.00015550929,0.00021653788,0.00017872248,0.0012454807,0.00023254807,0.00016342971,0.00042204282,0.0015315509,0.00008995299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007449959,0.0017459404,0.05448961,0.0010464543,0.00021871258,0.0003937289,0.008410841,0.00020469214,0.85943097,0.00011898084,0.024473198,0.042016923],"study_design_scores_gemma":[0.026662441,0.005016233,0.3243546,0.0008789629,0.000057963578,0.00002718702,0.016801983,0.00041988134,0.49313363,0.0021984517,0.12926488,0.0011838134],"about_ca_topic_score_codex":0.0034078755,"about_ca_topic_score_gemma":0.0003016529,"teacher_disagreement_score":0.36629733,"about_ca_system_score_codex":0.001808266,"about_ca_system_score_gemma":0.0008144995,"threshold_uncertainty_score":0.98952866},"labels":[],"label_agreement":null},{"id":"W4282958608","doi":"10.1158/1538-7445.am2022-1569","title":"Abstract 1569: pSTAT3+ stromal cells drive the invasive growth of brain metastases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Cancer research; Stromal cell; STAT3; Cancer; Immunohistochemistry; In vivo; Cell growth; Medicine; Cell culture; Biology; Pathology; Signal transduction; Internal medicine; Cell biology","score_opus":0.0894248913443657,"score_gpt":0.3944762808682294,"score_spread":0.3050513895238637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282958608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249674,0.0022537187,0.0000033093847,0.011727183,0.0001534254,0.0007893402,0.00042502387,0.000017986968,0.0021332577],"genre_scores_gemma":[0.99678177,0.0006039922,0.00004399066,0.0006696117,0.00017101936,0.0008689564,0.000025924362,0.00003157715,0.0008031481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971894,0.00034788225,0.0002711573,0.00033831043,0.0013601636,0.0004930837],"domain_scores_gemma":[0.9982512,0.00067869615,0.0000918574,0.00041032615,0.00041939082,0.00014851821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014633246,0.0001254528,0.0002907146,0.0001893256,0.00037707004,0.000026582815,0.0004072288,0.000032184213,0.006221885],"category_scores_gemma":[0.00020516965,0.00008850362,0.0001471812,0.00076438725,0.00037712287,0.00006338936,0.00034286137,0.00082495605,0.000019022445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011792199,0.0005844277,0.011194718,0.00059561606,0.00052247115,0.00013378743,0.0029194742,0.00013898169,0.66241044,0.0018668218,0.3105182,0.0079358565],"study_design_scores_gemma":[0.0020825064,0.0018598924,0.034806497,0.00016357556,0.00011382147,0.000017048755,0.009684464,0.00001914484,0.91184676,0.00040582067,0.038783576,0.00021691716],"about_ca_topic_score_codex":0.002627126,"about_ca_topic_score_gemma":0.00017627556,"teacher_disagreement_score":0.27173463,"about_ca_system_score_codex":0.00033616836,"about_ca_system_score_gemma":0.0011157799,"threshold_uncertainty_score":0.99468654},"labels":[],"label_agreement":null},{"id":"W4282959000","doi":"10.1158/1538-7445.am2022-3853","title":"Abstract 3853: Investigating PRL2/<i>PTP4A2</i> as a new target for glioblastoma treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Carcinogenesis; Context (archaeology); Lung cancer; Cancer; Medicine; Brain tumor; Glioma; Tumor microenvironment; Tumor progression; Breast cancer; Biology; Oncology; Pathology; Internal medicine","score_opus":0.06641577272742631,"score_gpt":0.39848524541062535,"score_spread":0.33206947268319903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710263,0.021908348,0.000081702005,0.00392191,0.00014269153,0.0017435537,0.0006039949,0.000029664865,0.00054184126],"genre_scores_gemma":[0.9862967,0.00028407073,0.0025449973,0.0006203359,0.0006594069,0.0035530368,0.00040757586,0.00006797777,0.005565872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985139,0.000065702814,0.00015615142,0.00044896858,0.00035071312,0.0004645685],"domain_scores_gemma":[0.9991348,0.000035936155,0.000051384235,0.00037372613,0.00012257935,0.00028157674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003363433,0.00013548433,0.00013381257,0.00006772873,0.0003995337,0.000043678156,0.00021938223,0.0000526879,0.00038371055],"category_scores_gemma":[0.0003284128,0.00013436562,0.000093333794,0.00021171267,0.000098641234,0.0000046130135,0.00029342866,0.00017480792,0.000012124219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008039435,0.00012506744,0.00038123023,0.00006242651,0.00009232019,0.000021251417,0.000081226695,0.0004180123,0.84988034,0.00058421254,0.13367054,0.013879451],"study_design_scores_gemma":[0.00070934073,0.0018999121,0.00006135986,0.000010112838,0.0000045621005,0.000011471201,0.00004252288,0.000009238435,0.6334169,0.0006275877,0.363112,0.00009498704],"about_ca_topic_score_codex":0.0010029018,"about_ca_topic_score_gemma":0.000099335135,"teacher_disagreement_score":0.22944146,"about_ca_system_score_codex":0.0002329712,"about_ca_system_score_gemma":0.0018911383,"threshold_uncertainty_score":0.54792714},"labels":[],"label_agreement":null},{"id":"W4282959167","doi":"10.1158/1538-7445.am2022-2035","title":"Abstract 2035: Imaging mass cytometry identifies structural and cellular composition of the mouse tissue microenvironment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Extracellular matrix; Stromal cell; Biology; Mass cytometry; Mass spectrometry imaging; Immune system; Cell biology; Pathology; Computational biology; Phenotype; Immunology; Chemistry; Cancer research; Medicine; Genetics","score_opus":0.02248253238145917,"score_gpt":0.3047121996773285,"score_spread":0.2822296672958693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960747,0.0031949896,0.00007103195,0.00022991725,0.00012295877,0.00016362581,0.00009282503,0.0000023947596,0.000047556983],"genre_scores_gemma":[0.9991355,0.00019579504,0.000033267883,0.000038753846,0.0000686145,0.000026722786,0.000045136694,0.0000133399235,0.00044290457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991436,0.000092809176,0.00011264657,0.00019890371,0.00027113644,0.00018089006],"domain_scores_gemma":[0.99968344,0.000009235584,0.00003495794,0.00020466247,0.000033571334,0.000034117744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022789181,0.00006609361,0.00007060399,0.000042948348,0.00028516253,0.000025522162,0.00021152185,0.000024502717,0.00013037396],"category_scores_gemma":[0.0000051791308,0.000056688357,0.000033306867,0.00008622915,0.00020479425,0.0000035392604,0.00020324411,0.00019654748,6.8727695e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059690672,0.000014904139,0.008071785,0.000039863484,0.000015562717,0.000002117678,0.0000761206,0.00015926552,0.9905231,0.000004736797,0.00037187795,0.0006609776],"study_design_scores_gemma":[0.00022804951,0.0000356142,0.009365664,0.0000060376806,0.0000048889415,0.000003145872,0.00018758798,0.000031712578,0.9874564,0.000031024098,0.002586848,0.0000630509],"about_ca_topic_score_codex":0.00030824196,"about_ca_topic_score_gemma":0.000016833206,"teacher_disagreement_score":0.0030667218,"about_ca_system_score_codex":0.00005471416,"about_ca_system_score_gemma":0.000036185913,"threshold_uncertainty_score":0.23116842},"labels":[],"label_agreement":null},{"id":"W4282959378","doi":"10.1158/1538-7445.am2022-978","title":"Abstract 978: The potential role of microbiome in metastatic HNSCC","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Metastasis; Medicine; Cancer research; Biomarker; Disease; Malignancy; Cancer; Defensin; Radiation therapy; Primary tumor; Oncology; Gene; Biology; Internal medicine","score_opus":0.03635721716576082,"score_gpt":0.3504909367911759,"score_spread":0.31413371962541503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9340276,0.06418754,0.0000014254459,0.0006889091,0.00029528502,0.00032805695,0.000092838665,0.000009373121,0.0003689552],"genre_scores_gemma":[0.9957942,0.00074101443,0.0000037994935,0.000059224214,0.000011831351,0.00026287837,0.000025611662,0.00001609337,0.00308537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978567,0.0010915099,0.00027749612,0.0001949629,0.00011087918,0.00046849588],"domain_scores_gemma":[0.9991847,0.00031958657,0.00006901493,0.0003408306,0.00007766069,0.000008151718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00181089,0.00009310057,0.00019562106,0.0003101581,0.00044255395,0.000012589612,0.00062006834,0.00004542544,0.008029452],"category_scores_gemma":[0.000047751317,0.00007015489,0.00008675038,0.0005635572,0.00045829167,0.0000510369,0.0002642114,0.00088863244,0.00009527168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014075543,0.00016225048,0.00013226348,0.000014779655,0.00012414776,0.000007563569,0.0011247966,0.0000982582,0.98329484,0.0002119869,0.0015577598,0.011863819],"study_design_scores_gemma":[0.0019167673,0.00028632383,0.01640492,0.000028748334,0.0000115723815,0.000057101213,0.0062392955,0.0000028834002,0.7621054,0.0006914316,0.21211472,0.00014085596],"about_ca_topic_score_codex":0.0030081458,"about_ca_topic_score_gemma":0.000058391273,"teacher_disagreement_score":0.22118944,"about_ca_system_score_codex":0.00013616374,"about_ca_system_score_gemma":0.00038954383,"threshold_uncertainty_score":0.99287736},"labels":[],"label_agreement":null},{"id":"W4282959799","doi":"10.1158/1538-7445.am2022-564","title":"Abstract 564: Targeting axonal guidance with anti-ROBO1 CAR T cells: A new therapeutic strategy for malignant brain cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McMaster University","funders":"","keywords":"Cancer; Medicine; Cancer research; Downregulation and upregulation; Glioma; Brain tumor; Chimeric antigen receptor; Cancer cell; Lung cancer; Immunotherapy; Internal medicine; Pathology; Biology; Gene","score_opus":0.1485057133815752,"score_gpt":0.43740882860226404,"score_spread":0.28890311522068884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486761,0.02635836,0.00036137077,0.015032164,0.0005216432,0.00531128,0.0004987224,0.00015017703,0.0030901958],"genre_scores_gemma":[0.94276184,0.0011188379,0.00028830106,0.0009366385,0.0013722795,0.0032561668,0.00006932537,0.00020395176,0.04999266],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941175,0.0003955265,0.00044657572,0.00096309156,0.0023881993,0.0016890815],"domain_scores_gemma":[0.9972501,0.00073428696,0.0001177338,0.00065632147,0.0007050685,0.0005365116],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003285835,0.00032413434,0.00055332965,0.0003906772,0.0008774448,0.00013215054,0.0006471265,0.000110294255,0.027951894],"category_scores_gemma":[0.00009104952,0.0002709027,0.00018670173,0.0011885084,0.00034112795,0.00012452861,0.00023517753,0.0019097955,0.000023490842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025202439,0.00017916261,0.0026244835,0.00042369665,0.00032595856,0.0001505307,0.0006510832,0.0039390055,0.8703632,0.0001578874,0.07890495,0.039759807],"study_design_scores_gemma":[0.008959225,0.003062911,0.00877841,0.0005531061,0.000085902524,0.0000706366,0.0032016402,0.0012452377,0.32073852,0.0005270662,0.65196455,0.00081278774],"about_ca_topic_score_codex":0.0081578465,"about_ca_topic_score_gemma":0.00079873437,"teacher_disagreement_score":0.5730596,"about_ca_system_score_codex":0.0015045952,"about_ca_system_score_gemma":0.0056668366,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W4282959844","doi":"10.1158/1538-7445.am2022-3099","title":"Abstract 3099: Biological evaluation of a novel AKR1C3 inhibitor in patient-derived prostate cancer cell line and xenograft models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Cancer research; Cancer; Androgen receptor; Carcinogenesis; Cell culture; Prostate; Medicine; Abiraterone acetate; Biology; Internal medicine; Oncology; Androgen deprivation therapy","score_opus":0.25092119821482306,"score_gpt":0.45414219526708133,"score_spread":0.20322099705225827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737206,0.021655066,0.0000020491007,0.0012061131,0.00009266815,0.0023834996,0.00032148717,0.000016627408,0.0006018827],"genre_scores_gemma":[0.98954165,0.006713775,0.000055243025,0.0000496391,0.000080674195,0.0032468012,0.00008862635,0.00002804658,0.00019551674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99653184,0.00026925412,0.00037322746,0.0005024707,0.0017153791,0.0006078142],"domain_scores_gemma":[0.998589,0.00012343712,0.000088048124,0.00025330394,0.000751088,0.00019512053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001984311,0.0001583447,0.0003284077,0.00032031437,0.00019748407,0.000020938907,0.00013298207,0.00008156397,0.0009681396],"category_scores_gemma":[0.000072246636,0.00012292387,0.000056885154,0.00071333814,0.00030014678,0.00013674035,0.0003295932,0.00071378745,0.000001450405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043874304,0.0015996154,0.00845552,0.00039583386,0.00008875134,0.00005599722,0.005117242,0.005083191,0.8961774,0.00002088043,0.00065367593,0.07796448],"study_design_scores_gemma":[0.053958923,0.008956331,0.06288883,0.0011652487,0.00018483082,0.00003053303,0.016213859,0.0478283,0.8024321,0.0014027145,0.0040114135,0.00092692045],"about_ca_topic_score_codex":0.004576975,"about_ca_topic_score_gemma":0.00046864207,"teacher_disagreement_score":0.09374529,"about_ca_system_score_codex":0.0013596929,"about_ca_system_score_gemma":0.0017625877,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W4282959988","doi":"10.1158/1538-7445.am2022-404","title":"Abstract 404: Identification of combination partners to combat acquired resistance to ulixertinib (ERK1/2 inhibitor) using transcriptomics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Transcriptome; PI3K/AKT/mTOR pathway; Cancer research; Drug resistance; Melanoma; Signal transduction; Biology; Phenotype; Gene; Protein kinase B; Acquired resistance; Gene expression; Cell biology; Genetics","score_opus":0.08828580308583767,"score_gpt":0.39857790460185183,"score_spread":0.31029210151601416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717313,0.00042629224,0.0004108982,0.0006010917,0.00030750068,0.0005495656,0.00014243048,0.0000079350575,0.00038117575],"genre_scores_gemma":[0.9982434,0.000041122217,0.00011578162,0.00012399683,0.00010729738,0.00026135158,0.00009624824,0.000023686944,0.0009871039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835014,0.00014868026,0.00031196355,0.00037805887,0.0005012508,0.00030989767],"domain_scores_gemma":[0.999108,0.000018621236,0.00007400365,0.0003836333,0.0002830638,0.0001326365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009925817,0.00009332294,0.00013008591,0.00015440257,0.0002542641,0.000028121865,0.0003288416,0.00005836772,0.000068693924],"category_scores_gemma":[0.00010468305,0.00010897573,0.000052578816,0.00043030118,0.000060145696,0.000006663587,0.00015190999,0.000116787916,0.00000636788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043473218,0.00007687105,0.0003762962,0.00004893889,0.00001568242,0.0000019299098,0.00042080745,0.0006004475,0.98885804,0.00025243594,0.008016986,0.00089682493],"study_design_scores_gemma":[0.00041142886,0.0001902824,0.0039605517,0.000022924538,0.0000043033806,8.5380714e-7,0.00037150845,0.000033477936,0.94642115,0.00009005256,0.048368238,0.00012523872],"about_ca_topic_score_codex":0.000104740946,"about_ca_topic_score_gemma":0.00012315073,"teacher_disagreement_score":0.04243691,"about_ca_system_score_codex":0.00016198479,"about_ca_system_score_gemma":0.00025903233,"threshold_uncertainty_score":0.44439012},"labels":[],"label_agreement":null},{"id":"W4282959999","doi":"10.1158/1538-7445.am2022-559","title":"Abstract 559: Targeting hematological malignancies and solid tumors with switchable chimeric antigen receptor-engineered iPSC-derived natural killer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chimeric antigen receptor; Cancer research; CD19; Induced pluripotent stem cell; CD33; NKG2D; Immunotherapy; Biology; Antigen; Immunology; Stem cell; Cell biology; CD34; Cytotoxic T cell; Immune system; Embryonic stem cell; Gene","score_opus":0.042511637850397604,"score_gpt":0.34551406794819167,"score_spread":0.30300243009779404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906952,0.005092361,0.0000072778284,0.0017288357,0.00030420852,0.0010952669,0.000016295015,0.0001016229,0.00095893187],"genre_scores_gemma":[0.9874752,0.0013470046,0.00040319492,0.00014421859,0.00023589603,0.0005139059,0.00004708693,0.00008839402,0.009745104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957684,0.00024273759,0.00034410885,0.00070585357,0.0016774714,0.001261386],"domain_scores_gemma":[0.9984558,0.0003004008,0.00007424238,0.00041704375,0.00037271585,0.0003797989],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015166416,0.0002722695,0.00058923033,0.0003643443,0.00071284483,0.000092294395,0.00034007398,0.00008441575,0.014457868],"category_scores_gemma":[0.00013488567,0.00021244003,0.00009211607,0.0010645986,0.0004527326,0.00011578357,0.00045339562,0.0019194784,0.00004556761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014416362,0.00012036408,0.002992235,0.00022619514,0.00013281505,0.00034476168,0.0007405561,0.00014153782,0.9761536,0.00002099387,0.01646904,0.0012162684],"study_design_scores_gemma":[0.0046220957,0.0018669066,0.024415929,0.00042891246,0.000028456296,0.00045036475,0.005823365,0.0008628922,0.8778696,0.000061564395,0.08271652,0.00085340353],"about_ca_topic_score_codex":0.0005005588,"about_ca_topic_score_gemma":0.000015982929,"teacher_disagreement_score":0.098284006,"about_ca_system_score_codex":0.00045538164,"about_ca_system_score_gemma":0.00061115314,"threshold_uncertainty_score":0.98644304},"labels":[],"label_agreement":null},{"id":"W4282960066","doi":"10.1158/1538-7445.am2022-1193","title":"Abstract 1193: Enhancing pediatric cancer variant curation and representation through standardized classification and automation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Context (archaeology); Terminology; Data curation; Disease; Cancer; Pediatric cancer; Medicine; Data science; Computer science; Biology; Pathology; Internal medicine","score_opus":0.06046935526973776,"score_gpt":0.4049935783996543,"score_spread":0.3445242231299165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265707,0.0055403705,0.0005286418,0.00055077835,0.00012202321,0.00031209982,0.00012669677,0.000009280754,0.0001530488],"genre_scores_gemma":[0.99141514,0.007473395,0.00009542586,0.00004434152,0.00026674708,0.0004046725,0.00016280239,0.000014013123,0.00012346887],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892664,0.0001240411,0.00015188241,0.00033490997,0.00029028978,0.00017224831],"domain_scores_gemma":[0.99952805,0.000026219403,0.00007067818,0.00015357077,0.0001674769,0.00005401663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004416848,0.00006999974,0.00007494063,0.000064810905,0.0004428998,0.00006763778,0.000070555274,0.000042445918,0.000101518766],"category_scores_gemma":[0.00006974407,0.00007162399,0.000020642947,0.00016864274,0.000047027348,0.000018906936,0.00012366712,0.00012535571,7.33186e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025614587,0.000042249518,0.0057375054,0.00009899409,0.000033733715,0.0000061391265,0.0006722591,0.0005167878,0.98186815,0.00035647157,0.0025251952,0.007886355],"study_design_scores_gemma":[0.004867941,0.0007355353,0.7234077,0.00006296102,0.00016522028,0.00006205966,0.0074179834,0.003928147,0.20491146,0.00381638,0.049581278,0.0010433868],"about_ca_topic_score_codex":0.0005100167,"about_ca_topic_score_gemma":0.00013304577,"teacher_disagreement_score":0.77695674,"about_ca_system_score_codex":0.00009141304,"about_ca_system_score_gemma":0.00030755711,"threshold_uncertainty_score":0.3406472},"labels":[],"label_agreement":null},{"id":"W4282960177","doi":"10.1158/1538-7445.am2022-lb188","title":"Abstract LB188: Identification of intrinsic molecular vulnerabilities in inherited and treatment-related hypermutant patient-derived glioma cell line models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Temozolomide; Oncology; Internal medicine; Cancer research","score_opus":0.05754110397353954,"score_gpt":0.3464188156310112,"score_spread":0.28887771165747167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922069,0.005825584,0.000001097758,0.0006123114,0.000047028178,0.0010283514,0.00010581409,0.000017810522,0.00015514645],"genre_scores_gemma":[0.9980051,0.0007398927,0.000018914863,0.0000148754125,0.000010425148,0.0010725977,0.00007426177,0.00002665941,0.000037297723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819773,0.0001837377,0.000437822,0.00036009937,0.00052189117,0.0002987151],"domain_scores_gemma":[0.99917364,0.000119634744,0.00009058582,0.0003174898,0.00019087375,0.00010780022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257931,0.00013381607,0.00029582815,0.0005089472,0.00012263443,0.000019553827,0.000073369396,0.00005312882,0.00023818982],"category_scores_gemma":[0.000039702798,0.00011760269,0.000059370846,0.00075627805,0.00013559619,0.000070718896,0.00010153268,0.00025660705,0.0000029969337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043222282,0.0013829626,0.0030951097,0.00009521911,0.00008703918,0.00040315525,0.0022333371,0.0024974237,0.9690902,0.0001188622,0.000025507761,0.020538956],"study_design_scores_gemma":[0.0052664285,0.0015721449,0.020528167,0.00007683938,0.00005169722,0.000027667922,0.002462987,0.0017121406,0.96726936,0.0007812164,0.00011728454,0.00013408576],"about_ca_topic_score_codex":0.0020707923,"about_ca_topic_score_gemma":0.00007468146,"teacher_disagreement_score":0.020404872,"about_ca_system_score_codex":0.00066999864,"about_ca_system_score_gemma":0.00021853094,"threshold_uncertainty_score":0.47956985},"labels":[],"label_agreement":null},{"id":"W4282960185","doi":"10.1158/1538-7445.am2022-3068","title":"Abstract 3068: Identify targetable molecular drivers of chemotherapy resistance in gastroesophageal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transcriptome; Chemotherapy; Exome sequencing; Cancer research; Medicine; Adenocarcinoma; Drug resistance; Internal medicine; Biology; Oncology; Cancer; Gene; Phenotype; Gene expression; Genetics","score_opus":0.0434027417993664,"score_gpt":0.3835053874654479,"score_spread":0.3401026456660815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97685254,0.01799413,0.000016744392,0.0012817394,0.00013141391,0.0005496179,0.000076512006,0.000013688485,0.003083631],"genre_scores_gemma":[0.99558467,0.0008302542,0.00037325977,0.00017932017,0.00007400196,0.00026001022,0.000017732214,0.00003847247,0.002642293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738044,0.00013048109,0.0003059424,0.00040768122,0.0011885709,0.0005869092],"domain_scores_gemma":[0.999097,0.00005051746,0.000075556374,0.00043743587,0.00018160611,0.00015788933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011300972,0.00012216084,0.00034593788,0.00039199583,0.00012342937,0.000015291223,0.00027584174,0.000039439485,0.005048211],"category_scores_gemma":[0.000033890414,0.00012993882,0.00012469936,0.0010046789,0.00017052762,0.000064112945,0.00013646789,0.0007503688,0.00000916187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024573212,0.00047677185,0.078977525,0.0007758176,0.00016420374,0.0012392675,0.0016042113,0.0004272687,0.8914463,0.0004055051,0.018316504,0.0037092897],"study_design_scores_gemma":[0.007313031,0.0004970915,0.3858145,0.00026106596,0.0000490113,0.000016772474,0.0018881281,0.000011974846,0.54338187,0.0006500732,0.059834816,0.00028168163],"about_ca_topic_score_codex":0.0013858124,"about_ca_topic_score_gemma":0.00024221896,"teacher_disagreement_score":0.34806445,"about_ca_system_score_codex":0.00076578604,"about_ca_system_score_gemma":0.0007034935,"threshold_uncertainty_score":0.9958613},"labels":[],"label_agreement":null},{"id":"W4282960284","doi":"10.1158/1538-7445.am2022-849","title":"Abstract 849: Characterization and prevention of radiation-induced malignancies in Li-Fraumeni Syndrome","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Metformin; Medicine; Cancer; Radiation therapy; Cancer research; DNA repair; DNA damage; Oncology; Internal medicine; Bioinformatics; Biology; Genetics; Gene; DNA; Insulin","score_opus":0.06087739405098337,"score_gpt":0.3693630078933037,"score_spread":0.3084856138423203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972766,0.00096226716,0.00003334524,0.00066858606,0.00012207016,0.00072740734,0.000039143295,0.000014905976,0.00015564269],"genre_scores_gemma":[0.9983594,0.0005111282,0.000014871834,0.000029782941,0.00003485074,0.00041660236,0.00009541306,0.00002198036,0.000515965],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99855477,0.00012531069,0.0002488745,0.00024107276,0.0005913843,0.00023857881],"domain_scores_gemma":[0.9995039,0.00003832277,0.000080304184,0.00020119402,0.00010530423,0.00007094919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075568055,0.00007311559,0.00018585881,0.0004201354,0.0000966159,0.000012109085,0.0000784055,0.00005614944,0.0006047335],"category_scores_gemma":[0.000084509964,0.00008161488,0.0000348329,0.0007060252,0.000051143492,0.00008625869,0.0000941745,0.0004321952,0.000004228117],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018728421,0.00008640195,0.0049988325,0.00018701977,0.000026825888,0.00006487865,0.0006121926,0.00004850087,0.9529295,0.000070889255,0.00006876458,0.040718924],"study_design_scores_gemma":[0.0020598036,0.00067324913,0.8478181,0.00032039246,0.00001804017,0.00007060612,0.00031318373,0.00011487222,0.14457454,0.000099339,0.003817051,0.000120849254],"about_ca_topic_score_codex":0.0004296811,"about_ca_topic_score_gemma":0.000050265535,"teacher_disagreement_score":0.8428192,"about_ca_system_score_codex":0.0004936505,"about_ca_system_score_gemma":0.0005212373,"threshold_uncertainty_score":0.6621408},"labels":[],"label_agreement":null},{"id":"W4282960804","doi":"10.1158/1538-7445.am2022-3456","title":"Abstract 3456: Discrepancies in the metastatic potential of high-grade serous ovarian cancer cells representing disease progression when comparing two-dimensional assays versus three-dimensional organotypic culture model systems","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Serous fluid; Ovarian cancer; Metastasis; Pathology; Cell culture; Extracellular matrix; Cancer; Cancer research; Fibronectin; Cancer cell; Gentamicin protection assay; Medicine; Biology; Chemistry; Internal medicine; Cell biology","score_opus":0.10560702601404888,"score_gpt":0.3900224235753238,"score_spread":0.28441539756127493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458356,0.009569923,0.000053163953,0.0026100776,0.0008770172,0.0017250065,0.00041370976,0.000035918736,0.00013163571],"genre_scores_gemma":[0.99732494,0.000087823195,0.00058248796,0.000061822786,0.00031856782,0.0010259367,0.0001440565,0.00005647135,0.00039791537],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9944009,0.0005017606,0.000618989,0.0007329626,0.00294,0.000805355],"domain_scores_gemma":[0.9981231,0.00024227296,0.00025323546,0.0006979243,0.00039849323,0.00028497557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020608522,0.0002826245,0.0006223426,0.00029803257,0.00063166127,0.000083691826,0.00047181433,0.000051285588,0.00051857944],"category_scores_gemma":[0.00008665699,0.00019945152,0.00018689179,0.00079129194,0.00027883952,0.00015529103,0.0005793675,0.0012746969,0.000004508838],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069285464,0.0009410353,0.0029026167,0.0010174838,0.0004234441,0.000578826,0.0013461773,0.8114329,0.16527753,0.00070985727,0.0067937043,0.0016478912],"study_design_scores_gemma":[0.06646774,0.0019577446,0.06655646,0.0068739546,0.0037116027,0.0002491579,0.012177494,0.7612364,0.0655975,0.0048629707,0.007292922,0.0030160064],"about_ca_topic_score_codex":0.027271565,"about_ca_topic_score_gemma":0.0022353942,"teacher_disagreement_score":0.09968003,"about_ca_system_score_codex":0.00071324775,"about_ca_system_score_gemma":0.0015162763,"threshold_uncertainty_score":0.9792059},"labels":[],"label_agreement":null},{"id":"W4282961029","doi":"10.1158/1538-7445.am2022-ct236","title":"Abstract CT236: INTERLINK-1: A phase 3, randomized, double-blind, placebo-controlled, multicenter, global study of monalizumab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma previously treated with an immune checkpoint inhibitor","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; Internal medicine; Nivolumab; Oncology; Cancer; Discontinuation; Head and neck cancer; Phases of clinical research; Chemotherapy; Immunotherapy; Colorectal cancer","score_opus":0.04767354555543456,"score_gpt":0.3697721642947267,"score_spread":0.32209861873929213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818868,0.0021305294,0.0000024582093,0.00010513287,0.000042399824,0.015710283,0.000066170156,0.000016717951,0.00003947816],"genre_scores_gemma":[0.9950532,0.000062164705,0.000046728812,0.000014435804,0.000013894854,0.0045842966,0.00011840174,0.000045366312,0.000061509396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957784,0.0008471996,0.0009323057,0.0006287946,0.0012642515,0.0005490796],"domain_scores_gemma":[0.9984131,0.00021828308,0.00036382957,0.00040976985,0.00043167206,0.0001633408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018222935,0.0003403015,0.0012866051,0.00053906965,0.00013552465,0.000053327516,0.00020251707,0.000046297322,0.00014210022],"category_scores_gemma":[0.00003794303,0.0002090022,0.00007614418,0.0011755686,0.00028089675,0.00019687985,0.00009068207,0.0006535279,3.7760944e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8977248,0.023917247,0.06831844,0.00041823633,0.00030949916,0.00020416372,0.0044209585,0.00008476929,0.00025652075,7.283813e-7,0.000005173236,0.0043394873],"study_design_scores_gemma":[0.9026416,0.048581682,0.041830912,0.00047623072,0.0002261897,0.000013444789,0.004827176,0.0005529273,0.00061789475,0.0000014837044,0.0000063968982,0.0002240809],"about_ca_topic_score_codex":0.0152142,"about_ca_topic_score_gemma":0.014143206,"teacher_disagreement_score":0.026487527,"about_ca_system_score_codex":0.0014641416,"about_ca_system_score_gemma":0.00075149006,"threshold_uncertainty_score":0.99134356},"labels":[],"label_agreement":null},{"id":"W4282961127","doi":"10.1158/1538-7445.am2022-6018","title":"Abstract 6018: Expansion of mouse mammary epithelial stem cells in serum-free organoid growth medium","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; Dispase; Biology; Cell biology; Cell culture; Epithelium; Stem cell; Molecular biology; Collagenase; Biochemistry","score_opus":0.030562233469653654,"score_gpt":0.30870861095727337,"score_spread":0.2781463774876197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971596,0.0014687537,0.000023547664,0.00052733696,0.00023657996,0.00024123627,0.00012491106,0.000005408023,0.0002126396],"genre_scores_gemma":[0.9950281,0.0015923203,0.000055429937,0.00003226996,0.00026559064,0.00008585588,0.000019769808,0.000026183672,0.0028944924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984312,0.00014196085,0.00021111002,0.00043167794,0.00047725945,0.00030680394],"domain_scores_gemma":[0.9991454,0.000011200376,0.000055473352,0.0005232101,0.00019660048,0.00006811054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079688407,0.000093608214,0.00012104368,0.00012578757,0.00012055596,0.0000112755915,0.0004941688,0.00008225993,0.00014292917],"category_scores_gemma":[0.000027328368,0.00009124291,0.000047750826,0.00027950224,0.00009930387,0.000004025653,0.0007296728,0.00031311467,0.0000043282967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021076082,0.00007298271,0.00077614153,0.000065035216,0.00001218,0.00000807944,0.00009999362,0.00023454384,0.9939162,0.000029202347,0.0032885373,0.0012863203],"study_design_scores_gemma":[0.00044922807,0.00032872937,0.0036040666,0.0000067155192,0.0000021150536,0.0000030760896,0.00029810707,0.000008137224,0.988588,0.0000714204,0.0065393564,0.00010108611],"about_ca_topic_score_codex":0.00031449652,"about_ca_topic_score_gemma":0.000068826164,"teacher_disagreement_score":0.005328261,"about_ca_system_score_codex":0.000072280076,"about_ca_system_score_gemma":0.00039562237,"threshold_uncertainty_score":0.3720778},"labels":[],"label_agreement":null},{"id":"W4282961792","doi":"10.1158/1538-7445.am2022-5394","title":"Abstract 5394: Uterine leiomyosarcoma with homologous recombination deficiency is highly sensitive to polo-like kinase 4 inhibitor","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Homologous recombination; Molecular biology; Mitotic catastrophe; Apoptosis; Mitosis; Cell cycle; Cancer research; Cell biology; Genetics; Gene","score_opus":0.025586006636475696,"score_gpt":0.33611573461465505,"score_spread":0.31052972797817935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940291,0.00063800626,0.000085347616,0.003053701,0.00034512134,0.00047259702,0.00046337728,0.000012577954,0.0009001829],"genre_scores_gemma":[0.9963049,0.00030731742,0.00016644834,0.0009873206,0.00026436924,0.0003920144,0.00012583478,0.000038840557,0.0014129342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982072,0.0000937035,0.0001719468,0.00056990987,0.00044551928,0.0005117355],"domain_scores_gemma":[0.99896336,0.00004757683,0.000050938073,0.00041954007,0.0003429433,0.00017564833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045958793,0.00014944846,0.0001402572,0.00018264186,0.00041622683,0.000056441084,0.00028497883,0.000064680156,0.00019541205],"category_scores_gemma":[0.000060164082,0.00015095183,0.000049212318,0.00043094807,0.00012342718,0.000005021557,0.00054032344,0.00030865183,0.000023461766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991659,0.00027055145,0.0010796094,0.000045581015,0.000044643413,0.00018466808,0.00044810123,0.00057895103,0.92800057,0.00023190065,0.055202477,0.012921298],"study_design_scores_gemma":[0.001454226,0.0035469632,0.009328011,0.000028813878,0.000012646581,0.000074046,0.00075481774,0.000035142377,0.6305527,0.00014420449,0.35357046,0.0004979617],"about_ca_topic_score_codex":0.001268842,"about_ca_topic_score_gemma":0.00042713672,"teacher_disagreement_score":0.29836798,"about_ca_system_score_codex":0.00031734005,"about_ca_system_score_gemma":0.00053112785,"threshold_uncertainty_score":0.6155637},"labels":[],"label_agreement":null},{"id":"W4282961803","doi":"10.1158/1538-7445.am2022-5734","title":"Abstract 5734: The effect of PRAME on retinoid response and cell proliferation in cutaneous and head and neck squamous cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Retinoid; Cell growth; Cell culture; Biology; Cell; Cell cycle; Cancer; Medicine; Internal medicine; Retinoic acid; Head and neck cancer","score_opus":0.02076201019566685,"score_gpt":0.3204493167109208,"score_spread":0.29968730651525394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870989,0.011052083,8.867818e-8,0.0006144073,0.0000869997,0.0006784539,0.00003457,0.0000072571365,0.00042727168],"genre_scores_gemma":[0.9966491,0.00018217858,9.047805e-7,0.000048513524,0.000009941099,0.00017755394,0.000006579298,0.0000142427525,0.002910988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969089,0.0022213354,0.00018725541,0.00027367065,0.00009196939,0.00031689045],"domain_scores_gemma":[0.99790484,0.001767101,0.000051886185,0.00021245262,0.000042549018,0.00002115579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016940125,0.000116209085,0.00019493797,0.0002092303,0.00033403336,0.000024089699,0.0001355043,0.00009210536,0.00020824952],"category_scores_gemma":[0.00022772027,0.00008399884,0.000020978938,0.000142671,0.00036006107,0.000030707408,0.00020792207,0.0008457147,0.000007765854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041766547,0.000070385744,0.018473707,0.00015405266,0.000007267513,0.000040011273,0.0020888406,0.000012024122,0.93464845,0.00001665539,0.0008615663,0.0018605101],"study_design_scores_gemma":[0.0028137136,0.008376934,0.10221757,0.00003470532,0.000007834854,0.00015424081,0.0007532385,0.000013033656,0.87903595,0.00001155108,0.006464996,0.000116220246],"about_ca_topic_score_codex":0.00071722147,"about_ca_topic_score_gemma":0.00006654063,"teacher_disagreement_score":0.08374386,"about_ca_system_score_codex":0.00009682444,"about_ca_system_score_gemma":0.00013136235,"threshold_uncertainty_score":0.36742568},"labels":[],"label_agreement":null},{"id":"W4282961847","doi":"10.1158/1538-7445.am2022-60","title":"Abstract 60: Functional mapping reveals widespread remodelling and unrecognized pathway dependencies in recurrent glioblastoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"PTEN; Glioblastoma; Cancer; Cancer research; Medicine; Biology; Signal transduction; Internal medicine; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.15311181591809003,"score_gpt":0.3728429656389958,"score_spread":0.2197311497209058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880893,0.0068327044,0.000029527562,0.0022691982,0.00030583644,0.00063235906,0.00004157933,0.000035890567,0.0010439538],"genre_scores_gemma":[0.9959404,0.0016760458,0.00011829745,0.00017011141,0.00020167626,0.0010076902,0.000015118596,0.000031339052,0.0008393317],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99728477,0.00019913257,0.00034793944,0.0005217225,0.0010958334,0.0005505963],"domain_scores_gemma":[0.99901974,0.00026973124,0.000063315085,0.00022958314,0.0002391606,0.00017843893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021179814,0.00014227464,0.00030274506,0.0004926982,0.0003736802,0.00005276546,0.00013155262,0.000060849387,0.00200201],"category_scores_gemma":[0.00016730449,0.00012451853,0.00006869022,0.0008268535,0.00011153982,0.00011512928,0.00024260726,0.0010756297,0.000012782357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010968009,0.0009031372,0.0689226,0.0016206481,0.00025497036,0.0005441822,0.0049412753,0.0018764415,0.38096705,0.00038108503,0.022003084,0.50661755],"study_design_scores_gemma":[0.024120206,0.0072001405,0.531238,0.0081297355,0.00014731815,0.0005147288,0.027942777,0.011422052,0.13438137,0.0073287305,0.2450833,0.0024916297],"about_ca_topic_score_codex":0.00052971084,"about_ca_topic_score_gemma":0.00028745466,"teacher_disagreement_score":0.5041259,"about_ca_system_score_codex":0.00078900374,"about_ca_system_score_gemma":0.0005495122,"threshold_uncertainty_score":0.9989103},"labels":[],"label_agreement":null},{"id":"W4282961898","doi":"10.1158/1538-7445.am2022-1839","title":"Abstract 1839: Nelfinavir induced-cytotoxicity towards high-grade serous ovarian cancer cells involves induction of the unfolded protein response, modulation of protein synthesis, DNA damage, lysosomal impairment, and potentiation of toxicity caused by proteasome inhibition","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Unfolded protein response; Nelfinavir; Cancer research; Pharmacology; Medicine; Biology; Chemistry; Endoplasmic reticulum; Immunology; Cell biology","score_opus":0.04260717220798169,"score_gpt":0.31636442164737705,"score_spread":0.27375724943939533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011344,0.00013016119,0.0000084017465,0.0037566477,0.00005692124,0.005533332,0.00036112394,0.000024828394,0.000015135695],"genre_scores_gemma":[0.99596316,0.000034707056,0.0001081045,0.000012940813,0.000045411325,0.003213301,0.000054419674,0.00003554719,0.00053239346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99613667,0.0008994838,0.00064032635,0.0004498871,0.0014807918,0.0003928448],"domain_scores_gemma":[0.99842054,0.00007831393,0.00051601167,0.00040845998,0.0004342598,0.00014242771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019061908,0.00022572333,0.0004470145,0.00041970226,0.0003357896,0.000020897727,0.00016172245,0.00015303293,0.0001895897],"category_scores_gemma":[0.0002530188,0.00018482047,0.00009218951,0.0011157854,0.00022551273,0.00024212332,0.00021554207,0.0005420356,5.8384325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023317095,0.0008893178,0.003855219,0.0006192262,0.00016688355,0.0000063256853,0.0011604113,0.00007866632,0.9883567,0.000035468045,0.00015285253,0.0023472323],"study_design_scores_gemma":[0.001523748,0.00032509267,0.26265642,0.0004697846,0.000043505013,0.000001667882,0.00037309856,0.00006559593,0.7342553,0.00015477244,0.000019995674,0.000110994275],"about_ca_topic_score_codex":0.004461157,"about_ca_topic_score_gemma":0.00019095834,"teacher_disagreement_score":0.25880122,"about_ca_system_score_codex":0.0011453411,"about_ca_system_score_gemma":0.0016009927,"threshold_uncertainty_score":0.753676},"labels":[],"label_agreement":null},{"id":"W4282962127","doi":"10.1158/1538-7445.am2022-572","title":"Abstract 572: Pre-clinical evaluation of Claudin 18.2 TAC T cells for the treatment of gastric cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Cancer research; Cancer; Claudin; Tight junction; In vivo; Immunotherapy; Cytotoxic T cell; Medicine; Cancer cell; Immunology; In vitro; Chemistry; Biology; Internal medicine; Biochemistry","score_opus":0.3995313886288464,"score_gpt":0.5792230089990879,"score_spread":0.17969162037024144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282962127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796041,0.012706474,0.000012053678,0.0012783535,0.00035547273,0.0046247034,0.0003080421,0.000009575273,0.0011011985],"genre_scores_gemma":[0.97156894,0.010563517,0.000036572543,0.000030394733,0.000544256,0.0059542805,0.00002655352,0.00004232392,0.011233149],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99526066,0.00062095723,0.00052888866,0.00038596205,0.0026973116,0.0005062466],"domain_scores_gemma":[0.99580467,0.0019263919,0.0001499905,0.0006648794,0.0013113051,0.0001427813],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007030693,0.00012272199,0.00040004947,0.00026142094,0.00022069685,0.000012096745,0.00032112864,0.000067914334,0.046396267],"category_scores_gemma":[0.00024266014,0.00008560168,0.000267844,0.00078857335,0.00035058951,0.000029365941,0.00009325416,0.00049830653,0.000006062679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00627985,0.0014440672,0.0076827477,0.00022892425,0.0006480974,0.0000043914265,0.0009738139,0.0022778304,0.39241713,0.000012341933,0.033017974,0.5550128],"study_design_scores_gemma":[0.022397157,0.014454627,0.13971028,0.00022293863,0.0008001229,0.0000081429625,0.001992796,0.012701463,0.4383175,0.00033046334,0.36876717,0.00029732243],"about_ca_topic_score_codex":0.0040874095,"about_ca_topic_score_gemma":0.0003930501,"teacher_disagreement_score":0.5547155,"about_ca_system_score_codex":0.0016611149,"about_ca_system_score_gemma":0.0029011574,"threshold_uncertainty_score":0.95447546},"labels":[],"label_agreement":null},{"id":"W4282963229","doi":"10.1158/1538-7445.am2022-5900","title":"Abstract 5900: Integrating prior knowledge of transcription factor occupied elements with transcriptome-wide association analysis identifies 153 breast cancer susceptibility genes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Genome-wide association study; Transcriptome; Gene; Biology; Computational biology; Genetics; Cancer; Genetic association; Gene expression; Genotype; Single-nucleotide polymorphism","score_opus":0.04533398588918788,"score_gpt":0.3737854022554531,"score_spread":0.3284514163662652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533314,0.002273816,0.00030279811,0.0004748022,0.00018724138,0.0004271489,0.0008483596,0.000014395768,0.00013830968],"genre_scores_gemma":[0.9969222,0.0007672634,0.0000332825,0.00003747685,0.00011299311,0.0006638209,0.00025678822,0.00002439279,0.0011817875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975182,0.00037456516,0.00042337718,0.0005807353,0.00071326015,0.00038990512],"domain_scores_gemma":[0.9984811,0.000046848105,0.00024217012,0.00039516328,0.0007361245,0.000098581804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010360033,0.00016733949,0.00025705536,0.0003143241,0.0003823201,0.000053485754,0.00035218985,0.00010021647,0.0014227929],"category_scores_gemma":[0.000055465498,0.00014941007,0.0001791349,0.0010950131,0.00009281215,0.00001984542,0.00007199919,0.0003342188,0.0000018006734],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042416912,0.00014603935,0.18261942,0.000085985244,0.0004176656,2.7300985e-7,0.00080379593,0.0003326119,0.80561393,0.000002859474,0.0012989189,0.008254295],"study_design_scores_gemma":[0.0009764404,0.00018518424,0.49580556,0.000043444772,0.0001619652,4.5484617e-7,0.0031066046,0.00011782337,0.48806262,0.000012829753,0.011274922,0.00025215428],"about_ca_topic_score_codex":0.0010173613,"about_ca_topic_score_gemma":0.0044038678,"teacher_disagreement_score":0.31755134,"about_ca_system_score_codex":0.0005920012,"about_ca_system_score_gemma":0.0005515334,"threshold_uncertainty_score":0.99949},"labels":[],"label_agreement":null},{"id":"W4282963232","doi":"10.1158/1538-7445.am2022-4035","title":"Abstract 4035: Driver-gene dependencies reveal clinically actionable drug repositioning opportunities","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Synthetic lethality; Drug repositioning; Computational biology; Pharmacogenomics; Cancer; Cancer drugs; Drug; Drug discovery; Gene; Biology; Medicine; Cancer research; Bioinformatics; Genetics; Mutant; Pharmacology","score_opus":0.21821538235848745,"score_gpt":0.45186442301579016,"score_spread":0.23364904065730271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566947,0.00080591376,0.020824915,0.009219643,0.0013468047,0.00043896644,0.00006877625,0.0002239538,0.010376292],"genre_scores_gemma":[0.97409767,0.00015502716,0.016420752,0.0004122409,0.00028616353,0.00048329175,0.000025999178,0.00002268094,0.008096193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953876,0.0009864998,0.0004561275,0.0006368569,0.0019721389,0.0005607385],"domain_scores_gemma":[0.9970179,0.0015095127,0.00014472018,0.00061235885,0.00052858476,0.0001869312],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.005714218,0.00013078518,0.00018873702,0.0003427259,0.0015836576,0.00038109554,0.0014801573,0.00003475643,0.0006329268],"category_scores_gemma":[0.00026258468,0.0001463703,0.000106097046,0.0008332842,0.00016847125,0.00082603085,0.0017316998,0.0009674733,0.00003251265],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047174445,0.0007811307,0.00436887,0.00023546763,0.00031060373,0.0016113924,0.008014512,0.45568997,0.06295733,0.13814366,0.14015603,0.1872593],"study_design_scores_gemma":[0.0047312295,0.0015630698,0.16411407,0.0005020516,0.00006611083,0.0010755729,0.020257788,0.12341828,0.10408529,0.28583014,0.29038513,0.0039712703],"about_ca_topic_score_codex":0.0007653633,"about_ca_topic_score_gemma":0.000024694637,"teacher_disagreement_score":0.3322717,"about_ca_system_score_codex":0.00076287205,"about_ca_system_score_gemma":0.0020933459,"threshold_uncertainty_score":0.99971616},"labels":[],"label_agreement":null},{"id":"W4282963647","doi":"10.1158/1538-7445.am2022-4133","title":"Abstract 4133: High prevalence and heterogeneity of emergence of <i>BRCA</i> reversion mutations at progression on niraparib treatment in <i>BRCA</i>-mutant metastatic castration-resistant prostate cancer (mCRPC) patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reversion; Frameshift mutation; Prostate cancer; Medicine; Missense mutation; Cancer research; Mutation; Cancer; Nonsense mutation; Allele; Oncology; Internal medicine; Biology; Genetics; Phenotype; Gene","score_opus":0.08300330439989648,"score_gpt":0.4233405694843785,"score_spread":0.34033726508448203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202836,0.0030576468,0.000001009025,0.0005986675,0.00016147085,0.0024291526,0.0016333765,0.00001456064,0.00007575255],"genre_scores_gemma":[0.99273366,0.0043425173,0.00009062334,0.000049381964,0.000025870095,0.0024251428,0.000118664146,0.000031451742,0.00018268258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99645555,0.0003642308,0.0006865597,0.0005820209,0.0014688843,0.0004427532],"domain_scores_gemma":[0.99841154,0.00020153883,0.00034411415,0.00041089853,0.0004603368,0.00017157578],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007012861,0.00021791944,0.00043536813,0.0003501663,0.00031620293,0.000010504085,0.00015241491,0.000046260335,0.0010336782],"category_scores_gemma":[0.000057392135,0.00018795497,0.000081217004,0.00082522025,0.0003362888,0.00012377482,0.0001243931,0.00034247802,0.0000024950616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007916032,0.002032742,0.2014671,0.0016283827,0.0001634407,0.00006423902,0.0028343773,0.0022513089,0.7725875,0.00005166447,0.00078798993,0.008215247],"study_design_scores_gemma":[0.007439575,0.004163739,0.22944333,0.0014256493,0.000091493224,0.000006251277,0.00048454956,0.00008119488,0.7555224,0.00014610714,0.00094788143,0.0002478807],"about_ca_topic_score_codex":0.0024729744,"about_ca_topic_score_gemma":0.00089989183,"teacher_disagreement_score":0.02797624,"about_ca_system_score_codex":0.001496745,"about_ca_system_score_gemma":0.0007700738,"threshold_uncertainty_score":0.99987954},"labels":[],"label_agreement":null},{"id":"W4282963737","doi":"10.1158/1538-7445.am2022-1428","title":"Abstract 1428: DNA methylation predicts early onset of primary tumor in patients with Li-Fraumeni syndrome","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; London Health Sciences Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Cancer; DNA methylation; Germline; Medicine; Li–Fraumeni syndrome; Methylation; Oncology; Internal medicine; Germline mutation; Genetics; Biology; Mutation; Gene","score_opus":0.02586013508913795,"score_gpt":0.31192758044456204,"score_spread":0.2860674453554241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977279,0.0011509073,0.000016566823,0.00004146381,0.00007177687,0.00042679513,0.00013224951,0.000003887982,0.00042850117],"genre_scores_gemma":[0.9991846,0.000087631575,0.00006531631,0.000017646498,0.00003549867,0.00017768117,0.00025388825,0.000022977554,0.00015476801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998385,0.00018860995,0.0002183113,0.00030259436,0.00063339376,0.00027205265],"domain_scores_gemma":[0.9993329,0.000032798027,0.00008712875,0.00028525406,0.00019665224,0.00006527732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007661955,0.00008990074,0.0001366994,0.0001688346,0.00009691828,0.000012036742,0.00020322972,0.0000499063,0.00011105649],"category_scores_gemma":[0.000051296225,0.00008700735,0.000030393325,0.00033567162,0.00008147373,0.000006939947,0.00018777409,0.00025479044,0.0000019262236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012189224,0.00041504388,0.5477446,0.0001160486,0.0000751651,0.000014709162,0.00023716445,0.0020518284,0.44047162,0.000010736207,0.00031714173,0.0073270304],"study_design_scores_gemma":[0.0009235459,0.0010341986,0.9192984,0.000018369768,0.0000042695665,5.399347e-7,0.000027090135,0.0000069857715,0.07732523,0.000075050906,0.0011891301,0.00009719325],"about_ca_topic_score_codex":0.0002849711,"about_ca_topic_score_gemma":0.000059414106,"teacher_disagreement_score":0.3715538,"about_ca_system_score_codex":0.00012950833,"about_ca_system_score_gemma":0.00029922943,"threshold_uncertainty_score":0.35480568},"labels":[],"label_agreement":null},{"id":"W4282964062","doi":"10.1158/1538-7445.am2022-775","title":"Abstract 775: Evaluation of Erb-B2 expression from archival tumor tissue in early stage epithelial ovarian carcinoma patient prognosis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Gastroenterology; Regimen; Cancer; Population; Chemotherapy; Oncology; Pathology; Biology","score_opus":0.10595877025289831,"score_gpt":0.40456598914017233,"score_spread":0.29860721888727404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338657,0.0011057355,0.0000023910561,0.00096093235,0.0002408488,0.002266121,0.00086064433,0.000015414258,0.0011613258],"genre_scores_gemma":[0.9952376,0.000065306296,0.00016846498,0.000043190004,0.0002052875,0.0040430604,0.00011900854,0.000039763134,0.00007833861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954025,0.0005915326,0.00044729604,0.0005749888,0.0025042272,0.00047941328],"domain_scores_gemma":[0.99864227,0.00021698148,0.00013694631,0.0004773218,0.00033828037,0.00018821296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014348506,0.00016499888,0.0003545576,0.0003753242,0.00018219638,0.000027494836,0.0001958607,0.000038972947,0.004319883],"category_scores_gemma":[0.000113566784,0.00014832368,0.00008063391,0.00049495924,0.00010006858,0.00008516351,0.00023973192,0.0006153623,0.000017344551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036794918,0.0032967753,0.52396315,0.00028057164,0.00018997178,0.0005913546,0.010281152,0.0012861773,0.27000886,0.0001293853,0.0021428212,0.18415025],"study_design_scores_gemma":[0.0038496754,0.00092575105,0.7527178,0.00024903042,0.000055586755,0.0000018779333,0.000618277,0.0001737668,0.2387354,0.00017908594,0.0023773855,0.00011639133],"about_ca_topic_score_codex":0.025989564,"about_ca_topic_score_gemma":0.00037757595,"teacher_disagreement_score":0.2287546,"about_ca_system_score_codex":0.0014605614,"about_ca_system_score_gemma":0.0013365021,"threshold_uncertainty_score":0.9965903},"labels":[],"label_agreement":null},{"id":"W4282964229","doi":"10.1158/1538-7445.am2022-75","title":"Abstract 75: Highly multiplexed <i>EGFR</i> mutation detection from liquid biopsy samples using the 6-color Crystal Digital PCR™","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Digital polymerase chain reaction; Liquid biopsy; Epidermal growth factor receptor; Lung cancer; Biomarker; Cancer research; Mutation; Somatic cell; EGFR inhibitors; Medicine; Cancer; Biology; Oncology; Internal medicine; Polymerase chain reaction; Gene; Genetics","score_opus":0.057039002546365576,"score_gpt":0.3394607102565162,"score_spread":0.2824217077101506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956641,0.0013977968,0.00048675586,0.00025490738,0.00040694603,0.00036091183,0.0013016355,0.000012728244,0.00011420986],"genre_scores_gemma":[0.9982457,0.00017169322,0.000081257436,0.00012464228,0.0007096689,0.00017640009,0.00037373631,0.00003650407,0.000080401354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985389,0.00009212843,0.0001968367,0.00041077376,0.0003942421,0.00036708277],"domain_scores_gemma":[0.9991599,0.00015820074,0.00007639328,0.0003429437,0.00017920212,0.00008341264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035925725,0.00012591084,0.00010552791,0.00006882057,0.0006692846,0.00015742872,0.0003160384,0.00007355545,0.00011998021],"category_scores_gemma":[0.00020032338,0.00011426416,0.00008311666,0.00023115332,0.00015588719,0.000010435038,0.0003990672,0.00030725598,0.0000052810046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006910133,0.000047989244,0.00017697568,0.0000075520325,0.00004555477,0.000009808473,0.00016648506,0.0066355774,0.98858035,0.000010040196,0.0005802285,0.0030484067],"study_design_scores_gemma":[0.0011593068,0.0006562861,0.0027124395,0.000014774545,0.000022258075,0.000025066049,0.0020054555,0.0011789739,0.9052538,0.00019341803,0.08643363,0.0003445943],"about_ca_topic_score_codex":0.0037360275,"about_ca_topic_score_gemma":0.0005910179,"teacher_disagreement_score":0.0858534,"about_ca_system_score_codex":0.00028725402,"about_ca_system_score_gemma":0.0003383835,"threshold_uncertainty_score":0.5647781},"labels":[],"label_agreement":null},{"id":"W4282964309","doi":"10.1158/1538-7445.am2022-5906","title":"Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Population; Cancer registry; Cancer; Ovarian cancer; Internal medicine; National Death Index; Oncology; Proportional hazards model; Cohort; Disease; Gynecology; Cohort study; Hazard ratio; Confidence interval; Environmental health","score_opus":0.08812359254121675,"score_gpt":0.40248729101678404,"score_spread":0.3143636984755673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933489,0.0011803573,0.000004816631,0.0009682119,0.0007471842,0.0026231548,0.00086839206,0.00007742183,0.00018157644],"genre_scores_gemma":[0.9944603,0.00062783645,0.000019721236,0.00005433578,0.00041579126,0.0040620025,0.0001311836,0.000058905604,0.00016994735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953817,0.0011826331,0.00048913644,0.00091200694,0.0013027206,0.0007317682],"domain_scores_gemma":[0.99742204,0.0012509959,0.00018314579,0.000554952,0.00023958237,0.00034929533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035208124,0.00031607776,0.00076303276,0.0003163345,0.0009941902,0.00006966248,0.00020749182,0.00009593917,0.0034851914],"category_scores_gemma":[0.00046726008,0.00024488207,0.00014172777,0.0007384371,0.00020495722,0.000096811455,0.00014962182,0.0010474188,0.00000433907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046222223,0.00075605226,0.9936797,0.00006191731,0.0005029599,0.00007612171,0.0006787628,0.0014380601,0.00005677307,0.00003322731,0.0002581839,0.001996032],"study_design_scores_gemma":[0.0024570387,0.0007848134,0.99376357,0.00004936392,0.00020061903,9.39731e-7,0.0015523551,0.00014043385,0.00015908865,0.00008793655,0.0005745487,0.00022930551],"about_ca_topic_score_codex":0.56747955,"about_ca_topic_score_gemma":0.043113966,"teacher_disagreement_score":0.5243656,"about_ca_system_score_codex":0.0015897319,"about_ca_system_score_gemma":0.00072177895,"threshold_uncertainty_score":0.9986002},"labels":[],"label_agreement":null},{"id":"W4282964792","doi":"10.1158/1538-7445.am2022-3897","title":"Abstract 3897: Ribosomal translational regulation is a potential mechanism for leukemia-related thrombo-embolic event in childhood acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Sherbrooke; Université Laval","funders":"","keywords":"Interquartile range; Medicine; Lymphoblastic Leukemia; KEGG; Leukemia; Gene signature; Cancer; Acute lymphocytic leukemia; Internal medicine; Oncology; Gene; Cancer research; Gene expression; Transcriptome; Biology; Genetics","score_opus":0.026293942168069337,"score_gpt":0.3465837729098511,"score_spread":0.32028983074178174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882609,0.0003849794,0.0014323544,0.004496617,0.00043615783,0.003458181,0.0006081577,0.0001089578,0.00081366824],"genre_scores_gemma":[0.9931169,0.00018818633,0.00034332662,0.00038694893,0.00046550724,0.0025893506,0.00050495635,0.00015025775,0.0022545303],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9927041,0.0003061195,0.00093324174,0.0011286464,0.0033348496,0.0015930658],"domain_scores_gemma":[0.9975452,0.00050527474,0.00016469904,0.0006456462,0.00069166144,0.00044751226],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018360643,0.00039429805,0.00067017664,0.0011809352,0.00085273257,0.0000814269,0.000616015,0.00032776158,0.005535737],"category_scores_gemma":[0.00023311283,0.00040267315,0.00034655485,0.0017855752,0.00028423435,0.00026519972,0.00034325483,0.0016299568,0.000106475105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015962765,0.0024115127,0.0020492454,0.0014071924,0.0033766916,0.0015958225,0.013057377,0.059677657,0.80077857,0.028314244,0.04298981,0.02837911],"study_design_scores_gemma":[0.09318044,0.004335851,0.34963322,0.0012467451,0.0008376729,0.0014897117,0.0023330397,0.37294123,0.0854013,0.08154599,0.0047744727,0.0022803391],"about_ca_topic_score_codex":0.001281605,"about_ca_topic_score_gemma":0.000071623945,"teacher_disagreement_score":0.7153773,"about_ca_system_score_codex":0.015571781,"about_ca_system_score_gemma":0.013752522,"threshold_uncertainty_score":0.9998425},"labels":[],"label_agreement":null},{"id":"W4282964833","doi":"10.1158/1538-7445.am2022-6239","title":"Abstract 6239: Colposcopy referral rates in an organized cytology-based cervix screening program after receipt of multiple rounds of HPV-based screening in the FOCAL trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Concordia University; McGill University; BC Cancer Agency; Simon Fraser University; University of British Columbia; BC Centre for Disease Control; B.C. Women's Hospital & Health Centre","funders":"","keywords":"Colposcopy; Medicine; Referral; Cervical screening; Population; Gynecology; Cohort; Cervix; Obstetrics; Cytology; Cervical cancer; Family medicine; Cancer; Internal medicine; Pathology","score_opus":0.19541441793859957,"score_gpt":0.4851484257294792,"score_spread":0.28973400779087966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300545,0.0006799949,0.000050012954,0.0020536333,0.000077042205,0.0034183522,0.00009606581,0.000030744017,0.0005886792],"genre_scores_gemma":[0.99474925,0.000022113534,0.0010627786,0.00023534142,0.00018028711,0.003519067,0.0001412255,0.00005455714,0.000035388584],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99415547,0.0014134734,0.00078638486,0.0005880904,0.0020968427,0.00095972914],"domain_scores_gemma":[0.99708426,0.0012516135,0.00012781742,0.00067780295,0.0006445317,0.00021399534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005396076,0.00021347664,0.0006987874,0.00089132,0.00020004004,0.000051430914,0.0007035725,0.00016624523,0.008274324],"category_scores_gemma":[0.0007034299,0.00017088979,0.00015423082,0.0027905821,0.00053615455,0.00011916959,0.0002214357,0.0022139717,0.0000020094583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52473646,0.0035666598,0.3434644,0.0010179133,0.00008151954,0.00029508123,0.0016233019,0.0020697392,0.013502555,0.000026074777,0.00045787517,0.10915842],"study_design_scores_gemma":[0.10307537,0.00936934,0.8506239,0.00018405978,0.00003516955,0.000003959055,0.0032570488,0.011571041,0.019718472,0.00005671792,0.0018134713,0.00029141802],"about_ca_topic_score_codex":0.007986948,"about_ca_topic_score_gemma":0.0080825575,"teacher_disagreement_score":0.50715953,"about_ca_system_score_codex":0.00043549642,"about_ca_system_score_gemma":0.0019554496,"threshold_uncertainty_score":0.99861896},"labels":[],"label_agreement":null},{"id":"W4282965023","doi":"10.1158/1538-7445.am2022-5400","title":"Abstract 5400: Detection of satellite tumor cells in peritumoral edema in myxofibrosarcoma and undifferentiated pleomorphic sarcoma using targeted gene sequencing","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Sarcoma; Myxofibrosarcoma; Medicine; Circulating tumor cell; Population; Pathology; Digital polymerase chain reaction; Cancer research; Cancer; Gene; Internal medicine; Biology; Polymerase chain reaction; Metastasis","score_opus":0.0986801945710639,"score_gpt":0.3624975422154249,"score_spread":0.263817347644361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282965023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988784,0.010124472,0.0000016518,0.00012003357,0.00008931035,0.0007670988,0.00007193898,0.000016163549,0.000025312596],"genre_scores_gemma":[0.9989083,0.00056873314,0.000116177245,0.00003169297,0.000042442025,0.0002464805,0.000034499975,0.000036635316,0.000015075636],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760467,0.00031289365,0.00043955058,0.00042949477,0.00065778743,0.0005555855],"domain_scores_gemma":[0.99925727,0.00015442885,0.00009467765,0.0002509131,0.00010625184,0.000136455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078035507,0.00016857483,0.00042800323,0.00078489585,0.00016918001,0.000025924477,0.00010755818,0.00005070661,0.00029874],"category_scores_gemma":[0.000038380513,0.00016620714,0.00006207177,0.0010387779,0.00014578867,0.00007613656,0.00018016933,0.00059521693,0.0000022327997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043090226,0.00028676313,0.26118588,0.00016831535,0.000029165918,0.000708674,0.0004363521,0.00014701563,0.7337591,0.000005606683,0.0000029251325,0.0028392824],"study_design_scores_gemma":[0.002162134,0.0002449167,0.55925906,0.00017461633,0.000017319826,0.000076333636,0.0006737337,0.0010002648,0.4361766,0.00005619195,0.000052322874,0.00010652724],"about_ca_topic_score_codex":0.012078911,"about_ca_topic_score_gemma":0.0013511122,"teacher_disagreement_score":0.29807317,"about_ca_system_score_codex":0.0016619771,"about_ca_system_score_gemma":0.0004249012,"threshold_uncertainty_score":0.99449974},"labels":[],"label_agreement":null},{"id":"W4282965232","doi":"10.1158/1538-7445.am2022-ct011","title":"Abstract CT011: NeoCOAST: open-label, randomized, phase 2, multidrug platform study of neoadjuvant durvalumab alone or combined with novel agents in patients (pts) with resectable, early-stage non-small-cell lung cancer (NSCLC)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Durvalumab; Tolerability; Clinical endpoint; Neoadjuvant therapy; Internal medicine; Lung cancer; Gastroenterology; Oncology; Cancer; Lymph node; Surgery; Randomized controlled trial; Immunotherapy; Breast cancer; Adverse effect; Pembrolizumab","score_opus":0.10182909005067348,"score_gpt":0.4069291801461712,"score_spread":0.3051000900954977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282965232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818086,0.0006382866,0.000011957357,0.00019681329,0.00019616749,0.015929215,0.0005332231,0.000027963497,0.0006577658],"genre_scores_gemma":[0.98873574,0.0004456871,0.00010990105,0.00015146137,0.000056281788,0.0057585556,0.00010640005,0.00014417135,0.004491832],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939291,0.00037476918,0.0010692595,0.000997597,0.0024875156,0.0011417958],"domain_scores_gemma":[0.9970886,0.00044926064,0.00049572304,0.0009587349,0.000694215,0.0003134689],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033595501,0.00048425197,0.0015513371,0.0007222631,0.0005357441,0.00012304814,0.0010011316,0.000101872676,0.0023586552],"category_scores_gemma":[0.00007682244,0.00033148788,0.00008554931,0.0021134636,0.00038973195,0.0003725864,0.00070841296,0.0014396529,0.0000026345651],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9040952,0.022116886,0.049005326,0.00058910536,0.0012278812,0.00040209424,0.008119263,0.00044227944,0.008996426,0.0000016625755,0.0012577544,0.0037461552],"study_design_scores_gemma":[0.9301939,0.018743329,0.0370147,0.0011300385,0.00021082125,0.0000061823107,0.00529306,0.0013782973,0.00499034,8.162284e-7,0.0005281864,0.0005103526],"about_ca_topic_score_codex":0.12398864,"about_ca_topic_score_gemma":0.022320604,"teacher_disagreement_score":0.10166804,"about_ca_system_score_codex":0.0016691865,"about_ca_system_score_gemma":0.0025293415,"threshold_uncertainty_score":0.9999137},"labels":[],"label_agreement":null},{"id":"W4282965447","doi":"10.1158/1538-7445.am2022-5704","title":"Abstract 5704: IDH2 mutation reduce radiotherapy induced immune response in glioblastoma by affecting micronucleus formation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"IDH2; Cancer research; Biology; DNA methylation; Isocitrate dehydrogenase; Mutation; Immune checkpoint; Immune system; Cell biology; Genetics; IDH1; Immunotherapy; Gene; Gene expression","score_opus":0.038377167971960155,"score_gpt":0.37037218617803014,"score_spread":0.33199501820606997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282965447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868776,0.010674948,0.000011070809,0.0011031318,0.00051936763,0.00057342555,0.000049549275,0.000054120934,0.00013676347],"genre_scores_gemma":[0.99738675,0.0002124569,0.0000065128893,0.0000830743,0.000024055535,0.00038271135,0.00004429176,0.00003743994,0.0018227319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959645,0.0024634951,0.00042184637,0.00033100863,0.000154183,0.00066492584],"domain_scores_gemma":[0.99875313,0.0006789362,0.00012286255,0.0003053065,0.000115430055,0.000024329749],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035117096,0.00015923011,0.00024018156,0.00065530627,0.00068512664,0.000048773814,0.00040266642,0.00014909614,0.002543028],"category_scores_gemma":[0.0002894026,0.00016914382,0.00007454252,0.0006514198,0.00013800668,0.00023985915,0.00016740472,0.0013759299,0.00013252156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02343512,0.00013591888,0.00001772263,0.000022175409,0.000044769145,0.000020782269,0.0041694627,0.00004361965,0.9484517,0.0000116983865,0.00578351,0.017863497],"study_design_scores_gemma":[0.0023857427,0.0013741116,0.0045764437,0.000063577165,0.000002755885,0.00010885572,0.0045352196,0.000015602962,0.9596027,0.000012417771,0.027141998,0.00018053422],"about_ca_topic_score_codex":0.0011584543,"about_ca_topic_score_gemma":0.000046843565,"teacher_disagreement_score":0.021358486,"about_ca_system_score_codex":0.001345934,"about_ca_system_score_gemma":0.00031912635,"threshold_uncertainty_score":0.9983688},"labels":[],"label_agreement":null},{"id":"W4282966005","doi":"10.1158/1538-7445.am2022-3396","title":"Abstract 3396: Identification of small cell lung cancer stage-specific DNA methylation in patients using liquid biopsies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Epigenetics; Methylation; Cancer; Lung cancer; Cancer research; Biology; Stage (stratigraphy); Medicine; Molecular biology; Oncology; DNA; Pathology; Gene; Internal medicine; Genetics; Gene expression","score_opus":0.05714215785733618,"score_gpt":0.36141588488992343,"score_spread":0.30427372703258726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231553,0.006299915,0.000065037566,0.00005261766,0.0002970928,0.0004202174,0.00044118095,0.000003028319,0.000105380976],"genre_scores_gemma":[0.9967195,0.002485411,0.000040316605,0.00001992937,0.00012694605,0.00021398137,0.00015718205,0.00002697324,0.00020978303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855834,0.00011049715,0.0003363668,0.00035621153,0.00034523048,0.00029335657],"domain_scores_gemma":[0.99914575,0.000038857193,0.00015109577,0.00031227892,0.00029914142,0.00005288398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068344903,0.00009737883,0.00012454379,0.00019938071,0.00015943476,0.0000285841,0.00025597806,0.00006429188,0.00019730302],"category_scores_gemma":[0.000048827314,0.00011478684,0.000049089427,0.00035754425,0.000074457144,0.0000061504925,0.00026708408,0.00021500973,9.677941e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038125415,0.00012294881,0.018068144,0.00009055748,0.000015675181,0.0000010337692,0.00021843416,0.023768928,0.9556693,0.00001875638,0.0005471217,0.0010978428],"study_design_scores_gemma":[0.00080665335,0.00019392718,0.044760644,0.000022398859,0.000007784393,1.06834065e-7,0.0002955622,0.00046989514,0.9437194,0.00001548917,0.009536759,0.00017138092],"about_ca_topic_score_codex":0.001422251,"about_ca_topic_score_gemma":0.0003288221,"teacher_disagreement_score":0.026692502,"about_ca_system_score_codex":0.00040394528,"about_ca_system_score_gemma":0.0004273827,"threshold_uncertainty_score":0.46808714},"labels":[],"label_agreement":null},{"id":"W4282966080","doi":"10.1158/1538-7445.am2022-1192","title":"Abstract 1192: The Clinical Genome Resource (ClinGen) somatic cancer clinical domain working group","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer; Somatic cell; Computational biology; Genetics; Bioinformatics; Medicine; Biology; Gene","score_opus":0.14889845669546534,"score_gpt":0.4585117458423907,"score_spread":0.3096132891469253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97402835,0.018536057,0.000059614926,0.003578548,0.001090741,0.0006542295,0.00015187931,0.000016944015,0.0018836504],"genre_scores_gemma":[0.9818052,0.00990099,0.00013143187,0.0018525851,0.0043217083,0.00090643694,0.00009817114,0.00007666249,0.00090681895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959871,0.00087579194,0.00080537045,0.0008224892,0.0007097771,0.0007994268],"domain_scores_gemma":[0.9976887,0.0007318533,0.00020186452,0.0009844771,0.00013355436,0.00025953446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066685025,0.00020102276,0.0003177933,0.00007744198,0.0009842633,0.000116651165,0.0011627391,0.00018041024,0.00073239225],"category_scores_gemma":[0.00042933135,0.00017064012,0.0003065338,0.00036962458,0.00054080953,0.000003706944,0.0013873267,0.0014599815,0.000029034469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004738375,0.0020764878,0.19146363,0.00027616438,0.0018150149,0.000280147,0.0015147348,0.009683029,0.2179342,0.0024198308,0.3076335,0.2601649],"study_design_scores_gemma":[0.0009903394,0.00039155106,0.039511953,0.000028971172,0.000025107644,0.000006084612,0.0006191577,0.000037979025,0.00043732446,0.0005141348,0.9571715,0.00026589457],"about_ca_topic_score_codex":0.00049371016,"about_ca_topic_score_gemma":0.0009452386,"teacher_disagreement_score":0.649538,"about_ca_system_score_codex":0.00022893738,"about_ca_system_score_gemma":0.00088090054,"threshold_uncertainty_score":0.80191815},"labels":[],"label_agreement":null},{"id":"W4282966213","doi":"10.1158/1538-7445.am2022-ct165","title":"Abstract CT165: Primary analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Clinical endpoint; Interquartile range; Confidence interval; Phases of clinical research; Basal cell carcinoma; Oncology; Gastroenterology; Adverse effect; Clinical trial; Basal cell","score_opus":0.055210996013870126,"score_gpt":0.37506820833916016,"score_spread":0.31985721232529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621993,0.0003213414,0.000020199419,0.00017969098,0.00005364155,0.0013911243,0.001633453,0.0000048995016,0.0001756933],"genre_scores_gemma":[0.99764186,0.000013381245,0.00016082964,0.0001029637,0.000052232655,0.0011712064,0.0005699673,0.000035791803,0.00025179083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974986,0.00018851057,0.00043727778,0.00064959325,0.0007127578,0.00051329203],"domain_scores_gemma":[0.9987403,0.00014227944,0.00013017564,0.00044966058,0.00041362288,0.00012392936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009951642,0.00018927957,0.00043517738,0.0005655321,0.00018884064,0.000019430121,0.0003244691,0.00004653136,0.000030279436],"category_scores_gemma":[0.00017159834,0.00015125937,0.00010843222,0.0012162032,0.00011316232,0.000004919747,0.00027183647,0.00026549332,9.2249184e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14345586,0.008235313,0.07321785,0.001602547,0.0023636816,0.00011244827,0.005425526,0.02267778,0.7036271,0.000007913914,0.02364418,0.015629806],"study_design_scores_gemma":[0.027998205,0.02162103,0.14356256,0.00019504568,0.00034752453,3.2908923e-7,0.0016581583,0.00028407195,0.7931671,0.000007305312,0.010390037,0.00076862494],"about_ca_topic_score_codex":0.00016415666,"about_ca_topic_score_gemma":0.00026869486,"teacher_disagreement_score":0.11545766,"about_ca_system_score_codex":0.0002474403,"about_ca_system_score_gemma":0.00055017904,"threshold_uncertainty_score":0.61681783},"labels":[],"label_agreement":null},{"id":"W4282966580","doi":"10.1158/1538-7445.am2022-1151","title":"Abstract 1151: Pharmacogenomics genotyping from clinical somatic whole exome sequencing: Aldy, a computational tool","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Germline; Pharmacogenomics; Genotyping; Genotype; Genetics; Germline mutation; Somatic cell; Exome sequencing; Biology; Medicine; Oncology; Bioinformatics; Gene; Mutation","score_opus":0.1307082533667497,"score_gpt":0.4334413052413955,"score_spread":0.30273305187464583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354553,0.0033687092,0.00038588225,0.0005813776,0.0005256397,0.00035043643,0.00088904344,0.000013106515,0.0003402513],"genre_scores_gemma":[0.9952068,0.00080057007,0.00071971165,0.0008703493,0.0011859993,0.0002642026,0.000642182,0.000047432706,0.00026275756],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979005,0.00018762985,0.00042320255,0.0005549824,0.0004715166,0.00046219034],"domain_scores_gemma":[0.99892974,0.00025250565,0.00010173545,0.00036723193,0.0001918938,0.0001569152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011117212,0.00014263333,0.0001948293,0.00008292037,0.00046145078,0.00008180329,0.00048449537,0.00008262309,0.00077522773],"category_scores_gemma":[0.000165555,0.00016645114,0.00012992791,0.00017497077,0.00015137409,0.000005564538,0.00068134535,0.00054646225,0.000056690213],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000429482,0.00019057903,0.005754288,0.000046789886,0.0002703201,0.000061801504,0.00032431746,0.05908159,0.8849923,0.00014750201,0.03327979,0.015421228],"study_design_scores_gemma":[0.0057790237,0.0008690323,0.032066934,0.00007131814,0.000093918985,0.000036837188,0.001524529,0.011771968,0.06743452,0.008092083,0.8709199,0.0013399707],"about_ca_topic_score_codex":0.0005839378,"about_ca_topic_score_gemma":0.0000834436,"teacher_disagreement_score":0.83764005,"about_ca_system_score_codex":0.00041164493,"about_ca_system_score_gemma":0.0016067851,"threshold_uncertainty_score":0.84882},"labels":[],"label_agreement":null},{"id":"W4282966748","doi":"10.1158/1538-7445.am2022-ct503","title":"Abstract CT503: A phase I/Ib study of the safety and preliminary efficacy of NZV930 alone and in combination with spartalizumab and/or taminadenant in patients (pts) with advanced malignancies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Oncology; Cancer; Pharmacodynamics; Pharmacokinetics; Adverse effect","score_opus":0.022875674406897317,"score_gpt":0.32929099898163217,"score_spread":0.30641532457473486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976547,0.0015843691,0.0000022386123,0.000058205133,0.0000073584238,0.00066153577,0.000018932136,8.5258716e-7,0.000011860809],"genre_scores_gemma":[0.9995777,0.0002374093,0.000009237875,0.0000055708792,0.0000050540543,0.000093632065,0.000011422535,0.000008903044,0.00005106645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991271,0.00011265888,0.00015645854,0.00021171104,0.00024942655,0.00014263082],"domain_scores_gemma":[0.9996493,0.000042063297,0.000068596404,0.00013880014,0.00007487099,0.000026399252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002632989,0.00007208631,0.00013421854,0.0000703054,0.00007986505,0.000005170453,0.00008598252,0.000022412176,0.000007495345],"category_scores_gemma":[0.000027458773,0.00004575599,0.0000062573863,0.00022115392,0.00013741835,0.0000064973,0.00018508216,0.00012985441,1.0137046e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076680966,0.0066136178,0.75350285,0.00047990336,0.00014124592,0.00007153134,0.0069278427,0.003353453,0.13787536,0.000024739767,0.00013421052,0.014194283],"study_design_scores_gemma":[0.020212037,0.012180949,0.93861073,0.00017416781,0.000014756237,0.0000070903793,0.003115935,0.000050350893,0.02537055,0.000004692881,0.00014583443,0.00011292643],"about_ca_topic_score_codex":0.0004003574,"about_ca_topic_score_gemma":0.00034260118,"teacher_disagreement_score":0.18510787,"about_ca_system_score_codex":0.000027644432,"about_ca_system_score_gemma":0.00010185071,"threshold_uncertainty_score":0.18658751},"labels":[],"label_agreement":null},{"id":"W4282966985","doi":"10.1158/1538-7445.am2022-3046","title":"Abstract 3046: A common gut commensal utilizes tryptophan to promote cancer via the aryl hydrocarbon receptor","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gut flora; Aryl hydrocarbon receptor; Cancer; Biology; Antibiotics; Ruminococcus; Feces; Metabolite; Physiology; Microbiology; Pharmacology; Immunology; Endocrinology; Biochemistry; Gene; Genetics","score_opus":0.056157770994343346,"score_gpt":0.40408181170472374,"score_spread":0.3479240407103804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843301,0.0034465732,0.0000055015125,0.0101150945,0.00035827095,0.0008498744,0.00020592574,0.000015577732,0.00067309354],"genre_scores_gemma":[0.9943221,0.0007554168,0.00003022511,0.0017235948,0.0004910015,0.0010329131,0.00009659136,0.000044330085,0.0015038293],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979446,0.00020702579,0.0002244941,0.00048469016,0.0004266737,0.0007125034],"domain_scores_gemma":[0.9990161,0.00003060972,0.0000558047,0.00057775725,0.000118179545,0.00020154713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090988586,0.00016154263,0.00018086302,0.00007923701,0.00080397853,0.000045259898,0.0006711825,0.000088603345,0.0011736358],"category_scores_gemma":[0.000025113215,0.00013205103,0.00007687922,0.0003566479,0.00013905294,0.000003386977,0.0006229136,0.0006969931,0.000032727196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003429699,0.000079592384,0.00080335065,0.00004032782,0.00003898531,0.0000041346643,0.00036817463,0.000054639066,0.9093642,0.000016477938,0.080403864,0.008483255],"study_design_scores_gemma":[0.0005417252,0.00054380944,0.0066128173,0.000031845124,0.0000067539445,0.000007912531,0.00030195856,0.000029978155,0.30756727,0.00006406213,0.684073,0.00021888809],"about_ca_topic_score_codex":0.0039430913,"about_ca_topic_score_gemma":0.0016354157,"teacher_disagreement_score":0.6036691,"about_ca_system_score_codex":0.00026525886,"about_ca_system_score_gemma":0.0005320577,"threshold_uncertainty_score":0.9997394},"labels":[],"label_agreement":null},{"id":"W4282967158","doi":"10.1158/1538-7445.am2022-2021","title":"Abstract 2021: Wilms tumor and pure erythroid leukemia arising from the same clone in an adolescent","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Wilms' tumor; Medicine; clone (Java method); Pathology; Leukemia; Nephrectomy; Bone marrow; Chemotherapy; Cancer research; Biology; Kidney; Internal medicine; Genetics; Gene","score_opus":0.032198534208742295,"score_gpt":0.3388941798105953,"score_spread":0.306695645601853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416317,0.013983108,0.0000022223353,0.0012458718,0.00014209801,0.00021293624,0.00007204959,0.0000035173898,0.00017503007],"genre_scores_gemma":[0.9956904,0.0030515767,0.0000098114915,0.00042736295,0.0004060885,0.000109572204,0.00007517249,0.00001917805,0.00021082854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986183,0.00018221399,0.00013875948,0.00038725827,0.00032978202,0.0003436599],"domain_scores_gemma":[0.9995052,0.000024946861,0.000034874916,0.00029099602,0.000050704573,0.00009324851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047877527,0.00009711384,0.0001041772,0.00004166187,0.0003041443,0.00005172245,0.00029175138,0.00006705991,0.00020665531],"category_scores_gemma":[0.000024145736,0.00007263429,0.000034274974,0.00020573304,0.00018356791,0.0000055615906,0.00028856762,0.00081458705,0.0000033789838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038044152,0.000046015062,0.012578929,0.000019536525,0.00003753881,0.000054062508,0.00032149156,0.0018861871,0.9610665,0.000011292433,0.009565802,0.014032228],"study_design_scores_gemma":[0.0049485127,0.0013660757,0.32215384,0.00047195543,0.00004150316,0.00006890208,0.010820822,0.0006391578,0.3952853,0.0012180592,0.2618727,0.0011131382],"about_ca_topic_score_codex":0.002750271,"about_ca_topic_score_gemma":0.00087015645,"teacher_disagreement_score":0.5657812,"about_ca_system_score_codex":0.00024432235,"about_ca_system_score_gemma":0.00045696317,"threshold_uncertainty_score":0.41576055},"labels":[],"label_agreement":null},{"id":"W4282967195","doi":"10.1158/1538-7445.am2022-5048","title":"Abstract 5048: Imaging based EGFR mutation subtype classification using EfficientNet","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mutation; Epidermal growth factor receptor; Lymph node; Medicine; Cancer research; Computer science; Biology; Cancer; Pathology; Internal medicine; Genetics; Gene","score_opus":0.10442309308096148,"score_gpt":0.456435762780487,"score_spread":0.3520126696995255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680425,0.00082135515,0.001667439,0.007939031,0.0003301856,0.00038538565,0.000009982519,0.00006234072,0.0019800516],"genre_scores_gemma":[0.99805665,0.000015637248,0.000593053,0.00059840165,0.00023827002,0.000097973985,0.000079317746,0.00003639361,0.0002842785],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99779904,0.0001925916,0.00020809112,0.00033392126,0.0010534454,0.00041289374],"domain_scores_gemma":[0.9991094,0.00017387352,0.00007087453,0.00026359176,0.00021846904,0.00016377447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020375485,0.00008790243,0.00014201732,0.00037346967,0.0005923537,0.000057145557,0.00016375295,0.00002453264,0.001590453],"category_scores_gemma":[0.00035267603,0.00008762113,0.000053703512,0.0006836513,0.00015688194,0.00005946109,0.00007865782,0.0011228442,0.000019561929],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057327887,0.0004126662,0.06460076,0.00036299828,0.000052207455,0.0004395835,0.00081384054,0.06011777,0.7372416,0.0005277195,0.011687006,0.12317056],"study_design_scores_gemma":[0.0016585452,0.000090263675,0.07950262,0.00012163641,0.000031607437,0.00006112651,0.0008740419,0.885529,0.0028553964,0.000097215314,0.029016156,0.00016243638],"about_ca_topic_score_codex":0.0008011324,"about_ca_topic_score_gemma":0.0000033651709,"teacher_disagreement_score":0.8254112,"about_ca_system_score_codex":0.00090933364,"about_ca_system_score_gemma":0.00075187243,"threshold_uncertainty_score":0.99932224},"labels":[],"label_agreement":null},{"id":"W4282967222","doi":"10.1158/1538-7445.am2022-ct007","title":"Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Prostate cancer; Olaparib; Oncology; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Progressive disease; PARP inhibitor; Cancer; Gastroenterology; Clinical trial; Phases of clinical research; Adverse effect; Chemotherapy","score_opus":0.15561641512835195,"score_gpt":0.4129968895698667,"score_spread":0.25738047444151474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932565,0.0001723483,0.000001501451,0.0023703123,0.00031006656,0.0031278853,0.000085476684,0.000013667998,0.00066221],"genre_scores_gemma":[0.99549735,0.00012915391,0.000015841473,0.00012198803,0.00039041537,0.0034810207,0.00008987403,0.000045044926,0.00022929275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964259,0.00045449368,0.0006848318,0.00050786376,0.0013980283,0.00052885065],"domain_scores_gemma":[0.99863863,0.00034858013,0.00019008527,0.000426861,0.00030313423,0.00009271939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012615076,0.00018542662,0.0003886809,0.0007041548,0.00041605573,0.00003586892,0.00027053984,0.00010174516,0.0012374831],"category_scores_gemma":[0.0002495833,0.00014290214,0.00006996873,0.0025103467,0.00029409313,0.00019194074,0.00010365733,0.0013806932,0.0000039949464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14650981,0.008621599,0.7289718,0.00072335446,0.00022387416,0.00019075365,0.023664871,0.01995455,0.03306123,0.00040532884,0.033068527,0.004604315],"study_design_scores_gemma":[0.22206445,0.006428138,0.7300905,0.0012979397,0.00003024117,0.000008303758,0.003386629,0.0006783798,0.025817335,0.0002780424,0.009379674,0.00054036896],"about_ca_topic_score_codex":0.0046212003,"about_ca_topic_score_gemma":0.054352637,"teacher_disagreement_score":0.07555464,"about_ca_system_score_codex":0.003576321,"about_ca_system_score_gemma":0.0014452798,"threshold_uncertainty_score":0.9996755},"labels":[],"label_agreement":null},{"id":"W4282967516","doi":"10.1158/1538-7445.am2022-1580","title":"Abstract 1580: Cancer cells promote phenotypic alterations in adjacent hepatocytes to facilitate vessel co-option in colorectal cancer liver metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer cell; Metastasis; Downregulation and upregulation; Cancer research; Cancer; Colorectal cancer; Epithelial–mesenchymal transition; Liver cancer; Motility; Gene knockdown; Biology; Apoptosis; Cell biology; Chemistry; Medicine; Internal medicine; Hepatocellular carcinoma; Biochemistry","score_opus":0.07549367872509552,"score_gpt":0.37314912790691257,"score_spread":0.2976554491818171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98769486,0.0072443746,0.00029346897,0.0009558717,0.0002741695,0.0021519114,0.0011656014,0.000016423977,0.00020329429],"genre_scores_gemma":[0.98499036,0.004883932,0.00011005553,0.00016687097,0.00016135031,0.008600879,0.00017694551,0.000068535686,0.00084108853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99585366,0.00058524014,0.0004219437,0.0009929719,0.0010565921,0.001089618],"domain_scores_gemma":[0.9988677,0.000047665868,0.00006893328,0.0004170958,0.00032414624,0.00027448463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013641398,0.0002679803,0.00030066425,0.00059200684,0.00033921443,0.00008487997,0.00057177304,0.00014960146,0.0021542888],"category_scores_gemma":[0.000086481785,0.00030227337,0.00010529109,0.0011273925,0.00012623462,0.000020767367,0.00054598623,0.0010566631,0.000048494276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010504663,0.00021243641,0.00020794691,0.00008886221,0.00007820032,0.00005248208,0.0009826544,0.04298235,0.93685853,0.000028740924,0.0037053903,0.013751905],"study_design_scores_gemma":[0.0011894632,0.0004706052,0.0020345969,0.00008406382,0.000010306396,0.0000028864074,0.0003767891,0.0012276415,0.9566905,0.00004314901,0.037514716,0.00035527267],"about_ca_topic_score_codex":0.022119107,"about_ca_topic_score_gemma":0.021053953,"teacher_disagreement_score":0.04175471,"about_ca_system_score_codex":0.0018896214,"about_ca_system_score_gemma":0.0016009747,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W4282967609","doi":"10.1158/1538-7445.am2022-lb503","title":"Abstract LB503: Using JBrowse 2 plugins to visualize cancer genomic data","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Phylogenetic Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Plug-in; World Wide Web; Computer science; JavaScript; Genomics; Genome; Computational biology; Biology; Programming language; Genetics; Gene","score_opus":0.22210978382627752,"score_gpt":0.4775546873444002,"score_spread":0.25544490351812266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98765045,0.008910907,0.000021134896,0.00059760595,0.00037177512,0.00037351032,0.0017034427,0.0000029319235,0.0003682626],"genre_scores_gemma":[0.99588686,0.0016855714,0.00018523641,0.00040113472,0.00067161466,0.00030865107,0.000101596794,0.000046964415,0.000712389],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980826,0.00010881821,0.00018387623,0.0006819369,0.00037652956,0.00056625117],"domain_scores_gemma":[0.9987506,0.000021693113,0.000041862946,0.00089361717,0.00013655535,0.00015564954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072346587,0.00013986327,0.0001535719,0.000101431244,0.0005794527,0.000044888147,0.0010173671,0.000047920454,0.0007060815],"category_scores_gemma":[0.000046239777,0.00014933385,0.00004391942,0.00025917834,0.00009381857,0.0000010625633,0.0031654267,0.00025266033,0.000010672613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113261034,0.0000386883,0.0023774216,0.000019407758,0.00009592558,0.000006917926,0.0001639097,0.004059071,0.97644186,0.000023224946,0.013867645,0.0027926876],"study_design_scores_gemma":[0.00048769498,0.00019418764,0.010753604,0.000013123461,0.000018535029,0.0000073687634,0.0005145619,0.00016984166,0.07336557,0.000066314,0.9140703,0.00033888067],"about_ca_topic_score_codex":0.0039747367,"about_ca_topic_score_gemma":0.0008799952,"teacher_disagreement_score":0.9030763,"about_ca_system_score_codex":0.00021397516,"about_ca_system_score_gemma":0.0006543646,"threshold_uncertainty_score":0.77310973},"labels":[],"label_agreement":null},{"id":"W4282967960","doi":"10.1158/1538-7445.am2022-ct168","title":"Abstract CT168: Randomized phase 2 trial of sunitinib or cediranib in alveolar soft part sarcoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Sunitinib; Clinical endpoint; Randomized controlled trial; Alveolar soft part sarcoma; Surgery; Tolerability; Phases of clinical research; Oncology; Gastroenterology; Clinical trial; Cancer; Soft tissue; Adverse effect","score_opus":0.18074717726907147,"score_gpt":0.4749018091824065,"score_spread":0.294154631913335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886363,0.0038028604,9.558755e-7,0.0021563682,0.00027199133,0.003119914,0.00013898581,0.000021287506,0.0018513462],"genre_scores_gemma":[0.9933123,0.0012427446,0.000027065555,0.00014215308,0.00030173123,0.004207446,0.000074235075,0.000033131768,0.00065921695],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966496,0.00068270834,0.0005898789,0.00034770984,0.0012113263,0.0005187787],"domain_scores_gemma":[0.9971474,0.0019719063,0.000103889695,0.00041376892,0.00018362062,0.00017945688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035804957,0.00014811491,0.0008346405,0.00042830393,0.00016319324,0.000017221862,0.00020230254,0.000055981796,0.011602316],"category_scores_gemma":[0.00086226495,0.0001091947,0.0002407742,0.000706381,0.00024449214,0.000050616753,0.00014119959,0.00066977675,0.000019514975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95360506,0.0056493683,0.0016234271,0.00012713936,0.00025411736,0.0010527143,0.0005605591,0.000012143218,0.0019781466,0.00017231323,0.006983617,0.027981414],"study_design_scores_gemma":[0.9568559,0.0016115193,0.00094732863,0.00015432514,0.00008264386,0.000016550333,0.0006313001,0.00003670639,0.006504829,0.00015547348,0.032888267,0.00011517108],"about_ca_topic_score_codex":0.0019199091,"about_ca_topic_score_gemma":0.0001868373,"teacher_disagreement_score":0.027866242,"about_ca_system_score_codex":0.00040052496,"about_ca_system_score_gemma":0.00092456763,"threshold_uncertainty_score":0.9893012},"labels":[],"label_agreement":null},{"id":"W4282968255","doi":"10.1158/1538-7445.am2022-ct234","title":"Abstract CT234: PANOVA-3: A phase 3 study of tumor treating fields with gemcitabine and nab-paclitaxel for front-line treatment of locally advanced pancreatic adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Oncology; Pancreatic cancer; Internal medicine; Paclitaxel; Cancer; Concomitant; Mesothelioma; Chemotherapy; Pathology","score_opus":0.08068710920922723,"score_gpt":0.41535785241226264,"score_spread":0.3346707432030354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282968255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884048,0.0070648855,0.00001477472,0.00040592,0.000027841588,0.0037544435,0.00023172334,0.000014724916,0.000080870464],"genre_scores_gemma":[0.9940182,0.00022464429,0.00038998114,0.000018477365,0.00005738184,0.0049849073,0.000042602947,0.00003891154,0.00022489426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796784,0.00008798152,0.00042911456,0.00045305328,0.0006467891,0.00041522065],"domain_scores_gemma":[0.9984337,0.0004604758,0.00016080303,0.00042390788,0.00035541583,0.00016566984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031738164,0.00020839393,0.0006945018,0.0002675746,0.00021306929,0.000011324785,0.000096102114,0.000029552992,0.00028519187],"category_scores_gemma":[0.00007686449,0.00014820116,0.00008400407,0.00033545584,0.00011788964,0.00004798253,0.00006469919,0.00015673274,6.022778e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045522608,0.05375081,0.6349923,0.0021969986,0.0034710176,0.0016775772,0.016952572,0.0013273021,0.07109818,0.000088128,0.0005347174,0.16838777],"study_design_scores_gemma":[0.19252202,0.29155874,0.3566924,0.0010112928,0.0016975746,0.00014668766,0.04492393,0.0012892396,0.10863308,0.00012515378,0.00081057264,0.00058932503],"about_ca_topic_score_codex":0.0032658782,"about_ca_topic_score_gemma":0.00066173746,"teacher_disagreement_score":0.27829993,"about_ca_system_score_codex":0.000413611,"about_ca_system_score_gemma":0.00034981195,"threshold_uncertainty_score":0.6043468},"labels":[],"label_agreement":null},{"id":"W4282968611","doi":"10.1158/1538-7445.am2022-5905","title":"Abstract 5905: User characteristics of “Cook For Your Life” - a website designed to support cancer patients and survivors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Demographics; Family medicine; Breast cancer; Gerontology; Demography; Internal medicine","score_opus":0.09014835941150455,"score_gpt":0.41809990418360543,"score_spread":0.32795154477210087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282968611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951295,0.0008064135,0.000027200107,0.0007026756,0.00037411993,0.0018188007,0.0010460109,0.000015124634,0.00008011538],"genre_scores_gemma":[0.9958649,0.0009474278,0.000047629143,0.00045088862,0.00024048035,0.0011137064,0.00010305963,0.00004503,0.0011868261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977136,0.00010894829,0.00033520075,0.00034462052,0.00092723564,0.000570367],"domain_scores_gemma":[0.99837965,0.00014228678,0.000073173695,0.0002769419,0.0005572272,0.00057071325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012553775,0.00012505657,0.00043448881,0.00028017446,0.0002686472,0.000015580541,0.00012815249,0.000061988445,0.00090663217],"category_scores_gemma":[0.00029332167,0.000112079295,0.00013343796,0.00038530698,0.00007679446,0.000043911434,0.0001448709,0.0003725224,0.0000068375325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057300576,0.00042142827,0.8902204,0.0021404102,0.00044428525,0.000035430123,0.002461326,0.000052046922,0.009501418,0.000019920702,0.035487756,0.053485516],"study_design_scores_gemma":[0.002358382,0.0011046054,0.83968943,0.000074602074,0.000069954614,0.0000025655975,0.0002812353,0.0000116061,0.0017517081,0.0000047619073,0.15449765,0.0001534851],"about_ca_topic_score_codex":0.005399977,"about_ca_topic_score_gemma":0.00033180753,"teacher_disagreement_score":0.1190099,"about_ca_system_score_codex":0.0003705223,"about_ca_system_score_gemma":0.0013991336,"threshold_uncertainty_score":0.9926986},"labels":[],"label_agreement":null},{"id":"W4282968918","doi":"10.1158/1538-7445.am2022-5221","title":"Abstract 5221: The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"In vivo; MAPK/ERK pathway; Cancer research; MEK inhibitor; Glioma; Medicine; Pharmacology; Biology; Kinase; Cell biology","score_opus":0.07356030715229593,"score_gpt":0.3468177770872878,"score_spread":0.27325746993499184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282968918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062204,0.0008147919,7.844152e-7,0.0064104036,0.00011081018,0.0017823735,0.00003952802,0.000019008365,0.00020022855],"genre_scores_gemma":[0.9979793,0.00037944654,0.000015943659,0.000085781416,0.00011897643,0.001284869,0.000013395418,0.00004334357,0.00007897305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971479,0.00021396915,0.00034108057,0.0005274003,0.0011457294,0.0006239005],"domain_scores_gemma":[0.99882084,0.0004863772,0.00009599322,0.0003323263,0.00010350986,0.00016092986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079727656,0.00021530574,0.00035111187,0.0008085615,0.00023807703,0.00007102587,0.00016653234,0.000089993795,0.00013997506],"category_scores_gemma":[0.0000933191,0.00014942832,0.000047135436,0.0017868225,0.00013128539,0.00017377554,0.00024080019,0.00089774176,0.0000063321204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014655131,0.02206505,0.81973076,0.0015828991,0.00023555724,0.013507153,0.013187982,0.033226807,0.061948992,0.00024765165,0.0066171517,0.012994877],"study_design_scores_gemma":[0.039598465,0.0069707963,0.7721904,0.001260396,0.00017032013,0.00021635673,0.006799374,0.026299194,0.14173628,0.0008710261,0.0028184042,0.0010689656],"about_ca_topic_score_codex":0.0028331904,"about_ca_topic_score_gemma":0.008827519,"teacher_disagreement_score":0.0797873,"about_ca_system_score_codex":0.0018001549,"about_ca_system_score_gemma":0.0005365974,"threshold_uncertainty_score":0.609351},"labels":[],"label_agreement":null},{"id":"W4282969229","doi":"10.1158/1538-7445.am2022-3405","title":"Abstract 3405: Characterizing treatment response in head and neck cancer through viral ctDNA quantification and fragment length","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Liquid biopsy; Head and neck cancer; Medicine; Digital polymerase chain reaction; Biopsy; Cancer; Internal medicine; Biomarker; Saliva; Oncology; Pathology; Gastroenterology; Polymerase chain reaction; Biology; Gene","score_opus":0.07442716296407098,"score_gpt":0.3953690069990607,"score_spread":0.3209418440349897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559916,0.011425049,0.0000045806405,0.0021364368,0.00013068313,0.0003830993,0.00023925306,0.000004148262,0.000077586374],"genre_scores_gemma":[0.97793865,0.020513982,0.000039115203,0.0001980227,0.00015103898,0.00081242505,0.00006605484,0.000021611944,0.00025911626],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873894,0.00013733054,0.00016950117,0.0004399813,0.00019221866,0.00032203],"domain_scores_gemma":[0.99952406,0.00006675983,0.00004479599,0.00024187104,0.000049146012,0.00007337551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049102836,0.00011605413,0.00013053375,0.00007515498,0.00025244238,0.000054271135,0.00010402865,0.000054224485,0.00007915885],"category_scores_gemma":[0.000045472516,0.000119029224,0.000025222165,0.00011334227,0.00009744635,0.0000073468045,0.00020674644,0.0001817089,0.0000012927406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026326869,0.0001337776,0.012281602,0.00003218407,0.000035404006,0.000014717755,0.00083899236,0.00023554011,0.96666646,0.00009852067,0.00060962245,0.016420484],"study_design_scores_gemma":[0.002930494,0.0018808628,0.38853884,0.00007073297,0.000014250915,0.00000979924,0.0008868087,0.00013755103,0.22773802,0.00016126505,0.3772423,0.0003890795],"about_ca_topic_score_codex":0.0038851774,"about_ca_topic_score_gemma":0.0010781648,"teacher_disagreement_score":0.73892844,"about_ca_system_score_codex":0.00036927947,"about_ca_system_score_gemma":0.00036196428,"threshold_uncertainty_score":0.5873252},"labels":[],"label_agreement":null},{"id":"W4282969256","doi":"10.1158/1538-7445.am2022-2003","title":"Abstract 2003: Poor diet quality is associated with immune aging in survivors of pediatric acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Inflammation; Biomarker; Immune system; Cancer; Immunosenescence; Oxidative stress; Cohort; Internal medicine; Quality of life (healthcare); Oncology; Immunology; Physiology; Biology","score_opus":0.11170386463916812,"score_gpt":0.4484017433834557,"score_spread":0.3366978787442876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943461,0.0017207171,0.0000032868882,0.0021393443,0.00013888936,0.00050561846,0.000151937,0.00002850401,0.0009656215],"genre_scores_gemma":[0.9968559,0.0010284159,0.000032949247,0.00035716317,0.00012003523,0.00022722456,0.000047944774,0.000029112745,0.0013012561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711305,0.00033600806,0.00048283816,0.00029971125,0.0011691767,0.00059919927],"domain_scores_gemma":[0.9986102,0.00033063462,0.00014654774,0.00024974518,0.0005015632,0.00016131868],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030709454,0.0001083475,0.00039430123,0.00052565825,0.00024375331,0.0000124863445,0.0001743917,0.000054212087,0.0018810302],"category_scores_gemma":[0.00028876372,0.000101989404,0.000043047625,0.0025125465,0.00010071488,0.000056023226,0.00012545864,0.00095216505,0.000008609769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007961553,0.0012204961,0.9324341,0.0032272618,0.0003758669,0.0006780766,0.005181055,0.00027342394,0.02433193,0.00022964888,0.021309284,0.0027773094],"study_design_scores_gemma":[0.0068655843,0.00071868644,0.9851326,0.00041828977,0.00005363816,0.000008559628,0.0016686115,0.00028651409,0.00255071,0.00008822955,0.0019928005,0.00021582884],"about_ca_topic_score_codex":0.012632969,"about_ca_topic_score_gemma":0.0007959213,"teacher_disagreement_score":0.052698452,"about_ca_system_score_codex":0.0026052105,"about_ca_system_score_gemma":0.0023496312,"threshold_uncertainty_score":0.99903136},"labels":[],"label_agreement":null},{"id":"W4282969281","doi":"10.1158/1538-7445.am2022-3385","title":"Abstract 3385: Pre-diagnosis plasma cell-free DNA methylation profiling reveals signatures of cancers up to7 years prior to clinical detection","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Wilfrid Laurier University; Ontario Institute for Cancer Research","funders":"","keywords":"Cell-free fetal DNA; DNA methylation; Biomarker; Oncology; Medicine; Cancer; Liquid biopsy; Breast cancer; Pancreatic cancer; Subtyping; Internal medicine; Cancer research; Biology; Gene; Gene expression; Genetics","score_opus":0.05289370759823727,"score_gpt":0.3988532342084961,"score_spread":0.34595952661025886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954838,0.002032593,0.000045950328,0.00024214537,0.000822921,0.00083090045,0.00034431578,0.000009584221,0.00018774606],"genre_scores_gemma":[0.9960163,0.0015588552,0.0002576754,0.00013232097,0.00056085596,0.0010194881,0.000050747523,0.000040562558,0.00036318766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979183,0.00019265137,0.0004210744,0.0005385184,0.000533278,0.00039617662],"domain_scores_gemma":[0.99861646,0.00023782074,0.00014719013,0.0005515455,0.00027882558,0.00016818203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015390271,0.00012845555,0.00021178128,0.00016054042,0.00021631326,0.000032040134,0.0005020507,0.0001499853,0.00014090381],"category_scores_gemma":[0.00070722564,0.00014826059,0.00012539454,0.0003684385,0.00008053595,0.000005764081,0.00057258416,0.0004969081,0.000003892215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008917987,0.00009839196,0.0035281621,0.00007818222,0.00005907581,0.000004199257,0.00019202784,0.0109500475,0.9443131,0.000018268567,0.013617162,0.026249567],"study_design_scores_gemma":[0.00078126905,0.0008001456,0.016467737,0.000023046638,0.000017708711,7.15924e-7,0.0002316435,0.000067130415,0.9369434,0.00010039166,0.044379186,0.00018760223],"about_ca_topic_score_codex":0.0010729746,"about_ca_topic_score_gemma":0.00084294257,"teacher_disagreement_score":0.030762024,"about_ca_system_score_codex":0.0004113126,"about_ca_system_score_gemma":0.0008443866,"threshold_uncertainty_score":0.60458916},"labels":[],"label_agreement":null},{"id":"W4282969370","doi":"10.1158/1538-7445.am2022-ct247","title":"Abstract CT247: A phase I/II trial investigating safety and efficacy of autologous TAC T cells targeting HER2 in relapsed or refractory solid tumors (TACTIC-2)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chimeric antigen receptor; Leukapheresis; Cancer research; T cell; Immunohistochemistry; Breast cancer; Antigen; Cancer; T-cell receptor; Immunotherapy; Oncology; Immunology; Internal medicine; Immune system; Biology; CD34; Stem cell","score_opus":0.10108806075607954,"score_gpt":0.4461038510280492,"score_spread":0.3450157902719697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938425,0.0010199918,0.0000011811726,0.0010411355,0.00022704352,0.002340733,0.000059995913,0.00004871044,0.0014187393],"genre_scores_gemma":[0.99485666,0.00045825428,0.00014868852,0.00009493762,0.00036710428,0.00037561014,0.000031215754,0.00008595102,0.003581601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944492,0.0009790937,0.000975189,0.0007210833,0.0018150391,0.0010603861],"domain_scores_gemma":[0.9963514,0.0021111919,0.00025312477,0.00056367816,0.00028293036,0.00043767435],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060776626,0.00023964727,0.00079490885,0.0007448364,0.00062043226,0.000036703295,0.0003759687,0.00013919528,0.008696942],"category_scores_gemma":[0.0029093062,0.00021674881,0.000116623574,0.0014953691,0.0006109251,0.00010259809,0.00061993743,0.0031034201,0.000007117029],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12385982,0.0015007657,0.0003087926,0.00037674035,0.00008945332,0.0005687408,0.0036020314,0.00023029394,0.8367922,0.000009704629,0.0014448967,0.031216592],"study_design_scores_gemma":[0.41210482,0.038028777,0.0050501735,0.0014132877,0.000094276504,0.0001478947,0.012112251,0.0031860431,0.4598448,0.00015483661,0.06679158,0.0010712649],"about_ca_topic_score_codex":0.0023641747,"about_ca_topic_score_gemma":0.00012620317,"teacher_disagreement_score":0.37694737,"about_ca_system_score_codex":0.0012144825,"about_ca_system_score_gemma":0.0028372922,"threshold_uncertainty_score":0.99919647},"labels":[],"label_agreement":null},{"id":"W4282969533","doi":"10.1158/1538-7445.am2022-1042","title":"Abstract 1042: Fc3TSR improves intratumoral treatment delivery by normalizing tumor vasculature and reducing interstitial fluid pressure in an orthotopic, syngeneic mouse model of epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; In vivo; Paclitaxel; Ovarian cancer; Lymphatic system; Cancer; Tumor microenvironment; Cancer research; Angiogenesis; Perfusion; Pathology; Lymphangiogenesis; Tumor hypoxia; Internal medicine; Biology; Radiation therapy","score_opus":0.03142775787270159,"score_gpt":0.33905126463168905,"score_spread":0.3076235067589875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853494,0.012176798,0.0000069604084,0.00008744744,0.000081153215,0.0006551428,0.0015790539,0.000008307711,0.00005569334],"genre_scores_gemma":[0.99509674,0.0029350393,0.000051912368,0.000033886743,0.00018446519,0.0009955148,0.00020691863,0.00004036494,0.0004551349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978243,0.00019437807,0.00025976484,0.0006437645,0.0004619027,0.00061588484],"domain_scores_gemma":[0.99918103,0.000015393693,0.000066663844,0.00037500926,0.00014994168,0.00021197823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033772574,0.00021274379,0.00026109183,0.00016314934,0.00025184022,0.000062215804,0.00029587423,0.00008504623,0.0001345835],"category_scores_gemma":[0.000020017835,0.0001995996,0.00008378546,0.00017738157,0.00018470405,0.000032247503,0.00033732256,0.00038761922,3.831594e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015746892,0.0002718883,0.002208857,0.00009060094,0.00023679176,0.000026491394,0.0003997291,0.0052739484,0.9816561,0.000012661803,0.00048542005,0.0077628405],"study_design_scores_gemma":[0.002860464,0.0014622908,0.0012113835,0.000054379354,0.00004638237,0.000008004769,0.00031364503,0.0032635015,0.9886446,0.000031847652,0.0018221578,0.00028134428],"about_ca_topic_score_codex":0.022533888,"about_ca_topic_score_gemma":0.0073916083,"teacher_disagreement_score":0.01514228,"about_ca_system_score_codex":0.00033748784,"about_ca_system_score_gemma":0.00086661574,"threshold_uncertainty_score":0.9839752},"labels":[],"label_agreement":null},{"id":"W4282969792","doi":"10.1158/1538-7445.am2022-1685","title":"Abstract 1685: Deep learning approaches to deciphering intra-tumoural heterogeneity in glioblastoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Workflow; Precision medicine; Tumor heterogeneity; Computational biology; Cluster analysis; Glioblastoma; Pharmacogenomics; Tumour heterogeneity; Computer science; Laser capture microdissection; Artificial intelligence; Bioinformatics; Biology; Machine learning; Cancer; Cancer research; Database","score_opus":0.12395924035455103,"score_gpt":0.39536261296594233,"score_spread":0.2714033726113913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919351,0.00089739804,0.00022337501,0.0050808997,0.00016255822,0.0004221465,0.000001929433,0.00005654122,0.0012200939],"genre_scores_gemma":[0.9981366,0.00005893151,0.00040725485,0.00032185935,0.0002811757,0.00041496658,0.0000053917975,0.000049997758,0.00032382846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972466,0.00027729265,0.00027440433,0.00046723438,0.0009694859,0.0007649556],"domain_scores_gemma":[0.99911106,0.00017929214,0.00003868644,0.00024554427,0.000052663036,0.0003727649],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024300867,0.00013632668,0.0002804107,0.000427194,0.0004047653,0.000058143833,0.00029863746,0.0000436472,0.00084499817],"category_scores_gemma":[0.0005570632,0.00013540863,0.00007089002,0.00091975526,0.00010977582,0.000064608605,0.00043139298,0.0027709168,0.000028865403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018593494,0.000418,0.2354283,0.00040222256,0.00011321491,0.0013123865,0.005561157,0.19204319,0.076908104,0.0002631563,0.0015555427,0.4841354],"study_design_scores_gemma":[0.00857546,0.0033569778,0.59006244,0.0009274888,0.000056308134,0.00064641854,0.011861021,0.198717,0.028718876,0.0004788061,0.1551607,0.0014385328],"about_ca_topic_score_codex":0.00073842093,"about_ca_topic_score_gemma":0.00024037182,"teacher_disagreement_score":0.48269683,"about_ca_system_score_codex":0.00082491245,"about_ca_system_score_gemma":0.00020650862,"threshold_uncertainty_score":0.9995297},"labels":[],"label_agreement":null},{"id":"W4282970097","doi":"10.1158/1538-7445.am2022-2043","title":"Abstract 2043: The role of CCL20 in response to radiation in head and neck squamous cell carcinomas","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Université de Sherbrooke","funders":"","keywords":"CCL20; Immune system; Radioresistance; Medicine; Cancer research; Flow cytometry; Head and neck squamous-cell carcinoma; Immunology; Chemokine; Head and neck cancer; Pathology; Cancer; Radiation therapy; Internal medicine","score_opus":0.04106055679100809,"score_gpt":0.3689616573978996,"score_spread":0.3279011006068915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282970097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136704,0.0051636347,1.8651309e-7,0.0023214219,0.0000266863,0.0004369295,0.000010648917,0.0000032472515,0.00067018607],"genre_scores_gemma":[0.99930835,0.000077256285,0.0000080485115,0.00006116071,0.00005903185,0.00014070071,0.0000034290495,0.000011478877,0.00033054998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988207,0.00019266209,0.00016970039,0.00016896686,0.00041350728,0.00023446874],"domain_scores_gemma":[0.9993691,0.00032619757,0.000022125032,0.00015955014,0.000049876227,0.000073140145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017824435,0.000051384155,0.00013631719,0.00027780564,0.00006791996,0.000008318688,0.00008992797,0.000026195668,0.0003870619],"category_scores_gemma":[0.00015801635,0.000041947333,0.00002075307,0.0005988834,0.000038942842,0.000020966643,0.00010038131,0.00046842845,0.0000022716679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004419834,0.00014611869,0.2579752,0.00008320332,0.000003102319,0.00003413917,0.005838568,0.00079307065,0.7169009,0.000013561891,0.00092720764,0.012865138],"study_design_scores_gemma":[0.0030574403,0.0006017319,0.76994383,0.000072883566,0.000004240109,0.0000059855124,0.004377265,0.00051668833,0.18702325,0.0000974442,0.034204047,0.000095181626],"about_ca_topic_score_codex":0.005710117,"about_ca_topic_score_gemma":0.00046730766,"teacher_disagreement_score":0.5298776,"about_ca_system_score_codex":0.00040244713,"about_ca_system_score_gemma":0.00034113516,"threshold_uncertainty_score":0.8632027},"labels":[],"label_agreement":null},{"id":"W4282970098","doi":"10.1158/1538-7445.am2022-1759","title":"Abstract 1759: PRO1160, a novel CD70-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mouse models of renal cell carcinoma and non-Hodgkin lymphoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Profound Medical (Canada)","funders":"","keywords":"In vivo; Antibody-drug conjugate; Cancer research; Antibody; Lymphoma; Cancer; Monoclonal antibody; Conjugate; Chemistry; Medicine; Biology; Immunology; Internal medicine","score_opus":0.06835948229947149,"score_gpt":0.35660567162505064,"score_spread":0.28824618932557916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282970098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290437,0.0016256795,0.000019097213,0.0008016084,0.00006001464,0.0012900457,0.0005834541,0.000039119946,0.0026766392],"genre_scores_gemma":[0.9961249,0.00055126916,0.00022438467,0.000053308126,0.00010941929,0.00032925175,0.00006330618,0.000060486287,0.0024836273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99578696,0.0002867862,0.0005006842,0.0007724758,0.0015788764,0.0010742255],"domain_scores_gemma":[0.9981382,0.00041989423,0.00013890576,0.0004370154,0.0004672158,0.000398782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016827796,0.00030287536,0.00072793936,0.0007382824,0.0003964485,0.00005343318,0.00039928211,0.000090657566,0.00039669947],"category_scores_gemma":[0.000073452014,0.00027270094,0.0001246393,0.0011644824,0.0006487362,0.00023098357,0.0006102583,0.0010145999,0.0000061427318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003023384,0.0012125291,0.054458715,0.0010336054,0.000060336504,0.00045319225,0.0005307322,0.0015076888,0.9352121,0.00004559016,0.0009714704,0.0014906587],"study_design_scores_gemma":[0.005332535,0.0007214266,0.29101148,0.00025623656,0.000023593737,0.000115488765,0.0006584477,0.034077328,0.6668571,0.000079315054,0.00045578447,0.00041125514],"about_ca_topic_score_codex":0.020534588,"about_ca_topic_score_gemma":0.0005178527,"teacher_disagreement_score":0.26835498,"about_ca_system_score_codex":0.0004014942,"about_ca_system_score_gemma":0.0017959519,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W4282970131","doi":"10.1158/1538-7445.am2022-1853","title":"Abstract 1853: TH1902, a SORT1 docetaxel peptide-drug conjugate, inhibits tumor growth of human cancer stem-like cells (CD133+) from both triple-negative breast cancers and ovarian cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Homeobox protein NANOG; SOX2; Cancer stem cell; Cancer research; CD44; Biology; Triple-negative breast cancer; Population; Stem cell; Cancer; Ovarian cancer; Cancer cell; Breast cancer; Internal medicine; Cell; Medicine; Induced pluripotent stem cell; Cell biology; Embryonic stem cell; Genetics","score_opus":0.03430642932677555,"score_gpt":0.32712895340718007,"score_spread":0.29282252408040454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282970131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831188,0.008812337,0.0000090323665,0.00048330377,0.00042230866,0.00095379975,0.0049231853,0.000020154379,0.0012571084],"genre_scores_gemma":[0.9901308,0.0035562613,0.000039084163,0.00027019737,0.0004134448,0.0018252645,0.00015743771,0.000085598906,0.003521903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963843,0.00032597777,0.00055539265,0.0010859671,0.00085432985,0.0007939865],"domain_scores_gemma":[0.99807173,0.00006414688,0.0003392323,0.0006685707,0.0005456138,0.00031070085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007404055,0.00035251,0.00046753653,0.00021683551,0.0008263111,0.000092176175,0.0006591152,0.00010831889,0.001076572],"category_scores_gemma":[0.00001905476,0.00036106643,0.00014494408,0.0005897892,0.00080127,0.00003209945,0.0004657972,0.0007226503,0.0000039886095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007492411,0.00009947919,0.0035926136,0.0001498471,0.00034945027,0.000014976714,0.0010033515,0.00086426956,0.9628317,0.00015674591,0.028365707,0.0018226455],"study_design_scores_gemma":[0.005419086,0.0005599972,0.02488632,0.00028168,0.00011360952,0.000018196357,0.0053347913,0.00010299829,0.93625855,0.00052734197,0.025391048,0.0011063576],"about_ca_topic_score_codex":0.12030512,"about_ca_topic_score_gemma":0.020063987,"teacher_disagreement_score":0.10024113,"about_ca_system_score_codex":0.001029566,"about_ca_system_score_gemma":0.0029742054,"threshold_uncertainty_score":0.9998841},"labels":[],"label_agreement":null},{"id":"W4282970563","doi":"10.1158/1538-7445.am2022-5650","title":"Abstract 5650: RP-6306, a novel PKMYT1 inhibitor, demonstrates synthetic lethality as monotherapy and in combination with gemcitabine in <i>CCNE1</i> amplified cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Cyclin-dependent kinase 1; Cyclin E1; Wee1; Cancer research; Genome instability; Cell cycle; Biology; Molecular biology; Mitosis; Phosphorylation; Cyclin-dependent kinase 2; Cell biology; Chemistry; Cancer; Protein kinase A; DNA damage; Biochemistry; Genetics; DNA","score_opus":0.04949660986831002,"score_gpt":0.35829293988424993,"score_spread":0.3087963300159399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282970563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896071,0.0040307282,0.000038410446,0.0034079256,0.00013863717,0.0016600593,0.000096381445,0.000040223516,0.0009805337],"genre_scores_gemma":[0.99631804,0.001218257,0.00008316132,0.00032845594,0.000067790475,0.0016497148,0.000025450961,0.000074737596,0.00023436526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681026,0.00022089829,0.0004200088,0.00073379965,0.0011014283,0.0007135971],"domain_scores_gemma":[0.9988326,0.00021489606,0.00010309692,0.00042456636,0.00021662789,0.00020823626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014128605,0.00024710363,0.00043391142,0.0006093808,0.00019095308,0.000055322318,0.00019899938,0.00013498317,0.00056176557],"category_scores_gemma":[0.00006646335,0.0002403103,0.00005029901,0.0013752145,0.00033623594,0.00011467133,0.00013096159,0.0016547849,0.000007057521],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003702041,0.0008954828,0.016268253,0.00028237153,0.00007530018,0.00027012624,0.0013146383,0.0022168858,0.967326,0.0002124861,0.00041087647,0.0070255324],"study_design_scores_gemma":[0.039367605,0.0027237972,0.1487153,0.0028997436,0.00008237546,0.00020751457,0.0032932,0.0022778122,0.78422964,0.0010202492,0.013887714,0.0012950486],"about_ca_topic_score_codex":0.019795353,"about_ca_topic_score_gemma":0.0055182194,"teacher_disagreement_score":0.18309636,"about_ca_system_score_codex":0.0017406764,"about_ca_system_score_gemma":0.0015442288,"threshold_uncertainty_score":0.9867319},"labels":[],"label_agreement":null},{"id":"W4282971186","doi":"10.1158/1538-7445.am2022-976","title":"Abstract 976: Interrogating the pre-metastastic gene signature to block brain metastases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Transcriptome; Brain metastasis; Gene signature; Medicine; Population; Cancer; In vitro; Pathology; Cell culture; Melanoma; Primary tumor; Metastasis; Gene; Biology; Internal medicine; Gene expression; Genetics","score_opus":0.07547144535684232,"score_gpt":0.4173471751189755,"score_spread":0.3418757297621332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458153,0.0009320712,0.000016909331,0.009010806,0.00004409579,0.00025533175,0.0009086528,0.00005513548,0.0041954396],"genre_scores_gemma":[0.98994493,0.000013873638,0.00006358711,0.00036768746,0.00036617726,0.0020696458,0.00008879484,0.000029961928,0.0070553524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979502,0.00008335306,0.0002365852,0.00045248595,0.0007592398,0.0005181412],"domain_scores_gemma":[0.9980287,0.00092992134,0.0000624958,0.0006750738,0.00013281177,0.00017102418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00097148295,0.0001445767,0.00014559994,0.000053447926,0.0010421226,0.000095848576,0.00096366863,0.000043947457,0.01226558],"category_scores_gemma":[0.00046728755,0.00012049899,0.00008885484,0.0006618067,0.00012024862,0.0000488293,0.0007674404,0.0014239912,0.0000476769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056787423,0.00008418694,0.000025180754,0.00007691678,0.00005789418,0.000012210951,0.00082231074,0.0033115323,0.95646054,0.00009710717,0.03582566,0.0031696684],"study_design_scores_gemma":[0.0002148039,0.000019630832,0.000058349517,0.00003569837,0.000015959864,0.000016142718,0.0029314505,0.00009033055,0.7983906,0.00022712443,0.19784501,0.00015489128],"about_ca_topic_score_codex":0.00024797616,"about_ca_topic_score_gemma":0.00009640673,"teacher_disagreement_score":0.16201934,"about_ca_system_score_codex":0.00029921625,"about_ca_system_score_gemma":0.00022408273,"threshold_uncertainty_score":0.9886373},"labels":[],"label_agreement":null},{"id":"W4282971198","doi":"10.1158/1538-7445.am2022-4066","title":"Abstract 4066: Anticancer effects of the gold complex auranofin on high-grade serous ovarian cancer cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Ovarian cancer; Cancer research; Thioredoxin reductase; Cancer cell; Medicine; Cancer; Cell growth; Viability assay; Apoptosis; Chemotherapy; Cell cycle; Internal medicine; Chemistry; Thioredoxin; Biochemistry; Oxidative stress","score_opus":0.043050253506074346,"score_gpt":0.3675606722056359,"score_spread":0.32451041869956154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942775,0.0015704469,0.0000051280476,0.0014027262,0.00056683493,0.00054653065,0.00027552916,0.000006982657,0.0013483522],"genre_scores_gemma":[0.9963496,0.00054160424,0.0000105716845,0.0003724961,0.00029079805,0.0004559664,0.00004036303,0.00002610469,0.001912546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798894,0.0004976073,0.00018422355,0.0004580187,0.00039852088,0.00047266865],"domain_scores_gemma":[0.99901295,0.00011833268,0.00009470666,0.00055573654,0.00014308702,0.00007518725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038925718,0.00015770509,0.00019986177,0.00006458262,0.0003489489,0.000014578629,0.0007134171,0.00011199817,0.0004433517],"category_scores_gemma":[0.00004737089,0.00011710641,0.00010539597,0.00032696093,0.00046276973,0.0000031907784,0.00044287796,0.00054184254,0.000005807091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032927401,0.000113639326,0.0018716577,0.00010298605,0.00010725097,0.000009292395,0.000067088244,0.00061904936,0.97596633,0.0003587048,0.019031622,0.0014230941],"study_design_scores_gemma":[0.00074544613,0.000295966,0.06027404,0.000040819326,0.000010661436,0.0000013548763,0.00005513864,0.0000068883696,0.9084765,0.00017252441,0.029786283,0.00013438928],"about_ca_topic_score_codex":0.0016378956,"about_ca_topic_score_gemma":0.00024170434,"teacher_disagreement_score":0.067489855,"about_ca_system_score_codex":0.00011431582,"about_ca_system_score_gemma":0.00031347063,"threshold_uncertainty_score":0.485439},"labels":[],"label_agreement":null},{"id":"W4282971285","doi":"10.1158/1538-7445.am2022-1229","title":"Abstract 1229: miRNA and response to trastuzumab","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"","keywords":"Trastuzumab; Lapatinib; Medicine; Pertuzumab; Oncology; Internal medicine; Clinical endpoint; Breast cancer; Cancer; Clinical trial","score_opus":0.06302451686101232,"score_gpt":0.4115005039291933,"score_spread":0.34847598706818095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937006,0.0022761899,0.000027469894,0.002464953,0.000072270595,0.00021630712,0.00007533386,0.0000052905953,0.0011615419],"genre_scores_gemma":[0.9932141,0.00030571045,0.000043379943,0.00023516442,0.00011812027,0.0006806812,0.000013499902,0.000016397697,0.005372982],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891883,0.00014797437,0.00008929813,0.00030866725,0.00027566878,0.00025955503],"domain_scores_gemma":[0.99945474,0.000023491311,0.000014617235,0.00029640467,0.00009051982,0.000120256846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088002154,0.000060708022,0.000059675473,0.000087583045,0.00035559048,0.00003152856,0.00021195429,0.000030102632,0.0005456432],"category_scores_gemma":[0.000063512205,0.00006253036,0.000024080702,0.00020711865,0.00006852062,0.0000019817744,0.00023623597,0.00018771434,0.0000146275],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095120084,0.000030290574,0.00016251499,0.0000058646597,0.000012573465,0.000003596739,0.00016289965,0.0001292885,0.9514707,0.00003806824,0.035180815,0.011852223],"study_design_scores_gemma":[0.00041084044,0.000431467,0.029961282,0.000005598684,0.000002351386,0.0000074120894,0.0006878617,0.0000063662633,0.11693136,0.000052309828,0.85136724,0.0001359118],"about_ca_topic_score_codex":0.00017952254,"about_ca_topic_score_gemma":0.000046832196,"teacher_disagreement_score":0.8345393,"about_ca_system_score_codex":0.00011948215,"about_ca_system_score_gemma":0.0003285729,"threshold_uncertainty_score":0.597441},"labels":[],"label_agreement":null},{"id":"W4282971362","doi":"10.1158/1538-7445.am2022-5731","title":"Abstract 5731: Structure-based development of a novel MYC inhibitor for neuroendocrine prostate cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Cancer research; In silico; Cancer; Drug discovery; Biology; Chemistry; Gene; Computational biology; Bioinformatics; Genetics","score_opus":0.1123499322314152,"score_gpt":0.45688991081849545,"score_spread":0.34453997858708024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853201,0.0032061285,0.00005154054,0.0058524464,0.0003881303,0.0036053162,0.0013435351,0.000051160347,0.00018163437],"genre_scores_gemma":[0.9886357,0.00015155642,0.0013462974,0.00025186816,0.00033238294,0.007467681,0.00007567789,0.00008076816,0.0016580789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956593,0.00007582734,0.00050266576,0.0006095501,0.00210579,0.0010468544],"domain_scores_gemma":[0.9978721,0.00030242436,0.00012512422,0.0004323361,0.0010059703,0.00026203314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079915056,0.00022117149,0.00046633874,0.00049497146,0.00067604164,0.000027750957,0.00035863052,0.000025194202,0.0013756199],"category_scores_gemma":[0.00033589161,0.00019298425,0.00011217349,0.0009289593,0.00031102085,0.000067336354,0.00047441755,0.0009193774,0.0000020133857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008718983,0.0008090928,0.011205882,0.004695917,0.0005239492,0.00009496465,0.0021875743,0.0018917938,0.8832787,0.00009591954,0.041484132,0.04501305],"study_design_scores_gemma":[0.0133961,0.0013090668,0.026306111,0.00053615804,0.000059719663,0.000014292209,0.00095257023,0.00058680907,0.6390399,0.00008106178,0.31730688,0.0004113791],"about_ca_topic_score_codex":0.0007986493,"about_ca_topic_score_gemma":0.00065239304,"teacher_disagreement_score":0.27582273,"about_ca_system_score_codex":0.0019258544,"about_ca_system_score_gemma":0.0058464645,"threshold_uncertainty_score":0.9997895},"labels":[],"label_agreement":null},{"id":"W4282971516","doi":"10.1158/1538-7445.am2022-6397","title":"Abstract 6397: Understanding the glioblastoma microenvironment with spatial resolution in PDX models","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tumor microenvironment; Phenotype; Biology; Transcriptome; Cancer research; Genetic heterogeneity; Glioblastoma; Disease; Tumour heterogeneity; In vivo; Cancer; Pathology; Gene; Medicine; Genetics; Gene expression; Tumor cells","score_opus":0.08017802225159629,"score_gpt":0.3082241421398284,"score_spread":0.22804611988823212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933558,0.0009143175,0.003992693,0.0006854001,0.00007498672,0.00030086748,0.000030983938,0.0000046356236,0.00064029696],"genre_scores_gemma":[0.9990715,0.0002796402,0.00002212831,0.00008533077,0.000114080365,0.00016937591,0.000019109084,0.000021294318,0.0002175561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987153,0.00013879774,0.00011743448,0.00028893186,0.00038994942,0.00034962746],"domain_scores_gemma":[0.99964917,0.00001882556,0.00002591204,0.00024084965,0.000019927333,0.000045304252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054457446,0.00008585541,0.00007306598,0.00006696551,0.0003739394,0.000028435408,0.0002518202,0.000043093507,0.000101388956],"category_scores_gemma":[0.000005745217,0.000067304914,0.00003159191,0.00015874917,0.000171175,0.0000043046075,0.00014388334,0.00038261776,0.0000018183274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016645272,0.000118714874,0.0012846031,0.000020079211,0.000029652165,0.000017302758,0.00046783828,0.07568937,0.918285,0.00020247478,0.0010394967,0.0011809573],"study_design_scores_gemma":[0.010216748,0.0063909483,0.017222676,0.00024215449,0.00004866268,0.0000835993,0.015427058,0.026826099,0.84043103,0.0055585783,0.07594672,0.0016057064],"about_ca_topic_score_codex":0.0012465825,"about_ca_topic_score_gemma":0.0035284641,"teacher_disagreement_score":0.07785393,"about_ca_system_score_codex":0.00042743498,"about_ca_system_score_gemma":0.00015959298,"threshold_uncertainty_score":0.28760773},"labels":[],"label_agreement":null},{"id":"W4282971845","doi":"10.1158/1538-7445.am2022-1062","title":"Abstract 1062: Antiproliferative activity of EC359, an inhibitor of leukemia inhibitory factor receptor (LIF-R), singly and in combination with chemotherapy drugs against pancreatic cancer cell lines","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Docetaxel; Irinotecan; Cancer research; Cancer; Chemotherapy; Medicine; Internal medicine; Cancer cell; Oncology; Chemistry; Colorectal cancer","score_opus":0.04771243732982426,"score_gpt":0.3602519306785044,"score_spread":0.31253949334868014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764174,0.0006287982,0.0000036310876,0.00036346447,0.00011153378,0.0007332339,0.00019769192,0.000016178814,0.0003037227],"genre_scores_gemma":[0.9984611,0.0007693501,0.000054279633,0.000049279843,0.00016850495,0.00025358112,0.000029748366,0.00003815758,0.00017596666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998216,0.00018595209,0.0003099053,0.000342927,0.0006766364,0.000268627],"domain_scores_gemma":[0.9988066,0.0001887237,0.00019160635,0.00022231037,0.00047908974,0.00011166053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048493576,0.00015450946,0.00041426733,0.00029142218,0.00015766114,0.000018100383,0.00009414413,0.00006314584,0.000513983],"category_scores_gemma":[0.00004521355,0.00013371572,0.000047832276,0.00047845603,0.00018557018,0.00024539776,0.000056300763,0.0006560624,5.5574253e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026521485,0.0006530801,0.01533454,0.00036704837,0.000047177356,0.0000043094888,0.004238325,0.00018694514,0.9684483,0.0000062769204,0.00027005945,0.00779178],"study_design_scores_gemma":[0.0030425375,0.0013463495,0.037728656,0.0005072023,0.000013559678,0.000001519204,0.0021272884,0.0005112395,0.954028,0.000006321857,0.0005545882,0.00013273383],"about_ca_topic_score_codex":0.0048281983,"about_ca_topic_score_gemma":0.00057180686,"teacher_disagreement_score":0.022394117,"about_ca_system_score_codex":0.0010769714,"about_ca_system_score_gemma":0.0012644213,"threshold_uncertainty_score":0.7298824},"labels":[],"label_agreement":null},{"id":"W4282971936","doi":"10.1158/1538-7445.am2022-623","title":"Abstract 623: NK cells are involved in promoting anti-tumor responses to DPX-peptide immunotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Immune system; Immunotherapy; Antigen; Cancer research; Survivin; Medicine; Immunology; Ovarian cancer; Cancer immunotherapy; Tumor antigen; Biology; Cancer; Internal medicine","score_opus":0.05835145364397961,"score_gpt":0.36039166035841497,"score_spread":0.3020402067144354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774068,0.018385787,0.0000030190504,0.0017535635,0.00076484,0.0011442067,0.0001408911,0.0000820325,0.00031886506],"genre_scores_gemma":[0.98476976,0.0010353116,0.00002181624,0.0007021017,0.00005184475,0.0012474011,0.000025812222,0.00008179252,0.012064134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99471647,0.0023948916,0.0005937447,0.0007077395,0.00027410887,0.0013130312],"domain_scores_gemma":[0.9978375,0.00096028193,0.00016336839,0.00079414406,0.00019464485,0.00005008676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004272201,0.00029043359,0.0005095095,0.000806832,0.0011430959,0.00007792522,0.0011011001,0.00013660958,0.009155599],"category_scores_gemma":[0.00031976096,0.00029172548,0.00014296504,0.0013020881,0.0003251826,0.00016198949,0.0004866562,0.001909401,0.00079922134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006367662,0.00034228197,0.0052186213,0.0000523579,0.00011985284,0.00010438514,0.0033741537,0.000074445066,0.96997774,0.000028567158,0.009162973,0.0051769856],"study_design_scores_gemma":[0.0021426936,0.00042303055,0.055203512,0.00019454723,0.0000034015698,0.00002370136,0.0040055173,0.000001645508,0.66570085,0.000048123256,0.27190214,0.00035083486],"about_ca_topic_score_codex":0.0022400548,"about_ca_topic_score_gemma":0.00019503012,"teacher_disagreement_score":0.30427685,"about_ca_system_score_codex":0.00070534315,"about_ca_system_score_gemma":0.00078053225,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W4282972075","doi":"10.1158/1538-7445.am2022-3881","title":"Abstract 3881: Immune profiling of advanced prostate cancer harboring homologous recombination deficiency","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Immune system; Cancer; Immune checkpoint; Cancer research; Tumor microenvironment; Prostate; Internal medicine; CD8; Oncology; Stromal cell; Immunotherapy; Immunology","score_opus":0.05647749439758661,"score_gpt":0.3997149279789818,"score_spread":0.3432374335813952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97095615,0.024249448,0.0000029266946,0.0014579833,0.0005346828,0.001151664,0.000072037685,0.000043946788,0.0015311891],"genre_scores_gemma":[0.9920771,0.0043541077,0.00011984114,0.000051315757,0.000066411834,0.001628711,0.000026907079,0.000038042854,0.0016375768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761784,0.00011814241,0.0004209016,0.0003871715,0.00091794686,0.0005380183],"domain_scores_gemma":[0.99890906,0.00009287745,0.00015779611,0.00035532322,0.0004097791,0.00007514538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016003085,0.00012992663,0.00028126934,0.00035461716,0.00041590005,0.000017979335,0.00024787732,0.00004824759,0.0015851895],"category_scores_gemma":[0.00007726329,0.00012428591,0.000107979766,0.0011067506,0.00020228664,0.000113220995,0.00015002044,0.0007223121,0.0000036436395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032971487,0.00023070062,0.005582104,0.0003993231,0.00006546973,0.000027928729,0.0008569728,0.0004019334,0.8645477,0.00008894978,0.00024755963,0.1242542],"study_design_scores_gemma":[0.0058777668,0.0014160948,0.11125088,0.0005250284,0.000039543353,0.000027553482,0.0032666863,0.00011518207,0.86710817,0.00027158097,0.009769274,0.00033223335],"about_ca_topic_score_codex":0.0023669398,"about_ca_topic_score_gemma":0.000043633052,"teacher_disagreement_score":0.12392196,"about_ca_system_score_codex":0.0011771788,"about_ca_system_score_gemma":0.0010819566,"threshold_uncertainty_score":0.9993275},"labels":[],"label_agreement":null},{"id":"W4282972367","doi":"10.1158/1538-7445.am2022-ct022","title":"Abstract CT022: CheckMate 848: A randomized, open-label, phase 2 study of nivolumab in combination with ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Cohort; Cancer; Immunotherapy","score_opus":0.058200113624989905,"score_gpt":0.4146993516726031,"score_spread":0.3564992380476132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909467,0.00030701113,0.000007957834,0.00022240385,0.000051659554,0.008271976,0.00014434409,0.000012562671,0.000035372315],"genre_scores_gemma":[0.99533135,0.00008795472,0.000253307,0.000048126192,0.000010879446,0.0037877276,0.00009556066,0.00006367825,0.0003214159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99567086,0.00065777823,0.0009826686,0.0005282405,0.0016948847,0.0004655718],"domain_scores_gemma":[0.9980199,0.00039903348,0.00048818009,0.00041351723,0.0005917363,0.00008765703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021707756,0.00025030636,0.0012272787,0.00079316297,0.00015068435,0.000033013413,0.00044858851,0.000027461003,0.0019023757],"category_scores_gemma":[0.00012558834,0.00016988786,0.000042455806,0.0018629367,0.0003576909,0.00028479515,0.0001247168,0.00052543066,0.0000010804553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95719355,0.013386254,0.003199583,0.0003199547,0.0005784942,0.00022526098,0.0056296224,0.001343692,0.002960649,0.000009794946,0.000048192265,0.015104977],"study_design_scores_gemma":[0.92443377,0.028761692,0.033180412,0.00070257514,0.00007214608,0.000012999123,0.010226414,0.00057885674,0.0016859855,0.00005648164,0.000033050754,0.00025562666],"about_ca_topic_score_codex":0.014003823,"about_ca_topic_score_gemma":0.003318842,"teacher_disagreement_score":0.032759763,"about_ca_system_score_codex":0.0009920707,"about_ca_system_score_gemma":0.001992466,"threshold_uncertainty_score":0.99901},"labels":[],"label_agreement":null},{"id":"W4282972517","doi":"10.1158/1538-7445.am2022-2332","title":"Abstract 2332: Repurposing simvastatin to inhibit the mevalonate pathway as a therapeutic strategy to treat high-grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Guelph","funders":"","keywords":"Simvastatin; Ovarian cancer; Cancer research; Mevalonate pathway; Biology; Serous fluid; Cancer; Metastasis; Downregulation and upregulation; Internal medicine; Medicine; Reductase; Endocrinology; Enzyme; Gene","score_opus":0.05905811743219932,"score_gpt":0.37911641390673123,"score_spread":0.32005829647453193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788755,0.010466566,0.00004341608,0.00507997,0.0025461083,0.0013498534,0.0004334606,0.000028937373,0.0011761949],"genre_scores_gemma":[0.980812,0.0010910248,0.000036092344,0.0026391302,0.005219156,0.0025182436,0.000057829693,0.00008404072,0.0075424775],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967092,0.0004089119,0.000309115,0.00081637397,0.0008502518,0.0009061257],"domain_scores_gemma":[0.99853283,0.000059515474,0.00007134914,0.00075427623,0.00025912537,0.00032288395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011429688,0.00025943603,0.00026019814,0.00016234159,0.0007757901,0.00015431238,0.0006773251,0.00009486335,0.0010068746],"category_scores_gemma":[0.00006501952,0.000211199,0.000116439835,0.00071728596,0.00011663668,0.0000094252355,0.0004906145,0.000600508,0.00003137008],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006530177,0.00008014006,0.00007313034,0.000031787942,0.00008079278,0.000004051736,0.0009278128,0.0049080574,0.8525501,0.00040546316,0.03471652,0.10556917],"study_design_scores_gemma":[0.00082827994,0.00061148603,0.0018462404,0.000030881234,0.00002256542,0.000014648397,0.00095029286,0.000009251591,0.20367086,0.00031945592,0.7913755,0.00032051283],"about_ca_topic_score_codex":0.016585331,"about_ca_topic_score_gemma":0.0046995073,"teacher_disagreement_score":0.75665903,"about_ca_system_score_codex":0.00034286783,"about_ca_system_score_gemma":0.0013723109,"threshold_uncertainty_score":0.99990636},"labels":[],"label_agreement":null},{"id":"W4282972784","doi":"10.1158/1538-7445.am2022-6154","title":"Abstract 6154: Distinct immunosuppressive environments elicited in vessel co-opting and angiogenic colorectal cancer liver metastases and changes following treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Sherbrooke; McGill University","funders":"","keywords":"Colorectal cancer; Immune system; Medicine; FOXP3; Stroma; Angiogenesis; Pathology; Cancer research; CD8; Stromal cell; Immunohistochemistry; Cancer cell; Cancer; Immunology; Internal medicine","score_opus":0.07170143097605657,"score_gpt":0.3830492088904579,"score_spread":0.3113477779144013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415777,0.056369677,3.5330393e-7,0.00071998686,0.00007156672,0.00083623326,0.00028459704,0.0000141370265,0.00012578233],"genre_scores_gemma":[0.9832171,0.013205666,0.000017429475,0.0000736217,0.0000934283,0.003072283,0.00007021096,0.00003787344,0.00021236745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979601,0.00018585575,0.00020074312,0.0005140445,0.0005866941,0.0005525555],"domain_scores_gemma":[0.9993811,0.00019463232,0.00006513666,0.0001671313,0.000024985759,0.00016696191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004764327,0.00019782857,0.00037527303,0.0002671435,0.00042856325,0.000048090846,0.00010122516,0.000048723592,0.0008328847],"category_scores_gemma":[0.00003504265,0.00017325126,0.000078422905,0.00032541816,0.00016470673,0.00008224172,0.00021708212,0.00035154208,0.0000023849266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017196601,0.0006472121,0.4693848,0.00025382923,0.0009965047,0.0006078668,0.0050144424,0.00006873127,0.38041434,0.0000076186197,0.0012080878,0.1396769],"study_design_scores_gemma":[0.0050636902,0.0015511668,0.85340804,0.00033297113,0.00025404038,0.000027914484,0.0033794579,0.00019831312,0.11275281,0.000007059654,0.02267043,0.00035410252],"about_ca_topic_score_codex":0.0066147014,"about_ca_topic_score_gemma":0.00053495425,"teacher_disagreement_score":0.38402325,"about_ca_system_score_codex":0.0010272658,"about_ca_system_score_gemma":0.00020641906,"threshold_uncertainty_score":0.9999494},"labels":[],"label_agreement":null},{"id":"W4282972797","doi":"10.1158/1538-7445.am2022-312","title":"Abstract 312: Redirecting T cells to tumor targets with functionally diverse CD3-binding antibodies","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Bispecific antibody; Antibody; Computational biology; Epitope; Antigen; CD3; Cancer research; Monoclonal antibody; Biology; Immunology; Chemistry","score_opus":0.0902143120204825,"score_gpt":0.39676277529355697,"score_spread":0.3065484632730745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823968,0.00084316445,0.0000051195693,0.004031324,0.0003710208,0.00077555043,0.0002559035,0.00006399144,0.011257172],"genre_scores_gemma":[0.96334106,0.00018604605,0.00035426405,0.0004856341,0.00071731734,0.0004097583,0.000052493324,0.000054754742,0.03439868],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954283,0.00015737534,0.00025538687,0.0006192566,0.002493021,0.0010466598],"domain_scores_gemma":[0.99823153,0.0003637451,0.000054582586,0.00031003743,0.0005347738,0.00050535414],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015300694,0.00020206707,0.00033358732,0.00059441006,0.0015241802,0.000071792856,0.0003291391,0.000034674176,0.008017061],"category_scores_gemma":[0.00013623715,0.00016254281,0.00010339262,0.0010877701,0.0002229181,0.00010965238,0.00069085095,0.0014230788,0.0003334033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078004957,0.00041392646,0.05819597,0.00056065136,0.00037031382,0.0026779303,0.0016944399,0.0009274527,0.76666427,0.00021128863,0.14681369,0.013669542],"study_design_scores_gemma":[0.0028542555,0.0032206033,0.11942645,0.000616269,0.000058107762,0.00035916615,0.00912855,0.00018628623,0.14711879,0.00010455252,0.7160995,0.0008274575],"about_ca_topic_score_codex":0.0024388798,"about_ca_topic_score_gemma":0.00021513787,"teacher_disagreement_score":0.6195455,"about_ca_system_score_codex":0.00064405106,"about_ca_system_score_gemma":0.00082185835,"threshold_uncertainty_score":0.9997757},"labels":[],"label_agreement":null},{"id":"W4282972903","doi":"10.1158/1538-7445.am2022-5399","title":"Abstract 5399: Synergistic combination nanomedicine of doxorubicin and oligo hyaluronic acid inhibits DNA damage repair and overcomes drug resistance in metastatic triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Doxorubicin; CD44; MAPK/ERK pathway; Biology; Cancer; Chemistry; Molecular biology; Breast cancer; Medicine; Kinase; Chemotherapy; Cell biology; In vitro; Internal medicine; Biochemistry","score_opus":0.02527189271343526,"score_gpt":0.3421778339682793,"score_spread":0.316905941254844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282972903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725082,0.025574815,0.0000049445234,0.0007486953,0.00009322775,0.00041483398,0.000426203,0.0000073102606,0.00022179502],"genre_scores_gemma":[0.9936744,0.0040952847,0.000039863517,0.00009530585,0.000068133886,0.0004183151,0.000057937938,0.000028926628,0.0015218643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804187,0.00028002422,0.0003319497,0.0005044161,0.00046924848,0.00037249076],"domain_scores_gemma":[0.99919015,0.00010478078,0.00012840603,0.00027495832,0.00020060968,0.00010106376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011045694,0.00016392067,0.00029565362,0.0001746539,0.00020149643,0.000015947218,0.00017351452,0.00004782223,0.00020809777],"category_scores_gemma":[0.00010909012,0.00015573546,0.000055559412,0.000462621,0.00039590412,0.000013983096,0.00028400923,0.00026728326,4.0867897e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011655068,0.00019858262,0.014185994,0.00063096546,0.00018153495,0.000028284816,0.0009167411,0.00009356167,0.97021115,0.00067563984,0.009304241,0.0024077971],"study_design_scores_gemma":[0.007477745,0.0006264773,0.40151966,0.0006705301,0.000099911704,0.000017859875,0.0030700741,0.00024306348,0.5736707,0.0011268398,0.010762804,0.00071434985],"about_ca_topic_score_codex":0.0016851329,"about_ca_topic_score_gemma":0.0030398094,"teacher_disagreement_score":0.39654046,"about_ca_system_score_codex":0.00022911465,"about_ca_system_score_gemma":0.00042692278,"threshold_uncertainty_score":0.63507074},"labels":[],"label_agreement":null},{"id":"W4282973317","doi":"10.1158/1538-7445.am2022-6299","title":"Abstract 6299: Population kinetics (PopKin) of non-small cell lung cancer (NSCLC) adjuvant therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Population; Oncology; Internal medicine; Chemotherapy; Surgery","score_opus":0.04543331961204916,"score_gpt":0.41282728985439077,"score_spread":0.3673939702423416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282973317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855057,0.007927995,0.00010994315,0.0029557524,0.0003867165,0.0006470694,0.000030188621,0.000025605792,0.0024110414],"genre_scores_gemma":[0.99421173,0.0031029456,0.00024756533,0.00037313116,0.0004156031,0.00028323018,0.000046983634,0.000054653523,0.0012641574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976901,0.0001308703,0.00032866152,0.00033200742,0.0010412743,0.00047713335],"domain_scores_gemma":[0.9989816,0.00013826134,0.00011613508,0.00034407133,0.00022582589,0.00019409502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010800406,0.000130578,0.00031185924,0.00028465196,0.00021862927,0.000021443428,0.00027001312,0.00005474053,0.0023585067],"category_scores_gemma":[0.000082429346,0.0001157753,0.00009517906,0.00052014756,0.000110598805,0.000037078236,0.00014709831,0.0013144729,0.000003527008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007327367,0.0005323731,0.2239227,0.0007763995,0.00012735283,0.0000975801,0.0017843646,0.0067393095,0.5526829,0.000055646484,0.015782708,0.19676597],"study_design_scores_gemma":[0.0072001643,0.0010079166,0.84117246,0.00070364744,0.00009208166,0.000021025806,0.000725037,0.035901457,0.045035098,0.00013587392,0.067528486,0.00047673032],"about_ca_topic_score_codex":0.008177436,"about_ca_topic_score_gemma":0.00005115291,"teacher_disagreement_score":0.6172498,"about_ca_system_score_codex":0.00045523787,"about_ca_system_score_gemma":0.00044540246,"threshold_uncertainty_score":0.99855345},"labels":[],"label_agreement":null},{"id":"W4282973720","doi":"10.1158/1538-7445.am2022-732","title":"Abstract 732: Weight gain after age 18 and breast cancer risk: A meta-analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Publication bias; Cochrane Library; Weight gain; Confidence interval; Oncology; Cancer; Subgroup analysis; Cohort study; Study heterogeneity; Internal medicine; Demography; Gynecology; Body weight","score_opus":0.11878318916502828,"score_gpt":0.4302475121909676,"score_spread":0.3114643230259393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282973720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9034574,0.08890361,0.000010917436,0.004340983,0.00014044977,0.00076987187,0.0015200634,0.000035268044,0.00082141807],"genre_scores_gemma":[0.98480386,0.009480958,0.000021419522,0.00042111936,0.0003291605,0.0018807368,0.000033821692,0.000036672267,0.0029922505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963597,0.0005072614,0.0002913488,0.0005909719,0.0015396087,0.00071112753],"domain_scores_gemma":[0.99836993,0.00015586421,0.00006361303,0.00065262447,0.000219121,0.000538823],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025502478,0.00017764827,0.00092638383,0.00061713485,0.00047850562,0.00004321525,0.00014917375,0.00007264227,0.034233414],"category_scores_gemma":[0.000046071847,0.00012901948,0.0011065251,0.001509721,0.00018889847,0.00005668422,0.00021812935,0.0013012245,0.00002128427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005872652,0.0005904561,0.4626791,0.0013332133,0.39748266,0.005822864,0.0039873146,0.0014694126,0.0014991378,0.00003991959,0.066084705,0.05313856],"study_design_scores_gemma":[0.0012803795,0.00008127471,0.83604497,0.0000110366955,0.055517245,0.00005916205,0.00036661787,0.00006992027,0.00016788798,0.00004325051,0.106114656,0.00024358663],"about_ca_topic_score_codex":0.032219134,"about_ca_topic_score_gemma":0.0028739842,"teacher_disagreement_score":0.37336588,"about_ca_system_score_codex":0.00054712675,"about_ca_system_score_gemma":0.00065182603,"threshold_uncertainty_score":0.9742254},"labels":[],"label_agreement":null},{"id":"W4282973976","doi":"10.1158/1538-7445.am2022-2168","title":"Abstract 2168: Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Glioma; Biology; Cancer research; Tumor microenvironment; CDKN2A; CDKN2B; Tumor progression; Somatic evolution in cancer; Pathology; Genetics; Cancer; Medicine","score_opus":0.04702365432810312,"score_gpt":0.3396680582315769,"score_spread":0.2926444039034738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282973976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198455,0.0054364703,4.5739634e-7,0.0015045004,0.000014137042,0.0005871212,0.00042196352,0.0000033481588,0.00004747703],"genre_scores_gemma":[0.9948044,0.0044712913,0.000009869219,0.000022895423,0.000006295893,0.0003939548,0.0000821533,0.000013354243,0.00019580436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982825,0.00020895126,0.00018964616,0.00029508793,0.00070033903,0.00032348745],"domain_scores_gemma":[0.99909425,0.00034546093,0.000111511465,0.00029222114,0.00007102121,0.00008553818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074853754,0.0001064674,0.00035352347,0.00038498332,0.00016160056,0.000014158959,0.00011765235,0.00002326981,0.00022297566],"category_scores_gemma":[0.000031436633,0.00006986921,0.00005051695,0.0011469986,0.00030658272,0.000011993766,0.00023588163,0.00026514867,8.838595e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010272457,0.00091002265,0.979683,0.00005902319,0.00080530747,0.00029729342,0.0009893035,0.00096282264,0.013338369,0.000008054128,0.00013609118,0.0017835118],"study_design_scores_gemma":[0.004116025,0.00038039044,0.98569816,0.000068523375,0.00040288296,0.0000043964897,0.0003007904,0.0010932793,0.0077894963,0.00001814513,0.00005427075,0.000073614036],"about_ca_topic_score_codex":0.0013470397,"about_ca_topic_score_gemma":0.011483134,"teacher_disagreement_score":0.010136094,"about_ca_system_score_codex":0.0011226945,"about_ca_system_score_gemma":0.00006164731,"threshold_uncertainty_score":0.6407858},"labels":[],"label_agreement":null},{"id":"W4282974114","doi":"10.1158/1538-7445.am2022-ct023","title":"Abstract CT023: Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Oncology; Cancer; Population; Biomarker; Immunotherapy; Biology","score_opus":0.13156981162370937,"score_gpt":0.4390292633664952,"score_spread":0.3074594517427859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282974114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587504,0.022068365,0.000246009,0.010260143,0.0017007525,0.005237998,0.00064171467,0.0003183782,0.00077621936],"genre_scores_gemma":[0.9515656,0.0096609965,0.0003310475,0.0008352849,0.0015820415,0.010583193,0.0004700011,0.00025349314,0.024718298],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9926347,0.00016096848,0.0010160288,0.0017737878,0.002205839,0.002208691],"domain_scores_gemma":[0.9967684,0.00028021642,0.0004705873,0.0011344078,0.000678917,0.00066744565],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009446634,0.00088634004,0.0014744971,0.0012734076,0.0015998551,0.0001668965,0.0007677941,0.00020397964,0.008287257],"category_scores_gemma":[0.000096683805,0.000829044,0.0007263904,0.002828242,0.00036589088,0.00035100093,0.00038195896,0.0009867506,0.000045550976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06578021,0.002763321,0.12734295,0.0029776702,0.0063633365,0.0012715824,0.0022409793,0.019538421,0.056894008,0.00009618263,0.08833942,0.62639195],"study_design_scores_gemma":[0.10767124,0.012500044,0.633971,0.00087026623,0.0026451321,0.00022133451,0.0036887578,0.011177538,0.09052913,0.00029489686,0.13392404,0.002506634],"about_ca_topic_score_codex":0.021017231,"about_ca_topic_score_gemma":0.0020673017,"teacher_disagreement_score":0.6238853,"about_ca_system_score_codex":0.011818699,"about_ca_system_score_gemma":0.0022895944,"threshold_uncertainty_score":0.99969995},"labels":[],"label_agreement":null},{"id":"W4282974171","doi":"10.1158/1538-7445.am2022-1076","title":"Abstract 1076: The peptide-drug conjugate TH1902 inhibits growth of subcutaneous melanoma xenografts and formation of lung metastases in a syngeneic mouse model","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Melanoma; Medicine; Lung; Cancer research; Subcutaneous injection; Cancer; Lung cancer; Pharmacology; Pathology; Internal medicine","score_opus":0.02976119661809746,"score_gpt":0.3164540540785309,"score_spread":0.28669285746043344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282974171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961327,0.0027209385,0.000031442745,0.0002589744,0.000022836239,0.00041373106,0.00020645783,0.0000034086756,0.00020951642],"genre_scores_gemma":[0.99854904,0.0008226317,0.000035355846,0.00003683447,0.000025001696,0.00017946874,0.000065167784,0.000012889129,0.00027362423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988105,0.0001913483,0.00025980355,0.00018594511,0.00034745666,0.00020492985],"domain_scores_gemma":[0.99945134,0.000034820194,0.000099881836,0.00020871083,0.00016300469,0.00004225369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008093043,0.00008322569,0.00012669875,0.0001310558,0.00012316807,0.00001398276,0.00020315005,0.000033924356,0.000031435855],"category_scores_gemma":[0.00007675834,0.00006741019,0.000041924155,0.00021364176,0.00015466726,0.0000125598735,0.00024853917,0.00019815996,4.0590498e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028354343,0.00005465891,0.000477408,0.00012943495,0.000022952605,0.0000028907136,0.00037375608,0.0011362626,0.9948646,0.00018035938,0.00194717,0.0005270061],"study_design_scores_gemma":[0.0003913067,0.00014507744,0.00013929485,0.000019880956,0.000005833509,0.000008793523,0.0003392748,0.0014833409,0.99687195,0.000097959026,0.00042127864,0.000075992735],"about_ca_topic_score_codex":0.00046444894,"about_ca_topic_score_gemma":0.00032303596,"teacher_disagreement_score":0.0024163325,"about_ca_system_score_codex":0.00004491734,"about_ca_system_score_gemma":0.00017360429,"threshold_uncertainty_score":0.27489078},"labels":[],"label_agreement":null},{"id":"W4282974204","doi":"10.1158/1538-7445.am2022-1508","title":"Abstract 1508: Chromatin accessibility of primary human cancers ties regional mutational processes with tissues of origin","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Chromatin; Genetics; Epigenetics; Mutagenesis; Computational biology; Insertional mutagenesis; Genome; Mutation; Context (archaeology); Point mutation; Cancer; Gene","score_opus":0.0750129453810466,"score_gpt":0.4012203816539157,"score_spread":0.32620743627286913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282974204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938684,0.004142701,0.000010198345,0.00012463643,0.000037654223,0.00023504677,0.00035102392,0.0000035507794,0.0012267989],"genre_scores_gemma":[0.9982827,0.00057962467,0.00013534431,0.000041202955,0.00013560931,0.00025871847,0.00024826976,0.000017183527,0.00030137243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986873,0.000053199004,0.00022286062,0.00028949525,0.00054266554,0.00020447587],"domain_scores_gemma":[0.99898,0.00008923238,0.00013909399,0.00024403888,0.0004945687,0.000053055977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037778437,0.00008897279,0.00016105785,0.000077513076,0.00017420542,0.0000137300285,0.00031335533,0.000037612812,0.00034869593],"category_scores_gemma":[0.00007649746,0.00008385926,0.000032330085,0.0002594368,0.00037765916,0.0000063027874,0.00018721329,0.00015433811,4.0381698e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009877994,0.00023105512,0.028045662,0.0014758188,0.00014435242,0.00000829665,0.0006132769,0.004992212,0.9494135,0.00034984402,0.01184711,0.0018911166],"study_design_scores_gemma":[0.0016996063,0.0016045755,0.1290247,0.00018251367,0.000026148833,0.000011184276,0.0014214589,0.00001045374,0.8236102,0.0010483335,0.040984675,0.00037618514],"about_ca_topic_score_codex":0.0021939948,"about_ca_topic_score_gemma":0.0015250499,"teacher_disagreement_score":0.12580328,"about_ca_system_score_codex":0.00024009625,"about_ca_system_score_gemma":0.0035732584,"threshold_uncertainty_score":0.6338807},"labels":[],"label_agreement":null},{"id":"W4282974316","doi":"10.1158/1538-7445.am2022-2002","title":"Abstract 2002: A genome-wide association study identifies novel sepsis risk loci in children with Down syndrome-associated acute lymphoblastic leukemia: A report from the Children’s Oncology Group","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Sepsis; Genome-wide association study; Common Terminology Criteria for Adverse Events; Internal medicine; Population; Oncology; Minor allele frequency; Single-nucleotide polymorphism; Cancer; Genetics; Biology; Genotype","score_opus":0.026566488172327762,"score_gpt":0.333086815057164,"score_spread":0.3065203268848362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282974316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144506,0.00065280386,0.00000850654,0.0028811486,0.00017065475,0.003545001,0.001032024,0.00009172237,0.00017305718],"genre_scores_gemma":[0.9938939,0.00029262304,0.000022670129,0.00031177542,0.00016829172,0.0022106862,0.0007943848,0.00008604039,0.0022195796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99370426,0.0007480488,0.0007749016,0.0010141595,0.0026995079,0.0010591346],"domain_scores_gemma":[0.99606305,0.0017902211,0.00059873913,0.00090412307,0.0004399523,0.00020391888],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042488864,0.0003208968,0.0007354323,0.00040731346,0.0008149245,0.00012114949,0.00067971164,0.0002158673,0.0014075241],"category_scores_gemma":[0.0023443266,0.0002537151,0.00013074656,0.0017587771,0.00020393846,0.00017140372,0.0005830825,0.0027708637,0.000065109554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049792574,0.0013592638,0.9738126,0.000007860646,0.003281253,0.0011003927,0.0029164671,0.00063823495,0.0004823428,4.313506e-7,0.0155775435,0.00032572335],"study_design_scores_gemma":[0.008272258,0.0012319904,0.98712385,0.00007277686,0.00050648116,0.0002699566,0.001806955,0.00003260231,0.00003353215,0.000026252028,0.00036775446,0.0002555881],"about_ca_topic_score_codex":0.09967329,"about_ca_topic_score_gemma":0.03295338,"teacher_disagreement_score":0.06671991,"about_ca_system_score_codex":0.019052789,"about_ca_system_score_gemma":0.0021925578,"threshold_uncertainty_score":0.99999154},"labels":[],"label_agreement":null},{"id":"W4282975240","doi":"10.1158/1538-7445.am2022-2248","title":"Abstract 2248: Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Debulking; Tubal ligation; Oncology; Body mass index; Gynecology; Fallopian tube cancer; Fallopian tube; Odds ratio; Breast cancer; Internal medicine; Cancer; Population; Family planning","score_opus":0.07651840889275054,"score_gpt":0.34002138268189935,"score_spread":0.26350297378914883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897946,0.004018622,3.5539986e-7,0.0042703273,0.00035368226,0.00078370207,0.0013006128,0.000050353938,0.00024290367],"genre_scores_gemma":[0.9927161,0.00086171244,0.000004268194,0.00026616754,0.00044550947,0.0034581684,0.0008114971,0.000074111165,0.0013624647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966191,0.00021178731,0.00025796154,0.0006291648,0.0016173258,0.00066467165],"domain_scores_gemma":[0.9987429,0.00024839537,0.00009351596,0.00040998225,0.000065617336,0.00043960885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005725565,0.00022736478,0.00035203225,0.00028214089,0.0004828833,0.00004976043,0.00011345137,0.000057383004,0.010758999],"category_scores_gemma":[0.000041179672,0.0001866107,0.00011906422,0.00043963833,0.00022338373,0.00014355071,0.00013956742,0.00067892065,0.000011761296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028916497,0.0012584523,0.9689362,0.00009700924,0.00059107423,0.0006737127,0.00042684763,0.00012369182,0.0017943459,0.0000075317485,0.018930156,0.004269329],"study_design_scores_gemma":[0.00136506,0.00019011136,0.98788947,0.00018958886,0.00015686858,0.0000026951125,0.00033021602,0.0000021172589,0.0012892792,0.000016023652,0.008364888,0.00020367219],"about_ca_topic_score_codex":0.0012105308,"about_ca_topic_score_gemma":0.00013690826,"teacher_disagreement_score":0.01895328,"about_ca_system_score_codex":0.005218579,"about_ca_system_score_gemma":0.0017433224,"threshold_uncertainty_score":0.9986002},"labels":[],"label_agreement":null},{"id":"W4282975377","doi":"10.1158/1538-7445.am2022-3476","title":"Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"MEK inhibitor; Ovarian cancer; KRAS; Cancer research; Serous fluid; Cell culture; Cancer; Medicine; MAPK/ERK pathway; Biology; Signal transduction; Pathology; Internal medicine; Cell biology; Genetics","score_opus":0.1960953692630206,"score_gpt":0.4668614546880892,"score_spread":0.27076608542506864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831636,0.0012240644,0.000057197052,0.0068922094,0.00043210803,0.0025411532,0.00030022243,0.000024855735,0.00021182452],"genre_scores_gemma":[0.9952485,0.00033210302,0.0002526943,0.0002058871,0.0003027567,0.0033908733,0.000040523613,0.000058088433,0.00016857502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947713,0.0010713359,0.0007006192,0.00076660933,0.0021282537,0.0005618535],"domain_scores_gemma":[0.9972205,0.0010211426,0.0001624191,0.0004986421,0.0007105941,0.000386676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005942033,0.00022651243,0.0005363563,0.0005670338,0.00030423253,0.000042986198,0.00013118403,0.00012413634,0.0009109367],"category_scores_gemma":[0.00044136107,0.00020416995,0.000076415825,0.0011369437,0.00017369146,0.00014676394,0.00019629418,0.000995066,0.000008764538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14015728,0.011483923,0.39115116,0.0013073013,0.0020440777,0.0015633699,0.019149773,0.28676164,0.020336054,0.0034720232,0.02098074,0.101592645],"study_design_scores_gemma":[0.032591797,0.007470272,0.9224839,0.0023197557,0.0007218187,0.00008904085,0.003239476,0.018180238,0.0077826735,0.0018223729,0.0025545848,0.0007440182],"about_ca_topic_score_codex":0.0044731996,"about_ca_topic_score_gemma":0.0026554642,"teacher_disagreement_score":0.5313328,"about_ca_system_score_codex":0.0021580874,"about_ca_system_score_gemma":0.004437429,"threshold_uncertainty_score":0.9974118},"labels":[],"label_agreement":null},{"id":"W4282975662","doi":"10.1158/1538-7445.am2022-1431","title":"Abstract 1431: ADO contributes to tumour initiating phenotypes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Gene knockdown; Cancer research; Cell growth; Cell culture; Clonogenic assay; Cell biology; Molecular biology; Genetics","score_opus":0.05122138103506957,"score_gpt":0.37769974838806253,"score_spread":0.32647836735299296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759733,0.016903529,0.00007078008,0.0014481408,0.001184894,0.0004237148,0.00021889688,0.000018036426,0.0037586892],"genre_scores_gemma":[0.9940527,0.0006460649,0.00005567847,0.0008311478,0.0019814172,0.00063268456,0.000063992586,0.000032668417,0.0017036281],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833137,0.00013204897,0.00017309,0.00040268284,0.00041504804,0.0005457579],"domain_scores_gemma":[0.99923134,0.000039983322,0.000037680948,0.00029728675,0.0002469465,0.00014674291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008806471,0.00011094718,0.00015200987,0.00012566471,0.0004559471,0.000051007963,0.00038471358,0.000053289034,0.0005946837],"category_scores_gemma":[0.00025645542,0.00011761525,0.00006732317,0.0003524095,0.00007158517,0.0000038975927,0.0005127618,0.00037626355,0.000030711388],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021135616,0.000040376624,0.00038100182,0.000022006827,0.00004205155,0.0000029100984,0.00011924385,0.00032734405,0.9101977,0.00021621308,0.074976645,0.01346315],"study_design_scores_gemma":[0.0005212634,0.000120980156,0.0056887437,0.000013408428,0.000006438581,0.0000027725807,0.00043559994,0.0000047783196,0.19973981,0.00015783196,0.7931598,0.00014857028],"about_ca_topic_score_codex":0.0005663859,"about_ca_topic_score_gemma":0.00024482058,"teacher_disagreement_score":0.71818316,"about_ca_system_score_codex":0.000108915476,"about_ca_system_score_gemma":0.0005121796,"threshold_uncertainty_score":0.65113693},"labels":[],"label_agreement":null},{"id":"W4282975806","doi":"10.1158/1538-7445.am2022-2625","title":"Abstract 2625: Personalized chemotherapy treatments for microsatellite instable tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Microsatellite instability; Organoid; Cancer; Chemotherapy; Medicine; Cancer research; Biology; Mutation; Oncology; Bioinformatics; Internal medicine; Microsatellite; Gene; Genetics","score_opus":0.11470244976038982,"score_gpt":0.43349590408535826,"score_spread":0.3187934543249684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880917,0.004825552,0.0000076250053,0.0019755617,0.0002708849,0.001859666,0.00023414205,0.00004314935,0.0026916987],"genre_scores_gemma":[0.96949905,0.0007863207,0.00056705746,0.0006205855,0.00023246452,0.003793141,0.00007437553,0.00008081755,0.024346182],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770516,0.00007168233,0.00020927873,0.0004638602,0.00086323655,0.00068677263],"domain_scores_gemma":[0.99901503,0.00016071198,0.000048733993,0.0003353262,0.00025056116,0.00018963478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006635819,0.00015750862,0.0002905833,0.00019541025,0.00046268365,0.000033287113,0.00023003889,0.000052107902,0.008662989],"category_scores_gemma":[0.00005629469,0.00014557816,0.00013758159,0.00048752286,0.00019727743,0.00003681066,0.00010109793,0.00046685,0.000025835356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073395716,0.0005493314,0.0120934015,0.00032021868,0.00041963227,0.000060452003,0.0025087888,0.000071224254,0.887105,0.00008650407,0.044483304,0.04496258],"study_design_scores_gemma":[0.008870966,0.0017922991,0.020772781,0.000096901815,0.00005041743,0.000035342928,0.0011836868,0.000057841466,0.2754683,0.0004334543,0.6909519,0.00028613862],"about_ca_topic_score_codex":0.0005646928,"about_ca_topic_score_gemma":0.000024428677,"teacher_disagreement_score":0.6464686,"about_ca_system_score_codex":0.0017409339,"about_ca_system_score_gemma":0.0010332883,"threshold_uncertainty_score":0.99224323},"labels":[],"label_agreement":null},{"id":"W4282975906","doi":"10.1158/1538-7445.am2022-5112","title":"Abstract 5112: Investigating the use of circulating tumor DNA for sarcoma management","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Amplicon; Digital polymerase chain reaction; Circulating tumor DNA; Circulating tumor cell; Multiplex polymerase chain reaction; Biology; Multiplex; Sarcoma; Polymerase chain reaction; Cancer; Metastasis; Medicine; Pathology; Bioinformatics; Genetics; Gene","score_opus":0.1431379682380876,"score_gpt":0.37846304329052927,"score_spread":0.23532507505244166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997288,0.000890684,0.000087141874,0.00050161564,0.00012702163,0.0005859536,0.00019003218,0.0000035223177,0.00032602265],"genre_scores_gemma":[0.99790365,0.00013518595,0.0006194982,0.00036620113,0.00019212112,0.00046403127,0.000051630017,0.000024501094,0.00024320351],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892825,0.00006371189,0.00018308459,0.00024736242,0.00028323784,0.00029435699],"domain_scores_gemma":[0.9992291,0.00017111292,0.00007540704,0.00034346178,0.00012862665,0.000052347594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065766816,0.000072415205,0.000084409396,0.000048952952,0.00039438298,0.000039944483,0.00030143623,0.000019595464,0.000052380565],"category_scores_gemma":[0.00021771465,0.00006522994,0.000066515706,0.00016305891,0.00012755762,0.0000025780237,0.0004954038,0.00016025399,6.8168686e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012542788,0.000066126915,0.0027455152,0.00020892292,0.0001166431,0.000008374148,0.00022038692,0.018361293,0.9337533,0.002029638,0.028730836,0.013633545],"study_design_scores_gemma":[0.0014336973,0.0005096527,0.012105824,0.000077735,0.000035503694,0.000010987768,0.001555172,0.0016260926,0.2754764,0.0016345014,0.70517516,0.00035926915],"about_ca_topic_score_codex":0.00031253873,"about_ca_topic_score_gemma":0.000055779754,"teacher_disagreement_score":0.67644435,"about_ca_system_score_codex":0.000082482686,"about_ca_system_score_gemma":0.0001952879,"threshold_uncertainty_score":0.3033315},"labels":[],"label_agreement":null},{"id":"W4282976130","doi":"10.1158/1538-7445.am2022-1844","title":"Abstract 1844: Anti-tumor activity of a dual BET/CBP/EP300 inhibitor, NEO2734, in undifferentiated pleomorphic sarcomas and identification of genes involved in resistance","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Society for Arts and Technology","funders":"","keywords":"Bromodomain; Cancer research; Sarcoma; Biology; BET inhibitor; Rhabdomyosarcoma; Gene; Epigenetics; Medicine; Pathology; Genetics","score_opus":0.04516344419988888,"score_gpt":0.3372830173146622,"score_spread":0.2921195731147733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282976130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598294,0.0032165868,0.000010070599,0.0001832891,0.000068668174,0.00038737757,0.00011301927,0.0000034330242,0.0000346184],"genre_scores_gemma":[0.9990451,0.00044645366,0.000013655754,0.000009477992,0.000037096575,0.00016883617,0.00007266318,0.000014138339,0.00019258556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983584,0.00030982235,0.00036111998,0.0003398789,0.00039786357,0.0002328611],"domain_scores_gemma":[0.9993407,0.000034342887,0.00016428645,0.00027472907,0.00013932612,0.00004660324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009691205,0.000094435454,0.00018866405,0.00027677004,0.00007987177,0.00001493924,0.00017346621,0.000059759117,0.0000501522],"category_scores_gemma":[0.00012736212,0.000103517326,0.00003419356,0.0005059765,0.00020528697,0.000012530254,0.00023058121,0.00027843306,4.5570746e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032360997,0.00016237944,0.032486968,0.00013653444,0.000012482096,0.000005555831,0.00008372615,0.000037488157,0.96586657,0.000051324,0.00028178937,0.0005515928],"study_design_scores_gemma":[0.0006933811,0.000072619165,0.1742596,0.000043390577,0.000001999019,6.913716e-7,0.00016459075,0.000038140424,0.8239984,0.00006438434,0.00057978544,0.000083030354],"about_ca_topic_score_codex":0.00090588606,"about_ca_topic_score_gemma":0.0026296692,"teacher_disagreement_score":0.14186816,"about_ca_system_score_codex":0.00008978246,"about_ca_system_score_gemma":0.00027166423,"threshold_uncertainty_score":0.42213142},"labels":[],"label_agreement":null},{"id":"W4282976142","doi":"10.1158/1538-7445.am2022-3445","title":"Abstract 3445: Long term effect of radiotherapy on risk of second primary lung cancer and overall mortality among lung cancer patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Proportional hazards model; Internal medicine; Oncology; Cancer; Hazard ratio; Confidence interval","score_opus":0.021770776471970323,"score_gpt":0.3961267504642641,"score_spread":0.37435597399229376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282976142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714043,0.024429744,4.0720292e-7,0.00015166117,0.00030714885,0.0021336912,0.0011025728,0.000015939253,0.0004544938],"genre_scores_gemma":[0.9831722,0.01358571,0.0000037970499,0.000101204256,0.00017272319,0.0024837109,0.000060057595,0.00005608694,0.0003645106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968983,0.00029868048,0.00041920025,0.0005834403,0.0012925077,0.00050787017],"domain_scores_gemma":[0.9983876,0.00040220926,0.00027654777,0.00048957055,0.00022662093,0.00021747821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091002235,0.00025534563,0.0007034945,0.00023788452,0.00022642167,0.000019677109,0.00018680519,0.00008118955,0.0033687546],"category_scores_gemma":[0.000031525142,0.0002029734,0.00016658388,0.0003182991,0.00026138918,0.000105305975,0.00014437591,0.0007065401,3.22696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017400841,0.00051845773,0.97342575,0.0032619599,0.0015300208,0.000030706102,0.0005700658,0.000258667,0.0019196126,0.000003868457,0.004731129,0.012009678],"study_design_scores_gemma":[0.0061761285,0.0012348383,0.9756693,0.0008598248,0.00031145805,6.4379003e-7,0.000009733905,0.000092303366,0.015305026,0.0000030219185,0.00017971077,0.00015801076],"about_ca_topic_score_codex":0.016470378,"about_ca_topic_score_gemma":0.0016463228,"teacher_disagreement_score":0.014824055,"about_ca_system_score_codex":0.003173299,"about_ca_system_score_gemma":0.00058506976,"threshold_uncertainty_score":0.9975423},"labels":[],"label_agreement":null},{"id":"W4282976408","doi":"10.1158/1538-7445.am2022-5896","title":"Abstract 5896: Reproductive, hormonal and lifestyle correlates of circulating osteoprotegerin levels in women with a <i>BRCA1</i> mutation","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Osteoprotegerin; Medicine; Breast cancer; Oncology; Internal medicine; Biomarker; Hormone; Cancer; Family history; Physiology; Endocrinology; Receptor; Activator (genetics); Biology; Genetics","score_opus":0.06772380362105275,"score_gpt":0.38313336655328506,"score_spread":0.3154095629322323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282976408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968636,0.0011630564,9.707861e-7,0.00065622985,0.000022865885,0.0007835473,0.00002552437,0.000009808175,0.00047439738],"genre_scores_gemma":[0.99872315,0.00004081045,0.00007196255,0.000045907316,0.00002542286,0.0008632592,0.000007821064,0.000016326469,0.00020534892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985691,0.00008744741,0.00019450062,0.00030314794,0.000509376,0.00033644307],"domain_scores_gemma":[0.9994145,0.00010148503,0.00006451714,0.000171578,0.00012588601,0.00012205528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009251659,0.00007036559,0.00018454743,0.00018042982,0.00014402732,0.0000068600643,0.00003893205,0.000027231974,0.00018673325],"category_scores_gemma":[0.00010162718,0.000060772763,0.0000098203145,0.0004839123,0.00010126779,0.000062740604,0.000057836365,0.00047529244,0.0000019199326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075935475,0.0006846444,0.82614875,0.0011281978,0.00017725208,0.0009879234,0.014422739,0.0006925316,0.039489545,0.00008066356,0.00014803505,0.10844617],"study_design_scores_gemma":[0.002575754,0.001007736,0.9919367,0.00013357616,0.0000059845156,0.000097533346,0.0018329361,0.000051152158,0.0019779555,0.00018485672,0.00013530647,0.000060544564],"about_ca_topic_score_codex":0.0024577605,"about_ca_topic_score_gemma":0.00008185858,"teacher_disagreement_score":0.16578792,"about_ca_system_score_codex":0.00048149805,"about_ca_system_score_gemma":0.0006037028,"threshold_uncertainty_score":0.3715415},"labels":[],"label_agreement":null},{"id":"W4282976653","doi":"10.1158/1538-7445.am2022-2367","title":"Abstract 2367: Characterizing the reciprocal regulation of an ABI1-dependent androgen receptor axis in prostate cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Androgen receptor; LNCaP; Cell biology; Molecular biology; Biology; Prostate cancer; Cancer","score_opus":0.0812202773113444,"score_gpt":0.40870092008312003,"score_spread":0.32748064277177563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282976653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878543,0.0035521928,2.9389759e-7,0.005805214,0.0001978833,0.0018431603,0.00023415366,0.000024347493,0.0004884431],"genre_scores_gemma":[0.99022377,0.0022907574,0.000018014614,0.000088955974,0.00023347654,0.0028392293,0.00014720148,0.000045246397,0.0041133394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964809,0.0003752736,0.00039201946,0.00049221085,0.0015722166,0.00068737724],"domain_scores_gemma":[0.9987485,0.000121875295,0.00010459266,0.00048823774,0.0003536671,0.00018313277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023926874,0.00015275332,0.0003017861,0.00037075317,0.0004158133,0.000039174553,0.0003262938,0.00005756789,0.003973462],"category_scores_gemma":[0.000062743544,0.000108932145,0.0000700476,0.0010083565,0.00026878496,0.00019704468,0.00025054876,0.0010712456,0.0000126449295],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00880735,0.0006793146,0.068475865,0.00047053627,0.00016648107,0.00012345667,0.006203653,0.00032171077,0.79574865,0.0000848439,0.0024214515,0.11649667],"study_design_scores_gemma":[0.0075453767,0.0019410547,0.47037175,0.0006203151,0.000044415887,0.000035699235,0.005876721,0.000687232,0.46811768,0.00031397535,0.04403974,0.00040602664],"about_ca_topic_score_codex":0.004062541,"about_ca_topic_score_gemma":0.00062156335,"teacher_disagreement_score":0.40189588,"about_ca_system_score_codex":0.0015733145,"about_ca_system_score_gemma":0.0013142404,"threshold_uncertainty_score":0.99693704},"labels":[],"label_agreement":null},{"id":"W4282977080","doi":"10.1158/1538-7445.am2022-ct035","title":"Abstract CT035: Safety, preliminary efficacy and pharmacodynamic (PD) analysis of maveropepimut-S, intermittent low-dose cyclophosphamide and pembrolizumab in patients with advanced, metastatic bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec; William Osler Health System; Université Laval","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cyclophosphamide; Cancer; Oncology; Immunotherapy; Survivin; Bladder cancer; CD8; Immune system; Chemotherapy; Immunology","score_opus":0.01755569767508987,"score_gpt":0.3322421358152522,"score_spread":0.31468643814016234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477351,0.050826237,0.0000024976619,0.00012128387,0.00013648924,0.0007687972,0.0003459813,0.000013080216,0.000050582796],"genre_scores_gemma":[0.98674613,0.011834775,0.000008001775,0.00006161803,0.0000040644272,0.00038139967,0.00012297064,0.00003416861,0.0008068893],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976163,0.0006550426,0.00045901767,0.00049380504,0.00020727214,0.0005685446],"domain_scores_gemma":[0.9988336,0.0004723503,0.00016774039,0.00032815424,0.00015996194,0.000038173926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006305341,0.00022999482,0.00056046323,0.00081036985,0.00033995582,0.000016772416,0.0003142388,0.000057110166,0.0023469713],"category_scores_gemma":[0.00004205333,0.00019637961,0.00007126214,0.0010710844,0.0005683164,0.00015054757,0.00038554124,0.00079159933,0.0000040373316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20604895,0.0026695626,0.13373132,0.0004790653,0.01152629,0.00009881424,0.0057608034,0.008022678,0.20787315,0.000048287806,0.0006215161,0.42311954],"study_design_scores_gemma":[0.011811284,0.0012112446,0.9786332,0.00014201578,0.00031973456,0.000006280778,0.0005671672,0.0000518728,0.0050002323,0.000007845667,0.0019976948,0.0002513908],"about_ca_topic_score_codex":0.0017201266,"about_ca_topic_score_gemma":0.00016833718,"teacher_disagreement_score":0.8449019,"about_ca_system_score_codex":0.00029579797,"about_ca_system_score_gemma":0.00027090323,"threshold_uncertainty_score":0.998565},"labels":[],"label_agreement":null},{"id":"W4282977486","doi":"10.1158/1538-7445.am2022-1944","title":"Abstract 1944: Prognostic biomarkers for gallbladder cancer: A machine learning approach","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gallbladder cancer; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Disease; Cancer; Predictive modelling; Machine learning; Computer science","score_opus":0.10835713111464683,"score_gpt":0.3930252109767348,"score_spread":0.284668079862088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88939714,0.07676758,0.00010766717,0.015137707,0.0007289262,0.005172896,0.0005347309,0.00027104153,0.011882327],"genre_scores_gemma":[0.98152524,0.0012255221,0.00023867488,0.00029764435,0.0005842678,0.010891604,0.0001876492,0.000094539384,0.0049548373],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666476,0.00015507122,0.00030919738,0.00072940526,0.0011527388,0.0009888402],"domain_scores_gemma":[0.99860114,0.00030932864,0.00008416018,0.00035323767,0.00039482547,0.00025733566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012032449,0.00024349983,0.0004378917,0.00040273627,0.0012588012,0.000060490678,0.00031654426,0.00006531794,0.0017836959],"category_scores_gemma":[0.00023532567,0.00022132385,0.00021984937,0.00091167755,0.00024337885,0.00007546878,0.00037646113,0.0012414224,0.000010136057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077049653,0.0013456577,0.5959096,0.003634299,0.003514856,0.0002538755,0.007286736,0.0017913277,0.037776586,0.00036243428,0.25517076,0.0852489],"study_design_scores_gemma":[0.011458466,0.0024817933,0.29107922,0.00036278102,0.0005213407,0.00013958215,0.007579314,0.0049976227,0.0028131865,0.00027096615,0.67718893,0.0011068078],"about_ca_topic_score_codex":0.0031810016,"about_ca_topic_score_gemma":0.00028463968,"teacher_disagreement_score":0.42201814,"about_ca_system_score_codex":0.00090465817,"about_ca_system_score_gemma":0.00091026654,"threshold_uncertainty_score":0.9991288},"labels":[],"label_agreement":null},{"id":"W4282978282","doi":"10.1158/1538-7445.am2022-538","title":"Abstract 538: Cell-free whole genome sequencing for the detection of cancer in patients with germline <i>BRCA1/2</i> mutations","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Germline; Ovarian cancer; Breast cancer; Cancer; Germline mutation; Digital polymerase chain reaction; Biology; Cancer research; Internal medicine; Medicine; Oncology; Mutation; Genetics; Gene; Polymerase chain reaction","score_opus":0.02517415277626236,"score_gpt":0.3193909574214359,"score_spread":0.2942168046451736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933254,0.003820798,0.00023536819,0.00027619797,0.00012267708,0.00068555947,0.001452164,0.0000025083657,0.000079321435],"genre_scores_gemma":[0.99780107,0.000428092,0.000036772828,0.000073801675,0.00014335859,0.0012083846,0.000121999554,0.000025120124,0.00016143416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990123,0.000037303515,0.00016735475,0.00024320731,0.00027185967,0.00026800105],"domain_scores_gemma":[0.9991825,0.00009333325,0.00007361381,0.0003372962,0.00027285772,0.000040399365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038533358,0.00007828568,0.00009132169,0.000076675926,0.00026190918,0.00001738262,0.0003033666,0.00003633833,0.000057486497],"category_scores_gemma":[0.0000623737,0.0000656145,0.000040425017,0.00025042635,0.00009240158,0.0000036479407,0.00019768499,0.00020349419,4.7208232e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057323236,0.00009334798,0.0072831344,0.00006459755,0.00004496155,9.431079e-7,0.00022369341,0.058373593,0.9276748,0.000009983767,0.0004299658,0.0052277897],"study_design_scores_gemma":[0.008819211,0.0021282232,0.22524846,0.00005319283,0.000072517665,0.0000011898827,0.0016948191,0.00069345545,0.6112458,0.00033384425,0.14915034,0.00055896287],"about_ca_topic_score_codex":0.0020337,"about_ca_topic_score_gemma":0.0047257217,"teacher_disagreement_score":0.31642896,"about_ca_system_score_codex":0.0002997886,"about_ca_system_score_gemma":0.00055438455,"threshold_uncertainty_score":0.30743593},"labels":[],"label_agreement":null},{"id":"W4282978314","doi":"10.1158/1538-7445.am2022-117","title":"Abstract 117: Therapeutic targeting of hypoxia tolerance and oxygen consumption in pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hypoxia (environmental); HIF1A; Biology; Tumor hypoxia; Pancreatic cancer; Cancer research; Glycolysis; Angiogenesis; Pathology; Internal medicine; Oxygen; Medicine; Endocrinology; Metabolism; Cancer; Chemistry; Radiation therapy; Genetics","score_opus":0.05049208888396786,"score_gpt":0.3604164839374996,"score_spread":0.30992439505353175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8948503,0.10412173,0.000006721316,0.00014780246,0.00033033243,0.00029525906,0.000078606216,0.000004518738,0.00016472577],"genre_scores_gemma":[0.9754998,0.022902085,0.00003048052,0.00011576228,0.00044683338,0.000537015,0.000023905433,0.000023322586,0.00042078272],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985137,0.00017056399,0.0002299106,0.00036535776,0.00034025658,0.00038019472],"domain_scores_gemma":[0.9994978,0.00003839575,0.00007253045,0.00022282513,0.00009818057,0.00007028213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007869733,0.00011055669,0.00020016936,0.00011359578,0.00015718948,0.00001590957,0.00019999764,0.00006147338,0.00046443043],"category_scores_gemma":[0.000039005667,0.00011456614,0.000043484582,0.00021858774,0.00016721679,0.0000064270102,0.0001807035,0.00031118657,0.0000015303247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028659272,0.00004419146,0.024189187,0.00013163609,0.000037086706,0.0000013611733,0.00027665703,0.000552069,0.959284,0.000038750288,0.001850502,0.013307929],"study_design_scores_gemma":[0.0026689977,0.00024903592,0.53073543,0.00012888116,0.000034493132,0.000009279649,0.0009256711,0.00019162516,0.20614693,0.0002789963,0.25816303,0.0004675955],"about_ca_topic_score_codex":0.0018151967,"about_ca_topic_score_gemma":0.0006162777,"teacher_disagreement_score":0.7531371,"about_ca_system_score_codex":0.00008483293,"about_ca_system_score_gemma":0.00028052,"threshold_uncertainty_score":0.50851876},"labels":[],"label_agreement":null},{"id":"W4282978625","doi":"10.1158/1538-7445.am2022-5895","title":"Abstract 5895: Examining the association between arsenic exposure and cancer risk among Canadian adults","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Arsenic contamination and mitigation","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Arsenic; Medicine; Environmental health; Biomonitoring; Cancer; Risk assessment; Cancer registry; Inorganic arsenic; Risk factor; Cancer prevention; Internal medicine; Environmental chemistry; Chemistry","score_opus":0.03659985060516234,"score_gpt":0.3116995546085207,"score_spread":0.27509970400335837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942365,0.0002649341,0.0000012666293,0.0012567611,0.00011696428,0.00033498486,0.00012548997,0.000013329859,0.003649739],"genre_scores_gemma":[0.9963124,0.0003288974,0.0000037475966,0.000087261426,0.00010227383,0.00038430488,0.000014922369,0.000011951859,0.0027542731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998179,0.00028549583,0.00013720425,0.00026862795,0.0007380756,0.0003915506],"domain_scores_gemma":[0.9992939,0.00026106954,0.000092556525,0.0001563103,0.000031513537,0.00016464177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019099765,0.00007124865,0.000076033815,0.000069819034,0.0012477157,0.000052033312,0.0002162555,0.000046888283,0.0055827145],"category_scores_gemma":[0.0001392005,0.000062835294,0.000019472353,0.0003691682,0.00010600843,0.00014372489,0.00018886256,0.000624112,0.000033860215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068006602,0.000003765695,0.89349395,0.0000027364947,0.000015280946,0.0000019964048,0.0024626693,0.00026151977,0.000284684,0.000007373868,0.002854842,0.10060441],"study_design_scores_gemma":[0.00023165015,0.000028721577,0.9683835,0.000010004982,0.000009123567,2.4142665e-7,0.0017731682,0.00021003603,0.00014760127,0.000050286522,0.029078193,0.00007748143],"about_ca_topic_score_codex":0.56182677,"about_ca_topic_score_gemma":0.7002628,"teacher_disagreement_score":0.138436,"about_ca_system_score_codex":0.002567999,"about_ca_system_score_gemma":0.00017024581,"threshold_uncertainty_score":0.99532634},"labels":[],"label_agreement":null},{"id":"W4282978672","doi":"10.1158/1538-7445.am2022-131","title":"Abstract 131: The role of p66ShcA in the melanoma oncogenesis process","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Jewish General Hospital","funders":"","keywords":"Melanoma; Melanocyte; Carcinogenesis; Cancer research; Biology; Neuroblastoma RAS viral oncogene homolog; Malignant transformation; Immunosurveillance; Oncogene; MAPK/ERK pathway; Cancer; Signal transduction; Immunology; Cell cycle; Cell biology; Genetics","score_opus":0.04281531826041886,"score_gpt":0.3965422250151573,"score_spread":0.35372690675473845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992667,0.0024866618,0.0000013980988,0.0005176958,0.000038129063,0.00023297455,0.0000212072,0.0000011294208,0.004033761],"genre_scores_gemma":[0.9989705,0.0001836283,0.0000027220358,0.00008952436,0.000095864976,0.0004488881,0.000026113494,0.0000070345263,0.00017570944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989868,0.0002245778,0.000103022605,0.00014059234,0.00038356526,0.00016143586],"domain_scores_gemma":[0.9996301,0.00004043443,0.00003100321,0.0002200503,0.0000627324,0.000015696653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010443281,0.00004267771,0.000048375987,0.000034974066,0.00016784716,0.000012309397,0.0004207007,0.000025088539,0.0001979173],"category_scores_gemma":[0.000033874814,0.000026816439,0.000026731312,0.00021834254,0.000069150025,0.0000015892399,0.000093511146,0.00016210908,0.0000020444445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017387397,0.00008195682,0.014862477,0.000025964448,0.00002017106,0.0000038915523,0.0015759964,0.00033565616,0.97034293,0.00020801462,0.002230929,0.010138133],"study_design_scores_gemma":[0.00040432462,0.0002688312,0.033458136,0.000009110588,0.000004872878,0.000007380506,0.013275657,0.000037558726,0.88598675,0.0007147036,0.065742224,0.00009047196],"about_ca_topic_score_codex":0.00037215455,"about_ca_topic_score_gemma":0.00017767564,"teacher_disagreement_score":0.0843562,"about_ca_system_score_codex":0.000027872515,"about_ca_system_score_gemma":0.00017363719,"threshold_uncertainty_score":0.21670556},"labels":[],"label_agreement":null},{"id":"W4282978920","doi":"10.1158/1538-7445.am2022-ct521","title":"Abstract CT521: Phase 1b trial of the MNK1/2 inhibitor tomivosertib combined with paclitaxel in patients with metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Concordia University; McGill University; University of British Columbia; University of Alberta; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Metastatic breast cancer; Pharmacology; Internal medicine; Pharmacodynamics; Breast cancer; Cmax; Cancer; Oncology; Gastroenterology; Adverse effect","score_opus":0.03467389512554236,"score_gpt":0.36566647269976776,"score_spread":0.3309925775742254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663246,0.00046305222,0.000003232136,0.00041046122,0.00025866192,0.0013094159,0.00079571916,0.000005928778,0.000121062585],"genre_scores_gemma":[0.9979635,0.00003230148,0.000019283116,0.00009877725,0.00016458919,0.0013001788,0.000056640172,0.00004953822,0.00031521756],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997295,0.00032763724,0.00031616428,0.00047844884,0.0010764126,0.00050632004],"domain_scores_gemma":[0.9987226,0.000055057324,0.00016672589,0.0005842381,0.00036876797,0.00010260019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007241946,0.00018822403,0.00026601186,0.0001104475,0.00020525012,0.000026220829,0.00055200444,0.00005397739,0.00048153222],"category_scores_gemma":[0.000050703875,0.00012700206,0.0000695661,0.0006364721,0.00031682278,0.000010607897,0.00028560986,0.00052211,0.0000011395342],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49187085,0.008046622,0.08916476,0.00038045784,0.0008691534,0.000030684125,0.00071950594,0.00375008,0.38208494,0.00005601937,0.012119765,0.010907167],"study_design_scores_gemma":[0.43353325,0.021846512,0.08204057,0.0005783231,0.00013285354,0.0000088463,0.0008145512,0.000064467145,0.44379115,0.00009524271,0.015951755,0.0011424773],"about_ca_topic_score_codex":0.0012149005,"about_ca_topic_score_gemma":0.001017115,"teacher_disagreement_score":0.061706208,"about_ca_system_score_codex":0.00034872832,"about_ca_system_score_gemma":0.001407766,"threshold_uncertainty_score":0.52724403},"labels":[],"label_agreement":null},{"id":"W4282978930","doi":"10.1158/1538-7445.am2022-161","title":"Abstract 161: Regulation of Abl at mitotic centrosomes and survival by ILK in glioblastoma cells","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Trinity Western University; Western University","funders":"","keywords":"Centrosome; Integrin-linked kinase; Mitosis; Biology; Cancer research; Cell biology; Cancer cell; Cancer; Kinase; Cell cycle; Protein kinase A; Genetics; Cyclin-dependent kinase 2","score_opus":0.022696297237412257,"score_gpt":0.3009956844624492,"score_spread":0.27829938722503694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143505,0.007182397,0.0000018933483,0.00020852541,0.00049284945,0.00026916296,0.00017945231,0.0000107902915,0.0002198618],"genre_scores_gemma":[0.99355024,0.00042261565,0.000004844029,0.000014481492,0.000016585864,0.000077858625,0.00002724543,0.000015523266,0.005870589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863225,0.0003318838,0.0002230641,0.00026527498,0.00013256645,0.0004149726],"domain_scores_gemma":[0.9994839,0.00016882944,0.00006436156,0.00020751162,0.000054228243,0.000021180898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007109399,0.000091179965,0.00019668507,0.00018407255,0.00027522468,0.000009552798,0.0002002258,0.000090600945,0.0050599603],"category_scores_gemma":[0.000025978523,0.000091937756,0.000033719905,0.0002659361,0.00020053139,0.00005645161,0.00031429148,0.00046922476,0.00003643565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004581195,0.00008825626,0.0012189248,0.00003391685,0.000026824859,0.0000026325004,0.00035696325,0.00005910712,0.98925513,0.00022181604,0.006668049,0.00161025],"study_design_scores_gemma":[0.0012032704,0.00027030858,0.018590992,0.000022652446,0.0000035505145,0.0000034111065,0.00053620123,0.000008567474,0.94868106,0.00015073137,0.030428529,0.00010075165],"about_ca_topic_score_codex":0.00083366485,"about_ca_topic_score_gemma":0.00024839412,"teacher_disagreement_score":0.040574107,"about_ca_system_score_codex":0.00026678437,"about_ca_system_score_gemma":0.00009303848,"threshold_uncertainty_score":0.99584955},"labels":[],"label_agreement":null},{"id":"W4282978982","doi":"10.1158/1538-7445.am2022-ct008","title":"Abstract CT008: Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; KRAS; Clinical endpoint; Internal medicine; Oncology; Progression-free survival; Phases of clinical research; Primary tumor; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Confidence interval; Clinical trial; Cancer; Surgery; Metastasis","score_opus":0.08801611529296685,"score_gpt":0.435598304098453,"score_spread":0.3475821888054862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282978982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390715,0.0015694426,0.0000011263563,0.00063898496,0.000045401986,0.0008763245,0.0002079699,0.00003239513,0.0027212205],"genre_scores_gemma":[0.99703044,0.00034926657,0.0000123049485,0.000043396998,0.000019351988,0.00082237547,0.0001174042,0.00003082751,0.0015746632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974304,0.00013028648,0.00033811387,0.0004602397,0.001126051,0.000514908],"domain_scores_gemma":[0.99882597,0.00020068053,0.00009126081,0.00039603058,0.00035267405,0.00013341132],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045436647,0.0001966285,0.0007865846,0.0010233504,0.00020506582,0.000019049781,0.00018334611,0.00004664155,0.0031066125],"category_scores_gemma":[0.000052667183,0.0001407655,0.00016015318,0.003450988,0.00023090577,0.00005688422,0.00017233618,0.0005072681,0.000005798081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032454135,0.0005212882,0.98675615,0.00010201598,0.0035149062,0.0003952911,0.0011292555,0.00030052158,0.0012677127,0.000010283059,0.00026919116,0.002487963],"study_design_scores_gemma":[0.0031908639,0.0009320085,0.9929889,0.000087633074,0.0005471717,0.0000037442917,0.000772811,0.000049196864,0.0012124458,0.000005316499,0.00008000396,0.000129946],"about_ca_topic_score_codex":0.0077907285,"about_ca_topic_score_gemma":0.008388684,"teacher_disagreement_score":0.006232701,"about_ca_system_score_codex":0.0011548618,"about_ca_system_score_gemma":0.00053118786,"threshold_uncertainty_score":0.9988165},"labels":[],"label_agreement":null},{"id":"W4282979011","doi":"10.1158/1538-7445.am2022-324","title":"Abstract 324: Discovery of novel functional TROP2 antibodies for treatment of epithelial cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cancer research; In vivo; Cancer; Metastasis; Antibody; Intracellular; Cancer cell; Downregulation and upregulation; Extracellular; Antibody-drug conjugate; Biology; Immunology; Cell biology; Monoclonal antibody; Genetics","score_opus":0.17824344595736766,"score_gpt":0.46742746372008676,"score_spread":0.28918401776271907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669755,0.004958488,0.00010221522,0.0018860858,0.00030108256,0.0016787478,0.0030278452,0.000013840888,0.0013341265],"genre_scores_gemma":[0.9921872,0.0020041377,0.00015526428,0.00003557301,0.00046611158,0.0023173732,0.00008874576,0.00002927728,0.0027163206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970513,0.00007142886,0.00032350054,0.00036150616,0.0016597765,0.00053246226],"domain_scores_gemma":[0.99839485,0.00051504304,0.00009911214,0.00034171322,0.0005651306,0.00008415448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073274085,0.00014507536,0.00049255375,0.00036736674,0.00030338147,0.000013642572,0.00018981358,0.000033284297,0.00041114702],"category_scores_gemma":[0.00015820772,0.000115481314,0.0002278826,0.0004675921,0.0004696971,0.00009925056,0.00011560227,0.0001958442,0.0000012560579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016027533,0.002681945,0.018894505,0.0023138046,0.0016045535,0.00004020582,0.00407444,0.0013062874,0.9107788,0.0016239999,0.029321263,0.0113326525],"study_design_scores_gemma":[0.038523726,0.025448993,0.26716986,0.0006576285,0.00046707547,0.0000480388,0.018994123,0.000335169,0.46403414,0.0005639194,0.1830569,0.00070042606],"about_ca_topic_score_codex":0.0046808133,"about_ca_topic_score_gemma":0.00023640378,"teacher_disagreement_score":0.44674468,"about_ca_system_score_codex":0.0021170042,"about_ca_system_score_gemma":0.0023472256,"threshold_uncertainty_score":0.7076021},"labels":[],"label_agreement":null},{"id":"W4282979181","doi":"10.1158/1538-7445.am2022-388","title":"Abstract 388: AI/ML-driven discovery of a novel proteoglycan for precision targeting of ADCs for disruption of stromal barriers and direct anti-tumor activity","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Stromal cell; Cancer-Associated Fibroblasts; Cancer research; Cancer; Medicine; Triple-negative breast cancer; Cancer cell; Fibroblast activation protein, alpha; Breast cancer; Tumor microenvironment; Tumor cells; Internal medicine","score_opus":0.06428709810769946,"score_gpt":0.41034370056206676,"score_spread":0.3460566024543673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939907,0.0006451224,0.00071173307,0.0003151266,0.000093614726,0.002577259,0.0016267156,0.000006552018,0.000033157266],"genre_scores_gemma":[0.9982222,0.00012209863,0.0004624583,0.00001190692,0.000071513234,0.00095028366,0.00003142067,0.000025623238,0.00010252144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998462,0.00006565336,0.0003255543,0.00029182853,0.00056601496,0.00028894976],"domain_scores_gemma":[0.9988729,0.00033728496,0.00022419215,0.00020081656,0.00029389616,0.00007091467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014171735,0.00010384496,0.00038260667,0.00018635285,0.00017021227,0.000011245288,0.0001256156,0.000041518848,0.00006413689],"category_scores_gemma":[0.00032521778,0.000090447844,0.00014975069,0.00029469118,0.0002587759,0.00014894955,0.00009543914,0.00021946678,1.8220753e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020551063,0.0002235491,0.0072008804,0.0014126286,0.00013565306,8.639341e-7,0.00043301992,0.00009538199,0.95945156,0.000015904581,0.00031144544,0.010168077],"study_design_scores_gemma":[0.0075414134,0.0032164361,0.07202686,0.0005710959,0.000058660913,0.0000038450207,0.0014209602,0.0017129767,0.9110497,0.000025757694,0.0022226514,0.00014959848],"about_ca_topic_score_codex":0.0010272469,"about_ca_topic_score_gemma":0.00004980514,"teacher_disagreement_score":0.06482598,"about_ca_system_score_codex":0.00023105943,"about_ca_system_score_gemma":0.0006705005,"threshold_uncertainty_score":0.36883563},"labels":[],"label_agreement":null},{"id":"W4282979207","doi":"10.1158/1538-7445.am2022-346","title":"Abstract 346: Synergistic antiproliferative activity of novel RAD51 inhibitor JKYN-1 and its mesylate salt with standard-of-care cancer drugs","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ontario Institute for Cancer Research; London Health Sciences Centre","funders":"","keywords":"Cancer cell; Cancer; Cytotoxicity; Cancer research; Chemistry; Pharmacology; RAD51; Cell growth; Biology; In vitro; DNA repair; DNA; Biochemistry; Genetics","score_opus":0.04368471514293023,"score_gpt":0.37295483117059836,"score_spread":0.32927011602766815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884578,0.0090945,0.00013180466,0.00019430243,0.00014504872,0.0004567823,0.001317467,0.000004952645,0.00019735034],"genre_scores_gemma":[0.9971083,0.0020786915,0.00004739488,0.00003559659,0.00014458492,0.0002960643,0.000024986817,0.000037014128,0.00022739061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983972,0.000080769714,0.00017142635,0.00041480907,0.000596177,0.00033965433],"domain_scores_gemma":[0.9989574,0.00003271088,0.00012509318,0.0002569698,0.00052815164,0.00009968666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038525197,0.00015146329,0.00027381966,0.000095898125,0.0002152847,0.000017534256,0.00020100316,0.00006909722,0.0001169918],"category_scores_gemma":[0.000019117046,0.00013563871,0.000052015894,0.00024282621,0.00016997584,0.000007136432,0.00027099703,0.0003152893,1.7571477e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032266623,0.00007468165,0.000116014075,0.00027961758,0.000147124,0.0000030158205,0.0009348737,0.00041887784,0.9879029,0.0003366823,0.00008537094,0.006474214],"study_design_scores_gemma":[0.0015241953,0.0013467083,0.00026552184,0.0000912569,0.000023545426,0.0000019764689,0.000751261,0.000055472745,0.98852724,0.000026659127,0.0072211972,0.00016498762],"about_ca_topic_score_codex":0.0004812389,"about_ca_topic_score_gemma":0.0003041607,"teacher_disagreement_score":0.0086504845,"about_ca_system_score_codex":0.00019030915,"about_ca_system_score_gemma":0.0010232361,"threshold_uncertainty_score":0.5531186},"labels":[],"label_agreement":null},{"id":"W4282979246","doi":"10.1158/1538-7445.am2022-5135","title":"Abstract 5135: Antitumor activity of dostarlimab by PD-L1 and tumor mutation burden (TMB) in patients (pts) with mismatch repair deficient and proficient (dMMR and MMRp) tumors in the GARNET trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; Kelowna General Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Discontinuation; Cancer; Regimen; Cohort; DNA mismatch repair; Colorectal cancer","score_opus":0.040545499747145705,"score_gpt":0.35342969108194366,"score_spread":0.31288419133479795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496514,0.001515355,3.1922255e-7,0.0007181528,0.000041469233,0.0024337666,0.00010959636,0.000009496138,0.00020672631],"genre_scores_gemma":[0.999033,0.0001286154,0.000012722497,0.000053517502,0.0000320972,0.00063269597,0.000029893461,0.00001544289,0.000062019986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975275,0.00029475818,0.00028796872,0.0004466612,0.0010717411,0.000371402],"domain_scores_gemma":[0.9991791,0.00029233054,0.0001038074,0.00020171997,0.00011507214,0.00010793601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013285988,0.00014296678,0.00034892102,0.00030433174,0.00016170267,0.000029958443,0.00009518938,0.000030401303,0.00007774907],"category_scores_gemma":[0.00015617578,0.00009486758,0.000029164034,0.00091610255,0.0002260543,0.00007789075,0.00013035674,0.00048918196,4.6420968e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3073694,0.00721161,0.61853117,0.0022007574,0.00020636948,0.000927744,0.014419443,0.00020408572,0.009075309,0.000086394764,0.0014008522,0.038366813],"study_design_scores_gemma":[0.095936336,0.009391791,0.8851002,0.00028366834,0.000057856007,0.000036113037,0.0047613736,0.00020044472,0.0032209605,0.000059168637,0.00072793115,0.0002241956],"about_ca_topic_score_codex":0.0071412064,"about_ca_topic_score_gemma":0.0003244513,"teacher_disagreement_score":0.26656896,"about_ca_system_score_codex":0.00038148835,"about_ca_system_score_gemma":0.00024684673,"threshold_uncertainty_score":0.99947035},"labels":[],"label_agreement":null},{"id":"W4282979332","doi":"10.1158/1538-7445.am2022-5609","title":"Abstract 5609: Investigating the undifferentiated pleomorphic sarcoma microenvironment through cytokine profiles of primary tumor and immune infiltrates","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Sarcoma; Tumor microenvironment; Medicine; Immunotherapy; Cancer research; Metastasis; Primary tumor; Tumor-infiltrating lymphocytes; Pathology; Biology; Immunology; Immune system; Cancer; Internal medicine","score_opus":0.08738755263842835,"score_gpt":0.3458595544076957,"score_spread":0.2584720017692674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783994,0.016344344,3.560362e-7,0.0038095284,0.00004122261,0.0009674304,0.00013463496,0.000016381404,0.00028673324],"genre_scores_gemma":[0.997434,0.0009906433,0.00010045806,0.00027062077,0.00005348937,0.0009388111,0.00009390292,0.000029807148,0.00008821916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980537,0.00020478436,0.00032713305,0.00030397438,0.0007350728,0.00037532195],"domain_scores_gemma":[0.9990182,0.00033836192,0.000120641496,0.00037120457,0.00006430519,0.00008728714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669749,0.00014800599,0.0003228286,0.00009246166,0.00043917645,0.00002642074,0.00017790444,0.000025153426,0.0008960274],"category_scores_gemma":[0.000058236674,0.00010013422,0.00006538059,0.00032896813,0.00053909415,0.00004797034,0.000375569,0.00055783597,0.000005232401],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002406676,0.000657883,0.41947147,0.0003895167,0.00028578154,0.00011744057,0.0012008834,0.00003283289,0.5734382,0.0002429539,0.0012821208,0.002640235],"study_design_scores_gemma":[0.0014886031,0.000329866,0.8171314,0.00018704169,0.000055210643,0.00006146604,0.00091621256,0.000018317442,0.17824157,0.00026909792,0.0012140053,0.00008722371],"about_ca_topic_score_codex":0.0018993021,"about_ca_topic_score_gemma":0.00002190913,"teacher_disagreement_score":0.39765993,"about_ca_system_score_codex":0.00037525856,"about_ca_system_score_gemma":0.00026972152,"threshold_uncertainty_score":0.9810872},"labels":[],"label_agreement":null},{"id":"W4282979343","doi":"10.1158/1538-7445.am2022-3364","title":"Abstract 3364: Diagnosing Li-Fraumeni syndrome from the somatic genome","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Loss of heterozygosity; Germline; Germline mutation; Exact test; Chromothripsis; Li–Fraumeni syndrome; Cancer; Somatic cell; Genetics; Oncology; Medicine; Genetic testing; Cancer research; Biology; Internal medicine; Allele; Mutation; Gene; Genome instability","score_opus":0.08697631907017275,"score_gpt":0.38227023021066486,"score_spread":0.2952939111404921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97405106,0.014775875,0.000022308712,0.007845646,0.0004208779,0.0010753412,0.00018316801,0.00007757216,0.0015481494],"genre_scores_gemma":[0.99628955,0.0005754317,0.00003843552,0.0006782326,0.00033629138,0.0011927227,0.00006504691,0.00007803404,0.00074623036],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967122,0.00026430475,0.0002931681,0.0004773181,0.0015566685,0.00069635635],"domain_scores_gemma":[0.99813974,0.00056026113,0.00006818286,0.0008748436,0.00013654251,0.0002204246],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011068241,0.00016109523,0.0002844823,0.00017746357,0.0007726533,0.00007498234,0.0005096721,0.00007158043,0.008605622],"category_scores_gemma":[0.00023335249,0.00013131309,0.00013243088,0.0008242361,0.0002031686,0.00006350959,0.0004914052,0.0017977406,0.00027333692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072091864,0.00065960834,0.006068342,0.0003762611,0.00095296756,0.0056381417,0.0070296335,0.0029113188,0.9091377,0.00022352488,0.04521198,0.02106958],"study_design_scores_gemma":[0.009342497,0.0019401561,0.44083112,0.0015101113,0.00043038625,0.001111019,0.0074743517,0.0010540526,0.036115594,0.0034220202,0.4954817,0.0012869779],"about_ca_topic_score_codex":0.003085828,"about_ca_topic_score_gemma":0.00013340595,"teacher_disagreement_score":0.87302214,"about_ca_system_score_codex":0.0015169341,"about_ca_system_score_gemma":0.00095007516,"threshold_uncertainty_score":0.9923006},"labels":[],"label_agreement":null},{"id":"W4282979998","doi":"10.1158/1538-7445.am2022-2273","title":"Abstract 2273: Unsupervised clustering of multi-omics molecular layers reveals consensus molecular subtypes showing potential therapeutic opportunities for pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omics; Pancreatic cancer; Computational biology; Biology; Transcriptome; Metabolomics; Cancer; Proteome; Bioinformatics; Precision medicine; Molecular medicine; Gene; Genetics; Gene expression; Cell cycle","score_opus":0.12035664266017425,"score_gpt":0.3683587835653453,"score_spread":0.24800214090517103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97737956,0.017454896,0.002150933,0.00067042594,0.00032002767,0.0008608749,0.0010450351,0.000011410537,0.000106823805],"genre_scores_gemma":[0.99474895,0.002641609,0.0005621714,0.00049099314,0.00014028014,0.00090722454,0.00013252818,0.00008665248,0.00028960625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979433,0.00016264671,0.0003760794,0.00049365195,0.00042355058,0.00060081854],"domain_scores_gemma":[0.9987916,0.0000908895,0.00012348947,0.00046851905,0.00039761074,0.00012793785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007626876,0.00021333879,0.00030957547,0.00015419653,0.00030544758,0.000048972328,0.00043696896,0.000109146786,0.00015332365],"category_scores_gemma":[0.00010729704,0.00024192325,0.00019722548,0.00016856364,0.00021147323,0.0000041841377,0.0003814697,0.00026887035,5.5256515e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005663187,0.000073385396,0.00036089684,0.0002325846,0.00026747494,0.000046267516,0.00011686892,0.040929183,0.94986314,0.00011901065,0.00071673933,0.0067081433],"study_design_scores_gemma":[0.0043290854,0.00086344103,0.0013001004,0.00013832355,0.00022635878,0.000023447685,0.0043973117,0.009611292,0.95911455,0.00041519536,0.018691622,0.00088929775],"about_ca_topic_score_codex":0.0007694835,"about_ca_topic_score_gemma":0.00015788309,"teacher_disagreement_score":0.03131789,"about_ca_system_score_codex":0.00019915347,"about_ca_system_score_gemma":0.0007731468,"threshold_uncertainty_score":0.98653436},"labels":[],"label_agreement":null},{"id":"W4282980092","doi":"10.1158/1538-7445.am2022-6354","title":"Abstract 6354: Using imaging mass cytometry to visualize the multiple myeloma tumor microenvironment post immune priming","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Bone marrow; Immune system; Bortezomib; Multiple myeloma; Mass cytometry; Medicine; Tumor microenvironment; Pathology; Cancer research; Antibody; Cancer; Biology; Immunology; Internal medicine; Phenotype","score_opus":0.08591920822418289,"score_gpt":0.42007541671015014,"score_spread":0.3341562084859673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282980092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867535,0.003515297,0.00025011995,0.007885109,0.00012638909,0.00093532854,0.000056004512,0.000029424373,0.00044878258],"genre_scores_gemma":[0.99690473,0.00010368563,0.0004707664,0.0019283533,0.00009754451,0.0002880396,0.000015163406,0.0000402671,0.00015146902],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99753946,0.00015164075,0.00029313922,0.00037320628,0.0009360216,0.0007065567],"domain_scores_gemma":[0.9985763,0.00063481,0.000051656436,0.00040595594,0.00010738506,0.0002239246],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010276212,0.00014087441,0.00025597433,0.00021322677,0.0007726333,0.000059878734,0.00031453336,0.000024674833,0.002525767],"category_scores_gemma":[0.0009466562,0.000104420316,0.00009297351,0.0006063539,0.00017113099,0.00004236712,0.00057462725,0.0007582283,0.00006878995],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004656772,0.00028105514,0.04565828,0.00014780783,0.00003928098,0.0005435339,0.00061896484,0.0003862147,0.94452685,0.000053285534,0.0023481688,0.004930869],"study_design_scores_gemma":[0.004601613,0.00095906766,0.6758161,0.00068192306,0.0001113226,0.00034382974,0.027775796,0.0040604654,0.18058454,0.0002703067,0.10394928,0.0008457196],"about_ca_topic_score_codex":0.001007251,"about_ca_topic_score_gemma":0.000010957955,"teacher_disagreement_score":0.7639423,"about_ca_system_score_codex":0.0006625802,"about_ca_system_score_gemma":0.00023678139,"threshold_uncertainty_score":0.9983861},"labels":[],"label_agreement":null},{"id":"W4282980164","doi":"10.1158/1538-7445.am2022-5730","title":"Abstract 5730: FOXR2 is an oncogenic driver across adult and pediatric cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Carcinogenesis; Epigenetics; Biology; Oncogene; Cancer; Pediatric cancer; Cancer research; Transcription factor; Transcriptome; Neuroblastoma; Genetics; Gene expression; Gene; Cell cycle; Cell culture","score_opus":0.08584361719967742,"score_gpt":0.45560157317778716,"score_spread":0.36975795597810973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282980164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995287,0.0016025947,3.100221e-7,0.0012551593,0.000118380616,0.0006907798,0.0003208949,0.000042434323,0.00068245264],"genre_scores_gemma":[0.9926767,0.0024860336,0.000019317098,0.0004530628,0.00035164095,0.00064672047,0.00002604504,0.000049319227,0.003291187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652684,0.00015108862,0.00018191045,0.0006174576,0.0015103361,0.0010123636],"domain_scores_gemma":[0.99836314,0.000112116795,0.000038352544,0.00045260118,0.0003576048,0.0006762065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000510959,0.00015732125,0.0002291698,0.00024585627,0.0008333597,0.00007041078,0.00024637717,0.000050878047,0.0030119934],"category_scores_gemma":[0.000076279226,0.00014345192,0.00007308663,0.0007820207,0.00023121854,0.00015269588,0.00039755067,0.0010466347,0.000083758765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009640344,0.0021211838,0.5914677,0.0012475319,0.00082411204,0.006899165,0.011775537,0.00014462505,0.11353642,0.00011827076,0.12328486,0.1389403],"study_design_scores_gemma":[0.01838785,0.0084959,0.86922014,0.00009761702,0.00014752701,0.00034804968,0.0052424506,0.00036677014,0.038449977,0.0003608106,0.058063727,0.0008191716],"about_ca_topic_score_codex":0.0049176067,"about_ca_topic_score_gemma":0.00045662338,"teacher_disagreement_score":0.2777525,"about_ca_system_score_codex":0.0011474903,"about_ca_system_score_gemma":0.0013445034,"threshold_uncertainty_score":0.9978994},"labels":[],"label_agreement":null},{"id":"W4282980393","doi":"10.1158/1538-7445.am2022-1741","title":"Abstract 1741: Cancer cell-derived extracellular vesicle mimicking: A parametric study of the physicochemical characteristics of EVs and their influence on cellular uptake in metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Concordia University; École de Technologie Supérieure; McGill University Health Centre","funders":"","keywords":"Zeta potential; Liposome; Microvesicles; Biophysics; Chemistry; Cancer cell; Vesicle; Nanoparticle tracking analysis; Lipid bilayer; Tumor microenvironment; Internalization; Cell; Cell biology; Cancer; Biochemistry; Nanotechnology; Biology; Membrane; Nanoparticle; Materials science","score_opus":0.03929037992520492,"score_gpt":0.3305831615266498,"score_spread":0.2912927816014449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282980393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913402,0.0075201513,0.0000036016186,0.000049938226,0.0000655073,0.0007720904,0.0002060035,0.000004251984,0.000038217655],"genre_scores_gemma":[0.9989346,0.0004888952,0.000013073262,0.000027126636,0.000048153684,0.0003776368,0.000016280163,0.000038602582,0.000055577588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975538,0.0004121892,0.00046070092,0.00054442877,0.00062190875,0.00040692755],"domain_scores_gemma":[0.9985648,0.00011293647,0.00023675374,0.00078403257,0.00019825035,0.000103234386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008395728,0.00020274922,0.00031004113,0.000121518904,0.00016736092,0.000019771664,0.00071574544,0.00007514492,0.0000827236],"category_scores_gemma":[0.00017543198,0.00016940331,0.000104123734,0.00069665787,0.00030573332,0.000009532212,0.0006618929,0.00052552513,5.6415166e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038498378,0.0012700681,0.013755543,0.0001290729,0.00006843927,0.00001000554,0.00067545334,0.0009676294,0.97978646,0.000009983425,0.000052456417,0.0028899298],"study_design_scores_gemma":[0.0009241791,0.00036907327,0.055488307,0.0000411381,0.000023407705,7.5736756e-7,0.002393899,0.000110476954,0.94005567,0.00002697158,0.0004049221,0.00016119226],"about_ca_topic_score_codex":0.00095690053,"about_ca_topic_score_gemma":0.00007217389,"teacher_disagreement_score":0.041732766,"about_ca_system_score_codex":0.00015544724,"about_ca_system_score_gemma":0.0003027936,"threshold_uncertainty_score":0.6908066},"labels":[],"label_agreement":null},{"id":"W4282980569","doi":"10.1158/1538-7445.am2022-5660","title":"Abstract 5660: Anti-proliferation effect of polo-like kinase-4 inhibitor in ovarian cancer via AKT/mTOR/p70S6K pathway","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Cell growth; Cell cycle; RPTOR; Kinase; Ovarian cancer; Biology; Chemistry; Cancer; Cell biology; Signal transduction; Biochemistry","score_opus":0.019117773932274977,"score_gpt":0.3333608811595094,"score_spread":0.3142431072272344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282980569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564254,0.0026229399,0.00003476972,0.00022111628,0.0003956713,0.0006136126,0.00020062778,0.000006701077,0.00026203078],"genre_scores_gemma":[0.9975511,0.0005602518,0.000015151612,0.000092947324,0.00037472378,0.00074274983,0.00017108038,0.000037872745,0.00045412063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979826,0.00035176598,0.00028765894,0.0004707696,0.00042626847,0.00048093786],"domain_scores_gemma":[0.9992626,0.00003652252,0.00008037356,0.00039276385,0.00013725892,0.000090485046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010723397,0.0001622908,0.0002355575,0.00018854883,0.0001941807,0.000024145485,0.00032392333,0.00014354766,0.00041593696],"category_scores_gemma":[0.00005091714,0.0001600146,0.00009057452,0.0003658067,0.00011036326,0.000007955327,0.00031435996,0.00047971096,0.0000048285633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040728642,0.00008766256,0.01646249,0.00012755957,0.000036654958,0.000013329665,0.000100360325,0.0005954183,0.97510356,0.000018924258,0.002402157,0.0046446286],"study_design_scores_gemma":[0.0010920462,0.00054898416,0.0073230034,0.000040469382,0.00000689612,0.0000038158987,0.00005641013,0.00009285637,0.97537184,0.000012772501,0.015271876,0.00017906082],"about_ca_topic_score_codex":0.0027234706,"about_ca_topic_score_gemma":0.0012484143,"teacher_disagreement_score":0.012869719,"about_ca_system_score_codex":0.00022172915,"about_ca_system_score_gemma":0.00055804197,"threshold_uncertainty_score":0.6525206},"labels":[],"label_agreement":null},{"id":"W4282980664","doi":"10.1158/1538-7445.am2022-670","title":"Abstract 670: Distinct biochemical properties of KRAS Q61H mutant render cancer cells resistant to SHP2 inhibitors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"KRAS; Phosphorylation; Cancer research; GTPase; Biology; Mutant; Kinase; MAPK/ERK pathway; Signal transduction; HEK 293 cells; Mutation; Cell biology; Chemistry; Biochemistry; Receptor; Gene","score_opus":0.054093307055357386,"score_gpt":0.3475781959780369,"score_spread":0.29348488892267954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282980664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966141,0.031025715,0.000005531405,0.00082004606,0.00022009817,0.0006424411,0.00096385524,0.000013726786,0.00016758917],"genre_scores_gemma":[0.99716693,0.00040644707,0.000046995974,0.000106050415,0.00031367334,0.0012739721,0.00006685795,0.000049455564,0.0005695911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974621,0.00014376076,0.00034316708,0.0006278814,0.000824824,0.00059830234],"domain_scores_gemma":[0.9988008,0.000021904678,0.000086385066,0.0005952934,0.00029437957,0.00020120305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006692276,0.00018617386,0.00021646528,0.000117423784,0.0002614939,0.00003126243,0.0006034896,0.00008413355,0.0005078286],"category_scores_gemma":[0.00020565599,0.00016795748,0.00008977905,0.00044493872,0.00029505644,0.000005452261,0.0010275298,0.00038873896,0.0000085901875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010510397,0.00010186236,0.00015908167,0.00013191732,0.000056085722,0.0000125475535,0.00010297375,0.00012574522,0.95896596,0.00002880465,0.03805587,0.0012081348],"study_design_scores_gemma":[0.00031369342,0.00028266874,0.00081894745,0.00008394153,0.000008937941,0.0000018004522,0.00017383178,0.0000026140112,0.95359176,0.00002430955,0.044487093,0.00021040658],"about_ca_topic_score_codex":0.003955776,"about_ca_topic_score_gemma":0.00038660032,"teacher_disagreement_score":0.03102596,"about_ca_system_score_codex":0.00026542795,"about_ca_system_score_gemma":0.00081641495,"threshold_uncertainty_score":0.6849107},"labels":[],"label_agreement":null},{"id":"W4282981095","doi":"10.1158/1538-7445.am2022-5489","title":"Abstract 5489: Utilization of cancer cell line screening and bioinformatic analyses to identify optimal developmental pathways for the novel anticancer agent BOLD-100","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Cancer; Bladder cancer; Pancreatic cancer; Medicine; Cancer research; Cell cycle; Cancer cell; Oncology; Bioinformatics; Biology; Internal medicine","score_opus":0.4294867054162781,"score_gpt":0.5325836394453554,"score_spread":0.10309693402907727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282981095","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41119185,0.002043829,0.5849467,0.0006365188,0.00019775455,0.0007170761,0.0001542091,0.000019648794,0.000092413975],"genre_scores_gemma":[0.9322378,0.00025172322,0.066408254,0.00019276282,0.00006619886,0.00075907283,0.000011407264,0.000015471134,0.000057323065],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99767953,0.00010611249,0.00038567977,0.00036069256,0.0010749752,0.00039299528],"domain_scores_gemma":[0.9982573,0.0008965308,0.0001260634,0.00025894964,0.00034928598,0.000111863206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020252557,0.0001278021,0.00018349443,0.00024402658,0.0006181253,0.00018458188,0.0008782128,0.000022991502,0.00015137947],"category_scores_gemma":[0.00010772773,0.0001063005,0.000065897206,0.0011135913,0.00007864432,0.000429186,0.0011414415,0.00021411765,0.0000015263386],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012979691,0.00012667023,0.00032415334,0.00022854141,0.0001125314,0.0000022079785,0.004295631,0.7426439,0.11335683,0.0015336721,0.00091268827,0.13633338],"study_design_scores_gemma":[0.0009172605,0.00019248266,0.046391748,0.000103492144,0.000026209675,0.000004342286,0.002461311,0.8446225,0.10069139,0.00025558023,0.004043609,0.00029010704],"about_ca_topic_score_codex":0.0015891087,"about_ca_topic_score_gemma":0.00015931403,"teacher_disagreement_score":0.5210459,"about_ca_system_score_codex":0.00042039587,"about_ca_system_score_gemma":0.0008477245,"threshold_uncertainty_score":0.47541827},"labels":[],"label_agreement":null},{"id":"W4282981142","doi":"10.1158/1538-7445.am2022-6400","title":"Abstract 6400: JBrowse 2: An extensible open-source platform for modern genome analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Phylogenetic Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Plug-in; Computer science; Genome; Contig; Reference genome; World Wide Web; Sequence assembly; Synteny; Visualization; Computational biology; Open source; Data science; Data mining; Biology; Software; Programming language; Genetics","score_opus":0.11018016239510384,"score_gpt":0.40069718051991476,"score_spread":0.2905170181248109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282981142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385744,0.0035024516,0.0003995464,0.00018095678,0.00006843879,0.0005940415,0.0005605616,0.0000029354858,0.0008336374],"genre_scores_gemma":[0.99497956,0.00047752835,0.00030400496,0.00015878754,0.00022695659,0.0010252662,0.00025423098,0.00003797065,0.0025356829],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841833,0.000055519704,0.00017934197,0.00056884775,0.00028064323,0.00049732346],"domain_scores_gemma":[0.99897015,0.000030813,0.000051280906,0.00056945573,0.00024644673,0.00013186179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009322373,0.00012512639,0.0002067855,0.00014904627,0.0007574473,0.000094272866,0.0008040612,0.000054816475,0.0002819695],"category_scores_gemma":[0.000030713938,0.00012781778,0.00012488631,0.00036829282,0.0000867568,0.0000018759085,0.0010717579,0.00017984366,0.0000021906278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003718572,0.000101273436,0.0011222697,0.000017562594,0.0005701205,0.0000023140158,0.00033906227,0.020422427,0.9688725,0.00006731066,0.0011639965,0.006949309],"study_design_scores_gemma":[0.0025187803,0.0019537215,0.036573716,0.0000058040678,0.00025525835,0.00000814289,0.003013649,0.0032653932,0.076498404,0.0025195621,0.8724939,0.00089361594],"about_ca_topic_score_codex":0.00072908343,"about_ca_topic_score_gemma":0.00068130577,"teacher_disagreement_score":0.8923741,"about_ca_system_score_codex":0.0000846796,"about_ca_system_score_gemma":0.00025151606,"threshold_uncertainty_score":0.5825749},"labels":[],"label_agreement":null},{"id":"W4282981679","doi":"10.1158/1538-7445.am2022-ct185","title":"Abstract CT185: A phase I dose escalation study of a tegavivint (BC2059) a first-in-class TBL1 inhibitor for patients with progressive, unresectable desmoid tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Familial adenomatous polyposis; Internal medicine; Cmin; Gastroenterology; Nuclear medicine; Cancer; Surgery; Pharmacokinetics; Cmax; Colorectal cancer","score_opus":0.06401263804924762,"score_gpt":0.413709845570424,"score_spread":0.3496972075211764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282981679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915962,0.00065496453,0.0000015604254,0.00031608978,0.00009054022,0.0070130844,0.00013285817,0.000037853748,0.00015682103],"genre_scores_gemma":[0.9898801,0.000009498836,0.00006884207,0.000014758228,0.00011920637,0.009552021,0.000046273995,0.00006193071,0.00024739816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965429,0.00014874547,0.00047340512,0.00056211266,0.0015878415,0.0006850314],"domain_scores_gemma":[0.9979432,0.00046807743,0.0001730982,0.00041987034,0.000830238,0.00016551522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009643091,0.0002051503,0.0005122174,0.0005485642,0.0004460987,0.00002414336,0.00019220404,0.000034544744,0.00035771294],"category_scores_gemma":[0.00057869457,0.00017044896,0.00006084694,0.0014221062,0.00020879028,0.000120240366,0.00027012828,0.00063543743,0.0000031339778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033662103,0.02386981,0.9090696,0.0015525462,0.00040752557,0.0008841097,0.014623927,0.00044815298,0.0030770288,0.000022911216,0.004098852,0.008283443],"study_design_scores_gemma":[0.0809239,0.046886183,0.8321412,0.0014015574,0.00017500359,0.000025248546,0.028380591,0.00052378344,0.0053992374,0.00008007243,0.003483149,0.00058003695],"about_ca_topic_score_codex":0.0012038841,"about_ca_topic_score_gemma":0.0011596573,"teacher_disagreement_score":0.076928355,"about_ca_system_score_codex":0.0010029674,"about_ca_system_score_gemma":0.0005829645,"threshold_uncertainty_score":0.6950706},"labels":[],"label_agreement":null},{"id":"W4282981780","doi":"10.1158/1538-7445.am2022-1000","title":"Abstract 1000: E-cadherin and EGFR interactions result in hyper-proliferation via ERK signaling in breast cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Cadherin; Cancer research; MAPK/ERK pathway; Metastasis; Cancer; Epithelial–mesenchymal transition; Tumor progression; PI3K/AKT/mTOR pathway; Medicine; Internal medicine; Signal transduction; Biology; Cell biology; Cell; Genetics","score_opus":0.036328558056758734,"score_gpt":0.3735306482854009,"score_spread":0.33720209022864217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282981780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937575,0.0025778026,0.00011871996,0.0020715233,0.00019743557,0.00059848774,0.00014160399,0.000010390021,0.0005265374],"genre_scores_gemma":[0.99607706,0.0012810591,0.00003602388,0.00015209282,0.00023362284,0.0014510857,0.00007351967,0.000047018308,0.0006485302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974669,0.0003634243,0.00030739847,0.00063860265,0.0006109314,0.00061274186],"domain_scores_gemma":[0.9992474,0.000044302476,0.00005008305,0.00032504118,0.0002001215,0.00013309262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012168401,0.00015291949,0.00016630537,0.00042981777,0.0002729958,0.00006774032,0.00029668727,0.00011589361,0.0011012452],"category_scores_gemma":[0.00005343559,0.00017597167,0.00004620156,0.00073572557,0.00010539502,0.000017048467,0.0004660492,0.0011994725,0.0000073910396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007249922,0.000087797525,0.0013722199,0.000038226135,0.00002555356,0.0000309377,0.00024923615,0.008749337,0.977454,0.000029675939,0.001069294,0.010168705],"study_design_scores_gemma":[0.003661482,0.0003898877,0.018734057,0.00022227858,0.00001111747,0.00012311549,0.0017572875,0.0025674817,0.9358501,0.00028799864,0.035723742,0.0006714402],"about_ca_topic_score_codex":0.0055780015,"about_ca_topic_score_gemma":0.007153663,"teacher_disagreement_score":0.04160391,"about_ca_system_score_codex":0.0007576178,"about_ca_system_score_gemma":0.00065549964,"threshold_uncertainty_score":0.9998119},"labels":[],"label_agreement":null},{"id":"W4282982404","doi":"10.1158/1538-7445.am2022-4011","title":"Abstract 4011: Prognostic value of transcriptomic analysis in residual post neo-adjuvant triple negative breast cancer tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IGNIS Innovation (Canada); Jewish General Hospital","funders":"","keywords":"Breast cancer; Capecitabine; Cancer research; Oncology; Thymidylate synthase; Cancer; Medicine; Transcriptome; Triple-negative breast cancer; Downregulation and upregulation; Internal medicine; Population; Biology; Gene expression; Gene; Fluorouracil; Colorectal cancer; Genetics","score_opus":0.050107068262035155,"score_gpt":0.37704952933315095,"score_spread":0.3269424610711158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282982404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693454,0.0036268283,0.0000022628208,0.005916858,0.00015563381,0.0013931837,0.0014557459,0.000030604937,0.0004843641],"genre_scores_gemma":[0.9958443,0.0007991692,0.000029137493,0.00023769145,0.00016865671,0.0023442672,0.00007296584,0.00005658596,0.0004472096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955093,0.00043757368,0.0006990625,0.0007254422,0.0017579745,0.0008706365],"domain_scores_gemma":[0.9982244,0.00023390923,0.00015998216,0.00048235277,0.0006306519,0.00026872015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015465068,0.00024870035,0.0008772045,0.0013868554,0.0002690662,0.000032446143,0.00043378343,0.000082838116,0.0076879137],"category_scores_gemma":[0.00012736005,0.0002279934,0.00030888506,0.00458841,0.0003410188,0.00012760154,0.00016363108,0.0012908954,0.0000070714555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00889843,0.001749,0.8419215,0.0009915131,0.002153808,0.00029720075,0.0077314232,0.0064954557,0.10247531,0.0002104816,0.0053329607,0.021742886],"study_design_scores_gemma":[0.0029341783,0.00059143145,0.9761161,0.00031817146,0.00047758312,0.000014318365,0.0039004476,0.00054489996,0.014470174,0.000054969634,0.00033354707,0.00024413592],"about_ca_topic_score_codex":0.050994795,"about_ca_topic_score_gemma":0.0058351047,"teacher_disagreement_score":0.13419461,"about_ca_system_score_codex":0.0014360726,"about_ca_system_score_gemma":0.0022768406,"threshold_uncertainty_score":0.9932192},"labels":[],"label_agreement":null},{"id":"W4282982459","doi":"10.1158/1538-7445.am2022-lb501","title":"Abstract LB501: Making discoveries with Kids First Variant DataBase and WorkBench","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Python (programming language); Ensembl; Computer science; Scripting language; World Wide Web; UniProt; Genomics; Biology; Genome; Genetics; Gene; Programming language","score_opus":0.041306236217392,"score_gpt":0.3559578348749911,"score_spread":0.3146515986575991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282982459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887484,0.008080759,0.00012276992,0.0006777005,0.00009032978,0.0002510791,0.0005071895,0.000007894861,0.0015138759],"genre_scores_gemma":[0.99675137,0.0015453951,0.00015265436,0.00013483438,0.00027662126,0.0002790015,0.00020468343,0.000022259106,0.00063320296],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987766,0.00006651212,0.00009815738,0.0003882752,0.0003454865,0.00032497785],"domain_scores_gemma":[0.99939626,0.000020638803,0.000025903704,0.00034881302,0.00008629523,0.00012208086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030281264,0.000096529715,0.00008091422,0.000059184087,0.00063002075,0.00007277797,0.00019173117,0.000030411571,0.00045098038],"category_scores_gemma":[0.000039760405,0.00008967415,0.000023276023,0.00015248447,0.00025974485,0.0000068796035,0.00039431683,0.00018604002,0.0000017054773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008625716,0.0012320544,0.102411985,0.0014033185,0.0004230292,0.0008999641,0.0013891774,0.0018581876,0.7322806,0.0023601302,0.13704039,0.01007545],"study_design_scores_gemma":[0.0045968485,0.0017218593,0.058904167,0.0002932865,0.0000647762,0.00015820666,0.004121099,0.00006664035,0.06894184,0.0011699535,0.85884374,0.0011175789],"about_ca_topic_score_codex":0.00018002692,"about_ca_topic_score_gemma":0.00030413104,"teacher_disagreement_score":0.72180337,"about_ca_system_score_codex":0.000042221654,"about_ca_system_score_gemma":0.0002973335,"threshold_uncertainty_score":0.4937919},"labels":[],"label_agreement":null},{"id":"W4282982544","doi":"10.1158/1538-7445.am2022-844","title":"Abstract 844: Germline <i>TP53</i> missense mutations at codon338 confer adult-onset cancer risk through weakened p53 protein oligomeric stability that impairs its tumor suppressive mechanisms","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Missense mutation; Germline; Biology; Cancer; Cancer research; Phenotype; Germline mutation; Genetics; Mutation; Gene","score_opus":0.07165280722441374,"score_gpt":0.3690018492073797,"score_spread":0.29734904198296597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282982544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761499,0.004734967,0.00014200727,0.004812899,0.0005888972,0.005641522,0.006698415,0.0002386244,0.0009927659],"genre_scores_gemma":[0.9863179,0.0010710419,0.00026396767,0.00064766774,0.00020910548,0.009261378,0.00041605672,0.0002142224,0.0015986862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99231046,0.0010480814,0.00077355857,0.0014701671,0.0027575982,0.0016401226],"domain_scores_gemma":[0.9955204,0.0003629305,0.0004314733,0.0013865116,0.001621462,0.00067722413],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015080353,0.0005597005,0.0008584551,0.0003621395,0.0014542659,0.000086066844,0.0005705853,0.00020621497,0.019498749],"category_scores_gemma":[0.000715082,0.0005497441,0.00037196802,0.0015583731,0.00056761823,0.00023310563,0.00071276154,0.0027258086,0.00017742907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005475587,0.0008743914,0.00096797233,0.0007641873,0.0005400987,0.0017024727,0.003899023,0.0018267338,0.9650424,0.00021193818,0.017271733,0.0014234748],"study_design_scores_gemma":[0.0072948206,0.0009172002,0.003428678,0.0005015632,0.00030550838,0.00041856148,0.0043030605,0.0010676591,0.96251243,0.0008430663,0.017564232,0.0008431938],"about_ca_topic_score_codex":0.012637774,"about_ca_topic_score_gemma":0.0032501414,"teacher_disagreement_score":0.019321319,"about_ca_system_score_codex":0.0043592225,"about_ca_system_score_gemma":0.0036844797,"threshold_uncertainty_score":0.9998457},"labels":[],"label_agreement":null},{"id":"W4282982979","doi":"10.1158/1538-7445.am2022-3999","title":"Abstract 3999: HLA-G, SPAG9 and STAT3 signalling: An alliance that promotes early-stage brain metastases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Brain metastasis; Metastatic breast cancer; Breast cancer; Melanoma; Oncology; Metastasis; Cancer; Internal medicine; Cancer research","score_opus":0.14670426917480858,"score_gpt":0.39630043057551606,"score_spread":0.24959616140070748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282982979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384401,0.05778732,0.000018431243,0.0013119221,0.00036571905,0.00084393955,0.0004934397,0.00006071996,0.0006784398],"genre_scores_gemma":[0.9835433,0.00040775913,0.000028555349,0.00007237539,0.00008250134,0.0005494508,0.00009659811,0.000036226833,0.015183257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663794,0.0013755456,0.00023379957,0.0008188922,0.00022059961,0.00071324833],"domain_scores_gemma":[0.99878126,0.00035416763,0.00009863182,0.00053282303,0.00016052299,0.00007260575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026700464,0.00018861814,0.00030024882,0.00014332372,0.0008800639,0.00007529066,0.00046176315,0.00008710281,0.0052515874],"category_scores_gemma":[0.00013035291,0.00017053196,0.00005671315,0.0002899483,0.00043027822,0.00025740117,0.000323309,0.000909038,0.00010160193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034379767,0.00022010243,0.024140311,0.00022317524,0.00026967275,0.000087810666,0.003283402,0.000055149165,0.95173025,0.0010160146,0.009221446,0.009408896],"study_design_scores_gemma":[0.0019066798,0.0015261648,0.090625845,0.00020112001,0.000028962599,0.00006847398,0.0037423817,0.0000027960616,0.5503166,0.0012840988,0.34962952,0.00066736364],"about_ca_topic_score_codex":0.0021832983,"about_ca_topic_score_gemma":0.00016801547,"teacher_disagreement_score":0.40141365,"about_ca_system_score_codex":0.00011306516,"about_ca_system_score_gemma":0.00025983274,"threshold_uncertainty_score":0.99565774},"labels":[],"label_agreement":null},{"id":"W4282983004","doi":"10.1158/1538-7445.am2022-ct006","title":"Abstract CT006: Phase Ib expansion trial of the safety and efficacy of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor elimusertib in advanced solid tumors with DNA damage response (DDR) defects","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Adverse effect; Prostate cancer; Cancer research","score_opus":0.019018951228582062,"score_gpt":0.34311112276982286,"score_spread":0.3240921715412408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793565,0.0005581065,0.0000013652049,0.00018452089,0.00009321456,0.0011223655,0.00007076069,0.0000056030162,0.000028406508],"genre_scores_gemma":[0.9995584,0.00008340261,0.000023355326,0.000017008957,0.000025655892,0.000089459536,0.000010897942,0.000026902106,0.0001649085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977774,0.0008104133,0.00029724633,0.00036487434,0.00045962224,0.00029043798],"domain_scores_gemma":[0.9990297,0.00015139546,0.00013857709,0.0005300489,0.00008533858,0.0000649688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015288412,0.00012974266,0.00021545046,0.00008568321,0.0001930096,0.000010388631,0.0003126508,0.00007768279,0.000024568782],"category_scores_gemma":[0.00048409903,0.000083444764,0.000060869002,0.00042198133,0.00030359233,0.000008065924,0.0005640915,0.00039236594,1.3325275e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09895125,0.00017790936,0.00045625743,0.000032735952,0.000025351988,0.000009662284,0.0002621263,0.00017287197,0.8985489,0.0000097137845,0.000075128526,0.0012780792],"study_design_scores_gemma":[0.03217458,0.002182599,0.020008992,0.00011896759,0.000013689697,0.000010122785,0.00040802275,0.000033765482,0.94431335,0.00003381371,0.00058250123,0.00011959379],"about_ca_topic_score_codex":0.000096189004,"about_ca_topic_score_gemma":0.00014503431,"teacher_disagreement_score":0.06677667,"about_ca_system_score_codex":0.00007412902,"about_ca_system_score_gemma":0.00047142775,"threshold_uncertainty_score":0.34027785},"labels":[],"label_agreement":null},{"id":"W4282983084","doi":"10.1158/1538-7445.am2022-1977","title":"Abstract 1977: Extending the capabilities of a high-parameter immunophenotyping assay with cytoplasmic staining applications for mass cytometry","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"","keywords":"Mass cytometry; Flow cytometry; Viability assay; Molecular biology; Staining; Biology; Peripheral blood mononuclear cell; Cell culture; Cytometry; Immune system; Cell; Chemistry; Immunology; In vitro; Biochemistry; Phenotype","score_opus":0.04343334469038135,"score_gpt":0.33521571089865076,"score_spread":0.2917823662082694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239636,0.001580154,0.014594592,0.00023328235,0.000077839424,0.0007399621,0.00018503619,0.000008314654,0.00018446773],"genre_scores_gemma":[0.99609214,0.00011066806,0.0011804375,0.000043859767,0.00013123681,0.0020064672,0.00006325234,0.00003132278,0.0003406065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987588,0.000119681,0.0001820026,0.00029335188,0.00030259753,0.00034358958],"domain_scores_gemma":[0.9990375,0.0002928828,0.000065111395,0.00037068527,0.00019614235,0.000037674417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011008603,0.00009779332,0.0001338308,0.000096316355,0.00054934144,0.00003564033,0.00038063803,0.000046053865,0.00006412565],"category_scores_gemma":[0.00007267067,0.000076186494,0.00006384028,0.00027415948,0.00023835381,0.0000048028473,0.00010076165,0.00029876948,5.8499927e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046851064,0.000046524405,0.0012514769,0.00011863202,0.00008760506,5.3871497e-7,0.00022327752,0.0014352143,0.99103755,0.0004972203,0.00015629173,0.0046771355],"study_design_scores_gemma":[0.0015888454,0.0010103674,0.002326453,0.00005998557,0.000040938627,0.000008363396,0.005582971,0.00033659465,0.93876725,0.0019046922,0.0479795,0.000394016],"about_ca_topic_score_codex":0.00048598,"about_ca_topic_score_gemma":0.00006128375,"teacher_disagreement_score":0.0522703,"about_ca_system_score_codex":0.00010905259,"about_ca_system_score_gemma":0.00028344648,"threshold_uncertainty_score":0.42251456},"labels":[],"label_agreement":null},{"id":"W4282983424","doi":"10.1158/1538-7445.am2022-455","title":"Abstract 455: Automating integration of histomorphologic and immunohistochemistry data using computer vision tools","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Convolutional neural network; Artificial intelligence; Pathology; Glioma; Computer science; Immunohistochemistry; Deep learning; Schwannoma; Scale-invariant feature transform; ATRX; Medicine; Feature extraction; Biology; Cancer research","score_opus":0.1586580104194773,"score_gpt":0.4852931253728527,"score_spread":0.3266351149533754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959784,0.0015159724,0.0009723739,0.00079715904,0.00012041582,0.0001785495,0.000028698605,0.000022031772,0.00038639604],"genre_scores_gemma":[0.9939122,0.00007419382,0.0055360016,0.00010342668,0.00012292786,0.000015009882,0.00012577054,0.00001415023,0.00009630043],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987093,0.0000921769,0.00021979063,0.00027378032,0.0005143803,0.00019052783],"domain_scores_gemma":[0.9991751,0.00017964313,0.000083924,0.00038680973,0.000103659215,0.00007091407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017650679,0.000065890345,0.00017830383,0.00010771706,0.00026590377,0.000029559684,0.0002419464,0.000031650055,0.00042275817],"category_scores_gemma":[0.00033320626,0.000058943675,0.000020888436,0.00019591533,0.00021251934,0.00009145407,0.00060288503,0.0008917623,7.90103e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007439892,0.00004547577,0.00055118394,0.00013295977,0.000015243518,0.0000463074,0.00019651122,0.00028649042,0.8623292,0.000014406105,0.0031675308,0.13314033],"study_design_scores_gemma":[0.002793142,0.00072937086,0.037577674,0.0012124132,0.0000733753,0.00064991176,0.0012057971,0.92393285,0.018104723,0.00017875593,0.013201133,0.00034084372],"about_ca_topic_score_codex":0.00062274473,"about_ca_topic_score_gemma":6.9505387e-7,"teacher_disagreement_score":0.9236464,"about_ca_system_score_codex":0.00035044548,"about_ca_system_score_gemma":0.00025294506,"threshold_uncertainty_score":0.46289054},"labels":[],"label_agreement":null},{"id":"W4282983643","doi":"10.1158/1538-7445.am2022-385","title":"Abstract 385: iRGD mediated delivery of neoantigens to enable immunotherapy in integrin b5-rich tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Cancer research; Pancreatic cancer; Immunotherapy; Tumor microenvironment; Integrin; Stromal cell; Stroma; Immune system; Immunosurveillance; Medicine; Immunology; Cancer; Immunohistochemistry; Internal medicine; Receptor","score_opus":0.07954352637616002,"score_gpt":0.40651290960471126,"score_spread":0.32696938322855124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867082,0.002682019,0.0000018696215,0.0020499555,0.00015238255,0.0015041849,0.00008184279,0.000037009282,0.006782502],"genre_scores_gemma":[0.9857648,0.0016058941,0.00005141644,0.00031951707,0.00015153213,0.0008701135,0.00003926793,0.00008530544,0.011112175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951208,0.00040858434,0.00053970085,0.0005526807,0.0022811454,0.0010970784],"domain_scores_gemma":[0.9977029,0.0005625139,0.00006459181,0.0007574751,0.0005984771,0.00031404803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036428063,0.00019295428,0.000531525,0.001471852,0.00019544884,0.000031028023,0.00066475937,0.00008716983,0.04320589],"category_scores_gemma":[0.00027957716,0.00018570447,0.000119990065,0.00316258,0.00021768735,0.00007960323,0.0004465276,0.0020000632,0.000120082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038119133,0.0003874441,0.019028896,0.00014245074,0.000100241785,0.0003273333,0.0023930287,0.00028909565,0.94617885,0.00003470248,0.007842785,0.01946325],"study_design_scores_gemma":[0.008249728,0.0028369387,0.14955911,0.00054728996,0.000012916037,0.00006053661,0.00909396,0.00023081202,0.6017782,0.00024507515,0.22678207,0.0006033534],"about_ca_topic_score_codex":0.017377645,"about_ca_topic_score_gemma":0.0009632548,"teacher_disagreement_score":0.34440064,"about_ca_system_score_codex":0.0017265053,"about_ca_system_score_gemma":0.001935597,"threshold_uncertainty_score":0.9891657},"labels":[],"label_agreement":null},{"id":"W4282983957","doi":"10.1158/1538-7445.am2022-1221","title":"Abstract 1221: Comprehensive cell-type classification of tumor and normal cells from single cell RNA sequencing in pan cancer settings","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cell type; Transcriptome; Annotation; Classifier (UML); Computational biology; Cancer cell; Cancer; Biology; Cell; Stromal cell; Gene; Bioinformatics; Gene expression; Artificial intelligence; Cancer research; Computer science; Genetics","score_opus":0.07258767436462935,"score_gpt":0.3219515189230378,"score_spread":0.24936384455840846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467796,0.004031737,0.000009376512,0.00009625703,0.00019641047,0.00023366006,0.00017771996,0.000005052978,0.00057180994],"genre_scores_gemma":[0.9986119,0.0006898127,0.000104328334,0.000108867556,0.00012632094,0.000064677835,0.000087257395,0.000026314807,0.00018048672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986237,0.00013286287,0.0002380627,0.00038626915,0.00029568985,0.00032339338],"domain_scores_gemma":[0.9993785,0.00005157016,0.000092473834,0.00021751068,0.00018829896,0.0000716554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025112217,0.000115318435,0.00015907967,0.00008993204,0.0001494702,0.000023943952,0.00022024523,0.00006761954,0.00016180416],"category_scores_gemma":[0.000011060398,0.00012675952,0.000036985344,0.00021928377,0.00013443812,0.0000071427758,0.0001445512,0.00038103267,0.0000017310676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023702969,0.00007684487,0.0029876302,0.00010625678,0.000011098506,0.000007180778,0.0004486963,0.0008374288,0.99256283,0.000001129238,0.00078360556,0.0019402737],"study_design_scores_gemma":[0.00061041594,0.00020081608,0.005731083,0.000028732324,0.0000065710774,6.3809466e-7,0.0012402285,0.00030620073,0.98567206,0.0000138723835,0.006050607,0.00013879572],"about_ca_topic_score_codex":0.007884261,"about_ca_topic_score_gemma":0.0006670947,"teacher_disagreement_score":0.0072171665,"about_ca_system_score_codex":0.00023145233,"about_ca_system_score_gemma":0.00046557645,"threshold_uncertainty_score":0.9987223},"labels":[],"label_agreement":null},{"id":"W4282983982","doi":"10.1158/1538-7445.am2022-1194","title":"Abstract 1194: Redesigning CIViC: Enhancing the structured curation of complex cancer variant data","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"KRAS; Resource (disambiguation); Cancer; Metadata; Interpretation (philosophy); Interface (matter); Precision medicine; Computational biology; Colorectal cancer; Biology; Computer science; Genetics; World Wide Web","score_opus":0.14118475930958974,"score_gpt":0.4168382481937128,"score_spread":0.27565348888412305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282983982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860701,0.0072067194,0.00090084155,0.0019719566,0.00056510646,0.00063304446,0.0018491606,0.000008220448,0.00079487375],"genre_scores_gemma":[0.99703926,0.0012840063,0.00012762206,0.00017836911,0.00051588565,0.00019716773,0.00046720094,0.000025026091,0.00016544065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984191,0.00015314396,0.00025107406,0.00041092784,0.00044370414,0.00032206537],"domain_scores_gemma":[0.9986655,0.00010056927,0.000113287184,0.00086306396,0.00019950912,0.00005804338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011447314,0.00009880583,0.00012745816,0.00005483241,0.00047558514,0.00004634038,0.0008912647,0.00004629951,0.00064866117],"category_scores_gemma":[0.00018418582,0.00008457538,0.000036719375,0.00023867775,0.00013171826,0.0000075335115,0.0010515486,0.00032101825,0.0000011972405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001254399,0.000023366458,0.00020703227,0.000031980777,0.00005566615,0.0000039749475,0.0002175301,0.0031964146,0.970659,0.00026033123,0.01933822,0.005881014],"study_design_scores_gemma":[0.0012940955,0.0003931067,0.013392485,0.0000671446,0.0000535617,0.00001903205,0.0023946736,0.0018259629,0.59654003,0.0010450372,0.38250625,0.000468613],"about_ca_topic_score_codex":0.0027988206,"about_ca_topic_score_gemma":0.003282372,"teacher_disagreement_score":0.37411898,"about_ca_system_score_codex":0.00012665955,"about_ca_system_score_gemma":0.00089705235,"threshold_uncertainty_score":0.71023846},"labels":[],"label_agreement":null},{"id":"W4282984166","doi":"10.1158/1538-7445.am2022-5205","title":"Abstract 5205: VG2025: Transcriptional and translational dually regulated (TTDR) oncolytic virus for cancer immunotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Virus; Internal ribosome entry site; Biology; Viral replication; Cancer research; microRNA; Cell culture; Virology; Gene; Molecular biology; Messenger RNA; Translation (biology); Genetics","score_opus":0.06407653571937082,"score_gpt":0.4057102329477719,"score_spread":0.3416336972284011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282984166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97465414,0.019857569,0.00008819968,0.0028902409,0.00020206743,0.0010836482,0.0010288911,0.000025315863,0.0001699099],"genre_scores_gemma":[0.9892167,0.0039394037,0.0000895708,0.00038233984,0.000537701,0.002981863,0.00030517997,0.0001033757,0.0024438994],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997396,0.0002413406,0.00026978255,0.00059822196,0.0008646266,0.0006300557],"domain_scores_gemma":[0.99899787,0.000088527835,0.000046490673,0.00031932237,0.00039965948,0.00014812857],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013891257,0.00018064132,0.00018617943,0.00018634145,0.0006055047,0.000059714515,0.00040281218,0.00011574834,0.001742152],"category_scores_gemma":[0.000028670842,0.0001922375,0.00012562741,0.00032501563,0.0002721962,0.00001062283,0.00007671599,0.0004654608,0.0000027804194],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010033762,0.00012627307,0.00021659464,0.00004819987,0.00020375208,0.0000032081316,0.00023729271,0.0014952144,0.9532762,0.000110118905,0.003982414,0.030266931],"study_design_scores_gemma":[0.0059439656,0.0033721116,0.008014239,0.000032599473,0.000017500326,0.000011020336,0.0002239547,0.00047686233,0.44985098,0.0011216733,0.5304157,0.0005193769],"about_ca_topic_score_codex":0.00040289693,"about_ca_topic_score_gemma":0.0014596898,"teacher_disagreement_score":0.5264333,"about_ca_system_score_codex":0.00016319536,"about_ca_system_score_gemma":0.0014019014,"threshold_uncertainty_score":0.99917036},"labels":[],"label_agreement":null},{"id":"W4282984379","doi":"10.1158/1538-7445.am2022-1711","title":"Abstract 1711: A multi-modal analysis approach leveraging multiplexed spatial phenotyping and multi-omics analysis to better understand the prognostic value of tertiary lymphoid structures in non-small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Context (archaeology); Oncology; Tissue microarray; Cancer; Biology; Pathology; Medicine; Cancer research; Internal medicine","score_opus":0.05884652223617326,"score_gpt":0.3666898211647326,"score_spread":0.30784329892855933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282984379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834137,0.008846138,0.0042082677,0.0006726215,0.000044091412,0.0025044864,0.00026278853,0.000017207469,0.000030709336],"genre_scores_gemma":[0.9953239,0.00025500005,0.0023962343,0.00021303182,0.00009349191,0.0014755793,0.000097245604,0.00004949304,0.000096044234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959749,0.00042045952,0.00050834153,0.0008867491,0.0012546037,0.00095495855],"domain_scores_gemma":[0.99827445,0.00039916066,0.00013005317,0.00058532023,0.00025002746,0.00036102007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012176177,0.00030384053,0.0007276935,0.0016536685,0.00050512486,0.00008607981,0.0004185154,0.00008191939,0.0002770668],"category_scores_gemma":[0.00009592385,0.00023308382,0.00027611558,0.0033902447,0.00023541115,0.00007484158,0.00052320684,0.00095822604,6.6419193e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009244767,0.0004430983,0.8604112,0.00045147078,0.0035696598,0.000105140134,0.0069268057,0.11509347,0.0074286135,0.0000039610686,0.000035031517,0.0046070646],"study_design_scores_gemma":[0.003801619,0.00009298813,0.75245017,0.00004192343,0.0012928807,0.000002804257,0.0024917156,0.23661746,0.0030141198,0.000010307158,0.0000047352764,0.00017927968],"about_ca_topic_score_codex":0.06126731,"about_ca_topic_score_gemma":0.009221921,"teacher_disagreement_score":0.121524,"about_ca_system_score_codex":0.00200632,"about_ca_system_score_gemma":0.00086701685,"threshold_uncertainty_score":0.9504882},"labels":[],"label_agreement":null},{"id":"W4282984391","doi":"10.1158/1538-7445.am2022-5914","title":"Abstract 5914: E-cadherin and beta-catenin in oral dysplasia progression","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Dalhousie University; University of British Columbia","funders":"","keywords":"Adherens junction; Epithelial–mesenchymal transition; Cadherin; Beta-catenin; Epithelial dysplasia; Immunohistochemistry; Catenin; Wnt signaling pathway; Cancer; Pathology; Tumor progression; Medicine; Biopsy; Cancer research; Biology; Cell; Internal medicine; Signal transduction; Metastasis","score_opus":0.048050446969097875,"score_gpt":0.4015696963847803,"score_spread":0.3535192494156824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282984391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917548,0.005339551,0.00004508158,0.00085013476,0.00013281133,0.0006893391,0.000047303536,0.000013658799,0.0011273248],"genre_scores_gemma":[0.9963378,0.0009279244,0.00011499985,0.000065007574,0.00010809122,0.0010884434,0.00007511441,0.000051489737,0.0012311424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725676,0.00034470763,0.0002122512,0.0006462782,0.0008237544,0.0007162761],"domain_scores_gemma":[0.9992725,0.000023904253,0.00003996016,0.000358704,0.00012782274,0.000177075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014834094,0.00015060506,0.00016454981,0.000261541,0.0003043955,0.000057753903,0.00040839094,0.00013630101,0.000721144],"category_scores_gemma":[0.00007138888,0.0001559579,0.000049412145,0.00053022924,0.00018316077,0.000006736144,0.0009847925,0.0009719777,0.00001444281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000499601,0.00008650912,0.00043691212,0.000044953067,0.000030679745,0.00007790194,0.00010012233,0.00029208895,0.9736056,0.000080318634,0.003847488,0.02089786],"study_design_scores_gemma":[0.0018636624,0.00087474345,0.0047652344,0.00005353345,0.0000059255703,0.000040935614,0.00044976268,0.00017134302,0.8635095,0.00017173184,0.12775393,0.00033968943],"about_ca_topic_score_codex":0.00054710096,"about_ca_topic_score_gemma":0.0004236055,"teacher_disagreement_score":0.12390645,"about_ca_system_score_codex":0.00024731518,"about_ca_system_score_gemma":0.0004917383,"threshold_uncertainty_score":0.7896021},"labels":[],"label_agreement":null},{"id":"W4283073652","doi":"10.1158/0008-5472.can-22-0418","title":"Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Polygenic risk score; Internal medicine; Lung cancer; Odds ratio; Risk assessment; Cohort; Oncology; Radiation therapy; Risk stratification; Nomogram; Single-nucleotide polymorphism; Gene; Genotype; Genetics; Biology","score_opus":0.07780409574957191,"score_gpt":0.39332896216239277,"score_spread":0.31552486641282085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283073652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514456,0.038152967,0.000032765696,0.0052301567,0.0009344446,0.0029411835,0.0003202941,0.00015202217,0.0007905834],"genre_scores_gemma":[0.9814792,0.011898635,0.000053998454,0.0012596425,0.0010906252,0.003416802,0.000036122427,0.00015559807,0.0006093426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99118966,0.002062896,0.0007164968,0.0013817771,0.0030559262,0.001593246],"domain_scores_gemma":[0.9968638,0.00083227956,0.00017304735,0.0011190238,0.00036112804,0.00065072795],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042690914,0.00041152458,0.0007577451,0.0015364506,0.0009349205,0.00009692103,0.0008194079,0.00012002272,0.0022118879],"category_scores_gemma":[0.0004516359,0.00042316617,0.00023438284,0.00432988,0.00021359416,0.00017241575,0.00075939874,0.0029704345,0.000036715555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028433548,0.00072803575,0.9113642,0.00014753382,0.00035552576,0.00016253213,0.03451498,0.0034926725,0.0032731977,0.000077270146,0.02315898,0.019881723],"study_design_scores_gemma":[0.004742809,0.00088288396,0.95583826,0.00050854206,0.000033920358,0.000019229668,0.005689687,0.00011058424,0.0034511865,0.00024088063,0.027939389,0.0005426058],"about_ca_topic_score_codex":0.08469703,"about_ca_topic_score_gemma":0.012365254,"teacher_disagreement_score":0.07233178,"about_ca_system_score_codex":0.0035517593,"about_ca_system_score_gemma":0.0024066614,"threshold_uncertainty_score":0.999822},"labels":[],"label_agreement":null},{"id":"W4283364094","doi":"10.1158/1538-7445.am2022-682","title":"Abstract 682: Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance])","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Interquartile range; Proportional hazards model; Colorectal cancer; Oncology; Cancer; Inflammation; Gastroenterology; Confidence interval","score_opus":0.05023248151119182,"score_gpt":0.35934542490992055,"score_spread":0.30911294339872875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283364094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931168,0.0005801401,0.0000026909854,0.00039542932,0.00024132097,0.0021520131,0.0011403597,0.00007658258,0.0022946573],"genre_scores_gemma":[0.9958901,0.00011669961,0.00007830356,0.000059330712,0.000113433074,0.0026135035,0.00018739885,0.00009730198,0.00084394944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946494,0.0003531478,0.00052876107,0.0006243128,0.0029665686,0.0008778163],"domain_scores_gemma":[0.9969688,0.00027985498,0.000393523,0.0006284698,0.0013366042,0.0003927623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015014356,0.00028478674,0.0005224821,0.00037914224,0.0006521903,0.000042606433,0.00043480715,0.000119581404,0.0030674618],"category_scores_gemma":[0.00013614359,0.00024452602,0.00011520404,0.0013732997,0.0008332396,0.0002185768,0.00028467545,0.0008919025,0.000009163368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053709303,0.00045018128,0.98420405,0.00048511915,0.0011255827,0.000110528985,0.000402488,0.00018208197,0.0022505976,0.00004454994,0.0041563935,0.0012174685],"study_design_scores_gemma":[0.0053030187,0.00047654327,0.9859086,0.0003488721,0.00013211236,5.260202e-7,0.00082340307,0.000042019958,0.0031539837,0.0000072611583,0.003511522,0.00029212655],"about_ca_topic_score_codex":0.0021583936,"about_ca_topic_score_gemma":0.0018567222,"teacher_disagreement_score":0.0030582983,"about_ca_system_score_codex":0.0021725618,"about_ca_system_score_gemma":0.0023466202,"threshold_uncertainty_score":0.99784386},"labels":[],"label_agreement":null},{"id":"W4283364422","doi":"10.1158/1538-7445.am2022-ct561","title":"Abstract CT561: KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; TIGIT; Internal medicine; Oncology; Atezolizumab; Lung cancer; Phases of clinical research; Gastroenterology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.06263140322258151,"score_gpt":0.39675302328117185,"score_spread":0.33412162005859036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283364422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905401,0.0013632374,0.000011883522,0.00035409458,0.000058859936,0.0070903376,0.00013932095,0.000021292582,0.00042091202],"genre_scores_gemma":[0.99713564,0.0003415333,0.000033849596,0.000064729604,0.00003622287,0.0020811716,0.00008276296,0.000068669455,0.00015541328],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959764,0.00040873158,0.00062320876,0.00064287713,0.0017387304,0.0006100778],"domain_scores_gemma":[0.99827075,0.0003124239,0.00024932082,0.0004925791,0.00049218425,0.00018274429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016873735,0.0003133823,0.0011285213,0.00075300504,0.00032737115,0.000049896393,0.00023389341,0.00004469405,0.00048723957],"category_scores_gemma":[0.000042414253,0.00021689404,0.000086145534,0.0013629548,0.0006174368,0.00017547392,0.00014920655,0.00083827385,0.0000015439333],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8937223,0.0051135174,0.09176669,0.00023830193,0.001212256,0.000107503336,0.0035303736,0.00014424765,0.00031204606,0.000004887411,0.000058300153,0.0037895734],"study_design_scores_gemma":[0.91076744,0.010272691,0.07366735,0.00043600085,0.00031284086,0.00002662146,0.0028050656,0.000078023,0.0011469888,0.000005975187,0.0002016063,0.00027938813],"about_ca_topic_score_codex":0.007244248,"about_ca_topic_score_gemma":0.0019570354,"teacher_disagreement_score":0.018099345,"about_ca_system_score_codex":0.0005203535,"about_ca_system_score_gemma":0.0006583458,"threshold_uncertainty_score":0.9993666},"labels":[],"label_agreement":null},{"id":"W4283367034","doi":"10.1158/1538-7445.am2022-sy25-02","title":"Abstract SY25-02: Double-edged “soil”: Stromal microenvironment in breast cancer development","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Population; Medicine; Cancer; Tumor microenvironment; Stromal cell; Oncology; Internal medicine; Pathology","score_opus":0.08768239651525518,"score_gpt":0.38919732884897645,"score_spread":0.3015149323337213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283367034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854411,0.0063508432,0.000001858474,0.004802809,0.00033330877,0.0008749017,0.00018753049,0.000024985984,0.001982695],"genre_scores_gemma":[0.9905495,0.0023153916,0.00008484807,0.00030453902,0.00027229034,0.0024265859,0.000044169905,0.00005628444,0.0039464002],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99657136,0.00010015274,0.00040014737,0.00061468675,0.0013748592,0.0009387758],"domain_scores_gemma":[0.999064,0.00004498077,0.00006592716,0.00041156466,0.00009024743,0.00032323244],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011513163,0.0002047224,0.00037029374,0.0003918539,0.00036593896,0.000035705856,0.00029148176,0.00005483138,0.021946125],"category_scores_gemma":[0.000005133406,0.00019870071,0.00008962158,0.0006562203,0.00014638588,0.00006782855,0.00042725925,0.0011655813,0.000069515314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009618397,0.0019691915,0.097506575,0.0010775563,0.00049492385,0.0010051475,0.0037373363,0.0024151867,0.563584,0.00006541803,0.043336038,0.27519023],"study_design_scores_gemma":[0.008876099,0.00018598516,0.48442632,0.00034478813,0.000047161742,0.00009361835,0.0017628786,0.000013056613,0.10296128,0.000009831643,0.40084043,0.00043856725],"about_ca_topic_score_codex":0.0063116737,"about_ca_topic_score_gemma":0.001581856,"teacher_disagreement_score":0.46062273,"about_ca_system_score_codex":0.004352503,"about_ca_system_score_gemma":0.0019608568,"threshold_uncertainty_score":0.99946964},"labels":[],"label_agreement":null},{"id":"W4283372003","doi":"10.1158/1538-7445.am2022-lb129","title":"Abstract LB129: Analysis of KRAS wildtype pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Ottawa Hospital; Pancreas Centre (Canada)","funders":"","keywords":"KRAS; Cancer research; Adenocarcinoma; Biology; Mutation; Cancer; Colorectal cancer; Medicine; Gene; Oncology; Internal medicine; Genetics","score_opus":0.08516131918667791,"score_gpt":0.4210897308677343,"score_spread":0.3359284116810564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283372003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246687,0.0033936703,0.00003816922,0.0019905802,0.00004364148,0.0008940163,0.00016318586,0.00002337951,0.0009864704],"genre_scores_gemma":[0.9971911,0.00010403659,0.00041703528,0.00028460054,0.000092821356,0.0007328259,0.000104483326,0.000027867438,0.001045246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967917,0.00041915738,0.00040855067,0.0004783751,0.0013488183,0.0005534026],"domain_scores_gemma":[0.99767405,0.00094358006,0.00008795529,0.0004905374,0.00044814707,0.00035575713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001887717,0.00015093126,0.0007313208,0.0014314305,0.00041466727,0.000027148728,0.00022688162,0.00008521682,0.002830525],"category_scores_gemma":[0.00058329164,0.00013781719,0.00013138608,0.0020263304,0.00031112926,0.00006497478,0.0002242392,0.000630307,0.000009226036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012840325,0.00018622333,0.9233541,0.00031611297,0.0006784252,0.00032085794,0.001445703,0.00035656177,0.06872019,0.00007599131,0.0028535104,0.00040829187],"study_design_scores_gemma":[0.0011584982,0.0008456089,0.9898515,0.00011769734,0.0006714721,0.000020959073,0.0019546945,0.0010913039,0.0038249912,0.000113792594,0.00022027903,0.00012920103],"about_ca_topic_score_codex":0.0015733391,"about_ca_topic_score_gemma":0.00007155547,"teacher_disagreement_score":0.06649741,"about_ca_system_score_codex":0.00044715984,"about_ca_system_score_gemma":0.00089118996,"threshold_uncertainty_score":0.998081},"labels":[],"label_agreement":null},{"id":"W4283388855","doi":"10.1158/1538-7445.am2022-lb113","title":"Abstract LB113: Genomic classification to refine prognosis in clear cell renal cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"BAP1; Clear cell renal cell carcinoma; Renal cell carcinoma; Oncology; Medicine; Proportional hazards model; Cohort; Internal medicine; Kidney cancer; Clear cell; Survival analysis; Cancer; Bioinformatics; Biology","score_opus":0.14122640779904944,"score_gpt":0.38077072319849065,"score_spread":0.2395443153994412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283388855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978313,0.0016106127,0.0000012444286,0.0032763528,0.000092990114,0.0016186849,0.000044492648,0.000032172014,0.015010421],"genre_scores_gemma":[0.992098,0.00009976458,0.00017248032,0.00015198323,0.00019972547,0.0022541038,0.00006870609,0.00006813031,0.004887142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967468,0.0002473549,0.00039174044,0.00071019516,0.0011547453,0.0007491837],"domain_scores_gemma":[0.99868137,0.00011046346,0.000069571804,0.0005735049,0.00020245202,0.00036264982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011679466,0.00018541138,0.00029733867,0.00068986084,0.0002554167,0.000037430334,0.00032194334,0.000070505914,0.0023825436],"category_scores_gemma":[0.000032889027,0.00018001995,0.0000961717,0.0010884269,0.00007277013,0.000051666808,0.00031304426,0.0010303989,0.00032980173],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017858653,0.0006803935,0.07247072,0.00023790367,0.000013430979,0.0005133736,0.00089440885,0.00021602419,0.90817505,0.000019935542,0.010494407,0.0044985013],"study_design_scores_gemma":[0.0018000765,0.0016282522,0.7467031,0.00003470481,0.000021351692,0.000016486734,0.0007717176,0.00007778778,0.23142062,0.00001454775,0.017338673,0.00017267969],"about_ca_topic_score_codex":0.0025782606,"about_ca_topic_score_gemma":0.00016877122,"teacher_disagreement_score":0.6767544,"about_ca_system_score_codex":0.0035027748,"about_ca_system_score_gemma":0.0008447835,"threshold_uncertainty_score":0.99852943},"labels":[],"label_agreement":null},{"id":"W4283836458","doi":"10.1158/0008-5472.can-21-3656","title":"CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Shenzhen Science and Technology Innovation Program; Recruitment Program of Global Experts; Shanghai Jiao Tong University; National Natural Science Foundation of China; Sun Yat-sen University; Natural Science Foundation of Guangdong Province; Case Western Reserve University","keywords":"Oncolytic virus; Cancer research; Palbociclib; Kinase; Cyclin-dependent kinase; Biology; Virotherapy; Cell cycle; Cell; Cancer; Tumor cells; Cell biology","score_opus":0.020436599717334063,"score_gpt":0.33878647375011106,"score_spread":0.318349874032777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283836458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593616,0.0026978601,0.000051697523,0.00013245453,0.000048198996,0.0005531603,0.000033659795,0.00001208171,0.00053474517],"genre_scores_gemma":[0.99781686,0.0007492966,0.000020645286,0.0001092284,0.00014685425,0.00046306144,0.00006691748,0.00004583433,0.0005812766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972181,0.0006884987,0.0002306682,0.0006135725,0.0006685302,0.00058065134],"domain_scores_gemma":[0.99926054,0.0001136475,0.000091848895,0.00024468516,0.00017780923,0.000111453795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012613223,0.00015315822,0.0001527452,0.0002761931,0.0005166001,0.00005666571,0.00021466725,0.0000784483,0.00012576029],"category_scores_gemma":[0.0000864777,0.00017408478,0.000042185522,0.0006504796,0.00013193983,0.00001783586,0.00030734536,0.00078698,0.000006206167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026847646,0.00025890375,0.0001407919,0.000047579775,0.000012774208,0.0000066630123,0.0003388544,0.00047601623,0.9905516,8.041036e-7,0.0012565532,0.0042247213],"study_design_scores_gemma":[0.0013242076,0.003302825,0.00010653295,0.000030047473,0.0000027288725,0.0000018126372,0.00062607013,0.0001896766,0.9913507,0.00003286388,0.0028500222,0.0001824841],"about_ca_topic_score_codex":0.00050720904,"about_ca_topic_score_gemma":0.00043183332,"teacher_disagreement_score":0.004042237,"about_ca_system_score_codex":0.00048571173,"about_ca_system_score_gemma":0.0004814449,"threshold_uncertainty_score":0.70989716},"labels":[],"label_agreement":null},{"id":"W4284970869","doi":"10.1158/0008-5472.can-22-0671","title":"FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Deutsche Krebshilfe; U.S. Department of Defense","keywords":"Transcription factor; Biology; Carcinogenesis; Oncogene; Epigenetics; Cancer research; Cancer; Transcription (linguistics); Genetics; Promoter; Transcriptional regulation; Gene; Gene expression; Cell cycle","score_opus":0.12505260695897108,"score_gpt":0.38841601179040525,"score_spread":0.26336340483143417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284970869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921177,0.0039891102,0.00025921958,0.0019275317,0.00035030168,0.00051577593,0.0004882575,0.00003433376,0.0003177915],"genre_scores_gemma":[0.9940107,0.0009064934,0.000050407485,0.0004146971,0.0003357082,0.0007403501,0.0004957246,0.00006707663,0.0029788802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967958,0.00047634475,0.0002428817,0.0007797149,0.0010866293,0.0006186367],"domain_scores_gemma":[0.9988254,0.000020931979,0.00005731591,0.00053058116,0.00034764365,0.0002181273],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000608258,0.00020625159,0.00017999818,0.00017231007,0.00057175814,0.00006706867,0.00051558187,0.0001648666,0.0040654894],"category_scores_gemma":[0.000020239677,0.00022373402,0.00012799527,0.0004195527,0.00025138012,0.00002085175,0.00011885002,0.00043580032,0.000014746039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028532764,0.0001562562,0.003127988,0.000024389756,0.00010180622,0.0000032972498,0.00034264417,0.0006887023,0.9786912,0.0001405219,0.002830263,0.013607603],"study_design_scores_gemma":[0.0008468316,0.00045567512,0.048324686,0.000014895086,0.000016533892,0.0000075331927,0.00017485197,0.00011412939,0.801161,0.0002874594,0.14830923,0.00028717137],"about_ca_topic_score_codex":0.0003094349,"about_ca_topic_score_gemma":0.00019484552,"teacher_disagreement_score":0.1775302,"about_ca_system_score_codex":0.0002148553,"about_ca_system_score_gemma":0.00055445614,"threshold_uncertainty_score":0.99684495},"labels":[],"label_agreement":null},{"id":"W4285005121","doi":"10.1158/0008-5472.can-21-2454","title":"The X-Linked Helicase DDX3X Is Required for Lymphoid Differentiation and MYC-Driven Lymphomagenesis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research","keywords":"Biology; Germinal center; Lymphoma; Haematopoiesis; Cancer research; Allele; B cell; Genetics; Gene; Immunology; Stem cell; Antibody","score_opus":0.05248596759125311,"score_gpt":0.3677081259979046,"score_spread":0.31522215840665146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285005121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364394,0.002441035,0.00006646034,0.003039012,0.00013447495,0.0003312878,0.00011856296,0.0000074452446,0.0002177623],"genre_scores_gemma":[0.9871688,0.0019989738,0.000039286042,0.00046834524,0.00028619374,0.00082546374,0.00005864663,0.000015793312,0.009138535],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988202,0.000141837,0.00017312732,0.0002952935,0.00028407632,0.00028545235],"domain_scores_gemma":[0.999361,0.00009855688,0.000046599398,0.00023195145,0.00017798296,0.00008394598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039413312,0.00008399245,0.00008821651,0.000029977471,0.0010451472,0.000067414876,0.00024296051,0.00005028766,0.00015137174],"category_scores_gemma":[0.000066247856,0.00006621073,0.00006643014,0.00009054258,0.00018689342,0.000003310556,0.00030528722,0.00007105937,0.0000032872854],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012103806,0.00020836513,0.003937406,0.00011145918,0.00017615793,0.0000056692875,0.00065621885,0.000042954103,0.8369413,0.0010326902,0.043101933,0.112575434],"study_design_scores_gemma":[0.0034771871,0.0017214561,0.0110983355,0.000016671887,0.00003938754,0.000036571186,0.0037510914,0.0011355621,0.3021293,0.0022982238,0.6738749,0.0004213224],"about_ca_topic_score_codex":0.000043049797,"about_ca_topic_score_gemma":0.000027491418,"teacher_disagreement_score":0.63077295,"about_ca_system_score_codex":0.000046184592,"about_ca_system_score_gemma":0.00014068696,"threshold_uncertainty_score":0.8038533},"labels":[],"label_agreement":null},{"id":"W4285492936","doi":"10.1158/0008-5472.can-22-0887","title":"The Mechanisms of Action of Tumor Treating Fields","year":2022,"lang":"en","type":"review","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioblastoma; Medicine; Mesothelioma; Cancer; Treatment modality; Oncology; Pharmacology; Internal medicine; Cancer research; Pathology","score_opus":0.22010906917267706,"score_gpt":0.4598140727345037,"score_spread":0.23970500356182664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285492936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037910389,0.9947549,0.000028048635,0.00003416783,0.0004230193,0.0005868857,0.000085961285,0.000014256877,0.0002817379],"genre_scores_gemma":[0.0026256677,0.996103,0.0000474048,0.0000043234686,0.000083357336,0.0006157865,0.0000040032455,0.000025286576,0.00049117225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971236,0.0009086606,0.00045936456,0.00026535615,0.0008922039,0.00035080945],"domain_scores_gemma":[0.99738675,0.0016039588,0.00029576715,0.0005114857,0.00015383607,0.0000482173],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028917706,0.00011676544,0.0005330636,0.00013701154,0.0002738903,0.000033911365,0.0006772242,0.00006126966,0.0020702805],"category_scores_gemma":[0.00036707515,0.00007709889,0.00015487842,0.00060157105,0.0001778215,0.000054623328,0.0003159649,0.00042618284,0.000028999055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049068938,0.000046952155,3.958448e-7,0.008455832,0.000030331892,0.00000926993,0.00009259061,0.00002124442,0.07396095,0.0014960407,0.0008650445,0.9149723],"study_design_scores_gemma":[0.00012456576,0.00020412146,1.7077136e-7,0.0024368498,0.00008409273,0.0000051544916,0.00026848537,0.000015142812,0.32629555,0.000618027,0.66982096,0.0001268759],"about_ca_topic_score_codex":0.0007959845,"about_ca_topic_score_gemma":0.00008304401,"teacher_disagreement_score":0.9148454,"about_ca_system_score_codex":0.0003300101,"about_ca_system_score_gemma":0.0010532796,"threshold_uncertainty_score":0.99884194},"labels":[],"label_agreement":null},{"id":"W4285987610","doi":"10.1158/0008-5472.can-22-0121","title":"Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Institute for Advanced Research; Memorial Sloan-Kettering Cancer Center","keywords":"PI3K/AKT/mTOR pathway; Biology; RPTOR; Regulator; Cancer research; Protein kinase B; Effector; Receptor tyrosine kinase; Cell biology; Signal transduction; Genetics; Gene","score_opus":0.06756196971193393,"score_gpt":0.42177600027487633,"score_spread":0.35421403056294243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285987610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637735,0.0014514211,0.00004465829,0.00057993573,0.00022470862,0.0003369275,0.0003475665,0.000011376723,0.000626069],"genre_scores_gemma":[0.9968012,0.000054709068,0.00006316039,0.00017406406,0.00024752296,0.0014631514,0.00020507703,0.00002709498,0.0009640143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842423,0.00022908322,0.0001604516,0.00036568695,0.00042687426,0.0003936928],"domain_scores_gemma":[0.9994372,0.0000654513,0.00005574228,0.00023165041,0.00012942421,0.00008053208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044724933,0.00008744467,0.00009429489,0.00018276148,0.00046282914,0.000027530194,0.00028731875,0.00005167369,0.0008466889],"category_scores_gemma":[0.00015782543,0.0001030874,0.00004760489,0.0005803928,0.00013099649,0.000005938599,0.00030227972,0.000421851,0.000010966604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009381488,0.00011134024,0.0067003537,0.000015346468,0.000028159537,0.00001262119,0.00015040002,0.0011949084,0.979769,0.00011229513,0.011391923,0.0004198724],"study_design_scores_gemma":[0.0011319013,0.0002626905,0.0026711898,0.00003470022,0.000004049401,0.000008035008,0.0026082436,0.000094629475,0.92107207,0.00029284693,0.07162368,0.00019597373],"about_ca_topic_score_codex":0.00027359207,"about_ca_topic_score_gemma":0.00013456577,"teacher_disagreement_score":0.060231756,"about_ca_system_score_codex":0.0004908629,"about_ca_system_score_gemma":0.0004705595,"threshold_uncertainty_score":0.927065},"labels":[],"label_agreement":null},{"id":"W4289261303","doi":"10.1158/0008-5472.can-21-3956","title":"Germline Missense Variants in <i>CDC20</i> Result in Aberrant Mitotic Progression and Familial Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill Genome Centre; Institute for Research in Immunology and Cancer; McGill University and Génome Québec Innovation Centre; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Cancer Research UK","keywords":"Biology; CDC20; Spindle checkpoint; Cancer research; Missense mutation; Mitosis; Genetics; Cell cycle; Cancer; Mutation; Spindle apparatus; Cell division; Gene; Cell; Anaphase","score_opus":0.03220888370232307,"score_gpt":0.37388516778854725,"score_spread":0.3416762840862242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289261303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904152,0.007971148,0.0000046927776,0.0006711024,0.00017341405,0.00045839476,0.000103416,0.00000445779,0.0001981351],"genre_scores_gemma":[0.9934684,0.004385396,0.00004980506,0.000190922,0.00017863911,0.0005833176,0.000060609775,0.00002606421,0.001056847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981665,0.00030369198,0.00022945671,0.000499597,0.00031473802,0.0004860142],"domain_scores_gemma":[0.9995025,0.000023395156,0.000036533213,0.00027060395,0.000078268306,0.000088728084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007994737,0.0001191734,0.00015672289,0.00015791312,0.00014348418,0.00002148432,0.00021345695,0.000097482334,0.00008173021],"category_scores_gemma":[0.00006806801,0.000117061885,0.000029014116,0.00036605052,0.000111278205,0.0000042352244,0.0004220409,0.00048485037,0.0000013749052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005645208,0.00013977438,0.011485145,0.000053720098,0.000013167073,0.00009579288,0.0002632304,0.00037619553,0.97301644,0.000013484178,0.004113699,0.009864803],"study_design_scores_gemma":[0.018753741,0.0023267262,0.14169455,0.00088952377,0.00004210725,0.00018935709,0.0025605976,0.0054501058,0.55338484,0.00043764326,0.2723184,0.0019524293],"about_ca_topic_score_codex":0.0020770386,"about_ca_topic_score_gemma":0.0053506675,"teacher_disagreement_score":0.41963166,"about_ca_system_score_codex":0.00015488132,"about_ca_system_score_gemma":0.00039997217,"threshold_uncertainty_score":0.4773645},"labels":[],"label_agreement":null},{"id":"W4289515481","doi":"10.1158/1538-7445.sabcs21-pd4-04","title":"Abstract PD4-04: Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2-positive metastatic breast cancer with brain metastases (HER2CLIMB)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Regimen; Internal medicine; Oncology; Trastuzumab; Placebo; Breast cancer; Population; Cancer; Colorectal cancer; Pathology","score_opus":0.035335978021690674,"score_gpt":0.3621909480056609,"score_spread":0.3268549699839702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289515481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96695,0.00055809284,0.000024028433,0.004980555,0.000035263773,0.0066466765,0.020636583,0.00003122105,0.00013760125],"genre_scores_gemma":[0.9898975,0.000078377605,0.0012363284,0.00030876065,0.00005093268,0.0052522733,0.0021239675,0.00010236142,0.0009494859],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961117,0.00040462427,0.0005406455,0.00087192626,0.0012268664,0.00084423996],"domain_scores_gemma":[0.99689835,0.00079539185,0.00023590375,0.0005149094,0.0010604748,0.0004949847],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011959879,0.00039081814,0.00086341315,0.00041092047,0.00037864345,0.000044870314,0.00019886035,0.000039865175,0.000973875],"category_scores_gemma":[0.00013645433,0.00026890478,0.00009389897,0.0011768767,0.00026749258,0.00011641326,0.00012308932,0.00043135902,0.0000030810124],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63246423,0.018579189,0.058551624,0.0030650394,0.014660116,0.0007927814,0.013300471,0.0025899166,0.0075734025,0.000117814794,0.13511167,0.11319372],"study_design_scores_gemma":[0.15634647,0.06844159,0.71969414,0.002565464,0.003543254,0.0002208013,0.008071748,0.00022770268,0.020378966,0.000038685055,0.018936204,0.0015349854],"about_ca_topic_score_codex":0.007099833,"about_ca_topic_score_gemma":0.001956426,"teacher_disagreement_score":0.6611425,"about_ca_system_score_codex":0.0007614756,"about_ca_system_score_gemma":0.0010187672,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W4292343005","doi":"10.1158/0008-5472.758.65.3","title":"ΔNp63α Up-Regulates the <i>Hsp70</i> Gene in Human Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Transactivation; Biology; Gene isoform; Transcription factor; Transcription (linguistics); Hsp70; Colocalization; Gene expression; Gene; Cell biology; Molecular biology; Genetics; Heat shock protein","score_opus":0.06080320250297327,"score_gpt":0.4289626606859535,"score_spread":0.36815945818298024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292343005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841577,0.008347908,0.000010083593,0.0050512524,0.000077514174,0.00068810524,0.00003174653,0.000009483517,0.0016262056],"genre_scores_gemma":[0.9784447,0.0025311331,0.000038717677,0.00025726462,0.0011407409,0.001236074,0.000026489746,0.00004714115,0.016277768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716735,0.0004015086,0.00024057002,0.0005503208,0.0006836844,0.0009565528],"domain_scores_gemma":[0.9987177,0.000039026632,0.000024551551,0.00075495284,0.0002997683,0.00016399253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015504733,0.00015639783,0.00015339251,0.00014881532,0.0003573145,0.0000728943,0.0008173735,0.00018287529,0.0007616353],"category_scores_gemma":[0.00012421931,0.00011810038,0.00006730153,0.0005198521,0.00039695212,0.000008276185,0.000501666,0.0006445331,0.000058300127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007931466,0.000040925363,0.0018489977,0.000020023095,0.000026411422,0.000004178375,0.00011683513,0.000298471,0.96719486,0.000064268475,0.018537864,0.011767841],"study_design_scores_gemma":[0.00046473742,0.00007736439,0.0011507554,0.000026622682,0.0000016844607,0.0000025958539,0.00005413182,0.00003434087,0.8083385,0.000055874174,0.18966942,0.00012396486],"about_ca_topic_score_codex":0.002999827,"about_ca_topic_score_gemma":0.008977975,"teacher_disagreement_score":0.17113155,"about_ca_system_score_codex":0.00026587077,"about_ca_system_score_gemma":0.00061209174,"threshold_uncertainty_score":0.8339372},"labels":[],"label_agreement":null},{"id":"W4292895541","doi":"10.1158/0008-5472.4287.72.17","title":"Highlights from Recent Cancer Literature","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.09094710602646557,"score_gpt":0.490147522526705,"score_spread":0.39920041650023946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292895541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7992725,0.14772077,0.000010173286,0.034181464,0.0014220525,0.0008477379,0.00037743195,0.00008177041,0.016086102],"genre_scores_gemma":[0.9335494,0.040767998,0.00031690046,0.00082468556,0.0034117473,0.001044368,0.00022463237,0.00004631421,0.019813966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843615,0.00007139826,0.0001293055,0.00024979014,0.0005397775,0.0005735619],"domain_scores_gemma":[0.9987628,0.00007083997,0.000024538185,0.00032155402,0.00043843122,0.0003818726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017245427,0.0001165201,0.00017769182,0.0001321154,0.00017745662,0.000046766057,0.00009178015,0.000096652904,0.0042527225],"category_scores_gemma":[0.000034738347,0.00008141455,0.000050360897,0.00057643943,0.00007388817,0.00016986999,0.00004612469,0.00036547,0.000181364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010528462,0.0013269901,0.14592852,0.00032236375,0.0017478754,0.00016024079,0.020359956,0.000007355055,0.058763046,0.006164248,0.4979166,0.26624998],"study_design_scores_gemma":[0.0012402146,0.00006722508,0.043574635,0.00039685503,0.00011141391,0.0000036625552,0.0001310733,0.0000031029113,0.022014804,0.00028795193,0.93206066,0.00010840294],"about_ca_topic_score_codex":0.0025000141,"about_ca_topic_score_gemma":0.00019288219,"teacher_disagreement_score":0.43414405,"about_ca_system_score_codex":0.0008478501,"about_ca_system_score_gemma":0.0004942899,"threshold_uncertainty_score":0.99665755},"labels":[],"label_agreement":null},{"id":"W4293053502","doi":"10.1158/1538-7445.am2022-4087","title":"Abstract 4087: Developing a standardized framework for curating oncology datasets generated by manual abstraction and artificial intelligence","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Consistency (knowledge bases); Computer science; Population; Test (biology); Lung cancer; Medicine; Artificial intelligence; Data mining; Machine learning; Oncology; Biology","score_opus":0.13042506893935205,"score_gpt":0.5168611613552492,"score_spread":0.38643609241589716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293053502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85537726,0.001820973,0.11620277,0.02377943,0.0006684287,0.0011736632,0.00069858157,0.00007008378,0.00020881827],"genre_scores_gemma":[0.97254455,0.00055824535,0.024039377,0.00081681117,0.0006101194,0.00061311375,0.00068872917,0.00004435485,0.0000847068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981239,0.00015240735,0.00031963867,0.00038295906,0.0005741053,0.00044701697],"domain_scores_gemma":[0.9986817,0.0007425653,0.00008898892,0.00015736066,0.00016189808,0.00016747895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002615355,0.000103788036,0.00024081825,0.00014848744,0.0008011648,0.000074904834,0.0001314232,0.000077625235,0.00045996427],"category_scores_gemma":[0.0012874973,0.00010070035,0.000031485746,0.0003019319,0.00017776905,0.000073885705,0.00014428693,0.0015615203,0.0000030708925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017159565,0.00014177825,0.00029115466,0.00029926162,0.00012256566,0.00011946381,0.0009627387,0.0006254283,0.14682396,0.005368238,0.036642022,0.80688745],"study_design_scores_gemma":[0.002100797,0.0015345226,0.0013892512,0.0005569956,0.00010123083,0.0002431892,0.007583724,0.04123869,0.06843687,0.02420325,0.8519102,0.00070131605],"about_ca_topic_score_codex":0.0003160688,"about_ca_topic_score_gemma":0.000016804448,"teacher_disagreement_score":0.81526816,"about_ca_system_score_codex":0.0006572257,"about_ca_system_score_gemma":0.00078020536,"threshold_uncertainty_score":0.67841154},"labels":[],"label_agreement":null},{"id":"W4293101897","doi":"10.1158/0008-5472.can-22-1215","title":"Notch Signaling Promotes Mature T-Cell Lymphomagenesis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Notch signaling pathway; Cancer research; Biology; T cell; Cell growth; Lymphoma; Signal transduction; Immunology; Cell biology; Genetics; Immune system","score_opus":0.07120128710731898,"score_gpt":0.38355342241072005,"score_spread":0.31235213530340106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293101897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834316,0.0072791744,0.0000011694611,0.0039020171,0.00013433788,0.0006513149,0.000051577987,0.00004976858,0.0044990517],"genre_scores_gemma":[0.99013627,0.00029576072,0.00015094441,0.000345578,0.00022165482,0.0016464846,0.000033615295,0.000034817087,0.0071349056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978662,0.00016155146,0.00014255336,0.00037022168,0.0009817091,0.00047772247],"domain_scores_gemma":[0.9991391,0.000134522,0.000028579385,0.00034583692,0.00017184862,0.00018015417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005317592,0.00011482261,0.00020066861,0.00018127264,0.0005105819,0.0000393969,0.00016578464,0.000043841937,0.0038349594],"category_scores_gemma":[0.000031645148,0.00009536361,0.000092867114,0.0006122222,0.00006248614,0.000034397443,0.00023468211,0.0002616607,0.0000974108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009882861,0.0029159149,0.0837267,0.00057202805,0.00029967655,0.0018220032,0.0020492466,0.00021869666,0.7684149,0.00032684582,0.09359711,0.045068614],"study_design_scores_gemma":[0.0050024805,0.001019137,0.021281267,0.00011205255,0.00010161268,0.000096265445,0.0012036348,0.00009853248,0.84424865,0.00017635079,0.12641352,0.00024648893],"about_ca_topic_score_codex":0.00070347264,"about_ca_topic_score_gemma":0.000010663319,"teacher_disagreement_score":0.07583377,"about_ca_system_score_codex":0.0011530229,"about_ca_system_score_gemma":0.0007366928,"threshold_uncertainty_score":0.9970757},"labels":[],"label_agreement":null},{"id":"W4293395719","doi":"10.1158/0008-5472.18.65.1","title":"The Dual ErbB1/ErbB2 Inhibitor, Lapatinib (GW572016), Cooperates with Tamoxifen to Inhibit Both Cell Proliferation- and Estrogen-Dependent Gene Expression in Antiestrogen-Resistant Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sylvester Comprehensive Cancer Center, University of Miami Health Systems; U.S. Department of Defense","keywords":"Tamoxifen; Lapatinib; Estrogen receptor; Antiestrogen; Cancer research; Breast cancer; Cyclin D1; Cancer; Medicine; Biology; Internal medicine; Endocrinology; Pharmacology; Cell cycle; Trastuzumab","score_opus":0.03860283302467069,"score_gpt":0.3709254548999244,"score_spread":0.3323226218752537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293395719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724487,0.011239859,0.000016734768,0.012308312,0.00011269473,0.0030685526,0.0002742352,0.000057866087,0.0004730184],"genre_scores_gemma":[0.98610854,0.004299512,0.00063349673,0.00038817181,0.0012876381,0.0031587805,0.000022671178,0.00013219146,0.003969018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937946,0.000478984,0.00065976847,0.001046854,0.002450192,0.0015696037],"domain_scores_gemma":[0.99688256,0.00029590627,0.000095992684,0.0008192049,0.0010810863,0.00082527724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019160733,0.0004028228,0.00051806774,0.00044594266,0.00072457537,0.000391188,0.00039553884,0.00020331223,0.00049783644],"category_scores_gemma":[0.0001530829,0.0002656125,0.000055591063,0.001249341,0.0005550089,0.00027527873,0.0004411492,0.0013441497,0.000064871165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007664386,0.00046603425,0.115093514,0.0003919672,0.000085773114,0.00023208189,0.002434289,0.00058714085,0.8332018,0.00007978539,0.02150717,0.018256033],"study_design_scores_gemma":[0.0050638174,0.001108091,0.016869193,0.0013701031,0.000028642256,0.00010956534,0.0010446877,0.00025720993,0.9374916,0.000017586914,0.036141492,0.00049800106],"about_ca_topic_score_codex":0.0023066804,"about_ca_topic_score_gemma":0.008227347,"teacher_disagreement_score":0.10428978,"about_ca_system_score_codex":0.0013851845,"about_ca_system_score_gemma":0.0035211977,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W4295163539","doi":"10.1158/0008-5472.can-22-1417","title":"Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China; Science and Technology Commission of Shanghai Municipality; Natural Science Foundation of Shanghai","keywords":"Immune system; Immunotherapy; Cancer immunotherapy; Biology; Cancer; Polyadenylation; Immune checkpoint; Immunology; Cancer research; Gene; Gene expression; Genetics","score_opus":0.034222595433211093,"score_gpt":0.385732173932351,"score_spread":0.3515095784991399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295163539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972263,0.0018213416,0.000033892342,0.00033362707,0.00011100138,0.00035518545,0.000048396018,0.0000045314323,0.000065741595],"genre_scores_gemma":[0.99451894,0.002261806,0.0000036870174,0.000024336243,0.00005802795,0.00046183576,0.00012018319,0.000026064205,0.0025251084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845415,0.00034989108,0.00023248815,0.00022517522,0.00044737084,0.00029093452],"domain_scores_gemma":[0.9995315,0.000013146616,0.000075619675,0.00019506829,0.00014839867,0.000036241898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008049387,0.000066887544,0.00010557174,0.00019924984,0.000114116156,0.0000061789033,0.0002662786,0.00004466778,0.0003016587],"category_scores_gemma":[0.00003279811,0.00006987904,0.000044970588,0.00044344325,0.000057655714,0.0000073153083,0.00018573487,0.0002894227,0.0000012944573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035115998,0.000059361537,0.016291998,0.0000120644845,0.000039329032,0.0000013856001,0.00022598033,0.000510784,0.9774457,0.00003818796,0.00002282737,0.005001185],"study_design_scores_gemma":[0.0010525263,0.0002743491,0.07648243,0.000031740095,0.0000011650443,0.0000012210484,0.0001376643,0.00048198862,0.91922235,0.00008030414,0.0021397423,0.000094490126],"about_ca_topic_score_codex":0.0028623242,"about_ca_topic_score_gemma":0.00012599818,"teacher_disagreement_score":0.060190435,"about_ca_system_score_codex":0.00018648597,"about_ca_system_score_gemma":0.0002734405,"threshold_uncertainty_score":0.4326997},"labels":[],"label_agreement":null},{"id":"W4297020689","doi":"10.1158/0008-5472.can-22-1293","title":"Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation; Cancer Research Society","keywords":"Cancer research; Myeloid leukemia; Biology; Syk; Tyrosine kinase; Signal transduction; Cell biology","score_opus":0.050080916667233966,"score_gpt":0.39064886233310875,"score_spread":0.3405679456658748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297020689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894096,0.0027943146,0.000074494856,0.003970753,0.00026513633,0.0017707477,0.0001810018,0.00005217016,0.0014817718],"genre_scores_gemma":[0.9903972,0.0007004548,0.0011559722,0.0002662816,0.0002675428,0.0011209722,0.000061899314,0.000102505874,0.0059271622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99295974,0.00093353755,0.0007814276,0.0008574155,0.0031013463,0.0013665434],"domain_scores_gemma":[0.99749935,0.0006881248,0.00013306174,0.00072381727,0.00062645983,0.0003291788],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003706233,0.00025971245,0.00069209555,0.0008870621,0.0005004464,0.000044962377,0.00075699337,0.00012542623,0.0014420798],"category_scores_gemma":[0.0005972281,0.00024810166,0.000116599396,0.0034055766,0.00026984868,0.00026818228,0.0014617655,0.0023409808,0.00002546028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004558294,0.00013091436,0.011715525,0.000733801,0.00011073631,0.0005459851,0.005751036,0.0037984638,0.88541204,0.00022392708,0.08567704,0.0013422102],"study_design_scores_gemma":[0.006631598,0.0010097928,0.0053813416,0.0019114165,0.000048966875,0.000025405103,0.015004332,0.0005401066,0.8411801,0.00060248695,0.1270019,0.00066255964],"about_ca_topic_score_codex":0.0024581912,"about_ca_topic_score_gemma":0.00014018134,"teacher_disagreement_score":0.044231962,"about_ca_system_score_codex":0.0072088297,"about_ca_system_score_gemma":0.0034805662,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W4297338671","doi":"10.1158/0008-5472.can-22-0834","title":"Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Uehara Memorial Foundation; National Cancer Center Japan; Takeda Science Foundation; RIKEN; Foundation for Computational Science; Japan Agency for Medical Research and Development; Naito Foundation","keywords":"Druggability; Biology; In silico; Carcinogenesis; Mutation; Cancer research; Mutant; Genetics; Computational biology; Cancer; Gene","score_opus":0.1897931860188335,"score_gpt":0.4590355024854119,"score_spread":0.2692423164665784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297338671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80061364,0.000097477234,0.19639407,0.000956675,0.0002892799,0.0002992056,0.00007946552,0.00004963715,0.0012205658],"genre_scores_gemma":[0.98427093,0.0000073664196,0.015039544,0.000053645505,0.0000758012,0.00034235726,0.0000048718593,0.000011144975,0.00019434572],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99721736,0.0006773596,0.00015800208,0.0005742577,0.00094745035,0.00042558098],"domain_scores_gemma":[0.9975622,0.0016776393,0.00007529826,0.0002936904,0.0002581899,0.00013296772],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002095753,0.00011015726,0.00015304972,0.00035707877,0.0015020791,0.00020941607,0.00061606354,0.00002704369,0.000057289348],"category_scores_gemma":[0.0003871617,0.00012413596,0.00003625482,0.0015856191,0.00027527596,0.00054663944,0.0015228768,0.00066268,0.00000596633],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007985118,0.0002671521,0.0037910151,0.00007579,0.00013303634,0.000112997295,0.011787473,0.13654092,0.5465931,0.21151257,0.00064246746,0.0884636],"study_design_scores_gemma":[0.0025563797,0.00048661255,0.10143663,0.00017328416,0.000033185544,0.0002845511,0.0050596483,0.6599469,0.19678296,0.027260834,0.004568415,0.0014105664],"about_ca_topic_score_codex":0.0011040975,"about_ca_topic_score_gemma":0.000045362976,"teacher_disagreement_score":0.523406,"about_ca_system_score_codex":0.00072583044,"about_ca_system_score_gemma":0.0013179673,"threshold_uncertainty_score":0.9997978},"labels":[],"label_agreement":null},{"id":"W4297745080","doi":"10.1158/0008-5472.can-04-4244","title":"Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":469,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Research Society","keywords":"Glypican 3; Wnt signaling pathway; Autocrine signalling; Paracrine signalling; Cell biology; Frizzled; Heparan sulfate; LRP6; Chemistry; Cancer research; Signal transduction; LRP5; Cell growth; Biology; Glycosaminoglycan; Receptor; Hepatocellular carcinoma; Biochemistry","score_opus":0.0470705236807691,"score_gpt":0.3402952533733229,"score_spread":0.2932247296925538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297745080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057496,0.007466399,0.00013638294,0.0010666127,0.000057150497,0.0003126627,0.000018441611,0.000008768454,0.0003586204],"genre_scores_gemma":[0.9975724,0.00021379844,0.00027873053,0.00010353578,0.00049278466,0.00015127455,0.000035529458,0.000031573327,0.0011203716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981438,0.00017503253,0.00028926742,0.00038576423,0.00051730825,0.0004888363],"domain_scores_gemma":[0.9990592,0.00007517625,0.00007108058,0.00028584898,0.00041016057,0.00009856056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097217737,0.0001430861,0.00016173431,0.000046394154,0.0002198645,0.000034609406,0.0005015382,0.000125929,0.00017549469],"category_scores_gemma":[0.00014395137,0.00010706328,0.00007685755,0.00024755433,0.00030497627,0.000005614554,0.00021505349,0.0002912905,0.0000071980976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009113916,0.000033691744,0.027006106,0.00003764276,0.000049187805,0.0000015514689,0.00016537274,0.00012685239,0.9643856,0.000059946953,0.006315577,0.0017272815],"study_design_scores_gemma":[0.00038431783,0.0001421602,0.0004554814,0.00004092806,0.00000969094,0.0000020130349,0.00006553973,0.00036352154,0.98831517,0.00006227904,0.0100111235,0.0001477678],"about_ca_topic_score_codex":0.00047228736,"about_ca_topic_score_gemma":0.00004666817,"teacher_disagreement_score":0.026550625,"about_ca_system_score_codex":0.0000829058,"about_ca_system_score_gemma":0.0005691732,"threshold_uncertainty_score":0.4365914},"labels":[],"label_agreement":null},{"id":"W4303986990","doi":"10.1158/0008-5472.can-22-1902","title":"Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)","year":2022,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute; Université du Québec à Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Tumor microenvironment; Context (archaeology); Primary tumor; Breast cancer; Cancer; Metastatic breast cancer; Medicine; Dormancy; Cancer research; Oncology; Lymphatic system; Metastasis; Biology; Internal medicine; Immunology","score_opus":0.18639547446669955,"score_gpt":0.47249923960603607,"score_spread":0.28610376513933655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303986990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009070629,0.99475265,0.0000015753914,0.00018040786,0.0002477093,0.0015843236,0.0019348044,0.0000170257,0.00037443565],"genre_scores_gemma":[0.00008011737,0.99381685,0.00010629397,0.00004431638,0.00031265197,0.0018163489,0.00017666283,0.00013572875,0.003511018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605894,0.0005820722,0.00068169966,0.00082162814,0.0011593376,0.0006963499],"domain_scores_gemma":[0.9981147,0.00020513556,0.0002662563,0.000863168,0.00010240617,0.00044834026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012375016,0.00039954437,0.001987462,0.0006231578,0.0001976021,0.000032067353,0.00035497829,0.00012629338,0.013270185],"category_scores_gemma":[0.000023919576,0.0003209807,0.0003396062,0.0009146716,0.00043930224,0.00010433311,0.00041688402,0.0013832047,0.000018528517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012146734,0.00017523565,0.000042460142,0.033740394,0.00053506973,0.00008437969,0.00016120159,7.219629e-7,0.00011521157,0.000026601003,0.0026006517,0.9623966],"study_design_scores_gemma":[0.0007332814,0.0002484793,0.000054038537,0.0060068476,0.00159566,0.00036709703,0.00013632649,7.696506e-7,0.000065116365,0.000009983973,0.99052614,0.00025626962],"about_ca_topic_score_codex":0.0036336419,"about_ca_topic_score_gemma":0.00025275632,"teacher_disagreement_score":0.98792547,"about_ca_system_score_codex":0.0010252098,"about_ca_system_score_gemma":0.0018694409,"threshold_uncertainty_score":0.99992424},"labels":[],"label_agreement":null},{"id":"W4306412026","doi":"10.1158/0008-5472.can-22-1123","title":"The 5-Hydroxymethylcytosine Landscape of Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; University of Toronto; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; National Human Genome Research Institute; Canadian Institutes of Health Research; Jane ja Aatos Erkon Säätiö; Stand Up To Cancer; National Institutes of Health; University of Wisconsin Carbone Cancer Center; Svenska Läkaresällskapet; Safeway Foundation; Prostate Cancer Canada; Vetenskapsrådet; Prostate Cancer Foundation; American Association for Cancer Research; Movember Foundation","keywords":"Cancer; 5-Hydroxymethylcytosine; Prostate; Biology; Medicine; Physiology; Internal medicine; Genetics; DNA methylation; Gene","score_opus":0.03686843628494731,"score_gpt":0.3801408490908182,"score_spread":0.3432724128058709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306412026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532315,0.044410974,0.000012468143,0.0009636353,0.00016606548,0.00022404705,0.00007487796,0.0000029287582,0.0009134759],"genre_scores_gemma":[0.9857783,0.009474679,0.000015111313,0.000026171358,0.0001661735,0.0004985109,0.000029379187,0.000016397742,0.0039953054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987733,0.00023592665,0.00013669912,0.0001996908,0.00039256996,0.00026180825],"domain_scores_gemma":[0.99936867,0.000043248743,0.00005042095,0.00028770042,0.00020587048,0.000044114095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010695073,0.000058114692,0.00006940619,0.00004575356,0.00043944712,0.000017661658,0.00027121577,0.000029339788,0.00019922461],"category_scores_gemma":[0.00006328151,0.000044337474,0.00003925752,0.00027395092,0.00012115189,0.0000012712728,0.00031113904,0.00019064071,0.0000013134618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016824894,0.00002553451,0.009777858,0.000012825618,0.000038873543,7.216831e-7,0.00011814039,0.0017274163,0.9655843,0.0000978363,0.0055521023,0.016896136],"study_design_scores_gemma":[0.00027199907,0.00021620016,0.0017684354,0.0000034799982,0.0000038860408,2.9900303e-7,0.0001768557,0.0000738797,0.6272313,0.00024406885,0.3699486,0.00006096707],"about_ca_topic_score_codex":0.00030477493,"about_ca_topic_score_gemma":0.00021457976,"teacher_disagreement_score":0.3643965,"about_ca_system_score_codex":0.00003289519,"about_ca_system_score_gemma":0.00028130415,"threshold_uncertainty_score":0.33799163},"labels":[],"label_agreement":null},{"id":"W4308653809","doi":"10.1158/0008-5472.can-22-1433","title":"Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; Genentech; National Institutes of Health; University of California, San Francisco; Scheme for Promotion of Academic and Research Collaboration; Astellas Pharma; Clovis Oncology; U.S. Department of Defense; Sanofi; Celgene; Prostate Cancer Foundation; AstraZeneca; Amgen; Pfizer; Advanced Accelerator Applications","keywords":"Prostate cancer; Medicine; Immunotherapy; Cancer; Cancer research; T cell; Immunology; Internal medicine; Immune system","score_opus":0.053846302946261894,"score_gpt":0.41391753279444676,"score_spread":0.36007122984818485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308653809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93425184,0.05739909,0.00000106453,0.0063662212,0.000111973044,0.0011125593,0.00005978356,0.000024527506,0.00067291193],"genre_scores_gemma":[0.9823396,0.012968054,0.0000505906,0.00024667662,0.000086313245,0.0016846111,0.0000075343773,0.00005572492,0.0025608852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970871,0.00037544192,0.00033408942,0.00047654746,0.00085168146,0.00087509106],"domain_scores_gemma":[0.99897987,0.00022078141,0.000070474765,0.0003045541,0.0002976004,0.00012674974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011336925,0.00015480314,0.00036891695,0.00051444944,0.00030700947,0.00002632015,0.00024126844,0.0000073650763,0.00073908264],"category_scores_gemma":[0.00012201348,0.00014422313,0.00004990874,0.0010353419,0.00036041683,0.000071978735,0.0008121859,0.0011569447,0.0000021663195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310399,0.00031493278,0.5570263,0.0022061574,0.0001439518,0.0014485853,0.004728756,0.00029402087,0.4030983,0.00006200209,0.0045480565,0.023797864],"study_design_scores_gemma":[0.049254682,0.004837661,0.34617844,0.0030658839,0.00032087587,0.0008961374,0.047007162,0.009309249,0.30257374,0.0018879059,0.23247653,0.0021917422],"about_ca_topic_score_codex":0.008964457,"about_ca_topic_score_gemma":0.00041080674,"teacher_disagreement_score":0.22792847,"about_ca_system_score_codex":0.00082071306,"about_ca_system_score_gemma":0.00085182884,"threshold_uncertainty_score":0.99763495},"labels":[],"label_agreement":null},{"id":"W4308679208","doi":"10.1158/0008-5472.can-22-1888","title":"Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"Medical Research Council; National Cancer Institute; Cancer Research UK; American Lebanese Syrian Associated Charities; Alberta Machine Intelligence Institute; St. Jude Children's Research Hospital","keywords":"Breast cancer; Haplotype; Oncology; Population; Cancer; Genome-wide association study; Case-control study; Medicine; Genotype; Hazard ratio; Genetics; Internal medicine; Biology; Single-nucleotide polymorphism; Gene; Confidence interval","score_opus":0.027906044414611763,"score_gpt":0.34709214160846613,"score_spread":0.3191860971938544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308679208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922284,0.0038693044,0.00007337438,0.00047426813,0.00006643871,0.00022366122,0.0027333254,0.000010029702,0.00032119517],"genre_scores_gemma":[0.9961452,0.000994706,0.00003179486,0.00008522199,0.00008900399,0.00073609035,0.00033059338,0.00003543491,0.0015519768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980108,0.00037728524,0.00018322724,0.0004352147,0.000628049,0.00036539664],"domain_scores_gemma":[0.99866694,0.00006393656,0.00013211998,0.00045810002,0.0006020926,0.000076784476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070420536,0.00011290275,0.00021674094,0.0003217065,0.00035398378,0.000018426399,0.00040866077,0.00006216151,0.0017717452],"category_scores_gemma":[0.000100634694,0.000105674706,0.00010595286,0.0020643394,0.00022340636,0.000003935172,0.00030600277,0.000325071,0.0000016700053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073057093,0.00017465126,0.70656025,0.000026350803,0.006500994,0.000008971244,0.0006770079,0.13166837,0.14458932,0.000013556002,0.006177522,0.002872437],"study_design_scores_gemma":[0.00093379035,0.00035213548,0.9364796,0.000018240147,0.0007135851,0.000002863951,0.0009677421,0.00038257462,0.034359813,0.000038109727,0.025425015,0.0003264907],"about_ca_topic_score_codex":0.0017578264,"about_ca_topic_score_gemma":0.004004582,"teacher_disagreement_score":0.22991939,"about_ca_system_score_codex":0.0006302033,"about_ca_system_score_gemma":0.0011255374,"threshold_uncertainty_score":0.9991408},"labels":[],"label_agreement":null},{"id":"W4309108362","doi":"10.1158/1538-7445.panca22-a070","title":"Abstract A070: Comparison of pancreatic cancer mouse models identifies potential drivers of tumor initiation and progression","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; KRAS; Pancreatic cancer; Cancer research; Biology; Cre recombinase; Pancreas; Tamoxifen; Cancer; Tumor initiation; Breast cancer; Genetically modified mouse; Carcinogenesis; Pancreatic ductal adenocarcinoma; Transgene; Endocrinology; Gene; Colorectal cancer; Genetics","score_opus":0.12387890341511933,"score_gpt":0.44741804066698887,"score_spread":0.32353913725186956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165076,0.006785044,0.000029220912,0.0002754325,0.00012612606,0.0005778062,0.00018313646,0.000011404002,0.00036106503],"genre_scores_gemma":[0.997184,0.0018374436,0.0000887173,0.000017948121,0.00006504644,0.0003079227,0.000027193497,0.000019909772,0.00045184794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980423,0.00010396584,0.00032853,0.00024568386,0.0010233355,0.00025617165],"domain_scores_gemma":[0.9991164,0.00005750111,0.00017154243,0.00020505924,0.00034376973,0.00010568622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005497939,0.00009123973,0.00036215424,0.00026003143,0.00017077773,0.000014317218,0.0001076692,0.000028395736,0.0009641388],"category_scores_gemma":[0.000029243287,0.00008354206,0.000064838416,0.00035111295,0.00022732977,0.00011037516,0.00016712288,0.0003565546,7.1027796e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019689312,0.00047580426,0.02225924,0.002066478,0.00022083429,0.000030659245,0.003970727,0.006392462,0.9325479,0.00014662828,0.00392263,0.025997689],"study_design_scores_gemma":[0.0039790366,0.00088155485,0.024169331,0.0007662283,0.0003213876,0.000011469163,0.008180047,0.00417331,0.9551529,0.00035653435,0.0017623549,0.0002458116],"about_ca_topic_score_codex":0.003385516,"about_ca_topic_score_gemma":0.00016429575,"teacher_disagreement_score":0.025751878,"about_ca_system_score_codex":0.00024508193,"about_ca_system_score_gemma":0.0004905543,"threshold_uncertainty_score":0.9999491},"labels":[],"label_agreement":null},{"id":"W4309108390","doi":"10.1158/1538-7445.panca22-a054","title":"Abstract A054: Activating transcription factor 3 promotes KRAS-mediated pancreatic ductal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pancreatic cancer; Cancer research; KRAS; ATF3; Stromal cell; Pancreatic Intraepithelial Neoplasia; Biology; Medicine; Pathology; Adenocarcinoma; Cancer; Internal medicine; Gene expression; Pancreatic ductal adenocarcinoma; Gene","score_opus":0.14048492305406354,"score_gpt":0.422392519735828,"score_spread":0.28190759668176446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899,0.002649623,0.000017535162,0.0028496103,0.00016428341,0.0015548773,0.0001381819,0.000100719335,0.0035351762],"genre_scores_gemma":[0.99434155,0.0003567696,0.00013048401,0.0001190876,0.00040691145,0.0015026376,0.00011906264,0.00006104896,0.0029624302],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9956269,0.000491309,0.00040964677,0.0005839272,0.0018371326,0.0010510852],"domain_scores_gemma":[0.9979391,0.00075350015,0.00008243407,0.00044816453,0.00037649414,0.00040027278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015302692,0.00020821625,0.0005577042,0.00049573317,0.0008796815,0.00004769212,0.00032886118,0.00012829261,0.0140211545],"category_scores_gemma":[0.0007370853,0.00018699882,0.00012560443,0.0010015833,0.00035092735,0.00015426672,0.0001814255,0.0020202992,0.00013657463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011238846,0.00041631822,0.4351717,0.00039446898,0.0002711453,0.0003921072,0.002151832,0.0000037680438,0.5544585,0.000073277355,0.002354168,0.003188858],"study_design_scores_gemma":[0.0030341265,0.00145523,0.9766582,0.0001646083,0.00007451671,0.00014818147,0.0024256231,0.0004956798,0.010952906,0.00022017394,0.0041078706,0.00026284892],"about_ca_topic_score_codex":0.001632794,"about_ca_topic_score_gemma":0.000042554555,"teacher_disagreement_score":0.54350555,"about_ca_system_score_codex":0.0013015921,"about_ca_system_score_gemma":0.0017511462,"threshold_uncertainty_score":0.9868802},"labels":[],"label_agreement":null},{"id":"W4309108397","doi":"10.1158/1538-7445.panca22-b036","title":"Abstract B036: The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Genome instability; Cancer; Gene duplication; Cancer research; Adenocarcinoma; Aneuploidy; Pancreatic cancer; Somatic evolution in cancer; Chromosome instability; Tumor progression; Genome; Primary tumor; Gene; Genetics; Metastasis; Chromosome; DNA; DNA damage","score_opus":0.06561900313269729,"score_gpt":0.42663935689311405,"score_spread":0.36102035376041675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822558,0.011158755,0.0000014125751,0.0017364373,0.000020550873,0.001145979,0.000040767267,0.000007050147,0.003633236],"genre_scores_gemma":[0.99768627,0.00041354218,0.000058227557,0.000017249105,0.000076340846,0.0010751844,0.000031438547,0.00001675647,0.0006250108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997612,0.0003169347,0.00036604068,0.00024497457,0.0010693528,0.0003906911],"domain_scores_gemma":[0.99871945,0.0003477345,0.000106560896,0.0004682956,0.00026859686,0.00008934667],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022195876,0.00007980238,0.00035390785,0.00030358363,0.00017476197,0.0000054439633,0.00032724568,0.00005601615,0.0012018548],"category_scores_gemma":[0.00020146444,0.000056724188,0.000057326626,0.0008259286,0.00043776495,0.00003930312,0.00026110758,0.0007456038,0.0000132710675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006772198,0.00031359054,0.64121747,0.0001831548,0.00005114094,0.000024270876,0.001368251,0.000019356023,0.3517818,0.00027064537,0.00015592203,0.0039371904],"study_design_scores_gemma":[0.0009920406,0.00069127005,0.98416626,0.000104984516,0.00003145332,0.000023883222,0.0034030345,0.00031516948,0.00717125,0.0006431594,0.0024043801,0.00005308127],"about_ca_topic_score_codex":0.001328208,"about_ca_topic_score_gemma":0.00004438843,"teacher_disagreement_score":0.3446105,"about_ca_system_score_codex":0.00038437292,"about_ca_system_score_gemma":0.0010018077,"threshold_uncertainty_score":0.99971116},"labels":[],"label_agreement":null},{"id":"W4309108398","doi":"10.1158/1538-7445.panca22-b024","title":"Abstract B024: Phosphoinositide focused CRISPR screen reveals ITGAV as a critical gene in pancreatic cancer growth and invasion","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Biology; KRAS; Cancer; Pancreatic cancer; Signal transduction; Gene; Genetics; Mutation","score_opus":0.05291283046190505,"score_gpt":0.4047778135306629,"score_spread":0.35186498306875785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441095,0.021563271,0.0000067074716,0.0020906813,0.0000699281,0.000639284,0.00036458694,0.000010829139,0.0008437784],"genre_scores_gemma":[0.98938763,0.0074958745,0.000055844703,0.00035139316,0.00018658847,0.001888946,0.00010210887,0.00004706495,0.00048456612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969988,0.0003296382,0.00025444519,0.0007399674,0.00080531096,0.00087185256],"domain_scores_gemma":[0.99891996,0.00013797152,0.00003553944,0.00038871542,0.0001798514,0.0003379848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074520655,0.00019284351,0.00024612306,0.00021415076,0.0004229689,0.000081284044,0.00034688442,0.000081324186,0.0008509273],"category_scores_gemma":[0.00039461555,0.00019164826,0.00006941578,0.00042918746,0.0002678687,0.000015325455,0.0006643554,0.0005511498,0.000013023412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001790665,0.00025591557,0.11497314,0.00015661484,0.000108852866,0.00041136864,0.00014852059,0.000020759218,0.8655148,0.00018084976,0.009848196,0.006590293],"study_design_scores_gemma":[0.004551394,0.0013065069,0.13021316,0.00021363005,0.000036275356,0.00006867993,0.0003982622,0.000031800955,0.8517807,0.002091117,0.00872636,0.0005821123],"about_ca_topic_score_codex":0.042098165,"about_ca_topic_score_gemma":0.0031600434,"teacher_disagreement_score":0.03893812,"about_ca_system_score_codex":0.00035985414,"about_ca_system_score_gemma":0.00080331543,"threshold_uncertainty_score":0.9642806},"labels":[],"label_agreement":null},{"id":"W4309108403","doi":"10.1158/1538-7445.panca22-b075","title":"Abstract B075: Sirtuin 6 histone deacetylase is required for the integrated stress response and resistance to inhibition of transcriptional cyclin dependent kinases in Pancreatic Ductal Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Histone deacetylase; Sirtuin; Biology; Cyclin-dependent kinase; Kinase; SIRT6; Histone; HDAC6; Histone deacetylase inhibitor; Cell biology; Acetylation; Cancer; Cell cycle; Genetics","score_opus":0.04475399065094296,"score_gpt":0.35197842458843615,"score_spread":0.3072244339374932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968407,0.027420625,0.0000610729,0.0016008854,0.00021366792,0.00081275054,0.0014581307,0.0000043472623,0.000021560618],"genre_scores_gemma":[0.9952265,0.0015743827,0.00008639071,0.00014559655,0.0002345284,0.0012426231,0.000103692,0.00002443026,0.0013618326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982159,0.00029507803,0.00028971487,0.00043190958,0.0004325997,0.00033477633],"domain_scores_gemma":[0.9991623,0.0001717087,0.000063278705,0.00029782494,0.00021016724,0.00009472585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013363415,0.00012641962,0.00018741984,0.00016872308,0.00023345069,0.00002139969,0.00020423242,0.00006648155,0.000102324346],"category_scores_gemma":[0.0002681636,0.00011416874,0.000069159585,0.00030133416,0.00019262017,0.000008664164,0.00010897391,0.00025111838,5.6400194e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011493694,0.00009698923,0.0005566855,0.000085064756,0.000036080783,0.0000061084365,0.0006584953,0.00013747765,0.98141724,0.00008188425,0.004735888,0.00069440214],"study_design_scores_gemma":[0.0030823823,0.00060045515,0.12140299,0.00014035836,0.000041795243,0.000012594747,0.0033621683,0.000025770345,0.819233,0.00016851258,0.051647417,0.00028255171],"about_ca_topic_score_codex":0.0008698819,"about_ca_topic_score_gemma":0.0030390217,"teacher_disagreement_score":0.16218422,"about_ca_system_score_codex":0.0001990126,"about_ca_system_score_gemma":0.00052035355,"threshold_uncertainty_score":0.4655666},"labels":[],"label_agreement":null},{"id":"W4309108410","doi":"10.1158/1538-7445.panca22-a077","title":"Abstract A077: PancreaCult™ Organoid Medium Kits support the robust establishment and expansion of human pancreatic duct organoids","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Canada's Michael Smith Genome Sciences Centre; Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; Pancreatic duct; Cell biology; PDX1; Cell culture; Biology; Chemistry; Pancreas; Endocrinology; Islet","score_opus":0.07669552159149606,"score_gpt":0.36456529745821253,"score_spread":0.28786977586671647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309108410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057716,0.0015371214,0.0000023592133,0.002633912,0.0002047162,0.0007209567,0.00005135874,0.000043117656,0.0042292685],"genre_scores_gemma":[0.9943221,0.000524011,0.000035251407,0.00028521742,0.000257333,0.0003901691,0.00008691686,0.000040977397,0.0040579773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969821,0.00023252463,0.00038958006,0.00041240337,0.0014510421,0.00053233444],"domain_scores_gemma":[0.9983273,0.0003564915,0.00010271134,0.00056174974,0.00039203104,0.00025971598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019534673,0.0001745519,0.0004279041,0.00025678825,0.0006531719,0.000038779934,0.00024531706,0.00006282354,0.011287576],"category_scores_gemma":[0.0004187633,0.000121178935,0.00006568342,0.00079815375,0.00037579724,0.000094285846,0.00032139875,0.00073156337,0.000020782678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033995544,0.00022275794,0.048269045,0.0004630603,0.00015509388,0.000056360073,0.0022017437,0.00003077897,0.90180254,0.0002171435,0.04474735,0.0014941852],"study_design_scores_gemma":[0.0054440927,0.0024809083,0.43045822,0.00035090453,0.0003386185,0.00011214377,0.017189011,0.000064497865,0.5157961,0.0003168257,0.027010676,0.00043798386],"about_ca_topic_score_codex":0.0009494629,"about_ca_topic_score_gemma":0.000021884085,"teacher_disagreement_score":0.3860064,"about_ca_system_score_codex":0.0003237976,"about_ca_system_score_gemma":0.0008240692,"threshold_uncertainty_score":0.9896162},"labels":[],"label_agreement":null},{"id":"W4309113436","doi":"10.1158/1538-7445.panca22-b074","title":"Abstract B074: Loss of ATF3 affects the molecular response and epigenetic reprogramming to KRAS-dependent pancreatic ductal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"KRAS; Cancer research; Biology; Pancreatic cancer; Histone; Epigenetics; Histone deacetylase inhibitor; Chromatin; Cancer; Histone deacetylase; Gene; Mutation; Genetics","score_opus":0.06201809569579523,"score_gpt":0.4153252304072144,"score_spread":0.35330713471141917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309113436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790889,0.010940432,0.000024574108,0.0074569965,0.00006673999,0.0018953737,0.000022603155,0.00002051619,0.0004838676],"genre_scores_gemma":[0.99611276,0.00044311583,0.00018157902,0.00018980454,0.00009043152,0.0013287861,0.000005061273,0.000040840907,0.0016075985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955861,0.0011433135,0.00031473624,0.0005598351,0.0016047382,0.0007913008],"domain_scores_gemma":[0.99710333,0.0013727547,0.000069497946,0.00081182463,0.00026578573,0.00037679533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057080067,0.00016013393,0.00048594977,0.0003585005,0.0004939729,0.000032393662,0.00038562194,0.00007425404,0.00075469975],"category_scores_gemma":[0.0012095257,0.00012244604,0.00008432717,0.00079928985,0.00058663357,0.000030281048,0.00067470345,0.00096828566,0.000022898732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009899807,0.0003223217,0.6387747,0.00047339578,0.00039534416,0.0027914643,0.0033659053,0.00006778422,0.33438468,0.0002732296,0.0013866054,0.007864754],"study_design_scores_gemma":[0.0017100906,0.0026998648,0.97333753,0.00014014797,0.00013546468,0.00037396478,0.0030857453,0.000063626496,0.015975246,0.00017350505,0.0021456953,0.00015909593],"about_ca_topic_score_codex":0.0011593688,"about_ca_topic_score_gemma":0.000060395112,"teacher_disagreement_score":0.33456284,"about_ca_system_score_codex":0.0004993412,"about_ca_system_score_gemma":0.0011354089,"threshold_uncertainty_score":0.8263433},"labels":[],"label_agreement":null},{"id":"W4309185558","doi":"10.1158/1538-7445.panca22-b031","title":"Abstract B031: Loss of GATA6 leads to reduced cell fitness and PDA molecular subtype changes","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"GATA6; Biology; Cancer research; Gene expression; Gene; Genetics","score_opus":0.048398920344711174,"score_gpt":0.376097960297738,"score_spread":0.32769903995302685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309185558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134016,0.007064363,0.00004445062,0.0005853969,0.00008866557,0.00023037582,0.00006497997,0.0000030842896,0.0005785119],"genre_scores_gemma":[0.9981257,0.0008896535,0.00009765977,0.000054408887,0.00009176431,0.00013432914,0.0000430954,0.000021398197,0.00054201426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988676,0.0001066776,0.000113724825,0.00031563928,0.00033178646,0.00026459608],"domain_scores_gemma":[0.9993658,0.000019076046,0.00003948473,0.00029339237,0.00018029628,0.00010197038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000591287,0.00008018948,0.00010305962,0.00009692657,0.00012201921,0.000015154451,0.00020731949,0.000055953053,0.00012643564],"category_scores_gemma":[0.00005218855,0.00008586937,0.000026325226,0.00022485324,0.000083561135,0.0000015444473,0.00034142853,0.00016262743,0.0000021309618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010889797,0.0000340328,0.0012479556,0.00005137003,0.00001054147,0.0000058482033,0.00008783939,0.0003472479,0.9947545,0.000032575255,0.00036897257,0.0029502322],"study_design_scores_gemma":[0.00022449325,0.0003986782,0.004614569,0.0000068044437,0.0000037737736,6.594255e-7,0.00007712239,0.000005549581,0.97695315,0.00009668593,0.017520769,0.00009776481],"about_ca_topic_score_codex":0.00017142054,"about_ca_topic_score_gemma":0.000055405173,"teacher_disagreement_score":0.017801356,"about_ca_system_score_codex":0.00003322955,"about_ca_system_score_gemma":0.00014839847,"threshold_uncertainty_score":0.3501651},"labels":[],"label_agreement":null},{"id":"W4309185717","doi":"10.1158/1538-7445.panca22-b066","title":"Abstract B066: Elucidating the role of insulin receptor isoform expression in metastatic pancreatic ductal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Ottawa Hospital; Spinal Cord Injury BC","funders":"","keywords":"Insulin receptor; Insulin; Cancer research; Biology; Endocrinology; Cancer; Internal medicine; Medicine; Insulin resistance","score_opus":0.0792924187879503,"score_gpt":0.4102171607777687,"score_spread":0.3309247419898184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309185717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247623,0.010462214,0.0000049989353,0.0012328533,0.00006485279,0.0011898585,0.000049664704,0.000015576486,0.004503771],"genre_scores_gemma":[0.9963276,0.00075684406,0.00039933992,0.00005819908,0.00013265511,0.0013518301,0.00003222868,0.00003268283,0.0009086506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962283,0.0006574551,0.0005351894,0.00037386085,0.0014825405,0.0007226513],"domain_scores_gemma":[0.9977995,0.0011345826,0.00012528674,0.00053583033,0.00023957655,0.00016523534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038265518,0.0001433272,0.0005320905,0.00041776814,0.00042726996,0.000017524811,0.00045076193,0.000057614878,0.0061535635],"category_scores_gemma":[0.0008371371,0.00010077288,0.0000877446,0.0010604549,0.00039450315,0.000089880865,0.00047034342,0.0015455353,0.000045007346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018478686,0.000547886,0.59358144,0.0003556555,0.00014803634,0.00012718455,0.004962405,0.000044959143,0.38614362,0.0002635629,0.0019675675,0.010009818],"study_design_scores_gemma":[0.0042393203,0.0015105335,0.8895892,0.00055293133,0.00010528163,0.00009754565,0.034930624,0.0012808539,0.058971427,0.0017158309,0.0067522433,0.00025422237],"about_ca_topic_score_codex":0.0023489804,"about_ca_topic_score_gemma":0.00008429444,"teacher_disagreement_score":0.3271722,"about_ca_system_score_codex":0.00067222764,"about_ca_system_score_gemma":0.0013939294,"threshold_uncertainty_score":0.99475497},"labels":[],"label_agreement":null},{"id":"W4309185735","doi":"10.1158/1538-7445.panca22-b029","title":"Abstract B029: Epigenetic characterization of patient-derived organoids and cancer-associated fibroblasts from endoscopic ultrasound of pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; Lawson Health Research Institute; Western University","funders":"","keywords":"Epigenetics; Pancreatic cancer; Gemcitabine; Cancer; Medicine; Cancer research; Oncology; Pathology; Internal medicine; Biology; Gene; Genetics","score_opus":0.04076084027248251,"score_gpt":0.3643490072303221,"score_spread":0.3235881669578396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309185735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287903,0.004271083,0.0000051625425,0.00039665797,0.00013495567,0.0010464885,0.0010885306,0.000018958637,0.00015912372],"genre_scores_gemma":[0.9897793,0.00835002,0.000042370044,0.000057398105,0.0000968966,0.0009721322,0.00020574639,0.000043242973,0.00045288503],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99685746,0.0004310843,0.00056358875,0.0004357909,0.0011376404,0.000574452],"domain_scores_gemma":[0.9977932,0.00077223004,0.00027958746,0.0003546407,0.00057417894,0.0002261764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055274763,0.00018027976,0.0007753736,0.0003032188,0.00026682604,0.000013646118,0.00021307668,0.00012388523,0.008020306],"category_scores_gemma":[0.00042303593,0.00017071568,0.00006473197,0.0007801611,0.00048251677,0.000069986796,0.00021277435,0.0006267676,0.0000031780771],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041035126,0.00020104875,0.33699024,0.00026336056,0.00029156575,0.0000108132535,0.0015370823,0.000011776541,0.65701973,0.00000537149,0.000133151,0.0031254787],"study_design_scores_gemma":[0.0018526512,0.00078815006,0.71132505,0.0004709674,0.00014860561,0.0000020686489,0.0006145218,0.00007282298,0.28429443,0.000077024364,0.00024417712,0.000109524706],"about_ca_topic_score_codex":0.02237299,"about_ca_topic_score_gemma":0.00077192177,"teacher_disagreement_score":0.37433484,"about_ca_system_score_codex":0.0007356316,"about_ca_system_score_gemma":0.0018761082,"threshold_uncertainty_score":0.9928865},"labels":[],"label_agreement":null},{"id":"W4309188841","doi":"10.1158/1538-7445.panca22-c051","title":"Abstract C051: Ceramide signaling regulates PDA aggression through exosome reprogramming of the stroma","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ceramide; Microvesicles; Exosome; Biology; Sphingomyelin; Cancer research; Pancreatic cancer; Tumor progression; Stroma; Sphingomyelin phosphodiesterase; Tumor microenvironment; Cell biology; Cancer; Apoptosis; microRNA; Endocrinology; Immunology; Biochemistry; Cholesterol; Gene","score_opus":0.05253284332530849,"score_gpt":0.369106444805531,"score_spread":0.3165736014802225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309188841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97179615,0.024562716,0.000010525574,0.00039364013,0.0024472054,0.00033851634,0.000047617366,0.000010355371,0.00039324793],"genre_scores_gemma":[0.9923953,0.0017530018,0.00009953518,0.00007717201,0.00392316,0.00024413606,0.000028962415,0.00003327059,0.0014454894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979698,0.00022140371,0.00025520645,0.00044302194,0.00065616914,0.00045439982],"domain_scores_gemma":[0.9989149,0.000038287624,0.00013265389,0.0006638342,0.00018619785,0.00006411257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083442254,0.00012139362,0.00016980826,0.00004960988,0.00049899827,0.000030061661,0.00054663885,0.000076849894,0.00025240425],"category_scores_gemma":[0.00012236497,0.000096774624,0.00014833281,0.0003417632,0.0002464471,0.000007153394,0.0006393214,0.00043407772,0.0000013658484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016980644,0.00004850394,0.0009846237,0.000052964704,0.000039670515,3.824937e-7,0.00025834158,0.00077098294,0.97235006,0.00008003852,0.012038855,0.013205752],"study_design_scores_gemma":[0.00037824377,0.00009242384,0.0023254794,0.00008690572,0.000008444587,0.000005125171,0.00054528017,0.000007481877,0.5145483,0.00026247773,0.48162994,0.00010990459],"about_ca_topic_score_codex":0.0008895747,"about_ca_topic_score_gemma":0.000083429135,"teacher_disagreement_score":0.4695911,"about_ca_system_score_codex":0.00008721902,"about_ca_system_score_gemma":0.0003793744,"threshold_uncertainty_score":0.39463547},"labels":[],"label_agreement":null},{"id":"W4309189138","doi":"10.1158/1538-7445.panca22-a003","title":"Abstract A003: Developmental parallels in pancreatic cancer subtypes revealed by single cell transcriptomics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; KRAS; Pancreatic cancer; Cancer research; Basal (medicine); Gene; Cancer; Mutation; Genetics","score_opus":0.09860176322175405,"score_gpt":0.40045155073893196,"score_spread":0.3018497875171779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309189138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97483873,0.008167758,0.0000057696775,0.0027043049,0.00011937695,0.0012111003,0.00014518062,0.000033801152,0.012773979],"genre_scores_gemma":[0.97722024,0.0032577165,0.00025203745,0.0003641281,0.00011175045,0.0023005486,0.00007128848,0.00005360812,0.016368713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628174,0.0003798421,0.00046686773,0.00054964214,0.001247196,0.0010746836],"domain_scores_gemma":[0.9987821,0.00037521662,0.00006121159,0.00028287154,0.00018070702,0.00031788996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017943728,0.00019842136,0.00061384594,0.00039210543,0.00040078833,0.000030863244,0.00036645858,0.000120182376,0.009475167],"category_scores_gemma":[0.000111367415,0.00019032008,0.000080104706,0.00094365445,0.0002949903,0.00008582123,0.00016039127,0.0014625414,0.00006857186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018137004,0.0009628208,0.58235717,0.0004244986,0.00012307783,0.00029042186,0.0020229318,0.000032450876,0.3503428,0.000025478526,0.058535896,0.003068757],"study_design_scores_gemma":[0.019759938,0.002397271,0.683942,0.0007860094,0.00023150355,0.0001327112,0.010976319,0.00053294917,0.055830337,0.00058683084,0.22361855,0.0012055599],"about_ca_topic_score_codex":0.0058213,"about_ca_topic_score_gemma":0.0008356612,"teacher_disagreement_score":0.29451248,"about_ca_system_score_codex":0.0030255772,"about_ca_system_score_gemma":0.002699001,"threshold_uncertainty_score":0.9914303},"labels":[],"label_agreement":null},{"id":"W4309189468","doi":"10.1158/1538-7445.panca22-a031","title":"Abstract A031: Proteogenomic analysis of the PDAC epithelium reveals tissue markers of subtype identity and biology","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; University of Waterloo; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Biology; Stromal cell; Transcriptome; Proteomics; Cancer research; Gene expression profiling; Proteogenomics; Gene; Computational biology; Gene expression; Bioinformatics; Genetics","score_opus":0.12950571750090592,"score_gpt":0.47604730281210766,"score_spread":0.3465415853112017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309189468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934808,0.0021022905,0.0000106734,0.001130572,0.00005082263,0.0009037029,0.00015534244,0.0000044420945,0.0021613808],"genre_scores_gemma":[0.99681354,0.0006400458,0.00006268201,0.000039439223,0.000036847654,0.00024877032,0.000011833897,0.000010369272,0.0021365057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978733,0.0006828203,0.00032835058,0.00025787498,0.00051862746,0.0003390433],"domain_scores_gemma":[0.9985243,0.00046684872,0.00013043737,0.00046885558,0.00031165272,0.0000978811],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004159738,0.000074654214,0.0005520672,0.00047734048,0.00020782709,0.000005212363,0.00032476967,0.0000673477,0.0043376964],"category_scores_gemma":[0.00053340715,0.00005323116,0.00009906592,0.0015471181,0.00076787214,0.000031616222,0.00044459928,0.0005372751,0.0000041977887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008974163,0.00009775035,0.6466089,0.0002206409,0.0009976522,0.0000065765926,0.00026280544,0.000011000843,0.34782076,0.00040784315,0.0007873644,0.0018813118],"study_design_scores_gemma":[0.0006069873,0.00049766194,0.98663807,0.00003566705,0.0004454697,0.0000053128474,0.00044578058,0.000090865,0.008973133,0.00078506616,0.0014207376,0.000055267745],"about_ca_topic_score_codex":0.005070709,"about_ca_topic_score_gemma":0.00043613923,"teacher_disagreement_score":0.34002918,"about_ca_system_score_codex":0.00024957804,"about_ca_system_score_gemma":0.000738051,"threshold_uncertainty_score":0.9965725},"labels":[],"label_agreement":null},{"id":"W4309190644","doi":"10.1158/1538-7445.panca22-b053","title":"Abstract B053: Targeting SMURF1 with low-dose proteasome inhibitors in pancreatic cancer organoids","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; Spinal Cord Injury BC; Pancreas Centre (Canada)","funders":"","keywords":"Bortezomib; Cancer research; Carfilzomib; Pancreatic cancer; Proteasome; Proteasome inhibitor; Cancer; Biology; Oncology; Medicine; Internal medicine; Bioinformatics; Multiple myeloma; Genetics","score_opus":0.05085420456134391,"score_gpt":0.4022669930523733,"score_spread":0.35141278849102936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309190644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858104,0.0038148346,0.0000025805962,0.0036655923,0.00012301687,0.0025448694,0.00004143281,0.000056658435,0.003940606],"genre_scores_gemma":[0.9860773,0.00084649667,0.00015572045,0.00020846006,0.0004718889,0.006477163,0.000031555726,0.00008214539,0.0056492784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950173,0.00048504167,0.00047820294,0.00068129366,0.001998429,0.0013397717],"domain_scores_gemma":[0.9981779,0.0004079109,0.00009455197,0.0004835621,0.00042648677,0.0004096064],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029874402,0.00024040542,0.00069146405,0.00066934497,0.00058355305,0.000040594252,0.0003720704,0.00012159327,0.009246465],"category_scores_gemma":[0.0004347768,0.00019396584,0.00006822069,0.0020113948,0.0004478833,0.00012864174,0.00036796383,0.0025104778,0.00007130992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029460483,0.00064606726,0.8981994,0.00083398045,0.000185498,0.0011761265,0.0022129654,0.00020920124,0.080151305,0.000058793543,0.008643806,0.0047368533],"study_design_scores_gemma":[0.01519423,0.003409667,0.9182157,0.0024401085,0.00017525344,0.00013448765,0.01124195,0.0010710792,0.02303458,0.0003749319,0.0237515,0.00095650175],"about_ca_topic_score_codex":0.008357749,"about_ca_topic_score_gemma":0.0007834216,"teacher_disagreement_score":0.057116725,"about_ca_system_score_codex":0.002477934,"about_ca_system_score_gemma":0.0044840844,"threshold_uncertainty_score":0.9997908},"labels":[],"label_agreement":null},{"id":"W4309190654","doi":"10.1158/1538-7445.panca22-a036","title":"Abstract A036: Plasma extracellular RNA for the detection of pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Subtyping; Transcriptome; Pancreatic cancer; Liquid biopsy; Gene; RNA; Gene expression profiling; Cancer; Cancer research; Medicine; Gene expression; Biology; Oncology; Internal medicine; Genetics","score_opus":0.04674640545509699,"score_gpt":0.36289596357958465,"score_spread":0.31614955812448764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309190654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580583,0.03947259,0.0007676153,0.00027016472,0.0002629025,0.0007721287,0.00021573124,0.000007948762,0.00017263074],"genre_scores_gemma":[0.99361396,0.0012035604,0.000038058453,0.00002987264,0.00033987575,0.0024383825,0.000028579909,0.000039310104,0.0022684103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984228,0.00014463952,0.00021079878,0.0003402904,0.0004647624,0.0004167364],"domain_scores_gemma":[0.9989702,0.00014198567,0.00008908205,0.0005047252,0.00020656528,0.00008743836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010956867,0.000106760155,0.00011561822,0.00006334326,0.00047993168,0.000020719757,0.0005023806,0.00006184804,0.00048664352],"category_scores_gemma":[0.00017057019,0.000091724265,0.00012510603,0.00022240967,0.00020697003,0.0000039518186,0.00024538883,0.0002962116,0.0000027829703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997126,0.00006474395,0.0002848252,0.00009616298,0.00009806889,0.0000029961489,0.00006479661,0.001759194,0.96956754,0.000050644267,0.0019115192,0.025599808],"study_design_scores_gemma":[0.0005278075,0.00018739501,0.0009804462,0.000013499069,0.000033871416,0.0000019619952,0.00036235127,0.00057022035,0.9114053,0.00012393457,0.085679345,0.00011382672],"about_ca_topic_score_codex":0.00043329803,"about_ca_topic_score_gemma":0.00022730704,"teacher_disagreement_score":0.08376783,"about_ca_system_score_codex":0.00013333552,"about_ca_system_score_gemma":0.00038693316,"threshold_uncertainty_score":0.53284055},"labels":[],"label_agreement":null},{"id":"W4309191159","doi":"10.1158/1538-7445.panca22-c075","title":"Abstract C075: The loss of ATRX induces a sex-specific progression of pancreatic ductal adenocarcinoma in the presence of oncogenic KRASG12D","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"ATRX; Cancer research; Pancreatic cancer; Biology; Cancer; Synthetic lethality; Pancreas; Pathology; Medicine; DNA repair; Internal medicine; Endocrinology; Mutation; Gene","score_opus":0.06153521463569821,"score_gpt":0.38091567039487007,"score_spread":0.31938045575917184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309191159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744281,0.02458662,0.000002987055,0.0002535894,0.00005148777,0.00038880212,0.000060571336,0.0000016821582,0.00022611683],"genre_scores_gemma":[0.99802655,0.0014908899,0.000021293086,0.000011497677,0.00009876014,0.00023357064,0.000016131511,0.000012578421,0.00008871071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981399,0.00034394852,0.00030615757,0.00025054175,0.0007149676,0.00024445652],"domain_scores_gemma":[0.99907285,0.000110569075,0.00013850456,0.0005221181,0.0001304794,0.00002546671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014204491,0.000086495864,0.00016319587,0.000061065315,0.00011823315,0.000008440597,0.00071758166,0.000054397948,0.00009817832],"category_scores_gemma":[0.000058073798,0.000054665285,0.00008074316,0.00038084696,0.0003844735,0.0000037232967,0.0002885126,0.00034188066,4.1522915e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031093578,0.00014288,0.014947754,0.0001746395,0.000047347734,0.0000068075233,0.001853852,0.00066040934,0.97644216,0.00006770872,0.0007037168,0.0046417788],"study_design_scores_gemma":[0.0008459403,0.00084345735,0.05695926,0.00020085764,0.000019866851,0.0000318167,0.0063026478,0.00012324943,0.93121624,0.00035995085,0.00294127,0.00015542768],"about_ca_topic_score_codex":0.0006602664,"about_ca_topic_score_gemma":0.000059588434,"teacher_disagreement_score":0.045225915,"about_ca_system_score_codex":0.00004212846,"about_ca_system_score_gemma":0.00040820043,"threshold_uncertainty_score":0.22291857},"labels":[],"label_agreement":null},{"id":"W4309191349","doi":"10.1158/1538-7445.panca22-a064","title":"Abstract A064: High-throughput organoid drug screening to identify molecular vulnerabilities in pancreatic cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Organoid; KRAS; Pancreatic cancer; Drug repositioning; Drug discovery; Cancer; CDKN2A; Medicine; Drug; Transcriptome; Targeted therapy; Biology; Computational biology; Bioinformatics; Oncology; Cancer research; Internal medicine; Pharmacology; Gene; Colorectal cancer; Genetics","score_opus":0.0354162529900986,"score_gpt":0.38024007301001345,"score_spread":0.34482382001991485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309191349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921406,0.007056782,0.00015307222,0.001885273,0.0003704298,0.00058174244,0.00033911632,0.000012666979,0.00038683048],"genre_scores_gemma":[0.99438983,0.0011903851,0.00024205544,0.0007647462,0.00042235458,0.0017230123,0.00009986488,0.00006937487,0.0010983851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973592,0.00021783906,0.00032041947,0.0007202408,0.00063409394,0.00074820133],"domain_scores_gemma":[0.9988321,0.000106667685,0.00005501443,0.0005961239,0.0002158783,0.000194182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010347879,0.00019581131,0.00024708346,0.000230215,0.00034855428,0.00009533206,0.0005793225,0.00007119162,0.0012878466],"category_scores_gemma":[0.00025572698,0.0002251713,0.000079207945,0.0006018019,0.0001227666,0.000007781283,0.00092793937,0.00055227434,0.00001619288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033419268,0.00010325467,0.011394151,0.000091607566,0.00007677369,0.00006851994,0.0006330845,0.035544466,0.92272353,0.00035331707,0.024646576,0.0040305345],"study_design_scores_gemma":[0.002007288,0.00045788396,0.050665326,0.00014684045,0.000030819927,0.000008846979,0.0030139878,0.00007185061,0.7525168,0.0011644961,0.18900493,0.0009109432],"about_ca_topic_score_codex":0.017274538,"about_ca_topic_score_gemma":0.004875054,"teacher_disagreement_score":0.17020673,"about_ca_system_score_codex":0.0004804514,"about_ca_system_score_gemma":0.0007409614,"threshold_uncertainty_score":0.9996251},"labels":[],"label_agreement":null},{"id":"W4309223929","doi":"10.1158/1538-7445.panca22-a007","title":"Abstract A007: Pancreatic cancer comprises co-existing transcriptional states regulated by distinct master regulator programs","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Pancreatic cancer; Cancer; Cancer research; Regulator; Clear cell renal cell carcinoma; Gene; Genetics; Medicine; Renal cell carcinoma; Oncology","score_opus":0.0756722674089933,"score_gpt":0.3671233186833895,"score_spread":0.2914510512743962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309223929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834712,0.012391775,0.000049753802,0.0007065406,0.00026346341,0.00061301625,0.0017363223,0.00002542778,0.00074247416],"genre_scores_gemma":[0.9915322,0.0013732057,0.000059808826,0.00016300182,0.00045735255,0.0013044445,0.0017619715,0.00006927923,0.0032787358],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975212,0.00015065294,0.00033666065,0.0006221525,0.0006742965,0.0006950184],"domain_scores_gemma":[0.9989565,0.00007925926,0.00009984705,0.00039519687,0.00026186547,0.00020733514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006009321,0.0002150991,0.00023156972,0.00007976758,0.00062817003,0.000118018455,0.0004138476,0.00008677695,0.0012701085],"category_scores_gemma":[0.000052857977,0.00022306254,0.000107640306,0.0002707215,0.00031019025,0.0000068440368,0.00021012811,0.0004154581,0.000007966666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090839434,0.00029917722,0.02255464,0.00016778405,0.0002279713,0.000018703064,0.00025278318,0.0016056823,0.8520906,0.00012226975,0.10445496,0.017297067],"study_design_scores_gemma":[0.00164692,0.00054388354,0.019519106,0.0000851948,0.000040076207,0.000011053062,0.00055159663,0.00030209037,0.06435086,0.00025830083,0.9121475,0.00054340536],"about_ca_topic_score_codex":0.0018263285,"about_ca_topic_score_gemma":0.0003809555,"teacher_disagreement_score":0.8076926,"about_ca_system_score_codex":0.00033000438,"about_ca_system_score_gemma":0.0005405273,"threshold_uncertainty_score":0.99964285},"labels":[],"label_agreement":null},{"id":"W4310959732","doi":"10.1158/0008-5472.can-22-2912","title":"The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Weill Cornell Medical College; National Institutes of Health; National Institute of Allergy and Infectious Diseases; C.V. Starr Center for the Study of the American Experience, Washington College","keywords":"Cytidine deaminase; Somatic hypermutation; Mutagenesis; Biology; APOBEC3G; Cancer; Somatic evolution in cancer; Genome instability; Genetics; APOBEC; Cancer research; Bladder cancer; Insertional mutagenesis; Mutation; Cancer cell; Genome; Gene; DNA damage; DNA","score_opus":0.034200783902671485,"score_gpt":0.38649300469306286,"score_spread":0.35229222079039135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310959732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232472,0.07269385,0.00013672649,0.0030934128,0.00019601593,0.00041228376,0.00013922098,0.0000038666954,0.00007743201],"genre_scores_gemma":[0.9860914,0.009862064,0.000017505134,0.00013814206,0.00022951828,0.0019849797,0.000025041743,0.000021037635,0.0016303305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983719,0.00029252743,0.00017234414,0.00037843746,0.00035243962,0.0004323463],"domain_scores_gemma":[0.9993372,0.00007496368,0.000034575398,0.00023173809,0.00022483051,0.00009671232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011285704,0.000101921134,0.00010561416,0.000112544665,0.0006228683,0.000045079127,0.00021845443,0.000060336693,0.000119738594],"category_scores_gemma":[0.00013230597,0.00008751464,0.00003145452,0.0004411927,0.00012277185,0.0000032809078,0.00039667255,0.0002209979,0.0000015492989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035061713,0.000035532077,0.03267373,0.000013400641,0.00005968714,0.0000033219792,0.00011395246,0.0050383704,0.9393536,0.00024278401,0.0029934284,0.01912161],"study_design_scores_gemma":[0.0012171901,0.00034237115,0.13624495,0.000026304051,0.000021344724,0.0000012057106,0.0006081034,0.00051866664,0.5518065,0.00087654695,0.30804586,0.00029094235],"about_ca_topic_score_codex":0.005600352,"about_ca_topic_score_gemma":0.013431295,"teacher_disagreement_score":0.38754705,"about_ca_system_score_codex":0.00036536387,"about_ca_system_score_gemma":0.00048711663,"threshold_uncertainty_score":0.8466094},"labels":[],"label_agreement":null},{"id":"W4311092858","doi":"10.1158/1538-7445.crc22-a010","title":"Abstract A010: Molecular characteristics and prognosis of early-onset colorectal cancer according to detailed anatomical locations: Comparison to later-onset cases","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"KRAS; Microsatellite instability; Colorectal cancer; Rectum; Ascending colon; Medicine; Cecum; Internal medicine; Descending colon; Oncology; Cancer; Gastroenterology; Pathology; Biology; Allele; Genetics; Microsatellite; Gene","score_opus":0.08351651842178887,"score_gpt":0.4192397456211893,"score_spread":0.33572322719940045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311092858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436,0.0009522982,0.00001556247,0.0017509072,0.00026680762,0.0018945507,0.0006791159,0.000034785357,0.00004595438],"genre_scores_gemma":[0.9958346,0.00010636249,0.00029401982,0.00025943876,0.0000853994,0.0032690177,0.00003988293,0.0000571312,0.00005417299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970675,0.00019850551,0.00048110797,0.00057680806,0.0010442513,0.00063181063],"domain_scores_gemma":[0.99818,0.0003911406,0.00009768672,0.00032350418,0.00053474423,0.00047292496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006762377,0.00020856896,0.0005351535,0.00049446255,0.00027712042,0.000055320947,0.00030013896,0.00008821179,0.0008922646],"category_scores_gemma":[0.00053907733,0.00021351306,0.00007012104,0.0010585311,0.00020895815,0.00004346217,0.00055051217,0.0007173595,0.000014418591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022091158,0.0001899601,0.8291472,0.00021669302,0.00011585524,0.00008326966,0.0010281287,0.0001985633,0.15705207,0.0000039871047,0.0021757854,0.0075793783],"study_design_scores_gemma":[0.0006641658,0.0015106156,0.79640245,0.00022877613,0.000064242275,0.000042711683,0.0010059217,0.00017568158,0.19849828,0.00001382824,0.0011530715,0.00024022715],"about_ca_topic_score_codex":0.002361442,"about_ca_topic_score_gemma":0.00055517425,"teacher_disagreement_score":0.04144622,"about_ca_system_score_codex":0.0009606573,"about_ca_system_score_gemma":0.0009626144,"threshold_uncertainty_score":0.97696716},"labels":[],"label_agreement":null},{"id":"W4311092960","doi":"10.1158/1538-7445.crc22-b005","title":"Abstract B005: Investigating the effects of cancer treatment on gut microbiota in colorectal cancer patients: Study protocol","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Colorectal cancer; Gut flora; Dysbiosis; Adverse effect; Cancer; Discontinuation; Internal medicine; Quality of life (healthcare); Disease; Oncology; Depression (economics); Immunology","score_opus":0.04092190232383956,"score_gpt":0.4275851910890145,"score_spread":0.3866632887651749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311092960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95362145,0.00039160394,2.6026498e-8,0.0002676084,0.00014435101,0.045363773,0.00012368614,0.0000040914315,0.00008341098],"genre_scores_gemma":[0.8032336,0.000096377684,0.000002397383,0.00011525127,0.000098921264,0.19623332,0.000018485036,0.000023440043,0.000178189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980664,0.00042426595,0.00027407784,0.00044092914,0.000318555,0.00047575965],"domain_scores_gemma":[0.99932045,0.00007862733,0.00011458286,0.0002659881,0.00014306427,0.0000772836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045402642,0.00016230604,0.00019668322,0.000102595,0.00034497268,0.000018826353,0.00033636726,0.00006066521,0.0001612169],"category_scores_gemma":[0.00006425944,0.0001174137,0.000055491742,0.00034706926,0.00014884793,0.000003091948,0.00026351624,0.00040003625,0.00000203395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043640344,0.0009594485,0.12649404,0.00017442685,0.00006333661,0.0000033418528,0.0010585297,0.00017634823,0.8653019,0.00000238765,0.0021828886,0.0031469502],"study_design_scores_gemma":[0.0038918112,0.0044604223,0.4793011,0.00012862269,0.000010333749,3.700804e-7,0.0005517496,0.0000036345457,0.50044006,0.0000047648914,0.011045062,0.00016203722],"about_ca_topic_score_codex":0.014741347,"about_ca_topic_score_gemma":0.009917944,"teacher_disagreement_score":0.36486182,"about_ca_system_score_codex":0.00075893104,"about_ca_system_score_gemma":0.0011114909,"threshold_uncertainty_score":0.99181956},"labels":[],"label_agreement":null},{"id":"W4311098240","doi":"10.1158/1538-7445.cancepi22-pr004","title":"Abstract PR004: High-density CRISPR screens reveal mechanisms of chromatin regulation of stemness networks in acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Biology; Chromatin; CRISPR; Epigenetics; Myeloid leukemia; Cancer research; Genetics; Cell biology; Gene","score_opus":0.0207354049729865,"score_gpt":0.35167746133633937,"score_spread":0.3309420563633529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102974,0.0006326534,0.0077132643,0.00006211198,0.0001261946,0.0002887628,0.00005108737,0.0000051233555,0.00009106248],"genre_scores_gemma":[0.998892,0.00015939277,0.00036967345,0.000010757142,0.00008274153,0.00008561814,0.00008149943,0.00002044051,0.00029786248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867594,0.000109872715,0.00027777115,0.0002672119,0.0003862855,0.00028290672],"domain_scores_gemma":[0.9993633,0.000021972273,0.00007757683,0.0003318373,0.0001547011,0.000050583447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008450053,0.00009319728,0.0001865546,0.00011420541,0.000078318575,0.0000059173,0.00023993671,0.00009011594,0.000094644114],"category_scores_gemma":[0.000027881366,0.00010287592,0.00005067317,0.0003026722,0.00006451585,0.0000034698855,0.00028293903,0.00027286846,3.888856e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016589914,0.000025519787,0.00037141485,0.00008010867,0.00003575215,0.0000038122353,0.000057021854,0.056899507,0.939486,0.00014318243,0.0008296415,0.0019021158],"study_design_scores_gemma":[0.0004713978,0.00020589556,0.08792498,0.000041383853,0.000008034644,0.0000035224934,0.00015045093,0.0011213422,0.9095581,0.00023115119,0.00017784159,0.00010585888],"about_ca_topic_score_codex":0.0015326698,"about_ca_topic_score_gemma":0.00033675987,"teacher_disagreement_score":0.08755356,"about_ca_system_score_codex":0.00013777956,"about_ca_system_score_gemma":0.00020402376,"threshold_uncertainty_score":0.41951585},"labels":[],"label_agreement":null},{"id":"W4311098395","doi":"10.1158/1538-7445.cancepi22-a007","title":"Abstract A007: Integrative multiomic analysis reveals NOTCH signaling is derepressed by loss of PRC2 in malignant peripheral nerve sheath tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"PRC2; Cancer research; Biology; Epigenetics; Histone H3; EZH2; Epigenomics; Genetics; DNA methylation; Gene; Gene expression","score_opus":0.06122796140405693,"score_gpt":0.3865045323685219,"score_spread":0.32527657096446494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961661,0.0016992781,0.000009644613,0.00087528455,0.00004637818,0.0006620228,0.0003332722,0.000018499863,0.00018952142],"genre_scores_gemma":[0.9984661,0.00009456993,0.0000773268,0.00013149616,0.00005703509,0.00042041304,0.00006293106,0.000036072455,0.00065407896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967404,0.00040379062,0.00061682356,0.0006031267,0.0010865955,0.000549239],"domain_scores_gemma":[0.99862206,0.00029600642,0.00014773196,0.00043610434,0.00032053026,0.00017757705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001229617,0.00019126132,0.0007090004,0.00065381854,0.0001923947,0.000037315578,0.00028704287,0.00005581863,0.0038108628],"category_scores_gemma":[0.0001233182,0.0001592268,0.00026011321,0.002021072,0.00018715156,0.00009700948,0.00019072222,0.00080891466,0.000003625701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000879058,0.0003133049,0.10134939,0.0001551123,0.00030892267,0.00062670175,0.0024281286,0.0007825037,0.8869847,0.000016697033,0.0058359695,0.00031951928],"study_design_scores_gemma":[0.0023723154,0.0006824623,0.09219293,0.0004547798,0.00015600146,0.000039097034,0.005353798,0.0014613653,0.8963702,0.00006187081,0.000556223,0.00029896104],"about_ca_topic_score_codex":0.006329326,"about_ca_topic_score_gemma":0.000097483884,"teacher_disagreement_score":0.0093855,"about_ca_system_score_codex":0.0005305503,"about_ca_system_score_gemma":0.00044551416,"threshold_uncertainty_score":0.9970998},"labels":[],"label_agreement":null},{"id":"W4311098671","doi":"10.1158/1538-7445.cancepi22-a010","title":"Abstract A010: Methylation profiling reveals the role of PRC2 in regulating DNA methylome stochasticity in malignant peripheral nerve sheath tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"PRC2; Biology; Epigenetics; DNA methylation; Cancer research; Methylation; Genetics; CpG site; Carcinogenesis; EZH2; Cancer; Gene; Gene expression","score_opus":0.07100068802872331,"score_gpt":0.37606677723765597,"score_spread":0.30506608920893263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624866,0.0015778585,0.000006752254,0.0006276525,0.000042136977,0.0010658107,0.000025792753,0.000014221006,0.00039112355],"genre_scores_gemma":[0.9990748,0.000014462042,0.00015205637,0.000026059432,0.000077738914,0.0005400651,0.0000115619205,0.000029579342,0.00007367125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970483,0.00057739235,0.0005671732,0.00036124326,0.0009724097,0.00047345375],"domain_scores_gemma":[0.9989023,0.00043038226,0.0001250532,0.00031765163,0.00014409407,0.00008052037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036844611,0.00012162533,0.00036582135,0.00034400655,0.00018248709,0.000024058145,0.00020483242,0.000041478277,0.00029271387],"category_scores_gemma":[0.0004405621,0.000092638744,0.000076061755,0.0010384026,0.00009762658,0.00009121815,0.00020705863,0.0008688734,9.101445e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044677051,0.000109711764,0.05446844,0.00015890818,0.000012189229,0.000106573025,0.0016351318,0.003490928,0.9371749,0.00067883346,0.000017649145,0.0016999199],"study_design_scores_gemma":[0.0014329427,0.00062492635,0.4139664,0.00064618466,0.000012602983,0.00005941802,0.009010985,0.0068741674,0.5657604,0.0013193043,0.000098480814,0.00019424349],"about_ca_topic_score_codex":0.0019367164,"about_ca_topic_score_gemma":0.00008337016,"teacher_disagreement_score":0.3714146,"about_ca_system_score_codex":0.0004678321,"about_ca_system_score_gemma":0.00041782742,"threshold_uncertainty_score":0.37776983},"labels":[],"label_agreement":null},{"id":"W4311194927","doi":"10.1158/1538-7445.cancepi22-b002","title":"Abstract B002: A CRISPR/Cas9 screening strategy for identifying modifiers of the viral mimicry response","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Molecular mimicry; Cell biology; Trans-activating crRNA; Interferon; CRISPR; Genetics; Immune system; Cas9; Gene","score_opus":0.11434967116983762,"score_gpt":0.4658976351301807,"score_spread":0.35154796396034305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311194927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926977,0.0022716557,0.0040035504,0.00025496376,0.0001651978,0.00037282598,0.0001196146,0.0000053065482,0.00010917718],"genre_scores_gemma":[0.9984485,0.00006169605,0.0001815867,0.000036321577,0.00012107934,0.00028773228,0.000013539337,0.000025527655,0.00082400657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987641,0.00013901187,0.00016423105,0.0002604684,0.00032358832,0.00034863193],"domain_scores_gemma":[0.99938023,0.00006424174,0.000040153802,0.00034484948,0.00011734448,0.000053153333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012152907,0.00008479595,0.00009330103,0.00007622609,0.00032982067,0.000024608147,0.00040890064,0.000050654347,0.00006944853],"category_scores_gemma":[0.00013606722,0.00007731589,0.00011461202,0.00017340569,0.00009272151,0.0000029923767,0.0003212696,0.0002739286,4.6246322e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080821844,0.000016776798,0.0001346328,0.00005461445,0.000035555768,0.0000015058937,0.00012876357,0.028081091,0.9648603,0.000023710687,0.0033090862,0.0025457432],"study_design_scores_gemma":[0.0006007768,0.00022251863,0.006858013,0.000024961528,0.000009204038,0.0000050797485,0.0012986095,0.00054540084,0.9699891,0.00008967101,0.020224182,0.00013244072],"about_ca_topic_score_codex":0.00015780391,"about_ca_topic_score_gemma":0.000030747065,"teacher_disagreement_score":0.02753569,"about_ca_system_score_codex":0.000049008795,"about_ca_system_score_gemma":0.00023429774,"threshold_uncertainty_score":0.31528503},"labels":[],"label_agreement":null},{"id":"W4311288760","doi":"10.1158/0008-5472.can-22-2770","title":"A Genetically Encoded Magnetic Resonance Imaging Reporter Enables Sensitive Detection and Tracking of Spontaneous Metastases in Deep Tissues","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Ontario Institute for Cancer Research; Western University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Metastasis; Magnetic resonance imaging; Cancer cell; Cancer; Bioluminescence imaging; Reporter gene; In vivo; Context (archaeology); Cancer research; Lymph node; Pathology; Primary tumor; Preclinical imaging; Biology; Medicine; Gene; Transfection; Radiology; Internal medicine; Gene expression","score_opus":0.04246353775952633,"score_gpt":0.33241381022570843,"score_spread":0.2899502724661821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311288760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902979,0.008845723,0.00020652822,0.00011019251,0.000066261404,0.00024669888,0.000060261096,0.000016339678,0.0001500625],"genre_scores_gemma":[0.9990108,0.00020949969,0.00052626233,0.000032587795,0.000030077692,0.00010950324,0.0000027763347,0.000012504898,0.000065971064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795586,0.00058198086,0.00026666286,0.00034245345,0.0005357845,0.00031725108],"domain_scores_gemma":[0.9993724,0.00020777008,0.000047555273,0.0001609082,0.00016045627,0.000050916697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013643228,0.000082661965,0.0001899072,0.00020084708,0.00021544652,0.000053719163,0.00011317075,0.000014585679,0.0006818849],"category_scores_gemma":[0.00009010143,0.00007916419,0.000024374784,0.00034098275,0.0002161128,0.00010711272,0.00012692706,0.00017103483,0.0000024115864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000242936,0.0000291598,0.00026065676,0.0000381356,0.000001965384,0.0012695658,0.00090673275,0.00012643234,0.9740772,0.00006816435,0.000005861823,0.022973176],"study_design_scores_gemma":[0.00036520362,0.00022280954,0.005578548,0.000049194547,0.000012303493,0.0008205625,0.001421739,0.0009045435,0.98833483,0.0012172546,0.0009453357,0.00012765254],"about_ca_topic_score_codex":0.0018823794,"about_ca_topic_score_gemma":0.0021358905,"teacher_disagreement_score":0.022845523,"about_ca_system_score_codex":0.000090498914,"about_ca_system_score_gemma":0.00007793258,"threshold_uncertainty_score":0.7466161},"labels":[],"label_agreement":null},{"id":"W4317104887","doi":"10.1158/1538-7445.agca22-b024","title":"Abstract B024: Increasing cellular longevity in budding yeast by activating the Anaphase Promoting Complex","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Aging, and Longevity in Model Organisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Biology; Anaphase-promoting complex; Model organism; Ubiquitin ligase; Longevity; Cell biology; Mitosis; Function (biology); Genetic screen; Multicellular organism; Genetics; Phenotype; Gene; Ubiquitin","score_opus":0.08435170655315874,"score_gpt":0.3824924143113434,"score_spread":0.2981407077581847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317104887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975368,0.0007326324,0.00014196734,0.0006971431,0.00008406027,0.00036093526,0.000035755034,0.000026960333,0.00038374678],"genre_scores_gemma":[0.9987492,0.0003276408,0.00008435773,0.00007499356,0.000344363,0.00006872515,0.000116134375,0.000046777506,0.00018778183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977978,0.0003117747,0.00024616113,0.00048450928,0.00043675312,0.0007230314],"domain_scores_gemma":[0.9991612,0.00009163317,0.00006995007,0.0004268792,0.00013537373,0.0001149999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025642435,0.00016002859,0.00015609048,0.00012543406,0.0004154307,0.00012230399,0.00046227276,0.00012396976,0.00007542913],"category_scores_gemma":[0.0004202424,0.00014051025,0.00005625262,0.00054995506,0.00020752668,0.000009281213,0.00035949345,0.0004951781,0.00002541992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003531902,0.000039420207,0.0061603556,0.00006741861,0.000020108131,0.000013233311,0.0008554718,0.0003215691,0.9844219,0.0000055030146,0.002400205,0.0056595076],"study_design_scores_gemma":[0.0005458266,0.00007922971,0.028928177,0.00010890702,0.0000049568316,0.000005138773,0.0012370615,0.001818264,0.95686203,0.000093391915,0.010034208,0.0002828099],"about_ca_topic_score_codex":0.0017041598,"about_ca_topic_score_gemma":0.00039789395,"teacher_disagreement_score":0.027559862,"about_ca_system_score_codex":0.00009044561,"about_ca_system_score_gemma":0.00016005193,"threshold_uncertainty_score":0.57298416},"labels":[],"label_agreement":null},{"id":"W4317105297","doi":"10.1158/1538-7445.agca22-b006","title":"Abstract B006: Does TFPI1 drive development of multiple drug resistant cancer and can the anaphase promoting complex prevent it","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Nuclear localization sequence; Regulator; Cell biology; Biology; Cancer cell; Ubiquitin ligase; Multiple drug resistance; NLS; Nuclear transport; Mutant; Cancer research; Cancer; Cell nucleus; Nucleus; Ubiquitin; Drug resistance; Genetics; Gene","score_opus":0.055959072488438594,"score_gpt":0.37898167736911875,"score_spread":0.32302260488068013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317105297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967139,0.0008587143,0.0000072146536,0.0015839888,0.000057996553,0.0005116757,0.00016759995,0.000008544074,0.00009041343],"genre_scores_gemma":[0.9963286,0.0018354957,0.00011650361,0.0000612659,0.00011338911,0.00030441803,0.00009587797,0.000022848173,0.0011216359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861205,0.00008065143,0.0002534393,0.0003535491,0.00028722483,0.0004131133],"domain_scores_gemma":[0.9992723,0.000056432393,0.000075673,0.00028709206,0.00021541411,0.0000930826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079204194,0.000120891615,0.00013740524,0.00007266395,0.00030173984,0.00003179411,0.0002717252,0.00006323644,0.000043004384],"category_scores_gemma":[0.00008309876,0.00007974902,0.00004040921,0.00022699627,0.00020836844,0.00000318585,0.00030832746,0.00017921376,0.0000020972905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008440311,0.000043439893,0.0025335257,0.0001800907,0.00008468791,0.0000036845115,0.0020046087,0.000032964464,0.9808521,0.000008467129,0.005036425,0.009135546],"study_design_scores_gemma":[0.0004956474,0.00004448119,0.021748243,0.0001655548,0.000008421448,7.592969e-7,0.0016203827,0.00016359914,0.91711974,0.000028679298,0.058442988,0.00016147985],"about_ca_topic_score_codex":0.0014636808,"about_ca_topic_score_gemma":0.026687304,"teacher_disagreement_score":0.06373239,"about_ca_system_score_codex":0.00007360175,"about_ca_system_score_gemma":0.000521489,"threshold_uncertainty_score":0.99107313},"labels":[],"label_agreement":null},{"id":"W4317107485","doi":"10.1158/1538-7445.metastasis22-pr002","title":"Abstract PR002: Identification of metabolic adaptation mechanisms that drive anoikis suppression and metastasis in Ewing sarcoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Anoikis; Cancer research; Chemistry; Programmed cell death; Glutathione; Cancer cell; Metastasis; Biology; Cell biology; Cancer; Biochemistry; Apoptosis; Genetics; Enzyme","score_opus":0.10244917023270388,"score_gpt":0.3955621016635948,"score_spread":0.2931129314308909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317107485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532217,0.0030353835,0.00089642877,0.00024857902,0.00006814634,0.00026588852,0.000059506747,0.0000071884997,0.00009672908],"genre_scores_gemma":[0.9935369,0.0056017637,0.00013459935,0.00000935011,0.00003970616,0.00024129907,0.00009475707,0.0000148466,0.00032678604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988518,0.00011152222,0.00020345756,0.00031082128,0.0002967099,0.00022569024],"domain_scores_gemma":[0.9994116,0.000028401413,0.00007437972,0.00027184509,0.00016527841,0.000048522892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009094716,0.00007554505,0.000114724615,0.00023864486,0.000091334485,0.000032053762,0.00013867085,0.000079564044,0.00003660257],"category_scores_gemma":[0.00007358413,0.00007167127,0.00003390312,0.00044718283,0.00008013525,0.00001575483,0.0000900929,0.0001109165,0.0000067415067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004194181,0.00002080045,0.0008083546,0.000038456026,0.000021715914,9.523947e-7,0.000267717,0.00024769537,0.9695961,0.00059368263,0.00031666836,0.028045908],"study_design_scores_gemma":[0.00027248086,0.000027234057,0.105386294,0.000031792304,0.000007684694,5.629045e-7,0.0009401034,0.0004327324,0.8901535,0.0006324025,0.002040771,0.000074411706],"about_ca_topic_score_codex":0.00036031628,"about_ca_topic_score_gemma":0.00016588163,"teacher_disagreement_score":0.10457794,"about_ca_system_score_codex":0.000020093481,"about_ca_system_score_gemma":0.00010521105,"threshold_uncertainty_score":0.29226696},"labels":[],"label_agreement":null},{"id":"W4317107626","doi":"10.1158/1538-7445.metastasis22-a033","title":"Abstract A033: Identification of gemcitabine-resistant populations using scRNA-sequencing in triple negative breast cancer patient-derived xenograft","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Triple-negative breast cancer; Gemcitabine; Breast cancer; Medicine; Metastasis; Oncology; Chemotherapy; Cancer; Doxorubicin; Population; Internal medicine; Cancer research; Paclitaxel","score_opus":0.10392987013910555,"score_gpt":0.3990078356791861,"score_spread":0.29507796554008053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317107626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997128,0.0010708983,0.000045724355,0.0002190452,0.00024429534,0.00042883446,0.0007977039,0.000009242373,0.000056235884],"genre_scores_gemma":[0.99793434,0.001409178,0.00008566029,0.000023268747,0.00016435572,0.000183119,0.00011242756,0.00003093535,0.000056724384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839544,0.000075077805,0.00042594806,0.00036836072,0.00032245726,0.00041273545],"domain_scores_gemma":[0.99893636,0.000048372738,0.00014939206,0.0003174288,0.00046047813,0.00008796249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004609557,0.00011859238,0.00016288561,0.00029525982,0.00015274844,0.00004454979,0.00019752652,0.000102294725,0.000055883218],"category_scores_gemma":[0.00023114267,0.00012735624,0.0000666035,0.00085370307,0.00014959514,0.000012777447,0.00014532023,0.000172788,0.000004990115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016909358,0.000024376737,0.005463568,0.00005588218,0.00002575485,0.0000046226573,0.0003176222,0.012370777,0.97860307,0.000051706753,0.00055424444,0.0023593085],"study_design_scores_gemma":[0.00089876744,0.00007351059,0.23734576,0.00018447943,0.000015653533,0.0000020158607,0.0013147134,0.0019076531,0.7572308,0.000453068,0.0003231832,0.00025040243],"about_ca_topic_score_codex":0.015041297,"about_ca_topic_score_gemma":0.006967309,"teacher_disagreement_score":0.2318822,"about_ca_system_score_codex":0.00046838127,"about_ca_system_score_gemma":0.00086810713,"threshold_uncertainty_score":0.9915176},"labels":[],"label_agreement":null},{"id":"W4317107792","doi":"10.1158/1538-7445.metastasis22-a047","title":"Abstract A047: Tumor-derived bacteria drive breast cancer metastasis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Metastasis; Breast cancer; Metastatic breast cancer; Immune system; Primary tumor; Tumor progression; Cancer; Syngenic; Cancer research; Medicine; Tumor microenvironment; Microbiome; Disease; Biology; Immunology; Pathology; Internal medicine; Bioinformatics","score_opus":0.0659127661064721,"score_gpt":0.4164104737135872,"score_spread":0.35049770760711507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317107792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993823,0.0016325007,0.0000031937307,0.001472458,0.00021094896,0.0004707211,0.0016504062,0.000048231275,0.000688521],"genre_scores_gemma":[0.99067485,0.004942406,0.000023759412,0.00010793007,0.00067629135,0.0011541047,0.00033683315,0.00006735506,0.0020164703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971125,0.00015097605,0.00021020624,0.0007104549,0.00070405094,0.0011117704],"domain_scores_gemma":[0.9984958,0.00003941855,0.000050940864,0.0006069185,0.00042703515,0.00037987746],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054967863,0.00022272821,0.00022913903,0.00023816002,0.0003799088,0.00016369206,0.00047864343,0.00010418232,0.0019523345],"category_scores_gemma":[0.00007149009,0.00019838105,0.00014186953,0.00075826293,0.00035050686,0.000014198164,0.00042325043,0.0003337956,0.0004276225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000496929,0.0000707762,0.004048252,0.00006936238,0.00034440658,0.00010040765,0.000065240514,0.000031442727,0.9358007,0.000010634485,0.044539273,0.0144226],"study_design_scores_gemma":[0.0017476047,0.00022061096,0.17447,0.00010564973,0.000025767811,0.00002189993,0.00024089144,0.00001166488,0.71536577,0.00011299426,0.107286625,0.00039050094],"about_ca_topic_score_codex":0.006358533,"about_ca_topic_score_gemma":0.0031377922,"teacher_disagreement_score":0.22043489,"about_ca_system_score_codex":0.0002377906,"about_ca_system_score_gemma":0.0010486754,"threshold_uncertainty_score":0.99896},"labels":[],"label_agreement":null},{"id":"W4317107798","doi":"10.1158/1538-7445.metastasis22-a024","title":"Abstract A024: A potent eIF4A1/2 inhibitor CR-1-31B down-modulates the antioxidant stress response in osteosarcoma cells and inhibits <i>in vivo</i> lung metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"In vivo; Cancer research; Oxidative stress; Metastasis; Integrated stress response; Ex vivo; Pharmacology; Chemistry; Medicine; Biology; Cancer; Messenger RNA; Biochemistry; Translation (biology); Internal medicine","score_opus":0.024778584839114735,"score_gpt":0.3339127999723112,"score_spread":0.3091342151331965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317107798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97948563,0.017647883,0.0000023171658,0.0010744439,0.00047443685,0.0007089075,0.00049511984,0.000018206145,0.00009304723],"genre_scores_gemma":[0.98523456,0.0127251735,0.00001839069,0.000120190474,0.00067022076,0.00029966497,0.00002935933,0.000044652996,0.0008578082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970615,0.0005142448,0.00037279652,0.0006788479,0.0005182715,0.00085435],"domain_scores_gemma":[0.9988756,0.00021432921,0.00006603829,0.0005201476,0.00015678474,0.00016710721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024059615,0.00023731511,0.00028836704,0.00036912915,0.00017665313,0.00011598323,0.0003450126,0.00016812755,0.00004414267],"category_scores_gemma":[0.0002310616,0.00018641877,0.00009133349,0.0008584788,0.00031825143,0.000017727503,0.00043388756,0.0004725113,0.000012732058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013138843,0.00007622479,0.0011134264,0.00010261676,0.000029013305,0.00004455801,0.00032304073,0.00035081495,0.98040986,0.000012849514,0.012837153,0.0033865662],"study_design_scores_gemma":[0.0013774193,0.00013797841,0.03249416,0.00019385625,0.000011255875,0.000008222674,0.00070353394,0.00007861312,0.91046184,0.000037008864,0.054247934,0.0002481523],"about_ca_topic_score_codex":0.0013508514,"about_ca_topic_score_gemma":0.002237142,"teacher_disagreement_score":0.06994799,"about_ca_system_score_codex":0.00008283456,"about_ca_system_score_gemma":0.0004130178,"threshold_uncertainty_score":0.76019365},"labels":[],"label_agreement":null},{"id":"W4322760552","doi":"10.1158/1538-7445.sabcs22-p2-03-08","title":"Abstract P2-03-08: Deconstructing the molecular characteristics of ER+ HER2+ early breast cancer in the POETIC trial using multiplex immunofluorescence and gene expression profiles","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Cohort; Cancer; Multiplex; Internal medicine; Oncology; Immune system; Gynecology; Gastroenterology; Immunology; Biology; Bioinformatics","score_opus":0.035131558445107805,"score_gpt":0.3607537482476564,"score_spread":0.3256221898025486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322760552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956617,0.003200667,0.0000055768414,0.00017574156,0.00013532466,0.00071207795,0.00008039152,0.000006419798,0.000022117278],"genre_scores_gemma":[0.9973982,0.0021102685,0.000048286216,0.000014906604,0.00020723128,0.0001614981,0.000016687522,0.000024151992,0.00001876109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983809,0.0003100489,0.00025428832,0.00030602052,0.00033963716,0.0004091265],"domain_scores_gemma":[0.99927205,0.00010732319,0.00009925567,0.00033325746,0.00013597867,0.000052142877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009659596,0.00013389421,0.00015690207,0.000085555825,0.0002142419,0.00005739772,0.00034681772,0.0001631064,0.000015819185],"category_scores_gemma":[0.00011765875,0.00008307017,0.00005948466,0.00035145864,0.0003539876,0.000008293956,0.00020175926,0.00044342122,0.0000027029196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001496392,0.000025192445,0.0075233593,0.00005457356,0.000034211123,0.000020977064,0.00037904593,0.00006608349,0.98343277,0.0000061359456,0.00003604765,0.0069252355],"study_design_scores_gemma":[0.003234927,0.00013812563,0.11227128,0.00027569066,0.000016248285,0.000029356506,0.0005545244,0.00027975385,0.8829821,0.000020057465,0.000046613677,0.00015136095],"about_ca_topic_score_codex":0.0008736873,"about_ca_topic_score_gemma":0.000017895012,"teacher_disagreement_score":0.10474792,"about_ca_system_score_codex":0.000033378856,"about_ca_system_score_gemma":0.00023344529,"threshold_uncertainty_score":0.3387503},"labels":[],"label_agreement":null},{"id":"W4322760569","doi":"10.1158/1538-7445.sabcs22-p2-01-06","title":"Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Pertuzumab; Medicine; Breast cancer; Neoadjuvant therapy; Trastuzumab; Oncology; Internal medicine; Clinical endpoint; Cancer; Perioperative; Exact test; Clinical trial; Surgery","score_opus":0.15228257007957094,"score_gpt":0.48874254072948536,"score_spread":0.3364599706499144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322760569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891253,0.00041887828,0.0000038423527,0.006327656,0.00008299473,0.0016177492,0.0014661457,0.000024147543,0.00093330053],"genre_scores_gemma":[0.994582,0.0029966792,0.000014223181,0.00023824051,0.000087957014,0.00092087185,0.00006318253,0.000041749605,0.0010550857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605006,0.00032590338,0.00061536435,0.0005828731,0.0016469839,0.00077882496],"domain_scores_gemma":[0.99772626,0.000449091,0.00011990637,0.0006834342,0.0007260928,0.00029521124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012153257,0.00019659127,0.00071450695,0.001444815,0.00012355256,0.000037630296,0.00041270332,0.0000976202,0.0017374564],"category_scores_gemma":[0.00018918765,0.00014155377,0.00017536305,0.0068882806,0.0006254427,0.00010194183,0.00026179227,0.0006089947,0.00001207799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031755413,0.00046620442,0.82501316,0.00030637186,0.0005363779,0.00007976909,0.0071323817,0.000476728,0.0960985,0.000042575124,0.0058402973,0.06083209],"study_design_scores_gemma":[0.0021146687,0.00025683842,0.9743514,0.0009958878,0.00004589939,0.000004560047,0.0016281719,0.00062202255,0.016561357,0.000011984901,0.0032589084,0.00014830974],"about_ca_topic_score_codex":0.05094047,"about_ca_topic_score_gemma":0.02666423,"teacher_disagreement_score":0.14933822,"about_ca_system_score_codex":0.0015004342,"about_ca_system_score_gemma":0.00074593385,"threshold_uncertainty_score":0.9991751},"labels":[],"label_agreement":null},{"id":"W4322760627","doi":"10.1158/1538-7445.sabcs22-p2-03-07","title":"Abstract P2-03-07: Multi-parametric algorithm integrating on-treatment Ki67 value and standard clinicopathological variables to predict risk of recurrences for women &amp;gt; 70 years old with early ER+HER2- tumours in POETIC trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Exemestane; Overfitting; Estrogen receptor; Oncology; Gynecology; Cancer; Aromatase","score_opus":0.07924917526543351,"score_gpt":0.41307806613555514,"score_spread":0.33382889087012163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322760627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963036,0.00070180005,0.00015351694,0.00013513815,0.00014450596,0.0014216336,0.0010603789,0.00001836765,0.00006104371],"genre_scores_gemma":[0.991265,0.0024218794,0.0035625827,0.000013772101,0.0002054021,0.0022056908,0.000053331245,0.000031993095,0.00024034838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976745,0.00024393112,0.0003413743,0.00069428654,0.0004160798,0.0006298058],"domain_scores_gemma":[0.998683,0.00053205725,0.00011593548,0.0003001434,0.00020692789,0.00016193242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014913172,0.00023126624,0.0004368176,0.00030784254,0.00012580727,0.000047233512,0.00020220451,0.00014326286,0.000016883203],"category_scores_gemma":[0.00087639265,0.00016434107,0.000070331014,0.0007092305,0.00027247847,0.0000072650073,0.00013405649,0.00023712727,0.0000075576318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0997035,0.0021831398,0.39488852,0.00031217292,0.0011042462,0.000117084855,0.0082945395,0.002634587,0.0061267456,0.0000851491,0.0019824107,0.4825679],"study_design_scores_gemma":[0.05166426,0.03135309,0.8981687,0.000797641,0.00013070308,0.000006471364,0.003162098,0.00019695163,0.009696141,0.00049512816,0.0036074843,0.00072135276],"about_ca_topic_score_codex":0.0011600145,"about_ca_topic_score_gemma":0.0004888606,"teacher_disagreement_score":0.50328016,"about_ca_system_score_codex":0.00029865894,"about_ca_system_score_gemma":0.00034386478,"threshold_uncertainty_score":0.67016345},"labels":[],"label_agreement":null},{"id":"W4322760629","doi":"10.1158/1538-7445.sabcs22-p4-02-16","title":"Abstract P4-02-16: Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; McMaster University Medical Centre; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Context (archaeology); Oncology; Breast cancer; Proportional hazards model; Tissue microarray; Clinical endpoint; H&E stain; Immunohistochemistry; Clinical trial; Biopsy; Pathology; Confidence interval; Cancer","score_opus":0.08191813096318543,"score_gpt":0.3781484435970991,"score_spread":0.29623031263391364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322760629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566853,0.0024852005,0.0000043143145,0.0008410061,0.00005637892,0.0006129404,0.000100599944,0.000007172172,0.00022385728],"genre_scores_gemma":[0.9975167,0.0013178389,0.000025904685,0.0000643779,0.0003682635,0.0006216732,0.00003982327,0.000013725066,0.000031705058],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875826,0.00015966495,0.00016705148,0.00028354314,0.00033084085,0.00030066853],"domain_scores_gemma":[0.9993437,0.00025778188,0.000052627907,0.0001917066,0.000117119205,0.00003704321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067175773,0.000105754,0.00014755953,0.00008315239,0.000120536984,0.000020671296,0.00017374764,0.000056893376,0.000014029501],"category_scores_gemma":[0.0002031138,0.00007629174,0.000040969895,0.00031937985,0.00039764523,0.000005559032,0.000063590836,0.00014745313,0.0000012594795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04396614,0.0006308396,0.29692933,0.0005341607,0.0009201248,0.000065805405,0.008056644,0.00046202465,0.6143347,0.0002655999,0.020093983,0.013740676],"study_design_scores_gemma":[0.030773638,0.0017561798,0.8462696,0.00032125646,0.000033635653,0.000032518343,0.0032529663,0.00010474279,0.11169609,0.000629504,0.0047853994,0.00034445425],"about_ca_topic_score_codex":0.0010009242,"about_ca_topic_score_gemma":0.00053445966,"teacher_disagreement_score":0.5493403,"about_ca_system_score_codex":0.00011305792,"about_ca_system_score_gemma":0.0002819608,"threshold_uncertainty_score":0.31110868},"labels":[],"label_agreement":null},{"id":"W4322769103","doi":"10.1158/1538-7445.sabcs22-pd10-08","title":"Abstract PD10-08: PD10-08 Immune cell infiltration associated with poor anti-proliferative response to aromatase inhibitors in postmenopausal women with primary ER-positive HER2-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"FOXP3; Breast cancer; Immune system; Medicine; Internal medicine; Oncology; Aromatase; Estrogen receptor; Cancer; Immunology","score_opus":0.010477621266426351,"score_gpt":0.29873946839823834,"score_spread":0.28826184713181197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957556,0.00037877617,0.0000022853324,0.0010625412,0.00006676336,0.0014412786,0.00091900694,0.000040613693,0.00033313123],"genre_scores_gemma":[0.9970673,0.0003169549,0.000022812168,0.00016954656,0.0001371026,0.0009657549,0.0005261364,0.00007827124,0.0007161236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99661225,0.00069137244,0.00031343737,0.0007387829,0.000652706,0.000991445],"domain_scores_gemma":[0.99853116,0.00020445893,0.00013153715,0.00032836158,0.000499451,0.0003050517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001321047,0.00033692797,0.00036047876,0.0003684498,0.0002713737,0.00009305787,0.0002561004,0.00030365022,0.000051917723],"category_scores_gemma":[0.00013126135,0.00026548028,0.00003829227,0.0015237583,0.00029248447,0.000036429134,0.00017484782,0.00072810316,0.00005269941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016041758,0.00025071256,0.004496306,0.00005011359,0.00027701625,0.00026831226,0.0017460445,0.0010838334,0.9732949,0.0000020272228,0.0019486004,0.0005403735],"study_design_scores_gemma":[0.002520409,0.0027335077,0.37003615,0.00039087745,0.000016378923,0.000014095503,0.0010793733,0.000014631008,0.6227378,0.000008379123,0.000083097824,0.0003652764],"about_ca_topic_score_codex":0.0011460907,"about_ca_topic_score_gemma":0.0006054419,"teacher_disagreement_score":0.36553985,"about_ca_system_score_codex":0.00079421443,"about_ca_system_score_gemma":0.0017749182,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W4322769118","doi":"10.1158/1538-7445.sabcs22-pd18-10","title":"Abstract PD18-10: Treatment of HER2-positive (HER2+) hormone-receptor positive (HR+) metastatic breast cancer (mBC) with the novel combination of zanidatamab, palbociclib, and fulvestrant","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Zymeworks (Canada); Sunnybrook Health Science Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Fulvestrant; Palbociclib; Metastatic breast cancer; Trastuzumab; Tolerability; Internal medicine; Oncology; Pertuzumab; Combination therapy; Breast cancer; Cancer; Adverse effect; Estrogen receptor","score_opus":0.05721189662845406,"score_gpt":0.39040719515226985,"score_spread":0.3331952985238158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850174,0.002992366,0.000078166515,0.007251275,0.00005268499,0.0015890979,0.0027703564,0.000040529525,0.000208098],"genre_scores_gemma":[0.9950116,0.0028779,0.00016810665,0.000047460264,0.00010717356,0.0006291476,0.00015620183,0.000069243244,0.0009331505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974635,0.00012875277,0.00035788948,0.00049308455,0.0009843169,0.00057242584],"domain_scores_gemma":[0.9976682,0.0005460591,0.00021426268,0.00042390305,0.00096119125,0.00018638729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046622136,0.00028748353,0.00058890454,0.0002642807,0.00018540151,0.000028654802,0.00018553704,0.00007135646,0.00045768908],"category_scores_gemma":[0.000023360257,0.00018158804,0.000091802176,0.0010616431,0.0010496817,0.00020806571,0.00006337805,0.0002927738,0.000017178627],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013819257,0.0019323461,0.0032596362,0.0006652656,0.0027290042,0.00007650125,0.012311093,0.00029541907,0.8516481,0.0005857411,0.0012741006,0.11140354],"study_design_scores_gemma":[0.012370678,0.004731542,0.7710724,0.0012576679,0.00040946493,0.00008285384,0.0070779514,0.00015617955,0.20089085,0.00016916102,0.0014036146,0.00037766912],"about_ca_topic_score_codex":0.006143578,"about_ca_topic_score_gemma":0.0005115159,"teacher_disagreement_score":0.7678127,"about_ca_system_score_codex":0.0006294163,"about_ca_system_score_gemma":0.000689118,"threshold_uncertainty_score":0.92872924},"labels":[],"label_agreement":null},{"id":"W4322769123","doi":"10.1158/1538-7445.sabcs22-pd10-07","title":"Abstract PD10-07: PD10-07 Low plasma estradiol, low expression of estrogen responsive genes and TP53 mutations are associated with poor anti-proliferative response to aromatase inhibitors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Estrogen; Aromatase; Internal medicine; Estrogen receptor; Breast cancer; Immunohistochemistry; Estrogen receptor alpha; Medicine; Aromatase inhibitor; Endocrinology; Biology; Oncology; Cancer; Cancer research","score_opus":0.02261956742019334,"score_gpt":0.332846761262597,"score_spread":0.31022719384240366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676603,0.0011122453,0.0000053847143,0.00054032984,0.00008570663,0.00081372523,0.000612329,0.000036794412,0.000027459197],"genre_scores_gemma":[0.9983184,0.0004644564,0.00007106828,0.000029475143,0.00012595968,0.00023564791,0.00033024498,0.000057257115,0.00036752623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973422,0.0005868405,0.0003005303,0.00062592514,0.0005386942,0.0006058035],"domain_scores_gemma":[0.99829304,0.00037815422,0.00014789295,0.00037481356,0.00046588996,0.00034021083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010221739,0.00025437595,0.00031082483,0.00033540922,0.00032292865,0.000060084916,0.00023278792,0.00032890742,0.000020602169],"category_scores_gemma":[0.001006601,0.00021012683,0.00007689624,0.0007191715,0.00036800024,0.000019099169,0.00018851619,0.00040035174,0.000044476867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004266538,0.000102529244,0.003851653,0.00007235915,0.00015803923,0.00021249322,0.0003387315,0.0012161122,0.9852717,0.000003946871,0.0041155205,0.0003904071],"study_design_scores_gemma":[0.0012662377,0.00091537286,0.021701006,0.0005916291,0.000024059103,0.000016217227,0.00085824204,0.00008972403,0.9739774,0.0000109900175,0.00029929462,0.000249851],"about_ca_topic_score_codex":0.000054007436,"about_ca_topic_score_gemma":0.000030446936,"teacher_disagreement_score":0.017849352,"about_ca_system_score_codex":0.000086382686,"about_ca_system_score_gemma":0.0007567064,"threshold_uncertainty_score":0.8568724},"labels":[],"label_agreement":null},{"id":"W4322769163","doi":"10.1158/1538-7445.sabcs22-pd17-06","title":"Abstract PD17-06: Immunohistochemical markers and determinants of clinical response in the Penelope-B trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Palbociclib; Medicine; Oncology; Internal medicine; Proportional hazards model; Breast cancer; Hazard ratio; Estrogen receptor; Immunohistochemistry; Progesterone receptor; Cancer; Confidence interval; Metastatic breast cancer","score_opus":0.23591794451281867,"score_gpt":0.5581976815810864,"score_spread":0.32227973706826774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953573,0.0010395924,5.802685e-7,0.002266538,0.00013492185,0.0008790235,0.000015672802,0.000019172388,0.00028724663],"genre_scores_gemma":[0.99798363,0.0007589012,0.000043997337,0.000089770256,0.00024608354,0.00029552946,0.0000043016753,0.000024305036,0.0005534654],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99738806,0.00054819154,0.0005699172,0.0003333134,0.000714803,0.00044570214],"domain_scores_gemma":[0.9966731,0.0025134569,0.00008490641,0.00046301112,0.00015873127,0.00010676107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00784739,0.00010862614,0.00040768232,0.00024110326,0.00007301971,0.000013944159,0.00027479546,0.00012510063,0.00014569695],"category_scores_gemma":[0.002039119,0.0000758592,0.00008484715,0.0007243046,0.00075196836,0.000064771535,0.00012046583,0.0007868409,0.000030706695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.759277,0.00025151233,0.03986401,0.00027488347,0.000073784984,0.0004048058,0.0016849631,0.0000034416473,0.0856254,0.000018601611,0.0030612901,0.10946034],"study_design_scores_gemma":[0.035747696,0.0010398315,0.9447674,0.00044772282,0.000014940024,0.000029216275,0.0018123549,0.000030390325,0.0041842815,0.00022231856,0.011576265,0.00012758511],"about_ca_topic_score_codex":0.00022531112,"about_ca_topic_score_gemma":0.000034945326,"teacher_disagreement_score":0.9049034,"about_ca_system_score_codex":0.00014454035,"about_ca_system_score_gemma":0.0007375122,"threshold_uncertainty_score":0.3418476},"labels":[],"label_agreement":null},{"id":"W4322769237","doi":"10.1158/1538-7445.sabcs22-pd4-03","title":"Abstract PD4-03: PD4-03 Pelareorep primes the tumor for checkpoint inhibition therapy by activating the interferon-gamma signaling pathway and tumor inflammation signature in early breast cancer patients - results of the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Immune checkpoint; Breast cancer; Tumor microenvironment; Atezolizumab; Oncology; Letrozole; Cancer; Internal medicine; Immune system; Immunotherapy; Oncolytic virus; Cancer research; Immunology; Nivolumab","score_opus":0.030607237379500954,"score_gpt":0.33851757943456334,"score_spread":0.3079103420550624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936706,0.00087493507,0.0000030359843,0.0016696721,0.000119839126,0.0025905322,0.0010196747,0.000009455856,0.000042272764],"genre_scores_gemma":[0.9971386,0.00045137008,0.0000023110736,0.000043410455,0.00036508124,0.001647534,0.00018578116,0.000035418063,0.00013044568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976955,0.00031522798,0.00040225274,0.00045432366,0.0006090655,0.00052365044],"domain_scores_gemma":[0.9986854,0.00023508917,0.00021943527,0.00037377086,0.00041455094,0.0000717421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014006245,0.00019050934,0.00018144673,0.000093178445,0.00037454735,0.000111774316,0.00034776243,0.000103399114,0.0000145862405],"category_scores_gemma":[0.00031761217,0.000104138635,0.000111934656,0.0004552158,0.00027668098,0.000029261557,0.00022999983,0.00048432735,0.0000016785891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027886966,0.00013492149,0.0034381882,0.00010113825,0.00013576605,0.0000026909588,0.0011466874,0.00010488512,0.94067043,0.0000074111426,0.002382213,0.023988694],"study_design_scores_gemma":[0.014134584,0.0007642498,0.02412114,0.00027919922,0.0000059626655,0.000001162626,0.00038657305,0.00006384426,0.95851797,0.00013402982,0.0014460669,0.00014519306],"about_ca_topic_score_codex":0.003212289,"about_ca_topic_score_gemma":0.0011680346,"teacher_disagreement_score":0.0238435,"about_ca_system_score_codex":0.00018504082,"about_ca_system_score_gemma":0.0005007176,"threshold_uncertainty_score":0.48560414},"labels":[],"label_agreement":null},{"id":"W4322769277","doi":"10.1158/1538-7445.sabcs22-p5-07-08","title":"Abstract P5-07-08: Evaluating the risk of cardiotoxicity associated with concurrent trastuzumab emtansine (TDM1) and radiation therapy in patients with early-stage HER2 positive breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Cardiotoxicity; Internal medicine; Oncology; Breast cancer; Trastuzumab; Ejection fraction; Trastuzumab emtansine; Radiation therapy; Adjuvant therapy; Cardiology; Heart failure; Cancer; Chemotherapy","score_opus":0.0851732530163475,"score_gpt":0.44099505400862105,"score_spread":0.35582180099227356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993478,0.001430704,0.0000029121707,0.0008225279,0.0000706773,0.0027949035,0.0011806887,0.000037174,0.00018238525],"genre_scores_gemma":[0.9934819,0.005333427,0.000004810293,0.000034287135,0.00013155668,0.0006436447,0.00007360368,0.00007120516,0.00022558562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99460924,0.0008749999,0.0003941782,0.0005846823,0.0026725417,0.00086436],"domain_scores_gemma":[0.9966909,0.0009432496,0.00020754492,0.00041475013,0.0015217526,0.0002217851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036062193,0.00025103503,0.0005281121,0.00036505386,0.00028029334,0.000068952024,0.00022926975,0.00013178501,0.00045164672],"category_scores_gemma":[0.00043083343,0.00015619608,0.000062168,0.0018913051,0.0006524172,0.00015728288,0.00008653781,0.0013463562,0.000009559556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003396539,0.00019940594,0.9063001,0.00015345555,0.0005226709,0.000030756062,0.0029953355,0.0004950124,0.0011110351,0.000004350404,0.0005281691,0.08426314],"study_design_scores_gemma":[0.0070940135,0.0023586587,0.986401,0.0011906431,0.000045572557,0.000001334143,0.00047697686,0.0004524405,0.0017454803,0.000008661381,0.00005539772,0.00016979277],"about_ca_topic_score_codex":0.019679222,"about_ca_topic_score_gemma":0.0036882814,"teacher_disagreement_score":0.08409335,"about_ca_system_score_codex":0.0016660184,"about_ca_system_score_gemma":0.0020463096,"threshold_uncertainty_score":0.98684883},"labels":[],"label_agreement":null},{"id":"W4322769285","doi":"10.1158/1538-7445.sabcs22-pd9-06","title":"Abstract PD9-06: Histopathological and molecular immune landscape and DNA damage response signatures to predict response to carboplatin and docetaxel in TNT trial TNBC cohort","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"","keywords":"Immune system; Docetaxel; Oncology; Carboplatin; Medicine; Triple-negative breast cancer; Internal medicine; Breast cancer; Cancer; Cohort; Cancer research; Immunology; Chemotherapy; Cisplatin","score_opus":0.04054599805270391,"score_gpt":0.38241318281013653,"score_spread":0.3418671847574326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428994,0.0049174395,0.0000014651881,0.008441868,0.00010203191,0.0019847099,0.00006750407,0.00005431889,0.00014070369],"genre_scores_gemma":[0.9970812,0.00086394703,0.000041867275,0.0003953516,0.00009545965,0.0004690828,0.000014053705,0.000033454926,0.0010055699],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970778,0.0006824831,0.00036484667,0.0006455769,0.0006503862,0.0005788802],"domain_scores_gemma":[0.9982346,0.0008757869,0.00003762044,0.00038586435,0.0001102246,0.0003559037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067476556,0.00020176914,0.00043548085,0.00079965015,0.00013856184,0.00007861448,0.00014016604,0.00020749983,0.00010120816],"category_scores_gemma":[0.0016143018,0.00016693628,0.000048541446,0.0010100397,0.00027429947,0.000055869117,0.00023406917,0.0006114522,0.000007721723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34995604,0.000042326585,0.005774659,0.00005452499,0.00003392801,0.0011034547,0.00080737536,0.0000068442973,0.63784385,0.0000036567194,0.0023455792,0.0020277987],"study_design_scores_gemma":[0.019260963,0.002206312,0.9577213,0.00029707156,0.0000190466,0.000027812368,0.00039801796,0.000037951704,0.01155197,0.000023227893,0.008254515,0.00020182072],"about_ca_topic_score_codex":0.0003913808,"about_ca_topic_score_gemma":0.00007969354,"teacher_disagreement_score":0.9519466,"about_ca_system_score_codex":0.00024061574,"about_ca_system_score_gemma":0.00036479058,"threshold_uncertainty_score":0.68074644},"labels":[],"label_agreement":null},{"id":"W4322769430","doi":"10.1158/1538-7445.sabcs22-p3-07-10","title":"Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Paclitaxel; Taxane; Breast cancer; Medicine; Internal medicine; Cancer; Oncology","score_opus":0.0716905380113208,"score_gpt":0.46528426938408063,"score_spread":0.3935937313727598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192387,0.00039728128,3.358685e-7,0.0030831115,0.00026123002,0.0027658946,0.0007285288,0.00004712034,0.0007926256],"genre_scores_gemma":[0.9941285,0.0012326856,0.00001764832,0.000078096215,0.00022127514,0.0014537888,0.00012541813,0.00005924019,0.002683342],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99705917,0.00020014675,0.00045613947,0.00060210767,0.0009020036,0.0007804572],"domain_scores_gemma":[0.99814487,0.00045015445,0.00016101504,0.00032322897,0.0006038155,0.00031691996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060467276,0.00028139565,0.00068461976,0.000518279,0.00013115062,0.0000245314,0.00017287105,0.00015006581,0.002285025],"category_scores_gemma":[0.000098302924,0.0002243588,0.00007675604,0.0013313988,0.0005319429,0.00018409324,0.00011372287,0.0006595995,0.000045161923],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72122014,0.009759982,0.13429889,0.0008688259,0.0009577272,0.0002579087,0.0036296647,0.00003620807,0.0065407003,0.000039114257,0.017365828,0.10502499],"study_design_scores_gemma":[0.42518288,0.011888687,0.5550721,0.00081758143,0.00013247029,0.000002654793,0.00071169855,0.000048497175,0.0035822822,0.00016347563,0.0020647168,0.00033294418],"about_ca_topic_score_codex":0.00705696,"about_ca_topic_score_gemma":0.001777599,"teacher_disagreement_score":0.4207732,"about_ca_system_score_codex":0.0006813544,"about_ca_system_score_gemma":0.0009915692,"threshold_uncertainty_score":0.9995551},"labels":[],"label_agreement":null},{"id":"W4322769468","doi":"10.1158/1538-7445.sabcs22-p6-01-17","title":"Abstract P6-01-17: A single-center prospective cohort study to evaluate circulating tumor cells as a monitoring tool in women with breast cancer treated with neoadjuvant chemotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Circulating tumor cell; Breast cancer; Oncology; Internal medicine; Cancer; Chemotherapy; Inflammatory breast cancer; Stage (stratigraphy); Cohort; Metastasis","score_opus":0.057826868684606215,"score_gpt":0.3977600386161776,"score_spread":0.33993316993157136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913627,0.00014007819,3.1557707e-7,0.0010518713,0.000066745546,0.006786226,0.00008219516,0.00010465009,0.00040523853],"genre_scores_gemma":[0.9843118,0.000175642,0.000019574132,0.00011867033,0.00030028354,0.0143917315,0.000006951109,0.00011398217,0.0005613562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959318,0.00009377229,0.0003413765,0.0009904352,0.0015137525,0.0011288526],"domain_scores_gemma":[0.99843824,0.0001121175,0.00008400796,0.00050853187,0.0005525533,0.0003045433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009022683,0.0003406891,0.00062642584,0.00047668885,0.00017547197,0.00012562906,0.00015109782,0.000043516044,0.0006511571],"category_scores_gemma":[0.000020653297,0.00023861878,0.000044209446,0.0021075169,0.00009251888,0.00012508119,0.00007747187,0.00047572193,0.000060152786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007597443,0.0020656525,0.9537202,0.00010204343,0.000686332,0.0013983547,0.007973182,0.00084125786,0.013757368,3.5325618e-7,0.0003000195,0.011557799],"study_design_scores_gemma":[0.010548899,0.0028937766,0.96858543,0.0018949494,0.000059872033,0.00003831598,0.0037622063,0.000040844065,0.011815079,0.000004086221,0.00008608482,0.00027048396],"about_ca_topic_score_codex":0.016990196,"about_ca_topic_score_gemma":0.0024869975,"teacher_disagreement_score":0.014865208,"about_ca_system_score_codex":0.005983217,"about_ca_system_score_gemma":0.0008801343,"threshold_uncertainty_score":0.99783266},"labels":[],"label_agreement":null},{"id":"W4322769557","doi":"10.1158/1538-7445.sabcs22-p4-03-28","title":"Abstract P4-03-28: Patient Reported Symptom Burden Amongst Immigrant and Canadian Long-Term Resident Women Undergoing Breast Cancer Surgery","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Logistic regression; Population; Immigration; Cancer; Comorbidity; Demography; Cohort; Retrospective cohort study; Gerontology; Family medicine; Surgery; Internal medicine; Environmental health","score_opus":0.12095198023595659,"score_gpt":0.3947715643044051,"score_spread":0.2738195840684485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98699564,0.0034581001,5.159541e-7,0.007392918,0.00034223596,0.0007028175,0.00012965377,0.00011538267,0.0008627207],"genre_scores_gemma":[0.9891755,0.007614354,0.0000032686928,0.0003426778,0.00059605006,0.00059437467,0.00005611913,0.00006715472,0.0015504779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506694,0.00011467076,0.00061819545,0.0008086336,0.0015420062,0.0018495757],"domain_scores_gemma":[0.9967643,0.00039378798,0.00014753212,0.00062262476,0.0006673478,0.0014044323],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017517653,0.00028218108,0.0005416786,0.0009193446,0.0005268347,0.00019305025,0.00021919902,0.00018839528,0.0013132913],"category_scores_gemma":[0.0003174509,0.0002597334,0.00011553688,0.0015295997,0.00029646853,0.00025304293,0.00018270896,0.0007594446,0.000101466816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061829615,0.000019167692,0.9242669,0.0005653036,0.00030771692,0.00540923,0.0039188825,0.00009857645,0.0041210414,0.000010806332,0.028467583,0.032196514],"study_design_scores_gemma":[0.00057323714,0.00008178323,0.9913389,0.0022315108,0.000035344066,0.00019440344,0.0028724272,0.00003117103,0.00060449034,0.000042336764,0.0017041722,0.00029021237],"about_ca_topic_score_codex":0.75966144,"about_ca_topic_score_gemma":0.49084473,"teacher_disagreement_score":0.2688167,"about_ca_system_score_codex":0.0034414057,"about_ca_system_score_gemma":0.0051431265,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W4322769648","doi":"10.1158/1538-7445.sabcs22-p5-05-01","title":"Abstract P5-05-01: Personalized Cancer Monitoring (PCM): a novel ctDNA tool to detect molecular residual disease in patients with early-stage breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Multiplex; Oncology; Internal medicine; Circulating tumor DNA; Minimal residual disease; Cancer; Stage (stratigraphy); Digital polymerase chain reaction; Bioinformatics; Polymerase chain reaction; Genetics; Biology; Gene","score_opus":0.0296368776532989,"score_gpt":0.345047436794356,"score_spread":0.3154105591410571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941168,0.0014210927,0.00002782973,0.000660542,0.000292628,0.0009086704,0.0024986358,0.000026004735,0.000047788188],"genre_scores_gemma":[0.9952238,0.0015478586,0.00008037638,0.00016539743,0.00061844854,0.0015035381,0.00009736807,0.00010810863,0.00065509643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690205,0.000058318306,0.00028908177,0.00087612355,0.0008365788,0.001037877],"domain_scores_gemma":[0.99841416,0.000049929888,0.00006889346,0.0005722088,0.000442243,0.00045255668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003884732,0.00029884768,0.00026399546,0.00028581708,0.00018134405,0.00013230073,0.00045515675,0.00014213762,0.00016435274],"category_scores_gemma":[0.00014029264,0.00028872467,0.00008643866,0.0008586559,0.00015235481,0.000015802505,0.00037201415,0.0003833481,0.000022281787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061640567,0.00019523899,0.584237,0.00024866324,0.00022642927,0.00015153382,0.000381902,0.013429224,0.37959805,0.000036870613,0.0040442194,0.0112868445],"study_design_scores_gemma":[0.0030488006,0.00020696386,0.94978654,0.00034633075,0.000023489352,3.9657252e-7,0.00008144043,0.000023392942,0.038153317,0.000012712481,0.0078135375,0.0005030915],"about_ca_topic_score_codex":0.009514753,"about_ca_topic_score_gemma":0.0022832598,"teacher_disagreement_score":0.36554953,"about_ca_system_score_codex":0.00048686334,"about_ca_system_score_gemma":0.0012297613,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W4322769650","doi":"10.1158/1538-7445.sabcs22-p5-02-27","title":"Abstract P5-02-27: Serum thymidine kinase activity as a prognostic marker in women with metastatic breast cancer treated with two different schedules of palbociclib plus second-line endocrine therapy within the CCTG MA38 trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; BC Cancer Agency; Queen's University","funders":"","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Dosing; Breast cancer; Cancer; Randomization; Gastroenterology; Clinical trial","score_opus":0.07700599130751773,"score_gpt":0.40800145374454355,"score_spread":0.3309954624370258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886899,0.0015165929,0.0000086931195,0.004510712,0.00013422078,0.00443759,0.0004930229,0.00012572802,0.00008355733],"genre_scores_gemma":[0.9910766,0.0010596144,0.000049914554,0.00012635962,0.0003083741,0.005499911,0.0000303986,0.00016507981,0.0016837437],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950751,0.0005021184,0.00059974764,0.0008592718,0.0015874862,0.0013762627],"domain_scores_gemma":[0.99702185,0.0008067511,0.000326691,0.0008801724,0.00059816416,0.00036634927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012668062,0.00057094934,0.0011177667,0.00059561135,0.00019963253,0.000070645736,0.00043707536,0.0000769128,0.002364404],"category_scores_gemma":[0.00011629929,0.0003089836,0.0000984426,0.0024547752,0.0008861826,0.00027323957,0.00014186042,0.0013127637,0.00002038048],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76563495,0.0019376853,0.06285584,0.0013388875,0.0026787356,0.001137461,0.0034579972,0.0026315951,0.076209426,0.00010984437,0.00008281762,0.08192472],"study_design_scores_gemma":[0.18719155,0.006329936,0.7037678,0.002926046,0.00019489505,0.00019647006,0.0045544417,0.000737308,0.09228408,0.0005544425,0.0004550575,0.0008080122],"about_ca_topic_score_codex":0.004095487,"about_ca_topic_score_gemma":0.006430631,"teacher_disagreement_score":0.64091194,"about_ca_system_score_codex":0.0013440882,"about_ca_system_score_gemma":0.0019789163,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W4322769656","doi":"10.1158/1538-7445.sabcs22-p5-02-22","title":"Abstract P5-02-22: Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving the Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib: Biomarker Results from POLARIS","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Breast cancer; Biomarker; Oncology; Medicine; Internal medicine; Cancer; CDKN2A; Cancer research; Biology; Metastatic breast cancer; Genetics","score_opus":0.03956129808422907,"score_gpt":0.34768262221763374,"score_spread":0.30812132413340465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938485,0.0015699652,0.000012392687,0.0018345986,0.00020355817,0.001299809,0.00110828,0.00007429917,0.000048594247],"genre_scores_gemma":[0.9982606,0.00037110975,0.00025441407,0.00011268523,0.00035651913,0.0003693957,0.00013060737,0.00009363902,0.000051012303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964824,0.00020304263,0.00071395136,0.00076941284,0.0010524865,0.0007787416],"domain_scores_gemma":[0.99757236,0.00062761444,0.00028348208,0.00064243743,0.00066322903,0.00021086921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009669177,0.00028393627,0.0004752604,0.00045490966,0.00034553997,0.00006905319,0.0002367988,0.00009928147,0.00011562226],"category_scores_gemma":[0.00034665363,0.00021302179,0.00005932406,0.001477651,0.00038509522,0.00034813315,0.00022859618,0.0005468315,0.0000073143487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010541238,0.00020940493,0.27301437,0.00024163109,0.00030916333,0.00010213329,0.0042548925,0.00081748725,0.4603639,0.000009271276,0.000069680194,0.25006685],"study_design_scores_gemma":[0.0069266935,0.00009689798,0.966624,0.0016270269,0.000033399032,0.000006074364,0.0010250913,0.00016230698,0.023113668,0.00007494942,0.000079739715,0.000230105],"about_ca_topic_score_codex":0.0062856916,"about_ca_topic_score_gemma":0.0017186465,"teacher_disagreement_score":0.69360965,"about_ca_system_score_codex":0.00073268125,"about_ca_system_score_gemma":0.0005953018,"threshold_uncertainty_score":0.9502127},"labels":[],"label_agreement":null},{"id":"W4322769668","doi":"10.1158/1538-7445.sabcs22-p4-07-02","title":"Abstract P4-07-02: Toxicity profile of single agent trastuzumab deruxtecan in solid tumors: A meta-analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Toxicity; Internal medicine; Clinical trial; Neutropenia; Anemia; Trastuzumab; Oncology; Odds ratio; Confidence interval; Phases of clinical research; Breast cancer; Gastroenterology; Cancer","score_opus":0.17030514145085163,"score_gpt":0.42571557965962153,"score_spread":0.2554104382087699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947899,0.0030941882,0.00001739314,0.00070072577,0.000032025124,0.00037420876,0.00031417795,0.00001753701,0.00065982895],"genre_scores_gemma":[0.99806124,0.00033886926,0.000050525126,0.00003337805,0.000091221904,0.0007458606,0.000111674846,0.00002625036,0.00054100767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784863,0.0001380447,0.00035175952,0.00056109624,0.00051513244,0.00058531633],"domain_scores_gemma":[0.99899733,0.00006607582,0.00008967866,0.00048946746,0.00026042055,0.0000970386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006427387,0.0001847469,0.0006136371,0.00037985458,0.000098648154,0.00002263138,0.0002990145,0.00009612545,0.00060358725],"category_scores_gemma":[0.0001212224,0.00015615356,0.00044221728,0.0014140087,0.00021812436,0.000006147773,0.00025164688,0.00017383933,0.0000452027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031293576,0.0005187916,0.008682755,0.00015217782,0.031580012,0.00005252893,0.0006000908,0.0013431994,0.95074487,0.000012801702,0.0033602172,0.0026396376],"study_design_scores_gemma":[0.00056358636,0.00022826882,0.08737553,0.0000178655,0.0029811128,0.0000014407717,0.0006855291,0.00001931604,0.90714175,0.00009284732,0.0006740079,0.00021872939],"about_ca_topic_score_codex":0.0027486067,"about_ca_topic_score_gemma":0.006103103,"teacher_disagreement_score":0.07869278,"about_ca_system_score_codex":0.00020608332,"about_ca_system_score_gemma":0.00027846632,"threshold_uncertainty_score":0.66088575},"labels":[],"label_agreement":null},{"id":"W4322769686","doi":"10.1158/1538-7445.sabcs22-p6-05-50","title":"Abstract P6-05-50: Lobular Breast Cancer Alliance Inc. Survey of Individuals with Metastatic Invasive Lobular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Invasive lobular carcinoma; Breast cancer; Metastasis; Cancer; Oncology; Colorectal cancer; Metastatic breast cancer; Internal medicine; Radiology","score_opus":0.14684774749278878,"score_gpt":0.41349435147684616,"score_spread":0.2666466039840574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832151,0.008760571,0.0000022265783,0.003276682,0.00013494212,0.0014196363,0.0029699947,0.000052340358,0.00016851384],"genre_scores_gemma":[0.98668945,0.010444586,0.00006584043,0.0001779265,0.00015004387,0.0014564963,0.00034488548,0.0000881527,0.00058264384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958083,0.0002622871,0.00047930703,0.00073836115,0.00175006,0.0009616722],"domain_scores_gemma":[0.99656576,0.0007371286,0.00018019775,0.0007616609,0.0013325312,0.00042269338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016277722,0.00031933447,0.000788285,0.00039293765,0.00017220533,0.000057895006,0.0003384395,0.000100858015,0.001715782],"category_scores_gemma":[0.00016559081,0.000244241,0.00010055867,0.0020703403,0.0004609838,0.00014687504,0.00017838331,0.0005414018,0.00015885351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008237362,0.00043362912,0.9489126,0.001086459,0.0011343485,0.00073712185,0.0006913032,0.00035533778,0.003043625,0.000029822433,0.03634285,0.006409141],"study_design_scores_gemma":[0.0030603935,0.00047076668,0.97572315,0.0010582673,0.00017276245,0.000032961965,0.0002518438,0.000018950916,0.016434254,0.000035721416,0.0025097372,0.00023116653],"about_ca_topic_score_codex":0.09987747,"about_ca_topic_score_gemma":0.020529903,"teacher_disagreement_score":0.079347566,"about_ca_system_score_codex":0.00083456043,"about_ca_system_score_gemma":0.002812442,"threshold_uncertainty_score":0.99919677},"labels":[],"label_agreement":null},{"id":"W4322769691","doi":"10.1158/1538-7445.sabcs22-p4-06-10","title":"Abstract P4-06-10: Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? – A Real World Comparison in the Neoadjuvant Setting","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Anthracycline; Medicine; Breast cancer; Internal medicine; Regimen; Oncology; Population; Cohort; Cancer; Chemotherapy; Neoadjuvant therapy; Proportional hazards model; Surgery","score_opus":0.04173362805682795,"score_gpt":0.4138440627531767,"score_spread":0.37211043469634875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892486,0.0012388993,6.342278e-7,0.008349597,0.000034278535,0.0005946922,0.00020426739,0.000008687764,0.00032037336],"genre_scores_gemma":[0.9901379,0.007678343,0.000009308061,0.00014004929,0.0003427392,0.0013751654,0.0000634198,0.000027602078,0.00022549876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978522,0.00019786143,0.00028730827,0.00043189776,0.00050632044,0.00072439556],"domain_scores_gemma":[0.9991281,0.00014360239,0.000096212185,0.00046334075,0.000119051736,0.000049678314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077393674,0.00020649876,0.00030747094,0.00016941711,0.00015332665,0.00003741434,0.00038904193,0.000063005136,0.00013523153],"category_scores_gemma":[0.0000085446145,0.00011420891,0.000055949862,0.0010191816,0.0003013121,0.000007275284,0.000053833875,0.00019077187,0.000007428559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069494196,0.002397043,0.7334462,0.00018941684,0.0007339036,0.00013019487,0.052372634,0.00084824325,0.07250035,0.000023461678,0.015394496,0.11501466],"study_design_scores_gemma":[0.0031795304,0.00042973697,0.9551915,0.00012700929,0.0000150365795,0.0000053582153,0.0068210796,0.0000454605,0.024879364,0.000022080518,0.009118631,0.00016524327],"about_ca_topic_score_codex":0.016411994,"about_ca_topic_score_gemma":0.023138309,"teacher_disagreement_score":0.22174528,"about_ca_system_score_codex":0.0004458355,"about_ca_system_score_gemma":0.00032172442,"threshold_uncertainty_score":0.99468684},"labels":[],"label_agreement":null},{"id":"W4322769729","doi":"10.1158/1538-7445.sabcs22-p6-10-05","title":"Abstract P6-10-05: Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA splicing; Biology; Splicing factor; Interactome; Transcriptome; Cancer research; Alternative splicing; Olaparib; Gene silencing; Genetics; Computational biology; Gene; RNA; Gene expression; Exon; Polymerase","score_opus":0.09038889512773303,"score_gpt":0.41188106071583575,"score_spread":0.32149216558810273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289936,0.0028791267,0.000071713126,0.0027962143,0.000032349577,0.0006091284,0.00017505369,0.000017378441,0.0005196796],"genre_scores_gemma":[0.9905469,0.005836814,0.00003537427,0.00012019334,0.00011943171,0.001011334,0.00023579091,0.000022506692,0.0020716488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830484,0.00032976136,0.00020813264,0.0005030621,0.0002957105,0.00035849022],"domain_scores_gemma":[0.99884397,0.00017141827,0.00006380343,0.00062513823,0.00025065706,0.000045039003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096878293,0.0001169154,0.00010787001,0.00010703233,0.00030169202,0.00008752346,0.00018373638,0.000077530574,0.00008407872],"category_scores_gemma":[0.0002392406,0.00009323339,0.00004785651,0.0005559582,0.00017459992,0.00002260704,0.000052840405,0.00022302217,0.000012377899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006402808,0.000045888926,0.0007497547,0.000030343941,0.000025443163,0.000008121525,0.0010816188,0.0001633385,0.9868115,0.00024204288,0.007826498,0.0023751664],"study_design_scores_gemma":[0.0011589401,0.00015967952,0.1351213,0.00010021869,0.000006154076,0.0000034595587,0.001586816,0.000036931804,0.7604079,0.00092687685,0.10027235,0.00021935275],"about_ca_topic_score_codex":0.0004922125,"about_ca_topic_score_gemma":0.0007931906,"teacher_disagreement_score":0.2264036,"about_ca_system_score_codex":0.00007560925,"about_ca_system_score_gemma":0.00022479164,"threshold_uncertainty_score":0.38019472},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4322769852","doi":"10.1158/1538-7445.sabcs22-p3-04-02","title":"Abstract P3-04-02: Population level access to diagnostic mammography and ultrasound guided breast biopsy in Nigeria: a geospatial analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Medicine; Mammography; Breast cancer; Geospatial analysis; Population; Public health; Breast imaging; Breast cancer screening; Family medicine; Environmental health; Cancer; Nursing; Geography; Cartography; Internal medicine","score_opus":0.24131905651474247,"score_gpt":0.48650739213933036,"score_spread":0.2451883356245879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961712,0.000348631,0.000066414716,0.0022362932,0.00009293604,0.00062840804,0.00018924978,0.00005264887,0.00021426726],"genre_scores_gemma":[0.9984537,0.00046189956,0.000085493564,0.00018353328,0.00024138895,0.00028088942,0.00015660583,0.00002140772,0.00011508051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973257,0.00008948357,0.0003642383,0.0005464325,0.0009865544,0.0006875753],"domain_scores_gemma":[0.99838036,0.0005463949,0.00005084731,0.00034681632,0.0003287236,0.00034685823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012198887,0.00015790475,0.00038589464,0.0017015927,0.00016628568,0.00018718572,0.00024673776,0.00011480698,0.00040114217],"category_scores_gemma":[0.00093020615,0.00014703367,0.000103463746,0.006826113,0.000094084404,0.00025398002,0.00015670175,0.0003744613,0.00003970996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002959045,0.000026547332,0.9820382,0.00007678113,0.00015112122,0.00020069185,0.0003311565,0.00065879984,0.0044021695,0.000010183528,0.0035297784,0.008278664],"study_design_scores_gemma":[0.00058021664,0.00006892338,0.99789196,0.00025480764,0.00007126226,0.00003469481,0.00032956665,0.000092196875,0.00028855915,0.00014546268,0.000095323805,0.00014704958],"about_ca_topic_score_codex":0.0536781,"about_ca_topic_score_gemma":0.030780133,"teacher_disagreement_score":0.022897966,"about_ca_system_score_codex":0.0003102226,"about_ca_system_score_gemma":0.00018489842,"threshold_uncertainty_score":0.9869056},"labels":[],"label_agreement":null},{"id":"W4322769985","doi":"10.1158/1538-7445.sabcs22-tc1-3-1","title":"Abstract TC1-3-1: Ki 67 Ki67 – a clinically relevant biomarker or just <i>nice to have</i> information?","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Biomarker; Population; Cohort; Cancer; Clinical trial","score_opus":0.2118287432103727,"score_gpt":0.5158105906984785,"score_spread":0.30398184748810575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91635555,0.000941478,0.00040517803,0.061490513,0.0011676664,0.0035204382,0.00037616305,0.0008484211,0.01489459],"genre_scores_gemma":[0.97388107,0.0016718499,0.0012525707,0.0056179403,0.0009444754,0.0014676183,0.000112732,0.00012068343,0.014931092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960961,0.000094263945,0.0007757151,0.00048663656,0.0014589616,0.0010883565],"domain_scores_gemma":[0.996575,0.0008184725,0.0001146289,0.00087756704,0.0009821211,0.0006322272],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021591622,0.00023500394,0.00042671472,0.00065321603,0.000258181,0.00010056249,0.00040992707,0.00017322283,0.0016343822],"category_scores_gemma":[0.0017085136,0.00018133609,0.00012927753,0.0019795946,0.00028912604,0.00048635225,0.00030891673,0.0008367812,0.0041420213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023538439,0.00025870127,0.013586423,0.0013916497,0.00047194355,0.0005120228,0.0043693623,0.00029238683,0.053374857,0.000191963,0.19899786,0.7030144],"study_design_scores_gemma":[0.0037357218,0.00054833165,0.13741407,0.0008054425,0.000031470157,0.000046902718,0.0030347272,0.00013474507,0.0028462657,0.00021258634,0.85084045,0.00034926413],"about_ca_topic_score_codex":0.0005406724,"about_ca_topic_score_gemma":0.00020599984,"teacher_disagreement_score":0.70266515,"about_ca_system_score_codex":0.0006105845,"about_ca_system_score_gemma":0.0014755772,"threshold_uncertainty_score":0.99927825},"labels":[],"label_agreement":null},{"id":"W4322770094","doi":"10.1158/1538-7445.sabcs22-p3-03-12","title":"Abstract P3-03-12: Risk of recurrence with adjuvant endocrine therapy in real world patients with hormone receptor positive/human epidermal growth factor receptor-negative early breast cancer: a US database analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Stage (stratigraphy); Cohort; Cancer; Medical record; Proportional hazards model; Adjuvant therapy; Adjuvant; Retrospective cohort study","score_opus":0.04564387843784488,"score_gpt":0.3743183163418518,"score_spread":0.3286744379040069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322770094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876327,0.0008039666,0.000019208754,0.00064727355,0.00006735947,0.0018031778,0.00871784,0.00010217845,0.00020632839],"genre_scores_gemma":[0.98904914,0.008288249,0.00034949082,0.000039042294,0.0002212681,0.00093825127,0.000641476,0.00012059942,0.00035250522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943207,0.00048654934,0.0007100922,0.0011787821,0.001977649,0.0013262535],"domain_scores_gemma":[0.9958717,0.0005886554,0.0004853884,0.00077959115,0.0017949913,0.0004796222],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006910203,0.00053481985,0.0011897177,0.0018994703,0.00027823038,0.000048112634,0.00045160152,0.000088420384,0.0013210204],"category_scores_gemma":[0.000105635685,0.0003913083,0.00016139467,0.0067281346,0.00094194413,0.0006300517,0.00016169748,0.0014563764,0.000029207516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022486158,0.000531179,0.9109944,0.00013759508,0.0018938924,0.00007998877,0.0015735979,0.000111432426,0.012711395,0.000013946898,0.0002452403,0.049221195],"study_design_scores_gemma":[0.008639654,0.0016029662,0.97647643,0.0009214185,0.00016235156,0.0000024096416,0.00028936952,0.000024333707,0.0112945065,0.00002431441,0.00013514221,0.00042712764],"about_ca_topic_score_codex":0.08881301,"about_ca_topic_score_gemma":0.020352658,"teacher_disagreement_score":0.06846035,"about_ca_system_score_codex":0.0012916689,"about_ca_system_score_gemma":0.00082150457,"threshold_uncertainty_score":0.9998539},"labels":[],"label_agreement":null},{"id":"W4322770969","doi":"10.1158/1538-7445.sabcs22-ot3-32-01","title":"Abstract OT3-32-01: OPTIMA, a prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in high clinical risk early breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Population; Cancer; Randomized controlled trial; Gynecology; Interim analysis","score_opus":0.15514271317249284,"score_gpt":0.5186807093158099,"score_spread":0.36353799614331705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322770969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851573,0.0009782752,0.00020441154,0.001350875,0.00047812395,0.011070687,0.0005774093,0.00012260082,0.000060295286],"genre_scores_gemma":[0.98459446,0.007729764,0.00067053956,0.00007902718,0.0006720715,0.0060541984,0.00001600002,0.00008104021,0.00010288977],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.992119,0.0033697998,0.0013823978,0.0011326035,0.0011880798,0.00080810476],"domain_scores_gemma":[0.9756286,0.02166563,0.00032826437,0.00091613096,0.001018439,0.00044294124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018675512,0.00033400315,0.0017912625,0.00037370317,0.00024652726,0.000052061183,0.00042789688,0.0003115667,0.0003227975],"category_scores_gemma":[0.007492563,0.00021467867,0.0003442321,0.0018793935,0.0014841685,0.00015766616,0.00024888176,0.0017577321,0.000019362406],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73753655,0.0006144205,0.15173565,0.000056131947,0.0002714644,0.000023581679,0.00043632684,0.00008946386,0.0066414988,0.0000061510846,0.00021167258,0.10237708],"study_design_scores_gemma":[0.34811422,0.0004439646,0.6420991,0.00074433984,0.00005386749,0.0000039845186,0.000083354236,0.00013360573,0.007337325,0.0006536599,0.00018649067,0.00014611079],"about_ca_topic_score_codex":0.0040140525,"about_ca_topic_score_gemma":0.00036654077,"teacher_disagreement_score":0.49036342,"about_ca_system_score_codex":0.0004250409,"about_ca_system_score_gemma":0.0011024942,"threshold_uncertainty_score":0.8969839},"labels":[],"label_agreement":null},{"id":"W4322771015","doi":"10.1158/1538-7445.sabcs22-p6-05-43","title":"Abstract P6-05-43: Validity of EQ-5D-5L for women with breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Services and Policy Research; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Construct validity; Breast cancer; EQ-5D; Distress; Quality of life (healthcare); Confidence interval; Wilcoxon signed-rank test; Convergent validity; Spearman's rank correlation coefficient; Criterion validity; Cancer; Disease; Gynecology; Physical therapy; Clinical psychology; Internal medicine; Health related quality of life; Mann–Whitney U test; Psychometrics; Statistics","score_opus":0.6761242864357961,"score_gpt":0.5347314587386696,"score_spread":0.14139282769712658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652879,0.0006789517,0.00009534804,0.0265949,0.00048461085,0.0013400674,0.003933865,0.0000656835,0.0015186513],"genre_scores_gemma":[0.99005497,0.0007868001,0.00012955826,0.00079877384,0.0007739879,0.0030846032,0.00003635211,0.00007238738,0.0042625577],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99589044,0.00020478723,0.001865014,0.000678062,0.00029128563,0.0010703959],"domain_scores_gemma":[0.99627066,0.0015700149,0.0008124468,0.0006102487,0.00042295337,0.00031367087],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022962436,0.00017868375,0.00086181244,0.00062426616,0.00029302918,0.0000798418,0.000496136,0.00014799139,0.0025305355],"category_scores_gemma":[0.0010176254,0.00019506141,0.00008757475,0.0008448842,0.00023144473,0.00035849816,0.00009606952,0.00032947413,0.0007618441],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001116567,0.00037191133,0.2852254,0.009035726,0.0006783272,0.000009333046,0.013186078,0.003611033,0.00067102886,0.028808394,0.6516534,0.0056328247],"study_design_scores_gemma":[0.003307616,0.00045545876,0.77074075,0.0005915367,0.000009095686,0.0000053142717,0.0049340315,0.0017586458,0.00043047528,0.024104,0.19288813,0.0007749606],"about_ca_topic_score_codex":0.0074309884,"about_ca_topic_score_gemma":0.0016049381,"teacher_disagreement_score":0.48551536,"about_ca_system_score_codex":0.0017512906,"about_ca_system_score_gemma":0.0010152381,"threshold_uncertainty_score":0.9991786},"labels":[],"label_agreement":null},{"id":"W4322771110","doi":"10.1158/1538-7445.sabcs22-p6-05-59a","title":"Abstract P6-05-59A: Developing a Community Standard of Care for Individuals Diagnosed with Breast Cancer Patients Across Oregon","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Public relations; Family medicine; Political science; Business; Nursing","score_opus":0.11743784096337616,"score_gpt":0.3908194186978482,"score_spread":0.273381577734472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772274,0.0015391009,0.000059347385,0.0008254121,0.0003234168,0.0009785515,0.018333428,0.00004323954,0.00067010266],"genre_scores_gemma":[0.9962874,0.0020468603,0.00010777608,0.00011058219,0.00017261309,0.000881416,0.00015157006,0.00007013892,0.00017161222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778175,0.000040644274,0.0006346241,0.000418688,0.00016666489,0.0009576536],"domain_scores_gemma":[0.99786097,0.00037365468,0.0003731915,0.00044383298,0.00078829133,0.00016006445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001643417,0.0002163758,0.00070018624,0.00032970883,0.0006635768,0.00012620447,0.0005943027,0.00016766958,0.00020671629],"category_scores_gemma":[0.0002656124,0.00021931622,0.00010921551,0.00080919033,0.0003270342,0.00040790407,0.00022590355,0.0005413402,0.000056181434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00116286,0.00012210624,0.922845,0.0015181646,0.00026977243,0.000004459329,0.02162009,0.00037253092,0.00003789915,0.0066604493,0.013224677,0.032162007],"study_design_scores_gemma":[0.0030106325,0.0004398967,0.9515647,0.00046760493,0.0000064054902,4.063319e-7,0.0024669934,0.0000101324395,0.00094539765,0.0029897466,0.037708953,0.00038912828],"about_ca_topic_score_codex":0.010203485,"about_ca_topic_score_gemma":0.0089545995,"teacher_disagreement_score":0.031772878,"about_ca_system_score_codex":0.0010781577,"about_ca_system_score_gemma":0.0005715775,"threshold_uncertainty_score":0.99638766},"labels":[],"label_agreement":null},{"id":"W4322771117","doi":"10.1158/1538-7445.sabcs22-p5-02-04","title":"Abstract P5-02-04: Immune Signatures Display Subtype-Specific Activation in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Oncology; Trastuzumab; Immune system; Cancer; Metastatic breast cancer; Lymph node; Population; Immunohistochemistry; Immunology","score_opus":0.08660148971338832,"score_gpt":0.4245499976174978,"score_spread":0.33794850790410946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738044,0.0032344814,0.0000011570273,0.01847676,0.0002179387,0.00062205415,0.00014061738,0.00006896782,0.0034335891],"genre_scores_gemma":[0.9774137,0.010056175,0.000008173709,0.00012778005,0.000842036,0.0003992756,0.00013187982,0.000050054263,0.01097093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965163,0.00012672038,0.00033390563,0.00051745755,0.0014618109,0.0010438452],"domain_scores_gemma":[0.99846613,0.0004147895,0.00004717576,0.00037129593,0.000433973,0.0002666459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011256575,0.0001966298,0.00034327366,0.0007741918,0.00023882093,0.00006802842,0.00031906704,0.0001868653,0.0053504757],"category_scores_gemma":[0.000077502824,0.00015477471,0.00011055623,0.002074544,0.0002882258,0.00016676226,0.00019940108,0.0015508797,0.0006820082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033152925,0.00021068427,0.06332406,0.00056592305,0.000102041275,0.00029236652,0.00051216054,0.00014583199,0.8096167,0.00081930246,0.074227914,0.046867713],"study_design_scores_gemma":[0.0009648039,0.000070318194,0.91717046,0.0006654438,0.0000042700963,0.0000076265064,0.00026040256,0.00013524371,0.03540101,0.00019664825,0.0449406,0.00018319784],"about_ca_topic_score_codex":0.0067158747,"about_ca_topic_score_gemma":0.0005260334,"teacher_disagreement_score":0.8538464,"about_ca_system_score_codex":0.0005287763,"about_ca_system_score_gemma":0.00057428423,"threshold_uncertainty_score":0.9998985},"labels":[],"label_agreement":null},{"id":"W4322771132","doi":"10.1158/1538-7445.sabcs22-p1-13-02","title":"Abstract P1-13-02: The Aberrant Activity of Retrotransposon Elements Mediates the Chemo-tolerant Persister Cells Relapse in TNBC","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Drug resistance; Doxorubicin; Biology; Cancer; Metastasis; Cancer research; Tumor microenvironment; Reprogramming; Chemotherapy; Cancer cell; Medicine; Cell; Genetics","score_opus":0.054570629240968865,"score_gpt":0.35480969395420014,"score_spread":0.30023906471323125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642795,0.00053759577,0.000004445824,0.0016511207,0.00018977479,0.0005371586,0.00005745474,0.000011121156,0.0005833456],"genre_scores_gemma":[0.99723464,0.0012402183,0.000010997031,0.000060896957,0.00013410966,0.00021592557,0.000020356936,0.000028552593,0.0010543133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980541,0.0002270934,0.00022750505,0.00037334123,0.0005908226,0.00052717765],"domain_scores_gemma":[0.9990288,0.00010287062,0.00006662118,0.00062143465,0.00011664999,0.00006360604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020702383,0.00013329065,0.00015649754,0.00008017289,0.00013331683,0.000024321118,0.00058949133,0.00014000715,0.00013908283],"category_scores_gemma":[0.000081467595,0.000083273786,0.00011358199,0.00041777006,0.00024010404,0.000006500574,0.00018340426,0.00044121,0.00003006287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028322477,0.00005096763,0.00072736724,0.00007092726,0.000048168135,0.000011362442,0.00059954927,0.00008326339,0.99304116,0.000008897912,0.0024170817,0.0026580202],"study_design_scores_gemma":[0.0004775389,0.00014235167,0.012146247,0.000054992226,0.000007601143,7.6519274e-7,0.00046645247,0.00018037774,0.98265415,0.0000671302,0.0037031285,0.000099266115],"about_ca_topic_score_codex":0.0005449252,"about_ca_topic_score_gemma":0.0009791582,"teacher_disagreement_score":0.01141888,"about_ca_system_score_codex":0.00007016156,"about_ca_system_score_gemma":0.00018670442,"threshold_uncertainty_score":0.33958066},"labels":[],"label_agreement":null},{"id":"W4322771176","doi":"10.1158/1538-7445.sabcs22-ot3-26-01","title":"Abstract OT3-26-01: CCTG MA40: DOUBLE-BLIND PLACEBO CONTROLLED PHASE III TRIAL OF FULVESTRANT AND IPATASERTIB FOR ADVANCED HER-2 NEGATIVE AND ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCER POST FIRST LINE CDK 4/6 AND AROMATASE INHIBITOR THERAPY (FINER)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University Health Network; Vancouver Hospital and Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Oncology; Breast cancer; Anastrozole; Placebo; PTEN; Exemestane; Cancer; Palbociclib; Tolerability; Estrogen receptor; Metastatic breast cancer; PI3K/AKT/mTOR pathway; Adverse effect; Tamoxifen; Pathology; Biology","score_opus":0.076524905853375,"score_gpt":0.42588625224610077,"score_spread":0.34936134639272576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651716,0.010381704,0.000018792995,0.0067547816,0.00024775974,0.009096194,0.008210961,0.00009967046,0.000018545625],"genre_scores_gemma":[0.9804875,0.012490725,0.00021288758,0.00012881962,0.0009722258,0.0048787924,0.00045804883,0.0001499391,0.00022101385],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963464,0.00013928351,0.0007930709,0.000983837,0.0007792804,0.0009580896],"domain_scores_gemma":[0.99646115,0.0012778216,0.000334582,0.00044267456,0.0009004393,0.0005833206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010386297,0.00051893434,0.001299593,0.0004738345,0.0004126602,0.0000877385,0.00018298256,0.00022612973,0.00021171969],"category_scores_gemma":[0.00018570176,0.00041877662,0.00015208103,0.0006965728,0.0009982915,0.0003946955,0.00012479888,0.0006096154,0.000004275106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7717799,0.000491057,0.00011100787,0.00038532607,0.0007173045,0.000043777283,0.0012794025,0.000038611746,0.1544534,0.000031843403,0.0003532659,0.0703151],"study_design_scores_gemma":[0.8830426,0.005250326,0.001549376,0.0012300805,0.00018093386,0.0000556044,0.0017529781,0.00015131835,0.10412068,0.00016187078,0.0020044888,0.000499758],"about_ca_topic_score_codex":0.0016012405,"about_ca_topic_score_gemma":0.00052295777,"teacher_disagreement_score":0.11126268,"about_ca_system_score_codex":0.00029038527,"about_ca_system_score_gemma":0.00081235066,"threshold_uncertainty_score":0.99982643},"labels":[],"label_agreement":null},{"id":"W4322771248","doi":"10.1158/1538-7445.sabcs22-p2-09-01","title":"Abstract P2-09-01: An Emerging Technology for Breast Cancer Detection - Preliminary Data of Breast Cancer Detection using Novel Low Dose Positron Emission Mammography","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University; Hydrogenics (Canada); Thunder Bay Regional Research Institute; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Positron emission tomography; Mammography; Histopathology; Radiology; Nuclear medicine; Oncology; Internal medicine; Pathology","score_opus":0.14975115603193093,"score_gpt":0.48494900243232425,"score_spread":0.3351978464003933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980345,0.00054706784,0.0060173,0.009453361,0.00019280662,0.001517364,0.0015444368,0.000364454,0.000018226923],"genre_scores_gemma":[0.995249,0.0013844469,0.001276325,0.000042484477,0.00054384826,0.0012267361,0.0001240766,0.00007488752,0.00007821686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975256,0.000038177815,0.00040432595,0.00074849883,0.0006178748,0.0006655203],"domain_scores_gemma":[0.99791247,0.00008101811,0.00015935759,0.0009780707,0.00059443555,0.00027467805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009214033,0.00019728564,0.00031815792,0.0009728485,0.00041073313,0.000031091844,0.0004925837,0.00026057646,0.0002033687],"category_scores_gemma":[0.00007190706,0.00017939898,0.000082359125,0.0023634138,0.0003360492,0.00026849043,0.00031835295,0.0007319184,0.0000021895196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068372436,0.00015989585,0.002222423,0.0005298309,0.00005292948,0.0000031228376,0.000041209376,0.000049631857,0.7638235,0.0000071328286,0.0006748423,0.23175173],"study_design_scores_gemma":[0.0028293193,0.000531578,0.19577771,0.004280089,0.00031289094,0.00023283203,0.0006754871,0.12931843,0.6603752,0.00043822164,0.004672545,0.00055572495],"about_ca_topic_score_codex":0.0075587244,"about_ca_topic_score_gemma":0.00036158567,"teacher_disagreement_score":0.231196,"about_ca_system_score_codex":0.00040775072,"about_ca_system_score_gemma":0.0004640811,"threshold_uncertainty_score":0.99905},"labels":[],"label_agreement":null},{"id":"W4322771254","doi":"10.1158/1538-7445.sabcs22-p3-04-04","title":"Abstract P3-04-04: Correlation of Mammographic Microcalcifications with Final Surgical Pathology after Neoadjuvant Chemotherapy for Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Surgical pathology; Mammography; Radiology; Cancer; Chemotherapy; Breast imaging; Neoadjuvant therapy; Occult; Ductal carcinoma; Breast MRI; Oncology; Pathology; Internal medicine","score_opus":0.04145855590273183,"score_gpt":0.3712873554914757,"score_spread":0.32982879958874384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922209,0.002796066,0.0001602504,0.0029525524,0.000096837066,0.00053889735,0.0011123553,0.00002076413,0.00010140219],"genre_scores_gemma":[0.9931851,0.003573318,0.0001089329,0.00005001747,0.00027295697,0.0020968688,0.0001878575,0.000038761416,0.0004861956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985689,0.00005455073,0.0002036397,0.00046328714,0.0002480882,0.000461547],"domain_scores_gemma":[0.9989902,0.000074282376,0.00007298951,0.00031594952,0.00047025536,0.0000763313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028549097,0.00015916994,0.00020708892,0.0001621121,0.0001517386,0.000014767041,0.00016900217,0.00014259202,0.00016667224],"category_scores_gemma":[0.000011323393,0.00012842659,0.00009936257,0.0004940624,0.00041816698,0.000006432041,0.000061907405,0.00015266122,0.0000089206205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02046345,0.0006998448,0.41154853,0.0005249338,0.0011940093,0.00011848601,0.00096492213,0.0010377073,0.38428596,0.00026492792,0.020078156,0.15881906],"study_design_scores_gemma":[0.0031001815,0.0003006921,0.95360297,0.00012541462,0.00003909072,0.00004685216,0.00018963056,0.000039006452,0.028717311,0.00009880842,0.013497002,0.00024304731],"about_ca_topic_score_codex":0.0002780907,"about_ca_topic_score_gemma":0.0006577556,"teacher_disagreement_score":0.5420544,"about_ca_system_score_codex":0.000066685905,"about_ca_system_score_gemma":0.00027175545,"threshold_uncertainty_score":0.5237084},"labels":[],"label_agreement":null},{"id":"W4322771259","doi":"10.1158/1538-7445.sabcs22-p2-05-03","title":"Abstract P2-05-03: Perceived Guideline Clarity &amp; Deferral to Patient Preferences impact guideline concordant care for breast cancer screening in women age 40-49","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trillium Health Centre; Quebec - Clinical Research Organization in Cancer; Kingston Health Sciences Centre; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Guideline; Referral; CLARITY; Family medicine; Population; Cancer screening; Concordance; Breast cancer screening; Qualitative research; Breast cancer; Mammography; Psychology; Cancer; Pathology; Environmental health","score_opus":0.2969960182858109,"score_gpt":0.5173037290545207,"score_spread":0.2203077107687098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878608,0.0015667606,0.00008344943,0.005400258,0.00027167314,0.002248743,0.0019010847,0.00013121055,0.0005360164],"genre_scores_gemma":[0.9928702,0.0006530636,0.0015013429,0.0014574591,0.00080093124,0.0018775245,0.00038283633,0.00007649913,0.00038015895],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99408305,0.00016088021,0.0011123104,0.0009819913,0.0016618599,0.0019999316],"domain_scores_gemma":[0.9958443,0.0002036181,0.00014139221,0.0006519926,0.0022412825,0.00091739965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021768813,0.0004092405,0.0008189072,0.0007171994,0.0003659381,0.00014511087,0.0005407669,0.0002374271,0.0017385059],"category_scores_gemma":[0.00065544405,0.00033763048,0.00022827311,0.0017882442,0.00021703819,0.0002510059,0.00036023097,0.0010205572,0.000091643786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019947942,0.00020237402,0.11789924,0.0009688716,0.00044752334,0.0007032428,0.025920765,0.018428206,0.06749334,0.000016615488,0.3464335,0.40153837],"study_design_scores_gemma":[0.0039135627,0.0012751446,0.87172604,0.0024592052,0.00004961314,0.000034550634,0.022650467,0.00069930893,0.0006071285,0.00021594307,0.095671125,0.000697903],"about_ca_topic_score_codex":0.06549409,"about_ca_topic_score_gemma":0.03632878,"teacher_disagreement_score":0.7538268,"about_ca_system_score_codex":0.0026978126,"about_ca_system_score_gemma":0.0020718959,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4322771354","doi":"10.1158/1538-7445.sabcs22-p5-13-05","title":"Abstract P5-13-05: Profiling of APOBEC3 dysregulation in breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Downregulation and upregulation; Cancer research; Cancer; Tumor microenvironment; Gene expression profiling; Biology; Carcinogenesis; Immune system; Somatic cell; Gene; Gene expression; Medicine; Immunology; Genetics; Tumor cells","score_opus":0.1250532056700027,"score_gpt":0.4462627097361085,"score_spread":0.3212095040661058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913705,0.0010174297,0.0000015790362,0.0053848857,0.00017607921,0.0006335098,0.00008175083,0.000051883686,0.0012824087],"genre_scores_gemma":[0.9962197,0.0019996956,0.000028643573,0.0000665523,0.00032686393,0.0006833216,0.000027255615,0.00003698994,0.0006109776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785775,0.00006246432,0.0003293031,0.00035274116,0.0008586226,0.0005391115],"domain_scores_gemma":[0.9989985,0.00008491842,0.000060870618,0.0002876133,0.00043792746,0.00013016783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010330708,0.000114296345,0.000290785,0.0005146217,0.0000712572,0.000019028716,0.00014576003,0.000108671076,0.0012902182],"category_scores_gemma":[0.000051739957,0.00010015594,0.00007327658,0.0018305951,0.00014761569,0.00010589486,0.000080565434,0.00043728048,0.000045578217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082273094,0.00018396418,0.56336033,0.0014528497,0.00008347012,0.00003811027,0.0006806802,0.00085958984,0.3241623,0.00019420333,0.014765446,0.09339629],"study_design_scores_gemma":[0.0010964883,0.00006909102,0.90213174,0.0009619559,0.000014346818,0.0000032165892,0.00044584513,0.0007567363,0.09330993,0.0000921288,0.0010096922,0.0001088539],"about_ca_topic_score_codex":0.005873206,"about_ca_topic_score_gemma":0.0008747076,"teacher_disagreement_score":0.33877137,"about_ca_system_score_codex":0.00045809872,"about_ca_system_score_gemma":0.000671541,"threshold_uncertainty_score":0.99962276},"labels":[],"label_agreement":null},{"id":"W4322771414","doi":"10.1158/1538-7445.sabcs22-p2-11-10","title":"Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hazard ratio; Breast cancer; Internal medicine; Oncology; Proportional hazards model; Stage (stratigraphy); Tamoxifen; Cancer; Confidence interval; Exemestane; Univariate analysis; Multivariate analysis","score_opus":0.05135266437666297,"score_gpt":0.36680976656069825,"score_spread":0.3154571021840353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199337,0.00044422442,0.000013455961,0.0019378951,0.00015859121,0.002521698,0.0028420768,0.000011556452,0.00007710938],"genre_scores_gemma":[0.9898601,0.0010118828,0.00000921519,0.000034814453,0.00021090244,0.008465518,0.00006236894,0.000042078133,0.00030312984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735785,0.00025972413,0.00036042297,0.00058913033,0.0006491041,0.00078378635],"domain_scores_gemma":[0.9987337,0.00017547507,0.00016140493,0.00047845967,0.0003778133,0.000073151416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010756459,0.00025136373,0.00031713533,0.00014434893,0.00020672868,0.000057212634,0.00055791816,0.00012724668,0.00007873283],"category_scores_gemma":[0.00006093418,0.00015206948,0.0000586903,0.00097318477,0.00033569423,0.00003001303,0.00021093375,0.00029781257,0.0000014671064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32633415,0.0020728337,0.4061293,0.0011685371,0.0013070891,0.000044694665,0.0150063895,0.17473748,0.04605056,0.00019330304,0.004506189,0.022449452],"study_design_scores_gemma":[0.035502408,0.0007751616,0.95122224,0.0007886339,0.000064690874,0.000008023026,0.0021091267,0.0010480933,0.00708362,0.0003534108,0.0005059677,0.00053865276],"about_ca_topic_score_codex":0.009464179,"about_ca_topic_score_gemma":0.00583228,"teacher_disagreement_score":0.5450929,"about_ca_system_score_codex":0.00048272367,"about_ca_system_score_gemma":0.0010817671,"threshold_uncertainty_score":0.9971319},"labels":[],"label_agreement":null},{"id":"W4322771485","doi":"10.1158/1538-7445.sabcs22-p4-08-07","title":"Abstract P4-08-07: Inhibition of the NUDT5 phosphatase suppresses the growth of triple-negative breast cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Phosphatase; Cancer research; Estrogen receptor; Cancer; Oncology; Internal medicine; Biology; Enzyme","score_opus":0.04517888625998348,"score_gpt":0.360214403686659,"score_spread":0.31503551742667557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938764,0.0019518605,0.000009310423,0.0016417344,0.00017046175,0.0004189202,0.001153882,0.00000584796,0.0007715974],"genre_scores_gemma":[0.99612296,0.0026330487,0.000004803985,0.000043422675,0.00014697133,0.00026681717,0.000068055386,0.000015577878,0.00069837034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987951,0.000118097734,0.00019930123,0.00023738557,0.0003871016,0.00026302433],"domain_scores_gemma":[0.9988129,0.00006125413,0.000105210886,0.00047803577,0.00049736514,0.000045242003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005288563,0.00008786886,0.000106978485,0.000052552165,0.00018456164,0.000016851565,0.00037585513,0.000074139534,0.00022353439],"category_scores_gemma":[0.00015361143,0.000054454686,0.000086592816,0.00062003086,0.0005487275,0.000007548626,0.00015362464,0.0001872078,0.000015121537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024381124,0.000040198855,0.0015595045,0.00011298406,0.000079750396,9.78535e-7,0.0002584917,0.00025113788,0.929683,0.0007126672,0.06469722,0.002360223],"study_design_scores_gemma":[0.0003999982,0.000044819688,0.044213712,0.00006546718,0.000008956341,0.000001303827,0.00041147735,0.000015666483,0.9511834,0.0003236525,0.0032645129,0.000067069384],"about_ca_topic_score_codex":0.0031884562,"about_ca_topic_score_gemma":0.00046722445,"teacher_disagreement_score":0.061432704,"about_ca_system_score_codex":0.00007008468,"about_ca_system_score_gemma":0.000605854,"threshold_uncertainty_score":0.48200133},"labels":[],"label_agreement":null},{"id":"W4322771533","doi":"10.1158/1538-7445.sabcs22-p6-12-05","title":"Abstract P6-12-05: The role of endothelial-specific AXL and its associated signaling pathways in the tumor microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Tumor microenvironment; GAS6; Metastasis; Receptor tyrosine kinase; Cancer research; Tumor progression; Angiogenesis; Biology; Signal transduction; Cancer; Cell biology; Tumor cells","score_opus":0.07290618165111482,"score_gpt":0.3135697278486248,"score_spread":0.24066354619751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799536,0.018789738,2.1214184e-7,0.00046243274,0.000084282605,0.00036713362,0.000102945254,0.000011316955,0.00022833147],"genre_scores_gemma":[0.99682105,0.0026910575,3.976191e-7,0.000028600098,0.000026939597,0.00011146805,0.000041223015,0.000011793877,0.0002674846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862283,0.00045861566,0.00022605687,0.00019117692,0.000119133154,0.0003821601],"domain_scores_gemma":[0.9991823,0.00049295265,0.0000737216,0.00020042497,0.000040466497,0.000010136024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018814947,0.00008676415,0.00015074528,0.000111718175,0.00025096867,0.000021358537,0.0002917962,0.00007777725,0.00023628262],"category_scores_gemma":[0.00006568012,0.00005296355,0.000043479584,0.00027307306,0.00020265188,0.000048628015,0.000106145286,0.00042098982,0.00010675415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006334373,0.000051785246,0.0010780938,0.00000969047,0.00003442,0.0000030235908,0.00206769,0.00003394508,0.99109447,0.00022970044,0.00095231587,0.004381507],"study_design_scores_gemma":[0.0006285615,0.00006775631,0.16431384,0.00007553396,0.000004935139,0.0000037512134,0.002263028,0.000019079996,0.80447334,0.00041553294,0.027665881,0.000068753194],"about_ca_topic_score_codex":0.00028846422,"about_ca_topic_score_gemma":0.0000666429,"teacher_disagreement_score":0.18662114,"about_ca_system_score_codex":0.00009570002,"about_ca_system_score_gemma":0.000055366934,"threshold_uncertainty_score":0.2587129},"labels":[],"label_agreement":null},{"id":"W4322771675","doi":"10.1158/1538-7445.sabcs22-p6-14-07","title":"Abstract P6-14-07: Genetic ablation of ACF7, a member of the +TIP family of microtubule-binding proteins, impairs metastasis of HER2-positive breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Breast cancer; Cancer; Metastasis; Cancer research; Biology; Mammary tumor; Tumor progression; Pathology; Medicine; Genetics","score_opus":0.06393541670915065,"score_gpt":0.37534557584454326,"score_spread":0.3114101591353926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242985,0.0028606316,0.00001912966,0.00061634975,0.00013570444,0.0020356276,0.0012589929,0.000019368474,0.00062434596],"genre_scores_gemma":[0.99789035,0.0011624752,0.00012360234,0.0000150364385,0.00008044543,0.0003368955,0.000024014285,0.00006491583,0.00030228804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966877,0.00024356783,0.0007156243,0.0003939448,0.0014394714,0.0005196748],"domain_scores_gemma":[0.9972499,0.00017372711,0.0004306485,0.00066377834,0.001353128,0.00012881891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011209041,0.0001994468,0.00060207804,0.0004957405,0.00007986856,0.000007612182,0.0003358104,0.00017756288,0.0005351918],"category_scores_gemma":[0.00016577686,0.00015723307,0.00028352402,0.002062592,0.000582207,0.000063610336,0.00021255382,0.00057180465,0.000012807333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008216396,0.0001406127,0.0058907256,0.0014820897,0.0005380651,0.000014279931,0.0013575742,0.0011118571,0.97831804,0.000016361239,0.0013939597,0.008914798],"study_design_scores_gemma":[0.0014259192,0.00019457225,0.26248503,0.0020614334,0.00014619945,0.00001003608,0.00058200327,0.00009019077,0.7327455,0.00002780328,0.00013243115,0.00009889691],"about_ca_topic_score_codex":0.012041372,"about_ca_topic_score_gemma":0.0006227762,"teacher_disagreement_score":0.2565943,"about_ca_system_score_codex":0.0005620628,"about_ca_system_score_gemma":0.0017192703,"threshold_uncertainty_score":0.99453753},"labels":[],"label_agreement":null},{"id":"W4322771698","doi":"10.1158/1538-7445.sabcs22-p2-11-26","title":"Abstract P2-11-26: The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Digital polymerase chain reaction; Oncology; Chemotherapy; Internal medicine; Triple-negative breast cancer; Breast cancer; Capecitabine; Biomarker; Circulating tumor DNA; Adjuvant; Minimal residual disease; Circulating tumor cell; Cancer; Metastasis; Polymerase chain reaction; Gene; Colorectal cancer; Biology; Leukemia","score_opus":0.020604735553693795,"score_gpt":0.32253432088884304,"score_spread":0.30192958533514924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956693,0.0017487681,0.0000017399828,0.0012232687,0.00007619869,0.0007693613,0.00034927344,0.000014339092,0.00014774941],"genre_scores_gemma":[0.99741876,0.0007379702,0.000023603397,0.00019116186,0.0004375199,0.0009774858,0.000022463904,0.00006950936,0.000121497906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99807525,0.00009424234,0.00029524346,0.00047333262,0.00043879697,0.0006231228],"domain_scores_gemma":[0.99887216,0.0001845156,0.000110563444,0.00040858838,0.00032320883,0.00010093634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006325084,0.00018618975,0.00023050877,0.00013637604,0.00011648163,0.00005339843,0.00033631106,0.00006961963,0.00012861485],"category_scores_gemma":[0.00016990426,0.00013721001,0.000057584675,0.0006729295,0.00031316406,0.000008315497,0.00016475894,0.00029388568,0.000008668664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025554493,0.00018337183,0.25237864,0.00020520203,0.00016373734,0.00013587346,0.001780117,0.0025524166,0.72631353,0.00006461729,0.004021024,0.009646019],"study_design_scores_gemma":[0.001927181,0.0002256913,0.806208,0.000320118,0.000015462678,0.000017655415,0.0015631882,0.00018531317,0.18701498,0.00024724184,0.0019878424,0.00028731182],"about_ca_topic_score_codex":0.0049121035,"about_ca_topic_score_gemma":0.008936506,"teacher_disagreement_score":0.5538294,"about_ca_system_score_codex":0.00012722875,"about_ca_system_score_gemma":0.0009929413,"threshold_uncertainty_score":0.7425664},"labels":[],"label_agreement":null},{"id":"W4322771719","doi":"10.1158/1538-7445.sabcs22-p1-14-01","title":"Abstract P1-14-01: Incidence, Clinicopathological Features and Treatment Outcomes Of Young Breast Cancer Patients: A Cohort Analysis From a High-Volume Tertiary Cancer Center in The United Arab Emirates","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Incidence (geometry); Cohort; Population; Cancer registry; Pediatrics; Internal medicine; Gynecology","score_opus":0.0378770199099063,"score_gpt":0.38449953891891253,"score_spread":0.3466225190090062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936713,0.0017199899,0.0000022630154,0.0013514856,0.00016852775,0.000551099,0.002481212,0.00001308756,0.000041044957],"genre_scores_gemma":[0.98744196,0.009536883,0.000020758114,0.00025134863,0.00016346987,0.0014262198,0.00081299513,0.000024302572,0.00032206887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976103,0.00033361578,0.0004040655,0.0006593575,0.0005212524,0.00047145598],"domain_scores_gemma":[0.9987881,0.00015882969,0.00012870431,0.0004982268,0.0003408245,0.00008528808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060766516,0.00022601336,0.00037718593,0.00042585382,0.00014244784,0.00006173391,0.00040448978,0.00021397366,0.0002507312],"category_scores_gemma":[0.00009645417,0.00015051242,0.00013563981,0.0015475566,0.00038296994,0.000014076146,0.00020131434,0.00029954224,0.0000047097274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021325647,0.00018788292,0.9865824,0.000014812371,0.0005695856,0.000014605675,0.0004885373,0.00069214846,0.0056647123,0.000002258168,0.0032034745,0.002366305],"study_design_scores_gemma":[0.0009514737,0.000101077705,0.9949453,0.000044697383,0.00014559955,0.000001346647,0.0003084229,0.00006252174,0.002686824,0.000027244307,0.0005633466,0.00016217203],"about_ca_topic_score_codex":0.033394523,"about_ca_topic_score_gemma":0.022537371,"teacher_disagreement_score":0.010857151,"about_ca_system_score_codex":0.00034539844,"about_ca_system_score_gemma":0.00037179433,"threshold_uncertainty_score":0.9952988},"labels":[],"label_agreement":null},{"id":"W4322771803","doi":"10.1158/1538-7445.sabcs22-p2-13-04","title":"Abstract P2-13-04: Inclusion of Patients with Leptomeningeal Disease in Phase III Randomized Clinical Trials of Patients with Advanced Breast Cancer, Lung Cancer, and Melanoma: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; University of Toronto; Health Sciences Centre; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Cancer; Lung cancer; Randomized controlled trial; Internal medicine; Population; Clinical trial; Asymptomatic; Oncology; Surgery","score_opus":0.12760428898839052,"score_gpt":0.5297660016737155,"score_spread":0.40216171268532497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039628044,0.92551214,0.0000024082835,0.00012053356,0.00013696813,0.02871557,0.0058598337,0.00001839524,0.0000061141836],"genre_scores_gemma":[0.014137151,0.97283936,0.000029227373,0.000026352049,0.00009558617,0.011640013,0.0010356625,0.00012830421,0.0000683421],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98677313,0.004572457,0.004780147,0.0009832022,0.0022209298,0.0006701409],"domain_scores_gemma":[0.98888665,0.00513835,0.003236204,0.00087634305,0.001227248,0.00063519704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01458384,0.000692132,0.014021875,0.0006683373,0.00014638426,0.000020180856,0.00034591084,0.00020914718,0.00023502269],"category_scores_gemma":[0.0029213945,0.0003633073,0.0008171732,0.0014098716,0.0005433158,0.00011878515,0.00045622754,0.0009108954,0.0000015889347],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07889175,0.0015679487,0.0041038077,0.7620698,0.0027845604,0.0000682336,0.000088435394,0.000002956502,8.341636e-8,0.0000030358458,0.00013748114,0.15028189],"study_design_scores_gemma":[0.2177923,0.000622352,0.0016826208,0.766276,0.012654548,0.0000010618966,0.000013047716,0.000012865484,3.97961e-7,0.000003038219,0.0006410783,0.00030069074],"about_ca_topic_score_codex":0.0018615201,"about_ca_topic_score_gemma":0.00030416658,"teacher_disagreement_score":0.1499812,"about_ca_system_score_codex":0.0009080262,"about_ca_system_score_gemma":0.0033415805,"threshold_uncertainty_score":0.99988186},"labels":[],"label_agreement":null},{"id":"W4322771857","doi":"10.1158/1538-7445.sabcs22-p2-24-04","title":"Abstract P2-24-04: The ER antagonist giredestrant induces profound chromatin remodeling including activation of cis-regulatory elements bound by FOXA1 and GATA3 in HR+ breast cancer models","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Chromatin; FOXA1; Transcriptome; Cancer research; Gene silencing; Breast cancer; Biology; Fulvestrant; Small interfering RNA; Chromatin immunoprecipitation; Chromatin remodeling; In vivo; Chemistry; Cell biology; Cancer; Estrogen receptor; Gene; Gene expression; RNA; Genetics; Promoter","score_opus":0.06995242485404893,"score_gpt":0.3818827093526198,"score_spread":0.31193028449857085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570477,0.0027928932,0.000011179013,0.0006492595,0.00007683448,0.00051407184,0.00010131633,0.000011322246,0.00013835392],"genre_scores_gemma":[0.99625605,0.0031505928,0.000015002069,0.000027778355,0.00012528534,0.00016649727,0.00009746037,0.0000321065,0.00012923482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983017,0.00012601096,0.00030250286,0.00038788447,0.00042789703,0.0004540471],"domain_scores_gemma":[0.99937916,0.000050306717,0.00010004656,0.0002567953,0.00013579245,0.00007789552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010607882,0.0001524639,0.00016631214,0.00012379745,0.00029031243,0.00006405781,0.00023015797,0.00019552134,0.000013479258],"category_scores_gemma":[0.000028646435,0.0001177932,0.00003959145,0.00038745324,0.00025057327,0.000029539593,0.00018658757,0.00039599396,0.0000016349887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019998221,0.000037488542,0.0011465577,0.0001256634,0.000069077396,0.0000025563122,0.00027449278,0.0012164302,0.986411,0.0000200601,0.0014539312,0.009042778],"study_design_scores_gemma":[0.0011116628,0.00012362664,0.014197792,0.0004890202,0.00001550152,0.0000075842468,0.00074460835,0.005337225,0.9769017,0.00053365313,0.00027656558,0.00026106244],"about_ca_topic_score_codex":0.0017984771,"about_ca_topic_score_gemma":0.00016636243,"teacher_disagreement_score":0.013051234,"about_ca_system_score_codex":0.00012330404,"about_ca_system_score_gemma":0.00035828384,"threshold_uncertainty_score":0.48034674},"labels":[],"label_agreement":null},{"id":"W4322771858","doi":"10.1158/1538-7445.sabcs22-p1-11-19","title":"Abstract P1-11-19: A real-world evidence study of treatment patterns in patients with HER2-positive metastatic breast cancer who have received at least 2-lines of therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; AstraZeneca (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Discontinuation; Internal medicine; Oncology; Breast cancer; Cancer; Interquartile range","score_opus":0.13987231841483044,"score_gpt":0.4563584420705444,"score_spread":0.31648612365571394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412733,0.0008223185,0.0000021766566,0.00093324564,0.00005566228,0.0032943971,0.0006799643,0.000036143712,0.000048757858],"genre_scores_gemma":[0.99241626,0.004413578,0.00001992851,0.000038644794,0.00009098333,0.0016305831,0.000041438543,0.00008780684,0.0012607494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629384,0.00033649892,0.00061915064,0.00070784724,0.0013249019,0.0007177441],"domain_scores_gemma":[0.99716306,0.0005594397,0.0002951646,0.0006682147,0.0010759323,0.00023818611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005529338,0.00035271636,0.0009230554,0.00078672473,0.00011660641,0.000015683954,0.00026475312,0.00005140679,0.0005723294],"category_scores_gemma":[0.000048660513,0.0002505041,0.00009086938,0.0016396382,0.0003600334,0.0002208913,0.00010945587,0.00031071744,0.0000061072074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013489234,0.0015966014,0.9357432,0.00032854904,0.0006134749,0.00007049322,0.008431774,0.0012598325,0.0026872074,0.0000015713649,0.000066667024,0.03571136],"study_design_scores_gemma":[0.009747011,0.0031025745,0.9737838,0.003125408,0.000069274894,0.0000024493818,0.0037898053,0.00004166784,0.0060418793,0.000010489766,0.000082794446,0.00020286899],"about_ca_topic_score_codex":0.10921703,"about_ca_topic_score_gemma":0.12050145,"teacher_disagreement_score":0.03804054,"about_ca_system_score_codex":0.0026715384,"about_ca_system_score_gemma":0.0009004189,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W4322771875","doi":"10.1158/1538-7445.sabcs22-ot2-16-05","title":"Abstract OT2-16-05: Safety Analyses of NRG BR004: A Randomized, Double-blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-line HER2-Positive Metastatic Breast Cancer (MBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pertuzumab; Taxane; Metastatic breast cancer; Atezolizumab; Internal medicine; Oncology; Clinical endpoint; Placebo; Trastuzumab; Randomized controlled trial; Breast cancer; Ixabepilone; Interim analysis; Surgery; Cancer; Nivolumab; Pathology","score_opus":0.16414596421967279,"score_gpt":0.48526084246379503,"score_spread":0.3211148782441222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98166573,0.003095926,0.00050427334,0.003232642,0.000243857,0.008961517,0.0015988455,0.00010738313,0.0005898521],"genre_scores_gemma":[0.9889462,0.0051949234,0.00017367516,0.00006168582,0.00039883514,0.0034988823,0.00020553124,0.00013806866,0.00138219],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99305713,0.0005580283,0.0017591049,0.0010200847,0.002283108,0.0013225523],"domain_scores_gemma":[0.99409026,0.0023363365,0.0007221194,0.0008811377,0.0015499054,0.00042023355],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027658797,0.0006267137,0.0029532826,0.0015702106,0.00021496826,0.000039630748,0.0005210667,0.00019801655,0.0023353887],"category_scores_gemma":[0.00034604655,0.00042804398,0.0004217683,0.0043007075,0.00167154,0.0003122249,0.00017670663,0.0011156744,0.000018389972],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94478816,0.0014006825,0.00006106189,0.0011009749,0.0024659354,0.00053675217,0.0016423623,0.006517139,0.006360568,0.000050993913,0.00018641482,0.03488893],"study_design_scores_gemma":[0.9570276,0.0024564902,0.00041583378,0.0034188249,0.0006229374,0.00014212365,0.0016712296,0.00046962462,0.032871626,0.00011414278,0.0003469142,0.00044266082],"about_ca_topic_score_codex":0.03362893,"about_ca_topic_score_gemma":0.010239569,"teacher_disagreement_score":0.034446273,"about_ca_system_score_codex":0.0024696137,"about_ca_system_score_gemma":0.0038228189,"threshold_uncertainty_score":0.99981713},"labels":[],"label_agreement":null},{"id":"W4322771950","doi":"10.1158/1538-7445.sabcs22-ot2-03-02","title":"Abstract OT2-03-02: lidERA Breast Cancer: A phase III adjuvant study of giredestrant (GDC-9545) vs physician’s choice of endocrine therapy in patients with estrogen receptor+, HER2– early breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Endocrine system; Cancer; Adjuvant; Oncology; Internal medicine; Estrogen; Estrogen receptor; Gynecology; Hormone","score_opus":0.022131205143811984,"score_gpt":0.35690617727168983,"score_spread":0.3347749721278778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517775,0.002077163,3.9813654e-7,0.00025395452,0.00011979181,0.0014929771,0.00080784626,0.00002178949,0.000048339913],"genre_scores_gemma":[0.99510914,0.0036205605,0.000004052588,0.000028062688,0.00024604597,0.00065894774,0.000120607416,0.00008167435,0.00013089928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969247,0.00022072291,0.0004930267,0.0007010325,0.0008292023,0.0008313402],"domain_scores_gemma":[0.99837506,0.000050037022,0.00021717901,0.00055213564,0.0006001897,0.00020538006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033195168,0.00033764038,0.00055122946,0.00024820125,0.0001253297,0.000028941555,0.00046559545,0.00016464434,0.00011524699],"category_scores_gemma":[0.000013584776,0.00026604862,0.00011730641,0.0009834941,0.00025047458,0.000025537807,0.0001400264,0.0005415015,0.0000075437874],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012234822,0.0036225133,0.35307646,0.00017720065,0.0008939982,0.000039268594,0.00088920863,0.0008961946,0.56795615,0.0000028675756,0.0013856898,0.05882563],"study_design_scores_gemma":[0.020575777,0.004658484,0.75691485,0.00047132108,0.000047013098,0.0000034676734,0.00044464238,0.000031986052,0.21604761,0.0000041774683,0.00037483283,0.00042581474],"about_ca_topic_score_codex":0.024113106,"about_ca_topic_score_gemma":0.0012737332,"teacher_disagreement_score":0.4038384,"about_ca_system_score_codex":0.00014959073,"about_ca_system_score_gemma":0.00061259937,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W4322771976","doi":"10.1158/1538-7445.sabcs22-her2-17","title":"Abstract HER2-17: HER2-17 Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 “Ultra-Low” Setting: Implications for Precision Therapy in HER2- Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Immunohistochemistry; Medicine; Breast cancer; Trastuzumab; Cancer; Oncology; Internal medicine; HER2/neu; Metastatic breast cancer; Cancer research","score_opus":0.08948907469710293,"score_gpt":0.47710320349969243,"score_spread":0.3876141288025895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322771976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96274805,0.0009962361,0.018241081,0.010672856,0.00012542239,0.004990845,0.0018666772,0.00011183509,0.0002470188],"genre_scores_gemma":[0.9817571,0.002769823,0.0065188357,0.00031581818,0.00022351409,0.0072652483,0.0005073585,0.0001087564,0.000533546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970842,0.00017635441,0.00052432454,0.00097541756,0.0003471117,0.0008925658],"domain_scores_gemma":[0.99777913,0.0006109975,0.0001966687,0.00081588485,0.00048452464,0.000112791015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018537719,0.0003192731,0.00030159453,0.00021343381,0.0004939306,0.000110040164,0.0007482178,0.00033074385,0.000017987388],"category_scores_gemma":[0.00023166678,0.00025766672,0.00016777539,0.00082148035,0.00023138284,0.00003086878,0.00014344281,0.00048684992,0.0000032567316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003952409,0.00023330608,0.0011238365,0.00007611411,0.0000245657,0.0000015722667,0.0004497245,0.0007711626,0.941819,0.00007937998,0.007806828,0.04721927],"study_design_scores_gemma":[0.0054875803,0.0013987968,0.19269931,0.002150175,0.000030463245,0.000037450332,0.004979935,0.0060709678,0.6527132,0.005825952,0.12683989,0.0017662904],"about_ca_topic_score_codex":0.0005434942,"about_ca_topic_score_gemma":0.0032950395,"teacher_disagreement_score":0.2891058,"about_ca_system_score_codex":0.00025048977,"about_ca_system_score_gemma":0.00036746208,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W4322772011","doi":"10.1158/1538-7445.sabcs22-ot2-16-02","title":"Abstract OT2-16-02: Open-label, phase 3b/4 study of trastuzumab deruxtecan (T-DXd) in patients with or without baseline brain metastasis with advanced/metastatic human epidermal growth factor receptor 2–positive breast cancer: DESTINY-Breast12","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Trastuzumab; Brain metastasis; Metastatic breast cancer; Population; Phases of clinical research; Cancer; Breast cancer; Clinical trial; Metastasis","score_opus":0.12707601355900042,"score_gpt":0.46226401639619025,"score_spread":0.33518800283718986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605716,0.00025115686,0.000050419818,0.0014116841,0.00005871728,0.0072612613,0.0047601745,0.0000809824,0.00006843164],"genre_scores_gemma":[0.9946683,0.00012922905,0.0011490899,0.00013857383,0.000086688415,0.0025931844,0.0006505569,0.00019344469,0.0003909348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99313056,0.0010090956,0.0009867194,0.0013511553,0.002076462,0.0014459932],"domain_scores_gemma":[0.99567837,0.00090354646,0.00040259145,0.0008328087,0.0014828269,0.000699858],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018885458,0.00069499866,0.0016115436,0.0009699708,0.00043873079,0.0001167113,0.0005970024,0.00008502464,0.0020569419],"category_scores_gemma":[0.00026752497,0.00045357284,0.000076483324,0.0032612556,0.0004742775,0.0005425535,0.0002940086,0.00092227163,0.00002350346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0827497,0.042923752,0.47945482,0.0016276349,0.0044144713,0.0014873146,0.0045839464,0.0002542682,0.0041479585,0.00003514206,0.0028646728,0.37545633],"study_design_scores_gemma":[0.15073813,0.0407339,0.7884005,0.0031522335,0.0009230995,0.00006892712,0.008040469,0.00010194164,0.0065874937,0.000036637346,0.00016336553,0.0010533008],"about_ca_topic_score_codex":0.014559664,"about_ca_topic_score_gemma":0.013339454,"teacher_disagreement_score":0.37440303,"about_ca_system_score_codex":0.0013294071,"about_ca_system_score_gemma":0.0016372057,"threshold_uncertainty_score":0.9997916},"labels":[],"label_agreement":null},{"id":"W4322772041","doi":"10.1158/1538-7445.sabcs22-p2-15-04","title":"Abstract P2-15-04: Surgical outcomes of ambulatory mastectomy with immediate alloplastic reconstruction for breast cancer or risk reduction","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Breast reconstruction; Surgery; Prophylactic Mastectomy; Ambulatory; Implant; Mammaplasty; Retrospective cohort study; Cohort; Cancer; Internal medicine","score_opus":0.06571308700215048,"score_gpt":0.384580721696479,"score_spread":0.31886763469432855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611866,0.00020840587,0.0000139983,0.0008383693,0.0011717117,0.00087388785,0.0005670622,0.0000995696,0.000108304426],"genre_scores_gemma":[0.9962061,0.00075524166,0.00013299852,0.0000030672231,0.00091086,0.00042965153,0.000040654573,0.00004740955,0.0014740098],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795276,0.00007831124,0.0003900689,0.00041558314,0.0006057167,0.00055753824],"domain_scores_gemma":[0.99844295,0.00032023055,0.00018023592,0.00023429064,0.00060448697,0.00021778171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007448341,0.00018275883,0.00045952437,0.000569843,0.00020293194,0.000022874463,0.00008684169,0.00018293888,0.000874938],"category_scores_gemma":[0.000046729634,0.000118645024,0.0001152291,0.0008546895,0.00044110807,0.00016979885,0.00003254414,0.00053706137,0.000030862502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013769988,0.00011007053,0.22894524,0.0011073028,0.0007255497,0.00007982279,0.00024420113,0.00022575191,0.010273105,0.00004386912,0.0021775893,0.74229753],"study_design_scores_gemma":[0.00808101,0.00044506445,0.957881,0.0010592581,0.00026429762,0.019052032,0.0013628317,0.00031117955,0.010280494,0.00014450299,0.00078696804,0.00033139423],"about_ca_topic_score_codex":0.0010645752,"about_ca_topic_score_gemma":0.00036742078,"teacher_disagreement_score":0.7419661,"about_ca_system_score_codex":0.00027679966,"about_ca_system_score_gemma":0.0009076655,"threshold_uncertainty_score":0.9579958},"labels":[],"label_agreement":null},{"id":"W4322772055","doi":"10.1158/1538-7445.sabcs22-ot1-03-05","title":"Abstract OT1-03-05: TROPION-Breast02: Phase 3, open-label, randomized study of first-line datopotamab deruxtecan versus chemotherapy in patients with locally recurrent inoperable or metastatic TNBC who are not candidates for anti-PD-(L)1 therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Phases of clinical research; Metastatic breast cancer; Neutropenia; Chemotherapy; Cancer; Breast cancer","score_opus":0.18287316189759106,"score_gpt":0.49214510451055715,"score_spread":0.3092719426129661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790996,0.0011370595,0.000015606172,0.0027759227,0.00017567152,0.016248807,0.00045600918,0.000052694882,0.000038650523],"genre_scores_gemma":[0.9844224,0.0077804746,0.00009565318,0.0000941119,0.00010922691,0.0067687966,0.00016017673,0.000120117686,0.0004490697],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99461097,0.0005066231,0.0008583984,0.00093889737,0.0018672846,0.0012178583],"domain_scores_gemma":[0.99491155,0.0020327487,0.00026584638,0.00082223094,0.0016523177,0.00031528543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002748697,0.0004381086,0.0019818924,0.0007952006,0.00033034114,0.00013896088,0.00077151984,0.00007876279,0.00032799365],"category_scores_gemma":[0.0012758621,0.00027364132,0.00008888442,0.0022308528,0.00050919154,0.0002837525,0.0003126168,0.0007133142,0.000011383988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9260356,0.00984041,0.018076427,0.0011176758,0.0022970096,0.00013874708,0.0034586913,0.00012581944,0.0004104289,0.0000060823913,0.0056088967,0.03288424],"study_design_scores_gemma":[0.94498545,0.02082995,0.02222211,0.0018187851,0.00013628966,0.0000011167776,0.0031091117,0.0009415801,0.0035807427,0.000026444714,0.0019518732,0.00039653166],"about_ca_topic_score_codex":0.0064363787,"about_ca_topic_score_gemma":0.011489662,"teacher_disagreement_score":0.03248771,"about_ca_system_score_codex":0.00085619546,"about_ca_system_score_gemma":0.0014004709,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W4322772086","doi":"10.1158/1538-7445.sabcs22-p2-02-03","title":"Abstract P2-02-03: Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Meta-analysis; Hazard ratio; Radiation therapy; Odds ratio; Cancer; Randomized controlled trial; Confidence interval; Stage (stratigraphy); Adjuvant; Surgery","score_opus":0.08878633912509037,"score_gpt":0.4233653845854718,"score_spread":0.3345790454603814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064339815,0.99015456,0.000006777369,0.0003653521,0.000029033967,0.0026290955,0.006153815,0.000003936847,0.000014011258],"genre_scores_gemma":[0.0080274595,0.98981583,0.0000082160295,0.00003260789,0.000038854807,0.001778823,0.00013755118,0.000029822051,0.00013083158],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99731773,0.00058499235,0.0008543149,0.00050914125,0.0004868477,0.00024696352],"domain_scores_gemma":[0.99835277,0.00018507717,0.0005499593,0.0005490679,0.0002844408,0.000078706245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012237778,0.0002727902,0.0025528844,0.00032675316,0.000067446104,0.000024004,0.00030530491,0.00012365874,0.000052692787],"category_scores_gemma":[0.00019092858,0.0001741539,0.00049611984,0.0010553438,0.00012734451,0.000010876148,0.00029932742,0.00023615643,0.0000015221647],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026153043,0.00007311169,0.0003759112,0.86590135,0.08712572,0.0000068519075,0.00026327194,0.000052529806,0.000041983338,0.000034649893,0.0007227514,0.04514035],"study_design_scores_gemma":[0.0027568175,0.0005051156,0.09490147,0.25982144,0.60122615,0.00003930553,0.00017149864,0.000008000773,0.00032734332,0.000031033236,0.038771648,0.001440185],"about_ca_topic_score_codex":0.0018386026,"about_ca_topic_score_gemma":0.0012973647,"teacher_disagreement_score":0.6060799,"about_ca_system_score_codex":0.0003020471,"about_ca_system_score_gemma":0.00040285598,"threshold_uncertainty_score":0.71017903},"labels":[],"label_agreement":null},{"id":"W4322772091","doi":"10.1158/1538-7445.sabcs22-p2-02-05","title":"Abstract P2-02-05: Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Denosumab; Breast cancer; Cancer; Stage (stratigraphy); Internal medicine; Logistic regression; Adjuvant; Oncology; Cohort; Retrospective cohort study; Adjuvant therapy; Osteoporosis","score_opus":0.1380026668075249,"score_gpt":0.42171871822842805,"score_spread":0.28371605142090317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965076,0.00014902081,5.2685766e-7,0.0012816407,0.00004594277,0.0011188682,0.0008599149,0.000017874025,0.000018640361],"genre_scores_gemma":[0.99753076,0.0012623365,0.0000036298156,0.00017620076,0.000020208978,0.00039864008,0.00022681362,0.0000317291,0.00034970162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976354,0.00014929558,0.00031337206,0.00028749957,0.0009159192,0.0006984905],"domain_scores_gemma":[0.99895877,0.0001958706,0.00006967494,0.00034193046,0.0002590143,0.00017474443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060779677,0.00013689605,0.0002778484,0.0006309234,0.000074521704,0.00002455372,0.00012182384,0.00006215091,0.00017970841],"category_scores_gemma":[0.00003365374,0.00008520825,0.000028887122,0.0013831145,0.0000823058,0.00010727849,0.000057083693,0.00056193175,0.00001671558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013536005,0.00035767801,0.9900132,0.00039661367,0.000039434915,0.00030941627,0.0022158374,0.00047515298,0.000044979068,0.0000040724763,0.0002502495,0.004539812],"study_design_scores_gemma":[0.0043529407,0.00025029384,0.9932236,0.0008816867,0.000010458058,0.000001120278,0.00064396946,0.00015762396,0.000108082524,0.0000052358596,0.00029062756,0.00007434239],"about_ca_topic_score_codex":0.22688507,"about_ca_topic_score_gemma":0.022196105,"teacher_disagreement_score":0.20468897,"about_ca_system_score_codex":0.0004529088,"about_ca_system_score_gemma":0.00035036702,"threshold_uncertainty_score":0.9956463},"labels":[],"label_agreement":null},{"id":"W4322772104","doi":"10.1158/1538-7445.sabcs22-ot1-01-01","title":"Abstract OT1-01-01: A randomised phase II trial of palbociclib and fulvestrant vs standard endocrine therapy in patients with ER positive HER2 negative breast cancer and ctDNA detected molecular relapse during adjuvant endocrine therapy (TRAK-ER)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Fulvestrant; Palbociclib; Medicine; Oncology; Breast cancer; Internal medicine; Tamoxifen; Cancer; Estrogen receptor; Gynecology; Metastatic breast cancer","score_opus":0.023026925003652506,"score_gpt":0.36025714966292083,"score_spread":0.33723022465926833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927844,0.0029481263,0.000008770118,0.0013500258,0.000089908914,0.0053441375,0.0008664076,0.000086866414,0.000027342858],"genre_scores_gemma":[0.9888157,0.0092014875,0.0000785381,0.00007335835,0.00016339497,0.0013938561,0.00005227082,0.00013617774,0.00008521936],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99567676,0.0003206144,0.0006792131,0.00089705846,0.0013416063,0.0010847341],"domain_scores_gemma":[0.99776137,0.0003997228,0.00024260028,0.0004677399,0.00074620405,0.00038236188],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056502485,0.00050700293,0.0011229359,0.0006401296,0.00024080898,0.00004353309,0.00019357256,0.00010729272,0.00030026503],"category_scores_gemma":[0.00011267165,0.00038213114,0.00011775009,0.0012826691,0.00090397213,0.00029179655,0.00011244798,0.0009251368,0.0000011616462],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7654061,0.0008191662,0.008061619,0.00020214933,0.00071957224,0.00041497248,0.0032814087,0.000059821952,0.14379941,0.0000055442174,0.00001320626,0.07721705],"study_design_scores_gemma":[0.5240258,0.0068354136,0.31228843,0.00090389594,0.000042733183,0.000028763738,0.0004140056,0.00001746452,0.15490593,0.0001143709,0.000084659536,0.00033854067],"about_ca_topic_score_codex":0.0020675822,"about_ca_topic_score_gemma":0.00046134953,"teacher_disagreement_score":0.30422682,"about_ca_system_score_codex":0.00048503917,"about_ca_system_score_gemma":0.00065095007,"threshold_uncertainty_score":0.9998631},"labels":[],"label_agreement":null},{"id":"W4322772114","doi":"10.1158/1538-7445.sabcs22-ot1-03-04","title":"Abstract OT1-03-04: Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy in previously-treated, inoperable or metastatic HR+/HER2– breast cancer: TROPION-Breast01","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Vinorelbine; Eribulin; Internal medicine; Chemotherapy; Oncology; Breast cancer; Gemcitabine; Cancer","score_opus":0.07280313990434058,"score_gpt":0.42821128420626087,"score_spread":0.3554081443019203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98257494,0.0040609986,0.000012305415,0.009218251,0.00018462706,0.0027508345,0.0006924819,0.0002505664,0.000255022],"genre_scores_gemma":[0.9852503,0.008520773,0.00040225877,0.0008207526,0.00048823495,0.0017611746,0.00025233135,0.0002569314,0.0022472397],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99309325,0.00056792283,0.0011244488,0.0013264524,0.0018641358,0.0020237681],"domain_scores_gemma":[0.9960551,0.00070573215,0.000321119,0.0013489099,0.0008618649,0.00070721895],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001497059,0.0006987042,0.0015593681,0.0013007984,0.0002541547,0.00011384042,0.0009402231,0.00020733732,0.002909098],"category_scores_gemma":[0.00030939054,0.000563381,0.00021968616,0.005305398,0.00095694105,0.00061175885,0.00017452061,0.0014891076,0.00015487314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019569699,0.0024633147,0.37010613,0.008425505,0.0019490479,0.0022021516,0.010770665,0.00063499145,0.42100537,0.00028099783,0.013357557,0.14923458],"study_design_scores_gemma":[0.036741473,0.0017874517,0.7128274,0.008836019,0.00039681027,0.0009498221,0.0057122777,0.00061628217,0.13500035,0.0009607819,0.094057545,0.0021137851],"about_ca_topic_score_codex":0.03442941,"about_ca_topic_score_gemma":0.0060344394,"teacher_disagreement_score":0.34272128,"about_ca_system_score_codex":0.0013515115,"about_ca_system_score_gemma":0.0031773627,"threshold_uncertainty_score":0.9996818},"labels":[],"label_agreement":null},{"id":"W4322772123","doi":"10.1158/1538-7445.sabcs22-ot1-12-01","title":"Abstract OT1-12-01: A phase III trial evaluating De-escalation of Breast Radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancer: NRG-BR007","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Breast-conserving surgery; Oncology; Internal medicine; Stage (stratigraphy); Radiation therapy; Gynecology; Cancer; Mastectomy","score_opus":0.10782367027430277,"score_gpt":0.4492157448137875,"score_spread":0.3413920745394847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946936,0.0017244937,0.000039054332,0.0008406452,0.0004466284,0.00082001433,0.0012331579,0.000042670257,0.00015976196],"genre_scores_gemma":[0.99671876,0.0012721067,0.00003288053,0.000028248744,0.0007743942,0.00058882183,0.0003242597,0.00007358751,0.00018692759],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99624246,0.00041625183,0.0007442147,0.0006946731,0.0010179449,0.0008844642],"domain_scores_gemma":[0.9979213,0.00042214248,0.0003952528,0.00053368614,0.00053955556,0.00018804525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028827558,0.00030093463,0.00059112767,0.0003925802,0.00028124568,0.000046943147,0.00031588224,0.00022690462,0.00029321693],"category_scores_gemma":[0.0002469486,0.0003135497,0.0003600086,0.00091613625,0.00022219577,0.000041256775,0.00024510984,0.0002819345,0.000005795366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04223756,0.00060730684,0.09324085,0.0006763256,0.0013807111,0.000032335713,0.00088805315,0.0013523771,0.58968514,0.000013783961,0.0036751204,0.26621044],"study_design_scores_gemma":[0.059389025,0.000665867,0.787947,0.0014376288,0.00032688613,0.000067134664,0.0017124403,0.0017323912,0.14524186,0.000101355734,0.00046613446,0.0009122822],"about_ca_topic_score_codex":0.011823103,"about_ca_topic_score_gemma":0.0011958876,"teacher_disagreement_score":0.69470614,"about_ca_system_score_codex":0.00047123118,"about_ca_system_score_gemma":0.001929874,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W4322772140","doi":"10.1158/1538-7445.sabcs22-her2-15","title":"Abstract HER2-15: HER2-15 Retrospective Study to Estimate the Prevalence and Describe the Clinicopathological Characteristics, Treatment Patterns, and Outcomes of HER2-Low Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Immunohistochemistry; Concordance; Internal medicine; Breast cancer; Trastuzumab; Oncology; Metastatic breast cancer; Cancer","score_opus":0.09410522239188455,"score_gpt":0.47343707429145787,"score_spread":0.3793318518995733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593605,0.0013145203,0.0000056356816,0.009212748,0.00018456078,0.0024461558,0.00080021995,0.000069758906,0.000030347835],"genre_scores_gemma":[0.9928884,0.004211296,0.000022515775,0.00023511681,0.00023715022,0.0013172224,0.000006670167,0.000056124212,0.0010255108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968921,0.00032034045,0.00046256324,0.0007545705,0.00086512655,0.00070533203],"domain_scores_gemma":[0.9978785,0.0005124871,0.00014610442,0.0007377717,0.00047551247,0.00024961602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014694883,0.00032455157,0.0006714619,0.0001312845,0.00035293496,0.00007954263,0.00033044355,0.00007959783,0.0005194903],"category_scores_gemma":[0.0002513596,0.0001701113,0.00008229662,0.00051142287,0.00074383477,0.00009453686,0.00033771122,0.0005788863,0.000022014476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000987122,0.00036538905,0.9468783,0.00028204196,0.00017600818,0.00010518992,0.0039830455,0.000009016974,0.0008928125,0.000014321891,0.00010455636,0.046202194],"study_design_scores_gemma":[0.001443941,0.0010732323,0.9932605,0.000443303,0.000099747966,0.000037380003,0.0027384935,0.000017928003,0.00039290043,0.000068763155,0.00025773433,0.00016607615],"about_ca_topic_score_codex":0.0033570756,"about_ca_topic_score_gemma":0.0021614383,"teacher_disagreement_score":0.0463822,"about_ca_system_score_codex":0.0005574968,"about_ca_system_score_gemma":0.0002534146,"threshold_uncertainty_score":0.69369376},"labels":[],"label_agreement":null},{"id":"W4322772345","doi":"10.1158/1538-7445.sabcs22-gs4-03","title":"Abstract GS4-03: Validation of Profile for the Omission of Local Adjuvant Radiotherapy (POLAR) in a meta-analysis of three randomized controlled trials of breast conserving surgery +/- radiotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Oncology; Breast-conserving surgery; Internal medicine; Tamoxifen; Randomized controlled trial; Cohort; Systemic therapy; Cancer; Hazard ratio; Mastectomy; Surgery; Confidence interval","score_opus":0.18069146064534738,"score_gpt":0.43991372751008095,"score_spread":0.2592222668647336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9339688,0.058233228,0.0022781072,0.0011221289,0.000064737265,0.003191734,0.0011201465,0.0000047835947,0.000016330501],"genre_scores_gemma":[0.99047166,0.00774841,0.00014392995,0.000012117196,0.00005228428,0.0013866235,0.000113552655,0.000021978922,0.000049458995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996326,0.0012052316,0.0014289825,0.00028967636,0.00048993324,0.00026017206],"domain_scores_gemma":[0.9894284,0.008514248,0.0009238756,0.0004217633,0.00067634316,0.0000353478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014348785,0.00017048705,0.0042335717,0.0005246133,0.000047282338,0.000007106895,0.000228637,0.00011315467,0.00020577984],"category_scores_gemma":[0.0015204252,0.000093643626,0.0023362427,0.0009072854,0.0004771995,0.0000061160254,0.000045964513,0.0000822652,1.41132e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16778684,0.00023912727,0.005425439,0.00038698752,0.18323001,8.9243645e-7,0.00043410095,0.004257937,0.6313821,0.000033376728,0.000989218,0.005833966],"study_design_scores_gemma":[0.14758532,0.0001852954,0.026306307,0.0001377642,0.02837905,0.0000011352477,0.0006951725,0.0035084982,0.7927997,0.00011127364,0.000112409725,0.00017807813],"about_ca_topic_score_codex":0.0031772184,"about_ca_topic_score_gemma":0.00044494343,"teacher_disagreement_score":0.1614176,"about_ca_system_score_codex":0.000054929897,"about_ca_system_score_gemma":0.00045514043,"threshold_uncertainty_score":0.49730313},"labels":[],"label_agreement":null},{"id":"W4322772349","doi":"10.1158/1538-7445.sabcs22-ed2-2","title":"Abstract ED2-2: Screening for high risk patients: Does everyone need annual MRI with mammogram?","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overdiagnosis; Medicine; Mammography; Guideline; Breast cancer; Observational study; Magnetic resonance imaging; Breast cancer screening; Breast MRI; Cancer; Radiology; Internal medicine; Pathology","score_opus":0.10852219370273448,"score_gpt":0.4246486123896038,"score_spread":0.3161264186868693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946808,0.0003390138,0.00048982643,0.0017146673,0.00021733949,0.0013466172,0.0006761778,0.00018182801,0.0003537363],"genre_scores_gemma":[0.99397504,0.000425992,0.0012556681,0.00020706275,0.00073757983,0.0006548581,0.00020322423,0.00006285433,0.0024777073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996565,0.00006871206,0.00029386795,0.0005615592,0.001440179,0.001070697],"domain_scores_gemma":[0.99742806,0.00034378242,0.000095851516,0.00042919963,0.0013584346,0.0003446935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012387079,0.00020150213,0.00034800815,0.00038005775,0.00042437075,0.00008120667,0.0002698319,0.00012848419,0.00026016615],"category_scores_gemma":[0.0004244681,0.00013593282,0.00009583854,0.0013891296,0.0002320534,0.0002833127,0.00012539933,0.000676315,0.000075071795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006744334,0.00012766966,0.7742152,0.00039560025,0.0003403148,0.0001376626,0.0007456595,0.0005593982,0.0008810327,0.00011154002,0.13452856,0.08121302],"study_design_scores_gemma":[0.005903878,0.0017287057,0.95099235,0.0009720056,0.00009404945,0.0000040202112,0.0035421872,0.00016183243,0.003389437,0.0003148305,0.032551814,0.00034490015],"about_ca_topic_score_codex":0.009315657,"about_ca_topic_score_gemma":0.0015922554,"teacher_disagreement_score":0.17677712,"about_ca_system_score_codex":0.0002773508,"about_ca_system_score_gemma":0.00038427868,"threshold_uncertainty_score":0.9972814},"labels":[],"label_agreement":null},{"id":"W4322773831","doi":"10.1158/1538-7445.sabcs22-ed13-3","title":"Abstract ED13-3: Cardiovascular toxicity and breast cancer: Detection and prevention strategies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Cardiac toxicity; Presentation (obstetrics); Disease; Coronary artery disease; Risk stratification; Internal medicine; Oncology; Intensive care medicine; Toxicity; Surgery","score_opus":0.0725827089490739,"score_gpt":0.3973751944397525,"score_spread":0.32479248549067863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322773831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946765,0.0031131452,0.00006880354,0.00087983283,0.00009491245,0.00052582845,0.000025179183,0.000088131776,0.0005277232],"genre_scores_gemma":[0.98727494,0.011719815,0.000009483905,0.00002731453,0.00044063941,0.00020039879,0.000008478339,0.000021096375,0.0002978542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986402,0.000080134014,0.00012624978,0.0003311864,0.0005167198,0.00030555055],"domain_scores_gemma":[0.99939793,0.000047770212,0.000022921357,0.00020121325,0.00019344626,0.00013672674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093149766,0.000101490026,0.00022245747,0.00019648738,0.00021141669,0.00008146017,0.000040205963,0.00012418315,0.00006316664],"category_scores_gemma":[0.000026748177,0.00009608481,0.00009626215,0.00049403147,0.00015799694,0.00020092152,0.000040690935,0.00035509633,0.0000075619737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013680616,0.00001719694,0.0007429118,0.00034548182,0.0002385524,0.000014021125,0.00029480032,0.00004270605,0.72572047,0.000029020364,0.00018571806,0.2722323],"study_design_scores_gemma":[0.002056362,0.00015735312,0.4508289,0.00046126707,0.000096373136,0.00010517944,0.0017168076,0.0001675657,0.5399922,0.0012434578,0.0029846819,0.00018984928],"about_ca_topic_score_codex":0.0015827658,"about_ca_topic_score_gemma":0.00041521268,"teacher_disagreement_score":0.450086,"about_ca_system_score_codex":0.00020331409,"about_ca_system_score_gemma":0.00027791254,"threshold_uncertainty_score":0.3918225},"labels":[],"label_agreement":null},{"id":"W4322773947","doi":"10.1158/1538-7445.sabcs22-gs1-05","title":"Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Randomized controlled trial; Internal medicine; Breast cancer; Oncology; Chemotherapy; Cancer","score_opus":0.21796005366166593,"score_gpt":0.49331972929268575,"score_spread":0.2753596756310198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322773947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454993,0.0009942872,0.000069655136,0.0015927028,0.00040649966,0.0014856337,0.0005441747,0.00006623593,0.0002908902],"genre_scores_gemma":[0.9895277,0.0026725694,0.00038606487,0.000046978315,0.0011816041,0.0042260615,0.0011200113,0.00006247361,0.00077651197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978839,0.00016401247,0.00026188363,0.0006203765,0.00036142854,0.000708379],"domain_scores_gemma":[0.9990262,0.00012214744,0.00007449723,0.00039990488,0.00021547262,0.00016177948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008538102,0.00022296335,0.0002657432,0.00019093182,0.000652746,0.00009371391,0.00025733098,0.00013497435,0.00010058689],"category_scores_gemma":[0.00013549774,0.0001929244,0.00014831853,0.0003029927,0.00014186834,0.000015327034,0.00022672757,0.00010462663,0.00005044782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067678384,0.0020274457,0.011858524,0.0002979726,0.0043004253,0.00007448713,0.0030808568,0.0020193327,0.71009505,0.0013086965,0.089597195,0.107661635],"study_design_scores_gemma":[0.12545948,0.0061616446,0.030597681,0.00023991456,0.00028016677,0.000007510497,0.004003302,0.00013993878,0.5212288,0.0018626491,0.30871576,0.0013031886],"about_ca_topic_score_codex":0.0003755805,"about_ca_topic_score_gemma":0.0005151402,"teacher_disagreement_score":0.21911857,"about_ca_system_score_codex":0.0003220058,"about_ca_system_score_gemma":0.00040001588,"threshold_uncertainty_score":0.78672284},"labels":[],"label_agreement":null},{"id":"W4322773988","doi":"10.1158/1538-7445.sabcs22-ed2-3","title":"Abstract ED2-3: Hormonal exposure and risk in BRCA1/2 carriers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Cancer; Ovarian cancer; Gynecology; Oncology; Population; Cancer prevention; Hormone replacement therapy (female-to-male); Mastectomy; Internal medicine; Disease; Hormonal therapy; Environmental health","score_opus":0.03660959631187361,"score_gpt":0.365383781377763,"score_spread":0.3287741850658894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322773988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018353,0.0086811865,0.000002045961,0.00020965353,0.00007665878,0.00015851973,0.00016345877,0.000009896442,0.0005150659],"genre_scores_gemma":[0.9786015,0.020267613,0.000014102332,0.000033921966,0.00034406464,0.000101202975,0.000085323605,0.000016757907,0.00053548196],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988921,0.00007845317,0.000113191265,0.00032386163,0.00022995265,0.00036241428],"domain_scores_gemma":[0.9994511,0.000022736183,0.000017814093,0.00021821757,0.00011010038,0.0001800338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004710785,0.000079904814,0.00007779095,0.00012340253,0.00011202415,0.000032529973,0.0001286665,0.00010424165,0.000058225298],"category_scores_gemma":[0.00013547801,0.00008218887,0.00003281983,0.00023563864,0.00017424386,0.0000029834791,0.00010482528,0.00017708377,0.00001578744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004929219,0.000075967175,0.3405587,0.00013699745,0.00006051438,0.00005159891,0.0002768365,0.00013044027,0.5891245,0.000033459666,0.052960787,0.016097296],"study_design_scores_gemma":[0.0016597627,0.00022638634,0.8816153,0.000038711274,0.000008382707,0.000002125114,0.00075600314,0.000023792092,0.070150025,0.0008920918,0.04439652,0.0002309383],"about_ca_topic_score_codex":0.00041868378,"about_ca_topic_score_gemma":0.0005889302,"teacher_disagreement_score":0.5410566,"about_ca_system_score_codex":0.000026969763,"about_ca_system_score_gemma":0.00022207921,"threshold_uncertainty_score":0.33515647},"labels":[],"label_agreement":null},{"id":"W4322774011","doi":"10.1158/1538-7445.sabcs22-her2-06","title":"Abstract HER2-06: HER2-06 Outcome analysis of HER2-zero or HER2-low hormone receptor-positive (HR+) breast cancer patients - characterization of the molecular phenotype in combination with molecular subtyping","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Neoadjuvant therapy; Biomarker; Hormone receptor; Stage (stratigraphy); Trastuzumab; Biopsy; Pathology; Biology","score_opus":0.027486313822030494,"score_gpt":0.35326751890507757,"score_spread":0.3257812050830471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565315,0.00034652397,0.0002741402,0.0016034553,0.0000884654,0.001414354,0.0005058687,0.000046281733,0.00006776063],"genre_scores_gemma":[0.99795717,0.00042597004,0.000055681332,0.00015376165,0.000043290027,0.00041140238,0.0005025981,0.000101860154,0.00034829509],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99599826,0.0003315709,0.00072768854,0.0006308487,0.001630966,0.00068069104],"domain_scores_gemma":[0.9970314,0.00013785502,0.00044309362,0.0006597362,0.001571649,0.00015624703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007000396,0.00032471586,0.00081520434,0.00092339475,0.0001253389,0.00002972043,0.00039107027,0.00017786567,0.00033034562],"category_scores_gemma":[0.00011819231,0.00024011989,0.00018908374,0.0062802983,0.0004367084,0.00023782816,0.00015780391,0.000620625,0.0000138891055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033816653,0.00063446723,0.34818646,0.00050424127,0.0013310262,0.00003347304,0.0016547159,0.0024924895,0.62933785,0.00009115818,0.00003443458,0.01231802],"study_design_scores_gemma":[0.0028833493,0.00027262984,0.9242536,0.000949242,0.00023847392,0.0000013670852,0.0002804913,0.00029337147,0.07043578,0.00003711118,0.00011359792,0.00024098276],"about_ca_topic_score_codex":0.003277661,"about_ca_topic_score_gemma":0.0005261279,"teacher_disagreement_score":0.57606715,"about_ca_system_score_codex":0.0010340454,"about_ca_system_score_gemma":0.0005429728,"threshold_uncertainty_score":0.9791805},"labels":[],"label_agreement":null},{"id":"W4322774038","doi":"10.1158/1538-7445.sabcs22-gs1-01","title":"Abstract GS1-01: Race and clinical outcomes in the RxPONDER Trial (SWOG S1007)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Pacific islanders; Breast cancer; Demography; Oncology; Ethnic group; Race (biology); Cancer; Clinical trial; Population","score_opus":0.16469826517515274,"score_gpt":0.509310755294749,"score_spread":0.34461249011959627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908265,0.0011504224,0.0000010385919,0.0065129753,0.00024328046,0.0004669331,0.000028778946,0.000011500909,0.00075855455],"genre_scores_gemma":[0.9938672,0.003994692,0.000009017925,0.00023478315,0.0005364476,0.00034013446,0.00002414746,0.000017202921,0.000976332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983975,0.0002493251,0.00021926686,0.0003903572,0.00033497642,0.0004085599],"domain_scores_gemma":[0.9991113,0.00037928403,0.000031192172,0.00035014166,0.00006861756,0.000059463964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016526119,0.00011446566,0.00019268545,0.000074988784,0.00014801028,0.00004126734,0.00025682925,0.00011939139,0.00004187936],"category_scores_gemma":[0.00037047488,0.00007480495,0.00008180525,0.00027567297,0.00029033434,0.000004033002,0.00022958955,0.00030544025,0.000044850076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017681435,0.0006436058,0.7917923,0.00008231872,0.0007597449,0.00012996187,0.0011335356,0.000020842357,0.0080154,0.00021301724,0.14261815,0.03690972],"study_design_scores_gemma":[0.012486026,0.00025413532,0.95466685,0.000017135888,0.000013237292,0.0000020716875,0.0006720372,0.0000022881745,0.00088501594,0.00017479948,0.03069899,0.0001274349],"about_ca_topic_score_codex":0.0004999663,"about_ca_topic_score_gemma":0.0011291422,"teacher_disagreement_score":0.16287456,"about_ca_system_score_codex":0.000038154125,"about_ca_system_score_gemma":0.00016648819,"threshold_uncertainty_score":0.30504575},"labels":[],"label_agreement":null},{"id":"W4322774045","doi":"10.1158/1538-7445.sabcs22-gs4-09","title":"Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pregnancy; Breast cancer; Interim analysis; Population; Clinical endpoint; Cancer; Obstetrics; Gynecology; Randomized controlled trial; Oncology; Internal medicine","score_opus":0.12111767061212812,"score_gpt":0.4281222154545928,"score_spread":0.30700454484246464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801533,0.0023274075,0.000005664336,0.007627088,0.0003536884,0.003349307,0.0055947155,0.000049870898,0.0005389355],"genre_scores_gemma":[0.9865719,0.008334861,0.00002299907,0.00018693382,0.0009565452,0.0014211948,0.0001320159,0.00006948216,0.0023040664],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969904,0.00017484663,0.0006094294,0.0006223091,0.00081712246,0.0007859301],"domain_scores_gemma":[0.99654216,0.0017970253,0.0002281566,0.00052968634,0.00067882065,0.00022416352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012454414,0.0002474639,0.00062349177,0.00021635283,0.0002775557,0.00005400666,0.0002677998,0.00009376567,0.00014512119],"category_scores_gemma":[0.00033511347,0.00015189617,0.000101676575,0.0006589781,0.00044333847,0.000104344865,0.00016449994,0.0006839231,0.0000044138865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6448531,0.00013942245,0.024332345,0.00024308899,0.00063516997,0.00007801502,0.00937288,0.000018777118,0.010105986,0.000018139915,0.0031486955,0.30705437],"study_design_scores_gemma":[0.08765143,0.001946138,0.8929037,0.002393249,0.000052109368,0.00001282517,0.003537493,0.000020327308,0.0028403436,0.00008296807,0.008290934,0.00026846843],"about_ca_topic_score_codex":0.011929562,"about_ca_topic_score_gemma":0.0018509217,"teacher_disagreement_score":0.86857134,"about_ca_system_score_codex":0.0007721391,"about_ca_system_score_gemma":0.0011518368,"threshold_uncertainty_score":0.99465007},"labels":[],"label_agreement":null},{"id":"W4322774054","doi":"10.1158/1538-7445.sabcs22-p2-23-17","title":"Abstract P2-23-17: Programmed death ligand-1 expression in triple-negative breast cancer from Nigeria","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Triple-negative breast cancer; Medicine; Breast cancer; Incidence (geometry); Immunohistochemistry; Cancer; Oncology; Estrogen receptor; Internal medicine; Pathology","score_opus":0.09576948097587393,"score_gpt":0.42849388761945884,"score_spread":0.33272440664358494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900104,0.0028938488,0.0000016253958,0.004857244,0.00042312779,0.0014368852,0.00040930594,0.0001132093,0.00086368946],"genre_scores_gemma":[0.9866743,0.005989961,0.000047502886,0.0002381867,0.00070242205,0.0017483416,0.000109419176,0.000063841515,0.004425993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99689984,0.00014233428,0.00040551147,0.00063494063,0.00097545073,0.00094189116],"domain_scores_gemma":[0.9986072,0.00031007646,0.00008197495,0.0004533302,0.0002827842,0.00026459547],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010268192,0.0002320728,0.00042258578,0.00048388462,0.00018553321,0.00008325402,0.0002794372,0.0002128757,0.0022289618],"category_scores_gemma":[0.00010547352,0.0001848835,0.0001333595,0.001755496,0.00023963152,0.00012462444,0.0001145013,0.0007936895,0.00011763484],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011891958,0.00023725325,0.08236878,0.00017075492,0.00019644944,0.00025120733,0.0026762555,0.000010731838,0.7743956,0.0000027301223,0.044710048,0.083088234],"study_design_scores_gemma":[0.006955318,0.00015365913,0.79922205,0.0018336994,0.000014237819,0.0000056387457,0.0012571306,0.000041115673,0.17638588,0.00018816577,0.01367754,0.00026554658],"about_ca_topic_score_codex":0.020401401,"about_ca_topic_score_gemma":0.004630083,"teacher_disagreement_score":0.71685326,"about_ca_system_score_codex":0.0009492846,"about_ca_system_score_gemma":0.001100937,"threshold_uncertainty_score":0.99868315},"labels":[],"label_agreement":null},{"id":"W4322774088","doi":"10.1158/1538-7445.sabcs22-p1-01-04","title":"Abstract P1-01-04: Comparing the Effects of TC and Anthracycline-based Chemotherapy in Women with Breast Cancer HER2 Negative Treated in the Adjuvant Setting – An individual Patient Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Anthracycline; Docetaxel; Taxane; Population; Meta-analysis; Regimen; Hazard ratio; Cancer; Confidence interval","score_opus":0.10972099519088875,"score_gpt":0.44410646641234774,"score_spread":0.334385471221459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913678,0.0018907768,4.5063902e-7,0.005295853,0.000018107705,0.0012606499,0.0001083466,0.000015749727,0.0000422544],"genre_scores_gemma":[0.9970677,0.0005954897,0.000006875617,0.00046298228,0.00004898802,0.0017401165,0.000032294956,0.000022294756,0.0000232862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976591,0.00053855346,0.00029276323,0.00036786776,0.00062362384,0.00051810377],"domain_scores_gemma":[0.9981065,0.0012742794,0.00011644522,0.00028303594,0.000120284174,0.00009947525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012780976,0.00018706154,0.0007411022,0.00050003483,0.000121504665,0.000033011584,0.000187128,0.000056482375,0.00035390593],"category_scores_gemma":[0.00002767938,0.00009325328,0.00009797015,0.0024176452,0.00031684394,0.00007337065,0.00004056613,0.0005006004,9.89227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011120405,0.0014757002,0.825831,0.00060527667,0.035941005,0.00040452232,0.05396987,0.004992867,0.009385657,0.0000042759016,0.0009999803,0.055269465],"study_design_scores_gemma":[0.005192174,0.0007293646,0.97522104,0.00008965688,0.004112471,0.0000025541974,0.0036141276,0.00095172256,0.009891382,0.000012454686,0.00007349377,0.00010955972],"about_ca_topic_score_codex":0.02572698,"about_ca_topic_score_gemma":0.020555863,"teacher_disagreement_score":0.14939006,"about_ca_system_score_codex":0.00031324517,"about_ca_system_score_gemma":0.00026313393,"threshold_uncertainty_score":0.9973164},"labels":[],"label_agreement":null},{"id":"W4322774163","doi":"10.1158/1538-7445.sabcs22-p1-05-32","title":"Abstract P1-05-32: Outcomes of diagnostic breast imaging in young women (less than 50 years old)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Mammography; Breast imaging; Breast cancer screening; Cancer; Population; Medical diagnosis; Radiology; Incidence (geometry); Retrospective cohort study; Obstetrics; Gynecology; Internal medicine","score_opus":0.13457119779146315,"score_gpt":0.44977982926561483,"score_spread":0.3152086314741517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950112,0.00073548185,0.0000015032978,0.0015784339,0.0001861875,0.00035909464,0.000050494113,0.000050891133,0.00202673],"genre_scores_gemma":[0.9980503,0.00064694096,0.000012038096,0.000088246255,0.00014964337,0.00022084128,0.00000956493,0.00003104276,0.00079142785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997278,0.000069584465,0.0003327061,0.0003489347,0.0010799584,0.0008908531],"domain_scores_gemma":[0.9985446,0.0005994316,0.000056314908,0.00036987284,0.0002027934,0.00022702938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016300207,0.00013008938,0.0003762628,0.00053130835,0.000064036154,0.00003426355,0.00028903378,0.00006353178,0.00033550177],"category_scores_gemma":[0.0007155862,0.000119887845,0.00007593175,0.0011529898,0.00024904544,0.00015754742,0.00017449174,0.00051436346,0.00008985316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016266124,0.00003783395,0.9720213,0.00014404378,0.000030183866,0.0004782397,0.0018505672,0.000057945188,0.003861686,0.00006182005,0.0022829985,0.019010767],"study_design_scores_gemma":[0.0008780359,0.000050023715,0.990771,0.00066964317,0.0000073125398,0.000024049592,0.006376574,0.000028455268,0.00048161336,0.0002164639,0.000388499,0.00010830833],"about_ca_topic_score_codex":0.020730054,"about_ca_topic_score_gemma":0.0018424218,"teacher_disagreement_score":0.01890246,"about_ca_system_score_codex":0.00063245633,"about_ca_system_score_gemma":0.00041385216,"threshold_uncertainty_score":0.98579097},"labels":[],"label_agreement":null},{"id":"W4322774167","doi":"10.1158/1538-7445.sabcs22-p2-11-34","title":"Abstract P2-11-34: Mitotic spindle hotspot counting using deep learning networks is highly associated with clinical outcomes in patients with early-stage triple-negative breast cancer who did not receive systemic therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Triple-negative breast cancer; Medicine; Cohort; Oncology; Breast cancer; Internal medicine; Hazard ratio; Stage (stratigraphy); Proportional hazards model; Cancer; Biology","score_opus":0.06003398759239935,"score_gpt":0.40805212454070355,"score_spread":0.3480181369483042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965441,0.0002360656,0.000067368135,0.0012965545,0.00032448984,0.0012977073,0.00004115207,0.000121059355,0.00007146344],"genre_scores_gemma":[0.9968205,0.0010302542,0.00005183504,0.00038212712,0.00036046235,0.00014833015,0.000042443866,0.0001488958,0.001015121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947243,0.00065574044,0.0007790638,0.0008477966,0.0017038953,0.001289201],"domain_scores_gemma":[0.9965099,0.001421861,0.0004365181,0.00036122047,0.0008977358,0.00037277603],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034481229,0.00037189867,0.0010506744,0.00051619735,0.00044430495,0.00016437916,0.00031280768,0.00026935755,0.0001659374],"category_scores_gemma":[0.0011357367,0.00026586142,0.00013417628,0.0018806347,0.0004767559,0.00023709032,0.00012988946,0.0033043989,0.000011842885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016276981,0.00016605911,0.9765842,0.0001121279,0.00045796242,0.00013466012,0.0012789809,0.011129067,0.00010665344,0.0000027000435,0.00016254334,0.008237343],"study_design_scores_gemma":[0.008400211,0.00040105783,0.947011,0.0033856286,0.000055408957,0.000003701285,0.00059587165,0.03973305,0.000033363325,0.0000026424125,0.00006916978,0.00030892066],"about_ca_topic_score_codex":0.012213658,"about_ca_topic_score_gemma":0.00076259766,"teacher_disagreement_score":0.02957323,"about_ca_system_score_codex":0.0011960441,"about_ca_system_score_gemma":0.0006568457,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W4322774169","doi":"10.1158/1538-7445.sabcs22-p2-02-04","title":"Abstract P2-02-04: De-escalation of bone-targeted treatment: Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Zoledronic acid; Breast cancer; Anastrozole; Internal medicine; Oncology; Bisphosphonate; Tamoxifen; Hazard ratio; Proportional hazards model; Cancer; Osteoporosis; Confidence interval","score_opus":0.08237220571675799,"score_gpt":0.44443173787264056,"score_spread":0.3620595321558826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916957,0.0006250238,5.5440626e-7,0.0012555292,0.00011934599,0.0049012885,0.0011394806,0.000045149813,0.00021793375],"genre_scores_gemma":[0.99432164,0.0021174008,0.000019525318,0.00001075507,0.00007898603,0.0026196854,0.00011530591,0.000053696585,0.00066300016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727464,0.00025516274,0.0006449956,0.00041796512,0.00068639603,0.0007208236],"domain_scores_gemma":[0.9974869,0.0008571534,0.00028221885,0.0005654557,0.00052193715,0.00028635692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006557643,0.00026336717,0.0007701196,0.00030698112,0.0002520062,0.000011352497,0.00012821688,0.00013189267,0.00017753924],"category_scores_gemma":[0.00010067807,0.00014774918,0.00023595963,0.0007876316,0.00019669179,0.000072496034,0.00004677478,0.00020213069,0.000011534866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009739868,0.0053318515,0.83544266,0.0005891725,0.0013306314,0.000056486257,0.007928876,0.00025774282,0.024968246,0.000012422033,0.00031063505,0.11403139],"study_design_scores_gemma":[0.013531146,0.002838319,0.9612471,0.00041785993,0.00033516606,0.0000045736087,0.0006708558,0.0002070016,0.020436527,0.000037506103,0.0001712355,0.00010273519],"about_ca_topic_score_codex":0.05149996,"about_ca_topic_score_gemma":0.011544138,"teacher_disagreement_score":0.1258044,"about_ca_system_score_codex":0.0009722391,"about_ca_system_score_gemma":0.0011369186,"threshold_uncertainty_score":0.95481616},"labels":[],"label_agreement":null},{"id":"W4322774244","doi":"10.1158/1538-7445.sabcs22-p5-03-05","title":"Abstract P5-03-05: Distinct molecular differences between African American/Black and White women with Triple Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"PTEN; Breast cancer; Triple-negative breast cancer; Oncology; Medicine; Internal medicine; Cancer; Hazard ratio; Copy-number variation; Genetic variation; Triple negative; Gene; Cancer research; Biology; Genetics; Confidence interval; PI3K/AKT/mTOR pathway","score_opus":0.038120126122450526,"score_gpt":0.3606949926680146,"score_spread":0.32257486654556405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954767,0.0002686258,0.000042475014,0.002075245,0.000067925626,0.00043015456,0.00082356203,0.000034517383,0.0007807866],"genre_scores_gemma":[0.996624,0.00079306663,0.00006897437,0.00007603097,0.00038510206,0.0009871322,0.000059664784,0.00006063567,0.0009454054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750966,0.0001565957,0.00021050127,0.0007408628,0.0005574401,0.00082492334],"domain_scores_gemma":[0.9987499,0.00008283288,0.00010480704,0.00042545627,0.00035759783,0.0002793936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043824015,0.00023880367,0.00029430215,0.00018799368,0.00023233336,0.00010428362,0.0003805999,0.00009343436,0.0002211605],"category_scores_gemma":[0.00007124202,0.00019907221,0.000038707934,0.0012093941,0.0012690042,0.000011695047,0.00026532728,0.00033937677,0.000023918243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022121156,0.00012632333,0.5070711,0.0003656413,0.0014272354,0.00010013136,0.0068904315,0.0006088995,0.32512316,0.000030573487,0.030416686,0.12562776],"study_design_scores_gemma":[0.0008594126,0.00043407036,0.95862186,0.000070498034,0.00002389486,0.0000045367387,0.0038271751,0.000031058604,0.031553168,0.00017337095,0.0040086415,0.00039232484],"about_ca_topic_score_codex":0.002001254,"about_ca_topic_score_gemma":0.0010570041,"teacher_disagreement_score":0.4515508,"about_ca_system_score_codex":0.00038656752,"about_ca_system_score_gemma":0.0008241553,"threshold_uncertainty_score":0.81179285},"labels":[],"label_agreement":null},{"id":"W4322774253","doi":"10.1158/1538-7445.sabcs22-p2-02-01","title":"Abstract P2-02-01: Benefit of adjuvant bisphosphonates in early breast cancer treated with contemporary systemic therapy: A meta-analysis of randomized control trials","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Anthracycline; Randomized controlled trial; Hazard ratio; Proportional hazards model; Meta-analysis; Cancer; Adjuvant; Confidence interval","score_opus":0.22973627823620646,"score_gpt":0.4507000195836156,"score_spread":0.22096374134740915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9353584,0.05706123,0.0000010040252,0.0015071793,0.000029797231,0.004201307,0.0016672249,0.00003483461,0.00013904132],"genre_scores_gemma":[0.98897636,0.0061947335,0.000004104279,0.000060689956,0.000018865174,0.0037394168,0.0000874451,0.00004345168,0.0008749412],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9952437,0.0009666706,0.0015632862,0.00048043893,0.0011661026,0.000579787],"domain_scores_gemma":[0.9950592,0.002628632,0.0006133627,0.0005045996,0.00092483667,0.00026937324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069637042,0.00027528516,0.006146204,0.0014749293,0.000057991547,0.000016563306,0.00016301662,0.00015342195,0.00094245863],"category_scores_gemma":[0.00023684812,0.00015112398,0.0011378062,0.0034535166,0.00029540437,0.000083934756,0.000021769114,0.0003456823,0.000009684259],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4513626,0.00052868825,0.28039956,0.0007216305,0.25549105,0.0002286952,0.0009585603,0.00044321278,0.0065514,0.000036023695,0.00027958673,0.0029990138],"study_design_scores_gemma":[0.41380012,0.00062390417,0.5184579,0.0006864379,0.054690726,0.0000075442285,0.00033216874,0.0004180004,0.010671292,0.000041005827,0.00003287303,0.00023805666],"about_ca_topic_score_codex":0.19479041,"about_ca_topic_score_gemma":0.0035685739,"teacher_disagreement_score":0.23805831,"about_ca_system_score_codex":0.00026069296,"about_ca_system_score_gemma":0.0012932391,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W4322774367","doi":"10.1158/1538-7445.sabcs22-p1-02-01","title":"Abstract P1-02-01: Comparing the efficacy of aromatase inhibitors vs tamoxifen in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and trial-level meta-analysis","year":2023,"lang":"en","type":"review","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); McGill University Health Centre; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Tamoxifen; Hazard ratio; Meta-analysis; Randomized controlled trial; Population; Gynecology; Cancer; Confidence interval","score_opus":0.30001612865526334,"score_gpt":0.4709470240388539,"score_spread":0.17093089538359058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031188605,0.9740133,0.0000030256376,0.00096056185,0.0001075335,0.01524543,0.0064508202,0.00007332587,0.00002711426],"genre_scores_gemma":[0.010523122,0.9774673,0.00004483735,0.00007056093,0.00039861005,0.010490763,0.00036385987,0.00024136595,0.00039956952],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9885633,0.003063868,0.0034551623,0.0015297366,0.0021651688,0.001222781],"domain_scores_gemma":[0.9903311,0.0045398325,0.0021188424,0.0015842242,0.0009344421,0.0004915708],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0048071085,0.0011526314,0.0143912565,0.0016535774,0.00037301058,0.00012686185,0.0010634369,0.00041284336,0.000875379],"category_scores_gemma":[0.0013133786,0.0007131563,0.002594414,0.005674301,0.0010107536,0.00031988192,0.00049659057,0.0026049253,0.000061384104],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004023718,0.0003785086,0.00006437499,0.83436257,0.14971283,0.000057328798,0.0011921065,0.000005366615,0.00009001542,0.000039278253,0.0010806205,0.008993306],"study_design_scores_gemma":[0.018310443,0.0008074786,0.0073786103,0.5257345,0.44189146,0.000060033453,0.00043772033,0.0000030123108,0.0001982771,0.000055543915,0.003163684,0.0019592165],"about_ca_topic_score_codex":0.010746417,"about_ca_topic_score_gemma":0.00086359197,"teacher_disagreement_score":0.30862805,"about_ca_system_score_codex":0.0019008056,"about_ca_system_score_gemma":0.0012417124,"threshold_uncertainty_score":0.9996961},"labels":[],"label_agreement":null},{"id":"W4322774387","doi":"10.1158/1538-7445.sabcs22-p1-12-07","title":"Abstract P1-12-07: Management of genitourinary symptoms in breast cancer patients: An updated systematic review of available evidence from randomized trials","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Gynecology; Population; Randomized controlled trial; Breast cancer; Cochrane Library; Internal medicine; Obstetrics; Cancer","score_opus":0.15729834884117608,"score_gpt":0.4358005210066627,"score_spread":0.27850217216548667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86365026,0.12646638,0.0000019713048,0.0008390885,0.00045483815,0.0072638886,0.0006531449,0.000050597035,0.0006198298],"genre_scores_gemma":[0.7940982,0.20138319,0.000009645666,0.000104389306,0.00013451965,0.0029604146,0.00020343957,0.000043560474,0.0010626697],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936628,0.001920329,0.0017616964,0.0005108143,0.0016475315,0.0004968681],"domain_scores_gemma":[0.9962594,0.0013086715,0.00050211896,0.00084757304,0.0008896747,0.00019256183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010786681,0.0002179366,0.0027234629,0.00044598375,0.000046962887,0.00002039496,0.00043162212,0.000103147126,0.0067931884],"category_scores_gemma":[0.0006211259,0.00016208619,0.000316698,0.0014445451,0.00020063251,0.00020412887,0.00017569863,0.00035515125,0.00010620262],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053706042,0.0005709926,0.0109014595,0.90048134,0.0019521806,0.00016192665,0.0015104257,0.000019606645,0.0035884713,0.000022441744,0.024714926,0.0023702043],"study_design_scores_gemma":[0.052458707,0.00023162768,0.02053066,0.92032427,0.0015949404,0.0000021499986,0.0010713773,0.000106426975,0.0031732062,0.000060791102,0.0001277978,0.00031807285],"about_ca_topic_score_codex":0.02522217,"about_ca_topic_score_gemma":0.00081639766,"teacher_disagreement_score":0.0749168,"about_ca_system_score_codex":0.0005031414,"about_ca_system_score_gemma":0.000483498,"threshold_uncertainty_score":0.99411476},"labels":[],"label_agreement":null},{"id":"W4322774447","doi":"10.1158/1538-7445.sabcs22-p4-03-19","title":"Abstract P4-03-19: Expected real-world impact of escalation and de-escalation of Her2-directed therapy in breast cancer patients receiving neoadjvuant therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Breast cancer; Neoadjuvant therapy; Cancer; Oncology; Internal medicine; Stage (stratigraphy)","score_opus":0.07584245732976164,"score_gpt":0.4295655626963287,"score_spread":0.35372310536656704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699336,0.0005000452,0.000001360741,0.0009209521,0.00007696297,0.00088066806,0.000050988263,0.000067655215,0.000508017],"genre_scores_gemma":[0.98150575,0.017776368,0.00001789227,0.00002345213,0.00010399035,0.00015177143,0.00006173629,0.000034498753,0.00032454394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798566,0.00013871047,0.0004279384,0.0003111912,0.0006726824,0.00046384562],"domain_scores_gemma":[0.9987733,0.00023972194,0.00016367216,0.0002383175,0.0004435164,0.00014149203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007718676,0.00015854414,0.00038442158,0.0010075477,0.000062847,0.0000217345,0.000113277514,0.00008225422,0.0005609239],"category_scores_gemma":[0.000083759296,0.00012777916,0.00009327784,0.0024753355,0.000115471456,0.00014065907,0.00005056578,0.00029055352,0.0000023882048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015142071,0.00014977665,0.87913585,0.00011842436,0.0001092177,0.0000043769314,0.0010864626,0.00019519374,0.022087017,0.0000048990873,0.0018829288,0.093711674],"study_design_scores_gemma":[0.0034201266,0.00026202216,0.9924643,0.00036657907,0.000008843922,4.4477392e-7,0.000108733315,0.00069547637,0.002451637,0.000051159554,0.000073612246,0.00009708297],"about_ca_topic_score_codex":0.04722606,"about_ca_topic_score_gemma":0.0027566466,"teacher_disagreement_score":0.11332846,"about_ca_system_score_codex":0.0007804965,"about_ca_system_score_gemma":0.00042212522,"threshold_uncertainty_score":0.95911855},"labels":[],"label_agreement":null},{"id":"W4322774476","doi":"10.1158/1538-7445.sabcs22-p6-05-12","title":"Abstract P6-05-12: Understanding Patient Perspectives on Window of Opportunity Clinical Trial Participation in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Toronto; Ontario Institute for Cancer Research; McMaster University; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Cancer; Window of opportunity; Oncology; Family medicine; Internal medicine","score_opus":0.596055075499918,"score_gpt":0.5828673150379452,"score_spread":0.013187760461972786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765578,0.00010464835,0.000007095623,0.021609176,0.0003679119,0.0006450506,0.000043174306,0.00002146593,0.0006436892],"genre_scores_gemma":[0.99762434,0.0016187098,0.0000035354517,0.00008510472,0.0004108988,0.00011261427,0.00002046633,0.000014379224,0.00010994714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976449,0.00024336542,0.00046048407,0.00028991117,0.0010251884,0.0003361558],"domain_scores_gemma":[0.99870664,0.0004803664,0.00009632192,0.0001960495,0.00025304843,0.00026758472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028164107,0.000078970465,0.00025446148,0.00035626697,0.00008856936,0.000012702061,0.00007025623,0.00021600765,0.00064829155],"category_scores_gemma":[0.0004553622,0.000060679733,0.00008034538,0.00072657457,0.0007661147,0.00004892266,0.00004829726,0.00086120336,0.000008519769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22853616,0.008759439,0.119951814,0.002058651,0.00078759895,0.00046413462,0.04822432,0.0010157471,0.03014269,0.027761752,0.033719838,0.49857786],"study_design_scores_gemma":[0.021388702,0.0014367712,0.9634118,0.0010763351,0.000025305975,0.0000013059515,0.0079671275,0.0008903775,0.00057774276,0.0025942216,0.0004968583,0.00013346519],"about_ca_topic_score_codex":0.0015882378,"about_ca_topic_score_gemma":0.00065185584,"teacher_disagreement_score":0.84345996,"about_ca_system_score_codex":0.0006893941,"about_ca_system_score_gemma":0.0011294764,"threshold_uncertainty_score":0.7098338},"labels":[],"label_agreement":null},{"id":"W4322774554","doi":"10.1158/1538-7445.sabcs22-p4-03-11","title":"Abstract P4-03-11: Population-based survival outcomes of pure vs mixed invasive lobular breast carcinoma in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Invasive lobular carcinoma; Medicine; Proportional hazards model; Incidence (geometry); Population; Survival analysis; Demography; Breast cancer; Carcinoma; Internal medicine; Oncology; Cancer; Invasive ductal carcinoma; Mathematics; Environmental health","score_opus":0.04236091948337815,"score_gpt":0.3222701176277687,"score_spread":0.2799091981443905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973264,0.00020817223,4.543923e-7,0.0014160863,0.00023952321,0.00028280768,0.00035970245,0.000008313818,0.0001585604],"genre_scores_gemma":[0.99875504,0.00003261938,0.00000814534,0.000054247626,0.00007368077,0.00018338824,0.000502621,0.000028550203,0.00036173765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981045,0.00010160601,0.0002614869,0.00042833257,0.00057867623,0.0005254142],"domain_scores_gemma":[0.99902457,0.00012963168,0.000066658045,0.00039800903,0.00027630085,0.00010485439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030768797,0.00018249381,0.00031375248,0.00015348577,0.000107890875,0.000014220772,0.00026793344,0.000108152075,0.00015867625],"category_scores_gemma":[0.00010877008,0.00017003715,0.00007383812,0.00039691722,0.0000921523,0.0000051684524,0.0001511766,0.00020654943,0.0000056872864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018731109,0.00004511225,0.98910546,0.000065987166,0.00008902778,0.000047922877,0.00006900674,0.00081980403,0.0067703207,0.000015028363,0.0025873575,0.00019765267],"study_design_scores_gemma":[0.0009836056,0.00003576323,0.9801804,0.000042517328,0.000009457317,0.0000012525239,0.00019514887,0.000004796326,0.017831517,0.000021466081,0.0005455595,0.00014852987],"about_ca_topic_score_codex":0.9912165,"about_ca_topic_score_gemma":0.9994235,"teacher_disagreement_score":0.011061197,"about_ca_system_score_codex":0.00083222793,"about_ca_system_score_gemma":0.0035884217,"threshold_uncertainty_score":0.6933914},"labels":[],"label_agreement":null},{"id":"W4322774598","doi":"10.1158/1538-7445.sabcs22-p4-09-12","title":"Abstract P4-09-12: Baseline and End-of-Treatment Biomarkers in Patients With PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From BYLieve Study Cohorts A and B","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Letrozole; Biomarker; Cancer; Breast cancer; Aromatase inhibitor; Cohort; Hazard ratio; Cancer research; Estrogen receptor; Biology; Confidence interval; Aromatase; Genetics","score_opus":0.034773631021361856,"score_gpt":0.3609850733321113,"score_spread":0.3262114423107494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054754,0.001430706,0.0000051409743,0.00070470467,0.000085004576,0.0033149766,0.0037788749,0.000075337244,0.000057692392],"genre_scores_gemma":[0.9961656,0.0016613669,0.0003070235,0.00003368839,0.00012439431,0.001157536,0.00034616838,0.00010961055,0.00009461762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962465,0.00033595154,0.0005619695,0.0010605793,0.0009399859,0.0008549996],"domain_scores_gemma":[0.9975564,0.0006619407,0.00021925934,0.000397452,0.0007516335,0.00041330623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004710117,0.00047621215,0.00089132757,0.0005824246,0.00023397758,0.000037523707,0.00014915502,0.00012531619,0.00062111],"category_scores_gemma":[0.00009994865,0.0003747846,0.000055492623,0.0010664192,0.00074438093,0.00036329526,0.00015220759,0.0004961952,0.000007735051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01663383,0.0010139964,0.80496836,0.00011131674,0.0014241388,0.00007402144,0.004772804,0.000034251687,0.046684023,0.00000267163,0.00012903921,0.12415155],"study_design_scores_gemma":[0.018736161,0.0025465938,0.9640406,0.00068889663,0.000077930505,0.0000026515231,0.0021371858,0.000020559075,0.011259965,0.000035224406,0.00009806373,0.00035618077],"about_ca_topic_score_codex":0.022976859,"about_ca_topic_score_gemma":0.0035263987,"teacher_disagreement_score":0.15907222,"about_ca_system_score_codex":0.001512204,"about_ca_system_score_gemma":0.00049858104,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W4322774660","doi":"10.1158/1538-7445.sabcs22-p3-02-02","title":"Abstract P3-02-02: Real-World Time-to-Treatment Discontinuation in Hormone-Receptor-Positive Metastatic Breast Cancer Patients following CDK4/6 Inhibitor Treatment, Based on Observational Data Collected Through Patient-Partnered Research","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Regimen; Medicine; Metastatic breast cancer; Breast cancer; Internal medicine; Medical record; Oncology; Observational study; Cancer; Cohort","score_opus":0.22782759749489598,"score_gpt":0.4755263896598825,"score_spread":0.2476987921649865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802502,0.00039034322,0.000007003149,0.006226706,0.0002596796,0.0052842447,0.0062194974,0.00015734263,0.0012050173],"genre_scores_gemma":[0.9790326,0.00051673135,0.00045740776,0.00019934127,0.00046640326,0.0058701425,0.0072722556,0.00018939291,0.0059957616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9923704,0.00079514453,0.00080869667,0.0015500681,0.0028585724,0.0016170868],"domain_scores_gemma":[0.99530226,0.0015599971,0.00017867253,0.0012493961,0.0012694205,0.00044023222],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011472448,0.00053427496,0.00083190895,0.0014891183,0.0006206721,0.00014529807,0.00048509808,0.00012384231,0.0012252366],"category_scores_gemma":[0.00037870195,0.00044760722,0.00016512685,0.006125784,0.0002715261,0.00070269546,0.0002680278,0.0006512368,0.00063009094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06597602,0.016243579,0.17737135,0.00038058747,0.004099212,0.0008405821,0.016575063,0.012476584,0.1893162,0.00012215789,0.08038054,0.43621814],"study_design_scores_gemma":[0.022211207,0.0066105938,0.9165721,0.003283782,0.00016591199,0.000001865727,0.0011909816,0.0056364266,0.022815797,0.0001335885,0.02042477,0.0009529564],"about_ca_topic_score_codex":0.014427866,"about_ca_topic_score_gemma":0.0059660655,"teacher_disagreement_score":0.7392008,"about_ca_system_score_codex":0.00968344,"about_ca_system_score_gemma":0.0027793716,"threshold_uncertainty_score":0.9997976},"labels":[],"label_agreement":null},{"id":"W4322774722","doi":"10.1158/1538-7445.sabcs22-p4-03-15","title":"Abstract P4-03-15: Does age affect outcome? Data from a large cohort from British Columbia, 2005-2014","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Proportional hazards model; Cancer; Cohort; Oncology; Disease; Pathological; Stage (stratigraphy); Prognostic variable","score_opus":0.26020123548349466,"score_gpt":0.48351857980358254,"score_spread":0.22331734432008787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815092,0.0033168036,0.000011897363,0.0014030623,0.00061459,0.00094758836,0.008511791,0.00023786965,0.0034471634],"genre_scores_gemma":[0.9773715,0.0026080338,0.00012386669,0.00082285254,0.0017489542,0.00025809844,0.0036410901,0.000074982476,0.013350596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947644,0.00017770275,0.00047676705,0.0011981309,0.001979992,0.0014030072],"domain_scores_gemma":[0.99673927,0.00062912516,0.00008268191,0.0017279187,0.00026381342,0.0005571692],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028400915,0.00018791147,0.0006344247,0.00013208608,0.000397903,0.00063991564,0.0011130158,0.00023075583,0.018737722],"category_scores_gemma":[0.0009105594,0.00021438645,0.00012654185,0.0007161571,0.00024347092,0.00037453137,0.000962138,0.0011659386,0.0024129602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008647272,0.000036677826,0.513718,0.00004973708,0.00013307708,0.0017886074,0.00004869887,0.0000013695588,0.002486688,0.0000010844419,0.47904575,0.0026038394],"study_design_scores_gemma":[0.0013510295,0.00005785606,0.83847845,0.0005358939,0.000071029186,0.000005992607,0.00033523777,0.00011083988,0.00023286122,0.0002843441,0.15830895,0.00022754092],"about_ca_topic_score_codex":0.6635612,"about_ca_topic_score_gemma":0.6762886,"teacher_disagreement_score":0.32476044,"about_ca_system_score_codex":0.00049761636,"about_ca_system_score_gemma":0.0006393244,"threshold_uncertainty_score":0.9983638},"labels":[],"label_agreement":null},{"id":"W4322774773","doi":"10.1158/1538-7445.sabcs22-p4-01-42","title":"Abstract P4-01-42: Pooled analysis of post-progression treatments after first-line ribociclib + endocrine therapy in patients with HR+/HER2− advanced breast cancer in the MONALEESA-2, -3, and -7 studies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Cancer; Propensity score matching; Adjuvant therapy; Targeted therapy; Randomized controlled trial","score_opus":0.04679614256199177,"score_gpt":0.43014768948204934,"score_spread":0.3833515469200576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792744,0.014632352,7.534545e-7,0.0040403507,0.000043912616,0.0014710082,0.00048741634,0.000031634554,0.000018209661],"genre_scores_gemma":[0.9836672,0.013790164,0.000042716147,0.00016424707,0.00006562582,0.0020070288,0.00008253346,0.000052074935,0.00012840409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682933,0.00016783897,0.00046275381,0.00061669416,0.0011875144,0.00073589553],"domain_scores_gemma":[0.99814874,0.00038919778,0.00014622972,0.0005019686,0.000693077,0.00012077427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005152065,0.00031840132,0.0007847037,0.0010645419,0.00011785082,0.0000213054,0.0002220771,0.00006994952,0.0002827014],"category_scores_gemma":[0.000058961585,0.00018509636,0.00010226506,0.0037913525,0.0004427245,0.00022950202,0.00011190789,0.00046837394,0.0000036920935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014669141,0.0005363039,0.8062891,0.00017745247,0.0016876599,0.000114084934,0.0029041409,0.0008562667,0.0013802573,0.0000029675177,0.000013467504,0.17136917],"study_design_scores_gemma":[0.009656874,0.0007511919,0.9859512,0.0008842396,0.00023379347,0.0000024469173,0.0012875316,0.00006319381,0.0007849696,0.000046653164,0.00016427081,0.00017364463],"about_ca_topic_score_codex":0.0016159372,"about_ca_topic_score_gemma":0.007237524,"teacher_disagreement_score":0.17966211,"about_ca_system_score_codex":0.0005554004,"about_ca_system_score_gemma":0.00018581105,"threshold_uncertainty_score":0.7548011},"labels":[],"label_agreement":null},{"id":"W4322774777","doi":"10.1158/1538-7445.sabcs22-p3-03-09","title":"Abstract P3-03-09: Assessment of Breast Cancer Chemotherapy Dose Reduction in an Integrated Healthcare Delivery System","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Dosing; Breast cancer; Body surface area; Cancer; Chemotherapy; Regimen; Cyclophosphamide; Oncology; Internal medicine","score_opus":0.129252762229023,"score_gpt":0.49677149008717275,"score_spread":0.36751872785814976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933902,0.00084050867,0.0000023088892,0.0039443634,0.00039970235,0.00083993725,0.00029454054,0.000095355535,0.00019305905],"genre_scores_gemma":[0.9939959,0.0047257696,0.000023406714,0.00003904864,0.00041063898,0.000401992,0.0000844273,0.0000492291,0.00026959943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99761367,0.00014460743,0.0004094373,0.00044842594,0.0008218533,0.0005619778],"domain_scores_gemma":[0.99846953,0.000044005625,0.00009450437,0.0004099697,0.00072289293,0.00025911783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000996294,0.00015926502,0.00041180238,0.0006321706,0.00009448611,0.000029832836,0.00016586728,0.00015165849,0.00045899348],"category_scores_gemma":[0.00000876651,0.00013416405,0.00007478185,0.0017630518,0.00014539064,0.00015065385,0.000038663016,0.0007732613,0.000014439577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004015536,0.00047440117,0.28483564,0.0041201175,0.00021276518,0.0001629149,0.0030771184,0.0008433528,0.2638301,0.00017729097,0.007709034,0.43054172],"study_design_scores_gemma":[0.0018484147,0.00030307827,0.9834508,0.0018467429,0.000011828902,0.000016368449,0.005929279,0.0012680686,0.0038610646,0.000008767961,0.0013098989,0.00014573283],"about_ca_topic_score_codex":0.10281546,"about_ca_topic_score_gemma":0.006059874,"teacher_disagreement_score":0.69861513,"about_ca_system_score_codex":0.0027629146,"about_ca_system_score_gemma":0.0021919925,"threshold_uncertainty_score":0.90315896},"labels":[],"label_agreement":null},{"id":"W4322774790","doi":"10.1158/1538-7445.sabcs22-p4-07-46","title":"Abstract P4-07-46: The Out-of-Pocket Cost of Breast Cancer Care in Nigeria: A Prospective Analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Health care; Payment; Cancer; Family medicine; Finance; Economic growth; Business","score_opus":0.08531886873329515,"score_gpt":0.37292971077923126,"score_spread":0.2876108420459361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97449774,0.0085761165,0.000019114847,0.0013869657,0.000442093,0.0007702278,0.0037908247,0.000019247931,0.010497693],"genre_scores_gemma":[0.99369884,0.0047623343,0.0000057273105,0.000051946037,0.00021305727,0.00054001505,0.000017611872,0.000031651613,0.00067879807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790645,0.00003731239,0.00076449144,0.0005025546,0.00014055708,0.000648646],"domain_scores_gemma":[0.99847245,0.00018342776,0.00035770473,0.0005417442,0.00034323853,0.00010140866],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014513626,0.00016573939,0.0007376122,0.0009453888,0.00012538087,0.000053067037,0.000569847,0.00014273523,0.0020651522],"category_scores_gemma":[0.00015371,0.00015301959,0.0002315864,0.0024781288,0.0003700379,0.00023276455,0.00015519188,0.0004682258,0.00022649612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032636346,0.00007483898,0.96904844,0.00020901686,0.000579658,0.000007711324,0.008843443,0.003272813,0.00027811472,0.0048401784,0.0030188626,0.009500545],"study_design_scores_gemma":[0.0006210167,0.000044699234,0.98878634,0.00007814259,0.00001860831,1.8918371e-7,0.0016042019,0.00012616377,0.0008809379,0.0028685783,0.0047807326,0.0001903798],"about_ca_topic_score_codex":0.0153523665,"about_ca_topic_score_gemma":0.020197898,"teacher_disagreement_score":0.019737896,"about_ca_system_score_codex":0.0008326073,"about_ca_system_score_gemma":0.0004040381,"threshold_uncertainty_score":0.99884707},"labels":[],"label_agreement":null},{"id":"W4322774845","doi":"10.1158/1538-7445.sabcs22-p4-08-21","title":"Abstract P4-08-21: Development of novel inhibitors of the serum/glucocorticoid induced kinase (SGK) family to address limitations of AKT/PI3K/mTOR inhibitors in breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Kinase; Cancer research; FOXO3; Phosphorylation; mTORC2; SGK1; Signal transduction; Biology; Cell biology; Chemistry; mTORC1","score_opus":0.14199432822894234,"score_gpt":0.3839800521784673,"score_spread":0.24198572394952497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692094,0.00042748865,0.000016440623,0.00065510924,0.00037930702,0.00089342357,0.00053846644,0.000007364784,0.00016144168],"genre_scores_gemma":[0.9985034,0.00030000613,0.00031652747,0.000059509377,0.0001246916,0.00050536357,0.00002171414,0.000044773085,0.00012405106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972363,0.00011229697,0.00072439073,0.0004762858,0.00091848965,0.00053220167],"domain_scores_gemma":[0.9981612,0.000095348754,0.00023796165,0.0006049541,0.0007506777,0.00014983935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000988193,0.00019544004,0.0003393357,0.00040654567,0.000081028375,0.000013046532,0.0006079617,0.00017609981,0.00005331177],"category_scores_gemma":[0.00028922706,0.0001691707,0.00011933564,0.0015978154,0.00015424893,0.000012745617,0.0005152762,0.00029722517,0.0000069502566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022305238,0.00014259793,0.0032870653,0.0002403496,0.00008022904,0.0000010364903,0.0005795295,0.00091897306,0.9751124,0.000027744227,0.0010413392,0.01834573],"study_design_scores_gemma":[0.0007495639,0.000083614745,0.12742326,0.00040428748,0.000009594501,4.5809404e-7,0.00076681154,0.000008393262,0.8687153,0.000008702416,0.0016821785,0.0001478659],"about_ca_topic_score_codex":0.0012134725,"about_ca_topic_score_gemma":0.0021444005,"teacher_disagreement_score":0.124136195,"about_ca_system_score_codex":0.00018160883,"about_ca_system_score_gemma":0.0021152082,"threshold_uncertainty_score":0.6898581},"labels":[],"label_agreement":null},{"id":"W4322774970","doi":"10.1158/1538-7445.sabcs22-pd13-06","title":"Abstract PD13-06: PD13-06 Long-Term and Very-Long-Term Disease Control in Patients From BYLieve Study Cohort A With PIK3CA-Mutant, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Advanced Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Cohort; Oncology; Population; Hazard ratio; Cancer; Breast cancer; Adverse effect; Gastroenterology; Estrogen receptor; Confidence interval","score_opus":0.0275034566686928,"score_gpt":0.3540003620675184,"score_spread":0.3264969053988256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414844,0.001843295,0.000023954019,0.0009716298,0.00020505696,0.006444731,0.0060757874,0.00022994455,0.00005714438],"genre_scores_gemma":[0.99277496,0.0013686839,0.0000434253,0.00021211489,0.0005679028,0.0034172554,0.0008522108,0.00027189928,0.00049154006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923449,0.000549923,0.0009299889,0.0019740353,0.0023114032,0.0018897589],"domain_scores_gemma":[0.99540883,0.00068905676,0.00036726423,0.00095082575,0.0013687778,0.0012152697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006192245,0.0008938578,0.0014666658,0.0007976505,0.0005722904,0.00016386222,0.0005603213,0.00022481037,0.001542315],"category_scores_gemma":[0.00020135399,0.0007697782,0.00015394558,0.0016942753,0.0009988026,0.000944969,0.0003189401,0.0016235233,0.00012421656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020408187,0.0012895751,0.9328421,0.0002830054,0.0010792946,0.0004426458,0.0017568204,0.000032422442,0.026296766,0.0000033081387,0.0003353995,0.015230496],"study_design_scores_gemma":[0.025780888,0.0011404245,0.9682932,0.0014912458,0.00018212636,0.0000049877563,0.00046200372,0.0000108042905,0.0017732154,0.000029857507,0.000033737975,0.0007975429],"about_ca_topic_score_codex":0.0030295649,"about_ca_topic_score_gemma":0.001981514,"teacher_disagreement_score":0.035451084,"about_ca_system_score_codex":0.002273749,"about_ca_system_score_gemma":0.00090670265,"threshold_uncertainty_score":0.9994753},"labels":[],"label_agreement":null},{"id":"W4322775022","doi":"10.1158/1538-7445.sabcs22-p4-07-60","title":"Abstract P4-07-60: Identification of Optimal Carboplatin Containing Regimen for Triple Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Carboplatin; Medicine; Regimen; Triple-negative breast cancer; Breast cancer; Cyclophosphamide; Internal medicine; Oncology; Paclitaxel; Chemotherapy; Chemotherapy regimen; Cancer; Surgery; Cisplatin","score_opus":0.14303665979491595,"score_gpt":0.4943778950274041,"score_spread":0.35134123523248817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915773,0.00083180825,0.000012641632,0.00419276,0.0003573525,0.0015704496,0.00063449895,0.00005656389,0.00076660083],"genre_scores_gemma":[0.9897225,0.00082604896,0.000036342793,0.00005087181,0.000537578,0.002089369,0.0000969885,0.000035940055,0.00660439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983363,0.00006470306,0.00033722082,0.00035077523,0.00042742532,0.00048356637],"domain_scores_gemma":[0.9984316,0.0004289421,0.0001325126,0.00021582813,0.0006506587,0.00014045394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008644471,0.00012281508,0.0003198686,0.00029856854,0.00015297315,0.000020391612,0.00013228874,0.00009209327,0.0013260603],"category_scores_gemma":[0.00010008417,0.00011235547,0.00009775555,0.000679627,0.00018941336,0.00009482354,0.000049243365,0.00027539517,0.000045053668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009802748,0.00024082966,0.011228531,0.0007560683,0.00075555866,0.00005879429,0.0046785814,0.00066841475,0.8670535,0.00019485755,0.07306754,0.031494595],"study_design_scores_gemma":[0.014507369,0.0010549022,0.44358793,0.0005505194,0.00031348199,0.000014469618,0.0027465413,0.0032139656,0.526859,0.00038938806,0.0064314012,0.00033104577],"about_ca_topic_score_codex":0.0051073665,"about_ca_topic_score_gemma":0.00043642925,"teacher_disagreement_score":0.4323594,"about_ca_system_score_codex":0.0005591123,"about_ca_system_score_gemma":0.0008649199,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W4322775130","doi":"10.1158/1538-7445.sabcs22-p4-03-30","title":"Abstract P4-03-30: Patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Oncology; Cancer; Colorectal cancer","score_opus":0.11628946331537403,"score_gpt":0.4670810383718094,"score_spread":0.3507915750564354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925943,0.0006531898,0.000002359042,0.0037870612,0.00015887278,0.0014093989,0.0012618132,0.000081928476,0.000051049632],"genre_scores_gemma":[0.9906826,0.0069302274,0.000023192451,0.00039497102,0.00015738806,0.001177803,0.00014775914,0.00008895705,0.000397075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684227,0.00031273335,0.00056111853,0.000671176,0.0007806072,0.0008320878],"domain_scores_gemma":[0.9979017,0.00075909233,0.00018075272,0.0003770031,0.0004679015,0.00031359345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000709227,0.00033042792,0.00080551463,0.00030506146,0.00014176822,0.000054964403,0.00013044884,0.000100638674,0.000945706],"category_scores_gemma":[0.00011935645,0.00022537787,0.0001014605,0.00062362093,0.0003837419,0.00011963845,0.00006448673,0.0006117804,0.000045511828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013174986,0.0006088208,0.73274714,0.00004923328,0.00075951027,0.00025749634,0.0013828514,0.0000068646787,0.00026097454,0.000003921558,0.0000642007,0.26254147],"study_design_scores_gemma":[0.00542611,0.0012360548,0.9903715,0.0008575844,0.00005180982,0.000012829856,0.000875094,0.000028214316,0.000426821,0.000028805527,0.0004557217,0.00022945303],"about_ca_topic_score_codex":0.008509659,"about_ca_topic_score_gemma":0.0036262164,"teacher_disagreement_score":0.26231202,"about_ca_system_score_codex":0.0012903517,"about_ca_system_score_gemma":0.0007624097,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W4322775162","doi":"10.1158/1538-7445.sabcs22-p4-07-03","title":"Abstract P4-07-03: The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Interquartile range; Internal medicine; Oncology; Prospective cohort study; Cohort; Cancer; Logistic regression; Gynecology","score_opus":0.0684520206467842,"score_gpt":0.3978296457534012,"score_spread":0.329377625106617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473643,0.00009586146,0.0000014001076,0.001603254,0.00002679056,0.0013416937,0.00030138082,0.000024317169,0.0018688577],"genre_scores_gemma":[0.9836078,0.00012514814,0.000011629571,0.000008818989,0.00010402251,0.0025839733,0.000015891152,0.00003651399,0.01350618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979846,0.000043030348,0.00021399379,0.00033371503,0.00064187235,0.00078280026],"domain_scores_gemma":[0.99890727,0.00025107377,0.00006503266,0.00033116108,0.00025522843,0.00019025199],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007943865,0.00017150644,0.00031422122,0.0003187939,0.000114965704,0.000026712418,0.00021038935,0.000063631196,0.0009847727],"category_scores_gemma":[0.000045163088,0.00009081419,0.00006614217,0.0010594634,0.00021611413,0.00006474609,0.000056465924,0.00035273813,0.0001538218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007257535,0.0004163472,0.8874958,0.0004047333,0.0007484618,0.000153186,0.05658219,0.0009733449,0.0045344373,0.000016207026,0.0288514,0.012566315],"study_design_scores_gemma":[0.002785763,0.00043347463,0.99148095,0.0007188073,0.000015332958,0.0000014136169,0.0023494982,0.00019952604,0.0015547855,0.000054843436,0.0002820528,0.00012353079],"about_ca_topic_score_codex":0.001256149,"about_ca_topic_score_gemma":0.00036603678,"teacher_disagreement_score":0.10398513,"about_ca_system_score_codex":0.0010196022,"about_ca_system_score_gemma":0.0012903087,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W4322775166","doi":"10.1158/1538-7445.sabcs22-pd3-04","title":"Abstract PD3-04: Locoregional Stereotactic Body Radiotherapy in Breast Cancer Patients Unsuitable for Surgical Resection","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Hospital; Varian Medical Systems (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical endpoint; Context (archaeology); Breast cancer; Radiation therapy; Surgery; Radiosurgery; Cancer; Primary tumor; Stage (stratigraphy); Lymph node; Internal medicine; Randomized controlled trial; Metastasis","score_opus":0.04863621606015378,"score_gpt":0.3986804903493369,"score_spread":0.3500442742891831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427295,0.0016722103,0.0000038050548,0.00240609,0.0003269071,0.00067110587,0.0004336678,0.000021074922,0.00019219371],"genre_scores_gemma":[0.99061924,0.004997667,0.000007432617,0.00005733422,0.00083117135,0.0020681785,0.00023695339,0.000048342205,0.0011336928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803114,0.00008783327,0.00020657144,0.00054746575,0.00041852894,0.00070845295],"domain_scores_gemma":[0.99915403,0.000106635795,0.000049027556,0.00022149687,0.00036538125,0.000103442864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043434312,0.00016938541,0.00019536089,0.00020529403,0.00020837072,0.0000395347,0.00018717039,0.00013639621,0.0001472925],"category_scores_gemma":[0.000033860644,0.0001536297,0.000085353044,0.0005380263,0.0001498993,0.0000133898475,0.000101102276,0.00020181751,0.0000145745125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009304684,0.00071065343,0.82227296,0.0003114029,0.00058106467,0.000042578704,0.00026139204,0.00034389328,0.042429373,0.000089832494,0.10681063,0.016841525],"study_design_scores_gemma":[0.006460999,0.00027708133,0.9218323,0.00012733613,0.000010898756,0.000008256279,0.00008980233,0.00006601213,0.008569446,0.000094413845,0.06218593,0.00027751335],"about_ca_topic_score_codex":0.002085067,"about_ca_topic_score_gemma":0.00094337045,"teacher_disagreement_score":0.09955934,"about_ca_system_score_codex":0.00045516572,"about_ca_system_score_gemma":0.00031553177,"threshold_uncertainty_score":0.62648374},"labels":[],"label_agreement":null},{"id":"W4322775169","doi":"10.1158/1538-7445.sabcs22-pd11-09","title":"Abstract PD11-09: PD11-09 Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): updated results from BEGONIA, a phase 1b/2 study","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Sherbrooke; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Triple-negative breast cancer; Tolerability; Cancer; Breast cancer; Adverse effect","score_opus":0.11298569127230479,"score_gpt":0.46541165906745285,"score_spread":0.35242596779514807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94549465,0.003607592,0.00034590805,0.011886025,0.00078778365,0.012124429,0.024771765,0.0006392801,0.00034258876],"genre_scores_gemma":[0.9696946,0.0037307618,0.00084229314,0.00023544308,0.0011733755,0.011984522,0.0027520754,0.00043817097,0.009148752],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9896407,0.00051553285,0.0016928668,0.0027446458,0.0025550618,0.002851208],"domain_scores_gemma":[0.99150527,0.0021747577,0.00056892936,0.0022254423,0.0023232005,0.0012024335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016880493,0.0011721408,0.0019430363,0.0011103993,0.0011851179,0.00023230002,0.0010142437,0.0002755509,0.0023901367],"category_scores_gemma":[0.0011061162,0.0010128589,0.00040846822,0.0037556454,0.000774245,0.00079160783,0.0003869086,0.0013235663,0.00047990098],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21395047,0.016398452,0.0021260353,0.00090628694,0.0078004263,0.0030211147,0.013035951,0.007198283,0.031679973,0.000074506184,0.013127832,0.6906807],"study_design_scores_gemma":[0.6058969,0.030857371,0.042049915,0.0062543876,0.0027237893,0.00036697157,0.037992004,0.008471557,0.115661465,0.009982748,0.13481715,0.004925736],"about_ca_topic_score_codex":0.03908156,"about_ca_topic_score_gemma":0.024895715,"teacher_disagreement_score":0.68575495,"about_ca_system_score_codex":0.0047204616,"about_ca_system_score_gemma":0.0043946397,"threshold_uncertainty_score":0.9992322},"labels":[],"label_agreement":null},{"id":"W4322775208","doi":"10.1158/1538-7445.sabcs22-p6-01-16","title":"Abstract P6-01-16: Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cohort; Breast cancer; Oncology; Prospective cohort study; Exome; Cohort study; Digital polymerase chain reaction; Cancer; Exome sequencing; Mutation; Polymerase chain reaction; Biology","score_opus":0.014792446059152113,"score_gpt":0.2920353753678071,"score_spread":0.277242929308655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979368,0.00025120052,0.0000053967888,0.0002969731,0.00014114793,0.0004946023,0.0006627558,0.0000067085025,0.00020445518],"genre_scores_gemma":[0.99891746,0.00060257484,0.0000042973006,0.000022596894,0.00013554345,0.00011369822,0.000056899826,0.000033075503,0.0001138499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850786,0.00006031682,0.0002496205,0.000401532,0.0003895992,0.00039107926],"domain_scores_gemma":[0.99916816,0.00005532744,0.00010557719,0.00031376712,0.00027535486,0.0000818051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004847312,0.00012946138,0.00015458505,0.00010597562,0.00013363209,0.000039710892,0.00018653621,0.00011498619,0.000008899988],"category_scores_gemma":[0.000107045955,0.00010159039,0.000040318846,0.00047508426,0.0001758188,0.0000080733,0.00017480574,0.00027517337,0.0000014184939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011196369,0.000070246126,0.8185433,0.00008574233,0.000070468785,0.000004770441,0.0001788714,0.0013903261,0.15580125,0.000010475213,0.00040020535,0.022324715],"study_design_scores_gemma":[0.0014093382,0.000120388424,0.9742071,0.00012450127,0.000010401349,0.0000015533865,0.00010900108,0.00029748635,0.023381151,0.000024080937,0.00018347133,0.00013153392],"about_ca_topic_score_codex":0.008689936,"about_ca_topic_score_gemma":0.023298338,"teacher_disagreement_score":0.1556638,"about_ca_system_score_codex":0.00032177655,"about_ca_system_score_gemma":0.00027871988,"threshold_uncertainty_score":0.9979113},"labels":[],"label_agreement":null},{"id":"W4322775232","doi":"10.1158/1538-7445.sabcs22-pd6-05","title":"Abstract PD6-05: PD6-05 Retrospective analysis of VES-13 questionnaires in the Senior Women’s Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Referral; Breast cancer; Retrospective cohort study; Geriatrics; Cancer; Geriatric oncology; Family medicine; Physical therapy; Internal medicine; Gerontology; Psychiatry","score_opus":0.0644712697773294,"score_gpt":0.4253375242899398,"score_spread":0.3608662545126104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766849,0.0018833441,3.53902e-7,0.018121272,0.00049725774,0.0008905029,0.00053681165,0.000036320715,0.001349179],"genre_scores_gemma":[0.9870952,0.002028841,0.000009404328,0.00077393156,0.0002553574,0.00060941564,0.000059558683,0.000028827306,0.009139516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425775,0.00034532463,0.0007019763,0.0007841851,0.0025672666,0.00134347],"domain_scores_gemma":[0.99742705,0.0006419034,0.00020855106,0.00075177697,0.00057906425,0.00039166145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044669453,0.00023763279,0.0007713489,0.0005543392,0.00043797665,0.00004922783,0.00062240293,0.00010970751,0.007469119],"category_scores_gemma":[0.00041077586,0.00017814888,0.00013888093,0.0038503383,0.00067196315,0.00017942839,0.00018209153,0.0008966673,0.000020877773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004037934,0.0001234426,0.7560566,0.00024705986,0.00052630267,0.00013018303,0.013275736,0.00051698944,0.00027362676,0.000026383528,0.22405545,0.004364389],"study_design_scores_gemma":[0.00092574715,0.00030202977,0.98892075,0.0005261174,0.000063543695,0.000012211142,0.004014931,0.00018067421,0.00008785063,0.000036205663,0.0047723716,0.00015757357],"about_ca_topic_score_codex":0.9982379,"about_ca_topic_score_gemma":0.99986714,"teacher_disagreement_score":0.23286411,"about_ca_system_score_codex":0.03527708,"about_ca_system_score_gemma":0.016218295,"threshold_uncertainty_score":0.9934382},"labels":[],"label_agreement":null},{"id":"W4322775239","doi":"10.1158/1538-7445.sabcs22-p5-04-04","title":"Abstract P5-04-04: Does reducing the frequency of regularly scheduled physical examinations affect recurrence detection in patients with early breast cancer?","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Cancer; Survivorship curve; Internal medicine","score_opus":0.04270936918234883,"score_gpt":0.3761701835210674,"score_spread":0.33346081433871855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967424,0.00027662545,0.0000018880236,0.0014224963,0.00014658338,0.0011109206,0.00014040133,0.000033212495,0.00012545404],"genre_scores_gemma":[0.9978659,0.00035304125,0.000011428773,0.000008640263,0.00020532994,0.0014213995,0.000018644054,0.000028159859,0.00008744493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979113,0.00013073617,0.00021361411,0.0004115221,0.00089235854,0.0004405097],"domain_scores_gemma":[0.998541,0.00029738204,0.000089285815,0.00041831928,0.00054580835,0.00010820606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052695157,0.00014636679,0.00027011105,0.0003227583,0.00017932993,0.000040007413,0.00015556264,0.000058898488,0.0001138174],"category_scores_gemma":[0.000098744655,0.0000841807,0.00006603148,0.0017111261,0.00025418925,0.00016590164,0.00005200061,0.0004967334,0.000014540651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057756365,0.0008011234,0.8219988,0.00033418176,0.00019026973,0.00002355315,0.0017478772,0.00010368718,0.015241273,0.00009577964,0.00030831774,0.1585776],"study_design_scores_gemma":[0.0016551898,0.000409659,0.9753572,0.0011588123,0.00004076116,9.544655e-7,0.0001741013,0.000057658915,0.020947963,0.0000855823,0.000020551584,0.000091575865],"about_ca_topic_score_codex":0.020678189,"about_ca_topic_score_gemma":0.0057941936,"teacher_disagreement_score":0.15848602,"about_ca_system_score_codex":0.00082458736,"about_ca_system_score_gemma":0.0004595275,"threshold_uncertainty_score":0.9858432},"labels":[],"label_agreement":null},{"id":"W4322775281","doi":"10.1158/1538-7445.sabcs22-p6-10-13","title":"Abstract P6-10-13: An update to a Phase I trial of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors with HER2-negative breast cancer expansion cohorts","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; Breast cancer; Cancer; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Discontinuation; Fulvestrant; Progressive disease; Chemotherapy; Adverse effect; Estrogen receptor","score_opus":0.025105656088246223,"score_gpt":0.3826312031732073,"score_spread":0.3575255470849611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717957,0.000056055604,0.000007405332,0.00016863275,0.00013851636,0.0013623287,0.001028539,0.000014154204,0.000044800538],"genre_scores_gemma":[0.99799556,0.00031905065,0.000081592596,0.000083849365,0.00028180602,0.0006384144,0.00045764947,0.000067454515,0.00007463486],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975652,0.000114559916,0.00034092233,0.0007205644,0.00061455276,0.00064421084],"domain_scores_gemma":[0.9982628,0.000035768106,0.000119527715,0.0005365006,0.0007008774,0.00034448167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046893212,0.00023761002,0.0003590005,0.00023962534,0.000109888984,0.00004986898,0.00029817913,0.00011463916,0.00012105984],"category_scores_gemma":[0.00007460647,0.00019933603,0.00003965423,0.0007193475,0.00020335772,0.00003125837,0.0001624774,0.00023996468,0.000006562992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48671195,0.0049163206,0.055947885,0.00026296158,0.00030043026,0.00015768224,0.0023062972,0.029307052,0.29646233,0.000017983008,0.0074194716,0.11618966],"study_design_scores_gemma":[0.13955148,0.03196468,0.37167603,0.0009376575,0.000054760352,0.00000424527,0.0014293619,0.0002506155,0.44930318,0.00008772689,0.0033128296,0.0014274408],"about_ca_topic_score_codex":0.0047747823,"about_ca_topic_score_gemma":0.019445911,"teacher_disagreement_score":0.34716046,"about_ca_system_score_codex":0.00018939201,"about_ca_system_score_gemma":0.0011137516,"threshold_uncertainty_score":0.99844664},"labels":[],"label_agreement":null},{"id":"W4322775334","doi":"10.1158/1538-7445.sabcs22-p5-08-05","title":"Abstract P5-08-05: Conception and Pregnancy Among Young Breast Cancer Survivors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Breast cancer; Fertility preservation; Live birth; Gynecology; Fertility; Cancer; In vitro fertilisation; Assisted reproductive technology; Population; Infertility; Internal medicine","score_opus":0.0930811366206809,"score_gpt":0.4277561674264581,"score_spread":0.3346750308057772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903304,0.0042674774,0.0000033644903,0.0023033204,0.00055247254,0.00070075755,0.0002720267,0.00014457961,0.0014255932],"genre_scores_gemma":[0.9773267,0.016305374,0.0000032971757,0.000052218536,0.0005476442,0.000460723,0.00004026236,0.000052362244,0.0052114236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765366,0.00006445447,0.000239899,0.0005109467,0.00079868134,0.0007323426],"domain_scores_gemma":[0.9987728,0.00009437629,0.000056809575,0.0003305706,0.00032087308,0.00042457116],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052281265,0.00017522906,0.00029334537,0.00031852926,0.00026434002,0.00007740908,0.00013275814,0.00014518165,0.0020336218],"category_scores_gemma":[0.00005731497,0.00015012949,0.00007297647,0.0009586306,0.0005842878,0.00019431212,0.000115491304,0.0006335142,0.00010096085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021889209,0.00004252945,0.8836995,0.00050821266,0.00009216923,0.00013355692,0.0016701226,0.000029230336,0.011067238,0.00007146887,0.019163813,0.0833033],"study_design_scores_gemma":[0.0010349604,0.000068805915,0.99090457,0.0011039746,0.000023719129,0.000011916987,0.00088792143,0.00009359194,0.00075819256,0.00007071443,0.0048714536,0.00017020566],"about_ca_topic_score_codex":0.07632511,"about_ca_topic_score_gemma":0.019456377,"teacher_disagreement_score":0.10720508,"about_ca_system_score_codex":0.0004808061,"about_ca_system_score_gemma":0.0004866958,"threshold_uncertainty_score":0.99887866},"labels":[],"label_agreement":null},{"id":"W4322775372","doi":"10.1158/1538-7445.sabcs22-p3-07-04","title":"Abstract P3-07-04: A multicenter, single-arm, open-label Phase I study of AN1004 (Pelareorep) oncolytic virus plus paclitaxel in Chinese patients with Hormone receptor-positive and HER2-negative advanced/metastatic breast cancer (REO 026-1)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Tolerability; Internal medicine; Oncology; Oncolytic virus; Regimen; Cancer; Population; Response Evaluation Criteria in Solid Tumors; Paclitaxel; Phases of clinical research; Chemotherapy; Adverse effect","score_opus":0.054225639134540274,"score_gpt":0.4234907528237706,"score_spread":0.3692651136892303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924561,0.0016867872,0.000003578119,0.00019702934,0.00006429787,0.00385978,0.0016034804,0.000016937614,0.000112040645],"genre_scores_gemma":[0.9954655,0.002283185,0.00007850361,0.000048119367,0.00007115977,0.001502351,0.00018186022,0.00010624714,0.000263076],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995664,0.0006648614,0.000539615,0.0010803121,0.0010733813,0.0009778359],"domain_scores_gemma":[0.99753153,0.00024177416,0.00020824256,0.000669349,0.0010198832,0.00032919468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011988698,0.00040443623,0.0005951871,0.00040720322,0.00023680557,0.000114740695,0.00073186593,0.000119499186,0.00015128189],"category_scores_gemma":[0.00023544856,0.00033800513,0.000044650304,0.0014738349,0.0005304776,0.000067042936,0.00072316994,0.0006057835,0.000020463736],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10442168,0.01581611,0.015946973,0.00024876388,0.0007673449,0.00011344678,0.0042832717,0.00072370237,0.77603024,0.0000010298379,0.0006082309,0.08103923],"study_design_scores_gemma":[0.24775447,0.16395669,0.28762642,0.0018948006,0.0001494952,0.000010941327,0.014545407,0.001204604,0.27984455,0.00015594852,0.00043720647,0.0024194673],"about_ca_topic_score_codex":0.0060776067,"about_ca_topic_score_gemma":0.013080871,"teacher_disagreement_score":0.49618566,"about_ca_system_score_codex":0.000566579,"about_ca_system_score_gemma":0.0007727388,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4322775415","doi":"10.1158/1538-7445.sabcs22-p6-01-18","title":"Abstract P6-01-18: Predicting response of triple negative breast cancer to neoadjuvant chemotherapy using a deep convolutional neural network-based artificial intelligence tool","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Triple-negative breast cancer; Receiver operating characteristic; Breast cancer; Artificial intelligence; Convolutional neural network; Medicine; Stage (stratigraphy); Cancer; Deep learning; Oncology; Internal medicine; Machine learning; Pathology; Computer science; Biology","score_opus":0.10682659218930736,"score_gpt":0.44550141574931906,"score_spread":0.3386748235600117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823043,0.0002921063,0.0042556636,0.01166097,0.0004987822,0.0007928549,0.000082499275,0.00008363362,0.000029239582],"genre_scores_gemma":[0.99614847,0.00008956654,0.0015068608,0.0007254158,0.0011718964,0.00015174359,0.00001590807,0.000057839534,0.00013227404],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967124,0.00030286997,0.0005316601,0.00047820408,0.0011007522,0.00087413186],"domain_scores_gemma":[0.99772555,0.00094785966,0.00012688918,0.0002958499,0.0005679781,0.00033589234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033195214,0.00018738507,0.00040571328,0.00041847676,0.00036029413,0.000064853324,0.00025486248,0.00010448371,0.0011326312],"category_scores_gemma":[0.0013925263,0.00016965896,0.0001172771,0.0018504603,0.00049521547,0.00008388469,0.000099455814,0.001009677,0.000014924042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022645155,0.00020590462,0.036275063,0.00033784605,0.00021889972,0.00021076672,0.0023848899,0.49906954,0.23669304,0.00012889337,0.0046419175,0.19718806],"study_design_scores_gemma":[0.0010018363,0.00022310231,0.14503908,0.0009190473,0.000027681297,0.000021803518,0.00039864934,0.84193,0.009658498,0.00027028282,0.00031130877,0.00019875393],"about_ca_topic_score_codex":0.0034077317,"about_ca_topic_score_gemma":0.00010398566,"teacher_disagreement_score":0.3428604,"about_ca_system_score_codex":0.0005530946,"about_ca_system_score_gemma":0.0016940698,"threshold_uncertainty_score":0.9997805},"labels":[],"label_agreement":null},{"id":"W4322775439","doi":"10.1158/1538-7445.sabcs22-p6-01-39","title":"Abstract P6-01-39: The impact of the 21-gene Recurrence Score® assay upon physician treatment recommendations in the neoadjuvant setting in lymph node-negative breast cancer patients in a multicenter prospective study in Quebec","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital; Université Laval; Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Neoadjuvant therapy; Chemotherapy; Prospective cohort study; Cohort; Lymph node; Cancer","score_opus":0.04136052293896654,"score_gpt":0.39625436951483933,"score_spread":0.3548938465758728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456465,0.00024179964,1.6497711e-7,0.0022430175,0.00008677104,0.0022241466,0.00053175836,0.0000039835036,0.00010372168],"genre_scores_gemma":[0.9961947,0.00054738304,0.0000028476923,0.000051016767,0.00007375243,0.0030288694,0.00004800768,0.00002184957,0.000031537827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973239,0.00083533657,0.00036716866,0.0005211807,0.00038161175,0.0005708086],"domain_scores_gemma":[0.9989095,0.00027669515,0.00013955431,0.00045145943,0.00019043488,0.00003235892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093706575,0.00023730921,0.00026022084,0.00018304645,0.00016501654,0.00003689306,0.00044391493,0.00006368592,0.0000132462565],"category_scores_gemma":[0.00014545125,0.00012585828,0.00009602345,0.0013935012,0.00017961647,0.000021702475,0.00025718124,0.0003308953,0.0000031342158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049389707,0.0013976911,0.9632673,0.000013030629,0.000118398486,0.000005732598,0.01527062,0.001215808,0.0028144948,0.0000010271542,0.00012937562,0.015272601],"study_design_scores_gemma":[0.0031795101,0.00012909398,0.985583,0.0003014844,0.000009596225,3.5211863e-7,0.0062199766,0.00009510873,0.004328837,0.00002648381,0.000008805108,0.00011774574],"about_ca_topic_score_codex":0.36412868,"about_ca_topic_score_gemma":0.50991124,"teacher_disagreement_score":0.14578255,"about_ca_system_score_codex":0.0021101078,"about_ca_system_score_gemma":0.0006376309,"threshold_uncertainty_score":0.64010566},"labels":[],"label_agreement":null},{"id":"W4322775453","doi":"10.1158/1538-7445.sabcs22-p6-04-02","title":"Abstract P6-04-02: Ki67 Assessment Protocol: Companion Diagnostic Biomarker for LUMINA Prospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Prospective cohort study; Protocol (science); Cancer; Radiation therapy; Biomarker; Oncology; Pathology; Internal medicine; Nuclear medicine","score_opus":0.07947251442612975,"score_gpt":0.47622793187453233,"score_spread":0.3967554174484026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8994626,0.00011437746,0.00004071972,0.00057378295,0.0002059824,0.098138146,0.00019427386,0.00006560157,0.001204538],"genre_scores_gemma":[0.64639825,0.00005463086,0.000031649735,0.000014297233,0.00024239393,0.35269022,0.00010141883,0.000038142916,0.00042902483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756444,0.0001402444,0.00024636945,0.00080074056,0.0005776363,0.0006705446],"domain_scores_gemma":[0.9985133,0.0002643985,0.00006925673,0.000488981,0.0005467787,0.00011729184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010764013,0.00022785644,0.00026358018,0.0001368633,0.00041466922,0.000066683795,0.00028348225,0.000095974814,0.000084666244],"category_scores_gemma":[0.00029635118,0.00019765536,0.00009305941,0.00046634095,0.00021097566,0.000008085236,0.00033731115,0.00018854532,0.00004471586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047861267,0.0007151423,0.94397694,0.00015629518,0.0006163542,0.000020671992,0.00020573665,0.000023994457,0.022249218,0.000024984925,0.027218344,0.00431369],"study_design_scores_gemma":[0.0023818722,0.0005841787,0.97555685,0.000056707933,0.00003294859,0.0000013943664,0.0005709297,0.000016536078,0.011696097,0.000098904726,0.008796583,0.0002070111],"about_ca_topic_score_codex":0.00069890614,"about_ca_topic_score_gemma":0.0006602714,"teacher_disagreement_score":0.25455207,"about_ca_system_score_codex":0.00036675885,"about_ca_system_score_gemma":0.000394303,"threshold_uncertainty_score":0.8060152},"labels":[],"label_agreement":null},{"id":"W4322775459","doi":"10.1158/1538-7445.sabcs22-p5-03-07","title":"Abstract P5-03-07: Prevalence of Pathogenic Variants in Cancer Predisposition Genes in Women with Young Onset Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Calgary; Women's College Hospital; University of Toronto","funders":"","keywords":"CHEK2; PALB2; Breast cancer; MSH6; Medicine; MSH2; Cancer; MLH1; Oncology; Genetic predisposition; Internal medicine; Germline mutation; Genetics; Biology; Mutation; Gene; DNA mismatch repair; Colorectal cancer","score_opus":0.03211306733447546,"score_gpt":0.366176840686679,"score_spread":0.33406377335220355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921874,0.0049828524,0.000006020993,0.00047260965,0.00018080077,0.00054475886,0.001486607,0.000013167739,0.00012581257],"genre_scores_gemma":[0.98139256,0.014787767,0.000032459215,0.000039388415,0.00021776828,0.0028703792,0.00004714109,0.000046036035,0.0005665063],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976581,0.00016117407,0.00032134666,0.0006245296,0.0005154029,0.0007194619],"domain_scores_gemma":[0.99899983,0.00003331089,0.00009201277,0.00044136797,0.00032942448,0.00010402365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008557503,0.00017481294,0.00020460041,0.00032499988,0.00007589187,0.000026093627,0.0003931146,0.00016975559,0.0005952007],"category_scores_gemma":[0.000028093598,0.00016719951,0.00003264278,0.001168144,0.00027880605,0.000020592339,0.00016481546,0.00029998852,0.000015138509],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001423503,0.00011661156,0.2374814,0.00061383756,0.00008930138,0.0000353756,0.0011564164,0.008580941,0.73269707,0.0000051980314,0.0017156008,0.016084742],"study_design_scores_gemma":[0.0009525063,0.00012588533,0.94201046,0.00045624934,0.000009046505,0.000010720359,0.00041346822,0.00012240483,0.055331536,0.000050771436,0.00030545352,0.00021147104],"about_ca_topic_score_codex":0.004047148,"about_ca_topic_score_gemma":0.009413973,"teacher_disagreement_score":0.7045291,"about_ca_system_score_codex":0.0009787012,"about_ca_system_score_gemma":0.0019968757,"threshold_uncertainty_score":0.68181986},"labels":[],"label_agreement":null},{"id":"W4322775460","doi":"10.1158/1538-7445.sabcs22-p5-08-06","title":"Abstract P5-08-06: Breastfeeding in Survivors of Early Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breastfeeding; Breast cancer; Population; Obstetrics; Gynecology; Incidence (geometry); Cancer; Pediatrics; Demography; Internal medicine; Environmental health","score_opus":0.11092759779547437,"score_gpt":0.43851204709500025,"score_spread":0.3275844492995259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929752,0.0008494275,7.719214e-7,0.0033607015,0.0002739366,0.00042289996,0.00026987705,0.00006109216,0.001786126],"genre_scores_gemma":[0.99515975,0.002332507,0.0000038732665,0.000035352998,0.00045172256,0.00020193424,0.000016313712,0.000050991704,0.0017475842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973607,0.000053951902,0.00036367265,0.00040927122,0.0010009528,0.0008114488],"domain_scores_gemma":[0.998784,0.00016467132,0.000066501365,0.00034060422,0.00038524528,0.00025898247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010992483,0.0001564511,0.00040498213,0.00078949373,0.00008118276,0.000029659293,0.00022431271,0.0001320936,0.0020914811],"category_scores_gemma":[0.000059829956,0.00013803039,0.0001042936,0.0023148926,0.00023754696,0.00013211332,0.0001249878,0.000752337,0.0001484175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062649,0.00008708853,0.89374954,0.00045264943,0.00007067104,0.00009625133,0.0013656777,0.00008358485,0.04639222,0.00007169507,0.008904486,0.048099637],"study_design_scores_gemma":[0.0010851135,0.00006982496,0.9919701,0.00071969006,0.000010963432,0.000007241801,0.00045885172,0.0000472974,0.0029112077,0.00006129111,0.0025287045,0.00012969019],"about_ca_topic_score_codex":0.14024359,"about_ca_topic_score_gemma":0.013633451,"teacher_disagreement_score":0.12661014,"about_ca_system_score_codex":0.00055350794,"about_ca_system_score_gemma":0.000816248,"threshold_uncertainty_score":0.9988207},"labels":[],"label_agreement":null},{"id":"W4322775476","doi":"10.1158/1538-7445.sabcs22-p3-08-09","title":"Abstract P3-08-09: Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Toronto; McGill University Health Centre; Université de Montréal; McGill University","funders":"","keywords":"Organoid; Breast cancer; Triple-negative breast cancer; Cancer; Medicine; Cancer research; Precision medicine; Oncology; Metastasis; Targeted therapy; Internal medicine; Pathology; Biology; Genetics","score_opus":0.15747674038876713,"score_gpt":0.47935726226502956,"score_spread":0.3218805218762624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894376,0.0008209096,0.0007543111,0.006962156,0.00022912705,0.0012112199,0.00014402972,0.0000415607,0.00039911905],"genre_scores_gemma":[0.9857666,0.006946111,0.0006360278,0.00047332118,0.00041902758,0.00065991137,0.00007598092,0.000059952974,0.0049630716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695665,0.000092094444,0.0006164174,0.0006684136,0.0011327139,0.0005337379],"domain_scores_gemma":[0.99804634,0.00013407951,0.00008881465,0.00043521458,0.0006891722,0.0006063628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016520373,0.00018840666,0.0005436535,0.0004654818,0.00009647268,0.000020958005,0.00018403973,0.00011033008,0.0008497453],"category_scores_gemma":[0.00012005305,0.00015202013,0.00005732086,0.0012246581,0.0001444233,0.000099005585,0.0002110549,0.00032915117,0.00009154419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012039294,0.00006695278,0.0012061732,0.00040070983,0.00006424719,0.000026116402,0.0013131526,0.00007924581,0.62999964,0.0000108594395,0.0037505894,0.3618784],"study_design_scores_gemma":[0.0018589939,0.00058197865,0.3403713,0.0034878247,0.000096461146,0.000010548593,0.0001578288,0.00023771568,0.61833525,0.000060457252,0.034462065,0.00033958902],"about_ca_topic_score_codex":0.0013288402,"about_ca_topic_score_gemma":0.00015812101,"teacher_disagreement_score":0.3615388,"about_ca_system_score_codex":0.00028346412,"about_ca_system_score_gemma":0.0007171878,"threshold_uncertainty_score":0.9304115},"labels":[],"label_agreement":null},{"id":"W4322775477","doi":"10.1158/1538-7445.sabcs22-pd5-03","title":"Abstract PD5-03: PD5-03 Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Digital polymerase chain reaction; Multiplex; Medicine; Circulating tumor DNA; Internal medicine; Minimal residual disease; Oncology; Breast cancer; Stage (stratigraphy); Cancer; Multiplex polymerase chain reaction; Polymerase chain reaction; Bioinformatics; Biology; Genetics; Leukemia; Gene","score_opus":0.06724700861028891,"score_gpt":0.3810912684185115,"score_spread":0.31384425980822256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958775,0.000802096,0.00011163985,0.00034528083,0.000095460935,0.0013318525,0.0013718033,0.0000072733837,0.000057077836],"genre_scores_gemma":[0.998607,0.00012978603,0.000018824405,0.000048639125,0.00022229365,0.0008100761,0.000094726136,0.00003400498,0.000034694218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980864,0.00019273571,0.00036568474,0.00046804437,0.00040833827,0.00047878956],"domain_scores_gemma":[0.99889475,0.00042160263,0.00012383038,0.0002478021,0.0001961666,0.00011582208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011900588,0.0001643858,0.00025695981,0.00019985979,0.00013136439,0.00011934555,0.00021019374,0.0000948752,0.000017746528],"category_scores_gemma":[0.0008566879,0.00014947202,0.00009731239,0.00050778914,0.00020115808,0.000016414839,0.00008347248,0.00028372745,9.3990525e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02502315,0.0002623257,0.032555763,0.00057001406,0.000120948265,0.000109873254,0.0024832892,0.012796352,0.91542286,0.00010493166,0.00043167273,0.010118841],"study_design_scores_gemma":[0.07578066,0.0018423493,0.28350526,0.00094763626,0.00011915761,0.0000075805956,0.0104498435,0.037779942,0.58506095,0.0010141766,0.002100012,0.0013924334],"about_ca_topic_score_codex":0.0030231923,"about_ca_topic_score_gemma":0.002966148,"teacher_disagreement_score":0.3303619,"about_ca_system_score_codex":0.00025889376,"about_ca_system_score_gemma":0.0009986614,"threshold_uncertainty_score":0.6095292},"labels":[],"label_agreement":null},{"id":"W4322775479","doi":"10.1158/1538-7445.sabcs22-pd17-08","title":"Abstract PD17-08: Pooled gene expression analysis and association with treatment response in patients with HR+/HER2− advanced breast cancer in the MONALEESA-2, -3, and -7 trials","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer; Cyclin-dependent kinase 6; Metastatic breast cancer; Progression-free survival; Gene expression; Gene; Palbociclib; Bioinformatics; Cyclin D1; Biology; Overall survival; Cell cycle; Genetics","score_opus":0.0491737236380621,"score_gpt":0.4054284037579695,"score_spread":0.3562546801199074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933321,0.0013517668,0.0000065907725,0.0034843134,0.000021124626,0.0014364895,0.00032315322,0.000026544136,0.00001793522],"genre_scores_gemma":[0.9965306,0.0015207932,0.00009927581,0.00006550755,0.00008160986,0.0012693551,0.000051689447,0.000035918416,0.00034523927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667233,0.00076667615,0.00036555273,0.00054675236,0.0010814399,0.00056725624],"domain_scores_gemma":[0.99783915,0.0011855067,0.00018567564,0.00034614088,0.0003092758,0.0001342542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028756075,0.00022756447,0.0006714184,0.0007995483,0.00013929103,0.00005196795,0.00010733034,0.00010206608,0.00012625137],"category_scores_gemma":[0.00020077483,0.00012742533,0.000050706505,0.0024661664,0.00013212209,0.00019816606,0.0000415413,0.00036846142,0.0000028796383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047321483,0.00019979662,0.8788164,0.000044248092,0.00053505274,0.000054183118,0.001994986,0.0011848898,0.019132312,9.3613636e-7,0.000024043457,0.050691616],"study_design_scores_gemma":[0.011276397,0.00059693935,0.9820651,0.00035638252,0.00019111714,0.000002291586,0.0008312302,0.00004155191,0.004248265,0.000020370671,0.00022509534,0.00014527295],"about_ca_topic_score_codex":0.001838001,"about_ca_topic_score_gemma":0.0029670147,"teacher_disagreement_score":0.10324863,"about_ca_system_score_codex":0.0016373477,"about_ca_system_score_gemma":0.0004028616,"threshold_uncertainty_score":0.5196254},"labels":[],"label_agreement":null},{"id":"W4322775509","doi":"10.1158/1538-7445.sabcs22-pd9-05","title":"Abstract PD9-05: Stromal tumor-infiltrating lymphocytes identify early-stage triple-negative breast cancer patients with favorable outcomes at 10-year follow-up in the absence of systemic therapy: a pooled analysis of 1835 patients","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Oncology; Triple-negative breast cancer; Internal medicine; Systemic therapy; Breast cancer; Stage (stratigraphy); Adjuvant therapy; Biomarker; Cancer","score_opus":0.04254153472431679,"score_gpt":0.36010775946637796,"score_spread":0.3175662247420612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996339,0.00044844954,5.110888e-7,0.00011669134,0.00013163772,0.0015601835,0.0012514472,0.00002575991,0.00012629834],"genre_scores_gemma":[0.9977787,0.00051074894,0.000006186464,0.000051381307,0.000029690314,0.00040128874,0.00009524315,0.000041690426,0.0010850392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578774,0.00032286925,0.00077214814,0.0005129479,0.0019262526,0.00067804876],"domain_scores_gemma":[0.9972504,0.00060638256,0.0004625155,0.0005789252,0.0009977887,0.00010399056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014030081,0.00027571982,0.0008461875,0.00091748027,0.00019408255,0.00005466635,0.00046956132,0.00009465331,0.0009040901],"category_scores_gemma":[0.0001591734,0.00017452458,0.00029574946,0.004488075,0.0003716882,0.00020789079,0.00009046846,0.0003244339,0.000009767388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104740495,0.0002320028,0.96496904,0.00029161197,0.0022238381,0.000015808082,0.0038363538,0.00011870147,0.01615719,0.000002787441,0.0003544243,0.0013241721],"study_design_scores_gemma":[0.012165402,0.00049486523,0.9777946,0.00087820046,0.00017889452,8.2231406e-7,0.0029648065,0.00007755191,0.005255677,0.0000026647745,0.00001614327,0.00017039306],"about_ca_topic_score_codex":0.031316277,"about_ca_topic_score_gemma":0.0042098463,"teacher_disagreement_score":0.02710643,"about_ca_system_score_codex":0.00096834934,"about_ca_system_score_gemma":0.0007719921,"threshold_uncertainty_score":0.98991525},"labels":[],"label_agreement":null},{"id":"W4322775512","doi":"10.1158/1538-7445.sabcs22-p5-02-14","title":"Abstract P5-02-14: Identification of mechanisms of acquired resistance to ribociclib plus endocrine therapy using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Oncology; Cancer","score_opus":0.2759882814859952,"score_gpt":0.47739272994277016,"score_spread":0.20140444845677496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919433,0.00473073,0.0006242416,0.0010209535,0.00003988145,0.0013950375,0.00021903244,0.000013423577,0.00001338149],"genre_scores_gemma":[0.9971616,0.0014058085,0.00097500684,0.000026328287,0.000075302945,0.0002426143,0.000021556947,0.00002749774,0.00006428477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761933,0.00036027483,0.0007553549,0.00033572718,0.00061275676,0.00031655558],"domain_scores_gemma":[0.9974238,0.0015043742,0.00029327115,0.00037069118,0.0003352286,0.00007260456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036952794,0.0001429296,0.00060398947,0.0003688858,0.000080492,0.000015177639,0.00013449237,0.000034134864,0.000051077648],"category_scores_gemma":[0.00072234205,0.0001023909,0.00006235719,0.0008177836,0.00023259025,0.00008477027,0.000050828494,0.000084,4.604183e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018151915,0.000057028403,0.0014574926,0.00038585122,0.00009003213,0.000015044589,0.002347489,0.0004072764,0.9625429,0.0004329468,0.000007787083,0.03044096],"study_design_scores_gemma":[0.004890579,0.000336734,0.08008513,0.0009434103,0.000042875654,0.00001364815,0.0033418117,0.00045080468,0.90451163,0.004872831,0.00037901616,0.00013154869],"about_ca_topic_score_codex":0.0012957155,"about_ca_topic_score_gemma":0.00028085333,"teacher_disagreement_score":0.07862764,"about_ca_system_score_codex":0.0003115489,"about_ca_system_score_gemma":0.00039330786,"threshold_uncertainty_score":0.41753796},"labels":[],"label_agreement":null},{"id":"W4322775514","doi":"10.1158/1538-7445.sabcs22-p3-01-03","title":"Abstract P3-01-03: Characterization of neutropenia in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) advanced breast cancer on palbociclib in a real-world setting: Results from POLARIS","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Neutropenia; Febrile neutropenia; Internal medicine; Breast cancer; Adverse effect; Cancer; Oncology; Aromatase inhibitor; Metastatic breast cancer; Estrogen receptor; Chemotherapy; Aromatase","score_opus":0.03499175233405395,"score_gpt":0.3568053691348744,"score_spread":0.32181361680082043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873933,0.00008884052,0.000002681608,0.003336697,0.00015538528,0.0021186126,0.006456815,0.00010739188,0.0003402523],"genre_scores_gemma":[0.99533534,0.0009068749,0.0001503172,0.00014302395,0.00033782996,0.0006234546,0.0018880824,0.00016513735,0.00044993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947756,0.00045144523,0.0010066574,0.001170608,0.0014402617,0.0011554614],"domain_scores_gemma":[0.9969798,0.0006027236,0.0005250807,0.0006172535,0.0009566218,0.00031853173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006496667,0.00048762184,0.0009254887,0.0011816663,0.00018881403,0.00004613702,0.00037343943,0.00020140436,0.0007170348],"category_scores_gemma":[0.00020759717,0.00042814217,0.00009226966,0.003061795,0.0004076981,0.00064420654,0.0001536217,0.0014257026,0.00006133782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058754984,0.0007402971,0.40384793,0.00019675172,0.00023954647,0.000050198774,0.0057045785,0.00013326001,0.48335135,0.000032093696,0.00028753476,0.046661474],"study_design_scores_gemma":[0.0136695,0.0007240431,0.944153,0.0019390828,0.00001531081,3.8864658e-7,0.00037489884,0.000022416212,0.038469825,0.000043550222,0.0002019738,0.00038601801],"about_ca_topic_score_codex":0.021664158,"about_ca_topic_score_gemma":0.0056153527,"teacher_disagreement_score":0.5403051,"about_ca_system_score_codex":0.002260127,"about_ca_system_score_gemma":0.00055097445,"threshold_uncertainty_score":0.999817},"labels":[],"label_agreement":null},{"id":"W4322775526","doi":"10.1158/1538-7445.sabcs22-pd11-02","title":"Abstract PD11-02: PD11-02 A Phase II Randomized Window of Opportunity Trial Evaluating Cytotoxic and Immunomodulatory effects of Intratumoral INT230-6 in Early Stage Breast Cancer: the INVINCIBLE Trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; McMaster University; Ontario Institute for Cancer Research; Institute of Cancer Research; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Tumor microenvironment; Cancer; Cytotoxic T cell; Immune system; Immunotherapy; Oncology; Clinical trial; Internal medicine; Immunology; Cancer research; Biology; In vitro","score_opus":0.11706761168293735,"score_gpt":0.45392317659157977,"score_spread":0.33685556490864244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779696,0.003106354,0.0000011344432,0.0010378213,0.00061417924,0.007144544,0.00018047325,0.000034645895,0.00008390392],"genre_scores_gemma":[0.99350524,0.0036480874,0.000008314932,0.000065136715,0.00047999778,0.0018172781,0.00002382899,0.000049084792,0.0004030082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948848,0.0013639703,0.0011459726,0.00049742055,0.0013825531,0.0007253159],"domain_scores_gemma":[0.99627787,0.0020053308,0.00043520425,0.0006393014,0.00041743123,0.00022486616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011698462,0.00028714622,0.0012794997,0.0006873876,0.00026321702,0.000048310336,0.00036454876,0.00019651634,0.0004844753],"category_scores_gemma":[0.0014995235,0.00020331096,0.0003137736,0.001560949,0.0012565907,0.00018945218,0.00022827771,0.0010579585,0.0000024394415],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7134745,0.00045315732,0.00027743628,0.0006058581,0.0003661481,0.000042693875,0.0017158609,0.000009884453,0.25912693,0.000009107814,0.0002968561,0.02362154],"study_design_scores_gemma":[0.9225731,0.0055031367,0.016350446,0.0012254337,0.000121210716,0.000006384798,0.00048609325,0.00032022365,0.053050555,0.0000604362,0.0001005978,0.00020236889],"about_ca_topic_score_codex":0.016567705,"about_ca_topic_score_gemma":0.00068399066,"teacher_disagreement_score":0.20909859,"about_ca_system_score_codex":0.00051902235,"about_ca_system_score_gemma":0.0034589153,"threshold_uncertainty_score":0.98998106},"labels":[],"label_agreement":null},{"id":"W4322775565","doi":"10.1158/1538-7445.sabcs22-p4-03-33","title":"Abstract P4-03-33: A Population-based Analysis of Prophylactic G-CSF Biosimilar and Originator Administration over time among Patients Diagnosed with Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"F. Ménard (Canada)","funders":"","keywords":"Medicine; Docetaxel; Febrile neutropenia; Internal medicine; Pertuzumab; Cyclophosphamide; Oncology; Biosimilar; Breast cancer; Trastuzumab; Carboplatin; Metastatic breast cancer; Population; Cancer; Neutropenia; Chemotherapy; Cisplatin","score_opus":0.02958841702895987,"score_gpt":0.38100807384061697,"score_spread":0.3514196568116571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979129,0.000053062413,0.0000013030527,0.00052741444,0.00005102234,0.00076281454,0.0004820125,0.00004951695,0.00015997833],"genre_scores_gemma":[0.9987119,0.00008299962,0.000006715336,0.000054881795,0.00008109218,0.00053933694,0.00020055662,0.000030791147,0.00029176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818945,0.0000662874,0.00024682784,0.0003828762,0.00077543454,0.0003391145],"domain_scores_gemma":[0.99859554,0.00015225042,0.00011441235,0.00029175478,0.0006434394,0.0002026344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002515581,0.00014369763,0.00033821014,0.00078158174,0.00016991803,0.000051131396,0.0000753829,0.00007968782,0.0015814677],"category_scores_gemma":[0.000050420585,0.00011233469,0.00007930657,0.0030193639,0.00017194079,0.00018260563,0.000022560755,0.00026866872,0.000016909238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007234071,0.00018047565,0.9921607,0.00024071179,0.00041728365,0.000024790383,0.00006745419,0.00033972028,0.003994484,0.000008505583,0.0005977585,0.0012447487],"study_design_scores_gemma":[0.0014442772,0.00030703808,0.994114,0.00017358366,0.00049275445,6.698819e-7,0.000019371168,0.0006874019,0.0024644104,0.0000050687963,0.00017078675,0.00012064038],"about_ca_topic_score_codex":0.008280845,"about_ca_topic_score_gemma":0.0036386885,"teacher_disagreement_score":0.0046421564,"about_ca_system_score_codex":0.00037128798,"about_ca_system_score_gemma":0.0007222581,"threshold_uncertainty_score":0.99933124},"labels":[],"label_agreement":null},{"id":"W4323050383","doi":"10.1158/1538-7445.sabcs22-p3-07-18","title":"Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Oncology; Breast cancer; Taxane; Cancer; Internal medicine; Immunotherapy; Pembrolizumab","score_opus":0.08534702685228639,"score_gpt":0.4775520246060658,"score_spread":0.39220499775377937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323050383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949018,0.00034586035,1.3878031e-7,0.0007047188,0.00015975759,0.0030954883,0.0003949575,0.000040309355,0.00035699684],"genre_scores_gemma":[0.9967292,0.0006340908,0.0000063452503,0.000047181962,0.00008869431,0.0013672037,0.00007148807,0.000045776396,0.0010100045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749815,0.00017461674,0.0003648875,0.0005309756,0.0008124449,0.0006189229],"domain_scores_gemma":[0.9985422,0.0002432404,0.0001182939,0.00028903014,0.00056555844,0.00024169736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004427892,0.00022597966,0.000578158,0.0005587635,0.00012765195,0.00001840896,0.00014680046,0.00008375591,0.0014522972],"category_scores_gemma":[0.00005296371,0.00017962565,0.000035873512,0.0016668298,0.00026344426,0.00016029207,0.00011300668,0.0005609616,0.000017040074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067773,0.009708897,0.8336167,0.0004555349,0.00076981226,0.00024828035,0.007512636,0.00009909458,0.0044779335,0.0000066928424,0.007001496,0.068329975],"study_design_scores_gemma":[0.087082334,0.007128033,0.9014571,0.0002980945,0.00009186631,0.0000016909297,0.0018364515,0.00004608965,0.0016431949,0.000029518795,0.00021617128,0.00016948982],"about_ca_topic_score_codex":0.008524769,"about_ca_topic_score_gemma":0.0035875055,"teacher_disagreement_score":0.06816048,"about_ca_system_score_codex":0.00056954834,"about_ca_system_score_gemma":0.0006985059,"threshold_uncertainty_score":0.9994605},"labels":[],"label_agreement":null},{"id":"W4323050795","doi":"10.1158/1538-7445.sabcs22-p3-07-14","title":"Abstract P3-07-14: A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Breast cancer; Taxane; PTEN; Neutropenia; Cohort; Metastatic breast cancer; Chemotherapy","score_opus":0.15451503812154424,"score_gpt":0.49154997275969453,"score_spread":0.33703493463815026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323050795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880175,0.0035647594,0.0000049057066,0.0011476844,0.0004280161,0.0053187837,0.0012816099,0.000088381996,0.00014836018],"genre_scores_gemma":[0.9922545,0.0013306456,0.00009373636,0.00015774865,0.00028443986,0.004877385,0.00013106814,0.0001674944,0.0007029639],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99328965,0.0004894721,0.0012025059,0.00105185,0.002182394,0.0017841317],"domain_scores_gemma":[0.996089,0.00049855834,0.00042122044,0.0009224368,0.0012389594,0.0008298642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026064627,0.00050392625,0.0016118686,0.0018971987,0.0003795212,0.000043328313,0.00054895703,0.00014194245,0.0018936733],"category_scores_gemma":[0.00052621047,0.00041312413,0.000120274264,0.004039265,0.00040069866,0.00042391464,0.00016976954,0.0012358356,0.000037701957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02648998,0.004892707,0.23678258,0.0012008965,0.001568498,0.00051827455,0.010843016,0.0035438144,0.0068676346,0.000036174002,0.0033060592,0.70395035],"study_design_scores_gemma":[0.120348945,0.018689416,0.8165503,0.00494861,0.0004411965,0.0000057960556,0.011510979,0.00011647315,0.0038821425,0.0004038108,0.021720568,0.0013817486],"about_ca_topic_score_codex":0.25038227,"about_ca_topic_score_gemma":0.4676882,"teacher_disagreement_score":0.7025686,"about_ca_system_score_codex":0.0028763183,"about_ca_system_score_gemma":0.004096968,"threshold_uncertainty_score":0.99983203},"labels":[],"label_agreement":null},{"id":"W4323295151","doi":"10.1158/0008-5472.can-22-2433","title":"LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; University of Massachusetts Boston; U.S. Department of Defense","keywords":"Prostate cancer; Cancer research; Coactivator; Corepressor; Androgen receptor; Enzalutamide; Enhancer; BRD4; EZH2; Cancer; Histone; Biology; Androgen deprivation therapy; Epigenetics; FOXA1; Transcription factor; Medicine; Nuclear receptor; Bromodomain; Breast cancer; Internal medicine; Gene; Genetics","score_opus":0.1109575234202194,"score_gpt":0.4066697140039471,"score_spread":0.29571219058372766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323295151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418163,0.0038524275,0.000030511097,0.00074883003,0.00016987105,0.00068038667,0.0001269628,0.000022016742,0.00018738057],"genre_scores_gemma":[0.9921071,0.00410842,0.00005977944,0.000018291843,0.00035240373,0.0013033161,0.00066376646,0.00003439132,0.001352531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802077,0.00017396535,0.0002736203,0.00049076026,0.0004977281,0.0005431573],"domain_scores_gemma":[0.99930775,0.00001866828,0.00003904689,0.00022398238,0.0002958418,0.00011470244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006328648,0.00013827214,0.00012882227,0.00018519163,0.00016322637,0.00006932472,0.00013334105,0.00014600447,0.0000924737],"category_scores_gemma":[0.000041435917,0.00013854702,0.00006965438,0.00073499954,0.00014714187,0.000014631386,0.00006157596,0.00024120345,0.000027446471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020454271,0.000060730817,0.008483115,0.00005650665,0.00002048048,0.000011784535,0.00041759247,0.0010482103,0.9790496,0.00007255796,0.0003629597,0.010211911],"study_design_scores_gemma":[0.0013770018,0.00051026314,0.05951676,0.0001405635,0.000011558783,0.000001048411,0.0004472536,0.00028886707,0.9097273,0.0007557236,0.026887178,0.000336522],"about_ca_topic_score_codex":0.00088679173,"about_ca_topic_score_gemma":0.008924108,"teacher_disagreement_score":0.069322355,"about_ca_system_score_codex":0.00016548343,"about_ca_system_score_gemma":0.00051934534,"threshold_uncertainty_score":0.56497836},"labels":[],"label_agreement":null},{"id":"W4324303332","doi":"10.1158/0008-5472.can-22-2932","title":"FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"Horizon 2020 Framework Programme; Karolinska Institutet; China Scholarship Council; Cancerfonden","keywords":"Immune system; Tumor microenvironment; Biology; Pancreatic cancer; Cell; Immunology; Medicine; Cancer research; Physiology; Internal medicine; Endocrinology; Cancer; Genetics","score_opus":0.03427678463066434,"score_gpt":0.3424350934847107,"score_spread":0.3081583088540463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324303332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966881,0.00249946,0.000014123938,0.00020616286,0.000026806189,0.00035620984,0.000023080318,0.000012300311,0.00017373571],"genre_scores_gemma":[0.9913506,0.0029397407,0.000058424626,0.00004995844,0.00013294896,0.00031613852,0.000050862407,0.00002646921,0.005074895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998644,0.00013333217,0.00015188781,0.00043084822,0.00022334505,0.00041660515],"domain_scores_gemma":[0.99960154,0.000011838584,0.000025856772,0.0002340638,0.000028372704,0.00009833293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051265105,0.00011529294,0.00012526981,0.0001280994,0.00011366752,0.000045735556,0.00017459337,0.00007502821,0.00008130294],"category_scores_gemma":[0.000020069932,0.00010656105,0.000029370312,0.00014616542,0.00012712747,0.0000073447104,0.00024475768,0.00017427753,0.000030258361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008367887,0.00006968933,0.005564651,0.000053695938,0.000011317803,0.000028256758,0.00018228496,0.00010114863,0.9920411,0.000015332671,0.00023124878,0.0016176008],"study_design_scores_gemma":[0.001052172,0.00046261953,0.04191115,0.00006617927,0.0000063758353,0.000006640773,0.0013956154,0.00032574584,0.9494869,0.00015588569,0.0049082683,0.00022240919],"about_ca_topic_score_codex":0.0004530058,"about_ca_topic_score_gemma":0.00023326797,"teacher_disagreement_score":0.04255416,"about_ca_system_score_codex":0.00004972487,"about_ca_system_score_gemma":0.000062435305,"threshold_uncertainty_score":0.43454334},"labels":[],"label_agreement":null},{"id":"W4362524627","doi":"10.1158/1538-7445.am2023-4680","title":"Abstract 4680: Intracranial breast cancer brain metastases (BCBM) models - stereotactic vs. intracarotid inoculation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Medicine; Breast cancer; Brain metastasis; Extravasation; Cancer; Oncology; Metastatic breast cancer; Primary tumor; Metastasis; Pathology; Internal medicine","score_opus":0.1229293280386864,"score_gpt":0.42932374786967237,"score_spread":0.306394419830986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96575797,0.00083876,0.000058214264,0.029717617,0.00033267695,0.0013844427,0.0009830936,0.0002019382,0.00072528736],"genre_scores_gemma":[0.994456,0.0015037111,0.00016531139,0.00049838884,0.0008760971,0.000823562,0.00024527867,0.00008217214,0.0013495074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99633545,0.00029216064,0.00042605333,0.0006591002,0.0013122213,0.00097498816],"domain_scores_gemma":[0.9979327,0.0004990313,0.00009274509,0.0005616406,0.00048926484,0.00042464238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016787179,0.00028436392,0.00048698034,0.0005517613,0.00030135128,0.00012797624,0.00020599822,0.00013616313,0.002899466],"category_scores_gemma":[0.0001512726,0.00023053687,0.00017684679,0.0013890509,0.00021362462,0.00039073967,0.0001431354,0.00077052973,0.00024715188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008874319,0.0020822892,0.040859107,0.0027097503,0.004126804,0.0048018903,0.0020755595,0.009410759,0.045829717,0.0047019417,0.24538699,0.62914085],"study_design_scores_gemma":[0.012969846,0.0011081966,0.92063576,0.0016286387,0.0007262681,0.0005328064,0.0011232492,0.01798309,0.010279319,0.0031515162,0.028729627,0.0011316942],"about_ca_topic_score_codex":0.0049171494,"about_ca_topic_score_gemma":0.0003190757,"teacher_disagreement_score":0.87977666,"about_ca_system_score_codex":0.00071389304,"about_ca_system_score_gemma":0.0007633988,"threshold_uncertainty_score":0.998012},"labels":[],"label_agreement":null},{"id":"W4362524638","doi":"10.1158/1538-7445.am2023-2001","title":"Abstract 2001: Engineering extracellular vesicle like liposomes with integrin αVβ5 to study its role in cancer metastasis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; McGill University Health Centre","funders":"","keywords":"Liposome; Chemistry; Extracellular vesicle; Nanoparticle tracking analysis; Metastasis; Microvesicles; Integrin; Vesicle; Cancer cell; Biophysics; Dynamic light scattering; Biochemistry; Cancer; Cell biology; Biology; Nanotechnology; Materials science; Membrane; Nanoparticle; Cell","score_opus":0.05467187940719178,"score_gpt":0.37702519857047734,"score_spread":0.3223533191632856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899603,0.008400952,0.000029948089,0.000325079,0.00010723012,0.00094532425,0.00007606727,0.00004613015,0.00010892888],"genre_scores_gemma":[0.9960235,0.000709637,0.00016400669,0.00003746585,0.0002319033,0.0012165932,0.000028917952,0.00008790329,0.0015001023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973507,0.00013378836,0.00027215903,0.00072897703,0.00060341787,0.0009109508],"domain_scores_gemma":[0.99874,0.000049554277,0.000037781447,0.00060895365,0.00021733984,0.00034635531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011369234,0.00023510407,0.0002255494,0.000359397,0.000100832876,0.000065935084,0.00053246523,0.00010478927,0.00025021358],"category_scores_gemma":[0.0001683206,0.00021862901,0.000060858234,0.0012653971,0.000054881464,0.000015745822,0.00035563283,0.00044058185,0.00013150061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025916088,0.00029298742,0.0076972246,0.000070584174,0.00013504346,0.00021087175,0.0005245051,0.008264605,0.974724,0.000012715271,0.0015205864,0.0062877475],"study_design_scores_gemma":[0.0013676033,0.00059014274,0.05821792,0.00015828577,0.000031641695,0.000003339264,0.0026764078,0.00049382646,0.9115943,0.000012111067,0.024319088,0.00053533993],"about_ca_topic_score_codex":0.0007634107,"about_ca_topic_score_gemma":0.0013108234,"teacher_disagreement_score":0.06312967,"about_ca_system_score_codex":0.0001783659,"about_ca_system_score_gemma":0.00033235992,"threshold_uncertainty_score":0.8915432},"labels":[],"label_agreement":null},{"id":"W4362524723","doi":"10.1158/1538-7445.am2023-4967","title":"Abstract 4967: Investigating the therapeutic efficacy of EO3001 in clear cell carcinoma of the ovary","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Mitochondrion; Cancer research; Chemistry; Oxidative stress; Protein kinase B; Ovarian cancer; Biology; Cell biology; Cancer; Biochemistry; Apoptosis; Genetics","score_opus":0.10531736887088758,"score_gpt":0.38706391123217243,"score_spread":0.2817465423612848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611413,0.0019036195,0.000003270021,0.00075591385,0.000088506466,0.00033684727,0.00002287601,0.0000037558177,0.00077107735],"genre_scores_gemma":[0.99915457,0.0003186937,0.00003079855,0.00009055819,0.00009288461,0.00006395113,0.000005419841,0.000023065644,0.0002200341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984646,0.00026465603,0.00024333053,0.00023982521,0.0004541869,0.00033342102],"domain_scores_gemma":[0.9989672,0.00013341868,0.00009311807,0.00062005257,0.00014090879,0.00004534558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014092651,0.000088383844,0.00013220932,0.00008103349,0.00008390212,0.0000101318765,0.0006784265,0.000079878264,0.00005729037],"category_scores_gemma":[0.00019340626,0.00005658624,0.0000863135,0.0006883162,0.0003241208,0.000002968979,0.00031822384,0.00030488492,0.0000062329636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073908064,0.00002537523,0.0032936663,0.000098726385,0.000017345072,0.0000013467998,0.00023030642,0.00027356425,0.99008197,0.000095678995,0.0010245725,0.004783554],"study_design_scores_gemma":[0.00040651538,0.00008978869,0.090938024,0.000043485725,0.00000550086,5.227624e-7,0.00032752845,0.000032521537,0.9060277,0.00031388446,0.0017574161,0.00005711834],"about_ca_topic_score_codex":0.00052338047,"about_ca_topic_score_gemma":0.0001263193,"teacher_disagreement_score":0.08764435,"about_ca_system_score_codex":0.000029108669,"about_ca_system_score_gemma":0.00041264328,"threshold_uncertainty_score":0.23075198},"labels":[],"label_agreement":null},{"id":"W4362524751","doi":"10.1158/1538-7445.am2023-2466","title":"Abstract 2466: Detection of extracellular vesicle-associated DNA in mouse metastatic breast cancer cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University Health Centre","funders":"","keywords":"Extracellular vesicle; Liquid biopsy; Breast cancer; Metastatic breast cancer; Cancer; Cancer research; Cancer cell; Biology; Molecular biology; Pathology; Medicine; Gene; Microvesicles; Genetics; microRNA","score_opus":0.04223412871029119,"score_gpt":0.35784830117962685,"score_spread":0.31561417246933565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568564,0.0030665963,0.000024671137,0.00014277577,0.00013657076,0.00040879723,0.00040883172,0.000028703147,0.00009741313],"genre_scores_gemma":[0.99599504,0.0017461398,0.000014945786,0.0000157418,0.00011983839,0.0002553628,0.00007251966,0.00006109095,0.0017193307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976518,0.00026976212,0.00037808705,0.0004979754,0.00054766535,0.000654713],"domain_scores_gemma":[0.99888843,0.00006512611,0.00011610298,0.000473002,0.0002895576,0.00016779776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013048782,0.00017064845,0.00021764048,0.0002814864,0.00009310203,0.000029149307,0.00037761556,0.00015338194,0.00016981857],"category_scores_gemma":[0.00015027783,0.00018137333,0.00010997961,0.0009120298,0.0002200132,0.000012548909,0.00017302939,0.000338228,0.000050285777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002062036,0.00018501034,0.001483533,0.00013901322,0.00007781854,0.00004226758,0.0000772308,0.00085119694,0.99166155,0.000008626595,0.00088842557,0.004379122],"study_design_scores_gemma":[0.0007583788,0.00006314098,0.016812112,0.000069178466,0.000013889321,0.0000013712199,0.0002074748,0.00026630829,0.9809743,0.00008475817,0.0005688269,0.00018022956],"about_ca_topic_score_codex":0.0013752842,"about_ca_topic_score_gemma":0.0013260783,"teacher_disagreement_score":0.01532858,"about_ca_system_score_codex":0.00022024589,"about_ca_system_score_gemma":0.0003623592,"threshold_uncertainty_score":0.73961896},"labels":[],"label_agreement":null},{"id":"W4362524815","doi":"10.1158/1538-7445.am2023-4066","title":"Abstract 4066: Lipid nanoparticle library towards development next generation genomic medicines","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nucleic acid; Transfection; Genetic enhancement; Cancer; In vivo; Computational biology; Chemistry; Biology; Gene; Biochemistry; Genetics","score_opus":0.14559315042629897,"score_gpt":0.38076795503274824,"score_spread":0.23517480460644927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962662,0.0012211294,0.0000070230544,0.0012084492,0.00028495822,0.00015368618,0.000008943832,0.000030562605,0.00081906316],"genre_scores_gemma":[0.9923101,0.0021554404,0.00006490893,0.00023348289,0.0012566434,0.00014743971,0.00018279505,0.00002455123,0.0036246544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880487,0.000050110146,0.00017701593,0.00032179622,0.00025974173,0.00038645905],"domain_scores_gemma":[0.9995106,0.000010128869,0.00002381231,0.00024014011,0.00010495606,0.00011039659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003592571,0.00009597831,0.00008897704,0.00010647301,0.00015748381,0.000075240416,0.00025781064,0.00008838634,0.000372599],"category_scores_gemma":[0.000038567385,0.000084858715,0.000034196437,0.0002552969,0.00007713518,0.000015141428,0.00028809652,0.00012284341,0.00041016648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004322239,0.000013835529,0.00082720164,0.00001855221,0.000024241113,0.000008569704,0.0001421011,0.00005396391,0.8870579,0.0000049620353,0.079843484,0.031961937],"study_design_scores_gemma":[0.00017813356,0.000087653505,0.014836124,0.000021148813,0.0000019518873,0.0000015203381,0.00014143765,0.00008090642,0.9075891,0.000017770104,0.07694068,0.00010360941],"about_ca_topic_score_codex":0.000047665493,"about_ca_topic_score_gemma":0.000046891262,"teacher_disagreement_score":0.031858325,"about_ca_system_score_codex":0.000031613938,"about_ca_system_score_gemma":0.0005468113,"threshold_uncertainty_score":0.52719975},"labels":[],"label_agreement":null},{"id":"W4362524891","doi":"10.1158/1538-7445.am2023-4212","title":"Abstract 4212: Comparison of thirty-year population-based incidence rates of invasive lobular vs ductal vs mixed breast carcinoma in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Incidence (geometry); Medicine; Breast cancer; Lobular carcinoma; Population; Invasive lobular carcinoma; Cancer registry; Ductal carcinoma; Invasive ductal carcinoma; Demography; Cancer; Internal medicine","score_opus":0.07535406295541838,"score_gpt":0.36445261630648024,"score_spread":0.2890985533510618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977751,0.00021673557,5.493994e-7,0.0011244552,0.000120304,0.00045713503,0.00010330753,0.000011553592,0.00019089217],"genre_scores_gemma":[0.999405,0.000010826273,0.00002682902,0.000033544457,0.00005566237,0.000057493136,0.00015239426,0.000024382669,0.00023384669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974121,0.00012370433,0.00050893956,0.00033847854,0.0011278774,0.0004888931],"domain_scores_gemma":[0.9982485,0.00037810914,0.00012814457,0.00042899154,0.00061290665,0.00020335807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006675086,0.00014895173,0.00052223774,0.00043534744,0.000085342734,0.000011523202,0.00024195391,0.00010791218,0.00087320094],"category_scores_gemma":[0.00019254761,0.00013691877,0.00007146799,0.0010934726,0.00015905144,0.00006674529,0.000096604854,0.0006537417,0.000010188285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084127736,0.00009517416,0.9812124,0.00036947188,0.000023854247,0.0001773046,0.00038472808,0.0005924187,0.013043204,0.000055520497,0.002973293,0.00023134807],"study_design_scores_gemma":[0.0011589065,0.00014981681,0.9748347,0.00055365637,0.000014647688,0.000011166171,0.0009871846,0.0003135896,0.021782652,0.000027149745,0.00005674097,0.00010983447],"about_ca_topic_score_codex":0.99262935,"about_ca_topic_score_gemma":0.991649,"teacher_disagreement_score":0.008739447,"about_ca_system_score_codex":0.0012350051,"about_ca_system_score_gemma":0.00883009,"threshold_uncertainty_score":0.9967889},"labels":[],"label_agreement":null},{"id":"W4362524901","doi":"10.1158/1538-7445.am2023-2474","title":"Abstract 2474: Uncovering a new therapeutic vulnerability for preventing brain metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Transcriptome; Medicine; Population; Brain metastasis; In vitro; Druggability; Cancer; Cell; Biology; Metastasis; Internal medicine; Gene; Gene expression","score_opus":0.2583849681656494,"score_gpt":0.5132082353199036,"score_spread":0.2548232671542542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5238348,0.000944787,0.46168455,0.010920014,0.0006405301,0.0011541907,0.000044959343,0.00035735653,0.0004187774],"genre_scores_gemma":[0.96829534,0.000052153882,0.027897611,0.00031513322,0.00051726704,0.00058411143,0.000016251748,0.000040815965,0.0022813228],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99726266,0.0004605275,0.00025617046,0.00059482,0.0007706699,0.00065518357],"domain_scores_gemma":[0.9940677,0.0049755466,0.000054513388,0.0005202455,0.00022989903,0.00015209189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065203747,0.00012391535,0.00017781185,0.0002733183,0.0003162244,0.000340263,0.0009833217,0.00003922604,0.00006294986],"category_scores_gemma":[0.001128083,0.00011771715,0.00012186115,0.0016263183,0.00006575893,0.0005370196,0.0005126437,0.0003015633,0.000051415547],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065431,0.00007254092,0.0005594615,0.00031939498,0.00011571312,0.000013654291,0.0011341709,0.12816156,0.024801474,0.02767145,0.019648084,0.7974371],"study_design_scores_gemma":[0.0015611394,0.0002040817,0.04355364,0.00024689364,0.0000136451035,0.0000053071544,0.00020727425,0.25559437,0.040596,0.5795238,0.07786322,0.00063066854],"about_ca_topic_score_codex":0.0005663889,"about_ca_topic_score_gemma":0.000112165326,"teacher_disagreement_score":0.7968064,"about_ca_system_score_codex":0.00023383109,"about_ca_system_score_gemma":0.0010597314,"threshold_uncertainty_score":0.48003662},"labels":[],"label_agreement":null},{"id":"W4362524905","doi":"10.1158/1538-7445.am2023-1886","title":"Abstract 1886: Identifying T-cell engagers with optimal potency and cytokine-release profiles with a diverse panel of CD3-binding antibodies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Antibody; Epitope; Cytokine; CD3; T cell; Potency; Biology; Computational biology; Immunology; Cancer research; In vitro; Antigen; Immune system; Biochemistry; CD8","score_opus":0.148357465777704,"score_gpt":0.4010108907446283,"score_spread":0.25265342496692433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362524905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950015,0.00097498624,0.0000064368237,0.0007884449,0.00003285427,0.0006789417,0.00014589039,0.00005697929,0.0023139839],"genre_scores_gemma":[0.9898134,0.0034224659,0.0003472367,0.000017295657,0.00014497257,0.000097360324,0.000053945765,0.000046786237,0.006056574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968103,0.00011199172,0.00025215183,0.00049965625,0.0014677653,0.00085811585],"domain_scores_gemma":[0.99841547,0.00037496578,0.00007762123,0.00027769434,0.00050178735,0.00035246808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009884143,0.00021756683,0.00040187145,0.00062788225,0.00046472097,0.00006904857,0.00020644431,0.00008202679,0.0002794867],"category_scores_gemma":[0.000107610475,0.00014494675,0.000065665015,0.0010288132,0.0008758958,0.00018478169,0.00026069794,0.00091985095,0.000065644694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005365644,0.00021434484,0.19476439,0.004476587,0.00032280953,0.0027294485,0.0028425544,0.00015588147,0.7771217,0.00011821753,0.0029585592,0.0089298645],"study_design_scores_gemma":[0.0068306574,0.0025638144,0.4752209,0.0045508016,0.00018442635,0.00019183142,0.024413241,0.0008191858,0.48115182,0.00005944827,0.003203619,0.00081025733],"about_ca_topic_score_codex":0.003049001,"about_ca_topic_score_gemma":0.00010239244,"teacher_disagreement_score":0.29596987,"about_ca_system_score_codex":0.000087816494,"about_ca_system_score_gemma":0.0006023364,"threshold_uncertainty_score":0.5910757},"labels":[],"label_agreement":null},{"id":"W4362525077","doi":"10.1158/1538-7445.am2023-4961","title":"Abstract 4961: Novel biased PAR2 inhibitors with best-in-class properties reduce resistance to both chemotherapy and immunotherapy in oncology models","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"In vivo; Tumor microenvironment; Cancer research; Proteases; Cancer; Immunotherapy; Immune system; Pharmacology; Cancer cell; Medicine; Biology; Immunology; Internal medicine; Enzyme; Biochemistry","score_opus":0.1906925512241528,"score_gpt":0.41561032580942253,"score_spread":0.22491777458526974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362525077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809807,0.0009817855,0.000033151995,0.015274702,0.000064432475,0.0012313109,0.0000067022056,0.000049181774,0.0013780224],"genre_scores_gemma":[0.99483716,0.0014027071,0.0003827053,0.00060805446,0.000090354115,0.0006056283,0.000004032203,0.00005407324,0.0020152999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980897,0.00007726801,0.00028663295,0.00045182422,0.0005497489,0.0005448679],"domain_scores_gemma":[0.999235,0.00009749416,0.000041122064,0.00030635303,0.0001601315,0.00015992617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009997888,0.00015275666,0.0003652984,0.0005971625,0.00008383294,0.00003230625,0.00011983766,0.00013287058,0.00006436114],"category_scores_gemma":[0.00004016162,0.00012063737,0.000024888994,0.0013585605,0.00015046133,0.00011411596,0.0000360816,0.00045800587,0.000017635477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035970078,0.0004032155,0.0011609027,0.00017276643,0.000051412488,0.00005431968,0.0038293065,0.0005844992,0.97448903,0.0006423929,0.0012271127,0.013788057],"study_design_scores_gemma":[0.029838586,0.0032456098,0.10554007,0.0056947367,0.000024738303,0.000018137198,0.0076613515,0.00389672,0.8044365,0.0016471873,0.037035592,0.0009607536],"about_ca_topic_score_codex":0.0009828787,"about_ca_topic_score_gemma":0.0028789293,"teacher_disagreement_score":0.17005248,"about_ca_system_score_codex":0.00042354956,"about_ca_system_score_gemma":0.00070321216,"threshold_uncertainty_score":0.4919449},"labels":[],"label_agreement":null},{"id":"W4362525148","doi":"10.1158/1538-7445.am2023-1891","title":"Abstract 1891: Breaking barriers to access intracellular targets with T-cell engagers: Discovery of diverse, developable, and ultra-specific antibodies against a MAGE-A4 pMHC","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Antibody; Major histocompatibility complex; Computational biology; Antigen; Intracellular; MHC class I; Biology; Cell biology; Immunology","score_opus":0.0840318442335572,"score_gpt":0.38293625391182357,"score_spread":0.29890440967826637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362525148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824924,0.0032389539,0.00003500909,0.0015847771,0.00010720556,0.00086307985,0.00020080883,0.000057605004,0.0056633153],"genre_scores_gemma":[0.98109514,0.013141172,0.00022404098,0.00014257064,0.0002213458,0.000107364904,0.00006913283,0.00006053909,0.0049386937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960987,0.0001639188,0.0003719235,0.00069779216,0.001536827,0.0011308659],"domain_scores_gemma":[0.99762964,0.0005801714,0.000075270735,0.00040032953,0.00058250915,0.000732069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014911437,0.00028456518,0.00052905997,0.0008246414,0.00056904677,0.0002365561,0.0004650311,0.000114419374,0.00037744237],"category_scores_gemma":[0.00030211985,0.00021586062,0.000083880506,0.0017584567,0.00074051035,0.00044139527,0.0004385548,0.0010105429,0.00007845898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031692537,0.00012069133,0.1518415,0.0023762165,0.00025576103,0.0017239482,0.0033705062,0.00022903095,0.8011311,0.00014878811,0.022326788,0.013306409],"study_design_scores_gemma":[0.002617581,0.00056342507,0.27986553,0.0023166735,0.000041550516,0.00003366259,0.008583787,0.00007388793,0.6564146,0.000092655624,0.04868414,0.00071250775],"about_ca_topic_score_codex":0.0014587865,"about_ca_topic_score_gemma":0.00019408486,"teacher_disagreement_score":0.1447165,"about_ca_system_score_codex":0.00017602887,"about_ca_system_score_gemma":0.0008783904,"threshold_uncertainty_score":0.88025403},"labels":[],"label_agreement":null},{"id":"W4362525510","doi":"10.1158/1538-7445.am2023-724","title":"Abstract 724: Leaving cancer patients behind for greener pastures: The clinical oncology workforce in Nigeria","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workforce; Medicine; Remuneration; Workload; Population; Mentorship; Salary; Family medicine; Nursing; Promotion (chess); Attendance; Medical education; Business; Political science; Environmental health; Management","score_opus":0.23992652245162305,"score_gpt":0.6086291205290681,"score_spread":0.3687025980774451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362525510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803399,0.0028613205,0.000027722916,0.012319919,0.0018147731,0.001399934,0.000030402645,0.00004039476,0.0011656531],"genre_scores_gemma":[0.97022,0.0123387715,0.00019477973,0.0022239455,0.0035098935,0.0020889752,0.000033513486,0.000061892235,0.009328192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775255,0.0002503937,0.00045034706,0.00041677573,0.00040091082,0.00072902977],"domain_scores_gemma":[0.99682045,0.0023616157,0.00009381543,0.00031409602,0.0002692602,0.0001407854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026954105,0.00012899721,0.0004013831,0.00017665871,0.0002886518,0.000013253871,0.00030741762,0.00033016063,0.00034326574],"category_scores_gemma":[0.000741568,0.00008208092,0.0001141304,0.0004850587,0.0006251713,0.00007128118,0.00008446896,0.0012251335,0.000035810364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022529967,0.00026971524,0.51589286,0.00007638752,0.00009974261,0.0000506026,0.0019004161,0.00025355254,0.00048659174,0.0000571721,0.067049034,0.41161096],"study_design_scores_gemma":[0.0038195828,0.0007723193,0.518791,0.00021602055,0.000012456426,0.0000016170462,0.00045933246,0.00008256368,0.00016750793,0.00049048435,0.47507375,0.00011334873],"about_ca_topic_score_codex":0.00032096004,"about_ca_topic_score_gemma":0.0048713987,"teacher_disagreement_score":0.4114976,"about_ca_system_score_codex":0.00070219726,"about_ca_system_score_gemma":0.001062857,"threshold_uncertainty_score":0.5322664},"labels":[],"label_agreement":null},{"id":"W4362525948","doi":"10.1158/1538-7445.am2023-1631","title":"Abstract 1631: Combination of olverembatinib (HQP1351) with BCL-2 inhibitor lisaftoclax (APG-2575) overcomes resistance in gastrointestinal stromal tumors (GISTs)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"GiST; Imatinib; PDGFRA; Cancer research; Tyrosine-kinase inhibitor; Myeloid leukemia; Medicine; Stromal cell; Tyrosine kinase; Stromal tumor; Imatinib mesylate; Internal medicine; Cancer; Receptor","score_opus":0.07082521652207506,"score_gpt":0.3914402362792761,"score_spread":0.320615019757201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362525948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214715,0.00022612792,0.0000068789436,0.0015770643,0.00002654402,0.0012735671,0.00008295624,0.000089085166,0.004570626],"genre_scores_gemma":[0.9950646,0.00006373518,0.0010540906,0.000014380912,0.00014536978,0.00040415916,0.00009521459,0.000059754497,0.0030986578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953991,0.00018203874,0.0005544092,0.00062041124,0.0020437124,0.001200314],"domain_scores_gemma":[0.9974211,0.00059227314,0.00014787122,0.00051944976,0.0008767796,0.00044255174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013387962,0.00027709358,0.00052846904,0.00092031783,0.00014193107,0.000056142555,0.00028769643,0.000048253474,0.0005084393],"category_scores_gemma":[0.0009537625,0.00022390675,0.00010249211,0.0020435685,0.0005787557,0.00018666117,0.00015295681,0.001009135,0.00013261073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010906179,0.0015642757,0.8725346,0.002502949,0.00011151978,0.007536465,0.00046199493,0.00011569537,0.08931939,0.001655664,0.011604371,0.0016869205],"study_design_scores_gemma":[0.0061549335,0.003252674,0.967193,0.00697735,0.0000147578385,0.00019407572,0.0009066343,0.000108559114,0.01429029,0.00039160665,0.0003178574,0.00019825272],"about_ca_topic_score_codex":0.0012781946,"about_ca_topic_score_gemma":0.0019913432,"teacher_disagreement_score":0.09465844,"about_ca_system_score_codex":0.0009682485,"about_ca_system_score_gemma":0.0014556167,"threshold_uncertainty_score":0.91306525},"labels":[],"label_agreement":null},{"id":"W4362534013","doi":"10.1158/1538-7445.am2023-5223","title":"Abstract 5223: Circulating lipoprotein lipids and colorectal cancer risk: A Mendelian randomization analysis from the GECCO consortium","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Mendelian randomization; Genome-wide association study; Single-nucleotide polymorphism; Colorectal cancer; Apolipoprotein B; Internal medicine; Blood lipids; Medicine; Genetics; High-density lipoprotein; Triglyceride; Apolipoprotein A1; Genetic association; Cholesterol; Lipoprotein; Oncology; Cancer; Biology; Endocrinology; Genotype; Gene; Genetic variants","score_opus":0.0332000499076254,"score_gpt":0.35095081725143923,"score_spread":0.3177507673438138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910934,0.0062988135,0.0001173686,0.002309764,0.0010680474,0.0005507743,0.0003510457,0.00002950038,0.00016534465],"genre_scores_gemma":[0.9772446,0.0105062965,0.000026709691,0.00033903983,0.010692881,0.00060687336,0.00021166602,0.000032998625,0.00033892482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978919,0.0003277445,0.00027107936,0.0005654907,0.00043625128,0.00050753326],"domain_scores_gemma":[0.99894637,0.00018302469,0.000112860354,0.00036321962,0.00027297498,0.00012156868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013106847,0.00016225106,0.00027866423,0.00016490792,0.00044635334,0.00011351581,0.00025022717,0.00018283246,0.00022459771],"category_scores_gemma":[0.00041414538,0.00012673235,0.00014732897,0.0010783254,0.00026947603,0.000009468879,0.00017231394,0.00040366955,0.000011063616],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008986876,0.000023858613,0.05277568,0.00003686005,0.0014456093,0.000001239267,0.00088434236,0.003593763,0.8411269,0.000019179377,0.06361617,0.035577666],"study_design_scores_gemma":[0.0070516425,0.000114735936,0.49505815,0.00008815616,0.0007400382,0.000002395018,0.0014244419,0.0042939493,0.1195298,0.00030335423,0.37068602,0.0007072966],"about_ca_topic_score_codex":0.023339119,"about_ca_topic_score_gemma":0.010809065,"teacher_disagreement_score":0.72159714,"about_ca_system_score_codex":0.00006168746,"about_ca_system_score_gemma":0.00035043983,"threshold_uncertainty_score":0.98316455},"labels":[],"label_agreement":null},{"id":"W4362534156","doi":"10.1158/1538-7445.am2023-1313","title":"Abstract 1313: Hepatic pre-metastatic niche formation by uveal melanoma extracellular vesicles","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Stromal cell; Tumor microenvironment; Hepatic stellate cell; Cancer research; Melanoma; Cell biology; Extracellular matrix; Pathology; Biology; Stroma; Cancer cell; Chemistry; Cancer; Medicine","score_opus":0.044641857617663976,"score_gpt":0.3714934887664402,"score_spread":0.32685163114877624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774403,0.010131821,0.00039523735,0.00039588052,0.00011957043,0.0005502163,0.00015039297,0.000059293452,0.00045358387],"genre_scores_gemma":[0.9930911,0.0014755032,0.00011408656,0.000052358635,0.00021849136,0.00036352262,0.0006224529,0.000062455365,0.003999998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974996,0.0002516085,0.00035076897,0.0005008029,0.0006602213,0.0007369934],"domain_scores_gemma":[0.9987404,0.00008770685,0.00008760551,0.00063794065,0.00019366057,0.0002526904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012531078,0.00019190859,0.0001650567,0.00015082928,0.00024279571,0.00009818381,0.00050878874,0.00013414062,0.00021409642],"category_scores_gemma":[0.00028592168,0.00019281569,0.00010533935,0.00048708884,0.00021704633,0.000023656685,0.00023411133,0.00032284512,0.0003419546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120130586,0.00008066316,0.0010349166,0.00020857467,0.000048894497,0.00003788218,0.00012745296,0.00012337152,0.9296947,0.000039305956,0.06022065,0.008263419],"study_design_scores_gemma":[0.00071192737,0.00021136657,0.004781999,0.00006430105,0.000022024256,0.0000068490585,0.000273057,0.00091841206,0.94837815,0.00052696135,0.043801215,0.00030372752],"about_ca_topic_score_codex":0.00011989382,"about_ca_topic_score_gemma":0.00006055797,"teacher_disagreement_score":0.018683422,"about_ca_system_score_codex":0.000095405434,"about_ca_system_score_gemma":0.0002403233,"threshold_uncertainty_score":0.78627956},"labels":[],"label_agreement":null},{"id":"W4362534260","doi":"10.1158/1538-7445.am2023-1315","title":"Abstract 1315: NETs act as immunosuppressive agents within lymph nodes during cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; McGill University Health Centre","funders":"","keywords":"Metastasis; Cytotoxic T cell; CD8; Cancer research; Immunosuppression; Cancer; Lymph; Immunology; Population; Immune system; Cancer cell; Medicine; Biology; In vitro; Pathology; Internal medicine","score_opus":0.0735291292889007,"score_gpt":0.4070769335114041,"score_spread":0.3335478042225034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97088253,0.018283779,4.5336344e-7,0.0008359315,0.003663073,0.00052072166,0.00012916145,0.00024559538,0.005438767],"genre_scores_gemma":[0.9441492,0.0063085603,0.0000046840614,0.0001532918,0.00020559583,0.0009555473,0.00009441101,0.00010225052,0.048026465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964085,0.0003642131,0.00048284937,0.000797646,0.00032334882,0.0016234072],"domain_scores_gemma":[0.9981543,0.00036161253,0.00016618284,0.00084464496,0.00039475787,0.00007854678],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009772475,0.00033812274,0.00042131025,0.00049213396,0.000915923,0.00009571554,0.0011065761,0.00044580683,0.01692446],"category_scores_gemma":[0.0002455412,0.00031625363,0.00014886646,0.0010103309,0.000765543,0.00025690437,0.00071220426,0.0013555216,0.00836075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006312581,0.00006132883,0.0064820945,0.00017477674,0.0004648963,0.00013298102,0.0021944689,0.0005871668,0.95139945,0.00006227418,0.031892687,0.0059166006],"study_design_scores_gemma":[0.0021794653,0.000039334685,0.14673366,0.00049642194,0.000022611932,0.000025218305,0.0008422173,0.000007674539,0.81223965,0.00019391198,0.0368119,0.00040795238],"about_ca_topic_score_codex":0.0074613756,"about_ca_topic_score_gemma":0.00017241738,"teacher_disagreement_score":0.14025156,"about_ca_system_score_codex":0.0008925448,"about_ca_system_score_gemma":0.0010482259,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W4362534734","doi":"10.1158/1538-7445.am2023-4338","title":"Abstract 4338: Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Neoadjuvant therapy; Internal medicine; Hazard ratio; Oncology; Proportional hazards model; Stage (stratigraphy); Cancer; Surgery; Breast cancer; Confidence interval","score_opus":0.16655116705278283,"score_gpt":0.46828710777728594,"score_spread":0.3017359407245031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669722,0.007994287,2.860921e-7,0.022526918,0.00030939703,0.0009474044,0.00008170199,0.000075878954,0.0010919406],"genre_scores_gemma":[0.9691397,0.023538116,0.000021846476,0.0006820508,0.00022976125,0.00084322365,0.000009542913,0.00005139186,0.0054843943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997271,0.00014438985,0.00029022637,0.0005649015,0.00073606416,0.0009934318],"domain_scores_gemma":[0.99849504,0.00037885,0.000021815462,0.00033831378,0.00036540013,0.00040060372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019508392,0.00019716345,0.00053504156,0.0005516979,0.00023078136,0.000052443724,0.00016450646,0.000108032094,0.00072923256],"category_scores_gemma":[0.00027282856,0.00016331475,0.000048688886,0.0015225746,0.00016449198,0.00008681323,0.00014422023,0.00060251635,0.00010734393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030113379,0.00022941073,0.24726447,0.0003665766,0.0002666759,0.00069076277,0.012334453,0.0004461937,0.50696546,0.00008148506,0.043127347,0.15811379],"study_design_scores_gemma":[0.0042228242,0.0008659618,0.9050359,0.00072324486,0.0000044674516,0.000002122224,0.0014137476,0.00007818846,0.009463655,0.000034106695,0.07794627,0.00020949887],"about_ca_topic_score_codex":0.01795601,"about_ca_topic_score_gemma":0.0086168,"teacher_disagreement_score":0.6577714,"about_ca_system_score_codex":0.0005081799,"about_ca_system_score_gemma":0.0009590703,"threshold_uncertainty_score":0.9885835},"labels":[],"label_agreement":null},{"id":"W4362534904","doi":"10.1158/1538-7445.am2023-4247","title":"Abstract 4247: Impact of 70% ethanol intraductal injections in MNU rat models for breast cancer prevention","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciencetech (Canada)","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Ductal carcinoma; Cancer; Ablative case; Surgery; Internal medicine; Radiation therapy","score_opus":0.09026162667986141,"score_gpt":0.4490573058223144,"score_spread":0.358795679142453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974586,0.0010108416,0.00016747996,0.00036616562,0.0001888795,0.0004916954,0.00019918749,0.000008660385,0.00010848676],"genre_scores_gemma":[0.99392873,0.0038201855,0.000025676609,0.0000034768807,0.0004970458,0.00036741717,0.00006641789,0.000024401366,0.0012666511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888957,0.0000472773,0.00018424811,0.00036172918,0.00018393077,0.0003332659],"domain_scores_gemma":[0.99934447,0.000011941395,0.000046954796,0.00021918015,0.00031864585,0.000058789792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005029284,0.000091307535,0.00011548201,0.0001820801,0.00007927043,0.000014807459,0.00012894295,0.00012796567,0.00005666791],"category_scores_gemma":[0.000036096797,0.00008120183,0.00011520228,0.0004570447,0.000101226855,0.00000845108,0.00007238538,0.00016066464,0.0000029559133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003376718,0.00006456472,0.0013767933,0.00006729043,0.000052907773,5.7255147e-7,0.000088919325,0.018053912,0.9655844,0.000026313994,0.0031565167,0.011190143],"study_design_scores_gemma":[0.0012706856,0.0009688412,0.12338574,0.00015683277,0.000018572553,0.000012676815,0.0003064981,0.0028611633,0.86717385,0.0023681691,0.0011632999,0.00031364852],"about_ca_topic_score_codex":0.0012385712,"about_ca_topic_score_gemma":0.000521041,"teacher_disagreement_score":0.12200894,"about_ca_system_score_codex":0.0001027621,"about_ca_system_score_gemma":0.0005014959,"threshold_uncertainty_score":0.33113146},"labels":[],"label_agreement":null},{"id":"W4362534918","doi":"10.1158/1538-7445.am2023-4176","title":"Abstract 4176: Timing of pregnancy-related factors and breast cancer risk for women across a range of absolute risk","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Demography; Absolute risk reduction; Prospective cohort study; Proportional hazards model; Pregnancy; Menarche; Odds ratio; Confidence interval; Obstetrics; Cohort study; Family history; Gynecology; Cancer; Internal medicine; Genetics","score_opus":0.10683479235877,"score_gpt":0.4413722184159295,"score_spread":0.3345374260571595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362534918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883934,0.004689446,0.0000037663576,0.00018415261,0.00018348916,0.0010591235,0.0052900757,0.00004651227,0.00015000407],"genre_scores_gemma":[0.97658134,0.021707997,0.000009684884,0.0000043993423,0.00009717065,0.00049371563,0.00001852679,0.000057454865,0.0010297195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761593,0.000060511094,0.00044952688,0.00042233025,0.000600979,0.00085073354],"domain_scores_gemma":[0.9982103,0.00042981395,0.00025672518,0.00036018604,0.0004743402,0.00026863886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010368462,0.00019007926,0.00057063426,0.0002708062,0.00021011254,0.000020366926,0.00016569397,0.00016576731,0.000554856],"category_scores_gemma":[0.00019392028,0.00014962314,0.00014401173,0.0008631456,0.00040973898,0.000104599196,0.00012509903,0.0005561861,0.000004843645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013863622,0.00010146865,0.87926894,0.0019731163,0.0006265891,0.000010413402,0.015810335,0.000089410314,0.010015801,0.000010436827,0.0022228167,0.08848429],"study_design_scores_gemma":[0.0029197508,0.0002277894,0.9879461,0.0012592567,0.000067452675,0.0000018256803,0.0025356337,0.00026087734,0.0034499848,0.00016943137,0.0010120446,0.00014983494],"about_ca_topic_score_codex":0.026852384,"about_ca_topic_score_gemma":0.0014112145,"teacher_disagreement_score":0.108677156,"about_ca_system_score_codex":0.00037502724,"about_ca_system_score_gemma":0.00042249635,"threshold_uncertainty_score":0.9796279},"labels":[],"label_agreement":null},{"id":"W4362535022","doi":"10.1158/1538-7445.am2023-4256","title":"Abstract 4256: cBioPortal for Cancer Genomics","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Colorectal cancer; Medicine; Citation; Cancer; Library science; World Wide Web; Computer science; Internal medicine","score_opus":0.08255949436716035,"score_gpt":0.42395410592727056,"score_spread":0.3413946115601102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362535022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920111,0.0039710063,0.0000803042,0.0011354687,0.00061751826,0.0005321898,0.00076354074,0.000023804256,0.00086512056],"genre_scores_gemma":[0.9751294,0.018184762,0.000093192044,0.00024190139,0.0018398825,0.0011472407,0.00027240187,0.000068280795,0.0030229064],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850446,0.000016618844,0.00018816217,0.0004429623,0.00021847771,0.0006293023],"domain_scores_gemma":[0.9990737,0.00007431495,0.000043600827,0.00035599596,0.0002977758,0.00015463382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005411393,0.00012559773,0.00013721515,0.00011144301,0.00020573342,0.000060841805,0.00030937963,0.0001424469,0.0001308883],"category_scores_gemma":[0.00015965324,0.00013035347,0.00010520836,0.00026245834,0.00013187087,0.000002991051,0.00018921269,0.00015730051,0.000057069527],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019041548,0.000028282695,0.0015354526,0.000085351894,0.000075420925,0.000007202927,0.00007118779,0.00086894864,0.8346939,0.00023034829,0.14134532,0.02086818],"study_design_scores_gemma":[0.00062797836,0.00013390614,0.004698141,0.000028797698,0.000009840468,0.0000011223838,0.0001324107,0.00012226998,0.27438793,0.000482164,0.71914536,0.0002300648],"about_ca_topic_score_codex":0.00060479814,"about_ca_topic_score_gemma":0.00111116,"teacher_disagreement_score":0.57780004,"about_ca_system_score_codex":0.00012800148,"about_ca_system_score_gemma":0.0007872708,"threshold_uncertainty_score":0.53156596},"labels":[],"label_agreement":null},{"id":"W4362535232","doi":"10.1158/1538-7445.am2023-4601","title":"Abstract 4601: Vitamin D supplementation attenuates resistance to anti-angiogenic therapy in colorectal cancer liver metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Colorectal cancer; Metastasis; Internal medicine; Cancer; Vitamin D and neurology; Population; Gastroenterology; Oncology; Vitamin; Angiogenesis; Cancer research","score_opus":0.05620454209176267,"score_gpt":0.39290623513479744,"score_spread":0.33670169304303477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362535232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834824,0.013703432,0.000008125526,0.00089261035,0.00049215835,0.00069758215,0.000582887,0.000020638097,0.00012014684],"genre_scores_gemma":[0.96140844,0.03448965,0.00005605563,0.00016116587,0.001062967,0.0011970085,0.00027188013,0.00004401291,0.0013088316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979255,0.00012799166,0.00023921444,0.0005676442,0.00044739537,0.00069225894],"domain_scores_gemma":[0.9992519,0.00005548284,0.000045793156,0.00026157885,0.00024167783,0.0001435515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007962503,0.0001712156,0.00021313575,0.0003050804,0.00013830299,0.0000558309,0.00030811498,0.000099276425,0.0004195147],"category_scores_gemma":[0.00007946547,0.00016689763,0.00009770197,0.0009810025,0.00011038656,0.000013055795,0.00013332232,0.00017521363,0.000071601484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043309343,0.00004012928,0.0053233267,0.000034859113,0.00007182113,0.000008433995,0.00021884912,0.00017132022,0.8961447,0.000014817969,0.081428654,0.016109988],"study_design_scores_gemma":[0.0009435291,0.000092685514,0.14466964,0.000042422475,0.000007321122,6.269718e-7,0.00017519011,0.0000061252663,0.6619474,0.000022722674,0.19189924,0.00019305728],"about_ca_topic_score_codex":0.0030538242,"about_ca_topic_score_gemma":0.030367557,"teacher_disagreement_score":0.23419727,"about_ca_system_score_codex":0.00012143146,"about_ca_system_score_gemma":0.00041224872,"threshold_uncertainty_score":0.9873257},"labels":[],"label_agreement":null},{"id":"W4362536143","doi":"10.1158/1538-7445.am2023-2641","title":"Abstract 2641: ZW191, a novel FRa-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-drug conjugate; Camptothecin; Antibody; Cytotoxicity; Humanized antibody; DU145; Cancer research; Conjugate; Chemistry; Cell culture; Monoclonal antibody; Molecular biology; Cancer cell; Cancer; Biology; Medicine; Immunology; In vitro; Biochemistry; Internal medicine","score_opus":0.127248917654099,"score_gpt":0.4785073000761052,"score_spread":0.35125838242200624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362536143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027265,0.0022144879,0.000019623461,0.009908688,0.00068181154,0.0016096256,0.00014915258,0.0004241203,0.004719826],"genre_scores_gemma":[0.9865945,0.0023110048,0.00019895013,0.0003266968,0.0022371265,0.00072309974,0.00014451171,0.00018399731,0.007280138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925068,0.00020006082,0.0007096783,0.001148126,0.0030435899,0.0023917172],"domain_scores_gemma":[0.996163,0.0007735614,0.0000990356,0.0009546248,0.0010646511,0.00094509503],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005066281,0.00036721068,0.0006454591,0.001113773,0.00065662747,0.00026105,0.00063192693,0.00023619899,0.0022905502],"category_scores_gemma":[0.0015977637,0.00033732128,0.00021400557,0.0031614222,0.0005703211,0.00027324434,0.0006920463,0.0027716309,0.0022029863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050139555,0.00020655394,0.016476013,0.001245715,0.00013000458,0.00080289965,0.0015415476,0.000060599406,0.9005085,0.00009843261,0.06800931,0.010419023],"study_design_scores_gemma":[0.0095647555,0.0006991018,0.09624818,0.0048094057,0.0000753389,0.00006657152,0.0054980717,0.0022933001,0.5465047,0.0003813497,0.33243492,0.0014243571],"about_ca_topic_score_codex":0.0060538948,"about_ca_topic_score_gemma":0.00025259133,"teacher_disagreement_score":0.35400385,"about_ca_system_score_codex":0.0010763031,"about_ca_system_score_gemma":0.0019902117,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W4362536429","doi":"10.1158/1538-7445.am2023-1385","title":"Abstract 1385: Oncogenic regulation of autophagy and DNA emission","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Autophagy; ATG5; Cell biology; Biology; HRAS; Chromatin; Cytoplasm; Cancer cell; DNA damage; DNA repair; Molecular biology; Chemistry; DNA; Cancer; Apoptosis; Gene; Mutation; Biochemistry; Genetics; KRAS","score_opus":0.07389328939884493,"score_gpt":0.41574441285485747,"score_spread":0.34185112345601254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362536429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650955,0.0021467123,0.000017952034,0.00028404093,0.000048527312,0.000115658004,0.000017569457,0.000008548888,0.00085144676],"genre_scores_gemma":[0.993075,0.0027462982,0.000018949033,0.0000110185865,0.00013384483,0.00005967803,0.000046575824,0.0000112876105,0.0038973112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992886,0.00003440925,0.00011171236,0.00020620551,0.00018887971,0.0001701912],"domain_scores_gemma":[0.99951607,0.0000150448295,0.000030843312,0.00022973258,0.00015001766,0.00005830552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039472542,0.00004850228,0.000062979925,0.00007826976,0.00007951548,0.000010432309,0.0000989164,0.000078145546,0.00009636156],"category_scores_gemma":[0.000049475875,0.000044376677,0.000026149266,0.00024474252,0.00010045816,0.0000032362698,0.000072681614,0.00007495542,0.000010632256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036476176,0.000009030955,0.00030655533,0.00003246218,0.000010599146,4.3465e-7,0.000034240795,0.000036302758,0.96577865,0.000075357624,0.0077897543,0.025890153],"study_design_scores_gemma":[0.00018936717,0.00005047594,0.10226908,0.00002321239,0.000002274172,7.315223e-7,0.000055651657,0.00007240701,0.8697221,0.00022056869,0.027341707,0.000052380154],"about_ca_topic_score_codex":0.000080637576,"about_ca_topic_score_gemma":0.000013851356,"teacher_disagreement_score":0.10196253,"about_ca_system_score_codex":0.000023012648,"about_ca_system_score_gemma":0.00015582534,"threshold_uncertainty_score":0.18096285},"labels":[],"label_agreement":null},{"id":"W4362539767","doi":"10.1158/1538-7445.am2023-3814","title":"Abstract 3814: In CLL the U1 snRNA driver mutation alters splicing in multiple genes and pathways","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Spliceosome; Biology; RNA splicing; Intron; Genetics; Small nuclear RNA; Exon; Gene; Mutation; Splicing factor; RNA; Non-coding RNA","score_opus":0.10234488015314688,"score_gpt":0.3832937394767256,"score_spread":0.2809488593235787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362539767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971516,0.0017407567,0.00001599103,0.0005874513,0.000047348927,0.00022418355,0.000013593846,0.0000050800063,0.00021396275],"genre_scores_gemma":[0.9951669,0.0041596135,0.000013455743,0.000047865582,0.00009828913,0.00023614694,0.000030024012,0.0000118674025,0.00023582045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991798,0.00006250283,0.000116721,0.00024188872,0.00014628745,0.00025283676],"domain_scores_gemma":[0.99964625,0.000044208362,0.00002030762,0.0001955053,0.000059170772,0.000034555014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056587294,0.00005890489,0.00005853918,0.00010991069,0.000099495104,0.00003148076,0.00013278077,0.000058682417,0.000017794851],"category_scores_gemma":[0.000053804415,0.000047041853,0.000017370496,0.00031887542,0.00010190248,0.000005702008,0.00007500757,0.00014951003,0.000011518791],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039729974,0.000013040054,0.020239463,0.000021736461,0.0000064518526,0.000008747009,0.00041249619,0.0017115877,0.9452666,0.000044529086,0.0009437544,0.031291846],"study_design_scores_gemma":[0.0009772218,0.000060604176,0.7178136,0.00006713327,0.0000022949996,0.000002464158,0.0018273193,0.0022106434,0.26235613,0.00027399044,0.014235909,0.00017268547],"about_ca_topic_score_codex":0.0015193624,"about_ca_topic_score_gemma":0.0029286386,"teacher_disagreement_score":0.69757414,"about_ca_system_score_codex":0.000052338288,"about_ca_system_score_gemma":0.000105668885,"threshold_uncertainty_score":0.22968318},"labels":[],"label_agreement":null},{"id":"W4362539804","doi":"10.1158/1538-7445.am2023-3651","title":"Abstract 3651: The role of caspase-1 in basal-like breast cancer and the tumor microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tumor microenvironment; Cancer research; Breast cancer; Gene knockdown; Medicine; Cancer; Caspase 3; Estrogen receptor; Immune system; Apoptosis; Biology; Immunology; Internal medicine; Programmed cell death","score_opus":0.034471047079649444,"score_gpt":0.3531149410124961,"score_spread":0.31864389393284664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362539804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96343523,0.014987649,7.93916e-8,0.020090135,0.00009137613,0.00070042757,0.00012326491,0.000010723846,0.000561139],"genre_scores_gemma":[0.9846579,0.013129045,0.0000017151636,0.0005167255,0.00013193564,0.00044619187,0.0000047166645,0.000021856838,0.0010899148],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852395,0.00010793164,0.00022361841,0.00023055036,0.000513693,0.00040026865],"domain_scores_gemma":[0.9992156,0.0002647031,0.000049000406,0.00035114834,0.000056139972,0.000063420026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015600533,0.00010253112,0.000207671,0.00013291795,0.00012932035,0.000021688678,0.00019415248,0.00004004759,0.00083740376],"category_scores_gemma":[0.000020102989,0.00005423864,0.00006700949,0.0005886423,0.00091300695,0.000034808727,0.00010869355,0.00040351742,0.000021942864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020920452,0.00020475297,0.12287522,0.0004466827,0.0004592431,0.00013081498,0.0049670637,0.00006810247,0.6850738,0.00013486076,0.03061956,0.13409947],"study_design_scores_gemma":[0.00463969,0.000060521972,0.9257668,0.00036861532,0.000022847398,0.000024897163,0.0027809755,0.00012714599,0.019969262,0.00018435967,0.045957543,0.00009732938],"about_ca_topic_score_codex":0.02300023,"about_ca_topic_score_gemma":0.002583636,"teacher_disagreement_score":0.8028916,"about_ca_system_score_codex":0.0002600175,"about_ca_system_score_gemma":0.00027646325,"threshold_uncertainty_score":0.9835057},"labels":[],"label_agreement":null},{"id":"W4362539969","doi":"10.1158/1538-7445.am2023-4468","title":"Abstract 4468: Tumor-derived extracellular vesicles transmit retroelement and pericentromeric RNAs to drive proinflammatory and DNA damage responses in stromal fibroblasts and immune cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ontario Institute for Cancer Research","funders":"","keywords":"Proinflammatory cytokine; Immune system; Stromal cell; Cancer research; Biology; Cancer; Inflammation; Immunology; Prostate cancer; Microvesicles; microRNA; Gene","score_opus":0.022592696558698316,"score_gpt":0.32004097415825594,"score_spread":0.2974482775995576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362539969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982346,0.008787538,0.000016598795,0.0004066306,0.000038175098,0.0007967849,0.00007421627,0.000022607857,0.000034009183],"genre_scores_gemma":[0.9973163,0.0016583942,0.00024232226,0.000023002956,0.00008110891,0.00019335448,0.0000285214,0.000052935924,0.0004040792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760914,0.0002699433,0.00032866298,0.000724761,0.00037054185,0.00069693883],"domain_scores_gemma":[0.99902606,0.000084594874,0.00005826853,0.00038975308,0.000088875815,0.0003524768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095727324,0.00022657958,0.00023365198,0.00025286718,0.00017392261,0.00010648955,0.00022550859,0.00009952435,0.00013113397],"category_scores_gemma":[0.000119940705,0.00023820563,0.00004173977,0.000348216,0.00039631553,0.000019449903,0.0003538203,0.00029042226,0.000008700497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075714325,0.00004636451,0.0029899618,0.00024225196,0.000034197285,0.0002445642,0.0005239366,0.000032070635,0.9920418,0.000017239996,0.0002178204,0.0028525987],"study_design_scores_gemma":[0.0008719148,0.0003116194,0.265763,0.000107415086,0.000008301189,0.0000061586074,0.00084287446,0.000059520866,0.7301988,0.00004436434,0.0015684149,0.00021762453],"about_ca_topic_score_codex":0.00007128105,"about_ca_topic_score_gemma":0.00008580193,"teacher_disagreement_score":0.26277304,"about_ca_system_score_codex":0.00006506778,"about_ca_system_score_gemma":0.00020540398,"threshold_uncertainty_score":0.97137433},"labels":[],"label_agreement":null},{"id":"W4362540557","doi":"10.1158/1538-7445.am2023-5121","title":"Abstract 5121: TriTCE Co-stim, next generation costimulatory trispecific T cell engagers for the treatment of solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"CD28; Paratope; T cell; Cancer research; T-cell receptor; CD3; Chemistry; Cytokine; Immunology; Cell biology; Antigen; Biology; Immune system; CD8; Epitope","score_opus":0.3824438603027866,"score_gpt":0.497373707859677,"score_spread":0.1149298475568904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869534,0.0060273116,0.000021259519,0.002874571,0.00019709683,0.0020112027,0.0003742195,0.000038784114,0.0015021656],"genre_scores_gemma":[0.96605575,0.014137017,0.000043982523,0.0000520082,0.0011591784,0.0007539927,0.0001766357,0.00004092933,0.01758053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997557,0.00013293185,0.00034650677,0.0003514872,0.0009515284,0.0006605907],"domain_scores_gemma":[0.9969829,0.0019091265,0.000058991543,0.00037936328,0.00044653149,0.00022310755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012597152,0.00015954007,0.0003478863,0.00030910768,0.00049505115,0.0000381118,0.00021031994,0.000087999855,0.00081341533],"category_scores_gemma":[0.0001369108,0.000100805046,0.00021122885,0.0005970136,0.000346922,0.000058983154,0.00003096625,0.0003781463,0.00018734962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002763734,0.0004977526,0.001439125,0.00049640983,0.00019649307,0.000090681,0.0012814441,0.0009769646,0.7992691,0.00011390118,0.1315997,0.061274745],"study_design_scores_gemma":[0.004148828,0.0021057208,0.01536252,0.000116956515,0.00005274441,0.0000052195264,0.0011433997,0.01238039,0.60763323,0.00006202003,0.35679433,0.00019465275],"about_ca_topic_score_codex":0.00060131215,"about_ca_topic_score_gemma":0.00004607975,"teacher_disagreement_score":0.22519463,"about_ca_system_score_codex":0.0003494316,"about_ca_system_score_gemma":0.0006699243,"threshold_uncertainty_score":0.89063275},"labels":[],"label_agreement":null},{"id":"W4362540648","doi":"10.1158/1538-7445.am2023-4499","title":"Abstract 4499: The peptide-drug conjugate sudocetaxel zendusortide (TH1902) potentiates anti-tumoral activity of the anti-PD-L1 checkpoint inhibitor and induces immune cell infiltration in a B16-F10 syngeneic melanoma model","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Docetaxel; Cancer research; Granzyme B; Cytotoxic T cell; Immune system; Medicine; Melanoma; Immune checkpoint; Immunotherapy; Tumor-infiltrating lymphocytes; Cancer; T cell; Immunology; Pharmacology; Internal medicine; Chemistry; In vitro","score_opus":0.03862515120491353,"score_gpt":0.32111325621120557,"score_spread":0.28248810500629207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963677,0.0011251543,0.000008411085,0.0014553774,0.00012340683,0.00062037853,0.00006430653,0.000013374973,0.00022189286],"genre_scores_gemma":[0.9976336,0.0015208562,0.000014835629,0.00004004319,0.00012508912,0.00012493944,0.000037593203,0.000027220542,0.00047583785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981369,0.00024209428,0.00035881708,0.00040282198,0.0004319994,0.00042737],"domain_scores_gemma":[0.99906653,0.000041485688,0.00017353088,0.00046052787,0.0001860105,0.00007192938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012155698,0.00017601193,0.00021903179,0.00014311851,0.00023881202,0.00007853854,0.00037816944,0.0001382337,0.00001924589],"category_scores_gemma":[0.00016830092,0.000120055614,0.000100545556,0.0005282177,0.00035766698,0.000034623874,0.00037261494,0.000489038,0.0000070016554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007364831,0.000057708334,0.006162967,0.00008039529,0.000022335651,0.0000029721764,0.00014425738,0.00051065505,0.99152285,0.000014328019,0.0007551336,0.0006527647],"study_design_scores_gemma":[0.00042686507,0.000044789907,0.14395535,0.00006957128,0.000006192911,0.0000019680294,0.00020312733,0.00078702834,0.85414684,0.00008181189,0.00015456503,0.000121869976],"about_ca_topic_score_codex":0.0012206751,"about_ca_topic_score_gemma":0.00048564942,"teacher_disagreement_score":0.1377924,"about_ca_system_score_codex":0.000043378073,"about_ca_system_score_gemma":0.00040084653,"threshold_uncertainty_score":0.48957258},"labels":[],"label_agreement":null},{"id":"W4362540678","doi":"10.1158/1538-7445.am2023-3315","title":"Abstract 3315: Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Prostate cancer; Germline; Medicine; Cancer; Oncology; Biomarker; Internal medicine; Gene; Genetics; Biology","score_opus":0.3323757829996484,"score_gpt":0.571522447385508,"score_spread":0.23914666438585958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282384,0.001492412,0.000002809535,0.0017579233,0.00046029597,0.0028318916,0.0004615047,0.000066801054,0.000102508355],"genre_scores_gemma":[0.9918994,0.0030536398,0.00007826487,0.00002279551,0.00028494914,0.0012669388,0.00016244575,0.00007252158,0.003159073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603045,0.00020112825,0.0008927877,0.0006297214,0.0011412699,0.0011046497],"domain_scores_gemma":[0.9972244,0.0012432048,0.0001578856,0.0003709976,0.000732162,0.00027134657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046019815,0.00021539233,0.0006627045,0.0007490818,0.00018812905,0.000036244885,0.00024394374,0.00015453857,0.00038455674],"category_scores_gemma":[0.0011330472,0.000158728,0.0002745819,0.0010585027,0.0003706395,0.00011475069,0.00020967217,0.00070128456,0.000017931996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024642702,0.00020745813,0.8722662,0.00069633865,0.000350532,0.00006151062,0.0005911184,0.00018415756,0.09271542,0.0000034115124,0.0012001924,0.029259408],"study_design_scores_gemma":[0.0062413365,0.00052228884,0.9815449,0.00047181107,0.00005573661,0.0000010837874,0.0008808801,0.0029241787,0.0068108337,0.000096411786,0.00030481792,0.0001457381],"about_ca_topic_score_codex":0.0025920835,"about_ca_topic_score_gemma":0.00043414492,"teacher_disagreement_score":0.1092787,"about_ca_system_score_codex":0.0005971127,"about_ca_system_score_gemma":0.0018200474,"threshold_uncertainty_score":0.64727396},"labels":[],"label_agreement":null},{"id":"W4362540776","doi":"10.1158/1538-7445.am2023-3188","title":"Abstract 3188: Patient-derived TAC01-HER2 TAC T cells produced in Cocoon® Platform is highly functional in models of solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"In vivo; CD8; In vitro; Population; Cancer research; T cell; Cytotoxic T cell; Medicine; Chimeric antigen receptor; Antigen; Molecular biology; Chemistry; Immunology; Biology; Immune system; Biochemistry","score_opus":0.14977035715370438,"score_gpt":0.40363075826807926,"score_spread":0.2538604011143749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406385,0.00034386187,0.000002567152,0.0013402833,0.00018699415,0.0018915038,0.00010699931,0.000051103936,0.0020128053],"genre_scores_gemma":[0.99418855,0.00086490804,0.000016680866,0.00010030556,0.00019661851,0.00071088044,0.00006053439,0.00007737623,0.0037841531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99523246,0.00011216258,0.00068305054,0.0006971291,0.0020981806,0.0011770256],"domain_scores_gemma":[0.99790674,0.00032713875,0.000088537134,0.0006392484,0.00075907167,0.00027923394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017925507,0.00022098637,0.00056013686,0.0014888264,0.00008350828,0.00002757006,0.0003039914,0.00018197937,0.004092473],"category_scores_gemma":[0.00016404968,0.00020649238,0.00010509154,0.0032221586,0.00030943003,0.00023480583,0.00023523852,0.0013284407,0.00020630231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024008309,0.00030158623,0.0027045722,0.0004964996,0.000054937667,0.00020196658,0.0026135389,0.0021496331,0.9679134,0.000036509722,0.012103695,0.009022841],"study_design_scores_gemma":[0.0031923598,0.0005170201,0.024715343,0.0006197667,0.000004966886,0.0000047011677,0.0012800046,0.002931706,0.9637224,0.0007445357,0.002048353,0.00021885039],"about_ca_topic_score_codex":0.004702134,"about_ca_topic_score_gemma":0.00072167534,"teacher_disagreement_score":0.022010772,"about_ca_system_score_codex":0.0009808774,"about_ca_system_score_gemma":0.0017301746,"threshold_uncertainty_score":0.99681795},"labels":[],"label_agreement":null},{"id":"W4362540794","doi":"10.1158/1538-7445.am2023-3951","title":"Abstract 3951: Unprecedented forward genetic screens reveal mechanisms of action, drug resistances, and hidden efficacies at amino acid resolution: combination of 5-ALA and Artesunate as a treatment option for glioblastoma multiforme","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Artemisinin; Artesunate; Computational biology; Drug discovery; Biology; Genetic screen; Cancer; Amino acid; Gene; Mechanism of action; Drug; Genetics; Bioinformatics; Pharmacology; Phenotype; In vitro; Plasmodium falciparum","score_opus":0.04366231795575349,"score_gpt":0.33136848738400815,"score_spread":0.28770616942825467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959186,0.0014805603,0.0009332101,0.00013256699,0.00014788435,0.0009926214,0.00023717596,0.00009654956,0.00006085373],"genre_scores_gemma":[0.9941503,0.0039203884,0.0006650569,0.000002099337,0.00003709517,0.00033318473,0.00004812253,0.00004472819,0.0007990392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855167,0.000028994094,0.0003480656,0.0002570056,0.0004336639,0.0003806266],"domain_scores_gemma":[0.99908376,0.00020257811,0.00008966115,0.00022021346,0.00030039085,0.00010339338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039342593,0.00016763953,0.00027045413,0.00035812377,0.00018250027,0.00002806993,0.000109416076,0.00010293506,0.0000147567025],"category_scores_gemma":[0.000058602778,0.00016150638,0.000055782843,0.00047176378,0.00016308548,0.00015397625,0.00005214792,0.000114225004,0.000004857345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012171814,0.000043586133,0.00026216666,0.0010334463,0.00017644011,0.0000037624095,0.00096005935,0.0015989647,0.97802347,0.00055419444,0.00077442965,0.015352318],"study_design_scores_gemma":[0.0031682816,0.0007913916,0.01849337,0.00036663128,0.0000525028,0.000005783997,0.00066546333,0.010853305,0.9599226,0.0043559074,0.0011140232,0.00021073419],"about_ca_topic_score_codex":0.00022074382,"about_ca_topic_score_gemma":0.0012562579,"teacher_disagreement_score":0.018231204,"about_ca_system_score_codex":0.00063524215,"about_ca_system_score_gemma":0.00006686661,"threshold_uncertainty_score":0.6586039},"labels":[],"label_agreement":null},{"id":"W4362540881","doi":"10.1158/1538-7445.am2023-5309","title":"Abstract 5309: Isolation and validation of small extracellular vesicles from rhabdomyosarcoma cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Nanoparticle tracking analysis; Extracellular vesicles; Chemistry; Cell culture; Molecular biology; Materials science; Nanotechnology; Microvesicles; Biology; Cell biology; Biochemistry","score_opus":0.05412856365475499,"score_gpt":0.34746064126781945,"score_spread":0.29333207761306446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939398,0.004962268,0.00033193512,0.00014674505,0.0000882224,0.00025565716,0.0001054362,0.000020382144,0.00014956013],"genre_scores_gemma":[0.9973605,0.0011474953,0.00041417556,0.000010148437,0.00022363331,0.000049347895,0.00024054003,0.000032388925,0.00052176515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998649,0.00013560452,0.00022928219,0.0003906778,0.00029493653,0.00030048593],"domain_scores_gemma":[0.9991632,0.00007314871,0.00007250902,0.0003937238,0.00017621112,0.00012118457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066978566,0.00010876063,0.000116302755,0.000117811665,0.00009759505,0.000037544123,0.00022274746,0.00013588215,0.00009131434],"category_scores_gemma":[0.00011418752,0.00011554475,0.00005208964,0.000257353,0.00019787463,0.000008625249,0.00018085718,0.00015400369,0.00003751848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008706569,0.000039591603,0.0033517992,0.00006739905,0.00003137856,0.000009215725,0.0001001038,0.0001820533,0.9891892,0.00003898549,0.0012157067,0.0056874817],"study_design_scores_gemma":[0.0003557398,0.000060546794,0.01944938,0.00003904935,0.000009881688,4.0615967e-7,0.00012840527,0.00027371882,0.9763785,0.00071232324,0.0024750982,0.000116976626],"about_ca_topic_score_codex":0.00024122978,"about_ca_topic_score_gemma":0.000031298478,"teacher_disagreement_score":0.016097581,"about_ca_system_score_codex":0.000023396304,"about_ca_system_score_gemma":0.00012472305,"threshold_uncertainty_score":0.47117782},"labels":[],"label_agreement":null},{"id":"W4362540957","doi":"10.1158/1538-7445.am2023-1830","title":"Abstract 1830: E7386, a selective inhibitor of the interaction between β-catenin and CREB-binding protein (CBP), in combination with lenvatinib (LEN), exerts antitumor activity in preclinical tumor models with prior immune checkpoint inhibitor (ICI)-based combination treatment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Medicine; Combination therapy; Pharmacology; Atezolizumab; Lenvatinib; Cancer; Cancer research; Nivolumab; Hepatocellular carcinoma; Internal medicine; Immunotherapy; Sorafenib","score_opus":0.11003940237014151,"score_gpt":0.3999675666540996,"score_spread":0.28992816428395807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516857,0.000022749538,0.000033721666,0.0021272774,0.000015915944,0.0024519607,0.000036493657,0.000041784,0.00010153208],"genre_scores_gemma":[0.9986344,0.000018828963,0.00006323327,0.000009844008,0.0000497635,0.0008936794,0.00007031713,0.000036347963,0.00022356526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973125,0.00037151552,0.00056167314,0.00053338206,0.0008012459,0.0004197076],"domain_scores_gemma":[0.99857354,0.00033303513,0.00030195637,0.00026032855,0.0004190581,0.00011210029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014185407,0.00022737587,0.00055681646,0.0008975854,0.00016434849,0.00004617585,0.00009431556,0.000108212036,0.000020692582],"category_scores_gemma":[0.0002110383,0.00015371686,0.00008830255,0.0021038183,0.00033689867,0.00036879032,0.00006231793,0.0007681722,0.0000036014922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007458621,0.0031602827,0.12788214,0.00097155717,0.0002084387,0.000091786,0.0026732483,0.0010629953,0.8491167,0.00006530099,0.00003682389,0.0072721317],"study_design_scores_gemma":[0.008724959,0.0014391994,0.25453195,0.004887385,0.000035924175,0.0000029179491,0.0007137426,0.005979717,0.723439,0.00008126109,0.0000045547276,0.00015941724],"about_ca_topic_score_codex":0.0026799466,"about_ca_topic_score_gemma":0.001735798,"teacher_disagreement_score":0.12664981,"about_ca_system_score_codex":0.0011459297,"about_ca_system_score_gemma":0.00082534313,"threshold_uncertainty_score":0.62683916},"labels":[],"label_agreement":null},{"id":"W4362540965","doi":"10.1158/1538-7445.am2023-1154","title":"Abstract 1154: Investigating the functional role of GPNMB in glioblastoma and the tumor immune microenvironment and its targeted elimination using CAR-Ts","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Cancer research; Flow cytometry; Tumor microenvironment; Tissue microarray; Immunotherapy; Glioma; Immune system; Immunohistochemistry; Biology; Medicine; Immunology; Tumor cells","score_opus":0.06544406792514754,"score_gpt":0.3587911702735495,"score_spread":0.293347102348402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362540965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900011,0.006094536,4.3606826e-7,0.0028937832,0.000033545588,0.00085190363,0.000011195652,0.000010299422,0.00010322156],"genre_scores_gemma":[0.99793655,0.0012387638,0.000009468804,0.000043808832,0.00010803453,0.00014677293,0.0000057265925,0.000024095449,0.0004868016],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980226,0.00025463567,0.00025898154,0.00024798675,0.00083193183,0.0003838234],"domain_scores_gemma":[0.99890506,0.0005926833,0.00005951436,0.0002109507,0.00014445162,0.00008731589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022942966,0.00009851457,0.0001989272,0.00027303948,0.00022459237,0.000034810026,0.00011420895,0.000046583376,0.00039248136],"category_scores_gemma":[0.00036359206,0.00006310044,0.000035924044,0.0007298338,0.0006667116,0.000068564084,0.000211549,0.00060257706,0.000007613006],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007586875,0.0000209707,0.006333578,0.000119205644,0.000037715294,0.000010811584,0.0015128586,0.00021636402,0.9855238,0.00008380522,0.00006745559,0.0053147497],"study_design_scores_gemma":[0.0028222683,0.00014216009,0.57653403,0.0002887221,0.000015120155,0.000026905536,0.0033072953,0.012076266,0.40386233,0.00032344615,0.000520736,0.00008072461],"about_ca_topic_score_codex":0.0013185034,"about_ca_topic_score_gemma":0.00016157248,"teacher_disagreement_score":0.58166146,"about_ca_system_score_codex":0.0002500057,"about_ca_system_score_gemma":0.0002295131,"threshold_uncertainty_score":0.42973956},"labels":[],"label_agreement":null},{"id":"W4362541058","doi":"10.1158/1538-7445.am2023-50","title":"Abstract 50: Tumorigenic properties of uveal melanoma cancer cells cultured in 3D or on a reconstructed extracellular matrix","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Extracellular matrix; Stromal cell; Fibronectin; Pathology; Matrigel; Metastasis; Cancer research; Hepatic stellate cell; Melanoma; Tumor microenvironment; Cell biology; Biology; Chemistry; Angiogenesis; Cancer; Medicine; Tumor cells","score_opus":0.1219714962515977,"score_gpt":0.4251870484909572,"score_spread":0.3032155522393595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231315,0.005290449,1.8468063e-7,0.0006723498,0.00024909226,0.00091056817,0.000052633088,0.000043473567,0.00046811218],"genre_scores_gemma":[0.98330396,0.0018542224,0.00006442236,0.000015285854,0.00012959914,0.00045134724,0.000017594615,0.0000297056,0.014133872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981436,0.00014022809,0.00031587578,0.00035994546,0.0005017654,0.000538571],"domain_scores_gemma":[0.9992291,0.00008461474,0.000064946544,0.00029426266,0.00019529856,0.00013182162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005047707,0.00015018471,0.00038094725,0.0003918924,0.000091557755,0.00001119873,0.00014688894,0.00018134336,0.0014001473],"category_scores_gemma":[0.00008459774,0.00009939525,0.00007142194,0.00085842214,0.00025035435,0.000053319472,0.000050085884,0.0005500231,0.00023706864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054706354,0.00044593262,0.058555797,0.0007954786,0.0003478567,0.0017615241,0.0013037875,0.00006459384,0.91692984,0.00004209514,0.002631698,0.011650736],"study_design_scores_gemma":[0.006169384,0.0011832234,0.114318065,0.0017000175,0.00008206119,0.000031595995,0.00096984504,0.000097225085,0.86903954,0.000060728245,0.006108776,0.00023956539],"about_ca_topic_score_codex":0.0020825714,"about_ca_topic_score_gemma":0.0012905786,"teacher_disagreement_score":0.05576227,"about_ca_system_score_codex":0.0004961059,"about_ca_system_score_gemma":0.0011068158,"threshold_uncertainty_score":0.99951273},"labels":[],"label_agreement":null},{"id":"W4362541075","doi":"10.1158/1538-7445.am2023-2982","title":"Abstract 2982: TriTCE CPI, next generation trispecific T cell engagers with integrated checkpoint inhibition (CPI) for the treatment of solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cancer research; Immune checkpoint; Antibody; Tumor microenvironment; T cell; Cancer immunotherapy; Antigen; Immunotherapy; Cancer; CD3; Immune system; Medicine; Chemistry; CD8; Immunology; Tumor cells; Internal medicine","score_opus":0.2713833320261897,"score_gpt":0.43792675585395063,"score_spread":0.16654342382776094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901191,0.002549352,0.000050632825,0.0043197297,0.000097288415,0.0019509165,0.00023758745,0.000039583625,0.0006358037],"genre_scores_gemma":[0.98045903,0.00845726,0.00008294905,0.000034633915,0.0006930706,0.0010579585,0.00028499373,0.000040488332,0.00888963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763525,0.00013686767,0.00035821853,0.00037178566,0.00089907955,0.0005987863],"domain_scores_gemma":[0.9979801,0.0007373738,0.00007079328,0.0003159063,0.00071150076,0.00018432394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011655461,0.00017941532,0.00033928914,0.0003455324,0.00040334565,0.000052015912,0.0001290513,0.000083836254,0.00046280673],"category_scores_gemma":[0.000098170116,0.00009838909,0.00015711221,0.0010344868,0.00033801404,0.00008453246,0.00002793486,0.00044134707,0.0000699241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049490226,0.00050118665,0.0006107709,0.00038842548,0.00014768618,0.00010232054,0.0018035112,0.0002857335,0.92608404,0.00009363499,0.019222816,0.045810837],"study_design_scores_gemma":[0.0036138508,0.0029272686,0.0072329533,0.00024374109,0.000041905463,0.000009630293,0.002610268,0.0046125236,0.9220827,0.0000555169,0.05641368,0.0001559307],"about_ca_topic_score_codex":0.0016452009,"about_ca_topic_score_gemma":0.00033083366,"teacher_disagreement_score":0.045654908,"about_ca_system_score_codex":0.00041227273,"about_ca_system_score_gemma":0.0006406991,"threshold_uncertainty_score":0.5067409},"labels":[],"label_agreement":null},{"id":"W4362541076","doi":"10.1158/1538-7445.am2023-5705","title":"Abstract 5705: Digital pathology based prognostic &amp; predictive biomarkers in metastatic non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Oncology; Immunotherapy; Lung cancer; Carboplatin; Internal medicine; Paclitaxel; Docetaxel; Immune system; Cancer; Cancer research; Nivolumab; Chemotherapy; Immunology; Cisplatin","score_opus":0.0501117867464615,"score_gpt":0.40735712356758724,"score_spread":0.35724533682112575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027133,0.001465166,0.00047774104,0.00383981,0.00027248092,0.0011751057,0.000089974186,0.00009884944,0.0023095522],"genre_scores_gemma":[0.9968033,0.00051124213,0.00028141605,0.00023174367,0.00018842466,0.00085913035,0.00013165244,0.00006685285,0.0009262638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973463,0.00014188199,0.00033722335,0.0005564893,0.00068836287,0.00092976243],"domain_scores_gemma":[0.99820334,0.00084546866,0.000065191794,0.000320052,0.00022190691,0.00034401973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016114437,0.00018683575,0.00036823802,0.0007702678,0.00011513487,0.000077003926,0.0002404191,0.00009350802,0.0005381931],"category_scores_gemma":[0.001220786,0.00016035659,0.0000896179,0.0014140116,0.00033588498,0.0000946319,0.00011979966,0.0012553192,0.00009970717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087016134,0.00045837602,0.8721078,0.0027571379,0.0003458163,0.0032103432,0.00194042,0.004796716,0.03752745,0.0000098103155,0.034745682,0.041230306],"study_design_scores_gemma":[0.008748776,0.00047141014,0.78024966,0.0034658627,0.00020786059,0.00003870843,0.0009907179,0.19158322,0.0023214205,0.0002558394,0.011044973,0.0006215541],"about_ca_topic_score_codex":0.0010752835,"about_ca_topic_score_gemma":0.00018961399,"teacher_disagreement_score":0.1867865,"about_ca_system_score_codex":0.00042465894,"about_ca_system_score_gemma":0.0012425735,"threshold_uncertainty_score":0.6539152},"labels":[],"label_agreement":null},{"id":"W4362541128","doi":"10.1158/1538-7445.am2023-6522","title":"Abstract 6522: Improved detection of low frequency mutations in ovarian and endometrial cancers by utilizing a highly accurate sequencing platform","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Endometrial cancer; Germline mutation; Germline; Medicine; Oncology; Internal medicine; Cancer; Biology; Gene; Mutation; Genetics","score_opus":0.06048615072481249,"score_gpt":0.36071413070670727,"score_spread":0.30022797998189477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973008,0.0014855886,0.00007875625,0.00008306335,0.00021138712,0.00034119585,0.00024070915,0.000008328415,0.0002501498],"genre_scores_gemma":[0.99599355,0.0034540463,0.000040922238,0.000018804029,0.00017398813,0.00016539734,0.0000869567,0.00002223436,0.00004407004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877524,0.000032297456,0.00025887985,0.0003283916,0.00018195361,0.00042321585],"domain_scores_gemma":[0.99933356,0.00015046993,0.00007423707,0.00018971911,0.00015867937,0.000093322094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066858623,0.00010310713,0.00014282658,0.00029608357,0.00011928433,0.00004177105,0.00013540889,0.00012739011,0.00001435352],"category_scores_gemma":[0.0005338088,0.00011118729,0.000037729566,0.00073857064,0.00012900963,0.000012362671,0.00010414614,0.00021925567,0.0000021649048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013992334,0.000008058734,0.0005212844,0.000065858105,0.000024950528,0.0000046459645,0.00015160136,0.00030262826,0.9926114,0.000034960172,0.0001329191,0.006001766],"study_design_scores_gemma":[0.0014834533,0.00020490205,0.00468161,0.00006763229,0.0000063971793,0.0000017940988,0.00069114816,0.0005873146,0.9910103,0.00035261555,0.00075255625,0.00016028417],"about_ca_topic_score_codex":0.011688187,"about_ca_topic_score_gemma":0.007991424,"teacher_disagreement_score":0.0058414815,"about_ca_system_score_codex":0.00035975192,"about_ca_system_score_gemma":0.00077103643,"threshold_uncertainty_score":0.9948931},"labels":[],"label_agreement":null},{"id":"W4362541130","doi":"10.1158/1538-7445.am2023-3050","title":"Abstract 3050: Quality control samples for future population-based microbiome studies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Jaccard index; UniFrac; Microbiome; Intraclass correlation; Biology; Statistics; Population; Metagenomics; Diversity index; Principal component analysis; Alpha diversity; Mathematics; Genetics; Ecology; Medicine; Reproducibility; Species diversity; Cluster analysis; Bacteria; 16S ribosomal RNA","score_opus":0.19780972315516093,"score_gpt":0.5209525222921364,"score_spread":0.32314279913697547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937523,0.0043802555,0.000056226647,0.00439262,0.0003394449,0.0006126065,0.0007957837,0.000026233545,0.000021581633],"genre_scores_gemma":[0.9962221,0.000791529,0.00011493971,0.0003865853,0.0009539165,0.0002848441,0.0007322638,0.000024597104,0.0004892182],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986687,0.00011118365,0.00021458926,0.00036004218,0.00014881109,0.00049669336],"domain_scores_gemma":[0.9990158,0.00016119846,0.000050903483,0.00028035484,0.00040844092,0.00008331441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011965373,0.00010825491,0.00018424208,0.00010793513,0.00030664535,0.000027560392,0.00017747539,0.00013668441,0.00003804664],"category_scores_gemma":[0.0001937351,0.00009554441,0.00009114906,0.00023707711,0.000089481706,0.0000025549916,0.00004588048,0.00013613043,0.000022437529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022716801,0.000023069018,0.0073578795,0.00037783137,0.00008026809,7.5747926e-7,0.00006474451,0.000065615975,0.9492694,0.00011574895,0.041099288,0.0013182203],"study_design_scores_gemma":[0.0032474485,0.00030574301,0.6002137,0.00010796198,0.000020050633,9.260524e-7,0.0012859936,0.000014848597,0.1322336,0.0004959658,0.26165974,0.0004139948],"about_ca_topic_score_codex":0.00049286004,"about_ca_topic_score_gemma":0.00089249713,"teacher_disagreement_score":0.8170358,"about_ca_system_score_codex":0.00008714647,"about_ca_system_score_gemma":0.0003287758,"threshold_uncertainty_score":0.3896188},"labels":[],"label_agreement":null},{"id":"W4362541147","doi":"10.1158/1538-7445.am2023-5618","title":"Abstract 5618: Multi-institutional validation of a radiomics-based artificial intelligence method for predicting response to PD-1/PD-L1 immune checkpoint inhibitor (ICI) therapy in stage IV NSCLC","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radiomics; Medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Stage (stratigraphy); Immunohistochemistry; Radiology; Clinical trial; Phases of clinical research","score_opus":0.15828938373078166,"score_gpt":0.48826919582315303,"score_spread":0.32997981209237137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90788573,0.00020749301,0.08350483,0.006379145,0.00030087304,0.0015613512,0.000066013745,0.000064304055,0.000030273364],"genre_scores_gemma":[0.9812724,0.000106854175,0.017212398,0.00014160885,0.00037551756,0.0005394007,0.000072348295,0.000048680886,0.00023078802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969338,0.00037951555,0.0007602987,0.0004895002,0.0008338689,0.00060300436],"domain_scores_gemma":[0.99715126,0.0017050755,0.00012969693,0.00033799466,0.00044636714,0.00022963513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011901394,0.00017512917,0.00041473858,0.0010123171,0.00020554278,0.000046132343,0.00025251784,0.0001255999,0.000121041194],"category_scores_gemma":[0.005405624,0.00015351112,0.00015083484,0.0013660605,0.00027677676,0.00008933539,0.000076637756,0.00085214805,0.0000161007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010710762,0.00021559457,0.0014475831,0.00028173934,0.00004568796,0.000042518044,0.0017680619,0.032878194,0.8655197,0.00014120254,0.00009606233,0.08685289],"study_design_scores_gemma":[0.0023398919,0.0006371146,0.02119133,0.0009727934,0.000010921826,0.000003265012,0.0009825424,0.3064832,0.6652875,0.000187217,0.0017231173,0.00018111663],"about_ca_topic_score_codex":0.0014319639,"about_ca_topic_score_gemma":0.00004486834,"teacher_disagreement_score":0.27360502,"about_ca_system_score_codex":0.0005697235,"about_ca_system_score_gemma":0.0014022072,"threshold_uncertainty_score":0.6471427},"labels":[],"label_agreement":null},{"id":"W4362541165","doi":"10.1158/1538-7445.am2023-1647","title":"Abstract 1647: <i>In vivo</i> efficacy and metabolism of a new synthetized dual EGFR-DNA targeting combi-molecule in a human stem cells-derived model of glioblastoma implanted intracranially in mice","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Temozolomide; U87; In vivo; Cancer research; Context (archaeology); Apoptosis; Biology; Cell culture; Stem cell; Cytotoxicity; In vitro; Glioblastoma; Cell biology; Biochemistry; Genetics","score_opus":0.051016995386861996,"score_gpt":0.3570694828323065,"score_spread":0.3060524874454445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973834,0.0010341684,0.0000010206834,0.0004215107,0.00003061998,0.00093091524,0.00007383254,0.000020029931,0.000104513645],"genre_scores_gemma":[0.99902594,0.00066515955,0.000058118545,0.000016374355,0.000027594355,0.00012554061,0.0000072702555,0.0000360253,0.000037966183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997735,0.00014850884,0.00060707243,0.0004024915,0.000544393,0.0005624815],"domain_scores_gemma":[0.9990236,0.00034835876,0.000109992114,0.000217751,0.0001317688,0.00016852011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089872984,0.00017938299,0.0006755873,0.00089670566,0.00003919929,0.000016495547,0.00013624021,0.00011176975,0.000048426486],"category_scores_gemma":[0.00007420947,0.00016359265,0.000062981875,0.0011294665,0.00012850454,0.000056734843,0.00012662046,0.00038828858,0.0000037001585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013712748,0.00059754873,0.0012619955,0.00030094298,0.00005616435,0.00046578993,0.002234515,0.0006949003,0.9915522,0.00005010097,0.00043055942,0.000984031],"study_design_scores_gemma":[0.012284409,0.0002144791,0.020486873,0.0010296712,0.00002748842,0.000005846511,0.00069130294,0.0018923566,0.96315116,0.000063075524,0.000025886451,0.00012742609],"about_ca_topic_score_codex":0.0061403275,"about_ca_topic_score_gemma":0.002977885,"teacher_disagreement_score":0.028400991,"about_ca_system_score_codex":0.00015558662,"about_ca_system_score_gemma":0.00037471467,"threshold_uncertainty_score":0.9282379},"labels":[],"label_agreement":null},{"id":"W4362541177","doi":"10.1158/1538-7445.am2023-1512","title":"Abstract 1512: Evolution of large copy number variants in breast cancer through genetic network rewiring","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Gene; Genetics; Cancer; Copy-number variation; Breast cancer; Gene dosage; Comparative genomic hybridization; Triple-negative breast cancer; Computational biology; Cancer research; Chromosome; Gene expression; Genome","score_opus":0.0355937408127856,"score_gpt":0.38534838075433414,"score_spread":0.34975463994154854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353945,0.003774985,0.000109890025,0.0005312561,0.00037275784,0.00026775608,0.00038441425,0.000010927838,0.0010085846],"genre_scores_gemma":[0.9879239,0.010451343,0.000093193834,0.00007393996,0.0008890426,0.00018108884,0.000045457018,0.00003831825,0.0003037048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981997,0.000070247916,0.0002767815,0.0004145012,0.0003074476,0.0007313247],"domain_scores_gemma":[0.9991773,0.000059621027,0.00006676921,0.00037305077,0.00023988097,0.00008341532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006018359,0.00012659213,0.0001813552,0.000069881935,0.00010708712,0.000024399911,0.00026988442,0.00016098208,0.00034623203],"category_scores_gemma":[0.00006426122,0.00013537542,0.00006013446,0.0007346802,0.0001056531,0.0000069588064,0.00027385954,0.00023902331,0.000051392613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049744034,0.00013657863,0.5857669,0.00023888565,0.000112120695,0.00004258052,0.00025245413,0.021128861,0.28821248,0.0008747802,0.09970534,0.0030315565],"study_design_scores_gemma":[0.0013616071,0.000061020564,0.94830704,0.00029745724,0.000012297737,0.000007711634,0.000189399,0.0003158489,0.020812077,0.0014827467,0.026852455,0.0003003619],"about_ca_topic_score_codex":0.005463845,"about_ca_topic_score_gemma":0.0030829913,"teacher_disagreement_score":0.3625401,"about_ca_system_score_codex":0.00023893545,"about_ca_system_score_gemma":0.00064489164,"threshold_uncertainty_score":0.82597363},"labels":[],"label_agreement":null},{"id":"W4362541180","doi":"10.1158/1538-7445.am2023-2987","title":"Abstract 2987: BamQuery: a new proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Proteogenomics; Computational biology; Biology; Proteome; Proteomics; Exon; Genetics; RNA splicing; Intron; Genomics; RNA; Genome; Gene","score_opus":0.07694283564650214,"score_gpt":0.4014034146286646,"score_spread":0.3244605789821624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964265,0.0005680865,0.00003580639,0.0020120104,0.000047534177,0.00058939605,0.000018122546,0.000055636585,0.00024690162],"genre_scores_gemma":[0.9914652,0.0017279367,0.0005524309,0.00020044163,0.0004515406,0.00017444564,0.00002936698,0.000029754863,0.0053688614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864733,0.00005866425,0.00015454156,0.0004258496,0.00025919577,0.00045442255],"domain_scores_gemma":[0.99925494,0.000027624545,0.000033353546,0.00042246896,0.00014977495,0.000111849724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006304378,0.00012687013,0.00013110614,0.000113873466,0.00032569384,0.00009100637,0.00023977715,0.00007434381,0.000018846767],"category_scores_gemma":[0.00015330531,0.00009200361,0.00005997187,0.00046199898,0.00014336039,0.0000053460926,0.00027940303,0.0002269373,0.00004041699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009889781,0.000008882976,0.00021226329,0.00001622108,0.000037829737,0.000008032076,0.00007376282,0.000009968832,0.96799016,0.000009480967,0.02114732,0.010387209],"study_design_scores_gemma":[0.00018278116,0.0001369544,0.0072280387,0.00004656552,0.000006579632,0.000009518495,0.0004482308,0.000006662995,0.8342728,0.00021328761,0.15727808,0.00017053369],"about_ca_topic_score_codex":0.0003019429,"about_ca_topic_score_gemma":0.0000760677,"teacher_disagreement_score":0.13613075,"about_ca_system_score_codex":0.000056250865,"about_ca_system_score_gemma":0.0002490188,"threshold_uncertainty_score":0.37517983},"labels":[],"label_agreement":null},{"id":"W4362541216","doi":"10.1158/1538-7445.am2023-2993","title":"Abstract 2993: Unmutated tumor antigens are abundant and contribute to tumor control in melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Melanoma; Antigen; Cancer research; Immune checkpoint; Biology; Immunotherapy; Major histocompatibility complex; Tumor antigen; Immune system; Immunology","score_opus":0.03907128213056634,"score_gpt":0.3571037906141813,"score_spread":0.318032508483615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274726,0.012616976,0.0000052305286,0.0030128416,0.0003480245,0.00078688824,0.00029335706,0.000090289635,0.00009911345],"genre_scores_gemma":[0.99564344,0.00094484776,0.000002025156,0.00045928088,0.000033927154,0.00028479853,0.000035493227,0.000033953118,0.0025622365],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975015,0.0005316975,0.00035017333,0.0004339649,0.000111191825,0.0010714713],"domain_scores_gemma":[0.9986041,0.00073351833,0.00006822973,0.00032000622,0.00021516497,0.00005895148],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016662477,0.00019134904,0.0004340097,0.0006414889,0.000340645,0.00006244206,0.00031945563,0.00012043229,0.00071664783],"category_scores_gemma":[0.0004087772,0.00016807289,0.000057940062,0.0009177259,0.00035476979,0.00009773975,0.00012032391,0.00076276454,0.0012687279],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032995818,0.00006579889,0.012407356,0.000043304262,0.00015031423,0.00035295013,0.0006297929,0.0000188898,0.971134,0.00006408831,0.009049471,0.0027844456],"study_design_scores_gemma":[0.0058400696,0.00040416667,0.6272213,0.00034208485,0.000008995843,0.00006920925,0.0011630818,0.000011823957,0.22921099,0.000097755124,0.13530236,0.0003281892],"about_ca_topic_score_codex":0.00190925,"about_ca_topic_score_gemma":0.00046379483,"teacher_disagreement_score":0.74192303,"about_ca_system_score_codex":0.00015578873,"about_ca_system_score_gemma":0.00032225763,"threshold_uncertainty_score":0.9995089},"labels":[],"label_agreement":null},{"id":"W4362541217","doi":"10.1158/1538-7445.am2023-1400","title":"Abstract 1400: Novel expression biomarkers via prediction of response to FOLFIRINOX (FFX) treatment for PDAC","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Gene; Gene expression; False discovery rate; Transcriptome; Biology; Fold change; Gene expression profiling; Regression; Oncology; Computational biology; Medicine; Genetics; Internal medicine; Statistics; Mathematics","score_opus":0.11563292099657263,"score_gpt":0.4629144595931316,"score_spread":0.34728153859655897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841948,0.00015581548,0.0025161705,0.011239283,0.00028073517,0.001125278,0.00012815412,0.00008120884,0.0002785223],"genre_scores_gemma":[0.9950613,0.00020888557,0.0014167714,0.00008635737,0.00030933367,0.0006095035,0.000061905055,0.000044185905,0.002201753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982596,0.000072591305,0.00026263564,0.00034351344,0.0006041599,0.0004574729],"domain_scores_gemma":[0.998421,0.0006575416,0.000045709967,0.0003223755,0.00024280963,0.00031055676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002006637,0.000111234,0.0002371757,0.0005299919,0.00014509066,0.00001712589,0.00012446809,0.00008079631,0.00011688068],"category_scores_gemma":[0.001087261,0.000086824526,0.00010011251,0.00064332347,0.000114233524,0.00004450798,0.00006472858,0.00022708786,0.000027499022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004882798,0.00012475377,0.001891377,0.00015627,0.00007900546,0.00001583822,0.00043827202,0.00016392389,0.9307175,0.0000082391925,0.018921584,0.042600423],"study_design_scores_gemma":[0.010532948,0.003327011,0.2752056,0.001710204,0.00008077434,0.000019411747,0.0005802823,0.014104268,0.5260788,0.0002352086,0.16787827,0.0002472078],"about_ca_topic_score_codex":0.000393166,"about_ca_topic_score_gemma":0.0000066782886,"teacher_disagreement_score":0.4046387,"about_ca_system_score_codex":0.00040130227,"about_ca_system_score_gemma":0.00033917002,"threshold_uncertainty_score":0.35406014},"labels":[],"label_agreement":null},{"id":"W4362541229","doi":"10.1158/1538-7445.am2023-4052","title":"Abstract 4052: Direct selection of PD1+ CD39+ tumor infiltrating lymphocytes (TIL) from tumor dissociates enrich for functional tumor-reactive cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tumor-infiltrating lymphocytes; Cancer research; Cell sorting; Population; Adoptive cell transfer; Antigen; Cancer; Immunotherapy; Medicine; T cell; Immunology; Biology; Flow cytometry; CD8; Immune system; Internal medicine","score_opus":0.08352439900389312,"score_gpt":0.39616652613189246,"score_spread":0.3126421271279993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916349,0.000556908,0.0000127026115,0.00040383765,0.00040655033,0.001664888,0.0004843801,0.00017063109,0.0046652155],"genre_scores_gemma":[0.9876118,0.00020663437,0.000102063015,0.000078088946,0.0013186742,0.0012025253,0.00022430354,0.000121817655,0.0091341315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99545515,0.00023328938,0.0005600421,0.0007768487,0.0018205651,0.001154123],"domain_scores_gemma":[0.99415493,0.0034034736,0.0002006117,0.00038494388,0.0015351688,0.0003208806],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021907107,0.0002896555,0.0006463099,0.0006698549,0.00040189855,0.000095176954,0.00027987608,0.00010943691,0.0041107475],"category_scores_gemma":[0.0014303668,0.0002682078,0.00028190168,0.0020278625,0.00031963826,0.00020702083,0.00013254838,0.0008244578,0.00016090195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002704287,0.00020270952,0.021379063,0.0003017661,0.0003013868,0.00004530265,0.00046579464,0.00009884156,0.95601547,0.00002129242,0.012511881,0.0059521953],"study_design_scores_gemma":[0.0025169854,0.0005124292,0.10372667,0.00035356803,0.00004671916,0.000009872258,0.0012771835,0.0011136507,0.8808718,0.00029383227,0.009034428,0.00024290217],"about_ca_topic_score_codex":0.005738012,"about_ca_topic_score_gemma":0.00044482757,"teacher_disagreement_score":0.08234761,"about_ca_system_score_codex":0.0017378707,"about_ca_system_score_gemma":0.002035283,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W4362541240","doi":"10.1158/1538-7445.am2023-1358","title":"Abstract 1358: Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Melanoma; Acral lentiginous melanoma; Internal medicine; Oncology; Stage (stratigraphy); Nodular melanoma; Immune system; Immunohistochemistry; Tumor microenvironment; Chemotherapy; Pathogenesis; Gastroenterology; Cancer; Cancer research; Immunology; Biology","score_opus":0.03637493811701858,"score_gpt":0.33470062760359615,"score_spread":0.29832568948657756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531466,0.0010902202,0.0000053632757,0.0011498876,0.00007712682,0.0008566925,0.000009107144,0.000024330966,0.0014726291],"genre_scores_gemma":[0.99649155,0.0010046378,0.0000951563,0.000052772848,0.000054887456,0.00024207108,0.000012633342,0.000017812252,0.0020284916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988182,0.000048909496,0.00024651253,0.00022463906,0.00036276618,0.00029894616],"domain_scores_gemma":[0.9995461,0.000085903586,0.00003472784,0.0002094611,0.0000368958,0.00008692631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003643922,0.000077349454,0.00017473876,0.00033194633,0.00006315369,0.00001389175,0.000069632944,0.000032300515,0.0003021953],"category_scores_gemma":[0.000059253303,0.00007237715,0.0000312397,0.00040255772,0.0001374686,0.000023564944,0.000120435434,0.00023194017,0.00006458082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039848525,0.00030400578,0.096709184,0.001152451,0.00010707365,0.00091466244,0.0008636553,0.00031342427,0.8637401,0.00007190203,0.0026740697,0.032750983],"study_design_scores_gemma":[0.00073770777,0.00022356902,0.98592514,0.0001666749,0.000015630998,0.00004352877,0.0002963481,0.00013508675,0.0098241335,0.00005082874,0.0025176737,0.000063651416],"about_ca_topic_score_codex":0.00037429642,"about_ca_topic_score_gemma":0.000076145916,"teacher_disagreement_score":0.889216,"about_ca_system_score_codex":0.00022871059,"about_ca_system_score_gemma":0.00012288909,"threshold_uncertainty_score":0.33088264},"labels":[],"label_agreement":null},{"id":"W4362541254","doi":"10.1158/1538-7445.am2023-6495","title":"Abstract 6495: The relationship between inflammatory diet score and cancer-specific outcomes: Systematic review and meta-analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Prostate cancer; Meta-analysis; Internal medicine; Colorectal cancer; Ovarian cancer; PsycINFO; Breast cancer; Oncology; Cause of death; MEDLINE; Prospective cohort study; Disease; Biology","score_opus":0.4881396880940774,"score_gpt":0.49137919953858916,"score_spread":0.003239511444511789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541254","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30449322,0.6409918,8.93274e-7,0.051640335,0.000024286144,0.0022881443,0.00026405073,0.000045821762,0.00025141216],"genre_scores_gemma":[0.89706147,0.09855202,0.0000057980546,0.0004412502,0.00010118687,0.00194241,0.00003491831,0.00001906428,0.0018418906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809843,0.00018475333,0.0004076784,0.000302024,0.000704567,0.000302515],"domain_scores_gemma":[0.99691385,0.002194338,0.00008544546,0.00038483553,0.00027633188,0.0001451842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021906886,0.00013756029,0.0011802161,0.00020937453,0.00044072868,0.00004900902,0.00011963734,0.00005190101,0.00027989433],"category_scores_gemma":[0.00056913536,0.00007354259,0.0002808351,0.0012795215,0.00024219004,0.000055654742,0.00013152762,0.00040108172,0.000041475007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045361205,0.000021645345,0.74337655,0.17361271,0.047306597,0.000032329866,0.00023762195,0.0000039341585,0.000010426421,0.0012383132,0.034082934,0.000031546002],"study_design_scores_gemma":[0.0002318128,0.00003550863,0.9253997,0.001922075,0.06990883,0.000001049795,0.00027944744,0.000001013026,0.000002428174,0.00044177516,0.0016853113,0.000091007016],"about_ca_topic_score_codex":0.00034178188,"about_ca_topic_score_gemma":0.00020594275,"teacher_disagreement_score":0.5925682,"about_ca_system_score_codex":0.00010897368,"about_ca_system_score_gemma":0.000071616414,"threshold_uncertainty_score":0.3389773},"labels":[],"label_agreement":null},{"id":"W4362541272","doi":"10.1158/1538-7445.am2023-2049","title":"Abstract 2049: Clinically and biologically distinct molecular subtypes of lung squamous cell carcinoma (LUSC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncology; Internal medicine; Lung cancer; Medicine; Stage (stratigraphy); Hazard ratio; Proportional hazards model; Univariate analysis; Disease; Cancer; Multivariate analysis; Biology; Confidence interval","score_opus":0.08829657409586263,"score_gpt":0.4146140991709871,"score_spread":0.3263175250751245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892307,0.0036399004,0.000005709461,0.0015173248,0.00007901693,0.00047352933,0.00004242332,0.0000505276,0.0049608513],"genre_scores_gemma":[0.9981222,0.0009033676,0.00004540038,0.000104349696,0.00014210748,0.00016291243,0.00002298431,0.000029690396,0.00046700053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794817,0.00011102986,0.00039883784,0.00046582625,0.0005720974,0.0005040201],"domain_scores_gemma":[0.99856806,0.00036305588,0.00007369378,0.00036008438,0.0003821153,0.0002529969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012164667,0.00013893981,0.00036936166,0.00018414765,0.00009543968,0.000024399616,0.00019508656,0.0001534862,0.00047895274],"category_scores_gemma":[0.00038041087,0.000105317835,0.000112348825,0.00065395125,0.00039744974,0.000032506498,0.0002021917,0.00048223828,0.00004088183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009202082,0.0002258179,0.6737067,0.0011878457,0.000042129162,0.00020993502,0.0001744275,0.000008013008,0.30258673,0.00015177114,0.007818746,0.012967655],"study_design_scores_gemma":[0.001392696,0.0010419483,0.918122,0.000121203906,0.00004644776,0.0000034651625,0.00014927043,0.00015957034,0.07741979,0.00014241216,0.0012438145,0.00015739049],"about_ca_topic_score_codex":0.0005218722,"about_ca_topic_score_gemma":0.000024318391,"teacher_disagreement_score":0.24441527,"about_ca_system_score_codex":0.00008706487,"about_ca_system_score_gemma":0.00035304742,"threshold_uncertainty_score":0.52441967},"labels":[],"label_agreement":null},{"id":"W4362541389","doi":"10.1158/1538-7445.am2023-3539","title":"Abstract 3539: Indoleamine-2,3-dioxygenase 2 (IDO-2) is expressed in hepatoblastoma cells and associated with metastatic state","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Indoleamine 2,3-dioxygenase; Hepatoblastoma; Medicine; Kynurenine; Carcinogenesis; Malignancy; Cancer research; Immune system; Internal medicine; Cancer; Immunology; Biology; Tryptophan","score_opus":0.09905565641191566,"score_gpt":0.36813709566273617,"score_spread":0.2690814392508205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809283,0.00010809148,0.0000021439896,0.0004740832,0.00004559707,0.00049351907,0.000274992,0.000100619174,0.00040809775],"genre_scores_gemma":[0.9972943,0.00066933595,0.000006983581,0.00028551044,0.000015701038,0.00018855161,0.0000050238045,0.000044450964,0.0014901463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971653,0.00030001183,0.00022010549,0.00062442187,0.00084057025,0.0008495716],"domain_scores_gemma":[0.9984428,0.0009448146,0.000059675098,0.00027735985,0.000081286715,0.0001940609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007565664,0.00017427442,0.00023203933,0.0005194062,0.00016625343,0.00013398004,0.0003148908,0.000049213544,0.00019696602],"category_scores_gemma":[0.000516224,0.00014695819,0.000030117886,0.0021585848,0.00034746903,0.0002096237,0.00014570127,0.00051531533,0.00014322992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022947557,0.00011603076,0.00064642285,0.0000972843,0.00001528742,0.00044127344,0.0016559165,0.00017228838,0.9874168,0.000013785872,0.0059253476,0.0032700924],"study_design_scores_gemma":[0.0018387799,0.00013150567,0.035691544,0.00015972933,0.0000013741262,0.0000012682672,0.00049377646,0.00057728786,0.95941556,0.00040872843,0.0010678894,0.00021256012],"about_ca_topic_score_codex":0.0004644754,"about_ca_topic_score_gemma":0.0010318162,"teacher_disagreement_score":0.03504512,"about_ca_system_score_codex":0.00012000563,"about_ca_system_score_gemma":0.00024198028,"threshold_uncertainty_score":0.59927815},"labels":[],"label_agreement":null},{"id":"W4362541435","doi":"10.1158/1538-7445.am2023-6499","title":"Abstract 6499: Towards a combined immunohistochemistry-based subtyping of ovarian endometrioid carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Immunohistochemistry; Medicine; Tissue microarray; Hazard ratio; Oncology; Population; Stage (stratigraphy); PTEN; Pathology; Subtyping; Internal medicine; Ovarian carcinoma; Carcinoma; Cancer; Ovarian cancer; Biology; Confidence interval","score_opus":0.10543866130781597,"score_gpt":0.42253028598887005,"score_spread":0.31709162468105406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668784,0.0021501463,0.0000073698884,0.0041732746,0.00019463952,0.00073354895,0.00012703941,0.00008395003,0.005842183],"genre_scores_gemma":[0.9977683,0.00040473178,0.000109742294,0.00006885245,0.00017364489,0.0005928866,0.00012094457,0.000045182547,0.00071573706],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760264,0.000054448636,0.0003578424,0.00043348252,0.0009247026,0.0006268947],"domain_scores_gemma":[0.9981657,0.00032920818,0.00008553181,0.00065698224,0.0005175317,0.00024502666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090656977,0.00017302272,0.00043896536,0.0006091081,0.00014365769,0.000029795627,0.00022223157,0.000119781296,0.0014003984],"category_scores_gemma":[0.0003319013,0.00015620796,0.00018053949,0.00209307,0.00021967947,0.00004165869,0.0000881579,0.00042568005,0.00008777724],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042173597,0.0013745412,0.12213082,0.0033863015,0.00080127653,0.00112114,0.00085434876,0.00010442226,0.78153193,0.00059962535,0.02923017,0.054648053],"study_design_scores_gemma":[0.007558469,0.00057835307,0.49559978,0.00061665283,0.000070333794,0.0000053307494,0.00018107968,0.000121252255,0.49054217,0.00009063352,0.0044545042,0.00018142605],"about_ca_topic_score_codex":0.003909773,"about_ca_topic_score_gemma":0.000020252794,"teacher_disagreement_score":0.37346897,"about_ca_system_score_codex":0.00088169164,"about_ca_system_score_gemma":0.0019601244,"threshold_uncertainty_score":0.99951243},"labels":[],"label_agreement":null},{"id":"W4362541469","doi":"10.1158/1538-7445.am2023-354","title":"Abstract 354: The progression of changes in cardiac structure and function in mice with epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; York University; University of New Brunswick; University of Guelph","funders":"","keywords":"Ovarian cancer; Medicine; Atrophy; Cardiac function curve; Cancer; Internal medicine; Ejection fraction; Pathology; Tumor progression; Oncology; Cardiology; Endocrinology; Heart failure","score_opus":0.03686414588161828,"score_gpt":0.3672553423242432,"score_spread":0.3303911964426249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033797,0.0069042807,3.814834e-7,0.0019030301,0.00007388522,0.0006038526,0.000068509085,0.000010389023,0.0000976993],"genre_scores_gemma":[0.9974471,0.0019940652,0.0000032125927,0.00002554268,0.00023934439,0.00016800137,0.0000144094365,0.000012576388,0.00009575713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890566,0.000114306036,0.0000826871,0.00020333989,0.00045254116,0.00024148489],"domain_scores_gemma":[0.99960583,0.00005529936,0.000020203644,0.00017456138,0.00007758808,0.00006652215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059650344,0.00006851495,0.00019527589,0.0001905977,0.000052605537,0.000012200169,0.00005317092,0.0000637867,0.00005765827],"category_scores_gemma":[0.000022704067,0.000040850617,0.000037672206,0.0007500943,0.00012063491,0.0000354559,0.000048758408,0.00036693536,0.0000011543652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031888073,0.000052483498,0.48911428,0.0009117704,0.0003376302,0.00012396253,0.001392631,0.00015358366,0.325843,0.00004816923,0.000546617,0.17828707],"study_design_scores_gemma":[0.0010100752,0.000081910606,0.9635948,0.00056007697,0.00004915724,0.000001760464,0.0003059842,0.00002252586,0.03293589,0.000028392995,0.0013611229,0.000048285594],"about_ca_topic_score_codex":0.0026902254,"about_ca_topic_score_gemma":0.003369156,"teacher_disagreement_score":0.47448054,"about_ca_system_score_codex":0.000053307518,"about_ca_system_score_gemma":0.00022741748,"threshold_uncertainty_score":0.4066834},"labels":[],"label_agreement":null},{"id":"W4362541487","doi":"10.1158/1538-7445.am2023-740","title":"Abstract 740: Prevalence and cancer-specific patterns of cannabis use among US cancer survivors, 2016-2021","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Cancer; Cannabis; Confidence interval; Logistic regression; Cross-sectional study; Internal medicine; Psychiatry","score_opus":0.08087293356834838,"score_gpt":0.3978751292630581,"score_spread":0.3170021956947098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728645,0.015776755,0.000001922689,0.008134568,0.00044231126,0.001274386,0.0011801263,0.000061374325,0.0002640518],"genre_scores_gemma":[0.7951878,0.12899847,0.000004145308,0.000057555175,0.0006507254,0.0015770808,0.00003816371,0.000094618576,0.073391475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947274,0.00022433745,0.0005532239,0.0009700034,0.002059943,0.001465138],"domain_scores_gemma":[0.99665225,0.000116663134,0.0001304839,0.0008862101,0.0014772884,0.0007370841],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016709743,0.000319189,0.0006114734,0.0007541683,0.00029713128,0.00015912823,0.00043629028,0.00023666621,0.0058073984],"category_scores_gemma":[0.00023752693,0.0002782713,0.0001614117,0.0017884827,0.0008251954,0.0003167827,0.0004271422,0.0011737046,0.000046029156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032434583,0.000097348624,0.7222063,0.0023187494,0.000116200994,0.00017766285,0.00068420975,0.000060475704,0.034627307,0.000030296196,0.20040464,0.038952485],"study_design_scores_gemma":[0.0008187016,0.00013900349,0.82916373,0.001269548,0.000026692938,0.0000037590962,0.00029654952,0.000061686624,0.011232432,0.000013788616,0.15673572,0.00023837453],"about_ca_topic_score_codex":0.23334843,"about_ca_topic_score_gemma":0.03273554,"teacher_disagreement_score":0.20061289,"about_ca_system_score_codex":0.00069230224,"about_ca_system_score_gemma":0.001855348,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W4362541501","doi":"10.1158/1538-7445.am2023-6064","title":"Abstract 6064: Patient-partnered research enables germline characterization of angiosarcoma predisposition genes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MUTYH; MSH6; Angiosarcoma; Germline; Exome sequencing; Genetics; Cancer; Sarcoma; Biology; Exome; Medicine; Germline mutation; Gene; Pathology; DNA mismatch repair; Colorectal cancer; Mutation","score_opus":0.13023924007053994,"score_gpt":0.42873487790956005,"score_spread":0.2984956378390201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944953,0.0012019014,0.00000979124,0.0026375477,0.000116024254,0.0008557888,0.00011631525,0.00008789317,0.0004794416],"genre_scores_gemma":[0.99498314,0.0018753877,0.000027286285,0.00002784456,0.0004639969,0.00028226315,0.0006594895,0.00004424695,0.0016363349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964923,0.0002623701,0.0003908723,0.00042012264,0.001643393,0.0007909079],"domain_scores_gemma":[0.9978164,0.00015191441,0.00007046441,0.00050530775,0.0012289915,0.0002269587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017749722,0.00013582851,0.00030755426,0.0009127005,0.0002755956,0.000045648914,0.00019885221,0.0001254585,0.0004309146],"category_scores_gemma":[0.00018985987,0.00011821597,0.00015781104,0.0021347895,0.00028652983,0.00015755721,0.00018318144,0.00048146778,0.00014581921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028824172,0.0001966888,0.0062547815,0.0004775095,0.000070717375,0.00014180694,0.00045770244,0.000008773384,0.95839,0.0001747652,0.003316424,0.030222582],"study_design_scores_gemma":[0.001275961,0.00058564334,0.29987717,0.00088719715,0.000026940908,0.000020491116,0.00049538113,0.00052581076,0.6711909,0.00025875884,0.02467239,0.00018332592],"about_ca_topic_score_codex":0.00028781663,"about_ca_topic_score_gemma":0.000017834727,"teacher_disagreement_score":0.2936224,"about_ca_system_score_codex":0.00016022172,"about_ca_system_score_gemma":0.00038393066,"threshold_uncertainty_score":0.4820707},"labels":[],"label_agreement":null},{"id":"W4362541577","doi":"10.1158/1538-7445.am2023-4919","title":"Abstract 4919: Estrogen regulates the immune microenvironment and immunotherapy response of colorectal liver metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Immune system; Estrogen; Tumor microenvironment; Immunotherapy; Cancer research; Medicine; Cytokine; Estrogen receptor; Fulvestrant; Immunology; Internal medicine; Cancer; Biology; Breast cancer","score_opus":0.04309681675962143,"score_gpt":0.3523527244101272,"score_spread":0.3092559076505058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9294449,0.06736077,4.4844222e-7,0.0023254545,0.0000627462,0.0006773812,0.000052113977,0.000033233402,0.000042959535],"genre_scores_gemma":[0.95774037,0.039862968,0.000032889504,0.000044689743,0.00011258783,0.00021046356,0.000016481259,0.000045521676,0.0019340365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772084,0.00047211832,0.0003381155,0.00031719345,0.0006240993,0.00052760844],"domain_scores_gemma":[0.9979867,0.0011636816,0.00008921921,0.0005395652,0.00011721223,0.00010364538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025846548,0.00017284174,0.00037427098,0.00028441104,0.00026489687,0.000038948456,0.000237547,0.00008166349,0.0005267296],"category_scores_gemma":[0.00021499915,0.00012082602,0.0001463409,0.0005479543,0.0010242151,0.00007053427,0.00013198993,0.0003738761,0.000050785733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023278506,0.000097099626,0.0019755135,0.00013973129,0.00026524308,0.000108761684,0.0014375356,0.0000232221,0.94906026,0.000021981548,0.0022489855,0.021343134],"study_design_scores_gemma":[0.0013124563,0.00050151715,0.4681798,0.00022421085,0.000035794732,0.00007554643,0.0012198628,0.000033328855,0.4947545,0.000018311464,0.03353765,0.000107033185],"about_ca_topic_score_codex":0.0012374668,"about_ca_topic_score_gemma":0.000020960188,"teacher_disagreement_score":0.4662043,"about_ca_system_score_codex":0.00019614362,"about_ca_system_score_gemma":0.0004009165,"threshold_uncertainty_score":0.576732},"labels":[],"label_agreement":null},{"id":"W4362541656","doi":"10.1158/1538-7445.am2023-168","title":"Abstract 168: Esophageal adenocarcinoma-on-a-chip; modeling patient specific disease progression and a step towards functional precision oncology","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"","keywords":"Docetaxel; Stromal cell; Cancer research; Medicine; Esophageal cancer; Organoid; Adenocarcinoma; Cancer; Chemotherapy; Pathology; Oncology; Internal medicine; Biology; Cell biology","score_opus":0.17215936858259234,"score_gpt":0.4357737182193671,"score_spread":0.26361434963677477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820299,0.0122848805,0.0000809637,0.002426282,0.0005136558,0.0010039235,0.000087032706,0.00007705204,0.001496304],"genre_scores_gemma":[0.9925401,0.0051906453,0.00017185339,0.00011508682,0.000726002,0.00045138004,0.00008491524,0.00004324495,0.00067672983],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970642,0.00009123984,0.0002951742,0.00064101303,0.0013119869,0.00059641805],"domain_scores_gemma":[0.9984917,0.0001585585,0.0000469101,0.00036323146,0.0003121584,0.0006274337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008288144,0.00017265412,0.00028748496,0.00043440887,0.0002687874,0.000048212347,0.00009626554,0.00010233713,0.000820763],"category_scores_gemma":[0.00010775381,0.0001346824,0.000096954216,0.00058456435,0.00015163817,0.00007369551,0.0001942768,0.0006501388,0.00014050039],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006913789,0.00033088287,0.0023888506,0.00032969422,0.000059891543,0.00071488396,0.000452331,0.0012268154,0.005104147,0.00012819152,0.029873077,0.95247746],"study_design_scores_gemma":[0.018839642,0.008903492,0.517397,0.0044878256,0.0002950817,0.00011253628,0.0028476068,0.034598652,0.016584186,0.002646459,0.3918921,0.0013954204],"about_ca_topic_score_codex":0.00011593429,"about_ca_topic_score_gemma":0.000018488943,"teacher_disagreement_score":0.95108205,"about_ca_system_score_codex":0.0005680307,"about_ca_system_score_gemma":0.0009859535,"threshold_uncertainty_score":0.89867795},"labels":[],"label_agreement":null},{"id":"W4362541661","doi":"10.1158/1538-7445.am2023-1785","title":"Abstract 1785: Multi-step engineering of gene-edited CAR T cells using RNA lipid nanoparticles","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"CD19; Chimeric antigen receptor; Molecular biology; Transfection; Gene expression; Biology; Cell biology; Chemistry; Flow cytometry; T cell; Gene; Immune system; Immunology; Biochemistry","score_opus":0.1706561909875915,"score_gpt":0.43312415718407987,"score_spread":0.2624679661964884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977502,0.0005929523,0.000038466787,0.000250549,0.0003401083,0.0006956341,0.00004763229,0.00011623842,0.00016820301],"genre_scores_gemma":[0.99457586,0.0007544851,0.00078940776,0.000018128676,0.0007744564,0.000098833945,0.000015106319,0.000102540944,0.0028711734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675035,0.00009315757,0.00037388486,0.00041802667,0.0013444367,0.0010201485],"domain_scores_gemma":[0.9980728,0.00034531215,0.00004809056,0.00057581917,0.00058956037,0.0003684153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015485662,0.00017285663,0.0003755153,0.00075222366,0.00011681154,0.000040041967,0.0002905158,0.00014065378,0.0017213784],"category_scores_gemma":[0.00025032446,0.00016400522,0.00013133435,0.001903161,0.00021211468,0.00009056167,0.00015861541,0.00071561016,0.00015042246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024169112,0.00008050716,0.0013091204,0.00045688354,0.000110317465,0.00013289534,0.00045198214,0.0019887353,0.98833513,0.000004616416,0.0013389786,0.0055491384],"study_design_scores_gemma":[0.0013658758,0.000117178846,0.0083421925,0.00026214521,0.000016268963,0.000006893508,0.0003032921,0.019820701,0.96460325,0.0000015464041,0.0050235647,0.00013709733],"about_ca_topic_score_codex":0.0020355731,"about_ca_topic_score_gemma":0.00006783181,"teacher_disagreement_score":0.023731891,"about_ca_system_score_codex":0.0004619645,"about_ca_system_score_gemma":0.00053358753,"threshold_uncertainty_score":0.99919116},"labels":[],"label_agreement":null},{"id":"W4362541711","doi":"10.1158/1538-7445.am2023-6098","title":"Abstract 6098: Genome wide CRISPR screen reveals genetic vulnerabilities of next generation PARP1 inhibitor AZD5305","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Synthetic lethality; PARP1; CRISPR; PARP inhibitor; Genetic screen; Biology; Genetics; Cancer research; Gene; Mutant; Poly ADP ribose polymerase; Polymerase","score_opus":0.25147998503733265,"score_gpt":0.4536434933570905,"score_spread":0.20216350831975782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876771,0.0049980627,0.00007356249,0.003939908,0.0003253482,0.001118299,0.00014943712,0.00013241863,0.001585871],"genre_scores_gemma":[0.98811054,0.0039569917,0.0003047212,0.00046855272,0.0021511032,0.00074792845,0.00013063801,0.00008081222,0.004048711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630487,0.00027269017,0.0006846533,0.00057866925,0.0013847179,0.00077437033],"domain_scores_gemma":[0.9974411,0.00043080602,0.0001282996,0.00076764775,0.00093695516,0.0002951644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017719357,0.0002142201,0.0004652988,0.00061597873,0.00024260138,0.00006628546,0.0002585821,0.00017861846,0.0023945004],"category_scores_gemma":[0.00041740848,0.00020390103,0.00014258505,0.0012485732,0.00047516637,0.00019913596,0.00010867791,0.0006320739,0.000337133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031895458,0.00007545893,0.008340863,0.00047300282,0.000092344104,0.00004553027,0.00082526193,0.00044016438,0.9150223,0.00007144582,0.068896376,0.005398279],"study_design_scores_gemma":[0.0040860362,0.0009705898,0.32104805,0.0010152945,0.000059424106,0.000022205837,0.0013846647,0.0006216774,0.6144682,0.0018249573,0.053900253,0.0005986586],"about_ca_topic_score_codex":0.0009198933,"about_ca_topic_score_gemma":0.00011065496,"teacher_disagreement_score":0.3127072,"about_ca_system_score_codex":0.00060936494,"about_ca_system_score_gemma":0.0007903819,"threshold_uncertainty_score":0.99851745},"labels":[],"label_agreement":null},{"id":"W4362541736","doi":"10.1158/1538-7445.am2023-3843","title":"Abstract 3843: Potent human ClpP protease agonists with anticancer properties bind the enzyme with improved structural complementarity and alter the mitochondrial N-terminome","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protease; Cancer cell; Enzyme; Proteases; Cancer; Biochemistry; Chemistry; Apoptosis; Cancer research; Biology; Genetics","score_opus":0.07138559896965588,"score_gpt":0.35881364651092273,"score_spread":0.28742804754126683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952327,0.00041814925,0.0000202482,0.0024963042,0.0002456997,0.0014207729,0.00006630866,0.000016211116,0.0000835853],"genre_scores_gemma":[0.9964961,0.00010807522,0.000049178027,0.0002597682,0.0010288372,0.0006224424,0.00009190236,0.000027924076,0.0013157725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832946,0.00019915793,0.00016788156,0.00046736328,0.00033866634,0.00049746555],"domain_scores_gemma":[0.99914414,0.000025729169,0.00005988668,0.0004679012,0.00019977443,0.000102576305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035636747,0.00017527708,0.0001456776,0.00005209333,0.00077957934,0.0001447234,0.00030633516,0.000078028344,0.00013119793],"category_scores_gemma":[0.000028487035,0.0000808105,0.00003654716,0.00018691663,0.00085707783,0.0000088424795,0.00020872186,0.0003933771,0.000011930991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013475395,0.000015475705,0.0023126681,0.000048734433,0.00009347752,0.000015576086,0.00031971387,0.000025320289,0.9917335,0.000038611517,0.0028582742,0.0011910959],"study_design_scores_gemma":[0.005050299,0.0029017895,0.053125955,0.00012639168,0.00008014591,0.00009730407,0.0013812693,0.00016282278,0.83630705,0.00017499608,0.099906646,0.0006853254],"about_ca_topic_score_codex":0.0011361309,"about_ca_topic_score_gemma":0.0019844214,"teacher_disagreement_score":0.15542646,"about_ca_system_score_codex":0.000036824014,"about_ca_system_score_gemma":0.00024672828,"threshold_uncertainty_score":0.5995973},"labels":[],"label_agreement":null},{"id":"W4362541846","doi":"10.1158/1538-7445.am2023-4730","title":"Abstract 4730: ASCL1 activates neuronal stem cell-like lineage programming through the remodeling of the chromatin landscape in prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"EZH2; Biology; Chromatin; Cancer research; PRC2; Transcription factor; Gene knockdown; Epigenetics; Polycomb-group proteins; Histone; Chromatin remodeling; Cell biology; Repressor; Cell culture; Genetics","score_opus":0.10345213902859018,"score_gpt":0.4124139236962895,"score_spread":0.3089617846676993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846925,0.004845189,9.601963e-7,0.0071496014,0.00022232237,0.0021144596,0.000062442385,0.0000612697,0.00085121987],"genre_scores_gemma":[0.9866089,0.005535866,0.00002516727,0.00007769642,0.00024921529,0.0011330147,0.000022888542,0.000061621766,0.006285579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647784,0.00023296064,0.00042196215,0.00047960473,0.0013850265,0.001002593],"domain_scores_gemma":[0.9983941,0.00042307714,0.000112524314,0.00058722275,0.0003702284,0.000112887414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013220621,0.00020958835,0.00033420816,0.00020931178,0.0003682811,0.00007593842,0.0004843134,0.00009377454,0.00019424746],"category_scores_gemma":[0.000058795427,0.000110466535,0.00013348201,0.0022130434,0.00040505463,0.0001565797,0.0003362174,0.0012496533,0.000025204945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047017788,0.0009510471,0.19859008,0.0057463134,0.00047753102,0.00036478124,0.033555645,0.011148357,0.54430294,0.000086984706,0.027055904,0.17301862],"study_design_scores_gemma":[0.009546103,0.0007402931,0.27878693,0.0045409976,0.000100608275,0.000015801526,0.01547877,0.0075650397,0.6352394,0.00024317676,0.047130425,0.0006124282],"about_ca_topic_score_codex":0.0031828997,"about_ca_topic_score_gemma":0.00059629715,"teacher_disagreement_score":0.1724062,"about_ca_system_score_codex":0.00035287722,"about_ca_system_score_gemma":0.0014415793,"threshold_uncertainty_score":0.5429191},"labels":[],"label_agreement":null},{"id":"W4362542218","doi":"10.1158/1538-7445.am2023-939","title":"Abstract 939: Genomic characterization of PMBCL, cHL and DLBCL utilizing tissue and liquid biopsies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Lymphoma; Cancer research; Liquid biopsy; Cancer; Gene; Pathology; Population; Medicine; Biology; Internal medicine; Genetics","score_opus":0.10647327242046294,"score_gpt":0.4201807178689819,"score_spread":0.313707445448519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957637,0.001944458,2.6228253e-7,0.0014688371,0.00004616823,0.00032714874,0.00004339981,0.000025183303,0.0003808284],"genre_scores_gemma":[0.98603463,0.013313368,0.000008709629,0.000029445759,0.0000978025,0.00009693241,0.000046823097,0.000015215172,0.0003570655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991893,0.00002176846,0.0001343174,0.00020443521,0.00022208391,0.00022807019],"domain_scores_gemma":[0.99954855,0.00008072457,0.000030110228,0.0001378802,0.000097137425,0.000105567546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027054414,0.00007269013,0.00017132079,0.00019143982,0.00008495269,0.00002370141,0.000035864225,0.000050201874,0.00010200879],"category_scores_gemma":[0.000040510826,0.00005942141,0.000015411952,0.00025293484,0.00013917412,0.00005696705,0.000079141275,0.00007550299,0.000027467077],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018885618,0.00007050262,0.034329724,0.00031450798,0.00005071406,0.00004874808,0.0005680393,2.5565157e-7,0.9362252,0.00008709641,0.00022484465,0.027891554],"study_design_scores_gemma":[0.0008645018,0.00023131279,0.74475116,0.00018338069,0.000014708393,0.0000070917586,0.00015512532,0.000017006803,0.24906757,0.000011072909,0.0046525095,0.000044553108],"about_ca_topic_score_codex":0.00043354373,"about_ca_topic_score_gemma":0.00001961645,"teacher_disagreement_score":0.71042144,"about_ca_system_score_codex":0.000094043484,"about_ca_system_score_gemma":0.00012149852,"threshold_uncertainty_score":0.24231347},"labels":[],"label_agreement":null},{"id":"W4362542513","doi":"10.1158/1538-7445.am2023-6194","title":"Abstract 6194: A bifunctional inhibitor of PARP and HDAC enzymes with activity in Ewing sarcoma 3D spheroid and metastasis models","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Olaparib; PARP inhibitor; Propidium iodide; PARP1; Histone deacetylase; Cancer research; Poly ADP ribose polymerase; Biology; Viability assay; Vorinostat; Molecular biology; Histone; Programmed cell death; Polymerase; Cell; Apoptosis; Biochemistry; DNA","score_opus":0.16218327571532282,"score_gpt":0.41834854464282134,"score_spread":0.2561652689274985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945144,0.0027214217,0.000069658934,0.0015206769,0.00004641061,0.00043810034,0.000073129326,0.00003574734,0.00058044994],"genre_scores_gemma":[0.9972941,0.0017687086,0.00024290044,0.00004908808,0.00014489747,0.00024760465,0.000007753044,0.00003029093,0.00021465415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817336,0.000103840975,0.00020171533,0.0003825572,0.0007419907,0.00039654138],"domain_scores_gemma":[0.9990442,0.00033354157,0.000053466225,0.00021254379,0.00019896618,0.00015732403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979787,0.00013272,0.00032104683,0.0004071595,0.000095002586,0.000026008947,0.00005774824,0.00007624834,0.00020307576],"category_scores_gemma":[0.000049097365,0.00011015576,0.000029756007,0.00090478273,0.00038216662,0.00024205181,0.00007280765,0.0004668339,0.0000045872757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075197075,0.00044947752,0.06476953,0.0018417576,0.00050775363,0.00024837386,0.0029830195,0.0016690565,0.7497105,0.00069803343,0.006330196,0.16327262],"study_design_scores_gemma":[0.013508546,0.0013400901,0.33908835,0.0025263664,0.00007050211,0.00007880795,0.0019866095,0.0049893307,0.6289547,0.0025030528,0.0044174287,0.00053617015],"about_ca_topic_score_codex":0.001117816,"about_ca_topic_score_gemma":0.0004178571,"teacher_disagreement_score":0.27431884,"about_ca_system_score_codex":0.00020891814,"about_ca_system_score_gemma":0.00042416167,"threshold_uncertainty_score":0.44920215},"labels":[],"label_agreement":null},{"id":"W4362542562","doi":"10.1158/1538-7445.am2023-5045","title":"Abstract 5045: NTSR1-targeted alpha therapeutic [Ac-225]-FPI-2059 induces growth inhibition in a preclinical colorectal tumor model","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Patheon (Canada)","funders":"","keywords":"Biodistribution; Medicine; Pharmacokinetics; Colorectal cancer; Cancer research; In vivo; Cancer; Pharmacology; Radioligand; Therapeutic index; Internal medicine; Receptor; Drug; Biology","score_opus":0.2649107592631865,"score_gpt":0.5139435806128593,"score_spread":0.24903282134967275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011046,0.00045748454,0.00001379871,0.0061945394,0.000048868646,0.00078877993,0.000053470678,0.00013236282,0.002200266],"genre_scores_gemma":[0.9970316,0.0004806951,0.00003876124,0.00028797484,0.00030313188,0.0011676128,0.000089105364,0.000036657624,0.0005644344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765354,0.00008837571,0.0003936697,0.0005243929,0.00067388883,0.0006661566],"domain_scores_gemma":[0.99874294,0.00038565966,0.00004585905,0.0002609419,0.00023973818,0.0003248616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011503468,0.00015735222,0.00028279785,0.00021790121,0.00015592937,0.00003707014,0.00015731384,0.00017205531,0.00045991156],"category_scores_gemma":[0.00034543662,0.00014174504,0.00009156972,0.0014598779,0.00033053505,0.00010892942,0.00008479064,0.0013302722,0.00024085726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075774564,0.00042809115,0.0020721927,0.00030604555,0.00005293911,0.00012805907,0.00027771032,0.00021831597,0.9905598,0.00024247014,0.0025345003,0.0024221314],"study_design_scores_gemma":[0.003284383,0.00018374,0.048599854,0.0003686961,0.000040354793,0.000025440857,0.0002334204,0.021855954,0.91874367,0.005518774,0.0008435107,0.00030218306],"about_ca_topic_score_codex":0.00010449933,"about_ca_topic_score_gemma":0.00001927716,"teacher_disagreement_score":0.07181611,"about_ca_system_score_codex":0.00030783215,"about_ca_system_score_gemma":0.00061020855,"threshold_uncertainty_score":0.5780195},"labels":[],"label_agreement":null},{"id":"W4362542641","doi":"10.1158/1538-7445.am2023-5622","title":"Abstract 5622: Integrative cross-platform characterisation of mammographic screen-detected breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Mammography; Cohort; Disease; Stage (stratigraphy); Pathology; Biology","score_opus":0.06041375774035328,"score_gpt":0.44233841650912764,"score_spread":0.38192465876877435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945358,0.00023300087,0.000035928297,0.0033420883,0.00022283668,0.00040975993,0.00014807447,0.00010914917,0.00096334313],"genre_scores_gemma":[0.9963971,0.0016935589,0.000040144627,0.0000944575,0.00043406474,0.00015980144,0.00009641678,0.000042997253,0.0010414828],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997812,0.00006876304,0.00033968766,0.0003457735,0.000886547,0.0005472815],"domain_scores_gemma":[0.9983821,0.00023484386,0.000107821645,0.0002927463,0.0007411564,0.00024131555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001611188,0.00014778187,0.00032102765,0.0006795358,0.0001787269,0.000055942688,0.00020772114,0.00011952987,0.0015219245],"category_scores_gemma":[0.00043379492,0.0001133988,0.00010970176,0.0016491729,0.00054475514,0.00016291333,0.000085367756,0.0012059473,0.000052434883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009124593,0.00009836657,0.3509715,0.0005324545,0.0002425143,0.00008640859,0.0011609171,0.00005497341,0.41270763,0.00020623149,0.005438656,0.22758788],"study_design_scores_gemma":[0.0009824189,0.00008038121,0.98527586,0.0007726881,0.000018924007,0.000015833695,0.00021973588,0.0018863414,0.009099146,0.00017236914,0.0013640661,0.000112248716],"about_ca_topic_score_codex":0.0037289688,"about_ca_topic_score_gemma":0.00013911712,"teacher_disagreement_score":0.63430434,"about_ca_system_score_codex":0.00020730046,"about_ca_system_score_gemma":0.00045080326,"threshold_uncertainty_score":0.99939084},"labels":[],"label_agreement":null},{"id":"W4362542679","doi":"10.1158/1538-7445.am2023-3942","title":"Abstract 3942: Differential expression of a novel transport receptor, SORT1 (sortilin), in cancer versus healthy tissues that can be utilized for targeted delivery of anti-cancer drugs","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medicinal Plant Pharmacodynamics Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Cancer; Immunohistochemistry; Tissue microarray; Pathology; Cancer research; Medicine; Biology; Internal medicine","score_opus":0.43923251542334835,"score_gpt":0.5738419473937676,"score_spread":0.13460943197041925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840608,0.0029487035,0.000016172464,0.0020936856,0.0018337716,0.002190583,0.006687934,0.00006170427,0.00010661175],"genre_scores_gemma":[0.9603319,0.036207605,0.00003527105,0.00011123106,0.00031372768,0.0016364738,0.0005572172,0.00007650703,0.00073005195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99482954,0.00049444416,0.0009234015,0.0007676165,0.0014468104,0.0015381866],"domain_scores_gemma":[0.9961743,0.0019466198,0.00030449676,0.00034336816,0.00071534043,0.0005158945],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002779552,0.00035331948,0.0008882219,0.0010075903,0.00025882243,0.0000120375735,0.0008423411,0.00049900636,0.005117383],"category_scores_gemma":[0.00013840324,0.00033292166,0.00020042101,0.0013036053,0.0007267336,0.00015456142,0.00017340947,0.0019639062,0.000007219387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022934694,0.00071963493,0.011933945,0.0020020497,0.00025888553,0.000020125663,0.0022152418,0.0016058056,0.9454233,0.00003549696,0.0073048305,0.005545995],"study_design_scores_gemma":[0.015942045,0.00035774833,0.008463395,0.0004920127,0.00008161345,4.5944938e-7,0.0010573108,0.011300582,0.94975054,0.000014197237,0.01219984,0.00034028012],"about_ca_topic_score_codex":0.008047196,"about_ca_topic_score_gemma":0.0030174667,"teacher_disagreement_score":0.033258904,"about_ca_system_score_codex":0.0005433943,"about_ca_system_score_gemma":0.0018572988,"threshold_uncertainty_score":0.99991226},"labels":[],"label_agreement":null},{"id":"W4362542732","doi":"10.1158/1538-7445.am2023-3934","title":"Abstract 3934: PRMT5 is an actionable target in CDK4/6 inhibitor-resistant ER+/Rb-deficient breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protein arginine methyltransferase 5; Biology; Cancer research; Cancer; Cell cycle; Cell growth; Prostate cancer; Molecular biology; Methyltransferase; Genetics; Gene; Methylation","score_opus":0.043148967281148864,"score_gpt":0.37583709376736446,"score_spread":0.3326881264862156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937338,0.0018775591,0.000007998172,0.002477708,0.00043396704,0.00047103388,0.00037660406,0.000040601473,0.00058070535],"genre_scores_gemma":[0.9927529,0.0015377703,0.000019886063,0.00008368608,0.00093599997,0.00046739622,0.0002378555,0.00006139622,0.0039030942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733055,0.00011279706,0.0003017451,0.0007501885,0.00070344855,0.00080128206],"domain_scores_gemma":[0.9988017,0.00002059699,0.00007095919,0.00053048553,0.00038461943,0.00019162238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007848198,0.00019204132,0.00017877627,0.00033443823,0.00022274209,0.000074514894,0.0002985264,0.0002731868,0.001061961],"category_scores_gemma":[0.00003504186,0.00019789864,0.00007846887,0.0011115215,0.00015730747,0.000022917038,0.0001775054,0.00040419257,0.00009546389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232826,0.00009228314,0.0042523774,0.00007861325,0.000041530526,0.000009805675,0.00019540059,0.010284597,0.93113786,0.000019668107,0.048389472,0.004975111],"study_design_scores_gemma":[0.0014663612,0.00023352876,0.24671742,0.00021633168,0.000010264353,0.000009128532,0.0005903269,0.0011047018,0.609093,0.00028536262,0.13971946,0.00055408303],"about_ca_topic_score_codex":0.004215654,"about_ca_topic_score_gemma":0.0041331234,"teacher_disagreement_score":0.32204482,"about_ca_system_score_codex":0.00059597776,"about_ca_system_score_gemma":0.00093545124,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W4362542917","doi":"10.1158/1538-7445.am2023-206","title":"Abstract 206: Organoid models for predicting drug response in high grade serous and triple negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Triple-negative breast cancer; Organoid; Medicine; Breast cancer; Cancer; Clinical trial; Oncology; Ovarian cancer; Drug; Chemotherapy; Internal medicine; Cancer research; Pharmacology; Biology","score_opus":0.03786121779140905,"score_gpt":0.35611155695332075,"score_spread":0.3182503391619117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996173,0.0009985943,0.000060690723,0.0012122142,0.00011333265,0.0006283405,0.00077014795,0.000017659344,0.000026014586],"genre_scores_gemma":[0.99365675,0.0034819215,0.00006653891,0.000071837465,0.00024445105,0.00064724154,0.000073865995,0.000041845204,0.0017155353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985277,0.00012975921,0.00018213643,0.00044751723,0.0001881842,0.00052466843],"domain_scores_gemma":[0.999287,0.00014699326,0.000040199342,0.00022167533,0.00019982504,0.00010432407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010057675,0.00012643055,0.00015037805,0.0001581763,0.00015704987,0.000041667878,0.00019069004,0.00012905634,0.000021960448],"category_scores_gemma":[0.00014832697,0.00012327715,0.000037025977,0.00038174124,0.000112725356,0.000011909224,0.0001728178,0.00023994014,0.0000027040558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026662303,0.000043358752,0.0029253438,0.00011843404,0.00005138522,0.000008710971,0.00062702294,0.00228617,0.9779444,0.000029232291,0.010488506,0.0028112207],"study_design_scores_gemma":[0.006949458,0.0003902425,0.11471462,0.00038640897,0.000027735497,0.000019882804,0.0022147142,0.010861017,0.8567599,0.0022353344,0.004687522,0.0007531467],"about_ca_topic_score_codex":0.00325153,"about_ca_topic_score_gemma":0.003597577,"teacher_disagreement_score":0.121184476,"about_ca_system_score_codex":0.00010705409,"about_ca_system_score_gemma":0.00040218924,"threshold_uncertainty_score":0.5027096},"labels":[],"label_agreement":null},{"id":"W4362542927","doi":"10.1158/1538-7445.am2023-3776","title":"Abstract 3776: Identification of hypoxia regulated long noncoding RNA, MARVEL in kidney cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Clear cell renal cell carcinoma; Long non-coding RNA; Biology; Cancer research; Carcinogenesis; Kidney cancer; Cancer; Transcriptome; Angiogenesis; Microarray; RNA; Microarray analysis techniques; Metastasis; Renal cell carcinoma; Gene expression; Medicine; Pathology; Gene; Genetics","score_opus":0.05482067553696452,"score_gpt":0.397574009624876,"score_spread":0.3427533340879115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502647,0.001902528,0.0003482984,0.00082601013,0.00033469484,0.00070958777,0.00015178164,0.00003064733,0.0006700113],"genre_scores_gemma":[0.9907514,0.004526539,0.000021197813,0.000045354765,0.00023546196,0.00046973937,0.00019597606,0.00006843841,0.0036859203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969241,0.00020263475,0.0004936203,0.00067713193,0.0008881541,0.0008143273],"domain_scores_gemma":[0.99835145,0.00004517,0.00011927146,0.00067130214,0.0005792275,0.00023359951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020537921,0.00017217481,0.00022461746,0.0006458307,0.00012663197,0.00005620754,0.00057235744,0.0003047567,0.00035629087],"category_scores_gemma":[0.0005626759,0.00018759015,0.00010125167,0.0018363311,0.00020551482,0.000014457851,0.00035607742,0.0005454108,0.000062687686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022429563,0.00004235353,0.00041350807,0.0002179346,0.000066202454,0.000028449922,0.000084358406,0.0016930596,0.9785115,0.00004372795,0.009816197,0.008858393],"study_design_scores_gemma":[0.00081256573,0.00006548987,0.02270187,0.0002896069,0.0000066529965,0.0000024365918,0.000093544695,0.0005961785,0.9722458,0.00011991104,0.0028740969,0.00019185682],"about_ca_topic_score_codex":0.0021511924,"about_ca_topic_score_gemma":0.0012921081,"teacher_disagreement_score":0.022288363,"about_ca_system_score_codex":0.00032100827,"about_ca_system_score_gemma":0.0011441208,"threshold_uncertainty_score":0.7649705},"labels":[],"label_agreement":null},{"id":"W4362542930","doi":"10.1158/1538-7445.am2023-2530","title":"Abstract 2530: DELE1 loss and dysfunctional integrated stress signaling in <i>TP53</i> mutated AML is a novel pathway for venetoclax resistance","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Venetoclax; Myeloid leukemia; Cancer research; Integrated stress response; Leukemia; MCL1; Cytarabine; Biology; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gene; Downregulation and upregulation; Genetics; Translation (biology)","score_opus":0.08802920100020656,"score_gpt":0.39442406025205257,"score_spread":0.306394859251846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362542930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209946,0.0010081158,0.00014868082,0.0035740025,0.00010539987,0.001599861,0.0009937235,0.000108594526,0.00036217307],"genre_scores_gemma":[0.99057496,0.0006644667,0.00036590052,0.00025916364,0.00032631244,0.0012692403,0.00037037383,0.00009633623,0.0060732244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962961,0.000097146476,0.00044739025,0.0007899095,0.0011587132,0.0012107202],"domain_scores_gemma":[0.9971139,0.0009671919,0.00006320012,0.0003953622,0.0011017872,0.00035859528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020864778,0.00023877568,0.00041631394,0.00082472543,0.00026975322,0.000101505895,0.00028652704,0.00023897461,0.0003164275],"category_scores_gemma":[0.00076043594,0.00021602171,0.00008225951,0.0024707504,0.00042904972,0.00015244489,0.00016743415,0.0013598998,0.0000598245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007836178,0.00019321102,0.012258171,0.0021411546,0.00025758377,0.00070680765,0.001705215,0.0007911311,0.92422396,0.00038575745,0.04181192,0.0076889344],"study_design_scores_gemma":[0.030617615,0.0011657592,0.10478689,0.006561556,0.00007479117,0.000072370225,0.0055435738,0.019322375,0.6824498,0.0022283182,0.1457716,0.0014053244],"about_ca_topic_score_codex":0.0017419799,"about_ca_topic_score_gemma":0.0012463806,"teacher_disagreement_score":0.2417741,"about_ca_system_score_codex":0.0022137242,"about_ca_system_score_gemma":0.003602846,"threshold_uncertainty_score":0.880911},"labels":[],"label_agreement":null},{"id":"W4362543029","doi":"10.1158/1538-7445.am2023-1502","title":"Abstract 1502: PRAME modulates the effect of retinoids on keratinocyte differentiation and cell cycle progression in basal cell carcinoma and cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer research; Biology; Retinoid; Keratinocyte; Cell cycle; Molecular biology; Cell culture; Cell; Retinoic acid; Biochemistry","score_opus":0.024877569790644708,"score_gpt":0.342848848752373,"score_spread":0.3179712789617283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916845,0.0043621575,4.3427866e-7,0.0006337882,0.00012206495,0.0015734574,0.000031347823,0.000027868318,0.0015643794],"genre_scores_gemma":[0.9984194,0.00045272458,0.000014320577,0.00001964208,0.00016591522,0.0003319621,0.000018961126,0.00005388719,0.00052316167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973548,0.00032413585,0.00033812085,0.0005716842,0.00079587725,0.0006153895],"domain_scores_gemma":[0.99803585,0.0011592811,0.0001151859,0.00041998713,0.00012579381,0.00014390658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077184977,0.00025841393,0.00044219798,0.00032050963,0.00023959359,0.000051548406,0.00015568147,0.00014895828,0.000044851367],"category_scores_gemma":[0.00012222072,0.00017337674,0.0000557301,0.00052237354,0.00034610066,0.000056929235,0.00025455703,0.0007495372,0.000013936877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017883413,0.00011185617,0.86983633,0.002429764,0.000010604473,0.0002709019,0.0018837012,0.00009131225,0.1173947,0.0000028028571,0.0010291843,0.0051505216],"study_design_scores_gemma":[0.0020551935,0.0016800233,0.62795764,0.00014745403,0.000023699487,0.000007015557,0.00020546111,0.001099982,0.36666232,0.000022261465,0.000027583877,0.000111366506],"about_ca_topic_score_codex":0.0011279909,"about_ca_topic_score_gemma":0.0001336988,"teacher_disagreement_score":0.24926761,"about_ca_system_score_codex":0.0002454015,"about_ca_system_score_gemma":0.00012999764,"threshold_uncertainty_score":0.70700985},"labels":[],"label_agreement":null},{"id":"W4362543242","doi":"10.1158/1538-7445.am2023-1134","title":"Abstract 1134: Therapeutic potential of an antibody-drug conjugate directed against a tumor-specific epitope on podocalyxin","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antibody-drug conjugate; Cancer research; Podocalyxin; Antibody; In vivo; Epitope; Medicine; Monoclonal antibody; Pathology; Biology; Immunology; Kidney; Internal medicine","score_opus":0.05051229401181832,"score_gpt":0.3958035683771424,"score_spread":0.3452912743653241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962369,0.0012417643,0.000014850821,0.00047894905,0.00015529891,0.00055446196,0.000109012,0.00005689394,0.0011518656],"genre_scores_gemma":[0.9941117,0.0037412941,0.00002532671,0.000097378106,0.0003362995,0.00011145765,0.0004102767,0.00005120847,0.0011150183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720657,0.0003543682,0.00028887915,0.00058483105,0.00087574334,0.0006896274],"domain_scores_gemma":[0.99848807,0.000048958565,0.00006379871,0.00065617013,0.0005221466,0.0002208561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011845573,0.00017242509,0.00021040911,0.00034410832,0.00021524567,0.00007426184,0.0005040891,0.00011575589,0.0003300773],"category_scores_gemma":[0.00010021857,0.00015558179,0.00010513466,0.0007960548,0.00030836306,0.000010723221,0.00017513058,0.00044085667,0.0002183658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063056406,0.00012387733,0.0002492071,0.0000523921,0.000046915375,0.00006944836,0.000051092597,0.00050441857,0.9669196,0.00006793327,0.0031382402,0.028146304],"study_design_scores_gemma":[0.0011327319,0.00041186344,0.032809507,0.00007707614,0.0000030639862,0.0000032254134,0.00016638034,0.00076287147,0.9183164,0.000115502175,0.04596405,0.00023730287],"about_ca_topic_score_codex":0.00026732913,"about_ca_topic_score_gemma":0.00009446406,"teacher_disagreement_score":0.04860318,"about_ca_system_score_codex":0.00005122931,"about_ca_system_score_gemma":0.00030885113,"threshold_uncertainty_score":0.6344441},"labels":[],"label_agreement":null},{"id":"W4362543280","doi":"10.1158/1538-7445.am2023-2057","title":"Abstract 2057: Pan-cancer analysis of ion channel genes reveals patterns of large-scale transcriptional dysregulation and novel oncogenes with functions in cellular connectivity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Druggability; Biology; Cancer; Transcriptome; Gene; Cancer research; Cancer cell; Computational biology; Gene expression; Genetics","score_opus":0.05731927518358685,"score_gpt":0.3639651817438282,"score_spread":0.3066459065602413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607664,0.0010870013,0.0016789426,0.00019666772,0.000029180776,0.00023175307,0.0006755289,0.000004153733,0.000020140491],"genre_scores_gemma":[0.997517,0.0014424566,0.000014202035,0.0000065115046,0.0000850812,0.00014092779,0.00024734729,0.000013145899,0.00053334987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867773,0.000083944644,0.00020051816,0.0003223234,0.00039578954,0.0003196883],"domain_scores_gemma":[0.99930865,0.000050769228,0.00005856693,0.0001968243,0.00031515348,0.00007005877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087170705,0.000088475375,0.00021561945,0.00045165358,0.00008194318,0.000011451131,0.000099679346,0.000092908434,0.00005831424],"category_scores_gemma":[0.000028273393,0.00007788716,0.000067947476,0.00096945127,0.00010354857,0.000011256019,0.00005241928,0.00012115236,4.9895516e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024183196,0.00007566558,0.15448242,0.00011319976,0.00022097406,0.0000012757924,0.00010654628,0.0044298773,0.8391754,0.00001985681,0.000032736876,0.0011002095],"study_design_scores_gemma":[0.00055408425,0.00013282632,0.6580045,0.00006324964,0.00003512696,2.7539926e-7,0.00047468656,0.001986928,0.33855513,0.0000146565335,0.000103615384,0.00007488299],"about_ca_topic_score_codex":0.0021098687,"about_ca_topic_score_gemma":0.008998808,"teacher_disagreement_score":0.5035221,"about_ca_system_score_codex":0.000038280163,"about_ca_system_score_gemma":0.00014242964,"threshold_uncertainty_score":0.50215465},"labels":[],"label_agreement":null},{"id":"W4362543480","doi":"10.1158/1538-7445.am2023-5041","title":"Abstract 5041: TEM-1 targeted alpha therapeutic [Ac-225]-FPI-1848 induces regression in pre-clinical sarcoma xenograft models","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Patheon (Canada)","funders":"","keywords":"Biodistribution; Sarcoma; Medicine; Cancer research; Ex vivo; Immunoconjugate; Pathology; Cancer; In vivo; Stromal cell; Monoclonal antibody; Antibody; Internal medicine; Immunology; Biology","score_opus":0.19910613962821347,"score_gpt":0.4664856555762543,"score_spread":0.2673795159480409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755799,0.019371059,0.000005551037,0.0016864159,0.001170118,0.0006198753,0.000057247915,0.00015202865,0.0013578057],"genre_scores_gemma":[0.9875113,0.0071917432,0.000008809917,0.00019982528,0.00018852213,0.00043011105,0.00013172843,0.000045970948,0.004291984],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958898,0.0011069287,0.00065479806,0.00084173225,0.00018207193,0.0013246593],"domain_scores_gemma":[0.99826884,0.0007040365,0.0001257928,0.000590452,0.0002240016,0.00008688944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026560717,0.000269621,0.0005339204,0.00057614903,0.0003461416,0.000038089765,0.0007474342,0.0007759976,0.0017007404],"category_scores_gemma":[0.00015007405,0.00020839117,0.00015191479,0.0012506754,0.00073738216,0.00015299751,0.00033094574,0.0020728982,0.0007764902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017079902,0.00046734876,0.03608271,0.00010550648,0.000346646,0.00007194483,0.0015668337,0.00011079271,0.77203673,0.00034530985,0.045233466,0.1419247],"study_design_scores_gemma":[0.0062629227,0.0013854464,0.74093455,0.0005389695,0.000033498338,0.000029757335,0.0011967418,0.0001464055,0.10927472,0.0071431333,0.13220689,0.0008469697],"about_ca_topic_score_codex":0.0034070434,"about_ca_topic_score_gemma":0.0016631434,"teacher_disagreement_score":0.7048518,"about_ca_system_score_codex":0.0001904311,"about_ca_system_score_gemma":0.00056694105,"threshold_uncertainty_score":0.99921185},"labels":[],"label_agreement":null},{"id":"W4362543540","doi":"10.1158/1538-7445.am2023-2554","title":"Abstract 2554: Phosphorylationdependent control of protein synthesis in response to inhibitors of mRNA translation and mitochondrial respiration in HeLa cancer cell line","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Anisomycin; Phosphorylation; Biology; Kinase; Ribosomal protein s6; Protein phosphorylation; Cell biology; P70-S6 Kinase 1; Ribosomal s6 kinase; mTORC1; Protein kinase A; Molecular biology; Protein kinase B","score_opus":0.04160264855892689,"score_gpt":0.35356122589736866,"score_spread":0.3119585773384418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996263,0.0014102549,0.000073564406,0.0010238828,0.0000648422,0.0009824184,0.000108339824,0.0000032768594,0.000070413626],"genre_scores_gemma":[0.9978751,0.0013274611,0.00010629043,0.000014230523,0.00010750848,0.0003770605,0.000016305397,0.000013177392,0.00016285974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803513,0.0002324448,0.0004978011,0.0002586268,0.0006412931,0.00033468206],"domain_scores_gemma":[0.9991816,0.00016532633,0.00007537677,0.00019666973,0.00026350326,0.0001174996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021198587,0.00009601034,0.00018894937,0.00037941855,0.000032879,0.000015186145,0.00016195515,0.00018813163,0.000044608678],"category_scores_gemma":[0.00073085754,0.0000902785,0.00003866777,0.0005374288,0.00014717944,0.000010620972,0.000068079185,0.00018193372,0.0000035587843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035069434,0.000060813967,0.001359867,0.00021275191,0.000009600976,0.0000019816769,0.00045200187,0.0006614503,0.9672253,0.000001538399,0.00013776778,0.026369972],"study_design_scores_gemma":[0.0014413028,0.00041628125,0.018479884,0.00021189268,0.000002896993,1.1120046e-7,0.00029589012,0.0007604091,0.9770234,0.000030589195,0.0012404851,0.00009685462],"about_ca_topic_score_codex":0.0019802589,"about_ca_topic_score_gemma":0.0043511484,"teacher_disagreement_score":0.026273116,"about_ca_system_score_codex":0.00008981368,"about_ca_system_score_gemma":0.00047512798,"threshold_uncertainty_score":0.36814508},"labels":[],"label_agreement":null},{"id":"W4362543636","doi":"10.1158/1538-7445.am2023-5897","title":"Abstract 5897: Tumor-derived bacteria drive breast cancer metastasis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Provincial Health Services Authority","funders":"","keywords":"Metastasis; Breast cancer; Metastatic breast cancer; Immune system; Primary tumor; Cancer research; Cancer; Medicine; Microbiome; Biology; Tumor microenvironment; Immunology; Internal medicine; Bioinformatics","score_opus":0.0659127661064721,"score_gpt":0.4164104737135872,"score_spread":0.35049770760711507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360245,0.0016457114,0.0000033583142,0.0014519979,0.0002111555,0.00047262612,0.0017070369,0.00004832338,0.000857348],"genre_scores_gemma":[0.9903211,0.0049116476,0.00002383062,0.00010767571,0.00067285344,0.0011742458,0.00034053897,0.00006778541,0.0023802961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971173,0.0001506625,0.00020728138,0.00071170426,0.00069835514,0.0011147069],"domain_scores_gemma":[0.9985025,0.000038676677,0.000050160445,0.0006033683,0.00042413457,0.0003811396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053865695,0.00022248176,0.00022759255,0.00023562451,0.00030814175,0.00012062566,0.0004787775,0.00010340894,0.0020173613],"category_scores_gemma":[0.000063960855,0.0001985089,0.00014019392,0.0007483476,0.00028324814,0.000014123719,0.00041950148,0.00033222276,0.00043681863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049495103,0.00006983679,0.0040248707,0.00006853397,0.0003411905,0.00010241614,0.000055517205,0.000031494936,0.9303005,0.000010927507,0.0505765,0.013923293],"study_design_scores_gemma":[0.0017595512,0.00021877322,0.17647313,0.0001051472,0.000025203128,0.000022058983,0.0002316609,0.000011696568,0.7195996,0.000110840105,0.10105127,0.0003910569],"about_ca_topic_score_codex":0.0049907304,"about_ca_topic_score_gemma":0.0031538578,"teacher_disagreement_score":0.21070085,"about_ca_system_score_codex":0.00023376948,"about_ca_system_score_gemma":0.00084574235,"threshold_uncertainty_score":0.99889493},"labels":[],"label_agreement":null},{"id":"W4362543748","doi":"10.1158/1538-7445.am2023-892","title":"Abstract 892: Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4) demonstrates durable clinical responses by inducing broad immune engagement with anti-tumor activity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Medicine; CD8; Cancer research; FOXP3; Immunotherapy; Immunology; T cell; Internal medicine; Oncology","score_opus":0.1878490284929845,"score_gpt":0.4787060654354717,"score_spread":0.2908570369424872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873427,0.0021921133,0.000015682182,0.0036276327,0.00023542762,0.0019403773,0.00013646032,0.0003114201,0.0041981474],"genre_scores_gemma":[0.96911985,0.005329354,0.00010118054,0.00011135342,0.00042838606,0.00067950494,0.0000685973,0.00017002897,0.023991747],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9917227,0.0012618626,0.0008410677,0.0012791823,0.0026993041,0.002195903],"domain_scores_gemma":[0.99420977,0.0027045107,0.00019380097,0.0013428823,0.0007869414,0.0007621146],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0105388705,0.00045473225,0.0009628192,0.00086597726,0.00083075714,0.00026579155,0.00068323174,0.00029673608,0.0033189375],"category_scores_gemma":[0.0011567771,0.00037504875,0.00027356815,0.0025811344,0.001008376,0.00039180557,0.0004108158,0.0037308815,0.00047402264],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006663044,0.000582709,0.03645252,0.0003647484,0.00050557946,0.00072132266,0.00025559988,0.000025109051,0.86965305,0.000010562259,0.013909244,0.07085653],"study_design_scores_gemma":[0.004807365,0.0019273999,0.51315534,0.0007543568,0.00006215651,0.000038136546,0.0011669745,0.0003191711,0.4539195,0.00002955429,0.023362221,0.00045781504],"about_ca_topic_score_codex":0.0054144217,"about_ca_topic_score_gemma":0.00040986112,"teacher_disagreement_score":0.47670284,"about_ca_system_score_codex":0.0008138266,"about_ca_system_score_gemma":0.003577513,"threshold_uncertainty_score":0.9998701},"labels":[],"label_agreement":null},{"id":"W4362543756","doi":"10.1158/1538-7445.am2023-90","title":"Abstract 90: Exploring the role of common circulating tumor cell-associated genes in estrogen receptor-positive breast cancer recurrence","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Gene signature; Circulating tumor cell; Oncology; Cancer; Cancer research; Gene; Internal medicine; Primary tumor; Estrogen; Metastasis; Gene expression; Biology; Genetics","score_opus":0.053319357035947215,"score_gpt":0.3473880520450251,"score_spread":0.2940686950090779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926506,0.0057233754,7.19004e-7,0.00025695277,0.00018121967,0.00029190563,0.00054849684,0.000009034486,0.0003376546],"genre_scores_gemma":[0.9918119,0.007296878,0.000006906072,0.000026836819,0.0002546756,0.00044316082,0.000091173824,0.000031111464,0.000037391263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846166,0.0001194361,0.0002574097,0.00034795268,0.00030888684,0.00050466094],"domain_scores_gemma":[0.99908864,0.0001697287,0.00010183057,0.0002947978,0.0002656441,0.000079378704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070904987,0.00012805042,0.00017097175,0.00010221104,0.00015678092,0.000036822523,0.0003618412,0.00006814832,0.00004159707],"category_scores_gemma":[0.00011088224,0.00011571279,0.00006875663,0.0006083414,0.00014446865,0.000007785826,0.00026682275,0.0002923219,0.000010124836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009358001,0.000059621172,0.08255318,0.000038433518,0.00003980131,0.0000072210814,0.00041736063,0.0025578886,0.889758,0.00004143629,0.0006725521,0.023760952],"study_design_scores_gemma":[0.00044733757,0.000077047276,0.18384477,0.00024757392,0.000009202631,0.0000024754613,0.0013655128,0.00026218576,0.8113943,0.00016090326,0.0019744232,0.00021429588],"about_ca_topic_score_codex":0.007503855,"about_ca_topic_score_gemma":0.0015488443,"teacher_disagreement_score":0.1012916,"about_ca_system_score_codex":0.00018920956,"about_ca_system_score_gemma":0.00043091393,"threshold_uncertainty_score":0.9991053},"labels":[],"label_agreement":null},{"id":"W4362543757","doi":"10.1158/1538-7445.am2023-827","title":"Abstract 827: Comparative study of calcein encapsulation into nanoparticles using three different micromixers as a model for small drug molecules","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; McGill University Health Centre","funders":"","keywords":"Calcein; Liposome; Micromixer; Nanocarriers; Chromatography; Materials science; Zeta potential; Chemistry; Microfluidics; Nanotechnology; Drug delivery; Analytical Chemistry (journal); Nanoparticle; Membrane; Biochemistry","score_opus":0.22194354565442337,"score_gpt":0.4322375742827711,"score_spread":0.21029402862834773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974837,0.00015083383,0.0004148346,0.00014018644,0.00011249922,0.0015657683,0.00005670198,0.000067408364,0.000008125994],"genre_scores_gemma":[0.9989123,0.000008779303,0.00048618185,0.000008695089,0.00004416517,0.00045093056,0.000006799096,0.00002981269,0.000052353214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975157,0.00021518346,0.0004389911,0.00050318183,0.00070250157,0.0006244381],"domain_scores_gemma":[0.99843735,0.00042930248,0.00012014659,0.00038259354,0.00048460453,0.00014601892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012485698,0.00017294372,0.00033239427,0.0002780572,0.00031751813,0.00009786097,0.0004000238,0.000048234506,0.000054357984],"category_scores_gemma":[0.00010992352,0.00015328398,0.000063266845,0.0005691793,0.00024189302,0.00017122601,0.00022444034,0.00015312499,0.000060346927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042892646,0.0003203273,0.0006182796,0.0000907645,0.000021978209,0.000005473757,0.007823624,0.10284107,0.8873468,0.000100417,0.00011889232,0.00028344986],"study_design_scores_gemma":[0.00095007726,0.00016738534,0.001658907,0.000067863155,0.00001761822,2.1133198e-7,0.002945814,0.23472074,0.75781715,0.0015265993,0.000001820595,0.00012583222],"about_ca_topic_score_codex":0.0046403813,"about_ca_topic_score_gemma":0.0047719507,"teacher_disagreement_score":0.13187967,"about_ca_system_score_codex":0.00033655192,"about_ca_system_score_gemma":0.0003382836,"threshold_uncertainty_score":0.70149},"labels":[],"label_agreement":null},{"id":"W4362543823","doi":"10.1158/1538-7445.am2023-2250","title":"Abstract 2250: Immuno-oncology study to profile the tumor microenvironment in multiple human cancers using high-plex imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Tumor microenvironment; Cancer research; Cancer; Immune system; Tissue microarray; Pathology; Extracellular matrix; Medicine; Biology; Phenotype; Immunohistochemistry; Immunology; Internal medicine; Cell biology","score_opus":0.08755150563077185,"score_gpt":0.39659916207583396,"score_spread":0.3090476564450621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769026,0.0004547498,0.0000394652,0.00032866688,0.00024901202,0.0010465726,0.00005753562,0.000015212103,0.000118511],"genre_scores_gemma":[0.9986909,0.00011718288,0.00009966388,0.00014000387,0.00026888383,0.0003496425,0.00004540627,0.00004813906,0.0002401987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997907,0.0002195057,0.0002787913,0.0005324179,0.0003483224,0.0007139962],"domain_scores_gemma":[0.9992663,0.000056023786,0.000046243935,0.00045359146,0.00007386239,0.00010392392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011076557,0.00016427416,0.00019509869,0.00023423073,0.00036097117,0.000057111258,0.000501779,0.00005691954,0.00012833044],"category_scores_gemma":[0.00006159108,0.0001397584,0.000054217784,0.0005904753,0.00019234513,0.000006271471,0.00026096706,0.00036502923,0.00003123853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019323565,0.000130143,0.05885882,0.000027976937,0.00003569194,0.000049524904,0.0005388752,0.0013474338,0.9364312,9.361398e-7,0.0008952761,0.0014908622],"study_design_scores_gemma":[0.002594595,0.000620658,0.2132436,0.00007897754,0.000015639895,0.0000044342733,0.0070818667,0.0005297582,0.7670852,0.000020275094,0.008316498,0.000408503],"about_ca_topic_score_codex":0.0113419285,"about_ca_topic_score_gemma":0.0038947249,"teacher_disagreement_score":0.16934603,"about_ca_system_score_codex":0.0007164475,"about_ca_system_score_gemma":0.0003285122,"threshold_uncertainty_score":0.99524164},"labels":[],"label_agreement":null},{"id":"W4362543839","doi":"10.1158/1538-7445.am2023-1064","title":"Abstract 1064: Cancer-specific molecular subtypes of pancreatic cancer reveal clinically relevant molecular dependency","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pancreatic cancer; Omics; Computational biology; Biology; Cancer; Transcriptome; Metabolomics; Molecular medicine; KRAS; Proteome; Bioinformatics; Genetics; Gene; Gene expression; Cell cycle; Colorectal cancer","score_opus":0.05491137576291802,"score_gpt":0.39714328531233845,"score_spread":0.3422319095494204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96686864,0.029262353,0.00008652971,0.0011280089,0.00048580722,0.000588227,0.00044706295,0.000030524843,0.0011028593],"genre_scores_gemma":[0.91410017,0.083411686,0.00015081088,0.0001904081,0.0005120028,0.0006127596,0.00011455584,0.0000982769,0.00080931577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964967,0.00016349423,0.0006952471,0.0008951509,0.0008104236,0.00093900453],"domain_scores_gemma":[0.9976056,0.00019641698,0.00020088088,0.00094122597,0.0007589394,0.0002969083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011503462,0.00029012258,0.00044604373,0.00022655562,0.0001514947,0.000060087033,0.0007363751,0.00031375495,0.00034162853],"category_scores_gemma":[0.00042868385,0.0002931644,0.00024026034,0.0007812786,0.00035414577,0.000008181588,0.00042598543,0.0005043251,0.000064173444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004333989,0.0000788899,0.007983419,0.00021456828,0.00019737458,0.0001100912,0.0000757983,0.0018753628,0.95991135,0.00032748937,0.015069766,0.013722516],"study_design_scores_gemma":[0.0014459044,0.0005296902,0.021331485,0.0004175225,0.00007304468,0.0000048812512,0.00017452566,0.00006509428,0.9173475,0.0014979282,0.05647437,0.0006380553],"about_ca_topic_score_codex":0.0025436832,"about_ca_topic_score_gemma":0.0006627247,"teacher_disagreement_score":0.05414933,"about_ca_system_score_codex":0.000192482,"about_ca_system_score_gemma":0.0014235367,"threshold_uncertainty_score":0.9999521},"labels":[],"label_agreement":null},{"id":"W4362543936","doi":"10.1158/1538-7445.am2023-1279","title":"Abstract 1279: Investigating the impact of PGC-1α-coupled metabolic reprogramming on breast cancer metastasis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Jewish General Hospital; Institute for Research in Immunology and Cancer; McGill University","funders":"","keywords":"Biology; Metastasis; Breast cancer; Coactivator; Cancer research; Cancer; Context (archaeology); Endocrinology; Internal medicine; Medicine; Transcription factor; Genetics; Gene","score_opus":0.08480541556675486,"score_gpt":0.4289531462342888,"score_spread":0.34414773066753396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856272,0.0118693495,0.0000040202144,0.0009334351,0.00045099625,0.00049248914,0.00034118627,0.000031968175,0.0002493942],"genre_scores_gemma":[0.98283225,0.013503077,0.000032369553,0.00008202731,0.002205851,0.0005499091,0.000058638903,0.000063625695,0.00067222764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973221,0.00020124405,0.0003467566,0.000609297,0.0006744212,0.000846199],"domain_scores_gemma":[0.9982225,0.000102160084,0.00015286873,0.000842299,0.00045409732,0.0002260761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018973545,0.00023993284,0.00035338022,0.00021867614,0.00030299593,0.00007720699,0.0005547846,0.00014061916,0.00021487866],"category_scores_gemma":[0.0003455879,0.00014982169,0.00032502867,0.001221775,0.00042936148,0.000011418077,0.00025367917,0.000480368,0.000025209954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001860472,0.000050371134,0.001958626,0.0000590853,0.0004163058,0.0000019828171,0.00025868585,0.0019595013,0.87738144,0.000059463237,0.013253347,0.10441514],"study_design_scores_gemma":[0.0019152345,0.0003093689,0.2717667,0.00026062102,0.00014202268,0.000019162057,0.00089525676,0.00044603244,0.57203925,0.0002562511,0.15129426,0.0006558601],"about_ca_topic_score_codex":0.0135248685,"about_ca_topic_score_gemma":0.0006679989,"teacher_disagreement_score":0.3053422,"about_ca_system_score_codex":0.000079269346,"about_ca_system_score_gemma":0.0009476737,"threshold_uncertainty_score":0.99304414},"labels":[],"label_agreement":null},{"id":"W4362543946","doi":"10.1158/1538-7445.am2023-173","title":"Abstract 173: Genomic characterization of patient-derived pancreatic cancer organoids","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Toronto","funders":"","keywords":"Organoid; Transcriptome; KRAS; Pancreatic cancer; CDKN2A; Biology; Cancer research; Cancer; PTEN; Irinotecan; Internal medicine; Colorectal cancer; Oncology; Medicine; Gene; Genetics; Gene expression; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.03207441286818929,"score_gpt":0.336797973624828,"score_spread":0.3047235607566387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362543946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976443,0.0009434821,0.000014249767,0.0002608067,0.00027261107,0.00032250717,0.0003508109,0.0000149839525,0.00017623512],"genre_scores_gemma":[0.9853757,0.013148386,0.000013790749,0.00008919536,0.00038518163,0.00024616078,0.00035104837,0.000044333665,0.0003461772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987027,0.000046874255,0.00024293616,0.00033625693,0.00026208945,0.00040913295],"domain_scores_gemma":[0.9991074,0.000038990267,0.00008767621,0.00035115978,0.000308538,0.00010621777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002350011,0.00011992753,0.00016529864,0.00013828055,0.00010565892,0.000029393683,0.0002279568,0.0001161839,0.00027919075],"category_scores_gemma":[0.00011226596,0.0001223155,0.000058801787,0.00040680266,0.00012295402,0.0000047341437,0.00020845972,0.00013599175,0.000046444962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010509494,0.000025893984,0.0046455143,0.00007736184,0.00005137028,0.0000033931688,0.0001877674,0.0001426398,0.9857397,0.000019884916,0.0018081408,0.0071932343],"study_design_scores_gemma":[0.00034186323,0.00012939627,0.07710856,0.000049916027,0.000010539467,6.2661445e-7,0.00011622202,0.000026337611,0.9061528,0.000042285028,0.015877921,0.00014352103],"about_ca_topic_score_codex":0.0005493725,"about_ca_topic_score_gemma":0.0002080095,"teacher_disagreement_score":0.0795869,"about_ca_system_score_codex":0.00009728242,"about_ca_system_score_gemma":0.0005178291,"threshold_uncertainty_score":0.49878815},"labels":[],"label_agreement":null},{"id":"W4362544048","doi":"10.1158/1538-7445.am2023-3671","title":"Abstract 3671: Targeting SLC2A1 and SLC38A2-mediated metabolic shift in SMARCA4/A2-dual deficient cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Glutamine; SMARCA4; Cancer research; GLUT1; Biology; Cancer; Glucose transporter; Internal medicine; Medicine; Endocrinology; Epigenetics; Biochemistry; Amino acid; Chromatin remodeling","score_opus":0.056025171967445095,"score_gpt":0.3881858977241782,"score_spread":0.3321607257567331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97832674,0.01986799,0.000008953148,0.00064650265,0.00021714618,0.00026163142,0.000110566536,0.00003301585,0.0005274626],"genre_scores_gemma":[0.9867412,0.011720135,0.000027022304,0.00013105462,0.00042084538,0.00032344155,0.00015450123,0.000044225668,0.00043758552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977569,0.00011384406,0.0002881614,0.00059190317,0.00047105722,0.000778155],"domain_scores_gemma":[0.9992777,0.00007255814,0.000050491144,0.0002808561,0.00015249479,0.00016589317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001215257,0.00017437148,0.00021506214,0.00022354844,0.00016920498,0.000064050924,0.00021516244,0.00017068468,0.00024875582],"category_scores_gemma":[0.00020320565,0.0001636272,0.000057347876,0.0006999188,0.00016974853,0.000007304287,0.00026440155,0.0004031219,0.000053484986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016754537,0.00005684909,0.01384499,0.00018551292,0.000067942776,0.00003233541,0.0005556787,0.0032748675,0.950214,0.000049437265,0.018905748,0.01264508],"study_design_scores_gemma":[0.004827677,0.00029661876,0.21914175,0.0006478898,0.00004425166,0.000009665629,0.0022515997,0.0058711465,0.42921138,0.00068617414,0.33550107,0.001510783],"about_ca_topic_score_codex":0.0034459196,"about_ca_topic_score_gemma":0.0022982522,"teacher_disagreement_score":0.52100265,"about_ca_system_score_codex":0.00008520633,"about_ca_system_score_gemma":0.00047521017,"threshold_uncertainty_score":0.6672524},"labels":[],"label_agreement":null},{"id":"W4362544049","doi":"10.1158/1538-7445.am2023-3677","title":"Abstract 3677: DNA damage signaling activates <i>de novo</i> GTP synthesis to promote chemoradiation resistance in glioblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Purine; DNA damage; Nucleotide salvage; Cancer research; DNA repair; DNA synthesis; In vivo; Biology; In vitro; Purine metabolism; Guanine; Biochemistry; DNA; Chemistry; Enzyme; Nucleotide; Gene; Genetics","score_opus":0.03308971699942246,"score_gpt":0.35816919161245536,"score_spread":0.3250794746130329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580806,0.0003689016,0.000021457547,0.0025249496,0.00003448965,0.00044510487,0.000045742032,0.000031942087,0.00071932294],"genre_scores_gemma":[0.99738944,0.00027861202,0.0001579141,0.0001206216,0.0002482174,0.0005757733,0.000025883304,0.000050965016,0.0011525996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975333,0.00013573711,0.00021460891,0.000626239,0.0005657184,0.00092438055],"domain_scores_gemma":[0.99895334,0.00010352001,0.000032243835,0.00042933717,0.0002141988,0.00026734124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013654892,0.00016141834,0.00017069369,0.00028241376,0.00014083227,0.00008225736,0.00049209426,0.00020953912,0.00007994563],"category_scores_gemma":[0.0012165197,0.00016343493,0.00007004491,0.0012786569,0.00012048757,0.000009231236,0.0003025593,0.00040862485,0.000098335564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005435247,0.00005380546,0.0002608866,0.00013233029,0.000021358177,0.000056591933,0.00011325414,0.00007837194,0.9910339,0.000019819236,0.0051291003,0.002557051],"study_design_scores_gemma":[0.00024170575,0.000078074416,0.00200465,0.00018529514,0.0000022423035,0.000001190635,0.00007615425,0.000019817135,0.9768351,0.000115059906,0.02025335,0.00018740463],"about_ca_topic_score_codex":0.00012126734,"about_ca_topic_score_gemma":0.00037268156,"teacher_disagreement_score":0.015124248,"about_ca_system_score_codex":0.00018081839,"about_ca_system_score_gemma":0.00034520592,"threshold_uncertainty_score":0.6664683},"labels":[],"label_agreement":null},{"id":"W4362544056","doi":"10.1158/1538-7445.am2023-2259","title":"Abstract 2259: Novel metallotherapeutic BOLD-100 induces circulating cytokine changes when administered in combination with FOLFOX in advanced gastrointestinal cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"FOLFOX; Medicine; Oxaliplatin; Cancer; Population; Oncology; Immune system; Internal medicine; Colorectal cancer; Pharmacology; Immunology","score_opus":0.12011748322202367,"score_gpt":0.3805282088504118,"score_spread":0.2604107256283881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768716,0.00015358417,0.0000122048195,0.0009762417,0.0001315802,0.00081844226,0.000078893434,0.00008128622,0.00006060261],"genre_scores_gemma":[0.9985367,0.000034764857,0.00024151166,0.00008338391,0.000053098134,0.000890626,0.000021780337,0.000051491697,0.00008666449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684805,0.00017533806,0.0003809095,0.00061215676,0.0010376372,0.00094588444],"domain_scores_gemma":[0.99874645,0.00033603504,0.00014446951,0.00028627887,0.00035619963,0.00013056019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014040822,0.00020478966,0.00030049385,0.0006521419,0.00012864385,0.000119736564,0.0003832803,0.000054732056,0.0003101593],"category_scores_gemma":[0.00017859711,0.00018704154,0.000025535592,0.0014443414,0.00017148035,0.00039332794,0.0001390085,0.00037898758,0.000057088055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041887205,0.00037091534,0.04604532,0.00011936987,0.0000067470837,0.000052272335,0.00078810635,0.0015329279,0.945802,0.000021264072,0.000023819446,0.004818424],"study_design_scores_gemma":[0.0056324997,0.0009009401,0.45022056,0.0015983363,0.000010016497,0.000004947909,0.0006916018,0.0014479402,0.5388431,0.00016555525,0.00009714673,0.00038739824],"about_ca_topic_score_codex":0.0042531956,"about_ca_topic_score_gemma":0.01095817,"teacher_disagreement_score":0.4069589,"about_ca_system_score_codex":0.000748109,"about_ca_system_score_gemma":0.0004888611,"threshold_uncertainty_score":0.7627333},"labels":[],"label_agreement":null},{"id":"W4362544072","doi":"10.1158/1538-7445.am2023-2516","title":"Abstract 2516: Analysis of CLL Celllular Environment and Response (ACCER) is a novel method to understand the microenvironment in CLL","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Chronic lymphocytic leukemia; Tumor microenvironment; Stromal cell; Ibrutinib; Cancer research; Cell culture; Bone marrow; Fludarabine; Medicine; Leukemia; Chemistry; Immunology; Biology; Internal medicine; Chemotherapy; Tumor cells; Genetics","score_opus":0.14163263964478942,"score_gpt":0.45270551414889826,"score_spread":0.3110728745041088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888266,0.0012304314,0.0006023049,0.007844101,0.00001770946,0.0011166615,0.00011548006,0.000012223777,0.00017839827],"genre_scores_gemma":[0.9936287,0.0019146918,0.00056614756,0.00027322583,0.00004229302,0.00018011802,0.000012812681,0.000041515465,0.0033405276],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960747,0.00041141367,0.00043789396,0.00066498684,0.0015893219,0.00082172506],"domain_scores_gemma":[0.9970348,0.001610697,0.00005599187,0.0009182072,0.00005735921,0.00032295447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0070057455,0.00017547175,0.00048572756,0.0013545139,0.00012205208,0.000036884907,0.00034957245,0.00012169616,0.0012547121],"category_scores_gemma":[0.00024013093,0.00013075858,0.00013568306,0.002613329,0.00044325998,0.000043766937,0.000570394,0.0005683704,0.00009970637],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071253492,0.00029851505,0.0027553,0.00034411516,0.0013283088,0.00026960083,0.015005874,0.004747726,0.95565045,0.00006373537,0.004722797,0.0076882415],"study_design_scores_gemma":[0.024798848,0.0011371004,0.57207227,0.0006022591,0.0009326225,0.000039249684,0.028560044,0.03217176,0.28800574,0.00019143439,0.050801314,0.00068733934],"about_ca_topic_score_codex":0.0037366012,"about_ca_topic_score_gemma":0.00019775011,"teacher_disagreement_score":0.6676447,"about_ca_system_score_codex":0.013260836,"about_ca_system_score_gemma":0.0019734418,"threshold_uncertainty_score":0.9996583},"labels":[],"label_agreement":null},{"id":"W4362544124","doi":"10.1158/1538-7445.am2023-2274","title":"Abstract 2274: An immune-educating therapy, Maveropepimut-S, elicits a diverse and active anti-tumor T cell response in patients with advanced recurrent ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MEG-3 (Canada); Nova Scotia Hospital","funders":"","keywords":"Survivin; Immunotherapy; T cell; Immune system; Immunology; T-cell receptor; Cancer research; Medicine; Epitope; Ovarian cancer; Antigen; Population; Cancer; Biology; Internal medicine","score_opus":0.0733019451402827,"score_gpt":0.42089817160453186,"score_spread":0.34759622646424915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526244,0.0013914363,1.8128644e-7,0.0012634511,0.00012661108,0.0013247689,0.00018801825,0.00004138046,0.00040172832],"genre_scores_gemma":[0.9942387,0.003939067,0.00004398237,0.00010182226,0.00014186272,0.00040317394,0.000070469425,0.000056943063,0.0010039989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964661,0.00039196346,0.0003055305,0.0006666902,0.0011601185,0.0010096153],"domain_scores_gemma":[0.9981605,0.0003890644,0.00008423691,0.0003827176,0.0005672206,0.00041629194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012279701,0.00024910812,0.00040560725,0.0006198417,0.00036661685,0.00006428418,0.00026272738,0.000077980745,0.0006055259],"category_scores_gemma":[0.00015051644,0.00018515141,0.000051241866,0.0012968632,0.00030624043,0.00025678627,0.00022891702,0.0010334786,0.00005450612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1061361,0.0013804472,0.4822873,0.0006053522,0.00017090786,0.00045824845,0.006966818,0.000106515494,0.1403002,0.000019521807,0.0010403837,0.26052824],"study_design_scores_gemma":[0.004614897,0.00167561,0.9765061,0.0006229089,0.000007091377,0.0000024896742,0.0016617201,0.0000690727,0.011675546,0.000014459377,0.0029227696,0.00022732688],"about_ca_topic_score_codex":0.0057064295,"about_ca_topic_score_gemma":0.00042703815,"teacher_disagreement_score":0.49421883,"about_ca_system_score_codex":0.000403863,"about_ca_system_score_gemma":0.0010123434,"threshold_uncertainty_score":0.86264527},"labels":[],"label_agreement":null},{"id":"W4362544136","doi":"10.1158/1538-7445.am2023-3700","title":"Abstract 3700: Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle in prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Citric acid cycle; IDH1; Isocitrate dehydrogenase; IDH2; Biology; Prostate cancer; Mitochondrion; Tricarboxylic acid; Biochemistry; Cancer research; Cancer; Enzyme; Genetics","score_opus":0.03127654487757563,"score_gpt":0.3601113747704069,"score_spread":0.32883482989283125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868917,0.009147506,0.0000060013863,0.0006633785,0.0012527679,0.0008990814,0.00039736694,0.000050995408,0.00069122243],"genre_scores_gemma":[0.9697926,0.02138183,0.000016620104,0.00015965974,0.0030532384,0.0015177719,0.00015738701,0.000084406,0.0038365019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99666846,0.00017944467,0.00037701608,0.0008453564,0.00059000944,0.0013396919],"domain_scores_gemma":[0.9987223,0.00004149323,0.00008270883,0.000551141,0.00030209913,0.00030021858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007213734,0.00026957723,0.00032840122,0.00039146474,0.00021421212,0.00009657168,0.00047265564,0.00016289036,0.00015470643],"category_scores_gemma":[0.00019920141,0.00027048975,0.00016211321,0.001165983,0.00024313042,0.00001806914,0.00026845484,0.0005941478,0.00007046064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072767335,0.000073150295,0.0005711751,0.00009407315,0.00007475378,0.0000678149,0.00027671468,0.0016824132,0.95874566,0.00002663852,0.027325671,0.010334254],"study_design_scores_gemma":[0.0034997705,0.00015054383,0.0032521961,0.00007959254,0.0000194907,0.0000100114,0.0003880227,0.00028427708,0.7611415,0.00035434304,0.23030561,0.00051464327],"about_ca_topic_score_codex":0.0025715036,"about_ca_topic_score_gemma":0.0035304592,"teacher_disagreement_score":0.20297994,"about_ca_system_score_codex":0.00025173233,"about_ca_system_score_gemma":0.0016049349,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W4362544178","doi":"10.1158/1538-7445.am2023-3434","title":"Abstract 3434: Selective glucocorticoid receptor modulation reveals a new role for CLEC10A in patients with solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Glucocorticoid receptor; Medicine; Internal medicine; Oncology; Glucocorticoid; Confounding; Bioinformatics; Pharmacology; Biology","score_opus":0.059963316763689066,"score_gpt":0.4351800655281019,"score_spread":0.37521674876441286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925141,0.0002617343,0.000014672715,0.0020352642,0.00008010203,0.0042568287,0.00006364866,0.00008397615,0.00068970816],"genre_scores_gemma":[0.9935971,0.00017822308,0.00012111196,0.00006594832,0.00032183016,0.0015504688,0.00010168577,0.00007191522,0.0039917026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965603,0.00008634182,0.00033550922,0.0005899316,0.0013464354,0.0010814768],"domain_scores_gemma":[0.99788433,0.00035875879,0.00007394306,0.0003569996,0.0010496011,0.00027639052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009668392,0.0001793209,0.00043516292,0.00064981927,0.0001662885,0.0000444534,0.00018190718,0.000087189575,0.00015293914],"category_scores_gemma":[0.00088743516,0.00014578021,0.00006410884,0.0020692414,0.00013172932,0.00018430967,0.000120870405,0.0006004289,0.0001605059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010877717,0.00033009358,0.82068646,0.0011316247,0.00036325693,0.00002104319,0.002932476,0.0010775574,0.044268012,0.00008527861,0.082089074,0.036137402],"study_design_scores_gemma":[0.005518548,0.0012963585,0.9830303,0.0007373713,0.000012828855,3.629983e-7,0.0003827931,0.00037905315,0.0061154314,0.0006720244,0.0016754587,0.00017943933],"about_ca_topic_score_codex":0.0014157773,"about_ca_topic_score_gemma":0.00044273215,"teacher_disagreement_score":0.16234386,"about_ca_system_score_codex":0.0016423545,"about_ca_system_score_gemma":0.0015332479,"threshold_uncertainty_score":0.59447443},"labels":[],"label_agreement":null},{"id":"W4362544237","doi":"10.1158/1538-7445.am2023-3708","title":"Abstract 3708: Platelet-derived microparticles modulate breast cancer malignant processes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Breast cancer; Cancer; Metastasis; Malignancy; Internalization; Cancer research; Cancer cell; Medicine; Platelet activation; Platelet; Mitochondrion; Metastatic breast cancer; Immunology; Biology; Pathology; Internal medicine; Cell biology; Receptor","score_opus":0.04925191727657878,"score_gpt":0.3727099690000851,"score_spread":0.3234580517235063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206907,0.0055725556,0.000010424166,0.0013061943,0.00013303853,0.00034429002,0.0003498585,0.00006455867,0.0001499998],"genre_scores_gemma":[0.9923194,0.005386079,0.000029720928,0.00009143119,0.00048523003,0.00040785628,0.00008698951,0.000069882815,0.0011234047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977567,0.00008963055,0.0002326094,0.0006213973,0.0004486886,0.0008509501],"domain_scores_gemma":[0.9986891,0.00003406515,0.000054947977,0.00050248543,0.00045353782,0.00026585883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000501828,0.00018703996,0.00015396625,0.00011906596,0.0002612253,0.00009067066,0.00048398212,0.00014055739,0.0003435612],"category_scores_gemma":[0.00011789195,0.00017339396,0.00007160683,0.00064894045,0.0003058396,0.000011957204,0.0003215705,0.00023510697,0.00022418523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024108242,0.00006471586,0.0027136141,0.00026585849,0.00006820627,0.00008853601,0.00009829063,0.00054734567,0.9780552,0.000008364007,0.009852284,0.007996529],"study_design_scores_gemma":[0.00048398826,0.000038712187,0.024885556,0.00010644742,0.000008144344,0.000011401364,0.00014165671,0.00006793482,0.9661376,0.00014402842,0.0077348473,0.00023971466],"about_ca_topic_score_codex":0.00034127833,"about_ca_topic_score_gemma":0.00024826924,"teacher_disagreement_score":0.022171943,"about_ca_system_score_codex":0.00007340166,"about_ca_system_score_gemma":0.00069597136,"threshold_uncertainty_score":0.70708},"labels":[],"label_agreement":null},{"id":"W4362544444","doi":"10.1158/1538-7445.am2023-4783","title":"Abstract 4783: ADO is essential for redox homeostasis in liver cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Cancer research; Biology; Cell growth; Liver cancer; Selenoprotein; Transcriptome; Medicine; Hepatocellular carcinoma; Immunology; Glutathione; Internal medicine; Biochemistry","score_opus":0.064483148638823,"score_gpt":0.4101947668173346,"score_spread":0.3457116181785116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633274,0.03240382,0.00002208713,0.0010876143,0.0013201721,0.0006708602,0.0005992633,0.000023026581,0.00054576184],"genre_scores_gemma":[0.90206045,0.08388458,0.000047720256,0.0002955441,0.0046686423,0.0015668765,0.00014892279,0.00006910723,0.0072581368],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980125,0.000054845765,0.00021253654,0.0005764043,0.00037333788,0.0007703662],"domain_scores_gemma":[0.9990948,0.000040994913,0.00004223479,0.0003891826,0.00028779346,0.00014498038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064624846,0.00015096484,0.00020225348,0.00023687084,0.0001422369,0.000050116523,0.00033217395,0.00019849812,0.0005656111],"category_scores_gemma":[0.00010651225,0.00015253616,0.00012746539,0.0005847854,0.00015509073,0.00000858135,0.00018164983,0.00025258242,0.000052503132],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038837356,0.0000415661,0.00044438208,0.00016399212,0.000063629384,0.00000569151,0.00027440776,0.000073695854,0.5761831,0.00003477679,0.3359841,0.08634232],"study_design_scores_gemma":[0.0009755868,0.000056893678,0.0101219285,0.00005432399,0.000010411355,9.267987e-7,0.00014212156,0.00003763221,0.28364766,0.00008499752,0.704676,0.00019150903],"about_ca_topic_score_codex":0.0029874314,"about_ca_topic_score_gemma":0.0038546142,"teacher_disagreement_score":0.3686919,"about_ca_system_score_codex":0.00009042504,"about_ca_system_score_gemma":0.0006383776,"threshold_uncertainty_score":0.6220244},"labels":[],"label_agreement":null},{"id":"W4362544614","doi":"10.1158/1538-7445.am2023-5434","title":"Abstract 5434: Machine-learning-based epigenetic detection of early-stage lung cancers using the EpiCheck liquid biopsy platform","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"DNA methylation; Liquid biopsy; Lung cancer; Methylation; Epigenetics; Biology; Oncology; Computational biology; Cancer; Bioinformatics; Internal medicine; Gene; Medicine; Genetics; Gene expression","score_opus":0.07899670864868054,"score_gpt":0.3950936996744417,"score_spread":0.31609699102576116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369895,0.004030026,0.0014711651,0.00007556737,0.00017326878,0.0003369747,0.000043713546,0.00001893332,0.00015141377],"genre_scores_gemma":[0.99760604,0.001551562,0.00004024821,0.000011676305,0.0002121165,0.000078582525,0.00005191471,0.000042527456,0.00040533923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998282,0.00014222259,0.00026222426,0.00035205536,0.00044648914,0.0005150113],"domain_scores_gemma":[0.99902946,0.000081707745,0.00011954181,0.0003854134,0.00028898136,0.000094881965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001298521,0.00014076872,0.0001361077,0.00018288748,0.00035329422,0.00003759866,0.0002788489,0.00017120545,0.00006389355],"category_scores_gemma":[0.00017801896,0.00011680578,0.00009808803,0.000644986,0.00020614214,0.0000056366516,0.0001337434,0.00036181769,0.000007583215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026038906,0.000010048071,0.00403716,0.00008345635,0.000042042557,0.0000028294808,0.00009681032,0.04533719,0.9485869,0.0000039874326,0.000011409264,0.0015278136],"study_design_scores_gemma":[0.00031374538,0.00032281096,0.011442112,0.00003429943,0.000011976199,3.5909665e-7,0.00011563195,0.012505604,0.97133666,0.00001908211,0.0037581786,0.00013956436],"about_ca_topic_score_codex":0.0043899505,"about_ca_topic_score_gemma":0.0009655713,"teacher_disagreement_score":0.032831583,"about_ca_system_score_codex":0.00014621117,"about_ca_system_score_gemma":0.00045237225,"threshold_uncertainty_score":0.66363215},"labels":[],"label_agreement":null},{"id":"W4362545030","doi":"10.1158/1538-7445.am2023-3143","title":"Abstract 3143: A bioinformatic pipeline for identifying change-of-metabolic-function cancer mutations","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Genetics; Metabolic pathway; In silico; Indel; KRAS; Computational biology; Cancer; Mutation; Gene; Cancer research; Biochemistry; Genotype","score_opus":0.14197581880256618,"score_gpt":0.42652665795142,"score_spread":0.2845508391488538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362545030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96661747,0.012332227,0.013797808,0.0013218683,0.0014726564,0.0022295788,0.0007295859,0.000055752513,0.0014430475],"genre_scores_gemma":[0.9912619,0.004125717,0.00022587672,0.00014197188,0.000975654,0.0013919221,0.0004619022,0.000027635384,0.0013874016],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988455,0.000019192858,0.00031262345,0.00017187133,0.00023193333,0.00041888742],"domain_scores_gemma":[0.9991766,0.00004089006,0.000101714715,0.00024813492,0.0003499264,0.00008269895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007657546,0.000102141006,0.00014342005,0.00020258926,0.0001852324,0.000041738902,0.00019796652,0.000120632336,0.00007947985],"category_scores_gemma":[0.00006401094,0.0000955525,0.00009208717,0.00047576154,0.00009536044,0.000016148586,0.000110738874,0.00014275267,0.00004045852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051177095,0.00008164646,0.0014485677,0.0017746344,0.0003542757,0.000001538805,0.0022435866,0.0028449926,0.46359366,0.0018312212,0.09818775,0.42712635],"study_design_scores_gemma":[0.0044218223,0.0004801408,0.032737784,0.00072786043,0.00016813428,0.0000046516802,0.0040209293,0.048897132,0.23207904,0.0057391976,0.6696343,0.0010890282],"about_ca_topic_score_codex":0.00027603717,"about_ca_topic_score_gemma":0.000261243,"teacher_disagreement_score":0.57144654,"about_ca_system_score_codex":0.000020596684,"about_ca_system_score_gemma":0.0001920563,"threshold_uncertainty_score":0.38965178},"labels":[],"label_agreement":null},{"id":"W4362545300","doi":"10.1158/1538-7445.am2023-5071","title":"Abstract 5071: Olverembatinib (HQP1351) enhances antitumor effects of immunotherapy in renal cell carcinoma (RCC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Axitinib; Cancer research; Immunotherapy; Lenvatinib; Medicine; Tumor microenvironment; Cancer immunotherapy; Cancer; Pharmacology; Sorafenib; Internal medicine","score_opus":0.06318448062453177,"score_gpt":0.3873964400267268,"score_spread":0.32421195940219505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362545300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562807,0.0076008597,0.0000013264163,0.0002807758,0.00017695077,0.0011642351,0.000013942447,0.000044231816,0.0050896364],"genre_scores_gemma":[0.9941394,0.002719509,0.000063705666,0.000030910323,0.00017795601,0.0003916131,0.000026267799,0.00005254597,0.0023981018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971011,0.00016440864,0.00042079296,0.00048488608,0.0010627975,0.0007659621],"domain_scores_gemma":[0.99831325,0.00059625093,0.00009461249,0.00056213414,0.00025691072,0.00017682908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008596955,0.00021239763,0.0005044811,0.0007216088,0.0000822837,0.000022625587,0.00026584853,0.00011309247,0.0004995598],"category_scores_gemma":[0.000108786815,0.00017423787,0.00014659755,0.0014132914,0.00023869945,0.00008193954,0.00009050015,0.00056362397,0.00021036324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007633492,0.00024831266,0.035740852,0.0013756127,0.00004544095,0.000998148,0.0007081644,0.000016352224,0.95103836,0.00001423143,0.0021437902,0.0069073727],"study_design_scores_gemma":[0.0020893875,0.0005823757,0.38856062,0.00043870808,0.000009028768,0.0000039853685,0.00011346996,0.000011211582,0.60762227,0.000040666808,0.00043958798,0.00008870474],"about_ca_topic_score_codex":0.0024417061,"about_ca_topic_score_gemma":0.00012407734,"teacher_disagreement_score":0.35281977,"about_ca_system_score_codex":0.00044796473,"about_ca_system_score_gemma":0.00066232774,"threshold_uncertainty_score":0.7105214},"labels":[],"label_agreement":null},{"id":"W4362545405","doi":"10.1158/1538-7445.am2023-223","title":"Abstract 223: Identifying gene amplifications in p53 abnormal endometrial carcinomas by shallow whole genome sequencing","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometrial cancer; Gene duplication; Carcinogenesis; Ovarian cancer; Oncology; Gene; Biology; Cancer research; Cancer; Biomarker; Internal medicine; Medicine; Genetics","score_opus":0.11385366057830214,"score_gpt":0.3871151222826844,"score_spread":0.27326146170438226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362545405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928501,0.004803149,0.00010807084,0.00034219545,0.00027472703,0.00037680767,0.00060608564,0.000019081474,0.0006197475],"genre_scores_gemma":[0.9928554,0.0041063875,0.00007057228,0.000064339154,0.000707413,0.00030854726,0.0008836374,0.00004401423,0.00095964066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979774,0.00006844954,0.00031154556,0.00054361066,0.00037801208,0.00072101864],"domain_scores_gemma":[0.9989998,0.00012183468,0.000056106106,0.00045994084,0.0001913446,0.00017099129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010587346,0.0001431155,0.00016793901,0.00038183018,0.00021700021,0.00013037538,0.00043141496,0.0001504306,0.00008441792],"category_scores_gemma":[0.00036027085,0.0001634489,0.00007941015,0.0009604306,0.00012201391,0.000010313619,0.00029305127,0.00032932122,0.0001244642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060588853,0.000028050143,0.005225834,0.000033366778,0.000025589276,0.000024277539,0.00013756928,0.0009094172,0.98741096,0.00003419917,0.0051815915,0.000928542],"study_design_scores_gemma":[0.0037959476,0.0002536177,0.12570174,0.00007544534,0.000019944284,0.000011832379,0.0010911908,0.00020889517,0.6814424,0.00040346183,0.18620908,0.0007864948],"about_ca_topic_score_codex":0.0021309962,"about_ca_topic_score_gemma":0.001329645,"teacher_disagreement_score":0.3059686,"about_ca_system_score_codex":0.00037742342,"about_ca_system_score_gemma":0.0006675051,"threshold_uncertainty_score":0.6665253},"labels":[],"label_agreement":null},{"id":"W4362546319","doi":"10.1158/1538-7445.am2023-3445","title":"Abstract 3445: Immune cells infiltration and activation are higher in breast cancers resistant to antiestrogen therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Stromal cell; Tumor-infiltrating lymphocytes; Tumor microenvironment; Immune system; Estrogen receptor; Pathology; Tissue microarray; Breast cancer; Medicine; Cancer research; Cancer; Biology; Immunohistochemistry; Internal medicine; Immunology; Immunotherapy","score_opus":0.08462259529889507,"score_gpt":0.39378585147067025,"score_spread":0.3091632561717752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362546319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351734,0.00058630784,0.0000015788636,0.004996206,0.000085628686,0.0004345368,0.000020133552,0.000032076216,0.0003262054],"genre_scores_gemma":[0.99678415,0.002012961,0.000014126594,0.00008618173,0.00025206426,0.00011068039,0.000021848973,0.000023393975,0.0006946148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877876,0.000038225797,0.0001823057,0.00024555137,0.00042542838,0.00032971313],"domain_scores_gemma":[0.99944705,0.000079168116,0.000035759975,0.0001578904,0.00016629347,0.000113811104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005417498,0.00009010389,0.00017865698,0.00031848633,0.0000860768,0.00004131272,0.00006123533,0.00006978217,0.00034157885],"category_scores_gemma":[0.000021506406,0.0000783141,0.00002733248,0.0009436042,0.0000489886,0.00008236474,0.000030920975,0.00028893966,0.00001688597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007199917,0.000019553232,0.014257394,0.000083125946,0.000020343708,0.000012951829,0.0003974707,0.00011739319,0.97238517,0.000011725804,0.0039349496,0.008039959],"study_design_scores_gemma":[0.00089642295,0.000078954756,0.47450757,0.0004438341,0.0000022765712,0.0000012380357,0.00053699745,0.00003660641,0.5157773,0.000030041523,0.0075974567,0.0000912884],"about_ca_topic_score_codex":0.0038575241,"about_ca_topic_score_gemma":0.00013915189,"teacher_disagreement_score":0.46025017,"about_ca_system_score_codex":0.00047513316,"about_ca_system_score_gemma":0.00028193142,"threshold_uncertainty_score":0.58314484},"labels":[],"label_agreement":null},{"id":"W4362546664","doi":"10.1158/1538-7445.am2023-345","title":"Abstract 345: Cutaneous T-cell lymphoma: ectopic expression of gametocyte specific factor 1 (GTSF1) stimulates the Th phenotype","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene knockdown; Biology; Ectopic expression; Transcriptome; Cancer research; Phenotype; Immune system; Gene expression profiling; Gene expression; Immunology; Gene; Genetics","score_opus":0.10601838269266348,"score_gpt":0.4066748421608379,"score_spread":0.30065645946817443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362546664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877025,0.0037033665,0.0000088891575,0.0010944679,0.00017591966,0.0015577067,0.00009258117,0.000112074,0.004484776],"genre_scores_gemma":[0.98765486,0.0038337784,0.000030705483,0.0000466647,0.00034019066,0.00020305593,0.00003817764,0.000087673,0.007764916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954696,0.00026854002,0.00044972607,0.00064432574,0.002084046,0.0010837613],"domain_scores_gemma":[0.9963406,0.0013911695,0.00009422822,0.000994732,0.0008920059,0.000287273],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000729466,0.000269333,0.00048743645,0.00053057884,0.0003735358,0.000084762236,0.0006132407,0.00017709569,0.0033228847],"category_scores_gemma":[0.00044826753,0.00017891565,0.0001793614,0.0016918855,0.0006422338,0.00007799701,0.00034968034,0.0006339461,0.0007385045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019071186,0.00045378614,0.008975313,0.0006156878,0.00008025403,0.00062112726,0.0024337757,0.00027412342,0.9438912,0.00004679449,0.017158834,0.023541981],"study_design_scores_gemma":[0.005475001,0.0010228057,0.040282186,0.000686053,0.000031015305,0.00017255664,0.0031587896,0.0010758598,0.91527414,0.000705984,0.0316373,0.00047829398],"about_ca_topic_score_codex":0.0007105657,"about_ca_topic_score_gemma":0.00008445781,"teacher_disagreement_score":0.03130687,"about_ca_system_score_codex":0.00055779325,"about_ca_system_score_gemma":0.0010968732,"threshold_uncertainty_score":0.9975882},"labels":[],"label_agreement":null},{"id":"W4362592058","doi":"10.1158/1538-7445.am2023-5142","title":"Abstract 5142: 50-parameter flow cytometry by CyTOF empowers comprehensive single-cell immune profiling of pulmonary immunosenescence in aged mice","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Immunosenescence; Mass cytometry; Flow cytometry; Immune system; Immunology; Biology; Antibody; Phenotype; Genetics","score_opus":0.05775244397403355,"score_gpt":0.3377831415835639,"score_spread":0.2800306976095303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922032,0.006391523,0.000078323916,0.000083484236,0.00024172259,0.00043284296,0.00013429142,0.00002165146,0.0004129783],"genre_scores_gemma":[0.99658924,0.0020734568,0.0002786298,0.000040789924,0.00008274107,0.000073974006,0.0003095793,0.00005474203,0.0004968717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976682,0.00018050062,0.00044650136,0.0005625651,0.00045491918,0.0006873295],"domain_scores_gemma":[0.9989054,0.00017253238,0.00009078064,0.00046425834,0.00026626047,0.0001007745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005842655,0.0002147582,0.0003104589,0.00030032964,0.00011189058,0.000037368187,0.0005183603,0.00025022452,0.000033931967],"category_scores_gemma":[0.000108801716,0.00022274353,0.00013244848,0.0008691178,0.00031993273,0.00001265121,0.00018996108,0.0005353794,0.000020242018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056674023,0.00024136681,0.004998933,0.00027691995,0.00003717616,0.00003504572,0.00013501782,0.00028486457,0.9905105,4.1311006e-7,0.0004692852,0.002443711],"study_design_scores_gemma":[0.00073066953,0.00017599639,0.009906851,0.00013171803,0.000004530998,0.000003286865,0.0005285568,0.00029169946,0.9868778,0.000010337678,0.0011048331,0.00023371282],"about_ca_topic_score_codex":0.00080970925,"about_ca_topic_score_gemma":0.000042635438,"teacher_disagreement_score":0.0049079177,"about_ca_system_score_codex":0.00009579166,"about_ca_system_score_gemma":0.00020091672,"threshold_uncertainty_score":0.9083218},"labels":[],"label_agreement":null},{"id":"W4362592192","doi":"10.1158/1538-7445.am2023-4858","title":"Abstract 4858: Effect of mTOR activity in peripheral blood mononuclear cells with metformin in high-risk prostate cancer patients receiving external beam radiotherapy and androgen deprivation therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; Research Manitoba; CancerCare Manitoba","funders":"","keywords":"Metformin; Medicine; PI3K/AKT/mTOR pathway; Peripheral blood mononuclear cell; Prostate cancer; Placebo; Internal medicine; Population; Androgen deprivation therapy; Endocrinology; Cancer; Oncology; Pharmacology; Insulin; Biology; Pathology; Apoptosis","score_opus":0.015905231033452583,"score_gpt":0.3208520352614278,"score_spread":0.3049468042279752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963105,0.0027071459,0.000006899232,0.000024256922,0.000073009105,0.0007910681,0.00006717197,0.000010110531,0.000009852161],"genre_scores_gemma":[0.9821861,0.017114745,0.00007383068,0.000010700957,0.00010464611,0.00039328032,0.000013213852,0.000051467807,0.00005204197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822855,0.00023786261,0.0002246501,0.00047637735,0.00038269162,0.00044987776],"domain_scores_gemma":[0.99933535,0.000103010934,0.0001262938,0.00024293069,0.00011779449,0.000074644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011124371,0.0001790173,0.0002575798,0.00019230507,0.00006912692,0.00003534681,0.00019501914,0.00013601112,0.000037336365],"category_scores_gemma":[0.000052597417,0.00014873159,0.00003630061,0.0004646693,0.00014177011,0.000024469895,0.00006731139,0.00033149603,6.395896e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017273157,0.000056308327,0.37499794,0.000060961644,0.000053544674,0.0000047339577,0.00026461657,0.0016079115,0.5881417,1.4821171e-7,0.00003417302,0.033050645],"study_design_scores_gemma":[0.0033415095,0.001063052,0.26132414,0.00014086225,0.000004857848,4.429807e-7,0.000013767362,0.0001317426,0.73371005,0.0000079712545,0.00012727393,0.00013436325],"about_ca_topic_score_codex":0.0045165853,"about_ca_topic_score_gemma":0.0010269696,"teacher_disagreement_score":0.14556834,"about_ca_system_score_codex":0.00018648744,"about_ca_system_score_gemma":0.000194413,"threshold_uncertainty_score":0.68277556},"labels":[],"label_agreement":null},{"id":"W4362592213","doi":"10.1158/1538-7445.am2023-2942","title":"Abstract 2942: ZW171, a T cell-engaging, bispecific antibody for the treatment of mesothelin-expressing solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Mesothelin; Cancer research; Bispecific antibody; Paratope; Antibody; T cell; CD3; Cytotoxicity; Chemistry; Antigen; Medicine; Immunology; Immune system; Monoclonal antibody; In vitro; Biochemistry; CD8","score_opus":0.18099702164617418,"score_gpt":0.4940730700699903,"score_spread":0.3130760484238161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98040146,0.008559054,0.000028578466,0.005627541,0.00019672666,0.0015242905,0.00020815952,0.00006032053,0.003393887],"genre_scores_gemma":[0.9560765,0.017738953,0.00008575526,0.000045980523,0.0008804164,0.0005385949,0.00007568639,0.000060748844,0.02449738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970318,0.00011153006,0.00038130343,0.0004281837,0.0010861085,0.000961086],"domain_scores_gemma":[0.9970387,0.0016406088,0.00007444478,0.0005222393,0.00048738508,0.00023657885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013145683,0.00019822057,0.00043210175,0.00040985548,0.0006250854,0.00006407802,0.00033459606,0.000080534344,0.0006526424],"category_scores_gemma":[0.00011603734,0.0001172162,0.00026864707,0.00080639095,0.00050892256,0.00005450943,0.000091386246,0.00042692292,0.00015741782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020384435,0.0006033209,0.0067102253,0.00105864,0.00029440704,0.00016615026,0.002931023,0.00018297796,0.9105222,0.00020074329,0.025790745,0.04950108],"study_design_scores_gemma":[0.0026753189,0.0015289813,0.037201352,0.00057961716,0.000059226506,0.00001247062,0.002430162,0.0019155642,0.5718795,0.0003019636,0.38117883,0.00023701189],"about_ca_topic_score_codex":0.0013901626,"about_ca_topic_score_gemma":0.00005730023,"teacher_disagreement_score":0.35538808,"about_ca_system_score_codex":0.00020705927,"about_ca_system_score_gemma":0.0006114087,"threshold_uncertainty_score":0.71459764},"labels":[],"label_agreement":null},{"id":"W4362592233","doi":"10.1158/1538-7445.am2023-4513","title":"Abstract 4513: St. Jude Survivorship Portal: A data portal for storing, analyzing, and sharing large and complex cancer survivorship datasets","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Survivorship curve; Medicine; Cohort; Cancer; Oncology; Internal medicine","score_opus":0.3791369971395935,"score_gpt":0.513054823435037,"score_spread":0.13391782629544358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96740663,0.006327365,0.000034915818,0.005041171,0.00061527063,0.0016835774,0.018265853,0.00026749383,0.00035772365],"genre_scores_gemma":[0.9817565,0.004039516,0.00013503684,0.00041844707,0.0015044496,0.00047180982,0.010359566,0.00017812254,0.0011365617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937526,0.00022886341,0.00080431876,0.0018828649,0.001587541,0.0017438042],"domain_scores_gemma":[0.9953696,0.0010417306,0.00023003634,0.0020552818,0.0003781858,0.0009251383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009688739,0.00044693268,0.00090985105,0.00065943995,0.0006425208,0.00028227616,0.0009980302,0.00023484415,0.00086005655],"category_scores_gemma":[0.0012206576,0.00045106033,0.00009789775,0.0012274071,0.00041532444,0.0005622289,0.0016654768,0.0010819669,0.000021312284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010270848,0.0003088646,0.68992573,0.0050259177,0.0009068279,0.00037454546,0.0026709284,0.000009901108,0.0032383606,0.0011051922,0.29019973,0.005206882],"study_design_scores_gemma":[0.004748404,0.00024582408,0.81849253,0.0014439045,0.0002350103,0.00004200072,0.0026677458,0.0013450383,0.0003578302,0.00042614402,0.1690985,0.00089706696],"about_ca_topic_score_codex":0.056316722,"about_ca_topic_score_gemma":0.19854094,"teacher_disagreement_score":0.14222421,"about_ca_system_score_codex":0.0001999271,"about_ca_system_score_gemma":0.0007741032,"threshold_uncertainty_score":0.9997941},"labels":[],"label_agreement":null},{"id":"W4362592235","doi":"10.1158/1538-7445.am2023-3965","title":"Abstract 3965: KIFC1 is a therapeutic target in lung cancers with extra centrosomes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital","funders":"","keywords":"Centrosome; Biology; Mitosis; Cancer research; Chromosome instability; Lung cancer; Genome instability; Cancer; Cell biology; Cell cycle; Genetics; Pathology; Gene; Chromosome; Medicine; DNA damage","score_opus":0.0364438046826976,"score_gpt":0.3666155513935552,"score_spread":0.3301717467108576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933978,0.0044084364,0.000041459793,0.00078284246,0.00008496597,0.00035025598,0.00007233805,0.000016846905,0.0008450584],"genre_scores_gemma":[0.99082106,0.0059305145,0.000037853606,0.0002896716,0.0001800662,0.00022870809,0.00007545724,0.000039115253,0.0023975628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984459,0.000054211407,0.00013829059,0.00041886378,0.00028777527,0.0006549229],"domain_scores_gemma":[0.9994158,0.000020050895,0.000027928976,0.00032852104,0.00011100119,0.00009666792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033822257,0.00013064592,0.00013281673,0.00014882653,0.000092487484,0.00004116349,0.0002733223,0.00012108744,0.00020263347],"category_scores_gemma":[0.0000142644185,0.00011181525,0.00004618143,0.00050854846,0.00013413146,0.0000056452977,0.00009371561,0.00027942797,0.000029006995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023368518,0.000030883726,0.026658429,0.000102165825,0.000083381085,0.00002765156,0.00032409932,0.0005598048,0.954216,0.000046029618,0.0149074765,0.0028103916],"study_design_scores_gemma":[0.0023517355,0.00033654075,0.070554055,0.00023353625,0.000015564437,0.0000072331145,0.001027179,0.0010386495,0.7134819,0.0002338549,0.21008016,0.00063957646],"about_ca_topic_score_codex":0.0009151912,"about_ca_topic_score_gemma":0.0012816616,"teacher_disagreement_score":0.24073409,"about_ca_system_score_codex":0.00016975218,"about_ca_system_score_gemma":0.000589001,"threshold_uncertainty_score":0.45596936},"labels":[],"label_agreement":null},{"id":"W4362592237","doi":"10.1158/1538-7445.am2023-6576","title":"Abstract 6576: Gabriella Miller Kids First Data Resource Center (KFDRC): Empowering discovery across germline and somatic variation in pediatric cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Context (archaeology); Computer science; Interoperability; Metadata; World Wide Web; Medicine; Biology","score_opus":0.05705458608724079,"score_gpt":0.40120172982961727,"score_spread":0.3441471437423765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378884,0.004377135,0.000011439341,0.00055981183,0.00013856086,0.00023410386,0.00077404245,0.000010115033,0.00010597032],"genre_scores_gemma":[0.9849393,0.013118867,0.000009386404,0.000057134657,0.0005029743,0.000090136265,0.0005512727,0.000032634165,0.00069834274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984228,0.00004971684,0.0002158134,0.00055313983,0.00024936564,0.0005091389],"domain_scores_gemma":[0.9991669,0.000049449507,0.000046236204,0.0005559559,0.000068132715,0.00011333602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005993385,0.00012608594,0.00012838776,0.00010793846,0.0001792689,0.00013222745,0.00038192805,0.00010584093,0.00004288154],"category_scores_gemma":[0.00012377626,0.000118004864,0.000031918204,0.00033376293,0.00007613395,0.00001865665,0.0008090896,0.00017714569,0.00001061704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010856992,0.00041330783,0.47994503,0.0021720184,0.00019932604,0.00024032654,0.0030525236,0.0043384642,0.42059484,0.000017253285,0.079756714,0.008184507],"study_design_scores_gemma":[0.0012753474,0.000060598453,0.9377224,0.00012756365,0.000014031448,0.000004137581,0.0004005398,0.0005606229,0.0028058111,0.000038667287,0.056649417,0.00034085588],"about_ca_topic_score_codex":0.0008644309,"about_ca_topic_score_gemma":0.0023868321,"teacher_disagreement_score":0.45777738,"about_ca_system_score_codex":0.00005548295,"about_ca_system_score_gemma":0.00021603104,"threshold_uncertainty_score":0.48120987},"labels":[],"label_agreement":null},{"id":"W4362592335","doi":"10.1158/1538-7445.am2023-5590","title":"Abstract 5590: Liquid biopsy testing in metastatic or advanced breast cancer patients during the COVID-19 pandemic","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Association of Nurses in Oncology","funders":"","keywords":"Liquid biopsy; KRAS; Metastatic breast cancer; Breast cancer; Indel; Medicine; Biopsy; Cancer; Ion semiconductor sequencing; Cell-free fetal DNA; Oncology; Multiplex; Amplicon; Internal medicine; Cancer research; DNA sequencing; Single-nucleotide polymorphism; Gene; Bioinformatics; Biology; Genotype; Polymerase chain reaction; Genetics","score_opus":0.10944096802651873,"score_gpt":0.42281695067404473,"score_spread":0.313375982647526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663776,0.0010597003,0.0000042002607,0.000878717,0.00020081773,0.0005213578,0.000578561,0.000026621085,0.00009226046],"genre_scores_gemma":[0.9936871,0.004389549,0.000025496345,0.0003258216,0.0002756932,0.00072481815,0.00006551275,0.000046481895,0.00045952058],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980132,0.00010334333,0.0002897382,0.00050621934,0.00036674013,0.00072075735],"domain_scores_gemma":[0.99869984,0.0003579649,0.00007998171,0.00038400266,0.00025991423,0.0002183077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075809006,0.00017001425,0.00017174665,0.00016786555,0.00029843207,0.000058495407,0.00042637272,0.0000827959,0.00015058204],"category_scores_gemma":[0.0012882365,0.00012611321,0.000051652667,0.0009820103,0.00018674345,0.000008256321,0.00036082638,0.00033555954,0.000025210165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021686142,0.00012574666,0.28568667,0.00040093804,0.00008959503,0.00008948483,0.00037277592,0.01154359,0.68693984,0.000010530448,0.003519544,0.009052638],"study_design_scores_gemma":[0.006586344,0.00067310274,0.910635,0.0003393243,0.00003455177,0.00006224691,0.0010902183,0.00023335223,0.036358293,0.00017070606,0.04291846,0.00089842087],"about_ca_topic_score_codex":0.003105753,"about_ca_topic_score_gemma":0.004537451,"teacher_disagreement_score":0.6505816,"about_ca_system_score_codex":0.00043285853,"about_ca_system_score_gemma":0.0012445988,"threshold_uncertainty_score":0.5142747},"labels":[],"label_agreement":null},{"id":"W4362592380","doi":"10.1158/1538-7445.am2023-1458","title":"Abstract 1458: The PAX5 transcription factor is a suppressor of NFAT-mediated breast cancer aggressivity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"NFAT; Cancer research; Transcription factor; Breast cancer; Medicine; Biology; Cancer; Internal medicine; Gene; Biochemistry","score_opus":0.08277783532370771,"score_gpt":0.39741280694054026,"score_spread":0.31463497161683257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912134,0.0024035417,0.00000597167,0.0021326467,0.00022429459,0.0003427463,0.0035654288,0.000025960846,0.00008601324],"genre_scores_gemma":[0.9968617,0.0017212011,0.0000023916805,0.00012117815,0.0003448012,0.0003462573,0.00011371424,0.000034874374,0.00045387854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817735,0.0001623347,0.00020073475,0.00039037334,0.0005863455,0.0004828555],"domain_scores_gemma":[0.99881166,0.0000881448,0.00007459071,0.00051235605,0.0003748889,0.00013838238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051206787,0.0001370905,0.00014308098,0.00007613107,0.00015080301,0.000032255066,0.00048327874,0.00015152169,0.0009176482],"category_scores_gemma":[0.00015976635,0.00010197293,0.000121509205,0.00046504845,0.00033376346,0.0000067047654,0.00011958183,0.00028543058,0.000039881583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002942256,0.000042531523,0.005771989,0.00011897076,0.00008273672,0.000006674194,0.00030603286,0.000060399667,0.9661222,0.0000031263232,0.02405076,0.0031403394],"study_design_scores_gemma":[0.00047253942,0.00004243355,0.09063264,0.000110917244,0.00001188232,0.0000013651398,0.0001064346,0.000047042933,0.90350384,0.000039388087,0.004905557,0.00012595957],"about_ca_topic_score_codex":0.00083595916,"about_ca_topic_score_gemma":0.00014691208,"teacher_disagreement_score":0.08486065,"about_ca_system_score_codex":0.00005290215,"about_ca_system_score_gemma":0.00044455475,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W4362592451","doi":"10.1158/1538-7445.am2023-2182","title":"Abstract 2182: The evolution of high grade serous ovarian cancer under the pressure of non-cytotoxic and cytotoxic treatment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Olaparib; Cancer research; Cytotoxic T cell; Homologous recombination; Synthetic lethality; Serous fluid; Ovarian cancer; Biology; Cisplatin; Cancer; Medicine; Chemotherapy; DNA repair; Internal medicine; Genetics; Gene; In vitro; Poly ADP ribose polymerase","score_opus":0.10094327415207974,"score_gpt":0.4243555562334652,"score_spread":0.3234122820813855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980694,0.00587107,0.00003065077,0.01116427,0.00019055899,0.0014564118,0.00022477933,0.000034787965,0.0003334656],"genre_scores_gemma":[0.9909678,0.0054472014,0.000012129853,0.00009103528,0.00036064477,0.0011485791,0.00001035318,0.000037704936,0.0019245473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978508,0.00017939624,0.0003217013,0.00033527764,0.0008568241,0.0004560024],"domain_scores_gemma":[0.99839854,0.0004084848,0.00012887588,0.0006394999,0.00031457187,0.00011004621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008589951,0.00016539244,0.0003306207,0.0002084594,0.00024717685,0.000020266414,0.00023082066,0.000117983094,0.00045775293],"category_scores_gemma":[0.000030301175,0.0000929373,0.00008879928,0.0010296821,0.0006964669,0.000067236164,0.00007440876,0.00039679106,0.000013323052],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014167808,0.00029584422,0.009260709,0.000708249,0.0010521454,0.000021365508,0.0032666065,0.0031070067,0.961436,0.0020499786,0.010443305,0.0069420114],"study_design_scores_gemma":[0.005237934,0.0007325849,0.6433342,0.0007636491,0.00018137666,0.000017317143,0.0025205598,0.00046361538,0.33836597,0.00273015,0.005463724,0.00018888203],"about_ca_topic_score_codex":0.018642858,"about_ca_topic_score_gemma":0.0010571512,"teacher_disagreement_score":0.63407356,"about_ca_system_score_codex":0.0007873625,"about_ca_system_score_gemma":0.0010061897,"threshold_uncertainty_score":0.9878921},"labels":[],"label_agreement":null},{"id":"W4362592728","doi":"10.1158/1538-7445.am2023-2482","title":"Abstract 2482: On the verge of metastasis: CTH defines a cell-state-dependent adaptive response to microenvironmental stresses","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Cancer research; Ovarian cancer; Metastasis; Ovary; Biology; Cancer; Clear cell carcinoma; Clear cell; Internal medicine; Medicine; Carcinoma; Endocrinology","score_opus":0.13740362697708575,"score_gpt":0.40288255619184404,"score_spread":0.2654789292147583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925015,0.00094420585,0.0000013264691,0.005065735,0.000086186876,0.0007138131,0.00023511836,0.00002152643,0.00043057773],"genre_scores_gemma":[0.99688596,0.00050281716,0.0000143943735,0.00010855154,0.00006313017,0.00023221425,0.000007938063,0.000017230615,0.0021677914],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804497,0.00043951845,0.0001936796,0.00044103464,0.00049390376,0.00038689512],"domain_scores_gemma":[0.99845564,0.00070590933,0.000040110885,0.0005562615,0.00012730659,0.00011476563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022741568,0.00011607595,0.00021112636,0.00018221226,0.00013926311,0.0000075499756,0.00019921325,0.000051132716,0.00047078353],"category_scores_gemma":[0.00058804126,0.00007231077,0.000069417,0.0004340023,0.00038292166,0.00002841302,0.000159342,0.00040226412,0.00038284954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051715426,0.00031977298,0.009406132,0.000088528206,0.00015198339,0.00007767482,0.0009359339,0.00008401799,0.92299336,0.00001823773,0.011650544,0.0025584013],"study_design_scores_gemma":[0.00031828065,0.0005011703,0.497695,0.00006254033,0.000010843382,0.0000012317186,0.0011552243,0.0000014037398,0.4975836,0.000053430613,0.0025702633,0.000046998346],"about_ca_topic_score_codex":0.0002680895,"about_ca_topic_score_gemma":0.000034110195,"teacher_disagreement_score":0.48828888,"about_ca_system_score_codex":0.00018958286,"about_ca_system_score_gemma":0.00023236331,"threshold_uncertainty_score":0.5154749},"labels":[],"label_agreement":null},{"id":"W4362592757","doi":"10.1158/1538-7445.am2023-3956","title":"Abstract 3956: Identifying PIKfyve as potential target in clear cell renal cell carcinoma with a loss of the von Hippel-Lindau tumor suppressor gene","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Cancer research; Clear cell renal cell carcinoma; Gene knockdown; Biology; Renal cell carcinoma; Von Hippel–Lindau disease; Cancer; Tumor suppressor gene; Suppressor; Carcinogenesis; Clear cell; Programmed cell death; Cancer cell; Pathology; Gene; Medicine; Genetics; Disease; Apoptosis","score_opus":0.0428851298971027,"score_gpt":0.36062790438122944,"score_spread":0.31774277448412674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958825,0.0015106491,0.000005250361,0.0005454141,0.00015404314,0.00077570614,0.00008099423,0.000031695196,0.0010137423],"genre_scores_gemma":[0.9967459,0.00017633385,0.000027317263,0.00009765595,0.0003040537,0.00012289509,0.000027800303,0.000063037514,0.0024350318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971069,0.00016797236,0.00032470777,0.00043966508,0.0012264793,0.00073424954],"domain_scores_gemma":[0.9987463,0.00008951722,0.000103888364,0.0005928789,0.00025471405,0.00021275076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007486765,0.00017572133,0.00031131718,0.0003166444,0.00016488713,0.000037319194,0.00041776648,0.000095484764,0.0011006092],"category_scores_gemma":[0.00004003219,0.00012162349,0.00013430878,0.0009743615,0.00031367323,0.00009505795,0.00018429497,0.00080470083,0.00014940166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042503313,0.00037126575,0.029361254,0.0008060941,0.000067098925,0.0026944173,0.0017875065,0.00045756417,0.95727324,0.000020241225,0.0026904126,0.00022059595],"study_design_scores_gemma":[0.0027455795,0.0002862215,0.2243781,0.00020603208,0.000027508408,0.000015182046,0.00059386657,0.00021291939,0.77082664,0.00022781073,0.00036214385,0.00011800203],"about_ca_topic_score_codex":0.0017251469,"about_ca_topic_score_gemma":0.00006944914,"teacher_disagreement_score":0.19501683,"about_ca_system_score_codex":0.00019404152,"about_ca_system_score_gemma":0.0010278855,"threshold_uncertainty_score":0.99981254},"labels":[],"label_agreement":null},{"id":"W4362592768","doi":"10.1158/1538-7445.am2023-3281","title":"Abstract 3281: GEN1042 (DuoBody-CD40x4-1BB)®in combination with PD-1 blockade reverses T-cell exhaustion <i>in vitro</i>","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"CD28; T cell; CD40; Priming (agriculture); Immune system; IL-2 receptor; Mixed lymphocyte reaction; Cytokine; Immunology; Biology; Chemistry; Cancer research; In vitro; Cytotoxic T cell; Biochemistry","score_opus":0.06643323065617299,"score_gpt":0.38639158776393967,"score_spread":0.31995835710776666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990363,0.0013425192,0.0000039692864,0.0036890835,0.00016899384,0.0009315527,0.000021822727,0.000075646894,0.0034033968],"genre_scores_gemma":[0.990999,0.002988438,0.000050089213,0.00016696393,0.00014982691,0.0003287518,0.00008322077,0.00004360172,0.0051901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761623,0.00009797699,0.00031367308,0.0004430819,0.0008620165,0.0006670157],"domain_scores_gemma":[0.99914736,0.00014881979,0.000059644688,0.0003409888,0.00018882177,0.00011435438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014307649,0.0001614664,0.00027190702,0.00077328016,0.00010371917,0.000037326103,0.00016672467,0.0001385134,0.00039912446],"category_scores_gemma":[0.000048114387,0.00013993696,0.00006313664,0.0022208195,0.00018660961,0.00013885972,0.000044375756,0.00066248036,0.0001211978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008090849,0.0002772818,0.005878765,0.0003575267,0.00003449282,0.00029711865,0.00044865784,0.00007159044,0.96312463,0.000008941352,0.008648852,0.012761263],"study_design_scores_gemma":[0.013880117,0.0006249478,0.18947698,0.0010532404,0.000023054532,0.00001844678,0.0014411402,0.00022126321,0.7615805,0.00011294502,0.0312147,0.00035266695],"about_ca_topic_score_codex":0.0035593999,"about_ca_topic_score_gemma":0.0007276458,"teacher_disagreement_score":0.20154415,"about_ca_system_score_codex":0.0008308536,"about_ca_system_score_gemma":0.0005394089,"threshold_uncertainty_score":0.5706464},"labels":[],"label_agreement":null},{"id":"W4362592856","doi":"10.1158/1538-7445.am2023-4493","title":"Abstract 4493: Sudocetaxel Zendusortide (TH1902), a peptide-drug conjugate for the treatment of sortilin-positive (SORT1+) TNBC and Her2-positive breast cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Internalization; Breast cancer; Cancer research; Triple-negative breast cancer; Cancer; Endosome; Cancer cell; Biology; Receptor; Medicine; Internal medicine","score_opus":0.046516362144696614,"score_gpt":0.39498254959281537,"score_spread":0.34846618744811875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141985,0.0027295088,0.00007160606,0.0019045119,0.00017842188,0.0016081033,0.0016508434,0.000019111068,0.00041805275],"genre_scores_gemma":[0.9863689,0.0076820767,0.000045973433,0.000054540375,0.00033842467,0.0017542166,0.00017148402,0.00004972184,0.0035346728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982077,0.00010743807,0.000282295,0.00052946736,0.00030114842,0.00057195284],"domain_scores_gemma":[0.99846554,0.00031806636,0.00011330455,0.00041455956,0.000548733,0.00013980921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042392628,0.00020525404,0.00023179315,0.000117406686,0.00034948796,0.000054739838,0.00023164532,0.00010384773,0.000089121306],"category_scores_gemma":[0.00009207175,0.0001572359,0.00015800199,0.00028290687,0.00045816723,0.000012592775,0.000102953294,0.00019882736,0.000017823897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015853471,0.00017803446,0.0028350132,0.000097526696,0.0008792389,0.000031216794,0.0009989291,0.00032811848,0.956531,0.000093689116,0.01124104,0.02520086],"study_design_scores_gemma":[0.0012262879,0.0007943777,0.054626,0.00013354424,0.00006660471,0.000020996684,0.0014288758,0.00014062191,0.9223713,0.00011084828,0.01884928,0.00023123923],"about_ca_topic_score_codex":0.007654114,"about_ca_topic_score_gemma":0.0045799855,"teacher_disagreement_score":0.051790986,"about_ca_system_score_codex":0.00025070665,"about_ca_system_score_gemma":0.00054296694,"threshold_uncertainty_score":0.998954},"labels":[],"label_agreement":null},{"id":"W4362592958","doi":"10.1158/1538-7445.am2023-2329","title":"Abstract 2329: Disulfiram metabolite modulates NK and T cell cytotoxicity against metastatic colorectal cancer through tumor derived NKG2D ligands","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; KRAS; Cancer research; NKG2D; Cancer; Cetuximab; Immunotherapy; Internal medicine; Oncology; Immunology; Cytotoxic T cell; Biology; In vitro","score_opus":0.056668302240950756,"score_gpt":0.36314218921682717,"score_spread":0.3064738869758764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95271003,0.04321107,0.0000066119383,0.00047405605,0.0010627117,0.0008649717,0.00045266715,0.00019182837,0.0010260476],"genre_scores_gemma":[0.9745304,0.020980174,0.000043927153,0.00021917206,0.00013408455,0.001062521,0.00015005018,0.00009347828,0.0027861805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964613,0.00033799777,0.0005121634,0.00088394445,0.00026412075,0.0015405158],"domain_scores_gemma":[0.9981875,0.0007022229,0.00015561565,0.000504378,0.00035571808,0.000094566494],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011585496,0.0004020001,0.0006782887,0.00029872352,0.00072369433,0.00010625755,0.0006127651,0.00023240046,0.00140037],"category_scores_gemma":[0.0001790993,0.00035511894,0.0001496134,0.0010892568,0.0012223966,0.00029695762,0.0005440763,0.0013171256,0.00066661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036788586,0.00009679395,0.0019275359,0.00030044714,0.0003475698,0.00005729945,0.0015376138,0.00017600825,0.986762,0.000044090397,0.006038846,0.0023439245],"study_design_scores_gemma":[0.001727175,0.00009965835,0.024064464,0.00013744229,0.000056459354,0.0000086589125,0.00066247006,0.000043128523,0.96052617,0.0003061911,0.011974932,0.0003932225],"about_ca_topic_score_codex":0.002200659,"about_ca_topic_score_gemma":0.0002928093,"teacher_disagreement_score":0.026235787,"about_ca_system_score_codex":0.00033975844,"about_ca_system_score_gemma":0.0005938307,"threshold_uncertainty_score":0.9998901},"labels":[],"label_agreement":null},{"id":"W4362592993","doi":"10.1158/1538-7445.am2023-4542","title":"Abstract 4542: Development of a one-step molecular classifier for endometrial carcinoma using an amplicon-based gene panel and next generation sequencing technology","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amplicon; Indel; Concordance; Microsatellite instability; Molecular diagnostics; Biology; Computational biology; DNA sequencing; Genetics; Gene; Bioinformatics; Microsatellite; Polymerase chain reaction; Single-nucleotide polymorphism; Genotype","score_opus":0.3669315115361739,"score_gpt":0.40444368908878575,"score_spread":0.037512177552611825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362592993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099064,0.0011726547,0.006996209,0.00011200925,0.000101738595,0.00051695073,0.000087471955,0.000010406193,0.000011932648],"genre_scores_gemma":[0.9918489,0.00017132323,0.0071373726,0.00004505887,0.00029566447,0.0002502422,0.00020414383,0.00003432905,0.000012984939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986799,0.00003323713,0.00026150493,0.00042546797,0.00021049746,0.00038941513],"domain_scores_gemma":[0.9991139,0.000062935986,0.00007322883,0.000295516,0.0003546579,0.00009973485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005784661,0.0001171874,0.00017108463,0.0003813889,0.00017187733,0.000047385085,0.00016803243,0.00019258336,0.000007698597],"category_scores_gemma":[0.00025514342,0.00013044765,0.000041505602,0.00042827823,0.00013610281,0.000005625541,0.00012004438,0.000114942624,9.476217e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014082299,0.000026281385,0.00047801298,0.00007094819,0.000035899753,0.000003981419,0.00006235123,0.001367503,0.98581564,0.000055566397,0.000052042626,0.011890946],"study_design_scores_gemma":[0.0010623368,0.00023633162,0.000512068,0.000021841657,0.000011485669,0.0000014302267,0.00013855724,0.006669914,0.98936105,0.00004847652,0.0017900603,0.00014647958],"about_ca_topic_score_codex":0.00023274336,"about_ca_topic_score_gemma":0.00024644446,"teacher_disagreement_score":0.011744466,"about_ca_system_score_codex":0.00017797643,"about_ca_system_score_gemma":0.0014036206,"threshold_uncertainty_score":0.53195006},"labels":[],"label_agreement":null},{"id":"W4362593043","doi":"10.1158/1538-7445.am2023-5101","title":"Abstract 5101: Inhibition of Notch reverses immunosuppression in basal-like breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Notch signaling pathway; Immune system; Cancer research; Breast cancer; Tumor microenvironment; Melanoma; Immunotherapy; Cancer; Cytotoxic T cell; Immunology; Internal medicine; Biology; In vitro; Receptor","score_opus":0.053595247144273564,"score_gpt":0.3990555080367128,"score_spread":0.34546026089243925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960597,0.0025520176,0.000008876577,0.00042426595,0.00017180984,0.00019535834,0.00013386465,0.0000075308967,0.00044658294],"genre_scores_gemma":[0.9891054,0.009849137,0.000017919365,0.000020931779,0.00017645852,0.00011697065,0.00011657576,0.000021013362,0.0005755899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876195,0.0000959726,0.0002158804,0.0002863035,0.00032863507,0.0003112639],"domain_scores_gemma":[0.9993426,0.00003385912,0.00005471047,0.00025998498,0.00025383735,0.00005501572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006878837,0.000086827386,0.000113066686,0.00018896206,0.000065173095,0.000014461255,0.00012636719,0.00014252267,0.00022822578],"category_scores_gemma":[0.000056231078,0.000082929546,0.00004602184,0.00049451855,0.00009710131,0.00000694784,0.0001414713,0.00018319697,0.000016046743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013670704,0.000031731895,0.010925792,0.000066187466,0.000010923448,0.000003760192,0.000073058596,0.00050812453,0.9772393,0.000006262307,0.003676416,0.00732172],"study_design_scores_gemma":[0.00036365332,0.000040918363,0.21124011,0.00015238204,0.0000021835315,2.1710386e-7,0.000081998594,0.000033164186,0.78429824,0.00014160355,0.0035603233,0.00008519945],"about_ca_topic_score_codex":0.001499232,"about_ca_topic_score_gemma":0.0005750571,"teacher_disagreement_score":0.20031433,"about_ca_system_score_codex":0.000055297245,"about_ca_system_score_gemma":0.00019606281,"threshold_uncertainty_score":0.33817688},"labels":[],"label_agreement":null},{"id":"W4362593049","doi":"10.1158/1538-7445.am2023-2766","title":"Abstract 2766: Automation of linear range determination: Enzymatic progress curve applications","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"InterDigital (Canada)","funders":"","keywords":"Calibration curve; Curve fitting; Residence time (fluid dynamics); Computer science; Heuristic; Range (aeronautics); Biological system; Biology; Statistics; Mathematics; Materials science; Detection limit; Engineering","score_opus":0.055837502512462146,"score_gpt":0.4309429960216558,"score_spread":0.37510549350919364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963535,0.0011539104,0.00045432395,0.00021141705,0.00010800538,0.0006420425,0.000073937874,0.000043970835,0.00095890195],"genre_scores_gemma":[0.9967205,0.00049353624,0.00011989868,0.000018567005,0.000336421,0.0013172037,0.0001257012,0.000017092421,0.00085107284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898344,0.00007279425,0.000185915,0.00023142641,0.00030050168,0.00022590092],"domain_scores_gemma":[0.9991673,0.00003377061,0.00006847601,0.00030544354,0.00034878432,0.00007622749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038889766,0.000075362135,0.000088228786,0.00012856732,0.00017252803,0.000021422878,0.00018511488,0.00009074183,0.0001456072],"category_scores_gemma":[0.0000754302,0.00007015053,0.00006228075,0.00044236917,0.00013979658,0.0000068372824,0.00010237242,0.00009780185,0.00008868508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012298666,0.00024317476,0.010548068,0.00092176517,0.000071824994,0.000005301564,0.0002634235,0.0005418824,0.84787905,0.00023287944,0.06128581,0.077883825],"study_design_scores_gemma":[0.0013131115,0.0005163979,0.072582126,0.00028893058,0.000025560514,0.0000051033035,0.00041645148,0.002705131,0.8406573,0.0013291795,0.07970928,0.0004514358],"about_ca_topic_score_codex":0.000034091157,"about_ca_topic_score_gemma":0.00002155026,"teacher_disagreement_score":0.07743239,"about_ca_system_score_codex":0.000023800465,"about_ca_system_score_gemma":0.00012358205,"threshold_uncertainty_score":0.28606555},"labels":[],"label_agreement":null},{"id":"W4362593083","doi":"10.1158/1538-7445.am2023-3998","title":"Abstract 3998: Metronomic gemcitabine plus neratinib effectively inhibits the growth of human Her-2 positive breast cancer cells intracranially implanted into immunodeficient mice","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neratinib; Gemcitabine; Lapatinib; Medicine; Breast cancer; Oncology; Cancer; Metastatic breast cancer; Internal medicine; In vivo; Cancer research; Trastuzumab; Biology","score_opus":0.03244288141759056,"score_gpt":0.38009187465678124,"score_spread":0.3476489932391907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093634,0.0025842967,0.000047563368,0.0033030075,0.00033588093,0.0017100952,0.0006601727,0.00011773815,0.00030487723],"genre_scores_gemma":[0.99740833,0.00052623363,0.000057111294,0.00016195847,0.00054079114,0.0007461322,0.000071882256,0.00011552481,0.00037203354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99627745,0.00030713435,0.0005991659,0.00071658567,0.0010578563,0.0010417884],"domain_scores_gemma":[0.9971196,0.0005994865,0.00022998558,0.0005577669,0.00128288,0.00021029357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015016367,0.0003790346,0.0006996653,0.0005461696,0.0005495812,0.0000671847,0.00053675455,0.00015319412,0.00043798858],"category_scores_gemma":[0.000073708514,0.00028034707,0.00018653882,0.0017776279,0.00080817007,0.0002123308,0.00030267314,0.0011730632,0.00010409583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002759465,0.00014157873,0.0009657821,0.00041375126,0.0004329045,0.00004524506,0.003376071,0.00038776067,0.97538245,0.00019374008,0.0005230874,0.015378194],"study_design_scores_gemma":[0.0050197816,0.0005181724,0.2833731,0.0011738545,0.00010284408,0.00006341914,0.0017630198,0.00018294982,0.70694774,0.00026290579,0.00021421383,0.00037799397],"about_ca_topic_score_codex":0.016726863,"about_ca_topic_score_gemma":0.000994032,"teacher_disagreement_score":0.2824073,"about_ca_system_score_codex":0.0019896738,"about_ca_system_score_gemma":0.001143245,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W4362593107","doi":"10.1158/1538-7445.am2023-5915","title":"Abstract 5915: Exploring the impact of microbiome in the response of combined radiation with immune checkpoint blockade in muscle invasive bladder cancer (MIBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; McGill University Health Centre","funders":"","keywords":"Microbiome; Medicine; Immune checkpoint; Akkermansia muciniphila; Immune system; Radiation therapy; Cancer; Immunology; Akkermansia; Blockade; Immunotherapy; Immunity; Bladder cancer; Gut flora; Cancer research; Internal medicine; Bioinformatics; Lactobacillus; Biology","score_opus":0.12049045173666441,"score_gpt":0.41143941378249904,"score_spread":0.29094896204583465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945833,0.0013298943,2.1056806e-7,0.0025484194,0.000054970726,0.0012405599,0.00008762031,0.000012063998,0.00014292933],"genre_scores_gemma":[0.9965414,0.0021058104,0.000003309461,0.000024076511,0.000067679655,0.0010484768,0.000016164182,0.00003191991,0.00016116329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979407,0.00035248292,0.00039870257,0.00025662224,0.0005732699,0.0004782219],"domain_scores_gemma":[0.9984322,0.00070495554,0.00010780201,0.00048291116,0.00021089368,0.000061247185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997658,0.00015463507,0.00034057107,0.00053202244,0.00007392043,0.0000170902,0.0002839991,0.00005903821,0.00021328357],"category_scores_gemma":[0.00019726696,0.000082584294,0.00010902891,0.002261304,0.00027172305,0.00010677385,0.000063751424,0.0004912675,0.000009262162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010187868,0.00034421385,0.050118223,0.00019376454,0.00027650673,0.00009599082,0.016999843,0.0009544158,0.91614467,0.0000043960977,0.00041551286,0.0042646225],"study_design_scores_gemma":[0.003376149,0.0006634543,0.7736763,0.00046090168,0.000020589197,0.0000029665616,0.00238538,0.000018231724,0.21924882,0.000027284557,0.000054288772,0.000065672684],"about_ca_topic_score_codex":0.037799183,"about_ca_topic_score_gemma":0.002262061,"teacher_disagreement_score":0.72355807,"about_ca_system_score_codex":0.0006438813,"about_ca_system_score_gemma":0.001562476,"threshold_uncertainty_score":0.9686082},"labels":[],"label_agreement":null},{"id":"W4362593182","doi":"10.1158/1538-7445.am2023-609","title":"Abstract 609: The predictive power of tertiary lymphoid structures in assessing response to trimodal therapy in muscle invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Bladder cancer; Germinal center; Tumor microenvironment; Medicine; Cystectomy; FOXP3; Immune system; Pathology; H&E stain; Tissue microarray; CD20; CD68; Cancer; Immunohistochemistry; Internal medicine; Immunology; B cell; Antibody","score_opus":0.07675676988286696,"score_gpt":0.43098091567197466,"score_spread":0.3542241457891077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991164,0.0019264377,0.0000013039852,0.004409062,0.00019142435,0.0014928858,0.00012377473,0.000029852154,0.00066124776],"genre_scores_gemma":[0.99658483,0.0013196599,0.000011000141,0.0005495988,0.00014710712,0.0010210309,0.000007954659,0.00004901318,0.00030981898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972283,0.000416568,0.0003566545,0.0004649988,0.00087491446,0.00065851666],"domain_scores_gemma":[0.9982786,0.00079818483,0.00005754423,0.0004417605,0.00026428257,0.00015963354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013576176,0.00019149247,0.00034575106,0.00073699944,0.00010636147,0.000041956988,0.00028437687,0.00012781828,0.00080603565],"category_scores_gemma":[0.00035782883,0.00012848643,0.00008000555,0.0018108301,0.00022834523,0.00014923124,0.000113416194,0.00053578854,0.000016436645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018538238,0.00042629265,0.31786242,0.00013619696,0.00033681834,0.00044828706,0.022451874,0.0011153275,0.57337934,0.000012503247,0.006603224,0.05868947],"study_design_scores_gemma":[0.003577376,0.0004048781,0.9264209,0.00038428514,0.000009887019,0.0000031543516,0.0027128248,0.000018478966,0.0654872,0.00024268747,0.00063013047,0.000108161345],"about_ca_topic_score_codex":0.011360358,"about_ca_topic_score_gemma":0.0022697418,"teacher_disagreement_score":0.60855854,"about_ca_system_score_codex":0.0008789008,"about_ca_system_score_gemma":0.002818515,"threshold_uncertainty_score":0.9952231},"labels":[],"label_agreement":null},{"id":"W4362593247","doi":"10.1158/1538-7445.am2023-3787","title":"Abstract 3787: miR 2355-5p regulates tumor growth and angiogenesis in VHL-inactivated clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Concordia University; Université de Sherbrooke; Université de Moncton","funders":"","keywords":"Clear cell renal cell carcinoma; Clonogenic assay; Cancer research; Biology; Carcinogenesis; microRNA; Cell growth; Cancer; Cell; Renal cell carcinoma; Pathology; Medicine; Gene; Genetics","score_opus":0.02875855990382867,"score_gpt":0.3106352312318775,"score_spread":0.2818766713280488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873638,0.0099412305,0.0000012258835,0.00021313303,0.00026207327,0.0003285227,0.000076173135,0.0000241546,0.0017896648],"genre_scores_gemma":[0.99185795,0.0048689027,0.000030878367,0.000059988382,0.00088339805,0.00014206124,0.000083104125,0.00005832856,0.0020153646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784595,0.00013136062,0.00023464346,0.00065688265,0.00035197154,0.000779208],"domain_scores_gemma":[0.999121,0.000049180486,0.00005589271,0.00038230733,0.00017104062,0.00022058161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586224,0.00019995327,0.00023540712,0.00030482683,0.0001516107,0.00005515891,0.00028469565,0.00017362938,0.00013001572],"category_scores_gemma":[0.00006717954,0.00019764435,0.00009075143,0.0007321925,0.00019585242,0.000011509201,0.0002522933,0.0002864394,0.000030746527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037486653,0.00004934344,0.0028737278,0.00015391063,0.000014257886,0.000025145922,0.00011001819,0.000032332933,0.97754526,0.000006763251,0.017469432,0.0013449483],"study_design_scores_gemma":[0.00093914743,0.0001319294,0.10640897,0.000021363088,0.0000075931634,0.000004079682,0.00019264499,0.000018450173,0.8590001,0.000045426757,0.033015788,0.00021453032],"about_ca_topic_score_codex":0.0025781363,"about_ca_topic_score_gemma":0.00029746466,"teacher_disagreement_score":0.11854517,"about_ca_system_score_codex":0.00006264992,"about_ca_system_score_gemma":0.000355222,"threshold_uncertainty_score":0.80597025},"labels":[],"label_agreement":null},{"id":"W4362593327","doi":"10.1158/1538-7445.am2023-755","title":"Abstract 755: The impact of cancer treatment on cognitive function and quality of life in patients undergoing treatment at a tertiary care hospital in New Delhi, India","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Cognition; Cancer; Outpatient clinic; Informed consent; Pediatrics; Psychiatry; Internal medicine; Alternative medicine; Pathology","score_opus":0.09087507669382516,"score_gpt":0.44206274759039854,"score_spread":0.3511876708965734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339414,0.0036233126,1.2320885e-7,0.0004478188,0.00007993227,0.0019401178,0.00029329848,0.000013018809,0.0002082386],"genre_scores_gemma":[0.99449503,0.004624145,4.1297255e-7,0.000026613909,0.000067843175,0.00048057106,0.00006619537,0.000022660564,0.00021654248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818385,0.00016506911,0.00038106428,0.0003490096,0.00050600327,0.00041503497],"domain_scores_gemma":[0.9985521,0.00073861855,0.00013114234,0.00016188521,0.00028118884,0.0001350975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025030534,0.00019574995,0.00042499515,0.00041238507,0.000089000336,0.00000787484,0.000045727866,0.000081856975,0.000114345305],"category_scores_gemma":[0.0002659125,0.00012422285,0.000111284426,0.0006951378,0.00019663188,0.000058010522,0.00007601711,0.00021738232,0.0000069544585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004433895,0.00049104495,0.95649385,0.00017725177,0.0005961608,0.0000066481243,0.008543304,0.000093055176,0.0003157,0.0000015597498,0.0002484916,0.02859904],"study_design_scores_gemma":[0.012382019,0.0047238977,0.97513574,0.0011717736,0.000067960726,7.887223e-8,0.004865277,0.0000063513517,0.0015265251,0.00001703665,0.000006892588,0.000096440344],"about_ca_topic_score_codex":0.07768681,"about_ca_topic_score_gemma":0.028940314,"teacher_disagreement_score":0.0487465,"about_ca_system_score_codex":0.004256548,"about_ca_system_score_gemma":0.0014596492,"threshold_uncertainty_score":0.99956596},"labels":[],"label_agreement":null},{"id":"W4362593389","doi":"10.1158/1538-7445.am2023-4011","title":"Abstract 4011: Preferential cytotoxicity of ESK981 in neuroendocrine prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Cancer research; Population; Prostate; Apoptosis; Pathology; Internal medicine; Biology","score_opus":0.13775562520555845,"score_gpt":0.46056723938636646,"score_spread":0.322811614180808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915682,0.0018799478,3.8555075e-7,0.0029252765,0.00018019344,0.0015377658,0.00018690802,0.00008136252,0.0016399374],"genre_scores_gemma":[0.9777059,0.012288197,0.0000076466295,0.00003274356,0.00021530836,0.0011721887,0.00006825281,0.00005185448,0.008457914],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996575,0.00013247291,0.0003999586,0.0005321695,0.0012385917,0.0011217966],"domain_scores_gemma":[0.9986231,0.00016661016,0.000060136557,0.00042967504,0.0004427345,0.0002777914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066513347,0.00018693316,0.00042612717,0.0008862524,0.00010811049,0.000030187863,0.00025535788,0.00006145561,0.0015894034],"category_scores_gemma":[0.00014365494,0.00014876995,0.000100935606,0.0022014647,0.00036362457,0.00012842973,0.00024400285,0.0009038089,0.00011124743],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005944121,0.0006211184,0.32245487,0.0020578313,0.00022180004,0.0013604619,0.0010239169,0.00022004334,0.61277205,0.00009635993,0.018273871,0.03495357],"study_design_scores_gemma":[0.0049856706,0.000438758,0.5977423,0.0007346937,0.000020021713,0.0000073663114,0.00025385807,0.00017631885,0.39175406,0.00029039042,0.0034239627,0.00017256853],"about_ca_topic_score_codex":0.004927507,"about_ca_topic_score_gemma":0.0012156841,"teacher_disagreement_score":0.27528745,"about_ca_system_score_codex":0.0005768847,"about_ca_system_score_gemma":0.0013705278,"threshold_uncertainty_score":0.9993233},"labels":[],"label_agreement":null},{"id":"W4362593403","doi":"10.1158/1538-7445.am2023-ng14","title":"Abstract NG14: Dissecting immune microenvironment of T-cell acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network","funders":"","keywords":"Immune system; Leukemia; Immunology; Immunotherapy; Medicine; Tumor microenvironment; Biology; Cancer research","score_opus":0.056896164349953204,"score_gpt":0.3906074047209294,"score_spread":0.3337112403709762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929152,0.0010630755,0.000004641783,0.0004255663,0.00017838829,0.00072142074,0.000033105378,0.000064814645,0.0045937714],"genre_scores_gemma":[0.9618672,0.0042008013,0.0000380406,0.000021203134,0.00028635815,0.00019244416,0.00003533263,0.00008143338,0.03327715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965514,0.000108251894,0.0004064701,0.00046768016,0.0014609714,0.001005231],"domain_scores_gemma":[0.99818456,0.00049582677,0.00006962503,0.0006954603,0.00027265848,0.00028187968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015985558,0.00017401895,0.00039001834,0.0005165188,0.00017645085,0.00003339811,0.00035285062,0.00012173359,0.007298675],"category_scores_gemma":[0.00018425331,0.00015698808,0.00016665626,0.0011698701,0.0003778499,0.000062446044,0.00032404347,0.0007899989,0.0007248983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007535942,0.00009479461,0.0025633716,0.0004724391,0.0001550346,0.00021236716,0.00044713743,0.00007792325,0.98064315,0.0000055683254,0.0033943555,0.011180236],"study_design_scores_gemma":[0.0020370162,0.0003250716,0.07659509,0.00031983506,0.000030604067,0.000014682155,0.00061378465,0.0001621784,0.91398644,0.000036901394,0.0057411403,0.0001372621],"about_ca_topic_score_codex":0.001401586,"about_ca_topic_score_gemma":0.000037437312,"teacher_disagreement_score":0.07403172,"about_ca_system_score_codex":0.0016688624,"about_ca_system_score_gemma":0.00087983836,"threshold_uncertainty_score":0.9936088},"labels":[],"label_agreement":null},{"id":"W4362593405","doi":"10.1158/1538-7445.am2023-5959","title":"Abstract 5959: Dissecting the stromal drivers of gastroesophageal adenocarcinoma chemoresistance","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Tumor microenvironment; Stromal cell; Cancer-Associated Fibroblasts; Docetaxel; Cancer; Medicine; Cancer research; Immune system; Cancer cell; Adenocarcinoma; Chemotherapy; Tumor progression; Internal medicine; Immunology","score_opus":0.11489508602245828,"score_gpt":0.4262666987980669,"score_spread":0.3113716127756086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349445,0.0022594044,0.000005057736,0.001533342,0.00022259112,0.00037406888,0.000053298176,0.00004373673,0.0020140402],"genre_scores_gemma":[0.99637353,0.00061079906,0.000058403763,0.000037499936,0.00051325304,0.00009219287,0.000012705862,0.00003047019,0.0022711337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99786294,0.000056665667,0.00023484745,0.0003107006,0.000910815,0.0006240641],"domain_scores_gemma":[0.9987097,0.00023160795,0.00006620808,0.00043747938,0.00038306892,0.00017193613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010408625,0.00011448998,0.00025389198,0.00018289937,0.0002057426,0.000024931023,0.00024976424,0.000049401842,0.0006895045],"category_scores_gemma":[0.0002110019,0.00008135819,0.00013063094,0.0010447722,0.00034251783,0.000054458706,0.00011803445,0.000554717,0.000053742817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016955634,0.00016654191,0.23343645,0.0016736889,0.00039248716,0.00065986515,0.003190755,0.00017020901,0.63765997,0.00033803034,0.0750964,0.045520056],"study_design_scores_gemma":[0.0012411259,0.00019990034,0.8291916,0.00028786864,0.000053399126,0.000010575571,0.003223467,0.000031844687,0.16106454,0.00006704686,0.0045244806,0.00010411658],"about_ca_topic_score_codex":0.0005420527,"about_ca_topic_score_gemma":0.0001689253,"teacher_disagreement_score":0.59575516,"about_ca_system_score_codex":0.00021084074,"about_ca_system_score_gemma":0.00042983834,"threshold_uncertainty_score":0.7549591},"labels":[],"label_agreement":null},{"id":"W4362593425","doi":"10.1158/1538-7445.am2023-6545","title":"Abstract 6545: Investigating secondary findings in a pediatric cancer cohort: preliminary findings","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Germline; Cancer; Cohort; Medicine; Indel; Single-nucleotide polymorphism; Clinical significance; Genetics; Oncology; Internal medicine; Bioinformatics; Gene; Biology; Genotype","score_opus":0.11619187164616929,"score_gpt":0.43560534714316584,"score_spread":0.31941347549699656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978039,0.0036787943,6.010831e-7,0.013433367,0.00050405477,0.0013600562,0.00010724973,0.00025407216,0.0026227892],"genre_scores_gemma":[0.98908305,0.0043216213,0.00006363144,0.0010654834,0.0014532666,0.0012600321,0.00007875552,0.00012331117,0.0025508252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99448633,0.00024318119,0.0008123798,0.0010058759,0.0019452145,0.001507042],"domain_scores_gemma":[0.99727565,0.0010464975,0.00010766377,0.00062195165,0.00033437146,0.0006138639],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004753985,0.0003262077,0.00066065916,0.001500218,0.00033107676,0.00009879948,0.0004876899,0.00029071412,0.001729706],"category_scores_gemma":[0.0014976626,0.00034081124,0.00015043392,0.004123714,0.00034853703,0.00031101424,0.00039404133,0.0024940814,0.00043463425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028769663,0.0001006273,0.8874743,0.0024221586,0.00008355943,0.00027941537,0.00721679,0.00007721213,0.0053150095,0.00004725594,0.09305122,0.0036447637],"study_design_scores_gemma":[0.0018014713,0.00022374192,0.98802155,0.0012390071,0.00004434841,0.00001157518,0.0010187392,0.00010667235,0.0035440924,0.0003074957,0.0033342147,0.00034707133],"about_ca_topic_score_codex":0.011374268,"about_ca_topic_score_gemma":0.0024255803,"teacher_disagreement_score":0.10054728,"about_ca_system_score_codex":0.0011193714,"about_ca_system_score_gemma":0.003170272,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W4362593589","doi":"10.1158/1538-7445.am2023-6028","title":"Abstract 6028: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Pyrimidine metabolism; Biology; Transcriptome; Cancer research; Metastasis; Context (archaeology); Disease; Cancer; Computational biology; Bioinformatics; Gene; Medicine; Pathology; Genetics; Gene expression","score_opus":0.05970889583774845,"score_gpt":0.396658834100079,"score_spread":0.33694993826233055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97291553,0.022264749,0.0000059438903,0.00065833866,0.001239553,0.00053299713,0.0001626423,0.000049096503,0.0021711655],"genre_scores_gemma":[0.96426,0.02524862,0.000018779358,0.00013971324,0.0028955934,0.0016098438,0.0000671749,0.00006519096,0.0056950864],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700683,0.00022566979,0.0003210489,0.0007699621,0.0005908253,0.0010856725],"domain_scores_gemma":[0.99870354,0.0000963091,0.000058668575,0.0005341997,0.000394281,0.00021299742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012153139,0.00023871638,0.00035548082,0.0004139015,0.00020941145,0.00006540219,0.0004739317,0.0002342843,0.00031479253],"category_scores_gemma":[0.00034576553,0.00023430084,0.00013040904,0.0012730698,0.00031797113,0.000013956815,0.00024808903,0.00059110654,0.00008469258],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046192674,0.000074672476,0.0028590318,0.00011111649,0.00012816754,0.0000072100406,0.0008180649,0.00073656195,0.9053169,0.00036068275,0.055679683,0.033446006],"study_design_scores_gemma":[0.0011656702,0.00010818205,0.07264183,0.00006306008,0.000013546861,0.0000029880566,0.0008296914,0.000023281129,0.39075387,0.00059372355,0.5334421,0.00036211073],"about_ca_topic_score_codex":0.0057662125,"about_ca_topic_score_gemma":0.009852329,"teacher_disagreement_score":0.514563,"about_ca_system_score_codex":0.00014502919,"about_ca_system_score_gemma":0.0011261313,"threshold_uncertainty_score":0.9554511},"labels":[],"label_agreement":null},{"id":"W4362593599","doi":"10.1158/1538-7445.am2023-4670","title":"Abstract 4670: True bench-to-bedside science: An international pilot study modeling hard-to-cure pediatric cancers to prioritize therapeutic intervention","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Jewish General Hospital; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Cancer; Oncology; Zebrafish; Internal medicine; Biology","score_opus":0.13849493152990183,"score_gpt":0.48340668713239504,"score_spread":0.3449117556024932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928897,0.00011594838,0.0012955851,0.003440078,0.00027881074,0.0015970285,0.00010023553,0.000045809684,0.00023681646],"genre_scores_gemma":[0.9957964,0.0002766888,0.00019164162,0.0002749339,0.0008969862,0.0019248587,0.000072288494,0.000039949045,0.0005262961],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958893,0.000118127,0.0003165669,0.0009945349,0.0017731509,0.00090834196],"domain_scores_gemma":[0.99730605,0.00004334219,0.000031648233,0.00069581746,0.0010051832,0.0009179506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031030995,0.00015662312,0.00014179887,0.0009892267,0.0004048091,0.00025516876,0.0015997972,0.0000621388,0.0001653115],"category_scores_gemma":[0.0008415203,0.00015440563,0.00005078725,0.0030107207,0.00015498465,0.00003197032,0.00081288785,0.00038797362,0.0002591205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043729407,0.00042281993,0.004333675,0.00003262653,0.000059170183,0.000008915773,0.00044714607,0.0050684307,0.9601967,0.00007218422,0.0051128073,0.023808228],"study_design_scores_gemma":[0.006948793,0.027488343,0.7110273,0.0003359143,0.00008744311,0.0000099701365,0.009097793,0.018462613,0.15813944,0.0019737335,0.063921876,0.002506771],"about_ca_topic_score_codex":0.0018043966,"about_ca_topic_score_gemma":0.0017903727,"teacher_disagreement_score":0.80205727,"about_ca_system_score_codex":0.0006024798,"about_ca_system_score_gemma":0.0013475678,"threshold_uncertainty_score":0.62964785},"labels":[],"label_agreement":null},{"id":"W4362593635","doi":"10.1158/1538-7445.am2023-3014","title":"Abstract 3014: Association between HLA-KIR allele interaction combinations and density of T-cell subsets in colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Odds ratio; Colorectal cancer; Human leukocyte antigen; Genome-wide association study; CD8; T cell; Biology; Immunology; Immune system; Quartile; Confidence interval; Medicine; Oncology; Cancer; Internal medicine; Genotype; Genetics; Antigen; Single-nucleotide polymorphism; Gene","score_opus":0.07854447037274405,"score_gpt":0.42259466917876437,"score_spread":0.34405019880602034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623156,0.0004508295,7.6669625e-7,0.0018877821,0.00013226089,0.00041950785,0.0000569591,0.00002577661,0.0007945373],"genre_scores_gemma":[0.99607956,0.0027393247,0.000005416882,0.000027561031,0.000090934846,0.000121674726,0.00006552626,0.000014718941,0.00085529755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986838,0.00009296268,0.00023901807,0.00020758454,0.00047923546,0.00029737232],"domain_scores_gemma":[0.9990902,0.0003476755,0.00009201716,0.000096075106,0.00030630446,0.00006772755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011497777,0.0000781766,0.00021621528,0.00035650624,0.00008884685,0.000019692223,0.00006675492,0.000117707226,0.0002791674],"category_scores_gemma":[0.00011254827,0.00007673367,0.000045853278,0.0008220854,0.00008504122,0.000098901255,0.000043567168,0.0004012613,0.000016413982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006389012,0.000099643185,0.6080687,0.0001663646,0.00010502201,0.0000074304244,0.00075742626,0.0000054177285,0.37273058,0.000006049621,0.008556631,0.008857812],"study_design_scores_gemma":[0.0019520789,0.00010279191,0.8644848,0.00013144789,0.000016123378,5.904217e-7,0.00035139098,0.000052647687,0.13130379,0.000048820228,0.0014929071,0.00006264444],"about_ca_topic_score_codex":0.009350794,"about_ca_topic_score_gemma":0.0058682715,"teacher_disagreement_score":0.25641605,"about_ca_system_score_codex":0.0010376605,"about_ca_system_score_gemma":0.00031937848,"threshold_uncertainty_score":0.997246},"labels":[],"label_agreement":null},{"id":"W4362593672","doi":"10.1158/1538-7445.am2023-6417","title":"Abstract 6417: Deciphering aberrant STING pathway and exploring oncolytic viruses therapy in low grade serous ovarian carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa","funders":"","keywords":"Oncolytic virus; Biology; Sting; Cancer research; Vesicular stomatitis virus; Interferon; Virus; Virology","score_opus":0.25151686111610927,"score_gpt":0.39587454010810236,"score_spread":0.1443576789919931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921934,0.006349704,0.0000020854282,0.00021790716,0.0004903662,0.0003306553,0.000013439843,0.00008719443,0.00031523124],"genre_scores_gemma":[0.99605006,0.0026100578,0.00000584919,0.000055283075,0.00006304912,0.0003279286,0.0000068039726,0.0000397203,0.0008412438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800366,0.00034616893,0.0002963274,0.00038976973,0.00010244349,0.0008616023],"domain_scores_gemma":[0.9989346,0.0006332276,0.00004113647,0.00027052226,0.0000788065,0.000041695614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011616553,0.00017187794,0.00026838144,0.0004291052,0.00030768622,0.00006171955,0.00027281916,0.0001456098,0.00036748959],"category_scores_gemma":[0.00018101431,0.00015357626,0.00004803276,0.0005549689,0.00022503345,0.00017628165,0.000187842,0.00080023025,0.00023622728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000776566,0.00005463227,0.009107184,0.00006784533,0.00005357563,0.00012079651,0.0041640825,0.000037467045,0.9379286,0.00006268052,0.00020882995,0.047417704],"study_design_scores_gemma":[0.0023291165,0.0003269028,0.284843,0.00051637343,0.0000026304606,0.000030372048,0.0039358838,0.000032239157,0.6983819,0.00006748242,0.00926296,0.00027113367],"about_ca_topic_score_codex":0.0038836556,"about_ca_topic_score_gemma":0.0005878587,"teacher_disagreement_score":0.27573583,"about_ca_system_score_codex":0.0002134967,"about_ca_system_score_gemma":0.00025867228,"threshold_uncertainty_score":0.6262658},"labels":[],"label_agreement":null},{"id":"W4362593810","doi":"10.1158/1538-7445.am2023-4279","title":"Abstract 4279: Method for identifying microsatellite instability high DNA abnormality samples","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Nurses in Oncology","funders":"","keywords":"Microsatellite instability; Amplicon; Microsatellite; Computational biology; Polymerase chain reaction; Biology; DNA sequencing; Genetics; Computer science; DNA; Gene","score_opus":0.29591531954850575,"score_gpt":0.5142327773624656,"score_spread":0.2183174578139599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349344,0.0009042426,0.00069886574,0.0014174237,0.00072390505,0.0016616125,0.00031424852,0.00017079251,0.0006154984],"genre_scores_gemma":[0.9892383,0.0004775933,0.0076046055,0.0001453784,0.00048067266,0.0009750328,0.00014471999,0.00006413868,0.00086951983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663186,0.00021071463,0.0004376929,0.00074051775,0.00094852736,0.0010306947],"domain_scores_gemma":[0.996887,0.0012506197,0.00006794892,0.0007056568,0.0007892702,0.00029945868],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048048445,0.00019947003,0.00041784107,0.0002541616,0.00032525847,0.000093309725,0.00033103104,0.00018765817,0.00095692714],"category_scores_gemma":[0.0010418365,0.00018174868,0.00017731937,0.0011760133,0.00030382106,0.00010496146,0.00024679417,0.00064066827,0.00012569025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012623844,0.00010601251,0.019811403,0.0022437153,0.00014953264,0.00003503616,0.0010742688,0.000067608984,0.89164627,0.0002160377,0.008074419,0.07531334],"study_design_scores_gemma":[0.0012012328,0.00019195952,0.4635297,0.0002790134,0.00003286464,0.0000075693347,0.0003679195,0.0000757544,0.4956484,0.003805677,0.034639146,0.00022074554],"about_ca_topic_score_codex":0.0035388195,"about_ca_topic_score_gemma":0.0007476957,"teacher_disagreement_score":0.4437183,"about_ca_system_score_codex":0.0008236997,"about_ca_system_score_gemma":0.00082266185,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W4362593887","doi":"10.1158/1538-7445.am2023-4509","title":"Abstract 4509: A pan-Canadian precision oncology program for children, adolescents and young adults with hard-to-cure cancer: The PRecision Oncology For Young peopLE (PROFYLE) Program","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Occupational Cancer Research Centre; CancerCare Manitoba; Spinal Cord Injury BC; McGill University; McGill University Health Centre; Izaak Walton Killam Health Centre; BC Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; Baker Hughes (Canada); Concordia University; Cancer Care Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine; Precision medicine; Disease; Family medicine; Pathology","score_opus":0.05304616960510961,"score_gpt":0.43631030895701217,"score_spread":0.38326413935190257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95968646,0.00061576726,0.000011618391,0.008570697,0.0002919021,0.029908655,0.00052860624,0.00017464829,0.0002116464],"genre_scores_gemma":[0.9484839,0.0021542998,0.00085823087,0.00011691417,0.00045638188,0.046363324,0.00023853357,0.00011861127,0.0012098447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99523264,0.00021262182,0.000387246,0.0010988336,0.0010785294,0.0019901355],"domain_scores_gemma":[0.996419,0.00050018897,0.000103097,0.0005962187,0.0011896291,0.0011918548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013888776,0.0003350826,0.00058377895,0.0006657111,0.00092595065,0.0001689577,0.00045186954,0.00028845458,0.000055453373],"category_scores_gemma":[0.00054618355,0.00021632752,0.00013530499,0.0014430917,0.00030131266,0.00013747082,0.00020568229,0.0008903692,0.000051152958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01308059,0.00090902956,0.111321576,0.000560926,0.00026733163,0.00009363604,0.0013561024,0.000009529088,0.001205243,0.000008018835,0.032313682,0.83887434],"study_design_scores_gemma":[0.011162859,0.020052155,0.90844125,0.0015163769,0.00011713098,0.00010385178,0.0006213145,0.00058830355,0.0015737946,0.000065901615,0.05547578,0.00028129018],"about_ca_topic_score_codex":0.04683334,"about_ca_topic_score_gemma":0.41224164,"teacher_disagreement_score":0.83859307,"about_ca_system_score_codex":0.0015625895,"about_ca_system_score_gemma":0.004097525,"threshold_uncertainty_score":0.9595139},"labels":[],"label_agreement":null},{"id":"W4362593895","doi":"10.1158/1538-7445.am2023-3615","title":"Abstract 3615: Targeting tumor-brain crosstalk in invasive brain metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Breast cancer; Lung cancer; Cancer research; Crosstalk; Cancer; Melanoma; Tumor microenvironment; Brain metastasis; Medicine; Brain tumor; Metastasis; Oncology; Biology; Internal medicine; Pathology","score_opus":0.1265846824460059,"score_gpt":0.45498707805832367,"score_spread":0.32840239561231777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97348166,0.0021340381,0.0000028423217,0.02174866,0.00012353517,0.0008964687,0.00022286295,0.00009974205,0.0012901734],"genre_scores_gemma":[0.9946307,0.0003437247,0.00018462632,0.0009954342,0.00027340546,0.00052110146,0.00023372401,0.000059859696,0.0027574182],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967764,0.00030283784,0.00037853618,0.0005775575,0.00091969006,0.0010449641],"domain_scores_gemma":[0.99712145,0.0018731381,0.000058741687,0.00041397932,0.00022428637,0.00030838558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00360372,0.00020547939,0.00041102752,0.0006498463,0.00021755598,0.00008488619,0.00018836131,0.00006591683,0.0017389223],"category_scores_gemma":[0.0027922776,0.00016986992,0.00013424364,0.0018093341,0.000258448,0.00012850351,0.00019225337,0.0006773582,0.0005396835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011804821,0.0008038288,0.043517824,0.0014159607,0.0005421239,0.017481513,0.002437875,0.0004516383,0.21051757,0.0011361977,0.6889702,0.03154479],"study_design_scores_gemma":[0.016480764,0.0017871406,0.43034247,0.0024658286,0.000110708555,0.0001322431,0.012926281,0.00022606316,0.19177477,0.0035915007,0.33906105,0.0011011803],"about_ca_topic_score_codex":0.0029306067,"about_ca_topic_score_gemma":0.0010313857,"teacher_disagreement_score":0.38682464,"about_ca_system_score_codex":0.00045521357,"about_ca_system_score_gemma":0.0008743712,"threshold_uncertainty_score":0.99917364},"labels":[],"label_agreement":null},{"id":"W4362593905","doi":"10.1158/1538-7445.am2023-5311","title":"Abstract 5311: Lipidomic profiling of extracellular vesicles derived from cancer cell lines: Lipid species as potential biomarkers and cellular uptake enhancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Concordia University; École de Technologie Supérieure","funders":"","keywords":"Lipidome; Microvesicles; Biology; Extracellular vesicle; Lipidomics; Lipid droplet; Cancer cell; Cell culture; Extracellular; Biochemistry; Chemistry; Cell biology; Cancer; microRNA; Genetics","score_opus":0.04770915819376097,"score_gpt":0.3507596953645124,"score_spread":0.3030505371707514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988198,0.008497934,0.00075962447,0.00028430778,0.00010267635,0.00047244312,0.0004153062,0.00017215201,0.0010975668],"genre_scores_gemma":[0.97560644,0.017499682,0.0037861234,0.000009197553,0.00070553005,0.0008407102,0.00013237598,0.00007975272,0.0013401863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767977,0.00003274443,0.0004774222,0.00067749975,0.00051449856,0.0006180443],"domain_scores_gemma":[0.99863565,0.0001869673,0.00019319961,0.00054491917,0.00025319116,0.00018605911],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039012148,0.00024314427,0.00031875924,0.00012909483,0.00028610736,0.00007335843,0.00046992733,0.00022001694,0.001966418],"category_scores_gemma":[0.000052891228,0.00025002574,0.0001103106,0.00043989558,0.0004308569,0.00015345566,0.0002516318,0.00048778945,0.000033992645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016360574,0.00004183385,0.0002761418,0.0003184265,0.000066848224,0.000010917937,0.00022799103,0.00019600075,0.9916449,0.000073792566,0.00042186218,0.006557631],"study_design_scores_gemma":[0.00047325218,0.000018331866,0.00024050879,0.00020488651,0.000023795232,4.4897422e-7,0.0016225696,0.00050930044,0.99239177,0.001019412,0.0032485141,0.00024722176],"about_ca_topic_score_codex":0.0034302175,"about_ca_topic_score_gemma":0.000101704565,"teacher_disagreement_score":0.012591546,"about_ca_system_score_codex":0.00027179345,"about_ca_system_score_gemma":0.00034461182,"threshold_uncertainty_score":0.9999952},"labels":[],"label_agreement":null},{"id":"W4362593963","doi":"10.1158/1538-7445.am2023-ng07","title":"Abstract NG07: Targeting polyamines metabolism in acute myeloid leukemia stem cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Haematopoiesis; Myeloid leukemia; Stem cell; Arginine; Progenitor cell; Leukemia; Population; Cancer research; Myeloid; Biology; Bone marrow; Immunology; Medicine; Cell biology; Biochemistry; Amino acid","score_opus":0.039236041568990174,"score_gpt":0.3513035635457518,"score_spread":0.31206752197676163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97962874,0.016956707,0.0000073096894,0.00030112106,0.0017156296,0.00034552705,0.00011473319,0.00003931851,0.0008909282],"genre_scores_gemma":[0.9535771,0.030224007,0.0000573473,0.00014449547,0.0040251096,0.00033532246,0.00010182126,0.000079201,0.011455581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974357,0.00012996518,0.0003180882,0.0006350656,0.0005045602,0.0009766314],"domain_scores_gemma":[0.99903756,0.00004557915,0.000061338105,0.00045156112,0.00021184504,0.000192132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011617936,0.00020897294,0.00028522054,0.00031743932,0.00016086752,0.00007000006,0.00047754092,0.0002221309,0.00010900067],"category_scores_gemma":[0.000050023384,0.00020163243,0.0001195873,0.0008735011,0.00015779045,0.000012559157,0.0003246876,0.00045486915,0.00014150934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011399772,0.000015156439,0.00018360079,0.000049089063,0.000057189445,0.000017785931,0.00015168173,0.00019222725,0.931208,0.000029928986,0.05169404,0.016287295],"study_design_scores_gemma":[0.0005858736,0.000023190345,0.0066384883,0.000025724776,0.000009923235,0.0000022224103,0.00026121846,0.000022836883,0.59062535,0.000031928972,0.4015781,0.00019514284],"about_ca_topic_score_codex":0.0011125336,"about_ca_topic_score_gemma":0.0004130419,"teacher_disagreement_score":0.34988403,"about_ca_system_score_codex":0.00012036135,"about_ca_system_score_gemma":0.0007022019,"threshold_uncertainty_score":0.8222332},"labels":[],"label_agreement":null},{"id":"W4362594015","doi":"10.1158/1538-7445.am2023-2935","title":"Abstract 2935: ZW270, a conditionally masked IL-12 cytokine fusion protein displaying potent anti-tumor activity absent systemic toxicity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Potency; Cytokine; Pharmacology; Cytotoxic T cell; Fusion protein; Toxicity; Recombinant DNA; Chemistry; Immunology; Cancer research; Biology; In vitro; Biochemistry","score_opus":0.09976051613072782,"score_gpt":0.4081692322461326,"score_spread":0.30840871611540477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98691934,0.00026962662,0.000020350953,0.0070832255,0.00018686475,0.0021894213,0.0006360431,0.00016298598,0.0025321105],"genre_scores_gemma":[0.9877611,0.00055971154,0.000029551133,0.00013010616,0.0007855116,0.00081100635,0.00017759099,0.000062492865,0.00968295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99435294,0.0002727814,0.0004485302,0.0007825663,0.0027846838,0.0013585009],"domain_scores_gemma":[0.99779296,0.00033928824,0.000110295565,0.00052002544,0.0006254872,0.000611958],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020091012,0.00030655813,0.00057104276,0.0006268187,0.00067504024,0.000105866326,0.000380557,0.00015588039,0.0013808318],"category_scores_gemma":[0.00032084555,0.00024252829,0.000228052,0.0011065068,0.0003984578,0.00017851204,0.0004950494,0.001401191,0.0009791058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001686707,0.0002652387,0.008719813,0.001873541,0.00013731595,0.0014771856,0.00015383433,0.00006271348,0.97428477,0.00027064708,0.005986733,0.0050815116],"study_design_scores_gemma":[0.0027205173,0.00063680485,0.6967965,0.0031220587,0.000032962133,0.00022111439,0.0004015353,0.0014280417,0.2803919,0.00027178766,0.013451773,0.0005250005],"about_ca_topic_score_codex":0.0018134417,"about_ca_topic_score_gemma":0.000120136516,"teacher_disagreement_score":0.69389284,"about_ca_system_score_codex":0.00071706757,"about_ca_system_score_gemma":0.00100701,"threshold_uncertainty_score":0.9997988},"labels":[],"label_agreement":null},{"id":"W4362594105","doi":"10.1158/1538-7445.am2023-3938","title":"Abstract 3938: <i>In vivo</i> genome-wide CRISPR screen in pancreatic ductal adenocarcinoma defines HSPE1 as a potential oncogene by acting through G2/M cell cycle arrest","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carcinogenesis; Cancer research; CRISPR; Cell cycle checkpoint; Cell cycle; Pancreatic cancer; Small hairpin RNA; Biology; Oncogene; Cancer; Gene knockdown; KRAS; In vivo; Cell culture; Gene; Genetics","score_opus":0.0240889135923905,"score_gpt":0.3631005337458455,"score_spread":0.339011620153455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720944,0.009360845,0.00014148616,0.00032591223,0.00015665368,0.0003637278,0.000084625644,0.00002550012,0.0023318115],"genre_scores_gemma":[0.99434966,0.0037381353,0.00011339114,0.00007891277,0.0004025365,0.00014846555,0.00011770662,0.00006723986,0.000983948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763834,0.00008259754,0.0003243636,0.00063624716,0.00040238968,0.0009160818],"domain_scores_gemma":[0.99926865,0.00006788093,0.000043538414,0.0003971462,0.00008304693,0.00013974545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052620657,0.0002232266,0.00024051235,0.00017843331,0.00011666342,0.000063059146,0.00038110843,0.00018926112,0.00013969769],"category_scores_gemma":[0.00012490859,0.00024133633,0.00008583952,0.0006259407,0.00009610005,0.000013281135,0.00027126577,0.0004150331,0.000070601054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000123336,0.000054823864,0.019453667,0.00010704421,0.000025527308,0.00015337276,0.00018475368,0.004155349,0.97197807,0.0000024077779,0.003450193,0.00031142822],"study_design_scores_gemma":[0.0012643386,0.00016978732,0.0644398,0.00009053481,0.000012939493,0.000010709647,0.0009602629,0.00023106846,0.92424566,0.00008053457,0.008073582,0.00042081383],"about_ca_topic_score_codex":0.0049158805,"about_ca_topic_score_gemma":0.0010923191,"teacher_disagreement_score":0.04773247,"about_ca_system_score_codex":0.00009645067,"about_ca_system_score_gemma":0.00024978895,"threshold_uncertainty_score":0.984141},"labels":[],"label_agreement":null},{"id":"W4362594122","doi":"10.1158/1538-7445.am2023-6667","title":"Abstract 6667: Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"T-cell receptor; Biology; Immune system; Pembrolizumab; T cell; Immune checkpoint; Immunology; Cancer research; Immunotherapy","score_opus":0.030198213604252788,"score_gpt":0.35987041134560416,"score_spread":0.32967219774135137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569374,0.0012126345,5.507928e-7,0.0010533935,0.00011570764,0.0008736131,0.00008436771,0.000037015703,0.00092900323],"genre_scores_gemma":[0.9938344,0.0039295238,0.000036605114,0.000024901225,0.00007278946,0.00031559062,0.00010115139,0.000050657174,0.0016343845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776244,0.000087863846,0.0004705774,0.00041818127,0.0007485972,0.000512318],"domain_scores_gemma":[0.99905926,0.00006656774,0.00012825108,0.00029801927,0.00033380341,0.000114102346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076811423,0.0001893642,0.00039822276,0.0003450055,0.00010032278,0.00002930041,0.000121415476,0.00011782526,0.00046581935],"category_scores_gemma":[0.000028118266,0.0001440837,0.000078257435,0.0011091838,0.00031538605,0.00009793837,0.000074009164,0.00051015726,0.0000032876148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004122582,0.00033622523,0.6395603,0.0005234535,0.000119370285,0.000024551227,0.00040503877,0.000016033342,0.33201456,0.0000036032068,0.0007012615,0.022173028],"study_design_scores_gemma":[0.0064664283,0.00094559294,0.9338548,0.0011234634,0.000016645168,0.0000011004748,0.0010010098,0.00041323245,0.055414762,0.000002990088,0.00058013486,0.00017982739],"about_ca_topic_score_codex":0.008863847,"about_ca_topic_score_gemma":0.001061191,"teacher_disagreement_score":0.29429454,"about_ca_system_score_codex":0.001759546,"about_ca_system_score_gemma":0.000679351,"threshold_uncertainty_score":0.9977362},"labels":[],"label_agreement":null},{"id":"W4362594135","doi":"10.1158/1538-7445.am2023-1741","title":"Abstract 1741: Inhibition of pcsk9 impairs the development of vessel co-option and potentiates anti-angiogenic therapy in colorectal cancer liver metastases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University Health Centre","funders":"","keywords":"Medicine; Angiogenesis; Colorectal cancer; Cancer; Cancer research; Blood vessel; Internal medicine; Cholesterol; Oncology","score_opus":0.050345981071355864,"score_gpt":0.36544595114123957,"score_spread":0.3150999700698837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502386,0.014092626,0.0000069318176,0.00008615203,0.0003048367,0.00032542006,0.00012519947,0.000005126343,0.00002982692],"genre_scores_gemma":[0.9707719,0.02834776,0.000025155385,0.000012568566,0.0005011068,0.00019045454,0.000088252964,0.000014665703,0.00004810596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888563,0.00010093531,0.00023788605,0.00023442069,0.00027255967,0.00026858595],"domain_scores_gemma":[0.9995364,0.00003866549,0.000075427386,0.00012532063,0.00017988913,0.00004429878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291754,0.00009689283,0.00016561589,0.00015707615,0.00008700972,0.000013379227,0.00011120152,0.000077802884,0.000053878764],"category_scores_gemma":[0.00003082676,0.00007389628,0.000060123468,0.00033988056,0.00022521689,0.00000869901,0.0000752616,0.000108923225,0.000002190178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020213277,0.00004384538,0.0044896854,0.000072656105,0.000084713065,2.2922353e-7,0.0005908533,0.00009083753,0.9747878,0.000012891336,0.0027442595,0.016880099],"study_design_scores_gemma":[0.00053430395,0.00006079257,0.22636963,0.00004384255,0.0000064480187,6.596694e-7,0.00036124742,0.00001081155,0.76046795,0.000017366812,0.012056259,0.00007068302],"about_ca_topic_score_codex":0.0009606878,"about_ca_topic_score_gemma":0.0010136416,"teacher_disagreement_score":0.22187996,"about_ca_system_score_codex":0.000033464523,"about_ca_system_score_gemma":0.00042695858,"threshold_uncertainty_score":0.30134028},"labels":[],"label_agreement":null},{"id":"W4362594156","doi":"10.1158/1538-7445.am2023-5760","title":"Abstract 5760: Molecular, immune, and microbial profiles of early-onset, intermediate-onset, and later-onset CRCs","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"KRAS; Microsatellite instability; Colorectal cancer; Age of onset; Medicine; Internal medicine; Cancer; Oncology; Gastroenterology; Biology; Genetics; Disease; Gene; Microsatellite; Allele","score_opus":0.04423971322434717,"score_gpt":0.3780475635882365,"score_spread":0.3338078503638893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207586,0.00548302,9.998495e-7,0.0011420179,0.00016641125,0.0006418677,0.00022634966,0.00004915111,0.00021430555],"genre_scores_gemma":[0.99295604,0.0055508153,0.000028589757,0.00010082089,0.00007284366,0.00012257368,0.000052218038,0.000042071726,0.0010740373],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818796,0.00011187023,0.00035298103,0.0003820017,0.0004293923,0.0005357986],"domain_scores_gemma":[0.99902576,0.00020439106,0.00007248406,0.00034281667,0.00019208508,0.0001624332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096277863,0.00017339847,0.0003465217,0.0004170368,0.0001237141,0.00005654586,0.00015884283,0.00014860959,0.00026346886],"category_scores_gemma":[0.00010440935,0.00014907861,0.00008578829,0.00061134575,0.00086170784,0.00007945876,0.00018666517,0.00045773818,0.000022036664],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005159952,0.000078019446,0.13629355,0.00082213205,0.00027769196,0.00019072862,0.0012207774,4.134701e-7,0.829681,0.0000042294364,0.009482583,0.016788924],"study_design_scores_gemma":[0.0022492576,0.00042944745,0.75385344,0.0006161355,0.000026012483,0.00005986515,0.000313521,0.000011963223,0.24007665,0.00006869116,0.002136595,0.00015841748],"about_ca_topic_score_codex":0.0016349981,"about_ca_topic_score_gemma":0.000103831684,"teacher_disagreement_score":0.6175599,"about_ca_system_score_codex":0.000098033415,"about_ca_system_score_gemma":0.00038394376,"threshold_uncertainty_score":0.60792494},"labels":[],"label_agreement":null},{"id":"W4362594355","doi":"10.1158/1538-7445.am2023-5596","title":"Abstract 5596: Cell free DNA levels and fragmentation patterns in different liquid biopsy analytes (blood, urine and vaginal fluid) in cervical cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Liquid biopsy; Biopsy; Medicine; Cervical cancer; Urine; Cancer; Cell-free fetal DNA; Intraepithelial neoplasia; Cervical intraepithelial neoplasia; DNA fragmentation; Field cancerization; Dysplasia; Internal medicine; Pathology; Oncology; Apoptosis; Biology; Programmed cell death; Prostate cancer","score_opus":0.03380923435283535,"score_gpt":0.3418572858748089,"score_spread":0.30804805152197356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694914,0.0016832447,0.00000322891,0.00048356465,0.000089699395,0.00027377924,0.00046137357,0.0000051776306,0.000050803967],"genre_scores_gemma":[0.99240613,0.0069149057,0.000007857163,0.00006715303,0.00018480618,0.00018708462,0.00013880148,0.000023410332,0.000069871196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998627,0.000051099338,0.00022145307,0.00044542577,0.0002429545,0.00041206685],"domain_scores_gemma":[0.99946624,0.00006504412,0.00003584119,0.00021473908,0.00009064815,0.00012751043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022169761,0.00014389883,0.00016141658,0.00021778623,0.000057634785,0.000050506023,0.00016587676,0.00010910077,0.00007712573],"category_scores_gemma":[0.00005870677,0.00013630673,0.000023735967,0.00024385334,0.00008492034,0.0000072784937,0.00035734382,0.00019665461,0.000001900655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021388438,0.00014082984,0.60109967,0.0001579369,0.000020546442,0.000018628847,0.00017987887,0.00007945501,0.39612353,0.0000061499754,0.0005317143,0.001427795],"study_design_scores_gemma":[0.0018391557,0.00026235892,0.85727155,0.00007363605,0.0000074979444,5.447243e-7,0.0000965729,0.000060441136,0.13983545,0.000060191516,0.00034042486,0.00015217814],"about_ca_topic_score_codex":0.003652481,"about_ca_topic_score_gemma":0.006776174,"teacher_disagreement_score":0.25628808,"about_ca_system_score_codex":0.00008438457,"about_ca_system_score_gemma":0.00010851467,"threshold_uncertainty_score":0.5558427},"labels":[],"label_agreement":null},{"id":"W4362594416","doi":"10.1158/1538-7445.am2023-4729","title":"Abstract 4729: LSD1 activates oncogenic super-enhancers in castration-resistant prostate cancer by forming nuclear condensates with BRD4","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"FOXA1; Androgen receptor; Cancer research; Coactivator; Prostate cancer; BRD4; Transcription factor; Demethylase; Enhancer; Enzalutamide; EZH2; Chromatin; Transactivation; Biology; Chemistry; Histone; Cancer; Bromodomain; Gene; Genetics","score_opus":0.07513378526280544,"score_gpt":0.41479220041049364,"score_spread":0.3396584151476882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868078,0.0042997063,1.4240068e-7,0.0056094136,0.00009550895,0.0017120426,0.00025056273,0.00013606153,0.0010887436],"genre_scores_gemma":[0.9816837,0.0076363767,0.000022001095,0.000089941524,0.00016345872,0.0012908046,0.0001616761,0.00011703077,0.008835059],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99586797,0.00009948814,0.00039749668,0.0007570706,0.0013744447,0.0015035077],"domain_scores_gemma":[0.9983394,0.00026501526,0.000074668096,0.00040975376,0.0005090782,0.00040207471],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087064813,0.00030846288,0.00047585033,0.00061168656,0.00039847437,0.00015252094,0.0002637083,0.00015928083,0.0011210057],"category_scores_gemma":[0.00008273333,0.00023129862,0.000085352076,0.002027339,0.0005137716,0.00038371055,0.00011197984,0.0010377764,0.00016455431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004927561,0.0001526889,0.016474143,0.00058130466,0.0002512579,0.00057867216,0.0028061646,0.00006519927,0.9488984,0.000024447138,0.013934657,0.011305526],"study_design_scores_gemma":[0.012777679,0.0020014585,0.07390447,0.0030952631,0.00008535692,0.000025562278,0.012456303,0.0002810853,0.86334884,0.00024047517,0.03091273,0.0008707547],"about_ca_topic_score_codex":0.010410043,"about_ca_topic_score_gemma":0.003271401,"teacher_disagreement_score":0.08554952,"about_ca_system_score_codex":0.0018240481,"about_ca_system_score_gemma":0.0020660958,"threshold_uncertainty_score":0.9997921},"labels":[],"label_agreement":null},{"id":"W4362594427","doi":"10.1158/1538-7445.am2023-5882","title":"Abstract 5882: Prevention of antibiotic-induced dysbiosis in human volunteers by DAV132 and preservation of responsiveness to anti-PD-1 demonstrated by transplantation of human feces into tumor-bearing mice","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dysbiosis; Ceftazidime; Antibiotics; Human microbiome; Piperacillin/tazobactam; Medicine; Piperacillin; Avibactam; Microbiome; Pharmacology; Gut flora; Microbiology; Immunology; Internal medicine; Biology; Bacteria; Bioinformatics","score_opus":0.0529711391113715,"score_gpt":0.4109218020582572,"score_spread":0.35795066294688566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900097,0.0003059965,0.0000104834435,0.00010447543,0.000017859935,0.00041925488,0.000101631456,0.0000046387822,0.00003470702],"genre_scores_gemma":[0.99909973,0.0004490708,0.000026070189,0.000005985848,0.000011169124,0.000013934572,0.00030895337,0.000014364696,0.000070749644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987808,0.00016353611,0.00035136103,0.00028350306,0.00019120632,0.00022958506],"domain_scores_gemma":[0.9994194,0.000030632873,0.00010641407,0.00015312503,0.00023528014,0.00005518436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008407687,0.000088045694,0.0001920945,0.0002460744,0.000080761856,0.000010535736,0.00015335294,0.00010963948,0.000007371174],"category_scores_gemma":[0.00005198772,0.000096569034,0.000028264034,0.0004958643,0.0001028022,0.000016218048,0.000051774903,0.00012224531,4.4984677e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002135923,0.00006684695,0.03548033,0.00092327106,0.000021813621,8.132651e-7,0.0004511956,0.000027416478,0.9621521,0.00001053134,0.00033851605,0.00031355734],"study_design_scores_gemma":[0.00039197094,0.00029395448,0.27767268,0.0002803768,0.000005457824,3.6043127e-7,0.0002891903,0.0000071959043,0.72096825,0.0000122903475,0.000019580499,0.000058688624],"about_ca_topic_score_codex":0.0053585074,"about_ca_topic_score_gemma":0.0016315174,"teacher_disagreement_score":0.24219234,"about_ca_system_score_codex":0.000036763915,"about_ca_system_score_gemma":0.00014857264,"threshold_uncertainty_score":0.8100496},"labels":[],"label_agreement":null},{"id":"W4362594496","doi":"10.1158/1538-7445.am2023-776","title":"Abstract 776: Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Breast biopsy; Breast disease; Cancer; Biopsy; Risk factor; Oncology; Internal medicine; Mammography; Gynecology; Obstetrics","score_opus":0.035725376994293734,"score_gpt":0.3490187466181554,"score_spread":0.3132933696238617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911646,0.0007738388,6.631515e-7,0.0052388697,0.00009608668,0.0008190727,0.0017323149,0.00011060164,0.000063910076],"genre_scores_gemma":[0.9926844,0.0053952867,0.0000029473345,0.00007065348,0.00049308577,0.00081391906,0.000048668404,0.000076626224,0.00041441066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996621,0.00011982324,0.00024337828,0.00078159967,0.0010172868,0.0012168811],"domain_scores_gemma":[0.99794036,0.000096017,0.000092347305,0.00049581745,0.00032919168,0.0010462686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009825439,0.00029670863,0.0004774,0.00087348477,0.000272779,0.000101823025,0.00018644912,0.00013338806,0.00078582927],"category_scores_gemma":[0.000021735725,0.00023220232,0.000057342608,0.0020696328,0.00093870837,0.00019106771,0.00016855374,0.0010511829,0.000017745346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037984827,0.00010675684,0.96503055,0.00035054644,0.000117937525,0.00047914742,0.0008563546,0.00003127685,0.00044553657,0.0000060540183,0.0010872802,0.027690062],"study_design_scores_gemma":[0.0019480147,0.000117710995,0.99490654,0.0006865486,0.00004246295,0.00006937013,0.0014234956,0.0000912556,0.000056903667,0.00006120678,0.0003241179,0.00027234672],"about_ca_topic_score_codex":0.098637834,"about_ca_topic_score_gemma":0.09650461,"teacher_disagreement_score":0.029876001,"about_ca_system_score_codex":0.00069474586,"about_ca_system_score_gemma":0.00074756984,"threshold_uncertainty_score":0.94689363},"labels":[],"label_agreement":null},{"id":"W4362594519","doi":"10.1158/1538-7445.am2023-4305","title":"Abstract 4305: Germline structural variants shape prostate cancer clinical and molecular evolution","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Germline; Cancer; Single-nucleotide polymorphism; Germline mutation; Medicine; Oncology; Internal medicine; Genetics; Biology; Genotype; Gene; Mutation","score_opus":0.12908124149744687,"score_gpt":0.5054803646120697,"score_spread":0.3763991231146228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809086,0.008433586,0.0000018298377,0.008309225,0.00033173256,0.001186111,0.00016192265,0.00012500734,0.00054203125],"genre_scores_gemma":[0.9824118,0.012080628,0.000037831047,0.000117287964,0.00055509864,0.0004940493,0.00009292753,0.000058033238,0.0041523394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654007,0.00018166107,0.0004082649,0.00071317283,0.0011085358,0.0010482873],"domain_scores_gemma":[0.99823135,0.00018407819,0.00005577072,0.00039227845,0.00060955365,0.00052696164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015485168,0.0002067843,0.00038919094,0.00041349282,0.0003046068,0.00008442542,0.0001795846,0.00018538076,0.0009856196],"category_scores_gemma":[0.00023762869,0.0001574103,0.000103711754,0.0012058247,0.0007069771,0.00016189822,0.00024543947,0.0010198017,0.00015049858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005061876,0.00018725968,0.60544753,0.0012676169,0.0007790933,0.002258274,0.00077223347,0.000070837275,0.17956488,0.00052653113,0.021774177,0.18228967],"study_design_scores_gemma":[0.004637454,0.00034788725,0.9831336,0.0004148719,0.000051598145,0.000017947976,0.00020165884,0.0017998824,0.0045164824,0.0013967905,0.003257284,0.00022450136],"about_ca_topic_score_codex":0.0012092814,"about_ca_topic_score_gemma":0.00008348374,"teacher_disagreement_score":0.37768608,"about_ca_system_score_codex":0.00043397816,"about_ca_system_score_gemma":0.0013163254,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W4362594548","doi":"10.1158/1538-7445.am2023-3019","title":"Abstract 3019: Density of T cell subsets in colorectal cancer in relation to disease-specific survival","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Colorectal cancer; Hazard ratio; KRAS; CD8; Stromal cell; Microsatellite instability; Proportional hazards model; Oncology; T cell; Internal medicine; Medicine; Cancer; Cytotoxic T cell; Cancer research; Confidence interval; Biology; Immunology; Immune system; Genetics; Allele","score_opus":0.10334140350255044,"score_gpt":0.4007434649016552,"score_spread":0.29740206139910474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951252,0.0014852834,9.236799e-7,0.0016426104,0.0002822689,0.0007370698,0.00007338779,0.000023186865,0.00063006877],"genre_scores_gemma":[0.9956085,0.0035294336,0.000005886982,0.000031369305,0.00011230133,0.00020436574,0.000024524725,0.00002377824,0.00045985015],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99812204,0.00010871547,0.0003049207,0.0003347918,0.0006693898,0.0004601449],"domain_scores_gemma":[0.9992267,0.00018465664,0.00003914834,0.00020704135,0.00017272914,0.00016971849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001262181,0.00010246423,0.00024714723,0.00061975815,0.00004599257,0.000012859481,0.00012872386,0.00008471974,0.00065416633],"category_scores_gemma":[0.00006676297,0.00009821981,0.000062340834,0.002165103,0.00011566737,0.00006328291,0.000057931164,0.0003914884,0.000058664646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076342127,0.000114147355,0.4675776,0.00017935003,0.0000149097095,0.00011296127,0.0006797423,0.00016411392,0.5151817,0.000012958857,0.0023805206,0.005947748],"study_design_scores_gemma":[0.001640721,0.00007276475,0.949625,0.0003466816,0.000003210926,3.1769335e-7,0.00022495897,0.000054065436,0.0464672,0.000027808266,0.0014458783,0.00009135437],"about_ca_topic_score_codex":0.0053305025,"about_ca_topic_score_gemma":0.008503651,"teacher_disagreement_score":0.48204744,"about_ca_system_score_codex":0.0008777685,"about_ca_system_score_gemma":0.0006596973,"threshold_uncertainty_score":0.8058161},"labels":[],"label_agreement":null},{"id":"W4362594551","doi":"10.1158/1538-7445.am2023-5026","title":"Abstract 5026: Protein tyrosine phosphatase Ptpn1 knockout in mouse models drives B-cell hematological malignancies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Biology; Protein tyrosine phosphatase; Molecular biology; Genetics; Receptor","score_opus":0.0657912175857927,"score_gpt":0.3573373356672397,"score_spread":0.291546118081447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96378356,0.033503823,0.00005208062,0.00054763234,0.000055823595,0.0010915846,0.00055125786,0.00007333843,0.00034088775],"genre_scores_gemma":[0.99151856,0.0025778306,0.00024107468,0.0000703146,0.00013652288,0.0014449174,0.0004686847,0.000058550937,0.0034835518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718744,0.00014119367,0.0003538534,0.000767911,0.00055019883,0.000999379],"domain_scores_gemma":[0.998788,0.000048664235,0.00006919744,0.000679273,0.00021132217,0.00020355558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082843384,0.00025420028,0.00027960338,0.000210014,0.00016573163,0.00008386956,0.0006418571,0.00024317396,0.000112314134],"category_scores_gemma":[0.00028701764,0.00023237293,0.00008877744,0.00068083074,0.00035350383,0.000023977744,0.00062550075,0.00042158744,0.00016700536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030862348,0.00020809929,0.00035293415,0.00020898515,0.000016517735,0.000137216,0.000051441,0.0007922842,0.9770344,0.0025314689,0.01756056,0.0007974723],"study_design_scores_gemma":[0.00087781885,0.00018382556,0.0004261647,0.000112163936,0.0000023842265,0.00000292849,0.00010128032,0.000111330904,0.9904711,0.0010587323,0.00637755,0.0002747047],"about_ca_topic_score_codex":0.00055052625,"about_ca_topic_score_gemma":0.00018270884,"teacher_disagreement_score":0.030925993,"about_ca_system_score_codex":0.00008363728,"about_ca_system_score_gemma":0.00035446585,"threshold_uncertainty_score":0.9475893},"labels":[],"label_agreement":null},{"id":"W4362594560","doi":"10.1158/1538-7445.am2023-6700","title":"Abstract 6700: Characterizing circulating tumor DNA release kinetics and fragment length in a chemotherapy resistant model of esophageal adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fluorometer; Cisplatin; Chemotherapy; Cancer research; Cell culture; Adenocarcinoma; DNA; Digital polymerase chain reaction; Molecular biology; Biomarker; Cancer; Biology; Medicine; Chemistry; Internal medicine; Gene; Genetics; Polymerase chain reaction","score_opus":0.0480406329449598,"score_gpt":0.334100477125072,"score_spread":0.2860598441801122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697816,0.0020471634,0.00001976393,0.00036684494,0.000047175672,0.0002809915,0.00010992291,0.000007823368,0.00014212268],"genre_scores_gemma":[0.99638826,0.0029556623,0.0001284956,0.00011989474,0.00017300424,0.00008628359,0.00004318652,0.000038896713,0.00006632466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985801,0.000038831135,0.00028893442,0.0003942638,0.00026867774,0.00042919244],"domain_scores_gemma":[0.9993217,0.000060831662,0.00007379173,0.00030840188,0.00012096729,0.00011430438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049786683,0.0001279669,0.00018356685,0.00016378055,0.00006510988,0.00003249612,0.00017298805,0.00008701644,0.000015096509],"category_scores_gemma":[0.00013636041,0.00013742424,0.00004454983,0.000262905,0.00012186389,0.0000045232605,0.00017748188,0.00020277957,0.0000022061274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024298637,0.000045849218,0.007428484,0.00013963494,0.000016369393,0.000031441006,0.00027141106,0.0012259956,0.98760873,0.00006123242,0.00026082605,0.002667011],"study_design_scores_gemma":[0.0015754469,0.00028890432,0.24286146,0.00019285851,0.000007949422,0.0000036938657,0.00033822507,0.0066172695,0.74689895,0.00031404608,0.0006208063,0.00028041398],"about_ca_topic_score_codex":0.0002878089,"about_ca_topic_score_gemma":0.00015733506,"teacher_disagreement_score":0.24070984,"about_ca_system_score_codex":0.00009657983,"about_ca_system_score_gemma":0.00029088528,"threshold_uncertainty_score":0.5603998},"labels":[],"label_agreement":null},{"id":"W4362594584","doi":"10.1158/1538-7445.am2023-69","title":"Abstract 69: Minimally invasive brain metastases are characterized by elevated immune cell infiltrate","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Concordia University; Montreal Neurological Institute and Hospital; University of Toronto; McGill University and Génome Québec Innovation Centre; McGill University","funders":"","keywords":"Breast cancer; Lung cancer; Brain metastasis; Medicine; Gene signature; Melanoma; Cancer research; Immunotherapy; Transcriptome; Cancer; Tumor microenvironment; Immune system; Metastasis; Pathology; Biology; Internal medicine; Immunology; Gene expression; Gene","score_opus":0.08635693966743585,"score_gpt":0.3908978623490505,"score_spread":0.30454092268161465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851554,0.0032709604,0.0000018939197,0.0081196,0.00010467276,0.0013533032,0.0011114595,0.00014532651,0.0007373804],"genre_scores_gemma":[0.9821491,0.0031515236,0.00007325596,0.0005781211,0.00020840838,0.0010157899,0.0014033841,0.000082100574,0.011338307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690044,0.0002969355,0.00041836392,0.0005585909,0.00089084654,0.0009348417],"domain_scores_gemma":[0.9977082,0.0008130547,0.00013965153,0.00055080064,0.00041324957,0.00037506872],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015181868,0.0002656707,0.0005580787,0.00038266802,0.00022261473,0.00009390426,0.00023376236,0.000110763554,0.0027621188],"category_scores_gemma":[0.0003517652,0.00021500455,0.00017970224,0.0012832293,0.00020788574,0.00012910696,0.00013728999,0.000606276,0.0011462477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007964127,0.00031871823,0.0014113316,0.0005091481,0.00033574697,0.00096046284,0.0001399579,0.0000024774038,0.91457045,0.000009879927,0.07673447,0.004210957],"study_design_scores_gemma":[0.0062872856,0.0007144189,0.073315635,0.0004535618,0.0001154308,0.000015507312,0.0010577549,0.000009255242,0.79584956,0.00006071162,0.121791735,0.0003291447],"about_ca_topic_score_codex":0.00071931793,"about_ca_topic_score_gemma":0.0000607739,"teacher_disagreement_score":0.11872088,"about_ca_system_score_codex":0.00024883632,"about_ca_system_score_gemma":0.00068788644,"threshold_uncertainty_score":0.99963146},"labels":[],"label_agreement":null},{"id":"W4362594648","doi":"10.1158/1538-7445.am2023-5440","title":"Abstract 5440: Deep-learning model for tumor type classification enables enhanced clinical decision support in cancer diagnosis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Indel; Cancer; Deep learning; Medicine; Deep sequencing; Classifier (UML); Artificial intelligence; Computational biology; Medical diagnosis; Oncology; Machine learning; Bioinformatics; Genome; Gene; Computer science; Internal medicine; Biology; Genetics; Pathology; Single-nucleotide polymorphism","score_opus":0.17118639149031678,"score_gpt":0.4840069900520184,"score_spread":0.31282059856170163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954386,0.0014369764,0.0014333347,0.00037843556,0.00039004837,0.0005648906,0.00010581012,0.000020074254,0.00023183039],"genre_scores_gemma":[0.96045476,0.03515083,0.00036958428,0.00014329875,0.0005354843,0.0023120728,0.0002192169,0.00005103455,0.0007637392],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980355,0.00006535225,0.00041639205,0.0006130033,0.00028688626,0.00058286235],"domain_scores_gemma":[0.9984795,0.00048443695,0.00008791468,0.00033056596,0.0004677483,0.00014986817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014716071,0.00013733831,0.000207675,0.00018394143,0.00015707924,0.000058159767,0.000304317,0.00018616125,0.00012990164],"category_scores_gemma":[0.0016130793,0.0001404655,0.000097336,0.0004896311,0.000110592075,0.000008131951,0.00017643232,0.00033346209,0.000042960884],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020666355,0.00029218374,0.06731268,0.00020773223,0.000088038585,0.000015642336,0.00035853338,0.065074705,0.44576254,0.0001894399,0.09191515,0.3267167],"study_design_scores_gemma":[0.006243097,0.0017406285,0.19549653,0.00045493292,0.000057390025,0.0000019855404,0.0009966864,0.17366911,0.28139737,0.0031460114,0.33547616,0.0013200953],"about_ca_topic_score_codex":0.00025749687,"about_ca_topic_score_gemma":0.002495978,"teacher_disagreement_score":0.3253966,"about_ca_system_score_codex":0.00016674428,"about_ca_system_score_gemma":0.0008442678,"threshold_uncertainty_score":0.5728017},"labels":[],"label_agreement":null},{"id":"W4362594663","doi":"10.1158/1538-7445.am2023-2599","title":"Abstract 2599: Targeting SETD2-inactivated cells with STF-62247 leads to cell cycle arrest","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Biology; Histone; Histone methyltransferase; Genetics; Cell biology; Gene; Cancer research","score_opus":0.03805926246127887,"score_gpt":0.3698957838804843,"score_spread":0.3318365214192054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956987,0.00059797004,0.00011028847,0.00031280587,0.00016168556,0.00032334033,0.00003993539,0.000030078176,0.0027252168],"genre_scores_gemma":[0.9959762,0.0007007522,0.00019468636,0.000043880435,0.00039775006,0.00010728334,0.00012559592,0.000052162577,0.0024016995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982353,0.000091507274,0.00016449021,0.0004818133,0.000414937,0.0006119633],"domain_scores_gemma":[0.99905986,0.000048090835,0.00004219892,0.00035102208,0.00029017514,0.0002086566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074761605,0.00013916014,0.00012062086,0.00014130985,0.00020013639,0.00006588684,0.00025217817,0.00012587971,0.00008678985],"category_scores_gemma":[0.000069375754,0.00012479302,0.000038576978,0.00063671765,0.000073386116,0.0000052428377,0.00016526134,0.00025786308,0.00021456013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116949224,0.000029863015,0.0013467248,0.00004182447,0.000015409742,0.000011429277,0.00009905017,0.0070455656,0.9838573,0.0000028342893,0.0061281333,0.00130493],"study_design_scores_gemma":[0.00029452395,0.00022958717,0.0051241945,0.000025182764,0.000003364049,1.148425e-7,0.0001440369,0.00006249415,0.9700291,0.00003219057,0.023879113,0.00017607701],"about_ca_topic_score_codex":0.00033922013,"about_ca_topic_score_gemma":0.00014336417,"teacher_disagreement_score":0.01775098,"about_ca_system_score_codex":0.00006829424,"about_ca_system_score_gemma":0.00023033995,"threshold_uncertainty_score":0.50889117},"labels":[],"label_agreement":null},{"id":"W4362594696","doi":"10.1158/1538-7445.am2023-5695","title":"Abstract 5695: Deep learning risk prediction model of distant recurrence from H&amp;E endometrial cancer slides","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Vancouver General Hospital","funders":"","keywords":"Medicine; Concordance; Artificial intelligence; Endometrial cancer; Risk stratification; Internal medicine; Cutoff; Oncology; Machine learning; Cancer; Computer science","score_opus":0.16388003217323344,"score_gpt":0.4123272824228798,"score_spread":0.24844725024964637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81560266,0.0025513691,0.17760451,0.00030190783,0.0022567164,0.0005244227,0.00034825006,0.00041633644,0.00039381842],"genre_scores_gemma":[0.98594123,0.0108638685,0.0017285505,0.0000066563634,0.000620955,0.00048388363,0.000018260967,0.000031031206,0.0003055732],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960935,0.0003273251,0.00047545004,0.00082368887,0.0015792925,0.000700746],"domain_scores_gemma":[0.9973108,0.0010038716,0.0002551008,0.00069904374,0.0005548042,0.00017637094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022688431,0.00017968593,0.0002817239,0.00068848475,0.00044982735,0.00016692624,0.0011045777,0.00014376813,0.00016319806],"category_scores_gemma":[0.0009557746,0.00017663471,0.000106583,0.0032733763,0.00021066777,0.0006356071,0.00048192884,0.0011738032,0.00008562738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039157592,0.00005848033,0.010941951,0.00012716056,0.00013051971,0.0000066623516,0.004286874,0.33607593,0.102995835,0.00036273044,0.003596962,0.54102534],"study_design_scores_gemma":[0.0015203909,0.00023900159,0.019781182,0.0004421075,0.00002697823,8.256583e-7,0.00030096906,0.8855373,0.0691032,0.014058743,0.008555128,0.0004341503],"about_ca_topic_score_codex":0.009461012,"about_ca_topic_score_gemma":0.0015236543,"teacher_disagreement_score":0.5494614,"about_ca_system_score_codex":0.0008223379,"about_ca_system_score_gemma":0.00057743624,"threshold_uncertainty_score":0.99713504},"labels":[],"label_agreement":null},{"id":"W4362594742","doi":"10.1158/1538-7445.am2023-1757","title":"Abstract 1757: Characterizing novel immunomodulating interactions for potentiating HDAC3 inhibition in non-Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"GNAS complex locus; Cancer research; Chromatin; Biology; Epigenetics; Diffuse large B-cell lymphoma; Lymphoma; Neuroblastoma RAS viral oncogene homolog; Panobinostat; BRD4; Histone deacetylase; Bromodomain; Histone; Immunology; Cancer; Genetics; KRAS","score_opus":0.06945753305440429,"score_gpt":0.39751042637813194,"score_spread":0.32805289332372767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739146,0.00006867896,0.00075451663,0.0006525732,0.0002670882,0.00046889414,0.000050664985,0.000022675156,0.00032346928],"genre_scores_gemma":[0.997311,0.00008830427,0.0002996412,0.00007236824,0.00048709085,0.0005701335,0.0004147151,0.000031682197,0.00072506117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987629,0.000035994362,0.0002632737,0.00033269322,0.00019302868,0.00041211306],"domain_scores_gemma":[0.99944085,0.000047076457,0.000074552525,0.00019809423,0.00018554779,0.00005387765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080597546,0.00010052903,0.00010202978,0.0002560322,0.00024811894,0.00007594275,0.00010166842,0.00009064154,0.000031108044],"category_scores_gemma":[0.00028489565,0.00010880528,0.00006804961,0.00042348032,0.000043720655,0.000024157085,0.00013177739,0.00015883498,0.000023319408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006328551,0.000036311958,0.0003704321,0.000045369343,0.000012683879,0.0000020258665,0.00010025378,0.00009278146,0.9812809,0.000023998859,0.0009617285,0.01701021],"study_design_scores_gemma":[0.0010031686,0.00007307052,0.041375943,0.00021959146,0.0000018798897,0.0000032451394,0.0003308962,0.001551811,0.9430429,0.000045150824,0.012190653,0.0001617294],"about_ca_topic_score_codex":0.00029986002,"about_ca_topic_score_gemma":0.00015477737,"teacher_disagreement_score":0.04100551,"about_ca_system_score_codex":0.00011869992,"about_ca_system_score_gemma":0.00013459746,"threshold_uncertainty_score":0.44369504},"labels":[],"label_agreement":null},{"id":"W4362594875","doi":"10.1158/1538-7445.am2023-4515","title":"Abstract 4515: PIONEER: harnessing multi-omics data to enhance immunotherapeutic target discovery and development","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Proteomics; Computational biology; Computer science; Omics; Epigenome; Pediatric cancer; Translational research; Epigenomics; Bioinformatics; Cancer; Biology; Biotechnology; DNA methylation","score_opus":0.24175845899079412,"score_gpt":0.49265749901709716,"score_spread":0.25089904002630303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950452,0.0014407381,0.00019653916,0.0021318805,0.00010714981,0.0007937649,0.00010416457,0.000076813834,0.00010373871],"genre_scores_gemma":[0.9901622,0.0016011074,0.0018362612,0.00019736114,0.00010472328,0.00025576327,0.00019348222,0.000059777856,0.0055893282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975607,0.00006529073,0.00020934643,0.00061231665,0.0007744233,0.0007779198],"domain_scores_gemma":[0.9986113,0.00018905375,0.00002415217,0.0006970054,0.00014636425,0.00033214598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079903536,0.00014869595,0.00021777961,0.00035981683,0.0003095436,0.0001678826,0.00033422865,0.000052134,0.00010692841],"category_scores_gemma":[0.00018004516,0.00012392293,0.000019462257,0.00066188414,0.00013519386,0.0002961909,0.0006484122,0.00044133273,0.0004892769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012998551,0.0004329214,0.010395479,0.0005786513,0.0003639963,0.00073778373,0.0011611849,0.000030892126,0.77268094,0.000010863248,0.006111093,0.20619631],"study_design_scores_gemma":[0.0031298154,0.00035552587,0.4003421,0.00092193927,0.000019339923,0.000027390242,0.00061317603,0.000611667,0.48363918,0.000035834037,0.10989072,0.00041331263],"about_ca_topic_score_codex":0.00022457984,"about_ca_topic_score_gemma":0.000084143016,"teacher_disagreement_score":0.3899466,"about_ca_system_score_codex":0.000314395,"about_ca_system_score_gemma":0.00092820445,"threshold_uncertainty_score":0.62888277},"labels":[],"label_agreement":null},{"id":"W4362594902","doi":"10.1158/1538-7445.am2023-79","title":"Abstract 79: Study of tumor microenvironment of ovarian clear cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Tumor microenvironment; Medicine; CD8; Immunotherapy; Carboplatin; Tissue microarray; Immune system; Cancer research; Chemotherapy; Oncology; Cancer; Internal medicine; Immunology; Cisplatin","score_opus":0.0914925713484444,"score_gpt":0.38798600666972943,"score_spread":0.296493435321285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954667,0.00066874793,2.0722132e-7,0.00072640274,0.00008699102,0.0010788114,0.00005329069,0.000015412974,0.0019034427],"genre_scores_gemma":[0.9984793,0.00035597806,0.00002647506,0.000024481564,0.00010344986,0.00027991371,0.000009446994,0.000034055316,0.0006868935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805266,0.00007579983,0.00033107557,0.0003539814,0.00078871835,0.00039777928],"domain_scores_gemma":[0.99896634,0.00011878637,0.00008322875,0.0005473734,0.00012463558,0.00015966191],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005524917,0.000118397766,0.00034885452,0.00027768392,0.000066145534,0.000008353358,0.00015403677,0.00003964143,0.0010677831],"category_scores_gemma":[0.000020984511,0.00009961847,0.00008037294,0.00057601416,0.00012689254,0.000028895425,0.00012845136,0.0002484371,0.000120825236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016222333,0.0068214824,0.8066522,0.0013737237,0.0003650762,0.00090966665,0.0047151065,0.00014102554,0.15149063,0.000055468085,0.019043498,0.0068099126],"study_design_scores_gemma":[0.0035444328,0.0020170477,0.87217855,0.00011134709,0.000059461596,0.0000018584557,0.0025774639,0.000008132592,0.11747336,0.000013969198,0.0019463075,0.00006804647],"about_ca_topic_score_codex":0.003868706,"about_ca_topic_score_gemma":0.000118467615,"teacher_disagreement_score":0.065526396,"about_ca_system_score_codex":0.0003101771,"about_ca_system_score_gemma":0.00027769033,"threshold_uncertainty_score":0.9998454},"labels":[],"label_agreement":null},{"id":"W4362594938","doi":"10.1158/1538-7445.am2023-578","title":"Abstract 578: Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microbial metabolism and enzyme function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Cancer research; Chemotherapy; Medicine; Lysyl oxidase; Doxorubicin; Cancer; Breast cancer chemotherapy; Oncology; Internal medicine; Chemistry; Enzyme","score_opus":0.03700720814003581,"score_gpt":0.3536754526585529,"score_spread":0.31666824451851705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372643,0.0011514517,0.000024423543,0.002952538,0.00061142416,0.0004893669,0.00056142197,0.000024693021,0.00045826912],"genre_scores_gemma":[0.9873024,0.0025034258,0.000067352354,0.0005583486,0.0012727542,0.0004031856,0.000056360386,0.000055052446,0.0077811154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982241,0.00006133641,0.00023205137,0.0005359905,0.00033729733,0.00060926884],"domain_scores_gemma":[0.9992099,0.000026349295,0.00004315833,0.00034000003,0.00022469519,0.00015589112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006712594,0.00015938228,0.0001877258,0.00027004324,0.00012320944,0.00003921178,0.0002642097,0.00016276276,0.00031599242],"category_scores_gemma":[0.00009494643,0.000155302,0.00006177771,0.0012652809,0.0000924216,0.000013209489,0.00013117104,0.0002973138,0.00009065824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066047005,0.00004402764,0.0008701485,0.00004741108,0.000020272983,0.0000026793707,0.00027076493,0.00013751231,0.83791906,0.000018457742,0.15785572,0.0021534816],"study_design_scores_gemma":[0.0017226117,0.000049173144,0.15723805,0.00016137537,0.0000033132328,0.0000012393809,0.00019546296,0.000006635137,0.6342075,0.000075282085,0.20605658,0.00028279805],"about_ca_topic_score_codex":0.003653236,"about_ca_topic_score_gemma":0.0074740066,"teacher_disagreement_score":0.20371157,"about_ca_system_score_codex":0.00015463027,"about_ca_system_score_gemma":0.0003307582,"threshold_uncertainty_score":0.63330317},"labels":[],"label_agreement":null},{"id":"W4362595058","doi":"10.1158/1538-7445.am2023-2926","title":"Abstract 2926: PROTECTTM, a novel trispecific antibody masking platform with integrated immune modulation displays unique activity and differentiated modes of action","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Effector; Cancer research; Downregulation and upregulation; Antibody; Cancer immunotherapy; Immune checkpoint; In vivo; Immune system; Chemistry; Immunotherapy; Cell biology; Biology; Immunology; Biochemistry","score_opus":0.1814091650591598,"score_gpt":0.4456687634559548,"score_spread":0.264259598396795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966317,0.00017558612,0.00090098754,0.00055868574,0.0000331008,0.0011283158,0.000103531864,0.00006737239,0.00040075384],"genre_scores_gemma":[0.9969602,0.0011061956,0.00007909689,0.0000030227313,0.000083170264,0.00016721118,0.00016280888,0.00003696992,0.0014012764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99782175,0.00007015462,0.00026036214,0.00038924176,0.0009242817,0.0005341919],"domain_scores_gemma":[0.99875605,0.00022419567,0.00009310022,0.00025735743,0.0005041454,0.00016516497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073176157,0.00018502398,0.0003779756,0.0006126158,0.00025075016,0.000052143023,0.00012191122,0.0001407001,0.00013344637],"category_scores_gemma":[0.00008926956,0.00012802864,0.000061970306,0.0013630848,0.00032911237,0.00022256073,0.00011765555,0.00091673713,0.000007780087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052714925,0.00018198333,0.008216005,0.00078531774,0.00014331054,0.00002759433,0.0002048808,0.00015531006,0.9686744,0.00021711018,0.000048081507,0.01607449],"study_design_scores_gemma":[0.0014021259,0.00039112088,0.5896929,0.0007213365,0.000014495498,0.000015594196,0.00029564963,0.02392036,0.3831382,0.00011026911,0.00016968927,0.00012827427],"about_ca_topic_score_codex":0.0054378826,"about_ca_topic_score_gemma":0.00032199116,"teacher_disagreement_score":0.58553624,"about_ca_system_score_codex":0.00019906981,"about_ca_system_score_gemma":0.00032538662,"threshold_uncertainty_score":0.8220488},"labels":[],"label_agreement":null},{"id":"W4362595171","doi":"10.1158/1538-7445.am2023-3620","title":"Abstract 3620: N-myristoylation inhibition reduces angiogenesis and cancer cell migration","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NAEJA-RGM Pharmaceuticals (Canada); University of Alberta","funders":"","keywords":"Angiogenesis; Cancer research; LYN; Proto-oncogene tyrosine-protein kinase Src; Chorioallantoic membrane; Cell biology; Metastasis; Cancer cell; Myristoylation; Cell migration; Biology; Chemistry; Signal transduction; Cancer; Medicine; Cell; Internal medicine; Biochemistry; Phosphorylation","score_opus":0.049313460247829614,"score_gpt":0.36813781847508126,"score_spread":0.31882435822725164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727034,0.025203934,0.0000088596835,0.00061873684,0.0005086296,0.00024501138,0.000118881144,0.000024678979,0.000567862],"genre_scores_gemma":[0.92505854,0.07087926,0.000017215145,0.000051146348,0.0017456193,0.00030276785,0.0002522299,0.000021022051,0.0016722002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877447,0.00006459302,0.00014781667,0.00038596525,0.00029168077,0.00033547974],"domain_scores_gemma":[0.9994258,0.00001857748,0.000047082576,0.00018562995,0.00022017113,0.000102733895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044807582,0.00010808962,0.00010431172,0.00011364947,0.00019934226,0.000052694806,0.000078965175,0.00013582519,0.00011686384],"category_scores_gemma":[0.000035797715,0.00010865739,0.0000514738,0.00032797683,0.00010466991,0.000015061572,0.00007463663,0.00010179588,0.000024488858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006838569,0.000014482429,0.0004603008,0.00004624654,0.000015182673,7.3223566e-7,0.00014964554,0.0000872744,0.91988194,0.000005919198,0.05094778,0.028322121],"study_design_scores_gemma":[0.0003374026,0.00004579699,0.016937286,0.000027020476,0.00001135181,9.823473e-7,0.00022108486,0.00002549795,0.79079455,0.00004578783,0.19141474,0.00013847408],"about_ca_topic_score_codex":0.0022910868,"about_ca_topic_score_gemma":0.0023095736,"teacher_disagreement_score":0.14046696,"about_ca_system_score_codex":0.00006582583,"about_ca_system_score_gemma":0.00022528421,"threshold_uncertainty_score":0.44309196},"labels":[],"label_agreement":null},{"id":"W4362595178","doi":"10.1158/1538-7445.am2023-2610","title":"Abstract 2610: <i>GNAQ/GNA11</i> and <i>BAP1</i> mutant isogenic cell lines engineered by CRISPR/Cas9 gene editing to model ocular melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"GNAQ; Biology; CRISPR; Molecular biology; Genetics; Gene; Cancer research; Mutation","score_opus":0.029934751537024653,"score_gpt":0.3537900385713593,"score_spread":0.3238552870343347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381447,0.002544899,0.0017353045,0.00092820905,0.000069351314,0.00031620942,0.00027682525,0.00010433774,0.00021037011],"genre_scores_gemma":[0.99224275,0.0037068846,0.0015451997,0.00030090628,0.00052312127,0.00009610672,0.00022004932,0.00006153161,0.0013034265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779105,0.000058553105,0.00027825392,0.0007246488,0.000429909,0.0007175718],"domain_scores_gemma":[0.9988649,0.000033763794,0.000054314994,0.00047510708,0.00031355562,0.00025837636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067084347,0.00024018752,0.0002453327,0.00018470405,0.00022848323,0.0000743893,0.00029238345,0.00022352925,0.0000049225346],"category_scores_gemma":[0.00011936422,0.00022024216,0.000102826096,0.00058785436,0.000120809025,0.00000872194,0.00032139625,0.00029741024,0.000015649392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049741615,0.000026814294,0.00006272143,0.000045431723,0.00004292934,0.000018943856,0.00003574323,0.00048193167,0.96719974,0.0000026565228,0.028654316,0.003379013],"study_design_scores_gemma":[0.0002597048,0.00012396334,0.00003734232,0.00003507255,0.000017479699,0.0000055441674,0.00009358039,0.0017681661,0.98082167,0.000056098124,0.016516134,0.00026523074],"about_ca_topic_score_codex":0.00010556792,"about_ca_topic_score_gemma":0.000049005852,"teacher_disagreement_score":0.013621926,"about_ca_system_score_codex":0.00005093249,"about_ca_system_score_gemma":0.00011648182,"threshold_uncertainty_score":0.8981215},"labels":[],"label_agreement":null},{"id":"W4362595462","doi":"10.1158/1538-7445.am2023-3997","title":"Abstract 3997: Preclinical characterization of ARX517, a next-generation anti-PSMA antibody drug conjugate for the treatment of metastatic castration-resistant prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Prostate cancer; Cancer research; Cancer; Medicine; Antibody-drug conjugate; Cancer cell; Antibody; Prostate; Antigen; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.2840586282121687,"score_gpt":0.49573328824091406,"score_spread":0.21167466002874535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98645675,0.003273035,0.000020100757,0.004454729,0.00026236178,0.004292283,0.0011733385,0.00003316262,0.00003424432],"genre_scores_gemma":[0.95639336,0.036598682,0.00004266076,0.000019666792,0.0003529678,0.0025025907,0.0011044026,0.000046146382,0.0029395465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728936,0.00016283244,0.00066401716,0.0004485561,0.0008561818,0.00057906494],"domain_scores_gemma":[0.99746364,0.0006278367,0.00022459214,0.00043160623,0.0010990574,0.00015328475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011716225,0.00020408552,0.00052569405,0.00031078374,0.00028303877,0.00006492897,0.00015959788,0.000067465524,0.00022504422],"category_scores_gemma":[0.00012410755,0.00012651832,0.00018504691,0.0009391385,0.00042793772,0.00017941125,0.00003214075,0.00019152938,0.000012040927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022626908,0.00048364268,0.0052116034,0.0007653137,0.0005375077,0.000020828267,0.001767473,0.00013405627,0.96858335,0.00006300647,0.00061927317,0.019551253],"study_design_scores_gemma":[0.0067072003,0.001945216,0.14151394,0.00053286046,0.00031727957,0.0000022586087,0.0007318913,0.005002244,0.83634245,0.000069544665,0.0066432427,0.0001918603],"about_ca_topic_score_codex":0.0014459401,"about_ca_topic_score_gemma":0.00045235865,"teacher_disagreement_score":0.13630234,"about_ca_system_score_codex":0.00032696378,"about_ca_system_score_gemma":0.0014842071,"threshold_uncertainty_score":0.5159267},"labels":[],"label_agreement":null},{"id":"W4362595504","doi":"10.1158/1538-7445.am2023-3555","title":"Abstract 3555: Proteomic characterization of rhabdomyosarcoma-derived extracellular vesicles reveals a fusion-positive protein signature","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Rhabdomyosarcoma; Proteome; Cancer research; Biology; Cell culture; Metastasis; Alveolar rhabdomyosarcoma; Fusion protein; Cancer; Pathology; Medicine; Bioinformatics; Sarcoma; Biochemistry; Gene","score_opus":0.02696984546369754,"score_gpt":0.32808619624795643,"score_spread":0.3011163507842589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602276,0.0010696155,0.00011081962,0.00046862933,0.00007244443,0.0018336999,0.00026172836,0.00004302919,0.000117278236],"genre_scores_gemma":[0.99580365,0.00038169033,0.00017634318,0.000025148409,0.00032496257,0.0007096959,0.0005974745,0.00007061338,0.0019103886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748594,0.00031964298,0.000380443,0.00061162974,0.000610731,0.0005916399],"domain_scores_gemma":[0.9985159,0.00003263278,0.00016985279,0.00061506813,0.00047931724,0.00018722394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010558782,0.00020985625,0.00022703696,0.00021486531,0.00019580769,0.00004532479,0.00049663376,0.00027917454,0.00013452716],"category_scores_gemma":[0.00027912474,0.00020974844,0.00012535858,0.0006376062,0.00031468357,0.000017184133,0.00031789075,0.00039914803,0.000061299485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043374175,0.000113969,0.0003947166,0.0002562327,0.0000569314,0.000050040642,0.00014030412,0.000017212822,0.99478865,0.000084366904,0.00050545693,0.003158391],"study_design_scores_gemma":[0.00049790455,0.00015778103,0.030981302,0.00025155122,0.000008949864,0.0000020480502,0.000066099645,0.000038104004,0.9667102,0.00034034374,0.0007324577,0.00021325488],"about_ca_topic_score_codex":0.000037626563,"about_ca_topic_score_gemma":0.0000060693,"teacher_disagreement_score":0.030586585,"about_ca_system_score_codex":0.000065738845,"about_ca_system_score_gemma":0.0003691195,"threshold_uncertainty_score":0.85532933},"labels":[],"label_agreement":null},{"id":"W4362595513","doi":"10.1158/1538-7445.am2023-3441","title":"Abstract 3441: A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Division of Chemistry; National Science Foundation; National Cancer Institute; School of Medicine, New York University; National Institutes of Health; New York State Department of Health","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Cancer research; Cell growth; Chemistry; Cancer; Dihydrotestosterone; Cancer cell; Bicalutamide; Androgen; Pharmacology; Biology; Internal medicine; Medicine; Biochemistry; Hormone","score_opus":0.12261233080071712,"score_gpt":0.40126300467570625,"score_spread":0.2786506738749891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780126,0.011548904,0.0000039266524,0.0051516662,0.00020389026,0.0032847363,0.0009790106,0.00017949384,0.00063577516],"genre_scores_gemma":[0.9492087,0.03380996,0.000021536387,0.000071330134,0.00032083516,0.003156658,0.0004063216,0.000095803334,0.012908861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954485,0.000253011,0.00033346278,0.00083734473,0.0019066083,0.0012210498],"domain_scores_gemma":[0.99827003,0.0001591134,0.00010263566,0.00036292334,0.00066170836,0.00044358577],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012609406,0.00033192997,0.0004139457,0.00028430135,0.00062299875,0.00015578399,0.00019268008,0.00018309515,0.0016010371],"category_scores_gemma":[0.00004210419,0.00025889298,0.00015653645,0.0008972541,0.00029958604,0.0004207758,0.00008252947,0.00083343784,0.00011924213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054079164,0.0003848096,0.0104347,0.0005221168,0.00017900557,0.00003372994,0.0018463385,0.00006283247,0.9432726,0.0000054392267,0.01359705,0.024253456],"study_design_scores_gemma":[0.0064737177,0.00050821126,0.025421664,0.0004910255,0.000019433546,0.000001851321,0.00056420354,0.0006433895,0.9499336,0.000035428933,0.015603822,0.00030365982],"about_ca_topic_score_codex":0.0028016295,"about_ca_topic_score_gemma":0.00032760875,"teacher_disagreement_score":0.028803904,"about_ca_system_score_codex":0.0014010306,"about_ca_system_score_gemma":0.0012856919,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W4362595523","doi":"10.1158/1538-7445.am2023-4248","title":"Abstract 4248: Epithelial ovarian cancer causes cardiac dysfunction and myofilament dysregulation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; York University; University of New Brunswick; University of Guelph","funders":"","keywords":"Medicine; Ovarian cancer; Myofilament; Cancer; Internal medicine; Cardiac function curve; Endocrinology; Ascites; Cardiology; Pathology; Heart failure; Myocyte","score_opus":0.09961862735893834,"score_gpt":0.41390991680022876,"score_spread":0.3142912894412904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981382,0.0030622804,0.000004009762,0.011745594,0.0008830166,0.0009905384,0.00020026667,0.000121231235,0.0016110308],"genre_scores_gemma":[0.9855854,0.009458844,0.000027651062,0.000115705676,0.0011865188,0.0013236976,0.000078465964,0.0000443809,0.0021793353],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786806,0.000078597,0.00022282904,0.00051233097,0.0007753776,0.0005428312],"domain_scores_gemma":[0.9989344,0.00015092608,0.000047689962,0.00033650702,0.0002760308,0.00025446585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000655094,0.00016728879,0.0002958927,0.00032131065,0.00026833598,0.00008041181,0.00006137934,0.00011405958,0.0010258633],"category_scores_gemma":[0.000050762344,0.00014045244,0.00007962299,0.00071070326,0.00014049344,0.00011647214,0.000058822734,0.0002949033,0.00016640767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013511406,0.00039519102,0.3567087,0.00092978217,0.0013980735,0.00027190277,0.0018390644,0.00040468172,0.17890653,0.0017974561,0.09337998,0.3626175],"study_design_scores_gemma":[0.0017852152,0.00020149277,0.92407274,0.000341697,0.0001067576,0.0000025460943,0.00024712732,0.000071130155,0.029156107,0.00019425827,0.04367319,0.00014776165],"about_ca_topic_score_codex":0.00541921,"about_ca_topic_score_gemma":0.0003850685,"teacher_disagreement_score":0.56736404,"about_ca_system_score_codex":0.00083605736,"about_ca_system_score_gemma":0.0005072994,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W4362595567","doi":"10.1158/1538-7445.am2023-5124","title":"Abstract 5124: The effect of lenvatinib in combination with chemotherapy plus immune checkpoint inhibitors on tumor microenvironments in the mouse syngeneic tumor model","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Medicine; Lewis lung carcinoma; Lung cancer; Cancer research; Cancer; Lenvatinib; Combination therapy; Pharmacology; Internal medicine; Metastasis","score_opus":0.021629333649930194,"score_gpt":0.3180388339111953,"score_spread":0.2964095002612651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976918,0.00047282432,0.0000043754676,0.0008312824,0.000029720139,0.0008147076,0.000036591297,0.0000033045642,0.000115389805],"genre_scores_gemma":[0.99826306,0.00093573274,0.0000065920294,0.00013079857,0.000055441065,0.0004359381,0.000047266956,0.000029977815,0.00009517396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869394,0.00013012864,0.00023557749,0.00027681445,0.00033775897,0.0003257845],"domain_scores_gemma":[0.99930304,0.00014653604,0.000075724645,0.00041293236,0.00003308238,0.00002870063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013234079,0.00013057336,0.00015617088,0.000113203045,0.00007170049,0.000025169102,0.00035443003,0.000048640046,0.000008161857],"category_scores_gemma":[0.0000915443,0.00007985462,0.0000498965,0.00032822764,0.00017810686,0.0000036384347,0.000090603084,0.0002900764,0.0000068074105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010786736,0.00009731011,0.004158796,0.00007161179,0.000022808,0.000011822487,0.0003946044,0.02488038,0.967114,0.000017206045,0.0008194333,0.0013334084],"study_design_scores_gemma":[0.002551098,0.0008435626,0.029655138,0.00007283404,0.000003516426,0.0000014203008,0.00019962735,0.0011192212,0.964859,0.00003881711,0.00054513855,0.0001106232],"about_ca_topic_score_codex":0.0006099818,"about_ca_topic_score_gemma":0.0003683991,"teacher_disagreement_score":0.025496343,"about_ca_system_score_codex":0.00016066122,"about_ca_system_score_gemma":0.00016159644,"threshold_uncertainty_score":0.32563767},"labels":[],"label_agreement":null},{"id":"W4362595587","doi":"10.1158/1538-7445.am2023-2633","title":"Abstract 2633: Zanidatamab zovodotin (ZW49) induces hallmarks of immunogenic cell death and is active in patient-derived xenograft models of gastric cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Calreticulin; Cancer research; Cancer; Immunogenic cell death; Antibody; Medicine; Flow cytometry; Cancer cell; Immunology; Biology; Internal medicine; Cell biology; Endoplasmic reticulum","score_opus":0.11822324861768685,"score_gpt":0.4046570870025205,"score_spread":0.28643383838483366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902949,0.0060502184,0.0000012077583,0.00083037704,0.000049998525,0.00069955655,0.0005032651,0.0000143841935,0.0015561046],"genre_scores_gemma":[0.9797494,0.019153096,0.000057187575,0.000039370716,0.00006158491,0.00017623756,0.000053668246,0.000034760877,0.0006747079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969018,0.00014741324,0.00050254934,0.00046406858,0.0011902603,0.00079390267],"domain_scores_gemma":[0.9983722,0.0003636929,0.00013102067,0.00034330724,0.0005563971,0.00023341239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006566241,0.00019878296,0.0005331722,0.0008835988,0.000100067475,0.000018600027,0.00029078656,0.00014987079,0.0007359664],"category_scores_gemma":[0.00007712624,0.00016542921,0.00010952858,0.0014562829,0.0003767806,0.00016868807,0.00040916793,0.00084606145,0.000016057313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026442355,0.00027659675,0.01654617,0.0011486707,0.00018259328,0.00010406364,0.0031501825,0.000103193735,0.9339965,0.000040333012,0.0014692767,0.040338192],"study_design_scores_gemma":[0.0021752072,0.00072617864,0.26455462,0.0008461751,0.000030688578,0.0000092284035,0.0020115385,0.0008308155,0.7276051,0.00034508712,0.00065270177,0.00021261921],"about_ca_topic_score_codex":0.02327125,"about_ca_topic_score_gemma":0.00056130206,"teacher_disagreement_score":0.24800846,"about_ca_system_score_codex":0.00019108773,"about_ca_system_score_gemma":0.0008707199,"threshold_uncertainty_score":0.98323286},"labels":[],"label_agreement":null},{"id":"W4362595644","doi":"10.1158/1538-7445.am2023-3010","title":"Abstract 3010: Epigenetic age acceleration in older adults with hematologic malignancies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Cytopenia; Internal medicine; Epigenetics; Oncology; DNA methylation; Bone marrow; Biology; Genetics","score_opus":0.10718116705070807,"score_gpt":0.4101375395545209,"score_spread":0.30295637250381285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924492,0.0007443148,0.0000058639453,0.004023725,0.000083606064,0.0011145949,0.000009884926,0.000116503754,0.0014523055],"genre_scores_gemma":[0.9947189,0.00084799156,0.00008277672,0.00011152919,0.00011860493,0.0006872316,0.000052741358,0.000036801866,0.0033434026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997771,0.00006787458,0.000246456,0.00042849223,0.00079634524,0.0006898094],"domain_scores_gemma":[0.99896926,0.0001908972,0.000033728236,0.00039118362,0.0002666679,0.00014825148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005594955,0.00013936986,0.0002598735,0.0004473439,0.00009338789,0.000048804894,0.00017916459,0.00011819522,0.0007109047],"category_scores_gemma":[0.00022547127,0.000107668864,0.000033263797,0.0013796046,0.00019957182,0.00009932641,0.00007528119,0.0005330569,0.00042340043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044005155,0.0013016461,0.41619506,0.008815071,0.0002364187,0.019745642,0.02815997,0.0012082101,0.3247835,0.00057864736,0.10606852,0.08850681],"study_design_scores_gemma":[0.0027926203,0.0002567408,0.9550717,0.0020718367,0.000006655967,0.000031566156,0.0013489546,0.00012780294,0.03712403,0.00013272531,0.00087076094,0.00016463561],"about_ca_topic_score_codex":0.001055953,"about_ca_topic_score_gemma":0.0025333837,"teacher_disagreement_score":0.5388766,"about_ca_system_score_codex":0.00025840534,"about_ca_system_score_gemma":0.00032947163,"threshold_uncertainty_score":0.7783908},"labels":[],"label_agreement":null},{"id":"W4362595669","doi":"10.1158/1538-7445.am2023-1128","title":"Abstract 1128: Lineage tracing of CAR T cells in patients with B cell malignancies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Chimeric antigen receptor; Immunology; T cell; Medicine; Immunotherapy; CD19; Cancer research; T-cell receptor; Cancer immunotherapy; Biology; Antigen; Immune system","score_opus":0.06974373913961528,"score_gpt":0.38487324908452086,"score_spread":0.3151295099449056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948938,0.00017801468,0.0000010407059,0.00020000615,0.00006676019,0.0009479392,0.000055586515,0.000036860547,0.003620015],"genre_scores_gemma":[0.9895695,0.00046417263,0.000030104313,0.000022861583,0.000109972796,0.00012181143,0.000029707688,0.00005861303,0.009593299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968544,0.00010424705,0.00031176116,0.0003780638,0.001539893,0.00081160426],"domain_scores_gemma":[0.9984163,0.00028799448,0.000049403516,0.00047411697,0.00057444564,0.00019775389],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013234741,0.00014053224,0.0003493543,0.00076232164,0.00006727493,0.000024033941,0.00023389686,0.00010501206,0.0022702522],"category_scores_gemma":[0.0000684328,0.000113398826,0.000066306595,0.0018522154,0.00025290877,0.00008235758,0.00010471451,0.0007798477,0.00012701232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013677904,0.0002840851,0.16601919,0.000941058,0.000036283272,0.0001469556,0.0012667613,0.0002813135,0.8234696,0.000004958544,0.0031625698,0.0030194672],"study_design_scores_gemma":[0.003255852,0.0005732832,0.36856952,0.0005035212,0.000007240323,4.4125846e-7,0.0005816177,0.000062718136,0.623086,0.000007028273,0.003227226,0.00012554888],"about_ca_topic_score_codex":0.0014381876,"about_ca_topic_score_gemma":0.00023387346,"teacher_disagreement_score":0.20255034,"about_ca_system_score_codex":0.00033515232,"about_ca_system_score_gemma":0.0005696639,"threshold_uncertainty_score":0.9986418},"labels":[],"label_agreement":null},{"id":"W4362595700","doi":"10.1158/1538-7445.am2023-6671","title":"Abstract 6671: Simplifying high-parameter phenotypic and functional characterization of cancer immune cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Immune system; Antibody; Cancer research; Antigen; Biology; Immunology; Flow cytometry; Cytotoxic T cell; Cancer immunotherapy; Mass cytometry; Immunotherapy; Phenotype; In vitro","score_opus":0.06184119521049866,"score_gpt":0.34362009954215605,"score_spread":0.2817789043316574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943195,0.0013268593,0.000038761485,0.00044717785,0.0033288228,0.00023107558,0.000038695314,0.000059645103,0.00020949233],"genre_scores_gemma":[0.9820899,0.0021767686,0.0000031279847,0.000055536748,0.000101741745,0.00014843392,0.00028271766,0.000022427594,0.015119398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988232,0.000127306,0.0002943427,0.0002813129,0.000102449565,0.00037136037],"domain_scores_gemma":[0.99916637,0.00023671698,0.00010500235,0.00019148516,0.00027759885,0.000022846682],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043836958,0.000116320174,0.00019928659,0.00034071982,0.00026072984,0.000026807307,0.00009949804,0.00016632775,0.0071484335],"category_scores_gemma":[0.000055223663,0.00010755435,0.000050998126,0.0004431861,0.00021135117,0.00017776096,0.00009667761,0.00048015395,0.0006358402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035115835,0.00003374923,0.000745808,0.000078005774,0.00010790741,7.965309e-7,0.00019517144,0.00003258816,0.981637,0.00011839279,0.0038133767,0.012886038],"study_design_scores_gemma":[0.0005743134,0.000057777233,0.20311102,0.000077498014,0.0000123197915,0.0000014850574,0.00014934415,0.000019346066,0.76427156,0.00004761267,0.031577807,0.00009990081],"about_ca_topic_score_codex":0.0013490707,"about_ca_topic_score_gemma":0.00002932477,"teacher_disagreement_score":0.21736543,"about_ca_system_score_codex":0.00010065535,"about_ca_system_score_gemma":0.00010816565,"threshold_uncertainty_score":0.99375916},"labels":[],"label_agreement":null},{"id":"W4362595709","doi":"10.1158/1538-7445.am2023-3142","title":"Abstract 3142: Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Indel; Concordance; Whole genome sequencing; Genome; Biology; Genetics; Computational biology; DNA sequencing; INDEL Mutation; Mutation; Gene; Single-nucleotide polymorphism","score_opus":0.16825081203281148,"score_gpt":0.4700158524644575,"score_spread":0.301765040431646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507225,0.0019484767,0.000033628246,0.0006406552,0.00024224295,0.00019064521,0.00030499214,0.000013972868,0.0015531476],"genre_scores_gemma":[0.9901542,0.006846253,0.0000999099,0.00018622816,0.001296809,0.000083730425,0.0005961285,0.000029718822,0.00070704374],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978044,0.00012876373,0.0004822282,0.00066227256,0.0002904889,0.0006318207],"domain_scores_gemma":[0.9986614,0.0003567501,0.00008062116,0.0005188208,0.00018701103,0.00019540568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002005318,0.00012838178,0.00033481853,0.00040587396,0.00010672743,0.00005249802,0.00036996353,0.00026956547,0.0003126341],"category_scores_gemma":[0.0005142348,0.00013527252,0.00017988811,0.0012697288,0.00016385352,0.0000044048134,0.0003645196,0.00050410023,0.00017548994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016719148,0.0000636803,0.030247698,0.000013700231,0.00039473592,0.00014784225,0.00018664173,0.0065108,0.9513009,0.000027649156,0.0033889646,0.0075501753],"study_design_scores_gemma":[0.0019965817,0.00046219263,0.48647138,0.00004613461,0.0001310877,0.000001326307,0.0012438138,0.0007659699,0.048239507,0.00086998695,0.45921227,0.0005597236],"about_ca_topic_score_codex":0.0034448246,"about_ca_topic_score_gemma":0.011474598,"teacher_disagreement_score":0.9030614,"about_ca_system_score_codex":0.00041849102,"about_ca_system_score_gemma":0.0011326608,"threshold_uncertainty_score":0.6403095},"labels":[],"label_agreement":null},{"id":"W4362595746","doi":"10.1158/1538-7445.am2023-1736","title":"Abstract 1736: Role of brain fatty acid binding protein in glioblastoma microtube formation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Fatty acid-binding protein; Arachidonic acid; Cancer research; Polyunsaturated fatty acid; Docosahexaenoic acid; Fatty acid; Biochemistry; Biology; Chemistry; Gene; Enzyme","score_opus":0.030438329920944137,"score_gpt":0.34862668775083844,"score_spread":0.3181883578298943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985856,0.00029029942,0.0000065346294,0.00031876913,0.000038155442,0.0004909885,0.00004485428,0.000017769027,0.00020703945],"genre_scores_gemma":[0.9991123,0.00013064305,0.000034458182,0.000012157182,0.00009495333,0.00032905085,0.000049727034,0.000025421718,0.00021128722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986384,0.00011621874,0.00022380432,0.00026895004,0.000302948,0.0004496796],"domain_scores_gemma":[0.9994738,0.000019082036,0.000056179666,0.00023002218,0.00014661781,0.00007430843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077460136,0.00010306207,0.00012386969,0.00034936325,0.000073433206,0.00002415548,0.00024854863,0.00017296159,0.000068582],"category_scores_gemma":[0.00020847416,0.00010170009,0.000044985263,0.00078355777,0.000096217685,0.000016021393,0.0001685522,0.00028736066,0.000059100912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020609533,0.000028428738,0.0014482536,0.00008756365,0.0000151130425,0.0000024758488,0.00015438166,0.000024262616,0.99251086,0.000007344655,0.0011710861,0.0043441276],"study_design_scores_gemma":[0.00038530063,0.0001402665,0.00090741925,0.00009493846,6.3389643e-7,0.0000012999753,0.00036686953,0.000029748666,0.9944429,0.00004015995,0.0034887425,0.000101738086],"about_ca_topic_score_codex":0.000086019856,"about_ca_topic_score_gemma":0.00015644886,"teacher_disagreement_score":0.0042423895,"about_ca_system_score_codex":0.00011157821,"about_ca_system_score_gemma":0.00019958377,"threshold_uncertainty_score":0.41472095},"labels":[],"label_agreement":null},{"id":"W4362595767","doi":"10.1158/1538-7445.am2023-4833","title":"Abstract 4833: Inhibiting the mitochondrial RNA degradosome complex SUV3 and PNPase increases dsRNA in the cytoplasm, triggers a viral mimicry response and kills AML cells and progenitors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Gene knockdown; Small hairpin RNA; RNA interference; Myeloid leukemia; Molecular biology; Cell biology; Cancer research; RNA; Gene; Genetics","score_opus":0.05977300108846799,"score_gpt":0.3537148730375583,"score_spread":0.29394187194909027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923255,0.0044019544,2.3509901e-7,0.002063297,0.00021337628,0.00078577234,0.00011654681,0.000034166045,0.00005917468],"genre_scores_gemma":[0.9972746,0.0014477341,0.000006881846,0.0001486628,0.00008668355,0.00019447913,0.00002001089,0.000024256662,0.00079670624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963114,0.0021161158,0.0003201862,0.00040064575,0.00013631073,0.0007153241],"domain_scores_gemma":[0.99588174,0.0036555834,0.00006756118,0.00026551593,0.00008053032,0.00004905748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237183,0.00020640493,0.00027465037,0.00039381796,0.0006530389,0.0001533095,0.00030376666,0.00018199327,0.00009538877],"category_scores_gemma":[0.00058080687,0.00012821685,0.000054083186,0.00043560468,0.0013657415,0.00011760945,0.0002880587,0.00091406034,0.00005469479],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00757392,0.00005119762,0.00066055363,0.000043994864,0.000057524314,0.000065816275,0.0024287887,9.034384e-7,0.9780573,0.000036153513,0.0047114207,0.0063124145],"study_design_scores_gemma":[0.0063201087,0.00081320666,0.15292944,0.00038487423,0.000041755524,0.00031901174,0.014841252,0.000015950296,0.7880326,0.00018592595,0.035641156,0.00047471712],"about_ca_topic_score_codex":0.0017739049,"about_ca_topic_score_gemma":0.0003069751,"teacher_disagreement_score":0.19002472,"about_ca_system_score_codex":0.0000759944,"about_ca_system_score_gemma":0.00023470454,"threshold_uncertainty_score":0.5228532},"labels":[],"label_agreement":null},{"id":"W4362595770","doi":"10.1158/1538-7445.am2023-5919","title":"Abstract 5919: The significant role of HMGB1 in mesothelial cells in contributing to the mesothelioma development induced by asbestos","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mesothelial Cell; Mesothelioma; HMGB1; Pathology; Peritoneum; Mesothelium; Inflammation; Medicine; Asbestos; Carcinogenesis; Cancer research; Biology; Immunology; Cancer; Internal medicine","score_opus":0.05588290519191563,"score_gpt":0.38001875654400696,"score_spread":0.32413585135209133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666756,0.00026804983,6.3208546e-7,0.0019576305,0.00003114098,0.0007430385,0.00009338125,0.00001018036,0.0002283631],"genre_scores_gemma":[0.9991134,0.00007281357,0.000007439235,0.0001600887,0.000066788845,0.0003359434,0.000030364494,0.000014932922,0.00019825458],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826986,0.00011011535,0.0002589783,0.00021160819,0.0006997885,0.00044962607],"domain_scores_gemma":[0.99934936,0.0002510615,0.000031830325,0.00020667604,0.000044577348,0.00011646941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015663124,0.00008355691,0.00014406643,0.00016557159,0.00010944345,0.000013826411,0.00022387525,0.000042738793,0.00019599978],"category_scores_gemma":[0.00011332418,0.00004902607,0.000026540187,0.00068839215,0.000074419724,0.000035747456,0.00012285954,0.00027018203,0.00011673987],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000493271,0.0002031485,0.08720891,0.00003612198,0.00001978564,0.000015355597,0.0017089858,0.0003073059,0.8952878,0.000024119647,0.0012293261,0.013465868],"study_design_scores_gemma":[0.0004730516,0.000075448064,0.73165774,0.00010354489,0.0000032612845,2.4569462e-7,0.0017120893,0.000060983086,0.26147935,0.000045057226,0.0043343944,0.000054825738],"about_ca_topic_score_codex":0.002053374,"about_ca_topic_score_gemma":0.00070280756,"teacher_disagreement_score":0.6444488,"about_ca_system_score_codex":0.00027657996,"about_ca_system_score_gemma":0.00033406232,"threshold_uncertainty_score":0.31041008},"labels":[],"label_agreement":null},{"id":"W4362595780","doi":"10.1158/1538-7445.am2023-5182","title":"Abstract 5182: CD47 is a promising therapeutic target in non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital","funders":"","keywords":"CD47; Immune system; Cancer research; Immunology; Immunotherapy; Biology; Cancer; Lung cancer; Immune checkpoint; T cell; Medicine; Oncology","score_opus":0.0711427886481756,"score_gpt":0.3866943713584551,"score_spread":0.3155515827102795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723664,0.024406524,0.000008572356,0.00089657377,0.00040109188,0.00061974133,0.00003712707,0.000049822644,0.0012141782],"genre_scores_gemma":[0.99005985,0.0020224967,0.000006838194,0.00010034025,0.00007115462,0.0004557131,0.0000445562,0.000034707366,0.0072043524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982236,0.00017947081,0.00027247926,0.0003992313,0.00010594163,0.00081929844],"domain_scores_gemma":[0.9993234,0.00014511404,0.000060990456,0.00030198172,0.00013868613,0.000029779076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009390156,0.00015041624,0.0002446268,0.00038911332,0.00024290476,0.0000409649,0.0003152069,0.00022723657,0.0024193937],"category_scores_gemma":[0.000019648394,0.00013469975,0.000071804345,0.00085078453,0.00014063933,0.000116509385,0.0001282431,0.00069674297,0.00044186393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011464566,0.0000615579,0.017805608,0.00014100906,0.00006577513,0.0000061341943,0.0020446142,0.00012493996,0.95685154,0.00001434637,0.012866519,0.00990329],"study_design_scores_gemma":[0.0014913273,0.000051619612,0.2700009,0.000281689,0.000011129725,0.000001447712,0.00037977257,0.0003211721,0.7061652,0.00017778148,0.02089605,0.0002218948],"about_ca_topic_score_codex":0.0025837063,"about_ca_topic_score_gemma":0.00027502203,"teacher_disagreement_score":0.2521953,"about_ca_system_score_codex":0.00034297688,"about_ca_system_score_gemma":0.00041381823,"threshold_uncertainty_score":0.99849254},"labels":[],"label_agreement":null},{"id":"W4362595866","doi":"10.1158/1538-7445.am2023-1723","title":"Abstract 1723: Ferroptosis is a novel therapeutic target for RB1 deficient lethal prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Gene knockdown; Cancer research; Cancer; Cancer cell; Medicine; Prostate; Apoptosis; Biology; Internal medicine; Genetics","score_opus":0.1982311121086879,"score_gpt":0.45908648100780236,"score_spread":0.2608553688991144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96570045,0.0066856216,0.000057117668,0.022491554,0.0005129471,0.002644972,0.0007619539,0.0001905538,0.00095483597],"genre_scores_gemma":[0.9810167,0.0032518932,0.00018002857,0.001094245,0.0005669215,0.008050058,0.00006566171,0.00012772866,0.0056467513],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99602365,0.000047380883,0.00040008064,0.0008287589,0.0012901628,0.0014099339],"domain_scores_gemma":[0.99792737,0.0002020772,0.00008334096,0.0005376312,0.0008962932,0.00035329128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012574185,0.00028427652,0.0004697194,0.0004544735,0.00042572874,0.00013412579,0.0003264677,0.00017421419,0.0022770797],"category_scores_gemma":[0.000085857064,0.00023252942,0.00026427393,0.0016479183,0.00026499684,0.000110764944,0.00014301855,0.0006442096,0.00018135614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003750509,0.001054578,0.06523464,0.003236531,0.0010128496,0.000039330662,0.0059723235,0.00055571395,0.52469563,0.0007126958,0.26888782,0.12484738],"study_design_scores_gemma":[0.0076292166,0.0016553701,0.109596886,0.001381992,0.000232224,0.000010661892,0.0024528059,0.0033654287,0.2679219,0.000554029,0.60427856,0.00092094246],"about_ca_topic_score_codex":0.001944914,"about_ca_topic_score_gemma":0.00013656102,"teacher_disagreement_score":0.33539075,"about_ca_system_score_codex":0.0007021251,"about_ca_system_score_gemma":0.0012176236,"threshold_uncertainty_score":0.998635},"labels":[],"label_agreement":null},{"id":"W4362595928","doi":"10.1158/1538-7445.am2023-6127","title":"Abstract 6127: MDM2 inhibition in combination with MEK inhibition in pre-clinical models of lung adenocarcinomas with <i>MDM2</i> amplification","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"MAPK/ERK pathway; Trametinib; Cancer research; MEK inhibitor; Kinase; Growth inhibition; Phosphorylation; Mdm2; Medicine; Targeted therapy; Cell culture; Cell growth; Cancer; Chemistry; Internal medicine; Biology; Cell biology; Biochemistry; Genetics","score_opus":0.11553786246494334,"score_gpt":0.4134202785240412,"score_spread":0.2978824160590978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447566,0.0004724539,0.0007746522,0.001293952,0.000053145843,0.0018632996,0.00002827485,0.00006808142,0.000970482],"genre_scores_gemma":[0.9979127,0.0007527751,0.00010911054,0.000052277144,0.000057929297,0.0006133897,0.00030694576,0.000059907357,0.00013497184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968714,0.00025074868,0.00064880506,0.0005842461,0.0011475107,0.0004972919],"domain_scores_gemma":[0.99846685,0.00020373231,0.00016476196,0.00043548364,0.0005808771,0.00014826702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021087462,0.00017066395,0.0003893363,0.000986923,0.00005900089,0.000025143589,0.00006765765,0.00022927347,0.000048840324],"category_scores_gemma":[0.00013980483,0.00015359261,0.000052132487,0.002538073,0.00029389616,0.00028815726,0.000056004483,0.001051053,0.000019259482],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026089787,0.0042481003,0.18133447,0.0048899604,0.0003804941,0.002497658,0.011663036,0.073986016,0.65704113,0.00586183,0.010608383,0.02139914],"study_design_scores_gemma":[0.018766036,0.0022284524,0.81880015,0.0059640156,0.00007579388,0.00005799105,0.0006878868,0.020597557,0.12985061,0.002346929,0.0001729738,0.000451621],"about_ca_topic_score_codex":0.002141078,"about_ca_topic_score_gemma":0.0029239752,"teacher_disagreement_score":0.63746566,"about_ca_system_score_codex":0.0008454914,"about_ca_system_score_gemma":0.00094319734,"threshold_uncertainty_score":0.62633246},"labels":[],"label_agreement":null},{"id":"W4362595933","doi":"10.1158/1538-7445.am2023-6569","title":"Abstract 6569: ClinGen Somatic and CIViC collaborate to comprehensively evaluate somatic variants in cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Somatic cell; Cancer; Germline; Precision medicine; Biology; Genetics; Bioinformatics; Computational biology; Medicine; Gene","score_opus":0.10278725436044281,"score_gpt":0.43674392465328904,"score_spread":0.33395667029284626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993707,0.0034802863,0.000007133818,0.0013532555,0.00023744506,0.0006696369,0.00016830312,0.000014742444,0.00036222156],"genre_scores_gemma":[0.9896378,0.008667829,0.000074441356,0.0003200992,0.00025160797,0.00047992473,0.000034573863,0.00004426425,0.0004894541],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981901,0.00008840179,0.00028488526,0.0004946432,0.00034217662,0.00059976464],"domain_scores_gemma":[0.9988811,0.00013532887,0.00005169729,0.0003435435,0.0003659525,0.00022236994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007980352,0.00015935388,0.00022804363,0.00024376907,0.00013824034,0.000091481495,0.00024572146,0.00011286438,0.00012487374],"category_scores_gemma":[0.0003220849,0.00016381069,0.000031455034,0.0007236084,0.00009765305,0.000005737157,0.0003220936,0.00018974203,0.0001049569],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000217121,0.00005449978,0.013887071,0.00030451434,0.000096206226,0.0000515475,0.00065443205,0.0051535554,0.9571824,0.00007266226,0.011538272,0.010787698],"study_design_scores_gemma":[0.004224004,0.0007062586,0.81874406,0.00093895587,0.000055606157,0.000007238837,0.0013434923,0.0037067574,0.12738775,0.0024634565,0.039333962,0.0010884678],"about_ca_topic_score_codex":0.0012858019,"about_ca_topic_score_gemma":0.004964979,"teacher_disagreement_score":0.8297947,"about_ca_system_score_codex":0.00012668555,"about_ca_system_score_gemma":0.00066238345,"threshold_uncertainty_score":0.6680006},"labels":[],"label_agreement":null},{"id":"W4362596003","doi":"10.1158/1538-7445.am2023-4774","title":"Abstract 4774: Adaptation to chronic oxidative stress promotes metabolic rewiring to maintain redox balance in HER2+ breast tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Jewish General Hospital; McGill University","funders":"","keywords":"Breast cancer; Oxidative stress; Reactive oxygen species; Cancer research; Tumor microenvironment; Cancer; In vivo; Glycolysis; Biology; Medicine; Internal medicine; Metabolism; Biochemistry; Genetics","score_opus":0.037015610072212796,"score_gpt":0.3635064074765537,"score_spread":0.32649079740434095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305975,0.0033486583,0.000110257395,0.0016889558,0.00034511194,0.0008987527,0.00023865384,0.00003209729,0.00027774318],"genre_scores_gemma":[0.99403006,0.0015138477,0.00013711539,0.000107575695,0.0017801876,0.00084253657,0.00011104691,0.000052076422,0.0014255552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748546,0.00015419295,0.00027101184,0.00069965364,0.0005087356,0.00088092516],"domain_scores_gemma":[0.99890995,0.00003086247,0.00004786428,0.0004589482,0.0002747805,0.00027761402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011041687,0.00019035173,0.00025548265,0.00037177504,0.00012414028,0.00007313295,0.00044091375,0.000111620924,0.00007860872],"category_scores_gemma":[0.00024755034,0.0001956973,0.00006228984,0.0012840678,0.00008178087,0.000015565052,0.0003054209,0.00031948727,0.00011359374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024313672,0.00004247205,0.0009150261,0.000084228006,0.00003725196,0.000011426254,0.0007486466,0.0043729786,0.9452855,0.00014371886,0.0042597842,0.043855835],"study_design_scores_gemma":[0.0011679939,0.00029548703,0.18206401,0.0005052376,0.0000106879215,0.0000099660565,0.0019274332,0.00030040173,0.6923026,0.00020152486,0.120649144,0.0005655088],"about_ca_topic_score_codex":0.0024986959,"about_ca_topic_score_gemma":0.0067955307,"teacher_disagreement_score":0.25298288,"about_ca_system_score_codex":0.00021364653,"about_ca_system_score_gemma":0.000704375,"threshold_uncertainty_score":0.79803044},"labels":[],"label_agreement":null},{"id":"W4362596072","doi":"10.1158/1538-7445.am2023-3099","title":"Abstract 3099: Hnd-01: a potent inhibitor of wild type mutant BTK","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bruton's tyrosine kinase; Ibrutinib; Dasatinib; Tyrosine kinase; Cancer research; Chemistry; Chronic lymphocytic leukemia; LYN; Pharmacology; breakpoint cluster region; Biology; Biochemistry; Signal transduction; Leukemia; Receptor; Immunology","score_opus":0.12255677442471503,"score_gpt":0.44540527916648814,"score_spread":0.3228485047417731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894255,0.001156337,0.0000014637527,0.0024285857,0.0003112145,0.00084413507,0.000035719248,0.000104483086,0.005692568],"genre_scores_gemma":[0.99061126,0.0024183418,0.00002903023,0.00007790567,0.0006779016,0.00014027856,0.000029817009,0.00006692406,0.0059485743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99564904,0.00009990224,0.0004070774,0.00049839215,0.0022512467,0.0010943473],"domain_scores_gemma":[0.99746937,0.00040656317,0.000056011777,0.00078632124,0.0008463311,0.0004354102],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016249729,0.00016438558,0.00039441255,0.0006086476,0.00012958051,0.000032939595,0.00035952567,0.00017687996,0.0015289217],"category_scores_gemma":[0.0009386185,0.00013536446,0.00011793332,0.0025177342,0.00048668557,0.00007916036,0.00037203953,0.0008485506,0.0012900017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0033476602,0.00040342344,0.0015078668,0.0026294966,0.00036878043,0.0026301013,0.0013804754,0.00017679896,0.7804177,0.0004411083,0.16340016,0.04329644],"study_design_scores_gemma":[0.02665607,0.0019394627,0.027169561,0.0028653322,0.000079682155,0.00020210672,0.0019455265,0.004121905,0.7901281,0.0007152744,0.14357461,0.0006023423],"about_ca_topic_score_codex":0.0030110744,"about_ca_topic_score_gemma":0.0001203186,"teacher_disagreement_score":0.0426941,"about_ca_system_score_codex":0.008295302,"about_ca_system_score_gemma":0.014362167,"threshold_uncertainty_score":0.99948764},"labels":[],"label_agreement":null},{"id":"W4362596199","doi":"10.1158/1538-7445.am2023-3617","title":"Abstract 3617: Investigating a role for PIKfyve in cell migration and invasion of clear cell renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Biology; Cancer research; Clear cell renal cell carcinoma; Gene knockdown; Small hairpin RNA; Cell biology; Programmed cell death; Angiogenesis; Metastasis; Cancer; Renal cell carcinoma; Pathology; Cell culture; Medicine; Apoptosis; Biochemistry; Genetics","score_opus":0.09187318543754602,"score_gpt":0.3861822095921061,"score_spread":0.29430902415456006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576306,0.0020484582,0.0000024449394,0.00036399567,0.000027895469,0.0006588252,0.00002744164,0.000019128327,0.0010887367],"genre_scores_gemma":[0.998276,0.0004571585,0.000096079806,0.00006573208,0.0001208241,0.00016074766,0.00004092218,0.000027174206,0.00075534265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987181,0.000060813385,0.00023134476,0.00026638128,0.0003605871,0.00036278553],"domain_scores_gemma":[0.99921453,0.00021204518,0.000060259863,0.00019274584,0.00014963766,0.00017079331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074102695,0.0000904843,0.00018252396,0.0002837888,0.000082398496,0.000015692165,0.00008557656,0.00009037737,0.000071551454],"category_scores_gemma":[0.00007181115,0.00008273972,0.000046545065,0.00047124756,0.00011153908,0.0000698191,0.00005089419,0.00028097344,0.000016040727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040872634,0.000090752146,0.032483663,0.0008811132,0.0000048163615,0.00002050643,0.001961706,0.00003975168,0.9606397,0.000012144902,0.0015912006,0.0018659094],"study_design_scores_gemma":[0.0020020036,0.00040123885,0.14401025,0.00017149729,0.000009991877,4.878948e-7,0.00116276,0.00142743,0.8494402,0.0005684488,0.00073066546,0.00007499916],"about_ca_topic_score_codex":0.0014508743,"about_ca_topic_score_gemma":0.000214999,"teacher_disagreement_score":0.11152658,"about_ca_system_score_codex":0.00009331485,"about_ca_system_score_gemma":0.00043310938,"threshold_uncertainty_score":0.33740282},"labels":[],"label_agreement":null},{"id":"W4362596213","doi":"10.1158/1538-7445.am2023-676","title":"Abstract 676: Neuro-oncology imaging mass cytometry panels enable spatial investigation of brain tumor microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Tumor microenvironment; Brain tumor; Human brain; Pathology; Medicine; Cancer; Central nervous system; Cancer research; Biology; Neuroscience; Internal medicine","score_opus":0.05565743455330932,"score_gpt":0.34158849887526016,"score_spread":0.2859310643219508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996824,0.00037823868,0.0003896105,0.0015299608,0.00023630577,0.00025539825,0.000055116987,0.000016030526,0.0003153107],"genre_scores_gemma":[0.9982565,0.00043795447,0.00010029598,0.0003404064,0.0003389014,0.000069258036,0.00010455487,0.000034523127,0.00031762887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842405,0.00015420662,0.00024828326,0.00038893174,0.00031783333,0.00046671228],"domain_scores_gemma":[0.9993307,0.00009922671,0.00006826532,0.00028305032,0.00009442083,0.00012431489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077002455,0.00011955348,0.00016055007,0.00018304595,0.00010789494,0.000024217637,0.0002639839,0.00008877354,0.00010087324],"category_scores_gemma":[0.00015077952,0.00012253241,0.00006637898,0.00032423437,0.00030829935,0.000006435256,0.00011541239,0.00025863916,0.000034496697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011480542,0.000025210906,0.023054725,0.00008295822,0.000020017063,0.000024748877,0.00009825039,0.00014418748,0.968537,0.0000040219825,0.0036524727,0.0042416104],"study_design_scores_gemma":[0.0005205516,0.00015578096,0.023278458,0.000026461388,0.0000049517994,0.0000035156168,0.00012553151,0.00016208932,0.9567886,0.00012684189,0.018691694,0.000115521805],"about_ca_topic_score_codex":0.0008507499,"about_ca_topic_score_gemma":0.00007037452,"teacher_disagreement_score":0.015039221,"about_ca_system_score_codex":0.000096927484,"about_ca_system_score_gemma":0.0002822616,"threshold_uncertainty_score":0.49967265},"labels":[],"label_agreement":null},{"id":"W4362596219","doi":"10.1158/1538-7445.am2023-2593","title":"Abstract 2593: A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neuroblastoma; Cancer research; Biology; Metastasis; Reprogramming; Transcription factor; Gene; Cancer; Genetics; Cell culture","score_opus":0.12733114202938517,"score_gpt":0.43904506386780395,"score_spread":0.3117139218384188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956416,0.00033933012,0.000008298321,0.0016928477,0.000112507514,0.0012935394,0.000041257914,0.0001907212,0.0006799084],"genre_scores_gemma":[0.9965978,0.0011827206,0.00020273599,0.000079466794,0.00015985583,0.00080792623,0.000037827784,0.00008401566,0.0008476109],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99503237,0.00026274924,0.00042648782,0.0009643803,0.0018179405,0.0014960953],"domain_scores_gemma":[0.9977758,0.0006328142,0.000070281305,0.00057072117,0.0002530262,0.00069735985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021980214,0.00026154792,0.00046143576,0.0013084536,0.00026987056,0.00014537844,0.00023732494,0.0001326286,0.00028885785],"category_scores_gemma":[0.0008699302,0.00023195306,0.00010070009,0.0021368605,0.00018507586,0.00018091872,0.0004493457,0.0012475473,0.0002799626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023255858,0.0006698861,0.02043213,0.0013663338,0.00052314135,0.018012881,0.0021866255,0.000039617116,0.7515749,0.0012767616,0.0013392213,0.20025294],"study_design_scores_gemma":[0.019802755,0.00411474,0.5709685,0.0017814827,0.00015868044,0.00052502874,0.005472651,0.0021852935,0.3803902,0.00788151,0.005513342,0.001205828],"about_ca_topic_score_codex":0.0011802337,"about_ca_topic_score_gemma":0.00040437674,"teacher_disagreement_score":0.55053633,"about_ca_system_score_codex":0.00036693356,"about_ca_system_score_gemma":0.00046781,"threshold_uncertainty_score":0.94587713},"labels":[],"label_agreement":null},{"id":"W4362596323","doi":"10.1158/1538-7445.am2023-4753","title":"Abstract 4753: LSD1 &amp;8211mediated FOXA2/AP1 transcription program drives lineage plasticity in prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"FOXA2; FOXA1; Transcription factor; Biology; Chromatin; Cancer research; Carcinogenesis; Cell biology; Computational biology; Genetics; Cancer; Gene","score_opus":0.14919442325819343,"score_gpt":0.4747075890183594,"score_spread":0.325513165760166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832566,0.0025703127,0.0000027400727,0.0037850144,0.00027243452,0.0035407825,0.00021796171,0.00039132862,0.0008937911],"genre_scores_gemma":[0.9644759,0.016840713,0.00006691983,0.000048714843,0.0004629733,0.005653504,0.00042174596,0.00009526067,0.011934245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952743,0.00018537704,0.0004929379,0.0008196719,0.0015284477,0.0016992687],"domain_scores_gemma":[0.9981641,0.00027464586,0.00006392779,0.00037616424,0.00060123357,0.00051988446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010176521,0.0003100053,0.0004995115,0.0010668801,0.00027128437,0.00012030258,0.00028450793,0.00020729066,0.0012353726],"category_scores_gemma":[0.00024174285,0.00024942428,0.00013827842,0.003219599,0.00053306756,0.00024960906,0.00011059258,0.0014945864,0.00040961624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008750764,0.0020351922,0.1923586,0.003994948,0.00052446977,0.0016625691,0.008342905,0.0008225374,0.58152074,0.000050031955,0.05000893,0.14992829],"study_design_scores_gemma":[0.014481933,0.0014426969,0.7525935,0.0029362747,0.000093865,0.000012189286,0.0012860958,0.0017606181,0.117128216,0.00023518226,0.107262805,0.0007665949],"about_ca_topic_score_codex":0.0034829476,"about_ca_topic_score_gemma":0.0047254744,"teacher_disagreement_score":0.5602349,"about_ca_system_score_codex":0.0010983773,"about_ca_system_score_gemma":0.0015139633,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W4362596380","doi":"10.1158/1538-7445.am2023-446","title":"Abstract 446: LONP1 inhibition induces mitochondrial proteotoxic stress and is cytotoxic to acute myeloid leukemia cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Myeloid leukemia; Cell biology; Mitochondrion; Myeloid; Gene knockdown; Haematopoiesis; Stem cell; Cancer research; Apoptosis; Genetics","score_opus":0.04589022327723571,"score_gpt":0.38117745765047123,"score_spread":0.33528723437323554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968385,0.000254616,0.000019485056,0.0008825262,0.00013762411,0.0011048283,0.00041699034,0.000031089934,0.00031431642],"genre_scores_gemma":[0.99251956,0.0019975442,0.0000642869,0.00014712624,0.0010034622,0.0008456344,0.0001398636,0.000052055846,0.0032304884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997393,0.000121290184,0.00021696671,0.0007380602,0.00070256955,0.00082810497],"domain_scores_gemma":[0.9988724,0.000047388876,0.00003709195,0.00044178174,0.00023816634,0.00036319302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044302444,0.00019224819,0.00017851059,0.0002798169,0.00030016596,0.0001473939,0.0002991305,0.00025051073,0.00021279765],"category_scores_gemma":[0.00009756336,0.00018055289,0.00007000941,0.0006671063,0.00022579575,0.000015953665,0.0005286652,0.00045276753,0.0002998561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032624532,0.00003168233,0.00012369677,0.00009386807,0.00006713058,0.00006115193,0.00014590273,0.000019859672,0.9697441,0.0000035984972,0.02590725,0.0034755173],"study_design_scores_gemma":[0.0005896793,0.00035831417,0.001505634,0.0001103434,0.000006133471,0.0000016947258,0.0001995917,0.0000135351465,0.9870879,0.000035913818,0.009880536,0.00021074536],"about_ca_topic_score_codex":0.00036187872,"about_ca_topic_score_gemma":0.00013882178,"teacher_disagreement_score":0.017343782,"about_ca_system_score_codex":0.00013202724,"about_ca_system_score_gemma":0.0005899635,"threshold_uncertainty_score":0.7362733},"labels":[],"label_agreement":null},{"id":"W4362596385","doi":"10.1158/1538-7445.am2023-3562","title":"Abstract 3562: Dissecting mechanisms underlying <i>FOXR2</i>-mediated gliomagenesis in diffuse midline gliomas","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenetics; Carcinogenesis; Biology; Transcription factor; Cancer research; Histone; Genetics; Cell biology; Cancer; Gene","score_opus":0.11139389826707598,"score_gpt":0.4248114574817907,"score_spread":0.31341755921471476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968114,0.0018923545,0.00009075605,0.000230554,0.00026327837,0.00035749984,0.00006464454,0.00007051509,0.00021898068],"genre_scores_gemma":[0.99805886,0.00072671904,0.000048593014,0.000060598195,0.00021142823,0.00027590434,0.00023375741,0.00007407484,0.00031005873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752206,0.00016102217,0.00027969247,0.000639897,0.0005768792,0.0008204754],"domain_scores_gemma":[0.99880314,0.00013876133,0.00005209722,0.0005416956,0.00025405368,0.00021025432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009702809,0.00018600287,0.00018268806,0.0004724586,0.0002023189,0.00008070896,0.0004643988,0.00017932979,0.0001075972],"category_scores_gemma":[0.0012757251,0.00019371258,0.00010337076,0.0016496406,0.0001266452,0.000009721949,0.00036639557,0.00028635032,0.00009479186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009979894,0.00011969314,0.0030067726,0.00009232482,0.000042605236,0.00019072226,0.00006453577,0.00013515087,0.9929346,0.00004638925,0.0016125342,0.0016548587],"study_design_scores_gemma":[0.0023078516,0.00013761688,0.15021762,0.00019567081,0.00001476794,0.000009801891,0.00097482954,0.00024882273,0.8414096,0.0011618083,0.0027886229,0.00053294736],"about_ca_topic_score_codex":0.00055079383,"about_ca_topic_score_gemma":0.000990067,"teacher_disagreement_score":0.15152498,"about_ca_system_score_codex":0.00012503586,"about_ca_system_score_gemma":0.00028258175,"threshold_uncertainty_score":0.789937},"labels":[],"label_agreement":null},{"id":"W4362596417","doi":"10.1158/1538-7445.am2023-2931","title":"Abstract 2931: Functional characterization of KJ-103, a novel therapeutic anti-TROP2 heavy chain-only antibody","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"In vivo; Cancer research; Antibody-dependent cell-mediated cytotoxicity; Pancreatic cancer; CD47; Cancer; Immune system; Antibody; Tumor microenvironment; Metastasis; Cancer cell; Immunology; Medicine; Biology; Internal medicine; Monoclonal antibody","score_opus":0.14366046199731303,"score_gpt":0.4370772311070142,"score_spread":0.29341676910970116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896778,0.00039382555,0.000109625915,0.006571302,0.00022395256,0.00067472964,0.0002591077,0.000069074915,0.002020603],"genre_scores_gemma":[0.9892738,0.0021484403,0.000021867085,0.00032266497,0.00089293055,0.00009913718,0.0009947423,0.000044746837,0.0062016924],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961388,0.000118100754,0.00038989875,0.00046014873,0.0020625219,0.0008304978],"domain_scores_gemma":[0.99808764,0.00029172725,0.00007638302,0.0003796779,0.00092959986,0.00023496727],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014051418,0.00019308613,0.00040090494,0.00073862605,0.0002557723,0.000050994462,0.00027976657,0.0001436981,0.0014456225],"category_scores_gemma":[0.00011790021,0.00015560583,0.0001487587,0.0020762342,0.0003558005,0.00013636681,0.000120865225,0.00075103686,0.00041694212],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009766766,0.0003667476,0.03272163,0.00062971533,0.00013717703,0.00007955724,0.00029576104,0.000006513323,0.95228684,0.0012425078,0.0015532507,0.009703624],"study_design_scores_gemma":[0.0011294817,0.00040290106,0.92121506,0.00026809287,0.00001875834,0.00005290929,0.00018462348,0.00029256946,0.039701696,0.0000833568,0.036490235,0.00016034093],"about_ca_topic_score_codex":0.00053613517,"about_ca_topic_score_gemma":0.000019162459,"teacher_disagreement_score":0.91258514,"about_ca_system_score_codex":0.00011386504,"about_ca_system_score_gemma":0.0009772081,"threshold_uncertainty_score":0.9994672},"labels":[],"label_agreement":null},{"id":"W4362596434","doi":"10.1158/1538-7445.am2023-3501","title":"Abstract 3501: A genome-wide screen for determinants of radioresistance in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radioresistance; Cancer; Biology; Radiation therapy; Clonogenic assay; Cancer research; Head and neck cancer; Gene; Medicine; Cell; Genetics; Internal medicine","score_opus":0.06014700490056435,"score_gpt":0.4092516001485252,"score_spread":0.34910459524796084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899848,0.008066767,0.0001437617,0.0002949059,0.00007268229,0.0009629191,0.0002880759,0.000011456973,0.0001746177],"genre_scores_gemma":[0.9882501,0.009041566,0.00014059835,0.000052943895,0.00016299763,0.0010008476,0.000057274017,0.000062719184,0.0012309976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772656,0.00008887253,0.00030509286,0.0006020934,0.00046731345,0.00081006216],"domain_scores_gemma":[0.99891996,0.00009297446,0.000063415915,0.0004266721,0.0003298166,0.00016713054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010376234,0.00015811589,0.00026691795,0.0003458661,0.00011277552,0.000031593565,0.0003766601,0.00020676269,0.00006352708],"category_scores_gemma":[0.00032257094,0.00016495623,0.00007687678,0.0007139258,0.00023587495,0.000008050795,0.0002583905,0.00028877603,0.000005729505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009517612,0.0000379509,0.008195661,0.00038384504,0.000052298983,0.000026522486,0.00009989067,0.0003627065,0.9751128,0.000023363256,0.002969755,0.011783477],"study_design_scores_gemma":[0.0028758869,0.00049635966,0.14902262,0.000417818,0.0000101269325,0.0000030491165,0.00014519827,0.0004083834,0.8114432,0.0003067182,0.03452065,0.00034996122],"about_ca_topic_score_codex":0.0016716896,"about_ca_topic_score_gemma":0.009027576,"teacher_disagreement_score":0.16366954,"about_ca_system_score_codex":0.00014486726,"about_ca_system_score_gemma":0.00065460143,"threshold_uncertainty_score":0.672672},"labels":[],"label_agreement":null},{"id":"W4362596451","doi":"10.1158/1538-7445.am2023-2435","title":"Abstract 2435: Single cell spatial analysis identifies regulators of brain tumor initiating cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biglycan; Wnt signaling pathway; Extracellular matrix; Tumor microenvironment; Transcriptome; Biology; Cancer research; Cell biology; Cell growth; Signal transduction; Proteoglycan; Decorin; Genetics; Gene expression; Tumor cells; Gene","score_opus":0.09751023535654653,"score_gpt":0.3980199911021281,"score_spread":0.3005097557455816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492407,0.0004706002,0.000014784237,0.0011511283,0.00017172244,0.0003329722,0.000066256885,0.00006612257,0.0028023394],"genre_scores_gemma":[0.9974914,0.0001742929,0.000037692924,0.00009321078,0.00030026265,0.00012786522,0.000037676007,0.00003807126,0.0016995231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973499,0.00011114146,0.00043202055,0.00042143068,0.0011157352,0.0005697755],"domain_scores_gemma":[0.9984236,0.0003290311,0.00013087095,0.0004373758,0.00049716636,0.00018195414],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013276587,0.00013721366,0.00044546052,0.00093866605,0.00015002063,0.000057184494,0.00020787293,0.00007811193,0.0017387565],"category_scores_gemma":[0.00019740827,0.00012540928,0.00024817104,0.0034016692,0.00022369821,0.000091476606,0.00014300933,0.00036990995,0.00009186795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016513199,0.00018280938,0.029297972,0.00079613784,0.00039777372,0.000058027832,0.0009244464,0.00032229043,0.9390485,0.0000105074405,0.022182405,0.006613997],"study_design_scores_gemma":[0.0005594587,0.00018255449,0.121719286,0.00020935632,0.00017970428,5.5107057e-7,0.0011672539,0.00036397486,0.87391067,0.000037399594,0.0015409387,0.00012886705],"about_ca_topic_score_codex":0.0034959456,"about_ca_topic_score_gemma":0.00054149504,"teacher_disagreement_score":0.092421316,"about_ca_system_score_codex":0.00021129908,"about_ca_system_score_gemma":0.0003367953,"threshold_uncertainty_score":0.99917376},"labels":[],"label_agreement":null},{"id":"W4362596546","doi":"10.1158/1538-7445.am2023-3522","title":"Abstract 3522: DICER1 Platform domain missense variants led to tumor susceptibility via failure of precursor miRNA binding","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Missense mutation; Germline; microRNA; Ribonuclease III; Biology; Genetics; Germline mutation; Dicer; Loss function; RNase H; Heteroduplex; Cancer research; Phenotype; Mutation; RNase P; Gene; RNA; RNA interference","score_opus":0.09049279366590288,"score_gpt":0.4137862380920894,"score_spread":0.32329344442618657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200624,0.0001872599,0.000009301239,0.003085416,0.0001334797,0.0016277519,0.00011863663,0.000103499624,0.0027284343],"genre_scores_gemma":[0.99698526,0.000046806483,0.0002810172,0.000051572857,0.0001833365,0.00028483203,0.000018216619,0.000050969615,0.0020979727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966988,0.00009413523,0.00050935586,0.0005397785,0.0012436983,0.0009142281],"domain_scores_gemma":[0.99751264,0.0007609304,0.000078568264,0.0006397601,0.00056067004,0.00044740987],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023256736,0.00021554022,0.0005625342,0.0005732284,0.00019783582,0.000034361423,0.00026979725,0.000099130346,0.0015534185],"category_scores_gemma":[0.0016285895,0.00018338206,0.0001320006,0.0017275532,0.00025232977,0.00010732235,0.00031301723,0.0005668519,0.0010692815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011847381,0.00020640799,0.0185036,0.0017663537,0.0003624837,0.0005947173,0.005733093,0.0000081922135,0.9337342,0.00004792396,0.02425167,0.013606648],"study_design_scores_gemma":[0.004730851,0.0009628734,0.9000803,0.0021348214,0.000112805945,0.00006133385,0.010040521,0.00017356059,0.07035842,0.0012970957,0.0094153285,0.000632094],"about_ca_topic_score_codex":0.0008670731,"about_ca_topic_score_gemma":0.001928252,"teacher_disagreement_score":0.8815767,"about_ca_system_score_codex":0.00050038355,"about_ca_system_score_gemma":0.00050440675,"threshold_uncertainty_score":0.9997085},"labels":[],"label_agreement":null},{"id":"W4362596584","doi":"10.1158/1538-7445.am2023-152","title":"Abstract 152: Robust establishment and expansion of human fallopian tube organoids in serum-free culture","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; Population; Biology; Fallopian tube; Ovarian cancer; Cell culture; Andrology; Pathology; Cancer; Cell biology; Medicine; Anatomy","score_opus":0.11225872690376194,"score_gpt":0.4150825961280511,"score_spread":0.30282386922428917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952213,0.000992619,4.8923835e-7,0.0017643077,0.00006459304,0.00040758957,0.000021224412,0.000025383633,0.0015024614],"genre_scores_gemma":[0.99726427,0.0006687055,0.000018931954,0.000026854177,0.0001265584,0.000051628802,0.000023507839,0.000010543363,0.0018089773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986934,0.000091035174,0.0001904875,0.00039260782,0.0003165878,0.00031588157],"domain_scores_gemma":[0.99909997,0.000043855543,0.000022971624,0.0004873314,0.00024959876,0.00009625008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012370731,0.00008315401,0.00021370454,0.0002002642,0.00009196876,0.0000087893695,0.00014387244,0.00013910342,0.0002649639],"category_scores_gemma":[0.00039950438,0.0000629443,0.000024875888,0.0006301505,0.00031522446,0.000069512076,0.0001767771,0.0005081006,0.000009198657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081618794,0.0000987393,0.37025794,0.00042382698,0.000030099787,0.000051988824,0.0018827053,0.000010616675,0.61492777,0.00009346639,0.0073947376,0.0040119174],"study_design_scores_gemma":[0.0008257862,0.00020879955,0.9231342,0.00015019444,0.000004340932,0.0000019663655,0.0008331566,0.000005235119,0.07337671,0.0004172153,0.0009891393,0.00005326345],"about_ca_topic_score_codex":0.0006949224,"about_ca_topic_score_gemma":0.0003891539,"teacher_disagreement_score":0.55287623,"about_ca_system_score_codex":0.00012688436,"about_ca_system_score_gemma":0.00016416285,"threshold_uncertainty_score":0.29011688},"labels":[],"label_agreement":null},{"id":"W4362596626","doi":"10.1158/1538-7445.am2023-4727","title":"Abstract 4727: RAS and PP2A activities converge on phosphoregulation of epigenetic complexes in cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protein phosphatase 2; Epigenetics; Biology; Transcription factor; Chromatin; Cell biology; Phosphorylation; Psychological repression; Cancer research; Gene expression; Phosphatase; Gene; Genetics","score_opus":0.08571084503450441,"score_gpt":0.4184551224396053,"score_spread":0.33274427740510093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435735,0.004779121,0.000011030626,0.0001677642,0.0000880196,0.00020855443,0.00005647898,0.000005526562,0.00032616948],"genre_scores_gemma":[0.98925734,0.01001862,0.000012461756,0.000013105282,0.00009653579,0.000099463774,0.000052642685,0.000017482094,0.00043234832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898887,0.0000757138,0.00016331594,0.00026277153,0.0002537422,0.00025557695],"domain_scores_gemma":[0.9995543,0.00007262491,0.00004573349,0.00018016068,0.000095474636,0.00005175685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047834674,0.000085503714,0.00012248763,0.00015960677,0.000061748375,0.000015777818,0.000093637806,0.00009650893,0.00008739139],"category_scores_gemma":[0.000057237055,0.00008429724,0.000026477948,0.00027308782,0.0001660242,0.0000037191294,0.000073604926,0.00011703221,0.000003831265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001633115,0.000026689802,0.02871491,0.00006506887,0.000018388764,0.0000012434386,0.00013975544,0.0011730993,0.9576341,0.00009840275,0.00040518533,0.01155986],"study_design_scores_gemma":[0.00027932847,0.00012569604,0.29234368,0.000041392017,0.0000018743065,5.313789e-8,0.00009511205,0.000104368075,0.70392084,0.00031745102,0.0027003211,0.00006990349],"about_ca_topic_score_codex":0.00092509075,"about_ca_topic_score_gemma":0.0009897264,"teacher_disagreement_score":0.26362875,"about_ca_system_score_codex":0.000038899587,"about_ca_system_score_gemma":0.00012443322,"threshold_uncertainty_score":0.34375414},"labels":[],"label_agreement":null},{"id":"W4362596649","doi":"10.1158/1538-7445.am2023-3121","title":"Abstract 3121: Exercise and tumor genomic landscapes in 2,879 patients with cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"STK11; Breast cancer; Colorectal cancer; Medicine; Cancer; Lung cancer; Internal medicine; Oncology; Prostate cancer; KRAS","score_opus":0.02254181944670094,"score_gpt":0.32711395573652824,"score_spread":0.3045721362898273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503124,0.0039392384,8.524862e-7,0.00016353055,0.00009279472,0.00032828344,0.00018070433,0.000008608485,0.00025475808],"genre_scores_gemma":[0.9882735,0.010725063,0.000014058482,0.00006594918,0.00017159169,0.0003187588,0.00009154332,0.000032844848,0.00030667728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883914,0.000020211719,0.00012819088,0.00037338963,0.00020540565,0.00043365613],"domain_scores_gemma":[0.99946606,0.00003548024,0.00002965795,0.00021661427,0.00013653269,0.000115647614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023146428,0.00011295189,0.00013244308,0.00014024306,0.00008514472,0.00004838071,0.00015928019,0.00006286838,0.00008937061],"category_scores_gemma":[0.000041240946,0.00009953936,0.00002062713,0.00027618487,0.00008764278,0.0000043228238,0.00017851348,0.0001643129,0.000018548035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012680942,0.00012998366,0.80402964,0.00022584283,0.00006457922,0.00004818193,0.00033585212,0.0015028813,0.12650107,0.000032815205,0.02923143,0.03662965],"study_design_scores_gemma":[0.002261278,0.00019682305,0.9423535,0.00019231458,0.000009515826,6.767196e-7,0.00013986453,0.000060678125,0.017954875,0.00007572806,0.036463007,0.00029173424],"about_ca_topic_score_codex":0.0014479761,"about_ca_topic_score_gemma":0.0051500504,"teacher_disagreement_score":0.13832389,"about_ca_system_score_codex":0.00007089493,"about_ca_system_score_gemma":0.00030253592,"threshold_uncertainty_score":0.40590972},"labels":[],"label_agreement":null},{"id":"W4362596757","doi":"10.1158/1538-7445.am2023-677","title":"Abstract 677: Increasing plexity of imaging mass cytometry for tumor tissue analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Antibody; Pathology; Tissue microarray; Medicine; Tumor microenvironment; Immune system; Phenotype; Cancer research; Immunohistochemistry; Immunology; Chemistry","score_opus":0.07890907366560812,"score_gpt":0.4133448477454089,"score_spread":0.3344357740798008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555707,0.000652704,0.0027790796,0.00015227278,0.00008859371,0.00021205842,0.00016984226,0.000015650317,0.00037271297],"genre_scores_gemma":[0.9985342,0.00019449726,0.00047361144,0.00003078449,0.00023267228,0.00006378463,0.00015759826,0.000024459841,0.00028841745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987409,0.00007053013,0.00019611546,0.0003248054,0.00026850868,0.0003991558],"domain_scores_gemma":[0.9991998,0.00009266305,0.000046944995,0.00028511253,0.0002875813,0.00008788632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011528084,0.000093286115,0.00018892923,0.00035150582,0.00012507978,0.00003270504,0.0002506426,0.000060483646,0.000060153132],"category_scores_gemma":[0.00023188096,0.000092971924,0.00013018669,0.0010881923,0.0001457992,0.0000044969693,0.000064334425,0.00013276616,0.0000058341434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020996148,0.000022863,0.04046811,0.00011453595,0.00015537025,0.000004573291,0.000033821132,0.00013654437,0.9553257,0.000013106127,0.0006656842,0.002849712],"study_design_scores_gemma":[0.00038915034,0.0000621959,0.035232604,0.000024377505,0.00005016887,7.974748e-7,0.00013409747,0.00062795996,0.958329,0.00013358585,0.0048896987,0.00012636895],"about_ca_topic_score_codex":0.0011800212,"about_ca_topic_score_gemma":0.00017663077,"teacher_disagreement_score":0.00523551,"about_ca_system_score_codex":0.000041933785,"about_ca_system_score_gemma":0.00016210377,"threshold_uncertainty_score":0.37912852},"labels":[],"label_agreement":null},{"id":"W4362596761","doi":"10.1158/1538-7445.am2023-5218","title":"Abstract 5218: Genome-wide association study of African Americans reveals new susceptibility loci contributing to lung cancer and mechanisms of population-specific etiology","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lung cancer; Genome-wide association study; Lung cancer susceptibility; Genetic predisposition; Population; Medicine; Cancer; Genetic association; Incidence (geometry); Oncology; Internal medicine; Demography; Biology; Genetics; Single-nucleotide polymorphism; Genotype; Environmental health; Disease; Gene","score_opus":0.062307055644293986,"score_gpt":0.3988043147964826,"score_spread":0.3364972591521886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964297,0.0008710118,0.0007492916,0.00088626845,0.00006850036,0.0007625669,0.00015903906,0.000009912056,0.0000637363],"genre_scores_gemma":[0.9976935,0.0011035252,0.000063319014,0.000039123006,0.00013325916,0.00022218547,0.00009087812,0.00001880015,0.00063543866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981693,0.00018715416,0.00038045854,0.0004464456,0.00036332023,0.0004533155],"domain_scores_gemma":[0.9985709,0.00015825397,0.00020938307,0.0003694036,0.0005670956,0.00012492925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016169365,0.00010668573,0.0002687332,0.00014891561,0.00015072101,0.000017279463,0.00020404455,0.00010728211,0.00009267995],"category_scores_gemma":[0.00042675232,0.00010699257,0.00004387252,0.0006851197,0.00005951144,0.0000059808995,0.00016360304,0.00015253389,0.000002211701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013145735,0.00006641211,0.34860885,0.00004569245,0.00009806188,5.044268e-7,0.00046501434,0.0008276602,0.643675,0.00009217521,0.003116443,0.0028726885],"study_design_scores_gemma":[0.00056563836,0.00030734495,0.98043066,0.000022226346,0.000015513095,7.922611e-8,0.0016329403,0.000015241981,0.015027432,0.000414952,0.001441645,0.00012630736],"about_ca_topic_score_codex":0.0072455644,"about_ca_topic_score_gemma":0.002126816,"teacher_disagreement_score":0.6318218,"about_ca_system_score_codex":0.00028175474,"about_ca_system_score_gemma":0.00019111266,"threshold_uncertainty_score":0.99936527},"labels":[],"label_agreement":null},{"id":"W4362596830","doi":"10.1158/1538-7445.am2023-2154","title":"Abstract 2154: Differential expression of the PI3K-Akt signaling pathway pre and post chemotherapy in relation to hormonal profile in African women","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Doxorubicin; Chemotherapy; Breast cancer; Oncology; Internal medicine; Medicine; Triple-negative breast cancer; Cancer; Cancer research","score_opus":0.05051001500496954,"score_gpt":0.360266778448425,"score_spread":0.30975676344345543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996664,0.00018015604,0.0000010290443,0.002013405,0.000037773134,0.0008045718,0.000025662679,0.000012240856,0.000261184],"genre_scores_gemma":[0.9987229,0.000121138735,0.000012171088,0.00004634745,0.000080622085,0.00064579997,0.000007528228,0.00001955872,0.00034390544],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985408,0.00008499407,0.00021939672,0.00025243766,0.0005480076,0.00035435133],"domain_scores_gemma":[0.9994934,0.00008421475,0.000039502316,0.00017823339,0.00010861458,0.00009599253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000612344,0.00008293178,0.00018480518,0.00027445945,0.00005909879,0.000017567794,0.0001172434,0.000073196876,0.00035630286],"category_scores_gemma":[0.00007710676,0.000057000063,0.000029518842,0.00088592875,0.00007175161,0.000053392334,0.000099945515,0.0003668514,0.0000037991867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009411785,0.00008284965,0.056091543,0.00015222892,0.0000071888335,0.0000027860312,0.006064321,0.000033718552,0.9204844,0.000011427561,0.00024968854,0.015878625],"study_design_scores_gemma":[0.00080280274,0.00018756356,0.7263565,0.00051384023,0.0000012009832,2.5000855e-7,0.0010590105,0.000056205314,0.27074388,0.000035029654,0.00019451302,0.000049198192],"about_ca_topic_score_codex":0.00056304975,"about_ca_topic_score_gemma":0.00007761826,"teacher_disagreement_score":0.67026496,"about_ca_system_score_codex":0.0002908257,"about_ca_system_score_gemma":0.00023408473,"threshold_uncertainty_score":0.39012665},"labels":[],"label_agreement":null},{"id":"W4362596836","doi":"10.1158/1538-7445.am2023-3621","title":"Abstract 3621: Identification of podocalyxin-positive tumor buds in pancreatic ductal adenocarcinoma: Implications for solid tumor collective invasion","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Adenocarcinoma; Cancer research; Medicine; Tumor progression; Pathology; Metastasis; Cancer; Tumor budding; Internal medicine","score_opus":0.06713977367423099,"score_gpt":0.40789054697788824,"score_spread":0.3407507733036572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961431,0.00047507373,0.0001786181,0.00080075033,0.00005046409,0.0016314093,0.00036407544,0.000013430324,0.000343087],"genre_scores_gemma":[0.99593675,0.00019461493,0.000048384783,0.000025761587,0.00012378122,0.0018640859,0.0003519272,0.00003165693,0.0014230437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810266,0.00015386367,0.00039068147,0.0005049328,0.0003483853,0.0004994785],"domain_scores_gemma":[0.99833524,0.00016332987,0.000102589715,0.00039878703,0.00088662555,0.00011344245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011929915,0.00012125732,0.0001927561,0.00045750814,0.00021735115,0.00004237008,0.00031753047,0.000087214066,0.000042850374],"category_scores_gemma":[0.0008833668,0.00012314926,0.00008482462,0.0012380964,0.00020417887,0.000013484917,0.00015978541,0.00022365301,0.000033347816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040181138,0.00009019638,0.017689899,0.00011759709,0.000036275596,0.0000056887034,0.00016094878,0.00013067169,0.9779321,0.00018747822,0.00290393,0.00034338227],"study_design_scores_gemma":[0.0006246917,0.0001910982,0.4724378,0.000045973215,0.0000050014587,0.000004527386,0.0002684648,0.0001991893,0.5251907,0.0007279712,0.00020800557,0.000096576645],"about_ca_topic_score_codex":0.0003867511,"about_ca_topic_score_gemma":0.00027535835,"teacher_disagreement_score":0.4547479,"about_ca_system_score_codex":0.00021882006,"about_ca_system_score_gemma":0.00092147663,"threshold_uncertainty_score":0.50218815},"labels":[],"label_agreement":null},{"id":"W4362596929","doi":"10.1158/1538-7445.am2023-5640","title":"Abstract 5640: Identifying pathophysiological features of mouse tumors using imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Tumor microenvironment; Context (archaeology); Mass cytometry; Immune system; Cancer research; Medicine; Pathology; Biology; Immunology; Phenotype","score_opus":0.10893851610823614,"score_gpt":0.40411687501788296,"score_spread":0.29517835890964683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980591,0.0010507907,0.00027003206,0.000052718635,0.00014707842,0.0001348856,0.000050701776,0.000023203114,0.0002115206],"genre_scores_gemma":[0.99832314,0.0005900818,0.00022706523,0.000034968256,0.00027207282,0.000019475128,0.00005316645,0.000030976567,0.00044902536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985318,0.00008830303,0.00019716159,0.00036668743,0.0003482803,0.00046772597],"domain_scores_gemma":[0.99935615,0.00003885118,0.000048299607,0.0002761714,0.00019017128,0.0000903637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054186844,0.000119126045,0.00016685447,0.00019626798,0.00015312014,0.000044450495,0.00030318162,0.00010506793,0.000036068966],"category_scores_gemma":[0.00012624459,0.00010781118,0.00010625263,0.00050147244,0.00020905476,0.000006720473,0.00013832658,0.00029884613,0.000010024095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010497744,0.000025430587,0.005034015,0.00010863709,0.000021827957,0.000023885412,0.00004131171,0.00026614033,0.9918275,0.000010450594,0.0006504013,0.0018854238],"study_design_scores_gemma":[0.00027637123,0.000044582837,0.021312946,0.0000654793,0.0000045024003,0.0000025466315,0.00024363784,0.00015255282,0.9774034,0.000121255405,0.00023709731,0.00013564326],"about_ca_topic_score_codex":0.00035289786,"about_ca_topic_score_gemma":0.000015545325,"teacher_disagreement_score":0.01627893,"about_ca_system_score_codex":0.000043969474,"about_ca_system_score_gemma":0.00013856174,"threshold_uncertainty_score":0.43964124},"labels":[],"label_agreement":null},{"id":"W4362596960","doi":"10.1158/1538-7445.am2023-3039","title":"Abstract 3039: Evaluation of intra-tumoral pks+ <i>E. coli</i>, enterotoxigenic <i>B. fragilis</i> and <i>Fusobacterium nucleatum,</i> overall and in early onset disease, in colorectal cancer cases","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Colorectal cancer; Fusobacterium nucleatum; Bacteroides fragilis; Hazard ratio; Cancer; Internal medicine; Medicine; Carcinogenesis; Oncology; Microbiome; Microsatellite instability; Proportional hazards model; Biology; Gastroenterology; Cancer research; Bioinformatics; Genetics; Confidence interval; Microsatellite; Gene; Bacteria","score_opus":0.052012354329760695,"score_gpt":0.3881816804254809,"score_spread":0.3361693260957202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956578,0.0025980305,8.970903e-8,0.00045541377,0.000093581046,0.00078239135,0.0003690353,0.000006502105,0.000037163692],"genre_scores_gemma":[0.9937951,0.005509323,0.0000034581294,0.00011695634,0.00007312132,0.00033695024,0.000098546254,0.000022547565,0.000043972483],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99831617,0.00023121099,0.00025745513,0.00041869289,0.00031603687,0.00046045848],"domain_scores_gemma":[0.9993958,0.000046629466,0.000052659136,0.00015509668,0.00019018484,0.00015965078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024032,0.00013043558,0.00019064712,0.00018548286,0.000066961395,0.000035144425,0.000119770986,0.00010804682,0.000050269427],"category_scores_gemma":[0.00009970129,0.0001333996,0.000029703986,0.00031169262,0.00021351088,0.000015190917,0.00014811849,0.00025252372,0.0000027848723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007698529,0.000057777976,0.25397038,0.0001669533,0.000012366535,0.000019921212,0.0002594999,0.000054407228,0.7424036,0.0000029076095,0.0017470312,0.0005352766],"study_design_scores_gemma":[0.0013278824,0.00015983926,0.94016594,0.00015902823,0.000008545285,0.0000033379977,0.0000791482,0.000083241874,0.057147194,0.00005152777,0.0006872665,0.00012702534],"about_ca_topic_score_codex":0.0043377,"about_ca_topic_score_gemma":0.009373127,"teacher_disagreement_score":0.6861956,"about_ca_system_score_codex":0.00015461058,"about_ca_system_score_gemma":0.000734467,"threshold_uncertainty_score":0.65573335},"labels":[],"label_agreement":null},{"id":"W4362596977","doi":"10.1158/1538-7445.am2023-4773","title":"Abstract 4773: DEAD Box 1 (DDX1) protects its RNA targets in cells exposed to oxidative stress","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; DEAD box; Stress granule; RNA Helicase A; Oxidative stress; Cell biology; RNA; RNA-binding protein; DNA damage; Cytoplasm; Gene knockdown; Cancer research; Genetics; Apoptosis; Helicase; Messenger RNA; DNA; Biochemistry; Gene; Translation (biology)","score_opus":0.069334534051494,"score_gpt":0.39524959643257934,"score_spread":0.32591506238108536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362596977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963057,0.0007580175,0.000029512445,0.00073179073,0.00008008096,0.0011248176,0.000108406195,0.000021432968,0.0008402489],"genre_scores_gemma":[0.9929019,0.00077869644,0.000056214256,0.000071662056,0.0002470772,0.00078880356,0.00006533098,0.00003500628,0.0050552944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972459,0.00018676821,0.0002112614,0.00060013286,0.0006532795,0.0011026749],"domain_scores_gemma":[0.9988326,0.00006362095,0.00003017857,0.0004048468,0.00032338977,0.00034540758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011095672,0.00015844234,0.00017239313,0.00036055766,0.00015806516,0.00007553965,0.0005217644,0.00015295163,0.00013927792],"category_scores_gemma":[0.0004327536,0.00014974475,0.000054680855,0.00091526855,0.000080902915,0.000010469778,0.00040353832,0.0004919532,0.00035406448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026854253,0.000048244674,0.00029885597,0.00009777685,0.0000237709,0.00008310902,0.00018130333,0.00042640002,0.9839094,0.000008539674,0.009740332,0.004913678],"study_design_scores_gemma":[0.00049832015,0.0002665857,0.0037893434,0.00011275752,7.064542e-7,4.191564e-7,0.00031329875,0.00006286114,0.9875914,0.000023582508,0.007171543,0.00016922042],"about_ca_topic_score_codex":0.000603977,"about_ca_topic_score_gemma":0.0012158738,"teacher_disagreement_score":0.0047444575,"about_ca_system_score_codex":0.00012838483,"about_ca_system_score_gemma":0.0004420797,"threshold_uncertainty_score":0.6106414},"labels":[],"label_agreement":null},{"id":"W4362597000","doi":"10.1158/1538-7445.am2023-sy31-02","title":"Abstract SY31-02: Determinants of hypoxia in pancreatic cancer and identification of ULK1 as a potential therapeutic target","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Hypoxia (environmental); Tumor microenvironment; Cancer research; Tumor hypoxia; Pancreatic cancer; Immune system; Radiation therapy; Biology; Medicine; Cancer; Immunology; Internal medicine; Oxygen; Chemistry","score_opus":0.041906623184496644,"score_gpt":0.38465920954340094,"score_spread":0.34275258635890427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362597000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816421,0.01749272,0.0000064194955,0.00008791186,0.00029936904,0.00030154907,0.00008844666,0.0000051094225,0.000076326985],"genre_scores_gemma":[0.97591287,0.022600943,0.000009884041,0.000016937098,0.00028958594,0.00018906983,0.000021767588,0.000021723223,0.0009371915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986176,0.000078103105,0.00032623584,0.00032386507,0.00031998643,0.00033420234],"domain_scores_gemma":[0.99930114,0.000027811642,0.000108705426,0.00029033062,0.00020397302,0.00006805782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070517114,0.00010278395,0.00022726438,0.0002012324,0.000049646445,0.000015897303,0.00019828363,0.00011693802,0.000062791965],"category_scores_gemma":[0.00008585298,0.000098925724,0.00005412518,0.0003797145,0.00021834981,0.000008445689,0.000100668156,0.00013393804,0.000005747686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019645934,0.000035152174,0.009531135,0.00020550667,0.000036698875,0.0000022406891,0.00016023782,0.00008732962,0.9667699,0.0000150792675,0.00039399302,0.02256629],"study_design_scores_gemma":[0.00061185815,0.000075783275,0.33070344,0.00008034376,0.000017909466,0.0000025683116,0.00020179112,0.00011264499,0.6645808,0.0003427428,0.0031622017,0.00010791238],"about_ca_topic_score_codex":0.0023742355,"about_ca_topic_score_gemma":0.0006757872,"teacher_disagreement_score":0.3211723,"about_ca_system_score_codex":0.000028858354,"about_ca_system_score_gemma":0.00037037232,"threshold_uncertainty_score":0.4034074},"labels":[],"label_agreement":null},{"id":"W4362597283","doi":"10.1158/1538-7445.am2023-4755","title":"Abstract 4755: Screening non-small cell lung cancer organoids with epigenetic probes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; University of Toronto","funders":"","keywords":"Epigenetics; Organoid; Cancer research; Carcinogenesis; DNA methylation; Biology; Epigenetic therapy; Cancer; Matrigel; Lung cancer; Medicine; Cell biology; Pathology; Genetics; Gene expression; Gene","score_opus":0.032552453046004085,"score_gpt":0.3491225101421697,"score_spread":0.31657005709616565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362597283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154717,0.0055008633,0.0005779082,0.00053872424,0.0001685604,0.0007557561,0.00004362178,0.00004723342,0.0008201427],"genre_scores_gemma":[0.9879288,0.0033630223,0.00022006748,0.000036355512,0.00081120146,0.00064549333,0.00012605522,0.00009841209,0.0067706113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977682,0.000071086644,0.00021516441,0.0006596707,0.0005044428,0.00078142626],"domain_scores_gemma":[0.998808,0.000029200177,0.0000711033,0.00049427146,0.00041879798,0.00017860503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050445605,0.00020725049,0.00017196093,0.00021229246,0.00026169178,0.000071968105,0.00034954582,0.00022740806,0.00023802822],"category_scores_gemma":[0.000027258473,0.00018986485,0.000063360916,0.00094403635,0.00016224907,0.000007656569,0.00020668213,0.00036968268,0.000043208816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018891577,0.000024969266,0.0135968,0.00022018197,0.00009331311,0.000010504453,0.00017310507,0.019066865,0.9449187,0.000002164445,0.011851658,0.009852824],"study_design_scores_gemma":[0.0009230937,0.00019737968,0.053776566,0.00022701698,0.00002776068,0.0000026288424,0.00015725775,0.0009990718,0.92996925,0.000010762019,0.013375641,0.000333594],"about_ca_topic_score_codex":0.0010511405,"about_ca_topic_score_gemma":0.001587962,"teacher_disagreement_score":0.040179767,"about_ca_system_score_codex":0.00015150626,"about_ca_system_score_gemma":0.00086880155,"threshold_uncertainty_score":0.7742464},"labels":[],"label_agreement":null},{"id":"W4362597321","doi":"10.1158/1538-7445.am2023-42","title":"Abstract 42: <i>In vivo</i> subcutaneous and orthotopic cancer xenograft modeling in the SRG immunodeficient rat","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"In vivo; Cancer; Cancer research; Cancer cell; Medicine; Matrigel; Pathology; Biology; Internal medicine; Angiogenesis","score_opus":0.06485226356493029,"score_gpt":0.3715189479386013,"score_spread":0.306666684373671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362597321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670787,0.030744577,0.0000057311936,0.000637814,0.0004889232,0.0004071193,0.000039311733,0.000010142159,0.0005876966],"genre_scores_gemma":[0.9534347,0.044512816,0.0000057427483,0.00020106015,0.0005191753,0.00042690555,0.00001662764,0.000024221446,0.0008587312],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982087,0.00012138175,0.0002220417,0.00043971182,0.00037061906,0.0006375184],"domain_scores_gemma":[0.9993958,0.000041368836,0.000026394528,0.00037621398,0.00009727232,0.000062952095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001018445,0.00013820066,0.00016716344,0.00017718818,0.00013877805,0.00006630772,0.00032158618,0.00012411903,0.00005801245],"category_scores_gemma":[0.000046663856,0.000110442816,0.000053484295,0.00060020137,0.00012329222,0.0000061608325,0.00015654974,0.00038851795,0.000006930759],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027603793,0.00005771345,0.0017792801,0.00010206606,0.00002169791,0.0000501394,0.0010990973,0.008659137,0.962525,0.000053241314,0.004755088,0.020621503],"study_design_scores_gemma":[0.003870693,0.00033978894,0.010381977,0.0004176995,0.000032587606,0.00007897481,0.004716873,0.007336881,0.1308606,0.00047761432,0.8404321,0.001054174],"about_ca_topic_score_codex":0.004707354,"about_ca_topic_score_gemma":0.007737859,"teacher_disagreement_score":0.835677,"about_ca_system_score_codex":0.000059795555,"about_ca_system_score_gemma":0.0003059977,"threshold_uncertainty_score":0.71161425},"labels":[],"label_agreement":null},{"id":"W4365483307","doi":"10.1158/0008-5472.can-23-0505","title":"Fueling the Tumor Microenvironment with Cancer-Associated Adipocytes","year":2023,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Cancer; Adipose tissue; Cancer research; Breast cancer; Proinflammatory cytokine; Biology; Cancer cell; Tumor progression; Medicine; Inflammation; Internal medicine; Immunology","score_opus":0.041697196810469836,"score_gpt":0.33360011986277177,"score_spread":0.2919029230523019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365483307","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1579344,0.1379961,0.000022785804,0.67611724,0.02050568,0.0033332394,0.002731536,0.00014254187,0.0012164686],"genre_scores_gemma":[0.0082258275,0.11765798,0.000047577392,0.3604758,0.34378815,0.00823341,0.0024781805,0.00089820236,0.15819487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633694,0.0003603942,0.0002740498,0.0009065503,0.0009346121,0.0011874755],"domain_scores_gemma":[0.99852437,0.00009574878,0.00014984868,0.00086475315,0.00025481533,0.00011045854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007246837,0.00037799508,0.00038790778,0.00013216054,0.00041350067,0.000117992204,0.0008699724,0.000466103,0.00024099625],"category_scores_gemma":[0.00010175657,0.00026278434,0.00016591726,0.00037389708,0.00054242584,0.0000037454047,0.000377148,0.0020349748,0.00007340467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090018235,0.000015599368,0.00016645518,0.00011239176,0.00034254006,0.0000062438926,0.000076826516,0.00007764896,0.06093702,0.000001133543,0.93704313,0.0011309878],"study_design_scores_gemma":[0.00052551215,0.00013817733,0.00033679418,0.00023011427,0.000083123676,0.0000059210543,0.00008971766,0.000004172427,0.01719027,0.000014667338,0.9810298,0.00035172736],"about_ca_topic_score_codex":0.003604713,"about_ca_topic_score_gemma":0.0031022527,"teacher_disagreement_score":0.32328248,"about_ca_system_score_codex":0.00036886707,"about_ca_system_score_gemma":0.0010770145,"threshold_uncertainty_score":0.9999824},"labels":[],"label_agreement":null},{"id":"W4365511759","doi":"10.1158/1538-7445.am2023-lb118","title":"Abstract LB118: Evidence of tumor response in orbital lesions treated with tebentafusp in metastatic uveal melanoma patients","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Clinical trial; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Internal medicine; Oncology; Pathology; Cancer research","score_opus":0.1315122516565175,"score_gpt":0.455080503544667,"score_spread":0.3235682518881495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365511759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810857,0.00035647632,1.2316919e-7,0.00049551233,0.000022369779,0.0007936342,0.000030057214,0.00001694004,0.00017634481],"genre_scores_gemma":[0.99906695,0.000088251036,0.00003648845,0.000015086995,0.000008853173,0.00027179692,0.000024231298,0.000018847584,0.0004695121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810934,0.0003763142,0.00027408265,0.00028608702,0.0005317589,0.00042241876],"domain_scores_gemma":[0.9986045,0.000811911,0.000049956005,0.00024675546,0.00017043122,0.00011647149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011266173,0.00010769555,0.00031280133,0.0007142737,0.000050557443,0.000006179898,0.000107079875,0.000047988975,0.00020360887],"category_scores_gemma":[0.0006168213,0.000078681056,0.00003567006,0.0015347342,0.00019779238,0.00010239462,0.000057879875,0.0003720968,0.00009506013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016768567,0.000658177,0.9701856,0.00014648132,0.000073877236,0.0039447593,0.00042200205,0.000027957089,0.006143541,0.0000055913765,0.00018509453,0.0014383931],"study_design_scores_gemma":[0.004301095,0.002342983,0.9858868,0.0011027382,0.000025207071,0.000009369302,0.0003584635,0.000025727468,0.005832444,0.000021831684,0.00003077136,0.000062569576],"about_ca_topic_score_codex":0.0025165267,"about_ca_topic_score_gemma":0.0016422843,"teacher_disagreement_score":0.015701242,"about_ca_system_score_codex":0.0004796217,"about_ca_system_score_gemma":0.0007497053,"threshold_uncertainty_score":0.38042524},"labels":[],"label_agreement":null},{"id":"W4365511862","doi":"10.1158/1538-7445.am2023-lb313","title":"Abstract LB313: EGFRvIII-targeted alpha therapy shows significant therapeutic efficacy as both a single-agent and in combination with standard of care against preclinical GBM models","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Biodistribution; Cancer research; Medicine; In vivo; Targeted therapy; Radiation therapy; Spect imaging; Blood–brain barrier; Cancer; Nuclear medicine; Biology; Internal medicine","score_opus":0.21161123822548192,"score_gpt":0.47030299948530524,"score_spread":0.2586917612598233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365511862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926487,0.0026393016,0.000022564083,0.0019696099,0.00001681961,0.0011972106,0.000055995515,0.000048969036,0.0014007965],"genre_scores_gemma":[0.99644154,0.002800035,0.000036550122,0.000108787266,0.00005241218,0.00031692674,0.000060714898,0.00003075212,0.00015225344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981257,0.0000902104,0.00031591766,0.00039474008,0.0006936449,0.00037978622],"domain_scores_gemma":[0.9986901,0.00043451975,0.000055018783,0.0003035777,0.0002994815,0.000217272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006325975,0.00013723563,0.00031934716,0.00013903603,0.000093941366,0.000027764652,0.00014172318,0.000109697976,0.00010117719],"category_scores_gemma":[0.00006853668,0.000106395615,0.0000487908,0.0007256525,0.00033760737,0.0000626861,0.000034857047,0.0005579956,0.000005232827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007908881,0.0008329993,0.0034394816,0.00060725043,0.00015036929,0.0000636977,0.002644225,0.001326945,0.9087892,0.00026011342,0.00022629708,0.07375054],"study_design_scores_gemma":[0.015792679,0.0028276688,0.0483668,0.0009541493,0.00006100653,0.00000613988,0.0029421845,0.0041975016,0.91752976,0.0010201732,0.005894584,0.00040737644],"about_ca_topic_score_codex":0.00005454298,"about_ca_topic_score_gemma":0.000019111985,"teacher_disagreement_score":0.073343165,"about_ca_system_score_codex":0.00027543085,"about_ca_system_score_gemma":0.00044397666,"threshold_uncertainty_score":0.4338687},"labels":[],"label_agreement":null},{"id":"W4365511893","doi":"10.1158/1538-7445.am2023-lb094","title":"Abstract LB094: Arginine pre-conditioning improves T-cell potency and metabolic fitness measured by real-time impedance and seahorse assays","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Unilever (Canada)","funders":"","keywords":"Glutamine; T cell; Biology; Arginine; Molecular biology; Cell biology; Biochemistry; Immunology; Immune system; Amino acid","score_opus":0.028081964963771505,"score_gpt":0.3579780458771251,"score_spread":0.3298960809133536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365511893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854649,0.012340421,0.0000064801275,0.0004216262,0.000044287925,0.00052089494,0.0002127909,0.000044172102,0.00094443886],"genre_scores_gemma":[0.9706101,0.021112183,0.0000323941,0.00003716692,0.00025144956,0.00034608145,0.00022617463,0.00006884066,0.007315641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728787,0.00027513574,0.00023057083,0.0007397845,0.00063271134,0.00083392824],"domain_scores_gemma":[0.9987245,0.00009067272,0.000060035312,0.0004876552,0.00033810237,0.00029900676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019261768,0.00021867665,0.00024899296,0.0001556174,0.00034319985,0.000126456,0.000320703,0.0001949426,0.0001221607],"category_scores_gemma":[0.0001613004,0.0002119264,0.00005163072,0.0004894945,0.00039472347,0.000019259072,0.0002765514,0.00040400718,0.000041757652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006921391,0.000035597728,0.00042830827,0.00009097396,0.000068584595,0.000008591523,0.00013649226,0.000023297107,0.9748919,0.000004975516,0.008824289,0.014794867],"study_design_scores_gemma":[0.0011915277,0.0007192616,0.009727669,0.000035686957,0.0000123712525,0.000004719739,0.000117266914,0.00027000037,0.9812262,0.00012759247,0.0062783505,0.00028932735],"about_ca_topic_score_codex":0.0005889609,"about_ca_topic_score_gemma":0.00017548655,"teacher_disagreement_score":0.01485482,"about_ca_system_score_codex":0.0000366515,"about_ca_system_score_gemma":0.00036286926,"threshold_uncertainty_score":0.8642108},"labels":[],"label_agreement":null},{"id":"W4365512004","doi":"10.1158/1538-7445.am2023-ct223","title":"Abstract CT223: Long-term survival follow-up of tebentafusp in previously treated metastatic uveal melanoma (mUM)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Internal medicine; Surgery; Gastroenterology; Nuclear medicine","score_opus":0.09083529365230505,"score_gpt":0.391083260233183,"score_spread":0.30024796658087793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840029,0.013886374,0.0000016535864,0.00024139562,0.0006053303,0.0006643181,0.000081574115,0.00006691807,0.0004495534],"genre_scores_gemma":[0.98124564,0.0038714965,0.0000021741453,0.00001752529,0.000021992819,0.0002221034,0.0001618023,0.000042865737,0.014414376],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969032,0.0010160605,0.0005299518,0.0003962542,0.00017732166,0.0009772581],"domain_scores_gemma":[0.9983381,0.0008534797,0.000106951586,0.00048813553,0.0001797397,0.000033565568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019406036,0.00021510593,0.000554664,0.00072671624,0.00016092333,0.000024862718,0.00052931247,0.00019214636,0.00267647],"category_scores_gemma":[0.00020652641,0.00018644037,0.00015729271,0.0011849172,0.00046795336,0.00016368213,0.0001487668,0.0006730184,0.0007553427],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040164995,0.00020980652,0.05697894,0.00019228856,0.0005240484,0.00010046847,0.0012455537,0.000007804542,0.91199005,0.0000936015,0.0015535594,0.023087384],"study_design_scores_gemma":[0.005936352,0.00056068646,0.5319922,0.00034271783,0.00003067688,0.00001631689,0.00057399843,0.0000013439285,0.45564675,0.000057873007,0.004580242,0.0002608135],"about_ca_topic_score_codex":0.0036824024,"about_ca_topic_score_gemma":0.0011385595,"teacher_disagreement_score":0.4750133,"about_ca_system_score_codex":0.00018432247,"about_ca_system_score_gemma":0.00043014716,"threshold_uncertainty_score":0.9982352},"labels":[],"label_agreement":null},{"id":"W4365512024","doi":"10.1158/1538-7445.am2023-ct266","title":"Abstract CT266: Chinese race and origin have no clinically meaningful effect on tiragolumab and atezolizumab pharmacokinetics and safety in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atezolizumab; Medicine; Dosing; Adverse effect; Internal medicine; Pharmacokinetics; Oncology; Cancer; Immunotherapy","score_opus":0.02831565334505279,"score_gpt":0.4150989559091454,"score_spread":0.3867833025640926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967469,0.00072971184,4.3600528e-7,0.00054160797,0.00010096675,0.0011625402,0.000038291026,0.00004063963,0.00063893315],"genre_scores_gemma":[0.99421126,0.0047871983,0.000022280848,0.00014152113,0.00010513798,0.00008889915,0.000027668159,0.0000469625,0.00056910067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784,0.00013386879,0.00036021936,0.00053778786,0.0006057342,0.00052241096],"domain_scores_gemma":[0.9987305,0.0005471997,0.00007634619,0.00024480905,0.00018499036,0.00021616001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011848263,0.00022626687,0.0004612399,0.00027506144,0.00014106669,0.00004686553,0.00009245154,0.000091010996,0.00008595024],"category_scores_gemma":[0.00023687413,0.00015958928,0.000032609816,0.00050792744,0.0003538188,0.00009262749,0.00009477313,0.00065069174,0.0000124018225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09088662,0.0001707856,0.71508235,0.0006662501,0.00014928625,0.00015686559,0.0010040276,0.00003436277,0.010338322,0.000002839258,0.0007578958,0.1807504],"study_design_scores_gemma":[0.020959508,0.00440734,0.9700679,0.00088048406,0.000018125178,0.000005579993,0.000078337536,0.00021550896,0.00089117745,0.000009980807,0.0022648855,0.00020112957],"about_ca_topic_score_codex":0.0002435602,"about_ca_topic_score_gemma":0.00013407801,"teacher_disagreement_score":0.2549856,"about_ca_system_score_codex":0.00020557416,"about_ca_system_score_gemma":0.00017271005,"threshold_uncertainty_score":0.6507862},"labels":[],"label_agreement":null},{"id":"W4365512035","doi":"10.1158/1538-7445.am2023-ct212","title":"Abstract CT212: A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Liquid biopsy; Lung cancer; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Chemotherapy regimen; Cancer; Stage (stratigraphy); Pembrolizumab; Clinical endpoint; Phases of clinical research; Clinical trial; Immunotherapy; Biology","score_opus":0.026628435551512536,"score_gpt":0.35984805243586704,"score_spread":0.33321961688435453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967046,0.0010023525,0.00003598029,0.00002451182,0.00004011918,0.0010189951,0.0011379534,0.000005500783,0.000030027013],"genre_scores_gemma":[0.9981987,0.0010869844,0.000078568664,0.00001435611,0.000015032354,0.00020796328,0.00011546543,0.000042757994,0.00024019307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979979,0.00018352615,0.0004680483,0.00048676046,0.00045235688,0.00041143896],"domain_scores_gemma":[0.99821484,0.00009873545,0.00024554422,0.0006133338,0.000740209,0.00008733938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006706662,0.00019183189,0.00047048944,0.0006404565,0.00005581983,0.00001019053,0.00036480968,0.00011127956,0.000061505714],"category_scores_gemma":[0.00007262912,0.0001819507,0.00012096712,0.0015610126,0.00014793455,0.0000055254986,0.00023123572,0.0002040038,4.4702054e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021049678,0.005540256,0.15993601,0.00014709198,0.0014808573,0.000017424112,0.0021243843,0.0070204088,0.80120593,7.7787394e-7,0.00018366237,0.0012934965],"study_design_scores_gemma":[0.026650965,0.005954391,0.41804734,0.00015301308,0.00020115249,5.3450798e-8,0.0014964936,0.0013770538,0.54548943,7.363172e-7,0.00031011392,0.0003192652],"about_ca_topic_score_codex":0.0065355743,"about_ca_topic_score_gemma":0.0033624328,"teacher_disagreement_score":0.25811133,"about_ca_system_score_codex":0.00014010293,"about_ca_system_score_gemma":0.0005608642,"threshold_uncertainty_score":0.9879877},"labels":[],"label_agreement":null},{"id":"W4365512043","doi":"10.1158/1538-7445.am2023-ct216","title":"Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Queen's University","funders":"","keywords":"Medicine; Lung cancer; Pemetrexed; Carboplatin; Oncology; Internal medicine; Circulating tumor DNA; Pembrolizumab; Cancer; Chemotherapy; Cisplatin; Immunotherapy","score_opus":0.02854456281744619,"score_gpt":0.37507480064666626,"score_spread":0.3465302378292201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725426,0.002831544,0.000053078697,0.006503097,0.0003790981,0.0018429272,0.00087082566,0.00002171773,0.00024347033],"genre_scores_gemma":[0.988971,0.0038147483,0.000042088952,0.0007345229,0.0016648831,0.0019732418,0.00024561957,0.00010403066,0.0024498443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969472,0.00017292905,0.0004850681,0.0008339939,0.0006005908,0.00096019945],"domain_scores_gemma":[0.9980642,0.00051990995,0.00011242478,0.0006759439,0.00034333288,0.00028417283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016144997,0.0003117035,0.00030961193,0.00024939806,0.00029864104,0.00014399888,0.00077762536,0.00020188614,0.0003488371],"category_scores_gemma":[0.00048111906,0.00027950612,0.00015054793,0.00083921815,0.00016720929,0.000008694124,0.00029704976,0.00052181666,0.000048230933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06563419,0.0003774364,0.0002503164,0.000106241394,0.00010531759,0.00007624037,0.00072796864,0.0046906285,0.850508,0.0000041129124,0.07446005,0.0030594952],"study_design_scores_gemma":[0.10330028,0.0018073367,0.0034963265,0.00020641198,0.000057699363,0.000009025919,0.00037978563,0.0013739148,0.74448776,0.00007992765,0.1439527,0.00084880856],"about_ca_topic_score_codex":0.0033443572,"about_ca_topic_score_gemma":0.0018425332,"teacher_disagreement_score":0.10602021,"about_ca_system_score_codex":0.00032002645,"about_ca_system_score_gemma":0.0016666589,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W4365512087","doi":"10.1158/1538-7445.am2023-ct234","title":"Abstract CT234: A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chimeric antigen receptor; Breast cancer; Cancer; Leukapheresis; Immunotherapy; T cell; Clinical trial; Oncology; Cancer research; Internal medicine; Immunology; Immune system; Stem cell; CD34","score_opus":0.16290501504143873,"score_gpt":0.48638303389157284,"score_spread":0.3234780188501341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937265,0.00045670153,5.860088e-7,0.0016831028,0.00014066056,0.0020411885,0.000039111077,0.000093454786,0.0018186857],"genre_scores_gemma":[0.98996466,0.0011327356,0.000047880032,0.00005881667,0.00040930597,0.00023855268,0.000033356915,0.00007460958,0.008040085],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957859,0.00042951328,0.0007932173,0.0006154839,0.0013655057,0.0010104042],"domain_scores_gemma":[0.99668145,0.0018212899,0.00013216095,0.0005959144,0.00032133798,0.00044784794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046026274,0.00020769896,0.0007357685,0.0009885918,0.00023682971,0.00003223493,0.00029099814,0.00022326823,0.0026947472],"category_scores_gemma":[0.0043669827,0.00017116131,0.0000965648,0.0022682378,0.00084150437,0.00008569469,0.00031234027,0.0017488234,0.00003914682],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13539654,0.0009149428,0.00079684186,0.00060859986,0.00011808622,0.00084022793,0.0034356925,0.00004956128,0.72271,0.00002988347,0.0030185573,0.13208106],"study_design_scores_gemma":[0.6046091,0.036883123,0.10402001,0.0056077065,0.00009041673,0.00012399911,0.005389842,0.0035026749,0.1924989,0.0004856256,0.045639858,0.0011487806],"about_ca_topic_score_codex":0.001801661,"about_ca_topic_score_gemma":0.0004016358,"teacher_disagreement_score":0.5302111,"about_ca_system_score_codex":0.00057338557,"about_ca_system_score_gemma":0.0023839986,"threshold_uncertainty_score":0.9982169},"labels":[],"label_agreement":null},{"id":"W4365512104","doi":"10.1158/1538-7445.am2023-lb362","title":"Abstract LB362: Epigenome-wide DNA methylation alterations precede diagnosis since birth and affect prognosis of pediatric B-cell acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epigenome; DNA methylation; Oncology; Leukemia; Methylation; Population; Biology; Acute leukemia; Cancer; Medicine; Bioinformatics; Cancer research; Internal medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.04158526941162493,"score_gpt":0.3560426376277204,"score_spread":0.3144573682160955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940963,0.0044038403,0.00028143259,0.00018807035,0.0000977659,0.0005375527,0.00011819069,0.000019739859,0.00025712233],"genre_scores_gemma":[0.97065693,0.027942168,0.00013966326,0.000010310701,0.00027140364,0.00049115124,0.00015199151,0.00003541517,0.00030094082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832225,0.00016821339,0.00028457597,0.0004566418,0.00036654854,0.000401798],"domain_scores_gemma":[0.9988249,0.00034850577,0.00010925906,0.00028164766,0.0003001433,0.00013552715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008097625,0.0001504695,0.00016806963,0.00029180595,0.00020415922,0.0000588421,0.00017696069,0.00015218997,0.000031259115],"category_scores_gemma":[0.00026076328,0.00014787141,0.00006823796,0.0007298187,0.00011089156,0.000013187464,0.00016049818,0.0001410056,0.000017594772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054232332,0.000052598978,0.11162845,0.00018455404,0.00006819836,0.000002150486,0.00013567835,0.0010917572,0.8823277,0.000012871925,0.00045199052,0.0039898218],"study_design_scores_gemma":[0.00041667337,0.0002632984,0.18801664,0.000017164011,0.000044302837,1.2995405e-7,0.000029064684,0.00014988995,0.809388,0.00010213118,0.0014235472,0.00014914584],"about_ca_topic_score_codex":0.00013669135,"about_ca_topic_score_gemma":0.00016625837,"teacher_disagreement_score":0.076388195,"about_ca_system_score_codex":0.00009643809,"about_ca_system_score_gemma":0.00036182388,"threshold_uncertainty_score":0.6030021},"labels":[],"label_agreement":null},{"id":"W4365512133","doi":"10.1158/1538-7445.am2023-ct151","title":"Abstract CT151: A phase II study of optimized individualized adaptive radiation therapy for hepatocellular carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Liver function; Toxicity; Clinical endpoint; Radiation therapy; Internal medicine; Nuclear medicine; Clinical trial; Oncology; Urology; Surgery","score_opus":0.30011829213400143,"score_gpt":0.4352344125167324,"score_spread":0.13511612038273096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002266,0.0022409365,0.000020108713,0.00047306455,0.00009356387,0.006691516,0.00015097164,0.00008562349,0.00022154528],"genre_scores_gemma":[0.9938242,0.00077478687,0.00016174199,0.00002291762,0.00020002386,0.0041223196,0.00026106546,0.00006214462,0.0005708439],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736476,0.00022986671,0.00042371184,0.00048599287,0.00091053295,0.00058514817],"domain_scores_gemma":[0.99828315,0.0003871952,0.000115427894,0.00043675458,0.0005595765,0.00021789627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016267453,0.00020887781,0.0005529318,0.00065909873,0.00032364042,0.000026215346,0.00018785098,0.00012891764,0.00038346657],"category_scores_gemma":[0.0001242307,0.00017449689,0.00020296768,0.0012074402,0.00010316597,0.00009296946,0.00008058545,0.0002842169,0.000022688504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026934426,0.009115441,0.6890347,0.00039006938,0.001854965,0.0004937094,0.022257276,0.000022752869,0.08094238,0.00008464905,0.00846663,0.16040301],"study_design_scores_gemma":[0.27025062,0.07472795,0.16424386,0.0003931186,0.00076183205,0.000009283546,0.011822292,0.03595777,0.42456073,0.0004509877,0.015817383,0.0010041806],"about_ca_topic_score_codex":0.0010763226,"about_ca_topic_score_gemma":0.000013984349,"teacher_disagreement_score":0.5247908,"about_ca_system_score_codex":0.0002021833,"about_ca_system_score_gemma":0.0005265375,"threshold_uncertainty_score":0.71157765},"labels":[],"label_agreement":null},{"id":"W4365512156","doi":"10.1158/1538-7445.am2023-ct149","title":"Abstract CT149: BOLD-100-001 (TRIO039): a phase 1b/2a dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced colorectal cancer: interim efficacy, safety and tolerability analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology; Jewish General Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Hamilton Health Sciences; University of Alberta","funders":"","keywords":"FOLFOX; Medicine; Clinical endpoint; Internal medicine; Oncology; Interim analysis; Colorectal cancer; Phases of clinical research; Cancer; Clinical trial; Gastroenterology; Oxaliplatin","score_opus":0.047848172929242726,"score_gpt":0.44631787789748234,"score_spread":0.39846970496823964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966441,0.00006725344,0.0000051973384,0.00037317618,0.000009936973,0.0026840125,0.00007807172,0.000041238553,0.000097005846],"genre_scores_gemma":[0.9986913,0.00020718623,0.000011315966,0.000010837523,0.000018365981,0.0007301536,0.0002278621,0.000024182958,0.00007876124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977926,0.00011739879,0.00051143253,0.00056084915,0.0006428002,0.00037491496],"domain_scores_gemma":[0.9987587,0.00024561418,0.00013103592,0.00030578597,0.00038741902,0.00017147804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000607733,0.00018441422,0.000540049,0.000412379,0.00009214441,0.00001913156,0.00012908736,0.00009154988,0.0001766487],"category_scores_gemma":[0.000063191816,0.0001475342,0.000038043952,0.0038374222,0.00021690903,0.00012676988,0.000039572828,0.000481777,0.0000010845786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028509602,0.019114237,0.89665705,0.0002523048,0.0003841029,0.0000109188895,0.0014749239,0.001546863,0.029133353,0.000003057021,0.000022344282,0.022891272],"study_design_scores_gemma":[0.037290215,0.0026490819,0.93303967,0.00017434356,0.00011177512,2.9354965e-7,0.00031101855,0.0018734299,0.02435885,0.000004742911,0.0000493245,0.00013723677],"about_ca_topic_score_codex":0.0017521788,"about_ca_topic_score_gemma":0.0011381075,"teacher_disagreement_score":0.036382664,"about_ca_system_score_codex":0.0006037365,"about_ca_system_score_gemma":0.00019167925,"threshold_uncertainty_score":0.601627},"labels":[],"label_agreement":null},{"id":"W4365512159","doi":"10.1158/1538-7445.am2023-ct160","title":"Abstract CT160: Phase 1b/2a clinical trial of the oral BET inhibitor PLX2853 as monotherapy for ARID1A mutated gynecologic cancers and in combination with carboplatin for platinum resistant ovarian cance","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bromodomain; Medicine; Carboplatin; Tolerability; BET inhibitor; Combination therapy; Internal medicine; Ovarian cancer; Phases of clinical research; Oncology; BRD4; Cancer; Gynecologic oncology; Endometrial cancer; Clinical trial; Pharmacology; Chemotherapy; Adverse effect; Epigenetics; Cisplatin; Chemistry","score_opus":0.10538728984909965,"score_gpt":0.45466410157271736,"score_spread":0.3492768117236177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553716,0.00016366043,0.00003941067,0.0009973246,0.00025851358,0.0027196903,0.0002017207,0.000009719529,0.00007282306],"genre_scores_gemma":[0.9975163,0.00023982923,0.00014126863,0.00007511355,0.00019885496,0.0013160426,0.00013187443,0.000025009438,0.0003557033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846,0.00016527362,0.00040108213,0.0003895306,0.00025830243,0.00032580658],"domain_scores_gemma":[0.99904585,0.00023470119,0.00016276121,0.00024200568,0.00024373154,0.000070940376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015756581,0.00012039546,0.00021924489,0.00009746965,0.00014610287,0.000030019697,0.00018581196,0.00017813197,0.000009015453],"category_scores_gemma":[0.0006794487,0.00008858461,0.00005908254,0.0003759671,0.0002735546,0.000009729333,0.00005067897,0.00020693317,3.902827e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18049909,0.0006635238,0.002193952,0.00020944209,0.0001802206,0.000006066134,0.00032956203,0.00034584594,0.7758063,0.00040106132,0.010849359,0.028515575],"study_design_scores_gemma":[0.21825108,0.013646781,0.013725823,0.00023221636,0.00002631063,0.0000011918378,0.0005364488,0.001709295,0.7264647,0.0014168267,0.023539184,0.00045014796],"about_ca_topic_score_codex":0.0009939945,"about_ca_topic_score_gemma":0.0042957794,"teacher_disagreement_score":0.04934161,"about_ca_system_score_codex":0.00012628632,"about_ca_system_score_gemma":0.0009278668,"threshold_uncertainty_score":0.36123756},"labels":[],"label_agreement":null},{"id":"W4365512210","doi":"10.1158/1538-7445.am2023-ct278","title":"Abstract CT278: <i>ERBB2</i> amplification detected in ctDNA as a surrogate for tumor tissue FISH analysis of HER2 status in a phase 1 study with zanidatamab for the treatment of locally advanced or metastatic HER2 expressing cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Concordance; Cancer; Gene duplication; Cancer research; Breast cancer; Medicine; Copy-number variation; Biology; Colorectal cancer; Gene; Oncology; Internal medicine; Genome; Genetics","score_opus":0.06689138497758919,"score_gpt":0.4319311904659967,"score_spread":0.36503980548840753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994063,0.0009539067,0.000490841,0.00007338837,0.000032189382,0.0028225514,0.0015545639,0.0000046485957,0.000004888124],"genre_scores_gemma":[0.9932757,0.0024551065,0.00023567735,0.00001775299,0.000027784254,0.003593827,0.00030335365,0.000031172032,0.00005962136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984161,0.00007474327,0.00039805062,0.00043189604,0.00024023282,0.00043895846],"domain_scores_gemma":[0.9983982,0.00056900986,0.0001657782,0.00044156765,0.0003544107,0.00007102449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004966602,0.00014822622,0.0003786543,0.00029649053,0.00007271249,0.000029391924,0.0002077313,0.000035896133,0.000015192969],"category_scores_gemma":[0.00027983484,0.000106851214,0.000066693996,0.0013838502,0.00011698581,0.000008232745,0.00003691949,0.000066035966,2.594797e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025357883,0.002222961,0.0053638853,0.0003624002,0.0017378384,0.000036990405,0.0031442305,0.083308,0.7781573,0.0000065871286,0.00026416112,0.100037746],"study_design_scores_gemma":[0.02478057,0.017546367,0.023249602,0.00024011917,0.00069757656,0.0000010381706,0.012624968,0.0068274466,0.90337956,0.000036841935,0.010200398,0.00041550412],"about_ca_topic_score_codex":0.0101014245,"about_ca_topic_score_gemma":0.11158382,"teacher_disagreement_score":0.12522225,"about_ca_system_score_codex":0.00029918997,"about_ca_system_score_gemma":0.0011758256,"threshold_uncertainty_score":0.9964904},"labels":[],"label_agreement":null},{"id":"W4365512223","doi":"10.1158/1538-7445.am2023-ct229","title":"Abstract CT229: CRESTONE: A Phase 2 study of seribantumab in adult patients with neuregulin-1 (NRG1) fusion positive locally advanced or metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Medicine; Cohort; Internal medicine; Oncology; Cancer; Response Evaluation Criteria in Solid Tumors; ErbB; Adenocarcinoma; Cancer research; Phases of clinical research; Chemotherapy","score_opus":0.076277487442443,"score_gpt":0.4803886962775271,"score_spread":0.4041112088350841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308485,0.00012532626,0.000004955822,0.00073503,0.00009606986,0.0054009687,0.00019469674,0.000075666816,0.00028241216],"genre_scores_gemma":[0.9970988,0.0003151,0.00006803408,0.000085444124,0.000077763085,0.0014082376,0.000092787246,0.00012303647,0.00073077815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9929835,0.0004928252,0.00081098056,0.0009265239,0.0034378883,0.0013482644],"domain_scores_gemma":[0.99553496,0.0005914306,0.000168546,0.00084040564,0.0023605141,0.0005041263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015559032,0.00033921408,0.00087796606,0.0012673328,0.00019205984,0.000046793204,0.000497821,0.00009256274,0.00063205825],"category_scores_gemma":[0.0010138085,0.00024731347,0.00007271446,0.00422497,0.00044468904,0.00022648163,0.0003163651,0.0014251878,0.00008669142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24766558,0.038622446,0.2067718,0.007961452,0.0013696229,0.020774718,0.032786414,0.0048309024,0.100466534,0.00006464887,0.009370341,0.32931554],"study_design_scores_gemma":[0.07238759,0.040707707,0.8392854,0.0057992814,0.00010580247,0.000024523693,0.012809084,0.0013461832,0.026510911,0.000055188953,0.00029415727,0.0006741873],"about_ca_topic_score_codex":0.0028472908,"about_ca_topic_score_gemma":0.0037350503,"teacher_disagreement_score":0.6325136,"about_ca_system_score_codex":0.00084145204,"about_ca_system_score_gemma":0.0026590687,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W4365512242","doi":"10.1158/1538-7445.am2023-ct174","title":"Abstract CT174: First-in-class anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies: Phase 1 results","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Pharmacodynamics; Cancer; Oncology; Internal medicine; Pharmacokinetics; Immunotherapy; Antibody; Adverse effect; Pharmacology; Immunology","score_opus":0.04987680613467357,"score_gpt":0.4245616367554918,"score_spread":0.37468483062081825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370116,0.0006804884,0.0000011344848,0.0021820972,0.00022668754,0.0014371707,0.00022940431,0.00007992129,0.0014619429],"genre_scores_gemma":[0.9952882,0.002702479,0.000021671372,0.00015221065,0.00011630258,0.00025132933,0.0002812665,0.00006293058,0.0011235895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962977,0.00008332118,0.0005919566,0.00070079195,0.0011580312,0.001168156],"domain_scores_gemma":[0.99847376,0.00023788922,0.00010583931,0.00062460074,0.00036527056,0.00019262251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013642007,0.00025077173,0.0004967342,0.00090248254,0.00015424052,0.00004952609,0.00028689316,0.00015323324,0.00028646743],"category_scores_gemma":[0.00022128111,0.000202894,0.00008184456,0.0029022424,0.00031449128,0.0002211082,0.00008287211,0.00070126104,0.0001053473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14055851,0.0040706038,0.49736127,0.0016317698,0.00039777535,0.0019903095,0.0042981836,0.0008404765,0.23598881,0.000025124553,0.032635055,0.0802021],"study_design_scores_gemma":[0.04357061,0.0014112128,0.9068122,0.0022009157,0.000009815185,0.0000024088945,0.0005322303,0.0001036685,0.011637263,0.000013586552,0.033388242,0.00031784468],"about_ca_topic_score_codex":0.001530606,"about_ca_topic_score_gemma":0.0016346923,"teacher_disagreement_score":0.40945095,"about_ca_system_score_codex":0.00074161845,"about_ca_system_score_gemma":0.0006846462,"threshold_uncertainty_score":0.82737774},"labels":[],"label_agreement":null},{"id":"W4365512264","doi":"10.1158/1538-7445.am2023-ct176","title":"Abstract CT176: Pharmacokinetic/pharmacodynamic (PK/PD) relationships of the novel Treg depleter RG6292 in Phase Ia and Ib studies in patients with solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Population; Medicine; Effector; Cmax; Antibody; Immune system; Pharmacology; Cancer research; Immunology","score_opus":0.2151227855460076,"score_gpt":0.5107631853545207,"score_spread":0.2956403998085131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522823,0.0009254181,4.1596468e-7,0.0023419918,0.00006712002,0.0009241939,0.000110118024,0.000013163196,0.00038934106],"genre_scores_gemma":[0.99726325,0.0010900504,0.00001742505,0.00006117779,0.000073887255,0.0001735054,0.000023391114,0.000027501532,0.0012698042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751127,0.00017795875,0.0003874302,0.00033437627,0.0010000503,0.00058894017],"domain_scores_gemma":[0.9986906,0.0005586962,0.000063960484,0.00021050265,0.00033409172,0.00014212266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011130476,0.00015443921,0.00035124266,0.0005742691,0.00015414815,0.0000135054515,0.0001989818,0.000052971194,0.00010778444],"category_scores_gemma":[0.0002769452,0.00009587378,0.000046113204,0.0015098862,0.0006488691,0.00008966586,0.00023129254,0.0010576132,0.000015386178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004048525,0.00066837965,0.9359125,0.0009718339,0.00017370786,0.00011043725,0.0019481516,0.0002072066,0.047073543,0.000054892647,0.0022075598,0.0066232705],"study_design_scores_gemma":[0.007233625,0.00026973546,0.98505217,0.00082941144,0.000016945629,0.0000035497906,0.0004919332,0.00083914574,0.0044729975,0.000067613,0.0006104809,0.00011239433],"about_ca_topic_score_codex":0.00073178444,"about_ca_topic_score_gemma":0.00069943117,"teacher_disagreement_score":0.04913968,"about_ca_system_score_codex":0.00019180849,"about_ca_system_score_gemma":0.0002662147,"threshold_uncertainty_score":0.4594862},"labels":[],"label_agreement":null},{"id":"W4365512265","doi":"10.1158/1538-7445.am2023-ct110","title":"Abstract CT110: Safety and anti-tumor activity of a novel Treg depleter RG6292, as a single agent and in combination with atezolizumab in patients with solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rash; Adverse effect; Atezolizumab; Internal medicine; Gastroenterology; Surgery; Cancer; Nivolumab; Immunotherapy","score_opus":0.053231216726673435,"score_gpt":0.35702177253605033,"score_spread":0.3037905558093769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840873,0.00014071625,0.0000045326196,0.00047029543,0.000016436035,0.00076423795,0.00002702384,0.00001178182,0.00015621806],"genre_scores_gemma":[0.9995624,0.00021480244,0.000013720289,0.00003477306,0.000009616994,0.00005853098,0.000013237309,0.0000213364,0.000071605005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867964,0.000046443565,0.00019226779,0.00027958222,0.00048119022,0.00032090797],"domain_scores_gemma":[0.9994989,0.000086437765,0.00006793068,0.00015257599,0.00012153101,0.00007263143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045963548,0.000110797526,0.00028302948,0.00040448352,0.000050012262,0.000019243425,0.000051705545,0.000042535994,0.00002645003],"category_scores_gemma":[0.000037510974,0.00008211747,0.00001616612,0.0008066184,0.000251978,0.00009588191,0.000042944383,0.00024028315,9.319368e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065806076,0.001814156,0.73125917,0.00078913494,0.00014439499,0.00016215727,0.0022119354,0.000037767095,0.13665281,0.000012584279,0.000089557696,0.061020248],"study_design_scores_gemma":[0.015104986,0.0011649663,0.9712393,0.0009547686,0.000006531172,0.0000060495518,0.00018288288,0.00010422473,0.011063469,0.0000063957673,0.00007026846,0.00009612705],"about_ca_topic_score_codex":0.0028872977,"about_ca_topic_score_gemma":0.0015371012,"teacher_disagreement_score":0.23998015,"about_ca_system_score_codex":0.00032646162,"about_ca_system_score_gemma":0.00025786663,"threshold_uncertainty_score":0.43647495},"labels":[],"label_agreement":null},{"id":"W4365512273","doi":"10.1158/1538-7445.am2023-ct206","title":"Abstract CT206: A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Niagara Health System; Windsor Regional Hospital; North York General Hospital; Grand River Hospital; St Joseph's Health Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Pembrolizumab; Internal medicine; KRAS; Response Evaluation Criteria in Solid Tumors; Oncology; Lung cancer; Adverse effect; MEK inhibitor; Gastroenterology; Cancer; Phases of clinical research; Clinical trial; Kinase; MAPK/ERK pathway; Immunotherapy; Colorectal cancer","score_opus":0.03269849598645779,"score_gpt":0.4195021822245747,"score_spread":0.3868036862381169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946167,0.00031185918,0.0000023881546,0.00018623336,0.00006840069,0.004017668,0.000061501174,0.000029590507,0.00070566585],"genre_scores_gemma":[0.99685913,0.00015582204,0.000041422463,0.000016473647,0.000030570118,0.0023857148,0.00007785797,0.000053678417,0.0003793318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764884,0.00008816317,0.00036719954,0.00047943162,0.0008860644,0.0005303322],"domain_scores_gemma":[0.9987197,0.00012491297,0.00011766578,0.00032162442,0.00057408964,0.00014201278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035117948,0.00019198662,0.00039699624,0.00090072124,0.00008205381,0.00002063825,0.00012624777,0.00006159314,0.00008511697],"category_scores_gemma":[0.00003021358,0.00014267908,0.000027677559,0.0023332383,0.000083873754,0.00015165942,0.000049895494,0.0004261441,0.0000059650743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008092614,0.008616394,0.9565638,0.0005982489,0.00017655162,0.00012650862,0.010807833,0.00084873085,0.0018087846,0.0000040878485,0.00031354924,0.012042945],"study_design_scores_gemma":[0.09132593,0.0063151694,0.89353514,0.0013324047,0.00009298296,3.4312075e-7,0.003589594,0.00019156885,0.0033657078,0.0000055807877,0.00007030843,0.00017529885],"about_ca_topic_score_codex":0.006644529,"about_ca_topic_score_gemma":0.0055407165,"teacher_disagreement_score":0.08323331,"about_ca_system_score_codex":0.00087763893,"about_ca_system_score_gemma":0.0014357502,"threshold_uncertainty_score":0.9999703},"labels":[],"label_agreement":null},{"id":"W4365512278","doi":"10.1158/1538-7445.am2023-ct202","title":"Abstract CT202: Xevinapant plus avelumab in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Phase 1b dose-expansion results and exploratory biomarker analyses","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; Spinal Cord Injury BC; University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Avelumab; Response Evaluation Criteria in Solid Tumors; Oncology; Lung cancer; Clinical endpoint; Progressive disease; Adverse effect; Cohort; Cancer; Chemotherapy; Tolerability; Gastroenterology; Immunotherapy; Nivolumab; Clinical trial","score_opus":0.14204790365486764,"score_gpt":0.48933486052402336,"score_spread":0.3472869568691557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302566,0.0029043818,0.000015902742,0.00064421614,0.00016309168,0.0022270728,0.0004285974,0.00006278172,0.00052831403],"genre_scores_gemma":[0.99181616,0.0037821059,0.00027131377,0.000084765335,0.00006248177,0.001778906,0.0002861827,0.00007750459,0.0018405872],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969514,0.00012682063,0.00048588964,0.0007918241,0.00085781707,0.0007862455],"domain_scores_gemma":[0.9982084,0.0002796827,0.00013737884,0.00048246415,0.0005284604,0.0003635833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053926685,0.0003007849,0.0005234849,0.00079374533,0.00027503862,0.000064841115,0.00014724057,0.00007659522,0.00016278213],"category_scores_gemma":[0.00011855585,0.00020102317,0.000060927894,0.0019716588,0.00019756869,0.0002773332,0.00010517293,0.00040714297,0.000025499414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12876794,0.013024025,0.077483885,0.010548143,0.0046110773,0.0062187556,0.04544787,0.0061456244,0.12429629,0.000013661376,0.047811497,0.53563124],"study_design_scores_gemma":[0.2764639,0.0075313533,0.64276505,0.00928518,0.0016934789,0.000010700189,0.015578997,0.008320208,0.03328934,0.000031105912,0.0035215765,0.0015091329],"about_ca_topic_score_codex":0.0029278887,"about_ca_topic_score_gemma":0.0024858667,"teacher_disagreement_score":0.56528115,"about_ca_system_score_codex":0.0012367906,"about_ca_system_score_gemma":0.0022716273,"threshold_uncertainty_score":0.8197487},"labels":[],"label_agreement":null},{"id":"W4365512324","doi":"10.1158/1538-7445.am2023-ct119","title":"Abstract CT119: A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with <i>FGFR3</i> alterations (trial in progress)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Fibroblast growth factor receptor; Hyperphosphatemia; Mucositis; Fibroblast growth factor receptor 1; Cancer; Internal medicine; Cancer research; Oncology; Fibroblast growth factor; Receptor; Chemotherapy","score_opus":0.03827723797424968,"score_gpt":0.41846664809599116,"score_spread":0.38018941012174146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579746,0.00014674802,0.0000022661166,0.00024865408,0.000050886665,0.003500755,0.00006706911,0.000018538545,0.00016760395],"genre_scores_gemma":[0.99670947,0.00007756333,0.00002106909,0.000007260622,0.0001659429,0.0026783922,0.00010309445,0.00006084825,0.00017638269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99629647,0.00028718845,0.000606509,0.0008255432,0.0009039402,0.0010803542],"domain_scores_gemma":[0.99873286,0.00008959237,0.000110789406,0.00051873317,0.0003819304,0.00016609042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010700191,0.00025057944,0.00040332507,0.000991714,0.00015859953,0.00006118632,0.0004736056,0.00015329746,0.000027459511],"category_scores_gemma":[0.00021480239,0.00023133216,0.00005722964,0.0022685423,0.0002970193,0.00003843693,0.00031485647,0.000798714,0.000009877072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034940284,0.004763094,0.05420312,0.00032996037,0.00009319409,0.00033139388,0.002615121,0.0030524,0.89703774,0.000021960657,0.0009975364,0.0016141698],"study_design_scores_gemma":[0.13018331,0.027547015,0.14337975,0.0010390385,0.000010685486,0.000006482948,0.0038337277,0.00039821406,0.6919969,0.00014812466,0.00062373857,0.0008330249],"about_ca_topic_score_codex":0.0015637657,"about_ca_topic_score_gemma":0.020917282,"teacher_disagreement_score":0.20504089,"about_ca_system_score_codex":0.00033232255,"about_ca_system_score_gemma":0.0008920787,"threshold_uncertainty_score":0.9969484},"labels":[],"label_agreement":null},{"id":"W4365512331","doi":"10.1158/1538-7445.am2023-ct265","title":"Abstract CT265: Phase 1 dose-escalation study of SGN-TGT monotherapy in patients with advanced malignancies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"TIGIT; Medicine; Tolerability; Internal medicine; Antibody; Immune system; Oncology; Immunology; T cell; Adverse effect","score_opus":0.0774468423390009,"score_gpt":0.4359110392759378,"score_spread":0.3584641969369369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974024,0.00037565778,0.0000011997637,0.0002691375,0.000075165204,0.0016668425,0.00002434957,0.000038743638,0.00014645743],"genre_scores_gemma":[0.9987377,0.00049333344,0.0000148397185,0.000035141227,0.000042284624,0.00031345253,0.000025246973,0.000032799155,0.00030523763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980747,0.00007401629,0.00031595654,0.0003052665,0.00084660633,0.0003834193],"domain_scores_gemma":[0.99911004,0.00009241571,0.000076532684,0.00033161335,0.0003189205,0.00007045297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006298483,0.00012355005,0.0002702833,0.00047415175,0.00007294413,0.000015336986,0.00012531389,0.000057418718,0.00026105344],"category_scores_gemma":[0.000031294745,0.00009426704,0.000039548286,0.0015710687,0.00012666256,0.00012355756,0.00002541713,0.00025215355,0.000011194581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05415553,0.0038496004,0.58106077,0.0002419342,0.0002467337,0.00004527968,0.005085508,0.00022528593,0.13542716,0.0000051087695,0.0009974533,0.21865967],"study_design_scores_gemma":[0.029096095,0.0039276807,0.9568122,0.00032025774,0.000008381739,2.2889755e-7,0.0015515295,0.000027469283,0.0072812852,0.000009716852,0.00085909746,0.00010605538],"about_ca_topic_score_codex":0.00095333596,"about_ca_topic_score_gemma":0.00046907255,"teacher_disagreement_score":0.37575147,"about_ca_system_score_codex":0.00026548916,"about_ca_system_score_gemma":0.00024294324,"threshold_uncertainty_score":0.38440984},"labels":[],"label_agreement":null},{"id":"W4365512340","doi":"10.1158/1538-7445.am2023-ct171","title":"Abstract CT171: A first-in-human phase I study of the ATM inhibitor M4076 in patients with advanced solid tumors (DDRiver Solid Tumors 410): Part 1A results","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tolerability; Pharmacokinetics; Rash; Medicine; Pharmacodynamics; Adverse effect; Pharmacology; In vivo; Internal medicine; Biology","score_opus":0.03243345781171774,"score_gpt":0.37198492193375604,"score_spread":0.3395514641220383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978559,0.00004712353,3.5423284e-7,0.000090180794,0.000121285506,0.0015558433,0.00011628394,0.000017711387,0.00019528688],"genre_scores_gemma":[0.9987855,0.000035029774,0.000008015612,0.000019621373,0.00010199911,0.00044486136,0.00007244362,0.00005007991,0.00048245513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706036,0.00019554529,0.00052832154,0.0006971708,0.0008036558,0.0007149332],"domain_scores_gemma":[0.9985798,0.00004317212,0.00015666404,0.00082100736,0.00027577125,0.00012358693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086141337,0.00021228024,0.0003083434,0.00021745637,0.00016424246,0.000024397417,0.0005518257,0.00010508788,0.000029317798],"category_scores_gemma":[0.00021878362,0.00016154768,0.00006498371,0.00085638074,0.00018697331,0.000014350911,0.00042953106,0.00041384375,0.0000108234235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010291781,0.006218144,0.11593918,0.00034123188,0.00020125376,0.00026723483,0.004900539,0.007054973,0.8446593,0.000019420142,0.0062368116,0.003870093],"study_design_scores_gemma":[0.022453623,0.006973928,0.25173646,0.00079857,0.000012837479,0.0000010510935,0.002565278,0.000084817344,0.7132806,0.000065668246,0.0015231323,0.00050403347],"about_ca_topic_score_codex":0.00053428597,"about_ca_topic_score_gemma":0.0041177603,"teacher_disagreement_score":0.13579728,"about_ca_system_score_codex":0.00015478882,"about_ca_system_score_gemma":0.00028120933,"threshold_uncertainty_score":0.6587723},"labels":[],"label_agreement":null},{"id":"W4365512356","doi":"10.1158/1538-7445.am2023-ct124","title":"Abstract CT124: A first-in-clinic phase 1 study of GSK3745417 STING agonist in relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Sting; Tolerability; Myelodysplastic syndromes; Leukemia; Stimulator of interferon genes; Internal medicine; Bone marrow; Cancer research; Immunology; Oncology; Pharmacology; Immune system; Adverse effect; Innate immune system","score_opus":0.05234164559355544,"score_gpt":0.3799489385241098,"score_spread":0.3276072929305544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961262,0.0023022103,5.3313113e-7,0.000108795444,0.00045200682,0.00069565786,0.00011068269,0.00004738285,0.00015656622],"genre_scores_gemma":[0.993292,0.0023479087,0.000002407657,0.000009045739,0.000019516992,0.00023322714,0.0000314285,0.000038545488,0.004025919],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969469,0.0007572478,0.0007061015,0.00057003845,0.00015897436,0.0008607417],"domain_scores_gemma":[0.9971176,0.0021106564,0.00016614678,0.0004339236,0.0001232194,0.00004846724],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021321098,0.00022770194,0.00057673815,0.00104149,0.000292578,0.000031151532,0.00041265893,0.00027051012,0.00093354686],"category_scores_gemma":[0.0007039848,0.00021147134,0.000056724315,0.000935661,0.00047261652,0.00010941259,0.00033702486,0.0017340409,0.0005397925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022987062,0.0035633256,0.07609862,0.0007001157,0.0014458653,0.0028828983,0.016527,0.00026510408,0.840829,0.000041608353,0.0067533655,0.027906025],"study_design_scores_gemma":[0.0240832,0.0074464,0.93163735,0.0009913802,0.000079117046,0.00008136638,0.009493118,0.000050975894,0.02278548,0.00007534428,0.0027699294,0.00050632836],"about_ca_topic_score_codex":0.007935102,"about_ca_topic_score_gemma":0.0038967014,"teacher_disagreement_score":0.8555387,"about_ca_system_score_codex":0.00043930512,"about_ca_system_score_gemma":0.0004993063,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W4365512629","doi":"10.1158/1538-7445.am2023-ct062","title":"Abstract CT062: GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Oncology; Biomarker; Randomization; Clinical trial; Glioblastoma; Agile software development; Internal medicine; Cancer research; Computer science; Biology","score_opus":0.17798702851810663,"score_gpt":0.4789060208767832,"score_spread":0.3009189923586766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906951,0.0010946713,6.8255747e-7,0.0039143553,0.00028849833,0.003385388,0.00021412359,0.00007147624,0.00033565855],"genre_scores_gemma":[0.9954673,0.0012291223,0.000044897508,0.00008936902,0.0002773735,0.00270507,0.00003439068,0.000031364627,0.00012110039],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969664,0.00009905962,0.00036472882,0.0006592439,0.0010404806,0.0008700494],"domain_scores_gemma":[0.9980384,0.00064542075,0.00005531729,0.00039918165,0.00028529152,0.0005763731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011318687,0.00022985297,0.0004417792,0.000527156,0.00014805414,0.0000679309,0.00014183554,0.0001143975,0.00022490586],"category_scores_gemma":[0.0008778592,0.00017309093,0.00008872849,0.0017900661,0.00011876576,0.00010707185,0.00018243036,0.00038864888,0.00029647764],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29401198,0.005719301,0.019056775,0.00028771663,0.00053740316,0.0078124087,0.0033056564,0.00025357102,0.011597479,0.00023601881,0.14171071,0.515471],"study_design_scores_gemma":[0.6200236,0.032702502,0.2779222,0.0031993054,0.0001993357,0.000048319147,0.0031690719,0.0029346745,0.022787353,0.00057149515,0.03555406,0.0008880801],"about_ca_topic_score_codex":0.002263777,"about_ca_topic_score_gemma":0.005058563,"teacher_disagreement_score":0.5145829,"about_ca_system_score_codex":0.0010910758,"about_ca_system_score_gemma":0.00051097444,"threshold_uncertainty_score":0.70584434},"labels":[],"label_agreement":null},{"id":"W4365512763","doi":"10.1158/1538-7445.am2023-ct058","title":"Abstract CT058: TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Prostate cancer; Internal medicine; Combination therapy; Cancer; Oncology; Bevacizumab; Phases of clinical research; Immunotherapy; Chemotherapy","score_opus":0.07314861898670705,"score_gpt":0.47179241001322003,"score_spread":0.398643791026513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491805,0.0003196741,0.000003388307,0.0005170444,0.000037968628,0.004049962,0.00004571084,0.000033483946,0.00007471384],"genre_scores_gemma":[0.9970233,0.0015210077,0.000046624828,0.00004834615,0.000021314387,0.0011138315,0.00003582884,0.000071098,0.00011863437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586326,0.00024312818,0.0005293476,0.0007058594,0.0017760635,0.00088231673],"domain_scores_gemma":[0.998292,0.0002854579,0.0001427026,0.00047323355,0.0005834716,0.00022311257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074384187,0.0002739722,0.0006850185,0.0011338269,0.00012899005,0.000042297812,0.00023272689,0.00003827399,0.00010323044],"category_scores_gemma":[0.00025406064,0.000202547,0.000026428032,0.0019992406,0.0003660051,0.00029929003,0.00015541141,0.0006544282,0.000011985284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018807149,0.0064131473,0.9426793,0.001037114,0.00032592737,0.00074022403,0.006542027,0.00029845227,0.0021984298,0.0000079117835,0.0002406086,0.020709751],"study_design_scores_gemma":[0.06343371,0.0083118,0.91551024,0.0018260432,0.000033369928,0.0000027551507,0.006625632,0.000603696,0.0032859852,0.000051464107,0.000079670004,0.00023566803],"about_ca_topic_score_codex":0.002985856,"about_ca_topic_score_gemma":0.004024584,"teacher_disagreement_score":0.044626556,"about_ca_system_score_codex":0.00074251846,"about_ca_system_score_gemma":0.0006286066,"threshold_uncertainty_score":0.8259627},"labels":[],"label_agreement":null},{"id":"W4365512785","doi":"10.1158/1538-7445.am2023-ct065","title":"Abstract CT065: Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic breast cancer (HER2CLIMB-05, trial in progress)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Medicine; Internal medicine; Capecitabine; Metastatic breast cancer; Oncology; Neratinib; Taxane; Trastuzumab; Progression-free survival; Breast cancer; Cancer; Colorectal cancer; Chemotherapy","score_opus":0.12400111099607009,"score_gpt":0.4907828270774674,"score_spread":0.3667817160813973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537195,0.0012995903,0.000008688935,0.003335788,0.0001073554,0.009651089,0.00014940981,0.0000473046,0.000028855977],"genre_scores_gemma":[0.9864342,0.0010875628,0.000111849105,0.000057853224,0.000115519055,0.0115440255,0.000026403653,0.00009062186,0.0005319397],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99678624,0.00023173599,0.0005831274,0.0006706642,0.0009356103,0.0007926133],"domain_scores_gemma":[0.99805236,0.0006681332,0.00018678964,0.00036901914,0.00055822666,0.0001654769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015118613,0.0002859705,0.000742598,0.0007269868,0.000108299006,0.000039589744,0.00022173705,0.00007665129,0.0002452464],"category_scores_gemma":[0.00016675262,0.0002004617,0.00004930858,0.001802694,0.00040321372,0.00023599039,0.000046582445,0.00053936266,0.0000028656016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6323249,0.0074402504,0.009390674,0.0007471565,0.00035171327,0.00024003223,0.012095788,0.0001418231,0.002213136,0.00004680412,0.00029163784,0.3347161],"study_design_scores_gemma":[0.7603738,0.032736428,0.1621168,0.0025061916,0.00007755279,0.00009651171,0.036445122,0.00075547275,0.0022234442,0.00050119095,0.0016196483,0.0005478511],"about_ca_topic_score_codex":0.0029809806,"about_ca_topic_score_gemma":0.0050704614,"teacher_disagreement_score":0.33416826,"about_ca_system_score_codex":0.00093978556,"about_ca_system_score_gemma":0.0016627045,"threshold_uncertainty_score":0.81745905},"labels":[],"label_agreement":null},{"id":"W4365513174","doi":"10.1158/1538-7445.am2023-ct061","title":"Abstract CT061: TRIDENT phase 3 study (EF-32): First-line Tumor Treating Fields (TTFields; 200 kHz) therapy concomitant with chemo-radiation, followed by maintenance TTFields/temozolomide in newly diagnosed glioblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Concomitant; Temozolomide; Internal medicine; Radiation therapy; Oncology; Adverse effect; Phases of clinical research; Surgery; Clinical trial","score_opus":0.05033569187163088,"score_gpt":0.39741478776613187,"score_spread":0.347079095894501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860905,0.0020838692,0.000008329396,0.007849989,0.00016199544,0.003247952,0.000077089564,0.000121415986,0.00035888236],"genre_scores_gemma":[0.9928544,0.003146117,0.000017051927,0.00041966088,0.00025190844,0.0021931697,0.000059570386,0.00007428546,0.000983847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962141,0.0001558707,0.00068478874,0.0008331313,0.0010466403,0.0010654972],"domain_scores_gemma":[0.997127,0.0013118341,0.00016843555,0.00067599624,0.00034681326,0.00036992296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010367202,0.00038892083,0.0007462042,0.00052695855,0.00028211626,0.000117146265,0.00030048893,0.00016959352,0.00064299174],"category_scores_gemma":[0.00051906385,0.00028906038,0.00014446073,0.0017280352,0.000118542375,0.00015978845,0.000077991215,0.000789551,0.000084439045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01846436,0.012624195,0.59472495,0.00031381173,0.0011087648,0.018446099,0.0078318305,0.0009777419,0.020318002,0.000022487668,0.23715754,0.08801021],"study_design_scores_gemma":[0.28716627,0.037147947,0.3533767,0.0030411847,0.00029401042,0.000115260096,0.016104499,0.0025729297,0.27760234,0.00016722149,0.020510668,0.00190099],"about_ca_topic_score_codex":0.0070515466,"about_ca_topic_score_gemma":0.007852993,"teacher_disagreement_score":0.26870188,"about_ca_system_score_codex":0.00065943535,"about_ca_system_score_gemma":0.0005017937,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W4365513372","doi":"10.1158/1538-7445.am2023-ct037","title":"Abstract CT037: Nivolumab plus ipilimumab vs chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma: CheckMate 649 biomarker analyses","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Internal medicine; Oncology; Cancer; Ipilimumab; Pemetrexed; Biomarker; Chemotherapy; Immunotherapy; Biology","score_opus":0.1584976595064492,"score_gpt":0.46073225989458755,"score_spread":0.3022346003881383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550968,0.031320382,0.00008777553,0.006953514,0.0013906616,0.0037947933,0.00065072445,0.00041647276,0.00028890042],"genre_scores_gemma":[0.9287592,0.047559872,0.00013070658,0.00040246767,0.0015074561,0.0066630053,0.0003990645,0.00022884148,0.014349368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99406487,0.00013744064,0.0009044868,0.0014585879,0.0014043914,0.0020302548],"domain_scores_gemma":[0.9970255,0.0003497406,0.00030794315,0.0009449629,0.0008062191,0.00056562957],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095202937,0.000738906,0.0011507159,0.0012137868,0.0010126248,0.00015118907,0.00047471464,0.00033993315,0.002790613],"category_scores_gemma":[0.00008512106,0.00062833884,0.00068140216,0.0032714582,0.0005264949,0.00031496325,0.00010039466,0.0005829329,0.00011827847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12450723,0.0009978788,0.016805802,0.001555413,0.00426583,0.00052835944,0.0013496712,0.004236955,0.26614264,0.000016304435,0.028366964,0.551227],"study_design_scores_gemma":[0.10415568,0.010659563,0.5836006,0.0020226003,0.0010485658,0.00013367944,0.0014511491,0.0080992095,0.23302406,0.00018685122,0.053960744,0.0016572835],"about_ca_topic_score_codex":0.020205075,"about_ca_topic_score_gemma":0.003048951,"teacher_disagreement_score":0.5667948,"about_ca_system_score_codex":0.0062141884,"about_ca_system_score_gemma":0.0027529232,"threshold_uncertainty_score":0.9996168},"labels":[],"label_agreement":null},{"id":"W4365513632","doi":"10.1158/1538-7445.am2023-ct035","title":"Abstract CT035: Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; FOLFIRINOX; Gemcitabine; Oncology; Pancreatic cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Adenocarcinoma; Chemotherapy; Stage (stratigraphy); Phases of clinical research; Gastroenterology; Surgery; Irinotecan; Colorectal cancer","score_opus":0.14054429483023875,"score_gpt":0.4599368219700027,"score_spread":0.31939252713976396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916885,0.0018921245,0.00007447345,0.0008923078,0.00020199647,0.0013898122,0.0033877348,0.000023393468,0.00044969347],"genre_scores_gemma":[0.9865423,0.0050575943,0.00012275805,0.000038778435,0.0003726648,0.0030958676,0.0007357761,0.0000634273,0.003970868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744135,0.000108774024,0.00028100685,0.0005498867,0.00074606785,0.0008729062],"domain_scores_gemma":[0.998397,0.000184554,0.00006674959,0.00045527125,0.0005410633,0.00035537797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082405267,0.00018501011,0.00029175842,0.00028147674,0.00017696814,0.000059605456,0.00035679247,0.00008617513,0.0004996799],"category_scores_gemma":[0.00026934576,0.00016941379,0.00013372328,0.0006922281,0.00017130145,0.000012930831,0.00017731558,0.00016137683,0.000067515546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032574134,0.00023529006,0.0072791334,0.0010182767,0.0009796802,0.00005349148,0.00041175427,0.0005723604,0.86268216,0.00015180673,0.08609711,0.03726154],"study_design_scores_gemma":[0.0049482696,0.0018805992,0.039629627,0.00034294897,0.00008165221,0.0000020004745,0.0009480186,0.00009606592,0.8235856,0.00065454264,0.12726378,0.00056687323],"about_ca_topic_score_codex":0.010847201,"about_ca_topic_score_gemma":0.013253293,"teacher_disagreement_score":0.04116668,"about_ca_system_score_codex":0.00016760467,"about_ca_system_score_gemma":0.0008150028,"threshold_uncertainty_score":0.99573964},"labels":[],"label_agreement":null},{"id":"W4365513900","doi":"10.1158/1538-7445.am2023-ct029","title":"Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with <i>KRAS G12C</i> mutation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"KRAS; Cetuximab; Medicine; Colorectal cancer; Internal medicine; Cancer; Adverse effect; Rash; Oncology; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Toxicity","score_opus":0.054246663526332735,"score_gpt":0.4157220768474836,"score_spread":0.36147541332115085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509305,0.00017600467,6.517043e-7,0.00026163668,0.000033713066,0.0027710272,0.000038765866,0.00003513808,0.0015900418],"genre_scores_gemma":[0.99763495,0.00010668422,0.000010683653,0.000012798294,0.000022900907,0.0017347677,0.00004629716,0.00005169747,0.00037921334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977693,0.000080314334,0.00025722274,0.00042219707,0.0010292311,0.00044172522],"domain_scores_gemma":[0.9990419,0.00010228636,0.00009762483,0.00017323982,0.0004957509,0.00008919816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002927149,0.00018977848,0.0004315733,0.0005806648,0.000091283575,0.000018554352,0.00008648997,0.00004698831,0.0001374612],"category_scores_gemma":[0.00003078012,0.00012301494,0.000017882296,0.0020978379,0.00017726218,0.00012536247,0.00004427719,0.00032036216,0.0000065036834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018383136,0.005145707,0.955883,0.0001671104,0.00024405686,0.00026184475,0.0059287082,0.0002481267,0.00036251007,0.0000069953257,0.00023276037,0.013136038],"study_design_scores_gemma":[0.040920265,0.013876757,0.939538,0.00050182134,0.0000467139,0.0000011523732,0.0036056521,0.000048836075,0.0012533338,0.000007271257,0.000063881234,0.00013633656],"about_ca_topic_score_codex":0.010706818,"about_ca_topic_score_gemma":0.06097803,"teacher_disagreement_score":0.05027121,"about_ca_system_score_codex":0.00077668496,"about_ca_system_score_gemma":0.000449369,"threshold_uncertainty_score":0.99588096},"labels":[],"label_agreement":null},{"id":"W4365514035","doi":"10.1158/1538-7445.am2023-ct026","title":"Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; IDH1; Pharmacology; Myeloid; Oncology; Mutant; Chemistry","score_opus":0.09156463445167855,"score_gpt":0.4493115501688034,"score_spread":0.35774691571712486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365514035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501306,0.0006047062,8.6740295e-7,0.0007531632,0.00008289592,0.0030518814,0.000085102096,0.000045451005,0.00036289552],"genre_scores_gemma":[0.9971431,0.0009641669,0.000018797202,0.000016216893,0.000120340024,0.0010123407,0.000022955035,0.000067545436,0.0006345651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99484295,0.00024446368,0.001006528,0.0006881998,0.0020681515,0.0011497324],"domain_scores_gemma":[0.99753505,0.0005362511,0.00014757038,0.00083690445,0.00068427157,0.00025996717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003071157,0.00024436624,0.0008529569,0.0021162627,0.00011490151,0.000018020895,0.0005032814,0.00014957733,0.00042903752],"category_scores_gemma":[0.000813795,0.0002203437,0.000107345084,0.0039976956,0.00042906756,0.00014953598,0.00041775464,0.0011783026,0.00004381807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037101326,0.0033624447,0.05280917,0.001956999,0.00010400888,0.0018000656,0.0074566165,0.0006296821,0.9219706,0.000050199928,0.0012930398,0.004857048],"study_design_scores_gemma":[0.050791055,0.0080940835,0.39454362,0.0042206976,0.000038889484,0.000017140865,0.030147195,0.0008054411,0.50873315,0.0001647356,0.001946972,0.00049704587],"about_ca_topic_score_codex":0.005737454,"about_ca_topic_score_gemma":0.0031927053,"teacher_disagreement_score":0.41323745,"about_ca_system_score_codex":0.0015441744,"about_ca_system_score_gemma":0.0012497072,"threshold_uncertainty_score":0.89853555},"labels":[],"label_agreement":null},{"id":"W4365514037","doi":"10.1158/1538-7445.am2023-ct018","title":"Abstract CT018: Safety and efficacy of three PARP inhibitors (PARPi) combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor (ATRi) camonsertib in patients (pts) with solid tumors harboring DNA damage response (DDR) alterations","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Internal medicine; Tolerability; Response Evaluation Criteria in Solid Tumors; Neutropenia; Oncology; Phases of clinical research; Clinical trial; Chemotherapy; Adverse effect; Biology","score_opus":0.03680148951694935,"score_gpt":0.34670898946915435,"score_spread":0.309907499952205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365514037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993373,0.0004448257,0.0000044735502,0.0037987253,0.0000729914,0.0019960927,0.00012241809,0.00008214329,0.000105366664],"genre_scores_gemma":[0.99896324,0.00023981826,0.000028033372,0.000061374565,0.00009375629,0.00028852615,0.000068252375,0.00007633732,0.0001806701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967677,0.00037751917,0.0005959316,0.000590213,0.0009961613,0.00067247194],"domain_scores_gemma":[0.9975564,0.0009875391,0.00018400712,0.0005928753,0.0004003261,0.00027887532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018424173,0.0002901519,0.0005076481,0.00066493906,0.00038521743,0.00007154908,0.00018148196,0.00012556641,0.00006680909],"category_scores_gemma":[0.0003068174,0.00019672583,0.000046055648,0.0019807643,0.0008933921,0.00022284426,0.00013249762,0.0009000098,0.000010440539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19675888,0.0011047375,0.57811064,0.00082356646,0.00061600516,0.00070932414,0.009517597,0.0012961072,0.19909894,0.0001797289,0.0063820225,0.0054024477],"study_design_scores_gemma":[0.017396418,0.0021815426,0.9368607,0.0018940758,0.00004248073,0.000009844,0.00059170346,0.00021270575,0.03992884,0.00002842805,0.00058961543,0.0002636553],"about_ca_topic_score_codex":0.00053174986,"about_ca_topic_score_gemma":0.00079998525,"teacher_disagreement_score":0.35875005,"about_ca_system_score_codex":0.00040280624,"about_ca_system_score_gemma":0.00069934985,"threshold_uncertainty_score":0.8022247},"labels":[],"label_agreement":null},{"id":"W4365514056","doi":"10.1158/1538-7445.am2023-ct028","title":"Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; KRAS; Internal medicine; Neutropenia; Adverse effect; Cetuximab; Gastroenterology; Nausea; Oncology; Cancer; Colorectal cancer; Toxicity","score_opus":0.04016513602020642,"score_gpt":0.4080571464614021,"score_spread":0.3678920104411957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365514056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959292,0.0004300866,9.519495e-8,0.00031485147,0.000057550646,0.0028482748,0.000058842084,0.000032872063,0.0003282201],"genre_scores_gemma":[0.99833953,0.00023702491,0.00000490771,0.000014468509,0.000056847788,0.001143027,0.000018042187,0.000039935316,0.0001462245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972768,0.0000825688,0.00043157267,0.0006041582,0.00093095796,0.00067397277],"domain_scores_gemma":[0.99888945,0.0001486673,0.00009701926,0.00025691645,0.00043770237,0.00017026228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004068235,0.0002525289,0.0006845453,0.00065184914,0.00020320612,0.000020982767,0.00010506296,0.00005482527,0.000036781745],"category_scores_gemma":[0.00010068419,0.00018373429,0.00004153835,0.00152965,0.00019714881,0.00010935426,0.00015510154,0.00046674165,0.0000045599277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014471828,0.0073931525,0.9387887,0.0004679489,0.00045986508,0.0008495903,0.017138546,0.00016796478,0.006457466,0.000007234079,0.0003429913,0.013454693],"study_design_scores_gemma":[0.025988478,0.012598507,0.9502519,0.0007512656,0.00003891306,0.0000013721348,0.004836074,0.000022567923,0.0051989094,0.000030722735,0.00010113178,0.00018019977],"about_ca_topic_score_codex":0.0044024163,"about_ca_topic_score_gemma":0.012080418,"teacher_disagreement_score":0.013274494,"about_ca_system_score_codex":0.00095751515,"about_ca_system_score_gemma":0.00034356094,"threshold_uncertainty_score":0.74924666},"labels":[],"label_agreement":null},{"id":"W4365517014","doi":"10.1158/1538-7445.am2023-ct116","title":"Abstract CT116: First-in-human study of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced/metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Cancer research; Bone marrow; Pharmacodynamics; Internal medicine; Oncology; Pharmacokinetics","score_opus":0.04782754742602915,"score_gpt":0.4095079670512926,"score_spread":0.3616804196252635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365517014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982228,0.0001075749,6.0867563e-7,0.00010878681,0.000051384508,0.0013676907,0.00002478568,0.000028068705,0.000088278575],"genre_scores_gemma":[0.9994375,0.00027350264,0.0000073618357,0.000006019301,0.000018928038,0.000068446825,0.00009439646,0.000035201017,0.000058621306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976981,0.00012825773,0.0004032297,0.0004413191,0.00081516465,0.0005139009],"domain_scores_gemma":[0.9991592,0.00009702686,0.0000980208,0.0002636974,0.00021097953,0.00017103659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039321775,0.00016981766,0.00042386565,0.0008878501,0.0001111937,0.000024253404,0.00013144057,0.00007004495,0.00006894514],"category_scores_gemma":[0.00008458207,0.00012524985,0.000025724901,0.0012247415,0.00015472157,0.00017634897,0.00007448339,0.00047590182,0.0000051787842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055352575,0.0013786406,0.9709672,0.00054193055,0.000080074584,0.00011804401,0.0023058362,0.00007088719,0.022445025,0.0000026927348,0.00003221792,0.0015039581],"study_design_scores_gemma":[0.006890946,0.0023660634,0.9847844,0.0007040722,0.000020273998,0.000001018428,0.0021360128,0.00015464376,0.0027859793,0.000022938568,0.0000034792401,0.00013012956],"about_ca_topic_score_codex":0.0016392205,"about_ca_topic_score_gemma":0.001605746,"teacher_disagreement_score":0.019659046,"about_ca_system_score_codex":0.00012857732,"about_ca_system_score_gemma":0.00011529073,"threshold_uncertainty_score":0.51075405},"labels":[],"label_agreement":null},{"id":"W4366083364","doi":"10.1158/0008-5472.can-22-3004","title":"Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Ontario Brain Institute; Alberta Cancer Foundation; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Biglycan; Wnt signaling pathway; Biology; Versican; Extracellular matrix; Transcriptome; Cancer research; Cell biology; Phenotype; Tumor microenvironment; Brain tumor; Tumor progression; Signal transduction; Pathology; Proteoglycan; Genetics; Gene expression; Gene; Decorin; Medicine; Tumor cells","score_opus":0.05748118114609737,"score_gpt":0.3396568177715605,"score_spread":0.28217563662546313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366083364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977216,0.00036780728,0.00040251453,0.00015598445,0.00022707116,0.00015692691,0.00007257288,0.000022318403,0.000873188],"genre_scores_gemma":[0.9967423,0.00013317326,0.00005946065,0.000055311393,0.00028285355,0.000032061704,0.00011530149,0.000032757795,0.002546751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815506,0.00019564007,0.00029900356,0.00042345843,0.00046138803,0.00046544135],"domain_scores_gemma":[0.99902,0.00009427315,0.000081417726,0.0004066406,0.0002952308,0.00010248364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008287871,0.00012952618,0.00023162486,0.00037411187,0.0001480735,0.00004952546,0.0003271963,0.00011042892,0.00011079321],"category_scores_gemma":[0.00013286543,0.00013180204,0.00019709433,0.0013092363,0.00022438877,0.000005303466,0.00015248072,0.00018026136,0.000020541176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007060943,0.000057849244,0.00568273,0.00008687379,0.00015355989,0.000007362688,0.00018703821,0.000713292,0.98843825,0.0000071458117,0.0035450172,0.0010502593],"study_design_scores_gemma":[0.00032930533,0.00014817981,0.0021091998,0.000022008358,0.000047818266,3.7931537e-7,0.00024579206,0.0004476725,0.993545,0.000046021272,0.0029164855,0.0001421502],"about_ca_topic_score_codex":0.0012040591,"about_ca_topic_score_gemma":0.0009103842,"teacher_disagreement_score":0.005106725,"about_ca_system_score_codex":0.00003714193,"about_ca_system_score_gemma":0.000162882,"threshold_uncertainty_score":0.5374731},"labels":[],"label_agreement":null},{"id":"W4366716888","doi":"10.1158/1538-7445.am2023-lb078","title":"Abstract LB078: pbfusion: Detecting gene-fusion and other transcriptional abnormalities using PacBio HiFi data","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Fusion transcript; Exon; Computational biology; Gene; Genetics; Fusion gene; DNA sequencing; Genome; Breakpoint; Chromosomal translocation","score_opus":0.22522884018247485,"score_gpt":0.45742830112032595,"score_spread":0.2321994609378511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366716888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996183,0.0014352682,0.0010181189,0.00037901962,0.000047118097,0.00023727516,0.00027782327,0.00003707265,0.0003853248],"genre_scores_gemma":[0.99627656,0.0015646797,0.00089009205,0.00015638412,0.00028216987,0.000090468886,0.00031367646,0.000028026932,0.00039794075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987994,0.000073394505,0.00014509902,0.00045946206,0.00018989804,0.00033276534],"domain_scores_gemma":[0.9992498,0.000020583217,0.00003091526,0.00052941835,0.00009279216,0.00007646446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008043956,0.00010009627,0.00008567599,0.00008899509,0.00037780797,0.0000401049,0.0003340843,0.00015478447,0.00009601706],"category_scores_gemma":[0.000040095514,0.00009348005,0.000030366456,0.00021383876,0.00020272745,0.000006075167,0.00042576052,0.00018751541,0.000008659733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002701358,0.000010195301,0.0008225263,0.000021829977,0.000017219681,0.0000033104295,0.000031515494,0.0000139035965,0.9934848,0.00020357454,0.0013589396,0.004005185],"study_design_scores_gemma":[0.00036747122,0.00009428576,0.0072253835,0.00006202733,0.000012589055,0.00003598193,0.00028483488,0.0006805171,0.7378547,0.00070200115,0.25238588,0.0002943072],"about_ca_topic_score_codex":0.0004905018,"about_ca_topic_score_gemma":0.00013556617,"teacher_disagreement_score":0.25563008,"about_ca_system_score_codex":0.00001996279,"about_ca_system_score_gemma":0.0001162689,"threshold_uncertainty_score":0.38120058},"labels":[],"label_agreement":null},{"id":"W4366716971","doi":"10.1158/1538-7445.am2023-lb127","title":"Abstract LB127: VAL-083 in patients with recurrent glioblastoma treated under expanded access program","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Medicine; Lomustine; Internal medicine; Oncology; Clinical trial; Adjuvant; Glioblastoma; Progression-free survival; Radiation therapy; Expanded access; Surgery; Chemotherapy; Cancer research; Vincristine","score_opus":0.11495776121690891,"score_gpt":0.46332187803037383,"score_spread":0.3483641168134649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366716971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957355,0.0001687417,1.1342745e-7,0.0013292524,0.00007417956,0.0020413895,0.000027713568,0.00014196445,0.00048110547],"genre_scores_gemma":[0.9970046,0.00023819807,0.00000917783,0.000028516073,0.000062983156,0.0022777445,0.000103675186,0.000041790645,0.00023330595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976052,0.000067469235,0.00021682255,0.0004540197,0.000944735,0.0007117402],"domain_scores_gemma":[0.99889153,0.000115207375,0.00004053904,0.00034943316,0.00035606013,0.0002472576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028252104,0.00017812544,0.0002839006,0.0006293579,0.00009827688,0.000094192015,0.00016446976,0.000082643426,0.00034876756],"category_scores_gemma":[0.000038982034,0.00010571116,0.000054975008,0.002072044,0.00011037747,0.00012209751,0.00010564829,0.0003493361,0.00015848225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032185016,0.0026823701,0.86076677,0.00014792285,0.00016039962,0.0003269456,0.00017986294,0.000060620474,0.00022892434,0.000013638892,0.0057173017,0.12649672],"study_design_scores_gemma":[0.0066039064,0.0020908278,0.98429084,0.00055866665,0.000023431672,0.0000011816301,0.00008721652,0.000029078745,0.005160887,0.000042200394,0.0009900162,0.00012174281],"about_ca_topic_score_codex":0.0007445151,"about_ca_topic_score_gemma":0.00089980266,"teacher_disagreement_score":0.12637497,"about_ca_system_score_codex":0.0005688734,"about_ca_system_score_gemma":0.00024860486,"threshold_uncertainty_score":0.4310776},"labels":[],"label_agreement":null},{"id":"W4378745836","doi":"10.1158/0008-5472.can-22-3713","title":"A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Cancer Institute; National Institute on Aging; Deutsche Krebshilfe; School of Public Health, Imperial College London; Cancer Research UK; Wageningen University and Research; National Institute for Health and Care Research; Agència de Gestió d'Ajuts Universitaris i de Recerca; Ontario Ministry of Research and Innovation; National Health and Medical Research Council; National Institute of Diabetes and Digestive and Kidney Diseases; World Cancer Research Fund; Medical Research Council; Centers for Disease Control and Prevention; National Institutes of Health; Instituto de Salud Carlos III; World Health Organization; Xarxa de Bancs de Tumors de Catalunya; Junta de Castilla y León; Grantová Agentura České Republiky; Herzfelder'sche Familienstiftung; Institut Gustave-Roussy; National Human Genome Research Institute; Cancer Council Victoria; Associazione Italiana per la Ricerca sul Cancro; Vetenskapsrådet; Mutuelle Générale de l'Education Nationale; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Ministerstvo Zdravotnictví Ceské Republiky; Canadian Institutes of Health Research; Cancerfonden; NIHR Imperial Biomedical Research Centre; Johns Hopkins University; Centre International de Recherche sur le Cancer; Canadian Cancer Society Research Institute; Institut National de la Santé et de la Recherche Médicale; Food Standards Agency; Harvard T.H. Chan School of Public Health; Génome Québec; Univerzita Karlova v Praze; McGill University; University of Pittsburgh; Ligue Contre le Cancer; Deutsches Krebsforschungszentrum; Fred Hutchinson Cancer Research Center; Imperial College London; U.S. Department of Health and Human Services; Office of Research Infrastructure Programs, National Institutes of Health; American Institute for Cancer Research; Damon Runyon Cancer Research Foundation; Brigham and Women's Hospital; American Cancer Society","keywords":"Colorectal cancer; Locus (genetics); Body mass index; Gene; Biology; Cancer; Medicine; Oncology; Genetics; Cancer research; Internal medicine","score_opus":0.03687123721568086,"score_gpt":0.3670161089392511,"score_spread":0.3301448717235702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378745836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960696,0.0012655878,0.00022832533,0.0015375778,0.00017778177,0.00046580707,0.000030827938,0.000014879748,0.00020962495],"genre_scores_gemma":[0.9939389,0.0037883315,0.000091774855,0.00012001938,0.00035425206,0.00075321575,0.00002938933,0.000036730482,0.0008873725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976286,0.000643321,0.0002709672,0.0005050009,0.00030213123,0.00064992456],"domain_scores_gemma":[0.9990369,0.00012415736,0.00012883407,0.00035841062,0.0002476193,0.00010407587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012038437,0.0001578893,0.00019883184,0.00015901646,0.00022216272,0.00003452667,0.000389877,0.0001994864,0.000032014384],"category_scores_gemma":[0.00035604034,0.00010961491,0.00005080758,0.00078044785,0.00026959556,0.0000038969797,0.00019558473,0.00051540165,0.000026460722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047863505,0.000032973552,0.7580173,0.000018740822,0.00013662911,0.000044188,0.00035613048,0.015812362,0.2111225,0.000012038263,0.010968099,0.0030004291],"study_design_scores_gemma":[0.0010230542,0.0004015093,0.9384638,0.00005709958,0.000018612991,0.000016036698,0.0006019192,0.004010973,0.051851798,0.0004472644,0.002852522,0.0002553956],"about_ca_topic_score_codex":0.0045926347,"about_ca_topic_score_gemma":0.010713066,"teacher_disagreement_score":0.18044654,"about_ca_system_score_codex":0.0001690151,"about_ca_system_score_gemma":0.00054804015,"threshold_uncertainty_score":0.69427204},"labels":[],"label_agreement":null},{"id":"W4378781378","doi":"10.1158/0008-5472.can-22-2319","title":"Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; Genome Canada; Canadian Institutes of Health Research; Fondation du cancer du sein du Québec; Ontario Research Foundation; Breast Cancer Research Foundation","keywords":"Missense mutation; Breast cancer; Ovarian cancer; Biology; Clinical significance; Cancer research; Olaparib; Genetics; DNA repair; Internal medicine; Medicine; Cancer; Gene; Mutation; Polymerase; Poly ADP ribose polymerase","score_opus":0.27271650083026494,"score_gpt":0.5002358237862455,"score_spread":0.2275193229559806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378781378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968184,0.000094840965,0.00047633238,0.0012806832,0.00024033274,0.0008534739,0.0001404596,0.000019346693,0.00007611186],"genre_scores_gemma":[0.9975208,0.00090736576,0.00014017978,0.000055403554,0.0002444115,0.00031074663,0.0000701817,0.00002433988,0.0007265597],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980564,0.0002289894,0.00059000205,0.00034197012,0.0004888052,0.0002938012],"domain_scores_gemma":[0.9979723,0.0009869261,0.00017727214,0.00021122475,0.00056757004,0.00008471305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025218092,0.000091351045,0.00036193721,0.00042941494,0.00006756886,0.000012162183,0.000074626456,0.00010904075,0.00014158401],"category_scores_gemma":[0.00092755485,0.00008997574,0.000056297973,0.0010978106,0.0002982135,0.00011674852,0.000042078736,0.0002693492,0.0000032072774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00256657,0.000119881035,0.027483892,0.00055632566,0.00007135273,0.0000147062965,0.00044613116,0.000020212154,0.96248984,0.00028986498,0.0006889499,0.0052522807],"study_design_scores_gemma":[0.0040135207,0.00034103973,0.88495964,0.00091004244,0.000015514748,0.0000066731036,0.00044438348,0.0013559113,0.10671916,0.00086629373,0.0002712756,0.00009657064],"about_ca_topic_score_codex":0.00028354622,"about_ca_topic_score_gemma":0.000030529805,"teacher_disagreement_score":0.8574757,"about_ca_system_score_codex":0.00015728465,"about_ca_system_score_gemma":0.00060842204,"threshold_uncertainty_score":0.36691043},"labels":[],"label_agreement":null},{"id":"W4379107137","doi":"10.1158/1538-7445.prca2023-b048","title":"Abstract B048: Performance of diagnostic biomarkers in the Canary Prostate cancer Active Surveillance Study (PASS)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biomarker; Prostate cancer; Medicine; Prostate biopsy; Receiver operating characteristic; Biopsy; Oncology; Proportional hazards model; Internal medicine; Prostate; Cancer","score_opus":0.0954286920670956,"score_gpt":0.44263827012801205,"score_spread":0.34720957806091646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379107137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873129,0.0030376988,3.1326834e-8,0.0048108473,0.00015917096,0.0034106022,0.00019193394,0.00004055162,0.0010362339],"genre_scores_gemma":[0.97877914,0.016789377,0.0000015547354,0.00004353709,0.00013933571,0.003177353,0.00005170671,0.000041231124,0.0009767833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606615,0.00039466325,0.00037871816,0.0005286174,0.0015982442,0.0010336306],"domain_scores_gemma":[0.9968339,0.0018238019,0.0000799339,0.0005725129,0.00051870587,0.00017110926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002797472,0.00021033591,0.0004031179,0.00065936707,0.0002395962,0.00003620978,0.00044452926,0.00008041601,0.00026537516],"category_scores_gemma":[0.00053737435,0.0001349367,0.0000728311,0.0034546293,0.00046623708,0.0001461813,0.00016148986,0.00084128225,0.00005542326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030725107,0.00055057544,0.94275904,0.00060291233,0.0003916472,0.00060283643,0.006333415,0.00011830996,0.006484804,0.0000033117494,0.0076050772,0.031475544],"study_design_scores_gemma":[0.0028417238,0.0007656062,0.9839152,0.0004321853,0.000019530436,0.0000034547795,0.0068608196,0.000111553796,0.0037831108,0.000015069445,0.0011146315,0.00013710916],"about_ca_topic_score_codex":0.02028825,"about_ca_topic_score_gemma":0.007980916,"teacher_disagreement_score":0.041156147,"about_ca_system_score_codex":0.0007615743,"about_ca_system_score_gemma":0.0016651204,"threshold_uncertainty_score":0.98623574},"labels":[],"label_agreement":null},{"id":"W4379142547","doi":"10.1158/1538-7445.prca2023-b012","title":"Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epigenomics; Prostate cancer; PTEN; Androgen receptor; DNA methylation; Cancer research; Epigenome; Biology; Copy number analysis; Epigenetics; Cancer; Genetics; Gene; Genome; PI3K/AKT/mTOR pathway; Copy-number variation; Gene expression","score_opus":0.14173364227613844,"score_gpt":0.4509753376702075,"score_spread":0.30924169539406904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379142547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880844,0.005854172,5.24028e-7,0.0026646126,0.00011924428,0.0017797594,0.0002665098,0.000057572506,0.0011732563],"genre_scores_gemma":[0.9630777,0.027314056,0.000053639193,0.000026015023,0.000112730646,0.0008243577,0.00005554442,0.000056595945,0.0084793465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99734825,0.00009195949,0.0003231754,0.00052378187,0.0008161913,0.000896653],"domain_scores_gemma":[0.9984215,0.00029640546,0.00008398663,0.00033815915,0.0005047584,0.00035520774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009929342,0.00020015158,0.00045577346,0.0006713391,0.00022932733,0.000042047126,0.00018584638,0.00006982275,0.0007627757],"category_scores_gemma":[0.000056736266,0.00015734059,0.00008838307,0.0011758206,0.0007956687,0.00013037768,0.00020819825,0.000558681,0.00016696239],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00824096,0.00024309191,0.08974308,0.0029466487,0.0015977359,0.0006078476,0.01170716,0.00025889484,0.8348844,0.00033317046,0.01285754,0.036579475],"study_design_scores_gemma":[0.0218087,0.001056475,0.6199989,0.001257892,0.00025506606,0.000016545946,0.0061796336,0.00023069029,0.3361816,0.0015826041,0.010878517,0.0005534014],"about_ca_topic_score_codex":0.0036531228,"about_ca_topic_score_gemma":0.0003416359,"teacher_disagreement_score":0.5302558,"about_ca_system_score_codex":0.00069445005,"about_ca_system_score_gemma":0.001595687,"threshold_uncertainty_score":0.83518595},"labels":[],"label_agreement":null},{"id":"W4379144020","doi":"10.1158/1538-7445.prca2023-a037","title":"Abstract A037: Kinase GRK3 connects angiogenesis and neuroendocrine differentiation in prostate cancer progression by enhancing epigenetic activity of HDAC2","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Angiogenesis; Cancer research; Cancer; Biology; Medicine; Epigenetics; Bioinformatics; Internal medicine; Genetics; Gene","score_opus":0.059532009574431645,"score_gpt":0.42324376671507125,"score_spread":0.3637117571406396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379144020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858796,0.009746493,0.000001268452,0.002601763,0.00009351186,0.0014578504,0.00011815863,0.000046841207,0.000054523796],"genre_scores_gemma":[0.9725693,0.025298584,0.000006481637,0.000013742021,0.000071182374,0.00097370514,0.00006729156,0.000044325454,0.0009553878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973889,0.00017456683,0.0002755672,0.00052892615,0.0008350704,0.0007969407],"domain_scores_gemma":[0.9988939,0.00023626725,0.00008162744,0.0002696533,0.00027353657,0.00024500597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005106417,0.00018403906,0.00036598975,0.00058718823,0.00014227981,0.00003459793,0.00010887802,0.00005136713,0.00015909757],"category_scores_gemma":[0.00014273445,0.00014688238,0.000057904334,0.0013199992,0.0002470521,0.00012462446,0.00016274578,0.00038651968,0.00000883554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012732574,0.00019989263,0.131565,0.001138708,0.000057645924,0.00021260437,0.00036733627,0.0000121049,0.7945053,0.000002991797,0.0008129896,0.069852136],"study_design_scores_gemma":[0.001962642,0.00027539342,0.35322165,0.0006149199,0.00001973116,0.0000026059306,0.00010215283,0.00015638543,0.64325,0.00003985247,0.0002580797,0.000096608164],"about_ca_topic_score_codex":0.0023064131,"about_ca_topic_score_gemma":0.0007387427,"teacher_disagreement_score":0.22165667,"about_ca_system_score_codex":0.00035735255,"about_ca_system_score_gemma":0.0004616565,"threshold_uncertainty_score":0.5989689},"labels":[],"label_agreement":null},{"id":"W4379160459","doi":"10.1158/1538-7445.prca2023-ia006","title":"Abstract IA006: Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Primary tumor; Genotyping; PTEN; Metastasis; Oncology; Cancer; Exome sequencing; Internal medicine; Biology; Gene; Genotype; Mutation; Genetics","score_opus":0.48387487464407114,"score_gpt":0.5867622778331104,"score_spread":0.10288740318903927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379160459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825875,0.003438444,0.000012073624,0.009426332,0.0003024055,0.0031433136,0.00043726005,0.00010421988,0.00054841384],"genre_scores_gemma":[0.98291725,0.0077269436,0.00021602112,0.00023708402,0.00049476046,0.0029632836,0.00022745517,0.00008040385,0.005136808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957546,0.0002846458,0.00072388386,0.0007624298,0.0009789253,0.0014955037],"domain_scores_gemma":[0.9972274,0.0012608189,0.000098486955,0.0004407442,0.0005670793,0.00040552026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046768393,0.00023376176,0.0006354482,0.00058770954,0.00032296864,0.00009491489,0.0002845919,0.000115300354,0.0007353766],"category_scores_gemma":[0.00056746544,0.00018922365,0.00020585199,0.0016541696,0.00042671728,0.00018468681,0.00021163771,0.0009936837,0.000115390685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01859838,0.0010385199,0.54193425,0.0053723757,0.0013284788,0.0011579891,0.002947972,0.00051138416,0.10646858,0.00049141975,0.086304404,0.23384622],"study_design_scores_gemma":[0.011015024,0.00043399175,0.92994297,0.0010198809,0.00007118444,0.000005578182,0.00085979287,0.0026756355,0.005786903,0.0014441392,0.04637241,0.00037247973],"about_ca_topic_score_codex":0.0034871066,"about_ca_topic_score_gemma":0.0015259334,"teacher_disagreement_score":0.3880087,"about_ca_system_score_codex":0.0009422471,"about_ca_system_score_gemma":0.0020751806,"threshold_uncertainty_score":0.80518585},"labels":[],"label_agreement":null},{"id":"W4379160699","doi":"10.1158/1538-7445.prca2023-b015","title":"Abstract B015: HOXA9 promotes enzalutamide resistance in RB-p53 deficient prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; Lawson Health Research Institute; Western University","funders":"","keywords":"LNCaP; Enzalutamide; Biology; Cancer research; Prostate cancer; CRISPR; Gene; Cancer; Androgen receptor; Genetics","score_opus":0.11796973676142204,"score_gpt":0.4522466675357946,"score_spread":0.3342769307743726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379160699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616845,0.01925738,5.001834e-7,0.010727955,0.00024267896,0.0024123609,0.00020361197,0.00019085423,0.0052801324],"genre_scores_gemma":[0.9432074,0.015102518,0.00004750785,0.00010570199,0.00030417374,0.003285878,0.00011006737,0.00009737268,0.037739374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458385,0.000179008,0.00047997618,0.0009411956,0.0018954014,0.0019205722],"domain_scores_gemma":[0.99783295,0.00030728598,0.00007145057,0.0006638545,0.0006704366,0.0004540195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021417604,0.00029892646,0.0004891373,0.0010953008,0.00032842325,0.0001185312,0.00037298625,0.00017467387,0.00081131794],"category_scores_gemma":[0.00026467326,0.00023845745,0.000119692995,0.0037502148,0.00051215873,0.00019067599,0.00025062743,0.0012681049,0.00048234392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010546645,0.0013386791,0.4325301,0.006845983,0.0004898897,0.004437788,0.0119004315,0.00034196748,0.3576652,0.00096043595,0.118784264,0.054158606],"study_design_scores_gemma":[0.009072237,0.0005638046,0.75592935,0.0052859974,0.000050082515,0.00000873453,0.0019417488,0.00018793167,0.116560414,0.002285475,0.107340075,0.00077412743],"about_ca_topic_score_codex":0.002699314,"about_ca_topic_score_gemma":0.0057755904,"teacher_disagreement_score":0.32339928,"about_ca_system_score_codex":0.0019024011,"about_ca_system_score_gemma":0.0023478216,"threshold_uncertainty_score":0.97240126},"labels":[],"label_agreement":null},{"id":"W4379160823","doi":"10.1158/1538-7445.prca2023-b046","title":"Abstract B046: Multimodal biomarkers that predict the presence of Gleason pattern 4: Potential impact for active surveillance","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Western University; McGill University; London Health Sciences Centre; Queen's University; Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Cohort; Prostate cancer; Medicine; Oncology; DNA methylation; Internal medicine; Cancer; Biopsy; Biology; Gene; Gene expression; Genetics","score_opus":0.08602895832986038,"score_gpt":0.4304992085937567,"score_spread":0.3444702502638963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379160823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003386,0.0016586157,0.00005472992,0.0039169313,0.0002626534,0.0023303132,0.0015403426,0.00004915916,0.00015338781],"genre_scores_gemma":[0.99467844,0.0032545547,0.000013279159,0.000029224464,0.00024554107,0.0014436403,0.00013165073,0.000038372877,0.00016527434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773824,0.000111506015,0.0002087037,0.00041721648,0.0008342204,0.0006900925],"domain_scores_gemma":[0.99793947,0.0008703835,0.000096796895,0.0004723094,0.0004326448,0.00018839238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095506274,0.00017025425,0.000306272,0.00016503608,0.00018800674,0.0000370303,0.00025673237,0.000084001906,0.00023988808],"category_scores_gemma":[0.0002368119,0.0001037915,0.00022074928,0.0005314714,0.0003281287,0.000098103286,0.00011268896,0.0002766826,0.000020440059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063423505,0.00049903995,0.53814346,0.0010047345,0.002003852,0.00012737112,0.0014417254,0.00068974786,0.04961489,0.0000084990315,0.06876734,0.33135697],"study_design_scores_gemma":[0.002443308,0.0006496185,0.9468413,0.00033308577,0.00003471822,0.0000041870126,0.0004998414,0.0014241801,0.046235487,0.000056466564,0.0013723203,0.00010550876],"about_ca_topic_score_codex":0.004638609,"about_ca_topic_score_gemma":0.00023994168,"teacher_disagreement_score":0.4086978,"about_ca_system_score_codex":0.0004449274,"about_ca_system_score_gemma":0.0005599667,"threshold_uncertainty_score":0.701222},"labels":[],"label_agreement":null},{"id":"W4379160843","doi":"10.1158/1538-7445.prca2023-a047","title":"Abstract A047: Panorama of complex structural variants in primary localized prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Chromothripsis; PTEN; Cancer; Biology; Computational biology; Disease; Chromoplexy; Genetics; Medicine; Internal medicine; PCA3; DNA; DNA damage; Genome instability","score_opus":0.13376762748070392,"score_gpt":0.4569883562943501,"score_spread":0.32322072881364616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379160843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98951745,0.0027523756,4.6787886e-7,0.0030880326,0.00015861953,0.0015512137,0.00025281485,0.00007023657,0.002608773],"genre_scores_gemma":[0.9882713,0.004613951,0.00004551936,0.00008241055,0.0001718635,0.00065303274,0.0002190062,0.000053940028,0.005888997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964008,0.00015910275,0.00045443396,0.0005202714,0.0013537132,0.0011117344],"domain_scores_gemma":[0.9984381,0.00021053161,0.0000745934,0.00043803983,0.0005578457,0.0002808401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010495236,0.00020203125,0.0005584284,0.0007594344,0.00016601046,0.000054637418,0.0002761774,0.00013107587,0.002335231],"category_scores_gemma":[0.00010013506,0.00015481931,0.000094326075,0.002356123,0.0006478666,0.00013854173,0.00022315008,0.0007524436,0.00009719947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008328584,0.00025999793,0.37921235,0.0034088467,0.0003806077,0.0011378566,0.0028812748,0.00028401724,0.4817713,0.00012293123,0.024717491,0.097494744],"study_design_scores_gemma":[0.0068773828,0.00027248595,0.9682239,0.0007686327,0.000019243296,0.000005052636,0.00039230456,0.00045490332,0.016471315,0.00043255746,0.005895819,0.00018635753],"about_ca_topic_score_codex":0.006303698,"about_ca_topic_score_gemma":0.00052238215,"teacher_disagreement_score":0.5890116,"about_ca_system_score_codex":0.0010486386,"about_ca_system_score_gemma":0.0023743904,"threshold_uncertainty_score":0.99857676},"labels":[],"label_agreement":null},{"id":"W4379160884","doi":"10.1158/1538-7445.prca2023-b073","title":"Abstract B073: Inhibiting prostate cancer by targeting the metabolic mevalonate pathway","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mevalonate pathway; LNCaP; Statin; Prostate cancer; Medicine; Pharmacology; Cancer research; Fluvastatin; Cholesterol; Cancer; Sterol regulatory element-binding protein; Biology; Simvastatin; Internal medicine; Biosynthesis; Sterol; Biochemistry; Enzyme","score_opus":0.038429670572629804,"score_gpt":0.36374594438588326,"score_spread":0.32531627381325345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379160884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9156384,0.076487504,0.0000068063073,0.0020167248,0.003469689,0.0006370664,0.00042491502,0.00006195188,0.0012569756],"genre_scores_gemma":[0.92591935,0.048209477,0.000012819687,0.00046538774,0.014603615,0.0012483113,0.0002216227,0.00009606794,0.009223316],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971794,0.00020315303,0.00030758407,0.0006178486,0.0006477461,0.0010442627],"domain_scores_gemma":[0.998874,0.00006684597,0.00009365685,0.0004063482,0.00038280434,0.00017634814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020781592,0.00021574773,0.00022750779,0.000110433255,0.00054499944,0.0001207844,0.00046938178,0.00013978619,0.00018255749],"category_scores_gemma":[0.00023934398,0.0001621425,0.00012612742,0.00072348677,0.00027321378,0.00001306421,0.00035031064,0.0005350418,0.000076413045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007640973,0.000012349425,0.00042648017,0.000039678544,0.000062973326,4.1409587e-7,0.00024377409,0.00011545767,0.724506,0.00008215064,0.25150818,0.022926133],"study_design_scores_gemma":[0.00036834032,0.000023347053,0.0013815502,0.000032764314,0.000010179626,6.9424044e-7,0.0003747849,0.00001760787,0.27510113,0.000089289366,0.7224342,0.00016611721],"about_ca_topic_score_codex":0.0019320148,"about_ca_topic_score_gemma":0.00048145113,"teacher_disagreement_score":0.47092602,"about_ca_system_score_codex":0.000049155617,"about_ca_system_score_gemma":0.00062002667,"threshold_uncertainty_score":0.66119796},"labels":[],"label_agreement":null},{"id":"W4379768595","doi":"10.1158/0008-5472.can-23-0593","title":"The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"University of California, San Francisco; Movember Foundation; National Cancer Institute; Prostate Cancer Foundation; American Association for Cancer Research; Stand Up To Cancer; U.S. Department of Defense","keywords":"Prostate cancer; Androgen receptor; Epigenomics; Biology; DNA methylation; Cancer research; Epigenetics; PTEN; Androgen deprivation therapy; Cancer; Genetics; Gene; PI3K/AKT/mTOR pathway; Gene expression","score_opus":0.06860340805537776,"score_gpt":0.41148345188611163,"score_spread":0.3428800438307339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087965,0.006865839,0.000002534585,0.0009738014,0.00009170178,0.0006663219,0.0001648403,0.000009790652,0.00034552536],"genre_scores_gemma":[0.9741568,0.019548047,0.00001530027,0.000014996175,0.0001236469,0.0005366286,0.000031130137,0.000037531212,0.005535893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809396,0.00023400057,0.00020424085,0.00038776448,0.00041888337,0.0006611203],"domain_scores_gemma":[0.9988587,0.00017994658,0.000054926008,0.00039650153,0.00037700485,0.00013293345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012840764,0.00012369502,0.00016284871,0.0001455122,0.00026779683,0.00006561684,0.00039782614,0.000060425886,0.00008690625],"category_scores_gemma":[0.00014428224,0.000087746324,0.000049120914,0.0005068594,0.00054448075,0.0000053514923,0.000493817,0.00027343174,0.00003550968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078524376,0.00001526737,0.016994378,0.00010385572,0.0001888815,0.000005616509,0.0005149953,0.00012842166,0.96382964,0.000082103055,0.010022462,0.0073291617],"study_design_scores_gemma":[0.0023861805,0.00040615888,0.044960734,0.000056647987,0.0000198152,0.0000036833885,0.0018093842,0.00021254804,0.90094215,0.0005890395,0.048343822,0.00026981716],"about_ca_topic_score_codex":0.0013598512,"about_ca_topic_score_gemma":0.001588695,"teacher_disagreement_score":0.062887445,"about_ca_system_score_codex":0.00007151161,"about_ca_system_score_gemma":0.00070850324,"threshold_uncertainty_score":0.3578191},"labels":[],"label_agreement":null},{"id":"W4379983361","doi":"10.1158/1538-7445.am2023-3387","title":"Abstract 3387: ctDNA dynamics in early stage node negative lung cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Circulating tumor DNA; Stage (stratigraphy); Internal medicine; Lung cancer; Occult; Oncology; Prospective cohort study; Lung; Primary tumor; Gastroenterology; Cancer; Surgery; Metastasis; Pathology","score_opus":0.03800442296135572,"score_gpt":0.38232815850931773,"score_spread":0.34432373554796203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935079,0.0008063256,0.00002442576,0.00055733573,0.00033479955,0.00035302844,0.00046043383,0.00001799455,0.003937748],"genre_scores_gemma":[0.99114186,0.0053014103,0.00003441296,0.00012105849,0.00033699017,0.0002600128,0.00014577628,0.00004825243,0.0026102476],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981965,0.00005822085,0.00021097025,0.0004875289,0.0003371451,0.0007096624],"domain_scores_gemma":[0.9990922,0.00011294216,0.000045550976,0.00040364795,0.00019277453,0.00015288936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005691151,0.00014787643,0.00015711495,0.00021914787,0.0001245932,0.000071702816,0.00035413535,0.00015243806,0.00009443627],"category_scores_gemma":[0.00025310647,0.00016038418,0.00006209493,0.0006704647,0.00018120061,0.000006605645,0.00026922216,0.00038469755,0.00005432067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001495628,0.00018061628,0.29935947,0.0005631236,0.0003448383,0.00040320426,0.002178728,0.038332272,0.50868946,0.0030506365,0.12526183,0.020140193],"study_design_scores_gemma":[0.005876661,0.0007316249,0.5636256,0.00046447688,0.00002929972,0.0000034093844,0.0052087666,0.016061734,0.27899036,0.001495485,0.12563322,0.0018793775],"about_ca_topic_score_codex":0.016105238,"about_ca_topic_score_gemma":0.028089762,"teacher_disagreement_score":0.26426613,"about_ca_system_score_codex":0.0010123154,"about_ca_system_score_gemma":0.0009621722,"threshold_uncertainty_score":0.9904466},"labels":[],"label_agreement":null},{"id":"W4379983432","doi":"10.1158/1538-7445.am2023-1413","title":"Abstract 1413: Chromosome arm aneuploidies as genetic vulnerabilities of triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University; Concordia University","funders":"","keywords":"Copy-number variation; Triple-negative breast cancer; Breast cancer; Gene duplication; Biology; Comparative genomic hybridization; Cancer research; Cancer; Gene; Genetics; Oncology; Medicine; Chromosome; Genome","score_opus":0.04326291852615955,"score_gpt":0.3720420171759911,"score_spread":0.32877909864983157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910511,0.005244598,0.0000029330931,0.00077709736,0.00040181354,0.00039890435,0.0011192178,0.000019979856,0.000984395],"genre_scores_gemma":[0.97059,0.02534087,0.000027311084,0.00010253715,0.00076379016,0.0004876224,0.000055676843,0.000049089173,0.0025830816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807763,0.00008283803,0.00029995767,0.0004981023,0.00043713028,0.00060433376],"domain_scores_gemma":[0.9985641,0.00016431013,0.00008338783,0.000467818,0.0005599404,0.00016039635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004252603,0.00018328997,0.00025062406,0.00017777248,0.00017346891,0.00004367868,0.00036909943,0.00014526561,0.00078156637],"category_scores_gemma":[0.0003243023,0.00017778506,0.00011052191,0.0004981082,0.0005113453,0.0000062521226,0.0002840208,0.00025827257,0.000057978923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005397809,0.00013949678,0.006330715,0.0003468167,0.00022145339,0.000029041956,0.0006556668,0.00183887,0.9311886,0.00022072035,0.043183442,0.015305401],"study_design_scores_gemma":[0.0014947734,0.00062281726,0.141606,0.00016687944,0.000029732044,0.000017110031,0.0013228101,0.00006717031,0.8226128,0.0022318226,0.029325543,0.00050253834],"about_ca_topic_score_codex":0.0061996607,"about_ca_topic_score_gemma":0.0021876146,"teacher_disagreement_score":0.13527529,"about_ca_system_score_codex":0.00013516609,"about_ca_system_score_gemma":0.0009678554,"threshold_uncertainty_score":0.9372074},"labels":[],"label_agreement":null},{"id":"W4379983442","doi":"10.1158/1538-7445.am2023-2658","title":"Abstract 2658: ZW251, a novel glypican-3-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Glypican 3; Antibody; Flow cytometry; Cell culture; Immunoconjugate; Antibody-drug conjugate; Internalization; Molecular biology; Monoclonal antibody; Chemistry; Camptothecin; Cytotoxicity; Cancer research; Cell; In vitro; Biology; Hepatocellular carcinoma; Biochemistry; Immunology","score_opus":0.09549190664465584,"score_gpt":0.4433106334636574,"score_spread":0.34781872681900156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799216,0.0018080388,0.000007798913,0.012552677,0.00034844785,0.00084619835,0.00015459115,0.00021944515,0.004141215],"genre_scores_gemma":[0.9761893,0.0025577657,0.00017907405,0.00032664396,0.0018508383,0.0002462084,0.00022264903,0.000086083644,0.01834145],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.994766,0.00012234063,0.0005361216,0.0007977599,0.0020277132,0.0017500495],"domain_scores_gemma":[0.9973527,0.0006413407,0.000073218296,0.0004895984,0.00069824717,0.00074485],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023302312,0.00029862922,0.0005268806,0.00072301325,0.0006548107,0.00015975723,0.00041850633,0.00014398199,0.0014060681],"category_scores_gemma":[0.0005959266,0.00024505996,0.00021654807,0.0018228969,0.0005072147,0.00019774912,0.0005551964,0.0016915628,0.0015335362],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011297197,0.00021252726,0.017532187,0.00084908854,0.00015717426,0.00072585547,0.000886217,0.000024894194,0.9350326,0.00037516054,0.035385087,0.0076894914],"study_design_scores_gemma":[0.0071083163,0.0007218741,0.20353688,0.0027110684,0.000069205926,0.000103060134,0.003454649,0.002268493,0.38437966,0.0006587729,0.3937413,0.0012467054],"about_ca_topic_score_codex":0.0058268583,"about_ca_topic_score_gemma":0.0001762882,"teacher_disagreement_score":0.5506529,"about_ca_system_score_codex":0.00030226697,"about_ca_system_score_gemma":0.00078490755,"threshold_uncertainty_score":0.9995068},"labels":[],"label_agreement":null},{"id":"W4379983451","doi":"10.1158/1538-7445.am2023-23","title":"Abstract 23: Development of a biallelic<i>Dicer1</i>mutant mouse strain for studying the pathogenesis of DICER1 syndrome-associated cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Dicer; Missense mutation; Cancer research; Genetics; Ribonuclease III; Allele; Mutation; Null allele; Carcinogenesis; Pathogenesis; Cancer; Gene; Immunology; Transfection; RNA interference","score_opus":0.19627106723004667,"score_gpt":0.4314416878037714,"score_spread":0.23517062057372473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941437,0.0015156891,0.000008774912,0.0012449954,0.00010498113,0.0020351338,0.00071766705,0.00005580192,0.0001732163],"genre_scores_gemma":[0.9955714,0.000937561,0.00010038453,0.000042608764,0.000058551617,0.002042286,0.00003585904,0.000057989746,0.0011533578],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99679977,0.00012487161,0.0007104114,0.00035494514,0.001301633,0.000708356],"domain_scores_gemma":[0.99724144,0.0010827337,0.00019209876,0.00037745066,0.0009646891,0.00014159479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028776913,0.00019287837,0.0006091959,0.00033134542,0.00031284452,0.000018619481,0.00032363314,0.000098539735,0.00024007652],"category_scores_gemma":[0.0010419842,0.00013781693,0.00014797521,0.0013068592,0.00027037162,0.000043676733,0.00025142176,0.00029165804,0.000021715183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045093894,0.00041388086,0.017481571,0.002414482,0.0021890549,0.00006881183,0.016259762,0.0000690365,0.87930715,0.000023992849,0.0025964,0.07872494],"study_design_scores_gemma":[0.0034571951,0.0003613057,0.9356685,0.001485692,0.00022170259,0.0000042649745,0.0123316785,0.00018504425,0.043145668,0.0000837038,0.0027327596,0.00032244774],"about_ca_topic_score_codex":0.00086337054,"about_ca_topic_score_gemma":0.0037254482,"teacher_disagreement_score":0.91818696,"about_ca_system_score_codex":0.0004979952,"about_ca_system_score_gemma":0.0016386749,"threshold_uncertainty_score":0.5620011},"labels":[],"label_agreement":null},{"id":"W4379983501","doi":"10.1158/1538-7445.am2023-1177","title":"Abstract 1177: Genomic characteristics and clinical outcomes of early onset colorectal cancer (EOCRC): Findings from AACR Project GENIE Biopharma Collaborative registry","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Stage (stratigraphy); Cancer; Exact test; Oncology; Colorectal cancer; Cohort; Incidence (geometry); Population; Cancer registry; Multivariate analysis; Biology","score_opus":0.1304243840597342,"score_gpt":0.4806977723498529,"score_spread":0.35027338829011867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077976,0.0020853786,1.3378428e-7,0.001307005,0.0004261761,0.0011964497,0.0038625128,0.00005744687,0.00028512895],"genre_scores_gemma":[0.9815396,0.016507464,0.000033632798,0.000072493865,0.000297057,0.00054899335,0.000109704124,0.000042888678,0.00084815087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975289,0.00012165421,0.0005527347,0.00060084526,0.0006222004,0.00057365705],"domain_scores_gemma":[0.99801904,0.00077050016,0.0001584543,0.00026619446,0.00058423565,0.00020156935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006242817,0.00024734274,0.0008183534,0.0002600265,0.00023724845,0.000055636418,0.00017575106,0.0001639897,0.00025106597],"category_scores_gemma":[0.00036278067,0.00019419854,0.00013608807,0.0008950353,0.0007271454,0.000075158,0.00025370612,0.00058014994,0.00003318806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030209133,0.00015059735,0.966935,0.00012353859,0.001171407,0.00019660174,0.0015738234,2.152112e-7,0.01177865,0.0000048438924,0.00976812,0.005276314],"study_design_scores_gemma":[0.0022878738,0.0007321299,0.98981416,0.00017164196,0.00015113843,0.000002453928,0.0007872087,0.000010920493,0.0031834007,0.000022199918,0.0026671311,0.0001697137],"about_ca_topic_score_codex":0.010146865,"about_ca_topic_score_gemma":0.0013649118,"teacher_disagreement_score":0.022879211,"about_ca_system_score_codex":0.00048422406,"about_ca_system_score_gemma":0.0015826393,"threshold_uncertainty_score":0.99644464},"labels":[],"label_agreement":null},{"id":"W4379983529","doi":"10.1158/1538-7445.am2023-339","title":"Abstract 339: Exploring the roles of GSDMD in mammary tumorigenesis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Carcinogenesis; Cancer; Pyroptosis; Breast cancer; Medicine; Cancer research; Bioinformatics; Oncology; Internal medicine; Inflammation; Biology; Inflammasome","score_opus":0.08509545731183157,"score_gpt":0.37014285943426783,"score_spread":0.2850474021224363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569356,0.0023921062,0.0000021824137,0.00053647865,0.00009006772,0.00013162247,0.0000070573988,0.0000064327514,0.0011404624],"genre_scores_gemma":[0.99165267,0.007385451,0.000003880641,0.000020823347,0.000091164904,0.0002460129,0.000022435306,0.000013627412,0.0005639148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991042,0.00006310399,0.00014084547,0.00017440175,0.00020199693,0.00031546256],"domain_scores_gemma":[0.99951565,0.000030518855,0.00002061171,0.00032058728,0.000089265086,0.000023352592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069081446,0.00006210402,0.00007837997,0.000118694894,0.00007348365,0.000014416485,0.00034755634,0.00004120808,0.000025927522],"category_scores_gemma":[0.00008153602,0.000048478356,0.000047112633,0.00043188286,0.00009470346,0.0000061188184,0.00019403236,0.00014292616,0.000023633656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006693224,0.000016214075,0.004744644,0.000047460304,0.000022536742,0.000007476296,0.0003595382,0.0002233402,0.9675103,0.000091114576,0.0022801096,0.024630364],"study_design_scores_gemma":[0.00024625973,0.000051898936,0.1149295,0.000038546994,0.0000013458084,4.848529e-7,0.0014735601,0.000012015467,0.8566311,0.00016099525,0.026369615,0.00008465209],"about_ca_topic_score_codex":0.0002226003,"about_ca_topic_score_gemma":0.00043281465,"teacher_disagreement_score":0.110879146,"about_ca_system_score_codex":0.000016594886,"about_ca_system_score_gemma":0.00015583211,"threshold_uncertainty_score":0.197689},"labels":[],"label_agreement":null},{"id":"W4379983662","doi":"10.1158/1538-7445.am2023-5661","title":"Abstract 5661: Pre-clinical development of a dopamine receptor 2, PD-1, and CD47 trispecific antibody for the treatment of solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"CD47; Antibody; Lung cancer; Cancer; Cancer research; Medicine; Receptor; Antibody-dependent cell-mediated cytotoxicity; Dopamine receptor D2; Immunotherapy; Immunology; Internal medicine; Oncology; Monoclonal antibody","score_opus":0.21703842922088595,"score_gpt":0.5328918572125444,"score_spread":0.31585342799165844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560714,0.0013158831,0.000021595986,0.00069154985,0.000091040085,0.0020265896,0.00012828207,0.000022954015,0.00009496252],"genre_scores_gemma":[0.9850369,0.008635005,0.0002842579,0.000006462858,0.00018128367,0.0007310974,0.000059688027,0.000035438585,0.005029856],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977564,0.000090025205,0.00053650554,0.00036753374,0.0007146944,0.0005348368],"domain_scores_gemma":[0.99738777,0.0015372378,0.00009230591,0.00036918782,0.00036749648,0.00024599573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010559034,0.00014158725,0.00045632359,0.00026761342,0.00016441406,0.000012763773,0.00014669605,0.000060959155,0.00021516466],"category_scores_gemma":[0.0002820798,0.00008430366,0.000121427074,0.0005476929,0.0004345265,0.000034080174,0.00007042599,0.00018822344,0.000036509493],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012831713,0.0033901045,0.027894856,0.0012113752,0.0014923848,0.0001241478,0.0020194843,0.000008255995,0.3434306,0.000026283657,0.011829065,0.59574175],"study_design_scores_gemma":[0.00963823,0.0068526748,0.5023472,0.0004620947,0.00006182149,0.000007586807,0.0005512755,0.00012115655,0.39357737,0.000030796346,0.086212166,0.00013767194],"about_ca_topic_score_codex":0.00013271821,"about_ca_topic_score_gemma":0.000063681495,"teacher_disagreement_score":0.59560406,"about_ca_system_score_codex":0.00017217244,"about_ca_system_score_gemma":0.00087363,"threshold_uncertainty_score":0.34378034},"labels":[],"label_agreement":null},{"id":"W4379983719","doi":"10.1158/1538-7445.am2023-1662","title":"Abstract 1662: Understanding the sensitivity of cancer cells to myristoylation inhibitors for oncology applications","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer; Cancer research; Cancer cell; Biology; Lymphoma; Kinase; Cell culture; Ovarian cancer; Internal medicine; Oncology; Medicine; Cell biology; Genetics","score_opus":0.11081317852088345,"score_gpt":0.4385456287120127,"score_spread":0.32773245019112923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379983719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540621,0.0033716713,0.020812118,0.007840734,0.007021129,0.0040863464,0.0009307625,0.000048733196,0.0018264155],"genre_scores_gemma":[0.9887407,0.0017051905,0.00004713224,0.00011452652,0.007092379,0.0014354474,0.00004707323,0.000023907065,0.00079363934],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889195,0.000097057586,0.00016827158,0.0002873087,0.00022156005,0.0003338653],"domain_scores_gemma":[0.9991353,0.00018594044,0.000058637477,0.00027224125,0.0002632704,0.00008457985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013358264,0.00008054398,0.00013064024,0.000110432906,0.0002301794,0.000016325492,0.00013604983,0.000109759225,0.000019897845],"category_scores_gemma":[0.00008067139,0.00006769057,0.00007211798,0.00043940145,0.00016079773,0.0000036974604,0.0000988906,0.00013519893,0.0000093595645],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010847715,0.00001662536,0.00012524516,0.000051766237,0.00002964168,3.952941e-8,0.00023100252,0.0012559202,0.8864957,0.00032956107,0.09840318,0.012952861],"study_design_scores_gemma":[0.00026408365,0.000060588405,0.0014661001,0.000018263821,0.000011167908,2.5972707e-7,0.0007645128,0.000056008448,0.31393835,0.00029684865,0.6830405,0.00008332218],"about_ca_topic_score_codex":0.0009706328,"about_ca_topic_score_gemma":0.0036556344,"teacher_disagreement_score":0.58463734,"about_ca_system_score_codex":0.00022264438,"about_ca_system_score_gemma":0.00051328196,"threshold_uncertainty_score":0.27603412},"labels":[],"label_agreement":null},{"id":"W4379984147","doi":"10.1158/1538-7445.am2023-3812","title":"Abstract 3812: Circular RNAs from the PAX5 oncogene are overexpressed in B-cell malignancies and modulate cancer processes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Dr. Georges-L.-Dumont University Hospital Centre; Université de Moncton","funders":"","keywords":"Biology; microRNA; Cancer; Cancer cell; Oncogene; PAX5; Cancer research; Gene; Cell; Genetics; Computational biology; Transcription factor; Cell cycle","score_opus":0.05939724680214593,"score_gpt":0.360958805574106,"score_spread":0.30156155877196006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95325917,0.044932287,0.000004493846,0.00071326917,0.00008662725,0.00037498208,0.00042598872,0.000020954478,0.00018225276],"genre_scores_gemma":[0.9786075,0.019704998,0.0000055297764,0.00019715569,0.00035681462,0.00050482416,0.00009884592,0.000045652538,0.0004787272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981006,0.00011885998,0.00018918836,0.00059026177,0.0004648238,0.0005362629],"domain_scores_gemma":[0.9989235,0.000111529785,0.000063860214,0.0005304731,0.00025085115,0.00011980077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039668666,0.00017112661,0.00016997724,0.000080665246,0.00017663282,0.00009713202,0.00045586305,0.00013881321,0.00011086576],"category_scores_gemma":[0.00031522207,0.00013985722,0.000055172954,0.0005369312,0.0002530683,0.000012643311,0.00034073825,0.00024635115,0.000018470182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007103698,0.0000440311,0.05409234,0.000250182,0.00005149066,0.000039843755,0.00014659368,0.0007074157,0.9354411,0.000003295514,0.008279705,0.0008730174],"study_design_scores_gemma":[0.00080336025,0.0000283068,0.3081689,0.00031720797,0.00001427457,0.0000014839262,0.00045146354,0.000035734207,0.6627145,0.00029338297,0.02691422,0.00025722582],"about_ca_topic_score_codex":0.0021976805,"about_ca_topic_score_gemma":0.001947927,"teacher_disagreement_score":0.2727266,"about_ca_system_score_codex":0.00007274719,"about_ca_system_score_gemma":0.0005508485,"threshold_uncertainty_score":0.5703212},"labels":[],"label_agreement":null},{"id":"W4379984223","doi":"10.1158/1538-7445.am2023-1379","title":"Abstract 1379: Studying the autophagic flux in response to hypoxia in BAP1-mutated pleural mesothelioma cells linked to asbestos exposure","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Mesothelioma; Autophagy; Cancer research; BAP1; Tumor microenvironment; Asbestos; Cancer cell; Programmed cell death; Hypoxia (environmental); Cancer; Biology; Medicine; Chemistry; Pathology; Apoptosis; Internal medicine; Tumor cells; Materials science","score_opus":0.09796905493885784,"score_gpt":0.41116441750247923,"score_spread":0.3131953625636214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224615,0.0002548593,4.0265496e-7,0.0058398964,0.00009632986,0.0012572974,0.000059248192,0.000046351517,0.00019947275],"genre_scores_gemma":[0.9944848,0.000039876057,0.000018125516,0.0005379009,0.000113724134,0.0005799419,0.000025321371,0.00003283689,0.0041675027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99763066,0.0002657487,0.0002824578,0.00037855352,0.0008726294,0.000569974],"domain_scores_gemma":[0.9987839,0.0005388967,0.000019533558,0.0003238691,0.000049435796,0.00028440147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015180113,0.00013424027,0.0001990216,0.00065899023,0.00011319713,0.000034886125,0.00024088066,0.000061035007,0.0007069758],"category_scores_gemma":[0.00033090127,0.00009890536,0.00004836829,0.0017616352,0.000078063174,0.00006197031,0.00018666545,0.00041855298,0.0013358464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064933053,0.00023027997,0.113777615,0.00007391646,0.0000264902,0.00078205636,0.0024314504,0.0052228994,0.8611748,0.000003375748,0.0061744554,0.0036093574],"study_design_scores_gemma":[0.0010685899,0.00032965883,0.98477906,0.00021107492,0.000005734096,0.0000022414995,0.0011865752,0.00013224203,0.010164543,0.000023719436,0.0019912575,0.000105292405],"about_ca_topic_score_codex":0.0008134156,"about_ca_topic_score_gemma":0.00035431402,"teacher_disagreement_score":0.8710015,"about_ca_system_score_codex":0.00056943623,"about_ca_system_score_gemma":0.00028211297,"threshold_uncertainty_score":0.99944174},"labels":[],"label_agreement":null},{"id":"W4379984225","doi":"10.1158/1538-7445.am2023-3104","title":"Abstract 3104: Synthesis and optimization of small molecules designed to stimulate the immune system by inducing DNA damage and blocking PD-1/PD-L1","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immune system; Immunotherapy; Cancer research; Cancer; Melanoma; Cancer immunotherapy; PD-L1; Cancer cell; Immune checkpoint; DNA damage; Chemistry; Biology; DNA; Immunology; Medicine; Biochemistry; Internal medicine","score_opus":0.04154112190295163,"score_gpt":0.29819978725211194,"score_spread":0.2566586653491603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901712,0.002699215,0.0060105813,0.00012989593,0.00009909767,0.00054146757,0.00006201864,0.00014590514,0.00014063611],"genre_scores_gemma":[0.99842954,0.00068133784,0.0005973627,0.000005865044,0.00003982459,0.00013173149,0.000005336946,0.000068113855,0.000040877007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987432,0.000046368223,0.00026090458,0.00021978476,0.00031783024,0.00041192645],"domain_scores_gemma":[0.9988855,0.00057569187,0.000036581157,0.00028351662,0.000118229975,0.000100475096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008998795,0.00014553193,0.00021884155,0.00024284387,0.00018438174,0.00009761371,0.00022777921,0.00008737155,0.000015692814],"category_scores_gemma":[0.00013731464,0.000121798796,0.00002519691,0.00068059046,0.00008487305,0.0000979224,0.000120615514,0.00023827833,0.0000047965614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042458087,0.0000030649494,0.000048952697,0.00046409757,0.000060880255,0.0000067333635,0.00060258014,0.45138085,0.54355603,0.000029691133,0.000087841465,0.0037168267],"study_design_scores_gemma":[0.00040079677,0.000051582,0.0020363717,0.0010162096,0.000033812,0.0000026984508,0.0009688823,0.25363904,0.74142706,0.000027748842,0.00015020845,0.0002456134],"about_ca_topic_score_codex":0.00038913198,"about_ca_topic_score_gemma":0.000031283613,"teacher_disagreement_score":0.19787103,"about_ca_system_score_codex":0.0001996701,"about_ca_system_score_gemma":0.000050279938,"threshold_uncertainty_score":0.49668106},"labels":[],"label_agreement":null},{"id":"W4379984253","doi":"10.1158/1538-7445.am2023-1587","title":"Abstract 1587: Breast cancer treatment: Exploring bazedoxifene, a known SERM, SERD and indirect STAT3 inhibitor","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Selective estrogen receptor modulator; Breast cancer; Tamoxifen; Estrogen receptor; Cancer research; Medicine; Cancer; Progesterone receptor; Antiestrogen; Internal medicine; Oncology","score_opus":0.0768082847370306,"score_gpt":0.3746554732646347,"score_spread":0.2978471885276041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900356,0.008050463,4.3364446e-7,0.0005337338,0.00024252107,0.00035828326,0.00018033701,0.00004964481,0.00054900924],"genre_scores_gemma":[0.9550735,0.04127976,0.000007717948,0.00002502468,0.0007003135,0.0007542483,0.000075346965,0.000053475407,0.0020306592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982655,0.00010688195,0.00015712222,0.00051883946,0.00028594118,0.00066571456],"domain_scores_gemma":[0.99926245,0.000044225017,0.000034655015,0.000281323,0.00012895711,0.00024837657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036271708,0.00019766913,0.00019043763,0.00017679574,0.0002472823,0.00006671293,0.00014817741,0.00018435762,0.00008327632],"category_scores_gemma":[0.000023677761,0.00016225255,0.00007135135,0.00048323988,0.00014970293,0.000014462619,0.00017280491,0.0002805304,0.000069366804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036461122,0.00006319407,0.008616747,0.000112082256,0.0002479387,0.00007920152,0.00035219282,0.0000831531,0.9174773,0.000010787086,0.0068526575,0.06574011],"study_design_scores_gemma":[0.0017749883,0.0004802263,0.05696847,0.00022780523,0.000032109143,0.000030770767,0.0003327132,0.000044492874,0.8989957,0.00003167085,0.04068207,0.00039901084],"about_ca_topic_score_codex":0.00075769424,"about_ca_topic_score_gemma":0.00023027671,"teacher_disagreement_score":0.0653411,"about_ca_system_score_codex":0.0001331905,"about_ca_system_score_gemma":0.0003513944,"threshold_uncertainty_score":0.6616467},"labels":[],"label_agreement":null},{"id":"W4379984278","doi":"10.1158/1538-7445.am2023-1217","title":"Abstract 1217: The <i>FAM72</i> gene family promotes cancer development by disabling the base excision repair system","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"","keywords":"DNA glycosylase; Biology; Carcinogenesis; Base excision repair; DNA repair; Cancer; Cancer research; Gene; DNA damage; MUTYH; Mutation; Uracil-DNA glycosylase; Tumor progression; DNA mismatch repair; Genetics; DNA","score_opus":0.09401855500166753,"score_gpt":0.3864500913142659,"score_spread":0.29243153631259833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212075,0.014181721,0.000119415134,0.0019710802,0.00025007184,0.00062229356,0.000098640194,0.000060508693,0.00057552295],"genre_scores_gemma":[0.9882316,0.005347426,0.000036746842,0.00018105928,0.0004883946,0.0018226365,0.00009986284,0.00004062405,0.003751661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997982,0.00015531603,0.0002601356,0.00049517385,0.00057638227,0.0005309507],"domain_scores_gemma":[0.9987658,0.00007348271,0.00006292271,0.00073405943,0.00026800315,0.000095687385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016616174,0.00014873275,0.000113562775,0.00005057377,0.0008490376,0.00010238565,0.0005794549,0.000101341204,0.00004222455],"category_scores_gemma":[0.00006390485,0.00008618847,0.00008246165,0.00054737396,0.0001981023,0.0000069696384,0.0002482266,0.0002796908,0.00006979031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005022165,0.000021648984,0.00045245988,0.00007278867,0.000063697364,0.0000030211427,0.00020080114,0.00021252924,0.85945535,0.000027813288,0.124217786,0.015221905],"study_design_scores_gemma":[0.00026738146,0.000036688132,0.0067415494,0.00012525992,0.00000977481,0.0000019444908,0.0011139042,0.00021504734,0.5160018,0.00001365377,0.4752844,0.0001885884],"about_ca_topic_score_codex":0.0007392044,"about_ca_topic_score_gemma":0.00019286771,"teacher_disagreement_score":0.35106662,"about_ca_system_score_codex":0.00019053623,"about_ca_system_score_gemma":0.00057496945,"threshold_uncertainty_score":0.65301967},"labels":[],"label_agreement":null},{"id":"W4379984315","doi":"10.1158/1538-7445.am2023-3330","title":"Abstract 3330: Development of a genome-wide multiomic atlas of early-stage lung cancer enables identification of novel methylation biomarkers for disease detection beyond TCGA","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lung cancer; DNA methylation; Cancer; Liquid biopsy; Population; Bisulfite sequencing; Stage (stratigraphy); Medicine; Oncology; Biology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.050731527037113484,"score_gpt":0.3770592125966136,"score_spread":0.32632768555950015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903134,0.001712162,0.0061756005,0.00005026734,0.00014219436,0.00071830273,0.0008679512,0.0000053521344,0.000014763982],"genre_scores_gemma":[0.99712366,0.0014887204,0.00029644876,0.0000045619704,0.0000717624,0.0005095905,0.00026853624,0.000027322876,0.00020941623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865234,0.00002709523,0.00046589028,0.00031529338,0.00027892034,0.00026048033],"domain_scores_gemma":[0.99865127,0.0001285013,0.00025197252,0.00026618587,0.0006157953,0.00008627717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078508235,0.00010301917,0.00015728577,0.00025467176,0.000099921366,0.000015355627,0.0001808575,0.000089555535,0.000017209504],"category_scores_gemma":[0.00028165348,0.000111103276,0.00008625411,0.00037249926,0.0001280723,0.000008992436,0.00009877312,0.00006189338,8.077334e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006043218,0.000063462605,0.008296828,0.00063747435,0.00015459726,2.2381384e-7,0.00025554287,0.0036992016,0.9799535,0.000010694168,0.00012276511,0.006201389],"study_design_scores_gemma":[0.000652355,0.000044688713,0.16300581,0.00004673031,0.000023078064,2.7207486e-8,0.00011082988,0.0013518312,0.8333669,0.000022857761,0.001277945,0.0000969529],"about_ca_topic_score_codex":0.00093476224,"about_ca_topic_score_gemma":0.0007847323,"teacher_disagreement_score":0.154709,"about_ca_system_score_codex":0.00015406369,"about_ca_system_score_gemma":0.00077984907,"threshold_uncertainty_score":0.45306602},"labels":[],"label_agreement":null},{"id":"W4379984540","doi":"10.1158/1538-7445.am2023-333","title":"Abstract 333: Interleukin 23 receptor is a critical regulator of the mitotic spindle and necessary for AML viability","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cell biology; Mitosis; Biology; Flow cytometry; Intracellular; Regulator; Centrosome; Molecular biology; Cell; Cell cycle; Biochemistry","score_opus":0.12033177751072033,"score_gpt":0.4656050694423401,"score_spread":0.34527329193161976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593937,0.0007871358,0.000003001858,0.03784448,0.00017156817,0.00087672245,0.00023775487,0.000021476084,0.0006641915],"genre_scores_gemma":[0.9913274,0.0003641265,0.00010764505,0.00020633246,0.00038119667,0.000231906,0.00001496828,0.000025499938,0.007340897],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772173,0.00011902493,0.00028784186,0.00038923716,0.0008704176,0.00061173167],"domain_scores_gemma":[0.9975652,0.0011755028,0.000028610502,0.00041700172,0.0005632695,0.00025042682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013708636,0.00011934403,0.00029316833,0.0001620554,0.00023160614,0.000031083964,0.00027592955,0.000109786684,0.0008003313],"category_scores_gemma":[0.0013319432,0.00007676003,0.00014852831,0.000635201,0.0010963947,0.000062048675,0.00032130355,0.00055035943,0.00006730287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050252057,0.00050660694,0.094418444,0.010776572,0.00030084542,0.00004100354,0.0018493533,0.00000384389,0.4862979,0.0037589173,0.36292577,0.034095526],"study_design_scores_gemma":[0.001880126,0.0010148812,0.6440593,0.0014443074,0.0000459886,0.000022198692,0.0012817321,0.0009792787,0.22640823,0.005565231,0.11701629,0.0002824601],"about_ca_topic_score_codex":0.0005984803,"about_ca_topic_score_gemma":0.00006274033,"teacher_disagreement_score":0.54964083,"about_ca_system_score_codex":0.00012254574,"about_ca_system_score_gemma":0.00046027167,"threshold_uncertainty_score":0.87630665},"labels":[],"label_agreement":null},{"id":"W4379984570","doi":"10.1158/1538-7445.am2023-5460","title":"Abstract 5460: Novel immunohistochemistry-based predictive and prognostic tests for hormone receptor-positive breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Winnipeg","funders":"","keywords":"Immunohistochemistry; Breast cancer; Internal medicine; Oncology; Medicine; Predictive marker; Cancer; Adjuvant; Clinical endpoint; Endocrine system; Pathology; Hormone; Clinical trial","score_opus":0.026258556395098668,"score_gpt":0.36411093021655705,"score_spread":0.3378523738214584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906344,0.0072338297,0.000095269315,0.0007258519,0.00011907488,0.0010605227,0.00143996,0.000044592205,0.0002174279],"genre_scores_gemma":[0.9947478,0.0017072159,0.00008266528,0.000042326727,0.00039956893,0.0017583397,0.0005125958,0.00005844674,0.00069099624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983014,0.000042001677,0.00017059661,0.00056752656,0.0002981698,0.0006203478],"domain_scores_gemma":[0.99885595,0.00015648443,0.000058582566,0.00026190816,0.0004739813,0.00019309351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004579628,0.00019727177,0.00017135074,0.00009987235,0.00029073493,0.000047626905,0.00020833073,0.00028597243,0.00002488277],"category_scores_gemma":[0.00017294796,0.00018103955,0.00008157115,0.00036369168,0.0003424643,0.0000072144885,0.00012464418,0.00036003717,0.000013046931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010814336,0.00007660369,0.0010992966,0.00011746291,0.00015513023,0.000004675693,0.000056840454,0.00014657223,0.9788271,0.0000076198558,0.015844187,0.0025830665],"study_design_scores_gemma":[0.0029527836,0.0008657262,0.071678475,0.00033230026,0.00005421275,0.000014782263,0.00013522079,0.0006212943,0.9200396,0.000030563195,0.002833462,0.00044155907],"about_ca_topic_score_codex":0.00018799205,"about_ca_topic_score_gemma":0.00000870631,"teacher_disagreement_score":0.07057918,"about_ca_system_score_codex":0.00013240428,"about_ca_system_score_gemma":0.0005728907,"threshold_uncertainty_score":0.7382578},"labels":[],"label_agreement":null},{"id":"W4379984631","doi":"10.1158/1538-7445.am2023-2109","title":"Abstract 2109: Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Multiplex; Immune system; Cytokine; Immunoassay; Lung cancer; Cancer; Immunology; Medicine; Cancer research; Oncology; Internal medicine; Biology; Antibody; Bioinformatics","score_opus":0.09367647996915328,"score_gpt":0.3657848765528228,"score_spread":0.27210839658366953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983199,0.000039081224,0.00079712126,0.00028513512,0.000011958901,0.00033853634,0.00012738614,0.000029567092,0.000051316423],"genre_scores_gemma":[0.99848604,0.0003751442,0.00037460146,0.0000142921135,0.00006979825,0.00010509988,0.0004492177,0.000021987667,0.000103792634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988723,0.00005966854,0.00016741834,0.0003709203,0.00026484224,0.00026485795],"domain_scores_gemma":[0.99931824,0.000041911462,0.000055873188,0.00029854436,0.00022442824,0.00006100932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038516932,0.00009586229,0.00013048643,0.00009277257,0.00006637952,0.000015384228,0.00013692873,0.00011854284,0.000006106161],"category_scores_gemma":[0.00013137865,0.00008171068,0.00002638064,0.0004387833,0.00012254376,0.000008212204,0.000098796845,0.00018105163,0.0000029573177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020164388,0.0000519716,0.003226376,0.00002232528,0.000011081088,0.0000041793883,0.000021670503,0.0000313804,0.99143213,0.000009988681,0.0001901562,0.0047971257],"study_design_scores_gemma":[0.00032654585,0.000059980146,0.08233763,0.00011211063,0.0000031343677,9.692849e-7,0.000029288927,0.001154709,0.9147805,0.00004997904,0.0010435445,0.00010160888],"about_ca_topic_score_codex":0.00033792108,"about_ca_topic_score_gemma":0.00023056664,"teacher_disagreement_score":0.079111256,"about_ca_system_score_codex":0.000039887007,"about_ca_system_score_gemma":0.000093760464,"threshold_uncertainty_score":0.33320647},"labels":[],"label_agreement":null},{"id":"W4379984669","doi":"10.1158/1538-7445.am2023-645","title":"Abstract 645: Impact of sex differences on cross-talk between the gut microbiome, CEACAMs, and TGF-β signaling in cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Biology; Microbiome; Immune system; Cancer research; Immunology; Genetics","score_opus":0.09615661996080616,"score_gpt":0.457440011456084,"score_spread":0.36128339149527783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811983,0.0006187595,1.419626e-7,0.00025267003,0.00009126469,0.00052781973,0.00007573323,0.000022260068,0.0002915405],"genre_scores_gemma":[0.9987709,0.0004349298,0.0000015690001,0.000020455302,0.00035319306,0.00007828663,0.0000151279455,0.000023722048,0.00030181205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982168,0.0001274363,0.00026971512,0.000283623,0.0005258591,0.0005765549],"domain_scores_gemma":[0.9985872,0.0008124082,0.00006110451,0.0002542681,0.00012145027,0.00016355337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017375262,0.00014443358,0.0003334494,0.00039497955,0.0001426861,0.00004049036,0.000178802,0.0001140187,0.00020126888],"category_scores_gemma":[0.00016950538,0.00008745826,0.00007900624,0.0007669362,0.00042927178,0.000053167732,0.00007196801,0.0006403979,0.00002370136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027474167,0.00001681204,0.7456674,0.00035342507,0.000084826155,0.00007792398,0.0012197117,0.00009840256,0.24381246,0.0000040917394,0.0013924444,0.006997791],"study_design_scores_gemma":[0.00089649437,0.0003155216,0.94886816,0.0004915663,0.000009009647,0.0000018934661,0.000268864,0.00005146856,0.048768345,0.000039346694,0.00019853697,0.00009078678],"about_ca_topic_score_codex":0.0058760922,"about_ca_topic_score_gemma":0.00019661283,"teacher_disagreement_score":0.2032008,"about_ca_system_score_codex":0.00043356422,"about_ca_system_score_gemma":0.00063428836,"threshold_uncertainty_score":0.8882933},"labels":[],"label_agreement":null},{"id":"W4379984688","doi":"10.1158/1538-7445.am2023-5526","title":"Abstract 5526: State-of-the-art biobanking of gastroesophageal adenocarcinoma samples: Integrating non-viable biospecimens with 3D and 2D cell models and their characterization, validation, and utilization of cell models for precision oncology","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biobank; Context (archaeology); Precision medicine; Translational research; Computational biology; Biorepository; Personalized medicine; Computer science; Bioinformatics; Medicine; Biology; Pathology","score_opus":0.1190190879669486,"score_gpt":0.3667264815173453,"score_spread":0.24770739355039673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741753,0.0008197817,0.023331651,0.00009038102,0.000038163398,0.0010713548,0.00034664405,0.000008045733,0.00011867502],"genre_scores_gemma":[0.9952806,0.0023072497,0.0019473401,0.000011467097,0.000033169945,0.000083958286,0.00010509249,0.00002851534,0.00020260028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986792,0.000052804022,0.00038354943,0.00031367692,0.00030181467,0.00026891107],"domain_scores_gemma":[0.9985395,0.0002491552,0.00023035778,0.00021264079,0.0006818593,0.00008646627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081217143,0.00012992759,0.00036677867,0.0002488239,0.000113686314,0.000019044026,0.000081552374,0.00006151314,0.000018142653],"category_scores_gemma":[0.000033159053,0.000088727706,0.000032058415,0.000514581,0.00024511004,0.000171111,0.000100140394,0.00015186929,1.5465453e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087023014,0.00011262203,0.010588145,0.0021509721,0.000054193715,0.0000012271864,0.006398116,0.0020143983,0.95123607,0.00006352077,0.000163139,0.026347376],"study_design_scores_gemma":[0.0022493657,0.00089771755,0.012556367,0.0006487802,0.00006633201,0.0000039305437,0.001276622,0.030014317,0.9508768,0.0011308404,0.00017747033,0.00010148857],"about_ca_topic_score_codex":0.00023084202,"about_ca_topic_score_gemma":0.00006618721,"teacher_disagreement_score":0.027999919,"about_ca_system_score_codex":0.00007764865,"about_ca_system_score_gemma":0.00040763128,"threshold_uncertainty_score":0.3618211},"labels":[],"label_agreement":null},{"id":"W4379984869","doi":"10.1158/1538-7445.am2023-2657","title":"Abstract 2657: Preclinical model to evaluate the safety and efficacy of PODO83: A monoclonal antibody against podocalyxin that targets tumor growth and metastasis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Cancer research; Monoclonal antibody; Biology; Metastasis; Epitope; Pathology; Cancer; Antibody; Immunology; Kidney; Medicine; Endocrinology; Podocyte","score_opus":0.14546652052191358,"score_gpt":0.44924358990057467,"score_spread":0.3037770693786611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920673,0.0061457036,0.000039732186,0.003085699,0.00017793589,0.00058567023,0.00027329806,0.000033422948,0.0004518137],"genre_scores_gemma":[0.9944623,0.0047483654,0.000031579497,0.00021994622,0.00004551626,0.00009758813,0.00006603085,0.00002255304,0.0003060826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977648,0.0005111397,0.00034833443,0.0005505879,0.00014851167,0.0006766261],"domain_scores_gemma":[0.99833494,0.0010036342,0.000063554704,0.0003167286,0.00019560923,0.000085514665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023203413,0.00017891385,0.00041717957,0.00020742438,0.0003541411,0.000023674154,0.0003505196,0.00015464533,0.00013774393],"category_scores_gemma":[0.00047389462,0.00011928153,0.00008326679,0.0004531672,0.0007806948,0.0000519943,0.00045857782,0.0006674614,0.000049522478],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003414064,0.0001341097,0.01537747,0.00013251194,0.0005551944,0.000016023301,0.001087676,0.00039754112,0.94233584,0.0007377717,0.004005635,0.03180615],"study_design_scores_gemma":[0.0049669123,0.00088903937,0.8289307,0.00018305374,0.00011340667,0.000037231268,0.00076904375,0.0007626105,0.15252687,0.0010314173,0.009310042,0.00047966916],"about_ca_topic_score_codex":0.00045067945,"about_ca_topic_score_gemma":0.00010616041,"teacher_disagreement_score":0.8135532,"about_ca_system_score_codex":0.00004485116,"about_ca_system_score_gemma":0.00030484414,"threshold_uncertainty_score":0.48641598},"labels":[],"label_agreement":null},{"id":"W4379984937","doi":"10.1158/1538-7445.am2023-1837","title":"Abstract 1837: E7386, a selective inhibitor of the interaction between β-catenin and CREB-binding protein (CBP), enhances antitumor activity in combination with lenvatinib (LEN), and LEN + anti-PD-1 antibody in a preclinical tumor model","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Cancer research; Population; Medicine; Chemistry; Pharmacology","score_opus":0.16830660519183713,"score_gpt":0.49233501208204594,"score_spread":0.32402840689020884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482864,0.0001235724,0.000013486719,0.0019288461,0.00004293207,0.0027421073,0.00004817954,0.000033391247,0.00023886641],"genre_scores_gemma":[0.99865127,0.00031255113,0.00006232917,0.000009784974,0.00009714572,0.00056155754,0.000015551268,0.000046111443,0.00024372835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99643606,0.00049214385,0.0004957804,0.00071324705,0.0011680817,0.00069468893],"domain_scores_gemma":[0.9982556,0.0007246606,0.00018098365,0.0003007941,0.00038304745,0.00015492675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003516291,0.00021166762,0.00057996146,0.0008474952,0.00016508246,0.00006843177,0.00022347867,0.0001454376,0.000017419477],"category_scores_gemma":[0.00095459085,0.00015926188,0.000044360713,0.0022041514,0.00063597766,0.00042539075,0.00028859157,0.0018785888,0.000004667916],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016160482,0.00025656962,0.3667827,0.0010569784,0.00004737584,0.000037108963,0.0011371855,0.00008142836,0.6238809,0.000027085038,0.00008449822,0.0049921223],"study_design_scores_gemma":[0.0025822036,0.0006560674,0.5775108,0.0026352208,0.000012468217,0.0000059558797,0.00051113666,0.0039907983,0.41177937,0.0001479891,0.000021552227,0.00014646753],"about_ca_topic_score_codex":0.0036108573,"about_ca_topic_score_gemma":0.0016405989,"teacher_disagreement_score":0.21210152,"about_ca_system_score_codex":0.0005643665,"about_ca_system_score_gemma":0.0013935437,"threshold_uncertainty_score":0.8161638},"labels":[],"label_agreement":null},{"id":"W4379984948","doi":"10.1158/1538-7445.am2023-1558","title":"Abstract 1558: Targeting CDK9 via the small-molecule inhibitor enitociclib as a therapeutic strategy to treat <i>MYCN</i>-amplified rhabdomyosarcoma and neuroblastoma in children","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuroblastoma; Cancer research; Viability assay; Biology; Molecular biology; Apoptosis; Chemistry; Cell culture; Genetics","score_opus":0.062135759154649556,"score_gpt":0.3880754105895953,"score_spread":0.32593965143494574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183375,0.00064646144,0.000003222838,0.0039965142,0.00004430014,0.002431482,0.000029779072,0.00012012575,0.0008943877],"genre_scores_gemma":[0.9967568,0.0003928659,0.000015603728,0.00043844263,0.00027211406,0.0008514227,0.000025344923,0.00009434067,0.001153103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960617,0.00039490216,0.00035885308,0.00078659476,0.0010149158,0.001383027],"domain_scores_gemma":[0.9980884,0.00055075396,0.000045373356,0.0005234491,0.00019724139,0.00059476105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092403457,0.00030502854,0.0003608062,0.00064499024,0.00037879686,0.00018365271,0.00035586936,0.000114468756,0.0001826373],"category_scores_gemma":[0.00019480805,0.00021571264,0.00009637857,0.001899101,0.00027762016,0.000105258616,0.00034119876,0.0010977545,0.0005062429],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028219023,0.0004681255,0.052388113,0.00019968537,0.00019733481,0.0016015052,0.00062827795,0.000059759834,0.8695472,0.00006657476,0.0038016974,0.068219826],"study_design_scores_gemma":[0.008147014,0.0046572364,0.6856175,0.00042422808,0.000058642338,0.00039948992,0.00067970663,0.0002207347,0.2972566,0.00062999054,0.0013734481,0.00053543516],"about_ca_topic_score_codex":0.0022132592,"about_ca_topic_score_gemma":0.0002745421,"teacher_disagreement_score":0.6332294,"about_ca_system_score_codex":0.00021769435,"about_ca_system_score_gemma":0.00047944815,"threshold_uncertainty_score":0.87965065},"labels":[],"label_agreement":null},{"id":"W4379984961","doi":"10.1158/1538-7445.am2023-5523","title":"Abstract 5523: Impact of COVID-19 on longitudinal breast cancer research studies involving TNBC patients","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Data collection; Cancer; Prospective cohort study; Longitudinal study; Cohort; Pandemic; Informed consent; Blood collection; Blood sampling; Cohort study; Disease; Family medicine; Emergency medicine; Coronavirus disease 2019 (COVID-19); Internal medicine; Pathology; Alternative medicine","score_opus":0.5958809931007647,"score_gpt":0.6145284127810805,"score_spread":0.018647419680315802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896922,0.0039606453,8.545159e-7,0.0039942865,0.0002248965,0.00084073405,0.00040426725,0.000080522994,0.00080161134],"genre_scores_gemma":[0.99103814,0.007107494,0.000005976921,0.00014842441,0.00048648272,0.00040183146,0.00003527061,0.00005012615,0.00072622485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933678,0.00031970927,0.00048741244,0.00074094074,0.003579524,0.0015046418],"domain_scores_gemma":[0.99406344,0.0010541837,0.00011199923,0.000648208,0.0033414022,0.00078075705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043573966,0.00025342533,0.0005907834,0.0012122074,0.00060681987,0.00006337674,0.00048059862,0.00015595907,0.0012088006],"category_scores_gemma":[0.0025545303,0.00019626747,0.00022342453,0.0035215302,0.00084285554,0.00022472383,0.00043472947,0.0014169548,0.00018348328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029553885,0.00015338314,0.82445353,0.00087892934,0.00041590864,0.00029987574,0.0016044796,0.0010939558,0.0045648683,0.000069430374,0.15760177,0.0059084734],"study_design_scores_gemma":[0.0017412963,0.00095175364,0.990138,0.0017106432,0.000023405215,0.000008197939,0.002979779,0.000062294544,0.00090152863,0.00032083128,0.0009755733,0.0001867049],"about_ca_topic_score_codex":0.056547884,"about_ca_topic_score_gemma":0.0032037878,"teacher_disagreement_score":0.16568446,"about_ca_system_score_codex":0.004746129,"about_ca_system_score_gemma":0.0037744183,"threshold_uncertainty_score":0.99970424},"labels":[],"label_agreement":null},{"id":"W4379985065","doi":"10.1158/1538-7445.am2023-5241","title":"Abstract 5241: Association of polygenic risk scores with breast cancer risk among women with benign breast disease","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Breast disease; Odds ratio; Case-control study; Population; Internal medicine; Oncology; Gynecology; Obstetrics; Demography; Cancer; Environmental health","score_opus":0.01469117801710265,"score_gpt":0.32267827949483785,"score_spread":0.3079871014777352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379985065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468863,0.00077972695,0.000022266388,0.00050515047,0.00008746027,0.00042548866,0.0033218602,0.00003074014,0.00013870272],"genre_scores_gemma":[0.99377614,0.0032593985,0.00002880075,0.000020681493,0.00042329877,0.001020746,0.00009957929,0.00007038881,0.001300955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733824,0.00020808214,0.00023249605,0.0005947184,0.0008772651,0.00074919866],"domain_scores_gemma":[0.9979967,0.00007477714,0.0002651265,0.0005654529,0.00081689865,0.00028105936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009480581,0.00019889363,0.00020607875,0.00020576263,0.0002746024,0.000058435253,0.00035320662,0.00013672089,0.00032843868],"category_scores_gemma":[0.00009825193,0.00016088023,0.00005747967,0.0009599451,0.0003426477,0.00001969981,0.0001385459,0.00040665275,0.000018979097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020089275,0.000065286345,0.9542313,0.00009451501,0.000534573,0.000009174106,0.0003935888,0.008576361,0.02099662,0.0000034083246,0.0060189776,0.0070672203],"study_design_scores_gemma":[0.0009923585,0.00014935857,0.98833996,0.00010893373,0.00005643767,0.0000025607335,0.00045829423,0.00007909725,0.00891976,0.000055129694,0.00061033416,0.00022778995],"about_ca_topic_score_codex":0.0049859057,"about_ca_topic_score_gemma":0.0055558877,"teacher_disagreement_score":0.0341086,"about_ca_system_score_codex":0.00095147034,"about_ca_system_score_gemma":0.0019053605,"threshold_uncertainty_score":0.75372314},"labels":[],"label_agreement":null},{"id":"W4379985135","doi":"10.1158/1538-7445.am2023-53","title":"Abstract 53: Zebrafish <i>tp53</i> mutants recapitulate Li-Fraumeni syndrome phenotypes and provide a preclinical platform for evaluating tumor preventive compounds","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children; Izaak Walton Killam Health Centre; University of Ottawa","funders":"","keywords":"Zebrafish; Li–Fraumeni syndrome; Cancer; Cancer research; Loss of heterozygosity; Phenotype; Biology; Germline; Germline mutation; Medicine; Mutation; Genetics; Gene; Allele","score_opus":0.17589046039139056,"score_gpt":0.4664888762921103,"score_spread":0.2905984159007197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379985135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908625,0.0018536833,0.000027070198,0.0016489432,0.0003617792,0.0040002256,0.00017556592,0.000215042,0.0008551888],"genre_scores_gemma":[0.9951853,0.00046150008,0.00056163216,0.00017644542,0.0002769454,0.0017350473,0.000091697606,0.00012964042,0.0013817631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99600166,0.000119511824,0.0006453539,0.00091771054,0.001218966,0.0010968028],"domain_scores_gemma":[0.99712175,0.0011325394,0.0001660068,0.00055387197,0.0006021484,0.00042370358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034278731,0.00028005414,0.00060941477,0.00038235364,0.00042259938,0.000117739975,0.0002688019,0.00021767622,0.00018550246],"category_scores_gemma":[0.0015846487,0.00026348393,0.00017610473,0.0009441493,0.00034554178,0.00020949569,0.00029696643,0.0010681705,0.000105833926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016101237,0.0011989792,0.0061957785,0.010280113,0.002698413,0.0026728602,0.008276786,0.00078054395,0.7204089,0.00042021394,0.05115297,0.1798132],"study_design_scores_gemma":[0.0908941,0.030008532,0.2840935,0.033299956,0.002493719,0.0028017862,0.006090615,0.06030121,0.30470687,0.031746868,0.14807801,0.005484804],"about_ca_topic_score_codex":0.0003106167,"about_ca_topic_score_gemma":0.0002932407,"teacher_disagreement_score":0.41570202,"about_ca_system_score_codex":0.0005798194,"about_ca_system_score_gemma":0.001295875,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W4380029463","doi":"10.1158/1538-7445.am2023-6362","title":"Abstract 6362: Overcoming resistance to immunotherapy due to loss of antigen presentation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytotoxic T cell; Cancer research; Immune system; CD8; Immunotherapy; Melanoma; CD40; Immunology; Tumor microenvironment; Antigen presentation; Biology; T cell; Cancer immunotherapy; In vitro","score_opus":0.086722358174086,"score_gpt":0.4450993976130972,"score_spread":0.3583770394390112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98795563,0.0014782924,0.00004597128,0.007314644,0.00020844536,0.0010100467,0.000051984694,0.0000561102,0.0018788734],"genre_scores_gemma":[0.9901732,0.001808499,0.00019020181,0.00041340376,0.00023044067,0.00024945347,0.0000151942595,0.00004381635,0.006875764],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99791026,0.00006838718,0.0003197888,0.00034094747,0.00085129746,0.0005092914],"domain_scores_gemma":[0.99877447,0.0001840816,0.00004847346,0.00047134826,0.00035760054,0.00016401122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011976183,0.000116212184,0.00026883412,0.00052182394,0.00013123975,0.000033249915,0.00024030317,0.000072410396,0.00065133086],"category_scores_gemma":[0.00011889869,0.00010766629,0.000092693226,0.002013262,0.00011197794,0.00008236124,0.00006697253,0.00022256757,0.0001436132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071826666,0.0000509808,0.0059727365,0.00020401237,0.00014557247,0.00007476143,0.0020398663,0.0000309229,0.9161784,0.00004436342,0.042582303,0.025493419],"study_design_scores_gemma":[0.0016031913,0.00022339937,0.5398652,0.0006200018,0.000005098696,0.0000035248522,0.00052727864,0.0000052005344,0.3427476,0.00010394669,0.11414897,0.00014655951],"about_ca_topic_score_codex":0.001598044,"about_ca_topic_score_gemma":0.00048112718,"teacher_disagreement_score":0.5734308,"about_ca_system_score_codex":0.00032754184,"about_ca_system_score_gemma":0.00036115636,"threshold_uncertainty_score":0.7131616},"labels":[],"label_agreement":null},{"id":"W4380029485","doi":"10.1158/1538-7445.am2023-2105","title":"Abstract 2105: Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Abiraterone acetate; Prednisone; Internal medicine; Oncology; Enzalutamide; Stage (stratigraphy); Placebo; Regimen; Cancer; Prostate; Androgen deprivation therapy; Urology; Androgen receptor; Pathology","score_opus":0.20828137408403608,"score_gpt":0.4999385068985145,"score_spread":0.2916571328144784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839171,0.004462171,0.000002480951,0.0056203073,0.000090917885,0.0028474252,0.0013622614,0.000067815105,0.00162948],"genre_scores_gemma":[0.9624017,0.009224564,0.0001012807,0.000034692177,0.00005967069,0.0033959998,0.00034306524,0.00007181469,0.024367245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99579245,0.00028192377,0.00070971274,0.0006803784,0.0013691594,0.0011663918],"domain_scores_gemma":[0.9975366,0.00048680673,0.00017623583,0.00062465033,0.0008249819,0.000350701],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017273352,0.00025591053,0.00056690816,0.0011395455,0.00024851254,0.000057170368,0.00027755162,0.00006425284,0.0014363512],"category_scores_gemma":[0.00020976408,0.00020734762,0.00013000461,0.0032758247,0.00049120793,0.0002418408,0.00020011423,0.00062608457,0.00013628759],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062559424,0.0007265233,0.079949185,0.0051151067,0.00089718134,0.0009809312,0.005199654,0.0014994703,0.8697701,0.00054794364,0.015223256,0.013834684],"study_design_scores_gemma":[0.00918865,0.00072010874,0.793528,0.0012138712,0.00018868949,0.000013671802,0.0042556073,0.00044356578,0.18274091,0.0014848114,0.0057913717,0.00043069007],"about_ca_topic_score_codex":0.0075513106,"about_ca_topic_score_gemma":0.006254465,"teacher_disagreement_score":0.7135789,"about_ca_system_score_codex":0.0014265223,"about_ca_system_score_gemma":0.0019326623,"threshold_uncertainty_score":0.9994765},"labels":[],"label_agreement":null},{"id":"W4380029570","doi":"10.1158/1538-7445.am2023-5511","title":"Abstract 5511: Investigating Wee1 and Myt1 combined inhibition as a potential cancer therapeutic strategy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Wee1; Biology; Cancer research; Kinase; Cancer; Cell cycle; Synthetic lethality; Cancer cell; Cyclin-dependent kinase 1; Cell cycle checkpoint; DNA repair; Cell biology; Genetics; DNA","score_opus":0.0957075201556583,"score_gpt":0.3972903867391306,"score_spread":0.3015828665834723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940798,0.0026224796,0.0000046508476,0.0015247058,0.000092897186,0.00033848383,0.000051647803,0.00003356986,0.0012517419],"genre_scores_gemma":[0.9956459,0.0022006296,0.000013280043,0.00025263496,0.00038267224,0.0003335465,0.00009707782,0.000030922925,0.0010433547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985848,0.00012238628,0.00014951389,0.0003757953,0.00031112434,0.00045639492],"domain_scores_gemma":[0.99937963,0.000023621165,0.000040703922,0.00024866458,0.00016397519,0.00014341743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000577643,0.00012257803,0.00010882061,0.00009605249,0.0002491743,0.00009136151,0.00015920083,0.00014823614,0.00019255141],"category_scores_gemma":[0.00006776317,0.00011715896,0.000038516835,0.00029277257,0.00023337669,0.000008039397,0.00020593233,0.00030076306,0.00005281375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007949118,0.000014410167,0.0006486271,0.00008204953,0.00003845825,0.0000127123985,0.0001090764,0.00006756217,0.9823941,0.00014776822,0.0019782237,0.014427543],"study_design_scores_gemma":[0.0008414797,0.0003581597,0.013532556,0.00011571086,0.000009875579,0.000006337573,0.0004426176,0.00014478766,0.976287,0.0038824775,0.004159463,0.00021950333],"about_ca_topic_score_codex":0.00080764043,"about_ca_topic_score_gemma":0.00019996059,"teacher_disagreement_score":0.014208039,"about_ca_system_score_codex":0.000034783385,"about_ca_system_score_gemma":0.00039392832,"threshold_uncertainty_score":0.47776037},"labels":[],"label_agreement":null},{"id":"W4380029575","doi":"10.1158/1538-7445.am2023-1035","title":"Abstract 1035: Early ctDNA reduction is associated with better overall survival in the Ph 3 trial of tebentafusp in previously untreated metastatic uveal melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Melanoma; GNAQ; Gastroenterology; Neuroblastoma RAS viral oncogene homolog; Oncology; Cancer; KRAS; Gene; Mutation; Cancer research; Biology; Genetics","score_opus":0.09860576474639243,"score_gpt":0.41386939002461515,"score_spread":0.3152636252782227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495864,0.00011389383,1.2100253e-7,0.0023759236,0.00009391409,0.0014892546,0.000030391202,0.000017572227,0.00092028093],"genre_scores_gemma":[0.99849814,0.00013512498,0.0000055878927,0.000046799447,0.00007520841,0.0003068731,0.00008884892,0.00001971213,0.0008237086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977185,0.00057193614,0.00028450918,0.00027473594,0.0006998086,0.00045048943],"domain_scores_gemma":[0.99915963,0.0003243912,0.000078268604,0.00024841656,0.00013277197,0.0000565196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017990803,0.00011936668,0.0003619943,0.00035120285,0.000059493883,0.000015712387,0.00012474885,0.00010196522,0.0002354166],"category_scores_gemma":[0.00016167505,0.00007592988,0.000058035897,0.0011249275,0.00015865797,0.000082298524,0.0000274533,0.0005352488,0.00003959489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087764755,0.003976932,0.8567906,0.00030572515,0.002201051,0.0039728,0.013450417,0.000050318795,0.009515408,0.00006753672,0.0048803636,0.017024092],"study_design_scores_gemma":[0.061025552,0.0028349252,0.9316943,0.00034059345,0.00012703543,0.000009659344,0.0005359463,0.000018272785,0.0029111537,0.00023937532,0.00016427087,0.00009887164],"about_ca_topic_score_codex":0.0060338024,"about_ca_topic_score_gemma":0.0022520418,"teacher_disagreement_score":0.07490374,"about_ca_system_score_codex":0.00041268117,"about_ca_system_score_gemma":0.00039512813,"threshold_uncertainty_score":0.91213447},"labels":[],"label_agreement":null},{"id":"W4380029579","doi":"10.1158/1538-7445.am2023-5393","title":"Abstract 5393: Comparison of deep learning approaches applied to hematoxylin and eosin-stained whole slide images from women with benign breast disease to predict risk of developing invasive breast cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Convolutional neural network; Artificial intelligence; H&E stain; Deep learning; Pooling; Receiver operating characteristic; Pattern recognition (psychology); Computer science; Hyperparameter; Breast cancer; Digital pathology; Set (abstract data type); Feature (linguistics); Medicine; Pathology; Machine learning; Cancer; Staining; Internal medicine","score_opus":0.056569257416390566,"score_gpt":0.3316191630211277,"score_spread":0.27504990560473713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616633,0.00044441066,0.035032738,0.001314903,0.00006850079,0.0009027059,0.0003790649,0.0001264695,0.000067875444],"genre_scores_gemma":[0.9951016,0.00017395531,0.003352715,0.000026227413,0.00012172927,0.0011299858,0.000011443236,0.000042601896,0.000039789807],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99666864,0.00018859428,0.0004287337,0.0008633448,0.0011017141,0.0007489555],"domain_scores_gemma":[0.9977379,0.000514375,0.00022698891,0.0005528208,0.00047573601,0.00049218506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010419739,0.00023951248,0.00048101816,0.0005334798,0.0003085023,0.00015249867,0.0007998596,0.00007259764,0.000033141863],"category_scores_gemma":[0.00011594718,0.0002187386,0.000033299257,0.0021867286,0.00021749346,0.0003086929,0.00075147074,0.0005101039,0.000013929254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035890334,0.00015907695,0.20607403,0.0013298852,0.00047562807,0.00002875571,0.03361658,0.2569956,0.054625086,0.00027569983,0.001164326,0.4416663],"study_design_scores_gemma":[0.0010168499,0.00025914714,0.90986013,0.0009305593,0.00002895498,0.0000037361206,0.007825186,0.016735073,0.061900645,0.00071602786,0.00021070924,0.00051300443],"about_ca_topic_score_codex":0.0032847743,"about_ca_topic_score_gemma":0.0013632381,"teacher_disagreement_score":0.7037861,"about_ca_system_score_codex":0.00072480185,"about_ca_system_score_gemma":0.0008713207,"threshold_uncertainty_score":0.8919901},"labels":[],"label_agreement":null},{"id":"W4380029780","doi":"10.1158/1538-7445.am2023-6453","title":"Abstract 6453: Lifestyle and environmental factors in relation to colorectal cancer risk and survival by colibactin tumor mutational signature status","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Colorectal cancer; Hazard ratio; Proportional hazards model; Internal medicine; Oncology; Medicine; Cohort; Logistic regression; Confidence interval; Cancer; Quartile; Biology","score_opus":0.03226709210537056,"score_gpt":0.35735330873565163,"score_spread":0.3250862166302811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955906,0.0015078352,0.0000011989381,0.00052624557,0.00025364186,0.0009401718,0.0009930418,0.00003782636,0.00014942115],"genre_scores_gemma":[0.9971489,0.0016405527,0.000029050148,0.000051471656,0.00012508561,0.0003652608,0.00020821276,0.000045771674,0.00038570282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976071,0.00014646503,0.00023737912,0.0005294678,0.00085080374,0.0006287991],"domain_scores_gemma":[0.9987081,0.00064893195,0.000056734767,0.0001220407,0.000061893414,0.0004022673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005922067,0.00018269119,0.00025560497,0.00033148754,0.00016811029,0.00004316686,0.00007582318,0.00014641257,0.0006379949],"category_scores_gemma":[0.00035542346,0.0001706301,0.00002773141,0.0006336984,0.00022705291,0.00009333125,0.00012505343,0.0008679657,0.00001810274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006882597,0.000048240167,0.7995424,0.00006373003,0.000036580786,0.00003465946,0.0017753475,0.00029069214,0.19118004,0.0000034166244,0.0036757789,0.002660834],"study_design_scores_gemma":[0.0011219345,0.00027734885,0.9693646,0.0000830921,0.000013838992,0.00000329908,0.001460064,0.00020345714,0.02428626,0.00004431205,0.0029743453,0.0001674579],"about_ca_topic_score_codex":0.0034491273,"about_ca_topic_score_gemma":0.0018452345,"teacher_disagreement_score":0.16982216,"about_ca_system_score_codex":0.0008828946,"about_ca_system_score_gemma":0.00040084546,"threshold_uncertainty_score":0.69855964},"labels":[],"label_agreement":null},{"id":"W4380029867","doi":"10.1158/1538-7445.am2023-4461","title":"Abstract 4461: Optimized human immunophenotyping panels enhance the flexibility for high-dimensional flow cytometry analysis with CyTOF","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Population; Immunophenotyping; Immune system; Biology; Immunology; Peripheral blood mononuclear cell; Cancer research; Flow cytometry; Phenotype; Medicine; Genetics","score_opus":0.0800373039034273,"score_gpt":0.3932176660852366,"score_spread":0.31318036218180934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947849,0.00048155407,0.0034452828,0.00045565524,0.00010161372,0.000488348,0.00011525821,0.00003818194,0.00008923093],"genre_scores_gemma":[0.99706805,0.0001459265,0.00081282656,0.000074189615,0.00027428812,0.0003063818,0.0002551014,0.00004156047,0.0010216829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981114,0.00012355176,0.00024201497,0.0005625184,0.00042047477,0.00054002454],"domain_scores_gemma":[0.99868464,0.0001481323,0.00005366004,0.00061549706,0.00041302285,0.00008501477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014777363,0.0001593112,0.00024672234,0.00017373104,0.00055713434,0.00007469244,0.0004153952,0.00013029847,0.00011847935],"category_scores_gemma":[0.00009891227,0.000111014146,0.00016291605,0.0010764389,0.0002912209,0.000007132934,0.00010861335,0.00028458546,0.0000140785305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092834706,0.000056621022,0.00045836606,0.000052416977,0.00055565184,0.0000027351766,0.00007143397,0.015925884,0.9790975,0.000027782367,0.0007041788,0.002119099],"study_design_scores_gemma":[0.0014823393,0.00034190062,0.018995183,0.000044309596,0.00013176842,8.423862e-7,0.00013149992,0.0026048287,0.9744658,0.00032135542,0.0011671201,0.00031303757],"about_ca_topic_score_codex":0.0007268107,"about_ca_topic_score_gemma":0.0002645202,"teacher_disagreement_score":0.018536815,"about_ca_system_score_codex":0.00006840051,"about_ca_system_score_gemma":0.00021485159,"threshold_uncertainty_score":0.45270255},"labels":[],"label_agreement":null},{"id":"W4380029950","doi":"10.1158/1538-7445.am2023-6464","title":"Abstract 6464: Antidepressant use and lung cancer risk and mortality: A meta-analysis of observational studies","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Internal medicine; Relative risk; Oncology; Subgroup analysis; Antidepressant; Cancer; Confidence interval; Observational study","score_opus":0.5125278731995447,"score_gpt":0.5236663492749288,"score_spread":0.011138476075384096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8859994,0.11190157,0.0000015641532,0.001236534,0.000045511366,0.00038761317,0.000378761,0.00002615426,0.00002290587],"genre_scores_gemma":[0.85854363,0.13958089,0.000019573376,0.00007194015,0.000119619144,0.00035115867,0.00002816699,0.000022175593,0.0012628214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762225,0.0002300581,0.0004021669,0.000458773,0.000890346,0.00039643064],"domain_scores_gemma":[0.99714863,0.0013985902,0.00013685162,0.00043201732,0.0007430667,0.00014082088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017236469,0.00017108336,0.0011269181,0.0006935543,0.0002036345,0.000056660152,0.00010050392,0.000074797725,0.00032489956],"category_scores_gemma":[0.00080807076,0.0001284675,0.00032121493,0.0016986167,0.00058038835,0.00019431511,0.00013905503,0.00033694628,0.0000015803477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006368391,0.000052185347,0.85330707,0.0006886459,0.13156961,0.00006544957,0.0013659318,0.00036428534,0.00436137,0.000054284123,0.00576275,0.0017715953],"study_design_scores_gemma":[0.00049276307,0.000046196194,0.9466999,0.00007606552,0.047755864,0.0000024454891,0.00057934766,0.00085488363,0.0013185032,0.000035982852,0.002022832,0.00011518377],"about_ca_topic_score_codex":0.012606507,"about_ca_topic_score_gemma":0.0024520205,"teacher_disagreement_score":0.09339287,"about_ca_system_score_codex":0.00010956061,"about_ca_system_score_gemma":0.0003733099,"threshold_uncertainty_score":0.9939686},"labels":[],"label_agreement":null},{"id":"W4380029952","doi":"10.1158/1538-7445.am2023-5548","title":"Abstract 5548: Clinical management and decision making in early ER-positive breast cancers through improved prognosis and pathway directed molecular profiling","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Precision medicine; Personalized medicine; Bioinformatics; Cancer; Biology; Pathology","score_opus":0.04381208628055051,"score_gpt":0.39755112633493195,"score_spread":0.35373904005438145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380029952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953346,0.0030225373,0.00011068529,0.00015797476,0.0001284931,0.00076047925,0.00013658419,0.00001987156,0.0003287451],"genre_scores_gemma":[0.9882299,0.009810802,0.0012781759,0.00008811185,0.00014062371,0.0003413688,0.000040738672,0.000036970338,0.000033347827],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982018,0.00007502461,0.00029780486,0.00067735044,0.00024409432,0.0005039652],"domain_scores_gemma":[0.99928033,0.00015245771,0.00005608377,0.00024189378,0.0001601891,0.00010902593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007589983,0.00015347128,0.00019089239,0.0001269712,0.00012188737,0.00010075876,0.00015939228,0.00015336907,0.000005606543],"category_scores_gemma":[0.00011240527,0.00015362029,0.000047799324,0.00040844773,0.00019678436,0.000009748548,0.00045673142,0.00028393575,0.000003073968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019232107,0.0001455274,0.1746285,0.00033952668,0.0003177604,0.00033776756,0.00047269728,0.000310916,0.34623173,0.0004668203,0.0013329836,0.47349256],"study_design_scores_gemma":[0.0033337642,0.0006475744,0.8908782,0.00090177933,0.000037945345,0.000014211747,0.00069796364,0.0012336782,0.096861266,0.0019851818,0.002728721,0.00067970355],"about_ca_topic_score_codex":0.0007683747,"about_ca_topic_score_gemma":0.00060950516,"teacher_disagreement_score":0.7162497,"about_ca_system_score_codex":0.0001232635,"about_ca_system_score_gemma":0.00021576969,"threshold_uncertainty_score":0.6264454},"labels":[],"label_agreement":null},{"id":"W4380030049","doi":"10.1158/1538-7445.am2023-4834","title":"Abstract 4834: Mitochondrial ClpXP degrades serine phosphorylated protein aggregates","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biochemistry; Biology; Phosphorylation; Serine; Protease; Proteolysis; Enzyme","score_opus":0.10041325325070322,"score_gpt":0.42381041797001956,"score_spread":0.32339716471931634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380030049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893544,0.000658779,0.0000025697689,0.0068697585,0.0000555473,0.0005938917,0.000042001306,0.00025163236,0.0021714272],"genre_scores_gemma":[0.970952,0.00043802912,0.000067790854,0.00010655858,0.00061900396,0.00042552012,0.00013365364,0.00003978781,0.027217677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783033,0.00006920506,0.00025410412,0.00038769824,0.0008398213,0.0006188463],"domain_scores_gemma":[0.99884933,0.000076590826,0.00004346728,0.00034060044,0.0003838684,0.000306138],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044531198,0.00014095125,0.0002643271,0.00049064204,0.00020615145,0.00006732146,0.00014285126,0.00011828989,0.004046889],"category_scores_gemma":[0.00026741502,0.00011702461,0.00014338133,0.001708641,0.00020378969,0.00006887916,0.00008140119,0.0006221187,0.0017072477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004443338,0.00010428428,0.0008651488,0.00023072421,0.00012703022,0.00045343136,0.0001476213,0.000017061986,0.959501,0.000079101155,0.023789508,0.0142407175],"study_design_scores_gemma":[0.0029339117,0.0002505311,0.016699394,0.0021464326,0.000034786353,0.000014712599,0.0005257367,0.00041516483,0.9152149,0.00051865063,0.060945693,0.00030010546],"about_ca_topic_score_codex":0.00075707736,"about_ca_topic_score_gemma":0.00022724662,"teacher_disagreement_score":0.044286158,"about_ca_system_score_codex":0.00019024618,"about_ca_system_score_gemma":0.0003470673,"threshold_uncertainty_score":0.99907005},"labels":[],"label_agreement":null},{"id":"W4380030103","doi":"10.1158/1538-7445.am2023-3338","title":"Abstract 3338: Targeted serum metabolomics for noninvasive detection of colorectal neoplasia","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Calgary","funders":"","keywords":"Metabolomics; Metabolome; Colorectal cancer; Metabolite; Medicine; Receiver operating characteristic; Internal medicine; Biomarker; Area under the curve; Cancer; Oncology; Chemistry; Chromatography; Biochemistry","score_opus":0.042811408620372034,"score_gpt":0.36252353518240155,"score_spread":0.3197121265620295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380030103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961563,0.0019624566,0.00014899115,0.00018599075,0.0003412949,0.0006138158,0.00029089162,0.000016531427,0.0002837407],"genre_scores_gemma":[0.9945306,0.0037768038,0.00018394062,0.000016446951,0.00024882218,0.00052254205,0.00007520672,0.000029296521,0.00061634224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987157,0.000047999438,0.00020022184,0.00034882795,0.00022417016,0.00046307634],"domain_scores_gemma":[0.99912083,0.00008324154,0.000072818395,0.00021212517,0.00044007858,0.00007092541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007156502,0.00011787865,0.00021788711,0.00020672967,0.0001745987,0.000017327679,0.00019787958,0.00013095039,0.000032365406],"category_scores_gemma":[0.0003784741,0.00011112836,0.00011841758,0.0005483966,0.00014501691,0.000004082235,0.00015650567,0.00015208534,0.0000111664585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029260165,0.00002134244,0.00067039306,0.00006780742,0.00016751663,0.0000015020498,0.000049384096,0.000059342074,0.993469,0.00012253642,0.002014032,0.0030645232],"study_design_scores_gemma":[0.0005331115,0.00028401724,0.016884947,0.000007213909,0.00001431138,0.0000012474371,0.00023889323,0.000049780854,0.95148826,0.00022969604,0.03015959,0.00010895771],"about_ca_topic_score_codex":0.00007901029,"about_ca_topic_score_gemma":0.00033745478,"teacher_disagreement_score":0.041980784,"about_ca_system_score_codex":0.000035604346,"about_ca_system_score_gemma":0.0001940943,"threshold_uncertainty_score":0.45316827},"labels":[],"label_agreement":null},{"id":"W4380030117","doi":"10.1158/1538-7445.am2023-6437","title":"Abstract 6437: Development of therapeutic vaccines against ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ovarian cancer; Biology; CD8; Antigen; Immunogenicity; Immunology; Immune system; Cytotoxic T cell; Immunotherapy; T cell; Cancer; Cancer immunotherapy; Cancer research; Genetics; In vitro","score_opus":0.09858224482511252,"score_gpt":0.3987793230437049,"score_spread":0.3001970782185924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380030117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660146,0.031230783,0.000008577024,0.00076702423,0.00067780004,0.000321636,0.000029508737,0.000086362365,0.0008636717],"genre_scores_gemma":[0.9827583,0.0058411416,0.000017129672,0.00008816755,0.000048798724,0.00033900765,0.00004315814,0.000035290854,0.010829045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823546,0.00027106729,0.00037583147,0.0002880706,0.00013041681,0.000699122],"domain_scores_gemma":[0.9989302,0.00034481552,0.00008134483,0.00035387644,0.00026770527,0.000022036147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012233516,0.00015844787,0.00027853428,0.00042511732,0.00042491878,0.000018943249,0.00046279715,0.00019157547,0.0034334555],"category_scores_gemma":[0.00005827731,0.00013057674,0.000077934215,0.0008269727,0.00022863055,0.00008094603,0.00012775524,0.0004832048,0.00076921604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063292886,0.000053133237,0.000936669,0.00006144838,0.00033297838,0.0000031671334,0.0016711836,0.000014171492,0.803384,0.000112496426,0.003738798,0.18905902],"study_design_scores_gemma":[0.0009698259,0.000044421606,0.10924255,0.00014811537,0.000005626673,0.0000013203139,0.0005195716,0.0000011166892,0.6850843,0.00007753903,0.20376047,0.00014512592],"about_ca_topic_score_codex":0.000510793,"about_ca_topic_score_gemma":0.0001757426,"teacher_disagreement_score":0.20002168,"about_ca_system_score_codex":0.00013880119,"about_ca_system_score_gemma":0.0012002955,"threshold_uncertainty_score":0.99747753},"labels":[],"label_agreement":null},{"id":"W4380082910","doi":"10.1158/1538-7445.am2023-1533","title":"Abstract 1533: ZW220, a novel NaPi2b-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"In vivo; Internalization; Camptothecin; Cancer research; Cell culture; Antibody; Folate receptor; Humanized antibody; Chemistry; Molecular biology; Biology; Cell; Cancer cell; Monoclonal antibody; Cancer; Immunology; Biochemistry","score_opus":0.12199925904167135,"score_gpt":0.46463712956088055,"score_spread":0.3426378705192092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380082910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978419,0.0028258571,0.00001599015,0.015019339,0.000558734,0.00043121568,0.000039449842,0.0002477537,0.0024426742],"genre_scores_gemma":[0.9912697,0.0014887779,0.00015446142,0.0006157539,0.0011357196,0.00015107622,0.00006947476,0.000045701356,0.0050693275],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970845,0.00009709902,0.00035524534,0.0005505173,0.0009041016,0.0010085416],"domain_scores_gemma":[0.99830604,0.0005566007,0.000054172982,0.00033543972,0.00037057398,0.0003771916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025923892,0.00018606416,0.00041112292,0.00037347001,0.0004685461,0.00005138159,0.00018164027,0.000099603276,0.00032633933],"category_scores_gemma":[0.0016359129,0.00015046947,0.00009758958,0.0009126442,0.00058915635,0.00008784434,0.00028575346,0.0012908184,0.0006101511],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000234464,0.00015495461,0.04549948,0.0007369205,0.0001674334,0.0011816592,0.0029965756,0.00000952255,0.85012096,0.000050593608,0.090880334,0.007967089],"study_design_scores_gemma":[0.01780388,0.00079892983,0.3924078,0.0075653987,0.00027727542,0.0002274247,0.018570887,0.0022217033,0.2780852,0.00065680646,0.27950665,0.0018780448],"about_ca_topic_score_codex":0.0010138266,"about_ca_topic_score_gemma":0.0000391136,"teacher_disagreement_score":0.5720358,"about_ca_system_score_codex":0.00012932043,"about_ca_system_score_gemma":0.00032813364,"threshold_uncertainty_score":0.78424615},"labels":[],"label_agreement":null},{"id":"W4380086049","doi":"10.1158/1538-7445.am2023-1538","title":"Abstract 1538: Revisiting the dogma of antibody drug conjugates (ADCs): Emerging data challenge the benefit of linker stability and the primacy of payload delivery","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Tolerability; Medicine; Drug; Antibody-drug conjugate; Therapeutic index; Pharmacology; Payload (computing); Linker; Cancer research; Antibody; Monoclonal antibody; Adverse effect; Immunology; Computer science","score_opus":0.22548872914863063,"score_gpt":0.4925144957504283,"score_spread":0.26702576660179766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380086049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424962,0.02535282,0.000002309292,0.028673206,0.00007513998,0.0016438084,0.0003169468,0.000021769976,0.0014178461],"genre_scores_gemma":[0.9579457,0.041320797,0.00001853065,0.000047863563,0.00035545757,0.00010580411,0.00003996772,0.00003808785,0.00012779143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953263,0.0006538805,0.0007903715,0.0005549173,0.0019806987,0.00069386285],"domain_scores_gemma":[0.9910541,0.004934261,0.0002517734,0.0023618112,0.0012764768,0.00012153067],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.016927455,0.00017852374,0.0005954706,0.00017941164,0.0003378655,0.00004254434,0.0014542018,0.000080912374,0.0004961538],"category_scores_gemma":[0.0020118358,0.00008805152,0.000113703616,0.0012093368,0.0027228324,0.00014587629,0.0017109932,0.0012684964,0.000009501943],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007408985,0.00041617185,0.13695803,0.025720216,0.0017917189,0.000088492285,0.04233613,0.0001535342,0.33386523,0.0074807494,0.008765451,0.4350153],"study_design_scores_gemma":[0.016300177,0.00087993545,0.5694162,0.015442424,0.00059413916,0.00003210565,0.070971616,0.014374332,0.26198643,0.0062100994,0.042834673,0.0009578456],"about_ca_topic_score_codex":0.008469409,"about_ca_topic_score_gemma":0.00037341414,"teacher_disagreement_score":0.43405744,"about_ca_system_score_codex":0.0001122346,"about_ca_system_score_gemma":0.0008298515,"threshold_uncertainty_score":0.9999912},"labels":[],"label_agreement":null},{"id":"W4380086563","doi":"10.1158/1538-7445.am2023-4846","title":"Abstract 4846: Mitochondria packaged from platelet-derived microvesicles modulate the metabolism and mitochondrial dynamics of breast cancer cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Mitochondrion; Cancer cell; Cancer research; Biology; Cancer; Breast cancer; Microvesicles; Metastasis; Cell biology; Microvesicle; Flow cytometry; Pathology; Immunology; Medicine; microRNA; Biochemistry","score_opus":0.021948137473439162,"score_gpt":0.318457820487986,"score_spread":0.29650968301454683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380086563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941416,0.0059372624,0.00003806497,0.0011174999,0.00055378396,0.0005307806,0.0023367736,0.000023208764,0.000048470563],"genre_scores_gemma":[0.9940399,0.003850509,0.0001492489,0.00006197543,0.00090489554,0.00017763133,0.0002298283,0.000070338676,0.0005156694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977463,0.00023299205,0.0003228261,0.00062941085,0.00047146017,0.00059703365],"domain_scores_gemma":[0.9985453,0.00012787143,0.00011949662,0.0007381689,0.0002695502,0.0001996397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036412635,0.00022901155,0.00026187487,0.000103961625,0.00022867255,0.0000824248,0.0006031243,0.00021619127,0.00016224696],"category_scores_gemma":[0.00007613086,0.00018445415,0.00012930346,0.0003687635,0.00062659587,0.000013094703,0.00043469958,0.00039764974,0.000023098954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047679344,0.000042245287,0.00029130912,0.00005403482,0.00018944942,0.000016440159,0.00017067831,0.00019465567,0.9854287,0.000024436622,0.0072873966,0.0058238925],"study_design_scores_gemma":[0.0010594942,0.000027117647,0.031616375,0.000054235974,0.000036223555,0.000002436138,0.00027314803,0.0003878386,0.9637262,0.0005412101,0.0020523618,0.00022336202],"about_ca_topic_score_codex":0.0019082385,"about_ca_topic_score_gemma":0.00079892273,"teacher_disagreement_score":0.031325065,"about_ca_system_score_codex":0.00005772866,"about_ca_system_score_gemma":0.000293665,"threshold_uncertainty_score":0.75218225},"labels":[],"label_agreement":null},{"id":"W4380146425","doi":"10.1158/1538-7445.am2023-nd09","title":"Abstract ND09: M3913 induces the maladaptive unfolded protein response through a novel mechanism resulting in strong anti-tumor activity","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Unfolded protein response; Cancer research; Downregulation and upregulation; Endoplasmic reticulum; Cancer; Biology; Medicine; Cell biology; Genetics; Gene","score_opus":0.09647170917546978,"score_gpt":0.40010509853264153,"score_spread":0.30363338935717177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380146425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968585,0.00022579743,0.00004631437,0.0012904907,0.000074358235,0.00082671223,0.00014279371,0.000023787814,0.00051128684],"genre_scores_gemma":[0.998382,0.00014983705,0.000046796493,0.000044108056,0.00015729813,0.00068350293,0.000020444631,0.0000334972,0.00048255236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976223,0.00037340084,0.00021502572,0.0005683053,0.000509651,0.0007113043],"domain_scores_gemma":[0.998997,0.00015018377,0.00008471387,0.000494616,0.00016398492,0.000109502296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00171445,0.00017650244,0.00017380243,0.00011567402,0.00027497107,0.00008276716,0.0004246426,0.00012397402,0.000032530992],"category_scores_gemma":[0.0009391505,0.00013447322,0.00007917781,0.00059670536,0.0002232447,0.000017683025,0.00037513245,0.0005136631,0.000021467627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015019956,0.00007926248,0.00022250887,0.000042875083,0.000030548574,0.00006334876,0.00023109093,0.00021433907,0.996235,0.00037005224,0.00029137445,0.00071758544],"study_design_scores_gemma":[0.0011853168,0.00014893358,0.04051495,0.00017601762,0.000004967648,0.0000030045226,0.0015872305,0.00018400713,0.9548427,0.0003494473,0.00079615245,0.00020729216],"about_ca_topic_score_codex":0.0017236244,"about_ca_topic_score_gemma":0.0003002079,"teacher_disagreement_score":0.04139234,"about_ca_system_score_codex":0.00009130731,"about_ca_system_score_gemma":0.000594013,"threshold_uncertainty_score":0.5483659},"labels":[],"label_agreement":null},{"id":"W4380987185","doi":"10.1158/0008-5472.can-22-3682","title":"CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer","funders":"Fondation Toulouse Cancer Santé; Institut National Du Cancer; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"Myeloid leukemia; CD36; Medicine; Metastasis; Chemotherapy; Leukemia; Myeloid; Cancer; Oncology; Cancer research; Immunology; Internal medicine; Receptor","score_opus":0.039987535429705325,"score_gpt":0.3731437392433297,"score_spread":0.3331562038136244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380987185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883081,0.008575755,0.000009636223,0.00066908536,0.0013314694,0.00022154003,0.00006794152,0.000018418132,0.0007980797],"genre_scores_gemma":[0.85411936,0.117500275,0.00015056621,0.0002543661,0.00726905,0.0005572069,0.00012972081,0.00007064351,0.019948786],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985028,0.00013477796,0.00014994084,0.00044019424,0.00026270674,0.00050955976],"domain_scores_gemma":[0.9993934,0.000029406905,0.000021952876,0.00032075244,0.000099724515,0.00013473566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069538975,0.00011414095,0.00016979378,0.0002214785,0.000106003165,0.00003871097,0.00020704535,0.00011925321,0.000049116803],"category_scores_gemma":[0.00010380667,0.00010825022,0.000050477487,0.0005563834,0.00021399398,0.000006860516,0.0002880779,0.00025756878,0.000033264892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017248275,0.000011630909,0.0021982698,0.000042367155,0.000084275074,0.0000025396357,0.00031493764,0.000040452414,0.82849234,0.00017405399,0.14280625,0.025660427],"study_design_scores_gemma":[0.00086203427,0.00008971259,0.011637488,0.000028643872,0.000015213594,0.0000054764187,0.00033390248,0.00003149817,0.08734222,0.000222189,0.89925987,0.00017173585],"about_ca_topic_score_codex":0.00063207204,"about_ca_topic_score_gemma":0.00083426735,"teacher_disagreement_score":0.75645363,"about_ca_system_score_codex":0.00007921869,"about_ca_system_score_gemma":0.00040661244,"threshold_uncertainty_score":0.44143158},"labels":[],"label_agreement":null},{"id":"W4383187429","doi":"10.1158/0008-5472.can-23-1066","title":"Repurposing Two Old Friends to Fight Cancer: Caffeine and Statins","year":2023,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research","keywords":"Mevalonate pathway; Statin; Repurposing; Caffeine; Cancer; Prenylation; Medicine; Pharmacology; HMG-CoA reductase; Cholesterol; Limiting; Lovastatin; Drug repositioning; Reductase; Cancer research; Enzyme; Drug; Chemistry; Biology; Internal medicine; Biochemistry","score_opus":0.058477185136022757,"score_gpt":0.41132647818586143,"score_spread":0.3528492930498387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383187429","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15597843,0.100305125,0.000103607264,0.69103855,0.03970681,0.0034133175,0.0057199295,0.00020076473,0.003533471],"genre_scores_gemma":[0.0012740953,0.08277331,0.00024365498,0.3024136,0.3511135,0.0040245806,0.0019298281,0.00059744075,0.25563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996237,0.0002369844,0.0003322261,0.0012430175,0.00076818373,0.001182617],"domain_scores_gemma":[0.99822086,0.000065722255,0.000090194924,0.0008692598,0.0004702979,0.0002836497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061887363,0.00037857337,0.00047290866,0.00035710612,0.0002906266,0.00015432197,0.0005272125,0.0005542326,0.00022016175],"category_scores_gemma":[0.00014527095,0.00036966143,0.00011931533,0.00054974685,0.00023491695,0.0000063286757,0.0006103433,0.0014542963,0.000039202485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008291552,0.000007752465,0.00013113201,0.00021823452,0.00013380528,0.0000084055855,0.00019033859,0.00002490874,0.06951374,0.000011702862,0.9192753,0.010401805],"study_design_scores_gemma":[0.0005690329,0.00015640327,0.00009321983,0.00022836006,0.000043652915,0.0000071156633,0.00004359683,0.00000648331,0.013359924,0.000036936413,0.9850248,0.00043044606],"about_ca_topic_score_codex":0.008813928,"about_ca_topic_score_gemma":0.0041850475,"teacher_disagreement_score":0.38862494,"about_ca_system_score_codex":0.00020826337,"about_ca_system_score_gemma":0.00091321935,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W4385294637","doi":"10.1158/0008-5472.can-22-3620","title":"Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Terry Fox Research Institute; VGH and UBC Hospital Foundation","keywords":"Biology; Cancer research; Mutation; Cancer; Germline; Dicer; KRAS; Missense mutation; Genetics; Zebrafish; Phenotype; Gene; RNA interference; RNA","score_opus":0.146198326838494,"score_gpt":0.4163707003538768,"score_spread":0.2701723735153828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911402,0.0031088202,0.000003903829,0.0024421103,0.00013447412,0.0012993326,0.00010634689,0.000045957524,0.0017188824],"genre_scores_gemma":[0.9946104,0.0029602258,0.00009411798,0.00012348875,0.00005175831,0.0012610909,0.000049756785,0.000032425385,0.00081671955],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99657476,0.00038714826,0.0007793307,0.00036415682,0.0012458026,0.0006487991],"domain_scores_gemma":[0.99644655,0.002183548,0.00018192366,0.00034055574,0.0007447901,0.000102642756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026082904,0.0001845797,0.0006025993,0.00056107825,0.00020463264,0.000017337366,0.00040294783,0.00012959162,0.0005321926],"category_scores_gemma":[0.001113421,0.00013718322,0.000112306676,0.0034134379,0.00041501375,0.00006431102,0.0001671341,0.00062836596,0.00009188258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009815242,0.0053121024,0.2799532,0.004824666,0.0032589904,0.0018342633,0.20159647,0.0010232185,0.31722984,0.00030597224,0.058836233,0.1248435],"study_design_scores_gemma":[0.0027600196,0.00033496288,0.95768464,0.00092884374,0.00010273541,0.000013321727,0.012967755,0.00016063137,0.013208018,0.000110842586,0.0114642875,0.00026392704],"about_ca_topic_score_codex":0.00085073564,"about_ca_topic_score_gemma":0.0049287877,"teacher_disagreement_score":0.67773145,"about_ca_system_score_codex":0.0005679282,"about_ca_system_score_gemma":0.0012916987,"threshold_uncertainty_score":0.5827136},"labels":[],"label_agreement":null},{"id":"W4385441753","doi":"10.1158/0008-5472.can-23-1387","title":"Turning Down the Temperature on Leukemia Stem Cells","year":2023,"lang":"en","type":"letter","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Oxidative phosphorylation; Myeloid leukemia; Leukemia; Stem cell; Oxidative damage; Biology; Cell biology; Cancer research; Chemistry; Biochemistry; Oxidative stress; Immunology","score_opus":0.06263608491944518,"score_gpt":0.34796339643725993,"score_spread":0.28532731151781476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385441753","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02975948,0.05085263,0.0000010093717,0.87065625,0.03358341,0.002871233,0.00092302915,0.0005625726,0.0107903825],"genre_scores_gemma":[0.0071240836,0.0045752414,0.0000017435531,0.24598958,0.006353076,0.001431215,0.00043216455,0.0003399346,0.73375297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468714,0.001714885,0.0004090569,0.0010214364,0.00041796625,0.0017495324],"domain_scores_gemma":[0.9954847,0.0023152176,0.00015105253,0.0016355503,0.0003886692,0.000024817575],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0016531476,0.0005004876,0.0005693553,0.0004293471,0.0010316861,0.00016532735,0.002103131,0.0026150756,0.002978099],"category_scores_gemma":[0.00006815335,0.00033068593,0.00024577323,0.00080703717,0.0010640136,0.000050539355,0.0006116666,0.019867051,0.013965244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079035,0.000005180442,0.0000033085369,0.0001510645,0.0002509953,0.00015156536,0.00036312087,0.000049766124,0.24084502,0.0000142925965,0.7560795,0.0020071664],"study_design_scores_gemma":[0.00038155113,0.00009931295,0.000018380366,0.00046979423,0.000025134646,0.000012517101,0.00015755011,3.789763e-7,0.20702173,0.00003424659,0.7914859,0.00029352948],"about_ca_topic_score_codex":0.00074004626,"about_ca_topic_score_gemma":0.000046630743,"teacher_disagreement_score":0.72296256,"about_ca_system_score_codex":0.0019252629,"about_ca_system_score_gemma":0.0015191264,"threshold_uncertainty_score":0.9999145},"labels":[],"label_agreement":null},{"id":"W4385837020","doi":"10.1158/1538-7445.kidney23-b019","title":"Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Clear cell renal cell carcinoma; Renal cell carcinoma; Medicine; Clear cell; Chromophobe cell; Immunotherapy; Oncocytoma; Kidney cancer; Internal medicine; Pathology; Oncology; Cancer","score_opus":0.022459518939340922,"score_gpt":0.3176976655483354,"score_spread":0.2952381466089945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385837020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947391,0.0032491358,0.000025783842,0.00134506,0.000060296872,0.0003865942,0.000089609566,0.0000032099608,0.00010116619],"genre_scores_gemma":[0.98995143,0.009451517,0.000017933933,0.00020333202,0.00010717466,0.00009678249,0.000060301743,0.000025429446,0.000086105865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888074,0.000131163,0.00024752846,0.00031585962,0.00018749628,0.00023719142],"domain_scores_gemma":[0.9993219,0.00010891545,0.00008468683,0.00036410612,0.00005622364,0.00006421049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008330444,0.00010603074,0.00017093691,0.00005830341,0.000095137424,0.000027020918,0.00014291583,0.000072662726,0.000019706418],"category_scores_gemma":[0.000048372287,0.000083729734,0.000065739834,0.000109331966,0.0005073262,0.000002260407,0.00012709232,0.00017724495,0.0000037757231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009067816,0.000049121987,0.0012134941,0.000032002463,0.000022629856,0.000010831606,0.000044475382,0.000019208064,0.99585176,0.000057913232,0.00018575521,0.0016060232],"study_design_scores_gemma":[0.0028859193,0.0003820669,0.09150705,0.000027968268,0.000008732295,0.0000014633522,0.000026811054,0.00007901922,0.90014756,0.000059046833,0.0047770734,0.00009727065],"about_ca_topic_score_codex":0.00020491735,"about_ca_topic_score_gemma":0.00001128205,"teacher_disagreement_score":0.09570418,"about_ca_system_score_codex":0.000024228719,"about_ca_system_score_gemma":0.00015368672,"threshold_uncertainty_score":0.34143993},"labels":[],"label_agreement":null},{"id":"W4385837070","doi":"10.1158/1538-7445.kidney23-pr005","title":"Abstract PR005: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomas","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Genetic heterogeneity; Transcriptome; Metastasis; Tumour heterogeneity; Cancer research; Primary tumor; Biology; Clear cell; Cancer; Tumor heterogeneity; Cell; Tumor progression; Gene; Pathology; Gene expression; Medicine; Phenotype; Genetics","score_opus":0.059024121585410975,"score_gpt":0.35657530579932245,"score_spread":0.29755118421391147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385837070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955039,0.0036156431,0.0000144625,0.00006453699,0.000048533548,0.00022592064,0.00011197733,0.0000043738823,0.00041064352],"genre_scores_gemma":[0.9967074,0.0027120793,0.000072745475,0.000028251525,0.000105629704,0.00006527582,0.00013839916,0.000021925745,0.00014832684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881214,0.00007910215,0.00019401261,0.00034873353,0.00022070018,0.00034532434],"domain_scores_gemma":[0.99936867,0.00005452918,0.000040770723,0.0003100311,0.000104751634,0.00012123491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006463908,0.00009612121,0.00015335981,0.00013804727,0.00004952232,0.000021467346,0.00017840308,0.00006813474,0.000018505683],"category_scores_gemma":[0.000046886304,0.00009759106,0.00003705311,0.00024307909,0.0001477211,0.000004638892,0.00020715538,0.00015325751,0.0000054735738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010616205,0.000055092692,0.009754133,0.00015760247,0.000014513019,0.000025119845,0.00007915057,0.00029351443,0.98725253,0.000015725213,0.0008920086,0.0013544648],"study_design_scores_gemma":[0.00060219516,0.00025755176,0.08059441,0.000022553795,0.0000068752984,0.0000012543846,0.00008259303,0.00006964631,0.9142828,0.00008258254,0.0038747808,0.00012272722],"about_ca_topic_score_codex":0.0008305115,"about_ca_topic_score_gemma":0.00094486173,"teacher_disagreement_score":0.07296969,"about_ca_system_score_codex":0.000052244457,"about_ca_system_score_gemma":0.0003388441,"threshold_uncertainty_score":0.3979648},"labels":[],"label_agreement":null},{"id":"W4385837082","doi":"10.1158/1538-7445.kidney23-a012","title":"Abstract A012: Investigating the heterogeneity and clinical significance of tumor-associated macrophages in renal cell carcinoma milieu","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Stromal cell; Cancer research; Biology; Renal cell carcinoma; Clear cell renal cell carcinoma; Population; Cancer; Chemokine; Downregulation and upregulation; Tumor progression; Paracrine signalling; Immunology; Medicine; Oncology; Inflammation; Gene; Receptor; Tumor cells; Genetics","score_opus":0.1520732265575444,"score_gpt":0.43225706332938085,"score_spread":0.28018383677183645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385837082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994665,0.002689837,1.982066e-7,0.0016213362,0.00007399052,0.00057166774,0.000038994014,0.000024983532,0.0003139725],"genre_scores_gemma":[0.9980588,0.0012411817,0.000024501,0.0001613375,0.00013279683,0.00020502096,0.000008195511,0.000026491974,0.00014165955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755174,0.00034863266,0.0005072665,0.00041386785,0.0006516668,0.00052683015],"domain_scores_gemma":[0.9984987,0.0006529345,0.00011343102,0.0003179249,0.00022938676,0.00018766306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031041258,0.00012490913,0.00036244036,0.00015566716,0.00013857149,0.000026174816,0.00021311588,0.00009706063,0.000066692555],"category_scores_gemma":[0.0005516703,0.000090438145,0.00009323154,0.001081795,0.0006835268,0.00004553631,0.00016361673,0.00083006005,0.000012144287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012607711,0.00012226249,0.8577469,0.0003284282,0.000034047414,0.00007282915,0.00035746177,0.000022151236,0.13331984,0.000005868701,0.0029925136,0.0048716525],"study_design_scores_gemma":[0.0009653396,0.00023963826,0.8461304,0.00024099107,0.000016759626,0.0000014286909,0.00038266255,0.00023156458,0.15148328,0.00003676181,0.00019593383,0.00007525655],"about_ca_topic_score_codex":0.0031799697,"about_ca_topic_score_gemma":0.0013203018,"teacher_disagreement_score":0.01816345,"about_ca_system_score_codex":0.00016504008,"about_ca_system_score_gemma":0.0004971048,"threshold_uncertainty_score":0.4807184},"labels":[],"label_agreement":null},{"id":"W4385838013","doi":"10.1158/1538-7445.kidney23-b011","title":"Abstract B011: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomas","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Citation; Renal cell carcinoma; Cancer; Medicine; Library science; Atlas (anatomy); Oncology; Internal medicine; Anatomy; Computer science","score_opus":0.1410458831664498,"score_gpt":0.3938010448498674,"score_spread":0.2527551616834176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385838013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382484,0.0036418524,0.0000021766457,0.0001854017,0.000033248434,0.000645363,0.000030978317,0.000024056744,0.0016120733],"genre_scores_gemma":[0.9984108,0.0005784589,0.000108547814,0.000018661234,0.00006203949,0.00013243963,0.00007436609,0.000034397137,0.000580245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977573,0.00018967554,0.00031768295,0.00044203963,0.0007678539,0.0005254114],"domain_scores_gemma":[0.99887556,0.00017246752,0.000051968826,0.0004514105,0.0001630425,0.00028554915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011063926,0.00014983362,0.00038828552,0.0004985104,0.000057386016,0.000017272088,0.00013204936,0.000062849365,0.000120031626],"category_scores_gemma":[0.00003318147,0.00012578335,0.00006700751,0.0007021535,0.00021563421,0.00008535953,0.00012887664,0.000389964,0.000040894083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004204733,0.00021284881,0.069066964,0.0010063899,0.00004668123,0.0011133938,0.000453851,0.00004391114,0.92510915,0.000009899588,0.0003678385,0.002148593],"study_design_scores_gemma":[0.0011865507,0.00042728492,0.48441026,0.00009159802,0.00002732986,0.000007958081,0.00013366717,0.00006279462,0.5133636,0.000040253908,0.00017464698,0.00007405907],"about_ca_topic_score_codex":0.0021190306,"about_ca_topic_score_gemma":0.00029309368,"teacher_disagreement_score":0.41534328,"about_ca_system_score_codex":0.00038149633,"about_ca_system_score_gemma":0.00045338902,"threshold_uncertainty_score":0.5129296},"labels":[],"label_agreement":null},{"id":"W4385838031","doi":"10.1158/1538-7445.kidney23-b010","title":"Abstract B010: Germline susceptibility to renal cell carcinoma and implications for genetic screening","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McMaster University; Juravinski Cancer Centre; University of Ottawa; McGill University","funders":"","keywords":"Germline; Oncology; Cancer; Renal cell carcinoma; Population; Medicine; Kidney cancer; Germline mutation; Internal medicine; Genetic testing; Biology; Genetics; Gene; Mutation","score_opus":0.09242876095878882,"score_gpt":0.42410497091779087,"score_spread":0.33167620995900204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385838031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302256,0.0010647237,0.0021077145,0.0026086585,0.000063629304,0.00066312525,0.00027621622,0.00001754936,0.0001758334],"genre_scores_gemma":[0.9936572,0.00020626685,0.003351075,0.00011208469,0.00044945112,0.0010029615,0.00012349569,0.000032816773,0.0010646778],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986809,0.000041075717,0.00016793195,0.0005280754,0.00015103894,0.00043095922],"domain_scores_gemma":[0.99890435,0.00007058281,0.000026120675,0.0004657207,0.00037206252,0.00016116697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056835025,0.00009643687,0.00009082902,0.00012912649,0.00025339128,0.0000426661,0.00022905476,0.000093229275,0.000040646486],"category_scores_gemma":[0.00013589092,0.000101863996,0.00004527181,0.00040012872,0.00012120984,0.0000031759553,0.00020478667,0.00012523624,0.000015508971],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007045166,0.00001408201,0.013079379,0.000056644727,0.000011758173,6.3009276e-7,0.00008894659,0.00072381675,0.9380855,0.000012755994,0.029018069,0.018837964],"study_design_scores_gemma":[0.00044254176,0.00018499861,0.6384026,0.000010671821,0.000007262119,0.0000018730284,0.00011603491,0.00008074702,0.32094476,0.00026178936,0.039387424,0.00015928969],"about_ca_topic_score_codex":0.0001787061,"about_ca_topic_score_gemma":0.00042038367,"teacher_disagreement_score":0.62532324,"about_ca_system_score_codex":0.000097088414,"about_ca_system_score_gemma":0.00038016148,"threshold_uncertainty_score":0.4153893},"labels":[],"label_agreement":null},{"id":"W4386346473","doi":"10.1158/0008-5472.can-23-1856","title":"Using Machine Learning to Predict <i>TP53</i> Mutation Status and Aggressiveness of Prostate Cancer from Routine Histology Images","year":2023,"lang":"en","type":"letter","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Prostate cancer; Cancer; Biomarker; Mutation; Histology; Medicine; Oncology; Prostate; Internal medicine; Biology; Genetics; Gene","score_opus":0.07832069754635498,"score_gpt":0.39128608212138694,"score_spread":0.312965384575032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47771645,0.06991752,0.030417286,0.40296176,0.00919397,0.0049944855,0.0037276235,0.00090310146,0.00016783131],"genre_scores_gemma":[0.6724339,0.082823604,0.03567077,0.13078964,0.030761957,0.0129174,0.0020739185,0.002303829,0.030224942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951214,0.00083586323,0.00048924,0.0012318571,0.0012744712,0.0010471713],"domain_scores_gemma":[0.9973869,0.0006383078,0.0004141148,0.00063969835,0.0007573989,0.00016361884],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00077915296,0.0003362748,0.0005830881,0.0008287507,0.00033458034,0.00018141924,0.00086170883,0.00040571773,0.000054935354],"category_scores_gemma":[0.00025666124,0.00034087914,0.00006628579,0.0014353257,0.00033942537,0.00024383121,0.000996815,0.0025453132,0.00001197834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092692446,0.000070801034,0.058830265,0.0039037948,0.0008788301,0.0022685705,0.016207745,0.039378542,0.09703569,0.000033498527,0.46844536,0.31201997],"study_design_scores_gemma":[0.0032808043,0.0013287822,0.007450351,0.006673541,0.00021381468,0.000057996676,0.00026948092,0.08244542,0.10022372,0.002391714,0.7935356,0.0021288148],"about_ca_topic_score_codex":0.056970466,"about_ca_topic_score_gemma":0.001334807,"teacher_disagreement_score":0.32509023,"about_ca_system_score_codex":0.0015095804,"about_ca_system_score_gemma":0.0011495764,"threshold_uncertainty_score":0.99990433},"labels":[],"label_agreement":null},{"id":"W4386438154","doi":"10.1158/0008-5472.can-23-0816","title":"Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":853,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Research Resources; Stand Up To Cancer; Ben and Catherine Ivy Foundation; Instituto Tecnológico de Costa Rica; Adenoid Cystic Carcinoma Research Foundation; Parker Institute for Cancer Immunotherapy; National Cancer Institute; Robertson Foundation; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation; American Association for Cancer Research; Prostate Cancer Foundation; Cholangiocarcinoma Foundation","keywords":"Cancer; Medicine; Genomics; Visualization; Data science; Bioinformatics; Computer science; Data mining; Genome; Internal medicine; Biology; Genetics; Gene","score_opus":0.15791545342917504,"score_gpt":0.5056920842015609,"score_spread":0.34777663077238585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386438154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355316,0.004652169,0.000052750955,0.0001729137,0.000051574727,0.00026758472,0.0012253899,0.0000024846656,0.000021958269],"genre_scores_gemma":[0.96583796,0.033002563,0.0000335614,0.00002949926,0.00017465699,0.000027884535,0.00085514004,0.000009870665,0.000028846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887615,0.0001555604,0.00022634897,0.00042060224,0.00014616655,0.00017514412],"domain_scores_gemma":[0.9991743,0.0001944935,0.000058035086,0.00038051142,0.00014804162,0.0000446177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009819373,0.00006926564,0.00015592114,0.00012163155,0.000066561755,0.000038409682,0.00023845221,0.00007280431,0.00001397503],"category_scores_gemma":[0.00029110815,0.000056112014,0.000024566736,0.001004604,0.0002914694,0.0000046991504,0.00060949684,0.000099145815,0.0000013426779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002054234,0.00003063316,0.92237324,0.000012519072,0.00034564218,0.000006627994,0.00014763871,0.000035042514,0.07151181,0.000023116101,0.0033345423,0.001973778],"study_design_scores_gemma":[0.0007574066,0.00015371031,0.9825905,0.000013601576,0.00012451467,5.310425e-7,0.00051115116,0.002526668,0.008502602,0.000043360775,0.004667051,0.00010889838],"about_ca_topic_score_codex":0.0028400333,"about_ca_topic_score_gemma":0.008569904,"teacher_disagreement_score":0.06300921,"about_ca_system_score_codex":0.000019009225,"about_ca_system_score_gemma":0.00039583034,"threshold_uncertainty_score":0.47822073},"labels":[],"label_agreement":null},{"id":"W4387002182","doi":"10.1158/0008-5472.can-23-1475","title":"EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Optometric Education Trust Fund","funders":"Daiichi Sankyo Europe; National Cancer Institute; Stand Up To Cancer; Genentech; National Institutes of Health; National Cancer Institute - Singapore; Revolution Medicines; Memorial Sloan-Kettering Cancer Center; Fondation Bertarelli; Ipsen; Samuel Waxman Cancer Research Foundation; Cancer Prevention and Research Institute of Texas; Bristol-Myers Squibb; AstraZeneca; Dana-Farber Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Nut; Suppressor; Gene silencing; BRD4; Biology; Gene; Tumor suppressor gene; Cancer research; Bromodomain; Genetics; Histone; Carcinogenesis","score_opus":0.028696603845973133,"score_gpt":0.33023775541040806,"score_spread":0.30154115156443495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387002182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587476,0.0013488568,0.000054145894,0.0014277546,0.000098982346,0.00050712744,0.00012055113,0.000034519046,0.00053327053],"genre_scores_gemma":[0.9925188,0.0003235302,0.0000955631,0.00030782225,0.00037943322,0.00052300445,0.00017473412,0.00004356127,0.0056335456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982096,0.0001328727,0.00015503286,0.00051856396,0.00041364518,0.00057029317],"domain_scores_gemma":[0.9988725,0.000028058603,0.000028538398,0.00033506422,0.0005072272,0.00022860008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035481917,0.00015283919,0.00014522266,0.00013508105,0.00023564677,0.000087359076,0.00034499372,0.00007985556,0.000119441385],"category_scores_gemma":[0.0001699665,0.00012722811,0.000036349105,0.00061826117,0.00014020625,0.0000097683715,0.0002483612,0.00018636437,0.000116253264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119427335,0.000015652451,0.0030974143,0.00003441979,0.000020653226,0.000014428517,0.00013332568,0.000031864154,0.8673965,0.000031945776,0.12874892,0.000355492],"study_design_scores_gemma":[0.0003958749,0.00038020062,0.00092146965,0.000040232913,0.0000034520524,0.00000421739,0.00030639593,0.000039636478,0.95413655,0.0000097827,0.043579116,0.00018307452],"about_ca_topic_score_codex":0.00072038913,"about_ca_topic_score_gemma":0.0001871826,"teacher_disagreement_score":0.0867401,"about_ca_system_score_codex":0.000065304404,"about_ca_system_score_gemma":0.00035100005,"threshold_uncertainty_score":0.5188212},"labels":[],"label_agreement":null},{"id":"W4387241722","doi":"10.1158/0008-5472.can-23-2629","title":"A Landmark Paper That Introduced Proteasome Inhibition in Myeloma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Bortezomib; Proteasome; Proteasome inhibitor; Thalidomide; Medicine; Ubiquitin; Cancer research; Cancer; Disease; Immunology; Biology; Internal medicine; Cell biology; Genetics","score_opus":0.12636119859493644,"score_gpt":0.4338443846064408,"score_spread":0.3074831860115044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387241722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860445,0.00035192058,0.0000012427314,0.009176268,0.000062195795,0.0016398741,0.000023432174,0.00009871003,0.0026018126],"genre_scores_gemma":[0.9907721,0.0007673658,0.00003087044,0.00009682968,0.00031169024,0.002002674,0.000110208486,0.00003460271,0.0058736526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971851,0.00023529382,0.00016365096,0.0004365562,0.00108965,0.00088975794],"domain_scores_gemma":[0.9989524,0.0001602004,0.000018130115,0.00038152715,0.00019782376,0.0002899326],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011602454,0.00012207904,0.00023171844,0.00076262763,0.0001248009,0.000044665376,0.000081371254,0.0000955345,0.001001903],"category_scores_gemma":[0.00047607033,0.00009589495,0.000055666496,0.0016762521,0.00013058778,0.0001473055,0.00014738504,0.0006094355,0.00106367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004155173,0.0005427126,0.40735027,0.0008007681,0.00018713367,0.0049136016,0.0012394554,0.0000143932775,0.4304599,0.0002878638,0.039030783,0.11101795],"study_design_scores_gemma":[0.0070329495,0.00045513033,0.88293874,0.000585981,0.000008439414,0.000032588065,0.00039530807,0.00023310645,0.092031285,0.0007207284,0.015391474,0.00017425485],"about_ca_topic_score_codex":0.0010805561,"about_ca_topic_score_gemma":0.000615565,"teacher_disagreement_score":0.47558847,"about_ca_system_score_codex":0.00052260596,"about_ca_system_score_gemma":0.00042091776,"threshold_uncertainty_score":0.9999113},"labels":[],"label_agreement":null},{"id":"W4387397274","doi":"10.1158/0008-5472.can-23-1992","title":"XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Leukemia and Lymphoma Society","keywords":"DNA damage; Biology; Cancer research; DNA repair; Cancer; Nuclear export signal; Chemoimmunotherapy; Cancer cell; Genome instability; Telomere; DNA; Cell nucleus; Gene; Genetics; Immunotherapy","score_opus":0.06695154396672318,"score_gpt":0.36591134781767737,"score_spread":0.2989598038509542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387397274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977035,0.0009858073,0.00011260934,0.00011645688,0.00024074537,0.0004610181,0.00013361567,0.00000886134,0.00023741553],"genre_scores_gemma":[0.9960339,0.0011143889,0.000109675304,0.00002262582,0.00038477103,0.0003244886,0.00007395959,0.00002438811,0.001911788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989529,0.000056419773,0.00017048963,0.00030141018,0.00021383596,0.00030494196],"domain_scores_gemma":[0.9994154,0.000021860364,0.000053733173,0.00022527273,0.00024173733,0.000041976822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032651704,0.00008041287,0.00012259734,0.00012112368,0.00006672806,0.000010087962,0.00013784351,0.00011959183,0.000060704126],"category_scores_gemma":[0.00003117476,0.00007815557,0.000045493718,0.0003598798,0.00008758572,0.0000070920487,0.00006413185,0.000092906455,0.0000033911676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004573934,0.000013462416,0.0010039181,0.00008244483,0.000019763027,0.0000010217394,0.00014484128,0.0025521228,0.9829997,0.000063778905,0.0062857117,0.0063758865],"study_design_scores_gemma":[0.00048741224,0.00020211007,0.012949599,0.00006784059,0.0000040915143,2.3252936e-7,0.00020898688,0.0006360767,0.9753362,0.00028433074,0.009730448,0.00009267865],"about_ca_topic_score_codex":0.00043423127,"about_ca_topic_score_gemma":0.000713722,"teacher_disagreement_score":0.011945681,"about_ca_system_score_codex":0.000063736035,"about_ca_system_score_gemma":0.0001807167,"threshold_uncertainty_score":0.31870916},"labels":[],"label_agreement":null},{"id":"W4387529303","doi":"10.1158/0008-5472.can-23-2545","title":"The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"Daiichi Sankyo Europe; National Institutes of Health; National Cancer Institute; Strong; Samuel Waxman Cancer Research Foundation; Garron Family Cancer Centre; National Heart, Lung, and Blood Institute; Dana-Farber Cancer Institute; Amgen; Fondation Bertarelli; Cancer Prevention and Research Institute of Texas; Alex's Lemonade Stand Foundation for Childhood Cancer; Dana-Farber/Harvard Cancer Center; AstraZeneca","keywords":"Cancer research; Bromodomain; CD44; Biology; Epigenetics; BMI1; Transcriptome; BRD4; Pathology; Cell; Medicine; Stem cell; Cell biology; Gene expression; Genetics; Gene","score_opus":0.04429623205560875,"score_gpt":0.35837554359577195,"score_spread":0.3140793115401632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387529303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952984,0.0012997622,0.00007815723,0.0018030972,0.00013577248,0.00029457067,0.000021129435,0.000010125565,0.0010589701],"genre_scores_gemma":[0.9939944,0.003205768,0.000012517534,0.000024615301,0.00016633813,0.0001163645,0.000072065086,0.000010301312,0.002397602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990039,0.000119227,0.00016064488,0.0001532346,0.00031341577,0.00024961904],"domain_scores_gemma":[0.9994641,0.000024795321,0.000032551496,0.0002359248,0.00019180702,0.00005083835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006645805,0.000058969807,0.00006719147,0.000070920396,0.00022278706,0.000022458067,0.00020304906,0.00006970659,0.000029969035],"category_scores_gemma":[0.00007443082,0.000041277028,0.000047010777,0.00030358337,0.00015781354,0.000005297791,0.00007835929,0.00010309611,0.000023894689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008008419,0.000009755616,0.000484129,0.000030359333,0.000009681576,8.657789e-7,0.0002000536,0.000008743546,0.97463626,0.0002971711,0.0121735,0.012069391],"study_design_scores_gemma":[0.0002673155,0.00011375128,0.002862271,0.000021809974,0.0000016760742,9.093443e-7,0.00033844283,0.000115661875,0.91394085,0.00012072987,0.082165286,0.000051325285],"about_ca_topic_score_codex":0.0001576122,"about_ca_topic_score_gemma":0.000110106266,"teacher_disagreement_score":0.06999178,"about_ca_system_score_codex":0.000022210632,"about_ca_system_score_gemma":0.00015235534,"threshold_uncertainty_score":0.17135204},"labels":[],"label_agreement":null},{"id":"W4387764764","doi":"10.1158/0008-5472.can-23-1129","title":"Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"National Cancer Institute; Fondazione AIRC per la ricerca sul cancro ETS; Fondazione Regionale per la Ricerca Biomedica; National Human Genome Research Institute; Regione Lombardia; Associazione Italiana per la Ricerca sul Cancro","keywords":"Enhancer; Biology; Enhancer RNAs; Carcinogenesis; Epigenomics; Genetics; Gene; Chromatin; Transcription factor; Computational biology; Gene expression; DNA methylation","score_opus":0.038274428561875365,"score_gpt":0.36485681186941943,"score_spread":0.3265823833075441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387764764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782371,0.014675911,0.0049960352,0.00024270063,0.0009393827,0.00045931156,0.000113947506,0.000054407126,0.0002811989],"genre_scores_gemma":[0.98224413,0.008066915,0.0001904393,0.000042717435,0.0012414362,0.0006782394,0.0006118954,0.00008798132,0.006836245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974409,0.00014534057,0.00031208832,0.00066176266,0.0005916674,0.00084827625],"domain_scores_gemma":[0.9986968,0.000062369865,0.000110086774,0.0006088042,0.00033669753,0.00018521432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007042667,0.00025560704,0.00023916975,0.000220332,0.00054291537,0.00017898675,0.00042990452,0.00019985513,0.0011448176],"category_scores_gemma":[0.000028854933,0.0002530883,0.00014547499,0.0005257109,0.00020861857,0.000019418441,0.00029660456,0.00033996798,0.000060940794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005617316,0.000025381732,0.0019936739,0.00007300315,0.00020611168,0.000009351832,0.00029232854,0.06830887,0.89324796,0.000019146994,0.032345183,0.0034228396],"study_design_scores_gemma":[0.0009647412,0.00014092517,0.058306463,0.00022458036,0.00004832558,0.000014097176,0.0006419579,0.03300348,0.89337975,0.000856049,0.011600825,0.00081881636],"about_ca_topic_score_codex":0.00019583119,"about_ca_topic_score_gemma":0.00020466515,"teacher_disagreement_score":0.05631279,"about_ca_system_score_codex":0.0003920964,"about_ca_system_score_gemma":0.0005379067,"threshold_uncertainty_score":0.99999213},"labels":[],"label_agreement":null},{"id":"W4387893341","doi":"10.1158/0008-5472.can-23-1362","title":"Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Clear cell; Biology; Clear cell carcinoma; Cancer research; Carcinogenesis; Ovarian cancer; Endometrial cancer; ARID1A; Estrogen receptor; Carcinoma; Cancer; Gene; Genetics; Mutation; Breast cancer","score_opus":0.10151018179538283,"score_gpt":0.39247657291981786,"score_spread":0.290966391124435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387893341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937261,0.003091371,0.000012441179,0.00038068456,0.0001386092,0.0004969882,0.000050300474,0.000039586583,0.0020639382],"genre_scores_gemma":[0.99660164,0.0007301105,0.00016678477,0.000012321035,0.00003713159,0.00015058352,0.000031307158,0.000036643094,0.0022334484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975509,0.0001022509,0.00051147485,0.00031155103,0.00096333766,0.0005605099],"domain_scores_gemma":[0.9985334,0.0002484803,0.00012022855,0.000296812,0.0005639714,0.00023708444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011843549,0.00013683489,0.00042443394,0.00079425354,0.000098460674,0.000009976362,0.00018755723,0.00006773747,0.00063325436],"category_scores_gemma":[0.00024828,0.0001135089,0.00009381013,0.0027627684,0.00019609478,0.0000462811,0.00012409779,0.00032793728,0.00006339931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022120809,0.00064734503,0.38842374,0.0041428944,0.000478327,0.00009662942,0.008300335,0.000034470482,0.42510894,0.00009269597,0.019025195,0.15143736],"study_design_scores_gemma":[0.002355846,0.0005979362,0.41048008,0.0004301884,0.000047243117,0.0000020537886,0.00024913775,0.000096984266,0.56580776,0.000046986625,0.019724,0.00016181638],"about_ca_topic_score_codex":0.0012668477,"about_ca_topic_score_gemma":0.00009508349,"teacher_disagreement_score":0.15127553,"about_ca_system_score_codex":0.0005330685,"about_ca_system_score_gemma":0.00172524,"threshold_uncertainty_score":0.6933691},"labels":[],"label_agreement":null},{"id":"W4388006468","doi":"10.1158/1538-7445.am2023-1030","title":"Abstract 1030: Development of a genome-wide methylome enrichment platform for multi-cancer early detection (MCED)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Association of Canadian Map Libraries and Archives","funders":"","keywords":"Cancer; DNA methylation; Receiver operating characteristic; Stage (stratigraphy); Oncology; Confidence interval; Methylation; Cell-free fetal DNA; Bisulfite; Internal medicine; Medicine; Biology; DNA; Genetics; Gene; Gene expression","score_opus":0.11168845420182497,"score_gpt":0.4012634242657466,"score_spread":0.28957497006392163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388006468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352926,0.0020936786,0.0030632624,0.00008615374,0.00022248577,0.00072119245,0.00016776077,0.000017389912,0.00009881834],"genre_scores_gemma":[0.9928673,0.0027730197,0.0012221404,0.00004674507,0.00030349405,0.0015808003,0.00009699985,0.000045442266,0.0010640618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835,0.000017888418,0.00033449093,0.00042391487,0.00032026393,0.000553421],"domain_scores_gemma":[0.99896973,0.0001101715,0.00008924696,0.0002903903,0.00040597303,0.00013445938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082035136,0.00014604085,0.00018240776,0.00019866445,0.00020625583,0.000035714005,0.00026777203,0.00014395476,0.00005304688],"category_scores_gemma":[0.00019882606,0.00014627467,0.00009510902,0.00035273665,0.000089100395,0.0000058161236,0.00021071416,0.00015322988,0.000023399189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028946457,0.000059757098,0.0013890729,0.00015561895,0.00013667821,0.000001451894,0.0004058983,0.0005556991,0.9580524,0.0000139620115,0.000922556,0.03801743],"study_design_scores_gemma":[0.0010350075,0.00019362466,0.05899388,0.000033918546,0.000010465062,2.7073233e-7,0.0001758975,0.000102941565,0.8315525,0.00006968846,0.10763323,0.0001985809],"about_ca_topic_score_codex":0.00034321414,"about_ca_topic_score_gemma":0.0012328348,"teacher_disagreement_score":0.12649992,"about_ca_system_score_codex":0.00024073594,"about_ca_system_score_gemma":0.00069602724,"threshold_uncertainty_score":0.5964908},"labels":[],"label_agreement":null},{"id":"W4388281394","doi":"10.1158/0008-5472.can-23-1290","title":"Targeting MTHFD2 to Exploit Cancer-Specific Metabolism and the DNA Damage Response","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Blood Cancer UK; Novo Nordisk Fonden; Sheffield Hospitals Charity; University of Sheffield; Wellcome Trust","keywords":"Cancer; Cancer research; Cancer cell; Biology; Medicine; Genetics","score_opus":0.059840910614569386,"score_gpt":0.3754366788392715,"score_spread":0.31559576822470214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388281394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513109,0.039779026,0.000054102322,0.0064715003,0.0012933956,0.0006693314,0.00011262326,0.000036966896,0.00027215827],"genre_scores_gemma":[0.8892004,0.08512818,0.000100638536,0.0009251103,0.007068429,0.0021781551,0.0000506863,0.000107603126,0.015240806],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714196,0.0006583828,0.00023482993,0.00064770726,0.00052015117,0.0007969794],"domain_scores_gemma":[0.99862444,0.00016995896,0.00004368429,0.0006023693,0.0003032556,0.00025629628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034166425,0.00018911518,0.00026784968,0.00020598673,0.00045892553,0.00012664053,0.00050253526,0.00012288104,0.00013255581],"category_scores_gemma":[0.0005183011,0.00014387084,0.0000888863,0.00088375347,0.00042974524,0.000009502884,0.0006007715,0.0003427675,0.000070114256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025189922,0.000009222973,0.000042533855,0.000018902096,0.000047578364,0.0000033434978,0.0008463003,0.000117293705,0.82572824,0.00028218556,0.15882334,0.011562045],"study_design_scores_gemma":[0.0013245807,0.00004222808,0.0026373013,0.000024008912,0.000011720344,0.0000017731056,0.0007485259,0.000027455842,0.10458193,0.00011338957,0.89030284,0.00018423323],"about_ca_topic_score_codex":0.00057970575,"about_ca_topic_score_gemma":0.00020676015,"teacher_disagreement_score":0.7314795,"about_ca_system_score_codex":0.000051342457,"about_ca_system_score_gemma":0.00035985763,"threshold_uncertainty_score":0.5866883},"labels":[],"label_agreement":null},{"id":"W4388866319","doi":"10.1158/0008-5472.can-22-2948","title":"Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Hospital for Sick Children; Institute for Work & Health; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Generalitat de Catalunya; University of Pennsylvania; Centres de Recerca de Catalunya; U.S. Department of Defense","keywords":"Synthetic lethality; Biology; Cancer research; Gene knockdown; CRISPR; Regulator; Topoisomerase; Cancer; Gene; DNA repair; Genetics; In vitro","score_opus":0.16552091427197432,"score_gpt":0.45339567540482567,"score_spread":0.2878747611328514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388866319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494964,0.00048649136,0.00009080095,0.0033268074,0.00023365098,0.000689134,0.00007835207,0.000024412575,0.00012070454],"genre_scores_gemma":[0.99617445,0.0010503363,0.000031012965,0.00035588423,0.00029452922,0.0009532906,0.000080643236,0.00003575763,0.0010241158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981753,0.00017145151,0.00020873144,0.00052483246,0.00038029242,0.00053934724],"domain_scores_gemma":[0.99922436,0.000027953527,0.00003574588,0.00035826015,0.00021207318,0.00014159214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077147275,0.0001364122,0.00015110997,0.00024826574,0.00012394237,0.0000473102,0.00015217738,0.00015271879,0.00011969986],"category_scores_gemma":[0.000075454685,0.00013715899,0.000051046536,0.00083305186,0.00005963447,0.000008664184,0.00019216168,0.00024715724,0.000047170914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001465417,0.000044383567,0.000651598,0.000045388693,0.00002004905,0.0000102162785,0.00032866155,0.0010769899,0.98204905,0.00010314369,0.0008917129,0.014632295],"study_design_scores_gemma":[0.0005818909,0.00019473897,0.0037791382,0.00014718233,0.000006272935,0.00000181348,0.000158803,0.00039928948,0.97968584,0.0005295798,0.01429943,0.00021601294],"about_ca_topic_score_codex":0.0021196976,"about_ca_topic_score_gemma":0.0034130304,"teacher_disagreement_score":0.014416281,"about_ca_system_score_codex":0.00020889143,"about_ca_system_score_gemma":0.00031957665,"threshold_uncertainty_score":0.5593181},"labels":[],"label_agreement":null},{"id":"W4389992996","doi":"10.1158/0008-5472.can-23-0900","title":"CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; World Health Organization","keywords":"Lung cancer; Consumption (sociology); Cigarette smoking; CYP2A6; Medicine; Environmental health; Cancer; Oncology; Internal medicine; Sociology; Metabolism","score_opus":0.050982808518283705,"score_gpt":0.4068027135811094,"score_spread":0.35581990506282574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389992996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575263,0.002545302,0.000010643938,0.0010520441,0.0001786833,0.0002895222,0.00007665431,0.000019640414,0.00007490532],"genre_scores_gemma":[0.99321336,0.005907832,0.0000014622334,0.000050600753,0.00007935581,0.00015665595,0.000044382985,0.000019515897,0.0005268241],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985944,0.00020437577,0.0001420672,0.0004309425,0.00021441128,0.00041381302],"domain_scores_gemma":[0.99951553,0.00005138429,0.000020450914,0.00023516049,0.00008210942,0.000095354095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007130716,0.00011052508,0.00012859513,0.00013452995,0.0001070761,0.000032796303,0.000121931575,0.00015393896,0.00025827545],"category_scores_gemma":[0.00005249395,0.00010748768,0.00004231514,0.0003160305,0.00018339336,0.0000087290455,0.00011454003,0.00039284682,0.0000064841443],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000252914,0.00002928741,0.2169325,0.00009276116,0.000051043175,0.000014676405,0.0002407924,0.00010972052,0.7716774,0.00002158648,0.0015576418,0.009019713],"study_design_scores_gemma":[0.0016002107,0.00017719423,0.70686495,0.00020666255,0.000019263938,0.000005673362,0.00008171103,0.0012438348,0.28675994,0.00009461778,0.002631308,0.00031464573],"about_ca_topic_score_codex":0.0024787881,"about_ca_topic_score_gemma":0.003971272,"teacher_disagreement_score":0.48993242,"about_ca_system_score_codex":0.00009691427,"about_ca_system_score_gemma":0.00014814522,"threshold_uncertainty_score":0.438322},"labels":[],"label_agreement":null},{"id":"W4390726324","doi":"10.1158/1538-7445.dnarepair24-b001","title":"Abstract B001: Identification of monoallelic <i>ATM</i> loss-of-function and homologous recombination deficiency (HRD) in high-grade ovarian tumor with prolonged response to camonsertib and low-dose gemcitabine combination therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Debulking; Olaparib; Internal medicine; Oncology; Ovarian cancer; Neutropenia; Progressive disease; Cisplatin; Surgery; Chemotherapy; Cancer","score_opus":0.04393376931211829,"score_gpt":0.36786548185211565,"score_spread":0.32393171253999736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390726324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948,0.0032001848,0.00014789464,0.0052663623,0.00013781991,0.0016596032,0.00002977673,0.000041051968,0.00003728023],"genre_scores_gemma":[0.9978157,0.0011440845,0.00007273557,0.00007061541,0.000033747077,0.000643286,0.000024328323,0.000035198904,0.00016026312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99785215,0.0002924565,0.00048890413,0.0004883475,0.0005954707,0.00028268175],"domain_scores_gemma":[0.9986647,0.00033287724,0.000116150266,0.00030563265,0.0004705203,0.00011016935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024942064,0.00014937873,0.00028183722,0.0009112823,0.00008667121,0.000050679006,0.00009390332,0.00008443869,0.00004056968],"category_scores_gemma":[0.00016746603,0.00012971666,0.000026509157,0.0012940418,0.00029562874,0.00022808443,0.000028221946,0.00037627044,0.0000040458553],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016139286,0.0005723556,0.014384208,0.00068273436,0.00005129753,0.00005605069,0.0015874351,0.0000873261,0.952071,0.0014091567,0.000132725,0.012826388],"study_design_scores_gemma":[0.006027077,0.0023941195,0.85082585,0.0008926388,0.00002048617,0.000043158157,0.00021087167,0.00048581947,0.1359254,0.0028777556,0.00013813566,0.00015870485],"about_ca_topic_score_codex":0.00081493706,"about_ca_topic_score_gemma":0.00013958267,"teacher_disagreement_score":0.83644164,"about_ca_system_score_codex":0.00038091428,"about_ca_system_score_gemma":0.00046352734,"threshold_uncertainty_score":0.52896917},"labels":[],"label_agreement":null},{"id":"W4390728809","doi":"10.1158/1538-7445.dnarepair24-pr009","title":"Abstract PR009: SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Immune checkpoint; Innate immune system; Cancer research; Biology; Cancer immunotherapy; Cancer; Immunotherapy; Immunology; Genetics","score_opus":0.057468567070748905,"score_gpt":0.37186751856501926,"score_spread":0.31439895149427033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390728809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9525355,0.046206977,0.000037909183,0.0005124452,0.00010432232,0.00031949833,0.000059162925,0.000012518252,0.00021166704],"genre_scores_gemma":[0.9959069,0.0024455308,0.00010026715,0.000016989678,0.00017820079,0.00016879226,0.000034977827,0.00003268862,0.001115652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985529,0.00007662054,0.00024792113,0.00044878726,0.00036629068,0.0003074711],"domain_scores_gemma":[0.99920624,0.00003402781,0.00005756006,0.00040215135,0.00021674759,0.00008327971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000731673,0.00012970131,0.00015872349,0.00011800739,0.00014482392,0.000080960664,0.00018123869,0.00011246415,0.00021555572],"category_scores_gemma":[0.000051511866,0.00010583213,0.000074678224,0.0002146383,0.00021583549,0.000014559145,0.00020684354,0.000254743,0.0000062814047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016384486,0.000034339875,0.00017023819,0.0003024905,0.0000396433,0.0000061378796,0.00022066737,0.000008418823,0.988683,0.000040432184,0.001036852,0.009293939],"study_design_scores_gemma":[0.00024801889,0.0001243012,0.0056557483,0.00053727295,0.000008186929,0.0000066183484,0.00015687144,0.0000840528,0.9828415,0.00014857393,0.010065617,0.00012322502],"about_ca_topic_score_codex":0.00019279121,"about_ca_topic_score_gemma":0.0000060743173,"teacher_disagreement_score":0.043761443,"about_ca_system_score_codex":0.000044748704,"about_ca_system_score_gemma":0.00029580537,"threshold_uncertainty_score":0.43157092},"labels":[],"label_agreement":null},{"id":"W4390757470","doi":"10.1158/1538-7445.dnarepair24-ia003","title":"Abstract IA003: Molecular and imaging biomarkers of PARP inhibitors for small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Context (archaeology); PARP inhibitor; Cancer; Cancer research; Liquid biopsy; Positron emission tomography; Biomarker; Oncology; Poly ADP ribose polymerase; Bioinformatics; Pathology; Internal medicine; Nuclear medicine; DNA; Biology; Genetics","score_opus":0.04924374847328876,"score_gpt":0.4434771862253096,"score_spread":0.39423343775202085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390757470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7810196,0.20807691,0.00009183548,0.005992132,0.0003429956,0.0018421261,0.0001623305,0.000064883876,0.0024071445],"genre_scores_gemma":[0.9905693,0.0064678118,0.00020608256,0.0000734437,0.00035366532,0.0012885068,0.0000097854445,0.00007611686,0.00095530995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974685,0.000062092855,0.00030137302,0.0005865135,0.000784924,0.000796635],"domain_scores_gemma":[0.9983686,0.0004266048,0.000037659418,0.00030447083,0.0005915627,0.00027105957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234391,0.00018960182,0.0003449993,0.0005057359,0.0001427373,0.00008512328,0.00016679152,0.000071164985,0.00018530255],"category_scores_gemma":[0.00021191739,0.00015763733,0.00013144527,0.00070123456,0.0005148272,0.00010188769,0.00021137277,0.0005146466,0.0000037254877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007385455,0.000084169624,0.034877475,0.018607382,0.0008855522,0.00027979692,0.001347525,0.000019467454,0.7954581,0.00018482532,0.09746369,0.050053496],"study_design_scores_gemma":[0.003489387,0.00035320886,0.013076582,0.006524201,0.00034189416,0.000013988703,0.0015321681,0.0026084564,0.913618,0.0004370615,0.057501018,0.00050399086],"about_ca_topic_score_codex":0.002862808,"about_ca_topic_score_gemma":0.00018046661,"teacher_disagreement_score":0.20954964,"about_ca_system_score_codex":0.00066115387,"about_ca_system_score_gemma":0.0013391742,"threshold_uncertainty_score":0.6428264},"labels":[],"label_agreement":null},{"id":"W4390779193","doi":"10.1158/1538-7445.dnarepair24-ia020","title":"Abstract IA020: Micronuclei are a nexus of DNA damage signaling and genomic instability","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Genome instability; Micronucleus test; DNA damage; Chromothripsis; Biology; Chromatin; DNA repair; Chromosome instability; Cell biology; Genetics; Cancer research; DNA; Gene; Chemistry; Chromosome","score_opus":0.0641664662003624,"score_gpt":0.3693618925466047,"score_spread":0.3051954263462423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390779193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95770055,0.040480994,0.000003545781,0.000345187,0.0002974558,0.00019739762,0.00011204436,0.000034221837,0.0008286277],"genre_scores_gemma":[0.997916,0.00048965786,0.000005970257,0.000024130195,0.000031677533,0.000027535922,0.000010593822,0.000020005695,0.0014744252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987454,0.00026656204,0.00023630499,0.0003112716,0.00005260305,0.00038789492],"domain_scores_gemma":[0.9991946,0.00037650493,0.000032550975,0.00024714388,0.00012341999,0.000025743608],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088373234,0.000109997694,0.00021407715,0.00021308818,0.00013828589,0.0000464151,0.00021572482,0.00014883192,0.0021849596],"category_scores_gemma":[0.000110571076,0.00009420025,0.00006300852,0.00017844372,0.0006332507,0.00008112929,0.00018743068,0.00063143065,0.00022351214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046941175,0.000035874305,0.0004021988,0.0003001071,0.00010275874,0.000014242711,0.00110294,0.0000016944241,0.9901896,0.00023448459,0.001733529,0.0054131225],"study_design_scores_gemma":[0.00038241036,0.00014235213,0.02708358,0.00035872447,0.000011395549,0.000015617179,0.0014407085,0.000004587824,0.9237623,0.00015791712,0.04652183,0.00011857844],"about_ca_topic_score_codex":0.0005563511,"about_ca_topic_score_gemma":0.00007411974,"teacher_disagreement_score":0.066427335,"about_ca_system_score_codex":0.00013271824,"about_ca_system_score_gemma":0.00026660284,"threshold_uncertainty_score":0.9987272},"labels":[],"label_agreement":null},{"id":"W4390836742","doi":"10.1158/1538-7445.dnarepair24-a033","title":"Abstract A033: The ING5 epigenetic reader regulates a subset of DNA repair genes to maintain genomic integrity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; DNA repair; Epigenetics; DNA damage; Histone; Stem cell; Cell biology; Genetics; Molecular biology; Cancer research; Gene; DNA","score_opus":0.06785037486901964,"score_gpt":0.3972528313033918,"score_spread":0.32940245643437216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390836742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96349365,0.03389791,0.00020376402,0.0013940452,0.00017808953,0.00039468834,0.00005721892,0.000018987375,0.00036165596],"genre_scores_gemma":[0.9943202,0.003903452,0.00030007024,0.000048412257,0.00043529898,0.00012595633,0.00003922871,0.000036863592,0.0007905037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983294,0.00019226124,0.00028320221,0.00046839312,0.00033000848,0.00039676306],"domain_scores_gemma":[0.998896,0.00010617981,0.000034002285,0.0005861863,0.0002650233,0.000112597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017623282,0.00013517268,0.0001383745,0.00012896067,0.00012228181,0.000065296736,0.00036232028,0.00015670086,0.00010315472],"category_scores_gemma":[0.00019269498,0.00010051147,0.00012375611,0.00035541208,0.00020992615,0.0000036842318,0.00023696484,0.00031595473,0.000027944927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007094733,0.000019202062,0.0016434721,0.00010074612,0.00008026527,0.000004668422,0.00021452425,0.00029404776,0.98029035,0.00025232785,0.0017951095,0.0152343325],"study_design_scores_gemma":[0.00008938221,0.00017575416,0.03553972,0.00007650316,0.000012430401,0.0000014088625,0.00017740995,0.0000958015,0.9044646,0.0012010918,0.058033373,0.00013249514],"about_ca_topic_score_codex":0.0006564051,"about_ca_topic_score_gemma":0.0005613222,"teacher_disagreement_score":0.07582573,"about_ca_system_score_codex":0.000081753824,"about_ca_system_score_gemma":0.00038718665,"threshold_uncertainty_score":0.40987387},"labels":[],"label_agreement":null},{"id":"W4390914920","doi":"10.1158/1538-7445.panca2023-pr12","title":"Abstract PR12: Targeting CDK7/9 in basal pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cyclin-dependent kinase 7; Biology; Cancer research; Basal (medicine); Histone deacetylase; Cell biology; Kinase; Protein kinase A; Genetics; Gene; Histone; Cyclin-dependent kinase 2; Endocrinology","score_opus":0.08348506235782635,"score_gpt":0.46145680681395834,"score_spread":0.377971744456132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390914920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9053748,0.08257665,0.000052348638,0.006816582,0.0005587445,0.0008104577,0.00005057405,0.00017736385,0.0035824736],"genre_scores_gemma":[0.9908337,0.0028337066,0.0002598492,0.0002591331,0.0012575089,0.0010310232,0.000013101872,0.00009575178,0.0034162048],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971937,0.00008673688,0.00033899245,0.0005977754,0.0008576885,0.00092512456],"domain_scores_gemma":[0.9988694,0.00031866692,0.000028341175,0.00032199945,0.00023555351,0.00022601032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001006278,0.00020370109,0.00036050205,0.00047770655,0.0001032206,0.00008116412,0.00019709302,0.00011465642,0.0044178637],"category_scores_gemma":[0.00016505804,0.00017176993,0.000085191445,0.001232022,0.00024787977,0.00023914038,0.00008710507,0.001225822,0.00018012071],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019342698,0.00023247406,0.053691644,0.004695553,0.00045345433,0.001776098,0.0045286254,0.0007258593,0.5118015,0.00094836304,0.02072627,0.39848593],"study_design_scores_gemma":[0.005978947,0.00051349576,0.26878065,0.018749185,0.00014191076,0.000077306264,0.0036102198,0.0024944185,0.13312624,0.007029616,0.5581509,0.0013471113],"about_ca_topic_score_codex":0.0034687095,"about_ca_topic_score_gemma":0.0006630893,"teacher_disagreement_score":0.5374246,"about_ca_system_score_codex":0.0015288551,"about_ca_system_score_gemma":0.0013741837,"threshold_uncertainty_score":0.9964922},"labels":[],"label_agreement":null},{"id":"W4390915013","doi":"10.1158/1538-7445.panca2023-b055","title":"Abstract B055: Hyperinsulinemia acts via acinar cell insulin receptors to drive obesity-associated pancreatic cancer initiation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; University of British Columbia","funders":"","keywords":"Hyperinsulinemia; Endocrinology; Internal medicine; Insulin; Pancreatic cancer; Biology; Insulin receptor; Pancreas; Cancer; Cancer research; Pancreatic Intraepithelial Neoplasia; Medicine; Insulin resistance","score_opus":0.03194762671280462,"score_gpt":0.34951104661614046,"score_spread":0.31756341990333586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663227,0.027937595,0.000074594514,0.000582642,0.0020686034,0.00061788905,0.00019435023,0.000057775735,0.0021438594],"genre_scores_gemma":[0.9706815,0.021894585,0.00006987063,0.00027453853,0.0030711663,0.00054916483,0.0002210289,0.00007985519,0.0031582818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974628,0.00016090952,0.00031369913,0.00075219624,0.0005556659,0.0007547055],"domain_scores_gemma":[0.99864423,0.000063373256,0.000058343096,0.00041183492,0.0004838246,0.00033836666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006896091,0.00025873558,0.0002884746,0.00024330412,0.00021240488,0.00013041768,0.00035809499,0.00031486,0.0005498504],"category_scores_gemma":[0.00023226495,0.00025500928,0.00012686382,0.00080693676,0.000102514445,0.000020879099,0.00020203622,0.0005556027,0.00018543698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018770431,0.00009781009,0.0008152502,0.00019803742,0.00010949988,0.000006846526,0.00058963936,0.00020722768,0.957947,0.000015689422,0.022124572,0.017700681],"study_design_scores_gemma":[0.00059477787,0.00018808032,0.013240236,0.00019343196,0.000042596334,0.0000020079558,0.00015712013,0.000046438367,0.50003934,0.000055274024,0.48509222,0.0003484641],"about_ca_topic_score_codex":0.0014251657,"about_ca_topic_score_gemma":0.0013675427,"teacher_disagreement_score":0.46296763,"about_ca_system_score_codex":0.00040113865,"about_ca_system_score_gemma":0.0010359891,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W4390915074","doi":"10.1158/1538-7445.panca2023-a046","title":"Abstract A046: nSMase2-generated ceramide promotes PDA aggression through exosome reprogramming of the stroma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Exosome; Microvesicles; Biology; Small hairpin RNA; Cancer research; Cell biology; Ceramide; Pancreatic cancer; Stromal cell; Tumor microenvironment; microRNA; Reprogramming; Hepatic stellate cell; Cell culture; Cell; Immune system; Apoptosis; Immunology; Cancer; Gene knockdown; Endocrinology; Gene; Genetics","score_opus":0.059824351170454336,"score_gpt":0.4000615029529131,"score_spread":0.3402371517824588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567943,0.041473046,0.000041353214,0.00047181477,0.0002819017,0.0004274637,0.00006215221,0.000027310949,0.00042065096],"genre_scores_gemma":[0.9967034,0.0012084547,0.0002315814,0.00002736535,0.00043885745,0.00012977488,0.000051781935,0.00004822742,0.0011605631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980473,0.00018651462,0.00025920433,0.0005516109,0.0005126393,0.0004427677],"domain_scores_gemma":[0.99879086,0.00004241384,0.000060249127,0.0007832042,0.0002273038,0.00009594506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006058943,0.00014701062,0.00012553287,0.000051145344,0.00016686459,0.00009342381,0.0005040083,0.00015522857,0.00012314253],"category_scores_gemma":[0.00027165803,0.000104475104,0.00014013967,0.00044890086,0.00036910048,0.000011351544,0.00035964715,0.00039245945,0.000015017278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072264425,0.00006907128,0.0008113879,0.00026041572,0.000064470114,0.0000351055,0.00009992169,0.000049954386,0.98003167,0.00009535205,0.0035440396,0.014866326],"study_design_scores_gemma":[0.00017636921,0.000087389024,0.0011743737,0.00057952426,0.00001288732,0.0000059665413,0.00007289501,0.000077281504,0.9736499,0.00045292222,0.02358765,0.00012282924],"about_ca_topic_score_codex":0.00020401034,"about_ca_topic_score_gemma":0.00004854332,"teacher_disagreement_score":0.04026459,"about_ca_system_score_codex":0.00006821624,"about_ca_system_score_gemma":0.00049558637,"threshold_uncertainty_score":0.42603713},"labels":[],"label_agreement":null},{"id":"W4390915122","doi":"10.1158/1538-7445.panca2023-a086","title":"Abstract A086: TFEB protects pancreatic cancer cells against nucleolar stress","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"TFEB; Autophagy; Cancer research; Biology; Pancreatic cancer; Gemcitabine; Cell biology; Cancer; Apoptosis; Biochemistry; Genetics","score_opus":0.06077962629190455,"score_gpt":0.39234035085260677,"score_spread":0.33156072456070224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397218,0.044323366,0.000042120166,0.0025259375,0.0010519956,0.0023982038,0.00030156173,0.00034480725,0.009290199],"genre_scores_gemma":[0.9841424,0.008550086,0.000081041166,0.00024764077,0.0011339742,0.0015036757,0.00003530683,0.00018479124,0.0041210367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960745,0.00013230713,0.0003750788,0.00087274355,0.0014417048,0.0011036793],"domain_scores_gemma":[0.9981013,0.00015837987,0.000047145357,0.0007650228,0.00042981646,0.0004983256],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075599924,0.0003056197,0.00043542078,0.00051722646,0.00021861788,0.00020155334,0.00032270965,0.00028342093,0.0022293904],"category_scores_gemma":[0.00013121356,0.00027117308,0.00019788278,0.0012985348,0.00029643328,0.00015286212,0.0001560308,0.0020625838,0.00068188645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026446415,0.000110558474,0.00017307159,0.0026262647,0.00035530154,0.0013698266,0.000681018,0.00035137517,0.92796737,0.00008848152,0.021268228,0.04474402],"study_design_scores_gemma":[0.0012497044,0.00025133643,0.0021341378,0.0070720627,0.00011623504,0.000018445524,0.00022368181,0.0010240432,0.8743482,0.000086444226,0.1130668,0.00040888882],"about_ca_topic_score_codex":0.0026709815,"about_ca_topic_score_gemma":0.00046711328,"teacher_disagreement_score":0.091798574,"about_ca_system_score_codex":0.001573858,"about_ca_system_score_gemma":0.0025267461,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W4390915129","doi":"10.1158/1538-7445.panca2023-a040","title":"Abstract A040: Assessing the ability of Fc3TSR to remodel the tumor microenvironment and enhance efficacy of immunotherapies and chemotherapy in a murine model of pancreatic ductal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Gemcitabine; Tumor microenvironment; Pancreatic cancer; Cancer research; Cancer; Metastasis; Angiogenesis; Adenocarcinoma; Internal medicine; Pathology","score_opus":0.035455894598994286,"score_gpt":0.37309708786233164,"score_spread":0.33764119326333736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95070374,0.048110187,0.00012682875,0.0006901826,0.000013665039,0.0003033788,0.000023293898,0.000001201974,0.000027531538],"genre_scores_gemma":[0.99366647,0.005974917,0.00015861302,0.00004305841,0.000038612132,0.000055578315,0.0000014325564,0.000015753358,0.000045580462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991003,0.0000668037,0.000226214,0.00025850994,0.00017948887,0.0001686364],"domain_scores_gemma":[0.99947655,0.000089279,0.000044862656,0.0003121868,0.00005093975,0.000026162676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000698487,0.00009017941,0.000161454,0.00004198214,0.000043094464,0.000017550185,0.00016709685,0.00003933583,0.00001500596],"category_scores_gemma":[0.00002781778,0.000055581153,0.00004979869,0.00011820985,0.0004508304,0.000005572897,0.00011086718,0.000106322295,1.4661462e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018300953,0.00004173334,0.008829575,0.00021371282,0.000057496054,5.3503874e-7,0.00074537867,0.00045267915,0.98527145,0.00002155218,0.00004653544,0.0041363547],"study_design_scores_gemma":[0.0002778497,0.00011064551,0.3172834,0.0002099045,0.000010650417,0.0000027088454,0.00031794608,0.0010761798,0.6803779,0.00011972793,0.00014324072,0.000069838046],"about_ca_topic_score_codex":0.00029278998,"about_ca_topic_score_gemma":0.000031399613,"teacher_disagreement_score":0.30845383,"about_ca_system_score_codex":0.00003353698,"about_ca_system_score_gemma":0.00013988314,"threshold_uncertainty_score":0.22665337},"labels":[],"label_agreement":null},{"id":"W4390915191","doi":"10.1158/1538-7445.panca2023-b090","title":"Abstract B090: Targeting the unfolded protein response enhances sensitivity to chemotherapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Unfolded protein response; Pancreatic cancer; Cancer research; Gemcitabine; Activating transcription factor; Organoid; Cancer cell; Integrated stress response; Biology; Cancer; Transcriptome; Medicine; Internal medicine; Cell biology; Endoplasmic reticulum; Gene expression; Messenger RNA; Gene","score_opus":0.08497424538435476,"score_gpt":0.4715250302868815,"score_spread":0.3865507849025267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93525726,0.0020952348,0.00009578765,0.057662178,0.000111540074,0.0017403371,0.000014073103,0.000089350986,0.00293426],"genre_scores_gemma":[0.98504055,0.00034255366,0.00029518164,0.0004751603,0.0006809671,0.00075981714,0.0000035546113,0.00003907185,0.012363173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967412,0.0007371681,0.00024293123,0.00046377702,0.0010327578,0.00078218465],"domain_scores_gemma":[0.99692744,0.0019674827,0.000019375238,0.00042020422,0.00037769318,0.0002877855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009707437,0.00014460349,0.000324371,0.00027069834,0.00033904487,0.000121872916,0.00018790991,0.000121883495,0.0014249963],"category_scores_gemma":[0.0016271031,0.00008917701,0.000086347856,0.00098842,0.0003932859,0.00007638782,0.000109843815,0.0010815416,0.00063172914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039248588,0.00006679225,0.0011076261,0.00026834593,0.00013373859,0.0004707722,0.0016970241,0.0000026534883,0.94212455,0.00015188957,0.02882507,0.021226685],"study_design_scores_gemma":[0.0015121496,0.0012475181,0.097163275,0.0022361665,0.000051568768,0.000070316986,0.0019955745,0.001143239,0.656614,0.0009381502,0.2366667,0.0003613339],"about_ca_topic_score_codex":0.0008640836,"about_ca_topic_score_gemma":0.0001112963,"teacher_disagreement_score":0.28551054,"about_ca_system_score_codex":0.00048989744,"about_ca_system_score_gemma":0.0019142864,"threshold_uncertainty_score":0.9994878},"labels":[],"label_agreement":null},{"id":"W4390915206","doi":"10.1158/1538-7445.panca2023-ia15","title":"Abstract IA15: What the surgeon has learned from pancreas cancer genomics, and vice versa","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genomics; Disease; Medicine; Genome; Biology; Genetics; Internal medicine; Gene","score_opus":0.21024805566704857,"score_gpt":0.45422348099422455,"score_spread":0.24397542532717598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84443593,0.10620848,0.0000060789007,0.046013147,0.00040686844,0.0006297543,0.0000648865,0.000053456948,0.0021814087],"genre_scores_gemma":[0.8578507,0.13438427,0.000045219032,0.00041243405,0.00090811827,0.00039595185,0.000029616738,0.000049422004,0.005924266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973128,0.00024033745,0.0002628607,0.00060017663,0.00081816944,0.00076566334],"domain_scores_gemma":[0.99700034,0.0018393374,0.000028710014,0.0004910426,0.00029288442,0.00034769112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020114623,0.00017702508,0.00043584092,0.0001958302,0.00042617298,0.00051372405,0.00025708342,0.00019385773,0.004415894],"category_scores_gemma":[0.0002585807,0.0001170801,0.00008367602,0.00046348677,0.0009577092,0.00024922393,0.00019547339,0.001372935,0.00034380512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042137485,0.00027354545,0.15342666,0.0015766972,0.002789168,0.001598484,0.01338514,0.000021654945,0.109906875,0.00093497377,0.15911265,0.5527604],"study_design_scores_gemma":[0.0019647651,0.00027934476,0.23354904,0.0020643803,0.0003264841,0.000036712572,0.0049621793,0.0019618238,0.004384531,0.00217119,0.74798036,0.0003192087],"about_ca_topic_score_codex":0.03606587,"about_ca_topic_score_gemma":0.002640705,"teacher_disagreement_score":0.58886766,"about_ca_system_score_codex":0.00072556926,"about_ca_system_score_gemma":0.0027772305,"threshold_uncertainty_score":0.99649423},"labels":[],"label_agreement":null},{"id":"W4390915337","doi":"10.1158/1538-7445.panca2023-pr09","title":"Abstract PR09: Pancreatic cancer cachexia is mediated by tumor-derived PTHrP","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Adipose tissue; Cachexia; KRAS; Lipolysis; Endocrinology; Internal medicine; Wasting; Adipocyte; White adipose tissue; Cancer; Cancer research; Adipose triglyceride lipase; Medicine; Colorectal cancer","score_opus":0.041528584530706035,"score_gpt":0.37794347713339216,"score_spread":0.33641489260268614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81198126,0.18216476,0.000021228283,0.001560705,0.0013895879,0.00042910423,0.0006831713,0.000050830142,0.0017193356],"genre_scores_gemma":[0.93712443,0.048113555,0.000022720234,0.0006737879,0.0034958331,0.00084064784,0.00022559523,0.00010084281,0.009402557],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738777,0.000105631094,0.00027698127,0.00079825765,0.00060097594,0.0008303579],"domain_scores_gemma":[0.99881077,0.000060250248,0.00004248399,0.0005049546,0.00027845154,0.00030307696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005481539,0.00025567182,0.00028041858,0.00013396947,0.00017136008,0.00014685719,0.00040975353,0.00020312396,0.0017699838],"category_scores_gemma":[0.00011890943,0.00023158033,0.000139123,0.00045907116,0.00028897313,0.000013321221,0.00016609508,0.00053199095,0.00014865925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008260374,0.000025303916,0.00016807928,0.00015692759,0.00014034398,0.000007664783,0.00017407101,0.000005136169,0.70751977,0.000010686922,0.28442043,0.007289],"study_design_scores_gemma":[0.00034503627,0.000052878688,0.0010048284,0.00011237329,0.000026515045,0.0000043003383,0.00008617126,0.000024260708,0.3918723,0.000039709328,0.606219,0.00021266264],"about_ca_topic_score_codex":0.0037086846,"about_ca_topic_score_gemma":0.0006814074,"teacher_disagreement_score":0.32179853,"about_ca_system_score_codex":0.00016137831,"about_ca_system_score_gemma":0.0012611143,"threshold_uncertainty_score":0.9991425},"labels":[],"label_agreement":null},{"id":"W4390915338","doi":"10.1158/1538-7445.panca2023-b073","title":"Abstract B073: Understanding treatment response in pancreatic cancer: NetraAI provides genetic differentiation in FOLFIRINOX and gemcitabine response","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Pancreatic cancer; Oncology; Internal medicine; Chemotherapy; Cancer; Biology; Medicine; Cancer research; Bioinformatics; Irinotecan","score_opus":0.0855619075787892,"score_gpt":0.4223365486978676,"score_spread":0.3367746411190784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97081727,0.016844155,0.00013451905,0.0112074055,0.00013307398,0.0007268313,0.000008724836,0.000043141452,0.000084899526],"genre_scores_gemma":[0.9925249,0.006083083,0.00008274302,0.00007283835,0.00013873493,0.0003620971,0.0000058061646,0.0000437825,0.0006860095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976955,0.00048756468,0.000323995,0.00048184674,0.00046970023,0.00054138154],"domain_scores_gemma":[0.9981716,0.001349642,0.000027230848,0.0002103627,0.000040156832,0.00020095852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020872878,0.00016743346,0.000312835,0.0009192661,0.00009169788,0.00013579486,0.00008188485,0.00008969498,0.0001595021],"category_scores_gemma":[0.00062460086,0.00013469516,0.000044124332,0.00070727436,0.00018140207,0.00009566197,0.000045845143,0.00069923996,0.000005944931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037395444,0.00036178177,0.5127358,0.0018658254,0.00027213243,0.0026517364,0.0069916015,0.0008984637,0.31484073,0.0004754523,0.0007182125,0.12079287],"study_design_scores_gemma":[0.0024658705,0.00070431747,0.97158265,0.0023430423,0.000047055182,0.000022694781,0.00049993343,0.019102037,0.000618412,0.00083045266,0.0016307996,0.00015272108],"about_ca_topic_score_codex":0.0034112476,"about_ca_topic_score_gemma":0.00073802844,"teacher_disagreement_score":0.4588469,"about_ca_system_score_codex":0.0027837998,"about_ca_system_score_gemma":0.00085612986,"threshold_uncertainty_score":0.727954},"labels":[],"label_agreement":null},{"id":"W4390915367","doi":"10.1158/1538-7445.panca2023-c059","title":"Abstract C059: Hub gene analysis identifies CAD as a potential mediator for drug resistance in pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic cancer; Biology; Cancer research; Cancer; Gemcitabine; Bioinformatics; Genetics","score_opus":0.06228320243116175,"score_gpt":0.46032173843148316,"score_spread":0.3980385360003214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385389,0.048360296,0.00012580682,0.008760795,0.00033807132,0.0014996588,0.00021730382,0.00006872788,0.002090421],"genre_scores_gemma":[0.9445904,0.0097705675,0.00034333777,0.000105344676,0.0009598617,0.0034835562,0.00008419965,0.000060853625,0.040601887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579704,0.0002230034,0.00058588426,0.0008466224,0.0014057602,0.0011417154],"domain_scores_gemma":[0.9972407,0.0010770039,0.000056132794,0.00054927793,0.00067924213,0.000397648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028859575,0.00023603541,0.0009128382,0.001508892,0.00024112003,0.00015536734,0.00034839893,0.00021016148,0.0036351343],"category_scores_gemma":[0.00075795176,0.00019874335,0.000309997,0.0026850537,0.00046881312,0.00016488759,0.00011417267,0.00094871596,0.0001508466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01069917,0.0010035166,0.4216322,0.01306155,0.014918075,0.0061699073,0.010987516,0.0001875159,0.23982216,0.0028358197,0.26746127,0.011221293],"study_design_scores_gemma":[0.010464503,0.0005987747,0.81176376,0.0057252813,0.008229512,0.000048362,0.005030369,0.008793281,0.05775906,0.016868498,0.07309895,0.0016196644],"about_ca_topic_score_codex":0.007825303,"about_ca_topic_score_gemma":0.021215113,"teacher_disagreement_score":0.39013153,"about_ca_system_score_codex":0.0012029907,"about_ca_system_score_gemma":0.0033620736,"threshold_uncertainty_score":0.9987817},"labels":[],"label_agreement":null},{"id":"W4390915393","doi":"10.1158/1538-7445.panca2023-a094","title":"Abstract A094: LIN28B/HMGA2 axis accelerates PDA by promoting oncogenic protein synthesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HMGA2; KRAS; Biology; Cancer research; Pancreatic cancer; Cancer; Cell biology; Genetics; Mutation; Gene; microRNA","score_opus":0.06355722947147281,"score_gpt":0.39599821791719003,"score_spread":0.33244098844571723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96983343,0.02495655,0.00006841443,0.0020541728,0.00011645172,0.0005406941,0.00012988246,0.000037750196,0.0022626647],"genre_scores_gemma":[0.98974895,0.0016083017,0.000050676226,0.000034455847,0.0005579871,0.0017017114,0.000050605402,0.0000520094,0.00619532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822545,0.0001230427,0.00022175063,0.00060068176,0.00034039258,0.00048868527],"domain_scores_gemma":[0.99918616,0.00004937689,0.000030984465,0.00041609394,0.00017967564,0.0001377394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009837648,0.0001447689,0.00012056988,0.00008974701,0.00021380154,0.0002415838,0.00036610267,0.000167013,0.0008124746],"category_scores_gemma":[0.00017200595,0.00012927412,0.00009314822,0.0003412421,0.00013930451,0.000011759316,0.00011834947,0.0003692476,0.0001280953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029311925,0.00003732346,0.00006717326,0.00012797423,0.000065832945,0.000005262765,0.000060311213,0.0000032350285,0.89497584,0.00004086199,0.0215597,0.08302718],"study_design_scores_gemma":[0.00006931603,0.00005827797,0.00015892638,0.000141493,0.0000061523406,0.0000020462787,0.00006292345,0.000048070833,0.82509124,0.000065409935,0.17415603,0.00014013353],"about_ca_topic_score_codex":0.0003346116,"about_ca_topic_score_gemma":0.00005513704,"teacher_disagreement_score":0.15259632,"about_ca_system_score_codex":0.00011956596,"about_ca_system_score_gemma":0.0005663286,"threshold_uncertainty_score":0.88960266},"labels":[],"label_agreement":null},{"id":"W4390915696","doi":"10.1158/1538-7445.panca2023-a041","title":"Abstract A041: Characterizing antigen presentation associated immune escape mechanisms in pancreatic adenocarcinoma using an integrative computational approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Loss of heterozygosity; Human leukocyte antigen; Biology; Pancreatic cancer; Adenocarcinoma; Transcriptome; Immunotherapy; Cancer research; Antigen; Cancer; Immune system; Immunology; Gene; Allele; Gene expression; Genetics","score_opus":0.06031906172541105,"score_gpt":0.3741670398635915,"score_spread":0.31384797813818044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390915696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091405,0.004427263,0.0036573664,0.000079169324,0.00017218203,0.0003998011,0.00012455758,0.000014543231,0.00021109736],"genre_scores_gemma":[0.99704415,0.00072075904,0.0008937638,0.00003877154,0.00022239485,0.00011136804,0.0008567461,0.000040516046,0.00007153711],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984337,0.0001529199,0.00026036828,0.0004726122,0.00030794812,0.0003724371],"domain_scores_gemma":[0.99940544,0.00008055042,0.000049529343,0.00018708264,0.00019169864,0.00008570044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067214173,0.00014723126,0.00017341475,0.00020486716,0.000120819306,0.00019021708,0.0002003024,0.00013982799,0.00004595741],"category_scores_gemma":[0.00011032498,0.00014556767,0.00006020311,0.00036439946,0.00008294689,0.00002294043,0.00011043402,0.00031808662,0.0000051850025],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009265544,0.00013373118,0.0038601528,0.00007823647,0.000099797704,0.000020330339,0.00074145634,0.0042159017,0.9885728,0.0005803824,0.00013225207,0.0014723112],"study_design_scores_gemma":[0.0017050592,0.0006821794,0.48519102,0.0008702779,0.000056751927,0.000024839199,0.0034499634,0.13597924,0.3655927,0.0050313557,0.0005050087,0.0009116273],"about_ca_topic_score_codex":0.0013486331,"about_ca_topic_score_gemma":0.00019621036,"teacher_disagreement_score":0.6229801,"about_ca_system_score_codex":0.00028027775,"about_ca_system_score_gemma":0.0005830131,"threshold_uncertainty_score":0.5936077},"labels":[],"label_agreement":null},{"id":"W4390917779","doi":"10.1158/1538-7445.panca2023-b025","title":"Abstract B025: IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cardiotoxicity; FOLFIRINOX; Myocarditis; Cancer; Pancreatic cancer; Internal medicine; Blockade; Oncology; Chemotherapy","score_opus":0.05690371483072138,"score_gpt":0.39486169239733965,"score_spread":0.3379579775666183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390917779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9125876,0.08492066,0.0000043239966,0.0006522077,0.00018477373,0.001009002,0.00017534928,0.000038513263,0.00042760468],"genre_scores_gemma":[0.94444454,0.05246693,0.00003033512,0.00005731834,0.00017787528,0.0003778241,0.000007742405,0.000052223826,0.0023851935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787605,0.00011522091,0.00041050193,0.0004660239,0.0006111197,0.00052107003],"domain_scores_gemma":[0.9990835,0.00024424336,0.000046688452,0.00038279514,0.00012019573,0.00012258782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010055079,0.00019659122,0.00048364265,0.00037600443,0.000067227214,0.0000557566,0.00016758073,0.00014731011,0.00028591143],"category_scores_gemma":[0.000029587305,0.00016123118,0.00015239292,0.0006361398,0.00031533538,0.00016402506,0.000061031114,0.0005751233,0.0000031698073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022326305,0.0002223128,0.0013508186,0.0009282243,0.00047440655,0.000017102437,0.001385811,0.00002936232,0.88788676,0.00002752117,0.0006607413,0.1047843],"study_design_scores_gemma":[0.005882562,0.0006442347,0.07443808,0.0037210216,0.00008844166,0.0000069072075,0.00049871916,0.0009823872,0.9050907,0.00039196975,0.007830618,0.00042436956],"about_ca_topic_score_codex":0.009597665,"about_ca_topic_score_gemma":0.0002949048,"teacher_disagreement_score":0.10435993,"about_ca_system_score_codex":0.00052080996,"about_ca_system_score_gemma":0.0007863573,"threshold_uncertainty_score":0.99699754},"labels":[],"label_agreement":null},{"id":"W4390917798","doi":"10.1158/1538-7445.panca2023-b067","title":"Abstract B067: Patient-specific differences in cancer-associated fibroblasts alter tumor organoid phenotype and chemosensitivity in pancreatic ductal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Pancreatic cancer; Gemcitabine; Tumor microenvironment; Cancer research; Cancer; Cancer-Associated Fibroblasts; Medicine; Cancer cell; Adenocarcinoma; Reprogramming; Oncology; Biology; Pathology; Internal medicine; Cell","score_opus":0.07257815742872262,"score_gpt":0.3774531831340692,"score_spread":0.30487502570534664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390917798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774845,0.018651411,0.0000010631524,0.0017052438,0.0001510598,0.0009264182,0.000057619072,0.000046280533,0.000976377],"genre_scores_gemma":[0.995092,0.003531749,0.000031573734,0.00006579,0.00021648349,0.00034873385,0.000018833827,0.000046312074,0.000648553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966359,0.00033009902,0.00044277761,0.00073570583,0.00084316306,0.0010123345],"domain_scores_gemma":[0.998246,0.0009141534,0.00004475102,0.00028249196,0.00022450506,0.00028809736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010792344,0.00024374784,0.0007498833,0.00063998735,0.000115117065,0.000089275585,0.00014381761,0.0001804308,0.0009819086],"category_scores_gemma":[0.00037456938,0.00020122982,0.00005370522,0.0012776625,0.00052845123,0.0001536748,0.00016694928,0.001384102,0.00006218484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065886875,0.0003027022,0.9368752,0.0006805273,0.000114088354,0.002149807,0.0023822337,0.0000011788873,0.05027866,0.00006163025,0.0012793642,0.005215688],"study_design_scores_gemma":[0.0013808538,0.00045322278,0.9905879,0.0019630527,0.000028696235,0.000036965073,0.00064622425,0.0007001948,0.003618734,0.00024747866,0.000143393,0.00019329735],"about_ca_topic_score_codex":0.007855894,"about_ca_topic_score_gemma":0.004020927,"teacher_disagreement_score":0.053712636,"about_ca_system_score_codex":0.0012929769,"about_ca_system_score_gemma":0.0013118105,"threshold_uncertainty_score":0.99993134},"labels":[],"label_agreement":null},{"id":"W4390933424","doi":"10.1158/1538-7445.panca2023-c109","title":"Abstract C109: Nanostring-based subtyping of pancreatic ductal adenocarcinoma is strongly influenced by the stromal compartment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; Pancreas Centre (Canada)","funders":"","keywords":"Subtyping; Stroma; Stromal cell; Adenocarcinoma; Pancreatic cancer; Oncology; Pancreatic ductal adenocarcinoma; Cancer research; Biology; Pathology; Internal medicine; Medicine; Cancer; Immunohistochemistry","score_opus":0.08786800377398649,"score_gpt":0.43007273748561153,"score_spread":0.3422047337116251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390933424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738323,0.018415637,0.000029808934,0.0044185873,0.00011063602,0.0010318717,0.00015635812,0.00004529379,0.001959513],"genre_scores_gemma":[0.99763286,0.00035142593,0.000093721355,0.0001067754,0.00020437654,0.00032691486,0.000040224677,0.00003504058,0.00120863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674827,0.00020791069,0.00044484902,0.0004594002,0.0013309707,0.0008085968],"domain_scores_gemma":[0.99778783,0.0009721776,0.00005632535,0.0005425541,0.00037558647,0.00026555223],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014159956,0.0001909786,0.0005134274,0.0002651416,0.00023624566,0.00007272994,0.00035716026,0.00013287547,0.0017505244],"category_scores_gemma":[0.00019861099,0.00012839652,0.00013768542,0.0006876211,0.00087004015,0.00008529229,0.00011119155,0.001008021,0.00010054645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015373266,0.00038109306,0.7612011,0.0020765848,0.0009958602,0.0003849695,0.0014196449,0.000041122876,0.178005,0.0006394496,0.051093355,0.0022245343],"study_design_scores_gemma":[0.0034089375,0.0019797226,0.9030251,0.0023898652,0.00041656417,0.00007149499,0.0016237211,0.004902131,0.073722534,0.00022089186,0.007917554,0.00032148615],"about_ca_topic_score_codex":0.0016474411,"about_ca_topic_score_gemma":0.000049320195,"teacher_disagreement_score":0.14182404,"about_ca_system_score_codex":0.0005553539,"about_ca_system_score_gemma":0.0024037024,"threshold_uncertainty_score":0.999162},"labels":[],"label_agreement":null},{"id":"W4391163993","doi":"10.1158/0008-5472.can-23-2659","title":"The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Barbara Ann Karmanos Cancer Institute; Jilin University; Children's Hospital of Michigan; Chimerix; National Institutes of Health; U CAN-CER VIVE Foundation; Children’s Hospital of Michigan Foundation; American Lebanese Syrian Associated Charities; MEI Pharma; St. Jude Children's Research Hospital; Wayne State University","keywords":"Myeloid leukemia; Haematopoiesis; Oxidative stress; Leukemia; Oxidative phosphorylation; Cancer research; Myeloid; Mitochondrion; Biology; MCL1; Stem cell; Biochemistry; Cell biology; Immunology; Downregulation and upregulation; Gene","score_opus":0.03620855809262768,"score_gpt":0.37703502994797955,"score_spread":0.34082647185535186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391163993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97741336,0.008386158,0.00005974489,0.010466043,0.00047589318,0.0023020713,0.00024016564,0.00008161166,0.0005749732],"genre_scores_gemma":[0.9843446,0.0060060928,0.00030750223,0.00019375159,0.00086408015,0.0013688272,0.00008857169,0.000109274246,0.0067173075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99526215,0.00048041297,0.0004562882,0.0009870554,0.0014819838,0.0013321305],"domain_scores_gemma":[0.9971173,0.0010029963,0.000037777587,0.0006769154,0.0005397567,0.00062527996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001612297,0.00030755668,0.00041195587,0.00069126784,0.0004428421,0.0004059153,0.0005011009,0.00024781527,0.00023577716],"category_scores_gemma":[0.00061251427,0.00020409006,0.00008288785,0.0020138228,0.000543094,0.00032092375,0.00059573917,0.0022296663,0.00028004436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055862283,0.000086392494,0.0016336341,0.00044588107,0.0005570662,0.0016108846,0.0057898583,0.00029041112,0.9096452,0.0004958124,0.036372863,0.03748579],"study_design_scores_gemma":[0.003513762,0.0007011167,0.008644414,0.0012607946,0.00008290964,0.00007098606,0.0015379911,0.0068391617,0.90044224,0.0005268606,0.07588816,0.0004916249],"about_ca_topic_score_codex":0.0026513194,"about_ca_topic_score_gemma":0.0014068108,"teacher_disagreement_score":0.039515294,"about_ca_system_score_codex":0.0037879376,"about_ca_system_score_gemma":0.0031838953,"threshold_uncertainty_score":0.9905325},"labels":[],"label_agreement":null},{"id":"W4391263220","doi":"10.1158/0008-5472.can-23-1749","title":"Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Palbociclib; Cancer research; Senescence; Cyclin-dependent kinase 4; KRAS; Cancer; Telomere; Cancer cell; Biology; Cell cycle; Breast cancer; Medicine; Cyclin-dependent kinase 2; Cell biology; Internal medicine; Biochemistry","score_opus":0.08410937371333618,"score_gpt":0.4478843793961258,"score_spread":0.36377500568278964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391263220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482028,0.044410724,0.00009690051,0.006415757,0.000115662115,0.0005061953,0.00002766548,0.00007268426,0.00015162636],"genre_scores_gemma":[0.99435115,0.004058786,0.00030783605,0.00012790652,0.00028812006,0.0002244876,0.0000025296063,0.000042868825,0.00059629855],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981624,0.00013368251,0.00016850942,0.00056323997,0.0004273354,0.0005448258],"domain_scores_gemma":[0.9991763,0.00026688346,0.00001799596,0.00017903668,0.000178056,0.00018168353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009481335,0.0001558317,0.00028465583,0.00026792192,0.000120239034,0.00007904604,0.00004591166,0.00007950949,0.00012426343],"category_scores_gemma":[0.00012421407,0.00013467764,0.000024194967,0.00067230035,0.00043230312,0.00022676868,0.00013347776,0.0006608791,0.0000057575958],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041682596,0.0000496844,0.15294307,0.0018155696,0.000083302395,0.0004328474,0.0029320517,0.000019394478,0.57237315,0.00025251674,0.00016749049,0.2685141],"study_design_scores_gemma":[0.004594979,0.000694505,0.5608381,0.016901307,0.0001268891,0.00074881135,0.003694637,0.012213993,0.35599583,0.00285683,0.040091425,0.0012427127],"about_ca_topic_score_codex":0.0033713959,"about_ca_topic_score_gemma":0.001817821,"teacher_disagreement_score":0.407895,"about_ca_system_score_codex":0.00042340212,"about_ca_system_score_gemma":0.0004234529,"threshold_uncertainty_score":0.5491995},"labels":[],"label_agreement":null},{"id":"W4391443074","doi":"10.1158/1538-7445.canevol23-a038","title":"Abstract A038: Evaluating DCIS progression: A comparative analysis of CNA predictive power derived from lpWGS and WES data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Predictive power; Internal medicine; Oncology; Philosophy; Epistemology","score_opus":0.2762030793997237,"score_gpt":0.5678453063348907,"score_spread":0.291642226935167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391443074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601268,0.03514833,0.00012157645,0.00074731786,0.00012893794,0.0004197586,0.0012427801,0.000042055963,0.002022443],"genre_scores_gemma":[0.998358,0.00048202605,0.00043367708,0.00002656591,0.00017770875,0.000075780554,0.0003576847,0.000013513893,0.0000750541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979176,0.00014155632,0.00023927065,0.00052579347,0.0009106474,0.00026514838],"domain_scores_gemma":[0.99692696,0.001795696,0.000042893796,0.00057820126,0.000497244,0.00015901374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011176418,0.000113758135,0.0004488872,0.00039122248,0.00008663065,0.00008666517,0.00015587603,0.00005829999,0.0005023388],"category_scores_gemma":[0.00083530915,0.00008828337,0.00008072231,0.0010436643,0.0003688353,0.00013416937,0.0003006523,0.00046280076,0.000012162723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003278814,0.00064413954,0.5572698,0.0012982048,0.023401935,0.0006906569,0.04344703,0.000570661,0.19608797,0.00014091247,0.062641986,0.11052788],"study_design_scores_gemma":[0.0010431759,0.00038076832,0.9460813,0.0023942594,0.0027666485,0.0000042945053,0.0037441463,0.027898354,0.013622369,0.00019619604,0.0016859802,0.00018250811],"about_ca_topic_score_codex":0.0015419659,"about_ca_topic_score_gemma":0.00009410757,"teacher_disagreement_score":0.3888115,"about_ca_system_score_codex":0.00011505141,"about_ca_system_score_gemma":0.0005861943,"threshold_uncertainty_score":0.55002576},"labels":[],"label_agreement":null},{"id":"W4391446028","doi":"10.1158/1538-7445.advbc23-ia16","title":"Abstract IA16: Creation and preliminary analyses of a full spectrum of breast cancers initiated de novo from normal human mammary cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Human breast; Medicine; Breast cancer; Cancer research; Cancer; Oncology; Biology; Internal medicine","score_opus":0.10337962413084463,"score_gpt":0.4532357359209101,"score_spread":0.3498561117900655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842817,0.01274023,0.00029298803,0.0008438394,0.000073715455,0.00033776218,0.00039876727,0.000047445144,0.00098353],"genre_scores_gemma":[0.9979457,0.0010340211,0.00037522567,0.000030669962,0.00026152094,0.000072300325,0.000055723136,0.00003904943,0.0001857781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982956,0.000078375204,0.00033780135,0.00036027835,0.00053189107,0.00039604952],"domain_scores_gemma":[0.99900997,0.00018709165,0.00007928337,0.00031543372,0.0002471758,0.00016104752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034416284,0.0001548247,0.00035263487,0.00043069007,0.00006895323,0.000027462185,0.000154579,0.000100625206,0.0007258994],"category_scores_gemma":[0.000020642081,0.00014120908,0.00007704066,0.0006161163,0.0004240063,0.00022813,0.000091467606,0.0004399574,0.000004037135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020694803,0.00007005565,0.0026589904,0.00094728364,0.00040660307,0.00016377709,0.0012261262,0.00021127136,0.9767872,0.00008988896,0.00018180438,0.015187502],"study_design_scores_gemma":[0.0018832356,0.0008877634,0.26637232,0.002635027,0.0001877363,0.00014865774,0.0009562423,0.00053583476,0.7242836,0.0013761749,0.0005074942,0.00022595642],"about_ca_topic_score_codex":0.010968915,"about_ca_topic_score_gemma":0.00049883936,"teacher_disagreement_score":0.26371333,"about_ca_system_score_codex":0.0005903075,"about_ca_system_score_gemma":0.0010624742,"threshold_uncertainty_score":0.99561715},"labels":[],"label_agreement":null},{"id":"W4391446094","doi":"10.1158/1538-7445.advbc23-a081","title":"Abstract A081: Real-world treatment patterns and clinical outcomes in patients with HER2+ metastatic breast cancer receiving systemic therapy in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Systemic therapy; Medicine; Metastatic breast cancer; Breast cancer; Cancer; Oncology; Internal medicine; Intensive care medicine","score_opus":0.07777638033646204,"score_gpt":0.42533386187962047,"score_spread":0.3475574815431584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493235,0.0016450628,0.0000014098558,0.0014460332,0.00028044684,0.0013615265,0.00020771191,0.000030742605,0.00009472951],"genre_scores_gemma":[0.9948597,0.0027243777,0.000027993432,0.00012370982,0.00009193775,0.0006931996,0.000023195911,0.00007295766,0.0013829218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970387,0.00018248455,0.0005696986,0.00069247134,0.00080654485,0.0007100537],"domain_scores_gemma":[0.9986199,0.00049891794,0.00006869633,0.0003744923,0.00018777813,0.00025022373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055971555,0.0002999739,0.00072683004,0.00040449243,0.00006358543,0.0000615766,0.00013338459,0.000057785815,0.0007019004],"category_scores_gemma":[0.000015784904,0.00020128493,0.00006049877,0.0005529703,0.00013655142,0.00017495373,0.000040890798,0.0008681132,0.0000026236619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013542474,0.00022862594,0.9022571,0.00022648633,0.00040448367,0.00029268983,0.00067220494,0.000050066265,0.000018815797,0.0000046914033,0.000046135377,0.09444447],"study_design_scores_gemma":[0.004816257,0.00035802025,0.9906552,0.0028243042,0.00003181094,0.000011555928,0.00026548537,0.000013998136,0.000030269443,0.000012988999,0.00078307925,0.00019705672],"about_ca_topic_score_codex":0.99612087,"about_ca_topic_score_gemma":0.9995218,"teacher_disagreement_score":0.094247416,"about_ca_system_score_codex":0.009767257,"about_ca_system_score_gemma":0.005244368,"threshold_uncertainty_score":0.99403405},"labels":[],"label_agreement":null},{"id":"W4391446198","doi":"10.1158/1538-7445.advbc23-a078","title":"Abstract A078: Characterization of normal human male mammary cells and their <i>de novo</i> transformed derivatives","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Endocrinology; Biology","score_opus":0.05943411211892613,"score_gpt":0.37396071679706255,"score_spread":0.3145266046781364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187756,0.0024715038,0.0003432354,0.0010712328,0.00009827566,0.00036582013,0.00016416893,0.000026353926,0.0035818634],"genre_scores_gemma":[0.9915597,0.00583583,0.000055124547,0.00007185653,0.00020595979,0.000077792734,0.000043780383,0.000025439664,0.00212454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896324,0.000037908598,0.00019088556,0.00023575302,0.00025171757,0.00032052494],"domain_scores_gemma":[0.99949884,0.00006359509,0.000021242959,0.00016328083,0.000117909,0.00013512447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047166867,0.00010431023,0.00020727982,0.00019081075,0.00007748811,0.00004784221,0.00008494266,0.000061906205,0.0007036736],"category_scores_gemma":[0.0000072949306,0.00008169802,0.00006196629,0.00034163825,0.00017570968,0.00016300828,0.00003416892,0.0003140836,0.0000053197105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011186889,0.000045681463,0.00036610416,0.001438944,0.000064006475,0.00003495231,0.0016951236,5.317251e-7,0.9472027,0.00017111149,0.00029432768,0.048574675],"study_design_scores_gemma":[0.0004768256,0.00014369159,0.013075485,0.00042990057,0.00001761797,0.000024356483,0.00019597459,0.000017240534,0.9471686,0.0000472963,0.03832124,0.00008177705],"about_ca_topic_score_codex":0.00020213008,"about_ca_topic_score_gemma":0.000041887233,"teacher_disagreement_score":0.048492897,"about_ca_system_score_codex":0.000106683015,"about_ca_system_score_gemma":0.00039610162,"threshold_uncertainty_score":0.7704732},"labels":[],"label_agreement":null},{"id":"W4391446323","doi":"10.1158/1538-7445.advbc23-b083","title":"Abstract B083: The associations of breast density, hormone use, family history, reproductive and lifestyle factors with triple negative breast cancer: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Breast cancer; Family history; Medicine; Oncology; Triple-negative breast cancer; Internal medicine; Cancer; Gynecology; Gerontology; Demography; Physiology","score_opus":0.27174417151535085,"score_gpt":0.4454823724600424,"score_spread":0.17373820094469156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004961302,0.98698545,8.4993235e-7,0.0011172268,0.00006154284,0.00559377,0.0056661856,0.000028164204,0.000050712115],"genre_scores_gemma":[0.0045559863,0.99076414,0.0000063131847,0.000087125794,0.00011903729,0.0019643542,0.00009157008,0.00009164493,0.0023198328],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952244,0.0007588672,0.0010983562,0.0011236382,0.0013075451,0.00048720668],"domain_scores_gemma":[0.9952365,0.0009823451,0.00092378,0.0011606258,0.0013615978,0.00033510977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021636714,0.000614088,0.00759504,0.00069724245,0.00020082617,0.0001082613,0.0002869497,0.00022431742,0.00020220582],"category_scores_gemma":[0.0005223125,0.00029598322,0.0012820587,0.0023875367,0.00067626254,0.00017417785,0.00021669152,0.0015144447,0.0000046002087],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006570077,0.00010532835,0.00033177517,0.7070279,0.27498206,0.000034928944,0.0011353327,6.2535634e-7,0.0000042293595,0.00003457461,0.014653365,0.0016241566],"study_design_scores_gemma":[0.00023385337,0.000104452156,0.011872623,0.042622384,0.9310894,0.0001006378,0.00031332663,9.522837e-7,9.214533e-7,0.0000071773998,0.013268741,0.00038555192],"about_ca_topic_score_codex":0.044594422,"about_ca_topic_score_gemma":0.0039076633,"teacher_disagreement_score":0.6644055,"about_ca_system_score_codex":0.0022372124,"about_ca_system_score_gemma":0.002671919,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W4391446349","doi":"10.1158/1538-7445.advbc23-b067","title":"Abstract B067: Identification of Gemcitabine-resistant Populations using scRNA-Sequencing in Triple Negative Breast Cancer Patient-Derived Xenografts","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Ontario Genomics; McGill University","funders":"","keywords":"Triple-negative breast cancer; Gemcitabine; Breast cancer; Cancer; Triple negative; Oncology; Identification (biology); Internal medicine; Medicine; Biology","score_opus":0.08483007984841097,"score_gpt":0.3955964910555031,"score_spread":0.31076641120709214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071014,0.0071392586,0.0001328349,0.00021760963,0.00048554494,0.0004025662,0.0008236613,0.000007908771,0.00008048351],"genre_scores_gemma":[0.9976803,0.0015825715,0.00012874456,0.000021828213,0.00028700207,0.000153076,0.00006473406,0.00003300605,0.000048740752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984719,0.00006621099,0.00041498625,0.00040314632,0.0002963231,0.00034743777],"domain_scores_gemma":[0.9991373,0.00004657779,0.00008771539,0.00027512724,0.00037019193,0.00008307589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841359,0.00012317601,0.00015033202,0.00025481964,0.00011162481,0.000087139386,0.00017017346,0.00010281957,0.00007777652],"category_scores_gemma":[0.00013689016,0.00012667647,0.000072967094,0.0005647334,0.00014612138,0.000016596805,0.00010749299,0.00021050542,0.000002970841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014175019,0.000025419395,0.001431742,0.00012082953,0.000037289603,0.0000075859725,0.00035661433,0.005311552,0.98749906,0.00013896747,0.00050722895,0.004421964],"study_design_scores_gemma":[0.00061451877,0.00008943674,0.060678158,0.0005239031,0.00002776579,0.0000052933906,0.0008498755,0.0028379692,0.93257326,0.00058238074,0.00092501426,0.00029242542],"about_ca_topic_score_codex":0.013610796,"about_ca_topic_score_gemma":0.005707118,"teacher_disagreement_score":0.059246417,"about_ca_system_score_codex":0.00062789966,"about_ca_system_score_gemma":0.0011965933,"threshold_uncertainty_score":0.99295765},"labels":[],"label_agreement":null},{"id":"W4391446423","doi":"10.1158/1538-7445.advbc23-b042","title":"Abstract B042: A screen to identify modifiers of BRCA1 protein level for cancer prevention and treatment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Cancer prevention; Cancer; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.14626089247257829,"score_gpt":0.4687144041789737,"score_spread":0.3224535117063954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391446423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982096,0.0045077936,0.0016390552,0.0013544433,0.00010894023,0.0016599315,0.0005751745,0.000008049353,0.00032567573],"genre_scores_gemma":[0.9883924,0.0029866176,0.0007224398,0.00003038445,0.00031906398,0.0011011446,0.00007922699,0.000023077544,0.006345645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985069,0.000041289473,0.00024229918,0.00034357642,0.0004337084,0.00043219613],"domain_scores_gemma":[0.9991835,0.000035015746,0.000025796478,0.00022642885,0.00030079373,0.00022849023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074996747,0.000117087526,0.00014733187,0.00017652308,0.00008754761,0.00008087918,0.00019611484,0.00012138944,0.000064304506],"category_scores_gemma":[0.00015424068,0.00009358924,0.00008417208,0.00019274351,0.00020690606,0.000007349107,0.00013451646,0.000115499315,0.000008502292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000222196,0.000048724713,0.000072696224,0.0004833177,0.00012614272,0.000001444193,0.00019486053,0.000013077873,0.7514692,0.000058959326,0.0038085438,0.24350081],"study_design_scores_gemma":[0.00080944045,0.0016415702,0.0045214575,0.00045780273,0.000020213964,0.0000011481652,0.00029917984,0.0003533725,0.8771379,0.0004947048,0.11406991,0.00019329049],"about_ca_topic_score_codex":0.0011767584,"about_ca_topic_score_gemma":0.0010753467,"teacher_disagreement_score":0.24330753,"about_ca_system_score_codex":0.00011312352,"about_ca_system_score_gemma":0.0007490814,"threshold_uncertainty_score":0.38164586},"labels":[],"label_agreement":null},{"id":"W4391489487","doi":"10.1158/1538-7445.dnarepair24-b026","title":"Abstract B026: Detection and characterization of DDR reversion alterations in baseline tissue and plasma samples from patients enrolled in the TRESR and ATTACC Phase I clinical trials","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PALB2; CHEK2; Medicine; Gemcitabine; Population; Internal medicine; Oncology; Cancer research; Cancer; Germline mutation; Biology; Mutation; Gene; Genetics","score_opus":0.1340642635525664,"score_gpt":0.47601370455145364,"score_spread":0.34194944099888724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391489487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983102,0.00060979003,0.00016751862,0.0001782197,0.000080356054,0.00045431659,0.00019018775,0.0000026182204,0.0000068089053],"genre_scores_gemma":[0.9973479,0.0021564146,0.00004444135,0.00001953888,0.00013472706,0.000060816445,0.00020111994,0.000007466437,0.000027557677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985183,0.0006630843,0.00032392234,0.00026319455,0.00013214395,0.00009937922],"domain_scores_gemma":[0.9993722,0.00038705542,0.00004454425,0.00010911106,0.000052134703,0.000034989447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027748921,0.000060486444,0.00014706982,0.000096045864,0.00004051364,0.000044117904,0.000049528593,0.000100821264,0.000022224967],"category_scores_gemma":[0.00068119337,0.00004571909,0.000017950486,0.000112118905,0.000058831138,0.000011798716,0.000051748593,0.00014465231,4.580025e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048311614,0.00006450728,0.0015572421,0.000033386434,0.00001128925,0.000002133805,0.00015918062,7.819967e-7,0.90728164,0.0000039003435,0.000036614372,0.09036623],"study_design_scores_gemma":[0.003759983,0.00068449165,0.05148386,0.00017360788,0.000016724272,0.000001133215,0.00015018781,0.001585084,0.93920463,0.000119834884,0.0027205863,0.000099850055],"about_ca_topic_score_codex":0.00030791733,"about_ca_topic_score_gemma":0.0006439958,"teacher_disagreement_score":0.090266384,"about_ca_system_score_codex":0.000013985146,"about_ca_system_score_gemma":0.000050127168,"threshold_uncertainty_score":0.18643704},"labels":[],"label_agreement":null},{"id":"W4392362268","doi":"10.1158/1538-7445.brain23-a030","title":"Abstract A030: The Montreal Cognitive Assessment (MoCA) administered virtually or via Duo APP in primary brain tumor patients: a preliminary analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Cognition; Cognitive impairment; Medicine; Gerontology; Psychology; Psychiatry","score_opus":0.05019018144996633,"score_gpt":0.41830269842323764,"score_spread":0.3681125169732713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392362268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666421,0.004028738,0.00014428997,0.011974114,0.00026882617,0.0036058456,0.00042482614,0.00013709441,0.012774162],"genre_scores_gemma":[0.9918692,0.0006140432,0.000020031497,0.0012919239,0.00024302147,0.0023299607,0.00016712106,0.00006536202,0.00339932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99586457,0.00032402176,0.0005729916,0.0008496793,0.0015495801,0.0008391501],"domain_scores_gemma":[0.99653447,0.0020860236,0.0000893416,0.0003766909,0.0006835943,0.00022986473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012772063,0.00032290004,0.0006102027,0.00096312363,0.000267251,0.0001385423,0.00024951706,0.00011200165,0.0014060276],"category_scores_gemma":[0.0005552079,0.00021319179,0.0002509811,0.0030104432,0.0005646826,0.00020220323,0.00033765766,0.001462793,0.00010406276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046816494,0.008199483,0.16716513,0.0058594127,0.02577805,0.011098597,0.025076468,0.00029017634,0.0036731502,0.00010233051,0.08848585,0.6174548],"study_design_scores_gemma":[0.0044185054,0.0031536988,0.98398286,0.00216509,0.00097937,0.000017148292,0.00250217,0.00089530135,0.0002278738,0.000080460646,0.0012835171,0.00029400183],"about_ca_topic_score_codex":0.002010597,"about_ca_topic_score_gemma":0.003073396,"teacher_disagreement_score":0.81681776,"about_ca_system_score_codex":0.002605669,"about_ca_system_score_gemma":0.0018094644,"threshold_uncertainty_score":0.99950683},"labels":[],"label_agreement":null},{"id":"W4392362299","doi":"10.1158/1538-7445.brain23-b035","title":"Abstract B035: A compendium of syngeneic, transplantable pediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Compendium; Medicine; Glioma; Cancer research; Immunology; Oncology; History","score_opus":0.11871350572975084,"score_gpt":0.3832936586991677,"score_spread":0.26458015296941684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392362299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89547473,0.10061085,0.000020433981,0.0015271673,0.0002904139,0.0007727079,0.00025188914,0.00007418685,0.000977631],"genre_scores_gemma":[0.980748,0.017753769,0.000068745634,0.000023835304,0.00044620922,0.0004541666,0.000048370803,0.000060118065,0.0003967792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732536,0.00012871296,0.00041231487,0.00053008465,0.00095767283,0.0006458284],"domain_scores_gemma":[0.9983927,0.0006102741,0.000039835457,0.0004897685,0.00025358933,0.00021385826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076076074,0.00021891894,0.0004849666,0.0006520392,0.00013236135,0.000082290026,0.0002058395,0.00012752533,0.0012646831],"category_scores_gemma":[0.000010607933,0.00016575947,0.00017302662,0.0009871804,0.00018087252,0.00014883775,0.00003623295,0.000489085,0.000102998245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020527495,0.0037624391,0.027549531,0.014162941,0.0018314051,0.003979804,0.0046572494,0.001642173,0.8408037,0.047531303,0.03677509,0.015251626],"study_design_scores_gemma":[0.0094079245,0.0024020425,0.14521144,0.003512535,0.001205279,0.00037079444,0.0013854261,0.0011424477,0.7848802,0.03228026,0.016984295,0.0012173457],"about_ca_topic_score_codex":0.0015037732,"about_ca_topic_score_gemma":0.00007363524,"teacher_disagreement_score":0.117661916,"about_ca_system_score_codex":0.00035362216,"about_ca_system_score_gemma":0.00043372865,"threshold_uncertainty_score":0.9996483},"labels":[],"label_agreement":null},{"id":"W4392367358","doi":"10.1158/1538-7445.ovarian23-b113","title":"Abstract B113: Associations between risk factors and epithelial ovarian cancer survival by racial and ethnic group: an analysis from the ovarian cancer association consortium","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Oncology; Ethnic group; Medicine; Internal medicine; Association (psychology); Gynecology; Cancer; Psychology; Political science","score_opus":0.10635256479189263,"score_gpt":0.43005911439091044,"score_spread":0.3237065495990178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392367358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552216,0.013198372,0.00004607664,0.010037907,0.00057759683,0.0007369815,0.019925613,0.00007607013,0.00017980159],"genre_scores_gemma":[0.9801783,0.01597408,0.000024001258,0.000118642165,0.0019557925,0.0005057265,0.0008773544,0.000058185855,0.000307928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960218,0.0006964656,0.0004624371,0.0009247516,0.0011887872,0.0007057553],"domain_scores_gemma":[0.9959774,0.002676574,0.00020240794,0.00041007844,0.00031829177,0.00041522583],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022458206,0.00031732084,0.00070889585,0.00026835213,0.00065647665,0.00043412327,0.00018340709,0.00033628524,0.0011735903],"category_scores_gemma":[0.00038267695,0.0002248073,0.00019320179,0.0013027734,0.0002030042,0.00028481244,0.000098998426,0.0011478107,0.000008820831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079582496,0.00010757053,0.95785785,0.000029866702,0.0055209114,0.000007990762,0.002425482,0.000018213233,0.00068688707,0.000139154,0.0023540496,0.030772453],"study_design_scores_gemma":[0.0014055675,0.00011269848,0.9849081,0.000113832844,0.0034646129,1.2060981e-7,0.000349605,0.00024769723,0.0005814566,0.00026655025,0.008321365,0.00022837],"about_ca_topic_score_codex":0.31242198,"about_ca_topic_score_gemma":0.08953015,"teacher_disagreement_score":0.22289182,"about_ca_system_score_codex":0.0021956617,"about_ca_system_score_gemma":0.00068057154,"threshold_uncertainty_score":0.99973947},"labels":[],"label_agreement":null},{"id":"W4392368462","doi":"10.1158/1538-7445.ovarian23-ia008","title":"Abstract IA008: Rare ovarian cancers: the sequelae of specific interactions between cell contexts mutations and microenvironments","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Medicine; Cancer; Genetics","score_opus":0.09773548315498548,"score_gpt":0.41163900520571917,"score_spread":0.3139035220507337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392368462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95596015,0.026157532,0.000028715462,0.01105819,0.00033567683,0.0009866677,0.000533587,0.00002787105,0.0049116174],"genre_scores_gemma":[0.9928015,0.0049797585,0.000066628236,0.000054418833,0.00036842565,0.00031791173,0.00004736353,0.000029869969,0.0013341173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986844,0.000065006185,0.00023989387,0.0003466364,0.00037395963,0.00029011353],"domain_scores_gemma":[0.9989767,0.00043471775,0.000038371367,0.00031545165,0.00009066239,0.00014406344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028712914,0.00012304104,0.00020728503,0.00016898496,0.00018363114,0.00008491189,0.00010320501,0.000049374292,0.0015728706],"category_scores_gemma":[0.000013319648,0.00008581107,0.000076287026,0.00031855237,0.00032652135,0.000105430656,0.00006163922,0.0004780815,0.00007617205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006411326,0.00091822306,0.17203495,0.0029422315,0.0033168066,0.00089068984,0.016222892,0.00013453832,0.14712869,0.0018919589,0.16876319,0.48511472],"study_design_scores_gemma":[0.0020750395,0.00032839613,0.5729543,0.0016424434,0.0002831396,0.000027885015,0.0022373628,0.000025661417,0.0687223,0.0005478678,0.35094854,0.00020705965],"about_ca_topic_score_codex":0.0019726488,"about_ca_topic_score_gemma":0.00024909983,"teacher_disagreement_score":0.48490766,"about_ca_system_score_codex":0.000804828,"about_ca_system_score_gemma":0.00043651572,"threshold_uncertainty_score":0.9993398},"labels":[],"label_agreement":null},{"id":"W4392369444","doi":"10.1158/1538-7445.ovarian23-b004","title":"Abstract B004: Precision medicine opportunities: uniformity across stromal components of ovarian cancer histotype contrasts heterogeneous disease","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Disease; Ovarian cancer; Stromal cell; Cancer; Medicine; Pathology; Oncology; Internal medicine","score_opus":0.20172250818107304,"score_gpt":0.4540773509795154,"score_spread":0.25235484279844234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95036316,0.03564841,0.00001620415,0.009723887,0.00092630996,0.0010411557,0.0012022072,0.00007688573,0.0010018067],"genre_scores_gemma":[0.98720556,0.009945991,0.000021832,0.00014720717,0.0006625065,0.00047474113,0.00016112142,0.00006275401,0.0013182821],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99665445,0.000103320446,0.0005350557,0.00062896824,0.0013418794,0.00073629635],"domain_scores_gemma":[0.9976864,0.00033904,0.00008293201,0.0005900569,0.0005329365,0.00076866115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008131843,0.0002704192,0.0005684115,0.00025284934,0.00019267871,0.00005348371,0.00023744287,0.00011964171,0.0037510346],"category_scores_gemma":[0.00009110171,0.00020353727,0.00016501872,0.0004107907,0.00057766394,0.00014315164,0.0001202245,0.00051160355,0.000031914053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016487796,0.0035503134,0.10503738,0.011922918,0.0046169874,0.013673678,0.0066223782,0.0007034351,0.04605506,0.0035229605,0.06525975,0.72254735],"study_design_scores_gemma":[0.010121418,0.0022130345,0.7474609,0.015831199,0.0007050279,0.000074647745,0.0007292812,0.0010884424,0.010148033,0.0008836538,0.21005298,0.00069135503],"about_ca_topic_score_codex":0.0084802145,"about_ca_topic_score_gemma":0.00058816717,"teacher_disagreement_score":0.721856,"about_ca_system_score_codex":0.0013525928,"about_ca_system_score_gemma":0.0013740482,"threshold_uncertainty_score":0.9981224},"labels":[],"label_agreement":null},{"id":"W4392369497","doi":"10.1158/1538-7445.ovarian23-a109","title":"Abstract A109: Novel germline genetic variants in pseudogenes associated with overall survival in advanced stage ovarian cancer treated with carboplatin, paclitaxel, and bevacizumab: Results from the ROSiA trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carboplatin; Paclitaxel; Bevacizumab; Germline; Oncology; Medicine; Ovarian cancer; Internal medicine; Stage (stratigraphy); Cancer; Chemotherapy; Biology; Gene; Genetics; Cisplatin","score_opus":0.08140658505046139,"score_gpt":0.3784360474014882,"score_spread":0.2970294623510268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98091143,0.009965963,0.0000049047517,0.0038224559,0.00019552396,0.0023356378,0.0023427878,0.00005377894,0.0003675402],"genre_scores_gemma":[0.9939287,0.0033658221,0.00012353895,0.00008530936,0.00037699548,0.0012992838,0.00021036222,0.00009652387,0.0005135054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616736,0.00025044655,0.0006127145,0.0011111157,0.0010218224,0.00083655975],"domain_scores_gemma":[0.9974996,0.0013132937,0.00011931582,0.000581321,0.00024672554,0.00023975699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010558164,0.00039167062,0.0006854222,0.00028486722,0.00013802276,0.00019680239,0.00019006386,0.00019785874,0.00024576136],"category_scores_gemma":[0.00023288207,0.00023829704,0.000060163577,0.0012161748,0.00023051634,0.00016506837,0.000075387165,0.0008886458,0.0000038260605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31279013,0.0034345242,0.5885886,0.0005201176,0.0037738117,0.0075214007,0.006711115,0.004631837,0.02262976,0.00049090496,0.0010509415,0.04785688],"study_design_scores_gemma":[0.09457798,0.0012110363,0.89840245,0.0028407213,0.00014694735,0.0000057320344,0.00022246699,0.0007524139,0.0008823753,0.000032746146,0.00063069625,0.00029443737],"about_ca_topic_score_codex":0.08239107,"about_ca_topic_score_gemma":0.09577314,"teacher_disagreement_score":0.3098139,"about_ca_system_score_codex":0.0014631847,"about_ca_system_score_gemma":0.0016996108,"threshold_uncertainty_score":0.97174716},"labels":[],"label_agreement":null},{"id":"W4392369751","doi":"10.1158/1538-7445.brain23-ia007","title":"Abstract IA007: Distinct immune landscapes characterize highly and minimally invasive brain metastases","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Medicine; Pathology; Cancer; Biology; Immunology; Internal medicine","score_opus":0.036829887585139075,"score_gpt":0.3169672979419484,"score_spread":0.28013741035680934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691497,0.027477855,0.000031142925,0.00067773677,0.00057718926,0.00030822004,0.00053198665,0.00029395137,0.0009521984],"genre_scores_gemma":[0.9954808,0.003270231,0.00006164309,0.00002524884,0.0003860369,0.00017093755,0.000066333,0.00009000574,0.00044877836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984019,0.000029091088,0.00026624606,0.0003133765,0.00041957767,0.00056982634],"domain_scores_gemma":[0.9986573,0.0008285772,0.000015985572,0.00025309768,0.000087047294,0.00015800979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061091327,0.00020879868,0.00025707335,0.00027114328,0.0001094651,0.00030942194,0.00024813224,0.00008815757,0.0004810262],"category_scores_gemma":[0.00014099339,0.00018071434,0.00006913193,0.0004362927,0.00012010639,0.000321296,0.00009559574,0.00054462213,0.00011676153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007932159,0.00001235084,0.0001662127,0.0011210584,0.00024403108,0.00019567345,0.0005153285,0.00005413916,0.96553564,0.00022382043,0.0062378068,0.025614597],"study_design_scores_gemma":[0.0015909082,0.0003173118,0.03958602,0.001964348,0.000092581664,0.000048550875,0.000379652,0.0014356974,0.60400426,0.0015183995,0.3479696,0.0010926708],"about_ca_topic_score_codex":0.00020212546,"about_ca_topic_score_gemma":0.00036159443,"teacher_disagreement_score":0.36153138,"about_ca_system_score_codex":0.00022621416,"about_ca_system_score_gemma":0.00020475716,"threshold_uncertainty_score":0.7369317},"labels":[],"label_agreement":null},{"id":"W4392370377","doi":"10.1158/1538-7445.brain23-a048","title":"Abstract A048: Development and validation of a microfluidic cell culture model for examining cerebral microvascular barrier responses to the tumor microenvironment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Tumor microenvironment; Neuroscience; Blood–brain barrier; Microfluidics; Medicine; Biology; Cancer research; Tumor cells; Nanotechnology; Materials science; Central nervous system","score_opus":0.06769856365746724,"score_gpt":0.3420066658232964,"score_spread":0.2743081021658292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392370377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97914046,0.014341201,0.005210824,0.00030851632,0.00009506322,0.0007269161,0.000053339074,0.00004454684,0.00007915618],"genre_scores_gemma":[0.9934103,0.00082938233,0.0036504744,0.000029205366,0.000094574716,0.00051528664,0.0000099681165,0.000052948973,0.0014078753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982071,0.00006690351,0.00026088237,0.00033454516,0.00061486015,0.0005157002],"domain_scores_gemma":[0.9991438,0.0003285247,0.000011550677,0.0002598984,0.000084929656,0.00017131455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021927455,0.00013604111,0.0001440206,0.00023162494,0.00015235951,0.00012092887,0.00032602472,0.00007212082,0.00006923575],"category_scores_gemma":[0.00016926239,0.000101466845,0.00004460821,0.00030506324,0.00014163236,0.000063022846,0.00020086287,0.00042206456,0.000029863611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049164173,0.000012344707,0.00015754468,0.0010689169,0.00006054605,0.000005122948,0.0038455164,0.0013456591,0.97181034,0.00000972094,0.011896973,0.009738124],"study_design_scores_gemma":[0.00017558652,0.000034131077,0.00089692575,0.00028559618,0.000007666755,0.0000021044643,0.0002659383,0.007123547,0.90501535,0.00002974326,0.08604425,0.00011917876],"about_ca_topic_score_codex":0.000028529405,"about_ca_topic_score_gemma":0.0000057107745,"teacher_disagreement_score":0.07414728,"about_ca_system_score_codex":0.0003296341,"about_ca_system_score_gemma":0.00028167514,"threshold_uncertainty_score":0.41376978},"labels":[],"label_agreement":null},{"id":"W4392372688","doi":"10.1158/1538-7445.brain23-a020","title":"Abstract A020: Neural stem cells expressing PTEN-L suppress glioblastoma invasion <i>in vivo</i>","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"PTEN; Glioblastoma; In vivo; Neural stem cell; Cancer research; Biology; Stem cell; Cancer; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.03989813276999059,"score_gpt":0.3545918662739249,"score_spread":0.3146937335039343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392372688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051554,0.0150367385,0.0004571128,0.00050594565,0.00080195774,0.0007733836,0.000118357595,0.00006328212,0.0017276842],"genre_scores_gemma":[0.99454004,0.0018345315,0.000035836954,0.00008994006,0.0005610998,0.00031216914,0.000015612559,0.00011433649,0.0024964213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962367,0.0002858768,0.0003388389,0.0010475416,0.0009839643,0.0011070984],"domain_scores_gemma":[0.9986763,0.00008749248,0.000032695112,0.0006918845,0.00023612096,0.0002755127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001050139,0.0002631846,0.00022388648,0.00044229516,0.0001761622,0.0003406571,0.0006579258,0.0003534964,0.0005082708],"category_scores_gemma":[0.00004308308,0.0002591304,0.00014562985,0.00076668063,0.00021665095,0.000024883127,0.00058044883,0.0010792814,0.00008616846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045632775,0.000048921713,0.000005980535,0.00025771765,0.000038689537,0.000294199,0.000116344294,0.0013581504,0.9654896,0.000027590488,0.017951662,0.01395478],"study_design_scores_gemma":[0.00049045874,0.00021269938,0.000019244524,0.00038713546,0.0000055002265,0.000018672146,0.00016928739,0.0016716697,0.93612474,0.000038938284,0.060605563,0.00025608117],"about_ca_topic_score_codex":0.0003633846,"about_ca_topic_score_gemma":0.00038763034,"teacher_disagreement_score":0.042653903,"about_ca_system_score_codex":0.00027561083,"about_ca_system_score_gemma":0.0006293759,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W4392375149","doi":"10.1158/1538-7445.ovarian23-a040","title":"Abstract A040: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Ovarian cancer; Extracellular vesicle; Medicine; Extracellular vesicles; Cancer; Internal medicine; Oncology; Biology; Microvesicles; Biochemistry; Cell biology; Gene","score_opus":0.09461480233040871,"score_gpt":0.3909556865586987,"score_spread":0.29634088422829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392375149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88515973,0.033850666,0.07822501,0.00042039985,0.00036101445,0.0010140762,0.00072548434,0.00006887077,0.00017473973],"genre_scores_gemma":[0.98748374,0.0001548741,0.009044117,0.000061312334,0.0018612092,0.00041006008,0.00009508653,0.00014581486,0.00074379036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709684,0.0000636366,0.00036910395,0.0010078137,0.00053712795,0.000925471],"domain_scores_gemma":[0.99840075,0.00020871712,0.0000736113,0.0006450794,0.000372993,0.00029887597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012823769,0.00028009497,0.00020853715,0.00019692034,0.00037393795,0.00031225308,0.0005110252,0.0002516392,0.0002408654],"category_scores_gemma":[0.00039937618,0.00029253008,0.00022656407,0.00043178318,0.00026337677,0.000021150896,0.00019260228,0.00050696376,0.000006338679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020032814,0.00020900564,0.0008595371,0.0005779576,0.0001167901,0.000048474394,0.000029001334,0.001808121,0.9863498,0.00015081011,0.00044321353,0.009206966],"study_design_scores_gemma":[0.0011917261,0.00015257008,0.0006293138,0.00039814357,0.000097108,0.0000075325574,0.000080922844,0.018458256,0.9569962,0.0000670286,0.021498252,0.0004229182],"about_ca_topic_score_codex":0.0008481087,"about_ca_topic_score_gemma":0.00013954993,"teacher_disagreement_score":0.102323994,"about_ca_system_score_codex":0.00019519494,"about_ca_system_score_gemma":0.0013510581,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W4392375289","doi":"10.1158/1538-7445.brain23-b041","title":"Abstract B041: Biomarkers of neurocognitive functioning: molecular signatures for cognitive outcomes in a cohort of primary brain tumor patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Cohort; Medicine; Cognition; Oncology; Brain tumor; Internal medicine; Pathology; Psychiatry","score_opus":0.04060719730336524,"score_gpt":0.39225477897427485,"score_spread":0.3516475816709096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392375289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890038,0.0027786307,0.000077372366,0.0009829338,0.00027429458,0.0037848912,0.000593703,0.000033662393,0.0024707373],"genre_scores_gemma":[0.9980814,0.00014136748,0.000027243179,0.00029828577,0.000045524845,0.0010203681,0.00010317526,0.00005430666,0.00022832674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975714,0.000104615334,0.00046857548,0.0005117471,0.00087181653,0.00047181748],"domain_scores_gemma":[0.9963866,0.0017807728,0.00009929253,0.0001320142,0.0014980717,0.00010328435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007506921,0.00020666503,0.0005617592,0.00084323355,0.000058354126,0.000017219234,0.0000928085,0.00009594649,0.000116442614],"category_scores_gemma":[0.0020248273,0.00018183184,0.00020050743,0.00095327117,0.00052163366,0.000108361804,0.00010271836,0.00057213375,0.0000060480183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015451079,0.002138026,0.7618188,0.009610267,0.0064218827,0.0004308772,0.0023939533,0.000058627815,0.16053666,0.00018249574,0.0070677414,0.033889532],"study_design_scores_gemma":[0.005338937,0.001421967,0.9357561,0.0041752793,0.00022237067,0.0000019378342,0.0007727737,0.000022156644,0.051632635,0.00027926138,0.00020109482,0.00017551795],"about_ca_topic_score_codex":0.00047395955,"about_ca_topic_score_gemma":0.000058358954,"teacher_disagreement_score":0.17393722,"about_ca_system_score_codex":0.00060032855,"about_ca_system_score_gemma":0.001031681,"threshold_uncertainty_score":0.7414887},"labels":[],"label_agreement":null},{"id":"W4392375334","doi":"10.1158/1538-7445.brain23-b042","title":"Abstract B042: A survey of Neuro-Oncology (NOB) clinical providers to assess the feasibility and utility of the administration of the Montreal Cognitive Assessment (MoCA) cognition duo app in an outpatient clinic","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognition; Outpatient clinic; Cognitive impairment; Administration (probate law); Psychiatry; Internal medicine","score_opus":0.3776459628432263,"score_gpt":0.5633922588575182,"score_spread":0.18574629601429188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392375334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903984,0.0003657288,0.000015486386,0.0030504533,0.0003444623,0.0043858285,0.0004752945,0.000010283377,0.00095405715],"genre_scores_gemma":[0.9990405,0.0003112383,0.0000056569284,0.00014726374,0.000053531265,0.0003750192,0.000020167465,0.000015707548,0.000030959014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434584,0.0029583713,0.00096466026,0.0005316696,0.00089607685,0.00030336305],"domain_scores_gemma":[0.9914968,0.006098408,0.00026048056,0.00042497728,0.0016086816,0.000110623405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007975394,0.00015153163,0.0004913982,0.000110686946,0.00011960883,0.000021886162,0.00021122891,0.00015009288,0.00007874633],"category_scores_gemma":[0.005329457,0.000084438296,0.0001327735,0.0008629039,0.0015525843,0.00009841864,0.00026964606,0.0012096156,0.0000012617793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007926392,0.0015107344,0.9452795,0.00060412573,0.0002216145,0.000008383422,0.0015134551,0.000003075861,0.0015270027,0.0000080561895,0.000662808,0.040734857],"study_design_scores_gemma":[0.0016433772,0.0032858988,0.98846924,0.00077711657,0.0001443456,0.0000028652075,0.0027102884,0.0002732174,0.0024589866,0.0001387744,0.000030042711,0.00006583542],"about_ca_topic_score_codex":0.003770482,"about_ca_topic_score_gemma":0.033529874,"teacher_disagreement_score":0.043189757,"about_ca_system_score_codex":0.00030695123,"about_ca_system_score_gemma":0.0034484093,"threshold_uncertainty_score":0.9841057},"labels":[],"label_agreement":null},{"id":"W4392375451","doi":"10.1158/1538-7445.ovarian23-a013","title":"Abstract A013: Auranofin induces lethality driven by reactive oxygen species in high-grade serous ovarian cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Reactive oxygen species; Serous fluid; Ovarian cancer; Serous ovarian cancer; Cancer research; Cancer; Medicine; Chemistry; Biology; Internal medicine; Biochemistry","score_opus":0.0540875566330786,"score_gpt":0.3824577517486561,"score_spread":0.3283701951155775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392375451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98603415,0.007996642,0.000011096612,0.0022411197,0.00037007165,0.00034266076,0.00052858284,0.000018593435,0.0024570716],"genre_scores_gemma":[0.9912976,0.0038866703,0.000020523103,0.000089530644,0.0005566834,0.00026032416,0.00023476643,0.000030567426,0.0036233196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978819,0.00030791512,0.0002316511,0.0007335488,0.00024992306,0.00059507944],"domain_scores_gemma":[0.9992699,0.00009147545,0.000041969306,0.00032977253,0.00015050561,0.00011638442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055748416,0.00020450662,0.00022206662,0.0001308758,0.00013865352,0.00008488026,0.0004115206,0.00035531033,0.00030118923],"category_scores_gemma":[0.000048619422,0.00017677223,0.000072779454,0.00036074946,0.00044179038,0.0000176831,0.00018097283,0.0007133311,0.000027867996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014522392,0.000057808218,0.0023954567,0.00008378489,0.00012676559,0.00004012642,0.00023618349,0.00003377932,0.9761544,0.00016047794,0.019125955,0.0014400571],"study_design_scores_gemma":[0.000324279,0.00008703044,0.0409645,0.00010310734,0.000006530772,0.0000014955265,0.00022547698,0.000004726882,0.9042026,0.00030038497,0.053575028,0.00020485399],"about_ca_topic_score_codex":0.005451495,"about_ca_topic_score_gemma":0.002140097,"teacher_disagreement_score":0.07195179,"about_ca_system_score_codex":0.00019015554,"about_ca_system_score_gemma":0.00042998214,"threshold_uncertainty_score":0.8241066},"labels":[],"label_agreement":null},{"id":"W4392376195","doi":"10.1158/1538-7445.brain23-b044","title":"Abstract B044: Elongation control of mRNA translation drives Group 3 medulloblastoma adaptation to nutrient deprivation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Translation (biology); Medulloblastoma; Messenger RNA; Adaptation (eye); Biology; Internal medicine; Medicine; Cancer research; Neuroscience; Genetics; Gene","score_opus":0.04073662695577996,"score_gpt":0.3663393799109732,"score_spread":0.32560275295519325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502543,0.004984143,0.04328545,0.000500901,0.00016831393,0.00056821224,0.000065361484,0.000019851768,0.0001534641],"genre_scores_gemma":[0.99868935,0.0003511676,0.00022047208,0.00003348251,0.00026922306,0.00023307955,0.00014586735,0.000023537004,0.000033822922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987074,0.00009635832,0.00021272448,0.00033224878,0.00044547807,0.00020575343],"domain_scores_gemma":[0.99933505,0.000062350264,0.00003291231,0.00022091788,0.0002576309,0.00009111533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000468797,0.000088604065,0.0000898268,0.0001825825,0.000065988264,0.00004646951,0.00014550796,0.00008923781,0.000058085592],"category_scores_gemma":[0.00016459424,0.00009078871,0.00007140874,0.0003289135,0.00007347428,0.000014573073,0.00002553126,0.00011319248,0.000015293113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022614932,0.000046012196,0.0005590834,0.00012586497,0.000055467444,0.0000022920524,0.00029949445,0.0017486806,0.94472915,0.0004974237,0.00041396607,0.051296394],"study_design_scores_gemma":[0.00089428946,0.00037370133,0.0403937,0.00031315046,0.000032732172,0.0000023665295,0.0003583335,0.0031572334,0.9359701,0.0009372047,0.017340079,0.00022710016],"about_ca_topic_score_codex":0.00011336846,"about_ca_topic_score_gemma":0.00016559202,"teacher_disagreement_score":0.051069297,"about_ca_system_score_codex":0.0000830381,"about_ca_system_score_gemma":0.00019082337,"threshold_uncertainty_score":0.3702256},"labels":[],"label_agreement":null},{"id":"W4392376240","doi":"10.1158/1538-7445.ovarian23-a037","title":"Abstract A037: Exploring the therapeutic effectiveness of EO3001 in the treatment of clear cell ovarian cancers with ARID1A mutations","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ARID1A; Ovarian cancer; Medicine; Oncology; Cancer research; Internal medicine; Cancer; Biology; Mutation; Genetics; Gene","score_opus":0.08906224066333106,"score_gpt":0.3898139217642079,"score_spread":0.30075168110087686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068093,0.0079226345,0.000076687305,0.00012451992,0.000072244526,0.00035835785,0.000021423777,0.0000037517939,0.0007394331],"genre_scores_gemma":[0.9963667,0.002948387,0.000013329368,0.000008363752,0.00008814033,0.0004842843,0.0000101473715,0.000016739123,0.0000639534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990651,0.00018876734,0.00012214624,0.00020038811,0.00023548631,0.00018811849],"domain_scores_gemma":[0.9994024,0.00018293146,0.000022836075,0.00028394558,0.00008790019,0.000019979621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059935334,0.000082149505,0.000100881574,0.000053436528,0.00006748496,0.000023416274,0.00018167413,0.000035514204,0.00001704678],"category_scores_gemma":[0.0000067811557,0.00004310048,0.000054112264,0.000296731,0.00017439648,0.000004343492,0.000014160964,0.00012609345,0.0000012945796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008724052,0.00019385386,0.0008487499,0.000700843,0.0002288916,0.000014610168,0.004756415,0.024581684,0.929407,0.00025404335,0.00006406205,0.038077462],"study_design_scores_gemma":[0.0009530938,0.0013521833,0.014654366,0.00046188434,0.000044144057,0.0000049860546,0.00293879,0.00061618135,0.97243106,0.00027149532,0.0061356616,0.0001361362],"about_ca_topic_score_codex":0.0028173774,"about_ca_topic_score_gemma":0.0006306376,"teacher_disagreement_score":0.0430241,"about_ca_system_score_codex":0.00013948759,"about_ca_system_score_gemma":0.00049361424,"threshold_uncertainty_score":0.42590508},"labels":[],"label_agreement":null},{"id":"W4392376312","doi":"10.1158/1538-7445.brain23-ia004","title":"Abstract IA004: Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Glioblastoma; Refractory (planetary science); Medicine; Immunotherapy; Cancer research; Oncology; Biology; Cancer; Immunology; Internal medicine","score_opus":0.070886333453477,"score_gpt":0.4095909609713426,"score_spread":0.3387046275178656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95613176,0.041940805,0.0000017911415,0.0011429124,0.000057037883,0.00042685066,0.000047939106,0.000039740706,0.0002111617],"genre_scores_gemma":[0.99628675,0.0028962258,0.000086569984,0.000038831782,0.00013684272,0.00039431732,0.0000113845845,0.000038072314,0.00011102874],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985841,0.00003455106,0.00016595532,0.00040513513,0.00039045254,0.00041982386],"domain_scores_gemma":[0.9993802,0.0002100737,0.000017881344,0.00017901156,0.00008287921,0.00012999684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027858026,0.000166802,0.00023344833,0.00035944328,0.00009782568,0.00009269959,0.000051232677,0.00006648052,0.0001715554],"category_scores_gemma":[0.000016655335,0.00010821391,0.000053162614,0.00042422971,0.00016008138,0.000101791775,0.000030729992,0.00027580748,0.000023116296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024750058,0.0021886453,0.2941438,0.00063897076,0.0011646537,0.0021635673,0.0026434315,0.000049734186,0.57883644,0.000105409345,0.0014718681,0.11411845],"study_design_scores_gemma":[0.009762874,0.0045650024,0.67184395,0.0021444557,0.000103134036,0.00019885364,0.0008084734,0.00027308712,0.25103596,0.00005534152,0.058785867,0.00042298972],"about_ca_topic_score_codex":0.0016252097,"about_ca_topic_score_gemma":0.0011661489,"teacher_disagreement_score":0.37770015,"about_ca_system_score_codex":0.00061293837,"about_ca_system_score_gemma":0.0003501811,"threshold_uncertainty_score":0.44128352},"labels":[],"label_agreement":null},{"id":"W4392376363","doi":"10.1158/1538-7445.brain23-pr-011","title":"Abstract PR-011: The role of tumor microenvironment in metastasis and relapses of medulloblastoma using immunocompetent mouse models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Medulloblastoma; Tumor microenvironment; Metastasis; Cancer research; Medicine; Biology; Cancer; Internal medicine; Tumor cells","score_opus":0.04119882513874581,"score_gpt":0.3537129865526486,"score_spread":0.3125141614139028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387831,0.060509957,0.000008834015,0.00007829121,0.000016629998,0.00033454536,0.00013066549,0.0000020735417,0.00013589962],"genre_scores_gemma":[0.9935393,0.0061119753,0.00009914619,0.000005250467,0.000026203024,0.00011266006,0.00000963081,0.000019357667,0.000076487726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879426,0.00009538551,0.00019770235,0.0002755388,0.00033453415,0.00030257655],"domain_scores_gemma":[0.99954087,0.000038712707,0.000031073676,0.00027673415,0.00005197273,0.000060616236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043929892,0.000096871874,0.00014088674,0.00011752727,0.000050075858,0.00002486994,0.00018670682,0.00003739901,0.00004604182],"category_scores_gemma":[0.000018392358,0.000069457325,0.00006257157,0.00016160189,0.0003088045,0.00000893252,0.00023645275,0.00017793255,0.0000014056735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024285546,0.00008187301,0.00085096015,0.0001229257,0.00016932643,0.000010706457,0.00016316156,0.0007294785,0.9895871,0.00006981146,0.00006019416,0.007911582],"study_design_scores_gemma":[0.00035962753,0.000188287,0.0007991326,0.00014845387,0.000013551711,0.000007938703,0.0004180666,0.00077117566,0.9942644,0.0003034814,0.0026578822,0.000067963454],"about_ca_topic_score_codex":0.0038298683,"about_ca_topic_score_gemma":0.00046008555,"teacher_disagreement_score":0.054756183,"about_ca_system_score_codex":0.00010681796,"about_ca_system_score_gemma":0.00025114245,"threshold_uncertainty_score":0.5789641},"labels":[],"label_agreement":null},{"id":"W4392376557","doi":"10.1158/1538-7445.ovarian23-a074","title":"Abstract A074: Maveropepimut-S, a DPX-based immune-educating therapy, combined with Pembrolizumab and Cyclophosphamide in recurrent ovarian cancer, results from the Phase 1/2 PESCO Trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Cyclophosphamide; Oncology; Internal medicine; Ovarian cancer; Cancer; Gynecology; Chemotherapy; Immunotherapy","score_opus":0.08518002733598602,"score_gpt":0.42276661610663885,"score_spread":0.33758658877065284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9151186,0.06747556,0.000003792418,0.013273978,0.00085079303,0.0023406597,0.00035469554,0.00006521001,0.00051673746],"genre_scores_gemma":[0.98241705,0.014832795,0.00004114209,0.00033467184,0.0007309802,0.0010378441,0.00012680652,0.000072495255,0.0004062457],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966887,0.00029792805,0.0006423172,0.0007896867,0.0008724504,0.0007088984],"domain_scores_gemma":[0.9977488,0.0011101214,0.0001100574,0.000657324,0.00019365478,0.00018004602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020336425,0.00030831777,0.0004642066,0.00025241976,0.00028391936,0.0002756398,0.00032702918,0.00013479021,0.0006492592],"category_scores_gemma":[0.00016102561,0.00019039144,0.00012291502,0.0011434988,0.00045990996,0.00012689327,0.000058598187,0.0012632548,0.0000083496925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6722487,0.00065533083,0.00086574716,0.00018789507,0.00042429465,0.00020565976,0.0031863737,0.000013786612,0.023890283,0.000030143996,0.0040000314,0.29429176],"study_design_scores_gemma":[0.7107136,0.011048299,0.117705904,0.013860772,0.00018086664,0.000031258078,0.0028431194,0.0013778479,0.035885073,0.00027595347,0.10497725,0.0011000071],"about_ca_topic_score_codex":0.04915741,"about_ca_topic_score_gemma":0.0037169345,"teacher_disagreement_score":0.29319173,"about_ca_system_score_codex":0.00084515096,"about_ca_system_score_gemma":0.003437705,"threshold_uncertainty_score":0.95717436},"labels":[],"label_agreement":null},{"id":"W4392376655","doi":"10.1158/1538-7445.brain23-b045","title":"Abstract B045: Adaptive purine metabolism drives radiation therapy resistance in H3K27M-diffuse midline glioma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Glioma; Radiation therapy; Purine; Medicine; Cancer research; Metabolism; Oncology; Internal medicine; Biology; Biochemistry","score_opus":0.07640854726954528,"score_gpt":0.4087432299920083,"score_spread":0.332334682722463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85024744,0.14052804,0.0000022058541,0.006811901,0.00020185998,0.00077378465,0.000051844843,0.000061359606,0.0013215737],"genre_scores_gemma":[0.9789791,0.018556748,0.00013982688,0.00007017815,0.00050066604,0.0008291578,0.000032588257,0.00004583489,0.0008459145],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978219,0.00011159874,0.00028874987,0.0005264349,0.00073368615,0.00051762775],"domain_scores_gemma":[0.99890554,0.00030253283,0.000030375368,0.00036610762,0.00020598476,0.00018947913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006084025,0.00018488817,0.0003225805,0.00073485664,0.00008909675,0.00009122058,0.00013289838,0.000098634584,0.00063245517],"category_scores_gemma":[0.000091746384,0.0001408966,0.00010706454,0.0012737189,0.00013809976,0.00016734604,0.00003950496,0.0004908142,0.00011572319],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007195061,0.0054149777,0.018769419,0.0010460141,0.0016709686,0.012826554,0.008218993,0.00007647593,0.57777137,0.01765323,0.052912686,0.29644427],"study_design_scores_gemma":[0.0079647275,0.00031716583,0.6101137,0.0011048323,0.00005068549,0.000015959704,0.0002474421,0.00016975573,0.22402488,0.0019869232,0.15371197,0.00029198444],"about_ca_topic_score_codex":0.0009823318,"about_ca_topic_score_gemma":0.00091409835,"teacher_disagreement_score":0.59134424,"about_ca_system_score_codex":0.0004944533,"about_ca_system_score_gemma":0.0003806363,"threshold_uncertainty_score":0.69249403},"labels":[],"label_agreement":null},{"id":"W4392376948","doi":"10.1158/1538-7445.ovarian23-a064","title":"Abstract A064: Study of molecular pathways involved in the development of ovarian cancer brain metastases","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ovarian cancer; Cancer; Brain cancer; Medicine; Oncology; Cancer research; Internal medicine; Biology","score_opus":0.08582432200450622,"score_gpt":0.3877814888321481,"score_spread":0.30195716682764184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392376948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897639,0.008967564,0.000072153554,0.0004371615,0.00006771509,0.00046494158,0.00008692657,0.0000037411812,0.00013588801],"genre_scores_gemma":[0.99920344,0.00025030866,0.00006229187,0.00005179664,0.00005087846,0.00030194578,0.000027891856,0.000018267128,0.000033180106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848187,0.00022166371,0.00030913096,0.00028741418,0.00043256566,0.00026734883],"domain_scores_gemma":[0.99946105,0.00007071585,0.000024533008,0.00028933067,0.00011043865,0.000043903903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012773457,0.00011012391,0.0001540458,0.00013083433,0.00005262897,0.000023265271,0.00032342898,0.0000623617,0.000095797215],"category_scores_gemma":[0.00003443078,0.000078852754,0.00005904495,0.00038600175,0.000090108886,0.0000041171156,0.000068352165,0.00021789447,0.00000192204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011406472,0.00026111986,0.000897525,0.00017387324,0.00014425137,0.000034618235,0.0040272498,0.00016707578,0.9852085,0.00021890654,0.00047625956,0.008276545],"study_design_scores_gemma":[0.00078377494,0.00038186525,0.011994651,0.0001667188,0.000019912888,0.0000011172884,0.0040306128,0.000012455357,0.9758944,0.000094027964,0.006475791,0.00014469716],"about_ca_topic_score_codex":0.0017537748,"about_ca_topic_score_gemma":0.0047223293,"teacher_disagreement_score":0.011097125,"about_ca_system_score_codex":0.000031317213,"about_ca_system_score_gemma":0.00069889746,"threshold_uncertainty_score":0.32155222},"labels":[],"label_agreement":null},{"id":"W4392377096","doi":"10.1158/1538-7445.ovarian23-a063","title":"Abstract A063: What can we learn from a retrospective evaluation of HER2, P53 and P16INK4A protein expression in rare ovarian tumors?","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Protein expression; Ovarian cancer; Expression (computer science); Medicine; Cancer research; Oncology; Internal medicine; Biology; Cancer; Genetics; Computer science; Programming language; Gene","score_opus":0.09902015996392277,"score_gpt":0.42399858196376344,"score_spread":0.32497842199984067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535932,0.03438545,0.0000020614996,0.009327471,0.00013955383,0.0017822216,0.00007211681,0.00002414839,0.0006738052],"genre_scores_gemma":[0.99437654,0.0036917375,0.000082402345,0.000027713417,0.000277802,0.0012420934,0.000036381258,0.000033390716,0.00023192671],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973966,0.00022190464,0.0002669394,0.0005761495,0.0012152984,0.00032311067],"domain_scores_gemma":[0.99888146,0.00013013922,0.000046461864,0.0003238066,0.00046986225,0.00014824669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001306079,0.0001458791,0.0003154842,0.00030274896,0.000066343295,0.00013855612,0.00008081336,0.00011069345,0.0015687476],"category_scores_gemma":[0.00018826274,0.00011594533,0.00005418196,0.00052832835,0.00012071419,0.00024972012,0.0000714653,0.00054890336,0.000012906749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018840218,0.0011299918,0.089397624,0.0022492707,0.0005980323,0.0009918895,0.020321293,0.000086221626,0.29976544,0.0006816521,0.0053791823,0.57751536],"study_design_scores_gemma":[0.004736698,0.0006193375,0.74760246,0.02369305,0.000117396216,0.000006708827,0.003946437,0.0006257247,0.21057546,0.0062868013,0.0015610587,0.00022888476],"about_ca_topic_score_codex":0.00673281,"about_ca_topic_score_gemma":0.002051747,"teacher_disagreement_score":0.6582048,"about_ca_system_score_codex":0.0014694182,"about_ca_system_score_gemma":0.0011491706,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4392377773","doi":"10.1158/1538-7445.ovarian23-a114","title":"Abstract A114: Robust establishment and expansion of multilineage human fallopian tube organoids in serum-free medium","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Fallopian tube; Biology; Medicine; Cell biology; Andrology; Gynecology","score_opus":0.08149484387439326,"score_gpt":0.40948197546433035,"score_spread":0.3279871315899371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940097,0.0022327325,0.000002168274,0.0019447826,0.0001212738,0.00046030214,0.000052724256,0.00003133966,0.0011450005],"genre_scores_gemma":[0.9969451,0.00078981457,0.000147535,0.000023490698,0.00015467546,0.0000812072,0.000026216603,0.000031836364,0.0018001624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844897,0.000036881018,0.00025707763,0.00035880084,0.0005458458,0.00035244838],"domain_scores_gemma":[0.99923503,0.00007543762,0.000016793027,0.00037939407,0.00012658667,0.00016678034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047429767,0.00012506644,0.00024621122,0.00035540396,0.000056419638,0.00004493175,0.00013453068,0.00008398558,0.00065409666],"category_scores_gemma":[0.00006641441,0.00009670718,0.000036332247,0.00040483105,0.0001355382,0.000113181275,0.00020948524,0.00039725393,0.000009088033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004322404,0.0007780136,0.29456657,0.004708415,0.00033399437,0.0030641218,0.0036427202,0.000045596084,0.6397184,0.0005248031,0.0072068563,0.044978254],"study_design_scores_gemma":[0.0043351366,0.00058644934,0.8363872,0.001963341,0.00004110551,0.000021512664,0.00054199167,0.0003615349,0.14860882,0.00013081117,0.006846214,0.00017584326],"about_ca_topic_score_codex":0.00276652,"about_ca_topic_score_gemma":0.001181149,"teacher_disagreement_score":0.54182065,"about_ca_system_score_codex":0.00023157288,"about_ca_system_score_gemma":0.000279204,"threshold_uncertainty_score":0.7161899},"labels":[],"label_agreement":null},{"id":"W4392377811","doi":"10.1158/1538-7445.ovarian23-a066","title":"Abstract A066: The cytotoxic effects of oxaliplatin and 5-fluorouracil against low-grade serous ovarian cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Fluorouracil; Serous fluid; Ovarian cancer; Cytotoxic T cell; Medicine; Oncology; Internal medicine; Cancer research; Colorectal cancer; Cancer; Biology; In vitro; Genetics","score_opus":0.05591241180573824,"score_gpt":0.42301676986968617,"score_spread":0.3671043580639479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964018,0.028362555,0.0000030535955,0.004404358,0.0006521824,0.0011385104,0.00007176135,0.000047650043,0.0013019497],"genre_scores_gemma":[0.98428506,0.01119787,0.000014237366,0.00028720067,0.0006869439,0.0005956194,0.00001009008,0.00004161847,0.0028813416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982436,0.00013510988,0.00022671024,0.00038752312,0.0005072102,0.0004998826],"domain_scores_gemma":[0.99856704,0.00080330187,0.000038613776,0.00027233668,0.00012951589,0.00018918654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051117287,0.00017775482,0.00030684037,0.00018003813,0.00015097957,0.000055660596,0.00014868425,0.00011766434,0.00068895984],"category_scores_gemma":[0.00003211167,0.000116682386,0.00008941774,0.0005308579,0.00032846746,0.00007544975,0.00008716888,0.000726786,0.000036868456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036154315,0.00014223023,0.0013511028,0.002536587,0.000407212,0.00038069254,0.0015090437,0.000036077578,0.9333603,0.0000746434,0.017507939,0.042332653],"study_design_scores_gemma":[0.002664462,0.00043890972,0.023221133,0.0015559577,0.00021583344,0.00001890908,0.00014989483,0.0003527273,0.94916743,0.000141259,0.021884246,0.00018926221],"about_ca_topic_score_codex":0.0026744294,"about_ca_topic_score_gemma":0.0003969422,"teacher_disagreement_score":0.04214339,"about_ca_system_score_codex":0.00039009738,"about_ca_system_score_gemma":0.0007399296,"threshold_uncertainty_score":0.7543627},"labels":[],"label_agreement":null},{"id":"W4392378834","doi":"10.1158/1538-7445.ovarian23-a099","title":"Abstract A099: Preliminary pharmacodynamic characterization in patients with platinum-resistant ovarian cancer treated with nemvaleukin in combination with pembrolizumab","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Ovarian cancer; Medicine; Pharmacodynamics; Cancer; Oncology; Internal medicine; Pharmacokinetics; Immunotherapy","score_opus":0.02656305725333194,"score_gpt":0.3457545401023751,"score_spread":0.3191914828490432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392378834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994904,0.00052831275,0.000011962423,0.0015465018,0.00006122168,0.0021446696,0.00027052045,0.000060431037,0.0004723833],"genre_scores_gemma":[0.9963767,0.0003632594,0.000032527034,0.000047408776,0.00007385141,0.001923321,0.00073853164,0.00008792771,0.00035645167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743974,0.00009763508,0.00031129326,0.0006787787,0.0009071935,0.0005653684],"domain_scores_gemma":[0.9990815,0.00011329276,0.000071160364,0.0002868433,0.00028885598,0.00015834774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026295113,0.0002744861,0.00036041028,0.0007054523,0.000086931635,0.00010592911,0.00010978614,0.00009470033,0.00040925285],"category_scores_gemma":[0.000009912582,0.00018386627,0.000023978742,0.0015736539,0.00012622311,0.00033533853,0.000029249994,0.0005881882,0.000011180378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025470847,0.0014391084,0.94465375,0.00088836753,0.000259613,0.00092437136,0.00073653564,0.00030771285,0.003187327,0.00013402005,0.000112765825,0.021885589],"study_design_scores_gemma":[0.015685,0.0029933576,0.9739967,0.004406404,0.00009555196,0.000005183971,0.000051377137,0.0008686518,0.0013404527,0.000007047716,0.00033094373,0.00021935643],"about_ca_topic_score_codex":0.0041675516,"about_ca_topic_score_gemma":0.0028581622,"teacher_disagreement_score":0.029342929,"about_ca_system_score_codex":0.0024203178,"about_ca_system_score_gemma":0.0011497906,"threshold_uncertainty_score":0.7497849},"labels":[],"label_agreement":null},{"id":"W4392379123","doi":"10.1158/1538-7445.ovarian23-b016","title":"Abstract B016: Repurposing nelfinavir for re-sensitizing platinum-resistant high grade serous ovarian cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Repurposing; Medicine; Ovarian cancer; Serous fluid; Cancer; Oncology; Internal medicine; Nelfinavir; Serous ovarian cancer; Cancer research; Biology; Immunology","score_opus":0.10763554771106329,"score_gpt":0.41796062062802514,"score_spread":0.3103250729169619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392379123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426075,0.035716634,0.00014131945,0.014637023,0.002247386,0.002262415,0.00045855227,0.00028070773,0.0016484204],"genre_scores_gemma":[0.9872212,0.0039321254,0.0006037352,0.0005977412,0.0017113319,0.0006639219,0.00004541537,0.00013680603,0.0050877286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99680644,0.00008298259,0.00047366318,0.00076684885,0.00082780275,0.0010422354],"domain_scores_gemma":[0.9982938,0.00048016393,0.00006582147,0.00052802137,0.00032425858,0.0003079338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015442848,0.00026373443,0.0004047041,0.00036285,0.00040767813,0.00027038643,0.00020159416,0.0002090698,0.0008258022],"category_scores_gemma":[0.000092964714,0.00022630351,0.00020176369,0.00086733705,0.0002385805,0.0001631547,0.00006681048,0.00079183,0.000029320267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038055198,0.00005661451,0.000047667465,0.0012129637,0.00034855233,0.00046231545,0.0008584004,0.000033372886,0.8882896,0.00020764959,0.03650304,0.06817435],"study_design_scores_gemma":[0.0036691353,0.0006491559,0.0038397359,0.0051830392,0.00016146441,0.000056379038,0.0008053922,0.00050948194,0.6065271,0.0005515084,0.3775027,0.0005448959],"about_ca_topic_score_codex":0.010983246,"about_ca_topic_score_gemma":0.0011291832,"teacher_disagreement_score":0.34099966,"about_ca_system_score_codex":0.0015421162,"about_ca_system_score_gemma":0.0017301934,"threshold_uncertainty_score":0.9956027},"labels":[],"label_agreement":null},{"id":"W4392379573","doi":"10.1158/1538-7445.ovarian23-a101","title":"Abstract A101: A novel ovarian cancer organotypic tumor slice culture model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ovarian cancer; Cancer; Medicine; Oncology; Cancer research; Internal medicine","score_opus":0.06326803084254527,"score_gpt":0.4196948734824779,"score_spread":0.35642684263993263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392379573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489539,0.039222583,0.0006320993,0.0019637123,0.00033966586,0.00086594,0.0010785692,0.00008125065,0.0068622474],"genre_scores_gemma":[0.98169565,0.003987329,0.00017196461,0.00020310764,0.0008851081,0.0008389922,0.00011517154,0.00007472276,0.0120279705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975331,0.00004248086,0.00017889905,0.0007672795,0.0006389593,0.00083927735],"domain_scores_gemma":[0.9988518,0.000020103425,0.000021909433,0.00047419796,0.00032311134,0.0003088808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036185991,0.0002179487,0.00016534077,0.00014745328,0.00022889637,0.0002215056,0.0004320959,0.00015251977,0.0006028003],"category_scores_gemma":[0.00006517053,0.00018006086,0.000099548386,0.0005119709,0.00017833115,0.00001645852,0.00025194386,0.00057790865,0.00013006406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026083423,0.000099282384,0.00018037953,0.00019192106,0.00025002455,0.00005776088,0.00015760874,0.00040764318,0.94239986,0.0003222633,0.04980964,0.0058627794],"study_design_scores_gemma":[0.0018335219,0.00033452362,0.0017431435,0.00041540997,0.000043695472,0.000031538093,0.00013813951,0.0020444582,0.5872083,0.00059673464,0.40502694,0.0005836424],"about_ca_topic_score_codex":0.0038777923,"about_ca_topic_score_gemma":0.0023017102,"teacher_disagreement_score":0.3552173,"about_ca_system_score_codex":0.00033323478,"about_ca_system_score_gemma":0.0018456121,"threshold_uncertainty_score":0.7342669},"labels":[],"label_agreement":null},{"id":"W4392379834","doi":"10.1158/1538-7445.ovarian23-b103","title":"Abstract B103: The impact of ULK1 deficiency on autophagy, cell viability, and tumor progression in experimental models of ovarian cancer metastasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Autophagy; Cancer; Ovarian cancer; Metastasis; Cancer research; Medicine; Tumor progression; Oncology; Biology; Internal medicine; Apoptosis; Genetics","score_opus":0.05023570441314776,"score_gpt":0.4334552380702344,"score_spread":0.3832195336570866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392379834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97109026,0.026709698,0.00010151164,0.00012409971,0.00007004483,0.0007856437,0.00012962589,0.0000067449123,0.000982345],"genre_scores_gemma":[0.9984226,0.00096692116,0.00004653179,0.0000071625836,0.000054721957,0.00037026702,0.000010133936,0.000036292808,0.000085356616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779356,0.00022923078,0.0002921003,0.00054344576,0.0006634647,0.00047818365],"domain_scores_gemma":[0.9991237,0.00006649967,0.000052408886,0.0004605917,0.00018726052,0.00010954238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012157755,0.00017000847,0.00021035213,0.00023884042,0.00007748496,0.000048063186,0.0003627756,0.00012046066,0.00019878568],"category_scores_gemma":[0.00005260369,0.00011571129,0.00013752225,0.00054985663,0.0003664899,0.000012711171,0.00031834978,0.00046847394,0.0000018087226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041077906,0.00022191597,0.000054349508,0.00023138293,0.00005099352,0.000014374571,0.0003009045,0.0047120103,0.98765457,0.00019213944,0.00030793267,0.0058486513],"study_design_scores_gemma":[0.00045290226,0.00074956845,0.0006739206,0.00020998527,0.000007394765,0.0000035318924,0.0001969184,0.0025928149,0.99458486,0.0002973503,0.000120134624,0.00011059158],"about_ca_topic_score_codex":0.0034728886,"about_ca_topic_score_gemma":0.00013632623,"teacher_disagreement_score":0.027332326,"about_ca_system_score_codex":0.00026687028,"about_ca_system_score_gemma":0.0010704511,"threshold_uncertainty_score":0.5249992},"labels":[],"label_agreement":null},{"id":"W4392380865","doi":"10.1158/1538-7445.ovarian23-pr-012","title":"Abstract PR-012: Proteogenomic analysis of enriched tumor epithelium identifies prognostic signatures and an increased dependency of homologous recombination proficient cells on bmi1 in high grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"BMI1; Serous fluid; Homologous recombination; Serous ovarian cancer; Epithelial ovarian cancer; Cancer research; Biology; Ovarian cancer; Cancer; Pathology; Medicine; Genetics; Gene","score_opus":0.02418655293242229,"score_gpt":0.3664522764632353,"score_spread":0.342265723530813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392380865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958819,0.0024148172,0.00017472931,0.00013075347,0.00004157328,0.0011259764,0.00018024111,0.000013716553,0.000036268375],"genre_scores_gemma":[0.99773157,0.0006347393,0.00016339522,0.000019007111,0.00003575835,0.0011622162,0.00017391653,0.000020028843,0.00005935138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849856,0.0002082618,0.0002981929,0.000528905,0.00021105334,0.00025502229],"domain_scores_gemma":[0.99926,0.000053478987,0.000093605224,0.00033656604,0.00019411337,0.0000622032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007328015,0.0001309435,0.00022645474,0.00047645307,0.000057662175,0.000027411677,0.00024025897,0.00016897068,0.000041878957],"category_scores_gemma":[0.000062910156,0.00011550487,0.00006775813,0.00070074963,0.00018679745,0.0000063687867,0.00008912257,0.00026081264,6.433899e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096162956,0.00021191701,0.0031091643,0.00017653419,0.00018372995,0.0000105093595,0.000080161466,0.00034293687,0.9936211,0.0005904557,0.00005837692,0.0015189301],"study_design_scores_gemma":[0.00020350348,0.0003447881,0.09401722,0.0000662326,0.000087766486,0.0000012646867,0.00004192364,0.00033698528,0.90398115,0.0007546966,0.000044035787,0.0001204389],"about_ca_topic_score_codex":0.0035633068,"about_ca_topic_score_gemma":0.0011545934,"teacher_disagreement_score":0.09090806,"about_ca_system_score_codex":0.00006595402,"about_ca_system_score_gemma":0.0002612111,"threshold_uncertainty_score":0.5386678},"labels":[],"label_agreement":null},{"id":"W4392381125","doi":"10.1158/1538-7445.ovarian23-b047","title":"Abstract B047: Development and validation of an improved risk stratification model for ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Risk stratification; Oncology; Stratification (seeds); Medicine; Cancer; Internal medicine; Biology","score_opus":0.141937194678425,"score_gpt":0.4483739181862786,"score_spread":0.30643672350785356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392381125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185765,0.003288823,0.0015915817,0.0013987855,0.00011888076,0.0012711225,0.00022405278,0.0000319747,0.00021711453],"genre_scores_gemma":[0.9927915,0.0012085736,0.0034583937,0.000016302964,0.00016252186,0.001869933,0.00008650088,0.000026827576,0.00037950007],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998826,0.000027267635,0.0002402955,0.00038056067,0.00029469354,0.00023112817],"domain_scores_gemma":[0.99920565,0.00009907452,0.000046290028,0.00021193855,0.0003037794,0.00013326097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069198554,0.00009941469,0.00016332004,0.00015480327,0.000117014075,0.00006954969,0.000056605615,0.000072032664,0.00012445061],"category_scores_gemma":[0.00003310766,0.00008135663,0.000034378463,0.00019317219,0.000060371218,0.0001404799,0.00001702851,0.00017444725,0.0000023271882],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073235796,0.00046128294,0.0043569165,0.002199831,0.0005907767,0.000008303881,0.0045606983,0.0011839854,0.089200936,0.002252902,0.0016534659,0.89279854],"study_design_scores_gemma":[0.0033749864,0.00058188516,0.085541025,0.0011654478,0.00029844372,0.0000031572522,0.00038682699,0.192454,0.7073442,0.0025944244,0.0059526353,0.00030297754],"about_ca_topic_score_codex":0.0011895982,"about_ca_topic_score_gemma":0.00057645043,"teacher_disagreement_score":0.8924956,"about_ca_system_score_codex":0.00041189708,"about_ca_system_score_gemma":0.0014428307,"threshold_uncertainty_score":0.3317627},"labels":[],"label_agreement":null},{"id":"W4392381498","doi":"10.1158/1538-7445.ovarian23-b054","title":"Abstract B054: Defective STING signaling in low-grade serous ovarian cancer: an opportunity for oncolytic viruses therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of British Columbia; Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Serous ovarian cancer; Sting; Medicine; Serous fluid; Ovarian cancer; Viral therapy; Cancer; Cancer research; Oncology; Internal medicine; Virology; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.18790882024671537,"score_gpt":0.4742950491577752,"score_spread":0.2863862289110598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392381498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985618,0.01195244,0.0000748847,0.0003915531,0.00018868117,0.0012618548,0.00019407271,0.00004272269,0.00027579616],"genre_scores_gemma":[0.9931685,0.0035996137,0.000058966125,0.0002522282,0.00094413396,0.0015711453,0.0000675504,0.000110395864,0.00022748979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689215,0.00042011298,0.00031012372,0.0008474673,0.00054879807,0.0009813317],"domain_scores_gemma":[0.9984372,0.00025911513,0.000043246102,0.00048298304,0.0004467504,0.00033067144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026943071,0.00024333087,0.00024672094,0.0003289108,0.00027402866,0.00021466351,0.0005398674,0.00023206741,0.00026528322],"category_scores_gemma":[0.00023647764,0.00023208148,0.00011394336,0.00072501396,0.00020539296,0.00002697416,0.000114771916,0.0007161916,0.0000093918425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026978943,0.00015647504,0.00080646673,0.00020765407,0.00014340768,0.000042537322,0.0004426007,0.0016339966,0.9093504,0.000022527638,0.00041421983,0.084081806],"study_design_scores_gemma":[0.0014213452,0.0023495026,0.00084802305,0.00035175815,0.000006579407,0.0000037446953,0.00047305052,0.0008775389,0.9841183,0.00055520376,0.008624777,0.00037018236],"about_ca_topic_score_codex":0.0029967837,"about_ca_topic_score_gemma":0.007611425,"teacher_disagreement_score":0.083711624,"about_ca_system_score_codex":0.0004666738,"about_ca_system_score_gemma":0.0033906007,"threshold_uncertainty_score":0.9464008},"labels":[],"label_agreement":null},{"id":"W4392382029","doi":"10.1158/1538-7445.ovarian23-b001","title":"Abstract B001: Comparative exploration of cultured spheroids and organoids as models to study epithelial ovarian cancer pathobiology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Organoid; Spheroid; Ovarian cancer; Epithelial ovarian cancer; Biology; Cancer research; Ovarian carcinomas; Cancer; Computational biology; Pathology; Medicine; Cell biology; Cell culture; Ovarian carcinoma; Genetics","score_opus":0.26484158530792246,"score_gpt":0.4819044421405836,"score_spread":0.21706285683266113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392382029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876068,0.007062831,0.00029822285,0.0017724839,0.000317825,0.0014296167,0.00017972344,0.000032906522,0.0012995483],"genre_scores_gemma":[0.9954819,0.0019700155,0.00018960299,0.00008808781,0.0004043092,0.00058119884,0.000015790938,0.000027299102,0.0012417624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982825,0.00013827288,0.00028336552,0.0004867932,0.00046320268,0.00034585013],"domain_scores_gemma":[0.99896055,0.0000827565,0.00003153217,0.0002475295,0.00045036385,0.0002272727],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006626413,0.00015428105,0.00041220375,0.00019095394,0.000096529955,0.00004986907,0.000105894615,0.00008438636,0.0011216337],"category_scores_gemma":[0.000026333411,0.00011724779,0.000050904237,0.0006809573,0.00014351172,0.00018916687,0.00009420618,0.00040228319,0.00003593019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017427806,0.00040452916,0.00053248496,0.000420036,0.00050171855,0.00011951655,0.053290397,0.00047069392,0.85997874,0.0009196909,0.004698585,0.076920815],"study_design_scores_gemma":[0.007157057,0.005629766,0.009195231,0.0014215526,0.00050969434,0.0000317095,0.049179185,0.00060962414,0.8760393,0.0043538283,0.045122825,0.00075020036],"about_ca_topic_score_codex":0.006567927,"about_ca_topic_score_gemma":0.0024536203,"teacher_disagreement_score":0.07617061,"about_ca_system_score_codex":0.00024243114,"about_ca_system_score_gemma":0.00067981257,"threshold_uncertainty_score":0.9997915},"labels":[],"label_agreement":null},{"id":"W4392383296","doi":"10.1158/1538-7445.ovarian23-ia016","title":"Abstract IA016: Opportunistic salpingectomy for ovarian cancer prevention","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Medicine; Salpingectomy; Cancer; Gynecology; Oncology; Internal medicine; Biology; Pregnancy; Genetics","score_opus":0.22408348042819576,"score_gpt":0.5060121483599012,"score_spread":0.2819286679317054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52834225,0.14531446,0.0035030406,0.23719421,0.009194682,0.018571306,0.0027846096,0.0012705456,0.053824913],"genre_scores_gemma":[0.9773109,0.004007378,0.00025903955,0.00016492352,0.0014541439,0.005315465,0.000100624624,0.00007330014,0.011314235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803907,0.000039256804,0.00025250774,0.00056364195,0.00053650496,0.0005690262],"domain_scores_gemma":[0.9988058,0.0002561673,0.000029548068,0.0003275179,0.00030588484,0.00027506705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070787943,0.00016121476,0.00026736362,0.00026989178,0.00019138015,0.00014584753,0.00011199895,0.00010546736,0.0043403944],"category_scores_gemma":[0.00007324712,0.00013187894,0.0001738254,0.0004955902,0.00009832752,0.000108915076,0.000041045314,0.00035965221,0.00011546306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009170619,0.0007049781,0.004660265,0.0050382204,0.0016152011,0.00061972294,0.0005224918,0.000023494917,0.015706293,0.023796974,0.2729471,0.6734482],"study_design_scores_gemma":[0.0033214744,0.00079443934,0.04068408,0.0040518264,0.00042414461,0.000022145561,0.00012253784,0.0004993212,0.009251646,0.004216959,0.9362899,0.0003215424],"about_ca_topic_score_codex":0.0008832483,"about_ca_topic_score_gemma":0.00027194005,"teacher_disagreement_score":0.67312664,"about_ca_system_score_codex":0.0010942504,"about_ca_system_score_gemma":0.0021241086,"threshold_uncertainty_score":0.99656975},"labels":[],"label_agreement":null},{"id":"W4393057067","doi":"10.1158/1538-7445.am2024-1243","title":"Abstract 1243: Shifted mSWI/SNF complex assembly and function underlie therapeutically targetable dependencies in endometrial carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Function (biology); Cancer research; Carcinoma; Endometrial cancer; Medicine; Internal medicine; Biology; Cancer; Cell biology","score_opus":0.12495259353348372,"score_gpt":0.41456843251143083,"score_spread":0.2896158389779471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393057067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687315,0.026971726,0.00022156624,0.00084140437,0.00014956977,0.0005172598,0.000033888984,0.00002039506,0.0025126596],"genre_scores_gemma":[0.9971427,0.0015270127,0.000029526915,0.000046610417,0.00027162945,0.00012815578,0.00006414589,0.000039294537,0.0007509662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99768054,0.00024385104,0.0002041085,0.0006407948,0.0005723999,0.0006583049],"domain_scores_gemma":[0.9990701,0.00025791858,0.000015584363,0.0002805133,0.00024210324,0.00013375416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012781363,0.00015775932,0.00018025495,0.0004354798,0.00014488361,0.00020901457,0.00024622437,0.00017771426,0.0005777948],"category_scores_gemma":[0.00032962742,0.00014912145,0.000058931142,0.0007718015,0.00024387552,0.000017429858,0.00023178422,0.0005382626,0.0000367609],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072448724,0.00007435205,0.010426253,0.00014737046,0.000100827805,0.000037115693,0.000103035934,0.000020102741,0.9595768,0.00072945683,0.0014323072,0.026627934],"study_design_scores_gemma":[0.0043350505,0.001643113,0.5983623,0.0001528953,0.000032751814,0.000020865193,0.0013991153,0.0017255287,0.24511476,0.004281704,0.14214852,0.00078335847],"about_ca_topic_score_codex":0.0013859591,"about_ca_topic_score_gemma":0.0022218097,"teacher_disagreement_score":0.714462,"about_ca_system_score_codex":0.00012484756,"about_ca_system_score_gemma":0.00061383017,"threshold_uncertainty_score":0.6326448},"labels":[],"label_agreement":null},{"id":"W4393057081","doi":"10.1158/1538-7445.am2024-4357","title":"Abstract 4357: Examining the role of end-stage kidney as a potential intermediate stage in the development of renal cell carcinomas; understanding the pathogenesis allowing for early detection","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Stage (stratigraphy); Pathogenesis; Kidney; Medicine; Renal cell carcinoma; Pathology; Internal medicine; Biology","score_opus":0.11662281140169924,"score_gpt":0.3597868093562705,"score_spread":0.24316399795457128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393057081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418956,0.002318059,0.0006544064,0.00022533965,0.00013375458,0.0012786769,0.000051039384,0.000012537668,0.0011365963],"genre_scores_gemma":[0.9987929,0.00007882478,0.00006246692,0.000023110915,0.00013402032,0.0004855608,0.000013994404,0.000036593337,0.0003725511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975731,0.0002445536,0.00044637077,0.0003296045,0.0009480444,0.00045834717],"domain_scores_gemma":[0.99861443,0.00072059844,0.00008719642,0.00035979203,0.00012353074,0.000094463474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030566715,0.00016007022,0.00022626753,0.0002828988,0.00023997166,0.00007440871,0.00031663338,0.00007436228,0.00011212468],"category_scores_gemma":[0.00011554131,0.00008340737,0.00013319378,0.00048523283,0.00020373834,0.00007637668,0.000111544265,0.0004906787,0.000004176929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064763403,0.00006653283,0.002926377,0.000667249,0.00015950557,0.00010922394,0.025192546,0.000094623836,0.95239544,0.000089256806,0.000023707133,0.01762791],"study_design_scores_gemma":[0.0010781701,0.0006062185,0.10423119,0.00066404155,0.000110509485,0.000009989929,0.040855013,0.00066082063,0.8501955,0.00018415278,0.001275328,0.00012901369],"about_ca_topic_score_codex":0.0009261712,"about_ca_topic_score_gemma":0.0004025555,"teacher_disagreement_score":0.10219988,"about_ca_system_score_codex":0.0008430792,"about_ca_system_score_gemma":0.0011882574,"threshold_uncertainty_score":0.3401254},"labels":[],"label_agreement":null},{"id":"W4393071125","doi":"10.1158/1538-7445.am2024-3341","title":"Abstract 3341: Targeting CXCR4 via the small molecule inhibitor NMX1 as a therapeutic strategy to treat high-risk malignancies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacology; Medicine; CXCR4; Immunology; Chemokine; Inflammation","score_opus":0.06277623033500104,"score_gpt":0.3803638971700607,"score_spread":0.3175876668350597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759801,0.016406635,0.00013471766,0.00459574,0.00024361882,0.000711945,0.000023698507,0.00010226664,0.0018012929],"genre_scores_gemma":[0.9932219,0.0010808761,0.00005575881,0.00028644546,0.0014784272,0.00025682486,0.000014919152,0.00007369001,0.0035311556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761677,0.00012522019,0.00029056295,0.00050660333,0.0007376207,0.0007232383],"domain_scores_gemma":[0.9987101,0.00037117954,0.00003123706,0.0003470888,0.00027926554,0.0002611126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011952873,0.00021310634,0.0002720678,0.00020665767,0.00029204672,0.00024334663,0.00022962468,0.000115986026,0.0015410627],"category_scores_gemma":[0.0001333391,0.00013307172,0.00014079116,0.0007972997,0.00013467977,0.00006259788,0.00010783919,0.00096135645,0.0003309414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002208499,0.000058648955,0.00043893215,0.0003752574,0.00011439862,0.00017977771,0.0011772106,0.00012575994,0.9279209,0.0003128292,0.0076972116,0.06137826],"study_design_scores_gemma":[0.00062374095,0.0006690927,0.001145578,0.0008199868,0.00009194044,0.000026033644,0.0011709166,0.00036402728,0.968268,0.0007978441,0.025762105,0.000260732],"about_ca_topic_score_codex":0.0048111286,"about_ca_topic_score_gemma":0.0001610514,"teacher_disagreement_score":0.06111753,"about_ca_system_score_codex":0.00036731234,"about_ca_system_score_gemma":0.00063018757,"threshold_uncertainty_score":0.99937165},"labels":[],"label_agreement":null},{"id":"W4393071141","doi":"10.1158/1538-7445.am2024-5588","title":"Abstract 5588: Protein Arginine Methyltransferase 2 is involved in the control of inflammatory processes in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Giro (Canada)","funders":"","keywords":"Myeloid leukemia; Protein arginine methyltransferase 5; Methyltransferase; Medicine; Cancer research; Myeloid; Immunology; Biology; Methylation; Biochemistry; Gene","score_opus":0.02428918699364988,"score_gpt":0.34197916452483196,"score_spread":0.31768997753118206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98203063,0.015334818,0.0000714717,0.0013217485,0.00004893513,0.0009580732,0.00006382478,0.000008128384,0.00016236854],"genre_scores_gemma":[0.9967019,0.0020601419,0.000013418595,0.00005575997,0.00017340075,0.0007384176,0.000034949553,0.000025255069,0.00019676809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984636,0.0001518946,0.0003023243,0.00035976525,0.00039453708,0.00032789214],"domain_scores_gemma":[0.99937075,0.00006725026,0.0000303622,0.000295302,0.00019388048,0.000042436597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011331056,0.00012571264,0.00015681566,0.00022446176,0.000034476514,0.000038235383,0.00029213252,0.00017975028,0.00006135335],"category_scores_gemma":[0.00009104142,0.000099125406,0.0000524041,0.0007506754,0.00017037221,0.0000126116975,0.000033417396,0.00045243168,0.0000057719753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037377563,0.000024382394,0.0007566003,0.0005686616,0.00007316744,0.000019841618,0.00070643134,0.00067793997,0.99167454,0.000037947448,0.0006629905,0.0044236975],"study_design_scores_gemma":[0.0009939396,0.0001332941,0.005362565,0.00041390664,0.00001234726,0.000002040902,0.0001897154,0.00022749393,0.9814492,0.0001904953,0.010889811,0.00013522895],"about_ca_topic_score_codex":0.0005339062,"about_ca_topic_score_gemma":0.0019257024,"teacher_disagreement_score":0.014671256,"about_ca_system_score_codex":0.00019705773,"about_ca_system_score_gemma":0.0017564305,"threshold_uncertainty_score":0.40422165},"labels":[],"label_agreement":null},{"id":"W4393071189","doi":"10.1158/1538-7445.am2024-6383","title":"Abstract 6383: Targeting radiation-induced fibrosis: Exploring promising therapeutic avenues and innovative assessment methods","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Intensive care medicine; Medical physics; Cancer research","score_opus":0.20747766085335642,"score_gpt":0.5367178837876885,"score_spread":0.3292402229343321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97678274,0.016877363,0.00048208825,0.00359935,0.00041899222,0.000775448,0.0000074308605,0.00012322658,0.0009333621],"genre_scores_gemma":[0.9930903,0.00079600676,0.00464579,0.00007597224,0.0006540104,0.00055050355,0.000013000701,0.00004857934,0.00012585416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813443,0.0003039701,0.0002416703,0.00038324273,0.00052904716,0.00040761748],"domain_scores_gemma":[0.9983477,0.00094553526,0.000042964955,0.00018303265,0.00035063273,0.00013015274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032978295,0.00013060366,0.00021427189,0.00039774663,0.00020342582,0.00019799873,0.00008152029,0.00007844856,0.00011474986],"category_scores_gemma":[0.0004864807,0.00011346944,0.000035919675,0.000997118,0.00007153585,0.00036072134,0.000051741485,0.0008475232,0.000015312764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036053414,0.00001879751,0.0033019956,0.00062048866,0.00013233638,0.000021991837,0.0018981342,0.000011538529,0.6163829,0.0004777752,0.000647713,0.37645027],"study_design_scores_gemma":[0.00150291,0.0005797952,0.3771958,0.00291679,0.000080645004,0.000016815797,0.0024631564,0.003836106,0.5795764,0.001355056,0.030031374,0.0004451589],"about_ca_topic_score_codex":0.00008909364,"about_ca_topic_score_gemma":0.0000026237128,"teacher_disagreement_score":0.3760051,"about_ca_system_score_codex":0.00054908264,"about_ca_system_score_gemma":0.000687701,"threshold_uncertainty_score":0.46271494},"labels":[],"label_agreement":null},{"id":"W4393071289","doi":"10.1158/1538-7445.am2024-483","title":"Abstract 483: Unraveling the impact of cancer cell derived membrane and cytosolic proteins using synthetic small extracellular vesicles","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; McGill University Health Centre","funders":"","keywords":"Cytosol; Extracellular vesicles; Extracellular; Chemistry; Vesicle; Cell biology; Cancer cell; Cancer; Cell; Biochemistry; Biology; Membrane; Enzyme; Genetics","score_opus":0.05934395875555327,"score_gpt":0.3838277157856419,"score_spread":0.32448375703008864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8521872,0.14668253,0.00019850931,0.000084672814,0.000064700944,0.0005427542,0.000082604354,0.000013941086,0.00014306653],"genre_scores_gemma":[0.99312246,0.0059170234,0.00018074043,0.000008584022,0.00031114824,0.00013962989,0.000011330502,0.00007196032,0.00023709884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981211,0.0001885403,0.00028250396,0.0005387595,0.00032604864,0.0005430478],"domain_scores_gemma":[0.9989347,0.0000881921,0.00006595296,0.0005402678,0.00019198935,0.00017891364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080855226,0.0002146177,0.0001881863,0.000080894366,0.0001960366,0.00011934967,0.00039430708,0.00015260895,0.00019163005],"category_scores_gemma":[0.000086015265,0.00015641314,0.00016907592,0.0002421846,0.00047386644,0.00001193925,0.000234266,0.00035455206,0.00000447548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011602748,0.00006413785,0.00055234355,0.0004781657,0.00014159881,0.000029643323,0.00024585886,0.0015192131,0.99308693,0.000018949488,0.00005006965,0.003697063],"study_design_scores_gemma":[0.00023613438,0.00009481246,0.0018592039,0.00030689655,0.000044849807,0.000008583971,0.00019624348,0.0020694798,0.9945365,0.00007355339,0.0003861614,0.00018754415],"about_ca_topic_score_codex":0.0046486985,"about_ca_topic_score_gemma":0.00030926618,"teacher_disagreement_score":0.14093526,"about_ca_system_score_codex":0.0001470327,"about_ca_system_score_gemma":0.0008785321,"threshold_uncertainty_score":0.7027473},"labels":[],"label_agreement":null},{"id":"W4393071322","doi":"10.1158/1538-7445.am2024-3484","title":"Abstract 3484: Mechanism of BRAF V600E resistance revealed by cell panel screening and bioinformatics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Mechanism (biology); Medicine; Computational biology; Bioinformatics; Biology; Physics","score_opus":0.05578470948236121,"score_gpt":0.33464701982419764,"score_spread":0.27886231034183645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96517825,0.021567238,0.002257611,0.00028976428,0.0001431376,0.00030199694,0.0002893367,0.00001972316,0.009952968],"genre_scores_gemma":[0.9895095,0.0029250132,0.001093747,0.000038499555,0.00012822126,0.000038394188,0.00005770097,0.000022508604,0.006186409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893945,0.000040342868,0.00020375353,0.0002493124,0.00026746895,0.00029967297],"domain_scores_gemma":[0.99945664,0.00004203874,0.000035964,0.0002539772,0.00010868174,0.00010268782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057345163,0.00010037306,0.000121864425,0.00007346745,0.00007980038,0.00004889116,0.00017283595,0.00012488822,0.000053027405],"category_scores_gemma":[0.000042784548,0.00009080626,0.000041740972,0.00014469694,0.000109079534,0.000007754138,0.00012698268,0.00020414084,0.0000087837525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054365883,0.000012080668,0.000051377836,0.00075333146,0.000023834382,0.000008191717,0.00012641311,0.000001100216,0.9634504,0.00044808327,0.030875275,0.0041955635],"study_design_scores_gemma":[0.00030657434,0.00013242131,0.00019538074,0.00022513124,0.000007887867,0.0000035124942,0.00021030876,0.00011718365,0.9266888,0.000326339,0.071640946,0.00014554117],"about_ca_topic_score_codex":0.00007088805,"about_ca_topic_score_gemma":0.00004086194,"teacher_disagreement_score":0.04076567,"about_ca_system_score_codex":0.000016317917,"about_ca_system_score_gemma":0.00015250278,"threshold_uncertainty_score":0.37029716},"labels":[],"label_agreement":null},{"id":"W4393071362","doi":"10.1158/1538-7445.am2024-6694","title":"Abstract 6694: Gut microbial drivers of response to bladder-sparing therapy in human muscle-invasive bladder cancer enhance immunotherapy efficacy and limit immunosuppression following fecal microbiome transplantation <i>in vivo</i>","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); Centre Hospitalier de l’Université de Montréal; Institute of Infection and Immunity; McGill University Health Centre","funders":"","keywords":"Immunosuppression; Microbiome; Immunotherapy; Transplantation; Bladder cancer; Medicine; Cancer; In vivo; Ex vivo; Immunology; Immune system; Biology; Internal medicine; Bioinformatics","score_opus":0.04121302489874531,"score_gpt":0.3974398220793401,"score_spread":0.3562267971805948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849008,0.011648175,0.0000110268,0.0011307942,0.00031616836,0.001624859,0.000125297,0.000041449664,0.00020145184],"genre_scores_gemma":[0.98560345,0.013000404,0.00005805341,0.00016398467,0.00013423397,0.0004054921,0.00001875995,0.00008465912,0.0005309757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972256,0.00026336536,0.0005239435,0.0007584366,0.00052767707,0.00070096576],"domain_scores_gemma":[0.9988544,0.00046764823,0.000053090247,0.00034745716,0.00011906729,0.00015833773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085226895,0.0003117771,0.00051050767,0.00079505105,0.00022365064,0.00013747747,0.00022864927,0.00020145226,0.00038726194],"category_scores_gemma":[0.000031976855,0.00028231472,0.00014885305,0.00094993383,0.00017881334,0.00022312235,0.00005252898,0.0006595728,0.000008934841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008200741,0.0002563035,0.0025192758,0.0003021353,0.00028618932,0.00033177235,0.009127254,0.00008305463,0.960198,0.0000024569724,0.0004372794,0.018255562],"study_design_scores_gemma":[0.007698751,0.0007159218,0.10602495,0.004281611,0.000044805936,0.000009872859,0.0003595718,0.000008078317,0.87855566,0.000015878597,0.00200991,0.00027498158],"about_ca_topic_score_codex":0.007783302,"about_ca_topic_score_gemma":0.0021163544,"teacher_disagreement_score":0.10350568,"about_ca_system_score_codex":0.0006926276,"about_ca_system_score_gemma":0.0007821134,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W4393071678","doi":"10.1158/1538-7445.am2024-3575","title":"Abstract 3575: The estrogenic endocrine disrupting compounds bisphenol-a (BPA) and alpha-zeranol (aZAL) induce early mammary hyperplasia in female ACI rats","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Zeranol; Endocrine system; Bisphenol A; Internal medicine; Endocrinology; Medicine; Alpha (finance); Hyperplasia; Physiology; Chemistry; Hormone; Surgery","score_opus":0.032254056896466425,"score_gpt":0.3616909242349604,"score_spread":0.329436867338494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546475,0.042615086,0.000006515579,0.0008057311,0.00018806008,0.0003987612,0.000015696334,0.000025622185,0.0012970218],"genre_scores_gemma":[0.99435824,0.004272571,0.000039903156,0.000048456237,0.0002850388,0.00016879637,0.0000287911,0.00004452275,0.00075370003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810135,0.00017776083,0.00022059237,0.00055178953,0.00031043476,0.00063807255],"domain_scores_gemma":[0.99925846,0.00012192657,0.000026446223,0.00038419693,0.000070530536,0.00013841534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061591406,0.00019642392,0.00016950798,0.00013458247,0.00021740115,0.00021473841,0.000363979,0.00019082935,0.000020123149],"category_scores_gemma":[0.000057801324,0.00014475799,0.000080166115,0.0004191018,0.00025187343,0.000019931958,0.00032208348,0.0009297913,0.000028288317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119882345,0.000039616178,0.005221705,0.00011623955,0.00012679152,0.00024302719,0.00029677895,0.000017992035,0.97529197,0.00019170149,0.0009737863,0.017360507],"study_design_scores_gemma":[0.001252308,0.0005855722,0.027238235,0.00038704486,0.000036311496,0.0003447032,0.00041928922,0.00027918007,0.9429272,0.0002335089,0.025787264,0.00050942926],"about_ca_topic_score_codex":0.00034006222,"about_ca_topic_score_gemma":0.00008711668,"teacher_disagreement_score":0.039710715,"about_ca_system_score_codex":0.000067983805,"about_ca_system_score_gemma":0.00031167018,"threshold_uncertainty_score":0.5903059},"labels":[],"label_agreement":null},{"id":"W4393071888","doi":"10.1158/1538-7445.am2024-2914","title":"Abstract 2914: AI/ML-driven discovery of CTHRC1, collagen triple helix repeat-containing 1, a novel proteoglycan for stroma + tumor targeting and delivery of 4-1BB costimulation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Stroma; Triple helix; Medicine; Proteoglycan; Cancer research; Chemistry; Immunology; Anatomy; Cartilage; Stereochemistry; Immunohistochemistry","score_opus":0.05112483774378429,"score_gpt":0.4076410583531972,"score_spread":0.3565162206094129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014324,0.0028542306,0.0034805145,0.0017118672,0.00014053682,0.0013555371,0.00011119023,0.000029814611,0.000173052],"genre_scores_gemma":[0.996236,0.00017519547,0.0025598768,0.00006794307,0.0003224151,0.00017891036,0.000057879734,0.000045277335,0.00035646601],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99817634,0.000054254982,0.00044932222,0.00038666802,0.0005555549,0.00037789127],"domain_scores_gemma":[0.9986497,0.0005259612,0.000105918116,0.00018438752,0.0003963749,0.00013765387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552406,0.00012883973,0.00038373633,0.00029171788,0.000119570475,0.00007486997,0.00011292962,0.000065160144,0.000039922063],"category_scores_gemma":[0.0011470699,0.0001105558,0.000096145915,0.00033548195,0.00025161039,0.00019540163,0.00008376864,0.00043927252,7.656033e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014701557,0.00008921727,0.012903988,0.0031868976,0.00018539798,0.000052181404,0.001076638,0.00076871,0.9635923,0.00036515493,0.001819603,0.014489756],"study_design_scores_gemma":[0.01625495,0.00457585,0.08530343,0.015123097,0.00046124335,0.00010994813,0.004142951,0.6426183,0.20668943,0.0007675496,0.023076842,0.0008763831],"about_ca_topic_score_codex":0.0011582137,"about_ca_topic_score_gemma":0.000025175437,"teacher_disagreement_score":0.7569029,"about_ca_system_score_codex":0.00019551256,"about_ca_system_score_gemma":0.00075842417,"threshold_uncertainty_score":0.45083347},"labels":[],"label_agreement":null},{"id":"W4393071900","doi":"10.1158/1538-7445.am2024-3883","title":"Abstract 3883: Cryo-EM-guided enhancement of target selectivity of a novel p97 inhibitor for treating multiple myeloma and acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple myeloma; Myeloid leukemia; Medicine; Cancer research; Myeloid; Pharmacology; Internal medicine","score_opus":0.05690115510205083,"score_gpt":0.3702199128890037,"score_spread":0.31331875778695284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959263,0.0011434703,0.0011424442,0.00014455203,0.00023435877,0.0008414074,0.0004536807,0.000044544006,0.000069192705],"genre_scores_gemma":[0.9948986,0.00008183098,0.004089473,0.000012339766,0.00017940646,0.00042788396,0.0000079301535,0.0000345246,0.0002679838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976089,0.00008336507,0.00048282568,0.0005458822,0.0006839796,0.0005950201],"domain_scores_gemma":[0.99805695,0.0009060454,0.00010668095,0.00028765877,0.0005111098,0.00013154522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001940447,0.00016393556,0.00033698513,0.00021972586,0.00014660915,0.00009902889,0.00023237348,0.00008389439,0.00018972845],"category_scores_gemma":[0.00039729045,0.00014701033,0.00007538666,0.00052037614,0.00026833412,0.00029478304,0.00017008308,0.00020522399,0.0000113775495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038558972,0.00012067177,0.00036676406,0.0008166623,0.000049155606,0.000006289163,0.0008437626,0.00018614541,0.9921128,0.00006670872,0.0015166845,0.003528751],"study_design_scores_gemma":[0.0010934947,0.00026601137,0.0008909321,0.00038115808,0.000022326803,0.0000024475617,0.00015128599,0.0059541413,0.9907196,0.000094325245,0.0002848309,0.00013941954],"about_ca_topic_score_codex":0.0010273012,"about_ca_topic_score_gemma":0.00019206287,"teacher_disagreement_score":0.0057679955,"about_ca_system_score_codex":0.00058789976,"about_ca_system_score_gemma":0.0010636847,"threshold_uncertainty_score":0.59949076},"labels":[],"label_agreement":null},{"id":"W4393072112","doi":"10.1158/1538-7445.am2024-6095","title":"Abstract 6095: Lung cancer risk assessment with the INTEGRAL protein panel: Preliminary results from development and validation in the Lung Cancer Cohort Consortium","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Cancer; Cohort; Oncology; Internal medicine; Lung","score_opus":0.056451231462881966,"score_gpt":0.3935363698912951,"score_spread":0.33708513842841314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851994,0.0024106049,0.00019274878,0.0073038014,0.000086045016,0.0030885648,0.00020818406,0.000030615978,0.0014800343],"genre_scores_gemma":[0.99173653,0.0018846402,0.00019772716,0.00019209734,0.00011805455,0.0053620697,0.000036837053,0.000038132843,0.00043390578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995813,0.0007471543,0.00038814818,0.0009710602,0.0013736954,0.0007069293],"domain_scores_gemma":[0.9985413,0.00075593125,0.0001093847,0.0004259187,0.000032102194,0.00013536972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046788873,0.00023604924,0.00018433975,0.00008738709,0.0005504495,0.00025181557,0.00043227582,0.00009127037,0.0009565573],"category_scores_gemma":[0.000091072674,0.00013687908,0.000025963696,0.00054736214,0.0005610017,0.00035639785,0.0002821552,0.0014935099,0.000024572812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085537817,0.00015665525,0.829942,0.00028405714,0.0002730597,0.00019052597,0.023514464,0.0038699356,0.0075430945,0.000041448166,0.010132631,0.12319676],"study_design_scores_gemma":[0.0005325484,0.00006741401,0.97844553,0.00079446874,0.000046226327,0.0000018779499,0.0017124097,0.005000266,0.0052294177,0.00004137888,0.00789231,0.00023617489],"about_ca_topic_score_codex":0.061452694,"about_ca_topic_score_gemma":0.009748808,"teacher_disagreement_score":0.14850351,"about_ca_system_score_codex":0.0025599964,"about_ca_system_score_gemma":0.0006494402,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W4393072330","doi":"10.1158/1538-7445.am2024-1448","title":"Abstract 1448: Investigating the effects of estrogen on the initiation of prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Government of Newfoundland and Labrador; Memorial University of Newfoundland","funders":"","keywords":"Prostate cancer; Cancer; Medicine; Estrogen; Prostate; Internal medicine; Oncology","score_opus":0.10785178043211657,"score_gpt":0.4464590085819904,"score_spread":0.3386072281498738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96326166,0.02311942,5.402763e-7,0.010136293,0.000222774,0.0014951058,0.000049547332,0.000022108607,0.0016925631],"genre_scores_gemma":[0.992732,0.004835718,0.0000063955003,0.000108103304,0.000271822,0.0009445897,0.000010889551,0.000029264003,0.0010612466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797213,0.00017711738,0.00023466785,0.00024180402,0.0009903853,0.00038387382],"domain_scores_gemma":[0.9975649,0.001577469,0.000054769032,0.00033337632,0.00037605912,0.00009340229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136659,0.000113832575,0.00018813468,0.00017294957,0.00016052542,0.000041283958,0.00020043642,0.000059026144,0.00023485979],"category_scores_gemma":[0.0004999359,0.000053526415,0.00008467905,0.0008449698,0.0006131765,0.000068212,0.00007652489,0.00072892726,0.000017680533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009933716,0.00023686989,0.03780886,0.010589248,0.000979315,0.0001416386,0.010734584,0.00008963606,0.80220515,0.006967307,0.02806817,0.10118584],"study_design_scores_gemma":[0.0008887554,0.00064820214,0.028955268,0.0054125786,0.00006839875,0.0000026076118,0.00055611745,0.00019506767,0.9580172,0.0012488996,0.00392122,0.00008569153],"about_ca_topic_score_codex":0.0011320887,"about_ca_topic_score_gemma":0.00004848558,"teacher_disagreement_score":0.15581204,"about_ca_system_score_codex":0.00028298906,"about_ca_system_score_gemma":0.0013516692,"threshold_uncertainty_score":0.3166867},"labels":[],"label_agreement":null},{"id":"W4393072481","doi":"10.1158/1538-7445.am2024-149","title":"Abstract 149: Modeling patient-specific <i>CHEK2</i> genetic variants associated with high-risk neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"CHEK2; Neuroblastoma; Medicine; Genetics; Oncology; Internal medicine; Biology; Cancer research; Mutation; Gene; Germline mutation","score_opus":0.05300717004199528,"score_gpt":0.3437253068774087,"score_spread":0.2907181368354134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394315,0.0025824409,0.000093520866,0.0005071704,0.00021878499,0.0009443657,0.00016608601,0.00021865373,0.0013258439],"genre_scores_gemma":[0.9959736,0.0022333753,0.00012297899,0.00006711311,0.0002344142,0.00031097617,0.00003826348,0.00013753871,0.00088176975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99551344,0.0002473489,0.00032621901,0.000890195,0.0018227729,0.0012000004],"domain_scores_gemma":[0.99792796,0.00036880697,0.000042300362,0.0005613401,0.00050912774,0.000590474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042826528,0.0002836777,0.00033853127,0.0005220673,0.00031569114,0.00022843634,0.0002229795,0.00012536824,0.00062723097],"category_scores_gemma":[0.00017521778,0.00021244792,0.000104184954,0.0013107085,0.0002023837,0.00017649838,0.00013875206,0.0015239752,0.00041072184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012734834,0.0049879835,0.016902344,0.002047326,0.005403828,0.07199983,0.0027231374,0.019217541,0.36159354,0.00051503215,0.06702783,0.4348468],"study_design_scores_gemma":[0.037367597,0.035904314,0.56702983,0.019445717,0.0011832084,0.0013402568,0.0008713672,0.13433975,0.1695218,0.006855089,0.022142222,0.003998878],"about_ca_topic_score_codex":0.00082652934,"about_ca_topic_score_gemma":0.00014710608,"teacher_disagreement_score":0.55012745,"about_ca_system_score_codex":0.0005908625,"about_ca_system_score_gemma":0.00082599616,"threshold_uncertainty_score":0.8663375},"labels":[],"label_agreement":null},{"id":"W4393072698","doi":"10.1158/1538-7445.am2024-1808","title":"Abstract 1808: Discovery of highly selective novel MTA-cooperative PRMT5 inhibitors for the treatment of cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Cancer; Medicine; Pharmacology; Internal medicine","score_opus":0.04284572349528641,"score_gpt":0.38269034225909876,"score_spread":0.33984461876381233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735703,0.022687852,0.0009055501,0.0005462428,0.00041593678,0.0011311288,0.00052879885,0.0000069385005,0.00020728882],"genre_scores_gemma":[0.99288374,0.004170699,0.000031046013,0.0000057767197,0.0005877995,0.00058876845,0.000059764097,0.000028542656,0.0016438442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989142,0.000033479864,0.0002115921,0.00033683793,0.00025221994,0.00025166123],"domain_scores_gemma":[0.9991274,0.00014008359,0.000053776304,0.00024459808,0.0003988531,0.000035316534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024037548,0.00012151867,0.00015338908,0.00008565827,0.00009143938,0.000031335487,0.00012960791,0.00011071559,0.000012996174],"category_scores_gemma":[0.000041383097,0.00008309619,0.00013012168,0.00033741177,0.00026223765,0.0000107236765,0.000029061843,0.00009852151,9.423974e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048234637,0.00006883336,0.000056220324,0.00010049362,0.0004383245,3.554827e-7,0.00054187037,0.009038697,0.9732695,0.00016114082,0.00399075,0.011851448],"study_design_scores_gemma":[0.0005207573,0.0008919567,0.0009269846,0.00009511786,0.00003626134,7.7010134e-7,0.00019493348,0.00039953878,0.9635304,0.000029522269,0.033286832,0.000086873544],"about_ca_topic_score_codex":0.0019464855,"about_ca_topic_score_gemma":0.0014705163,"teacher_disagreement_score":0.029296083,"about_ca_system_score_codex":0.0005266169,"about_ca_system_score_gemma":0.0013582867,"threshold_uncertainty_score":0.33885643},"labels":[],"label_agreement":null},{"id":"W4393072776","doi":"10.1158/1538-7445.am2024-1815","title":"Abstract 1815: Optimization of Lin28 inhibitors: A promising therapeutic approach for the suppression of cancer cell proliferation, stemness properties, and spheroid growth","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Spheroid; Cancer; LIN28; Cancer research; Cell growth; Cancer stem cell; Cell biology; Biology; Medicine; Internal medicine; SOX2; Cell culture; Biochemistry; Genetics; Embryonic stem cell","score_opus":0.10491187101968551,"score_gpt":0.3807152790211305,"score_spread":0.275803408001445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82472545,0.15121236,0.010731339,0.0025882411,0.00022173872,0.009594457,0.00008355192,0.00006370764,0.0007791749],"genre_scores_gemma":[0.9918624,0.0047083264,0.0007135962,0.000018044722,0.00025008788,0.0013349827,0.000018743467,0.000057694087,0.0010360786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978043,0.00013629624,0.00038076643,0.00039292584,0.00094064063,0.0003450647],"domain_scores_gemma":[0.9981115,0.0002751006,0.000066833745,0.0002846959,0.0011585685,0.00010332759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230505,0.0001363945,0.00025590128,0.000121171455,0.00016536136,0.00009119251,0.0001748963,0.00011718854,0.00018215617],"category_scores_gemma":[0.00013254293,0.00008047316,0.000068119494,0.0005464747,0.00031300305,0.00014336935,0.0001075189,0.00040643205,5.990302e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015672105,0.00026398507,0.001506621,0.013961187,0.00013793798,0.000002933681,0.0022295478,0.0038701766,0.94845754,0.000039531158,0.0013456626,0.026617683],"study_design_scores_gemma":[0.0010148706,0.00030674445,0.00061714655,0.0014541554,0.00006575742,0.0000031934562,0.0009881378,0.101544335,0.8932166,0.0000246617,0.00065913843,0.00010527625],"about_ca_topic_score_codex":0.0012880266,"about_ca_topic_score_gemma":0.000048111804,"teacher_disagreement_score":0.16713701,"about_ca_system_score_codex":0.00021450457,"about_ca_system_score_gemma":0.0010072083,"threshold_uncertainty_score":0.32816005},"labels":[],"label_agreement":null},{"id":"W4393072815","doi":"10.1158/1538-7445.am2024-2648","title":"Abstract 2648: CD155 regulates cell growth and immune evasion in diffuse midline glioma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Evasion (ethics); Immune system; Glioma; Immune escape; Medicine; Anatomy; Biology; Immunology; Cancer research","score_opus":0.03497036371567701,"score_gpt":0.35787530168806553,"score_spread":0.3229049379723885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95899194,0.03970935,0.0000044911703,0.0003510307,0.00012891532,0.00019176689,0.000036227535,0.000018180977,0.0005680971],"genre_scores_gemma":[0.9976511,0.0014525485,0.000041761225,0.000023900942,0.00025589732,0.000082545404,0.00004877552,0.000035588942,0.00040786507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986673,0.00008070833,0.00017418804,0.00045595568,0.00026523264,0.000356599],"domain_scores_gemma":[0.9994168,0.00006288704,0.000015874308,0.00029827922,0.000085519874,0.000120617944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051298056,0.00011910964,0.00010698084,0.00014709792,0.00006386399,0.00007749351,0.00021009192,0.00013188201,0.000075095275],"category_scores_gemma":[0.00014146222,0.000108404725,0.00004867316,0.00030581898,0.00016554208,0.000005986718,0.00021207632,0.00026345914,0.000016540534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015080198,0.00009797893,0.00063540024,0.0003080341,0.000014498562,0.000112337315,0.000077633034,0.00001031414,0.99586475,0.00003885998,0.0014187216,0.0012706827],"study_design_scores_gemma":[0.0006543518,0.00008705731,0.004985891,0.00018689019,0.0000050827884,0.00000511329,0.00005147193,0.00007490748,0.9919886,0.00042680174,0.0014035098,0.00013029808],"about_ca_topic_score_codex":0.00024547504,"about_ca_topic_score_gemma":0.000032358905,"teacher_disagreement_score":0.038659178,"about_ca_system_score_codex":0.000042709675,"about_ca_system_score_gemma":0.00020096418,"threshold_uncertainty_score":0.44206163},"labels":[],"label_agreement":null},{"id":"W4393072939","doi":"10.1158/1538-7445.am2024-7140","title":"Abstract 7140: A new series of flavonoid derivatives with anti-cancer activity includes SDN207, SND210, SND524, and SND562 as potent microtubule-targeting agents","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Cancer; Microtubule; Flavonoid; Pharmacology; Medicine; Chemistry; Biology; Cancer research; Biochemistry; Internal medicine; Cell biology","score_opus":0.10442314201316864,"score_gpt":0.46100781995566215,"score_spread":0.3565846779424935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97374076,0.013499924,0.00007236499,0.009351838,0.00016507023,0.0011276867,0.000054990098,0.000089521396,0.0018978368],"genre_scores_gemma":[0.9792332,0.01247748,0.0007068483,0.0001241755,0.0005998218,0.00023826398,0.000014213317,0.00010501925,0.0065009953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949482,0.00024691777,0.00043593862,0.00091703545,0.0022981344,0.0011537498],"domain_scores_gemma":[0.99731976,0.0006679403,0.000083018844,0.00049695146,0.00062395394,0.00080839114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019266978,0.0003453333,0.000673115,0.0005713692,0.00030786134,0.00018151915,0.00039893267,0.00023006837,0.0021243403],"category_scores_gemma":[0.0014584921,0.00025803258,0.00010767892,0.001227063,0.001591705,0.0004521821,0.0005707953,0.0019518739,0.00005566727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016099979,0.00018412397,0.0064459913,0.003582644,0.0004637564,0.00036683175,0.0018617067,0.000015600646,0.9207759,0.00012222858,0.01315507,0.05141618],"study_design_scores_gemma":[0.0015645633,0.00097550725,0.041377764,0.0042723557,0.00006111192,0.00002322818,0.0010916039,0.00017323263,0.93893963,0.0003724592,0.0108124735,0.00033608254],"about_ca_topic_score_codex":0.004479235,"about_ca_topic_score_gemma":0.00021203901,"teacher_disagreement_score":0.0510801,"about_ca_system_score_codex":0.0005750937,"about_ca_system_score_gemma":0.0035809688,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W4393072996","doi":"10.1158/1538-7445.am2024-6574","title":"Abstract 6574: UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Cancer research; Oncology; Pathology","score_opus":0.07231235519616343,"score_gpt":0.43185712957170386,"score_spread":0.35954477437554044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393072996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97040534,0.018072583,0.000016676793,0.009262517,0.00008147744,0.0013515014,0.00013125577,0.00006727384,0.00061134994],"genre_scores_gemma":[0.9957447,0.0008222508,0.00007987687,0.0004336805,0.00014357672,0.0008314714,0.000014152283,0.00006684644,0.0018634135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978322,0.00005769952,0.00015239371,0.00055460836,0.00066482264,0.00073831785],"domain_scores_gemma":[0.9989065,0.00022702165,0.000013015413,0.00030529415,0.00012779282,0.00042039782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022758338,0.00015699312,0.0002154893,0.0004090622,0.00012933658,0.000115224066,0.00012391819,0.000034164266,0.0005794814],"category_scores_gemma":[0.00006460945,0.000121934245,0.000097983335,0.00039706496,0.00020226308,0.000055985136,0.0000919315,0.00052072003,0.00009380406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028197167,0.0005538698,0.011468993,0.00430903,0.001244264,0.013272382,0.0006172301,0.0000022369388,0.8311293,0.0018449089,0.034498632,0.09823942],"study_design_scores_gemma":[0.005246682,0.0038822917,0.042270258,0.0005426857,0.00014457967,0.000444245,0.00011712346,0.0006151225,0.70652425,0.0032973208,0.23656848,0.00034695657],"about_ca_topic_score_codex":0.00014954893,"about_ca_topic_score_gemma":0.0000064914707,"teacher_disagreement_score":0.20206985,"about_ca_system_score_codex":0.00015376348,"about_ca_system_score_gemma":0.0006125702,"threshold_uncertainty_score":0.6344915},"labels":[],"label_agreement":null},{"id":"W4393073056","doi":"10.1158/1538-7445.am2024-1130","title":"Abstract 1130: Leveraging the IVIS imaging technologies for drug potency testing in orthotopic and metastatic tumor models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Potency; Drug; Medical physics; Radiology; Pharmacology; Biology; In vitro","score_opus":0.1912893460059827,"score_gpt":0.46429127425544114,"score_spread":0.27300192824945846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8394819,0.015283677,0.009527817,0.13072084,0.00006713609,0.002594026,0.000025403826,0.00070142536,0.0015978081],"genre_scores_gemma":[0.9884409,0.00036986754,0.009159146,0.00016071631,0.00005154695,0.0014686763,0.0000029354057,0.000022548978,0.00032367976],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99882627,0.00002389222,0.0001926153,0.00030929604,0.00028357963,0.00036435126],"domain_scores_gemma":[0.99882936,0.00071725016,0.000018033628,0.00025765246,0.00012408075,0.00005360842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013425549,0.00008741644,0.00014584174,0.00022297328,0.00016403725,0.00010216737,0.00016546292,0.000016357255,0.000017157123],"category_scores_gemma":[0.0005411779,0.00005666938,0.000029826533,0.0005923784,0.0002676893,0.00010158596,0.00011586668,0.000641828,0.000002152563],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028890188,0.000086796565,0.0050255554,0.0026029958,0.000051443883,0.00029014077,0.0014427081,0.00005865123,0.062588826,0.0110418415,0.018358584,0.89842355],"study_design_scores_gemma":[0.0012791692,0.0000906495,0.0059223855,0.007259004,0.00012149446,0.00025566123,0.006213529,0.6486836,0.0262971,0.2595328,0.04385326,0.0004913381],"about_ca_topic_score_codex":0.00094101555,"about_ca_topic_score_gemma":0.000027459198,"teacher_disagreement_score":0.89793223,"about_ca_system_score_codex":0.00010909749,"about_ca_system_score_gemma":0.0002576062,"threshold_uncertainty_score":0.2788459},"labels":[],"label_agreement":null},{"id":"W4393073070","doi":"10.1158/1538-7445.am2024-7053","title":"Abstract 7053: Serine phosphorylation marks proteins for degradation by the mitochondrial matrix protease, ClpXP","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Guelph; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Serine protease; Phosphorylation; Serine; Protease; Matrix (chemical analysis); Chemistry; Biochemistry; Biology; Cell biology; Enzyme","score_opus":0.038949063579113034,"score_gpt":0.37631961750762816,"score_spread":0.3373705539285151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8840763,0.020025557,0.062471412,0.011693739,0.0061217295,0.011828372,0.0010672221,0.00014058738,0.0025750627],"genre_scores_gemma":[0.84130627,0.0019766984,0.004211395,0.00041631437,0.0109451115,0.015008212,0.0031446097,0.00019791012,0.122793496],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986869,0.000119511235,0.00018511988,0.00043007772,0.00025456073,0.00032379446],"domain_scores_gemma":[0.99932486,0.000058527017,0.00003170756,0.00029521598,0.00021694408,0.00007273276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005466728,0.000119128876,0.00009037824,0.0000607207,0.00022589104,0.000120089244,0.00019754653,0.00018748383,0.0003084707],"category_scores_gemma":[0.0002035793,0.000087813896,0.00008525165,0.0002027966,0.00010179009,0.0000076936,0.000059792605,0.00028611085,0.00003913395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000579597,0.000020402565,0.00002737517,0.0000890418,0.00002858984,0.0000014731293,0.000027593014,0.000021871721,0.86137694,0.00021660377,0.12431323,0.0132972635],"study_design_scores_gemma":[0.0003488497,0.00021139064,0.0000747705,0.000026435158,0.000007434745,0.0000051633883,0.000026156178,0.000119012315,0.41618535,0.00023067395,0.58267033,0.000094407216],"about_ca_topic_score_codex":0.0002275654,"about_ca_topic_score_gemma":0.00020906155,"teacher_disagreement_score":0.45835713,"about_ca_system_score_codex":0.000060663268,"about_ca_system_score_gemma":0.0003053651,"threshold_uncertainty_score":0.35809466},"labels":[],"label_agreement":null},{"id":"W4393073073","doi":"10.1158/1538-7445.am2024-7061","title":"Abstract 7061: Targeting metabolic vulnerabilities in ARID1A/B dual-deficient dedifferentiated endometrial carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ARID1A; Medicine; Endometrial cancer; Cancer research; Carcinoma; Oncology; Internal medicine; Biology; Cancer; Gene; Genetics; Mutation","score_opus":0.05861144684577816,"score_gpt":0.38067416231726436,"score_spread":0.3220627154714862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457547,0.05234038,0.00005073173,0.0001830915,0.0006869955,0.00025368543,0.00006023105,0.000029700193,0.0006404931],"genre_scores_gemma":[0.99605805,0.0018025299,0.000045257486,0.000023066208,0.0010303193,0.00019924056,0.000093256145,0.000040164934,0.0007081132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978288,0.00016742984,0.00033001465,0.0005829621,0.00048405066,0.00060673145],"domain_scores_gemma":[0.99928594,0.00010857821,0.000026073996,0.00029316996,0.0001822074,0.00010403243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001285903,0.00016602788,0.00020867489,0.00032798774,0.00012265144,0.0001433603,0.00020213948,0.00015304532,0.0003157381],"category_scores_gemma":[0.00037748195,0.00014588778,0.00011511696,0.0006191076,0.00013731953,0.0000070715028,0.00015811673,0.0005045021,0.000027396916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015418923,0.000059852016,0.0015943702,0.00021935318,0.00005700562,0.000025539584,0.0003761335,0.001064776,0.98363245,0.00016209054,0.004768518,0.007885751],"study_design_scores_gemma":[0.0015048069,0.0001897468,0.005901631,0.0002292206,0.000021454483,0.000008757684,0.000767731,0.0025039131,0.93836975,0.00035335458,0.049708046,0.0004415661],"about_ca_topic_score_codex":0.0014277903,"about_ca_topic_score_gemma":0.0002388884,"teacher_disagreement_score":0.05053785,"about_ca_system_score_codex":0.00013556724,"about_ca_system_score_gemma":0.00052617857,"threshold_uncertainty_score":0.59491307},"labels":[],"label_agreement":null},{"id":"W4393073075","doi":"10.1158/1538-7445.am2024-6812","title":"Abstract 6812: Durable control of brain tumors by glioma inhibitory macrophages and IL33","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Brain cancer; Glioma; Cancer research; Inhibitory postsynaptic potential; Medicine; Biology; Cancer; Internal medicine","score_opus":0.020514586986245545,"score_gpt":0.3401135176444744,"score_spread":0.31959893065822886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.754838,0.24067476,0.000017019309,0.0014845295,0.0008102515,0.00029870772,0.00021517089,0.000049145663,0.0016124485],"genre_scores_gemma":[0.9865831,0.0013422924,0.000004389175,0.00007960313,0.00008001045,0.00012474728,0.000017977907,0.000036578585,0.011731268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836886,0.00023913424,0.00028893191,0.00039994172,0.00012025473,0.0005828529],"domain_scores_gemma":[0.9987586,0.0007352297,0.000041972857,0.00027949197,0.00014993694,0.00003477721],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010570447,0.00014986968,0.00027871126,0.00024543717,0.00016731641,0.000045504654,0.0002669105,0.00020809533,0.0027130581],"category_scores_gemma":[0.00010668744,0.00013273084,0.000060250346,0.00033578475,0.001033036,0.00011509635,0.00011808247,0.0008371087,0.0002750937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016698021,0.000028587483,0.0001678059,0.00031597711,0.00013732116,0.00004666868,0.00031668213,0.0000024871838,0.8582979,0.00017651953,0.13189892,0.00844416],"study_design_scores_gemma":[0.0009564992,0.00011851443,0.0010108969,0.00031737136,0.000010869069,0.000031628988,0.00023136109,0.0000026053085,0.85332733,0.0002073962,0.14365172,0.00013381208],"about_ca_topic_score_codex":0.00094439695,"about_ca_topic_score_gemma":0.000024691537,"teacher_disagreement_score":0.23933247,"about_ca_system_score_codex":0.00015956949,"about_ca_system_score_gemma":0.00034573275,"threshold_uncertainty_score":0.99819857},"labels":[],"label_agreement":null},{"id":"W4393073111","doi":"10.1158/1538-7445.am2024-3732","title":"Abstract 3732: Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab + lenalidomide in patients with follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenalidomide; Rituximab; Pharmacodynamics; Follicular lymphoma; Medicine; Lymphoma; Pharmacology; Internal medicine; Pharmacokinetics; Multiple myeloma","score_opus":0.02130235424238004,"score_gpt":0.3691542417916172,"score_spread":0.3478518875492372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755204,0.0006999569,0.0000046930936,0.00043433186,0.000020844342,0.0010286104,0.00001991805,0.000016044944,0.00022355742],"genre_scores_gemma":[0.99910784,0.00042013728,0.000027167296,0.000016135233,0.000014695436,0.00021339078,0.000011432335,0.00003533438,0.00015389305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818444,0.00011542222,0.00014284032,0.00036562202,0.00079364446,0.0003980086],"domain_scores_gemma":[0.9994089,0.000109734705,0.00002370762,0.00016078874,0.00016399827,0.00013285817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002911765,0.000137744,0.0002664493,0.00048055817,0.00004023795,0.000042098658,0.00007183371,0.000047592766,0.00009238885],"category_scores_gemma":[0.000019571924,0.00009775133,0.000026318117,0.0006980971,0.00018194901,0.0002281655,0.000029316892,0.00033828086,0.0000056799263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06115691,0.006852864,0.65499455,0.0015184935,0.0005265601,0.0025764399,0.0008089745,0.0000691925,0.07582553,0.00009968636,0.000082682185,0.19548814],"study_design_scores_gemma":[0.03564832,0.002214296,0.93394876,0.0009069362,0.000014044814,0.000011036903,0.000041982035,0.00073947373,0.026201293,0.00007453606,0.00008909855,0.00011023301],"about_ca_topic_score_codex":0.0023200675,"about_ca_topic_score_gemma":0.00073890795,"teacher_disagreement_score":0.27895424,"about_ca_system_score_codex":0.00065139175,"about_ca_system_score_gemma":0.00054476,"threshold_uncertainty_score":0.39861834},"labels":[],"label_agreement":null},{"id":"W4393073134","doi":"10.1158/1538-7445.am2024-1022","title":"Abstract 1022: Integration of cerebrospinal fluid methylome and proteome can obviate the need for biopsy in central nervous system lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cerebrospinal fluid; Proteome; Liquid biopsy; Lymphoma; Medicine; Biopsy; Pathology; Brain biopsy; Primary central nervous system lymphoma; Central nervous system; Cancer; Biology; Bioinformatics; Internal medicine","score_opus":0.06656938442436865,"score_gpt":0.3891376129802975,"score_spread":0.3225682285559288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895262,0.004809508,0.0000115526955,0.0034522593,0.00014096207,0.0018304545,0.0000965597,0.000021377462,0.000111136265],"genre_scores_gemma":[0.99805343,0.0002036158,0.000065382854,0.000012594828,0.00013709979,0.001400151,0.00001909186,0.000020689034,0.00008796593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987298,0.00006189415,0.00024131183,0.00025292498,0.00034490525,0.00036913969],"domain_scores_gemma":[0.9993129,0.00020828345,0.000028147497,0.00018611453,0.00016087435,0.000103731756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064876076,0.00010643881,0.00022274852,0.00025483713,0.00007653242,0.000064493135,0.00007966074,0.00006209419,0.00002336573],"category_scores_gemma":[0.000082501865,0.00006273262,0.00006448055,0.00048123297,0.000114141454,0.00004562364,0.000031323223,0.00014139821,0.0000030244053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010707447,0.00029631483,0.0134545015,0.0040411744,0.0002994472,0.00030638985,0.0025918907,0.00002546052,0.86209536,0.004969609,0.0008728396,0.10997626],"study_design_scores_gemma":[0.0026952836,0.0006705762,0.74185944,0.0027576855,0.000082435385,0.00007682511,0.0022863501,0.001661368,0.24668273,0.00019397456,0.0009080044,0.00012532869],"about_ca_topic_score_codex":0.0073961355,"about_ca_topic_score_gemma":0.00055344147,"teacher_disagreement_score":0.72840494,"about_ca_system_score_codex":0.00065455126,"about_ca_system_score_gemma":0.00038344154,"threshold_uncertainty_score":0.9992137},"labels":[],"label_agreement":null},{"id":"W4393073206","doi":"10.1158/1538-7445.am2024-4205","title":"Abstract 4205: Investigating micro-environmental changes in a syngeneic radio-recurrent prostate cancer model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Internal medicine","score_opus":0.09410602987980621,"score_gpt":0.4209191944268821,"score_spread":0.3268131645470759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92915237,0.06439058,0.000003426575,0.005297939,0.00019904858,0.00062297296,0.00012238303,0.0000448429,0.00016644037],"genre_scores_gemma":[0.9836776,0.013440107,0.00008455429,0.00029370835,0.00035933245,0.0006371573,0.00002997943,0.000044358185,0.001433173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998292,0.00006413807,0.00020648926,0.00041145366,0.00052966713,0.00049620494],"domain_scores_gemma":[0.99946034,0.000085168205,0.000025848707,0.00019037222,0.000026369948,0.00021191488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066377455,0.00013957513,0.00019333138,0.00040653572,0.0000921425,0.00006730256,0.00011005611,0.00008729301,0.0008898622],"category_scores_gemma":[0.000031987543,0.000121562625,0.000047639376,0.00050920265,0.00017819398,0.00011274294,0.000044358458,0.00074425444,0.00008145736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019766537,0.00010163776,0.022985172,0.0007706051,0.00008999335,0.000078500525,0.0041515357,0.0016628819,0.8563832,0.000037854592,0.0048858514,0.10865508],"study_design_scores_gemma":[0.004414578,0.000650582,0.12478876,0.006484399,0.00008814493,0.000037506867,0.0016567304,0.105761,0.7239914,0.0011325615,0.030057982,0.000936352],"about_ca_topic_score_codex":0.00047422803,"about_ca_topic_score_gemma":0.00026462704,"teacher_disagreement_score":0.13239183,"about_ca_system_score_codex":0.0010093666,"about_ca_system_score_gemma":0.00058112375,"threshold_uncertainty_score":0.9743367},"labels":[],"label_agreement":null},{"id":"W4393073239","doi":"10.1158/1538-7445.am2024-4215","title":"Abstract 4215: Single-cell proteomic characterization of the tumor microenvironment in humanized NOG-EXL patient-derived xenograft (PDX) models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cell; Cancer research; Chemistry; Medicine; Biochemistry","score_opus":0.038111509572436024,"score_gpt":0.2639340777576359,"score_spread":0.22582256818519986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965852,0.0009698744,0.0002794167,0.00006475711,0.00039383848,0.001204682,0.00011336547,0.00007569361,0.00031319106],"genre_scores_gemma":[0.9989138,0.00041916827,0.000062624626,0.000014654946,0.00007463142,0.00033032088,0.000018485065,0.0000905798,0.00007568435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998349,0.000036017882,0.00037829278,0.00026269033,0.0004996061,0.00047435562],"domain_scores_gemma":[0.99945533,0.000042282027,0.000041091047,0.00035242,0.00004828519,0.000060593215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023755911,0.00017625795,0.000197898,0.00022773568,0.00006795395,0.00007065477,0.0003232618,0.00007598734,0.00020902153],"category_scores_gemma":[0.000008701693,0.00014396892,0.00007623018,0.00048658164,0.00012622835,0.00025571385,0.00010224604,0.0005365691,0.00002983042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000468068,0.000053986776,0.00007446233,0.00055646943,0.000024386885,0.000008869453,0.0013446922,0.005426946,0.98843724,0.00001324855,0.000056020926,0.003956884],"study_design_scores_gemma":[0.0004343312,0.000058483085,0.0014296696,0.00049320323,0.000007555821,0.0000012389182,0.00005782848,0.0071585365,0.9888353,0.00021654289,0.0011474566,0.0001598884],"about_ca_topic_score_codex":0.000101168145,"about_ca_topic_score_gemma":0.000042283646,"teacher_disagreement_score":0.0037969956,"about_ca_system_score_codex":0.0009057019,"about_ca_system_score_gemma":0.00012043898,"threshold_uncertainty_score":0.58708817},"labels":[],"label_agreement":null},{"id":"W4393073289","doi":"10.1158/1538-7445.am2024-4236","title":"Abstract 4236: PDX-derived organoids (PDXO) are valuable tools to unveil the shortcomings of new anti-cancer drug candidates","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fluorine in Organic Chemistry","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Organoid; Cancer; Drug; Medicine; Biology; Computational biology; Pharmacology; Oncology; Cancer research; Internal medicine; Genetics","score_opus":0.2661781804108691,"score_gpt":0.5349383879298936,"score_spread":0.26876020751902446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96860284,0.008978538,0.0000042225115,0.017900195,0.0012971598,0.00066514267,0.00034726615,0.00011311333,0.0020914972],"genre_scores_gemma":[0.9619429,0.002596749,0.000027807315,0.0007757951,0.0013002944,0.00024290253,0.000016640015,0.000080223384,0.033016652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971061,0.00021294101,0.0004599513,0.00062577403,0.0006650468,0.00093019975],"domain_scores_gemma":[0.9973619,0.0012326346,0.00007840172,0.00053116627,0.00036205418,0.00043382467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017991127,0.00028288792,0.00039325378,0.00015803729,0.00033314136,0.00015148603,0.0010816291,0.00023376802,0.023745583],"category_scores_gemma":[0.00039171305,0.00022129779,0.00012102938,0.0011149703,0.0004193469,0.00017607182,0.00048809804,0.0021462534,0.00042687575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013524528,0.0000553467,0.0063352487,0.00036861372,0.0002363481,0.00004554696,0.0016506258,0.00019657891,0.66131854,0.00004117604,0.32356742,0.006049279],"study_design_scores_gemma":[0.0004001406,0.000022417646,0.0023151273,0.0001765557,0.00005665482,0.0000061001233,0.000574056,0.00009432028,0.76519746,0.00012615789,0.23083402,0.00019696515],"about_ca_topic_score_codex":0.002022541,"about_ca_topic_score_gemma":0.00038283307,"teacher_disagreement_score":0.10387891,"about_ca_system_score_codex":0.0005605538,"about_ca_system_score_gemma":0.0018448621,"threshold_uncertainty_score":0.97714686},"labels":[],"label_agreement":null},{"id":"W4393073328","doi":"10.1158/1538-7445.am2024-6599","title":"Abstract 6599: 3D genomic analysis reveals novel enhancer hijacking mechanisms caused by complex structural alterations that drive oncogene overexpression","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Enhancer; Oncogene; Biology; Cancer research; Cell biology; Cancer; Genetics; Computational biology; Gene; Gene expression","score_opus":0.18460482854299134,"score_gpt":0.48257775260103336,"score_spread":0.297972924058042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770799,0.006520024,0.0058277096,0.003678541,0.0005036017,0.0020278615,0.0015397537,0.00023672332,0.0025858863],"genre_scores_gemma":[0.99104595,0.0014692924,0.0013910955,0.00026957618,0.0007652671,0.00061535643,0.0005443478,0.0001384517,0.003760679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937379,0.00025636322,0.00063187955,0.0013116997,0.002641405,0.0014207747],"domain_scores_gemma":[0.99697727,0.0005533672,0.000100558704,0.0010379546,0.0006764822,0.00065439026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016869017,0.00039956218,0.0007519948,0.0011843522,0.00060603506,0.0005275105,0.00058768754,0.00027816714,0.014213771],"category_scores_gemma":[0.0001648717,0.000342485,0.00033413226,0.0024172317,0.00033612785,0.00031638046,0.0003812936,0.0017006143,0.00023307372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014453736,0.00005561397,0.0008375956,0.0004917982,0.0010173125,0.000085993874,0.0007403914,0.00032674934,0.9660142,0.00035029493,0.024510823,0.0054246704],"study_design_scores_gemma":[0.0026530449,0.0004933833,0.03695368,0.0028359639,0.0007806909,0.000035787318,0.00070701254,0.0192611,0.8947479,0.0016205005,0.038840998,0.0010699005],"about_ca_topic_score_codex":0.0020903593,"about_ca_topic_score_gemma":0.0005118011,"teacher_disagreement_score":0.07126628,"about_ca_system_score_codex":0.003026087,"about_ca_system_score_gemma":0.0015126086,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W4393073384","doi":"10.1158/1538-7445.am2024-1634","title":"Abstract 1634: Cyclin D1 induces Akt1 activity in RB deficient prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Cyclin D1; Cancer; AKT1; Prostate; Cancer research; Medicine; Oncology; Internal medicine; Biology; Phosphorylation; Cell biology; Protein kinase B; Cell cycle","score_opus":0.1029190100800717,"score_gpt":0.448608913677852,"score_spread":0.3456899035977803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96219325,0.027567266,0.0000084346875,0.0044185426,0.0010274836,0.0012458285,0.000116171126,0.00012860158,0.0032944141],"genre_scores_gemma":[0.99126065,0.004887715,0.000019774083,0.00011002447,0.0003875746,0.001039249,0.000015185175,0.000087921166,0.0021918942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647844,0.00013398,0.00032416315,0.0008535719,0.0012162318,0.0009935951],"domain_scores_gemma":[0.9986996,0.00017913648,0.000041656145,0.0005212212,0.000258179,0.0003002308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013816409,0.00023411369,0.0003573016,0.00073784776,0.000118556294,0.00013082701,0.00021776675,0.00023323942,0.0011137929],"category_scores_gemma":[0.00018386057,0.00020778386,0.00012302198,0.0017854552,0.00025794678,0.00016682703,0.00016010708,0.002244046,0.0002449752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007221743,0.00025559097,0.0023475497,0.0010591585,0.00012544502,0.001086264,0.001707755,0.00055324956,0.84129363,0.00013389291,0.010346272,0.14036898],"study_design_scores_gemma":[0.003639704,0.0005897402,0.13687205,0.0075298413,0.00010208717,0.00005769848,0.00066363194,0.0014046467,0.7131413,0.00044623148,0.1347312,0.00082181476],"about_ca_topic_score_codex":0.012903116,"about_ca_topic_score_gemma":0.006112203,"teacher_disagreement_score":0.13954717,"about_ca_system_score_codex":0.0023583698,"about_ca_system_score_gemma":0.002991342,"threshold_uncertainty_score":0.9997993},"labels":[],"label_agreement":null},{"id":"W4393073484","doi":"10.1158/1538-7445.am2024-1274","title":"Abstract 1274: Investigating PLOD2 as a therapeutic target to overcome metastasis in radiorecurrent prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Cancer; Prostate cancer; Metastasis; Medicine; Prostate; Oncology; Internal medicine","score_opus":0.1563689354340288,"score_gpt":0.4845338166096226,"score_spread":0.3281648811755938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8871545,0.09039014,0.0000038055505,0.01755967,0.00043719038,0.0023891574,0.00018189567,0.00009149558,0.0017921488],"genre_scores_gemma":[0.9799936,0.009971201,0.00015143433,0.00039686752,0.00050914014,0.0034337523,0.000047235844,0.000103746395,0.0053930306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995639,0.00020177102,0.0004221891,0.00087670446,0.0015118658,0.0013484157],"domain_scores_gemma":[0.9982286,0.000287903,0.000030034493,0.0004317336,0.00033157162,0.000690121],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016211073,0.00030048442,0.00047911113,0.0010827316,0.00017843918,0.00024636736,0.0002846502,0.0001143472,0.0033787484],"category_scores_gemma":[0.00017658548,0.000225261,0.00013518699,0.0026026233,0.00029284618,0.00024087541,0.0001835204,0.001459723,0.0004552716],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002594113,0.0006174014,0.072617404,0.0046629957,0.0013640622,0.0024633103,0.02154417,0.00049039285,0.25385287,0.0008288388,0.028327381,0.61063707],"study_design_scores_gemma":[0.009720893,0.0029101018,0.13276632,0.018422334,0.00029714793,0.00007939148,0.003704591,0.001976638,0.34385574,0.009319729,0.47516978,0.0017773265],"about_ca_topic_score_codex":0.005752052,"about_ca_topic_score_gemma":0.000511466,"teacher_disagreement_score":0.6088597,"about_ca_system_score_codex":0.0023793853,"about_ca_system_score_gemma":0.003337064,"threshold_uncertainty_score":0.9975323},"labels":[],"label_agreement":null},{"id":"W4393073490","doi":"10.1158/1538-7445.am2024-3624","title":"Abstract 3624: A low-cost kit for gentle, effective and timely extracellular vesicle (GET EVs) isolation: Accelerating development of RNA-based liquid biopsies for neuroendocrine neoplasms","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Extracellular vesicles; Extracellular vesicle; Neuroendocrine tumors; Isolation (microbiology); Biology; Computational biology; Medicine; Pathology; Cell biology; Bioinformatics; Microvesicles; Biochemistry; microRNA","score_opus":0.07984744614803076,"score_gpt":0.4193228851022547,"score_spread":0.33947543895422394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850166,0.0051888824,0.0017399051,0.0019805906,0.0001764296,0.005542242,0.00013222359,0.00008698482,0.00013613582],"genre_scores_gemma":[0.9897832,0.00016599774,0.004574246,0.000052548457,0.0002726789,0.00411599,0.000060317227,0.000094854084,0.00088011706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997044,0.0000892336,0.0005042512,0.0006899751,0.00077905384,0.0008934616],"domain_scores_gemma":[0.99673516,0.0019190664,0.000076797296,0.00029795372,0.000668218,0.00030280498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071226386,0.00024908822,0.00041030216,0.0004981071,0.00033161955,0.00014239988,0.0001979102,0.000018256269,0.00014981866],"category_scores_gemma":[0.0008969385,0.0002203953,0.00011875718,0.0005883555,0.00026666597,0.00026197147,0.000121447934,0.00050183997,0.000014203641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005221284,0.00018655184,0.00040427988,0.0068434034,0.00014001632,0.00051722757,0.0002744138,0.00023001955,0.93435156,0.00014495796,0.0016559978,0.0500303],"study_design_scores_gemma":[0.0024490326,0.0013709557,0.0014147811,0.0009178208,0.000030831805,0.00006200046,0.00014566322,0.008249654,0.9562989,0.00006561517,0.028801344,0.00019341077],"about_ca_topic_score_codex":0.000047001427,"about_ca_topic_score_gemma":0.00004728605,"teacher_disagreement_score":0.049836885,"about_ca_system_score_codex":0.00030312806,"about_ca_system_score_gemma":0.0010885742,"threshold_uncertainty_score":0.898746},"labels":[],"label_agreement":null},{"id":"W4393073579","doi":"10.1158/1538-7445.am2024-6440","title":"Abstract 6440: Novel N-myristoyltransferase immunohistochemistry-based predictive and prognostic tests for breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Winnipeg","funders":"","keywords":"Immunohistochemistry; Breast cancer; Cancer; Medicine; Internal medicine; Oncology; Cancer research; Pathology","score_opus":0.03402021455980189,"score_gpt":0.3785588341143043,"score_spread":0.3445386195545024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88181037,0.10594987,0.0020641983,0.0012657117,0.0013293386,0.0014253884,0.0056795212,0.00006252048,0.0004131044],"genre_scores_gemma":[0.99016064,0.0036360344,0.00012845937,0.00010432317,0.0026641993,0.0021383606,0.0001486254,0.00007228055,0.0009470816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812734,0.000026273721,0.00021003356,0.00072119024,0.0003332388,0.0005819195],"domain_scores_gemma":[0.9989091,0.00010811413,0.000025795782,0.00032514668,0.00042007898,0.00021176189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043062965,0.00022182007,0.00019785296,0.0001053465,0.00020555055,0.00011654254,0.00022897654,0.00019840748,0.00013431825],"category_scores_gemma":[0.000106632324,0.00021061744,0.00011879809,0.00023023976,0.00036477434,0.000010799448,0.00005986094,0.0003462228,0.000003255824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059573137,0.00007532876,0.00025057976,0.00067409745,0.00012242966,0.0000026599967,0.00007282136,0.00008585188,0.9644194,0.000030451489,0.014791442,0.018879177],"study_design_scores_gemma":[0.003326498,0.00043138064,0.0237487,0.0009697764,0.00018666868,0.000054662447,0.00014181952,0.0007996063,0.62028587,0.00012941388,0.34911138,0.0008142337],"about_ca_topic_score_codex":0.0005020668,"about_ca_topic_score_gemma":0.00016614365,"teacher_disagreement_score":0.34413356,"about_ca_system_score_codex":0.00013920099,"about_ca_system_score_gemma":0.0015303352,"threshold_uncertainty_score":0.858873},"labels":[],"label_agreement":null},{"id":"W4393073646","doi":"10.1158/1538-7445.am2024-1919","title":"Abstract 1919: Activity and affinity tuning next-generation immunotoxins for targeted therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Immunotoxin; Medicine; Targeted therapy; Cancer research; Oncology; Cancer; Internal medicine; Immunology; Antibody; Monoclonal antibody","score_opus":0.15310919065353457,"score_gpt":0.38638001619924983,"score_spread":0.23327082554571527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95490295,0.04176068,0.00037422197,0.00062262407,0.0011630016,0.00074554037,0.00013322914,0.00010624947,0.0001915333],"genre_scores_gemma":[0.9917495,0.005333033,0.00008879309,0.000052407475,0.00020387112,0.0005095414,0.000077373224,0.0000395727,0.0019459078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854475,0.00018928801,0.00017577466,0.0004506222,0.00008141511,0.000558126],"domain_scores_gemma":[0.9992006,0.00032944372,0.00003116248,0.0002637402,0.00014096731,0.00003411912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011347653,0.00016726066,0.00020359839,0.0002119493,0.00062433735,0.00020935605,0.00019991198,0.00025798954,0.0010471457],"category_scores_gemma":[0.00009443696,0.0001430556,0.000083710926,0.00024696023,0.00020643562,0.00032890213,0.00008513311,0.000743692,0.00009015169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021483579,0.000048722708,0.000010918411,0.00004725738,0.00012749662,0.0000024403914,0.00045297446,0.0000026536056,0.8887699,0.0010592468,0.0024663133,0.106797226],"study_design_scores_gemma":[0.0007091194,0.00025448427,0.0020241297,0.00006796724,0.0000069396624,0.0000051431775,0.00015142385,0.0001337058,0.9221829,0.000354736,0.07393903,0.00017039505],"about_ca_topic_score_codex":0.0007525032,"about_ca_topic_score_gemma":0.000128126,"teacher_disagreement_score":0.10662683,"about_ca_system_score_codex":0.00012739854,"about_ca_system_score_gemma":0.00029788754,"threshold_uncertainty_score":0.999866},"labels":[],"label_agreement":null},{"id":"W4393073674","doi":"10.1158/1538-7445.am2024-645","title":"Abstract 645: A systems biology approach uncovers the anticancer mechanisms of curcumin","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Curcumin; Computational biology; Biology; Medicine; Pharmacology; Physiology","score_opus":0.05889306327232177,"score_gpt":0.41018407441019683,"score_spread":0.3512910111378751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.786372,0.06254066,0.11454003,0.008500164,0.0020105164,0.0036383308,0.0014334592,0.00012016158,0.020844644],"genre_scores_gemma":[0.9971953,0.00066267507,0.000105599196,0.000048234164,0.00040368034,0.00058954605,0.00008630901,0.000024511215,0.00088416785],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853927,0.00010139107,0.000215277,0.00043985108,0.0003354165,0.00036879795],"domain_scores_gemma":[0.9991042,0.00009838207,0.00003452588,0.0004956997,0.00017322696,0.00009397739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009414721,0.00010963445,0.0001386338,0.00008953744,0.00010030547,0.00004558476,0.00048627573,0.0001705398,0.00009321082],"category_scores_gemma":[0.000077589015,0.00007230021,0.00007755221,0.0005229116,0.00060849026,0.000003328368,0.00018983196,0.00029604172,0.000029614535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026781263,0.000042205316,0.00005927479,0.0002129448,0.00009856767,0.0000013392375,0.000058709,0.00003274508,0.9548754,0.028755661,0.012532974,0.003303374],"study_design_scores_gemma":[0.0002962799,0.00018799918,0.00026982746,0.00011593452,0.000027290342,0.00001254208,0.0006127465,0.0005704897,0.4560291,0.0040437644,0.5376134,0.00022064772],"about_ca_topic_score_codex":0.0007169657,"about_ca_topic_score_gemma":0.000019918552,"teacher_disagreement_score":0.52508044,"about_ca_system_score_codex":0.00006430917,"about_ca_system_score_gemma":0.00045703948,"threshold_uncertainty_score":0.2948317},"labels":[],"label_agreement":null},{"id":"W4393073766","doi":"10.1158/1538-7445.am2024-6476","title":"Abstract 6476: Solving the real-world data challenge: A hybrid resourcing model to curate RWD at scale","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Technologies in Various Fields","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scale (ratio); Computer science; Medicine; Geography; Cartography","score_opus":0.2308162779702552,"score_gpt":0.4587147740257314,"score_spread":0.2278984960554762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073766","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12460411,0.011615892,0.6811918,0.134074,0.0016021981,0.0019496485,0.00018712298,0.0031960856,0.04157912],"genre_scores_gemma":[0.9792823,0.0021265028,0.013489477,0.00020902746,0.00026050562,0.0002466788,0.0000052200535,0.00004769569,0.0043325694],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99641997,0.00008358445,0.00027789042,0.0012337862,0.0009671836,0.0010176133],"domain_scores_gemma":[0.995095,0.0006730503,0.00004163279,0.0038755129,0.00016277107,0.00015203592],"candidate_categories":["open_science"],"consensus_categories":["open_science"],"category_scores_codex":[0.0020820994,0.00019115083,0.00019651857,0.00040420535,0.0006712089,0.00054415135,0.00671664,0.00006837126,0.000038539583],"category_scores_gemma":[0.00027286142,0.00014400427,0.00004698813,0.0015940315,0.00030973775,0.0006867257,0.010217552,0.0014986938,0.0002011765],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074359705,0.00006598204,0.00010519036,0.0003410985,0.000096973614,0.0005435527,0.0045113536,0.034966983,0.02163028,0.080538884,0.13916585,0.7179595],"study_design_scores_gemma":[0.00013256972,0.00008107024,0.00015299048,0.0005055904,0.000006336892,0.000013451618,0.0001896417,0.8638435,0.0129378745,0.03950092,0.08221379,0.00042225159],"about_ca_topic_score_codex":0.0009478651,"about_ca_topic_score_gemma":0.0046422486,"teacher_disagreement_score":0.8546782,"about_ca_system_score_codex":0.0007562725,"about_ca_system_score_gemma":0.00039885208,"threshold_uncertainty_score":0.9986575},"labels":[],"label_agreement":null},{"id":"W4393073813","doi":"10.1158/1538-7445.am2024-5049","title":"Abstract 5049: Detecting chromosomal copy number variations and point mutations in Glioma using a single assay; sparing tissue while significantly reducing testing time and cost","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Point mutation; Biology; Medicine; Genetics; Mutation; Gene","score_opus":0.12625712704826322,"score_gpt":0.40971508852706345,"score_spread":0.2834579614788002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393073813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957696,0.0012436837,0.00005566947,0.00055804587,0.00006686052,0.0007229258,0.000031707594,0.00006327077,0.0014882394],"genre_scores_gemma":[0.9971414,0.000027200776,0.002352766,0.000009006339,0.00018589514,0.000177956,0.000013637597,0.000042890526,0.000049199967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983586,0.00009033382,0.00027969104,0.00047479424,0.00033801532,0.00045857934],"domain_scores_gemma":[0.9982765,0.0011531585,0.000040360206,0.00015632411,0.0001863121,0.00018737087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085516507,0.00014491167,0.00023249048,0.00038804812,0.00031817853,0.00029821743,0.000043792366,0.00007913777,0.00025461378],"category_scores_gemma":[0.0006240426,0.00013868535,0.000022614011,0.0010541818,0.00010993956,0.00020794259,0.00008448273,0.00040784432,0.00003579875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027513779,0.00016178643,0.021228492,0.00024978197,0.000070471324,0.00089798175,0.0012478806,0.0005161243,0.9407937,0.00004038829,0.00008043173,0.034685478],"study_design_scores_gemma":[0.0040396135,0.00064254366,0.1438926,0.012423367,0.0003554334,0.0022899818,0.0016531611,0.1399837,0.6929042,0.0005045475,0.0005384962,0.0007724035],"about_ca_topic_score_codex":0.004379668,"about_ca_topic_score_gemma":0.00031917228,"teacher_disagreement_score":0.24788952,"about_ca_system_score_codex":0.0006081736,"about_ca_system_score_gemma":0.00031504646,"threshold_uncertainty_score":0.66207767},"labels":[],"label_agreement":null},{"id":"W4393074213","doi":"10.1158/1538-7445.am2024-79","title":"Abstract 79: Enabling fast and convenient immune profiling of fresh and long-term stabilized human whole blood samples with CyTOF","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Immune system; Human blood; Whole blood; Profiling (computer programming); Term (time); Medicine; Immunology; Computational biology; Biology; Computer science; Physiology; Physics; Programming language","score_opus":0.04178572550435592,"score_gpt":0.36479643402316153,"score_spread":0.3230107085188056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393074213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95155156,0.04776426,0.0000625723,0.00005661411,0.00002537013,0.00035237742,0.00010336602,0.000011372938,0.0000725128],"genre_scores_gemma":[0.9982794,0.001066281,0.0001787525,0.0000051777574,0.00010572337,0.00007573747,0.0000821743,0.000034722703,0.00017201748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987169,0.00006637243,0.00020057654,0.0004462395,0.00026324537,0.0003066888],"domain_scores_gemma":[0.9993255,0.00004400775,0.00003708534,0.00031327715,0.00015602003,0.00012409421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005061644,0.00012350692,0.00015260013,0.000087467175,0.00011733887,0.000092738264,0.00015088459,0.000080899634,0.00005033197],"category_scores_gemma":[0.00005345764,0.00010540765,0.00003605871,0.00012265838,0.0004919324,0.000009237369,0.00021145573,0.00022329681,9.713783e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001437854,0.00006267448,0.021525964,0.00089517294,0.000111722366,0.00004269801,0.00014283054,0.00000907518,0.97529167,0.00008843234,0.000020271214,0.0016657274],"study_design_scores_gemma":[0.0007235045,0.00023513073,0.014798767,0.00033427446,0.000032572232,0.0000099346735,0.0002761974,0.000012120621,0.98315144,0.000056542627,0.00023846427,0.00013105986],"about_ca_topic_score_codex":0.00009645109,"about_ca_topic_score_gemma":0.0001126154,"teacher_disagreement_score":0.04672786,"about_ca_system_score_codex":0.000019982393,"about_ca_system_score_gemma":0.00021825905,"threshold_uncertainty_score":0.42983994},"labels":[],"label_agreement":null},{"id":"W4393074425","doi":"10.1158/1538-7445.am2024-4970","title":"Abstract 4970: Multi-modal machine learning approaches for predicting cancer type and Gleason grade leveraging public TCGA data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Modal; Medicine; Cancer; Oncology; Internal medicine; Computer science","score_opus":0.47508014294862255,"score_gpt":0.4808718296959181,"score_spread":0.005791686747295521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393074425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200928,0.17163481,0.00060142094,0.005147672,0.0006593029,0.0012901801,0.00024058294,0.0001805978,0.00015266717],"genre_scores_gemma":[0.9843678,0.012771208,0.00031569446,0.000044757406,0.0011626079,0.00020818708,0.0003329047,0.000074478914,0.0007223784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748796,0.00011161899,0.00023221486,0.00073898805,0.00065183884,0.0007773702],"domain_scores_gemma":[0.9985402,0.0003226115,0.000030419662,0.00047833688,0.00022211882,0.00040628726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023960974,0.00016867534,0.00032154346,0.0002875177,0.00041742483,0.00018990098,0.00021854724,0.00013082521,0.000096434116],"category_scores_gemma":[0.0008319281,0.00013394773,0.00008324092,0.00061420974,0.0001364139,0.00025351226,0.00024932798,0.0013411656,0.000007243783],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000575969,0.00013439119,0.30245626,0.008977993,0.0011669402,0.00012757894,0.0027282897,0.00051060144,0.0038086104,0.00012619272,0.0056390814,0.6737481],"study_design_scores_gemma":[0.0039793816,0.00029562815,0.1425924,0.002140392,0.0003028669,0.00009381629,0.0018795698,0.3470733,0.0010333505,0.00004787019,0.5000419,0.0005195402],"about_ca_topic_score_codex":0.0072277323,"about_ca_topic_score_gemma":0.0006989635,"teacher_disagreement_score":0.67322856,"about_ca_system_score_codex":0.00034932606,"about_ca_system_score_gemma":0.0013379989,"threshold_uncertainty_score":0.9993832},"labels":[],"label_agreement":null},{"id":"W4393074697","doi":"10.1158/1538-7445.am2024-835","title":"Abstract 835: Occupational-related exposure to benzene and risk of female genital cancers: Systematic review and meta-analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Occupational exposure; Oncology; Gynecology; Environmental health; Internal medicine","score_opus":0.07802754552062646,"score_gpt":0.4152120717457949,"score_spread":0.3371845262251684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393074697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63660526,0.3620302,0.000038190075,0.00021350179,0.000013081599,0.0006048531,0.00043640955,0.0000034388884,0.000055064706],"genre_scores_gemma":[0.97109485,0.027703438,0.00006556493,0.00006630828,0.000023714161,0.00034265278,0.00004033126,0.000012483833,0.00065066665],"study_design_codex":"bench_or_experimental","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986535,0.00014699418,0.00030800924,0.00038708252,0.000315705,0.00018872027],"domain_scores_gemma":[0.9992098,0.000057361816,0.000055459695,0.00031273413,0.00025056518,0.0001140369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010399984,0.00011669028,0.0005612669,0.00015444041,0.000071522736,0.000048567814,0.000107471154,0.00007145836,0.00024823926],"category_scores_gemma":[0.00009113499,0.000087678716,0.00024317874,0.00051094417,0.000066886496,0.000005011875,0.00012147253,0.0001356853,0.0000037523753],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015224608,0.00011127876,0.0060743033,0.25401318,0.3205086,0.000043680808,0.00094466825,0.0015197888,0.41181332,0.00024117724,0.004039059,0.00053869875],"study_design_scores_gemma":[0.0010649047,0.0018753335,0.062260736,0.005692435,0.7528482,0.00005251832,0.00137788,0.00032524153,0.17041041,0.00019988872,0.002286992,0.0016054797],"about_ca_topic_score_codex":0.00091022043,"about_ca_topic_score_gemma":0.0009746573,"teacher_disagreement_score":0.43233958,"about_ca_system_score_codex":0.000049719445,"about_ca_system_score_gemma":0.00019553199,"threshold_uncertainty_score":0.35754344},"labels":[],"label_agreement":null},{"id":"W4393074988","doi":"10.1158/1538-7445.am2024-6198","title":"Abstract 6198: <i>TP53</i> mutational clusters stratify the Li-Fraumeni syndrome spectrum","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Medicine; Mutation; Genetics; Cancer; Cancer research; Biology; Internal medicine; Germline mutation; Gene","score_opus":0.06317362037156604,"score_gpt":0.402976706159255,"score_spread":0.339803085787689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393074988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073462,0.017130153,0.00025288502,0.04991657,0.0014515708,0.001700732,0.000151248,0.00025177066,0.021798909],"genre_scores_gemma":[0.9937616,0.00066569186,0.00004359823,0.00044728175,0.0005735369,0.00031721027,0.00004831712,0.000074441996,0.004068315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969169,0.00010142901,0.00029129136,0.00053290726,0.0014029129,0.00075454323],"domain_scores_gemma":[0.9987231,0.00029974148,0.000029116462,0.00052055274,0.0001633372,0.00026416325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010826687,0.00018499067,0.00021479788,0.00028801162,0.00024074997,0.00020824787,0.0002870514,0.00015270314,0.0025727847],"category_scores_gemma":[0.00009808984,0.00013478711,0.000156886,0.0009858984,0.00036811148,0.0001224579,0.00010448928,0.0016948112,0.00077244587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001784267,0.0005923282,0.0006621069,0.004086388,0.0027804584,0.025623348,0.007042272,0.004681613,0.40821442,0.017020682,0.4426834,0.08482871],"study_design_scores_gemma":[0.0079004,0.0030526114,0.062089417,0.0077449246,0.00066523254,0.008339396,0.0037439165,0.010023061,0.1417598,0.014309883,0.73841476,0.0019566184],"about_ca_topic_score_codex":0.0006789849,"about_ca_topic_score_gemma":0.00036323903,"teacher_disagreement_score":0.29573134,"about_ca_system_score_codex":0.00091715885,"about_ca_system_score_gemma":0.0021518643,"threshold_uncertainty_score":0.998339},"labels":[],"label_agreement":null},{"id":"W4393074992","doi":"10.1158/1538-7445.am2024-6233","title":"Abstract 6233: Characterizing variants of uncertain significance in the tumor suppressor gene known as phosphatase and tensin homolog (PTEN)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tensin; PTEN; Suppressor; Gene; Phosphatase; Tumor suppressor gene; Biology; Cancer research; Genetics; PI3K/AKT/mTOR pathway; Carcinogenesis; Phosphorylation; Signal transduction","score_opus":0.05155114221875123,"score_gpt":0.37596939369284604,"score_spread":0.3244182514740948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393074992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687013,0.028804515,0.00001734382,0.0010830928,0.0002496405,0.00044543002,0.00033875313,0.000011019813,0.00034888805],"genre_scores_gemma":[0.99711055,0.0015420874,0.00007175274,0.0002921003,0.0003836803,0.00025164353,0.00007016867,0.000036458572,0.00024157004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794775,0.00021186746,0.00028876463,0.0006078316,0.0004157278,0.00052804],"domain_scores_gemma":[0.99899006,0.00019325319,0.0000540636,0.00049507065,0.0001778437,0.00008973281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015380316,0.0001759641,0.00020784524,0.00012362016,0.00009819021,0.00010164136,0.00047618296,0.00012720628,0.00014818992],"category_scores_gemma":[0.00025896626,0.00013595511,0.00005704181,0.00038374888,0.00040635804,0.000015393578,0.00016573476,0.0004680775,0.000015766109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024261707,0.00004853374,0.00039798472,0.00020601037,0.000050961546,0.00023770127,0.00026823368,0.00003463556,0.9907332,0.00016358256,0.0033038945,0.00431265],"study_design_scores_gemma":[0.00040988298,0.00023570022,0.008809533,0.0002917024,0.000013609311,0.000050759045,0.00017620935,0.0001296019,0.96119577,0.00024209767,0.028237792,0.00020732451],"about_ca_topic_score_codex":0.0013172616,"about_ca_topic_score_gemma":0.00011241555,"teacher_disagreement_score":0.029537408,"about_ca_system_score_codex":0.00007851695,"about_ca_system_score_gemma":0.00063316064,"threshold_uncertainty_score":0.55440885},"labels":[],"label_agreement":null},{"id":"W4393075281","doi":"10.1158/1538-7445.am2024-2429","title":"Abstract 2429: Longitudinal ctDNA monitoring using a high sensitivity tumor-informed assay in patients with metastatic HR+/HER2− breast cancer receiving endocrine therapy and CDK4/6 inhibitors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Internal medicine; Endocrine system; Breast cancer; Cancer; Fulvestrant; Cancer research; Tamoxifen; Hormone","score_opus":0.0455605321367666,"score_gpt":0.3597306889629734,"score_spread":0.3141701568262068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946793,0.004013734,0.000026068554,0.00018287961,0.00035713302,0.0004065333,0.0002904935,0.000012269396,0.000031637846],"genre_scores_gemma":[0.9957798,0.0032554967,0.00016470325,0.000024638883,0.0005589578,0.00010548082,0.00003268915,0.000053975633,0.000024236406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981215,0.00009659371,0.00023984579,0.0005411524,0.00041105284,0.0005898287],"domain_scores_gemma":[0.99912107,0.00017386072,0.00005336304,0.00023869555,0.0002597087,0.00015328435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005940564,0.00022231753,0.00023008665,0.00019374001,0.00013996611,0.00019062008,0.000102609025,0.000056183584,0.000035085803],"category_scores_gemma":[0.000087500004,0.00019104288,0.000043826385,0.0003693781,0.00015981079,0.000029160736,0.00015034404,0.00038178792,0.0000016554736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086619804,0.0001225362,0.8371996,0.0003115044,0.00023252727,0.00017263078,0.0001890767,0.0013967159,0.11519684,0.000014233476,0.00033440013,0.043963682],"study_design_scores_gemma":[0.0015160053,0.00021730622,0.9207418,0.0007946887,0.000022417726,0.000026353364,0.0001059994,0.0002593434,0.07513234,0.00002636959,0.000799539,0.00035786096],"about_ca_topic_score_codex":0.010481209,"about_ca_topic_score_gemma":0.002844646,"teacher_disagreement_score":0.083542116,"about_ca_system_score_codex":0.0004176094,"about_ca_system_score_gemma":0.0007907043,"threshold_uncertainty_score":0.99610806},"labels":[],"label_agreement":null},{"id":"W4393075448","doi":"10.1158/1538-7445.am2024-2421","title":"Abstract 2421: Targeted and low-pass whole genome sequencing of cerebrospinal fluid circulating tumor DNA for the diagnosis and monitoring of pediatric, adolescent and young adult CNS tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Western University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cerebrospinal fluid; Medicine; DNA sequencing; Circulating tumor DNA; DNA; Pathology; Cancer; Biology; Internal medicine; Genetics","score_opus":0.041591462651703874,"score_gpt":0.33427229771903205,"score_spread":0.29268083506732817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535297,0.045376346,0.000063661384,0.00013299764,0.00015371258,0.00041581996,0.000310717,0.00000431426,0.0000127218655],"genre_scores_gemma":[0.98480237,0.014166125,0.000110202884,0.0000130972485,0.0006796803,0.00017096469,0.00001440034,0.00002870983,0.000014427111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988774,0.000023875058,0.00025019384,0.00035318395,0.00019363778,0.00030169747],"domain_scores_gemma":[0.9992398,0.00016213671,0.00006242026,0.00017629107,0.00026330393,0.000096068376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004135982,0.00012289346,0.0001647008,0.00007792523,0.00014905249,0.00007458849,0.00011796229,0.00006188358,0.0000037930881],"category_scores_gemma":[0.00023857086,0.00010503933,0.00004728011,0.00013393642,0.00017583465,0.00000809227,0.00017676025,0.00016343774,1.8000055e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006196846,0.000015130498,0.0723135,0.0012589437,0.000053778214,0.0000060165385,0.00028938887,0.00013983059,0.92379457,0.00004167296,0.00013769539,0.0018875136],"study_design_scores_gemma":[0.0009154327,0.0004718683,0.40284818,0.00070597144,0.00011041831,0.000019990075,0.0017065118,0.0011969063,0.5907205,0.00013638762,0.0008145164,0.00035331986],"about_ca_topic_score_codex":0.00060960255,"about_ca_topic_score_gemma":0.00007151736,"teacher_disagreement_score":0.33307406,"about_ca_system_score_codex":0.000072075934,"about_ca_system_score_gemma":0.00030470075,"threshold_uncertainty_score":0.42833796},"labels":[],"label_agreement":null},{"id":"W4393075460","doi":"10.1158/1538-7445.am2024-5666","title":"Abstract 5666: Exploring spatially resolved intra-tumoral heterogeneity of glioblastoma and neuronal mechanisms facilitating brain invasion","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Brain cancer; Neuroscience; Brain tumor; Cancer; Tumor heterogeneity; Biology; Medicine; Cancer research; Pathology; Internal medicine","score_opus":0.15505509220503866,"score_gpt":0.39488972679205525,"score_spread":0.2398346345870166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952282,0.0019068096,0.000047801186,0.0020718575,0.00014833691,0.00041834396,0.000046654957,0.000043595424,0.00008843709],"genre_scores_gemma":[0.998856,0.00033595026,0.00033576306,0.000046169673,0.00010874271,0.00025820333,0.000008426973,0.00002733437,0.000023408718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981947,0.000093762224,0.0002601662,0.00041572945,0.0006634528,0.0003721892],"domain_scores_gemma":[0.99890953,0.0005072658,0.000026989153,0.0002125111,0.00014391154,0.00019976801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007297525,0.00013504512,0.00024302687,0.00029086857,0.0001042043,0.00006246888,0.00007919009,0.000052538202,0.00016337217],"category_scores_gemma":[0.00025133012,0.00011074964,0.00007361628,0.0003388165,0.00012535503,0.000132801,0.00012471866,0.00035146752,0.000016399836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041728377,0.0001373877,0.0028190343,0.00087992306,0.00010438693,0.0005917662,0.00087177235,0.00003881845,0.9113568,0.0006428775,0.00045605982,0.08168391],"study_design_scores_gemma":[0.0011690096,0.0013842309,0.04127362,0.0013583603,0.000029733237,0.000033221837,0.00040806428,0.0007405782,0.9521571,0.000598276,0.0007187141,0.00012913528],"about_ca_topic_score_codex":0.0006304884,"about_ca_topic_score_gemma":0.00041279418,"teacher_disagreement_score":0.08155477,"about_ca_system_score_codex":0.00016114648,"about_ca_system_score_gemma":0.00022537053,"threshold_uncertainty_score":0.45162395},"labels":[],"label_agreement":null},{"id":"W4393075499","doi":"10.1158/1538-7445.am2024-3800","title":"Abstract 3800: Next generation of spatial biology: High-throughput multiplexed Imaging Mass Cytometry™ with whole slide modes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Throughput; Multiplexing; Cytometry; Computer science; Biology; Computational biology; Flow cytometry; Molecular biology; Genetics; Telecommunications","score_opus":0.109803636366284,"score_gpt":0.37227996782647566,"score_spread":0.26247633146019167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97723204,0.004484382,0.016902328,0.00045467523,0.0002749774,0.00024363163,0.0001449789,0.00002376828,0.00023924011],"genre_scores_gemma":[0.9964468,0.00060722727,0.0014227438,0.000041560834,0.0008450621,0.000066897024,0.0002795739,0.00004313965,0.00024697743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858505,0.000082146464,0.00021195036,0.0004915622,0.0002484485,0.00038086675],"domain_scores_gemma":[0.999309,0.000037071255,0.000033569173,0.00029384842,0.00024705206,0.00007944845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038238903,0.0001503578,0.00016684862,0.00015823489,0.00011043112,0.000100423196,0.00021798068,0.00012730541,0.00007403763],"category_scores_gemma":[0.000042862113,0.0001241998,0.00006326068,0.000250195,0.00026121768,0.000016239961,0.000055231274,0.00026710573,0.000010808598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017004885,0.00003526021,0.0030367435,0.000098055214,0.00007142465,0.00000933517,0.000060825554,0.0005266597,0.9815358,0.00008767886,0.0006619138,0.013706282],"study_design_scores_gemma":[0.00051085587,0.00018872693,0.0009101557,0.000081009755,0.000012436457,0.0000024539645,0.00006026953,0.0051474646,0.9857935,0.00008558135,0.007040833,0.00016674022],"about_ca_topic_score_codex":0.0030395524,"about_ca_topic_score_gemma":0.00056303217,"teacher_disagreement_score":0.0192148,"about_ca_system_score_codex":0.00006610473,"about_ca_system_score_gemma":0.00030955594,"threshold_uncertainty_score":0.50647205},"labels":[],"label_agreement":null},{"id":"W4393075673","doi":"10.1158/1538-7445.am2024-3236","title":"Abstract 3236: Discovery of hydrazide-based HDAC8 selective PROTACs","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hydrazide; Chemistry; Organic chemistry","score_opus":0.038610401574008336,"score_gpt":0.38803050793616706,"score_spread":0.3494201063621587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894107,0.0042304704,0.00042633733,0.00064936996,0.00016882557,0.00054010114,0.0000670893,0.000018285227,0.004488798],"genre_scores_gemma":[0.9966334,0.00019044019,0.000048507598,0.00004541791,0.00029499838,0.00025478264,0.00004423707,0.000021432012,0.0024667846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989515,0.00006645633,0.00014195156,0.0002982087,0.0003032869,0.00023857468],"domain_scores_gemma":[0.9994892,0.000028979464,0.000022093196,0.00022235885,0.00018551594,0.00005185655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042152987,0.00008214774,0.00008448597,0.0001089337,0.00005602542,0.00006200343,0.00016236147,0.000092565926,0.000073715426],"category_scores_gemma":[0.00012178671,0.00007011348,0.00006849211,0.0003039502,0.00015489585,0.000010584247,0.000058394566,0.00022274748,0.000017790198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009600815,0.000033193177,0.0002809794,0.00015247158,0.000032103108,0.0000037147267,0.000024359286,0.000034554472,0.97881347,0.0001935241,0.015966015,0.004369585],"study_design_scores_gemma":[0.00014850203,0.00015173618,0.0008278563,0.00011263111,0.0000026789705,6.374423e-7,0.000020280271,0.000045111115,0.95388746,0.00013299487,0.04459031,0.00007981016],"about_ca_topic_score_codex":0.0001499505,"about_ca_topic_score_gemma":0.00005264851,"teacher_disagreement_score":0.028624296,"about_ca_system_score_codex":0.000060586808,"about_ca_system_score_gemma":0.00073267537,"threshold_uncertainty_score":0.28591445},"labels":[],"label_agreement":null},{"id":"W4393075724","doi":"10.1158/1538-7445.am2024-6909","title":"Abstract 6909: KRASG12C inhibitor resistance in patient-derived non-small cell lung cancer models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cancer; Lung cancer; Internal medicine; Oncology","score_opus":0.09395832323132718,"score_gpt":0.4287630284169272,"score_spread":0.3348047051856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8964657,0.06765151,0.000054504468,0.0047426596,0.00084259553,0.0024821034,0.00018438579,0.0001486595,0.027427834],"genre_scores_gemma":[0.97560656,0.010533633,0.00028422492,0.00023246171,0.0010500234,0.0029746997,0.000023293342,0.00020332242,0.00909177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933733,0.00023720975,0.00073771883,0.0013611721,0.0023179322,0.0019727105],"domain_scores_gemma":[0.9970269,0.00048065343,0.00006084849,0.0009604178,0.000766862,0.0007042957],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017861765,0.00040066094,0.00061004213,0.0010978018,0.0002323102,0.0002730445,0.00058520073,0.00034897742,0.002647309],"category_scores_gemma":[0.00015309844,0.00036922356,0.00018587263,0.0023928995,0.00039242065,0.00034941296,0.0003609854,0.00306609,0.0002993627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002191305,0.0005663716,0.005868153,0.01597801,0.0002354629,0.0043858676,0.010213376,0.0011722259,0.65292406,0.0003742938,0.26986095,0.036229935],"study_design_scores_gemma":[0.00799629,0.0009327765,0.015060291,0.032273896,0.00014798906,0.000028221843,0.0031275896,0.019094976,0.7143442,0.0025226027,0.20234962,0.002121523],"about_ca_topic_score_codex":0.007086507,"about_ca_topic_score_gemma":0.005865593,"teacher_disagreement_score":0.07914083,"about_ca_system_score_codex":0.0039608665,"about_ca_system_score_gemma":0.0057486896,"threshold_uncertainty_score":0.99988776},"labels":[],"label_agreement":null},{"id":"W4393075891","doi":"10.1158/1538-7445.am2024-3203","title":"Abstract 3203: Extravasation and metastasis dynamics are cytoplasmically controlled by the epitranscriptome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Extravasation; Metastasis; Medicine; Cancer; Internal medicine; Pathology","score_opus":0.03439670131063609,"score_gpt":0.3793306098968505,"score_spread":0.3449339085862144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511029,0.042555306,0.00019087728,0.003924837,0.00010534377,0.00067450624,0.0005355746,0.000017674185,0.00089296635],"genre_scores_gemma":[0.9895805,0.007426289,0.000012863027,0.00007078341,0.00014494166,0.00047919116,0.00013059856,0.00002682736,0.002127991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984668,0.00013058748,0.00015206411,0.0004027593,0.00042999873,0.000417804],"domain_scores_gemma":[0.99934083,0.00009769499,0.000020482152,0.00025411422,0.00014768989,0.00013915976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006693146,0.00012830771,0.00015539824,0.00007642106,0.0001937912,0.00023294638,0.00019964507,0.00008741454,0.00011650491],"category_scores_gemma":[0.00008440685,0.000084650936,0.00008856655,0.00019343193,0.00025694683,0.000009629323,0.00007189439,0.00030928035,0.000018235596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017508534,0.000114931965,0.0017748838,0.00022890887,0.0010540589,0.000056631266,0.00012114585,0.0000157756,0.849659,0.00055380934,0.050778583,0.09389137],"study_design_scores_gemma":[0.015447364,0.0015976732,0.02489674,0.000499154,0.00029021964,0.00010019704,0.0012867885,0.0025665252,0.50274485,0.002644189,0.446802,0.0011242962],"about_ca_topic_score_codex":0.0007808625,"about_ca_topic_score_gemma":0.0016889344,"teacher_disagreement_score":0.39602342,"about_ca_system_score_codex":0.00013090522,"about_ca_system_score_gemma":0.0002366423,"threshold_uncertainty_score":0.3451965},"labels":[],"label_agreement":null},{"id":"W4393075940","doi":"10.1158/1538-7445.am2024-6641","title":"Abstract 6641: Improving response to bladder-sparing therapies by combining radiotherapy to immuno-potentiating agents in immunologically cold models of bladder cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Radiation therapy; Oncology; Urology; Internal medicine","score_opus":0.09754294860238281,"score_gpt":0.41478729054625263,"score_spread":0.3172443419438698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547409,0.039164953,0.00032464907,0.0029945683,0.00032237402,0.0016639807,0.00012169713,0.00009862096,0.00056829624],"genre_scores_gemma":[0.99285156,0.0027129317,0.00046802746,0.0005494328,0.0001358669,0.0012211915,0.00000800427,0.00011401047,0.001938962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99636835,0.00025522453,0.0006202374,0.00079017226,0.000969307,0.0009967342],"domain_scores_gemma":[0.99842477,0.00039100234,0.00006848652,0.00052369904,0.0003164493,0.0002755814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001656119,0.00032611963,0.0005972309,0.0007096575,0.00020331766,0.00016603958,0.0004105785,0.0001863666,0.0011395245],"category_scores_gemma":[0.00012647445,0.00027958272,0.00014247913,0.0013117497,0.00013818823,0.0002423608,0.00019488992,0.0008564819,0.000029677463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004584164,0.00021531482,0.0015979212,0.0002334683,0.00071120774,0.0001288477,0.0064256154,0.0013820406,0.9432191,0.0000419129,0.0029069,0.038553488],"study_design_scores_gemma":[0.014887772,0.006747231,0.14053027,0.011828685,0.00030917756,0.00003359985,0.007020629,0.008382313,0.77795553,0.00056775735,0.029658893,0.0020781292],"about_ca_topic_score_codex":0.011489915,"about_ca_topic_score_gemma":0.00029913103,"teacher_disagreement_score":0.16526358,"about_ca_system_score_codex":0.0013626309,"about_ca_system_score_gemma":0.0010274538,"threshold_uncertainty_score":0.9999656},"labels":[],"label_agreement":null},{"id":"W4393076009","doi":"10.1158/1538-7445.am2024-5846","title":"Abstract 5846: Inhibiting elements of the proteasome recovery pathway sensitizes glioblastoma to proteasome inhibitors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Proteasome; Glioblastoma; Cancer research; Medicine; Biology; Cell biology","score_opus":0.03280040290794848,"score_gpt":0.3365026613466335,"score_spread":0.303702258438685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301946,0.001626188,0.00001447644,0.0009629286,0.00039429727,0.001982301,0.00020371974,0.00003432789,0.0017623052],"genre_scores_gemma":[0.99600476,0.00009938621,0.00011849095,0.0001248015,0.00094639295,0.0008428242,0.000011811097,0.00006248068,0.0017890374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730766,0.00024126898,0.0004092765,0.00062284013,0.0007515578,0.00066739257],"domain_scores_gemma":[0.9988435,0.000055835353,0.00007686215,0.0005103812,0.00033295417,0.0001804705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015842955,0.00021414102,0.00019268363,0.00019307745,0.0002200449,0.00012066333,0.00041076384,0.00018045501,0.00011670073],"category_scores_gemma":[0.00042837433,0.00016318317,0.00017635745,0.0007018625,0.0001868117,0.000014961059,0.0005667336,0.0005237643,0.00006915758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002026172,0.00003757195,0.00033730993,0.0004170293,0.000058374426,0.00001230618,0.00019779499,0.000028082102,0.97552466,0.000091215705,0.0038393969,0.019253634],"study_design_scores_gemma":[0.00020613568,0.00040354708,0.00047123997,0.0009021181,0.000004743081,0.000008835068,0.00015479494,0.000010116473,0.9639139,0.00021684222,0.033513766,0.00019394816],"about_ca_topic_score_codex":0.00012819987,"about_ca_topic_score_gemma":0.0001060498,"teacher_disagreement_score":0.029674368,"about_ca_system_score_codex":0.0001222324,"about_ca_system_score_gemma":0.0007579312,"threshold_uncertainty_score":0.6654417},"labels":[],"label_agreement":null},{"id":"W4393076149","doi":"10.1158/1538-7445.am2024-586","title":"Abstract 586: Tumor cell-intrinsic PD-1 activation drives therapeutic resistance in colorectal cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Cancer research; Tumor cells; Oncology; Internal medicine","score_opus":0.0415455642376489,"score_gpt":0.3745279020776056,"score_spread":0.33298233783995673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457538,0.04605161,0.0000052987457,0.0032269058,0.0004993574,0.00092917774,0.000029742469,0.00009685703,0.0034072406],"genre_scores_gemma":[0.9816734,0.010050523,0.00002187593,0.00017261639,0.00094197126,0.0007268259,0.000010833726,0.00007969257,0.0063222554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970989,0.00020297458,0.0003800435,0.0006478726,0.00086449314,0.0008056874],"domain_scores_gemma":[0.99857575,0.0005938882,0.000058620528,0.00035060957,0.0002450967,0.00017606404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000782578,0.00024983526,0.0004043967,0.00063076155,0.00017647927,0.00014807307,0.00025011678,0.00013786202,0.0011739],"category_scores_gemma":[0.00006543353,0.00022032562,0.00013679359,0.0012700678,0.000344791,0.00023320229,0.0000538356,0.0011243077,0.00012568787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051991404,0.00020128788,0.0015351591,0.0015166961,0.0000900506,0.00037871636,0.0022843578,0.000041419527,0.9456647,0.00012711601,0.012664394,0.030296966],"study_design_scores_gemma":[0.0013965311,0.00020743402,0.13207902,0.0024896422,0.00003466495,0.000010347317,0.0007487364,0.00008417537,0.7486958,0.00016876175,0.11377537,0.00030950137],"about_ca_topic_score_codex":0.0025823973,"about_ca_topic_score_gemma":0.001617476,"teacher_disagreement_score":0.19696888,"about_ca_system_score_codex":0.0015163813,"about_ca_system_score_gemma":0.002040883,"threshold_uncertainty_score":0.99973917},"labels":[],"label_agreement":null},{"id":"W4393076308","doi":"10.1158/1538-7445.am2024-1377","title":"Abstract 1377: The role of TIM3 and PD1 blockades in head and neck cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Head and neck cancer; Medicine; Head and neck; Cancer; Internal medicine; Surgery","score_opus":0.06444341815186098,"score_gpt":0.4428683161894439,"score_spread":0.3784248980375829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96408015,0.026778841,2.4108456e-7,0.005655431,0.000009252374,0.0001266104,0.000024811512,0.000009566185,0.0033150874],"genre_scores_gemma":[0.99504864,0.0030827953,0.000006222277,0.00009349643,0.00012323401,0.00006116046,0.0000024800208,0.000008828171,0.0015731428],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921584,0.000032349995,0.00012195492,0.00017372382,0.00027197303,0.00018415388],"domain_scores_gemma":[0.9996188,0.00010441248,0.00001041879,0.000113269256,0.00007323637,0.00007982285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037140946,0.00005527925,0.00013234648,0.00018109515,0.000047311383,0.000035144752,0.00004110618,0.000039990697,0.0008642469],"category_scores_gemma":[0.00003722475,0.000035308432,0.000028035533,0.00041352524,0.00021148099,0.000041354942,0.00004091788,0.0003370279,0.0000077176555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031829652,0.00013557765,0.106582485,0.0014057244,0.00023515236,0.00016435937,0.003103723,0.000028310771,0.6652706,0.0009894711,0.011271756,0.21049449],"study_design_scores_gemma":[0.0026938578,0.00032790523,0.5732007,0.013362325,0.00011847814,0.000046204037,0.00445628,0.005001595,0.2506092,0.0032826392,0.14656171,0.00033911876],"about_ca_topic_score_codex":0.0040644845,"about_ca_topic_score_gemma":0.0020474885,"teacher_disagreement_score":0.4666182,"about_ca_system_score_codex":0.00006480397,"about_ca_system_score_gemma":0.000197423,"threshold_uncertainty_score":0.9462898},"labels":[],"label_agreement":null},{"id":"W4393076328","doi":"10.1158/1538-7445.am2024-1124","title":"Abstract 1124: Prevention of radiation-induced malignancies in Li-Fraumeni syndrome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Medicine; Internal medicine; Oncology; Genetics; Biology; Mutation; Germline mutation","score_opus":0.08428287062830625,"score_gpt":0.41860356347929556,"score_spread":0.3343206928509893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378813,0.011897615,0.000029056548,0.0009968819,0.00032347773,0.0007142908,0.000019506582,0.000048537244,0.0021825186],"genre_scores_gemma":[0.9970759,0.0010941657,0.000029867977,0.000017646826,0.00010509946,0.00024348668,0.000019587538,0.000037951188,0.0013762865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816906,0.000078090736,0.000325142,0.0003364109,0.0007142539,0.00037706608],"domain_scores_gemma":[0.99928653,0.000100146775,0.000035370693,0.00031362893,0.00015581143,0.00010850899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009207627,0.00010532883,0.00023833546,0.00064529484,0.000035965568,0.000031279706,0.0001189757,0.00014367088,0.0007262655],"category_scores_gemma":[0.00015733203,0.00010181375,0.00009748055,0.0011579697,0.00008157776,0.00011336792,0.00004981532,0.00064013246,0.00010385913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015778278,0.00012830563,0.0012333001,0.0013477899,0.00012047077,0.0006844305,0.00076784834,0.000094017734,0.918996,0.0005714854,0.0021822136,0.07371636],"study_design_scores_gemma":[0.0025480415,0.0010515399,0.19130382,0.0077829272,0.00007220541,0.00016603898,0.00041429276,0.00050951715,0.7799187,0.001326377,0.01458792,0.00031865577],"about_ca_topic_score_codex":0.00096385897,"about_ca_topic_score_gemma":0.00020393467,"teacher_disagreement_score":0.19007052,"about_ca_system_score_codex":0.0007182187,"about_ca_system_score_gemma":0.0013041709,"threshold_uncertainty_score":0.79520977},"labels":[],"label_agreement":null},{"id":"W4393076473","doi":"10.1158/1538-7445.am2024-4798","title":"Abstract 4798: MRI screening for brain metastases (BrM) versus SYMptom-directed brain imaging for patients with triple negative (TN) or HER2+ metastatic breast cancer (MBC): An ad-hoc interim analysis of a randomized phase II pilot study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Lakeridge Health; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Cancer; Post-hoc analysis; Breast cancer; Internal medicine; Triple-negative breast cancer; Triple negative; Radiology","score_opus":0.12396728366246669,"score_gpt":0.4764188270255029,"score_spread":0.35245154336303625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96077955,0.0041526025,0.0044767996,0.0030200686,0.00027149357,0.014249515,0.0128643615,0.0001663473,0.000019290632],"genre_scores_gemma":[0.9833669,0.00015326575,0.0053528864,0.00012556555,0.00011827684,0.009102323,0.0011862884,0.00012859877,0.00046588498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947591,0.0010027392,0.00095001276,0.0011137644,0.001270279,0.0009041223],"domain_scores_gemma":[0.9903926,0.0066625783,0.00028884353,0.00060288404,0.0016335777,0.00041949708],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041899383,0.0005067548,0.002142664,0.0014908793,0.00039687584,0.0001755812,0.00027634302,0.000037678066,0.0011505216],"category_scores_gemma":[0.0013744216,0.00032526717,0.0005570072,0.0027413575,0.0004090196,0.0003931979,0.00011191318,0.00040254497,0.0000013138674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8050413,0.010549015,0.00043559168,0.0008986984,0.048432816,0.0001423034,0.0033450478,0.00023960744,0.0011138634,0.000039446677,0.003173719,0.12658858],"study_design_scores_gemma":[0.8548375,0.05725127,0.0033520733,0.0020016024,0.032189567,0.000008910416,0.008640908,0.037059553,0.0019021747,0.000059021033,0.0018729888,0.000824452],"about_ca_topic_score_codex":0.0050104344,"about_ca_topic_score_gemma":0.005836692,"teacher_disagreement_score":0.12576413,"about_ca_system_score_codex":0.0006211797,"about_ca_system_score_gemma":0.0010467457,"threshold_uncertainty_score":0.99991995},"labels":[],"label_agreement":null},{"id":"W4393076480","doi":"10.1158/1538-7445.am2024-4416","title":"Abstract 4416: Rapid, low-input, targeted NGS workflow for DNA methylation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Workflow; DNA methylation; Computational biology; Methylation; DNA; Biology; Genetics; Medicine; Computer science; Database; Gene; Gene expression","score_opus":0.04227744242079238,"score_gpt":0.37785352488442103,"score_spread":0.33557608246362863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432455,0.046806652,0.0032092803,0.0018799048,0.0013796206,0.0010005357,0.0005059372,0.000044729175,0.0019278404],"genre_scores_gemma":[0.990709,0.0048359046,0.00036429468,0.0001496524,0.0017538633,0.00045813003,0.00031214315,0.00005643922,0.0013605636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860895,0.00003589241,0.00018706192,0.00047608535,0.00023573352,0.00045628453],"domain_scores_gemma":[0.99911046,0.00016046411,0.00002371479,0.00031195398,0.0002657037,0.00012772088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006791283,0.00012994578,0.0001223029,0.000117888914,0.00013548271,0.0001453622,0.00021805946,0.00016590557,0.0002304794],"category_scores_gemma":[0.00022664978,0.00012682205,0.00011855238,0.00025360196,0.000095566895,0.0000062683057,0.000099589524,0.00021078199,0.000041035226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017883917,0.000027663666,0.000050088584,0.00018487549,0.00008234475,0.000005760316,0.00006638276,0.00020837697,0.82869595,0.00035042872,0.07240808,0.097741224],"study_design_scores_gemma":[0.00034173182,0.00015171707,0.0006061495,0.00007983181,0.000011404352,0.0000010019618,0.000029092029,0.0002891905,0.5552206,0.0010942704,0.44200543,0.0001695647],"about_ca_topic_score_codex":0.00008912548,"about_ca_topic_score_gemma":0.00012679421,"teacher_disagreement_score":0.36959735,"about_ca_system_score_codex":0.00011901729,"about_ca_system_score_gemma":0.0005527317,"threshold_uncertainty_score":0.5171653},"labels":[],"label_agreement":null},{"id":"W4393076484","doi":"10.1158/1538-7445.am2024-1533","title":"Abstract 1533: Characterizing tumor-immune surveillance in Li-Fraumeni syndrome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Immune system; Medicine; Cancer; Immunology; Biology; Internal medicine; Genetics; Mutation; Germline mutation; Gene","score_opus":0.05991527616478999,"score_gpt":0.3872837382212071,"score_spread":0.3273684620564171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393076484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664016,0.02443646,0.000010574974,0.0036391804,0.0007559789,0.0007543022,0.000050984272,0.00017351775,0.0037773966],"genre_scores_gemma":[0.99591154,0.0016955442,0.000027981303,0.00014060906,0.00028486457,0.00033427755,0.000039993713,0.000103128936,0.0014620395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969073,0.0001245957,0.0004425027,0.00067706953,0.0009237606,0.000924756],"domain_scores_gemma":[0.9987476,0.00018638305,0.000037703176,0.00060971576,0.00017990051,0.00023868342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016872503,0.0002157358,0.0004415359,0.0007195262,0.000091555004,0.00013205106,0.00026114503,0.00015089127,0.0012988739],"category_scores_gemma":[0.00020620468,0.00020850518,0.0001330793,0.0015731156,0.00018293402,0.00015657945,0.00015581596,0.0018659817,0.0006637991],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032624637,0.000111826426,0.0034549534,0.0013737242,0.00013675522,0.010737401,0.0005371993,0.000030869614,0.9638287,0.00017386036,0.0025480264,0.016740473],"study_design_scores_gemma":[0.0031575216,0.0006615756,0.69604915,0.009344484,0.000033008233,0.0015494915,0.0003080609,0.00084486033,0.11530701,0.00025226286,0.17166153,0.00083104835],"about_ca_topic_score_codex":0.0014727913,"about_ca_topic_score_gemma":0.00025481655,"teacher_disagreement_score":0.84852165,"about_ca_system_score_codex":0.0012710699,"about_ca_system_score_gemma":0.001146243,"threshold_uncertainty_score":0.99961406},"labels":[],"label_agreement":null},{"id":"W4393084604","doi":"10.1158/1538-7445.am2024-7565","title":"Abstract 7565: Tumor classification and deconvolution in liquid biopsy using enriched methylation sequencing","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Methylation; Deconvolution; Biopsy; Computational biology; Biology; Pathology; Medicine; Genetics; Computer science; Algorithm; Gene","score_opus":0.11363741326078798,"score_gpt":0.41514988897219623,"score_spread":0.30151247571140827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870939,0.011380626,0.0007676521,0.00018421409,0.00015907519,0.00017806936,0.000022544333,0.0000080847285,0.00020579566],"genre_scores_gemma":[0.9973479,0.0019005988,0.00027476499,0.000027218799,0.00030393296,0.000053035652,0.00004084596,0.000018722574,0.000032984197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990958,0.00004923949,0.00015690403,0.00033255247,0.00013406326,0.00023141367],"domain_scores_gemma":[0.99961174,0.00005490156,0.000023296616,0.0001464551,0.00010390166,0.00005968474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065474754,0.000075699056,0.000073998795,0.0001654297,0.000070181224,0.00007850196,0.00007151515,0.000084871506,0.000020695185],"category_scores_gemma":[0.00013808423,0.00007948416,0.000023196793,0.0002545201,0.00007772632,0.000009563977,0.0000627921,0.00017802996,0.0000047194994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006697877,0.000006858239,0.0006700607,0.00006957731,0.000010164783,0.000007672373,0.000089485016,0.00026105688,0.99535936,0.00044145182,0.00011737744,0.0028999725],"study_design_scores_gemma":[0.00084418454,0.00035568333,0.04409345,0.00038805886,0.00002832382,0.000046757512,0.0009903595,0.03082959,0.9015843,0.0019148551,0.018353293,0.0005711053],"about_ca_topic_score_codex":0.0008292966,"about_ca_topic_score_gemma":0.00033900622,"teacher_disagreement_score":0.093775004,"about_ca_system_score_codex":0.00035633246,"about_ca_system_score_gemma":0.0005412527,"threshold_uncertainty_score":0.324127},"labels":[],"label_agreement":null},{"id":"W4393084628","doi":"10.1158/1538-7445.am2024-286","title":"Abstract 286: Multiplex imaging of human pancreatic tumors reveal novel dynamics of dysplastic stem cells, remodeling of associated fibroblasts and cell-to-cell spatial dependencies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Concordia University; Université de Montréal","funders":"","keywords":"Stromal cell; Dysplasia; Pathology; Pancreatic cancer; Cancer research; Tumor microenvironment; Stem cell; Mesenchymal stem cell; Cell; Ductal cells; Biology; Medicine; Cancer; Internal medicine; Cell biology; Immunohistochemistry","score_opus":0.05918151996763486,"score_gpt":0.3775342470725117,"score_spread":0.31835272710487683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543,0.0014144009,0.0007838192,0.00013186704,0.00006795927,0.0008022828,0.0002244696,0.000024665,0.001120523],"genre_scores_gemma":[0.99740666,0.00023731071,0.00061907276,0.0000061825567,0.0000674815,0.000045498782,0.000023588298,0.000051000683,0.001543206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685425,0.00014427061,0.00077662466,0.0004594824,0.0011400643,0.0006253375],"domain_scores_gemma":[0.99712527,0.0013149122,0.00016344957,0.0003385724,0.000792377,0.00026540062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017819812,0.00020074884,0.00085576036,0.0006314382,0.00011321209,0.000023170476,0.00023537062,0.00014474377,0.00010303371],"category_scores_gemma":[0.0002654117,0.00017930593,0.000099632955,0.00060670293,0.00047525825,0.0000787468,0.00022556898,0.0007283993,0.000005676936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003745933,0.00027994893,0.07054346,0.0056115948,0.00012021947,0.000056487344,0.0013415862,0.0003186871,0.91992116,0.000037341302,0.00022481906,0.001170119],"study_design_scores_gemma":[0.0052337227,0.0021685536,0.16938551,0.01229991,0.000506399,0.000029256678,0.004496618,0.29601753,0.5091801,0.00019487565,0.000017573384,0.0004699453],"about_ca_topic_score_codex":0.0082338005,"about_ca_topic_score_gemma":0.0008883844,"teacher_disagreement_score":0.41074103,"about_ca_system_score_codex":0.0005163455,"about_ca_system_score_gemma":0.0012239629,"threshold_uncertainty_score":0.99837047},"labels":[],"label_agreement":null},{"id":"W4393084746","doi":"10.1158/1538-7445.am2024-6385","title":"Abstract 6385: St. Jude Survivorship Portal: Sharing and analyzing large clinical and genomic datasets from pediatric cancer survivors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Survivorship curve; Cancer; Medicine; Pediatric cancer; Cancer survivorship; Oncology; Gerontology; Internal medicine","score_opus":0.1663510312076407,"score_gpt":0.4863785426301176,"score_spread":0.3200275114224769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9103261,0.08084781,0.000016578664,0.0029928181,0.00096305914,0.0006188919,0.0038600527,0.00016018147,0.00021450387],"genre_scores_gemma":[0.96037745,0.03430321,0.00006316869,0.00037487686,0.0037306058,0.00012180308,0.00061690307,0.00013080038,0.00028117633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945533,0.00039443088,0.0010214759,0.0017019578,0.0011920882,0.0011367017],"domain_scores_gemma":[0.9963828,0.0014891074,0.00012354493,0.00089942117,0.00018926464,0.0009158698],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007392523,0.0003839795,0.00084379176,0.00057751127,0.00031915703,0.00040378326,0.00042532265,0.00031126602,0.001541576],"category_scores_gemma":[0.0005591167,0.00036549583,0.0001580374,0.0009334407,0.00039700538,0.00037381783,0.00072805205,0.0021098745,0.00005900314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000272874,0.00011379467,0.978834,0.0014796905,0.0004109702,0.00035783363,0.0011042927,0.0000034879777,0.00054736884,0.00016621723,0.011262655,0.0054468354],"study_design_scores_gemma":[0.0015932051,0.00012423452,0.962723,0.00095441437,0.0003102421,0.000016145885,0.00072370126,0.00042464247,0.00014605102,0.0005182075,0.03194342,0.00052274525],"about_ca_topic_score_codex":0.08373749,"about_ca_topic_score_gemma":0.10878278,"teacher_disagreement_score":0.050051346,"about_ca_system_score_codex":0.00022818305,"about_ca_system_score_gemma":0.0010610356,"threshold_uncertainty_score":0.9998797},"labels":[],"label_agreement":null},{"id":"W4393084914","doi":"10.1158/1538-7445.am2024-6376","title":"Abstract 6376: Establishment of the Consortium for Childhood Cancer Predisposition and the Childhood Cancer Predisposition Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cancer; Childhood cancer; Genetic predisposition; Medicine; Internal medicine; Disease","score_opus":0.04974223331248532,"score_gpt":0.41307199316297083,"score_spread":0.3633297598504855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92974,0.028416375,0.000026412205,0.030638063,0.0012770401,0.00827166,0.001106323,0.00009236874,0.00043174883],"genre_scores_gemma":[0.98807967,0.0032364365,0.000018914363,0.0006212401,0.001721231,0.005688708,0.00003849433,0.0000864711,0.0005088287],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9953913,0.00047387293,0.00077889924,0.00086190173,0.0017752071,0.0007188127],"domain_scores_gemma":[0.9971634,0.0009482391,0.00019247999,0.00082526414,0.0006356422,0.0002349441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003217573,0.000335176,0.0006366836,0.00023798327,0.00055450766,0.00022404858,0.0004602496,0.00015625662,0.0003533123],"category_scores_gemma":[0.0003262412,0.00020452248,0.00027546278,0.0009007281,0.00084420806,0.0002842259,0.0002723241,0.0010646116,0.0000038486387],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021263264,0.012964721,0.21871407,0.021519069,0.014559312,0.000089618574,0.31013313,0.001351482,0.037514698,0.009404243,0.17162555,0.18086085],"study_design_scores_gemma":[0.010467747,0.0008562717,0.95666176,0.0050522997,0.0009755977,0.00002199713,0.006237787,0.0002884039,0.013526077,0.0011217206,0.0043965383,0.0003938156],"about_ca_topic_score_codex":0.01040845,"about_ca_topic_score_gemma":0.0039985846,"teacher_disagreement_score":0.73794764,"about_ca_system_score_codex":0.0006303285,"about_ca_system_score_gemma":0.0019404369,"threshold_uncertainty_score":0.9961813},"labels":[],"label_agreement":null},{"id":"W4393084941","doi":"10.1158/1538-7445.am2024-6716","title":"Abstract 6716: DLL3 TriTCE Co-Stim: A next generation trispecific T cell engager with integrated CD28 costimulation for the treatment of DLL3-expressing cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Cancer research; Medicine; Cell; Cancer; Internal medicine; Biology","score_opus":0.29885606712149465,"score_gpt":0.4732763836450434,"score_spread":0.17442031652354872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96899796,0.020790504,0.0016230764,0.0014406812,0.0003017802,0.0046254313,0.00019256372,0.00008322396,0.0019448097],"genre_scores_gemma":[0.97707474,0.0066966675,0.0002242012,0.000025754134,0.0010130776,0.0014378616,0.00020940439,0.000094666924,0.013223604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997187,0.00022103351,0.0003749019,0.00055417954,0.0010636785,0.0005991619],"domain_scores_gemma":[0.99677,0.0016860502,0.0000640224,0.00052379805,0.00077644165,0.00017968779],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013098296,0.00023406373,0.00037437904,0.00042434252,0.00036346357,0.0002467265,0.00018032818,0.00013716597,0.0024303293],"category_scores_gemma":[0.0000880719,0.00014103821,0.00015525812,0.0009725064,0.0003434428,0.00017380505,0.000015349648,0.00065753993,0.00001885152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037152383,0.00019096739,0.00027697659,0.00034091558,0.00024133995,0.0000357466,0.0019414687,0.0021472927,0.8293941,0.000018624283,0.01001552,0.15168183],"study_design_scores_gemma":[0.0049476833,0.0024595712,0.0008573077,0.0005666747,0.00012935326,0.000008017698,0.001327818,0.055035934,0.68828386,0.000011747379,0.24617322,0.00019878523],"about_ca_topic_score_codex":0.0032499742,"about_ca_topic_score_gemma":0.00048989296,"teacher_disagreement_score":0.2361577,"about_ca_system_score_codex":0.0026559213,"about_ca_system_score_gemma":0.0022995113,"threshold_uncertainty_score":0.9984816},"labels":[],"label_agreement":null},{"id":"W4393084984","doi":"10.1158/1538-7445.am2024-3504","title":"Abstract 3504: ARS2 and paraspeckle interactions: A nexus for lncRNA mediated drug resistance and cancer progression in hepatocellular carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Hepatocellular carcinoma; Cancer; Medicine; Drug resistance; Nexus (standard); Liver cancer; Cancer research; Oncology; Internal medicine; Biology; Genetics","score_opus":0.03920915757400178,"score_gpt":0.39938262103269856,"score_spread":0.3601734634586968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674509,0.12824443,0.0003114715,0.0020401643,0.00027426143,0.0012591559,0.00013703434,0.000024302753,0.0002582588],"genre_scores_gemma":[0.98331994,0.01150476,0.00015024998,0.00004899397,0.00027949372,0.00216624,0.00008730162,0.00006965848,0.002373358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976203,0.00014079429,0.0002768044,0.00085808535,0.00044304747,0.00066097366],"domain_scores_gemma":[0.998976,0.00014152825,0.00003903877,0.00032534348,0.0003018593,0.00021622369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093443465,0.00020492604,0.00020707169,0.00032442587,0.00017651923,0.00018448163,0.00021282703,0.00017797969,0.00008194696],"category_scores_gemma":[0.0001992942,0.00019534669,0.00005953905,0.00047086325,0.00023869901,0.000022190981,0.00022200333,0.0006290668,0.0000053672356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007891424,0.00004849139,0.0008350785,0.0007189351,0.00008065209,0.00010567327,0.0002831031,0.000018139242,0.97509885,0.00021557063,0.0085433,0.013263041],"study_design_scores_gemma":[0.001961743,0.00021477403,0.0018707148,0.0015467999,0.000026872049,0.000021351254,0.00041225445,0.005153397,0.6975491,0.001147421,0.28957754,0.0005179927],"about_ca_topic_score_codex":0.0008816522,"about_ca_topic_score_gemma":0.0033479482,"teacher_disagreement_score":0.28103426,"about_ca_system_score_codex":0.0002491944,"about_ca_system_score_gemma":0.0006749882,"threshold_uncertainty_score":0.7966007},"labels":[],"label_agreement":null},{"id":"W4393084988","doi":"10.1158/1538-7445.am2024-3510","title":"Abstract 3510: A radiogenomic approach for triple-negative breast cancer risk stratification","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Risk stratification; Cancer; Internal medicine; Oncology","score_opus":0.062313688167205714,"score_gpt":0.4315073901216721,"score_spread":0.3691937019544664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393084988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9265557,0.020868355,0.018344408,0.021247417,0.0011594945,0.004384293,0.0010681666,0.0003142277,0.0060579353],"genre_scores_gemma":[0.98911154,0.0029452355,0.0020386733,0.000101214195,0.001607384,0.001320037,0.000081245074,0.00006925992,0.0027254291],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980043,0.00010477582,0.00027005075,0.00056397624,0.00053348194,0.0005233827],"domain_scores_gemma":[0.9987417,0.00039548744,0.000050861865,0.0002889718,0.00025675684,0.0002662536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017948084,0.00015118373,0.00026394997,0.00030152636,0.0002522849,0.00016263437,0.00018772243,0.000099880126,0.0004742913],"category_scores_gemma":[0.00034022832,0.00012040883,0.00013501967,0.0005345889,0.00026537542,0.0001125579,0.000030730513,0.0012287031,0.000023716877],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012278067,0.00024131208,0.004323848,0.0025513314,0.00077145506,0.000047562673,0.0037458965,0.0013555358,0.16496062,0.0015777928,0.06921538,0.74998146],"study_design_scores_gemma":[0.009413315,0.0005818023,0.16070522,0.002664377,0.00072174217,0.00026537562,0.0034505604,0.7374551,0.024764646,0.004008897,0.054818723,0.0011502119],"about_ca_topic_score_codex":0.003081556,"about_ca_topic_score_gemma":0.000028602823,"teacher_disagreement_score":0.7488313,"about_ca_system_score_codex":0.0006348699,"about_ca_system_score_gemma":0.0010638487,"threshold_uncertainty_score":0.5338172},"labels":[],"label_agreement":null},{"id":"W4393085018","doi":"10.1158/1538-7445.am2024-3536","title":"Abstract 3536: Paracell: A high throughput, deep learning-based pipeline for single-cell phenotypic profiling","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Profiling (computer programming); Computational biology; Phenotype; Pipeline (software); Computer science; Biology; Genetics; Gene","score_opus":0.06110891044154527,"score_gpt":0.3501968021055509,"score_spread":0.2890878916640056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252077,0.022496628,0.04727181,0.00075865455,0.00093256455,0.0011368291,0.0001000709,0.00012321088,0.001972567],"genre_scores_gemma":[0.9940251,0.00040707277,0.00097621564,0.00010562392,0.0011364445,0.00029525036,0.00031221908,0.00009771661,0.0026443328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979673,0.00009091981,0.0002667228,0.00068751717,0.00032499232,0.0006625529],"domain_scores_gemma":[0.9990775,0.00014186607,0.000036778038,0.00031016304,0.00029988374,0.00013382455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068674475,0.00021032523,0.00018997682,0.00010893878,0.00023718002,0.00015919704,0.00029606733,0.0002313945,0.000121141275],"category_scores_gemma":[0.00011995232,0.00019579165,0.00015551403,0.0002549611,0.00016284127,0.000008092741,0.000055213157,0.000516776,0.00003888491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043128824,0.0001567775,0.00020213901,0.0006121845,0.000034869554,0.000011404775,0.00007327852,0.0041231182,0.9809571,0.00006360445,0.0015445281,0.011789726],"study_design_scores_gemma":[0.000834087,0.00041858054,0.000026924292,0.00010170514,0.000021151374,0.0000015060997,0.00006874737,0.008471651,0.901658,0.00015611135,0.08798554,0.00025598027],"about_ca_topic_score_codex":0.00022711448,"about_ca_topic_score_gemma":0.00014697948,"teacher_disagreement_score":0.086441,"about_ca_system_score_codex":0.000101135534,"about_ca_system_score_gemma":0.0003982317,"threshold_uncertainty_score":0.7984152},"labels":[],"label_agreement":null},{"id":"W4393085303","doi":"10.1158/1538-7445.am2024-6996","title":"Abstract 6996: A role for the cell adhesion molecule NCAM1 in regulating activity of the receptor tyrosine kinase RET in cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Saskatchewan; Queen's University","funders":"","keywords":"Receptor tyrosine kinase; Cancer; Tyrosine kinase; Cancer research; Cell adhesion molecule; ROR1; Neural cell adhesion molecule; Cell biology; Chemistry; Cell adhesion; Receptor; Biology; Kinase; Cell; Signal transduction; Biochemistry; Platelet-derived growth factor receptor; Genetics","score_opus":0.11762551135676212,"score_gpt":0.46308895044232273,"score_spread":0.3454634390855606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679414,0.016800737,0.000006968097,0.011037156,0.0002978335,0.0024414253,0.00012499328,0.000023288798,0.0013262172],"genre_scores_gemma":[0.9932038,0.0017989636,0.00004852707,0.00006873869,0.00037706783,0.0018647604,0.000004590793,0.00007164951,0.0025619003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663764,0.00030132942,0.00038509394,0.0005655641,0.0012812346,0.00082912354],"domain_scores_gemma":[0.99755955,0.0011764496,0.000062280305,0.0007333072,0.00033697626,0.0001314635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031639661,0.00017637465,0.00032910937,0.00035135448,0.00015476206,0.000066450266,0.00051199895,0.0001690386,0.00084116426],"category_scores_gemma":[0.0006871655,0.00010956019,0.00014183066,0.0020112423,0.00034620575,0.00011086422,0.00027533123,0.0016337895,0.000014060414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011349706,0.00016077254,0.0069401287,0.0018491247,0.000025284211,0.000018023531,0.0011241337,0.00025296726,0.92418605,0.00006175453,0.012411525,0.05183526],"study_design_scores_gemma":[0.0013524807,0.00021883531,0.040053867,0.0035597996,0.000015474863,0.0000015866764,0.0004869365,0.0049478365,0.9298816,0.00016596592,0.019176424,0.00013921928],"about_ca_topic_score_codex":0.016416967,"about_ca_topic_score_gemma":0.006103285,"teacher_disagreement_score":0.051696043,"about_ca_system_score_codex":0.0016859702,"about_ca_system_score_gemma":0.0020470002,"threshold_uncertainty_score":0.9901328},"labels":[],"label_agreement":null},{"id":"W4393085311","doi":"10.1158/1538-7445.am2024-5238","title":"Abstract 5238: uPAR as a novel immunotherapeutic target in recurrent glioblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McMaster University","funders":"","keywords":"Urokinase receptor; Glioblastoma; Cancer research; Medicine; Oncology; Internal medicine; Receptor","score_opus":0.049014812941778674,"score_gpt":0.3688488358099602,"score_spread":0.3198340228681815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92546123,0.06355283,0.0005118633,0.00041323557,0.0027835174,0.0008008172,0.00014053023,0.0006056741,0.0057302983],"genre_scores_gemma":[0.9958193,0.0028372002,0.00011173446,0.00002706052,0.00028380923,0.0003073178,0.00000612048,0.00012424546,0.00048323974],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998021,0.000014946773,0.00029313716,0.0003156005,0.00058284367,0.0007724588],"domain_scores_gemma":[0.9992995,0.00017505966,0.000010126943,0.00032620583,0.00007397457,0.00011508083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005604751,0.0002004552,0.0002016076,0.00054805697,0.000058686088,0.00016333739,0.000365898,0.00012895941,0.001097356],"category_scores_gemma":[0.000027428834,0.00017209703,0.00007603086,0.0011582796,0.00009173737,0.00024184305,0.000053998978,0.0010486405,0.0006172009],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035034143,0.00007784656,0.00007460337,0.0010118141,0.00019638048,0.0001596765,0.001617241,0.0070650214,0.880526,0.0010016273,0.0033177538,0.10460171],"study_design_scores_gemma":[0.0017297899,0.00052469503,0.0013875944,0.002508043,0.000018077075,0.000030110778,0.00026713696,0.023815373,0.34131014,0.008723754,0.61876106,0.00092424185],"about_ca_topic_score_codex":0.00025940983,"about_ca_topic_score_gemma":0.0003128235,"teacher_disagreement_score":0.6154433,"about_ca_system_score_codex":0.001159014,"about_ca_system_score_gemma":0.00031963404,"threshold_uncertainty_score":0.99981576},"labels":[],"label_agreement":null},{"id":"W4393085416","doi":"10.1158/1538-7445.am2024-5552","title":"Abstract 5552: Uncovering clinically significant tumor microenvironment interaction programs across diverse cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Tumor microenvironment; Cancer; Cancer research; Medicine; Computational biology; Biology; Internal medicine","score_opus":0.06327672240530194,"score_gpt":0.4135254824330007,"score_spread":0.3502487600276988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947381,0.0027062595,0.000097289965,0.00025422126,0.0010023371,0.00049413607,0.00017651405,0.000022455577,0.0005086672],"genre_scores_gemma":[0.9916333,0.005949862,0.00009324618,0.00014602559,0.0010447559,0.0004368919,0.00008654085,0.000046454075,0.0005629121],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981132,0.0000433447,0.00029267746,0.00063393574,0.00032077724,0.00059604493],"domain_scores_gemma":[0.9992432,0.00007713447,0.00004632663,0.00035933504,0.000090840134,0.00018316082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006601773,0.00016058922,0.00013871558,0.000049125163,0.00016634165,0.00024500745,0.00027856106,0.00009786754,0.00015898707],"category_scores_gemma":[0.0000921263,0.00015558214,0.00012366884,0.00015879293,0.00024225039,0.000009862644,0.0003325286,0.00042340756,0.00009454445],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045965516,0.00009550835,0.0044616773,0.00020047076,0.00015394708,0.000117913434,0.00028223277,0.0021695488,0.8697749,0.000023475093,0.013932173,0.10832855],"study_design_scores_gemma":[0.00060068746,0.0007014461,0.0041797035,0.00036289642,0.000022075717,0.0000088818,0.0014953685,0.00017423306,0.1886188,0.00007464852,0.8033409,0.0004203674],"about_ca_topic_score_codex":0.0018716946,"about_ca_topic_score_gemma":0.00074458594,"teacher_disagreement_score":0.78940874,"about_ca_system_score_codex":0.0006204398,"about_ca_system_score_gemma":0.0005603021,"threshold_uncertainty_score":0.63444555},"labels":[],"label_agreement":null},{"id":"W4393085424","doi":"10.1158/1538-7445.am2024-5567","title":"Abstract 5567: Breast cancer cell alteration of immune cell transcriptome through indirect communication","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ansys (Canada)","funders":"","keywords":"Transcriptome; Immune system; Breast cancer; Cancer; Cell; Medicine; Biology; Cancer research; Immunology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.0509913962833782,"score_gpt":0.3710130746020573,"score_spread":0.3200216783186791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6166621,0.37730476,0.000030544707,0.00092604524,0.0006703942,0.00039435682,0.0002804676,0.000070385395,0.0036609517],"genre_scores_gemma":[0.9335115,0.05891117,0.000018210681,0.00004218424,0.000047157726,0.00025567444,0.00011328371,0.00004462581,0.007056209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978427,0.0006522735,0.0004984387,0.0003366708,0.0001443743,0.0005255253],"domain_scores_gemma":[0.9986178,0.00040419243,0.00008898644,0.00059706665,0.00027424213,0.000017712084],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010755048,0.00019669265,0.00032365584,0.00019540836,0.00035155696,0.00007281166,0.00056222186,0.00026751927,0.007110611],"category_scores_gemma":[0.000011734365,0.00017284755,0.00016943623,0.0004959394,0.00047989388,0.00046910622,0.00007523828,0.0008971777,0.00025446143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008402283,0.00017618206,0.00006716652,0.00036476206,0.00017652687,0.0000024975059,0.004953602,0.00001707854,0.97497565,0.00018967512,0.0040536635,0.014182978],"study_design_scores_gemma":[0.00082090707,0.000110144276,0.0055602393,0.0004573729,0.000025904905,0.000011563501,0.00064435485,0.0000053173976,0.9222687,0.00010891817,0.0698097,0.00017690031],"about_ca_topic_score_codex":0.0088773025,"about_ca_topic_score_gemma":0.00014606792,"teacher_disagreement_score":0.3183936,"about_ca_system_score_codex":0.00029079252,"about_ca_system_score_gemma":0.0005598182,"threshold_uncertainty_score":0.9977227},"labels":[],"label_agreement":null},{"id":"W4393085465","doi":"10.1158/1538-7445.am2024-6030","title":"Abstract 6030: Optimizing the therapeutic index of targeted α-particle radioimmuotherapy (TART) of HER2-positive breast cancer tumors in NRG mice with 225Ac-labeled trastuzumab","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Trastuzumab; Medicine; Cancer; Breast cancer; Oncology; Internal medicine","score_opus":0.05427913274159446,"score_gpt":0.4167995084334799,"score_spread":0.36252037569188544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982955,0.00985676,0.000046702782,0.0058189505,0.00002102905,0.0007005764,0.00009881679,0.000024844188,0.0004773196],"genre_scores_gemma":[0.9981135,0.0009559394,0.000038293438,0.000103016275,0.000105109684,0.00041195215,0.000006325417,0.000036718,0.00022910534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983278,0.000084141386,0.00032529497,0.00031920633,0.0005232217,0.00042033737],"domain_scores_gemma":[0.99898016,0.00031865758,0.000050914005,0.00027855096,0.0002483223,0.00012341149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055127207,0.00014433014,0.00030087002,0.00008747972,0.00008129871,0.000025855885,0.00021999546,0.00006936831,0.00074261514],"category_scores_gemma":[0.000011838906,0.00009329711,0.00006620162,0.0011962546,0.00058499555,0.00007930263,0.000022753433,0.000750722,0.000004591143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016600471,0.00028366334,0.003696108,0.00045335855,0.00028073677,0.00003412488,0.001510062,0.0009340293,0.9801662,0.00016401349,0.00013788593,0.010679777],"study_design_scores_gemma":[0.0018076053,0.00014264803,0.08106045,0.0010944403,0.000059421058,0.000041099374,0.0008452755,0.00442672,0.90997714,0.0000673844,0.00034672665,0.00013110087],"about_ca_topic_score_codex":0.0012161963,"about_ca_topic_score_gemma":0.00006227277,"teacher_disagreement_score":0.07736434,"about_ca_system_score_codex":0.00032524572,"about_ca_system_score_gemma":0.0007157109,"threshold_uncertainty_score":0.81311154},"labels":[],"label_agreement":null},{"id":"W4393085476","doi":"10.1158/1538-7445.am2024-5898","title":"Abstract 5898: Inhibition of the LONP1 ATPase domain induces mitochondrial proteotoxic stress and is cytotoxic to acute myeloid leukemia cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Cytotoxic T cell; Biology; Cancer research; Leukemia; Apoptosis; Myeloid; Mitochondrion; Cell biology; Immunology; In vitro; Genetics","score_opus":0.023156327259903412,"score_gpt":0.33208529020830907,"score_spread":0.30892896294840566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922685,0.0042542284,0.000022459175,0.00059967145,0.0010622663,0.0010301315,0.0005143563,0.000010219885,0.00023819068],"genre_scores_gemma":[0.9929713,0.0026812651,0.00008849306,0.0001431608,0.0023660706,0.0004372526,0.000020075067,0.000036413654,0.0012559679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998311,0.000099484256,0.00021993912,0.0005192457,0.00045027523,0.0004000909],"domain_scores_gemma":[0.9992109,0.000023784312,0.00004205534,0.00041052577,0.00015302433,0.00015973834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003244538,0.00016030294,0.00016897517,0.000119070864,0.00014938135,0.00009470702,0.00025197858,0.00018955626,0.00008048103],"category_scores_gemma":[0.000034806806,0.000122017336,0.00010084476,0.00036507292,0.00027500675,0.0000120194545,0.00023473446,0.0003650605,0.000012988536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022620568,0.000023457362,0.000016695763,0.00018966148,0.000075886455,0.000004334016,0.00049213745,0.000010342812,0.98199606,0.000023001992,0.013588911,0.0033532784],"study_design_scores_gemma":[0.0004411325,0.0001252668,0.0007461706,0.00022236991,0.000017982296,0.000003786723,0.00013348917,0.000001968011,0.9381132,0.00010592042,0.059953153,0.00013555305],"about_ca_topic_score_codex":0.00039998058,"about_ca_topic_score_gemma":0.00030071125,"teacher_disagreement_score":0.04636424,"about_ca_system_score_codex":0.00010748358,"about_ca_system_score_gemma":0.0007391217,"threshold_uncertainty_score":0.49757224},"labels":[],"label_agreement":null},{"id":"W4393085497","doi":"10.1158/1538-7445.am2024-6359","title":"Abstract 6359: Development of PSMA x CD3 T-cell engagers using an integrated, functional approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Computer science; Medicine","score_opus":0.37455860750680386,"score_gpt":0.42261122886524677,"score_spread":0.048052621358442904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581987,0.00018212173,0.001719847,0.000034613833,0.00051019574,0.0001865403,0.000012141557,0.000082600316,0.0014520783],"genre_scores_gemma":[0.9986088,0.000056730063,0.0005335674,0.000034536875,0.00010082414,0.000044845307,0.0000020846437,0.0000286802,0.0005899248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978265,0.00010212674,0.00022042997,0.0005619518,0.00081724965,0.0004717528],"domain_scores_gemma":[0.9993565,0.0002097525,0.000021397862,0.00019623304,0.00006819696,0.00014792259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080031273,0.00012554126,0.00011658519,0.0003796397,0.000288189,0.00013855191,0.00034245945,0.00005019902,0.00014488575],"category_scores_gemma":[0.00013265743,0.00010553537,0.00004204959,0.0012196997,0.00020727025,0.00041032402,0.000091564056,0.0007563667,0.000029115161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018505118,0.000063884385,0.000012258478,0.0001499467,0.0000016283466,0.000026787782,0.0003867115,0.0040296065,0.9892526,0.00015002729,0.000117819145,0.0057902075],"study_design_scores_gemma":[0.00008511032,0.00002681701,0.00013886424,0.000067648616,0.0000017299514,0.000011243178,0.00019552873,0.017564826,0.9767907,0.000017288923,0.004984298,0.00011594521],"about_ca_topic_score_codex":0.000051983556,"about_ca_topic_score_gemma":0.0000030976869,"teacher_disagreement_score":0.013535218,"about_ca_system_score_codex":0.0002028149,"about_ca_system_score_gemma":0.00076427986,"threshold_uncertainty_score":0.43036076},"labels":[],"label_agreement":null},{"id":"W4393085499","doi":"10.1158/1538-7445.am2024-5911","title":"Abstract 5911: <i>In vivo</i> efficacy of a novel peptide-conjugated drug in patient-derived xenograft models of breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"In vivo; Medicine; Breast cancer; Cancer; Drug; Conjugated system; Cancer research; Peptide; Oncology; Internal medicine; Pharmacology; Biology; Chemistry; Biochemistry; Biotechnology","score_opus":0.03895114565903772,"score_gpt":0.36620158830460137,"score_spread":0.32725044264556363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889422,0.008389268,0.000008919992,0.00026663125,0.000071190094,0.00060467096,0.0010640768,0.000007855157,0.000645169],"genre_scores_gemma":[0.9959576,0.0032875452,0.000027384589,0.000017584834,0.00006924555,0.000356349,0.00004378775,0.000039479397,0.00020101054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978409,0.00008232272,0.00039212333,0.00052583026,0.00054181606,0.00061704044],"domain_scores_gemma":[0.9991132,0.00006658788,0.000051895306,0.000357697,0.0002674206,0.00014318882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038518326,0.00017317705,0.00027087773,0.0003590607,0.000033508557,0.000030225845,0.00029168994,0.000110561465,0.0002304446],"category_scores_gemma":[0.000033699635,0.00015726335,0.0001144183,0.00074501126,0.00025996886,0.000019197334,0.00019297206,0.00034053953,0.0000030981137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011430704,0.00049511215,0.0019820584,0.00032070288,0.00013383586,0.00004199507,0.0005080519,0.002076183,0.98439914,0.00002691438,0.0020616103,0.0068113166],"study_design_scores_gemma":[0.0034230154,0.00023350366,0.007860728,0.000988683,0.000010805842,0.0000066379216,0.00021536008,0.00071130163,0.9845401,0.00008357939,0.0017027077,0.0002235663],"about_ca_topic_score_codex":0.030229889,"about_ca_topic_score_gemma":0.015309417,"teacher_disagreement_score":0.014920473,"about_ca_system_score_codex":0.00021654206,"about_ca_system_score_gemma":0.0010161633,"threshold_uncertainty_score":0.9762279},"labels":[],"label_agreement":null},{"id":"W4393085631","doi":"10.1158/1538-7445.am2024-1859","title":"Abstract 1859: Diverse CD28-binding IgG and heavy chain-only antibodies for T-cell engager development","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Antibody; Immunology; Molecular biology; Medicine; Cancer research; Biology","score_opus":0.1360297226570499,"score_gpt":0.43865930934429803,"score_spread":0.30262958668724815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739467,0.014424747,0.000023737983,0.004050307,0.000272931,0.0009206897,0.00010379351,0.000068644484,0.0061884653],"genre_scores_gemma":[0.9427922,0.004348405,0.0006205833,0.00012310118,0.0007031404,0.00022920156,0.00006642882,0.00005358385,0.051063385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723935,0.00007177502,0.0002726915,0.00057634653,0.0009167961,0.00092306547],"domain_scores_gemma":[0.9983083,0.0007779432,0.00002049215,0.00019739577,0.000307731,0.00038812179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017324989,0.00020548595,0.00030939502,0.00046809838,0.00068354927,0.00018713543,0.0001715099,0.00011376749,0.00068997557],"category_scores_gemma":[0.00014133232,0.00015902736,0.000105061925,0.00037120408,0.00035393503,0.00012321526,0.0002632469,0.0009390101,0.00024246969],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004838573,0.00053669646,0.04267719,0.01797433,0.0008689116,0.0015884264,0.009951938,0.0000050213102,0.34669745,0.0033589369,0.14854513,0.4229574],"study_design_scores_gemma":[0.0013307785,0.00041150913,0.029648375,0.0014467011,0.000036833153,0.00006510082,0.0014982667,0.00021718215,0.1544295,0.00020139512,0.81033087,0.00038349818],"about_ca_topic_score_codex":0.00034868185,"about_ca_topic_score_gemma":0.000094996474,"teacher_disagreement_score":0.6617857,"about_ca_system_score_codex":0.0002738454,"about_ca_system_score_gemma":0.0012442294,"threshold_uncertainty_score":0.75547487},"labels":[],"label_agreement":null},{"id":"W4393085665","doi":"10.1158/1538-7445.am2024-3973","title":"Abstract 3973: Cancer B cell blueprint reveals dysfunctional extra-follicular dominance with therapeutic opportunity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dysfunctional family; Blueprint; Dominance (genetics); Cancer; Biology; Medicine; Genetics; Gene","score_opus":0.11333548300662961,"score_gpt":0.4031269207504355,"score_spread":0.2897914377438059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8728768,0.10925381,0.00010166384,0.005898376,0.0006055249,0.0011107876,0.000102465034,0.0001358819,0.009914655],"genre_scores_gemma":[0.9639807,0.019564305,0.00007351768,0.00071204145,0.0006275813,0.0008592367,0.000019506644,0.00007403073,0.01408913],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970787,0.00010454281,0.0003272349,0.0006672066,0.0011251097,0.00069718086],"domain_scores_gemma":[0.9985087,0.0001751146,0.00005329307,0.00054484233,0.0003937092,0.00032436417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013292936,0.00025209796,0.00032969363,0.00018163437,0.00023687605,0.0001288876,0.00022740077,0.00015037964,0.011059736],"category_scores_gemma":[0.00001898787,0.00018003103,0.00016899376,0.00074334425,0.00040868524,0.00019291368,0.00005092714,0.0008709767,0.00008109967],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006882867,0.00032628037,0.0039306735,0.0018988115,0.0008957823,0.00068113324,0.000664704,0.000049038532,0.7519584,0.0004990231,0.025374603,0.2068387],"study_design_scores_gemma":[0.0050643836,0.0010636753,0.1446066,0.0042821425,0.00024778576,0.00016153717,0.000875399,0.00018429148,0.14857523,0.0006227006,0.69350356,0.00081271265],"about_ca_topic_score_codex":0.004367485,"about_ca_topic_score_gemma":0.00062909204,"teacher_disagreement_score":0.6681289,"about_ca_system_score_codex":0.0012828091,"about_ca_system_score_gemma":0.0027138393,"threshold_uncertainty_score":0.98984426},"labels":[],"label_agreement":null},{"id":"W4393085675","doi":"10.1158/1538-7445.am2024-1862","title":"Abstract 1862: ZW191 - a FRα-targeting antibody drug conjugate with strong preclinical activity across multiple FRα-expressing indications","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-drug conjugate; Medicine; Drug; Conjugate; Antibody; Pharmacology; Cancer research; Immunology; Monoclonal antibody","score_opus":0.1774213273968225,"score_gpt":0.5574039194081839,"score_spread":0.3799825920113614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394644,0.0045101484,0.00031875036,0.0055335313,0.0003298721,0.0017015593,0.0003446309,0.0003105729,0.0030045072],"genre_scores_gemma":[0.994089,0.0009406681,0.0005286209,0.000067961846,0.0012553293,0.0007683624,0.000100698766,0.00016577424,0.0020835677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932664,0.00045528766,0.00057910354,0.0013335012,0.0024610837,0.0019046463],"domain_scores_gemma":[0.99510163,0.0023021204,0.000101595266,0.00097550394,0.000725115,0.0007940368],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00488016,0.00034996972,0.00059397327,0.0004063793,0.00087992306,0.00066912017,0.000601439,0.00026323594,0.0014490595],"category_scores_gemma":[0.0014460587,0.0002839284,0.00017391673,0.0015018774,0.0012533283,0.00053353887,0.00046916824,0.0042405585,0.00034291545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035733737,0.001149689,0.18939705,0.005562051,0.0009902149,0.0015284658,0.0095807845,0.00035370298,0.6277462,0.00014518938,0.03551517,0.12445807],"study_design_scores_gemma":[0.0092325695,0.0014624152,0.31745732,0.017209398,0.00021424987,0.00012341871,0.0056295404,0.015228835,0.45050636,0.00032649434,0.18078896,0.0018204199],"about_ca_topic_score_codex":0.0042905794,"about_ca_topic_score_gemma":0.0008637061,"teacher_disagreement_score":0.17723987,"about_ca_system_score_codex":0.0011221353,"about_ca_system_score_gemma":0.003628581,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W4393085725","doi":"10.1158/1538-7445.am2024-2848","title":"Abstract 2848: MYC and TGFβ promote group 3 medulloblastoma tumor resistance through deregulation of Polycomb targets","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Deregulation; Cancer research; Transforming growth factor; Resistance (ecology); Oncology; Medicine; Internal medicine; Biology; Market economy; Economics; Ecology","score_opus":0.050015443114093006,"score_gpt":0.3927874233376613,"score_spread":0.3427719802235683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561071,0.03632069,0.00000794086,0.004065781,0.00012083069,0.0006913421,0.000039300136,0.000044178963,0.0026028305],"genre_scores_gemma":[0.99768794,0.00090820633,0.00040878975,0.000038447903,0.00014852003,0.0002234012,0.00001635705,0.00003117324,0.0005371625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839205,0.00004568389,0.00022795235,0.0003769705,0.00060871843,0.00034862725],"domain_scores_gemma":[0.9992448,0.00016110014,0.00003465554,0.00026210333,0.00016945318,0.00012789518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003769214,0.0001253603,0.00023763602,0.00016996342,0.00009418929,0.000049427592,0.00007049324,0.000057401532,0.00037359077],"category_scores_gemma":[0.000071543545,0.00009681043,0.00006151616,0.0004384691,0.0002022622,0.00013649862,0.00005221505,0.00024007367,0.00003276018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018860789,0.0010839815,0.023245513,0.00751003,0.0009179415,0.002481896,0.0044951364,0.000010636275,0.8436022,0.01519607,0.05003016,0.049540367],"study_design_scores_gemma":[0.0025430159,0.0007188546,0.37163,0.0043659457,0.00012551059,0.00006242809,0.00031899475,0.00016918858,0.54643315,0.005574052,0.067790866,0.00026799776],"about_ca_topic_score_codex":0.0005243282,"about_ca_topic_score_gemma":0.00030120093,"teacher_disagreement_score":0.3483845,"about_ca_system_score_codex":0.00021446924,"about_ca_system_score_gemma":0.00019395411,"threshold_uncertainty_score":0.4090557},"labels":[],"label_agreement":null},{"id":"W4393085783","doi":"10.1158/1538-7445.am2024-61","title":"Abstract 61: A novel immunotherapy for metastatic prostate cancer: A monoclonal antibody that can bind both STEAP1 and STEAP2","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Monoclonal antibody; Immunotherapy; Prostate cancer; Medicine; Cancer; Prostate; Cancer research; Antibody; Oncology; Monoclonal; Internal medicine; Immunology","score_opus":0.1437745693739447,"score_gpt":0.47844501829862335,"score_spread":0.3346704489246787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88411635,0.09792522,0.00006830459,0.011467452,0.00032989756,0.0038846985,0.001756509,0.00010554044,0.00034599847],"genre_scores_gemma":[0.942301,0.038738966,0.000385434,0.00017880481,0.0004023545,0.003510339,0.00021153185,0.00015434437,0.014117234],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963984,0.00007378789,0.000328693,0.0008567972,0.0011140195,0.001228293],"domain_scores_gemma":[0.9982941,0.00045167125,0.000050202776,0.00039831447,0.00038483908,0.00042084797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001257367,0.00033404925,0.0005273766,0.0006087674,0.00044384546,0.00047260433,0.00021892149,0.000106546526,0.00044755448],"category_scores_gemma":[0.000042526855,0.00024176865,0.00016070597,0.0007463752,0.0006202843,0.00022780891,0.00010466274,0.0008315403,0.000013965991],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007976898,0.0006135187,0.020809092,0.006668594,0.0029646044,0.00058786105,0.007166782,0.000026223186,0.7484043,0.00064833614,0.009086821,0.19504693],"study_design_scores_gemma":[0.044175692,0.0058425665,0.12410372,0.010751496,0.00076699595,0.00030194302,0.00635962,0.004953685,0.21005985,0.0023460037,0.5882086,0.0021298134],"about_ca_topic_score_codex":0.004605695,"about_ca_topic_score_gemma":0.00055410934,"teacher_disagreement_score":0.57912177,"about_ca_system_score_codex":0.0008765996,"about_ca_system_score_gemma":0.003610362,"threshold_uncertainty_score":0.9859039},"labels":[],"label_agreement":null},{"id":"W4393085897","doi":"10.1158/1538-7445.am2024-6139","title":"Abstract 6139: Genetic modifiers of KRAS-mutant colorectal cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"KRAS; Colorectal cancer; Cancer; Mutant; Medicine; Oncology; Cancer research; Biology; Internal medicine; Genetics; Gene","score_opus":0.09137930213570061,"score_gpt":0.44313090458041643,"score_spread":0.3517516024447158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939387,0.050135747,0.0000035740732,0.0011717539,0.00048185026,0.0005998413,0.0001366249,0.000053824497,0.008029771],"genre_scores_gemma":[0.9875512,0.00968863,0.000030587522,0.000036448786,0.0003696084,0.00068487384,0.000005343809,0.000037219164,0.0015960663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99807394,0.000034990888,0.0002510554,0.0004107401,0.0007224831,0.0005067862],"domain_scores_gemma":[0.9991504,0.00015222709,0.000026112919,0.0001901537,0.00030677897,0.00017435863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002505101,0.00015849435,0.00034396595,0.00025174473,0.00012239267,0.000037293634,0.00011991707,0.00008170209,0.0020113876],"category_scores_gemma":[0.000047748526,0.00011710856,0.00012974232,0.0006687045,0.0003514931,0.000053557123,0.00008637785,0.00041797396,0.000041851214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034703352,0.000493627,0.04302216,0.003418485,0.0028672386,0.0015351432,0.0077173454,0.00033441404,0.5163784,0.00055820344,0.038709242,0.3814954],"study_design_scores_gemma":[0.003449965,0.0026592186,0.59457,0.0033374913,0.0004921241,0.00006958976,0.002345443,0.0013041539,0.31901303,0.00074618345,0.071371615,0.0006412191],"about_ca_topic_score_codex":0.004038806,"about_ca_topic_score_gemma":0.00088167086,"teacher_disagreement_score":0.55154777,"about_ca_system_score_codex":0.0007959179,"about_ca_system_score_gemma":0.0011436747,"threshold_uncertainty_score":0.9989009},"labels":[],"label_agreement":null},{"id":"W4393085943","doi":"10.1158/1538-7445.am2024-3419","title":"Abstract 3419: Demographic, health history, and lifestyle factors in association with biomarkers of colorectal cancer prognosis: A pilot study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Colorectal cancer; Medicine; Cancer; Internal medicine; Oncology; Gerontology; Demography","score_opus":0.06975170963047969,"score_gpt":0.39632979288414794,"score_spread":0.3265780832536682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393085943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500312,0.046482507,5.519992e-7,0.0012235793,0.0002317707,0.0018738994,0.000035173685,0.00004090676,0.000080369085],"genre_scores_gemma":[0.99068046,0.008597487,0.000008806857,0.000030583782,0.00008356905,0.00049555226,0.0000089340665,0.000033658016,0.00006095845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974505,0.00025481064,0.00031985508,0.0004116354,0.0010236341,0.0005396006],"domain_scores_gemma":[0.9990019,0.00025249858,0.000073915464,0.00014672974,0.00020448568,0.0003204231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023637929,0.00014059943,0.00044837035,0.0007190551,0.00007677068,0.000020405445,0.000066003275,0.00007081578,0.00007277921],"category_scores_gemma":[0.00012196675,0.00010217114,0.000068617584,0.0009437658,0.00013963346,0.00008021582,0.000029665045,0.00066466606,0.0000013616158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007664604,0.00037547294,0.986793,0.0010916647,0.0005889627,0.000041133535,0.0030322187,0.0000029040548,0.0012279901,0.000002907501,0.0023873195,0.0036899792],"study_design_scores_gemma":[0.0013700452,0.0026102609,0.98953176,0.00080176,0.00004844778,0.0000030193085,0.0016050254,0.000013256565,0.00051570125,0.0000019092674,0.0034042061,0.00009458701],"about_ca_topic_score_codex":0.08241165,"about_ca_topic_score_gemma":0.028618071,"teacher_disagreement_score":0.053793576,"about_ca_system_score_codex":0.003013598,"about_ca_system_score_gemma":0.0033814132,"threshold_uncertainty_score":0.98910713},"labels":[],"label_agreement":null},{"id":"W4393086019","doi":"10.1158/1538-7445.am2024-4529","title":"Abstract 4529: Characterization of PARP inhibitor combination therapies in triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"PARP inhibitor; Breast cancer; Triple-negative breast cancer; Cancer; Oncology; Medicine; Internal medicine; Poly ADP ribose polymerase; Biology; Genetics; Polymerase; DNA","score_opus":0.07488099161520893,"score_gpt":0.42956798928539136,"score_spread":0.3546869976701824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98621976,0.0025231435,0.000026322647,0.0084399115,0.0006095169,0.0009756116,0.0004037955,0.00006354581,0.00073839293],"genre_scores_gemma":[0.9927653,0.0045752875,0.000013529772,0.00013164738,0.00053013663,0.00085273635,0.00006145174,0.000045924786,0.0010239531],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99790704,0.00014551982,0.00041004198,0.0003770185,0.0007969335,0.00036344063],"domain_scores_gemma":[0.99883807,0.00019249781,0.000075269505,0.00022526184,0.000569301,0.00009958131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083131134,0.00014923478,0.00030119647,0.00066168566,0.00006590023,0.000054638098,0.00011443186,0.00012791163,0.0026166602],"category_scores_gemma":[0.00004506969,0.00013167511,0.00007297868,0.0013579729,0.00027365875,0.0003174264,0.000030306674,0.0006028353,0.000033108154],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010917145,0.000221204,0.008003208,0.0007594979,0.00011549271,0.00002802008,0.003414867,0.000007198352,0.93861794,0.0006887929,0.0018696291,0.045182414],"study_design_scores_gemma":[0.0038060693,0.00021453822,0.55137444,0.004220704,0.00001957795,0.000012839288,0.00048100593,0.00030611092,0.4332083,0.0012274432,0.004909717,0.00021926296],"about_ca_topic_score_codex":0.0012166708,"about_ca_topic_score_gemma":0.00021000707,"teacher_disagreement_score":0.54337126,"about_ca_system_score_codex":0.0009589373,"about_ca_system_score_gemma":0.0009102722,"threshold_uncertainty_score":0.99829507},"labels":[],"label_agreement":null},{"id":"W4393086036","doi":"10.1158/1538-7445.am2024-6029","title":"Abstract 6029: 225Ac/89Zr labeled anti nectin 4 radioimmunoconjugates as theranostics against nectin 4 positive triple negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Triple-negative breast cancer; Cancer; Medicine; Breast cancer; Triple negative; Internal medicine; Oncology","score_opus":0.03006825370737185,"score_gpt":0.362794429156805,"score_spread":0.3327261754494331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282018,0.057142872,0.0000064822502,0.0038059673,0.00317196,0.0010247602,0.0010740322,0.00022425439,0.0053478763],"genre_scores_gemma":[0.97914606,0.010834744,0.000009124404,0.00046915017,0.0005265096,0.0006011779,0.00013634565,0.00009673318,0.008180147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961613,0.0006908575,0.0004976447,0.0010292646,0.00019019333,0.0014307526],"domain_scores_gemma":[0.9975096,0.0011515489,0.00010807534,0.00047888065,0.00064835936,0.00010354624],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010088142,0.0004444182,0.000623413,0.0004314845,0.00077683915,0.00019880827,0.00063072966,0.000559702,0.008586562],"category_scores_gemma":[0.00022420486,0.00036979042,0.00021677394,0.0011657032,0.0009165419,0.00020881175,0.00021695707,0.0022205173,0.0012311817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011278099,0.00014826815,0.001518992,0.000118184995,0.001167209,0.00012521292,0.002057583,0.000036409543,0.90331274,0.00058396655,0.026159123,0.06364452],"study_design_scores_gemma":[0.004396899,0.0008310592,0.062367428,0.0012064693,0.0001380268,0.00035466076,0.0025289538,0.00003400811,0.8281174,0.0011109266,0.09781407,0.0011001076],"about_ca_topic_score_codex":0.015316345,"about_ca_topic_score_gemma":0.0015590705,"teacher_disagreement_score":0.075195335,"about_ca_system_score_codex":0.0007544935,"about_ca_system_score_gemma":0.0015734049,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W4393086058","doi":"10.1158/1538-7445.am2024-5561","title":"Abstract 5561: Whole slide Imaging Mass Cytometry allows the rapid profiling of the immune landscape of histopathologically aggressive prostate tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Mass cytometry; Pathology; Prostate; Medicine; Immune system; Biology; Immunology; Cancer; Internal medicine","score_opus":0.043471730883069895,"score_gpt":0.37962980912157046,"score_spread":0.3361580782385006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8826479,0.10077187,0.000011849782,0.0096186055,0.0002838116,0.0018038383,0.00017299103,0.00004831718,0.0046408214],"genre_scores_gemma":[0.99315363,0.0030116595,0.000081612416,0.000038591537,0.00016339344,0.000377613,0.000024467265,0.000043491713,0.0031055238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99687123,0.00024560018,0.00048071519,0.00043577203,0.0012898253,0.0006768327],"domain_scores_gemma":[0.99797654,0.00044036243,0.00016584464,0.0006517772,0.00064672896,0.00011875411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022209527,0.00018948741,0.00039156486,0.00033995186,0.00023796801,0.000064833424,0.0005348231,0.00007335798,0.00041333592],"category_scores_gemma":[0.00038063398,0.00008964498,0.00023497679,0.0013912268,0.0009816017,0.00010808525,0.00028153,0.0011764307,0.000022559414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086964126,0.0000979082,0.03928816,0.001614921,0.00015726876,0.00065010815,0.0012318505,0.000026261196,0.9350068,0.00010524787,0.0017950718,0.019156778],"study_design_scores_gemma":[0.0019163765,0.00043179598,0.13051137,0.0050304737,0.00009691638,0.00008267847,0.0024727474,0.0004724458,0.85367364,0.00045485338,0.00464449,0.00021218322],"about_ca_topic_score_codex":0.00016976755,"about_ca_topic_score_gemma":0.000005312449,"teacher_disagreement_score":0.11050575,"about_ca_system_score_codex":0.00033814425,"about_ca_system_score_gemma":0.0013349483,"threshold_uncertainty_score":0.51110715},"labels":[],"label_agreement":null},{"id":"W4393086094","doi":"10.1158/1538-7445.am2024-7525","title":"Abstract 7525: Investigating B7-H3 as a checkpoint and antibody drug conjugate target across prostate cancer variants- both androgen receptor dependent and independent","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Androgen receptor; Conjugate; Antibody-drug conjugate; Medicine; Cancer; Drug; Cancer research; Prostate; Antibody; Oncology; Internal medicine; Monoclonal antibody; Pharmacology; Immunology; Mathematics","score_opus":0.0526785314060331,"score_gpt":0.43040853946832364,"score_spread":0.3777300080622905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92695254,0.06159388,0.0000030841586,0.007564097,0.0003435064,0.0020003805,0.00055967964,0.00012804894,0.00085480436],"genre_scores_gemma":[0.95502067,0.033519763,0.00013387168,0.00019298594,0.00043306142,0.00091997394,0.00012160238,0.00011758506,0.009540465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99504906,0.00019649878,0.00051245803,0.001235032,0.0015302408,0.0014767227],"domain_scores_gemma":[0.9978974,0.0002352672,0.00007903407,0.00041007515,0.0004248588,0.0009533793],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002553895,0.0004047565,0.00055623055,0.00032332054,0.0006066919,0.0006809757,0.00021730442,0.00019940706,0.0009936322],"category_scores_gemma":[0.00019253803,0.00031179716,0.00008856657,0.00070353266,0.00093149574,0.00042748105,0.0005051472,0.0014366821,0.00008028482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002090305,0.0002774914,0.20192285,0.0054807914,0.0013513576,0.0022114245,0.019573167,0.000019508216,0.7214123,0.0002922167,0.006476184,0.03889243],"study_design_scores_gemma":[0.018571364,0.001943072,0.15026137,0.013326296,0.00033027845,0.00062430557,0.013128999,0.0019131781,0.7220757,0.0040236744,0.071688265,0.0021134918],"about_ca_topic_score_codex":0.0083039785,"about_ca_topic_score_gemma":0.0006643675,"teacher_disagreement_score":0.06521208,"about_ca_system_score_codex":0.00086397404,"about_ca_system_score_gemma":0.0020941067,"threshold_uncertainty_score":0.9999334},"labels":[],"label_agreement":null},{"id":"W4393086096","doi":"10.1158/1538-7445.am2024-217","title":"Abstract 217: Establishment of a spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Organoid; Cancer; Biology; Phenotype; Cancer research; Lung cancer; Pathology; Cell biology; Medicine; Genetics; Gene","score_opus":0.056160142263670845,"score_gpt":0.37364340853799854,"score_spread":0.3174832662743277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759271,0.019713635,0.00011180401,0.00094462256,0.00019298124,0.0012085474,0.0011806244,0.000037631988,0.0006830298],"genre_scores_gemma":[0.9883639,0.008710419,0.00061236107,0.0001771222,0.00016741658,0.00044650942,0.000041810665,0.00007545199,0.001404968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971234,0.00007599813,0.0005322754,0.00067507086,0.00089468394,0.0006985339],"domain_scores_gemma":[0.99804497,0.0000991043,0.00012710365,0.0003939258,0.0007911268,0.00054379995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070215506,0.00029423006,0.0006803525,0.0003543211,0.000102088234,0.00006475069,0.0002342889,0.00019038223,0.00030255006],"category_scores_gemma":[0.00009043776,0.00024966162,0.00013538082,0.0010103426,0.00024032989,0.00010694736,0.00018444263,0.00060979225,0.0000038620333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052321376,0.00016703358,0.009210052,0.0056017907,0.00037154087,0.00001927915,0.0031887498,0.007075238,0.95398784,0.000017669468,0.009882033,0.009955535],"study_design_scores_gemma":[0.0018181144,0.0004157688,0.0067404616,0.0033232542,0.00029766577,0.0000013996896,0.00010677651,0.005821551,0.9792999,0.000046002115,0.0018303266,0.00029876365],"about_ca_topic_score_codex":0.021145843,"about_ca_topic_score_gemma":0.011986281,"teacher_disagreement_score":0.02531205,"about_ca_system_score_codex":0.0009440132,"about_ca_system_score_gemma":0.0032779097,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W4393086604","doi":"10.1158/1538-7445.am2024-3737","title":"Abstract 3737: Molecular and early clinical characterization of the anti-CD73 antibody S095024 (Sym024)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Antibody; Medicine; Immunology","score_opus":0.04168008365820456,"score_gpt":0.40535309119553203,"score_spread":0.36367300753732745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551633,0.04206631,0.000022358383,0.000730601,0.0011435936,0.00026198808,0.000036757476,0.000029671555,0.000545398],"genre_scores_gemma":[0.99652314,0.0022448618,7.3691797e-7,0.000039432372,0.0000113201295,0.000020761134,0.000026510046,0.000018005732,0.0011152088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986092,0.00029190778,0.0003396791,0.0003078833,0.00010127032,0.00035005866],"domain_scores_gemma":[0.9993895,0.000120068784,0.000050350787,0.00031492108,0.00011720567,0.000007923676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011031538,0.0001052698,0.00020348991,0.00012494576,0.00020672278,0.00005124099,0.0003222161,0.00019524373,0.00025845112],"category_scores_gemma":[0.00009640782,0.000073796204,0.00010606753,0.00041837266,0.0008424635,0.00010669229,0.0001731029,0.00079233997,0.000101153826],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027665197,0.000057676527,0.0040442636,0.00009830116,0.000087188324,0.0000048732322,0.0003627326,0.0000010533796,0.97262883,0.0012077488,0.000067054134,0.021412598],"study_design_scores_gemma":[0.00038839207,0.000086428976,0.66266626,0.00034191727,0.000021245614,0.0000069235602,0.00012236099,0.000006877996,0.29299545,0.00018176924,0.043059174,0.00012319825],"about_ca_topic_score_codex":0.0003044705,"about_ca_topic_score_gemma":0.0000013205632,"teacher_disagreement_score":0.6796334,"about_ca_system_score_codex":0.000020278443,"about_ca_system_score_gemma":0.00022608119,"threshold_uncertainty_score":0.3442367},"labels":[],"label_agreement":null},{"id":"W4393086609","doi":"10.1158/1538-7445.am2024-5112","title":"Abstract 5112: Discovery of nuclear envelope mislocalization in <i>MYC-</i>driven group 3 medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; National Research Council Canada; University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Envelope (radar); Biology; Group (periodic table); Computational biology; Cancer research; Chemistry; Computer science","score_opus":0.02097454862541558,"score_gpt":0.33246347981239543,"score_spread":0.31148893118697984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954269,0.002733464,0.00024001082,0.00018878697,0.00014635452,0.00019975958,0.00007306233,0.000009434893,0.0009822577],"genre_scores_gemma":[0.9954121,0.0036933261,0.0000656953,0.000057099853,0.00016051452,0.000038930175,0.00009174001,0.000034035067,0.00044654275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989027,0.000061779734,0.00019644949,0.00033256953,0.00022602767,0.00028050962],"domain_scores_gemma":[0.99959964,0.000021520164,0.00002160805,0.00023182547,0.00007773492,0.0000476824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000322533,0.0000940598,0.000112846596,0.00013591895,0.000037386682,0.000055859313,0.00022365384,0.00013638406,0.000073505376],"category_scores_gemma":[0.000041899097,0.00008920158,0.000059285325,0.00029355838,0.00013387966,0.000012888108,0.00014349754,0.00020765145,0.000015058762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009037266,0.000049731836,0.0010165384,0.00021465575,0.000032648502,0.000011485361,0.00012639408,0.00015467034,0.9890087,0.0007143824,0.005346072,0.0032343355],"study_design_scores_gemma":[0.00083337957,0.00042806653,0.01239075,0.00085567875,0.000015708161,0.000011580423,0.00041967636,0.0012524908,0.69617486,0.00029692546,0.28688192,0.00043896033],"about_ca_topic_score_codex":0.0003169947,"about_ca_topic_score_gemma":0.00068430434,"teacher_disagreement_score":0.29283386,"about_ca_system_score_codex":0.000069689995,"about_ca_system_score_gemma":0.00020129616,"threshold_uncertainty_score":0.3637535},"labels":[],"label_agreement":null},{"id":"W4393086675","doi":"10.1158/1538-7445.am2024-7101","title":"Abstract 7101: Remodeling of cancer cells by chemotherapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Medicine; Chemotherapy; Cancer research; Oncology; Internal medicine","score_opus":0.045937688480582314,"score_gpt":0.43977426361824146,"score_spread":0.39383657513765913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273576,0.0695508,0.0000670256,0.00070148025,0.00017564069,0.0003078619,0.00036443942,0.000015784706,0.0014593763],"genre_scores_gemma":[0.96512365,0.03074862,0.0000404775,0.000054323562,0.00033666112,0.00020478884,0.000054277436,0.000045477344,0.0033917304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983605,0.0000447016,0.00017054821,0.00044856156,0.00047996693,0.0004956866],"domain_scores_gemma":[0.99928534,0.000027760758,0.000021295418,0.00031705524,0.00020283021,0.00014571309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037031816,0.00012616353,0.0001354189,0.0001022851,0.00007598409,0.000061017043,0.00026619204,0.00010964888,0.0006173535],"category_scores_gemma":[0.00001528961,0.0001097767,0.00009451524,0.00027998994,0.00016301233,0.000006860081,0.0000892384,0.00026064756,0.000028969447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018015139,0.00004683396,0.00023291701,0.00014996904,0.000148389,0.000006288453,0.000049523213,0.00006625222,0.8873922,0.000011368097,0.063278496,0.048437618],"study_design_scores_gemma":[0.00036551256,0.00010926331,0.000118191696,0.00011805501,0.0000050710714,6.5439144e-7,0.000025093976,0.000086436856,0.8396947,0.000072234994,0.15931009,0.00009473052],"about_ca_topic_score_codex":0.0057577486,"about_ca_topic_score_gemma":0.0006441177,"teacher_disagreement_score":0.09603159,"about_ca_system_score_codex":0.00013816726,"about_ca_system_score_gemma":0.00062377285,"threshold_uncertainty_score":0.87040323},"labels":[],"label_agreement":null},{"id":"W4393086835","doi":"10.1158/1538-7445.am2024-937","title":"Abstract 937: Prioritizing treatment targets for an adolescent with metastatic processive malignancy using proteomics and personalized xenograft models within an actionable timeframe","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Calgary; Children's Hospital of Eastern Ontario; University of British Columbia","funders":"","keywords":"Malignancy; Medicine; Proteomics; Computational biology; Bioinformatics; Oncology; Internal medicine; Biology; Genetics","score_opus":0.23055866222886265,"score_gpt":0.463828122777998,"score_spread":0.23326946054913536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97656304,0.016943235,0.001023344,0.0006810857,0.00006909158,0.0044048424,0.00017935804,0.000075140335,0.00006086412],"genre_scores_gemma":[0.98175174,0.0015363112,0.012278457,0.000054660715,0.0002488539,0.0035913077,0.00007610451,0.000089622095,0.00037292717],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99799937,0.000052624568,0.00022702626,0.0006863019,0.0005100203,0.0005246774],"domain_scores_gemma":[0.99890697,0.00007204892,0.000054836768,0.00023609515,0.00038846605,0.0003415764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003604305,0.00024671998,0.0003716125,0.00022259796,0.0002997587,0.00023644025,0.00006236947,0.00006218728,0.000049347498],"category_scores_gemma":[0.000013125842,0.00017295418,0.00006623289,0.00028753869,0.00016224671,0.0004796405,0.000020950856,0.00024465765,0.0000019882104],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0392672,0.018598294,0.0139704235,0.04791035,0.01121079,0.0043786084,0.1003437,0.021664493,0.47520652,0.0091977855,0.0017354408,0.2565164],"study_design_scores_gemma":[0.04765474,0.041174322,0.00932691,0.03539742,0.0050713355,0.0012520091,0.021546239,0.45633617,0.35803625,0.010867491,0.010231544,0.0031055487],"about_ca_topic_score_codex":0.0021547084,"about_ca_topic_score_gemma":0.0005409347,"teacher_disagreement_score":0.43467167,"about_ca_system_score_codex":0.0014208137,"about_ca_system_score_gemma":0.0017694192,"threshold_uncertainty_score":0.7052867},"labels":[],"label_agreement":null},{"id":"W4393086997","doi":"10.1158/1538-7445.am2024-969","title":"Abstract 969: Tumor-agnostic ctDNA monitoring in patients with metastatic HR+/HER2- breast cancer receiving first-line CDK4/6 inhibitor and endocrine therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Metastatic breast cancer; Endocrine system; Internal medicine; Breast cancer; Hormone","score_opus":0.02934312723772911,"score_gpt":0.3457609927686588,"score_spread":0.31641786553092965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393086997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737569,0.024278624,0.000009889522,0.0006386124,0.00038128585,0.00050104066,0.00035426588,0.000014639474,0.00006472863],"genre_scores_gemma":[0.97830874,0.020211244,0.000057549732,0.000045245157,0.000777594,0.00036967077,0.000043504602,0.00006971591,0.000116728086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812233,0.00005208347,0.00025548798,0.0006091316,0.00038186496,0.00057906815],"domain_scores_gemma":[0.9990702,0.00018837852,0.00004164815,0.0002890125,0.00024098197,0.00016977647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031772308,0.00022653256,0.00021690204,0.0001784429,0.00012919493,0.00016590822,0.00018935345,0.000054586322,0.000120401855],"category_scores_gemma":[0.00010343897,0.00019138945,0.00004173326,0.00035999133,0.00012650003,0.000017445827,0.00015503958,0.0003846711,0.000005861242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016083276,0.00037564998,0.8476771,0.0007289616,0.00032459386,0.00018735997,0.00037213764,0.0022080017,0.0638769,0.000028832677,0.0026487308,0.07996341],"study_design_scores_gemma":[0.0035781595,0.0008247149,0.906844,0.0016965409,0.000031653726,0.000018220935,0.00011124455,0.00011803856,0.06566637,0.00010852892,0.020372532,0.00062996324],"about_ca_topic_score_codex":0.0025330877,"about_ca_topic_score_gemma":0.0016065362,"teacher_disagreement_score":0.07933345,"about_ca_system_score_codex":0.0002217517,"about_ca_system_score_gemma":0.00042054383,"threshold_uncertainty_score":0.7804636},"labels":[],"label_agreement":null},{"id":"W4393087127","doi":"10.1158/1538-7445.am2024-722","title":"Abstract 722: A cancer-associated fibroblast model to discover mechanisms of growth, survival, and treatment sensitivity in PAX3/7-FKHR fusion-positive alveolar rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Alveolar rhabdomyosarcoma; Rhabdomyosarcoma; Medicine; Oncology; PAX3; Cancer; Cancer research; Internal medicine; Biology; Sarcoma; Pathology","score_opus":0.07197862899406421,"score_gpt":0.3912124755162822,"score_spread":0.319233846522218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988956,0.002667128,0.00008085033,0.004812381,0.00008937679,0.0012881345,0.00076497387,0.00003762421,0.00036998265],"genre_scores_gemma":[0.996219,0.0026303942,0.0001254192,0.00007069216,0.00006675796,0.0005171091,0.00004318086,0.000053159216,0.0002743071],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997438,0.00017899324,0.00032202536,0.00066896965,0.00076692435,0.00062505674],"domain_scores_gemma":[0.9984117,0.00066991395,0.000041307227,0.0002791091,0.00028896215,0.00030896472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007249826,0.00027521333,0.0005874301,0.0004458834,0.00011377263,0.00006829439,0.000072172304,0.00013608506,0.00012301822],"category_scores_gemma":[0.000100544916,0.0002124563,0.00014093785,0.0007766946,0.0001241492,0.00013159949,0.0001492123,0.00033349864,0.00001532477],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033037807,0.0060519604,0.1457681,0.00126459,0.0024635012,0.0051865987,0.0076450114,0.0016371522,0.7450883,0.008412732,0.0025360011,0.07064227],"study_design_scores_gemma":[0.005203515,0.0019464708,0.54031414,0.006909801,0.0002579408,0.000025221387,0.000995373,0.008302991,0.43244618,0.002957274,0.00010487819,0.00053623243],"about_ca_topic_score_codex":0.028783495,"about_ca_topic_score_gemma":0.016341263,"teacher_disagreement_score":0.394546,"about_ca_system_score_codex":0.0017562083,"about_ca_system_score_gemma":0.00080481253,"threshold_uncertainty_score":0.9776839},"labels":[],"label_agreement":null},{"id":"W4393087180","doi":"10.1158/1538-7445.am2024-3299","title":"Abstract 3299: Harnessing PIKfyve as a therapeutic vulnerability in neuroendocrine prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Cancer; Medicine; Vulnerability (computing); Prostate; Oncology; Internal medicine; Computer science","score_opus":0.09684557134616648,"score_gpt":0.47790503663842276,"score_spread":0.3810594652922563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9281946,0.053327817,0.000023892373,0.015030407,0.00057266053,0.0012393399,0.000045661127,0.0002088123,0.0013568414],"genre_scores_gemma":[0.9908136,0.0025704352,0.000043336295,0.0005716504,0.00056376634,0.0014839038,0.000009267115,0.00011341427,0.0038306427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996472,0.00018956223,0.0004065306,0.00088656234,0.00095464225,0.0010906861],"domain_scores_gemma":[0.99850535,0.00032639795,0.000039352835,0.00055664993,0.00031174635,0.00026052774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078532525,0.00027851813,0.00042302645,0.00050500367,0.00016175181,0.00016156732,0.0002368994,0.00006014716,0.0026406322],"category_scores_gemma":[0.0001340964,0.00022966746,0.000107766085,0.0015107231,0.00046959877,0.00036141582,0.000113897586,0.0017995368,0.0001328178],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00221864,0.00020912371,0.020722019,0.0018535398,0.00015848654,0.0017052924,0.0020020523,0.00035408096,0.18648729,0.00049161795,0.00040884578,0.78338903],"study_design_scores_gemma":[0.008159648,0.00096957677,0.3852145,0.009647763,0.0001408257,0.0006016692,0.00223825,0.0020302502,0.17285568,0.025636246,0.3911535,0.0013520638],"about_ca_topic_score_codex":0.0044364766,"about_ca_topic_score_gemma":0.0008995467,"teacher_disagreement_score":0.78203696,"about_ca_system_score_codex":0.001507561,"about_ca_system_score_gemma":0.0019051236,"threshold_uncertainty_score":0.9982711},"labels":[],"label_agreement":null},{"id":"W4393087263","doi":"10.1158/1538-7445.am2024-948","title":"Abstract 948: A novel combinatorial therapy for lethal neuroendocrine prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Oncology; Internal medicine","score_opus":0.12911341980746494,"score_gpt":0.4749412569118677,"score_spread":0.3458278371044028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9213891,0.048652884,0.000018124667,0.020888036,0.0024708412,0.0043241093,0.0006180388,0.00021627093,0.0014226042],"genre_scores_gemma":[0.9628938,0.016429543,0.00004650645,0.00015081432,0.0021754722,0.0054447423,0.00009456442,0.0001272748,0.012637293],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967336,0.000049616858,0.0002758287,0.00072548934,0.0010548006,0.0011606289],"domain_scores_gemma":[0.9982642,0.00036270963,0.00002579659,0.0003692618,0.0006209723,0.00035706826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063730194,0.00024392369,0.00034944265,0.00039202964,0.0002787168,0.00021442225,0.00023339495,0.00007140017,0.0010236779],"category_scores_gemma":[0.00008769532,0.00017660431,0.00018729563,0.0008243312,0.00032555312,0.00017825095,0.00009605734,0.0009165774,0.000059195816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017735338,0.001289166,0.0074554393,0.0034526505,0.0011590951,0.0015687168,0.0012044962,0.000036728386,0.5933201,0.003330787,0.11212516,0.25732237],"study_design_scores_gemma":[0.018748173,0.0025158406,0.0084474,0.001345031,0.00007273274,0.000075222124,0.00016323211,0.00067617826,0.2523551,0.0025695486,0.71256196,0.00046955672],"about_ca_topic_score_codex":0.0017138019,"about_ca_topic_score_gemma":0.0000566451,"teacher_disagreement_score":0.6004368,"about_ca_system_score_codex":0.00071922946,"about_ca_system_score_gemma":0.0024053864,"threshold_uncertainty_score":0.9998895},"labels":[],"label_agreement":null},{"id":"W4393087308","doi":"10.1158/1538-7445.am2024-1869","title":"Abstract 1869: The AI-powered KisoSeek™ platform identifies functional anti-TROP2 heavy-chain antibodies with potent anti-cancer activity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PTC (Canada); Biotechnology Research Institute","funders":"","keywords":"Cancer; Antibody; Medicine; Cancer research; Computational biology; Immunology; Internal medicine; Biology","score_opus":0.13705381631061797,"score_gpt":0.45390233069392055,"score_spread":0.3168485143833026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638993,0.0050518643,0.00017252423,0.025773812,0.00018850458,0.0006655301,0.0001497399,0.000110040375,0.0039886762],"genre_scores_gemma":[0.9921041,0.002671272,0.000013087558,0.00033863744,0.0009327893,0.00050376065,0.000040346724,0.000034842426,0.0033611231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750656,0.000042898115,0.00020604243,0.000532674,0.0011291214,0.00058272015],"domain_scores_gemma":[0.99876183,0.00027945527,0.000032073134,0.00043739672,0.00028660573,0.00020264799],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007330767,0.0002045016,0.000264152,0.00012054121,0.00051160034,0.00026656876,0.00024084692,0.00010828736,0.0014440696],"category_scores_gemma":[0.000044896817,0.00012604709,0.00011885096,0.00069547613,0.00063355215,0.00024608843,0.000066657565,0.0013711357,0.000104283135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007531045,0.00035436338,0.0022361286,0.0012027393,0.00043472394,0.00018728683,0.00035741122,0.00013654072,0.95298535,0.0011686456,0.030183015,0.010000673],"study_design_scores_gemma":[0.00107499,0.0001321098,0.113098085,0.00075606816,0.00015936267,0.00013053551,0.0007418915,0.00070534425,0.8076404,0.00045132113,0.07477527,0.0003346501],"about_ca_topic_score_codex":0.00026120155,"about_ca_topic_score_gemma":0.00002544235,"teacher_disagreement_score":0.14534499,"about_ca_system_score_codex":0.00025235108,"about_ca_system_score_gemma":0.00060948776,"threshold_uncertainty_score":0.99946874},"labels":[],"label_agreement":null},{"id":"W4393087338","doi":"10.1158/1538-7445.am2024-2071","title":"Abstract 2071: Pre-clinical evidence for new camptothecin-peptide conjugates in the treatment of sortilin-positive colorectal cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Camptothecin; Colorectal cancer; Medicine; Oncology; Peptide; Conjugate; Internal medicine; Cancer research; Pharmacology; Cancer; Biology; Biochemistry","score_opus":0.23890152010350582,"score_gpt":0.5347413630396376,"score_spread":0.29583984293613175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93847835,0.05395254,0.0000064511096,0.0034353398,0.00031311627,0.0026122073,0.00014077217,0.000022134627,0.0010391136],"genre_scores_gemma":[0.96951216,0.025448048,0.000055252924,0.00007302783,0.00061038736,0.0014896631,0.000010802828,0.000025920452,0.0027747545],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99792814,0.00011324133,0.00045492998,0.00050294213,0.0005133037,0.00048743148],"domain_scores_gemma":[0.99577636,0.0035438952,0.000050775478,0.00025233254,0.00023939801,0.00013726432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082919607,0.00019092043,0.00047479864,0.00015205474,0.00011529581,0.00004628454,0.00016105466,0.00008258532,0.0002877989],"category_scores_gemma":[0.0002847626,0.00011060643,0.00024783678,0.00044778702,0.00039701315,0.000083776424,0.00002782183,0.00028127345,0.000011836893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047551576,0.0025006197,0.23469488,0.0024588716,0.004212305,0.00085115863,0.061044764,0.0001803619,0.021159112,0.00076746615,0.08564596,0.5389329],"study_design_scores_gemma":[0.0062719425,0.02089487,0.8852065,0.004020429,0.00051658,0.000021550828,0.0032881517,0.0003648952,0.037795596,0.00073540874,0.040544815,0.00033924606],"about_ca_topic_score_codex":0.016219195,"about_ca_topic_score_gemma":0.010313481,"teacher_disagreement_score":0.6505116,"about_ca_system_score_codex":0.0014875049,"about_ca_system_score_gemma":0.0024397103,"threshold_uncertainty_score":0.9903319},"labels":[],"label_agreement":null},{"id":"W4393087426","doi":"10.1158/1538-7445.am2024-1129","title":"Abstract 1129: A multifaceted study of X-Ray radiation therapy across diverse mouse tumor models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Radiation therapy; X-Ray Therapy; Medicine; Internal medicine","score_opus":0.08520245929482793,"score_gpt":0.4186385862950946,"score_spread":0.33343612700026665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97873366,0.019632244,0.000042239408,0.00004826674,0.0005735314,0.0006750771,0.00017279139,0.000020759262,0.00010143259],"genre_scores_gemma":[0.99058646,0.0069953743,0.000015801223,0.000030617477,0.0009264293,0.00024372705,0.000032287557,0.00003605146,0.0011332567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984042,0.00010666897,0.00020419559,0.0004541472,0.00042995063,0.0004008509],"domain_scores_gemma":[0.9991846,0.0000263263,0.000037557955,0.00039991218,0.00024765448,0.000103955776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063069334,0.00013297591,0.0001706823,0.00009514168,0.00012304247,0.00006961218,0.00026350652,0.00008734263,0.0000763346],"category_scores_gemma":[0.000039813236,0.00011694519,0.00008372466,0.00027767383,0.00011625655,0.000014913763,0.00012158654,0.0002483551,0.000011609434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035568635,0.00024044204,0.00015502943,0.00005221117,0.00016513179,0.000004732841,0.0030647335,0.002461427,0.9372164,0.00000908388,0.003994152,0.05228097],"study_design_scores_gemma":[0.0053165,0.0010596745,0.011402794,0.00006988717,0.000030637857,0.000002971011,0.007790307,0.0018468942,0.78528553,0.00007014249,0.18661737,0.00050726195],"about_ca_topic_score_codex":0.0024030453,"about_ca_topic_score_gemma":0.00052911125,"teacher_disagreement_score":0.18262322,"about_ca_system_score_codex":0.000054776505,"about_ca_system_score_gemma":0.0002983949,"threshold_uncertainty_score":0.47688866},"labels":[],"label_agreement":null},{"id":"W4393087438","doi":"10.1158/1538-7445.am2024-1457","title":"Abstract 1457: Decoding the molecular mechanisms related to mutations in the GNAQ/11 and BAP1 genes in ocular melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"GNAQ; BAP1; Melanoma; Gene; Cancer research; Genetics; Mutation; Biology; Medicine","score_opus":0.06384493593161968,"score_gpt":0.4285465839006315,"score_spread":0.36470164796901183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704037,0.008845515,0.00011451491,0.017964674,0.000056682715,0.0012755768,0.0000067791107,0.00002308215,0.0013095146],"genre_scores_gemma":[0.9978217,0.0006883855,0.00015826494,0.0002672401,0.00003225151,0.0005228572,0.000009357136,0.00003822843,0.00046171562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726915,0.000381211,0.00028177915,0.00044260448,0.001054661,0.0005706037],"domain_scores_gemma":[0.99859387,0.00066708407,0.000012685993,0.00043459775,0.00013796893,0.00015381053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003042137,0.00012661095,0.00017136481,0.000524594,0.00015047511,0.00017810178,0.0003423383,0.000102946324,0.00041558445],"category_scores_gemma":[0.00042376935,0.00007786475,0.000056655932,0.0020063706,0.0001466215,0.00006128067,0.00018864189,0.001030595,0.00011776928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011344298,0.00012095984,0.0034511315,0.0003911231,0.00007436834,0.005445222,0.0051370687,0.00040628162,0.9233819,0.018632933,0.001352803,0.041492756],"study_design_scores_gemma":[0.00518949,0.0013332957,0.25223854,0.004632421,0.0001446033,0.0008325783,0.021788497,0.021854378,0.5699732,0.043094996,0.07772388,0.0011941172],"about_ca_topic_score_codex":0.0016460363,"about_ca_topic_score_gemma":0.0011887101,"teacher_disagreement_score":0.35340872,"about_ca_system_score_codex":0.00029899456,"about_ca_system_score_gemma":0.00037124523,"threshold_uncertainty_score":0.45503584},"labels":[],"label_agreement":null},{"id":"W4393087447","doi":"10.1158/1538-7445.am2024-272","title":"Abstract 272: Novel role for eIF4E in homing of acute myeloid leukemia cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; Homing (biology); Cancer research; Medicine; Leukemia; Computational biology; Immunology; Biology; Ecology","score_opus":0.03817901272873336,"score_gpt":0.3738671664058164,"score_spread":0.33568815367708305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404216,0.0033320605,0.0003747494,0.00025910998,0.0001996766,0.00037747223,0.00014741508,0.000007588703,0.0012597624],"genre_scores_gemma":[0.9961989,0.0007079062,0.00029326885,0.00003339819,0.0002610805,0.00018060081,0.00004621947,0.000020385765,0.002258271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991423,0.000016895789,0.00015893558,0.00025843713,0.00017014018,0.00025333196],"domain_scores_gemma":[0.9996261,0.000027852568,0.000019466057,0.00017200866,0.00010512265,0.00004946335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045901202,0.00006997802,0.00008862815,0.00011677258,0.00003491371,0.000031273838,0.00016957776,0.00014114726,0.000046876987],"category_scores_gemma":[0.000038204995,0.000065469176,0.000060203434,0.00018103441,0.000071830924,0.0000061182727,0.0000751221,0.00022013285,0.000009091168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007551136,0.000014683931,0.000045254474,0.00009878183,0.00003101273,0.0000014816766,0.00005072782,0.000032743195,0.9855742,0.00011096363,0.0062583964,0.0077062524],"study_design_scores_gemma":[0.0002784974,0.000070668786,0.00027883545,0.00008162526,0.0000032529692,6.223726e-7,0.000048845544,0.00017881911,0.913726,0.00007187174,0.085193135,0.00006783133],"about_ca_topic_score_codex":0.00019247839,"about_ca_topic_score_gemma":0.00007930168,"teacher_disagreement_score":0.07893474,"about_ca_system_score_codex":0.00010087362,"about_ca_system_score_gemma":0.00048663054,"threshold_uncertainty_score":0.26697555},"labels":[],"label_agreement":null},{"id":"W4393087474","doi":"10.1158/1538-7445.am2024-1256","title":"Abstract 1256: RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Regulator; Suppressor; RNA splicing; Key (lock); Cancer research; Biology; Cancer; Genetics; Gene; Ecology","score_opus":0.04650345724214157,"score_gpt":0.3863577202305406,"score_spread":0.33985426298839905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699034,0.017440178,0.0000060689927,0.0023866652,0.00026030946,0.00080582645,0.000113217924,0.000051500174,0.00194588],"genre_scores_gemma":[0.99730194,0.00094483636,0.00009289106,0.00015192892,0.00024297948,0.0002410322,0.000007807508,0.0000758288,0.0009407339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736696,0.00006645547,0.000392041,0.00063552853,0.00087424536,0.0006647757],"domain_scores_gemma":[0.9988148,0.00016468677,0.000047233203,0.00049359276,0.00021864768,0.00026101503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080760673,0.0001909499,0.00043064854,0.000647076,0.00006377538,0.000057302284,0.0001656636,0.0001400481,0.0008253696],"category_scores_gemma":[0.00015648943,0.0001778643,0.000090156675,0.0010875065,0.0003410135,0.00010745434,0.00013523964,0.0010182442,0.000024470775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008923938,0.00006472698,0.0012747281,0.0027959358,0.00020796509,0.0010218658,0.003528688,0.00012002063,0.9644603,0.00089197524,0.017919345,0.006822062],"study_design_scores_gemma":[0.0039413557,0.0005874536,0.04278491,0.009168436,0.00010936628,0.00014146611,0.0007780085,0.0012150755,0.9077974,0.00094358984,0.032078344,0.0004545665],"about_ca_topic_score_codex":0.017198795,"about_ca_topic_score_gemma":0.0014624944,"teacher_disagreement_score":0.05666287,"about_ca_system_score_codex":0.0012409711,"about_ca_system_score_gemma":0.0018894239,"threshold_uncertainty_score":0.9893458},"labels":[],"label_agreement":null},{"id":"W4393087526","doi":"10.1158/1538-7445.am2024-7130","title":"Abstract 7130: Dysregulated DNA repaired elicited by type 1 PRMT inhibitor in clear cell renal cell carcinoma enables development of novel combination therapies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cancer research; DNA; Renal cell carcinoma; Clear cell renal cell carcinoma; Cell; Internal medicine; Medicine; Biology; Cell biology; Genetics","score_opus":0.029192293189840096,"score_gpt":0.3108372527927262,"score_spread":0.28164495960288616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98419106,0.014222169,0.000013472737,0.00015153443,0.00015323824,0.00026127364,0.000024191204,0.000015339667,0.0009677344],"genre_scores_gemma":[0.9962201,0.0009871528,0.00006695071,0.000015881968,0.00007562952,0.0000460741,0.00015283651,0.000032095424,0.0024032956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985647,0.000060355247,0.00030258487,0.000386246,0.00034558473,0.0003405231],"domain_scores_gemma":[0.999426,0.000022820992,0.0000492322,0.00018721253,0.00024341112,0.00007132214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004556534,0.00013508186,0.0001387967,0.00017723697,0.000077695404,0.000036658526,0.00018026686,0.00022509925,0.00004863096],"category_scores_gemma":[0.00001620673,0.00011390616,0.000048496117,0.00052869314,0.00012985399,0.000008745834,0.00007868066,0.000290734,0.000007371705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034219303,0.00014376805,0.00018467689,0.0003050478,0.00004164333,0.000006350664,0.00049904257,0.00010036918,0.9876834,0.0000073950932,0.008691822,0.0019942548],"study_design_scores_gemma":[0.00076624023,0.00023711887,0.0017080201,0.00018955064,0.000004588705,9.549966e-7,0.00016275365,0.00018324782,0.97006935,0.000010247417,0.026526995,0.00014093668],"about_ca_topic_score_codex":0.0002677033,"about_ca_topic_score_gemma":0.00009579713,"teacher_disagreement_score":0.017835174,"about_ca_system_score_codex":0.00016348044,"about_ca_system_score_gemma":0.000790993,"threshold_uncertainty_score":0.4644958},"labels":[],"label_agreement":null},{"id":"W4393087550","doi":"10.1158/1538-7445.am2024-1450","title":"Abstract 1450: Novel whole slide imaging modes for imaging mass cytometry reveal cellular and structural composition of mouse glioblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Glioblastoma; Flow cytometry; Pathology; Cytometry; Chemistry; Cancer research; Medicine; Biology; Molecular biology; Biochemistry; Phenotype; Gene","score_opus":0.026201794964217286,"score_gpt":0.3754828592860762,"score_spread":0.34928106432185896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98340845,0.011853527,0.0029869776,0.00037026464,0.00006487829,0.0004203348,0.0007770513,0.00001535382,0.00010313312],"genre_scores_gemma":[0.998196,0.00024753378,0.0005588008,0.000018055902,0.0002301897,0.00014252926,0.00018210635,0.00003985271,0.00038490252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985229,0.00003671429,0.00017548507,0.00044945691,0.00034286734,0.00047261393],"domain_scores_gemma":[0.9993198,0.000051070627,0.000029231804,0.00022874054,0.00023178032,0.00013941116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003602907,0.00013841716,0.00014509173,0.00022613931,0.00014997958,0.00013599187,0.00016551658,0.00005045354,0.0000181059],"category_scores_gemma":[0.00003110987,0.00012818168,0.00008146843,0.00020589906,0.00022013937,0.000023323406,0.00013040974,0.00019458731,0.0000027530816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042070245,0.000020954352,0.0015630473,0.00037855175,0.00008788004,0.000017386837,0.000038190683,0.000051051527,0.9864919,0.00003725951,0.0012663638,0.0096266745],"study_design_scores_gemma":[0.0008357759,0.00013949165,0.00088645256,0.00013340167,0.000013261728,0.000011408344,0.0000957853,0.002712562,0.9932487,0.00017746871,0.001611895,0.00013382002],"about_ca_topic_score_codex":0.0005797364,"about_ca_topic_score_gemma":0.0000587382,"teacher_disagreement_score":0.01478755,"about_ca_system_score_codex":0.0001279947,"about_ca_system_score_gemma":0.00019564242,"threshold_uncertainty_score":0.5227097},"labels":[],"label_agreement":null},{"id":"W4393087771","doi":"10.1158/1538-7445.am2024-7178","title":"Abstract 7178: Neuronal cells derived from iPSCs cell to evaluate neurotoxicity after 48 or 72 hours in high-through put screening format","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Neurotoxicity; Induced pluripotent stem cell; Medicine; Neuroscience; Biology; Internal medicine; Biochemistry; Toxicity; Embryonic stem cell","score_opus":0.08673244660932904,"score_gpt":0.38925106996653897,"score_spread":0.3025186233572099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309164,0.0010669726,0.001944534,0.0008435147,0.0008781753,0.00092187943,0.00017583335,0.00028506294,0.0007924052],"genre_scores_gemma":[0.9954441,0.00072524947,0.0018261325,0.00016994469,0.0005121607,0.0007328283,0.000014978397,0.00014483012,0.00042974594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948493,0.00024812494,0.00047643593,0.0007158089,0.0020168577,0.0016934457],"domain_scores_gemma":[0.9977569,0.0010321989,0.000016525473,0.00053755444,0.0001530639,0.00050373113],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017810448,0.00030124545,0.00031960473,0.00053918484,0.00011406853,0.00041974385,0.00084904506,0.00020613968,0.0033785193],"category_scores_gemma":[0.00028570447,0.00026612525,0.00009024274,0.0015036768,0.00019589985,0.0003929087,0.0006575654,0.002303837,0.0012812031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009765045,0.00011413883,0.0015115982,0.0015164638,0.0001023071,0.0016699949,0.0021041292,0.025302816,0.8616193,0.000011403076,0.038933102,0.06613827],"study_design_scores_gemma":[0.0015730052,0.00024993106,0.106433906,0.0018337327,0.000019590965,0.000004653527,0.00020347605,0.04259338,0.80619174,0.0004720596,0.03948744,0.0009371069],"about_ca_topic_score_codex":0.0023270654,"about_ca_topic_score_gemma":0.0004532089,"teacher_disagreement_score":0.1049223,"about_ca_system_score_codex":0.0005483047,"about_ca_system_score_gemma":0.00039301554,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W4393087838","doi":"10.1158/1538-7445.am2024-5169","title":"Abstract 5169: Circulating levels of ANGPTL3, PCSK9, apoCIII and lipoprotein (a) in high-grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université Laval","funders":"","keywords":"PCSK9; Medicine; Internal medicine; Ovarian cancer; Serous ovarian cancer; Endocrinology; Serous fluid; Cancer; Lipoprotein; Cholesterol; Oncology; LDL receptor","score_opus":0.06163891854085327,"score_gpt":0.3818024693202445,"score_spread":0.3201635507793912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95457256,0.041909967,0.000044531305,0.00058848155,0.0018250762,0.00039796164,0.00021584478,0.000014822495,0.0004307523],"genre_scores_gemma":[0.9898983,0.0033235108,0.000111333,0.000053908523,0.005504847,0.00024829368,0.000018541097,0.000045125824,0.00079611305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816185,0.0001018427,0.00029037488,0.0005596095,0.00036976568,0.00051655184],"domain_scores_gemma":[0.9993238,0.00004032088,0.000044506374,0.00032013317,0.00014198062,0.00012926669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007895219,0.00016403534,0.0002536373,0.00019934405,0.00008205135,0.00006738674,0.00020864473,0.00020051959,0.0002065124],"category_scores_gemma":[0.000083679784,0.0001592606,0.00006635224,0.00041649002,0.00020579401,0.000013686215,0.00015777347,0.00041351962,0.0000036445126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006297455,0.000028256974,0.0010953811,0.00041638582,0.00006830556,0.0000030461586,0.00033009582,0.00012929934,0.9104318,0.00035517607,0.0032491891,0.083830096],"study_design_scores_gemma":[0.0021654689,0.00019088353,0.16467522,0.0010425149,0.000038846512,0.000020465992,0.0004668445,0.00018253423,0.52292514,0.0011412214,0.30651,0.00064088457],"about_ca_topic_score_codex":0.015660822,"about_ca_topic_score_gemma":0.0056692194,"teacher_disagreement_score":0.38750666,"about_ca_system_score_codex":0.0001035372,"about_ca_system_score_gemma":0.0006465049,"threshold_uncertainty_score":0.99089396},"labels":[],"label_agreement":null},{"id":"W4393087932","doi":"10.1158/1538-7445.am2024-5179","title":"Abstract 5179: Tumor microenvironment (TME) biomarkers of TIGIT and PD-L1 immune checkpoint blockade in cervical cancer: An exploratory biomarker analysis from SKYSCRAPER-04 (SKY04) study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"TIGIT; Immune checkpoint; Blockade; Tumor microenvironment; Biomarker; Medicine; Cancer; Cervical cancer; Cancer research; PD-L1; Immunotherapy; Oncology; Internal medicine; Receptor; Chemistry","score_opus":0.060043761568762906,"score_gpt":0.37937197225120045,"score_spread":0.31932821068243755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93795794,0.058684886,0.00000448978,0.0014241387,0.00021418421,0.0012533953,0.00029874133,0.000052060324,0.00011014071],"genre_scores_gemma":[0.9918205,0.0069614486,0.000044711436,0.000084816376,0.0001614453,0.0006148001,0.00007653041,0.000079750374,0.00015600002],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99552596,0.00036530566,0.0010058356,0.0011646741,0.001158097,0.0007801487],"domain_scores_gemma":[0.99824625,0.0002410221,0.0001231941,0.00090206903,0.0001281449,0.00035929773],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020336583,0.00039513718,0.00090061536,0.0013963605,0.0001328783,0.00012681654,0.00037277638,0.0001723965,0.0034426358],"category_scores_gemma":[0.000033392495,0.00033814195,0.0003246114,0.0026228682,0.00069478096,0.00024850736,0.00022751432,0.00073073944,0.000019033405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006597436,0.0012375707,0.13327718,0.00042801772,0.0054634144,0.0004582161,0.0039705425,0.000015124893,0.8114902,0.0000010592861,0.00029374118,0.03676755],"study_design_scores_gemma":[0.0038150172,0.00066024804,0.9086615,0.00075674366,0.0006698508,0.0000065275403,0.007019277,0.0004857145,0.07398402,0.000028302607,0.0035302353,0.00038259255],"about_ca_topic_score_codex":0.032983836,"about_ca_topic_score_gemma":0.008250617,"teacher_disagreement_score":0.7753843,"about_ca_system_score_codex":0.001169688,"about_ca_system_score_gemma":0.00070370693,"threshold_uncertainty_score":0.9999071},"labels":[],"label_agreement":null},{"id":"W4393087951","doi":"10.1158/1538-7445.am2024-6325","title":"Abstract 6325: Lineage tracing defines responding CAR T cells in patients with B cell malignancies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Lineage (genetic); Cell lineage; Cancer research; Biology; Medicine; Genetics; Gene; Cellular differentiation","score_opus":0.06131275062229219,"score_gpt":0.3844948816443257,"score_spread":0.3231821310220335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393087951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897762,0.0028350495,0.000005879834,0.0004432155,0.00020022732,0.0010339346,0.000056533805,0.000081025115,0.0055679306],"genre_scores_gemma":[0.97607183,0.0006855978,0.00009015061,0.000045550576,0.0003356953,0.00019050944,0.000024751827,0.00010694093,0.02244899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962054,0.00015447443,0.00034108708,0.00065524015,0.001603855,0.001039939],"domain_scores_gemma":[0.998267,0.0005323162,0.000027260965,0.00048399335,0.00042023024,0.0002691865],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001731656,0.0002230953,0.00035408605,0.0015095604,0.00013348373,0.00019105458,0.00025310135,0.00014673146,0.0028227835],"category_scores_gemma":[0.000089729685,0.00017342629,0.00009076578,0.0022384706,0.00023051539,0.0001995784,0.00011160311,0.0014383411,0.00018894208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025309094,0.00022047965,0.047111545,0.001649279,0.000060550115,0.00077965466,0.0015436427,0.0001039079,0.93619704,0.00004484797,0.0028341895,0.0069239363],"study_design_scores_gemma":[0.0040033613,0.0010825102,0.10976627,0.0035768615,0.0000318774,0.000007514217,0.000771192,0.00018066747,0.8320726,0.00003334138,0.04802755,0.00044625677],"about_ca_topic_score_codex":0.00082952133,"about_ca_topic_score_gemma":0.00021815649,"teacher_disagreement_score":0.104124464,"about_ca_system_score_codex":0.00088098965,"about_ca_system_score_gemma":0.0009234567,"threshold_uncertainty_score":0.9980888},"labels":[],"label_agreement":null},{"id":"W4393088074","doi":"10.1158/1538-7445.am2024-2350","title":"Abstract 2350: Comparison of normalization methods for RT-qPCR microRNA expression in cancer datasets","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"microRNA; Normalization (sociology); Cancer; Computational biology; Expression (computer science); Medicine; Biology; Oncology; Bioinformatics; Cancer research; Internal medicine; Genetics; Computer science; Gene","score_opus":0.11423525296079882,"score_gpt":0.5301074416076776,"score_spread":0.4158721886468788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382683,0.046413302,0.012866494,0.00021968983,0.0002970924,0.0007971181,0.0010273614,0.000012312242,0.00009831062],"genre_scores_gemma":[0.9942667,0.0010026305,0.0027143855,0.000013818728,0.00022276439,0.0003838951,0.0012612918,0.000030674273,0.00010387013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876803,0.00014941081,0.00027319335,0.00036258984,0.00017710008,0.00026968165],"domain_scores_gemma":[0.9993622,0.00006892412,0.000052451356,0.00028536053,0.0001670964,0.00006400158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008298588,0.00009725896,0.00014142603,0.00015782275,0.00005249935,0.00003465595,0.0002081734,0.00013385493,0.00012230517],"category_scores_gemma":[0.00010704232,0.00009238408,0.000054009175,0.00026584807,0.000083826395,0.000012070406,0.000115283576,0.0001384997,0.0000024338128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017233842,0.000052263957,0.0011980053,0.0005335213,0.00002331108,6.677908e-7,0.000102217266,0.00056649226,0.9508637,0.000024338548,0.019518131,0.026944973],"study_design_scores_gemma":[0.00026416508,0.000042651296,0.004751336,0.0002854673,0.000007763572,3.369351e-7,0.000043225922,0.0011515783,0.89950895,0.00006901164,0.09378353,0.00009198376],"about_ca_topic_score_codex":0.00024962204,"about_ca_topic_score_gemma":0.00021528045,"teacher_disagreement_score":0.0742654,"about_ca_system_score_codex":0.000109161934,"about_ca_system_score_gemma":0.0003395929,"threshold_uncertainty_score":0.37673134},"labels":[],"label_agreement":null},{"id":"W4393088097","doi":"10.1158/1538-7445.am2024-3046","title":"Abstract 3046: The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cancer research; Cancer; Prostate cancer; Disease; Cell metabolism; Prostate; Estrogen; Cell growth; Signal transduction; Medicine; Biology; Internal medicine; Metabolism; Cell biology; Genetics","score_opus":0.04946783977888265,"score_gpt":0.4088317890626978,"score_spread":0.35936394928381515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7718252,0.21697637,0.0000018086091,0.008232458,0.00012312771,0.002424515,0.00008620283,0.00008199412,0.00024834904],"genre_scores_gemma":[0.9697889,0.023888338,0.000047070786,0.00007481069,0.00052605744,0.0029265569,0.000072702656,0.000057780115,0.0026177808],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721426,0.00013823372,0.00025421713,0.000722612,0.00096538686,0.0007052666],"domain_scores_gemma":[0.9985347,0.00012749691,0.00003839443,0.00033958675,0.00031823883,0.0006416063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012789225,0.00021449458,0.00023338394,0.00012953229,0.00045921406,0.0004649586,0.00010223841,0.000083740044,0.00023860062],"category_scores_gemma":[0.00006898094,0.0001207332,0.00006540254,0.00041997395,0.00045937352,0.0002905243,0.00015209704,0.00065133226,0.000008927077],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034097652,0.00036856416,0.06523906,0.00504697,0.000387384,0.0015205656,0.005648132,0.000016295047,0.19456743,0.00054628093,0.0048920885,0.71835744],"study_design_scores_gemma":[0.008346508,0.0015447148,0.09481328,0.008280079,0.0008386479,0.00012478768,0.0033904677,0.0026444595,0.59634,0.004383953,0.27798682,0.0013062811],"about_ca_topic_score_codex":0.0005329171,"about_ca_topic_score_gemma":0.00004883706,"teacher_disagreement_score":0.7170512,"about_ca_system_score_codex":0.0002488869,"about_ca_system_score_gemma":0.0018011393,"threshold_uncertainty_score":0.4923357},"labels":[],"label_agreement":null},{"id":"W4393088472","doi":"10.1158/1538-7445.am2024-5501","title":"Abstract 5501: Novel whole slide imaging modes for imaging mass cytometry unveil extensive cellular heterogeneity in human glioma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Glioma; Cytometry; Flow cytometry; Pathology; Medicine; Biology; Cancer research; Immunology; Phenotype","score_opus":0.04472834520750016,"score_gpt":0.4147246606184698,"score_spread":0.36999631541096967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593169,0.012127879,0.026864238,0.0003945102,0.000040727748,0.00047746245,0.000064284046,0.00005952047,0.0006544979],"genre_scores_gemma":[0.9975454,0.00019704802,0.00086335745,0.00009483752,0.00034004328,0.0003419739,0.00016153735,0.000077070654,0.00037873533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977179,0.00006684184,0.00031316865,0.00085298764,0.00036475065,0.0006843438],"domain_scores_gemma":[0.998775,0.000059194168,0.000042329346,0.00058160786,0.0004270126,0.0001148467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011702055,0.00021188546,0.00022812859,0.00062406686,0.00016550094,0.00025418124,0.00042901663,0.000098908626,0.000030577186],"category_scores_gemma":[0.00012836838,0.00021891313,0.00020221889,0.00062260684,0.00021003344,0.000026643285,0.000261506,0.000372771,0.0000086918135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003660198,0.000048337064,0.0015811535,0.00017133518,0.00006361257,0.0001199609,0.000031568732,0.00006746126,0.990267,0.000025025069,0.0044231247,0.0031648614],"study_design_scores_gemma":[0.0003085184,0.00003183041,0.00045908164,0.0001227258,0.000017847764,0.0000071486343,0.00016590001,0.002799578,0.9858643,0.00033351308,0.009649787,0.00023976446],"about_ca_topic_score_codex":0.0005723557,"about_ca_topic_score_gemma":0.00016888649,"teacher_disagreement_score":0.038228516,"about_ca_system_score_codex":0.00022225658,"about_ca_system_score_gemma":0.00019835502,"threshold_uncertainty_score":0.8927018},"labels":[],"label_agreement":null},{"id":"W4393088507","doi":"10.1158/1538-7445.am2024-4784","title":"Abstract 4784: PATHFINDER 2: A prospective study to evaluate safety and performance of a multi-cancer early detection test in a population setting","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pathfinder; Cancer; Medicine; Test (biology); Population; Prospective cohort study; Gerontology; Environmental health; Oncology; Internal medicine; Computer science; Biology; Library science","score_opus":0.03753463260634923,"score_gpt":0.41820715975400863,"score_spread":0.3806725271476594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974751,0.00084770494,0.00032585033,0.00010243165,0.000018549932,0.0011456069,0.000031110925,0.000014789786,0.000038863956],"genre_scores_gemma":[0.9983529,0.0003681031,0.0001477527,0.000013438154,0.000052911462,0.0009286236,0.0000074830327,0.000016823791,0.00011200033],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99900585,0.00006504052,0.00018441121,0.00039388528,0.00015019746,0.0002006266],"domain_scores_gemma":[0.999587,0.000023144776,0.000026665315,0.00017468754,0.00014541409,0.000043094762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007641374,0.00008595803,0.00009777542,0.00013050262,0.000082262566,0.000023062106,0.00008833477,0.00007503714,0.0000108603945],"category_scores_gemma":[0.00007185499,0.00007809426,0.000022332024,0.00033436183,0.00004795406,0.000006064575,0.000107808904,0.0002089184,0.0000018556894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016008454,0.00010789526,0.23812172,0.0000574407,0.000022392922,0.0000013949127,0.00033253245,0.00007055448,0.7314497,0.000006135045,0.000013544555,0.029656585],"study_design_scores_gemma":[0.00029341842,0.00062923774,0.8698163,0.000103404775,0.000006633024,0.0000012941789,0.00007869062,0.00091851753,0.12785806,0.000019559502,0.0001841158,0.00009076674],"about_ca_topic_score_codex":0.0011666691,"about_ca_topic_score_gemma":0.0013245539,"teacher_disagreement_score":0.6316946,"about_ca_system_score_codex":0.000084755375,"about_ca_system_score_gemma":0.00008063162,"threshold_uncertainty_score":0.31845912},"labels":[],"label_agreement":null},{"id":"W4393088519","doi":"10.1158/1538-7445.am2024-6853","title":"Abstract 6853: Spatial proteomic and transcriptomic characterization of the inflammatory landscape of formalin fixed paraffin embedded Barrett’s esophagus tissues","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Transcriptome; Esophagus; Pathology; Medicine; Biology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.03335307621718509,"score_gpt":0.3578801222016462,"score_spread":0.32452704598446114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96872693,0.02835659,0.00001566985,0.0010568525,0.0001340591,0.001477321,0.00014078799,0.000027562655,0.000064249536],"genre_scores_gemma":[0.9978004,0.0011645177,0.000019143292,0.000014880326,0.00019293513,0.00035064563,0.000036183686,0.000029510862,0.00039179786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817073,0.00011327428,0.00033123908,0.0002760403,0.0007480389,0.00036068907],"domain_scores_gemma":[0.9992234,0.00007234732,0.00005557619,0.00029332354,0.0002070073,0.00014833425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057731115,0.00013608877,0.00028637418,0.00022911023,0.0000822186,0.000037351605,0.00015794481,0.000093626855,0.00047160982],"category_scores_gemma":[0.000051701827,0.00008998733,0.0000928883,0.00034890976,0.0002714494,0.00013433036,0.00006176885,0.0004384355,0.000010640861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024961221,0.00018795046,0.104980595,0.005951272,0.00038864303,0.00015896765,0.004075166,0.000009710779,0.8473675,0.00040156007,0.0004717609,0.033510745],"study_design_scores_gemma":[0.0012123701,0.000331455,0.34303665,0.0007977449,0.00003659496,0.000009682043,0.000070857335,0.0003251035,0.6539425,0.000076327655,0.000094220304,0.00006649573],"about_ca_topic_score_codex":0.0004841606,"about_ca_topic_score_gemma":0.00015915032,"teacher_disagreement_score":0.23805605,"about_ca_system_score_codex":0.00013959508,"about_ca_system_score_gemma":0.000839325,"threshold_uncertainty_score":0.51637965},"labels":[],"label_agreement":null},{"id":"W4393088686","doi":"10.1158/1538-7445.am2024-684","title":"Abstract 684: DT-9045, a novel PAR2 inhibitor with best-in-class properties that reduces resistance to both EGFR-targeting therapies and immunotherapy in oncology models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada); Université de Montréal","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.1920960856307969,"score_gpt":0.44219075160412197,"score_spread":0.2500946659733251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88282895,0.08788749,0.000036635643,0.023557989,0.00016107343,0.0019566107,0.000028281971,0.000067840774,0.0034751561],"genre_scores_gemma":[0.9808235,0.012137507,0.00082933536,0.00026755143,0.0003880626,0.0019554358,0.000004081651,0.00013114295,0.0034633693],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995469,0.0002546964,0.0004884199,0.0010114809,0.0014604058,0.001316003],"domain_scores_gemma":[0.9983881,0.00047221303,0.000045187742,0.00046865837,0.00031869224,0.00030711616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031242324,0.00031826706,0.0006186901,0.0009872516,0.0001726652,0.00024219835,0.00035446556,0.0002222717,0.0001809235],"category_scores_gemma":[0.00015082699,0.00023167333,0.000054527012,0.0014511816,0.0006534401,0.0003760644,0.00015927145,0.001801261,0.000025885838],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010606325,0.00062083174,0.0059593935,0.0028177132,0.0002615335,0.0010078402,0.03344935,0.00046312468,0.8459761,0.00073613954,0.009009803,0.08909182],"study_design_scores_gemma":[0.014398089,0.00638335,0.01779065,0.04394982,0.00005615623,0.00013099816,0.047338895,0.0039475537,0.32069004,0.0019143507,0.5411493,0.0022507661],"about_ca_topic_score_codex":0.0033563105,"about_ca_topic_score_gemma":0.006909746,"teacher_disagreement_score":0.53213954,"about_ca_system_score_codex":0.0022675223,"about_ca_system_score_gemma":0.0031583542,"threshold_uncertainty_score":0.9447364},"labels":[],"label_agreement":null},{"id":"W4393088736","doi":"10.1158/1538-7445.am2024-7445","title":"Abstract 7445: Association between C-reactive protein and cognitive impairment in IDH-mutant gliomas","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mutant; Association (psychology); Cognitive impairment; Biology; Cognition; Neuroscience; Genetics; Psychology; Gene; Psychotherapist","score_opus":0.06306467728401892,"score_gpt":0.4247743827270802,"score_spread":0.36170970544306125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933303,0.003435286,0.0000013329978,0.0043624854,0.000044080218,0.0016170403,0.00010638694,0.000032346365,0.0010680045],"genre_scores_gemma":[0.9981865,0.000161554,0.000009267696,0.00001995306,0.00019909012,0.0011555528,0.00002725518,0.000022380953,0.00021844188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982494,0.00008744187,0.00018229513,0.0003629458,0.00065341865,0.0004645128],"domain_scores_gemma":[0.9990339,0.00048185748,0.000029260555,0.00009296488,0.00020439044,0.00015760573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010025832,0.00011647856,0.00022406204,0.00040735345,0.00007456867,0.00008690523,0.000037205275,0.00010654156,0.00017255727],"category_scores_gemma":[0.00018547864,0.000092084476,0.000046561443,0.00059286447,0.00005790852,0.00010359862,0.00005735498,0.0004959748,0.000063260006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005901409,0.00082528347,0.7712181,0.0008318107,0.001332333,0.002915436,0.0027805206,0.0000014517931,0.15151154,0.0002694975,0.001535468,0.066188425],"study_design_scores_gemma":[0.0020673575,0.00048944383,0.8068338,0.0022278128,0.00009775695,0.0000066559865,0.0005616965,0.000026829357,0.18637514,0.00036502923,0.000837037,0.00011146839],"about_ca_topic_score_codex":0.0018699198,"about_ca_topic_score_gemma":0.0002572412,"teacher_disagreement_score":0.06607696,"about_ca_system_score_codex":0.0015762378,"about_ca_system_score_gemma":0.00036676292,"threshold_uncertainty_score":0.41218072},"labels":[],"label_agreement":null},{"id":"W4393088747","doi":"10.1158/1538-7445.am2024-7453","title":"Abstract 7453: Psychometric analysis of Neuro-QoL Perceived Cognitive Function tool in primary brain tumor patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Brain function; Psychology; Medicine; Clinical psychology; Brain tumor; Gerontology; Neuroscience; Psychiatry","score_opus":0.1031312617354489,"score_gpt":0.39163462689207745,"score_spread":0.28850336515662856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965075,0.000111906375,0.00007798034,0.0004490458,0.00032907608,0.00047292717,0.000090109446,0.00005375106,0.001907651],"genre_scores_gemma":[0.9988289,0.000091071655,0.0000019573363,0.0004532572,0.000045195604,0.0002097563,0.00001859715,0.000020879608,0.00033039032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976666,0.00029205787,0.00032513996,0.00062570185,0.0007715884,0.0003189206],"domain_scores_gemma":[0.9982032,0.001244053,0.00006229954,0.00021406151,0.00021457887,0.00006179636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068083307,0.00010909329,0.00019510106,0.0030011828,0.000098854245,0.0001038844,0.00019240049,0.000051851097,0.0006816546],"category_scores_gemma":[0.001872879,0.000103435596,0.00011295821,0.011007486,0.00017970752,0.0002522539,0.000044203018,0.00056196516,0.00009059085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005604133,0.00041117024,0.014495966,0.00026666175,0.00008559721,0.00001902461,0.0006063138,0.00016568838,0.90294397,0.0003002262,0.00086327264,0.07928171],"study_design_scores_gemma":[0.0005161923,0.00014654727,0.98216677,0.00010075718,0.000047154823,6.687072e-7,0.00010447543,0.0009610099,0.015108072,0.00013163424,0.0006109568,0.00010573946],"about_ca_topic_score_codex":0.00015441659,"about_ca_topic_score_gemma":0.000071032715,"teacher_disagreement_score":0.9676708,"about_ca_system_score_codex":0.00041517336,"about_ca_system_score_gemma":0.0002661522,"threshold_uncertainty_score":0.746364},"labels":[],"label_agreement":null},{"id":"W4393088752","doi":"10.1158/1538-7445.am2024-1529","title":"Abstract 1529: Development of lymphoid aggregates in metastatic uveal melanoma tumors treated with tebentafusp","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Melanoma; Medicine; Pathology; Metastatic melanoma; Cancer research","score_opus":0.04583376854698679,"score_gpt":0.35220714041709666,"score_spread":0.3063733718701099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9229395,0.07594873,0.0000048057245,0.00011402016,0.00009801145,0.00031780062,0.000025818885,0.000037442613,0.00051386],"genre_scores_gemma":[0.9949179,0.0009458903,0.000058275557,0.0000110596775,0.000008596494,0.00019936821,0.0000453437,0.000031326363,0.0037821862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831885,0.00030105538,0.00038794448,0.0003146106,0.00012071776,0.0005568061],"domain_scores_gemma":[0.9992004,0.0004038859,0.000049082017,0.00022198568,0.00010396158,0.000020666885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008742688,0.00017304922,0.00031572796,0.00057349564,0.00013868134,0.000032760843,0.00027118082,0.00008997667,0.0017030569],"category_scores_gemma":[0.00003640634,0.00012409312,0.000050437837,0.00068793586,0.0004019017,0.00011508315,0.000057251786,0.00042753236,0.00022664534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025112182,0.0001804801,0.004685944,0.00023914206,0.0005453912,0.000120488854,0.002814497,0.000010252976,0.88786554,0.00012947152,0.00029775492,0.10059983],"study_design_scores_gemma":[0.0014785023,0.00030663275,0.022875875,0.0010410269,0.000012370976,0.00007029831,0.0009798284,0.0000026751861,0.940557,0.00003076393,0.03246514,0.0001798656],"about_ca_topic_score_codex":0.0016996872,"about_ca_topic_score_gemma":0.00037048577,"teacher_disagreement_score":0.10041996,"about_ca_system_score_codex":0.00029087704,"about_ca_system_score_gemma":0.0012833601,"threshold_uncertainty_score":0.9992095},"labels":[],"label_agreement":null},{"id":"W4393088833","doi":"10.1158/1538-7445.am2024-1287","title":"Abstract 1287: The ACCESS consortium: Advancing childhood cancer experience, science and survivorship in Canada","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Childhood cancer; Survivorship curve; Cancer; Cancer survivorship; Gerontology; Medicine; Internal medicine","score_opus":0.10585021170372749,"score_gpt":0.46023169604926206,"score_spread":0.35438148434553457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95528823,0.019883726,0.000002442583,0.02081194,0.0009944713,0.0009004145,0.000051257255,0.000051513176,0.0020160282],"genre_scores_gemma":[0.9938189,0.0031008183,0.00001109398,0.0017395908,0.0005185733,0.00057474,0.0000024789424,0.000045431578,0.000188412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994257,0.00018828824,0.0005043059,0.0009425439,0.0028280471,0.0012798541],"domain_scores_gemma":[0.99719834,0.001040617,0.000058166897,0.0006432142,0.00053982844,0.0005198268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004770105,0.00023855649,0.00039387884,0.0004831145,0.00048155332,0.00042758178,0.00085838645,0.00006599744,0.0006420633],"category_scores_gemma":[0.0011615119,0.00017627681,0.000042864074,0.0032275133,0.0013015228,0.0006197022,0.0004381685,0.0014102632,0.0000079716065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004138473,0.00018572564,0.8150598,0.00263116,0.00018191588,0.0007488545,0.03576658,0.00019091385,0.016713982,0.0010915417,0.02337631,0.10363937],"study_design_scores_gemma":[0.0006428931,0.000044528202,0.9634787,0.002085256,0.000016754087,0.00003464235,0.0076318244,0.00020954308,0.0097938385,0.00022376618,0.015527266,0.0003110225],"about_ca_topic_score_codex":0.97572374,"about_ca_topic_score_gemma":0.98489773,"teacher_disagreement_score":0.14841887,"about_ca_system_score_codex":0.0036116757,"about_ca_system_score_gemma":0.03174171,"threshold_uncertainty_score":0.97374743},"labels":[],"label_agreement":null},{"id":"W4393088906","doi":"10.1158/1538-7445.am2024-2311","title":"Abstract 2311: Precise assessment of cancer cell growth and survival by artificial intelligence","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BGC Engineering (Canada)","funders":"","keywords":"Cancer; Cancer survival; Medicine; Oncology; Internal medicine","score_opus":0.07129761671495684,"score_gpt":0.48214353162600854,"score_spread":0.4108459149110517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393088906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95341396,0.025818042,0.001408885,0.006386017,0.00064399967,0.00041320664,0.000055270946,0.000048962585,0.011811646],"genre_scores_gemma":[0.9879087,0.010754494,0.00024189547,0.000047064048,0.0003366173,0.00007393834,0.000009018294,0.000029081419,0.0005991566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982647,0.00007139212,0.0002576565,0.00034302718,0.0007198467,0.00034339],"domain_scores_gemma":[0.999104,0.00034138488,0.000028800643,0.00015726578,0.00015098874,0.00021754326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011102482,0.000102645565,0.00022746158,0.00011428272,0.00007340869,0.00007277183,0.00012850555,0.000064379296,0.00080829667],"category_scores_gemma":[0.00014044679,0.000082586346,0.00004651269,0.00030043747,0.00030212692,0.000075957796,0.00008175964,0.0008816769,0.000005145311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013254085,0.00020191706,0.0114984,0.0027719014,0.0001312909,0.000097332246,0.0006267789,0.000056507102,0.53163713,0.003382596,0.0091192415,0.44034433],"study_design_scores_gemma":[0.0016368532,0.0012745191,0.061684556,0.0067960965,0.00036371985,0.000029439272,0.0025341485,0.10479498,0.73407716,0.008554133,0.07716279,0.001091642],"about_ca_topic_score_codex":0.00540708,"about_ca_topic_score_gemma":0.00008929429,"teacher_disagreement_score":0.4392527,"about_ca_system_score_codex":0.00018188794,"about_ca_system_score_gemma":0.00057674834,"threshold_uncertainty_score":0.8850282},"labels":[],"label_agreement":null},{"id":"W4393089081","doi":"10.1158/1538-7445.am2024-4135","title":"Abstract 4135: First demonstration of magnetic particle imaging for sentinel lymph node identification","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Characterization and Applications of Magnetic Nanoparticles","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sentinel lymph node; Medicine; Internal medicine; Cancer; Breast cancer","score_opus":0.04057551239130263,"score_gpt":0.34127451235129086,"score_spread":0.3006989999599882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98801225,0.0033709905,0.00541957,0.0019669307,0.00014990123,0.0003521648,0.000051064577,0.00017064273,0.00050647825],"genre_scores_gemma":[0.9987668,0.00035297594,0.00011479936,0.000008159302,0.000100459656,0.00044994554,0.000022095217,0.000023923552,0.00016084708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991768,0.0000101701435,0.00024944768,0.00016167127,0.0001941312,0.0002077695],"domain_scores_gemma":[0.9994766,0.00012551353,0.00001498914,0.00017770949,0.00015416047,0.00005100071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033072158,0.00006413205,0.00006905544,0.00009678267,0.00008171353,0.00012904221,0.00011679993,0.000025335941,0.0001989786],"category_scores_gemma":[0.000030468638,0.000068273446,0.00003374717,0.00037768518,0.00007088025,0.00014701244,0.000015344793,0.00006718241,0.000051739302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000697514,0.000021808572,0.0015424459,0.00047463545,0.000007388985,5.7800963e-7,0.00011665291,0.0012590381,0.96132183,0.0020403278,0.001489556,0.031718764],"study_design_scores_gemma":[0.00032254163,0.0000053105423,0.08486934,0.00016391599,0.000016977687,0.000001754844,0.00011914617,0.27957627,0.62672687,0.0006860225,0.00737241,0.00013941329],"about_ca_topic_score_codex":0.000016453889,"about_ca_topic_score_gemma":0.0000045782826,"teacher_disagreement_score":0.33459494,"about_ca_system_score_codex":0.00006400853,"about_ca_system_score_gemma":0.000047855858,"threshold_uncertainty_score":0.27841103},"labels":[],"label_agreement":null},{"id":"W4393089137","doi":"10.1158/1538-7445.am2024-1675","title":"Abstract 1675: Investigating the role of SRC-family kinases in MPNST tumorigenesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Institute for Research in Immunology and Cancer","funders":"","keywords":"Carcinogenesis; Kinase; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Biology; Medicine; Cancer; Genetics","score_opus":0.10988932173833389,"score_gpt":0.425393810406268,"score_spread":0.3155044886679341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586828,0.030388718,5.950512e-7,0.0010302876,0.00028039768,0.00047428452,0.000020698853,0.000031621123,0.009090639],"genre_scores_gemma":[0.99804616,0.0008881575,0.00006618164,0.00013355953,0.00031601367,0.00026984193,0.0000032319656,0.00003653329,0.00024034362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798733,0.000101019294,0.00029506214,0.0003304569,0.00084181,0.00044430076],"domain_scores_gemma":[0.99869466,0.00059647084,0.000028572767,0.0003487139,0.00021025725,0.000121323064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010958341,0.00011899788,0.00021851846,0.0002734239,0.00007385817,0.00004212166,0.00025357548,0.00007773508,0.0003601526],"category_scores_gemma":[0.00040393768,0.00008174268,0.00006873468,0.0011290503,0.00044068482,0.000048869813,0.00011974345,0.00069543475,0.000040588955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008911309,0.00004156709,0.04550602,0.00058263814,0.000043465727,0.00005672166,0.001156614,0.00012887617,0.9076057,0.0002222147,0.0027523013,0.04181477],"study_design_scores_gemma":[0.00032053475,0.00023202275,0.30796945,0.0016836193,0.000022113947,0.000007860457,0.0024273738,0.00045097218,0.6660154,0.0019789762,0.018752128,0.00013956713],"about_ca_topic_score_codex":0.0036732885,"about_ca_topic_score_gemma":0.00048699667,"teacher_disagreement_score":0.26246345,"about_ca_system_score_codex":0.0004236071,"about_ca_system_score_gemma":0.0013709716,"threshold_uncertainty_score":0.5552938},"labels":[],"label_agreement":null},{"id":"W4393089166","doi":"10.1158/1538-7445.am2024-4168","title":"Abstract 4168: Pre-clinical demonstration of Raman spectroscopy-assisted photothermal therapy for prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ProAmpac (Canada); Polytechnique Montréal; McGill University","funders":"","keywords":"Prostate cancer; Photothermal therapy; Raman spectroscopy; Cancer; Prostate; Medicine; Oncology; Internal medicine; Materials science; Nanotechnology; Optics; Physics","score_opus":0.0704719711603808,"score_gpt":0.5016808585310589,"score_spread":0.43120888737067814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845155,0.01069622,0.0006907323,0.00092995376,0.00022647623,0.0011331482,0.00024387319,0.00004526706,0.0015188503],"genre_scores_gemma":[0.97730684,0.0169305,0.00069411454,0.00008393595,0.000858194,0.0014304082,0.00012105656,0.00005021403,0.002524715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781483,0.000093724695,0.00039633052,0.0005756186,0.0005514766,0.00056802976],"domain_scores_gemma":[0.99896,0.00015634735,0.00004794848,0.0003293805,0.00032835736,0.0001779464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013083732,0.00015010049,0.0002092344,0.00009932568,0.00008819593,0.000067083914,0.00039641905,0.0002851459,0.00066534936],"category_scores_gemma":[0.00014427026,0.000118196425,0.00015822373,0.0003440861,0.0006825996,0.000007803532,0.000099790006,0.0004995547,0.0000040259474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001146567,0.00014123536,0.00096703117,0.00021015777,0.00010557348,0.0000029523214,0.000025582462,6.9934686e-7,0.91438466,0.0000915298,0.042529143,0.040394846],"study_design_scores_gemma":[0.00047929503,0.0007728558,0.0032343876,0.00015163695,0.0000058372307,0.0000013004875,0.000013154906,0.00006514884,0.9043205,0.0004423834,0.09039207,0.000121475765],"about_ca_topic_score_codex":0.00022067298,"about_ca_topic_score_gemma":0.00006521963,"teacher_disagreement_score":0.047862925,"about_ca_system_score_codex":0.00009124458,"about_ca_system_score_gemma":0.00086327316,"threshold_uncertainty_score":0.7285109},"labels":[],"label_agreement":null},{"id":"W4393089268","doi":"10.1158/1538-7445.am2024-7335","title":"Abstract 7335: Characterizing germline variants in patients with small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; Western University","funders":"","keywords":"Germline; Cancer; Lung cancer; Medicine; Oncology; Internal medicine; Biology; Cancer research; Genetics; Gene","score_opus":0.06340972096898669,"score_gpt":0.4157031245460039,"score_spread":0.3522934035770172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786176,0.013053438,0.0000073876627,0.0031503201,0.00034959416,0.0016603288,0.00014679227,0.00009774849,0.00291676],"genre_scores_gemma":[0.9912442,0.003075665,0.0000743887,0.00017406554,0.0006417898,0.0011187798,0.00004113897,0.00010460798,0.0035253435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996078,0.00010162464,0.00034997778,0.00079126045,0.0014322962,0.0012468462],"domain_scores_gemma":[0.99832165,0.00023324134,0.000040339095,0.00045840637,0.00062169775,0.0003246563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001023268,0.00026470065,0.00044325122,0.0006877594,0.00016398384,0.00015687155,0.00028166527,0.00011582004,0.0014409206],"category_scores_gemma":[0.00011032495,0.00019592338,0.00006964002,0.0014202608,0.00022824726,0.00024668095,0.00024349379,0.0015842658,0.000075749755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028947724,0.00065314997,0.88638955,0.009046762,0.00060188305,0.0011717761,0.0026995083,0.000037474158,0.041006226,0.000054639557,0.021251539,0.03419271],"study_design_scores_gemma":[0.0030856924,0.00032426685,0.9721655,0.0043974877,0.00005253033,0.0000019586444,0.000099677876,0.00019650791,0.0049663554,0.00001379315,0.01441389,0.00028233283],"about_ca_topic_score_codex":0.003404202,"about_ca_topic_score_gemma":0.0010726114,"teacher_disagreement_score":0.08577595,"about_ca_system_score_codex":0.0019384276,"about_ca_system_score_gemma":0.0018908508,"threshold_uncertainty_score":0.9994719},"labels":[],"label_agreement":null},{"id":"W4393089534","doi":"10.1158/1538-7445.am2024-3650","title":"Abstract 3650: Deep learning-based image cytometry and co-localization index in tumor immune microenvironment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Immune system; Tumor microenvironment; Flow cytometry; Cancer research; Cytometry; Index (typography); Medicine; Pathology; Immunology; Computer science; World Wide Web","score_opus":0.01977205213123029,"score_gpt":0.3898936218034814,"score_spread":0.3701215696722511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757111,0.012734852,0.0062293075,0.0038278066,0.000112914226,0.00041807262,0.000003960789,0.00007050595,0.0008914581],"genre_scores_gemma":[0.9977621,0.0011525882,0.00014266891,0.00024197788,0.00014772938,0.00006808028,0.000032257,0.000046165067,0.00040645272],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99829096,0.000116620475,0.00024243063,0.00037001164,0.00055968715,0.00042029307],"domain_scores_gemma":[0.9993694,0.0002170798,0.000025503408,0.00016303388,0.00004238525,0.00018260376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001451369,0.00011838943,0.00021254555,0.00057764753,0.00011235724,0.000114251394,0.00009277293,0.000063684754,0.0007234545],"category_scores_gemma":[0.0003611161,0.00010437241,0.000041807947,0.0005366979,0.00034125123,0.0000753245,0.000054155716,0.0015560242,0.000058606747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005312215,0.0002836046,0.3201656,0.0029670945,0.00010735998,0.0024134028,0.0010629237,0.0064879823,0.5366229,0.00005920909,0.0018178062,0.12748088],"study_design_scores_gemma":[0.002570679,0.00024968738,0.51103616,0.0019871895,0.000027424701,0.000062525505,0.0004224214,0.40117392,0.019191701,0.00008876034,0.06290869,0.00028084303],"about_ca_topic_score_codex":0.0006547543,"about_ca_topic_score_gemma":0.000016240048,"teacher_disagreement_score":0.5174312,"about_ca_system_score_codex":0.00040967876,"about_ca_system_score_gemma":0.00019149653,"threshold_uncertainty_score":0.792132},"labels":[],"label_agreement":null},{"id":"W4393090005","doi":"10.1158/1538-7445.am2024-831","title":"Abstract 831: Occupational-related exposure to benzene and risk of breast cancer: Systematic review and meta-analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Breast cancer; Medicine; Oncology; Cancer; Occupational exposure; Environmental health; Internal medicine","score_opus":0.058550985478502564,"score_gpt":0.4108469849702839,"score_spread":0.3522959994917813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5495113,0.4473931,0.000028296923,0.0010709468,0.000015733953,0.00068373414,0.0012509548,0.000004330426,0.000041628417],"genre_scores_gemma":[0.935753,0.0632127,0.00002892171,0.00009050042,0.00002488301,0.00040384123,0.00003230946,0.000012205828,0.00044167324],"study_design_codex":"bench_or_experimental","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99865115,0.00015844626,0.00030710205,0.00038400132,0.0003151541,0.000184152],"domain_scores_gemma":[0.99916923,0.00005088029,0.00005921179,0.0003114916,0.00029209538,0.00011711744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010529946,0.00011693803,0.0006009226,0.00015115392,0.00006922358,0.000045173456,0.0001107268,0.00007116394,0.00035981747],"category_scores_gemma":[0.000047082773,0.00008508699,0.00023138263,0.0005398836,0.00006139712,0.000004296609,0.00012029372,0.00013834193,0.00000269895],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016180944,0.00013316076,0.00865187,0.2509407,0.30547965,0.00002550586,0.0003877786,0.0011567079,0.42451468,0.00030779935,0.0072051296,0.0010352115],"study_design_scores_gemma":[0.0008658055,0.0008112514,0.2004909,0.00703695,0.7144537,0.00007535819,0.00043609174,0.00025418116,0.072122484,0.00017250274,0.0019978734,0.0012828887],"about_ca_topic_score_codex":0.001258246,"about_ca_topic_score_gemma":0.0008902781,"teacher_disagreement_score":0.40897408,"about_ca_system_score_codex":0.000035908757,"about_ca_system_score_gemma":0.00015930925,"threshold_uncertainty_score":0.3939749},"labels":[],"label_agreement":null},{"id":"W4393090123","doi":"10.1158/1538-7445.am2024-1264","title":"Abstract 1264: A targeted methylation-based multi-cancer early detection blood test preferentially detects high-grade prostate cancer and minimizes overdiagnosis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Overdiagnosis; Prostate cancer; Cancer; Medicine; Cancer detection; Blood test; Oncology; Methylation; Internal medicine; Cancer research; Biology; Gene; Genetics","score_opus":0.0675508575601891,"score_gpt":0.39294347940809304,"score_spread":0.32539262184790396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93906116,0.053373918,0.0000345462,0.0037304212,0.00040761195,0.0024337715,0.0006349996,0.0002700909,0.000053488613],"genre_scores_gemma":[0.9668765,0.023053594,0.00023342279,0.00006925413,0.00058436586,0.005780446,0.00006820741,0.00013539517,0.003198825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99579626,0.00016601561,0.0004438346,0.0011074707,0.0013479668,0.0011384252],"domain_scores_gemma":[0.9972129,0.0010184603,0.00008085132,0.00041694325,0.00073612045,0.0005347201],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007194371,0.0004129617,0.0005127669,0.0008616693,0.00044603768,0.0004025682,0.00019874952,0.000279246,0.0010000675],"category_scores_gemma":[0.00029837948,0.00032689824,0.00016090031,0.0014385734,0.00044221463,0.00034302767,0.00011807955,0.0012312754,0.00004261009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018082301,0.00075266574,0.052228633,0.0026689437,0.0011538662,0.00025318784,0.0011340012,0.00020183691,0.8336169,0.000007790359,0.0013336102,0.1048403],"study_design_scores_gemma":[0.006973706,0.0008321505,0.20139912,0.0018357638,0.00038688045,0.000003413976,0.00009028306,0.0016560308,0.783538,0.00007244579,0.0028261743,0.0003860706],"about_ca_topic_score_codex":0.012086818,"about_ca_topic_score_gemma":0.0033571802,"teacher_disagreement_score":0.14917049,"about_ca_system_score_codex":0.0008803781,"about_ca_system_score_gemma":0.0020640476,"threshold_uncertainty_score":0.9999183},"labels":[],"label_agreement":null},{"id":"W4393090197","doi":"10.1158/1538-7445.am2024-2085","title":"Abstract 2085: Targeting the translation initiation complex component eIF4G1 in melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; University of British Columbia","funders":"","keywords":"Translation (biology); Component (thermodynamics); Eukaryotic translation; Melanoma; Medicine; Computational biology; Biology; Computer science; Cancer research; Genetics; Messenger RNA; Physics","score_opus":0.12980046808830806,"score_gpt":0.42568631646270566,"score_spread":0.2958858483743976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077064,0.004172813,0.00026249883,0.0014464599,0.0001743154,0.00026352116,0.000017903567,0.000008987854,0.0028828904],"genre_scores_gemma":[0.99839157,0.0006606057,0.00006124992,0.000058867714,0.00032323654,0.00008981383,0.0003016907,0.000012150164,0.00010083246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908787,0.00013455602,0.00014987437,0.00020098519,0.00023572285,0.00019098438],"domain_scores_gemma":[0.9997348,0.00005956668,0.0000148581885,0.000108232154,0.000054290143,0.000028229959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000826534,0.000059547194,0.000051468443,0.0000703431,0.00009576109,0.00006792117,0.00011265904,0.00005922044,0.00020979844],"category_scores_gemma":[0.000024828274,0.00004597104,0.00002892044,0.00017134729,0.000052932042,0.0000064067176,0.00002501487,0.00018056402,0.000026278118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045191016,0.000014663896,0.00084662286,0.00005188506,0.000013212761,0.0000055169035,0.00039566174,0.00018980578,0.9803122,0.00021166379,0.0068928716,0.01102067],"study_design_scores_gemma":[0.0011622133,0.00022370425,0.12640508,0.00025131684,0.000012661447,0.000008105003,0.0012987041,0.007548703,0.6403879,0.0009816176,0.22135176,0.0003682102],"about_ca_topic_score_codex":0.00022274935,"about_ca_topic_score_gemma":0.00022121561,"teacher_disagreement_score":0.3399243,"about_ca_system_score_codex":0.0000533098,"about_ca_system_score_gemma":0.000088876666,"threshold_uncertainty_score":0.22971457},"labels":[],"label_agreement":null},{"id":"W4393090202","doi":"10.1158/1538-7445.am2024-6235","title":"Abstract 6235: Clinical and phenotypic consequences of HLA mediated antigen presentation deficiency in pancreatic adenocarcinoma at bulk and single-cell resolution","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Human leukocyte antigen; Presentation (obstetrics); Phenotype; Adenocarcinoma; Medicine; Antigen presentation; Antigen; Immunology; Cancer research; Biology; Cancer; Internal medicine; Genetics; T cell; Immune system; Gene; Surgery","score_opus":0.15168027346601193,"score_gpt":0.4341458578869346,"score_spread":0.2824655844209227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93646735,0.05964219,0.00000323439,0.0009830515,0.00006141114,0.00063275296,0.00003705015,0.000021337919,0.0021516543],"genre_scores_gemma":[0.9856134,0.0134179415,0.00004943921,0.00002037187,0.00010323686,0.000056570432,0.000018984578,0.00002147707,0.00069857674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975913,0.00023953931,0.0004852156,0.00048909604,0.0007373098,0.00045753215],"domain_scores_gemma":[0.99827766,0.0010432133,0.00004390772,0.00020409776,0.0002132386,0.00021789185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020362793,0.00011766532,0.00033251385,0.000491748,0.00010684551,0.000065985296,0.00009889918,0.00015622066,0.0003390981],"category_scores_gemma":[0.0004424496,0.00009778975,0.000042929365,0.0007331922,0.0012898804,0.00012812084,0.00013830594,0.0006106935,0.0000348331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010782921,0.00019352739,0.6286092,0.0016962636,0.000037128608,0.00019175796,0.00096996594,0.0000045079596,0.3561404,0.00018533609,0.0009672293,0.009926373],"study_design_scores_gemma":[0.0016341411,0.0006193479,0.970388,0.0008195461,0.00003030934,0.000027335445,0.00039097175,0.0010999986,0.022287628,0.00040038078,0.0021647287,0.00013763215],"about_ca_topic_score_codex":0.003315943,"about_ca_topic_score_gemma":0.0009629349,"teacher_disagreement_score":0.34177878,"about_ca_system_score_codex":0.00022042026,"about_ca_system_score_gemma":0.0006558533,"threshold_uncertainty_score":0.50127363},"labels":[],"label_agreement":null},{"id":"W4393090365","doi":"10.1158/1538-7445.am2024-6002","title":"Abstract 6002: Increased ferroptosis sensitivity and epithelial to mesenchymal transition of breast cancer cells overcoming chemotherapeutic mediated apoptotic caspase activation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apoptosis; Cancer research; Cancer; Medicine; Epithelial–mesenchymal transition; Breast cancer; Chemotherapeutic drugs; Internal medicine; Chemistry; Biochemistry; Metastasis","score_opus":0.05030107683782087,"score_gpt":0.3676002517234413,"score_spread":0.3172991748856204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942196,0.00060230313,0.00009573025,0.008148643,0.00014803855,0.000850833,0.00057214685,0.000066823355,0.000093526716],"genre_scores_gemma":[0.99764246,0.0011421234,0.000058630456,0.00037790777,0.00039883037,0.00024404816,0.000026368021,0.00006176418,0.000047881433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975428,0.00018435443,0.00032770514,0.00056805456,0.00085851917,0.00051858585],"domain_scores_gemma":[0.99853814,0.00039116153,0.000047483518,0.00024888394,0.0004289952,0.00034534934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010221639,0.00022671129,0.0004257551,0.00045829886,0.00013266914,0.00007514946,0.00007253425,0.00016315494,0.0007672253],"category_scores_gemma":[0.000052075313,0.00019919916,0.00011134357,0.0009811394,0.00019273057,0.00020786149,0.000044745924,0.0005467713,0.000017236474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011485035,0.00013854294,0.0007654585,0.0012134188,0.00019723387,0.000023688588,0.0013224963,0.00009127876,0.96919024,0.000016891652,0.00037028673,0.025521958],"study_design_scores_gemma":[0.0010435147,0.00019298363,0.071523,0.0020425466,0.00013479432,0.000020377998,0.00034594067,0.0027917137,0.92135555,0.00001158763,0.00031964175,0.00021837871],"about_ca_topic_score_codex":0.01423293,"about_ca_topic_score_gemma":0.00036010263,"teacher_disagreement_score":0.07075754,"about_ca_system_score_codex":0.0006002845,"about_ca_system_score_gemma":0.0006670708,"threshold_uncertainty_score":0.9923314},"labels":[],"label_agreement":null},{"id":"W4393090558","doi":"10.1158/1538-7445.am2024-5802","title":"Abstract 5802: An orally available small molecule JMBI-001 elicits MYC-synthetic lethality and anti-tumor immunity by disabling MKLP2-mediated cellular processes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Lethality; Synthetic lethality; Immunity; Cancer research; Small molecule; Cellular immunity; Medicine; Pharmacology; Chemistry; Immune system; Immunology; Biology; Toxicology; Biochemistry; Gene","score_opus":0.05799627455932033,"score_gpt":0.36522883100749076,"score_spread":0.30723255644817044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95710814,0.040532388,0.00002995478,0.0002389748,0.000072828465,0.0005345656,0.0005082462,0.000050162726,0.00092474686],"genre_scores_gemma":[0.98970294,0.007374647,0.00002778909,0.00005742437,0.00017969885,0.0003220444,0.0007905481,0.00007403776,0.0014708701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971008,0.00024370973,0.00026149003,0.00089563226,0.0005504867,0.00094790943],"domain_scores_gemma":[0.9984525,0.00010895362,0.000040470335,0.0005804529,0.0003866246,0.0004310229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834169,0.00026959102,0.00024659722,0.00014361665,0.00035883466,0.00041141408,0.0004437776,0.0001543944,0.00046963932],"category_scores_gemma":[0.00034828184,0.00024315485,0.000057078014,0.0005464699,0.0003974995,0.00003571705,0.00031873505,0.0005790585,0.00011543671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018954153,0.00030106556,0.0013318914,0.0008503432,0.00014443173,0.000113425376,0.000079272395,0.0000071295963,0.9891145,0.0000064441315,0.005798569,0.0020633773],"study_design_scores_gemma":[0.0008786247,0.00045488524,0.00044618014,0.00023940933,0.00002308724,0.000014051342,0.00013353412,0.00012197047,0.9508249,0.00006177597,0.046441607,0.00035993452],"about_ca_topic_score_codex":0.008940682,"about_ca_topic_score_gemma":0.0014443113,"teacher_disagreement_score":0.040643036,"about_ca_system_score_codex":0.000139458,"about_ca_system_score_gemma":0.00095172814,"threshold_uncertainty_score":0.99765885},"labels":[],"label_agreement":null},{"id":"W4393090648","doi":"10.1158/1538-7445.am2024-5795","title":"Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Cancer research; Degradation (telecommunications); Cell growth; Internal medicine; Biology; Medicine; Genetics; Computer science","score_opus":0.043518893897059846,"score_gpt":0.35792227037136676,"score_spread":0.31440337647430694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830098,0.0163128,0.00012953985,0.0001409375,0.000011667491,0.0002483782,0.00006444591,0.000008361254,0.00007402467],"genre_scores_gemma":[0.9872358,0.01219068,0.00025938495,0.0000062123618,0.00003232449,0.00002198169,0.000014642848,0.000012525939,0.00022644817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913555,0.000051632665,0.0001392738,0.00033672314,0.00016981557,0.00016699129],"domain_scores_gemma":[0.9994965,0.000027576853,0.000054642365,0.00008963268,0.00027059353,0.000061048464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039481468,0.00010272972,0.00015858987,0.0001416354,0.000063237334,0.00005001669,0.000038943133,0.000093674134,1.3842369e-7],"category_scores_gemma":[0.00002695477,0.00008189993,0.000013260803,0.00015997588,0.00029405433,0.0000122356,0.00010012204,0.00013413426,3.0311504e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006728904,0.000015310055,0.00039024744,0.0006404048,0.000046222453,0.0000013531976,0.00014699882,0.000006428849,0.99027836,0.000033739536,0.000097993056,0.008275663],"study_design_scores_gemma":[0.00014259928,0.00025150436,0.00090649835,0.00020344941,0.00001980272,0.0000056953295,0.00020512518,0.0010143064,0.9968276,0.00027504435,0.000054195163,0.000094204515],"about_ca_topic_score_codex":0.00036926943,"about_ca_topic_score_gemma":0.00014615372,"teacher_disagreement_score":0.008181457,"about_ca_system_score_codex":0.000018884077,"about_ca_system_score_gemma":0.0000871638,"threshold_uncertainty_score":0.33397824},"labels":[],"label_agreement":null},{"id":"W4393090680","doi":"10.1158/1538-7445.am2024-7408","title":"Abstract 7408: Robust profiling of cancer-related gene fusions: Analytical validation of PANCARNA for multiple cancer types","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Cancer; Profiling (computer programming); Computational biology; Biology; Medicine; Genetics; Computer science","score_opus":0.08376376817095889,"score_gpt":0.44316369947596146,"score_spread":0.3593999313050026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840302,0.012125726,0.0018772142,0.00047984967,0.00009098541,0.0007375868,0.00046827053,0.000023762492,0.0001663896],"genre_scores_gemma":[0.9911026,0.0055319094,0.0015576172,0.000013795968,0.00014471414,0.0011395558,0.00021742101,0.000026108253,0.00026627345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989214,0.00004315566,0.0002756938,0.00035542814,0.00016140688,0.00024290966],"domain_scores_gemma":[0.9991373,0.000057117875,0.000062207364,0.00026464657,0.00042367945,0.000055086035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042253544,0.000097098775,0.0001536161,0.000099285804,0.000072642346,0.000012383278,0.00019870092,0.00019817773,0.000085248554],"category_scores_gemma":[0.00008746939,0.000085224485,0.000105571955,0.00029127309,0.00014936004,0.000003706367,0.00007174193,0.00016618977,0.0000012077435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060863647,0.00004741607,0.0025346396,0.00021788414,0.000158691,6.1494825e-7,0.000023089764,0.00089796254,0.98979276,0.00053127814,0.001088072,0.004646702],"study_design_scores_gemma":[0.00018937433,0.00009170654,0.0007947908,0.00011395953,0.000039626066,6.199703e-7,0.000016025055,0.0019018265,0.9894942,0.00016686774,0.007100417,0.0000905836],"about_ca_topic_score_codex":0.000674489,"about_ca_topic_score_gemma":0.00012215265,"teacher_disagreement_score":0.007072389,"about_ca_system_score_codex":0.000054194414,"about_ca_system_score_gemma":0.00043876588,"threshold_uncertainty_score":0.34753534},"labels":[],"label_agreement":null},{"id":"W4393090748","doi":"10.1158/1538-7445.am2024-6642","title":"Abstract 6642: Exploring the x-ray psoralen activated cancer therapy mechanism of action in a genetically engineered mouse model of soft tissue sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer; Medicine; Soft tissue sarcoma; Sarcoma; Psoralen; Genetically modified organism; Genetically engineered; Cancer research; Mechanism of action; Pathology; Internal medicine; DNA; Biology; Genetics; Gene; In vitro","score_opus":0.15659739269055692,"score_gpt":0.4005203420942151,"score_spread":0.2439229494036582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885537,0.00989416,0.00023962434,0.00075881183,0.00014914827,0.00028472365,0.000059169008,0.0000099466215,0.000050711886],"genre_scores_gemma":[0.9830923,0.015851386,0.00005949827,0.0000257516,0.000116220384,0.0004660689,0.0000074970044,0.000020862244,0.0003604359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897873,0.00010151641,0.00019421225,0.00028174286,0.00015503945,0.00028878183],"domain_scores_gemma":[0.99949867,0.00007269756,0.00003030576,0.00022531743,0.00013974744,0.000033268756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042671117,0.00011318214,0.00016648712,0.00010681557,0.000059805614,0.0000073959245,0.00022864512,0.00017036744,0.000038426722],"category_scores_gemma":[0.00004886287,0.00008168056,0.000048101167,0.00019255842,0.00025251164,0.0000073317537,0.00009910904,0.00032096857,0.0000015556262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002799966,0.00005096661,0.00010588197,0.000071483606,0.00016028485,0.0000015659699,0.0002403514,0.0025575424,0.9821569,0.00023268774,0.0002525556,0.013889834],"study_design_scores_gemma":[0.00027202276,0.00017085436,0.0014835183,0.00004494635,0.0000057913803,3.9197573e-7,0.00010548349,0.0006183878,0.99581146,0.0002606007,0.0011459704,0.00008059589],"about_ca_topic_score_codex":0.00025915663,"about_ca_topic_score_gemma":0.00035147005,"teacher_disagreement_score":0.013809239,"about_ca_system_score_codex":0.00004439901,"about_ca_system_score_gemma":0.00024330882,"threshold_uncertainty_score":0.33308366},"labels":[],"label_agreement":null},{"id":"W4393090872","doi":"10.1158/1538-7445.am2024-2217","title":"Abstract 2217: Associations between intrauterine device use and ovarian cancer risk among 11 population-based case-control studies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Population; Oncology; Internal medicine; Gynecology; Environmental health","score_opus":0.13453900098400454,"score_gpt":0.4383096205294965,"score_spread":0.303770619545492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872657,0.0043298807,0.0001490308,0.006289193,0.0003332754,0.0006630538,0.0007381642,0.00012152045,0.000110151756],"genre_scores_gemma":[0.99723023,0.0010413073,0.00007508763,0.0002476839,0.0005994594,0.00024725386,0.000062303654,0.000037356873,0.00045934317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982915,0.00016755999,0.00029291213,0.00040144735,0.00045534477,0.00039121407],"domain_scores_gemma":[0.9977157,0.0013467558,0.000056484456,0.00022163895,0.00043487205,0.0002245131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773514,0.00015085995,0.00030925954,0.00035140887,0.00037477873,0.00020158463,0.000052579726,0.00011763954,0.00063827535],"category_scores_gemma":[0.0010082383,0.00012922293,0.00006844374,0.0006399903,0.0001318056,0.00025489408,0.000031638236,0.0005975796,0.000019404744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006996304,0.000029099672,0.98108643,0.00024530332,0.00061364763,0.00024094098,0.00035503277,0.00017495677,0.00006718684,0.0001542172,0.0040431446,0.012920079],"study_design_scores_gemma":[0.0015172644,0.00005063959,0.99163127,0.00025886192,0.0002929149,0.0000051436177,0.0003064756,0.0008813126,0.000044175,0.00016294356,0.004718205,0.0001307786],"about_ca_topic_score_codex":0.05525458,"about_ca_topic_score_gemma":0.021479566,"teacher_disagreement_score":0.033775013,"about_ca_system_score_codex":0.00056209986,"about_ca_system_score_gemma":0.00043813963,"threshold_uncertainty_score":0.99637586},"labels":[],"label_agreement":null},{"id":"W4393090873","doi":"10.1158/1538-7445.am2024-3127","title":"Abstract 3127: Development of three-dimensional cancer cell line spheroid models for the <i>in vitro</i> functional characterization of cytotoxic antibody-drug conjugates","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Spheroid; In vitro; Antibody-drug conjugate; Cytotoxic T cell; Cancer; Drug; Conjugate; Cell culture; Cancer cell lines; Cancer research; Antibody; Chemistry; Medicine; Biology; Cancer cell; Immunology; Pharmacology; Monoclonal antibody; Internal medicine; Biochemistry; Genetics; Mathematics","score_opus":0.12110038014965273,"score_gpt":0.4125313699256697,"score_spread":0.29143098977601695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789596,0.013691595,0.0016381243,0.0022940075,0.0004485643,0.0021534672,0.0005033489,0.000031345367,0.00027995725],"genre_scores_gemma":[0.9941565,0.001952242,0.0005065441,0.000079439335,0.00043877875,0.0012969173,0.00022719994,0.00007145531,0.0012709216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965534,0.000069659094,0.00067449285,0.00051062583,0.0015685024,0.0006233064],"domain_scores_gemma":[0.997711,0.00070177927,0.0000914145,0.0003546152,0.000993161,0.00014801373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021205314,0.0001972868,0.0004075566,0.00025072537,0.00014588656,0.000038377715,0.00027439976,0.00011993702,0.0012839492],"category_scores_gemma":[0.000060069855,0.00014331241,0.0001231726,0.0007443594,0.0003280972,0.00018864273,0.00014071584,0.000655823,0.000014849815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016815893,0.0001874888,0.0004354411,0.0024350015,0.00012715331,0.000009463135,0.00045789217,0.0016769296,0.9749223,0.00008550963,0.0011618193,0.016819442],"study_design_scores_gemma":[0.0011814613,0.00010141462,0.0064907405,0.00143547,0.000027149577,0.000002699176,0.000085502936,0.034957163,0.94982284,0.00018245423,0.0055684755,0.00014461532],"about_ca_topic_score_codex":0.0018938773,"about_ca_topic_score_gemma":0.0012160907,"teacher_disagreement_score":0.03328023,"about_ca_system_score_codex":0.0007847504,"about_ca_system_score_gemma":0.0049314187,"threshold_uncertainty_score":0.999629},"labels":[],"label_agreement":null},{"id":"W4393090887","doi":"10.1158/1538-7445.am2024-223","title":"Abstract 223: Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine","score_opus":0.0959895341810242,"score_gpt":0.4972038645440597,"score_spread":0.4012143303630355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9244088,0.035166357,0.00008679461,0.013774952,0.00046739765,0.002360637,0.00013848886,0.000057704554,0.023538882],"genre_scores_gemma":[0.98989797,0.0027700919,0.000118593125,0.00035002574,0.00042803507,0.0006121882,0.00001775688,0.000041571868,0.00576376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983619,0.000030285812,0.00026208488,0.000354839,0.0006655954,0.00032530626],"domain_scores_gemma":[0.9987987,0.00040662245,0.000029520774,0.00035934243,0.00019779756,0.0002079794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004094588,0.00015045806,0.00024203249,0.00027585027,0.00017438372,0.000034706012,0.00009768105,0.00006277684,0.00079418917],"category_scores_gemma":[0.000051405445,0.00007770874,0.00006460819,0.00052496,0.0002049705,0.000052251493,0.000024000377,0.00014996168,0.000018397084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018035581,0.00039833947,0.0066385292,0.0008957495,0.0008746428,0.00015151789,0.018734481,0.0003888392,0.042887177,0.0008423172,0.10814777,0.81823707],"study_design_scores_gemma":[0.005092325,0.0028573475,0.018393956,0.0039337627,0.00041600954,0.000011570517,0.002038063,0.0011113806,0.02193957,0.00025364867,0.9437525,0.00019985679],"about_ca_topic_score_codex":0.01486182,"about_ca_topic_score_gemma":0.0013701707,"teacher_disagreement_score":0.8356047,"about_ca_system_score_codex":0.0018411184,"about_ca_system_score_gemma":0.00121503,"threshold_uncertainty_score":0.9916983},"labels":[],"label_agreement":null},{"id":"W4393090913","doi":"10.1158/1538-7445.am2024-5604","title":"Abstract 5604: Modulating DNA repair through endo-exonuclease inhibition: a new therapeutic paradigm in oncology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Exonuclease; Cancer research; Medicine; DNA; Oncology; Internal medicine; Computational biology; Biology; Genetics; DNA polymerase","score_opus":0.09159522186155765,"score_gpt":0.4154772887217086,"score_spread":0.3238820668601509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981205,0.010386241,0.0001925631,0.0019546198,0.00031355178,0.0004762623,0.00001797826,0.00010258373,0.00535119],"genre_scores_gemma":[0.99580926,0.0008161341,0.00040895282,0.00035185582,0.0007403135,0.00019254319,0.00003522811,0.00005619862,0.0015895187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979687,0.00014502414,0.00027861394,0.0006728612,0.0003431306,0.0005916839],"domain_scores_gemma":[0.9992469,0.00007988453,0.000029980429,0.00044514562,0.00005761593,0.00014049002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075792155,0.00016318602,0.00017651556,0.0001262095,0.000092185386,0.000063017964,0.00019246194,0.00024522824,0.0004015342],"category_scores_gemma":[0.00008890776,0.00015841969,0.0001311205,0.00040017173,0.000120831086,0.00001676415,0.00017808782,0.00050742435,0.00009569541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013419183,0.00007881865,0.000102987295,0.00013068634,0.00007858341,0.00025606868,0.0005625631,0.00016054296,0.9597015,0.0042996802,0.0074563036,0.027038075],"study_design_scores_gemma":[0.0011144144,0.00069296866,0.0008432141,0.00037235432,0.000016489708,0.000051970554,0.00038515023,0.000884205,0.69204944,0.02404278,0.27914584,0.00040119377],"about_ca_topic_score_codex":0.00062354107,"about_ca_topic_score_gemma":0.0005028093,"teacher_disagreement_score":0.27168953,"about_ca_system_score_codex":0.00028771776,"about_ca_system_score_gemma":0.0010513099,"threshold_uncertainty_score":0.6460167},"labels":[],"label_agreement":null},{"id":"W4393090939","doi":"10.1158/1538-7445.am2024-5847","title":"Abstract 5847: Characterizing mechanisms of BRAF/MEK inhibitor resistance in BRAF V600 mutant colorectal cancer vs. melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Melanoma; Mutant; Cancer research; Medicine; Cancer; MEK inhibitor; Mutation; Oncology; Internal medicine; Biology; Genetics; Gene; MAPK/ERK pathway; Kinase","score_opus":0.05001674603240189,"score_gpt":0.3825361320690873,"score_spread":0.3325193860366854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712989,0.01876729,0.0000043695213,0.0037874132,0.0008213131,0.00096287177,0.0002920296,0.00007198413,0.003993856],"genre_scores_gemma":[0.99243027,0.004302086,0.00006518237,0.00012576798,0.0004294755,0.0010182572,0.000018652901,0.000064624954,0.0015456876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701303,0.00008246079,0.00050241256,0.0006816612,0.00094634906,0.0007740739],"domain_scores_gemma":[0.99889547,0.0002742572,0.00007126604,0.00026167446,0.0003084626,0.00018887706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006681361,0.00027046146,0.00064044754,0.0004812026,0.00014993908,0.000071951064,0.00018579746,0.00014431497,0.0010007205],"category_scores_gemma":[0.00010087574,0.00021968984,0.00014656353,0.0011116657,0.00027114362,0.00017249414,0.00015279722,0.0007366925,0.000031180505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006353816,0.0004401134,0.009377996,0.0027008234,0.0006625537,0.0020697396,0.0058475463,0.000004083256,0.9397682,0.0018231487,0.0038178004,0.02713421],"study_design_scores_gemma":[0.003354989,0.0014118045,0.2809903,0.0067901793,0.00011616142,0.000027615917,0.0012072964,0.00006537964,0.6797738,0.0012051268,0.024549393,0.00050797104],"about_ca_topic_score_codex":0.0031134603,"about_ca_topic_score_gemma":0.010362129,"teacher_disagreement_score":0.27161232,"about_ca_system_score_codex":0.0015208016,"about_ca_system_score_gemma":0.0011863309,"threshold_uncertainty_score":0.9999125},"labels":[],"label_agreement":null},{"id":"W4393090947","doi":"10.1158/1538-7445.am2024-1294","title":"Abstract 1294: Cancer related fatigue and the additive effect of treatment in the context of lymphoma and CLL: An analysis of Lymphoma Coalition’s 2022 Global Patient Survey","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Lymphoma; Context (archaeology); Medicine; Cancer; Internal medicine; Oncology; History","score_opus":0.053617154632795004,"score_gpt":0.42104498796879103,"score_spread":0.36742783333599605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980634,0.015382908,7.6157016e-7,0.0003511337,0.000048560923,0.001501504,0.0017500536,0.000009343414,0.00032175521],"genre_scores_gemma":[0.9926051,0.0065565724,0.00000191109,0.000024438013,0.000024599773,0.00057537097,0.00014422662,0.00001698146,0.000050822033],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956109,0.001898801,0.00055535295,0.00044909076,0.0010875737,0.00039831537],"domain_scores_gemma":[0.9945009,0.0042929933,0.00011593661,0.00052402174,0.0004352411,0.00013090782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038887192,0.00018842042,0.0007675601,0.00038116454,0.00007851012,0.000035123903,0.00020716545,0.00012238589,0.00023096311],"category_scores_gemma":[0.00044925237,0.00009876954,0.00015066184,0.0021811514,0.0012359287,0.000081789,0.00010860582,0.00016050159,0.000001021436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03114835,0.0016769915,0.20950237,0.003711232,0.016815484,0.000601289,0.055736654,0.0004690276,0.0026174567,0.0029082778,0.0029858097,0.6718271],"study_design_scores_gemma":[0.03996045,0.0039042884,0.90540904,0.0011614772,0.0013975245,0.000035664234,0.0060825753,0.029474147,0.011806032,0.00012076558,0.00044042332,0.00020763137],"about_ca_topic_score_codex":0.2697581,"about_ca_topic_score_gemma":0.02997147,"teacher_disagreement_score":0.69590664,"about_ca_system_score_codex":0.011490247,"about_ca_system_score_gemma":0.00613262,"threshold_uncertainty_score":0.9995017},"labels":[],"label_agreement":null},{"id":"W4393090969","doi":"10.1158/1538-7445.am2024-1296","title":"Abstract 1296: Evaluating the accuracy and reproducibility of ChatGPT models in answering lung cancer patient queries","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Southlake Regional Health Center","funders":"","keywords":"Reproducibility; Lung cancer; Medicine; Cancer; Question answering; Computer science; Medical physics; Oncology; Internal medicine; Information retrieval; Mathematics; Statistics","score_opus":0.5203333576261823,"score_gpt":0.6176051776411716,"score_spread":0.09727182001498935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598195,0.030369867,0.000013560336,0.008289761,0.0004201785,0.00082237093,0.000006672604,0.000015512773,0.0002425887],"genre_scores_gemma":[0.9952875,0.0038150044,0.000029432686,0.0000563207,0.0002453473,0.00043966106,0.000002176195,0.000013129017,0.00011142127],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823314,0.00012217373,0.0003821855,0.0005443368,0.00042977298,0.000288362],"domain_scores_gemma":[0.99822366,0.0006842149,0.000038770573,0.00058761373,0.0003969453,0.0000687723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042418703,0.0000707728,0.00014689528,0.00013292463,0.00011710541,0.000039060484,0.00007628244,0.00005257292,0.00017335196],"category_scores_gemma":[0.0017582552,0.000049169983,0.00002718047,0.0004813389,0.00019240857,0.00018390332,0.000063067746,0.0005108332,0.0000016825787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029542824,0.000055621807,0.02987418,0.0024232806,0.000029343695,0.0000070029555,0.04472094,0.001964368,0.027030338,0.00031863496,0.0005096083,0.89277124],"study_design_scores_gemma":[0.0002150809,0.0011717076,0.13818105,0.013014558,0.00009274411,0.00001810063,0.039748285,0.33722365,0.44759196,0.019522933,0.0027200074,0.00049993035],"about_ca_topic_score_codex":0.035111446,"about_ca_topic_score_gemma":0.0015962435,"teacher_disagreement_score":0.89227134,"about_ca_system_score_codex":0.00037964355,"about_ca_system_score_gemma":0.0012128358,"threshold_uncertainty_score":0.97131383},"labels":[],"label_agreement":null},{"id":"W4393092325","doi":"10.1158/1538-7445.am2024-1290","title":"Abstract 1290: Racial and ethnic representation and disparities on clinical guideline panels in oncology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Spinal Cord Injury BC","funders":"","keywords":"Guideline; Representation (politics); Ethnic group; Clinical Oncology; Medicine; Oncology; Internal medicine; Family medicine; Cancer; Political science; Sociology; Pathology; Anthropology","score_opus":0.4146491015193898,"score_gpt":0.5372226877774912,"score_spread":0.12257358625810139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481288,0.028708536,0.00004967752,0.0070977295,0.0008210913,0.0002707,0.0001183008,0.000021484524,0.014783689],"genre_scores_gemma":[0.9685762,0.029112354,0.000049536364,0.00043141333,0.0006833124,0.00008422829,0.000008023064,0.000021853197,0.0010330912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981962,0.000039430568,0.00077125477,0.0005601608,0.000053285494,0.00037965528],"domain_scores_gemma":[0.99899656,0.00056604133,0.000080728634,0.00018273095,0.000044261793,0.00012968527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029737304,0.00010696117,0.0003824575,0.00038033488,0.00007448864,0.00012485798,0.000120448625,0.000201562,0.00036389937],"category_scores_gemma":[0.00056232396,0.000115460694,0.000049748764,0.00025000403,0.0003278511,0.0002880251,0.00009108146,0.0006860117,0.00014397867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055190065,0.0001520091,0.10805779,0.00022652574,0.000093471914,0.00013409127,0.0024430908,0.00009773579,0.00015692839,0.25267678,0.029157817,0.60625184],"study_design_scores_gemma":[0.0011526336,0.0004526176,0.602358,0.00016433756,0.000004274033,0.000005494332,0.0002520798,0.0010970485,0.000097540265,0.12159886,0.27252138,0.00029577472],"about_ca_topic_score_codex":0.003242383,"about_ca_topic_score_gemma":0.0010761403,"teacher_disagreement_score":0.6059561,"about_ca_system_score_codex":0.00029314493,"about_ca_system_score_gemma":0.00017027736,"threshold_uncertainty_score":0.49015346},"labels":[],"label_agreement":null},{"id":"W4393092332","doi":"10.1158/1538-7445.am2024-4412","title":"Abstract 4412: Defining chromatin alterations in liver cancer at single cell resolution","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Chromatin; Biology; Medicine; Cancer research; Genetics; DNA","score_opus":0.05562172954043271,"score_gpt":0.36394605028164484,"score_spread":0.30832432074121213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9375315,0.055998117,0.000051738487,0.00038203373,0.00032316896,0.00020920212,0.00018351089,0.000012902596,0.0053078593],"genre_scores_gemma":[0.98834383,0.008648092,0.00011166377,0.00009010557,0.00047321361,0.00026131078,0.000112578986,0.000032736276,0.0019264611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987608,0.00004586637,0.00018199865,0.00040205926,0.00021132753,0.00039794733],"domain_scores_gemma":[0.99947494,0.00008183609,0.000021920718,0.00023165648,0.00010379635,0.00008587172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034208433,0.00010549082,0.000091959,0.00013214273,0.00014085938,0.0001094219,0.00014698114,0.000116643925,0.00037851516],"category_scores_gemma":[0.00006785382,0.000110200446,0.000049287904,0.00025416538,0.000088757406,0.000007275554,0.00017903949,0.00023092348,0.00009099383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068796886,0.00005152536,0.0006039046,0.00013703063,0.000015103832,0.000029177436,0.00026242662,0.0022819832,0.9534409,0.00018036412,0.035544086,0.007384681],"study_design_scores_gemma":[0.00048835285,0.00018863262,0.0056008943,0.0003474856,0.000011006129,0.000005173542,0.000099080025,0.0017988704,0.71205765,0.000125414,0.2789802,0.00029721367],"about_ca_topic_score_codex":0.0026894175,"about_ca_topic_score_gemma":0.010846361,"teacher_disagreement_score":0.24343611,"about_ca_system_score_codex":0.0005130256,"about_ca_system_score_gemma":0.0005044097,"threshold_uncertainty_score":0.6052524},"labels":[],"label_agreement":null},{"id":"W4393092407","doi":"10.1158/1538-7445.am2024-5862","title":"Abstract 5862: Retrotransposable elements mediate the drug-tolerant persistence in claudin-low breast cancer chemo-treatment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Persistence (discontinuity); Breast cancer; Cancer; Oncology; Medicine; Biology; Drug; Cancer research; Internal medicine; Pharmacology","score_opus":0.12423713233151024,"score_gpt":0.3904917160813115,"score_spread":0.26625458374980127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854203,0.002293704,0.0000010916744,0.008830197,0.00049904117,0.0010237681,0.0006833597,0.00008628931,0.0011622459],"genre_scores_gemma":[0.98950505,0.0067307986,0.000004679001,0.00040606645,0.00017233318,0.0016062157,0.0000058986802,0.00004032689,0.0015286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963466,0.00025658667,0.00030577162,0.0010023554,0.0010410876,0.0010475845],"domain_scores_gemma":[0.9988329,0.0003696879,0.00003716605,0.0004312769,0.000070202055,0.00025879662],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004704954,0.00027469973,0.0002442408,0.00017537584,0.00038883172,0.00024403053,0.00057951536,0.00007255874,0.0021069087],"category_scores_gemma":[0.000043330798,0.00016339688,0.0001496138,0.0010026756,0.00028669537,0.00021361247,0.00010625353,0.00058236555,0.0003099785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015358903,0.0020475893,0.015062322,0.0007443631,0.00020694596,0.0060224994,0.0025621664,0.0007881568,0.8795893,0.0025814082,0.0037829312,0.0850764],"study_design_scores_gemma":[0.0045673414,0.00064276723,0.10708332,0.0016314475,0.00013755547,0.00005204641,0.0004495944,0.0047517293,0.8547319,0.005066549,0.019828781,0.0010569731],"about_ca_topic_score_codex":0.001439015,"about_ca_topic_score_gemma":0.00066883594,"teacher_disagreement_score":0.092020996,"about_ca_system_score_codex":0.00083087635,"about_ca_system_score_gemma":0.0004260408,"threshold_uncertainty_score":0.9988053},"labels":[],"label_agreement":null},{"id":"W4393092495","doi":"10.1158/1538-7445.am2024-7381","title":"Abstract 7381: Mathematical modeling and validation of mechanistic target of rapamycin and N-myristoyltransferase signaling pathways in breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Winnipeg","funders":"","keywords":"Breast cancer; Cancer; Computational biology; Signal transduction; Cancer research; PI3K/AKT/mTOR pathway; Chemistry; Pharmacology; Medicine; Biology; Biochemistry; Internal medicine","score_opus":0.03291043681172018,"score_gpt":0.33781663347793467,"score_spread":0.3049061966662145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865508,0.0120557565,0.0009608115,0.00007688138,0.000022789758,0.0001758924,0.00007914895,0.0000041452454,0.00007374615],"genre_scores_gemma":[0.99742806,0.00232845,0.00011203566,0.0000030879066,0.00004298504,0.000040308045,0.000014017839,0.000016471546,0.000014587238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991689,0.00006151336,0.00019252893,0.00022636549,0.00017450987,0.00017622042],"domain_scores_gemma":[0.99970007,0.000048764312,0.00001573241,0.00009151349,0.00008368374,0.000060262177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005779737,0.00008086813,0.00013964176,0.00010806076,0.000030993317,0.000016898406,0.000057876012,0.00011912848,0.00006680831],"category_scores_gemma":[0.000023710641,0.000069212234,0.00002861292,0.00013515935,0.00009143337,0.000006009792,0.000036787358,0.0002015941,8.6960335e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001393801,0.000028594417,0.00016714858,0.0007824169,0.000040465533,0.000008476415,0.00018705348,0.0018800945,0.9948914,0.000305547,0.000015078756,0.0015543426],"study_design_scores_gemma":[0.0003094301,0.00010514889,0.000079546,0.000585498,0.000016288928,0.0000110726805,0.00010877983,0.015882066,0.9810686,0.001735439,0.00000886094,0.00008928885],"about_ca_topic_score_codex":0.00013667623,"about_ca_topic_score_gemma":0.0000055678797,"teacher_disagreement_score":0.014001971,"about_ca_system_score_codex":0.000022199149,"about_ca_system_score_gemma":0.00015742973,"threshold_uncertainty_score":0.2822393},"labels":[],"label_agreement":null},{"id":"W4393092514","doi":"10.1158/1538-7445.am2024-2232","title":"Abstract 2232: Association between sleep characteristics and cancer survival: Findings from the UK Biobank study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Alberta Health Services","funders":"","keywords":"Biobank; Medicine; Cancer; Association (psychology); Gerontology; Sleep (system call); Internal medicine; Oncology; Bioinformatics; Psychology; Biology","score_opus":0.12363740570257678,"score_gpt":0.44533437313001417,"score_spread":0.32169696742743736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796616,0.013748204,0.00000402361,0.004126893,0.0009291835,0.00086946704,0.00050180923,0.000051141957,0.00010766498],"genre_scores_gemma":[0.9884614,0.00851798,0.00000250815,0.000086185064,0.0021797596,0.00014976144,0.000064559266,0.00003481987,0.00050305994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975219,0.00019799607,0.000255006,0.0003945329,0.0011350297,0.00049558043],"domain_scores_gemma":[0.9981364,0.0010406143,0.000033878994,0.00031408406,0.00024584928,0.00022919867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025638714,0.00013220099,0.00035419187,0.00012013988,0.00027129243,0.00016261582,0.00012596314,0.00013975805,0.00044426843],"category_scores_gemma":[0.0003807124,0.00008550167,0.00010793813,0.000468373,0.00007447368,0.000055871908,0.0000864717,0.0010330711,0.000057627025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059181464,0.000023416651,0.9467455,0.0001338144,0.0007065508,0.000037374088,0.0014436007,3.114412e-7,0.00048944127,0.0000045342927,0.004929683,0.045426596],"study_design_scores_gemma":[0.0005435578,0.000066763,0.9603543,0.00022259606,0.00022254795,5.6490205e-7,0.0005119275,0.00001108611,0.00022407906,0.00001977323,0.037735015,0.00008778338],"about_ca_topic_score_codex":0.028165892,"about_ca_topic_score_gemma":0.0014914556,"teacher_disagreement_score":0.045338813,"about_ca_system_score_codex":0.00084871333,"about_ca_system_score_gemma":0.000527142,"threshold_uncertainty_score":0.97830564},"labels":[],"label_agreement":null},{"id":"W4393092526","doi":"10.1158/1538-7445.am2024-1293","title":"Abstract 1293: Uncovered: The breast cancer journey of a Black woman from advocacy to awareness to action","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Action (physics); Breast cancer; Cancer; Medicine; Internal medicine","score_opus":0.27454669316138447,"score_gpt":0.5163433149233894,"score_spread":0.2417966217620049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96818167,0.002701605,0.00009606005,0.026174558,0.0004996877,0.000640779,0.0003202475,0.00004337476,0.0013420287],"genre_scores_gemma":[0.9952887,0.0007890707,0.00004561919,0.0010945075,0.0013729148,0.00025866795,0.000010307978,0.000036258294,0.0011039409],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9972868,0.00007763798,0.00029353882,0.00047122315,0.0013051383,0.0005656549],"domain_scores_gemma":[0.9982627,0.00021291009,0.00003651702,0.00047862195,0.0006054992,0.0004037253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080544234,0.00015954426,0.00028347768,0.00025957602,0.0001560719,0.00013207167,0.00037134285,0.000088634646,0.002365841],"category_scores_gemma":[0.0001338232,0.00010978463,0.000107662105,0.0013161014,0.00013191107,0.00017770422,0.00016350525,0.000682736,0.00024559902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052278736,0.00013286373,0.059050776,0.0010238786,0.00061196,0.00032845276,0.010827875,0.0045823413,0.26480064,0.00018805239,0.42750743,0.22571786],"study_design_scores_gemma":[0.0011278859,0.00050138583,0.7690192,0.008977018,0.00015708875,0.000057172394,0.009674401,0.0004224457,0.052953638,0.0006222086,0.15604277,0.0004448083],"about_ca_topic_score_codex":0.091359764,"about_ca_topic_score_gemma":0.0077482676,"teacher_disagreement_score":0.7099684,"about_ca_system_score_codex":0.0010614854,"about_ca_system_score_gemma":0.0023132665,"threshold_uncertainty_score":0.9985461},"labels":[],"label_agreement":null},{"id":"W4393092556","doi":"10.1158/1538-7445.am2024-675","title":"Abstract 675: Targeting Bcl-2/Bcl-xl for small cell lung cancer treatment with LP-118","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.10506868197426737,"score_gpt":0.47593163215635753,"score_spread":0.37086295018209015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63435197,0.3187346,0.0002072892,0.021135332,0.0009794487,0.008318992,0.00070570345,0.00046890439,0.01509777],"genre_scores_gemma":[0.90281826,0.037569925,0.00058440113,0.00015042593,0.002675959,0.010942469,0.00006813215,0.00022534197,0.044965107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995486,0.00009585936,0.0003777038,0.0010573659,0.0012923499,0.0016906967],"domain_scores_gemma":[0.9972608,0.000762216,0.000052268595,0.00053484435,0.0008817238,0.00050811074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011763407,0.00039589236,0.0005869253,0.0004632528,0.0004949214,0.00022508965,0.00030388695,0.00013788862,0.001027878],"category_scores_gemma":[0.00012585208,0.00026533223,0.00020891489,0.00091265084,0.00036688164,0.00016123593,0.00016464648,0.00086670154,0.00007028205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070700394,0.001072556,0.03658239,0.030933378,0.004805227,0.001955079,0.011437225,0.00041910063,0.18698156,0.00037376047,0.52229285,0.19607686],"study_design_scores_gemma":[0.0072091883,0.0033184062,0.0045075826,0.0049765795,0.0005184406,0.000017672548,0.002024083,0.0021393455,0.09261324,0.00011622665,0.881774,0.0007852032],"about_ca_topic_score_codex":0.0066137975,"about_ca_topic_score_gemma":0.0020796668,"teacher_disagreement_score":0.35948122,"about_ca_system_score_codex":0.0043111774,"about_ca_system_score_gemma":0.0039170543,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W4393092577","doi":"10.1158/1538-7445.am2024-1842","title":"Abstract 1842: Global proteomics reveals integrin signaling as a driver of infiltration in glioblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Infiltration (HVAC); Integrin; Proteomics; Cancer research; Computational biology; Biology; Medicine; Internal medicine; Gene; Receptor; Genetics; Materials science","score_opus":0.05981073611913606,"score_gpt":0.4365587489976998,"score_spread":0.37674801287856374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926606,0.0013284264,0.00006383498,0.001133439,0.0000716994,0.0011917761,0.000028990595,0.000036631573,0.0034846386],"genre_scores_gemma":[0.9980754,0.00032331372,0.00024066867,0.00003736181,0.00016795115,0.00022681829,0.00000874688,0.000029112707,0.00089061086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997142,0.00016147833,0.0004170403,0.00042859153,0.0013200548,0.0005308381],"domain_scores_gemma":[0.99871564,0.00024226263,0.00003305416,0.00031638594,0.0004859393,0.00020669082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016296448,0.00013008933,0.00027143792,0.0004133677,0.00004321035,0.00007705662,0.00022013183,0.00015630444,0.001622755],"category_scores_gemma":[0.0006499813,0.00011399857,0.00009148639,0.0017690096,0.00022788695,0.00012571254,0.00014306138,0.0010787919,0.00026025058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009180113,0.0001006946,0.0069008186,0.0010849073,0.000039982748,0.00051002274,0.00037906683,0.00006709275,0.9742795,0.000785624,0.0016250878,0.013309185],"study_design_scores_gemma":[0.0011984974,0.00095056667,0.02512646,0.0039606453,0.000014891917,0.00006076297,0.0005433113,0.000970881,0.96128315,0.0024802643,0.0032124978,0.00019807741],"about_ca_topic_score_codex":0.0021591056,"about_ca_topic_score_gemma":0.00053235533,"teacher_disagreement_score":0.01822564,"about_ca_system_score_codex":0.0010918978,"about_ca_system_score_gemma":0.0013991456,"threshold_uncertainty_score":0.9992899},"labels":[],"label_agreement":null},{"id":"W4393092679","doi":"10.1158/1538-7445.am2024-6465","title":"Abstract 6465: A population-based analysis of brain metastasis burden and management in 8705 small cell lung cancer patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Brain metastasis; Lung cancer; Cancer; Metastasis; Oncology; Internal medicine; Population; Pathology; Environmental health","score_opus":0.06127359750672997,"score_gpt":0.44992459586566036,"score_spread":0.3886509983589304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975219,0.017897636,0.00001308497,0.0041237245,0.00007468306,0.0013470998,0.00023027774,0.000029630404,0.0010648696],"genre_scores_gemma":[0.9937381,0.003883883,0.00010678753,0.00007044313,0.000093661,0.000858614,0.00007743541,0.000034945348,0.0011361144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708563,0.00014254845,0.000395605,0.0005877226,0.0011981147,0.00059036346],"domain_scores_gemma":[0.9986242,0.00045725523,0.00004800383,0.00034066488,0.00034806033,0.00018178573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176998,0.00017436505,0.00050270115,0.0022063793,0.00008648251,0.000064584376,0.0001748755,0.00006410228,0.0006207654],"category_scores_gemma":[0.00012311919,0.00014657773,0.00014076925,0.0033837052,0.00013681538,0.00008203895,0.0001847539,0.00045746076,0.000003960771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005874634,0.00021668822,0.9167584,0.010945568,0.005248561,0.00017238042,0.0016389263,0.0028959897,0.0020313777,0.000104216255,0.0076502925,0.05175012],"study_design_scores_gemma":[0.0017557285,0.00013437305,0.98178643,0.0012163285,0.0010858601,1.099883e-7,0.00029296862,0.008689243,0.0013327813,0.000031051364,0.0034917037,0.000183404],"about_ca_topic_score_codex":0.027386699,"about_ca_topic_score_gemma":0.007081338,"teacher_disagreement_score":0.06502803,"about_ca_system_score_codex":0.0012543559,"about_ca_system_score_gemma":0.0003833797,"threshold_uncertainty_score":0.97909003},"labels":[],"label_agreement":null},{"id":"W4393092695","doi":"10.1158/1538-7445.am2024-2796","title":"Abstract 2796: Colibactin mutation signatures are associated with younger age of onset in colorectal cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Oncology; Mutation; Age of onset; Genetics; Internal medicine; Biology; Gene; Disease","score_opus":0.0611762516502723,"score_gpt":0.41196519987277047,"score_spread":0.3507889482224982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98312736,0.012816126,3.566827e-7,0.0010994128,0.00015514638,0.00070610916,0.00022563127,0.000042689553,0.0018271776],"genre_scores_gemma":[0.99706614,0.00090017583,0.000005691341,0.00004283819,0.000094608746,0.00073438,0.000058311132,0.000032498723,0.001065345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832124,0.000073251125,0.00020780752,0.00033829123,0.0006666707,0.00039275462],"domain_scores_gemma":[0.9990805,0.00035435447,0.000051767416,0.000097813,0.00033254086,0.0000830264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037727458,0.00014700243,0.00035480442,0.00031158645,0.00008049139,0.00003866681,0.000072191906,0.00010782161,0.0005508637],"category_scores_gemma":[0.00015712567,0.00010476978,0.00005845697,0.0009884868,0.00023158955,0.00009805513,0.000036770743,0.000588744,0.000005604506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020879434,0.002107876,0.63884634,0.0033402808,0.0049796063,0.015564173,0.02437679,0.00079168804,0.2019526,0.00018504937,0.04388723,0.04308894],"study_design_scores_gemma":[0.0013801387,0.00062408054,0.9762054,0.0022318547,0.00007220875,0.0000057385323,0.0009025126,0.000055312248,0.017082965,0.000052685904,0.0012613024,0.00012576484],"about_ca_topic_score_codex":0.00571945,"about_ca_topic_score_gemma":0.029219363,"teacher_disagreement_score":0.33735913,"about_ca_system_score_codex":0.0012806994,"about_ca_system_score_gemma":0.00077757664,"threshold_uncertainty_score":0.9884949},"labels":[],"label_agreement":null},{"id":"W4393092712","doi":"10.1158/1538-7445.am2024-1058","title":"Abstract 1058: Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Stratification (seeds); Stage (stratigraphy); Risk stratification; Melanoma; Immune system; Internal medicine; Oncology; Immunology; Cancer research; Biology","score_opus":0.07857506064394973,"score_gpt":0.43118707141041235,"score_spread":0.35261201076646265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343355,0.017352697,0.000056152705,0.0056486046,0.00030143786,0.0017327057,0.00010759997,0.000032879994,0.0013343852],"genre_scores_gemma":[0.9945896,0.0018240135,0.00022023602,0.00009469696,0.00008477082,0.00081994507,0.000036616457,0.00002364085,0.0023064786],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984116,0.000039840474,0.0003677852,0.00042830454,0.00036754535,0.0003849584],"domain_scores_gemma":[0.99923676,0.0001673449,0.000028042272,0.0002775735,0.00016482196,0.00012542991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001190717,0.00011635239,0.00017752202,0.00038818448,0.00013525416,0.00007923073,0.00010972312,0.000077188946,0.00032709117],"category_scores_gemma":[0.00009420091,0.00009965052,0.00005552862,0.0006909956,0.00012490609,0.00010043277,0.000054798278,0.00023789646,0.000007981903],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026979921,0.000077413155,0.00051559496,0.0005491882,0.00011339398,0.000026840089,0.002674367,0.0000031181055,0.5006933,0.00024360983,0.012180808,0.48022434],"study_design_scores_gemma":[0.0039375033,0.0028175528,0.06823598,0.003549906,0.000031329448,0.000015271879,0.0051651294,0.00053558714,0.21979809,0.00023918961,0.6952041,0.0004703724],"about_ca_topic_score_codex":0.0033768208,"about_ca_topic_score_gemma":0.0007295908,"teacher_disagreement_score":0.6830233,"about_ca_system_score_codex":0.0005527492,"about_ca_system_score_gemma":0.0006092506,"threshold_uncertainty_score":0.5104765},"labels":[],"label_agreement":null},{"id":"W4393092741","doi":"10.1158/1538-7445.am2024-5661","title":"Abstract 5661: Identifying and intervening rare resistant subclones to BRAF/MEK inhibitors in metastatic melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Metastatic melanoma; Melanoma; Cancer research; Medicine; Oncology; Internal medicine; Biology","score_opus":0.08646921128498422,"score_gpt":0.4047472445627559,"score_spread":0.3182780332777717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244333,0.015878659,0.00007638423,0.00043488416,0.00025632154,0.0002686134,0.000054779342,0.0000148166355,0.0005721967],"genre_scores_gemma":[0.99815583,0.00042508374,0.00017533738,0.000038135837,0.00022598558,0.00015232571,0.000028940887,0.000031655083,0.00076672324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849397,0.00011132293,0.00023659674,0.00048605504,0.0002607643,0.00041127173],"domain_scores_gemma":[0.99948525,0.00005790421,0.000018043482,0.0002170204,0.00007356114,0.00014822667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008894211,0.00012612944,0.00014834387,0.0002785634,0.00008583079,0.00017038577,0.00017505027,0.000069924645,0.000069006484],"category_scores_gemma":[0.00014021064,0.00011574025,0.000052791303,0.0003310986,0.00007186885,0.000011838624,0.000249989,0.00026685148,0.000021950776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014446597,0.000016810312,0.0012113324,0.00046265285,0.000040205163,0.00028556542,0.0005366927,0.0000082317765,0.9754361,0.00016762537,0.0039962647,0.017694037],"study_design_scores_gemma":[0.00060028996,0.0005398119,0.016194837,0.0015109,0.000016054288,0.00003482259,0.0016991684,0.00003583653,0.8889078,0.00052782375,0.08952205,0.00041062702],"about_ca_topic_score_codex":0.0006839877,"about_ca_topic_score_gemma":0.0016709816,"teacher_disagreement_score":0.08652834,"about_ca_system_score_codex":0.000064050466,"about_ca_system_score_gemma":0.000185241,"threshold_uncertainty_score":0.47197506},"labels":[],"label_agreement":null},{"id":"W4393092846","doi":"10.1158/1538-7445.am2024-2154","title":"Abstract 2154: <i>Actívatexto:</i>Feasibility and acceptability of a mobile intervention that promotes smoking cessation and physical activity among Latinos","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health and Lifestyle Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Smoking cessation; Medicine; Physical activity; Intervention (counseling); Gerontology; Family medicine; Physical therapy; Environmental health; Psychiatry","score_opus":0.2769021065227902,"score_gpt":0.5762569916182481,"score_spread":0.2993548850954579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950147,0.0017808753,0.000013196086,0.00040675394,0.00019547896,0.0016500519,0.000074700016,0.000055449505,0.00080877874],"genre_scores_gemma":[0.998369,0.0005043769,0.000008205656,0.000009525719,0.00023570762,0.0007518088,0.000004636018,0.000015920126,0.00010082215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975141,0.00084256596,0.0002876339,0.00045347496,0.00042248014,0.00047970028],"domain_scores_gemma":[0.99767536,0.0016128231,0.00009733556,0.0002200025,0.00023363264,0.000160834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035429585,0.00011936143,0.0002904321,0.00011557752,0.0005451332,0.000032756372,0.000082361075,0.00012459031,0.0003645489],"category_scores_gemma":[0.0005132212,0.00009539545,0.000052323256,0.00029606748,0.00043541787,0.00038601184,0.00023936329,0.0011333553,0.000005086066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010647888,0.00014228428,0.84033996,0.0076762526,0.000030432671,0.0000014987415,0.00991835,7.6065214e-7,0.0014527806,0.000066591856,0.00019906122,0.14006554],"study_design_scores_gemma":[0.0003526044,0.00011550101,0.99235785,0.0006356247,0.000010887499,1.583428e-7,0.0031451015,0.00027605076,0.0017723438,0.0006324921,0.0006251191,0.00007628931],"about_ca_topic_score_codex":0.00617881,"about_ca_topic_score_gemma":0.0015880867,"teacher_disagreement_score":0.15201786,"about_ca_system_score_codex":0.00028208998,"about_ca_system_score_gemma":0.00033119533,"threshold_uncertainty_score":0.9340553},"labels":[],"label_agreement":null},{"id":"W4393092860","doi":"10.1158/1538-7445.am2024-6142","title":"Abstract 6142: Interactions of processed meat and red meat intake with pathway-based polygenic risk scores for colorectal cancer: A novel approach for PRSs construction","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Colorectal cancer; Medicine; Red meat; Cancer; Internal medicine; Oncology; Pathology","score_opus":0.039809610573598365,"score_gpt":0.3492080850605812,"score_spread":0.3093984744869828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797275,0.005795908,0.010357872,0.00018458725,0.00012874143,0.0014238684,0.002287452,0.000017450837,0.00007661555],"genre_scores_gemma":[0.9926939,0.0008346088,0.0037046147,0.000014216406,0.0003388756,0.0019493678,0.00034360331,0.000036886708,0.00008395054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988149,0.00003068688,0.00020138186,0.0004747873,0.00019498382,0.0002832755],"domain_scores_gemma":[0.9989852,0.00007339738,0.00006620496,0.00015897484,0.00059294316,0.0001233311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021477498,0.00013751148,0.00015469138,0.00013732995,0.0001705033,0.000074576266,0.00011271851,0.00009652236,0.000013238906],"category_scores_gemma":[0.000114396455,0.00011933931,0.0000814012,0.00018805136,0.00033919862,0.000012516277,0.000028639692,0.00013607388,1.3778265e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043745027,0.00017402136,0.0041218456,0.0018042098,0.00019053376,5.3901874e-7,0.000098357494,0.00029387415,0.9823365,0.0000884946,0.0009834046,0.005533715],"study_design_scores_gemma":[0.002509863,0.0006871179,0.00233064,0.00022667993,0.00008720841,0.000006199275,0.0004500161,0.0019078194,0.9863586,0.00016133495,0.0050769406,0.00019762102],"about_ca_topic_score_codex":0.0002639212,"about_ca_topic_score_gemma":0.0008852771,"teacher_disagreement_score":0.012966371,"about_ca_system_score_codex":0.00005142041,"about_ca_system_score_gemma":0.0010783467,"threshold_uncertainty_score":0.4866516},"labels":[],"label_agreement":null},{"id":"W4393092956","doi":"10.1158/1538-7445.am2024-1381","title":"Abstract 1381: Characterization of the 12-lipoxygenase expression in the megakaryoblastic cell line, Dami","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Université de Moncton","funders":"","keywords":"Lipoxygenase; Cell culture; Medicine; Chemistry; Biology; Enzyme; Biochemistry; Genetics","score_opus":0.04486757517653595,"score_gpt":0.3348256495174554,"score_spread":0.28995807434091947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051845,0.002294163,0.000045000612,0.0009618373,0.0031169262,0.0003435269,0.000014415015,0.000019867723,0.0026858079],"genre_scores_gemma":[0.98743445,0.0004994064,6.849753e-7,0.00008188403,0.000083307,0.00008929192,0.00005493638,0.000012119614,0.0117438985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988748,0.0003694609,0.00022422099,0.0001917655,0.00010878347,0.00023097411],"domain_scores_gemma":[0.99930567,0.00026605287,0.000044166245,0.00029026516,0.00008578579,0.000008085131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006760681,0.00008247025,0.00009333316,0.00015665153,0.00015615173,0.000037700567,0.00029909684,0.00011893769,0.0019316067],"category_scores_gemma":[0.00007213783,0.000044947763,0.000062269435,0.00035917733,0.0001454074,0.00013249529,0.00007306866,0.0008038014,0.000290592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012952327,0.000068308385,0.000114647206,0.000090000634,0.000010394417,0.0000020616746,0.0009088774,0.000014936116,0.9875015,0.000057089284,0.009499811,0.0016028541],"study_design_scores_gemma":[0.0002182826,0.00005661255,0.02131657,0.00026571992,0.000005186275,0.0000042450506,0.00032867945,0.000033202792,0.8595214,0.000020941005,0.11817863,0.00005054963],"about_ca_topic_score_codex":0.00018765013,"about_ca_topic_score_gemma":0.00004071492,"teacher_disagreement_score":0.12798011,"about_ca_system_score_codex":0.00007706889,"about_ca_system_score_gemma":0.00013925835,"threshold_uncertainty_score":0.99898076},"labels":[],"label_agreement":null},{"id":"W4393092962","doi":"10.1158/1538-7445.am2024-1588","title":"Abstract 1588: Identification of new signaling pathways between fibroblasts &amp; tumor cells in pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Montréal","funders":"","keywords":"Pancreatic cancer; Cancer; Cancer research; Signal transduction; Medicine; Cancer-Associated Fibroblasts; Identification (biology); Cancer cell; Pathology; Cell biology; Internal medicine; Biology","score_opus":0.1620914096714021,"score_gpt":0.45360610539640916,"score_spread":0.2915146957250071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054253,0.0062493538,0.00012606452,0.0008797819,0.00013786335,0.00090679206,0.0001323411,0.000044765242,0.0009805096],"genre_scores_gemma":[0.99223506,0.0013245462,0.00022040922,0.000022939681,0.0006489582,0.0002905972,0.000036722642,0.00004592301,0.005174855],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968662,0.00017268774,0.00069818663,0.00051510887,0.0010430829,0.00070469035],"domain_scores_gemma":[0.9978809,0.0009758711,0.000077829594,0.0004224491,0.0003161482,0.00032683444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022798267,0.00016596487,0.0006114887,0.0006985359,0.000080939266,0.000061200335,0.00025765316,0.00015006897,0.002383939],"category_scores_gemma":[0.00030301133,0.00014338495,0.00010188569,0.0012267418,0.00026891904,0.00012952421,0.000092728944,0.0009519046,0.0003077785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002515748,0.00008570123,0.13852905,0.0023712914,0.00018805165,0.00011108387,0.0017718698,0.00007354947,0.83726597,0.00010653918,0.009068807,0.010176497],"study_design_scores_gemma":[0.002127278,0.00038499612,0.5475697,0.0077715633,0.00026160106,0.000012212177,0.00068540656,0.00083139876,0.4271237,0.0024710447,0.010388465,0.00037265135],"about_ca_topic_score_codex":0.007473026,"about_ca_topic_score_gemma":0.0006490146,"teacher_disagreement_score":0.4101423,"about_ca_system_score_codex":0.00074552564,"about_ca_system_score_gemma":0.003457355,"threshold_uncertainty_score":0.99913627},"labels":[],"label_agreement":null},{"id":"W4393092971","doi":"10.1158/1538-7445.am2024-4974","title":"Abstract 4974: Development of an ovarian cancer diagnosis score using electronic health records","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Ovarian cancer; Health records; Oncology; Internal medicine; Gynecology; Health care; Political science","score_opus":0.16026140487714097,"score_gpt":0.4879002879306825,"score_spread":0.32763888305354155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366823,0.0602894,0.00006601084,0.0015411085,0.00045822316,0.0007437247,0.000041705858,0.00005100915,0.00012651547],"genre_scores_gemma":[0.9786998,0.019358836,0.0004238645,0.00012410415,0.0006455867,0.000484875,0.000030257637,0.00005651766,0.00017615825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701464,0.00013869489,0.0004221861,0.00046261455,0.00095490075,0.0010069344],"domain_scores_gemma":[0.99869764,0.000087882596,0.000045873177,0.00037902143,0.00027002383,0.00051957986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023532088,0.00014655261,0.00042027238,0.00043385668,0.00024925172,0.000036305584,0.00013499579,0.00011118251,0.0009028728],"category_scores_gemma":[0.000057733527,0.00011917939,0.0001450796,0.00088541646,0.00009733623,0.00010756849,0.000052168576,0.0009011236,0.000014901679],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003270494,0.00015162314,0.029961156,0.0045936937,0.0005342884,0.0000811246,0.0027985107,0.00007888141,0.0031922285,0.00009197974,0.003250836,0.95493865],"study_design_scores_gemma":[0.0023101298,0.00079617894,0.43572888,0.008333455,0.00014005939,0.00007125868,0.0009073247,0.00072879274,0.051936876,0.00017018644,0.498316,0.00056085765],"about_ca_topic_score_codex":0.028300786,"about_ca_topic_score_gemma":0.0078285895,"teacher_disagreement_score":0.9543778,"about_ca_system_score_codex":0.0029638896,"about_ca_system_score_gemma":0.019200422,"threshold_uncertainty_score":0.98858243},"labels":[],"label_agreement":null},{"id":"W4393092985","doi":"10.1158/1538-7445.am2024-7363","title":"Abstract 7363: Clinical, genomic, transcriptomic and immunologic profile of BRAF mutant colorectal tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Transcriptome; Mutant; Cancer research; Medicine; Biology; Internal medicine; Cancer; Genetics; Gene; Gene expression","score_opus":0.11345396476073875,"score_gpt":0.44969458244055943,"score_spread":0.33624061767982066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94991004,0.04380579,9.791926e-7,0.00084388495,0.00032698523,0.0007652869,0.000109235625,0.000051293817,0.004186514],"genre_scores_gemma":[0.98886204,0.0098840315,0.000035276666,0.000028485807,0.00016790826,0.0002572494,0.000007145091,0.00002594268,0.00073190284],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99843156,0.000074505224,0.00037733387,0.00041805237,0.00031561073,0.000382908],"domain_scores_gemma":[0.9992948,0.00022736115,0.000032237003,0.00016989834,0.00016073769,0.000114974166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007364544,0.00014055826,0.00044106532,0.00017401364,0.000117875046,0.00003679241,0.00009929856,0.00009204592,0.00091365573],"category_scores_gemma":[0.00007521598,0.00009912011,0.0001310653,0.00031016933,0.0006708285,0.000054200304,0.00008342644,0.00054023846,0.000035731617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039651,0.00054831133,0.035817552,0.0018769024,0.0015948715,0.0007941486,0.0029216218,0.0000017632735,0.72664857,0.00040198193,0.0051449332,0.22028425],"study_design_scores_gemma":[0.0026818642,0.003997815,0.9233445,0.0010753172,0.00016612366,0.00007996253,0.0016043208,0.0001198549,0.05543363,0.00024933222,0.010998314,0.0002489654],"about_ca_topic_score_codex":0.00082213955,"about_ca_topic_score_gemma":0.00015775021,"teacher_disagreement_score":0.8875269,"about_ca_system_score_codex":0.0002802723,"about_ca_system_score_gemma":0.0006546228,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W4393093002","doi":"10.1158/1538-7445.am2024-5002","title":"Abstract 5002: Next-generation mRNA-LNP vaccine prototype achieves tumor clearance in a GBM mouse model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Virology; Messenger RNA; Medicine; Cancer research; Immunology; Biology; Gene; Genetics","score_opus":0.10537944005242235,"score_gpt":0.41228867943315023,"score_spread":0.3069092393807279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784643,0.009608267,0.000050052713,0.00063600193,0.00007285729,0.0009962735,0.00011175695,0.000025771396,0.0006525628],"genre_scores_gemma":[0.9916627,0.0030786286,0.00009236069,0.00006516368,0.00055489695,0.001192292,0.00011060459,0.000053445467,0.003189929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804884,0.0000855665,0.00020479063,0.00060902163,0.0004473739,0.0006044176],"domain_scores_gemma":[0.9992817,0.000014916216,0.000019610874,0.0003763529,0.00014515575,0.00016225835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048862107,0.00016267295,0.00014541636,0.00019828188,0.00012391646,0.00020370654,0.00027423498,0.00010069512,0.00015463794],"category_scores_gemma":[0.00006825478,0.00014386135,0.000070609094,0.00035466705,0.00006541401,0.000028541352,0.000140233,0.00044505272,0.000100489546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009861626,0.000116974865,0.00032919194,0.00016048954,0.000059431437,0.000063552,0.00007513553,0.0013626317,0.97666854,0.00005171229,0.0063092103,0.0138169825],"study_design_scores_gemma":[0.0014497554,0.00071914843,0.0020481485,0.00020215577,0.00000803335,0.000010543922,0.000053620646,0.015409249,0.95040333,0.00023817358,0.029121805,0.0003360173],"about_ca_topic_score_codex":0.0012474972,"about_ca_topic_score_gemma":0.0043061185,"teacher_disagreement_score":0.026265176,"about_ca_system_score_codex":0.00022434181,"about_ca_system_score_gemma":0.00068026176,"threshold_uncertainty_score":0.5866496},"labels":[],"label_agreement":null},{"id":"W4393093029","doi":"10.1158/1538-7445.am2024-624","title":"Abstract 624: Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Lymphoblastic Leukemia; Fusion gene; Cancer research; Gene; Medicine; Leukemia; Immunology; Biology; Genetics","score_opus":0.01898206474095364,"score_gpt":0.30654132622860497,"score_spread":0.2875592614876513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921843,0.004455008,0.00030390968,0.00028185302,0.00021491722,0.00039883546,0.00029737124,0.000027274948,0.001836538],"genre_scores_gemma":[0.9896452,0.0012175187,0.0005077309,0.00008248601,0.00041670742,0.00034545458,0.00010455058,0.000047201855,0.0076331785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982454,0.000062959145,0.00019904158,0.0005747324,0.0003494868,0.0005683696],"domain_scores_gemma":[0.9990158,0.000027335702,0.000028433586,0.0003469012,0.00038954584,0.00019196088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030789917,0.00018776747,0.00013963753,0.00014396882,0.0002551525,0.0002474422,0.00030020086,0.00012341735,0.00022810731],"category_scores_gemma":[0.00001947211,0.00015076487,0.00004648714,0.0006145579,0.000096506155,0.000011197404,0.00018256072,0.00016734087,0.00018175284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018091325,0.000034544555,0.00021965729,0.00012681194,0.000056028366,0.00004157162,0.00033919822,0.0024063243,0.9875266,0.00009825562,0.008029928,0.0009401681],"study_design_scores_gemma":[0.00036302608,0.0005683205,0.0013400761,0.000088189125,0.000029453546,0.00002175973,0.00022609465,0.00017812643,0.96811444,0.000040240455,0.02875033,0.00027994934],"about_ca_topic_score_codex":0.00027329914,"about_ca_topic_score_gemma":0.00016376798,"teacher_disagreement_score":0.020720402,"about_ca_system_score_codex":0.00029044587,"about_ca_system_score_gemma":0.001998634,"threshold_uncertainty_score":0.6148013},"labels":[],"label_agreement":null},{"id":"W4393093034","doi":"10.1158/1538-7445.am2024-775","title":"Abstract 775: Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Germline; Sarcoma; Genetic architecture; Germline mutation; Medicine; Cancer; Biology; Genetics; Pathology; Mutation; Gene; Phenotype","score_opus":0.11500729132129815,"score_gpt":0.4468245282320853,"score_spread":0.33181723691078713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9298195,0.06889145,0.0000010395707,0.0003744633,0.000041658917,0.0006073837,0.000036195077,0.000007520603,0.00022076629],"genre_scores_gemma":[0.9979407,0.001685539,0.00009745485,0.00001576594,0.000089044646,0.0001249488,0.000010093955,0.000021131074,0.000015329695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839973,0.00014885727,0.00030964537,0.00024338442,0.00063067384,0.00026767637],"domain_scores_gemma":[0.9987514,0.00074101664,0.000049193335,0.0002456811,0.00014402323,0.00006868495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335263,0.00010185116,0.00023958112,0.0002923988,0.000058019483,0.000020892368,0.00010756043,0.000056237066,0.000113704395],"category_scores_gemma":[0.00012990498,0.00006525215,0.000050846855,0.0005456558,0.00009469213,0.000027589467,0.000093209,0.00039056927,0.0000026398425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113785296,0.00029073213,0.6820269,0.0005299265,0.00006393385,0.00003809469,0.0010444407,0.0000656554,0.003312058,0.00003292281,0.0000419098,0.31243962],"study_design_scores_gemma":[0.0010087758,0.0003752297,0.99442023,0.0005235339,0.00006787517,0.0000046661144,0.00022140778,0.0006033606,0.0016009855,0.0010563249,0.00006340392,0.00005421559],"about_ca_topic_score_codex":0.0010657525,"about_ca_topic_score_gemma":0.00020200986,"teacher_disagreement_score":0.3123933,"about_ca_system_score_codex":0.00011777888,"about_ca_system_score_gemma":0.00024993013,"threshold_uncertainty_score":0.26609054},"labels":[],"label_agreement":null},{"id":"W4393093045","doi":"10.1158/1538-7445.am2024-1030","title":"Abstract 1030: Concordance between the DESTINY-Breast04 clinical trial assay (4B5[CDx]) and other HER2 IHC assays for HER2-low breast cancer in real-world practice: First phase of a large-scale, multicenter global ring study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Concordance; Breast cancer; Cancer; Destiny (ISS module); Medicine; Immunohistochemistry; Oncology; Internal medicine","score_opus":0.2276398584926865,"score_gpt":0.5914306417682521,"score_spread":0.3637907832755656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680827,0.0029957783,0.00008588803,0.012419376,0.00085472513,0.009340921,0.002957545,0.00009690087,0.0031661214],"genre_scores_gemma":[0.99129814,0.0012489944,0.0001843471,0.0001759798,0.002945304,0.003140235,0.000015435668,0.00013965975,0.0008518937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99193275,0.0012810696,0.0015556872,0.0013934582,0.0022327076,0.0016043485],"domain_scores_gemma":[0.98998773,0.0070674126,0.00025622477,0.000998184,0.0010741169,0.0006163504],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.018456027,0.00043748118,0.0011060915,0.0003636035,0.00033116934,0.00028096547,0.00071432453,0.0002789338,0.0007208173],"category_scores_gemma":[0.0021697741,0.0003237627,0.0002675026,0.0018759764,0.0009161582,0.00032773276,0.0004397924,0.0024722414,0.000028263697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07089803,0.0043552713,0.83409226,0.0025407344,0.0010409765,0.0003907406,0.0020846215,0.000048541257,0.00023637475,0.00013421323,0.006684097,0.07749415],"study_design_scores_gemma":[0.14358157,0.00435952,0.74064106,0.00794214,0.0006207044,0.000055874814,0.0053664222,0.0050792648,0.0004306792,0.00015053028,0.09096621,0.0008060519],"about_ca_topic_score_codex":0.028742198,"about_ca_topic_score_gemma":0.050639,"teacher_disagreement_score":0.09345121,"about_ca_system_score_codex":0.0017845468,"about_ca_system_score_gemma":0.0027195017,"threshold_uncertainty_score":0.99992144},"labels":[],"label_agreement":null},{"id":"W4393093059","doi":"10.1158/1538-7445.am2024-2427","title":"Abstract 2427: The development of a tissue-agnostic genome-wide methylome enrichment MRD assay for applications across the cancer care continuum for head and neck malignancies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Association of Canadian Map Libraries and Archives; University Health Network","funders":"","keywords":"Head and neck; Head and neck cancer; DNA methylation; Cancer; Oncology; Biology; Medicine; Computational biology; Internal medicine; Genetics; Surgery; Gene","score_opus":0.05720385399069514,"score_gpt":0.4574640619463747,"score_spread":0.4002602079556795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86523426,0.08064044,0.019808432,0.028074404,0.00028262523,0.005473083,0.00022931356,0.000043091986,0.00021433794],"genre_scores_gemma":[0.98416454,0.0013746453,0.0024014998,0.00031686277,0.0004229882,0.009681263,0.000040272866,0.00004228444,0.0015556564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983777,0.000049636907,0.0003177141,0.0003449436,0.0004287042,0.0004813369],"domain_scores_gemma":[0.997006,0.00212281,0.000050983603,0.00027696835,0.0004252056,0.00011804464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022872135,0.00012395755,0.00024065572,0.00006893612,0.0005071961,0.000107657004,0.00026261373,0.00005383786,0.000038236336],"category_scores_gemma":[0.00057988334,0.00006967482,0.0000633583,0.00027233645,0.00033699846,0.000032309857,0.0001146447,0.0004280247,0.0000029657324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030347856,0.000102314116,0.0089510735,0.0078405,0.0006993234,0.00001029193,0.042356372,0.00020306112,0.2210144,0.0009205133,0.01335528,0.70424336],"study_design_scores_gemma":[0.00085573125,0.00011838601,0.048032694,0.0006853432,0.00008354408,0.0000036887716,0.0030911895,0.00034227714,0.01842385,0.00032038515,0.9279162,0.00012671069],"about_ca_topic_score_codex":0.00030808206,"about_ca_topic_score_gemma":0.00041265538,"teacher_disagreement_score":0.9145609,"about_ca_system_score_codex":0.0002756552,"about_ca_system_score_gemma":0.00079479575,"threshold_uncertainty_score":0.3900994},"labels":[],"label_agreement":null},{"id":"W4393093060","doi":"10.1158/1538-7445.am2024-5025","title":"Abstract 5025: Extracellular vesicle DNA as a potential biomarker for cancer detection: A comparative analysis with ctDNA","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Extracellular vesicles; Biomarker; Extracellular vesicle; Cancer; Medicine; Biology; Internal medicine; Genetics; Gene; Microvesicles; Cell biology; microRNA","score_opus":0.05390775444007866,"score_gpt":0.40857082149634716,"score_spread":0.3546630670562685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95259815,0.038639773,0.0065471632,0.00047151916,0.00018736222,0.000726983,0.00021951174,0.000040915766,0.00056860235],"genre_scores_gemma":[0.99415237,0.00045564605,0.0001653449,0.000034169414,0.0005187605,0.0010940742,0.00011222633,0.0000478954,0.0034195243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768996,0.00012565272,0.00024254121,0.00083859777,0.000507742,0.00059550675],"domain_scores_gemma":[0.9987477,0.000057696652,0.00004949801,0.00049735996,0.00040150553,0.00024625633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060875335,0.0002233927,0.00023824065,0.0002836341,0.0002664332,0.00020625697,0.00032513458,0.00016217121,0.0005337067],"category_scores_gemma":[0.000036789057,0.00019501812,0.0002631229,0.0010288844,0.00033762126,0.000018053797,0.000104842904,0.0002711763,0.000040016934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010765756,0.000091172784,0.00022994632,0.00015914823,0.0017137981,0.00008270972,0.00012070352,0.0007228075,0.98396844,0.000063201594,0.0024586427,0.009312847],"study_design_scores_gemma":[0.000647014,0.0002932025,0.002578264,0.000076486926,0.00042009735,0.00000953729,0.00033990105,0.0030375188,0.9156463,0.00014556808,0.07646561,0.0003405061],"about_ca_topic_score_codex":0.00053543004,"about_ca_topic_score_gemma":0.0011026249,"teacher_disagreement_score":0.07400696,"about_ca_system_score_codex":0.00016981529,"about_ca_system_score_gemma":0.0006189031,"threshold_uncertainty_score":0.7952608},"labels":[],"label_agreement":null},{"id":"W4393093070","doi":"10.1158/1538-7445.am2024-6740","title":"Abstract 6740: Next-generation LNPs induce effective anti-tumor T cell responses","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Pacific Railway (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer research; Biology","score_opus":0.18236883560364034,"score_gpt":0.46299014508014313,"score_spread":0.28062130947650277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755081,0.009568283,0.000013296567,0.0022914011,0.00051583606,0.001764363,0.00004063764,0.0001422923,0.01015582],"genre_scores_gemma":[0.9665617,0.00155081,0.00003351941,0.00014688775,0.0020040765,0.00074015796,0.000030976447,0.00009949637,0.028832378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960567,0.00049647945,0.0002767463,0.00074868096,0.0015504173,0.00087098917],"domain_scores_gemma":[0.9974244,0.0010320735,0.0000327199,0.0005937158,0.0005607199,0.00035635722],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0029160434,0.00021326922,0.00032458347,0.0008237652,0.00025216307,0.00037763864,0.0002546591,0.00015809003,0.008355663],"category_scores_gemma":[0.0005305345,0.00018143415,0.00014665288,0.0013911363,0.0003051461,0.000263828,0.00013895975,0.0017871454,0.0009716549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083703425,0.00011319513,0.0007226411,0.00055085524,0.00008362521,0.000709867,0.00048651587,0.000009543595,0.92109376,0.0000723656,0.020488432,0.054832134],"study_design_scores_gemma":[0.00089545414,0.00054525497,0.01588977,0.00040888673,0.000022499476,0.00004516127,0.00021528002,0.0004717254,0.87798846,0.000064582295,0.103260174,0.0001927507],"about_ca_topic_score_codex":0.0010900308,"about_ca_topic_score_gemma":0.00009608167,"teacher_disagreement_score":0.08277174,"about_ca_system_score_codex":0.0010671437,"about_ca_system_score_gemma":0.0017349422,"threshold_uncertainty_score":0.9998062},"labels":[],"label_agreement":null},{"id":"W4393093102","doi":"10.1158/1538-7445.am2024-1121","title":"Abstract 1121: Targeting the DNA damage response in high-risk medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medulloblastoma; Medicine; DNA damage; Oncology; Cancer research; DNA; Biology; Genetics","score_opus":0.04655388786459958,"score_gpt":0.40006179929744906,"score_spread":0.3535079114328495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97584784,0.006906911,7.0144216e-7,0.015805218,0.00020852694,0.00052958226,0.000038598468,0.000051269686,0.0006113636],"genre_scores_gemma":[0.9976821,0.0009838657,0.00002916073,0.000078941586,0.00027931185,0.00046058197,0.0000086786595,0.000035004145,0.00044236702],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979133,0.00033578524,0.00021138073,0.00036052166,0.00066452794,0.00051450403],"domain_scores_gemma":[0.99793667,0.0014280101,0.000020293754,0.00036331397,0.00010993852,0.00014175478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029313033,0.00012054361,0.00017726209,0.0003451642,0.00016650886,0.000109443274,0.00016145757,0.00007120117,0.00092511124],"category_scores_gemma":[0.00065616093,0.00007217646,0.000073617666,0.0008676814,0.00015890683,0.00006828303,0.00009519206,0.0008013535,0.00035791684],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009937744,0.0011984159,0.1307902,0.00087678805,0.00074401184,0.017775593,0.006704287,0.00038864536,0.5539087,0.0021033096,0.18810868,0.08746362],"study_design_scores_gemma":[0.0018027208,0.00052662217,0.8447728,0.0011185368,0.000051677063,0.000018620742,0.0010594194,0.00034259894,0.092640154,0.0004640828,0.057045396,0.00015737767],"about_ca_topic_score_codex":0.0032714505,"about_ca_topic_score_gemma":0.00048400983,"teacher_disagreement_score":0.7139826,"about_ca_system_score_codex":0.0005174096,"about_ca_system_score_gemma":0.0004640693,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W4393093106","doi":"10.1158/1538-7445.am2024-6176","title":"Abstract 6176: Identifying poor prognosis stage I lung adenocarcinoma patients through novel morphological biomarker based on computational pathology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Stage (stratigraphy); Medicine; Biomarker; Adenocarcinoma; Pathology; Lung cancer; Lung; Oncology; Internal medicine; Cancer; Biology","score_opus":0.11966133644897951,"score_gpt":0.4505551289426281,"score_spread":0.3308937924936486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808486,0.0014060409,0.0062653837,0.0085581895,0.00054198183,0.0007032981,0.00008896467,0.00013262055,0.0014548954],"genre_scores_gemma":[0.99504614,0.000057934893,0.0024859286,0.0013407252,0.00024756385,0.00019309913,0.00018494843,0.000053906097,0.00038977334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970986,0.00013790802,0.0003260824,0.0006652624,0.0011659635,0.00060613756],"domain_scores_gemma":[0.99866205,0.00061038183,0.00004333009,0.00019743702,0.00027160018,0.00021517735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011691788,0.00018022126,0.0002705438,0.0003507422,0.00021959477,0.00015180398,0.00020131173,0.00014552775,0.0012356223],"category_scores_gemma":[0.00056702207,0.00014063198,0.0001241867,0.0005679311,0.00037043373,0.000110520334,0.00010594153,0.0013823399,0.00009162396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017839213,0.002688218,0.74748206,0.004411994,0.00053606735,0.009014527,0.0013711157,0.005884001,0.0767186,0.0025925862,0.08234045,0.06517647],"study_design_scores_gemma":[0.0026588493,0.0003760804,0.7534104,0.00119196,0.000052119984,0.0000454109,0.000081854625,0.23530632,0.0008104631,0.00023069177,0.0055846474,0.00025120281],"about_ca_topic_score_codex":0.0001902324,"about_ca_topic_score_gemma":0.0000017150624,"teacher_disagreement_score":0.22942233,"about_ca_system_score_codex":0.00039524466,"about_ca_system_score_gemma":0.00040330397,"threshold_uncertainty_score":0.99967736},"labels":[],"label_agreement":null},{"id":"W4393093173","doi":"10.1158/1538-7445.am2024-278","title":"Abstract 278: Investigating the functional role of cancer-associated fibroblasts in the emergence of drug-tolerant persisters in ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ovarian cancer; Cancer; Medicine; Drug; Cancer research; Cancer drugs; Oncology; Biology; Internal medicine; Pharmacology","score_opus":0.04376521771487084,"score_gpt":0.35073144653355837,"score_spread":0.3069662288186875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969312,0.02884145,0.0000029043129,0.0009929001,0.00012029971,0.0001966706,0.000067312365,0.0000025169895,0.0004639056],"genre_scores_gemma":[0.9975292,0.001786254,0.0000028830473,0.000059004826,0.00014470668,0.00021560986,0.000022036658,0.000013817461,0.00022646072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986466,0.00013381243,0.00025960436,0.00027003794,0.00039806956,0.0002918594],"domain_scores_gemma":[0.9994616,0.000085154024,0.000059060738,0.00018772928,0.00017176218,0.000034710138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009694032,0.00009682846,0.00012280224,0.00008643869,0.000073338386,0.00002329921,0.0003179256,0.00007860739,0.00019457651],"category_scores_gemma":[0.00009727946,0.00006578067,0.00006868598,0.00063167,0.00024901185,0.0000075833336,0.00008564487,0.00034325314,9.949898e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060367565,0.000042656575,0.018161587,0.0002615857,0.00006192292,0.00000307463,0.0026261972,0.0030293923,0.97160774,0.0000685797,0.0017816398,0.0022952254],"study_design_scores_gemma":[0.0005082044,0.000078113866,0.090242095,0.0010313881,0.000020830668,0.0000017775811,0.008191912,0.00097465445,0.89484864,0.00039296,0.0035170843,0.00019234887],"about_ca_topic_score_codex":0.01689438,"about_ca_topic_score_gemma":0.029613445,"teacher_disagreement_score":0.07675914,"about_ca_system_score_codex":0.000061873754,"about_ca_system_score_gemma":0.00085231115,"threshold_uncertainty_score":0.9896522},"labels":[],"label_agreement":null},{"id":"W4393093244","doi":"10.1158/1538-7445.am2024-4930","title":"Abstract 4930: Identification of CBX7 and PCDHB18 as novel prognostic biomarkers of cervical cancer: RNA-sequencing and machine learning analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer; Identification (biology); Cervical cancer; RNA; Biology; Computational biology; Medicine; Physiology; Oncology; Internal medicine; Bioinformatics; Genetics; Gene; Ecology","score_opus":0.04440099942385956,"score_gpt":0.37861616845420504,"score_spread":0.3342151690303455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96664023,0.02937769,0.0029275357,0.00027951598,0.00006284473,0.000378235,0.0001299133,0.000012490855,0.00019156317],"genre_scores_gemma":[0.9908247,0.008454504,0.00008636513,0.000008331457,0.00006620703,0.00011813667,0.00007143814,0.000033935183,0.00033637843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979816,0.000121401434,0.00036195878,0.00058847724,0.00058349065,0.00036306135],"domain_scores_gemma":[0.9989881,0.0001010908,0.00008539462,0.00027840893,0.0004002546,0.00014676889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012338195,0.00014036465,0.00024261852,0.00052600197,0.000107594184,0.00007971585,0.00020140084,0.00018002719,0.0001158221],"category_scores_gemma":[0.00037550562,0.0001368929,0.000098442484,0.0011272128,0.00035219165,0.0000119220485,0.000244615,0.00042278055,0.0000018136566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013371152,0.000023026636,0.0014031137,0.0005863592,0.0008923443,0.000008389353,0.00014066198,0.00079044193,0.9812586,0.0001164452,0.000035006597,0.014611958],"study_design_scores_gemma":[0.0003530348,0.00020849628,0.0059158984,0.00021067147,0.00018628426,0.000008366822,0.00019505946,0.008737877,0.9830853,0.00007521331,0.00087764737,0.00014620308],"about_ca_topic_score_codex":0.0054183826,"about_ca_topic_score_gemma":0.00080495386,"teacher_disagreement_score":0.024184491,"about_ca_system_score_codex":0.00012491373,"about_ca_system_score_gemma":0.0006125522,"threshold_uncertainty_score":0.819101},"labels":[],"label_agreement":null},{"id":"W4393093270","doi":"10.1158/1538-7445.am2024-1066","title":"Abstract 1066: Colocalization of ovarian cancer-associated biomarkers in tumors, cancer cells and extracellular vesicles","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colocalization; Cancer; Extracellular vesicles; Ovarian cancer; Medicine; Cancer research; Pathology; Microvesicles; Biology; Oncology; Internal medicine; Cell biology; Biochemistry; microRNA","score_opus":0.02812802985503805,"score_gpt":0.35243224193589784,"score_spread":0.3243042120808598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292309,0.06811435,0.00042572527,0.00064021576,0.00028794637,0.00074808864,0.00030818043,0.000023791954,0.00022075616],"genre_scores_gemma":[0.98181176,0.016806128,0.000035105906,0.00002763292,0.0001517378,0.00044187973,0.00007639623,0.00007253208,0.0005768418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731666,0.00025566545,0.00038245897,0.0007182509,0.0006440254,0.0006829579],"domain_scores_gemma":[0.9990315,0.00006681518,0.00006850533,0.0003214059,0.0003334983,0.00017829676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012792789,0.00020507349,0.00025371916,0.0004089188,0.00010516552,0.00009641431,0.00030363438,0.00032723724,0.00033963233],"category_scores_gemma":[0.00012631368,0.00021315155,0.00007673862,0.0010762643,0.00032062203,0.00001552112,0.00021002341,0.0004898601,0.0000050712188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023592594,0.0000684998,0.00025490974,0.00036270972,0.00023506723,0.000056771092,0.00014672289,0.0012072066,0.9838279,0.0001557204,0.0029224104,0.010526183],"study_design_scores_gemma":[0.0007128635,0.00015543375,0.0012969583,0.00072476774,0.000019259056,0.0000021488247,0.00013560998,0.0021893308,0.9858034,0.00013470036,0.008595008,0.00023051239],"about_ca_topic_score_codex":0.009205305,"about_ca_topic_score_gemma":0.0044517345,"teacher_disagreement_score":0.0525808,"about_ca_system_score_codex":0.00042745544,"about_ca_system_score_gemma":0.001419776,"threshold_uncertainty_score":0.9973925},"labels":[],"label_agreement":null},{"id":"W4393093306","doi":"10.1158/1538-7445.am2024-6962","title":"Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Biomarker; Cancer; Prostate; Oncology; Urinary system; Internal medicine; Biology","score_opus":0.06089445035445586,"score_gpt":0.44515856457292385,"score_spread":0.384264114218468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8608576,0.112912096,0.000014099325,0.01523979,0.00025309832,0.008215319,0.0019530231,0.00012923357,0.00042575857],"genre_scores_gemma":[0.9304226,0.043730997,0.0003551803,0.00028052242,0.0005184603,0.017123004,0.000253143,0.00015908244,0.007157025],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947231,0.00016824041,0.00049851445,0.0014892031,0.0014879921,0.001632988],"domain_scores_gemma":[0.9978208,0.0004048005,0.00008527388,0.00045945126,0.00063153036,0.0005981307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013717547,0.0005475696,0.0006429291,0.0007741613,0.0005159547,0.0006121438,0.00026461898,0.00024613802,0.00056063896],"category_scores_gemma":[0.000110951536,0.00038379047,0.00012315273,0.0010861458,0.000759963,0.000462858,0.00018643079,0.0008793212,0.000014033844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015221067,0.0013902452,0.10402118,0.02033052,0.0013715952,0.002158576,0.019229071,0.0000014562146,0.2378645,0.00010151766,0.05137699,0.5469333],"study_design_scores_gemma":[0.02078337,0.007901616,0.529859,0.016845666,0.001019393,0.0005414467,0.002839981,0.0023807387,0.031102704,0.0006413833,0.3842994,0.0017853351],"about_ca_topic_score_codex":0.0015570727,"about_ca_topic_score_gemma":0.00023071976,"teacher_disagreement_score":0.54514796,"about_ca_system_score_codex":0.00055487955,"about_ca_system_score_gemma":0.0019145138,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W4393093329","doi":"10.1158/1538-7445.am2024-6969","title":"Abstract 6969: Determining the role of obesity in breast cancer progression","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Cancer; Breast cancer; Medicine; Obesity; Oncology; Internal medicine","score_opus":0.037611648053744624,"score_gpt":0.41929782618765277,"score_spread":0.38168617813390815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96089697,0.03626564,5.388357e-7,0.001103875,0.00007305852,0.00036904175,0.000041665797,0.000019823505,0.0012293707],"genre_scores_gemma":[0.99812275,0.0012907989,0.0000040324044,0.000024001081,0.00028046448,0.00013813125,0.000004498239,0.000015389825,0.00011995339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987067,0.00007707003,0.00013074216,0.0002242775,0.0005854432,0.00027576034],"domain_scores_gemma":[0.9994271,0.00007551121,0.0000131235665,0.00026242537,0.00011967672,0.000102169615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066274416,0.000071150775,0.00016743035,0.00012841818,0.0000686754,0.00003220992,0.000117188436,0.00005697148,0.00025503206],"category_scores_gemma":[0.000020543872,0.00004471849,0.00013868992,0.00045028707,0.00012743942,0.00006620813,0.00008792988,0.00049588335,0.00001177064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025126358,0.00014451805,0.56940097,0.0006506616,0.00018482607,0.00012594795,0.00039426555,0.000013905261,0.038408108,0.000064220796,0.00053445937,0.38982683],"study_design_scores_gemma":[0.00035619445,0.000020079575,0.9745527,0.0016640344,0.00005747882,0.000010140867,0.00012182658,0.00017734834,0.01916142,0.00007244513,0.0037517317,0.000054600834],"about_ca_topic_score_codex":0.0008404741,"about_ca_topic_score_gemma":0.000083512336,"teacher_disagreement_score":0.40515172,"about_ca_system_score_codex":0.00013378686,"about_ca_system_score_gemma":0.00048934924,"threshold_uncertainty_score":0.27924222},"labels":[],"label_agreement":null},{"id":"W4393093393","doi":"10.1158/1538-7445.am2024-3467","title":"Abstract 3467: Tumor immune and microbial characteristics of colorectal cancer according to age at diagnosis and detailed anatomical location","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Immune system; Oncology; Internal medicine; Immunology","score_opus":0.04519978848637372,"score_gpt":0.38324866362877774,"score_spread":0.338048875142404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827987,0.014554967,0.000002850431,0.0015792585,0.00025962092,0.00061902835,0.00011467832,0.000023165903,0.00004772974],"genre_scores_gemma":[0.99257815,0.0065466305,0.00002946089,0.00009819789,0.00019388326,0.0003330925,0.000017622848,0.000029921253,0.00017301962],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987489,0.00004142633,0.00028194176,0.0003350452,0.0002783436,0.00031433912],"domain_scores_gemma":[0.9993106,0.00020223594,0.00003709754,0.0001315036,0.00017353853,0.00014498658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005088839,0.00012302372,0.00029736682,0.00024087247,0.00010737997,0.000070996706,0.000079170495,0.00007443292,0.00034641073],"category_scores_gemma":[0.00009267679,0.00010648934,0.000048278125,0.00048827025,0.00028259004,0.00006884597,0.00012078351,0.00028038814,0.000006798877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029818045,0.000037396607,0.07399905,0.00083472836,0.00014492734,0.00007823944,0.0005637249,4.1208034e-7,0.8640671,0.00000952225,0.0011337311,0.05614939],"study_design_scores_gemma":[0.0010134212,0.00024009611,0.6555742,0.0015766742,0.000051000312,0.000027946224,0.00020027114,0.00005702594,0.33493793,0.000006577413,0.0061716055,0.00014324635],"about_ca_topic_score_codex":0.0020937016,"about_ca_topic_score_gemma":0.000654415,"teacher_disagreement_score":0.58157516,"about_ca_system_score_codex":0.00057160633,"about_ca_system_score_gemma":0.00037075,"threshold_uncertainty_score":0.43425092},"labels":[],"label_agreement":null},{"id":"W4393093418","doi":"10.1158/1538-7445.am2024-3460","title":"Abstract 3460: Predicting cessation of immune checkpoint inhibitor therapy due to severe adverse events with an integrated autoimmune disease polygenic risk score","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Disease; Immune system; Oncology; Internal medicine; Cancer; Immunology","score_opus":0.044160872160162894,"score_gpt":0.3637827662763959,"score_spread":0.319621894116233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862869,0.010590244,0.0000542795,0.0009431009,0.00031411025,0.0013464023,0.00023883734,0.00012243811,0.00010373256],"genre_scores_gemma":[0.9963155,0.0021305722,0.00009388285,0.00004654658,0.00027152474,0.00029518778,0.0001210925,0.00007437275,0.0006513383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973176,0.0001739757,0.00052639615,0.00052637025,0.0009653726,0.0004902979],"domain_scores_gemma":[0.9984516,0.00009637546,0.00011213962,0.000578864,0.00045793838,0.00030306558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426275,0.00023305681,0.00034081,0.00046108107,0.00018088684,0.00003710473,0.0002332505,0.00010593408,0.0009003986],"category_scores_gemma":[0.00010532384,0.00016672423,0.00016950049,0.0013923147,0.00018931959,0.0002863805,0.00005685829,0.0007450281,0.000018512723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06719932,0.00066224,0.06357991,0.0013376313,0.001318721,0.00029324985,0.0046748524,0.00032318835,0.6223134,0.000011782364,0.0004888443,0.23779687],"study_design_scores_gemma":[0.0043578087,0.0017634066,0.91275644,0.005316064,0.00008402859,0.000024482875,0.0015051605,0.0006340667,0.07046805,0.000044605815,0.0027511946,0.00029467142],"about_ca_topic_score_codex":0.0075017535,"about_ca_topic_score_gemma":0.00031845362,"teacher_disagreement_score":0.8491765,"about_ca_system_score_codex":0.0006666273,"about_ca_system_score_gemma":0.0018279294,"threshold_uncertainty_score":0.99910736},"labels":[],"label_agreement":null},{"id":"W4393093446","doi":"10.1158/1538-7445.am2024-6548","title":"Abstract 6548: Leveraging compact feature sets for TCGA-based molecular subtype classification on new samples","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Analytical Chemistry and Chromatography","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Feature (linguistics); Computational biology; Pattern recognition (psychology); Computer science; Biology; Artificial intelligence","score_opus":0.1539543933072297,"score_gpt":0.4257806480665253,"score_spread":0.2718262547592956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95264643,0.004044507,0.0012927458,0.0133952405,0.00013060535,0.0003114181,0.0003635813,0.00033229773,0.027483163],"genre_scores_gemma":[0.99724776,0.000050359595,0.00011909353,0.00010671314,0.00030703848,0.000049940412,0.00021040605,0.000043436266,0.0018652624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983512,0.000016470723,0.00014852581,0.00048770054,0.0005189716,0.0004771016],"domain_scores_gemma":[0.99877757,0.00044686487,0.000026723283,0.00037370285,0.00013133815,0.00024382911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024828303,0.00016865594,0.00016246752,0.00010890724,0.00016023996,0.00020665265,0.0002936217,0.00018203733,0.0014954797],"category_scores_gemma":[0.000110346766,0.00015302088,0.00018407665,0.0004045807,0.00011504123,0.000056699708,0.000016905742,0.0007099256,0.000043894623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019802056,0.00005941851,0.0006131243,0.0015486589,0.00012492773,0.00004039103,0.000057322708,0.00025139283,0.8992395,0.0016419223,0.091068916,0.0051564],"study_design_scores_gemma":[0.00041854635,0.00002627655,0.0010775864,0.00072917796,0.00003090453,0.0000015023879,0.000120172306,0.0033446734,0.8982336,0.0019464819,0.093828715,0.00024235525],"about_ca_topic_score_codex":0.00012973887,"about_ca_topic_score_gemma":0.000006590625,"teacher_disagreement_score":0.04460131,"about_ca_system_score_codex":0.00025489443,"about_ca_system_score_gemma":0.000567658,"threshold_uncertainty_score":0.9994173},"labels":[],"label_agreement":null},{"id":"W4393093557","doi":"10.1158/1538-7445.am2024-3454","title":"Abstract 3454: Cell-free DNA methylation and fragmentomic signatures identify tissue damage and predict cancer risk","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wilfrid Laurier University; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer; DNA methylation; Biology; Computational biology; Methylation; DNA; Genetics; Cancer research; Gene; Gene expression","score_opus":0.02116081514798437,"score_gpt":0.3731252419718662,"score_spread":0.35196442682388185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.888393,0.10936881,0.00008527706,0.0004646317,0.00031900947,0.0003003968,0.0005859716,0.000014356435,0.00046859126],"genre_scores_gemma":[0.9304139,0.067720585,0.000058407204,0.00006426724,0.0006859397,0.00014114556,0.000059773058,0.00003690372,0.0008190743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986178,0.00007508757,0.00016535168,0.0005324525,0.00027101798,0.00033823747],"domain_scores_gemma":[0.9992244,0.00013178441,0.000037078313,0.00033929344,0.000114465474,0.0001529346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062197604,0.000145662,0.00012600173,0.00012618705,0.00016419486,0.0002502899,0.00020815509,0.0001828597,0.00014020315],"category_scores_gemma":[0.0001390777,0.00013904783,0.000032891396,0.00015221584,0.00018028257,0.000011841752,0.0003329578,0.00037903243,0.000005941897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007224829,0.00001738681,0.0016578239,0.00024454517,0.00007483968,0.0000150867445,0.00016750989,0.00018282981,0.9366982,0.000073088995,0.038660046,0.02213637],"study_design_scores_gemma":[0.00080364407,0.00021554284,0.049560502,0.00015317861,0.00006731012,0.0000024023411,0.00012701693,0.00037662676,0.80035216,0.0015546074,0.14646922,0.00031777093],"about_ca_topic_score_codex":0.0017352437,"about_ca_topic_score_gemma":0.0009366718,"teacher_disagreement_score":0.13634606,"about_ca_system_score_codex":0.000081205704,"about_ca_system_score_gemma":0.00025267035,"threshold_uncertainty_score":0.5670206},"labels":[],"label_agreement":null},{"id":"W4393093578","doi":"10.1158/1538-7445.am2024-1868","title":"Abstract 1868: Target-dependent considerations for the design of bispecific T-cell engagers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Bispecific antibody; Computer science; Medicine; Human–computer interaction; Immunology; Antibody","score_opus":0.27608712638577726,"score_gpt":0.4572063767417708,"score_spread":0.18111925035599352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45613056,0.25952685,0.0498375,0.099913,0.005827312,0.046568617,0.0014917591,0.00087838515,0.07982601],"genre_scores_gemma":[0.972896,0.0032587387,0.0007272375,0.000062795734,0.000538755,0.0010564977,0.0000079301835,0.00006715658,0.0213849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746907,0.00023423326,0.00028953317,0.00037708206,0.0010640293,0.0005660373],"domain_scores_gemma":[0.99186707,0.0068077953,0.00002436377,0.0005252191,0.0006114431,0.00016413382],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041586272,0.0001251599,0.00022393058,0.00034247778,0.0003318729,0.00014490994,0.00021039027,0.00009439087,0.016788596],"category_scores_gemma":[0.00055645214,0.000084776024,0.00014355416,0.0004984061,0.00040137052,0.000068944944,0.000062821826,0.0010578276,0.00010665449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047013472,0.0000925009,0.00004778783,0.0005093966,0.00017101935,0.00006674949,0.0008796862,0.00077477,0.9067652,0.0006929584,0.08284973,0.0066800164],"study_design_scores_gemma":[0.0015994705,0.00048037714,0.00038469315,0.00026908764,0.00005567814,0.000023729888,0.0016166273,0.0039305068,0.86400473,0.0024962542,0.124969035,0.000169793],"about_ca_topic_score_codex":0.0003464721,"about_ca_topic_score_gemma":0.000036141253,"teacher_disagreement_score":0.5167654,"about_ca_system_score_codex":0.00037585993,"about_ca_system_score_gemma":0.0019419235,"threshold_uncertainty_score":0.9841102},"labels":[],"label_agreement":null},{"id":"W4393093616","doi":"10.1158/1538-7445.am2024-6956","title":"Abstract 6956: Role of soluble CD109 in the progression of head and neck squamous cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Head and neck; Basal cell; Head and neck squamous-cell carcinoma; Medicine; Oncology; Head and neck cancer; Internal medicine; Cancer; Surgery","score_opus":0.027601142690696676,"score_gpt":0.36763830902542527,"score_spread":0.3400371663347286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577482,0.040392946,0.0000022255504,0.00021953293,0.000059977963,0.00026591987,0.000011536714,0.0000026623752,0.0012970337],"genre_scores_gemma":[0.99914914,0.0004264853,0.00001957591,0.0000046102955,0.000114434166,0.000056998386,0.000017636547,0.000013186871,0.0001979555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991041,0.00006674879,0.00015574279,0.00021970383,0.00025783415,0.00019589005],"domain_scores_gemma":[0.99959546,0.000032199114,0.000029355704,0.00022108083,0.00009144017,0.00003047577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045728486,0.00006498917,0.00008481953,0.000086622385,0.000033025917,0.000017668575,0.00013993132,0.00010715788,0.00002417317],"category_scores_gemma":[0.000019700468,0.000048940634,0.000033963504,0.00023760961,0.00012868436,0.0000044627714,0.00007731852,0.00017778882,0.0000014091831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013159837,0.00004375096,0.005294184,0.00027717178,0.0000054279,0.0000025045154,0.00037652245,0.00015353372,0.9753275,0.00003781623,0.0012621694,0.017087834],"study_design_scores_gemma":[0.00038761177,0.00033270768,0.032929715,0.00011061703,0.0000052063574,0.0000031538095,0.00023599334,0.00027763145,0.95479095,0.00011502293,0.010746551,0.00006483254],"about_ca_topic_score_codex":0.00069688226,"about_ca_topic_score_gemma":0.0003971687,"teacher_disagreement_score":0.041400954,"about_ca_system_score_codex":0.000026617907,"about_ca_system_score_gemma":0.0002521248,"threshold_uncertainty_score":0.19957411},"labels":[],"label_agreement":null},{"id":"W4393093632","doi":"10.1158/1538-7445.am2024-5738","title":"Abstract 5738: Repurposing disulfiram for cancer: A drug delivery and population-based approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Disulfiram; Medicine; Cancer; Repurposing; Drug repositioning; Drug; Population; Pharmacology; Oncology; Internal medicine; Environmental health; Biology","score_opus":0.2405012005417548,"score_gpt":0.5120243348855528,"score_spread":0.27152313434379793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344262,0.057257235,0.00015764002,0.005609348,0.00025003462,0.0017905085,0.00005788174,0.00011562518,0.00033556522],"genre_scores_gemma":[0.9936623,0.0023046315,0.00035593388,0.0007301378,0.0004682805,0.0012798116,0.000068026704,0.000040066137,0.001090821],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984706,0.000058246587,0.00019645972,0.00041333796,0.00040582786,0.00045553324],"domain_scores_gemma":[0.99878675,0.0005213738,0.000023483317,0.00019216417,0.00020756295,0.00026866392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010063498,0.00010685269,0.00020245244,0.00026269452,0.0002748315,0.00010156322,0.00005849022,0.00008010618,0.00021858905],"category_scores_gemma":[0.000109128385,0.000090632544,0.0000609134,0.00030479825,0.000088909095,0.00008436572,0.000024799601,0.0004490901,0.000011214045],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030064234,0.00032562888,0.14658716,0.039704688,0.0003043842,0.00011494832,0.0020438968,0.00029161997,0.020341825,0.0014717486,0.12295344,0.66285425],"study_design_scores_gemma":[0.0057028746,0.00043336273,0.4921811,0.007983222,0.0002439061,0.000029271074,0.0003996426,0.090874985,0.0047295927,0.0005298621,0.39618912,0.0007030822],"about_ca_topic_score_codex":0.0034032157,"about_ca_topic_score_gemma":0.00027516147,"teacher_disagreement_score":0.66215116,"about_ca_system_score_codex":0.0005268745,"about_ca_system_score_gemma":0.0010822788,"threshold_uncertainty_score":0.51446664},"labels":[],"label_agreement":null},{"id":"W4393093657","doi":"10.1158/1538-7445.am2024-3500","title":"Abstract 3500: Refining diagnosis of renal cell carcinoma subtypes through single-cell resolution transcriptomic signatures","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Renal cell carcinoma; Transcriptome; Clear cell renal cell carcinoma; Refining (metallurgy); Cell; Cancer research; Medicine; Cancer; Computational biology; Pathology; Biology; Oncology; Internal medicine; Chemistry; Gene; Genetics; Gene expression","score_opus":0.05114863327086275,"score_gpt":0.3296740331217806,"score_spread":0.27852539985091784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91140634,0.082054906,0.0001068339,0.0002976023,0.0003672504,0.00015678626,0.00024069849,0.000014148382,0.0053554666],"genre_scores_gemma":[0.99205136,0.0061566695,0.00017438807,0.000065541855,0.0005797424,0.0001227054,0.00009905247,0.00005168412,0.00069886784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831927,0.00007251178,0.00027519872,0.000527366,0.00033774163,0.0004679084],"domain_scores_gemma":[0.9991441,0.00015546673,0.000048024598,0.000358421,0.0002019803,0.00009202241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041126233,0.0001657079,0.00017397333,0.00012093733,0.000113291746,0.000078254096,0.00029385934,0.00022595588,0.00014017329],"category_scores_gemma":[0.000071925024,0.0001632727,0.00013871798,0.00027538676,0.00019823531,0.000010302526,0.00010473216,0.00039535723,0.000014355636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016902167,0.000095763055,0.00077700295,0.00033002457,0.000026610049,0.000019065012,0.00026675648,0.00070682087,0.965255,0.00013693652,0.030148732,0.0020682665],"study_design_scores_gemma":[0.0003418742,0.0003293111,0.0012125394,0.00011463862,0.000022104648,0.0000012797973,0.00008971793,0.000040595027,0.87183106,0.00013097773,0.12571682,0.00016910546],"about_ca_topic_score_codex":0.0011849692,"about_ca_topic_score_gemma":0.000509771,"teacher_disagreement_score":0.09556808,"about_ca_system_score_codex":0.00014027653,"about_ca_system_score_gemma":0.00052211736,"threshold_uncertainty_score":0.6658068},"labels":[],"label_agreement":null},{"id":"W4393093723","doi":"10.1158/1538-7445.am2024-3717","title":"Abstract 3717: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Theratechnologies (Canada)","funders":"","keywords":"Immune system; Sting; Cancer research; Immunology; Medicine; Biology","score_opus":0.04241800642560123,"score_gpt":0.33431567785934796,"score_spread":0.29189767143374673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8880212,0.10769049,0.000012987471,0.0010365604,0.0010783017,0.0003886969,0.00009242154,0.00013003463,0.0015493574],"genre_scores_gemma":[0.98841584,0.0045111617,0.000007521928,0.00009683523,0.00010533532,0.00010084824,0.000057029934,0.000060003105,0.006645405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971538,0.00055867835,0.0005012985,0.00056367175,0.0001631878,0.0010593468],"domain_scores_gemma":[0.99773514,0.0015124237,0.000086413515,0.00040603627,0.00020255815,0.00005741029],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020245765,0.0002763528,0.00036354022,0.0003878689,0.0007540312,0.000252292,0.00051550753,0.00020944687,0.0017765091],"category_scores_gemma":[0.00037945714,0.00018833738,0.00016140993,0.0005312509,0.0007369723,0.00019660238,0.00027965303,0.0017770495,0.0009863443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003447146,0.000049135906,0.00032948906,0.00018808323,0.00018743561,0.000115500035,0.00078178186,0.00000575282,0.98720366,0.00008676824,0.0028290008,0.007878672],"study_design_scores_gemma":[0.0007247947,0.00015604252,0.008502619,0.00051078596,0.00003048602,0.000086674205,0.0021256374,0.00006303681,0.9291455,0.00005145862,0.058326542,0.00027639855],"about_ca_topic_score_codex":0.0015333048,"about_ca_topic_score_gemma":0.000034927198,"teacher_disagreement_score":0.10317933,"about_ca_system_score_codex":0.00013331289,"about_ca_system_score_gemma":0.0004941723,"threshold_uncertainty_score":0.9997915},"labels":[],"label_agreement":null},{"id":"W4393093726","doi":"10.1158/1538-7445.am2024-67","title":"Abstract 67: Predicting colorectal patient prognoses by functional characterisation of heterogeneous cell types and their spatial interaction using a new technique: Whole slide imaging mass cytometry","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Colorectal cancer; Medicine; Pathology; Internal medicine; Biology; Cancer; Genetics","score_opus":0.03101204730136115,"score_gpt":0.3591058842236604,"score_spread":0.32809383692229926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200923,0.002508693,0.013843079,0.0006322191,0.00032147052,0.00046875214,0.000029860761,0.00006286014,0.00012381085],"genre_scores_gemma":[0.99878794,0.00013447333,0.00042405986,0.000035533914,0.00040953953,0.000057850073,0.000052596162,0.000035225927,0.00006276683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987322,0.000065275846,0.00025521612,0.000299888,0.00039103898,0.0002563727],"domain_scores_gemma":[0.99937195,0.0001844852,0.00007363959,0.000090346555,0.00014188245,0.00013770156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004949925,0.00011828032,0.0001746407,0.00031320867,0.00010630459,0.000096003154,0.000050313673,0.0000585634,0.00013447345],"category_scores_gemma":[0.00016103132,0.00009626031,0.00005052968,0.00025959653,0.00011396751,0.00015233166,0.00005768469,0.0006949862,0.0000026223904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017518822,0.000037872822,0.015194535,0.00034117544,0.000041350442,0.000023092096,0.00048387735,0.00006020973,0.88140655,7.312135e-7,0.0004790879,0.10175634],"study_design_scores_gemma":[0.0006506804,0.0004039143,0.009826519,0.0019458963,0.000055295346,0.00023080614,0.00061590585,0.14541496,0.8342258,0.00007739307,0.0063531706,0.00019966628],"about_ca_topic_score_codex":0.0011160623,"about_ca_topic_score_gemma":0.000004939858,"teacher_disagreement_score":0.14535475,"about_ca_system_score_codex":0.00027840317,"about_ca_system_score_gemma":0.00032765002,"threshold_uncertainty_score":0.39253816},"labels":[],"label_agreement":null},{"id":"W4393093750","doi":"10.1158/1538-7445.am2024-1249","title":"Abstract 1249: cBioPortal for Cancer Genomics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Genomics; Medicine; Biology; Computational biology; Genetics; Genome; Gene","score_opus":0.09450901345165652,"score_gpt":0.4506848571436513,"score_spread":0.3561758436919948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402693,0.053499274,0.00080280483,0.001769785,0.00066549756,0.000507383,0.0004450193,0.000024129135,0.0020168077],"genre_scores_gemma":[0.97823364,0.010898867,0.00010445966,0.00009047985,0.0013205286,0.001372299,0.00008049348,0.000043148146,0.007856078],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988938,0.000016031001,0.00014218895,0.00041103218,0.00017335193,0.0003636033],"domain_scores_gemma":[0.9993758,0.00001971347,0.000017185821,0.0002862382,0.00020942373,0.000091609116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038450904,0.00009379268,0.0000838429,0.00007204909,0.00014368875,0.000101331236,0.00022252851,0.00010935335,0.00032652487],"category_scores_gemma":[0.000024421779,0.000085540414,0.00008982382,0.00015232217,0.0001154196,0.000005015539,0.000056022338,0.00016405819,0.00002740697],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005890032,0.000017332837,0.000116678406,0.00011692411,0.00007204447,0.0000024776689,0.000049381997,0.00010879689,0.8923185,0.00056099007,0.044301484,0.062276497],"study_design_scores_gemma":[0.00013730982,0.000051477644,0.0006067324,0.000044520435,0.000007685067,0.0000013536348,0.000059945905,0.00012659075,0.2299201,0.00021765864,0.7687101,0.00011655785],"about_ca_topic_score_codex":0.00033031244,"about_ca_topic_score_gemma":0.0002834422,"teacher_disagreement_score":0.72440857,"about_ca_system_score_codex":0.00012696195,"about_ca_system_score_gemma":0.000806808,"threshold_uncertainty_score":0.35752183},"labels":[],"label_agreement":null},{"id":"W4393093781","doi":"10.1158/1538-7445.am2024-2898","title":"Abstract 2898: Development of the lipid kinase PIKfyve PROTAC degrader against neuroendocrine prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Prostate cancer; Prostate; Medicine; Cancer research; Internal medicine","score_opus":0.044842732114044076,"score_gpt":0.3679886500601447,"score_spread":0.3231459179461006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968196,0.006125335,0.000012734155,0.0019520402,0.00046220454,0.0008742028,0.0000473845,0.000016924214,0.0008271935],"genre_scores_gemma":[0.9922234,0.0011730273,0.00006253589,0.00013829835,0.00036957438,0.0008860677,0.000027147471,0.000033134238,0.005086823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984812,0.000083864084,0.00024594643,0.00037625188,0.00043616956,0.00037657598],"domain_scores_gemma":[0.99933153,0.000013729118,0.000041202165,0.00033180977,0.00019210749,0.00008961525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029831845,0.00013016557,0.000099872996,0.000079222635,0.00016148225,0.000057557852,0.00031515642,0.000044914912,0.00013338808],"category_scores_gemma":[0.000087447945,0.00008917454,0.00007143567,0.00035443885,0.00018027272,0.000008179511,0.00023758646,0.00033176848,0.000014831957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000579959,0.00003606247,0.00069562916,0.0002340398,0.00004244,0.0000071873333,0.00013873416,0.000025019192,0.8896531,0.0000365138,0.015432905,0.09364036],"study_design_scores_gemma":[0.00014485829,0.000027136064,0.0019448815,0.00015366956,0.000002275026,0.000001186905,0.000035908924,0.000013580377,0.7001251,0.000011899427,0.2974606,0.00007888124],"about_ca_topic_score_codex":0.000093731964,"about_ca_topic_score_gemma":0.00021371008,"teacher_disagreement_score":0.2820277,"about_ca_system_score_codex":0.00008834452,"about_ca_system_score_gemma":0.0011921956,"threshold_uncertainty_score":0.36364323},"labels":[],"label_agreement":null},{"id":"W4393093787","doi":"10.1158/1538-7445.am2024-883","title":"Abstract 883: Genetic characteristics between males and females with urothelial bladder cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Urothelial cancer; Cancer; Bladder cancer; Medicine; Urology; Oncology; Internal medicine","score_opus":0.11232281895213285,"score_gpt":0.42028536970988223,"score_spread":0.30796255075774936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768827,0.017010314,0.000022510385,0.0027072427,0.00020161748,0.00071645255,0.00044184196,0.0000917979,0.0019255136],"genre_scores_gemma":[0.98718834,0.00608182,0.00012012693,0.00014678655,0.0019365846,0.00048420017,0.000025486772,0.00009112278,0.003925554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788386,0.00004910056,0.0002255382,0.0005593364,0.0006907311,0.0005914257],"domain_scores_gemma":[0.9990126,0.00014428374,0.00002594406,0.0002879541,0.00020581065,0.00032340572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002100605,0.00023283406,0.00034762113,0.00022499701,0.0001681146,0.00016815924,0.00012072223,0.00011761312,0.0017327698],"category_scores_gemma":[0.000020135767,0.00016496182,0.000055026372,0.0003583719,0.0003902298,0.00009589421,0.00006529105,0.000568471,0.000099079596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010007975,0.00013108688,0.71089375,0.002152648,0.001475748,0.0011698777,0.0011289257,0.0000032950209,0.02049981,0.00013757752,0.006409211,0.25499725],"study_design_scores_gemma":[0.0011282051,0.00049894536,0.9451551,0.0011236959,0.00027742423,0.000047870297,0.00009519585,0.000018882922,0.00697447,0.0001013608,0.04433704,0.00024181136],"about_ca_topic_score_codex":0.0013495623,"about_ca_topic_score_gemma":0.0002480543,"teacher_disagreement_score":0.25475544,"about_ca_system_score_codex":0.00025633434,"about_ca_system_score_gemma":0.0011028145,"threshold_uncertainty_score":0.9991798},"labels":[],"label_agreement":null},{"id":"W4393093855","doi":"10.1158/1538-7445.am2024-2443","title":"Abstract 2443: Improved detection of low frequency mutations in ovarian and endometrial cancers by utilizing a highly accurate sequencing platform","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Endometrial cancer; Medicine; Oncology; Computational biology; Internal medicine; Biology; Cancer","score_opus":0.04950854226924452,"score_gpt":0.35740855904087043,"score_spread":0.30790001677162593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879344,0.010409062,0.00027086525,0.00008633746,0.00033720868,0.00032598662,0.0002592467,0.000007330019,0.00036957362],"genre_scores_gemma":[0.995412,0.004005082,0.000066096574,0.000017683997,0.0002387138,0.0001430984,0.000050852148,0.000023823104,0.000042667598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988394,0.000027646807,0.0002538004,0.00035835488,0.00016579758,0.00035499234],"domain_scores_gemma":[0.99943095,0.00014661177,0.00004346833,0.00016561362,0.00012635226,0.00008700772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005547127,0.00010696693,0.00013201154,0.0002543516,0.00008736847,0.00008247843,0.00011750672,0.00012777263,0.000021244936],"category_scores_gemma":[0.0003135568,0.00011034284,0.000042321462,0.00048389824,0.00012908466,0.000015887976,0.00007713495,0.00027125856,0.0000012921836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011263479,0.000008214533,0.0001396144,0.0001426782,0.00003639956,0.000007153933,0.00016744963,0.00013502041,0.9879001,0.000095698335,0.00010238402,0.01115266],"study_design_scores_gemma":[0.00085626123,0.00021559828,0.0007992431,0.0001556038,0.000009961933,0.000004067872,0.0004108471,0.000849315,0.9943052,0.00042624518,0.001808706,0.00015895389],"about_ca_topic_score_codex":0.011133894,"about_ca_topic_score_gemma":0.0068467297,"teacher_disagreement_score":0.010993706,"about_ca_system_score_codex":0.0004769633,"about_ca_system_score_gemma":0.001069598,"threshold_uncertainty_score":0.99545103},"labels":[],"label_agreement":null},{"id":"W4393094037","doi":"10.1158/1538-7445.am2024-5111","title":"Abstract 5111: Rational synergistic radiosensitization strategies for group 3 medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Internal medicine; Gerontology; Cancer research","score_opus":0.13244132696943264,"score_gpt":0.4120065527186563,"score_spread":0.2795652257492237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90457374,0.00086455117,0.061459757,0.011507971,0.0035334493,0.0019303539,0.00025196106,0.0008340423,0.015044176],"genre_scores_gemma":[0.9971336,0.00008486614,0.000044546417,0.00014269842,0.00053348753,0.0004917165,0.000016708655,0.00002712287,0.0015252393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998439,0.00011525852,0.00017124423,0.00044419846,0.00053090847,0.00029939978],"domain_scores_gemma":[0.99874014,0.0008481396,0.000024266337,0.00015674891,0.00014926784,0.000081459155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005748215,0.000088383495,0.00007735419,0.0002360856,0.0003375046,0.00047899666,0.00015152025,0.000058928523,0.0003723577],"category_scores_gemma":[0.00046919342,0.00008262685,0.00004980296,0.00064635725,0.00020639788,0.00034051194,0.000019270328,0.0002680639,0.0001332995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052818734,0.000018013263,0.0000013075506,0.000119177595,0.0000038922976,0.000010008982,0.00012955978,0.00023293012,0.8352013,0.14946985,0.0070064403,0.007754669],"study_design_scores_gemma":[0.0005334977,0.00020936756,0.0017860882,0.00022570256,0.0000119106835,0.000033975517,0.00086354325,0.055960882,0.7971293,0.03502359,0.10787687,0.0003452785],"about_ca_topic_score_codex":0.000027919203,"about_ca_topic_score_gemma":0.000063808206,"teacher_disagreement_score":0.11444627,"about_ca_system_score_codex":0.00023796706,"about_ca_system_score_gemma":0.00042007098,"threshold_uncertainty_score":0.46189758},"labels":[],"label_agreement":null},{"id":"W4393094075","doi":"10.1158/1538-7445.am2024-4847","title":"Abstract 4847: Diverging global incidence trends of early-onset and later-onset cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Age of onset; Cancer; Pediatrics; Demography; Oncology; Internal medicine; Disease; Physics; Sociology","score_opus":0.07356735176665763,"score_gpt":0.4272938993333801,"score_spread":0.35372654756672245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802205,0.011304323,0.0000039144707,0.0011757363,0.0003070202,0.0001884771,0.00049197586,0.000051958137,0.0062561184],"genre_scores_gemma":[0.9955074,0.0026732297,0.000051333263,0.00014814307,0.00017925061,0.00005854101,0.000027858254,0.000022061888,0.0013321686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979902,0.000062661056,0.000270823,0.00046543358,0.00069099315,0.0005199027],"domain_scores_gemma":[0.9990635,0.00018249433,0.00003380617,0.00030369576,0.000141011,0.00027553018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006078056,0.00015570922,0.00030842217,0.00030315074,0.00011848654,0.000073072435,0.00017386793,0.00010247014,0.0017945255],"category_scores_gemma":[0.000056023306,0.00013593848,0.00008381604,0.0008490115,0.0004490758,0.00021835996,0.00015057666,0.0005470274,0.000022256467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018001802,0.000044806664,0.61769146,0.0020366758,0.00042442203,0.000818656,0.0025750822,0.00005478136,0.011761605,0.00012032112,0.039376475,0.32329553],"study_design_scores_gemma":[0.0011608856,0.00039514914,0.97167677,0.0012543969,0.000061207844,0.00008130505,0.00034593456,0.00037431414,0.005690065,0.00022239795,0.018503252,0.000234354],"about_ca_topic_score_codex":0.0102622425,"about_ca_topic_score_gemma":0.000993977,"teacher_disagreement_score":0.35398528,"about_ca_system_score_codex":0.0011088601,"about_ca_system_score_gemma":0.0018326258,"threshold_uncertainty_score":0.999118},"labels":[],"label_agreement":null},{"id":"W4393094090","doi":"10.1158/1538-7445.am2024-5072","title":"Abstract 5072: Multi-omic, multi-scale characterisation of colorectal cancer defines spatiotemporal patterns of recurrence","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Colorectal cancer; Cancer; Scale (ratio); Medicine; Computational biology; Oncology; Biology; Internal medicine; Geography; Cartography","score_opus":0.13868819974294985,"score_gpt":0.44704539206247235,"score_spread":0.3083571923195225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755956,0.00931997,0.000040780775,0.0010336888,0.0004799935,0.0007175122,0.0006728696,0.000033769753,0.000141851],"genre_scores_gemma":[0.99208117,0.006388371,0.00019867,0.000016311913,0.00015922029,0.0004926092,0.00005194811,0.000028881004,0.00058280636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830204,0.000051931995,0.0003906325,0.00038675236,0.00052911526,0.00033953172],"domain_scores_gemma":[0.9989654,0.00013696408,0.00009343642,0.00017991413,0.0005242628,0.0001000122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003459259,0.00016708647,0.0004186271,0.0002495834,0.00008031668,0.000022499913,0.00011397514,0.00009151687,0.0006101854],"category_scores_gemma":[0.0000676196,0.0001313154,0.00012341705,0.000377332,0.00021426876,0.0001132671,0.000085641426,0.00033330786,0.000012322217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010879282,0.00048788622,0.6665402,0.0022735023,0.0003712638,0.00003782798,0.0039899135,0.000008969615,0.21560827,0.000017273056,0.0007259877,0.10885098],"study_design_scores_gemma":[0.0010943068,0.0003493408,0.8653626,0.0013729392,0.00005492134,0.0000029002006,0.0003083283,0.0005226237,0.12956034,0.0000062071854,0.00125278,0.000112700385],"about_ca_topic_score_codex":0.01280121,"about_ca_topic_score_gemma":0.0060675493,"teacher_disagreement_score":0.19882242,"about_ca_system_score_codex":0.00043995012,"about_ca_system_score_gemma":0.00059340586,"threshold_uncertainty_score":0.9937726},"labels":[],"label_agreement":null},{"id":"W4393094857","doi":"10.1158/1538-7445.am2024-521","title":"Abstract 521: Anticancer mechanisms of epigallocatechin gallate revealed via cellular and molecular profiling","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigallocatechin gallate; Gallate; Profiling (computer programming); Computational biology; Chemistry; Cancer research; Biology; Pharmacology; Biochemistry; Polyphenol; Computer science; Antioxidant","score_opus":0.04292185579509052,"score_gpt":0.38278753464830884,"score_spread":0.33986567885321833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799084,0.014629934,0.002301459,0.0012921566,0.00016023089,0.00072825106,0.000012878018,0.00007054037,0.0008961728],"genre_scores_gemma":[0.99799657,0.0006262665,0.00067747204,0.000060544346,0.000117651674,0.00009163559,0.0000065740446,0.000051542764,0.00037176636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821746,0.000067923625,0.00023323213,0.00040416216,0.0006138151,0.00046339649],"domain_scores_gemma":[0.9992113,0.00010429432,0.00002631392,0.000305178,0.00015614013,0.00019676848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001111413,0.00013814402,0.0002986705,0.00022692613,0.00006140644,0.00004074395,0.000106917236,0.000114556795,0.00023992205],"category_scores_gemma":[0.00006951651,0.00011230877,0.00006967088,0.00044768112,0.0001661605,0.000059568858,0.000089528556,0.00057734083,0.000029992018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012199811,0.00002936342,0.00023086634,0.0023366478,0.00009762757,0.00038997724,0.00016669098,0.000007823822,0.98464,0.0029355052,0.00019460557,0.008848919],"study_design_scores_gemma":[0.00043756713,0.00021914318,0.0014603673,0.0012091656,0.000045792236,0.00001461521,0.000056770674,0.0010646697,0.9912709,0.003778151,0.00032801167,0.00011482129],"about_ca_topic_score_codex":0.00054624607,"about_ca_topic_score_gemma":0.00000969463,"teacher_disagreement_score":0.01808817,"about_ca_system_score_codex":0.00011784934,"about_ca_system_score_gemma":0.00031554495,"threshold_uncertainty_score":0.45798188},"labels":[],"label_agreement":null},{"id":"W4393094944","doi":"10.1158/1538-7445.am2024-3226","title":"Abstract 3226: PRMT1 is a critical dependency in clear cell renal cell carcinoma with roles in post- transcriptional regulation and DNA damage response","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; University Health Network","funders":"","keywords":"Renal cell carcinoma; Clear cell renal cell carcinoma; Cancer; DNA damage; Dependency (UML); Cell; Internal medicine; Cancer research; Biology; DNA; Medicine; Genetics","score_opus":0.01985769534150335,"score_gpt":0.32970723335513435,"score_spread":0.309849538013631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907679,0.0065024635,0.000043263848,0.0017941906,0.000043365584,0.0003070448,0.00007000749,0.000009077658,0.00046271272],"genre_scores_gemma":[0.99865794,0.00022638445,0.000077073004,0.000033430817,0.00014689592,0.00008226557,0.000057931607,0.00003539324,0.0006826714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822366,0.00022047716,0.00021892076,0.0005568211,0.0004045318,0.00037558918],"domain_scores_gemma":[0.9994133,0.00008119666,0.000017011453,0.00022223899,0.00016528042,0.000100949175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000800958,0.00013621425,0.00011370646,0.0003181392,0.00006758479,0.00007990237,0.0001158616,0.00022162651,0.00017481609],"category_scores_gemma":[0.000045010995,0.00013282085,0.000037356625,0.00035782743,0.00018652303,0.000025170402,0.000047566697,0.00041754032,0.000008288991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003817104,0.000054275326,0.0011571393,0.00015425154,0.0000072149714,0.000047845377,0.00046566455,0.00032865506,0.9922631,0.00004995609,0.0004206689,0.0012341662],"study_design_scores_gemma":[0.0010622683,0.00060560927,0.35410106,0.00018493425,0.0000099855915,0.000015985821,0.00028237415,0.001034817,0.6398259,0.00018041184,0.0024789125,0.0002177672],"about_ca_topic_score_codex":0.00040582358,"about_ca_topic_score_gemma":0.0021029564,"teacher_disagreement_score":0.35294393,"about_ca_system_score_codex":0.00021279936,"about_ca_system_score_gemma":0.0007898428,"threshold_uncertainty_score":0.5416277},"labels":[],"label_agreement":null},{"id":"W4393095090","doi":"10.1158/1538-7445.am2024-6657","title":"Abstract 6657: Oncolytic Vaccinia Virus Carrying OPCML Tumor Suppressor is active in Epithelial Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Oncolytic virus; Vaccinia; Ovarian cancer; Virology; Virus; Cancer research; Cancer; Suppressor; Biology; Medicine; Internal medicine; Gene; Genetics","score_opus":0.05634957584144204,"score_gpt":0.42342252581076073,"score_spread":0.3670729499693187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432815,0.010286885,0.0000044205935,0.0018012372,0.0003988272,0.0008084717,0.00071088586,0.00003124013,0.0016298828],"genre_scores_gemma":[0.993086,0.002553223,0.000015597394,0.00029626748,0.0012530141,0.0010481887,0.00004257403,0.000114828144,0.0015903197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99628186,0.00030629899,0.00034217138,0.0010311321,0.0008445073,0.0011940473],"domain_scores_gemma":[0.9985817,0.00012619093,0.000040321494,0.000670909,0.00029868737,0.00028220186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012834314,0.00028571402,0.00029541773,0.0004271647,0.0002006683,0.00020323435,0.0007357134,0.0002360687,0.0028803628],"category_scores_gemma":[0.00012881057,0.0002729814,0.0001476184,0.00079421804,0.00020631506,0.000024034496,0.00033289866,0.0011347386,0.00017533256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039570397,0.00007616458,0.0002159089,0.00017483222,0.00017170471,0.00016679036,0.0006217955,0.00013722066,0.9609262,0.000013204293,0.0070198104,0.02651933],"study_design_scores_gemma":[0.0009836731,0.0007047563,0.0020229626,0.00023451644,0.000010444424,0.000005992566,0.00017618414,0.0002145076,0.9519607,0.00011306307,0.04326017,0.0003130206],"about_ca_topic_score_codex":0.006061327,"about_ca_topic_score_gemma":0.010352916,"teacher_disagreement_score":0.036240358,"about_ca_system_score_codex":0.00066602434,"about_ca_system_score_gemma":0.0026006189,"threshold_uncertainty_score":0.9999722},"labels":[],"label_agreement":null},{"id":"W4393095354","doi":"10.1158/1538-7445.am2024-5042","title":"Abstract 5042: Urine as a non-invasive proxy for plasma in prostate cancer-related liquid biopsy applications","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Outotec (Canada)","funders":"","keywords":"Liquid biopsy; Prostate cancer; Medicine; Urine; Urology; Prostate; Biopsy; Oncology; Pathology; Cancer; Internal medicine","score_opus":0.04351945427204805,"score_gpt":0.4129559650503768,"score_spread":0.36943651077832873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95258176,0.003268783,0.000036134403,0.026577871,0.0002407762,0.009564868,0.00013796934,0.0001973267,0.0073945103],"genre_scores_gemma":[0.955097,0.005602788,0.00012308644,0.00018242195,0.0001907482,0.028596807,0.0000505562,0.000055382927,0.010101215],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982027,0.000022269081,0.0002931711,0.0005180693,0.00043677728,0.0005270525],"domain_scores_gemma":[0.99910414,0.00013945796,0.000022178254,0.0002910014,0.00024813006,0.00019508814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005520485,0.00014173938,0.0002167366,0.00048592844,0.00011043929,0.00005453445,0.00015397964,0.00008397563,0.00067104225],"category_scores_gemma":[0.00003733792,0.00012026101,0.00007908886,0.0010753494,0.00010426928,0.00007539305,0.00006213127,0.0005524959,0.00018596245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01008411,0.0036588276,0.0029326314,0.034913205,0.0024499008,0.0021054335,0.016479384,0.00033568015,0.55739844,0.01544007,0.083706915,0.2704954],"study_design_scores_gemma":[0.008775146,0.0017017049,0.0051720226,0.004452667,0.00023099758,0.00005264043,0.001421995,0.0017429717,0.16637589,0.0011243676,0.80842334,0.0005262612],"about_ca_topic_score_codex":0.001769414,"about_ca_topic_score_gemma":0.0007575923,"teacher_disagreement_score":0.7247164,"about_ca_system_score_codex":0.0003869685,"about_ca_system_score_gemma":0.0013087298,"threshold_uncertainty_score":0.7347442},"labels":[],"label_agreement":null},{"id":"W4393095401","doi":"10.1158/1538-7445.am2024-1353","title":"Abstract 1353: Potentiating salvage radiotherapy in radiorecurrent prostate cancer through anti-CTLA4 therapy: Implications from a syngeneic model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Radiation therapy; Prostate cancer; Medicine; Cancer; Salvage therapy; Oncology; Prostate; Internal medicine; Cancer research; Chemotherapy","score_opus":0.14604115314615207,"score_gpt":0.47460272396079645,"score_spread":0.3285615708146444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7600297,0.2216697,0.000120399585,0.014821961,0.00024954553,0.0019052601,0.0005164538,0.00012888519,0.0005581386],"genre_scores_gemma":[0.7877779,0.20728932,0.00030048768,0.000219797,0.00051574374,0.0025001972,0.00015288142,0.00011088033,0.0011327678],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962714,0.00014257591,0.0004627482,0.0009977934,0.0009600353,0.0011654812],"domain_scores_gemma":[0.99849784,0.00023334267,0.00005243021,0.00061990356,0.00032536846,0.00027111982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006923131,0.0003238212,0.00049188925,0.000504885,0.00029423533,0.0002492248,0.00034416188,0.00016868838,0.0008425456],"category_scores_gemma":[0.000033447996,0.00024683526,0.0001799736,0.0015115977,0.00030309838,0.0003543958,0.00009298081,0.0012571086,0.000043478507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012197421,0.00067617814,0.03463773,0.00085001584,0.0010139593,0.0003659464,0.010505168,0.002088538,0.66363245,0.0003252439,0.016015982,0.268669],"study_design_scores_gemma":[0.027967148,0.0014480508,0.46752444,0.014241813,0.00031164373,0.000055758206,0.0023051612,0.07286296,0.27446124,0.0112049915,0.12483306,0.0027837292],"about_ca_topic_score_codex":0.007482934,"about_ca_topic_score_gemma":0.00040235286,"teacher_disagreement_score":0.43288672,"about_ca_system_score_codex":0.0019242206,"about_ca_system_score_gemma":0.0025493044,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W4393095444","doi":"10.1158/1538-7445.am2024-78","title":"Abstract 78: Superior resolution of intracellular markers with CyTOF reveals greater functional diversity of human T cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Biology; Evolutionary biology; Diversity (politics); Intracellular; Computational biology; Cell biology; Sociology; Anthropology","score_opus":0.05747383846946807,"score_gpt":0.297700794930771,"score_spread":0.24022695646130293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436916,0.014668259,0.00003635347,0.00004089191,0.00016025786,0.00020050918,0.00016079524,0.000018072671,0.0003457001],"genre_scores_gemma":[0.9981663,0.00037890114,0.000005144173,0.0000044624526,0.00004201073,0.000025732486,0.000036858422,0.000013550067,0.0013270002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892247,0.00019425126,0.0001692581,0.00026946288,0.0001807599,0.00026378362],"domain_scores_gemma":[0.9994204,0.000061102,0.000031322117,0.00025019265,0.00020908265,0.000027893011],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072192587,0.00009327196,0.00021665794,0.00012995937,0.00022196646,0.000012497709,0.0001561481,0.00011736099,0.002587001],"category_scores_gemma":[0.000010236694,0.00007243224,0.00016660658,0.0001995574,0.00058823015,0.00007479549,0.00016118356,0.00026936576,0.00005166228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040003404,0.000050114257,0.010623206,0.0002788344,0.00056196074,0.00000819708,0.0003096862,0.0000338849,0.98250365,0.00012513653,0.00426983,0.00083544396],"study_design_scores_gemma":[0.0007117817,0.00027130512,0.33060616,0.00049291505,0.00011763817,0.000003621823,0.00052077824,0.0000013803171,0.6644686,0.000048852195,0.002628277,0.00012868555],"about_ca_topic_score_codex":0.000709027,"about_ca_topic_score_gemma":0.000020578947,"teacher_disagreement_score":0.31998295,"about_ca_system_score_codex":0.0000960712,"about_ca_system_score_gemma":0.0001265618,"threshold_uncertainty_score":0.99832475},"labels":[],"label_agreement":null},{"id":"W4393095493","doi":"10.1158/1538-7445.am2024-1216","title":"Abstract 1216: Pan-RAS inhibition by a tumor-targeted biotherapeutic","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Cancer research; Internal medicine; Medicine","score_opus":0.04314403548258395,"score_gpt":0.40966398997534936,"score_spread":0.3665199544927654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93724656,0.059528023,0.000043594082,0.00094809657,0.0001476381,0.00041903285,0.00033508503,0.000042398337,0.0012895867],"genre_scores_gemma":[0.9917047,0.0049251397,0.0000124543885,0.000141844,0.0003806393,0.00038576525,0.00028818852,0.000048880065,0.0021124051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981493,0.00008902408,0.00014592332,0.0005366053,0.00045610595,0.0006230923],"domain_scores_gemma":[0.99935454,0.000030467218,0.000015286336,0.0003033323,0.0001197415,0.00017663313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037643177,0.00014690356,0.00010952511,0.0001443977,0.00014767027,0.00017392282,0.00016523513,0.00009978318,0.0005643174],"category_scores_gemma":[0.00003528034,0.00012861633,0.000087388355,0.00038183975,0.00018562836,0.000010338988,0.00009726595,0.0003327315,0.00022792755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013649833,0.00006990016,0.00035721023,0.00010018887,0.00013510475,0.00006438616,0.000034391986,0.000001578682,0.90368325,0.000029734814,0.071221046,0.024166701],"study_design_scores_gemma":[0.0004646931,0.00027636933,0.00089374866,0.00009944766,0.0000064964497,0.000008448606,0.000036502828,0.000013427738,0.75321513,0.00021246383,0.24463657,0.00013667608],"about_ca_topic_score_codex":0.0016740728,"about_ca_topic_score_gemma":0.00045333034,"teacher_disagreement_score":0.17341553,"about_ca_system_score_codex":0.00020178073,"about_ca_system_score_gemma":0.0004698394,"threshold_uncertainty_score":0.617888},"labels":[],"label_agreement":null},{"id":"W4393095506","doi":"10.1158/1538-7445.am2024-4281","title":"Abstract 4281: BMP signaling impaired telocytes-Foxl1+disrupt the extracellular matrix network enabling the development of colitis-associated cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Extracellular matrix; Cancer; Neuroscience; Cancer research; Medicine; Biology; Cell biology; Internal medicine","score_opus":0.11032280628446514,"score_gpt":0.42213046383310576,"score_spread":0.3118076575486406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.801728,0.19384255,0.000038941325,0.0022560048,0.0003190403,0.0011278226,0.000021743774,0.00006964676,0.0005962447],"genre_scores_gemma":[0.9922379,0.001717863,0.000084310384,0.00006786778,0.00072185206,0.00070296816,0.000010429387,0.000049942526,0.0044068573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693155,0.0001800231,0.00054992235,0.00036881588,0.0011381991,0.0008315109],"domain_scores_gemma":[0.99828583,0.00076676306,0.00008867662,0.00033660527,0.0004033826,0.000118749886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035315657,0.0001982699,0.0003650457,0.00010727185,0.00081941,0.00011827446,0.0002928043,0.0001173916,0.0006791333],"category_scores_gemma":[0.00017808723,0.000111645924,0.00013837674,0.0010989268,0.0003535424,0.00007526775,0.00024539037,0.0009844971,0.000049023085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035048008,0.0007306172,0.030150961,0.0074040466,0.008135191,0.0012643324,0.051646084,0.0033188027,0.49729127,0.0026062052,0.11779624,0.27615145],"study_design_scores_gemma":[0.005425754,0.0007456413,0.22178417,0.024803868,0.00090924767,0.00007407645,0.032718524,0.002736274,0.46088278,0.0034151832,0.24482234,0.001682141],"about_ca_topic_score_codex":0.0020284187,"about_ca_topic_score_gemma":0.001455506,"teacher_disagreement_score":0.2744693,"about_ca_system_score_codex":0.0006948232,"about_ca_system_score_gemma":0.0014411531,"threshold_uncertainty_score":0.74360335},"labels":[],"label_agreement":null},{"id":"W4393095518","doi":"10.1158/1538-7445.am2024-3012","title":"Abstract 3012: Characterizing the functional significance of \"variant of uncertain significance\" of the tumour suppressor <i>CDH1</i>","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University; McMaster University; University of Toronto","funders":"","keywords":"CDH1; Suppressor; Cancer; Medicine; Clinical significance; Cancer research; Computational biology; Biology; Genetics; Internal medicine; Cadherin; Cell","score_opus":0.07930126142558172,"score_gpt":0.4004470904916086,"score_spread":0.32114582906602684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97615784,0.005049313,0.000058611018,0.0110077225,0.0007481017,0.0017154106,0.00070211984,0.000026292433,0.004534587],"genre_scores_gemma":[0.99665546,0.0003635714,0.000035585264,0.000086909546,0.00028864088,0.00042339024,0.000020274489,0.000029565186,0.0020966255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997809,0.00013134103,0.00044306094,0.0003137183,0.0009664485,0.00033645742],"domain_scores_gemma":[0.9981649,0.00059913687,0.00014083293,0.00048284934,0.00053238304,0.000079913116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007967054,0.00013883285,0.00030653962,0.00012750119,0.0001456502,0.00002600492,0.00028762044,0.00006664515,0.00082476245],"category_scores_gemma":[0.0001316591,0.00007519167,0.00018377554,0.00080468395,0.0005911435,0.00009572982,0.00007826009,0.0004761051,0.000009356971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003484888,0.00017954933,0.0017610249,0.0012480282,0.0004130825,0.000023146093,0.001355043,0.00015320496,0.98190176,0.0027269297,0.0064461175,0.003443614],"study_design_scores_gemma":[0.0010782504,0.00025574287,0.162856,0.0018632293,0.00028461538,0.000017515827,0.0011546466,0.00016530823,0.80779207,0.0006384451,0.023756238,0.0001379319],"about_ca_topic_score_codex":0.0021196338,"about_ca_topic_score_gemma":0.000079968064,"teacher_disagreement_score":0.17410968,"about_ca_system_score_codex":0.00027318374,"about_ca_system_score_gemma":0.0021397604,"threshold_uncertainty_score":0.90305704},"labels":[],"label_agreement":null},{"id":"W4393095529","doi":"10.1158/1538-7445.am2024-3665","title":"Abstract 3665: Stratifying prostate cancer patients through circulating genes related to prostate cell subtypes, drug targets, and therapeutic resistance","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; McGill University Health Centre","funders":"","keywords":"Prostate cancer; Medicine; Drug resistance; Prostate; Oncology; Cancer; Drug; Internal medicine; Cancer research; Biology; Pharmacology; Genetics","score_opus":0.05768977247174798,"score_gpt":0.3993755486917812,"score_spread":0.3416857762200332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82619536,0.16297999,0.0000021929459,0.004944478,0.00030987343,0.0025996773,0.00019527397,0.00014231449,0.0026308151],"genre_scores_gemma":[0.95416254,0.020753393,0.00014705282,0.00014391752,0.00016410497,0.0011386023,0.00008852997,0.00012956279,0.023272272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956279,0.00016265713,0.00049984676,0.001075284,0.0013737436,0.0012606131],"domain_scores_gemma":[0.9982015,0.00022489631,0.00006540276,0.00041178317,0.00068466587,0.00041175992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097058516,0.00035405223,0.00041666275,0.00034100394,0.0005332651,0.00036002975,0.00021896047,0.00013529381,0.0003818265],"category_scores_gemma":[0.00004902406,0.00027474455,0.000091546295,0.0013623141,0.0003055823,0.00030696302,0.00017296986,0.0010905004,0.00008042872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064095967,0.0010069017,0.28419015,0.01957677,0.0016491397,0.0019116981,0.062569864,0.00043363668,0.40493417,0.00090793293,0.029662462,0.18674769],"study_design_scores_gemma":[0.016746363,0.0020916173,0.279366,0.018478945,0.00056689105,0.00003044588,0.0070657725,0.0009891344,0.33894646,0.0089229895,0.32363346,0.003161947],"about_ca_topic_score_codex":0.0014279031,"about_ca_topic_score_gemma":0.00043201874,"teacher_disagreement_score":0.293971,"about_ca_system_score_codex":0.0009758168,"about_ca_system_score_gemma":0.0013203202,"threshold_uncertainty_score":0.9999705},"labels":[],"label_agreement":null},{"id":"W4393095547","doi":"10.1158/1538-7445.am2024-5063","title":"Abstract 5063: Exploring the mutational landscape of <i>KRAS</i> and <i>NRAS</i> in tumors with non-V600 <i>BRAF</i> mutations","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Biology; Cancer research; Cancer; Computational biology; Genetics; Colorectal cancer","score_opus":0.049181328696039195,"score_gpt":0.33532084791382694,"score_spread":0.28613951921778774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938821,0.0024135483,0.000044224416,0.0003961143,0.00007467276,0.00020615695,0.000055746415,0.000006418613,0.0029210134],"genre_scores_gemma":[0.9987152,0.00042760753,0.00004542056,0.000045548117,0.00017323198,0.0002938934,0.00004947148,0.000018773537,0.00023081401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905074,0.000043032327,0.00014667754,0.0002693291,0.0002535975,0.0002366542],"domain_scores_gemma":[0.999566,0.000090823065,0.00001955615,0.00017066467,0.00009542821,0.000057527348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004191223,0.00008744154,0.00009268896,0.00009625032,0.00008215764,0.00004664619,0.00013830222,0.000040628347,0.000034083918],"category_scores_gemma":[0.000029506922,0.000059523798,0.000026514197,0.00029645584,0.00017960013,0.000012010503,0.000067267254,0.00021739923,0.00000513052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017666194,0.000057827736,0.009634511,0.00035383238,0.0000718758,0.00010092392,0.0011778651,0.0006696933,0.9748289,0.00064682,0.004232187,0.00804891],"study_design_scores_gemma":[0.0013510922,0.00060037273,0.08173615,0.00066082535,0.000023399947,0.00008715654,0.0023427417,0.00023030827,0.87784374,0.0005763311,0.034176763,0.0003711118],"about_ca_topic_score_codex":0.0001944302,"about_ca_topic_score_gemma":0.0003881541,"teacher_disagreement_score":0.09698514,"about_ca_system_score_codex":0.000014480115,"about_ca_system_score_gemma":0.00035164107,"threshold_uncertainty_score":0.242731},"labels":[],"label_agreement":null},{"id":"W4393095560","doi":"10.1158/1538-7445.am2024-5058","title":"Abstract 5058: Genomic alterations predictive of outcome in early staged cervical cancer: <i>A translational investigation from the SENTICOL III trial</i>","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cervical cancer; Oncology; Outcome (game theory); Cancer; Internal medicine","score_opus":0.1405597269983317,"score_gpt":0.42695369837536673,"score_spread":0.28639397137703504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98281056,0.005307545,0.000024833942,0.008384712,0.00042426752,0.0018907824,0.00076626276,0.000031964533,0.00035908172],"genre_scores_gemma":[0.99684954,0.0006206957,0.00003291586,0.00019011834,0.00085274957,0.0010388664,0.00012509171,0.000025789823,0.0002642229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975895,0.00021001823,0.00057079963,0.00039172493,0.0009159013,0.00032205443],"domain_scores_gemma":[0.9982076,0.0011272155,0.00005272664,0.00024391086,0.00020725749,0.00016123879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075758516,0.00014046086,0.0003351441,0.0002504085,0.00011878083,0.00007186399,0.00016989185,0.00011073898,0.0011455484],"category_scores_gemma":[0.00011609558,0.00009605969,0.00013327679,0.0011143275,0.00022938222,0.00015021478,0.000039113085,0.0007318545,0.000025724952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050449364,0.00073745544,0.81199557,0.00078519527,0.0014037912,0.000118729,0.012592652,0.00061736855,0.09657317,0.0014693602,0.0028858688,0.020371482],"study_design_scores_gemma":[0.031438854,0.0004857287,0.9543497,0.00071798835,0.00017761014,8.9691866e-7,0.00022310657,0.00041090004,0.008479702,0.002281599,0.001289917,0.00014401496],"about_ca_topic_score_codex":0.023104088,"about_ca_topic_score_gemma":0.0030580007,"teacher_disagreement_score":0.14235412,"about_ca_system_score_codex":0.0005440947,"about_ca_system_score_gemma":0.0010170321,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W4393095582","doi":"10.1158/1538-7445.am2024-4327","title":"Abstract 4327: Development of bioluminescent biosensors to monitor the interaction betweenGSDMD and caspase-1 in living cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bioluminescence; Biosensor; Microbiology; Biology; Biochemistry","score_opus":0.05598880746018148,"score_gpt":0.39692269389163803,"score_spread":0.34093388643145656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962704,0.0024146552,0.000014582975,0.00066798617,0.00016475079,0.0003352078,0.00001336276,0.0000071579107,0.00011188501],"genre_scores_gemma":[0.9978399,0.0011693793,0.00008206818,0.000020443078,0.00030773622,0.00012963887,0.000009172504,0.000021141726,0.00042051598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984314,0.00007060453,0.0002674159,0.00042756827,0.00035026847,0.0004527289],"domain_scores_gemma":[0.9993058,0.00011565913,0.000022648075,0.0002491481,0.00018142036,0.00012534819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009997049,0.00012949601,0.00012814077,0.00021878308,0.000104960614,0.00007536916,0.0002704014,0.00011813741,0.000035767218],"category_scores_gemma":[0.00011903011,0.00009636791,0.000038017315,0.00053819135,0.00018926547,0.000011968916,0.00027974896,0.00034078938,0.000021085272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043360036,0.00003811623,0.0029733365,0.00023439694,0.000023003327,0.0000060559646,0.0006162467,0.0000043179325,0.9647156,0.0000028369489,0.0013943152,0.029948404],"study_design_scores_gemma":[0.00006706158,0.00006210173,0.010075837,0.0006043183,0.000002508601,0.0000025422885,0.0013321341,0.00002874793,0.97565585,0.0000018060784,0.012047656,0.0001194573],"about_ca_topic_score_codex":0.00046613772,"about_ca_topic_score_gemma":0.00041789332,"teacher_disagreement_score":0.029828945,"about_ca_system_score_codex":0.00010214003,"about_ca_system_score_gemma":0.0002611643,"threshold_uncertainty_score":0.39297694},"labels":[],"label_agreement":null},{"id":"W4393095630","doi":"10.1158/1538-7445.am2024-494","title":"Abstract 494: Fluorescent carbon dots: A novel bioimaging tool to reveal the mechanism of action of anticancer drugs in cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Mechanism (biology); Mechanism of action; Fluorescence; Action (physics); Site of action; Cancer research; Nanotechnology; Pharmacology; Computational biology; Chemistry; Medicine; Biology; Biochemistry; Materials science; In vitro; Internal medicine","score_opus":0.04095184537329265,"score_gpt":0.39849235367920244,"score_spread":0.3575405083059098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976327,0.0007729859,0.00030109304,0.0006891416,0.00009924842,0.0002784478,0.000039953557,0.000011442195,0.00017502235],"genre_scores_gemma":[0.99806803,0.0009303959,0.0006373604,0.000039883656,0.00013260182,0.000034734225,0.0000061381675,0.000016626498,0.00013420847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987625,0.00004870644,0.00024438702,0.00032682053,0.0003544411,0.0002631284],"domain_scores_gemma":[0.999382,0.00003392793,0.00004217528,0.0003132871,0.00019227726,0.000036333437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086616474,0.000098209755,0.00014853028,0.00018415568,0.000033165332,0.000020303729,0.00019251417,0.0000827014,0.0000034992968],"category_scores_gemma":[0.0000498044,0.000070068956,0.00007248007,0.00052540825,0.0001342894,0.000004262094,0.00012449625,0.00022662453,6.5681587e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087905595,0.000035220888,0.00004909524,0.00011661271,0.000032282296,0.0000016284719,0.000108159846,0.000019653025,0.9862537,0.000100208534,0.00027403384,0.01292155],"study_design_scores_gemma":[0.00009846936,0.000074584874,0.00030800808,0.0002594981,0.000009790741,8.634172e-7,0.00020410566,0.00018058733,0.9972954,0.00012407065,0.0013593276,0.00008530236],"about_ca_topic_score_codex":0.00092033646,"about_ca_topic_score_gemma":0.00015723507,"teacher_disagreement_score":0.012836248,"about_ca_system_score_codex":0.000094350435,"about_ca_system_score_gemma":0.00017994383,"threshold_uncertainty_score":0.2857329},"labels":[],"label_agreement":null},{"id":"W4393095638","doi":"10.1158/1538-7445.am2024-427","title":"Abstract 427: A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Glioblastoma; Phenotype; Stem cell; Cancer; Disease; Oncology; Signature (topology); Biology; Pathology; Cancer research; Medicine; Internal medicine; Political science; Genetics; Gene","score_opus":0.019186054687958684,"score_gpt":0.3680467939213234,"score_spread":0.3488607392333647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84180564,0.15425678,0.00003958824,0.0023745757,0.00037159174,0.00095505494,0.00014732442,0.000004667795,0.000044810913],"genre_scores_gemma":[0.99354225,0.004528046,0.000007630529,0.00021841332,0.0005432086,0.00088370923,0.000020780191,0.000029443705,0.00022650695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985613,0.00016464262,0.00020441103,0.00041154152,0.0003039675,0.00035413855],"domain_scores_gemma":[0.9992811,0.00017176183,0.00004342917,0.00030430628,0.00012350055,0.00007591492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008516273,0.00014445151,0.00014458984,0.00014001266,0.000069720925,0.00007738632,0.00028848596,0.000121756006,0.00003757093],"category_scores_gemma":[0.000047693517,0.00008999945,0.000084365754,0.00039427856,0.0002007615,0.000013285051,0.000111933594,0.00038301572,8.6319733e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017650864,0.00009437447,0.0001848459,0.0006444224,0.000039098057,0.000014520532,0.0011216447,0.0003471905,0.92270213,0.00011166817,0.008994976,0.06398006],"study_design_scores_gemma":[0.0027845697,0.0006616939,0.018216146,0.0018763433,0.00008986156,0.0000048898646,0.0024909198,0.0011839012,0.69044197,0.00077302224,0.28092584,0.00055087707],"about_ca_topic_score_codex":0.00027722042,"about_ca_topic_score_gemma":0.0012820602,"teacher_disagreement_score":0.27193084,"about_ca_system_score_codex":0.000061196835,"about_ca_system_score_gemma":0.00044137414,"threshold_uncertainty_score":0.3670071},"labels":[],"label_agreement":null},{"id":"W4393095653","doi":"10.1158/1538-7445.am2024-231","title":"Abstract 231: Live cell painting of drug responses in high grade serous cancer organoids","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Organoid; Serous fluid; Cancer; Medicine; Cancer drugs; Drug; Biology; Internal medicine; Pharmacology; Cell biology","score_opus":0.06879202942954424,"score_gpt":0.40400917102542067,"score_spread":0.33521714159587646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847215,0.0112636825,0.0000016914987,0.0020700665,0.0003448715,0.00038427344,0.000037496982,0.000052668525,0.0011237764],"genre_scores_gemma":[0.9879211,0.0015091952,0.00002776788,0.0001821279,0.00041674075,0.00009184455,0.0000058174146,0.000042619606,0.009802743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794984,0.0002321486,0.0003429013,0.00034704915,0.0006875473,0.00044050583],"domain_scores_gemma":[0.99876785,0.00047173613,0.000040562827,0.00024641707,0.00034280945,0.00013064343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015058257,0.00012532172,0.0002567913,0.0006177373,0.00008164972,0.000037889968,0.00013819347,0.000110809,0.0020102402],"category_scores_gemma":[0.00016314512,0.00010286786,0.00007019119,0.0009161172,0.0001823386,0.000096058895,0.00007382221,0.0008909114,0.00013167932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011336487,0.0003406586,0.040568616,0.004695152,0.00012389866,0.0014029961,0.012873282,0.00039268564,0.88807046,0.00019312267,0.028761338,0.021444112],"study_design_scores_gemma":[0.0023239832,0.00020401165,0.06920457,0.004164179,0.000051907777,0.000012493182,0.006225504,0.0005895968,0.8950606,0.00010447431,0.021681227,0.0003774383],"about_ca_topic_score_codex":0.004307734,"about_ca_topic_score_gemma":0.00062947674,"teacher_disagreement_score":0.028635956,"about_ca_system_score_codex":0.00047551194,"about_ca_system_score_gemma":0.0013970104,"threshold_uncertainty_score":0.9989021},"labels":[],"label_agreement":null},{"id":"W4393095901","doi":"10.1158/1538-7445.am2024-1451","title":"Abstract 1451: Replication repair deficient mouse models provide insights into gliomagenesis and response to immunotherapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Immunotherapy; Replication (statistics); Cancer research; Medicine; Cancer immunotherapy; Biology; Immunology; Immune system; Virology","score_opus":0.03991582128844042,"score_gpt":0.37579575065953014,"score_spread":0.33587992937108974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723327,0.02549377,0.00067711604,0.00070156215,0.000045733555,0.0005915609,0.000015239533,0.000053866297,0.00008843448],"genre_scores_gemma":[0.9968887,0.001192641,0.00035705254,0.000074758675,0.00011312366,0.00043926857,0.000030635143,0.000040417945,0.00086337846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846894,0.0001593185,0.00017711894,0.0006705188,0.0002849734,0.00023916256],"domain_scores_gemma":[0.998824,0.00004067564,0.0000199384,0.0007564236,0.00022952756,0.00012941055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009132872,0.0001092549,0.0000810542,0.00022772091,0.00013785015,0.00010174182,0.00016186977,0.00010427884,0.000020192836],"category_scores_gemma":[0.0001355837,0.00010153093,0.00005580657,0.00035023663,0.00008951942,0.000013437395,0.0001327164,0.00010100556,0.000018191313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010839213,0.00002740683,0.000022910637,0.000094935654,0.00003896287,0.00000610174,0.00047595866,0.00058039464,0.9817044,0.000093194554,0.0036935452,0.012178227],"study_design_scores_gemma":[0.00018283505,0.00014528043,0.002722291,0.0000674853,0.0000050497256,0.0000030086317,0.000064457876,0.0011240209,0.9224714,0.00038796366,0.07267617,0.00015003374],"about_ca_topic_score_codex":0.00023243786,"about_ca_topic_score_gemma":0.000067896275,"teacher_disagreement_score":0.06898262,"about_ca_system_score_codex":0.0001931732,"about_ca_system_score_gemma":0.00039481072,"threshold_uncertainty_score":0.41403112},"labels":[],"label_agreement":null},{"id":"W4393095905","doi":"10.1158/1538-7445.am2024-1955","title":"Abstract 1955: Novel long-acting covalent PI3Kα inhibitors boost potential action in cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"","keywords":"Cancer; Action (physics); Medicine; PI3K/AKT/mTOR pathway; Pharmacology; Cancer research; Chemistry; Internal medicine; Biochemistry; Signal transduction; Physics","score_opus":0.10969898531185081,"score_gpt":0.44625209124195103,"score_spread":0.33655310593010024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97657424,0.01877843,0.0003903258,0.0007450688,0.0022422525,0.00037988237,0.00010405221,0.000039866467,0.00074588816],"genre_scores_gemma":[0.9926337,0.002987672,0.00003516019,0.00008292884,0.0026677435,0.00036692587,0.00005131792,0.00007333799,0.0011012246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974998,0.00007662988,0.00031474588,0.0007552082,0.0006327938,0.0007207916],"domain_scores_gemma":[0.99919534,0.000046716406,0.000052370044,0.00033906108,0.000219604,0.00014693952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089646626,0.00020778974,0.00017187712,0.00025993714,0.00014904742,0.000162759,0.00030589342,0.0002611614,0.0005720152],"category_scores_gemma":[0.000093273535,0.00021012001,0.0001138715,0.0005090188,0.00017285546,0.00002281288,0.00019282315,0.0007960604,0.0000411598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020077932,0.00006399483,0.0016210788,0.0002715967,0.00007936826,0.000049366347,0.0000894046,0.0022336086,0.956287,0.000012415878,0.008520654,0.030570734],"study_design_scores_gemma":[0.0006484872,0.00015455128,0.0060877185,0.00066835084,0.00001604389,0.000012752314,0.00017074466,0.00037080792,0.89026785,0.000024905179,0.101219036,0.0003587743],"about_ca_topic_score_codex":0.0035404216,"about_ca_topic_score_gemma":0.00271056,"teacher_disagreement_score":0.09269838,"about_ca_system_score_codex":0.0006788855,"about_ca_system_score_gemma":0.0014152603,"threshold_uncertainty_score":0.85684454},"labels":[],"label_agreement":null},{"id":"W4393096024","doi":"10.1158/1538-7445.am2024-135","title":"Abstract 135: Resolving the tumorigenesis continuum of DICER1 syndrome with novel lineage-trackable genetically engineered mouse model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Genetically engineered; Carcinogenesis; Lineage (genetic); Genetically modified organism; Biology; Genetics; Computational biology; Cancer research; Evolutionary biology; Cancer; Gene","score_opus":0.06798498780348375,"score_gpt":0.3684453488954512,"score_spread":0.3004603610919675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861445,0.00823564,0.0006989797,0.0016069191,0.00008021972,0.0008345767,0.00015989292,0.00008555005,0.0021537452],"genre_scores_gemma":[0.9889194,0.00064248755,0.00083766325,0.00004581747,0.00014637501,0.00032811958,0.000005712709,0.000077205295,0.008997245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750507,0.000037920836,0.00039017666,0.00039765355,0.0010647669,0.00060442265],"domain_scores_gemma":[0.9978987,0.0007075398,0.000034592224,0.00054403226,0.00063204404,0.00018306843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010504596,0.00019556162,0.0004120601,0.00023055507,0.00013262272,0.00008127606,0.00028141603,0.00008089718,0.0002536153],"category_scores_gemma":[0.00041891183,0.00012053104,0.000098807956,0.0006619851,0.0003957655,0.000081268336,0.00015072906,0.00065418886,0.00003932154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997403,0.00027075945,0.0009430561,0.0032841929,0.001032104,0.00052853633,0.0024770407,0.0024714672,0.97882533,0.00036811482,0.004932625,0.004367059],"study_design_scores_gemma":[0.0069869007,0.0023170363,0.14031367,0.009936891,0.0013078382,0.00061363034,0.0042447937,0.17628127,0.64204985,0.00037098592,0.013851607,0.0017255136],"about_ca_topic_score_codex":0.00040562425,"about_ca_topic_score_gemma":0.00037426912,"teacher_disagreement_score":0.33677545,"about_ca_system_score_codex":0.00019325018,"about_ca_system_score_gemma":0.00083261007,"threshold_uncertainty_score":0.49151132},"labels":[],"label_agreement":null},{"id":"W4393096072","doi":"10.1158/1538-7445.am2024-5466","title":"Abstract 5466: <i>In vivo</i> characterization of neuroblastoma intratumoral heterogeneity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"In vivo; Neuroblastoma; Medicine; Cancer research; Internal medicine; Oncology; Pharmacology; Biology; Genetics","score_opus":0.06367178485682878,"score_gpt":0.4095277657417476,"score_spread":0.3458559808849188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964723,0.00031408345,0.000003834121,0.0009358581,0.00015212214,0.0005392068,0.00009422897,0.00004812783,0.0014402253],"genre_scores_gemma":[0.9982473,0.00057110493,0.000009411439,0.000050668317,0.00014479629,0.00013849064,0.000019079578,0.000036658654,0.0007824571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800897,0.000102657956,0.00025083637,0.0003853749,0.0007350122,0.0005171231],"domain_scores_gemma":[0.9992252,0.0000976596,0.000021209233,0.00027077465,0.00017137942,0.0002137818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037804598,0.00012111527,0.00022404952,0.0005053659,0.000043625372,0.00005386691,0.00012432835,0.000060972405,0.0005771284],"category_scores_gemma":[0.00006057638,0.000102038306,0.000075907854,0.00093786645,0.00016767615,0.00015976549,0.00007733765,0.000567322,0.00008773942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005061113,0.00021051208,0.0049855043,0.0006009479,0.000040747986,0.0011200656,0.00006407199,0.0000017320407,0.98519784,0.00007966646,0.0005956442,0.006597167],"study_design_scores_gemma":[0.00072720734,0.000516096,0.14774215,0.00059918663,0.000008308655,0.000038591832,0.000009889202,0.00012047503,0.84616643,0.000037220176,0.0039613233,0.00007311405],"about_ca_topic_score_codex":0.00017188503,"about_ca_topic_score_gemma":0.00011494293,"teacher_disagreement_score":0.14275664,"about_ca_system_score_codex":0.00020561903,"about_ca_system_score_gemma":0.00050495757,"threshold_uncertainty_score":0.6319151},"labels":[],"label_agreement":null},{"id":"W4393096100","doi":"10.1158/1538-7445.am2024-926","title":"Abstract 926: Adaptive universal platform for real-world observational studies (AUPROS): An emerging model for clinical, epidemiologic, and precision oncology research","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Precision oncology; Observational study; Medicine; Clinical Oncology; Medical physics; Oncology; Internal medicine; Cancer","score_opus":0.7609573847194339,"score_gpt":0.6698915856855782,"score_spread":0.0910657990338557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231914,0.012830354,0.0137323765,0.043428373,0.00082975195,0.0037672096,0.00013926857,0.00015444605,0.0019268144],"genre_scores_gemma":[0.92059153,0.03579911,0.03159872,0.0005699266,0.0023918026,0.0012963341,0.00013357546,0.00009373454,0.0075252648],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996883,0.00030788162,0.0005811629,0.000796811,0.0006544245,0.00077671575],"domain_scores_gemma":[0.98302674,0.014977554,0.000066869325,0.00026530377,0.0013052588,0.00035826006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021382036,0.00015409039,0.00056624314,0.00051533506,0.0005884825,0.00006367592,0.00022590415,0.00018366476,0.00003628509],"category_scores_gemma":[0.007298886,0.00011661073,0.00012672703,0.00047275418,0.0009701651,0.0002633493,0.00020846199,0.0018127252,0.000003775179],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006694278,0.00033021302,0.007641925,0.0017198827,0.00071415526,0.00009906499,0.0036435875,0.0029930957,0.0036266006,0.070942,0.23480515,0.66679007],"study_design_scores_gemma":[0.0016823012,0.001811727,0.006747962,0.0008301786,0.00005360058,0.000004898633,0.0018798786,0.86339486,0.000059948743,0.04064927,0.08273134,0.00015402613],"about_ca_topic_score_codex":0.00039555796,"about_ca_topic_score_gemma":0.00028299494,"teacher_disagreement_score":0.8604018,"about_ca_system_score_codex":0.0008373115,"about_ca_system_score_gemma":0.0016116011,"threshold_uncertainty_score":0.87379754},"labels":[],"label_agreement":null},{"id":"W4393096215","doi":"10.1158/1538-7445.am2024-1392","title":"Abstract 1392: Neutrophil extracellular trap (NET)-induced pancreatic tumor metastasis requires integrin-linked kinase (ILK) signaling","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Neutrophil extracellular traps; Integrin-linked kinase; Metastasis; Cancer research; Kinase; Integrin; Medicine; Trap (plumbing); Cell biology; Immunology; Biology; Internal medicine; Protein kinase A; Cancer; Inflammation; Receptor; Cyclin-dependent kinase 2","score_opus":0.10223723556074905,"score_gpt":0.3661041764839357,"score_spread":0.26386694092318663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488645,0.046916418,0.000098445715,0.001184378,0.0011419741,0.0008001032,0.00013532962,0.00026468287,0.0005941249],"genre_scores_gemma":[0.994252,0.0010020031,0.000085433545,0.00011526549,0.00039456857,0.0005314859,0.00010557393,0.000120104865,0.0033935462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954074,0.0008376362,0.00067194947,0.0011543754,0.0003134398,0.0016152038],"domain_scores_gemma":[0.99790066,0.00075060775,0.000093935494,0.0007186564,0.00035347117,0.00018269148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002203298,0.0004891414,0.0006741154,0.0007429511,0.000582035,0.00024522448,0.0007763708,0.00031436837,0.0061677936],"category_scores_gemma":[0.00019667271,0.000400268,0.000309287,0.0010127902,0.00046038922,0.00036041724,0.00023900157,0.0022875376,0.0021632449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034993302,0.00012895631,0.000022495318,0.00031956536,0.000551825,0.0009335031,0.0005184873,0.000017638224,0.97417694,0.006406351,0.0017247259,0.014849604],"study_design_scores_gemma":[0.0007712193,0.0004147356,0.0002730555,0.0006630576,0.00012458937,0.00005922291,0.000582556,0.000017823117,0.95547134,0.0009833961,0.040205732,0.00043325475],"about_ca_topic_score_codex":0.0022840092,"about_ca_topic_score_gemma":0.00015045465,"teacher_disagreement_score":0.045914415,"about_ca_system_score_codex":0.00043619712,"about_ca_system_score_gemma":0.0007317806,"threshold_uncertainty_score":0.9998449},"labels":[],"label_agreement":null},{"id":"W4393096286","doi":"10.1158/1538-7445.am2024-2346","title":"Abstract 2346: Meningioma molecular classification predict response to surgical resection and adjuvant radiotherapy: An integrated clinicomolecular analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Adjuvant radiotherapy; Medicine; Radiation therapy; Meningioma; Surgical resection; Resection; Oncology; Internal medicine; Pathology; Surgery","score_opus":0.0912842997709242,"score_gpt":0.4555820397184414,"score_spread":0.36429773994751724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679984,0.004545576,0.002730347,0.0042388393,0.00012596457,0.00081213395,0.00001729758,0.00014317426,0.0005868269],"genre_scores_gemma":[0.9974373,0.00020546447,0.0005019234,0.000043198106,0.00015990848,0.00028681642,0.00008135197,0.000041416028,0.0012426056],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99660504,0.0007084975,0.00040906336,0.00082961854,0.000981824,0.00046597724],"domain_scores_gemma":[0.9983073,0.00024806394,0.000033536777,0.00060955103,0.0003147787,0.0004868068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045363726,0.00018255053,0.00037022267,0.0017517911,0.00015324194,0.00025732288,0.00016913157,0.00014476823,0.000422383],"category_scores_gemma":[0.00021179159,0.00015259556,0.00015350137,0.0031134174,0.00013585438,0.0001366854,0.000068151836,0.0005712263,0.000021294065],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019584626,0.00026558634,0.0044964273,0.00033343438,0.0028779223,0.012904643,0.001493681,0.00042860425,0.8931021,0.0013589176,0.0035281228,0.059625953],"study_design_scores_gemma":[0.006317387,0.010245883,0.42298526,0.0019779326,0.00232529,0.00068021327,0.0027171145,0.1400191,0.0636725,0.00032847625,0.34742495,0.0013058945],"about_ca_topic_score_codex":0.00030331544,"about_ca_topic_score_gemma":0.000027621327,"teacher_disagreement_score":0.82942957,"about_ca_system_score_codex":0.0004756994,"about_ca_system_score_gemma":0.00032131936,"threshold_uncertainty_score":0.62226665},"labels":[],"label_agreement":null},{"id":"W4393096318","doi":"10.1158/1538-7445.am2024-7434","title":"Abstract 7434: Deployment of a visualization tool directly linked to the CellEngine cytometry analysis software to accelerate analysis of complex cytometry data sets in the context of ongoing clinical trials","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Software deployment; Context (archaeology); Computer science; Software; Visualization; Flow cytometry; Data mining; Data science; Medicine; Software engineering; Biology; Immunology; Operating system","score_opus":0.3172663386635719,"score_gpt":0.5673949544569103,"score_spread":0.25012861579333845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998047,0.0025412103,0.015773015,0.00040435584,0.000018429786,0.0007434541,0.00048610126,0.000012826611,0.00004013591],"genre_scores_gemma":[0.9967043,0.0017328521,0.00040255566,0.00016698558,0.000080811624,0.000100044235,0.0007511415,0.00002108474,0.000040264193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99562734,0.0013304384,0.0013489894,0.0006389831,0.00077390776,0.00028031593],"domain_scores_gemma":[0.99609405,0.0014187803,0.00023665997,0.0015833402,0.0005936119,0.00007353886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016000507,0.00015212804,0.0008963674,0.0019150879,0.00004975039,0.00007500327,0.0012748069,0.0001327301,0.00014191362],"category_scores_gemma":[0.0038238287,0.00009995074,0.00047975904,0.010165636,0.00012245748,0.000013189606,0.00064190704,0.00025682867,0.0000022269649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036644074,0.00027756713,0.021682937,0.00020182488,0.008203954,0.0000070899214,0.00057106203,0.0017021783,0.9061031,0.000007440185,0.009907584,0.050968863],"study_design_scores_gemma":[0.0006605334,0.0005977332,0.15870845,0.00024411731,0.0056129745,4.933752e-7,0.0014041624,0.015167828,0.80195034,0.000009357067,0.015247818,0.00039619772],"about_ca_topic_score_codex":0.0013078145,"about_ca_topic_score_gemma":0.0032390184,"teacher_disagreement_score":0.1370255,"about_ca_system_score_codex":0.000061054234,"about_ca_system_score_gemma":0.00022546411,"threshold_uncertainty_score":0.55454886},"labels":[],"label_agreement":null},{"id":"W4393096329","doi":"10.1158/1538-7445.am2024-60","title":"Abstract 60: Functional mapping of glioblastoma recurrence reveals targetable dependencies in an axonal guidance pathway in highly invasive brain cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Medicine; Functional connectivity; Brain cancer; Cancer; Cancer research; Oncology; Pathology; Internal medicine; Neuroscience; Biology","score_opus":0.05688864469130228,"score_gpt":0.34378013452579836,"score_spread":0.2868914898344961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95337355,0.04414607,0.000051321484,0.0003570892,0.0010071766,0.00033623495,0.00019902975,0.000011116883,0.00051843846],"genre_scores_gemma":[0.99397254,0.0033208332,0.00011048278,0.000101232705,0.0011170573,0.0003453696,0.000054544613,0.000029650932,0.0009482885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748933,0.0001932403,0.000422756,0.00069261616,0.0005697447,0.00063231593],"domain_scores_gemma":[0.9990184,0.00012549164,0.00006532001,0.00034156203,0.00031208873,0.00013718498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001551072,0.00018291995,0.00026701618,0.0004189948,0.00007080911,0.0000632816,0.00035680548,0.00018175982,0.0001862363],"category_scores_gemma":[0.00035074644,0.00018756569,0.000079901605,0.0008664912,0.00023920184,0.000046469715,0.00014662925,0.00050276326,0.000009304476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029314222,0.00004815038,0.003036146,0.0003232834,0.00002707042,0.000024734194,0.00036560433,0.0012995119,0.97511995,0.00020231084,0.011232271,0.008027841],"study_design_scores_gemma":[0.0011748698,0.0003812604,0.09902882,0.0014250581,0.000005079742,0.000015230057,0.0008524209,0.00014230507,0.7108638,0.0009365652,0.18464796,0.000526615],"about_ca_topic_score_codex":0.002816315,"about_ca_topic_score_gemma":0.022876801,"teacher_disagreement_score":0.26425612,"about_ca_system_score_codex":0.00033153384,"about_ca_system_score_gemma":0.002879475,"threshold_uncertainty_score":0.99495316},"labels":[],"label_agreement":null},{"id":"W4393096372","doi":"10.1158/1538-7445.am2024-5150","title":"Abstract 5150: An immunohistochemical survey of predictive biomarkers for immunotherapy in ampullary carcinoma identifies strata with unique prognostic signatures","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pancreas Centre (Canada); University of British Columbia","funders":"","keywords":"Immunotherapy; Immunohistochemistry; Medicine; Pathology; Cancer; Oncology; Internal medicine","score_opus":0.07710531280330105,"score_gpt":0.41742136466313196,"score_spread":0.34031605185983094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740999,0.023449754,0.000014994804,0.00019177758,0.00008017107,0.0016160945,0.00038959202,0.000030209903,0.00012751171],"genre_scores_gemma":[0.9976178,0.0007009293,0.000061143655,0.0000124713215,0.00005653209,0.0010174462,0.00043826338,0.000044052416,0.000051383617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836725,0.00014488945,0.00026962193,0.0004230439,0.0004364177,0.00035880567],"domain_scores_gemma":[0.9982634,0.00090217654,0.000034633526,0.00032170914,0.0003757493,0.00010230454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009940414,0.0001601073,0.00030736098,0.00032427258,0.00005668008,0.000052204585,0.00015432954,0.000108716136,0.00008574378],"category_scores_gemma":[0.000113114955,0.000112661204,0.000060745508,0.00055464683,0.00027263985,0.00011825504,0.000026186364,0.00037216657,0.0000012237749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075372397,0.0009079724,0.92622256,0.0010637816,0.0007527696,0.000460055,0.00089699076,0.00002457622,0.058113985,0.00011950698,0.0016084968,0.0022920738],"study_design_scores_gemma":[0.0016154395,0.0013783667,0.949629,0.0009970854,0.00003655459,0.000012044251,0.0002079206,0.00017209144,0.04567057,0.00013321958,0.000039787345,0.00010790374],"about_ca_topic_score_codex":0.010046536,"about_ca_topic_score_gemma":0.001206771,"teacher_disagreement_score":0.023517884,"about_ca_system_score_codex":0.00030514548,"about_ca_system_score_gemma":0.00096850394,"threshold_uncertainty_score":0.9965457},"labels":[],"label_agreement":null},{"id":"W4393096392","doi":"10.1158/1538-7445.am2024-923","title":"Abstract 923: Biomarker use in oncology approvals in the US","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Oncology; Biomarker; Precision oncology; Internal medicine; Medical physics; Cancer; Biology","score_opus":0.27606407978141023,"score_gpt":0.42474930184534687,"score_spread":0.14868522206393664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9149607,0.015842631,0.00002005882,0.00469281,0.00061039155,0.00045279914,0.00012361065,0.000018291603,0.0632787],"genre_scores_gemma":[0.99408704,0.003462897,0.000026305292,0.0004923554,0.0002367163,0.0003320664,0.000005526974,0.000028556882,0.0013285566],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811316,0.000063798136,0.00056846614,0.0005093638,0.00007228335,0.000672936],"domain_scores_gemma":[0.9989545,0.0005206433,0.000062676045,0.0003567913,0.000033899378,0.00007153567],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0041129957,0.00012745694,0.0003316152,0.0007683575,0.00006652628,0.00031936637,0.000482486,0.00018395546,0.0009251696],"category_scores_gemma":[0.000321363,0.0001133159,0.00008211486,0.0009197497,0.00019995711,0.0005480301,0.00007932319,0.00080397946,0.00086887245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038990268,0.00047905472,0.2853762,0.000435619,0.00012429069,0.000733303,0.0067152465,0.0005147762,0.0007609408,0.4529057,0.09652462,0.15504034],"study_design_scores_gemma":[0.00036790932,0.000048091344,0.36412126,0.00008089457,9.1943036e-7,0.0000036083577,0.00013314022,0.00043164502,0.00004267585,0.019789593,0.6148217,0.00015858193],"about_ca_topic_score_codex":0.014073858,"about_ca_topic_score_gemma":0.0071780677,"teacher_disagreement_score":0.5182971,"about_ca_system_score_codex":0.0009930608,"about_ca_system_score_gemma":0.00032619032,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W4393096401","doi":"10.1158/1538-7445.am2024-2373","title":"Abstract 2373: Functional and specific T-cell engagers against a peptide-MHC tumor target","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Major histocompatibility complex; Biology; Computer science; Psychology; Computational biology; Medicine; Antigen; Immunology","score_opus":0.106342958946202,"score_gpt":0.3899743948057807,"score_spread":0.28363143585957873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9039788,0.020051964,0.000022803244,0.0023776414,0.00044906564,0.00083470554,0.000062243125,0.00012956219,0.072093174],"genre_scores_gemma":[0.92227244,0.0052960594,0.000120100616,0.00020675123,0.0016587024,0.00026123822,0.00005372747,0.00009978282,0.070031166],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964408,0.00016800992,0.00026240246,0.0007189954,0.0015471029,0.0008626764],"domain_scores_gemma":[0.9981805,0.0005404575,0.000018407996,0.00043274256,0.0003343347,0.00049353193],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022606198,0.0002013671,0.00027770342,0.0006135503,0.00027043468,0.0002531034,0.00017201755,0.000102505655,0.026211994],"category_scores_gemma":[0.00011079022,0.00017440354,0.00012888177,0.00085516926,0.00047779173,0.00014423441,0.00014099857,0.0021903939,0.00080985716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069247594,0.00010870425,0.0013005018,0.0007190666,0.00009524991,0.0010396108,0.00044999845,0.000021152255,0.8238206,0.00015194017,0.15074944,0.02085127],"study_design_scores_gemma":[0.001472556,0.0002907702,0.009818063,0.00043368078,0.000011497391,0.00006137076,0.00080350327,0.00033506038,0.07072754,0.00022708347,0.9155804,0.0002384913],"about_ca_topic_score_codex":0.00019626776,"about_ca_topic_score_gemma":0.000021788604,"teacher_disagreement_score":0.76483095,"about_ca_system_score_codex":0.0006798335,"about_ca_system_score_gemma":0.0011295566,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W4393096405","doi":"10.1158/1538-7445.am2024-3468","title":"Abstract 3468: Emerging lessons from patient-reported hospital discharge experiences among hospitalized cancer patients with frequent emergency department use","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Emergency department; Medicine; Cancer; Hospital discharge; Emergency medicine; Patient discharge; Medical emergency; Intensive care medicine; MEDLINE; Internal medicine; Nursing","score_opus":0.1726169086147549,"score_gpt":0.5305081273113212,"score_spread":0.35789121869656637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784455,0.0060513774,0.000010030221,0.005544248,0.005099531,0.0030722958,0.000773324,0.00017991176,0.0008237936],"genre_scores_gemma":[0.98649144,0.0024418961,0.00004425608,0.000075632684,0.0006320501,0.00923517,0.00015561144,0.00010203526,0.0008219076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99335957,0.0011856245,0.0011381224,0.0010704895,0.0017345501,0.0015116663],"domain_scores_gemma":[0.9968791,0.00080330024,0.00041469466,0.00053776073,0.0008327529,0.0005324093],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012920169,0.00036029943,0.00045749533,0.00026565685,0.0017941507,0.00016561808,0.0003400811,0.00025453416,0.010600328],"category_scores_gemma":[0.00038447988,0.00025673656,0.00011206007,0.00085219706,0.00020719663,0.001328185,0.00021141095,0.0015986357,0.00015209704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013434315,0.00020859757,0.9191057,0.0004694185,0.00036067894,0.000079690246,0.046643604,0.0000072529588,0.00010146782,0.00020001708,0.027203964,0.0054852585],"study_design_scores_gemma":[0.0008554601,0.00046456262,0.8148248,0.0030931558,0.000051171686,1.8693434e-7,0.02138597,0.000038346334,0.00015523545,0.00010600581,0.15845531,0.0005697912],"about_ca_topic_score_codex":0.097688384,"about_ca_topic_score_gemma":0.009119228,"teacher_disagreement_score":0.13125135,"about_ca_system_score_codex":0.00091739715,"about_ca_system_score_gemma":0.001750548,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W4393096417","doi":"10.1158/1538-7445.am2024-1308","title":"Abstract 1308: Policy guiding secondary findings from genome sequencing pertinent to cancer: Results from a systematic review","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cancer; Genome; Computational biology; Medicine; Biology; Genetics; Gene","score_opus":0.7601205681887503,"score_gpt":0.6662166164327904,"score_spread":0.09390395175595989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026388722,0.9659731,0.0000018830494,0.013936944,0.0006044985,0.009851819,0.007081536,0.00016303711,0.0021232963],"genre_scores_gemma":[0.00014402047,0.97562414,0.00014109652,0.0018673305,0.00410063,0.006450047,0.0008389865,0.00041419623,0.010419575],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9827971,0.0014390083,0.0048119132,0.0030787298,0.005687561,0.002185697],"domain_scores_gemma":[0.96541375,0.025408784,0.0006752498,0.004028147,0.0024227188,0.0020513367],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.022893785,0.0010559465,0.0069172704,0.0017779447,0.000402131,0.00048511126,0.0026077793,0.0015401503,0.0024080444],"category_scores_gemma":[0.08149664,0.00076126313,0.0014760327,0.0039587775,0.00042358408,0.0001401405,0.0022248423,0.013204471,0.0040343255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009595982,0.00003858731,8.1759725e-7,0.958489,0.0015255384,0.0006173535,0.00082049455,7.7716567e-7,0.00025530622,0.00012600538,0.012429229,0.025600933],"study_design_scores_gemma":[0.00033492048,0.00010467203,0.0000043039236,0.7305669,0.0022225073,0.00001466122,0.00012066386,0.0000025223167,0.000018308154,0.0006807377,0.26545292,0.00047683233],"about_ca_topic_score_codex":0.046047445,"about_ca_topic_score_gemma":0.0020423008,"teacher_disagreement_score":0.25302368,"about_ca_system_score_codex":0.015489399,"about_ca_system_score_gemma":0.03841726,"threshold_uncertainty_score":0.99975604},"labels":[],"label_agreement":null},{"id":"W4393096561","doi":"10.1158/1538-7445.am2024-6719","title":"Abstract 6719: TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated CD28 costimulation, engineered to improve responses in the treatment of solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"CD28; Cancer research; T cell; Medicine; Immune system; Immunology","score_opus":0.17556246383653798,"score_gpt":0.43762412715906307,"score_spread":0.2620616633225251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919594,0.002454162,0.00010181147,0.0011863335,0.00009219926,0.0030348597,0.00017582948,0.00004548581,0.0009498968],"genre_scores_gemma":[0.98877674,0.0012082653,0.00009985296,0.00003966954,0.00040952943,0.00097104354,0.00012320622,0.00006456663,0.008307149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969885,0.00027276162,0.00045214698,0.0005155636,0.0011824878,0.00058858783],"domain_scores_gemma":[0.99725413,0.0014148412,0.00003586145,0.0005732563,0.0005195807,0.00020235623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020970714,0.0002298151,0.00039865804,0.0009911354,0.00012457951,0.00015203688,0.00021680875,0.000114951465,0.0018083238],"category_scores_gemma":[0.00022543402,0.00013967729,0.00009204227,0.0018779313,0.00015429397,0.00014742377,0.000017055288,0.00081905985,0.00006211081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071421256,0.0004304743,0.00022086143,0.00018843959,0.00008870253,0.00029412433,0.0058744876,0.00095349015,0.944751,0.00002468302,0.0039332462,0.036098357],"study_design_scores_gemma":[0.0048224116,0.0059530577,0.0055555226,0.00048014385,0.000039378807,0.000024498258,0.0026755258,0.009947045,0.9151509,0.000016570119,0.055094797,0.0002401845],"about_ca_topic_score_codex":0.0010366677,"about_ca_topic_score_gemma":0.0003746116,"teacher_disagreement_score":0.05116155,"about_ca_system_score_codex":0.0014400111,"about_ca_system_score_gemma":0.001612422,"threshold_uncertainty_score":0.99910414},"labels":[],"label_agreement":null},{"id":"W4393096595","doi":"10.1158/1538-7445.am2024-1646","title":"Abstract 1646: IL-23R is a regulator of the mitotic spindle and is critical for cell viability in AML","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Regulator; Mitosis; Cell biology; Biology; Cancer research; Genetics; Gene","score_opus":0.0322433505389554,"score_gpt":0.3833845044804443,"score_spread":0.3511411539414889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930631,0.0041989405,0.000041901476,0.0017487227,0.000097668926,0.00038344073,0.00021468694,0.0000024848882,0.00024905297],"genre_scores_gemma":[0.9984896,0.00042341108,0.00007297102,0.00012661057,0.00012204862,0.00009147509,0.0000050982967,0.000015436292,0.00065332284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999055,0.000042909684,0.00015220197,0.0003349118,0.00014630007,0.00026864253],"domain_scores_gemma":[0.99942416,0.000069413734,0.000011346443,0.00031600936,0.00012420698,0.000054876364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042850614,0.000076124874,0.00010142459,0.000041445033,0.0000517062,0.00003092327,0.00017403717,0.00012896977,0.000057451314],"category_scores_gemma":[0.000115844465,0.000058195194,0.00007509209,0.00013211714,0.000269654,0.0000035180565,0.00013972115,0.00018494546,0.0000022614627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058462836,0.000057333207,0.0018413101,0.00079503533,0.000014041579,8.6292073e-7,0.0001467363,0.0000017175664,0.9870469,0.00014745482,0.008315235,0.0015749203],"study_design_scores_gemma":[0.00023325859,0.000115917086,0.0072449464,0.000105840794,0.000008271709,0.0000013510952,0.00009690046,0.0002384866,0.957703,0.0007071509,0.03346005,0.0000848506],"about_ca_topic_score_codex":0.00017259103,"about_ca_topic_score_gemma":0.00014647527,"teacher_disagreement_score":0.029343912,"about_ca_system_score_codex":0.00004047323,"about_ca_system_score_gemma":0.00026619688,"threshold_uncertainty_score":0.23731312},"labels":[],"label_agreement":null},{"id":"W4393096624","doi":"10.1158/1538-7445.am2024-4507","title":"Abstract 4507: Discovery of a smart molecular glue: A small-molecular compound selectively degrades Nrf2 in KEAP1-mutated tumor cells, by restoring the broken KEAP1 mutant/Nrf2 interaction","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis and biological activity","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Jewish General Hospital","funders":"","keywords":"Mutant; KEAP1; Biology; Cancer research; Genetics; Transcription factor; Gene","score_opus":0.062281249297253996,"score_gpt":0.35198765913406166,"score_spread":0.2897064098368077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934174,0.0036355217,0.000035758192,0.0004687144,0.00012481029,0.00026933773,0.00018680865,0.000060390445,0.0018012546],"genre_scores_gemma":[0.9990024,0.00036196352,0.000017644186,0.000028561635,0.00009345805,0.00020556465,0.000019234065,0.00004446768,0.00022670103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973393,0.0002857485,0.00040242934,0.0006861434,0.00063890504,0.0006474504],"domain_scores_gemma":[0.9982197,0.0010440499,0.00009698111,0.00037638843,0.00016148206,0.00010136913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009937662,0.00026247994,0.00035971697,0.00015985421,0.00013904835,0.0002904603,0.00052728405,0.00016292719,0.00022298838],"category_scores_gemma":[0.00034556197,0.00018152659,0.00016971143,0.0007938473,0.00029870894,0.00020400062,0.00020766257,0.0013245497,0.000012734882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038514676,0.00022423874,0.001146909,0.00038727626,0.00013410173,0.0003306431,0.0001570003,0.000056671543,0.9934798,0.000055445817,0.00036573986,0.0032770485],"study_design_scores_gemma":[0.00023296998,0.00007117997,0.0015204663,0.00069267995,0.000019231247,0.000016979318,0.00041155526,0.00033468797,0.9929663,0.00025768694,0.0032563638,0.00021988577],"about_ca_topic_score_codex":0.0048840586,"about_ca_topic_score_gemma":0.00043501132,"teacher_disagreement_score":0.0055850013,"about_ca_system_score_codex":0.0007597433,"about_ca_system_score_gemma":0.00031456962,"threshold_uncertainty_score":0.7402439},"labels":[],"label_agreement":null},{"id":"W4393096629","doi":"10.1158/1538-7445.am2024-3580","title":"Abstract 3580: Understanding and overcoming innate and acquired resistance to type I and II RAF inhibitors in anaplastic thyroid cancer using translational functional genomics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Anaplastic thyroid cancer; Cancer; Medicine; Thyroid; Cancer research; Thyroid cancer; Internal medicine","score_opus":0.14378910166716483,"score_gpt":0.3935343153801012,"score_spread":0.24974521371293637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9349569,0.0606122,0.000047540834,0.0035347566,0.00021768475,0.0004071681,0.00005714691,0.000017169652,0.0001494368],"genre_scores_gemma":[0.9927256,0.0064931,0.00013006396,0.0000823889,0.00025553617,0.00007940818,0.000007858385,0.000030351279,0.0001956823],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860895,0.000030312309,0.00020524544,0.00045662487,0.00036232322,0.0003365666],"domain_scores_gemma":[0.99937165,0.00023620909,0.000019568333,0.00009067358,0.000088717425,0.00019316538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036601973,0.0001428343,0.00020911811,0.00037453652,0.00024173899,0.000105039704,0.000030288831,0.00007364369,0.00008671572],"category_scores_gemma":[0.000037187747,0.00013123603,0.000019206302,0.0005928749,0.00015107171,0.00015275914,0.00006397499,0.00023315114,0.0000011245354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012189093,0.00037960944,0.22065163,0.004284006,0.0011239016,0.00076392305,0.016481819,0.004374928,0.68334204,0.012034886,0.013293297,0.031080883],"study_design_scores_gemma":[0.01356641,0.0016509476,0.8925333,0.014787996,0.00041437216,0.00011030134,0.0036697274,0.008237738,0.021727705,0.006991763,0.03489754,0.0014121821],"about_ca_topic_score_codex":0.0005651514,"about_ca_topic_score_gemma":0.0029977465,"teacher_disagreement_score":0.6718817,"about_ca_system_score_codex":0.0012818003,"about_ca_system_score_gemma":0.0006408693,"threshold_uncertainty_score":0.53516495},"labels":[],"label_agreement":null},{"id":"W4393096647","doi":"10.1158/1538-7445.am2024-6774","title":"Abstract 6774: Establishment and optimization of an air liquid interface co-culture system to evaluate phenotypic changes in primary human Barrett's esophagus cells upon different environmental exposures","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Interface (matter); Phenotype; Esophagus; Liquid culture; Medicine; Primary (astronomy); Pathology; Chemistry; Internal medicine; Biology; Biochemistry; Physics; Gene","score_opus":0.029979242594287813,"score_gpt":0.35689637361858373,"score_spread":0.3269171310242959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93155736,0.06675749,0.00019077753,0.0004284703,0.0002330615,0.0007207016,0.00003924308,0.000041439707,0.000031479638],"genre_scores_gemma":[0.9978021,0.00052846415,0.00013562904,0.000010031947,0.00032793626,0.00016027888,0.000067623005,0.00003361915,0.0009343466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998476,0.00010765922,0.00021628827,0.00035924546,0.0005650726,0.0002756946],"domain_scores_gemma":[0.99950033,0.000036502202,0.000022611031,0.00019717866,0.000040530744,0.00020285003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004888717,0.000160917,0.00029860577,0.00030743727,0.00005865242,0.000025225414,0.00008905957,0.00008163029,0.00013420498],"category_scores_gemma":[0.000011813914,0.00011487472,0.000021170943,0.0001698492,0.00008708115,0.00006118101,0.00005736298,0.0003668263,0.0000039140828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003764746,0.0001245909,0.00043032633,0.00220061,0.000061253064,0.000101834834,0.0053164726,0.054220196,0.9335024,0.000021625785,0.00048859825,0.0031556608],"study_design_scores_gemma":[0.0013809759,0.0032797896,0.020036327,0.003650034,0.000049093578,0.000017457149,0.0019836875,0.0068804435,0.9620316,8.072484e-7,0.0004926511,0.0001971351],"about_ca_topic_score_codex":0.00010159901,"about_ca_topic_score_gemma":0.00003684681,"teacher_disagreement_score":0.06624474,"about_ca_system_score_codex":0.0006708351,"about_ca_system_score_gemma":0.000052538555,"threshold_uncertainty_score":0.4684455},"labels":[],"label_agreement":null},{"id":"W4393096790","doi":"10.1158/1538-7445.am2024-6027","title":"Abstract 6027: 89Zr-matuzumab and 225Ac-matuzumab as a theranostic for epidermal growth factor receptor-positive KRAS wild-type colorectal and breast cancer xenografts","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"KRAS; Colorectal cancer; Medicine; Oncology; Internal medicine; Breast cancer; Epidermal growth factor receptor; Cancer research; Epidermal growth factor; Human Epidermal Growth Factor Receptor 2; Cancer; Receptor","score_opus":0.044671223042287565,"score_gpt":0.39606411923801654,"score_spread":0.351392896195729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449146,0.043410856,0.000003146715,0.006779183,0.00063089316,0.0018273001,0.0011358969,0.00010124127,0.0011969251],"genre_scores_gemma":[0.9826036,0.013935804,0.000040167753,0.00016834053,0.0007322948,0.001088783,0.000049243656,0.0000831142,0.0012986248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973914,0.00008243498,0.00029506785,0.00080789137,0.0005977996,0.00082539],"domain_scores_gemma":[0.99790245,0.00084760046,0.000046370522,0.0001773707,0.00066723285,0.000358964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030616755,0.0003620288,0.00058339816,0.00028382448,0.0004811293,0.00021127578,0.00011104304,0.00017180742,0.0007770046],"category_scores_gemma":[0.00018347579,0.00027118585,0.00011845507,0.00054832327,0.0005497459,0.0002201198,0.00015028956,0.00058462843,0.000030654825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057085916,0.0010587476,0.08057746,0.009466024,0.010791649,0.0014140889,0.032770652,0.000009371303,0.18635415,0.0025265901,0.06822463,0.5497207],"study_design_scores_gemma":[0.010246438,0.0075583966,0.8971827,0.0056293746,0.00087578833,0.0006817314,0.002875655,0.0003472869,0.034563303,0.0013338872,0.03728377,0.0014216462],"about_ca_topic_score_codex":0.0054881275,"about_ca_topic_score_gemma":0.0008371268,"teacher_disagreement_score":0.81660527,"about_ca_system_score_codex":0.0010448924,"about_ca_system_score_gemma":0.0010561137,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W4393096802","doi":"10.1158/1538-7445.am2024-5241","title":"Abstract 5241: Generation of allogeneic CAR-T circumvents functional deficits in patient-derived autologous product for glioblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Medicine; Product (mathematics); Cancer research; Mathematics","score_opus":0.13576936141394785,"score_gpt":0.4057190539522579,"score_spread":0.26994969253831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076355,0.005432908,0.000047981688,0.00090946566,0.00057573343,0.0019000202,0.00006528156,0.000044098015,0.00026093874],"genre_scores_gemma":[0.9965188,0.0003845514,0.0000619091,0.000031698768,0.00072312396,0.0010134184,0.00008331555,0.000057816153,0.0011253742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997196,0.00012557501,0.00039457018,0.0006023779,0.0010602701,0.0006212056],"domain_scores_gemma":[0.998548,0.00023817441,0.000036757778,0.00035642087,0.00067793386,0.00014274343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010494726,0.00014938506,0.00029392386,0.00071542413,0.00008954185,0.000045393856,0.00013493522,0.00012331127,0.002287765],"category_scores_gemma":[0.00029234594,0.00013596895,0.00012648993,0.0007986199,0.00018298942,0.000097090204,0.00006828907,0.00054961914,0.00004609961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012492088,0.00015179554,0.0012274544,0.0006716425,0.00011031948,0.00008060346,0.0005481623,0.00032323715,0.90757465,0.000060654496,0.004545524,0.08345677],"study_design_scores_gemma":[0.0015203519,0.0011867298,0.025376571,0.00039150324,0.000022636945,0.00005229192,0.00019977127,0.0012602801,0.95803344,0.00014351985,0.011642229,0.00017067618],"about_ca_topic_score_codex":0.0004318242,"about_ca_topic_score_gemma":0.0004489798,"teacher_disagreement_score":0.08328609,"about_ca_system_score_codex":0.00077759277,"about_ca_system_score_gemma":0.0013749854,"threshold_uncertainty_score":0.99862427},"labels":[],"label_agreement":null},{"id":"W4393096830","doi":"10.1158/1538-7445.am2024-6028","title":"Abstract 6028: Preferential tumor-to-normal tissue biodistribution and single-dose efficacy with ABD147, a DLL3-targeted engineered antibody-based radiotherapeutic, in preclinical small cell lung cancer models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Biodistribution; Medicine; Cancer; Pathology; Radioimmunotherapy; Lung cancer; Cancer research; Antibody; Monoclonal antibody; Internal medicine; Biology; In vivo; Immunology","score_opus":0.10323605793788523,"score_gpt":0.4506887193218676,"score_spread":0.34745266138398234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95779735,0.033796646,0.0014294008,0.0027975098,0.0002257101,0.0030839029,0.00039244303,0.00018135096,0.00029567728],"genre_scores_gemma":[0.99559695,0.0017073296,0.00049259776,0.00010592094,0.0004946467,0.0009990748,0.00012779058,0.000104907704,0.000370767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955509,0.00022232781,0.0005280899,0.0010889864,0.0012443326,0.0013653868],"domain_scores_gemma":[0.99783444,0.0005325656,0.000050359722,0.0005021027,0.00048105454,0.00059949094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001208302,0.00039722136,0.00065458036,0.0007751966,0.00017532306,0.00023703689,0.00029867873,0.00018368784,0.0003533897],"category_scores_gemma":[0.00016149468,0.00031910505,0.00009007876,0.0014920761,0.0004031047,0.00021078507,0.00017147436,0.0015495693,0.000016964788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014200033,0.001530575,0.022049477,0.009715792,0.0009600052,0.0011158068,0.0027229385,0.010678515,0.90160275,0.00008786179,0.0034068658,0.031929415],"study_design_scores_gemma":[0.029212447,0.006267001,0.1820139,0.014731866,0.0006600465,0.00005869483,0.00041874408,0.119078144,0.62319916,0.00008149933,0.022179702,0.0020987794],"about_ca_topic_score_codex":0.002399639,"about_ca_topic_score_gemma":0.0010101948,"teacher_disagreement_score":0.27840355,"about_ca_system_score_codex":0.0016747726,"about_ca_system_score_gemma":0.0023999584,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W4393096831","doi":"10.1158/1538-7445.am2024-3910","title":"Abstract 3910: The Atlas of Blood Cancer Genomes: A resource for therapeutic and biomarker development","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biomarker; Cancer; Atlas (anatomy); Resource (disambiguation); Genome; Oncology; Biology; Medicine; Internal medicine; Computer science; Genetics; Anatomy; Gene","score_opus":0.06847345323816519,"score_gpt":0.3844354776527048,"score_spread":0.31596202441453963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8119477,0.18546839,0.00007780439,0.0013502819,0.00012661809,0.0004798759,0.00013722458,0.00000574832,0.00040637297],"genre_scores_gemma":[0.98221976,0.01572206,0.00008250455,0.00012542066,0.00029403213,0.00057503395,0.000026496444,0.000032963773,0.0009217135],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899274,0.000028846578,0.00017147206,0.00032309772,0.0001798623,0.00030398628],"domain_scores_gemma":[0.99935776,0.00017363938,0.000026883108,0.00023533274,0.00014098699,0.000065379645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005742049,0.000104083716,0.00010405664,0.00006336991,0.00013838887,0.000068749716,0.00020895046,0.00008115313,0.000050023653],"category_scores_gemma":[0.00003532298,0.00007404621,0.000052374548,0.0001479004,0.00020190314,0.0000021901544,0.00014040992,0.000119798926,0.0000019507845],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019741422,0.00003839028,0.0006073713,0.00039317587,0.0004573471,0.0000032196072,0.00051696243,0.00003949644,0.8620182,0.00031349782,0.012571234,0.12284368],"study_design_scores_gemma":[0.0002981165,0.00008447478,0.0023592825,0.00008995052,0.000033180233,0.0000025770512,0.00013481655,0.000039362534,0.25007507,0.00014243607,0.74663526,0.00010546431],"about_ca_topic_score_codex":0.00020399925,"about_ca_topic_score_gemma":0.00038048232,"teacher_disagreement_score":0.73406404,"about_ca_system_score_codex":0.00004016157,"about_ca_system_score_gemma":0.0007139583,"threshold_uncertainty_score":0.30195168},"labels":[],"label_agreement":null},{"id":"W4393096869","doi":"10.1158/1538-7445.am2024-2881","title":"Abstract 2881: Comparing the effects of proton and photon therapy on promoting cancer aggressiveness in ovarian cancer and glioblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"Cancer; Glioblastoma; Medicine; Proton therapy; Ovarian cancer; Oncology; Internal medicine; Cancer research; Radiation therapy","score_opus":0.06841273162653946,"score_gpt":0.4207338671216159,"score_spread":0.3523211354950765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94899225,0.046833493,6.115181e-7,0.0013958383,0.00012048553,0.0025076177,0.000006775904,0.000023051442,0.00011984632],"genre_scores_gemma":[0.9847608,0.0126342755,0.0000016142302,0.000115813324,0.00017306225,0.0022285616,0.0000010044713,0.000023903036,0.00006092762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984464,0.00019079472,0.00018811338,0.00040358832,0.00036398415,0.0004071255],"domain_scores_gemma":[0.99890065,0.0006960196,0.000043479475,0.0001695642,0.000080237,0.00011002902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008441819,0.00016132675,0.00033028595,0.00015439061,0.00011062641,0.000047770598,0.00011256253,0.000107160246,0.00006812762],"category_scores_gemma":[0.000079278005,0.00008723901,0.000038364913,0.00046324587,0.0003090522,0.00004495876,0.00007197973,0.0006783698,0.0000017101058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018541481,0.0001459297,0.071053185,0.0050713555,0.00019700105,0.00019548438,0.002445987,0.00001251875,0.75026315,0.00017143035,0.00001941735,0.1685704],"study_design_scores_gemma":[0.0019197845,0.0010740872,0.13910751,0.010243543,0.000018899682,0.000009753089,0.000044848006,0.0008317602,0.84481126,0.0003203064,0.0014870347,0.00013120375],"about_ca_topic_score_codex":0.0028175798,"about_ca_topic_score_gemma":0.0003394753,"teacher_disagreement_score":0.1684392,"about_ca_system_score_codex":0.00014487859,"about_ca_system_score_gemma":0.00022215623,"threshold_uncertainty_score":0.42593566},"labels":[],"label_agreement":null},{"id":"W4393096937","doi":"10.1158/1538-7445.am2024-3542","title":"Abstract 3542: The Chemical Probes Portal: An essential resource providing expert advice on chemical tools for cancer research","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"","keywords":"Advice (programming); Cancer; Resource (disambiguation); Medicine; Computer science; Internal medicine","score_opus":0.1364041699980706,"score_gpt":0.4841213603232055,"score_spread":0.34771719032513493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650134,0.02173617,0.000014746664,0.007732559,0.00014391437,0.0016549492,0.00027287516,0.00007548876,0.0033558863],"genre_scores_gemma":[0.98775434,0.002839575,0.000047200934,0.00028886786,0.0032117057,0.0045369044,0.00019482653,0.000059715727,0.0010668662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957853,0.0003041336,0.00027467468,0.0011146442,0.0011428029,0.0013784484],"domain_scores_gemma":[0.997553,0.00076073885,0.000025114587,0.0005876162,0.00065841095,0.00041514318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024212035,0.00023919875,0.00021402663,0.00011677408,0.0005643989,0.00047570525,0.0008930328,0.0002944458,0.00022244155],"category_scores_gemma":[0.0022419337,0.00015037306,0.00018034945,0.0004681332,0.0010702964,0.000025661633,0.00059563806,0.0010589543,0.000024181883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015248636,0.00014718102,0.000029128494,0.00020621788,0.00011096665,0.000020842263,0.00015398063,0.000004940185,0.8648565,0.00057885505,0.106241,0.026125528],"study_design_scores_gemma":[0.00030097572,0.0003633155,0.00009329586,0.00017386931,0.0000065692807,0.0000021534518,0.00068851345,0.000052580104,0.6819153,0.00037718134,0.31583363,0.00019260767],"about_ca_topic_score_codex":0.0002675019,"about_ca_topic_score_gemma":0.000108420514,"teacher_disagreement_score":0.20959263,"about_ca_system_score_codex":0.00015862101,"about_ca_system_score_gemma":0.0009813767,"threshold_uncertainty_score":0.6132035},"labels":[],"label_agreement":null},{"id":"W4393101183","doi":"10.1158/1538-7445.am2024-6333","title":"Abstract 6333: A high-parameter mass cytometry panel for the functional characterization of CAR T cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"TIGIT; Mass cytometry; Flow cytometry; Granzyme B; Cytokine; T cell; Immune system; Cancer research; Immunology; Tumor microenvironment; Cell therapy; Biology; Cell biology; Stem cell; Phenotype","score_opus":0.15866238021223067,"score_gpt":0.41540188587425836,"score_spread":0.2567395056620277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393101183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038875,0.0011758509,0.002114043,0.0032195116,0.0007611774,0.0016035424,0.00030556918,0.000047024412,0.0003845134],"genre_scores_gemma":[0.9745691,0.0011328589,0.00007955022,0.00008917658,0.0011660247,0.00073260354,0.00010859176,0.00006303224,0.022059064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976105,0.000076955395,0.0002632661,0.00037444328,0.0011765647,0.0004982733],"domain_scores_gemma":[0.9973371,0.001462906,0.00003141113,0.0004280003,0.00060855213,0.00013200362],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001511506,0.0001248276,0.00023293629,0.00046048095,0.00012871504,0.000097281154,0.00020676908,0.0001236167,0.008623886],"category_scores_gemma":[0.00014977735,0.00008450487,0.00015753473,0.0009778915,0.00027172192,0.00009733798,0.000059512644,0.000680924,0.00010070109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009556009,0.000048953443,0.0002915722,0.0007351913,0.00023664809,0.000015997806,0.00014605369,0.000013108868,0.9667868,0.00016134972,0.0036385288,0.026970195],"study_design_scores_gemma":[0.00097121694,0.00032983793,0.040529646,0.0002849892,0.00005591172,0.000007777048,0.00013022048,0.0012487755,0.85288376,0.00022688702,0.10320863,0.00012232472],"about_ca_topic_score_codex":0.0002799415,"about_ca_topic_score_gemma":0.00000870173,"teacher_disagreement_score":0.113903016,"about_ca_system_score_codex":0.00036964763,"about_ca_system_score_gemma":0.000703175,"threshold_uncertainty_score":0.9922824},"labels":[],"label_agreement":null},{"id":"W4393102388","doi":"10.1158/1538-7445.am2024-2052","title":"Abstract 2052: Screening novel format antibodies to design bispecific ADCs that address target heterogeneity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Bispecific antibody; Medicine; Antibody; Oncology; Cancer research; Immunology; Monoclonal antibody","score_opus":0.34709494027979776,"score_gpt":0.47729900415849585,"score_spread":0.1302040638786981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393102388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9266302,0.035448752,0.010418525,0.014046571,0.0010177437,0.0026095042,0.00057734275,0.00033915433,0.008912213],"genre_scores_gemma":[0.9792949,0.00410191,0.0049687126,0.00038085532,0.0011939106,0.00033211964,0.000077902376,0.00010168663,0.009548024],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995257,0.00012640793,0.00036158113,0.0007619149,0.0020518682,0.0014412084],"domain_scores_gemma":[0.99759007,0.0006219681,0.000027542743,0.0005047777,0.00048329978,0.0007723405],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019738027,0.0003122003,0.00045859168,0.0008054513,0.0004802056,0.0003644332,0.00048635848,0.00016408952,0.0018283512],"category_scores_gemma":[0.00015531009,0.00023789426,0.00022155899,0.0010376943,0.00034738964,0.00030700717,0.0004442885,0.0013021735,0.00080250594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005183687,0.0004276783,0.0187979,0.0039245505,0.000955669,0.0017183868,0.0019278679,0.00082812767,0.53563297,0.0011521769,0.35404545,0.07540553],"study_design_scores_gemma":[0.00092615274,0.00062357174,0.051939026,0.0026292151,0.00003464253,0.000154982,0.00050710846,0.0024334332,0.29838136,0.00017035859,0.64163727,0.00056289515],"about_ca_topic_score_codex":0.0010496759,"about_ca_topic_score_gemma":0.00011032693,"teacher_disagreement_score":0.2875918,"about_ca_system_score_codex":0.0002947454,"about_ca_system_score_gemma":0.00057523826,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W4393983007","doi":"10.1158/1538-7445.am2024-ct203","title":"Abstract CT203: Multi-omic analysis of serial biopsies to inform biomarkers of sensitivity to olaparib and durvalumab in patients with metastatic <i>BRCA</i>-wildtype triple negative breast cancer (mTNBC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Olaparib; Medicine; Breast cancer; Oncology; Atezolizumab; Biomarker; Internal medicine; PARP inhibitor; Cancer research; Triple-negative breast cancer; Cancer; Biology; Immunotherapy; Gene; Nivolumab; Genetics","score_opus":0.059833608512475246,"score_gpt":0.4129483053899583,"score_spread":0.35311469687748304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421394,0.0003630336,0.00004444606,0.0015637631,0.00014864159,0.001386674,0.0021829756,0.00002070147,0.00007584052],"genre_scores_gemma":[0.9987304,0.00018212116,0.00045704228,0.00013522104,0.000046012254,0.00026417538,0.00004168548,0.000033765245,0.00010953402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751866,0.0001541921,0.000494892,0.00048187436,0.0008988028,0.0004515775],"domain_scores_gemma":[0.998156,0.0003411176,0.000096614334,0.0003279367,0.0008120685,0.00026627904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011316708,0.00020790176,0.0007248524,0.001717176,0.00006463188,0.000039147322,0.00009804911,0.00007112221,0.00034953834],"category_scores_gemma":[0.00014779494,0.00016807254,0.00009500546,0.0048820274,0.00032629305,0.00019630756,0.00008341644,0.00031572676,0.0000064479136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055596422,0.0012319187,0.6093493,0.0032171954,0.014086979,0.0001240513,0.019098168,0.007954497,0.210453,0.000066899025,0.0040987595,0.074722774],"study_design_scores_gemma":[0.005526928,0.000497187,0.9550673,0.0011871998,0.0003775592,0.000002639303,0.00058749935,0.0008279082,0.035489094,0.000008409963,0.00021943083,0.00020886728],"about_ca_topic_score_codex":0.020900367,"about_ca_topic_score_gemma":0.012969637,"teacher_disagreement_score":0.34571794,"about_ca_system_score_codex":0.00082541467,"about_ca_system_score_gemma":0.0009073482,"threshold_uncertainty_score":0.98561954},"labels":[],"label_agreement":null},{"id":"W4393983127","doi":"10.1158/1538-7445.am2024-sy36-01","title":"Abstract SY36-01: Somatic evolution, cancer, and our inevitable decline with age: Inextricably linked","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Somatic cell; Cancer; Gerontology; Demography; Biology; Medicine; Genetics; Sociology","score_opus":0.11623921279938014,"score_gpt":0.4673127411587975,"score_spread":0.35107352835941735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8890437,0.07046196,0.00013016928,0.03499261,0.00038198003,0.0012367268,0.000028911241,0.00016260323,0.0035613463],"genre_scores_gemma":[0.97529286,0.008467599,0.00019157842,0.00028437807,0.0012218753,0.00043395776,0.000015085243,0.000047714308,0.014044936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959518,0.000074368894,0.00033021363,0.00066942326,0.0019503521,0.0010238767],"domain_scores_gemma":[0.99784416,0.00027752848,0.00003454778,0.00045657158,0.0006513177,0.00073588546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00231864,0.0002054528,0.00042186579,0.000824956,0.0002787158,0.00017812705,0.00027846484,0.00012274829,0.00038494784],"category_scores_gemma":[0.00065853016,0.00013400515,0.00004831144,0.0026504728,0.0005396695,0.00027015366,0.00017824852,0.0011939103,0.000082714854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027485425,0.0007651771,0.11414842,0.014876875,0.0008398246,0.0061725713,0.004217363,0.00014332453,0.30548072,0.002328047,0.2936376,0.25464153],"study_design_scores_gemma":[0.012550539,0.003593301,0.70625055,0.017774949,0.0004259676,0.00064004696,0.008092105,0.007993846,0.008556814,0.0033081358,0.22965752,0.001156243],"about_ca_topic_score_codex":0.0058216034,"about_ca_topic_score_gemma":0.0011244534,"teacher_disagreement_score":0.5921021,"about_ca_system_score_codex":0.00070062664,"about_ca_system_score_gemma":0.0030898484,"threshold_uncertainty_score":0.8800562},"labels":[],"label_agreement":null},{"id":"W4393983153","doi":"10.1158/1538-7445.am2024-ct081","title":"Abstract CT081: A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced, or metastatic claudin 18.2+ solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Phase (matter); Oncology; Internal medicine; Claudin; Phases of clinical research; Cancer research; Toxicity; Chemistry; Tight junction","score_opus":0.09422062859099477,"score_gpt":0.4516854115260862,"score_spread":0.35746478293509143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905639,0.0035403606,0.00002251882,0.00085121684,0.000063340565,0.0039714957,0.000044357406,0.00005473955,0.0008880283],"genre_scores_gemma":[0.9957314,0.00092635106,0.00015869476,0.000057436122,0.00009160001,0.00043926638,0.0000075479647,0.00008892071,0.0024987864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99528414,0.00062090124,0.0006478318,0.00075452204,0.0016927129,0.0009998874],"domain_scores_gemma":[0.9955896,0.0029512753,0.000084109124,0.0006500035,0.00038017635,0.00034484154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004308021,0.00028160983,0.0007225508,0.0006690536,0.0001988605,0.0001344871,0.00040143018,0.000068679874,0.0014612786],"category_scores_gemma":[0.00083340856,0.00016430633,0.000061714505,0.0027898094,0.0010661116,0.00015943215,0.00023767362,0.001872416,0.000014046047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031090146,0.0019309843,0.0048362073,0.0033645297,0.00082401576,0.005648416,0.01172042,0.0019128764,0.7933491,0.00006188317,0.0008906994,0.14437073],"study_design_scores_gemma":[0.10801053,0.05052077,0.10628464,0.02118996,0.000628346,0.0009326657,0.053303763,0.018351305,0.62793833,0.00056792155,0.01031038,0.0019613993],"about_ca_topic_score_codex":0.0025684477,"about_ca_topic_score_gemma":0.0030182889,"teacher_disagreement_score":0.16541077,"about_ca_system_score_codex":0.0004999691,"about_ca_system_score_gemma":0.0030827005,"threshold_uncertainty_score":0.9994515},"labels":[],"label_agreement":null},{"id":"W4393983276","doi":"10.1158/1538-7445.am2024-ct063","title":"Abstract CT063: Phase Ib trial of ATR inhibitor (ATRi) tuvusertib + ATM inhibitor (ATMi) lartesertib (M4076) in patients (pts) with advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Phase (matter); Internal medicine; Pharmacology; Chemistry","score_opus":0.04407971436405525,"score_gpt":0.42376940895817367,"score_spread":0.3796896945941184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910228,0.0023835064,0.0000043542823,0.00071465736,0.0005634834,0.0038866221,0.00012560509,0.00011916087,0.0011797906],"genre_scores_gemma":[0.9953589,0.0004429063,0.00007675336,0.000046441775,0.0011592803,0.0007661436,0.00009224449,0.00017198843,0.0018853382],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922787,0.00026025035,0.0011532581,0.0011780792,0.003436297,0.0016934396],"domain_scores_gemma":[0.9962576,0.0008236598,0.00013154293,0.0010494555,0.0010376439,0.00070007227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019826414,0.00044784017,0.0009881112,0.0011166041,0.00014469327,0.00012926402,0.00052459206,0.0003009381,0.0007673003],"category_scores_gemma":[0.0011654848,0.0003504063,0.00023172642,0.002631134,0.00068310084,0.0004948464,0.0003132928,0.0018038756,0.00024113336],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.5786452,0.010739237,0.006213973,0.010415598,0.0010270155,0.005430658,0.0045306394,0.00046897947,0.17969185,0.00020094634,0.037287354,0.16534851],"study_design_scores_gemma":[0.6774261,0.019402927,0.002868664,0.010155275,0.00012354134,0.00004384247,0.00070225756,0.0026542442,0.2683989,0.000119761375,0.017178183,0.000926295],"about_ca_topic_score_codex":0.0018695119,"about_ca_topic_score_gemma":0.00057975744,"teacher_disagreement_score":0.16442223,"about_ca_system_score_codex":0.015435444,"about_ca_system_score_gemma":0.01960758,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W4393983476","doi":"10.1158/1538-7445.am2024-ct286","title":"Abstract CT286: TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Tumor-infiltrating lymphocytes; Melanoma; Oncology; Metastatic melanoma; Immunotherapy; Internal medicine; Cancer; Cancer research","score_opus":0.09603221829209885,"score_gpt":0.4251622067439079,"score_spread":0.3291299884518091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484236,0.005987793,0.000005503065,0.00021311876,0.00009137539,0.0051738974,0.00007123519,0.00006992917,0.0035447848],"genre_scores_gemma":[0.98840004,0.0034807539,0.00005941834,0.000024405215,0.00011559823,0.0023032546,0.000051644234,0.00015385996,0.005411037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941031,0.000704745,0.0008814356,0.0010469639,0.001988694,0.0012750997],"domain_scores_gemma":[0.9969649,0.0012389892,0.00013723834,0.0008028239,0.00054740376,0.00030865934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017209902,0.0004734473,0.0011040944,0.0019095608,0.00014544657,0.0001769076,0.0003964776,0.00010555724,0.0033333658],"category_scores_gemma":[0.00014083477,0.00033970148,0.00012425735,0.0033707514,0.00029452742,0.00038192343,0.00008566132,0.001053767,0.000039391405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20488408,0.024453096,0.02388871,0.002737517,0.0010541126,0.012910603,0.027911283,0.0008542972,0.5327596,0.000063654035,0.00046583157,0.16801718],"study_design_scores_gemma":[0.30894998,0.097477615,0.026412793,0.004003556,0.00018751051,0.00030459985,0.020973505,0.012219791,0.52336407,0.00018716772,0.00478766,0.0011317644],"about_ca_topic_score_codex":0.018695673,"about_ca_topic_score_gemma":0.0067522204,"teacher_disagreement_score":0.16688542,"about_ca_system_score_codex":0.003585837,"about_ca_system_score_gemma":0.004228035,"threshold_uncertainty_score":0.9999055},"labels":[],"label_agreement":null},{"id":"W4393983586","doi":"10.1158/1538-7445.am2024-ct238","title":"Abstract CT238: Associations of ctDNA levels during neoadjuvant treatment with pathological response in patients with resectable NSCLC from the phase 3 AEGEAN trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pathological; Neoadjuvant therapy; Complete response; Phases of clinical research; Clinical trial; Cancer; Chemotherapy; Breast cancer","score_opus":0.2390266558910949,"score_gpt":0.40967585028247167,"score_spread":0.17064919439137677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393983586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944044,0.0014859524,0.0000018217391,0.0012082735,0.000052962947,0.0020345426,0.0005839971,0.000032325304,0.00019573269],"genre_scores_gemma":[0.99860376,0.00008426645,0.000044598844,0.0000112584175,0.00015193624,0.0005928897,0.00012255988,0.00003219387,0.0003565603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975626,0.000451722,0.00029292726,0.0004139407,0.0008218503,0.00045696684],"domain_scores_gemma":[0.99825644,0.0009871267,0.00005202085,0.0003672206,0.00020686665,0.00013034129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009867919,0.0001737945,0.0003560924,0.00020550829,0.00015847659,0.000063147054,0.00011868993,0.00010224756,0.00039594914],"category_scores_gemma":[0.0001642177,0.00008723504,0.000086643595,0.0006851948,0.00015786619,0.00009431777,0.00003886264,0.00042877602,0.00001715227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21736155,0.0019054547,0.75735223,0.000047274407,0.0003995638,0.0013277257,0.0022438676,0.0000038909716,0.009409516,0.000009048862,0.00012417791,0.009815687],"study_design_scores_gemma":[0.070913926,0.01003069,0.90288544,0.0006538439,0.00012496757,0.0000021509215,0.0002272345,0.00004396449,0.014542527,0.000021389093,0.00042732328,0.00012655028],"about_ca_topic_score_codex":0.0019446147,"about_ca_topic_score_gemma":0.00041878372,"teacher_disagreement_score":0.14644763,"about_ca_system_score_codex":0.0008959007,"about_ca_system_score_gemma":0.00085154746,"threshold_uncertainty_score":0.43353656},"labels":[],"label_agreement":null},{"id":"W4393985262","doi":"10.1158/1538-7445.am2024-lb396","title":"Abstract LB396: The power of NetraAI: Precision medicine in oncology through sub-insight learning from small data sets","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Precision oncology; Clinical Oncology; Oncology; Internal medicine; Medical physics; Cancer","score_opus":0.19733868170692995,"score_gpt":0.48915427810643963,"score_spread":0.2918155963995097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393985262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91520363,0.031803474,0.00034708958,0.038565017,0.0007287221,0.00048589226,0.000018456696,0.000049791266,0.012797952],"genre_scores_gemma":[0.9912315,0.0069396948,0.00026008624,0.00038867467,0.0005599938,0.000029291072,0.00012458152,0.000043411143,0.0004227792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997253,0.0003819352,0.0004587874,0.00057768944,0.0008617802,0.00046681528],"domain_scores_gemma":[0.9960923,0.0028048337,0.000061055005,0.0007484895,0.00015355836,0.00013974571],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038329866,0.0001421094,0.00041680562,0.0002471627,0.00010551456,0.00003771558,0.00064892694,0.00015148381,0.0012646843],"category_scores_gemma":[0.0026257879,0.000084907464,0.00004606473,0.00075411965,0.0006007673,0.00012913776,0.00039189777,0.003052774,0.00003956451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009002676,0.00026179076,0.01506196,0.0006423097,0.00034277886,0.001660773,0.020361729,0.000631118,0.19423723,0.0006423466,0.08805206,0.6772056],"study_design_scores_gemma":[0.0027149,0.0008719329,0.07536609,0.005439188,0.000099267774,0.000056663946,0.0022250062,0.027944487,0.0040406585,0.0023494663,0.8786532,0.00023911966],"about_ca_topic_score_codex":0.008495421,"about_ca_topic_score_gemma":0.00041747652,"teacher_disagreement_score":0.79060113,"about_ca_system_score_codex":0.00026848537,"about_ca_system_score_gemma":0.0007281797,"threshold_uncertainty_score":0.9996483},"labels":[],"label_agreement":null},{"id":"W4393985505","doi":"10.1158/1538-7445.am2024-ct184","title":"Abstract CT184: First-in-human trial of TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa (BA) in patients (pts) with advanced solid unresectable tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Solid tumor; TIGIT; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.024175688309760898,"score_gpt":0.3785753290395207,"score_spread":0.35439964072975977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393985505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696225,0.00072023144,0.0000021878086,0.00017542703,0.000049824142,0.0015175522,0.000047210768,0.000007775548,0.0005175441],"genre_scores_gemma":[0.99765253,0.0008552717,0.000015584921,0.000010172944,0.00007014777,0.00071737194,0.00011119424,0.000046046553,0.000521659],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779797,0.00009819563,0.00030323505,0.0005457352,0.00065205427,0.00060283614],"domain_scores_gemma":[0.99931335,0.000055871402,0.00004859928,0.0002945048,0.00017531663,0.00011234793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041099451,0.00017998439,0.0002598791,0.00046208198,0.00005939763,0.00006546488,0.00022319524,0.00010440508,0.00011762273],"category_scores_gemma":[0.00005817584,0.00013315142,0.000036891633,0.00082779897,0.00017077618,0.000032880813,0.00006404975,0.0003646757,0.0000061398214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49177745,0.0078114322,0.18754095,0.0015162234,0.0005207343,0.00095441146,0.001408827,0.0032075676,0.23669694,0.00020123631,0.0020866913,0.066277534],"study_design_scores_gemma":[0.20079994,0.034356777,0.07305921,0.0029438548,0.000011628916,0.000004963683,0.00035510084,0.0001335042,0.6806904,0.00040116007,0.0065265046,0.0007169471],"about_ca_topic_score_codex":0.005778119,"about_ca_topic_score_gemma":0.03913448,"teacher_disagreement_score":0.44399345,"about_ca_system_score_codex":0.00044607287,"about_ca_system_score_gemma":0.0008966763,"threshold_uncertainty_score":0.9783988},"labels":[],"label_agreement":null},{"id":"W4393986694","doi":"10.1158/1538-7445.am2024-lb395","title":"Abstract LB395: NetraAI-driven discovery of novel biomarkers in MSI-high colon cancer for precision immunotherapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer; Medicine; Immunotherapy; Colorectal cancer; Microsatellite instability; Oncology; Biomarker discovery; Cancer immunotherapy; Internal medicine; Cancer research; Biology; Genetics; Proteomics","score_opus":0.08902612866333698,"score_gpt":0.4406809275490307,"score_spread":0.35165479888569373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393986694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95746887,0.035455983,0.00023895726,0.0029713383,0.00093211746,0.0019569786,0.00052637496,0.00004157715,0.00040779114],"genre_scores_gemma":[0.9815409,0.014717535,0.0002686292,0.00012479245,0.00034247144,0.0010666695,0.000042094114,0.000079667734,0.0018172453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744457,0.000056908262,0.0005416552,0.00057292316,0.0007484883,0.0006354391],"domain_scores_gemma":[0.9985616,0.0005965301,0.000074376854,0.0004185054,0.0002587645,0.00009018839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001310096,0.00021691516,0.00044444622,0.0006808688,0.00008985303,0.00010192286,0.00028415074,0.00021019466,0.0005972084],"category_scores_gemma":[0.00006746727,0.00017521798,0.00024363287,0.0012586217,0.00035325854,0.00027750278,0.00005241298,0.0004765392,0.0000043607934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014581394,0.00029101357,0.0021815158,0.0009983693,0.00066520326,0.000020364452,0.0005361928,0.000060414608,0.8700449,0.00014646379,0.007502078,0.10297212],"study_design_scores_gemma":[0.025522448,0.0029893687,0.23857202,0.0142439455,0.00013908735,0.00002532572,0.0009636243,0.0023350022,0.54067725,0.00051110913,0.17305677,0.0009640492],"about_ca_topic_score_codex":0.011043818,"about_ca_topic_score_gemma":0.0017027797,"teacher_disagreement_score":0.3293676,"about_ca_system_score_codex":0.0010581969,"about_ca_system_score_gemma":0.0014490089,"threshold_uncertainty_score":0.99554175},"labels":[],"label_agreement":null},{"id":"W4393987697","doi":"10.1158/1538-7445.am2024-ct178","title":"Abstract CT178: Phase 1 trial of PF-07799933 (ARRY-440), a next-generation BRAF inhibitor, for BRAF-mutant cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Mutant; Medicine; Cancer research; Internal medicine; Cancer; Oncology; Biology; Genetics; Gene","score_opus":0.16352622464378694,"score_gpt":0.43476064472679554,"score_spread":0.2712344200830086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393987697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905968,0.0050146133,0.0004354832,0.00040178365,0.0013785796,0.0011190793,0.0004162615,0.000019223487,0.0006181895],"genre_scores_gemma":[0.99303895,0.0010353158,0.00008309434,0.000052310254,0.0038242145,0.00069009745,0.00029227865,0.000045039626,0.00093868474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981822,0.000079861115,0.00034553133,0.00053842005,0.00038805668,0.00046592494],"domain_scores_gemma":[0.99911577,0.000050579154,0.00005531306,0.00035755456,0.0002721849,0.00014858773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008554228,0.00016139644,0.00020518679,0.00014165022,0.00013102985,0.00010372769,0.00023739497,0.00020891563,0.00015706634],"category_scores_gemma":[0.00016421686,0.00014674415,0.00016063238,0.00023207636,0.00014341914,0.000015605814,0.00008107047,0.00022862088,0.000011765503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00402257,0.0000913668,0.0000030523702,0.00023138885,0.00007953572,0.000012396159,0.000108043714,0.0000359135,0.9362293,0.0002788955,0.02951313,0.029394398],"study_design_scores_gemma":[0.008942493,0.0014658662,0.000004209315,0.00008107703,0.000015717864,0.0000027784226,0.000061007606,0.00043319174,0.8365291,0.000091168826,0.1522224,0.00015100157],"about_ca_topic_score_codex":0.00040236177,"about_ca_topic_score_gemma":0.0004711399,"teacher_disagreement_score":0.12270927,"about_ca_system_score_codex":0.00014962758,"about_ca_system_score_gemma":0.0015746219,"threshold_uncertainty_score":0.59840524},"labels":[],"label_agreement":null},{"id":"W4393987709","doi":"10.1158/1538-7445.am2024-lb134","title":"Abstract LB134: Mutational signatures in colorectal cancer from 11 countries reveal new insights in early-onset colorectal cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Oncology; Internal medicine; Cancer research; Biology","score_opus":0.04808622204956325,"score_gpt":0.3916984989240104,"score_spread":0.3436122768744471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393987709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486805,0.043641206,0.0000021698854,0.0027240834,0.0018377318,0.0015070945,0.000778109,0.00010351529,0.00072557764],"genre_scores_gemma":[0.99184465,0.0029195724,0.00008507254,0.00028176804,0.0014770352,0.001853988,0.000095849035,0.000117778574,0.001324305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947576,0.00023279124,0.00070524163,0.0011893783,0.0019297067,0.0011852843],"domain_scores_gemma":[0.9974777,0.0012536765,0.000080761325,0.0002713709,0.00045119098,0.00046526938],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006444575,0.00045274952,0.00070548465,0.0010309331,0.00014738478,0.00021688643,0.0004446517,0.0005343068,0.00792257],"category_scores_gemma":[0.00029589006,0.00040985196,0.00014439946,0.0019485331,0.000588544,0.00028734203,0.00018768213,0.002264551,0.00009701486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0068821944,0.0002882473,0.69900155,0.00087701646,0.00045856228,0.0023701875,0.015954074,0.0032968353,0.14702438,0.00019156036,0.10933237,0.014323021],"study_design_scores_gemma":[0.0022157237,0.00032199136,0.8705805,0.0022123964,0.00004741414,0.000009451823,0.00039516474,0.00043539557,0.11159272,0.0011734106,0.010544994,0.00047084165],"about_ca_topic_score_codex":0.13969316,"about_ca_topic_score_gemma":0.24677326,"teacher_disagreement_score":0.17157894,"about_ca_system_score_codex":0.004093468,"about_ca_system_score_gemma":0.008952809,"threshold_uncertainty_score":0.9998353},"labels":[],"label_agreement":null},{"id":"W4393988139","doi":"10.1158/1538-7445.am2024-lb093","title":"Abstract LB093: Low IGFBP7 expression identifies a subset of breast cancers with favorable prognosis and sensitivity to IGF-1 receptor targeting with ganitumab: Data from I-SPY2 and SCAN-B","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Sensitivity (control systems); Cancer research; Cancer","score_opus":0.036835989703794016,"score_gpt":0.3366021910904113,"score_spread":0.29976620138661725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97882813,0.017897416,0.00013040152,0.00026328454,0.00019872776,0.00043884528,0.0021600751,0.0000162377,0.00006689846],"genre_scores_gemma":[0.9933916,0.0047273887,0.0003778127,0.00002785751,0.0007495876,0.00010702371,0.00034528653,0.000045174387,0.00022829846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980361,0.000108586486,0.00017243267,0.00084674364,0.00041862726,0.00041754293],"domain_scores_gemma":[0.99891436,0.00007112443,0.000049725426,0.00047550854,0.00027499584,0.00021429428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070752,0.00018682449,0.00025044425,0.0001045547,0.00016032546,0.0001767578,0.0001786634,0.00009874832,0.00006608288],"category_scores_gemma":[0.00006561396,0.00014388708,0.000020713649,0.00027928667,0.0003266174,0.000041849573,0.00036791957,0.0002549134,0.0000028914544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078510225,0.000025427646,0.002835212,0.0003419236,0.000110592635,0.000010647432,0.00034840588,0.000053200987,0.9682767,0.0000017718323,0.022078952,0.0051320796],"study_design_scores_gemma":[0.00076542294,0.00022263979,0.014791518,0.0015435257,0.000054293727,0.000024923293,0.0012089156,0.00013204492,0.9457422,0.000011026972,0.035130702,0.0003727704],"about_ca_topic_score_codex":0.010228642,"about_ca_topic_score_gemma":0.009168381,"teacher_disagreement_score":0.02253447,"about_ca_system_score_codex":0.000063194944,"about_ca_system_score_gemma":0.000826196,"threshold_uncertainty_score":0.9963623},"labels":[],"label_agreement":null},{"id":"W4393988196","doi":"10.1158/1538-7445.am2024-ct078","title":"Abstract CT078: Phase 1 study of SGN-EGFRd2 in solid tumors (SGNEGFRd2-001)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Solid tumor; Internal medicine; Phase (matter); Cancer; Oncology; Cancer research; Chemistry; Organic chemistry","score_opus":0.08510396615775197,"score_gpt":0.47966716511410556,"score_spread":0.3945631989563536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203247,0.0056157606,0.000010339233,0.00018784722,0.00013535422,0.00042712523,0.00005337993,0.000009672692,0.001528059],"genre_scores_gemma":[0.99684465,0.0008970859,0.000007900938,0.000016668439,0.00024860265,0.000363613,0.00002985111,0.000027042928,0.0015646075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985164,0.00008429329,0.00028013182,0.00043609564,0.00033803674,0.0003450455],"domain_scores_gemma":[0.99924886,0.00002486646,0.000029422275,0.00043758718,0.00017763455,0.00008163489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065315125,0.00010747961,0.00015302277,0.0002054074,0.000063609856,0.000049019418,0.00029783597,0.00007995884,0.00035094898],"category_scores_gemma":[0.000044812517,0.00009758178,0.000045704295,0.00044420594,0.00011918066,0.0000071591517,0.000102826154,0.0002891503,0.000027241995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019636807,0.001096396,0.0008211412,0.00013943583,0.000073890245,0.00004589072,0.0005067737,0.00032636564,0.95130223,0.0000857531,0.010018998,0.035386734],"study_design_scores_gemma":[0.007842398,0.004304354,0.02938777,0.0006263641,0.000041689895,0.000014069624,0.006989966,0.0008885847,0.7873797,0.0003664126,0.16129926,0.0008594304],"about_ca_topic_score_codex":0.0011020056,"about_ca_topic_score_gemma":0.00061968906,"teacher_disagreement_score":0.16392256,"about_ca_system_score_codex":0.00007804652,"about_ca_system_score_gemma":0.0004112596,"threshold_uncertainty_score":0.39792696},"labels":[],"label_agreement":null},{"id":"W4393988251","doi":"10.1158/1538-7445.am2024-ct263","title":"Abstract CT263: Atezolizumab clinical trial biopsies reveal varied immune landscapes in clear cell sarcoma and chondrosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Atezolizumab; Chondrosarcoma; Sarcoma; Medicine; Clinical trial; Cancer; Oncology; Pathology; Internal medicine; Immunotherapy; Pembrolizumab","score_opus":0.1152127818301636,"score_gpt":0.4628273948730781,"score_spread":0.3476146130429145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97297305,0.017194293,0.0000018099661,0.0032166995,0.00041730705,0.0013648841,0.000028833389,0.00008692378,0.0047161784],"genre_scores_gemma":[0.98612934,0.0068691606,0.00010839737,0.000058543734,0.00082098553,0.00020132073,0.000030394167,0.00008378687,0.005698085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99537444,0.0005125636,0.0008471388,0.0008993279,0.0013408902,0.0010256445],"domain_scores_gemma":[0.99731416,0.0013201414,0.00004410474,0.0006167006,0.00023155066,0.0004733695],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037674045,0.00024067958,0.00062458083,0.00063896034,0.00015667503,0.00025776116,0.0003518929,0.0003311387,0.0013287759],"category_scores_gemma":[0.0006406188,0.00019839109,0.00019667887,0.0011832664,0.00051516097,0.00013550255,0.0004490401,0.002584274,0.00041773575],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18076955,0.0022797203,0.017868858,0.004863846,0.0003367618,0.009663774,0.0016229007,0.000007781071,0.5122719,0.00040775732,0.03854312,0.23136403],"study_design_scores_gemma":[0.17317438,0.012264161,0.41248968,0.0040504388,0.00014265005,0.00032474968,0.0015984349,0.0025803228,0.10610438,0.0012081052,0.28458726,0.0014753969],"about_ca_topic_score_codex":0.0013188877,"about_ca_topic_score_gemma":0.00020428267,"teacher_disagreement_score":0.40616754,"about_ca_system_score_codex":0.00032226002,"about_ca_system_score_gemma":0.0010534944,"threshold_uncertainty_score":0.9997168},"labels":[],"label_agreement":null},{"id":"W4393988288","doi":"10.1158/1538-7445.am2024-ct002","title":"Abstract CT002: CTX130 allogeneic CRISPR-Cas9-engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Long-term follow-up and translational data from the phase 1 COBALT-RCC study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chimeric antigen receptor; CRISPR; Renal cell carcinoma; Medicine; Antigen; Cancer research; Immunology; Biology; Oncology; Immunotherapy; Immune system; Gene; Genetics","score_opus":0.07240042123301262,"score_gpt":0.3885031541100254,"score_spread":0.3161027328770128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985897,0.008019612,0.000026606649,0.00037688453,0.00031421825,0.0035367552,0.0015816716,0.000052839005,0.00019439386],"genre_scores_gemma":[0.99579704,0.0011144299,0.000093070455,0.000041069674,0.00037417232,0.00020856236,0.0011701607,0.0001433806,0.0010580933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99480754,0.0003855651,0.00051570096,0.0013219202,0.00199356,0.00097572926],"domain_scores_gemma":[0.9971608,0.0006658019,0.00005958546,0.0013760602,0.00033828302,0.00039948587],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013267018,0.00038925812,0.00052265264,0.00039633884,0.00023587923,0.00020938432,0.0008535892,0.0001466447,0.0041118558],"category_scores_gemma":[0.000042382228,0.00028169347,0.00008660909,0.0011925678,0.00030757295,0.00032344655,0.00029373114,0.0015807474,0.00009371168],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011309472,0.0019685545,0.29077703,0.00039905688,0.00032934398,0.00032482712,0.0028523807,0.00007494743,0.6675253,7.7179e-7,0.0047675823,0.019670729],"study_design_scores_gemma":[0.02679325,0.0030242228,0.8975617,0.0003870528,0.00014164262,0.0000029091368,0.00084751955,0.00047895912,0.0656823,0.000006006106,0.0045606415,0.00051378086],"about_ca_topic_score_codex":0.0017212562,"about_ca_topic_score_gemma":0.0009848856,"teacher_disagreement_score":0.6067847,"about_ca_system_score_codex":0.00027854863,"about_ca_system_score_gemma":0.0009705118,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W4393988289","doi":"10.1158/1538-7445.am2024-ct194","title":"Abstract CT194: N-myristoylation inhibitor zelenirstat: New mechanistic insights and efficacy signals from a first in human phase I study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Myristoylation; Pharmacology; Medicine; Chemistry; Biochemistry","score_opus":0.05712744378092964,"score_gpt":0.40205313325163605,"score_spread":0.3449256894707064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942612,0.0045069936,0.00020041555,0.00017915406,0.00020439489,0.00049622054,0.000020159296,0.00001807597,0.000113380534],"genre_scores_gemma":[0.998489,0.00024213955,0.000011083569,0.000017657527,0.000486412,0.000065433545,0.00012158352,0.0000210531,0.00054559106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881893,0.000078742225,0.00020230384,0.00044516413,0.00025705792,0.00019778474],"domain_scores_gemma":[0.99955255,0.000063553736,0.000023926921,0.0001806012,0.000066182976,0.00011316913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025864303,0.000113966285,0.00011381207,0.00016123785,0.00017145547,0.00011933308,0.00007915641,0.000099155084,0.00013713856],"category_scores_gemma":[0.00005278141,0.00010187463,0.00002782047,0.00021753085,0.000058016358,0.00001237838,0.00007179358,0.000202219,0.00001270307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029378035,0.00027145154,0.00030586447,0.00004195277,0.000048983577,0.00003401132,0.0012962486,0.00011125604,0.9870623,0.00005513329,0.0029820912,0.0074969535],"study_design_scores_gemma":[0.01040556,0.0027536391,0.044741534,0.0007167308,0.000056332174,0.0000042771812,0.0012321295,0.0013111705,0.8713865,0.0034010434,0.06328991,0.0007011192],"about_ca_topic_score_codex":0.0011881616,"about_ca_topic_score_gemma":0.0020384728,"teacher_disagreement_score":0.115675725,"about_ca_system_score_codex":0.00008197094,"about_ca_system_score_gemma":0.00016789291,"threshold_uncertainty_score":0.4154327},"labels":[],"label_agreement":null},{"id":"W4393988317","doi":"10.1158/1538-7445.am2024-ct054","title":"Abstract CT054: Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Medicine; Cancer; Oncology; Lung cancer; Cancer research; Disease; Internal medicine","score_opus":0.03345896056272359,"score_gpt":0.4453993473951861,"score_spread":0.41194038683246254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97636306,0.011637322,0.0000024312071,0.0077211917,0.0002451068,0.003122388,0.0005049156,0.00005488347,0.000348675],"genre_scores_gemma":[0.9938988,0.0026144716,0.000027978456,0.00022764223,0.00041003225,0.0019840044,0.00016182926,0.000064053966,0.0006111715],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99783254,0.00009619493,0.00032580606,0.00071874546,0.00060403376,0.00042269466],"domain_scores_gemma":[0.9988808,0.00022231245,0.000049117367,0.00043542183,0.0001712208,0.00024113555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042911552,0.00022512722,0.00024039827,0.00019090483,0.00014960267,0.00013416815,0.00009225432,0.00006864402,0.00019900709],"category_scores_gemma":[0.000047674028,0.00014189669,0.00005845206,0.0005843636,0.000112145295,0.00014983315,0.00006326938,0.000599047,0.000012824557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08335944,0.017394258,0.1419186,0.0025519447,0.0013376094,0.0066661844,0.07564011,0.00026022227,0.059856635,0.0000236625,0.02256058,0.58843076],"study_design_scores_gemma":[0.07373051,0.0034053675,0.8501734,0.015096773,0.00074247835,0.000005304202,0.0045144074,0.0019587257,0.037512638,0.00023460065,0.011852308,0.00077344844],"about_ca_topic_score_codex":0.0030697477,"about_ca_topic_score_gemma":0.0015510152,"teacher_disagreement_score":0.7082548,"about_ca_system_score_codex":0.0008241683,"about_ca_system_score_gemma":0.0008898981,"threshold_uncertainty_score":0.5786379},"labels":[],"label_agreement":null},{"id":"W4393988374","doi":"10.1158/1538-7445.am2024-ct256","title":"Abstract CT256: Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Investigational Drugs; Phases of clinical research; Lung cancer; Chemotherapy; Clinical trial; Immunotherapy; Biology","score_opus":0.12428141881778623,"score_gpt":0.44922300988849573,"score_spread":0.3249415910707095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512995,0.006764291,0.0000035139997,0.00088712206,0.00033157502,0.0040226723,0.0021236783,0.000081132865,0.00065607333],"genre_scores_gemma":[0.9952787,0.0012649376,0.000041627907,0.00012656639,0.00040317723,0.0010225667,0.0002933265,0.00012776977,0.0014413333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927597,0.00036991166,0.00093751115,0.0014179928,0.0033157163,0.0011991406],"domain_scores_gemma":[0.9957492,0.0008551419,0.00019967984,0.0009357861,0.0017218096,0.0005383786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011661863,0.00047135548,0.00091113884,0.0010846135,0.00023817157,0.00012662745,0.0005299433,0.00017533869,0.0005856526],"category_scores_gemma":[0.00068247,0.00037444252,0.00011600068,0.0017675066,0.00053674093,0.0003463655,0.00043536013,0.0019137973,0.00003014404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07471714,0.019576475,0.7321466,0.0086128805,0.0047362316,0.0044225235,0.04811533,0.003189825,0.023869501,0.00004219468,0.070199706,0.0103716],"study_design_scores_gemma":[0.07858862,0.002997254,0.9006752,0.0043433704,0.00023384999,0.0000010818227,0.0032568804,0.0016021499,0.004753449,0.0000212785,0.0029682748,0.0005586426],"about_ca_topic_score_codex":0.035502724,"about_ca_topic_score_gemma":0.004339909,"teacher_disagreement_score":0.16852856,"about_ca_system_score_codex":0.003128356,"about_ca_system_score_gemma":0.0047707064,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W4393988417","doi":"10.1158/1538-7445.am2024-ct104","title":"Abstract CT104: Results from a phase 1 study of the anti-immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830 plus pembrolizumab in patients with previously treated advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Antibody; Monoclonal antibody; Cancer research; Oncology; Virology; Internal medicine; Immunotherapy; Immunology; Cancer","score_opus":0.04156949515434699,"score_gpt":0.394824790099123,"score_spread":0.35325529494477603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952246,0.0050111283,0.0000018930981,0.00037710316,0.00032358282,0.003446064,0.0010783748,0.0000596994,0.0001796721],"genre_scores_gemma":[0.99818677,0.0006770123,0.000012241673,0.000050376,0.000090312366,0.0002457762,0.00022735563,0.000072545394,0.0004375933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959116,0.00025178373,0.00085697835,0.00081444276,0.0014307817,0.00073443487],"domain_scores_gemma":[0.99827063,0.0001999959,0.00013620556,0.0008704885,0.0003776672,0.00014500579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072143006,0.0003337562,0.00068930746,0.00037900615,0.0001628483,0.000064559754,0.0004780635,0.000121382254,0.0002442767],"category_scores_gemma":[0.000063502725,0.00021253075,0.00016843369,0.0016509383,0.0003599272,0.0001997526,0.000073096824,0.00094583526,0.000008287123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37435457,0.01071815,0.117372856,0.0010378758,0.002701146,0.0008463595,0.028174637,0.0005515655,0.39830175,0.000003480582,0.002407823,0.06352978],"study_design_scores_gemma":[0.09114268,0.005894102,0.8758842,0.0043018777,0.00016300753,0.000007241995,0.0018493844,0.00022035874,0.017770482,0.000009296016,0.0023882948,0.00036912478],"about_ca_topic_score_codex":0.011648814,"about_ca_topic_score_gemma":0.0014016597,"teacher_disagreement_score":0.7585113,"about_ca_system_score_codex":0.00085423706,"about_ca_system_score_gemma":0.0013470812,"threshold_uncertainty_score":0.9949327},"labels":[],"label_agreement":null},{"id":"W4393988434","doi":"10.1158/1538-7445.am2024-ct131","title":"Abstract CT131: Effect of rivoceranib administered as 200 mg once daily on the pharmacokinetics of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 substrates","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacokinetics; CYP1A2; CYP3A4; Pharmacology; CYP2C9; Medicine; Chemistry; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.10281463531614428,"score_gpt":0.4939783001597105,"score_spread":0.39116366484356624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680636,0.016361244,5.2522944e-7,0.0040027224,0.00035387278,0.0011663584,0.00015533171,0.00003701078,0.009859317],"genre_scores_gemma":[0.9907051,0.006162474,0.000007418944,0.0001653412,0.0004101446,0.00024400926,0.000021117747,0.000048750393,0.0022356594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763894,0.00024948656,0.00039374284,0.00046883692,0.0007366973,0.0005122978],"domain_scores_gemma":[0.99698967,0.0021264292,0.00008093853,0.0003523493,0.00023842715,0.00021219175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011264704,0.0002599665,0.00050386233,0.00027062895,0.000113253765,0.00004789431,0.00023590037,0.00012539049,0.002563177],"category_scores_gemma":[0.00011602611,0.00016572024,0.0001427866,0.00060481305,0.0006384922,0.00007007085,0.00008319962,0.00080097886,0.000064730695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008226655,0.00038115398,0.0070747985,0.0032182932,0.0010153009,0.00047699644,0.0016050556,0.000024087725,0.9231822,0.00072684657,0.030398365,0.023670232],"study_design_scores_gemma":[0.0041958787,0.0048236777,0.012390241,0.0012851743,0.00039664315,0.000053447715,0.00018709686,0.00020585411,0.9544124,0.00018620167,0.021664469,0.00019888664],"about_ca_topic_score_codex":0.000801937,"about_ca_topic_score_gemma":0.00006233898,"teacher_disagreement_score":0.031230215,"about_ca_system_score_codex":0.00020002406,"about_ca_system_score_gemma":0.0006102997,"threshold_uncertainty_score":0.9983486},"labels":[],"label_agreement":null},{"id":"W4393988447","doi":"10.1158/1538-7445.am2024-ct259","title":"Abstract CT259: Results from monotherapy dose escalation of MDNA11, a long-acting IL-2 superkine, in a phase 1/2 trial show evidence of single-agent activity in advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"De-escalation; Medicine; Phase (matter); Oncology; Pharmacology; Internal medicine; Chemistry","score_opus":0.11895616902019207,"score_gpt":0.4424506824484348,"score_spread":0.3234945134282427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856304,0.012557699,0.0000870619,0.00017313707,0.0005467353,0.000714764,0.00021307277,0.000007910411,0.00006920528],"genre_scores_gemma":[0.9932058,0.005655157,0.00007011215,0.000009457735,0.0007667968,0.00015207344,0.000040489722,0.000029298937,0.00007083745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99782944,0.00020931971,0.0005457291,0.0005917738,0.00043562733,0.00038810493],"domain_scores_gemma":[0.9989834,0.00025764576,0.00012274273,0.00039529763,0.00015745574,0.000083495004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012620913,0.00015977233,0.00036134207,0.00027388998,0.00003035277,0.000034813977,0.00022656728,0.00015327256,0.00003442727],"category_scores_gemma":[0.0006245342,0.0001576419,0.000113158676,0.0005377929,0.00013741903,0.00003860333,0.00008117403,0.00035154453,0.0000010901929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04321676,0.00030169904,0.00017150788,0.000118625125,0.00002976172,0.000009192071,0.000510815,0.00039421153,0.84164745,0.0000016105932,0.00008270407,0.11351568],"study_design_scores_gemma":[0.016953344,0.00074171205,0.006148235,0.0010517972,0.000008233521,6.795351e-7,0.00013637514,0.00038320353,0.97212195,0.000038307848,0.002246382,0.00016977558],"about_ca_topic_score_codex":0.0032643217,"about_ca_topic_score_gemma":0.0041028336,"teacher_disagreement_score":0.13047452,"about_ca_system_score_codex":0.00016638421,"about_ca_system_score_gemma":0.00068646966,"threshold_uncertainty_score":0.642845},"labels":[],"label_agreement":null},{"id":"W4393988483","doi":"10.1158/1538-7445.am2024-ct231","title":"Abstract CT231: Identification of a novel agnostic predictive multiomic signature via Elastic Net/Machine Learning in TALAPRO-2 (TP-2), a phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Placebo; Identification (biology); Medicine; Artificial intelligence; Computer science; Internal medicine; Biology; Pathology; Botany; Alternative medicine","score_opus":0.049828493289481565,"score_gpt":0.40044087060470873,"score_spread":0.35061237731522715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98106664,0.0011157601,0.012991853,0.0001676394,0.00018754376,0.0040113567,0.00039472696,0.000053509015,0.000010953335],"genre_scores_gemma":[0.9968494,0.00009556394,0.00074436975,0.0000059751214,0.000031753756,0.0020490806,0.000096966076,0.00004956859,0.00007728446],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9948899,0.0006596922,0.0011258395,0.0011012191,0.0016215688,0.00060177],"domain_scores_gemma":[0.9960477,0.0022655756,0.0003978261,0.00046625227,0.0006711551,0.00015150616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016962892,0.00038955925,0.0005923566,0.0012022934,0.00015703223,0.0001917114,0.0005708236,0.000079569465,0.000029256595],"category_scores_gemma":[0.0006085104,0.00033245358,0.00007897933,0.0026003427,0.00019514159,0.0008130352,0.0002029844,0.00081630785,0.0000048209945],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004076431,0.0056760195,0.009500306,0.00057843386,0.00028987264,0.00012300322,0.012997635,0.9276876,0.025162466,0.00009937468,0.0000054721995,0.013803401],"study_design_scores_gemma":[0.0141400695,0.0054964796,0.11388387,0.0011779988,0.00009217095,0.000004595836,0.0005121422,0.85420483,0.009875858,0.00024357943,0.000020122246,0.00034826592],"about_ca_topic_score_codex":0.012179118,"about_ca_topic_score_gemma":0.01261793,"teacher_disagreement_score":0.104383565,"about_ca_system_score_codex":0.0017244824,"about_ca_system_score_gemma":0.0017185158,"threshold_uncertainty_score":0.99991274},"labels":[],"label_agreement":null},{"id":"W4393988485","doi":"10.1158/1538-7445.am2024-ct207","title":"Abstract CT207: Association of gene expression profiles and clinical outcomes in patients with locally advanced or recurrent/metastatic cutaneous squamous cell carcinoma treated with pembrolizumab in KEYNOTE-629","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Basal cell; Internal medicine; Cancer research; Gene; Cancer; Dermatology; Biology; Immunotherapy; Genetics","score_opus":0.038568933583159284,"score_gpt":0.37899535634632797,"score_spread":0.3404264227631687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663264,0.0015288403,0.0000033064334,0.00014959692,0.00006783134,0.0014064785,0.00008338739,0.00002029992,0.000107600514],"genre_scores_gemma":[0.99850804,0.00044819992,0.0001846775,0.00002081088,0.000024343643,0.00015132288,0.000043485063,0.000038587463,0.0005805376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976415,0.00019312478,0.00052447314,0.00045475786,0.0007750284,0.00041110817],"domain_scores_gemma":[0.99867755,0.00061661465,0.0001210235,0.00022223804,0.00025788217,0.00010466398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057937694,0.0001822032,0.0004778112,0.00036553617,0.000038487557,0.0000313822,0.00009468779,0.000110829475,0.00011281472],"category_scores_gemma":[0.00014357308,0.00010925132,0.000051697978,0.00066479115,0.00015001568,0.00010971254,0.000028024331,0.0005638048,0.0000022746678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05239146,0.0006359851,0.9120466,0.00075044343,0.00006618626,0.0002775743,0.0003488443,0.000013905005,0.005875022,3.2659185e-7,0.000107714826,0.0274859],"study_design_scores_gemma":[0.015618982,0.0045070853,0.9621211,0.0012099358,0.000044234956,0.0000066559087,0.00020345894,0.00008875781,0.015955117,0.0000026612001,0.000086336106,0.00015564516],"about_ca_topic_score_codex":0.00085937616,"about_ca_topic_score_gemma":0.0010801156,"teacher_disagreement_score":0.050074488,"about_ca_system_score_codex":0.0007844336,"about_ca_system_score_gemma":0.000790017,"threshold_uncertainty_score":0.44551393},"labels":[],"label_agreement":null},{"id":"W4393988520","doi":"10.1158/1538-7445.am2024-lb198","title":"Abstract LB198: The PAX5 oncogene encodes circular RNA products involved in B cell cancer processes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Georges-L.-Dumont University Hospital Centre; Université de Moncton","funders":"","keywords":"Cancer; Oncogene; Cancer research; RNA; Biology; Gene; Medicine; Genetics; Cell cycle","score_opus":0.06322648990774668,"score_gpt":0.38658335929138643,"score_spread":0.3233568693836397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8044077,0.192473,0.0000073366464,0.0011992098,0.00024796135,0.00052620773,0.00007545729,0.000022826587,0.0010402888],"genre_scores_gemma":[0.97890514,0.0179683,0.000013265244,0.00012801358,0.0009475389,0.00095192436,0.00005114784,0.0000600882,0.00097457564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770546,0.00014400057,0.00022693013,0.0007537917,0.00056886295,0.0006009795],"domain_scores_gemma":[0.99872786,0.00007169742,0.00003259764,0.00063238165,0.00042062718,0.00011482689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079873455,0.00018997656,0.00014847858,0.00013541376,0.00014805379,0.00016902841,0.00063581567,0.00013494986,0.00014866269],"category_scores_gemma":[0.00042216227,0.00014463777,0.00007332015,0.0008989102,0.00031239897,0.000013366498,0.00023446421,0.0004406161,0.000035098103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056539462,0.00007929328,0.0032735136,0.0014776494,0.00006427951,0.00006170754,0.00020858696,0.00030840823,0.9809035,0.000019033236,0.008712171,0.004835339],"study_design_scores_gemma":[0.00022294375,0.000042455173,0.0032253766,0.00028231676,0.000015917323,0.0000023479954,0.00024483397,0.000017642204,0.9041806,0.00015454265,0.09140299,0.00020802897],"about_ca_topic_score_codex":0.0011405041,"about_ca_topic_score_gemma":0.0014614577,"teacher_disagreement_score":0.1745047,"about_ca_system_score_codex":0.00019634231,"about_ca_system_score_gemma":0.0028252199,"threshold_uncertainty_score":0.5898157},"labels":[],"label_agreement":null},{"id":"W4393988592","doi":"10.1158/1538-7445.am2024-lb196","title":"Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate cancer; Atlas (anatomy); Medicine; Prostate; Cancer; Internal medicine; Anatomy","score_opus":0.1021333569105468,"score_gpt":0.5019406697516867,"score_spread":0.3998073128411399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95655674,0.03515303,8.9180264e-7,0.0022732618,0.00022534125,0.0012754773,0.00012025269,0.000071626586,0.0043233596],"genre_scores_gemma":[0.97747624,0.012009256,0.00007382817,0.00002650256,0.0002612052,0.0012937965,0.000053619897,0.00006313535,0.008742439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969857,0.00011181445,0.0003954303,0.00060400786,0.0010508911,0.00085215794],"domain_scores_gemma":[0.99867314,0.0001689354,0.000039926592,0.00042800634,0.00039466313,0.0002953277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010212624,0.00018980185,0.00038987325,0.000744853,0.000091275855,0.00009604893,0.0002733477,0.00013032868,0.0024498466],"category_scores_gemma":[0.000070217306,0.00014198318,0.00008046344,0.0017483283,0.0003284054,0.0004581988,0.000119140175,0.0009639997,0.00006231818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026241066,0.00049087533,0.053720985,0.0049791816,0.00019761531,0.00081243704,0.0031953019,0.00019656892,0.6659514,0.00018467614,0.0056613954,0.26198548],"study_design_scores_gemma":[0.0062778015,0.0014608415,0.25828612,0.009001049,0.00005212344,0.00001489558,0.0016655781,0.0010689944,0.6859281,0.0010412632,0.03472896,0.00047426095],"about_ca_topic_score_codex":0.0040508737,"about_ca_topic_score_gemma":0.0015796111,"teacher_disagreement_score":0.2615112,"about_ca_system_score_codex":0.0009038959,"about_ca_system_score_gemma":0.0024926616,"threshold_uncertainty_score":0.998462},"labels":[],"label_agreement":null},{"id":"W4393988656","doi":"10.1158/1538-7445.am2024-ct282","title":"Abstract CT282: MK-2870-004: A phase 3 study of MK-2870 (SKB264) versus chemotherapy for previously treated advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) with <i>EGFR</i> mutations or other genomic alterations","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; non-small cell lung cancer (NSCLC); Phases of clinical research; Internal medicine; Oncology; Lung cancer","score_opus":0.07977450229271568,"score_gpt":0.4745303498865178,"score_spread":0.3947558475938021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782679,0.005262081,0.0007859816,0.0009909662,0.000291221,0.01230589,0.0011875639,0.00013304314,0.00077537325],"genre_scores_gemma":[0.97034883,0.0010585802,0.0016279045,0.0001540525,0.0002736568,0.014319671,0.00019507165,0.00022743295,0.0117947785],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968525,0.00011143423,0.00065495766,0.00088687736,0.00066801725,0.00082620303],"domain_scores_gemma":[0.99723524,0.0008126131,0.00017086913,0.00064402336,0.00080486166,0.0003324213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003937417,0.0004407985,0.00070832734,0.0005416739,0.00042564585,0.00015506118,0.0002549743,0.00008740051,0.0014549037],"category_scores_gemma":[0.000060575945,0.00029136796,0.00016655638,0.0013576213,0.00018658847,0.0002543704,0.000035791152,0.00042590126,0.000019594887],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19803211,0.0441854,0.008857709,0.021179583,0.036172263,0.0024761984,0.15252674,0.016779045,0.28394306,0.00020539177,0.029201925,0.20644058],"study_design_scores_gemma":[0.56109965,0.09761496,0.0074107,0.01371587,0.02262901,0.00015808381,0.0516485,0.022906905,0.15629555,0.000113135786,0.0622626,0.004145053],"about_ca_topic_score_codex":0.0044183107,"about_ca_topic_score_gemma":0.010486145,"teacher_disagreement_score":0.3630675,"about_ca_system_score_codex":0.0014944386,"about_ca_system_score_gemma":0.0046804273,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W4393988692","doi":"10.1158/1538-7445.am2024-ct114","title":"Abstract CT114: Phase 1 study of the anti-immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830 plus pembrolizumab in patients with previously untreated advanced head and neck squamous cell carcinoma (HNSCC) or non-small cell lung cancer (NSCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Head and neck squamous-cell carcinoma; Medicine; Antibody; Monoclonal antibody; Head and neck; Cancer research; Internal medicine; Oncology; Head and neck cancer; Cancer; Immunotherapy; Immunology; Surgery","score_opus":0.03041345447476762,"score_gpt":0.3604095163433503,"score_spread":0.32999606186858266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96766543,0.025715094,0.000004034242,0.0001997335,0.00041759055,0.0053807683,0.00032868536,0.000046199006,0.00024244002],"genre_scores_gemma":[0.9962051,0.0017073927,0.000021055363,0.00007667725,0.00009526883,0.00052105106,0.00005204194,0.00011970284,0.0012017373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958862,0.00021503467,0.000752076,0.00097254384,0.0011487032,0.0010254078],"domain_scores_gemma":[0.9982333,0.00016810335,0.00014862661,0.000779973,0.00043677958,0.00023321233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005057122,0.00049414206,0.0007990637,0.00044226047,0.00024603002,0.00009291969,0.00047617155,0.0001833081,0.000376226],"category_scores_gemma":[0.000015563553,0.00031360725,0.00015597961,0.0016435302,0.0003580347,0.00020937763,0.000114469505,0.0010786214,0.0000032062608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11783467,0.005881659,0.65543604,0.00527105,0.00051183713,0.00057127513,0.016706742,0.00040715776,0.18127508,8.517539e-7,0.0010708565,0.015032771],"study_design_scores_gemma":[0.095884435,0.0074970867,0.86577016,0.0024958067,0.00032573263,0.000013308663,0.0016619458,0.0006430643,0.02417746,0.000001069292,0.001011877,0.00051806186],"about_ca_topic_score_codex":0.016857084,"about_ca_topic_score_gemma":0.004449227,"teacher_disagreement_score":0.21033412,"about_ca_system_score_codex":0.0010929032,"about_ca_system_score_gemma":0.0027272138,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W4393988759","doi":"10.1158/1538-7445.am2024-ct019","title":"Abstract CT019: Biological mechanisms underlying objective responses in recurrent GBM patients treated with sequential bortezomib and temozolomide: An interim analysis of NCT03643549 Phase IB/II trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oceans Limited (Canada); Memorial University of Newfoundland","funders":"","keywords":"Temozolomide; Medicine; Bortezomib; Interim analysis; Interim; Oncology; Internal medicine; Clinical trial; Chemotherapy; Multiple myeloma","score_opus":0.24173225986923463,"score_gpt":0.5017023416009215,"score_spread":0.2599700817316869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971834,0.00093680515,0.000014284731,0.0001677787,0.00009015014,0.0012514816,0.00024657327,0.000032269225,0.00007726377],"genre_scores_gemma":[0.99880135,0.0004305365,0.00004882533,0.0000119839015,0.00003093801,0.00044213887,0.00018964997,0.000021260264,0.000023297602],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99776417,0.00032521557,0.00039012902,0.0006257003,0.0005056301,0.00038918058],"domain_scores_gemma":[0.99887776,0.0003453793,0.00006564138,0.00025508762,0.0002524091,0.00020373552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007764172,0.00019585126,0.0005758017,0.0012844387,0.00010687946,0.000062203726,0.00008961368,0.00012552881,0.00025509042],"category_scores_gemma":[0.00016597337,0.00012702128,0.0001182598,0.0016099428,0.0002145472,0.00011503462,0.00008165747,0.00036610858,0.000002105395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43240583,0.0173929,0.10078557,0.00041603466,0.0090654725,0.002452993,0.004617798,0.000046354835,0.2654953,0.0010104444,0.00021090246,0.1661004],"study_design_scores_gemma":[0.16209817,0.08807495,0.6274217,0.002514744,0.003198115,0.000022168193,0.0029067737,0.00252831,0.10954991,0.0006858956,0.00022761976,0.0007716819],"about_ca_topic_score_codex":0.0018079213,"about_ca_topic_score_gemma":0.0008096274,"teacher_disagreement_score":0.52663606,"about_ca_system_score_codex":0.00055649865,"about_ca_system_score_gemma":0.0003384352,"threshold_uncertainty_score":0.5179778},"labels":[],"label_agreement":null},{"id":"W4393988798","doi":"10.1158/1538-7445.am2024-ct281","title":"Abstract CT281: The phase 3 INTerpath-002 study design: Individualized neoantigen therapy (INT) V940 (mRNA-4157) plus pembrolizumab vs placebo plus pembrolizumab for resected early-stage non-small-cell lung cancer (NSCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Pembrolizumab; Medicine; non-small cell lung cancer (NSCLC); Lung cancer; Internal medicine; Placebo; Oncology; Stage (stratigraphy); Cancer; Immunotherapy; Biology; Pathology","score_opus":0.11472892218302619,"score_gpt":0.4371691381645255,"score_spread":0.3224402159814993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92795783,0.050179653,0.0006543211,0.0019479826,0.0012821518,0.015795445,0.0006006753,0.00030813258,0.0012738347],"genre_scores_gemma":[0.9587426,0.0152294,0.000092925504,0.0004438497,0.0013959708,0.010438924,0.000077536504,0.0003527336,0.013226027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99201345,0.00086670014,0.0011687381,0.0016821983,0.0021636512,0.0021052563],"domain_scores_gemma":[0.9952683,0.0016250492,0.00025428412,0.0014258045,0.00091306027,0.00051354524],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004478771,0.00086388265,0.0011757264,0.0009674663,0.0010767741,0.0009057802,0.0015202806,0.00043700705,0.0039921957],"category_scores_gemma":[0.0001675774,0.00060845376,0.0006355133,0.0020049422,0.00065425603,0.000344788,0.0003341192,0.0023328306,0.000079230405],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4894679,0.0024488484,0.0023181003,0.0034097387,0.007397752,0.0013653326,0.06533045,0.0003272087,0.21880966,0.0000332697,0.119327165,0.08976459],"study_design_scores_gemma":[0.4309006,0.024967644,0.033106305,0.00854959,0.0018088951,0.0001613347,0.017209103,0.028223775,0.20248857,0.0001311413,0.2484525,0.004000516],"about_ca_topic_score_codex":0.012511409,"about_ca_topic_score_gemma":0.0017273562,"teacher_disagreement_score":0.12912534,"about_ca_system_score_codex":0.003300037,"about_ca_system_score_gemma":0.007519818,"threshold_uncertainty_score":0.9999688},"labels":[],"label_agreement":null},{"id":"W4393988822","doi":"10.1158/1538-7445.am2024-ct284","title":"Abstract CT284: A phase 3 randomized controlled trial of zongertinib (BI 1810631) compared with standard of care in patients with locally advanced or metastatic nonsquamous non-small cell lung cancer harboring <i>HER2</i> tyrosine kinase domain mutations: Beamion LUNG-2","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Standard of care; Internal medicine; Oncology; Randomized controlled trial; Lung cancer; Cancer","score_opus":0.018943181692577412,"score_gpt":0.3876808565188834,"score_spread":0.368737674826306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685848,0.010582222,0.0009377999,0.00018815148,0.00021820406,0.018230082,0.0009058507,0.000039227423,0.00031370614],"genre_scores_gemma":[0.98832273,0.00050078327,0.0017578577,0.00002055259,0.000074697375,0.008767008,0.0002782504,0.00008979641,0.00018831065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99610215,0.00031157688,0.001119836,0.00059696665,0.0012885577,0.00058092776],"domain_scores_gemma":[0.995929,0.0012198297,0.000349051,0.00040488443,0.0018665625,0.00023069157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009562328,0.00037215985,0.0020964013,0.0006616124,0.00012195233,0.000060395625,0.00016166942,0.00007645872,0.00022794929],"category_scores_gemma":[0.00021741202,0.00022391957,0.00020788479,0.0013665288,0.0003723238,0.00019729362,0.00003566059,0.00047298914,0.0000012010444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97891146,0.0016053099,0.0011839244,0.003542138,0.0013294114,0.00019941234,0.0068484317,0.0019190658,0.0015162285,0.000025558455,0.00007070364,0.0028483474],"study_design_scores_gemma":[0.9783042,0.005055798,0.0004875374,0.0058525675,0.0018048723,0.0000011275888,0.001896211,0.0010428126,0.005214765,0.000012187674,0.00007726362,0.00025065642],"about_ca_topic_score_codex":0.0019035051,"about_ca_topic_score_gemma":0.002918147,"teacher_disagreement_score":0.019737989,"about_ca_system_score_codex":0.0014678843,"about_ca_system_score_gemma":0.0050257626,"threshold_uncertainty_score":0.9131175},"labels":[],"label_agreement":null},{"id":"W4393988846","doi":"10.1158/1538-7445.am2024-ct253","title":"Abstract CT253: Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Pembrolizumab; Medicine; Investigational Drugs; Chemotherapy; Cancer; Oncology; Stage (stratigraphy); Lung cancer; Internal medicine; Clinical trial; Immunotherapy; Biology","score_opus":0.16508682338391562,"score_gpt":0.4784425243929593,"score_spread":0.3133557010090437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664893,0.017261138,0.00005060895,0.0075353165,0.00033966498,0.004988292,0.0028745166,0.00009979124,0.00036134332],"genre_scores_gemma":[0.9819529,0.009267235,0.00020401363,0.00032796292,0.0010636573,0.0021978298,0.00021529706,0.00014677031,0.0046243113],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947455,0.0001492877,0.00085173524,0.0013761005,0.0018357363,0.001041629],"domain_scores_gemma":[0.995336,0.001602126,0.00016757907,0.00078155287,0.001568121,0.0005445989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014109861,0.00045157177,0.0008706787,0.0005633315,0.00041014637,0.00015350452,0.0004251716,0.00019096861,0.0006093323],"category_scores_gemma":[0.00086281897,0.0003848267,0.00016865456,0.0009167089,0.0006135133,0.00020701984,0.00033109012,0.0010779772,0.000009202373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12669091,0.008538365,0.04387761,0.03371822,0.011686998,0.0019036024,0.08346304,0.0033684701,0.23595148,0.00017302987,0.39965,0.050978266],"study_design_scores_gemma":[0.33854795,0.0121724205,0.17270222,0.013689661,0.0017536189,0.000025718115,0.016013913,0.094457835,0.21234465,0.00095134607,0.13444777,0.002892903],"about_ca_topic_score_codex":0.018200727,"about_ca_topic_score_gemma":0.0032722966,"teacher_disagreement_score":0.26520225,"about_ca_system_score_codex":0.0016413037,"about_ca_system_score_gemma":0.0024243044,"threshold_uncertainty_score":0.99986035},"labels":[],"label_agreement":null},{"id":"W4393988883","doi":"10.1158/1538-7445.am2024-ct232","title":"Abstract CT232: Intense exercise for survival among men with metastatic prostate cancer: 12-month feasibility results from the INTERVAL-GAP4 trial pilot site at Edith Cowan University, Australia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Gerontology; Oncology; Internal medicine; Cancer; Physical therapy","score_opus":0.21762359674858828,"score_gpt":0.43057351046672354,"score_spread":0.21294991371813526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739899,0.0024080144,0.0000073874035,0.007623389,0.00081007223,0.008344908,0.0056784763,0.00012386832,0.0010139697],"genre_scores_gemma":[0.92967147,0.0027999205,0.00004207781,0.000021944945,0.00085974776,0.0007654153,0.0007318511,0.00008745603,0.065020144],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951847,0.00040038468,0.0004873029,0.0011451341,0.0015792224,0.0012032546],"domain_scores_gemma":[0.9960154,0.0015156087,0.00011429005,0.000893701,0.0009076056,0.0005533894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029095404,0.00040250848,0.0006945954,0.00033425447,0.00056914386,0.0002762283,0.00051103614,0.00010843747,0.00064203393],"category_scores_gemma":[0.0002172836,0.00023902325,0.00022520882,0.0009858706,0.0012031848,0.0004046059,0.000377602,0.0011376692,0.00006188595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78365237,0.00051559904,0.034311686,0.0010960095,0.0016668335,0.0010581078,0.007975137,0.000035915415,0.004246919,0.00003603831,0.16000083,0.0054045483],"study_design_scores_gemma":[0.46621048,0.027263446,0.27834395,0.018428447,0.0038619714,0.000026082573,0.022644075,0.0016402232,0.037202217,0.001195235,0.14078623,0.0023976373],"about_ca_topic_score_codex":0.046260353,"about_ca_topic_score_gemma":0.034466673,"teacher_disagreement_score":0.31744188,"about_ca_system_score_codex":0.003025238,"about_ca_system_score_gemma":0.0019708537,"threshold_uncertainty_score":0.9831518},"labels":[],"label_agreement":null},{"id":"W4393988979","doi":"10.1158/1538-7445.am2024-ng07","title":"Abstract NG07: Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Microsatellite instability; Somatic hypermutation; Colorectal cancer; Cancer; Somatic cell; Germline mutation; Medicine; Biology; Oncology; Cancer research; Genetics; Microsatellite; Mutation; Gene; B cell; Allele","score_opus":0.06246435698537481,"score_gpt":0.38493488554672256,"score_spread":0.3224705285613477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785581,0.017742509,0.0000017016381,0.00086682633,0.00040557687,0.0011482153,0.00018609098,0.00006439346,0.0010265603],"genre_scores_gemma":[0.9929329,0.0057554836,0.000072808594,0.000025670093,0.00034832253,0.00037200312,0.0000635986,0.000059125414,0.00037007904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968738,0.00018292428,0.00046731246,0.0006397301,0.0010070213,0.00082922797],"domain_scores_gemma":[0.99841064,0.00078397425,0.00006758403,0.00018846802,0.00029386109,0.00025545878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013764291,0.0002109121,0.0003880619,0.00047615182,0.00010352426,0.00017492185,0.00012153816,0.00021459347,0.00071908574],"category_scores_gemma":[0.00018023793,0.00019984967,0.0000635025,0.0010387985,0.00019208455,0.00016304471,0.000097075404,0.001025334,0.0000807177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015506004,0.000054257336,0.65619206,0.0011415627,0.00004984718,0.000038299117,0.002140397,0.000025562791,0.32060263,0.0000072726307,0.0006787429,0.018914334],"study_design_scores_gemma":[0.00071084435,0.00013548702,0.83522236,0.00058373914,0.000027221238,0.0000023382006,0.0002854962,0.00007443351,0.15970771,0.00033327704,0.002745223,0.00017188667],"about_ca_topic_score_codex":0.0024421976,"about_ca_topic_score_gemma":0.0015788252,"teacher_disagreement_score":0.1790303,"about_ca_system_score_codex":0.0044294954,"about_ca_system_score_gemma":0.0011416127,"threshold_uncertainty_score":0.99939233},"labels":[],"label_agreement":null},{"id":"W4393988984","doi":"10.1158/1538-7445.am2024-ct018","title":"Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Enzalutamide; Medicine; TMPRSS2; Placebo; Erg; Oncology; Internal medicine; Prostate cancer; Cancer; Alternative medicine; Pathology; Ophthalmology; Disease; Coronavirus disease 2019 (COVID-19); Androgen receptor","score_opus":0.06675336489293053,"score_gpt":0.4413804102331712,"score_spread":0.37462704534024066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832873,0.0027948015,0.000006279337,0.00081121194,0.00019889174,0.011094587,0.0016056732,0.00005054971,0.00015074018],"genre_scores_gemma":[0.98816216,0.0011387578,0.000048646183,0.000039388433,0.00009482372,0.009757521,0.00020558567,0.00010579751,0.00044732483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956416,0.00024562422,0.00091073813,0.0010884507,0.0012444449,0.00086913473],"domain_scores_gemma":[0.99771357,0.00073923584,0.00020247482,0.00046944685,0.00052773254,0.00034754394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010534562,0.00047242915,0.00081948953,0.0009777996,0.00018311781,0.00011686616,0.00016388786,0.000108004744,0.00025852502],"category_scores_gemma":[0.00018332132,0.0003732274,0.00008813899,0.0013268165,0.00042221215,0.0003147005,0.000056508892,0.0005127617,0.000006891498],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53184557,0.03665383,0.19006996,0.007608549,0.00797103,0.0028971422,0.06886072,0.011072419,0.06573849,0.00014702762,0.002232656,0.0749026],"study_design_scores_gemma":[0.42801827,0.1270511,0.25934023,0.015543355,0.0014807641,0.0000628501,0.015628545,0.008107416,0.13314864,0.0004891351,0.008988079,0.0021416196],"about_ca_topic_score_codex":0.027791204,"about_ca_topic_score_gemma":0.027771724,"teacher_disagreement_score":0.10382731,"about_ca_system_score_codex":0.0029569769,"about_ca_system_score_gemma":0.002484016,"threshold_uncertainty_score":0.99987197},"labels":[],"label_agreement":null},{"id":"W4393989000","doi":"10.1158/1538-7445.am2024-ct169","title":"Abstract CT169: First-in-human, phase 1/2 study of GSK4524101, an oral DNA polymerase theta inhibitor (POLQi), alone or combined with the poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) niraparib in adults with solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PARP inhibitor; Poly ADP ribose polymerase; Polymerase; Molecular biology; DNA; Chemistry; Biology; Biochemistry","score_opus":0.0650436417362831,"score_gpt":0.4188500716926601,"score_spread":0.353806429956377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98192537,0.0041967183,0.0000042181337,0.007983117,0.0002585601,0.0047730017,0.00035712984,0.00017107507,0.00033083514],"genre_scores_gemma":[0.9951861,0.00028590206,0.000025948437,0.00038512918,0.0011045068,0.0017917037,0.00012816043,0.00024594527,0.00084661855],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921079,0.00067434396,0.0013910171,0.0015612235,0.002607335,0.0016581814],"domain_scores_gemma":[0.9962714,0.00061145186,0.00028626926,0.0016190135,0.00052170426,0.00069021014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002030024,0.00077581214,0.0013900119,0.0015314685,0.00047299688,0.00020496867,0.0007526047,0.00024034006,0.0013253492],"category_scores_gemma":[0.00007954688,0.00047761406,0.0001397852,0.003644901,0.0013455554,0.00064859376,0.00017996998,0.0022368564,0.000026796248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40798113,0.05329461,0.03407114,0.005613023,0.002667502,0.021207942,0.08743761,0.00048240574,0.3224053,0.00038621356,0.030007467,0.03444567],"study_design_scores_gemma":[0.13799758,0.060108382,0.018324096,0.017624084,0.0003421737,0.00031366234,0.03524341,0.0008393989,0.72315735,0.00008827125,0.0039385525,0.0020230364],"about_ca_topic_score_codex":0.014199639,"about_ca_topic_score_gemma":0.041245922,"teacher_disagreement_score":0.40075204,"about_ca_system_score_codex":0.0010472059,"about_ca_system_score_gemma":0.0024206457,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W4393989035","doi":"10.1158/1538-7445.am2024-ct258","title":"Abstract CT258: Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Fecal bacteriotherapy; Melanoma; Transplantation; Internal medicine; Oncology; Cancer; Immunotherapy; Biology; Antibiotics; Cancer research; Microbiology","score_opus":0.025639098908979776,"score_gpt":0.3580182507507146,"score_spread":0.33237915184173483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504,0.00064147764,0.0000031849595,0.0004404168,0.00009706366,0.0033699048,0.000111231224,0.000023209614,0.00027352344],"genre_scores_gemma":[0.9982292,0.0009880655,0.000023511084,0.000004858169,0.000057864,0.0002612323,0.00015260915,0.000043738215,0.00023893316],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972638,0.00016280208,0.00046602002,0.0005539035,0.0009746392,0.00057883834],"domain_scores_gemma":[0.9989475,0.0002705669,0.000055563203,0.0002559521,0.0003151315,0.00015529116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077892735,0.00020036519,0.0004470295,0.00084125,0.000090034526,0.000050579954,0.00012486137,0.00014357385,0.000107279295],"category_scores_gemma":[0.00008312195,0.0001575893,0.000045422155,0.0011517069,0.00027712446,0.00015721892,0.000041373834,0.00082400214,0.0000042653787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8548456,0.0040002423,0.001069457,0.0012329705,0.000081115824,0.00064355705,0.0011444318,0.00002291064,0.062011037,0.00002517544,0.000053735246,0.074869804],"study_design_scores_gemma":[0.8393575,0.061364643,0.010254153,0.0028212797,0.00007912511,0.00004143791,0.00037259478,0.00026872175,0.08477613,0.000021327442,0.00032688235,0.00031622604],"about_ca_topic_score_codex":0.000777432,"about_ca_topic_score_gemma":0.00085734227,"teacher_disagreement_score":0.07455358,"about_ca_system_score_codex":0.0006194494,"about_ca_system_score_gemma":0.0008734037,"threshold_uncertainty_score":0.6426305},"labels":[],"label_agreement":null},{"id":"W4393989103","doi":"10.1158/1538-7445.am2024-ct100","title":"Abstract CT100: Safety and efficacy of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced/metastatic solid tumors: First-in-human study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"GDF15; Medicine; Antibody; Oncology; Internal medicine; Immunology","score_opus":0.0308401320126218,"score_gpt":0.39579421378663676,"score_spread":0.36495408177401495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971415,0.0010924464,0.000003159261,0.00014131312,0.000051420753,0.0014182404,0.00003635136,0.000021752987,0.000093848765],"genre_scores_gemma":[0.999023,0.00077081367,0.000015044872,0.0000053068347,0.000024668934,0.000028310194,0.00006089713,0.00003357103,0.000038382605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795204,0.00012511312,0.0004158612,0.0004987696,0.00060796394,0.00040023268],"domain_scores_gemma":[0.99924076,0.00017579376,0.000059141545,0.00021229265,0.00014027886,0.00017174188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042306632,0.00018054472,0.00042324647,0.0006143466,0.00009435954,0.000050023747,0.00009092547,0.000068929156,0.000066663546],"category_scores_gemma":[0.00008109774,0.00012719497,0.000025852683,0.000652006,0.00021487515,0.0002091346,0.000067652625,0.0005353325,0.0000017496201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013775289,0.0013987413,0.9695235,0.0013376055,0.00015034816,0.00015717842,0.0027938427,0.000023808527,0.0165178,0.0000117884465,0.000013136334,0.0066947485],"study_design_scores_gemma":[0.0065094996,0.002103593,0.9867704,0.0018666135,0.00003813323,0.0000029736432,0.0007221377,0.00021236792,0.0016105822,0.000017453749,0.0000117171485,0.00013451901],"about_ca_topic_score_codex":0.0009010394,"about_ca_topic_score_gemma":0.0006005831,"teacher_disagreement_score":0.017246936,"about_ca_system_score_codex":0.00013988484,"about_ca_system_score_gemma":0.00013993583,"threshold_uncertainty_score":0.51868606},"labels":[],"label_agreement":null},{"id":"W4393989120","doi":"10.1158/1538-7445.am2024-ct133","title":"Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biliary tract cancer; Medicine; Cancer; Biliary tract; Internal medicine; Oncology; Gastroenterology; Gemcitabine","score_opus":0.06163239915122215,"score_gpt":0.4186272363775294,"score_spread":0.35699483722630726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931533,0.0063927597,0.0000030852805,0.0005608626,0.00023682103,0.0031685794,0.0001249614,0.000033889177,0.00016373335],"genre_scores_gemma":[0.9978506,0.0009215315,0.000035637564,0.000027544305,0.00006004188,0.00090371544,0.000053255793,0.00006669406,0.00008099341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653894,0.00016138892,0.00057567575,0.00077384745,0.0012766019,0.00067352917],"domain_scores_gemma":[0.9985882,0.00021985834,0.00010507623,0.0004120564,0.00051968754,0.00015512167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061339495,0.00031392052,0.00070785853,0.0009386789,0.000079717116,0.000052318006,0.00018658205,0.000057556295,0.00017101491],"category_scores_gemma":[0.000064347194,0.00022379447,0.00006271675,0.0017547007,0.0002189557,0.00034737107,0.00008253806,0.00091705663,0.000006728464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038855323,0.014269352,0.9247227,0.0015571378,0.00031907612,0.00046067932,0.007081448,0.00015578562,0.0007856189,0.0000037799175,0.0005365009,0.046222415],"study_design_scores_gemma":[0.0307792,0.004923918,0.9562445,0.0037113484,0.000113229275,0.0000019449842,0.0026802958,0.0002699201,0.00075156824,0.000007686949,0.00026673224,0.000249639],"about_ca_topic_score_codex":0.0026933243,"about_ca_topic_score_gemma":0.0047750184,"teacher_disagreement_score":0.04597278,"about_ca_system_score_codex":0.00076761487,"about_ca_system_score_gemma":0.0006103085,"threshold_uncertainty_score":0.9126074},"labels":[],"label_agreement":null},{"id":"W4393989179","doi":"10.1158/1538-7445.am2024-lb102","title":"Abstract LB102: Triaging oral premalignant lesions: Plasma ultrashort cell-free DNA-based liquid biopsy approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Biopsy; Medicine; Liquid biopsy; Pathology; Plasma cell; Dermatology; Cancer; Internal medicine","score_opus":0.11506196709690761,"score_gpt":0.4039929315496844,"score_spread":0.2889309644527768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741999,0.008619441,0.000040149054,0.0031416817,0.00031448907,0.0013556044,0.00012739372,0.00019932167,0.012002056],"genre_scores_gemma":[0.9949362,0.0009276198,0.0005609584,0.00009515629,0.00039834817,0.0013251473,0.000098096156,0.0000727928,0.0015856707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996731,0.000119397686,0.00037073606,0.000781402,0.0011661478,0.0008313227],"domain_scores_gemma":[0.99805707,0.0004900749,0.00003264905,0.0008075816,0.0002061844,0.00040646835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011512449,0.00026565744,0.00040444036,0.000460094,0.00022817196,0.0001778244,0.00032044656,0.00016124679,0.0006148541],"category_scores_gemma":[0.00016159215,0.00018879326,0.00022102454,0.00079546944,0.00019564206,0.00011448574,0.000111310204,0.00048298753,0.00021435319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00994632,0.010913341,0.029485425,0.011300541,0.0020160435,0.01237938,0.0027309086,0.0006598375,0.545581,0.0030624976,0.25286087,0.11906386],"study_design_scores_gemma":[0.009864075,0.0015755183,0.01996243,0.0032626032,0.00033272846,0.00014227716,0.0007045728,0.0022452052,0.91526276,0.00009743948,0.045960296,0.00059012446],"about_ca_topic_score_codex":0.00080791,"about_ca_topic_score_gemma":0.000029989602,"teacher_disagreement_score":0.36968175,"about_ca_system_score_codex":0.0009963462,"about_ca_system_score_gemma":0.0017997521,"threshold_uncertainty_score":0.76987654},"labels":[],"label_agreement":null},{"id":"W4393989181","doi":"10.1158/1538-7445.am2024-lb376","title":"Abstract LB376: Tirzepatide inhibits tumor growth in mice with diet-induced obesity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Obesity; Endocrinology; Internal medicine; Medicine; Cancer research","score_opus":0.0775574562619326,"score_gpt":0.3975583858607806,"score_spread":0.320000929598848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788402,0.007586608,5.3321554e-7,0.0021670542,0.00018697759,0.00050692534,0.000015550666,0.000068281675,0.010627875],"genre_scores_gemma":[0.99674517,0.00148166,0.000041078023,0.000110041285,0.00039586273,0.00022438975,0.000006793169,0.000024071302,0.0009709056],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815035,0.00004934356,0.00018375703,0.0004023715,0.0006628906,0.0005513125],"domain_scores_gemma":[0.999223,0.00017887482,0.000016394964,0.00013971435,0.000276935,0.00016507583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071807066,0.0001442769,0.00030494857,0.00026103022,0.000088372704,0.000054840333,0.00010708052,0.000048289963,0.00014599934],"category_scores_gemma":[0.00015275751,0.00009267961,0.00004650622,0.0009563177,0.000110460336,0.00012657187,0.00010054248,0.0007658771,0.00011969687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003977093,0.00084687973,0.16747108,0.005261579,0.00053164957,0.0040475163,0.006567791,0.0000022907664,0.72547984,0.0016437513,0.0313026,0.052867904],"study_design_scores_gemma":[0.0013499546,0.00055184617,0.84531754,0.0024731772,0.000057940884,0.000010192964,0.0007559791,0.000020083837,0.13033931,0.00025011634,0.018607734,0.00026613247],"about_ca_topic_score_codex":0.002179691,"about_ca_topic_score_gemma":0.0019857802,"teacher_disagreement_score":0.67784643,"about_ca_system_score_codex":0.0002240116,"about_ca_system_score_gemma":0.0004971909,"threshold_uncertainty_score":0.3779365},"labels":[],"label_agreement":null},{"id":"W4393989206","doi":"10.1158/1538-7445.am2024-ct265","title":"Abstract CT265: Trastuzumab emtansine in patients (pts) with <i>HER2</i> mutation-positive <i>(HER2</i>mut<i>)</i> tumors: TAPISTRY study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Trastuzumab; Trastuzumab emtansine; Medicine; Mutation; Internal medicine; Oncology; Cancer; Cancer research; Breast cancer; Biology; Genetics; Gene","score_opus":0.048789231404111184,"score_gpt":0.4222173071015696,"score_spread":0.37342807569745845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98455685,0.0021397814,0.000014394189,0.0021285464,0.00028657445,0.004022938,0.0002436366,0.0001748533,0.0064324494],"genre_scores_gemma":[0.99491626,0.00020823232,0.000059361333,0.00023519393,0.00057226256,0.0014901024,0.00010383499,0.00021037456,0.0022043518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99203503,0.00044946306,0.00076516304,0.0014395865,0.0037050715,0.0016056563],"domain_scores_gemma":[0.99641347,0.0007399422,0.00007063494,0.00088155904,0.0012839984,0.0006104088],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022374238,0.00047560286,0.0007140521,0.000961504,0.00025830735,0.00035226828,0.0005377403,0.00020290198,0.001426464],"category_scores_gemma":[0.0003462526,0.000391671,0.000119940254,0.0034734937,0.0005624336,0.00041071378,0.00020320048,0.00290551,0.00041713467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013522774,0.013548145,0.6787761,0.00793497,0.0016966781,0.036487546,0.024478745,0.00042718512,0.012256502,0.00022958417,0.07857733,0.13206446],"study_design_scores_gemma":[0.01584063,0.013062777,0.92111146,0.011353993,0.00015935655,0.00013438636,0.00909489,0.00020176858,0.016291576,0.00022685403,0.011258939,0.0012633619],"about_ca_topic_score_codex":0.006777124,"about_ca_topic_score_gemma":0.0038401047,"teacher_disagreement_score":0.2423354,"about_ca_system_score_codex":0.0033085619,"about_ca_system_score_gemma":0.00450609,"threshold_uncertainty_score":0.9998535},"labels":[],"label_agreement":null},{"id":"W4393989233","doi":"10.1158/1538-7445.am2024-lb054","title":"Abstract LB054: A novel chemical proteomics approach toward the identification of kinase targets to sensitize tumour cells to the standard of care drug paclitaxel","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Paclitaxel; Proteomics; Identification (biology); Standard of care; Medicine; Pharmacology; Drug; Computational biology; Cancer research; Chemistry; Cancer; Biology; Biochemistry; Internal medicine","score_opus":0.06782009018706889,"score_gpt":0.41930999430651594,"score_spread":0.351489904119447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97013205,0.003304322,0.00030297076,0.021667864,0.0002778081,0.0030111345,0.00076255115,0.000022269665,0.00051905395],"genre_scores_gemma":[0.9976226,0.0001543716,0.0003677041,0.00012728682,0.00037863737,0.00070108176,0.00003067536,0.000027601209,0.0005900302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982341,0.00007373177,0.00033588815,0.00034361205,0.00068212044,0.00033054108],"domain_scores_gemma":[0.9986583,0.00019735441,0.0000481799,0.000351926,0.0005957584,0.00014845804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001062143,0.00012356743,0.0002694936,0.00014121692,0.00006898164,0.00003644429,0.00023863613,0.00005587194,0.00009598991],"category_scores_gemma":[0.0000939652,0.00007293722,0.00010866204,0.0006059052,0.00017586235,0.000038141072,0.00012476873,0.00044261533,0.00002207875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015627749,0.00010452717,0.000031997737,0.0011721625,0.000107776985,0.0000120843,0.01499989,0.00013225949,0.95878774,0.000099807425,0.020782344,0.0022066145],"study_design_scores_gemma":[0.0005899231,0.00021645585,0.0006260356,0.00018326059,0.00007640785,0.000004498932,0.0033460853,0.000105456784,0.9838743,0.00003142702,0.010874169,0.00007194147],"about_ca_topic_score_codex":0.00072132255,"about_ca_topic_score_gemma":0.000055628476,"teacher_disagreement_score":0.027490586,"about_ca_system_score_codex":0.00052025967,"about_ca_system_score_gemma":0.0007542566,"threshold_uncertainty_score":0.29742935},"labels":[],"label_agreement":null},{"id":"W4393989319","doi":"10.1158/1538-7445.am2024-lb181","title":"Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Cancer research; Topoisomerase; DNA; Dual (grammatical number); Chemistry; Poly ADP ribose polymerase; Pharmacology; Medicine; Polymerase; Biochemistry","score_opus":0.07114726092234676,"score_gpt":0.3767257946361513,"score_spread":0.30557853371380456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95435053,0.032169733,0.000014741936,0.011250701,0.0005877858,0.0007751141,0.00032437092,0.000105604515,0.0004214152],"genre_scores_gemma":[0.9891784,0.008463539,0.0001179014,0.00016850122,0.0010674011,0.0001505516,0.00004026952,0.00008774522,0.0007256617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967604,0.000085845895,0.0004934135,0.0007948426,0.0011629292,0.00070254656],"domain_scores_gemma":[0.9982477,0.00047549364,0.000087345434,0.00041691508,0.00033374992,0.00043884103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008737746,0.00033272733,0.00056375266,0.0005143141,0.00027789045,0.00018931211,0.00010631207,0.00023235052,0.00029260968],"category_scores_gemma":[0.000115693394,0.00027896088,0.00014588653,0.0006590637,0.0009977636,0.0003314026,0.00016563572,0.00085922715,0.000016817348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015727523,0.00036592668,0.015154824,0.0037869792,0.00065510324,0.0008241942,0.0035160107,0.000020836123,0.92432266,0.00061783276,0.03473687,0.014426019],"study_design_scores_gemma":[0.008947133,0.0011611939,0.0992002,0.008825508,0.0002597073,0.0007358664,0.0031997536,0.0002786992,0.82415265,0.001122248,0.051174495,0.00094252505],"about_ca_topic_score_codex":0.0007762941,"about_ca_topic_score_gemma":0.00017275661,"teacher_disagreement_score":0.10016998,"about_ca_system_score_codex":0.00030893934,"about_ca_system_score_gemma":0.00045138772,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W4393989580","doi":"10.1158/1538-7445.am2024-ct212","title":"Abstract CT212: Phase Ib/II, global, open-label, randomized evaluation of atezolizumab (atezo) + etrumadenant (etruma) + chemotherapy (chemo) vs chemo alone in MORPHEUS-PDAC","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Chemotherapy; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.25813885759708444,"score_gpt":0.5709261974956136,"score_spread":0.31278733989852914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594486,0.0109670255,0.000031309184,0.015174833,0.00013104429,0.0034576773,0.00012883681,0.000064566404,0.01059614],"genre_scores_gemma":[0.9927541,0.0034893644,0.000178259,0.000193088,0.00027534485,0.0017277707,0.00010906368,0.000048871836,0.0012241211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958658,0.00022595674,0.00078080146,0.0007618363,0.0016691525,0.0006964206],"domain_scores_gemma":[0.9978969,0.00034231172,0.000100859295,0.0006586033,0.00065928686,0.00034200028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005372379,0.00027629983,0.0009074539,0.00018566468,0.00016497867,0.00012371856,0.0005798603,0.00023294378,0.0047918265],"category_scores_gemma":[0.0006015044,0.00022840855,0.00013508595,0.0017467984,0.0006008102,0.00022163204,0.00019773346,0.00090759597,0.000079614154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071207516,0.002688326,0.00009523322,0.00134249,0.0004940066,0.00008379031,0.00043568166,0.000038010065,0.7996029,0.001207689,0.013368695,0.10943566],"study_design_scores_gemma":[0.29230773,0.00023493756,0.0003375316,0.0013207952,0.00023642452,0.00004107311,0.000100304285,0.016753195,0.6724866,0.00323556,0.0126296505,0.00031622956],"about_ca_topic_score_codex":0.0008793776,"about_ca_topic_score_gemma":0.00002677047,"teacher_disagreement_score":0.22110021,"about_ca_system_score_codex":0.0015012707,"about_ca_system_score_gemma":0.0017091845,"threshold_uncertainty_score":0.99611795},"labels":[],"label_agreement":null},{"id":"W4393989657","doi":"10.1158/1538-7445.am2024-ct146","title":"Abstract CT146: AZD0466 in patients with advanced non-Hodgkin lymphoma: Efficacy and safety in an open-label phase 1 trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Open label; Hodgkin lymphoma; Lymphoma; Oncology; Internal medicine; Phases of clinical research; Clinical trial; Intensive care medicine","score_opus":0.08726353258399154,"score_gpt":0.47005823842994365,"score_spread":0.3827947058459521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377865,0.0014400933,5.726004e-7,0.0005195502,0.00013033289,0.0032924972,0.00006157773,0.000020617646,0.00075611786],"genre_scores_gemma":[0.9980147,0.00058651995,0.000089407375,0.000054609663,0.000104591934,0.00090700976,0.00008535432,0.000039808492,0.00011802708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978865,0.00009122009,0.0003160981,0.00063041196,0.0005659914,0.0005098071],"domain_scores_gemma":[0.99898654,0.00026136616,0.000027402542,0.00034688946,0.000120421784,0.00025736672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006405022,0.0001810228,0.00038507173,0.00034714243,0.000078733785,0.00015837819,0.00018126589,0.00008668889,0.00014769884],"category_scores_gemma":[0.000071627976,0.00012928928,0.000015638825,0.00071202725,0.00011692995,0.00033763115,0.00013335166,0.00023626852,0.000023365146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19035228,0.016132299,0.056555256,0.00022530153,0.00010241409,0.00092046,0.00083902566,0.000010373276,0.00081515854,0.0000807641,0.00059580035,0.7333709],"study_design_scores_gemma":[0.43538037,0.0074811243,0.55264944,0.0011802912,0.000021532733,0.0000019551806,0.00007276215,0.000077523575,0.0007331742,0.000020613177,0.0022295206,0.00015169483],"about_ca_topic_score_codex":0.001406077,"about_ca_topic_score_gemma":0.00083997886,"teacher_disagreement_score":0.7332192,"about_ca_system_score_codex":0.0011102745,"about_ca_system_score_gemma":0.00091587374,"threshold_uncertainty_score":0.5272264},"labels":[],"label_agreement":null},{"id":"W4393989833","doi":"10.1158/1538-7445.am2024-ct280","title":"Abstract CT280: FURVENT, Phase 3 trial testing furmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertions (FURMO-004)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Exon; Oncology; Chemotherapy; Internal medicine; Phases of clinical research; Biology; Genetics; Gene","score_opus":0.17402331634901724,"score_gpt":0.5215673596128443,"score_spread":0.34754404326382704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969908,0.0056248372,0.00022426718,0.012988578,0.00041718644,0.005631805,0.00038469562,0.00024600243,0.0045746267],"genre_scores_gemma":[0.97924596,0.0012605973,0.0010379392,0.0002024238,0.0012220782,0.007569552,0.0003488154,0.00011247906,0.009000147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975601,0.00004170805,0.00040428946,0.0007001922,0.0005821077,0.0007115911],"domain_scores_gemma":[0.9980373,0.00063121505,0.00007311237,0.00044205232,0.00047583657,0.00034051025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003529335,0.00030442968,0.0004212157,0.00031203995,0.0004658529,0.00013556393,0.00012527492,0.00010693864,0.0005988935],"category_scores_gemma":[0.00017614773,0.00021116651,0.00018027703,0.00086176523,0.00014503274,0.00019304136,0.00002081224,0.00031864955,0.00006357646],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19169329,0.0055323155,0.00050481706,0.0010188916,0.002307311,0.00049114553,0.0034964974,0.0005776843,0.038275428,0.00032258115,0.008276612,0.7475034],"study_design_scores_gemma":[0.38583443,0.05131693,0.0020618786,0.0037688112,0.0010418269,0.00008370145,0.00085743645,0.0015517717,0.051306307,0.0007569127,0.50059843,0.00082158565],"about_ca_topic_score_codex":0.001212189,"about_ca_topic_score_gemma":0.0009012049,"teacher_disagreement_score":0.74668187,"about_ca_system_score_codex":0.0016188051,"about_ca_system_score_gemma":0.0020526615,"threshold_uncertainty_score":0.861112},"labels":[],"label_agreement":null},{"id":"W4393989857","doi":"10.1158/1538-7445.am2024-lb107","title":"Abstract LB107: Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) + chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Lung cancer; Oncology; Internal medicine; non-small cell lung cancer (NSCLC); Circulating tumor DNA; Circulating tumor cell; Cancer; Immunotherapy; Metastasis","score_opus":0.045196187201826735,"score_gpt":0.3768658475747349,"score_spread":0.3316696603729082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545515,0.00081588305,0.00026418697,0.00035893935,0.00010080111,0.0021245861,0.00045988694,0.000010310113,0.00041025275],"genre_scores_gemma":[0.99784154,0.00047930854,0.0003879359,0.00012524029,0.00019868992,0.0006289856,0.00013710388,0.000084782405,0.000116413255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683255,0.000285032,0.000680433,0.0007537226,0.0007552522,0.0006930224],"domain_scores_gemma":[0.9981014,0.0004790497,0.00027422744,0.00063823856,0.00039006872,0.0001169738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015085626,0.00033395828,0.0005588974,0.00020359036,0.000097045806,0.00012559045,0.0005214667,0.00021027996,0.000066833134],"category_scores_gemma":[0.00020342332,0.00022019698,0.00012374765,0.0006212771,0.00015011763,0.000021467198,0.00007910774,0.0006707341,0.0000016538581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06516858,0.005689745,0.8564292,0.0012045407,0.002050726,0.0004923458,0.0029743416,0.0030787925,0.047595367,0.00006430471,0.002532585,0.01271946],"study_design_scores_gemma":[0.39464107,0.014020149,0.538619,0.0015006573,0.0006464189,0.000015464946,0.00096496346,0.0021743549,0.044265848,0.00028808878,0.00094829814,0.0019157138],"about_ca_topic_score_codex":0.0059649507,"about_ca_topic_score_gemma":0.011039467,"teacher_disagreement_score":0.32947248,"about_ca_system_score_codex":0.00059264724,"about_ca_system_score_gemma":0.0019272154,"threshold_uncertainty_score":0.90172607},"labels":[],"label_agreement":null},{"id":"W4394739391","doi":"10.1158/0008-5472.can-23-3340","title":"FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"CRIS Cancer Foundation; Rosetrees Trust; Cancer Research UK","keywords":"RNA; Computational biology; Biology; Genetics; Gene","score_opus":0.0665662517894281,"score_gpt":0.32536165559860697,"score_spread":0.25879540380917887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394739391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339736,0.0052696234,0.000088773435,0.00024640482,0.00018863197,0.00016968376,0.00017416378,0.0000056567724,0.0004596836],"genre_scores_gemma":[0.99691314,0.002130715,0.000111045934,0.0000377314,0.0001546843,0.000012585495,0.000027650847,0.000019626126,0.00059284957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900603,0.00016016245,0.00016212284,0.00026850787,0.00019988834,0.00020327036],"domain_scores_gemma":[0.99940926,0.00008465915,0.000034058263,0.00022118946,0.00020035701,0.000050476356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002751209,0.000090939495,0.00013216266,0.00005267967,0.000063128,0.000027398315,0.00016125973,0.000113709,0.000022523293],"category_scores_gemma":[0.00007506528,0.00006599575,0.00006124346,0.00022851885,0.00027439417,0.000004694449,0.00010929404,0.0002144635,0.0000014328056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001020466,0.000013755552,0.0003823627,0.00012009481,0.000056618697,0.0000021567805,0.00051142735,0.000028028766,0.9957649,0.000022846047,0.0007362753,0.0022595],"study_design_scores_gemma":[0.00022202407,0.000086330365,0.00023092487,0.00017123684,0.000013696023,8.177262e-7,0.00037041094,0.00024394481,0.99543065,0.00007325875,0.0030838277,0.00007288385],"about_ca_topic_score_codex":0.0015446182,"about_ca_topic_score_gemma":0.00021482045,"teacher_disagreement_score":0.0035157332,"about_ca_system_score_codex":0.00004195907,"about_ca_system_score_gemma":0.0003753324,"threshold_uncertainty_score":0.26912287},"labels":[],"label_agreement":null},{"id":"W4394817062","doi":"10.1158/1538-7445.fcs2023-p21","title":"Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Phenotype; Lymphoma; Cell; Biology; Computational biology; Medicine; Pathology; Genetics; Gene","score_opus":0.05183039074759968,"score_gpt":0.3178630824811817,"score_spread":0.266032691733582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394817062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000525,0.004569774,0.0014100889,0.00012030286,0.00059575174,0.0002127919,0.00011928456,0.000033043874,0.0029337273],"genre_scores_gemma":[0.997236,0.001010476,0.000026423899,0.000035695924,0.00035902663,0.000036440375,0.0001710791,0.000056813424,0.0010680298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979809,0.00015358496,0.0002523066,0.00053538935,0.00040792703,0.0006699187],"domain_scores_gemma":[0.99941397,0.000043670538,0.000026759299,0.00025603504,0.00015032118,0.00010922439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076675473,0.00017224945,0.00016685022,0.00015408281,0.00013646444,0.00011812283,0.00024504217,0.00026491104,0.000047482234],"category_scores_gemma":[0.00006830395,0.00017381505,0.0000975162,0.00032434525,0.00006504728,0.000012330072,0.00009681847,0.000297571,0.000027843842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028585788,0.0012963417,0.00093835575,0.00016241649,0.000026320824,0.000026501131,0.0002643451,0.0025528714,0.9914343,0.000016806587,0.00095430034,0.0020416072],"study_design_scores_gemma":[0.009421219,0.0005108908,0.0012302776,0.0003745691,0.000031696654,0.0000010822449,0.0004985333,0.06470627,0.89840555,0.00029790695,0.02373656,0.0007854077],"about_ca_topic_score_codex":0.0054360274,"about_ca_topic_score_gemma":0.00730756,"teacher_disagreement_score":0.093028694,"about_ca_system_score_codex":0.00034882315,"about_ca_system_score_gemma":0.00043251034,"threshold_uncertainty_score":0.82176834},"labels":[],"label_agreement":null},{"id":"W4394817385","doi":"10.1158/1538-7445.fcs2023-p28","title":"Abstract P28: Comprehensive Molecular Phenotyping of <i>ARID1A</i>-deficient Gastric Cancer Reveals Pervasive Epigenomic Reprogramming and Therapeutic Opportunities","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"ARID1A; Cancer research; Epigenetics; Biology; Epigenomics; Chromatin; Enhancer; Cancer; Bromodomain; Genetics; Gene; DNA methylation; Gene expression; Mutation","score_opus":0.1858655612336353,"score_gpt":0.4239057772134555,"score_spread":0.23804021597982022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394817385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8072966,0.18917012,0.0002885749,0.0016790975,0.00025301258,0.000793721,0.0000615416,0.000054013497,0.00040333736],"genre_scores_gemma":[0.97867244,0.019642899,0.00018037147,0.0003699573,0.00022814905,0.00033813593,0.000010223283,0.000070735514,0.00048708927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769163,0.0000949081,0.00037355535,0.0005738293,0.00065235107,0.00061373593],"domain_scores_gemma":[0.99858284,0.00019493056,0.000074423726,0.00039779284,0.00052769645,0.00022234434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006623829,0.00021332403,0.00045063932,0.00042279984,0.00015400631,0.00009428923,0.00014554677,0.00009849704,0.0005083648],"category_scores_gemma":[0.0000205333,0.00018660331,0.00013493077,0.0005508382,0.00031794573,0.00006342242,0.000098211414,0.0005748923,0.000006466009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002654589,0.00005175775,0.00022556703,0.001366056,0.00033959612,0.00022604127,0.0019033039,0.000075182346,0.6882278,0.004390818,0.0001684718,0.30275998],"study_design_scores_gemma":[0.008389607,0.0033083253,0.022206564,0.021655792,0.0012662269,0.0004956034,0.029200066,0.0041558915,0.6359607,0.024011044,0.24690339,0.0024467753],"about_ca_topic_score_codex":0.0020135464,"about_ca_topic_score_gemma":0.000044910463,"teacher_disagreement_score":0.30031317,"about_ca_system_score_codex":0.00041846817,"about_ca_system_score_gemma":0.00093434175,"threshold_uncertainty_score":0.7609462},"labels":[],"label_agreement":null},{"id":"W4396586623","doi":"10.1158/1538-7445.sabcs23-po4-10-12","title":"Abstract PO4-10-12: Value of Molecular Targets and Genome-Targeted Therapies FDA-Approved for Metastatic Breast Cancer, 2006-2023","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Cancer; Internal medicine; Targeted therapy","score_opus":0.08438742452159656,"score_gpt":0.44573949383322653,"score_spread":0.36135206931163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8709169,0.10960092,0.0003736244,0.013557659,0.00008311307,0.0017078205,0.0024200878,0.00007419455,0.0012656888],"genre_scores_gemma":[0.9934974,0.0023835,0.00032665546,0.000107214044,0.00019732885,0.0011466884,0.00007577878,0.000041628977,0.0022238418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985541,0.00003527543,0.000241393,0.00038335394,0.00037826525,0.0004076118],"domain_scores_gemma":[0.9989945,0.00023457261,0.000030573305,0.00024232504,0.00026731307,0.00023066191],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004938647,0.00014053709,0.00027222664,0.00010473136,0.0000978496,0.00004071362,0.0001371485,0.000063803775,0.0011326715],"category_scores_gemma":[0.0000583624,0.00011547026,0.00009311976,0.00037937227,0.00029008527,0.000056309018,0.00003858064,0.00034287563,0.000009592053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030792714,0.0001003257,0.00006897375,0.0022157636,0.00041385368,0.000022556205,0.00016809016,0.000051944768,0.9877275,0.00059039047,0.0031687263,0.005163907],"study_design_scores_gemma":[0.0026879665,0.00020209306,0.010713855,0.0005965538,0.00040465328,0.000049265527,0.00037521514,0.0030646503,0.87932795,0.0048772544,0.09730998,0.00039053435],"about_ca_topic_score_codex":0.00023033863,"about_ca_topic_score_gemma":0.000008337009,"teacher_disagreement_score":0.12258047,"about_ca_system_score_codex":0.00013678448,"about_ca_system_score_gemma":0.00040368616,"threshold_uncertainty_score":0.9997804},"labels":[],"label_agreement":null},{"id":"W4396586634","doi":"10.1158/1538-7445.sabcs23-po4-11-10","title":"Abstract PO4-11-10: Comparison of frozen embryo transfer cycle (FET) outcomes between young women with breast cancer (YWBC) with and without pathogenic variants (PV), and breast cancer-free PV carriers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Fertility Centre; CReATe Fertility Centre; University of Toronto","funders":"","keywords":"Breast cancer; Cancer; Medicine; Embryo transfer; Oncology; Embryo; Internal medicine; Biology; Genetics","score_opus":0.021075776311381827,"score_gpt":0.33420812689572654,"score_spread":0.31313235058434474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817758,0.009288645,0.00010366695,0.0012160446,0.00011835928,0.0005260274,0.006781486,0.000019434516,0.0001704891],"genre_scores_gemma":[0.9941832,0.0043652365,0.000047925798,0.00004937063,0.00036454477,0.000378867,0.000057791643,0.00009832203,0.00045475469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740744,0.000074565265,0.00035260053,0.00083521625,0.00054262613,0.00078755594],"domain_scores_gemma":[0.99856764,0.00007335547,0.000060991075,0.00054213154,0.0003358645,0.00042004167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004114772,0.00035578923,0.0005641764,0.00015661045,0.00020126687,0.00017213923,0.00037313267,0.00020580136,0.00020969525],"category_scores_gemma":[0.000016814474,0.0002767863,0.000056320627,0.00032228837,0.0006611334,0.00002743083,0.00020254773,0.00038758444,0.0000014724071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019411952,0.0000839626,0.87264526,0.00060225476,0.0010940515,0.000025284522,0.0016641481,0.0004481742,0.100599915,0.000050552997,0.0018519766,0.018993232],"study_design_scores_gemma":[0.0030032508,0.00053635624,0.9808449,0.00048399594,0.00020923982,0.00005544023,0.0011061524,0.00013062023,0.010060878,0.00006347336,0.0028888325,0.0006168329],"about_ca_topic_score_codex":0.00934681,"about_ca_topic_score_gemma":0.012595585,"teacher_disagreement_score":0.10819968,"about_ca_system_score_codex":0.00025866088,"about_ca_system_score_gemma":0.0012780085,"threshold_uncertainty_score":0.9999684},"labels":[],"label_agreement":null},{"id":"W4396586809","doi":"10.1158/1538-7445.sabcs23-po4-13-01","title":"Abstract PO4-13-01: A randomised trial comparing 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early breast cancer (REaCT-ZOL): Quality of life and toxicity outcomes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; McMaster University; Markham Stouffville Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Dosing; Breast cancer; Adjuvant; Internal medicine; Oncology; Quality of life (healthcare); Cancer","score_opus":0.09602372343925715,"score_gpt":0.40435249490411573,"score_spread":0.3083287714648586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995041,0.0014092324,8.8868234e-7,0.0005105283,0.00005821282,0.0023502442,0.00021057998,0.00002554031,0.00039373833],"genre_scores_gemma":[0.99947345,0.00006051872,0.000040490468,0.00003309448,0.000038273884,0.00022650666,0.000020844707,0.000037959795,0.00006888669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970874,0.00020347873,0.0006770708,0.00043355094,0.0010509539,0.00054752507],"domain_scores_gemma":[0.998441,0.00041825886,0.00017941678,0.0002807326,0.0003089377,0.00037164902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010171101,0.0002143345,0.0010748819,0.00032283328,0.00007210356,0.000037138743,0.00009049065,0.00009458895,0.000089256515],"category_scores_gemma":[0.00010094306,0.00014306171,0.00007226568,0.00048500538,0.00026850816,0.00018601942,0.000055298275,0.00050138053,0.0000027575932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31671742,0.0012274432,0.6734099,0.0011039492,0.00037312554,0.000020340442,0.00071121793,0.000019465933,0.0020070628,0.0000036510094,0.000017710361,0.0043887575],"study_design_scores_gemma":[0.18477419,0.0010534666,0.8113587,0.0017278362,0.00006533495,6.588297e-7,0.00003534786,0.00006378492,0.00079782435,0.0000071152804,0.0000051301163,0.00011063933],"about_ca_topic_score_codex":0.04037899,"about_ca_topic_score_gemma":0.0050232685,"teacher_disagreement_score":0.13794881,"about_ca_system_score_codex":0.00046614656,"about_ca_system_score_gemma":0.001252557,"threshold_uncertainty_score":0.9660112},"labels":[],"label_agreement":null},{"id":"W4396586818","doi":"10.1158/1538-7445.sabcs23-ps17-07","title":"Abstract PS17-07: Interim analysis of giredestrant + inavolisib in MORPHEUS Breast Cancer: a Phase Ib/II study of giredestrant treatment combinations in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Cancer; Estrogen receptor; Interim analysis; HER2 negative; Interim; Clinical trial","score_opus":0.09188087022298844,"score_gpt":0.48113297864485843,"score_spread":0.38925210842186997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800682,0.005173598,0.00001624612,0.0032253494,0.00021531867,0.0041712434,0.0067921,0.000056718334,0.0002812422],"genre_scores_gemma":[0.9885947,0.006517718,0.00011601844,0.00002263391,0.000093317925,0.0039665,0.000119545046,0.00012812906,0.00044141858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99228525,0.0007570787,0.0017334148,0.001432038,0.0023651922,0.0014270287],"domain_scores_gemma":[0.9961667,0.0006051948,0.00025807373,0.0009546411,0.0014594803,0.00055588514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001737993,0.0006278045,0.0019216045,0.003561303,0.00018288226,0.00009730412,0.0006811177,0.00018585632,0.004166304],"category_scores_gemma":[0.00012763876,0.0005512328,0.0003971892,0.008802692,0.0009211731,0.00038415298,0.00023886167,0.00142468,0.000016491302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02108835,0.049519178,0.21179253,0.0051646126,0.014316768,0.0033869413,0.033584803,0.020841176,0.14825551,0.00029587102,0.0014830562,0.4902712],"study_design_scores_gemma":[0.042784706,0.015241015,0.842711,0.01917456,0.0027537963,0.00013183079,0.021278601,0.013639921,0.040148687,0.00021482835,0.0004919619,0.0014291322],"about_ca_topic_score_codex":0.17743188,"about_ca_topic_score_gemma":0.05578261,"teacher_disagreement_score":0.63091844,"about_ca_system_score_codex":0.006328926,"about_ca_system_score_gemma":0.0055537173,"threshold_uncertainty_score":0.99969393},"labels":[],"label_agreement":null},{"id":"W4396586881","doi":"10.1158/1538-7445.sabcs23-ps10-01","title":"Abstract PS10-01: Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network; McGill University; Sinai Health System; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Germline; Medicine; Breast cancer; Gynecology; Oncology; Ovarian cancer; Cancer; Obstetrics; Internal medicine; Biology; Genetics","score_opus":0.02336483471162303,"score_gpt":0.3568423727597176,"score_spread":0.33347753804809455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93906796,0.05741041,0.00007549982,0.0003351555,0.00008863398,0.00034404427,0.0026483156,0.000004229041,0.000025725896],"genre_scores_gemma":[0.96885514,0.030340973,0.000051945437,0.00002370206,0.00036811197,0.00018825736,0.000075747055,0.000019421095,0.00007667162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989708,0.000056615292,0.00017260706,0.00037217804,0.0001580385,0.0002697716],"domain_scores_gemma":[0.9994881,0.00003501888,0.000028905992,0.00013676603,0.00016894794,0.00014224659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044983902,0.000096713695,0.00012332811,0.00009853871,0.00006800413,0.00003901319,0.000072749,0.0001154407,0.00006721937],"category_scores_gemma":[0.000043945285,0.0000942841,0.000045357283,0.000106625535,0.00024718783,0.0000073489878,0.000047470672,0.00013292169,4.4982804e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008698135,0.00005940276,0.017296882,0.00047138103,0.000082341365,0.00000728137,0.00014254496,0.000029976363,0.9361748,0.000047501722,0.002388952,0.04242913],"study_design_scores_gemma":[0.0034959828,0.00033512918,0.93588036,0.00030552642,0.00007536848,0.000019033569,0.00040027755,0.0005966185,0.04914351,0.0017233475,0.0076894495,0.00033540395],"about_ca_topic_score_codex":0.00066875794,"about_ca_topic_score_gemma":0.0007623804,"teacher_disagreement_score":0.91858345,"about_ca_system_score_codex":0.000037633905,"about_ca_system_score_gemma":0.00035167328,"threshold_uncertainty_score":0.3844794},"labels":[],"label_agreement":null},{"id":"W4396586998","doi":"10.1158/1538-7445.sabcs23-po4-13-02","title":"Abstract PO4-13-02: Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence after Breast Conserving Surgery for DCIS","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Breast-conserving surgery; Medicine; Breast cancer; Oncology; Internal medicine; Mastectomy; Cancer","score_opus":0.03209938135111762,"score_gpt":0.3342012692898006,"score_spread":0.302101887938683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96374565,0.02604416,0.006614062,0.0012965096,0.00037584073,0.0006122152,0.0011897259,0.000015954378,0.00010589075],"genre_scores_gemma":[0.9970315,0.0017265767,0.000027591792,0.000050171602,0.00019395542,0.00085491454,0.000055436507,0.000025550007,0.00003431702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865663,0.000091135385,0.0001943735,0.0004525639,0.00027791687,0.00032736573],"domain_scores_gemma":[0.9989509,0.00036494766,0.000039254566,0.0002741012,0.0002984159,0.00007238619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957865,0.0001436724,0.00015911952,0.00007031251,0.00012409389,0.000044183584,0.00013013101,0.00011859201,0.000024949033],"category_scores_gemma":[0.00009721449,0.000102609534,0.00009279629,0.00014609404,0.0005620165,0.000011951714,0.00022244139,0.00018802981,0.0000017531484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013325731,0.00007685864,0.0073891627,0.0011257393,0.00033249316,0.00003510476,0.00033119094,0.00004467379,0.8773912,0.000047815072,0.011453976,0.10043917],"study_design_scores_gemma":[0.0004410999,0.00015310252,0.040875573,0.0009665825,0.000049061993,0.0000341645,0.00082068227,0.00013947696,0.9540078,0.0002699558,0.002073482,0.00016903743],"about_ca_topic_score_codex":0.00039197042,"about_ca_topic_score_gemma":0.00013810488,"teacher_disagreement_score":0.10027013,"about_ca_system_score_codex":0.00009082507,"about_ca_system_score_gemma":0.00043578466,"threshold_uncertainty_score":0.41842955},"labels":[],"label_agreement":null},{"id":"W4396587010","doi":"10.1158/1538-7445.sabcs23-ss02-03","title":"Abstract SS02-03: Cancer risk associated with exogenous hormone use in BRCA mutation carriers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"BRCA mutation; Cancer; Medicine; Oncology; Mutation; Internal medicine; Genetics; Biology; Breast cancer; Gene","score_opus":0.04070177765583956,"score_gpt":0.3576762202900246,"score_spread":0.31697444263418506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701763,0.02838074,0.000022328708,0.00015148084,0.00011947925,0.00033730615,0.0005880545,0.00002136683,0.00020295424],"genre_scores_gemma":[0.9875997,0.010614461,0.00001919369,0.000051183884,0.0002878366,0.00030464143,0.000266002,0.00004352437,0.00081347435],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983759,0.00013760907,0.00016726626,0.00047479794,0.00037771533,0.00046671665],"domain_scores_gemma":[0.9991752,0.000052454056,0.000033932003,0.00024967213,0.0003036571,0.00018507216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041826017,0.00013680352,0.00012001373,0.00016110828,0.00013278254,0.00012979048,0.0001457405,0.00014996876,0.0000746602],"category_scores_gemma":[0.00019782431,0.0001273199,0.000053502736,0.00038896504,0.00018085456,0.000012838018,0.000045195953,0.00029767296,0.000010809886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022193843,0.0004887108,0.10308437,0.00036643597,0.0007053907,0.00061670126,0.0015190906,0.0048658988,0.81794417,0.000031222018,0.04838502,0.01977361],"study_design_scores_gemma":[0.005084425,0.0012188912,0.7585814,0.0007232694,0.00015273826,0.000011866297,0.001241121,0.0005509234,0.18994217,0.00068984565,0.040724788,0.0010785402],"about_ca_topic_score_codex":0.0050850892,"about_ca_topic_score_gemma":0.010082792,"teacher_disagreement_score":0.6554971,"about_ca_system_score_codex":0.0002510409,"about_ca_system_score_gemma":0.00087930006,"threshold_uncertainty_score":0.7687168},"labels":[],"label_agreement":null},{"id":"W4396587049","doi":"10.1158/1538-7445.sabcs23-po4-17-03","title":"Abstract PO4-17-03: Neoadjuvant chemotherapy in invasive lobular carcinoma of the breast: A retrospective study on survival outcomes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"","keywords":"Medicine; Oncology; Invasive lobular carcinoma; Retrospective cohort study; Internal medicine; Chemotherapy; Breast cancer; Neoadjuvant therapy; Cancer; Invasive ductal carcinoma","score_opus":0.04392015206942274,"score_gpt":0.37524350579076293,"score_spread":0.3313233537213402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934005,0.0020493811,5.3348475e-7,0.0024613019,0.0002569672,0.0007138193,0.0001612554,0.0000089579635,0.00094728306],"genre_scores_gemma":[0.99873185,0.0002550749,0.00000246877,0.00007059747,0.00017689665,0.00026533013,0.000007427184,0.000037000354,0.0004533632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808645,0.00016149688,0.00021470223,0.0005644587,0.0005772776,0.00039560942],"domain_scores_gemma":[0.9990804,0.00008128792,0.000040448576,0.0005499611,0.00019573102,0.00005215712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047861878,0.00020091563,0.00029087058,0.00012280051,0.00009780527,0.000032799646,0.0003623244,0.000087610926,0.00006876944],"category_scores_gemma":[0.000074844735,0.0001325569,0.00012933598,0.00044725044,0.00023049499,0.0000056054473,0.00022102814,0.00035448666,0.000010462055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039965822,0.00041575704,0.9523511,0.00004845039,0.0003694917,0.00004684351,0.001285468,0.00001960202,0.042172454,0.00006722578,0.0014015835,0.0014223962],"study_design_scores_gemma":[0.0011663433,0.00029420655,0.9506159,0.00011578448,0.000012627487,0.0000042521783,0.0011551412,9.657434e-7,0.04617352,0.00009679877,0.0002454298,0.00011907512],"about_ca_topic_score_codex":0.0026201308,"about_ca_topic_score_gemma":0.003076633,"teacher_disagreement_score":0.0053313407,"about_ca_system_score_codex":0.00035251558,"about_ca_system_score_gemma":0.00044362107,"threshold_uncertainty_score":0.54055136},"labels":[],"label_agreement":null},{"id":"W4396587059","doi":"10.1158/1538-7445.sabcs23-po5-05-14","title":"Abstract PO5-05-14: Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Recurrent breast cancer; Gynecology","score_opus":0.12425201806634079,"score_gpt":0.4887938110640621,"score_spread":0.3645417929977213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851362,0.0055969628,0.0000034143204,0.0054095094,0.00069055986,0.00071979384,0.00026448382,0.000057450638,0.0021215982],"genre_scores_gemma":[0.9863321,0.0037762101,0.000026370508,0.000120493416,0.0005598539,0.0017613888,0.000016737418,0.000054788634,0.0073520676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975946,0.00013317713,0.00022501725,0.000463236,0.0006247757,0.0009591929],"domain_scores_gemma":[0.9990073,0.00024880964,0.000023779725,0.00020292525,0.00018971607,0.0003274561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009054973,0.00019215174,0.00035940786,0.00039635843,0.00007575358,0.00007323985,0.00014755817,0.00006102312,0.01163383],"category_scores_gemma":[0.000021728263,0.00012786798,0.000041860196,0.0010591958,0.00018203388,0.000118343494,0.000055574434,0.0008348517,0.000066637665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08046866,0.00332979,0.26902413,0.009003049,0.004537505,0.024522888,0.03059451,0.00032502963,0.07687347,0.00035091094,0.09443282,0.40653723],"study_design_scores_gemma":[0.021540327,0.0046571754,0.8492096,0.0056848475,0.00048756218,0.00186234,0.0049125426,0.0005173075,0.007339063,0.00038601333,0.10231214,0.001091091],"about_ca_topic_score_codex":0.008305174,"about_ca_topic_score_gemma":0.027058968,"teacher_disagreement_score":0.5801855,"about_ca_system_score_codex":0.0034732115,"about_ca_system_score_gemma":0.0034012902,"threshold_uncertainty_score":0.9982986},"labels":[],"label_agreement":null},{"id":"W4396587097","doi":"10.1158/1538-7445.sabcs23-po4-09-03","title":"Abstract PO4-09-03: Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Environmental health; Cancer; Prospective cohort study; Oncology; Internal medicine","score_opus":0.09092251814135628,"score_gpt":0.4400029212375627,"score_spread":0.3490804030962064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827477,0.007609699,7.43551e-7,0.00086119655,0.00015725638,0.0012546577,0.0066943993,0.000017581839,0.00065680145],"genre_scores_gemma":[0.9962459,0.0024174128,0.000010744393,0.000017244094,0.0003125943,0.00029287682,0.00008846681,0.0000354312,0.0005793209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761176,0.00010106912,0.00025671127,0.00071497774,0.00092714804,0.00038830904],"domain_scores_gemma":[0.99884593,0.0001661284,0.000050577186,0.00047514448,0.00013033942,0.0003318994],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006925785,0.0001543827,0.0002773157,0.00039415972,0.00018409677,0.00006827209,0.0002360377,0.00006321477,0.0018469788],"category_scores_gemma":[0.000065961205,0.00012617311,0.00004052783,0.00039548485,0.00032076793,0.00025600332,0.00021202298,0.00065696344,0.000015039572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005869503,0.0003499689,0.95633215,0.00015748179,0.0011982156,0.00024290702,0.008683181,0.00002484976,0.004485707,0.00006383922,0.006121988,0.02175275],"study_design_scores_gemma":[0.0010143906,0.00028086346,0.9894897,0.00014534812,0.00012678743,0.000022132632,0.006367266,0.00010963692,0.0005832607,0.000056181183,0.0016821927,0.00012224293],"about_ca_topic_score_codex":0.63369733,"about_ca_topic_score_gemma":0.4240792,"teacher_disagreement_score":0.2096181,"about_ca_system_score_codex":0.00092213345,"about_ca_system_score_gemma":0.0015437016,"threshold_uncertainty_score":0.99906546},"labels":[],"label_agreement":null},{"id":"W4396587123","doi":"10.1158/1538-7445.sabcs23-po5-18-02","title":"Abstract PO5-18-02: A Population-Based Analysis of the Impact of Omission of Anthracyclines in the Neoadjuvant Setting on the Risk of Mortality","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Oncology; Internal medicine; Neoadjuvant therapy; Population; Cancer; Breast cancer; Environmental health","score_opus":0.11078843792056263,"score_gpt":0.48268174308951217,"score_spread":0.37189330516894953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980801,0.00036255422,0.0000029768325,0.00074535504,0.000060331276,0.0003369252,0.0002454386,0.0000032728367,0.00016309517],"genre_scores_gemma":[0.99982584,0.00006250295,0.0000063444404,0.0000035545927,0.00005497731,0.000010017731,0.000016917778,0.0000062546032,0.000013587272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983911,0.0003248572,0.00041752256,0.00013252643,0.0005898412,0.00014413852],"domain_scores_gemma":[0.998216,0.0010024516,0.00020054533,0.00037032153,0.0001838519,0.000026879292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021980507,0.00007374681,0.00029021638,0.00035211217,0.00005757822,0.00000736,0.00016420317,0.000060515024,0.00023606062],"category_scores_gemma":[0.00026433246,0.000028538769,0.00030668502,0.0015333153,0.00020645591,0.0000289769,0.000021263797,0.0004041899,3.3145994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031693358,0.000115860945,0.9398785,0.00028946597,0.0005850678,0.0000023181206,0.00066215394,0.004128961,0.020632822,0.000036530393,0.00014615442,0.033205237],"study_design_scores_gemma":[0.00022405789,0.000069509784,0.9746829,0.0008011919,0.00021661879,0.000009040805,0.0005311158,0.009355312,0.013965473,0.00011704846,0.0000016435895,0.000026037515],"about_ca_topic_score_codex":0.027124815,"about_ca_topic_score_gemma":0.0007527332,"teacher_disagreement_score":0.034804456,"about_ca_system_score_codex":0.0000798129,"about_ca_system_score_gemma":0.00037627033,"threshold_uncertainty_score":0.97935367},"labels":[],"label_agreement":null},{"id":"W4396587166","doi":"10.1158/1538-7445.sabcs23-po4-16-09","title":"Abstract PO4-16-09: Enhancing Research on Inflammatory Breast Cancer through Count Me In: Assessing the Accuracy of Self-Reported Diagnoses","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Medical diagnosis; Inflammatory breast cancer; Oncology; Internal medicine; Gerontology; Family medicine; Pathology","score_opus":0.08688002960005088,"score_gpt":0.4695409608812707,"score_spread":0.3826609312812198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971266,0.022127591,0.00000595635,0.0035996907,0.0003553897,0.00059746,0.00012208307,0.000034166427,0.0018917153],"genre_scores_gemma":[0.98320603,0.01455044,0.000013984134,0.00007063169,0.0008035582,0.0011059712,0.000024405053,0.00006234397,0.0001626358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99633265,0.00038522173,0.00046749852,0.00076497934,0.0011853452,0.00086428644],"domain_scores_gemma":[0.9972837,0.0010611276,0.00009724545,0.0006910301,0.0007805341,0.00008637158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022778746,0.00025036928,0.000278362,0.0002333653,0.0003865683,0.00018471351,0.00048128303,0.00018372203,0.00015901664],"category_scores_gemma":[0.000389124,0.00017957998,0.000110119305,0.000911783,0.0005365469,0.000044586788,0.00038866786,0.0009092729,0.000021937562],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009444864,0.00089435227,0.15145698,0.0023895367,0.002910031,0.00047693064,0.0059242626,0.0007346509,0.76058495,0.0012147545,0.033106744,0.039362337],"study_design_scores_gemma":[0.0010262615,0.00016968399,0.5102868,0.0030453382,0.00006843163,0.000042006042,0.0037749754,0.000027037147,0.44918558,0.0005142811,0.03140816,0.0004514047],"about_ca_topic_score_codex":0.0076410193,"about_ca_topic_score_gemma":0.0049125506,"teacher_disagreement_score":0.35882986,"about_ca_system_score_codex":0.0009553265,"about_ca_system_score_gemma":0.0022058652,"threshold_uncertainty_score":0.9989672},"labels":[],"label_agreement":null},{"id":"W4396587176","doi":"10.1158/1538-7445.sabcs23-ps14-08","title":"Abstract PS14-08: Safety evaluation from the KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Internal medicine; Breast cancer; Placebo; Triple-negative breast cancer; Metastatic breast cancer; Recurrent breast cancer; Cancer; Immunotherapy; Pathology","score_opus":0.058025912391397545,"score_gpt":0.3928854851214807,"score_spread":0.33485957273008315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806077,0.006482062,0.0000176707,0.0025225265,0.00028550197,0.009411742,0.0004660646,0.0000483748,0.00015836529],"genre_scores_gemma":[0.9917131,0.0050375317,0.000032663327,0.0003330963,0.0001868959,0.0018898175,0.000099765064,0.00010745909,0.0005996717],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9945123,0.00072338065,0.00083021785,0.0008868623,0.0022981472,0.0007490576],"domain_scores_gemma":[0.997156,0.0007206439,0.00019644956,0.00072389556,0.0010397964,0.00016318662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023567076,0.00043971164,0.0008347993,0.00035292542,0.0002115076,0.00013172823,0.0004349165,0.00012817839,0.0059003807],"category_scores_gemma":[0.000100152734,0.00025046416,0.00012673005,0.0019443526,0.0003655786,0.00025497426,0.000057904388,0.0009695476,0.000014862341],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58139694,0.002043552,0.021848358,0.00065562985,0.0033696822,0.000052774667,0.029046813,0.0012823262,0.00087036437,0.000003832276,0.004583395,0.35484633],"study_design_scores_gemma":[0.17308743,0.0067084515,0.7975634,0.005979676,0.00052310847,0.00001143111,0.005984462,0.0050678113,0.0021247366,0.000045404813,0.0022503033,0.0006537802],"about_ca_topic_score_codex":0.035940625,"about_ca_topic_score_gemma":0.019657627,"teacher_disagreement_score":0.77571505,"about_ca_system_score_codex":0.00452998,"about_ca_system_score_gemma":0.005437479,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W4396587181","doi":"10.1158/1538-7445.sabcs23-po4-24-05","title":"Abstract PO4-24-05: Fluid forces and hormone levels during mammary gland development drive changes in breast epithelium that are relevant to the progression of postpartum breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Mammary gland; Epithelium; Hormone; Internal medicine; Medicine; Cancer; Endocrinology; Pathology","score_opus":0.058460504855082474,"score_gpt":0.37289216468989383,"score_spread":0.31443165983481136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449175,0.022724707,0.000003520076,0.030617354,0.00022843177,0.0009789865,0.0004350111,0.00003345683,0.00006105321],"genre_scores_gemma":[0.98748124,0.010942013,0.00003201766,0.00008877683,0.00033697,0.00051940547,0.000010511319,0.000043080003,0.00054599694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99771106,0.00005755195,0.00026834343,0.00050891534,0.0008371228,0.0006170079],"domain_scores_gemma":[0.99907094,0.0000984085,0.00006019169,0.00030167907,0.00021791832,0.00025083552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006567769,0.00021251096,0.00034984952,0.00040528714,0.00016520762,0.00009398152,0.00020872864,0.00010198323,0.00016077857],"category_scores_gemma":[0.000018697541,0.00013162015,0.00004559818,0.0005696917,0.00015522781,0.00014123842,0.00027794635,0.00054240075,0.0000070026545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044421917,0.000206655,0.2810289,0.0045604846,0.0004002838,0.00077171397,0.015603434,0.000028391709,0.35349834,0.000044163804,0.01037462,0.32904083],"study_design_scores_gemma":[0.0007266496,0.00010748168,0.94519275,0.0047270968,0.00001718878,0.0001306312,0.00092638424,0.000032856628,0.04198389,0.000010612498,0.0059788567,0.00016559956],"about_ca_topic_score_codex":0.0026068867,"about_ca_topic_score_gemma":0.0061064963,"teacher_disagreement_score":0.6641639,"about_ca_system_score_codex":0.000448525,"about_ca_system_score_gemma":0.0006502255,"threshold_uncertainty_score":0.5367314},"labels":[],"label_agreement":null},{"id":"W4396587235","doi":"10.1158/1538-7445.sabcs23-ps16-03","title":"Abstract PS16-03: Intratumoral dosing of INT230-6 in Early-Stage Breast Cancer Patients Induces Tumor Cell Necrosis and Immunomodulatory Effects: A Phase II Randomized Window-Of-Opportunity Study – the INVINCIBLE Trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Ontario Institute for Cancer Research; Institute of Cancer Research; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Stage (stratigraphy); Dosing; Cancer; Necrosis; Window of opportunity; Oncology; Internal medicine; Therapeutic window; Pathology; Pharmacology; Biology","score_opus":0.08482277067803398,"score_gpt":0.436833172211823,"score_spread":0.35201040153378904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857692,0.0047050193,7.0709115e-7,0.0004410009,0.000623875,0.007835393,0.00026451045,0.000032516054,0.00032774167],"genre_scores_gemma":[0.9964267,0.00076849625,0.00000832027,0.000043374013,0.00033398918,0.0021200413,0.000012538582,0.00008125647,0.00020530829],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99378234,0.0014882489,0.0011240841,0.0007388936,0.001968346,0.0008980834],"domain_scores_gemma":[0.9963028,0.0016824114,0.00022401926,0.0006952874,0.00070076284,0.00039474227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00795279,0.0003471132,0.0012787486,0.0009735759,0.00026674426,0.0001523117,0.00050878536,0.0001500606,0.00042350034],"category_scores_gemma":[0.0009361463,0.00023998648,0.00020436899,0.0017968497,0.001318244,0.0003081018,0.00052390277,0.0022403833,0.0000049587024],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7234604,0.008219141,0.044370227,0.0063011497,0.0009020839,0.00042109372,0.019969085,0.000021857806,0.1648665,0.000027096738,0.0010565021,0.030384872],"study_design_scores_gemma":[0.71778977,0.008278962,0.14890145,0.004682669,0.00030112872,0.000007680658,0.0023700972,0.0002633486,0.11645935,0.00015812802,0.00028132,0.00050607964],"about_ca_topic_score_codex":0.043340903,"about_ca_topic_score_gemma":0.00082456024,"teacher_disagreement_score":0.10453122,"about_ca_system_score_codex":0.0008710138,"about_ca_system_score_gemma":0.0037363784,"threshold_uncertainty_score":0.97863644},"labels":[],"label_agreement":null},{"id":"W4396587274","doi":"10.1158/1538-7445.sabcs23-po5-27-05","title":"Abstract PO5-27-05: Computational design and validation of a novel peptide-drug conjugate for treatment of triple negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ProteinQure (Canada)","funders":"","keywords":"Triple-negative breast cancer; Conjugate; Medicine; Breast cancer; Drug; Cancer; Oncology; Peptide; Internal medicine; Pharmacology; Chemistry; Mathematics; Biochemistry","score_opus":0.12826137690349484,"score_gpt":0.4268134203051029,"score_spread":0.298552043401608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100053,0.00093342696,0.0018630003,0.0013337476,0.00004296775,0.0005183207,0.0037981158,0.00002580935,0.00048405986],"genre_scores_gemma":[0.99539125,0.0003507944,0.0006954329,0.0000041327557,0.00014183886,0.0008463686,0.0001085026,0.000018998355,0.002442707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990356,0.000012299911,0.00024238568,0.00028105514,0.0002453276,0.00018332888],"domain_scores_gemma":[0.9985883,0.00077791896,0.000069153655,0.00013319202,0.00036032434,0.000071114344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020157029,0.0001035922,0.00017681361,0.00005205319,0.00008774927,0.000036022127,0.000096492404,0.000053564316,0.0006197663],"category_scores_gemma":[0.00002780215,0.00009396047,0.000061181934,0.00019908324,0.00019611185,0.0000843662,0.000022699955,0.000082369384,0.0000016669713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037613095,0.0003095542,0.0001619124,0.0011397197,0.00020109217,0.000001226263,0.001276769,0.005142792,0.97823495,0.00052810274,0.005275192,0.0073525547],"study_design_scores_gemma":[0.0012834962,0.000028772423,0.00025969886,0.0002865097,0.000028954193,0.0000046102978,0.0002924211,0.0069908085,0.9876494,0.0012226155,0.0018593646,0.00009336994],"about_ca_topic_score_codex":0.00092575426,"about_ca_topic_score_gemma":0.000029366141,"teacher_disagreement_score":0.009414425,"about_ca_system_score_codex":0.00022701512,"about_ca_system_score_gemma":0.00049857347,"threshold_uncertainty_score":0.67860067},"labels":[],"label_agreement":null},{"id":"W4396587289","doi":"10.1158/1538-7445.sabcs23-po5-25-02","title":"Abstract PO5-25-02: Microenvironment based co-culture dependence of breast cancer and immune cell interactions on functional outcomes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Breast cancer; Tumor microenvironment; Cancer; Medicine; Cancer research; Oncology; Immunology; Internal medicine","score_opus":0.05825854148576385,"score_gpt":0.3971663862361489,"score_spread":0.33890784475038505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683159,0.016446333,0.000037692163,0.009238697,0.00062690704,0.0005688183,0.0010804554,0.000033108732,0.0036520911],"genre_scores_gemma":[0.9867165,0.0037574195,0.0000491191,0.00022325867,0.00020988239,0.00019380137,0.000037721096,0.00002941111,0.008782883],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998327,0.00003651822,0.00024082066,0.00039723754,0.0006779742,0.0003204569],"domain_scores_gemma":[0.9992394,0.00015841,0.000041915606,0.00026217173,0.00012403892,0.00017409907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003151735,0.00015550123,0.0002624776,0.00022521835,0.00011721844,0.000048078557,0.000088237255,0.00006315913,0.006083784],"category_scores_gemma":[0.000013262829,0.00011619098,0.00012582232,0.00023344276,0.00020563653,0.000088526,0.000046730453,0.0006822488,0.00006341836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000905818,0.00038003793,0.011634508,0.001330672,0.0002519181,0.00007927714,0.00040413174,0.00017090488,0.9278249,0.00006291094,0.025556492,0.03139842],"study_design_scores_gemma":[0.0021068882,0.00024916383,0.45641306,0.0015931412,0.00014179057,0.00004629916,0.00072048826,0.000079327205,0.402064,0.000025708832,0.13630301,0.00025711887],"about_ca_topic_score_codex":0.0019744523,"about_ca_topic_score_gemma":0.00022251293,"teacher_disagreement_score":0.5257609,"about_ca_system_score_codex":0.00056006806,"about_ca_system_score_gemma":0.00048044106,"threshold_uncertainty_score":0.99482477},"labels":[],"label_agreement":null},{"id":"W4396587344","doi":"10.1158/1538-7445.sabcs23-po4-19-05","title":"Abstract PO4-19-05: OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy (Alliance A012103)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Chemotherapy; Stage (stratigraphy); Internal medicine; Biology","score_opus":0.05608263485014749,"score_gpt":0.39940142169982334,"score_spread":0.34331878684967587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550403,0.0021505023,0.0004430334,0.009576626,0.00005181444,0.001683288,0.000049965016,0.00010202483,0.0004386852],"genre_scores_gemma":[0.98237306,0.0125892125,0.0020300958,0.0006421011,0.00022226907,0.0011318014,0.000029735704,0.00007827819,0.00090344046],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975565,0.0000813756,0.00042857474,0.00051796704,0.000863401,0.00055218406],"domain_scores_gemma":[0.9987327,0.00012064492,0.000074853466,0.0004965654,0.00030977427,0.0002654544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009029723,0.00021699784,0.00034525656,0.00024015737,0.000062563224,0.000068964524,0.00023497653,0.0001606715,0.0005973452],"category_scores_gemma":[0.00003870759,0.00015709428,0.0000947575,0.0007992187,0.00032446787,0.00016772529,0.00004127876,0.000934217,0.000013026966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012531127,0.0028672137,0.2718566,0.0015996495,0.00037557923,0.0003215261,0.009294402,0.000072574636,0.22335683,0.0005280148,0.027033413,0.45016307],"study_design_scores_gemma":[0.005463066,0.0019661973,0.78914434,0.0034788148,0.000012822287,0.000006130131,0.00013470923,0.0017365351,0.14053614,0.0004683444,0.05663203,0.00042087113],"about_ca_topic_score_codex":0.001181705,"about_ca_topic_score_gemma":0.000038290786,"teacher_disagreement_score":0.51728773,"about_ca_system_score_codex":0.0004125561,"about_ca_system_score_gemma":0.00053814927,"threshold_uncertainty_score":0.65405107},"labels":[],"label_agreement":null},{"id":"W4396587404","doi":"10.1158/1538-7445.sabcs23-po2-25-01","title":"Abstract PO2-25-01: Tumor Derived Chitinase-3 like 1 Induces Neutrophil Extracellular Traps that Promote T cell Exclusion and Resistance to Immunotherapies in Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Neutrophil extracellular traps; Chitinase; Cancer; Extracellular; Breast cancer; Medicine; Immunology; Cancer research; Internal medicine; Biology; Inflammation; Enzyme; Cell biology; Biochemistry","score_opus":0.038245905195956,"score_gpt":0.31480352910244075,"score_spread":0.27655762390648475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91356,0.07954632,0.000010879719,0.004753981,0.0005331476,0.0008396871,0.0003722245,0.000080316604,0.00030346029],"genre_scores_gemma":[0.99151534,0.0053455345,0.00004358442,0.0002822835,0.00011615509,0.0005755905,0.000032797365,0.00006712731,0.002021612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972861,0.00037538479,0.00035031635,0.00082556385,0.00020416004,0.0009584794],"domain_scores_gemma":[0.99913394,0.00015879978,0.00006031271,0.0003959874,0.00014764116,0.00010330896],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075406616,0.0003487751,0.00040432747,0.00059572334,0.00042042736,0.00017994446,0.00045555734,0.00021903795,0.0016059703],"category_scores_gemma":[0.000012936011,0.00029654705,0.00008069274,0.00070978736,0.00036330917,0.00036140208,0.00021412605,0.0012080099,0.00020275735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006811233,0.000099450575,0.00019540309,0.00029267065,0.00007319968,0.00022515589,0.0019389938,0.0000024562532,0.9862376,0.0002619824,0.0015411953,0.008450757],"study_design_scores_gemma":[0.0009715534,0.00012947491,0.021528518,0.0010055588,0.000014491762,0.00003059096,0.00075047463,5.782992e-7,0.9170525,0.00034260555,0.057803586,0.00037004062],"about_ca_topic_score_codex":0.0015890228,"about_ca_topic_score_gemma":0.00070778775,"teacher_disagreement_score":0.07795533,"about_ca_system_score_codex":0.0002868252,"about_ca_system_score_gemma":0.000392785,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W4396587423","doi":"10.1158/1538-7445.sabcs23-po3-19-03","title":"Abstract PO3-19-03: Addressing USPSTF 2023 Identified Key Gaps in Knowledge in Breast Cancer Screening through TMIST (ECOG-ACRIN EA1151) or its Ancillary Studies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Oncology; Environmental health","score_opus":0.2402534428005667,"score_gpt":0.5307182232119402,"score_spread":0.29046478041137347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79383504,0.1785926,0.000047301393,0.019179484,0.0013157213,0.0008049152,0.00009460982,0.00013819637,0.0059921327],"genre_scores_gemma":[0.95943487,0.029927572,0.00021864935,0.00043628094,0.0015197342,0.00040891912,0.000022613014,0.00011730547,0.007914058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959123,0.00028523596,0.0006826906,0.0009138993,0.0010042104,0.0012016486],"domain_scores_gemma":[0.99802434,0.00081351906,0.00006694286,0.00037370864,0.00038820345,0.00033326406],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031361035,0.00031733088,0.00069545256,0.0007521882,0.00027067703,0.0002524148,0.0003565451,0.00017432247,0.0018071643],"category_scores_gemma":[0.001150003,0.000254813,0.00011554085,0.002094404,0.00044960016,0.00040686116,0.00035292003,0.0027901153,0.00014624183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038729964,0.00084920693,0.077024676,0.025099544,0.0014608144,0.024608592,0.03353271,0.0028153027,0.10253561,0.00057745783,0.35340208,0.374221],"study_design_scores_gemma":[0.013379075,0.00036965188,0.46892676,0.110891536,0.00027718232,0.0010434629,0.021545123,0.045929506,0.0063565285,0.000822884,0.32812822,0.0023300692],"about_ca_topic_score_codex":0.006162117,"about_ca_topic_score_gemma":0.0040365783,"teacher_disagreement_score":0.3919021,"about_ca_system_score_codex":0.0013551785,"about_ca_system_score_gemma":0.0017735871,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W4396587478","doi":"10.1158/1538-7445.sabcs23-po3-07-08","title":"Abstract PO3-07-08: Breast density estimation with a microwave-frequency imaging system","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Microwave; Medicine; Estimation; Microwave imaging; Breast cancer; Breast density; Mammography; Internal medicine; Telecommunications; Cancer; Computer science; Engineering","score_opus":0.029277788033384156,"score_gpt":0.36712312598868596,"score_spread":0.3378453379553018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96913743,0.0075185127,0.0015991275,0.0046229037,0.00041661214,0.0010159541,0.000049320388,0.0004010482,0.015239089],"genre_scores_gemma":[0.9972338,0.0000766859,0.0013967868,0.00009591524,0.00061476417,0.00014071318,0.000034001336,0.0000649498,0.000342388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974788,0.00008369894,0.00026507073,0.00047447937,0.001078986,0.00061897055],"domain_scores_gemma":[0.9984452,0.00014315083,0.00003634378,0.0004983311,0.0006227496,0.00025421986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012821788,0.00018525586,0.00028013697,0.00057793845,0.00018317,0.00011082141,0.00017285414,0.00007989198,0.00044040193],"category_scores_gemma":[0.00006153737,0.00013644453,0.00007634422,0.0010099739,0.0003740317,0.00018883726,0.000046340043,0.0009982807,0.00036752934],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011204397,0.0001440404,0.0409099,0.011185492,0.00061685435,0.008850403,0.0030548726,0.000033157106,0.73168933,0.0042456826,0.015161883,0.18298794],"study_design_scores_gemma":[0.01087268,0.001492621,0.67791986,0.09547159,0.0012619232,0.028266968,0.010486365,0.01963506,0.14398478,0.00392779,0.004492767,0.002187609],"about_ca_topic_score_codex":0.0011262053,"about_ca_topic_score_gemma":0.000037049333,"teacher_disagreement_score":0.6370099,"about_ca_system_score_codex":0.00083952583,"about_ca_system_score_gemma":0.00083628885,"threshold_uncertainty_score":0.55640465},"labels":[],"label_agreement":null},{"id":"W4396587509","doi":"10.1158/1538-7445.sabcs23-po4-01-01","title":"Abstract PO4-01-01: Prognostic Impact of Adjuvant Trastuzumab for the Treatment of Localized Stage I Breast Cancer - Single Tertiary Center Experience","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Adjuvant; Cancer; Center (category theory); Biology","score_opus":0.059402594695119014,"score_gpt":0.4173113432547885,"score_spread":0.35790874855966953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580831,0.03678485,0.00009589236,0.0005202307,0.00019916764,0.0010526188,0.0031914904,0.000013072539,0.000059613034],"genre_scores_gemma":[0.9914606,0.0060236505,0.000023415401,0.000013602268,0.00027556546,0.0018319956,0.000071226525,0.000043526972,0.0002563669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998343,0.000057394518,0.00028560546,0.00047083458,0.00033133608,0.00051185605],"domain_scores_gemma":[0.9990344,0.00017290647,0.0000669694,0.00040019574,0.00023549129,0.00009002157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014915249,0.0002333576,0.0002867236,0.000079420046,0.0001238695,0.00003546634,0.00024939963,0.000082739025,0.00028158558],"category_scores_gemma":[0.000024803054,0.0001378081,0.0002883337,0.00021088768,0.00047031886,0.000010936116,0.00007371636,0.00008642044,0.000002046576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036935199,0.0019242981,0.09647039,0.0006954324,0.0027959403,0.000024761843,0.0040065725,0.0004839993,0.7644398,0.000019265435,0.0040977383,0.12134826],"study_design_scores_gemma":[0.004035992,0.002721056,0.4181794,0.0007295552,0.00020961044,0.000024288824,0.0015072648,0.00023954184,0.55131227,0.000027288952,0.020597652,0.0004161044],"about_ca_topic_score_codex":0.0046734414,"about_ca_topic_score_gemma":0.0007001825,"teacher_disagreement_score":0.321709,"about_ca_system_score_codex":0.0005006999,"about_ca_system_score_gemma":0.00057722017,"threshold_uncertainty_score":0.70648766},"labels":[],"label_agreement":null},{"id":"W4396587543","doi":"10.1158/1538-7445.sabcs23-po4-01-11","title":"Abstract PO4-01-11: Ovarian function suppression (OFS) use beyond five years?: Young breast cancer patient preferences","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Ovarian cancer; Cancer; Internal medicine; Gynecology","score_opus":0.07657311809511785,"score_gpt":0.3936742311747288,"score_spread":0.3171011130796109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863435,0.0043667825,0.000010345074,0.0018949935,0.0021115902,0.0007178764,0.0008206083,0.00012092703,0.0013225116],"genre_scores_gemma":[0.99204755,0.002665435,0.00001424587,0.00013049803,0.0010663777,0.00036055484,0.0000910272,0.000060257553,0.0035640728],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99711376,0.0000839552,0.00030590832,0.0006697794,0.0011630091,0.000663554],"domain_scores_gemma":[0.9987237,0.00014038714,0.00004912249,0.00040969782,0.00033266444,0.0003444598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035189968,0.00021530861,0.00028366168,0.000370863,0.00018881712,0.00030077028,0.0001572336,0.00019002492,0.0076726354],"category_scores_gemma":[0.00004109358,0.00016761033,0.0001249491,0.000679877,0.00017645459,0.00043875733,0.0001317052,0.00090428785,0.0001262977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003587296,0.00036061797,0.1466797,0.0011749078,0.0005675111,0.0004845678,0.0066584116,0.00015719116,0.05890885,0.00050367764,0.3189735,0.46194375],"study_design_scores_gemma":[0.00079136615,0.00029753742,0.8723445,0.0015984279,0.00010312599,0.000032654283,0.0008300869,0.00019165462,0.0028949005,0.00022580678,0.1204094,0.00028055842],"about_ca_topic_score_codex":0.05133436,"about_ca_topic_score_gemma":0.005879331,"teacher_disagreement_score":0.7256648,"about_ca_system_score_codex":0.00080138684,"about_ca_system_score_gemma":0.0010105866,"threshold_uncertainty_score":0.9932345},"labels":[],"label_agreement":null},{"id":"W4396587608","doi":"10.1158/1538-7445.sabcs23-po2-14-04","title":"Abstract PO2-14-04: Circulating tumor DNA after neoadjuvant chemotherapy is a better prognostic test than Residual Cancer Burden in patients with triple negative breast cancer and residual tumor","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Chemotherapy; Oncology; Internal medicine; Triple-negative breast cancer; Residual","score_opus":0.013973419633199074,"score_gpt":0.30207061397862295,"score_spread":0.28809719434542386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654664,0.006324231,0.0000018851556,0.0035268033,0.00018061732,0.0010409198,0.0022757612,0.000018216044,0.00008495241],"genre_scores_gemma":[0.9951543,0.0011208449,0.0000595808,0.00072807237,0.0012508074,0.0011917092,0.0000768087,0.00011546225,0.0003023795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971454,0.000065588545,0.00036228797,0.0009910804,0.00059176754,0.00084383634],"domain_scores_gemma":[0.9987267,0.00018713428,0.00008436589,0.00037645813,0.00040505937,0.0002202573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003604575,0.00034847748,0.00032024173,0.0002116732,0.00014686924,0.00026142923,0.00025614037,0.00013319457,0.000303573],"category_scores_gemma":[0.00013372298,0.00029700052,0.00006035585,0.0004396746,0.00031160808,0.000028247017,0.00020524976,0.0005475366,0.000009385422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024330863,0.00021809731,0.9109346,0.00054815,0.0003084885,0.00025405764,0.0020613754,0.0001344352,0.04922366,0.000006664603,0.011361183,0.022516174],"study_design_scores_gemma":[0.0029680724,0.00043759367,0.96852523,0.0011598028,0.00004274703,0.0000132227315,0.00019888705,0.00009072078,0.022644622,0.00009441459,0.003267553,0.00055713987],"about_ca_topic_score_codex":0.006616019,"about_ca_topic_score_gemma":0.00546975,"teacher_disagreement_score":0.057590596,"about_ca_system_score_codex":0.00033565538,"about_ca_system_score_gemma":0.0012134963,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W4396587616","doi":"10.1158/1538-7445.sabcs23-po3-23-02","title":"Abstract PO3-23-02: Delays in breast cancer surgery during the COVID-19 pandemic: A population-based analysis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Sinai Health System; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Mount Sinai Hospital; Health Sciences Centre","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Breast cancer; Cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Population; Internal medicine; Oncology; Surgery; General surgery; Virology; Disease; Outbreak; Environmental health; Infectious disease (medical specialty)","score_opus":0.26134234371125803,"score_gpt":0.5354025660967857,"score_spread":0.2740602223855277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91746265,0.005777026,0.000021318512,0.07565884,0.00015790827,0.00051840086,0.00025524932,0.00010099191,0.00004760791],"genre_scores_gemma":[0.9934255,0.0019560675,0.0000027743533,0.003174887,0.0005453323,0.00035395855,0.00007215428,0.000038677255,0.0004306723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969351,0.0002418869,0.00044553052,0.00053324096,0.0010160954,0.0008281191],"domain_scores_gemma":[0.99621874,0.0023965223,0.00004988585,0.000489869,0.00023210215,0.0006129027],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028288397,0.00017237668,0.00043560477,0.0015935049,0.00029620397,0.00011918012,0.00017334333,0.000153076,0.0023085235],"category_scores_gemma":[0.00068493193,0.000121514946,0.00024355383,0.0039975164,0.00011382323,0.000113058246,0.00005281635,0.0010899273,0.00003634985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005060742,0.00003825778,0.98471594,0.0018068079,0.00022081369,0.00030774772,0.0004686006,0.002932739,0.0009820429,0.000014338595,0.0027731683,0.005233491],"study_design_scores_gemma":[0.00041140258,0.000010654608,0.99249035,0.00045356288,0.00010541206,0.000022992439,0.00011324766,0.0015021358,0.000051696792,0.000049296996,0.0046598227,0.00012940356],"about_ca_topic_score_codex":0.22120671,"about_ca_topic_score_gemma":0.0789004,"teacher_disagreement_score":0.14230631,"about_ca_system_score_codex":0.0048864232,"about_ca_system_score_gemma":0.007925616,"threshold_uncertainty_score":0.9989336},"labels":[],"label_agreement":null},{"id":"W4396587639","doi":"10.1158/1538-7445.sabcs23-po2-20-04","title":"Abstract PO2-20-04: TACTIVE-U: phase 1b/2 umbrella study of vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, combined with other anticancer treatments in ER–positive advanced or metastatic breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chimera (genetics); Proteolysis; Estrogen receptor; Medicine; Cancer research; Estrogen; Internal medicine; Chemistry; Cancer; Biochemistry; Breast cancer","score_opus":0.06529943656489028,"score_gpt":0.4349569742338259,"score_spread":0.3696575376689356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97742414,0.011829147,0.000071099836,0.0011211316,0.00015008972,0.0079134125,0.0012387831,0.00012435859,0.00012784252],"genre_scores_gemma":[0.9892557,0.0011534163,0.0010428561,0.000060013273,0.00022620217,0.0071145664,0.000057770747,0.000260411,0.00082906295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994407,0.00040960844,0.00086201285,0.0013892243,0.0016250759,0.0013070969],"domain_scores_gemma":[0.99754703,0.00041388816,0.00026386324,0.00065714814,0.00072509155,0.00039300247],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007066581,0.0006933752,0.0013210921,0.0008143085,0.00022503329,0.00008974851,0.00036788167,0.0001249557,0.0018701869],"category_scores_gemma":[0.00006413538,0.0004884922,0.00017642207,0.0027375922,0.0005374353,0.0005848879,0.00008992331,0.0012332385,0.000023770497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10426983,0.016880339,0.02312871,0.0028848592,0.007917482,0.0013907608,0.014596216,0.0008993165,0.5770343,0.000058072397,0.00014240087,0.2507977],"study_design_scores_gemma":[0.21833114,0.041834064,0.087135665,0.032539647,0.0038871968,0.00047254117,0.042039663,0.0014846257,0.5626794,0.00031090018,0.0053522857,0.0039328383],"about_ca_topic_score_codex":0.0053410283,"about_ca_topic_score_gemma":0.0012646654,"teacher_disagreement_score":0.24686486,"about_ca_system_score_codex":0.0018497074,"about_ca_system_score_gemma":0.0021493216,"threshold_uncertainty_score":0.9997567},"labels":[],"label_agreement":null},{"id":"W4396587707","doi":"10.1158/1538-7445.sabcs23-po2-17-01","title":"Abstract PO2-17-01: Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2– advanced breast cancer: Final analysis of TreatER+ight, a Canadian prospective, real-world, observational study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); McGill University Health Centre; Jewish General Hospital; BC Cancer Agency; Ottawa Hospital; Windsor Regional Hospital; London Health Sciences Centre; Grand River Hospital; Saskatchewan Cancer Agency","funders":"","keywords":"Cancer; Medicine; Breast cancer; Oncology; Duration (music); Internal medicine; Prospective cohort study; Art","score_opus":0.06125053355173842,"score_gpt":0.4109199862730255,"score_spread":0.3496694527212871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590456,0.00023272302,8.238084e-7,0.0010199476,0.00008893922,0.0017862478,0.0008357267,0.000012518624,0.00011848938],"genre_scores_gemma":[0.99870515,0.000088669345,0.000018316025,0.0000059770473,0.00017890017,0.0004670296,0.000101871476,0.00003357507,0.00040054106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975367,0.0001131578,0.0005289762,0.0004979949,0.0009494003,0.00037375555],"domain_scores_gemma":[0.99830633,0.00008886677,0.00019613536,0.00046650151,0.0008127735,0.00012936586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002959682,0.00023440778,0.0005789447,0.0014317088,0.000082844956,0.000015717504,0.00013140943,0.000053176074,0.00045993607],"category_scores_gemma":[0.00002776856,0.00013954002,0.00018012497,0.004247064,0.00022145468,0.00021171037,0.000020698251,0.00029484503,7.695993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005888198,0.0008251088,0.956666,0.00010173629,0.0018690504,0.000006710929,0.0017146971,0.012071075,0.0024228822,0.000039014452,0.000056659173,0.018338855],"study_design_scores_gemma":[0.0027293016,0.0017574605,0.99047816,0.0004451562,0.0003096614,8.6240067e-7,0.0002981282,0.00010207216,0.0036870209,0.000022046597,0.00006308984,0.00010702093],"about_ca_topic_score_codex":0.32590395,"about_ca_topic_score_gemma":0.50189704,"teacher_disagreement_score":0.17599308,"about_ca_system_score_codex":0.006799143,"about_ca_system_score_gemma":0.002382367,"threshold_uncertainty_score":0.99701357},"labels":[],"label_agreement":null},{"id":"W4396587723","doi":"10.1158/1538-7445.sabcs23-po2-18-09","title":"Abstract PO2-18-09: A phase 3 randomized open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy in patients with ER+/HER2– early breast cancer and an intermediate or high risk of recurrence (CAMBRIA 1)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cancer; Breast cancer; Endocrine system; Adjuvant; Oncology; Adjuvant therapy; Internal medicine; Open label; Randomized controlled trial; Hormone","score_opus":0.05914551455094619,"score_gpt":0.438484531426877,"score_spread":0.3793390168759308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863188,0.005053802,0.000027345177,0.0002490781,0.00013689646,0.0067085717,0.0014480328,0.00003974664,0.000017672794],"genre_scores_gemma":[0.98001534,0.017671822,0.00021100683,0.000024587294,0.000107952714,0.0017539556,0.00002740433,0.000115664516,0.00007229832],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956688,0.0005873807,0.00079000543,0.00094199454,0.0013050704,0.0007066949],"domain_scores_gemma":[0.99708325,0.000463589,0.00031256312,0.00069271,0.0011471251,0.00030076952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014718818,0.00045733593,0.0016761941,0.00052268396,0.00010016516,0.00010974224,0.00048033384,0.00006640526,0.00044686126],"category_scores_gemma":[0.000059023212,0.00025779274,0.000049635404,0.0010637427,0.0009812282,0.0005950265,0.00010885341,0.00091635284,7.545378e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61380863,0.0036789319,0.033564962,0.00020754046,0.0009486159,0.00012744596,0.0038457788,0.000015059585,0.0012651719,0.000013650869,0.000009526526,0.34251466],"study_design_scores_gemma":[0.6088233,0.022571733,0.36131474,0.0028675762,0.0001271362,0.000016148066,0.0010119645,0.00007300365,0.0026658396,0.00012005708,0.00007318307,0.00033534045],"about_ca_topic_score_codex":0.031290416,"about_ca_topic_score_gemma":0.0054645236,"teacher_disagreement_score":0.34217933,"about_ca_system_score_codex":0.0003688586,"about_ca_system_score_gemma":0.0017899491,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W4396587769","doi":"10.1158/1538-7445.sabcs23-po3-28-01","title":"Abstract PO3-28-01: More Than a Diagnosis: An Untold Story of Quality of Life","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada)","funders":"","keywords":"History; Quality (philosophy); Medicine; Gerontology; Philosophy; Epistemology","score_opus":0.19234373520255357,"score_gpt":0.48679282070190966,"score_spread":0.2944490854993561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96169734,0.031955354,0.000044938857,0.002973472,0.00010082735,0.00036229758,0.00009462072,0.000051803465,0.002719358],"genre_scores_gemma":[0.99791616,0.0012579253,0.000021012222,0.00005871808,0.0001930817,0.00026558363,0.000021943233,0.000023546936,0.00024202139],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99810654,0.00021766526,0.00028519015,0.00029746725,0.00084748515,0.0002456337],"domain_scores_gemma":[0.9982102,0.00040809787,0.000035196037,0.00072424335,0.00038850584,0.00023378574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020416672,0.00008521478,0.00032908184,0.00027349635,0.000071167735,0.000017996908,0.0001800334,0.00009674903,0.0004049979],"category_scores_gemma":[0.00044812888,0.00007490732,0.00026935854,0.00062014326,0.00024536785,0.00008037075,0.0000673763,0.0006772991,0.000025221916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028676614,0.0039801993,0.26948747,0.020928804,0.009614016,0.00022437566,0.020462926,0.002173675,0.3826782,0.041099247,0.109549575,0.13693385],"study_design_scores_gemma":[0.0008874509,0.00016325816,0.97687244,0.0011174232,0.000120583565,0.0000054258603,0.0017169708,0.00009097182,0.011130138,0.00039930947,0.0073624076,0.00013363764],"about_ca_topic_score_codex":0.0046231737,"about_ca_topic_score_gemma":0.00023194963,"teacher_disagreement_score":0.70738494,"about_ca_system_score_codex":0.000156737,"about_ca_system_score_gemma":0.000909469,"threshold_uncertainty_score":0.69888866},"labels":[],"label_agreement":null},{"id":"W4396587780","doi":"10.1158/1538-7445.sabcs23-po3-02-05","title":"Abstract PO3-02-05: Racial and Ethnic Differences in Clinical Outcomes among North American Patients with Hormone Receptor-Positive, HER2-negative, Early Breast Cancer in the PALLAS Trial (AFT-05)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Medicine; Hormone receptor; Internal medicine; Oncology; Ethnic group; Cancer; Hormone; Clinical trial; Demography; Gynecology","score_opus":0.06929292016749988,"score_gpt":0.42962184328080993,"score_spread":0.36032892311331005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313414,0.0015795536,0.0000035092207,0.0023795313,0.00031242703,0.0020733392,0.00038510654,0.00004561763,0.00008676599],"genre_scores_gemma":[0.99547154,0.0024996144,0.00003744311,0.00020873743,0.00058381277,0.00095363945,0.000020655885,0.000068222085,0.00015632348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955031,0.0006510654,0.00068846234,0.00088049594,0.0013817593,0.00089510373],"domain_scores_gemma":[0.9972924,0.001563257,0.00015314312,0.00039359237,0.00033001072,0.0002676151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011542573,0.00037080227,0.00084541674,0.00042145682,0.0001441021,0.00013446345,0.00036491101,0.0001303789,0.00016754102],"category_scores_gemma":[0.0001932744,0.00022519525,0.00011975258,0.0018710591,0.0019861436,0.00035152477,0.000120166995,0.0021470876,0.00001138613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030435052,0.00029868932,0.8134285,0.00006209356,0.00019504665,0.00008638094,0.0031253705,0.0000042359347,0.000024782305,0.0000070465435,0.00010451897,0.15222828],"study_design_scores_gemma":[0.01948381,0.0015250068,0.9770111,0.0005846834,0.00003648698,0.0000029585556,0.0008699107,0.00001038424,0.000013833621,0.00003592924,0.00016189113,0.00026404476],"about_ca_topic_score_codex":0.026069967,"about_ca_topic_score_gemma":0.0662224,"teacher_disagreement_score":0.16358256,"about_ca_system_score_codex":0.00060390285,"about_ca_system_score_gemma":0.0007057202,"threshold_uncertainty_score":0.9804155},"labels":[],"label_agreement":null},{"id":"W4396587819","doi":"10.1158/1538-7445.sabcs23-po3-16-12","title":"Abstract PO3-16-12: European real-world experience of patients with HER2+ advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: first interim analysis of EUROPA T-DXd","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Interim; Oncology; Breast cancer; Cancer; Interim analysis; Internal medicine; Clinical trial; Political science","score_opus":0.09008420133693715,"score_gpt":0.4725778209887704,"score_spread":0.38249361965183326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925099,0.0020863428,0.000028011653,0.00043899813,0.00021460837,0.0013423564,0.00053412956,0.000078251855,0.002767412],"genre_scores_gemma":[0.9968614,0.0014293883,0.00025494825,0.000061236846,0.00008234494,0.00071907346,0.00012317188,0.000083415856,0.00038499362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996724,0.00022204072,0.0006656369,0.0007159646,0.0010050918,0.0006672293],"domain_scores_gemma":[0.99823254,0.00020769252,0.0002299353,0.00044433112,0.0006579917,0.00022752509],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027350846,0.00031266507,0.0007463513,0.0007748593,0.0001451689,0.000069822294,0.00029410786,0.000035364264,0.0021937017],"category_scores_gemma":[0.00002423714,0.00023287165,0.00020835128,0.003193077,0.0006349585,0.0003084303,0.00014139993,0.00047741408,0.000004947603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007866776,0.004043796,0.2639862,0.0030546172,0.0059968424,0.00044417614,0.02151071,0.000816702,0.0075831986,0.000021440652,0.0015964864,0.68307906],"study_design_scores_gemma":[0.0045185396,0.0032891189,0.95990247,0.0037443622,0.0024566846,0.000008259164,0.0019377044,0.0003782515,0.012776545,0.000017957656,0.01048438,0.00048575804],"about_ca_topic_score_codex":0.008896042,"about_ca_topic_score_gemma":0.008164751,"teacher_disagreement_score":0.69591624,"about_ca_system_score_codex":0.0011413494,"about_ca_system_score_gemma":0.00065907807,"threshold_uncertainty_score":0.99871844},"labels":[],"label_agreement":null},{"id":"W4396587839","doi":"10.1158/1538-7445.sabcs23-po3-15-04","title":"Abstract PO3-15-04: Oncotype DX Recurrence Score as an Informative Tool to Optimize Neoadjuvant Therapy in HR-positive, HER2-negative Breast Cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; HER2 negative; Gynecology; Cancer; Metastatic breast cancer","score_opus":0.04410454100374414,"score_gpt":0.3968007927289976,"score_spread":0.35269625172525343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037343,0.0035818026,0.000024029245,0.0014865197,0.00031776927,0.0009929959,0.00049406354,0.00003389405,0.0026955116],"genre_scores_gemma":[0.9927638,0.0049055154,0.00024438396,0.0003849161,0.00033453782,0.0009591777,0.00011714058,0.00004934603,0.00024113613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974622,0.00015431961,0.00030628225,0.00077998976,0.0005359607,0.00076122634],"domain_scores_gemma":[0.9987035,0.000100002544,0.000049113394,0.0004371059,0.00048574162,0.00022458556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004972384,0.00032340593,0.0002953451,0.00024785812,0.00019805379,0.00018330837,0.0004309005,0.00016032695,0.0002720152],"category_scores_gemma":[0.00008670639,0.00027839065,0.000087238,0.0007832171,0.00031764383,0.00007126776,0.00023486474,0.0005269748,0.00009352845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012949037,0.0006029873,0.013348898,0.00035325563,0.0014326574,0.00035654093,0.035526533,0.0046119955,0.08243318,0.000359255,0.018068645,0.829957],"study_design_scores_gemma":[0.0054833894,0.0046036732,0.6605438,0.0032961948,0.00004375313,0.0001255576,0.009101668,0.00026270235,0.29649612,0.00068422116,0.017367521,0.0019913567],"about_ca_topic_score_codex":0.018321866,"about_ca_topic_score_gemma":0.007133926,"teacher_disagreement_score":0.8279657,"about_ca_system_score_codex":0.00093236397,"about_ca_system_score_gemma":0.0016204998,"threshold_uncertainty_score":0.9999668},"labels":[],"label_agreement":null},{"id":"W4396587900","doi":"10.1158/1538-7445.sabcs23-po3-03-09","title":"Abstract PO3-03-09: Clinical Significance of Grade in Triple Negative Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Triple-negative breast cancer; Medicine; Breast cancer; Cancer; Triple negative; Internal medicine; Oncology; Clinical significance","score_opus":0.09856599263974057,"score_gpt":0.46368499536895214,"score_spread":0.36511900272921155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97570205,0.018096345,0.000008713732,0.0030318613,0.0006035428,0.000570858,0.00081977464,0.000020195132,0.0011466378],"genre_scores_gemma":[0.9892947,0.008502053,0.000039478553,0.00005830415,0.00073913403,0.00064978254,0.000023488286,0.00003952527,0.00065354723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99777186,0.0001944675,0.0004163402,0.0006871859,0.00040501505,0.00052516005],"domain_scores_gemma":[0.9990245,0.00019481748,0.00005825175,0.00035428748,0.00024935522,0.000118756136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000778276,0.00018809429,0.0003147418,0.00015254767,0.00007327987,0.000032264717,0.0003058982,0.00016754922,0.00028761005],"category_scores_gemma":[0.00010794863,0.00016258986,0.00014368785,0.00058876234,0.00055890525,0.000011119987,0.00017558523,0.00046891652,0.000026912763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037346906,0.0012694667,0.26738745,0.0012973809,0.0017976066,0.00021280063,0.0016483485,0.00035197777,0.4292536,0.00064408145,0.09047563,0.20192696],"study_design_scores_gemma":[0.002256558,0.00023309984,0.8291326,0.0006996414,0.00004200712,0.000010594104,0.00058877695,0.000040823707,0.14980294,0.0005709704,0.016218713,0.00040323287],"about_ca_topic_score_codex":0.006928412,"about_ca_topic_score_gemma":0.0043361266,"teacher_disagreement_score":0.56174517,"about_ca_system_score_codex":0.00022440251,"about_ca_system_score_gemma":0.0009373119,"threshold_uncertainty_score":0.9996845},"labels":[],"label_agreement":null},{"id":"W4396587921","doi":"10.1158/1538-7445.sabcs23-po2-23-07","title":"Abstract PO2-23-07: Three-dimensional navigated mass spectrometry for intraoperative margin assessment during breast cancer surgery","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; University of Manitoba; Queen's University","funders":"","keywords":"Medicine; Breast-conserving surgery; Breast cancer; Margin (machine learning); Cancer; Internal medicine; Mastectomy; Computer science","score_opus":0.04989357980425456,"score_gpt":0.40759763358655465,"score_spread":0.3577040537823001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97647893,0.003254531,0.00034842687,0.008459926,0.00031689423,0.0007889282,0.0034319137,0.0005348569,0.0063855657],"genre_scores_gemma":[0.98911536,0.0007773233,0.0011286378,0.000027061795,0.001012144,0.0034311342,0.0002254844,0.00010007126,0.0041827573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701184,0.000029155914,0.00040322758,0.0008215717,0.00082109513,0.0009131007],"domain_scores_gemma":[0.99827373,0.0005727638,0.000060892853,0.00047124873,0.00038922828,0.0002321341],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000756287,0.0002771208,0.0003472988,0.00036950706,0.0004116346,0.00028433168,0.00036829992,0.00019213303,0.036515765],"category_scores_gemma":[0.000027899781,0.0002518634,0.00020081413,0.0010825408,0.00019007038,0.00017777456,0.00013677543,0.0011847515,0.00006499075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113069524,0.0001181382,0.0036533894,0.0011263961,0.00024098979,0.000064488355,0.000026441829,0.00004860079,0.96210426,0.0041254084,0.025658123,0.0027207134],"study_design_scores_gemma":[0.0006732128,0.000039207767,0.03718934,0.0022422138,0.00006612224,0.00007075008,0.00013690541,0.003551595,0.9236575,0.009623752,0.021737099,0.0010123135],"about_ca_topic_score_codex":0.0011359432,"about_ca_topic_score_gemma":0.00019321206,"teacher_disagreement_score":0.03844675,"about_ca_system_score_codex":0.001800396,"about_ca_system_score_gemma":0.0010298535,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4396587962","doi":"10.1158/1538-7445.sabcs23-po3-16-11","title":"Abstract PO3-16-11: Attrition rates from first- to third-line therapy in HER2+ metastatic breast cancer in Europe","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Metastatic breast cancer; Medicine; Cancer; Breast cancer; Attrition; Oncology; Internal medicine","score_opus":0.1729663906008388,"score_gpt":0.5016200254026022,"score_spread":0.3286536348017634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93453413,0.02480712,0.0000024884507,0.038099915,0.00040456446,0.0010448474,0.0005194011,0.00004763618,0.0005398723],"genre_scores_gemma":[0.97592956,0.019533306,0.000021900409,0.00072994444,0.0006630846,0.0010548322,0.00008427656,0.00005281368,0.0019302933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799716,0.00015753144,0.00031055819,0.0005312641,0.00044173154,0.00056175195],"domain_scores_gemma":[0.99899846,0.00034025498,0.00002119596,0.00021105516,0.00022966987,0.00019937864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005705109,0.00018910867,0.00036137577,0.00056868466,0.000058455254,0.00006705912,0.00015121704,0.00006919452,0.0085534],"category_scores_gemma":[0.00003547278,0.00015317375,0.000057130346,0.0018663219,0.00008689111,0.00013074711,0.000052434196,0.0006247325,0.0001976044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012569304,0.0027136235,0.2786969,0.0014245387,0.00097599963,0.0047046663,0.0065618935,0.0011311413,0.26117787,0.00015366737,0.15886112,0.27102926],"study_design_scores_gemma":[0.008472392,0.00083365577,0.82633936,0.0028450263,0.00008023047,0.00002581173,0.0003223597,0.000464616,0.02986946,0.0004400008,0.12990339,0.00040368756],"about_ca_topic_score_codex":0.065024704,"about_ca_topic_score_gemma":0.058345016,"teacher_disagreement_score":0.54764247,"about_ca_system_score_codex":0.0012502599,"about_ca_system_score_gemma":0.00079912797,"threshold_uncertainty_score":0.9923529},"labels":[],"label_agreement":null},{"id":"W4396588053","doi":"10.1158/1538-7445.sabcs23-po2-08-07","title":"Abstract PO2-08-07: Evaluating chemotherapy receipt and candidacy for PARP inhibitors in germline BRCA1/2 carriers with early and locally advanced breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Candidacy; Germline; Oncology; Medicine; Receipt; Breast cancer; Internal medicine; Chemotherapy; Cancer; Biology; Genetics; Political science","score_opus":0.030620423048100576,"score_gpt":0.4033620712767669,"score_spread":0.3727416482286663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973427,0.023127383,0.000080491365,0.001972738,0.00016703343,0.00081227673,0.00029398163,0.00001536094,0.0001037408],"genre_scores_gemma":[0.9927319,0.004565539,0.00047317834,0.00013190824,0.00046963256,0.0011058032,0.000031138406,0.00007163132,0.00041923678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981868,0.00006049034,0.00022929905,0.0006951005,0.00032638022,0.0005018748],"domain_scores_gemma":[0.9991858,0.000073653806,0.0000421103,0.0002347565,0.0003160745,0.00014760034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075398333,0.00019018579,0.0001826746,0.00014684965,0.00014401005,0.00012665395,0.00013696292,0.00014618401,0.00010089621],"category_scores_gemma":[0.00005516792,0.00016717825,0.00003320189,0.00034420716,0.0003039246,0.000021291455,0.00006986095,0.00031049884,0.0000016637844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016774212,0.000029621482,0.011527433,0.00046985623,0.00019101931,0.000012775076,0.0013285112,0.0010342804,0.61524886,0.000024405916,0.0034526237,0.3650032],"study_design_scores_gemma":[0.017482087,0.003138687,0.28102577,0.0043025124,0.00013976586,0.00014540294,0.0028834578,0.0040415465,0.552493,0.0009964947,0.13091569,0.0024356071],"about_ca_topic_score_codex":0.0014474264,"about_ca_topic_score_gemma":0.0031154621,"teacher_disagreement_score":0.36256757,"about_ca_system_score_codex":0.0003765561,"about_ca_system_score_gemma":0.0015534648,"threshold_uncertainty_score":0.68173313},"labels":[],"label_agreement":null},{"id":"W4396588160","doi":"10.1158/1538-7445.sabcs23-po1-11-02","title":"Abstract PO1-11-02: Reporting of Post-protocol Therapies in Metastatic Breast Cancer Registration Clinical Trials: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Metastatic breast cancer; Protocol (science); Breast cancer; Oncology; Cancer; Medical physics; Internal medicine; Alternative medicine; Pathology","score_opus":0.6962956463772917,"score_gpt":0.7109323885794232,"score_spread":0.014636742202131514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022803279,0.8461721,3.187819e-7,0.0016767166,0.00030799038,0.15123193,0.0003633169,0.000031736075,0.00019310234],"genre_scores_gemma":[0.00003460833,0.7064957,0.000012723896,0.00010573289,0.00048341157,0.29158297,0.00008038939,0.0000758381,0.0011286142],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98189384,0.0048433496,0.010560108,0.0009131791,0.0011757895,0.0006137087],"domain_scores_gemma":[0.9889576,0.0030397717,0.0059338985,0.0008490161,0.0009852541,0.00023448766],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.038948916,0.0005442706,0.00992338,0.0007135439,0.00006101715,0.000059527396,0.00035373398,0.0003271995,0.0019895148],"category_scores_gemma":[0.0068218815,0.0003239395,0.0016642556,0.0014711173,0.00027275336,0.00009532549,0.000103715865,0.0018464453,0.000055446944],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002329331,0.00028474286,0.00003280401,0.8448023,0.0018874318,0.00042800055,0.00007547094,1.3378653e-7,0.000013548863,0.000017366432,0.0086844,0.14354086],"study_design_scores_gemma":[0.0012116452,0.00026153668,0.000054409673,0.85617113,0.010356158,0.00023122708,0.00006606155,0.0000022962818,0.00000406068,0.000024724997,0.1313893,0.00022746154],"about_ca_topic_score_codex":0.0032049506,"about_ca_topic_score_gemma":0.0012656233,"teacher_disagreement_score":0.1433134,"about_ca_system_score_codex":0.0012986389,"about_ca_system_score_gemma":0.008284627,"threshold_uncertainty_score":0.99992126},"labels":[],"label_agreement":null},{"id":"W4396588255","doi":"10.1158/1538-7445.sabcs23-gs01-10","title":"Abstract GS01-10: HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Trastuzumab emtansine; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Trastuzumab; Cancer; Double blind; Randomized controlled trial; Pathology; Alternative medicine","score_opus":0.1888228164544587,"score_gpt":0.5289525704182272,"score_spread":0.3401297539637685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401313,0.028031407,0.00008443317,0.007443706,0.0005031127,0.01891281,0.0025387844,0.00011956886,0.0022348608],"genre_scores_gemma":[0.9688291,0.010625791,0.00015301014,0.000066630746,0.0012199065,0.01115921,0.0002040897,0.00019922915,0.007543057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938933,0.00060090877,0.0011639175,0.0011463726,0.0018368092,0.0013586659],"domain_scores_gemma":[0.9935009,0.0032467528,0.00016694573,0.00064744597,0.0017306801,0.00070730835],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0058243917,0.0004796271,0.0017509431,0.00088934513,0.00023182387,0.00024379829,0.00035614145,0.0002232272,0.004701992],"category_scores_gemma":[0.00061492005,0.00036798345,0.00045289838,0.0015800674,0.001317776,0.00025212544,0.000121919285,0.0011769526,0.000037151516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90505093,0.0011643476,0.000023737617,0.004983843,0.0017155894,0.00020926948,0.0015609664,0.000012031823,0.009031756,0.00016749183,0.010962778,0.06511723],"study_design_scores_gemma":[0.95806503,0.0036570025,0.00012626174,0.0047951555,0.0009552456,0.00010654718,0.00044466255,0.00084058515,0.024994938,0.00019810324,0.005405298,0.00041116256],"about_ca_topic_score_codex":0.0070491955,"about_ca_topic_score_gemma":0.0009949997,"teacher_disagreement_score":0.06470607,"about_ca_system_score_codex":0.0012107394,"about_ca_system_score_gemma":0.005375626,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W4396588318","doi":"10.1158/1538-7445.sabcs23-po2-03-08","title":"Abstract PO2-03-08: Uncovering Novel Potential Prognostic Biomarkers in Basal-Like Breast Cancer using Transcriptomic Data of 1,899 Patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Canadian Navy","funders":"","keywords":"Breast cancer; Transcriptome; Basal (medicine); Medicine; Cancer; Oncology; Internal medicine; Computational biology; Biology; Genetics; Gene; Gene expression","score_opus":0.0731588741731784,"score_gpt":0.3836798850369904,"score_spread":0.310521010863812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98616916,0.00876975,0.00009624594,0.00033424646,0.0006611583,0.00045737895,0.003422075,0.000013773819,0.00007621227],"genre_scores_gemma":[0.9978061,0.0013072488,0.000099052966,0.000029447336,0.0002648028,0.0001163522,0.00028959187,0.000056624798,0.000030831947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978083,0.000056725024,0.0003095164,0.00077380275,0.00047880824,0.00057287863],"domain_scores_gemma":[0.9990894,0.00003471451,0.000047680805,0.0005276083,0.00020800676,0.000092596776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003714837,0.0002167106,0.00022776776,0.00021933475,0.00009368353,0.000055719396,0.00048582786,0.00012552402,0.0001005641],"category_scores_gemma":[0.00003473378,0.00020217082,0.00007414965,0.00047859858,0.00024226421,0.00003156552,0.000394391,0.00023999739,0.000005447236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009763138,0.00037317438,0.1084244,0.00079039135,0.0010336913,0.000031940803,0.00020878384,0.0009601356,0.87133974,0.000004762778,0.0025432778,0.013313395],"study_design_scores_gemma":[0.0046613235,0.00017253992,0.9179614,0.0023485061,0.00022613596,0.000022096347,0.0004039995,0.0020909028,0.06747189,0.000044849538,0.003810659,0.0007856539],"about_ca_topic_score_codex":0.008817846,"about_ca_topic_score_gemma":0.0022544616,"teacher_disagreement_score":0.80953705,"about_ca_system_score_codex":0.00033509865,"about_ca_system_score_gemma":0.0007811585,"threshold_uncertainty_score":0.9977825},"labels":[],"label_agreement":null},{"id":"W4396588374","doi":"10.1158/1538-7445.sabcs23-gs02-13","title":"Abstract GS02-13: Pregnancy after breast cancer in young women with germline BRCA pathogenic variants: results from an international cohort study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Germline; Breast cancer; Gynecology; Pregnancy; Cancer; Cohort; Obstetrics; Oncology; Internal medicine; Genetics; Biology; Gene","score_opus":0.035420269879506416,"score_gpt":0.40026845754889734,"score_spread":0.3648481876693909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991704,0.0023787373,0.0000037317163,0.0011666067,0.00074599666,0.001411698,0.0034128588,0.00007322868,0.00089008996],"genre_scores_gemma":[0.9926182,0.0023923921,0.0000105134,0.000049803315,0.0010222298,0.002264794,0.00011260211,0.000079114194,0.0014503569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963571,0.00010880016,0.00047650034,0.0010331998,0.0013132807,0.00071111444],"domain_scores_gemma":[0.9985169,0.00009256837,0.000052918134,0.0006413285,0.00036045632,0.00033580072],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087760563,0.00024906255,0.00038800866,0.00044627237,0.00007041687,0.00020210457,0.00031410105,0.00011485445,0.0050054807],"category_scores_gemma":[0.000033336823,0.00018897938,0.000050431172,0.0007643607,0.00016448893,0.00044505775,0.00012155188,0.0010056762,0.000041932584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008006421,0.000640472,0.9463789,0.00009501832,0.00054131285,0.0018414933,0.0071174414,0.000055647015,0.0024075578,0.0000041374105,0.000308382,0.032603234],"study_design_scores_gemma":[0.0032113686,0.00037106237,0.9922779,0.0019705677,0.000048172595,0.00002392972,0.00094644795,0.000199677,0.00005075468,0.000027569744,0.0006509685,0.00022157255],"about_ca_topic_score_codex":0.06179729,"about_ca_topic_score_gemma":0.04426032,"teacher_disagreement_score":0.045899022,"about_ca_system_score_codex":0.00208413,"about_ca_system_score_gemma":0.0012334383,"threshold_uncertainty_score":0.9959041},"labels":[],"label_agreement":null},{"id":"W4396590496","doi":"10.1158/1538-7445.sabcs23-po3-11-12","title":"Abstract PO3-11-12: A Pragmatic Randomized Trial Comparing Morning versus Evening Dosing of Endocrine Therapy for Early Breast Cancer: Final Results (REaCT-CHRONO Study)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; NOSM University; Ottawa Hospital","funders":"","keywords":"Evening; Morning; Medicine; Dosing; Endocrine system; Breast cancer; Randomized controlled trial; Cancer; Internal medicine; Oncology; Hormone","score_opus":0.10645048094598147,"score_gpt":0.4321037887125466,"score_spread":0.32565330776656515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861529,0.008863956,0.00005239926,0.0005933805,0.00071126857,0.0029127565,0.00031695084,0.00003425412,0.00036212782],"genre_scores_gemma":[0.994001,0.0014800746,0.00010755119,0.0000075781336,0.0011643437,0.0029346782,0.00007894076,0.00006254883,0.0001633376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718755,0.0002971799,0.00060808874,0.00071289676,0.0005413916,0.00065286754],"domain_scores_gemma":[0.99819547,0.00081024336,0.00016782175,0.00038715854,0.00033850552,0.00010078647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016832858,0.00029199544,0.00070137717,0.00020000925,0.00027249666,0.00011684141,0.0003027181,0.00008259613,0.000037225534],"category_scores_gemma":[0.00028504696,0.0002415977,0.00027007103,0.00027582468,0.00026558974,0.000021381786,0.00017697076,0.0002996913,0.000002398312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.939123,0.00035177928,0.0015588995,0.0002478257,0.0018638166,0.000018572795,0.0015047704,0.0003661276,0.03495925,0.000026196927,0.0009146272,0.019065166],"study_design_scores_gemma":[0.95862806,0.0013562584,0.010639139,0.000861062,0.00023453674,0.000009497525,0.0006878198,0.000330886,0.02462791,0.000038037688,0.0021807356,0.00040603356],"about_ca_topic_score_codex":0.005746149,"about_ca_topic_score_gemma":0.001231178,"teacher_disagreement_score":0.019505115,"about_ca_system_score_codex":0.00028269354,"about_ca_system_score_gemma":0.00068360486,"threshold_uncertainty_score":0.98520684},"labels":[],"label_agreement":null},{"id":"W4396590520","doi":"10.1158/1538-7445.sabcs23-po3-18-01","title":"Abstract PO3-18-01: Cirrhosis is associated with worse post-operative survival among patients with breast cancer: a population-based study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Cancer; Oncology; Population; Cirrhosis; Gastroenterology; Environmental health","score_opus":0.09609757875024172,"score_gpt":0.3708522832413041,"score_spread":0.2747547044910624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993807,0.0005105286,0.000001536925,0.0016233639,0.000112224254,0.0026765654,0.0008122299,0.000121164965,0.00033538704],"genre_scores_gemma":[0.99711484,0.000025136693,0.000009745339,0.00009343374,0.00014058636,0.0012367632,0.00048172293,0.00009926776,0.00079847756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964532,0.0002636085,0.0002817034,0.00072465785,0.0016040156,0.0006728184],"domain_scores_gemma":[0.9977028,0.00027870532,0.000062668776,0.00036651653,0.0012514236,0.00033792277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005743093,0.00032099962,0.0004659756,0.00041409067,0.00032218848,0.00020763627,0.00014622288,0.00012205618,0.0034960122],"category_scores_gemma":[0.000051447405,0.0002118967,0.00009797869,0.0014471851,0.00012947655,0.00023582611,0.00004084146,0.00067261263,0.000040727355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014342865,0.0010154519,0.9902387,0.00012067416,0.001105087,0.0004062022,0.0014508793,0.000012957524,0.00006548384,0.0000020534942,0.00053507765,0.0036131153],"study_design_scores_gemma":[0.0036105944,0.0014101502,0.99198216,0.0011684375,0.00031474337,9.3854095e-7,0.0005186176,0.0004088687,0.00027240755,0.0000018563379,0.000053447282,0.00025776261],"about_ca_topic_score_codex":0.029983781,"about_ca_topic_score_gemma":0.011354368,"teacher_disagreement_score":0.018629413,"about_ca_system_score_codex":0.001231016,"about_ca_system_score_gemma":0.0011850208,"threshold_uncertainty_score":0.99741495},"labels":[],"label_agreement":null},{"id":"W4396590541","doi":"10.1158/1538-7445.sabcs23-gs01-02","title":"Abstract GS01-02: Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer: KEYNOTE-756","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Placebo; Oncology; Breast cancer; Adjuvant; Internal medicine; Chemotherapy; Cancer; Stage (stratigraphy); Immunotherapy; Pathology","score_opus":0.056719152750950644,"score_gpt":0.4144835822188015,"score_spread":0.35776442946785086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95801944,0.02025519,0.00014683045,0.0027719883,0.0012530071,0.011234098,0.005757159,0.00034091822,0.00022139546],"genre_scores_gemma":[0.93676066,0.033744212,0.000056298275,0.00028679168,0.0011577836,0.005506496,0.00017006128,0.00043228554,0.021885412],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9912776,0.00046713577,0.0015844546,0.0019474798,0.0024987725,0.0022245527],"domain_scores_gemma":[0.99511695,0.0012612788,0.0004499322,0.0015787671,0.00089567906,0.00069737574],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019896494,0.0010808704,0.002017835,0.0009159729,0.00061845226,0.0003433096,0.0010866829,0.0003960925,0.009121306],"category_scores_gemma":[0.0001343268,0.00075541047,0.00064426893,0.0018513644,0.00065989577,0.00043997413,0.00019588119,0.001766624,0.0000366752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64183456,0.0025800583,0.0006516579,0.001550064,0.003808249,0.00080984697,0.005544664,0.00016617423,0.078960225,0.000011679404,0.047513507,0.2165693],"study_design_scores_gemma":[0.60147715,0.039188642,0.017873777,0.0041949116,0.0010408121,0.00042629015,0.007855192,0.0038835553,0.10434441,0.00004783711,0.21687278,0.0027946327],"about_ca_topic_score_codex":0.05922796,"about_ca_topic_score_gemma":0.005642845,"teacher_disagreement_score":0.21377467,"about_ca_system_score_codex":0.0032733402,"about_ca_system_score_gemma":0.006161891,"threshold_uncertainty_score":0.99948967},"labels":[],"label_agreement":null},{"id":"W4396590555","doi":"10.1158/1538-7445.sabcs23-po1-27-10","title":"Abstract PO1-27-10: Adjunctive statistical standardization of quantitated machine image analysis of Estrogen and Progesterone Receptors: CCTG MA.27 trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Essar Steel Algoma (Canada); Queen's University; London Health Sciences Centre; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Estrogen; Estrogen receptor; Progesterone receptor; Receptor; Internal medicine; Oncology; Medicine; Gynecology; Biology; Endocrinology; Cancer; Breast cancer","score_opus":0.08627632332797301,"score_gpt":0.48669926329992574,"score_spread":0.4004229399719527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9224052,0.0040798583,0.060584314,0.006331794,0.00019577194,0.0027074232,0.0025595953,0.00016366881,0.00097242143],"genre_scores_gemma":[0.98892033,0.0009869541,0.0086216,0.000012568792,0.000111957095,0.00017085824,0.0005829095,0.000027987127,0.00056480843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829453,0.000094510055,0.00038992855,0.00031107914,0.0006941432,0.0002157932],"domain_scores_gemma":[0.9986961,0.00031677456,0.000060390325,0.0002499509,0.0005107883,0.00016597882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010687292,0.000095971314,0.00039301845,0.0004342769,0.00003649947,0.00003214879,0.00008732227,0.00007026596,0.0018915345],"category_scores_gemma":[0.00045017397,0.00007466162,0.00007008448,0.0012912288,0.0004791141,0.00006545593,0.00005921837,0.00033194947,0.000005588829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043346707,0.002167916,0.0073620733,0.005799245,0.007729417,0.00017538482,0.0017754523,0.00004233268,0.5795292,0.037142586,0.23881981,0.07610984],"study_design_scores_gemma":[0.06807262,0.014376417,0.038759284,0.007628729,0.014262469,0.00004226083,0.0016261796,0.10899386,0.48154208,0.008264164,0.25462538,0.001806573],"about_ca_topic_score_codex":0.000585718,"about_ca_topic_score_gemma":0.000025508087,"teacher_disagreement_score":0.108951524,"about_ca_system_score_codex":0.00011895749,"about_ca_system_score_gemma":0.00037248316,"threshold_uncertainty_score":0.9990209},"labels":[],"label_agreement":null},{"id":"W4396590570","doi":"10.1158/1538-7445.sabcs23-po1-08-10","title":"Abstract PO1-08-10: Impact of Oncologist-Led Genetic Counseling and Testing on Prophylactic Mastectomy Rates Among Multi-Ethnic Women with Operable Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Ethnic group; Oncology; Internal medicine; Cancer; Genetic counseling; Genetic testing; Gynecology; Family medicine; Biology","score_opus":0.06574168956777844,"score_gpt":0.42159022637438776,"score_spread":0.35584853680660933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775905,0.011065464,0.000036452322,0.000089317226,0.000085615495,0.0005809796,0.00014336145,0.000022639542,0.00021712715],"genre_scores_gemma":[0.9965555,0.0010559207,0.00042817602,0.000019275463,0.00024680368,0.0008550941,0.000009637999,0.0000672554,0.00076230825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799603,0.00012447147,0.0002509298,0.0006485009,0.0003637765,0.00061628775],"domain_scores_gemma":[0.998629,0.00015396671,0.00007238697,0.00035351145,0.00063293823,0.00015823939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066436164,0.00022464895,0.00023095794,0.00017426978,0.00015848663,0.00012141395,0.00024112503,0.00015014279,0.00044290262],"category_scores_gemma":[0.00013072531,0.00016817928,0.000044670676,0.0006312951,0.00046385542,0.000017449122,0.00009848739,0.00042588415,0.00000957956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010313456,0.000112076064,0.021735534,0.0006572589,0.00038346622,0.00004304576,0.00073885213,0.026950287,0.9019578,0.0000011820656,0.00061339716,0.045775726],"study_design_scores_gemma":[0.0029838518,0.0037392909,0.79257876,0.0014397387,0.00007069162,0.00009636509,0.0013784022,0.006442721,0.1896366,0.000043371503,0.0007246469,0.0008655833],"about_ca_topic_score_codex":0.002250109,"about_ca_topic_score_gemma":0.00080131035,"teacher_disagreement_score":0.7708432,"about_ca_system_score_codex":0.00100134,"about_ca_system_score_gemma":0.0023293723,"threshold_uncertainty_score":0.6858152},"labels":[],"label_agreement":null},{"id":"W4396590625","doi":"10.1158/1538-7445.sabcs23-po3-10-02","title":"Abstract PO3-10-02: Cardiovascular Risk Factors and Outcomes in Native Americans who have Received Chemotherapy and/or Radiation: A Retrospective Single-center Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Single Center; Chemotherapy; Retrospective cohort study; Center (category theory); Radiation therapy; Internal medicine; Oncology; Cancer; Gerontology","score_opus":0.07451149466229663,"score_gpt":0.39309510188707436,"score_spread":0.31858360722477774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404484,0.0023940133,0.000022738224,0.0008467821,0.0000810697,0.0016924108,0.000074981705,0.00004749517,0.0007956705],"genre_scores_gemma":[0.9944988,0.0040901653,0.000014070928,0.000073144525,0.00018786156,0.00020980526,0.000010236926,0.00004641742,0.00086949515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977844,0.00024692784,0.00023674277,0.00062049844,0.0007547141,0.0003567587],"domain_scores_gemma":[0.9990004,0.00031773784,0.000040941344,0.00028648417,0.00020205883,0.00015243277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095172186,0.00021169173,0.0006111066,0.00038547904,0.00013108086,0.000116133124,0.00007233029,0.000114332775,0.0001971314],"category_scores_gemma":[0.0002766794,0.00015807027,0.0001604231,0.00058164145,0.00024668768,0.00016921994,0.00003542657,0.00074709154,0.0000030672056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081425905,0.0004579797,0.88568354,0.0001678274,0.00265205,0.00014989237,0.029478543,0.000015606296,0.010237731,0.0000059033873,0.0005555883,0.069781065],"study_design_scores_gemma":[0.004074473,0.00093086984,0.960062,0.00028666444,0.0000771101,0.000009793526,0.007841339,0.00009810105,0.023707295,0.00005675066,0.0026513939,0.00020419633],"about_ca_topic_score_codex":0.002594944,"about_ca_topic_score_gemma":0.00053410506,"teacher_disagreement_score":0.07437846,"about_ca_system_score_codex":0.001065118,"about_ca_system_score_gemma":0.00022580987,"threshold_uncertainty_score":0.64459187},"labels":[],"label_agreement":null},{"id":"W4396590627","doi":"10.1158/1538-7445.sabcs23-lbo1-04","title":"Abstract LBO1-04: Primary results from a phase 2a study of zanidatamab (zani) + palbociclib (palbo) + fulvestrant (fulv) in HER2+/HR+ metastatic breast cancer (mBC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Baker Hughes (Canada); Health Sciences Centre; Zymeworks (Canada); Ottawa Hospital; Jewish General Hospital","funders":"","keywords":"Palbociclib; Fulvestrant; Metastatic breast cancer; Medicine; Oncology; Internal medicine; Breast cancer; Cancer; Gynecology; Estrogen receptor","score_opus":0.10942888924298524,"score_gpt":0.4624104369764118,"score_spread":0.3529815477334266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97123957,0.015176897,0.000035690424,0.0035119895,0.00044914056,0.0024809088,0.006459786,0.00014975881,0.0004962378],"genre_scores_gemma":[0.9950115,0.0017266477,0.00024791044,0.0001664888,0.00067495304,0.0010449358,0.00028452187,0.00017344834,0.0006695885],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99354035,0.00038092994,0.0012094674,0.0015017979,0.0021203065,0.0012471329],"domain_scores_gemma":[0.99669176,0.0007981061,0.00020136137,0.0012896091,0.00056130165,0.0004578503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016883892,0.0005323036,0.0011768413,0.0008605869,0.00014166176,0.00012729484,0.00064165494,0.00015710859,0.0020036395],"category_scores_gemma":[0.00016028111,0.00045301087,0.00017953258,0.0021301878,0.0005006033,0.0005593253,0.00024231958,0.001857345,0.00007348002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04072535,0.010448983,0.0086749215,0.0036996154,0.0030547758,0.005563894,0.021867165,0.0006479814,0.4336855,0.00008759911,0.004832897,0.4667113],"study_design_scores_gemma":[0.13034178,0.0070319697,0.71585494,0.019914605,0.001393061,0.00038746314,0.031977475,0.0011619821,0.0462409,0.001959125,0.040994354,0.0027423217],"about_ca_topic_score_codex":0.03257549,"about_ca_topic_score_gemma":0.007913301,"teacher_disagreement_score":0.70718,"about_ca_system_score_codex":0.0016810164,"about_ca_system_score_gemma":0.002505337,"threshold_uncertainty_score":0.99979216},"labels":[],"label_agreement":null},{"id":"W4396590704","doi":"10.1158/1538-7445.sabcs23-po1-20-13","title":"Abstract PO1-20-13: TROPION-Breast04: A phase 3 study of neoadjuvant datopotamab deruxtecan (Dato-DXd) + durvalumab followed by adjuvant durvalumab vs the standard of care in treatment-naive early-stage triple negative or HR-low/HER2– breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Durvalumab; Medicine; Stage (stratigraphy); Adjuvant; Standard of care; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.02952137439804262,"score_gpt":0.3900360376195528,"score_spread":0.36051466322151016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96618265,0.010744115,0.0000037281463,0.0010316811,0.000302726,0.0025813775,0.0189388,0.00002684039,0.00018809922],"genre_scores_gemma":[0.99303275,0.0030941947,0.000009699884,0.000031683194,0.00023552398,0.002181173,0.0003021649,0.000114528484,0.0009982559],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954177,0.00049047434,0.00075986824,0.0012437734,0.0011426267,0.00094555994],"domain_scores_gemma":[0.99758154,0.00027475227,0.00022603667,0.0010479725,0.0006621479,0.00020753285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042357933,0.0006058814,0.00097482995,0.0003060707,0.00031334217,0.00008943344,0.00065633375,0.0002018809,0.00045757214],"category_scores_gemma":[0.00008899757,0.0003948357,0.00025575366,0.000960753,0.000587864,0.000034799483,0.0003019273,0.00049724855,0.00000795352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26997775,0.018113224,0.100734346,0.0029263285,0.014108456,0.0018562109,0.078509904,0.0015818749,0.19349098,0.00013135032,0.026211923,0.29235765],"study_design_scores_gemma":[0.1166952,0.05612298,0.18056904,0.004163627,0.0012835523,0.00008576156,0.10634229,0.00018921802,0.506282,0.00010471673,0.02554011,0.002621534],"about_ca_topic_score_codex":0.032603424,"about_ca_topic_score_gemma":0.048868593,"teacher_disagreement_score":0.312791,"about_ca_system_score_codex":0.0013000969,"about_ca_system_score_gemma":0.0019245862,"threshold_uncertainty_score":0.99985033},"labels":[],"label_agreement":null},{"id":"W4396590710","doi":"10.1158/1538-7445.sabcs23-po2-12-12","title":"Abstract PO2-12-12: REaCT 5G: A randomized study comparing bone pain after 5 days of filgrastim or one day of pegfilgrastim for primary febrile neutropenia prophylaxis during neo-/adjuvant chemotherapy for early breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Thunder Bay Regional Health Sciences Centre; NOSM University; Ottawa Hospital","funders":"","keywords":"Pegfilgrastim; Filgrastim; Medicine; Febrile neutropenia; Neutropenia; Bone pain; Internal medicine; Chemotherapy; Adjuvant; Surgery","score_opus":0.059736200333071345,"score_gpt":0.37885096722279565,"score_spread":0.3191147668897243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832788,0.003235014,0.00044677366,0.0007514829,0.00035330263,0.010738907,0.00075929496,0.00009411887,0.00034228986],"genre_scores_gemma":[0.98384696,0.00069993554,0.00023304681,0.000053073796,0.0007868622,0.012169325,0.000042259006,0.00017012317,0.001998391],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99583447,0.00035260743,0.0010500398,0.0008799354,0.0009889626,0.00089396304],"domain_scores_gemma":[0.9965749,0.0014102012,0.00022554536,0.00064137264,0.0008603734,0.00028762998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034197967,0.00040170457,0.0018255571,0.0006195873,0.00023147892,0.000117085416,0.0003021782,0.0001515421,0.0011630141],"category_scores_gemma":[0.00022055085,0.00030329128,0.0005091388,0.0007488455,0.00042625304,0.00023371792,0.00011038006,0.0007460814,0.0000057385864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49107635,0.0024544348,0.036564637,0.014159485,0.0028748005,0.00013319922,0.00398102,0.00019436619,0.39526394,0.000028407494,0.003544502,0.049724855],"study_design_scores_gemma":[0.22005473,0.005701916,0.69562817,0.0085772555,0.001151497,0.00006922429,0.00080261927,0.0008433842,0.06363887,0.00013327137,0.0024632872,0.0009357623],"about_ca_topic_score_codex":0.0051939627,"about_ca_topic_score_gemma":0.0019094456,"teacher_disagreement_score":0.6590635,"about_ca_system_score_codex":0.0007169922,"about_ca_system_score_gemma":0.0015125858,"threshold_uncertainty_score":0.99994195},"labels":[],"label_agreement":null},{"id":"W4396590738","doi":"10.1158/1538-7445.sabcs23-gs01-05","title":"Abstract GS01-05: Pembrolizumab + Olaparib vs Pembrolizumab + Chemotherapy After Induction With Pembrolizumab + Chemotherapy for Locally Recurrent Inoperable or Metastatic TNBC: Randomized Open-Label Phase 2 KEYLYNK-009 Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Chemotherapy; Oncology; Olaparib; Internal medicine; Open label; Induction chemotherapy; Cancer; Randomized controlled trial; Immunotherapy; Polymerase","score_opus":0.14351004019557545,"score_gpt":0.4841436015656345,"score_spread":0.34063356137005907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486466,0.010134999,0.0022385623,0.009477974,0.0013428979,0.026017765,0.00039593413,0.00045601762,0.001289221],"genre_scores_gemma":[0.94956845,0.0065542012,0.001086778,0.0017431541,0.0013447809,0.029624058,0.00017710536,0.0005154205,0.009386048],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990796,0.0009241332,0.0016104289,0.002243498,0.002489027,0.0019368776],"domain_scores_gemma":[0.994516,0.0011174727,0.00031521762,0.0015302846,0.0017485911,0.00077242736],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047854874,0.0010672904,0.0025354717,0.0011867369,0.00063932344,0.0011705244,0.0010239384,0.00032167742,0.0061934595],"category_scores_gemma":[0.00025897677,0.0007494802,0.00037019278,0.002255049,0.0009367738,0.0011240107,0.00018191467,0.0021296372,0.00014775773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8703218,0.0066003585,0.000030730407,0.0016209133,0.0030129412,0.0006447957,0.0047458718,0.000050391256,0.009280318,0.00018724159,0.022198819,0.081305794],"study_design_scores_gemma":[0.88441575,0.017290052,0.00025517936,0.0032948372,0.0006968844,0.0004145768,0.0012841015,0.0027095194,0.01538417,0.00072963623,0.07226124,0.0012640539],"about_ca_topic_score_codex":0.0010542711,"about_ca_topic_score_gemma":0.0004322591,"teacher_disagreement_score":0.08004174,"about_ca_system_score_codex":0.0025479803,"about_ca_system_score_gemma":0.005292189,"threshold_uncertainty_score":0.99986637},"labels":[],"label_agreement":null},{"id":"W4396590741","doi":"10.1158/1538-7445.sabcs23-gs01-12","title":"Abstract GS01-12: MONARCH 3: Final overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor as first-line therapy for HR+, HER2- advanced breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham","funders":"","keywords":"Aromatase inhibitor; Aromatase; Medicine; Nonsteroidal; Breast cancer; Internal medicine; Oncology; Cancer","score_opus":0.10098032848230017,"score_gpt":0.43732577981712517,"score_spread":0.336345451334825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950996,0.022683373,0.00015610714,0.012699214,0.0013190444,0.0031400535,0.0082613975,0.00022318431,0.00052162004],"genre_scores_gemma":[0.9825695,0.0069626,0.00048289122,0.00024990545,0.0027927002,0.0023192004,0.00033454772,0.00022021263,0.004068408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994601,0.00012775326,0.00093254726,0.0012581018,0.001718584,0.0013619941],"domain_scores_gemma":[0.99645376,0.0009791143,0.00017894566,0.0009198727,0.0009800299,0.00048825308],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013145994,0.0005314612,0.00092272356,0.00054108846,0.00027341634,0.00010667632,0.00049672264,0.00025175003,0.0010892854],"category_scores_gemma":[0.00016832608,0.00044816447,0.0003447404,0.0008195234,0.00068001606,0.00042286929,0.00017553104,0.0011441051,0.00007230055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18503141,0.0011011946,0.0015229726,0.0052161803,0.0013429691,0.0006426587,0.0031044693,0.003136728,0.2792018,0.0004371748,0.012451337,0.5068111],"study_design_scores_gemma":[0.08933482,0.0072832443,0.05440554,0.017397763,0.00026214868,0.00060982205,0.0014601749,0.0030045244,0.23719658,0.0038260035,0.58276796,0.0024513968],"about_ca_topic_score_codex":0.0027587956,"about_ca_topic_score_gemma":0.0012332739,"teacher_disagreement_score":0.5703167,"about_ca_system_score_codex":0.0010973809,"about_ca_system_score_gemma":0.002668971,"threshold_uncertainty_score":0.99982387},"labels":[],"label_agreement":null},{"id":"W4396590778","doi":"10.1158/1538-7445.sabcs23-po1-02-11","title":"Abstract PO1-02-11: Characterization of MammaPrint UltraLow Risk tumors in more than 1400 patients from the real-world evidence FLEX study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; FLEX; Oncology; Internal medicine; Computer science; Telecommunications","score_opus":0.05520924668828039,"score_gpt":0.39203892380935423,"score_spread":0.33682967712107387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699336,0.0010290149,0.000004892739,0.00063589314,0.00015665496,0.0007027429,0.00039389913,0.000012289305,0.00007126016],"genre_scores_gemma":[0.9963989,0.0026099943,0.000008380216,0.000023204093,0.0002445921,0.00037332115,0.00014097377,0.00002824459,0.00017238317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981962,0.00021834535,0.00027645283,0.00051720295,0.00046779652,0.00032400808],"domain_scores_gemma":[0.99906904,0.00014475195,0.00007057654,0.00046070383,0.00020174227,0.000053187567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050331256,0.00015957995,0.00018056255,0.00010329418,0.00010811154,0.000050420094,0.00034177548,0.000054206517,0.000062442574],"category_scores_gemma":[0.000110987465,0.00011417088,0.00006308663,0.0004388414,0.00017571342,0.000015055555,0.00016101831,0.00026352375,0.000011536112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022687446,0.00015834234,0.8538795,0.000042800086,0.00011868253,0.000009622396,0.0012184174,0.00002177982,0.13896835,0.0000051112165,0.00022016838,0.0051303557],"study_design_scores_gemma":[0.00035872898,0.00010796732,0.9393837,0.00033710434,0.000020136526,1.04641295e-7,0.00042130373,0.000008544493,0.058889486,0.000027539692,0.00034540036,0.000100007535],"about_ca_topic_score_codex":0.024492452,"about_ca_topic_score_gemma":0.013676844,"teacher_disagreement_score":0.08550419,"about_ca_system_score_codex":0.00018796649,"about_ca_system_score_gemma":0.00022623256,"threshold_uncertainty_score":0.9820035},"labels":[],"label_agreement":null},{"id":"W4396590792","doi":"10.1158/1538-7445.sabcs23-po3-02-02","title":"Abstract PO3-02-02: A prospective, international, observational, real-world evidence database, and collaborative platform for Investigator-Initiated Studies in Early-Stage Breast Cancer tested with MammaPrint and BluePrint– the FLEX Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blueprint; FLEX; Observational study; Stage (stratigraphy); Medicine; Breast cancer; Cancer; Medical physics; Internal medicine; Computer science; Engineering; Telecommunications","score_opus":0.3075331747702353,"score_gpt":0.48861202908478846,"score_spread":0.18107885431455317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834449,0.009522541,0.0000036813462,0.0038732272,0.00010094462,0.0019069286,0.0010256956,0.000021120948,0.000100942816],"genre_scores_gemma":[0.9838571,0.010944154,0.000099670506,0.00009141386,0.0001884943,0.004330024,0.000042791133,0.00003332461,0.00041303755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981928,0.00008499892,0.00024062356,0.00074128725,0.00040796303,0.0003323478],"domain_scores_gemma":[0.998183,0.0004595783,0.00006426667,0.00027730202,0.00091811194,0.000097753145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071666564,0.0002285106,0.00022583207,0.00016164135,0.0002909909,0.00016241557,0.00021942236,0.000045707522,0.000019307736],"category_scores_gemma":[0.00029463752,0.00015406925,0.000020917421,0.00066418777,0.00076766673,0.00006660344,0.00041332736,0.00026688172,0.0000010477484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015721326,0.0001504188,0.97949475,0.00032342537,0.0012909948,0.000043759734,0.0036108277,0.000059665475,0.010154314,0.0006563853,0.001563357,0.001079976],"study_design_scores_gemma":[0.0011864402,0.0002417618,0.9853628,0.0009527808,0.00004509987,0.00000573767,0.004976147,0.000044498323,0.005774318,0.00014453568,0.0010656922,0.00020015823],"about_ca_topic_score_codex":0.0053980923,"about_ca_topic_score_gemma":0.036232423,"teacher_disagreement_score":0.030834332,"about_ca_system_score_codex":0.00039125382,"about_ca_system_score_gemma":0.00086738064,"threshold_uncertainty_score":0.9813538},"labels":[],"label_agreement":null},{"id":"W4396590827","doi":"10.1158/1538-7445.sabcs23-po2-04-10","title":"Abstract PO2-04-10: Effect of Alpelisib Dose Modification for AE Management on Progression-Free Survival and Treatment Duration in SOLAR-1 and BYLieve Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Clinical trial; Duration (music); Oncology; Internal medicine","score_opus":0.3073220384706638,"score_gpt":0.5850373850860928,"score_spread":0.277715346615429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922123,0.0010080823,0.00003951935,0.0036712787,0.0000446743,0.0019234126,0.000079712554,0.000018556746,0.0010024508],"genre_scores_gemma":[0.9960383,0.00188864,0.00008196485,0.000014288739,0.00018157209,0.00066331,0.00008650319,0.000013156804,0.0010322226],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980878,0.00046598917,0.0005153096,0.0003510088,0.00040559797,0.00017426959],"domain_scores_gemma":[0.9979741,0.0015345268,0.00006558046,0.000226961,0.00009103898,0.00010780246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006617042,0.000101179045,0.00040401542,0.0003256074,0.00005096927,0.000051199648,0.00004341945,0.000084742096,0.000110348716],"category_scores_gemma":[0.00074285537,0.00006568356,0.00011127031,0.00023803103,0.0000993683,0.000057106015,0.000030851723,0.00015833911,0.0000068250733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008392123,0.00055176695,0.0036097413,0.0019470375,0.00045064124,0.00007537451,0.0002257371,0.0000110534165,0.025288718,0.00084286835,0.0056003476,0.9530046],"study_design_scores_gemma":[0.087207526,0.02552951,0.5236622,0.026623009,0.0017187301,0.000014060729,0.001598816,0.024893679,0.2752959,0.0030011449,0.029438898,0.0010164899],"about_ca_topic_score_codex":0.000090526664,"about_ca_topic_score_gemma":0.000078617624,"teacher_disagreement_score":0.9519881,"about_ca_system_score_codex":0.00015877985,"about_ca_system_score_gemma":0.0000879496,"threshold_uncertainty_score":0.2678498},"labels":[],"label_agreement":null},{"id":"W4396590840","doi":"10.1158/1538-7445.sabcs23-po1-11-11","title":"Abstract PO1-11-11: A Novel Body Composition Risk Score (B-Score) and Overall Survival among Patients with Early-Stage Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stage (stratigraphy); Medicine; Breast cancer; Internal medicine; Oncology; Cancer; Biology","score_opus":0.04880373288983106,"score_gpt":0.3614039627584814,"score_spread":0.3126002298686503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431837,0.0010939525,0.000039544175,0.0005164931,0.00039782093,0.0009738655,0.002212127,0.000089532325,0.000358283],"genre_scores_gemma":[0.9968855,0.0012038563,0.000015045124,0.00004949357,0.000545681,0.00019982748,0.00011786122,0.00009073401,0.00089202117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701464,0.00005864056,0.0002784337,0.0007077393,0.0012268563,0.0007136593],"domain_scores_gemma":[0.9985435,0.0001247847,0.00007367362,0.000363129,0.00045850073,0.00043643505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042450268,0.00027849578,0.00038362254,0.00031754049,0.00025024073,0.00025392996,0.00014354095,0.00014212022,0.00094014953],"category_scores_gemma":[0.000015207867,0.00020981254,0.00008551905,0.0005138061,0.00042168074,0.00034707424,0.00011128307,0.0009444429,0.000013838341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010716468,0.00018166726,0.9876866,0.00050151057,0.00018212872,0.00007285337,0.00047981594,0.000040700834,0.0037067211,0.00009770073,0.0016576746,0.0043210103],"study_design_scores_gemma":[0.002531976,0.00023863018,0.99142694,0.0014768888,0.000089333866,0.0000056031345,0.00006579384,0.00022697521,0.00049891387,0.000011867354,0.0031749322,0.00025215602],"about_ca_topic_score_codex":0.11738041,"about_ca_topic_score_gemma":0.017101474,"teacher_disagreement_score":0.10027894,"about_ca_system_score_codex":0.0007262018,"about_ca_system_score_gemma":0.00059393264,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W4396590847","doi":"10.1158/1538-7445.sabcs23-po1-16-12","title":"Abstract PO1-16-12: The McPeak-Sirois Group Breast Metastases Registry","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.1215819075740569,"score_gpt":0.4722868700741279,"score_spread":0.350704962500071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590847","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31027418,0.023048235,0.003651076,0.58326095,0.00056075293,0.0030820572,0.0007780942,0.0014561239,0.07388851],"genre_scores_gemma":[0.9892271,0.0016591672,0.00045282024,0.00074914546,0.0008296768,0.0006458666,0.000061883875,0.000038172846,0.0063361544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826807,0.00005932745,0.00018749468,0.00035007438,0.00072715327,0.00040786917],"domain_scores_gemma":[0.9986614,0.00028949685,0.00001898529,0.0006646825,0.0001289108,0.00023651302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011721369,0.00010657022,0.00015212389,0.000110290646,0.0001959479,0.00012664124,0.00031898037,0.00006367336,0.0023643265],"category_scores_gemma":[0.00013373226,0.000063354506,0.000094014424,0.0005216266,0.00047770378,0.0000618894,0.0001252424,0.0010124532,0.00016040332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042801126,0.00010057128,0.00013792177,0.00037557166,0.00008133076,0.000201965,0.000060489743,2.746097e-7,0.040047377,0.009256297,0.8649149,0.08478051],"study_design_scores_gemma":[0.000191482,0.0000495674,0.0030159957,0.0007056601,0.000054163163,0.0003265966,0.00018329534,0.00014515812,0.0054751877,0.0019162213,0.98783386,0.00010282608],"about_ca_topic_score_codex":0.0017567642,"about_ca_topic_score_gemma":0.00006527404,"teacher_disagreement_score":0.67895293,"about_ca_system_score_codex":0.00022286328,"about_ca_system_score_gemma":0.00032903184,"threshold_uncertainty_score":0.9985477},"labels":[],"label_agreement":null},{"id":"W4396590874","doi":"10.1158/1538-7445.sabcs23-gs03-03","title":"Abstract GS03-03: Ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2− early breast cancer: final invasive disease–free survival (iDFS) analysis from the NATALEE trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Aromatase inhibitor; Oncology; Breast cancer; Internal medicine; Nonsteroidal; Cancer; Adjuvant; Aromatase","score_opus":0.045699305010672396,"score_gpt":0.36555625623166677,"score_spread":0.3198569512209944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711479,0.0076363403,0.0000072244366,0.0041870764,0.0005577655,0.002695553,0.013586731,0.00010528082,0.000076124285],"genre_scores_gemma":[0.9939587,0.00063448376,0.000034337296,0.0001371725,0.0016048003,0.0019720723,0.001050826,0.000121767654,0.00048585367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942168,0.00037290872,0.00064327795,0.0013050963,0.0023340653,0.0011278604],"domain_scores_gemma":[0.9963515,0.0009872742,0.00014402057,0.0014016684,0.00046699392,0.0006485668],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005794891,0.00057141506,0.00093677477,0.0006135716,0.0002941878,0.0002759955,0.00066097896,0.00015842728,0.001607384],"category_scores_gemma":[0.00015025772,0.00036326452,0.00036813572,0.0022678461,0.00069334847,0.00048959104,0.00024948473,0.0010555699,0.00015344341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23480561,0.0017410141,0.6880048,0.00028513657,0.005827406,0.0016199616,0.0029298419,0.0003946074,0.0006921807,0.000047213674,0.0013386094,0.062313635],"study_design_scores_gemma":[0.046501763,0.0012880753,0.94594496,0.0013437725,0.00099638,0.0000047604776,0.0005615363,0.00004414473,0.0005994306,0.00022914553,0.0020342914,0.00045175105],"about_ca_topic_score_codex":0.040054824,"about_ca_topic_score_gemma":0.020882118,"teacher_disagreement_score":0.25794017,"about_ca_system_score_codex":0.0025411367,"about_ca_system_score_gemma":0.0034047053,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W4396590903","doi":"10.1158/1538-7445.sabcs23-ps01-02","title":"Abstract PS01-02: Long-term outcomes of sentinel lymph node biopsy following neoadjuvant chemotherapy for initially node-positive breast cancer: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Sentinel lymph node; Oncology; Chemotherapy; Sentinel node; Internal medicine; Lymph node; Biopsy; Node (physics); Term (time); Surgery; Cancer","score_opus":0.12093260130009614,"score_gpt":0.4623039283995158,"score_spread":0.34137132709941964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019668162,0.9894652,0.000024897197,0.0009029513,0.0000850462,0.00319601,0.0060643232,0.000017766459,0.000047170273],"genre_scores_gemma":[0.0025420294,0.9874777,0.00004948288,0.00025816224,0.0001433271,0.008348314,0.0004913612,0.00015126691,0.0005383247],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957539,0.0003450349,0.0012474024,0.0012871199,0.00065563835,0.00071093877],"domain_scores_gemma":[0.9975008,0.00024570353,0.00060551666,0.00086659734,0.0006130163,0.00016838824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011196911,0.00086291204,0.007216119,0.00041838444,0.00018032671,0.00010549851,0.00058784144,0.00032863088,0.00010412737],"category_scores_gemma":[0.00008516392,0.0005577573,0.00430716,0.0008876554,0.00023735827,0.000012242642,0.0003565605,0.0003060487,0.0000069706457],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037417143,0.00008591299,0.00038640611,0.6200965,0.37504455,0.000042375876,0.000038073318,7.155736e-7,0.000056243767,0.0000041243206,0.00013807572,0.004069594],"study_design_scores_gemma":[0.0007687933,0.00002278566,0.0021334265,0.07025316,0.9253343,0.00008292156,0.000023551363,0.0000011274475,0.00008343463,0.0000062021177,0.0005051533,0.00078518916],"about_ca_topic_score_codex":0.00058392115,"about_ca_topic_score_gemma":0.000054421598,"teacher_disagreement_score":0.5502897,"about_ca_system_score_codex":0.00031988623,"about_ca_system_score_gemma":0.0007647859,"threshold_uncertainty_score":0.9996874},"labels":[],"label_agreement":null},{"id":"W4396590909","doi":"10.1158/1538-7445.sabcs23-ed03-03","title":"Abstract ED03-03: Impact of exercise on breast cancer outcomes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Internal medicine; Gerontology","score_opus":0.10963681792085003,"score_gpt":0.5125646839461053,"score_spread":0.4029278660252553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843092,0.008158447,8.117798e-7,0.0028716954,0.00047848545,0.000517053,0.0007189454,0.00006618912,0.0028791719],"genre_scores_gemma":[0.9898731,0.005928398,0.000003871893,0.00004143634,0.00039853572,0.00019034752,0.000011203935,0.000057113568,0.0034959824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781257,0.000025552486,0.00026633608,0.00040562684,0.0009223756,0.00056755793],"domain_scores_gemma":[0.99878037,0.00016087666,0.00003315225,0.00044014695,0.0002802907,0.00030514188],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004148448,0.00019132113,0.00043741986,0.0004501382,0.00007059378,0.00005843534,0.00017307709,0.00011181369,0.007988603],"category_scores_gemma":[0.000030758107,0.00012490574,0.00033078017,0.0006812436,0.0002001118,0.00010228167,0.000058395726,0.00076440413,0.00018661632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028636027,0.0004431704,0.5126116,0.0023308399,0.00091412605,0.00030746008,0.0013046421,0.00024208425,0.045357384,0.00022803516,0.16422315,0.2691739],"study_design_scores_gemma":[0.00074392033,0.00026303626,0.98537797,0.002654838,0.00006114088,0.000009256445,0.000094972915,0.00005575385,0.0049949554,0.00007958757,0.0055036503,0.00016092129],"about_ca_topic_score_codex":0.031164126,"about_ca_topic_score_gemma":0.00029766146,"teacher_disagreement_score":0.47276634,"about_ca_system_score_codex":0.0011085541,"about_ca_system_score_gemma":0.0015828583,"threshold_uncertainty_score":0.99291825},"labels":[],"label_agreement":null},{"id":"W4396590916","doi":"10.1158/1538-7445.sabcs23-gs02-11","title":"Abstract GS02-11: Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Fertility preservation; Medicine; Endocrine system; Gynecology; Pregnancy; Fertility; Breast cancer; Obstetrics; Cancer; Oncology; Population; Internal medicine; Hormone; Biology","score_opus":0.13097759061859404,"score_gpt":0.44554360518122943,"score_spread":0.3145660145626354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690712,0.0070321206,0.0000060212496,0.02132379,0.00023333177,0.0016967459,0.00006880763,0.00017412988,0.00039383885],"genre_scores_gemma":[0.9961027,0.0016024197,0.000040320276,0.00006492917,0.000109337416,0.0011374155,0.00002719241,0.000026256022,0.0008894554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722,0.00022721963,0.00037166852,0.0012753261,0.0003937878,0.0005120201],"domain_scores_gemma":[0.99833393,0.0001688893,0.000045225293,0.00071899564,0.0006468714,0.00008605863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012545128,0.00019826346,0.00032668258,0.00036815996,0.00011057877,0.00005566278,0.0001898847,0.00014025907,0.00017697354],"category_scores_gemma":[0.001023179,0.00015079064,0.00005005479,0.00090798654,0.00037316143,0.00036856075,0.00025808538,0.0008780953,0.000017560387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00357999,0.0002976956,0.7594506,0.00044107248,0.000084759944,0.00002872671,0.0009749674,0.0000030953067,0.028113449,0.000023335062,0.0010008245,0.20600149],"study_design_scores_gemma":[0.00068845734,0.00019074621,0.97573715,0.0015018929,0.0000073655024,0.0000061271758,0.00025721738,0.000019950332,0.017554618,0.00028624703,0.0036225237,0.00012771746],"about_ca_topic_score_codex":0.0030876747,"about_ca_topic_score_gemma":0.0009561065,"teacher_disagreement_score":0.21628654,"about_ca_system_score_codex":0.00062726607,"about_ca_system_score_gemma":0.00029247813,"threshold_uncertainty_score":0.6149064},"labels":[],"label_agreement":null},{"id":"W4396590952","doi":"10.1158/1538-7445.sabcs23-po2-02-14","title":"Abstract PO2-02-14: Development of a multi-institutional, photograph-rich clinical dataset to test and validate a novel inflammatory breast cancer (IBC) scoring system","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada)","funders":"","keywords":"Inflammatory breast cancer; Cancer; Medicine; Test (biology); Breast cancer; Internal medicine; Oncology; Intensive care medicine; Biology","score_opus":0.15054023513144676,"score_gpt":0.4509293298399723,"score_spread":0.30038909470852554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984706,0.010521019,0.00008356952,0.000566604,0.000462313,0.0010075186,0.0025157135,0.00007504289,0.00006226004],"genre_scores_gemma":[0.99490756,0.0028506287,0.00042496913,0.00007369142,0.00065296044,0.0006404353,0.00015149309,0.00005184931,0.00024642635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969223,0.00010159263,0.0007844938,0.00068875245,0.0009092927,0.0005935626],"domain_scores_gemma":[0.99795496,0.0006005667,0.000079556754,0.000496649,0.0004385859,0.00042965476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002632329,0.00025397653,0.0005303471,0.0006212129,0.00025402682,0.00011244632,0.0002629713,0.00014507394,0.00015671519],"category_scores_gemma":[0.00027461437,0.00020681613,0.0001019034,0.00079641194,0.00039483185,0.00016938867,0.00021851982,0.00066786056,0.000059693608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011533544,0.0023307898,0.2273561,0.030506002,0.0021327324,0.0013952954,0.004966739,0.00022687933,0.43120712,0.00018560035,0.033531673,0.25462753],"study_design_scores_gemma":[0.003312226,0.0002159049,0.72902197,0.014635939,0.00013728747,0.00043165154,0.00083880953,0.00041051602,0.01747431,9.2185894e-7,0.23303166,0.0004888032],"about_ca_topic_score_codex":0.001609081,"about_ca_topic_score_gemma":0.0006892598,"teacher_disagreement_score":0.5016659,"about_ca_system_score_codex":0.0006381179,"about_ca_system_score_gemma":0.004174011,"threshold_uncertainty_score":0.8433717},"labels":[],"label_agreement":null},{"id":"W4396590990","doi":"10.1158/1538-7445.sabcs23-po3-11-10","title":"Abstract PO3-11-10: Second primary non-breast cancers in young breast cancer survivors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.022765424141402688,"score_gpt":0.35094784044865523,"score_spread":0.32818241630725253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96950626,0.017148564,0.0000046116156,0.0021998512,0.00089025305,0.00049589924,0.0022439805,0.000043082888,0.0074674664],"genre_scores_gemma":[0.98818964,0.0041980757,0.000013814141,0.00012001922,0.0012065043,0.0010883072,0.00016467833,0.00009974169,0.0049192156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686325,0.00010287523,0.0003329652,0.0010444626,0.0005977728,0.0010587006],"domain_scores_gemma":[0.9988554,0.000065734625,0.00004655903,0.00051699084,0.0003027983,0.0002125286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005960174,0.0003646788,0.0003475475,0.00029779275,0.00019813403,0.0001355732,0.00044536294,0.0002284652,0.002414793],"category_scores_gemma":[0.000014615694,0.0003357144,0.00014222522,0.00076085055,0.0003801125,0.000028777778,0.00032950277,0.0005012073,0.000081415565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020740584,0.0003461011,0.42627463,0.0021552995,0.0014401354,0.00039033452,0.0016915373,0.0006540219,0.35896853,0.00008688204,0.14075197,0.06516651],"study_design_scores_gemma":[0.0011988177,0.00006477156,0.9453073,0.00067956035,0.00003483207,0.000110289424,0.00047268,0.00003550451,0.015310646,0.00004254905,0.03613013,0.0006129043],"about_ca_topic_score_codex":0.060906727,"about_ca_topic_score_gemma":0.21616504,"teacher_disagreement_score":0.51903266,"about_ca_system_score_codex":0.0016151909,"about_ca_system_score_gemma":0.0019867753,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W4396590998","doi":"10.1158/1538-7445.sabcs23-gs02-04","title":"Abstract GS02-04: Surgical Treatment of Women with Breast Cancer and a BRCA1 Mutation: An International Analysis of the Impact of Bilateral Mastectomy on Survival","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Oncology; Cancer; Internal medicine; Gynecology; General surgery","score_opus":0.0390262050650931,"score_gpt":0.4147322922587332,"score_spread":0.3757060871936401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396590998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796957,0.0005501635,0.000003191615,0.00019193954,0.0000721318,0.00015927551,0.0008508084,0.0000026291716,0.00020030154],"genre_scores_gemma":[0.9990213,0.00051918364,0.00001391094,0.0000022378285,0.00011433779,0.00012119777,0.000039619772,0.0000136657645,0.00015453792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892956,0.00007836758,0.00017900471,0.00027646194,0.00034714426,0.00018946579],"domain_scores_gemma":[0.9992428,0.00004906161,0.000059492762,0.0002705039,0.00031516247,0.000062990584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026341327,0.00009898897,0.00018974925,0.00021156219,0.00003171148,0.000023024386,0.00016410873,0.000057502195,0.00034967603],"category_scores_gemma":[0.000008068598,0.00005784031,0.00009326841,0.00060049363,0.00026251533,0.000009656888,0.000041750664,0.00007520458,2.5769643e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062652226,0.00074293907,0.34143633,0.00022988746,0.014846036,0.000042373067,0.004931831,0.06681843,0.481398,0.0001879465,0.00010654534,0.082994446],"study_design_scores_gemma":[0.001035194,0.001109169,0.89336085,0.00008349168,0.00011746366,0.000015193564,0.0002917379,0.0007470809,0.10281217,0.00002780117,0.0002898688,0.00010996852],"about_ca_topic_score_codex":0.002253453,"about_ca_topic_score_gemma":0.0004795574,"teacher_disagreement_score":0.5519245,"about_ca_system_score_codex":0.000547093,"about_ca_system_score_gemma":0.00079762045,"threshold_uncertainty_score":0.38287073},"labels":[],"label_agreement":null},{"id":"W4396591029","doi":"10.1158/1538-7445.sabcs23-gs02-07","title":"Abstract GS02-07: Loco-Regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node-negative After Neoadjuvant Chemotherapy: Primary Outcomes of NRG Oncology/NSABP B-51/RTOG 1304","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Internal medicine; Biopsy; Chemotherapy; Node (physics); Presentation (obstetrics); Radiology","score_opus":0.04873972984312723,"score_gpt":0.37834317139810464,"score_spread":0.3296034415549774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654526,0.002441098,0.0000061809606,0.007881269,0.00014232413,0.0021343825,0.0002121072,0.000031752836,0.00060560537],"genre_scores_gemma":[0.9942675,0.0017933496,0.00034680948,0.00092136173,0.00012356554,0.0019032538,0.00024601727,0.000051652685,0.00034648785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969229,0.00014411254,0.0005340811,0.00067108957,0.0012202001,0.00050763495],"domain_scores_gemma":[0.99851584,0.0003817698,0.00014303652,0.00036703117,0.00040833023,0.00018398048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057917624,0.00027479278,0.00060334726,0.00037713288,0.000077616445,0.000041613617,0.00014651587,0.00018570528,0.0008226637],"category_scores_gemma":[0.00004056678,0.00019029935,0.00013912082,0.0004858621,0.00030763305,0.00019630704,0.00012176984,0.00046545942,0.00005456876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047383523,0.0016535709,0.94139093,0.0005995298,0.00041659098,0.00028449585,0.0022886747,0.000082043465,0.0015128847,0.000019059737,0.002203503,0.044810362],"study_design_scores_gemma":[0.0067420607,0.0013560205,0.9862852,0.00080865255,0.0000627995,0.0000035582575,0.00017001369,0.00004505698,0.0013888264,0.00009926561,0.0028556432,0.00018289704],"about_ca_topic_score_codex":0.001507007,"about_ca_topic_score_gemma":0.00057262904,"teacher_disagreement_score":0.04489427,"about_ca_system_score_codex":0.0045425124,"about_ca_system_score_gemma":0.0008901664,"threshold_uncertainty_score":0.99927884},"labels":[],"label_agreement":null},{"id":"W4396591058","doi":"10.1158/1538-7445.sabcs23-po4-02-04","title":"Abstract PO4-02-04: Overall survival and disease recurrence rates in patients with invasive lobular breast cancer of the PenelopeB cohort","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Breast cancer; Oncology; Internal medicine; Disease; Invasive lobular carcinoma; Cancer; Overall survival; Invasive ductal carcinoma","score_opus":0.023045777655731233,"score_gpt":0.33233754743276617,"score_spread":0.30929176977703493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881086,0.008996123,7.878863e-7,0.0014337768,0.00015715031,0.00046705533,0.0007004607,0.000004320711,0.00013172127],"genre_scores_gemma":[0.995959,0.0034450097,0.000004079316,0.000043445754,0.000099898534,0.00027114846,0.000041646246,0.000022681372,0.000113124086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855477,0.000095946736,0.00014767516,0.00046371054,0.00041802743,0.00031989432],"domain_scores_gemma":[0.99921614,0.000055132732,0.000036112768,0.00029093318,0.0002863279,0.00011537402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022153369,0.00015472148,0.00016072528,0.00005870592,0.000091799,0.000040249382,0.00020926494,0.0000510573,0.00006579562],"category_scores_gemma":[0.00006854795,0.00010007685,0.00003890294,0.0002537183,0.0003658595,0.000012824142,0.0002572878,0.00019570584,0.000001970907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065451715,0.00007708295,0.993699,0.00020707889,0.00017217486,0.000007900381,0.000084058236,0.000046670157,0.0017131423,0.000044184446,0.0012496588,0.0020445236],"study_design_scores_gemma":[0.0006606894,0.000046784266,0.9938641,0.0005218176,0.000024310797,6.8360663e-7,0.000042525186,0.0000024120225,0.004139468,0.00006724908,0.0005083124,0.000121629906],"about_ca_topic_score_codex":0.0025310728,"about_ca_topic_score_gemma":0.0018402892,"teacher_disagreement_score":0.007850363,"about_ca_system_score_codex":0.00013667598,"about_ca_system_score_gemma":0.00090917415,"threshold_uncertainty_score":0.40810156},"labels":[],"label_agreement":null},{"id":"W4396591111","doi":"10.1158/1538-7445.sabcs23-po1-02-01","title":"Abstract PO1-02-01: T Cell Receptor Sequencing to Monitor Pelareorep-Induced Expansion of Tumor Infiltrating Lymphocytes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Tumor-infiltrating lymphocytes; Receptor; Cancer research; T-cell receptor; Biology; Medicine; T cell; Immunology; Cancer; Internal medicine; Immune system; Immunotherapy","score_opus":0.04834690965594179,"score_gpt":0.3618034414249227,"score_spread":0.3134565317689809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263126,0.0048974617,0.000045350127,0.00019731469,0.0005246003,0.00033196126,0.00013762897,0.000017144812,0.0012172721],"genre_scores_gemma":[0.9971607,0.0008575793,0.00046960526,0.00008947703,0.0009457377,0.00012916552,0.000040342926,0.000050891762,0.00025650716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832505,0.00005229022,0.0002918182,0.0005034277,0.00037244507,0.00045494264],"domain_scores_gemma":[0.9989503,0.00012678167,0.000045297485,0.00039227802,0.0002909884,0.00019433977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056967756,0.00015548963,0.00016856563,0.00015775228,0.00011583451,0.00010541325,0.0002867692,0.00011336731,0.00015051036],"category_scores_gemma":[0.00027788532,0.00015289483,0.00008907352,0.00033206874,0.00006683691,0.000007999368,0.00022333622,0.00023591868,0.000050754403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009209082,0.000015732789,0.0002153028,0.00023156691,0.000022295098,0.000015236393,0.00024826,0.00030457927,0.98588246,0.000033146767,0.0056428104,0.0072965096],"study_design_scores_gemma":[0.00020584231,0.00030515663,0.0003163593,0.00025325414,0.000006529738,0.0000033217082,0.00050061184,0.000071176415,0.98921275,0.00003273096,0.008916343,0.00017593925],"about_ca_topic_score_codex":0.0014049868,"about_ca_topic_score_gemma":0.00011956112,"teacher_disagreement_score":0.00712057,"about_ca_system_score_codex":0.00035671235,"about_ca_system_score_gemma":0.0013373494,"threshold_uncertainty_score":0.62348706},"labels":[],"label_agreement":null},{"id":"W4396591120","doi":"10.1158/1538-7445.sabcs23-po3-01-13","title":"Abstract PO3-01-13: A study of the impact of the implementation of the Oncotype Dx 21-gene breast-cancer assay during the SARS-CoV-2 pandemic for 1-3 node positive early breast cancer: The Clatterbridge Cancer Centre Experience","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.03620729453630862,"score_gpt":0.41683221881177124,"score_spread":0.38062492427546263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846515,0.0037610668,0.0000046602436,0.0027780116,0.0004993388,0.0019243879,0.0063479394,0.000004612072,0.000028487186],"genre_scores_gemma":[0.9962647,0.0021939536,0.0000011834983,0.00013892123,0.0004869645,0.0007537025,0.000008537061,0.00004824881,0.00010380989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976585,0.00027369935,0.00044141407,0.00047726708,0.000610293,0.00053884473],"domain_scores_gemma":[0.9980182,0.00020335252,0.00028248603,0.00087959995,0.0005682014,0.000048140468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000615493,0.00024580938,0.00025322696,0.000043620235,0.0004214964,0.000078801146,0.0011647411,0.000105622225,0.00008725557],"category_scores_gemma":[0.00004062733,0.00011231263,0.00033834178,0.0005460829,0.00048982387,0.00001776672,0.00057310023,0.000420497,5.165909e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045482884,0.00008688611,0.22982606,0.000089421366,0.0004210021,6.094685e-7,0.0041874466,0.00095293316,0.7587358,0.000008354243,0.001894737,0.0033419232],"study_design_scores_gemma":[0.0006166942,0.00007337785,0.61551297,0.00018168631,0.000069635105,0.0000064841597,0.0016349585,0.000045663804,0.38154876,0.000015505755,0.0001908689,0.0001034007],"about_ca_topic_score_codex":0.091552414,"about_ca_topic_score_gemma":0.034271665,"teacher_disagreement_score":0.3856869,"about_ca_system_score_codex":0.00054298877,"about_ca_system_score_gemma":0.0017379834,"threshold_uncertainty_score":0.98335034},"labels":[],"label_agreement":null},{"id":"W4396591128","doi":"10.1158/1538-7445.sabcs23-po2-03-07","title":"Abstract PO2-03-07: Immune Landscape in PD-L1-positive and TROP2-positive Triple-Negative Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Canadian Navy","funders":"","keywords":"Triple-negative breast cancer; Medicine; Breast cancer; Cancer; Triple negative; Immune system; Oncology; Internal medicine; Immunology","score_opus":0.03418732605383803,"score_gpt":0.38823520985278925,"score_spread":0.35404788379895125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93069327,0.04759584,0.000004027108,0.009212033,0.0003913927,0.001316892,0.0009202866,0.000060291615,0.009805961],"genre_scores_gemma":[0.9851876,0.01115294,0.000019674928,0.00036400193,0.0005419628,0.00049579545,0.000054307253,0.000054455682,0.0021292784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99723065,0.00022167483,0.0003756291,0.00065877114,0.00078136945,0.00073192903],"domain_scores_gemma":[0.9987158,0.00049012806,0.00004619728,0.0002765774,0.0002919306,0.00017931928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011276613,0.00026739627,0.00045172256,0.00060275727,0.00016406669,0.0001746276,0.00018679435,0.00018275932,0.0031493355],"category_scores_gemma":[0.000047076657,0.00021537366,0.00014340896,0.0012253905,0.00041232945,0.00025630344,0.00006890033,0.001101144,0.00007753775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047992487,0.00093325396,0.021222606,0.0022239478,0.0024249323,0.003855552,0.02967477,0.000010606523,0.38538694,0.0005680706,0.045720387,0.45998645],"study_design_scores_gemma":[0.005703264,0.0006301225,0.9590144,0.0038760542,0.00008508817,0.00023999123,0.0034799334,0.00013202387,0.021343112,0.00017418416,0.004925177,0.00039661193],"about_ca_topic_score_codex":0.01483252,"about_ca_topic_score_gemma":0.0014451925,"teacher_disagreement_score":0.9377918,"about_ca_system_score_codex":0.0008233416,"about_ca_system_score_gemma":0.0009560267,"threshold_uncertainty_score":0.9977619},"labels":[],"label_agreement":null},{"id":"W4396591179","doi":"10.1158/1538-7445.sabcs23-gs02-02","title":"Abstract GS02-02: Are nodal ITCs after neoadjuvant chemotherapy an indication for axillary dissection? The OPBC05/EUBREAST-14R/ICARO study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Axillary Dissection; NODAL; Dissection (medical); Chemotherapy; Oncology; Breast cancer; Internal medicine; Radiology; Cancer; Mastectomy","score_opus":0.09843576198026013,"score_gpt":0.5145686091155839,"score_spread":0.4161328471353237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977382,0.0054207677,0.000014682771,0.013346479,0.0005617203,0.0027501015,0.00010158828,0.000089712994,0.00033294864],"genre_scores_gemma":[0.9908731,0.0009091853,0.000012366283,0.0005156877,0.0017604687,0.00395543,0.00005918528,0.00006124836,0.0018533005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99815404,0.000117865326,0.00022295711,0.0005141881,0.0005221607,0.0004687985],"domain_scores_gemma":[0.9988778,0.00024842756,0.00003919716,0.00039670436,0.00024899197,0.00018883913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008033335,0.0001778513,0.00023607515,0.00022691833,0.000266295,0.000117130425,0.00018905099,0.00010106311,0.0014343946],"category_scores_gemma":[0.00002512763,0.00011624802,0.00011330071,0.00049967546,0.00016373278,0.00014116376,0.000043001313,0.00055536174,0.000050259267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02201755,0.0063000973,0.2874647,0.0015819838,0.0030786598,0.0010535165,0.026858652,0.00004600316,0.08035638,0.00018078017,0.0841608,0.48690087],"study_design_scores_gemma":[0.004498408,0.0024521414,0.89285755,0.00025308042,0.00025580934,0.00006201637,0.0032329734,0.00026428115,0.0077511542,0.00029482233,0.08782156,0.00025621205],"about_ca_topic_score_codex":0.00040494945,"about_ca_topic_score_gemma":0.0005402498,"teacher_disagreement_score":0.6053928,"about_ca_system_score_codex":0.0005239732,"about_ca_system_score_gemma":0.00050440896,"threshold_uncertainty_score":0.99947846},"labels":[],"label_agreement":null},{"id":"W4396591197","doi":"10.1158/1538-7445.sabcs23-po3-14-10","title":"Abstract PO3-14-10: A single-center prospective cohort study to evaluate circulating tumor cells as a monitoring tool in women with breast cancer treated with neoadjuvant chemotherapy: final results of baseline data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; London Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Single Center; Breast cancer; Oncology; Chemotherapy; Prospective cohort study; Internal medicine; Cancer; Cohort; Gynecology","score_opus":0.10112453026881289,"score_gpt":0.41302342810211046,"score_spread":0.31189889783329755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930449,0.0005972743,0.0000055772593,0.000673103,0.00008981369,0.003962756,0.0011792537,0.000047832404,0.00039947595],"genre_scores_gemma":[0.99681306,0.00015876218,0.00014933616,0.000048040038,0.00039765282,0.0012873291,0.000037104834,0.00009826606,0.0010104313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956457,0.0001557076,0.0005484275,0.0012344809,0.0015888123,0.0008268723],"domain_scores_gemma":[0.9977154,0.00016004336,0.00010130464,0.00095206674,0.0008275611,0.00024359189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002962506,0.0003085461,0.00065743295,0.0004615545,0.00008256642,0.000113764654,0.00030657576,0.00004207888,0.00074143376],"category_scores_gemma":[0.00009140102,0.00021675174,0.00003635544,0.0017464983,0.00012342351,0.00020892732,0.00017004674,0.0006321022,0.000015551981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09744848,0.0041851075,0.5242218,0.0015507038,0.002014456,0.0030032576,0.012480358,0.00149287,0.21370491,0.0000010016029,0.0017547258,0.13814236],"study_design_scores_gemma":[0.028828148,0.0070393225,0.86565,0.012915414,0.0003836891,0.00020432481,0.006375011,0.0008393663,0.074793875,0.0000068008635,0.002165752,0.00079828355],"about_ca_topic_score_codex":0.016022833,"about_ca_topic_score_gemma":0.0018481785,"teacher_disagreement_score":0.34142825,"about_ca_system_score_codex":0.0022632792,"about_ca_system_score_gemma":0.0018246449,"threshold_uncertainty_score":0.99052954},"labels":[],"label_agreement":null},{"id":"W4396591214","doi":"10.1158/1538-7445.sabcs23-po3-17-10","title":"Abstract PO3-17-10: Real-World evidence for Pembrolizumab-based neoadjuvant chemotherapy in early-stage triple negative breast cancer: a single institution experience","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Stage (stratigraphy); Oncology; Chemotherapy; Cancer; Internal medicine; Neoadjuvant therapy; Triple-negative breast cancer","score_opus":0.1191619086055209,"score_gpt":0.40956065359596977,"score_spread":0.2903987449904489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854867,0.0064989375,0.001447556,0.0006679062,0.0011668524,0.0020608357,0.00066848117,0.00047790568,0.0015248328],"genre_scores_gemma":[0.9915393,0.002888476,0.00016531847,0.000051598745,0.0004394328,0.002361174,0.000013076952,0.00012256013,0.0024190878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971472,0.00003489453,0.00047090478,0.0006137384,0.0007209774,0.0010122848],"domain_scores_gemma":[0.99846524,0.0005774063,0.000044902677,0.0004381849,0.00026986463,0.00020438407],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005804833,0.00032985047,0.00036468744,0.0006956739,0.0001751639,0.00028685885,0.000498918,0.0001493143,0.0010951066],"category_scores_gemma":[0.00008801588,0.000319435,0.00013086906,0.0018460319,0.00029086063,0.0008683708,0.000041654475,0.000670699,0.000032060885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00699216,0.00025207075,0.004401547,0.00391491,0.00025797932,0.00023667414,0.011323057,0.098865084,0.7359848,0.0009418111,0.012903539,0.12392638],"study_design_scores_gemma":[0.010508546,0.000722461,0.071462154,0.013676591,0.000053683663,0.000010598485,0.0007641045,0.12348905,0.6885611,0.0009797694,0.087539285,0.0022326948],"about_ca_topic_score_codex":0.011610403,"about_ca_topic_score_gemma":0.010654586,"teacher_disagreement_score":0.121693686,"about_ca_system_score_codex":0.004000463,"about_ca_system_score_gemma":0.0010514483,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W4396591215","doi":"10.1158/1538-7445.sabcs23-gs02-01","title":"Abstract GS02-01: Randomized phase 3 study of datopotamab deruxtecan vs chemotherapy for patients with previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative breast cancer: Results from TROPION-Breast01","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Hormone receptor; Chemotherapy; Internal medicine; Breast cancer; Cancer; HER2 negative","score_opus":0.03609913088047207,"score_gpt":0.3900478600258503,"score_spread":0.3539487291453782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757166,0.0031392316,0.00022477644,0.0016020492,0.0001585043,0.011503009,0.007456364,0.00014117047,0.000058273905],"genre_scores_gemma":[0.9892939,0.0022101642,0.0011173517,0.00009293526,0.0003269887,0.005304718,0.0005937221,0.0002125197,0.00084773166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946902,0.000569016,0.0010420112,0.0012921803,0.001417865,0.0009887641],"domain_scores_gemma":[0.9943416,0.002304576,0.00032040503,0.00080503477,0.0018306457,0.00039769794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011593654,0.00058816414,0.0017872556,0.0004752175,0.00027371015,0.000121530844,0.00038371698,0.000119340366,0.0010679429],"category_scores_gemma":[0.0003350566,0.00037785718,0.0002027383,0.0014549397,0.0006893601,0.0004396263,0.00007881701,0.0007616665,0.00001173262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87252647,0.004119953,0.0009769979,0.00049388077,0.004689634,0.00005831167,0.008556309,0.00007519093,0.0063167503,0.000008752489,0.00078180764,0.10139593],"study_design_scores_gemma":[0.91859865,0.010662984,0.027070988,0.005089313,0.0012619859,0.000018734327,0.0044689667,0.00040636494,0.029486688,0.00024265608,0.0018183453,0.0008743125],"about_ca_topic_score_codex":0.023469565,"about_ca_topic_score_gemma":0.0012287856,"teacher_disagreement_score":0.10052162,"about_ca_system_score_codex":0.0012793115,"about_ca_system_score_gemma":0.0015952596,"threshold_uncertainty_score":0.9998673},"labels":[],"label_agreement":null},{"id":"W4396591228","doi":"10.1158/1538-7445.sabcs23-po1-04-07","title":"Abstract PO1-04-07: Disitamab vedotin, a clinical stage HER2-directed antibody-drug conjugate, shows potent antitumor activity as a monotherapy and in combination with tucatinib in preclinical breast cancer models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Medicine; Antibody-drug conjugate; Cancer; Oncology; Stage (stratigraphy); Breast cancer; Drug; Internal medicine; Conjugate; Pharmacology; Antibody; Monoclonal antibody; Immunology; Biology","score_opus":0.1508340742934629,"score_gpt":0.5248850737820561,"score_spread":0.37405099948859316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768092,0.0058581596,0.00001913257,0.012576566,0.00026957708,0.0029187943,0.00031405885,0.00015790004,0.0010766097],"genre_scores_gemma":[0.9768657,0.019572083,0.00008110243,0.0002024083,0.00032876074,0.0010538725,0.000036126057,0.00013974457,0.001720211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934429,0.0009857067,0.0009304499,0.0015326458,0.0018405379,0.0012677449],"domain_scores_gemma":[0.99654424,0.001368513,0.00011081891,0.0007145217,0.00064664904,0.0006152487],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005586109,0.00040084138,0.0009721146,0.00079056446,0.00013889282,0.00028644377,0.00039427556,0.00031450423,0.0011784589],"category_scores_gemma":[0.00030772615,0.00032860355,0.000128874,0.0016646323,0.00088773115,0.00052227586,0.00021593753,0.003582035,0.00005210525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029074576,0.005122551,0.71405655,0.0042513106,0.0005822473,0.0032618996,0.0030888217,0.0006449076,0.019430207,0.0004223205,0.0051279594,0.21493664],"study_design_scores_gemma":[0.009601012,0.0010588749,0.95192486,0.005924714,0.000035739748,0.00008093062,0.0004893428,0.025428684,0.0022815638,0.0003813991,0.0022527124,0.0005401782],"about_ca_topic_score_codex":0.034573924,"about_ca_topic_score_gemma":0.017497987,"teacher_disagreement_score":0.2378683,"about_ca_system_score_codex":0.0014388744,"about_ca_system_score_gemma":0.005183773,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W4396591266","doi":"10.1158/1538-7445.sabcs23-po1-18-02","title":"Abstract PO1-18-02: Histologic grade is a better predictor of specific survival than Ki67 in localized ER+/HER2- breast cancer: a real-world study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Pathology","score_opus":0.0802933533155122,"score_gpt":0.4005184308870681,"score_spread":0.32022507757155594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781029,0.014475735,0.0000046532678,0.0039931284,0.00053794397,0.00083873706,0.00096027914,0.000036266672,0.0010503271],"genre_scores_gemma":[0.9897497,0.0073136906,0.000018685216,0.000062206986,0.00067342975,0.00074049947,0.00005113044,0.000066335226,0.0013242874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996769,0.0002670522,0.00044854823,0.0009842683,0.00071927306,0.0008118224],"domain_scores_gemma":[0.9988394,0.00009456228,0.00007334932,0.00062700827,0.00021090146,0.00015478447],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068177073,0.0003248288,0.0004890198,0.00035892878,0.000113710164,0.00005672923,0.000466061,0.00015090012,0.0010014235],"category_scores_gemma":[0.00001667462,0.00027587925,0.00015473829,0.00076306995,0.00045179928,0.00001276648,0.00030530823,0.00047762852,0.000022439692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019704802,0.0011796186,0.87118924,0.0004923577,0.0011014927,0.00030648132,0.0019353441,0.00003264391,0.053462446,0.000060214345,0.05641824,0.01185145],"study_design_scores_gemma":[0.002232353,0.0002839099,0.94707924,0.00037996902,0.000055448807,0.000009125029,0.00081020425,0.000011834478,0.012657064,0.00012750278,0.035986934,0.00036644182],"about_ca_topic_score_codex":0.023729894,"about_ca_topic_score_gemma":0.031246623,"teacher_disagreement_score":0.07588998,"about_ca_system_score_codex":0.00067430723,"about_ca_system_score_gemma":0.0005807908,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4396591270","doi":"10.1158/1538-7445.sabcs23-po1-06-03","title":"Abstract PO1-06-03: Efficacy of First-line Treatments for Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer: A Systematic Literature Review and Network Meta-analysis Feasibility Assessment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Meta-analysis; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Oncology; Medicine; Hormone receptor; Breast cancer; Internal medicine; Cancer","score_opus":0.16044256383264885,"score_gpt":0.4900248596452728,"score_spread":0.329582295812624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591270","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12336788,0.8393145,0.00006329046,0.010913617,0.00017837156,0.01243448,0.013500859,0.00007691681,0.00015005447],"genre_scores_gemma":[0.8512797,0.13763401,0.00040007688,0.0002622322,0.00039845236,0.0063493135,0.0016220409,0.00008441044,0.0019697996],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953724,0.0008550148,0.0010792094,0.0010801468,0.00082065223,0.0007925585],"domain_scores_gemma":[0.9955233,0.0019798027,0.0003102067,0.0005299705,0.0012303705,0.00042635988],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017493844,0.0005447012,0.0033573874,0.00045934517,0.000340626,0.00012361543,0.00021533764,0.00014681187,0.0025555743],"category_scores_gemma":[0.00010209388,0.00036736677,0.0013471245,0.0021547948,0.0002653334,0.00023481048,0.00010263761,0.0006658507,0.000011591544],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003196136,0.003370486,0.008632442,0.2724259,0.6534766,0.00023500269,0.001790009,0.0000848145,0.010614161,0.00030840878,0.04447326,0.001392781],"study_design_scores_gemma":[0.009727547,0.0038730914,0.147539,0.03328124,0.80023986,0.00008449864,0.000117595424,0.0002774014,0.0030057267,0.00018385817,0.00065569236,0.0010144768],"about_ca_topic_score_codex":0.0009705911,"about_ca_topic_score_gemma":0.00028944245,"teacher_disagreement_score":0.7279118,"about_ca_system_score_codex":0.0015877411,"about_ca_system_score_gemma":0.00049525086,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W4396591286","doi":"10.1158/1538-7445.sabcs23-ps03-03","title":"Abstract PS03-03: The spatially resolved single-cell atlas of the tumor immune architecture revealed the central role of IFN-alpha and plasmacytoid dendritic cells in triple-negative breast cancer in the Mayo Clinic cohort and FinXX trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immune system; Triple-negative breast cancer; Triple negative; Cancer; Breast cancer; Cancer research; Pathology; Atlas (anatomy); Biology; Medicine; Immunology; Internal medicine; Anatomy","score_opus":0.02193138004293902,"score_gpt":0.310057030585977,"score_spread":0.28812565054303796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433642,0.050937943,6.097203e-7,0.0024680062,0.000542749,0.0021260872,0.000320262,0.0000077138175,0.00023241088],"genre_scores_gemma":[0.99386096,0.004436661,0.000002463372,0.00007396309,0.00007657399,0.00031576047,0.0000058725777,0.000028274077,0.0011994818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99529034,0.0027240783,0.0007146985,0.00038910925,0.00022322853,0.0006585739],"domain_scores_gemma":[0.994766,0.0043700426,0.00017775438,0.0005593192,0.000108231754,0.000018641975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029954344,0.0002397262,0.00046154638,0.00017984732,0.0003209221,0.00006788408,0.000850142,0.00018574687,0.0004517259],"category_scores_gemma":[0.00025965096,0.00011264079,0.00015692985,0.000645614,0.0019147615,0.00007088425,0.00020713963,0.0018134636,0.0000073893734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041837603,0.00025567028,0.00297111,0.00018316426,0.0002451722,0.000013073975,0.010170246,0.000035023193,0.93270844,0.00003785393,0.00042208724,0.0111205755],"study_design_scores_gemma":[0.018739114,0.000809068,0.3810592,0.0010975178,0.00009925947,0.00008917964,0.004744355,0.000023351966,0.5876746,0.0004759269,0.0049097943,0.0002785951],"about_ca_topic_score_codex":0.008851656,"about_ca_topic_score_gemma":0.0034376222,"teacher_disagreement_score":0.3780881,"about_ca_system_score_codex":0.00012587941,"about_ca_system_score_gemma":0.00078903185,"threshold_uncertainty_score":0.9977485},"labels":[],"label_agreement":null},{"id":"W4396591312","doi":"10.1158/1538-7445.sabcs23-po4-04-09","title":"Abstract PO4-04-09: Incidence, prevalence, risk factors, and impact of fatty liver disease in metastatic HR+/HER2− breast cancer patients treated with Endocrine Therapy and CDK 4/6 Inhibitor","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Metastatic breast cancer; Internal medicine; Oncology; Cancer; Endocrine system; Disease; Fatty liver; Gastroenterology; Hormone","score_opus":0.04752979416675778,"score_gpt":0.39115521483795074,"score_spread":0.34362542067119295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97349507,0.022436567,7.7893145e-7,0.00010200694,0.00005524949,0.00124104,0.0026099011,0.00003074573,0.000028642877],"genre_scores_gemma":[0.9486413,0.050724447,0.0000074969707,0.000008971133,0.00009652617,0.00021479,0.00003399365,0.00005266195,0.00021979318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975521,0.00013359237,0.00034234652,0.00060664804,0.00080157066,0.0005637499],"domain_scores_gemma":[0.99853253,0.00025310242,0.0000883418,0.00028155488,0.00033784352,0.0005066087],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030597465,0.00031202228,0.0004898956,0.00053692906,0.00008975422,0.00008782764,0.00010941963,0.000055560136,0.0009666996],"category_scores_gemma":[0.00005777948,0.00018791998,0.000097731645,0.00085819594,0.00044360466,0.00031942007,0.00007383518,0.0006440982,0.0000026770986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027484286,0.00026418557,0.9704194,0.001097617,0.00029478976,0.0001388843,0.00071923883,0.000022949369,0.0012668928,0.0000031664008,0.00031711636,0.022707347],"study_design_scores_gemma":[0.0022537159,0.00076258444,0.9934889,0.001582775,0.0001103701,0.0000068657387,0.00006325655,0.00021165854,0.0011310021,0.000014116538,0.0001795998,0.00019514779],"about_ca_topic_score_codex":0.10394398,"about_ca_topic_score_gemma":0.0023877118,"teacher_disagreement_score":0.101556264,"about_ca_system_score_codex":0.0005820806,"about_ca_system_score_gemma":0.00092794886,"threshold_uncertainty_score":0.99994653},"labels":[],"label_agreement":null},{"id":"W4396591360","doi":"10.1158/1538-7445.sabcs23-rf01-05","title":"Abstract RF01-05: Functional assessment of RAD51 foci and replication fork dynamics in PARPi resistant BRCA1/2 mutated breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"RAD51; Replication (statistics); Breast cancer; Cancer; Medicine; Cancer research; Biology; Oncology; Internal medicine; Genetics; Virology; DNA repair; Gene","score_opus":0.03566230920039255,"score_gpt":0.39481725489809494,"score_spread":0.3591549456977024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941365,0.0027758789,0.0002491967,0.0011375389,0.00016587392,0.00035272,0.0003616636,0.000016871269,0.00080375245],"genre_scores_gemma":[0.99722695,0.0012809184,0.00016392116,0.000025957965,0.00012594738,0.00030525302,0.00018136449,0.000027921718,0.0006617557],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985058,0.00007453081,0.00023185,0.00054779754,0.00035576866,0.00028425988],"domain_scores_gemma":[0.99923646,0.00003970609,0.000041340878,0.00038797632,0.00021909185,0.00007541563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008745892,0.00010156054,0.00012507089,0.00013017296,0.000057116635,0.000041769057,0.00013145086,0.0001303391,0.00011197165],"category_scores_gemma":[0.000037787056,0.00009972805,0.000043119468,0.00030796233,0.000119302305,0.000008914989,0.00011806746,0.00025208102,0.0000015289679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025579974,0.000051770214,0.0032755968,0.0002644823,0.000081134756,0.000013340513,0.00002973457,0.00013576297,0.9704271,0.0027369722,0.0021673471,0.020560944],"study_design_scores_gemma":[0.0018901218,0.00055708434,0.5012848,0.0009181053,0.000046704812,0.000058384914,0.00066430523,0.01682421,0.45997503,0.0037371267,0.013430805,0.00061330514],"about_ca_topic_score_codex":0.0011866282,"about_ca_topic_score_gemma":0.0028534445,"teacher_disagreement_score":0.5104521,"about_ca_system_score_codex":0.0004407835,"about_ca_system_score_gemma":0.0008049826,"threshold_uncertainty_score":0.40667918},"labels":[],"label_agreement":null},{"id":"W4396591373","doi":"10.1158/1538-7445.sabcs23-po5-01-11","title":"Abstract PO5-01-11: Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.0729794681656417,"score_gpt":0.40176650979657125,"score_spread":0.32878704163092953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762667,0.01604351,0.000016245513,0.0011206727,0.00009047442,0.00060867536,0.0052735666,0.000017534065,0.0005626325],"genre_scores_gemma":[0.995854,0.003423591,0.000003864617,0.000018028668,0.00031469448,0.00008921984,0.000096456075,0.000008724923,0.00019141026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798787,0.00022389856,0.0002412882,0.00046443244,0.0008216354,0.00026086482],"domain_scores_gemma":[0.9985534,0.00052630884,0.00005960816,0.00047224388,0.00020884242,0.00017959629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008798521,0.00012630697,0.0004638865,0.00017087528,0.00013997228,0.0000821803,0.00013414395,0.000057665307,0.00014806072],"category_scores_gemma":[0.00005174067,0.00007101096,0.00021399786,0.0013992911,0.00039476156,0.00007455945,0.00007230531,0.0005968926,0.0000028159302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40133515,0.00078317587,0.41200048,0.00062692416,0.06708592,0.0005109335,0.0152566675,0.0034835918,0.0046392144,0.00019247811,0.020808611,0.07327686],"study_design_scores_gemma":[0.01051259,0.0001183223,0.9785902,0.00079586165,0.003197211,0.0000024225083,0.0005868638,0.0016448165,0.00060710823,0.000033227345,0.0037855476,0.00012585464],"about_ca_topic_score_codex":0.028725524,"about_ca_topic_score_gemma":0.006360475,"teacher_disagreement_score":0.5665897,"about_ca_system_score_codex":0.00011395564,"about_ca_system_score_gemma":0.0005873943,"threshold_uncertainty_score":0.97774225},"labels":[],"label_agreement":null},{"id":"W4396591390","doi":"10.1158/1538-7445.sabcs23-po4-15-01","title":"Abstract PO4-15-01: A multi-center prospective cohort study to evaluate the presence of circulating tumor cells using the Epic Sciences platform among women with metastatic breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; University of Toronto; Health Sciences Centre; Mount Sinai Hospital","funders":"","keywords":"EPIC; Medicine; Cancer; European Prospective Investigation into Cancer and Nutrition; Prospective cohort study; Circulating tumor cell; Oncology; Breast cancer; Internal medicine; Metastatic breast cancer; Center (category theory); Cohort; Metastasis","score_opus":0.13419414658903475,"score_gpt":0.44649185189997465,"score_spread":0.3122977053109399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992434,0.0014755895,0.000049659666,0.00044964722,0.00022263025,0.004934762,0.00015465112,0.000025831718,0.00025323033],"genre_scores_gemma":[0.997584,0.00009886106,0.00013632933,0.00007182892,0.0001714585,0.0016659149,9.1103675e-7,0.000045882734,0.00022482111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958262,0.00019635067,0.00039455766,0.00072194525,0.0020059296,0.0008550507],"domain_scores_gemma":[0.99822104,0.00038706514,0.00008811138,0.0005139918,0.00056768645,0.00022208797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004708385,0.00023727826,0.00044258035,0.00026601902,0.0005150014,0.00022725292,0.0004472777,0.00001954815,0.00082780654],"category_scores_gemma":[0.00008627074,0.00011492074,0.00007641557,0.0019813087,0.0009198977,0.0002419988,0.00022948308,0.0006714233,0.000008964801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002011601,0.0016700437,0.81022066,0.0017251949,0.0026615844,0.00040701244,0.05818938,0.01067616,0.097025625,0.000044324257,0.0006945698,0.014673832],"study_design_scores_gemma":[0.0033377395,0.0011240505,0.91993845,0.0031271225,0.000565114,0.00010900691,0.043097537,0.00816395,0.019913988,0.000060042363,0.00017541867,0.00038756937],"about_ca_topic_score_codex":0.01625987,"about_ca_topic_score_gemma":0.0034299446,"teacher_disagreement_score":0.109717794,"about_ca_system_score_codex":0.0011097766,"about_ca_system_score_gemma":0.0018355809,"threshold_uncertainty_score":0.99029094},"labels":[],"label_agreement":null},{"id":"W4396591409","doi":"10.1158/1538-7445.sabcs23-po5-25-11","title":"Abstract PO5-25-11: Appropriate use of interventional cohort studies with threshold-crossing designs for de-escalation trials in breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; De-escalation; Breast cancer; Oncology; Cancer; Clinical trial; Internal medicine","score_opus":0.8202358938532961,"score_gpt":0.612634825643687,"score_spread":0.2076010682096091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96858805,0.011704564,0.002996738,0.013039089,0.00042622318,0.0018200893,0.0013521335,0.00002611467,0.000046996844],"genre_scores_gemma":[0.9952007,0.00087196875,0.00093056133,0.00019629342,0.00045543828,0.001813059,0.000028575683,0.000044084773,0.00045931802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951812,0.0004764819,0.0030467936,0.00056985015,0.00021290961,0.0005127606],"domain_scores_gemma":[0.994803,0.0038071473,0.0006730953,0.00025702876,0.00035514284,0.000104590305],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05401468,0.00015119603,0.0010608409,0.0006950591,0.00020125901,0.0003492016,0.00019023019,0.00012061583,0.00039609818],"category_scores_gemma":[0.0030222682,0.0001499374,0.00016941263,0.00044788545,0.00026489445,0.0006890394,0.00005063633,0.00027836082,0.000029414135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063101755,0.00025946568,0.8993946,0.007610801,0.0012635897,0.0000056214476,0.00647617,0.013045622,0.0004397713,0.04443319,0.02351665,0.0029235575],"study_design_scores_gemma":[0.0029668456,0.0002185592,0.9086654,0.0073425365,0.000053663778,0.0000088255865,0.0026060003,0.029411675,0.00039293297,0.035934933,0.011726233,0.00067237],"about_ca_topic_score_codex":0.007154902,"about_ca_topic_score_gemma":0.0041936776,"teacher_disagreement_score":0.050992414,"about_ca_system_score_codex":0.0020911496,"about_ca_system_score_gemma":0.0011461229,"threshold_uncertainty_score":0.9994565},"labels":[],"label_agreement":null},{"id":"W4396591572","doi":"10.1158/1538-7445.sabcs23-po5-12-02","title":"Abstract PO5-12-02: Landscape analysis of oncology nutrition research among patients being treated for breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.10372013001793255,"score_gpt":0.4749927894149453,"score_spread":0.37127265939701276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847068,0.004350792,0.0000033476483,0.00351054,0.00013076227,0.0011370416,0.0017537322,0.000031956966,0.0043749795],"genre_scores_gemma":[0.9914965,0.005190094,0.00002231695,0.000030504862,0.0005389979,0.0015202637,0.00035486024,0.000028877617,0.00081756467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974825,0.000114550974,0.00033061812,0.00044961515,0.0009954977,0.0006272367],"domain_scores_gemma":[0.9967852,0.0008081424,0.000036780893,0.00019726554,0.001985931,0.00018667598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001202054,0.00011902119,0.000462799,0.0012214782,0.0002706961,0.0000447109,0.00013067618,0.00014817221,0.001533919],"category_scores_gemma":[0.00012498176,0.00009739512,0.0002282458,0.0023335167,0.00030490576,0.00009349688,0.00009013032,0.0005291136,0.000010148036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053902897,0.0023772279,0.6685971,0.004267477,0.0054372516,0.00010785894,0.0007852973,0.000045054272,0.009893255,0.00061758334,0.23060536,0.07187621],"study_design_scores_gemma":[0.0028163865,0.0008615498,0.96134055,0.0013078423,0.00045808166,0.0000015069149,0.00069822156,0.00062460976,0.0017512481,0.0004212796,0.029586826,0.00013191646],"about_ca_topic_score_codex":0.005092885,"about_ca_topic_score_gemma":0.003008917,"teacher_disagreement_score":0.2927434,"about_ca_system_score_codex":0.0008331112,"about_ca_system_score_gemma":0.00037183636,"threshold_uncertainty_score":0.9993788},"labels":[],"label_agreement":null},{"id":"W4396591583","doi":"10.1158/1538-7445.sabcs23-po5-04-11","title":"Abstract PO5-04-11: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) beyond progression in hormone receptor positive advanced breast cancer: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Meta-analysis; Breast cancer; Medicine; Hormone receptor; Cyclin-dependent kinase 4; Cancer; Oncology; Cancer research; Internal medicine; Kinase; Biology; Cell cycle; Cyclin-dependent kinase 2; Genetics","score_opus":0.09274614306301798,"score_gpt":0.4757449913275471,"score_spread":0.3829988482645291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007658573,0.9787023,0.0000025270197,0.0034248235,0.00019097108,0.013844509,0.003536602,0.00012430303,0.000097344135],"genre_scores_gemma":[0.0005568676,0.97352713,0.00010850295,0.00023983713,0.00035138254,0.022395993,0.00034827084,0.00032995496,0.0021420792],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9893813,0.0013125128,0.0027268957,0.0024207816,0.002642964,0.0015155096],"domain_scores_gemma":[0.9947464,0.0006367022,0.0010870633,0.0016709828,0.0010696198,0.00078925857],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0034607213,0.0014756784,0.013207993,0.002382597,0.00023552791,0.00020890261,0.00073812297,0.0006208953,0.0010942785],"category_scores_gemma":[0.0002777699,0.0009510992,0.0025907715,0.0057912907,0.000543051,0.00040840395,0.00058375933,0.0032378847,0.00012806703],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002418772,0.00022218698,0.0000050734507,0.8149003,0.0676576,0.00045607256,0.0002154862,0.0000040482264,0.00010154077,0.000016419192,0.00053021265,0.11564921],"study_design_scores_gemma":[0.0009680349,0.0002084627,0.000025458892,0.43096954,0.5330498,0.00024434383,0.00021304715,0.0000021275787,0.000051886756,0.00003709397,0.033147912,0.001082248],"about_ca_topic_score_codex":0.0011382651,"about_ca_topic_score_gemma":0.00079650996,"teacher_disagreement_score":0.46539223,"about_ca_system_score_codex":0.003907565,"about_ca_system_score_gemma":0.0021394703,"threshold_uncertainty_score":0.99991626},"labels":[],"label_agreement":null},{"id":"W4396591594","doi":"10.1158/1538-7445.sabcs23-po4-08-09","title":"Abstract PO4-08-09: Concordance analysis of paired breast cancer core needle biopsies and surgical excision samples using the Oncotype DX Breast Recurrence Score® assay","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Concordance; Medicine; Breast cancer; Core biopsy; Surgical excision; Oncology; Cancer; Internal medicine; Radiology","score_opus":0.12510888158752315,"score_gpt":0.42154641378730423,"score_spread":0.2964375321997811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94506407,0.05107809,0.000050066545,0.0011200545,0.00023313214,0.00025731084,0.0020074642,0.00001835132,0.00017144014],"genre_scores_gemma":[0.9841305,0.015072277,0.000042440843,0.000029781648,0.00039474384,0.00011715467,0.00008595136,0.000030836738,0.000096327414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977682,0.00017178427,0.00031325183,0.0006971405,0.0005482048,0.000501374],"domain_scores_gemma":[0.9984956,0.00031545674,0.00009095087,0.00046769792,0.00050593255,0.0001243858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008174337,0.00024899273,0.00040053346,0.00023523434,0.00030057592,0.00009770655,0.0003196221,0.00014083431,0.0002063307],"category_scores_gemma":[0.000060335857,0.00017121703,0.00017349854,0.0013803166,0.00094258325,0.000021247612,0.0003311569,0.00030514132,0.0000030762455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026469997,0.000259204,0.44984415,0.0007152211,0.0056036953,0.00010341307,0.0012995338,0.0016802147,0.33115882,0.00047628142,0.004355007,0.20185746],"study_design_scores_gemma":[0.0012423114,0.00018376451,0.9584362,0.0014909396,0.0010369862,0.00023243282,0.0014201764,0.0022302356,0.02002689,0.00017305832,0.012829896,0.00069712783],"about_ca_topic_score_codex":0.0069245007,"about_ca_topic_score_gemma":0.0022939302,"teacher_disagreement_score":0.50859207,"about_ca_system_score_codex":0.00019449717,"about_ca_system_score_gemma":0.0005658964,"threshold_uncertainty_score":0.99968845},"labels":[],"label_agreement":null},{"id":"W4396591595","doi":"10.1158/1538-7445.sabcs23-ps07-02","title":"Abstract PS07-02: Benign breast disease and microcalcifications in percutaneous biopsies and breast cancer risk","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Disease; Cancer; Internal medicine; Radiology; Oncology","score_opus":0.04166762388050015,"score_gpt":0.37732903949103425,"score_spread":0.3356614156105341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486851,0.036946896,0.0000027788103,0.012370796,0.00006779693,0.0003873225,0.0012270539,0.00004564372,0.00026660544],"genre_scores_gemma":[0.9845774,0.014001685,0.00002279944,0.000058430207,0.00027969363,0.00018484764,0.000018052484,0.00003597143,0.0008211127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840564,0.00007035167,0.00019282685,0.0005299261,0.00035437578,0.0004469076],"domain_scores_gemma":[0.9989021,0.00015028229,0.000017528218,0.0002898664,0.00017585767,0.00046435412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038678985,0.00015258553,0.00020102148,0.00036773065,0.00020906309,0.00014494866,0.000092441885,0.000086344524,0.00067952665],"category_scores_gemma":[0.000028946251,0.00012282301,0.00004637997,0.00054076687,0.00043677067,0.00010750516,0.00009277149,0.00067289866,0.000028945624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001730579,0.0003875363,0.42007625,0.00240246,0.0002594271,0.0029138934,0.002617674,0.000035900674,0.16157025,0.0009859531,0.0077448185,0.39927524],"study_design_scores_gemma":[0.0003210664,0.000027556198,0.9938639,0.00080480886,0.00006871509,0.0014949896,0.0006418608,0.00053776964,0.00011602132,0.00019119422,0.0017914475,0.00014068095],"about_ca_topic_score_codex":0.0067775506,"about_ca_topic_score_gemma":0.0008086752,"teacher_disagreement_score":0.5737876,"about_ca_system_score_codex":0.00025698592,"about_ca_system_score_gemma":0.0006772097,"threshold_uncertainty_score":0.9998364},"labels":[],"label_agreement":null},{"id":"W4396591657","doi":"10.1158/1538-7445.sabcs23-ps12-04","title":"Abstract PS12-04: Inhibition of GPX4 enhances CDK4/6 inhibitor activity in breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Cancer; Breast cancer; Medicine; Cancer research; Internal medicine; Oncology; Pharmacology","score_opus":0.02241934872815906,"score_gpt":0.3695550030738969,"score_spread":0.34713565434573784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496574,0.012746761,0.00000639309,0.0006997578,0.00026670043,0.0002464196,0.00012270089,0.0000133312515,0.0009321949],"genre_scores_gemma":[0.99334866,0.005547695,0.0000063817506,0.000015677599,0.0004764677,0.00017158693,0.000020677013,0.000025761638,0.00038709881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863946,0.000107389744,0.00016749237,0.00039745387,0.00031476776,0.00037345666],"domain_scores_gemma":[0.9995234,0.000038506118,0.0000313943,0.00019403828,0.00012645424,0.00008619152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005181722,0.00012511351,0.00014657009,0.00017243583,0.00005539861,0.00003707662,0.00011949548,0.00023184907,0.00017555337],"category_scores_gemma":[0.000021853544,0.000107482585,0.00007853517,0.00042497946,0.0001946997,0.0000148225,0.00009863534,0.00049301336,0.000020390738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002480305,0.000075347176,0.0010174073,0.00027154016,0.000051130744,0.000024641695,0.00007605563,0.000044395827,0.98084044,0.000028921126,0.0039812154,0.013340847],"study_design_scores_gemma":[0.00027806882,0.00010160345,0.009918806,0.0004722248,0.0000056058593,0.0000057599573,0.000037835354,0.00003794211,0.9871156,0.000053004645,0.0018521713,0.00012136639],"about_ca_topic_score_codex":0.00096445373,"about_ca_topic_score_gemma":0.00027608534,"teacher_disagreement_score":0.01321948,"about_ca_system_score_codex":0.00011030699,"about_ca_system_score_gemma":0.0004566659,"threshold_uncertainty_score":0.43830127},"labels":[],"label_agreement":null},{"id":"W4396591725","doi":"10.1158/1538-7445.sabcs23-ps06-04","title":"Abstract PS06-04: The prognostic and predictive impact of circulating tumour DNA (ctDNA) dynamics in patients with metastatic Triple Negative Breast Cancer (TNBC) on olaparib based therapy: Results from Cohort E of the PlasmaMATCH trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Olaparib; Medicine; Triple-negative breast cancer; Oncology; Breast cancer; Internal medicine; Cancer; Metastatic breast cancer; Cohort; DNA; Biology; Poly ADP ribose polymerase","score_opus":0.02395909323853186,"score_gpt":0.3259963800096593,"score_spread":0.30203728677112746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988612,0.00051888725,0.000009622083,0.00029888924,0.00016027705,0.0018323563,0.008490248,0.000003383593,0.000074330164],"genre_scores_gemma":[0.99900573,0.00032576,0.000011243863,0.000024726785,0.00011267328,0.00028674683,0.00018866613,0.000033246957,0.000011230382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982205,0.00020763712,0.00034814034,0.00043518716,0.0004878332,0.00030070447],"domain_scores_gemma":[0.9983302,0.0007664909,0.00016238843,0.00035547983,0.0003194882,0.000065984445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000614566,0.00018173644,0.00025842132,0.00008521408,0.00009293781,0.000056554534,0.00026214225,0.00007880859,0.000016878335],"category_scores_gemma":[0.0004042485,0.00010232068,0.000099118566,0.00039209455,0.00032115425,0.000009028392,0.000091148584,0.00035768686,2.8517283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17261934,0.0012331485,0.7242595,0.00029158112,0.0024874823,0.000019243122,0.0020037545,0.03740208,0.046415064,0.000074519274,0.0016552729,0.01153901],"study_design_scores_gemma":[0.01664148,0.0013521599,0.96196723,0.00051534595,0.000066802226,5.1418556e-7,0.0002274029,0.005627439,0.013327702,0.00010229405,0.000016644597,0.00015496327],"about_ca_topic_score_codex":0.00879224,"about_ca_topic_score_gemma":0.0028860855,"teacher_disagreement_score":0.23770775,"about_ca_system_score_codex":0.00034512233,"about_ca_system_score_gemma":0.0012901381,"threshold_uncertainty_score":0.9978083},"labels":[],"label_agreement":null},{"id":"W4396591809","doi":"10.1158/1538-7445.sabcs23-po5-13-03","title":"Abstract PO5-13-03: Early Detection of Breast Cancer using Targeted Plasma Metabolomic Profiling","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Alberta; St. Boniface Hospital; The Metabolomics Innovation Centre","funders":"","keywords":"Breast cancer; Metabolomics; Profiling (computer programming); Medicine; Oncology; Internal medicine; Cancer; Bioinformatics; Biology; Computer science","score_opus":0.04598664908176303,"score_gpt":0.37101020691164427,"score_spread":0.32502355782988124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97212464,0.026226237,0.00010817548,0.00013945671,0.000573841,0.0002747207,0.00027570024,0.00001832394,0.00025892438],"genre_scores_gemma":[0.9935155,0.005181719,0.00015794329,0.000010348563,0.0006294413,0.00011095548,0.000014039198,0.000042882464,0.0003372048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983479,0.000077291836,0.00025931807,0.00049376127,0.00034172705,0.00047999903],"domain_scores_gemma":[0.99924254,0.000028992035,0.000056765795,0.0002568193,0.0003277897,0.00008710925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006106316,0.0001642365,0.00023872967,0.00026417078,0.00015555485,0.00006555902,0.00020923349,0.00014370841,0.00013022646],"category_scores_gemma":[0.00005607899,0.00014485906,0.00011875034,0.0005490383,0.00016858314,0.000012583228,0.00017129065,0.0003444293,0.000009264429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019453217,0.000022006736,0.0011617751,0.00016518745,0.00028892054,0.000004202968,0.000056956073,0.00013654631,0.9925123,0.000070453825,0.00016529179,0.0052218447],"study_design_scores_gemma":[0.00023885356,0.00007021101,0.013856432,0.000068487236,0.000031460393,0.0000075345856,0.00010779091,0.0004444677,0.98141176,0.000071603325,0.0035316707,0.00015970302],"about_ca_topic_score_codex":0.0020415625,"about_ca_topic_score_gemma":0.00032664087,"teacher_disagreement_score":0.021390846,"about_ca_system_score_codex":0.00010523895,"about_ca_system_score_gemma":0.00037979087,"threshold_uncertainty_score":0.5907181},"labels":[],"label_agreement":null},{"id":"W4396591833","doi":"10.1158/1538-7445.sabcs23-ps03-04","title":"Abstract PS03-04: Tumor immune microenvironment modulates resistance to estrogen suppression in ER+ breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Tumor microenvironment; Breast cancer; Estrogen; Immune system; Cancer; Medicine; Cancer research; Estrogen receptor; Internal medicine; Oncology; Immunology","score_opus":0.03220530550140412,"score_gpt":0.3696461242090047,"score_spread":0.3374408187076006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92031854,0.06340288,0.0000032674038,0.014140607,0.00038423855,0.0009362166,0.00025823782,0.000055597135,0.00050040573],"genre_scores_gemma":[0.9876126,0.0054735104,0.00007808965,0.00030721992,0.00034893714,0.0007489234,0.000020117517,0.000071681956,0.005338933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99720126,0.00008091642,0.0004237006,0.00068526104,0.0007954833,0.0008133738],"domain_scores_gemma":[0.9990227,0.000095876254,0.000033205677,0.0005235406,0.00008344322,0.000241216],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008214876,0.00022954529,0.00033746037,0.00041683952,0.00012662944,0.0001034719,0.00028167924,0.00009799947,0.0037734378],"category_scores_gemma":[0.000020018279,0.0001893592,0.00013561604,0.0008827104,0.00020365187,0.0001311235,0.00013034567,0.00069099537,0.0001324634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004922082,0.00013229593,0.0060747964,0.00063597003,0.00013499954,0.00036609842,0.00056892575,0.000068313224,0.93545,0.00002203316,0.023174347,0.028450137],"study_design_scores_gemma":[0.0020874578,0.0001515473,0.46611208,0.006789936,0.000031102554,0.000052233347,0.00032673727,0.00008449387,0.34585416,0.00009329821,0.17803158,0.00038537162],"about_ca_topic_score_codex":0.004474693,"about_ca_topic_score_gemma":0.0010950213,"teacher_disagreement_score":0.58959585,"about_ca_system_score_codex":0.0018076833,"about_ca_system_score_gemma":0.0005847776,"threshold_uncertainty_score":0.99713725},"labels":[],"label_agreement":null},{"id":"W4396591864","doi":"10.1158/1538-7445.sabcs23-ps02-04","title":"Abstract PS02-04: Associations of sleep health with quality of life among women with newly diagnosed breast cancer: baseline results from the AMBER cohort study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Athabasca University; Alberta Health Services","funders":"","keywords":"Medicine; Breast cancer; Cohort; Cancer; Sleep quality; Quality of life (healthcare); Gerontology; Baseline (sea); Cohort study; Oncology; Demography; Internal medicine; Psychiatry; Insomnia; Biology","score_opus":0.07293664265975336,"score_gpt":0.427286019234932,"score_spread":0.3543493765751786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336506,0.003955579,0.000015847612,0.0058880174,0.00012214294,0.0023408267,0.004155229,0.000039696846,0.000117580785],"genre_scores_gemma":[0.99625283,0.00239236,0.000018421275,0.00016773191,0.000475173,0.0004092906,0.0001243951,0.000043620596,0.00011614328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950341,0.0008372921,0.0007813365,0.00053698575,0.0021723015,0.000638005],"domain_scores_gemma":[0.9956625,0.0018618759,0.00024470573,0.00082042,0.0008797918,0.0005307153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008084333,0.00018106087,0.0008447961,0.00015220483,0.00020254745,0.000033954148,0.00018909358,0.00008515245,0.0002357653],"category_scores_gemma":[0.0005910932,0.000100176614,0.000114887116,0.0011339689,0.00032417802,0.00008921756,0.00005485291,0.0009176895,0.0000044036447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032573645,0.00036243745,0.97403693,0.0004192205,0.0018169302,0.0000277574,0.0068444517,0.00041197287,0.000040592524,0.00000336666,0.005068013,0.0077109355],"study_design_scores_gemma":[0.004037861,0.0004268542,0.9893138,0.0006143424,0.00010120613,0.0000012153462,0.004817943,0.000049211063,0.000033271994,0.0000032405153,0.0004982865,0.00010277789],"about_ca_topic_score_codex":0.5135605,"about_ca_topic_score_gemma":0.10539153,"teacher_disagreement_score":0.40816897,"about_ca_system_score_codex":0.0011361644,"about_ca_system_score_gemma":0.0052467845,"threshold_uncertainty_score":0.930757},"labels":[],"label_agreement":null},{"id":"W4396591874","doi":"10.1158/1538-7445.sabcs23-ps06-08","title":"Abstract PS06-08: Longitudinal Neoadjuvant and Post-operative Evaluation of Circulating Tumor DNA in Early Breast Cancer using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Cohort; Internal medicine","score_opus":0.057198589314755195,"score_gpt":0.40817757905186824,"score_spread":0.35097898973711306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947286,0.0036755954,0.000012871397,0.00017108534,0.00009931824,0.0005066599,0.0006938371,0.0000026470643,0.00010935153],"genre_scores_gemma":[0.99938196,0.00029662834,0.000019167122,0.000028158722,0.00008882374,0.00009437504,0.000056729947,0.000019118796,0.000015024071],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821264,0.00014993787,0.00036877333,0.00037841048,0.0005993374,0.0002908841],"domain_scores_gemma":[0.9985518,0.00008907319,0.000106409,0.00027189025,0.00091652805,0.00006430748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001579834,0.000131467,0.0002639417,0.00027338736,0.00008332151,0.00006588065,0.00016198469,0.00007051608,0.00014418218],"category_scores_gemma":[0.00020927552,0.00010465837,0.000109725464,0.000981927,0.00021285357,0.000016011127,0.0001405649,0.00023006795,4.6136287e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013631694,0.00003430139,0.24390458,0.0000957744,0.0006958066,0.000007063058,0.0005070478,0.015194095,0.7357688,0.000028196435,0.000059783757,0.0035682574],"study_design_scores_gemma":[0.00042285264,0.000047476675,0.9036646,0.00023192601,0.00040541086,0.000007746363,0.00025317355,0.028632347,0.06614878,0.000019355555,0.00003672648,0.00012959268],"about_ca_topic_score_codex":0.010842831,"about_ca_topic_score_gemma":0.008023242,"teacher_disagreement_score":0.66962,"about_ca_system_score_codex":0.00033657413,"about_ca_system_score_gemma":0.002053732,"threshold_uncertainty_score":0.99574405},"labels":[],"label_agreement":null},{"id":"W4396591900","doi":"10.1158/1538-7445.sabcs23-po4-16-02","title":"Abstract PO4-16-02: Can high progesterone receptor (PgR) expression identify tumours with low-risk tumour gene expression scores?","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Progesterone receptor; Oestrogen receptor; Cancer research; Gene; Gene expression; Internal medicine; Biology; Medicine; Oncology; Cancer; Endocrinology; Breast cancer; Genetics; Estrogen receptor","score_opus":0.06007723077115895,"score_gpt":0.3816555563743343,"score_spread":0.32157832560317534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767683,0.018634679,0.000039149836,0.0017526126,0.0005492976,0.0012456848,0.00033125668,0.00015681348,0.00052217825],"genre_scores_gemma":[0.99120295,0.0033456353,0.0004396739,0.000060406623,0.0011931178,0.0008297718,0.0001315774,0.00013062223,0.0026662222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99509645,0.0002984942,0.00047872597,0.0010762329,0.0020125816,0.0010375121],"domain_scores_gemma":[0.9978145,0.0001988033,0.0001156218,0.00073630316,0.0005857717,0.00054904673],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014552103,0.00039139786,0.00060402014,0.00048519493,0.000496808,0.00026467937,0.0002955087,0.0001461695,0.0019825704],"category_scores_gemma":[0.0001868491,0.00025793616,0.00015026638,0.0007841417,0.00037558767,0.00023331257,0.00031339546,0.0014057622,0.0002047291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011362504,0.00019102512,0.01784956,0.0013656508,0.00014050523,0.0009405337,0.00070762704,0.0000109667435,0.8981776,0.000031108793,0.07125561,0.0081935255],"study_design_scores_gemma":[0.0014104573,0.00058550446,0.0976717,0.0058841207,0.00010875196,0.00006901038,0.0009546057,0.000006941961,0.8887605,0.000060729824,0.004158634,0.00032904817],"about_ca_topic_score_codex":0.0017115569,"about_ca_topic_score_gemma":0.00031074326,"teacher_disagreement_score":0.079822145,"about_ca_system_score_codex":0.000654816,"about_ca_system_score_gemma":0.0008237752,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W4396596413","doi":"10.1158/1538-7445.sabcs23-rf02-01","title":"Abstract RF02-01: A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab in Hormone Receptor (HR)-Positive, HER2-Positive Metastatic Breast Cancer (ASPIRE)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Pertuzumab; Palbociclib; Anastrozole; Medicine; Trastuzumab; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Letrozole; Hormone receptor; Cancer; Tamoxifen","score_opus":0.052623292453304084,"score_gpt":0.4284209011597165,"score_spread":0.3757976087064124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396596413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646608,0.024523083,0.00008176537,0.005360013,0.00036437876,0.0025801456,0.0021237994,0.00007828513,0.00022771175],"genre_scores_gemma":[0.99128455,0.005663423,0.0003805428,0.0001381462,0.00056833157,0.001164983,0.00008289881,0.00012986067,0.0005872482],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99563414,0.00029573904,0.0008054959,0.000990515,0.0012039999,0.001070124],"domain_scores_gemma":[0.9979426,0.00051844993,0.00014194548,0.00043557378,0.0005147762,0.00044665724],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096638076,0.00045594812,0.00094662997,0.00083523855,0.00020525843,0.00008873552,0.0002592869,0.00014917622,0.0010347532],"category_scores_gemma":[0.000103237486,0.0003959885,0.00020002491,0.0013746308,0.00086965546,0.0004951184,0.00017552287,0.001277415,0.00001734158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18932095,0.0035095308,0.00033193707,0.0011753453,0.0011178228,0.00045794673,0.006638361,0.000040014624,0.2856127,0.00009513725,0.0012996919,0.51040053],"study_design_scores_gemma":[0.6011938,0.04438296,0.12290286,0.025210671,0.001364985,0.00055333145,0.012703442,0.003727362,0.15861751,0.0006201962,0.025717877,0.0030050087],"about_ca_topic_score_codex":0.005341879,"about_ca_topic_score_gemma":0.00055436476,"teacher_disagreement_score":0.50739557,"about_ca_system_score_codex":0.0016945777,"about_ca_system_score_gemma":0.0012883182,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W4396596489","doi":"10.1158/1538-7445.sabcs23-ps10-09","title":"Abstract PS10-09: Development of an absolute risk prediction model for premenopausal breast cancer in an international consortium","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.06133265386172068,"score_gpt":0.41322234426335724,"score_spread":0.35188969040163653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396596489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460447,0.0011114026,0.00054403953,0.00021572756,0.0002861506,0.0003944069,0.002696676,0.000016710668,0.00013042155],"genre_scores_gemma":[0.99663186,0.00081454683,0.00061116426,0.000009804387,0.00037226055,0.0011071468,0.00021926657,0.00002997594,0.00020398354],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859613,0.00004121583,0.00026573738,0.00047438435,0.0003101426,0.00031238407],"domain_scores_gemma":[0.99932027,0.000018956767,0.000045460736,0.00020400963,0.00033043357,0.00008084263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050091156,0.00012576397,0.00012244118,0.00013552804,0.00010414895,0.000038315415,0.00022056543,0.00009063279,0.00007699016],"category_scores_gemma":[0.00001750183,0.00011720852,0.00003213666,0.00011687177,0.0001196936,0.000030176674,0.00009485101,0.00015352176,0.0000020322889],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030908932,0.0006772551,0.05505773,0.0004563844,0.000993726,0.000008388309,0.0026490886,0.016132977,0.69770896,0.00016651579,0.0018667714,0.22119133],"study_design_scores_gemma":[0.0025012267,0.00034072515,0.77954584,0.0004441262,0.00006229144,0.0000086457485,0.00029683675,0.056729984,0.15378113,0.00028297628,0.005578205,0.0004280284],"about_ca_topic_score_codex":0.000712665,"about_ca_topic_score_gemma":0.0045829187,"teacher_disagreement_score":0.7244881,"about_ca_system_score_codex":0.00033058922,"about_ca_system_score_gemma":0.00086336693,"threshold_uncertainty_score":0.47796246},"labels":[],"label_agreement":null},{"id":"W4396596559","doi":"10.1158/1538-7445.sabcs23-po4-13-11","title":"Abstract PO4-13-11: Epigenetically defined sub-clonal heterogeneity drives therapy resistance in triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Cancer; Cancer research; Triple negative; Oncology; Medicine; Internal medicine; Biology","score_opus":0.04371232169632385,"score_gpt":0.3440757261405824,"score_spread":0.3003634044442586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396596559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539722,0.041599493,0.00012873458,0.00068969093,0.00094290945,0.0007401827,0.00075361266,0.00026963966,0.000903544],"genre_scores_gemma":[0.97899777,0.01912609,0.00015628633,0.00004819494,0.0004589673,0.00073790835,0.000014765416,0.00015331605,0.0003067062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967409,0.00007824112,0.00048893143,0.0006297402,0.00091677543,0.0011454433],"domain_scores_gemma":[0.9985276,0.00049917575,0.000027934262,0.00044632572,0.00024256023,0.0002563951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006844138,0.00036688763,0.00039162906,0.0004633601,0.0001394584,0.0002194729,0.00053667836,0.00021938441,0.00081043807],"category_scores_gemma":[0.000052212687,0.00033791375,0.00014465635,0.0013909352,0.00031807486,0.00031599012,0.00007242844,0.001015788,0.000081020204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001368001,0.00015629755,0.014639271,0.0012350165,0.00060980953,0.000392701,0.0021715013,0.0075241807,0.9073001,0.0014288978,0.010462891,0.052711304],"study_design_scores_gemma":[0.0036916747,0.00012221975,0.3516526,0.0021211656,0.000028441787,0.000014133721,0.00014577991,0.0025006123,0.6062714,0.009797601,0.022242378,0.0014120277],"about_ca_topic_score_codex":0.0012895045,"about_ca_topic_score_gemma":0.03361023,"teacher_disagreement_score":0.3370133,"about_ca_system_score_codex":0.0014446309,"about_ca_system_score_gemma":0.0006779991,"threshold_uncertainty_score":0.9999073},"labels":[],"label_agreement":null},{"id":"W4396596783","doi":"10.1158/1538-7445.sabcs23-po1-10-08","title":"Abstract PO1-10-08: Building awareness of triple negative breast cancer: Results from the Canadian Breast Cancer Network national survey","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.07952673178419561,"score_gpt":0.40129359552471394,"score_spread":0.3217668637405183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396596783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82877356,0.02802929,0.00001274853,0.01804039,0.0018988573,0.0008535272,0.12106498,0.00003830242,0.0012883422],"genre_scores_gemma":[0.99201417,0.0033044354,0.00002158847,0.00016852775,0.0025164238,0.0005302516,0.00067218224,0.000057615485,0.0007147902],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9968209,0.00032120437,0.00037975336,0.00082631235,0.0008198692,0.0008319205],"domain_scores_gemma":[0.9972924,0.00048822904,0.000102925034,0.0004270482,0.0014541363,0.00023527067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014079799,0.00028448738,0.00030074257,0.00012083551,0.00066787057,0.00014499247,0.000581162,0.00019888218,0.0006188489],"category_scores_gemma":[0.00019526017,0.0002184321,0.00012109743,0.0009006926,0.0004890869,0.000020242465,0.00022760309,0.00042882224,0.000015046721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041650883,0.00014373077,0.27095497,0.0001854854,0.0036997804,0.00004483333,0.0012592438,0.008265736,0.0137761505,0.00029420716,0.6574248,0.039785955],"study_design_scores_gemma":[0.0010551246,0.000025641884,0.9788381,0.000502201,0.000041191273,0.0000083575615,0.00010093938,0.00009490476,0.004695127,0.00028766505,0.014069385,0.00028136128],"about_ca_topic_score_codex":0.9299705,"about_ca_topic_score_gemma":0.9350036,"teacher_disagreement_score":0.7078831,"about_ca_system_score_codex":0.0012147134,"about_ca_system_score_gemma":0.007149856,"threshold_uncertainty_score":0.9984787},"labels":[],"label_agreement":null},{"id":"W4396597094","doi":"10.1158/0008-5472.can-23-2352","title":"Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; Revolution Medicines; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; University of Pennsylvania","keywords":"Stromal cell; Mass cytometry; Biology; Cancer research; Tumor microenvironment; Immune system; CD44; Population; Pancreatic cancer; Pathology; Cell; Cancer; Immunology; Medicine; Phenotype; Gene","score_opus":0.0433604002547117,"score_gpt":0.36473903235780913,"score_spread":0.3213786321030974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396597094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97061723,0.02722035,0.0005693638,0.00087025674,0.00023381402,0.00025281069,0.00005600277,0.00001786218,0.00016232047],"genre_scores_gemma":[0.99180305,0.0063433554,0.000054303273,0.00014644355,0.00039268433,0.00031451316,0.00005556621,0.00003333596,0.00085677544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827176,0.00022901318,0.0001998139,0.0004840773,0.00034326376,0.00047209352],"domain_scores_gemma":[0.9993008,0.00007423447,0.00001875862,0.00041503235,0.000116997544,0.00007420545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087450625,0.00014180457,0.00019980254,0.0003211232,0.000122353,0.00015458788,0.0003668608,0.0000886304,0.00019634207],"category_scores_gemma":[0.00007201014,0.00010267933,0.00019436405,0.0014950734,0.00016802594,0.000007851545,0.000081756436,0.00039243975,0.000010732568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000536132,0.00001895724,0.098729044,0.000072773,0.00042617324,0.000013437168,0.00015174382,0.00016389787,0.89534026,0.000009480322,0.00031245814,0.004708168],"study_design_scores_gemma":[0.0011426178,0.000089760324,0.14818853,0.00030399323,0.00050371507,0.0000032416506,0.0005234847,0.015566025,0.75015306,0.000101296384,0.08279275,0.0006315394],"about_ca_topic_score_codex":0.002619237,"about_ca_topic_score_gemma":0.0014404914,"teacher_disagreement_score":0.14518721,"about_ca_system_score_codex":0.0001175038,"about_ca_system_score_gemma":0.00024120692,"threshold_uncertainty_score":0.41871417},"labels":[],"label_agreement":null},{"id":"W4396597566","doi":"10.1158/1538-7445.sabcs23-po1-01-08","title":"Abstract PO1-01-08: The impact of drug-drug interactions between palbociclib and proton pump inhibitors on clinical outcomes of patients with hormone receptor positive, HER2-negative, early breast cancer: an exploratory analysis of the PALLAS study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Palbociclib; Drug; Oncology; Cancer; Breast cancer; Hormone receptor; Internal medicine; Pharmacology; Metastatic breast cancer","score_opus":0.06028534070307063,"score_gpt":0.447671778744674,"score_spread":0.3873864380416034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396597566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939001,0.00037621977,0.0000015646941,0.0008382056,0.00009589719,0.0029333408,0.0018001237,0.000022216464,0.000032302607],"genre_scores_gemma":[0.99887294,0.00022422729,0.000010308121,0.000017148363,0.00014738596,0.00055559905,0.000024024986,0.000056046254,0.00009231361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634564,0.0007256971,0.0007678666,0.00054515176,0.001241733,0.0003739075],"domain_scores_gemma":[0.9964238,0.0012639633,0.00036573652,0.0007067259,0.0010368236,0.00020297905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012135594,0.00028060086,0.0008992599,0.0004733694,0.00016274797,0.00003902608,0.00033319253,0.000058165,0.00017509458],"category_scores_gemma":[0.00010714072,0.00014043409,0.00032428987,0.0019651933,0.0010755571,0.00032155332,0.0001503549,0.0010301687,0.0000018043984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040000705,0.00091938785,0.96855223,0.00010048033,0.005966703,0.00000223201,0.008627767,0.00010378036,0.000770166,0.0000026796217,0.00010267483,0.010851829],"study_design_scores_gemma":[0.002117163,0.0014287898,0.98818374,0.00057992357,0.00064077287,2.8210692e-7,0.004201,0.00001162742,0.0026529746,0.00001630154,0.000036770693,0.00013066728],"about_ca_topic_score_codex":0.012960584,"about_ca_topic_score_gemma":0.0025240527,"teacher_disagreement_score":0.019631498,"about_ca_system_score_codex":0.00047671446,"about_ca_system_score_gemma":0.00069115264,"threshold_uncertainty_score":0.9936122},"labels":[],"label_agreement":null},{"id":"W4396597768","doi":"10.1158/1538-7445.sabcs23-po1-13-04","title":"Abstract PO1-13-04: Distinct immune signatures discriminate between patients defined as exceptional survivors of metastatic breast cancer compared to those with rapidly progressing treatment resistant breast cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Metastatic breast cancer; Immune system; Internal medicine; Cancer; Immunology","score_opus":0.06736305483458309,"score_gpt":0.3995147834842628,"score_spread":0.3321517286496797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396597768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784938,0.01213766,0.00001071754,0.0029485258,0.00026591434,0.0018922323,0.0037834095,0.0000768295,0.000390928],"genre_scores_gemma":[0.99671394,0.0007492303,0.00011881365,0.000048067326,0.00026413015,0.00096630293,0.00036956253,0.00010298177,0.000667001],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99580795,0.00022087949,0.00066953024,0.0008002822,0.0016081064,0.0008932315],"domain_scores_gemma":[0.9978894,0.0003305335,0.0001590611,0.0005008963,0.00072677986,0.0003933107],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007261702,0.0004485044,0.0007935136,0.00055484765,0.0002971122,0.00015639089,0.00029205313,0.00009858447,0.0011818272],"category_scores_gemma":[0.000028530992,0.00029980755,0.00023732107,0.0013459815,0.0006277434,0.00018713517,0.00008360297,0.00048893,0.000014794647],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087077364,0.0015964225,0.18406396,0.0045230985,0.0069748694,0.0004137939,0.007270978,0.00040446394,0.13674144,0.00009147457,0.0036427632,0.56719935],"study_design_scores_gemma":[0.0045882114,0.0014798553,0.97672343,0.006057768,0.00041703426,0.000021272775,0.00081782846,0.000042611307,0.006889327,0.00004052626,0.002486257,0.00043586735],"about_ca_topic_score_codex":0.06996439,"about_ca_topic_score_gemma":0.011005962,"teacher_disagreement_score":0.79265946,"about_ca_system_score_codex":0.0028992014,"about_ca_system_score_gemma":0.002833112,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W4396598436","doi":"10.1158/1538-7445.sabcs23-po4-15-12","title":"Abstract PO4-15-12: Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Circulating tumor DNA; Neoadjuvant therapy; Internal medicine; Cancer; Biology","score_opus":0.030761981354729392,"score_gpt":0.3497216214138965,"score_spread":0.3189596400591671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396598436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954596,0.001945361,0.000016587217,0.0006526619,0.00032144174,0.00084435137,0.00065535307,0.000018985778,0.00008564003],"genre_scores_gemma":[0.99759585,0.00041075645,0.00006259495,0.00015963073,0.000617879,0.0005762986,0.000021277148,0.00007909673,0.0004766291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977379,0.000099548844,0.00024260073,0.000687743,0.000555218,0.0006769924],"domain_scores_gemma":[0.99890405,0.00010042339,0.000031193747,0.0003761284,0.0002781894,0.00031003484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068605953,0.00021084318,0.00020083535,0.00025713758,0.00012202857,0.00018997777,0.00029778192,0.000086296764,0.00015674975],"category_scores_gemma":[0.000114719085,0.0001870609,0.00006256633,0.00046017766,0.000072398114,0.000011808534,0.00017399182,0.00032020823,0.000015246844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010985605,0.00012254147,0.38046405,0.000105611696,0.00012372584,0.00011346682,0.0014130301,0.0023972217,0.5801333,0.000010543911,0.0017912872,0.02233962],"study_design_scores_gemma":[0.0017072121,0.0007737107,0.9345493,0.00061803585,0.0000058693004,0.0000024396425,0.00019270761,0.000027572964,0.039746378,0.000005562146,0.02203097,0.00034029724],"about_ca_topic_score_codex":0.0028350255,"about_ca_topic_score_gemma":0.0006124063,"teacher_disagreement_score":0.5540852,"about_ca_system_score_codex":0.00044562615,"about_ca_system_score_gemma":0.0008862761,"threshold_uncertainty_score":0.7628122},"labels":[],"label_agreement":null},{"id":"W4396599098","doi":"10.1158/1538-7445.sabcs23-po1-18-12","title":"Abstract PO1-18-12: Trial in progress: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating locally advanced or ER+/HER2- metastatic breast cancer with an ESR1 mutation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Open label; Randomized controlled trial; Oncology; Internal medicine","score_opus":0.10982656949936029,"score_gpt":0.4989883495578806,"score_spread":0.3891617800585203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97509897,0.0044698436,0.00026107265,0.0007609622,0.00014404078,0.018858127,0.0003520868,0.000033729124,0.000021147762],"genre_scores_gemma":[0.9911486,0.00045748247,0.0019282541,0.000026675996,0.00014881919,0.0059689567,0.000026884101,0.00009489966,0.00019945786],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963797,0.00054493564,0.0009475538,0.00069656386,0.0008846674,0.00054662046],"domain_scores_gemma":[0.99669707,0.001675844,0.0003181913,0.0004830385,0.0006562488,0.00016961455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002258076,0.0003127473,0.0012246255,0.00029705488,0.00015635496,0.000081464605,0.00037573616,0.00006298131,0.00015711633],"category_scores_gemma":[0.00040830852,0.0001789946,0.000063016574,0.0009298412,0.0007184418,0.00045924136,0.00013665887,0.0004797773,3.5829686e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7265538,0.003081444,0.00012698899,0.001166067,0.00062481174,0.000053313383,0.0034684911,0.00075202173,0.0042693377,0.000018519586,0.000005418699,0.2598798],"study_design_scores_gemma":[0.9703427,0.008873126,0.0014175908,0.0048110336,0.00043836402,0.000035219786,0.0045196284,0.0058713597,0.003337929,0.0000448469,0.00008905904,0.00021915023],"about_ca_topic_score_codex":0.001877733,"about_ca_topic_score_gemma":0.004096867,"teacher_disagreement_score":0.25966066,"about_ca_system_score_codex":0.0005528841,"about_ca_system_score_gemma":0.0015390607,"threshold_uncertainty_score":0.7299188},"labels":[],"label_agreement":null},{"id":"W4396599206","doi":"10.1158/1538-7445.sabcs23-po5-07-01","title":"Abstract PO5-07-01: A novel clinical risk score that can accurately predict the survival of young breast cancer patients: A UAE-based cohort study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cohort; Internal medicine; Cancer","score_opus":0.34481269397255326,"score_gpt":0.5071624783000397,"score_spread":0.16234978432748642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970425,0.0020785506,0.000023317165,0.0019289515,0.0011631149,0.0025668475,0.0016876145,0.00007873585,0.0007686295],"genre_scores_gemma":[0.99685156,0.0010289886,0.000010378119,0.00016957558,0.00088450784,0.00072926976,0.000042969023,0.00006305792,0.00021970563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410695,0.0004115131,0.0007776019,0.0008719455,0.0029728813,0.0008591209],"domain_scores_gemma":[0.9965432,0.0008536456,0.00018597515,0.00080205157,0.001229112,0.0003859947],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051997975,0.00029856563,0.0006613015,0.00022780916,0.0003080499,0.00017314826,0.00065298856,0.00017913753,0.00097086927],"category_scores_gemma":[0.0005887244,0.00019333536,0.00027251808,0.0010912451,0.00064549065,0.00020985032,0.00022003305,0.0019477018,0.000029958786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017679087,0.00055767066,0.98170847,0.00022858902,0.0005590801,0.0000852767,0.0006286417,0.000108339176,0.00016288913,0.000011415742,0.0058060205,0.008375698],"study_design_scores_gemma":[0.0023732304,0.0007956434,0.9919234,0.00138369,0.00024849336,0.000008016491,0.0017391442,0.00047665805,0.00016105645,0.000012104489,0.00069424487,0.00018433623],"about_ca_topic_score_codex":0.071691565,"about_ca_topic_score_gemma":0.016496304,"teacher_disagreement_score":0.055195265,"about_ca_system_score_codex":0.00084958476,"about_ca_system_score_gemma":0.0036358642,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W4396599226","doi":"10.1158/1538-7445.sabcs23-po1-19-02","title":"Abstract PO1-19-02: A phase III trial evaluating De-escalation of Breast Radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancer: NRG-BR007","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast-conserving surgery; Medicine; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Surgery; Mastectomy","score_opus":0.08854814882428205,"score_gpt":0.4559461882738233,"score_spread":0.3673980394495413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853709,0.010202397,0.00011454713,0.0011628233,0.000620525,0.00077381986,0.00151915,0.000038395407,0.00019748285],"genre_scores_gemma":[0.99637246,0.0015656776,0.000052283936,0.00003668578,0.0009871859,0.00049217424,0.00022732094,0.00007662834,0.00018959981],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99642235,0.00037868397,0.0007407387,0.0007532275,0.0009562715,0.00074873306],"domain_scores_gemma":[0.99809915,0.0004343982,0.00025869993,0.00048347688,0.00051991886,0.00020435618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025454399,0.0003098002,0.0005511367,0.00036180165,0.00025208548,0.000082752704,0.00028874277,0.00022981664,0.00041425292],"category_scores_gemma":[0.00019124206,0.0003120143,0.00039449145,0.0007421817,0.00022947285,0.000050895855,0.00019923378,0.00033333516,0.0000039967526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03327344,0.00059990166,0.032715283,0.0013228599,0.0018264017,0.000051385738,0.0009100813,0.00075113634,0.52356744,0.000041029463,0.0038610364,0.40107998],"study_design_scores_gemma":[0.10223256,0.0017638837,0.53389704,0.0072511546,0.0012769179,0.00040857814,0.003585327,0.005908956,0.33826,0.00040176947,0.0025284302,0.0024853845],"about_ca_topic_score_codex":0.012614374,"about_ca_topic_score_gemma":0.00071611657,"teacher_disagreement_score":0.5011818,"about_ca_system_score_codex":0.000644437,"about_ca_system_score_gemma":0.0029479843,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W4396599443","doi":"10.1158/1538-7445.sabcs23-ps09-08","title":"Abstract PS09-08: Genomic characterization of endocrine resistance in ER+HER2+ breast cancers in the POETIC Trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Endocrine system; Breast cancer; Oncology; Internal medicine; Cancer research; Cancer; Hormone","score_opus":0.05891477362471634,"score_gpt":0.40997220219079605,"score_spread":0.3510574285660797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435026,0.0069957105,0.000018074317,0.0055937795,0.00033371066,0.0014648152,0.00013295653,0.00003072441,0.001079993],"genre_scores_gemma":[0.995834,0.0016776214,0.00003603602,0.00011426143,0.00063090737,0.00070734293,0.00003589447,0.000049645514,0.0009143205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975061,0.00018981642,0.0004893119,0.0004529062,0.00076903484,0.0005928498],"domain_scores_gemma":[0.9989921,0.0002465687,0.000066708686,0.0004546741,0.00016101255,0.000078931786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011246225,0.00017338089,0.0003600412,0.0005371485,0.000052345476,0.000047023193,0.00032079138,0.00007265606,0.000556878],"category_scores_gemma":[0.000066708955,0.00013277466,0.000075577846,0.0014617323,0.00029384473,0.00018386838,0.000049639413,0.00085005554,0.000025676949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060076274,0.00030529613,0.0033364238,0.002159686,0.00014322349,0.000645593,0.007893395,0.000120929544,0.8298854,0.0015211382,0.0003708209,0.093541816],"study_design_scores_gemma":[0.042723455,0.00059641164,0.850142,0.006042553,0.00005714995,0.00013082886,0.0019129844,0.00015863264,0.018635526,0.0020600199,0.07698887,0.0005515399],"about_ca_topic_score_codex":0.0019468972,"about_ca_topic_score_gemma":0.0032889165,"teacher_disagreement_score":0.84680563,"about_ca_system_score_codex":0.0016667658,"about_ca_system_score_gemma":0.0013496171,"threshold_uncertainty_score":0.60974234},"labels":[],"label_agreement":null},{"id":"W4396599494","doi":"10.1158/1538-7445.sabcs23-po1-24-06","title":"Abstract PO1-24-06: Prolactin Hormone-Induced Mammary Differentiation and Anti-tumorigenic Role in Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prolactin; Cancer; Breast cancer; Internal medicine; Hormone; Oncology; Medicine; Cancer research; Endocrinology","score_opus":0.04556663071623871,"score_gpt":0.35815183999483063,"score_spread":0.3125852092785919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97639006,0.01730506,0.0000034608677,0.004441263,0.00028993574,0.00074561674,0.000057627854,0.00009905407,0.00066790654],"genre_scores_gemma":[0.99129,0.007051144,0.0000087087965,0.0000884803,0.00050190376,0.00034739767,0.000037103317,0.00005973096,0.00061557617],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974097,0.00009036078,0.00037085544,0.0006345178,0.00075625186,0.0007382978],"domain_scores_gemma":[0.99903387,0.00008398057,0.00004123772,0.0003326185,0.00020749119,0.00030077697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059715234,0.00023399045,0.0003602586,0.0006967036,0.00012874237,0.00017341525,0.00017508732,0.00020054655,0.00024647004],"category_scores_gemma":[0.000042446103,0.00019546585,0.000079812555,0.0010042996,0.00008521524,0.00045270193,0.00012626617,0.0012853639,0.00006943107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006060242,0.0001838667,0.13112617,0.0006765169,0.00014843626,0.0002755836,0.0010906158,0.0000015820684,0.82234156,0.00017364802,0.0063013523,0.03707465],"study_design_scores_gemma":[0.0010525385,0.000107487525,0.9774567,0.00043664302,0.000032758846,0.00004348382,0.00022664691,0.00039693867,0.018008403,0.00019089585,0.0018356914,0.00021183453],"about_ca_topic_score_codex":0.00243729,"about_ca_topic_score_gemma":0.0001904846,"teacher_disagreement_score":0.8463305,"about_ca_system_score_codex":0.0005658247,"about_ca_system_score_gemma":0.00084173394,"threshold_uncertainty_score":0.7970866},"labels":[],"label_agreement":null},{"id":"W4396599570","doi":"10.1158/1538-7445.sabcs23-po4-25-08","title":"Abstract PO4-25-08: Secretory breast carcinoma (SBC) in an 8-year-old male: Report of an exceptionally rare case with review of clinicoradiologic and pathomolecular findings of SBC in the male pediatric population","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Misericordia Community Hospital; University of Alberta","funders":"","keywords":"Medicine; General surgery","score_opus":0.08455401971214546,"score_gpt":0.4331566584070791,"score_spread":0.3486026386949337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97009957,0.027913446,6.436817e-7,0.0005626055,0.000030598756,0.0010584837,0.000119985096,0.0000065774643,0.0002081037],"genre_scores_gemma":[0.99264675,0.006713732,0.00012580938,0.00006340545,0.00014452061,0.00011286323,0.00008751082,0.000019440256,0.00008593908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997424,0.00039560872,0.0007682054,0.0004172889,0.0006994395,0.0002954335],"domain_scores_gemma":[0.9986251,0.00023634407,0.00017445027,0.00043068203,0.00042323812,0.000110174515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004044058,0.00013342884,0.0005062957,0.0004095484,0.000040661278,0.0000079949195,0.0001266415,0.00009864231,0.00031028368],"category_scores_gemma":[0.00025778476,0.00009230349,0.000048816397,0.0008996182,0.00020515153,0.00011625914,0.000057625166,0.0005527255,0.000001080246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031811706,0.00012297467,0.9629852,0.023537023,0.000013284468,0.00987417,0.0005559022,0.000003256933,0.00043785857,0.000049483384,0.00017904631,0.0019236854],"study_design_scores_gemma":[0.00054785726,0.0005556435,0.9847486,0.0036968656,0.00004547454,0.009661829,0.00057805754,0.000025812466,0.000016159065,0.000021066071,0.000025586014,0.00007707148],"about_ca_topic_score_codex":0.0034201199,"about_ca_topic_score_gemma":0.00073787273,"teacher_disagreement_score":0.022547223,"about_ca_system_score_codex":0.00016267129,"about_ca_system_score_gemma":0.00066844915,"threshold_uncertainty_score":0.5170221},"labels":[],"label_agreement":null},{"id":"W4396599757","doi":"10.1158/1538-7445.sabcs23-ps17-06","title":"Abstract PS17-06: A phase I trial of the PI3K inhibitor (PI3Ki) copanlisib and fulvestrant in combination with continuous or intermittent abemaciclib in patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Fulvestrant; Medicine; Estrogen receptor; Internal medicine; Estrogen; Oncology; Cancer; Breast cancer","score_opus":0.033909403583169254,"score_gpt":0.3827888557235882,"score_spread":0.34887945214041893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276197,0.0009279791,0.000017181766,0.0015374379,0.00016081014,0.0038886177,0.00063301384,0.000026166366,0.000046807458],"genre_scores_gemma":[0.998115,0.00018757701,0.00012522268,0.000058785885,0.000109539586,0.0011228548,0.00003330513,0.00007250612,0.00017520494],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99688524,0.00030888265,0.00053866603,0.000616197,0.0010868375,0.00056415936],"domain_scores_gemma":[0.99835014,0.00039792215,0.00017029358,0.00030991153,0.00060557004,0.000166156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062235864,0.00031298056,0.0006430632,0.00038894842,0.0000787328,0.0000682268,0.00019143158,0.000079977355,0.00025037583],"category_scores_gemma":[0.000085601554,0.00018021568,0.00006176701,0.0012698576,0.0008290303,0.00032921063,0.00007875581,0.00091239356,0.000003214166],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59384394,0.005920642,0.08311782,0.0022152013,0.0014095618,0.000413868,0.016560182,0.00012837892,0.009516003,0.00020229236,0.00036089006,0.2863112],"study_design_scores_gemma":[0.306239,0.014510238,0.6196814,0.02092695,0.00029658282,0.00008396334,0.0050791483,0.00017376852,0.031498533,0.0003238019,0.0004577479,0.00072884397],"about_ca_topic_score_codex":0.0030836074,"about_ca_topic_score_gemma":0.0022995826,"teacher_disagreement_score":0.5365636,"about_ca_system_score_codex":0.0010664511,"about_ca_system_score_gemma":0.0013103664,"threshold_uncertainty_score":0.7348982},"labels":[],"label_agreement":null},{"id":"W4396599772","doi":"10.1158/1538-7445.sabcs23-ps12-08","title":"Abstract PS12-08: MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Fulvestrant; Atezolizumab; Medicine; Oncology; Internal medicine; Cancer; Interim analysis; Breast cancer; Metastatic breast cancer; Disease; Estrogen receptor; Clinical trial; Immunotherapy; Pembrolizumab","score_opus":0.06473927860091323,"score_gpt":0.4428545749237581,"score_spread":0.3781152963228449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98178726,0.011659133,0.000011382186,0.0004670576,0.00007971484,0.0020221348,0.003926032,0.000028195293,0.000019102463],"genre_scores_gemma":[0.9963484,0.002322857,0.000035891866,0.0000137065545,0.00005163495,0.00091622653,0.00014054103,0.00005224615,0.0001185298],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99684656,0.00021575516,0.0007304127,0.0007226726,0.0009422113,0.00054237555],"domain_scores_gemma":[0.9983277,0.00019942784,0.00014905802,0.00047641023,0.00047631963,0.00037112337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003933934,0.0003243323,0.0010670363,0.001310321,0.00008484961,0.000030551153,0.00016561526,0.000042790838,0.0006640038],"category_scores_gemma":[0.000039875347,0.00025519138,0.00018928465,0.0024008031,0.00037829988,0.00021791313,0.00010323715,0.00035128722,0.000002737235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09432938,0.025863348,0.13758278,0.0020365722,0.024141045,0.0009510635,0.030873464,0.0010380517,0.07925505,0.000042645188,0.00018144523,0.60370517],"study_design_scores_gemma":[0.030834652,0.0108151045,0.9406905,0.0016394982,0.0038292357,0.0000075636026,0.004573953,0.000981147,0.005958664,0.000057458165,0.00019699415,0.00041521512],"about_ca_topic_score_codex":0.0071628783,"about_ca_topic_score_gemma":0.0007351937,"teacher_disagreement_score":0.80310774,"about_ca_system_score_codex":0.0013131499,"about_ca_system_score_gemma":0.0007232288,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W4396599802","doi":"10.1158/1538-7445.sabcs23-ps12-09","title":"Abstract PS12-09: Capivasertib plus cyclin-dependent kinase 4/6 inhibitor and fulvestrant in hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: updated Phase 1b analysis from CAPItello-292","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Fulvestrant; Human Epidermal Growth Factor Receptor 2; Oncology; Internal medicine; Hormone receptor; Cancer research; Medicine; Cancer; Breast cancer; Epidermal growth factor receptor; Estrogen receptor","score_opus":0.03672440036031972,"score_gpt":0.3882298435116482,"score_spread":0.3515054431513285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396599802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95987153,0.024305426,0.00009739382,0.0043886034,0.0004171168,0.0017722193,0.008806712,0.00023954242,0.00010147757],"genre_scores_gemma":[0.9890935,0.0067544403,0.0003680808,0.0001577989,0.0010768845,0.00087564014,0.0009226927,0.00019735092,0.0005536417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931187,0.00045444167,0.0011437251,0.002039174,0.001643387,0.0016005613],"domain_scores_gemma":[0.99648416,0.00065542466,0.00022057978,0.0007618962,0.00086401385,0.001013914],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007464331,0.0008098437,0.0014825969,0.0016103865,0.00039791226,0.00025009722,0.00043434478,0.0003768489,0.004466275],"category_scores_gemma":[0.00013098844,0.00073880353,0.0003327942,0.0029002442,0.00093400344,0.00094733236,0.00022913897,0.0023430916,0.000099975914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0105311675,0.0011456052,0.003635734,0.000383302,0.0031661897,0.00097358925,0.0064526945,0.00023313075,0.8846772,0.00006021711,0.00077245745,0.087968715],"study_design_scores_gemma":[0.05204157,0.0016721132,0.26227716,0.0035524145,0.0014829689,0.0000768678,0.005739734,0.00129963,0.66550756,0.0010307935,0.0027218421,0.0025973802],"about_ca_topic_score_codex":0.031086912,"about_ca_topic_score_gemma":0.004753761,"teacher_disagreement_score":0.25864142,"about_ca_system_score_codex":0.0037990573,"about_ca_system_score_gemma":0.0013554102,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W4396632991","doi":"10.1158/1538-7445.sabcs23-po4-18-01","title":"Abstract PO4-18-01: International Validation of a Staging Model for de novo Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cancer; Breast cancer; Metastatic breast cancer; Oncology; Internal medicine","score_opus":0.1117743134727594,"score_gpt":0.45954753987251407,"score_spread":0.34777322639975466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396632991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979716,0.005061102,0.0077956566,0.0035047221,0.0003294573,0.0004472238,0.0025966861,0.000021476726,0.00052769727],"genre_scores_gemma":[0.99654275,0.0010772564,0.0005422344,0.000046282355,0.0003084784,0.000713655,0.000110643196,0.000030522024,0.00062819157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989187,0.000027403583,0.00015949244,0.00031673952,0.0002778081,0.00029985656],"domain_scores_gemma":[0.99937713,0.00005076371,0.000032850134,0.00015566402,0.00032932844,0.000054232743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037796982,0.00010561103,0.00011533772,0.000113646274,0.000073246025,0.000044899967,0.00018349632,0.000042861233,0.0001913127],"category_scores_gemma":[0.000037344445,0.0000959653,0.000078774974,0.00013330531,0.00009919799,0.000011825339,0.00009573719,0.00010485636,0.000002609944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000993958,0.00019548646,0.007514496,0.000892535,0.001628748,0.000011932995,0.001130267,0.016848741,0.91523904,0.0006377484,0.019479787,0.035427254],"study_design_scores_gemma":[0.0031606378,0.00015367738,0.019055191,0.0009623808,0.00023850956,0.000041420884,0.0007894008,0.03521258,0.92501307,0.0031431254,0.011624241,0.0006057619],"about_ca_topic_score_codex":0.0005968662,"about_ca_topic_score_gemma":0.00019823658,"teacher_disagreement_score":0.03482149,"about_ca_system_score_codex":0.0002607751,"about_ca_system_score_gemma":0.0006550056,"threshold_uncertainty_score":0.3913351},"labels":[],"label_agreement":null},{"id":"W4396917703","doi":"10.1158/0008-5472.can-23-2397","title":"HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of <i>UXS1</i> That Confers Genetic Susceptibility to Gastroesophageal Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Institute of General Medical Sciences; Fonds de Recherche du Québec - Santé; Institute of Cancer Research; National Cancer Institute; National Institutes of Health; McGill University; Génome Québec; Cancer Research Society","keywords":"Biology; Genetics; Linkage disequilibrium; Epigenomics; Computational biology; Gene; CpG site; Genome-wide association study; Genome; Cancer; Enhancer; Genetic association; DNA methylation; Single-nucleotide polymorphism; Transcription factor; Genotype; Gene expression","score_opus":0.06031538829181084,"score_gpt":0.38786366487390683,"score_spread":0.327548276582096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396917703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839903,0.008733701,0.0056078187,0.00045659923,0.0003174639,0.0006186867,0.00007246506,0.000016305628,0.00018663715],"genre_scores_gemma":[0.9975286,0.0005026364,0.00069711707,0.00004792886,0.00034388175,0.00025638432,0.000021513022,0.000045222147,0.0005567194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783725,0.00024090483,0.0002982168,0.00067483686,0.00042413015,0.00052468],"domain_scores_gemma":[0.9989043,0.000055386903,0.000047511545,0.00049215765,0.00033322672,0.00016744128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011532072,0.0001671564,0.00019157937,0.00017425955,0.00011246166,0.0001140806,0.0003123015,0.0001284332,0.00016847039],"category_scores_gemma":[0.00010117854,0.00015808809,0.00011470864,0.00028458878,0.00019402553,0.0000050118088,0.00020683822,0.00024115622,0.000010926147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009982057,0.00003339808,0.016908808,0.00026984207,0.000070741335,0.000011890338,0.00020206781,0.0014435374,0.97087234,0.000021806196,0.000278145,0.009787607],"study_design_scores_gemma":[0.0002454743,0.00025590757,0.01809672,0.0001288648,0.000021116795,8.120323e-7,0.000057611847,0.00042835242,0.97592723,0.00018310372,0.0045022205,0.00015259723],"about_ca_topic_score_codex":0.0009824967,"about_ca_topic_score_gemma":0.0010087265,"teacher_disagreement_score":0.013538275,"about_ca_system_score_codex":0.000118610515,"about_ca_system_score_gemma":0.0007659117,"threshold_uncertainty_score":0.6446645},"labels":[],"label_agreement":null},{"id":"W4396933407","doi":"10.1158/0008-5472.can-24-1256","title":"Connie Eaves, PhD, FAACR: In Memoriam (1944–2024)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Michael Smith Health Research BC","funders":"","keywords":"Eaves; Medicine; Philosophy; History; Archaeology","score_opus":0.12260365308005405,"score_gpt":0.5545654469554154,"score_spread":0.4319617938753614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396933407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50533575,0.30558792,0.0006233429,0.05216934,0.02976951,0.0024136999,0.000064528496,0.00037272397,0.10366321],"genre_scores_gemma":[0.872451,0.025488578,0.0007715174,0.0014010774,0.009186787,0.0005557901,0.000013893995,0.00008610533,0.090045236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842304,0.00012756223,0.0001829609,0.00037660034,0.00039659135,0.0004932444],"domain_scores_gemma":[0.99903244,0.00044177668,0.000010505241,0.0002781354,0.000104223924,0.00013289163],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088340795,0.00010364154,0.00024309216,0.0003443983,0.00008193957,0.000025347019,0.0001557321,0.00015386274,0.0038692928],"category_scores_gemma":[0.00016125011,0.00008091293,0.000051823612,0.00081686734,0.00043066675,0.00009183489,0.000048958682,0.0011201431,0.00024978942],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001652132,0.0003189655,0.016668351,0.0011773253,0.00033841626,0.004857027,0.0030658243,0.00007907257,0.0279514,0.013052724,0.7395822,0.19125655],"study_design_scores_gemma":[0.0011562257,0.0003179641,0.0014280693,0.00040381242,0.000010491065,0.000066036744,0.0003130384,0.00026498578,0.0031115592,0.003490407,0.98933,0.00010743903],"about_ca_topic_score_codex":0.00012962795,"about_ca_topic_score_gemma":0.0001487395,"teacher_disagreement_score":0.3671153,"about_ca_system_score_codex":0.0007275413,"about_ca_system_score_gemma":0.0007990919,"threshold_uncertainty_score":0.9970413},"labels":[],"label_agreement":null},{"id":"W4396999564","doi":"10.1158/0008-5472.can-24-0521","title":"Large-Scale Alternative Polyadenylation-Wide Association Studies to Identify Putative Cancer Susceptibility Genes","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Vanderbilt University","keywords":"Biology; Genetics; Three prime untranslated region; Gene; Prostate cancer; Genotype; Cancer; Polyadenylation; Allele; Genetic association; Untranslated region; Single-nucleotide polymorphism; Gene expression; Messenger RNA","score_opus":0.07539044961850802,"score_gpt":0.490200887030518,"score_spread":0.41481043741200996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396999564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692838,0.02250239,0.0005883678,0.006291162,0.0004046964,0.0004869692,0.00023613102,0.000022686472,0.00018376858],"genre_scores_gemma":[0.9692143,0.006368797,0.00007466777,0.0002930957,0.0009060217,0.0006004938,0.000046574187,0.00003212162,0.02246391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997341,0.00035109802,0.0002063894,0.0006358156,0.0007766343,0.00068908854],"domain_scores_gemma":[0.99812144,0.00039949038,0.00003297652,0.00024957114,0.0010118858,0.00018461036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019033666,0.00013715941,0.00017138333,0.00018282118,0.00028180017,0.00017051809,0.00026150237,0.000107390464,0.00013301727],"category_scores_gemma":[0.0015943927,0.00012173,0.00008586574,0.00053815066,0.00009365532,0.000019818368,0.00034376522,0.0003382246,0.000085459804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011332574,0.00003221631,0.034332298,0.00012664201,0.00042270322,0.000011300461,0.0023337465,0.00038653164,0.9107835,0.000049014878,0.0467757,0.0046329927],"study_design_scores_gemma":[0.00043840852,0.000298342,0.015817957,0.00021435137,0.00002305753,7.478304e-7,0.0043338174,0.00058946555,0.9048996,0.00085010374,0.0722222,0.00031191838],"about_ca_topic_score_codex":0.0010423381,"about_ca_topic_score_gemma":0.0048459405,"teacher_disagreement_score":0.025446502,"about_ca_system_score_codex":0.0008180494,"about_ca_system_score_gemma":0.00045927157,"threshold_uncertainty_score":0.49640054},"labels":[],"label_agreement":null},{"id":"W4399323434","doi":"10.1158/0008-5472.can-23-3854","title":"Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Genome-wide association study; Breast cancer; Cancer; SNP; Oncology; Triple-negative breast cancer; Biology; Case-control study; Genetic association; Single-nucleotide polymorphism; Medicine; Internal medicine; Genetics; Gene; Genotype","score_opus":0.13516813493516322,"score_gpt":0.46896714219082325,"score_spread":0.33379900725566003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399323434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708093,0.013128404,0.00528321,0.00071114546,0.0008151855,0.0009687063,0.0074683274,0.000041555533,0.0007741985],"genre_scores_gemma":[0.9919006,0.0029409952,0.0002064174,0.00015025804,0.000805972,0.0013386325,0.00015845631,0.0000661168,0.0024325387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794686,0.00018395415,0.00028040417,0.0006155685,0.00035124228,0.00062194746],"domain_scores_gemma":[0.9983292,0.00018397401,0.00007207994,0.00050543406,0.00073737925,0.000171885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009597977,0.00021542412,0.00020154804,0.00025506067,0.000439249,0.00028393028,0.00028355196,0.0001991302,0.0013210546],"category_scores_gemma":[0.00013393082,0.00019362142,0.00016049163,0.0005020252,0.00027561776,0.000032829765,0.0002141802,0.00039174553,0.000053453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027153464,0.00031377265,0.031208875,0.0032541363,0.010303434,0.014734985,0.0112481145,0.010709011,0.35151362,0.00045398215,0.39094436,0.17260036],"study_design_scores_gemma":[0.004208866,0.00067257846,0.02829714,0.0005212816,0.0010109349,0.019543706,0.01038758,0.006563079,0.45111766,0.0014685307,0.4738751,0.002333549],"about_ca_topic_score_codex":0.0016819736,"about_ca_topic_score_gemma":0.0064339614,"teacher_disagreement_score":0.17026682,"about_ca_system_score_codex":0.00042073955,"about_ca_system_score_gemma":0.0016441118,"threshold_uncertainty_score":0.9995919},"labels":[],"label_agreement":null},{"id":"W4399326604","doi":"10.1158/0008-5472.can-23-0519","title":"Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University; McGill University Health Centre","funders":"Cancer Council South Australia; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; Dana-Farber Cancer Institute; Government of South Australia; Foundation Medicine; McGill University; McGill University Health Centre; World Cancer Research Fund International; World Cancer Research Fund; Harvard T.H. Chan School of Public Health; Brown University; Università degli Studi di Milano; National Cancer Institute; Brigham and Women's Hospital; Università degli Studi di Pavia; U.S. Department of Defense","keywords":"Prostate cancer; Tumor microenvironment; Cancer research; Cancer; Glycolysis; Biology; Lactate dehydrogenase; Anaerobic glycolysis; Lactate dehydrogenase A; Tumor progression; Internal medicine; Cancer cell; Endocrinology; Medicine; Metabolism; Biochemistry","score_opus":0.04075172549784481,"score_gpt":0.36724300654914854,"score_spread":0.32649128105130376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399326604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94588864,0.05188699,0.00002377126,0.0010714164,0.00031820303,0.0006822223,0.00009731011,0.000009942852,0.00002149488],"genre_scores_gemma":[0.9693103,0.027114239,0.00013434993,0.00016954791,0.0007744285,0.00040617987,0.000031672716,0.000040984127,0.0020182983],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846804,0.000082971696,0.00018267099,0.00061628,0.00020390222,0.00044613006],"domain_scores_gemma":[0.9995446,0.000010817302,0.000017575747,0.00019756082,0.00007158688,0.00015786245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044077297,0.00014914066,0.00015876371,0.00012841825,0.00009884901,0.000119232405,0.000096882584,0.000058382855,0.000042197233],"category_scores_gemma":[0.000023237946,0.00013786962,0.000023332672,0.00022912196,0.00009397133,0.0000151391805,0.00022280723,0.00021932652,0.0000083161685],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045046338,0.000015274049,0.0005406403,0.00014413195,0.000028819519,0.0000070852325,0.00046852836,0.0016104804,0.96455723,0.000013276898,0.0022335628,0.029930515],"study_design_scores_gemma":[0.0014643811,0.0004696834,0.008418507,0.00052271376,0.00003529855,0.00001526599,0.00015583076,0.003515365,0.4671029,0.00020329324,0.51758474,0.00051202957],"about_ca_topic_score_codex":0.0013526907,"about_ca_topic_score_gemma":0.0013621522,"teacher_disagreement_score":0.5153512,"about_ca_system_score_codex":0.00011214356,"about_ca_system_score_gemma":0.00018980275,"threshold_uncertainty_score":0.562216},"labels":[],"label_agreement":null},{"id":"W4400530775","doi":"10.1158/0008-5472.can-24-0890","title":"An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of California, San Francisco; American Association for Cancer Research; Prostate Cancer Foundation; Movember Foundation; U.S. Department of Defense; Princess Margaret Cancer Foundation; National Institutes of Health; Ontario Institute for Cancer Research; Government of Ontario; Stand Up To Cancer","keywords":"Prostate cancer; Chromatin; Epigenetics; Androgen receptor; Biology; Transcriptome; Epigenetic therapy; Cancer research; Computational biology; Transcription factor; Enzalutamide; Cancer; Bioinformatics; Gene; Genetics; DNA methylation; Gene expression","score_opus":0.049833216991354255,"score_gpt":0.4701664521484493,"score_spread":0.4203332351570951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400530775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93500894,0.05991279,0.0000026471948,0.0022885182,0.00017557124,0.0022148013,0.000047776117,0.00005684045,0.00029212746],"genre_scores_gemma":[0.9877424,0.006240645,0.00006571748,0.000012031966,0.0002759542,0.0027932478,0.0000190194,0.00005216105,0.002798806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99680847,0.00031441878,0.00039099267,0.00055141014,0.0010731106,0.0008615945],"domain_scores_gemma":[0.9987646,0.00012778146,0.000058892005,0.0004858517,0.00035639416,0.00020651196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012578263,0.00017491479,0.00031085667,0.00050127966,0.00021512857,0.00008850983,0.00030584208,0.0000727675,0.0003433275],"category_scores_gemma":[0.00008728782,0.00010471227,0.000067709494,0.0018587651,0.00037879008,0.00029366376,0.00013858805,0.00071375637,0.000019927134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001641987,0.0001967072,0.1348695,0.0030091726,0.000069026755,0.00021759287,0.0017760168,0.00024183124,0.82878214,0.00006630624,0.00044887813,0.028680822],"study_design_scores_gemma":[0.0026543764,0.00086139934,0.41099373,0.008596784,0.00003703701,0.000017165983,0.0008675786,0.0013898687,0.5726689,0.0006851577,0.0010245898,0.00020340295],"about_ca_topic_score_codex":0.0009943463,"about_ca_topic_score_gemma":0.00042910682,"teacher_disagreement_score":0.27612424,"about_ca_system_score_codex":0.0014042174,"about_ca_system_score_gemma":0.0017430093,"threshold_uncertainty_score":0.42700425},"labels":[],"label_agreement":null},{"id":"W4401533648","doi":"10.1158/0008-5472.can-23-3887","title":"The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple-Negative Breast Cancer by Attenuating TGFβ Signaling","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Breast cancer; Metastasis; Suppressor; Triple-negative breast cancer; Transforming growth factor; Transcription factor; Biology; Cancer; Zinc finger; Medicine; Internal medicine; Gene; Genetics","score_opus":0.04733456585778599,"score_gpt":0.36950368669767614,"score_spread":0.32216912083989013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401533648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824488,0.012853072,0.000029543513,0.0026762334,0.00017324783,0.0008256061,0.00056183257,0.000019137984,0.00041252573],"genre_scores_gemma":[0.99398625,0.0011227784,0.00007744015,0.000077100456,0.00028630212,0.0016732708,0.000038681308,0.00004181568,0.0026963493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978809,0.00039456147,0.00022462558,0.00050194387,0.00041023735,0.0005877514],"domain_scores_gemma":[0.99939173,0.000119602766,0.000031667856,0.00020545954,0.00015967745,0.000091837996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112232,0.00015790015,0.00012747025,0.00008119129,0.00031390516,0.00021240124,0.0003552195,0.00008509026,0.0002122149],"category_scores_gemma":[0.00017691283,0.000117231415,0.000057801313,0.00046032394,0.00019505543,0.00001268657,0.00023896499,0.00047158607,0.000017993136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014244679,0.000018169903,0.00040663627,0.0000890404,0.00006647993,0.000011880067,0.00026075522,0.000021139094,0.9629227,0.000036786452,0.00840276,0.027621217],"study_design_scores_gemma":[0.00029605554,0.00006207309,0.0003142901,0.00021911612,0.0000051869956,0.000005866731,0.00035748305,0.00008101803,0.9706288,0.0001181053,0.027747838,0.00016417702],"about_ca_topic_score_codex":0.0011169626,"about_ca_topic_score_gemma":0.00061464385,"teacher_disagreement_score":0.02745704,"about_ca_system_score_codex":0.0001237651,"about_ca_system_score_gemma":0.0006141163,"threshold_uncertainty_score":0.47805583},"labels":[],"label_agreement":null},{"id":"W4401875585","doi":"10.1158/0008-5472.can-23-3890","title":"<i>PTEN</i> Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Biotechnology and Biological Sciences Research Council; Imperial Experimental Cancer Medicine Centre; Ligue Contre le Cancer; Ovarian Cancer Action; China Scholarship Council; National Institute for Health and Care Research; Cancéropôle Lyon Auvergne-Rhône-Alpes; NIHR Imperial Biomedical Research Centre; Cancer Research UK; Imperial College London; Cancer Research Institute","keywords":"PTEN; Cancer research; PI3K/AKT/mTOR pathway; Biology; Tumor microenvironment; Immune system; Ovarian carcinoma; Macrophage; Ovarian cancer; Cancer; Immunology; Signal transduction; Cell biology; In vitro","score_opus":0.031072251892633494,"score_gpt":0.3300347971313376,"score_spread":0.2989625452387041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401875585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97150356,0.015093259,0.000107194835,0.0028274616,0.0056615807,0.0003245304,0.000040381932,0.00012499763,0.004317015],"genre_scores_gemma":[0.9487173,0.00066978106,0.000005806913,0.00014005192,0.00011374791,0.0001232627,0.00011623427,0.000032239845,0.050081555],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983191,0.00034780084,0.00024308119,0.0004137948,0.00008788652,0.00058834144],"domain_scores_gemma":[0.9994552,0.00016980921,0.000020276062,0.00021702639,0.00010874472,0.000028952947],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005398637,0.00014287402,0.00018404011,0.00042438717,0.00018582544,0.00008930284,0.00025075072,0.00024717522,0.0043752375],"category_scores_gemma":[0.000041334933,0.00012996253,0.00006717672,0.0006112027,0.00021783088,0.00017305589,0.00012286771,0.0013472609,0.002241081],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009225709,0.0002631611,0.007893323,0.00035168117,0.00024245116,0.00061871787,0.001350197,0.00007176333,0.831432,0.022425493,0.09502453,0.039404143],"study_design_scores_gemma":[0.0031961042,0.0005010333,0.022660417,0.0005232187,0.00003965854,0.00039185176,0.0024887954,0.0027709885,0.223534,0.0011682421,0.7420305,0.0006951532],"about_ca_topic_score_codex":0.0070410003,"about_ca_topic_score_gemma":0.0014161982,"teacher_disagreement_score":0.647006,"about_ca_system_score_codex":0.0009298061,"about_ca_system_score_gemma":0.00021611027,"threshold_uncertainty_score":0.9995712},"labels":[],"label_agreement":null},{"id":"W4401875977","doi":"10.1158/0008-5472.can-23-4024","title":"Fitness Screens Map State-Specific Glioblastoma Stem Cell Vulnerabilities","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biology; Stem cell; Context (archaeology); Cancer research; Genetic heterogeneity; Gene; Genetics; Computational biology; Phenotype","score_opus":0.08017606560292605,"score_gpt":0.383302278504516,"score_spread":0.3031262129015899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401875977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530512,0.039059397,0.000017014032,0.0043124417,0.00043186173,0.0006718525,0.00012793549,0.0001373886,0.002190881],"genre_scores_gemma":[0.98096037,0.002007581,0.000033042408,0.000043689084,0.00037795643,0.00065162475,0.000010241054,0.000055970027,0.015859533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767095,0.00012922828,0.00021396186,0.0005175529,0.00083489955,0.00063338014],"domain_scores_gemma":[0.9985902,0.00036447425,0.000013336722,0.0004609306,0.0002978156,0.0002732563],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000526605,0.00016688391,0.00025562293,0.0003854299,0.00016898106,0.0001778003,0.000135595,0.00006965178,0.0017456715],"category_scores_gemma":[0.000008154781,0.00012564322,0.000112252565,0.00063169637,0.00023293945,0.00009137343,0.0001002105,0.00049335626,0.00098013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016960768,0.0014597189,0.010976785,0.005163801,0.00055374677,0.007451784,0.0061400514,0.00029994317,0.0765817,0.004954413,0.65583575,0.22888622],"study_design_scores_gemma":[0.0016088324,0.0011216106,0.0024563018,0.0010616037,0.000040468676,0.000032372314,0.001994325,0.00021936999,0.40389103,0.00049782754,0.5868309,0.00024536884],"about_ca_topic_score_codex":0.00039646216,"about_ca_topic_score_gemma":0.00012077854,"teacher_disagreement_score":0.3273093,"about_ca_system_score_codex":0.00060634164,"about_ca_system_score_gemma":0.00036825624,"threshold_uncertainty_score":0.9997977},"labels":[],"label_agreement":null},{"id":"W4401876319","doi":"10.1158/0008-5472.can-24-3073","title":"Bottom-up or Top-down: Inflammation Reprograms Paneth Cells to Develop Bowel Cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; University of Calgary","funders":"","keywords":"LGR5; Stem cell; Cancer stem cell; Biology; Paneth cell; Carcinogenesis; Progenitor cell; Crypt; Colorectal cancer; Context (archaeology); Cancer; Cancer research; Immunology; Cell biology; Genetics; Small intestine; Endocrinology","score_opus":0.11444482680910982,"score_gpt":0.44255345409254104,"score_spread":0.3281086272834312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401876319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95460093,0.011760379,0.00054094585,0.017844258,0.0035744726,0.0032172708,0.0001320728,0.00040541613,0.007924282],"genre_scores_gemma":[0.8537552,0.010080659,0.0032233302,0.0010201008,0.0035679243,0.0023365626,0.00008443221,0.00017173885,0.1257601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679315,0.00011825992,0.00038166606,0.00075897743,0.0010911255,0.00085682643],"domain_scores_gemma":[0.99792933,0.00016362678,0.000031024494,0.00058823294,0.0007505958,0.0005372033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015559958,0.00020657039,0.0003315839,0.0004391717,0.000159771,0.00020968352,0.00022119355,0.00013029331,0.0027036814],"category_scores_gemma":[0.0002706012,0.00015693116,0.0000852934,0.0028457395,0.00013734288,0.00013236812,0.00015257593,0.0007717346,0.0005994336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010788471,0.000022583155,0.00022953284,0.0011729941,0.00017340154,0.00033195852,0.0028116498,0.00006761186,0.1548716,0.00016883096,0.16178112,0.67728984],"study_design_scores_gemma":[0.0005339628,0.00029738471,0.00024037482,0.0006793803,0.000049512568,0.000019824161,0.0005465583,0.00007761369,0.26154146,0.00003690849,0.7357931,0.0001839318],"about_ca_topic_score_codex":0.0067362585,"about_ca_topic_score_gemma":0.002184506,"teacher_disagreement_score":0.67710596,"about_ca_system_score_codex":0.0018176925,"about_ca_system_score_gemma":0.0047596097,"threshold_uncertainty_score":0.999878},"labels":[],"label_agreement":null},{"id":"W4402266256","doi":"10.1158/1538-7445.pediatric24-a033","title":"Abstract A033 Early relapse detection: The power and potential of adrenergic and mesenchymal neuroblastoma specific mRNA-based minimal residual disease detection in liquid biopsies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Minimal residual disease; Medicine; Mesenchymal stem cell; Messenger RNA; Disease; Adrenergic; Cancer research; Pathology; Oncology; Internal medicine; Biology; Gene; Bone marrow; Genetics","score_opus":0.03397176884292186,"score_gpt":0.3538029445022731,"score_spread":0.31983117565935126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989082,0.0023852042,0.00017659791,0.007704438,0.00008071301,0.00040523443,0.000019285095,0.000060007416,0.00008655816],"genre_scores_gemma":[0.9986891,0.000670649,0.00009307986,0.000041221752,0.00019520952,0.00017998449,0.0000025935378,0.000020827316,0.00010730174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986392,0.00008451974,0.00022205102,0.00033915066,0.0004669518,0.00024810713],"domain_scores_gemma":[0.999245,0.00017139029,0.000025729263,0.00024979096,0.00011198669,0.00019612008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005783439,0.00010019598,0.00013494794,0.000281497,0.00012283609,0.00006493242,0.00008774875,0.000067413814,0.00011282282],"category_scores_gemma":[0.000103982566,0.0000717,0.000041490788,0.0005199044,0.0006038775,0.0000703986,0.00007247054,0.0006086693,0.0000034296081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023166933,0.000105192456,0.00052791106,0.00037429074,0.000024473395,0.0002838052,0.00022658588,0.000012495694,0.97810274,0.00022096078,0.0012703931,0.016534483],"study_design_scores_gemma":[0.0016340974,0.0019511705,0.43015054,0.0013224606,0.00008924687,0.00011520618,0.0003305576,0.004422455,0.5460248,0.00059228874,0.013067789,0.0002994021],"about_ca_topic_score_codex":0.00030619334,"about_ca_topic_score_gemma":0.000049310107,"teacher_disagreement_score":0.4320779,"about_ca_system_score_codex":0.000059223235,"about_ca_system_score_gemma":0.0001896713,"threshold_uncertainty_score":0.29238412},"labels":[],"label_agreement":null},{"id":"W4402266257","doi":"10.1158/1538-7445.pediatric24-a009","title":"Abstract A009 Single cell transcriptomic signature of Li-Fraumeni Syndrome soft tissue sarcomas","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Medicine; Sarcoma; Soft tissue; Pathology; Cancer research; Biology; Oncology; Gene; Genetics; Germline mutation; Mutation","score_opus":0.06713023641149299,"score_gpt":0.3872694561532048,"score_spread":0.3201392197417118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87778753,0.113599546,0.000009705442,0.0031908725,0.00028364154,0.00068220106,0.00009081608,0.000078634715,0.004277067],"genre_scores_gemma":[0.9950494,0.0012476983,0.00009161703,0.000076413,0.00017229203,0.00019384055,0.00002864988,0.00006119942,0.0030788516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788827,0.000059106453,0.00028102734,0.00045270566,0.0007877114,0.0005311904],"domain_scores_gemma":[0.9988841,0.00029648602,0.000025451154,0.0003967974,0.0001701851,0.0002269859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038163303,0.00018364695,0.00037143246,0.00034737075,0.00007471514,0.000059098176,0.00018347042,0.00017139855,0.0022436637],"category_scores_gemma":[0.000027859973,0.00014500311,0.00015263782,0.0005833616,0.00016669807,0.000090254616,0.000041180723,0.00068793783,0.00024686017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022362651,0.0014188477,0.0024662735,0.0022130122,0.00029094063,0.0034859574,0.0010355845,0.000015429343,0.88422984,0.00020188956,0.027743107,0.076675475],"study_design_scores_gemma":[0.0018611341,0.0012560643,0.03288546,0.0019910773,0.00018251178,0.00015637632,0.00031577016,0.000045873214,0.82160515,0.00045117247,0.13898575,0.00026364927],"about_ca_topic_score_codex":0.00056088367,"about_ca_topic_score_gemma":0.000053257827,"teacher_disagreement_score":0.117261924,"about_ca_system_score_codex":0.00041590343,"about_ca_system_score_gemma":0.0004219566,"threshold_uncertainty_score":0.99866843},"labels":[],"label_agreement":null},{"id":"W4402266260","doi":"10.1158/1538-7445.pediatric24-b073","title":"Abstract B073: Radiotherapy dosing in intracranial ependymoma using the National Cancer Database","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dosing; Ependymoma; Medicine; Radiation therapy; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.18240383555016682,"score_gpt":0.5027136227315538,"score_spread":0.32030978718138703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627781,0.027892435,0.000019388795,0.007937937,0.00033327055,0.0005120836,0.00010684058,0.000024131046,0.0003958481],"genre_scores_gemma":[0.9958541,0.0021535854,0.00014570846,0.00030083716,0.0011316716,0.00030090887,0.0000147524825,0.00003154002,0.00006691119],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818915,0.00007090807,0.00018158751,0.000322164,0.00084939395,0.00038678042],"domain_scores_gemma":[0.9992555,0.00030823195,0.000016248474,0.000164276,0.00016058459,0.0000951689],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087442616,0.00010965123,0.00015117845,0.00030496475,0.00014977294,0.00013278266,0.00011743638,0.00005434409,0.0016173247],"category_scores_gemma":[0.00005492529,0.00007071647,0.000057359302,0.00070431764,0.0001261642,0.0001345816,0.00003885877,0.00052350864,0.000020018793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011337422,0.0007829568,0.02509059,0.00070050487,0.0007727771,0.0052748495,0.0017822692,0.001225223,0.7759119,0.0028161341,0.021270404,0.16323864],"study_design_scores_gemma":[0.019187246,0.0007732955,0.49046344,0.015561047,0.00041281225,0.0011960067,0.001300606,0.08346325,0.19230932,0.002864621,0.19108294,0.0013854307],"about_ca_topic_score_codex":0.005748292,"about_ca_topic_score_gemma":0.00091980386,"teacher_disagreement_score":0.5836026,"about_ca_system_score_codex":0.0012564824,"about_ca_system_score_gemma":0.0009992495,"threshold_uncertainty_score":0.99929535},"labels":[],"label_agreement":null},{"id":"W4402266265","doi":"10.1158/1538-7445.pediatric24-a031","title":"Abstract A031 Early metastatic dissemination in a MYCN-driven zebrafish model of high-risk neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Zebrafish; Medicine; Oncology; Cancer research; Internal medicine; Biology; Genetics; Gene","score_opus":0.060768049548260324,"score_gpt":0.41408183563119116,"score_spread":0.35331378608293085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970085,0.00047365518,0.000058993177,0.00068786,0.000066327135,0.00079434086,0.00018409119,0.000052237254,0.0006740004],"genre_scores_gemma":[0.9974536,0.00062318286,0.0001580695,0.000013476124,0.000053881064,0.00030308074,0.000019138477,0.000056146007,0.0013194496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971883,0.00019836873,0.0003274679,0.0004906783,0.0011849026,0.0006102432],"domain_scores_gemma":[0.99858004,0.0004903787,0.00004055412,0.00035600582,0.0002701791,0.00026283207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006912296,0.0001602115,0.0003184875,0.00091041334,0.000064679654,0.00006982935,0.00018459206,0.00005821132,0.00024814485],"category_scores_gemma":[0.0003737477,0.00013293847,0.00010103414,0.0011061426,0.00019678028,0.00023050394,0.000106701234,0.00090733235,0.00010958093],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030298985,0.0017751681,0.010748634,0.0035335494,0.0007005602,0.004246391,0.0021893624,0.003314991,0.8147176,0.0013054167,0.007062837,0.1473756],"study_design_scores_gemma":[0.005719159,0.0037220367,0.5888376,0.004853518,0.00022234191,0.000059217244,0.0002633384,0.120278835,0.2702127,0.005085149,0.0002524031,0.0004936661],"about_ca_topic_score_codex":0.00233807,"about_ca_topic_score_gemma":0.00047519474,"teacher_disagreement_score":0.578089,"about_ca_system_score_codex":0.00031164126,"about_ca_system_score_gemma":0.00058451545,"threshold_uncertainty_score":0.54210734},"labels":[],"label_agreement":null},{"id":"W4402266270","doi":"10.1158/1538-7445.pediatric24-b024","title":"Abstract B024: Single cell transcriptomics and patient-derived tumoroids reveal that hepatobiliary lineage programs cooperate with Wnt pathway mutations to drive cell proliferation in hepatoblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Hepatoblastoma; Wnt signaling pathway; Lineage (genetic); Cancer research; Cell growth; Biology; Transcriptome; Cell; Genetics; Gene; Medicine; Computational biology; Internal medicine; Gene expression","score_opus":0.05140030899510943,"score_gpt":0.32301844791666023,"score_spread":0.2716181389215508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955821,0.0011465198,0.000042259115,0.0007239826,0.00013110829,0.0018676701,0.00005971522,0.00007064777,0.00037602178],"genre_scores_gemma":[0.99806404,0.00014809721,0.00026299257,0.0002470494,0.000106395215,0.000735624,0.00010996226,0.000045893583,0.0002799655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981361,0.00021210186,0.0002583178,0.0005835123,0.00030070002,0.0005092629],"domain_scores_gemma":[0.99915564,0.000121139725,0.000028270137,0.00021154569,0.00025121888,0.00023218097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003547392,0.00019368637,0.00029107076,0.0002967702,0.00014189449,0.00007480665,0.00008901968,0.00015271029,0.000051466486],"category_scores_gemma":[0.000018447192,0.00015262792,0.000039375525,0.0005690589,0.00028137432,0.00016953188,0.000047118272,0.0007845621,0.000037456095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011845425,0.00048680705,0.014446123,0.0006300674,0.000024312716,0.00084894104,0.013176909,0.00014585015,0.96287656,0.000020424162,0.00022802535,0.005931417],"study_design_scores_gemma":[0.0016348897,0.004316673,0.021257037,0.0007287926,0.000033093853,0.000060370843,0.0018059217,0.0009795412,0.9680571,0.000060139762,0.00078855664,0.00027788497],"about_ca_topic_score_codex":0.00026662933,"about_ca_topic_score_gemma":0.00067650963,"teacher_disagreement_score":0.011370987,"about_ca_system_score_codex":0.00021636701,"about_ca_system_score_gemma":0.00065715134,"threshold_uncertainty_score":0.6223986},"labels":[],"label_agreement":null},{"id":"W4402266275","doi":"10.1158/1538-7445.pediatric24-a082","title":"Abstract A082 Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Cancer research; Medicine","score_opus":0.11111564864760264,"score_gpt":0.4130410444905546,"score_spread":0.30192539584295197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883656,0.004424046,0.000012523632,0.0031646006,0.000031790896,0.0014076361,0.000038379014,0.000021204894,0.0025342307],"genre_scores_gemma":[0.9972289,0.00013169789,0.00007927835,0.0000065864256,0.000098889235,0.0023312569,0.0000026431337,0.000026391575,0.000094332245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987959,0.000051363153,0.00018873511,0.00023481422,0.00039497056,0.00033420787],"domain_scores_gemma":[0.99870497,0.00093453645,0.000024359097,0.00019277306,0.000076562814,0.00006679592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006189643,0.00008947153,0.00019302504,0.0002616963,0.00009672503,0.00004227928,0.00009814216,0.000053720483,0.00016968008],"category_scores_gemma":[0.000231882,0.00005552145,0.00009167568,0.00045068984,0.000108902415,0.000045420493,0.000034523284,0.00020899005,0.000010175998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079212786,0.00055176904,0.0205667,0.0019258531,0.0005798924,0.00025860794,0.004225787,0.00013167213,0.8309381,0.017311461,0.0011196696,0.12159836],"study_design_scores_gemma":[0.0013670364,0.0004667941,0.011093526,0.0068828557,0.00010104213,0.000010976698,0.010513247,0.0026642408,0.95759356,0.006097722,0.0030564321,0.00015259394],"about_ca_topic_score_codex":0.00086790574,"about_ca_topic_score_gemma":0.0005286927,"teacher_disagreement_score":0.12665543,"about_ca_system_score_codex":0.0007322902,"about_ca_system_score_gemma":0.00028432385,"threshold_uncertainty_score":0.22640991},"labels":[],"label_agreement":null},{"id":"W4402266276","doi":"10.1158/1538-7445.pediatric24-b021","title":"Abstract B021: Enhancing clinical decision-making: The role of ex vivo drug sensitivity profiling in pediatric precision medicine","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ex vivo; Medicine; Drug; Profiling (computer programming); Precision medicine; Pharmacology; Oncology; Intensive care medicine; In vivo; Computer science; Pathology; Biotechnology; Biology","score_opus":0.16137017714407015,"score_gpt":0.5606185676639365,"score_spread":0.3992483905198663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93424207,0.053145822,0.0000483041,0.0049122674,0.00047548363,0.0006116292,0.000007336393,0.000026178328,0.006530893],"genre_scores_gemma":[0.97836524,0.019679027,0.00012256575,0.00010617578,0.0015714432,0.000033824384,9.019971e-7,0.000020415342,0.00010042733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99683535,0.0004759527,0.0006518745,0.00043587407,0.0011508077,0.00045015363],"domain_scores_gemma":[0.9794531,0.019731898,0.00007488841,0.00029231465,0.00030238676,0.00014545053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013270203,0.00012551536,0.0003924429,0.00023267546,0.0001370018,0.0000321006,0.00015669134,0.0000912119,0.0005465179],"category_scores_gemma":[0.0066229184,0.000071262846,0.00009688964,0.0010941488,0.0002815335,0.00013464747,0.00025640434,0.0016917074,0.000040918505],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032188087,0.00034744,0.10176439,0.0013634757,0.00017071096,0.00063292607,0.0024587424,0.0000660844,0.05513134,0.0003666784,0.011226145,0.8232533],"study_design_scores_gemma":[0.005491955,0.0014223242,0.48177123,0.017782476,0.0007932628,0.00012732732,0.013036824,0.02330114,0.11289268,0.015795544,0.32669678,0.0008884667],"about_ca_topic_score_codex":0.0004896646,"about_ca_topic_score_gemma":0.00035355723,"teacher_disagreement_score":0.8223648,"about_ca_system_score_codex":0.00016479248,"about_ca_system_score_gemma":0.00042916168,"threshold_uncertainty_score":0.7928731},"labels":[],"label_agreement":null},{"id":"W4402266277","doi":"10.1158/1538-7445.pediatric24-b001","title":"Abstract B001: Timing the development of chemoresistance in relapsed pediatric cancer with mutational signatures","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer; Medicine; Oncology; Internal medicine; Biology; Cancer research","score_opus":0.07843128036268,"score_gpt":0.4262245335047705,"score_spread":0.34779325314209053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903847,0.00778783,0.00000471425,0.0013576722,0.000048433638,0.0005085582,0.00001612505,0.000019132163,0.0012190712],"genre_scores_gemma":[0.9974464,0.00037609658,0.0002070558,0.000024699617,0.00013581729,0.0005073378,0.000008307245,0.00002625813,0.0012680213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979076,0.000049336144,0.00021108257,0.00029866895,0.0011173971,0.0004159182],"domain_scores_gemma":[0.9990825,0.00038159327,0.000026071117,0.00016534049,0.00023416108,0.00011029956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005251605,0.00010619084,0.00015052415,0.00034143432,0.000109613735,0.00003323068,0.00014357963,0.000046319485,0.0004342937],"category_scores_gemma":[0.00007371244,0.000061932085,0.00003180205,0.0010617615,0.00014652089,0.00005245509,0.000044481934,0.0006802928,0.000023112241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017714499,0.0026047812,0.2155745,0.01847193,0.0022832563,0.011164009,0.021024253,0.0038300066,0.43584383,0.0016288976,0.037370775,0.23248926],"study_design_scores_gemma":[0.0028056165,0.00023959843,0.8622483,0.0016907873,0.000044361932,0.000014440486,0.00038948396,0.0002431834,0.12929526,0.00016799784,0.0026701554,0.00019084118],"about_ca_topic_score_codex":0.00022320574,"about_ca_topic_score_gemma":0.0010531443,"teacher_disagreement_score":0.6466738,"about_ca_system_score_codex":0.00042422357,"about_ca_system_score_gemma":0.0028154512,"threshold_uncertainty_score":0.49944896},"labels":[],"label_agreement":null},{"id":"W4402266287","doi":"10.1158/1538-7445.pediatric24-a018","title":"Abstract A018 Transcriptional evolution from normal foetal haematopoiesis to myeloid leukaemia in Down syndrome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haematopoiesis; Myeloid leukaemia; Medicine; Down syndrome; Cancer research; Myeloid; Pathology; Biology; Genetics; Stem cell","score_opus":0.05560502137300056,"score_gpt":0.3862410180342773,"score_spread":0.33063599666127674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789679,0.005144141,0.0002005845,0.010042626,0.00038653865,0.0010947516,0.00030839397,0.00014062216,0.0037144439],"genre_scores_gemma":[0.99358445,0.00031957784,0.00031988166,0.00016938802,0.0006406973,0.00070206623,0.0001223857,0.00007940507,0.004062142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952061,0.00016331182,0.0004889394,0.00088522566,0.002028387,0.0012279892],"domain_scores_gemma":[0.99811035,0.00041346092,0.000018377632,0.00052168185,0.0003424706,0.00059363915],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016535785,0.0002558096,0.00045370733,0.0014085287,0.00017284795,0.00017443908,0.00043591895,0.00027971258,0.0058884206],"category_scores_gemma":[0.00025089472,0.00023498338,0.00017557779,0.0021091376,0.0003045897,0.00040699387,0.00018315724,0.0020765709,0.0023964536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003075794,0.00036207965,0.017423954,0.0018885882,0.00054086297,0.009880403,0.0033117938,0.0003065418,0.8587942,0.0039040826,0.07854267,0.021968998],"study_design_scores_gemma":[0.0035492505,0.00070291845,0.9073753,0.0034996509,0.00007367637,0.00057325984,0.0012846387,0.0017331376,0.021723256,0.002323311,0.056443494,0.00071815035],"about_ca_topic_score_codex":0.010144147,"about_ca_topic_score_gemma":0.0015032945,"teacher_disagreement_score":0.8899513,"about_ca_system_score_codex":0.0056196274,"about_ca_system_score_gemma":0.0033137365,"threshold_uncertainty_score":0.9983803},"labels":[],"label_agreement":null},{"id":"W4402266293","doi":"10.1158/1538-7445.pediatric24-a065","title":"Abstract A065 Immunoliposome for Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sarcoma; Ewing's sarcoma; Cancer; Cancer research; Internal medicine; Pathology","score_opus":0.1589408990331684,"score_gpt":0.4752266348032572,"score_spread":0.3162857357700888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91540545,0.07194806,0.0000112816615,0.007606298,0.00035281994,0.0009024504,0.000051467377,0.000096884556,0.0036252681],"genre_scores_gemma":[0.99453235,0.0017142098,0.00011878576,0.000102099075,0.0005879692,0.0011803766,0.000022490705,0.00004118244,0.0017005563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986605,0.000020691035,0.00014794893,0.00031035597,0.00039730073,0.0004631968],"domain_scores_gemma":[0.9989881,0.000469079,0.000008721244,0.0002602786,0.00016043185,0.00011337624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045214096,0.00009935692,0.00017553158,0.00022130487,0.00013023766,0.000099467754,0.00009419675,0.000060813883,0.00052922673],"category_scores_gemma":[0.0000739253,0.00007462288,0.00013628,0.0003161751,0.000074179035,0.00007184564,0.000045692694,0.00029481752,0.00025100165],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055484293,0.000665671,0.012394676,0.001838257,0.0009438631,0.0010528752,0.00088835944,0.000003070057,0.17253448,0.0065550325,0.06913653,0.73343235],"study_design_scores_gemma":[0.0031753052,0.0006726552,0.19044825,0.0028520846,0.00015563364,0.00007777452,0.00042535496,0.00019796132,0.20692948,0.002709519,0.59205055,0.00030545914],"about_ca_topic_score_codex":0.0003771671,"about_ca_topic_score_gemma":0.00001961972,"teacher_disagreement_score":0.7331269,"about_ca_system_score_codex":0.00043875794,"about_ca_system_score_gemma":0.00035406885,"threshold_uncertainty_score":0.57946616},"labels":[],"label_agreement":null},{"id":"W4402266297","doi":"10.1158/1538-7445.pediatric24-b023","title":"Abstract B023: Multicenter histology image integration and multiscale deep learning for pediatric sarcoma subtype classification","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histology; Medicine; Sarcoma; Pathology; Artificial intelligence; Computer science","score_opus":0.05485079013210358,"score_gpt":0.4273828383025217,"score_spread":0.37253204817041813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96612275,0.008847807,0.013944483,0.008977396,0.00045429426,0.00067332265,0.0000041922094,0.000110501926,0.0008652466],"genre_scores_gemma":[0.9935662,0.001984138,0.0020658663,0.00007432876,0.0006697461,0.0001763799,0.000052610656,0.00003842181,0.0013723171],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99874806,0.00008413665,0.00020193956,0.00036373996,0.0002668692,0.00033523553],"domain_scores_gemma":[0.99895966,0.00051119097,0.000032651875,0.00012469114,0.00022030578,0.0001515053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096398516,0.000096737655,0.000162669,0.00030787295,0.00017747449,0.000094340394,0.00007518906,0.00009420539,0.00015291665],"category_scores_gemma":[0.0010428634,0.00008001035,0.000050904728,0.00023339092,0.0001794524,0.00011034697,0.00003588111,0.0010383032,0.00003453678],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043717783,0.00010833272,0.053591873,0.0016599909,0.000058592555,0.00008354853,0.001631303,0.000023045666,0.31309617,0.00078999135,0.008602838,0.61991715],"study_design_scores_gemma":[0.0024813528,0.00037912442,0.32416502,0.0003832456,0.00013440987,0.00005095684,0.0007027429,0.591898,0.0024139206,0.00036416054,0.07676631,0.00026072876],"about_ca_topic_score_codex":0.00019620916,"about_ca_topic_score_gemma":0.00003366363,"teacher_disagreement_score":0.61965644,"about_ca_system_score_codex":0.00022885416,"about_ca_system_score_gemma":0.00013479122,"threshold_uncertainty_score":0.45109686},"labels":[],"label_agreement":null},{"id":"W4402266305","doi":"10.1158/1538-7445.pediatric24-a039","title":"Abstract A039 Circulating tumor DNA in pleuropulmonary blastoma (PPB)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pulmonary Blastoma; Medicine; Pathology; Internal medicine; Lung","score_opus":0.10575583946033333,"score_gpt":0.431891900507245,"score_spread":0.3261360610469117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96614295,0.007366994,0.0000014829358,0.0023959908,0.00019272785,0.00049181544,0.000020996704,0.000089966445,0.023297073],"genre_scores_gemma":[0.997257,0.00017562017,0.000030135214,0.000099089,0.00036785018,0.00021955793,0.0000050253443,0.000050886174,0.0017948479],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99787104,0.00007618544,0.00030285283,0.00040512608,0.00075880805,0.0005860101],"domain_scores_gemma":[0.9989272,0.00048138952,0.000015477426,0.00027321593,0.00014467379,0.00015809311],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008558993,0.00013591711,0.00026039715,0.00045147218,0.00008578802,0.00006489571,0.00012767354,0.00004740788,0.0011401029],"category_scores_gemma":[0.0005430812,0.00011800361,0.000077057324,0.00090946746,0.00016377581,0.000094830866,0.00016117207,0.0008127658,0.00066676334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046366552,0.00035694498,0.09108441,0.007371049,0.00044093485,0.032029733,0.007119296,0.000046599187,0.48595622,0.00054343656,0.017666427,0.3569213],"study_design_scores_gemma":[0.0010535992,0.0002284404,0.94925267,0.0043357094,0.000041665233,0.00024549584,0.0020135222,0.0027679708,0.004706866,0.0008096575,0.034168012,0.0003763887],"about_ca_topic_score_codex":0.0005980771,"about_ca_topic_score_gemma":0.00037339624,"teacher_disagreement_score":0.85816824,"about_ca_system_score_codex":0.00048810986,"about_ca_system_score_gemma":0.00054812344,"threshold_uncertainty_score":0.99977297},"labels":[],"label_agreement":null},{"id":"W4402266316","doi":"10.1158/1538-7445.pediatric24-a069","title":"Abstract A069 The role of <i>ABCB1</i> in doxorubicin resistant SMARCB1-deficient cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; SMARCB1; Medicine; Cancer; Cancer research; Internal medicine; Oncology; Biology; Genetics; Chemotherapy; Transcription factor; Gene","score_opus":0.03141824739927811,"score_gpt":0.36974734549944566,"score_spread":0.33832909810016754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9334434,0.0593494,0.000012084667,0.0005339921,0.00017056934,0.00022034666,0.000058729776,0.00001003383,0.006201389],"genre_scores_gemma":[0.9954039,0.0034649165,0.000016909433,0.000053401225,0.00022762455,0.00013133847,0.00001355284,0.000025967263,0.0006623846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984708,0.00008581125,0.00024373537,0.00037212262,0.00042679164,0.00040074348],"domain_scores_gemma":[0.9993194,0.00005547515,0.000027896951,0.00040692597,0.0001325001,0.000057843965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001017475,0.00010780632,0.00012402203,0.00009918777,0.000080315134,0.000045452667,0.00033662116,0.00009462385,0.000096994074],"category_scores_gemma":[0.00005312415,0.00007705044,0.00007955234,0.0004182285,0.00022141286,0.0000033735187,0.00012264823,0.00034322645,0.000010107806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015214462,0.000019360612,0.00027882308,0.00013516197,0.000028162185,0.000005623143,0.0002851133,0.0024411897,0.97898376,0.00026794028,0.003337954,0.01406475],"study_design_scores_gemma":[0.00027999707,0.0001315639,0.0013117566,0.00045537436,0.0000078474795,0.0000027036465,0.0010960209,0.0011823119,0.818398,0.0006170232,0.17635687,0.0001605474],"about_ca_topic_score_codex":0.0051246756,"about_ca_topic_score_gemma":0.0025089597,"teacher_disagreement_score":0.17301892,"about_ca_system_score_codex":0.0002328546,"about_ca_system_score_gemma":0.0009466284,"threshold_uncertainty_score":0.77470106},"labels":[],"label_agreement":null},{"id":"W4402266317","doi":"10.1158/1538-7445.pediatric24-a007","title":"Abstract A007 DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"DNA damage; Neuroblastoma; Cancer research; Poly ADP ribose polymerase; Medicine; Biology; DNA; Genetics; Polymerase; Cell culture","score_opus":0.061881303580996604,"score_gpt":0.4477320316786257,"score_spread":0.3858507280976291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499584,0.00208818,0.00010259578,0.0110324435,0.00018862424,0.00086473505,0.000036539055,0.00012140136,0.0005696097],"genre_scores_gemma":[0.99823606,0.0006455409,0.00008586872,0.00023339989,0.00017864621,0.00022616705,0.000010401581,0.000032775744,0.0003511212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770844,0.00037371193,0.00021574802,0.0005660063,0.0007407686,0.00039531983],"domain_scores_gemma":[0.9986127,0.0005982793,0.000031265252,0.00021627195,0.0002779902,0.00026347814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025385711,0.00014772598,0.00018656878,0.0004780487,0.00025020886,0.00016990164,0.000031698914,0.00009788974,0.00010249668],"category_scores_gemma":[0.00027328855,0.0001307158,0.000031113166,0.0007287165,0.0003332305,0.00026161093,0.0000919489,0.0005009338,0.00004124399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019392377,0.0000808391,0.00040274314,0.00043179537,0.0000100976,0.00032599698,0.0008932782,0.0000029300863,0.9650985,0.0002620887,0.0030902599,0.027462251],"study_design_scores_gemma":[0.0014880128,0.0015150055,0.2367975,0.0029958298,0.000018979475,0.0001726609,0.00029551837,0.0004154313,0.7449254,0.0005959052,0.010527082,0.00025266912],"about_ca_topic_score_codex":0.00006420953,"about_ca_topic_score_gemma":0.000056537625,"teacher_disagreement_score":0.23639476,"about_ca_system_score_codex":0.0002963568,"about_ca_system_score_gemma":0.00032495792,"threshold_uncertainty_score":0.53304356},"labels":[],"label_agreement":null},{"id":"W4402266327","doi":"10.1158/1538-7445.pediatric24-b022","title":"Abstract B022: Precision medicine for the fusion protein driven cancer, fibrolamellar carcinoma (FLC): Beyond sequencing","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Carcinoma; Internal medicine","score_opus":0.1704538178470529,"score_gpt":0.48484812532737664,"score_spread":0.3143943074803237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131081,0.034017596,0.00025300507,0.046356283,0.00021716104,0.0030221208,0.00010505051,0.00009706275,0.002823607],"genre_scores_gemma":[0.9884128,0.0021258967,0.00011249524,0.00016270204,0.002033664,0.002845823,0.000031082458,0.000043127722,0.0042324034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979208,0.00003959617,0.00028497804,0.00049655366,0.00075895205,0.0004991048],"domain_scores_gemma":[0.9981025,0.00083053636,0.000031291565,0.00045019586,0.00032504485,0.00026043822],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010252784,0.00015647992,0.0002230815,0.00009678174,0.00042779557,0.000059010443,0.00029650956,0.00012827766,0.0014593021],"category_scores_gemma":[0.00024698666,0.00009603203,0.00009546235,0.00063232746,0.00036009774,0.000073858326,0.00008279295,0.00089634233,0.000031032454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026148302,0.0000200334,0.00013207905,0.0011414508,0.000054114716,0.000026041153,0.00034186075,0.00007382765,0.93913895,0.0003714356,0.019588387,0.038850345],"study_design_scores_gemma":[0.0010258373,0.00017258733,0.0012898807,0.0018870658,0.000114957176,0.000019587542,0.00036280302,0.010334931,0.7339284,0.0012171039,0.24948733,0.00015953487],"about_ca_topic_score_codex":0.0005591657,"about_ca_topic_score_gemma":0.00002593744,"teacher_disagreement_score":0.22989893,"about_ca_system_score_codex":0.0006862964,"about_ca_system_score_gemma":0.0008715112,"threshold_uncertainty_score":0.9994535},"labels":[],"label_agreement":null},{"id":"W4402266328","doi":"10.1158/1538-7445.pediatric24-a060","title":"Abstract A060 Investigating underlying efficacy and mechanism of action of the KIF11 inhibitor filanesib in Ewing and clear cell sarcomas","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mechanism of action; Mechanism (biology); Action (physics); Sarcoma; Cancer research; Biology; Pathology; Genetics; Epistemology; Philosophy; Physics","score_opus":0.21727912824261564,"score_gpt":0.43755766093526965,"score_spread":0.22027853269265402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140567,0.007060707,9.397317e-7,0.00080994004,0.00006079846,0.00035933589,0.0000047172366,0.000008642489,0.0002892733],"genre_scores_gemma":[0.9990571,0.00072189636,0.000076421326,0.000018062663,0.000043621152,0.000032934477,0.0000012746171,0.000014957253,0.000033704477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991028,0.000055450033,0.00017700775,0.00019020258,0.00030403218,0.0001705167],"domain_scores_gemma":[0.9992706,0.00045948866,0.000031269716,0.00012887467,0.000046459845,0.000063275715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004455633,0.00007006044,0.00015806289,0.00015012856,0.000060090755,0.00002324365,0.000042080967,0.00005329997,0.00003150099],"category_scores_gemma":[0.0000961026,0.000048295864,0.000026892789,0.00029065553,0.00012526875,0.000050625546,0.00007125497,0.00030037048,0.0000010407822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008050737,0.0001492597,0.07152518,0.0019659067,0.00005189598,0.00004629598,0.002162703,0.000010029698,0.88515216,0.0007878775,0.0001433604,0.0379248],"study_design_scores_gemma":[0.0012398807,0.00019106803,0.38112438,0.0029582882,0.00003922804,0.000010884862,0.0015837312,0.0003076435,0.611453,0.0009009089,0.0001258779,0.00006511053],"about_ca_topic_score_codex":0.0011420734,"about_ca_topic_score_gemma":0.00010917251,"teacher_disagreement_score":0.3095992,"about_ca_system_score_codex":0.00009314378,"about_ca_system_score_gemma":0.00015113923,"threshold_uncertainty_score":0.19694482},"labels":[],"label_agreement":null},{"id":"W4402266338","doi":"10.1158/1538-7445.pediatric24-a040","title":"Abstract A040 Tumor educated platelets in detecting pediatric central nervous system tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Central nervous system; Platelet; Medicine; Pathology; Internal medicine","score_opus":0.02799110032119636,"score_gpt":0.35462347875489925,"score_spread":0.3266323784337029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796358,0.018565794,0.000012093987,0.00008882663,0.00047621393,0.0003445559,0.00003200239,0.000052901283,0.00079186197],"genre_scores_gemma":[0.99787897,0.00023321895,0.000030263684,0.000017863753,0.0012366606,0.00014895524,0.000029226823,0.000061666404,0.0003632003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997776,0.00014218877,0.00028793758,0.00059092167,0.00036920022,0.00083377707],"domain_scores_gemma":[0.9992123,0.000054469863,0.00003342606,0.00035618935,0.00010204255,0.00024153358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007444704,0.00016179225,0.00014201827,0.00024938415,0.00010505065,0.00012593814,0.00036155307,0.00011312465,0.00007595386],"category_scores_gemma":[0.00017908274,0.00016124353,0.00008417904,0.0006189512,0.00008126973,0.000008807053,0.00016549874,0.0005595366,0.000079626494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017029255,0.00008911316,0.009419963,0.0016046996,0.00003962803,0.0016502748,0.00019256011,0.00053997996,0.9744224,0.0000671907,0.0035195027,0.008284388],"study_design_scores_gemma":[0.00093004236,0.00023520038,0.08040235,0.0008684176,0.00003755584,0.00018909662,0.0015656021,0.0012953068,0.9051235,0.00009154185,0.008421685,0.0008397038],"about_ca_topic_score_codex":0.00042306157,"about_ca_topic_score_gemma":0.000122203,"teacher_disagreement_score":0.07098239,"about_ca_system_score_codex":0.0003189478,"about_ca_system_score_gemma":0.0009931563,"threshold_uncertainty_score":0.657532},"labels":[],"label_agreement":null},{"id":"W4402266354","doi":"10.1158/1538-7445.pediatric24-a070","title":"Abstract A070 Identifying therapeutic vulnerabilities in desmoplastic small round cell tumor through multi-omics analyses","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Omics; Computational biology; Biology; Desmoplastic small-round-cell tumor; Cancer; Medicine; Pathology; Bioinformatics; Internal medicine; Immunohistochemistry","score_opus":0.24618003211102507,"score_gpt":0.466517393966239,"score_spread":0.2203373618552139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766205,0.020359699,0.0015414574,0.00016662567,0.00029975668,0.00028508718,0.0000256208,0.00002132309,0.00067992555],"genre_scores_gemma":[0.99604034,0.0011874391,0.0003362579,0.000097030344,0.00023272206,0.00017460581,0.000040547537,0.000033181743,0.0018578988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985489,0.00014200305,0.00023375939,0.00044319758,0.00023179408,0.00040030523],"domain_scores_gemma":[0.9994419,0.000091978596,0.000025890105,0.00026724004,0.00011271266,0.000060231007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005515947,0.00013656881,0.00012771098,0.00014929517,0.000116497664,0.00020844635,0.00023777634,0.000098831704,0.00012776823],"category_scores_gemma":[0.00011383129,0.00012190977,0.00007880637,0.0003324647,0.00016802411,0.000018199924,0.000109354434,0.00040508594,0.000039255057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050573664,0.00006500975,0.0011262102,0.00026317788,0.000037115828,0.000021673928,0.00028218064,0.00029775922,0.99605894,0.00010272109,0.0005450815,0.0011495783],"study_design_scores_gemma":[0.00035789152,0.00008513781,0.001852232,0.00011105117,0.000008706438,0.0000033879296,0.0007958754,0.0005076305,0.9833653,0.00036227301,0.012362415,0.00018807703],"about_ca_topic_score_codex":0.0007324,"about_ca_topic_score_gemma":0.00088437984,"teacher_disagreement_score":0.019419812,"about_ca_system_score_codex":0.00013978206,"about_ca_system_score_gemma":0.00039081863,"threshold_uncertainty_score":0.4971336},"labels":[],"label_agreement":null},{"id":"W4402266355","doi":"10.1158/1538-7445.pediatric24-a049","title":"Abstract A049 A Wnt5a dependent feedback loop contributes to Ewing sarcoma cell motility","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Motility; Ewing's sarcoma; Feedback loop; Sarcoma; WNT5A; Biology; Medicine; Cancer research; Internal medicine; Cell biology; Computer science; Pathology; World Wide Web; Signal transduction","score_opus":0.0978898612942388,"score_gpt":0.42303509463558325,"score_spread":0.3251452333413445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95101607,0.033898048,0.000019183866,0.009085532,0.00031849786,0.0010694263,0.000084371015,0.00009907501,0.0044097956],"genre_scores_gemma":[0.99573475,0.00078438624,0.000060933555,0.0003333136,0.00028191786,0.0005770837,0.000018769739,0.000043180615,0.0021656754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997409,0.00008175227,0.00028111617,0.0006181434,0.00084892625,0.0007610863],"domain_scores_gemma":[0.9982314,0.00055116974,0.000016199034,0.0004863844,0.00031095263,0.00040387758],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00096885575,0.00018571217,0.0003343562,0.00032757252,0.0001544745,0.00019628496,0.00018659163,0.00010451881,0.0013076918],"category_scores_gemma":[0.00016750296,0.00014576779,0.00014545833,0.0006782247,0.00008821932,0.000079035315,0.00016924759,0.0005908277,0.0012132088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012945097,0.002827816,0.4270546,0.002584338,0.0010057688,0.0052988944,0.0012783529,0.000041917596,0.14934328,0.00074120465,0.10531564,0.30321366],"study_design_scores_gemma":[0.0023343225,0.00041811558,0.6767105,0.0014322639,0.000121795805,0.000022672624,0.0004529965,0.000100847225,0.27029586,0.00042301873,0.04747453,0.0002131111],"about_ca_topic_score_codex":0.0015812344,"about_ca_topic_score_gemma":0.00020196957,"teacher_disagreement_score":0.30300054,"about_ca_system_score_codex":0.001172313,"about_ca_system_score_gemma":0.00055146625,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W4402266368","doi":"10.1158/1538-7445.pediatric24-a050","title":"Abstract A050 DNMT3B DNA methyltransferase acts as a major player and therapeutic target in rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNMT3B; Methyltransferase; Cancer research; Medicine; DNA; Biology; Genetics; Methylation","score_opus":0.04223550757398106,"score_gpt":0.3932760607775745,"score_spread":0.3510405532035934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640015,0.032793373,0.00005379358,0.0008396036,0.00011639966,0.00024534372,0.000036049383,0.000019792034,0.0018941808],"genre_scores_gemma":[0.9955485,0.0026344538,0.000060079525,0.0001902104,0.00025781768,0.00014901436,0.000019836141,0.00004215255,0.00109795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984529,0.00009226383,0.00018442894,0.00050395523,0.00030855965,0.00045789286],"domain_scores_gemma":[0.99947846,0.00005430041,0.000011232069,0.00024911456,0.0000744832,0.0001323875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068680826,0.00015048354,0.00014844179,0.00014011502,0.000081283375,0.00009800072,0.00017970994,0.00014169017,0.00034100362],"category_scores_gemma":[0.00004465325,0.0001310664,0.000058750436,0.00025047635,0.00013224038,0.0000062942913,0.000063380074,0.0004082187,0.00003050164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015421424,0.000029893066,0.0002056382,0.00018997754,0.000066440065,0.000053518354,0.00028704564,0.00013488777,0.98761326,0.000116866104,0.00095142506,0.0101968115],"study_design_scores_gemma":[0.00071102055,0.00021320437,0.0016891484,0.00033267925,0.000013488155,0.000025173562,0.00025367638,0.00057346834,0.951537,0.0013851444,0.04296519,0.00030080526],"about_ca_topic_score_codex":0.0006076361,"about_ca_topic_score_gemma":0.0002769302,"teacher_disagreement_score":0.042013764,"about_ca_system_score_codex":0.000079885096,"about_ca_system_score_gemma":0.0005459893,"threshold_uncertainty_score":0.53447324},"labels":[],"label_agreement":null},{"id":"W4402266370","doi":"10.1158/1538-7445.pediatric24-a004","title":"Abstract A004 The ETS1-driven expression of TNS3 in Ewing sarcoma cells enhances the formation of the focal adhesions that promote cell movement","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Focal adhesion; Sarcoma; Pathology; Ewing's sarcoma; Expression (computer science); Movement (music); Medicine; Cancer research; Cell; Biology; Art; Aesthetics; Genetics","score_opus":0.09197158544765918,"score_gpt":0.392043773941364,"score_spread":0.30007218849370487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98633707,0.006709444,0.000009358006,0.004742467,0.00013498597,0.0012074456,0.000021109534,0.000009119481,0.0008290161],"genre_scores_gemma":[0.9975939,0.001698854,0.000027054653,0.00006253676,0.000063014886,0.0003901211,0.0000029999453,0.000013561862,0.00014795925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831337,0.00016534298,0.00026661594,0.00018039913,0.0008080657,0.000266201],"domain_scores_gemma":[0.99886084,0.0005250333,0.000067462046,0.00041367146,0.00009111826,0.000041881918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007921167,0.00009824661,0.00016246676,0.000099959565,0.00014611367,0.000030886767,0.00027475532,0.000051048853,0.00013418507],"category_scores_gemma":[0.000030930558,0.00004004152,0.00011935122,0.0003853333,0.00016969678,0.00009114565,0.00016283966,0.00039926745,0.000009874433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089386245,0.0003944087,0.0045764362,0.00058474764,0.00003282635,0.000016816015,0.0052990215,0.00010475657,0.965033,0.00010334043,0.0028217013,0.020943535],"study_design_scores_gemma":[0.00038969336,0.000097705684,0.040419016,0.0017774722,0.0000238452,9.621642e-7,0.0014967885,0.00036242395,0.9535187,0.00023044259,0.001645543,0.00003740421],"about_ca_topic_score_codex":0.0006509537,"about_ca_topic_score_gemma":0.0002015347,"teacher_disagreement_score":0.03584258,"about_ca_system_score_codex":0.0002059276,"about_ca_system_score_gemma":0.00022029865,"threshold_uncertainty_score":0.17346406},"labels":[],"label_agreement":null},{"id":"W4402266373","doi":"10.1158/1538-7445.pediatric24-a071","title":"Abstract A071 Mechanisms of radiation resistance in medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Resistance (ecology); Radiation resistance; Medicine; Radiation; Biology; Cancer research; Ecology; Physics; Nuclear physics","score_opus":0.055978615618763966,"score_gpt":0.41328696149999267,"score_spread":0.35730834588122873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97607374,0.0151987765,0.00001448438,0.0037909779,0.00013724613,0.0003992592,0.000021753824,0.000024098728,0.004339641],"genre_scores_gemma":[0.9980394,0.0010482024,0.00010690973,0.000021443124,0.0000659756,0.0002340354,0.000007392572,0.000015785612,0.00046085552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988531,0.00003397025,0.0001686756,0.00021710062,0.0004923529,0.00023480975],"domain_scores_gemma":[0.9994778,0.00016222429,0.0000151612285,0.00017793592,0.0000891977,0.000077651755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004932962,0.00006335033,0.00014831536,0.00035970044,0.000024448227,0.000019122224,0.000058965503,0.00005319774,0.0004913829],"category_scores_gemma":[0.00007372038,0.00005129259,0.000046080007,0.0006362652,0.000050244264,0.000051106454,0.000019848661,0.0002056733,0.00005779969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009748735,0.0008926009,0.01229221,0.0028496776,0.00030583332,0.002361473,0.0017951032,0.00004356929,0.7304644,0.076083064,0.03193119,0.14000602],"study_design_scores_gemma":[0.0014945533,0.000226986,0.15986344,0.002230221,0.000025630747,0.000005479897,0.00018839391,0.00007695512,0.8096925,0.009815444,0.016280433,0.0000999768],"about_ca_topic_score_codex":0.00044951856,"about_ca_topic_score_gemma":0.0007710331,"teacher_disagreement_score":0.14757124,"about_ca_system_score_codex":0.0003802942,"about_ca_system_score_gemma":0.00029596832,"threshold_uncertainty_score":0.5380298},"labels":[],"label_agreement":null},{"id":"W4402266378","doi":"10.1158/1538-7445.pediatric24-b015","title":"Abstract B015: Transcriptome-based assessment of immune infiltration for molecular selection of pediatric patients with solid tumors for combination immune checkpoint inhibitor therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research; BC Children's Hospital; University Health Network; Université Laval; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Immune system; Transcriptome; Immune checkpoint; Medicine; Solid tumor; Selection (genetic algorithm); Cancer research; Immunotherapy; Immunology; Cancer; Biology; Internal medicine; Genetics; Gene; Gene expression; Computer science","score_opus":0.03721209823249799,"score_gpt":0.3925980597563694,"score_spread":0.3553859615238714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956835,0.0027743613,0.0036629853,0.00046756418,0.00019730159,0.0031487052,0.00011210294,0.000028017732,0.000040625455],"genre_scores_gemma":[0.9977083,0.00032815337,0.0004325613,0.000017326336,0.00010848927,0.0010913176,0.00022644513,0.00004562401,0.000041772033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981875,0.000050862058,0.000569663,0.00026447012,0.0006547214,0.00027278776],"domain_scores_gemma":[0.9983508,0.00014129894,0.00015209489,0.0001688204,0.0011403438,0.000046615864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010792401,0.00014005005,0.0003112483,0.00047207644,0.00008020981,0.000029555507,0.0000865298,0.00008986378,0.00007985977],"category_scores_gemma":[0.000031776985,0.00011197012,0.00021162763,0.00078247243,0.00010342847,0.00011993992,0.000004908782,0.00021296777,2.2458944e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074331253,0.00059632695,0.0045451988,0.002261035,0.00024694199,6.62893e-7,0.00019236121,0.00008217543,0.9742536,0.00007090738,0.000110694185,0.010206954],"study_design_scores_gemma":[0.008816723,0.004533449,0.16423495,0.00049981225,0.00006379363,3.474065e-7,0.00005929714,0.0012322976,0.820089,0.000054954253,0.00029780145,0.000117569434],"about_ca_topic_score_codex":0.00020920724,"about_ca_topic_score_gemma":0.0000124761045,"teacher_disagreement_score":0.15968975,"about_ca_system_score_codex":0.000403078,"about_ca_system_score_gemma":0.001260601,"threshold_uncertainty_score":0.4566009},"labels":[],"label_agreement":null},{"id":"W4402266383","doi":"10.1158/1538-7445.pediatric24-b016","title":"Abstract B016: Unravelling personalized drug vulnerabilities in pediatric solid tumors—functional precision medicine approach","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Personalized medicine; Precision medicine; Computational biology; Bioinformatics; Pharmacology; Pathology; Biology","score_opus":0.056560484668019745,"score_gpt":0.37035676767139925,"score_spread":0.3137962830033795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527231,0.04105541,0.0006334855,0.000768812,0.00053489755,0.00034251637,0.00005762968,0.000017025588,0.0038671352],"genre_scores_gemma":[0.9813447,0.01224052,0.000097943346,0.00006634935,0.0028731509,0.00022464187,0.00014289758,0.00003889454,0.002970927],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998071,0.0000913831,0.00030215175,0.00059535616,0.00049985107,0.00044022212],"domain_scores_gemma":[0.9991015,0.0002836514,0.000027645841,0.00026395876,0.0001989582,0.00012424191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014406359,0.00015492969,0.00019025596,0.0002835368,0.000120505865,0.000076159515,0.000218161,0.00011061437,0.00036641493],"category_scores_gemma":[0.0003397873,0.00013433256,0.00007290693,0.00041241807,0.00023111478,0.0000072678017,0.00013580272,0.00047191742,0.000021852795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022039264,0.000593891,0.019742783,0.0034987188,0.00024521168,0.00016325968,0.0058363085,0.02742213,0.57753015,0.0076352996,0.32762894,0.027499365],"study_design_scores_gemma":[0.011898113,0.0022242244,0.08583635,0.0027112877,0.00020842558,0.00013351209,0.01173824,0.017213494,0.20728107,0.019227866,0.63776463,0.0037627674],"about_ca_topic_score_codex":0.0005222248,"about_ca_topic_score_gemma":0.00017841911,"teacher_disagreement_score":0.3702491,"about_ca_system_score_codex":0.00018675867,"about_ca_system_score_gemma":0.0007586908,"threshold_uncertainty_score":0.54779226},"labels":[],"label_agreement":null},{"id":"W4402266385","doi":"10.1158/1538-7445.pediatric24-b031","title":"Abstract B031: Isolation and characterization of extracellular vesicles and nanoparticles from osteosarcoma cell lines: Unveiling supermeres and exomeres for therapeutic insights","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Extracellular vesicles; Osteosarcoma; Isolation (microbiology); Cancer research; Extracellular; Medicine; Pathology; Chemistry; Biology; Cell biology; Microbiology","score_opus":0.03704782209214599,"score_gpt":0.33051614383581185,"score_spread":0.2934683217436659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8974917,0.101658024,0.00022771319,0.00013439804,0.000047741578,0.00032646346,0.00009596263,0.000010413839,0.00000759472],"genre_scores_gemma":[0.9933469,0.006012264,0.00015941427,0.000014032304,0.00017523688,0.000066530265,0.00012452512,0.00003136276,0.00006968585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989739,0.00007380939,0.00020556175,0.000400403,0.00014755488,0.00019875637],"domain_scores_gemma":[0.9994756,0.00011730101,0.000036065063,0.00017102074,0.00010870134,0.00009134175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024251443,0.000114480914,0.00012022524,0.00008479033,0.000115666015,0.00010488631,0.00008137438,0.000104847146,0.000010037504],"category_scores_gemma":[0.000031458945,0.00010811843,0.000028232416,0.00009156478,0.00025942895,0.000026138136,0.00008307759,0.00009571801,7.100302e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014918805,0.000035462475,0.0022607348,0.00039442326,0.000036575115,0.0000031872487,0.00039166972,0.000002216846,0.97395545,0.000094317824,0.000010836336,0.022665946],"study_design_scores_gemma":[0.0003542033,0.00013986732,0.020501558,0.00010973582,0.000026009106,0.0000011890425,0.00024410039,0.0013121741,0.9748379,0.0008399732,0.0015119079,0.00012139372],"about_ca_topic_score_codex":0.00005427377,"about_ca_topic_score_gemma":0.000029874676,"teacher_disagreement_score":0.09585526,"about_ca_system_score_codex":0.00001090096,"about_ca_system_score_gemma":0.00008066098,"threshold_uncertainty_score":0.4408942},"labels":[],"label_agreement":null},{"id":"W4402266391","doi":"10.1158/1538-7445.pediatric24-b005","title":"Abstract B005: BMP signaling determines neuroblastoma sensitivity to retinoic acid by directing cell fate","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoic acid; Neuroblastoma; Cancer research; Cell fate determination; Cell biology; Chemistry; Biology; Medicine; Biochemistry; Transcription factor; Genetics; Cell culture","score_opus":0.05931583202868418,"score_gpt":0.40631818796478075,"score_spread":0.3470023559360966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922539,0.001354425,0.000026839447,0.002091217,0.00024005397,0.0008346652,0.00008112583,0.0002357019,0.002882099],"genre_scores_gemma":[0.9937716,0.00019780503,0.00008897824,0.00018027255,0.00042522646,0.00020137087,0.000014801741,0.000101959515,0.005018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961765,0.0002778531,0.00027575815,0.00086508086,0.0012076182,0.0011972273],"domain_scores_gemma":[0.99774575,0.00073421776,0.00002683992,0.00041729514,0.00031754057,0.00075832696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010582113,0.00026177673,0.0003260871,0.00050023524,0.00029058094,0.00025190954,0.00015280611,0.000092352435,0.00042969832],"category_scores_gemma":[0.00039109273,0.00022271885,0.00013540186,0.0010622316,0.00013471518,0.00016867132,0.00022665966,0.0010907007,0.00085922366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004425766,0.000120887795,0.0005678243,0.0005781713,0.00005649901,0.004279467,0.00018095563,0.000019025112,0.955422,0.000001388583,0.011191692,0.027139558],"study_design_scores_gemma":[0.00056190754,0.00061156176,0.002332584,0.0007192641,0.000022769913,0.00008458944,0.000062903884,0.00033959202,0.9858458,0.000012898612,0.009226647,0.00017949843],"about_ca_topic_score_codex":0.00049566943,"about_ca_topic_score_gemma":0.00009912921,"teacher_disagreement_score":0.030423827,"about_ca_system_score_codex":0.00039036368,"about_ca_system_score_gemma":0.00042814907,"threshold_uncertainty_score":0.9999187},"labels":[],"label_agreement":null},{"id":"W4402266395","doi":"10.1158/1538-7445.pediatric24-a036","title":"Abstract A036 The Stratified Medicine Paediatrics programme for cancers of childhood: Cell free DNA and serial tumour sequencing identifies subtype specific evolution and epigenetic states","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenetics; Childhood cancer; Medicine; DNA; DNA sequencing; Biology; Cancer; Genetics; Internal medicine; Gene","score_opus":0.07221781513428281,"score_gpt":0.3589187180082987,"score_spread":0.2867009028740159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88620806,0.108311,0.000023876166,0.003214132,0.00042040864,0.0015167338,0.00016531257,0.000024059493,0.00011643566],"genre_scores_gemma":[0.96696526,0.031274382,0.00004525508,0.000016562115,0.0009809012,0.00049911503,0.00003691558,0.00003044239,0.0001511922],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982875,0.000047793303,0.00031072702,0.00040669707,0.000521486,0.00042576817],"domain_scores_gemma":[0.99870723,0.00053890765,0.000062396386,0.00026738574,0.00026667988,0.0001574096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090378616,0.00015459077,0.00028063956,0.00018768056,0.00017663775,0.00009613375,0.0001101752,0.00006713089,0.000096917785],"category_scores_gemma":[0.000103540006,0.00010006178,0.000053755277,0.0003959968,0.00043097316,0.000072024624,0.00006069443,0.0002648276,0.0000014480157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003025607,0.0006097719,0.03214113,0.018798456,0.0014908173,0.00028025414,0.03458482,0.0005272206,0.6057439,0.0033614882,0.119221255,0.18021533],"study_design_scores_gemma":[0.015526984,0.0066460087,0.5388248,0.0054635447,0.0013269545,0.00006708861,0.026639916,0.0008429667,0.35939595,0.022495799,0.021868762,0.0009012331],"about_ca_topic_score_codex":0.007557496,"about_ca_topic_score_gemma":0.00305628,"teacher_disagreement_score":0.50668365,"about_ca_system_score_codex":0.00074534176,"about_ca_system_score_gemma":0.0010494621,"threshold_uncertainty_score":0.9990513},"labels":[],"label_agreement":null},{"id":"W4402266412","doi":"10.1158/1538-7445.pediatric24-b048","title":"Abstract B048: Galectin-3 regulation of immunosuppression in Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunosuppression; Sarcoma; Ewing's sarcoma; Medicine; Galectin-1; Galectin-3; Cancer research; Oncology; Internal medicine; Pathology","score_opus":0.062120179041945285,"score_gpt":0.39747578159303104,"score_spread":0.33535560255108576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576257,0.036879007,0.000009052432,0.00035299384,0.00085595617,0.0001982601,0.00001554217,0.0000363273,0.0040271548],"genre_scores_gemma":[0.9968561,0.00081645115,0.000008525215,0.000009999932,0.00006835378,0.00007793291,0.00002635258,0.000016427726,0.002119852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866503,0.00023353408,0.00027489,0.00032020934,0.00007378542,0.0004325207],"domain_scores_gemma":[0.99935246,0.00026832646,0.00003280517,0.00022014097,0.00011146693,0.000014832659],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008893656,0.00009550313,0.00018826225,0.0003988299,0.00010172424,0.000018598743,0.00020493308,0.00022411246,0.0027927812],"category_scores_gemma":[0.000070245056,0.000080799895,0.000058075017,0.0005784577,0.00023297514,0.00008657782,0.000093567796,0.0007293798,0.00012970538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001723595,0.000035379573,0.0032005738,0.000121448276,0.000038182476,0.000005762689,0.00046760793,0.000012959533,0.9453102,0.0004890243,0.0041186917,0.046027828],"study_design_scores_gemma":[0.0005235799,0.0001218426,0.19792709,0.0005765261,0.0000052640426,0.000016510836,0.00023112883,0.000011444052,0.7546164,0.00092890044,0.044928543,0.000112779104],"about_ca_topic_score_codex":0.0017605694,"about_ca_topic_score_gemma":0.00028605558,"teacher_disagreement_score":0.19472651,"about_ca_system_score_codex":0.00018467753,"about_ca_system_score_gemma":0.00026400774,"threshold_uncertainty_score":0.9981188},"labels":[],"label_agreement":null},{"id":"W4402266427","doi":"10.1158/1538-7445.pediatric24-pr006","title":"Abstract PR006: Liquid biopsy enables identification of mechanisms of tumor evolution in patients with newly diagnosed high-risk neuroblastoma: A report from the Children’s Oncology Group","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neuroblastoma; Medicine; Identification (biology); Pediatric oncology; Oncology; Internal medicine; Biopsy; Liquid biopsy; Precision oncology; Cancer; Biology","score_opus":0.01720854507069159,"score_gpt":0.32410036819128124,"score_spread":0.30689182312058966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969468,0.0004084503,0.00013417621,0.00040522276,0.00012936717,0.0015836847,0.00032788492,0.000030901985,0.00003349718],"genre_scores_gemma":[0.9990108,0.00014098879,0.00010401788,0.000010981048,0.000078125755,0.00040578892,0.00015492408,0.00004005483,0.00005428846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99697363,0.00031631536,0.00055182964,0.00054878,0.0011737446,0.00043570812],"domain_scores_gemma":[0.9980566,0.00061301544,0.00020435822,0.00055955956,0.00042974966,0.00013670961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089478085,0.00015507289,0.00032625374,0.00041522455,0.00008733615,0.000029518724,0.00022593958,0.000077610785,0.000104542974],"category_scores_gemma":[0.0005042857,0.00009962711,0.00007017137,0.00093733065,0.00030309253,0.00015030327,0.00010879069,0.0006311323,0.000018906854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019185716,0.0048805512,0.3924122,0.0006780202,0.0009967178,0.0038617703,0.00074087875,0.00018463783,0.5629599,0.0009526954,0.0015905229,0.01155642],"study_design_scores_gemma":[0.0029470164,0.0028537095,0.9397155,0.00047166875,0.00006061932,0.000022875947,0.00007174657,0.000034056862,0.053263895,0.00045948496,0.00002904717,0.00007037255],"about_ca_topic_score_codex":0.017028514,"about_ca_topic_score_gemma":0.0012678186,"teacher_disagreement_score":0.5473033,"about_ca_system_score_codex":0.0005602307,"about_ca_system_score_gemma":0.00084484945,"threshold_uncertainty_score":0.98951715},"labels":[],"label_agreement":null},{"id":"W4402266429","doi":"10.1158/1538-7445.pediatric24-a020","title":"Abstract A020 MYCN overexpression biases human sympatho-adrenergic development towards progenitor cells causing neuroblastoma-like tumor xenografts","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Progenitor cell; Cancer research; Progenitor; Medicine; Internal medicine; Biology; Stem cell; Cell biology; Genetics; Cell culture","score_opus":0.12089301366275312,"score_gpt":0.42760551434453375,"score_spread":0.30671250068178063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941232,0.0018354738,0.0000042606284,0.00027300336,0.00051389117,0.0012492615,0.000066938526,0.00029479523,0.0016391332],"genre_scores_gemma":[0.99490196,0.00021908895,0.00019466865,0.00010065802,0.0007911064,0.0006161288,0.000059644583,0.0001431965,0.0029735565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949258,0.00020179425,0.00047261515,0.0010372977,0.0019426387,0.0014198766],"domain_scores_gemma":[0.9978746,0.00022037898,0.000053113014,0.0005617803,0.00039495697,0.0008951615],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005798036,0.00039757055,0.0004128907,0.0008520453,0.00061466586,0.0003668402,0.00026932647,0.00011709807,0.0011142698],"category_scores_gemma":[0.000106194595,0.00031362547,0.00018061452,0.0010934703,0.00028779873,0.00025336162,0.0003958915,0.0011284943,0.00042883964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040592102,0.000475782,0.00027933804,0.0010798267,0.00017629577,0.007065239,0.00034894692,0.000025385745,0.9693054,0.000016263844,0.009843378,0.010978236],"study_design_scores_gemma":[0.0013066998,0.0007046162,0.01141957,0.0039623193,0.00003776164,0.0001871335,0.00009234962,0.00009476179,0.95291984,0.000021509055,0.028948897,0.0003045339],"about_ca_topic_score_codex":0.00048666226,"about_ca_topic_score_gemma":0.00007970892,"teacher_disagreement_score":0.019105518,"about_ca_system_score_codex":0.0008838044,"about_ca_system_score_gemma":0.0023992094,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W4402266434","doi":"10.1158/1538-7445.pediatric24-pr004","title":"Abstract PR004: Next generation pediatric precision oncology: Functional profiling of patient-derived viable tumor material to link genotype and phenotype","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Medicine; Genotype; Pediatric oncology; Phenotype; Oncology; Internal medicine; Profiling (computer programming); Computational biology; Bioinformatics; Cancer; Biology; Genetics; Computer science; Gene","score_opus":0.1298236690505636,"score_gpt":0.3987203447480792,"score_spread":0.26889667569751563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906775,0.0063373395,0.000014047322,0.0012123173,0.00061388453,0.00090417283,0.000040597242,0.000026953967,0.0001732257],"genre_scores_gemma":[0.99623144,0.00074870576,0.0009401313,0.00007917878,0.0014662968,0.00039569402,0.000065711916,0.000024199286,0.00004866783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986668,0.000055371387,0.00023949766,0.00033688304,0.00044946373,0.00025195724],"domain_scores_gemma":[0.99921507,0.00015591434,0.000030904976,0.00014878673,0.0003032986,0.00014603153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035695647,0.00009846553,0.00019080841,0.00025312134,0.00009690566,0.000065070795,0.00004101449,0.000071694354,0.0007637753],"category_scores_gemma":[0.00010362229,0.00007644869,0.00003553552,0.0003389947,0.00003857025,0.00009073898,0.00007441844,0.00019002799,0.00006614418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083379674,0.00020995243,0.0072649824,0.00036148162,0.00006499969,0.00008220119,0.00032036065,0.00007487165,0.88943154,0.0000940539,0.0037277134,0.09753406],"study_design_scores_gemma":[0.0014910452,0.00246255,0.08300819,0.0003223135,0.00016150235,0.00001874302,0.00018372331,0.0007432457,0.9012299,0.00028898037,0.00988376,0.00020600327],"about_ca_topic_score_codex":0.00021178799,"about_ca_topic_score_gemma":0.000023878205,"teacher_disagreement_score":0.09732806,"about_ca_system_score_codex":0.00033702396,"about_ca_system_score_gemma":0.00065151136,"threshold_uncertainty_score":0.83628047},"labels":[],"label_agreement":null},{"id":"W4402266442","doi":"10.1158/1538-7445.pediatric24-b052","title":"Abstract B052: IKAROS mediates antigen escape following CD19- or CD22-targeted immunotherapies in r/r B-ALL","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD22; CD19; Antigen; Immunotherapy; Immunology; Medicine; Cancer research; Biology; Immune system","score_opus":0.09034003884959542,"score_gpt":0.4392322278296833,"score_spread":0.3488921889800879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96334916,0.027390767,0.000016382759,0.0050663487,0.0006224241,0.0011623952,0.000042370175,0.00021523831,0.0021349278],"genre_scores_gemma":[0.98530465,0.0070870034,0.0002018369,0.00024478207,0.00067230326,0.00047594478,0.000050052386,0.00015074687,0.0058126897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947846,0.00020519693,0.00054990704,0.00081630505,0.002064583,0.0015793899],"domain_scores_gemma":[0.99719226,0.001486704,0.00003184646,0.0006398586,0.00026757488,0.00038176522],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025360598,0.0003092797,0.0005533634,0.0012048443,0.00016152687,0.0002622803,0.0005587794,0.0002907342,0.0043077683],"category_scores_gemma":[0.000908033,0.00022646657,0.00021292537,0.0021167533,0.00034585458,0.00032125806,0.000256405,0.001661927,0.00083901547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027431527,0.00029299242,0.012325655,0.0016189672,0.0011969435,0.009058518,0.0062476452,0.00003151636,0.8903894,0.00014898376,0.039245497,0.036700755],"study_design_scores_gemma":[0.022604136,0.0021959946,0.17892973,0.013067289,0.00020945568,0.00031853147,0.007145408,0.0080168815,0.39651474,0.0020494428,0.36677253,0.0021758624],"about_ca_topic_score_codex":0.0027885141,"about_ca_topic_score_gemma":0.00043347816,"teacher_disagreement_score":0.49387464,"about_ca_system_score_codex":0.0025858271,"about_ca_system_score_gemma":0.004784155,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W4402266458","doi":"10.1158/1538-7445.pediatric24-a063","title":"Abstract A063 Selective targeting of BET family epigenetic regulators in metastatic alveolar rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Sinai Health System","funders":"","keywords":"Alveolar rhabdomyosarcoma; Epigenetics; Rhabdomyosarcoma; Medicine; Cancer research; Oncology; Biology; Pathology; Genetics; Gene; Sarcoma","score_opus":0.04098955535231321,"score_gpt":0.37982786587636497,"score_spread":0.3388383105240518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773378,0.020961588,0.000094670235,0.00024280176,0.00014120436,0.00034553237,0.000042530086,0.00001144012,0.00082247966],"genre_scores_gemma":[0.9981978,0.0007757827,0.000275773,0.000028396711,0.00015068943,0.00012349559,0.00005972655,0.000029266357,0.0003590978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984059,0.00017718146,0.00029261172,0.0003913903,0.0003621285,0.00037081732],"domain_scores_gemma":[0.9994222,0.00005573134,0.000036673293,0.0002230118,0.00018194699,0.00008043045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010573859,0.00011753184,0.0001549833,0.00024799697,0.00005765858,0.000036292502,0.00021343613,0.000089536086,0.000072966],"category_scores_gemma":[0.00021009454,0.0001100027,0.00007797636,0.00058725337,0.00016197757,0.000009470757,0.0001015014,0.0003127467,0.000012904749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000528166,0.000034716875,0.0010438021,0.00015415404,0.000056421526,0.000011016486,0.00013226474,0.0000726865,0.9863589,0.00014801165,0.0070459316,0.0048892754],"study_design_scores_gemma":[0.00024002108,0.00014007256,0.0063372008,0.00014499287,0.0000056349477,0.0000013719462,0.00023491903,0.000110797875,0.9749175,0.00039192216,0.017346697,0.00012889084],"about_ca_topic_score_codex":0.00047575726,"about_ca_topic_score_gemma":0.00010717183,"teacher_disagreement_score":0.02086002,"about_ca_system_score_codex":0.00008510117,"about_ca_system_score_gemma":0.00048717778,"threshold_uncertainty_score":0.448578},"labels":[],"label_agreement":null},{"id":"W4402266468","doi":"10.1158/1538-7445.pediatric24-b051","title":"Abstract B051: Marrow and peripheral blood cytokine architecture differences between pediatric patients receiving CD19- and CD22-directed CART","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CD19; Cart; CD22; Peripheral blood; Cytokine; Internal medicine","score_opus":0.04081372465500761,"score_gpt":0.3545203461232341,"score_spread":0.3137066214682265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868249,0.009520631,0.00000495149,0.0014814475,0.000106421925,0.0007374433,0.00008820646,0.00013622819,0.0010997489],"genre_scores_gemma":[0.9931878,0.0036709455,0.00011898589,0.000026366839,0.0008636772,0.000118200594,0.000045273737,0.00006638172,0.0019023581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652976,0.00021519153,0.00030042118,0.00078325707,0.0013598137,0.00081153517],"domain_scores_gemma":[0.9980722,0.00067721267,0.000029368492,0.00031431255,0.00034673655,0.0005601843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069229526,0.00024675488,0.0003994783,0.00049147086,0.00024430364,0.00026094483,0.0001910674,0.00018087913,0.00074523233],"category_scores_gemma":[0.00046110823,0.00019277346,0.00006611742,0.0009151655,0.00031542624,0.00009236296,0.00031719383,0.0015551681,0.000018950164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019677341,0.00011063214,0.84993374,0.0020364549,0.0001591179,0.000264769,0.00085038744,0.0000010630919,0.039130017,0.000007222594,0.0026676024,0.104642205],"study_design_scores_gemma":[0.0012616075,0.00051229174,0.9907091,0.00041461154,0.00009748162,0.00001547086,0.000085862965,0.00007233485,0.003329915,0.00010523804,0.0031868618,0.00020922748],"about_ca_topic_score_codex":0.00047745867,"about_ca_topic_score_gemma":0.00013026649,"teacher_disagreement_score":0.14077534,"about_ca_system_score_codex":0.00017179763,"about_ca_system_score_gemma":0.00036955564,"threshold_uncertainty_score":0.81597716},"labels":[],"label_agreement":null},{"id":"W4402266498","doi":"10.1158/1538-7445.pediatric24-a030","title":"Abstract A030 Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Pediatric cancer; Period (music); Oncology; Internal medicine","score_opus":0.04425394060280891,"score_gpt":0.38398121148533654,"score_spread":0.33972727088252763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93613106,0.06051158,6.2082984e-7,0.0004884808,0.0004351241,0.0008252656,0.00040049845,0.00002995183,0.0011774302],"genre_scores_gemma":[0.9604556,0.035842173,0.000036223566,0.00014234186,0.00074784283,0.00082875375,0.000034822217,0.00006119819,0.0018510249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977249,0.00006987532,0.0003976869,0.00052154117,0.0006891766,0.00059682917],"domain_scores_gemma":[0.99914736,0.00011397272,0.00004113977,0.000328115,0.00018245161,0.00018698433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025713016,0.00022488783,0.00045071082,0.00061817275,0.00005143691,0.000050674953,0.00012685842,0.00013737408,0.013682482],"category_scores_gemma":[0.000017618257,0.00017947846,0.0001741156,0.0007133822,0.00016442729,0.00019199916,0.000034260553,0.00042709365,0.000029670404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034832524,0.00071386865,0.86770195,0.0025194131,0.00039152513,0.00053075724,0.00819199,0.00003269317,0.013451812,0.000029672867,0.012391628,0.09056142],"study_design_scores_gemma":[0.004691727,0.0009602216,0.9226619,0.0003749548,0.00005036449,0.0000025692048,0.0001985914,0.00006168648,0.0037906272,0.00001353457,0.06696797,0.0002258452],"about_ca_topic_score_codex":0.003336869,"about_ca_topic_score_gemma":0.001031794,"teacher_disagreement_score":0.09033557,"about_ca_system_score_codex":0.002022008,"about_ca_system_score_gemma":0.0024180245,"threshold_uncertainty_score":0.98721915},"labels":[],"label_agreement":null},{"id":"W4402266499","doi":"10.1158/1538-7445.pediatric24-b049","title":"Abstract B049: Oncolytic HSV1716-GMCSF combination strategies to remodel the immunosuppressive osteosarcoma tumor-microenvironment and promote anti-tumor immunity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Osteosarcoma; Tumor microenvironment; Medicine; Immunity; Cancer research; Immunology; Immune system; Tumor cells","score_opus":0.03407052938666342,"score_gpt":0.37086896700753336,"score_spread":0.3367984376208699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829008,0.012386147,0.000039975046,0.0024739439,0.00011392974,0.0012546292,0.00007648345,0.000024121195,0.00072995835],"genre_scores_gemma":[0.99665296,0.0017291182,0.00003128504,0.00014955224,0.00017635453,0.0004310042,0.000048753394,0.00006133096,0.0007196143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734205,0.00039103854,0.0002618769,0.00062583864,0.0006759105,0.00070329476],"domain_scores_gemma":[0.9987152,0.0000934288,0.000040039886,0.0007848099,0.00019150402,0.0001749693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016050426,0.00023084751,0.000189398,0.00016455856,0.0004662902,0.0004577671,0.0006807296,0.00009034728,0.00013566368],"category_scores_gemma":[0.00007480426,0.00017760083,0.00007681143,0.00034262295,0.0004920949,0.000027002316,0.00058919884,0.00075426133,0.000074339005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007062249,0.000090734764,0.000059369526,0.00013522002,0.000102413396,0.000048566595,0.00047547728,0.0002151269,0.98415625,0.000085689026,0.0015023134,0.012422622],"study_design_scores_gemma":[0.000709842,0.0023250335,0.0049517937,0.00023218477,0.000015211954,0.000041343123,0.0012402812,0.0004658768,0.9696752,0.00065019156,0.019380797,0.0003122398],"about_ca_topic_score_codex":0.00039392663,"about_ca_topic_score_gemma":0.00026031904,"teacher_disagreement_score":0.017878482,"about_ca_system_score_codex":0.00022779919,"about_ca_system_score_gemma":0.0007855106,"threshold_uncertainty_score":0.7242351},"labels":[],"label_agreement":null},{"id":"W4402266518","doi":"10.1158/1538-7445.pediatric24-a017","title":"Abstract A017 Dynamic modelling of EWS::FLI1 fluctuations reveals molecular determinants of phenotypic tumor plasticity and prognosis in Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; FLI1; Phenotype; Phenotypic plasticity; Ewing's sarcoma; Biology; Medicine; Genetics; Pathology; Chromosomal translocation; Gene","score_opus":0.10006069057361282,"score_gpt":0.41045146537378874,"score_spread":0.3103907748001759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755866,0.01129405,0.00012789025,0.0002002725,0.000032583946,0.0006318964,0.00004597624,0.0000127579515,0.00009588762],"genre_scores_gemma":[0.9983641,0.0007761045,0.00052549824,0.000008381828,0.000018905585,0.00025877563,0.0000048863762,0.000025052139,0.000018310842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850154,0.0000586559,0.00036999496,0.000312875,0.000446775,0.00031013633],"domain_scores_gemma":[0.99910307,0.00043169403,0.00004658987,0.00016008267,0.0001634826,0.00009510688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044630497,0.00011425412,0.00034387474,0.00039066147,0.000046616336,0.000022243954,0.00008319334,0.000051782874,0.000052146912],"category_scores_gemma":[0.00013737698,0.00009685626,0.000064312175,0.00045241916,0.00014466152,0.000069389986,0.00006192101,0.0002600519,0.0000037720695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046799774,0.0013282668,0.52951646,0.006713336,0.00036568166,0.0017924675,0.0023790824,0.0030969582,0.34527645,0.00070111826,0.00007611601,0.10828603],"study_design_scores_gemma":[0.0015809863,0.00036910907,0.7002648,0.007971575,0.00016464821,0.0000362082,0.0003147352,0.090610266,0.1967657,0.0016977019,0.000026134478,0.00019811277],"about_ca_topic_score_codex":0.00082628214,"about_ca_topic_score_gemma":0.00013985098,"teacher_disagreement_score":0.17074832,"about_ca_system_score_codex":0.00020749589,"about_ca_system_score_gemma":0.00026464261,"threshold_uncertainty_score":0.3949684},"labels":[],"label_agreement":null},{"id":"W4402266520","doi":"10.1158/1538-7445.pediatric24-b004","title":"Abstract B004: Putting function back into paediatric cancer genomics – modelling the therapeutic implications of novel genomic features","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genomics; Cancer; Function (biology); Computational biology; Medicine; Bioinformatics; Biology; Genome; Genetics; Internal medicine; Gene","score_opus":0.16794160001133024,"score_gpt":0.4390033547135228,"score_spread":0.27106175470219257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7463335,0.19429103,0.020874353,0.032076377,0.0013229762,0.0021744273,0.00032688046,0.00016212989,0.0024383743],"genre_scores_gemma":[0.9820842,0.013515052,0.00065924274,0.00046002545,0.0016902339,0.0006853783,0.000028855007,0.00008219324,0.00079479045],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980611,0.00006531177,0.00039384275,0.00047614172,0.00052670465,0.00047690712],"domain_scores_gemma":[0.99837786,0.00042580176,0.000087528795,0.0005284241,0.00045675947,0.00012360953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010281224,0.00017668377,0.00024016302,0.00034182135,0.0003008422,0.000100085774,0.0002825143,0.00013867325,0.00069144624],"category_scores_gemma":[0.000017260147,0.00013069423,0.00015519939,0.0010623464,0.00026201282,0.00012094205,0.000072538576,0.0009394775,0.00006206447],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037779566,0.0001156976,0.0007542551,0.00093651866,0.00046701584,0.000002570556,0.002238122,0.05053859,0.81999946,0.002691812,0.0110507645,0.110827416],"study_design_scores_gemma":[0.008415875,0.00093925494,0.06929862,0.003913634,0.0011504357,0.0001353431,0.0026800248,0.09881656,0.17251354,0.047381256,0.59312916,0.0016262847],"about_ca_topic_score_codex":0.0016814899,"about_ca_topic_score_gemma":0.00011547824,"teacher_disagreement_score":0.6474859,"about_ca_system_score_codex":0.0012765706,"about_ca_system_score_gemma":0.0014700326,"threshold_uncertainty_score":0.75708514},"labels":[],"label_agreement":null},{"id":"W4402266523","doi":"10.1158/1538-7445.pediatric24-a064","title":"Abstract A064 Characterizing the immune microenvironment and examining the effect of tumour-targeted MRgHIFU mediated hyperthermia in combination with thermosensitive liposomal doxorubicin in a mouse model of embryonal rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Doxorubicin; Rhabdomyosarcoma; Cancer research; Embryonal rhabdomyosarcoma; Immune system; Tumor microenvironment; Medicine; Immunology; Internal medicine; Sarcoma; Chemotherapy; Pathology","score_opus":0.0335336103769013,"score_gpt":0.3071696772681062,"score_spread":0.2736360668912049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990153,0.006967588,0.0000010289417,0.0016639367,0.000016723201,0.0011060998,0.000037073805,0.00000858276,0.00004597672],"genre_scores_gemma":[0.9987672,0.0007762851,0.000012618074,0.000027053646,0.000019529407,0.00031827632,0.000019757052,0.000030787058,0.000028481483],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983171,0.00030740845,0.00031053476,0.00027116976,0.0004935441,0.00030020214],"domain_scores_gemma":[0.9983077,0.00131137,0.00006643377,0.00021964699,0.00004950805,0.000045363427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012256976,0.00015855696,0.00035675085,0.0002260453,0.000057118847,0.000021456131,0.000103984705,0.000058432717,0.000023193483],"category_scores_gemma":[0.000064864005,0.00007930706,0.00004257293,0.00033763115,0.00032443483,0.00006405702,0.00007502752,0.00049176475,0.0000018962292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001111671,0.00019708759,0.06317901,0.0002087477,0.00012497311,0.00010840137,0.0023166009,0.00011189054,0.92497325,0.000021488553,0.0000030440992,0.007643812],"study_design_scores_gemma":[0.0018235164,0.00049362076,0.5178369,0.0008042696,0.00002651932,0.000010116252,0.00035568431,0.0037989737,0.47479218,0.000006887854,0.0000023430403,0.00004894937],"about_ca_topic_score_codex":0.0010446627,"about_ca_topic_score_gemma":0.00016048487,"teacher_disagreement_score":0.4546579,"about_ca_system_score_codex":0.00023911004,"about_ca_system_score_gemma":0.00013537136,"threshold_uncertainty_score":0.3234048},"labels":[],"label_agreement":null},{"id":"W4402266527","doi":"10.1158/1538-7445.pediatric24-pr003","title":"Abstract PR003: Canada’s path towards proteome guided therapies and advanced molecular pathology in pediatric precision oncology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Calgary; Children's Hospital of Eastern Ontario; McGill University; University of British Columbia","funders":"","keywords":"Pediatric oncology; Medicine; Precision oncology; Molecular pathology; Precision medicine; Oncology; Medical physics; Pathology; Internal medicine; Cancer; Biology","score_opus":0.03087254620961161,"score_gpt":0.3788371208763839,"score_spread":0.3479645746667723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517955,0.04440728,0.000049291106,0.0018183885,0.00033079414,0.00057310634,0.000083194915,0.0000087365825,0.0009336714],"genre_scores_gemma":[0.9728503,0.025735358,0.00025313577,0.00018414101,0.00030508687,0.0003965332,0.000034979817,0.000035875688,0.00020455946],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983051,0.000093986826,0.00025479938,0.0005811096,0.00027924863,0.00048577928],"domain_scores_gemma":[0.9993087,0.00008763142,0.000032699256,0.00029018408,0.00015187179,0.00012890437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070234213,0.00015359225,0.00018948768,0.00016001536,0.00006617664,0.000050781033,0.00022174558,0.0001876758,0.000041043866],"category_scores_gemma":[0.0002383246,0.00014234605,0.000036269215,0.00022407605,0.00010626731,0.000005704398,0.00022774759,0.00035685315,0.0000029498126],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024677173,0.00006427066,0.0018391205,0.00028316295,0.000039448347,0.00074150506,0.00028624767,0.00035169715,0.8721779,0.00030341596,0.014692411,0.10897404],"study_design_scores_gemma":[0.002561704,0.0016221554,0.06591795,0.00022806949,0.000034298206,0.00010353614,0.00043287742,0.00016006206,0.30947706,0.0034425037,0.6151025,0.0009172878],"about_ca_topic_score_codex":0.037741996,"about_ca_topic_score_gemma":0.13790578,"teacher_disagreement_score":0.6004101,"about_ca_system_score_codex":0.00034370518,"about_ca_system_score_gemma":0.0041902754,"threshold_uncertainty_score":0.9686658},"labels":[],"label_agreement":null},{"id":"W4402266531","doi":"10.1158/1538-7445.pediatric24-pr005","title":"Abstract PR005: A toolbox for the use of cfDNA in pediatric cancer patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Toolbox; Pediatric cancer; Oncology; Internal medicine; Computer science; Programming language","score_opus":0.0955604797764877,"score_gpt":0.3992706344238152,"score_spread":0.30371015464732753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98041326,0.017295783,0.000083162784,0.00051812344,0.00045128787,0.0006311492,0.00052096584,0.000003644749,0.000082614155],"genre_scores_gemma":[0.9789448,0.019200679,0.00004201114,0.00007793523,0.0006323353,0.00063456956,0.000036472946,0.000025771187,0.00040543234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990263,0.000022043921,0.0001803432,0.0002730411,0.00019736432,0.00030090843],"domain_scores_gemma":[0.99915725,0.00030759518,0.000026568505,0.00022711001,0.00023357612,0.000047893293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029488245,0.00008211599,0.00009088968,0.0000956204,0.000053153795,0.00006491259,0.00020356961,0.00008104841,0.000044396205],"category_scores_gemma":[0.0002701623,0.00006233287,0.00006736997,0.0002589948,0.00007480497,0.0000055233204,0.00008955161,0.00015996565,0.0000028899738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014221669,0.00052514917,0.187017,0.0021606307,0.00030774734,0.000013218,0.000876097,0.006939463,0.11685247,0.001055228,0.4350913,0.24773955],"study_design_scores_gemma":[0.0011664563,0.0004068815,0.12433358,0.00015710115,0.000047322796,4.1767987e-7,0.00005647636,0.0006445272,0.050979983,0.00019461589,0.82171935,0.0002932623],"about_ca_topic_score_codex":0.0014758266,"about_ca_topic_score_gemma":0.0020218417,"teacher_disagreement_score":0.3866281,"about_ca_system_score_codex":0.000085184874,"about_ca_system_score_gemma":0.0005992497,"threshold_uncertainty_score":0.25418606},"labels":[],"label_agreement":null},{"id":"W4402266536","doi":"10.1158/1538-7445.pediatric24-a054","title":"Abstract A054 A genome-derived cell state reporter permits dissection and control of intratumoral heterogeneity and chemoresistance","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genome; Dissection (medical); Cell; Cancer research; Biology; Tumour heterogeneity; Computational biology; Genetics; Gene; Cancer; Anatomy","score_opus":0.022230418734134835,"score_gpt":0.3081206845264307,"score_spread":0.2858902657922959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782235,0.010850211,0.00064354093,0.00012799852,0.00021606612,0.00011457305,0.000025315065,0.00006597684,0.00013394916],"genre_scores_gemma":[0.99841696,0.0012866424,0.000029983094,0.0000034341579,0.000099803976,0.00005227477,0.0000046097825,0.000018263987,0.00008801992],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99934435,0.000010210889,0.00013618203,0.00016211401,0.00015530975,0.00019183538],"domain_scores_gemma":[0.9997227,0.000036212507,0.000008490555,0.00008887844,0.000044380296,0.0000993098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023953906,0.00007250782,0.000102310194,0.00008588166,0.000028916236,0.00004709149,0.00003998897,0.000042638458,0.00002565449],"category_scores_gemma":[0.000010954845,0.00006477617,0.000015283977,0.00015807795,0.000093629635,0.00007413569,0.000012653498,0.00020375247,0.000001591727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021115828,0.00001115254,0.00045638744,0.002597458,0.000030397125,0.000018374838,0.00037244317,0.00018399331,0.98776114,0.0000055882233,0.00033546585,0.008206507],"study_design_scores_gemma":[0.00069989637,0.00011570516,0.53464705,0.0005119454,0.000027730332,0.000040378196,0.00014079562,0.018598014,0.43867585,0.00032329786,0.005807838,0.00041147016],"about_ca_topic_score_codex":0.00005556221,"about_ca_topic_score_gemma":0.00004018193,"teacher_disagreement_score":0.54908526,"about_ca_system_score_codex":0.00007294604,"about_ca_system_score_gemma":0.000039642153,"threshold_uncertainty_score":0.26414955},"labels":[],"label_agreement":null},{"id":"W4402266537","doi":"10.1158/1538-7445.pediatric24-a006","title":"Abstract A006 Targeting boundary cap cells leads to mouse <i>Smarcb1</i>-deficient peripheral nerve tumors recapitulating human peripheral rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peripheral; SMARCB1; Pathology; Cancer research; Medicine; Peripheral nerve; Biology; Anatomy; Internal medicine; Genetics; Transcription factor","score_opus":0.033742998532573266,"score_gpt":0.3585304501562639,"score_spread":0.3247874516236906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824185,0.008556913,0.00010903792,0.0004878821,0.0004525022,0.00045414653,0.000113065114,0.00010021759,0.0014843986],"genre_scores_gemma":[0.9914817,0.00017800492,0.0004441617,0.00020453005,0.0014698196,0.00023245461,0.0001486375,0.00014160572,0.0056990837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962778,0.00016428233,0.00053154334,0.001075994,0.0007989745,0.0011513683],"domain_scores_gemma":[0.9986897,0.000032689364,0.00006213055,0.0005564385,0.00031533866,0.0003436917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001204871,0.00035192058,0.00030538798,0.00016994248,0.00069478934,0.00049646135,0.0005229909,0.0001905678,0.0004595595],"category_scores_gemma":[0.00007847949,0.000342352,0.00022355479,0.00043809385,0.00025874257,0.00001613846,0.00035871196,0.00079343066,0.000041085572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007145805,0.00004433913,0.00023291247,0.0003566521,0.0000370183,0.00005353501,0.0012281246,0.012002763,0.9673446,0.000025399708,0.016327754,0.002275483],"study_design_scores_gemma":[0.00041995442,0.00037217926,0.0002638971,0.00056662183,0.000011962995,0.0000168265,0.0011432646,0.0016406805,0.9589061,0.000059184596,0.03593279,0.00066653447],"about_ca_topic_score_codex":0.0016832842,"about_ca_topic_score_gemma":0.00037824284,"teacher_disagreement_score":0.019605039,"about_ca_system_score_codex":0.0005611581,"about_ca_system_score_gemma":0.00079714943,"threshold_uncertainty_score":0.99990284},"labels":[],"label_agreement":null},{"id":"W4402266562","doi":"10.1158/1538-7445.pediatric24-a080","title":"Abstract A080 PRC1/BMI1 activity alters chromatin accessibility to regulate differentiation in atypical teratoid rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"BMI1; Chromatin; Biology; Cancer research; Medicine; Cell biology; Genetics; Stem cell; Gene","score_opus":0.04658290327365548,"score_gpt":0.4093670145565402,"score_spread":0.3627841112828847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970373,0.001006445,0.00030859845,0.00068702677,0.0002158633,0.000415425,0.00004127691,0.000033206205,0.00025485794],"genre_scores_gemma":[0.9985983,0.00017405665,0.00007450544,0.00005594189,0.0003731203,0.00022281319,0.0000511334,0.00003262856,0.0004175386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979943,0.00015363979,0.0002555333,0.00070266484,0.0004133413,0.0004805149],"domain_scores_gemma":[0.9992244,0.000040027124,0.000029071784,0.00043909013,0.00011106844,0.00015631615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076845725,0.00016174109,0.0001760694,0.00015089767,0.000099364464,0.00016422017,0.00028570465,0.0001478333,0.00013435919],"category_scores_gemma":[0.00010187932,0.00014550427,0.00008141519,0.000396853,0.00009077618,0.000017299919,0.00019937805,0.00039682767,0.000032346252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002862529,0.000060470364,0.0014596346,0.0002639256,0.000022179094,0.000008894158,0.00015570188,0.00042318922,0.9658256,0.000009371348,0.0013258188,0.030158933],"study_design_scores_gemma":[0.00034051327,0.00012261147,0.1471094,0.00046345382,0.000004298006,0.0000031512268,0.00003785137,0.0028171223,0.84698695,0.0002124397,0.0016664217,0.00023576856],"about_ca_topic_score_codex":0.00036929853,"about_ca_topic_score_gemma":0.0004658959,"teacher_disagreement_score":0.14564978,"about_ca_system_score_codex":0.0003116077,"about_ca_system_score_gemma":0.0004173183,"threshold_uncertainty_score":0.5933492},"labels":[],"label_agreement":null},{"id":"W4402266566","doi":"10.1158/1538-7445.pediatric24-a023","title":"Abstract A023 Establishment of the consortium for childhood cancer predisposition and the childhood cancer predisposition study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cancer; Genetic predisposition; Childhood cancer; Medicine; Internal medicine; Disease","score_opus":0.051812494407324876,"score_gpt":0.4153076946947234,"score_spread":0.3634952002873985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93308663,0.025783818,0.000026380014,0.029949216,0.0013110667,0.008218307,0.0011298335,0.00009479133,0.0003999365],"genre_scores_gemma":[0.98801315,0.003179062,0.000017490189,0.00058855064,0.0017252233,0.005808137,0.000039290484,0.00008815087,0.0005409324],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9953873,0.00046894496,0.0007781349,0.0008560749,0.0017862817,0.0007232442],"domain_scores_gemma":[0.9971486,0.0009703873,0.00019097375,0.0008236022,0.00063369604,0.00023278914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032773763,0.00033219298,0.0006315207,0.00023982958,0.0005538046,0.00022026381,0.0004631067,0.00015594097,0.0003476977],"category_scores_gemma":[0.0003343561,0.00020273971,0.00027998016,0.0009254103,0.0008314698,0.0002784011,0.000271356,0.001060194,0.000004315587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020800244,0.012594191,0.24322921,0.021210222,0.014658513,0.00009049007,0.29253978,0.0014480677,0.038606536,0.008327458,0.16938879,0.17710651],"study_design_scores_gemma":[0.00915201,0.00074897904,0.96283007,0.0045417305,0.0008506438,0.000018562952,0.005344099,0.0002548063,0.011546992,0.00096186047,0.003402827,0.0003474077],"about_ca_topic_score_codex":0.011757453,"about_ca_topic_score_gemma":0.004600728,"teacher_disagreement_score":0.71960086,"about_ca_system_score_codex":0.00063067884,"about_ca_system_score_gemma":0.0019282942,"threshold_uncertainty_score":0.99482334},"labels":[],"label_agreement":null},{"id":"W4402266567","doi":"10.1158/1538-7445.pediatric24-a010","title":"Abstract A010 The role of <i>TP53</i> on transposable elements in pediatric cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Transposable element; Cancer; Medicine; Biology; Genetics; Genome; Gene","score_opus":0.04894358363077682,"score_gpt":0.40997070360870025,"score_spread":0.3610271199779234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86609626,0.12816675,0.0000040164336,0.0029454448,0.00036594574,0.00037178473,0.000026772263,0.00002598449,0.0019970408],"genre_scores_gemma":[0.9861153,0.0070067756,0.00001129051,0.000023729,0.00096526556,0.000200856,0.000005313551,0.00002543374,0.0056460816],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998639,0.000037981994,0.00020197175,0.00021321015,0.00057654775,0.0003312769],"domain_scores_gemma":[0.99949026,0.00013837725,0.000012779259,0.00019003607,0.00008467005,0.00008389074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006775136,0.00009373326,0.00017528847,0.00027634684,0.000042179807,0.000010918429,0.000116765754,0.000052865034,0.00065770425],"category_scores_gemma":[0.00003689378,0.000054687018,0.000043034426,0.0008078421,0.000085542524,0.000026508762,0.000013006007,0.00072696514,0.000026487598],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070442434,0.00049766107,0.13125087,0.0048260908,0.00029782506,0.00038362946,0.006289387,0.00514771,0.6103848,0.0035891617,0.039473314,0.19715513],"study_design_scores_gemma":[0.0028293782,0.0009777118,0.098712616,0.0039939615,0.00014676737,0.000009636786,0.0009245181,0.0028240315,0.38314152,0.00026622612,0.5058527,0.00032094514],"about_ca_topic_score_codex":0.00069457,"about_ca_topic_score_gemma":0.00024751245,"teacher_disagreement_score":0.46637937,"about_ca_system_score_codex":0.00016490318,"about_ca_system_score_gemma":0.00033868616,"threshold_uncertainty_score":0.72014004},"labels":[],"label_agreement":null},{"id":"W4402266568","doi":"10.1158/1538-7445.pediatric24-a035","title":"Abstract A035 Characterization of circulating tumor DNA in a pediatric oncology cohort and implementation into the SickKids Cancer Sequencing (KiCS) precision oncology program","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Pediatric oncology; Precision oncology; Cancer; Cohort","score_opus":0.042165706176689355,"score_gpt":0.4412471043961375,"score_spread":0.39908139821944816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149567,0.0064253244,0.000030753414,0.00062419433,0.00031589682,0.0009469514,0.000033464534,0.000008436772,0.00011928211],"genre_scores_gemma":[0.97056174,0.027717967,0.00007114285,0.00007412755,0.000555395,0.0008724357,0.000106214175,0.000023350492,0.00001762613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860615,0.00013177661,0.0003441756,0.00038957925,0.00022412867,0.00030416605],"domain_scores_gemma":[0.9992889,0.0001712697,0.00009242317,0.00017512043,0.00020923882,0.00006301235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012397765,0.00010626719,0.00016260702,0.00015814896,0.00009559485,0.00009376507,0.00014882821,0.00011982577,0.00004951555],"category_scores_gemma":[0.000100522135,0.000089866575,0.000036664864,0.0003800833,0.00012437638,0.000019382771,0.00017010309,0.0002716607,0.0000013660697],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006118482,0.000030173744,0.016964365,0.00017583401,0.000026238979,0.0000122611455,0.0012383396,0.000084727246,0.68252116,0.000053307846,0.000104023195,0.29872835],"study_design_scores_gemma":[0.0020281337,0.0023937363,0.47120652,0.00053689914,0.00014818726,0.00003491849,0.0043811905,0.0027665752,0.4352658,0.000773711,0.079821244,0.00064308516],"about_ca_topic_score_codex":0.0024173262,"about_ca_topic_score_gemma":0.0049889404,"teacher_disagreement_score":0.45424214,"about_ca_system_score_codex":0.0005825081,"about_ca_system_score_gemma":0.0019359478,"threshold_uncertainty_score":0.36646527},"labels":[],"label_agreement":null},{"id":"W4402266588","doi":"10.1158/1538-7445.pediatric24-b027","title":"Abstract B027: Software for gene expression-based classification of pediatric BCP-ALL subtypes robustly predicts cases as members of subclass although they lack subtype-defining rearrangements","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subclass; Computational biology; Genetics; Expression (computer science); Gene; Biology; Gene expression; Medicine; Computer science; Programming language; Antibody","score_opus":0.14480466392103647,"score_gpt":0.4277714188804849,"score_spread":0.28296675495944845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98983264,0.0050462843,0.00059700373,0.0010404356,0.0003215088,0.0018745542,0.0005709149,0.00013192055,0.00058474636],"genre_scores_gemma":[0.9932612,0.0013261173,0.0028335953,0.000054237225,0.0005305529,0.00062530587,0.00027955783,0.00012505807,0.0009643374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954936,0.00020272673,0.0006931063,0.000732416,0.0020333517,0.00084479037],"domain_scores_gemma":[0.99375194,0.0033715686,0.00019115489,0.0007104622,0.0016260371,0.00034885542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019629674,0.00025544892,0.00050586433,0.0008112238,0.00013874608,0.000054405227,0.000432769,0.0002848705,0.00051557587],"category_scores_gemma":[0.0034427731,0.00021208501,0.00017957423,0.0010936942,0.0002972402,0.00017039593,0.00013435532,0.0006246058,0.00005684394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013691285,0.0011037237,0.05425082,0.028389646,0.0010618396,0.00070860726,0.002964282,0.0044309725,0.69186,0.00043515326,0.1825502,0.018553456],"study_design_scores_gemma":[0.017941367,0.0043526897,0.06516965,0.007044661,0.001258902,0.00009240159,0.0019789466,0.02607316,0.8473569,0.0008456655,0.026628735,0.0012569353],"about_ca_topic_score_codex":0.0017668811,"about_ca_topic_score_gemma":0.00012134794,"teacher_disagreement_score":0.15592147,"about_ca_system_score_codex":0.0011852443,"about_ca_system_score_gemma":0.006474295,"threshold_uncertainty_score":0.9991581},"labels":[],"label_agreement":null},{"id":"W4402266600","doi":"10.1158/1538-7445.pediatric24-a058","title":"Abstract A058 Response of neuroblastoma patient-derived xenografts to cyclophosphamide + topotecan enables identification of gene expression patterns associated with drug resistance","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Topotecan; Cyclophosphamide; Neuroblastoma; Identification (biology); Medicine; Drug resistance; Cancer research; Drug; Gene; Pharmacology; Oncology; Biology; Internal medicine; Chemotherapy; Genetics; Cell culture","score_opus":0.0277745145107931,"score_gpt":0.34407329132340725,"score_spread":0.31629877681261415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965211,0.00081317214,0.00003961339,0.0009683792,0.00010056301,0.0010993765,0.00030139502,0.00006419701,0.0000922087],"genre_scores_gemma":[0.99738026,0.00022866386,0.00009295878,0.000026019217,0.000039266888,0.0003026795,0.00003480782,0.000064442036,0.0018308803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99636346,0.0003925177,0.0005073738,0.0005851712,0.0015585583,0.0005929174],"domain_scores_gemma":[0.9975143,0.0006342729,0.00012633976,0.00058943464,0.0007890401,0.000346594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009006037,0.00018951093,0.0003431823,0.0006350078,0.0001222241,0.000056943176,0.00023319843,0.00007091338,0.00012802631],"category_scores_gemma":[0.000678151,0.00015158893,0.000089460234,0.0012166788,0.00020271355,0.00014737905,0.00010767732,0.0004262626,0.000018943434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010312274,0.0003145263,0.0018899317,0.00055572117,0.00013206278,0.0005611119,0.0010371025,0.000038685233,0.9810915,0.000003948652,0.0023326965,0.0017304484],"study_design_scores_gemma":[0.00079697405,0.0006928273,0.12457562,0.0024288127,0.00002161134,0.0000042651054,0.00019408029,0.000007051844,0.8708168,0.000016816726,0.0003479994,0.000097124735],"about_ca_topic_score_codex":0.00027196927,"about_ca_topic_score_gemma":0.0002762592,"teacher_disagreement_score":0.12268569,"about_ca_system_score_codex":0.00037908318,"about_ca_system_score_gemma":0.0006774321,"threshold_uncertainty_score":0.61816174},"labels":[],"label_agreement":null},{"id":"W4402266611","doi":"10.1158/1538-7445.pediatric24-a073","title":"Abstract A073 Epigenetic control of neuroblastoma differentiation through inhibition of the histone acetyltransferases KAT6A and KAT6B","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histone Acetyltransferases; Epigenetics; Histone; Cancer research; Biology; Genetics; Chemistry; DNA; Gene","score_opus":0.02745518741790831,"score_gpt":0.345890832337625,"score_spread":0.3184356449197167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990975,0.006612037,0.000918588,0.0008094831,0.00013884755,0.0003013867,0.00007071206,0.000005643999,0.00016828782],"genre_scores_gemma":[0.9983207,0.0012662238,0.000011089817,0.00003791177,0.00010086575,0.000050493698,0.000019592426,0.0000129092905,0.00018019216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991343,0.00010092769,0.00018166986,0.0002024345,0.00024388132,0.00013676877],"domain_scores_gemma":[0.99958897,0.000034879,0.000032857643,0.00018258973,0.00013209622,0.000028598848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018964557,0.00007217944,0.000093545765,0.000047188216,0.000060201182,0.000017184679,0.00008736646,0.000072357725,0.00005174531],"category_scores_gemma":[0.00006595453,0.000053612603,0.000058736194,0.00015500665,0.00025323496,0.000007921513,0.00004129559,0.00013447754,0.0000010615444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000619995,0.000026033733,0.0002585239,0.00017322725,0.000023541139,4.5571818e-7,0.00007820432,0.000017097338,0.99607444,0.00024605848,0.0006667508,0.0023736896],"study_design_scores_gemma":[0.00031092315,0.00013335052,0.009050941,0.00013331717,0.000009885986,0.000001266219,0.000027270611,0.000033011995,0.98683786,0.00018884407,0.0032223652,0.00005095806],"about_ca_topic_score_codex":0.00012533418,"about_ca_topic_score_gemma":0.00006648465,"teacher_disagreement_score":0.009236553,"about_ca_system_score_codex":0.000021132008,"about_ca_system_score_gemma":0.00012350468,"threshold_uncertainty_score":0.21862584},"labels":[],"label_agreement":null},{"id":"W4402266642","doi":"10.1158/1538-7445.pediatric24-b062","title":"Abstract B062: VCAN+ macrophages promote neuroblastoma cell growth, migration, and adrenergic to mesenchymal transition via the HB-EGF/ERBB signaling axis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ErbB; Cancer research; Epithelial–mesenchymal transition; Mesenchymal stem cell; Cell biology; Signal transduction; Biology; Internal medicine; Medicine; Endocrinology; Cancer; Metastasis","score_opus":0.03048758220933687,"score_gpt":0.3514560984213423,"score_spread":0.3209685162120054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818925,0.002822811,0.000082593615,0.013090701,0.00012461012,0.0012364445,0.00005892323,0.00009851167,0.0005929027],"genre_scores_gemma":[0.99670595,0.0007234364,0.000071433016,0.00024610403,0.00037939358,0.0002998801,0.00002051749,0.000065994114,0.0014873082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692833,0.00021242614,0.00026372797,0.0006853877,0.0011285507,0.0007815707],"domain_scores_gemma":[0.99848276,0.00029311978,0.000021278956,0.00033362125,0.00036270358,0.0005065166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407111,0.0002338967,0.00022993925,0.00042610476,0.000389637,0.00026955,0.0001946849,0.00008446835,0.00047633232],"category_scores_gemma":[0.00007963437,0.00015879958,0.0001009484,0.0010322706,0.0002448264,0.00019042469,0.000091576614,0.0008033593,0.00019745725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006004301,0.00016011359,0.00011159674,0.0007279884,0.000116791605,0.0015662231,0.0015461631,0.000078907324,0.98020047,0.000039324717,0.0034906454,0.011361331],"study_design_scores_gemma":[0.0011592555,0.0018613783,0.009885835,0.0005740708,0.000079390295,0.00019706592,0.00021926253,0.0010124628,0.9813543,0.00034929675,0.0030841029,0.00022356412],"about_ca_topic_score_codex":0.0013345225,"about_ca_topic_score_gemma":0.0003732086,"teacher_disagreement_score":0.014813431,"about_ca_system_score_codex":0.00019847005,"about_ca_system_score_gemma":0.00041525002,"threshold_uncertainty_score":0.6475659},"labels":[],"label_agreement":null},{"id":"W4402266667","doi":"10.1158/1538-7445.pediatric24-a056","title":"Abstract A056 Intertumoral epigenetic heterogeneity in response to a novel therapy in Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Epigenetics; Ewing's sarcoma; Oncology; Medicine; Biology; Internal medicine; Cancer research; Genetics; Pathology; Gene","score_opus":0.0823962811439642,"score_gpt":0.4157407430668233,"score_spread":0.3333444619228591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883134,0.009110779,0.000086928994,0.0011820243,0.00016659455,0.0003847977,0.00006572688,0.000007710806,0.00016408233],"genre_scores_gemma":[0.99696594,0.0020010304,0.00008729926,0.00028223472,0.00023030302,0.0002629893,0.000012936951,0.00003849989,0.000118769065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983914,0.00010632436,0.0002364511,0.0005250651,0.0002167221,0.0005240641],"domain_scores_gemma":[0.999299,0.00014010268,0.000012353434,0.00034073152,0.000073266565,0.00013453154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012301526,0.00013479202,0.00014722992,0.00034349892,0.000039124847,0.00010786952,0.00030728537,0.00010454292,0.000051559025],"category_scores_gemma":[0.00022924412,0.00013527929,0.00006204163,0.00046895328,0.00007101179,0.00000448917,0.0002214353,0.00031328993,0.00003212338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014493304,0.00009644145,0.0044824597,0.000032094606,0.000015971706,0.0000721844,0.00021480084,0.0004611787,0.97318023,0.00002781886,0.00069313514,0.01927434],"study_design_scores_gemma":[0.0017085233,0.00085352187,0.17733851,0.00040476446,0.0000020997215,0.000010461308,0.00023987502,0.0002275517,0.7321944,0.00011159044,0.08651299,0.00039571308],"about_ca_topic_score_codex":0.0012651094,"about_ca_topic_score_gemma":0.0048165456,"teacher_disagreement_score":0.24098584,"about_ca_system_score_codex":0.0002706218,"about_ca_system_score_gemma":0.0005706842,"threshold_uncertainty_score":0.5516529},"labels":[],"label_agreement":null},{"id":"W4402266699","doi":"10.1158/1538-7445.pediatric24-a025","title":"Abstract A025 Single cell transcriptomics reveals a non-canonical lymphoblast in refractory childhood T cell leukaemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblast; Non canonical; Cell; Refractory (planetary science); Cancer research; Biology; Medicine; Genetics; Oncology; Cell culture; Cell biology","score_opus":0.035110912576400435,"score_gpt":0.3182149554464151,"score_spread":0.28310404287001467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9068164,0.068947285,0.0000049177784,0.00045146653,0.001194963,0.00037861965,0.0001460335,0.00007267988,0.021987595],"genre_scores_gemma":[0.97996193,0.0053311647,0.000011301945,0.000084472726,0.00019867727,0.00012827772,0.000026873515,0.000051621984,0.01420567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974953,0.00021201093,0.00042835518,0.000669904,0.00014765035,0.0010467675],"domain_scores_gemma":[0.99902755,0.00040240702,0.000039298346,0.0003530359,0.00011071698,0.00006696991],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007820219,0.00025385243,0.0004065124,0.00038955305,0.00026444969,0.000067932,0.000439917,0.00045248924,0.0008432873],"category_scores_gemma":[0.000041058163,0.00021097469,0.0001629687,0.0005368803,0.0005123247,0.00011844468,0.00015748151,0.0016671444,0.0015001228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016576411,0.00045850547,0.0007477094,0.00034234402,0.00007010062,0.00007154219,0.002169473,0.00000863204,0.9610803,0.000037745245,0.030361965,0.004485882],"study_design_scores_gemma":[0.00259701,0.0005049784,0.013783823,0.00070394174,0.0000358627,0.000017555923,0.0012368475,0.000003142185,0.6945399,0.00021679787,0.28585288,0.000507281],"about_ca_topic_score_codex":0.0013245192,"about_ca_topic_score_gemma":0.0005457174,"teacher_disagreement_score":0.26654044,"about_ca_system_score_codex":0.0008539459,"about_ca_system_score_gemma":0.0010154028,"threshold_uncertainty_score":0.99927735},"labels":[],"label_agreement":null},{"id":"W4402266702","doi":"10.1158/1538-7445.pediatric24-ia010","title":"Abstract IA010: Opportunities and challenges for liquid biopsies in pediatric oncology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liquid biopsy; Pediatric oncology; Oncology; Internal medicine; Medical physics; Cancer; Intensive care medicine","score_opus":0.20176016709493463,"score_gpt":0.4249658879197431,"score_spread":0.22320572082480847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7803563,0.21215107,0.0000059238396,0.0053099487,0.00025582462,0.00023497496,0.00012173565,0.0000075472803,0.0015567177],"genre_scores_gemma":[0.599049,0.39966142,0.000029263512,0.000050578543,0.00068582664,0.00025862706,0.000024662822,0.000016818034,0.00022385945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911004,0.000023248589,0.00013397388,0.00031960843,0.00009830142,0.000314848],"domain_scores_gemma":[0.999462,0.00019725035,0.000014053859,0.00013993194,0.000102497004,0.00008425371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059120037,0.00008648699,0.00011029244,0.00017782151,0.000054424196,0.000043990414,0.00011682075,0.00013874023,0.00002219797],"category_scores_gemma":[0.00012233901,0.000084180865,0.000033845856,0.00008381521,0.00012342667,0.00000384344,0.00012310523,0.0001447794,0.0000030147576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026144737,0.00034063112,0.0013306905,0.00640011,0.0002328509,0.00031989193,0.002796167,0.00019631455,0.4328154,0.02511806,0.07382156,0.45401382],"study_design_scores_gemma":[0.00044114303,0.0010327064,0.0020364902,0.000056503108,0.000011830591,0.000007638886,0.0008007662,0.000032732438,0.0220239,0.0007522834,0.97261417,0.00018982805],"about_ca_topic_score_codex":0.000125188,"about_ca_topic_score_gemma":0.00091167854,"teacher_disagreement_score":0.8987926,"about_ca_system_score_codex":0.00006964057,"about_ca_system_score_gemma":0.00067484705,"threshold_uncertainty_score":0.3432796},"labels":[],"label_agreement":null},{"id":"W4402266728","doi":"10.1158/1538-7445.pediatric24-ia004","title":"Abstract IA004: Risk of therapy-related subsequent cancers in individuals with germline <i>TP53</i> variants","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; Sinai Health System; McGill University Health Centre; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Germline; Medicine; Oncology; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.054135432486705846,"score_gpt":0.380657739772378,"score_spread":0.32652230728567216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95675546,0.036554005,0.000026584647,0.00112306,0.00029628086,0.0013863706,0.00025892636,0.00009145908,0.0035078302],"genre_scores_gemma":[0.9833724,0.015239755,0.00010472304,0.00007360148,0.00013796682,0.00034231038,0.000043774366,0.00010564949,0.0005798404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964219,0.00021283857,0.00055975904,0.0006812782,0.0013429367,0.00078130496],"domain_scores_gemma":[0.9984432,0.0002288471,0.00010441031,0.0006171709,0.00034953989,0.0002568605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019631241,0.00025641115,0.000499733,0.00082665915,0.00007367886,0.00005087725,0.00025953617,0.00025338025,0.0012136265],"category_scores_gemma":[0.00012289488,0.00019949648,0.0001286571,0.0023776838,0.00038783287,0.00012323681,0.00007062908,0.0019085903,0.000056988563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003380441,0.0007902188,0.06740081,0.0020211518,0.00394829,0.003582285,0.007666125,0.008105655,0.73250586,0.0009275893,0.012271174,0.15740041],"study_design_scores_gemma":[0.025662508,0.004076713,0.37192842,0.018443318,0.0005462166,0.00031917015,0.0010784597,0.0024826014,0.4886827,0.0017768138,0.083424345,0.0015787443],"about_ca_topic_score_codex":0.010241844,"about_ca_topic_score_gemma":0.0014695935,"teacher_disagreement_score":0.3045276,"about_ca_system_score_codex":0.0015178666,"about_ca_system_score_gemma":0.0037844598,"threshold_uncertainty_score":0.9996994},"labels":[],"label_agreement":null},{"id":"W4402266730","doi":"10.1158/1538-7445.pediatric24-b053","title":"Abstract B053: Tumor-associated macrophages diminishes IL1RAP-targeting CAR-T cell therapy efficacy in Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Chimeric antigen receptor; T cell; Medicine; Immunology; Immune system","score_opus":0.08861207712633722,"score_gpt":0.42057948188926525,"score_spread":0.331967404762928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539904,0.033675883,0.0000010121257,0.0017910192,0.00034891628,0.0012929977,0.0000334533,0.0002145306,0.008651805],"genre_scores_gemma":[0.98331827,0.006410763,0.000034836947,0.00015279517,0.0007267097,0.00030486798,0.000042778942,0.00018276216,0.008826227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99434114,0.0004636404,0.00057718693,0.00095414487,0.0019408504,0.0017230499],"domain_scores_gemma":[0.9969863,0.0015870974,0.000050446593,0.0005803918,0.000396611,0.00039913453],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003946756,0.0003443998,0.0005877999,0.0009746895,0.00026883473,0.000372716,0.00051752094,0.00021302156,0.007861699],"category_scores_gemma":[0.00048050622,0.00030006532,0.0002546623,0.0022752213,0.000351966,0.00019988947,0.0002072615,0.0027394032,0.00027507346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007673329,0.00055902766,0.010465907,0.00050767267,0.00016290521,0.0024644972,0.0024293913,0.000027562133,0.9107321,0.000016283879,0.008101688,0.063765675],"study_design_scores_gemma":[0.007291161,0.0009942827,0.14223102,0.0023798302,0.000029694653,0.000034905162,0.0021490138,0.00061546895,0.757681,0.00018903326,0.08566985,0.00073472067],"about_ca_topic_score_codex":0.0031652562,"about_ca_topic_score_gemma":0.00019235458,"teacher_disagreement_score":0.15305103,"about_ca_system_score_codex":0.001440574,"about_ca_system_score_gemma":0.001325232,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W4402266746","doi":"10.1158/1538-7445.pediatric24-b064","title":"Abstract B064: Uncovering the lineage state specific regulation of STING in neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sting; Lineage (genetic); Neuroblastoma; Biology; Cancer research; Medicine; Genetics; Gene; Engineering","score_opus":0.06547823583930773,"score_gpt":0.37298489271447316,"score_spread":0.30750665687516543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644984,0.011326077,0.00001827356,0.00032342336,0.00051258464,0.00016748368,0.00001581132,0.000023659328,0.0011628626],"genre_scores_gemma":[0.99473774,0.0007390329,0.0000027685219,0.000010155948,0.000037768186,0.0000232728,0.000005123752,0.000014871717,0.004429253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989394,0.00026923834,0.00023573721,0.00018466784,0.000068425164,0.00030253638],"domain_scores_gemma":[0.9990895,0.00060179783,0.000026398498,0.00019638987,0.00007819848,0.000007762625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010163013,0.00007167014,0.00011061262,0.0002327849,0.00008672328,0.00003622215,0.0001975856,0.000059918828,0.0008691597],"category_scores_gemma":[0.000093451636,0.000050702936,0.000041246472,0.0003623011,0.00021960335,0.000080392,0.000096933014,0.0006500112,0.00019802984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040345924,0.00001493693,0.000107203436,0.00007024692,0.00002292853,0.000009641931,0.0008817054,0.0003012108,0.9765726,0.0002194585,0.0020576546,0.019338999],"study_design_scores_gemma":[0.00023771092,0.00009582837,0.039523818,0.00039890312,0.0000016022717,0.000008405392,0.00029180318,0.00004766218,0.8919047,0.000097258795,0.06733038,0.00006193442],"about_ca_topic_score_codex":0.00047466764,"about_ca_topic_score_gemma":0.00012877291,"teacher_disagreement_score":0.08466786,"about_ca_system_score_codex":0.00010219333,"about_ca_system_score_gemma":0.00014436204,"threshold_uncertainty_score":0.9516689},"labels":[],"label_agreement":null},{"id":"W4402266752","doi":"10.1158/1538-7445.pediatric24-pr011","title":"Abstract PR011: Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: Updated data from the iMATRIX Alectinib phase I/II open-label, multi-center study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alectinib; Medicine; Center (category theory); Solid tumor; Oncology; Internal medicine; Cancer; Crizotinib; Chemistry; Lung cancer","score_opus":0.1832606208784122,"score_gpt":0.5303666304707177,"score_spread":0.34710600959230553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901754,0.002495073,0.0000074545896,0.0013300027,0.0001308905,0.0045190654,0.0011666459,0.000061578816,0.00011387243],"genre_scores_gemma":[0.9967436,0.0007803804,0.00013752512,0.00013370281,0.00023521675,0.0005759757,0.0005902714,0.00006922359,0.0007340819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744576,0.00015210613,0.00034109465,0.0009221986,0.0005798995,0.00055891287],"domain_scores_gemma":[0.9985619,0.00012999424,0.000051571034,0.00088528416,0.00015675265,0.00021450546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006857128,0.00023671938,0.00033470857,0.00021846463,0.0005159978,0.0003665023,0.0006591192,0.000055245186,0.00037706265],"category_scores_gemma":[0.00011941685,0.00013401333,0.00001616999,0.0009343238,0.00014978676,0.0004655976,0.0008896571,0.0008751064,0.000027104441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009386298,0.032552686,0.8378552,0.00030193914,0.0032148287,0.0019372558,0.0133487815,0.000011542868,0.0072301854,0.0000068705044,0.0405132,0.05364121],"study_design_scores_gemma":[0.09845792,0.0048213326,0.8753809,0.007594151,0.00070572423,0.00011585651,0.0043343105,0.0014416716,0.0009872768,0.000013996874,0.005594043,0.0005528714],"about_ca_topic_score_codex":0.015279467,"about_ca_topic_score_gemma":0.009275423,"teacher_disagreement_score":0.089071624,"about_ca_system_score_codex":0.00035292492,"about_ca_system_score_gemma":0.0013116499,"threshold_uncertainty_score":0.9912779},"labels":[],"label_agreement":null},{"id":"W4402266756","doi":"10.1158/1538-7445.pediatric24-a043","title":"Abstract A043 Plasma circulating proteomic markers are associated with metastatic spread and outcome in osteosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Medicine; Oncology; Internal medicine; Pathology; Cancer research","score_opus":0.11850840307841057,"score_gpt":0.41292871254290564,"score_spread":0.29442030946449504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917065,0.0040359083,6.1041806e-7,0.0023155485,0.000042689353,0.0012139076,0.00003675181,0.000049353806,0.0005987399],"genre_scores_gemma":[0.9986477,0.00013674585,0.00009178081,0.00004206493,0.000036963924,0.00076076464,0.00001632841,0.000042666714,0.0002249962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981765,0.00011062185,0.0002555821,0.00040774982,0.0005719582,0.0004775971],"domain_scores_gemma":[0.9989174,0.00060023664,0.000040421357,0.00019231421,0.00009471883,0.00015492766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008472601,0.00015497387,0.00033589068,0.00033895488,0.00007984224,0.0001031495,0.000064041735,0.00005627164,0.00018044435],"category_scores_gemma":[0.00028375647,0.00010994026,0.00004908541,0.000568878,0.00011973563,0.00009034313,0.000048593192,0.000541476,0.000026040636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021500538,0.00019019358,0.97116786,0.00057131494,0.00033054018,0.0037080154,0.00029479,0.000014477381,0.0019533762,0.00003420906,0.00023200798,0.021288218],"study_design_scores_gemma":[0.0021237624,0.00019628184,0.99187016,0.0028636414,0.00007649015,0.000054733668,0.00047512035,0.0005702986,0.0014473656,0.00006265771,0.00013742372,0.00012203586],"about_ca_topic_score_codex":0.0012124202,"about_ca_topic_score_gemma":0.0009371588,"teacher_disagreement_score":0.021166183,"about_ca_system_score_codex":0.0007292564,"about_ca_system_score_gemma":0.0002706176,"threshold_uncertainty_score":0.44832337},"labels":[],"label_agreement":null},{"id":"W4402266759","doi":"10.1158/1538-7445.pediatric24-a002","title":"Abstract A002 A transgenic zebrafish screen identifies new collaborating oncogenic drivers in acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Lymphoblastic Leukemia; Cancer research; Leukemia; Cancer; Transgene; Biology; Medicine; Genetics; Gene","score_opus":0.03452869947627389,"score_gpt":0.38447681894465024,"score_spread":0.34994811946837634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899758,0.0046527507,0.00043455293,0.0027782228,0.0001340338,0.00067733007,0.00020695315,0.000047798916,0.0010925526],"genre_scores_gemma":[0.99130356,0.0025156138,0.00012369515,0.00010118666,0.000526815,0.00036384366,0.00014603579,0.000056161476,0.004863074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706,0.00012131107,0.00033106582,0.0007627686,0.0008700372,0.00085479254],"domain_scores_gemma":[0.9986748,0.00015859745,0.000026302254,0.00046026896,0.00023108198,0.00044895356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009028849,0.00018181345,0.00018521467,0.0003701969,0.00016241221,0.00025490625,0.00069209846,0.00024247693,0.0004998442],"category_scores_gemma":[0.00030707425,0.0001799311,0.00011215053,0.001747587,0.00040364344,0.000023152137,0.00023556524,0.0005861034,0.00022291855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009387119,0.000025297451,0.000108888504,0.000102305545,0.00015238079,0.000055512042,0.00015300528,0.000037008973,0.9382408,0.00013670244,0.046937086,0.013957094],"study_design_scores_gemma":[0.0021859054,0.0004183192,0.008217898,0.0006370691,0.00005428365,0.000017970136,0.0006564906,0.0008082394,0.7877452,0.0013672516,0.19722334,0.0006680716],"about_ca_topic_score_codex":0.0022408164,"about_ca_topic_score_gemma":0.003959433,"teacher_disagreement_score":0.15049568,"about_ca_system_score_codex":0.00064950256,"about_ca_system_score_gemma":0.005194303,"threshold_uncertainty_score":0.9214471},"labels":[],"label_agreement":null},{"id":"W4402266764","doi":"10.1158/1538-7445.pediatric24-a001","title":"Abstract A001: PAX3-FOXO1-induced transcriptional dysregulation in rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PAX3; FOXO1; Cancer research; Rhabdomyosarcoma; Medicine; Alveolar rhabdomyosarcoma; Biology; Genetics; Transcription factor; Gene; Sarcoma; Pathology","score_opus":0.06613577877352114,"score_gpt":0.4068723488508271,"score_spread":0.34073657007730596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985376,0.007759972,0.0015101888,0.0017930147,0.0004759629,0.0006659278,0.000058149704,0.000041177107,0.0023195797],"genre_scores_gemma":[0.9967387,0.00078152964,0.00007353146,0.00006550762,0.0006132984,0.00040431396,0.00011564365,0.00005770642,0.0011497788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714404,0.00019386114,0.00028308787,0.0007477692,0.0008870379,0.00074418174],"domain_scores_gemma":[0.9991028,0.00004226433,0.000018387016,0.0004237567,0.00023934965,0.00017345774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012239163,0.00018264636,0.00015291349,0.0004852036,0.00012244267,0.0001513032,0.00036805958,0.00031725672,0.0006568567],"category_scores_gemma":[0.000094471965,0.00018828637,0.0001241922,0.00082173967,0.00012949143,0.000016210637,0.00012149641,0.0008208953,0.00010912023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020755563,0.000044267785,0.000029401197,0.000110460496,0.00005416428,0.00006702066,0.00009477625,0.00030053427,0.95941114,0.0011659922,0.0023276915,0.03618702],"study_design_scores_gemma":[0.0008968491,0.00025094973,0.007113532,0.00026504596,0.0000073214633,0.000020239746,0.00010380386,0.0009122038,0.9171909,0.0009911632,0.07193153,0.00031647005],"about_ca_topic_score_codex":0.0005943661,"about_ca_topic_score_gemma":0.00071803195,"teacher_disagreement_score":0.069603845,"about_ca_system_score_codex":0.00034085743,"about_ca_system_score_gemma":0.0009791858,"threshold_uncertainty_score":0.7678095},"labels":[],"label_agreement":null},{"id":"W4402266765","doi":"10.1158/1538-7445.pediatric24-b065","title":"Abstract B065: A phase 1 study of abemaciclib, a CDK 4/6 inhibitor, with radiation in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyclin-dependent kinase; Glioma; Oncology; Cancer; Internal medicine; Cancer research; Cell cycle","score_opus":0.03209554356281608,"score_gpt":0.3941030076058603,"score_spread":0.36200746404304424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906582,0.0057942024,0.00003445754,0.0006018442,0.00008180386,0.0026131521,0.000047102083,0.00010135275,0.00006784044],"genre_scores_gemma":[0.9979699,0.0002365553,0.00009245568,0.000031545398,0.00055816496,0.0008736566,0.000028226372,0.000097332246,0.000112131216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970503,0.00011764967,0.00041221376,0.0006530847,0.0011639367,0.00060285354],"domain_scores_gemma":[0.9986449,0.00021066178,0.000086054024,0.00052477245,0.0003150402,0.00021858168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005529971,0.00026653605,0.0005047147,0.000991303,0.000073735864,0.00006617524,0.0001923222,0.000078525016,0.00017082551],"category_scores_gemma":[0.000080744554,0.00019040343,0.00004506073,0.0024078914,0.00028507962,0.00031584591,0.00006529703,0.0008337172,0.000012609907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024532063,0.009291617,0.35572866,0.00081122684,0.001583064,0.0027846992,0.013034372,0.00036034867,0.08661437,0.00006599104,0.00046767693,0.50472593],"study_design_scores_gemma":[0.08677943,0.013343244,0.85429883,0.0031564296,0.00021447333,0.00027041166,0.003352133,0.00010771643,0.036346406,0.00006411759,0.0015012601,0.00056556734],"about_ca_topic_score_codex":0.0028910888,"about_ca_topic_score_gemma":0.0013029155,"teacher_disagreement_score":0.50416034,"about_ca_system_score_codex":0.00055385026,"about_ca_system_score_gemma":0.0007703835,"threshold_uncertainty_score":0.77644265},"labels":[],"label_agreement":null},{"id":"W4402266782","doi":"10.1158/1538-7445.pediatric24-a048","title":"Abstract A048 SR59230A-induced ferroptosis sensitization of Ewing sarcoma cells via Beta-3 adrenergic receptor modulation: A novel therapeutic target","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sensitization; Cancer research; Medicine; Sarcoma; Modulation (music); Internal medicine; Immunology; Pathology; Physics","score_opus":0.11421650483999853,"score_gpt":0.3864159578087431,"score_spread":0.2721994529687446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863528,0.00496716,0.00095394504,0.0048210933,0.0006554499,0.0007934535,0.00006933386,0.0001365373,0.0012502477],"genre_scores_gemma":[0.9969769,0.0007311317,0.0005333691,0.00014402113,0.00071892276,0.00021840777,0.00007045582,0.00009157967,0.000515217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702615,0.00011092307,0.0005008112,0.00062046817,0.001155105,0.0005865749],"domain_scores_gemma":[0.99838865,0.00019996331,0.00007877496,0.0004568473,0.0006605454,0.00021523001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083856855,0.00024179526,0.00045231055,0.00048331526,0.00016938943,0.000096643096,0.00018156874,0.00020680051,0.0018117125],"category_scores_gemma":[0.00003078603,0.00020894253,0.00021552783,0.0013998282,0.00013675657,0.00021215895,0.00008062731,0.00062435266,0.00008686743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019134961,0.00018089749,0.0011304689,0.0008065818,0.0002735836,0.000008279182,0.00058073597,0.00042506354,0.96494806,0.0002939159,0.0015376945,0.029623363],"study_design_scores_gemma":[0.00087386236,0.00036676315,0.014573787,0.0011001523,0.00010486762,0.0000075785706,0.00018939353,0.013578967,0.9641517,0.00011871248,0.0046675787,0.00026666722],"about_ca_topic_score_codex":0.00074317877,"about_ca_topic_score_gemma":0.000028361108,"teacher_disagreement_score":0.029356696,"about_ca_system_score_codex":0.00052985747,"about_ca_system_score_gemma":0.0006083529,"threshold_uncertainty_score":0.99910074},"labels":[],"label_agreement":null},{"id":"W4402266787","doi":"10.1158/1538-7445.pediatric24-b033","title":"Abstract B033: Characterizing the spatial transcriptomic landscape of Osteosarcoma from diagnosis to relapse","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Transcriptome; Medicine; Oncology; Internal medicine; Cancer research; Biology; Genetics; Gene; Gene expression","score_opus":0.03627133552487184,"score_gpt":0.3700110392687593,"score_spread":0.33373970374388745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879327,0.0043985182,0.00070949085,0.005731632,0.00010222287,0.00039529297,0.00029121916,0.000019786889,0.000419128],"genre_scores_gemma":[0.9965458,0.0016076309,0.00012103383,0.0002548505,0.00031946588,0.00085461844,0.00013577683,0.000023022076,0.00013779681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903417,0.000070841175,0.00016144085,0.00034189157,0.00015540575,0.00023625111],"domain_scores_gemma":[0.9993848,0.000051286333,0.000018968443,0.00039873074,0.00007866311,0.00006751563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034092573,0.00009115999,0.00009884116,0.00006202903,0.00009050154,0.0000386456,0.0003577179,0.00012059949,0.00020518602],"category_scores_gemma":[0.000033572887,0.000066600536,0.00008383307,0.00018340195,0.00010937986,0.0000024902401,0.00011380197,0.00023542525,0.00002367558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046631198,0.000020209447,0.000993475,0.000020048275,0.000042487045,0.0000033822516,0.00009762766,0.0000015635147,0.9706788,0.0001546906,0.0076460326,0.020295052],"study_design_scores_gemma":[0.00007216892,0.00009174108,0.008341706,0.000060643863,0.000008215034,0.000001194452,0.000028151324,0.000011091355,0.76563746,0.00012354902,0.22555114,0.00007290942],"about_ca_topic_score_codex":0.00086399936,"about_ca_topic_score_gemma":0.00033654956,"teacher_disagreement_score":0.21790512,"about_ca_system_score_codex":0.000018970952,"about_ca_system_score_gemma":0.00011217067,"threshold_uncertainty_score":0.2715891},"labels":[],"label_agreement":null},{"id":"W4402266801","doi":"10.1158/1538-7445.pediatric24-a078","title":"Abstract A078 Targeted ferroptosis induction enhances chemotherapy and natural killer cell immunotherapy in neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Neuroblastoma; Medicine; Cancer research; Chemotherapy; Immunology; Immune system; Biology; Internal medicine; Cell culture","score_opus":0.03342636580414248,"score_gpt":0.3828018720843951,"score_spread":0.3493755062802526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98324305,0.011317821,0.0000013741295,0.0035185963,0.00040759973,0.0006756065,0.00000626494,0.00007865258,0.0007510635],"genre_scores_gemma":[0.9860178,0.009632872,0.000040931267,0.00013638058,0.0001933167,0.00022325183,0.000009886111,0.00005982327,0.0036856888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997773,0.00011242276,0.00021066822,0.00055814796,0.0006996204,0.0006461765],"domain_scores_gemma":[0.99927604,0.00015981404,0.000019411253,0.00024598424,0.000110971705,0.00018774913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035751352,0.0001892306,0.00023832689,0.00064881035,0.00011661522,0.00013548807,0.00011888886,0.000095825,0.00077610655],"category_scores_gemma":[0.000030967713,0.00014751428,0.00006817197,0.00093001116,0.00021754565,0.00022574227,0.000048143665,0.0010963596,0.00009374701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011961913,0.00020870217,0.0010528116,0.000294554,0.0000846782,0.0003455348,0.00043079501,0.0000020824846,0.9373541,0.000016209273,0.0021879459,0.05682639],"study_design_scores_gemma":[0.003226809,0.00096307887,0.19147795,0.0005347401,0.000008573937,0.00004916566,0.00016715398,0.00018436435,0.78860146,0.00017194987,0.014399648,0.00021511373],"about_ca_topic_score_codex":0.0005525595,"about_ca_topic_score_gemma":0.00009119072,"teacher_disagreement_score":0.19042514,"about_ca_system_score_codex":0.0003057464,"about_ca_system_score_gemma":0.00034108115,"threshold_uncertainty_score":0.8497822},"labels":[],"label_agreement":null},{"id":"W4402266813","doi":"10.1158/1538-7445.pediatric24-a013","title":"Abstract A013 Exploring the role of microbiota in cancer development in Li-Fraumeni Syndrome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Cancer; Medicine; Biology; Genetics; Internal medicine; Mutation; Gene; Germline mutation","score_opus":0.08648422583302554,"score_gpt":0.3877645048043521,"score_spread":0.3012802789713266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95702237,0.04210424,0.0000049263263,0.00019220014,0.00012030817,0.00019009353,0.000009287466,0.0000027347658,0.0003538516],"genre_scores_gemma":[0.9934319,0.0058441265,0.00004282414,0.0000067325454,0.00006524272,0.0003393009,0.000010127153,0.00001672777,0.0002430022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990253,0.000057042573,0.00020579733,0.00025512485,0.00018210281,0.00027465835],"domain_scores_gemma":[0.9996687,0.000033262655,0.000017298904,0.00018191336,0.00006518393,0.00003364059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007222292,0.00007591168,0.00008805977,0.00014464096,0.000037118985,0.000029476296,0.00019508792,0.00006574962,0.00006040098],"category_scores_gemma":[0.000026932687,0.000060387967,0.000026431973,0.0003306894,0.00006093758,0.0000050487024,0.00012229894,0.00023111906,0.0000070305077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019240031,0.000022124243,0.006178482,0.00006528265,0.000019269966,0.0000067309147,0.00045801583,0.0003832669,0.95293194,0.000027457168,0.000039756138,0.039848443],"study_design_scores_gemma":[0.000109372544,0.000029074985,0.074738204,0.00018011253,0.0000012932596,5.8306836e-7,0.00016224607,0.000030108406,0.87354976,0.00011756967,0.05100507,0.00007658629],"about_ca_topic_score_codex":0.001392003,"about_ca_topic_score_gemma":0.002455307,"teacher_disagreement_score":0.07938215,"about_ca_system_score_codex":0.0001178013,"about_ca_system_score_gemma":0.00040030482,"threshold_uncertainty_score":0.24625498},"labels":[],"label_agreement":null},{"id":"W4402266815","doi":"10.1158/1538-7445.pediatric24-a003","title":"Abstract A003 A zebrafish model of high-risk neuroblastoma exhibits multifocal primary disease","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Neuroblastoma; Disease; Medicine; Primary (astronomy); Internal medicine; Oncology; Biology; Genetics; Gene","score_opus":0.05973389356922194,"score_gpt":0.3790461990547391,"score_spread":0.31931230548551714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938195,0.0017409475,0.000062033534,0.0013458846,0.00014056693,0.00095528294,0.0005243826,0.00013468378,0.0012767552],"genre_scores_gemma":[0.9953627,0.0009267571,0.00014278121,0.0001028181,0.0002140603,0.0003106772,0.000039532202,0.00009230611,0.002808358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962356,0.00015684187,0.00033438546,0.0007297275,0.0016835502,0.00085987116],"domain_scores_gemma":[0.9976296,0.00038480267,0.00003827112,0.00061929075,0.0003860778,0.0009419687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004968073,0.00022731088,0.00036477673,0.0005658076,0.00014275176,0.000080494974,0.00024480792,0.00008680342,0.00042488848],"category_scores_gemma":[0.00032800136,0.00018317618,0.00019419788,0.00077091093,0.00040128498,0.00020592989,0.00023701476,0.00115636,0.000262119],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01495365,0.0033614503,0.009861958,0.009720078,0.0011923497,0.010910252,0.00056768593,0.0034737184,0.7325656,0.0012343756,0.06145127,0.15070762],"study_design_scores_gemma":[0.014328081,0.0041930764,0.585365,0.006069131,0.00056155736,0.000096548574,0.00010047004,0.0792131,0.29783422,0.005514018,0.005637224,0.0010876058],"about_ca_topic_score_codex":0.00063167984,"about_ca_topic_score_gemma":0.000057443893,"teacher_disagreement_score":0.575503,"about_ca_system_score_codex":0.0003720462,"about_ca_system_score_gemma":0.0019875027,"threshold_uncertainty_score":0.7469708},"labels":[],"label_agreement":null},{"id":"W4402266820","doi":"10.1158/1538-7445.pediatric24-a028","title":"Abstract A028 Unraveling the complex interplay of genetic, environmental, and lifestyle factors in cancer predisposition: A comprehensive review and analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Genetic predisposition; Medicine; Genetics; Biology; Gene","score_opus":0.08604213214234437,"score_gpt":0.43863705077019327,"score_spread":0.3525949186278489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022412354,0.97509646,0.0000040024242,0.00008386623,0.00004105318,0.00082900893,0.001514203,0.0000025771099,0.000016469623],"genre_scores_gemma":[0.02178826,0.97700065,0.000015754698,0.00006719702,0.00014045795,0.00032739312,0.00056594866,0.000031380274,0.0000629587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998228,0.00024248844,0.00045801577,0.00055903237,0.00024690334,0.00026554658],"domain_scores_gemma":[0.99923486,0.000069951035,0.00011806008,0.00037197478,0.0000724634,0.00013272165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022322807,0.00025959068,0.0007627766,0.00020988271,0.000081543905,0.00004329901,0.00023355872,0.00015665474,0.00016244143],"category_scores_gemma":[0.00002012903,0.00018344313,0.00022843805,0.00031698475,0.00042680308,0.0000030609954,0.00029518767,0.00030990917,0.0000021612375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018599129,0.0005681037,0.015422193,0.38427594,0.009337874,0.0000666059,0.0007127973,0.00006454647,0.014276943,0.00001693777,0.02056663,0.5545054],"study_design_scores_gemma":[0.00032824627,0.00014726353,0.018073397,0.0154362805,0.0057226424,0.000008581603,0.00017734355,0.000012946617,0.0002579155,0.000029719291,0.9593341,0.00047159567],"about_ca_topic_score_codex":0.00022266782,"about_ca_topic_score_gemma":0.00016493989,"teacher_disagreement_score":0.93876743,"about_ca_system_score_codex":0.00007246256,"about_ca_system_score_gemma":0.00022448933,"threshold_uncertainty_score":0.7480594},"labels":[],"label_agreement":null},{"id":"W4402266824","doi":"10.1158/1538-7445.pediatric24-b029","title":"Abstract B029: Studies in human bone cell co-cultures reveal a potential mechanism underlying bone fractures in children treated with entrectinib and suggest a positive association with vitamin D","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mechanism (biology); Medicine; Internal medicine; Bioinformatics; Biology","score_opus":0.047542767719168,"score_gpt":0.43524274198186313,"score_spread":0.38769997426269515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144953,0.0058829323,8.6730677e-7,0.0009918554,0.000019184605,0.001236198,0.000060608883,0.000039438994,0.00031938072],"genre_scores_gemma":[0.9973594,0.0010120954,0.0000328526,0.00005968301,0.00006141166,0.00025657233,0.00010226699,0.000034808112,0.0010809199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795836,0.00014750654,0.00023910058,0.0004719596,0.00061817234,0.00056488294],"domain_scores_gemma":[0.99932474,0.00016983646,0.000065356835,0.00011493933,0.00016816342,0.00015696668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055828044,0.00019724558,0.00039628302,0.00043162616,0.00020473194,0.00007349093,0.000035904555,0.00014213317,0.000031683237],"category_scores_gemma":[0.000037885566,0.00013304883,0.000023477993,0.00049157103,0.00010352834,0.00012006032,0.000025323112,0.0008325678,0.0000049253167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00516208,0.0015727497,0.8759106,0.0016486893,0.0015898548,0.0070847124,0.013422629,0.0000373021,0.08407652,0.000113424096,0.002204881,0.0071765836],"study_design_scores_gemma":[0.006244002,0.0016865664,0.9664639,0.0020617982,0.00012081787,0.00011586503,0.001588396,0.000010448224,0.021372791,0.00013015117,0.000019767238,0.00018549975],"about_ca_topic_score_codex":0.010718025,"about_ca_topic_score_gemma":0.005789891,"teacher_disagreement_score":0.09055331,"about_ca_system_score_codex":0.0013024907,"about_ca_system_score_gemma":0.00029460824,"threshold_uncertainty_score":0.9958697},"labels":[],"label_agreement":null},{"id":"W4402266827","doi":"10.1158/1538-7445.pediatric24-b054","title":"Abstract B054: Intratumoral injection with stimulator of interferon genes (STING) agonist increases T- and B-cell infiltrates in canine osteosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stimulator of interferon genes; Osteosarcoma; Sting; Agonist; Medicine; Cancer research; Interferon; Internal medicine; Immunology; Receptor; Innate immune system","score_opus":0.0324861786801544,"score_gpt":0.33947756461502215,"score_spread":0.30699138593486774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639071,0.034852076,0.0000027332837,0.00012561417,0.00018896311,0.00024147698,0.000056810557,0.00003743326,0.0005877632],"genre_scores_gemma":[0.9978225,0.0006653368,0.000008552731,0.000012577517,0.00003703658,0.000053842177,0.000032798518,0.000024936788,0.0013423875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867314,0.00025701438,0.0002792143,0.00031229478,0.00007494896,0.0004034135],"domain_scores_gemma":[0.9992292,0.00038521193,0.000039884115,0.00016723762,0.00014823623,0.00003022348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005135959,0.00015740067,0.00025223545,0.0004441743,0.000101268786,0.00006923946,0.00015641785,0.00013222096,0.00047149096],"category_scores_gemma":[0.00006809796,0.00012182128,0.00003052723,0.0003750706,0.000555915,0.00014165087,0.00010807994,0.000661266,0.00003491821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027997235,0.000111990914,0.008317791,0.00031351624,0.000066665954,0.000040455005,0.00050329126,0.000027321428,0.9807367,0.00013120203,0.00074322236,0.0062081395],"study_design_scores_gemma":[0.0010839363,0.0020191204,0.019573132,0.00084251136,0.00001523461,0.0001371347,0.0011164375,0.00003153633,0.9726836,0.000029793237,0.0022883376,0.00017922651],"about_ca_topic_score_codex":0.012653875,"about_ca_topic_score_gemma":0.0022037108,"teacher_disagreement_score":0.03418674,"about_ca_system_score_codex":0.00013240032,"about_ca_system_score_gemma":0.0004446877,"threshold_uncertainty_score":0.9939209},"labels":[],"label_agreement":null},{"id":"W4402266829","doi":"10.1158/1538-7445.pediatric24-b055","title":"Abstract B055: Disease control in patients treated with naxitamab for refractory/relapsed high-risk neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Refractory (planetary science); Medicine; Neuroblastoma; Disease; Internal medicine; Oncology; Biology","score_opus":0.02589515558956089,"score_gpt":0.35215554309965397,"score_spread":0.32626038751009306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943026,0.00057180616,0.000012315904,0.001057116,0.00009457116,0.0029157647,0.00072676153,0.00011973211,0.00019936453],"genre_scores_gemma":[0.9963742,0.0002465273,0.000018924464,0.00008690615,0.00015364139,0.0015749189,0.00013934923,0.00011291734,0.0012926091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658036,0.00018889317,0.0002873328,0.00078468863,0.0011407656,0.0010179594],"domain_scores_gemma":[0.99765575,0.0006260027,0.000039452043,0.00047690576,0.00046297,0.00073890097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039042847,0.00026554032,0.0003653954,0.00069562794,0.00016675485,0.00012414998,0.00017933342,0.000087395325,0.00028988416],"category_scores_gemma":[0.0003478533,0.0001882927,0.00011610012,0.000869902,0.00021046252,0.00021001356,0.000045578705,0.0009287683,0.00015505763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13752519,0.0063136755,0.7145598,0.0031750344,0.001606338,0.009415455,0.0002865478,0.00015199377,0.018104386,0.0002619005,0.026125032,0.08247464],"study_design_scores_gemma":[0.023477284,0.006400354,0.95991826,0.0008633884,0.00013099739,0.0000036155773,0.000018481658,0.00050262327,0.0028894942,0.00012237244,0.0054383613,0.00023475845],"about_ca_topic_score_codex":0.0008951886,"about_ca_topic_score_gemma":0.00020980659,"teacher_disagreement_score":0.24535847,"about_ca_system_score_codex":0.000670978,"about_ca_system_score_gemma":0.00088907615,"threshold_uncertainty_score":0.7678354},"labels":[],"label_agreement":null},{"id":"W4402266830","doi":"10.1158/1538-7445.pediatric24-a057","title":"Abstract A057 Molecular iodine reduces the invasiveness of neuroblastoma xenografts in zebrafish","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Neuroblastoma; Cancer research; Iodine; Medicine; Biology; Oncology; Internal medicine; Chemistry; Genetics; Gene; Cell culture","score_opus":0.0749415034412686,"score_gpt":0.4275900171493211,"score_spread":0.3526485137080525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786104,0.0034175015,0.0000012358544,0.005383816,0.00015471969,0.0007888878,0.00002901804,0.000038650855,0.0023251618],"genre_scores_gemma":[0.9982042,0.00072739867,0.000010416384,0.00008844275,0.00012963252,0.00028665178,0.000007845137,0.000043735312,0.00050169835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973517,0.00021133473,0.00027339262,0.00043721288,0.0010916679,0.000634702],"domain_scores_gemma":[0.9986543,0.00043522546,0.000024670051,0.00042947914,0.00025082487,0.00020550811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007638559,0.00014943889,0.0002559199,0.0005782405,0.00007951155,0.000078657,0.00031133596,0.000066009336,0.0003921605],"category_scores_gemma":[0.0002613749,0.000098203185,0.00011260999,0.0015899638,0.00042594242,0.00011050025,0.00016772357,0.00087770337,0.000093131806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072279474,0.0002775022,0.0007868009,0.0007473309,0.0001445287,0.0041949297,0.00026569804,0.000039080332,0.9762677,0.00025321968,0.0036151092,0.012685332],"study_design_scores_gemma":[0.0011602108,0.0005942344,0.038291566,0.0012117595,0.000019399595,0.00006111881,0.00013308051,0.00005586614,0.95372653,0.00027906254,0.0043729837,0.000094167124],"about_ca_topic_score_codex":0.0005584196,"about_ca_topic_score_gemma":0.0001284965,"teacher_disagreement_score":0.037504762,"about_ca_system_score_codex":0.00018036939,"about_ca_system_score_gemma":0.0008494921,"threshold_uncertainty_score":0.42938823},"labels":[],"label_agreement":null},{"id":"W4402266831","doi":"10.1158/1538-7445.pediatric24-a079","title":"Abstract A079 Mechanisms of chemotherapy resistance in rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Medicine; Chemotherapy; Resistance (ecology); Oncology; Internal medicine; Cancer research; Sarcoma; Biology; Pathology; Ecology","score_opus":0.07417848611840787,"score_gpt":0.4253129011863394,"score_spread":0.3511344150679315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94782335,0.034879968,0.000020354957,0.008949777,0.000118249285,0.0005671793,0.000022377675,0.000037597554,0.007581134],"genre_scores_gemma":[0.9953039,0.0026352236,0.00042569073,0.00009909832,0.000082038605,0.00028883741,0.0000047961394,0.000029643827,0.001130715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855936,0.00003885429,0.00021430885,0.00029823172,0.00055514293,0.00033410772],"domain_scores_gemma":[0.9992518,0.00023949103,0.000016305014,0.0002908248,0.00011014355,0.00009143624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058376655,0.00009583151,0.00023415615,0.00031844195,0.000029480174,0.00002390377,0.00010580874,0.000067295914,0.0009762359],"category_scores_gemma":[0.000037830345,0.000075311276,0.00007974802,0.0006547568,0.000094712785,0.000047485904,0.00002702944,0.00031601824,0.00005316509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026284494,0.002790562,0.05312198,0.004666505,0.0007249728,0.005169694,0.0031143131,0.0000067883507,0.53237784,0.11151432,0.047001783,0.23688278],"study_design_scores_gemma":[0.003332747,0.00029880102,0.35264695,0.0043522385,0.000031085325,0.000014321909,0.0003358242,0.000038683524,0.5678573,0.029362915,0.041513115,0.000216007],"about_ca_topic_score_codex":0.00051106524,"about_ca_topic_score_gemma":0.00043607003,"teacher_disagreement_score":0.29952496,"about_ca_system_score_codex":0.0003530431,"about_ca_system_score_gemma":0.00034200415,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W4402266832","doi":"10.1158/1538-7445.pediatric24-a081","title":"Abstract A081 Biomarker-driven targeting of NAD metabolism in rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; NAD+ kinase; Rhabdomyosarcoma; Cancer research; Medicine; Biology; Biochemistry; Pathology; Sarcoma; Enzyme","score_opus":0.0672654215004014,"score_gpt":0.4122057118408001,"score_spread":0.34494029034039875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595788,0.03715239,0.00007476783,0.00052445504,0.00018255188,0.0001760718,0.00005253149,0.000008185992,0.002250234],"genre_scores_gemma":[0.9955828,0.003202893,0.00013534386,0.000017000268,0.00021837962,0.00015052508,0.000035019624,0.000022141981,0.0006358784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988221,0.00007535176,0.00021365203,0.00033147138,0.0002491593,0.00030824498],"domain_scores_gemma":[0.9994651,0.000030068599,0.000024050734,0.00026784264,0.00015266868,0.000060252438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000655401,0.000084508596,0.000115284165,0.0001788858,0.000051311694,0.000037417667,0.00024994373,0.0000987571,0.00020462327],"category_scores_gemma":[0.00006541866,0.000076519435,0.00006662595,0.0004278021,0.00014389084,0.0000065038366,0.00009698891,0.00021049564,0.00001529586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043114895,0.00002723848,0.00061479514,0.00009988849,0.000037316848,0.0000071174372,0.00007338619,0.00006204151,0.96907693,0.00039177664,0.0075966427,0.021969737],"study_design_scores_gemma":[0.00035996718,0.00004481281,0.027057417,0.00016564883,0.0000073644233,0.000002244483,0.00020558423,0.00031954233,0.66463536,0.0002606131,0.30675775,0.0001837059],"about_ca_topic_score_codex":0.0006409718,"about_ca_topic_score_gemma":0.0001558289,"teacher_disagreement_score":0.30444157,"about_ca_system_score_codex":0.000048651662,"about_ca_system_score_gemma":0.00035821486,"threshold_uncertainty_score":0.3120372},"labels":[],"label_agreement":null},{"id":"W4402266839","doi":"10.1158/1538-7445.pediatric24-b030","title":"Abstract B030: Whole genome sequencing provides practice-changing benefits when performed on consecutive, unselected children with suspected cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.03691386298415621,"score_gpt":0.3392575419268604,"score_spread":0.3023436789427042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768283,0.018642623,0.00003176712,0.0013025181,0.00017759131,0.0008314583,0.00062011444,0.000054833756,0.0015108028],"genre_scores_gemma":[0.9914005,0.0049857297,0.00015505632,0.0003612325,0.0010220243,0.00048760808,0.00040678453,0.000101223,0.0010798761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974589,0.00008343788,0.00022998633,0.00081627764,0.00051442394,0.00089700724],"domain_scores_gemma":[0.9984653,0.00020392302,0.0000675434,0.00040888033,0.00064691,0.00020741418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053877686,0.00027080122,0.00020679462,0.00031256955,0.00034890973,0.0003135585,0.0003046347,0.00016927185,0.00019531304],"category_scores_gemma":[0.00030732874,0.00023541633,0.00006717493,0.00058701966,0.00021675468,0.000023846256,0.00014916722,0.0006222718,0.000037146838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012525686,0.00010256608,0.0026988096,0.00021852051,0.0008844039,0.00009618208,0.0016680293,0.004545055,0.96198225,0.00061130774,0.010561693,0.015378596],"study_design_scores_gemma":[0.0030241495,0.0029313222,0.03363008,0.0018400078,0.0002504943,0.00018145815,0.0021807973,0.0006509165,0.6637762,0.00024897445,0.28942928,0.0018563006],"about_ca_topic_score_codex":0.0021756857,"about_ca_topic_score_gemma":0.0022101037,"teacher_disagreement_score":0.29820606,"about_ca_system_score_codex":0.00066403294,"about_ca_system_score_gemma":0.002690194,"threshold_uncertainty_score":0.9599999},"labels":[],"label_agreement":null},{"id":"W4402266847","doi":"10.1158/1538-7445.pediatric24-b008","title":"Abstract B008: Decoding the primary site-specific regulation of rhabdomyosarcoma metastasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Medicine; Metastasis; Decoding methods; Oncology; Cancer research; Internal medicine; Cancer; Sarcoma; Pathology; Computer science; Algorithm","score_opus":0.14180037728341063,"score_gpt":0.41878308295206007,"score_spread":0.27698270566864946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9155475,0.07285322,0.000012360427,0.0057315878,0.00015099785,0.00053379894,0.000035553683,0.00003792759,0.0050970605],"genre_scores_gemma":[0.99369377,0.005038604,0.0002104143,0.000055200268,0.00025580698,0.00021565461,0.000028254031,0.000026684025,0.00047559667],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983719,0.00008311121,0.00023700338,0.00028345257,0.00072925905,0.0002952555],"domain_scores_gemma":[0.9985012,0.0007933706,0.000028243701,0.00039844724,0.0001925553,0.00008622633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094872026,0.00010106956,0.00021005717,0.00022776253,0.00012955755,0.000064584696,0.00011338312,0.000049216458,0.0013958917],"category_scores_gemma":[0.000048283167,0.00006145974,0.0001410381,0.0005726851,0.0001670482,0.00006659529,0.000066826666,0.00031697212,0.0001251501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036897112,0.00039682133,0.025188927,0.0009717159,0.00047279854,0.00028995983,0.0010590735,0.00002783237,0.20004918,0.004507435,0.06743259,0.6992347],"study_design_scores_gemma":[0.000921348,0.0001627791,0.682099,0.0012557168,0.00013595323,0.000038689454,0.00027362612,0.00012319584,0.12876108,0.0008213682,0.18527168,0.00013558495],"about_ca_topic_score_codex":0.0002491594,"about_ca_topic_score_gemma":0.000039869312,"teacher_disagreement_score":0.6990991,"about_ca_system_score_codex":0.0004003098,"about_ca_system_score_gemma":0.00024192566,"threshold_uncertainty_score":0.99951696},"labels":[],"label_agreement":null},{"id":"W4402266851","doi":"10.1158/1538-7445.pediatric24-b069","title":"Abstract B069: ACCESS: Advancing childhood cancer experience, science and survivorship in Canada","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The King's University; Western University; Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Survivorship curve; Childhood cancer; Cancer; Cancer survivorship; Medicine; Gerontology; Internal medicine","score_opus":0.10256835888227273,"score_gpt":0.46473489396203327,"score_spread":0.36216653507976054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629201,0.02265767,0.0000025217662,0.01016603,0.0010079775,0.00073870923,0.000054954067,0.00006946181,0.00238256],"genre_scores_gemma":[0.99404263,0.0034190991,0.000027520282,0.0011523443,0.00059202715,0.00047754683,0.00000376671,0.000055703353,0.00022937436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99383897,0.00012834025,0.0005159261,0.0011109074,0.0030041332,0.0014017418],"domain_scores_gemma":[0.99752104,0.0005939857,0.00005082915,0.00055894966,0.0005518581,0.0007233537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003812368,0.00025703837,0.00045406868,0.0008211898,0.00032370037,0.0003780934,0.0006867922,0.00007886293,0.00081773015],"category_scores_gemma":[0.0010928903,0.00023677894,0.000042653537,0.0036989886,0.00077328447,0.00086525246,0.00042420617,0.0013055797,0.000010420494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00041709517,0.00024408307,0.77742845,0.0043402035,0.00015885681,0.0011544236,0.029734118,0.00019006716,0.03039381,0.00066382875,0.018666895,0.13660818],"study_design_scores_gemma":[0.00078762084,0.00006164376,0.962561,0.003469269,0.000013736454,0.000028476423,0.005245755,0.00021477207,0.013213503,0.00019460218,0.013815465,0.00039412244],"about_ca_topic_score_codex":0.9809786,"about_ca_topic_score_gemma":0.9862364,"teacher_disagreement_score":0.1851326,"about_ca_system_score_codex":0.0054199444,"about_ca_system_score_gemma":0.03512315,"threshold_uncertainty_score":0.99839807},"labels":[],"label_agreement":null},{"id":"W4402266854","doi":"10.1158/1538-7445.pediatric24-a038","title":"Abstract A038 Plasma exosome concentrations in healthy canines and dogs with osteosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Exosome; Medicine; Internal medicine; Oncology; Pathology; Microvesicles; Biology; microRNA; Biochemistry","score_opus":0.03676142159623566,"score_gpt":0.37926477960986515,"score_spread":0.3425033580136295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97816646,0.019383825,0.00001248171,0.001312354,0.00006730082,0.00027562302,0.000055064833,0.000013149388,0.000713755],"genre_scores_gemma":[0.9974481,0.0015230427,0.00006828073,0.00006482853,0.00019346886,0.00014568842,0.000043777334,0.000025102363,0.00048770348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885535,0.00006578328,0.00012821061,0.00037782887,0.00021549089,0.00035734882],"domain_scores_gemma":[0.9994905,0.000043825497,0.000012498985,0.00021717015,0.00007703289,0.0001589938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027674725,0.000094465104,0.00008154617,0.00008561054,0.00008004046,0.00008528659,0.00013321753,0.00007553479,0.00006261759],"category_scores_gemma":[0.000040052688,0.000081785576,0.000018866582,0.00022701548,0.00024443626,0.000008609619,0.000075132906,0.00024588176,0.0000108645745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006279564,0.00007694043,0.027002348,0.00038942302,0.00004845977,0.00025761998,0.00027520309,0.0000784783,0.9585272,0.0009648799,0.0036031252,0.008148338],"study_design_scores_gemma":[0.004692373,0.0022926352,0.110691264,0.0010529722,0.00003819619,0.00015425782,0.001256564,0.0009913507,0.6730633,0.0009362036,0.20371506,0.0011158771],"about_ca_topic_score_codex":0.00047979166,"about_ca_topic_score_gemma":0.0030063626,"teacher_disagreement_score":0.285464,"about_ca_system_score_codex":0.00006440821,"about_ca_system_score_gemma":0.00067548564,"threshold_uncertainty_score":0.3335119},"labels":[],"label_agreement":null},{"id":"W4402266857","doi":"10.1158/1538-7445.pediatric24-b034","title":"Abstract B034: A transcriptional atlas provides a universal diagnostic platform for mesenchymal tumors and validation of preclinical models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children","funders":"","keywords":"Mesenchymal stem cell; Atlas (anatomy); Medicine; Computational biology; Bioinformatics; Cancer research; Pathology; Biology; Anatomy","score_opus":0.19850271218726234,"score_gpt":0.44298639094590125,"score_spread":0.2444836787586389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885399,0.0075094784,0.00008883631,0.0021921084,0.0000686288,0.0011207543,0.0001475627,0.000024578927,0.0003081507],"genre_scores_gemma":[0.9976665,0.0011550796,0.00019650134,0.000014028545,0.00014976028,0.000581764,0.000053482672,0.000018500305,0.00016442273],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988055,0.000022751772,0.00022092405,0.00028914798,0.00042237542,0.00023926249],"domain_scores_gemma":[0.9975162,0.0020309614,0.00002003871,0.00011193591,0.00019155191,0.00012927226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048121272,0.00009016721,0.00020056329,0.0001711821,0.00006365533,0.00003728916,0.000053253312,0.00006779997,0.00012053245],"category_scores_gemma":[0.00025432953,0.00006966593,0.00009697586,0.00016983956,0.0001686456,0.00018007636,0.000020956584,0.00019869283,0.000004500275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011086222,0.0057813665,0.13645138,0.018462183,0.0034350015,0.0014641583,0.0123614445,0.0020336,0.078202754,0.16297178,0.022456823,0.5452933],"study_design_scores_gemma":[0.02633737,0.009647272,0.5473806,0.01872958,0.0018633564,0.0002841152,0.0041842596,0.06688205,0.21211588,0.08025592,0.031020092,0.0012994431],"about_ca_topic_score_codex":0.00030892703,"about_ca_topic_score_gemma":0.00004700057,"teacher_disagreement_score":0.54399383,"about_ca_system_score_codex":0.00017919975,"about_ca_system_score_gemma":0.00057823985,"threshold_uncertainty_score":0.28408945},"labels":[],"label_agreement":null},{"id":"W4402266864","doi":"10.1158/1538-7445.pediatric24-b036","title":"Abstract B036: Integrating gene expression evaluation in molecular diagnostics for pediatric AML molecular classification","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Molecular diagnostics; Computational biology; Gene expression; Gene; Medicine; Biology; Bioinformatics; Cancer research; Oncology; Genetics","score_opus":0.09138569596190226,"score_gpt":0.4532522102560632,"score_spread":0.36186651429416095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641829,0.027945384,0.005322659,0.0004720709,0.00018142242,0.0014588098,0.00006122929,0.000022184448,0.00035330048],"genre_scores_gemma":[0.99185276,0.004206669,0.00059565745,0.000052650063,0.0004954354,0.0023129464,0.00033116678,0.00007607375,0.00007661343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970666,0.00037180024,0.00032248683,0.00073815853,0.0009045329,0.00059642695],"domain_scores_gemma":[0.99848026,0.00018657134,0.000042804524,0.0005003146,0.0006610035,0.00012904969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003140148,0.00018092085,0.00014337829,0.00041916713,0.00011821048,0.00014401616,0.00038194208,0.000232813,0.000086141066],"category_scores_gemma":[0.00081967027,0.00017491732,0.00010293779,0.0006683023,0.00008666096,0.000013808008,0.000121066754,0.00046945896,0.000021702284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039018388,0.00005870155,0.00035972625,0.00015964171,0.000022660508,0.000016203108,0.000074028685,0.00088560267,0.9697793,0.000117634736,0.0014468125,0.026689516],"study_design_scores_gemma":[0.0005721397,0.0005449072,0.00044595255,0.00010327172,0.000015011802,0.000001296317,0.00008814072,0.003181721,0.9924961,0.0006383638,0.0017173141,0.00019578314],"about_ca_topic_score_codex":0.00005050849,"about_ca_topic_score_gemma":0.00013307197,"teacher_disagreement_score":0.027669847,"about_ca_system_score_codex":0.0002999411,"about_ca_system_score_gemma":0.0010534517,"threshold_uncertainty_score":0.7132922},"labels":[],"label_agreement":null},{"id":"W4402266875","doi":"10.1158/1538-7445.pediatric24-b078","title":"Abstract B078: Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiation therapy; Glioma; Medicine; Neuroscience; Cancer research; Biology; Internal medicine","score_opus":0.049019137362670384,"score_gpt":0.3688698112096854,"score_spread":0.31985067384701504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043087,0.076661974,0.003910748,0.011148384,0.002205992,0.0008379649,0.00022051156,0.000047520673,0.0006582394],"genre_scores_gemma":[0.98442596,0.007522003,0.00009054052,0.00049912994,0.003418102,0.00022411277,0.000036901783,0.000060964543,0.0037222998],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998064,0.000291,0.00017778808,0.00050407305,0.0005499722,0.0004132139],"domain_scores_gemma":[0.999101,0.00007948363,0.000018116949,0.00038717504,0.0002625454,0.00015168385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013490889,0.00014779581,0.000120906916,0.00018115748,0.00023363935,0.00014047547,0.0003537524,0.00013332564,0.00058510393],"category_scores_gemma":[0.00009512785,0.000115067116,0.00009291451,0.00057069253,0.00015862059,0.000010696342,0.000061217994,0.00031560645,0.000055290875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018353208,0.000029390563,0.000005310032,0.000019964215,0.00010662593,0.000006746035,0.0005813151,0.00018425699,0.9437868,0.00054695876,0.034603074,0.01829423],"study_design_scores_gemma":[0.00042210228,0.00026055455,0.0028694812,0.000044541557,0.000011033487,0.000019004996,0.00030799225,0.000030396282,0.23717165,0.00012970381,0.7585742,0.00015935357],"about_ca_topic_score_codex":0.0001770234,"about_ca_topic_score_gemma":0.0002217887,"teacher_disagreement_score":0.7239711,"about_ca_system_score_codex":0.00018705266,"about_ca_system_score_gemma":0.00090699724,"threshold_uncertainty_score":0.64064777},"labels":[],"label_agreement":null},{"id":"W4402266882","doi":"10.1158/1538-7445.pediatric24-b035","title":"Abstract B035: Stratified Medicine Paediatrics2 – advancing precision medicine in paediatric cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer Medicine; Medicine; Cancer; Family medicine; Internal medicine","score_opus":0.15693596096488463,"score_gpt":0.5540981758823111,"score_spread":0.39716221491742654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7524262,0.15306967,0.000058787813,0.069374986,0.0076080943,0.0031344558,0.000112754075,0.0002968278,0.01391822],"genre_scores_gemma":[0.92862195,0.05543237,0.00002042098,0.000925415,0.011932469,0.00020383365,0.000033747718,0.000073144125,0.0027566357],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9940544,0.00079899066,0.0011385478,0.0008242569,0.0015465077,0.0016372908],"domain_scores_gemma":[0.99488866,0.0035439762,0.00012617098,0.00046438034,0.00042670208,0.00055012986],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007611852,0.0002692868,0.0005538079,0.0013508407,0.0006509737,0.000019953053,0.0004381279,0.0003114042,0.009713421],"category_scores_gemma":[0.0013039127,0.00018955744,0.00005744826,0.0031763476,0.00023733328,0.0002526127,0.00019586016,0.004109446,0.00028767603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003985391,0.00011335745,0.05704208,0.007787049,0.000035411715,0.000221968,0.017611371,0.00014837748,0.009114103,0.0020514415,0.68702954,0.21844678],"study_design_scores_gemma":[0.008256675,0.00070137385,0.45444015,0.049467422,0.000090928435,0.000004393305,0.021433815,0.0014883545,0.0002561763,0.010538558,0.45226708,0.0010550626],"about_ca_topic_score_codex":0.015900914,"about_ca_topic_score_gemma":0.013437657,"teacher_disagreement_score":0.39739805,"about_ca_system_score_codex":0.0018030966,"about_ca_system_score_gemma":0.0033019914,"threshold_uncertainty_score":0.99818814},"labels":[],"label_agreement":null},{"id":"W4402266886","doi":"10.1158/1538-7445.pediatric24-ia021","title":"Abstract IA021: Neogenes induced by oncogenic chimeric transcription factors as potential targets for therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Transcription factor; Medicine; Cancer; Cancer therapy; Biology; Genetics; Internal medicine; Gene","score_opus":0.13550399034543423,"score_gpt":0.4434800350480042,"score_spread":0.30797604470257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92598104,0.06927176,0.00013069187,0.0018682593,0.0009746149,0.0010879033,0.00020242375,0.000073930845,0.00040938082],"genre_scores_gemma":[0.9822678,0.013920594,0.00003905516,0.00013774926,0.00078489154,0.00042237586,0.00014438342,0.000071952236,0.00221123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980271,0.000049296115,0.00022647044,0.00048212538,0.0006393951,0.0005756133],"domain_scores_gemma":[0.9992258,0.00007629814,0.0000236797,0.00023139702,0.00019270509,0.00025011302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046857717,0.00018127532,0.00027602082,0.00024203495,0.00016464548,0.00009875245,0.00013496795,0.00012559358,0.00235521],"category_scores_gemma":[0.000024868701,0.00014146659,0.00027394216,0.0004735515,0.00008439574,0.000115318755,0.000015327763,0.00043801012,0.000054452288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005546052,0.00007394738,0.00003137713,0.00021492383,0.00021290447,0.000014464531,0.00038433293,0.000002667242,0.81054235,0.00001665271,0.011558998,0.1763928],"study_design_scores_gemma":[0.0010964345,0.0005233067,0.0010463996,0.00009745684,0.000054180236,0.0000060956563,0.00024496237,0.00001810148,0.6841901,0.0001016707,0.31247893,0.00014236398],"about_ca_topic_score_codex":0.0024058633,"about_ca_topic_score_gemma":0.000052354153,"teacher_disagreement_score":0.30091995,"about_ca_system_score_codex":0.00030737976,"about_ca_system_score_gemma":0.0008371512,"threshold_uncertainty_score":0.9985568},"labels":[],"label_agreement":null},{"id":"W4402266903","doi":"10.1158/1538-7445.pediatric24-pr008","title":"Abstract PR008: The impact of social determinants and neuropsychological factors on healthcare transition readiness among adolescent and young adult childhood cancer survivors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Childhood cancer; Neuropsychology; Medicine; Cancer; Young adult; Gerontology; Psychology; Clinical psychology; Developmental psychology; Psychiatry; Cognition; Internal medicine","score_opus":0.09418372627610018,"score_gpt":0.46264600782417165,"score_spread":0.3684622815480715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878968,0.0026069838,0.0000019195702,0.007702489,0.00033631065,0.000988818,0.00031673748,0.000057661684,0.000092307055],"genre_scores_gemma":[0.9964331,0.0025422813,0.0000012595958,0.00023316388,0.00056817336,0.000110902074,0.000016710155,0.00005389215,0.000040547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970149,0.00041094463,0.00042875716,0.0006443603,0.00091763225,0.00058345444],"domain_scores_gemma":[0.99874866,0.0002793656,0.00008291489,0.00028680323,0.0003077501,0.00029452937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095812784,0.00027190996,0.0004853217,0.0002267551,0.00030285635,0.000091703936,0.00016369487,0.000190608,0.00010470925],"category_scores_gemma":[0.0001194884,0.00016969949,0.00016405541,0.0005313126,0.00066241913,0.000127345,0.000056126304,0.0012461423,0.0000022947318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018898376,0.0004949141,0.90650535,0.0028693124,0.00030864845,0.00012545721,0.04448224,0.00001216174,0.0028803644,0.00008314103,0.0022391153,0.038109463],"study_design_scores_gemma":[0.0006681628,0.0005696554,0.994516,0.0015286688,0.000035517376,0.000019450104,0.0016574246,0.000054673557,0.00070877676,0.000048909842,0.00003426722,0.00015850722],"about_ca_topic_score_codex":0.053369567,"about_ca_topic_score_gemma":0.011567638,"teacher_disagreement_score":0.08801064,"about_ca_system_score_codex":0.00030471463,"about_ca_system_score_gemma":0.00044272176,"threshold_uncertainty_score":0.95293415},"labels":[],"label_agreement":null},{"id":"W4402266920","doi":"10.1158/1538-7445.pediatric24-b063","title":"Abstract B063: Unveiling the immune landscape of recurrent, MYC-driven medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Immune system; Medicine; Cancer research; Biology; Immunology","score_opus":0.07491363160490444,"score_gpt":0.4231741845953189,"score_spread":0.3482605529904145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94071597,0.049200125,0.000001421051,0.0055570602,0.00030785007,0.00044584507,0.000034210967,0.000037685877,0.003699856],"genre_scores_gemma":[0.99606746,0.003069223,0.000022265958,0.000018413111,0.00025882377,0.00021911827,0.000014280088,0.000024250803,0.0003061834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853027,0.000055215027,0.00022054248,0.00025182418,0.0006017398,0.00034038676],"domain_scores_gemma":[0.9989434,0.00037257306,0.000026188027,0.0003536951,0.00020081225,0.000103368235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005631996,0.00010185239,0.00020533237,0.00020820496,0.0001007357,0.000046647874,0.00015832092,0.000055607,0.0010787738],"category_scores_gemma":[0.00007927536,0.0000588029,0.00013062131,0.000605742,0.00014922487,0.000043568787,0.000080914135,0.00043222305,0.00014529869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012993993,0.0015765764,0.054322425,0.0033950103,0.002255002,0.0016912442,0.0046523856,0.00018965316,0.4673987,0.005658483,0.08334327,0.37421787],"study_design_scores_gemma":[0.00395623,0.0015628234,0.2814928,0.0076118065,0.00034370678,0.00011801761,0.002161956,0.002321853,0.552456,0.00066769886,0.14692184,0.0003852312],"about_ca_topic_score_codex":0.00038785092,"about_ca_topic_score_gemma":0.00008796558,"teacher_disagreement_score":0.37383264,"about_ca_system_score_codex":0.0001393423,"about_ca_system_score_gemma":0.00034223642,"threshold_uncertainty_score":0.99983436},"labels":[],"label_agreement":null},{"id":"W4402266922","doi":"10.1158/1538-7445.pediatric24-b026","title":"Abstract B026: Infant ALL without KMT2A rearrangements harbor clinically relevant alterations and share common origins with childhood ALL","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; London Health Sciences Centre","funders":"","keywords":"Medicine; Childhood cancer; Pediatrics; Cancer; Internal medicine","score_opus":0.07222446235901431,"score_gpt":0.43827958592405425,"score_spread":0.36605512356503994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762044,0.0028552688,0.00006492681,0.013350846,0.00017855933,0.0020945338,0.0002745805,0.00020349541,0.0047733765],"genre_scores_gemma":[0.99192315,0.003071609,0.00071876374,0.0008333091,0.00065216847,0.0005681717,0.00015436068,0.00012352457,0.0019549164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553585,0.00016523282,0.000554045,0.0009100245,0.0018063594,0.0010284932],"domain_scores_gemma":[0.9972626,0.00069336605,0.000054681783,0.00076198956,0.0005059033,0.00072148704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016268059,0.00028726706,0.0004773259,0.0004384086,0.00022371249,0.00038459114,0.00034834092,0.0001889567,0.001025764],"category_scores_gemma":[0.0003997872,0.0002031954,0.00008019673,0.0006292699,0.00046695987,0.00027781804,0.0002889471,0.0017626927,0.00031177964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015615208,0.0035186077,0.19373237,0.008608494,0.01003785,0.014596865,0.018307809,0.0001588016,0.1684156,0.006345831,0.46240008,0.09826248],"study_design_scores_gemma":[0.014543537,0.005209633,0.2408072,0.0091280565,0.00057732384,0.00048584357,0.0006418424,0.0072796866,0.0061867624,0.00045297926,0.7135296,0.0011575609],"about_ca_topic_score_codex":0.0017650239,"about_ca_topic_score_gemma":0.00067291496,"teacher_disagreement_score":0.25112948,"about_ca_system_score_codex":0.0014634338,"about_ca_system_score_gemma":0.003015438,"threshold_uncertainty_score":0.9998874},"labels":[],"label_agreement":null},{"id":"W4402266945","doi":"10.1158/1538-7445.pediatric24-b056","title":"Abstract B056: Unveiling the temporal impact: Exploring dynamic changes in the pediatric solid tumor microenvironment through time","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Solid tumor; Tumor microenvironment; Cancer; Medicine; Internal medicine","score_opus":0.27761761102745,"score_gpt":0.5173915512427828,"score_spread":0.23977394021533283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92492115,0.037397914,0.0000016181666,0.035763085,0.0001638832,0.00058980775,0.000020094321,0.000025155421,0.001117311],"genre_scores_gemma":[0.97152555,0.026450714,0.00000983893,0.0004756353,0.00082598615,0.00039876392,0.0000042608485,0.00002519226,0.00028404794],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998094,0.00015822645,0.00017598213,0.00029769412,0.0006566976,0.0006174029],"domain_scores_gemma":[0.99872494,0.0008847955,0.00002748546,0.0002541588,0.000028801238,0.0000798361],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019196873,0.0001378188,0.00017807721,0.00009012441,0.00027000238,0.00012352307,0.00025956472,0.000031143096,0.00095628866],"category_scores_gemma":[0.00010611305,0.00006739363,0.00007549033,0.0005916202,0.00015723569,0.00017026442,0.00016216263,0.0012178362,0.00027745106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053802454,0.0022013218,0.19493802,0.009919789,0.0024943298,0.010393565,0.11444861,0.0012094945,0.31700316,0.00032551563,0.10785723,0.23382874],"study_design_scores_gemma":[0.0027285153,0.0013701265,0.2995552,0.0014924068,0.00053748797,0.00030339757,0.019845901,0.00614429,0.012471232,0.00092715607,0.65373427,0.0008899942],"about_ca_topic_score_codex":0.0007131633,"about_ca_topic_score_gemma":0.00011445141,"teacher_disagreement_score":0.54587704,"about_ca_system_score_codex":0.000438226,"about_ca_system_score_gemma":0.00015746275,"threshold_uncertainty_score":0.99995697},"labels":[],"label_agreement":null},{"id":"W4402266947","doi":"10.1158/1538-7445.pediatric24-b011","title":"Abstract B011: Whole genome sequencing can reproduce all standard-of-care diagnostics for childhood cancer: Results from two national systems","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Childhood cancer; Cancer; Whole genome sequencing; Computational biology; Medicine; Genome; Genetics; Biology; Gene","score_opus":0.11297405039354458,"score_gpt":0.4423457458430591,"score_spread":0.3293716954495145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89877385,0.046502177,0.000013213807,0.004734533,0.00058952376,0.002701021,0.04540059,0.00010603568,0.0011790842],"genre_scores_gemma":[0.9914483,0.00398328,0.00011241669,0.000045868408,0.0014971214,0.00085656403,0.0010964114,0.000079465564,0.0008805803],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959523,0.00009959474,0.00045492098,0.0009062578,0.0018549629,0.0007319766],"domain_scores_gemma":[0.9961354,0.0012148016,0.00006959618,0.0005206458,0.0016962796,0.00036325998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000963247,0.000200764,0.00039638253,0.00036896692,0.00017821259,0.00014262782,0.00024642728,0.00008552861,0.000084106025],"category_scores_gemma":[0.001479561,0.0001703611,0.00012662509,0.0005070695,0.00016167221,0.000106545485,0.000108267515,0.0006465721,0.00003132953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022788413,0.0008911724,0.005493172,0.015093182,0.007287432,0.0050809737,0.024410138,0.010659755,0.7239004,0.002202003,0.09906396,0.08312941],"study_design_scores_gemma":[0.032068394,0.007776175,0.05158619,0.01879775,0.0006501494,0.00010272712,0.005355024,0.0016018257,0.34878683,0.0027921172,0.52904344,0.0014393473],"about_ca_topic_score_codex":0.007995154,"about_ca_topic_score_gemma":0.0017524881,"teacher_disagreement_score":0.4299795,"about_ca_system_score_codex":0.0027902175,"about_ca_system_score_gemma":0.005611344,"threshold_uncertainty_score":0.9986107},"labels":[],"label_agreement":null},{"id":"W4402266982","doi":"10.1158/1538-7445.pediatric24-b046","title":"Abstract B046: Addressing inequities in pediatric solid tumors: Insights from Hispanics in Puerto Rico","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Cancer; Demography; Environmental health; Sociology; Internal medicine","score_opus":0.1649602709601662,"score_gpt":0.4581751971521603,"score_spread":0.29321492619199413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396904,0.051795352,0.0000068677773,0.0044084657,0.00060558575,0.0006086853,0.00005419603,0.00012148237,0.0027089736],"genre_scores_gemma":[0.992326,0.003927557,0.00006262068,0.00038031396,0.0025104186,0.00023430327,0.00004698614,0.00008595619,0.0004258332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560857,0.0003106321,0.0008504183,0.0008059732,0.0015366077,0.00088782894],"domain_scores_gemma":[0.99778384,0.001106064,0.0000683246,0.0005538604,0.00018747826,0.00030045418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015610415,0.0002668547,0.00066584704,0.0014907315,0.00009688327,0.00021789502,0.0003747828,0.0002180574,0.0006210445],"category_scores_gemma":[0.0007132874,0.00025183687,0.00010682731,0.0021154373,0.0001745351,0.0003880834,0.00026074512,0.0021509756,0.00018480195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004842011,0.003492523,0.46723494,0.029197069,0.00069329544,0.024702106,0.16653903,0.0010338912,0.06934456,0.0045523657,0.14528602,0.0830822],"study_design_scores_gemma":[0.004738772,0.00040379778,0.9387498,0.014485846,0.00007662683,0.000022559228,0.007256926,0.0013694119,0.009393012,0.0081778355,0.014293999,0.0010313968],"about_ca_topic_score_codex":0.024408432,"about_ca_topic_score_gemma":0.019339655,"teacher_disagreement_score":0.47151488,"about_ca_system_score_codex":0.001439367,"about_ca_system_score_gemma":0.0025154385,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4402267008","doi":"10.1158/1538-7445.pediatric24-a067","title":"Abstract A067 Unlocking asparaginase resistance: MondoA's role in pediatric B-ALL's adaptation to nutrient scarcity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Nutrient; Resistance (ecology); Medicine; Adaptation (eye); Biology; Ecology; Neuroscience","score_opus":0.06480001737642431,"score_gpt":0.40473259499456515,"score_spread":0.33993257761814083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747792,0.011469689,0.00033911446,0.006426257,0.00026023778,0.0014946908,0.000040360806,0.00013402196,0.005056462],"genre_scores_gemma":[0.9924574,0.0019104666,0.00033889976,0.00015531984,0.00093559764,0.0007599167,0.00002672203,0.00007730314,0.0033383686],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994996,0.00017880305,0.00044427486,0.0008817258,0.002265355,0.0012338074],"domain_scores_gemma":[0.99756277,0.0006824549,0.000030355408,0.00055704196,0.0005454955,0.00062187784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002229184,0.0002248814,0.00033955934,0.0016008923,0.0001380435,0.00020192862,0.0003665111,0.00017898747,0.00037771568],"category_scores_gemma":[0.0007247178,0.0002065764,0.00009373943,0.003440053,0.00012900504,0.00022427386,0.00024626154,0.0014111368,0.0005394405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022157257,0.0026463624,0.06524297,0.02094011,0.00079044455,0.02743648,0.0462451,0.011002918,0.23829338,0.010612186,0.41319546,0.14143732],"study_design_scores_gemma":[0.021094209,0.0021428256,0.4152025,0.010823333,0.00040449534,0.00017809511,0.010248711,0.054392777,0.118018344,0.012231831,0.35242298,0.0028398912],"about_ca_topic_score_codex":0.0024627966,"about_ca_topic_score_gemma":0.0011866012,"teacher_disagreement_score":0.34995952,"about_ca_system_score_codex":0.0043839235,"about_ca_system_score_gemma":0.0037757745,"threshold_uncertainty_score":0.99943805},"labels":[],"label_agreement":null},{"id":"W4402267014","doi":"10.1158/1538-7445.pediatric24-a068","title":"Abstract A068 Emerging therapies for the treatment of the fusion protein driven cancer, fibrolamellar carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Oncology; Cancer research; Internal medicine","score_opus":0.13722651197699787,"score_gpt":0.47377734433127416,"score_spread":0.3365508323542763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93724597,0.036925618,0.00001343437,0.023664813,0.000065453765,0.0016636848,0.00007024398,0.000019051775,0.0003317104],"genre_scores_gemma":[0.9891589,0.004417029,0.000021765773,0.000026704656,0.000495784,0.0026200253,0.0000037671748,0.000017855971,0.003238154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911654,0.00002318997,0.00013037221,0.00019712752,0.0002984641,0.00023432213],"domain_scores_gemma":[0.9992411,0.00025167243,0.000019262008,0.0003078046,0.0001182484,0.00006192543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018212618,0.00008272443,0.000114217335,0.000026085785,0.00025287684,0.000025156392,0.00016092448,0.000045352328,0.00037160653],"category_scores_gemma":[0.000018811663,0.0000397929,0.00011998645,0.00029768486,0.00020607669,0.000020138448,0.000022392103,0.00020767032,0.0000039242136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000145126,0.000075427975,0.00061521697,0.0005043472,0.00011626957,0.0000024368392,0.0008749634,0.000049611044,0.94313186,0.00022463976,0.0014089929,0.05285112],"study_design_scores_gemma":[0.0003916589,0.0000906593,0.0031878075,0.0002482655,0.000053066666,0.0000013507213,0.00023273681,0.0013544076,0.75897783,0.00014156914,0.23527871,0.000041957428],"about_ca_topic_score_codex":0.00035686896,"about_ca_topic_score_gemma":0.00002151293,"teacher_disagreement_score":0.23386972,"about_ca_system_score_codex":0.00023703309,"about_ca_system_score_gemma":0.0003438175,"threshold_uncertainty_score":0.40688306},"labels":[],"label_agreement":null},{"id":"W4402267017","doi":"10.1158/1538-7445.pediatric24-a053","title":"Abstract A053 Investigating mechanisms responsible for MAP kinase pathway resistance in RAS-altered neuroblastoma cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Neuroblastoma; Biology; Kinase; Cell biology; Genetics; Cell culture","score_opus":0.09805020769349683,"score_gpt":0.41176544721889485,"score_spread":0.31371523952539804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852969,0.0030963358,0.00008033774,0.0063135624,0.0005373806,0.0026023372,0.00022277408,0.00017851098,0.001671834],"genre_scores_gemma":[0.98442644,0.00020027357,0.0017708455,0.00019560217,0.0003036739,0.0013512844,0.000022595776,0.00012102201,0.011608254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961162,0.00026101025,0.00040657926,0.0008909405,0.0010912719,0.0012339691],"domain_scores_gemma":[0.9976582,0.0009076001,0.000037887054,0.0005452558,0.00029273564,0.00055831234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015249737,0.00025131644,0.0003500893,0.00089025014,0.00021742428,0.000197762,0.00027087415,0.00012373397,0.00025903582],"category_scores_gemma":[0.0005659313,0.00022227188,0.00013548053,0.0011787062,0.00022438815,0.00020154884,0.0001466695,0.0010736285,0.0002549271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018717552,0.00016245332,0.000040234274,0.0020814019,0.000053870714,0.0020430353,0.00023473904,0.000011483443,0.9735696,0.0025707572,0.014144409,0.0032163032],"study_design_scores_gemma":[0.002435572,0.0008876451,0.0019137415,0.0029645085,0.000013536664,0.000011838642,0.00011429476,0.00031458127,0.95887244,0.010887088,0.021373594,0.00021116367],"about_ca_topic_score_codex":0.00022746604,"about_ca_topic_score_gemma":0.0009649554,"teacher_disagreement_score":0.014697121,"about_ca_system_score_codex":0.00064434286,"about_ca_system_score_gemma":0.0021648388,"threshold_uncertainty_score":0.9063984},"labels":[],"label_agreement":null},{"id":"W4402267024","doi":"10.1158/1538-7445.pediatric24-a055","title":"Abstract A055 YAP/TAZ induce a noradrenergic to mesenchymal transition through a core regulatory circuitry including FOSL2, TEAD4 and RUNX1 promoting invasion and chemoresistance in neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RUNX1; Cancer research; Neuroblastoma; Biology; Medicine; Transcription factor; Genetics; Gene; Cell culture","score_opus":0.09634687328767202,"score_gpt":0.37685258685554324,"score_spread":0.28050571356787124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194753,0.0065283463,0.000054595446,0.00066189404,0.0000891018,0.00037678028,0.000025505144,0.000030510919,0.00028574886],"genre_scores_gemma":[0.9985669,0.0005966314,0.000094122806,0.00012890414,0.00029747203,0.00013577388,0.000025276138,0.000046735615,0.00010813601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979706,0.00010658198,0.0002585145,0.0007876884,0.00037025576,0.0005063961],"domain_scores_gemma":[0.9993791,0.000059524897,0.0000308976,0.00025618484,0.00010333497,0.00017096053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009110307,0.00019656516,0.00019992117,0.00018733343,0.00020833526,0.00011862453,0.00016262423,0.0002091911,0.0000120827635],"category_scores_gemma":[0.00011715125,0.0001956219,0.000043258762,0.0004802525,0.00016920279,0.000025854577,0.00016314583,0.00050977606,0.0000034015789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011523977,0.000030660747,0.00029609844,0.00043497537,0.000018029983,0.000087981156,0.002434374,0.00006363635,0.9890207,0.0000832813,0.00011797992,0.007297025],"study_design_scores_gemma":[0.00062174274,0.0003517913,0.0062305075,0.0014676271,0.000011500537,0.000056918565,0.0005370899,0.00034899605,0.98715043,0.00064402306,0.0022093598,0.0003699881],"about_ca_topic_score_codex":0.00025337806,"about_ca_topic_score_gemma":0.0003263738,"teacher_disagreement_score":0.0069270367,"about_ca_system_score_codex":0.00009456753,"about_ca_system_score_gemma":0.00032204547,"threshold_uncertainty_score":0.797723},"labels":[],"label_agreement":null},{"id":"W4402267029","doi":"10.1158/1538-7445.pediatric24-b017","title":"Abstract B017: Aberrant translation of microproteins as a source of new cancer dependencies in medulloblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medulloblastoma; Translation (biology); Cancer; Medicine; Cancer research; Biology; Internal medicine; Genetics; Messenger RNA","score_opus":0.06967262658062738,"score_gpt":0.38449924806652597,"score_spread":0.3148266214858986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97015095,0.02774264,0.00010368115,0.00043326404,0.000071422466,0.0003471129,0.00004197746,0.000006766083,0.001102173],"genre_scores_gemma":[0.99621856,0.0020192682,0.00010340991,0.000015058984,0.00016744516,0.00011061498,0.000011060472,0.000022170962,0.0013324167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988227,0.0000625066,0.0002296325,0.00027967867,0.00033037955,0.0002751195],"domain_scores_gemma":[0.9995512,0.000029337203,0.000035128534,0.00019407054,0.00011585034,0.000074411735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987394,0.00009539318,0.00014297952,0.00015019483,0.000027678867,0.000018660854,0.00020145564,0.0001362235,0.00039708623],"category_scores_gemma":[0.00004770981,0.000087769426,0.000073348485,0.00028740423,0.00013023199,0.0000064369497,0.00004972182,0.00023728295,0.00000884666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020220884,0.000024893256,0.00047291158,0.00036183564,0.000036579782,0.0000052869523,0.0008888354,0.00010615813,0.9375715,0.000038167687,0.0005959191,0.059695683],"study_design_scores_gemma":[0.00030073282,0.00016194659,0.0013126092,0.0003939809,0.000004917068,0.0000031916038,0.00017518047,0.000037295467,0.9719952,0.00019150898,0.025335914,0.00008757575],"about_ca_topic_score_codex":0.01227762,"about_ca_topic_score_gemma":0.004481796,"teacher_disagreement_score":0.059608106,"about_ca_system_score_codex":0.000043252912,"about_ca_system_score_gemma":0.0010346997,"threshold_uncertainty_score":0.9942997},"labels":[],"label_agreement":null},{"id":"W4402267041","doi":"10.1158/1538-7445.pediatric24-a072","title":"Abstract A072 The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Medicine; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; Oncology; Biology; Signal transduction; Pathology; Sarcoma; Genetics","score_opus":0.10655166273614299,"score_gpt":0.4293892089708703,"score_spread":0.3228375462347273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8062964,0.16213307,0.0000010090398,0.021997228,0.00017259036,0.00074339844,0.000021154121,0.00005367371,0.008581469],"genre_scores_gemma":[0.9839731,0.011605379,0.00004520582,0.00028126143,0.00033874533,0.0010095829,0.000007526446,0.00003980002,0.0026994415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979205,0.00013544361,0.00022736072,0.0004334781,0.000738894,0.00054433243],"domain_scores_gemma":[0.9984625,0.00076553586,0.000017496333,0.0005139467,0.00011872521,0.000121806464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009082687,0.00015241522,0.00022304409,0.00023966725,0.00015104623,0.00012681156,0.00022661797,0.00007588177,0.00080180983],"category_scores_gemma":[0.00007234609,0.00008730658,0.00011369338,0.0007901041,0.00024733233,0.00008168986,0.000056007928,0.0006874453,0.00019259055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016776475,0.0017764755,0.18545403,0.00078205386,0.00063439243,0.0069705327,0.007719195,0.000008733639,0.056763913,0.017830059,0.1030745,0.61730844],"study_design_scores_gemma":[0.0016659886,0.00016680472,0.53569555,0.0013567162,0.000010077701,0.000013684672,0.0005150614,0.0000151471,0.03698372,0.002872809,0.42053643,0.00016801457],"about_ca_topic_score_codex":0.0006595486,"about_ca_topic_score_gemma":0.0012111189,"teacher_disagreement_score":0.6171405,"about_ca_system_score_codex":0.0004189315,"about_ca_system_score_gemma":0.00054722646,"threshold_uncertainty_score":0.8779255},"labels":[],"label_agreement":null},{"id":"W4402267044","doi":"10.1158/1538-7445.pediatric24-b066","title":"Abstract B066: Bridging patient reported outcomes and CTCAE to improve supportive care and trial design: The PROptimise initiative","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bridging (networking); Medicine; Family medicine; Nursing; Computer science","score_opus":0.6001958919793116,"score_gpt":0.5434753914052638,"score_spread":0.05672050057404776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508138,0.009579866,0.00044106296,0.032750245,0.0007603239,0.004083674,0.00032157052,0.000048253914,0.0012012242],"genre_scores_gemma":[0.99543655,0.00041644924,0.00036372748,0.0016035074,0.0003421063,0.0015084683,0.000009266586,0.00003777563,0.0002821586],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99641263,0.00037080195,0.0017728326,0.00074158004,0.00020058114,0.00050159363],"domain_scores_gemma":[0.9968345,0.0019252927,0.00040911665,0.00037461685,0.00020870384,0.00024776868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012096006,0.00016545694,0.00052978063,0.0003620392,0.00035848643,0.00037859927,0.00015886343,0.00009449908,0.00017043187],"category_scores_gemma":[0.0040541105,0.00014415421,0.00006243825,0.00028770094,0.00017206406,0.00032854886,0.00014763312,0.00044108258,0.0001271448],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012534272,0.0004846065,0.07066222,0.010534177,0.002993878,0.0003515625,0.46117473,0.0015431995,0.00047063341,0.041662466,0.23090373,0.16668454],"study_design_scores_gemma":[0.06050392,0.013481619,0.33245164,0.005189308,0.00023226925,0.000091433394,0.20323245,0.018900746,0.004087756,0.05449561,0.30131617,0.006017083],"about_ca_topic_score_codex":0.0017133047,"about_ca_topic_score_gemma":0.00012943026,"teacher_disagreement_score":0.2617894,"about_ca_system_score_codex":0.00076904934,"about_ca_system_score_gemma":0.00069018477,"threshold_uncertainty_score":0.5878438},"labels":[],"label_agreement":null},{"id":"W4402267050","doi":"10.1158/1538-7445.pediatric24-b075","title":"Abstract B075: The Open Single-cell Pediatric Cancer Atlas project: Collaborative analysis of pediatric tumor data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atlas (anatomy); Medicine; Cancer; Pediatric cancer; Oncology; Internal medicine; Anatomy","score_opus":0.19898528304021526,"score_gpt":0.4741819545754963,"score_spread":0.27519667153528105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8803942,0.10622957,0.0000047761005,0.002905573,0.00048078987,0.0023798968,0.0023106392,0.0000463073,0.0052482407],"genre_scores_gemma":[0.96721655,0.027268613,0.000045683413,0.00014983429,0.0013676591,0.0005661409,0.00018503972,0.000053456908,0.0031470214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967869,0.00021144959,0.00050941965,0.00079466176,0.0011332013,0.00056436314],"domain_scores_gemma":[0.99718386,0.00065047113,0.0001432481,0.0011957935,0.00070844183,0.00011820327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023254573,0.00021279552,0.0005149659,0.001102098,0.0002200408,0.0003113306,0.0015042765,0.000092696624,0.0019984888],"category_scores_gemma":[0.00014054803,0.00013625588,0.00015602296,0.013130076,0.00026747788,0.0003178657,0.00067573006,0.00068281294,0.000023230794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009602892,0.0014757903,0.08128186,0.0043633454,0.00946737,0.0004535651,0.007775536,0.0001770322,0.08201166,0.00014754073,0.76566124,0.037582166],"study_design_scores_gemma":[0.010505466,0.002663891,0.2085157,0.0011421132,0.021643497,0.000020018388,0.010884211,0.003047423,0.03836481,0.00008497231,0.70126134,0.0018665752],"about_ca_topic_score_codex":0.013400979,"about_ca_topic_score_gemma":0.0037453952,"teacher_disagreement_score":0.12723385,"about_ca_system_score_codex":0.0005466005,"about_ca_system_score_gemma":0.005948273,"threshold_uncertainty_score":0.9996871},"labels":[],"label_agreement":null},{"id":"W4402267052","doi":"10.1158/1538-7445.pediatric24-b077","title":"Abstract B077: M&amp;M: An RNA-seq based pan-cancer classifier for pediatric tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA-Seq; Pediatric cancer; Medicine; Cancer; Cancer research; Computational biology; Internal medicine; Biology; Transcriptome; Gene expression; Genetics; Gene","score_opus":0.13711448303257814,"score_gpt":0.47285723280174713,"score_spread":0.33574274976916896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733757,0.020976381,0.00029173,0.0012872536,0.00043591356,0.0010796073,0.0009280469,0.00005478211,0.0015706322],"genre_scores_gemma":[0.9855197,0.003703086,0.00014735262,0.00012728285,0.0023232761,0.0026645183,0.0003849975,0.00009335209,0.0050364346],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721843,0.00010196952,0.00022757944,0.0008544557,0.00063341536,0.00096412876],"domain_scores_gemma":[0.99859196,0.00009354563,0.000030798485,0.0005508108,0.0003621428,0.00037076054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069557107,0.00022355613,0.0001871705,0.0002647808,0.0002476936,0.00023939273,0.00042254213,0.00018150799,0.000727016],"category_scores_gemma":[0.00010871709,0.00019438857,0.0001755008,0.0004859788,0.00016823759,0.000019993364,0.00011133372,0.00039658783,0.00009302816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015798537,0.00038878847,0.00609445,0.0011119394,0.00032580542,0.00007749545,0.00009816624,0.00020916,0.76009375,0.00016650054,0.15200575,0.07784832],"study_design_scores_gemma":[0.0026291742,0.001190435,0.008921983,0.0002066892,0.00007233489,0.0000054679576,0.00008946415,0.00041180305,0.33636945,0.0007232639,0.64866596,0.0007139543],"about_ca_topic_score_codex":0.001870429,"about_ca_topic_score_gemma":0.002610025,"teacher_disagreement_score":0.49666023,"about_ca_system_score_codex":0.00027887023,"about_ca_system_score_gemma":0.00216962,"threshold_uncertainty_score":0.79603153},"labels":[],"label_agreement":null},{"id":"W4402267054","doi":"10.1158/1538-7445.pediatric24-b006","title":"Abstract B006: An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Mesenchymal stem cell; Gene; RNA-Seq; Gene expression; Biology; Computational biology; Cancer research; Genetics; Transcriptome; Cell culture","score_opus":0.157662350627585,"score_gpt":0.42040874401028666,"score_spread":0.26274639338270167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958808,0.0014312007,0.000026614882,0.00032856493,0.00018345162,0.0012345535,0.00007837836,0.000125083,0.000711342],"genre_scores_gemma":[0.99641895,0.0003431535,0.00023937716,0.000026398597,0.00013955239,0.00022451478,0.00009763949,0.0000831144,0.002427323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99596566,0.0002972601,0.00049381476,0.0009214983,0.0014788184,0.00084293267],"domain_scores_gemma":[0.9978869,0.00022023081,0.00006580161,0.0005635649,0.00042880635,0.0008346816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006848015,0.00028866253,0.00044061634,0.00045522468,0.00019581681,0.00014703292,0.00027759586,0.00014986341,0.00039234923],"category_scores_gemma":[0.00006392263,0.00021734166,0.00014218602,0.00055048737,0.0005583324,0.00034935173,0.00031922365,0.001076605,0.00004312426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014704433,0.0017464485,0.0015843775,0.0011626189,0.00012507408,0.0014851238,0.00041526114,0.00009855739,0.96891844,0.000034184,0.0025374424,0.020422019],"study_design_scores_gemma":[0.0031522058,0.009086321,0.002902743,0.0021724103,0.000074325166,0.000047943875,0.00036562394,0.0018439422,0.97758895,0.00052021944,0.0019301142,0.00031520982],"about_ca_topic_score_codex":0.00093502796,"about_ca_topic_score_gemma":0.00012324593,"teacher_disagreement_score":0.02010681,"about_ca_system_score_codex":0.00031290564,"about_ca_system_score_gemma":0.00066386047,"threshold_uncertainty_score":0.8862936},"labels":[],"label_agreement":null},{"id":"W4402267061","doi":"10.1158/1538-7445.pediatric24-a051","title":"Abstract A051 Genome-wide CRISPR/Cas9 library screening identified TP53 as a critical driver for resistance to EZH2 inhibitor in rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Genome; EZH2; Biology; Genetics; Medicine; Cancer research; Computational biology; Gene; Epigenetics","score_opus":0.046342135333935865,"score_gpt":0.4044556942213652,"score_spread":0.3581135588874293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800183,0.011783552,0.0019275316,0.0034982609,0.00031231533,0.0006264463,0.00015287455,0.000051485044,0.0016292091],"genre_scores_gemma":[0.987929,0.00045565786,0.0012242096,0.00047606876,0.0009853787,0.0005612032,0.00007396684,0.0000850863,0.008209439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975728,0.00008159246,0.0003382207,0.0007991434,0.00043281398,0.0007754444],"domain_scores_gemma":[0.9989587,0.00020034837,0.000019738067,0.00039781648,0.00017812729,0.00024527594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000715365,0.00018507129,0.00020118173,0.00023661685,0.0001528464,0.00027755921,0.00037851813,0.00016959234,0.00023282024],"category_scores_gemma":[0.00053947035,0.00018761987,0.00012768498,0.0004426456,0.00015195068,0.000028887329,0.00026840018,0.00040551412,0.00005816288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008964616,0.000057985242,0.00064973865,0.00094196625,0.00005671139,0.00013598846,0.0003972735,0.0004371766,0.921889,0.00041027577,0.06979348,0.004333931],"study_design_scores_gemma":[0.0007907892,0.0002825849,0.0052929367,0.0016802796,0.00001610784,0.000007783505,0.00047924515,0.0003636061,0.64281243,0.0020052004,0.34567773,0.0005912982],"about_ca_topic_score_codex":0.00014914728,"about_ca_topic_score_gemma":0.00028499332,"teacher_disagreement_score":0.27907658,"about_ca_system_score_codex":0.000115048606,"about_ca_system_score_gemma":0.00076155027,"threshold_uncertainty_score":0.7650916},"labels":[],"label_agreement":null},{"id":"W4402267067","doi":"10.1158/1538-7445.pediatric24-b003","title":"Abstract B003: Expanding therapeutic horizons: Unleashing the untapped potential of MEK inhibitor treatment in pediatric cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; New horizons; MEK inhibitor; Oncology; Internal medicine; Cancer research; MAPK/ERK pathway; Chemistry; Kinase","score_opus":0.04888439544571067,"score_gpt":0.40485437976079297,"score_spread":0.3559699843150823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509865,0.04714902,0.000019151435,0.00045529712,0.00026961786,0.00060166506,0.000077156634,0.0000113057895,0.0004302622],"genre_scores_gemma":[0.9749535,0.023206953,0.000007502656,0.000013415292,0.0007525453,0.00054175186,0.000033603104,0.00003498158,0.0004557504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980548,0.00015552384,0.0002287561,0.00045514654,0.00050489354,0.00060086907],"domain_scores_gemma":[0.99935263,0.00007967653,0.000032226868,0.00032760325,0.00009686112,0.00011101457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046453945,0.00016461105,0.00016170567,0.00024803117,0.00014603976,0.000103062564,0.00027506938,0.000098286655,0.00009511866],"category_scores_gemma":[0.00003367645,0.00011173786,0.000121759076,0.00061061856,0.00017020779,0.0000130439175,0.000109877896,0.00029232953,0.000014119803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009945569,0.00021448203,0.011714447,0.0003555722,0.0004955646,0.00016911367,0.0008226015,0.00067567895,0.8909547,0.00013104054,0.0023802726,0.091092005],"study_design_scores_gemma":[0.0049806396,0.0030472178,0.03253938,0.0005815454,0.0001601051,0.000022522125,0.0025157102,0.00031446552,0.9215153,0.0008230484,0.03278767,0.0007123911],"about_ca_topic_score_codex":0.008375776,"about_ca_topic_score_gemma":0.004804874,"teacher_disagreement_score":0.09037962,"about_ca_system_score_codex":0.0006964958,"about_ca_system_score_gemma":0.00151553,"threshold_uncertainty_score":0.99822754},"labels":[],"label_agreement":null},{"id":"W4402267071","doi":"10.1158/1538-7445.pediatric24-b038","title":"Abstract B038: RT-PCR and Interphase FISH reveal high frequencies of BCR-ABL in pediatric ALL patients in South-East Asia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fish <Actinopterygii>; Medicine; Interphase; Biology; Cancer research; Internal medicine; Genetics; Fishery","score_opus":0.058946916149883,"score_gpt":0.37735465087090014,"score_spread":0.31840773472101713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359703,0.003554594,3.4864314e-7,0.00058597175,0.00014219385,0.00064003794,0.00015869648,0.000021887094,0.0012992563],"genre_scores_gemma":[0.99757576,0.0012388284,0.00004167385,0.00004177329,0.00018452932,0.00014495774,0.000057819474,0.00003408039,0.0006805763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788094,0.00008799765,0.00040592876,0.0004544778,0.0006435808,0.0005270793],"domain_scores_gemma":[0.9991653,0.00018740947,0.000042489373,0.00028539757,0.00014573439,0.00017367055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005956903,0.00016003587,0.000328136,0.00072930666,0.000023115834,0.000034315653,0.00014640458,0.00012491785,0.00037532908],"category_scores_gemma":[0.00026683518,0.00013866974,0.000046568704,0.00076098286,0.00015058427,0.00013174783,0.00012741308,0.0007460882,0.00003592634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070916937,0.00050135935,0.9586133,0.002821872,0.00011022946,0.0010480337,0.008395174,0.000011743441,0.0035801309,0.00006761678,0.008632553,0.0155088315],"study_design_scores_gemma":[0.005413196,0.00045090762,0.9894583,0.001298423,0.000043224773,0.000007179236,0.00044933744,0.00006693222,0.0015248179,0.00014179063,0.0009864756,0.00015941891],"about_ca_topic_score_codex":0.0059726015,"about_ca_topic_score_gemma":0.0017794005,"teacher_disagreement_score":0.03084501,"about_ca_system_score_codex":0.0020768319,"about_ca_system_score_gemma":0.0011493491,"threshold_uncertainty_score":0.9028827},"labels":[],"label_agreement":null},{"id":"W4402267075","doi":"10.1158/1538-7445.pediatric24-a052","title":"Abstract A052 Project HOPE: A spatiotemporal single-cell landscape of high-grade gliomas in children, adolescents and young adults","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.04290059772305013,"score_gpt":0.3530126895421373,"score_spread":0.31011209181908717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830263,0.014995579,3.2002382e-7,0.00049739255,0.00008902261,0.0010107594,0.00007954307,0.000026552723,0.000274528],"genre_scores_gemma":[0.99821603,0.0012957361,0.000037590064,0.000011360958,0.00013546596,0.00016184027,0.000053034386,0.000030129057,0.00005882466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842405,0.000054273132,0.00023503622,0.00039486156,0.0005323491,0.00035944494],"domain_scores_gemma":[0.9994871,0.000046746038,0.00003106764,0.0002154723,0.00010527729,0.00011433839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029577868,0.00013531139,0.00025091504,0.0006203476,0.000037999434,0.000052715804,0.00007559017,0.000086192464,0.000063373845],"category_scores_gemma":[0.000035286677,0.000104938146,0.0000507431,0.0007583125,0.000094907904,0.000077231205,0.000063071304,0.0003314612,0.000013431467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004718844,0.0012785252,0.96059966,0.0013221237,0.00008673046,0.0005517305,0.0007109828,0.0000023499083,0.017675152,0.000021129825,0.0023986618,0.014881097],"study_design_scores_gemma":[0.0041773994,0.0005018726,0.932208,0.00336117,0.00003533057,0.000040413324,0.0001639264,0.00006001903,0.059033383,0.00002167105,0.00028092205,0.000115885596],"about_ca_topic_score_codex":0.0128826145,"about_ca_topic_score_gemma":0.001263665,"teacher_disagreement_score":0.041358232,"about_ca_system_score_codex":0.0001695545,"about_ca_system_score_gemma":0.0002783294,"threshold_uncertainty_score":0.99369067},"labels":[],"label_agreement":null},{"id":"W4402267081","doi":"10.1158/1538-7445.pediatric24-b025","title":"Abstract B025: Genome-wide study identifies novel genes associated with bone toxicities among children with acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; McMaster University","funders":"","keywords":"Lymphoblastic Leukemia; Gene; Medicine; Genome; Leukemia; Oncology; Genetics; Biology; Bioinformatics; Cancer research; Internal medicine","score_opus":0.047245678512884574,"score_gpt":0.36746738649605554,"score_spread":0.32022170798317096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929293,0.0041041053,0.0000147821,0.0002917525,0.00009652795,0.0017904763,0.00013366515,0.00016157955,0.00047785236],"genre_scores_gemma":[0.9905551,0.00048547055,0.000016817892,0.00006520326,0.0001294637,0.0006689057,0.0001061322,0.00008857422,0.007884299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696153,0.00006309398,0.00029940144,0.0006095205,0.0012094928,0.00085695816],"domain_scores_gemma":[0.9985914,0.00026182632,0.000057814064,0.0003770191,0.0003418475,0.00037008556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053890375,0.00026701094,0.00043972506,0.00040637577,0.00033692364,0.00019696991,0.00014103058,0.00010355669,0.00019339385],"category_scores_gemma":[0.000059268772,0.00017694708,0.000054340544,0.0008388919,0.00035719314,0.0002042141,0.00007622818,0.00057176454,0.00006975185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013087908,0.0007179232,0.9837696,0.00030702897,0.0043653282,0.002184927,0.0019102644,0.00006314825,0.0025627774,0.000007960247,0.00094236515,0.0018598789],"study_design_scores_gemma":[0.0035248687,0.0013288566,0.9913654,0.00080750586,0.00038035394,0.000061109444,0.0006647131,0.00003685886,0.0015558568,0.000011114952,0.000077978206,0.00018538508],"about_ca_topic_score_codex":0.0066719255,"about_ca_topic_score_gemma":0.007359185,"teacher_disagreement_score":0.007595791,"about_ca_system_score_codex":0.0017878067,"about_ca_system_score_gemma":0.0025312272,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W4402267084","doi":"10.1158/1538-7445.pediatric24-b039","title":"Abstract B039: Investigations on ethnographic disparities in molecular epidemiology of pediatric ALL and its impact on clinical outcome as well as cancer management planning strategies","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidemiology; Cancer; Medicine; Outcome (game theory); Pathology; Internal medicine","score_opus":0.25453766097337177,"score_gpt":0.5669495698385524,"score_spread":0.3124119088651806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97816604,0.012820348,0.000010210131,0.0039021524,0.00016121544,0.0008220891,0.0000455166,0.00004136174,0.004031069],"genre_scores_gemma":[0.9873547,0.010742312,0.00004949405,0.00056296017,0.00025359492,0.0003545671,0.000020838292,0.000046856218,0.0006146988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632955,0.0004897849,0.0007820471,0.0006643341,0.00088244054,0.0008518205],"domain_scores_gemma":[0.99546367,0.0034964331,0.00007757634,0.00036316022,0.00016625694,0.00043289879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003428552,0.00023585027,0.00059468765,0.0014128294,0.00007172071,0.000041939093,0.00026015093,0.00026405844,0.00034583485],"category_scores_gemma":[0.0011450979,0.00018103927,0.00015223143,0.0010771346,0.00053472543,0.00011915946,0.00017414487,0.0018056135,0.00013239264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018151376,0.00031050883,0.9419492,0.0041955616,0.0008708576,0.0026783047,0.0006162859,0.0095644295,0.0008101056,0.026333693,0.008982906,0.0018729983],"study_design_scores_gemma":[0.0027615642,0.0023331637,0.9734742,0.0022487412,0.00017244233,0.000020706493,0.0009265924,0.0031875635,0.00054354157,0.012947585,0.0010446662,0.0003392259],"about_ca_topic_score_codex":0.0044989954,"about_ca_topic_score_gemma":0.00009482427,"teacher_disagreement_score":0.031524997,"about_ca_system_score_codex":0.00084631797,"about_ca_system_score_gemma":0.0018381238,"threshold_uncertainty_score":0.7844593},"labels":[],"label_agreement":null},{"id":"W4402267104","doi":"10.1158/1538-7445.pediatric24-b018","title":"Abstract B018: Development of DNA methylation signature predictive of response to neoadjuvant chemotherapy in osteosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Osteosarcoma; DNA methylation; Chemotherapy; Oncology; Cancer research; Medicine; Neoadjuvant therapy; Signature (topology); Biology; Internal medicine; Computational biology; Cancer; Genetics; Breast cancer; Gene; Gene expression; Mathematics","score_opus":0.06265827325565324,"score_gpt":0.42199568287218475,"score_spread":0.3593374096165315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868924,0.00851104,0.00001970752,0.0032694598,0.0000654034,0.0008930627,0.000032208587,0.000016692651,0.00030002868],"genre_scores_gemma":[0.99851596,0.00024625155,0.000629329,0.00004192044,0.000046371493,0.00032953135,0.0000108034255,0.000023394714,0.00015641713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983292,0.00011350422,0.00033588088,0.00028582412,0.00067439064,0.00026115088],"domain_scores_gemma":[0.9988425,0.0005510854,0.000031481562,0.00021487566,0.0002487396,0.00011133303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013665899,0.00010614057,0.00027338628,0.00059751165,0.000027431184,0.000010669086,0.00009330327,0.00009294463,0.00026064776],"category_scores_gemma":[0.00014738721,0.00008227894,0.00005858981,0.00083568867,0.00006310524,0.00004616285,0.000042734224,0.00029149462,0.000014742813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068689575,0.0005069354,0.011477998,0.00039100638,0.0002101098,0.0001501224,0.008562755,0.000038101338,0.69531924,0.000052867832,0.00095395587,0.27546796],"study_design_scores_gemma":[0.0009592981,0.00032703212,0.4552934,0.001094127,0.000008994865,0.0000016131795,0.0003177563,0.000028049226,0.5374459,0.00005506303,0.0044202735,0.00004851871],"about_ca_topic_score_codex":0.000154057,"about_ca_topic_score_gemma":0.00008795131,"teacher_disagreement_score":0.44381538,"about_ca_system_score_codex":0.00059729174,"about_ca_system_score_gemma":0.0009708859,"threshold_uncertainty_score":0.33552378},"labels":[],"label_agreement":null},{"id":"W4402267106","doi":"10.1158/1538-7445.pediatric24-pr009","title":"Abstract PR009: Functional inhibition of natural killer cells enables surgery-induced accelerated neuroblastoma tumor growth in a mouse model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Cancer research; Medicine; Biology; Immunology; Cell culture; Genetics","score_opus":0.11046577908218343,"score_gpt":0.37113544822479044,"score_spread":0.26066966914260703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738467,0.0003362037,0.000004402768,0.0007539613,0.00029129523,0.00071095885,0.000047240206,0.00007829913,0.00039298594],"genre_scores_gemma":[0.99564475,0.0002538252,0.000019347079,0.00006973162,0.00012628979,0.00028568192,0.0000486743,0.000062059145,0.003489631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693865,0.00014081215,0.00038693863,0.0005583094,0.001231729,0.00074357545],"domain_scores_gemma":[0.99844265,0.00044990756,0.000038816153,0.0002288535,0.0005719062,0.0002678838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057423126,0.00020343067,0.00034488353,0.0012137133,0.00008687127,0.000084256826,0.000093411654,0.00008363649,0.00043696907],"category_scores_gemma":[0.00020938607,0.00016668842,0.0001380417,0.0012832236,0.00014877635,0.00030801777,0.000098623714,0.0010798087,0.00010188685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015398973,0.00039306932,0.0003579692,0.0007690063,0.00007759284,0.0010375455,0.000069731985,0.00024179883,0.9834364,0.000058990616,0.011040495,0.0009774736],"study_design_scores_gemma":[0.0011745037,0.00024345086,0.008391012,0.0006494599,0.000010334051,0.00002601954,0.000037102585,0.006980459,0.98213995,0.00013174154,0.000085477026,0.00013046646],"about_ca_topic_score_codex":0.0006570101,"about_ca_topic_score_gemma":0.00013843292,"teacher_disagreement_score":0.010955018,"about_ca_system_score_codex":0.00045820195,"about_ca_system_score_gemma":0.0016533429,"threshold_uncertainty_score":0.67973566},"labels":[],"label_agreement":null},{"id":"W4402267130","doi":"10.1158/1538-7445.pediatric24-a026","title":"Abstract A026 Cellular and zebrafish models for DICER1 related tumour predisposition (DRTP)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Biology; Cancer research; Genetic predisposition; Cancer; Medicine; Genetics; Gene","score_opus":0.07695344484637354,"score_gpt":0.3929571620628072,"score_spread":0.3160037172164336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96189594,0.022325957,0.00024587032,0.005786226,0.00021174415,0.0013862672,0.00012737556,0.00013556679,0.007885036],"genre_scores_gemma":[0.99465305,0.0007795579,0.00008411191,0.000052988875,0.0002482778,0.0005405244,0.000035331035,0.00004687964,0.0035593088],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99846494,0.000037769147,0.00023413595,0.00037309018,0.0004800405,0.00041005024],"domain_scores_gemma":[0.9990057,0.00035951915,0.00001641579,0.00017892737,0.00026488028,0.00017459899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074334303,0.0001222443,0.00022395556,0.00021285222,0.00015338806,0.00009456855,0.00007440158,0.0000976809,0.00024541988],"category_scores_gemma":[0.0001693586,0.00010359567,0.0000751189,0.00030945704,0.0001591671,0.00017075446,0.000084363935,0.00042421426,0.000055661618],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009864378,0.00024958057,0.0007335071,0.010833721,0.0013366608,0.0006662032,0.007904834,0.000118999706,0.80107534,0.0067293225,0.07140243,0.09796296],"study_design_scores_gemma":[0.017568512,0.0038840899,0.11257491,0.02119018,0.00218201,0.0003150162,0.0074994713,0.3371307,0.210462,0.16449076,0.11990368,0.0027986595],"about_ca_topic_score_codex":0.00017127067,"about_ca_topic_score_gemma":0.00004599895,"teacher_disagreement_score":0.59061337,"about_ca_system_score_codex":0.00022444296,"about_ca_system_score_gemma":0.00024098803,"threshold_uncertainty_score":0.42245087},"labels":[],"label_agreement":null},{"id":"W4402267132","doi":"10.1158/1538-7445.pediatric24-pr007","title":"Abstract PR007: Persistent poverty is associated with risk of early mortality among children with cancer: An analysis of SEER data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Poverty; Demography; Childhood cancer; Gerontology; Internal medicine; Economic growth; Sociology","score_opus":0.13439979842361816,"score_gpt":0.439753877542323,"score_spread":0.3053540791187048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913211,0.0022298596,0.000006354701,0.00023442594,0.00002520772,0.00073697296,0.0038466102,0.00004573687,0.001553729],"genre_scores_gemma":[0.9973072,0.0010905311,0.000008050834,0.000022304335,0.00006405407,0.000069994145,0.0007778207,0.00003416889,0.00062588684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968354,0.000117877506,0.00029830748,0.0006863921,0.0016457458,0.00041628993],"domain_scores_gemma":[0.99781203,0.00008356489,0.00014249113,0.0013088945,0.0004497324,0.0002032562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011084669,0.00017373102,0.000518396,0.00047770812,0.0000729279,0.00008172406,0.00045687155,0.00006723147,0.0015921317],"category_scores_gemma":[0.000059474616,0.000118535194,0.00014401814,0.0021221163,0.00049428974,0.00036042868,0.00018696283,0.0004516905,0.0000020033092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004022222,0.00025851635,0.9653322,0.0004411421,0.028313503,0.00004119679,0.00063585787,0.0010633322,0.00009553301,0.000028034063,0.0023591681,0.0010292951],"study_design_scores_gemma":[0.00083594985,0.00041716002,0.9844767,0.000753386,0.008349839,3.1911932e-7,0.00060256873,0.0041854517,0.00017088655,0.0000069440293,0.00007032171,0.00013048234],"about_ca_topic_score_codex":0.079986125,"about_ca_topic_score_gemma":0.02287148,"teacher_disagreement_score":0.05711465,"about_ca_system_score_codex":0.0005007366,"about_ca_system_score_gemma":0.0012903707,"threshold_uncertainty_score":0.99932057},"labels":[],"label_agreement":null},{"id":"W4402267138","doi":"10.1158/1538-7445.pediatric24-a045","title":"Abstract A045 Implementing ultra-sensitive, ctDNA-based liquid biopsy for disease monitoring in paediatric tumours","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Medicine; Disease monitoring; Biopsy; Disease; Oncology; Internal medicine; Cancer","score_opus":0.04314600574272282,"score_gpt":0.3899990083699611,"score_spread":0.3468530026272383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878164,0.009587256,0.00026306737,0.00071085396,0.0004698487,0.00048658112,0.00044800353,0.000015919399,0.00020205515],"genre_scores_gemma":[0.9958946,0.0015151246,0.00012549933,0.000048252386,0.0017071834,0.00043297262,0.00013144028,0.000049798018,0.00009509485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983191,0.000040383224,0.00022050619,0.0005086737,0.00023572097,0.00067562907],"domain_scores_gemma":[0.9991419,0.00021412567,0.000027267628,0.00024316987,0.00018029196,0.00019325233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007811553,0.00014043805,0.00011921161,0.0002261128,0.00012717933,0.00012320784,0.00017708697,0.000078994635,0.000023149165],"category_scores_gemma":[0.0002470931,0.0001470205,0.00011187476,0.000335236,0.00006941175,0.00000590725,0.00008128622,0.00022359905,0.00000744464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066689035,0.000059559217,0.012317416,0.00040787854,0.00003218398,0.00008712901,0.000064984626,0.00084563496,0.9760655,0.000078001845,0.0031996805,0.006175098],"study_design_scores_gemma":[0.0009592187,0.0002725076,0.018709637,0.0002738411,0.000028037308,0.0000017571897,0.00022777909,0.0004290928,0.93578976,0.00010780517,0.042818815,0.00038174313],"about_ca_topic_score_codex":0.0002950307,"about_ca_topic_score_gemma":0.00012449855,"teacher_disagreement_score":0.040275775,"about_ca_system_score_codex":0.00019912537,"about_ca_system_score_gemma":0.00092405494,"threshold_uncertainty_score":0.5995322},"labels":[],"label_agreement":null},{"id":"W4402267146","doi":"10.1158/1538-7445.pediatric24-ia026","title":"Abstract IA026: Are we ready to accelerate the development of new safe and effective anticancer medicines for children and adolescents?","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.22650553929480738,"score_gpt":0.533645390807665,"score_spread":0.30713985151285766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8953237,0.04690927,0.000057359004,0.055208728,0.00013852889,0.0019695524,0.000034649784,0.000015180962,0.00034305095],"genre_scores_gemma":[0.9877211,0.010874657,0.00013086117,0.0003934322,0.00042126255,0.00018198449,0.0000022812742,0.000015314261,0.00025912703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989197,0.000037616282,0.00016204236,0.00026351376,0.00033611123,0.00028098281],"domain_scores_gemma":[0.9989762,0.00054054253,0.000025370678,0.00009679386,0.00015417833,0.00020692061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087685225,0.000097353564,0.0002111062,0.0000710315,0.00017424798,0.00004394672,0.000074569936,0.000035472804,0.00007459728],"category_scores_gemma":[0.00022211735,0.000054702832,0.000018981556,0.00023756307,0.0001526009,0.000060389088,0.00011920821,0.00031358938,0.0000055082614],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019089457,0.000055338558,0.02525837,0.0024241053,0.0005202889,0.00000935584,0.004474653,0.0000012683251,0.0133816935,0.000070197915,0.05885005,0.8930457],"study_design_scores_gemma":[0.0010593385,0.0002023455,0.732223,0.0027104702,0.000096217474,0.0000059430777,0.0005632939,0.000020698883,0.01559291,0.00010824795,0.247323,0.00009455797],"about_ca_topic_score_codex":0.0002067344,"about_ca_topic_score_gemma":0.00017528296,"teacher_disagreement_score":0.8929512,"about_ca_system_score_codex":0.000080254336,"about_ca_system_score_gemma":0.00022202238,"threshold_uncertainty_score":0.22307166},"labels":[],"label_agreement":null},{"id":"W4402267147","doi":"10.1158/1538-7445.pediatric24-pr012","title":"Abstract PR012: MYOD1L122R induces chemoresistance and elevates cancer stem cell programs through WNT11-ROR2-VANGL2 signaling in aggressive rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Cancer research; Cancer; Medicine; Stem cell; Cancer stem cell; Biology; Internal medicine; Pathology; Sarcoma; Genetics","score_opus":0.04942078278328216,"score_gpt":0.3710482157573719,"score_spread":0.32162743297408974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87301016,0.12476492,0.0000146195725,0.0007308394,0.00024977603,0.0006250893,0.000041604857,0.00003196595,0.00053100503],"genre_scores_gemma":[0.98665214,0.010634638,0.00010032993,0.000030746603,0.0006305606,0.000670848,0.00006235002,0.00006878868,0.0011495871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975149,0.000114761504,0.00033215384,0.00084607373,0.00049494935,0.00069713383],"domain_scores_gemma":[0.999147,0.000061363906,0.00010655264,0.00032600993,0.00023776155,0.000121310164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005320732,0.0002556239,0.00023500717,0.00015325242,0.00015098359,0.00020249117,0.00027796873,0.0003034406,0.000063426094],"category_scores_gemma":[0.000024349521,0.00024101752,0.00007506581,0.00065754546,0.00035904368,0.000033602602,0.00017054465,0.0005664298,0.0000095723935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020767907,0.00005514229,0.001018045,0.0005548229,0.00007327608,0.00004275566,0.00064690935,0.00039695977,0.9246525,0.000059924136,0.0014191075,0.07087287],"study_design_scores_gemma":[0.00058522535,0.00013934624,0.0022827513,0.0011253011,0.0000144009455,0.00000692141,0.00046973833,0.000104371575,0.97813404,0.00033745074,0.016464187,0.00033628303],"about_ca_topic_score_codex":0.0008680023,"about_ca_topic_score_gemma":0.0011168715,"teacher_disagreement_score":0.11413028,"about_ca_system_score_codex":0.0002822172,"about_ca_system_score_gemma":0.00063602056,"threshold_uncertainty_score":0.9828409},"labels":[],"label_agreement":null},{"id":"W4402267154","doi":"10.1158/1538-7445.pediatric24-a044","title":"Abstract A044 Enhanced disease detection using single cell RNAseq in children with brain cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Disease; Medicine; Brain cancer; Cell; Computational biology; Oncology; Biology; Internal medicine; Genetics","score_opus":0.03113647400872957,"score_gpt":0.36094553280357194,"score_spread":0.32980905879484235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808777,0.017617945,0.00048617838,0.00014621012,0.000121491146,0.00043457135,0.0000852482,0.000024718485,0.0002059214],"genre_scores_gemma":[0.99801266,0.00037878228,0.0000530009,0.000058603557,0.0004960927,0.00020144472,0.000043329706,0.00006653357,0.0006895446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982396,0.00010956764,0.0001655428,0.00061682006,0.00036675736,0.00050173845],"domain_scores_gemma":[0.9992384,0.000021158368,0.00002891718,0.0003705207,0.000105799525,0.00023521663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034551948,0.00016174755,0.00010514866,0.00016451172,0.00010292657,0.000109373694,0.00022614362,0.000102864986,0.0001563839],"category_scores_gemma":[0.000059356167,0.00015095397,0.00006179604,0.00043358142,0.00017315244,0.00001578837,0.00010866686,0.0003489205,0.000014065735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029245383,0.0001018993,0.0045466507,0.00013035958,0.000039780363,0.00003660963,0.000040790917,0.001665923,0.98462206,0.0000025315258,0.00036550255,0.008155453],"study_design_scores_gemma":[0.00045063504,0.00009614645,0.017886218,0.00020801683,0.000017715813,0.000002814303,0.00003349663,0.00035903006,0.9790336,0.000046940244,0.0016363988,0.00022899303],"about_ca_topic_score_codex":0.00075053883,"about_ca_topic_score_gemma":0.0009854177,"teacher_disagreement_score":0.017239163,"about_ca_system_score_codex":0.00028300477,"about_ca_system_score_gemma":0.00070926896,"threshold_uncertainty_score":0.61557245},"labels":[],"label_agreement":null},{"id":"W4402267165","doi":"10.1158/1538-7445.pediatric24-b020","title":"Abstract B020: Improved outcome for patients with alternative lengthening of telomeres (ALT) neuroblastoma randomized to tandem myeloablative therapy on COG ANBL0532","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Cog; Medicine; Oncology; Internal medicine; Randomized controlled trial; Telomere; Biology; Genetics","score_opus":0.08066768923981135,"score_gpt":0.43188142934851087,"score_spread":0.35121374010869955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144834,0.00029410582,0.00007905311,0.0011110193,0.00015106442,0.005911228,0.00019987079,0.00006249727,0.00074279285],"genre_scores_gemma":[0.99642175,0.00025038183,0.00017506129,0.00017775365,0.00015529087,0.0016889942,0.000024433331,0.00009458303,0.0010117631],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966891,0.00024315763,0.00043934144,0.0006671933,0.0012092392,0.000751973],"domain_scores_gemma":[0.9949631,0.0033166914,0.00008358809,0.00034590522,0.00091113365,0.000379554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088115595,0.00028559254,0.00075176475,0.0006625229,0.00015345939,0.000078375844,0.00022127051,0.00006719276,0.00020855365],"category_scores_gemma":[0.00096097245,0.00017594456,0.00020857505,0.0006755826,0.00033088526,0.00013712702,0.00007528867,0.00061462197,0.00003945848],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7583773,0.0019344916,0.008317946,0.001092975,0.0037724816,0.00033140462,0.003664962,0.00013501987,0.09080885,0.0006236674,0.002050416,0.12889048],"study_design_scores_gemma":[0.44669065,0.035835788,0.100631334,0.0037269637,0.00022471277,0.000009247581,0.00033405607,0.0018633936,0.40306818,0.00073660014,0.0060684583,0.0008106169],"about_ca_topic_score_codex":0.00030947954,"about_ca_topic_score_gemma":0.000038811177,"teacher_disagreement_score":0.31225932,"about_ca_system_score_codex":0.00029934343,"about_ca_system_score_gemma":0.00045724754,"threshold_uncertainty_score":0.7174811},"labels":[],"label_agreement":null},{"id":"W4402267175","doi":"10.1158/1538-7445.pediatric24-pr001","title":"Abstract PR001: Inherited genetic variants in known cancer predisposition genes: A survey of the largest European cohort of patients under the age of 25 with whole genome sequencing data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetics; Cancer; Gene; Cohort; Biology; Genome; Genetic predisposition; Medicine; Internal medicine","score_opus":0.06719581834155527,"score_gpt":0.3435438883155789,"score_spread":0.2763480699740236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950994,0.006525949,0.000025672774,0.00003905448,0.0000636463,0.00044231923,0.0032933096,0.0000018604883,0.00009823677],"genre_scores_gemma":[0.99761707,0.0013550154,0.000013171244,0.000016881237,0.00005045236,0.000033752098,0.0008294011,0.000026733715,0.00005753657],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998599,0.0003282158,0.0002505122,0.00032182477,0.00029185918,0.00020858395],"domain_scores_gemma":[0.9988897,0.00003400066,0.00007380497,0.0006570393,0.0003102663,0.00003518569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000817364,0.00009330725,0.00012661613,0.000056936427,0.000051581585,0.000023049286,0.00059465977,0.00004750614,0.000022799983],"category_scores_gemma":[0.000043220825,0.000056497985,0.000029539262,0.0003658837,0.00022818043,0.0000068263075,0.00035818343,0.00014125547,7.135125e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014878962,0.000098842465,0.2845663,0.00028241763,0.00016518869,0.000010334274,0.00016050728,0.0019416721,0.7116587,0.000004588617,0.00014595466,0.0008166638],"study_design_scores_gemma":[0.00024538388,0.00007382526,0.99133545,0.0001875104,0.000021365613,7.746152e-7,0.000070784605,0.00009329444,0.007374973,0.000005611191,0.000523275,0.00006772185],"about_ca_topic_score_codex":0.005606183,"about_ca_topic_score_gemma":0.005562519,"teacher_disagreement_score":0.70676917,"about_ca_system_score_codex":0.000060226204,"about_ca_system_score_gemma":0.0007189116,"threshold_uncertainty_score":0.84749085},"labels":[],"label_agreement":null},{"id":"W4402267177","doi":"10.1158/1538-7445.pediatric24-ia015","title":"Abstract IA015: GD2-specific CAR T cell therapies for pediatric solid cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Solid tumor; Oncology; Cancer; Cancer research; Internal medicine","score_opus":0.12855894036498683,"score_gpt":0.4531213373343368,"score_spread":0.32456239696934996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8447252,0.13145822,0.00006936647,0.004184966,0.0012401897,0.0028751292,0.0002282295,0.00024660653,0.014972103],"genre_scores_gemma":[0.89529127,0.048213113,0.00011596187,0.000112824775,0.00508984,0.0015904005,0.00004175127,0.00019151498,0.04935331],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585,0.00010451107,0.00035905236,0.0008250447,0.0015135036,0.0013478594],"domain_scores_gemma":[0.9973523,0.0008046612,0.000031104188,0.00067226344,0.0007004879,0.00043919566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018460515,0.00026304368,0.00041208978,0.00083643006,0.00028379727,0.00026618008,0.00041654182,0.00020391426,0.012238909],"category_scores_gemma":[0.000064076405,0.00022156417,0.00028589126,0.001383234,0.00030613938,0.00014579583,0.00010447376,0.0013488954,0.0004048342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013118809,0.00011309171,0.0007697709,0.0024430898,0.00021683647,0.00027462264,0.0021870083,0.000040104107,0.67046726,0.00023130699,0.24070905,0.08123595],"study_design_scores_gemma":[0.0017024723,0.0006123859,0.0016419732,0.00020939093,0.000045647594,0.000016737706,0.00087273814,0.00017460612,0.098769985,0.00043016043,0.8952105,0.0003134192],"about_ca_topic_score_codex":0.0010932621,"about_ca_topic_score_gemma":0.00017824779,"teacher_disagreement_score":0.65450144,"about_ca_system_score_codex":0.001958029,"about_ca_system_score_gemma":0.0028726077,"threshold_uncertainty_score":0.98866403},"labels":[],"label_agreement":null},{"id":"W4402267180","doi":"10.1158/1538-7445.pediatric24-a012","title":"Abstract A012 Unravelling the role of METTL1 in Myc driven pediatric cancers using CRISPR Cas13d","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Cancer; Medicine; Biology; Cancer research; Computational biology; Genetics; Gene","score_opus":0.10901779373650294,"score_gpt":0.4285785326745884,"score_spread":0.31956073893808545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8700602,0.12544961,0.000011005496,0.0013783342,0.00028200782,0.00043125503,0.000024559202,0.000024782024,0.0023382164],"genre_scores_gemma":[0.99248433,0.006137022,0.000050299812,0.000048419468,0.00092240307,0.00010090233,0.0000030756105,0.000037777696,0.00021579649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979697,0.00007422785,0.00031069244,0.0003706434,0.0007130432,0.0005616846],"domain_scores_gemma":[0.9989988,0.00031837227,0.000036528232,0.00031324636,0.00022728216,0.00010575018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007859505,0.00014632754,0.0003050346,0.0004677313,0.00013630412,0.000047553156,0.00020533294,0.00007821082,0.00024108328],"category_scores_gemma":[0.00007913298,0.00010357423,0.00012107837,0.0013919297,0.00019768687,0.00009273632,0.0001179077,0.0008264003,0.000016220092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008727168,0.00018153625,0.7151574,0.0053031077,0.00093091954,0.00093366863,0.034837816,0.0039138882,0.17586917,0.0010142366,0.011480909,0.049504634],"study_design_scores_gemma":[0.0039437795,0.0006471522,0.75194526,0.004591451,0.0009787842,0.00011576522,0.028899135,0.018008024,0.13002826,0.002476013,0.057206176,0.0011602042],"about_ca_topic_score_codex":0.01844488,"about_ca_topic_score_gemma":0.0020784412,"teacher_disagreement_score":0.12242407,"about_ca_system_score_codex":0.00096591935,"about_ca_system_score_gemma":0.0013445538,"threshold_uncertainty_score":0.9880914},"labels":[],"label_agreement":null},{"id":"W4402267218","doi":"10.1158/1538-7445.pediatric24-b002","title":"Abstract B002: A novel NTRK2-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tyrosine kinase; Receptor tyrosine kinase; Chemistry; Mechanism (biology); Cell biology; Cancer research; Receptor; Biochemistry; Biology; Philosophy","score_opus":0.16115813381259803,"score_gpt":0.4563875239758575,"score_spread":0.2952293901632595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768669,0.0013363519,0.0048463107,0.012689944,0.0004846458,0.0014660836,0.00008675416,0.00016214966,0.0020608453],"genre_scores_gemma":[0.99263227,0.0009110657,0.0007821021,0.000100489895,0.001480251,0.00039506098,0.0000618609,0.00009383761,0.003543078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965245,0.000081350154,0.00051232334,0.00064666476,0.0015697498,0.00066539977],"domain_scores_gemma":[0.9978749,0.00041883823,0.00011034866,0.00050840597,0.0007225089,0.00036497877],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015724085,0.0002096422,0.00036765853,0.00064166303,0.00012908313,0.00015755187,0.0003212982,0.0001911778,0.003106777],"category_scores_gemma":[0.00084329344,0.00018809082,0.00011915389,0.0013149674,0.00017008629,0.00034434863,0.00017238723,0.0013088385,0.00012634452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047766438,0.00012090157,0.00024574233,0.0008542194,0.000096558884,0.000012050344,0.0006874779,0.0000022679105,0.89595276,0.0018824657,0.006133136,0.093534775],"study_design_scores_gemma":[0.0010532232,0.00037715904,0.008951449,0.004357962,0.000014713535,0.000013204779,0.00021797676,0.0007606614,0.9433947,0.0003891548,0.040290166,0.00017960566],"about_ca_topic_score_codex":0.0032808192,"about_ca_topic_score_gemma":0.00004323409,"teacher_disagreement_score":0.093355164,"about_ca_system_score_codex":0.0013813053,"about_ca_system_score_gemma":0.0023012424,"threshold_uncertainty_score":0.9978045},"labels":[],"label_agreement":null},{"id":"W4402267241","doi":"10.1158/1538-7445.pediatric24-b045","title":"Abstract B045: Addressing pediatric cancer disparities in Ghana, Sub-Saharan Africa: A call to action","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Call to action; Medicine; Cancer; Environmental health; Internal medicine; Business","score_opus":0.34894250338845695,"score_gpt":0.5588470957876999,"score_spread":0.20990459239924292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465335,0.034509238,0.000011473608,0.0138648655,0.0018403246,0.0012992802,0.00016238375,0.00013132939,0.0016476159],"genre_scores_gemma":[0.97771454,0.014321869,0.000011940828,0.0004818427,0.0036250304,0.00040307225,0.0000104839255,0.000055665125,0.0033755798],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9963897,0.00046213975,0.00047776065,0.0005584501,0.000714868,0.0013971237],"domain_scores_gemma":[0.9984453,0.0006328573,0.000045465094,0.00026716798,0.0001985564,0.00041067155],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018418431,0.00016955768,0.00027540722,0.0007736387,0.0007301013,0.00008308201,0.00024757837,0.00020419528,0.0008460835],"category_scores_gemma":[0.00018921519,0.00014915022,0.000057934925,0.0015418287,0.000058937447,0.00023266097,0.00016231868,0.0027097748,0.0004535285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004953662,0.00019814313,0.09693976,0.013924187,0.00003173531,0.00014450535,0.013536416,0.00010795035,0.008358347,0.00051433855,0.8011226,0.06462668],"study_design_scores_gemma":[0.0014059343,0.000108869164,0.79779935,0.015034213,0.000032739306,0.000001379625,0.0039519686,0.0003195344,0.0010909088,0.0005040392,0.17905246,0.0006986327],"about_ca_topic_score_codex":0.018056924,"about_ca_topic_score_gemma":0.027273536,"teacher_disagreement_score":0.70085955,"about_ca_system_score_codex":0.0019029045,"about_ca_system_score_gemma":0.0026773138,"threshold_uncertainty_score":0.999591},"labels":[],"label_agreement":null},{"id":"W4402267246","doi":"10.1158/1538-7445.pediatric24-b047","title":"Abstract B047: Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leukemia; CD19; Lymphoblastic Leukemia; Cancer research; Medicine; Biology; Immunology; Antigen","score_opus":0.052705287333144335,"score_gpt":0.3661746427095858,"score_spread":0.31346935537644144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082947,0.0035008811,0.000005859469,0.00077134394,0.00006274995,0.0010281762,0.00010234036,0.00010103533,0.0035981736],"genre_scores_gemma":[0.98924,0.00034182973,0.000037441987,0.00006794936,0.00036598346,0.0002163639,0.00009985036,0.0000973847,0.009533234],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99605954,0.0001627992,0.00022652456,0.0006680127,0.0019353804,0.00094773085],"domain_scores_gemma":[0.99864334,0.00036883308,0.000023785704,0.00030539915,0.00038799556,0.00027063338],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014466376,0.00022615188,0.00033121812,0.0006493654,0.00016217829,0.00016261397,0.00025022417,0.00019802335,0.004267388],"category_scores_gemma":[0.00007660097,0.00016495114,0.00009373996,0.0015603428,0.0004033614,0.00014438175,0.0000379455,0.0025455279,0.00004169955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014962411,0.00013122374,0.04496938,0.00025414088,0.00070823485,0.0005645692,0.0012707466,0.0007827245,0.9414727,0.00009023132,0.0031892313,0.0050705518],"study_design_scores_gemma":[0.0062566465,0.0015219947,0.88756806,0.004259008,0.00012314763,0.00010681013,0.0010180945,0.0009873497,0.0909213,0.000073024414,0.006522847,0.00064170395],"about_ca_topic_score_codex":0.0033708331,"about_ca_topic_score_gemma":0.0017470887,"teacher_disagreement_score":0.8505514,"about_ca_system_score_codex":0.0025803044,"about_ca_system_score_gemma":0.0028632502,"threshold_uncertainty_score":0.9997556},"labels":[],"label_agreement":null},{"id":"W4402267265","doi":"10.1158/1538-7445.pediatric24-b019","title":"Abstract B019: Characterization of the extracellular vesicle proteome in Li-Fraumeni Syndrome","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Extracellular vesicles; Extracellular vesicle; Extracellular; Proteome; Li–Fraumeni syndrome; Computational biology; Biology; Cancer research; Cell biology; Chemistry; Genetics; Microvesicles; Gene; Mutation; Germline mutation; microRNA","score_opus":0.050828818401081784,"score_gpt":0.3611713147513236,"score_spread":0.3103424963502418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102837,0.0037910736,0.000048780388,0.002713195,0.0003048927,0.0013788424,0.00003321341,0.000040011186,0.00066164276],"genre_scores_gemma":[0.99710244,0.00033222322,0.000014470844,0.000027437196,0.000104942046,0.0003224436,0.000015464477,0.000046421075,0.0020341678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981547,0.000094135954,0.0002973494,0.00033045808,0.00074635923,0.00037701568],"domain_scores_gemma":[0.9992242,0.00004492362,0.00003927855,0.0004567675,0.00014165284,0.00009319496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008120329,0.000107303276,0.00019867605,0.0003029556,0.000053119653,0.00003806699,0.00019786666,0.00012938248,0.00057803845],"category_scores_gemma":[0.00009684627,0.00008175237,0.00008713827,0.0013322659,0.00016279108,0.000102906095,0.00009301836,0.0008690213,0.000077878976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083932806,0.000066062115,0.00050220697,0.0006535465,0.00003459439,0.00027365613,0.00036808246,0.000021890777,0.9929881,0.00020658787,0.0001322511,0.0046690996],"study_design_scores_gemma":[0.00080404227,0.0001970824,0.14451975,0.003088554,0.00002475828,0.00008906575,0.000069682406,0.0005867641,0.83445907,0.00016753981,0.015853297,0.00014038503],"about_ca_topic_score_codex":0.0003567848,"about_ca_topic_score_gemma":0.000036200654,"teacher_disagreement_score":0.15852901,"about_ca_system_score_codex":0.0005847921,"about_ca_system_score_gemma":0.0008478393,"threshold_uncertainty_score":0.6329116},"labels":[],"label_agreement":null},{"id":"W4402267281","doi":"10.1158/1538-7445.pediatric24-b014","title":"Abstract B014: Increasing the clinical utility of transcriptome analysis in high-risk childhood precision oncology","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Transcriptome; Medicine; Oncology; Clinical Oncology; Internal medicine; Computational biology; Bioinformatics; Cancer; Biology; Genetics; Gene; Gene expression","score_opus":0.058514397793801506,"score_gpt":0.43908611632910105,"score_spread":0.38057171853529953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883281,0.009783951,0.00013987266,0.00045528013,0.00027692138,0.00026010492,0.00021243797,0.000004921246,0.0005384344],"genre_scores_gemma":[0.9848192,0.0145699065,0.00007462537,0.00004332139,0.00035135844,0.000048536003,0.000045774057,0.000015280006,0.00003202802],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99809414,0.00040465352,0.0004583443,0.00045914005,0.0002765991,0.00030712833],"domain_scores_gemma":[0.9984482,0.0007910335,0.000055364795,0.00046842507,0.00015040321,0.00008655322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004620003,0.00009904173,0.00026516998,0.00019666574,0.00007528576,0.000038578906,0.00034166608,0.00020902892,0.0001602517],"category_scores_gemma":[0.0006982376,0.00007388395,0.0002180306,0.0007520441,0.0002963699,0.0000037607117,0.00014153229,0.00060053694,0.00000603393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001793672,0.00084530923,0.31606805,0.00016648507,0.0017900874,0.0000447513,0.0010266225,0.0013927694,0.16549039,0.00036518008,0.0077705327,0.5032461],"study_design_scores_gemma":[0.0006217426,0.0003663172,0.95154107,0.000060514132,0.00016370146,0.0000019046789,0.0001525148,0.00041976944,0.01696441,0.0010326324,0.028544562,0.00013085411],"about_ca_topic_score_codex":0.0056016142,"about_ca_topic_score_gemma":0.0055492255,"teacher_disagreement_score":0.635473,"about_ca_system_score_codex":0.000072930074,"about_ca_system_score_gemma":0.000817995,"threshold_uncertainty_score":0.84680027},"labels":[],"label_agreement":null},{"id":"W4402267314","doi":"10.1158/1538-7445.pediatric24-a005","title":"Abstract A005 <i>TP53</i> variant clusters stratify the Li-Fraumeni spectrum and reveal an osteosarcoma-prone subgroup","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Osteosarcoma; Li–Fraumeni syndrome; Medicine; Cancer; Oncology; Internal medicine; Cancer research; Biology; Genetics; Gene; Mutation; Germline mutation","score_opus":0.05633931005505957,"score_gpt":0.38043898350279864,"score_spread":0.32409967344773905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93756944,0.022316784,0.00014154913,0.028458254,0.00076858094,0.0019232347,0.00010700227,0.00020951238,0.008505631],"genre_scores_gemma":[0.9948502,0.0014081661,0.00010741929,0.00042437666,0.0010305055,0.00024283488,0.000038633858,0.00009841039,0.0017994506],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669534,0.000217088,0.00034879785,0.00077656255,0.0010792242,0.0008829958],"domain_scores_gemma":[0.99834394,0.0002149611,0.000038704944,0.0008350356,0.00012924035,0.00043814114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017611152,0.00025252302,0.00030748502,0.00025858302,0.00030414428,0.00032371425,0.00031831075,0.00017563821,0.0005518743],"category_scores_gemma":[0.00007408888,0.00018222492,0.00010004012,0.00077019073,0.00048570617,0.00020857475,0.00019014542,0.0019393563,0.00010981876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018965073,0.00037757764,0.00045367616,0.0020781762,0.0007565038,0.006438289,0.0053192573,0.0001371898,0.79874206,0.005286143,0.056402914,0.12211172],"study_design_scores_gemma":[0.017447943,0.011882557,0.08337755,0.010328165,0.0013982507,0.0069838604,0.008359098,0.012082745,0.3450953,0.012472364,0.4869629,0.0036092505],"about_ca_topic_score_codex":0.0021707634,"about_ca_topic_score_gemma":0.0016503186,"teacher_disagreement_score":0.45364675,"about_ca_system_score_codex":0.00057407096,"about_ca_system_score_gemma":0.0011276886,"threshold_uncertainty_score":0.8425646},"labels":[],"label_agreement":null},{"id":"W4402267315","doi":"10.1158/1538-7445.pediatric24-b044","title":"Abstract B044: Dosimetric association between critical brain structure dose and scholastic achievement in pediatric brain tumor survivors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brain tumor; Association (psychology); Nuclear medicine; Internal medicine; Oncology; Psychology; Pathology; Psychotherapist","score_opus":0.04827298422578002,"score_gpt":0.4168550241092346,"score_spread":0.36858203988345456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681512,0.0074582514,0.0000015689003,0.023327785,0.00019099207,0.00056231505,0.00013926986,0.000038401424,0.00013022822],"genre_scores_gemma":[0.998387,0.00043079874,0.00002690694,0.00016840339,0.0006464006,0.00013205005,0.000035223755,0.00003336096,0.000139854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973645,0.00020001871,0.0002957206,0.00050055963,0.0010187961,0.00062038156],"domain_scores_gemma":[0.9952368,0.0040953024,0.00002692047,0.000184091,0.00016441225,0.00029245237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016206701,0.00016461006,0.00029487317,0.0011784375,0.00011393803,0.00021071009,0.000093350005,0.00013398947,0.0003207085],"category_scores_gemma":[0.0028454233,0.00013441013,0.000057320514,0.0019827578,0.00005874177,0.00014667571,0.00008983491,0.000962258,0.00005142465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052959025,0.00018404734,0.9808494,0.0007051764,0.00010166596,0.0004752896,0.00017849349,0.0000048045813,0.0030291511,0.00023103987,0.006520416,0.007667556],"study_design_scores_gemma":[0.0011276116,0.00023486384,0.99500626,0.00021489727,0.00008287817,0.000004340768,0.000044810382,0.000038780483,0.0010815727,0.00039671522,0.0016522899,0.00011496848],"about_ca_topic_score_codex":0.0011754216,"about_ca_topic_score_gemma":0.00056942913,"teacher_disagreement_score":0.030235812,"about_ca_system_score_codex":0.0012488194,"about_ca_system_score_gemma":0.00037612967,"threshold_uncertainty_score":0.54810864},"labels":[],"label_agreement":null},{"id":"W4402267325","doi":"10.1158/1538-7445.pediatric24-a047","title":"Abstract A047 Synergy between polarized dendritic cells, radiation and PD-1 blockade in effective treatment of rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Rhabdomyosarcoma; Medicine; Cancer research; PD-L1; Cancer; Internal medicine; Immunotherapy; Pathology; Sarcoma; Receptor","score_opus":0.04776069463017718,"score_gpt":0.3975310001460988,"score_spread":0.34977030551592164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94988394,0.047575437,0.0000024641072,0.0012045326,0.00007869285,0.00095809967,0.00006154817,0.00002230774,0.00021295191],"genre_scores_gemma":[0.9941481,0.0048124883,0.000037801245,0.000008950844,0.00021073116,0.00060378946,0.000026010286,0.000026264555,0.00012588719],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985704,0.00012757319,0.00023098952,0.00035172125,0.0003726586,0.00034668256],"domain_scores_gemma":[0.9985004,0.0010588985,0.000021879818,0.00019568132,0.000070012014,0.00015313325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003017222,0.00014108676,0.00037481546,0.0004569981,0.00006055097,0.00004645349,0.000046959667,0.00009548709,0.00010558524],"category_scores_gemma":[0.000042438125,0.00010847214,0.00008150302,0.0004362604,0.00014014512,0.000057186404,0.000026130643,0.00019785548,0.000019674295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003962734,0.0010359568,0.38985708,0.0007883215,0.00068594463,0.0010113033,0.0015618178,0.0000050321646,0.16231564,0.00022571566,0.00020666598,0.44191027],"study_design_scores_gemma":[0.00328164,0.0008428899,0.71892995,0.000664381,0.00013317037,0.0000103782095,0.00011036481,0.00006554454,0.2723871,0.00017246792,0.003305405,0.00009674832],"about_ca_topic_score_codex":0.0056076404,"about_ca_topic_score_gemma":0.00024536386,"teacher_disagreement_score":0.44181353,"about_ca_system_score_codex":0.0008945846,"about_ca_system_score_gemma":0.00029539247,"threshold_uncertainty_score":0.84771127},"labels":[],"label_agreement":null},{"id":"W4402267334","doi":"10.1158/1538-7445.pediatric24-ia016","title":"Abstract IA016: Mapping microglia – tumor crosstalk in pediatric brain cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crosstalk; Microglia; Medicine; Cancer; Oncology; Internal medicine; Inflammation; Engineering","score_opus":0.08257278667280911,"score_gpt":0.4338469163276648,"score_spread":0.3512741296548557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9352549,0.05191381,7.344838e-7,0.009856207,0.0003787386,0.00061206415,0.0000727509,0.000060267233,0.0018505256],"genre_scores_gemma":[0.9924173,0.0036463994,0.00002964797,0.00029556433,0.0008307406,0.0009753196,0.000013300879,0.00004758137,0.0017441919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978837,0.00004892575,0.00026300774,0.000514851,0.0005767516,0.0007127724],"domain_scores_gemma":[0.99905145,0.00029854506,0.000021310148,0.00026703574,0.00014586953,0.0002158138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067646883,0.00015924415,0.00025348453,0.00072813145,0.00009962374,0.00015493915,0.0001287946,0.00007354305,0.0020228683],"category_scores_gemma":[0.00010500108,0.00012899711,0.00010096656,0.0013617194,0.00009515503,0.000097819815,0.00008304545,0.00062474475,0.0003171841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025772696,0.0007262099,0.4825354,0.0034199648,0.00024296278,0.012748661,0.0020311007,0.000055468063,0.18043485,0.00026575386,0.2637773,0.053504616],"study_design_scores_gemma":[0.0027349633,0.00017106977,0.7779636,0.0019157825,0.000057105466,0.000056867,0.0003594738,0.0001320747,0.03900975,0.00025150078,0.17702168,0.00032614768],"about_ca_topic_score_codex":0.004133504,"about_ca_topic_score_gemma":0.0015716578,"teacher_disagreement_score":0.2954282,"about_ca_system_score_codex":0.0009733616,"about_ca_system_score_gemma":0.000983326,"threshold_uncertainty_score":0.99888945},"labels":[],"label_agreement":null},{"id":"W4402267340","doi":"10.1158/1538-7445.pediatric24-a074","title":"Abstract A074 Uncovering chemoresistance mechanisms in CIC-DUX4 sarcoma using a novel xenograft model","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Sarcoma; Cancer research; Cancer; Medicine; Internal medicine; Pathology","score_opus":0.16099948085298305,"score_gpt":0.43785230826791893,"score_spread":0.2768528274149359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98072207,0.014277089,0.0011654893,0.0013507693,0.0001427305,0.00059289427,0.000050780553,0.00007832063,0.0016198475],"genre_scores_gemma":[0.9943698,0.0009494707,0.003711225,0.000115090734,0.00014102603,0.00030375106,0.00000885588,0.00006551749,0.00033527572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766165,0.000022785269,0.00027219608,0.000553508,0.0008053587,0.0006844762],"domain_scores_gemma":[0.9991137,0.00016819891,0.000021941843,0.00037805768,0.00012726006,0.0001908718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005065621,0.00018938021,0.00030700117,0.0004372621,0.00010471688,0.00011473215,0.00015361942,0.000105722786,0.0002501716],"category_scores_gemma":[0.00005702278,0.00016350612,0.00011546146,0.0008525299,0.00008509159,0.00013958932,0.0001117268,0.00058984896,0.000039570165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006326152,0.0013137048,0.006505939,0.0017857639,0.00032838626,0.0023966301,0.0011673786,0.009649792,0.9353194,0.008491201,0.0013693256,0.031039855],"study_design_scores_gemma":[0.011448208,0.0005053528,0.06236558,0.01718317,0.00029340305,0.00025306226,0.0013278547,0.33528584,0.53688467,0.02358341,0.00936293,0.0015065342],"about_ca_topic_score_codex":0.0015547913,"about_ca_topic_score_gemma":0.0005118601,"teacher_disagreement_score":0.39843476,"about_ca_system_score_codex":0.001399438,"about_ca_system_score_gemma":0.00074190117,"threshold_uncertainty_score":0.6667586},"labels":[],"label_agreement":null},{"id":"W4402267369","doi":"10.1158/1538-7445.pediatric24-a014","title":"Abstract A014 INO80-complex N-terminal module resolves replication stress in PAX3-FOXO1 positive rhabdomyosarcoma and exposes therapeutic vulnerability","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vulnerability (computing); Replication (statistics); Alveolar rhabdomyosarcoma; Cancer research; Biology; Rhabdomyosarcoma; Medicine; Computer science; Computer security; Virology; Pathology; Sarcoma","score_opus":0.07728772227849243,"score_gpt":0.42455506672862275,"score_spread":0.3472673444501303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821242,0.016053015,0.00006104138,0.00057782995,0.000060122882,0.0004409815,0.00019110962,0.000021036745,0.0004706447],"genre_scores_gemma":[0.9981845,0.0008559473,0.000043780707,0.000067578185,0.00024324356,0.0002884966,0.00013056876,0.000026861062,0.00015904283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800557,0.0002526107,0.00022031814,0.0008170535,0.00031833726,0.00038608751],"domain_scores_gemma":[0.99888915,0.0001202491,0.000026667381,0.00069831713,0.00015081503,0.00011478124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007149994,0.00014948506,0.00014207695,0.00014035768,0.00012432571,0.00014072898,0.0002728462,0.000120117285,0.00009128881],"category_scores_gemma":[0.00017899381,0.000142813,0.0000631225,0.00024186079,0.00037649128,0.000015934651,0.0002006513,0.00031659383,0.000006359184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020390494,0.00012548002,0.019821832,0.00027603604,0.000055705514,0.000054172786,0.00017238609,0.0000225916,0.91163266,0.00023153104,0.00060449797,0.06679923],"study_design_scores_gemma":[0.00038523827,0.00019638319,0.41263813,0.0002436716,0.000012433743,0.000023448953,0.00023527516,0.0002479025,0.57694924,0.0015559788,0.0072522624,0.00026002162],"about_ca_topic_score_codex":0.00039651274,"about_ca_topic_score_gemma":0.0003873726,"teacher_disagreement_score":0.3928163,"about_ca_system_score_codex":0.000121760335,"about_ca_system_score_gemma":0.00024263823,"threshold_uncertainty_score":0.5823745},"labels":[],"label_agreement":null},{"id":"W4402267375","doi":"10.1158/1538-7445.pediatric24-b009","title":"Abstract B009: The Dutch childhood cancer genome project: Data-driven precision medicine and research","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Childhood cancer; Precision medicine; Cancer; Medicine; Genome; Family medicine; Computational biology; Genetics; Biology; Internal medicine; Pathology","score_opus":0.26822439667909415,"score_gpt":0.521125321111974,"score_spread":0.2529009244328798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6530453,0.25945768,0.000007869234,0.07469127,0.0008153217,0.003626613,0.0004199963,0.00013994935,0.007796041],"genre_scores_gemma":[0.89034146,0.09892461,0.000040805033,0.00042104526,0.002902531,0.00077941496,0.000120670644,0.0000917853,0.006377705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950335,0.00034387724,0.00041892644,0.0010271759,0.002235013,0.00094150647],"domain_scores_gemma":[0.99667346,0.0011191315,0.000037025093,0.0013960201,0.0005588601,0.00021550921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007003074,0.00022381192,0.0003561097,0.00070953683,0.0006163668,0.00023782074,0.0007541402,0.00016949943,0.002643552],"category_scores_gemma":[0.00040220912,0.00012657202,0.00006552079,0.0022223261,0.0014445202,0.00025803078,0.0006555485,0.0020281696,0.000054718705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028821963,0.00019849185,0.0008271802,0.0013943836,0.00090907037,0.0003613221,0.012008494,0.0000053287213,0.19563879,0.0002742037,0.3117993,0.47370127],"study_design_scores_gemma":[0.0019796914,0.00063923013,0.08110123,0.003124335,0.00007728171,0.000106031126,0.002212915,0.00043942314,0.001487306,0.0003191686,0.9082806,0.00023279393],"about_ca_topic_score_codex":0.012048641,"about_ca_topic_score_gemma":0.0011417352,"teacher_disagreement_score":0.5964813,"about_ca_system_score_codex":0.00062908186,"about_ca_system_score_gemma":0.0023839918,"threshold_uncertainty_score":0.9982682},"labels":[],"label_agreement":null},{"id":"W4402267381","doi":"10.1158/1538-7445.pediatric24-a015","title":"Abstract A015 FGF8 promotes non-canonical KRAS/MAPK pathway in favorable histology Wilms' tumor","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Wilms' tumor; Histology; Wilms tumour; Medicine; Cancer research; MAPK/ERK pathway; Oncology; Internal medicine; Cancer; Biology; Genetics; Signal transduction; Colorectal cancer","score_opus":0.032555004237064256,"score_gpt":0.36296569467021655,"score_spread":0.3304106904331523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96017903,0.029018518,0.00001796248,0.0012299621,0.0004894368,0.0003334767,0.000031586154,0.00002239069,0.008677611],"genre_scores_gemma":[0.9925536,0.0015725078,0.000031253727,0.00011724627,0.00042300328,0.00023405017,0.000038525548,0.000040794646,0.0049890475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998003,0.00009973805,0.00025499164,0.00063251675,0.0003166048,0.00069314305],"domain_scores_gemma":[0.9993282,0.000044790715,0.00002607022,0.00031830446,0.000117998476,0.00016466327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006469896,0.00016538703,0.00020143842,0.00017548482,0.00009421886,0.00006194658,0.00028911926,0.00026219967,0.00032897835],"category_scores_gemma":[0.000076736185,0.00013445962,0.00011759287,0.00042859284,0.00031142673,0.000008558744,0.0001485022,0.0008366377,0.00011182254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017831716,0.00006905622,0.0002546743,0.0002909143,0.00009144858,0.00056857994,0.00010667664,0.00012232384,0.97014374,0.00018731732,0.020090915,0.007896059],"study_design_scores_gemma":[0.0007149423,0.00050070573,0.001623586,0.0005306485,0.000009569732,0.00008583913,0.00011083799,0.0002171031,0.6138037,0.00054507324,0.38147688,0.00038111577],"about_ca_topic_score_codex":0.001078035,"about_ca_topic_score_gemma":0.0005064174,"teacher_disagreement_score":0.36138597,"about_ca_system_score_codex":0.00026135816,"about_ca_system_score_gemma":0.0017452124,"threshold_uncertainty_score":0.54831046},"labels":[],"label_agreement":null},{"id":"W4402267417","doi":"10.1158/1538-7445.pediatric24-a075","title":"Abstract A075 GD2-SADA, a bispecific fusion protein that forms self-assembling and disassembling (SADA), GD2-avid tetramers with high affinity for chelated radiolanthanides","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusion protein; Fusion; Chelation; Bispecific antibody; DOTA; Chemistry; Combinatorial chemistry; Medicine; Biochemistry; Recombinant DNA; Immunology; Organic chemistry; Philosophy","score_opus":0.11384640934077646,"score_gpt":0.42683856673114184,"score_spread":0.3129921573903654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027747,0.0035045047,0.00023162032,0.002925919,0.000054508553,0.001960766,0.00007841858,0.0002339585,0.0007328402],"genre_scores_gemma":[0.99537003,0.0014004925,0.00095248275,0.000034881876,0.00037542827,0.0011931923,0.00006629012,0.000068692156,0.0005384855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771214,0.000030664818,0.00026203383,0.0006669597,0.0006453462,0.0006828323],"domain_scores_gemma":[0.9985269,0.00048797714,0.000044730023,0.00032886653,0.0002015121,0.0004100604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085245987,0.00023757546,0.0003181531,0.00019092324,0.0004265486,0.00024079315,0.00017764387,0.00017881521,0.00013089238],"category_scores_gemma":[0.00009131488,0.00017104368,0.0000799878,0.00081471796,0.00019656112,0.00021576273,0.000059180446,0.0010172507,0.000012774476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084540003,0.00016316904,0.0006794771,0.0024575628,0.00019068534,0.000071079165,0.00030104886,0.000016758439,0.98646367,0.0007682675,0.0006718279,0.0073710848],"study_design_scores_gemma":[0.0018409715,0.00028382274,0.0036015837,0.0019365624,0.00012940133,0.00006788966,0.00077453384,0.0014246482,0.97210747,0.00055826537,0.016933745,0.000341117],"about_ca_topic_score_codex":0.00014039858,"about_ca_topic_score_gemma":0.000024138682,"teacher_disagreement_score":0.016261917,"about_ca_system_score_codex":0.00035535893,"about_ca_system_score_gemma":0.00047673934,"threshold_uncertainty_score":0.6974959},"labels":[],"label_agreement":null},{"id":"W4402267420","doi":"10.1158/1538-7445.pediatric24-b043","title":"Abstract B043: The MedSupport multilevel intervention to improve pediatric medication adherence: Results from a pilot study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Intervention (counseling); Family medicine; Nursing","score_opus":0.36503597525533354,"score_gpt":0.5696904922626546,"score_spread":0.204654517007321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685874,0.0067216065,0.000035394463,0.019302156,0.0010724671,0.0018497476,0.00019988124,0.00006934836,0.0021619808],"genre_scores_gemma":[0.9935647,0.0022356363,0.000021848218,0.00019745226,0.0015943289,0.00074096286,0.000024875462,0.000019566276,0.0016006028],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997459,0.0001944557,0.00039052602,0.0005014982,0.0010755307,0.00037898388],"domain_scores_gemma":[0.9976044,0.0014647713,0.000052015144,0.0003458612,0.00028031762,0.0002526305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034923807,0.00011728235,0.00017071674,0.00013498838,0.00021200844,0.00011659283,0.0002549195,0.000038072983,0.0013658181],"category_scores_gemma":[0.0016494261,0.000070536356,0.000053053795,0.0005490425,0.000077718156,0.00013444028,0.00022054091,0.0009769662,0.00054465124],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007658213,0.0022148127,0.0067763072,0.0005663203,0.00073089026,0.00027632227,0.008620124,0.0000032263245,0.020713627,0.00004171696,0.12711106,0.8252874],"study_design_scores_gemma":[0.0064017135,0.00860591,0.74717784,0.0006211152,0.00061897736,0.000005445019,0.0076606385,0.000813504,0.003761858,0.0004063563,0.22358465,0.00034197522],"about_ca_topic_score_codex":0.011340902,"about_ca_topic_score_gemma":0.0007412755,"teacher_disagreement_score":0.8249454,"about_ca_system_score_codex":0.00023452764,"about_ca_system_score_gemma":0.00029367063,"threshold_uncertainty_score":0.99954706},"labels":[],"label_agreement":null},{"id":"W4402267826","doi":"10.1158/1538-7445.pediatric24-b071","title":"Abstract B071: Automated extraction and provision of electronic health record data from children with cancer to National Childhood Cancer Center (NCCR) cancer registries","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Childhood cancer; Center (category theory); Medicine; Electronic health record; Family medicine; Environmental health; Health care; Internal medicine; Political science; Law","score_opus":0.13737910658723645,"score_gpt":0.5613914591780658,"score_spread":0.4240123525908293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8594232,0.05106208,0.00012569106,0.05944841,0.0009974224,0.010873191,0.017119067,0.00050517684,0.00044573288],"genre_scores_gemma":[0.8779515,0.0883462,0.00024471033,0.0019498239,0.0017449133,0.02715248,0.0014357005,0.00012300478,0.0010516393],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994768,0.00041027617,0.00091868785,0.0012341022,0.0011665636,0.0015023631],"domain_scores_gemma":[0.99677694,0.00056830246,0.00034068915,0.0007795665,0.00083177903,0.00070272584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019827276,0.00028005036,0.00047877402,0.0004269989,0.0011406901,0.000057812733,0.0005538406,0.00023278272,0.0019485585],"category_scores_gemma":[0.00014205818,0.00023050379,0.000032953107,0.0012109699,0.00016941596,0.0004109807,0.00028079672,0.0019201488,0.000061015133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094694586,0.00029714804,0.13254227,0.00291234,0.00032781105,0.0000020601553,0.0021565813,0.00015325598,0.0012008528,0.0008146323,0.56708354,0.2915626],"study_design_scores_gemma":[0.0013130138,0.0002320212,0.52444595,0.0043111457,0.00003206064,0.000002196534,0.0003131208,0.0010020128,0.00015688925,0.0002832888,0.46762055,0.00028776674],"about_ca_topic_score_codex":0.21895708,"about_ca_topic_score_gemma":0.13779283,"teacher_disagreement_score":0.3919037,"about_ca_system_score_codex":0.0027617468,"about_ca_system_score_gemma":0.024328806,"threshold_uncertainty_score":0.9989638},"labels":[],"label_agreement":null},{"id":"W4402267827","doi":"10.1158/1538-7445.pediatric24-a066","title":"Abstract A066 Acquired resistance to temozolomide in the Th-<i>MYCN</i> mouse as a clinically-relevant platform to evaluate novel therapeutic strategies against high-risk neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Neuroblastoma; Medicine; Oncology; Internal medicine; Cancer research; Glioblastoma; Biology; Genetics","score_opus":0.09779416987017203,"score_gpt":0.4416459486377764,"score_spread":0.34385177876760437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97704315,0.0010019256,0.000034896635,0.014679328,0.00021398859,0.0032041415,0.0001855891,0.00014890147,0.0034880613],"genre_scores_gemma":[0.99040455,0.0016986089,0.00015969443,0.0024749916,0.00030589444,0.0014238578,0.00001707983,0.00012012557,0.0033951912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9935667,0.00039064517,0.0007523935,0.0011773676,0.0025389523,0.0015739652],"domain_scores_gemma":[0.9956218,0.002014295,0.000064890766,0.0011834799,0.00040935524,0.0007061561],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003410443,0.00040708648,0.000532489,0.0007491044,0.00032010526,0.0005780682,0.0008729183,0.00015496514,0.00020272296],"category_scores_gemma":[0.0009343365,0.00026446301,0.00019333443,0.0020848706,0.0002987895,0.00031432108,0.00028569988,0.0015292447,0.0013992758],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026435534,0.0019527522,0.0013633552,0.0011166906,0.00087324425,0.006698643,0.004784334,0.0015444828,0.8558848,0.002459355,0.026700694,0.070186116],"study_design_scores_gemma":[0.037590113,0.035846237,0.3923896,0.01293028,0.0006948668,0.00038909703,0.013733805,0.0023831325,0.2728174,0.01665657,0.21077706,0.0037918256],"about_ca_topic_score_codex":0.0011768702,"about_ca_topic_score_gemma":0.0031883053,"teacher_disagreement_score":0.5830674,"about_ca_system_score_codex":0.0007049718,"about_ca_system_score_gemma":0.0022074503,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W4402267841","doi":"10.1158/1538-7445.pediatric24-a034","title":"Abstract A034 LIBERTY: LIquid Biopsy for rElapsed/RefracTorY neuroblastoma - a pilot study of characterization of circulating tumor DNA alterations in patients with relapsed and refractory neuroblastoma using a clinically validated liquid biopsy platform","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Refractory (planetary science); Liquid biopsy; Neuroblastoma; Medicine; Biopsy; Circulating tumor DNA; Pathology; Radiology; Internal medicine; Cancer; Biology","score_opus":0.08530423107458393,"score_gpt":0.37803989016419554,"score_spread":0.29273565908961163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559766,0.000058090154,0.000034740835,0.000088785564,0.00015184448,0.0037088774,0.0002452818,0.000076844684,0.000037870785],"genre_scores_gemma":[0.9989719,0.000045499128,0.00014106923,0.000032533884,0.00009957477,0.00036560156,0.00013737196,0.00015085039,0.000055633125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99544203,0.00029332432,0.0012319509,0.0009660306,0.0012408542,0.00082581077],"domain_scores_gemma":[0.99700403,0.0007544303,0.00034772747,0.0006045602,0.0009223236,0.0003668976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009486764,0.0003717885,0.0007189779,0.0012941802,0.0002237991,0.000098655066,0.00022085344,0.0001097561,0.00005664365],"category_scores_gemma":[0.000571017,0.00030960073,0.00009188107,0.00150727,0.00031504524,0.0006126035,0.00019785622,0.0009752511,0.0000042824227],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04821178,0.005485513,0.009463303,0.0012220846,0.00030781064,0.00045463027,0.0009208894,0.00004306953,0.93307257,0.000011424175,0.000011049204,0.0007958836],"study_design_scores_gemma":[0.03074112,0.22793813,0.6419679,0.006705209,0.00037168397,0.00011867241,0.00056230347,0.003387738,0.08726593,0.000020699454,0.00011759028,0.00080301525],"about_ca_topic_score_codex":0.00036973786,"about_ca_topic_score_gemma":0.00009447829,"teacher_disagreement_score":0.84580666,"about_ca_system_score_codex":0.0003296807,"about_ca_system_score_gemma":0.0010801697,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W4402267842","doi":"10.1158/1538-7445.pediatric24-a027","title":"Abstract A027 Investigations on association of month of birth and seasonality with chromosomal abnormalities of prognostic significance and disease incidences in pediatric acute lymphoblastic leukemia in Saudi Arabia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Disease; Leukemia; Pediatrics; Oncology; Internal medicine","score_opus":0.027948453357732404,"score_gpt":0.327659771725982,"score_spread":0.2997113183682496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518335,0.0028780345,0.000007124242,0.0006519897,0.000025023315,0.00084360095,0.00026054322,0.000013504336,0.00013680772],"genre_scores_gemma":[0.9969992,0.0023850002,0.00008234578,0.000014234322,0.000071063274,0.00023159574,0.000015374471,0.000022774975,0.00017839078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996969,0.00022842325,0.00051272387,0.00042352328,0.0014272827,0.0004390495],"domain_scores_gemma":[0.99636775,0.0025369127,0.00014866343,0.00021116502,0.00043366992,0.00030185658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014668397,0.00016152527,0.0004360316,0.0005958551,0.00004202114,0.000030266247,0.00013588574,0.00010662009,0.000033543914],"category_scores_gemma":[0.0023176908,0.00013033304,0.000034099103,0.0015757454,0.0007092685,0.00021250913,0.00009200714,0.00047155307,0.0000013510596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012803301,0.00010946128,0.98524445,0.006249368,0.000089723515,0.00018518233,0.0011041557,0.00048555175,0.0042426786,0.00036913418,0.00020107218,0.00043888664],"study_design_scores_gemma":[0.0016865053,0.00055489497,0.98773104,0.0026406855,0.000085500185,0.000005692281,0.00026677217,0.0031238208,0.0031766747,0.0006080782,0.000009630604,0.00011068487],"about_ca_topic_score_codex":0.0033938775,"about_ca_topic_score_gemma":0.0011023686,"teacher_disagreement_score":0.007444568,"about_ca_system_score_codex":0.0024065063,"about_ca_system_score_gemma":0.009851075,"threshold_uncertainty_score":0.99576217},"labels":[],"label_agreement":null},{"id":"W4402267843","doi":"10.1158/1538-7445.pediatric24-b007","title":"Abstract B007: High-risk pediatric cancer models in zebrafish, mouse and short-term culture predict individual patient responses to therapy","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; McGill University; Children's Hospital of Eastern Ontario","funders":"","keywords":"Zebrafish; Medicine; Cancer; Term (time); Pediatric cancer; Oncology; Cancer therapy; Internal medicine; Biology; Genetics","score_opus":0.049774934159857044,"score_gpt":0.38895829364231044,"score_spread":0.3391833594824534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97793484,0.018080935,0.00006366864,0.0012490283,0.00008223501,0.0010420657,0.0013805322,0.00003192811,0.0001347808],"genre_scores_gemma":[0.9550078,0.04150393,0.00007309325,0.0001308343,0.0005864137,0.002103506,0.00012350189,0.000049008013,0.0004219138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970009,0.00022339291,0.0002854276,0.0008175963,0.0009464735,0.000726237],"domain_scores_gemma":[0.9987129,0.000128488,0.000022917575,0.00043674803,0.00022287309,0.00047608226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009964112,0.00019632302,0.00017293365,0.00040642632,0.00017703701,0.00020192021,0.0004794558,0.00025535905,0.00011375651],"category_scores_gemma":[0.00026215805,0.00015993824,0.000054952558,0.00084857066,0.00022549226,0.000021559967,0.00041605844,0.00076643605,0.000014045093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017155324,0.00041934315,0.026192319,0.00031612234,0.0003057124,0.000086807915,0.0022306473,0.00043613932,0.660662,0.00020996763,0.12673369,0.18069172],"study_design_scores_gemma":[0.003278845,0.0039445087,0.3395763,0.0004773472,0.00006985149,0.000014546137,0.00085856067,0.0007143535,0.44162053,0.002082581,0.20568506,0.001677508],"about_ca_topic_score_codex":0.001195497,"about_ca_topic_score_gemma":0.00094047195,"teacher_disagreement_score":0.313384,"about_ca_system_score_codex":0.00014670192,"about_ca_system_score_gemma":0.0007319721,"threshold_uncertainty_score":0.6522092},"labels":[],"label_agreement":null},{"id":"W4402267850","doi":"10.1158/1538-7445.pediatric24-a022","title":"Abstract A022 Characterizing the cell of origin of Ewing sarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Ewing's sarcoma; Medicine; Pathology","score_opus":0.1446965860951734,"score_gpt":0.4395759025447306,"score_spread":0.2948793164495572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750541,0.018250402,8.499643e-7,0.0027734516,0.00012797878,0.00030439554,0.000026292977,0.000014134974,0.0034483855],"genre_scores_gemma":[0.9975535,0.0017081605,0.000025201716,0.00004201571,0.0001692998,0.000107955624,0.000005796724,0.000018829853,0.00036923794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884784,0.00004464516,0.00019625823,0.00017306826,0.00049450906,0.00024369388],"domain_scores_gemma":[0.99908626,0.00042048906,0.000028349239,0.00027724507,0.00012696724,0.000060660816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060410245,0.000071530376,0.00018383515,0.00014445731,0.00005243347,0.000021124655,0.000120510966,0.000035081255,0.00063272036],"category_scores_gemma":[0.00003325678,0.000042631375,0.00009554419,0.00036858997,0.00012282415,0.000042973992,0.00005627246,0.00029497617,0.00003495968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014989826,0.00041795202,0.07198624,0.0016450607,0.0002243919,0.00026529995,0.0015130087,0.0000019758843,0.8250295,0.00087139395,0.0048792562,0.093016036],"study_design_scores_gemma":[0.00050994905,0.00015093257,0.23925114,0.0011129949,0.000051306426,0.000008716346,0.0003652697,0.000034705135,0.7143434,0.00008377523,0.04403089,0.00005691032],"about_ca_topic_score_codex":0.00077205885,"about_ca_topic_score_gemma":0.000012791342,"teacher_disagreement_score":0.1672649,"about_ca_system_score_codex":0.00013911782,"about_ca_system_score_gemma":0.00030333284,"threshold_uncertainty_score":0.6927844},"labels":[],"label_agreement":null},{"id":"W4402267856","doi":"10.1158/1538-7445.pediatric24-b074","title":"Abstract B074: Clonal decomposition and DNA replication states defined by scaled single-cell DNA and RNA sequencing suggest clone-specific therapeutic vulnerabilities in neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"clone (Java method); DNA sequencing; Biology; DNA; Computational biology; Cancer research; Molecular biology; Genetics","score_opus":0.06619053812378871,"score_gpt":0.3749442080172322,"score_spread":0.3087536698934435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638594,0.009402486,0.000010630178,0.0027509124,0.000061594015,0.0007673677,0.0000783964,0.00007898631,0.00046368164],"genre_scores_gemma":[0.9953355,0.003614057,0.00004981964,0.00007822749,0.000093807685,0.00025970972,0.00008335648,0.00005422804,0.00043127718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973957,0.00022872363,0.0003080783,0.00080975756,0.0006426567,0.00061507925],"domain_scores_gemma":[0.99831754,0.0008354863,0.000031314314,0.0003635792,0.00016348323,0.00028859515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071835826,0.00020368608,0.00025292637,0.00043218455,0.00019088913,0.00025021567,0.00009401457,0.000088111316,0.000120920246],"category_scores_gemma":[0.00006384727,0.00017650137,0.00004199627,0.0005007896,0.00037498222,0.00023289512,0.00008060565,0.0007007364,0.00002477016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007062052,0.00020482003,0.0016208873,0.0005497468,0.00003491792,0.0002483902,0.00035925588,0.0000065028953,0.97395575,0.000068010995,0.0009881837,0.021257352],"study_design_scores_gemma":[0.0030023686,0.002082925,0.04939562,0.00088127557,0.000028673292,0.00017494266,0.00040541196,0.0011484923,0.9383234,0.0015951052,0.002668265,0.00029351164],"about_ca_topic_score_codex":0.00039843685,"about_ca_topic_score_gemma":0.00013720462,"teacher_disagreement_score":0.047774736,"about_ca_system_score_codex":0.0006829162,"about_ca_system_score_gemma":0.0002778791,"threshold_uncertainty_score":0.7197517},"labels":[],"label_agreement":null},{"id":"W4402267858","doi":"10.1158/1538-7445.pediatric24-a037","title":"Abstract A037 Changes in T-cell repertoire during high-risk neuroblastoma therapy: A report from the Children’s Oncology Group","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Neuroblastoma; Medicine; Oncology; Internal medicine; Repertoire; Pediatric oncology; Clinical Oncology; Cancer; Biology; Genetics","score_opus":0.042893646660775955,"score_gpt":0.3760488253009911,"score_spread":0.33315517864021515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808159,0.0074189915,4.4912872e-7,0.009158401,0.00026697307,0.0012734825,0.000108292435,0.00011996321,0.0008375784],"genre_scores_gemma":[0.9838092,0.012710817,0.00001773497,0.00017124922,0.0007940312,0.0007722659,0.000055903303,0.00008516477,0.0015836668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963839,0.00041555497,0.00031881905,0.00091385364,0.0010444806,0.0009234065],"domain_scores_gemma":[0.997884,0.00083763583,0.000058557052,0.00080877304,0.00012286822,0.00028820903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008991344,0.0002371015,0.00034740858,0.00038796145,0.00028201484,0.00012537571,0.00032986398,0.00014790743,0.0008408853],"category_scores_gemma":[0.00023226741,0.00015074133,0.000112537826,0.00083585025,0.00029121584,0.00010489629,0.00022150841,0.0019635684,0.0001817051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051247934,0.0015415902,0.14312321,0.00028711016,0.00071086263,0.068476304,0.0016015118,0.000016388383,0.55299807,0.000025137144,0.01512433,0.21097068],"study_design_scores_gemma":[0.0033008743,0.0012672198,0.8986697,0.00046809413,0.000027305938,0.0004141775,0.000117211384,0.000025419778,0.082411006,0.00014856181,0.012986904,0.00016348879],"about_ca_topic_score_codex":0.018163797,"about_ca_topic_score_gemma":0.007183129,"teacher_disagreement_score":0.7555465,"about_ca_system_score_codex":0.00073245564,"about_ca_system_score_gemma":0.0006943333,"threshold_uncertainty_score":0.98837435},"labels":[],"label_agreement":null},{"id":"W4402267859","doi":"10.1158/1538-7445.pediatric24-b042","title":"Abstract B042: Socioeconomic and racial disparities in pediatric cancer outcomes in the Ghanaian health sector: Challenges and strategies for equitable care","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socioeconomic status; Health equity; Medicine; Pediatric cancer; Cancer; Gerontology; Health care; Environmental health; Economic growth; Nursing; Population; Public health; Internal medicine; Economics","score_opus":0.2315536230838426,"score_gpt":0.5397536287857603,"score_spread":0.30820000570191763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7224951,0.24413702,5.199338e-7,0.031031014,0.0003557078,0.0013000009,0.00019531178,0.000020808215,0.00046456588],"genre_scores_gemma":[0.86316323,0.13483351,0.0000036290403,0.0005338403,0.0008725503,0.0004217243,0.000007964032,0.00002326378,0.00014030108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976374,0.0003758809,0.0003654206,0.00039060673,0.00020786154,0.001022831],"domain_scores_gemma":[0.99852,0.0011092792,0.000047537593,0.00014513415,0.000055906916,0.00012210479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022416287,0.00013902165,0.0003192932,0.00028541326,0.00065126055,0.00008764288,0.00016009182,0.00012649561,0.00006807085],"category_scores_gemma":[0.000033880315,0.000099788274,0.000030902218,0.0001239233,0.000107414606,0.00021446953,0.00010216038,0.0011995459,0.0000058167934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019941705,0.00008881204,0.5154661,0.045137115,0.00002904792,0.000012277603,0.32775664,0.000020377149,0.00001713435,0.03189011,0.010840632,0.068542354],"study_design_scores_gemma":[0.00087616313,0.00008132333,0.8547487,0.00090547075,0.0000049033183,2.5090444e-7,0.13277064,0.000027879947,9.511595e-7,0.0039012837,0.006544832,0.00013758225],"about_ca_topic_score_codex":0.018528633,"about_ca_topic_score_gemma":0.268528,"teacher_disagreement_score":0.33928263,"about_ca_system_score_codex":0.0007291959,"about_ca_system_score_gemma":0.0034648336,"threshold_uncertainty_score":0.98800707},"labels":[],"label_agreement":null},{"id":"W4402267860","doi":"10.1158/1538-7445.pediatric24-a019","title":"Abstract A019 Genetic and epigenetic characterization of <i>NUP98</i>-rearranged leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenetics; Leukemia; Genetics; Biology; Cancer; Medicine; Cancer research; Gene","score_opus":0.04043162475047939,"score_gpt":0.37311148468606226,"score_spread":0.33267985993558286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446286,0.014124857,0.00007357732,0.0002771235,0.00011152054,0.00037199707,0.000078898796,0.000015355707,0.0004837976],"genre_scores_gemma":[0.9864004,0.011874518,0.00003212324,0.000041555828,0.0003569841,0.0001303804,0.00007559613,0.00005228842,0.0010361362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982514,0.00015978108,0.00021987912,0.00048094842,0.00045435736,0.00043368098],"domain_scores_gemma":[0.999183,0.00004036821,0.00002689708,0.00039046805,0.00022163437,0.0001376403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007073376,0.00013499272,0.00014754041,0.00019660236,0.000091051916,0.00007562642,0.00025518896,0.00014923592,0.00023497468],"category_scores_gemma":[0.000047012323,0.00012844318,0.000057099576,0.00035967148,0.00029108408,0.0000066050934,0.00013601777,0.00028224362,0.00003154094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044669944,0.000015837082,0.00046314596,0.00023663674,0.00006192166,0.000009421484,0.00009219739,0.000025531283,0.93956643,0.00000929065,0.0003761638,0.058696695],"study_design_scores_gemma":[0.00030300883,0.0007538851,0.01479878,0.000106094805,0.0000075625762,0.00000516129,0.000023082153,0.00011129087,0.96761787,0.0000694533,0.016058974,0.00014482359],"about_ca_topic_score_codex":0.000120421224,"about_ca_topic_score_gemma":0.00013336068,"teacher_disagreement_score":0.05855187,"about_ca_system_score_codex":0.00008279439,"about_ca_system_score_gemma":0.0006951292,"threshold_uncertainty_score":0.52377605},"labels":[],"label_agreement":null},{"id":"W4402267865","doi":"10.1158/1538-7445.pediatric24-b010","title":"Abstract B010: Biological consequences of neural signatures in fusion-positive rhabdomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Biology; Medicine; Computational biology; Pathology; Sarcoma","score_opus":0.12084471105612703,"score_gpt":0.4440846824162859,"score_spread":0.32323997136015886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95235884,0.040250894,3.659719e-7,0.0050386563,0.000115817056,0.0004373115,0.000051745228,0.000024429128,0.0017219363],"genre_scores_gemma":[0.9972214,0.002231298,0.000035279183,0.00009732289,0.00010755481,0.00019648079,0.000011939711,0.000010750141,0.00008796346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99862605,0.00010803163,0.00020644476,0.00031494265,0.00041308187,0.00033143957],"domain_scores_gemma":[0.9987199,0.0008747948,0.000017173372,0.000151013,0.00013414146,0.00010300569],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042809232,0.00010382859,0.00024546683,0.00029203328,0.00004513294,0.000027121008,0.000105345884,0.00010502436,0.0010795332],"category_scores_gemma":[0.00012958108,0.00006592848,0.0000869074,0.0005092548,0.00047546747,0.000044086944,0.000063239655,0.0005071298,0.000023691578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010146914,0.0010162871,0.26300728,0.00046541315,0.00024885027,0.007785437,0.000981804,0.000043221407,0.58270156,0.0046052504,0.006748825,0.13138136],"study_design_scores_gemma":[0.00084941945,0.00058481505,0.80772805,0.0012779752,0.000018851664,0.00003307297,0.00038916737,0.0001062828,0.18669415,0.001095702,0.001107891,0.00011461815],"about_ca_topic_score_codex":0.0016885637,"about_ca_topic_score_gemma":0.00010999732,"teacher_disagreement_score":0.54472077,"about_ca_system_score_codex":0.00018667517,"about_ca_system_score_gemma":0.00031522952,"threshold_uncertainty_score":0.99983364},"labels":[],"label_agreement":null},{"id":"W4402267868","doi":"10.1158/1538-7445.pediatric24-a029","title":"Abstract A029 Investigating the role of environmental toxicant exposures and STAG2 loss in sarcomagenesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Antioxidants, Aging, Portulaca oleracea","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toxicant; Environmental health; Medicine; Toxicity; Internal medicine","score_opus":0.07354805222127468,"score_gpt":0.36376033859407825,"score_spread":0.29021228637280355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926354,0.0058443337,0.000001683893,0.00061141234,0.000056703102,0.00024492576,0.0000573058,0.000021598453,0.00052659743],"genre_scores_gemma":[0.9981588,0.0013560506,0.000017112287,0.00007800141,0.000065332235,0.000055119363,5.909237e-7,0.000024185538,0.0002448205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981017,0.00021156418,0.00024091691,0.00040848812,0.00064000895,0.00039728254],"domain_scores_gemma":[0.99910045,0.0005181189,0.000039053954,0.00024176434,0.000010021558,0.00009061582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095651357,0.00010287018,0.00012563716,0.00016425432,0.00014279032,0.00008739543,0.0003151333,0.000041341988,0.00023431709],"category_scores_gemma":[0.000206879,0.000075935786,0.000030380212,0.00035419274,0.0009905626,0.00017765454,0.0002379499,0.00044345995,0.000018648863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001095373,0.000024311214,0.062583044,0.00006312564,0.0000037783714,0.000057280082,0.0017854705,0.000021808339,0.91864425,0.00059645757,0.000083858504,0.01612568],"study_design_scores_gemma":[0.000100100246,0.00002973686,0.24861936,0.00014607576,0.0000023306297,0.00000855176,0.0007421129,0.000496262,0.7469497,0.0009797115,0.0018404354,0.00008567826],"about_ca_topic_score_codex":0.0008282943,"about_ca_topic_score_gemma":0.000121881836,"teacher_disagreement_score":0.18603632,"about_ca_system_score_codex":0.00011245877,"about_ca_system_score_gemma":0.00016329424,"threshold_uncertainty_score":0.3649769},"labels":[],"label_agreement":null},{"id":"W4402267869","doi":"10.1158/1538-7445.pediatric24-a011","title":"Abstract A011 Molecular analysis improves the diagnosis of young people with renal tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pathology","score_opus":0.045835140753660554,"score_gpt":0.369894839463151,"score_spread":0.3240596987094904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533994,0.009199011,0.000023632705,0.0018567631,0.000030643412,0.0005172614,0.000022688502,0.000025363193,0.0029846947],"genre_scores_gemma":[0.9978828,0.0005225928,0.00004779767,0.00001867194,0.00008532074,0.0006612648,0.00001637396,0.000030214493,0.00073499396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979706,0.00007775725,0.00020469418,0.00036375053,0.0010143704,0.00036883113],"domain_scores_gemma":[0.9987804,0.0002479144,0.000032898595,0.0005187271,0.0002810583,0.00013896025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005928795,0.00013044509,0.00030667597,0.00040934127,0.00007793,0.000058604157,0.00017355332,0.000042805787,0.00053476327],"category_scores_gemma":[0.000052974203,0.00006938946,0.0002023604,0.0021041357,0.00021201695,0.000050682313,0.00006495415,0.00041938142,0.000022561811],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013044992,0.00043070232,0.38929245,0.0018142401,0.01008295,0.0029061106,0.0044743363,0.00072625076,0.56546736,0.00067552517,0.004855122,0.017970437],"study_design_scores_gemma":[0.0003893494,0.0005545164,0.55622953,0.0003767701,0.001113536,0.000026831416,0.0004741428,0.00020725372,0.44000936,0.000058248643,0.0004556096,0.000104820545],"about_ca_topic_score_codex":0.0062442785,"about_ca_topic_score_gemma":0.0014506177,"teacher_disagreement_score":0.16693711,"about_ca_system_score_codex":0.00029430143,"about_ca_system_score_gemma":0.00050068146,"threshold_uncertainty_score":0.9439523},"labels":[],"label_agreement":null},{"id":"W4402267877","doi":"10.1158/1538-7445.pediatric24-b061","title":"Abstract B061: Dissecting pediatric sarcoma microenvironment using single-cell and spatial multi-omics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Computational biology; Omics; Medicine; Tumor microenvironment; Cancer; Biology; Cancer research; Bioinformatics; Pathology; Internal medicine","score_opus":0.12593706990709044,"score_gpt":0.4082897044346989,"score_spread":0.2823526345276085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811739,0.016518518,0.00020878359,0.00041522426,0.0003208222,0.00078618224,0.000026808673,0.000059241967,0.0004905451],"genre_scores_gemma":[0.99008584,0.003734328,0.00048046754,0.000031314255,0.0016078543,0.000053508313,0.00001231882,0.00010758316,0.0038867572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99718505,0.0001135169,0.0002890171,0.00064214016,0.00092079205,0.00084946817],"domain_scores_gemma":[0.9987398,0.00037499325,0.00002930842,0.0003588288,0.00014010267,0.00035699236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001127469,0.00019789422,0.00026200796,0.00049457065,0.00023505771,0.00021985876,0.00016104177,0.0001374526,0.0020698076],"category_scores_gemma":[0.00012246959,0.00018178321,0.00009449993,0.00051873317,0.00023828003,0.00009782641,0.00025688796,0.001257136,0.000076687225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025461952,0.00020432839,0.018894013,0.0009650752,0.00004377726,0.00030408223,0.000549699,0.000024129824,0.9283154,0.000002215864,0.0003248525,0.050117824],"study_design_scores_gemma":[0.0057863286,0.0011516698,0.0919504,0.00096380914,0.00021166747,0.00025783683,0.0014590833,0.01765328,0.8427608,0.00006967668,0.036827486,0.00090792845],"about_ca_topic_score_codex":0.0027084986,"about_ca_topic_score_gemma":0.00017949249,"teacher_disagreement_score":0.085554555,"about_ca_system_score_codex":0.0011171242,"about_ca_system_score_gemma":0.00044011843,"threshold_uncertainty_score":0.9988424},"labels":[],"label_agreement":null},{"id":"W4402267879","doi":"10.1158/1538-7445.pediatric24-b028","title":"Abstract B028: Deep mutational scanning of SMARCB1 identifies missense mutants that destabilize SWI/SNF complex stability and diminish remodeling activity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; SMARCB1; Mutant; SMARCA4; Genetics; Biology; SWI/SNF; Mutation; Cancer research; Transcription factor; Gene; Chromatin remodeling","score_opus":0.15983159173386693,"score_gpt":0.42122053601818366,"score_spread":0.2613889442843167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923517,0.0058436147,0.0007041447,0.00022824519,0.00014330688,0.00023053531,0.00009894429,0.000022584847,0.00037689687],"genre_scores_gemma":[0.99852306,0.0007777721,0.00032405564,0.000015633243,0.00015745663,0.000043724376,0.000039811024,0.000032394328,0.000086078275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981227,0.00013624078,0.0002482617,0.0005917317,0.000521853,0.00037924372],"domain_scores_gemma":[0.9989561,0.00018583842,0.000052373805,0.00033362312,0.0003482292,0.0001238396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011588468,0.00015674344,0.0001993083,0.00008977791,0.00018637812,0.00012013704,0.0001736817,0.0001294892,0.0001903159],"category_scores_gemma":[0.0002252829,0.00015134849,0.000085864805,0.00018963774,0.0004144213,0.000019389341,0.00017403773,0.00029648456,0.0000024698854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002367174,0.00003788018,0.0008293366,0.00063527894,0.000058358008,0.000011842439,0.000512794,0.00068519055,0.9760832,0.000011600893,0.00021018885,0.020687565],"study_design_scores_gemma":[0.000377307,0.00008557797,0.013504708,0.00034227982,0.00002139974,0.00003020884,0.0011118009,0.019737655,0.96335596,0.00064468884,0.0005337922,0.0002546072],"about_ca_topic_score_codex":0.0005554406,"about_ca_topic_score_gemma":0.00040952928,"teacher_disagreement_score":0.020432958,"about_ca_system_score_codex":0.00010502101,"about_ca_system_score_gemma":0.0004859868,"threshold_uncertainty_score":0.6171812},"labels":[],"label_agreement":null},{"id":"W4402267903","doi":"10.1158/1538-7445.pediatric24-b068","title":"Abstract B068: NL-4C: The Dutch Comprehensive Childhood Commons, a resource to tackle pediatric cancer worldwide","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Childhood cancer; Resource (disambiguation); Medicine; Political science; Gerontology; Internal medicine; Computer science","score_opus":0.13861888655435503,"score_gpt":0.5118983477941244,"score_spread":0.3732794612397693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82905424,0.057265744,0.0000075865128,0.10121403,0.0016310939,0.003483018,0.0004191686,0.0002804975,0.0066446327],"genre_scores_gemma":[0.9669683,0.009286913,0.000015131368,0.008083013,0.007154123,0.00053602346,0.000027045131,0.000113879316,0.007815589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994623,0.0010760091,0.0006309742,0.00075280236,0.0011520186,0.0017651763],"domain_scores_gemma":[0.9956168,0.002423051,0.00008517235,0.00081827113,0.00042034694,0.00063637504],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001978799,0.00027800587,0.00038510872,0.00046464996,0.0023220342,0.0001197858,0.00083411776,0.00019581453,0.0025962372],"category_scores_gemma":[0.0002127624,0.00019111559,0.00012988108,0.0021721097,0.00014898059,0.00011332337,0.00059964065,0.004528157,0.0021807533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012390561,0.00010574668,0.017834615,0.0017732268,0.000048918955,0.000059090456,0.01283175,0.00008227719,0.0002842652,0.0010125067,0.94446945,0.021374244],"study_design_scores_gemma":[0.0004319109,0.00004360915,0.2830331,0.0016748068,0.00002115071,0.0000016177613,0.0031043172,0.000031698222,0.000045211345,0.00017485755,0.71122557,0.00021215995],"about_ca_topic_score_codex":0.0076153106,"about_ca_topic_score_gemma":0.007407312,"teacher_disagreement_score":0.2651985,"about_ca_system_score_codex":0.0010003648,"about_ca_system_score_gemma":0.0032453658,"threshold_uncertainty_score":0.99899304},"labels":[],"label_agreement":null},{"id":"W4402267908","doi":"10.1158/1538-7445.pediatric24-a024","title":"Abstract A024 A homozygous start-loss mutation in <i>TERF1</i> causes a syndrome associated with long telomeres","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"","keywords":"Telomere; Mutation; Genetics; Biology; Medicine; Gene","score_opus":0.07007043103578871,"score_gpt":0.39097942902384236,"score_spread":0.32090899798805367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891217,0.007890181,0.00001085279,0.0014328614,0.0001769269,0.0007874997,0.0000827359,0.0002043707,0.00050239515],"genre_scores_gemma":[0.9960988,0.000971192,0.000022382554,0.000102146725,0.00013554214,0.0003013073,0.00006635847,0.00008039623,0.0022218695],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99669194,0.0001398895,0.00036993893,0.0006552672,0.0012306924,0.0009122407],"domain_scores_gemma":[0.99847305,0.000502763,0.000043241158,0.00036813947,0.00033627535,0.0002765284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093741564,0.00024547824,0.00042552844,0.0008488814,0.00014182513,0.00019240925,0.00019614722,0.0001636243,0.0005506462],"category_scores_gemma":[0.000292364,0.00019500148,0.00007174544,0.0021011138,0.00036741412,0.00029026813,0.000059164875,0.0011428284,0.00015286657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044030813,0.00248891,0.38191447,0.009070065,0.0020983792,0.3913942,0.024670893,0.000554668,0.085251585,0.0004544265,0.02460465,0.07309469],"study_design_scores_gemma":[0.0031892024,0.0014191695,0.96142346,0.009675435,0.00011916947,0.0019225066,0.0017929756,0.00030639546,0.015603222,0.00026386112,0.0035689385,0.0007156747],"about_ca_topic_score_codex":0.0033809762,"about_ca_topic_score_gemma":0.0066076904,"teacher_disagreement_score":0.57950896,"about_ca_system_score_codex":0.0009327856,"about_ca_system_score_gemma":0.001290496,"threshold_uncertainty_score":0.79519296},"labels":[],"label_agreement":null},{"id":"W4402267915","doi":"10.1158/1538-7445.pediatric24-pr002","title":"Abstract PR002: Somatic genetic development of Wilms tumor via normal kidneys in predisposed children","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wilms' tumor; Somatic cell; Wilms tumour; Medicine; Oncology; Biology; Physiology; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.016094755474513063,"score_gpt":0.323790055838886,"score_spread":0.3076953003643729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087214,0.00801124,0.0000613091,0.00007532129,0.00013691086,0.0003192706,0.000017570466,0.000009552771,0.0004966765],"genre_scores_gemma":[0.9983305,0.00068130816,0.00019874136,0.000020720885,0.00015853695,0.00012896612,0.00004416814,0.000024701163,0.0004123856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986114,0.00004827737,0.00029331102,0.00032758608,0.00033443954,0.00038501667],"domain_scores_gemma":[0.9995659,0.000013295576,0.000029905736,0.00019475339,0.00008375637,0.00011240904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003363348,0.00011601469,0.00012962017,0.00015061624,0.000053912507,0.000024839288,0.00024750704,0.00010766999,0.00011223715],"category_scores_gemma":[0.000026079755,0.000094771356,0.000048971273,0.00033849408,0.00011925366,0.000005148159,0.000105686304,0.0002902376,0.000027451722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009005955,0.000050930725,0.005669422,0.0003847899,0.00013329172,0.000023911176,0.0003433426,0.00043440456,0.9690701,0.0000035099622,0.0013292681,0.022467004],"study_design_scores_gemma":[0.0005159395,0.0001236588,0.13433391,0.00053964555,0.000009047441,0.000016055406,0.00004866575,0.00022101907,0.861098,0.00004470346,0.002855641,0.00019374148],"about_ca_topic_score_codex":0.00018694477,"about_ca_topic_score_gemma":0.000119173776,"teacher_disagreement_score":0.1286645,"about_ca_system_score_codex":0.000092530056,"about_ca_system_score_gemma":0.001103074,"threshold_uncertainty_score":0.38646638},"labels":[],"label_agreement":null},{"id":"W4402267926","doi":"10.1158/1538-7445.pediatric24-a076","title":"Abstract A076 Inhibiting iron-sulfur cluster export activates ferroptosis and potentiates cisplatin response in pediatric group 3 medulloblastomas","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cisplatin; Cluster (spacecraft); Sulfur; Cancer research; Chemistry; Pharmacology; Medicine; Internal medicine; Chemotherapy; Computer science; Computer network","score_opus":0.04849726168085864,"score_gpt":0.3694779925877403,"score_spread":0.3209807309068816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98111045,0.010602586,0.000006691247,0.006535841,0.00019310378,0.0007141293,0.000023244298,0.00010871751,0.00070521695],"genre_scores_gemma":[0.99353635,0.0043023406,0.00011685374,0.0001471981,0.00068818656,0.00058630185,0.000014835556,0.00009056425,0.0005173941],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965891,0.00024184489,0.0005043218,0.00082872773,0.0009616665,0.00087431935],"domain_scores_gemma":[0.99842113,0.0007365897,0.000055957957,0.00029279405,0.0001786638,0.00031483543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263547,0.00027474388,0.00039994184,0.0010034607,0.00018463047,0.00022685039,0.00015820842,0.00020733145,0.0006083717],"category_scores_gemma":[0.00027910635,0.00023379196,0.00011308987,0.0013954038,0.00019395657,0.0003276289,0.00024010806,0.0011435348,0.000059621514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010774736,0.00051461795,0.26481456,0.005362254,0.00018663953,0.00091481506,0.0041757566,0.000055340806,0.6321104,0.00011433025,0.0145367235,0.066439785],"study_design_scores_gemma":[0.0027116064,0.0010764885,0.8813063,0.0027962509,0.00012802359,0.00007336748,0.0023292108,0.00062189595,0.10407189,0.00013294998,0.0041499943,0.00060201914],"about_ca_topic_score_codex":0.00048218435,"about_ca_topic_score_gemma":0.00008990981,"teacher_disagreement_score":0.61649173,"about_ca_system_score_codex":0.00053220824,"about_ca_system_score_gemma":0.0005030674,"threshold_uncertainty_score":0.95337594},"labels":[],"label_agreement":null},{"id":"W4402267945","doi":"10.1158/1538-7445.pediatric24-b070","title":"Abstract B070: Chemotherapy is a major mutagen in relapsed childhood cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Mutagen; Chemotherapy; Oncology; Medicine; Cancer chemotherapy; Cancer; Internal medicine; Genetics; Biology; Carcinogen","score_opus":0.038992342799612306,"score_gpt":0.3937797501667678,"score_spread":0.3547874073671555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584503,0.03515293,0.000030520474,0.003230569,0.00048115803,0.00036171862,0.00014150629,0.00002679462,0.0021244565],"genre_scores_gemma":[0.9802544,0.011691928,0.000049260172,0.00117397,0.00080036296,0.000542022,0.00002429608,0.000080614715,0.0053831567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818,0.000046725094,0.00020204729,0.00062230567,0.00036349412,0.00058545644],"domain_scores_gemma":[0.99934345,0.00001843069,0.000022282868,0.00038951705,0.00010314493,0.00012319713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005170793,0.00017552244,0.00016090093,0.00017995447,0.00008595145,0.00010187037,0.00032410372,0.00020210735,0.0016044708],"category_scores_gemma":[0.000010697627,0.0001642333,0.00009048224,0.000442412,0.00008941001,0.000005075648,0.000095037416,0.00044005393,0.00005103039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014374047,0.00007545432,0.00010141013,0.00008188822,0.00012500245,0.000022802626,0.00060357037,0.000012723844,0.8803954,0.00014619998,0.009619582,0.10867223],"study_design_scores_gemma":[0.0011294876,0.00016389597,0.0014053856,0.00019259911,0.000008911535,0.0000041390276,0.000106462874,0.00006882048,0.65408635,0.0007872187,0.34180307,0.00024366393],"about_ca_topic_score_codex":0.0013007381,"about_ca_topic_score_gemma":0.0011251705,"teacher_disagreement_score":0.3321835,"about_ca_system_score_codex":0.00018381103,"about_ca_system_score_gemma":0.00074740977,"threshold_uncertainty_score":0.99930817},"labels":[],"label_agreement":null},{"id":"W4402267948","doi":"10.1158/1538-7445.pediatric24-a061","title":"Abstract A061 Overcoming chemotherapic resistance caused by β3-AR in Ewing’s sarcoma with the receptor’s antagonist","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Antagonist; Medicine; Receptor antagonist; Internal medicine; Receptor; Pathology","score_opus":0.05294734990264411,"score_gpt":0.38047508500709054,"score_spread":0.32752773510444644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152579,0.04784101,0.0000026925804,0.03234593,0.0001092252,0.0007452919,0.000041390387,0.00005994327,0.0035966467],"genre_scores_gemma":[0.9912035,0.0028938712,0.000042095293,0.0003807441,0.00021048947,0.0005048395,0.000021359117,0.00006409513,0.0046789898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785143,0.00009474306,0.00020699268,0.00049231044,0.0007624937,0.0005920141],"domain_scores_gemma":[0.9988352,0.00045144607,0.00002643879,0.00045611808,0.000098209,0.00013256617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076498906,0.0001849508,0.00026609236,0.00016426753,0.00020061708,0.00017343365,0.00019414946,0.00007990239,0.00065141235],"category_scores_gemma":[0.00003473696,0.00011119287,0.00006791649,0.0007507485,0.0002520739,0.00009202646,0.00004170195,0.00072251266,0.00007914102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020335687,0.0011871671,0.11308574,0.0014364225,0.0008488062,0.0022554894,0.005329386,0.0000065628606,0.21561787,0.0012815518,0.59142566,0.0654918],"study_design_scores_gemma":[0.0035120894,0.00024792223,0.12741013,0.0030064571,0.000051196617,0.000015001683,0.0010652904,0.000027176084,0.10269192,0.00011719573,0.7615473,0.0003083263],"about_ca_topic_score_codex":0.001197736,"about_ca_topic_score_gemma":0.0016244943,"teacher_disagreement_score":0.17012167,"about_ca_system_score_codex":0.00097083533,"about_ca_system_score_gemma":0.00046795863,"threshold_uncertainty_score":0.7132509},"labels":[],"label_agreement":null},{"id":"W4402267958","doi":"10.1158/1538-7445.pediatric24-b072","title":"Abstract B072: Cell alterations that drive vascular invasion and dissemination in pediatric liver cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vascular invasion; Cancer; Medicine; Liver cancer; Pathology; Cancer research; Internal medicine","score_opus":0.06390342305971985,"score_gpt":0.4029026726932646,"score_spread":0.3389992496335447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92728865,0.07019537,0.0000028798088,0.0010020928,0.00010086295,0.000585262,0.000045332552,0.000021115504,0.00075846014],"genre_scores_gemma":[0.8975906,0.100950606,0.0000113941605,0.00003165906,0.00023684296,0.000657434,0.000035693556,0.00001717822,0.00046858934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988073,0.000046928868,0.00011128899,0.00033947596,0.00045259212,0.00024240617],"domain_scores_gemma":[0.9993144,0.00025253094,0.000012782329,0.00014909836,0.00011278285,0.00015840381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025023118,0.000095538395,0.00012216429,0.00032946648,0.00008604447,0.00009364589,0.000046713307,0.00005689403,0.00078501186],"category_scores_gemma":[0.00002908905,0.00007527214,0.00005096071,0.00039408825,0.0000445407,0.00016581493,0.00004770218,0.00025630902,0.000050779025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012573232,0.0011096585,0.8873852,0.0043975734,0.00018587463,0.0012472167,0.0071127727,0.00006247339,0.008089521,0.0004106478,0.033116464,0.056756873],"study_design_scores_gemma":[0.0005658435,0.00008319321,0.9843409,0.0009057237,0.00015006545,0.0000015525912,0.00023466065,0.0003676826,0.011384322,0.000054886415,0.0018029911,0.00010819835],"about_ca_topic_score_codex":0.0014248204,"about_ca_topic_score_gemma":0.0005876126,"teacher_disagreement_score":0.09695569,"about_ca_system_score_codex":0.00040728482,"about_ca_system_score_gemma":0.0003410854,"threshold_uncertainty_score":0.8595329},"labels":[],"label_agreement":null},{"id":"W4402267965","doi":"10.1158/1538-7445.pediatric24-a016","title":"Abstract A016 EWSR1 in Ewing sarcoma cells exhibits enhanced recruitment to sites of active transcription compared to that observed in non-Ewing sarcoma cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ewing's sarcoma; Sarcoma; Cancer research; Transcription (linguistics); Biology; Medicine; Transcription factor; Pathology; Genetics; Gene","score_opus":0.2018719242440702,"score_gpt":0.40949443393572976,"score_spread":0.20762250969165957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509305,0.0017870921,0.00036209074,0.00047024517,0.0001978532,0.001333703,0.00009853528,0.000009605372,0.00064784876],"genre_scores_gemma":[0.9973856,0.0007010598,0.00024300838,0.00006008991,0.00013286444,0.00085953245,0.00004684336,0.00003163064,0.0005393669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979426,0.000127148,0.00034608826,0.00064490613,0.0004033134,0.0005359279],"domain_scores_gemma":[0.9991923,0.00005504804,0.000037113674,0.0003939633,0.00016962449,0.00015193914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006739488,0.00017868949,0.00025372743,0.00035585003,0.000064546424,0.00006809029,0.00033861058,0.00014108355,0.0001013356],"category_scores_gemma":[0.00002106562,0.00017872144,0.00008892812,0.00071557926,0.00005536258,0.000022313357,0.00010319648,0.00031764596,0.000028056615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034301582,0.00008723472,0.0001932791,0.00016020249,0.000029437537,0.0000080785785,0.0019795052,0.0013332989,0.9674873,0.00000808198,0.0007378667,0.02763273],"study_design_scores_gemma":[0.00048690438,0.00014927732,0.014350304,0.0005166249,0.0000045616775,2.8967307e-7,0.00095412746,0.00010560999,0.9775505,0.0000220518,0.0056724655,0.00018726531],"about_ca_topic_score_codex":0.0011823118,"about_ca_topic_score_gemma":0.0022363795,"teacher_disagreement_score":0.027445465,"about_ca_system_score_codex":0.0003988084,"about_ca_system_score_gemma":0.00027346588,"threshold_uncertainty_score":0.7288049},"labels":[],"label_agreement":null},{"id":"W4402267969","doi":"10.1158/1538-7445.pediatric24-b081","title":"Abstract B081: EWS::FLI1 alters DNA damage induced protein dynamics at the RNAPII CTD","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CTD; DNA damage; Biophysics; Cell biology; Chemistry; Biology; Physics; DNA; Genetics; Geology; Oceanography","score_opus":0.04696817361986361,"score_gpt":0.37730760840224525,"score_spread":0.33033943478238165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991564,0.001594779,0.000041478877,0.0018552346,0.00030301238,0.00071721367,0.000075853604,0.00004076737,0.0038076865],"genre_scores_gemma":[0.98562515,0.00019876048,0.000039910683,0.00010657023,0.00039861174,0.00046331531,0.000086216685,0.00006285002,0.013018592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980023,0.00015375821,0.00017788375,0.0005725174,0.00051218894,0.0005813792],"domain_scores_gemma":[0.9989329,0.000036769383,0.000027767624,0.00073407666,0.00013439309,0.00013411303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096762995,0.00016503874,0.00011342199,0.00008851237,0.00023245985,0.00014662692,0.00055540225,0.00019139056,0.00041912083],"category_scores_gemma":[0.00010876838,0.00012248525,0.000105201645,0.00029176683,0.00018532792,0.0000076482875,0.0005323418,0.0005284,0.00019269902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000888701,0.000018839177,0.000015841644,0.00009281805,0.00006614173,0.000039942104,0.000076157914,0.000013379881,0.98410845,0.0004951045,0.0072206054,0.0077638524],"study_design_scores_gemma":[0.000169624,0.00015827775,0.000228363,0.00009102741,0.0000061972137,0.0000064028623,0.00016394827,0.0003152913,0.95807964,0.00025291927,0.040367343,0.00016098631],"about_ca_topic_score_codex":0.00030328066,"about_ca_topic_score_gemma":0.00097226014,"teacher_disagreement_score":0.033146735,"about_ca_system_score_codex":0.00033963282,"about_ca_system_score_gemma":0.0003544584,"threshold_uncertainty_score":0.49948037},"labels":[],"label_agreement":null},{"id":"W4402267970","doi":"10.1158/1538-7445.pediatric24-ia003","title":"Abstract IA003: Genetic predisposition to pediatric cancer: the long way from discovery to surveillance guidelines","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Genetic predisposition; Pediatric cancer; Internal medicine; Disease","score_opus":0.10881831545919264,"score_gpt":0.46033288066636585,"score_spread":0.3515145652071732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8712704,0.039194107,0.000619047,0.084629744,0.0016735021,0.0014789408,0.0007343592,0.00014598019,0.00025391247],"genre_scores_gemma":[0.97669816,0.0062525026,0.00023352563,0.0029625606,0.010661344,0.0009850763,0.00005901429,0.00010155693,0.0020462424],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9953152,0.000252991,0.00067829865,0.0009862257,0.0019109395,0.0008563351],"domain_scores_gemma":[0.9969326,0.00083210494,0.000053415937,0.00093990396,0.00071145763,0.00053050526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019376937,0.00028676746,0.00043221383,0.00038068646,0.00026033015,0.00041540663,0.0005754362,0.00012618535,0.00074115494],"category_scores_gemma":[0.0006904451,0.00021071597,0.00016496443,0.0018127473,0.00010782181,0.00021191238,0.00029992734,0.00080992427,0.0004351223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015066086,0.00019607136,0.19366004,0.0021060575,0.0005133849,0.00036648609,0.0071129594,0.0029834528,0.020345254,0.00011087131,0.683983,0.087115765],"study_design_scores_gemma":[0.0005054928,0.00023840273,0.95144653,0.0013828357,0.00007958751,0.000008796709,0.0003586923,0.00015157158,0.0036347618,0.0001883477,0.04162816,0.00037680627],"about_ca_topic_score_codex":0.032806683,"about_ca_topic_score_gemma":0.016410915,"teacher_disagreement_score":0.7577865,"about_ca_system_score_codex":0.00083906914,"about_ca_system_score_gemma":0.001384543,"threshold_uncertainty_score":0.97363394},"labels":[],"label_agreement":null},{"id":"W4402267975","doi":"10.1158/1538-7445.pediatric24-b080","title":"Abstract B080: Survivorship care models for childhood cancer survivors in low- and middle-income countries: A scoping review","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"","keywords":"Survivorship curve; Childhood cancer; Low and middle income countries; Cancer survivorship; Cancer; Medicine; Gerontology; Low income; Demography; Developing country; Economic growth; Socioeconomics; Sociology; Economics; Internal medicine","score_opus":0.22884997919810138,"score_gpt":0.5026077569382814,"score_spread":0.27375777774018006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017313079,0.98441046,0.0000015775902,0.0004824216,0.0014524414,0.010154527,0.0012590332,0.000088880086,0.0019775247],"genre_scores_gemma":[0.0003357123,0.9857332,0.000012832268,0.00010202025,0.00085954106,0.011976103,0.00008193765,0.00018734329,0.00071131054],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925229,0.0011238921,0.0012620975,0.0014327699,0.0018534153,0.0018049356],"domain_scores_gemma":[0.99540716,0.0023523269,0.0002921869,0.00068163604,0.0008315855,0.00043511364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008173761,0.0006352889,0.0025098978,0.00076761,0.000724145,0.0004869683,0.0013491128,0.0007120492,0.00039186687],"category_scores_gemma":[0.0008279346,0.0005539823,0.00044654773,0.0024428847,0.0008290411,0.00044207845,0.000379525,0.0017855292,0.00005689373],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008944042,0.000019913958,0.00006817458,0.8953851,0.00010037921,0.000036040805,0.0075316434,0.000006634701,8.185954e-9,0.0009880719,0.0003412396,0.095513865],"study_design_scores_gemma":[0.000112927395,0.000014323911,0.000008046898,0.71100944,0.00017114138,9.085844e-7,0.0012561096,0.0000017581787,1.8239541e-7,0.00032955554,0.28660658,0.0004889906],"about_ca_topic_score_codex":0.11950017,"about_ca_topic_score_gemma":0.46034402,"teacher_disagreement_score":0.34084386,"about_ca_system_score_codex":0.0027357647,"about_ca_system_score_gemma":0.014266431,"threshold_uncertainty_score":0.9996912},"labels":[],"label_agreement":null},{"id":"W4402267976","doi":"10.1158/1538-7445.pediatric24-pr010","title":"Abstract PR010: Developing a safe and potent tumor-targeting gated CAR-T cell therapy for DIPG: A deadly pediatric brain tumor","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brain tumor; CAR T-cell therapy; Tumor cells; Cancer; Cancer research; Oncology; Internal medicine; Immunotherapy; Pathology; Chimeric antigen receptor","score_opus":0.07872022883180967,"score_gpt":0.4125548820167345,"score_spread":0.33383465318492483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953216,0.035274662,0.00012418252,0.006611261,0.0002489502,0.0029653506,0.00006391212,0.00015314632,0.0013425242],"genre_scores_gemma":[0.9809525,0.0066546276,0.0008750068,0.00056954694,0.0018323442,0.0010055364,0.000051186747,0.0001992262,0.0078599965],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99566334,0.00019886348,0.00048424432,0.00092859764,0.0013167936,0.0014081702],"domain_scores_gemma":[0.9969847,0.0014051272,0.000055118297,0.00039439037,0.00069973205,0.00046091457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034766232,0.0003125034,0.00046199327,0.0008036503,0.000371178,0.00031391814,0.0002967858,0.00012243133,0.0013357245],"category_scores_gemma":[0.00047706248,0.00026093874,0.00016907809,0.0014116132,0.00019915201,0.00014690442,0.00016876089,0.001280153,0.00006470486],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023603388,0.00015131435,0.0064495225,0.0042118644,0.00019891381,0.0008544601,0.0016208313,0.000013681655,0.8862052,0.00012173131,0.032976653,0.06483547],"study_design_scores_gemma":[0.009934495,0.002131357,0.033270996,0.0015589973,0.00009740352,0.00021347465,0.0017180169,0.0021306009,0.38659707,0.00090076035,0.56018806,0.001258766],"about_ca_topic_score_codex":0.00093038776,"about_ca_topic_score_gemma":0.00006162859,"teacher_disagreement_score":0.5272114,"about_ca_system_score_codex":0.0009058179,"about_ca_system_score_gemma":0.0028985506,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W4402267981","doi":"10.1158/1538-7445.pediatric24-b040","title":"Abstract B040: Rural-urban differences in multiple symptoms occurrence in pediatric cancer survivors after treatment completion in Nebraska, United States","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Pediatric cancer; Gerontology; Demography; Childhood cancer; Pediatrics; Environmental health; Internal medicine","score_opus":0.1008830850261331,"score_gpt":0.40742945292843336,"score_spread":0.3065463679023003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193706,0.021922614,0.0000027182907,0.0036940263,0.0005224979,0.0012759373,0.00049503177,0.00008342951,0.000066659624],"genre_scores_gemma":[0.978476,0.018720109,0.000007751399,0.00016777604,0.00044360457,0.0016405171,0.00027593903,0.000044363616,0.00022393042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956475,0.0005177432,0.00080531393,0.00080770795,0.0011453116,0.00107644],"domain_scores_gemma":[0.9977624,0.0012744028,0.00006859893,0.00043061815,0.00017811688,0.000285897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014139914,0.00037044846,0.0006933913,0.0023365489,0.000069674614,0.00013168785,0.00025782757,0.00018119063,0.00076181255],"category_scores_gemma":[0.00018172216,0.00031813356,0.00010552874,0.003787636,0.00024953723,0.00024568356,0.00010598188,0.001145562,0.000067844165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006491809,0.00042371536,0.98110497,0.0012403051,0.00003985002,0.00022628096,0.0101785995,0.00017705452,0.00013158769,0.000011058183,0.00073931844,0.0050780643],"study_design_scores_gemma":[0.0022724583,0.00028568995,0.98890424,0.0021599198,0.000021255844,0.000002201675,0.0019078532,0.0015382982,0.00018267518,0.000081770835,0.0023173324,0.0003263343],"about_ca_topic_score_codex":0.30522794,"about_ca_topic_score_gemma":0.35278216,"teacher_disagreement_score":0.047554217,"about_ca_system_score_codex":0.0025201542,"about_ca_system_score_gemma":0.0010720206,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W4402267982","doi":"10.1158/1538-7445.pediatric24-b079","title":"Abstract B079: Development of model systems to investigate the roles of canonical and reciprocal EWSR1 fusion proteins in sarcomagenesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Spaceflight effects on biology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reciprocal; Fusion; Computational biology; Non canonical; Computer science; Biology; Medicine; Cell biology; Linguistics; Philosophy","score_opus":0.13093308174136364,"score_gpt":0.4316971738874666,"score_spread":0.30076409214610295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988829,0.006289907,0.000067264475,0.003139117,0.00004831767,0.0013443015,0.000009578552,0.000012809527,0.00025970658],"genre_scores_gemma":[0.99826646,0.00023105566,0.00060050574,0.00003174279,0.000048530415,0.00050803955,0.0000023561593,0.00001737278,0.0002939095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985181,0.00014449793,0.00031609327,0.000281579,0.00044415187,0.00029554204],"domain_scores_gemma":[0.9991994,0.00023910953,0.000026446909,0.00022831715,0.00015926325,0.00014750223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018458499,0.00009275705,0.0002753938,0.00029340063,0.00004251199,0.000013587489,0.0001396164,0.000104898536,0.000016244825],"category_scores_gemma":[0.00023900166,0.000056021487,0.000023070936,0.00048666372,0.00025147723,0.000024308038,0.00016544484,0.00034268905,0.0000062044874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003702482,0.000044843844,0.0028860816,0.0013903085,0.000038469836,0.00002566648,0.0024762899,0.0002745684,0.97572386,0.00026799517,0.0005565767,0.015945066],"study_design_scores_gemma":[0.0010003131,0.00059220364,0.07422756,0.005272756,0.000022347956,0.000021052212,0.0008266454,0.013035465,0.8988909,0.0001460002,0.005772285,0.00019246664],"about_ca_topic_score_codex":0.0012266957,"about_ca_topic_score_gemma":0.0019325216,"teacher_disagreement_score":0.07683298,"about_ca_system_score_codex":0.00024819528,"about_ca_system_score_gemma":0.0017203453,"threshold_uncertainty_score":0.3051819},"labels":[],"label_agreement":null},{"id":"W4402267985","doi":"10.1158/1538-7445.pediatric24-b076","title":"Abstract B076: ROME, a novel membrane protein in vertebrates, enhances metastatic phenotype of Ewing sarcoma cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phenotype; Sarcoma; Ewing's sarcoma; Cancer research; Biology; Medicine; Pathology; Gene; Genetics","score_opus":0.09881490027729577,"score_gpt":0.40495699310089556,"score_spread":0.3061420928235998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709818,0.025484907,0.000008155472,0.0009737976,0.000113682836,0.0010651117,0.000044784694,0.000030253284,0.001297549],"genre_scores_gemma":[0.99742323,0.0008355417,0.00048329064,0.000031560143,0.000084917054,0.00063556636,0.000012175378,0.000036515125,0.0004571771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980126,0.00006445135,0.00034475434,0.0003940058,0.0007115809,0.00047259522],"domain_scores_gemma":[0.9990653,0.00034202382,0.000032592376,0.00028365888,0.00014577316,0.0001306546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077350624,0.0001515316,0.00038422577,0.00044068552,0.000041601485,0.000045738623,0.0001427329,0.000052319356,0.0010062826],"category_scores_gemma":[0.00008883155,0.00011568806,0.00008973232,0.0009602389,0.00012608252,0.00011734524,0.00005937419,0.00042619582,0.000115920324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017485966,0.00074946595,0.0007456731,0.0016766974,0.00020659847,0.0004439287,0.00050579256,0.0000089917785,0.9664702,0.0004462462,0.0003826051,0.028188946],"study_design_scores_gemma":[0.0013603957,0.00024089734,0.015992053,0.0025988135,0.00004909319,0.000006261914,0.00023006852,0.00027453853,0.977135,0.00020162667,0.0017954586,0.00011581751],"about_ca_topic_score_codex":0.002727805,"about_ca_topic_score_gemma":0.00044923284,"teacher_disagreement_score":0.028073126,"about_ca_system_score_codex":0.000325296,"about_ca_system_score_gemma":0.0006227831,"threshold_uncertainty_score":0.99990696},"labels":[],"label_agreement":null},{"id":"W4402268317","doi":"10.1158/1538-7445.pediatric24-b057","title":"Abstract B057: Dual-omic characterization of pediatric solid tumors identified a subset of tumors with epigenetically altered immune phenotype","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Phenotype; Immune system; Biology; Computational biology; Cancer research; Bioinformatics; Immunology; Genetics; Gene","score_opus":0.048089204687286335,"score_gpt":0.3841784662570931,"score_spread":0.3360892615698068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972744,0.000868194,0.000013849265,0.00037585132,0.00010439419,0.0008533087,0.00015446365,0.00003672345,0.00031881762],"genre_scores_gemma":[0.9978296,0.00078245514,0.000026285308,0.000009207219,0.00027613164,0.0001408739,0.00012243625,0.00005829413,0.0007546814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971742,0.00010938069,0.0004941232,0.00042111235,0.0012416401,0.0005595148],"domain_scores_gemma":[0.99849576,0.000152144,0.00009313197,0.00041263073,0.00059987034,0.00024644312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000557926,0.00016621548,0.0004160089,0.0006611225,0.00006665956,0.000048005637,0.0001608844,0.00006608433,0.0006835957],"category_scores_gemma":[0.000120998455,0.0001279663,0.00009224503,0.0011599623,0.000273025,0.00012391589,0.00008947488,0.00050301827,0.00009294205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001700692,0.00029304164,0.005540736,0.0016102558,0.00020024972,0.00049086864,0.00020424848,0.000009584653,0.9876677,0.000056640187,0.00014053937,0.0020854527],"study_design_scores_gemma":[0.0011404062,0.0010069686,0.49561435,0.00057111663,0.00006468071,0.000017069933,0.000028247085,0.0000855368,0.50129575,0.000045036868,0.000037713886,0.000093102244],"about_ca_topic_score_codex":0.00032995315,"about_ca_topic_score_gemma":0.000028881963,"teacher_disagreement_score":0.49007362,"about_ca_system_score_codex":0.0001579349,"about_ca_system_score_gemma":0.0014038121,"threshold_uncertainty_score":0.7484894},"labels":[],"label_agreement":null},{"id":"W4402268363","doi":"10.1158/1538-7445.pediatric24-b012","title":"Abstract B012: Clinical utility of real-time comprehensive molecular profiling in childhood brain tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Profiling (computer programming); Medicine; Oncology; Bioinformatics; Computational biology; Biology; Computer science; Programming language","score_opus":0.06787415059490763,"score_gpt":0.46003135780491916,"score_spread":0.3921572072100115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901196,0.0060986225,0.0000066196535,0.000386138,0.00006954077,0.00061059784,0.00015298244,0.000015297946,0.0025405998],"genre_scores_gemma":[0.99719095,0.0019319559,0.000079801954,0.00003247735,0.00016135533,0.00015146004,0.00012350666,0.000034344128,0.00029411883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975355,0.00031291728,0.00040421658,0.0006494839,0.00051964365,0.0005782404],"domain_scores_gemma":[0.9989158,0.0001620306,0.00003535689,0.0004610389,0.00023433167,0.00019146336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011459303,0.00014977786,0.00026621614,0.00018066447,0.000049985276,0.00004224594,0.00029817503,0.0001544478,0.00023972064],"category_scores_gemma":[0.00025133084,0.00013745655,0.0001610387,0.00043545765,0.0003458664,0.000007873607,0.0002448777,0.0005202577,0.00004484351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049518794,0.0003365162,0.014201917,0.0003218692,0.00022327028,0.000270493,0.00008122177,0.000029772735,0.96013886,0.00008183334,0.0042557763,0.01956329],"study_design_scores_gemma":[0.0018731944,0.000774525,0.16153821,0.00056040403,0.0000119815095,0.00001096866,0.00011859562,0.0002344243,0.8267832,0.00062827935,0.007171083,0.00029515743],"about_ca_topic_score_codex":0.001731678,"about_ca_topic_score_gemma":0.00025439,"teacher_disagreement_score":0.14733629,"about_ca_system_score_codex":0.000075872274,"about_ca_system_score_gemma":0.0011281858,"threshold_uncertainty_score":0.56053156},"labels":[],"label_agreement":null},{"id":"W4402268364","doi":"10.1158/1538-7445.pediatric24-b060","title":"Abstract B060: Clonal composition of αβ and γδ T cells in primary human neuroblastoma tumors – Is every child unique?","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Primary (astronomy); Composition (language); Biology; Cancer research; Medicine; Genetics; Philosophy; Cell culture; Linguistics","score_opus":0.03960838525554278,"score_gpt":0.3855815207311944,"score_spread":0.3459731354756516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176747,0.0011304271,9.403452e-7,0.001421244,0.000049840462,0.0006176593,0.000099221776,0.000035161233,0.0048780157],"genre_scores_gemma":[0.9982377,0.0006565215,0.00002193857,0.00014596606,0.000097272416,0.00008220924,0.000031046675,0.000038541242,0.0006887591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783367,0.00012677068,0.00026521808,0.00044200258,0.00083844207,0.00049388164],"domain_scores_gemma":[0.99916524,0.00018586083,0.000025365174,0.00024177929,0.00013187205,0.0002499061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041057498,0.000145413,0.0002687817,0.00062151125,0.00010534418,0.000052038366,0.000116028554,0.000068855494,0.0003649423],"category_scores_gemma":[0.000013979182,0.00012717508,0.00006699584,0.0005842521,0.00031077597,0.00013850334,0.00013412378,0.0008802359,0.000041784846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085990643,0.00042616614,0.0041764826,0.0018562095,0.00008833676,0.002284855,0.00024631454,0.000006111776,0.9792563,0.00013147514,0.005683173,0.0049847024],"study_design_scores_gemma":[0.0016899141,0.0011041022,0.46615458,0.0022664524,0.00001721432,0.000115140734,0.000030202584,0.00007437705,0.5270022,0.00019757256,0.0012178746,0.00013036262],"about_ca_topic_score_codex":0.00055361947,"about_ca_topic_score_gemma":0.000053411983,"teacher_disagreement_score":0.4619781,"about_ca_system_score_codex":0.00030965926,"about_ca_system_score_gemma":0.00041088532,"threshold_uncertainty_score":0.51860493},"labels":[],"label_agreement":null},{"id":"W4402268368","doi":"10.1158/1538-7445.pediatric24-b058","title":"Abstract B058: Clusterin overexpression in therapeutic T cell induces resistance to exhaustion","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clusterin; Cancer research; Medicine; Biology; Immunology; Internal medicine; Apoptosis; Genetics","score_opus":0.12710239558110026,"score_gpt":0.46971554009344113,"score_spread":0.3426131445123409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816741,0.005438575,0.00004738121,0.0032397546,0.00024051215,0.00072466605,0.0000234529,0.000070153015,0.008541401],"genre_scores_gemma":[0.99282855,0.00018851244,0.000073237636,0.00023877915,0.0003035839,0.0004299993,0.000007559508,0.00004204863,0.0058877207],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980485,0.00012591797,0.00023907049,0.0005153101,0.00057090167,0.00050030736],"domain_scores_gemma":[0.9990434,0.00020566964,0.00001673257,0.000405573,0.00011426931,0.0002143492],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075370993,0.0001278666,0.00018940303,0.0005430224,0.000061770035,0.00006649396,0.00018213491,0.00013414516,0.0010109905],"category_scores_gemma":[0.00009447669,0.00011182733,0.000046659352,0.0007827611,0.00009669434,0.00009612062,0.0001814309,0.000698469,0.00031762538],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009887259,0.000101108955,0.0011104296,0.0015318057,0.000010076575,0.0004393276,0.0007734901,0.000055485936,0.9824998,0.00012433357,0.007018421,0.0053470396],"study_design_scores_gemma":[0.0030472183,0.0005762154,0.46917045,0.019401817,0.00004006219,0.00003808963,0.0016175867,0.00028532822,0.43597972,0.0038390171,0.06530856,0.0006959328],"about_ca_topic_score_codex":0.00017860103,"about_ca_topic_score_gemma":0.00013988154,"teacher_disagreement_score":0.54652005,"about_ca_system_score_codex":0.0007917839,"about_ca_system_score_gemma":0.00043263796,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W4402268369","doi":"10.1158/1538-7445.pediatric24-a046","title":"Abstract A046 Expression of novel immune checkpoints HHLA2 and B7x on circulating tumor cells (CTCs) of pediatric, adolescent and young adult solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Medicine; Biology; Immunology","score_opus":0.05861498227172625,"score_gpt":0.3849851087447797,"score_spread":0.32637012647305347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98672736,0.011747924,0.00000811089,0.00024636032,0.00022117475,0.00050018646,0.00008529867,0.000020478827,0.0004430876],"genre_scores_gemma":[0.99576026,0.0036099125,0.00006887191,0.000035262907,0.00027458512,0.00003477166,0.0000051863753,0.00003620495,0.00017492264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807745,0.000040704756,0.00047718326,0.00038127304,0.000672686,0.0003506911],"domain_scores_gemma":[0.9991174,0.00012959843,0.00011052019,0.00026313055,0.00025451664,0.00012484952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077842834,0.00015683232,0.00035553897,0.00031627397,0.000079358346,0.00003270762,0.00010181419,0.00007809694,0.00015214997],"category_scores_gemma":[0.00008487277,0.0001257079,0.0000892168,0.00038631522,0.00024086499,0.0000788343,0.000091265385,0.00049058703,0.0000024058058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014201431,0.00016155755,0.0039366554,0.003193904,0.000051187828,0.00004159852,0.00082183763,0.0000054653806,0.98343617,0.000012916106,0.00053017423,0.0063883793],"study_design_scores_gemma":[0.0021663855,0.00033289293,0.15277778,0.004599325,0.000036475714,0.000026620392,0.0006010123,0.00025698636,0.8389519,0.000011129184,0.000099686615,0.00013985117],"about_ca_topic_score_codex":0.0010746848,"about_ca_topic_score_gemma":0.000020947087,"teacher_disagreement_score":0.14884111,"about_ca_system_score_codex":0.00016003338,"about_ca_system_score_gemma":0.00032326012,"threshold_uncertainty_score":0.51262194},"labels":[],"label_agreement":null},{"id":"W4402268380","doi":"10.1158/1538-7445.pediatric24-a062","title":"Abstract A062 Therapeutic targeting of the SAGA KAT module impairs MYCN-amplified neuroblastoma growth through reduction of the MYCN oncogenic gene expression program","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma; Cancer research; N-Myc; Gene; Medicine; Biology; Genetics; Cell culture; Ganglioneuroma","score_opus":0.07988098803194234,"score_gpt":0.4035038717389753,"score_spread":0.32362288370703296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402268380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151814,0.003274879,0.00000944584,0.0018066003,0.00042452785,0.0020759075,0.000040991505,0.00008014193,0.0007693533],"genre_scores_gemma":[0.99764293,0.0006906854,0.000119778764,0.00003062841,0.0002610191,0.00040853082,0.0000075213816,0.00007032169,0.0007686073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633616,0.00040366917,0.0004180893,0.000542563,0.0015987568,0.00070074335],"domain_scores_gemma":[0.9983215,0.00022352325,0.0001079551,0.00074910285,0.0004467974,0.00015112585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006483756,0.00021601828,0.0003019899,0.0001621966,0.0002962678,0.00005633028,0.00048560012,0.000114684946,0.00018623333],"category_scores_gemma":[0.000195521,0.0001150133,0.00032122617,0.0013187694,0.00059991056,0.00016856511,0.000327525,0.0010376967,0.000019333118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006218887,0.0004366391,0.0011770338,0.00070575654,0.0001812835,0.000032071104,0.00052129553,0.00005619275,0.98384976,0.00007676462,0.0026264053,0.009714901],"study_design_scores_gemma":[0.0008213426,0.0007939005,0.024416184,0.00089175696,0.000054237888,0.000059402868,0.0001974974,0.0001308852,0.97101825,0.0006753198,0.0008506875,0.00009054614],"about_ca_topic_score_codex":0.00045490937,"about_ca_topic_score_gemma":0.000014206814,"teacher_disagreement_score":0.02323915,"about_ca_system_score_codex":0.00031288914,"about_ca_system_score_gemma":0.00086750253,"threshold_uncertainty_score":0.46901062},"labels":[],"label_agreement":null},{"id":"W4402551343","doi":"10.1158/1538-7445.pancreatic24-b082","title":"Abstract B082: Oncogenic KRAS-mediated epigenetic reprogramming is altered by loss of Activating Transcription Factor 3","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Reprogramming; Epigenetics; KRAS; Transcription factor; Cancer research; Biology; Transcription (linguistics); Genetics; Cancer; Gene","score_opus":0.0570625945261774,"score_gpt":0.40504635020097446,"score_spread":0.34798375567479706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289454,0.015152432,0.00020506918,0.00037528807,0.00022537299,0.00047191896,0.00039639926,0.000031632,0.0002473646],"genre_scores_gemma":[0.9957972,0.0020644313,0.000059818907,0.000021995804,0.00043670277,0.00018588756,0.00020303785,0.00007291321,0.0011579685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971158,0.00018066178,0.00039769715,0.00076488435,0.0008276023,0.0007133801],"domain_scores_gemma":[0.99875635,0.000109913446,0.00005367436,0.0005143607,0.00035817982,0.00020751455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000807235,0.00018944975,0.00021179431,0.00022598727,0.00014511182,0.00008842775,0.00036640282,0.00025829097,0.00047733536],"category_scores_gemma":[0.00026522373,0.00018716815,0.00016619731,0.0006094929,0.0003334879,0.000014451893,0.00010532254,0.00063763466,0.00006155398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012192841,0.0000639848,0.00018989672,0.00034612423,0.00010587413,0.000012335543,0.0004499785,0.0000066004704,0.9539596,0.000002637296,0.008988004,0.035753075],"study_design_scores_gemma":[0.00029936712,0.00021848493,0.00027364292,0.00017773094,0.0000049531895,0.0000037596396,0.00010872323,0.00005864009,0.91181105,0.000013095359,0.08686513,0.00016544078],"about_ca_topic_score_codex":0.0006863385,"about_ca_topic_score_gemma":0.00007576378,"teacher_disagreement_score":0.07787712,"about_ca_system_score_codex":0.00022758258,"about_ca_system_score_gemma":0.0006227606,"threshold_uncertainty_score":0.7632495},"labels":[],"label_agreement":null},{"id":"W4402551376","doi":"10.1158/1538-7445.pancreatic24-a058","title":"Abstract A058: Primary cancer-associated fibroblasts alter tumor organoid chemosensitivity through epigenetic regulation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Organoid; Epigenetics; Cancer; Cancer research; Biology; Medicine; Internal medicine; Cell biology; Gene; Genetics","score_opus":0.07288540690973679,"score_gpt":0.40334092460194854,"score_spread":0.33045551769221176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709016,0.015912786,0.00006993752,0.0045854044,0.0007138287,0.000877049,0.00019744955,0.00017617615,0.0065657715],"genre_scores_gemma":[0.98770833,0.003134169,0.0001439745,0.00046737702,0.0010389619,0.00021891073,0.00009445251,0.00009644235,0.0070974003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969187,0.00012525689,0.00034609748,0.0007112364,0.0010928037,0.0008059349],"domain_scores_gemma":[0.9985419,0.00023174028,0.00006057495,0.0004444423,0.0004813511,0.0002399788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089928496,0.00023678596,0.00044106072,0.00020091826,0.00018811392,0.000114337556,0.00013065088,0.00012908252,0.0030637314],"category_scores_gemma":[0.00012276159,0.00020934272,0.00016413422,0.0011518428,0.00023394862,0.00020344397,0.00011825189,0.0008014667,0.00017582436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034166657,0.00015132429,0.00061621174,0.001604899,0.00025930256,0.00027009318,0.00064950355,0.00006894692,0.8925083,0.000046802284,0.046346426,0.057136465],"study_design_scores_gemma":[0.001221807,0.0002104293,0.070566535,0.0022769494,0.00014368721,0.000029855964,0.00008853974,0.00013859123,0.85128164,0.0004433501,0.0732556,0.00034304342],"about_ca_topic_score_codex":0.005098349,"about_ca_topic_score_gemma":0.0011089694,"teacher_disagreement_score":0.06995032,"about_ca_system_score_codex":0.0019757787,"about_ca_system_score_gemma":0.0019343441,"threshold_uncertainty_score":0.9978476},"labels":[],"label_agreement":null},{"id":"W4402551382","doi":"10.1158/1538-7445.pancreatic24-b072","title":"Abstract B072: Pharmacological depletion of fibrinogen suppresses the growth of primary tumors and liver metastasis of pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastasis; Pancreatic cancer; Medicine; Cancer; Fibrinogen; Internal medicine; Cancer research; Oncology","score_opus":0.050464199263043845,"score_gpt":0.36360972801827646,"score_spread":0.3131455287552326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89509284,0.10346778,0.000013589025,0.00014499336,0.00041878293,0.00026274836,0.00027960204,0.00000407458,0.000315575],"genre_scores_gemma":[0.94911134,0.04926033,0.00003541141,0.000026419868,0.0012442264,0.00012042042,0.00001804316,0.000014935853,0.00016887802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988297,0.00013125331,0.00023823453,0.00026407835,0.00031145022,0.00022527052],"domain_scores_gemma":[0.9993189,0.00012227116,0.000062282576,0.00017400912,0.00026393792,0.000058627687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053469825,0.00010108588,0.00024631055,0.00007829458,0.000042426316,0.000012887428,0.00020297486,0.00007110244,0.0002725428],"category_scores_gemma":[0.00007294973,0.00006886329,0.000091367234,0.0002102388,0.00047733233,0.000008077145,0.00015541035,0.00015627405,6.7624535e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024570085,0.000034993165,0.0019958501,0.001001893,0.00023546725,5.272316e-7,0.00013736161,0.00001914264,0.9736645,0.00010317749,0.01380215,0.008759186],"study_design_scores_gemma":[0.00027880268,0.000121434656,0.036142327,0.00014582399,0.000105515806,0.000003913196,0.0000808174,0.000012014259,0.9364291,0.0000561726,0.026543757,0.0000803573],"about_ca_topic_score_codex":0.0022378603,"about_ca_topic_score_gemma":0.00014055286,"teacher_disagreement_score":0.054207444,"about_ca_system_score_codex":0.000028634762,"about_ca_system_score_gemma":0.00040567707,"threshold_uncertainty_score":0.33829904},"labels":[],"label_agreement":null},{"id":"W4402551420","doi":"10.1158/1538-7445.pancreatic24-b002","title":"Abstract B002: Tumor-secreted PTHrP facilitates pancreatic cancer cachexia by regulation of <i>de novo</i> lipogenesis pathway","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Lipogenesis; Cachexia; Pancreatic cancer; Cancer research; Cancer; Internal medicine; Endocrinology; Cancer cachexia; Medicine; Chemistry; Biology; Lipid metabolism","score_opus":0.0332903076495696,"score_gpt":0.3424278618667296,"score_spread":0.30913755421716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88150215,0.11583259,0.000071724746,0.0002816321,0.00056303915,0.0003417027,0.00085680315,0.000028405104,0.00052195677],"genre_scores_gemma":[0.9793344,0.0144490395,0.00005061002,0.00007181026,0.0012708387,0.00043546187,0.00019123743,0.000057480735,0.0041391263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978394,0.00013724703,0.00032984835,0.00059213414,0.00048926,0.0006121195],"domain_scores_gemma":[0.99889237,0.00007503865,0.000059398066,0.0004456238,0.00034042797,0.00018715093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075420877,0.0002098278,0.00027688674,0.0001335628,0.00011495508,0.00006544304,0.0002905274,0.00017778708,0.00047537763],"category_scores_gemma":[0.00012918773,0.00019767841,0.00014685241,0.00044557446,0.00026363306,0.000014241116,0.00010145172,0.00027028655,0.000017562228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016676397,0.000030894353,0.00052823464,0.00042447093,0.00013004728,0.0000028059264,0.00027322042,0.00010192831,0.9583179,0.000040063413,0.021545038,0.01843868],"study_design_scores_gemma":[0.00029863985,0.00007381323,0.0033766462,0.00015109687,0.000027842942,0.000004778011,0.00011497222,0.00005991074,0.6978297,0.000082440245,0.2978,0.000180131],"about_ca_topic_score_codex":0.0032258362,"about_ca_topic_score_gemma":0.0005132783,"teacher_disagreement_score":0.27625498,"about_ca_system_score_codex":0.00015884079,"about_ca_system_score_gemma":0.0011017253,"threshold_uncertainty_score":0.8061092},"labels":[],"label_agreement":null},{"id":"W4402551460","doi":"10.1158/1538-7445.pancreatic24-a066","title":"Abstract A066: nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Pancreatic cancer; Tumor microenvironment; Secretion; Cancer; Exosome; Medicine; Cancer research; Microvesicles; Biology; Internal medicine; microRNA; Biochemistry","score_opus":0.030964563129919576,"score_gpt":0.3448482857622689,"score_spread":0.3138837226323493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97130126,0.024845924,0.00007059041,0.0021773796,0.0001807536,0.0006744469,0.0002351298,0.000035309135,0.0004792011],"genre_scores_gemma":[0.9922396,0.0031849209,0.00004422958,0.0006938618,0.00046938437,0.0010250233,0.00012570141,0.00005127712,0.0021659916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784243,0.00016448245,0.00025417973,0.00063391344,0.00047874797,0.0006262246],"domain_scores_gemma":[0.99912184,0.00008437,0.000032712465,0.000471171,0.000090792484,0.00019913235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007380489,0.00019376838,0.0001444489,0.00008564055,0.00018631552,0.0001346539,0.00056108186,0.000114957016,0.0021983185],"category_scores_gemma":[0.00016424153,0.00013862435,0.000109594796,0.00028115822,0.00031780795,0.000008313386,0.00034814177,0.00041526806,0.00046146498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001773145,0.000055934812,0.0006285847,0.00009865664,0.000103581064,0.00009739182,0.00010031896,0.00011311326,0.98222864,0.000024584013,0.01208114,0.0042907274],"study_design_scores_gemma":[0.00036502024,0.0003906163,0.036533847,0.00023016997,0.000046973506,0.00001701019,0.00027343896,0.00013644472,0.60729426,0.00015291983,0.3541686,0.0003907173],"about_ca_topic_score_codex":0.00019607237,"about_ca_topic_score_gemma":0.00010622846,"teacher_disagreement_score":0.3749344,"about_ca_system_score_codex":0.00022471728,"about_ca_system_score_gemma":0.0004357533,"threshold_uncertainty_score":0.9987138},"labels":[],"label_agreement":null},{"id":"W4402551544","doi":"10.1158/1538-7445.pancreatic24-b066","title":"Abstract B066: An AI approach to unraveling treatment response in pancreatic cancer: Insights from the COMPASS trial leveraging large language models (LLMs)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pancreatic cancer; Compass; Cancer; Medicine; Oncology; Internal medicine; Geography; Cartography","score_opus":0.09693064355433814,"score_gpt":0.4396428118134847,"score_spread":0.3427121682591465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760583,0.0098427655,0.001537801,0.010009315,0.00031821727,0.0012888181,0.000053371048,0.00008441155,0.00080698024],"genre_scores_gemma":[0.9955603,0.00063837954,0.00027505343,0.00093974924,0.0012301595,0.0007074728,0.000060571663,0.00006528966,0.0005230127],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968949,0.00061760016,0.00035119063,0.0006534838,0.0008231625,0.00065966864],"domain_scores_gemma":[0.99804413,0.00096407667,0.000027343496,0.0005228275,0.000090767884,0.0003508258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002143615,0.00021433838,0.00043066134,0.00036577706,0.00023528574,0.00024413173,0.0003078385,0.0000944861,0.00013086792],"category_scores_gemma":[0.00029455687,0.00013673458,0.00009352973,0.0007131487,0.00009719226,0.00015717877,0.000094050716,0.0013656144,0.000021725105],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17281885,0.0033322405,0.0067212125,0.0010720628,0.0016623145,0.0037228218,0.31679985,0.11329491,0.16034804,0.0034981617,0.014491579,0.20223796],"study_design_scores_gemma":[0.030415142,0.0009172499,0.015021852,0.0028818587,0.00016344259,0.000016125538,0.0090045845,0.9115936,0.0017370826,0.00094585627,0.02680204,0.00050114485],"about_ca_topic_score_codex":0.027818182,"about_ca_topic_score_gemma":0.0005991154,"teacher_disagreement_score":0.7982987,"about_ca_system_score_codex":0.001176771,"about_ca_system_score_gemma":0.0010855896,"threshold_uncertainty_score":0.97865564},"labels":[],"label_agreement":null},{"id":"W4402551545","doi":"10.1158/1538-7445.pancreatic24-pr-05","title":"Abstract PR-05: Endocrine beta-cell stress promotes pancreatic ductal adenocarcinoma through endocrine-exocrine cell crosstalk","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Endocrine system; Crosstalk; Enteroendocrine cell; Internal medicine; Cancer research; Endocrinology; Pancreatic ductal adenocarcinoma; Beta cell; Medicine; Pancreatic cancer; Hormone; Cancer; Insulin; Islet; Physics","score_opus":0.07042920762778458,"score_gpt":0.41559808347235366,"score_spread":0.34516887584456907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92242026,0.049054153,0.000010963788,0.007667604,0.0006288327,0.00309576,0.00047640095,0.0005472158,0.016098835],"genre_scores_gemma":[0.9532948,0.006516774,0.00054728944,0.0001212939,0.0015647752,0.001338705,0.00016199179,0.00031693172,0.036137424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9902319,0.00032771446,0.00094434136,0.0019908077,0.0032317874,0.003273494],"domain_scores_gemma":[0.9954453,0.001001991,0.0001117742,0.0015481814,0.00090378296,0.0009889696],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005528695,0.00078637636,0.0010359171,0.0008522797,0.00049832865,0.0006204338,0.0009803956,0.00004730682,0.00438281],"category_scores_gemma":[0.00043449842,0.0006572337,0.00040768893,0.002036423,0.0011197184,0.00096716406,0.000854905,0.0032373753,0.0010363654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018820671,0.0021863491,0.04371916,0.021203153,0.0005394046,0.17648755,0.00096001755,0.000060360926,0.6956776,0.0009861343,0.052999057,0.0032991618],"study_design_scores_gemma":[0.0034874708,0.0020099387,0.013278336,0.0013562037,0.00018176249,0.0037085852,0.0009471616,0.000117657444,0.9129106,0.00089632237,0.060374834,0.00073112635],"about_ca_topic_score_codex":0.0024019044,"about_ca_topic_score_gemma":0.00024491432,"teacher_disagreement_score":0.21723303,"about_ca_system_score_codex":0.00081234303,"about_ca_system_score_gemma":0.0021159162,"threshold_uncertainty_score":0.99974144},"labels":[],"label_agreement":null},{"id":"W4402551576","doi":"10.1158/1538-7445.pancreatic24-pr-17","title":"Abstract PR-17: Genomic and transcriptomic characterization of pancreatic cancer patients on the PASS-01 trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pancreatic cancer; Transcriptome; Cancer; Medicine; Internal medicine; Oncology; Cancer research; Computational biology; Biology; Genetics; Gene; Gene expression","score_opus":0.038653136898319444,"score_gpt":0.3404446214039071,"score_spread":0.3017914845055876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949084,0.002551167,0.000009208466,0.0006719076,0.0004229354,0.0006962933,0.00043900427,0.000005599723,0.0002955005],"genre_scores_gemma":[0.9883435,0.010103685,0.0000023068787,0.0001361061,0.0005797748,0.00034383123,0.00010327265,0.000029911842,0.0003576542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989404,0.000059061742,0.00020367357,0.00032035864,0.00022495861,0.00025154534],"domain_scores_gemma":[0.99946564,0.00009072729,0.000040093855,0.00022812476,0.0001105202,0.00006487514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003253253,0.0001145674,0.00013358811,0.0000716725,0.000091629125,0.000074530486,0.00016712408,0.00009225708,0.00014843958],"category_scores_gemma":[0.00006168453,0.00008551582,0.000059210106,0.00012908358,0.0001401121,0.0000046283267,0.000055835902,0.00018705617,0.000005400632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025338526,0.00006116963,0.0011172643,0.000112026006,0.00008859627,0.0000011830941,0.0001701611,0.000014687114,0.98628557,0.0001614256,0.0028666134,0.0065874266],"study_design_scores_gemma":[0.011839875,0.0021099383,0.23224272,0.0006147885,0.00011852118,0.0000013738503,0.000113239046,0.00020846416,0.6019673,0.00030427653,0.1499279,0.0005516155],"about_ca_topic_score_codex":0.00030384844,"about_ca_topic_score_gemma":0.00016024281,"teacher_disagreement_score":0.38431832,"about_ca_system_score_codex":0.00008823426,"about_ca_system_score_gemma":0.00035540626,"threshold_uncertainty_score":0.3487234},"labels":[],"label_agreement":null},{"id":"W4402551597","doi":"10.1158/1538-7445.pancreatic24-b005","title":"Abstract B005: Characterizing the role of fibroadipogenic progenitors in pancreatic cancer cachexia: the role of miR-27a-3p","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cachexia; Cancer; Pancreatic cancer; Medicine; Cancer research; Progenitor cell; Internal medicine; Biology; Genetics; Stem cell","score_opus":0.025021237607431964,"score_gpt":0.3424357499752475,"score_spread":0.31741451236781554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80789745,0.19030112,5.9732554e-7,0.00035008334,0.0003582718,0.00046842397,0.00011920094,0.0000064910646,0.0004983794],"genre_scores_gemma":[0.98517394,0.012213498,0.0000076134106,0.00003190141,0.0014881364,0.0005944506,0.000020975482,0.00004039114,0.0004290765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816716,0.00016450473,0.0003405139,0.0003883475,0.00043154103,0.0005079529],"domain_scores_gemma":[0.99906045,0.00008327271,0.00007997625,0.0005152063,0.00018475186,0.00007633973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000858686,0.00016699989,0.00024929788,0.00011335794,0.00010272238,0.000044530672,0.0005288032,0.00014829378,0.0001365172],"category_scores_gemma":[0.0000739,0.000107686225,0.00016000467,0.0004700029,0.0003400066,0.000011417305,0.00018230863,0.00044245113,0.0000063973216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013827324,0.000032325723,0.003273935,0.00014444471,0.0001602853,9.953467e-7,0.00075948297,0.000019845835,0.958396,0.00011058152,0.00050609553,0.03645769],"study_design_scores_gemma":[0.00017330462,0.00004773597,0.011615038,0.00015987984,0.000034493976,0.0000033598537,0.0006041228,0.000042658732,0.7198788,0.00018654918,0.2671514,0.000102669874],"about_ca_topic_score_codex":0.005705581,"about_ca_topic_score_gemma":0.001450826,"teacher_disagreement_score":0.2666453,"about_ca_system_score_codex":0.00008234915,"about_ca_system_score_gemma":0.0009219129,"threshold_uncertainty_score":0.862517},"labels":[],"label_agreement":null},{"id":"W4402551681","doi":"10.1158/1538-7445.pancreatic24-b032","title":"Abstract B032: Evaluating T cell-inflammation in pancreatic neuroendocrine tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Neuroendocrine tumors; Inflammation; Medicine; Pancreas; Internal medicine; Cancer research; Pathology; Oncology","score_opus":0.10225729492153583,"score_gpt":0.4724182175780439,"score_spread":0.3701609226565081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802842,0.004818189,0.0000032114788,0.005500007,0.00018452814,0.0013042552,0.000010476861,0.00016665901,0.007728443],"genre_scores_gemma":[0.9919811,0.0013656511,0.000121124,0.0000494146,0.0005111015,0.00070419296,0.00001644756,0.00008430703,0.005166694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955332,0.00029059677,0.00048725624,0.00070029026,0.0018306535,0.0011579538],"domain_scores_gemma":[0.9980566,0.0008166858,0.00003626533,0.00047960525,0.00029170277,0.000319123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011207367,0.00020912311,0.00034412634,0.0010617998,0.0001222047,0.00017046288,0.00026313958,0.000010175182,0.0013525713],"category_scores_gemma":[0.001185777,0.00018269103,0.0000904882,0.0017239946,0.00019314249,0.00035429877,0.00017267477,0.001639853,0.00049737794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065159646,0.00013467282,0.0109250415,0.00438576,0.000035013683,0.034960266,0.00024711926,0.00046962194,0.89701897,0.00029398288,0.0035665361,0.04731144],"study_design_scores_gemma":[0.004404056,0.0020510338,0.08576533,0.0057568643,0.00006169611,0.0018854268,0.000966643,0.012237496,0.8552259,0.0025194234,0.028474959,0.00065117714],"about_ca_topic_score_codex":0.0007569138,"about_ca_topic_score_gemma":0.00016931626,"teacher_disagreement_score":0.074840285,"about_ca_system_score_codex":0.0006155705,"about_ca_system_score_gemma":0.001036288,"threshold_uncertainty_score":0.99956036},"labels":[],"label_agreement":null},{"id":"W4402551704","doi":"10.1158/1538-7445.pancreatic24-c008","title":"Abstract C008: Patient-derived organoids and precision medicine: Insights from the PASS-01 clinical trial in PDAC","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Organoid; Precision medicine; Medicine; Clinical trial; Internal medicine; Computational biology; Oncology; Bioinformatics; Biology; Pathology; Neuroscience","score_opus":0.22716179798124075,"score_gpt":0.5427648478731496,"score_spread":0.31560304989190885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583508,0.025108233,0.0000012978692,0.0125165945,0.0015677518,0.0011974473,0.000022442413,0.00003196026,0.0012035229],"genre_scores_gemma":[0.9858913,0.010396539,0.0000102526255,0.0004421301,0.0026047437,0.00025135468,0.000037177862,0.000025440784,0.00034104977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782157,0.00035914953,0.00045137721,0.00048230248,0.0005701846,0.00031542874],"domain_scores_gemma":[0.9966397,0.0027553944,0.000033328663,0.00027354594,0.000105683655,0.00019231728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080760976,0.0001371791,0.0003530841,0.0001641919,0.000101904705,0.0000409596,0.00013750372,0.0001673193,0.0026505948],"category_scores_gemma":[0.00037462366,0.00007593003,0.000063721076,0.0004930771,0.00045597024,0.000075822616,0.000115455776,0.0010513811,0.00006183042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08082766,0.00071126135,0.01308006,0.00017246301,0.00054443354,0.0010308116,0.00849238,0.0000017541175,0.17218378,0.00013139038,0.23906602,0.48375797],"study_design_scores_gemma":[0.13664503,0.00930372,0.36348495,0.0024873298,0.00037276244,0.000017649818,0.0017169517,0.00019674895,0.019426271,0.0040237126,0.46190462,0.00042024767],"about_ca_topic_score_codex":0.0027371985,"about_ca_topic_score_gemma":0.0011451535,"teacher_disagreement_score":0.48333773,"about_ca_system_score_codex":0.0002601863,"about_ca_system_score_gemma":0.0006172703,"threshold_uncertainty_score":0.9982611},"labels":[],"label_agreement":null},{"id":"W4402551741","doi":"10.1158/1538-7445.pancreatic24-a010","title":"Abstract A010: A patient first approach using CRISPR-directed gene editing as an augmentative therapy for the treatment of pancreatic ductile adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Genetic enhancement; Genome editing; Medicine; Adenocarcinoma; Pancreatic cancer; Gene; Internal medicine; Cancer; Biology; Genetics","score_opus":0.07510771090053593,"score_gpt":0.4341230013169925,"score_spread":0.3590152904164566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95542985,0.040779255,0.0024939494,0.00006998184,0.00019906688,0.00085701374,0.00008349606,0.000016599959,0.000070805356],"genre_scores_gemma":[0.99370277,0.0038215364,0.0009238841,0.000009005765,0.00067736325,0.00066947663,0.000066662345,0.00003860786,0.00009072071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890894,0.000051467785,0.00016620061,0.00035645647,0.00020639993,0.00031053156],"domain_scores_gemma":[0.99937856,0.00010070763,0.00002703275,0.00027513955,0.00015094398,0.00006761349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002299295,0.00013470075,0.00013151829,0.00006513856,0.00017728294,0.000050671686,0.00013243902,0.00006535069,0.000042434865],"category_scores_gemma":[0.00002961178,0.000094431125,0.000090605936,0.00016688679,0.00009379769,0.0000053486506,0.000026810541,0.00008127453,9.079165e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029408003,0.00022046355,0.00038431157,0.00018604346,0.00041675346,0.0000053224376,0.0038547763,0.0051618465,0.9544806,0.000013904275,0.0005081328,0.03447375],"study_design_scores_gemma":[0.0004912068,0.0012542993,0.0015146199,0.000050195245,0.000036102723,0.000008844757,0.0019077081,0.008857433,0.97966206,0.000024269033,0.0060689845,0.00012426781],"about_ca_topic_score_codex":0.00086676306,"about_ca_topic_score_gemma":0.000048943835,"teacher_disagreement_score":0.03827291,"about_ca_system_score_codex":0.00010104629,"about_ca_system_score_gemma":0.00016710968,"threshold_uncertainty_score":0.38507897},"labels":[],"label_agreement":null},{"id":"W4402551833","doi":"10.1158/1538-7445.pancreatic24-a029","title":"Abstract A029: Evaluating and interpreting scGPT: A foundation model for single-cell biology in real-world cancer clinical trial data","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto","funders":"","keywords":"Cancer; Foundation (evidence); Clinical trial; Medicine; Computational biology; Biology; Oncology; Internal medicine; Geography; Archaeology","score_opus":0.4472695160902713,"score_gpt":0.5814287670375038,"score_spread":0.13415925094723247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958796,0.005723979,0.0011106043,0.00055208406,0.0007134632,0.00089756784,0.00037256296,0.000010810328,0.0010309573],"genre_scores_gemma":[0.99002707,0.0067188395,0.0006572912,0.000100365585,0.0012884383,0.0004255615,0.0003768313,0.000038392453,0.00036721333],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980806,0.00012900007,0.000443734,0.0008041552,0.00014482661,0.00039764654],"domain_scores_gemma":[0.99864995,0.0005897831,0.00006276819,0.00044202214,0.00016491732,0.00009053514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034127233,0.00012244268,0.00018983314,0.0001436808,0.00009139777,0.00014887216,0.0003405257,0.00015380354,0.00003088779],"category_scores_gemma":[0.0009626842,0.00012073093,0.000051637366,0.00017515528,0.00016738914,0.000012385673,0.00050112634,0.00032043312,0.0000025515492],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008802076,0.00016458257,0.0022874058,0.00037363142,0.000086995635,0.000004341479,0.00022305822,0.0021480655,0.6888287,0.000445964,0.0049071102,0.29172802],"study_design_scores_gemma":[0.022058094,0.0022041968,0.00045111563,0.0008443774,0.00009110368,0.0000018006584,0.00018176719,0.8770489,0.027457748,0.003928673,0.06499214,0.0007400924],"about_ca_topic_score_codex":0.0016111803,"about_ca_topic_score_gemma":0.008615054,"teacher_disagreement_score":0.8749008,"about_ca_system_score_codex":0.0001608139,"about_ca_system_score_gemma":0.0011969571,"threshold_uncertainty_score":0.49232644},"labels":[],"label_agreement":null},{"id":"W4402551843","doi":"10.1158/1538-7445.pancreatic24-c043","title":"Abstract C043: Hyperinsulinemia promotes pancreatic cancer progression by altering tumor metabolism","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of British Columbia","funders":"","keywords":"Hyperinsulinemia; Cancer; Pancreatic cancer; Medicine; Internal medicine; Cancer research; Endocrinology; Metabolism; Insulin; Insulin resistance","score_opus":0.03489475793664613,"score_gpt":0.38993039873800883,"score_spread":0.3550356408013627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7649548,0.2314537,0.000030990628,0.00058318663,0.0015845482,0.000516437,0.00020051155,0.000057904534,0.00061790674],"genre_scores_gemma":[0.95600814,0.03188799,0.00019333985,0.00013037752,0.0062689185,0.001523252,0.00010410404,0.00011451405,0.0037693619],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997423,0.00009659164,0.00029195388,0.00080656464,0.00057487935,0.00080698956],"domain_scores_gemma":[0.99896413,0.000033233802,0.00004691154,0.00046250905,0.00023232885,0.00026091124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006222881,0.00026934769,0.00029517428,0.00013884349,0.00020504028,0.00020455474,0.00038951132,0.0001553136,0.00042185516],"category_scores_gemma":[0.000101261685,0.0002257725,0.0001320811,0.0004005767,0.00021542063,0.000019849776,0.00023748656,0.0005128579,0.000041793875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011819877,0.0000411211,0.00010210664,0.00035731183,0.00010229104,0.000009598931,0.00011188712,0.000013909515,0.8903484,0.000039505812,0.03507291,0.07368281],"study_design_scores_gemma":[0.00027113798,0.00004731099,0.0006735075,0.00024317186,0.000025778048,0.000008525002,0.00004048095,0.00004797131,0.4626184,0.000036525827,0.5357896,0.00019754734],"about_ca_topic_score_codex":0.00084894884,"about_ca_topic_score_gemma":0.00014813207,"teacher_disagreement_score":0.50071675,"about_ca_system_score_codex":0.00009723507,"about_ca_system_score_gemma":0.0009331238,"threshold_uncertainty_score":0.92067355},"labels":[],"label_agreement":null},{"id":"W4402551935","doi":"10.1158/1538-7445.pancreatic24-b031","title":"Abstract B031: Alternate pain management strategies: targeting pancreatic cancer-related pain with Flavonoid","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pancreatic cancer; Cancer; Flavonoid; Pain management; Cancer pain; Internal medicine; Physical therapy; Biochemistry; Chemistry","score_opus":0.034438806828614194,"score_gpt":0.36782377777986863,"score_spread":0.3333849709512544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90422124,0.074384734,0.0002232285,0.0052612727,0.000480871,0.0020207074,0.000033495566,0.0005430661,0.012831375],"genre_scores_gemma":[0.96297807,0.022804542,0.00017179655,0.00022288953,0.0009055746,0.0011545034,0.000044196127,0.00014313785,0.011575294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958219,0.00065301615,0.0004887566,0.0007871,0.0011370584,0.0011121668],"domain_scores_gemma":[0.9980972,0.0007072212,0.00007263091,0.00056793535,0.0002573552,0.0002977012],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052406043,0.00034673567,0.00048691584,0.0005284092,0.0002769853,0.0003592517,0.00033467798,0.00013909939,0.0016523025],"category_scores_gemma":[0.00011734622,0.0002692052,0.0001483143,0.0010828486,0.0002900663,0.00025300853,0.000078091616,0.001067473,0.000121597885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009250948,0.00071167306,0.0063666594,0.02622655,0.0054476717,0.011705609,0.009732336,0.0022380778,0.06683581,0.0025144406,0.1264367,0.7325335],"study_design_scores_gemma":[0.008090864,0.004036419,0.022053283,0.036412347,0.0009921764,0.00019006392,0.03009708,0.017122388,0.017018024,0.0013262442,0.8603593,0.0023018268],"about_ca_topic_score_codex":0.005537207,"about_ca_topic_score_gemma":0.0003094351,"teacher_disagreement_score":0.7339226,"about_ca_system_score_codex":0.0011354897,"about_ca_system_score_gemma":0.0015918044,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W4402551973","doi":"10.1158/1538-7445.pancreatic24-a025","title":"Abstract A025: Cell of origin does not underlie transcription heterogeneity in pancreatic ductal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Biology; Adenocarcinoma; Pancreas; Pancreatic cancer; Transcription factor; Medicine; Cancer research; Internal medicine; Pathology; Cancer; Genetics; Gene","score_opus":0.14113749244038187,"score_gpt":0.4443749597926742,"score_spread":0.30323746735229234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521036,0.008345216,0.00003051609,0.0017741376,0.0001993886,0.00079291436,0.00005911237,0.00003889645,0.0035494491],"genre_scores_gemma":[0.9935093,0.0030831303,0.000110407775,0.000038645965,0.00021078464,0.00023483847,0.00001885272,0.00003521515,0.00275884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99724203,0.00022014417,0.00044257104,0.000489148,0.00092801376,0.0006781021],"domain_scores_gemma":[0.9986756,0.00048520733,0.000029440997,0.00036931378,0.00021129793,0.00022913006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016311087,0.00016144603,0.00053494546,0.0006070811,0.00007359951,0.000036701455,0.00019864773,0.00019560552,0.0012758638],"category_scores_gemma":[0.00010224184,0.00011566445,0.00012623616,0.00070305413,0.00045158883,0.00012258773,0.000048880163,0.0009712053,0.000117441356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007960713,0.00025712542,0.43678012,0.0026954222,0.00012819456,0.00058824103,0.00086588523,0.000004552107,0.5553214,0.00037868787,0.000609769,0.0015744934],"study_design_scores_gemma":[0.0018356192,0.0005196784,0.8838399,0.0009755785,0.00011838181,0.00003785772,0.00066274253,0.0007816289,0.10945572,0.0005818502,0.0010234397,0.0001675855],"about_ca_topic_score_codex":0.0028228618,"about_ca_topic_score_gemma":0.00078642863,"teacher_disagreement_score":0.44705978,"about_ca_system_score_codex":0.00066992984,"about_ca_system_score_gemma":0.0015103244,"threshold_uncertainty_score":0.9996371},"labels":[],"label_agreement":null},{"id":"W4403051377","doi":"10.1158/0008-5472.can-23-3374","title":"Resistance Management for Cancer: Lessons from Farmers","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Insect behavior and control techniques","field":"Agricultural and Biological Sciences","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Campbellford Memorial Hospital","funders":"Congressionally Directed Medical Research Programs; National Institutes of Health; National Cancer Institute; National Institute of Food and Agriculture; Arizona Biomedical Research Commission; U.S. Department of Agriculture","keywords":"Integrated pest management; Cancer; Medicine; Resistance (ecology); Psychological intervention; Intensive care medicine; Drug resistance; PEST analysis; Intervention (counseling); Biotechnology; Quality of life (healthcare); Drug development; Clinical trial; Oncology; Drug; Pharmacology; Internal medicine; Biology; Business; Nursing; Ecology; Marketing","score_opus":0.2780539585323155,"score_gpt":0.49891746048036983,"score_spread":0.22086350194805432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403051377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100953555,0.9913216,0.0000010989097,0.00096295524,0.00036546905,0.0020950714,0.0036198162,0.00014904473,0.0013839651],"genre_scores_gemma":[0.000093013674,0.9696037,0.000033783497,0.0000379721,0.00096667366,0.013289635,0.0002746547,0.000008307801,0.015692217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747074,0.00018306433,0.00033118925,0.00081886497,0.00050608633,0.00069006754],"domain_scores_gemma":[0.9992063,0.000288823,0.00007704907,0.0001588894,0.00015415861,0.00011479966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005662178,0.00031122603,0.00078503817,0.0000651061,0.00032675866,0.00021816282,0.00089597993,0.0002803619,0.0005783759],"category_scores_gemma":[0.000010772524,0.00011178635,0.00049816497,0.00065494946,0.000111652516,0.000043946173,0.00022531692,0.00064418284,0.00005783552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017608407,0.000016703476,5.6310876e-7,0.0025790455,0.000106740445,0.0000138226405,0.000011565597,6.953711e-9,0.0002201337,0.0016857438,0.036007922,0.95934016],"study_design_scores_gemma":[0.00004316578,0.000038270136,0.000013401977,0.008312491,0.00044656632,2.2693247e-7,0.000044301054,2.3242002e-7,0.000026401134,0.0015008921,0.9893104,0.00026369334],"about_ca_topic_score_codex":0.0028497672,"about_ca_topic_score_gemma":0.005410364,"teacher_disagreement_score":0.95907646,"about_ca_system_score_codex":0.00051655166,"about_ca_system_score_gemma":0.00010485795,"threshold_uncertainty_score":0.63328105},"labels":[],"label_agreement":null},{"id":"W4403247352","doi":"10.1158/1538-7445.pediatric24-ia013","title":"Abstract IA013: Increasing Diversity in Pediatric Cancer Clinical Trials: Challenges and Opportunities","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Medicine; Cancer; Diversity (politics); Pediatric cancer; Intensive care medicine; Oncology; Internal medicine; Political science","score_opus":0.885571842227936,"score_gpt":0.6600600364188882,"score_spread":0.22551180580904773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403247352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60997754,0.35810778,2.6602788e-7,0.025750361,0.00027876472,0.0002265556,0.000015608051,0.000023210792,0.0056199087],"genre_scores_gemma":[0.5190005,0.4798338,0.000003903095,0.00012367828,0.00084836094,0.000030945605,7.511277e-7,0.0000066987036,0.00015139412],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974867,0.0009605276,0.0003626505,0.00033837763,0.0004797168,0.0003720309],"domain_scores_gemma":[0.9932088,0.006248179,0.000040266532,0.00010664976,0.000119456985,0.00027665036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01575867,0.00009801299,0.00040997585,0.00020693571,0.0001873755,0.00005660949,0.00009038529,0.00010354159,0.00056871393],"category_scores_gemma":[0.0021093576,0.00007346334,0.00007347982,0.00018881977,0.0002147412,0.00018217841,0.0004176064,0.001107282,0.000014385213],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013153133,0.00011044546,0.06403642,0.0017160722,0.00019788835,0.0005874652,0.0013519343,4.7343087e-7,0.00009053051,0.00044488124,0.004932451,0.92521614],"study_design_scores_gemma":[0.0016097169,0.00019380137,0.69747376,0.00072057877,0.00027646846,0.0000133269705,0.002228718,0.00015270535,0.000053731557,0.00059321785,0.2964987,0.00018528196],"about_ca_topic_score_codex":0.0029792057,"about_ca_topic_score_gemma":0.00061453186,"teacher_disagreement_score":0.9250308,"about_ca_system_score_codex":0.00015828133,"about_ca_system_score_gemma":0.00040258653,"threshold_uncertainty_score":0.6227019},"labels":[],"label_agreement":null},{"id":"W4404040119","doi":"10.1158/0008-5472.can-24-2248","title":"FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hospital for Sick Children; University of Toronto; Centre Hospitalier Universitaire Sainte-Justine; McGill Genome Centre; McGill University; McGill University Health Centre; McGill-Queen's University Press; Jewish General Hospital","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; Lady Davis Institute for Medical Research; Fonds de Recherche du Québec - Santé; Faculty of Medicine, McGill University; Natural Sciences and Engineering Research Council of Canada; Fondation Charles-Bruneau; National Institute of Neurological Disorders and Stroke; Great Ormond Street Hospital Charity; Cancer Research UK; Alex's Lemonade Stand Foundation for Childhood Cancer; Brain Research UK; Rally Foundation; Canadian Institutes of Health Research; Genome Canada; St. Baldrick's Foundation","keywords":"Ganglionic eminence; Biology; Neural stem cell; Neuroscience; Cerebrum; Progenitor cell; Fate mapping; Gliogenesis; Transcription factor; Carcinogenesis; Progenitor; Chromatin; Central nervous system; Stem cell; Cell biology; Genetics; Gene","score_opus":0.05413190711925241,"score_gpt":0.413071525950547,"score_spread":0.3589396188312946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404040119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354834,0.0026655116,0.00005208705,0.007460691,0.0009844141,0.0018453962,0.00012753792,0.0004813668,0.0028346325],"genre_scores_gemma":[0.98935646,0.00020818431,0.000088483765,0.0002543568,0.0012063632,0.00057541666,0.000023420089,0.0001231062,0.0081641935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949543,0.00031114902,0.00032798166,0.0009550598,0.0016146373,0.0018368892],"domain_scores_gemma":[0.99719834,0.00032082727,0.000021113316,0.0006152209,0.00042529425,0.0014191857],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039852865,0.00030699492,0.00041496023,0.0007583843,0.0002802946,0.00028586292,0.0003604745,0.00010857029,0.0003566015],"category_scores_gemma":[0.00023398134,0.00024297994,0.00019834643,0.0014575677,0.00019896682,0.00017373567,0.00034750573,0.0011775034,0.0013021888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005498985,0.00097374036,0.005882815,0.006528885,0.001246411,0.06744023,0.002408523,0.0007643228,0.4719751,0.001974941,0.2633966,0.17190947],"study_design_scores_gemma":[0.0076803043,0.017102538,0.13879581,0.007012099,0.00036079768,0.0026252298,0.0015319329,0.02747076,0.5196707,0.00014247117,0.27598763,0.0016196975],"about_ca_topic_score_codex":0.0005974584,"about_ca_topic_score_gemma":0.00011795971,"teacher_disagreement_score":0.17028977,"about_ca_system_score_codex":0.00092927413,"about_ca_system_score_gemma":0.0008242983,"threshold_uncertainty_score":0.9994754},"labels":[],"label_agreement":null},{"id":"W4404293845","doi":"10.1158/0008-5472.can-24-1142","title":"Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or Somatostatinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; American Lebanese Syrian Associated Charities; National Institute of Allergy and Infectious Diseases; V Foundation for Cancer Research; American Cancer Society","keywords":"Neuroblastoma; Cancer research; Cre recombinase; Biology; Tyrosine hydroxylase; N-Myc; Dopamine; Gene; Endocrinology; Genetics; Cell culture; Transgene","score_opus":0.0773631034314157,"score_gpt":0.4189289859950965,"score_spread":0.3415658825636808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404293845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849164,0.00010086346,0.000040841325,0.00025406564,0.000042991964,0.0005084745,0.000058337435,0.000022248169,0.0004805285],"genre_scores_gemma":[0.998003,0.00005545973,0.0002898566,0.000008766483,0.000032358832,0.0002060915,0.00004915455,0.000025415102,0.0013298668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980589,0.00010950282,0.0003435655,0.00029833347,0.0008418152,0.00034788038],"domain_scores_gemma":[0.9990081,0.00040868702,0.00003989656,0.00016767724,0.0002479683,0.00012762923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029299356,0.00011120988,0.00022513958,0.00066062075,0.00005126718,0.000018021356,0.00011262063,0.00004700351,0.0004671793],"category_scores_gemma":[0.00013214922,0.000082939725,0.000042022748,0.0009219417,0.0002165217,0.00011149853,0.000086268556,0.00034172134,0.000032190266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011310512,0.00042322604,0.0035788564,0.001370444,0.000095518764,0.00041100188,0.00076460186,0.000018131346,0.97927856,0.0002065227,0.0007961575,0.0119259115],"study_design_scores_gemma":[0.0010707967,0.0005031369,0.09004835,0.0007728317,0.000006313226,0.000015033742,0.00012654702,0.000225654,0.9061759,0.000111696674,0.0008825698,0.00006113966],"about_ca_topic_score_codex":0.00010629465,"about_ca_topic_score_gemma":0.00009822375,"teacher_disagreement_score":0.086469494,"about_ca_system_score_codex":0.00026083572,"about_ca_system_score_gemma":0.0016380722,"threshold_uncertainty_score":0.51152855},"labels":[],"label_agreement":null},{"id":"W4404451062","doi":"10.1158/1538-7445.tumbody-c012","title":"Abstract C012: Dissemination of retrotransposable elements from the non-coding genome in tumor-derived extracellular vesicles target stromal and immune cells to induce local and systemic inflammation","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Extracellular vesicles; Stromal cell; Inflammation; Immune system; Microvesicles; Biology; Extracellular; Genome; Systemic inflammation; Cancer research; Cell biology; Immunology; Genetics; Gene; microRNA","score_opus":0.016929949486570086,"score_gpt":0.315153587091091,"score_spread":0.2982236376045209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97700197,0.020877184,0.0012318437,0.00013055331,0.000059776336,0.00055068935,0.000118245385,0.000005796058,0.00002392432],"genre_scores_gemma":[0.9987981,0.00062307087,0.0001950353,0.0000043527784,0.00012371244,0.000100130295,0.000079527854,0.00002548027,0.000050626502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862456,0.00011473647,0.00032556496,0.0003764878,0.00028161227,0.00027703322],"domain_scores_gemma":[0.99943393,0.00009089596,0.000048642167,0.0002515883,0.00008559801,0.00008934663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009028984,0.00011970728,0.00013519055,0.000090115675,0.00007742259,0.000075564,0.0002042785,0.00008511889,0.00003020433],"category_scores_gemma":[0.00006387466,0.00010620473,0.000029884995,0.00019860563,0.00015187533,0.000020324198,0.00012582685,0.00023067584,0.0000034356058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120192206,0.000017420904,0.0018655398,0.00030266147,0.00003222867,0.000022025037,0.00059379305,0.00019033901,0.9942102,0.00002277303,0.000032910528,0.002589912],"study_design_scores_gemma":[0.00020142345,0.00007055045,0.03515636,0.00055598904,0.000009774518,0.0000018092628,0.0007225761,0.00060105463,0.9623698,0.00006644284,0.00013715918,0.00010706388],"about_ca_topic_score_codex":0.00024433425,"about_ca_topic_score_gemma":0.000060488088,"teacher_disagreement_score":0.033290822,"about_ca_system_score_codex":0.00007967904,"about_ca_system_score_gemma":0.00011921675,"threshold_uncertainty_score":0.43309033},"labels":[],"label_agreement":null},{"id":"W4404451099","doi":"10.1158/1538-7445.tumbody-a025","title":"Abstract A025: Extracellular-vesicles from the peri-prostatic adipose tissue of obese, but not lean, men promote prostate cancer aggressivity","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prostate Cancer Canada","funders":"","keywords":"Adipose tissue; Prostate cancer; Medicine; Cancer; Prostate; Extracellular vesicles; Internal medicine; Extracellular vesicle; Endocrinology; Oncology; Biology; Microvesicles; Biochemistry; Cell biology; Gene; microRNA","score_opus":0.05143245163781155,"score_gpt":0.3772730400277233,"score_spread":0.32584058838991176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.788373,0.20536633,0.000010098856,0.0033741766,0.00017069308,0.0014196672,0.0008014782,0.000064615284,0.00041998003],"genre_scores_gemma":[0.9834864,0.008703043,0.00004159345,0.000068367626,0.0006944633,0.0004936572,0.00007078024,0.00007187131,0.0063697854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668497,0.00020976826,0.00037626157,0.00067213696,0.0014009912,0.0006558444],"domain_scores_gemma":[0.99809915,0.00032197993,0.00007145118,0.0008506182,0.00032608758,0.00033073782],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012190068,0.0002461489,0.00048510873,0.00012895155,0.000243404,0.00014835047,0.00032929707,0.00012390678,0.0010470799],"category_scores_gemma":[0.00016482556,0.00016700124,0.0003022544,0.00058190123,0.00051589665,0.00017722706,0.00019603825,0.0009840091,0.000090327456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008023881,0.00017819027,0.0034047244,0.0020045273,0.0013832279,0.0009520788,0.0024238161,0.000032546483,0.8155014,0.00008478186,0.005772329,0.16746001],"study_design_scores_gemma":[0.0013552278,0.00017521255,0.11709401,0.0048582293,0.0008105599,0.000021293929,0.0005866639,0.00043570463,0.84435767,0.00039652572,0.02959638,0.0003125209],"about_ca_topic_score_codex":0.007955837,"about_ca_topic_score_gemma":0.00037427846,"teacher_disagreement_score":0.19666329,"about_ca_system_score_codex":0.00022057872,"about_ca_system_score_gemma":0.001239442,"threshold_uncertainty_score":0.9998661},"labels":[],"label_agreement":null},{"id":"W4404451110","doi":"10.1158/1538-7445.tumbody-b025","title":"Abstract B025: Primary and metastatic tumors from triple negative breast cancer possess distinct immunological profiles","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Cancer; Breast cancer; Oncology; Triple negative; Triple-negative breast cancer; Metastatic breast cancer; Internal medicine; Cancer research; Pathology","score_opus":0.11590907836491267,"score_gpt":0.462187613932877,"score_spread":0.34627853556796434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97311896,0.015124263,0.000020276277,0.007706378,0.00006250105,0.000625645,0.0012213037,0.000084595864,0.0020360812],"genre_scores_gemma":[0.9953563,0.0017592219,0.00009757745,0.00009338026,0.0003841845,0.0009813461,0.00008400679,0.00002348308,0.0012204801],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848074,0.00005939862,0.00021262262,0.00046698525,0.0004020076,0.00037822122],"domain_scores_gemma":[0.9988182,0.00055782916,0.000022656037,0.00020765768,0.00015132583,0.00024231197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029267033,0.00014402445,0.000266637,0.00006103643,0.00016440135,0.000098203505,0.00013865366,0.00006292442,0.0026293995],"category_scores_gemma":[0.00009165332,0.00010403069,0.000056831843,0.00044278297,0.00057058915,0.00012033951,0.00008829276,0.00088521215,0.000043154647],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011279853,0.00031505423,0.003266202,0.0017890049,0.0005212622,0.0005525132,0.00036254237,0.0000038071432,0.8986749,0.00067763485,0.0052363793,0.08747269],"study_design_scores_gemma":[0.0022521089,0.00012385145,0.6393503,0.0019392223,0.00028102164,0.00017194307,0.0007248041,0.0007127132,0.34057888,0.003358113,0.0100655155,0.0004415431],"about_ca_topic_score_codex":0.0012105803,"about_ca_topic_score_gemma":0.000013820545,"teacher_disagreement_score":0.6360841,"about_ca_system_score_codex":0.00030821044,"about_ca_system_score_gemma":0.0005730774,"threshold_uncertainty_score":0.9982823},"labels":[],"label_agreement":null},{"id":"W4404451134","doi":"10.1158/1538-7445.tumbody-c005","title":"Abstract C005: Tumor vaccines and oncolytic virotherapy: systemic immunity vs. tumor microenvironment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunity; Tumor microenvironment; Immunology; Virology; Cancer research; Immune system","score_opus":0.03205470280149351,"score_gpt":0.36712655058101745,"score_spread":0.3350718477795239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94568,0.052349433,0.000009302539,0.00069238665,0.00013738968,0.00071936543,0.000068193556,0.000029516155,0.00031437643],"genre_scores_gemma":[0.98781323,0.0091609815,0.000018579569,0.00020938042,0.00051863556,0.00045118475,0.00002626395,0.000088122084,0.0017136069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754256,0.00029428146,0.000264425,0.00066744076,0.0005170799,0.0007142342],"domain_scores_gemma":[0.9989149,0.00008197451,0.000031518084,0.0006482905,0.00009850541,0.00022483926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014254495,0.00023076382,0.00022512347,0.00019993319,0.00024423274,0.00018712522,0.00046735496,0.00009690822,0.00048144514],"category_scores_gemma":[0.000045688215,0.00020405959,0.000089154346,0.00026862294,0.00026924588,0.000010796315,0.00027802947,0.00059712655,0.00013686488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015362815,0.000060116246,0.0006987447,0.00038355702,0.00012923878,0.00007387327,0.00009709818,0.00003097919,0.9836048,0.000008923791,0.0030468367,0.010329545],"study_design_scores_gemma":[0.0009615555,0.002115412,0.0034772812,0.00040353648,0.000013682723,0.00011110316,0.00023657166,0.000099635836,0.9344375,0.00009202127,0.05768795,0.00036372422],"about_ca_topic_score_codex":0.0003947814,"about_ca_topic_score_gemma":0.00034125935,"teacher_disagreement_score":0.054641113,"about_ca_system_score_codex":0.00026967193,"about_ca_system_score_gemma":0.0005471379,"threshold_uncertainty_score":0.83213085},"labels":[],"label_agreement":null},{"id":"W4404451153","doi":"10.1158/1538-7445.tumbody-pr018","title":"Abstract PR018: Inflammation-induced mechanotransduction is necessary and sufficient to create pre-cancerous squamous lung metaplasias and necessary to drive progression to dysplasia","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Inflammation; Mechanotransduction; Medicine; Lung; Dysplasia; Pathology; Cancer research; Internal medicine; Biology; Neuroscience","score_opus":0.04279189732606305,"score_gpt":0.4011355353077976,"score_spread":0.3583436379817346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694431,0.0061250324,0.00021195448,0.02004079,0.00048012022,0.0031499965,0.000060617196,0.00012063546,0.0003677491],"genre_scores_gemma":[0.99551606,0.0011045141,0.0003104688,0.00051127345,0.00047461205,0.0011833123,0.000017426806,0.000065785294,0.00081654923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969174,0.00009848691,0.00040885308,0.0009159362,0.000993634,0.0006656881],"domain_scores_gemma":[0.9985028,0.00016570436,0.00004046008,0.00037634667,0.00032559506,0.0005891262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010142162,0.00028538745,0.00036320972,0.0007512717,0.00030270073,0.0002949725,0.00016648577,0.00016766904,0.0003705233],"category_scores_gemma":[0.00009136903,0.00023551172,0.000067155874,0.0014415527,0.00009559671,0.00026354066,0.00013397064,0.00050477777,0.000033869528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055650156,0.000070650916,0.00083072245,0.0012052472,0.00022349518,0.00009339651,0.013850015,0.00006534119,0.7871626,0.000042075866,0.009239412,0.18165204],"study_design_scores_gemma":[0.0025140375,0.0034253413,0.08175315,0.004638749,0.00020945306,0.00013206934,0.0023147648,0.00096235494,0.86430466,0.00007536048,0.038948584,0.00072148157],"about_ca_topic_score_codex":0.0015972104,"about_ca_topic_score_gemma":0.000490645,"teacher_disagreement_score":0.18093055,"about_ca_system_score_codex":0.0007214335,"about_ca_system_score_gemma":0.0005431712,"threshold_uncertainty_score":0.9603889},"labels":[],"label_agreement":null},{"id":"W4404451222","doi":"10.1158/1538-7445.tumbody-a022","title":"Abstract A022: Disrupting redox homeostasis initiates anti-tumor immune responses in pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreatic cancer; Immune system; Homeostasis; Cancer; Medicine; Cancer research; Immunology; Internal medicine","score_opus":0.10657518161840639,"score_gpt":0.4440080008370467,"score_spread":0.3374328192186403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87927926,0.11306532,0.0000017752188,0.0048121973,0.00032925303,0.0006915055,0.00012831307,0.00011931005,0.0015730681],"genre_scores_gemma":[0.9708407,0.025889518,0.00004221615,0.00018628383,0.00051805424,0.0015975445,0.000018511564,0.0000955334,0.0008116545],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965323,0.00021803885,0.00056604174,0.00071464904,0.00095973484,0.0010091861],"domain_scores_gemma":[0.9982834,0.0006583239,0.00005475636,0.00047849148,0.0002883498,0.00023669284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018541462,0.00025879455,0.0005823587,0.0008359421,0.0001981467,0.00022347954,0.00025905384,0.00011792467,0.003258128],"category_scores_gemma":[0.00046849533,0.0002147053,0.00016575791,0.0019493653,0.00030049455,0.00025157782,0.00015891621,0.0012042964,0.000116390125],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002625441,0.00048145305,0.3267103,0.0073847375,0.00062938326,0.002469776,0.0036391919,0.000052657255,0.46613884,0.00035411716,0.011494859,0.17801924],"study_design_scores_gemma":[0.0016336989,0.00040909045,0.8350276,0.013137314,0.00013000862,0.000042255502,0.0024561072,0.00038934994,0.11981191,0.00015765284,0.026274133,0.0005309157],"about_ca_topic_score_codex":0.008064065,"about_ca_topic_score_gemma":0.00057337247,"teacher_disagreement_score":0.50831723,"about_ca_system_score_codex":0.0009721885,"about_ca_system_score_gemma":0.0015105517,"threshold_uncertainty_score":0.9985413},"labels":[],"label_agreement":null},{"id":"W4404451239","doi":"10.1158/1538-7445.tumbody-a035","title":"Abstract A035: Infection of primary mammary fibroblasts with cytomegalovirus coordinately increases autotaxin-lysophosphatidate-inflammatory signaling, which could increase breast cancer metastasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Autotaxin; Metastasis; Cancer; Medicine; Cancer research; Breast cancer; Cytomegalovirus; Internal medicine; Immunology; Receptor; Virus; Herpesviridae; Viral disease","score_opus":0.0405475897223617,"score_gpt":0.3469896181181868,"score_spread":0.3064420283958251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404451239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854917,0.010389585,0.000048885515,0.0012484947,0.0004232245,0.00084989466,0.00032260496,0.00023903353,0.0009865846],"genre_scores_gemma":[0.98854405,0.008963105,0.000112578295,0.00026599792,0.0005124574,0.0005396379,0.00015357666,0.000092358976,0.00081622676],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967107,0.00029989696,0.0005357248,0.00075936626,0.0010195973,0.0006747164],"domain_scores_gemma":[0.9969075,0.0004583604,0.00014628503,0.00055131956,0.0015042472,0.00043228673],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011032115,0.00035618388,0.00069044315,0.00076338847,0.00019777508,0.0001490706,0.00019780775,0.00025901414,0.002567828],"category_scores_gemma":[0.000114220886,0.0002792622,0.00015699827,0.0017913756,0.00039202604,0.0007996635,0.00016307189,0.0011350459,0.00010771231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013339998,0.0007946044,0.03391075,0.011532105,0.0020538603,0.0013649237,0.000406355,0.000963248,0.8303614,0.00041144993,0.02438608,0.08047518],"study_design_scores_gemma":[0.0066096256,0.002795029,0.67306566,0.012362606,0.0008306015,0.0011089018,0.00032022735,0.00083288364,0.25737214,0.00029193616,0.04307648,0.0013338993],"about_ca_topic_score_codex":0.01484791,"about_ca_topic_score_gemma":0.0010196365,"teacher_disagreement_score":0.6391549,"about_ca_system_score_codex":0.0008206187,"about_ca_system_score_gemma":0.0037504085,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W4405181043","doi":"10.1158/0008-5472.can-24-1875","title":"Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Adenosine; Cytotoxic T cell; Chemistry; Adenosine receptor; Cell biology; Nucleoside transporter; Pharmacology; Biology; Cancer research; Biochemistry; Receptor; Transporter; Agonist","score_opus":0.04959450282080792,"score_gpt":0.35291025576057533,"score_spread":0.3033157529397674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9058447,0.08839754,0.00017173083,0.002520066,0.00012794948,0.00020065694,0.000068781315,0.000021266796,0.0026473168],"genre_scores_gemma":[0.9860786,0.011757503,0.00006599937,0.00013545346,0.00054281676,0.00011004092,0.000027523338,0.000037335947,0.0012446898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872583,0.00012427119,0.00016829303,0.0003612423,0.00025264095,0.00036771028],"domain_scores_gemma":[0.9993591,0.0001237399,0.00001737601,0.00035485192,0.00007932841,0.000065610264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035838972,0.00014190224,0.0001292169,0.000046911213,0.00025370682,0.000121846184,0.00030410083,0.00009390664,0.00034703055],"category_scores_gemma":[0.000043730677,0.00009743933,0.000068375375,0.00021311444,0.00027941732,0.000012157893,0.00012757599,0.000331814,0.000013263877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010065001,0.00004271268,0.00021412513,0.00021887381,0.00009882789,0.00004364,0.0003929143,0.000040899442,0.94540817,0.00023574608,0.052124865,0.0010785664],"study_design_scores_gemma":[0.00014760932,0.00008180579,0.0005960411,0.000107545544,0.000044415814,0.000017832592,0.00031362218,0.000032095046,0.8180438,0.000121586956,0.18036015,0.00013347882],"about_ca_topic_score_codex":0.0005584347,"about_ca_topic_score_gemma":0.000027615977,"teacher_disagreement_score":0.12823528,"about_ca_system_score_codex":0.000013018977,"about_ca_system_score_gemma":0.00014979296,"threshold_uncertainty_score":0.39734608},"labels":[],"label_agreement":null},{"id":"W4405182706","doi":"10.1158/0008-5472.can-24-2052","title":"Plasma Cell–Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Canada's Michael Smith Genome Sciences Centre; Occupational Cancer Research Centre; BC Cancer Agency; University of British Columbia","funders":"Intramural Research Program; National Institutes of Health","keywords":"Prostate cancer; Cancer research; Immunoprecipitation; Phenotype; Biology; Medicine; Cancer; Internal medicine; Genetics; Gene","score_opus":0.08307303704932385,"score_gpt":0.4592454300956394,"score_spread":0.37617239304631556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405182706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95410013,0.04065672,0.000004260286,0.0019331446,0.00042335573,0.0020913936,0.00009036705,0.00009272252,0.00060790894],"genre_scores_gemma":[0.97236675,0.022577954,0.00042961884,0.000042215794,0.00029981756,0.001511753,0.000056016797,0.00006912875,0.0026467561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99662197,0.0003435527,0.00052439614,0.0008219785,0.0008119816,0.0008761396],"domain_scores_gemma":[0.9984203,0.00046495197,0.000046129484,0.00046263705,0.0003053918,0.0003006151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001630392,0.00022987327,0.00041547974,0.00044977164,0.00018123334,0.00013930675,0.00021779914,0.00017468819,0.00014348983],"category_scores_gemma":[0.00024175154,0.00018338714,0.00009239346,0.00094945607,0.00038520416,0.00027220292,0.00026008984,0.0011498587,0.000042821517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005091984,0.00049043103,0.2223292,0.0041121454,0.0003740506,0.0005895948,0.0028002819,0.00009096215,0.48065934,0.00012251147,0.0020629505,0.28127655],"study_design_scores_gemma":[0.015912028,0.0020546794,0.23636647,0.0045519844,0.000134592,0.00002481756,0.0011886961,0.0060524507,0.7254873,0.0010013683,0.0065957475,0.0006298568],"about_ca_topic_score_codex":0.0006060208,"about_ca_topic_score_gemma":0.0011473952,"teacher_disagreement_score":0.2806467,"about_ca_system_score_codex":0.0010643117,"about_ca_system_score_gemma":0.0016078267,"threshold_uncertainty_score":0.747831},"labels":[],"label_agreement":null},{"id":"W4405896280","doi":"10.1158/0008-5472.can-24-4907","title":"Switching Drivers: Epigenetic Rewiring to Genetic Progression in Glioma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Epigenetics; CDKN2A; Glioma; Cancer research; Biology; Tumor progression; PDGFRA; CDKN2B; Gene; Genetics; Stromal cell","score_opus":0.08285975771946295,"score_gpt":0.4691280991689585,"score_spread":0.3862683414494955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405896280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98045045,0.014103194,0.000024992838,0.0038449243,0.00016415826,0.00081563223,0.000002431759,0.00005245776,0.0005417812],"genre_scores_gemma":[0.9977576,0.0005885087,0.0005673229,0.000048147856,0.00020658066,0.00066665024,0.0000020533182,0.000032037926,0.00013109265],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827576,0.00006879016,0.00016786892,0.00042364077,0.00057146256,0.0004924769],"domain_scores_gemma":[0.9993058,0.00010398615,0.0000079358115,0.00025871166,0.00008530278,0.00023829863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003735678,0.00010374875,0.00016268983,0.0007316954,0.00007732132,0.00009124466,0.00010142557,0.000055604934,0.00020586528],"category_scores_gemma":[0.00007157928,0.00008094121,0.000047936705,0.0012022763,0.000029908539,0.000043098767,0.00012259993,0.00030431862,0.0002503737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012495837,0.00023477341,0.1332047,0.00046991097,0.000073325755,0.00658891,0.0020048516,0.00017333636,0.38369682,0.000120368284,0.0024121355,0.47089592],"study_design_scores_gemma":[0.0026062706,0.00145264,0.42068392,0.012714193,0.00007601942,0.00015368153,0.0006225656,0.001711073,0.526477,0.0006839079,0.032428525,0.00039021403],"about_ca_topic_score_codex":0.00044922842,"about_ca_topic_score_gemma":0.00020278477,"teacher_disagreement_score":0.47050568,"about_ca_system_score_codex":0.000592352,"about_ca_system_score_gemma":0.00024837238,"threshold_uncertainty_score":0.33006868},"labels":[],"label_agreement":null},{"id":"W4405990978","doi":"10.1158/0008-5472.can-24-0744","title":"MICAL2 Promotes Pancreatic Cancer Growth and Metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; McGill University; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Stand Up To Cancer; University of California, San Diego; Canadian Cancer Society Research Institute; National Institutes of Health; Terry Fox Research Institute; Foundation for the National Institutes of Health; Cancer Research UK; Ontario Institute for Cancer Research; Pancreatic Cancer Canada Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; Government of Ontario; American Association for Cancer Research; Princess Margaret Cancer Foundation; Hebrew University of Jerusalem","keywords":"KRAS; Cancer research; Metastasis; Biology; Pancreatic cancer; Transcription factor; Cancer; Genetics; Gene","score_opus":0.0420754202479576,"score_gpt":0.3923258082472749,"score_spread":0.3502503879993173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405990978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945536,0.05036105,0.00015133678,0.0022778385,0.000055637272,0.00018906759,0.000020346964,0.0000075412463,0.0014011627],"genre_scores_gemma":[0.99053097,0.0056330455,0.00015666313,0.00021218737,0.00020720302,0.00022974885,0.000012110057,0.000012040645,0.0030060222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990643,0.000101514,0.00010355849,0.00030237986,0.00014533273,0.00028287317],"domain_scores_gemma":[0.9995587,0.000040728642,0.00001566949,0.00017086981,0.00014621015,0.000067832705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024372556,0.00008734266,0.000116524934,0.00007953643,0.00012740202,0.000035147455,0.00014772428,0.00007409944,0.00008898066],"category_scores_gemma":[0.00009948991,0.00007397295,0.00003150601,0.00024597876,0.00014151812,0.0000027951369,0.00016789213,0.000144746,0.000002057356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010532478,0.000031247095,0.013999453,0.00019043108,0.0002331578,0.0000045781085,0.00005414744,0.000007501516,0.9492252,0.00084065506,0.031636037,0.0036722685],"study_design_scores_gemma":[0.0004190321,0.00009078115,0.0019714297,0.00010755847,0.00004906708,0.0000021444487,0.00008314059,0.000022965289,0.9723097,0.0008463348,0.023964886,0.00013297806],"about_ca_topic_score_codex":0.0008363643,"about_ca_topic_score_gemma":0.000043401073,"teacher_disagreement_score":0.044994958,"about_ca_system_score_codex":0.000018709843,"about_ca_system_score_gemma":0.00028040577,"threshold_uncertainty_score":0.30165294},"labels":[],"label_agreement":null},{"id":"W4407052516","doi":"10.1158/1538-7445.dnamethylation-b008","title":"Abstract B008: <i>Machine-learning modelling of lung cancer metastasis to the brain using alterations in DNA methylation</i>","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network; Thompson Rivers University; University of Toronto","funders":"","keywords":"DNA methylation; Cancer; Lung cancer; Methylation; Metastasis; Brain metastasis; Cancer research; Medicine; Computational biology; DNA; Oncology; Biology; Internal medicine; Genetics; Gene; Gene expression","score_opus":0.09172627303431077,"score_gpt":0.4598031114538534,"score_spread":0.36807683841954264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407052516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015945,0.0073644277,0.04528203,0.04320328,0.00021358617,0.0008215001,0.000019390975,0.000025711593,0.0014755472],"genre_scores_gemma":[0.99543804,0.0005980199,0.0017852488,0.0009390687,0.00016482676,0.0001445731,0.000010432257,0.000026108677,0.00089369406],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979849,0.00029717598,0.000401368,0.00031576675,0.00058302336,0.00041778095],"domain_scores_gemma":[0.998533,0.00069197867,0.00006637012,0.00027530125,0.00030829426,0.00012503374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029662177,0.000120519,0.0003042619,0.0005887497,0.0003053574,0.00005689235,0.00022142332,0.00005744791,0.00018877051],"category_scores_gemma":[0.00096034823,0.00009104704,0.000078739555,0.0014919944,0.0001125881,0.0000878626,0.00011367333,0.0013064563,0.0000020142015],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014055245,0.0000553113,0.013325135,0.0003348933,0.00014733858,0.000010793667,0.0017000759,0.88708174,0.0690438,0.0005656188,0.002040271,0.02555449],"study_design_scores_gemma":[0.0007466803,0.000026064923,0.0023399033,0.0011725808,0.000063793355,0.0000019498495,0.00025151978,0.9731091,0.009079811,0.00014974725,0.012952994,0.00010585052],"about_ca_topic_score_codex":0.011551011,"about_ca_topic_score_gemma":0.00061462016,"teacher_disagreement_score":0.0938435,"about_ca_system_score_codex":0.0003758565,"about_ca_system_score_gemma":0.00071948994,"threshold_uncertainty_score":0.9950312},"labels":[],"label_agreement":null},{"id":"W4407353657","doi":"10.1158/0008-5472.can-24-1793","title":"The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Winnipeg; University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Max Rady College of Medicine, University of Manitoba; CancerCare Manitoba Foundation; National Institutes of Health; Mitacs; Cancer Research Society","keywords":"Lapatinib; Brain metastasis; ErbB; Cancer research; Breast cancer; Medicine; Trastuzumab; Metastasis; ERBB3; Tyrosine-kinase inhibitor; Protein kinase B; In vivo; Cancer; Pharmacology; Epidermal growth factor receptor; Apoptosis; Internal medicine; Biology","score_opus":0.0386829827507961,"score_gpt":0.4128645391555423,"score_spread":0.37418155640474615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407353657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65108156,0.06817607,0.00014505179,0.26998183,0.0013805233,0.0046855765,0.0015731093,0.00016861122,0.0028076577],"genre_scores_gemma":[0.97849494,0.0029716229,0.00013761579,0.0031055047,0.00073518796,0.00135172,0.00005442388,0.00007106899,0.013077932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558026,0.0010026159,0.00040662923,0.0007648069,0.0010780388,0.0011676304],"domain_scores_gemma":[0.9955206,0.0027081033,0.000076800534,0.00074462575,0.0006252453,0.00032460617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028610455,0.00034577472,0.00055209716,0.00029881814,0.0008781936,0.00016532392,0.00035849298,0.00011716959,0.00073940255],"category_scores_gemma":[0.0006620041,0.00021347684,0.00026747675,0.0012383446,0.0005709653,0.00010146224,0.0002311829,0.00087421254,0.000074022],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034074404,0.00082105334,0.010058799,0.0006833224,0.0024436591,0.000429799,0.00036926178,0.000031578937,0.028090969,0.0043721017,0.55763507,0.39165697],"study_design_scores_gemma":[0.009893992,0.0010696566,0.21964061,0.0017195626,0.00044363888,0.00010638998,0.00090107875,0.000103072554,0.079352304,0.0011444576,0.6850982,0.00052705006],"about_ca_topic_score_codex":0.006354903,"about_ca_topic_score_gemma":0.0022214456,"teacher_disagreement_score":0.3911299,"about_ca_system_score_codex":0.000906239,"about_ca_system_score_gemma":0.0016292117,"threshold_uncertainty_score":0.9606754},"labels":[],"label_agreement":null},{"id":"W4407734681","doi":"10.1158/0008-5472.can-24-1643","title":"Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Cytotoxic T cell; Granzyme B; Chimeric antigen receptor; Granzyme; Cancer research; Immunology; T cell; CD8; Homing (biology); CD19; Biology; Immune system; Medicine; In vitro; Perforin","score_opus":0.08047372379180479,"score_gpt":0.3951829907347449,"score_spread":0.3147092669429401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407734681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927142,0.001849211,0.000039348386,0.0021611778,0.00022598256,0.0013577896,0.000028235385,0.00004860076,0.0015754236],"genre_scores_gemma":[0.98711383,0.004641647,0.00008954037,0.00022728404,0.0001717149,0.00032422575,0.0000064545857,0.000028876208,0.0073964405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99646354,0.00052315556,0.00043305196,0.00048285112,0.0011942157,0.00090316683],"domain_scores_gemma":[0.997418,0.0007593442,0.00008540084,0.0007250325,0.0008769548,0.00013530512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002618926,0.00019380655,0.00054080464,0.0003662771,0.00035112214,0.000055241624,0.0006191591,0.00015646496,0.0010455912],"category_scores_gemma":[0.00055245706,0.00012821193,0.00016062515,0.0014216908,0.0012057972,0.000072434836,0.00030237559,0.0010230847,0.000039449213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019007018,0.000099179146,0.0031303414,0.00068917143,0.00012522457,0.00003174644,0.00066188676,0.00004769819,0.98875,0.0003581424,0.0056858286,0.00023075736],"study_design_scores_gemma":[0.0006156135,0.00012648347,0.0011808892,0.00047160283,0.000013957163,0.0000040117848,0.0012138614,0.00011708463,0.9852006,0.00020623962,0.010744399,0.000105256026],"about_ca_topic_score_codex":0.00073912286,"about_ca_topic_score_gemma":0.00008342167,"teacher_disagreement_score":0.005821017,"about_ca_system_score_codex":0.00038557398,"about_ca_system_score_gemma":0.0009997699,"threshold_uncertainty_score":0.9998676},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4408326250","doi":"10.1158/1538-7445.genfunc25-ia026","title":"Abstract IA026: Pan-cancer <i>N</i>-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Medicine; Head and neck cancer; Cancer; Brain cancer; Atlas (anatomy); Oncology; Internal medicine; Surgery; Anatomy","score_opus":0.03458043876608569,"score_gpt":0.38002706983162604,"score_spread":0.34544663106554035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743228,0.022134982,0.00025590014,0.00093201536,0.00025429658,0.0010784284,0.00022148494,0.000008970666,0.0007911491],"genre_scores_gemma":[0.9896318,0.0070035323,0.00020248578,0.00025322664,0.00014735936,0.0018023326,0.000041450287,0.000030994423,0.00088685786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840456,0.00006235279,0.00027451932,0.0005238144,0.0002555394,0.00047923235],"domain_scores_gemma":[0.9989293,0.000038406582,0.000100174904,0.00041789789,0.00041629234,0.000097903176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023858737,0.00017836264,0.00022816332,0.00012508982,0.00021184934,0.00004515989,0.00026978125,0.00016315877,0.000101673824],"category_scores_gemma":[0.000051311068,0.00016541102,0.0001053117,0.00030609145,0.00031991067,0.000011137626,0.00010553955,0.00019200175,0.0000025454028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009344225,0.00004963921,0.0026847383,0.00020222884,0.00020496816,5.959624e-7,0.00014350041,0.00040827334,0.9512118,0.00017352692,0.006134504,0.037851788],"study_design_scores_gemma":[0.0014272084,0.00046817242,0.003827094,0.00016783252,0.000021703136,6.128189e-7,0.00035407758,0.000031214448,0.8350156,0.0006727978,0.15781702,0.00019665924],"about_ca_topic_score_codex":0.0036106636,"about_ca_topic_score_gemma":0.000843417,"teacher_disagreement_score":0.15168253,"about_ca_system_score_codex":0.00021433282,"about_ca_system_score_gemma":0.0014232663,"threshold_uncertainty_score":0.6745266},"labels":[],"label_agreement":null},{"id":"W4408326252","doi":"10.1158/1538-7445.genfunc25-a022","title":"Abstract A022: Decoding aneuploidy: Identifying drivers and therapeutic targets in recurrent breast cancer copy number alterations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Aneuploidy; Breast cancer; Biology; Oncology; Copy-number variation; Cancer; Medicine; Cancer research; Genetics; Chromosome; Genome; Gene","score_opus":0.04739355171319696,"score_gpt":0.41363648850928286,"score_spread":0.3662429367960859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510504,0.0118058855,0.00012237235,0.0012585188,0.0004037254,0.0003044794,0.0001550796,0.000006444818,0.0008384493],"genre_scores_gemma":[0.9798334,0.019172065,0.000049355775,0.00021982443,0.00018286033,0.00020770518,0.000032549873,0.000016644088,0.00028559795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988276,0.000052247302,0.00018295256,0.00039680925,0.00016204211,0.00037838155],"domain_scores_gemma":[0.99943596,0.00006371273,0.000033303244,0.0002102691,0.0001717924,0.00008498274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031193037,0.00011817317,0.00012688071,0.0001213339,0.00019564756,0.00010482888,0.00016874893,0.0000939734,0.00020262077],"category_scores_gemma":[0.000040520965,0.00012469954,0.000037852584,0.00024956817,0.0001244752,0.0000071767327,0.00016502745,0.00025562098,0.000005957854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003621711,0.00016239248,0.33467588,0.00029222932,0.0001830727,0.000021156719,0.00059412874,0.00078561774,0.5605545,0.0012811788,0.01657188,0.084515795],"study_design_scores_gemma":[0.0047271936,0.00016842941,0.5463623,0.00120587,0.00008264463,0.000024332508,0.0014860395,0.0009566136,0.3114789,0.003223964,0.12911181,0.0011719258],"about_ca_topic_score_codex":0.001009049,"about_ca_topic_score_gemma":0.004405997,"teacher_disagreement_score":0.24907559,"about_ca_system_score_codex":0.00020436668,"about_ca_system_score_gemma":0.0004636966,"threshold_uncertainty_score":0.50850993},"labels":[],"label_agreement":null},{"id":"W4408326281","doi":"10.1158/1538-7445.genfunc25-b028","title":"Abstract B028: Functional precision medicine in challenging breast cancer subtypes: Developing preclinical models for tailored therapy in complex and rare histologies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Cancer therapy; Medical physics","score_opus":0.381460089284411,"score_gpt":0.49678218532739127,"score_spread":0.11532209604298027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8697869,0.065718725,0.0020500054,0.057253975,0.00052969716,0.0025915364,0.00009596925,0.0000505363,0.0019226294],"genre_scores_gemma":[0.9613113,0.036541607,0.00030211353,0.0003524263,0.00020605113,0.0008498252,0.0000339491,0.000019997358,0.0003827401],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99810743,0.000078294266,0.00044188445,0.0005095288,0.00040247975,0.00046038596],"domain_scores_gemma":[0.9985847,0.00070344756,0.000051273106,0.00020816422,0.00036309005,0.00008933931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013070224,0.0001535619,0.0004879009,0.0005692088,0.000113960785,0.0000168527,0.00012419722,0.00012883636,0.00044450827],"category_scores_gemma":[0.00018476778,0.00012087455,0.000049558927,0.0005757933,0.00025772647,0.00010621179,0.0000816152,0.0004804138,7.905452e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01431807,0.00026346187,0.038484454,0.0017762507,0.00020836601,0.00003644416,0.0016897814,0.002582634,0.0167492,0.0021137616,0.018814836,0.90296274],"study_design_scores_gemma":[0.016436415,0.00037721664,0.92915535,0.0052720616,0.00003725429,0.000013943019,0.0021784324,0.005061967,0.0017584657,0.0066323127,0.032707736,0.00036885327],"about_ca_topic_score_codex":0.0031237868,"about_ca_topic_score_gemma":0.002964883,"teacher_disagreement_score":0.9025939,"about_ca_system_score_codex":0.0008389659,"about_ca_system_score_gemma":0.0009854301,"threshold_uncertainty_score":0.4929121},"labels":[],"label_agreement":null},{"id":"W4408326422","doi":"10.1158/1538-7445.genfunc25-b013","title":"Abstract B013: Precision medicine platform to guide the treatment of NSCLC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Precision medicine; Medical physics; Intensive care medicine; Oncology; Pathology","score_opus":0.2667261925396261,"score_gpt":0.4624859443440345,"score_spread":0.1957597518044084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383869,0.008693727,0.000022755125,0.01586883,0.00015538477,0.0016558182,0.000012362,0.00002034041,0.03518384],"genre_scores_gemma":[0.98076415,0.0031849085,0.00007398884,0.00016963355,0.00022172296,0.0005035387,0.000015555463,0.000013992561,0.015052536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840456,0.000046957728,0.0003069093,0.0002747967,0.00061718153,0.00034960723],"domain_scores_gemma":[0.9984281,0.00048178367,0.000030568124,0.0005465497,0.0003553951,0.00015759641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006949226,0.0001308688,0.00031274726,0.00031678673,0.0001453041,0.0000123020245,0.00017350698,0.00007398323,0.00095254084],"category_scores_gemma":[0.00015938947,0.00006761289,0.00010065458,0.0007750232,0.0001727638,0.000030963285,0.000045376437,0.00014692935,0.00006458808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001596872,0.00059590756,0.16332568,0.00019974516,0.0004178426,0.00009771688,0.0028735658,0.000002955117,0.047013886,0.0006004244,0.07666414,0.7066113],"study_design_scores_gemma":[0.0037576251,0.0032165025,0.11149054,0.001232962,0.00018251555,0.0000037914754,0.0007669749,0.000080458856,0.2156818,0.00040015197,0.6630761,0.00011054167],"about_ca_topic_score_codex":0.0030860018,"about_ca_topic_score_gemma":0.00022184919,"teacher_disagreement_score":0.7065007,"about_ca_system_score_codex":0.00057954877,"about_ca_system_score_gemma":0.0004482654,"threshold_uncertainty_score":0.9999607},"labels":[],"label_agreement":null},{"id":"W4408326441","doi":"10.1158/1538-7445.genfunc25-a044","title":"Abstract A044: Immune profiling tools for adult and pediatric cancer: From whole genome and transcriptome sequencing to immunotherapy clinical trial design","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Children's Hospital; University Health Network; Hospital for Sick Children; Université Laval; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Transcriptome; Immunotherapy; Computational biology; Cancer immunotherapy; Profiling (computer programming); Genome; Immune system; Clinical trial; Medicine; Cancer; Biology; Bioinformatics; Immunology; Genetics; Internal medicine; Gene; Computer science; Gene expression","score_opus":0.2122654958545585,"score_gpt":0.4736261182405916,"score_spread":0.2613606223860331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9422943,0.046340864,0.001035387,0.0046596006,0.00065649545,0.004600541,0.00028954193,0.000046609424,0.00007665156],"genre_scores_gemma":[0.93666625,0.052119892,0.0031924865,0.0018148444,0.0018734162,0.0031045787,0.000059884078,0.000080462145,0.0010881902],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972333,0.00019380702,0.00078944815,0.00071555784,0.0004229734,0.00064496946],"domain_scores_gemma":[0.997561,0.0011907873,0.000093006165,0.00039479457,0.000550763,0.0002096829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026316755,0.00023736982,0.00063446217,0.00036454076,0.00031749913,0.00020631625,0.00022881375,0.00023932046,0.00012450168],"category_scores_gemma":[0.0004201704,0.0002076118,0.00017634402,0.0006360441,0.00021774271,0.0001866689,0.000050879295,0.0006096701,0.0000031811646],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15142438,0.00008954755,0.0015947311,0.000341226,0.00040835174,0.000008453712,0.0005877145,0.000009548432,0.7176037,0.000018784574,0.0007263628,0.12718722],"study_design_scores_gemma":[0.42976433,0.013665033,0.26273298,0.003333142,0.0009830088,0.000013742593,0.0052326927,0.0005613587,0.17870836,0.0014780439,0.10136497,0.002162334],"about_ca_topic_score_codex":0.0029140557,"about_ca_topic_score_gemma":0.00012018973,"teacher_disagreement_score":0.5388953,"about_ca_system_score_codex":0.0005456849,"about_ca_system_score_gemma":0.0018035113,"threshold_uncertainty_score":0.8466163},"labels":[],"label_agreement":null},{"id":"W4408326527","doi":"10.1158/1538-7445.genfunc25-a025","title":"Abstract A025: Direct <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> and <i>FAT1</i> as potent tumor suppressors in sarcomagenesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CRISPR; In vivo; BAP1; Suppressor; Biology; Cancer research; Medicine; Cancer; Genetics; Gene","score_opus":0.018782877419168943,"score_gpt":0.3521488872475527,"score_spread":0.33336600982838377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96887946,0.016055243,0.000005478232,0.00092333276,0.00012125449,0.00044627363,0.00015651052,0.0000111603695,0.013401311],"genre_scores_gemma":[0.9913761,0.0036737514,0.000027658481,0.00070499536,0.00008753518,0.0002416046,0.000028079894,0.000025919879,0.0038343598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978448,0.00019219534,0.00030227663,0.0006722875,0.0003569053,0.00063150737],"domain_scores_gemma":[0.99911094,0.000068049,0.000035429952,0.00045792328,0.00013550815,0.00019215097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000625062,0.00019900741,0.00024893027,0.00026784078,0.0001222166,0.00009555648,0.0003750319,0.00012047989,0.00011210275],"category_scores_gemma":[0.00026315107,0.00019736405,0.0000754462,0.000419446,0.00026298146,0.000009798967,0.0003708323,0.00022662978,0.000012157304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037123187,0.000144024,0.029524047,0.00018280992,0.000042673615,0.00007368504,0.00005553231,0.0000714313,0.9216016,0.000020316686,0.04654788,0.0013647504],"study_design_scores_gemma":[0.0010301422,0.00007466487,0.079969846,0.0001969614,0.000013350739,0.0000030587998,0.00034528534,0.00000826279,0.88466704,0.00027639026,0.033188988,0.0002260344],"about_ca_topic_score_codex":0.0038066232,"about_ca_topic_score_gemma":0.0019271597,"teacher_disagreement_score":0.0504458,"about_ca_system_score_codex":0.000058500616,"about_ca_system_score_gemma":0.00049221335,"threshold_uncertainty_score":0.8048272},"labels":[],"label_agreement":null},{"id":"W4408326616","doi":"10.1158/1538-7445.genfunc25-a030","title":"Abstract A030: Lessons learned from the Metformin and Active Surveillance Trial (MAST): An opportunity to address intra-patient heterogeneity for biomarker development and precision medicine in low-risk prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Biomarker; Precision medicine; Oncology; Cancer; Internal medicine; Metformin; Pathology","score_opus":0.2379643585295032,"score_gpt":0.4860959972787471,"score_spread":0.24813163874924388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408326616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97576255,0.0060500484,0.00001754403,0.011606563,0.0002102478,0.0055489,0.00065843633,0.000019907264,0.00012581235],"genre_scores_gemma":[0.9844203,0.010585461,0.00012276326,0.00022173849,0.00013891455,0.0039605186,0.00015940006,0.000031012736,0.00035990373],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99677235,0.00042818178,0.0005035709,0.00082209206,0.00074748934,0.00072633027],"domain_scores_gemma":[0.9968746,0.0014704302,0.00010520442,0.00043630664,0.0005358844,0.0005776213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002900023,0.00025738214,0.00051749696,0.00036071538,0.00047436744,0.00007703305,0.00022307107,0.00013918006,0.0001372075],"category_scores_gemma":[0.0015980403,0.00015844248,0.00004054477,0.0006931477,0.00044728827,0.00014881472,0.00028149277,0.000619693,0.0000012329754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09013366,0.00026190092,0.015631942,0.00018855771,0.00028443517,0.000027186914,0.0049592024,0.000011340201,0.007348691,0.000009383022,0.001592159,0.87955153],"study_design_scores_gemma":[0.08601188,0.0030118534,0.70558196,0.0039314637,0.00011244876,0.0000031181441,0.0057655447,0.00038445243,0.14739776,0.00092822226,0.046264894,0.00060642255],"about_ca_topic_score_codex":0.010252735,"about_ca_topic_score_gemma":0.020610075,"teacher_disagreement_score":0.8789451,"about_ca_system_score_codex":0.0007878609,"about_ca_system_score_gemma":0.0021170708,"threshold_uncertainty_score":0.9972612},"labels":[],"label_agreement":null},{"id":"W4408784822","doi":"10.1158/0008-5472.can-24-2266","title":"An Anti-EGFR Antibody–Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Antitumor Responses in KRAS- and BRAF-Mutant Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan; Saskatoon Medical Imaging; Université Laval; Centre hospitalier de l'Université Laval; Saskatchewan Health Authority; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research","keywords":"Nimotuzumab; KRAS; Panitumumab; Medicine; Cetuximab; Colorectal cancer; Antibody-drug conjugate; Cancer research; Epidermal growth factor receptor; Cancer; Antibody; Monoclonal antibody; Pharmacology; Internal medicine; Immunology","score_opus":0.036049744244539654,"score_gpt":0.4232436732835745,"score_spread":0.3871939290390348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408784822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820999,0.010445815,0.0000014349014,0.0052429703,0.00013139824,0.0014151792,0.000081614846,0.000055862434,0.0005258059],"genre_scores_gemma":[0.9873947,0.010389494,0.000068440946,0.00035750653,0.0001052469,0.00073843077,0.000022751196,0.000043518503,0.0008799109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713516,0.00037528508,0.00032042252,0.0007456028,0.0005927636,0.0008307787],"domain_scores_gemma":[0.99846566,0.00041753205,0.00006221696,0.0004148939,0.00036353682,0.00027613342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089087256,0.00027001245,0.0006264483,0.00067222613,0.0002817455,0.00012501123,0.00019386136,0.000096047435,0.00024625243],"category_scores_gemma":[0.0001452921,0.00020188536,0.000047942725,0.0013825706,0.00036733705,0.00021251276,0.00009207774,0.00058879517,0.000010389075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00292474,0.00061221165,0.651504,0.00021265907,0.00019660687,0.0010029242,0.00043990594,0.000017701697,0.3383076,0.00014338894,0.0008670398,0.0037712816],"study_design_scores_gemma":[0.005521616,0.00046840947,0.6150918,0.0013421609,0.0000780599,0.000059103633,0.0004971466,0.00015079393,0.37464896,0.000020568858,0.0019291113,0.00019222818],"about_ca_topic_score_codex":0.009922443,"about_ca_topic_score_gemma":0.0067085465,"teacher_disagreement_score":0.036412127,"about_ca_system_score_codex":0.00057197775,"about_ca_system_score_gemma":0.0015590488,"threshold_uncertainty_score":0.99667054},"labels":[],"label_agreement":null},{"id":"W4409425585","doi":"10.1158/0008-5472.can-24-2418","title":"Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canada Foundation for Innovation","keywords":"Luciferase; Bioluminescence imaging; Metastasis; Cancer research; Genetically modified mouse; Immunotherapy; Immune system; Transgene; Biology; Immunity; Green fluorescent protein; Cancer; In vivo; Immunology; Cell culture; Medicine; Transfection; Gene; Biochemistry","score_opus":0.09148121467931193,"score_gpt":0.3913361983048296,"score_spread":0.29985498362551766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409425585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046254,0.00490418,0.0032187006,0.00027041935,0.00002033951,0.0010684363,0.000031326468,0.0000052693413,0.00001879009],"genre_scores_gemma":[0.97829884,0.0003843438,0.020475116,0.00007699404,0.000040591287,0.00059156434,0.000015886848,0.000013201102,0.00010348278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848026,0.0001012447,0.00028097082,0.0004497877,0.00019584899,0.0004918899],"domain_scores_gemma":[0.9989703,0.00004864288,0.000045717254,0.0002547463,0.00054483267,0.00013571711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008874106,0.00014683904,0.00022669547,0.00011882514,0.0003214831,0.000047453992,0.0002678336,0.00010367215,0.0000027985043],"category_scores_gemma":[0.00037800244,0.00012925618,0.000033606942,0.00031880557,0.00036955535,0.000014460175,0.0005458072,0.00020277895,1.3562513e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027366023,0.000054100587,0.00071342406,0.00047577603,0.000048538186,5.0570395e-7,0.00019709134,0.000021914972,0.9872761,0.00003587593,0.000048623282,0.010854441],"study_design_scores_gemma":[0.00048129325,0.00013526138,0.00038565305,0.00029008518,0.000007952193,0.000001893357,0.00059729745,0.0018788645,0.99537176,0.00007590214,0.0006371411,0.00013691379],"about_ca_topic_score_codex":0.00039048996,"about_ca_topic_score_gemma":0.00010993248,"teacher_disagreement_score":0.017256415,"about_ca_system_score_codex":0.00006898085,"about_ca_system_score_gemma":0.000719157,"threshold_uncertainty_score":0.5270914},"labels":[],"label_agreement":null},{"id":"W4409624278","doi":"10.1158/1538-7445.am2025-3678","title":"Abstract 3678: Liquid biopsy fragmentomics approach for the diagnosis of uterine tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Pathology; Liquid biopsy; Biopsy; Cancer; Internal medicine","score_opus":0.049657254259667306,"score_gpt":0.3906006465699898,"score_spread":0.34094339231032245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839307,0.008385436,0.0034732253,0.0010452112,0.00022706192,0.00079805,0.00040727863,0.000005158926,0.0017278646],"genre_scores_gemma":[0.9892099,0.007527618,0.00044823054,0.00018259231,0.00031398688,0.0013294535,0.00006322687,0.000020167232,0.00090485625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898356,0.000024158191,0.00020623625,0.0003017624,0.00016220662,0.00032209093],"domain_scores_gemma":[0.9989502,0.00019617862,0.00005016987,0.00046166652,0.0002878201,0.000054002252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005356874,0.00010384253,0.0001392828,0.00008010247,0.0001395096,0.00003446375,0.00043899214,0.000092918075,0.000041435233],"category_scores_gemma":[0.00023615666,0.00008223219,0.00010002231,0.00022183635,0.00021542575,0.0000020492296,0.0002575122,0.00013648423,9.878321e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002122633,0.00038597977,0.006206543,0.00090202386,0.00043481367,0.000002665199,0.00012779911,0.002993233,0.8958648,0.0038483795,0.067531325,0.019579817],"study_design_scores_gemma":[0.0007706088,0.00030476434,0.002803539,0.000054671487,0.000019596519,0.0000011022638,0.00026852288,0.0002244786,0.7744771,0.00019616354,0.22073328,0.00014615037],"about_ca_topic_score_codex":0.0005210541,"about_ca_topic_score_gemma":0.000055917117,"teacher_disagreement_score":0.15320197,"about_ca_system_score_codex":0.000060355276,"about_ca_system_score_gemma":0.0003952787,"threshold_uncertainty_score":0.33533314},"labels":[],"label_agreement":null},{"id":"W4409624304","doi":"10.1158/1538-7445.am2025-1118","title":"Abstract 1118: The GENIE BPC BRCA Cohort: a real-world repository of standardized clinical and genomic data for young patients with breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Cancer; Breast cancer; Real world data; Oncology; Internal medicine; Computer science; Data science","score_opus":0.048562685616541916,"score_gpt":0.42664734264071785,"score_spread":0.37808465702417593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918919,0.0027073966,0.00006285775,0.000648867,0.00031149137,0.0011001243,0.0025786555,0.0000056983754,0.0006930163],"genre_scores_gemma":[0.9950886,0.0024049568,0.00020146208,0.000079888836,0.0003583972,0.0005418074,0.00024931837,0.000021465688,0.00105412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982951,0.00013457428,0.00035598138,0.00059986406,0.0003169712,0.00029748646],"domain_scores_gemma":[0.9979629,0.0001408644,0.000117378586,0.0009356061,0.00077576557,0.00006751183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011657574,0.00012287035,0.00021314343,0.00006053109,0.00025322777,0.00004924747,0.0005839935,0.00009698334,0.000027790013],"category_scores_gemma":[0.00007845328,0.000081676335,0.00004825911,0.00022747263,0.0005923752,0.000008999659,0.0004410683,0.0002274293,2.8803046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022862135,0.00008204352,0.8848002,0.00014353647,0.0006650401,0.0000011501197,0.000049995193,0.00005757904,0.04405367,0.0000358778,0.04841625,0.019408427],"study_design_scores_gemma":[0.0017755221,0.000093185656,0.9513616,0.00009302139,0.000086108805,0.0000012852022,0.00005780291,0.000032113418,0.010981181,0.000038535916,0.03536185,0.00011782716],"about_ca_topic_score_codex":0.0022024764,"about_ca_topic_score_gemma":0.008582137,"teacher_disagreement_score":0.06656135,"about_ca_system_score_codex":0.0001978639,"about_ca_system_score_gemma":0.0019582647,"threshold_uncertainty_score":0.47890335},"labels":[],"label_agreement":null},{"id":"W4409624313","doi":"10.1158/1538-7445.am2025-1150","title":"Abstract 1150: Fluorescent dCFPyL (GUL-Cy5) for detecting circulating tumor and immune cells containing cancer extracellular vesicles in early metastatic prostate cancer prognostication","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Occupational Cancer Research Centre; University of Windsor; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Extracellular vesicles; Cancer; Immune system; Cancer research; Cancer cell; Fluorescence; Biology; Extracellular; Pathology; Medicine; Immunology; Internal medicine; Cell biology","score_opus":0.036280035804188836,"score_gpt":0.3691976673434282,"score_spread":0.33291763153923937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448258,0.052224282,0.00034073202,0.00029749968,0.00016644022,0.001975517,0.00010224126,0.000020490425,0.000046948113],"genre_scores_gemma":[0.99475175,0.0011076012,0.00078287884,0.000048140108,0.00015413706,0.0028161078,0.000036367273,0.00006263525,0.00024037882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972922,0.0001970011,0.0005561554,0.0007909275,0.00033902432,0.0008246717],"domain_scores_gemma":[0.99863124,0.00022561658,0.0001719345,0.0004026981,0.0004141526,0.0001543653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014687538,0.00025384984,0.00029189483,0.00021849251,0.00031404832,0.00015390989,0.0003093662,0.00010361641,0.000023700562],"category_scores_gemma":[0.00054249883,0.00026781016,0.000088216475,0.00040409737,0.00024896607,0.00002651634,0.00021386932,0.00040975408,0.0000017032082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004785068,0.00008282886,0.016288424,0.00071731297,0.00010456684,0.000027400916,0.00045656605,0.0006111647,0.9494253,0.00009829168,0.000047497564,0.03166219],"study_design_scores_gemma":[0.0015563063,0.00012871546,0.027374791,0.00079056015,0.00005722228,0.00000195009,0.0007208463,0.0015877761,0.9663608,0.0004129305,0.0007021801,0.0003059152],"about_ca_topic_score_codex":0.0016871406,"about_ca_topic_score_gemma":0.0006280185,"teacher_disagreement_score":0.051116683,"about_ca_system_score_codex":0.00026474986,"about_ca_system_score_gemma":0.00079824775,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W4409624317","doi":"10.1158/1538-7445.am2025-902","title":"Abstract 902: Examining the impact of chromosome 1q-located gamma secretase subunits in the resistance to BCMA-targeted therapies in multiple myeloma patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gamma secretase; Multiple myeloma; Cancer research; Medicine; Chromosome; Genetics; Internal medicine; Oncology; Biology; Gene","score_opus":0.09377439422504756,"score_gpt":0.4112129885647848,"score_spread":0.3174385943397372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926132,0.0023349049,0.0000013027925,0.0013349061,0.000039661198,0.0024627112,0.00014373758,0.000016640231,0.0010529549],"genre_scores_gemma":[0.9980671,0.00033916943,0.00002452693,0.00009027603,0.00004093456,0.00081477495,0.000090972746,0.000027354827,0.0005049014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636924,0.0006781384,0.000473585,0.00044374133,0.0010963018,0.0009390013],"domain_scores_gemma":[0.9968794,0.0014796079,0.00007065134,0.0007958923,0.00059475086,0.00017969223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017269468,0.00023201574,0.00040951665,0.0007878087,0.0002080429,0.000060421604,0.00060917437,0.00010647275,0.00022839315],"category_scores_gemma":[0.0017997883,0.0001275567,0.00009333331,0.0031325337,0.00030343473,0.00011152921,0.00014871955,0.0008787241,0.000024068278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00456488,0.0007381968,0.92287487,0.0002424694,0.00025697565,0.00018928053,0.004901,0.00010020927,0.045882303,0.000018375256,0.0021235354,0.018107923],"study_design_scores_gemma":[0.004610725,0.00039562507,0.97953176,0.000764118,0.000007823297,8.1359525e-7,0.001162911,0.00013174527,0.01288401,0.000058810612,0.00035203263,0.00009960611],"about_ca_topic_score_codex":0.0091487365,"about_ca_topic_score_gemma":0.008133047,"teacher_disagreement_score":0.05665693,"about_ca_system_score_codex":0.00083981897,"about_ca_system_score_gemma":0.0008287695,"threshold_uncertainty_score":0.9974494},"labels":[],"label_agreement":null},{"id":"W4409624323","doi":"10.1158/1538-7445.am2025-953","title":"Abstract 953: Oncolytic viruses as in situ personalized tumor vaccines for durable efficacy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Virology; Cancer research; Virus","score_opus":0.06751126091923056,"score_gpt":0.45066532770351503,"score_spread":0.3831540667842845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880032,0.0058661406,0.000015570828,0.0012790565,0.00010584704,0.001164069,0.00003741712,0.000014987657,0.00351374],"genre_scores_gemma":[0.99011666,0.0010297811,0.000046120014,0.00058587524,0.00025632084,0.0010228707,0.000037060254,0.00004177694,0.0068635545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977901,0.00017325861,0.00026048414,0.00059386465,0.00039115714,0.00079114945],"domain_scores_gemma":[0.99871254,0.00023716179,0.000035853667,0.00049153477,0.00039286457,0.00013005182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013030882,0.00017540506,0.00023996762,0.0003189613,0.00020357613,0.000081325,0.00055927166,0.0001329987,0.00030510224],"category_scores_gemma":[0.0006763145,0.0001675042,0.00012104249,0.000579939,0.00017135164,0.000007624087,0.00016603035,0.00034849276,0.000047872738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011028866,0.00017985934,0.0006685075,0.00015305444,0.000082576196,0.0000136830395,0.00006028637,0.00006990764,0.96942496,0.00008553053,0.0100044,0.008228377],"study_design_scores_gemma":[0.0036714205,0.0011906694,0.0018414574,0.000120512974,0.0000065063177,0.0000017159107,0.00017954312,0.000026478612,0.89222753,0.0003610654,0.10018636,0.00018676471],"about_ca_topic_score_codex":0.0005727323,"about_ca_topic_score_gemma":0.0037130085,"teacher_disagreement_score":0.09018196,"about_ca_system_score_codex":0.00022351339,"about_ca_system_score_gemma":0.0016642188,"threshold_uncertainty_score":0.68306226},"labels":[],"label_agreement":null},{"id":"W4409624339","doi":"10.1158/1538-7445.am2025-630","title":"Abstract 630: Directly engaging participants in rare cancer research is feasible: the osteosarcoma and leiomyosarcoma projects","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Cancer; Leiomyosarcoma; Medicine; Oncology; Internal medicine; Radiology; Cancer research","score_opus":0.13095352662525353,"score_gpt":0.4483205963409404,"score_spread":0.31736706971568684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576865,0.031298164,0.0000029096766,0.006492121,0.00021160745,0.0008929322,0.0001177294,0.000009335353,0.0032887268],"genre_scores_gemma":[0.9806381,0.015660184,0.000017603872,0.00048667734,0.00032428137,0.0011074072,0.000016691038,0.000034478362,0.0017145767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968282,0.0003965523,0.0002982813,0.00075314945,0.0005380695,0.0011857745],"domain_scores_gemma":[0.9981841,0.00045859977,0.000041920437,0.0006756617,0.00047660244,0.00016311325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002529482,0.00019278265,0.00022339808,0.00033613964,0.0005746118,0.00022751096,0.0005838338,0.0001774952,0.00009111431],"category_scores_gemma":[0.00067786797,0.00015868597,0.00005456302,0.0010593352,0.00060631265,0.000011055085,0.0007613604,0.0009317554,0.000008040756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075275416,0.00019065687,0.11281286,0.00040988572,0.00016413844,0.00006442055,0.0018163822,0.00008314497,0.7215871,0.000646797,0.07704362,0.08442823],"study_design_scores_gemma":[0.002057365,0.00021809817,0.113463335,0.000655398,0.000020768091,0.000004149509,0.0027542794,0.00014324904,0.6859231,0.0010489059,0.19329597,0.00041541233],"about_ca_topic_score_codex":0.008144966,"about_ca_topic_score_gemma":0.0106756985,"teacher_disagreement_score":0.11625235,"about_ca_system_score_codex":0.00027208176,"about_ca_system_score_gemma":0.0018611682,"threshold_uncertainty_score":0.9984599},"labels":[],"label_agreement":null},{"id":"W4409624400","doi":"10.1158/1538-7445.am2025-1969","title":"Abstract 1969: Advancing metastatic prostate cancer diagnostics: STEAP1-based imaging flow cytometry for circulating tumor cell detection and characterization","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Flow cytometry; Medicine; Circulating tumor cell; Cancer; Pathology; Prostate; Cancer research; Oncology; Internal medicine; Metastasis; Immunology","score_opus":0.0345317738888329,"score_gpt":0.3972625829221088,"score_spread":0.3627308090332759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98028857,0.009599227,0.0036004935,0.0022187838,0.00032648625,0.0033545557,0.00030493655,0.000083296436,0.00022365223],"genre_scores_gemma":[0.992322,0.0027774672,0.00055469584,0.00025200314,0.00019772122,0.0028614919,0.00015026581,0.000060069673,0.00082423905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974964,0.00010339833,0.00035886906,0.0006007976,0.00058158673,0.0008589057],"domain_scores_gemma":[0.9978678,0.00071872055,0.00010116832,0.00026726018,0.0008147015,0.00023031009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010485225,0.00022391937,0.00036092917,0.0008110349,0.000511398,0.00015447615,0.00010487599,0.000048410435,0.00009697609],"category_scores_gemma":[0.00045461784,0.00019676494,0.000080585305,0.001041031,0.00018016016,0.00023833931,0.000071123985,0.00050372496,0.0000043426853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012337669,0.00014863018,0.04789867,0.004320953,0.00011605754,0.00008664854,0.00029588645,0.0002658129,0.7788884,0.0000057559546,0.00018421975,0.16655523],"study_design_scores_gemma":[0.011685406,0.0004150293,0.12312728,0.003687581,0.00031555854,0.000009748277,0.0009855367,0.0670644,0.78537107,0.00017931941,0.006666538,0.00049256487],"about_ca_topic_score_codex":0.00045028617,"about_ca_topic_score_gemma":0.000094791496,"teacher_disagreement_score":0.16606265,"about_ca_system_score_codex":0.0010640648,"about_ca_system_score_gemma":0.0013525251,"threshold_uncertainty_score":0.8023842},"labels":[],"label_agreement":null},{"id":"W4409624454","doi":"10.1158/1538-7445.am2025-3681","title":"Abstract 3681: A tumor-naive method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell-free DNA","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytosine; DNA; Fraction (chemistry); Molecular biology; Biology; Chemistry; Genetics; Cancer research; Chromatography","score_opus":0.049246209447578904,"score_gpt":0.45184943201757144,"score_spread":0.40260322256999254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.545468,0.0005682365,0.4518858,0.00041168762,0.00006418259,0.00081170874,0.000043091826,0.000016990956,0.00073030364],"genre_scores_gemma":[0.82172525,0.000048047837,0.17655094,0.00021672907,0.00019453208,0.0009763605,0.00009967918,0.000024808616,0.00016367293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987127,0.000121332734,0.00024703008,0.00045268371,0.00012732347,0.00033892962],"domain_scores_gemma":[0.99912757,0.000086909764,0.00008468632,0.00042809185,0.00022705238,0.00004571445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010296891,0.00012014533,0.0001499353,0.00019210398,0.00019756074,0.000031431788,0.00027842436,0.0001341948,0.000016866063],"category_scores_gemma":[0.0003145694,0.00012467729,0.00008227089,0.00036339948,0.00007414298,0.0000062036447,0.00016946357,0.0002605068,0.0000012102605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007595049,0.000050184743,0.00033758892,0.0000817055,0.00001617737,0.0000016636228,0.000009758633,0.0008967441,0.9928358,0.0002409585,0.0014248956,0.0040285727],"study_design_scores_gemma":[0.00054630113,0.0000771779,0.0007315909,0.00008315862,0.000012223796,0.000002478145,0.00004508881,0.016677173,0.97155404,0.0028460678,0.0072912453,0.0001334457],"about_ca_topic_score_codex":0.00059778726,"about_ca_topic_score_gemma":0.0000980563,"teacher_disagreement_score":0.27625722,"about_ca_system_score_codex":0.00014258579,"about_ca_system_score_gemma":0.0002975282,"threshold_uncertainty_score":0.5084192},"labels":[],"label_agreement":null},{"id":"W4409624535","doi":"10.1158/1538-7445.am2025-1438","title":"Abstract 1438: HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lineage (genetic); Pancreatic cancer; Methylation; Biology; Cancer; Cancer research; Genetics; Gene","score_opus":0.042671526534600684,"score_gpt":0.39900368396288693,"score_spread":0.3563321574282863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847728,0.01102632,0.001597425,0.00042468956,0.00008097119,0.0005135547,0.00003955411,0.000009498158,0.0015352092],"genre_scores_gemma":[0.9925335,0.0037484786,0.00020633086,0.000034200246,0.00026511867,0.00033312716,0.000043376855,0.000016604981,0.002819258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874485,0.00011461114,0.00019816258,0.00040162948,0.00023537003,0.00030540253],"domain_scores_gemma":[0.99926287,0.000054416516,0.000050301933,0.00020745705,0.00033705964,0.00008790184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051556784,0.00012317412,0.00014574363,0.00012366883,0.0001795234,0.000051665662,0.00012754014,0.00015647715,0.00008731936],"category_scores_gemma":[0.00028316554,0.00011386219,0.00003130643,0.00023908715,0.00014039825,0.00000594465,0.00012973804,0.00023674866,0.00000433478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011800515,0.000025941357,0.0037748818,0.00008909486,0.000048579448,0.0000012902965,0.000036273992,0.00021134336,0.9799982,0.00013850658,0.00039169015,0.015166249],"study_design_scores_gemma":[0.0004790222,0.00012733958,0.03434625,0.000103007624,0.000017484117,1.06514214e-7,0.00003587981,0.0002352575,0.95059854,0.0003297244,0.013607436,0.00011995256],"about_ca_topic_score_codex":0.0010367875,"about_ca_topic_score_gemma":0.0006748355,"teacher_disagreement_score":0.030571368,"about_ca_system_score_codex":0.00006885537,"about_ca_system_score_gemma":0.00030903047,"threshold_uncertainty_score":0.46431655},"labels":[],"label_agreement":null},{"id":"W4409624560","doi":"10.1158/1538-7445.am2025-1117","title":"Abstract 1117: cBioPortal for cancer genomics","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Genomics; Medicine; Biology; Genetics; Internal medicine; Genome; Gene","score_opus":0.06044568255684692,"score_gpt":0.46972421974353246,"score_spread":0.40927853718668555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676862,0.0055541317,0.017051753,0.0044142986,0.00022847648,0.0012589738,0.0003153423,0.00005180017,0.0034390623],"genre_scores_gemma":[0.98759174,0.0033020314,0.0029528374,0.00031651335,0.00031657514,0.00093723397,0.0000685128,0.0000210818,0.0044934684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991876,0.000009832736,0.00012311082,0.00030821,0.000084762985,0.00028648658],"domain_scores_gemma":[0.9993468,0.000017917617,0.000027949245,0.00030337114,0.0002565769,0.00004738834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002091145,0.00007791024,0.00008215024,0.000053035514,0.00018771246,0.000023331348,0.00019980228,0.00010356753,0.000020032074],"category_scores_gemma":[0.000038907507,0.00007548586,0.00005824743,0.00014623826,0.00012811787,0.0000018726395,0.000100592675,0.00012384844,0.000002195598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005749065,0.000022368049,0.00015072279,0.00003246765,0.000023845212,3.452496e-7,0.0000054624747,0.000029134599,0.94482654,0.0011796855,0.02340216,0.030269757],"study_design_scores_gemma":[0.00012297317,0.000022730721,0.00035074996,0.000023170214,0.0000034842878,2.66194e-7,0.000018703238,0.00001871409,0.5504752,0.0013246682,0.44757628,0.00006310442],"about_ca_topic_score_codex":0.00014625923,"about_ca_topic_score_gemma":0.00021125517,"teacher_disagreement_score":0.42417413,"about_ca_system_score_codex":0.000077571756,"about_ca_system_score_gemma":0.0003469599,"threshold_uncertainty_score":0.3078224},"labels":[],"label_agreement":null},{"id":"W4409624565","doi":"10.1158/1538-7445.am2025-3161","title":"Abstract 3161: High throughput drug screening to uncover molecular vulnerabilities in pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Medicine; Drug; Internal medicine; Cancer research; Pharmacology; Cancer; Pancreatic cancer","score_opus":0.061147156633043286,"score_gpt":0.4292062000981499,"score_spread":0.36805904346510665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706975,0.0040412177,0.00016698125,0.011031533,0.00014103185,0.0014569174,0.000021345246,0.00004472187,0.012398746],"genre_scores_gemma":[0.98440546,0.0003022733,0.0012064355,0.0007334144,0.00019706432,0.00081052637,0.000017033986,0.00003634624,0.012291475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621695,0.0003784012,0.00047672857,0.00070558843,0.0010921026,0.0011302459],"domain_scores_gemma":[0.9974738,0.00095753605,0.00003325266,0.00072304864,0.00048288796,0.00032948345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021819847,0.00022895607,0.0007426916,0.0008768135,0.00021995435,0.00006458805,0.00037180286,0.00017302294,0.001294551],"category_scores_gemma":[0.0011836232,0.00020121796,0.000101318525,0.0015402816,0.00045590155,0.00012301088,0.0003261859,0.0012947101,0.00013976163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014813408,0.00025291642,0.9501381,0.00074506365,0.000284689,0.0009820499,0.0014231319,0.00012714964,0.024865432,0.0037207557,0.014038484,0.0019408881],"study_design_scores_gemma":[0.0028117632,0.00032929817,0.9756123,0.0013110179,0.00007756988,0.00001620108,0.0021434422,0.00011566473,0.011942027,0.0032295054,0.0021816941,0.00022952442],"about_ca_topic_score_codex":0.014148494,"about_ca_topic_score_gemma":0.00096450915,"teacher_disagreement_score":0.025474193,"about_ca_system_score_codex":0.0010432423,"about_ca_system_score_gemma":0.001951687,"threshold_uncertainty_score":0.9996184},"labels":[],"label_agreement":null},{"id":"W4409624586","doi":"10.1158/1538-7445.am2025-594","title":"Abstract 594: Lintuzumab-Ac225 has potent mutation agnostic antileukemic activity in preclinical models of AML","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Medicine; Mutation; Computational biology; Biology; Genetics; Gene","score_opus":0.17667081887451228,"score_gpt":0.47767883802279343,"score_spread":0.3010080191482811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863294,0.0012651144,0.0003569871,0.0044460553,0.00012412647,0.0014141155,0.000037562026,0.000038724585,0.005987939],"genre_scores_gemma":[0.9962785,0.00146147,0.0001625667,0.00009709539,0.00011570992,0.00031172638,0.00002235295,0.00003438198,0.0015161684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963963,0.0003318625,0.00060026505,0.0006512768,0.001204767,0.0008155153],"domain_scores_gemma":[0.99648297,0.001685212,0.000092096525,0.00070609513,0.00080502656,0.00022862655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024743094,0.00018892283,0.00057833263,0.0009835467,0.00012318682,0.00004715093,0.00040427898,0.00031056395,0.00024122819],"category_scores_gemma":[0.0021262506,0.00017395407,0.00013741612,0.0015069864,0.0006912926,0.0002193814,0.00029227644,0.0021002654,0.0000495824],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015433566,0.0025683,0.029054113,0.005554892,0.00062949775,0.0014358766,0.0019187535,0.018396357,0.5808436,0.0016126065,0.026390176,0.31616223],"study_design_scores_gemma":[0.015020518,0.0014157312,0.54283154,0.005765815,0.00012321283,0.00003774588,0.000739419,0.09146666,0.3313178,0.008194929,0.0025086582,0.00057793333],"about_ca_topic_score_codex":0.0059948945,"about_ca_topic_score_gemma":0.00049704587,"teacher_disagreement_score":0.51377743,"about_ca_system_score_codex":0.0028480666,"about_ca_system_score_gemma":0.0065418137,"threshold_uncertainty_score":0.9990902},"labels":[],"label_agreement":null},{"id":"W4409624595","doi":"10.1158/1538-7445.am2025-567","title":"Abstract 567: Effectiveness of [225Ac]Ac-labeled anti-MUC-16 radioimmunconjugate against CA125 expressing pancreatic and ovarian cancer xenografts","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec; University of Saskatchewan; Royal University Hospital; Université Laval","funders":"","keywords":"Medicine; Ovarian cancer; Pancreatic cancer; Cancer; Cancer research; Internal medicine; Oncology","score_opus":0.06525686574054686,"score_gpt":0.449099822002176,"score_spread":0.3838429562616292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816139,0.010825894,0.00003960968,0.0009812921,0.00009383983,0.00081874954,0.000054859986,0.00003924275,0.005532627],"genre_scores_gemma":[0.994486,0.003773949,0.00005395992,0.0000870621,0.00015604074,0.000865891,0.000018277942,0.00002489874,0.0005339249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981614,0.00017638956,0.00033194126,0.00045114371,0.00038527037,0.000493892],"domain_scores_gemma":[0.998172,0.00077488297,0.00006473026,0.00044649479,0.0003174295,0.00022446635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010002307,0.0001824282,0.000529819,0.00016400959,0.0002656337,0.00004800058,0.00019825663,0.00014176614,0.00016833592],"category_scores_gemma":[0.00020039975,0.000159701,0.00007374066,0.0007739403,0.00056613365,0.00008334475,0.000098729026,0.0006757298,0.000003920877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005194385,0.00014846963,0.014361074,0.0033520074,0.00024202181,0.000020446789,0.00007747954,0.00003993577,0.96896726,0.00020866889,0.00034112803,0.011722049],"study_design_scores_gemma":[0.0023952352,0.000026861211,0.05988467,0.0033481473,0.00013050988,0.0000045426304,0.00008470199,0.00013952744,0.9297369,0.00017305762,0.003931295,0.0001445149],"about_ca_topic_score_codex":0.0010487875,"about_ca_topic_score_gemma":0.000013370695,"teacher_disagreement_score":0.045523595,"about_ca_system_score_codex":0.0003705025,"about_ca_system_score_gemma":0.0006736157,"threshold_uncertainty_score":0.6512418},"labels":[],"label_agreement":null},{"id":"W4409624640","doi":"10.1158/1538-7445.am2025-1911","title":"Abstract 1911: Platform agnostic lung cancer plasma signature identified using multidimensional proteomics and explainable machine learning","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Signature (topology); Lung cancer; Proteomics; Computer science; Computational biology; Cancer; Medicine; Oncology; Internal medicine; Biology; Mathematics; Biochemistry","score_opus":0.0410544893370022,"score_gpt":0.4100107171718888,"score_spread":0.36895622783488663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849661,0.009697055,0.0005215751,0.0027517916,0.0003717254,0.0009282401,0.000014723614,0.00006503297,0.00068375195],"genre_scores_gemma":[0.99105394,0.0019920284,0.002024984,0.000307757,0.00029200377,0.00018733143,0.00003451039,0.000051615232,0.0040558497],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99758375,0.000086821434,0.0003273563,0.0005483346,0.00072685524,0.0007268595],"domain_scores_gemma":[0.99850845,0.0005513262,0.00008278523,0.00022816601,0.00034543755,0.00028385784],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001335858,0.00021905605,0.0003859629,0.0004668303,0.000703625,0.00010815201,0.0001557911,0.00019370935,0.00035272408],"category_scores_gemma":[0.0013803802,0.00018964194,0.000069033136,0.0005650496,0.00029023032,0.00016666378,0.00024711396,0.0028370265,0.0000041219464],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015261582,0.00021208698,0.11298176,0.0034642385,0.00057445234,0.0006211509,0.0011096237,0.021946564,0.81772035,0.0009424158,0.0070505706,0.031850625],"study_design_scores_gemma":[0.006074851,0.000120360666,0.027761817,0.005372945,0.00021929137,0.00007839875,0.00043490482,0.90366966,0.038911253,0.00027280857,0.016597759,0.0004859391],"about_ca_topic_score_codex":0.0038145378,"about_ca_topic_score_gemma":0.00008566366,"teacher_disagreement_score":0.8817231,"about_ca_system_score_codex":0.00059041753,"about_ca_system_score_gemma":0.00089143036,"threshold_uncertainty_score":0.99946344},"labels":[],"label_agreement":null},{"id":"W4409624655","doi":"10.1158/1538-7445.am2025-3249","title":"Abstract 3249: The development of a tissue-agnostic genome-wide methylome enrichment assay for lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Lung cancer; Computational biology; Genome; Biology; Medicine; Gerontology; Oncology; Genetics; Gene","score_opus":0.045835640078000756,"score_gpt":0.4225498887856224,"score_spread":0.3767142487076216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413669,0.037757877,0.01741916,0.0008848889,0.00024904276,0.0011159934,0.000049719623,0.0000047570898,0.0011516722],"genre_scores_gemma":[0.9933547,0.0020269295,0.0009908417,0.00006682712,0.00015293488,0.0011831955,0.00005077539,0.000017249551,0.0021565473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986269,0.00010248391,0.00030557782,0.0003175351,0.00029493353,0.00035255382],"domain_scores_gemma":[0.99879694,0.00029976273,0.00007020919,0.00032272036,0.00045235173,0.000057988316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017350045,0.00011147462,0.00014053624,0.00009934696,0.00022209405,0.000027580189,0.00032687638,0.00010480498,0.00007952203],"category_scores_gemma":[0.00040566828,0.00008542728,0.000053312986,0.00024378815,0.000096078584,0.0000023951332,0.00016790838,0.00013831124,0.0000013922531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000751798,0.000039929644,0.002682153,0.00018999058,0.0001699839,2.7158904e-7,0.00022551193,0.0010168576,0.9720518,0.0000688687,0.0013431256,0.022136357],"study_design_scores_gemma":[0.0002899233,0.00004529284,0.020992417,0.000044767814,0.00001885952,2.5607664e-8,0.0000577302,0.00004802171,0.8481555,0.00019996696,0.13005699,0.000090487185],"about_ca_topic_score_codex":0.00015349686,"about_ca_topic_score_gemma":0.00040822505,"teacher_disagreement_score":0.12871388,"about_ca_system_score_codex":0.00013577976,"about_ca_system_score_gemma":0.0009394212,"threshold_uncertainty_score":0.34836236},"labels":[],"label_agreement":null},{"id":"W4409624692","doi":"10.1158/1538-7445.am2025-3221","title":"Abstract 3221: Identification and characterization of FAK kinase as a novel regulator of PD-L1 stability and activity in cancer immune evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Regulator; Evasion (ethics); Immune system; Cancer; Cancer research; Biology; Immunology; Biochemistry; Gene; Genetics","score_opus":0.058529078279257005,"score_gpt":0.3672734656938127,"score_spread":0.3087443874145557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970448,0.0016114042,0.00006133416,0.00043733127,0.0001257407,0.0005083806,0.00014857695,0.0000065197382,0.000055927605],"genre_scores_gemma":[0.9980636,0.0013940586,0.0000052838454,0.000009867923,0.0000078421435,0.000120422876,0.000033280703,0.000007313206,0.00035831207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888706,0.00020212073,0.00029607335,0.00032973374,0.00007629437,0.00020868696],"domain_scores_gemma":[0.9991891,0.00012292861,0.00012758792,0.00025598242,0.00028662515,0.000017801412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088192435,0.00009835405,0.00026289935,0.00026328457,0.00009471793,0.000011091073,0.00011482437,0.00014560239,0.00023980615],"category_scores_gemma":[0.00009843605,0.000090945745,0.000024866744,0.00038274363,0.00036726578,0.00016054632,0.00013446706,0.0002836301,0.0000023678274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007717553,0.00018112277,0.003143012,0.00031353248,0.000038277034,5.064984e-7,0.000283985,5.481176e-7,0.9800881,0.00062016526,0.0000057852412,0.014553201],"study_design_scores_gemma":[0.0005740907,0.00004474894,0.38270032,0.00016615799,0.000006324344,3.336786e-7,0.000072812756,0.000003126786,0.616152,0.00014363778,0.00009517951,0.00004129569],"about_ca_topic_score_codex":0.0025832385,"about_ca_topic_score_gemma":0.00020710877,"teacher_disagreement_score":0.3795573,"about_ca_system_score_codex":0.00011522767,"about_ca_system_score_gemma":0.00023524193,"threshold_uncertainty_score":0.3905101},"labels":[],"label_agreement":null},{"id":"W4409624711","doi":"10.1158/1538-7445.am2025-1185","title":"Abstract 1185: Phosphorylation of the MYC oncoprotein disrupts the direct interaction of MYC with the ASF1A histone chaperone","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Histone; Chaperone (clinical); Phosphorylation; Cancer research; Transcription factor; Acetylation; Cell biology; Proto-Oncogene Proteins c-myc; Chemistry; Biology; Gene; Medicine; Genetics; Pathology","score_opus":0.032809794607784486,"score_gpt":0.37012752515280745,"score_spread":0.33731773054502295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828373,0.003265065,0.000044285145,0.0027189017,0.00011312184,0.00065807474,0.000025423682,0.0000036578672,0.010334168],"genre_scores_gemma":[0.996424,0.0003208673,0.000010651854,0.000082284685,0.00008773972,0.00021829108,0.000008063251,0.000010420028,0.0028376763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898493,0.00018024494,0.00015160402,0.00019385928,0.00030704562,0.00018234027],"domain_scores_gemma":[0.9990667,0.000079268946,0.00010363175,0.00048400578,0.00024551465,0.000020859143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007885521,0.000084021514,0.00010263464,0.00003250608,0.00020288004,0.000015511689,0.00037419365,0.00006838304,0.00008231293],"category_scores_gemma":[0.00011041899,0.000039900042,0.000060511287,0.00028442492,0.00039505397,0.000004889032,0.0001490398,0.00028150345,0.000002203726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042862227,0.0000440384,0.00043937739,0.000073974596,0.00005902496,2.847466e-7,0.00031699642,0.00007856101,0.97986615,0.00018576757,0.0023258568,0.016181342],"study_design_scores_gemma":[0.0002270676,0.00012768687,0.011113555,0.00012765123,0.000009952092,7.799998e-7,0.00032114668,0.000017280781,0.94777614,0.000051426443,0.040180255,0.00004708302],"about_ca_topic_score_codex":0.0007966247,"about_ca_topic_score_gemma":0.0005732458,"teacher_disagreement_score":0.037854396,"about_ca_system_score_codex":0.000064155145,"about_ca_system_score_gemma":0.00028862437,"threshold_uncertainty_score":0.16270764},"labels":[],"label_agreement":null},{"id":"W4409624717","doi":"10.1158/1538-7445.am2025-3250","title":"Abstract 3250: Tumor-independent monitoring of minimal residual disease in multiple myeloma using cfDNA fragmentomics","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Alberta Cancer Foundation; Queen Elizabeth II Health Sciences Centre; University of Toronto; University of New Brunswick; Dalhousie University; Vancouver General Hospital; Saint John Regional Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Minimal residual disease; Multiple myeloma; Medicine; Residual; Oncology; Internal medicine; Cancer research; Mathematics; Algorithm; Bone marrow","score_opus":0.12105039476548349,"score_gpt":0.4411958385278112,"score_spread":0.3201454437623277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409624717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953619,0.002391162,0.000008814444,0.0003671088,0.0001517969,0.0010344209,0.000067837704,0.000019617555,0.00059732643],"genre_scores_gemma":[0.99803245,0.00032145748,0.0004881538,0.000014160066,0.0001868385,0.00020377403,0.000017246744,0.00003049216,0.0007054312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996661,0.00014970082,0.00045718622,0.00051524997,0.0013211742,0.0008956693],"domain_scores_gemma":[0.99818105,0.0003857154,0.00006335761,0.00051905477,0.0003956613,0.0004551877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085525383,0.00019157409,0.00038898495,0.00092728174,0.00015922762,0.000045853936,0.00027026827,0.000088418936,0.00018607354],"category_scores_gemma":[0.00078590965,0.00017701183,0.00010090754,0.00084433245,0.00024242616,0.00012554337,0.00026654586,0.00071751926,0.000017352424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037468025,0.00052672584,0.88055426,0.0006570744,0.00013559045,0.0009079515,0.00015179018,0.0001197315,0.10550393,0.000027392556,0.00012864947,0.0075400905],"study_design_scores_gemma":[0.004316947,0.00009724944,0.87752116,0.0012957625,0.000025781206,0.000002165465,0.00038573984,0.0012402193,0.11478169,0.00008143923,0.00014503679,0.0001068122],"about_ca_topic_score_codex":0.0046695573,"about_ca_topic_score_gemma":0.00020092567,"teacher_disagreement_score":0.009277762,"about_ca_system_score_codex":0.0012660054,"about_ca_system_score_gemma":0.0019376128,"threshold_uncertainty_score":0.7218333},"labels":[],"label_agreement":null},{"id":"W4409625028","doi":"10.1158/1538-7445.am2025-3503","title":"Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Mesothelin; Cancer research; Bispecific antibody; Medicine; Antibody; Oncology; Cancer; Internal medicine; Monoclonal antibody; Immunology","score_opus":0.07131556111654894,"score_gpt":0.4300704647329971,"score_spread":0.35875490361644813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440474,0.0039118985,0.000052757616,0.0012893904,0.000095466785,0.0008022532,0.00006331147,0.000030244566,0.009349911],"genre_scores_gemma":[0.99358946,0.002309381,0.000087787186,0.000045195102,0.000101211925,0.00011611728,0.000015587624,0.000035475212,0.0036997655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99674237,0.0002620544,0.00036739398,0.00058104936,0.001127851,0.00091928133],"domain_scores_gemma":[0.9983573,0.00043375161,0.00008970434,0.00045556005,0.00046106,0.00020262224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010628569,0.00024233315,0.0006313711,0.0010470339,0.00025107036,0.000062574,0.00032579826,0.00011457045,0.00054050895],"category_scores_gemma":[0.00006780525,0.00018165415,0.00011106685,0.0016663205,0.000582274,0.00013967403,0.00018372838,0.0014592038,0.000012515945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046172664,0.0003664116,0.19727924,0.0019553828,0.00014399312,0.00031687005,0.00045942338,0.000054162505,0.7882191,0.00007364539,0.0005292139,0.0059852707],"study_design_scores_gemma":[0.0038920678,0.00026020763,0.5852431,0.0038906895,0.00004028128,0.000008196045,0.00059779664,0.0007022978,0.4031194,0.000054872413,0.0019463636,0.00024475978],"about_ca_topic_score_codex":0.012512548,"about_ca_topic_score_gemma":0.0011737839,"teacher_disagreement_score":0.38796383,"about_ca_system_score_codex":0.0005420126,"about_ca_system_score_gemma":0.0017286497,"threshold_uncertainty_score":0.9940632},"labels":[],"label_agreement":null},{"id":"W4409625031","doi":"10.1158/1538-7445.am2025-3594","title":"Abstract 3594: Performance of common general-population breast cancer risk prediction models in 14 cohorts","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Population; Oncology; Cancer; Gynecology; Environmental health","score_opus":0.05605219845152724,"score_gpt":0.4069407453513058,"score_spread":0.35088854689977855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513733,0.0016213668,0.000019003615,0.00047136337,0.00030668755,0.00066855556,0.0003265268,0.000027063516,0.0014220994],"genre_scores_gemma":[0.9870458,0.011492036,0.000016362268,0.000039235387,0.0002020858,0.000273291,0.00005077452,0.000019872656,0.00086051825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981892,0.00007130604,0.0004245624,0.00032710205,0.0006052634,0.0003825478],"domain_scores_gemma":[0.999081,0.000054330667,0.00009617578,0.00034285116,0.00032632673,0.00009932252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007057196,0.00012809024,0.00035382278,0.00048192023,0.00011369777,0.000017247461,0.00011724983,0.00013961997,0.0002906533],"category_scores_gemma":[0.000018609951,0.00011467992,0.00006426061,0.00077972043,0.00011551485,0.00020426132,0.00005828929,0.000680902,0.0000024671344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009947761,0.00011246443,0.92615134,0.00038343485,0.000052316296,0.0000032092337,0.00017535881,0.018467963,0.0022492677,0.00006707312,0.001957821,0.049384955],"study_design_scores_gemma":[0.0011111954,0.000074030686,0.96874994,0.0008824684,0.000032892476,0.0000019994118,0.00003650635,0.026159268,0.0022729854,0.00023404788,0.00036565,0.000079017474],"about_ca_topic_score_codex":0.0851285,"about_ca_topic_score_gemma":0.0076859244,"teacher_disagreement_score":0.07744258,"about_ca_system_score_codex":0.0009906841,"about_ca_system_score_gemma":0.00046709954,"threshold_uncertainty_score":0.9209637},"labels":[],"label_agreement":null},{"id":"W4409625038","doi":"10.1158/1538-7445.am2025-3591","title":"Abstract 3591: Global burden and trends in cancer incidence and mortality among young adults","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Cancer incidence; Incidence (geometry); Demography; Gerontology; Internal medicine","score_opus":0.06708205528515455,"score_gpt":0.47269192153991946,"score_spread":0.4056098662547649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835231,0.010093718,0.0000015843443,0.0017459571,0.00015752287,0.00030840453,0.00008553832,0.00002133624,0.004062866],"genre_scores_gemma":[0.9923864,0.006013479,0.0000057749016,0.000076044074,0.00020733855,0.00018579123,0.0000072816792,0.00000945471,0.0011084188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983212,0.00004524579,0.0002332898,0.0004808627,0.00046232805,0.00045712662],"domain_scores_gemma":[0.99925065,0.00005788572,0.00003456902,0.00026142222,0.0001487622,0.00024669364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005128787,0.00013683875,0.00028936678,0.0002730711,0.0001082699,0.000059085403,0.000110726476,0.00011952985,0.00032849447],"category_scores_gemma":[0.00009216469,0.00012023383,0.00003445842,0.0009737048,0.00041878605,0.00013131562,0.00015244706,0.00049931125,0.0000012895694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031737663,0.00001779752,0.87302494,0.00022075785,0.00003891588,0.000058855658,0.00048482988,0.000007622068,0.00040709696,0.00006252283,0.0015498466,0.12380943],"study_design_scores_gemma":[0.0013626525,0.000049933442,0.9954104,0.00071707135,0.000021611548,0.0000032783144,0.0004365178,0.00013646505,0.00020692701,0.00015524412,0.0013974257,0.000102466605],"about_ca_topic_score_codex":0.35860562,"about_ca_topic_score_gemma":0.15869261,"teacher_disagreement_score":0.19991301,"about_ca_system_score_codex":0.0008366915,"about_ca_system_score_gemma":0.000433969,"threshold_uncertainty_score":0.85665905},"labels":[],"label_agreement":null},{"id":"W4409625073","doi":"10.1158/1538-7445.am2025-550","title":"Abstract 550: Patient-derived organoids as a screening platform to identify mechanisms of osimertinib resistance in non-small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Organoid; Osimertinib; Lung cancer; Medicine; Cancer; Computational biology; Biology; Cancer research; Oncology; Internal medicine; Cell biology; Adenocarcinoma","score_opus":0.04241366480294725,"score_gpt":0.43045650748326825,"score_spread":0.388042842680321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838423,0.0031927854,0.00076597655,0.0015491402,0.00021337435,0.0018688007,0.00008018863,0.000027363205,0.008460036],"genre_scores_gemma":[0.9928197,0.00031141326,0.0014509215,0.0003657171,0.00004945992,0.0011550767,0.000021705058,0.000039860504,0.003786103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773717,0.000038129496,0.0004712225,0.0005011638,0.0006265423,0.0006257831],"domain_scores_gemma":[0.998561,0.00014316723,0.00009488879,0.00042753466,0.00055480923,0.00021860086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036596242,0.00019061835,0.00038608882,0.00062340347,0.0001659474,0.000042276646,0.00023190622,0.00012247595,0.000735197],"category_scores_gemma":[0.000108465894,0.00017412352,0.00008283809,0.0014211512,0.000072714145,0.000115412586,0.0001465958,0.0004464301,0.000018010547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015490849,0.00036012192,0.015441734,0.0014603275,0.00034093586,0.00012208434,0.005830887,0.00018387486,0.9565095,0.0005417828,0.0061840466,0.011475672],"study_design_scores_gemma":[0.0041583767,0.00021611723,0.119088866,0.0038238848,0.0001580581,7.724347e-7,0.0024691403,0.000055108343,0.86739993,0.0007688021,0.0016244678,0.00023647345],"about_ca_topic_score_codex":0.008057313,"about_ca_topic_score_gemma":0.005101503,"teacher_disagreement_score":0.103647135,"about_ca_system_score_codex":0.00096939254,"about_ca_system_score_gemma":0.001583528,"threshold_uncertainty_score":0.9985481},"labels":[],"label_agreement":null},{"id":"W4409625082","doi":"10.1158/1538-7445.am2025-541","title":"Abstract 541: PARP and autophagy inhibition synergy in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Lung cancer; Poly ADP ribose polymerase; Cancer research; Cancer; Biology; Medicine; Internal medicine; Apoptosis; Genetics; DNA","score_opus":0.05385608005567917,"score_gpt":0.4419410958944348,"score_spread":0.38808501583875565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93168926,0.045411784,0.000009213908,0.006508071,0.00017757683,0.0010354425,0.00003045321,0.000049973245,0.015088244],"genre_scores_gemma":[0.9715146,0.017026987,0.000035073597,0.00033005525,0.00022599155,0.0014544304,0.000009005736,0.000029745226,0.009374118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974598,0.00013502313,0.00031086194,0.0005994068,0.00059825025,0.0008966389],"domain_scores_gemma":[0.9986417,0.00032089115,0.000037471716,0.00035173056,0.00043228467,0.00021590161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010382439,0.00018748286,0.00038614043,0.00073102326,0.00020663772,0.00006779596,0.00014497762,0.00013887566,0.000528907],"category_scores_gemma":[0.0002520834,0.00016536763,0.000054280845,0.0011497117,0.00036157842,0.00010970637,0.00032266448,0.001037964,0.000011667273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028075122,0.000812807,0.32864252,0.015308211,0.0006218602,0.0012982979,0.003584942,0.00027728055,0.38486117,0.0026596922,0.17284288,0.08628283],"study_design_scores_gemma":[0.008761253,0.00031238643,0.6950597,0.006284759,0.000098851175,0.0000074063996,0.001226088,0.00082897843,0.24588764,0.0011041962,0.039914716,0.0005140131],"about_ca_topic_score_codex":0.013803552,"about_ca_topic_score_gemma":0.0077811936,"teacher_disagreement_score":0.3664172,"about_ca_system_score_codex":0.0016286846,"about_ca_system_score_gemma":0.0016518637,"threshold_uncertainty_score":0.99276364},"labels":[],"label_agreement":null},{"id":"W4409625084","doi":"10.1158/1538-7445.am2025-3592","title":"Abstract 3592: Hospital-treated infectious diseases and pancreatic cancer risk: Findings from a large population-based cohort","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Toronto","funders":"","keywords":"Medicine; Pancreatic cancer; Cancer; Cohort; Population; Internal medicine; Oncology; Environmental health","score_opus":0.03720031177480144,"score_gpt":0.4407812479444592,"score_spread":0.4035809361696578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702234,0.0059193857,0.000013389809,0.0046062884,0.00016971062,0.0012374752,0.0007115488,0.000106118474,0.00021376583],"genre_scores_gemma":[0.9948936,0.0029368054,0.0000061565083,0.0007702259,0.00019921163,0.00052086485,0.00016217794,0.000028155859,0.00048279166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980091,0.0001138231,0.00025944566,0.00047974035,0.00053402025,0.00060386834],"domain_scores_gemma":[0.9979553,0.0008465185,0.0000576199,0.00036318463,0.0003655306,0.00041180165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040009926,0.00017411646,0.00039752023,0.00040254224,0.00040556636,0.000078451674,0.000087095206,0.00014066935,0.0008555375],"category_scores_gemma":[0.0012283733,0.0001510502,0.00006889536,0.0007265738,0.00009461794,0.000087012195,0.000054474887,0.00056727283,0.000015632815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002984341,0.00014401172,0.9908582,0.0005195864,0.00016496994,0.000033604538,0.00013657128,0.0000137217685,0.00032528277,0.000026022992,0.0033715651,0.0041080406],"study_design_scores_gemma":[0.0021217456,0.00013416339,0.9937563,0.0011017121,0.00019366463,2.3276324e-7,0.000047118116,0.00021511487,0.00036832597,0.0003146796,0.0016161182,0.00013085309],"about_ca_topic_score_codex":0.26198062,"about_ca_topic_score_gemma":0.00879078,"teacher_disagreement_score":0.25318983,"about_ca_system_score_codex":0.0012766245,"about_ca_system_score_gemma":0.0018348115,"threshold_uncertainty_score":0.9367535},"labels":[],"label_agreement":null},{"id":"W4409625223","doi":"10.1158/1538-7445.am2025-243","title":"Abstract 243: FLT4, a novel regulator of renal cell carcinoma progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Regulator; Renal cell carcinoma; Cancer research; Medicine; Clear cell renal cell carcinoma; Biology; Internal medicine; Pathology; Genetics; Gene","score_opus":0.03490003839513737,"score_gpt":0.3787704806670403,"score_spread":0.3438704422719029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97344494,0.019069742,0.00011209244,0.00025267058,0.0005939387,0.0003547629,0.00008065179,0.000007199546,0.0060840244],"genre_scores_gemma":[0.9912067,0.0009684207,0.00019332927,0.000053131767,0.00093149365,0.00014109741,0.000038480626,0.000019318568,0.0064480393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985704,0.000050021226,0.0002197583,0.00040096487,0.00035501487,0.00040383227],"domain_scores_gemma":[0.9989493,0.000019507372,0.0000615435,0.00048733212,0.0003772749,0.00010503214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049921207,0.0001209909,0.00017830468,0.00013971685,0.000105537336,0.000021223465,0.00031964903,0.00017090347,0.000085627275],"category_scores_gemma":[0.00007017015,0.00010871743,0.000097894575,0.00030786986,0.00021748045,0.000004176515,0.00021530263,0.00023480531,0.000004099597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028502016,0.00009862758,0.0005878672,0.00016759391,0.000022400074,7.5514663e-7,0.00003875229,0.000017709159,0.95607173,0.000108955086,0.02934924,0.0132513335],"study_design_scores_gemma":[0.000742709,0.00007399467,0.0097963335,0.00006733435,0.000008691133,7.976929e-7,0.000038291797,0.0000062082445,0.71575713,0.00003459923,0.27339262,0.00008127439],"about_ca_topic_score_codex":0.00027343997,"about_ca_topic_score_gemma":0.00009532932,"teacher_disagreement_score":0.24404337,"about_ca_system_score_codex":0.00004655651,"about_ca_system_score_gemma":0.0009089009,"threshold_uncertainty_score":0.4433368},"labels":[],"label_agreement":null},{"id":"W4409625264","doi":"10.1158/1538-7445.am2025-717","title":"Abstract 717: Pan-cancer analysis of <i>TRIM37</i> copy-number and development of fit-for-screening in situ hybridization tools","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Cancer; In situ hybridization; Biology; Genetics; Oncology; Computational biology; Medicine; Gene; Gene expression","score_opus":0.10978580150785106,"score_gpt":0.43191221375166106,"score_spread":0.32212641224381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275637,0.005150715,0.0006835741,0.00012367567,0.00008775151,0.00028447332,0.00007180282,0.0000061499877,0.0008354615],"genre_scores_gemma":[0.9968028,0.0008836006,0.0001314997,0.00003175507,0.0000050016074,0.0001407157,0.000058612826,0.0000067710175,0.0019392145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886674,0.00015261023,0.0004108828,0.00021996157,0.00006525261,0.00028453654],"domain_scores_gemma":[0.9988884,0.0005328308,0.0000868687,0.00015874607,0.0003222764,0.000010915168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083484524,0.00009074789,0.00035578336,0.0005550667,0.00009164346,0.000012623849,0.00016214997,0.000117558164,0.0004949516],"category_scores_gemma":[0.00018736845,0.000084138876,0.000058989142,0.00077459664,0.0001954758,0.0000700771,0.00009976541,0.00021810808,0.0000048436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014245855,0.00006635474,0.036611434,0.00014930802,0.00092061877,4.6206526e-7,0.00072062475,0.000082135055,0.88380766,0.00009874741,0.0014525646,0.07466551],"study_design_scores_gemma":[0.0008752242,0.000026466232,0.18098861,0.00021305829,0.000052346997,2.2250892e-7,0.0003554765,0.000005210091,0.8001806,0.000008837666,0.017225094,0.00006881827],"about_ca_topic_score_codex":0.0007335474,"about_ca_topic_score_gemma":0.0008010405,"teacher_disagreement_score":0.14437719,"about_ca_system_score_codex":0.00008622152,"about_ca_system_score_gemma":0.00046654642,"threshold_uncertainty_score":0.5419373},"labels":[],"label_agreement":null},{"id":"W4409625280","doi":"10.1158/1538-7445.am2025-3012","title":"Abstract 3012: A highly potent selective CDK9 inhibitor OBP-004 reduces metastatic tumor burden in bone, brain, lung and lymph nodes and decreases growth of triple-negative breast cancer cells in bone","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Lymph; Medicine; Cancer; Cancer research; Lung; Breast cancer; Lung cancer; Internal medicine; Pathology","score_opus":0.028284781724783745,"score_gpt":0.3899130281984032,"score_spread":0.3616282464736194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675652,0.023846017,6.4940474e-7,0.0064611067,0.00012879103,0.0013450261,0.00026779066,0.000015033691,0.0003704173],"genre_scores_gemma":[0.99212897,0.00574528,0.000062270796,0.00021048666,0.0001516355,0.00084183324,0.000010710217,0.00002670883,0.00082212867],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997647,0.0002778405,0.00047233223,0.00059315976,0.00042096578,0.00058870454],"domain_scores_gemma":[0.99816835,0.00086892105,0.00017201915,0.00014325549,0.0004294931,0.000217943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006776091,0.000252593,0.00072570547,0.00093068514,0.000093417395,0.00003347193,0.000099238176,0.00007956754,0.00015111866],"category_scores_gemma":[0.0002855338,0.00021808842,0.00005937685,0.001291806,0.0004993637,0.00015773562,0.00011619146,0.00045033655,0.0000011632151],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013755718,0.0012241667,0.15394828,0.0028133227,0.0008812508,0.00085565593,0.0050148587,0.000041145966,0.79237247,0.00013362724,0.010906992,0.018052537],"study_design_scores_gemma":[0.01490795,0.0002855681,0.62288266,0.0021724745,0.00022777132,0.000050928917,0.0015316976,0.00020591156,0.356845,0.0005483944,0.00009028513,0.00025135608],"about_ca_topic_score_codex":0.06788778,"about_ca_topic_score_gemma":0.004481331,"teacher_disagreement_score":0.4689344,"about_ca_system_score_codex":0.0011802561,"about_ca_system_score_gemma":0.0019748472,"threshold_uncertainty_score":0.9383192},"labels":[],"label_agreement":null},{"id":"W4409625303","doi":"10.1158/1538-7445.am2025-2107","title":"Abstract 2107: Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic genealogy; Melanoma; Genetics; Medicine; Biology; Evolutionary biology; Environmental health; Population","score_opus":0.02681621296708197,"score_gpt":0.3285595308699375,"score_spread":0.3017433179028555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660575,0.0011557471,0.000316734,0.0002515909,0.00011681393,0.0006369051,0.0000098035,0.000022485992,0.0008841702],"genre_scores_gemma":[0.99748915,0.0009444789,0.00068963016,0.00005630761,0.00005204482,0.000109391076,0.000009624277,0.000013821768,0.0006355444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887234,0.00006373585,0.00020915439,0.0002732423,0.00038433645,0.00019716186],"domain_scores_gemma":[0.999124,0.00007551404,0.00006045255,0.00028844262,0.0003511859,0.00010042895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008238006,0.00009652877,0.00018275621,0.00034612213,0.00014224947,0.000024107723,0.00008324143,0.00006502746,0.00016820757],"category_scores_gemma":[0.000060395898,0.00007752789,0.000019957495,0.00059638004,0.00015533737,0.000029382118,0.000077027194,0.0002573822,0.000006491138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016908208,0.0006551705,0.78698087,0.0013600041,0.0006816481,0.00014917711,0.0011633004,0.0002697516,0.012082319,0.0004744035,0.0020110887,0.19248147],"study_design_scores_gemma":[0.0015253938,0.00039217257,0.99134773,0.00015615851,0.000063765874,0.0000018812492,0.00008447677,0.00009091713,0.0020716637,0.00033776768,0.0038556838,0.00007238899],"about_ca_topic_score_codex":0.0020758302,"about_ca_topic_score_gemma":0.0007486279,"teacher_disagreement_score":0.20436688,"about_ca_system_score_codex":0.00013918027,"about_ca_system_score_gemma":0.00021313448,"threshold_uncertainty_score":0.31614956},"labels":[],"label_agreement":null},{"id":"W4409625431","doi":"10.1158/1538-7445.am2025-1619","title":"Abstract 1619: The HIV protease inhibitor nelfinavir increases the sensitivity of epithelial ovarian cancer cells to cisplatin","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Nelfinavir; Cisplatin; Protease inhibitor (pharmacology); Ovarian cancer; Cancer research; Protease; Medicine; Epithelial ovarian cancer; Virology; Cancer; Pharmacology; Human immunodeficiency virus (HIV); Oncology; Internal medicine; Chemistry; Chemotherapy; Enzyme; Biochemistry; Antiretroviral therapy; Viral load","score_opus":0.03569192904997924,"score_gpt":0.37427730626071837,"score_spread":0.3385853772107391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95544064,0.0013319311,0.0000352539,0.03681823,0.00025745836,0.0021644759,0.00045936622,0.000029544733,0.0034630822],"genre_scores_gemma":[0.99365133,0.00042306713,0.000018145833,0.0019286149,0.00041665838,0.0007491532,0.000008890031,0.000025829624,0.0027783152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974032,0.00042547224,0.00031653637,0.00037870265,0.00083269225,0.0006434053],"domain_scores_gemma":[0.9979189,0.0006154231,0.00009301134,0.000580885,0.00054890616,0.00024288998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025014342,0.00017907072,0.00033523177,0.00017014676,0.00040835666,0.000054985474,0.00025241222,0.00012404785,0.00044668795],"category_scores_gemma":[0.001092913,0.00010540725,0.0001363759,0.001120817,0.0003797333,0.00006242753,0.00018708438,0.0008062542,0.00004324578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004086892,0.00048440142,0.017180003,0.00053801626,0.00037495804,0.000078427045,0.0017245978,0.0007552956,0.65460086,0.00047838196,0.26720157,0.05249661],"study_design_scores_gemma":[0.008124152,0.0005112418,0.26239833,0.0028921664,0.00032993365,0.0000050617473,0.0048609213,0.0005325354,0.61754775,0.00088595564,0.101360664,0.00055125396],"about_ca_topic_score_codex":0.048807144,"about_ca_topic_score_gemma":0.0032763272,"teacher_disagreement_score":0.24521834,"about_ca_system_score_codex":0.0005627566,"about_ca_system_score_gemma":0.0029764192,"threshold_uncertainty_score":0.9575269},"labels":[],"label_agreement":null},{"id":"W4409625604","doi":"10.1158/1538-7445.am2025-3801","title":"Abstract 3801: Serine starvation inhibits SRSF protein expression and modulates RNA splicing in breast cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"RNA splicing; Breast cancer; Serine; Protein expression; Cancer research; RNA-binding protein; Cancer; RNA; Chemistry; Cell biology; Biology; Molecular biology; Biochemistry; Phosphorylation; Genetics; Gene","score_opus":0.026820744379366972,"score_gpt":0.35687349003515345,"score_spread":0.33005274565578646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952003,0.0024601913,0.00006538157,0.0013016856,0.00005436568,0.0004447053,0.00005144105,0.0000068412814,0.00041513293],"genre_scores_gemma":[0.9949659,0.0026065893,0.00006721178,0.00006311403,0.000120553035,0.00053475634,0.000020839476,0.000014986452,0.0016060584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998918,0.000052646767,0.00017795747,0.00038673394,0.00017590562,0.00028877024],"domain_scores_gemma":[0.9994364,0.000009766682,0.00003834721,0.000256125,0.00020150267,0.000057883204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033388936,0.00010452059,0.00010470677,0.00013884978,0.00012211037,0.00004983284,0.00013360687,0.00011069331,0.00008235053],"category_scores_gemma":[0.000014588958,0.000096619915,0.000020590729,0.0003023773,0.00008361953,0.000013489408,0.000130325,0.00021062007,0.000002159194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012733626,0.000031741878,0.0022516958,0.00010993536,0.000009871895,8.824786e-7,0.000041123454,0.0005722401,0.9819585,0.000042867487,0.0012217023,0.013632102],"study_design_scores_gemma":[0.00043588693,0.000018668528,0.035693273,0.00034265325,0.0000018816196,3.7889103e-7,0.00007831219,0.00014710565,0.9600578,0.000107649954,0.0030152493,0.00010115762],"about_ca_topic_score_codex":0.0019944466,"about_ca_topic_score_gemma":0.00054021017,"teacher_disagreement_score":0.033441577,"about_ca_system_score_codex":0.00010933119,"about_ca_system_score_gemma":0.00025742844,"threshold_uncertainty_score":0.39400458},"labels":[],"label_agreement":null},{"id":"W4409625682","doi":"10.1158/1538-7445.am2025-4339","title":"Abstract 4339: Glucosinolates selectively target cancer cell types and exhibit antineoplastic effects","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer; Biology; Cancer research; Pharmacology; Medicine; Genetics","score_opus":0.01435333149478264,"score_gpt":0.3383701517333548,"score_spread":0.32401682023857215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652028,0.030752635,0.00008633188,0.00017875699,0.00016382863,0.00030813247,0.000054793352,0.000010665755,0.0032420587],"genre_scores_gemma":[0.9929849,0.004670302,0.0001190275,0.00010896167,0.00024686463,0.00015281487,0.000027000613,0.000021981146,0.0016681637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869144,0.000068743415,0.00013806706,0.00050237,0.0001469273,0.000452432],"domain_scores_gemma":[0.9992748,0.0001036136,0.000038421527,0.00020849264,0.00027431268,0.000100375626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018807048,0.00016210452,0.0001780088,0.000067241424,0.00016018013,0.00005233043,0.00020597439,0.00014658392,0.00007605746],"category_scores_gemma":[0.00013099988,0.00015290234,0.00004295263,0.0001715601,0.00020330762,0.000006603249,0.00019586881,0.0002474561,0.000007886125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015617648,0.00004774693,0.012878966,0.0003019708,0.000073208175,0.0000024769633,0.00004919231,0.00003375462,0.9796329,0.000031504776,0.005298957,0.0014931149],"study_design_scores_gemma":[0.0005199146,0.00008215609,0.034600813,0.00009616354,0.000012764181,5.2430545e-7,0.00004041446,0.000019998733,0.95486873,0.00027460928,0.0093305465,0.00015335045],"about_ca_topic_score_codex":0.0005465713,"about_ca_topic_score_gemma":0.00025157759,"teacher_disagreement_score":0.027782086,"about_ca_system_score_codex":0.00007433676,"about_ca_system_score_gemma":0.00034074142,"threshold_uncertainty_score":0.6235177},"labels":[],"label_agreement":null},{"id":"W4409625684","doi":"10.1158/1538-7445.am2025-1704","title":"Abstract 1704: Overcoming resistance in HER2-positive gastric and breast cancers: Efficacy of disitamab vedotin in preclinical models resistant to trastuzumab emtansine and trastuzumab deruxtecan","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Trastuzumab; Medicine; Trastuzumab emtansine; Internal medicine; Oncology; Breast cancer; Cancer","score_opus":0.08495907479758326,"score_gpt":0.45098030383120075,"score_spread":0.3660212290336175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97815543,0.010945921,0.00009503394,0.005691827,0.00007020995,0.0022375118,0.0002437471,0.000024913801,0.0025354049],"genre_scores_gemma":[0.99525267,0.0029663714,0.0006003703,0.00011227955,0.00010154059,0.00038690004,0.0000108491195,0.00006060098,0.0005084171],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946498,0.00048222096,0.0010631006,0.0012355538,0.0012982312,0.0012710743],"domain_scores_gemma":[0.9965028,0.0016932322,0.00009997779,0.00067080726,0.00052057323,0.00051261135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030103072,0.00034893214,0.0010087063,0.0014954471,0.00014811965,0.000087046275,0.00038317774,0.00025125506,0.000081454404],"category_scores_gemma":[0.0011011501,0.00034518374,0.00008365984,0.003023169,0.0007120198,0.00020474433,0.00033797187,0.0016767582,0.000002370001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13074714,0.004965471,0.25528798,0.016828777,0.0010013955,0.003279706,0.02546334,0.0034178146,0.17263554,0.004481028,0.0089386,0.3729532],"study_design_scores_gemma":[0.0077618835,0.00073087343,0.9737695,0.011127371,0.00003964924,0.000017471044,0.0015314212,0.00041782513,0.0028078773,0.0010628245,0.00040162943,0.000331697],"about_ca_topic_score_codex":0.01183914,"about_ca_topic_score_gemma":0.04816944,"teacher_disagreement_score":0.7184815,"about_ca_system_score_codex":0.003910915,"about_ca_system_score_gemma":0.0041271807,"threshold_uncertainty_score":0.9999129},"labels":[],"label_agreement":null},{"id":"W4409625693","doi":"10.1158/1538-7445.am2025-2216","title":"Abstract 2216: Modulating gut microbiota to enhance the efficacy of immunotherapy in triple negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rogue Research (Canada)","funders":"","keywords":"Triple-negative breast cancer; Medicine; Breast cancer; Cancer; Immunotherapy; Gut flora; Cancer immunotherapy; Oncology; Internal medicine; Immunology","score_opus":0.026658915613690114,"score_gpt":0.426381738235378,"score_spread":0.3997228226216879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924114,0.0035630767,0.000028256058,0.0026575602,0.000141161,0.0006766585,0.00011402039,0.0000035669248,0.00040431184],"genre_scores_gemma":[0.99614227,0.0017163034,0.00006865772,0.00042634734,0.00012348824,0.00014143721,0.0000091835,0.000016270815,0.0013560433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986853,0.000103680104,0.00027417636,0.00036222997,0.0001320682,0.00044252872],"domain_scores_gemma":[0.99915034,0.000078764984,0.00005851974,0.000410252,0.00025326668,0.000048883005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006165926,0.000116867,0.00017640482,0.00012879625,0.00014329357,0.000022387578,0.00041387987,0.00010728304,0.00014270173],"category_scores_gemma":[0.00007584859,0.000091596135,0.00005919231,0.0005927822,0.000152081,0.0000034859254,0.00015122964,0.00031605177,0.000005521924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004803097,0.00006365725,0.0017147851,0.00006418056,0.000039398707,5.26594e-7,0.00035351687,0.00023021732,0.97279257,0.000023749517,0.00512372,0.019113382],"study_design_scores_gemma":[0.0007674211,0.000055210734,0.32409433,0.0003351405,0.000002387796,8.1716286e-7,0.00016624984,0.000008238424,0.66944605,0.00003830678,0.0049789115,0.000106956766],"about_ca_topic_score_codex":0.007080596,"about_ca_topic_score_gemma":0.003467279,"teacher_disagreement_score":0.32237956,"about_ca_system_score_codex":0.00014633485,"about_ca_system_score_gemma":0.0007249645,"threshold_uncertainty_score":0.9995313},"labels":[],"label_agreement":null},{"id":"W4409625727","doi":"10.1158/1538-7445.am2025-777","title":"Abstract 777: Revealing the transcriptional and proteomic spatial neighborhoods of early prostate cancer and the tumor microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Prostate cancer; Tumor microenvironment; Cancer; Cancer research; Biology; Medicine; Computational biology; Internal medicine","score_opus":0.03598655560116233,"score_gpt":0.3683330395350453,"score_spread":0.332346483933883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94640815,0.027138686,0.000006869956,0.023274457,0.00007254236,0.0025607606,0.00008847011,0.000007927434,0.00044210727],"genre_scores_gemma":[0.980982,0.014229856,0.000022532662,0.00020201107,0.00012654896,0.0014012661,0.0000061291403,0.00001713381,0.0030125224],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982584,0.00014832016,0.00025972165,0.0003290037,0.00057638844,0.00042816892],"domain_scores_gemma":[0.99921054,0.00020181068,0.000052250914,0.00026345695,0.00015292862,0.000119012635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011647101,0.00013855447,0.000266711,0.00012515836,0.00035020307,0.00005923935,0.00015550057,0.000047789155,0.00016364545],"category_scores_gemma":[0.000056542216,0.00007021883,0.00005960697,0.00026445132,0.0015882431,0.00005937397,0.000112465066,0.00061060884,0.0000019110719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021655703,0.000264802,0.18595967,0.0025076475,0.00092963706,0.00005274798,0.00629095,0.00002873177,0.6991916,0.002122329,0.0016567785,0.07933943],"study_design_scores_gemma":[0.010138673,0.00029114657,0.91206247,0.0011251825,0.00012283296,0.000008711435,0.00052822137,0.00012284225,0.070054546,0.0010768328,0.0043436824,0.00012484878],"about_ca_topic_score_codex":0.006469219,"about_ca_topic_score_gemma":0.00019161233,"teacher_disagreement_score":0.7261028,"about_ca_system_score_codex":0.00025938766,"about_ca_system_score_gemma":0.00086513953,"threshold_uncertainty_score":0.9779567},"labels":[],"label_agreement":null},{"id":"W4409625751","doi":"10.1158/1538-7445.am2025-1277","title":"Abstract 1277: <i>Ex ovo</i> system for rapid and quantitative modelling of immunotherapy responses in pre-clinical and patient-derived xenografts: PDX<i>ovo</i>","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"In ovo; Medicine; Immunotherapy; Ex vivo; Oncology; Internal medicine; Biology; Cancer; Genetics; Embryo","score_opus":0.10291293510157996,"score_gpt":0.41197454331601707,"score_spread":0.3090616082144371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.831476,0.16603847,0.00042181605,0.00032408544,0.00039806264,0.0010840319,0.00011599224,0.000025908235,0.00011565752],"genre_scores_gemma":[0.9709926,0.027685933,0.00024928842,0.00010185786,0.0000138250125,0.00033671854,0.00001432498,0.000030897703,0.00057450926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966116,0.0013221636,0.0008662801,0.0005105681,0.000094340074,0.0005950316],"domain_scores_gemma":[0.9952402,0.0038300543,0.00017398444,0.00038841923,0.0003401244,0.000027176697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024153728,0.00023171175,0.00065287185,0.0005303859,0.00029950243,0.00004187418,0.0002785572,0.00034609032,0.000058758487],"category_scores_gemma":[0.00029568584,0.00020603777,0.0001208587,0.00039783338,0.0012603219,0.00015324292,0.000118601296,0.00064717734,0.0000052779383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04057404,0.0002097455,0.0016499343,0.0004236251,0.0005103394,0.000004312734,0.003505857,0.0000485001,0.9147302,0.0007458951,0.0008591003,0.036738466],"study_design_scores_gemma":[0.014805008,0.0030364587,0.021640781,0.0032495754,0.000047920064,0.000021177146,0.007584701,0.00018305454,0.8861863,0.00050786464,0.062171873,0.000565264],"about_ca_topic_score_codex":0.0010563424,"about_ca_topic_score_gemma":0.000050339786,"teacher_disagreement_score":0.13951667,"about_ca_system_score_codex":0.000080331185,"about_ca_system_score_gemma":0.0004551776,"threshold_uncertainty_score":0.8401977},"labels":[],"label_agreement":null},{"id":"W4409625903","doi":"10.1158/1538-7445.am2025-2917","title":"Abstract 2917: Utilizing artificial intelligence for the discovery of a novel CNS-penetrating ATR inhibitor","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neuroscience; Computational biology; Biology","score_opus":0.1542960270297705,"score_gpt":0.43400845880680655,"score_spread":0.2797124317770361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97366476,0.014160473,0.0059786164,0.0019309816,0.0015372629,0.00088883925,0.00010674923,0.000022824861,0.0017094637],"genre_scores_gemma":[0.9950797,0.00022792173,0.000036749832,0.00006124263,0.00007214919,0.00019476976,0.000007707029,0.000010624231,0.0043091592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879944,0.00011086887,0.00036079338,0.00023636033,0.0000671712,0.00042537914],"domain_scores_gemma":[0.997429,0.0019559648,0.0000637615,0.00028515715,0.0002573022,0.000008824759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011803838,0.00010352957,0.0001776302,0.00017163978,0.00038934237,0.000056664387,0.00041950878,0.00012806924,0.00018755296],"category_scores_gemma":[0.0007267391,0.00007249713,0.00011021776,0.00028945817,0.0005385841,0.00009836537,0.00016606975,0.000500849,0.000021525995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012969022,0.000088428744,0.00006436017,0.000087204746,0.00011456748,3.3033376e-7,0.0003183259,0.00001815776,0.9493402,0.013533214,0.002153623,0.032984667],"study_design_scores_gemma":[0.00021293099,0.00012586,0.0011460957,0.00029408303,0.000012432658,0.0000014938074,0.0031540738,0.000043098953,0.9855834,0.00030899723,0.009043254,0.00007423466],"about_ca_topic_score_codex":0.00062819006,"about_ca_topic_score_gemma":0.00024450713,"teacher_disagreement_score":0.036243223,"about_ca_system_score_codex":0.00008592109,"about_ca_system_score_gemma":0.00047636332,"threshold_uncertainty_score":0.2994546},"labels":[],"label_agreement":null},{"id":"W4409625952","doi":"10.1158/1538-7445.am2025-1792","title":"Abstract 1792: A novel lipid nanoparticle formulation transfects acute myeloid leukemia cells and primary AML samples with high efficiency and low toxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Toxicity; Medicine; Leukemia; Cancer research; Acute toxicity; Oncology; Internal medicine","score_opus":0.021126352723789123,"score_gpt":0.3047269050213964,"score_spread":0.2836005522976073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979429,0.0006929498,0.0005999048,0.00018437878,0.000048004775,0.00026762637,0.000054759203,0.000007551056,0.00020189845],"genre_scores_gemma":[0.9979456,0.001325256,0.00009627845,0.00015057328,0.000067184454,0.00005132003,0.000024280682,0.000009932247,0.00032959544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990109,0.000026971722,0.00012265121,0.00036334008,0.00016810039,0.00030802173],"domain_scores_gemma":[0.9995397,0.000042039628,0.000020454598,0.0001848816,0.00013568955,0.000077270844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022472446,0.00011101042,0.00012289865,0.000069510854,0.00015445056,0.000063043,0.00011821831,0.00009479356,0.000011709077],"category_scores_gemma":[0.000017121696,0.000091628186,0.000021971755,0.00015724235,0.0001548848,0.000013619039,0.00008126434,0.00014063071,0.0000016218548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004003944,0.000040406874,0.0009846017,0.000105693405,0.000046965382,0.0000021168757,0.00007872442,0.0000951348,0.99336,0.000043698845,0.00031960694,0.004522678],"study_design_scores_gemma":[0.00076404115,0.0003598278,0.032016236,0.000086556436,0.0000138072755,0.00000251308,0.00003910373,0.000085115906,0.96594244,0.000026497362,0.000553955,0.00010988258],"about_ca_topic_score_codex":0.00033208792,"about_ca_topic_score_gemma":0.0002786754,"teacher_disagreement_score":0.031031633,"about_ca_system_score_codex":0.00006474691,"about_ca_system_score_gemma":0.0003349618,"threshold_uncertainty_score":0.3736489},"labels":[],"label_agreement":null},{"id":"W4409625990","doi":"10.1158/1538-7445.am2025-1988","title":"Abstract 1988: Detection of minimal residual disease using cell free plasma DNA to guide maintenance therapy in high grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Serous ovarian cancer; Minimal residual disease; Serous fluid; Ovarian cancer; Maintenance therapy; Medicine; Oncology; Internal medicine; Cancer; Cancer research; Pathology; Biology; Chemotherapy","score_opus":0.03547429768867657,"score_gpt":0.35290592411056837,"score_spread":0.3174316264218918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486226,0.0027391985,0.00014211172,0.0008385081,0.00031067824,0.0004904879,0.00036060705,0.00000529597,0.0002508289],"genre_scores_gemma":[0.9953126,0.0030349905,0.00023310127,0.00022631013,0.00032151843,0.00021860671,0.000017703735,0.00002905969,0.00060613034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835265,0.00007214249,0.0003115927,0.0004966186,0.00026990112,0.00049708097],"domain_scores_gemma":[0.99889374,0.00006561344,0.000064521235,0.00054399134,0.00027345322,0.00015867445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039033307,0.00015543973,0.00018730412,0.00021721299,0.00009947126,0.000037650894,0.00041975826,0.00012634888,0.000036081874],"category_scores_gemma":[0.00021388746,0.00016004893,0.000059467144,0.00043431774,0.00011822897,0.0000057025454,0.00025340507,0.0002172659,0.0000016454487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014621294,0.000101855185,0.0049459618,0.00008608746,0.000032625976,0.000015401878,0.00006513282,0.003600596,0.978001,0.000054909928,0.0050706756,0.0065636192],"study_design_scores_gemma":[0.0018636714,0.00018012959,0.06397728,0.00014852788,0.000009700544,4.9672775e-7,0.000093757706,0.00010914623,0.9165679,0.0002494967,0.016610662,0.00018923309],"about_ca_topic_score_codex":0.01686083,"about_ca_topic_score_gemma":0.012903906,"teacher_disagreement_score":0.061433103,"about_ca_system_score_codex":0.00034071752,"about_ca_system_score_gemma":0.0012813718,"threshold_uncertainty_score":0.98968595},"labels":[],"label_agreement":null},{"id":"W4409626021","doi":"10.1158/1538-7445.am2025-5830","title":"Abstract 5830: Combining DNA methylation inhibition and STING agonist in the treatment of metastatic triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Medicine; DNA methylation; Metastatic breast cancer; Sting; Cancer research; Triple negative; Oncology; Agonist; Internal medicine; Cancer; Biology; Receptor; Gene; Genetics; Gene expression","score_opus":0.07396749196299293,"score_gpt":0.4106552030022718,"score_spread":0.33668771103927886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914176,0.0081440825,0.000008789552,0.0011549912,0.00014493043,0.00045649524,0.00008874726,0.0000069923444,0.00085320766],"genre_scores_gemma":[0.99703974,0.0014383869,0.000005902416,0.000035489717,0.00000943869,0.00025316342,0.00001884335,0.000005761955,0.0011932724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985727,0.0006880865,0.00024517,0.00017969379,0.000059744565,0.00025457842],"domain_scores_gemma":[0.99869674,0.00095666817,0.000065894565,0.00012996371,0.0001427377,0.000008005945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007947998,0.00009588529,0.00020778363,0.00026246987,0.0002156143,0.000026540736,0.000086307424,0.00006134312,0.00029009065],"category_scores_gemma":[0.00009538519,0.000065184846,0.000038219674,0.00035555798,0.0003430282,0.00007083554,0.000028395869,0.00024909465,0.000006845419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001884127,0.0002947511,0.0016093918,0.00010011247,0.00024000881,0.000005655548,0.007380207,0.000014279717,0.9138897,0.0009704534,0.00063114753,0.07298017],"study_design_scores_gemma":[0.0036423507,0.00042116575,0.14735885,0.00048602055,0.000042530828,0.000009254301,0.007121272,0.000015365062,0.83800566,0.000518552,0.0022761677,0.00010282986],"about_ca_topic_score_codex":0.005128832,"about_ca_topic_score_gemma":0.0014242622,"teacher_disagreement_score":0.14574946,"about_ca_system_score_codex":0.00023241853,"about_ca_system_score_gemma":0.00023848616,"threshold_uncertainty_score":0.7753294},"labels":[],"label_agreement":null},{"id":"W4409626072","doi":"10.1158/1538-7445.am2025-5541","title":"Abstract 5541: Dissecting chemotherapy resistance development in triple negative breast cancer through single cell multiome and lineage tracing","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Medicine; Chemotherapy; Internal medicine; Oncology; Lineage (genetic); Cancer; Cancer research; Biology; Gene; Genetics","score_opus":0.03340427168445989,"score_gpt":0.3615590001327471,"score_spread":0.3281547284482872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894258,0.0073938016,0.00016261463,0.0006560374,0.00019399708,0.00039105554,0.00007824105,0.000007391809,0.0016910752],"genre_scores_gemma":[0.99214405,0.0045556477,0.00066083553,0.00020812768,0.00022448161,0.00022986117,0.00001680567,0.000026377402,0.0019338138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858016,0.000045460714,0.00026388414,0.000493821,0.00017700462,0.00043968434],"domain_scores_gemma":[0.9992888,0.000111548274,0.000059621627,0.00021217234,0.00026042553,0.0000674617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003816062,0.00015405598,0.00017743254,0.00010609756,0.00019777575,0.00007657524,0.00017438468,0.00012315682,0.00003763255],"category_scores_gemma":[0.00012464494,0.00015868401,0.000033143704,0.00036937185,0.00012503544,0.00001025326,0.000117700016,0.00027006867,0.0000012396606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007414602,0.00021235355,0.00968926,0.00033977217,0.000059483347,0.000009447131,0.0017545028,0.00025495124,0.96744275,0.00003356526,0.0029743477,0.016488109],"study_design_scores_gemma":[0.0018043326,0.00003218771,0.051731262,0.00034197202,0.000004374592,6.6666365e-7,0.0005661128,0.000024585112,0.9243451,0.000087565015,0.020833967,0.00022788512],"about_ca_topic_score_codex":0.0015222636,"about_ca_topic_score_gemma":0.010387283,"teacher_disagreement_score":0.04309766,"about_ca_system_score_codex":0.00031063549,"about_ca_system_score_gemma":0.00059562695,"threshold_uncertainty_score":0.6470946},"labels":[],"label_agreement":null},{"id":"W4409626085","doi":"10.1158/1538-7445.am2025-3680","title":"Abstract 3680: Plasma DNA methylome profiling predicts response to olaparib and durvalumab in recurrent IDH-mutant gliomas: Results from a phase II trial","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Olaparib; Durvalumab; Medicine; Mutant; Oncology; Cancer research; Biology; Internal medicine; Genetics; DNA; Poly ADP ribose polymerase; Cancer; Gene; Immunotherapy","score_opus":0.09627781635434737,"score_gpt":0.4516584242745865,"score_spread":0.3553806079202392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836262,0.0021871342,0.0000011412944,0.0086348625,0.0004492747,0.0036758373,0.0009146393,0.000060088303,0.0004508334],"genre_scores_gemma":[0.99694556,0.00048782307,0.00017721557,0.00007977891,0.0002388915,0.0017274629,0.000099951154,0.000028909193,0.00021441426],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960945,0.00048759594,0.00074774766,0.0009456149,0.0009699316,0.00075459527],"domain_scores_gemma":[0.9967745,0.0017672327,0.00008169598,0.0006190284,0.00030699588,0.00045057596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003512652,0.00025902528,0.0005966653,0.0011939814,0.0002524994,0.00009273495,0.0002032059,0.00018905447,0.00007638908],"category_scores_gemma":[0.0043095634,0.0002145647,0.00008983323,0.0015169272,0.00013819268,0.00009526708,0.00029630985,0.0006985255,0.00002261008],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5774402,0.0034094136,0.00063240173,0.00012266327,0.00026691917,0.0012181029,0.0018810153,0.000014752855,0.36456636,0.000056618024,0.0034704343,0.046921104],"study_design_scores_gemma":[0.3768571,0.009933686,0.023753734,0.0034857679,0.00015902081,0.000009686988,0.0008521399,0.00050334405,0.56510234,0.0002587211,0.018729405,0.00035507698],"about_ca_topic_score_codex":0.0021605773,"about_ca_topic_score_gemma":0.00079786155,"teacher_disagreement_score":0.20058312,"about_ca_system_score_codex":0.000996192,"about_ca_system_score_gemma":0.0013459155,"threshold_uncertainty_score":0.8749695},"labels":[],"label_agreement":null},{"id":"W4409626118","doi":"10.1158/1538-7445.am2025-2123","title":"Abstract 2123: KJ-103: First-in-class naked anti-TROP2 HCAb with immune modulatory mechanisms and tumor regression potential in clinical trials","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Immune system; Medicine; Class (philosophy); Oncology; Internal medicine; Immunology; Computer science","score_opus":0.1037997744454655,"score_gpt":0.4694513717600073,"score_spread":0.3656515973145418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860586,0.0070572826,0.000046750058,0.004486887,0.00039210296,0.0014107048,0.000018423692,0.000022583807,0.00050666666],"genre_scores_gemma":[0.9946073,0.0038936513,0.0001342964,0.00035093309,0.00018105452,0.0002097554,0.000014564501,0.000028536688,0.0005798678],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99609876,0.0008170971,0.0010506195,0.00063275575,0.000796557,0.0006042332],"domain_scores_gemma":[0.99837136,0.00064463366,0.00016066706,0.0005192484,0.0001731501,0.00013093525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0100229075,0.00021951862,0.0009279409,0.0006487779,0.00014321343,0.00006806932,0.000248968,0.00023117573,0.00029243968],"category_scores_gemma":[0.000484312,0.00015266659,0.00016623402,0.0008691823,0.0003575145,0.00011313342,0.00008886221,0.0010992185,0.0000059180516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06810941,0.0017587992,0.051074848,0.0017843551,0.00067754503,0.0029322866,0.0007228857,0.00007047123,0.7314543,0.00050748984,0.0076622795,0.13324533],"study_design_scores_gemma":[0.025348654,0.001052323,0.93309474,0.00468836,0.0000659294,0.000033245495,0.0009946902,0.00039633218,0.027945075,0.00044156518,0.005627435,0.0003116362],"about_ca_topic_score_codex":0.0022901625,"about_ca_topic_score_gemma":0.00087496394,"teacher_disagreement_score":0.8820199,"about_ca_system_score_codex":0.00037302537,"about_ca_system_score_gemma":0.0009231806,"threshold_uncertainty_score":0.62255627},"labels":[],"label_agreement":null},{"id":"W4409626154","doi":"10.1158/1538-7445.am2025-4851","title":"Abstract 4851: Disrupting redox homeostasis in pancreatic ductal adenocarcinoma initiates anti-tumor immune responses","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immune system; Pancreatic ductal adenocarcinoma; Homeostasis; Adenocarcinoma; Pancreatic cancer; Cancer research; Medicine; Biology; Internal medicine; Cancer; Immunology","score_opus":0.0398548588019395,"score_gpt":0.3781883821652318,"score_spread":0.3383335233632923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982063,0.099122204,0.0000071650466,0.00046275026,0.00054815505,0.00036263894,0.000082542676,0.000015070867,0.0011931643],"genre_scores_gemma":[0.9842713,0.013129671,0.00005475567,0.000117598225,0.0007893003,0.00027041198,0.00005046464,0.000034393135,0.0012821351],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976898,0.0002537337,0.00038876815,0.00059587014,0.00032738675,0.00074446574],"domain_scores_gemma":[0.9988967,0.00013024444,0.00006857582,0.0005659561,0.00022957615,0.00010891793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010951393,0.0002025616,0.00033643292,0.00038911382,0.00021182824,0.00008867474,0.0004100061,0.00014353642,0.00010658493],"category_scores_gemma":[0.00073457137,0.00020110192,0.00011430278,0.00068672997,0.00029404365,0.000013764532,0.00031152446,0.00045140155,0.00001466915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068708614,0.00007958928,0.04308112,0.00020102691,0.00008687725,0.00003797212,0.00015912562,0.000016343873,0.94841474,0.00009182446,0.0023023093,0.004841991],"study_design_scores_gemma":[0.0011617497,0.00009405808,0.64370584,0.00029555568,0.000021931697,0.000013107898,0.0007985854,0.000007440408,0.32389545,0.0001319816,0.029609887,0.00026444017],"about_ca_topic_score_codex":0.0015382095,"about_ca_topic_score_gemma":0.0003898027,"teacher_disagreement_score":0.6245193,"about_ca_system_score_codex":0.00011399487,"about_ca_system_score_gemma":0.0009015466,"threshold_uncertainty_score":0.82006985},"labels":[],"label_agreement":null},{"id":"W4409626158","doi":"10.1158/1538-7445.am2025-2874","title":"Abstract 2874: ZW327, a novel Ly6E-targeting antibody-drug conjugate bearing a topoisomerase 1 inhibitor payload","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Conjugate; Antibody-drug conjugate; Topoisomerase; Drug; Antibody; Medicine; Pharmacology; Biology; Monoclonal antibody; Immunology; DNA; Genetics; Mathematics","score_opus":0.08370463835081471,"score_gpt":0.47499742427321706,"score_spread":0.39129278592240235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518874,0.005920303,0.00009235477,0.0148188,0.0008195847,0.001916323,0.00010201903,0.00020700686,0.024236185],"genre_scores_gemma":[0.9848137,0.0019630154,0.0003871426,0.0007488528,0.0012182369,0.0006133168,0.000058082125,0.00010479488,0.010092882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9936959,0.00020857381,0.00077218685,0.0011528685,0.002162364,0.002008116],"domain_scores_gemma":[0.99620456,0.00070048653,0.00009547821,0.0010227015,0.0013015069,0.0006752461],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003937185,0.0003784984,0.0006989448,0.0010523549,0.0006482047,0.00028616106,0.0006771808,0.0002462761,0.0023466125],"category_scores_gemma":[0.0015982796,0.00034828542,0.00022200275,0.0022356268,0.0006452786,0.00025294514,0.00069347315,0.002836304,0.00038549665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009602421,0.0003891466,0.022849064,0.0020764743,0.00022488205,0.00034297063,0.0007457653,0.0000341572,0.9059218,0.00052617455,0.045857918,0.020071363],"study_design_scores_gemma":[0.008809649,0.00038909,0.04183742,0.0061206007,0.00008854769,0.000034047778,0.0026770846,0.0008302899,0.6049226,0.0004650873,0.33291706,0.00090850814],"about_ca_topic_score_codex":0.0066675725,"about_ca_topic_score_gemma":0.0003632658,"teacher_disagreement_score":0.30099925,"about_ca_system_score_codex":0.0015876743,"about_ca_system_score_gemma":0.003388106,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W4409626245","doi":"10.1158/1538-7445.am2025-2726","title":"Abstract 2726: A circadian regulator drives tumor lineage plasticity through chromatin bivalency resolution","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Regulator; Chromatin; Circadian rhythm; Circadian clock; Biology; Cell biology; Genetics; Neuroscience; DNA","score_opus":0.07926364540869657,"score_gpt":0.3863786329879103,"score_spread":0.30711498757921374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97367513,0.0014281219,0.00017169215,0.001435999,0.00057189976,0.00065957155,0.00009294098,0.00014518433,0.021819469],"genre_scores_gemma":[0.9933692,0.00047695314,0.00010413454,0.00038766384,0.00041372172,0.00022959162,0.0000026875734,0.000031423184,0.0049845832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99680126,0.00027098745,0.00037461132,0.0008227728,0.0007555273,0.0009748733],"domain_scores_gemma":[0.9982945,0.0007422894,0.000081452294,0.0005045351,0.00015082091,0.00022640554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055094605,0.00020229688,0.00026230575,0.00038492787,0.0006699416,0.00015530783,0.00053318375,0.00013756617,0.00072050793],"category_scores_gemma":[0.0017691209,0.00019888484,0.000103498875,0.0014818766,0.00065099075,0.00035522302,0.0001864285,0.0008628573,0.00036676307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115450224,0.00012582948,0.0011356961,0.00031668105,0.0000125354145,0.0001488589,0.00091167784,0.00012136373,0.9302851,0.05109081,0.01387463,0.0018613774],"study_design_scores_gemma":[0.0006507506,0.000057128957,0.07271197,0.00049911335,0.000007864792,0.000011414573,0.00012247161,0.00047288186,0.8802222,0.0011662653,0.04385417,0.0002237755],"about_ca_topic_score_codex":0.00047373815,"about_ca_topic_score_gemma":0.00011621447,"teacher_disagreement_score":0.07157627,"about_ca_system_score_codex":0.00049136055,"about_ca_system_score_gemma":0.00097411236,"threshold_uncertainty_score":0.81102884},"labels":[],"label_agreement":null},{"id":"W4409626362","doi":"10.1158/1538-7445.am2025-5755","title":"Abstract 5755: Expansion of the known functional diversity of human T cells achieved due to the unprecedented resolution of intracellular proteins by mass cytometry (CyTOF)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Intracellular; Cell biology; Biology; Flow cytometry; Molecular biology; Chemistry; Genetics; Phenotype; Gene","score_opus":0.06391249395598095,"score_gpt":0.36842176197992066,"score_spread":0.30450926802393974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921475,0.0009638882,0.0005970521,0.0027877702,0.00012014658,0.0017450477,0.00017919728,0.000010838229,0.0014485731],"genre_scores_gemma":[0.99524426,0.00016692636,0.00003718204,0.000047741196,0.000080749036,0.000083304905,0.000016822361,0.000014829671,0.004308196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968249,0.00030631077,0.00042871345,0.00033180244,0.0016855301,0.00042273014],"domain_scores_gemma":[0.99775475,0.0002374407,0.00012434385,0.00071085244,0.0010465888,0.0001259939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020514566,0.00013131993,0.00036118866,0.00045575437,0.00051723915,0.000015608186,0.00057859236,0.00015167134,0.0007785462],"category_scores_gemma":[0.00025913308,0.00008427845,0.0001609095,0.0019563031,0.0005393189,0.00006182457,0.0007836971,0.00086243777,0.000013616136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015288328,0.00024648558,0.005700983,0.0005169559,0.0001234972,0.0000031497875,0.00033511381,0.00007036707,0.96859044,0.00016833075,0.0205972,0.002118629],"study_design_scores_gemma":[0.0010269869,0.00026915342,0.09289452,0.0005091274,0.00003174447,5.928807e-7,0.00043756564,0.000084732856,0.8976129,0.000085970656,0.006981171,0.00006551672],"about_ca_topic_score_codex":0.0063097025,"about_ca_topic_score_gemma":0.00054543593,"teacher_disagreement_score":0.087193534,"about_ca_system_score_codex":0.00043195102,"about_ca_system_score_gemma":0.00070132816,"threshold_uncertainty_score":0.95384246},"labels":[],"label_agreement":null},{"id":"W4409626424","doi":"10.1158/1538-7445.am2025-5777","title":"Abstract 5777: A guidance platform for nanoparticle mediated photothermal therapy for solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Photothermal therapy; Solid tumor; Medicine; Cancer research; Nanoparticle; Cancer; Nanotechnology; Materials science; Internal medicine","score_opus":0.059698117213224884,"score_gpt":0.3788761492943959,"score_spread":0.319178032081171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601246,0.0056846174,0.0025773824,0.0002761322,0.0007834656,0.002663933,0.00050009653,0.00032845384,0.0011734801],"genre_scores_gemma":[0.9936781,0.00073164044,0.00035573725,0.00017372389,0.00025002408,0.003963853,0.00003235637,0.00010896349,0.0007056284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979081,0.000009078334,0.00039815853,0.0003200208,0.00034983965,0.0010147592],"domain_scores_gemma":[0.9984328,0.00064826314,0.000036358742,0.0003844322,0.00036463622,0.0001335175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007664901,0.00022390885,0.00031305003,0.00023773786,0.00024841266,0.00009424394,0.0004783085,0.00013945637,0.00015512493],"category_scores_gemma":[0.00016822491,0.00020886328,0.00011458822,0.0006421096,0.00013162532,0.0002260431,0.000035579942,0.00029526866,0.000021573345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007763482,0.00004473138,0.00014804871,0.00040902183,0.00016315168,0.0000025583595,0.0002740547,0.0023131277,0.95943266,0.0004911817,0.015877975,0.020067116],"study_design_scores_gemma":[0.0030537888,0.0001547206,0.0007387851,0.00021384956,0.000008112609,5.3868484e-7,0.000099014665,0.009102106,0.90744185,0.0026810572,0.07624251,0.0002636437],"about_ca_topic_score_codex":0.00007597015,"about_ca_topic_score_gemma":0.00012439226,"teacher_disagreement_score":0.06036453,"about_ca_system_score_codex":0.0005082266,"about_ca_system_score_gemma":0.0003959353,"threshold_uncertainty_score":0.8517197},"labels":[],"label_agreement":null},{"id":"W4409626525","doi":"10.1158/1538-7445.am2025-2744","title":"Abstract 2744: Interrogating the functional roles of differential CTCF-binding sites in IDH-mutant gliomas using a novel CRISPR library","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CRISPR; Mutant; Biology; Genetics; Computational biology; Gene","score_opus":0.12775437564875194,"score_gpt":0.420787387844229,"score_spread":0.29303301219547706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526155,0.0013911277,0.000031410276,0.002044184,0.00013407435,0.0004015886,0.000034501943,0.000015728638,0.0006858133],"genre_scores_gemma":[0.99941266,0.00008650496,0.00008644884,0.000045592304,0.00013924636,0.00011113962,0.00001941306,0.000017086957,0.00008193373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985563,0.000056610654,0.00029560737,0.00025719916,0.00046437114,0.00036989342],"domain_scores_gemma":[0.9991437,0.0004154416,0.000058093225,0.0002130436,0.0001075932,0.0000621059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030981732,0.000116747164,0.00023351554,0.00052696984,0.0001674566,0.00006104417,0.0001350716,0.000067895526,0.00069944013],"category_scores_gemma":[0.00013356298,0.00007760656,0.00009198185,0.00080362,0.00015068908,0.000115665425,0.00021904091,0.00040564168,0.0000047335475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032935326,0.00042135763,0.16054778,0.00018904204,0.00015531408,0.00004565679,0.0005272462,0.00009508503,0.83423305,0.000776138,0.00031318807,0.002366765],"study_design_scores_gemma":[0.0029412964,0.00010515138,0.32071579,0.0023615481,0.00006949026,0.000012976342,0.003039904,0.0017660563,0.6683509,0.00026640712,0.0002651489,0.00010535671],"about_ca_topic_score_codex":0.00044248384,"about_ca_topic_score_gemma":0.0003729947,"teacher_disagreement_score":0.16588219,"about_ca_system_score_codex":0.00022697882,"about_ca_system_score_gemma":0.00038447432,"threshold_uncertainty_score":0.7658379},"labels":[],"label_agreement":null},{"id":"W4409626582","doi":"10.1158/1538-7445.am2025-4494","title":"Abstract 4494: Structure, dynamics and therapeutic potential of fatty acid synthase","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemistry","score_opus":0.019893113761929766,"score_gpt":0.3547905949080828,"score_spread":0.33489748114615303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97705126,0.019539645,0.00048435328,0.00022845002,0.0017017537,0.00020663484,0.0002325602,0.0000050213444,0.00055031246],"genre_scores_gemma":[0.99379283,0.0037565974,0.00005499512,0.00008673027,0.0014094462,0.000027768123,0.000035301404,0.000013441895,0.0008228686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901,0.00005793284,0.00014993011,0.0002962515,0.00020317188,0.00028269307],"domain_scores_gemma":[0.9993746,0.000014035853,0.00003452455,0.00030816515,0.00020159892,0.00006706975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002304602,0.00010199454,0.00015202662,0.00009877142,0.00009309731,0.000025805073,0.0001965978,0.00013932468,0.00008789431],"category_scores_gemma":[0.000044912536,0.00009317532,0.000049516104,0.00015653679,0.00027385599,0.000002870215,0.00013677556,0.000207067,7.377882e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021086774,0.000022729393,0.00094839407,0.000122055615,0.00008202332,1.7983007e-7,0.000018786566,0.000026327802,0.9580268,0.0006176592,0.0023946248,0.037529513],"study_design_scores_gemma":[0.0008727741,0.00008241031,0.03102213,0.000051245795,0.00003069203,0.0000032673195,0.00015744338,0.000096037205,0.91553587,0.0007307286,0.05126105,0.00015634068],"about_ca_topic_score_codex":0.00030578073,"about_ca_topic_score_gemma":0.0006127074,"teacher_disagreement_score":0.048866425,"about_ca_system_score_codex":0.000037105896,"about_ca_system_score_gemma":0.0003425934,"threshold_uncertainty_score":0.3799579},"labels":[],"label_agreement":null},{"id":"W4409626611","doi":"10.1158/1538-7445.am2025-4039","title":"Abstract 4039: An isogenic CRISPR screen identifies novel MYC-driven vulnerabilities","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"CRISPR; Biology; Computational biology; Genetics; Cancer research; Gene","score_opus":0.12796377370158396,"score_gpt":0.4667443649151886,"score_spread":0.33878059121360465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426308,0.018834839,0.0008561023,0.0097866785,0.0017981005,0.0008389655,0.0007081709,0.00016992552,0.024376377],"genre_scores_gemma":[0.9612608,0.0005126615,0.00034120755,0.0004621062,0.00011532207,0.00009430178,0.000035995225,0.000017806748,0.037159786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979404,0.00042016842,0.00030703074,0.00051934196,0.00011682143,0.00069623394],"domain_scores_gemma":[0.99844956,0.0005410931,0.00003572467,0.00054215366,0.00037171482,0.00005974071],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015696875,0.00016329337,0.0003001079,0.00028866032,0.00046834894,0.0000906753,0.00060586055,0.00036483648,0.0046749674],"category_scores_gemma":[0.00037743032,0.0001318076,0.00012035766,0.00047572333,0.0010681463,0.00014267156,0.00026234117,0.0010095743,0.00018251361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025440124,0.000206198,0.0013415747,0.00008766164,0.00027289038,0.0000037014318,0.00018332897,0.0000060952975,0.9367059,0.0056546046,0.044346236,0.010937415],"study_design_scores_gemma":[0.0013790027,0.00024625717,0.05257727,0.00021905081,0.00007119637,0.0000057280386,0.001441932,0.000027475098,0.78209424,0.0050248336,0.1565395,0.0003735338],"about_ca_topic_score_codex":0.002508946,"about_ca_topic_score_gemma":0.0009706475,"teacher_disagreement_score":0.15461168,"about_ca_system_score_codex":0.00013789663,"about_ca_system_score_gemma":0.00032691495,"threshold_uncertainty_score":0.9962349},"labels":[],"label_agreement":null},{"id":"W4409626698","doi":"10.1158/1538-7445.am2025-4153","title":"Abstract 4153: Biomarker-driven polyamine pathway targeting as a treatment approach for TNBC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Polyamine; Biomarker; Cancer research; Medicine; Computational biology; Biology; Biochemistry","score_opus":0.062323975259160246,"score_gpt":0.3931167434171777,"score_spread":0.3307927681580175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.921423,0.05254097,0.001954897,0.0009821509,0.0013535179,0.0021566493,0.0004038531,0.000041796495,0.01914315],"genre_scores_gemma":[0.9678552,0.006054089,0.0011647586,0.00018348802,0.0023090416,0.0019592133,0.0004717985,0.000048852344,0.019953571],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998261,0.00007357429,0.00021788708,0.0005965872,0.00022729865,0.0006237047],"domain_scores_gemma":[0.99909246,0.000045175875,0.00004633132,0.00041082964,0.00026859881,0.0001366185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004670516,0.00018765395,0.00022545035,0.00015065033,0.00024715945,0.000056893747,0.00028295149,0.00018112386,0.000059801634],"category_scores_gemma":[0.00015642094,0.00016359787,0.00016823749,0.00026909393,0.00014378798,0.000004846906,0.00012890769,0.00013555128,0.000007324572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043967724,0.00015321813,0.00015059188,0.00010726319,0.00017523683,0.0000014770575,0.00006767946,0.000047889567,0.9066939,0.00019661855,0.02433036,0.0676361],"study_design_scores_gemma":[0.0012604593,0.00017620783,0.0007451712,0.000023381193,0.000016201706,0.0000012294344,0.0001756921,0.000083298175,0.35074592,0.000060394934,0.64656746,0.00014458218],"about_ca_topic_score_codex":0.00083950796,"about_ca_topic_score_gemma":0.00012527156,"teacher_disagreement_score":0.6222371,"about_ca_system_score_codex":0.00014703386,"about_ca_system_score_gemma":0.00089567056,"threshold_uncertainty_score":0.6671328},"labels":[],"label_agreement":null},{"id":"W4409626711","doi":"10.1158/1538-7445.am2025-3883","title":"Abstract 3883: Evolution of genomic and epigenomic heterogeneity in prostate cancer from tissue and liquid biopsies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenomics; Prostate cancer; Prostate; Cancer research; Cancer; Liquid biopsy; Tumor heterogeneity; Medicine; Pathology; Biology; Internal medicine; DNA methylation; Genetics; Gene","score_opus":0.04962733224483373,"score_gpt":0.4188187183103404,"score_spread":0.36919138606550667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8962088,0.100507066,0.0000017646548,0.0018146799,0.00007440884,0.00093131984,0.00019696576,0.0000124702865,0.00025248982],"genre_scores_gemma":[0.9654193,0.033230994,0.000031494932,0.000022822553,0.0000686705,0.00033072731,0.000020183497,0.00001792753,0.0008578746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983989,0.00009120106,0.00027816338,0.000456144,0.00029812581,0.00047744808],"domain_scores_gemma":[0.9992185,0.00013604184,0.000043392898,0.00025072062,0.00020839022,0.00014292198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050590496,0.00014290227,0.00034692185,0.0004836108,0.00011292536,0.0000295083,0.00010332699,0.00009519832,0.00012969336],"category_scores_gemma":[0.000043449192,0.00011981389,0.000027692116,0.00039929795,0.0005339143,0.00008538653,0.00018915391,0.0003860117,0.0000055829423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027199725,0.000076820055,0.24786386,0.0005380489,0.00012211378,0.000035334873,0.0005860287,0.0000128097045,0.73376554,0.0000407257,0.00018372394,0.014055039],"study_design_scores_gemma":[0.0022372843,0.00025331238,0.7394962,0.00056760217,0.000025928459,0.0000014905155,0.00031912097,0.000035515837,0.2551552,0.000293267,0.0015218274,0.00009327075],"about_ca_topic_score_codex":0.027275039,"about_ca_topic_score_gemma":0.0038974765,"teacher_disagreement_score":0.4916323,"about_ca_system_score_codex":0.001017793,"about_ca_system_score_gemma":0.0010745119,"threshold_uncertainty_score":0.97920245},"labels":[],"label_agreement":null},{"id":"W4409626849","doi":"10.1158/1538-7445.am2025-4945","title":"Abstract 4945: Exposure to per and poly fluoroalkyl substances and cancer risk: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Cancer; Medicine; Oncology; Internal medicine; Environmental health","score_opus":0.16482505345644716,"score_gpt":0.46937834300175046,"score_spread":0.3045532895453033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029712248,0.9931814,0.00002668921,0.0009597639,0.000023555525,0.0048538223,0.00052687695,0.000028413575,0.00036973404],"genre_scores_gemma":[0.00031422797,0.9894722,0.00004622553,0.0002457784,0.00005362107,0.006891556,0.00003649958,0.000038275026,0.0029016184],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99630225,0.0006730709,0.00082208053,0.00096828555,0.00078951835,0.0004448081],"domain_scores_gemma":[0.99687177,0.0007556659,0.00021495608,0.0011885928,0.00054318487,0.00042583115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024401117,0.00043662332,0.006681807,0.00084965467,0.00027703907,0.00014655464,0.00023766563,0.00023214288,0.00044466113],"category_scores_gemma":[0.00039863848,0.0002849749,0.0016144905,0.0021120058,0.00016468202,0.00006353631,0.00021617548,0.00094561395,0.000015108959],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071099453,0.0000177704,0.000018433851,0.81383455,0.14325477,0.0000103802095,0.0000961935,0.0000011632075,6.650305e-7,0.000040511626,0.00096361677,0.041754816],"study_design_scores_gemma":[0.00018272744,0.000035855563,0.00018658057,0.09727645,0.8458923,0.000029770266,0.000058383277,6.6823986e-7,5.6659053e-7,0.000017188144,0.0560388,0.00028071433],"about_ca_topic_score_codex":0.0020545502,"about_ca_topic_score_gemma":0.00067864306,"teacher_disagreement_score":0.7165581,"about_ca_system_score_codex":0.00022180143,"about_ca_system_score_gemma":0.00068769924,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4409626880","doi":"10.1158/1538-7445.am2025-4905","title":"Abstract 4905: Mosaic chromosomal alterations overlapping hotspot and coldspot sites of somatic structural variation are associated with increased odds of hematological malignancy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Somatic cell; Malignancy; Biology; Genetics; Odds; Medicine; Evolutionary biology; Internal medicine; Gene","score_opus":0.02681664709660622,"score_gpt":0.3283097773782377,"score_spread":0.3014931302816315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975698,0.0015116193,0.000078795965,0.00009754707,0.000030371082,0.0002820018,0.00026592196,0.0000042941497,0.00015964026],"genre_scores_gemma":[0.9993333,0.00025639744,0.00010373519,0.000030724143,0.000036162437,0.000057632165,0.00013620294,0.0000078786625,0.0000379172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905175,0.00006802199,0.00023939763,0.00023350106,0.00020522084,0.00020208338],"domain_scores_gemma":[0.999062,0.00016292995,0.00013845887,0.00019033058,0.00039574498,0.000050508133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023340005,0.00009860564,0.0002158802,0.000087754626,0.00010493706,0.000028012673,0.00011561356,0.00012476847,0.000035676152],"category_scores_gemma":[0.00044185677,0.00008661783,0.000033461372,0.0002467751,0.00017198852,0.0000061709866,0.00008929885,0.00011662517,2.0978223e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001539385,0.000062366074,0.0715028,0.00023984507,0.0001346473,0.0000041635935,0.000086088054,0.0002643318,0.9259905,0.0011565415,0.0002637325,0.00014103405],"study_design_scores_gemma":[0.0011094646,0.00024941837,0.71406806,0.00044061927,0.000035488745,0.0000027414383,0.00012932549,0.0005820959,0.28270757,0.0004945079,0.000050314367,0.00013041295],"about_ca_topic_score_codex":0.00035447188,"about_ca_topic_score_gemma":0.0005902404,"teacher_disagreement_score":0.64328295,"about_ca_system_score_codex":0.000057276204,"about_ca_system_score_gemma":0.00039378644,"threshold_uncertainty_score":0.35321724},"labels":[],"label_agreement":null},{"id":"W4409626893","doi":"10.1158/1538-7445.am2025-2223","title":"Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Tannin, Tannase and Anticancer Activities","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; Université de Sherbrooke; Concordia University; Hôpital Charles-Le Moyne; McGill University","funders":"","keywords":"Cancer; Lung cancer; Prebiotic; Medicine; Cancer research; Immunotherapy; Cancer immunotherapy; Clinical trial; Internal medicine; Oncology; Pharmacology; Chemistry; Biochemistry","score_opus":0.03908393092619538,"score_gpt":0.40175214327040043,"score_spread":0.36266821234420504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715105,0.02594026,0.000004656857,0.00030501108,0.00022664532,0.0017206031,0.0001645444,0.00003995969,0.00008778803],"genre_scores_gemma":[0.9916418,0.0066989358,0.000017184197,0.00005086432,0.000037972797,0.00085779646,0.00007543097,0.000052432322,0.0005675448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737346,0.00044128037,0.00050251745,0.0007635747,0.00017916242,0.0007399952],"domain_scores_gemma":[0.99858874,0.0005955434,0.00017950701,0.00031993532,0.00024990924,0.00006638472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055694435,0.0003782139,0.0008033476,0.0005355901,0.00022304832,0.000088583256,0.00017100334,0.00026141235,0.00011593845],"category_scores_gemma":[0.000037523918,0.00025801614,0.00004187782,0.0006481619,0.0009106179,0.00038111024,0.00006584471,0.0008117035,8.322575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069455266,0.0019687756,0.8783392,0.00013743392,0.0010163839,0.000030174275,0.0020955768,0.000036867677,0.011884801,0.00008820317,0.00007542289,0.034871902],"study_design_scores_gemma":[0.18430817,0.005536724,0.7930978,0.00097309815,0.00015834165,0.0000030400474,0.0011823114,0.000058576526,0.012822624,0.000044302833,0.001318636,0.0004964036],"about_ca_topic_score_codex":0.01380618,"about_ca_topic_score_gemma":0.0069551105,"teacher_disagreement_score":0.114852905,"about_ca_system_score_codex":0.00051398855,"about_ca_system_score_gemma":0.0010331254,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W4409626899","doi":"10.1158/1538-7445.am2025-5482","title":"Abstract 5482: In vitro assays for prediction of ADC hematological toxicities: contribution of antibody, linker, and payload","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Payload (computing); Medicine; In vitro; Antibody; Cancer research; Pharmacology; Immunology; Chemistry; Computer science; Biochemistry","score_opus":0.09800763902043924,"score_gpt":0.4891025378489256,"score_spread":0.39109489882848636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939939,0.0017273984,0.0005257322,0.001788133,0.000019742205,0.0006169779,0.00025426396,0.000009847734,0.0010640479],"genre_scores_gemma":[0.99878424,0.0006481285,0.00007752455,0.000026557493,0.000041525556,0.00022445052,0.0000726285,0.0000031209872,0.000121826844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992351,0.000022447308,0.0002462146,0.0001553075,0.00016689785,0.0001740438],"domain_scores_gemma":[0.99912393,0.00040041827,0.000033699816,0.00011356011,0.00027076234,0.000057641962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005160126,0.000050237533,0.00021455309,0.00007971756,0.000039246024,0.0000040714353,0.000053797645,0.0001102786,0.00004602413],"category_scores_gemma":[0.00040412374,0.00004256181,0.000035552475,0.00026969492,0.00024729857,0.000025341276,0.000024039959,0.00024638756,3.2291928e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007905432,0.00014102162,0.0062652975,0.00084825,0.000023774053,0.0000013852326,0.0000238641,0.000002777377,0.98822063,0.0017555356,0.00034700107,0.0015799329],"study_design_scores_gemma":[0.0015486915,0.00005892887,0.02398663,0.00029387634,0.000017410217,0.0000020516432,0.0000883545,0.0005408534,0.9709012,0.0010522284,0.0014839004,0.000025859867],"about_ca_topic_score_codex":0.000029621968,"about_ca_topic_score_gemma":0.0000012880454,"teacher_disagreement_score":0.017721333,"about_ca_system_score_codex":0.00007458439,"about_ca_system_score_gemma":0.00014607559,"threshold_uncertainty_score":0.17356202},"labels":[],"label_agreement":null},{"id":"W4409626973","doi":"10.1158/1538-7445.am2025-5425","title":"Abstract 5425: Human mitochondrial ClpXP protease degrades serine phosphorylated substrates","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Toronto; University of Guelph; Princess Margaret Cancer Centre","funders":"","keywords":"Serine; Serine protease; Phosphorylation; Chemistry; Cell biology; Biochemistry; Mitochondrion; Protease; Biology; Enzyme","score_opus":0.049755684724425105,"score_gpt":0.3891255174883324,"score_spread":0.3393698327639073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409626973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899606,0.0017757828,0.00008411173,0.00058100524,0.0008790204,0.000694422,0.000039142153,0.000033538236,0.0059523582],"genre_scores_gemma":[0.97795,0.00037723605,0.00015030996,0.00018549146,0.0009184328,0.00049827265,0.00018608196,0.000028245006,0.019705925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982919,0.00015971556,0.00025647655,0.00055890344,0.00023233429,0.0005006578],"domain_scores_gemma":[0.9989885,0.000028057346,0.00004409108,0.00046573568,0.00033350225,0.00014007668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003221226,0.0001725017,0.00017615936,0.00015530123,0.00031333606,0.00007037322,0.0003269663,0.00028007783,0.0007134179],"category_scores_gemma":[0.00018381065,0.0001616096,0.00009404949,0.00037626218,0.0002477405,0.000004512182,0.00013683438,0.00044135225,0.00005387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005528206,0.00007540868,0.0018454782,0.000057296624,0.000054833105,0.000015427879,0.00002333903,0.000019418614,0.9684061,0.00043054044,0.026938353,0.0015810059],"study_design_scores_gemma":[0.0009763728,0.00020342528,0.004127948,0.00004432019,0.00000846538,0.0000033094623,0.000062707324,0.000003098825,0.8668665,0.0003576866,0.12718722,0.00015890377],"about_ca_topic_score_codex":0.00043118538,"about_ca_topic_score_gemma":0.0007136169,"teacher_disagreement_score":0.10153954,"about_ca_system_score_codex":0.000053388376,"about_ca_system_score_gemma":0.0004078561,"threshold_uncertainty_score":0.78114253},"labels":[],"label_agreement":null},{"id":"W4409627105","doi":"10.1158/1538-7445.am2025-4936","title":"Abstract 4936: The association between plasma IGFBP7 and cancer incidence, cancer mortality, and all-cause mortality in ARIC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Cancer incidence; Cancer; Incidence (geometry); Oncology; Internal medicine; Demography; Gerontology; Mathematics","score_opus":0.1730251894175807,"score_gpt":0.46739914527108056,"score_spread":0.2943739558534999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98424214,0.0073088855,0.0000012315617,0.0052440097,0.00021888844,0.00087005476,0.00011576049,0.000030225769,0.0019688264],"genre_scores_gemma":[0.97503716,0.022432689,0.0000036321444,0.00044114716,0.00031528788,0.00051274814,0.000017337521,0.000022973643,0.0012170387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704015,0.00019438237,0.00048178792,0.0005576951,0.0009972162,0.0007287728],"domain_scores_gemma":[0.9983879,0.00051577395,0.00012437454,0.0003903784,0.00035903076,0.0002225737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020270557,0.00022225009,0.00046451032,0.0003707835,0.00023907259,0.00011380419,0.00022616117,0.0002728659,0.00013220876],"category_scores_gemma":[0.00044475065,0.00016656565,0.000055360066,0.0010911397,0.0002897021,0.0002446357,0.00024911045,0.0012738962,0.0000062229437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007687007,0.00004496793,0.98577803,0.00025911038,0.0009239359,0.000021228176,0.0005026093,0.000006185222,0.0022761482,0.00017349719,0.0040574223,0.0058799954],"study_design_scores_gemma":[0.0011490945,0.000047399022,0.9890861,0.00033612395,0.00035569278,7.0795187e-7,0.00019625579,0.000070157046,0.0024794128,0.00047469023,0.005651599,0.00015280324],"about_ca_topic_score_codex":0.06214662,"about_ca_topic_score_gemma":0.019997168,"teacher_disagreement_score":0.04214945,"about_ca_system_score_codex":0.0012891584,"about_ca_system_score_gemma":0.0010637376,"threshold_uncertainty_score":0.99788535},"labels":[],"label_agreement":null},{"id":"W4409627106","doi":"10.1158/1538-7445.am2025-3828","title":"Abstract 3828: Understanding the molecular underpinnings of breast cancer brain metastases: implications for early detection and treatment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.13334653695075224,"score_gpt":0.4514655526728834,"score_spread":0.3181190157221312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91430336,0.006524925,0.012570226,0.06285645,0.00007344566,0.002492996,0.0007113482,0.000025682883,0.0004415788],"genre_scores_gemma":[0.9974036,0.0006765734,0.00010290895,0.00020215217,0.00003886282,0.001259975,0.00001220997,0.000016630052,0.0002870396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989932,0.00007612698,0.00018130957,0.0002769335,0.00018383758,0.0002885703],"domain_scores_gemma":[0.9988898,0.00047620633,0.000052099862,0.00029119558,0.00020629747,0.00008441233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005198657,0.000116375086,0.00021323151,0.00018994286,0.000294304,0.00003951651,0.00007100804,0.00004639125,0.000047693815],"category_scores_gemma":[0.00005074584,0.000075202326,0.00009891578,0.00045298756,0.00022940269,0.000043558804,0.000033802808,0.00012864565,5.9811344e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030626159,0.0009405671,0.027280686,0.0011980088,0.005608541,0.000023093155,0.0018114604,0.000217347,0.4616933,0.09311769,0.003625611,0.4014211],"study_design_scores_gemma":[0.013284306,0.0020736326,0.8044474,0.0012697929,0.0017138963,0.000046953366,0.0052531213,0.00022692452,0.12373205,0.034106754,0.013440461,0.00040469412],"about_ca_topic_score_codex":0.0035292367,"about_ca_topic_score_gemma":0.00061312487,"teacher_disagreement_score":0.7771667,"about_ca_system_score_codex":0.0009191985,"about_ca_system_score_gemma":0.0004148978,"threshold_uncertainty_score":0.53351736},"labels":[],"label_agreement":null},{"id":"W4409627141","doi":"10.1158/1538-7445.am2025-1694","title":"Abstract 1694: Combination of inhibitors of RAD51 and FLT-3 and other tyrosine kinase inhibitors synergistically inhibits proliferation of cultured human leukemia cell lines","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tyrosine kinase; Cancer research; Leukemia; Cell growth; Cell culture; Chemistry; Tyrosine-kinase inhibitor; Pharmacology; Biology; Cancer; Medicine; Biochemistry; Immunology; Internal medicine; Signal transduction; Genetics","score_opus":0.052923884148162306,"score_gpt":0.41336898773774405,"score_spread":0.36044510358958176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920957,0.00336919,0.000015797556,0.0008483869,0.00009156302,0.0011791184,0.00006145955,0.000017013092,0.002321783],"genre_scores_gemma":[0.99791765,0.0005846346,0.00014374345,0.000036267556,0.0001491293,0.0001120815,0.000021844597,0.00003245306,0.0010021679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972934,0.00016905596,0.00073368364,0.00041184376,0.0010305487,0.0003614624],"domain_scores_gemma":[0.99759793,0.0002475181,0.00017533396,0.000341728,0.0014640222,0.0001734445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381536,0.00018029775,0.00050860865,0.0006301555,0.00011677092,0.000029886827,0.00013740773,0.0002284031,0.00008491046],"category_scores_gemma":[0.00065066334,0.00015541853,0.000057964204,0.0008839438,0.00097467663,0.00009894449,0.00016894701,0.00055727904,0.0000011024435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005633193,0.00028832944,0.023564588,0.004806138,0.00005111418,0.0000058316937,0.0006094845,0.000020214664,0.96069795,0.0018141698,0.0035653594,0.004013519],"study_design_scores_gemma":[0.002721027,0.0005890889,0.025581207,0.0021456496,0.000037890753,0.0000016470008,0.00027574363,0.00013412458,0.9670971,0.0004153412,0.0008911762,0.00011000705],"about_ca_topic_score_codex":0.0015155798,"about_ca_topic_score_gemma":0.00018774273,"teacher_disagreement_score":0.0063991654,"about_ca_system_score_codex":0.00035419257,"about_ca_system_score_gemma":0.0010591319,"threshold_uncertainty_score":0.6337784},"labels":[],"label_agreement":null},{"id":"W4409627226","doi":"10.1158/1538-7445.am2025-3506","title":"Abstract 3506: Clinic enabling development of a TCR-Ab half life extended T cell engager against a novel solid tumor target","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"T-cell receptor; Solid tumor; Cancer research; T cell; Medicine; Chemistry; Cancer; Immunology; Internal medicine; Immune system","score_opus":0.13136231778522853,"score_gpt":0.4501290994282303,"score_spread":0.31876678164300176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563498,0.0046979375,0.0002665738,0.0014114456,0.00030516807,0.0018401332,0.000031252803,0.00007597024,0.035021752],"genre_scores_gemma":[0.9562065,0.0011903791,0.0022738816,0.00055788615,0.0003626798,0.0005736773,0.000037183025,0.00008915509,0.03870867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99477035,0.0002460631,0.000991155,0.00080776843,0.0018596499,0.0013250349],"domain_scores_gemma":[0.9962388,0.00095142564,0.00014215504,0.0008932712,0.0012163355,0.00055799197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005572912,0.00029481345,0.00075009384,0.0010884955,0.00038149595,0.000075904776,0.00060733705,0.00019745009,0.008470994],"category_scores_gemma":[0.0013558028,0.0002685159,0.00021930321,0.0015270063,0.0004044854,0.00010402453,0.00043407088,0.0022873322,0.00021132712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016931526,0.00094490446,0.00091985,0.0014797158,0.00028754416,0.00009595878,0.0012222019,0.000030880314,0.9664978,0.000023027435,0.006360781,0.020444203],"study_design_scores_gemma":[0.005043201,0.000214854,0.009146416,0.0011029975,0.000023785848,0.0000031874472,0.0016185603,0.00019805627,0.82684445,0.000050459108,0.15547235,0.0002816557],"about_ca_topic_score_codex":0.00032145774,"about_ca_topic_score_gemma":0.000076300756,"teacher_disagreement_score":0.14911157,"about_ca_system_score_codex":0.00092281343,"about_ca_system_score_gemma":0.009672462,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W4409627228","doi":"10.1158/1538-7445.am2025-4357","title":"Abstract 4357: Disparities in neurotoxicities in cisplatin-treated cancer patients: a population pharmacogenomics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Cisplatin; Population; Cancer; Oncology; Internal medicine; Chemotherapy; Pharmacology; Environmental health","score_opus":0.08408665197021355,"score_gpt":0.45947699120615626,"score_spread":0.3753903392359427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973763,0.002322902,8.839425e-7,0.000982104,0.00023869834,0.0015645304,0.00010347272,0.000028729164,0.005021052],"genre_scores_gemma":[0.9928357,0.0023989119,0.000013719709,0.00037085087,0.00012521114,0.0019118829,0.000167416,0.000025488149,0.002150818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982104,0.00013279417,0.00036921416,0.00040460643,0.00032306355,0.00055997074],"domain_scores_gemma":[0.99938124,0.00015705448,0.000047136135,0.00015955971,0.00016446003,0.00009057441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030398442,0.00017605406,0.00035424723,0.0008088318,0.00008995069,0.00003352425,0.00012928587,0.00011428355,0.0004337218],"category_scores_gemma":[0.000042295225,0.00016618634,0.000054379198,0.00101268,0.00012948975,0.00012546602,0.00007315156,0.00065103703,0.0000054900283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017078548,0.0007623215,0.9773494,0.00045969698,0.00007139334,0.00002998543,0.00034709726,0.0004077645,0.008989063,0.00012634802,0.0026189177,0.007130173],"study_design_scores_gemma":[0.006004381,0.00011064404,0.9857077,0.0003114937,0.000039006343,6.6128143e-7,0.00011047756,0.00057773024,0.005347215,0.00014547867,0.0015081862,0.00013702542],"about_ca_topic_score_codex":0.038230725,"about_ca_topic_score_gemma":0.004542515,"teacher_disagreement_score":0.03368821,"about_ca_system_score_codex":0.0015585668,"about_ca_system_score_gemma":0.0003904782,"threshold_uncertainty_score":0.9681738},"labels":[],"label_agreement":null},{"id":"W4409627233","doi":"10.1158/1538-7445.am2025-3997","title":"Abstract 3997: Advancing precision cancer medicine with patient-derived organoids: an endometrial cancer case study","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Organoid; Endometrial cancer; Cancer; Medicine; Precision medicine; Oncology; Internal medicine; Biology; Pathology; Neuroscience","score_opus":0.04245079796694196,"score_gpt":0.4186578599576473,"score_spread":0.37620706199070536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859269,0.010796706,0.000092021386,0.0004891917,0.0008640641,0.0013243896,0.00015314997,0.000017678982,0.00033584484],"genre_scores_gemma":[0.9913219,0.0060733687,0.00006770584,0.00026223855,0.00091516704,0.0010097845,0.000037993854,0.00005478898,0.00025704197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730587,0.00017278986,0.00039673148,0.0008626219,0.00057353324,0.0006884247],"domain_scores_gemma":[0.9977873,0.00023520547,0.00011321155,0.0007214045,0.0008656789,0.00027722522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007118529,0.00027128393,0.00035052912,0.0003433324,0.0003917568,0.00007827003,0.0003747181,0.00015006447,0.00046718022],"category_scores_gemma":[0.0005563764,0.00021759725,0.000048847,0.00087579194,0.00025156682,0.000016609234,0.00030380767,0.0004128726,0.0000026410896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022186828,0.00041302678,0.016781293,0.00009063047,0.0003036409,0.0005305019,0.001146655,0.0014721033,0.8539905,0.000012120847,0.009303671,0.11373719],"study_design_scores_gemma":[0.017625744,0.0087407725,0.0128784245,0.0010653379,0.00029382386,0.000100718746,0.019996598,0.000097474796,0.8547813,0.000132338,0.083062924,0.001224506],"about_ca_topic_score_codex":0.028604075,"about_ca_topic_score_gemma":0.047662567,"teacher_disagreement_score":0.112512685,"about_ca_system_score_codex":0.0004098242,"about_ca_system_score_gemma":0.0016603016,"threshold_uncertainty_score":0.9778645},"labels":[],"label_agreement":null},{"id":"W4409627418","doi":"10.1158/1538-7445.am2025-3822","title":"Abstract 3822: Development and characterization of mouse models of epithelioid sarcoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epithelioid sarcoma; Medicine; Cancer; Characterization (materials science); Sarcoma; Cancer research; Pathology; Internal medicine; Materials science; Nanotechnology","score_opus":0.08967518969603394,"score_gpt":0.391637223131899,"score_spread":0.3019620334358651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643123,0.0017055909,0.000030761195,0.00063188025,0.000020061641,0.00035346558,0.000022697343,0.0000066967523,0.00079761574],"genre_scores_gemma":[0.9973999,0.0015691775,0.00020077558,0.00003671842,0.000012549035,0.00012776439,0.000020120235,0.000008019037,0.00062497216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916464,0.000024888195,0.00021684973,0.00015252353,0.00028574184,0.00015535015],"domain_scores_gemma":[0.9993985,0.00007663739,0.000041081938,0.00016904442,0.00025960137,0.000055108132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000260028,0.00006366023,0.00019998415,0.00024243727,0.000040852014,0.00000626297,0.000053616146,0.000042388703,0.000063685286],"category_scores_gemma":[0.000022685275,0.000051111172,0.000024886664,0.00024294309,0.00008824884,0.000043500928,0.000053927346,0.000094671195,0.0000022790812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032407875,0.0006440311,0.084971674,0.00079465704,0.00020111071,0.000013331555,0.0007741147,0.000006527184,0.76650035,0.0015003886,0.00015061678,0.14411914],"study_design_scores_gemma":[0.0007169713,0.000039534658,0.34583458,0.00033165733,0.000012316587,6.4304453e-7,0.00005355111,0.000041256408,0.6521186,0.000102791484,0.0007189837,0.000029087192],"about_ca_topic_score_codex":0.00020123385,"about_ca_topic_score_gemma":0.000018429448,"teacher_disagreement_score":0.26086292,"about_ca_system_score_codex":0.000106226056,"about_ca_system_score_gemma":0.00034386426,"threshold_uncertainty_score":0.20842531},"labels":[],"label_agreement":null},{"id":"W4409627440","doi":"10.1158/1538-7445.am2025-2276","title":"Abstract 2276: Whole exome sequencing of immune-mediated colitis in cancer patients treated with immune checkpoint inhibitors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Exome sequencing; Immune system; Medicine; Immune checkpoint; Cancer; Colitis; Cancer research; Exome; Colorectal cancer; Microsatellite instability; Immunology; Mutation; Internal medicine; Biology; Immunotherapy; Genetics; Gene","score_opus":0.041526528618500085,"score_gpt":0.36221733324230776,"score_spread":0.32069080462380767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888636,0.0068073464,6.6002906e-7,0.000921881,0.00016867388,0.0011787496,0.00013287428,0.000035085322,0.0018683972],"genre_scores_gemma":[0.99557877,0.0018717032,0.000010485841,0.00007860878,0.00005657917,0.00052787387,0.000093516086,0.00003886885,0.0017435885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99723285,0.000109428,0.0008053817,0.0004298098,0.0007360712,0.00068648247],"domain_scores_gemma":[0.9984482,0.00014642747,0.00016859766,0.00042711268,0.0006968405,0.00011281459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088548067,0.00022464026,0.0005605948,0.0006085979,0.00010725685,0.00002914038,0.00021839622,0.00017233886,0.0005403965],"category_scores_gemma":[0.000121440324,0.00018097414,0.00013255353,0.00222023,0.00045049202,0.00013328088,0.00007983475,0.00065657555,0.000008750358],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00878056,0.00038573396,0.22905038,0.00080774474,0.00036704206,0.000059383365,0.0009115177,0.00002120894,0.7475716,0.0000067771152,0.00059368904,0.01144435],"study_design_scores_gemma":[0.0063844216,0.0004204235,0.6699832,0.0032604104,0.00002373177,0.0000012546391,0.0005352821,0.00001793446,0.31749317,0.00000832805,0.0017233,0.00014853658],"about_ca_topic_score_codex":0.06069937,"about_ca_topic_score_gemma":0.0030318967,"teacher_disagreement_score":0.4409328,"about_ca_system_score_codex":0.002578746,"about_ca_system_score_gemma":0.0020679287,"threshold_uncertainty_score":0.9455555},"labels":[],"label_agreement":null},{"id":"W4409627507","doi":"10.1158/1538-7445.am2025-1985","title":"Abstract 1985: 5hmC-sequencing of matched cfDNA and tissue from men with mCRPC is concordant and identifies loss of AR signaling in NEPC and DNPC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Computational biology; R package; Deep sequencing; Genetics; Medicine; Oncology; Internal medicine; Gene; Statistics; Genome; Mathematics","score_opus":0.02623808096416713,"score_gpt":0.3494637361977158,"score_spread":0.3232256552335487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877131,0.0114375735,0.000040390438,0.00024203448,0.000021014936,0.0001798449,0.0001234166,0.0000012175761,0.00024141351],"genre_scores_gemma":[0.9943804,0.005247538,0.00012822449,0.0000388131,0.000036987505,0.000021250986,0.000010935699,0.0000095608175,0.00012627195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992053,0.000026807867,0.00019179567,0.00027783564,0.0001247898,0.00017349556],"domain_scores_gemma":[0.99949265,0.000107479624,0.000054810338,0.00016377137,0.00013009894,0.00005119096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002558444,0.00008571122,0.00019670498,0.00008287044,0.000039747145,0.000030875985,0.00008639382,0.00007176011,0.00001580368],"category_scores_gemma":[0.00005547554,0.000079351455,0.000011291802,0.00010744183,0.00031721673,0.0000052169403,0.00015581322,0.000110475616,1.3000522e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021880359,0.000011061189,0.029257054,0.00020185288,0.00005268261,0.000009013525,0.00046706366,0.00003182994,0.96732366,0.000053831158,0.000260886,0.0021122897],"study_design_scores_gemma":[0.0007944062,0.000112223286,0.02115832,0.00025776323,0.000013742344,0.000001437981,0.0010542079,0.00003465463,0.97525775,0.0006663255,0.00056162337,0.00008751917],"about_ca_topic_score_codex":0.009226375,"about_ca_topic_score_gemma":0.001895455,"teacher_disagreement_score":0.008098733,"about_ca_system_score_codex":0.000034212426,"about_ca_system_score_gemma":0.0002455488,"threshold_uncertainty_score":0.99737126},"labels":[],"label_agreement":null},{"id":"W4409627890","doi":"10.1158/1538-7445.am2025-4203","title":"Abstract 4203: Discovery and development of a potent and highly selective ATR inhibitor IMP9064","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Pharmacology; Medicine","score_opus":0.019592009159614683,"score_gpt":0.34768018622396435,"score_spread":0.3280881770643497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327254,0.005293484,0.00007348745,0.00017119928,0.00003800718,0.00017193536,0.000030963405,0.0000025912454,0.00094579795],"genre_scores_gemma":[0.9980238,0.0010776214,0.00012088314,0.000029966317,0.000048838367,0.0000704097,0.000016885184,0.0000068090144,0.0006047845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920493,0.00003091941,0.00013523787,0.00027302688,0.00015045848,0.00020539612],"domain_scores_gemma":[0.99961174,0.000022182048,0.000025413225,0.00012683541,0.00013226295,0.00008156741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016509744,0.00008078938,0.00010180668,0.000065623324,0.0000999674,0.000033261338,0.00007194055,0.000063267034,0.000003879253],"category_scores_gemma":[0.00005914135,0.00006856985,0.000020465937,0.00008944644,0.00017062656,0.000005250917,0.00019582483,0.00009964465,5.4765724e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042916747,0.00008575068,0.023373174,0.00034769945,0.00012513279,0.000005921192,0.00017605432,0.00001239813,0.94750845,0.00021142824,0.004093699,0.02363114],"study_design_scores_gemma":[0.0006851985,0.0000800073,0.09842792,0.00010701575,0.000007934058,0.0000010365313,0.00026160217,0.000005176482,0.8942871,0.000095342824,0.0059367605,0.00010488829],"about_ca_topic_score_codex":0.00011813434,"about_ca_topic_score_gemma":0.000099640856,"teacher_disagreement_score":0.07505474,"about_ca_system_score_codex":0.000032531665,"about_ca_system_score_gemma":0.00048889965,"threshold_uncertainty_score":0.27961972},"labels":[],"label_agreement":null},{"id":"W4409627907","doi":"10.1158/1538-7445.am2025-2656","title":"Abstract 2656: Sec23b governs the migration of MDA-MB-231 breast cancer cells by regulating collagen I processing and secretion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Metropolitan University","funders":"","keywords":"Secretion; Breast cancer; Human breast; Cancer research; Cancer; Cell biology; Biology; Chemistry; Internal medicine; Endocrinology; Medicine","score_opus":0.03528175424529613,"score_gpt":0.394965507617794,"score_spread":0.35968375337249786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820306,0.005287566,0.00006427253,0.009241891,0.0000525537,0.00093654,0.00011475106,0.000020483583,0.0022513738],"genre_scores_gemma":[0.9907524,0.0020913824,0.000043128948,0.00013589689,0.00013545077,0.00018978096,0.000022038528,0.000026986296,0.0066029346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975238,0.00016606445,0.00031833575,0.00039500624,0.001142561,0.00045424054],"domain_scores_gemma":[0.9983485,0.0002543573,0.00009749649,0.00033174522,0.0008300212,0.00013792737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011790198,0.00013523162,0.00023680247,0.00014893488,0.00032119657,0.00009619709,0.0001971196,0.00012634906,0.00053654244],"category_scores_gemma":[0.00013238251,0.00009963643,0.000049872153,0.0010041035,0.0003682101,0.000103087754,0.00016314747,0.00045708008,0.0000056845256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039120248,0.000053144064,0.0070403805,0.0009836116,0.000039953444,0.000004644209,0.00046266097,0.00003043265,0.9119431,0.000019944753,0.022008609,0.05702231],"study_design_scores_gemma":[0.0015523776,0.00012132726,0.14271781,0.0019950338,0.000058083846,0.000010057136,0.0019500257,0.004877512,0.8279111,0.000100288366,0.018518258,0.00018814972],"about_ca_topic_score_codex":0.005710143,"about_ca_topic_score_gemma":0.0011045694,"teacher_disagreement_score":0.13567743,"about_ca_system_score_codex":0.0005211453,"about_ca_system_score_gemma":0.0009694243,"threshold_uncertainty_score":0.8632067},"labels":[],"label_agreement":null},{"id":"W4409627929","doi":"10.1158/1538-7445.am2025-5033","title":"Abstract 5033: Secondary findings from genome sequencing are prevalent in pediatric cancer patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Cancer; Medicine; Genome; Biology; Computational biology; Genetics; Internal medicine; Gene","score_opus":0.06126113700657649,"score_gpt":0.39880506247613356,"score_spread":0.3375439254695571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105626,0.003992985,4.8696296e-7,0.0008553589,0.00018047196,0.0011008357,0.00036261554,0.000031943946,0.002419029],"genre_scores_gemma":[0.99114436,0.0049613114,0.00001572357,0.00018878917,0.00017874944,0.00065033877,0.00006114064,0.000032433658,0.0027671382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971231,0.00011166258,0.0003180616,0.00062245794,0.0009556931,0.0008689876],"domain_scores_gemma":[0.99870855,0.00021714962,0.000047631216,0.00036385498,0.00036741488,0.0002954006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033282582,0.00018644112,0.0003306241,0.0008324136,0.00015753966,0.000057378107,0.00025753342,0.00011258458,0.0019452494],"category_scores_gemma":[0.00016457602,0.00016564384,0.00008076857,0.001096108,0.000097422846,0.00014400548,0.00021639538,0.0011399776,0.00012917486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007655715,0.00039259053,0.96994686,0.0007436867,0.00018516697,0.00056753156,0.0002637551,0.000013673572,0.019342734,0.000005243781,0.0034179434,0.004355261],"study_design_scores_gemma":[0.003373967,0.0001660707,0.9844974,0.00047423775,0.00004430466,6.0871037e-7,0.000068195775,0.000008866871,0.01041248,0.00010681174,0.0007362031,0.000110845656],"about_ca_topic_score_codex":0.0037141778,"about_ca_topic_score_gemma":0.0011326672,"teacher_disagreement_score":0.014550566,"about_ca_system_score_codex":0.0024768584,"about_ca_system_score_gemma":0.002051491,"threshold_uncertainty_score":0.9989671},"labels":[],"label_agreement":null},{"id":"W4409627961","doi":"10.1158/1538-7445.am2025-6167","title":"Abstract 6167: Defining the role of transcriptional coregulator MED15 in immune adaptation in cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Adaptation (eye); Immune system; Cancer research; Biology; Medicine; Immunology; Computational biology; Internal medicine; Neuroscience","score_opus":0.047582072625616124,"score_gpt":0.36706505585648536,"score_spread":0.3194829832308692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96533483,0.031170094,0.000013905599,0.00035521324,0.00006241087,0.00024674743,0.00004235603,0.000002041071,0.0027723773],"genre_scores_gemma":[0.9983051,0.0009617139,0.000025759527,0.000038611957,0.000042451044,0.00034871328,0.000025608428,0.0000074337045,0.00024461249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991114,0.00009926778,0.00019325808,0.00018096446,0.00019324124,0.00022184275],"domain_scores_gemma":[0.99963975,0.000039546685,0.000029375204,0.00015855163,0.000111473375,0.000021300999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071217737,0.0000626973,0.00009444144,0.00011133607,0.00004886855,0.000010565111,0.00019696767,0.000087212495,0.00012895791],"category_scores_gemma":[0.00006113819,0.00005207419,0.00003620474,0.00029955202,0.00011632681,0.0000038012954,0.000044255674,0.00022647253,0.0000018723374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021560604,0.00003560299,0.0057763797,0.00004345535,0.000015464273,6.790114e-7,0.00033616676,0.00071176037,0.9585791,0.003917931,0.00008702703,0.030280787],"study_design_scores_gemma":[0.00053784065,0.000037510395,0.09770503,0.00017400853,0.000002245513,2.6135422e-7,0.00064776524,0.00025212686,0.8867419,0.0014939989,0.012342353,0.00006495823],"about_ca_topic_score_codex":0.0029917823,"about_ca_topic_score_gemma":0.0045564584,"teacher_disagreement_score":0.09192865,"about_ca_system_score_codex":0.00006485849,"about_ca_system_score_gemma":0.0005562138,"threshold_uncertainty_score":0.45226997},"labels":[],"label_agreement":null},{"id":"W4409627965","doi":"10.1158/1538-7445.am2025-4523","title":"Abstract 4523: Personalized risk prediction for treatment intolerance in operable HPV-negative head and neck cancer: Beyond the eyeball test","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cancer; Head and neck cancer; Head and neck; Internal medicine; Test (biology); Oncology; Surgery; Biology","score_opus":0.07393741181617768,"score_gpt":0.4405620584470361,"score_spread":0.3666246466308584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94079715,0.039869986,0.000009216846,0.009471158,0.0002478706,0.002250031,0.00041065496,0.000026854988,0.006917099],"genre_scores_gemma":[0.9319775,0.055304743,0.0001027313,0.0004119846,0.00033137447,0.004872484,0.00001014672,0.000020857335,0.006968188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835044,0.000089031935,0.00025825694,0.00040737042,0.00032077503,0.0005741492],"domain_scores_gemma":[0.998364,0.00094141776,0.00004249568,0.0002316354,0.00030239768,0.000118084274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070825504,0.00017607101,0.00043107735,0.0001614427,0.0004859705,0.000041678722,0.00010170392,0.00008409089,0.00012625924],"category_scores_gemma":[0.00039145566,0.00011425898,0.0000674588,0.0005315821,0.00034984585,0.0001019617,0.000053888518,0.00035916312,0.000002974961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046414942,0.00081051467,0.6980743,0.0010300092,0.00065539405,0.000015026053,0.014857338,0.00010321933,0.0057078884,0.00045210266,0.036035925,0.23761682],"study_design_scores_gemma":[0.012080472,0.0013494213,0.8794219,0.0014908122,0.00010753516,0.0000022081233,0.0027838424,0.0010889273,0.0076211155,0.0005149174,0.09336146,0.00017741413],"about_ca_topic_score_codex":0.013484081,"about_ca_topic_score_gemma":0.0077954484,"teacher_disagreement_score":0.23743941,"about_ca_system_score_codex":0.0013241075,"about_ca_system_score_gemma":0.0009121524,"threshold_uncertainty_score":0.9930852},"labels":[],"label_agreement":null},{"id":"W4409627977","doi":"10.1158/1538-7445.am2025-2010","title":"Abstract 2010: A spatial profiling approach to evaluating the prognostic impact of heterogeneity in the triple-negative breast cancer immune microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Associated Medical Services; Institute of Cancer Research; University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Breast cancer; Tumor microenvironment; Immune system; Medicine; Profiling (computer programming); Spatial heterogeneity; Triple negative; Cancer; Oncology; Biology; Immunology; Internal medicine; Computer science; Ecology","score_opus":0.10893323240046233,"score_gpt":0.45839632555839627,"score_spread":0.34946309315793395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885052,0.0041756085,0.000033846267,0.0027344322,0.00012238542,0.003903364,0.00012677867,0.000007465413,0.0003909326],"genre_scores_gemma":[0.99689627,0.00050292746,0.00008686089,0.00016853603,0.00012007233,0.0020016083,0.000010573313,0.000018190156,0.00019496182],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99737436,0.0004549207,0.00044636228,0.00038060173,0.0008028778,0.000540892],"domain_scores_gemma":[0.99868286,0.00042255037,0.000103094586,0.0005347721,0.00019532348,0.00006139241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033614405,0.00018053332,0.0003189105,0.00021917626,0.00020829441,0.00004436611,0.00043050817,0.000075952375,0.00016858029],"category_scores_gemma":[0.00020168362,0.00009569175,0.00019900323,0.0010061095,0.00035164764,0.00004825044,0.00011989639,0.00067187793,0.0000033675506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01265826,0.0006834713,0.19770442,0.00038483724,0.00065732584,0.0000056023414,0.0030799177,0.00090915384,0.71279275,0.000009073741,0.00069755,0.07041761],"study_design_scores_gemma":[0.0021868835,0.0003923814,0.95680463,0.0005965841,0.000046948622,0.000008810524,0.00091668003,0.0005131214,0.03839727,0.000020976328,0.000025520822,0.00009021522],"about_ca_topic_score_codex":0.050264344,"about_ca_topic_score_gemma":0.0012395413,"teacher_disagreement_score":0.7591002,"about_ca_system_score_codex":0.0011173009,"about_ca_system_score_gemma":0.0012372818,"threshold_uncertainty_score":0.95606005},"labels":[],"label_agreement":null},{"id":"W4409627978","doi":"10.1158/1538-7445.am2025-6157","title":"Abstract 6157: PAR2 inhibitors reduce resistance to immunotherapy against cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Cancer; Immunotherapy; Cancer immunotherapy; Resistance (ecology); Internal medicine; Pharmacology; Cancer research; Oncology; Biology","score_opus":0.08492788500421826,"score_gpt":0.4722232129293173,"score_spread":0.387295327925099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8660947,0.028650427,0.00006270149,0.0476623,0.0015385287,0.0019756225,0.00012645878,0.0001997551,0.053689472],"genre_scores_gemma":[0.9310193,0.011788512,0.0002770438,0.0068131383,0.0012857185,0.0030883155,0.00001809777,0.000093603405,0.04561629],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962316,0.00015566946,0.0005665099,0.0008362741,0.0011832984,0.0010266096],"domain_scores_gemma":[0.9973484,0.00024061766,0.00008589299,0.0009969932,0.00095955224,0.0003685194],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012085435,0.00029288023,0.0004917055,0.0007398729,0.0004045349,0.00010239223,0.0004477479,0.00020685414,0.0019337737],"category_scores_gemma":[0.0001666375,0.00027988254,0.00016175458,0.0023264368,0.00036527278,0.00014360539,0.00010160842,0.0010737285,0.00018032026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024932264,0.00013362747,0.0019519168,0.0002824563,0.00018738235,0.000041143492,0.00055056915,0.00007445838,0.5329389,0.0004249791,0.4083824,0.05253897],"study_design_scores_gemma":[0.00223796,0.00007025838,0.014455568,0.0024023796,0.000010534693,9.796221e-7,0.00021039874,0.0000029767734,0.37822464,0.00043518085,0.6017176,0.00023151524],"about_ca_topic_score_codex":0.000860141,"about_ca_topic_score_gemma":0.00068958063,"teacher_disagreement_score":0.19333522,"about_ca_system_score_codex":0.0024356814,"about_ca_system_score_gemma":0.0024826515,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W4409628019","doi":"10.1158/1538-7445.am2025-2780","title":"Abstract 2780: Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research","funders":"","keywords":"Topoisomerase; Biology; Cancer; Genome; Genetics; Computational biology; DNA; Gene","score_opus":0.0759939413117744,"score_gpt":0.43364538955532966,"score_spread":0.35765144824355527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373884,0.01305485,0.000055718978,0.0008974023,0.00037649242,0.00041112374,0.000092635004,0.000011469877,0.0013614633],"genre_scores_gemma":[0.98163146,0.014669859,0.000035738285,0.00038930558,0.0001473898,0.00043493055,0.000067910754,0.000026669155,0.0025967527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983289,0.00006878308,0.00026242185,0.00046233504,0.00027513067,0.00060241006],"domain_scores_gemma":[0.99936664,0.00002215406,0.000046358764,0.00031115435,0.00016661736,0.00008704576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000494226,0.00015616264,0.00016677755,0.00028799384,0.00015798773,0.00006897611,0.00031147077,0.0001358347,0.00024869145],"category_scores_gemma":[0.000021334516,0.00015660517,0.000060674243,0.00048411018,0.00010390343,0.000006882034,0.00016583163,0.00028976402,0.000011329451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013940976,0.00006160173,0.00329943,0.00006777321,0.000112597496,0.0000095987625,0.000080983475,0.00008840914,0.9545548,0.00037137567,0.0010932743,0.040120736],"study_design_scores_gemma":[0.0011316276,0.00008110975,0.002115831,0.00013101233,0.000009994021,5.370364e-7,0.00034440626,0.000026703776,0.9352597,0.0008605006,0.059844397,0.00019418237],"about_ca_topic_score_codex":0.0015954705,"about_ca_topic_score_gemma":0.004486601,"teacher_disagreement_score":0.05875112,"about_ca_system_score_codex":0.00035587003,"about_ca_system_score_gemma":0.0007008419,"threshold_uncertainty_score":0.63861734},"labels":[],"label_agreement":null},{"id":"W4409628020","doi":"10.1158/1538-7445.am2025-1503","title":"Abstract 1503: Elucidating the role of transcription coregulator MED15 in cancer cell oxidative stress response and proliferation","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Oxidative stress; Transcription (linguistics); Transcription factor; Cancer research; Cancer; Cell growth; Biology; Medicine; Internal medicine; Genetics; Gene","score_opus":0.01714087083378016,"score_gpt":0.34966404296067005,"score_spread":0.33252317212688987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97973627,0.01899477,0.000010230069,0.00031792463,0.000040328523,0.0004176325,0.000027933369,0.0000029548066,0.00045195536],"genre_scores_gemma":[0.99701345,0.0024155874,0.00001180273,0.00001965901,0.000043534714,0.00018543794,0.000016574397,0.000008701236,0.00028524167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989971,0.0002735467,0.00015119526,0.0002203301,0.00016189653,0.00019592344],"domain_scores_gemma":[0.99955755,0.00006917189,0.00003975831,0.00016302567,0.00013649762,0.000033963333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729236,0.00007754787,0.00009181083,0.00006270448,0.0000979403,0.000020240068,0.00011912299,0.00012865863,0.000016197895],"category_scores_gemma":[0.00006713079,0.000057388916,0.00002536572,0.0001863459,0.00014465296,0.000007816742,0.000046489553,0.00022525567,4.4143505e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011206912,0.000043892313,0.004328097,0.00006296382,0.00002756826,7.456198e-7,0.00040632495,0.00015434586,0.9863984,0.0000657016,0.00012596269,0.0072653187],"study_design_scores_gemma":[0.0004454847,0.00010880508,0.020126875,0.00011997071,0.0000070594797,2.7828168e-7,0.0006878235,0.0001622941,0.97738725,0.00007209219,0.0008280972,0.000053971078],"about_ca_topic_score_codex":0.00075916265,"about_ca_topic_score_gemma":0.00058669253,"teacher_disagreement_score":0.017277189,"about_ca_system_score_codex":0.000061111285,"about_ca_system_score_gemma":0.00030190323,"threshold_uncertainty_score":0.23402521},"labels":[],"label_agreement":null},{"id":"W4409628026","doi":"10.1158/1538-7445.am2025-1605","title":"Abstract 1605: Pretreatment of bone anabolic agent delays or prevents multiple myeloma progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coquitlam College","funders":"","keywords":"Anabolism; Multiple myeloma; Medicine; Cancer research; Internal medicine","score_opus":0.11802903711022525,"score_gpt":0.5170269246188987,"score_spread":0.3989978875086734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832571,0.009184891,0.000005962631,0.0012005068,0.00025422435,0.0018433108,0.000054786506,0.00003417479,0.0041650375],"genre_scores_gemma":[0.978519,0.0030012757,0.00015440304,0.00008552569,0.0001404004,0.0010498872,0.000039794202,0.00002015548,0.016989559],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824315,0.00009747138,0.00031964504,0.00036001683,0.00050502404,0.00047466706],"domain_scores_gemma":[0.99898887,0.00018151225,0.00007341343,0.0003303602,0.0002499069,0.00017593714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003530419,0.00015482273,0.00037058146,0.00033417728,0.00012342393,0.0000118322705,0.000117386546,0.00010669493,0.0022633346],"category_scores_gemma":[0.0000622478,0.00010759965,0.00010326406,0.0006472411,0.00016869878,0.000049308932,0.000117402175,0.0002896564,0.00003227963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014148909,0.004054271,0.1604937,0.0019625593,0.0011994822,0.0005603708,0.0010400901,0.000026336613,0.26981193,0.000074957476,0.06583435,0.48079306],"study_design_scores_gemma":[0.012659435,0.0021894074,0.4022061,0.0018818432,0.0002943799,0.0000147322235,0.00021290942,0.000116881696,0.49592572,0.00009399875,0.08421324,0.00019136381],"about_ca_topic_score_codex":0.00078966125,"about_ca_topic_score_gemma":0.00035267536,"teacher_disagreement_score":0.48060167,"about_ca_system_score_codex":0.000703572,"about_ca_system_score_gemma":0.0010097449,"threshold_uncertainty_score":0.9986487},"labels":[],"label_agreement":null},{"id":"W4409628166","doi":"10.1158/1538-7445.am2025-4056","title":"Abstract 4056: Determining the role of ZNF687, an uncharacterized zinc finger transcription factor, in lung adenocarcinoma (LUAD)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Zinc finger; Transcription factor; Zinc finger transcription factor; Adenocarcinoma; Cancer research; Lung cancer; Biology; Medicine; Oncology; Cancer; Genetics; Gene","score_opus":0.035040562992389265,"score_gpt":0.36862172441374136,"score_spread":0.3335811614213521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310213,0.0046952455,0.00028378336,0.00024319175,0.00013909933,0.0006615985,0.00005272884,0.0000097144675,0.00081249763],"genre_scores_gemma":[0.99833333,0.0006965464,0.0000318273,0.00007323597,0.00011896485,0.00026851232,0.00007034751,0.000035426627,0.00037178403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762845,0.0003389528,0.000341316,0.0005394745,0.00053827337,0.0006135612],"domain_scores_gemma":[0.9987618,0.000052117954,0.00006170121,0.0006422623,0.0003820126,0.00010012982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090929074,0.0001744228,0.00021547404,0.0003100452,0.00015479443,0.00006813801,0.0006404909,0.00026852507,0.00017137382],"category_scores_gemma":[0.00015798776,0.00015198624,0.00010687208,0.00053631177,0.00019536706,0.000017852019,0.00018134214,0.0006590839,0.000004039531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004089413,0.00008102311,0.0045002564,0.00007916408,0.000051696472,0.0000041954754,0.0002594349,0.000050373314,0.97341937,0.00008906029,0.0000947153,0.020961756],"study_design_scores_gemma":[0.0010866817,0.00018432317,0.099537045,0.00012402279,0.000010187465,9.794763e-7,0.00025259596,0.00036329526,0.89286774,0.00015885563,0.0052622478,0.00015204586],"about_ca_topic_score_codex":0.0006412689,"about_ca_topic_score_gemma":0.00061210885,"teacher_disagreement_score":0.09503679,"about_ca_system_score_codex":0.00019448779,"about_ca_system_score_gemma":0.0006909112,"threshold_uncertainty_score":0.6197819},"labels":[],"label_agreement":null},{"id":"W4409628260","doi":"10.1158/1538-7445.am2025-4687","title":"Abstract 4687: Clonal hematopoiesis of indeterminate potential may protect against radiation-induced toxicities in breast cancer patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cancer; Breast cancer; Haematopoiesis; Cancer research; Oncology; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.03677074452498697,"score_gpt":0.3918577757729494,"score_spread":0.3550870312479624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943121,0.0006689132,0.0000021020649,0.002800972,0.00015972415,0.0011033058,0.00029824773,0.000012731138,0.0006418927],"genre_scores_gemma":[0.99824584,0.00040771096,0.000026496255,0.00013776921,0.00008706438,0.0006983126,0.000036486577,0.000018233997,0.00034207202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981264,0.00012115511,0.00035849868,0.000311739,0.00065887126,0.00042337316],"domain_scores_gemma":[0.99911445,0.00009427993,0.00007907466,0.00024847253,0.0003629711,0.000100741214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004833397,0.00014681036,0.0003439712,0.0004963174,0.00009640976,0.000024423485,0.00013231552,0.0001028014,0.00042507602],"category_scores_gemma":[0.000064712556,0.0001221157,0.00009712292,0.0005926256,0.00013048605,0.000081936174,0.00007994851,0.00039089654,0.000006236883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003667487,0.0025467067,0.45249596,0.0034067812,0.0009193475,0.00031764954,0.0011422891,0.00022790938,0.08208361,0.0004978985,0.0037953048,0.44889906],"study_design_scores_gemma":[0.0040261,0.00016046721,0.9090943,0.0011138291,0.000039146078,0.0000027515518,0.00025005193,0.000063273634,0.08460339,0.00012100384,0.00040098262,0.00012471958],"about_ca_topic_score_codex":0.0041022436,"about_ca_topic_score_gemma":0.00024081381,"teacher_disagreement_score":0.45659834,"about_ca_system_score_codex":0.00080913346,"about_ca_system_score_gemma":0.0009138838,"threshold_uncertainty_score":0.62013924},"labels":[],"label_agreement":null},{"id":"W4409628314","doi":"10.1158/1538-7445.am2025-3243","title":"Abstract 3243: Fragmentomic features of plasma cell-free DNA in patients with osteosarcoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Osteosarcoma; Medicine; Cancer research; DNA; Internal medicine; Oncology; Biology; Genetics","score_opus":0.011168090093849593,"score_gpt":0.30372991794548315,"score_spread":0.29256182785163354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252534,0.0013789055,0.000004254865,0.00020870156,0.00009942251,0.00033698507,0.00013049525,0.0000026302614,0.005313265],"genre_scores_gemma":[0.9985329,0.00049396016,0.00006754813,0.00006954287,0.000056284258,0.00007484685,0.000059272672,0.000016009382,0.0006296527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989218,0.000033340417,0.00016751183,0.00029946514,0.0002553522,0.00032253575],"domain_scores_gemma":[0.9991435,0.000054870605,0.000043423344,0.00048569406,0.00021494366,0.00005761116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019946844,0.000105915526,0.00013873872,0.0001625239,0.000047557387,0.000024316043,0.00040434676,0.00010899587,0.00003226178],"category_scores_gemma":[0.00009501542,0.00009541849,0.00003551369,0.0002521484,0.00013191545,0.0000029653274,0.0002735959,0.00020432711,0.000002157128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031705736,0.00067974767,0.26444393,0.00042009924,0.00012645789,0.000010043456,0.00017297358,0.00046418398,0.6500047,0.0003965448,0.06322135,0.016889378],"study_design_scores_gemma":[0.0031658346,0.000307127,0.32286918,0.00010330269,0.0000066238636,1.2692335e-7,0.00007234527,0.0000024166263,0.6612032,0.00014091852,0.012003595,0.00012531366],"about_ca_topic_score_codex":0.00057766435,"about_ca_topic_score_gemma":0.0013565574,"teacher_disagreement_score":0.058425244,"about_ca_system_score_codex":0.00011066488,"about_ca_system_score_gemma":0.00049910933,"threshold_uncertainty_score":0.3891053},"labels":[],"label_agreement":null},{"id":"W4409628316","doi":"10.1158/1538-7445.am2025-2020","title":"Abstract 2020: Fibroblast derived type III collagen pro-peptides (PRO-C3) in plasma is associated with outcome for patients with NSCLC treated with anti-PD1 plus chemotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Chemotherapy; Fibroblast; Internal medicine; Cancer research; Oncology; Chemistry; Biochemistry; In vitro","score_opus":0.05849214266834416,"score_gpt":0.38760542592312536,"score_spread":0.3291132832547812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922955,0.00024971756,0.000005647451,0.0018132948,0.00003325326,0.0033984892,0.00010141917,0.000061810555,0.0020408614],"genre_scores_gemma":[0.99295986,0.00021388047,0.00013478813,0.00030713432,0.00005007799,0.0008546188,0.00006916492,0.0000689531,0.005341541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974624,0.00005604175,0.00034697636,0.00060718384,0.00070697657,0.0008204073],"domain_scores_gemma":[0.99793565,0.00026152664,0.000103612016,0.0003267376,0.0012143796,0.00015806174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034497285,0.00030733505,0.0008091535,0.00027221316,0.00025906914,0.00005200168,0.00017491927,0.00014369411,0.00013588696],"category_scores_gemma":[0.00014306136,0.00019673935,0.00004708683,0.0016801356,0.0002954971,0.00010063893,0.000046384943,0.0003465883,0.000006856388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029976774,0.0006039921,0.9453238,0.0007060301,0.0011724096,0.000078498735,0.0018492503,0.00005169087,0.00478676,0.0000057326197,0.011705985,0.0037390285],"study_design_scores_gemma":[0.035692602,0.0046136393,0.933738,0.0045391577,0.00008641834,0.0000016361219,0.00064769975,0.00013390553,0.018098198,0.00000613919,0.0020706134,0.00037200094],"about_ca_topic_score_codex":0.0011392492,"about_ca_topic_score_gemma":0.0040599937,"teacher_disagreement_score":0.013311437,"about_ca_system_score_codex":0.0010806253,"about_ca_system_score_gemma":0.0015559521,"threshold_uncertainty_score":0.8022798},"labels":[],"label_agreement":null},{"id":"W4409628358","doi":"10.1158/1538-7445.am2025-3913","title":"Abstract 3913: New insights from transgenic mouse models of PyMT-induced breast cancer: identifying novel long non-coding RNA biomarkers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"","keywords":"Breast cancer; Genetically modified mouse; Computational biology; Cancer; Transgene; Biology; RNA; Cancer research; Genetics; Gene","score_opus":0.06742473756808541,"score_gpt":0.3777631622211927,"score_spread":0.3103384246531073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099586,0.006702601,0.07937663,0.0005472055,0.00046972625,0.0009991605,0.00032432293,0.000029789328,0.001591939],"genre_scores_gemma":[0.9932358,0.0046558105,0.00022972726,0.000071560506,0.0002995363,0.00021754205,0.00009845365,0.00008719543,0.0011043738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99640965,0.00012222573,0.0005374805,0.0010371624,0.0009870469,0.00090642954],"domain_scores_gemma":[0.9979089,0.00006487367,0.00012256096,0.0009154084,0.0006418181,0.0003464443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050343183,0.00033030647,0.000409164,0.00058384496,0.00026661754,0.00012411205,0.0010027792,0.0004733346,0.00019579582],"category_scores_gemma":[0.000060373237,0.00034849305,0.00026131046,0.0010860414,0.00020079497,0.000036576796,0.00042132346,0.00078307674,0.000009598992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006726958,0.00009393768,0.000022469203,0.00018488578,0.0007155739,0.0000067206056,0.00021238143,0.0014738584,0.98361063,0.00013297924,0.0015637022,0.0113101825],"study_design_scores_gemma":[0.0020695704,0.000064981126,0.0009843622,0.0005446559,0.000046371417,0.000001622677,0.00017775699,0.0011030257,0.9939639,0.00031711604,0.00041510703,0.00031155965],"about_ca_topic_score_codex":0.018638348,"about_ca_topic_score_gemma":0.004027696,"teacher_disagreement_score":0.08327717,"about_ca_system_score_codex":0.00045005936,"about_ca_system_score_gemma":0.0028222075,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W4409628417","doi":"10.1158/1538-7445.am2025-1565","title":"Abstract 1565: Design and development of biparatopic antibody-drug conjugates against protein tyrosine kinase 7","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Conjugate; Antibody; Tyrosine kinase; Drug; Pharmacology; Tyrosine; Medicine; Biology; Immunology; Biochemistry; Signal transduction","score_opus":0.12732124567528805,"score_gpt":0.46816191315220906,"score_spread":0.340840667476921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98087674,0.010885191,0.00035765255,0.002502148,0.00008543924,0.0024421008,0.000014753641,0.000042717547,0.0027932485],"genre_scores_gemma":[0.98975843,0.0015386534,0.0035204063,0.00012249495,0.0000912222,0.00069649896,0.00001840734,0.000035638248,0.0042182207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702555,0.00021344541,0.00048740994,0.0005275648,0.0010057242,0.00074033503],"domain_scores_gemma":[0.9980905,0.00028653574,0.00005911092,0.00048638997,0.0007978118,0.00027963912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002437144,0.00019338254,0.00043661168,0.0005936425,0.00024136368,0.00006237575,0.0002871779,0.000119712684,0.00035419982],"category_scores_gemma":[0.0003753894,0.00016689383,0.000040562158,0.0009342179,0.00058564,0.000080274884,0.0002477606,0.0007624408,0.00004403058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069627224,0.00021085195,0.0087798815,0.002922573,0.00013232016,0.00009356196,0.00065608474,0.000018541463,0.90910715,0.0002925922,0.0067958524,0.07029433],"study_design_scores_gemma":[0.0017648758,0.00013280979,0.022390803,0.0028600835,0.000009693944,0.0000018349015,0.00028302328,0.00009705422,0.9302322,0.00013561772,0.041932248,0.00015975375],"about_ca_topic_score_codex":0.00040970443,"about_ca_topic_score_gemma":0.00007234583,"teacher_disagreement_score":0.07013457,"about_ca_system_score_codex":0.00047910574,"about_ca_system_score_gemma":0.004455418,"threshold_uncertainty_score":0.790372},"labels":[],"label_agreement":null},{"id":"W4409628583","doi":"10.1158/1538-7445.am2025-5043","title":"Abstract 5043: reVUE: repository for variants with unexpected effects","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Medicine; Computational biology; Genetics","score_opus":0.026517021448140166,"score_gpt":0.41739399071652933,"score_spread":0.39087696926838916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94531536,0.0026004845,0.0030719019,0.013550922,0.00069819466,0.0016661762,0.0000042247143,0.00012351657,0.032969244],"genre_scores_gemma":[0.9809986,0.000107328495,0.0013396661,0.00043083733,0.0004977094,0.00043817572,0.000010428619,0.000030017849,0.016147258],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99871236,0.00006283072,0.00015834153,0.0003353894,0.00032315537,0.00040792677],"domain_scores_gemma":[0.99859965,0.0005609392,0.000032208576,0.00032476007,0.00032341864,0.0001590472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066495803,0.000095302305,0.00023403039,0.00021921303,0.00022700886,0.000048470192,0.00014421955,0.00007395919,0.000036479247],"category_scores_gemma":[0.0008415199,0.00007265903,0.00004877061,0.00046430877,0.0001706633,0.000039438048,0.000039886363,0.0007207823,0.000005095837],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003193977,0.00039541718,0.031610735,0.0071266186,0.00070457073,0.0009832163,0.00064324215,0.0001293297,0.7178717,0.0036617455,0.12930769,0.10437175],"study_design_scores_gemma":[0.01918825,0.0018741866,0.60846555,0.015531887,0.00040462386,0.00019130007,0.0004126981,0.0099391425,0.13957478,0.0019353098,0.20179638,0.0006858923],"about_ca_topic_score_codex":0.0003202942,"about_ca_topic_score_gemma":0.0000087015105,"teacher_disagreement_score":0.57829696,"about_ca_system_score_codex":0.0002202717,"about_ca_system_score_gemma":0.0005975759,"threshold_uncertainty_score":0.31314808},"labels":[],"label_agreement":null},{"id":"W4409628689","doi":"10.1158/1538-7445.am2025-3817","title":"Abstract 3817: Using gene-environment interactions to explore pathways for colorectal cancer risk","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Gene; Cancer research; Internal medicine; Genetics; Oncology; Biology","score_opus":0.11322401569193163,"score_gpt":0.4223922668131393,"score_spread":0.30916825112120766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229205,0.0034630087,0.0019842726,0.00035574118,0.00035680254,0.0007067333,0.00061266124,0.0000087132685,0.00022003947],"genre_scores_gemma":[0.99280375,0.0035460775,0.0007550662,0.0001721753,0.00063162536,0.0014678212,0.00009560305,0.000026000087,0.0005018918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987429,0.00005873543,0.00017016577,0.00044732078,0.00018403349,0.0003968902],"domain_scores_gemma":[0.99926805,0.00003396241,0.000034992732,0.00027196822,0.00020462924,0.00018639785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002207097,0.00012184374,0.00011101327,0.00012229367,0.00032481732,0.000045328616,0.00019902602,0.00008214217,0.00014131832],"category_scores_gemma":[0.0000949283,0.00012774106,0.00009747793,0.00013165685,0.00009882248,0.000004760258,0.00014942548,0.00014097987,0.000009018492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005564674,0.00012503662,0.0043189647,0.0000627528,0.00007940463,0.0000014827691,0.00013099852,0.0018955019,0.9730292,0.0000134124575,0.012938587,0.0068481807],"study_design_scores_gemma":[0.0007851086,0.00014397303,0.0121307,0.00006865339,0.000033390497,6.044283e-7,0.00040362755,0.00013125305,0.90694404,0.00045971482,0.07871313,0.00018582649],"about_ca_topic_score_codex":0.00045257894,"about_ca_topic_score_gemma":0.00032044016,"teacher_disagreement_score":0.06608519,"about_ca_system_score_codex":0.0002253673,"about_ca_system_score_gemma":0.0004584866,"threshold_uncertainty_score":0.52091295},"labels":[],"label_agreement":null},{"id":"W4409628692","doi":"10.1158/1538-7445.am2025-2856","title":"Abstract 2856: Pks+ E. coli trigger intestinal stem cell plasticity and early onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Stem cell; Biology; Internal medicine; Cancer research; Oncology; Genetics","score_opus":0.03701105287211671,"score_gpt":0.37796671951859573,"score_spread":0.340955666646479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008423,0.0062886006,0.000019165223,0.0003158568,0.00012544545,0.0005485062,0.00022939077,0.000014199822,0.0023746074],"genre_scores_gemma":[0.9913065,0.0022066052,0.000016390735,0.000053326636,0.00016083926,0.0006744577,0.000020498788,0.000023411723,0.0055379844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979897,0.00011964353,0.00019752601,0.0005826581,0.00040690505,0.00070353603],"domain_scores_gemma":[0.9990292,0.00012313145,0.000041073192,0.00021374828,0.00033837007,0.00025447828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032388608,0.00018754172,0.00020632602,0.00017305999,0.00027924197,0.00011881501,0.00028325967,0.0001454709,0.00019170782],"category_scores_gemma":[0.000070328475,0.00017010026,0.00006595127,0.00035305668,0.00040250912,0.000009348913,0.0003218818,0.00043377874,0.000018945486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035752428,0.00031878604,0.14764771,0.00033660425,0.0003034699,0.000079364356,0.00013403229,0.000029066634,0.77283263,0.000042969874,0.053902518,0.02079759],"study_design_scores_gemma":[0.002183384,0.0006195176,0.20277286,0.00017382308,0.000023609009,0.0000049673786,0.00009734753,0.000018293444,0.76867443,0.000081602615,0.02511975,0.00023038822],"about_ca_topic_score_codex":0.006690886,"about_ca_topic_score_gemma":0.0035809006,"teacher_disagreement_score":0.05512515,"about_ca_system_score_codex":0.0002468171,"about_ca_system_score_gemma":0.0012707856,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W4409628814","doi":"10.1158/1538-7445.am2025-4663","title":"Abstract 4663: Human papillomavirus circulating tumor DNA for risk stratification in cervical cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cervical cancer; Human papillomavirus; Risk stratification; Medicine; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.13198263633906315,"score_gpt":0.48915474124621716,"score_spread":0.357172104907154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848975,0.004125327,0.000013061174,0.00264611,0.00014486279,0.0016286131,0.00011285615,0.000031468186,0.0028079702],"genre_scores_gemma":[0.993514,0.0007814797,0.000054299162,0.00016694433,0.0002716552,0.0046055405,0.000040384624,0.00002524096,0.0005404703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981698,0.000065065295,0.00036601888,0.0004936363,0.00041022498,0.0004952624],"domain_scores_gemma":[0.99885935,0.000285334,0.000072799674,0.00036142088,0.00029736952,0.00012373064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066833623,0.00014028203,0.0003038276,0.00028554504,0.0002665325,0.000059608996,0.0001239333,0.00008230709,0.0006651529],"category_scores_gemma":[0.00012673186,0.00012514528,0.00010310959,0.00056801405,0.000102307094,0.00006402756,0.000040430365,0.00043370473,0.00001074814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006679186,0.0010241645,0.71099496,0.0014640418,0.00032953886,0.000080722086,0.0006597675,0.00022458506,0.11720235,0.0047534695,0.010099879,0.1524986],"study_design_scores_gemma":[0.0030485145,0.00014395543,0.9508441,0.00097540976,0.0000709496,9.829354e-7,0.00025030313,0.00017251093,0.03725304,0.0018061305,0.0053024082,0.00013166822],"about_ca_topic_score_codex":0.020051314,"about_ca_topic_score_gemma":0.01691345,"teacher_disagreement_score":0.23984917,"about_ca_system_score_codex":0.0014757059,"about_ca_system_score_gemma":0.0008299747,"threshold_uncertainty_score":0.9864743},"labels":[],"label_agreement":null},{"id":"W4409628836","doi":"10.1158/1538-7445.am2025-5412","title":"Abstract 5412: Developing combination therapies for telomerase-overexpressing cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Telomerase; Medicine; Cancer research; Cancer; Oncology; Internal medicine; Biology; Genetics","score_opus":0.12040481706332867,"score_gpt":0.456984695812989,"score_spread":0.33657987874966033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97512156,0.007916408,0.0010624108,0.009299559,0.00060714834,0.001404559,0.000038949245,0.000120943805,0.0044284905],"genre_scores_gemma":[0.9918533,0.0016931383,0.0011059759,0.00083456794,0.00024239947,0.00053949904,0.000033148433,0.000034497243,0.003663492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979303,0.000064786684,0.00031061738,0.00045621494,0.0005757413,0.0006623465],"domain_scores_gemma":[0.9982125,0.0004908046,0.00006105533,0.0003426595,0.00076800754,0.00012496373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007961378,0.00017574614,0.00032092858,0.00049887254,0.0005096533,0.00010648355,0.00022844766,0.00012869615,0.00019249861],"category_scores_gemma":[0.00035790016,0.00015879753,0.000088648936,0.0008386034,0.00025488107,0.00017262895,0.00006314641,0.00043713345,0.000012775456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016682337,0.00019475743,0.01994651,0.0028232622,0.00043372993,0.00003480925,0.0026257536,0.000041067357,0.47716948,0.011440044,0.051557194,0.43206516],"study_design_scores_gemma":[0.007226905,0.00029354842,0.21937074,0.005280853,0.00007916668,0.000007872053,0.0034542836,0.00043253895,0.49098498,0.0066797957,0.2655083,0.000681012],"about_ca_topic_score_codex":0.0011586382,"about_ca_topic_score_gemma":0.0002140803,"teacher_disagreement_score":0.43138415,"about_ca_system_score_codex":0.0012622974,"about_ca_system_score_gemma":0.0023011707,"threshold_uncertainty_score":0.6475575},"labels":[],"label_agreement":null},{"id":"W4409628844","doi":"10.1158/1538-7445.am2025-1625","title":"Abstract 1625: Redox homeostasis is a therapeutic vulnerability in lethal neuroendocrine prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Vulnerability (computing); Cancer; Homeostasis; Oncology; Cancer research; Internal medicine; Computer science","score_opus":0.04440643303984523,"score_gpt":0.4036885516768503,"score_spread":0.3592821186370051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93160003,0.061175942,0.000009746064,0.0039642453,0.00094191125,0.00068839686,0.00018361285,0.000015735664,0.0014203505],"genre_scores_gemma":[0.9595356,0.033109866,0.000015304633,0.00086244516,0.000718358,0.00087784015,0.000025151876,0.000033171887,0.0048222765],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974693,0.00022137367,0.00031897068,0.0007881306,0.00038870986,0.0008134878],"domain_scores_gemma":[0.9987985,0.00004823627,0.000050377843,0.00067035377,0.00030336066,0.00012920899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006376161,0.00021460452,0.00028210596,0.00022986194,0.00015874166,0.00006563273,0.00040909427,0.000099302226,0.00042374225],"category_scores_gemma":[0.00012474188,0.00020263145,0.00011487916,0.0007102645,0.0002950312,0.000010676436,0.00023997441,0.00062552496,0.000009396239],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009893747,0.00018094345,0.010816271,0.00026267426,0.00011531434,0.000015569423,0.000234724,0.0001061389,0.6840114,0.000088903565,0.032562144,0.27061653],"study_design_scores_gemma":[0.001481171,0.000090487054,0.0569948,0.00009203909,0.000016504504,0.000003899506,0.00012884517,0.000015472075,0.33640617,0.0005764194,0.60395205,0.00024211932],"about_ca_topic_score_codex":0.0041810367,"about_ca_topic_score_gemma":0.0031592185,"teacher_disagreement_score":0.5713899,"about_ca_system_score_codex":0.00016801589,"about_ca_system_score_gemma":0.0010895998,"threshold_uncertainty_score":0.82630706},"labels":[],"label_agreement":null},{"id":"W4409628866","doi":"10.1158/1538-7445.am2025-3337","title":"Abstract 3337: Unveiling m6A epitranscriptome-related genomic variations in bladder cancer: predictive biomarkers for disease progression and treatment outcome towards tailored therapeutics","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bladder cancer; Disease; Medicine; Cancer; Oncology; Urothelial cancer; Internal medicine","score_opus":0.07076003773436454,"score_gpt":0.4334947696684847,"score_spread":0.3627347319341202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97212887,0.02164776,0.0009208349,0.0027936783,0.00020300919,0.0015639637,0.000391931,0.000014904946,0.000335065],"genre_scores_gemma":[0.98717314,0.008839634,0.00010772068,0.000069380745,0.00007277621,0.0027027708,0.00013278621,0.00002285536,0.0008789573],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986764,0.00007557508,0.00027383977,0.00046882743,0.00014983997,0.00035547293],"domain_scores_gemma":[0.9993159,0.000033473323,0.00005019399,0.00028524062,0.00020703125,0.00010815647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003219624,0.00014994624,0.00015257405,0.00018118783,0.00021647177,0.00005234545,0.00015698605,0.00013127124,0.00003425712],"category_scores_gemma":[0.00002623365,0.00012812653,0.00007497085,0.00029189285,0.00017471267,0.0000093971985,0.00004409582,0.0001265123,8.7713516e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002346583,0.00039455006,0.08430132,0.00016904066,0.001028747,0.000003350153,0.00048041422,0.0009621829,0.7257726,0.00037188138,0.00056498894,0.18360431],"study_design_scores_gemma":[0.008107943,0.00064664177,0.8548618,0.00033671953,0.00029803632,6.7195793e-7,0.0006551951,0.0087048095,0.06544755,0.0014462371,0.058884043,0.0006103743],"about_ca_topic_score_codex":0.00047921532,"about_ca_topic_score_gemma":0.00032558333,"teacher_disagreement_score":0.77056044,"about_ca_system_score_codex":0.00036852938,"about_ca_system_score_gemma":0.000982028,"threshold_uncertainty_score":0.5224848},"labels":[],"label_agreement":null},{"id":"W4409628907","doi":"10.1158/1538-7445.am2025-5407","title":"Abstract 5407: Identifying synthetic lethality targets in DDX41-mutated MDS/AML","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Synthetic lethality; Lethality; Medicine; Cancer research; Biology; Genetics; DNA repair; Gene","score_opus":0.1045919042727418,"score_gpt":0.47149523414887945,"score_spread":0.36690332987613766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566854,0.0045984522,0.0000869163,0.010435656,0.0002789454,0.0013711703,0.000028138706,0.000101914615,0.026413398],"genre_scores_gemma":[0.98792565,0.001185816,0.00011579184,0.00029259053,0.0001659548,0.0004448063,0.000027755212,0.00004817056,0.009793493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955186,0.00040739306,0.0005275294,0.0007954014,0.0013803444,0.0013707008],"domain_scores_gemma":[0.9973865,0.0006997648,0.000048065293,0.00086658105,0.0006785192,0.00032053737],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040555843,0.00022243847,0.00050090236,0.0012875543,0.00023922224,0.00011313564,0.0005623036,0.0002546595,0.0017952353],"category_scores_gemma":[0.0017326322,0.00020502278,0.00011861995,0.002446104,0.0005029844,0.0001709594,0.0004321723,0.002525131,0.0004108954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002802075,0.00079371996,0.059031248,0.004389771,0.00046848424,0.0033543769,0.0018498608,0.0001261045,0.77067584,0.0016317609,0.082853064,0.07202371],"study_design_scores_gemma":[0.00826043,0.00023177579,0.50662464,0.004397023,0.00006793326,0.000050350765,0.0020735683,0.0011702223,0.42086154,0.0045388686,0.051066823,0.0006567926],"about_ca_topic_score_codex":0.0076355995,"about_ca_topic_score_gemma":0.0007685761,"teacher_disagreement_score":0.44759342,"about_ca_system_score_codex":0.00326898,"about_ca_system_score_gemma":0.0029670103,"threshold_uncertainty_score":0.99977607},"labels":[],"label_agreement":null},{"id":"W4409628918","doi":"10.1158/1538-7445.am2025-3339","title":"Abstract 3339: Evaluation of GATA6 and KRT17 immunostaining for subtype classification in pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Immunostaining; GATA6; Medicine; Adenocarcinoma; Pathology; Pancreatic cancer; Cancer research; Immunohistochemistry; Internal medicine; Biology; Cancer; Gene expression; Gene; Genetics","score_opus":0.24105788979563958,"score_gpt":0.5200340938992501,"score_spread":0.27897620410361057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289895,0.008829144,0.000035394623,0.0017113937,0.000050330207,0.0017626268,0.000012524473,0.000007946548,0.004691686],"genre_scores_gemma":[0.9970644,0.0010635277,0.0001980158,0.000023369677,0.000060348488,0.0008729079,0.000033634693,0.000011686583,0.00067208335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981057,0.00023257422,0.00034254836,0.00030010278,0.0006485163,0.00037053475],"domain_scores_gemma":[0.9975949,0.0008723639,0.000060903778,0.00029227923,0.0011056704,0.000073907286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051144985,0.0000859241,0.00035645766,0.00052732264,0.000108101165,0.000016260852,0.00010912576,0.00012497041,0.0001653227],"category_scores_gemma":[0.0020643007,0.000077072684,0.000035200574,0.0005555111,0.00031622814,0.00007064205,0.000055979395,0.00035358986,0.000004052525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001272742,0.0001195541,0.9165955,0.0007496966,0.00011476819,0.0000055147502,0.00062146573,0.0000038191106,0.06476673,0.0015790521,0.00059024664,0.013580921],"study_design_scores_gemma":[0.0031278334,0.000238267,0.98501015,0.0005215496,0.00013081756,0.000003666112,0.0016873582,0.0050666714,0.0022867399,0.0017332,0.00013922127,0.000054519387],"about_ca_topic_score_codex":0.0008996575,"about_ca_topic_score_gemma":0.0001520946,"teacher_disagreement_score":0.068414666,"about_ca_system_score_codex":0.00056006113,"about_ca_system_score_gemma":0.002426923,"threshold_uncertainty_score":0.4305257},"labels":[],"label_agreement":null},{"id":"W4409628978","doi":"10.1158/1538-7445.am2025-6262","title":"Abstract 6262: Changes in the spatial architecture of the tumor microenvironment associated with treatment resistance in muscle invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Tumor microenvironment; Cancer; Medicine; Pathology; Cancer research; Internal medicine; Oncology","score_opus":0.0389716449890969,"score_gpt":0.34232908957000874,"score_spread":0.30335744458091185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779445,0.004305378,9.1004244e-7,0.01289094,0.00007071877,0.0018409402,0.0001564542,0.00000659531,0.0027835998],"genre_scores_gemma":[0.9946434,0.0011775914,0.000010439223,0.0006496567,0.00007252457,0.0015870339,0.000009320472,0.000020644946,0.0018294215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980557,0.0002594514,0.00021724965,0.00036673868,0.00062572013,0.00047514366],"domain_scores_gemma":[0.99902517,0.00029781114,0.00007752707,0.00047048886,0.0000798564,0.000049154958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035921758,0.0001888533,0.00031919839,0.00019194328,0.00011257795,0.000017672493,0.0002769702,0.00006823523,0.00028326552],"category_scores_gemma":[0.0000779553,0.000095599215,0.00006372677,0.0007973973,0.0003335795,0.000022232867,0.000059072252,0.00048214293,0.000001804356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070706643,0.0042786193,0.7713204,0.00095160917,0.0015820144,0.0006490922,0.02841207,0.00062792574,0.12426123,0.0001228648,0.0063714786,0.054352008],"study_design_scores_gemma":[0.0038999028,0.00030485075,0.9368464,0.0016076564,0.00007354979,0.0000010313763,0.00074900914,0.0000016173502,0.051999733,0.00014259276,0.0042835544,0.00009010103],"about_ca_topic_score_codex":0.017879693,"about_ca_topic_score_gemma":0.4638772,"teacher_disagreement_score":0.4459975,"about_ca_system_score_codex":0.0015117739,"about_ca_system_score_gemma":0.0011421267,"threshold_uncertainty_score":0.98866034},"labels":[],"label_agreement":null},{"id":"W4409629079","doi":"10.1158/1538-7445.am2025-5629","title":"Abstract 5629: TEQ103, a novel therapeutic for the treatment of estrogen receptor alpha positive (ERα+) breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Cancer; Estrogen receptor alpha; Oncology; Alpha (finance); Internal medicine; Estrogen; Cancer research; Surgery","score_opus":0.03354769761284608,"score_gpt":0.39289734419657346,"score_spread":0.35934964658372737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93557465,0.058280244,0.00021130711,0.002810388,0.0003644951,0.0015249418,0.00076214055,0.000009599976,0.00046221373],"genre_scores_gemma":[0.98310614,0.012913587,0.000045751472,0.000100665384,0.00035407013,0.001200905,0.00005627204,0.0000270298,0.002195554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988742,0.000054246004,0.00016274613,0.00033062728,0.0001824943,0.00039571064],"domain_scores_gemma":[0.99908185,0.00015107122,0.000049900926,0.00033070717,0.0003197428,0.00006671391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024192756,0.00015238133,0.00016724988,0.000066263405,0.00020721184,0.000024517596,0.0002555336,0.00017132412,0.0000625885],"category_scores_gemma":[0.000015631545,0.000096590345,0.00016791443,0.0002236564,0.00023937155,0.0000033471315,0.000045690813,0.00014103296,0.0000039656375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010869427,0.00030065578,0.0008917767,0.000044956636,0.0009247673,7.4718673e-7,0.00012271073,0.000074219104,0.93719906,0.00028251004,0.0030069128,0.05606476],"study_design_scores_gemma":[0.0017623921,0.0007022347,0.0067808484,0.00009957351,0.000093653165,0.000003123007,0.0001478746,0.000060167084,0.9404811,0.0000409363,0.04969717,0.00013091597],"about_ca_topic_score_codex":0.0008637219,"about_ca_topic_score_gemma":0.000067756046,"teacher_disagreement_score":0.055933844,"about_ca_system_score_codex":0.00015601386,"about_ca_system_score_gemma":0.0005830459,"threshold_uncertainty_score":0.39388397},"labels":[],"label_agreement":null},{"id":"W4409629085","doi":"10.1158/1538-7445.am2025-6127","title":"Abstract 6127: Genomic instability regulates STING mediated anti-tumor immunity through distinctive cytosolic DNA structures","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sting; Genome instability; Immunity; DNA; Biology; Cancer research; Cell biology; DNA damage; Genetics; Immune system","score_opus":0.05216476694609487,"score_gpt":0.3804538108875052,"score_spread":0.32828904394141034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842277,0.008804628,0.00001485929,0.0004462856,0.0007148319,0.0005334707,0.00017299749,0.00010432012,0.0049808747],"genre_scores_gemma":[0.9977028,0.00033858826,0.000013167485,0.00012801687,0.000044337157,0.00010864638,0.0001016111,0.000026159529,0.0015366678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996876,0.001080798,0.00048395174,0.0005382353,0.0001116809,0.0009093397],"domain_scores_gemma":[0.99733204,0.0013524515,0.000114339324,0.00070215476,0.0004658079,0.00003319695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011467788,0.00026840856,0.00046826428,0.00026681655,0.0008996142,0.000069278336,0.0007294645,0.0002615379,0.0023192905],"category_scores_gemma":[0.0015223878,0.0002273731,0.00012315152,0.0005688277,0.0013550011,0.0001720609,0.0005488994,0.0015256332,0.0002111454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012889317,0.000102274724,0.0032655601,0.00011776529,0.00027888388,0.000007822726,0.0010093312,0.000007739414,0.9888755,0.0011278011,0.0015661727,0.002352186],"study_design_scores_gemma":[0.0008823159,0.00008904368,0.3460151,0.0001321752,0.000015146304,0.000007840679,0.0012746411,0.000002315803,0.63623637,0.0011806778,0.013984368,0.00018003445],"about_ca_topic_score_codex":0.004795847,"about_ca_topic_score_gemma":0.00032509927,"teacher_disagreement_score":0.3526392,"about_ca_system_score_codex":0.00052612653,"about_ca_system_score_gemma":0.00088240433,"threshold_uncertainty_score":0.99859273},"labels":[],"label_agreement":null},{"id":"W4409629099","doi":"10.1158/1538-7445.am2025-5542","title":"Abstract 5542: A novel approach for establishing clinically relevant models of chemoresistance","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Cancer; Computational biology; Intensive care medicine; Biology; Internal medicine","score_opus":0.20796995909738566,"score_gpt":0.4907501533846993,"score_spread":0.2827801942873136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6668608,0.02957482,0.10134426,0.018807748,0.0005314548,0.014293443,0.0017411292,0.00023814004,0.16660815],"genre_scores_gemma":[0.9796186,0.0015597967,0.01157599,0.0001297593,0.00018272644,0.0015692678,0.00006091728,0.00003456392,0.005268395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972523,0.000036039433,0.00050815585,0.00056279096,0.00091947,0.00072123343],"domain_scores_gemma":[0.9972286,0.0007387768,0.00007791118,0.0006308625,0.0010772827,0.0002465727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019276725,0.0001479047,0.0004712883,0.0003330395,0.00014925431,0.00005745986,0.0003264053,0.00012533629,0.000061398496],"category_scores_gemma":[0.0009531076,0.00012179136,0.00019504566,0.0007579934,0.00032606654,0.00014282718,0.00014203144,0.0006113871,0.0000022040897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06139314,0.010340614,0.010605824,0.02548478,0.003270117,0.00013067537,0.001862967,0.0037477133,0.45489785,0.055590775,0.15666735,0.21600817],"study_design_scores_gemma":[0.114753604,0.008525083,0.06899483,0.01804367,0.0011248301,0.000046677844,0.0062504485,0.09300239,0.4705033,0.062238153,0.15402782,0.0024891947],"about_ca_topic_score_codex":0.0011473953,"about_ca_topic_score_gemma":0.00010910177,"teacher_disagreement_score":0.31275773,"about_ca_system_score_codex":0.00064394163,"about_ca_system_score_gemma":0.0024020777,"threshold_uncertainty_score":0.49665073},"labels":[],"label_agreement":null},{"id":"W4409629140","doi":"10.1158/1538-7445.am2025-1734","title":"Abstract 1734: RP-1664: A potent and selective PLK4 inhibitor causing tumor regressions in TRIM37-high xenograft models of solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Solid tumor; Cancer research; Chemistry; Cancer; Medicine; Biology; Internal medicine","score_opus":0.04805494856115791,"score_gpt":0.3849947375998999,"score_spread":0.336939789038742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871745,0.010360619,0.00003051755,0.0005742687,0.0002644063,0.00047186334,0.000088172696,0.000021842741,0.001013804],"genre_scores_gemma":[0.99605906,0.000582025,0.00001603559,0.00006173703,0.000020490073,0.00013148751,0.000012488824,0.000017664268,0.003099013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979438,0.00048220728,0.00044227196,0.00039179643,0.000098636905,0.0006412664],"domain_scores_gemma":[0.9988704,0.0004113626,0.00008671014,0.00026945726,0.00032712225,0.000034985304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080879405,0.00017509756,0.00043801373,0.00082403905,0.0002540524,0.000020561214,0.00020171818,0.00018137395,0.0001599631],"category_scores_gemma":[0.000272455,0.00014864381,0.000068496716,0.00061928947,0.0005760164,0.00012566784,0.0002525008,0.0009903257,0.000014955222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028357985,0.00020360865,0.00037237117,0.00012270187,0.00012534998,0.000038429334,0.0011751486,0.000094520656,0.9864763,0.0006611556,0.003711247,0.004183373],"study_design_scores_gemma":[0.0020061068,0.00028162912,0.016387358,0.0014780943,0.00001391489,0.000020614338,0.0015271824,0.000045510038,0.9758003,0.00087741256,0.001393199,0.00016872758],"about_ca_topic_score_codex":0.0034357859,"about_ca_topic_score_gemma":0.00036784846,"teacher_disagreement_score":0.016014988,"about_ca_system_score_codex":0.00026784922,"about_ca_system_score_gemma":0.0008698148,"threshold_uncertainty_score":0.6061519},"labels":[],"label_agreement":null},{"id":"W4409629149","doi":"10.1158/1538-7445.am2025-4435","title":"Abstract 4435: PRAME-mediated retinoid resistance is overcome by EZH2 inhibition in keratinocyte carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Retinoid; Cancer research; EZH2; Internal medicine; Medicine; Chemistry; Biology; Cell culture; Biochemistry; Retinoic acid; Genetics; DNA; Methylation","score_opus":0.019567890812980666,"score_gpt":0.34610321863282323,"score_spread":0.32653532781984257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710651,0.014604101,0.000056386496,0.0013567774,0.00011246908,0.0003480511,0.00009752797,0.000014540193,0.012345039],"genre_scores_gemma":[0.9832063,0.002640057,0.000051225783,0.00050612126,0.00014122645,0.0002502887,0.00024231833,0.000025313548,0.012937192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979282,0.00015294048,0.00032529235,0.0006351505,0.00040589774,0.00055249035],"domain_scores_gemma":[0.99900514,0.00006233098,0.000063323925,0.0004623454,0.0003175321,0.000089307054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000700106,0.00017761973,0.00018467187,0.00015414089,0.00015766615,0.00008191667,0.0002553054,0.00030227794,0.00015041755],"category_scores_gemma":[0.00032992064,0.00018118825,0.00005777084,0.000608059,0.0002454042,0.000011976954,0.00016899219,0.00054223684,0.00002402699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027116813,0.0000514376,0.0064490302,0.00026202644,0.000016029073,0.000021765,0.00007404466,0.0000061188357,0.8846773,0.000072622344,0.10764747,0.00045101615],"study_design_scores_gemma":[0.0007979373,0.000058452195,0.004537598,0.0001701459,0.0000035253404,0.0000010995401,0.00010504032,0.000012122218,0.8843151,0.00026155362,0.109558344,0.00017909874],"about_ca_topic_score_codex":0.00032807447,"about_ca_topic_score_gemma":0.0002751995,"teacher_disagreement_score":0.0121411495,"about_ca_system_score_codex":0.00023470458,"about_ca_system_score_gemma":0.00074294675,"threshold_uncertainty_score":0.7388643},"labels":[],"label_agreement":null},{"id":"W4409629189","doi":"10.1158/1538-7445.am2025-4289","title":"Abstract 4289: Discovery of potent RAD51 inhibitors with anticancer activity in preclinical models of non-small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network","funders":"","keywords":"Cancer; Medicine; Lung cancer; Pharmacology; Cancer research; Computational biology; Oncology; Biology; Internal medicine","score_opus":0.06628005333678891,"score_gpt":0.4632152967950916,"score_spread":0.39693524345830267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869801,0.0034606555,0.00030503428,0.0010505469,0.00015649085,0.0013045626,0.000114631,0.000009300268,0.006618723],"genre_scores_gemma":[0.99510825,0.002164579,0.00017137399,0.000042645235,0.000081176186,0.0005043691,0.0000074857508,0.000024672447,0.0018954506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809474,0.000067652334,0.0004034528,0.00043343054,0.00057640247,0.00042432864],"domain_scores_gemma":[0.9986927,0.00026144754,0.00012482132,0.000410306,0.00040414146,0.00010660554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043122983,0.00016259728,0.00051310565,0.00035501822,0.000056070123,0.000017539382,0.00015231203,0.000115677416,0.000057102447],"category_scores_gemma":[0.000035224515,0.00011996589,0.00010313572,0.0008280561,0.00029798402,0.00020780577,0.00008975675,0.0005184605,6.412985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072352383,0.0036764485,0.78145593,0.007406972,0.0013038197,0.00009578228,0.002635642,0.013551362,0.13665892,0.00039703836,0.0032961646,0.04228668],"study_design_scores_gemma":[0.008579739,0.0005718266,0.5808366,0.0057914555,0.00041761197,0.0000010014661,0.00053442596,0.0028067448,0.39979652,0.00023364472,0.0001868838,0.00024353425],"about_ca_topic_score_codex":0.015156484,"about_ca_topic_score_gemma":0.0028449534,"teacher_disagreement_score":0.26313758,"about_ca_system_score_codex":0.00080492976,"about_ca_system_score_gemma":0.0037453135,"threshold_uncertainty_score":0.9914017},"labels":[],"label_agreement":null},{"id":"W4409629228","doi":"10.1158/1538-7445.am2025-2173","title":"Abstract 2173: Targeting USP7 with MEK1/2 inhibition synergizes to induce pyroptosis and enhance immunotherapy in <i>NRAS</i> mutant melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; Melanoma; Immunotherapy; Mutant; Pyroptosis; Medicine; Cancer; Chemistry; Apoptosis; Programmed cell death; KRAS; Internal medicine","score_opus":0.019763180053057047,"score_gpt":0.33967252033749074,"score_spread":0.3199093402844337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217725,0.0040562977,0.00009464634,0.000911503,0.000041390238,0.0004481532,0.000022890215,0.00000966806,0.0022381826],"genre_scores_gemma":[0.99684876,0.0017245411,0.00022998409,0.00032376347,0.000094111434,0.00039108208,0.00001958715,0.000020966798,0.00034721135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986568,0.00010454363,0.00018053333,0.00044033668,0.00021476031,0.00040300153],"domain_scores_gemma":[0.99946797,0.000038499165,0.000032878048,0.00022812159,0.00015445895,0.00007807407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006705863,0.00013344722,0.0001470697,0.0001532406,0.00013529853,0.00006135261,0.00014671723,0.0001237499,0.000052768464],"category_scores_gemma":[0.00007857823,0.00011718068,0.000023095356,0.00040664084,0.00011195771,0.000008431836,0.00012261781,0.00027836513,0.0000052984187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044072987,0.000034285644,0.0022147698,0.00006464809,0.000026496502,0.000008391493,0.00015866035,0.000021580185,0.98632145,0.000082356535,0.0006294497,0.009997179],"study_design_scores_gemma":[0.0004878635,0.00022246255,0.0030892359,0.00024834467,0.0000018903406,0.000001460096,0.00019751235,0.0000028707245,0.9795825,0.000082419094,0.015940543,0.00014288531],"about_ca_topic_score_codex":0.0005556541,"about_ca_topic_score_gemma":0.00041845956,"teacher_disagreement_score":0.015311093,"about_ca_system_score_codex":0.00006797045,"about_ca_system_score_gemma":0.00024302221,"threshold_uncertainty_score":0.47784895},"labels":[],"label_agreement":null},{"id":"W4409629260","doi":"10.1158/1538-7445.am2025-2003","title":"Abstract 2003: Targeting the human adrenomenulin 2 hormone inhibits cancer cell intravasation","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intravasation; Cancer; Medicine; Cancer research; Hormone; Cancer cell; Internal medicine","score_opus":0.021228924507643833,"score_gpt":0.35968545874013497,"score_spread":0.3384565342324911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341516,0.057735186,0.000021566064,0.0005633568,0.00016086499,0.00040971098,0.000012976455,0.000012241514,0.006932493],"genre_scores_gemma":[0.9855396,0.008869715,0.0000209328,0.00012740488,0.00038174377,0.00026170994,0.0000750955,0.000020617756,0.0047031743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986737,0.00013569498,0.00018463314,0.0003349055,0.0002412628,0.00042980953],"domain_scores_gemma":[0.999244,0.000024433893,0.0000483866,0.00027852267,0.0003336588,0.000071008886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072755193,0.00012513075,0.00010317562,0.00005586262,0.00043391943,0.000056680023,0.00028630978,0.00019128696,0.00012440489],"category_scores_gemma":[0.00006722332,0.000092735856,0.00004403419,0.00041201522,0.00016399738,0.0000059817585,0.00015807519,0.00047942894,0.000022570463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054276647,0.000037027123,0.0003442857,0.000035247005,0.000053107542,0.0000018391003,0.000088479275,0.00008181939,0.93007106,0.00007868965,0.064272046,0.0048821145],"study_design_scores_gemma":[0.0005172795,0.00009486037,0.0022977833,0.00004586562,0.0000128952715,3.806257e-7,0.00015378353,0.00002518172,0.95637727,0.000051375995,0.04030329,0.00012003709],"about_ca_topic_score_codex":0.0011024461,"about_ca_topic_score_gemma":0.00012470187,"teacher_disagreement_score":0.051388003,"about_ca_system_score_codex":0.00012200962,"about_ca_system_score_gemma":0.0004032604,"threshold_uncertainty_score":0.37816587},"labels":[],"label_agreement":null},{"id":"W4409629286","doi":"10.1158/1538-7445.am2025-2191","title":"Abstract 2191: A 50-marker mass cytometry intracellular cytokine staining panel: unprecedented resolution enables unrivaled detection of functional diversity present among human immune cell subsets","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Immune system; Biology; Cytokine; Flow cytometry; Intracellular; Immunology; Cell biology; Computational biology; Genetics; Phenotype; Gene","score_opus":0.05403930130711929,"score_gpt":0.31145710199775395,"score_spread":0.25741780069063463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898888,0.0021641378,0.0064327684,0.00006030594,0.00023520259,0.00037445212,0.000043665885,0.000020717056,0.00077996444],"genre_scores_gemma":[0.9974512,0.00042462366,0.000035658555,0.000009297194,0.00017650679,0.000047351194,0.0001680258,0.000022132728,0.0016652442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801856,0.0002203412,0.00033828837,0.0004679008,0.0004984653,0.0004564232],"domain_scores_gemma":[0.9988836,0.000059158436,0.00010791252,0.000369695,0.00048810968,0.00009154299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094143784,0.00017114088,0.00021214777,0.00032077968,0.00054374227,0.000042090764,0.0003082399,0.000253383,0.000107657615],"category_scores_gemma":[0.000082736275,0.0001802158,0.00013236889,0.00049511873,0.00029185216,0.000016221216,0.0003076838,0.00042687563,0.000002494666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010003241,0.00015045165,0.029294133,0.00022781965,0.00012975234,0.00000490739,0.00006081699,0.00089323474,0.9672643,0.000007970152,0.0003000416,0.0006662318],"study_design_scores_gemma":[0.0011420293,0.0001355417,0.112442434,0.00008797338,0.000028256394,4.904532e-7,0.00028125782,0.00028081328,0.8839375,0.000051327348,0.0014683837,0.00014403835],"about_ca_topic_score_codex":0.0028538625,"about_ca_topic_score_gemma":0.00045391294,"teacher_disagreement_score":0.08332686,"about_ca_system_score_codex":0.00021457537,"about_ca_system_score_gemma":0.0001767173,"threshold_uncertainty_score":0.7348987},"labels":[],"label_agreement":null},{"id":"W4409629417","doi":"10.1158/1538-7445.am2025-6061","title":"Abstract 6061: Dual PD-L1 blockade and VEGF-A neutralization with the bispecific antibody BNT327/PM8002 shows potent antitumor activity in preclinical models","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Blockade; Bispecific antibody; Medicine; Neutralization; Antibody; Cancer research; VEGF receptors; Pharmacology; Immunology; Internal medicine; Receptor; Monoclonal antibody","score_opus":0.12705428417367967,"score_gpt":0.4546985707906712,"score_spread":0.3276442866169915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824979,0.003433423,0.0001135375,0.010962815,0.00012644037,0.001014027,0.00002290947,0.000028287131,0.0018006929],"genre_scores_gemma":[0.9936912,0.004361011,0.000020257363,0.00023302597,0.00014468456,0.00013678474,0.000011231047,0.000022182023,0.0013796289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980244,0.00017825705,0.0002627976,0.00048747592,0.00056775333,0.00047932635],"domain_scores_gemma":[0.9989925,0.00025122619,0.000055778633,0.00042105417,0.00018203443,0.00009737415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012584165,0.00016580538,0.0003018898,0.00027749303,0.00020936568,0.00009678292,0.00016177996,0.00012962219,0.00012322517],"category_scores_gemma":[0.000037582628,0.00010674464,0.00006275124,0.00089276565,0.00053257437,0.00016424783,0.00008371975,0.00077024923,0.0000030069823],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03411384,0.0011571961,0.06408732,0.00095543225,0.00053834065,0.00027021172,0.0014602485,0.00080461305,0.80014956,0.0006719252,0.007474281,0.088317014],"study_design_scores_gemma":[0.0063835913,0.0006090769,0.93159765,0.0012088275,0.00006130583,0.000027723012,0.00061577343,0.0025069732,0.046333082,0.00020422935,0.010175391,0.0002763514],"about_ca_topic_score_codex":0.001610793,"about_ca_topic_score_gemma":0.0015575755,"teacher_disagreement_score":0.8675104,"about_ca_system_score_codex":0.00027701486,"about_ca_system_score_gemma":0.00068129407,"threshold_uncertainty_score":0.435292},"labels":[],"label_agreement":null},{"id":"W4409629442","doi":"10.1158/1538-7445.am2025-2435","title":"Abstract 2435: Automatic detection of prostate cancer in 3D pathology datasets based on synthetic immunolabeling of cytokeratins","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunolabeling; Pathology; Prostate cancer; Prostate; Cancer; Medicine; Internal medicine; Immunohistochemistry","score_opus":0.03515513617067792,"score_gpt":0.37998604888797954,"score_spread":0.3448309127173016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836186,0.0013234409,0.012154846,0.0007167973,0.0007902735,0.0008542058,0.00020020656,0.0000696314,0.0002719762],"genre_scores_gemma":[0.9984697,0.00028320486,0.00068470865,0.000042474265,0.000020669817,0.00045605123,0.0000040634236,0.000012138564,0.000027001186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773616,0.0003281475,0.00048333866,0.00048527398,0.00055539113,0.00041170232],"domain_scores_gemma":[0.9982497,0.00045340802,0.00016205062,0.00081049494,0.00028580875,0.000038531936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015674077,0.00013264568,0.00026960872,0.000852119,0.000118206546,0.00004172513,0.0006850576,0.00010278483,0.00006043383],"category_scores_gemma":[0.00021910186,0.00013040741,0.000040767016,0.0016836001,0.00019210982,0.0002363808,0.00019245154,0.00054854923,0.0000058409037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018913628,0.0001494905,0.0011603708,0.0008716279,0.00002565055,0.00001695257,0.00052513496,0.021235399,0.55756277,0.00012433699,0.00009259995,0.4180465],"study_design_scores_gemma":[0.0009761807,0.00026488112,0.02475183,0.0017428098,0.000007132296,0.0000014682776,0.00005583522,0.25786987,0.71359724,0.00036566652,0.0002185416,0.00014854742],"about_ca_topic_score_codex":0.0021260649,"about_ca_topic_score_gemma":0.0011055545,"teacher_disagreement_score":0.41789797,"about_ca_system_score_codex":0.00072870863,"about_ca_system_score_gemma":0.00092461443,"threshold_uncertainty_score":0.53178596},"labels":[],"label_agreement":null},{"id":"W4409629468","doi":"10.1158/1538-7445.am2025-1543","title":"Abstract 1543: Obesity promotes triple negative breast cancer progression through regulating the plasticity of adipose tissue","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Adipose tissue; Triple-negative breast cancer; Breast cancer; Cancer; Medicine; Obesity; Cancer research; Oncology; Internal medicine","score_opus":0.06413289112011165,"score_gpt":0.436817272810031,"score_spread":0.37268438168991935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005944,0.008365773,0.000057319754,0.005569153,0.0002599898,0.0018735868,0.00010767344,0.00004417482,0.0036629038],"genre_scores_gemma":[0.9934062,0.0007198368,0.00029226753,0.0000905545,0.00044092996,0.00033277512,0.0000063229854,0.000023488432,0.0046876706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977825,0.00018073525,0.0003539808,0.00038942753,0.00075940776,0.0005339219],"domain_scores_gemma":[0.99814576,0.00041439317,0.00013122777,0.00038414114,0.0008078181,0.00011664069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007276961,0.00017251282,0.00042126465,0.00012602485,0.00037199663,0.00002876372,0.00026803752,0.00013600709,0.00076332706],"category_scores_gemma":[0.00051193265,0.00010837335,0.000072465926,0.0009352182,0.0005624849,0.00015198853,0.00018491766,0.0007528197,0.000013329915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030162153,0.0009454074,0.02914343,0.0024553982,0.00074144267,0.000059726135,0.0073163966,0.000048680802,0.5472827,0.0035733616,0.019823339,0.38559392],"study_design_scores_gemma":[0.0017154869,0.00013730585,0.38920397,0.002468341,0.00016070419,0.000010755986,0.0004748238,0.00007915362,0.595314,0.0013879993,0.008913209,0.00013424286],"about_ca_topic_score_codex":0.0058261408,"about_ca_topic_score_gemma":0.00044895711,"teacher_disagreement_score":0.38545966,"about_ca_system_score_codex":0.00020420093,"about_ca_system_score_gemma":0.0010790298,"threshold_uncertainty_score":0.8807421},"labels":[],"label_agreement":null},{"id":"W4409629526","doi":"10.1158/1538-7445.am2025-6250","title":"Abstract 6250: Clinical significance of co localization index in rectal cancer: a deep learning approach to cell interaction analysis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Colorectal cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.0606715627317647,"score_gpt":0.48088089536944556,"score_spread":0.42020933263768084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93341756,0.00084955205,0.048987016,0.00152991,0.00020365349,0.00067279127,0.000003682598,0.000032450676,0.014303408],"genre_scores_gemma":[0.99715656,0.0009835263,0.00026206137,0.00028721656,0.00014608279,0.00018581444,0.000029009025,0.00001869803,0.000931035],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99757785,0.0003690994,0.0006017031,0.0004906478,0.0005820352,0.0003786833],"domain_scores_gemma":[0.9986431,0.00042258066,0.00012024044,0.00024637167,0.00033863678,0.0002290467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026622606,0.00011714658,0.0005012757,0.0011808872,0.000094529925,0.00003436515,0.00019176248,0.00013489852,0.00017434575],"category_scores_gemma":[0.0014729975,0.00010993035,0.00013367184,0.0031179597,0.00018262054,0.00006845061,0.00006903937,0.001750906,0.0000056817817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067631534,0.00034018865,0.71749455,0.00044561768,0.00023601088,0.000011049367,0.0006437377,0.18358864,0.0053490563,0.000035897527,0.0014867648,0.0896922],"study_design_scores_gemma":[0.0019045267,0.00017722248,0.40407753,0.00065753656,0.00019143679,0.0000011637466,0.001225623,0.57360035,0.0035123623,0.000037109712,0.014427239,0.00018792477],"about_ca_topic_score_codex":0.0058691013,"about_ca_topic_score_gemma":0.00030278263,"teacher_disagreement_score":0.3900117,"about_ca_system_score_codex":0.000484007,"about_ca_system_score_gemma":0.0006049713,"threshold_uncertainty_score":0.8872365},"labels":[],"label_agreement":null},{"id":"W4409629571","doi":"10.1158/1538-7445.am2025-5644","title":"Abstract 5644: Identification of alexidine as a novel small molecule inhibitor of TAZ-TEAD interaction in breast cancer cell migration","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Identification (biology); Cancer research; Cancer; Medicine; Biology; Oncology; Computational biology; Internal medicine","score_opus":0.03986098455402925,"score_gpt":0.3767249792686187,"score_spread":0.33686399471458944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970121,0.0013118675,0.00016776823,0.0003677712,0.00014355384,0.00023765035,0.00016626026,0.00000421315,0.0005888277],"genre_scores_gemma":[0.997969,0.0008911993,0.000021015541,0.000025347374,0.000092036506,0.0001335298,0.00009722994,0.000010615429,0.0007600544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988653,0.00006614359,0.00036166783,0.00030076975,0.00020688768,0.0001992083],"domain_scores_gemma":[0.999087,0.000025818636,0.0001274233,0.00025023372,0.00046942907,0.000040103325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005218314,0.00009333723,0.00013500701,0.00016644636,0.000039191473,0.000016714206,0.00016978577,0.00013341474,0.00006796419],"category_scores_gemma":[0.00006334687,0.00009575977,0.000057717833,0.00031754904,0.0000832059,0.000009411064,0.000060351642,0.00017761243,0.0000043350137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031732497,0.00019946946,0.0016158366,0.00021680455,0.000023230095,6.901915e-7,0.00014630725,0.00041759908,0.9952366,0.000025066316,0.00027407802,0.0015270051],"study_design_scores_gemma":[0.00046942447,0.000063798274,0.005120835,0.00021555279,0.0000071749905,8.3818037e-7,0.00026062643,0.00013604059,0.9929609,0.000019985187,0.00066920766,0.00007564142],"about_ca_topic_score_codex":0.008412256,"about_ca_topic_score_gemma":0.0031279568,"teacher_disagreement_score":0.005284299,"about_ca_system_score_codex":0.00011619004,"about_ca_system_score_gemma":0.0004570894,"threshold_uncertainty_score":0.9981908},"labels":[],"label_agreement":null},{"id":"W4409629585","doi":"10.1158/1538-7445.am2025-1718","title":"Abstract 1718: Role of IKKε in resistance to second-generation hormone therapy in prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Cancer; Medicine; Oncology; Internal medicine; Hormone therapy; Prostate; Resistance (ecology); Gynecology; Cancer research; Biology; Breast cancer; Ecology","score_opus":0.041225602115241525,"score_gpt":0.3780252642678524,"score_spread":0.33679966215261087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981366,0.016038321,0.0000053913764,0.000439677,0.000057063437,0.0004881203,0.000051026236,0.000003536873,0.0015508664],"genre_scores_gemma":[0.99429905,0.002334613,0.000061539606,0.00013654823,0.000091466885,0.0005375766,0.000023765731,0.000015577802,0.0024998696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877113,0.000093840375,0.00023721892,0.00036095936,0.00021027534,0.00032655388],"domain_scores_gemma":[0.9994005,0.000018221337,0.00003517136,0.0002897534,0.00020960225,0.000046772097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067633326,0.000093987255,0.00013856104,0.00021798254,0.000037594506,0.000019358862,0.00021849365,0.00008880915,0.00008612443],"category_scores_gemma":[0.000059543574,0.00009491582,0.000027115342,0.0005238107,0.00006233117,0.0000051682805,0.000071606264,0.00020581258,0.0000036548415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049645506,0.000049558086,0.004882304,0.00003705074,0.000013715317,0.0000029428877,0.00024925394,0.00046353586,0.9831118,0.00006602529,0.0037686238,0.0068587656],"study_design_scores_gemma":[0.0006397772,0.00008481759,0.030662399,0.00009153666,6.064259e-7,6.666788e-8,0.00007791557,0.000010273326,0.94446665,0.0001828946,0.023695093,0.00008798886],"about_ca_topic_score_codex":0.001135314,"about_ca_topic_score_gemma":0.028963048,"teacher_disagreement_score":0.038645137,"about_ca_system_score_codex":0.00014210843,"about_ca_system_score_gemma":0.0005891549,"threshold_uncertainty_score":0.9887558},"labels":[],"label_agreement":null},{"id":"W4409629661","doi":"10.1158/1538-7445.am2025-3927","title":"Abstract 3927: Bone Metastasis Technology Platform: Establishing clinically relevant bone metastasis models for breast and prostate cancer and multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Bone metastasis; Multiple myeloma; Metastasis; Breast cancer; Oncology; Prostate; Breast cancer metastasis; Cancer; Internal medicine; Cancer research","score_opus":0.11941295019644807,"score_gpt":0.4426454095660564,"score_spread":0.3232324593696083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8911359,0.05146514,0.000636414,0.053517126,0.00022340521,0.0016328689,0.0007671261,0.0001298075,0.00049223774],"genre_scores_gemma":[0.9681776,0.022526907,0.0054816585,0.0007027617,0.00014552838,0.0010305966,0.000025381352,0.000045031575,0.0018645326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99708176,0.00007562552,0.0006401084,0.0008143746,0.00048211974,0.0009060129],"domain_scores_gemma":[0.99709404,0.0013362489,0.00011751598,0.00041500057,0.0007377813,0.0002994137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030369074,0.00025857592,0.00086159626,0.00066338485,0.0004938298,0.00008412509,0.00015896269,0.0002419289,0.000034912908],"category_scores_gemma":[0.002444684,0.000200763,0.00008780195,0.0007401254,0.0014145533,0.00023852702,0.00038328365,0.0011614233,0.0000021631733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028999518,0.0002182063,0.033924203,0.0021021045,0.0009497255,0.00025507555,0.00096644723,0.000041560346,0.013108872,0.0007129236,0.013508391,0.93131256],"study_design_scores_gemma":[0.10812878,0.0065402198,0.28914973,0.029374802,0.00876606,0.0030909418,0.039707784,0.0590731,0.06175323,0.11282918,0.2759824,0.0056037507],"about_ca_topic_score_codex":0.00084416155,"about_ca_topic_score_gemma":0.00037301728,"teacher_disagreement_score":0.9257088,"about_ca_system_score_codex":0.00014350416,"about_ca_system_score_gemma":0.00058157457,"threshold_uncertainty_score":0.81868774},"labels":[],"label_agreement":null},{"id":"W4409629766","doi":"10.1158/1538-7445.am2025-1467","title":"Abstract 1467: Revealing therapeutically relevant states of cohesin through dominant-negative mutational mapping of Smc1 as a synthetic lethal anti-cancer approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cohesin; Cancer; Genetics; Biology; Computational biology; Cancer research; Gene; Chromosome","score_opus":0.07331210077378941,"score_gpt":0.3971763381974524,"score_spread":0.323864237423663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867349,0.0052717533,0.0014263153,0.00052617455,0.00006373166,0.0005569329,0.00017363911,0.00000562934,0.00524088],"genre_scores_gemma":[0.99480623,0.0025420089,0.0016103582,0.00008397408,0.00008213292,0.00024322515,0.000039764825,0.000020749427,0.0005715304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981696,0.00023577751,0.00037827552,0.00041692,0.0004186852,0.00038071768],"domain_scores_gemma":[0.9986915,0.0002437813,0.00013209133,0.0002887429,0.00059410924,0.000049778595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000977542,0.00014698763,0.00028377498,0.00011331024,0.000118751115,0.000019984638,0.00030162695,0.00015103044,0.00012490335],"category_scores_gemma":[0.00028678816,0.000129664,0.00010347057,0.00032915897,0.0005332611,0.00000819929,0.0001390403,0.00029395823,0.0000030214862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038751878,0.00012620911,0.0004495199,0.00061184366,0.00020160296,0.0000032976182,0.00077714724,0.0003036389,0.9922461,0.0013021366,0.0002366884,0.003354315],"study_design_scores_gemma":[0.00058787427,0.00011823609,0.0013139788,0.00045797892,0.000014374567,0.000002727097,0.0009853838,0.0001032989,0.991722,0.0026035872,0.0019623798,0.00012818373],"about_ca_topic_score_codex":0.00067930645,"about_ca_topic_score_gemma":0.000016497348,"teacher_disagreement_score":0.008071312,"about_ca_system_score_codex":0.000056886685,"about_ca_system_score_gemma":0.000816375,"threshold_uncertainty_score":0.5287545},"labels":[],"label_agreement":null},{"id":"W4409629788","doi":"10.1158/1538-7445.am2025-4380","title":"Abstract 4380: HBW-016-K, a novel orally available pan-KRAS inhibitor targeting both “ON” and “OFF” states, is potent, selective, efficacious, safe, and high tissue-penetrant","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hyperion Technologies (Canada)","funders":"","keywords":"Penetrant (biochemical); Pharmacology; Medicine; Chemistry","score_opus":0.041532051698618865,"score_gpt":0.39183705025910687,"score_spread":0.350304998560488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94437,0.008085544,0.0012553955,0.037626207,0.000102444625,0.0023460528,0.00020343595,0.00023189712,0.0057790247],"genre_scores_gemma":[0.9719965,0.00836471,0.006040697,0.0016794252,0.00022592531,0.00038264622,0.00005752741,0.00004661866,0.011205939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784225,0.000048360635,0.00031508846,0.0006466514,0.00055829016,0.00058935565],"domain_scores_gemma":[0.9986846,0.00028698237,0.000079326215,0.00034797651,0.00029482404,0.00030632384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009157379,0.00019125419,0.00033146766,0.00024959535,0.0003102882,0.0000945033,0.00016373837,0.00013205444,0.00046422737],"category_scores_gemma":[0.00030421306,0.00015815879,0.00003000056,0.00059954415,0.00034287645,0.0000618671,0.00014727718,0.00089179917,0.00003825568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003135096,0.00031380536,0.00211985,0.00052880286,0.00009032392,0.00003465124,0.00019359097,0.000001963903,0.3655984,0.000705281,0.5793058,0.05079399],"study_design_scores_gemma":[0.0033577592,0.0006043683,0.021868577,0.00169653,0.00007878982,0.000018878867,0.00014510607,0.0010016545,0.23471595,0.0009693215,0.7351557,0.00038736447],"about_ca_topic_score_codex":0.0026597823,"about_ca_topic_score_gemma":0.00004940592,"teacher_disagreement_score":0.15584987,"about_ca_system_score_codex":0.00020461556,"about_ca_system_score_gemma":0.0004999659,"threshold_uncertainty_score":0.6449528},"labels":[],"label_agreement":null},{"id":"W4409629821","doi":"10.1158/1538-7445.am2025-6106","title":"Abstract 6106: A regulated, cell-intrinsic cytokine engineering strategy to enhance the in vitro and in vivo persistence of iPSC-derived CAR-T cell therapies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"In vivo; Persistence (discontinuity); Cytokine; In vitro; Cell; Immunology; Cell biology; Biology; Cancer research; Medicine; Genetics; Engineering","score_opus":0.038009788108527766,"score_gpt":0.35332950943719427,"score_spread":0.3153197213286665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885122,0.0062818048,0.000007407329,0.0015488683,0.00004702254,0.0012067911,0.00001611265,0.000016761243,0.0023630331],"genre_scores_gemma":[0.9931024,0.0023835714,0.000056656023,0.00006385124,0.000057464236,0.00025422248,0.000001921797,0.000030739793,0.004049216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976377,0.0001438849,0.00036542708,0.00047850425,0.00066950783,0.000704968],"domain_scores_gemma":[0.99849874,0.00048238458,0.000037197486,0.00055128447,0.00028865677,0.00014174404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013607955,0.00018661651,0.00041105924,0.0007486164,0.00006875302,0.000049105292,0.00035601697,0.00011895778,0.0004958514],"category_scores_gemma":[0.000112466,0.0001486962,0.00006463437,0.0017073919,0.00025183766,0.00006968921,0.00017913728,0.0009799119,0.000004254636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020021817,0.0001072885,0.0008538513,0.00056485157,0.000032908465,0.00005643421,0.0017905295,0.00062528433,0.97997516,0.000008878786,0.00015084833,0.013831797],"study_design_scores_gemma":[0.0011848338,0.0002185922,0.02086802,0.00046274814,0.0000068462036,0.0000026481407,0.00185281,0.00031563168,0.9737916,0.000020690026,0.0011592321,0.00011636879],"about_ca_topic_score_codex":0.0032163693,"about_ca_topic_score_gemma":0.0008398945,"teacher_disagreement_score":0.020014169,"about_ca_system_score_codex":0.000497698,"about_ca_system_score_gemma":0.0006055187,"threshold_uncertainty_score":0.6063655},"labels":[],"label_agreement":null},{"id":"W4409629865","doi":"10.1158/1538-7445.am2025-5162","title":"Abstract 5162: Decreases in blood pressure in a patient-derived xenograft model of pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Guelph","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Medicine; Adenocarcinoma; Internal medicine; Blood pressure; Oncology; Pancreatic cancer; Urology; Cancer","score_opus":0.04454863862520688,"score_gpt":0.3560322536001186,"score_spread":0.3114836149749117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9439822,0.053727575,0.000002675089,0.00044686123,0.000044245367,0.00088457466,0.000030792944,0.00001864926,0.0008624635],"genre_scores_gemma":[0.99445105,0.0041691423,0.00005755121,0.000058716538,0.00006318494,0.0004031045,0.00001231734,0.000027485676,0.00075745926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976701,0.00019477631,0.00050838327,0.00042529393,0.000584342,0.0006171112],"domain_scores_gemma":[0.9986617,0.0003426762,0.00007294814,0.0005285451,0.00025887036,0.00013524783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047163173,0.00018766859,0.0005615279,0.0008934987,0.000059585353,0.000022519398,0.00023603972,0.00014963548,0.00021116703],"category_scores_gemma":[0.0004942334,0.0001749106,0.000112732676,0.00096763344,0.00032503763,0.00010507134,0.00010409259,0.00059988594,0.0000037863265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01174405,0.0016884158,0.45001554,0.0027538377,0.00044991524,0.00059121294,0.0036555128,0.0011671893,0.5180723,0.00010931473,0.0015486015,0.008204117],"study_design_scores_gemma":[0.006698405,0.0005904438,0.8163743,0.0041633975,0.0002878025,0.00004306059,0.0020193616,0.0018206008,0.16679104,0.000248978,0.0006853207,0.0002772901],"about_ca_topic_score_codex":0.0096145375,"about_ca_topic_score_gemma":0.001381396,"teacher_disagreement_score":0.36635876,"about_ca_system_score_codex":0.00015612815,"about_ca_system_score_gemma":0.0018897529,"threshold_uncertainty_score":0.99698055},"labels":[],"label_agreement":null},{"id":"W4409629958","doi":"10.1158/1538-7445.am2025-4591","title":"Abstract 4591: Development and validation of a molecular classifier of meningiomas","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Classifier (UML); Medicine; Computational biology; Computer science; Artificial intelligence; Biology","score_opus":0.1046990963864095,"score_gpt":0.42159747122816194,"score_spread":0.31689837484175243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409629958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981486,0.001006038,0.00021036755,0.00051950855,0.00003357555,0.00031211978,0.0000013077031,0.0000065545796,0.016424485],"genre_scores_gemma":[0.9971647,0.00001815031,0.0009405226,0.0000097790835,0.000009120951,0.000060299226,0.000005209237,0.0000060767184,0.0017861369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897605,0.000035296212,0.00023863913,0.00016523617,0.0004185989,0.00016617571],"domain_scores_gemma":[0.9994276,0.00005013603,0.000043544624,0.00017705742,0.00024830978,0.000053323627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070215564,0.000057815043,0.00016840297,0.00034859986,0.000040117822,0.000008667574,0.000068392525,0.000040248986,0.00009758862],"category_scores_gemma":[0.00007378334,0.000050846786,0.000025968617,0.00038619444,0.00009685401,0.000027877128,0.0000882735,0.000113326816,0.0000020359869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003038195,0.000100534526,0.009659145,0.0015336075,0.0002662024,0.00012039682,0.00078813935,0.000011973704,0.95655864,0.0066144313,0.0017086136,0.02233448],"study_design_scores_gemma":[0.0006303258,0.00006109008,0.044225954,0.00043326445,0.0000239834,0.0000020926202,0.00022777265,0.000018543644,0.94939506,0.00024336277,0.004696325,0.00004222299],"about_ca_topic_score_codex":0.00006658716,"about_ca_topic_score_gemma":0.0000017657679,"teacher_disagreement_score":0.03456681,"about_ca_system_score_codex":0.000080413985,"about_ca_system_score_gemma":0.00030573973,"threshold_uncertainty_score":0.20734718},"labels":[],"label_agreement":null},{"id":"W4409630048","doi":"10.1158/1538-7445.am2025-3896","title":"Abstract 3896: Multi-omic and multi-region profiling of uterine leiomyoma reveals intra- and inter-tumor heterogeneity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Profiling (computer programming); Uterine leiomyoma; Computational biology; Leiomyoma; Biology; Medicine; Pathology; Computer science","score_opus":0.12241686174584399,"score_gpt":0.460498550556295,"score_spread":0.33808168881045103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960703,0.0018637915,0.00020797888,0.00090075587,0.00008104655,0.00074048596,0.00003086387,0.000020839878,0.00008388978],"genre_scores_gemma":[0.9963908,0.00070663035,0.0017310975,0.0000775523,0.000048079623,0.00012669874,0.000008086991,0.00001810106,0.0008929152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988112,0.000055551758,0.0002714231,0.00037167917,0.00017407138,0.0003160669],"domain_scores_gemma":[0.9992794,0.000066724024,0.00005368386,0.00027767775,0.00018288232,0.00013967564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030137453,0.00014307667,0.0003338765,0.0002450691,0.00008387714,0.00002810392,0.00008214776,0.00005989142,0.00002605852],"category_scores_gemma":[0.00008438522,0.0001151937,0.000042331216,0.0001989712,0.00023675748,0.00007061529,0.00021502866,0.00025392036,0.0000025382894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068828167,0.00036592662,0.5568343,0.002284693,0.00027197582,0.00026407704,0.00016900356,8.477023e-7,0.39673948,0.000053211825,0.00022792151,0.0421003],"study_design_scores_gemma":[0.005586943,0.00037382622,0.72728854,0.0011032157,0.000042483454,0.000071642746,0.000108844564,0.00052087056,0.26338214,0.000031614636,0.0013587669,0.00013109742],"about_ca_topic_score_codex":0.0007881504,"about_ca_topic_score_gemma":0.00015781808,"teacher_disagreement_score":0.17045431,"about_ca_system_score_codex":0.00012729506,"about_ca_system_score_gemma":0.00011853398,"threshold_uncertainty_score":0.4697463},"labels":[],"label_agreement":null},{"id":"W4409630140","doi":"10.1158/1538-7445.am2025-4320","title":"Abstract 4320: Investigating the role of the RNA-binding protein DEAD box ATPase 55 (DDX55) in castration resistant prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; DEAD box; Cancer; ATPase; Cancer research; Biology; RNA; Medicine; Internal medicine; Biochemistry; Enzyme; Gene","score_opus":0.03037466630063797,"score_gpt":0.3535437570920132,"score_spread":0.32316909079137524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743767,0.008110548,0.000001439678,0.0012549824,0.00065071904,0.00095922546,0.00007507889,0.0000049888545,0.0015053287],"genre_scores_gemma":[0.99465907,0.0007396529,0.000031962274,0.00007324673,0.0011877138,0.000789168,0.000010787077,0.00001839687,0.0024900343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834645,0.00021144029,0.0003105099,0.00034082565,0.00036263463,0.00042813955],"domain_scores_gemma":[0.99911785,0.00003409969,0.00011085058,0.00043860413,0.00024009333,0.000058496644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010404331,0.00012841243,0.00014920099,0.00008967445,0.0002552915,0.00005308294,0.00039795355,0.00010980609,0.000030343203],"category_scores_gemma":[0.00027967745,0.000087039916,0.00006886337,0.00054011424,0.00032779516,0.000009765473,0.00019209863,0.00042979012,0.000001617957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015583127,0.000021012782,0.0034675738,0.000107802814,0.000026017398,1.4456529e-7,0.00033462577,0.00014416495,0.98351246,0.00037870803,0.0029265897,0.008925044],"study_design_scores_gemma":[0.00045066825,0.000024219638,0.010589956,0.00037817107,0.000008571751,3.4807564e-7,0.00077600934,0.000016812486,0.9043169,0.0004480686,0.082893394,0.00009687397],"about_ca_topic_score_codex":0.007064537,"about_ca_topic_score_gemma":0.015198229,"teacher_disagreement_score":0.0799668,"about_ca_system_score_codex":0.00014679799,"about_ca_system_score_gemma":0.0015512034,"threshold_uncertainty_score":0.9995475},"labels":[],"label_agreement":null},{"id":"W4409630167","doi":"10.1158/1538-7445.am2025-5117","title":"Abstract 5117: Investigating the role of secreted plasminogen receptors in the establishment of the pre-metastatic breast cancer niche","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Breast cancer; Cancer; Niche; Receptor; Metastatic breast cancer; Medicine; Cancer research; Biology; Immunology; Internal medicine; Ecology","score_opus":0.026818150049231188,"score_gpt":0.3430460628810226,"score_spread":0.3162279128317914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931316,0.0037351004,0.0000041703915,0.0014685369,0.000114007584,0.00067684223,0.00009623482,0.0000019976528,0.00077150436],"genre_scores_gemma":[0.9987403,0.00035982984,0.000018248938,0.00019343747,0.00007771207,0.00040052106,0.00000881325,0.000009596371,0.00019155169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847376,0.0003605701,0.0002580507,0.0002221251,0.0004054842,0.0002799838],"domain_scores_gemma":[0.99908864,0.00009249668,0.000103307015,0.0004931667,0.00019073489,0.000031661282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012577724,0.0000985912,0.00012025619,0.000053322965,0.00012828645,0.000023248875,0.000711477,0.00007021882,0.000058226353],"category_scores_gemma":[0.00020835527,0.000051559546,0.0000687202,0.0005188113,0.00028299572,0.0000060608036,0.00025260067,0.00033978923,5.4269816e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007277274,0.000039326904,0.006316335,0.00008400165,0.000052996656,2.534434e-7,0.0005051557,0.00014301676,0.985862,0.00026547824,0.0020675096,0.004591139],"study_design_scores_gemma":[0.00024795704,0.000044870954,0.0072989855,0.00022923213,0.000012695361,9.1550805e-7,0.0012236808,0.0000622802,0.98583287,0.00094924564,0.004042648,0.000054639764],"about_ca_topic_score_codex":0.0029150643,"about_ca_topic_score_gemma":0.0007802128,"teacher_disagreement_score":0.005608684,"about_ca_system_score_codex":0.00005551548,"about_ca_system_score_gemma":0.00072367786,"threshold_uncertainty_score":0.4406725},"labels":[],"label_agreement":null},{"id":"W4409630197","doi":"10.1158/1538-7445.am2025-5998","title":"Abstract 5998: Patient-derived organoids and precision medicine: Insights from the PASS-01 clinical trial in PDAC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Organoid; Precision medicine; Medicine; Clinical trial; Internal medicine; Computational biology; Oncology; Medical physics; Pathology; Biology; Neuroscience","score_opus":0.1563036722481564,"score_gpt":0.48781064612418396,"score_spread":0.33150697387602757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739868,0.009755346,0.0000017127986,0.012604595,0.0003720135,0.0015739088,0.000018476023,0.000018211824,0.0016689445],"genre_scores_gemma":[0.9901862,0.007967565,0.000025219199,0.0007080627,0.00038944848,0.00022375947,0.00004214248,0.000016234842,0.00044133695],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99686486,0.0005789587,0.0005353021,0.0005495773,0.0010186638,0.00045263127],"domain_scores_gemma":[0.99601513,0.002743625,0.000047106038,0.00056951976,0.0003167047,0.0003079413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010066826,0.00015386268,0.00045670412,0.00026655692,0.00021422321,0.000035089994,0.00023520572,0.00018730838,0.00072039146],"category_scores_gemma":[0.0026636166,0.00008260164,0.00006619771,0.0007344618,0.0005824214,0.00008281339,0.00027358218,0.0011027299,0.000047508598],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16130725,0.0026196996,0.14629635,0.0001348675,0.00069891114,0.0037093721,0.0009834099,0.0000011705833,0.11318799,0.00011788912,0.14198467,0.42895842],"study_design_scores_gemma":[0.0671282,0.0021088112,0.89821863,0.0011276013,0.00005100735,0.000005311734,0.00083444983,0.00005652207,0.003793316,0.0022033933,0.024350734,0.000122012585],"about_ca_topic_score_codex":0.0030271644,"about_ca_topic_score_gemma":0.000547829,"teacher_disagreement_score":0.7519223,"about_ca_system_score_codex":0.0001799323,"about_ca_system_score_gemma":0.0007501357,"threshold_uncertainty_score":0.7887782},"labels":[],"label_agreement":null},{"id":"W4409630213","doi":"10.1158/1538-7445.am2025-4596","title":"Abstract 4596: Spatial transcriptomics reveals subtype heterogeneity within the tumor epithelial compartment of pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Compartment (ship); Pancreatic cancer; Adenocarcinoma; Transcriptome; Ductal carcinoma; Medicine; Cancer research; Pathology; Internal medicine; Biology; Oncology; Cancer; Gene; Gene expression; Breast cancer; Genetics","score_opus":0.039365623956504836,"score_gpt":0.3491297049910059,"score_spread":0.30976408103450104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088806,0.0067413053,0.00013250891,0.00053542765,0.00043901015,0.00054429844,0.00030431358,0.000005081691,0.0004100151],"genre_scores_gemma":[0.99813163,0.00084187544,0.00006110622,0.00023276612,0.00034765952,0.00013931798,0.000049254748,0.000020550491,0.0001758393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847287,0.00013169268,0.00035880387,0.00037557483,0.0002951385,0.0003659333],"domain_scores_gemma":[0.9988922,0.00009672504,0.00009644591,0.00055337226,0.00027291683,0.00008837807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070501986,0.00015413578,0.00023950082,0.00007111341,0.00017530141,0.000042042066,0.00045253537,0.000087484885,0.000040184113],"category_scores_gemma":[0.00015821694,0.00012295788,0.00012103157,0.0001857062,0.0003626009,0.0000030400795,0.00015696765,0.0002530035,0.000006135364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072504225,0.0001052318,0.046046134,0.00013578472,0.00018915017,0.000008642588,0.00012208473,0.0003213789,0.9479434,0.0006509597,0.003329733,0.00042248526],"study_design_scores_gemma":[0.00091644615,0.00026107172,0.15943682,0.00008401855,0.000055161385,0.00000551543,0.00014744168,0.00007145447,0.83414775,0.00049901934,0.0042107766,0.00016452976],"about_ca_topic_score_codex":0.0018419222,"about_ca_topic_score_gemma":0.0019125188,"teacher_disagreement_score":0.11379563,"about_ca_system_score_codex":0.0001053115,"about_ca_system_score_gemma":0.00076562405,"threshold_uncertainty_score":0.5014076},"labels":[],"label_agreement":null},{"id":"W4409630346","doi":"10.1158/1538-7445.am2025-3261","title":"Abstract 3261: Plasma whole-genome sequencing to monitor pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic cancer; Cancer; Whole genome sequencing; Genome; Medicine; Computational biology; Internal medicine; Biology; Oncology; Genetics; Gene","score_opus":0.04492133902640405,"score_gpt":0.37785945443464,"score_spread":0.3329381154082359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870977,0.006079791,0.00010407001,0.0016667553,0.00050794083,0.00051047263,0.0003792398,0.000014777313,0.003639265],"genre_scores_gemma":[0.98835456,0.0029276086,0.00015127924,0.0006505437,0.00090470683,0.00071775354,0.000064574255,0.00003811074,0.00619088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981815,0.00004888876,0.00024146335,0.0005706923,0.00029577434,0.00066163414],"domain_scores_gemma":[0.9987438,0.00008280327,0.000037282825,0.0005387996,0.00036929196,0.00022804331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040394237,0.0001791012,0.00020377777,0.0001944792,0.00023442824,0.00011181474,0.00045363212,0.00015404074,0.00016654379],"category_scores_gemma":[0.00024484075,0.0001837288,0.00007704388,0.00044661545,0.00011333908,0.0000047032318,0.0003317047,0.0002869441,0.00007241676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017037267,0.000023557355,0.001445571,0.000094212795,0.0000923192,0.000009511348,0.00009218932,0.0021210134,0.9663609,0.00009439022,0.020502234,0.008993684],"study_design_scores_gemma":[0.0007920206,0.00018957081,0.016483594,0.00026109384,0.000031186955,0.0000018186557,0.0003595847,0.000056831395,0.49526346,0.00020336705,0.48596567,0.00039179478],"about_ca_topic_score_codex":0.0026976685,"about_ca_topic_score_gemma":0.0018499835,"teacher_disagreement_score":0.4710975,"about_ca_system_score_codex":0.00056637346,"about_ca_system_score_gemma":0.0011733457,"threshold_uncertainty_score":0.7492243},"labels":[],"label_agreement":null},{"id":"W4409630438","doi":"10.1158/1538-7445.am2025-5179","title":"Abstract 5179: Investigating the tumor suppressive role of RanBP9 in mice deficient in p53","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Medicine; Chemistry","score_opus":0.04586603544861472,"score_gpt":0.3930792782301348,"score_spread":0.34721324278152005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799021,0.008858682,0.0000040124537,0.002377953,0.00008963805,0.0008695717,0.000015773827,0.000011237609,0.007871046],"genre_scores_gemma":[0.9990959,0.000163416,0.00004135551,0.00021691163,0.000033293334,0.00028543954,0.000005111556,0.000018157149,0.00014040187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980833,0.000174648,0.0003725409,0.00031595922,0.00057518843,0.0004783874],"domain_scores_gemma":[0.9989576,0.00028684823,0.000064739084,0.00036811846,0.00024133526,0.00008136587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012250181,0.00010748514,0.0002579264,0.0004668534,0.00006340871,0.000017366823,0.0002663065,0.00008275448,0.00009841914],"category_scores_gemma":[0.0008290844,0.000084763866,0.00005722216,0.0015044437,0.00033071326,0.00003757291,0.00015529402,0.001130263,0.000010425996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030329596,0.00013071783,0.013210752,0.0003259133,0.000025256246,0.000094530806,0.0023608457,0.0012138966,0.972589,0.00065165013,0.0013916037,0.0077025383],"study_design_scores_gemma":[0.0035087517,0.00010658068,0.10362708,0.0037389148,0.000020939775,0.000012864508,0.0042428053,0.001290853,0.87856275,0.0014253609,0.0033215228,0.0001415931],"about_ca_topic_score_codex":0.006378069,"about_ca_topic_score_gemma":0.0022304235,"teacher_disagreement_score":0.09402627,"about_ca_system_score_codex":0.0006107208,"about_ca_system_score_gemma":0.0015562717,"threshold_uncertainty_score":0.9641775},"labels":[],"label_agreement":null},{"id":"W4409630451","doi":"10.1158/1538-7445.am2025-5533","title":"Abstract 5533: Drug tolerance mechanisms in patient-derived xenograft models with <i>epidermal growth factor receptor</i> mutated tumors treated with tyrosine kinase inhibitors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tyrosine kinase; Epidermal growth factor receptor; Cancer research; Receptor tyrosine kinase; Drug; Lapatinib; Tyrosine-kinase inhibitor; Medicine; Pharmacology; Biology; Receptor; Cancer; Internal medicine; Trastuzumab","score_opus":0.040799973165433046,"score_gpt":0.3462554423397977,"score_spread":0.30545546917436467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887586,0.0015480877,0.0001561744,0.0038771012,0.00012463854,0.0031071699,0.00017738387,0.00019799026,0.0020528466],"genre_scores_gemma":[0.99550337,0.0005514378,0.00059939665,0.00040286203,0.000114532464,0.0015639169,0.000101563724,0.00015652829,0.0010064145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99323076,0.00043723956,0.0007791134,0.0013108542,0.00232921,0.0019128221],"domain_scores_gemma":[0.9963561,0.00032727423,0.00014215164,0.0008750661,0.001634422,0.000664946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009085022,0.0005740778,0.00093254267,0.0013306573,0.00032590996,0.00015861106,0.00051284936,0.00023016901,0.0006062965],"category_scores_gemma":[0.00018061089,0.00043657736,0.00010860353,0.004287085,0.000737045,0.00044789675,0.000213108,0.0021934344,0.00004344228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021751733,0.0017561398,0.03662246,0.0029611844,0.0004987576,0.003862614,0.0044185035,0.0030601863,0.8870728,0.0007385253,0.016024712,0.021232398],"study_design_scores_gemma":[0.008084276,0.0015083546,0.008951085,0.006018898,0.00003648294,0.000026975602,0.0013689763,0.000883323,0.971148,0.00034280494,0.0009904456,0.00064034644],"about_ca_topic_score_codex":0.013421613,"about_ca_topic_score_gemma":0.0023656015,"teacher_disagreement_score":0.08407525,"about_ca_system_score_codex":0.0019140177,"about_ca_system_score_gemma":0.0029097786,"threshold_uncertainty_score":0.9998086},"labels":[],"label_agreement":null},{"id":"W4409630493","doi":"10.1158/1538-7445.am2025-7442","title":"Abstract 7442: Transforming breast cancer treatment decisions: AI tools improve Ki67 risk assessments with 90 pathologists","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Metropolitan University","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cancer; Risk assessment; Internal medicine; Gynecology; Computer science","score_opus":0.06110342346838599,"score_gpt":0.4816820623252491,"score_spread":0.42057863885686314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97282875,0.002582128,0.0023427836,0.015812298,0.00036228015,0.0013034487,0.00023382896,0.00007907865,0.004455431],"genre_scores_gemma":[0.9859195,0.008551639,0.0006587976,0.00070492795,0.0002929489,0.0008248042,0.000026845064,0.00004271105,0.002977854],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973358,0.00013279975,0.00033885444,0.00061102095,0.0008210742,0.0007604744],"domain_scores_gemma":[0.99827087,0.00047176474,0.00007154777,0.0004777518,0.0003911174,0.00031692613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011224226,0.00023928564,0.0004423889,0.00032196258,0.00039163005,0.00015412834,0.00023937458,0.00013075535,0.00047541474],"category_scores_gemma":[0.0003234548,0.00015577234,0.000113302434,0.00060043257,0.000331846,0.00018322324,0.00005909591,0.0013924399,0.000016368069],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092313375,0.0002668328,0.059404254,0.00012343953,0.0002934723,0.00028635404,0.0002453887,0.00021448635,0.012765461,0.00007879785,0.0017382381,0.92366016],"study_design_scores_gemma":[0.019027462,0.002065393,0.8505556,0.0072464794,0.0007192226,0.00018062424,0.0016210243,0.006614749,0.015421614,0.0009939229,0.09468768,0.0008662406],"about_ca_topic_score_codex":0.0053788093,"about_ca_topic_score_gemma":0.00033785825,"teacher_disagreement_score":0.9227939,"about_ca_system_score_codex":0.001241005,"about_ca_system_score_gemma":0.0018295755,"threshold_uncertainty_score":0.81311864},"labels":[],"label_agreement":null},{"id":"W4409630494","doi":"10.1158/1538-7445.am2025-7433","title":"Abstract 7433: Predicting overall survival (OS) differences using longitudinal AI-driven imaging-based prognostication (IPRO) in patients with advanced non-small cell lung cancer (aNSCLC)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lung cancer; Medicine; Internal medicine; Cancer; Lung; Oncology","score_opus":0.026888659920506756,"score_gpt":0.3791821962755002,"score_spread":0.35229353635499344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242455,0.0008718955,0.0023954723,0.0018431955,0.00029008425,0.0014316723,0.000019124749,0.00005005356,0.0006739281],"genre_scores_gemma":[0.9981349,0.00009142893,0.0008921195,0.00021013801,0.00016583163,0.00029935053,0.000040931005,0.000046508478,0.00011879767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970817,0.00012896795,0.00040242836,0.00068323687,0.0009081783,0.0007955067],"domain_scores_gemma":[0.9983535,0.0003322245,0.00012815026,0.00033612523,0.0006344505,0.00021558207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072580006,0.00024814266,0.00041825883,0.0004851271,0.00024890088,0.00010830228,0.00028317203,0.0000850856,0.00010954313],"category_scores_gemma":[0.00033812015,0.00020409057,0.000060087998,0.00070834695,0.00025479376,0.00017652538,0.00009868957,0.0014390626,0.0000016468455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006264275,0.00028264592,0.98020846,0.0008989689,0.000051375253,0.0000270226,0.00020753138,0.0063985228,0.0037180595,0.000011634037,0.00011168602,0.007457684],"study_design_scores_gemma":[0.004290543,0.00009892881,0.8345389,0.0029825296,0.00006636673,3.5689584e-7,0.00006144671,0.15692976,0.0007886817,0.000013524313,0.000061873994,0.00016708653],"about_ca_topic_score_codex":0.0035875791,"about_ca_topic_score_gemma":0.00029293803,"teacher_disagreement_score":0.15053123,"about_ca_system_score_codex":0.0007943319,"about_ca_system_score_gemma":0.0015721902,"threshold_uncertainty_score":0.8322572},"labels":[],"label_agreement":null},{"id":"W4409630653","doi":"10.1158/1538-7445.am2025-4186","title":"Abstract 4186: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Computational biology; Cancer research; Oncology; Biology","score_opus":0.2575320059382619,"score_gpt":0.5134667614376511,"score_spread":0.2559347554993892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98157334,0.0012023655,0.012885456,0.00160039,0.00026048566,0.0015783589,0.00024241798,0.00001540784,0.00064179994],"genre_scores_gemma":[0.99796104,0.00020285831,0.00068340177,0.000056192475,0.00029371493,0.00039966,0.000013023641,0.000023697658,0.000366429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982127,0.000050970815,0.0005331636,0.00035371428,0.00046080136,0.00038867528],"domain_scores_gemma":[0.99813974,0.00068727095,0.00013923156,0.0003003934,0.0006611709,0.000072192925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005551229,0.00014622814,0.0004492967,0.00045920492,0.000100257035,0.00001765564,0.000114321505,0.00009127779,0.000053026815],"category_scores_gemma":[0.0002395715,0.00012820656,0.00016826384,0.000901772,0.00045760814,0.000107789114,0.00002884611,0.0001456764,9.703984e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003080806,0.00094630156,0.001255855,0.00048974383,0.00021690705,0.0000039318666,0.00071958074,0.00059251115,0.96306896,0.0057423697,0.00065955747,0.023223503],"study_design_scores_gemma":[0.0010640181,0.0007948724,0.0012065948,0.00094470213,0.000027597609,0.0000018322634,0.0006895189,0.00047792948,0.99090445,0.0031482752,0.0006487773,0.000091433445],"about_ca_topic_score_codex":0.0012763175,"about_ca_topic_score_gemma":0.00013095049,"teacher_disagreement_score":0.027835516,"about_ca_system_score_codex":0.0012023568,"about_ca_system_score_gemma":0.0018434013,"threshold_uncertainty_score":0.5228112},"labels":[],"label_agreement":null},{"id":"W4409630656","doi":"10.1158/1538-7445.am2025-4623","title":"Abstract 4623: The relationship of KRAS mutation and clinical outcomes in patients treated with consolidation durvalumab for locally advanced non-small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Durvalumab; Medicine; Lung cancer; Oncology; Internal medicine; KRAS; Cancer; Immunotherapy","score_opus":0.059412391343784274,"score_gpt":0.4702794653159846,"score_spread":0.4108670739722003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467516,0.00048048128,0.00015415784,0.0010043685,0.000070423936,0.0027961773,0.00007557886,0.000010200631,0.0007334568],"genre_scores_gemma":[0.99694717,0.00020322487,0.00021188974,0.00008695711,0.000020151374,0.001083832,0.00008496295,0.000016243395,0.0013455768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987819,0.00008140697,0.00038319323,0.00027554506,0.00025273563,0.00022521403],"domain_scores_gemma":[0.997844,0.0011147604,0.0001123019,0.00020543959,0.00066189666,0.00006159177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043918283,0.00010774674,0.00025944036,0.00019758282,0.00014561905,0.000020129564,0.00006991047,0.000082621926,0.000029247269],"category_scores_gemma":[0.000265629,0.00006887665,0.000048215974,0.0004245153,0.00017028378,0.00008537282,0.000020790849,0.00025260454,9.0721795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010351905,0.00027846615,0.98677164,0.00029359013,0.0001735415,0.0000022433956,0.00037909922,0.00017224772,0.000063941865,0.0000997774,0.00025952922,0.010470717],"study_design_scores_gemma":[0.009665919,0.0003756559,0.98767185,0.0005291275,0.00020202348,1.7278286e-7,0.00030523603,0.00027022735,0.0007613957,0.000070213704,0.00008585825,0.00006231241],"about_ca_topic_score_codex":0.0015113393,"about_ca_topic_score_gemma":0.0020207362,"teacher_disagreement_score":0.010408404,"about_ca_system_score_codex":0.00038776133,"about_ca_system_score_gemma":0.0010750392,"threshold_uncertainty_score":0.28087083},"labels":[],"label_agreement":null},{"id":"W4409630666","doi":"10.1158/1538-7445.am2025-1269","title":"Abstract 1269: Development of humanized PDX mouse model for high grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Serous ovarian cancer; Ovarian cancer; Serous fluid; Cancer; Medicine; Cancer research; Internal medicine; Oncology","score_opus":0.08888913685801408,"score_gpt":0.42995419150226427,"score_spread":0.3410650546442502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301165,0.0024066896,0.0023193078,0.00041432906,0.00009281175,0.0009865426,0.00037123752,0.0000125420465,0.00038487962],"genre_scores_gemma":[0.98427606,0.0009120007,0.0014191841,0.000066693756,0.0001102312,0.0019856067,0.00015705221,0.00003277597,0.011040391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981677,0.000044244898,0.00028005688,0.00048532416,0.0003983321,0.00062437507],"domain_scores_gemma":[0.99888295,0.000031958356,0.000054266486,0.00040818343,0.0004879686,0.00013467271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004267455,0.00016232161,0.00022008856,0.0001701695,0.00026748586,0.000038332422,0.00039392104,0.00013658708,0.00009160853],"category_scores_gemma":[0.00006286508,0.00015071689,0.0000816571,0.0002236991,0.0001445027,0.000006634608,0.00021652844,0.00018712257,0.0000037416144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011713996,0.0002563471,0.00074406335,0.00033712064,0.00049966446,0.0000020374448,0.00019412076,0.00056760584,0.9657033,0.0004988922,0.010529982,0.019495452],"study_design_scores_gemma":[0.00284719,0.00009947894,0.0014705368,0.000081398655,0.000014913993,1.9830478e-7,0.000047143378,0.0002769272,0.98398966,0.0005884297,0.010424966,0.00015918714],"about_ca_topic_score_codex":0.002835184,"about_ca_topic_score_gemma":0.00825343,"teacher_disagreement_score":0.019336265,"about_ca_system_score_codex":0.0002992661,"about_ca_system_score_gemma":0.0023066897,"threshold_uncertainty_score":0.61460567},"labels":[],"label_agreement":null},{"id":"W4409630700","doi":"10.1158/1538-7445.am2025-2404","title":"Abstract 2404: Change in expression of microRNAs following limb amputation in canine osteosarcoma patients predicts survival time after chemotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Guelph","funders":"","keywords":"Osteosarcoma; Amputation; Chemotherapy; Medicine; microRNA; Oncology; Internal medicine; Cancer research; Pathology; Surgery; Biology; Gene","score_opus":0.05618058775280763,"score_gpt":0.409940394663065,"score_spread":0.3537598069102573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936612,0.001436772,0.0000024002184,0.00077836425,0.00013889783,0.0017685249,0.00002007524,0.000014541365,0.0021792229],"genre_scores_gemma":[0.997463,0.00026215354,0.000050007086,0.00007711014,0.00008950063,0.00055560755,0.000044085275,0.000033271575,0.0014252523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684584,0.00027506013,0.0004771192,0.00045272495,0.0012566475,0.00069260533],"domain_scores_gemma":[0.9987437,0.00034482233,0.000058197278,0.0003475446,0.00034968357,0.00015606266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016598499,0.00016131949,0.00042606,0.0010351813,0.000043309377,0.000023303546,0.00022986528,0.00017870715,0.000638797],"category_scores_gemma":[0.00033780397,0.00014502519,0.00008486711,0.0013830648,0.00010119226,0.0001488565,0.00017059501,0.0006819902,0.00002922814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026008873,0.00043740103,0.7234642,0.00067067164,0.00002450641,0.00011298072,0.0012180399,0.0000060330467,0.2529774,0.0000024945628,0.00034623928,0.018139122],"study_design_scores_gemma":[0.004273717,0.00027935352,0.8917807,0.0023745245,0.000004344682,2.702805e-7,0.00007947068,0.00013656142,0.10052694,0.000029398,0.0004207794,0.00009398367],"about_ca_topic_score_codex":0.005602119,"about_ca_topic_score_gemma":0.0014357849,"teacher_disagreement_score":0.16831644,"about_ca_system_score_codex":0.0007478255,"about_ca_system_score_gemma":0.0005018096,"threshold_uncertainty_score":0.84687656},"labels":[],"label_agreement":null},{"id":"W4409630718","doi":"10.1158/1538-7445.am2025-5932","title":"Abstract 5932: Molecular determinants of 10-second diagnosis of brain cancer types with laser mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Mass spectrometry; Cancer; Medicine; Oncology; Internal medicine; Chemistry; Chromatography","score_opus":0.023730336790710422,"score_gpt":0.36772350408352616,"score_spread":0.34399316729281576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827587,0.0126384,0.00003088531,0.00035121033,0.00008419325,0.00023276034,0.00016024857,0.000003326501,0.003740294],"genre_scores_gemma":[0.9915668,0.003932273,0.00021675912,0.00007107345,0.00006050428,0.00020632356,0.00000857106,0.000020376008,0.003917334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863976,0.00006493095,0.00025197444,0.00037489046,0.00029214384,0.00037629402],"domain_scores_gemma":[0.99897844,0.000079687845,0.000102184094,0.00039591486,0.00038402982,0.000059769533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042373087,0.00014595057,0.00033156786,0.00026517463,0.000061327846,0.0000136213475,0.00030767635,0.00010678629,0.00091974676],"category_scores_gemma":[0.00018201857,0.00012088693,0.00008233608,0.00058928155,0.0002769147,0.0000045364663,0.00013108774,0.00016089984,0.0000021907724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026628035,0.00006935254,0.045589734,0.00028886882,0.00030788794,0.0000075297253,0.0000157447,0.000025260983,0.94441485,0.00012276408,0.0068431995,0.0020485064],"study_design_scores_gemma":[0.00049299863,0.0002365501,0.025925584,0.00010702863,0.000024378434,4.1274845e-7,0.000069571586,0.0000020145899,0.95956296,0.00016482957,0.013298627,0.00011502278],"about_ca_topic_score_codex":0.0003372424,"about_ca_topic_score_gemma":0.0010375989,"teacher_disagreement_score":0.01966415,"about_ca_system_score_codex":0.000044610668,"about_ca_system_score_gemma":0.00034716417,"threshold_uncertainty_score":0.99999356},"labels":[],"label_agreement":null},{"id":"W4409630861","doi":"10.1158/1538-7445.am2025-5354","title":"Abstract 5354: Single-cell sequencing resolves prevalence of PD-L1/2-expressing tumor-associated endothelial cells in human solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Solid tumor; Cancer research; Tumor cells; Cancer; Medicine; Biology; Internal medicine","score_opus":0.05469945901623046,"score_gpt":0.36947485074947817,"score_spread":0.3147753917332477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409630861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914024,0.0044725174,0.000075086136,0.000039702896,0.00012307464,0.00032584765,0.0001096728,0.0000104501405,0.0034412527],"genre_scores_gemma":[0.996143,0.0006132601,0.00011022301,0.0000638366,0.00015533691,0.00009913035,0.000013410489,0.000031396892,0.0027703955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978146,0.00022377494,0.00044377072,0.0005341227,0.0003786442,0.0006050952],"domain_scores_gemma":[0.9989881,0.00008528971,0.00014886507,0.00041069844,0.00029154553,0.00007549917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010742294,0.00017755265,0.00026695326,0.00021580592,0.00017298575,0.00004420315,0.0004779894,0.00015639621,0.00010797827],"category_scores_gemma":[0.00013857531,0.00017924621,0.00011630642,0.00036280887,0.00029279845,0.000009996374,0.00024122836,0.0002912691,0.000002907853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014004043,0.00012142151,0.004188109,0.0003807456,0.00002822422,0.000012491143,0.00012700772,0.0009317782,0.9921612,0.000012023089,0.001516681,0.00038023584],"study_design_scores_gemma":[0.0005949335,0.00015382138,0.00420079,0.0007324947,0.0000096676995,5.043658e-7,0.00017840555,0.000042233674,0.992885,0.00007337019,0.0009642122,0.00016456176],"about_ca_topic_score_codex":0.00070943445,"about_ca_topic_score_gemma":0.00017294679,"teacher_disagreement_score":0.0047406144,"about_ca_system_score_codex":0.0003249961,"about_ca_system_score_gemma":0.00079939753,"threshold_uncertainty_score":0.7309448},"labels":[],"label_agreement":null},{"id":"W4409631137","doi":"10.1158/1538-7445.am2025-4023","title":"Abstract 4023: ACCESS: Advancing childhood cancer experience, science and survivorship in Canada","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Survivorship curve; Childhood cancer; Cancer; Cancer survivorship; Medicine; Gerontology; Oncology; Internal medicine","score_opus":0.08477673761480406,"score_gpt":0.46292972279095573,"score_spread":0.3781529851761517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97376215,0.007784093,0.0000034408502,0.0116559975,0.000694178,0.0008648587,0.000032359116,0.000035783214,0.0051671453],"genre_scores_gemma":[0.99404836,0.002111686,0.000032736418,0.0026652624,0.000228398,0.00051563745,0.0000028620186,0.000028783757,0.00036628344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945806,0.00014986671,0.0005536509,0.0009825722,0.0023707938,0.0013624856],"domain_scores_gemma":[0.99730027,0.00055833877,0.000085258485,0.00067207403,0.0008516397,0.00053239224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034557146,0.0002441795,0.00051935914,0.0008967888,0.00044455053,0.00018409376,0.0008336273,0.000082851635,0.00042111884],"category_scores_gemma":[0.0018963824,0.00023671812,0.00003662537,0.0041237264,0.00084209605,0.00057356287,0.00055543415,0.0010914392,0.000003151714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00026743082,0.00013622992,0.947555,0.0008447237,0.000050336475,0.00008766794,0.0044771135,0.0000723178,0.008002495,0.00027005357,0.0061059934,0.032130618],"study_design_scores_gemma":[0.0012259322,0.000030428553,0.9729665,0.0017461436,0.000009310883,0.000004168032,0.004337727,0.000044610257,0.014004599,0.00018018497,0.00521485,0.00023553922],"about_ca_topic_score_codex":0.9858034,"about_ca_topic_score_gemma":0.9923896,"teacher_disagreement_score":0.032818004,"about_ca_system_score_codex":0.005939793,"about_ca_system_score_gemma":0.038757797,"threshold_uncertainty_score":0.9978762},"labels":[],"label_agreement":null},{"id":"W4409631174","doi":"10.1158/1538-7445.am2025-5201","title":"Abstract 5201: Modeling human mammary epithelial lineages using patient-derived organoid cultures","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Biology; Epithelium; Cell biology; Cancer research; Genetics","score_opus":0.12220420847736661,"score_gpt":0.4552681284321467,"score_spread":0.3330639199547801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872752,0.0062511843,0.00074444886,0.0015630209,0.0003172546,0.0005388309,0.00004233749,0.00005951258,0.0032082452],"genre_scores_gemma":[0.99541044,0.0015817557,0.00080466934,0.000342733,0.00048327807,0.00007095104,0.000023172803,0.000033019096,0.0012499663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980385,0.000071759365,0.00031704915,0.0004358639,0.0005788833,0.0005579986],"domain_scores_gemma":[0.99872935,0.00004531278,0.00004440277,0.0004446954,0.0005523682,0.00018387722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041335612,0.00016836094,0.00032055378,0.00032126362,0.00038093465,0.0000869038,0.00020742205,0.000121431156,0.00052041403],"category_scores_gemma":[0.00009710241,0.00014069137,0.000119502045,0.0005384827,0.00012350736,0.00011554194,0.00020293462,0.00064683263,0.0000151878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018497283,0.00009044903,0.00019217357,0.0003231722,0.00011333878,0.000046328452,0.00039617662,0.0006758753,0.9731038,0.0001171957,0.0033817915,0.021374678],"study_design_scores_gemma":[0.00189299,0.00013725772,0.0006060747,0.00084874546,0.0000979877,0.000008017787,0.00076780963,0.0014222503,0.9667446,0.00039281233,0.026831198,0.00025025217],"about_ca_topic_score_codex":0.002924745,"about_ca_topic_score_gemma":0.0001350709,"teacher_disagreement_score":0.023449406,"about_ca_system_score_codex":0.000418707,"about_ca_system_score_gemma":0.0007899975,"threshold_uncertainty_score":0.5737227},"labels":[],"label_agreement":null},{"id":"W4409631188","doi":"10.1158/1538-7445.am2025-5639","title":"Abstract 5639: A potent aminosteroid (RM-581) that inhibits orally in mice the tumor growth in an orthotopic xenograft pancreatic cancer model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pancreatic cancer; Medicine; Cancer; Pharmacology; Cancer research; Internal medicine","score_opus":0.05733499535532268,"score_gpt":0.39468728680110765,"score_spread":0.337352291445785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895201,0.0070060263,0.000014590621,0.0012777246,0.000062964726,0.0010793052,0.00008114625,0.00000981765,0.00094834657],"genre_scores_gemma":[0.9930304,0.003739336,0.000029272293,0.00036819573,0.00008720165,0.0017470504,0.000051689618,0.000030789677,0.00091603276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973388,0.00024499642,0.00028604936,0.0006863667,0.00052586326,0.00091794325],"domain_scores_gemma":[0.999005,0.000049003687,0.000048886955,0.0004911207,0.00023669779,0.00016926508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006399853,0.00022973173,0.00025142374,0.0003142816,0.00016210921,0.000117723815,0.00060354965,0.00012481201,0.000054058208],"category_scores_gemma":[0.00008090135,0.00017551883,0.00007882088,0.0006579733,0.00017013322,0.00002478101,0.00032810375,0.00056841166,0.0000074283435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018375326,0.0006528314,0.34266114,0.00043987017,0.00019202141,0.0001800631,0.00057617034,0.0017088959,0.63139486,0.00014248352,0.0021134824,0.018100623],"study_design_scores_gemma":[0.004673668,0.00048369897,0.3559593,0.0006596202,0.000026593363,0.000006741218,0.00054412324,0.001125668,0.6335345,0.0011430469,0.0013678017,0.0004752727],"about_ca_topic_score_codex":0.017904632,"about_ca_topic_score_gemma":0.08519395,"teacher_disagreement_score":0.067289315,"about_ca_system_score_codex":0.000437907,"about_ca_system_score_gemma":0.001303792,"threshold_uncertainty_score":0.98863524},"labels":[],"label_agreement":null},{"id":"W4409631217","doi":"10.1158/1538-7445.am2025-5348","title":"Abstract 5348: Gene alterations in breast tumors reveal significant association with patient and tumor characteristics","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Breast tumor; Association (psychology); Oncology; Pathology; Internal medicine; Cancer; Cancer research; Psychology","score_opus":0.014230942890360185,"score_gpt":0.3057656391834872,"score_spread":0.291534696293127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752575,0.00038049583,0.0000271866,0.0010001033,0.00008138199,0.00027745334,0.00028285655,0.0000034481961,0.00042130036],"genre_scores_gemma":[0.9983778,0.00058631966,0.00007282777,0.00023799784,0.00014654284,0.00016277925,0.000093160204,0.000012353401,0.00031023275],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999003,0.000047785958,0.00018826335,0.00028985014,0.00018343815,0.000287696],"domain_scores_gemma":[0.9993801,0.000059930262,0.000059350055,0.00018056705,0.00024952198,0.00007053628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031538188,0.00009073265,0.00011920558,0.00010002045,0.00010411446,0.00007419862,0.00008915774,0.000060380313,0.000015113135],"category_scores_gemma":[0.00012083672,0.0000859454,0.000017652756,0.00018581635,0.0000617808,0.000003963755,0.00008682571,0.00019037629,0.0000021740825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040516534,0.0001252125,0.19900046,0.000071628194,0.000053011943,0.00002982703,0.00013567312,0.00013210355,0.7871182,0.00017194504,0.006532028,0.0062247263],"study_design_scores_gemma":[0.0010585049,0.00028524888,0.76982814,0.00021892255,0.000015664535,0.00000763581,0.0002271904,0.00007526266,0.21813725,0.00012859449,0.009737186,0.00028040473],"about_ca_topic_score_codex":0.0006022769,"about_ca_topic_score_gemma":0.00034118112,"teacher_disagreement_score":0.57082766,"about_ca_system_score_codex":0.00023283742,"about_ca_system_score_gemma":0.0005358378,"threshold_uncertainty_score":0.35047516},"labels":[],"label_agreement":null},{"id":"W4409631331","doi":"10.1158/1538-7445.am2025-5967","title":"Abstract 5967: Real-world outcomes of renal cell carcinoma and intracranial metastatic disease","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Renal cell carcinoma; Medicine; Disease; Internal medicine; Oncology; Cancer; Intensive care medicine","score_opus":0.06912516358414128,"score_gpt":0.4260845681837384,"score_spread":0.35695940459959713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917586,0.0026594324,0.000013632909,0.0034971593,0.00007176556,0.00057980645,0.00014079487,0.000011810832,0.003849718],"genre_scores_gemma":[0.9941494,0.00048048416,0.00029020314,0.00011705478,0.000047230405,0.00011397662,0.00002103455,0.00001383712,0.0047667865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985929,0.00009626825,0.000249929,0.0002847058,0.0004488147,0.00032739478],"domain_scores_gemma":[0.9988563,0.00032862992,0.000040764702,0.000338568,0.00017674928,0.0002589926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005252966,0.00012230598,0.0003464903,0.00032616858,0.0000888139,0.00002018523,0.000086086795,0.000018396975,0.00046376014],"category_scores_gemma":[0.00009662857,0.000089141526,0.00008696331,0.00040078067,0.00021971301,0.000040027473,0.00007980361,0.00026157504,0.000007885884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054738987,0.0015149184,0.9012163,0.003722811,0.00086020795,0.002103996,0.00031364395,0.000026219463,0.012381654,0.00401899,0.01254034,0.055826996],"study_design_scores_gemma":[0.0043852297,0.00015202012,0.9862058,0.00015046053,0.00026742218,0.0000016272941,0.000103995546,0.00003828705,0.0061445674,0.0006835985,0.0017918223,0.00007514022],"about_ca_topic_score_codex":0.0034300757,"about_ca_topic_score_gemma":0.00043334582,"teacher_disagreement_score":0.0849895,"about_ca_system_score_codex":0.00014792937,"about_ca_system_score_gemma":0.0006392219,"threshold_uncertainty_score":0.51852715},"labels":[],"label_agreement":null},{"id":"W4409631333","doi":"10.1158/1538-7445.am2025-2495","title":"Abstract 2495: Does single-cell gene expression reflect RNA abundance?","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gene expression; Biology; Computational biology; Gene; RNA; Genetics; Abundance (ecology); Cell; Ecology","score_opus":0.039552191462118476,"score_gpt":0.3831683048570671,"score_spread":0.34361611339494863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310948,0.016542025,0.008323339,0.0014955457,0.0009891259,0.0013313759,0.00010971564,0.00007877651,0.04003526],"genre_scores_gemma":[0.979813,0.003084152,0.0005993435,0.00022762145,0.0005097509,0.0004111547,0.00008059709,0.00007140602,0.015203005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665225,0.00025120395,0.0003187079,0.00096166425,0.00080635893,0.0010097952],"domain_scores_gemma":[0.9980384,0.000059959137,0.00006491364,0.0010159811,0.00059332117,0.00022743765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009334469,0.00025325894,0.00023223595,0.0003479207,0.00038146638,0.00014447464,0.0007968471,0.00039757264,0.00044354136],"category_scores_gemma":[0.00023603569,0.00021469124,0.00015034949,0.00069420243,0.00026915068,0.00001070761,0.000630342,0.0008114376,0.00006107576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004278948,0.00013960179,0.000021752654,0.00013492955,0.00005142653,0.000023979184,0.000035290548,0.00013690315,0.97202206,0.000046377852,0.019299768,0.0076600164],"study_design_scores_gemma":[0.0008071131,0.0001898155,0.00006929993,0.00016050611,0.0000074343743,0.0000019280603,0.000069225345,0.000013130555,0.9021083,0.00037190053,0.09598575,0.00021560406],"about_ca_topic_score_codex":0.00033214872,"about_ca_topic_score_gemma":0.00029018702,"teacher_disagreement_score":0.07668598,"about_ca_system_score_codex":0.00035047598,"about_ca_system_score_gemma":0.0009702856,"threshold_uncertainty_score":0.8754855},"labels":[],"label_agreement":null},{"id":"W4409631335","doi":"10.1158/1538-7445.am2025-4771","title":"Abstract 4771: A novel immunotherapy for metastatic prostate cancer: A monoclonal antibody that can bind both STEAP1 and STEAP2","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Monoclonal antibody; Prostate cancer; Immunotherapy; Medicine; Cancer; Prostate; Cancer research; Antibody; Monoclonal; Immunology; Oncology; Internal medicine","score_opus":0.1181053066470001,"score_gpt":0.4765475969791997,"score_spread":0.3584422903321996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381425,0.04089523,0.00010315223,0.013777528,0.00024673346,0.0047680824,0.0011471211,0.00006051835,0.00085916126],"genre_scores_gemma":[0.93774927,0.03268364,0.0005112016,0.00044251804,0.00018281583,0.0042116004,0.0001828528,0.00009237643,0.023943722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966722,0.00008650702,0.0003565414,0.00077528146,0.00090299774,0.0012064517],"domain_scores_gemma":[0.99809134,0.00043735164,0.00008261454,0.00048006157,0.000583597,0.00032504607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011598935,0.0003246467,0.0006069902,0.0006701993,0.00050500303,0.00019172663,0.0002669377,0.00011339764,0.0002480885],"category_scores_gemma":[0.0000719738,0.0002463023,0.00014270301,0.00083147344,0.0005682988,0.0001591703,0.00013452498,0.0007116511,0.0000045911056],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016120207,0.0011140675,0.11170555,0.0046113757,0.0031733685,0.00016302892,0.003507972,0.000034203422,0.69384474,0.00088119507,0.009989833,0.15485443],"study_design_scores_gemma":[0.0776227,0.0034939672,0.39307266,0.006628825,0.00062236196,0.00005853703,0.006567017,0.0013416752,0.25288847,0.0024786217,0.2537009,0.001524235],"about_ca_topic_score_codex":0.005333124,"about_ca_topic_score_gemma":0.0007781585,"teacher_disagreement_score":0.4409563,"about_ca_system_score_codex":0.0008860363,"about_ca_system_score_gemma":0.0034533276,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W4409631375","doi":"10.1158/1538-7445.am2025-6475","title":"Abstract 6475: Characterizing peri-tumoral tertiary lymphoid structures in non-muscle invasive bladder cancer using a spatial whole transcriptomics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Peri; Medicine; Lymphatic system; Pathology; Transcriptome; Cancer; Internal medicine; Biology; Gene; Gene expression","score_opus":0.06672396543935512,"score_gpt":0.3857057745671302,"score_spread":0.3189818091277751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992039,0.0027624625,0.00009790602,0.0012630075,0.0004747401,0.0014055327,0.00020271107,0.00003923569,0.0017153708],"genre_scores_gemma":[0.99628204,0.0007089099,0.00021569066,0.00096600654,0.00055483956,0.00065250194,0.000064006985,0.00006964104,0.00048634608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970788,0.0001129539,0.0004544209,0.00074876164,0.0006630526,0.000942059],"domain_scores_gemma":[0.99893427,0.000067459456,0.00006956614,0.00044721577,0.00025381582,0.0002276488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003508388,0.0003343586,0.0005674847,0.0005837135,0.00025887115,0.0001152519,0.00029881584,0.00021502891,0.00048830645],"category_scores_gemma":[0.000044583478,0.00029939413,0.000148761,0.00076040893,0.00027528105,0.00024134947,0.00010829326,0.0008193082,0.000008241425],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011188671,0.00036537438,0.1199578,0.00090411835,0.00034490088,0.00015830198,0.0029321017,0.00018254759,0.84013444,0.000019376712,0.0007311358,0.033151045],"study_design_scores_gemma":[0.006907227,0.00014809392,0.8442613,0.0012682388,0.00016665617,0.000024113548,0.0013844712,0.0011888044,0.1420393,0.00019496583,0.0019879097,0.00042893342],"about_ca_topic_score_codex":0.029846186,"about_ca_topic_score_gemma":0.0021312104,"teacher_disagreement_score":0.7243035,"about_ca_system_score_codex":0.0016203707,"about_ca_system_score_gemma":0.0031151967,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4409631380","doi":"10.1158/1538-7445.am2025-4876","title":"Abstract 4876: Avidity engineered multispecific antibodies that are highly efficacious in immune cell stimulation in patient tissue and in mice: significantly improved tumor control and turning cold tumors hot","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Avidity; Immune system; Antibody; Stimulation; Co-stimulation; Medicine; Immunology; Cancer research; Cell; T cell; Biology; Internal medicine","score_opus":0.01785870181254681,"score_gpt":0.32153997352942504,"score_spread":0.30368127171687825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693544,0.011601986,0.00000913793,0.0001378403,0.000045771656,0.0011124024,0.00011088978,0.0000060888165,0.000040421713],"genre_scores_gemma":[0.99806297,0.0014463654,0.000024173953,0.000015338803,0.000025381325,0.00028806052,0.00004304406,0.000017931674,0.00007673275],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833465,0.00014955313,0.00027830957,0.0005141712,0.00020027092,0.0005230351],"domain_scores_gemma":[0.99942195,0.00012871053,0.000059985632,0.00019555859,0.000097035576,0.00009675756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041648868,0.00017502498,0.00027851167,0.0003592907,0.00008119559,0.000072740404,0.00012214913,0.000103238,0.000007075255],"category_scores_gemma":[0.000120484925,0.00017143272,0.000024533952,0.00029366044,0.00014177893,0.000014551067,0.000115696566,0.00042379362,0.0000010672945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012249965,0.00016015,0.08950603,0.00017058659,0.000019310395,0.000107030115,0.00015241235,0.0005858147,0.9058351,0.000001685052,0.000054289394,0.0021826173],"study_design_scores_gemma":[0.0041419347,0.00018004287,0.5025652,0.0002135134,0.0000031023058,0.000001098751,0.0002700533,0.0005320454,0.4917051,0.0000079875235,0.0002466305,0.00013331177],"about_ca_topic_score_codex":0.0050837197,"about_ca_topic_score_gemma":0.007986427,"teacher_disagreement_score":0.41412997,"about_ca_system_score_codex":0.00023208378,"about_ca_system_score_gemma":0.00021466358,"threshold_uncertainty_score":0.76850975},"labels":[],"label_agreement":null},{"id":"W4409631386","doi":"10.1158/1538-7445.am2025-6326","title":"Abstract 6326: A comparative study of C3H and C57Bl/6 murine models of radiation-induced fibrosis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fibrosis; C57BL/6; Cancer research; Pathology; Immunology","score_opus":0.12307579269873116,"score_gpt":0.47193878624241625,"score_spread":0.3488629935436851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440455,0.0014739394,0.000011796601,0.0005773168,0.00004403201,0.0012311031,0.000018312856,0.000011937609,0.0022269958],"genre_scores_gemma":[0.999233,0.00015231795,0.000044786866,0.000019609432,0.000042868804,0.00014132711,0.0000053152903,0.00000880929,0.00035197294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986397,0.0001331014,0.0002882118,0.00023176512,0.0005215707,0.00018565646],"domain_scores_gemma":[0.9985189,0.00050714787,0.000083030274,0.00030176848,0.0005029864,0.000086173226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000599762,0.000089464505,0.0003747042,0.0004029537,0.00006218962,0.000010024854,0.00010579743,0.00006118128,0.00007106188],"category_scores_gemma":[0.00015753448,0.000079402955,0.000033371078,0.0006194272,0.00010385418,0.000101471545,0.000060460054,0.00028644572,0.0000019014909],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036204213,0.0032944726,0.19608608,0.0036765567,0.0014624159,0.000024281873,0.026824692,0.0040209396,0.69858736,0.0020642532,0.014242641,0.046095893],"study_design_scores_gemma":[0.00646286,0.0021983802,0.7493941,0.0005279698,0.00008189658,9.2806505e-7,0.0040794336,0.0024751152,0.23407629,0.000384166,0.00020153826,0.0001173374],"about_ca_topic_score_codex":0.0014614707,"about_ca_topic_score_gemma":0.0001614604,"teacher_disagreement_score":0.553308,"about_ca_system_score_codex":0.00011776536,"about_ca_system_score_gemma":0.00037103635,"threshold_uncertainty_score":0.32379586},"labels":[],"label_agreement":null},{"id":"W4409631461","doi":"10.1158/1538-7445.am2025-2317","title":"Abstract 2317: Historical trends in age of menarche and implications for breast cancer risk in the US population","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Menarche; Breast cancer; Medicine; Cancer; Demography; Population; Gynecology; Oncology; Internal medicine; Environmental health","score_opus":0.11787977937258698,"score_gpt":0.47164908341716233,"score_spread":0.35376930404457535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9565124,0.004621281,0.000007662362,0.03689773,0.0000568913,0.0006624962,0.00026093086,0.000004746388,0.0009758592],"genre_scores_gemma":[0.99532586,0.0024594916,0.00004089294,0.00008071698,0.000068236564,0.0016558315,0.000030913816,0.00000735655,0.0003306877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991091,0.00007129356,0.0002083049,0.0002240553,0.00017143931,0.00021583955],"domain_scores_gemma":[0.99932986,0.000271277,0.000037419988,0.0002278178,0.00009177842,0.00004184333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000593216,0.00006741119,0.00018819078,0.00036953553,0.00006788687,0.0000120541345,0.00008338773,0.000055171495,0.00006619186],"category_scores_gemma":[0.000042880132,0.00004673369,0.000040573937,0.0007488121,0.000055905726,0.00003252349,0.000022823728,0.0002361512,2.3114617e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022836556,0.00024217517,0.7877025,0.000101126316,0.00003522752,0.000003505714,0.00034105213,0.00002797872,0.0004467798,0.00089899293,0.0035003817,0.20647193],"study_design_scores_gemma":[0.0015090203,0.000058391295,0.99201405,0.00016478774,0.000032374144,0.0000011614047,0.00004654838,0.000022074084,0.00007439742,0.00087965553,0.0051628123,0.000034738085],"about_ca_topic_score_codex":0.04341818,"about_ca_topic_score_gemma":0.01682486,"teacher_disagreement_score":0.20643719,"about_ca_system_score_codex":0.001588354,"about_ca_system_score_gemma":0.00019332548,"threshold_uncertainty_score":0.9629518},"labels":[],"label_agreement":null},{"id":"W4409631478","doi":"10.1158/1538-7445.am2025-4298","title":"Abstract 4298: Investigating the potential of EO3001 as a therapeutic agent for clear cell ovarian cancers harboring ARID1A mutations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ARID1A; Cancer research; Ovarian cancer; Medicine; Oncology; Biology; Mutation; Internal medicine; Cancer; Gene; Genetics","score_opus":0.0627061197927309,"score_gpt":0.4090974168282487,"score_spread":0.3463912970355178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105394,0.0037619804,0.000396936,0.0018825075,0.00017462621,0.0009766932,0.000058003545,0.000010192654,0.0016851056],"genre_scores_gemma":[0.99650925,0.00070347096,0.00011721955,0.00029904352,0.00021019902,0.00061164587,0.000031594318,0.000034608336,0.0014829872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981631,0.00019866192,0.00025803832,0.0003960669,0.00042905085,0.0005550642],"domain_scores_gemma":[0.99876267,0.000117485055,0.00007170891,0.00050990615,0.00044907475,0.00008916306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012384441,0.00013471182,0.0001420466,0.00014419667,0.00043609744,0.00007075713,0.0005697967,0.00011651084,0.00009973564],"category_scores_gemma":[0.0001537354,0.00011266007,0.0001202876,0.0004324226,0.00042236905,0.000006266883,0.00015454677,0.0003677221,0.00000717552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010252909,0.000038391834,0.00013566615,0.00016247333,0.00014816818,0.0000014784455,0.00016544813,0.0032595647,0.9830552,0.00017275024,0.0010335889,0.01080199],"study_design_scores_gemma":[0.0009445483,0.0007479228,0.0009637795,0.00007727534,0.000022187227,6.0943603e-7,0.0006637641,0.0005022552,0.9861714,0.0010849887,0.008695808,0.00012542764],"about_ca_topic_score_codex":0.0013778375,"about_ca_topic_score_gemma":0.00056301616,"teacher_disagreement_score":0.010676562,"about_ca_system_score_codex":0.0001717891,"about_ca_system_score_gemma":0.002126624,"threshold_uncertainty_score":0.45941445},"labels":[],"label_agreement":null},{"id":"W4409631479","doi":"10.1158/1538-7445.am2025-5431","title":"Abstract 5431: The mitochondrial protease, YME1L regulates interferon signaling and is essential for AML growth and differentiation","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Interferon; Biology; Cell biology; Protease; Cancer research; Immunology; Enzyme; Biochemistry","score_opus":0.03008880398819404,"score_gpt":0.35137233106740723,"score_spread":0.3212835270792132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875903,0.007641732,0.0002327034,0.0029022126,0.0005536729,0.0008952387,0.00003912233,0.000018313822,0.00012669804],"genre_scores_gemma":[0.99494994,0.00043859528,0.000013769756,0.00008710931,0.00008624494,0.00034224242,0.000021729304,0.00001127286,0.004049094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890375,0.00022905327,0.00019132733,0.00028884623,0.000050169594,0.0003368772],"domain_scores_gemma":[0.99912477,0.00048719833,0.000042755008,0.00016253167,0.00016662155,0.000016137728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032459808,0.00011673416,0.00016278205,0.00015641304,0.00047802564,0.00010078393,0.00017806537,0.00015169417,0.00025091541],"category_scores_gemma":[0.000193513,0.00008092807,0.000048503196,0.00010812222,0.00042366906,0.000076811586,0.00015527739,0.0003683987,0.0000082993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030208714,0.000029483837,0.00019736556,0.00014139534,0.00015121428,3.197314e-7,0.0006678962,2.0370788e-7,0.9834411,0.00081684627,0.006034148,0.0054991343],"study_design_scores_gemma":[0.0012755317,0.0001963843,0.004760958,0.00020071633,0.000026055724,0.0000026896485,0.00036022443,0.000009265299,0.98655903,0.0011065061,0.005415753,0.00008686847],"about_ca_topic_score_codex":0.00036532,"about_ca_topic_score_gemma":0.000036758072,"teacher_disagreement_score":0.0073596365,"about_ca_system_score_codex":0.000041560914,"about_ca_system_score_gemma":0.000112285925,"threshold_uncertainty_score":0.3676635},"labels":[],"label_agreement":null},{"id":"W4409631508","doi":"10.1158/1538-7445.am2025-6437","title":"Abstract 6437: Mutational patterns in normal tissue hold the key to understanding the cellular origins of cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cancer; Biology; Key (lock); Computational biology; Genetics; Ecology","score_opus":0.06333678297923154,"score_gpt":0.39450413988556615,"score_spread":0.3311673569063346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900603,0.0024734421,0.00095574337,0.004622059,0.00024166332,0.00036889082,0.00017308598,0.0000018140079,0.0011029665],"genre_scores_gemma":[0.9977036,0.0009889276,0.000011130715,0.0003922939,0.00023335325,0.00019725882,0.00002038827,0.000011249229,0.0004418161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990215,0.000049969472,0.00017202256,0.00022226099,0.00024046811,0.0002938169],"domain_scores_gemma":[0.9993923,0.00013261082,0.000032519172,0.00028640233,0.00011037326,0.000045825305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004824241,0.000082437626,0.000089955705,0.00008715153,0.00013768072,0.000041283536,0.00036637255,0.00006396523,0.0001266827],"category_scores_gemma":[0.000074054435,0.000057902038,0.000035682144,0.00030911475,0.00012581216,0.0000027908682,0.00017904234,0.00021176609,0.0000033717986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002429708,0.000067843284,0.037642647,0.00011858026,0.00010521774,0.000011648013,0.00087969576,0.013059923,0.9170351,0.018161561,0.008742427,0.003932384],"study_design_scores_gemma":[0.0006751059,0.00010856631,0.055338707,0.00016519832,0.00001551064,5.954515e-7,0.0012908775,0.000090340494,0.8336223,0.001346146,0.10717212,0.00017457634],"about_ca_topic_score_codex":0.0072806603,"about_ca_topic_score_gemma":0.018891033,"teacher_disagreement_score":0.09842969,"about_ca_system_score_codex":0.00037507815,"about_ca_system_score_gemma":0.0007892492,"threshold_uncertainty_score":0.9993299},"labels":[],"label_agreement":null},{"id":"W4409631548","doi":"10.1158/1538-7445.am2025-5264","title":"Abstract 5264: Harnessing glioma-inhibitory macrophages for sustained control of glioblastoma progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Glioblastoma; Glioma; Medicine; Cancer research","score_opus":0.023684184993311968,"score_gpt":0.39092332958984904,"score_spread":0.36723914459653706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9185869,0.07234755,0.000749783,0.0013341857,0.0026387863,0.0020294427,0.00013017048,0.00009632819,0.0020868648],"genre_scores_gemma":[0.99296767,0.00015018026,0.00005517881,0.000046268964,0.000099153665,0.0007039942,0.000011906171,0.00003086629,0.0059347656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980041,0.00025233554,0.00041281196,0.00042144497,0.00012688943,0.0007824346],"domain_scores_gemma":[0.99763954,0.0009100955,0.00013568264,0.00042980336,0.0008599434,0.000024928877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012436402,0.00017841878,0.0003800026,0.00048044894,0.00042741065,0.00003324776,0.00046379803,0.00031848327,0.00058029906],"category_scores_gemma":[0.00038907907,0.00015707953,0.00013168753,0.00052672887,0.00085379987,0.000098093005,0.00016207893,0.00058066286,0.00003486398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029701616,0.00011602577,0.00033157677,0.0006657416,0.00018171113,0.0000102036865,0.00017504359,0.000013212068,0.93635267,0.00050719787,0.020064212,0.03861223],"study_design_scores_gemma":[0.003914815,0.00022237677,0.00095777423,0.0006230636,0.00002709517,0.0000030465933,0.00048542055,0.000008027058,0.95950896,0.00043331852,0.03368257,0.00013356323],"about_ca_topic_score_codex":0.00010432236,"about_ca_topic_score_gemma":0.000021871034,"teacher_disagreement_score":0.07438079,"about_ca_system_score_codex":0.00033416736,"about_ca_system_score_gemma":0.00090667745,"threshold_uncertainty_score":0.64055175},"labels":[],"label_agreement":null},{"id":"W4409631610","doi":"10.1158/1538-7445.am2025-7318","title":"Abstract 7318: ZW209, a DLL3 targeted trispecific T cell engager with integrated CD28 co-stimulation, demonstrates safety and potent preclinical efficacy in models of small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Medicine; Stimulation; Cancer; Cell; Cancer research; Co-stimulation; Pharmacology; Oncology; T cell; CD28; Biology; Internal medicine; Immunology; Immune system; Biochemistry","score_opus":0.090157316433527,"score_gpt":0.4251451087888187,"score_spread":0.33498779235529175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741634,0.013492493,0.00018155256,0.0014620249,0.00005626859,0.0016001079,0.0001663072,0.000026527448,0.008851305],"genre_scores_gemma":[0.98498887,0.007815509,0.00037130408,0.00006853987,0.000085131505,0.00015347375,0.00008926572,0.000034295877,0.006393586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966178,0.0003903553,0.00075848756,0.0006606577,0.0008175415,0.0007551634],"domain_scores_gemma":[0.99681646,0.0015338962,0.00010454961,0.0003522782,0.0008758978,0.0003169313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016236622,0.00027109453,0.00066752004,0.0006050132,0.00020782427,0.000048560618,0.0002638349,0.00023135002,0.00064275303],"category_scores_gemma":[0.0001625171,0.00019598805,0.000100346406,0.0011946742,0.00059519307,0.000099984514,0.00012188841,0.0018532408,0.0000061225896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053248327,0.003934781,0.64648384,0.0069267186,0.0007208266,0.00043382062,0.0027659948,0.035354484,0.20206362,0.00064843567,0.009812618,0.037606567],"study_design_scores_gemma":[0.015360059,0.0010200704,0.7678961,0.0035693375,0.00014770206,0.000007779281,0.0009989667,0.06570234,0.13788103,0.0002489621,0.006582504,0.00058514945],"about_ca_topic_score_codex":0.004778233,"about_ca_topic_score_gemma":0.0008611441,"teacher_disagreement_score":0.121412285,"about_ca_system_score_codex":0.00034941133,"about_ca_system_score_gemma":0.0021919606,"threshold_uncertainty_score":0.8051512},"labels":[],"label_agreement":null},{"id":"W4409631773","doi":"10.1158/1538-7445.am2025-6760","title":"Abstract 6760: Anticancer mechanisms of quercetin revealed via a systems biology approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Computational biology","score_opus":0.038339435882341656,"score_gpt":0.37987432585250397,"score_spread":0.3415348899701623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7708947,0.08225984,0.070482686,0.0010815824,0.020984774,0.0035681871,0.0005293852,0.00008284759,0.050115988],"genre_scores_gemma":[0.98741394,0.0036841137,0.00033985387,0.00011048497,0.0034619968,0.00046945852,0.000065392735,0.000028812683,0.004425926],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997988,0.0002332735,0.00036456235,0.0005785891,0.0002713183,0.0005642895],"domain_scores_gemma":[0.998672,0.000043147476,0.00009056681,0.0006210446,0.0004651752,0.000108037304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011868331,0.00017285287,0.000376159,0.00021347511,0.00011296365,0.000025478545,0.0004594146,0.0002878798,0.0000699007],"category_scores_gemma":[0.0001303469,0.00015725971,0.000117109455,0.0004251907,0.00032575143,0.0000042169845,0.00021184448,0.00030647073,0.000006006337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023426418,0.00007587761,0.0004441025,0.0003656471,0.000118045886,1.0377441e-7,0.000037574642,0.00006447354,0.96279454,0.006440413,0.025865428,0.003559543],"study_design_scores_gemma":[0.002014466,0.0002576586,0.005180929,0.000266327,0.000053297732,0.0000061277046,0.0004724977,0.00015280243,0.2943598,0.0023204016,0.69448084,0.00043483402],"about_ca_topic_score_codex":0.002266656,"about_ca_topic_score_gemma":0.00011495656,"teacher_disagreement_score":0.6686154,"about_ca_system_score_codex":0.00007873782,"about_ca_system_score_gemma":0.00067582703,"threshold_uncertainty_score":0.6412865},"labels":[],"label_agreement":null},{"id":"W4409631939","doi":"10.1158/1538-7445.am2025-7161","title":"Abstract 7161: HMGA2 predicts treatment outcome in pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancreatic cancer; Medicine; Internal medicine; Oncology; Cancer","score_opus":0.05745174032562029,"score_gpt":0.4264469484271801,"score_spread":0.36899520810155984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97137535,0.016223159,0.00044125406,0.001710045,0.00044418027,0.0015034709,0.00012419479,0.000031142565,0.008147215],"genre_scores_gemma":[0.976974,0.008084808,0.0000430895,0.00019028016,0.0002607958,0.002038021,0.000057660436,0.000048991395,0.012302321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970317,0.00020942076,0.00038548544,0.0007939108,0.00059259107,0.0009868754],"domain_scores_gemma":[0.99865246,0.00006207755,0.0000453891,0.0007525448,0.00029372185,0.00019379532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072959,0.0002513771,0.0003135675,0.0004649763,0.00016127249,0.00007287475,0.0004967798,0.00031256347,0.00052803295],"category_scores_gemma":[0.00021830403,0.00023319194,0.00012872275,0.000854697,0.00019532873,0.000007503766,0.00028341817,0.0005290523,0.00003973228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006111842,0.0002333017,0.012088301,0.00016905625,0.00026241643,0.000064625594,0.000092059585,0.0009917516,0.9472063,0.00021144125,0.00724118,0.030828383],"study_design_scores_gemma":[0.0031664635,0.0004449001,0.02515563,0.00035731177,0.000032786775,0.0000029996816,0.00016113328,0.00017541484,0.8748381,0.000268406,0.09504117,0.00035564433],"about_ca_topic_score_codex":0.005825018,"about_ca_topic_score_gemma":0.0057845362,"teacher_disagreement_score":0.08779999,"about_ca_system_score_codex":0.0010558047,"about_ca_system_score_gemma":0.0016532062,"threshold_uncertainty_score":0.95092916},"labels":[],"label_agreement":null},{"id":"W4409631950","doi":"10.1158/1538-7445.am2025-6501","title":"Abstract 6501: The SRG RAT supports in vivo human cell xenotransplantation through enhanced tumor microenvironment interactions","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Xenotransplantation; In vivo; Tumor microenvironment; Cancer research; Medicine; Transplantation; Immunology; Biology; Tumor cells; Internal medicine; Genetics","score_opus":0.02739486908423613,"score_gpt":0.398044785924575,"score_spread":0.3706499168403389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836404,0.001326837,0.00007671509,0.00064865476,0.00013048312,0.00060295593,0.00007071389,0.000005576556,0.008774032],"genre_scores_gemma":[0.99138564,0.0019789329,0.000018971446,0.00015524932,0.00009283145,0.00062697777,0.00009333982,0.000015335447,0.005632742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985571,0.000115466,0.00019485538,0.00039527495,0.0002714829,0.0004658212],"domain_scores_gemma":[0.9994395,0.00004024665,0.000034302317,0.0003673976,0.000060523806,0.000058053945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026066464,0.00012459405,0.000106640044,0.000088684996,0.00027399874,0.000056918332,0.00026476054,0.0000490327,0.0005961526],"category_scores_gemma":[0.00001366007,0.00009939687,0.00006370535,0.00021743953,0.00018008804,0.000012022199,0.000101867794,0.00032755887,0.000023927318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021065089,0.00016125261,0.0014339684,0.00005762516,0.000039288796,0.000022447277,0.00022426159,0.000067599,0.98810697,0.000023189825,0.008961854,0.0006909266],"study_design_scores_gemma":[0.00081058533,0.00009129906,0.0048451493,0.000068937086,0.000007279024,0.0000017013608,0.00024502975,0.0000012118414,0.95297426,0.00015582226,0.040716216,0.00008253509],"about_ca_topic_score_codex":0.0031126305,"about_ca_topic_score_gemma":0.0088857375,"teacher_disagreement_score":0.035132702,"about_ca_system_score_codex":0.00025326427,"about_ca_system_score_gemma":0.00026887676,"threshold_uncertainty_score":0.6527453},"labels":[],"label_agreement":null},{"id":"W4409631957","doi":"10.1158/1538-7445.am2025-6748","title":"Abstract 6748: Comparison of activities and identification of predictive genomic biomarkers of response to trastuzumab and the trastuzumab deruxtecan ADC using the OncoPanel® platform","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.1297112918120443,"score_gpt":0.4849850739072937,"score_spread":0.3552737820952494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913046,0.004444785,0.00021487095,0.0016310599,0.00007299913,0.0018671913,0.0001364975,0.000007981562,0.00032005273],"genre_scores_gemma":[0.9989168,0.00059242203,0.00006333114,0.000017891522,0.00003801256,0.00018064272,0.0000027563296,0.000021539825,0.00016658001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971403,0.00047184134,0.00066488964,0.0003438888,0.0009639463,0.00041512467],"domain_scores_gemma":[0.99625885,0.0024013652,0.00019847236,0.00054063735,0.00048739673,0.00011328601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055434518,0.0001441044,0.0005339642,0.00057352893,0.0002431889,0.000037417358,0.00033611432,0.00010009701,0.000039743994],"category_scores_gemma":[0.00081766915,0.00009463075,0.0000705792,0.000911766,0.002320636,0.000090465626,0.0002380018,0.0005448598,4.4039027e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03756976,0.00014980008,0.011840903,0.0011818535,0.0004748095,0.0000024987137,0.014101615,0.00018662625,0.8964888,0.00015317845,0.00048379516,0.037366387],"study_design_scores_gemma":[0.0039776727,0.00088446646,0.4184524,0.0012606387,0.0001505661,0.000009204721,0.03591531,0.0025810366,0.5358235,0.00031326542,0.0005139604,0.000117960546],"about_ca_topic_score_codex":0.0034199608,"about_ca_topic_score_gemma":0.00040910544,"teacher_disagreement_score":0.4066115,"about_ca_system_score_codex":0.0007552619,"about_ca_system_score_gemma":0.0019683437,"threshold_uncertainty_score":0.855048},"labels":[],"label_agreement":null},{"id":"W4409631974","doi":"10.1158/1538-7445.am2025-2171","title":"Abstract 2171: Amezalpat, a peroxisome proliferator-activated receptor alpha (PPARα) antagonist, inhibits suppressive macrophage development, activation and function","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre","funders":"","keywords":"Peroxisome proliferator-activated receptor; Peroxisome; Antagonist; Chemistry; Receptor; Alpha (finance); Function (biology); Peroxisome proliferator; Peroxisome proliferator-activated receptor alpha; Cell biology; Pharmacology; Endocrinology; Cancer research; Biology; Medicine; Biochemistry; Nuclear receptor; Transcription factor; Gene","score_opus":0.02680946258330607,"score_gpt":0.3400124083423511,"score_spread":0.313202945759045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566245,0.0013424471,0.00019501524,0.00045803536,0.00033554898,0.0009422009,0.00006636991,0.00006342766,0.0009345004],"genre_scores_gemma":[0.9951727,0.0009107452,0.0001554276,0.00025771823,0.00035803023,0.0008054442,0.0003665161,0.00006762426,0.0019058317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969691,0.00026339391,0.00043110223,0.0010133861,0.00051133725,0.0008116719],"domain_scores_gemma":[0.9984394,0.000064802625,0.00013984075,0.00044115642,0.00065840996,0.00025644564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060459017,0.00037572935,0.00030971578,0.00039396484,0.00066937273,0.00020893868,0.00031611018,0.00047798632,0.0002501167],"category_scores_gemma":[0.00031081444,0.00036447193,0.00006529016,0.00078335876,0.0003255985,0.00006067721,0.00035963,0.00077383604,0.000034638895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013696135,0.00014363661,0.0048505734,0.0001794548,0.00023037157,0.000002345405,0.0001681996,0.000010033573,0.97118115,0.00003293164,0.007592131,0.014239585],"study_design_scores_gemma":[0.0011440939,0.00017362174,0.0050630085,0.00018500998,0.000009248668,0.0000024022102,0.00022027652,0.0000056253616,0.9001831,0.000031424603,0.09266157,0.00032061618],"about_ca_topic_score_codex":0.00009261336,"about_ca_topic_score_gemma":0.000031246167,"teacher_disagreement_score":0.08506943,"about_ca_system_score_codex":0.00037134712,"about_ca_system_score_gemma":0.0012341853,"threshold_uncertainty_score":0.99988073},"labels":[],"label_agreement":null},{"id":"W4409632022","doi":"10.1158/1538-7445.am2025-1808","title":"Abstract 1808: Engineering lipid-polymer nanoparticles for siRNA delivery to breast cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Nanoparticle; Cancer; Cancer research; Medicine; Chemistry; Nanotechnology; Materials science; Internal medicine","score_opus":0.02951436296263805,"score_gpt":0.3558175480558279,"score_spread":0.32630318509318984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945333,0.0029565322,0.00014734876,0.001162263,0.00044587077,0.00033728496,0.00020990324,0.000012732017,0.00019474298],"genre_scores_gemma":[0.99418277,0.00092602446,0.00005295571,0.00042263532,0.00055243797,0.0005691997,0.000012696849,0.000023147926,0.0032581096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871415,0.000021211821,0.00016910302,0.00040269893,0.00016937993,0.000523441],"domain_scores_gemma":[0.9991705,0.00003877985,0.000019285111,0.00029499116,0.000344522,0.00013194745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002403364,0.00013311292,0.00013164515,0.00013293873,0.00011733334,0.00006190582,0.00032783105,0.0001085616,0.00012673208],"category_scores_gemma":[0.00003089515,0.0001290704,0.00008094886,0.00022773862,0.00004999244,0.0000070107953,0.00016741312,0.00013613755,0.000029607341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027391844,0.00003010027,0.0002684702,0.00007539895,0.000073111696,0.0000014268661,0.000033625984,0.0007692095,0.95670354,0.000026211272,0.029909408,0.011835585],"study_design_scores_gemma":[0.0002693311,0.000077947916,0.001897784,0.000118194046,0.000008838561,6.676149e-7,0.000057928337,0.000064086475,0.9656624,0.000007185396,0.03169323,0.00014236855],"about_ca_topic_score_codex":0.0006338812,"about_ca_topic_score_gemma":0.00025758642,"teacher_disagreement_score":0.011693217,"about_ca_system_score_codex":0.000077513694,"about_ca_system_score_gemma":0.0003319338,"threshold_uncertainty_score":0.5263338},"labels":[],"label_agreement":null},{"id":"W4409632034","doi":"10.1158/1538-7445.am2025-3542","title":"Abstract 3542: Nanofilament immunotherapy as an antigen-agnostic cancer vaccine","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Immunotherapy; Medicine; Cancer; Internal medicine","score_opus":0.039321451207831835,"score_gpt":0.40895516439915,"score_spread":0.36963371319131816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82546693,0.16776945,0.000015620146,0.0026107028,0.0014173924,0.00063430273,0.000045924386,0.00009520735,0.0019444705],"genre_scores_gemma":[0.92067456,0.047670033,0.000010765791,0.0011081166,0.00007184392,0.0006049582,0.000049873845,0.000046562902,0.029763306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702996,0.00066546944,0.00046485578,0.00060973165,0.00016031691,0.0010696389],"domain_scores_gemma":[0.9980621,0.00054975605,0.00008968967,0.00085801654,0.0003986591,0.00004178552],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001186312,0.0003040954,0.00043729256,0.0005483471,0.000838203,0.000095988,0.00086715486,0.00035067825,0.014800059],"category_scores_gemma":[0.00013435583,0.00026425655,0.00013701375,0.0007521183,0.00034881418,0.00028010018,0.00014345958,0.00093938597,0.00084448606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034622615,0.0003026651,0.0018619144,0.000042109652,0.0005508481,0.000012042681,0.00053007493,0.000013873103,0.8956062,0.001090882,0.010215242,0.086311854],"study_design_scores_gemma":[0.0021652947,0.00029128738,0.049768377,0.0002766749,0.000010482859,0.0000067538153,0.00026688326,8.295982e-7,0.57460344,0.00032753206,0.3720636,0.00021883725],"about_ca_topic_score_codex":0.0074629784,"about_ca_topic_score_gemma":0.00036315623,"teacher_disagreement_score":0.36184838,"about_ca_system_score_codex":0.00039033423,"about_ca_system_score_gemma":0.0012368516,"threshold_uncertainty_score":0.999981},"labels":[],"label_agreement":null},{"id":"W4409632041","doi":"10.1158/1538-7445.am2025-2166","title":"Abstract 2166: PTPN1/2 dual inhibition sensitizes solid tumors to checkpoint blockade immunotherapy by enhancing T cell cytotoxicity and by decreasing cancer cell immune evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Blockade; Immunotherapy; Immune checkpoint; Cytotoxicity; Cancer immunotherapy; Cancer research; Nivolumab; Cancer; Medicine; PD-L1; Immune system; Evasion (ethics); Immunology; Chemistry; Internal medicine; Receptor; In vitro","score_opus":0.013899035562653827,"score_gpt":0.336590691411531,"score_spread":0.32269165584887716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.910038,0.087729216,0.0002862338,0.0005753114,0.000072745665,0.0007049891,0.00034656093,0.00002120065,0.00022576893],"genre_scores_gemma":[0.9900716,0.008038244,0.00017852044,0.00025734687,0.00014736774,0.0003211917,0.00020346881,0.000047035464,0.00073523825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977121,0.00015244093,0.000386916,0.00069605716,0.0003765858,0.000675907],"domain_scores_gemma":[0.9989637,0.000057844576,0.00009755321,0.0004200837,0.0002747021,0.00018611527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007760447,0.00026191538,0.00027789338,0.00009222616,0.0003593479,0.00011748292,0.00017817477,0.00018940594,0.00009497752],"category_scores_gemma":[0.00010606923,0.0002691129,0.0000720265,0.00026736347,0.00017438695,0.000018480645,0.00032887823,0.00034867274,0.0000060017646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004963662,0.00009417831,0.000097118565,0.0001526468,0.00003081217,0.000007042023,0.000099591096,0.000028684146,0.991004,0.0000038388557,0.0060980744,0.0018876776],"study_design_scores_gemma":[0.0009663911,0.0001811336,0.000571786,0.00034010463,0.0000075816347,0.0000031673703,0.0002446858,0.000013882357,0.9950269,0.000032809516,0.002338923,0.0002726654],"about_ca_topic_score_codex":0.0066892207,"about_ca_topic_score_gemma":0.0005113898,"teacher_disagreement_score":0.080033615,"about_ca_system_score_codex":0.00030483046,"about_ca_system_score_gemma":0.00046836902,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W4409632049","doi":"10.1158/1538-7445.am2025-5858","title":"Abstract 5858: Prognostic and predictive role of T cell infiltration in stage III colon cancer (CC) treated with celecoxib: CALGB/SWOG 80702","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Celecoxib; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Colorectal cancer; Infiltration (HVAC); Cancer; Biology","score_opus":0.018488341706464885,"score_gpt":0.3455906986332482,"score_spread":0.3271023569267833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310553,0.0021763672,0.0000057376533,0.00013459614,0.00004408332,0.0016849836,0.000054900283,0.000021390235,0.0027723927],"genre_scores_gemma":[0.99732304,0.0006631865,0.000012606893,0.000026852777,0.00007506001,0.0007898374,0.000023706209,0.000020649133,0.0010650479],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984656,0.00010989258,0.00025564092,0.00031731796,0.00044304202,0.00040852692],"domain_scores_gemma":[0.9989815,0.00025698057,0.00007095457,0.00019324286,0.00035925486,0.00013811134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053179584,0.00014347295,0.0003336402,0.00037592844,0.0000767255,0.000017560822,0.000076457174,0.00013778801,0.000112597496],"category_scores_gemma":[0.000099457546,0.000113488924,0.000023819379,0.0006981373,0.00022404313,0.00009231917,0.000034850877,0.00052301376,0.0000024764993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004768806,0.00057268847,0.60792464,0.0018956249,0.00010343359,0.000114635746,0.0019823995,0.00013482923,0.37760878,0.00006109992,0.0005982537,0.004234796],"study_design_scores_gemma":[0.0075850883,0.0009596409,0.48498982,0.0012808092,0.000062336105,0.0000013570409,0.0006053324,0.0011264293,0.5023528,0.000021181973,0.00088766136,0.0001275544],"about_ca_topic_score_codex":0.004470794,"about_ca_topic_score_gemma":0.0027155897,"teacher_disagreement_score":0.12474402,"about_ca_system_score_codex":0.00037750427,"about_ca_system_score_gemma":0.0011557087,"threshold_uncertainty_score":0.67585325},"labels":[],"label_agreement":null},{"id":"W4409632064","doi":"10.1158/1538-7445.am2025-5173","title":"Abstract 5173: Heterozygous <i>Ppp2r1a</i> mutations with concurrent loss of Tp53 drive invasive high-grade uterine cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Uterine cancer; Gynecologic cancer; Internal medicine; Oncology; Biology; Ovarian cancer","score_opus":0.029874829500779555,"score_gpt":0.3778002671468566,"score_spread":0.34792543764607703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99213177,0.0048042857,0.00023659624,0.0007937301,0.00035480273,0.00045146784,0.00075337605,0.0000076025153,0.00046636842],"genre_scores_gemma":[0.98997796,0.008189068,0.00008735102,0.00022248625,0.00024699888,0.00046936568,0.00014614615,0.000026298232,0.0006343584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857765,0.000047328893,0.0002512002,0.00043775875,0.00027581464,0.0004102536],"domain_scores_gemma":[0.9987226,0.00010811088,0.000090165464,0.00040111507,0.00056088716,0.00011710915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015110539,0.00016661931,0.00022457397,0.00012343486,0.00012655662,0.00004151526,0.00032023306,0.00010682904,0.00013146354],"category_scores_gemma":[0.0000857756,0.00015181839,0.00006508406,0.0003151838,0.00045198013,0.0000056453464,0.00021727105,0.0002355597,0.000004365342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002943601,0.00020683653,0.007956343,0.00039018056,0.00034133185,0.000035810117,0.00017990764,0.0027000955,0.96388566,0.0008175642,0.015127226,0.008064675],"study_design_scores_gemma":[0.0016412815,0.0003449325,0.01445708,0.00027199383,0.00003621658,0.000003869254,0.00015419215,0.000011171259,0.9315867,0.00021514384,0.05104128,0.00023616584],"about_ca_topic_score_codex":0.0030708895,"about_ca_topic_score_gemma":0.006612957,"teacher_disagreement_score":0.035914052,"about_ca_system_score_codex":0.00014801857,"about_ca_system_score_gemma":0.0013597199,"threshold_uncertainty_score":0.6190974},"labels":[],"label_agreement":null},{"id":"W4409632085","doi":"10.1158/1538-7445.am2025-3602","title":"Abstract 3602: The association between longitudinal lipid trajectories and all-cause mortality in breast cancer survivors: A population-based study","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Public Health Ontario; McMaster University; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Cancer; Population; Oncology; Internal medicine; Gerontology; Environmental health","score_opus":0.06469204364852957,"score_gpt":0.40991272227649206,"score_spread":0.34522067862796246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947793,0.0017652385,0.000007751996,0.001217764,0.0013065774,0.00058813137,0.00023328656,0.0000090793155,0.00009285422],"genre_scores_gemma":[0.99396634,0.0009769173,0.0000020325679,0.000072515446,0.004167041,0.0004067718,0.000059075395,0.000014937028,0.0003343717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816805,0.00029140877,0.00026139914,0.00044148054,0.00043296945,0.0004047027],"domain_scores_gemma":[0.999116,0.00013843224,0.000073498326,0.00033727838,0.0002648153,0.00006995265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015113989,0.00014440418,0.0002177665,0.00011717775,0.00018806345,0.00009300059,0.00022091634,0.00013854614,0.00004093507],"category_scores_gemma":[0.00013760773,0.00011760135,0.000051524803,0.0004029965,0.00007146565,0.0000116126885,0.00009441363,0.00033223126,8.861189e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011691708,0.00008531928,0.9917057,0.000046337023,0.0004166774,1.6990612e-7,0.0001444368,0.00010990989,0.003967937,0.000020140882,0.0019169217,0.0014695144],"study_design_scores_gemma":[0.0007323992,0.000030569943,0.9883334,0.000037158457,0.00009311685,1.11954805e-7,0.00026311184,0.0000074175205,0.0006739592,0.000027220265,0.009683868,0.0001176539],"about_ca_topic_score_codex":0.07276035,"about_ca_topic_score_gemma":0.16149478,"teacher_disagreement_score":0.088734426,"about_ca_system_score_codex":0.00029011664,"about_ca_system_score_gemma":0.0005310012,"threshold_uncertainty_score":0.9334142},"labels":[],"label_agreement":null},{"id":"W4409632101","doi":"10.1158/1538-7445.am2025-5722","title":"Abstract 5722: Gene expression analysis of different PARPi combination approaches with carboplatin at primary tumor and metastatic site in xenograft model of triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Triple-negative breast cancer; Carboplatin; Medicine; Triple negative; Breast cancer; Metastatic breast cancer; Cancer; Cancer research; Oncology; Primary tumor; Internal medicine; Metastasis; Chemotherapy; Cisplatin","score_opus":0.10453306443742745,"score_gpt":0.38728790887168596,"score_spread":0.2827548444342585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586123,0.0015758891,0.00025502063,0.00045932413,0.000020169186,0.0009081993,0.0005074034,0.000010010098,0.00040273924],"genre_scores_gemma":[0.9977352,0.0006793802,0.00039835146,0.000042334425,0.000013391112,0.0006892412,0.00008071431,0.000018827262,0.00034257665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99786884,0.0001825119,0.00046445656,0.00041877432,0.00077189587,0.0002935118],"domain_scores_gemma":[0.99871373,0.00026886386,0.00020762847,0.00032410878,0.00038531327,0.000100374025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054762175,0.00017473612,0.0007279161,0.0011089091,0.00006968055,0.000011035546,0.000100084035,0.000054072854,0.00014936365],"category_scores_gemma":[0.000027738253,0.00013139057,0.00008184021,0.0016482002,0.00038320431,0.00009516364,0.0000854163,0.00032390826,2.079149e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062533887,0.00064280943,0.3769914,0.0014771764,0.0011876398,0.000009593737,0.0024643857,0.0110819535,0.59665143,0.00008208548,0.00022079711,0.002937357],"study_design_scores_gemma":[0.0050248,0.00011359017,0.6173941,0.0010447053,0.00037888304,0.0000013571481,0.0002733491,0.024297977,0.3511332,0.00021904345,0.0000023232221,0.00011666541],"about_ca_topic_score_codex":0.001741398,"about_ca_topic_score_gemma":0.0017397943,"teacher_disagreement_score":0.24551822,"about_ca_system_score_codex":0.00086694007,"about_ca_system_score_gemma":0.00050472456,"threshold_uncertainty_score":0.53579515},"labels":[],"label_agreement":null},{"id":"W4409632105","doi":"10.1158/1538-7445.am2025-5813","title":"Abstract 5813: Evolution of the tumor immune microenvironment (TIME) in hepatocellular carcinoma (HCC) with liver metastases treated with atezolizumab-bevacizumab (INTEGRATE)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Atezolizumab; Bevacizumab; Hepatocellular carcinoma; Medicine; Tumor microenvironment; Immune system; Cancer research; Oncology; Internal medicine; Cancer; Immunotherapy; Immunology; Chemotherapy; Nivolumab","score_opus":0.022800772796388785,"score_gpt":0.2918862055551203,"score_spread":0.26908543275873154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807218,0.016363982,0.000011836809,0.0006903669,0.000029007935,0.0013551178,0.000053760225,0.000015423264,0.0007587267],"genre_scores_gemma":[0.995427,0.0006080993,0.000035722558,0.00004322398,0.000020680469,0.00022839375,0.000017993514,0.0000297306,0.0035891386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99787956,0.00020196501,0.0003697233,0.00041167208,0.00064245675,0.0004946272],"domain_scores_gemma":[0.99889916,0.0000818227,0.00010767157,0.00064173795,0.000202487,0.000067144945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056870497,0.00022644927,0.00043574127,0.00034530283,0.00013777897,0.000022879092,0.00027912273,0.00006908415,0.0006473326],"category_scores_gemma":[0.000020646417,0.00012746656,0.00011910422,0.0011960014,0.0006978886,0.00006276223,0.000078182726,0.0004986425,0.00001311544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026659781,0.00044990017,0.22408994,0.00053975807,0.000528914,0.00027743488,0.00031506352,0.00004309445,0.7407024,0.000050949377,0.0011317709,0.005211019],"study_design_scores_gemma":[0.005196608,0.0005384214,0.5159016,0.0017763816,0.00009771416,0.000032375698,0.00048812776,0.00016767,0.47415805,0.000010700604,0.0014994376,0.00013285129],"about_ca_topic_score_codex":0.022580378,"about_ca_topic_score_gemma":0.0010210249,"teacher_disagreement_score":0.2918117,"about_ca_system_score_codex":0.0020344025,"about_ca_system_score_gemma":0.0011450859,"threshold_uncertainty_score":0.9839283},"labels":[],"label_agreement":null},{"id":"W4409632124","doi":"10.1158/1538-7445.am2025-4513","title":"Abstract 4513: Impact of patient safety regulatory considerations on early oncology clinical investigations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Clinical Oncology; Intensive care medicine; Oncology; Internal medicine; Cancer","score_opus":0.2089687885796303,"score_gpt":0.5577962700617949,"score_spread":0.3488274814821646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614851,0.00031704613,0.000016808774,0.02773784,0.00024805547,0.0005144975,0.00003369569,0.000017615725,0.009629364],"genre_scores_gemma":[0.9983842,0.00025674075,0.0001593657,0.0005514084,0.0001322232,0.000044272503,0.000021868791,0.000008511864,0.00044143386],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99815214,0.00027614346,0.0005517457,0.0002404627,0.00054743094,0.00023205281],"domain_scores_gemma":[0.99740463,0.0011878681,0.000086984546,0.0003387893,0.0007248869,0.0002568113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001582605,0.00007767583,0.00027497252,0.00030163533,0.00018403154,0.000011551598,0.000060670245,0.0003543192,0.0006039671],"category_scores_gemma":[0.0009939253,0.00005695092,0.00014724139,0.00046430563,0.0020762095,0.0000328666,0.0000510939,0.0010737403,0.00001674059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003115527,0.0030255127,0.1216638,0.000684592,0.0014212361,0.00009056761,0.0029711437,0.0008434912,0.058570378,0.33972716,0.16308159,0.304805],"study_design_scores_gemma":[0.0012559472,0.0013273146,0.9686098,0.00047804532,0.000028514633,0.0000020813043,0.00007156502,0.000102719794,0.0018506135,0.016921574,0.009290411,0.00006140747],"about_ca_topic_score_codex":0.0008933201,"about_ca_topic_score_gemma":0.00014702165,"teacher_disagreement_score":0.846946,"about_ca_system_score_codex":0.00052554405,"about_ca_system_score_gemma":0.005209902,"threshold_uncertainty_score":0.92421424},"labels":[],"label_agreement":null},{"id":"W4409632149","doi":"10.1158/1538-7445.am2025-7288","title":"Abstract 7288: Targeted degradation of mobile immune checkpoints to advance cancer therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer; Cancer therapy; Immune system; Computational biology; Cancer research; Biology; Medicine; Immunology; Genetics","score_opus":0.05268197465200714,"score_gpt":0.43817405838256285,"score_spread":0.3854920837305557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94642645,0.04670117,0.000050837476,0.0028477414,0.0003777431,0.0014177313,0.000045883135,0.00003609995,0.002096334],"genre_scores_gemma":[0.97134274,0.017103538,0.00016580806,0.00048068014,0.000116696545,0.0013929434,0.000019069907,0.000029087887,0.009349408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811256,0.00006414371,0.00042283398,0.0003703886,0.0005781035,0.00045198898],"domain_scores_gemma":[0.99857366,0.00010589965,0.000079973506,0.00050400523,0.00062933954,0.00010711916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007992667,0.00015242684,0.0003540934,0.0003989014,0.0001232874,0.00002098755,0.00025386165,0.00010360824,0.0020657794],"category_scores_gemma":[0.00007407932,0.00012891684,0.00012424444,0.00148076,0.00015471852,0.000095420575,0.000056195644,0.00035924604,0.000018587625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004390632,0.00013358965,0.0029843822,0.00017771298,0.00017440878,0.0000033086678,0.00023586198,0.00003444325,0.7768243,0.000027021755,0.00528641,0.20972796],"study_design_scores_gemma":[0.0024009377,0.0002857714,0.111939825,0.0007062061,0.0000105593235,7.2614097e-7,0.0002542701,0.000011052274,0.7825653,0.000049570914,0.10166183,0.00011392933],"about_ca_topic_score_codex":0.0054021124,"about_ca_topic_score_gemma":0.00033176286,"teacher_disagreement_score":0.20961402,"about_ca_system_score_codex":0.0005824933,"about_ca_system_score_gemma":0.0010491877,"threshold_uncertainty_score":0.9988465},"labels":[],"label_agreement":null},{"id":"W4409632156","doi":"10.1158/1538-7445.am2025-4499","title":"Abstract 4499: Drug target ID and binding site mapping in complex cellular environments using LiP-MS","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"Binding site; Computational biology; Drug; Chemistry; Biophysics; Biology; Pharmacology; Biochemistry","score_opus":0.07670121477878261,"score_gpt":0.38275001980723544,"score_spread":0.30604880502845283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815634,0.00080645026,0.00034609015,0.0003694725,0.000010426738,0.00017699559,0.000066947185,0.000028328732,0.016631909],"genre_scores_gemma":[0.9959709,0.00046644607,0.0012305761,0.000021470509,0.000058438236,0.0001175916,0.000055408134,0.000017090826,0.0020620867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987386,0.00002261429,0.00020199588,0.00035435407,0.00026790856,0.00041455714],"domain_scores_gemma":[0.9995044,0.00007209341,0.000039190876,0.0002954253,0.000016237076,0.00007269065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040312367,0.00010678895,0.00014981277,0.00028387614,0.00022385923,0.00007260283,0.00021831277,0.00007686925,0.0042156344],"category_scores_gemma":[0.000016312108,0.000117093274,0.00002596198,0.00048175384,0.00011066367,0.000063377614,0.0002358337,0.00051018916,0.000014880032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049954588,0.00003834444,0.022429045,0.00016536283,0.000011276237,0.000007260079,0.00008332301,0.000030239984,0.9753968,0.0003086714,0.0009859765,0.0005386988],"study_design_scores_gemma":[0.00040794624,0.0000036746753,0.009342165,0.00031141032,0.000005259187,0.0000010003887,0.00030284392,0.0023493336,0.82317966,0.0017982675,0.16207378,0.00022466147],"about_ca_topic_score_codex":0.0011765338,"about_ca_topic_score_gemma":0.000029760884,"teacher_disagreement_score":0.1610878,"about_ca_system_score_codex":0.00047864788,"about_ca_system_score_gemma":0.00005951701,"threshold_uncertainty_score":0.9966946},"labels":[],"label_agreement":null},{"id":"W4409632165","doi":"10.1158/1538-7445.am2025-2500","title":"Abstract 2500: An automated and scalable pipeline for high-dimensional immune cell phenotyping in mass cytometry datasets","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Mass cytometry; Pipeline (software); Immune system; Scalability; Flow cytometry; Computer science; Computational biology; Medicine; Immunology; Biology; Database; Genetics; Phenotype; Operating system","score_opus":0.034648280529261034,"score_gpt":0.37399653802535787,"score_spread":0.3393482574960968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940053,0.0036264264,0.0010417233,0.00022737434,0.0001858114,0.0003170062,0.00043583158,0.000021105367,0.00013942458],"genre_scores_gemma":[0.9971764,0.0003186609,0.0007128776,0.00009404903,0.00010087949,0.00006864278,0.0011296023,0.000018611066,0.0003802629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988239,0.000057348258,0.00020537809,0.000396592,0.00014524598,0.00037152745],"domain_scores_gemma":[0.99943316,0.000058473113,0.000024526782,0.00027478547,0.00013444445,0.000074602474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063071604,0.00010944043,0.00014853601,0.00016618309,0.00013601425,0.000047289243,0.00019888677,0.00014369375,0.000029977926],"category_scores_gemma":[0.00007483141,0.00010818981,0.00002447735,0.00026168363,0.000102903825,0.000008985525,0.00008548296,0.00019367461,0.0000021113801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041522234,0.000105124396,0.00092354044,0.00015509225,0.000014235825,0.0000029371768,0.000010250279,0.0002138107,0.9903475,0.000026748201,0.0037590836,0.0040264484],"study_design_scores_gemma":[0.0020433273,0.000105343584,0.006703022,0.00009843944,0.000007824958,6.11239e-7,0.000040686424,0.009635894,0.97611773,0.00015821193,0.004919001,0.00016993213],"about_ca_topic_score_codex":0.0010180756,"about_ca_topic_score_gemma":0.00025858477,"teacher_disagreement_score":0.0142298,"about_ca_system_score_codex":0.00004965224,"about_ca_system_score_gemma":0.00024071777,"threshold_uncertainty_score":0.44118524},"labels":[],"label_agreement":null},{"id":"W4409632168","doi":"10.1158/1538-7445.am2025-4498","title":"Abstract 4498: Drug screens identify new therapeutic targets that synergize with EZH1/2 inhibition in adult T-cell leukemia/lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Cancer research; Drug; Leukemia; Medicine; Adult T-cell leukemia/lymphoma; Cancer; Pharmacology; T-cell leukemia; Biology; Immunology; Internal medicine","score_opus":0.032810659204695766,"score_gpt":0.3281053979106002,"score_spread":0.29529473870590445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478542,0.038447883,0.00003090017,0.0021661061,0.0004551375,0.0004992283,0.000031204607,0.00006503207,0.010450264],"genre_scores_gemma":[0.95622396,0.0042920075,0.000009784693,0.00035839988,0.00005816572,0.00013198824,0.000039698654,0.00002450428,0.038861502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998037,0.00024297301,0.00025965,0.0004661194,0.00016282454,0.00083144504],"domain_scores_gemma":[0.9990837,0.00023462884,0.00006718063,0.00033918858,0.00023056657,0.000044723434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046710696,0.00023199416,0.00033461433,0.00042180184,0.00041758997,0.0000520686,0.00025793092,0.0002489897,0.0004930478],"category_scores_gemma":[0.00003470442,0.00017349047,0.00007784395,0.0006190927,0.0005228733,0.00013366937,0.00019733302,0.0007650857,0.0003574111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015046642,0.0002791831,0.01172419,0.000282468,0.00038582904,0.00009919056,0.0022722222,0.00005571004,0.83905554,0.0009841905,0.10733,0.036026813],"study_design_scores_gemma":[0.007032569,0.00015779103,0.08661741,0.0006766164,0.000047158985,0.000010774441,0.0039990027,0.0000021831545,0.84236324,0.00089780975,0.057792064,0.00040338378],"about_ca_topic_score_codex":0.011961547,"about_ca_topic_score_gemma":0.008829829,"teacher_disagreement_score":0.07489322,"about_ca_system_score_codex":0.0005995056,"about_ca_system_score_gemma":0.00096386956,"threshold_uncertainty_score":0.9946179},"labels":[],"label_agreement":null},{"id":"W4409632169","doi":"10.1158/1538-7445.am2025-2205","title":"Abstract 2205: Exploring the presence and role of causative viruses in glioblastoma using a multi-omics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Computational biology; Biology; Omics; Virology; Cancer research; Bioinformatics","score_opus":0.1189597495076789,"score_gpt":0.424823447833232,"score_spread":0.3058636983255531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995709,0.0019407027,0.0016639857,0.00006339629,0.000010495386,0.00035867994,0.000016860797,0.000003885036,0.0002329958],"genre_scores_gemma":[0.9975562,0.0008398306,0.0010664548,0.00003285964,0.000020397682,0.00043448294,0.0000028723448,0.000007169616,0.00003970199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929845,0.000078636855,0.0001235163,0.00024170872,0.00007627848,0.0001813975],"domain_scores_gemma":[0.99956644,0.00003445846,0.000029094306,0.00025116783,0.00009566344,0.000023160766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035736166,0.000066322944,0.00008336779,0.00007832883,0.000090833055,0.0000123097425,0.00020471592,0.00007062355,0.0000019109114],"category_scores_gemma":[0.00007536969,0.000052189545,0.000022570943,0.00023928781,0.00029268538,0.0000034238853,0.0002388217,0.000178714,1.5860655e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054585576,0.000039340397,0.0048262156,0.00002430849,0.000017582548,3.5624677e-7,0.00011819226,0.000119854005,0.9914582,0.00059973565,0.000033094107,0.0027085736],"study_design_scores_gemma":[0.00017142452,0.000037000438,0.00900534,0.00004076043,0.0000034388474,0.0000011354564,0.00056777993,0.00067428994,0.98675054,0.00023398927,0.0024546415,0.000059629503],"about_ca_topic_score_codex":0.0007538876,"about_ca_topic_score_gemma":0.00022563935,"teacher_disagreement_score":0.004707591,"about_ca_system_score_codex":0.00002390104,"about_ca_system_score_gemma":0.000118261036,"threshold_uncertainty_score":0.21282278},"labels":[],"label_agreement":null},{"id":"W4409632211","doi":"10.1158/1538-7445.am2025-6940","title":"Abstract 6940: Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Fusion gene; Lymphoblastic Leukemia; Cancer research; Gene; Medicine; Leukemia; Oncology; Biology; Internal medicine; Genetics","score_opus":0.015309053749216964,"score_gpt":0.3051329614832129,"score_spread":0.2898239077339959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274516,0.0016415559,0.00040651238,0.00033155436,0.00014851395,0.0004660583,0.00018279011,0.00001469626,0.0040631583],"genre_scores_gemma":[0.983773,0.00077801757,0.0006214811,0.00018138712,0.00016959019,0.00037115172,0.00008251925,0.00002559139,0.013997261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836284,0.000073260504,0.00021273732,0.0005165058,0.0002806293,0.00055401545],"domain_scores_gemma":[0.99877787,0.000025267576,0.00004617614,0.0004155499,0.0005883488,0.0001467925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002791317,0.0001810111,0.00015896742,0.00015539642,0.00034639833,0.00012701286,0.00035993135,0.00012945714,0.00012226141],"category_scores_gemma":[0.00003224229,0.0001525092,0.000040813207,0.00068130944,0.000105767096,0.000007772366,0.00023804302,0.00014346212,0.000059426424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034423466,0.000059670234,0.0011828811,0.00007927189,0.00005812767,0.000011063644,0.0001696895,0.0031315424,0.9871386,0.00012943882,0.0068526245,0.00084283284],"study_design_scores_gemma":[0.0007384032,0.0003889668,0.005469674,0.000060419574,0.000028100232,0.000004915874,0.00024595074,0.00005496633,0.9761662,0.00004806639,0.01656945,0.0002249097],"about_ca_topic_score_codex":0.00037539043,"about_ca_topic_score_gemma":0.00028155665,"teacher_disagreement_score":0.010972446,"about_ca_system_score_codex":0.00029127035,"about_ca_system_score_gemma":0.0022274095,"threshold_uncertainty_score":0.6219144},"labels":[],"label_agreement":null},{"id":"W4409632226","doi":"10.1158/1538-7445.am2025-5781","title":"Abstract 5781: Comparing prognostic association of manual vs. artificial intelligence derived quantifications from baseline computed tomography scans in MYSTIC, a global phase 3 trial for treatment of metastatic non-small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Computed tomography; Baseline (sea); Internal medicine; Nuclear medicine; Oncology; Radiology; Biology","score_opus":0.09449158892061528,"score_gpt":0.46828333748308754,"score_spread":0.37379174856247227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486396,0.0010188894,0.045814894,0.0013574667,0.00030582023,0.0024770983,0.0003102932,0.000015074806,0.00006087973],"genre_scores_gemma":[0.99585646,0.0002182455,0.0028221605,0.000024917836,0.00014902015,0.00069075887,0.00019273808,0.000013447364,0.000032230102],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978691,0.00019216047,0.00076253293,0.0003689859,0.00042778937,0.00037944128],"domain_scores_gemma":[0.99733764,0.0015402811,0.0002446161,0.00022198423,0.00053623406,0.00011926273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012068088,0.0001466426,0.00062509376,0.00037399266,0.00009094446,0.000030670355,0.00016624694,0.000069381895,0.000068727866],"category_scores_gemma":[0.00083574466,0.00013427962,0.0001433109,0.00093188614,0.00013665057,0.000035380403,0.000030760624,0.00022963641,7.2776385e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069272004,0.015454396,0.495204,0.005118526,0.002626181,0.000055041524,0.005435916,0.026047897,0.17601101,0.0010573422,0.001980929,0.20173676],"study_design_scores_gemma":[0.04069835,0.0011968911,0.06761144,0.0019586761,0.000923461,4.1735836e-7,0.00090650946,0.8178651,0.067887925,0.0004992907,0.0002176014,0.00023436935],"about_ca_topic_score_codex":0.009676992,"about_ca_topic_score_gemma":0.0025369064,"teacher_disagreement_score":0.7918172,"about_ca_system_score_codex":0.0007986741,"about_ca_system_score_gemma":0.0010679594,"threshold_uncertainty_score":0.99691767},"labels":[],"label_agreement":null},{"id":"W4409632265","doi":"10.1158/1538-7445.am2025-6947","title":"Abstract 6947: CRISPR/Cas9 kinome screen identifies PNKP as a novel fitness gene in HPV-negative head and neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Yukon University","funders":"","keywords":"CRISPR; Kinome; Head and neck squamous-cell carcinoma; Biology; Gene; Head and neck; Basal cell; Computational biology; Genetics; Cancer research; Medicine; Cancer; Head and neck cancer; Internal medicine","score_opus":0.053664108353658146,"score_gpt":0.3801940959541438,"score_spread":0.3265299876004856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96920997,0.022843322,0.0000111593645,0.0006045541,0.00048648272,0.00050412095,0.0001072813,0.000025466452,0.00620764],"genre_scores_gemma":[0.97533864,0.0003551878,0.000012928624,0.00016645131,0.000037794336,0.0001724231,0.000027792403,0.000022662969,0.023866097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978396,0.00034981477,0.00035601284,0.000482191,0.000104748025,0.0008676317],"domain_scores_gemma":[0.9985961,0.0006656425,0.000057034165,0.0003794023,0.00025418715,0.000047667574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074680825,0.00022251504,0.00036949542,0.0006618532,0.000306885,0.000077867226,0.0004064084,0.00029208369,0.0013234258],"category_scores_gemma":[0.0003417737,0.0002080071,0.00007260067,0.0004895713,0.00063348655,0.00018024286,0.0003925959,0.0009746707,0.0002696382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002543004,0.000282604,0.00901856,0.00017613584,0.000059098245,0.000033300035,0.0017343415,0.000004226901,0.97862124,0.0004161933,0.0052020275,0.0019092917],"study_design_scores_gemma":[0.0024120673,0.00019821712,0.2992085,0.000096035605,0.000008824303,0.000015457706,0.0013522765,0.0000025437087,0.69107795,0.000099543606,0.0053626103,0.00016597526],"about_ca_topic_score_codex":0.01927362,"about_ca_topic_score_gemma":0.0013665716,"teacher_disagreement_score":0.29018992,"about_ca_system_score_codex":0.00027674914,"about_ca_system_score_gemma":0.0005523083,"threshold_uncertainty_score":0.9995895},"labels":[],"label_agreement":null},{"id":"W4409632514","doi":"10.1158/1538-7445.am2025-4657","title":"Abstract 4657: Investigating the role of circulating bone cells in melanoma patients on immune checkpoint inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Medicine; Immune system; Cancer research; Immune checkpoint; Immunology; Immunotherapy","score_opus":0.031107553960477367,"score_gpt":0.3728583107759894,"score_spread":0.34175075681551204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898013,0.002020609,0.0000025792838,0.0025712813,0.00013545713,0.0004949523,0.0000027047533,0.000012738253,0.004958416],"genre_scores_gemma":[0.99904317,0.00023809404,0.00008467648,0.00028112726,0.00012331954,0.00006729623,0.000006004689,0.000019562909,0.00013675693],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824625,0.00014699146,0.00042503222,0.0002388727,0.00058816775,0.00035470258],"domain_scores_gemma":[0.99895465,0.00039282313,0.00009578647,0.00029998596,0.00017594546,0.000080799546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017838338,0.00010408101,0.0002572886,0.000254593,0.00013172485,0.000026372281,0.00017397887,0.0000666392,0.00006923932],"category_scores_gemma":[0.00085647014,0.00007111749,0.00006859321,0.0005720993,0.00025275588,0.00003440263,0.00008418914,0.0012232908,0.000005412379],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001170238,0.00016250162,0.13967866,0.00013913265,0.00003700165,0.000009102984,0.0010638008,0.00021244818,0.7247574,0.00018867195,0.00017542137,0.13345887],"study_design_scores_gemma":[0.0028936754,0.00020345302,0.5109585,0.002430659,0.000007621934,0.0000010156489,0.0007459155,0.0037486958,0.4748728,0.0010872261,0.002939798,0.0001106636],"about_ca_topic_score_codex":0.0020913514,"about_ca_topic_score_gemma":0.000015016623,"teacher_disagreement_score":0.37127984,"about_ca_system_score_codex":0.0002072041,"about_ca_system_score_gemma":0.00031355256,"threshold_uncertainty_score":0.53146577},"labels":[],"label_agreement":null},{"id":"W4409632521","doi":"10.1158/1538-7445.am2025-2514","title":"Abstract 2514: Refining oncology dose selection: A framework for tailored dose optimization in the era of targeted and immunotherapies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Selection (genetic algorithm); Oncology; Internal medicine; Medical physics; Computer science","score_opus":0.10307454890156185,"score_gpt":0.4969998379694983,"score_spread":0.39392528906793645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445495,0.008367161,0.00490225,0.036963537,0.000060054503,0.0012509391,0.000019803862,0.000029167655,0.003857613],"genre_scores_gemma":[0.9929493,0.00096180616,0.0047534816,0.0002951159,0.00008153176,0.0007651261,0.000011478439,0.00000661363,0.00017555714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999333,0.000050096445,0.00016929019,0.00015103265,0.00012774969,0.0001687788],"domain_scores_gemma":[0.99896,0.0006796568,0.00003059577,0.00012927887,0.0001699729,0.000030453926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059808936,0.000052541218,0.00013397845,0.000062175786,0.000121076344,0.000014824326,0.00008775284,0.00010560696,0.00011565941],"category_scores_gemma":[0.0002615441,0.000039581108,0.000023918466,0.0006002318,0.00017359461,0.00002749128,0.000015376088,0.000576206,4.4258684e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062199337,0.00073359517,0.003428853,0.0013904301,0.00026894466,0.0000062144723,0.004007528,0.005135864,0.85275185,0.016582588,0.003811285,0.105662934],"study_design_scores_gemma":[0.01925142,0.001485814,0.09688179,0.00299303,0.00023922985,0.000038141116,0.0077561396,0.027426854,0.6614856,0.0231624,0.15872626,0.0005533252],"about_ca_topic_score_codex":0.00007366411,"about_ca_topic_score_gemma":0.000008494424,"teacher_disagreement_score":0.19126624,"about_ca_system_score_codex":0.000115516144,"about_ca_system_score_gemma":0.0003080057,"threshold_uncertainty_score":0.25033605},"labels":[],"label_agreement":null},{"id":"W4409632616","doi":"10.1158/1538-7445.am2025-7266","title":"Abstract 7266: Nanotechnology-enabled photochemical immune stimulation in clinical veterinary models of head and neck cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Medicine; Head and neck cancer; Immune system; Cancer; Immunology; Internal medicine; Surgery","score_opus":0.08654652432987696,"score_gpt":0.41129300519440315,"score_spread":0.3247464808645262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929797,0.005057307,0.00025018738,0.00007270507,0.00025857188,0.00049872336,0.000020967815,0.00008046616,0.0007813866],"genre_scores_gemma":[0.9967274,0.0027234596,0.00025059676,0.000011947682,0.00003475773,0.00016184052,0.0000057155767,0.000027612728,0.00005663603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985054,0.000026681522,0.0005439362,0.000261422,0.0002376358,0.00042489026],"domain_scores_gemma":[0.99920344,0.00025956097,0.000033669177,0.00033168585,0.00011269466,0.000058927224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006265198,0.00013514102,0.0003405497,0.00036222592,0.000044234162,0.000016412434,0.00025474138,0.0002904619,0.000038810624],"category_scores_gemma":[0.000090842404,0.00014129233,0.00005106121,0.00066365785,0.00026167886,0.00016048756,0.00011764103,0.0008291278,0.0000021279598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067769334,0.000049993854,0.0037957206,0.0006893307,0.000095986805,0.000017584145,0.00017247717,0.067728765,0.90124094,0.00030887782,0.00032895175,0.024893666],"study_design_scores_gemma":[0.009987835,0.0006763253,0.055079836,0.0034131736,0.000040179315,0.0000060261436,0.00031870228,0.27453446,0.62799764,0.023385523,0.0037590677,0.000801232],"about_ca_topic_score_codex":0.0009517748,"about_ca_topic_score_gemma":0.0001643416,"teacher_disagreement_score":0.2732433,"about_ca_system_score_codex":0.00065271195,"about_ca_system_score_gemma":0.00029274717,"threshold_uncertainty_score":0.5761734},"labels":[],"label_agreement":null},{"id":"W4409632657","doi":"10.1158/1538-7445.am2025-2507","title":"Abstract 2507: Comparative assessment of data analysis methods to enable robust 10-second diagnosis of tissue pathologies with picosecond infrared laser mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University Health Network; University of Toronto","funders":"","keywords":"Mass spectrometry; Infrared; Picosecond; Laser; Materials science; Analytical Chemistry (journal); Medicine; Chemistry; Optics; Chromatography; Physics","score_opus":0.1860530376001525,"score_gpt":0.5322869979929757,"score_spread":0.3462339603928233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.937838,0.0025084468,0.01281787,0.0006469166,0.000100802405,0.0015822216,0.0009170931,0.00003724985,0.04355139],"genre_scores_gemma":[0.8362918,0.0003139506,0.15835498,0.00013358628,0.00007910125,0.0004353214,0.00021997475,0.0000249077,0.004146381],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967052,0.00044501756,0.00064496824,0.0007060677,0.0009374775,0.00056128245],"domain_scores_gemma":[0.9950982,0.0015381813,0.00020404806,0.0018757854,0.001094085,0.00018974699],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034120735,0.00023477031,0.0012476206,0.0024986565,0.0000900243,0.000028388049,0.00083722477,0.0001359281,0.011015911],"category_scores_gemma":[0.00044486442,0.00017944064,0.00010229239,0.006388224,0.00060388213,0.00018164945,0.00038576548,0.00071756955,0.0000043222426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023401096,0.0012753956,0.45345068,0.003602529,0.0126971295,0.00026461572,0.0022385246,0.002521426,0.44031563,0.0004891218,0.06831162,0.012493222],"study_design_scores_gemma":[0.0018194616,0.0012746468,0.4701466,0.00067315355,0.00092873967,0.0000017025183,0.0033205152,0.0001718861,0.5156364,0.00039693678,0.0054255472,0.00020444843],"about_ca_topic_score_codex":0.00041684532,"about_ca_topic_score_gemma":0.00027226083,"teacher_disagreement_score":0.14553711,"about_ca_system_score_codex":0.00028065348,"about_ca_system_score_gemma":0.0008406773,"threshold_uncertainty_score":0.98988813},"labels":[],"label_agreement":null},{"id":"W4409632764","doi":"10.1158/1538-7445.am2025-6508","title":"Abstract 6508: The SRG RAT, an immunodeficient model for immortalized cell line and primary patient derived orthotopic glioblastoma xenograft tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioblastoma; Immortalised cell line; Cancer research; Medicine; Cell culture; Biology","score_opus":0.05009167211612887,"score_gpt":0.3819319571248326,"score_spread":0.3318402850087037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880219,0.007446784,0.000077280216,0.0013440719,0.000095396135,0.0022455207,0.00005515332,0.000031503736,0.00068235066],"genre_scores_gemma":[0.9963177,0.0007335132,0.00018903543,0.00032426976,0.00004166953,0.0019073783,0.00004807242,0.000027063965,0.00041133302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982178,0.00006673504,0.00031237814,0.00043610507,0.00045386225,0.00051310443],"domain_scores_gemma":[0.9987186,0.00018098195,0.000059709313,0.00052659604,0.00036276653,0.0001513221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042700503,0.00018410492,0.00031453784,0.00022274925,0.0003748668,0.00007755484,0.0001548824,0.00007335644,0.00005633635],"category_scores_gemma":[0.00004429372,0.00011842483,0.00010940967,0.00035475713,0.00020002366,0.000060661623,0.00012760395,0.00028348638,0.00000384869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005941221,0.004264021,0.010071051,0.0017141043,0.00049512036,0.00027354748,0.004063097,0.0029333218,0.85803056,0.00055575307,0.006354269,0.10530391],"study_design_scores_gemma":[0.015998172,0.0035066498,0.076585904,0.001106925,0.00037303448,0.000019968127,0.0022912081,0.028642504,0.8592877,0.00062077213,0.011041799,0.00052537036],"about_ca_topic_score_codex":0.00042730186,"about_ca_topic_score_gemma":0.00022588458,"teacher_disagreement_score":0.10477854,"about_ca_system_score_codex":0.00025894176,"about_ca_system_score_gemma":0.0005610519,"threshold_uncertainty_score":0.48292246},"labels":[],"label_agreement":null},{"id":"W4409632782","doi":"10.1158/1538-7445.am2025-5815","title":"Abstract 5815: Both CD4 and CD8 T cells mediate antitumor immunity to prevent development of neoantigen-expressing autochthonous sarcomas","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immunity; CD8; Cytotoxic T cell; Immunology; Cancer research; Biology; Medicine; Immune system; Genetics; In vitro","score_opus":0.07726887156536029,"score_gpt":0.4268249320366299,"score_spread":0.34955606047126964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808426,0.0037141147,0.00010155415,0.0008893145,0.00016958987,0.0015937425,0.000018748331,0.000040261686,0.0053883973],"genre_scores_gemma":[0.9857918,0.0012400739,0.0019018888,0.00010798881,0.00011243683,0.00024672115,0.000011546856,0.000045247412,0.010542268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99666274,0.00023078117,0.00053710886,0.00051280577,0.0011826981,0.00087384303],"domain_scores_gemma":[0.998008,0.00034828318,0.00006896201,0.00068878575,0.00048195617,0.00040400404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026395996,0.00021249041,0.00050842727,0.00074069644,0.0003497584,0.00008045326,0.0004085613,0.00012016913,0.0017350287],"category_scores_gemma":[0.00019784275,0.00019271972,0.00007758926,0.0009356404,0.00034892323,0.00008318508,0.0005797546,0.00090081216,0.000040187973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062081974,0.00031008144,0.0016023448,0.00081929006,0.00014484387,0.00004861114,0.0019851988,0.000011672063,0.8903503,0.000022997869,0.0017973868,0.10228649],"study_design_scores_gemma":[0.0010623074,0.00016801053,0.059202727,0.001173229,0.000015662066,0.0000046231903,0.0004257552,0.000031312105,0.8982317,0.000065866916,0.03945804,0.00016078628],"about_ca_topic_score_codex":0.0010519039,"about_ca_topic_score_gemma":0.00021952052,"teacher_disagreement_score":0.102125704,"about_ca_system_score_codex":0.00057249767,"about_ca_system_score_gemma":0.0028083962,"threshold_uncertainty_score":0.9991775},"labels":[],"label_agreement":null},{"id":"W4409632787","doi":"10.1158/1538-7445.am2025-6522","title":"Abstract 6522: Sex differences in gut microbial composition during pelvic radiation therapy in experimental models of muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Radiation therapy; Bladder cancer; Cancer; Medicine; Anal cancer; Urology; Internal medicine; Physiology; Biology","score_opus":0.07603751464444992,"score_gpt":0.3998424462951537,"score_spread":0.3238049316507038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894381,0.007797931,0.0000026454568,0.00057053275,0.00013501947,0.0009540181,0.000044984223,0.000013354915,0.0010433967],"genre_scores_gemma":[0.9943314,0.0045990213,0.000010422955,0.00009376612,0.00010190022,0.0005565823,0.00001926195,0.000018581035,0.00026902478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984499,0.00011274361,0.00031435178,0.0003575735,0.00038692955,0.00037847593],"domain_scores_gemma":[0.9994842,0.00008662117,0.00005092622,0.00019250829,0.0001196443,0.000066103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017826825,0.00015209329,0.0003338854,0.00051412906,0.00007384295,0.000022065444,0.00012705814,0.00010631732,0.00047287607],"category_scores_gemma":[0.000008074849,0.00013657872,0.00006192411,0.0005206861,0.000112262096,0.00014480198,0.00004176863,0.00034018586,0.000002811332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012516348,0.0005681564,0.06407887,0.00018364961,0.000110185916,0.000027695474,0.0035362863,0.00028109053,0.921637,0.000027367609,0.00016392446,0.008134161],"study_design_scores_gemma":[0.0051010735,0.00014174839,0.44195107,0.0006079094,0.000008299416,7.927031e-7,0.0006013402,0.00011859944,0.55125594,0.00010836333,0.000016547852,0.00008832667],"about_ca_topic_score_codex":0.012855536,"about_ca_topic_score_gemma":0.0020052106,"teacher_disagreement_score":0.3778722,"about_ca_system_score_codex":0.0009955629,"about_ca_system_score_gemma":0.0007639216,"threshold_uncertainty_score":0.99371797},"labels":[],"label_agreement":null},{"id":"W4409632800","doi":"10.1158/1538-7445.am2025-6770","title":"Abstract 6770: TFEB-dependent signals confer resistance against chemotherapeutic drug-induced nucleolar stress","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Drug resistance; Drug; Medicine; Pharmacology; Cancer research; Cancer; Biology; Internal medicine; Genetics","score_opus":0.03989178016096559,"score_gpt":0.37055049926714984,"score_spread":0.3306587191061843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686342,0.0036877948,0.00011030791,0.0013286427,0.00028379197,0.0006211496,0.00006794731,0.000043645614,0.025222547],"genre_scores_gemma":[0.9788257,0.00072416756,0.00007953213,0.0007484962,0.0002100224,0.00021946101,0.000036911133,0.00005196138,0.01910374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974452,0.00024610764,0.0002863808,0.0007414515,0.0005796819,0.0007011802],"domain_scores_gemma":[0.9984361,0.00006697494,0.00006414289,0.0008298227,0.0004537327,0.00014921278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011700977,0.00022116443,0.0002281518,0.00015192272,0.00022700943,0.000110295856,0.0006760186,0.00023188717,0.0002496086],"category_scores_gemma":[0.00012944751,0.00022331571,0.000113803915,0.0002919384,0.0001449847,0.000008522966,0.00026097943,0.00045917692,0.000057638466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027750537,0.00009048124,0.00016035489,0.0001460937,0.00013298313,0.000013397878,0.00006275528,0.000030714655,0.98599535,0.0003055422,0.0066989255,0.006085912],"study_design_scores_gemma":[0.0006902042,0.00003977242,0.00047672607,0.00018592537,0.000009346303,3.090265e-7,0.00023245993,0.000010707785,0.9346779,0.00033318004,0.063132145,0.00021130533],"about_ca_topic_score_codex":0.00014853863,"about_ca_topic_score_gemma":0.00069312647,"teacher_disagreement_score":0.05643322,"about_ca_system_score_codex":0.00016871624,"about_ca_system_score_gemma":0.0007187735,"threshold_uncertainty_score":0.9106551},"labels":[],"label_agreement":null},{"id":"W4409632815","doi":"10.1158/1538-7445.am2025-6445","title":"Abstract 6445: Atypical teratoid rhabdoid tumor development mirrors developmental programs","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Pathology; Medicine; Biology; Medulloblastoma","score_opus":0.06988506179752633,"score_gpt":0.39995336308413915,"score_spread":0.3300683012866128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934722,0.0018807687,0.0001285764,0.00027485937,0.00017163415,0.00035358328,0.000005961996,0.000027167584,0.0036852492],"genre_scores_gemma":[0.9931305,0.00016245834,0.0021775698,0.00023158242,0.000117539494,0.00043563463,0.00007322321,0.00002366354,0.0036478192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823517,0.000053633834,0.00027627312,0.00050154486,0.00037815107,0.0005552364],"domain_scores_gemma":[0.99934655,0.000014868287,0.000031389936,0.0002407842,0.00023881625,0.00012756034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049387343,0.00016356126,0.00014536505,0.0000982092,0.00028292078,0.00007520158,0.00034743908,0.00011998166,0.00014959183],"category_scores_gemma":[0.00006141895,0.00015031849,0.000060740258,0.00028519478,0.0001633946,0.000004242793,0.00025050362,0.00029509168,0.000059040314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041738932,0.00019015041,0.008161603,0.00019966335,0.00013909083,0.000015146145,0.00020731683,0.000020247795,0.84438217,0.00005673341,0.013504024,0.1327065],"study_design_scores_gemma":[0.00064186484,0.000060340026,0.011963699,0.00024061072,0.0000039465995,0.000006967118,0.0002712015,0.000023198532,0.65409815,0.00005409221,0.33238825,0.00024767953],"about_ca_topic_score_codex":0.00010230132,"about_ca_topic_score_gemma":0.0003013447,"teacher_disagreement_score":0.31888422,"about_ca_system_score_codex":0.0002618395,"about_ca_system_score_gemma":0.0018433027,"threshold_uncertainty_score":0.612981},"labels":[],"label_agreement":null},{"id":"W4409632840","doi":"10.1158/1538-7445.am2025-4592","title":"Abstract 4592: TERT expression predicts progression-free survival in meningiomas","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Progression-free survival; Medicine; Internal medicine; Oncology; Expression (computer science); Overall survival; Cancer research; Computer science; Programming language","score_opus":0.08661467430795224,"score_gpt":0.44234273100706945,"score_spread":0.3557280566991172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9111195,0.0017913319,0.000034907003,0.0035614509,0.00038599715,0.0010728488,0.00000766942,0.00007713778,0.081949115],"genre_scores_gemma":[0.98638767,0.00006239771,0.00034605362,0.000041649622,0.00018339734,0.00058622094,0.000016355965,0.000023444834,0.012352826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970702,0.00014863092,0.0003570806,0.00051354326,0.0012292238,0.0006813252],"domain_scores_gemma":[0.9985861,0.00019594247,0.000042509393,0.0007748086,0.0002047314,0.00019587816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018345707,0.00015977194,0.0003024509,0.0006424583,0.00020030234,0.00008253124,0.00042931773,0.00012825943,0.00057952886],"category_scores_gemma":[0.00044926233,0.00012643955,0.00006760158,0.00097641285,0.00014003982,0.00011547356,0.0005330456,0.0006237156,0.000027867674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003957754,0.0010767332,0.20011064,0.002744185,0.00024218604,0.006246736,0.0013720094,0.00003852837,0.3792188,0.0021785533,0.34321454,0.059599347],"study_design_scores_gemma":[0.011698408,0.0006289738,0.710823,0.0120620895,0.000061249055,0.000026938516,0.0013218719,0.00040516953,0.18932906,0.0035772834,0.069538414,0.000527524],"about_ca_topic_score_codex":0.00034257435,"about_ca_topic_score_gemma":0.00004726394,"teacher_disagreement_score":0.5107124,"about_ca_system_score_codex":0.00034049354,"about_ca_system_score_gemma":0.00041208416,"threshold_uncertainty_score":0.6345434},"labels":[],"label_agreement":null},{"id":"W4409633012","doi":"10.1158/1538-7445.am2025-4935","title":"Abstract 4935: Disentangling the association between age and overall survival in an international cohort of patients with advanced prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Alberta Cancer Foundation; Ottawa Hospital; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Cohort; Oncology; Cancer; Internal medicine; Overall survival; Cancer survival; Demography; Gerontology; Gynecology","score_opus":0.03512817418960494,"score_gpt":0.39953095173888536,"score_spread":0.3644027775492804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603933,0.0006182384,5.01737e-7,0.0013503078,0.000119317665,0.0010313236,0.00024397261,0.0000072089592,0.0005897712],"genre_scores_gemma":[0.9964875,0.002503389,0.000012919548,0.000050705716,0.00005862782,0.00050574925,0.000120261284,0.0000113733795,0.00024947058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986768,0.000058277805,0.0001949462,0.00025016518,0.00057825143,0.00024159733],"domain_scores_gemma":[0.9991169,0.00018781253,0.000078462,0.00015534044,0.00040087625,0.00006063623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043707518,0.00008774618,0.00020893349,0.00012170101,0.00006356839,0.000034169127,0.00009312417,0.00003889839,0.000041835807],"category_scores_gemma":[0.00006243107,0.00005747378,0.000020462945,0.00023756444,0.000078608464,0.00014817092,0.000053654298,0.0002443528,3.8839562e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056468433,0.00014487532,0.98104614,0.00007833442,0.00022061537,0.000009289148,0.00032931243,0.000049873153,0.00012471405,0.000055307883,0.00007399908,0.017302845],"study_design_scores_gemma":[0.002831359,0.00014199888,0.9943998,0.000444331,0.000041937663,1.9241742e-8,0.00008897887,0.000011590191,0.0010688073,0.00007503901,0.00084489025,0.000051246552],"about_ca_topic_score_codex":0.0011757676,"about_ca_topic_score_gemma":0.0017431361,"teacher_disagreement_score":0.0172516,"about_ca_system_score_codex":0.0011203873,"about_ca_system_score_gemma":0.00026580287,"threshold_uncertainty_score":0.2929774},"labels":[],"label_agreement":null},{"id":"W4409633143","doi":"10.1158/1538-7445.am2025-5402","title":"Abstract 5402: Metabolic shift towards the <i>de novo</i> serine pathway in non-transformed breast cells drives epigenetic plasticity, oxidative DNA damage, and pro-tumorigenic cChanges associated with aging","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epigenetics; DNA damage; Serine; Cancer research; Biology; Oxidative phosphorylation; Oxidative stress; Cell biology; Oxidative damage; DNA; Genetics; Gene; Biochemistry; Phosphorylation","score_opus":0.025499766362075457,"score_gpt":0.330969193061097,"score_spread":0.30546942669902155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939533,0.0033729356,0.0005117942,0.00080123916,0.00006848702,0.0006259057,0.00009390251,0.000008111414,0.00056434167],"genre_scores_gemma":[0.99593836,0.0032417078,0.000048054575,0.00006225514,0.00012142881,0.00024105236,0.000041846568,0.000026940601,0.0002783798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982568,0.00020905527,0.00021792136,0.0004399426,0.00030744422,0.0005688482],"domain_scores_gemma":[0.99927676,0.00011894663,0.00006119874,0.00023285043,0.00021079696,0.00009946069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009253799,0.00019536125,0.00021696796,0.00015576062,0.00020345842,0.000091627604,0.000286048,0.0001311293,0.00001979813],"category_scores_gemma":[0.000086173764,0.00014404225,0.000040582087,0.0005112675,0.00028696537,0.000010139768,0.00015489126,0.00036262217,0.0000011827642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012706067,0.00008094321,0.0063424897,0.00007111053,0.000110961446,0.000008483012,0.0007386185,0.0003631494,0.98561484,0.000034206227,0.000016041256,0.0064920904],"study_design_scores_gemma":[0.0006476859,0.00010161973,0.28145376,0.00009972294,0.0000147063565,7.0268015e-7,0.00020236848,0.000056504403,0.71634114,0.00013042203,0.0008198799,0.0001315034],"about_ca_topic_score_codex":0.0004647351,"about_ca_topic_score_gemma":0.0067716697,"teacher_disagreement_score":0.27511126,"about_ca_system_score_codex":0.00007280563,"about_ca_system_score_gemma":0.00053839263,"threshold_uncertainty_score":0.58738726},"labels":[],"label_agreement":null},{"id":"W4409633240","doi":"10.1158/1538-7445.am2025-2830","title":"Abstract 2830: Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with a combination of PARP and ATR inhibitors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Poly ADP ribose polymerase; Kinase; Phosphorylation; Cancer research; Medicine; Pharmacology; Chemistry; Enzyme; Biochemistry; Polymerase","score_opus":0.016328131118455245,"score_gpt":0.3354533684543829,"score_spread":0.3191252373359276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967104,0.0020559258,0.000055650104,0.00035807784,0.000054975797,0.00042007587,0.000022597304,0.0000049095283,0.00031737017],"genre_scores_gemma":[0.9977844,0.0010503841,0.00011569773,0.00004410111,0.000028499075,0.00017153619,0.000032759388,0.000013227384,0.0007594425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991395,0.000036783615,0.00013333233,0.0003058986,0.00014621948,0.00023825958],"domain_scores_gemma":[0.9994967,0.000026311947,0.000029345185,0.0002146936,0.000156742,0.000076218224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016731465,0.000110072426,0.00014126748,0.00010735392,0.00009995448,0.000028140075,0.00009649359,0.00008487322,0.000008457327],"category_scores_gemma":[0.000025046897,0.000091375805,0.00005031056,0.00020292962,0.00007978832,0.000004385907,0.00009166782,0.00007674275,0.0000017062831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021430654,0.00010490026,0.017724477,0.0000508833,0.00014346107,0.00000396038,0.00019059685,0.000026320424,0.9673277,0.000051529478,0.0008064752,0.013355371],"study_design_scores_gemma":[0.00086082175,0.0007254639,0.007369791,0.00012970236,0.000024678953,3.661593e-7,0.00026979076,0.0000115819885,0.9830619,0.00003287604,0.0074114897,0.00010153891],"about_ca_topic_score_codex":0.0007672093,"about_ca_topic_score_gemma":0.000507117,"teacher_disagreement_score":0.015734179,"about_ca_system_score_codex":0.00009448059,"about_ca_system_score_gemma":0.00022519294,"threshold_uncertainty_score":0.37261972},"labels":[],"label_agreement":null},{"id":"W4409633291","doi":"10.1158/1538-7445.am2025-6978","title":"Abstract 6978: Discovery and characterization of BAY-805, a potent and selective DUB inhibitor of ubiquitin specific peptidase USP21","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Ubiquitin; Biology; Chemistry; Biochemistry; Gene","score_opus":0.027492961839773143,"score_gpt":0.32500289262766524,"score_spread":0.2975099307878921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659884,0.001776745,0.00009282637,0.00021838985,0.00004405915,0.00033442667,0.00016351095,0.0000027387348,0.0007684919],"genre_scores_gemma":[0.9965797,0.0024553442,0.000030128336,0.00002752871,0.00011920688,0.000045497167,0.00005864244,0.000010144853,0.0006738144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990956,0.00008087638,0.00018684642,0.00028076416,0.00016123538,0.0001946354],"domain_scores_gemma":[0.99945325,0.000028476057,0.00006330129,0.00016496157,0.00023824208,0.000051773135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036243102,0.00008906151,0.00014522941,0.00010883611,0.000064178224,0.000029761884,0.00008414237,0.000096046824,0.000022287157],"category_scores_gemma":[0.00005541789,0.00008343215,0.000031559615,0.00017670194,0.00022764466,0.000010904706,0.00015419367,0.00014027095,6.273181e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002956629,0.000046061967,0.0025567247,0.00025941292,0.000033059147,0.0000014064054,0.00012237624,6.827956e-7,0.9896631,0.00020189075,0.0002800747,0.0065395026],"study_design_scores_gemma":[0.00038750656,0.00016690372,0.052514236,0.00016538148,0.000004657553,0.0000012912732,0.000104829174,0.0000039390657,0.9436904,0.00009731834,0.0027931253,0.00007038885],"about_ca_topic_score_codex":0.000072054565,"about_ca_topic_score_gemma":0.000033911398,"teacher_disagreement_score":0.04995751,"about_ca_system_score_codex":0.000024049368,"about_ca_system_score_gemma":0.00018980174,"threshold_uncertainty_score":0.3402264},"labels":[],"label_agreement":null},{"id":"W4409633305","doi":"10.1158/1538-7445.am2025-6178","title":"Abstract 6178: Photochemical immune stimulation eradicates primary tumor and induces long-lasting anti-tumor immunity in a murine cutaneous melanoma model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Melanoma; Stimulation; Immunity; Medicine; Immune system; Immunology; Primary (astronomy); Cancer research; Internal medicine","score_opus":0.030977718087892327,"score_gpt":0.32046213534033985,"score_spread":0.2894844172524475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229527,0.0056425924,0.000250963,0.00005188945,0.00011848668,0.0006093909,0.00003315591,0.00012694787,0.0008713019],"genre_scores_gemma":[0.9987875,0.0005482092,0.00026264854,0.000024368273,0.00005674148,0.00018275139,0.000025208772,0.000050956005,0.0000616033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982569,0.000028284358,0.00042869523,0.00030531254,0.00037584247,0.0006049351],"domain_scores_gemma":[0.99904454,0.0003702472,0.00004212095,0.00032160123,0.00012213172,0.000099345416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044676004,0.0002218434,0.00034922108,0.00044499105,0.00014577185,0.000090845664,0.00033014157,0.000104037856,0.000049883063],"category_scores_gemma":[0.00012101388,0.00022725202,0.00004122262,0.0006782571,0.00017193267,0.00022873646,0.00017974625,0.001060791,0.000005935741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015740105,0.000052360625,0.0043593403,0.00067712687,0.00005443937,0.00008725668,0.00022349559,0.049190562,0.9405223,0.00002223219,0.0000545668,0.004598926],"study_design_scores_gemma":[0.0019643838,0.00007128644,0.05636727,0.0012344813,0.0000240424,0.000040804505,0.0001109695,0.21884042,0.7192945,0.0014451233,0.00010665536,0.0005000779],"about_ca_topic_score_codex":0.00055775885,"about_ca_topic_score_gemma":0.000086934466,"teacher_disagreement_score":0.22122781,"about_ca_system_score_codex":0.0007561291,"about_ca_system_score_gemma":0.00029447474,"threshold_uncertainty_score":0.92670685},"labels":[],"label_agreement":null},{"id":"W4409633319","doi":"10.1158/1538-7445.am2025-3630","title":"Abstract 3630: First-line therapies and subjective cognitive function trajectories among international metastatic hormone-sensitive prostate cancer survivors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Ottawa Hospital; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Cognition; Internal medicine; Cancer; Hormone therapy; Psychiatry; Breast cancer","score_opus":0.0465364506418908,"score_gpt":0.3896481365309057,"score_spread":0.34311168588901486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978232,0.010670923,0.00012719564,0.0045907106,0.00072243105,0.001935482,0.000404139,0.00008324325,0.0032338568],"genre_scores_gemma":[0.97737145,0.016696863,0.000010502249,0.00023244049,0.00027454892,0.0014878487,0.0000594415,0.000039514336,0.0038274054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997548,0.00015509209,0.00033412618,0.00063551834,0.000761071,0.0005661886],"domain_scores_gemma":[0.9964022,0.000940854,0.000108187305,0.00014198403,0.0022712424,0.00013550131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070149987,0.0002925598,0.0004588973,0.000588872,0.0004931372,0.000094745454,0.00008597869,0.00009268621,0.00024145073],"category_scores_gemma":[0.0005446015,0.00025180547,0.000092588045,0.0009139069,0.0011198465,0.00030677931,0.00013955383,0.00080905826,0.000011113254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041973326,0.0009972157,0.7314259,0.0013082636,0.01904282,0.00029568825,0.034788534,0.00013633579,0.015917549,0.0004651658,0.0058767074,0.14777249],"study_design_scores_gemma":[0.0039730985,0.00059556897,0.9701352,0.0012924052,0.00041843925,0.0000044683543,0.013917959,0.00007512396,0.0072455634,0.0005779712,0.0015216244,0.00024257813],"about_ca_topic_score_codex":0.01228963,"about_ca_topic_score_gemma":0.016811194,"teacher_disagreement_score":0.2387093,"about_ca_system_score_codex":0.00072649214,"about_ca_system_score_gemma":0.0005452856,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W4409633477","doi":"10.1158/1538-7445.am2025-1689","title":"Abstract 1689: Targeting PARP to enhance sensitivity to MEK inhibitors in low-grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; PARP inhibitor; Serous ovarian cancer; Serous fluid; Medicine; Cancer; Cancer research; Oncology; Poly ADP ribose polymerase; Internal medicine; Biology; Genetics; Polymerase; DNA","score_opus":0.043004986751201096,"score_gpt":0.43150662798386413,"score_spread":0.38850164123266306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474872,0.001887306,0.000057928977,0.04562694,0.0006339616,0.0018799021,0.00009434942,0.000056728004,0.002275682],"genre_scores_gemma":[0.99297994,0.0006912988,0.00033552438,0.0020504522,0.00061798765,0.0018743939,0.000012150497,0.000045201796,0.0013930624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99657065,0.00019027754,0.00044615343,0.00092948147,0.0007842211,0.0010792478],"domain_scores_gemma":[0.9981472,0.00036508043,0.000048030484,0.0005304706,0.00039512277,0.00051413587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001468297,0.00027097762,0.00053023186,0.0006354893,0.00019748733,0.00008603564,0.00016209843,0.00013100573,0.00040570737],"category_scores_gemma":[0.00037844456,0.00025050846,0.00009768436,0.0020993634,0.000081743536,0.00010106442,0.00020951105,0.0007446482,0.0001125605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002297118,0.0020064637,0.22408931,0.0017666395,0.0005991772,0.002307415,0.004417014,0.0044970443,0.24886304,0.00039623198,0.20495088,0.30380964],"study_design_scores_gemma":[0.0019486905,0.00025701293,0.48489526,0.005296849,0.00005087252,0.0000035286039,0.0004996926,0.000071391616,0.46038014,0.00010284388,0.0460794,0.00041432545],"about_ca_topic_score_codex":0.027935302,"about_ca_topic_score_gemma":0.016780332,"teacher_disagreement_score":0.30339533,"about_ca_system_score_codex":0.0026306633,"about_ca_system_score_gemma":0.0014229451,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W4409633492","doi":"10.1158/1538-7445.am2025-4748","title":"Abstract 4748: Understanding the RSAD2/CMPK2 signaling axis in PVT1 exon 9 overexpressed neuroendocrine prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PVT1; Prostate cancer; Exon; Cancer; Medicine; Prostate; Cancer research; Biology; Internal medicine; Genetics; Gene; Long non-coding RNA; RNA","score_opus":0.14421120429211431,"score_gpt":0.44431699319982326,"score_spread":0.30010578890770895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9439423,0.018767579,0.000042713164,0.025428686,0.0003958927,0.0028204569,0.000092172384,0.00007863141,0.008431571],"genre_scores_gemma":[0.9792176,0.008690671,0.000012964222,0.0003902936,0.00022223308,0.0013081962,0.000026392023,0.00005041588,0.010081217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99613875,0.00024043638,0.00043086958,0.00069352833,0.0011737392,0.0013226903],"domain_scores_gemma":[0.99818283,0.00061717065,0.00006348798,0.0006010908,0.00031844995,0.00021695816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010215802,0.00027065893,0.00041926917,0.00066428876,0.0004929395,0.00016982366,0.00040814624,0.00007349595,0.0011569902],"category_scores_gemma":[0.00021130902,0.00018100507,0.00011875946,0.0019369235,0.00049095455,0.00018309482,0.0002661413,0.0015514279,0.00002466574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154478485,0.0009249041,0.17680992,0.004245937,0.0010937114,0.0027940243,0.0039721504,0.0018918025,0.6938656,0.00356248,0.059870522,0.03552112],"study_design_scores_gemma":[0.032907914,0.0014838695,0.13567834,0.014677195,0.00032995472,0.000046889178,0.0137746865,0.0022216153,0.68880033,0.016969342,0.09169141,0.0014184312],"about_ca_topic_score_codex":0.0040834183,"about_ca_topic_score_gemma":0.0011380521,"teacher_disagreement_score":0.041131582,"about_ca_system_score_codex":0.0025873042,"about_ca_system_score_gemma":0.0018739532,"threshold_uncertainty_score":0.9997561},"labels":[],"label_agreement":null},{"id":"W4409633576","doi":"10.1158/1538-7445.am2025-6588","title":"Abstract 6588: Characterization of TGFb1-induced ApoEVs and their potential role in epithelial cell plasticity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Plasticity; Cell biology; Biology; Cancer research; Physics","score_opus":0.03458404189254469,"score_gpt":0.36102818025139194,"score_spread":0.3264441383588472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962159,0.0001929552,0.00007187263,0.0006331567,0.000064255306,0.00064479676,0.00004306374,0.000012465143,0.0021215724],"genre_scores_gemma":[0.99826723,0.0005039364,0.0000138665155,0.00003893481,0.00008934707,0.000073637246,0.000021983227,0.000017996214,0.00097305665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982505,0.00013261291,0.00030371704,0.00033857903,0.00054344954,0.00043116088],"domain_scores_gemma":[0.99910074,0.0001445055,0.000043521508,0.00022488054,0.00034646605,0.00013989268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064183987,0.00011703495,0.00027834618,0.00046134615,0.00007531237,0.000030589024,0.00016405505,0.0001403071,0.0003580101],"category_scores_gemma":[0.00016138429,0.00009803101,0.00004675327,0.00068701373,0.00016554343,0.00006231489,0.00020187981,0.000681076,0.000017627468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008414858,0.0001770063,0.0033880211,0.00038770284,0.000013067707,0.000022276847,0.00023305614,0.0000051825377,0.9734315,0.000025833491,0.000037027363,0.021437837],"study_design_scores_gemma":[0.0013187687,0.000117768715,0.2375015,0.00018678053,0.000004828609,0.0000012351488,0.00017870154,0.000567507,0.7594989,0.00007193034,0.0004947723,0.00005728291],"about_ca_topic_score_codex":0.0010288553,"about_ca_topic_score_gemma":0.000091604874,"teacher_disagreement_score":0.23411348,"about_ca_system_score_codex":0.00018908543,"about_ca_system_score_gemma":0.0005559737,"threshold_uncertainty_score":0.39975885},"labels":[],"label_agreement":null},{"id":"W4409633666","doi":"10.1158/1538-7445.am2025-6831","title":"Abstract 6831: Systems biology analysis of vitamin D3 reveals new anticancer properties","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Computational biology; Physiology; Cancer research","score_opus":0.14794177729450583,"score_gpt":0.4795455169632398,"score_spread":0.331603739668734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96248704,0.024236232,0.00007415992,0.004540268,0.00021735506,0.0010948123,0.000062875384,0.00004028486,0.007246987],"genre_scores_gemma":[0.970093,0.004093111,0.000037140635,0.00006541892,0.00018752138,0.00031077646,0.0000125948245,0.000017726883,0.025182694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970923,0.00025393593,0.00051354116,0.0005127994,0.0008436926,0.0007837343],"domain_scores_gemma":[0.99729264,0.00045924017,0.00007853747,0.00070350943,0.0012529119,0.00021319042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017809898,0.00017147635,0.0009396687,0.0017734688,0.00016735816,0.000038088972,0.00036434017,0.0001468575,0.00036169947],"category_scores_gemma":[0.0014741183,0.000120229895,0.00019043952,0.003900265,0.00082810165,0.000065181805,0.0003059808,0.00059535244,0.000026571748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046230835,0.00020073219,0.18562406,0.0027724775,0.0072766948,0.000030460817,0.0006124219,0.00014639366,0.73397374,0.0017737418,0.057627648,0.009499298],"study_design_scores_gemma":[0.0019939938,0.0004520332,0.92990124,0.0027492952,0.0011417056,0.0000016920175,0.0020863877,0.00046901344,0.04696422,0.00023724472,0.013730977,0.00027221473],"about_ca_topic_score_codex":0.0077750906,"about_ca_topic_score_gemma":0.00030926248,"teacher_disagreement_score":0.7442772,"about_ca_system_score_codex":0.0005107257,"about_ca_system_score_gemma":0.0014408344,"threshold_uncertainty_score":0.9988322},"labels":[],"label_agreement":null},{"id":"W4409633723","doi":"10.1158/1538-7445.am2025-3033","title":"Abstract 3033: Increased mitochondrial protein import necessitates greater reliance on the mitochondrial unfolded protein response (UPRmt) and the protease LONP1 to maintain mitochondrial protein solubility and cell viability in acute myeloid leukemia (AML)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Unfolded protein response; Mitochondrion; Myeloid leukemia; Cell biology; Cell; Protease; Biology; Chemistry; Cancer research; Endoplasmic reticulum; Biochemistry; Enzyme","score_opus":0.018269747941975518,"score_gpt":0.30734328555391627,"score_spread":0.28907353761194077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722583,0.0002663502,0.00020780048,0.0099440105,0.0005448657,0.016349457,0.00015737892,0.000036261143,0.00023557286],"genre_scores_gemma":[0.97664297,0.000050144456,0.0010809175,0.0007037731,0.0009991918,0.015702443,0.00005092161,0.0000706017,0.0046990244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99161756,0.0037858104,0.0008991042,0.0018297819,0.00073281385,0.0011349252],"domain_scores_gemma":[0.9968716,0.0004894201,0.00021275463,0.0016174781,0.00043894883,0.00036979164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037228013,0.0005848542,0.00064048485,0.0003227096,0.0007060053,0.00028382437,0.0008440194,0.0006101073,0.00014302749],"category_scores_gemma":[0.00404575,0.00038880375,0.00019102715,0.0008348164,0.0014342845,0.0000351259,0.0007038152,0.001433721,0.00002599891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09193793,0.00013783008,0.0006219844,0.00016632148,0.00006352799,0.000042503678,0.00028212165,0.000017821918,0.9034915,0.00021640462,0.0025422426,0.00047982746],"study_design_scores_gemma":[0.009847633,0.0011317455,0.005245231,0.0004083676,0.00003430287,0.000008997585,0.0002759862,0.000041166542,0.97193307,0.0026533892,0.0079016425,0.0005184624],"about_ca_topic_score_codex":0.002401622,"about_ca_topic_score_gemma":0.0011473483,"teacher_disagreement_score":0.082090296,"about_ca_system_score_codex":0.00045535006,"about_ca_system_score_gemma":0.0020024388,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W4409633726","doi":"10.1158/1538-7445.am2025-5411","title":"Abstract 5411: The IL-23 receptor localizes intracellularly in AML and stem cells where it regulates mitotic spindle formation to maintain cell viability","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Stem cell; Cell biology; Mitosis; Cancer research; Viability assay; Biology; Cell; Receptor; Genetics","score_opus":0.022362566505663508,"score_gpt":0.3257381044331799,"score_spread":0.3033755379275164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898244,0.0027484032,0.00014539614,0.005902849,0.00008793605,0.0008691588,0.000033745375,0.000008034337,0.0003800823],"genre_scores_gemma":[0.9941149,0.002206515,0.00005595828,0.00014722758,0.0001314278,0.00025149639,0.000025763535,0.000016667756,0.0030500914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787676,0.00021042346,0.00031869492,0.00053550757,0.00038251086,0.0006760846],"domain_scores_gemma":[0.9988597,0.00009660855,0.000040581715,0.0005448364,0.00030795176,0.00015030854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015989776,0.00017292071,0.0001788521,0.00013964725,0.00019663521,0.00013795988,0.000511049,0.00023579346,0.000066749446],"category_scores_gemma":[0.000079099824,0.000134896,0.000053685028,0.0005747321,0.0003692529,0.000025092526,0.0003430078,0.0004571291,0.000040052513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019811712,0.00007596427,0.0026271623,0.00045605536,0.000011312892,0.000002514729,0.00017586777,0.000024327717,0.97431606,0.000033004017,0.0150327915,0.0070468145],"study_design_scores_gemma":[0.00033808153,0.0001236595,0.0014584288,0.00020222166,0.0000035119153,7.829599e-7,0.0022168863,0.00009108898,0.96506625,0.0000935625,0.030256856,0.00014866874],"about_ca_topic_score_codex":0.00054503337,"about_ca_topic_score_gemma":0.0010769616,"teacher_disagreement_score":0.015224066,"about_ca_system_score_codex":0.00018424548,"about_ca_system_score_gemma":0.00031987933,"threshold_uncertainty_score":0.55008996},"labels":[],"label_agreement":null},{"id":"W4409633762","doi":"10.1158/1538-7445.am2025-7179","title":"Abstract 7179: Streamlined Glioma diagnosis from formalin-fixed paraffin-embedded (FFPE) tissue: One assay, a fraction of the cost and turnaround time","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Turnaround time; Medicine; Fraction (chemistry); Glioma; Pathology; Chromatography; Chemistry; Cancer research; Computer science","score_opus":0.05882150775677461,"score_gpt":0.40515795716802505,"score_spread":0.3463364494112504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987248,0.003426369,0.000016807797,0.006888635,0.00011796952,0.0013360704,0.00014645018,0.000027839005,0.00079186197],"genre_scores_gemma":[0.9972149,0.0011131051,0.00013395227,0.00011894222,0.00014617502,0.0007946083,0.00005157876,0.00002204283,0.0004046736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979676,0.00015726406,0.00035280312,0.0003844403,0.00072435825,0.00041354753],"domain_scores_gemma":[0.99760115,0.0011772513,0.000117162715,0.0005458697,0.00038937345,0.00016921999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057953375,0.00017842714,0.00043737117,0.0002606247,0.00022068771,0.00007225141,0.00018297278,0.00016051403,0.0008703534],"category_scores_gemma":[0.0004591014,0.00012632071,0.0000964498,0.00074142165,0.00022115931,0.00012271666,0.00015501337,0.00042622947,0.000044633263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017093917,0.0031021475,0.17914729,0.0005031076,0.0015666615,0.0001965213,0.00057385914,0.00004378879,0.61389464,0.00057713536,0.028921211,0.16976424],"study_design_scores_gemma":[0.0031876352,0.00019045747,0.37741578,0.0008965882,0.00020884973,0.0000035450796,0.00017290078,0.00017511933,0.61291873,0.00054658763,0.0041750213,0.00010878179],"about_ca_topic_score_codex":0.0076302416,"about_ca_topic_score_gemma":0.0004441594,"teacher_disagreement_score":0.19826849,"about_ca_system_score_codex":0.00040029624,"about_ca_system_score_gemma":0.00036792268,"threshold_uncertainty_score":0.998978},"labels":[],"label_agreement":null},{"id":"W4409633765","doi":"10.1158/1538-7445.am2025-6429","title":"Abstract 6429: Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Colorectal cancer; Medicine; Observational study; ANGPTL4; Oncology; Internal medicine; Cancer; Cancer research; Bioinformatics; Biology; Genetics; Gene","score_opus":0.16549684241284265,"score_gpt":0.4832495256997687,"score_spread":0.3177526832869261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96080047,0.026921973,0.00032746966,0.00852016,0.00023111966,0.0028086933,0.000054778466,0.000027099119,0.00030826748],"genre_scores_gemma":[0.9896756,0.0030080534,0.0002813668,0.00040148813,0.00035344594,0.0035192103,0.000029621677,0.000019393612,0.0027118577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998608,0.000060660444,0.00020647596,0.00038624162,0.0003463282,0.00039228646],"domain_scores_gemma":[0.9991027,0.00014411859,0.000047357364,0.0001658045,0.00042912163,0.00011090818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006877699,0.00011440295,0.0002102765,0.00016067103,0.0002179408,0.000055834935,0.00012996916,0.0000918416,0.00039887472],"category_scores_gemma":[0.00020578595,0.000098628785,0.00007856998,0.00032196887,0.00016613893,0.00015986741,0.0000674955,0.00023992619,0.000009152643],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00368518,0.00016640118,0.028509686,0.0010326651,0.0002403871,0.0000032250443,0.00022243045,0.0000475053,0.87261444,0.0020705985,0.005683215,0.085724264],"study_design_scores_gemma":[0.0039298153,0.00048324754,0.8578403,0.0007524151,0.00016963143,0.0000062327936,0.00024141408,0.00043250405,0.0828236,0.016363597,0.036721848,0.00023540156],"about_ca_topic_score_codex":0.0009379964,"about_ca_topic_score_gemma":0.00007819893,"teacher_disagreement_score":0.8293306,"about_ca_system_score_codex":0.00017389047,"about_ca_system_score_gemma":0.0018936687,"threshold_uncertainty_score":0.43673983},"labels":[],"label_agreement":null},{"id":"W4409633818","doi":"10.1158/1538-7445.am2025-2758","title":"Abstract 2758: Methylome plasticity as a biomarker of treatment response in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Lung cancer; Cancer; Biology; DNA methylation; Medicine; Cancer research; Oncology; Internal medicine; Genetics; Gene expression; Gene","score_opus":0.10422788769621784,"score_gpt":0.49205316455889025,"score_spread":0.38782527686267243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96773565,0.017637957,0.000009837746,0.0037254912,0.000151932,0.0017757077,0.00010971287,0.000032159183,0.008821565],"genre_scores_gemma":[0.9793298,0.0064562564,0.00005731164,0.00009342294,0.00007850704,0.0019053674,0.0000043504615,0.00003494201,0.012040007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966055,0.00048444947,0.0005058636,0.0006490913,0.0007491786,0.0010059197],"domain_scores_gemma":[0.99647826,0.00198963,0.00007363486,0.0005085341,0.00069578015,0.0002541606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019927244,0.00025922598,0.0006743774,0.0012987586,0.00014500493,0.000030425941,0.00030707108,0.00015355255,0.0012425503],"category_scores_gemma":[0.0011822917,0.00020459674,0.00014878021,0.0019370683,0.00049805635,0.000066432076,0.00027983647,0.00066488923,0.000024066876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.04248256,0.0009838525,0.11187697,0.0033917925,0.0010517823,0.000430317,0.0024270557,0.00014415335,0.80790603,0.0001020323,0.01644564,0.012757804],"study_design_scores_gemma":[0.008696062,0.0014664932,0.5952336,0.0027095564,0.00015983614,0.0000028221566,0.0009851322,0.00041294898,0.37447163,0.00018110548,0.015391997,0.00028880563],"about_ca_topic_score_codex":0.033409875,"about_ca_topic_score_gemma":0.0047992226,"teacher_disagreement_score":0.48335662,"about_ca_system_score_codex":0.0055746185,"about_ca_system_score_gemma":0.0066493535,"threshold_uncertainty_score":0.99967045},"labels":[],"label_agreement":null},{"id":"W4409633839","doi":"10.1158/1538-7445.am2025-7393","title":"Abstract 7393: Occupational benzene exposure and solid cancers: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Cancer Research","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Occupational exposure; Oncology; Cancer; Systematic review; Internal medicine; Environmental health; MEDLINE; Chemistry","score_opus":0.17296452511251512,"score_gpt":0.498193825001981,"score_spread":0.3252292998894659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028454793,0.99635905,0.00001785085,0.00012523783,0.00002265554,0.0022899392,0.0010294893,0.0000045355596,0.00012275764],"genre_scores_gemma":[0.000313165,0.9940845,0.000033456356,0.00023438096,0.00008012999,0.003016281,0.00036683094,0.000024327635,0.0018469781],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972239,0.0004469685,0.0006639227,0.000813106,0.00047839707,0.00037367328],"domain_scores_gemma":[0.9983417,0.00013914713,0.00024196829,0.0007362186,0.00038255315,0.00015842616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013568222,0.0003686198,0.0033844707,0.00031045146,0.00016829949,0.000104110084,0.00031649665,0.0002755049,0.00024722033],"category_scores_gemma":[0.00016249853,0.00026518732,0.0010237364,0.0006850471,0.00011720995,0.0000043037767,0.00035983586,0.0003607575,0.0000030109904],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058894166,0.000018870829,0.0000023410705,0.915807,0.07950122,0.0000059213503,0.000008003315,0.0000029684848,0.00005876857,0.000020565925,0.0018071184,0.002761303],"study_design_scores_gemma":[0.0001724191,0.0001362736,0.000022326363,0.040178396,0.7871887,0.000019056808,0.000029897925,0.0000013257062,0.00010523181,0.000012157956,0.17148282,0.000651389],"about_ca_topic_score_codex":0.00029421726,"about_ca_topic_score_gemma":0.0007166393,"teacher_disagreement_score":0.87562865,"about_ca_system_score_codex":0.00014889172,"about_ca_system_score_gemma":0.0014248198,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W4409633840","doi":"10.1158/1538-7445.am2025-6012","title":"Abstract 6012: PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Oncology; Internal medicine; Cancer research","score_opus":0.19960217398232777,"score_gpt":0.5205241300861528,"score_spread":0.32092195610382507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95824,0.018740743,0.000013082288,0.011072699,0.00039393845,0.0061704796,0.00015763912,0.000038650833,0.005172779],"genre_scores_gemma":[0.86984545,0.02836565,0.00005578994,0.00012648199,0.00049855537,0.0037672217,0.000018795363,0.00005610223,0.09726593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970154,0.00022982084,0.00044587284,0.0005505392,0.00090108666,0.0008572914],"domain_scores_gemma":[0.9936277,0.004475958,0.000067822344,0.0008543321,0.00075687305,0.00021727236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020267246,0.00020424937,0.0004820664,0.00026891517,0.00031163442,0.00005276607,0.00038375112,0.0001515821,0.0039070523],"category_scores_gemma":[0.00039590264,0.00012915443,0.00031860094,0.00074023666,0.0006160886,0.000042371354,0.00007420479,0.0007547029,0.000020031817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013074335,0.0021226273,0.015716475,0.001083702,0.0009010728,0.000025695914,0.0023663323,0.00019054639,0.33011472,0.00008152869,0.03194273,0.6023802],"study_design_scores_gemma":[0.01152804,0.0019142042,0.028108502,0.00044263265,0.00016310869,0.0000011864466,0.0007119989,0.00027411207,0.39034444,0.00009774616,0.56624323,0.00017081994],"about_ca_topic_score_codex":0.0023672455,"about_ca_topic_score_gemma":0.0005820974,"teacher_disagreement_score":0.60220945,"about_ca_system_score_codex":0.0009593947,"about_ca_system_score_gemma":0.0023372811,"threshold_uncertainty_score":0.9970035},"labels":[],"label_agreement":null},{"id":"W4409633910","doi":"10.1158/1538-7445.am2025-7397","title":"Abstract 7397: A multi-ancestry polygenic risk score improves lung cancer risk stratification across diverse populations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Polygenic risk score; Risk stratification; Lung cancer; Medicine; Cancer; Demography; Internal medicine; Oncology; Biology; Genetics; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.08103721685158555,"score_gpt":0.4594363407945058,"score_spread":0.37839912394292025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96899545,0.016671877,0.010248492,0.00047220362,0.00066599465,0.0013746396,0.0011613742,0.000047204736,0.00036278748],"genre_scores_gemma":[0.98273826,0.01120087,0.0002725002,0.000059556394,0.0003736905,0.0011236,0.00020677694,0.00005819772,0.0039665485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964366,0.00033514522,0.00041759427,0.0010535336,0.00070084975,0.0010562681],"domain_scores_gemma":[0.99769884,0.00004989832,0.00018549743,0.0010374472,0.00078628364,0.00024203218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011053641,0.00028785397,0.00024136792,0.00023583136,0.0010482655,0.00020955093,0.0007376614,0.00043873108,0.00020624907],"category_scores_gemma":[0.000516802,0.00029528813,0.00019514818,0.0009435005,0.00037942585,0.000026420192,0.00047852565,0.0012580608,0.000022103502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037454633,0.0001514498,0.014955299,0.00017210028,0.00036178308,0.000007254821,0.00020137597,0.0036909378,0.9270047,0.00014352535,0.00689511,0.046041936],"study_design_scores_gemma":[0.0038268846,0.00024013114,0.20889612,0.0004285835,0.00018198985,0.0000029215666,0.0013871129,0.007203914,0.7622981,0.0005506907,0.014068747,0.00091478624],"about_ca_topic_score_codex":0.013523952,"about_ca_topic_score_gemma":0.013987829,"teacher_disagreement_score":0.19394082,"about_ca_system_score_codex":0.00048280394,"about_ca_system_score_gemma":0.0015657854,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W4409633911","doi":"10.1158/1538-7445.am2025-7399","title":"Abstract 7399: Polygenic risk score-based smoking and drinking behaviors and head and neck squamous cell cancer risk by HPV status","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Polygenic risk score; Squamous cell cancer; Head and neck cancer; Oncology; Internal medicine; Cancer; Head and neck; Basal cell; Surgery; Biology; Genetics; Gene; Genotype","score_opus":0.032805195630762105,"score_gpt":0.3844168502546197,"score_spread":0.3516116546238576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87609035,0.12206407,0.000017561366,0.00029641125,0.00019438547,0.00080376276,0.00020296265,0.000039374965,0.00029112623],"genre_scores_gemma":[0.9403644,0.058870863,0.00003628766,0.00013989267,0.00012431199,0.00015095275,0.000020329922,0.000040297135,0.00025263143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971178,0.00020483464,0.00031674383,0.0006749711,0.00070085464,0.0009848005],"domain_scores_gemma":[0.99835926,0.00028468852,0.00008814547,0.0004094104,0.00019336642,0.00066514726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001118686,0.00023830544,0.00047073912,0.00038560637,0.000626533,0.00010375279,0.00008675372,0.00021286283,0.0001234931],"category_scores_gemma":[0.0001669102,0.00020593905,0.00010405112,0.0004884517,0.000374735,0.00007947043,0.000117946205,0.0014051878,0.0000015228113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041340658,0.000054173877,0.8888329,0.0006459762,0.00007859388,0.000030798346,0.00037926083,0.000021966895,0.0019754043,0.0000019441586,0.0009801098,0.10658546],"study_design_scores_gemma":[0.004810716,0.00018406978,0.97651964,0.000375507,0.00030439565,0.0000043740492,0.00026579836,0.00009342414,0.0057595964,0.000021464797,0.011458804,0.00020222376],"about_ca_topic_score_codex":0.10266103,"about_ca_topic_score_gemma":0.006795903,"teacher_disagreement_score":0.106383234,"about_ca_system_score_codex":0.0004838646,"about_ca_system_score_gemma":0.00123807,"threshold_uncertainty_score":0.9033144},"labels":[],"label_agreement":null},{"id":"W4409633951","doi":"10.1158/1538-7445.am2025-7410","title":"Abstract 7410: Make it better and faster: a retrospective study examining the introduction of an agnostic, reflexive, and expanded pathological protocol for lung cancer patients in Saskatchewan, Canada","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Pathological; Protocol (science); Lung cancer; Medicine; Cancer; Reflexivity; Retrospective cohort study; Oncology; Pathology; Internal medicine; Alternative medicine; Sociology; Social science","score_opus":0.05625772534206818,"score_gpt":0.4658112349045153,"score_spread":0.4095535095624471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943906,0.000058064034,0.0000037506568,0.0022554765,0.00005637179,0.053504143,0.0000697771,0.000005631665,0.00014077166],"genre_scores_gemma":[0.8561253,0.0000093407025,0.000056937017,0.00014843259,0.00010706717,0.14316055,0.000012053292,0.000009835936,0.00037046752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998667,0.00010625536,0.00024617556,0.00039698358,0.00032669757,0.0002568862],"domain_scores_gemma":[0.9991578,0.00014180077,0.0000618968,0.00019609502,0.00037686148,0.00006555638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040854226,0.00011193722,0.00023755162,0.00011627211,0.0001589067,0.000028081191,0.0000661233,0.00004910756,0.000048195518],"category_scores_gemma":[0.00014725073,0.0000726514,0.000012673216,0.00026036164,0.00013388711,0.00006387824,0.00006165638,0.00026493176,3.0979734e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012110692,0.0004788078,0.9570295,0.00033833296,0.00014556253,0.00001680101,0.0052367705,0.000009993809,0.0011611292,0.000009408518,0.0028213384,0.031541258],"study_design_scores_gemma":[0.0051149908,0.0008761354,0.9835129,0.00022809542,0.00006324254,8.3468984e-7,0.008719586,0.000038313425,0.00085806905,0.00005208655,0.00047099165,0.000064797285],"about_ca_topic_score_codex":0.15870409,"about_ca_topic_score_gemma":0.7030176,"teacher_disagreement_score":0.5443135,"about_ca_system_score_codex":0.00076535356,"about_ca_system_score_gemma":0.0009529422,"threshold_uncertainty_score":0.8468982},"labels":[],"label_agreement":null},{"id":"W4409634192","doi":"10.1158/1538-7445.am2025-5899","title":"Abstract 5899: Comparative analysis of transcription factor activities derived from low-pass whole genome sequencing of cell-free DNA and from ATAC-sequencing of tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"DNA sequencing; Biology; Transcription factor; Transcription (linguistics); DNA; Genome; Computational biology; Cancer genome sequencing; Genetics; Cancer research; Gene; Reference genome","score_opus":0.054077105371806336,"score_gpt":0.3400488420279681,"score_spread":0.28597173665616177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899165,0.004219993,0.00041685038,0.000033177257,0.000053338048,0.00019131754,0.0048964433,0.000002578972,0.0002698093],"genre_scores_gemma":[0.99803877,0.0012739317,0.00019510918,0.000015784792,0.000053337542,0.000025049214,0.00034785908,0.000009754528,0.000040386047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987452,0.00007911726,0.00035821894,0.00035313147,0.00024245796,0.0002219011],"domain_scores_gemma":[0.99888587,0.0001968293,0.00016356587,0.00042342136,0.00026592996,0.00006435525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017700253,0.00013371136,0.0004492455,0.00024321588,0.000059191298,0.000020601892,0.00027960486,0.00011060879,0.0000635074],"category_scores_gemma":[0.00006392365,0.00013905881,0.00012555634,0.0003523182,0.00030182127,0.000010669627,0.00014065272,0.00015360312,2.3725048e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022201458,0.000032261454,0.0032563584,0.00012923732,0.0006209854,0.0000014771474,0.0015622255,0.0014016476,0.9925201,0.000014254902,0.00004055973,0.00019887656],"study_design_scores_gemma":[0.0005199684,0.0000790793,0.06689636,0.000104243685,0.00013913782,4.077594e-8,0.0024069778,0.00018671881,0.92934406,0.00013374185,0.000085651605,0.00010403579],"about_ca_topic_score_codex":0.010605086,"about_ca_topic_score_gemma":0.004204462,"teacher_disagreement_score":0.06364,"about_ca_system_score_codex":0.00017958798,"about_ca_system_score_gemma":0.0006564907,"threshold_uncertainty_score":0.99598336},"labels":[],"label_agreement":null},{"id":"W4409634212","doi":"10.1158/1538-7445.am2025-6114","title":"Abstract 6114: Engineering novel synNotch CAR T cells to precisely and effectively target medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Neuroscience; Medicine; Biology","score_opus":0.036485709218601246,"score_gpt":0.38557038107882885,"score_spread":0.3490846718602276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877439,0.0013325192,0.00048592067,0.0017602713,0.00029585717,0.0020289565,0.000055162443,0.00008826864,0.0062091216],"genre_scores_gemma":[0.9830528,0.000343822,0.0008148994,0.00017885312,0.000317063,0.0006974428,0.0000056651334,0.00007153564,0.014517914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701583,0.0000734386,0.00025695458,0.00066665426,0.0010295558,0.00095755176],"domain_scores_gemma":[0.997632,0.000762636,0.000020120011,0.0005060658,0.0005599008,0.00051923795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015605754,0.00022741634,0.00043466617,0.0008482089,0.00015323685,0.00010043764,0.000294446,0.00016560446,0.0010839779],"category_scores_gemma":[0.0004694707,0.00021306172,0.00008505731,0.0013150322,0.00015318269,0.00008367001,0.00030296604,0.0010923969,0.0000888941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096084067,0.000106975574,0.0010238135,0.000698554,0.00017517163,0.000038429618,0.000338457,0.00026234126,0.97628367,0.000098653945,0.00785123,0.012161871],"study_design_scores_gemma":[0.001985679,0.00040811623,0.04200686,0.0009504592,0.000019671092,0.000010889751,0.000116491225,0.0005094226,0.8511324,0.000036238675,0.10260457,0.00021919498],"about_ca_topic_score_codex":0.0007848333,"about_ca_topic_score_gemma":0.000060400027,"teacher_disagreement_score":0.12515125,"about_ca_system_score_codex":0.0008027084,"about_ca_system_score_gemma":0.0007187133,"threshold_uncertainty_score":0.9998292},"labels":[],"label_agreement":null},{"id":"W4409634358","doi":"10.1158/1538-7445.am2025-2060","title":"Abstract 2060: Independent validation of endogenous retrotransposable elements as predictive biomarkers of immune checkpoint blockade response","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Blockade; Immune checkpoint; Endogeny; Biology; Immunology; Immune system; Medicine; Oncology; Internal medicine; Immunotherapy; Genetics; Receptor","score_opus":0.07578413369709242,"score_gpt":0.40858667782107094,"score_spread":0.3328025441239785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839113,0.0025676158,0.000016247926,0.0009082206,0.000089840825,0.0015745455,0.00018964754,0.00002094131,0.010721638],"genre_scores_gemma":[0.9957603,0.0014354426,0.00006514617,0.000013164619,0.000047819885,0.00024282515,0.00003377293,0.000028451954,0.0023730618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959408,0.00034338838,0.0008937596,0.00043319358,0.0017352877,0.000653545],"domain_scores_gemma":[0.9973491,0.000403021,0.00016551455,0.0006431592,0.0012499491,0.00018926503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051197936,0.00016640364,0.0004989691,0.0010915763,0.00015140258,0.000023525394,0.00035466193,0.00019296783,0.0020935468],"category_scores_gemma":[0.000786888,0.00015315838,0.00019554632,0.0014667608,0.00042894183,0.00010050331,0.00016219291,0.000756981,0.00003507438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035620857,0.0004626742,0.010313937,0.0008510676,0.00067230663,0.000053053944,0.0005125757,0.000032166317,0.9475093,0.000043236592,0.0003373354,0.0035914977],"study_design_scores_gemma":[0.0029397157,0.0009761527,0.054924674,0.0007713641,0.000056346064,0.000005206823,0.0005363231,0.000044672295,0.93642926,0.00018213657,0.0030451596,0.00008900717],"about_ca_topic_score_codex":0.0067213457,"about_ca_topic_score_gemma":0.00007630836,"teacher_disagreement_score":0.044610735,"about_ca_system_score_codex":0.0007989768,"about_ca_system_score_gemma":0.0028197,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W4409634720","doi":"10.1158/1538-7445.am2025-4792","title":"Abstract 4792: Highly specific GLUT-1 inhibiting antibodies for the treatment of pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer; Pancreatic cancer; Medicine; Antibody; Internal medicine; Cancer research; Oncology; Immunology","score_opus":0.061151499833139444,"score_gpt":0.394758567973441,"score_spread":0.33360706814030155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200387,0.17604843,0.000106645035,0.0008011293,0.000912107,0.0007591721,0.00019494699,0.000007364092,0.0011315382],"genre_scores_gemma":[0.83763516,0.15421234,0.00007022863,0.000058430018,0.001988549,0.0008728641,0.000027599815,0.000021269718,0.005113567],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987172,0.000046278605,0.00023613496,0.0003577548,0.00021180045,0.0004308658],"domain_scores_gemma":[0.999001,0.00015327118,0.00006409775,0.00039036645,0.00033840945,0.000052857846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034052765,0.00014561068,0.00023803175,0.0000928472,0.00025254994,0.000037307796,0.00022868393,0.00009421276,0.00006785688],"category_scores_gemma":[0.000056193898,0.000101731195,0.00015288513,0.00022801236,0.00026929603,0.00000405616,0.000058465324,0.00009621917,0.000002109305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036421293,0.00008880214,0.0009055045,0.0001435615,0.00023930508,4.41155e-7,0.00018362602,0.00008505248,0.87684345,0.00031733516,0.025073174,0.095755525],"study_design_scores_gemma":[0.00066516123,0.00009971168,0.0042846124,0.000074130556,0.00003168195,2.7121007e-7,0.00019624793,0.0000070270235,0.4857086,0.00006981845,0.5087916,0.0000711241],"about_ca_topic_score_codex":0.0014636709,"about_ca_topic_score_gemma":0.0009873995,"teacher_disagreement_score":0.48371843,"about_ca_system_score_codex":0.00010887833,"about_ca_system_score_gemma":0.00048876135,"threshold_uncertainty_score":0.41484776},"labels":[],"label_agreement":null},{"id":"W4409634813","doi":"10.1158/1538-7445.am2025-4656","title":"Abstract 4656: Fatty acid β-oxidation enzyme ECI1: a biomarker of poor survival outcome in prostate cancer patients after transurethral resection of the prostate (TURP)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Prostate cancer; Medicine; Transurethral resection of the prostate; Prostate; Urology; Resection; Biomarker; Oncology; Internal medicine; Prostatectomy; Cancer; Surgery; Chemistry","score_opus":0.03206290475208121,"score_gpt":0.36314666540368584,"score_spread":0.3310837606516046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184847,0.0033633201,0.000014430808,0.00046356994,0.0027495835,0.0009496472,0.00035473783,0.0000040880823,0.00025216673],"genre_scores_gemma":[0.9964275,0.0015873566,0.000011616426,0.000052114225,0.0004388226,0.0005404312,0.000051673735,0.000020756912,0.00086976105],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979816,0.0002464949,0.0004819397,0.00040064624,0.000483961,0.0004053689],"domain_scores_gemma":[0.99886864,0.000025172738,0.00012450121,0.0003656087,0.0005623606,0.00005372698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008708893,0.00015487656,0.0002554671,0.00019047846,0.00006829036,0.000018969939,0.00026979137,0.00014680433,0.000058683952],"category_scores_gemma":[0.00012179461,0.000119318145,0.000130515,0.00060271355,0.0002718034,0.000016390119,0.00012287732,0.00029049162,8.550307e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025760473,0.000117528216,0.264389,0.00035946947,0.00006133483,9.275056e-8,0.00027570975,0.000040148723,0.7248043,0.000011886178,0.0013639972,0.0060005193],"study_design_scores_gemma":[0.0013170288,0.00007196158,0.52606046,0.0001446097,0.000011673217,7.341807e-8,0.000066302244,0.00000515785,0.45892778,0.000033484666,0.013274173,0.000087322675],"about_ca_topic_score_codex":0.002962807,"about_ca_topic_score_gemma":0.0075159525,"teacher_disagreement_score":0.2658765,"about_ca_system_score_codex":0.00012583249,"about_ca_system_score_gemma":0.00054069835,"threshold_uncertainty_score":0.48656526},"labels":[],"label_agreement":null},{"id":"W4409634947","doi":"10.1158/1538-7445.am2025-2523","title":"Abstract 2523: Porphyrin-lipid nanoparticle-based multifunctional cancer: from cell to patient","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Porphyrin; Cancer; Cancer research; Nanoparticle; Nanotechnology; Chemistry; Medicine; Biochemistry; Internal medicine; Materials science","score_opus":0.03452838620574933,"score_gpt":0.3213101581569825,"score_spread":0.28678177195123317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409634947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906436,0.0025769535,0.00064683513,0.00060326507,0.002185083,0.00063101726,0.00043249025,0.00022762566,0.0020530897],"genre_scores_gemma":[0.99745286,0.00019582034,0.00029789822,0.0003356491,0.0003136528,0.0008190097,0.000026924406,0.00006368381,0.0004945084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977603,0.000025358033,0.00034239105,0.00040761096,0.0007004151,0.00076395134],"domain_scores_gemma":[0.9986879,0.00026714278,0.000025288673,0.0004689305,0.0002879708,0.0002627615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021433728,0.00022530791,0.00023197144,0.0003263259,0.00018525282,0.00009247221,0.00037024586,0.00011915192,0.0015706861],"category_scores_gemma":[0.00004317417,0.00022734783,0.00008252462,0.0008973735,0.000077983466,0.00012489513,0.000088906105,0.0005306313,0.00028504708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025665562,0.000073393625,0.0019005756,0.00014640116,0.00007621373,0.000010836251,0.0002015889,0.121824905,0.80909795,0.000032650616,0.027376814,0.039002027],"study_design_scores_gemma":[0.0010635916,0.00006345649,0.0044954536,0.00023379455,0.000015732761,8.4820115e-8,0.00008170239,0.0041198484,0.86601675,0.00017925525,0.123458564,0.0002717772],"about_ca_topic_score_codex":0.0028771586,"about_ca_topic_score_gemma":0.0009534639,"teacher_disagreement_score":0.117705055,"about_ca_system_score_codex":0.0013296773,"about_ca_system_score_gemma":0.00057617715,"threshold_uncertainty_score":0.999342},"labels":[],"label_agreement":null},{"id":"W4409635121","doi":"10.1158/1538-7445.am2025-6715","title":"Abstract 6715: Cross-species investigation of gene copy number and cancer resistance","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Guelph","funders":"","keywords":"Gene; Cancer; Biology; Genetics; Medicine; Computational biology","score_opus":0.044353263487261624,"score_gpt":0.39876989787863276,"score_spread":0.35441663439137117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807891,0.013524349,0.0000415615,0.0006628877,0.00017713614,0.00018567017,0.00020969976,0.00000412002,0.0044054487],"genre_scores_gemma":[0.9773446,0.015283285,0.00017041272,0.0001761882,0.00021820424,0.00012952492,0.000033452085,0.0000140335005,0.0066303117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989954,0.00003382902,0.0001979043,0.00032380383,0.00019490793,0.00025414492],"domain_scores_gemma":[0.9990704,0.000068300564,0.000054282973,0.000282813,0.00044806648,0.000076122924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033235425,0.00009553276,0.00013093099,0.00005794447,0.00012662912,0.000056704397,0.00017687437,0.00011423493,0.00011931875],"category_scores_gemma":[0.00014537638,0.00009810908,0.000034621757,0.00021718872,0.0004966223,0.000005024802,0.00012342563,0.00014242588,0.0000026858752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019585235,0.000011963144,0.15570009,0.0001619347,0.000045752102,0.0000013651061,0.00006905796,0.00005743751,0.81792355,0.0010314474,0.02384564,0.00095589244],"study_design_scores_gemma":[0.00039357305,0.00001969217,0.14008987,0.00008608446,0.000006202559,2.8230707e-7,0.000037740687,0.0000020783316,0.7743923,0.00066108274,0.084219635,0.00009144788],"about_ca_topic_score_codex":0.000708987,"about_ca_topic_score_gemma":0.0012427351,"teacher_disagreement_score":0.060373995,"about_ca_system_score_codex":0.000083525476,"about_ca_system_score_gemma":0.00061793136,"threshold_uncertainty_score":0.40007722},"labels":[],"label_agreement":null},{"id":"W4409635172","doi":"10.1158/1538-7445.am2025-6707","title":"Abstract 6707: Direct <i>in vivo</i> CRISPR screen identifies <i>BAP1</i> and <i>FAT1</i> as potent tumor suppressors in sarcomagenesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CRISPR; In vivo; BAP1; Biology; Medicine; Cancer; Cancer research; Genetics; Gene","score_opus":0.018948194329594166,"score_gpt":0.3523476866498208,"score_spread":0.33339949232022664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96879566,0.015970564,0.000006133174,0.0009298061,0.00012376545,0.00044830874,0.00015116466,0.0000111670315,0.013563426],"genre_scores_gemma":[0.9915998,0.0036212995,0.000024090912,0.0007038578,0.000090167625,0.00024223265,0.000027881526,0.000026185,0.0036644754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978503,0.00019135038,0.000300641,0.0006701121,0.00035701646,0.0006305852],"domain_scores_gemma":[0.99911237,0.00006682411,0.00003534707,0.00045869342,0.00013377395,0.00019300198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006215826,0.0001983269,0.00024754208,0.00026445315,0.000121920006,0.000096085365,0.00037386073,0.000119674005,0.000108375316],"category_scores_gemma":[0.00025860165,0.0001966459,0.00007468507,0.00041810324,0.00026069718,0.0000095995465,0.00036830932,0.0002259538,0.00001206778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037331268,0.00014769942,0.03188771,0.00018550726,0.000043544867,0.00007653726,0.000057776677,0.00008999231,0.91749907,0.000020939096,0.048300523,0.001317398],"study_design_scores_gemma":[0.001044959,0.00007666964,0.08331323,0.00019974503,0.000013534775,0.0000032120186,0.00034999414,0.000010571951,0.8805125,0.00028547397,0.033957757,0.0002323992],"about_ca_topic_score_codex":0.0037706727,"about_ca_topic_score_gemma":0.0018668482,"teacher_disagreement_score":0.051425513,"about_ca_system_score_codex":0.000058140526,"about_ca_system_score_gemma":0.0004889965,"threshold_uncertainty_score":0.8018987},"labels":[],"label_agreement":null},{"id":"W4409635351","doi":"10.1158/1538-7445.am2025-6557","title":"Abstract 6557: Human 16p11.2 microdeletion suppresses malignant progression of colon cancer through dysregulation of the tumor microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Colorectal cancer; Tumor microenvironment; Cancer; Medicine; Immune dysregulation; Cancer research; Biology; Pathology; Internal medicine; Disease","score_opus":0.04063737126404692,"score_gpt":0.4176217314667199,"score_spread":0.37698436020267295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937841,0.0033619625,0.000006830492,0.0009515226,0.00025263696,0.001231551,0.00003278415,0.000010359001,0.00036821765],"genre_scores_gemma":[0.99838257,0.0004706622,0.00003985149,0.000058032463,0.00012586662,0.00029859183,0.000012141191,0.000017502334,0.00059479295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982793,0.0001511005,0.00035515134,0.00025939988,0.0006409501,0.00031412623],"domain_scores_gemma":[0.99905986,0.000087587214,0.00016730661,0.00040056437,0.00023718202,0.000047529345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006179337,0.00012095725,0.00027961988,0.000114621886,0.00017229086,0.000008972569,0.00017781633,0.00009025617,0.00031015745],"category_scores_gemma":[0.000053669344,0.00007995152,0.000089811045,0.0003270816,0.00038867182,0.000059399554,0.000119407814,0.0003009832,0.0000031445775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037300013,0.00015353251,0.04419433,0.0017379095,0.000050735187,0.000006050145,0.00032178572,0.0000599381,0.94606656,0.00018235706,0.004108135,0.0027456493],"study_design_scores_gemma":[0.00073000585,0.00011142747,0.23679642,0.0022628882,0.00003687323,0.0000010052537,0.00006974154,0.000021800997,0.7558404,0.000096459014,0.003982801,0.000050148537],"about_ca_topic_score_codex":0.0010096288,"about_ca_topic_score_gemma":0.00016117471,"teacher_disagreement_score":0.1926021,"about_ca_system_score_codex":0.0003531474,"about_ca_system_score_gemma":0.00040929366,"threshold_uncertainty_score":0.33960065},"labels":[],"label_agreement":null},{"id":"W4409635383","doi":"10.1158/1538-7445.am2025-7361","title":"Abstract 7361: Scientific rationale and successful implementation of biospecimen collection in the NCI Connect Cohort for Cancer Prevention","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Cohort; Cancer prevention; Oncology; Internal medicine","score_opus":0.12168087490376339,"score_gpt":0.5309110046699609,"score_spread":0.4092301297661975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885089,0.0015644417,0.00006113183,0.005823231,0.00020014339,0.0029140867,0.000027917476,0.000005379268,0.00089479296],"genre_scores_gemma":[0.99388885,0.00089599384,0.00003187149,0.00008287951,0.00009838653,0.0014501611,0.000043809378,0.000004842011,0.0035032271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828136,0.00009505149,0.00024278177,0.00029483656,0.0007950754,0.00029089113],"domain_scores_gemma":[0.99867094,0.00034386455,0.000047786114,0.00017272726,0.0007083438,0.000056315286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043311752,0.000060832263,0.00015314225,0.0005567534,0.00029474747,0.00005656813,0.00013132549,0.00004047342,0.00040449263],"category_scores_gemma":[0.00025702742,0.000042757678,0.000031254258,0.0015587852,0.00041557907,0.000115134615,0.000030655014,0.00018036248,9.3676886e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008515869,0.00024139005,0.62197584,0.0010621303,0.00010903512,0.000004094275,0.00356496,0.000012655876,0.26503146,0.0023600403,0.044122428,0.06066442],"study_design_scores_gemma":[0.0028185297,0.00027520512,0.9087315,0.0003292357,0.00003196588,0.0000016596097,0.006877792,0.00020617587,0.06948121,0.0009498889,0.010243494,0.000053351512],"about_ca_topic_score_codex":0.003936443,"about_ca_topic_score_gemma":0.009879963,"teacher_disagreement_score":0.28675568,"about_ca_system_score_codex":0.00031170747,"about_ca_system_score_gemma":0.0018038485,"threshold_uncertainty_score":0.595075},"labels":[],"label_agreement":null},{"id":"W4409635450","doi":"10.1158/1538-7445.am2025-7055","title":"Abstract 7055: An IL1RAP ADC is efficacious in distinct oncofusion-driven pediatric cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.06598429712925268,"score_gpt":0.45857485451626595,"score_spread":0.39259055738701326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987045,0.0011297057,0.0000022034067,0.0022295895,0.00015890932,0.0010234824,0.00007453725,0.000054372576,0.008282236],"genre_scores_gemma":[0.99334913,0.0019358546,0.00003092063,0.00024054325,0.00026217793,0.00041009576,0.00002709518,0.00003505793,0.003709149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967928,0.00016675513,0.00030179915,0.0006764091,0.0010670397,0.0009951941],"domain_scores_gemma":[0.9982268,0.00029075312,0.00003635363,0.00060644187,0.00033166824,0.00050795166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047833464,0.00019998066,0.0003452945,0.000984835,0.00021978773,0.000057581976,0.00033350714,0.00012419796,0.0012938178],"category_scores_gemma":[0.00024654248,0.00016821627,0.00009216589,0.0018293213,0.00019546508,0.000119583994,0.00018217911,0.0010527936,0.00019815944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058988654,0.0024313992,0.75923604,0.0015358643,0.00029237702,0.004650137,0.0012315041,0.00012940154,0.026607094,0.00014636396,0.06170951,0.13613145],"study_design_scores_gemma":[0.0069500576,0.0011051985,0.9700888,0.00046199362,0.00004995551,0.000010365647,0.00023650876,0.0002726716,0.008721436,0.0002209793,0.011630971,0.00025108113],"about_ca_topic_score_codex":0.0053635226,"about_ca_topic_score_gemma":0.0030621896,"teacher_disagreement_score":0.21085274,"about_ca_system_score_codex":0.0016177075,"about_ca_system_score_gemma":0.002835384,"threshold_uncertainty_score":0.9996191},"labels":[],"label_agreement":null},{"id":"W4409635523","doi":"10.1158/1538-7445.am2025-5437","title":"Abstract 5437: N-myristoylation inhibitor zelenirstat reduces mitochondrial complex I activity, OXPHOS, glycolysis, and cancer stem cell growth in triple-negative breast cancer (TNBC) cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NAEJA-RGM Pharmaceuticals (Canada); University of Alberta","funders":"","keywords":"Triple-negative breast cancer; Cancer; Stem cell; Cancer research; Cancer stem cell; Oxidative phosphorylation; Breast cancer; Glycolysis; Medicine; Myristoylation; Biology; Internal medicine; Biochemistry; Cell biology; Metabolism","score_opus":0.06217476182250717,"score_gpt":0.4045219016292207,"score_spread":0.3423471398067135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98359114,0.0046638143,0.0000033798212,0.00675523,0.0007956687,0.0023214577,0.00058409944,0.000040917632,0.0012442877],"genre_scores_gemma":[0.9863714,0.008123895,0.000055954893,0.00017102587,0.0003765534,0.0013566223,0.000026779926,0.000042137748,0.003475612],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99673754,0.00025415365,0.00047161235,0.0008118753,0.0008247061,0.00090010033],"domain_scores_gemma":[0.9982618,0.00035224852,0.00015721718,0.00028650474,0.00053063454,0.0004115922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003797409,0.0003150677,0.00064206665,0.0006541003,0.00036922478,0.0000820889,0.00015405413,0.0002367697,0.00040955615],"category_scores_gemma":[0.000028389615,0.00028093488,0.000087843226,0.0012791031,0.0003830455,0.00025757874,0.00012462122,0.0009370603,0.000017382365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024063744,0.0020395531,0.08040415,0.0037889269,0.0005576009,0.00025981115,0.0034639789,0.000051414772,0.66980577,0.00006913795,0.05211373,0.16338219],"study_design_scores_gemma":[0.014791764,0.000337054,0.5467693,0.0015907962,0.00015292517,0.0000059778113,0.00064821035,0.00021311907,0.43248883,0.00018756083,0.0024197288,0.00039469192],"about_ca_topic_score_codex":0.08993146,"about_ca_topic_score_gemma":0.01242355,"teacher_disagreement_score":0.4663652,"about_ca_system_score_codex":0.0023077128,"about_ca_system_score_gemma":0.0026024038,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W4409635531","doi":"10.1158/1538-7445.am2025-7130","title":"Abstract 7130: Spatially resolved single-cell analysis reveals cGAS-STING-mediated tumor-immune interactions via IFNα as determinants of pembrolizumab sensitivity in triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pembrolizumab; Immune system; Medicine; Breast cancer; Cancer; Cancer research; Triple-negative breast cancer; Oncology; Internal medicine; Immunology; Immunotherapy","score_opus":0.03616361163697846,"score_gpt":0.3670689389749576,"score_spread":0.33090532733797917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385196,0.0021518616,0.00004162298,0.0004017511,0.0005564943,0.00063578243,0.0004601591,0.0000391221,0.001861244],"genre_scores_gemma":[0.9912921,0.00027680217,0.000011684703,0.00008456084,0.000029311193,0.00018882568,0.00006465282,0.000028640019,0.0080234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957588,0.0015518633,0.0009738751,0.00063145795,0.00018467773,0.00089938164],"domain_scores_gemma":[0.9959951,0.0020417357,0.00035733407,0.00059770356,0.00095440884,0.00005371852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016290603,0.00031307328,0.00096621667,0.0017577715,0.00030181263,0.000043160406,0.00041879556,0.00025512645,0.0027525998],"category_scores_gemma":[0.001061371,0.00029680328,0.00029013856,0.0022956762,0.00068472646,0.00019320671,0.00030111638,0.0013411533,0.00014030373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007886866,0.00053555245,0.027811334,0.00014014993,0.00070508965,0.00007392956,0.0006520066,0.000077646684,0.9563587,0.000007656152,0.0006317397,0.0051193633],"study_design_scores_gemma":[0.002633565,0.00018204605,0.35050753,0.0006458712,0.00013783571,0.000026211343,0.00052559923,0.00013608806,0.6445229,0.00003323921,0.00042090024,0.000228226],"about_ca_topic_score_codex":0.041912053,"about_ca_topic_score_gemma":0.039376236,"teacher_disagreement_score":0.32269618,"about_ca_system_score_codex":0.00080574927,"about_ca_system_score_gemma":0.001058936,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W4409635946","doi":"10.1158/1538-7445.am2025-6337","title":"Abstract 6337: A novel PMS2 mutant Lynch syndrome mouse model for cancer prevention studies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lynch syndrome; PMS2; Cancer; Mutant; Cancer prevention; Medicine; Internal medicine; Genetics; Cancer research; Biology; Colorectal cancer; Gene; DNA mismatch repair","score_opus":0.24462933014027785,"score_gpt":0.5105526769991433,"score_spread":0.26592334685886543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981647,0.009531623,0.001413549,0.0033590866,0.00056495884,0.002480621,0.00022951349,0.000071835595,0.0007018106],"genre_scores_gemma":[0.9582004,0.0031882382,0.00092397426,0.0002575517,0.00015587271,0.0048894486,0.000012621065,0.00005148671,0.032320388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742395,0.000038344842,0.00038571702,0.0006273352,0.00076918607,0.00075544225],"domain_scores_gemma":[0.997799,0.00028762338,0.00006756863,0.00048344367,0.0012031893,0.00015920322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090523943,0.00022351721,0.0004918508,0.00036791313,0.00024602385,0.000039014085,0.0002702977,0.00017243797,0.00024093808],"category_scores_gemma":[0.00049551955,0.00019373097,0.00015816506,0.00060915947,0.00028312198,0.00008074124,0.00019073232,0.0005489675,0.000011750272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023028702,0.000622763,0.0020546361,0.0043843715,0.0014571098,0.000022590068,0.0015822282,0.006619224,0.9328213,0.0006971648,0.026457932,0.02097781],"study_design_scores_gemma":[0.017079163,0.0024056851,0.020093132,0.007821609,0.00081609696,0.000040843963,0.0029719803,0.057372805,0.8519306,0.009987114,0.02809166,0.0013893174],"about_ca_topic_score_codex":0.00047978308,"about_ca_topic_score_gemma":0.0012582378,"teacher_disagreement_score":0.08089071,"about_ca_system_score_codex":0.0017750509,"about_ca_system_score_gemma":0.002277305,"threshold_uncertainty_score":0.79001194},"labels":[],"label_agreement":null},{"id":"W4409635973","doi":"10.1158/1538-7445.am2025-2819","title":"Abstract 2819: Metabolic determinants of ferroptosis in B-cell malignancies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Cancer research; Medicine; Biology","score_opus":0.08263366065745029,"score_gpt":0.4247307596577212,"score_spread":0.34209709900027097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409635973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763746,0.014400735,0.0000015843159,0.0010174874,0.00013037016,0.00050474034,0.000018852015,0.00001637916,0.0075352406],"genre_scores_gemma":[0.9897983,0.0065352945,0.000067739486,0.00017766962,0.000056161396,0.0004271955,0.0000022207507,0.000019973333,0.0029154483],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980393,0.000078208635,0.00041428438,0.00035669198,0.0005680111,0.00054346985],"domain_scores_gemma":[0.99893266,0.00011053392,0.00005755172,0.0004113609,0.00037972847,0.00010815086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080689095,0.00013702619,0.0005017595,0.0006369814,0.00006722552,0.000021084921,0.00024632664,0.000117249205,0.0005629744],"category_scores_gemma":[0.00012101219,0.00011646105,0.00011447599,0.001347116,0.00022367237,0.00007568516,0.00012576419,0.00041898998,0.000021601067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046441547,0.0005237323,0.66885746,0.0015286757,0.000053340027,0.000030823638,0.00043868058,0.000009794739,0.27524877,0.00029463813,0.0038270268,0.048722662],"study_design_scores_gemma":[0.0010740574,0.0000799243,0.43728545,0.0007900171,0.000026372434,7.0982924e-7,0.00037299554,0.000017740185,0.55299205,0.00007203247,0.0072112037,0.00007745923],"about_ca_topic_score_codex":0.003052506,"about_ca_topic_score_gemma":0.00081282615,"teacher_disagreement_score":0.27774325,"about_ca_system_score_codex":0.00018190923,"about_ca_system_score_gemma":0.00084034726,"threshold_uncertainty_score":0.6164175},"labels":[],"label_agreement":null},{"id":"W4409636126","doi":"10.1158/1538-7445.am2025-3924","title":"Abstract 3924: <i>in vitro- in vivo</i> model correlations and cross-species comparisons in osteosarcoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Osteosarcoma; In vivo; In vitro; Biology; Oncology; Internal medicine; Cancer research; Medicine; Genetics","score_opus":0.04931905231726596,"score_gpt":0.41919874366602006,"score_spread":0.3698796913487541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409636126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989003,0.0017116667,0.0012903857,0.0009639162,0.000017359545,0.00039982103,0.00006907243,0.0000074478808,0.0065372996],"genre_scores_gemma":[0.9965258,0.0008747615,0.00049484405,0.00013393487,0.000016022042,0.00048202436,0.00004421373,0.000008656597,0.0014197459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989805,0.000059338847,0.00021650504,0.00035159377,0.00008697365,0.00030507098],"domain_scores_gemma":[0.99956787,0.000034393703,0.000021483718,0.0002724116,0.000065106215,0.000038759612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837017,0.00008912621,0.00012915625,0.00021754709,0.00007612621,0.000030025094,0.00019810315,0.00017882438,0.00001507737],"category_scores_gemma":[0.00004482925,0.000093416085,0.000026657774,0.00037438172,0.00025245463,0.00000405515,0.00018351697,0.00034714356,0.0000013192239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008514356,0.000075463606,0.05270441,0.000016710956,0.000004605971,0.000002932969,0.000027001994,0.0008808419,0.9412138,0.0018908781,0.002521163,0.0005770694],"study_design_scores_gemma":[0.0012495124,0.000048419937,0.16305743,0.000095348914,0.0000027096216,0.0000020104185,0.00012571304,0.0053750267,0.7901704,0.0019056035,0.037727125,0.00024073603],"about_ca_topic_score_codex":0.0004964308,"about_ca_topic_score_gemma":0.0025623844,"teacher_disagreement_score":0.15104342,"about_ca_system_score_codex":0.00006610969,"about_ca_system_score_gemma":0.00018916109,"threshold_uncertainty_score":0.38093975},"labels":[],"label_agreement":null},{"id":"W4409636166","doi":"10.1158/1538-7445.am2025-7330","title":"Abstract 7330: MDNA113: A tumor targeting and conditionally activated anti-PD1-IL2SK to enhance the therapeutic index","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Therapeutic index; Medicine; Index (typography); Cancer research; Oncology; Pharmacology; Drug; World Wide Web; Computer science","score_opus":0.025216923807315803,"score_gpt":0.42049659827451197,"score_spread":0.39527967446719614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409636166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894974,0.0050604283,0.00008317326,0.0030030685,0.00006760338,0.00061247643,0.000081719045,0.00001079713,0.0015832868],"genre_scores_gemma":[0.9960827,0.000865137,0.00001606214,0.0006828203,0.00014615845,0.0004963738,0.000048936752,0.00001827039,0.0016435183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835974,0.00012089289,0.00014891596,0.00045994233,0.000368406,0.0005420733],"domain_scores_gemma":[0.99914265,0.000089596615,0.000029823272,0.00031671685,0.00028329119,0.00013794524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051496463,0.00013633567,0.0001285282,0.00011166363,0.0003874168,0.00011962774,0.00031874675,0.000067140034,0.00015006527],"category_scores_gemma":[0.00015431062,0.000100486664,0.000045704273,0.000403426,0.00024733078,0.000008222776,0.00026039802,0.0003191722,0.000019552079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034602874,0.00005993491,0.0049722507,0.000044290162,0.00018460865,0.0000112574635,0.00004748173,0.000029925674,0.97385854,0.00009343308,0.010339554,0.010012699],"study_design_scores_gemma":[0.0005567264,0.00015244754,0.058644608,0.00008830235,0.000007247023,0.0000027884998,0.00013484247,0.000010313188,0.8680947,0.00044055126,0.07172697,0.00014053484],"about_ca_topic_score_codex":0.0010365797,"about_ca_topic_score_gemma":0.0004892613,"teacher_disagreement_score":0.10576387,"about_ca_system_score_codex":0.000104219114,"about_ca_system_score_gemma":0.0006159755,"threshold_uncertainty_score":0.40977272},"labels":[],"label_agreement":null},{"id":"W4409636196","doi":"10.1158/1538-7445.am2025-5641","title":"Abstract 5641: Role of ceramide synthase 2 in drug-induced ER-stress, Ca2+ release and apoptosis in triple-negative breast cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Synthesis of heterocyclic compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Triple-negative breast cancer; Ceramide; Apoptosis; Cancer; Breast cancer; Cancer research; Drug; Medicine; Internal medicine; Chemistry; Pharmacology; Biochemistry","score_opus":0.025835496142957385,"score_gpt":0.34271558655331497,"score_spread":0.3168800904103576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409636196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897308,0.001982452,1.2320447e-7,0.000950412,0.00007743605,0.00030867264,0.00045350325,0.000025669711,0.006470952],"genre_scores_gemma":[0.99736404,0.0012582367,0.000016083584,0.000022835215,0.00008764943,0.00057246373,0.0000058647693,0.00003694371,0.00063588424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721205,0.00015130432,0.0005722306,0.00069864636,0.000612294,0.00075344706],"domain_scores_gemma":[0.99768656,0.0012031636,0.000121891164,0.0005990746,0.00021163361,0.00017764387],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005664736,0.00026337832,0.0005180212,0.0005763832,0.00010025041,0.00006956872,0.00055268925,0.00019552874,0.001057371],"category_scores_gemma":[0.0002995907,0.00027591138,0.00008199931,0.00075448136,0.0002867929,0.00017850815,0.00028650978,0.00096808583,0.000006607765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066741346,0.00030800924,0.028644305,0.00066247,0.00006910197,0.00002180543,0.0009174682,0.000069560905,0.93072724,0.00001865011,0.0006328511,0.037261132],"study_design_scores_gemma":[0.0015450482,0.000006807093,0.026950823,0.0018521972,0.000012690325,9.2015586e-7,0.002244937,0.00014388122,0.9664576,0.0002763454,0.00028607092,0.00022267422],"about_ca_topic_score_codex":0.09101312,"about_ca_topic_score_gemma":0.023391826,"teacher_disagreement_score":0.06762129,"about_ca_system_score_codex":0.0010859958,"about_ca_system_score_gemma":0.00072975364,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W4409636609","doi":"10.1158/1538-7445.am2025-6411","title":"Abstract 6411: The histone H3 E97K oncohistone creates a cellular histone H3 deficit and disrupts nucleosome stability","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Histone H3; Nucleosome; Histone; Cell biology; Histone octamer; Chemistry; Biology; Biochemistry; DNA","score_opus":0.05102409665301061,"score_gpt":0.38580747975071933,"score_spread":0.3347833830977087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409636609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541352,0.03205684,0.000059105358,0.0018998656,0.00017850811,0.00065716665,0.00010447312,0.000024946099,0.010883919],"genre_scores_gemma":[0.9916882,0.0017361931,0.000052120256,0.00019639009,0.00021214726,0.00031688728,0.0000537477,0.000033268538,0.0057110297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977167,0.00025499138,0.00030232285,0.00070076616,0.00039938075,0.00062578433],"domain_scores_gemma":[0.998505,0.00012888198,0.00006745319,0.00083195645,0.000297143,0.00016958638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013238348,0.00022760591,0.00025761066,0.00010409357,0.0005513499,0.00008054857,0.00048693153,0.00022138124,0.00040758363],"category_scores_gemma":[0.00029198884,0.0001808767,0.000103382765,0.00030390942,0.0009424087,0.000009167837,0.00040708942,0.0005435757,0.00002832454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003059098,0.00012311534,0.0018649531,0.00022107593,0.000060575356,0.000011927284,0.00026639982,0.0000031803459,0.9864824,0.0006557227,0.00418729,0.005817487],"study_design_scores_gemma":[0.00068531337,0.000204526,0.009269172,0.00008844046,0.000025358248,0.0000042619927,0.0003259028,0.000014744519,0.83619314,0.0007540444,0.15217438,0.00026069384],"about_ca_topic_score_codex":0.0014373835,"about_ca_topic_score_gemma":0.00046781194,"teacher_disagreement_score":0.15028921,"about_ca_system_score_codex":0.0002859464,"about_ca_system_score_gemma":0.0005023816,"threshold_uncertainty_score":0.73759377},"labels":[],"label_agreement":null},{"id":"W4409636613","doi":"10.1158/1538-7445.am2025-5748","title":"Abstract 5748: Metabolites of the orally potent anticancer agent and endoplasmic reticulum stress inducer RM-581","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Endoplasmic reticulum; Inducer; Pharmacology; Medicine; Orally active; Chemistry; Biochemistry; Oral administration","score_opus":0.024729266075199666,"score_gpt":0.3566524133682407,"score_spread":0.33192314729304107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409636613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161703,0.012124814,0.000010891021,0.0009541875,0.00024814362,0.000393322,0.0001724745,0.00000581316,0.004473333],"genre_scores_gemma":[0.9929585,0.0052497187,0.000030954034,0.0001583962,0.00010832269,0.0001285886,0.000016717317,0.000016866567,0.0013319323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831086,0.00014063877,0.00026072317,0.00044480085,0.00041746892,0.0004255153],"domain_scores_gemma":[0.9988545,0.00005103609,0.00007248412,0.0005695062,0.00032111077,0.00013132686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031776456,0.0001619837,0.00020332684,0.00008797675,0.00016661498,0.00005218352,0.0003951147,0.00012337668,0.000111228095],"category_scores_gemma":[0.000186731,0.000113077884,0.0001114198,0.00027822872,0.00045941403,0.0000062163185,0.0004488066,0.00027269247,0.000002595992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022049868,0.00015555474,0.060760673,0.00038661162,0.00020490051,0.000008080625,0.000078891564,0.00013315905,0.9249286,0.0015803893,0.004548557,0.0069941003],"study_design_scores_gemma":[0.00060346886,0.000042598327,0.11206322,0.00016677583,0.0000386297,0.0000014120302,0.00020395654,0.000016732673,0.8780063,0.00018842464,0.0085502835,0.0001181948],"about_ca_topic_score_codex":0.00041631193,"about_ca_topic_score_gemma":0.00017384496,"teacher_disagreement_score":0.051302552,"about_ca_system_score_codex":0.00003310045,"about_ca_system_score_gemma":0.0004933862,"threshold_uncertainty_score":0.46111825},"labels":[],"label_agreement":null},{"id":"W4409637247","doi":"10.1158/1538-7445.am2025-6908","title":"Abstract 6908: Autophagy disruption via PIKfyve inhibition as a novel strategy to enhance immunotherapy responses in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Multiple myeloma; Immunotherapy; Cancer immunotherapy; Cancer research; Biology; Cancer; Medicine; Immunology; Internal medicine; Biochemistry; Apoptosis","score_opus":0.0593214463097121,"score_gpt":0.4571631983761023,"score_spread":0.3978417520663902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409637247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134123,0.0029006654,0.00054815604,0.0016899615,0.00012294191,0.0012641245,0.00003080944,0.00007267415,0.002029411],"genre_scores_gemma":[0.99224627,0.0007705822,0.000080321806,0.00095396175,0.00016422101,0.00083112426,0.000028569682,0.000035358375,0.004889615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774486,0.00013830968,0.0003823747,0.00053624675,0.0005977198,0.0006005011],"domain_scores_gemma":[0.99865067,0.0003104604,0.00004843632,0.0005009093,0.0003029729,0.00018654103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008501168,0.00019351723,0.00030430598,0.00072391593,0.00017715538,0.00006147976,0.0001679796,0.00016605025,0.0008793566],"category_scores_gemma":[0.00024361006,0.00018330578,0.00009162258,0.0012027231,0.00015603214,0.00016692966,0.000058751233,0.0005980884,0.00019182326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007376514,0.00047627196,0.0012016896,0.00012058957,0.00006537404,0.00012693703,0.0005201873,0.000060204282,0.89376897,0.00035748444,0.00054182904,0.09538396],"study_design_scores_gemma":[0.0024918844,0.0005021223,0.34589225,0.0007069871,0.0000072883727,0.000006374711,0.0002554172,0.00014264917,0.6457006,0.0012393286,0.00289071,0.00016443092],"about_ca_topic_score_codex":0.0020413005,"about_ca_topic_score_gemma":0.00040585798,"teacher_disagreement_score":0.34469056,"about_ca_system_score_codex":0.0006945641,"about_ca_system_score_gemma":0.0010514192,"threshold_uncertainty_score":0.96283376},"labels":[],"label_agreement":null},{"id":"W4409637253","doi":"10.1158/1538-7445.am2025-6919","title":"Abstract 6919: Targeting CLIC3 as a novel strategy to inhibit metastasis in breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Metastasis; Medicine; Cancer; Breast cancer metastasis; Cancer research; Oncology; Internal medicine; Cancer metastasis","score_opus":0.11760117573500518,"score_gpt":0.5142735370755451,"score_spread":0.39667236134053996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409637253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95947874,0.0037775608,0.00000509807,0.020999163,0.0002751713,0.0010604738,0.00017090794,0.00003816207,0.014194713],"genre_scores_gemma":[0.9889045,0.0012099246,0.00004842446,0.0016171728,0.00037510245,0.0012093352,0.000021261874,0.000029488616,0.0065848213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977467,0.00007436466,0.00034388472,0.0005446605,0.00047792916,0.00081243564],"domain_scores_gemma":[0.99889326,0.00017515486,0.00003803637,0.00024122921,0.00035865823,0.00029364304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007742901,0.00019215957,0.0004003182,0.00069933856,0.00012895105,0.0000481157,0.00018702632,0.000116366835,0.006140463],"category_scores_gemma":[0.00006342619,0.00017107876,0.00008765766,0.0016919489,0.00011433037,0.000094260344,0.00013969597,0.0007564572,0.000116146926],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048508323,0.0011823655,0.060941458,0.00068211585,0.00060710235,0.00030557983,0.0008758236,0.0006173587,0.67490476,0.00064583827,0.14576857,0.10861817],"study_design_scores_gemma":[0.019321075,0.0011417324,0.5388524,0.0027678488,0.0003857415,0.00005108473,0.0023247232,0.00015762822,0.23405866,0.0006139059,0.199467,0.0008582214],"about_ca_topic_score_codex":0.034879316,"about_ca_topic_score_gemma":0.0056181233,"teacher_disagreement_score":0.4779109,"about_ca_system_score_codex":0.001329087,"about_ca_system_score_gemma":0.002065654,"threshold_uncertainty_score":0.9947681},"labels":[],"label_agreement":null},{"id":"W4409644074","doi":"10.1158/1538-7445.am2025-5215","title":"Abstract 5215: IL-17RA expression by NSCLC is vital for restraining homeostatic tumor cell proliferation and baseline cytokine production","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Homeostasis; Cytokine; Cell growth; Baseline (sea); Cancer research; Immunology; Medicine; Biology; Internal medicine; Genetics","score_opus":0.0761928336317277,"score_gpt":0.44039412346696183,"score_spread":0.36420128983523414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409644074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96740586,0.0037346873,0.00089943496,0.021532107,0.00033750877,0.004264361,0.00044435417,0.000088723085,0.0012929796],"genre_scores_gemma":[0.9864492,0.0008988467,0.0009271081,0.00040943242,0.00071924564,0.002078837,0.00015983822,0.00006562113,0.008291915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965264,0.0001876125,0.00045558932,0.0008667707,0.0011350411,0.00082859426],"domain_scores_gemma":[0.9976668,0.00043142456,0.00007790197,0.00051416917,0.0010174582,0.00029226125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029352168,0.0002216486,0.00035417374,0.00053877034,0.00042067887,0.00014069743,0.0001869022,0.0001315948,0.00032095387],"category_scores_gemma":[0.0014953743,0.00019789753,0.000063962856,0.0008215369,0.00029046548,0.00022738421,0.00012292824,0.00090998603,0.0000159995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016456094,0.00018255899,0.001633591,0.0022271422,0.00002876146,0.000016540202,0.0006607168,0.000009024843,0.76455146,0.00001721302,0.20099455,0.028032813],"study_design_scores_gemma":[0.0029076063,0.0006391395,0.001922968,0.001753152,0.00003231719,0.000010110689,0.0009253467,0.0007073838,0.9328028,0.00026554381,0.057819046,0.00021456242],"about_ca_topic_score_codex":0.0002527109,"about_ca_topic_score_gemma":0.00003707813,"teacher_disagreement_score":0.16825135,"about_ca_system_score_codex":0.00060039054,"about_ca_system_score_gemma":0.0015214153,"threshold_uncertainty_score":0.8070027},"labels":[],"label_agreement":null},{"id":"W4409644169","doi":"10.1158/1538-7445.am2025-3280","title":"Abstract 3280: Type I IFN receptor signaling in myeloid and T cells drives antitumor immunity elicited by intratumoral delivery of immunogenic recombinant modified vaccinia virus Ankara","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Recombinant DNA; Virus; Myeloid cells; Immunity; Vaccinia; Virology; Immunology; Biology; Receptor; Immune system; Cancer research; Gene","score_opus":0.02870450054551363,"score_gpt":0.35016617696088786,"score_spread":0.3214616764153742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409644169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299205,0.015966564,0.0000034629857,0.00014194656,0.00014959366,0.00049593544,0.00008104557,0.000009446489,0.00015994826],"genre_scores_gemma":[0.982552,0.016665094,0.000036204623,0.000051130697,0.000045364348,0.000071874885,0.00009864483,0.00003163813,0.0004480329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976416,0.00045975906,0.00042173895,0.0005072992,0.00033493232,0.00063464185],"domain_scores_gemma":[0.9986894,0.00010490625,0.00008176014,0.0005450483,0.00046893975,0.00010992127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001392666,0.00020606289,0.0003196889,0.00034720564,0.00016783178,0.000058072354,0.00055064546,0.00020663427,0.00014103632],"category_scores_gemma":[0.00011194737,0.00020704915,0.00006835583,0.0008309922,0.0002857807,0.0000148053405,0.00032776865,0.0006653133,0.000008619179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063518365,0.00018145023,0.00079335255,0.00011729092,0.00010391248,0.00000526677,0.0001075667,0.00007885664,0.9841734,0.0000070897627,0.0020108002,0.0060691494],"study_design_scores_gemma":[0.0012478763,0.0011924381,0.0026260677,0.00014712645,0.0000059650724,7.44492e-7,0.0001403678,0.000057761587,0.9933951,0.00005701775,0.00093969755,0.00018986028],"about_ca_topic_score_codex":0.0024641852,"about_ca_topic_score_gemma":0.00058624806,"teacher_disagreement_score":0.00922165,"about_ca_system_score_codex":0.00012699056,"about_ca_system_score_gemma":0.0007892146,"threshold_uncertainty_score":0.8443219},"labels":[],"label_agreement":null},{"id":"W4409644220","doi":"10.1158/1538-7445.am2025-4987","title":"Abstract 4987: Impact of treatment on cognitive function and quality of life in head and neck cancer patients: A prospective study in Indian population","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck cancer; Medicine; Quality of life (healthcare); Cognition; Cancer; Gerontology; Population; Prospective cohort study; Oncology; Internal medicine; Environmental health; Psychiatry; Nursing","score_opus":0.10396857881740493,"score_gpt":0.48887193886775115,"score_spread":0.3849033600503462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409644220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493897,0.0012497172,2.1701368e-7,0.00011078845,0.000042089374,0.003221875,0.00012749377,0.000005760936,0.00030309506],"genre_scores_gemma":[0.9984281,0.00071295025,6.465357e-7,0.00001981152,0.000022423825,0.00074123533,0.0000151316135,0.000009775612,0.000049897182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985076,0.00018306957,0.00040039414,0.00034135752,0.00032847453,0.00023906265],"domain_scores_gemma":[0.9989661,0.00029548534,0.00011237581,0.000094710325,0.0004598491,0.00007148787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044159242,0.00013903048,0.00047206553,0.00065922295,0.000053015832,0.000007661062,0.000022441194,0.000065541506,0.00003902201],"category_scores_gemma":[0.00048268575,0.00011137081,0.000038187,0.00077029347,0.0001489354,0.00007949415,0.000041441686,0.00028009503,3.9680893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011407485,0.0018289885,0.96962196,0.0002766465,0.00041642413,0.0000018521843,0.0033551585,0.000020207637,0.00024826784,0.000007725921,0.000012347216,0.012802952],"study_design_scores_gemma":[0.0145885935,0.006673112,0.97361404,0.0016958687,0.000050626517,4.7914085e-8,0.0029819172,0.000005443509,0.00023422197,0.0000856933,6.505241e-7,0.00006976196],"about_ca_topic_score_codex":0.13552214,"about_ca_topic_score_gemma":0.050508928,"teacher_disagreement_score":0.08501321,"about_ca_system_score_codex":0.0021328558,"about_ca_system_score_gemma":0.0005312717,"threshold_uncertainty_score":0.9668168},"labels":[],"label_agreement":null},{"id":"W4409645341","doi":"10.1158/1538-7445.am2025-3815","title":"Abstract 3815: High-penetrance rare variants underlying familial lung cancer risk: Insights from the Genetic Epidemiology of Lung Cancer Consortium","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Penetrance; Medicine; Epidemiology; Oncology; Cancer; Internal medicine; Genetics; Biology; Gene; Phenotype","score_opus":0.0681909123138101,"score_gpt":0.41358923545954135,"score_spread":0.34539832314573127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409645341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85459965,0.14027238,0.0013765546,0.0012216202,0.0007919123,0.00065567886,0.0007191085,0.000011984074,0.00035112162],"genre_scores_gemma":[0.94753766,0.04930735,0.0001451578,0.000418853,0.0005653858,0.0011013773,0.000070123715,0.000036022335,0.0008180438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968647,0.0006320421,0.0006192597,0.00086825056,0.0003426513,0.00067309086],"domain_scores_gemma":[0.997586,0.0004698035,0.00026384983,0.0009811622,0.0005733597,0.0001258097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064773567,0.00026314356,0.00042233622,0.00011411705,0.00050130987,0.000029801642,0.000877586,0.0003257677,0.00040085724],"category_scores_gemma":[0.0003361817,0.00020557092,0.00013978525,0.00051807216,0.000598704,0.000013427664,0.0002252846,0.0006350188,0.0000032755577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006048962,0.00010418299,0.4344276,0.0002634385,0.0010380675,0.000006102914,0.0003136872,0.00982733,0.50172824,0.00093759113,0.029525433,0.021223428],"study_design_scores_gemma":[0.0011257561,0.000043492404,0.9507349,0.00035963714,0.00012123102,4.782715e-7,0.00015894895,0.0011853417,0.037758373,0.0007965069,0.0074320245,0.00028332326],"about_ca_topic_score_codex":0.047422267,"about_ca_topic_score_gemma":0.009712976,"teacher_disagreement_score":0.5163073,"about_ca_system_score_codex":0.00026242877,"about_ca_system_score_gemma":0.0017290339,"threshold_uncertainty_score":0.958921},"labels":[],"label_agreement":null},{"id":"W4409646209","doi":"10.1158/1538-7445.am2025-1901","title":"Abstract 1901: Applications of silicon quantum dots as biomarkers for cancer detection and treatment, emphasizing biocompatibility studies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biocompatibility; Quantum dot; Nanotechnology; Cancer; Medicine; Materials science; Silicon; Cancer research; Optoelectronics; Internal medicine","score_opus":0.07693182556815112,"score_gpt":0.47525398436698946,"score_spread":0.39832215879883837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409646209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841286,0.009851962,0.00050273334,0.0002799492,0.00003125117,0.00072355254,0.00007436255,0.00001630558,0.00010703476],"genre_scores_gemma":[0.9891627,0.009609385,0.00018598558,0.000020421783,0.00006521336,0.0007689233,0.000017147699,0.000008151467,0.00016207143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990981,0.00004528693,0.00018556826,0.0003831636,0.00009266638,0.00019520942],"domain_scores_gemma":[0.9991506,0.00007447495,0.00006647901,0.00025812627,0.00041321613,0.00003714356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033154569,0.00010569132,0.00017670412,0.0001360123,0.00019681091,0.000014128738,0.0000804631,0.00009039151,0.0000011045622],"category_scores_gemma":[0.00009771715,0.00008573343,0.00007130116,0.00028955282,0.00032239693,0.000004116323,0.00005675193,0.00005386709,1.505635e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018218817,0.000045609537,0.0011134595,0.00009679005,0.00025115628,8.764706e-8,0.000021791886,0.0000020389068,0.8045208,0.00002174268,0.00007091911,0.1936734],"study_design_scores_gemma":[0.000306158,0.00019783531,0.002712444,0.000056954144,0.00003826354,2.6654274e-7,0.0003527412,0.00003296076,0.98657805,0.000607041,0.009038361,0.00007891332],"about_ca_topic_score_codex":0.0009401291,"about_ca_topic_score_gemma":0.0017175628,"teacher_disagreement_score":0.1935945,"about_ca_system_score_codex":0.00012385636,"about_ca_system_score_gemma":0.00014379136,"threshold_uncertainty_score":0.34961078},"labels":[],"label_agreement":null},{"id":"W4409652571","doi":"10.1158/1538-7445.am2025-813","title":"Abstract 813: <i>In vitro</i> and <i>in vivo</i> modelling of drug tolerance and minimal residual disease to discover effective therapeutic combination strategies for EGFR-mutated lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Drug; Medicine; In vivo; Lung cancer; Disease; Cancer; In vitro; Pharmacology; Oncology; Cancer research; Internal medicine; Biology; Biotechnology; Genetics","score_opus":0.030131876624509356,"score_gpt":0.4141105124048923,"score_spread":0.38397863578038294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409652571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98285764,0.011226042,0.00033952066,0.002327345,0.00006712871,0.0025734056,0.00028296933,0.000009762851,0.00031616326],"genre_scores_gemma":[0.9964602,0.00073612126,0.00009178461,0.00017222458,0.00003273354,0.002020208,0.000017163979,0.000018110119,0.0004514363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875516,0.000064561806,0.00023104073,0.00037651544,0.0002509774,0.00032174514],"domain_scores_gemma":[0.9991628,0.00034260238,0.000037368987,0.00013575159,0.00021218369,0.00010932473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031303297,0.00013388047,0.0002818977,0.0003087302,0.00009013647,0.000050106068,0.00005872253,0.00004282166,0.00001172151],"category_scores_gemma":[0.000023088765,0.000116121504,0.000029761375,0.0004499436,0.00012573568,0.00018652737,0.000033329638,0.00018264414,1.3745301e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061929703,0.0022891916,0.1922056,0.013803423,0.0012517526,0.0001323353,0.024234716,0.090288505,0.5573148,0.0070422045,0.0043392773,0.045168504],"study_design_scores_gemma":[0.03771441,0.0007328489,0.6060942,0.009096038,0.0008212004,0.000002000644,0.00708636,0.08208949,0.24354558,0.010729548,0.001232889,0.000855473],"about_ca_topic_score_codex":0.0034711123,"about_ca_topic_score_gemma":0.0012409101,"teacher_disagreement_score":0.41388857,"about_ca_system_score_codex":0.00043834065,"about_ca_system_score_gemma":0.0008827762,"threshold_uncertainty_score":0.5247307},"labels":[],"label_agreement":null},{"id":"W4409652574","doi":"10.1158/1538-7445.am2025-5341","title":"Abstract 5341: Duration of CDK4/6 inhibitor (CDKi) treatment in metastatic HR+ HER2- breast cancer (mHRBC) is associated with changes in AKT pathway protein expression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Protein kinase B; Cancer; Internal medicine; Cancer research; Signal transduction; Biology","score_opus":0.06060826507613826,"score_gpt":0.4004901628861432,"score_spread":0.33988189781000494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409652574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882073,0.0027296757,0.000017374208,0.0059995344,0.00006189665,0.0024229265,0.0002579723,0.00003282067,0.00027053562],"genre_scores_gemma":[0.9937964,0.00038106323,0.00010948759,0.00010858322,0.00009127005,0.003640744,0.0000313184,0.000046529978,0.0017946089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736655,0.00022787835,0.00045020913,0.00054076366,0.00079050247,0.00062407146],"domain_scores_gemma":[0.9986994,0.000157103,0.00017786508,0.00038025205,0.00047030183,0.000115056006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060302543,0.00026692214,0.000605081,0.000709132,0.00007878182,0.000023511751,0.00014421555,0.00012194139,0.0006047533],"category_scores_gemma":[0.00008827206,0.00019887999,0.000052853877,0.0014743969,0.00022379367,0.00018032295,0.000054681543,0.00046397018,0.0000035349235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005882645,0.0010962478,0.034269784,0.00077033084,0.00025243976,0.00014267725,0.0034578776,0.00016547987,0.8742103,0.000042662043,0.00013966869,0.07956986],"study_design_scores_gemma":[0.007541927,0.0005776873,0.15040532,0.007950994,0.000027452745,0.0000049688288,0.0013158638,0.000059548667,0.8305756,0.00020855464,0.0011177134,0.00021438171],"about_ca_topic_score_codex":0.007989992,"about_ca_topic_score_gemma":0.024277909,"teacher_disagreement_score":0.11613553,"about_ca_system_score_codex":0.0028341622,"about_ca_system_score_gemma":0.0015687984,"threshold_uncertainty_score":0.99861586},"labels":[],"label_agreement":null},{"id":"W4409652608","doi":"10.1158/1538-7445.am2025-4522","title":"Abstract 4522: Old dog, new tricks: The role of capecitabine in HPV-negative head and neck cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Head and neck cancer; Capecitabine; Medicine; Oncology; Head and neck; Cancer; Internal medicine; Surgery; Colorectal cancer","score_opus":0.06517023296398328,"score_gpt":0.4411252279736382,"score_spread":0.3759549950096549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409652608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9041382,0.061104525,0.0000011377984,0.009927271,0.00014260977,0.0006979115,0.000027665432,0.000012385722,0.023948308],"genre_scores_gemma":[0.9784301,0.013832364,0.000030625186,0.00038480794,0.0002880963,0.0002924035,0.0000014127727,0.00001535484,0.006724842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832594,0.00007634523,0.00029796793,0.0002931256,0.00046969982,0.00053689844],"domain_scores_gemma":[0.99880826,0.00046169947,0.000043486314,0.00028265108,0.00025355056,0.0001503468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061285065,0.00013920732,0.00044616495,0.00028133937,0.00012773731,0.000016758931,0.00015404032,0.0000803283,0.00049090397],"category_scores_gemma":[0.00035353942,0.00009245871,0.000052390802,0.0011513325,0.00030853378,0.0000766602,0.00013914423,0.0006372822,0.0000051586944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014946103,0.00027247728,0.54502493,0.00070336886,0.00034653352,0.00002016263,0.010227791,0.000015802247,0.020285003,0.0011587067,0.056996528,0.3634541],"study_design_scores_gemma":[0.0035637915,0.00021477789,0.87719196,0.001401134,0.000031034328,0.0000013403932,0.0031797704,0.00003344331,0.029921409,0.00094347994,0.08340068,0.00011718546],"about_ca_topic_score_codex":0.04462505,"about_ca_topic_score_gemma":0.010685326,"teacher_disagreement_score":0.36333692,"about_ca_system_score_codex":0.00040537253,"about_ca_system_score_gemma":0.001234697,"threshold_uncertainty_score":0.96173686},"labels":[],"label_agreement":null},{"id":"W4409652619","doi":"10.1158/1538-7445.am2025-7225","title":"Abstract 7225: The secreted cytokine Chitinase 3-like-1 promotes breast cancer metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Studies on Chitinases and Chitosanases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; Cancer research; Breast cancer; Medicine; Breast cancer metastasis; Chitinase; Cytokine; Cancer; Internal medicine; Oncology; Biology; Cancer metastasis; Enzyme; Biochemistry","score_opus":0.03771588220566978,"score_gpt":0.3873555369724184,"score_spread":0.34963965476674863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409652619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754955,0.012420812,0.000012458172,0.0077804886,0.00026098092,0.0004664205,0.0008560252,0.00002091341,0.0026863606],"genre_scores_gemma":[0.99181455,0.0047831098,0.00001341343,0.0007310977,0.0006019867,0.0006203566,0.0000686634,0.000028433731,0.0013383665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980992,0.00013733315,0.00022430257,0.0005288667,0.0003800981,0.00063020573],"domain_scores_gemma":[0.9988197,0.000085065905,0.000056522607,0.00057123357,0.000362626,0.000104838626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004248555,0.00021032887,0.00020468347,0.00009106135,0.00057679927,0.000081631886,0.000510581,0.00010219736,0.0003648032],"category_scores_gemma":[0.0001240254,0.00014408334,0.00014143321,0.00052229053,0.00041077205,0.0000048762845,0.0004097803,0.00036172944,0.000008926205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008714974,0.00024157984,0.013128818,0.00033498398,0.0011129415,0.000033451808,0.00013442186,0.00008522375,0.7910322,0.00036552426,0.12887017,0.06378918],"study_design_scores_gemma":[0.0012075664,0.00016369288,0.15298976,0.00026877882,0.00009252163,0.000016804997,0.0011744279,0.000021248772,0.66451764,0.00012372732,0.17902535,0.0003984476],"about_ca_topic_score_codex":0.0019117544,"about_ca_topic_score_gemma":0.003005438,"teacher_disagreement_score":0.13986094,"about_ca_system_score_codex":0.00006289036,"about_ca_system_score_gemma":0.00047917938,"threshold_uncertainty_score":0.5875548},"labels":[],"label_agreement":null},{"id":"W4409652646","doi":"10.1158/1538-7445.am2025-6535","title":"Abstract 6535: Association of <i>Bacteroides fragilis</i> and enterotoxigenic <i>Bacteroides fragilis</i> with specific T-cell subsets in the colorectal carcinoma microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Bacteroides fragilis; Biology; Cancer research; Microbiology; Antibiotics","score_opus":0.013383540336098655,"score_gpt":0.2907737301739991,"score_spread":0.2773901898379004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409652646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933774,0.0045745233,0.0000042991605,0.0007062851,0.000057827678,0.00068175973,0.00007393755,0.000003022085,0.00052097486],"genre_scores_gemma":[0.99499905,0.004017863,0.000029608203,0.00024840224,0.00006709177,0.00013307923,0.00006185866,0.000016075446,0.00042699982],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983449,0.00023293046,0.00027425992,0.00041329494,0.00026661155,0.000467992],"domain_scores_gemma":[0.99933636,0.00009316088,0.00010024493,0.00031553232,0.000097513206,0.000057162848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008954474,0.00015545553,0.00019933385,0.00011283353,0.00013063075,0.000051456438,0.00029590214,0.00015913935,0.00003461468],"category_scores_gemma":[0.000021061087,0.00011841682,0.000047848247,0.00021967544,0.00019619748,0.0000089283985,0.00012082351,0.00039519634,0.000004005912],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026806435,0.00011031667,0.25482097,0.0001153308,0.000020131527,0.000003508599,0.00026808726,0.000002599831,0.7405099,0.000004537239,0.0035760028,0.00030049426],"study_design_scores_gemma":[0.0008185173,0.00018179895,0.5253758,0.000057125253,0.0000064255346,0.0000022412669,0.0003139062,6.244982e-7,0.45796406,0.00001124871,0.015184566,0.000083712126],"about_ca_topic_score_codex":0.00049378216,"about_ca_topic_score_gemma":0.0012495313,"teacher_disagreement_score":0.28254586,"about_ca_system_score_codex":0.00019541723,"about_ca_system_score_gemma":0.00020960935,"threshold_uncertainty_score":0.48288977},"labels":[],"label_agreement":null},{"id":"W4409689287","doi":"10.1158/1538-7445.am2025-2395","title":"Abstract 2395: The role of exonized mobile elements in chimeric transcript emergence in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Glioblastoma; Biology; Cancer research; Genetics; Cell biology","score_opus":0.017161978685771025,"score_gpt":0.388269968225456,"score_spread":0.371107989539685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992529,0.0048477966,0.00010402712,0.00021537606,0.000021235264,0.0005805579,0.000016947157,0.0000040755003,0.0016810277],"genre_scores_gemma":[0.99637437,0.0019322687,0.00007238431,0.000053268694,0.00001605024,0.0013391618,0.000010258263,0.0000071088393,0.00019514629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990642,0.000093362134,0.00022777944,0.00025039836,0.00011060766,0.00025365458],"domain_scores_gemma":[0.9995338,0.000013643904,0.00003047551,0.00032833766,0.00007159171,0.000022154816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004927681,0.00007197897,0.00009999562,0.00011347389,0.000047917318,0.0000054434445,0.0003677824,0.000092953975,0.000088755696],"category_scores_gemma":[0.00002534513,0.00005780727,0.000043041255,0.0005349916,0.0001494543,0.0000017301767,0.00009136978,0.00020277231,0.0000017670766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009120168,0.00007674869,0.0057293675,0.000014343074,0.000012254571,6.832283e-7,0.000037913895,0.000027238917,0.9798004,0.0002702467,0.00051463814,0.013424976],"study_design_scores_gemma":[0.00028278396,0.00009829243,0.008736906,0.0000347459,0.0000020150246,3.1100964e-7,0.0002086787,0.000036624453,0.942001,0.0005915965,0.04794724,0.00005982765],"about_ca_topic_score_codex":0.0005175132,"about_ca_topic_score_gemma":0.0010022041,"teacher_disagreement_score":0.0474326,"about_ca_system_score_codex":0.000022339034,"about_ca_system_score_gemma":0.0001434015,"threshold_uncertainty_score":0.2357312},"labels":[],"label_agreement":null},{"id":"W4409689367","doi":"10.1158/1538-7445.am2025-2837","title":"Abstract 2837: Mechanisms promoting chromosomal instability following the loss of p53 and Rb","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cancer research; Genome instability; Chromosome instability; Instability; Chemistry; Biology; Cell biology; Genetics; Physics; DNA; DNA damage; Chromosome; Gene","score_opus":0.04580659037959888,"score_gpt":0.39230785061164963,"score_spread":0.34650126023205075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873144,0.003774273,0.00014523447,0.0027309388,0.0002126832,0.00097385666,0.000013943406,0.00003098802,0.0033866642],"genre_scores_gemma":[0.9991853,0.00019078125,0.00011361158,0.00007953062,0.000063148735,0.00014641586,0.0000036800786,0.000020461202,0.00019704022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980788,0.00013812259,0.0003135934,0.00037038993,0.0006734208,0.0004256214],"domain_scores_gemma":[0.9988046,0.00026005265,0.00005578954,0.00050510926,0.000269956,0.00010444729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020745997,0.00012140882,0.00033126964,0.0001612421,0.00021276869,0.000029941772,0.00018958864,0.000120673714,0.00012290369],"category_scores_gemma":[0.00074868806,0.000087226974,0.00012902256,0.00068158004,0.00029851787,0.000057991594,0.00022107702,0.0007730984,0.0000040193518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022008912,0.00012581884,0.006181087,0.0009937104,0.0002859037,0.00010522181,0.0011484481,0.000011565004,0.96759534,0.0022089172,0.00028114635,0.020842774],"study_design_scores_gemma":[0.0023562908,0.0003215951,0.041041594,0.0022562423,0.00013442352,0.000020474188,0.00085775385,0.00032568636,0.94628936,0.00386599,0.0023601954,0.00017037164],"about_ca_topic_score_codex":0.0007483426,"about_ca_topic_score_gemma":0.00015696412,"teacher_disagreement_score":0.034860507,"about_ca_system_score_codex":0.0003502301,"about_ca_system_score_gemma":0.0010423851,"threshold_uncertainty_score":0.35570127},"labels":[],"label_agreement":null},{"id":"W4409689373","doi":"10.1158/1538-7445.am2025-2777","title":"Abstract 2777: Smoking, clonal evolution, and lung cancer risk","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lung cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.019757658119748413,"score_gpt":0.3855937899595087,"score_spread":0.3658361318397603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115794,0.086173356,0.00015821689,0.00040813902,0.0002202141,0.00021817222,0.00019829175,0.0000090135645,0.0010352236],"genre_scores_gemma":[0.9793273,0.017963912,0.000030934854,0.00014408394,0.0005069883,0.00021363437,0.000040299405,0.000013670353,0.0017591265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987876,0.00008475589,0.00014162791,0.00040013887,0.00023513129,0.0003507749],"domain_scores_gemma":[0.99917215,0.000021807744,0.0000316742,0.0002719605,0.00035837182,0.00014401606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035767525,0.000104387094,0.00009494983,0.00010541535,0.00027778652,0.00005483956,0.00016847094,0.0001224329,0.00017772637],"category_scores_gemma":[0.00012496892,0.000106058804,0.00004958053,0.00018027223,0.00020336061,0.0000039357583,0.0001391623,0.00020517057,0.0000021908136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005254251,0.00016069286,0.550229,0.000469366,0.0002781847,0.0000062740655,0.00010204368,0.00014279493,0.20774598,0.00064612547,0.22804303,0.011651066],"study_design_scores_gemma":[0.0021608858,0.00009859675,0.7716676,0.0002352566,0.00008676041,0.0000016220923,0.00028880444,0.000106006795,0.09149486,0.003167732,0.13033529,0.00035661238],"about_ca_topic_score_codex":0.0009803092,"about_ca_topic_score_gemma":0.00079693523,"teacher_disagreement_score":0.22143857,"about_ca_system_score_codex":0.000102945996,"about_ca_system_score_gemma":0.0006454142,"threshold_uncertainty_score":0.43249524},"labels":[],"label_agreement":null},{"id":"W4409689383","doi":"10.1158/1538-7445.am2025-1225","title":"Abstract 1225: Phenotypically-relevant patient-derived 3D cell models to interrogate personalized medicine approaches at scale","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Personalized medicine; Scale (ratio); Computational biology; Medicine; Biology; Bioinformatics; Geography; Cartography","score_opus":0.12212237226213396,"score_gpt":0.35760647340464197,"score_spread":0.235484101142508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9359037,0.0030460614,0.00525142,0.0038570738,0.00046589188,0.0010607672,0.0000387967,0.0002862153,0.050090026],"genre_scores_gemma":[0.9941446,0.0005982201,0.0012001251,0.00014980567,0.00016624645,0.00053328637,0.000015637383,0.000067397676,0.003124678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961419,0.00015501973,0.00045268727,0.0006141149,0.0014448873,0.0011913513],"domain_scores_gemma":[0.9979656,0.0005498912,0.000024494917,0.0006001076,0.000296921,0.00056302553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013047339,0.00025745097,0.00038613437,0.00056955975,0.0002330209,0.00006543611,0.00083625596,0.00019173484,0.0017968782],"category_scores_gemma":[0.00029676003,0.00021915109,0.00007994158,0.0010686984,0.0006508985,0.000102762,0.00076264923,0.0011002317,0.00031701336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066236174,0.00015949403,0.00015567073,0.0016080483,0.00017581579,0.000035673598,0.0077578835,0.015736077,0.79484993,0.0004210919,0.053549595,0.12488834],"study_design_scores_gemma":[0.005995974,0.00065523194,0.0024037438,0.0038749406,0.0000620424,0.0000047883864,0.005015022,0.20668407,0.6012706,0.005099253,0.16745938,0.001474938],"about_ca_topic_score_codex":0.00039882204,"about_ca_topic_score_gemma":0.000194932,"teacher_disagreement_score":0.19357933,"about_ca_system_score_codex":0.0011252894,"about_ca_system_score_gemma":0.00020904951,"threshold_uncertainty_score":0.9991156},"labels":[],"label_agreement":null},{"id":"W4409689398","doi":"10.1158/1538-7445.am2025-678","title":"Abstract 678: A 10-second lipidomic based approach to diagnose common spinal tumor types with picosecond infrared laser mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Mass spectrometry; Infrared; Picosecond; Medicine; Laser; Chemistry; Optics; Chromatography; Physics","score_opus":0.02604778007598883,"score_gpt":0.33953104670094736,"score_spread":0.3134832666249585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96176213,0.003306247,0.00041274473,0.00034274388,0.00012616953,0.00060899905,0.000108462846,0.000016377953,0.033316128],"genre_scores_gemma":[0.98643774,0.00020063967,0.0014422096,0.00059817836,0.00031486189,0.00050246343,0.000059212427,0.00003631292,0.010408403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979475,0.00010311633,0.0002504242,0.00069257064,0.0003286504,0.00067772414],"domain_scores_gemma":[0.99881834,0.00006500691,0.00005949735,0.00062158046,0.00025368048,0.00018189297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061824307,0.00024488682,0.00036407943,0.0004540073,0.00021165183,0.00010930788,0.00047926692,0.00011060841,0.0008818582],"category_scores_gemma":[0.00017041824,0.00020769484,0.000088629124,0.0008406686,0.00019164626,0.000007813951,0.00022972032,0.0003848465,0.00003480673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026278694,0.00037325267,0.007798468,0.0003727922,0.00042656832,0.000021059172,0.000029008072,0.0001830624,0.9145852,0.0005311126,0.07192003,0.0011316146],"study_design_scores_gemma":[0.0022509957,0.0010917208,0.031088592,0.00011447163,0.000036560985,0.0000030010947,0.00019838523,0.000041969,0.79262716,0.00039748353,0.1716893,0.00046037431],"about_ca_topic_score_codex":0.00009681177,"about_ca_topic_score_gemma":0.00032413378,"teacher_disagreement_score":0.12195802,"about_ca_system_score_codex":0.00012798375,"about_ca_system_score_gemma":0.0004731919,"threshold_uncertainty_score":0.9655729},"labels":[],"label_agreement":null},{"id":"W4409689437","doi":"10.1158/1538-7445.am2025-2303","title":"Abstract 2303: The impact of adherence to cancer prevention guidelines on cancer risk, cancer incidence and mortality in a large cohort of Canadian adults","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Medicine; Cancer incidence; Cohort; Incidence (geometry); Cancer prevention; Oncology; Internal medicine; Cohort study","score_opus":0.06702543534060293,"score_gpt":0.4748979356676875,"score_spread":0.40787250032708455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084617,0.015996655,0.0000045199668,0.00040581913,0.00010627646,0.00080313237,0.0016336279,0.0000022354511,0.00020156102],"genre_scores_gemma":[0.96293354,0.03566448,0.000011875757,0.00011891802,0.0001348782,0.00083143235,0.000025734736,0.000011613201,0.00026752963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983549,0.00014202685,0.00036139268,0.00042428108,0.00030051905,0.00041684834],"domain_scores_gemma":[0.99833715,0.000032176056,0.000104609884,0.00040935137,0.0009096283,0.0002070957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008224102,0.0001419577,0.00021235297,0.00029152347,0.00011128049,0.000018070705,0.00029579957,0.0001144938,0.00018227188],"category_scores_gemma":[0.00034839005,0.00011239365,0.000084495674,0.00065243786,0.00016324256,0.000007432621,0.00009907399,0.00019588413,6.4127124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052717584,0.000083078754,0.9510127,0.00016950663,0.0001157987,0.000001501205,0.0001352121,0.0014195911,0.032373123,0.00001318804,0.008238029,0.005911147],"study_design_scores_gemma":[0.0006705324,0.00018816224,0.9556439,0.00075206073,0.000024113633,1.0949002e-7,0.00012904547,0.000084342115,0.04141539,0.00015151878,0.0008288409,0.000111975176],"about_ca_topic_score_codex":0.8676974,"about_ca_topic_score_gemma":0.918576,"teacher_disagreement_score":0.050878618,"about_ca_system_score_codex":0.00024822933,"about_ca_system_score_gemma":0.0031164915,"threshold_uncertainty_score":0.5528522},"labels":[],"label_agreement":null},{"id":"W4409689678","doi":"10.1158/1538-7445.am2025-2210","title":"Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre hospitalier universitaire de Québec; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Microbiome; Fecal bacteriotherapy; Melanoma; Immunotherapy; Medicine; Lung cancer; Cancer; Colorectal cancer; Transplantation; Toxicity; Profiling (computer programming); Lung; Internal medicine; Oncology; Immunology; Biology; Cancer research; Clostridium difficile; Bioinformatics; Microbiology","score_opus":0.020512407571308833,"score_gpt":0.3319119653673624,"score_spread":0.31139955779605355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149597,0.0035754342,0.000005176491,0.0022504805,0.000041739255,0.0022952307,0.00020787731,0.00003103944,0.00009707913],"genre_scores_gemma":[0.99575585,0.002585911,0.00011254792,0.00009254019,0.00003102767,0.00030321494,0.00008702013,0.00005190785,0.0009799723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99722815,0.0002597256,0.0003547357,0.0007413104,0.000611697,0.0008043661],"domain_scores_gemma":[0.998535,0.00037552344,0.000074995216,0.00037804592,0.00044480493,0.0001916792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011273683,0.00031625893,0.00052980054,0.0007370999,0.0002642581,0.00013599737,0.0001860607,0.00019954701,0.00010359677],"category_scores_gemma":[0.000048465317,0.00024029585,0.00004107676,0.00078697933,0.0004206608,0.00016734248,0.000082915685,0.0008170152,0.0000016497511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049755875,0.00026509294,0.3740012,0.0010065658,0.0001807026,0.00007005217,0.00064825144,0.00000777896,0.5721905,0.000009517763,0.00017298687,0.0016914416],"study_design_scores_gemma":[0.0090940455,0.00091263733,0.59560305,0.0015930679,0.0000445357,0.000008594662,0.00014315693,0.00006536764,0.39225003,0.000011220226,0.000063902924,0.00021037852],"about_ca_topic_score_codex":0.0018366778,"about_ca_topic_score_gemma":0.0005248261,"teacher_disagreement_score":0.22160184,"about_ca_system_score_codex":0.00072926155,"about_ca_system_score_gemma":0.00073211035,"threshold_uncertainty_score":0.97989804},"labels":[],"label_agreement":null},{"id":"W4409689702","doi":"10.1158/1538-7445.am2025-2611","title":"Abstract 2611: Cellular origin of DICER1 tumor predisposition syndrome informed by lineage-traceable genetically engineered mouse model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Sunnybrook Health Science Centre; McGill University; University of British Columbia","funders":"","keywords":"Lineage (genetic); Genetically engineered; Biology; Genetically modified organism; Genetics; Cancer research; Pathology; Medicine; Gene","score_opus":0.04056372487833237,"score_gpt":0.3711326713529866,"score_spread":0.33056894647465423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897291,0.0025779575,0.00079304026,0.00074022514,0.00006699433,0.0010273904,0.00023601405,0.000060772396,0.0047684764],"genre_scores_gemma":[0.98668665,0.00051170186,0.00057742005,0.00007876878,0.000039840237,0.00036687552,0.000054753535,0.00003139821,0.011652582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777013,0.000038870236,0.000505002,0.0003075882,0.0008195708,0.0005588423],"domain_scores_gemma":[0.9983629,0.0002952976,0.000053478907,0.00043905282,0.00064451667,0.00020473187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053264014,0.00018313392,0.00044324284,0.00033418875,0.00009877652,0.000030362153,0.00022242362,0.00011087826,0.00030883163],"category_scores_gemma":[0.0005203741,0.00016609166,0.000095801595,0.0005701783,0.00023242945,0.00010180692,0.00013356665,0.0005117102,0.000044500062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044403298,0.00033134533,0.0011346948,0.0028763849,0.00039355957,0.00006547386,0.0003794234,0.0014780253,0.9763033,0.00018727154,0.014313736,0.0020927568],"study_design_scores_gemma":[0.004481691,0.0005557783,0.012864694,0.0016326618,0.00026175074,0.000012808916,0.0005130318,0.046493653,0.92722064,0.00026857088,0.0052336343,0.00046106975],"about_ca_topic_score_codex":0.0003550073,"about_ca_topic_score_gemma":0.000057029352,"teacher_disagreement_score":0.049082637,"about_ca_system_score_codex":0.00044772826,"about_ca_system_score_gemma":0.0011831013,"threshold_uncertainty_score":0.6773021},"labels":[],"label_agreement":null},{"id":"W4409689781","doi":"10.1158/1538-7445.am2025-989","title":"Abstract 989: Vitamin D and the modifying effect of body mass index on ovarian cancer recurrence","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Cancer; Body mass index; Ovarian cancer; Oncology; Vitamin; Internal medicine; Vitamin D and neurology; Physiology; Endocrinology; Gynecology","score_opus":0.04625962051515442,"score_gpt":0.42589001499825707,"score_spread":0.37963039448310265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96271056,0.009654341,0.000023906045,0.013921129,0.000387202,0.0018524188,0.00005840773,0.000020790842,0.011371219],"genre_scores_gemma":[0.9922848,0.0053839493,0.000012467013,0.00017379156,0.00014036044,0.0013149761,0.000003694553,0.000015894184,0.0006701125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982154,0.00021889286,0.00023057968,0.00039969105,0.00055366306,0.00038178687],"domain_scores_gemma":[0.9980365,0.001166086,0.000059295882,0.00044828723,0.00018187037,0.00010792952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013668938,0.0001602372,0.00041436564,0.00022463388,0.00017571222,0.000043198157,0.00016371648,0.00009224986,0.00024537125],"category_scores_gemma":[0.00021395518,0.00009433785,0.00008182672,0.0005394998,0.0004069337,0.000043885393,0.00007581403,0.00056838506,0.000007044202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015519282,0.0004545429,0.5423718,0.0036747926,0.0015609442,0.00013610352,0.0007378557,0.00022791592,0.012283068,0.01159107,0.018292276,0.39315036],"study_design_scores_gemma":[0.023759233,0.0010774056,0.85826355,0.006298979,0.00031022725,0.000004151263,0.00015085877,0.0007193854,0.1011729,0.0010354628,0.0069691148,0.0002387215],"about_ca_topic_score_codex":0.005463498,"about_ca_topic_score_gemma":0.00016236067,"teacher_disagreement_score":0.39291164,"about_ca_system_score_codex":0.00044342852,"about_ca_system_score_gemma":0.0005089001,"threshold_uncertainty_score":0.8259211},"labels":[],"label_agreement":null},{"id":"W4409689931","doi":"10.1158/1538-7445.am2025-3344","title":"Abstract 3344: The 31-gene expression profile identifies patients at risk of developing early distant metastases and can guide risk-appropriate surveillance strategies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Norfolk General Hospital","funders":"","keywords":"Medicine; Gene expression; Oncology; Gene; Cancer research; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.04470844419887378,"score_gpt":0.38465967793873435,"score_spread":0.3399512337398606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042904,0.006580652,0.0000156158,0.00048580678,0.00014815161,0.0010103664,0.0007522895,0.000017609504,0.0005604591],"genre_scores_gemma":[0.9870078,0.011419451,0.00015196083,0.000014925539,0.00004430341,0.00052884215,0.000063266714,0.000016664359,0.00075277267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802744,0.00020203747,0.000372291,0.00041252136,0.0006143505,0.0003713633],"domain_scores_gemma":[0.99830925,0.00044531823,0.00018432428,0.00044242525,0.00053220044,0.000086470915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008861296,0.00016571043,0.00033569525,0.00013205144,0.00043287716,0.00009568486,0.00015504085,0.000053050207,0.00007465281],"category_scores_gemma":[0.0002860529,0.000100508245,0.00007057808,0.0003633212,0.00030595125,0.00008221561,0.00025468058,0.00027502497,0.0000035378887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007408217,0.00017315894,0.95647,0.0005767442,0.00045506205,0.000013839723,0.00091225293,0.000025803973,0.023206228,0.00011518472,0.0065504913,0.010760423],"study_design_scores_gemma":[0.0011234618,0.00009303737,0.7267941,0.00046870642,0.000059283764,3.6835632e-7,0.0005136383,0.000003407985,0.26892886,0.00033863666,0.0015968306,0.000079635276],"about_ca_topic_score_codex":0.017249279,"about_ca_topic_score_gemma":0.006262434,"teacher_disagreement_score":0.24572264,"about_ca_system_score_codex":0.00050478627,"about_ca_system_score_gemma":0.0007334937,"threshold_uncertainty_score":0.98929495},"labels":[],"label_agreement":null},{"id":"W4409689959","doi":"10.1158/1538-7445.am2025-1230","title":"Abstract 1230: High throughput quantitative molecular characterization of cytotoxic antibody-drug conjugates in spheroid models for improved functional characterization, screening and candidate selection","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Antibody-drug conjugate; Characterization (materials science); Cytotoxic T cell; Selection (genetic algorithm); High-throughput screening; Drug; Computational biology; Spheroid; Antibody; Chemistry; Biology; Pharmacology; Immunology; In vitro; Bioinformatics; Materials science; Nanotechnology; Monoclonal antibody; Computer science; Biochemistry","score_opus":0.06537420895556471,"score_gpt":0.4193367668752878,"score_spread":0.3539625579197231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94348043,0.0004048595,0.05096021,0.0024490585,0.0001267216,0.002151786,0.00030272926,0.00003237215,0.00009181036],"genre_scores_gemma":[0.9951823,0.0014237803,0.0008617288,0.00015540009,0.000100501245,0.00071357127,0.0009025177,0.000048524613,0.00061172957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761385,0.0001646585,0.0005165439,0.00059823954,0.00054286333,0.00056387676],"domain_scores_gemma":[0.9978857,0.00024486802,0.0001321376,0.00023873097,0.0013763882,0.00012216886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012748911,0.00019434915,0.00044121372,0.0006121324,0.00019341921,0.000076861164,0.0001340036,0.00014548874,0.00013868512],"category_scores_gemma":[0.0002689683,0.00019503827,0.000060122,0.0012506479,0.00028132746,0.00038125573,0.00009414103,0.00053134665,0.000001913782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019463099,0.00010094188,0.00623776,0.00095214957,0.000116823496,0.000004085483,0.00028446683,0.00022696101,0.98397565,0.0021133074,0.00007415239,0.003967414],"study_design_scores_gemma":[0.0037749854,0.00036698743,0.19253491,0.0014406071,0.00003595644,0.000003560806,0.00021398459,0.04077674,0.7586797,0.0012835737,0.00066290965,0.00022610738],"about_ca_topic_score_codex":0.0021660745,"about_ca_topic_score_gemma":0.00030975006,"teacher_disagreement_score":0.22529596,"about_ca_system_score_codex":0.00040169674,"about_ca_system_score_gemma":0.0011909466,"threshold_uncertainty_score":0.795343},"labels":[],"label_agreement":null},{"id":"W4409689988","doi":"10.1158/1538-7445.am2025-51","title":"Abstract 51: 10 second classification of spontaneous lymphoma in patient-derived tumor xenograft models","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Lymphoma; Oncology; Internal medicine; Cancer research","score_opus":0.044081619469770864,"score_gpt":0.3685598846149884,"score_spread":0.32447826514521755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901733,0.0026074876,0.000012735313,0.00012748357,0.000044249602,0.00044065138,0.00011172914,0.000005196976,0.006477175],"genre_scores_gemma":[0.9978895,0.00045720892,0.00002618542,0.00003278789,0.000032553377,0.0003176228,0.00008386734,0.000015069554,0.0011451752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985373,0.00009624563,0.00023624294,0.00038139132,0.0003198335,0.00042896872],"domain_scores_gemma":[0.999152,0.000035676716,0.000046890586,0.00039193296,0.00028072493,0.00009278623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024410163,0.000110723384,0.00015192684,0.00023571342,0.000070334034,0.000026642469,0.00024919456,0.000088926405,0.00030722423],"category_scores_gemma":[0.000066511486,0.000107312706,0.00006108749,0.00035573242,0.00016991417,0.000008399356,0.00013995088,0.00012404678,0.000011088638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011811338,0.00023481017,0.0006630325,0.00011105691,0.0000727589,0.000110874986,0.000078707395,0.00008536562,0.9598332,0.00008124196,0.0028495723,0.03469824],"study_design_scores_gemma":[0.0023048583,0.00045335252,0.024435692,0.00014251602,0.000006287403,0.00001613042,0.00032986118,0.0002131697,0.95125616,0.0007680207,0.019898126,0.00017584664],"about_ca_topic_score_codex":0.0013943352,"about_ca_topic_score_gemma":0.0059666457,"teacher_disagreement_score":0.03452239,"about_ca_system_score_codex":0.0002347116,"about_ca_system_score_gemma":0.0008171184,"threshold_uncertainty_score":0.4376085},"labels":[],"label_agreement":null},{"id":"W4409690039","doi":"10.1158/1538-7445.am2025-1206","title":"Abstract 1206: The molecular characterization initiative: Nationwide comprehensive clinical profiling of pediatric solid tissue malignancies at scale","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Profiling (computer programming); Medicine; Pathology; Computer science","score_opus":0.13142882445858775,"score_gpt":0.4905294974778832,"score_spread":0.3591006730192955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988773,0.0037818053,0.00006679778,0.004978215,0.00021493294,0.0010611968,0.00007439977,0.000016264285,0.001033389],"genre_scores_gemma":[0.9917515,0.0063992036,0.00006324845,0.00041322564,0.00026968258,0.00046054018,0.00008476237,0.000014828848,0.0005430294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838704,0.0001473081,0.00040846594,0.00028687366,0.00051109074,0.00025920002],"domain_scores_gemma":[0.99808776,0.00047827212,0.000115356896,0.00029620968,0.0009507429,0.00007167401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048275923,0.00010531795,0.0002895575,0.00018380028,0.00017192494,0.000022119104,0.00012234742,0.00008175999,0.00017573222],"category_scores_gemma":[0.0001751487,0.00007542405,0.000086988184,0.0006151109,0.0002211189,0.000052999403,0.0001297149,0.00028170872,0.000022905888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060583034,0.00066816504,0.44471636,0.0010236354,0.00038607622,0.00006715283,0.00055981503,0.000043827302,0.5285935,0.0009783339,0.0039835325,0.018373797],"study_design_scores_gemma":[0.000879183,0.00013431453,0.59161484,0.00018865294,0.000081885344,0.0000011904316,0.00010639313,0.000020801352,0.40243784,0.00006420381,0.004416686,0.000053984462],"about_ca_topic_score_codex":0.0001057717,"about_ca_topic_score_gemma":0.00004845599,"teacher_disagreement_score":0.14689852,"about_ca_system_score_codex":0.00026787317,"about_ca_system_score_gemma":0.00065043,"threshold_uncertainty_score":0.3075703},"labels":[],"label_agreement":null},{"id":"W4409690046","doi":"10.1158/1538-7445.am2025-427","title":"Abstract 427: Genome-wide CRISPR knockout screen identifies novel determinant of PARP inhibitor resistance in small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"CRISPR; PARP inhibitor; Cancer; Biology; Genetics; Genome; Cancer research; Knockout mouse; Lung cancer; Poly ADP ribose polymerase; Computational biology; Medicine; Gene; Pathology","score_opus":0.06454410470683547,"score_gpt":0.4333816477657002,"score_spread":0.36883754305886474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150788,0.06930298,0.00006308669,0.0037148905,0.0003247514,0.0022038368,0.00021286418,0.000045392237,0.009053347],"genre_scores_gemma":[0.9629656,0.00993877,0.00020219441,0.00017922158,0.00031230206,0.0015004445,0.000014216634,0.0000630771,0.024824178],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99534136,0.00016023102,0.000861533,0.0009203502,0.0013285008,0.0013880285],"domain_scores_gemma":[0.9965044,0.0007776249,0.00015800235,0.0009303274,0.0013587573,0.00027086854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019767235,0.00033688612,0.0008593174,0.0011629332,0.00027618857,0.000084380496,0.00068879384,0.0001945895,0.0003652605],"category_scores_gemma":[0.000932229,0.00029999876,0.0001748967,0.0019331512,0.0007478428,0.00018242684,0.0006809335,0.0013456648,0.00001541848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003983217,0.00084093114,0.3758613,0.015990464,0.0006633237,0.00038057566,0.003192273,0.00008751409,0.52981865,0.0001936178,0.06547999,0.0035081329],"study_design_scores_gemma":[0.004991529,0.00013726557,0.6910644,0.006787956,0.000115457144,0.0000011703847,0.0012190233,0.00004908345,0.2750427,0.00018572486,0.020008588,0.0003970593],"about_ca_topic_score_codex":0.0129074,"about_ca_topic_score_gemma":0.042891476,"teacher_disagreement_score":0.31520313,"about_ca_system_score_codex":0.0022056138,"about_ca_system_score_gemma":0.0031588448,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W4409690079","doi":"10.1158/1538-7445.am2025-896","title":"Abstract 896: Unleashing the power within: enhancing cancer treatment with invariant natural killer T cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Invariant (physics); Cancer; Medicine; Immunology; Mathematics; Internal medicine; Mathematical physics","score_opus":0.05312659537491095,"score_gpt":0.4053088560114074,"score_spread":0.3521822606364965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95558,0.007939359,0.000020080195,0.013902644,0.0012575765,0.0022491014,0.000011858861,0.000076904085,0.018962488],"genre_scores_gemma":[0.8726892,0.0019092525,0.000055084744,0.0006546987,0.00036241356,0.00080233044,0.000006534499,0.00006125458,0.12345924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99617213,0.00024097165,0.00035005188,0.0006785502,0.00147562,0.0010826706],"domain_scores_gemma":[0.99742943,0.000634275,0.00006644489,0.00091890444,0.0006924177,0.00025851474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015643354,0.00029924244,0.00043358083,0.00038621548,0.00054924784,0.00021505922,0.00044386517,0.00013730717,0.0072087455],"category_scores_gemma":[0.00009303532,0.00016426199,0.00013172172,0.0013001218,0.00048645158,0.00013714585,0.00017328773,0.0016194499,0.00007791831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033491931,0.00023981398,0.0030674792,0.00024621468,0.0009494622,0.00028873645,0.004129305,0.0001958618,0.9494459,0.00033055226,0.012346842,0.025410641],"study_design_scores_gemma":[0.0059239785,0.0010702257,0.015986044,0.002245019,0.00013367753,0.000030931205,0.003968623,0.00027276226,0.77623487,0.000118801494,0.19356252,0.00045258523],"about_ca_topic_score_codex":0.012115059,"about_ca_topic_score_gemma":0.007718308,"teacher_disagreement_score":0.18121567,"about_ca_system_score_codex":0.0024829817,"about_ca_system_score_gemma":0.003420013,"threshold_uncertainty_score":0.9944633},"labels":[],"label_agreement":null},{"id":"W4409690136","doi":"10.1158/1538-7445.am2025-67","title":"Abstract 67: Deciphering the mechanisms underlying the pathophysiology and chemotherapy resistance in acute myeloid leukemia using intravital imaging and humanized NSGW41IL7 mouse","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Myeloid leukemia; Pathophysiology; Medicine; Chemotherapy; Intravital microscopy; Cancer research; Pathology; Immunology; Internal medicine","score_opus":0.05095276051385272,"score_gpt":0.3950931339809373,"score_spread":0.3441403734670846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854029,0.0048947334,0.00044523564,0.0075983037,0.000070373455,0.0010732537,0.0000082231945,0.000033676948,0.00047332904],"genre_scores_gemma":[0.99199444,0.004962406,0.0007566749,0.0011015708,0.00007069201,0.00018759903,0.000003700349,0.00005401661,0.0008688778],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973885,0.00024820722,0.00033961568,0.0006121673,0.0005351851,0.000876347],"domain_scores_gemma":[0.9983304,0.00067384343,0.00006107824,0.0005875612,0.0002246128,0.00012250853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00197268,0.00023320602,0.00037638634,0.0003032483,0.00077797857,0.00018959702,0.0004164574,0.00012823574,0.00004294529],"category_scores_gemma":[0.0001865733,0.0001513753,0.000051600677,0.00081113074,0.00087402377,0.00015881265,0.0004182763,0.0016536522,0.0000023764644],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001050773,0.000020474137,0.0014045198,0.00019913359,0.00013171653,0.00012739596,0.0015357408,0.000019370325,0.97348046,0.0018849795,0.00047738268,0.019668067],"study_design_scores_gemma":[0.02804799,0.00041497618,0.66736335,0.004255177,0.00030296427,0.00021191296,0.02710835,0.025574015,0.1630542,0.076255694,0.0057792906,0.0016320769],"about_ca_topic_score_codex":0.0013445816,"about_ca_topic_score_gemma":0.00064981566,"teacher_disagreement_score":0.81042624,"about_ca_system_score_codex":0.0017388337,"about_ca_system_score_gemma":0.0012084326,"threshold_uncertainty_score":0.71843874},"labels":[],"label_agreement":null},{"id":"W4409690178","doi":"10.1158/1538-7445.am2025-802","title":"Abstract 802: Utilization of emotional support services among breast cancer patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Family medicine; Oncology; Internal medicine","score_opus":0.05510784426526169,"score_gpt":0.413779679359719,"score_spread":0.3586718350944573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889407,0.00063107535,0.000006485476,0.00087739096,0.00049716997,0.0003857662,0.0003613725,0.000023935341,0.008276105],"genre_scores_gemma":[0.9959895,0.00078997813,0.0000023406753,0.00019056715,0.00017061103,0.00014545066,0.00014275257,0.000016605287,0.0025521817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824023,0.0000457281,0.00025539167,0.00028560564,0.0008519497,0.00032108228],"domain_scores_gemma":[0.99810904,0.000049454742,0.000060855808,0.00024693122,0.0014138115,0.00011991856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003090675,0.00010502608,0.00021234958,0.00029062686,0.000097277974,0.000022074952,0.00016248535,0.00010257162,0.0033896174],"category_scores_gemma":[0.000016564052,0.00009496685,0.000072798786,0.0007750129,0.00016841375,0.00012378578,0.00008386743,0.00028987433,0.000012612429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036644965,0.00018722599,0.9612058,0.0013604969,0.00008919134,0.000003701799,0.00062138174,0.000014562194,0.0016025815,0.00015248274,0.0051907506,0.029205399],"study_design_scores_gemma":[0.00082421734,0.00005179266,0.9862312,0.00089654647,0.000026554475,5.1975417e-7,0.00039929827,0.00003495119,0.0062274616,0.00005738771,0.0051789302,0.00007113083],"about_ca_topic_score_codex":0.014394501,"about_ca_topic_score_gemma":0.008584002,"teacher_disagreement_score":0.029134268,"about_ca_system_score_codex":0.00035447962,"about_ca_system_score_gemma":0.0008524956,"threshold_uncertainty_score":0.9975214},"labels":[],"label_agreement":null},{"id":"W4409690336","doi":"10.1158/1538-7445.am2025-504","title":"Abstract 504: A comparative analysis of statistical and machine learning approaches to predict drug resistance based on synergistic genetic alterations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Computational biology; Resistance (ecology); Drug; Machine learning; Computer science; Artificial intelligence; Biology; Pharmacology; Ecology","score_opus":0.1965778109701726,"score_gpt":0.43779180902317416,"score_spread":0.24121399805300156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690336","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.101465926,0.00038850986,0.89388126,0.0016551078,0.000043287346,0.00031049506,0.00010433048,0.000024149747,0.0021269317],"genre_scores_gemma":[0.9461649,0.000009732888,0.053155597,0.00006112955,0.000014281068,0.00013619987,0.000021969732,0.0000043477867,0.0004318103],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975356,0.00073758693,0.00029187283,0.00053431414,0.00063541904,0.00026523584],"domain_scores_gemma":[0.995504,0.0037366068,0.000053987507,0.0003629388,0.00021891034,0.00012353582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012020549,0.00011629949,0.0003013952,0.00096373406,0.00022935413,0.00016268043,0.0004479208,0.00002508846,0.000037220165],"category_scores_gemma":[0.00042375596,0.00011043474,0.00004593617,0.0027515788,0.0001783248,0.00008549596,0.00019394557,0.00033429128,0.0000028896557],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009646661,0.00008146784,0.0016931247,0.00008429841,0.00017100788,0.000006002365,0.00070306344,0.92860717,0.00025062813,0.06434959,0.0005343556,0.0034228296],"study_design_scores_gemma":[0.00017595524,0.000038725135,0.09437895,0.0000880647,0.000043414286,5.8347077e-8,0.000032257238,0.9017357,0.000675014,0.0024125688,0.00033309218,0.00008616052],"about_ca_topic_score_codex":0.00024065329,"about_ca_topic_score_gemma":0.00060535,"teacher_disagreement_score":0.844699,"about_ca_system_score_codex":0.00015885501,"about_ca_system_score_gemma":0.00046193987,"threshold_uncertainty_score":0.4503398},"labels":[],"label_agreement":null},{"id":"W4409690342","doi":"10.1158/1538-7445.am2025-364","title":"Abstract 364: Oxaliplatin and 5-fluorouracil cause therapy-induced senescence in low-grade serous ovarian cancer cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Oxaliplatin; Serous fluid; Serous ovarian cancer; Medicine; Fluorouracil; Ovarian cancer; Oncology; Internal medicine; Cancer; Cancer research; Colorectal cancer","score_opus":0.10681956223516384,"score_gpt":0.4183417539859567,"score_spread":0.3115221917507929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743796,0.0060058283,0.000008143345,0.004215615,0.0003612627,0.0010247636,0.000035237572,0.00006694682,0.00084422634],"genre_scores_gemma":[0.9849352,0.011607524,0.00006388644,0.0006399196,0.00024404992,0.00029778847,0.000007911098,0.000042079093,0.0021616444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968034,0.00019836157,0.00045309123,0.0007789015,0.00078966893,0.0009765602],"domain_scores_gemma":[0.9983086,0.00033827417,0.000069336544,0.0006165532,0.00034199737,0.00032522506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009421118,0.0002945093,0.00050596986,0.00057057705,0.00023769822,0.00010266747,0.00029995738,0.00024826953,0.0004446889],"category_scores_gemma":[0.00013097732,0.00025969485,0.000065273314,0.0014313787,0.0002631196,0.00017856345,0.00012497758,0.0012040646,0.000027822733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007873268,0.00026072926,0.08604926,0.00059866445,0.00009828676,0.00041300678,0.0015497635,0.000019729023,0.83122087,0.00009843396,0.0016750122,0.0772289],"study_design_scores_gemma":[0.003904276,0.00014508888,0.50222844,0.0019295815,0.000022859831,0.000014840277,0.00077956397,0.00019146284,0.48679882,0.00013599057,0.003477379,0.0003716798],"about_ca_topic_score_codex":0.021645539,"about_ca_topic_score_gemma":0.0046121804,"teacher_disagreement_score":0.4161792,"about_ca_system_score_codex":0.0005658044,"about_ca_system_score_gemma":0.0015104334,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W4409690397","doi":"10.1158/1538-7445.am2025-299","title":"Abstract 299: Characterization of a senescence phenotype induced by advanced glycation end products in prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; McGill University","funders":"","keywords":"Glycation; Prostate cancer; Senescence; Cancer; Cancer research; Phenotype; Medicine; Biology; Internal medicine; Biochemistry; Gene; Receptor","score_opus":0.03158202242994189,"score_gpt":0.3854947067033683,"score_spread":0.35391268427342637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391097,0.0021762126,0.00011867149,0.0021792315,0.0001629114,0.000995752,0.0000953132,0.000009933738,0.00035100424],"genre_scores_gemma":[0.9916303,0.0041265427,0.00009040147,0.000059470894,0.0001000361,0.0006343073,0.00031418895,0.00002384178,0.0030208812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980731,0.00014580069,0.00031216972,0.0006230556,0.00040972352,0.0004361287],"domain_scores_gemma":[0.9982779,0.000026666117,0.00010416809,0.0004915263,0.0010407069,0.0000590423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006340138,0.0001351867,0.00016337498,0.0002433768,0.00008769357,0.00002297904,0.00031268087,0.000099096236,0.00006995213],"category_scores_gemma":[0.0005142906,0.00013918571,0.000020386713,0.0012711891,0.0001590404,0.000030508707,0.00013908125,0.00031447,0.000004526887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048675775,0.000089585796,0.001956497,0.00027361585,0.000015363374,5.9430823e-7,0.00011851638,0.00010160915,0.93048143,0.000049339716,0.00033418776,0.06609249],"study_design_scores_gemma":[0.0005369739,0.000069849266,0.025229052,0.0001479785,0.0000021513458,1.8311653e-7,0.00005401856,0.00001414904,0.954572,0.00006795781,0.019185362,0.00012028408],"about_ca_topic_score_codex":0.00038410912,"about_ca_topic_score_gemma":0.00017409743,"teacher_disagreement_score":0.06597221,"about_ca_system_score_codex":0.00017497536,"about_ca_system_score_gemma":0.0011371339,"threshold_uncertainty_score":0.56758285},"labels":[],"label_agreement":null},{"id":"W4409690415","doi":"10.1158/1538-7445.am2025-302","title":"Abstract 302: Study of treatment-induced senescence in head and neck squamous cell carcinoma according to HPV status","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Head and neck; Basal cell; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Head and neck cancer; Cancer; Surgery","score_opus":0.09900486938994613,"score_gpt":0.4241936017738175,"score_spread":0.32518873238387136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531364,0.0013195677,0.0000012658376,0.00030628423,0.00011579373,0.0015411612,0.0000145354,0.000021770307,0.0013659933],"genre_scores_gemma":[0.99871767,0.00024782858,0.00003353893,0.000060473612,0.00006040012,0.00018474895,0.000003292839,0.000022050937,0.00066999916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977533,0.000118900076,0.00036486564,0.00056851987,0.00045475888,0.00073965517],"domain_scores_gemma":[0.9986395,0.00027673537,0.00004254035,0.0004927456,0.00024536066,0.00030307774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037658538,0.0001919975,0.00047191887,0.0007223088,0.00012005969,0.000033976736,0.00016160961,0.000083791245,0.00006269437],"category_scores_gemma":[0.00016502311,0.00016757466,0.000038113492,0.0012749803,0.00007636576,0.00008059148,0.00012558188,0.0003734833,0.000008752294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008824268,0.0008005852,0.7641848,0.00032158862,0.000015398895,0.00016730033,0.004286149,0.000010890061,0.19242942,0.000006277192,0.00009089016,0.03680428],"study_design_scores_gemma":[0.0047652693,0.0021135204,0.9077621,0.00018467216,0.000020481159,0.0000021977266,0.014775241,0.000025859048,0.06994716,0.0000072110543,0.00026755824,0.00012874095],"about_ca_topic_score_codex":0.04246769,"about_ca_topic_score_gemma":0.0065023103,"teacher_disagreement_score":0.14357731,"about_ca_system_score_codex":0.0008214324,"about_ca_system_score_gemma":0.001058834,"threshold_uncertainty_score":0.9639086},"labels":[],"label_agreement":null},{"id":"W4409690442","doi":"10.1158/1538-7445.am2025-365","title":"Abstract 365: A dual mechanism of sensitivity to PLK4 inhibition by RP-1664 in neuroblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Sensitivity (control systems); Neuroblastoma; Dual (grammatical number); Mechanism (biology); Medicine; Chemistry; Cancer research; Biology; Philosophy; Genetics; Engineering; Epistemology","score_opus":0.04285613091951937,"score_gpt":0.40809630841103883,"score_spread":0.3652401774915195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199206,0.00008369982,0.00004047812,0.0039207814,0.00006598564,0.001029422,0.000105214756,0.000028225717,0.0027341335],"genre_scores_gemma":[0.9978785,0.000101285026,0.000026042098,0.0002803277,0.000040857245,0.00020618463,0.000015767091,0.000022458613,0.001428576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975386,0.00023613281,0.00026329624,0.0004542371,0.0008630721,0.00064462004],"domain_scores_gemma":[0.9987367,0.00029168182,0.000029220997,0.00033097854,0.0003246337,0.00028679328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007671779,0.00014176936,0.00030594438,0.0007736575,0.00007840268,0.000021913826,0.000066647866,0.00008797319,0.00016901412],"category_scores_gemma":[0.00038138512,0.00013210281,0.000064164306,0.001240393,0.00012642985,0.00008409742,0.00018569855,0.00063151156,0.000078103374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001518245,0.0005398789,0.00076916313,0.00026430446,0.00004478298,0.0010410269,0.00009967966,0.0000089060495,0.9797923,0.00049510633,0.009081554,0.0063450336],"study_design_scores_gemma":[0.002714377,0.0008889722,0.04402297,0.00072341115,0.000010257076,0.000016236892,0.000096338495,0.00007937835,0.9498791,0.0004962194,0.00097569154,0.00009704749],"about_ca_topic_score_codex":0.0016889434,"about_ca_topic_score_gemma":0.0008571929,"teacher_disagreement_score":0.043253805,"about_ca_system_score_codex":0.00039856808,"about_ca_system_score_gemma":0.00059618853,"threshold_uncertainty_score":0.5386996},"labels":[],"label_agreement":null},{"id":"W4409690532","doi":"10.1158/1538-7445.am2025-2147","title":"Abstract 2147: Radiosensitization via ATM inhibition in small cell lung cancer leads to increased immunogenicity and tumor infiltration","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Immunogenicity; Medicine; Infiltration (HVAC); Cancer research; Lung cancer; Cancer; Oncology; Pathology; Immune system; Internal medicine; Immunology","score_opus":0.032968959835324746,"score_gpt":0.39751457076864183,"score_spread":0.36454561093331705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542225,0.006367678,0.00015855694,0.004047341,0.00011972521,0.002092885,0.000037637743,0.000048869504,0.0017050538],"genre_scores_gemma":[0.9952536,0.0022365835,0.000093138195,0.0005594582,0.00020186158,0.000963372,0.000038070397,0.000029591418,0.0006243051],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975583,0.00021651422,0.0003795612,0.0005630434,0.00060619874,0.00067639054],"domain_scores_gemma":[0.99840236,0.0002534297,0.000052544514,0.00033283196,0.00073870143,0.00022015205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012910796,0.00019638715,0.0003686915,0.0007949663,0.00025631877,0.00008101241,0.000092512535,0.000105234416,0.00012785364],"category_scores_gemma":[0.00041903433,0.00019036747,0.000049754788,0.0016017645,0.00020197475,0.00016576298,0.00018746649,0.00073593704,0.000011146384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014577328,0.00013694844,0.16130306,0.001526146,0.0000776412,0.00010578889,0.0008806425,0.000222608,0.8248181,0.00006890167,0.005092037,0.0043103863],"study_design_scores_gemma":[0.0035125047,0.00019095952,0.53865,0.0017609068,0.000053303316,0.000008051281,0.00029975869,0.00093262736,0.4534441,0.00012622075,0.0007848898,0.00023667638],"about_ca_topic_score_codex":0.019505108,"about_ca_topic_score_gemma":0.008559728,"teacher_disagreement_score":0.37734693,"about_ca_system_score_codex":0.0022857026,"about_ca_system_score_gemma":0.0013868719,"threshold_uncertainty_score":0.98702407},"labels":[],"label_agreement":null},{"id":"W4409690540","doi":"10.1158/1538-7445.am2025-9","title":"Abstract 9: Genetic and oncogenic viruses as risk factors in Egyptian breast cancer patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Internal medicine; Biology","score_opus":0.05769043081050637,"score_gpt":0.431996843271182,"score_spread":0.37430641246067564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957676,0.0075432668,1.6470763e-7,0.00096585904,0.00016275639,0.0007003206,0.0002386077,0.00001596605,0.0007963184],"genre_scores_gemma":[0.98142135,0.017408388,0.0000063629986,0.00019949298,0.000083154206,0.0005192423,0.000008348956,0.000021087015,0.00033259063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839705,0.00006248587,0.00022810587,0.00042664807,0.00043596825,0.00044976507],"domain_scores_gemma":[0.9991503,0.0001626137,0.000041240673,0.00025167453,0.00019777859,0.00019641269],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001628068,0.00015411832,0.00027158947,0.00034877346,0.00012629287,0.00004333626,0.0000951164,0.000087038,0.0010014612],"category_scores_gemma":[0.00006058793,0.00012273832,0.0000598829,0.0005199103,0.00014625488,0.000053794338,0.0000887626,0.00040027933,0.000024014194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002624607,0.0003645941,0.95022297,0.00011414635,0.0001408718,0.000024490218,0.00027535929,0.000019279792,0.000588476,0.000011269436,0.0018106605,0.046165407],"study_design_scores_gemma":[0.0022444092,0.00014503323,0.9875822,0.00048987597,0.000058780828,0.0000011211748,0.00013515311,0.0000050106637,0.0048726834,0.00008519758,0.0042851167,0.00009538641],"about_ca_topic_score_codex":0.091891244,"about_ca_topic_score_gemma":0.011190097,"teacher_disagreement_score":0.08070115,"about_ca_system_score_codex":0.001089167,"about_ca_system_score_gemma":0.0007607353,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W4409690545","doi":"10.1158/1538-7445.am2025-626","title":"Abstract 626: Black/African American participation in cancer clinical trials: Healthcare professional perspectives","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Cancer; Health care; Medicine; Health professionals; Family medicine; Clinical trial; Alternative medicine; Political science; Law; Internal medicine; Pathology","score_opus":0.37938871039241645,"score_gpt":0.7258599002453,"score_spread":0.34647118985288355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91289157,0.010616727,0.000067946705,0.072056144,0.0009533575,0.0012268847,0.000023463821,0.000035586552,0.0021283224],"genre_scores_gemma":[0.9779626,0.015218741,0.00018126977,0.0011466069,0.0011427038,0.000946846,0.0000058354813,0.000017380806,0.0033780113],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960459,0.0017569031,0.0007174235,0.00050008314,0.00043850872,0.0005411702],"domain_scores_gemma":[0.99613595,0.002782837,0.00016747725,0.00029339443,0.00042873446,0.00019158532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006197354,0.000126061,0.00072337774,0.00035175384,0.0001714742,0.000011441818,0.0001681131,0.00016817778,0.00067222293],"category_scores_gemma":[0.0027610192,0.00009470735,0.00011943953,0.001089912,0.001475647,0.00007456462,0.000048337468,0.0015020913,0.000012389956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075809904,0.0013961579,0.46422854,0.00029338602,0.00025415586,0.00005935703,0.0055499445,0.000093311406,0.0013397924,0.0027277488,0.017814005,0.49866262],"study_design_scores_gemma":[0.0032996684,0.0006208999,0.92957294,0.00076374953,0.000028832666,8.5281215e-7,0.010968682,0.00020481061,0.00046481768,0.0010380839,0.052898213,0.00013844675],"about_ca_topic_score_codex":0.0019780747,"about_ca_topic_score_gemma":0.002749039,"teacher_disagreement_score":0.49852416,"about_ca_system_score_codex":0.001369695,"about_ca_system_score_gemma":0.0031617477,"threshold_uncertainty_score":0.736037},"labels":[],"label_agreement":null},{"id":"W4409690563","doi":"10.1158/1538-7445.am2025-38","title":"Abstract 38: Augmenting drug responses to PARP inhibitors in high grade serous cancer with inhibitors of the anti-apoptotic protein Bcl-XL","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Apoptosis; Poly ADP ribose polymerase; Cancer; Serous fluid; Drug; Cancer research; Serous ovarian cancer; Pharmacology; Biology; Internal medicine; Ovarian cancer; Enzyme; Biochemistry; Polymerase","score_opus":0.05261634181509617,"score_gpt":0.40690028335037987,"score_spread":0.3542839415352837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97379565,0.0018931788,0.0000055663513,0.020086393,0.00046188198,0.0030129587,0.000060052596,0.000053801938,0.00063050154],"genre_scores_gemma":[0.9920198,0.00028471902,0.0001050617,0.00042336676,0.0003480702,0.0019760465,0.0000040407813,0.000062511615,0.004776417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958215,0.0004171716,0.000698435,0.0006923742,0.0014599798,0.00091054366],"domain_scores_gemma":[0.9979463,0.00031496774,0.00018037186,0.00078838837,0.0005615839,0.00020837855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017223835,0.00029561846,0.00055973534,0.00086339656,0.00026736312,0.000059682447,0.0004403398,0.0001422687,0.0002654573],"category_scores_gemma":[0.0002984901,0.000212189,0.00011067343,0.003319564,0.00052269344,0.00014765217,0.00022308875,0.0011800921,0.000012264281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034890936,0.00046322742,0.20036685,0.0013343199,0.000212359,0.00007318316,0.0024610576,0.00094287127,0.76949644,0.00026851948,0.015000596,0.0058914768],"study_design_scores_gemma":[0.0033949362,0.00015811187,0.16728517,0.009150491,0.000025750947,0.0000036337624,0.0008494258,0.000008594653,0.81273234,0.00020773818,0.0059535443,0.00023028527],"about_ca_topic_score_codex":0.009777792,"about_ca_topic_score_gemma":0.0022840907,"teacher_disagreement_score":0.043235864,"about_ca_system_score_codex":0.0015287879,"about_ca_system_score_gemma":0.0025541352,"threshold_uncertainty_score":0.99681616},"labels":[],"label_agreement":null},{"id":"W4409690588","doi":"10.1158/1538-7445.am2025-215","title":"Abstract 215: A novel framework for deciphering 3D genome structure in colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Colorectal cancer; Cancer; Computational biology; Genome; Biology; Medicine; Genetics; Gene","score_opus":0.07846961380341613,"score_gpt":0.447258729203106,"score_spread":0.36878911539968984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882979,0.005337615,0.00086534943,0.0012690969,0.00089184765,0.0019050343,0.00023118436,0.000041488136,0.0011604973],"genre_scores_gemma":[0.9898529,0.00047782296,0.0064093173,0.0003089627,0.0005144078,0.0018234088,0.000013908287,0.000056506917,0.0005427886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99743325,0.00003426326,0.00035427778,0.0006390489,0.00061585015,0.0009233106],"domain_scores_gemma":[0.99834234,0.00060792995,0.000051012557,0.00034076706,0.00047514573,0.00018283054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004862374,0.00022560854,0.00043152593,0.00041505977,0.00015391364,0.00005558524,0.0003468722,0.00035801315,0.0018886246],"category_scores_gemma":[0.00071745977,0.00020971111,0.000095022115,0.0012281237,0.00022998537,0.000054037057,0.00017336664,0.0012602372,0.000005630953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025854316,0.00012994107,0.028039655,0.0010034778,0.00018633202,0.000022784547,0.0008375887,0.0023240652,0.94140434,0.0006104521,0.0013140906,0.021541823],"study_design_scores_gemma":[0.0058371713,0.0005899408,0.6818111,0.00294798,0.00008388241,0.0000114740105,0.00062868855,0.0009644723,0.2568908,0.006379582,0.04321979,0.00063509576],"about_ca_topic_score_codex":0.0015444133,"about_ca_topic_score_gemma":0.004347718,"teacher_disagreement_score":0.68451357,"about_ca_system_score_codex":0.0019560324,"about_ca_system_score_gemma":0.0021909939,"threshold_uncertainty_score":0.9990238},"labels":[],"label_agreement":null},{"id":"W4409690633","doi":"10.1158/1538-7445.am2025-680","title":"Abstract 680: HPV serology and circulating viral DNA for detection, genotyping, and measurement of disease burden in oropharyngeal cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Serology; Genotyping; Medicine; Cancer; Virology; Disease; Immunology; Pathology; Antibody; Genotype; Internal medicine; Biology; Genetics; Gene","score_opus":0.0969987401772753,"score_gpt":0.4222986759074319,"score_spread":0.3252999357301566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707752,0.025602398,0.000028602233,0.0023255234,0.00010918367,0.000719078,0.000021131038,0.000008778037,0.00041013514],"genre_scores_gemma":[0.99667305,0.0023125317,0.00001768781,0.000105927684,0.00019426549,0.0005493637,0.0000012530166,0.000011837637,0.00013409654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878633,0.000049022805,0.00022570792,0.00030315403,0.0002953235,0.00034046517],"domain_scores_gemma":[0.99922514,0.00009852466,0.00003320443,0.0001251903,0.00040041516,0.00011754587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007364447,0.000094423456,0.00031516797,0.00021452387,0.00014376281,0.000010116847,0.000048141676,0.00005511316,0.000050131883],"category_scores_gemma":[0.00025229208,0.000084815714,0.000028957193,0.00021609454,0.0001865711,0.000041008672,0.00007188472,0.00022374571,2.6701406e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004021,0.00008838147,0.15280284,0.00503923,0.00029189125,0.00001969656,0.0016022482,0.000055382712,0.5086408,0.00012704225,0.00092635787,0.32638514],"study_design_scores_gemma":[0.0032032356,0.00024396495,0.96751094,0.0008023452,0.000064160464,9.954737e-7,0.0003340368,0.0004429647,0.024172073,0.0003591816,0.0027617621,0.00010434182],"about_ca_topic_score_codex":0.003880994,"about_ca_topic_score_gemma":0.004045033,"teacher_disagreement_score":0.8147081,"about_ca_system_score_codex":0.0003637442,"about_ca_system_score_gemma":0.0006127447,"threshold_uncertainty_score":0.5866928},"labels":[],"label_agreement":null},{"id":"W4409690662","doi":"10.1158/1538-7445.am2025-155","title":"Abstract 155: Spatial analysis of tumor-immune-stromal cellular phenotypes and microenvironments in pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Stromal cell; Pancreatic cancer; Immune system; Cancer; Phenotype; Tumor microenvironment; Cancer research; Biology; Medicine; Immunology; Internal medicine; Genetics; Gene","score_opus":0.019861948647651964,"score_gpt":0.36648423665327234,"score_spread":0.3466222880056204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907604,0.0070764604,0.00009521136,0.0010525365,0.000060299473,0.0002305582,0.000014256226,0.0000067619985,0.0007035496],"genre_scores_gemma":[0.9977651,0.0012144856,0.00012278507,0.00011196861,0.000052472176,0.000058551017,0.000014893829,0.000012577273,0.00064714503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998601,0.00008527292,0.0003002455,0.00029039924,0.0003864255,0.00033662742],"domain_scores_gemma":[0.99941427,0.00014558971,0.00005444966,0.00023451408,0.000053736312,0.00009741945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006879826,0.00010045126,0.00044611312,0.00064836955,0.00006267464,0.000017217377,0.0001247785,0.000047381844,0.0006512453],"category_scores_gemma":[0.00017791343,0.00008852034,0.00007141449,0.000781831,0.0003028771,0.00003105041,0.00009625953,0.0005861075,0.000002241885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020261678,0.00008997326,0.63560474,0.00029051895,0.00056950434,0.000060026417,0.00021979188,0.0004156527,0.3436591,0.0000297672,0.0001432157,0.018715082],"study_design_scores_gemma":[0.0011207694,0.00004490248,0.972125,0.0004767904,0.00040325185,7.570961e-7,0.00012804191,0.0073228213,0.017175354,0.0000458176,0.0010815138,0.00007498584],"about_ca_topic_score_codex":0.017450651,"about_ca_topic_score_gemma":0.00042842052,"teacher_disagreement_score":0.33652025,"about_ca_system_score_codex":0.00021748342,"about_ca_system_score_gemma":0.00021539739,"threshold_uncertainty_score":0.98909223},"labels":[],"label_agreement":null},{"id":"W4409690752","doi":"10.1158/1538-7445.am2025-443","title":"Abstract 443: Targeting therapeutic vulnerabilities mediated by epigenetic reprogramming in ARID1A and ARID1B dual-deficient gynecologic cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ARID1A; Reprogramming; Cancer research; Epigenetics; Gynecologic cancer; Medicine; Cancer; Biology; Internal medicine; Genetics; Ovarian cancer; Mutation; Gene","score_opus":0.03265191759590889,"score_gpt":0.3691682070180238,"score_spread":0.33651628942211487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95243955,0.045499757,0.000094312534,0.00057879207,0.00016971723,0.00037712124,0.000026678435,0.00001968129,0.00079439656],"genre_scores_gemma":[0.9928455,0.0055843582,0.00007616736,0.00020694638,0.00007841261,0.00037494444,0.000059501257,0.00002112013,0.00075308373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792933,0.00017605432,0.00033234744,0.0006592608,0.00027799874,0.0006250033],"domain_scores_gemma":[0.9991624,0.00017627378,0.000055183016,0.00032476097,0.0001958852,0.00008554858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001346222,0.00017124685,0.00020655502,0.00013060446,0.00021860846,0.00008141971,0.00019198448,0.00018855678,0.000068948],"category_scores_gemma":[0.00045830675,0.00015829322,0.000047891765,0.00037418594,0.0003128942,0.0000052855976,0.00015645933,0.0004122873,0.000002702257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013424462,0.000076280645,0.010450326,0.0002335071,0.00006812973,0.000006028248,0.0003625555,0.0028520003,0.94102705,0.00003815734,0.0038502647,0.040901467],"study_design_scores_gemma":[0.0045193373,0.0008661717,0.029403279,0.0007550771,0.00005402895,0.0000069381354,0.008095324,0.005685616,0.78875923,0.0021542332,0.15826884,0.0014319433],"about_ca_topic_score_codex":0.0025955269,"about_ca_topic_score_gemma":0.0010770932,"teacher_disagreement_score":0.15441857,"about_ca_system_score_codex":0.00033523128,"about_ca_system_score_gemma":0.0006329215,"threshold_uncertainty_score":0.645501},"labels":[],"label_agreement":null},{"id":"W4409690809","doi":"10.1158/1538-7445.am2025-73","title":"Abstract 73: Molecular characterization of senescence induced by PARPi in preclinical xenograft mouse models of ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Ovarian cancer; Cancer; Senescence; Cancer research; Medicine; Biology; Oncology; Internal medicine","score_opus":0.1505554759126108,"score_gpt":0.4820722729312489,"score_spread":0.3315167970186381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416685,0.0010263782,0.00069609564,0.0021353178,0.00012029479,0.000858851,0.0001741015,0.000020486717,0.0008016188],"genre_scores_gemma":[0.99634165,0.0022734082,0.000072418035,0.00026172897,0.00005383456,0.0004775856,0.000048529775,0.000026902293,0.00044396374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763167,0.00018684416,0.0006701297,0.0004109848,0.00071019994,0.00039015344],"domain_scores_gemma":[0.9984779,0.00013520847,0.00015635464,0.0004811483,0.0006327145,0.00011669906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093740394,0.00014107751,0.00045402485,0.00041637686,0.000037239242,0.000012082706,0.00023401013,0.00021203456,0.00033343304],"category_scores_gemma":[0.000111174166,0.00014097756,0.0000801176,0.0011652575,0.00024467302,0.0001419551,0.000068344925,0.0006089443,0.0000021423054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009740873,0.00028499233,0.006339205,0.0004679745,0.00007461527,0.00000580258,0.0002735631,0.00012117335,0.9850826,0.00032364242,0.00034747334,0.005704828],"study_design_scores_gemma":[0.0024762542,0.0001114335,0.022529991,0.0013594893,0.000015517697,4.3375422e-7,0.00004612258,0.0005317958,0.9719272,0.0003728067,0.0005224754,0.000106456944],"about_ca_topic_score_codex":0.0023367477,"about_ca_topic_score_gemma":0.00011463542,"teacher_disagreement_score":0.016190786,"about_ca_system_score_codex":0.00039863968,"about_ca_system_score_gemma":0.0012987081,"threshold_uncertainty_score":0.5748898},"labels":[],"label_agreement":null},{"id":"W4409690938","doi":"10.1158/1538-7445.am2025-1127","title":"Abstract 1127: Differences in the clinical and genomic landscape in young onset (YO) gastroesophageal cancer (GEC): an analysis from AACR Project GENIE","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Medicine; Internal medicine; Oncology","score_opus":0.12054069166994177,"score_gpt":0.484159562163323,"score_spread":0.36361887049338126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97557485,0.020406011,0.0000031326354,0.001830704,0.0000818229,0.0012345377,0.00028650163,0.000017630846,0.0005648273],"genre_scores_gemma":[0.9910998,0.0069317576,0.000046051136,0.00018783701,0.00026382218,0.0010579143,0.00010312345,0.000017702994,0.00029200592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960619,0.0008012254,0.0005456827,0.0008320975,0.0008830433,0.00087600254],"domain_scores_gemma":[0.99827206,0.00066677073,0.00005615371,0.0006143277,0.00015350843,0.0002371485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022669565,0.00023171148,0.00068066275,0.0009841118,0.00015528423,0.00015685946,0.0004551176,0.00015147316,0.00052165607],"category_scores_gemma":[0.00012537575,0.00015210306,0.00014404325,0.0019149827,0.00044004148,0.00012508419,0.0001599167,0.0013541715,0.00000911941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014648369,0.00039849646,0.98869485,0.00007459461,0.00050224934,0.00051118014,0.0008791687,0.00001162167,0.00010670636,0.00002275176,0.0005714883,0.006762075],"study_design_scores_gemma":[0.0030866722,0.00036153162,0.99420005,0.00014834023,0.00017455542,0.0000027810693,0.00122323,0.00038088462,0.00012232736,0.0001523208,0.000050802737,0.00009649808],"about_ca_topic_score_codex":0.091559015,"about_ca_topic_score_gemma":0.16983119,"teacher_disagreement_score":0.07827218,"about_ca_system_score_codex":0.00050754246,"about_ca_system_score_gemma":0.0018444207,"threshold_uncertainty_score":0.91449034},"labels":[],"label_agreement":null},{"id":"W4409690968","doi":"10.1158/1538-7445.am2025-1075","title":"Abstract 1075: Piloting NTRK fusion-specific oncogenicity guidelines - lessons learned","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Computational biology; Pathology; Biology","score_opus":0.3339132989151987,"score_gpt":0.6040757495543332,"score_spread":0.27016245063913447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7359425,0.05948653,0.0018364893,0.14565176,0.0022453335,0.0011922306,0.000029391293,0.00022448557,0.053391315],"genre_scores_gemma":[0.8744626,0.06500155,0.004694597,0.0035812322,0.00350937,0.00028497356,0.000020657793,0.00006530197,0.04837973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979335,0.00013507318,0.0003757712,0.00048512575,0.00048529965,0.0005852051],"domain_scores_gemma":[0.9978954,0.00068018824,0.000058190457,0.0004873812,0.0007347629,0.00014407201],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001638685,0.0001460039,0.00034562073,0.00028537484,0.00054002804,0.00002646631,0.0002885736,0.00019679015,0.0018359175],"category_scores_gemma":[0.0006812292,0.00011803606,0.00009937878,0.0007675347,0.00049320096,0.000084740524,0.000117942516,0.0010536825,0.00009552346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013485652,0.00022797228,0.0049627377,0.00016862869,0.0001549406,0.00013171304,0.00023740002,0.00012638405,0.18937433,0.0036148846,0.18949448,0.61015797],"study_design_scores_gemma":[0.0018581431,0.00020996464,0.012807045,0.000535398,0.000015723828,0.000011916412,0.0003887316,0.000071414666,0.017870525,0.0027740174,0.9633161,0.00014104396],"about_ca_topic_score_codex":0.00019183809,"about_ca_topic_score_gemma":0.0001046062,"teacher_disagreement_score":0.7738216,"about_ca_system_score_codex":0.0007312831,"about_ca_system_score_gemma":0.0011340601,"threshold_uncertainty_score":0.99907655},"labels":[],"label_agreement":null},{"id":"W4409690995","doi":"10.1158/1538-7445.am2025-520","title":"Abstract 520: Repurposing verteporfin: anti-metastatic properties associate with extracellular matrix modulation in osteosarcoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Repurposing; Verteporfin; Osteosarcoma; Medicine; Extracellular matrix; Cancer research; Internal medicine; Oncology; Surgery; Biology; Cell biology","score_opus":0.09841137056178322,"score_gpt":0.4274948364516127,"score_spread":0.32908346588982945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983335,0.012001994,0.00001478627,0.0025276823,0.00006916028,0.0012181622,0.0000072150347,0.00003338839,0.00079260056],"genre_scores_gemma":[0.99276704,0.00035061373,0.0002057249,0.000052867385,0.00002174871,0.00024694318,0.000020254953,0.000022123282,0.0063126977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819213,0.00012469928,0.00031959452,0.00032871644,0.000488138,0.00054674275],"domain_scores_gemma":[0.9991978,0.0000804933,0.000060195413,0.00028351275,0.00025197293,0.00012604905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008110711,0.0001238632,0.0003042998,0.00037700246,0.00016794438,0.00004509384,0.00006958374,0.00006970808,0.000060854738],"category_scores_gemma":[0.00012407165,0.00009171552,0.000034263314,0.00075782987,0.00009388957,0.00011998738,0.00003216555,0.00048260225,0.000026122509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002801506,0.0010531492,0.82578766,0.0030547164,0.00036965046,0.0016847217,0.0010598927,0.00034022154,0.06340274,0.00039833688,0.0010526417,0.098994784],"study_design_scores_gemma":[0.0072938483,0.00048913044,0.9588351,0.0038831914,0.000086427484,0.000027975591,0.0004282118,0.0023336061,0.023107348,0.00039282255,0.0029061993,0.00021608535],"about_ca_topic_score_codex":0.004859291,"about_ca_topic_score_gemma":0.0007350873,"teacher_disagreement_score":0.1330475,"about_ca_system_score_codex":0.00071641704,"about_ca_system_score_gemma":0.0010590933,"threshold_uncertainty_score":0.7345827},"labels":[],"label_agreement":null},{"id":"W4409691001","doi":"10.1158/1538-7445.am2025-523","title":"Abstract 523: Minnelide as a potential treatment strategy for CIC::DUX4 sarcoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sarcoma; Internal medicine; Oncology; Pathology","score_opus":0.06243188665912073,"score_gpt":0.431297120002055,"score_spread":0.36886523334293425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449516,0.0043013226,0.00053674047,0.0020128773,0.0002598291,0.00094136933,0.00008856671,0.00001579332,0.0073483293],"genre_scores_gemma":[0.97776186,0.0007692007,0.000091735215,0.0001441705,0.00038425377,0.0006380694,0.00013174504,0.000015372845,0.02006358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886,0.000051672163,0.00015598889,0.00035417808,0.00017587363,0.0004022576],"domain_scores_gemma":[0.99934465,0.000020614945,0.000026768494,0.00029117917,0.00022949751,0.00008728396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027156336,0.00011314317,0.00010696502,0.00009901873,0.00019400047,0.00006430967,0.00019483146,0.00012852206,0.00016729972],"category_scores_gemma":[0.00008583483,0.0000987379,0.00009960782,0.00014355886,0.0000984594,0.000004338628,0.00007244438,0.00009882602,0.000023305094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039793891,0.00010715475,0.000099004195,0.000041626117,0.000086426306,0.000005145976,0.000013181326,0.0000534675,0.897325,0.0005856737,0.03804516,0.06324022],"study_design_scores_gemma":[0.0009141469,0.00041377643,0.00058144715,0.000024065424,0.0000068413456,0.0000013454539,0.000094363764,0.000022851498,0.76572496,0.0005715558,0.23155448,0.000090162575],"about_ca_topic_score_codex":0.00048280862,"about_ca_topic_score_gemma":0.00018551618,"teacher_disagreement_score":0.19350931,"about_ca_system_score_codex":0.00010857844,"about_ca_system_score_gemma":0.0006803737,"threshold_uncertainty_score":0.40264148},"labels":[],"label_agreement":null},{"id":"W4409691031","doi":"10.1158/1538-7445.am2025-350","title":"Abstract 350: AUTX-703, a novel and potent KAT2A and KAT2B protein degrader, induces differentiation and provides a potential therapeutic opportunity in subtypes of prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Prostate cancer; Cancer research; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.09845964466096474,"score_gpt":0.400477444474042,"score_spread":0.30201779981307725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96449625,0.027311409,0.000008232401,0.0056110015,0.00004411151,0.0023270142,0.00006166478,0.000017261504,0.0001230685],"genre_scores_gemma":[0.9863367,0.011042915,0.000035594545,0.00004759308,0.000040233528,0.0008691815,0.0000184988,0.000020668156,0.0015886019],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806404,0.000113685615,0.00031061185,0.0004799042,0.0005310332,0.0005007261],"domain_scores_gemma":[0.9990989,0.00009014692,0.00007716833,0.00019292807,0.00032077602,0.00022008341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006784514,0.00019149166,0.00037013504,0.000545888,0.00017038238,0.0000852714,0.00008988118,0.00013418036,0.000054370936],"category_scores_gemma":[0.00009257977,0.00014214257,0.00003242089,0.00049501425,0.0005550956,0.00016794233,0.00015699945,0.00057219015,3.1527082e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030798714,0.00057277235,0.19024219,0.003334491,0.0003320709,0.00004903533,0.0017105932,0.0000036651797,0.64992136,0.00028533692,0.00010803161,0.15036058],"study_design_scores_gemma":[0.005307856,0.0004277815,0.9180957,0.001676827,0.00007500155,0.000006561221,0.0009882365,0.00030542162,0.071579754,0.001135295,0.00023177642,0.00016978953],"about_ca_topic_score_codex":0.005762714,"about_ca_topic_score_gemma":0.0011066734,"teacher_disagreement_score":0.72785354,"about_ca_system_score_codex":0.00024709973,"about_ca_system_score_gemma":0.0013069967,"threshold_uncertainty_score":0.87115383},"labels":[],"label_agreement":null},{"id":"W4409691162","doi":"10.1158/1538-7445.am2025-1173","title":"Abstract 1173: Desaminotyrosine contributes to the anticancer effect of fecal microbial transplantation during immune checkpoint blockade in mice and patients","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Blockade; Fecal bacteriotherapy; Immune checkpoint; Transplantation; Immune system; Feces; Medicine; Immunology; Immunity; Cancer research; Biology; Microbiology; Internal medicine; Immunotherapy; Antibiotics; Receptor","score_opus":0.015366737300978558,"score_gpt":0.35868273604083517,"score_spread":0.34331599873985663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927468,0.001818311,0.000004966381,0.0036900456,0.00008644069,0.0014311931,0.000092517635,0.000008315982,0.00012145389],"genre_scores_gemma":[0.99756116,0.0018636264,0.000012416799,0.000058976304,0.0000595966,0.00030839696,0.000025957237,0.000011573674,0.00009832136],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983475,0.00018006707,0.00031889157,0.00027614099,0.0003928511,0.00048452846],"domain_scores_gemma":[0.9986754,0.0007118571,0.000031111646,0.00019131947,0.00027683104,0.000113484406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011048255,0.000118306896,0.00032306777,0.00037680974,0.00011143138,0.000038624785,0.00014904185,0.000077839824,0.00006232007],"category_scores_gemma":[0.0006592552,0.000081736165,0.000054522665,0.0007030602,0.00018219164,0.00005378727,0.00008664409,0.0004427769,0.0000066079447],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041506602,0.000089596884,0.33340344,0.0012452621,0.000044038912,0.000014049673,0.00015173557,0.0000051490238,0.6584869,0.000004379214,0.0002037069,0.0022010554],"study_design_scores_gemma":[0.0027154689,0.00016074078,0.5164993,0.00074021093,0.000017816086,8.2075184e-7,0.000012685348,0.0000056389135,0.47971678,0.0000033864012,0.00009480534,0.00003235561],"about_ca_topic_score_codex":0.0025439009,"about_ca_topic_score_gemma":0.000680463,"teacher_disagreement_score":0.18309587,"about_ca_system_score_codex":0.00027016547,"about_ca_system_score_gemma":0.00021922118,"threshold_uncertainty_score":0.38456342},"labels":[],"label_agreement":null},{"id":"W4409691169","doi":"10.1158/1538-7445.am2025-1040","title":"Abstract 1040: Voices of resilience: Analysing #MetastaticBreastCancer content on TikTok","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; McGill University","funders":"","keywords":"Resilience (materials science); Content (measure theory); Mathematics; Physics","score_opus":0.6976923820166144,"score_gpt":0.6867565281955457,"score_spread":0.010935853821068764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9196607,0.0025311103,0.00007542078,0.014237225,0.00020217587,0.0007242983,0.000037628382,0.000027885912,0.06250355],"genre_scores_gemma":[0.9761653,0.0025398775,0.0002499795,0.00051882444,0.00013983651,0.0001288952,0.000005445849,0.000020109841,0.020231748],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99489784,0.00025920323,0.00066392054,0.00060883316,0.0028789218,0.00069127785],"domain_scores_gemma":[0.9865575,0.009457608,0.00010410473,0.000902803,0.0027081668,0.00026983794],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0084179705,0.0001449357,0.0005071791,0.000760837,0.00019377709,0.000051591764,0.00052429375,0.00023044231,0.0013218762],"category_scores_gemma":[0.013143098,0.00011309842,0.00016972063,0.0017437163,0.001272242,0.000077128025,0.0002354429,0.0029958945,0.000082080296],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011603768,0.002272251,0.12532957,0.009073411,0.0020103997,0.00037122815,0.0012607316,0.00079042464,0.50771075,0.088943444,0.025249146,0.22538486],"study_design_scores_gemma":[0.006106699,0.0019306329,0.5229994,0.0151987085,0.0002497777,0.000005819382,0.004031334,0.00060004316,0.39543757,0.03865466,0.014318185,0.00046715155],"about_ca_topic_score_codex":0.002455303,"about_ca_topic_score_gemma":0.001052586,"teacher_disagreement_score":0.39766985,"about_ca_system_score_codex":0.00054721977,"about_ca_system_score_gemma":0.003121881,"threshold_uncertainty_score":0.99959105},"labels":[],"label_agreement":null},{"id":"W4409691179","doi":"10.1158/1538-7445.am2025-224","title":"Abstract 224: Methyl-CpG-binding domain protein 2 (Mbd2) as a therapeutic target in breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Cancer research; Cancer; Medicine; Computational biology; Biology; Oncology; Internal medicine","score_opus":0.026338773511571822,"score_gpt":0.38897338470387754,"score_spread":0.3626346111923057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98429686,0.008311462,0.000093702845,0.003945825,0.00021786083,0.0009035255,0.00007447483,0.000017424718,0.0021388906],"genre_scores_gemma":[0.99310845,0.0008045995,0.0000799407,0.00013418835,0.00032491208,0.0014849267,0.000047884074,0.000039319882,0.0039758002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978047,0.00021782191,0.0002852411,0.0006164546,0.0004192189,0.00065657444],"domain_scores_gemma":[0.9991302,0.00002923424,0.0000643156,0.0004438501,0.00023423425,0.00009819265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009603179,0.00019249704,0.00020299766,0.00033866192,0.00016380318,0.000065486274,0.00035720898,0.0002978155,0.00090980576],"category_scores_gemma":[0.00004024083,0.0001910244,0.00008645717,0.0008634136,0.00017617556,0.000011657693,0.0001699997,0.0005088617,0.000029179177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048375293,0.000054563036,0.0028234175,0.0000932304,0.00011263715,0.000005700809,0.00007359128,0.000600224,0.9742798,0.00033354128,0.002660274,0.018479269],"study_design_scores_gemma":[0.0014999069,0.00008129094,0.025804693,0.00045347164,0.000012402748,0.0000053964604,0.00021277268,0.0000854222,0.9079495,0.0031880406,0.06037231,0.00033475587],"about_ca_topic_score_codex":0.0024464673,"about_ca_topic_score_gemma":0.0014611887,"teacher_disagreement_score":0.06633027,"about_ca_system_score_codex":0.0005734444,"about_ca_system_score_gemma":0.0013264605,"threshold_uncertainty_score":0.99617356},"labels":[],"label_agreement":null},{"id":"W4409691190","doi":"10.1158/1538-7445.am2025-767","title":"Abstract 767: Discovering the geospatial framework in glioblastoma: Uncovering hotspots for glioma stem cell hide-out and their therapeutic implications","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; Mount Sinai Hospital; University of Toronto; University Health Network; University of Calgary; Hospital for Sick Children","funders":"","keywords":"Glioblastoma; Geospatial analysis; Glioma; Stem cell; Cancer research; Medicine; Biology; Computational biology; Geography; Genetics; Cartography","score_opus":0.03546302978660542,"score_gpt":0.3824284235722125,"score_spread":0.3469653937856071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988435,0.007850899,0.001334629,0.0010137632,0.00008859376,0.00084281416,0.00013782288,0.0000074094364,0.00028907746],"genre_scores_gemma":[0.9970496,0.0012116911,0.000020313288,0.000069556925,0.00013120964,0.0011731709,0.000010143162,0.000021705382,0.00031256434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871165,0.00006595576,0.00015858874,0.0004074873,0.00014957908,0.0005067149],"domain_scores_gemma":[0.9991522,0.00020905863,0.000031026506,0.0004255795,0.00010706929,0.000075079166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035994823,0.0001400026,0.00013079669,0.00012464447,0.00028213084,0.00011343202,0.00031678463,0.000107234,0.00001021042],"category_scores_gemma":[0.0000356224,0.00009905937,0.00006465745,0.00031361653,0.00015243464,0.00000995807,0.00024273233,0.00027600717,0.0000022164677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014027449,0.00017825108,0.016553733,0.00026374942,0.00022126597,0.0000047136355,0.00072008825,0.00034107862,0.8756617,0.00066691067,0.00092237024,0.10306343],"study_design_scores_gemma":[0.0021348775,0.00046571216,0.09028393,0.00025226318,0.000015346737,0.0000032799537,0.0010924515,0.00007466731,0.8843264,0.006386187,0.014677187,0.0002877115],"about_ca_topic_score_codex":0.0011136179,"about_ca_topic_score_gemma":0.005417221,"teacher_disagreement_score":0.102775715,"about_ca_system_score_codex":0.00015141196,"about_ca_system_score_gemma":0.0004054679,"threshold_uncertainty_score":0.40395236},"labels":[],"label_agreement":null},{"id":"W4409691232","doi":"10.1158/1538-7445.am2025-958","title":"Abstract 958: Myeloid cell populations drive early Vaccinia-induced anti-tumor responses differentially based on tumor cell immunogenicity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Immunogenicity; Vaccinia; Myeloid cells; Cell; Cancer research; Tumor cells; Biology; Myeloid; Cancer; Immunology; Virology; Immune system; Gene; Recombinant DNA; Genetics","score_opus":0.04737752606271254,"score_gpt":0.3843056003110265,"score_spread":0.33692807424831395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942492,0.0009084211,0.000049325736,0.0004662767,0.00020866054,0.0008463164,0.0002963077,0.000026053875,0.002949398],"genre_scores_gemma":[0.99630994,0.0001770476,0.000056270743,0.00021920688,0.00016838632,0.00043303514,0.0001512197,0.00004640127,0.0024384824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696684,0.0003471207,0.00031997374,0.0007973637,0.0006789995,0.00088970584],"domain_scores_gemma":[0.9982217,0.00011751513,0.000084110514,0.0009051232,0.00042429214,0.00024723762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046398994,0.00028255692,0.00027080637,0.0003914769,0.0005088844,0.00016217271,0.00059124,0.00013496887,0.00029584518],"category_scores_gemma":[0.00016689835,0.0002640922,0.00020413047,0.0005235059,0.00011973189,0.000014505861,0.0002678269,0.0005608222,0.000081851926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025413504,0.0005065761,0.014430869,0.00008732342,0.00007162488,0.000055451626,0.000021953541,0.000049395494,0.97906524,0.000028424729,0.0023889255,0.00075286534],"study_design_scores_gemma":[0.002047651,0.00065252406,0.2129901,0.000071919996,0.000017891207,6.9584945e-7,0.00002868435,0.000036275396,0.7818447,0.000060939707,0.002047831,0.00020083928],"about_ca_topic_score_codex":0.0037147016,"about_ca_topic_score_gemma":0.00081232394,"teacher_disagreement_score":0.19855922,"about_ca_system_score_codex":0.00029734624,"about_ca_system_score_gemma":0.0016559716,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W4409691343","doi":"10.1158/1538-7445.am2025-752","title":"Abstract 752: Hypoxia-driven spatial dynamics of epigenetic and transcriptional cell states in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Epigenetics; Hypoxia (environmental); Glioblastoma; Dynamics (music); Biology; Cancer research; Computational biology; Genetics; Chemistry; Psychology; Gene","score_opus":0.016332255472704164,"score_gpt":0.3212106753961511,"score_spread":0.30487841992344694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840035,0.01386487,0.00036655992,0.00028523704,0.00031633372,0.00024140062,0.00020450601,0.0000035202386,0.0007141093],"genre_scores_gemma":[0.98819786,0.010448737,0.000060135655,0.000039052575,0.00023487642,0.00006554057,0.00005013659,0.000013889084,0.0008897689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988584,0.000067580164,0.00021549845,0.0003195586,0.00022092194,0.00031804165],"domain_scores_gemma":[0.99950016,0.000028757602,0.000032967902,0.00020068776,0.00016625477,0.00007118045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027353986,0.0001066124,0.00016692141,0.00018731017,0.000053021577,0.000017946804,0.00017863528,0.00012109429,0.00006185379],"category_scores_gemma":[0.00002824191,0.00011018975,0.000050378978,0.00021484517,0.00024274303,0.0000040344567,0.000081643804,0.00020115127,0.000001464126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043679643,0.000091180045,0.002050782,0.0001761828,0.000028932818,0.0000012636151,0.00013118943,0.00056385284,0.974807,0.00023179004,0.00093559496,0.0205454],"study_design_scores_gemma":[0.0029268863,0.00039541235,0.1577856,0.00016460272,0.000024559424,0.000002315072,0.00044727093,0.0008914686,0.77267253,0.0011913377,0.06318166,0.00031635212],"about_ca_topic_score_codex":0.001773093,"about_ca_topic_score_gemma":0.010606465,"teacher_disagreement_score":0.20213449,"about_ca_system_score_codex":0.000055833563,"about_ca_system_score_gemma":0.00041419998,"threshold_uncertainty_score":0.59186566},"labels":[],"label_agreement":null},{"id":"W4409691404","doi":"10.1158/1538-7445.am2025-326","title":"Abstract 326: Chemotherapies change the NRF2 levels and impact the differentiation and growth of human high grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous ovarian cancer; Serous fluid; Ovarian cancer; Cancer; Oncology; Medicine; Internal medicine; Gynecology; Cancer research","score_opus":0.07178215362659095,"score_gpt":0.38960851269713337,"score_spread":0.3178263590705424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894955,0.007612251,0.000016748963,0.0022703721,0.00005010252,0.00034791217,0.00012268194,0.000002896369,0.00008153081],"genre_scores_gemma":[0.99678886,0.0024546795,0.00000601617,0.00012871486,0.00024445288,0.00015726397,0.000020256412,0.0000121105495,0.00018766726],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99917805,0.0000823848,0.00012447672,0.0002448005,0.00013766198,0.00023264212],"domain_scores_gemma":[0.99944997,0.00004540038,0.000055596396,0.00024052266,0.00016897464,0.000039515642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002716416,0.000111673144,0.00012773974,0.0000436845,0.00022355761,0.00004722254,0.00022200719,0.00008300252,0.000043004133],"category_scores_gemma":[0.000034350043,0.00006662865,0.000037816073,0.00010943197,0.0003988959,0.000005748077,0.00015247193,0.00017867531,1.9935375e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060651873,0.000023883293,0.027119715,0.00008936634,0.00014315719,1.7805013e-7,0.00054120854,8.684853e-7,0.96729594,0.00035216752,0.00067626976,0.0036966105],"study_design_scores_gemma":[0.00032136755,0.000037593418,0.51737297,0.00003163553,0.000009032968,2.8166752e-7,0.00010471995,0.000002583272,0.4806254,0.0012748076,0.00016821985,0.000051403746],"about_ca_topic_score_codex":0.004012096,"about_ca_topic_score_gemma":0.0008009782,"teacher_disagreement_score":0.49025327,"about_ca_system_score_codex":0.000034728928,"about_ca_system_score_gemma":0.00007798647,"threshold_uncertainty_score":0.60651165},"labels":[],"label_agreement":null},{"id":"W4409691405","doi":"10.1158/1538-7445.am2025-2522","title":"Abstract 2522: N-heterocyclic carbene (NHC)-protected gold nanoclusters for cancer imaging and therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nanocluster Synthesis and Applications","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University Health Network","funders":"","keywords":"Nanoclusters; Carbene; Cancer therapy; Cancer; Medicine; Chemistry; Internal medicine; Biochemistry; Organic chemistry","score_opus":0.0677678169791242,"score_gpt":0.40773113786348475,"score_spread":0.33996332088436054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978272,0.011976346,0.0003498951,0.0067800498,0.0003125159,0.0014279329,0.00013484049,0.00007391326,0.00067248585],"genre_scores_gemma":[0.99075633,0.002659596,0.00038603647,0.00034318876,0.00018610028,0.0041943663,0.0000037722893,0.00002872468,0.0014418854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982275,0.00008000114,0.00024722426,0.0005592937,0.0002979381,0.0005880937],"domain_scores_gemma":[0.99886304,0.00029957245,0.000059611368,0.00040573816,0.0002667951,0.00010521533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407287,0.00015497036,0.00021896811,0.00020328212,0.0004090623,0.0002566199,0.0004338039,0.000066050845,0.0002547429],"category_scores_gemma":[0.00005579386,0.00013212365,0.00005520743,0.0003842663,0.0002329635,0.00014985945,0.00015040384,0.00018205638,0.000012987519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000893909,0.000025216415,0.00034817244,0.00009504659,0.000013973717,6.660192e-7,0.00013129633,0.000015622465,0.9029991,0.00016281665,0.004079869,0.0920388],"study_design_scores_gemma":[0.0008664044,0.000020584925,0.0057543973,0.00022544316,0.000009193371,7.6915114e-7,0.00015317912,0.0002342835,0.9134247,0.00074815686,0.07837023,0.00019269164],"about_ca_topic_score_codex":0.0027668602,"about_ca_topic_score_gemma":0.0004408015,"teacher_disagreement_score":0.09184611,"about_ca_system_score_codex":0.00019416295,"about_ca_system_score_gemma":0.00021852314,"threshold_uncertainty_score":0.5387846},"labels":[],"label_agreement":null},{"id":"W4409691441","doi":"10.1158/1538-7445.am2025-189","title":"Abstract 189: The role of DEPTOR in promoting breast cancer initiation and progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cancer; Breast cancer; Oncology; Internal medicine","score_opus":0.020429403495006954,"score_gpt":0.3858317023910239,"score_spread":0.36540229889601694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97626466,0.021116195,0.000003153799,0.00074068416,0.0005004712,0.00034159707,0.000036725596,0.0000031504683,0.0009933958],"genre_scores_gemma":[0.993849,0.004165849,0.00001160062,0.000041032625,0.0014944798,0.00027741026,0.000008384198,0.000008408149,0.00014386425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991735,0.00007687537,0.00014489739,0.00021321353,0.00017028426,0.00022118272],"domain_scores_gemma":[0.9995641,0.000022560318,0.00004241525,0.00016221452,0.00017418154,0.000034500867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005215439,0.000066014734,0.000094340845,0.00007732086,0.00008406398,0.000021397449,0.0001344716,0.000078485,0.000031391366],"category_scores_gemma":[0.000060711758,0.00004857772,0.000023368155,0.00021860238,0.00013720339,0.000005833358,0.000114062954,0.0001736223,4.3018906e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014277686,0.000032827385,0.036822386,0.00009442117,0.000016406217,4.231491e-8,0.00023175639,0.000009398164,0.7913999,0.000101988495,0.0014587949,0.16968928],"study_design_scores_gemma":[0.0008080533,0.000048968257,0.355133,0.000439782,0.0000100786165,0.0000018605472,0.0005464372,0.00006194675,0.49077016,0.0003111584,0.1517533,0.00011523696],"about_ca_topic_score_codex":0.001057097,"about_ca_topic_score_gemma":0.0012975533,"teacher_disagreement_score":0.31831062,"about_ca_system_score_codex":0.0000382866,"about_ca_system_score_gemma":0.0004101952,"threshold_uncertainty_score":0.19809419},"labels":[],"label_agreement":null},{"id":"W4409691443","doi":"10.1158/1538-7445.am2025-755","title":"Abstract 755: Identifying the molecular signature of infiltrating edge cells in glioblastoma as drivers of tumor invasion and recurrence","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioblastoma; Signature (topology); Pathology; Tumor cells; Cancer research; Biology; Cancer; Medicine; Internal medicine","score_opus":0.042095427118836425,"score_gpt":0.3881619164245679,"score_spread":0.3460664893057315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931283,0.0048488136,0.0000015784351,0.0006909058,0.000055793837,0.0004612284,0.000008907328,0.000003426214,0.0008010427],"genre_scores_gemma":[0.9992991,0.00051236496,0.000033829758,0.00004519273,0.000010343753,0.0000596079,0.0000011932883,0.0000056805693,0.000032695745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989714,0.00007164533,0.00020160459,0.0001940083,0.00037131587,0.00019003598],"domain_scores_gemma":[0.9991905,0.00030181513,0.00005924653,0.00020229469,0.00019853491,0.00004762417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048488207,0.00007398403,0.0001833661,0.0002707243,0.00005288418,0.000014976143,0.00011080433,0.000048232174,0.000049236733],"category_scores_gemma":[0.00021271901,0.000051881834,0.000039155497,0.0006718535,0.00017585083,0.00004271714,0.00009335132,0.00035025924,0.0000018216235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486937,0.00012900116,0.019740304,0.00054426474,0.000043638327,0.00015451096,0.00074993545,0.000049266564,0.9701427,0.00048100282,0.00061210024,0.0071983896],"study_design_scores_gemma":[0.00082134793,0.00015386876,0.048053063,0.0020607058,0.00001841278,0.0000027061571,0.0009429271,0.000031878983,0.94747365,0.00023890795,0.00016661288,0.0000359186],"about_ca_topic_score_codex":0.00086839916,"about_ca_topic_score_gemma":0.00016874126,"teacher_disagreement_score":0.02831276,"about_ca_system_score_codex":0.00009129542,"about_ca_system_score_gemma":0.00027666442,"threshold_uncertainty_score":0.21156798},"labels":[],"label_agreement":null},{"id":"W4409691549","doi":"10.1158/1538-7445.am2025-584","title":"Abstract 584: Preclinical efficacy and safety of [161Tb]Tb-labeled anti-nectin-4 radioimmunoconjugate as theranostic against triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université Laval","funders":"","keywords":"Triple-negative breast cancer; Medicine; Cancer; Breast cancer; Oncology; Cancer research; Internal medicine; Pathology","score_opus":0.05146596342221781,"score_gpt":0.4413332187591838,"score_spread":0.389867255336966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701604,0.0137780495,0.000012889329,0.00586808,0.00012150268,0.0021543698,0.00020888665,0.000035507324,0.0076602804],"genre_scores_gemma":[0.95329094,0.04217802,0.000054645792,0.0004053436,0.00026011484,0.0006669251,0.000013730405,0.000037357353,0.0030929365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975352,0.00015231287,0.00058171066,0.0006828391,0.0004184477,0.0006294741],"domain_scores_gemma":[0.99688315,0.0016015548,0.00013032841,0.00044914844,0.00054029,0.0003955202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008405744,0.00027083253,0.00063820806,0.0001438605,0.00037591063,0.00004939773,0.00025508675,0.00023692346,0.0005406367],"category_scores_gemma":[0.00027430573,0.00024009819,0.00009174218,0.0007331758,0.00089323416,0.00007986045,0.00013209364,0.0012389034,0.0000047587364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077204583,0.0009702624,0.026886556,0.0042139776,0.0011104293,0.000054104326,0.0016936898,0.00007990034,0.9089572,0.00019002678,0.002393669,0.045729756],"study_design_scores_gemma":[0.029456839,0.00021820956,0.4305717,0.0058197556,0.00078145595,0.000019807005,0.00067591923,0.0018355891,0.5205708,0.00018276599,0.00915937,0.00070778985],"about_ca_topic_score_codex":0.0017826849,"about_ca_topic_score_gemma":0.000059940794,"teacher_disagreement_score":0.40368515,"about_ca_system_score_codex":0.00034478476,"about_ca_system_score_gemma":0.001743882,"threshold_uncertainty_score":0.979092},"labels":[],"label_agreement":null},{"id":"W4409691643","doi":"10.1158/1538-7445.am2025-581","title":"Abstract 581: Better together: Biparatopic [225Ac]Ac-labeled anti-HER2 antibody-drug radioconjugates using two domain-specific antibodies for the treatment of trastuzumab and T-DM1 resistant HER2-positive breast cancer xenografts","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université Laval","funders":"","keywords":"Trastuzumab; Medicine; Antibody; Cancer; Drug; Trastuzumab emtansine; Breast cancer; Pharmacology; Internal medicine; Immunology","score_opus":0.07219079361530506,"score_gpt":0.4560424873402374,"score_spread":0.38385169372493233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95720065,0.02955497,0.00010254816,0.010356033,0.000091772185,0.0017834716,0.00055959244,0.000024436864,0.00032650848],"genre_scores_gemma":[0.97986275,0.017969916,0.000369044,0.0001315692,0.00048544267,0.00059728435,0.00003288045,0.000032783126,0.00051830575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805516,0.00008332881,0.00039299714,0.0005349484,0.0003559776,0.00057758455],"domain_scores_gemma":[0.99829006,0.00063161034,0.00008559306,0.00043486358,0.0003970777,0.0001608207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734591,0.00026000806,0.00051788497,0.00012783518,0.0005600904,0.00007562697,0.00019537422,0.000089437446,0.00018532296],"category_scores_gemma":[0.00000870064,0.00017604957,0.00014444556,0.00053743384,0.0008010916,0.00006886818,0.000038492806,0.00030852234,0.0000017677421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012613353,0.00053950236,0.012492313,0.0005720803,0.0006948955,0.000019955021,0.00089171523,0.00003026017,0.96558535,0.00041395047,0.0011827988,0.01631585],"study_design_scores_gemma":[0.0052912007,0.00018849378,0.096223116,0.0008753092,0.0003221299,0.000021900347,0.0009376781,0.00025234648,0.8247728,0.00030266764,0.07054483,0.00026754854],"about_ca_topic_score_codex":0.001175418,"about_ca_topic_score_gemma":0.00007795357,"teacher_disagreement_score":0.14081256,"about_ca_system_score_codex":0.00047135956,"about_ca_system_score_gemma":0.00035553938,"threshold_uncertainty_score":0.7179093},"labels":[],"label_agreement":null},{"id":"W4409820846","doi":"10.1158/1538-7445.am2025-lb340","title":"Abstract LB340: Analyzing both germline and somatic variants using Variant WorkBench in the Kids First Data Resource Portal: Children’s Brain Tumor Network as an example","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Germline; Somatic cell; Workbench; Resource (disambiguation); Biology; Germline mutation; Genetics; Computational biology; Computer science; Mutation; Gene; Computer network; Data mining","score_opus":0.07344684777088202,"score_gpt":0.38482163811292736,"score_spread":0.31137479034204535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409820846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919717,0.00307439,0.00063499564,0.0025986591,0.000093659844,0.00071364787,0.00008273199,0.000010281283,0.00081994093],"genre_scores_gemma":[0.99588794,0.0010759187,0.0006854483,0.00075472065,0.00073293207,0.000045191515,0.00054157426,0.000025720932,0.00025058773],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99683195,0.00034827625,0.000499644,0.0006948481,0.0006930719,0.0009322087],"domain_scores_gemma":[0.9979036,0.00024575286,0.00008558019,0.001414273,0.000117360134,0.00023342979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005359434,0.000204598,0.0002488374,0.00021213964,0.0004515952,0.00028794442,0.0014012868,0.00018466494,0.00010913165],"category_scores_gemma":[0.00067321694,0.00015600628,0.00004158545,0.000758601,0.0004406266,0.000025759673,0.0010231187,0.00060121494,0.0000043168598],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023648883,0.0025614544,0.17906122,0.0033783962,0.0016017344,0.0009768661,0.0059865057,0.0039291778,0.2288717,0.002395546,0.4141287,0.15474382],"study_design_scores_gemma":[0.006467097,0.0017613948,0.6830106,0.0021185456,0.000171318,0.0003368348,0.005119749,0.046912186,0.005023521,0.004739401,0.24234058,0.0019987854],"about_ca_topic_score_codex":0.003899401,"about_ca_topic_score_gemma":0.0033620116,"teacher_disagreement_score":0.50394934,"about_ca_system_score_codex":0.000052653773,"about_ca_system_score_gemma":0.00075026,"threshold_uncertainty_score":0.63617516},"labels":[],"label_agreement":null},{"id":"W4409820850","doi":"10.1158/1538-7445.am2025-lb397","title":"Abstract LB397: Biomarker-guided dose selection in the iintune-1 study of dazostinag,a STING agonist, alone and in combination with pembrolizumab for patients with metastatic solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pembrolizumab; Medicine; Sting; Oncology; Internal medicine; Biomarker; Agonist; Cancer; Immunotherapy; Receptor; Biology","score_opus":0.05624023280462687,"score_gpt":0.39246531508822463,"score_spread":0.33622508228359776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409820850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975624,0.00035024583,0.000018223127,0.00013947561,0.00003614408,0.0016956682,0.000012039443,0.000006955158,0.00017886401],"genre_scores_gemma":[0.99920636,0.00001965274,0.000012129929,0.000013963566,0.0000018835622,0.0004390891,0.000023308172,0.000009963225,0.0002736731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984956,0.0005593174,0.0003003011,0.00023774403,0.000094944786,0.00031213523],"domain_scores_gemma":[0.9988256,0.0006282216,0.000089301255,0.00012824612,0.00032060314,0.000008003199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011068073,0.00011128526,0.0002459793,0.0004715896,0.00018281868,0.000027085429,0.00016352211,0.000044520977,0.000020387686],"category_scores_gemma":[0.00024695633,0.00007159405,0.000014322551,0.0006050974,0.00020698807,0.00008165479,0.000048140206,0.00032061842,0.000001069173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11022383,0.010200696,0.4442234,0.0012291014,0.0010365248,0.000030057463,0.015714454,0.00022131522,0.38307515,0.00054693513,0.001775736,0.031722806],"study_design_scores_gemma":[0.015508296,0.0034189748,0.9548038,0.00040412432,0.00002848409,0.0000065346503,0.0054433406,0.000050945695,0.02006472,0.00005628428,0.00010928742,0.00010516302],"about_ca_topic_score_codex":0.0027425413,"about_ca_topic_score_gemma":0.0028734487,"teacher_disagreement_score":0.5105804,"about_ca_system_score_codex":0.00013356868,"about_ca_system_score_gemma":0.0002467331,"threshold_uncertainty_score":0.41459203},"labels":[],"label_agreement":null},{"id":"W4409820963","doi":"10.1158/1538-7445.am2025-sy02-01","title":"Abstract SY02-01: Inflammatory memory and selective advantage in human clonal hematopoiesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Haematopoiesis; Cancer research; Biology; Immunology; Medicine; Genetics; Stem cell","score_opus":0.027434990656327804,"score_gpt":0.39231745020593667,"score_spread":0.36488245954960885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409820963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813045,0.011285741,0.0000031945451,0.00067820767,0.0001362486,0.00030401073,0.000020245576,0.000024327686,0.006243487],"genre_scores_gemma":[0.9905248,0.0005080702,0.000003903494,0.00004297392,0.000015439706,0.00018109285,0.00001577856,0.000009696028,0.008698202],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987951,0.00026493697,0.00021199507,0.00026100347,0.000052673637,0.00041429434],"domain_scores_gemma":[0.99922234,0.00040986927,0.00003011971,0.00018963713,0.00013095462,0.000017085684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076097954,0.00010096368,0.00018303521,0.00051720114,0.00039221696,0.000023257677,0.00018032972,0.00016574918,0.000740706],"category_scores_gemma":[0.00013438382,0.00009710412,0.000036455585,0.0003856091,0.00022406703,0.000093325165,0.00016114212,0.00069768116,0.00004418718],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046537357,0.000109829554,0.012935079,0.00016181859,0.0001405386,0.000021882192,0.00078869605,0.0000055084265,0.9606413,0.0098528955,0.008984309,0.0058927443],"study_design_scores_gemma":[0.0023128525,0.00007739509,0.55684984,0.00026647447,0.0000122295205,0.000013033339,0.0024863842,0.0000017898598,0.408333,0.0016640563,0.027781768,0.00020118008],"about_ca_topic_score_codex":0.00073922763,"about_ca_topic_score_gemma":0.0007621127,"teacher_disagreement_score":0.5523083,"about_ca_system_score_codex":0.00021698135,"about_ca_system_score_gemma":0.0003554979,"threshold_uncertainty_score":0.8110211},"labels":[],"label_agreement":null},{"id":"W4409820998","doi":"10.1158/1538-7445.am2025-sy26-02","title":"Abstract SY26-02: Keeping Mitochondria Happy: How peroxisomes regulate mitochondria oxidative stress","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Mitochondrion; Oxidative stress; Peroxisome; Oxidative phosphorylation; Cell biology; Chemistry; Biology; Biochemistry; Receptor","score_opus":0.031994348069149386,"score_gpt":0.3613786315656726,"score_spread":0.32938428349652327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409820998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606694,0.005657153,0.00027248383,0.0028859782,0.0010104594,0.0008965861,0.00015611129,0.00006171824,0.0029925653],"genre_scores_gemma":[0.9852438,0.001610964,0.00032799307,0.00021311526,0.000789107,0.0005874185,0.00013659257,0.000074631425,0.011016355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996519,0.00032932096,0.00032815538,0.0011134582,0.00063508854,0.0010749664],"domain_scores_gemma":[0.9978615,0.00012026414,0.00011451902,0.00093257497,0.0007043704,0.00026674743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048545704,0.00037885568,0.00038144746,0.0004011256,0.00047387547,0.00027367036,0.00087027246,0.00048572064,0.00024768116],"category_scores_gemma":[0.00062645384,0.00036603256,0.0001809787,0.0008017075,0.00049387803,0.00003392366,0.00051578047,0.0008783633,0.000041677486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031287354,0.00009655441,0.0018223665,0.00015056328,0.00031291074,0.000009033908,0.00013448216,0.00007309231,0.9650773,0.00013399178,0.02841579,0.0034610627],"study_design_scores_gemma":[0.0006958231,0.000119170756,0.0015323604,0.00036475825,0.00001583195,0.0000022184927,0.00050687185,0.000023216404,0.9478019,0.00014200008,0.048446827,0.00034905478],"about_ca_topic_score_codex":0.0001878787,"about_ca_topic_score_gemma":0.00019152343,"teacher_disagreement_score":0.020031037,"about_ca_system_score_codex":0.00029131866,"about_ca_system_score_gemma":0.00084365683,"threshold_uncertainty_score":0.9998792},"labels":[],"label_agreement":null},{"id":"W4409821025","doi":"10.1158/1538-7445.am2025-lb263","title":"Abstract LB263: A transcriptomic signature predicts mortality risk and immune checkpoint inhibitor response beyond molecular and morphological features in lung adenocarcinoma from never smokers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Transcriptome; Adenocarcinoma; Signature (topology); Lung cancer; Medicine; Immune checkpoint; Immune system; Gene signature; Lung; Oncology; Cancer research; Cancer; Internal medicine; Biology; Immunology; Immunotherapy; Gene; Genetics; Gene expression","score_opus":0.027463541753489168,"score_gpt":0.35023807594108175,"score_spread":0.3227745341875926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022096,0.09220715,0.0000075952,0.004025035,0.0001264035,0.0009864388,0.00020058079,0.0000344569,0.00020276246],"genre_scores_gemma":[0.9951942,0.003581769,0.000070805574,0.0004805503,0.0000907668,0.00036339436,0.000028304765,0.000029397197,0.0001608133],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970806,0.00046435144,0.00041279462,0.0008203157,0.00063048303,0.0005914265],"domain_scores_gemma":[0.9987965,0.0002781449,0.000060090624,0.0004462663,0.00016193696,0.0002570505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00162243,0.00026366077,0.0005271002,0.00036680704,0.00015303335,0.00008600724,0.00018209609,0.0004171943,0.00021369006],"category_scores_gemma":[0.00035362193,0.00021826796,0.00011730104,0.00066750014,0.0005227659,0.0001411442,0.00015738401,0.001855253,0.0000013837755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008283383,0.00016906727,0.31871557,0.0003403342,0.00026153226,0.0005207606,0.0008136686,0.000010446568,0.66575366,0.00004126011,0.0023059724,0.0027843753],"study_design_scores_gemma":[0.0031669817,0.00021297295,0.86958706,0.000592982,0.00012242525,0.000008464362,0.0004356888,0.00006586136,0.1249863,0.00034814602,0.00031067905,0.00016243872],"about_ca_topic_score_codex":0.0064677335,"about_ca_topic_score_gemma":0.00032140335,"teacher_disagreement_score":0.5508715,"about_ca_system_score_codex":0.00040786763,"about_ca_system_score_gemma":0.00048699498,"threshold_uncertainty_score":0.9777322},"labels":[],"label_agreement":null},{"id":"W4409821093","doi":"10.1158/1538-7445.am2025-lb416","title":"Abstract LB416: SAVANNAH: Clearance of plasma EGFRm in patients with EGFRm MET-overexpressed (OverExp) and/or -amplified (Amp) NSCLC post-osimertinib (osi) treated with savolitinib (savo) + osi","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Cancer; Adenocarcinoma","score_opus":0.0415253501626779,"score_gpt":0.39136179555278156,"score_spread":0.34983644539010367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829263,0.0005203668,0.000010195037,0.00056745304,0.000051076324,0.002084872,0.00037374647,0.000048342146,0.008051318],"genre_scores_gemma":[0.9945915,0.00019696966,0.00032030276,0.00021337753,0.00004351951,0.00052164483,0.00017608271,0.00006219079,0.00387446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700373,0.000112944734,0.0005037215,0.000728182,0.00088636857,0.000765033],"domain_scores_gemma":[0.99755704,0.00040470585,0.00015603726,0.0006241444,0.0009946994,0.0002633426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002830758,0.000338274,0.00066318596,0.0005363188,0.00018461517,0.00005717859,0.00021375532,0.00015913192,0.00046873186],"category_scores_gemma":[0.00018748608,0.00022518152,0.00006343858,0.0011420385,0.00041397972,0.00022953392,0.000083671446,0.0005626245,0.000012424652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08669073,0.003170166,0.84609485,0.0019172803,0.0019209855,0.00011250656,0.0034153166,0.00011651372,0.016349932,0.0011151868,0.0027120411,0.03638452],"study_design_scores_gemma":[0.024102047,0.002553335,0.94194883,0.0032911564,0.00023752257,0.0000031653287,0.0006622627,0.00002112363,0.020930214,0.00004396272,0.005891674,0.00031469084],"about_ca_topic_score_codex":0.00462616,"about_ca_topic_score_gemma":0.0011817702,"teacher_disagreement_score":0.09585403,"about_ca_system_score_codex":0.00056883064,"about_ca_system_score_gemma":0.0013614269,"threshold_uncertainty_score":0.9182636},"labels":[],"label_agreement":null},{"id":"W4409821181","doi":"10.1158/1538-7445.am2025-lb137","title":"Abstract LB137: Bispecific antibody-based redirection of endogenous IL-15 to PD-1 positive cells enhances antitumor activity over checkpoint inhibition alone","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; iCo Therapeutics (Canada)","funders":"","keywords":"Cancer research; Endogeny; Bispecific antibody; Antibody; PD-L1; Chemistry; Medicine; Cancer; Immunology; Immunotherapy; Internal medicine; Monoclonal antibody","score_opus":0.04376194582711108,"score_gpt":0.35991669966820483,"score_spread":0.31615475384109376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869622,0.0009256697,0.00063358346,0.00052682165,0.0035575344,0.0006462789,0.000076946686,0.000058112288,0.006612825],"genre_scores_gemma":[0.9937472,0.00039095798,0.000014473753,0.00010754888,0.00007431548,0.00010356773,0.00011398233,0.00001710501,0.005430856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824184,0.00032550073,0.0003534188,0.0004685369,0.00014794887,0.00046272922],"domain_scores_gemma":[0.9987082,0.00024241801,0.00013852911,0.000316195,0.0005602568,0.000034429268],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007421938,0.00017739723,0.00032214666,0.0006834747,0.00034811837,0.000037096645,0.00014288988,0.00021280727,0.0025657036],"category_scores_gemma":[0.00010272757,0.0001731502,0.00012919461,0.0007754496,0.0002546611,0.00019920395,0.000075930686,0.00069322245,0.00039878537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023270713,0.0003602985,0.000117442265,0.000106025305,0.00010627036,0.0000062633053,0.00018957855,0.00004719053,0.9812427,0.00004705587,0.011337691,0.004112415],"study_design_scores_gemma":[0.0009100867,0.00032785916,0.0126127,0.00034121753,0.000016586075,0.000004150056,0.0001950674,0.000006731448,0.9655277,0.000018271887,0.019899316,0.00014027533],"about_ca_topic_score_codex":0.0030920953,"about_ca_topic_score_gemma":0.00017575591,"teacher_disagreement_score":0.01571496,"about_ca_system_score_codex":0.00046034512,"about_ca_system_score_gemma":0.00037128574,"threshold_uncertainty_score":0.9983461},"labels":[],"label_agreement":null},{"id":"W4409821253","doi":"10.1158/1538-7445.am2025-lb432","title":"Abstract LB432: Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Oxaliplatin; In vivo; Peripheral neuropathy; Medicine; Pharmacology; Peripheral; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Biology; Endocrinology; Colorectal cancer","score_opus":0.15867087670373162,"score_gpt":0.5111299242472217,"score_spread":0.3524590475434901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896667,0.00097181794,0.000017744745,0.0011769269,0.0005308649,0.0031362537,0.00002681579,0.000051900177,0.004420991],"genre_scores_gemma":[0.99451536,0.0010954011,0.00006968747,0.00084613875,0.0002621066,0.0016375658,0.000010395219,0.000045828943,0.0015175152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965021,0.00062783645,0.0006131047,0.0008720459,0.00048691826,0.00089797337],"domain_scores_gemma":[0.99843264,0.0005036594,0.00008363184,0.00045064124,0.0002314709,0.0002979443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013260676,0.00029709507,0.000665994,0.0005495907,0.00015624109,0.00006079542,0.00025771649,0.00024543153,0.0002968278],"category_scores_gemma":[0.00018046732,0.00026659144,0.00013259993,0.0010876362,0.00029836904,0.0001918102,0.00012107261,0.0016751302,0.000011544655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004408918,0.0018840953,0.17942864,0.0007204752,0.00012290286,0.00110453,0.00091046526,0.002992457,0.78530294,0.00013994565,0.0011072346,0.021877412],"study_design_scores_gemma":[0.027443558,0.0039333347,0.4875073,0.0022937688,0.00014671289,0.0000056903878,0.0007383985,0.049326155,0.42523757,0.0006386464,0.0018744976,0.0008543587],"about_ca_topic_score_codex":0.0014311547,"about_ca_topic_score_gemma":0.0039205425,"teacher_disagreement_score":0.36006537,"about_ca_system_score_codex":0.001215169,"about_ca_system_score_gemma":0.0020178908,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W4409821254","doi":"10.1158/1538-7445.am2025-sy42-01","title":"Abstract SY42-01: Targeting fluidic force sensing mechanism to treat brain tumor metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Innovative Microfluidic and Catalytic Techniques Innovation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Metastasis; Mechanism (biology); Medicine; Brain metastasis; Cancer research; Cancer; Internal medicine; Physics","score_opus":0.038932468926418315,"score_gpt":0.3592816395036088,"score_spread":0.3203491705771905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.499037,0.0025681776,0.46448955,0.0029808907,0.0006070541,0.0012750222,0.00009459089,0.0009683189,0.027979411],"genre_scores_gemma":[0.99543357,0.00005417248,0.0018465369,0.0005264369,0.00014521414,0.000116383766,0.000031964384,0.000057383266,0.0017883164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981672,0.000050341227,0.0003755622,0.00035091504,0.00039314802,0.0006628379],"domain_scores_gemma":[0.99899524,0.00014518078,0.000024486893,0.0003386019,0.00042502407,0.00007144726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016648532,0.00020160875,0.0002424631,0.00074005505,0.00024198611,0.000091098016,0.0002802001,0.00008739997,0.0001880786],"category_scores_gemma":[0.00024956075,0.00020582079,0.00005201463,0.0023418781,0.000071967515,0.00013686164,0.0001418416,0.0005493396,0.00005428451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017339025,0.000006222987,0.000003913562,0.00019040912,0.00003271035,0.000016209835,0.00015859435,0.0000382216,0.8434785,0.009694725,0.11665231,0.029710863],"study_design_scores_gemma":[0.00018150013,0.000023802326,0.000038931652,0.00021242657,0.00000741068,0.000002452366,0.00035419883,0.00034679833,0.9664339,0.0025952451,0.02961858,0.00018478504],"about_ca_topic_score_codex":0.00016666067,"about_ca_topic_score_gemma":0.0000035546268,"teacher_disagreement_score":0.4963966,"about_ca_system_score_codex":0.0008440394,"about_ca_system_score_gemma":0.0001662223,"threshold_uncertainty_score":0.83931285},"labels":[],"label_agreement":null},{"id":"W4409821313","doi":"10.1158/1538-7445.am2025-lb148","title":"Abstract LB148: Perspectives of clinical trial staff on recruitment barriers to a multicenter randomized controlled colorectal polyp prevention trial","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Randomized controlled trial; Colorectal cancer; Clinical trial; Internal medicine; Oncology; Family medicine; Cancer","score_opus":0.20745593363582543,"score_gpt":0.5540534741086472,"score_spread":0.3465975404728218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94912505,0.0007218623,0.000010822756,0.0021253238,0.0015581521,0.034687042,0.000033338914,0.000039062426,0.011699344],"genre_scores_gemma":[0.9791225,0.0005164241,0.00007031693,0.0000832941,0.0005962615,0.014876009,0.000009490978,0.000025939968,0.0046997247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99382645,0.0020356027,0.0015139879,0.000760418,0.0012967215,0.00056681264],"domain_scores_gemma":[0.9933865,0.0046313996,0.00026262345,0.00042489578,0.0007000693,0.0005944753],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006870642,0.0002628059,0.002587686,0.0005585271,0.00014085199,0.0000421001,0.00021249235,0.00022529258,0.0023086749],"category_scores_gemma":[0.0152517995,0.00018219695,0.0012619477,0.0006597645,0.00047461764,0.000056481116,0.00012186011,0.0007408647,0.000031155934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9813562,0.0027134442,0.00022235613,0.00006121661,0.002024971,0.000031766525,0.0007999027,0.000007736033,0.00070639595,0.00023532643,0.00095332816,0.010887362],"study_design_scores_gemma":[0.9799589,0.012385141,0.0009016569,0.0005867025,0.0003388854,3.021692e-7,0.0013399929,0.00005194075,0.0029780203,0.000111059395,0.0012264354,0.000120979035],"about_ca_topic_score_codex":0.00036420368,"about_ca_topic_score_gemma":0.0001148086,"teacher_disagreement_score":0.029997488,"about_ca_system_score_codex":0.0011823389,"about_ca_system_score_gemma":0.002705362,"threshold_uncertainty_score":0.99860334},"labels":[],"label_agreement":null},{"id":"W4409821462","doi":"10.1158/1538-7445.am2025-lb059","title":"Abstract LB059: Fructose transporter (SLC2A5)-dependent regulation of STAT3 expression in cancer cells metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; University of Alberta","funders":"","keywords":"Metastasis; Cancer; Fructose; Transporter; Cancer research; Cancer cell; Glucose transporter; Biology; Medicine; Internal medicine; Biochemistry; Gene","score_opus":0.07298240855990548,"score_gpt":0.4384459709774019,"score_spread":0.36546356241749645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525786,0.00985728,0.00005984532,0.00070057594,0.00031576733,0.00073907396,0.00021892902,0.000021828673,0.002828863],"genre_scores_gemma":[0.99373245,0.0027490847,0.000086457956,0.000117728596,0.00012655616,0.00025636124,0.00003202537,0.000023751794,0.002875574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758875,0.0001214308,0.00046228827,0.00042066706,0.0009443178,0.000462549],"domain_scores_gemma":[0.99876904,0.00009627369,0.0000741325,0.00045600504,0.0003876505,0.0002168716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083503756,0.00015314543,0.00041375766,0.00061082083,0.00006133686,0.000020736856,0.00017214818,0.00011271253,0.0028738156],"category_scores_gemma":[0.000060361264,0.00012853961,0.00011773077,0.000694755,0.00014673693,0.00016153636,0.000043317646,0.00041786284,0.000012815146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021758277,0.0005458749,0.016151316,0.0012987035,0.00008621052,0.0000562924,0.0008237308,0.00037889727,0.93039554,0.000119286415,0.00799792,0.039970413],"study_design_scores_gemma":[0.0023211366,0.000037612925,0.38176745,0.00086110295,0.00007331354,2.0683989e-7,0.00050015416,0.000025586283,0.6077897,0.00035937605,0.0061584464,0.000105947336],"about_ca_topic_score_codex":0.0025639408,"about_ca_topic_score_gemma":0.0008783964,"teacher_disagreement_score":0.36561614,"about_ca_system_score_codex":0.0002426969,"about_ca_system_score_gemma":0.00097081275,"threshold_uncertainty_score":0.9980377},"labels":[],"label_agreement":null},{"id":"W4409821534","doi":"10.1158/1538-7445.am2025-lb037","title":"Abstract LB037: CD28 drives CAR T cell responses in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple myeloma; Medicine; Cancer research; Internal medicine","score_opus":0.10052210901345007,"score_gpt":0.4490982665798321,"score_spread":0.34857615756638205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502745,0.0037691307,0.0000040210703,0.003162273,0.00016364513,0.0011407372,0.000030329606,0.000055716777,0.041399624],"genre_scores_gemma":[0.8917468,0.00186073,0.0000610128,0.00017049085,0.00020531919,0.00040353052,0.000011324196,0.000042765856,0.10549799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99648243,0.00038065482,0.00035812406,0.0006165483,0.0011153657,0.0010468892],"domain_scores_gemma":[0.99697536,0.0014602749,0.000029688446,0.000799664,0.00046901352,0.00026601704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020532238,0.00018909015,0.0003911549,0.0013060392,0.0001901432,0.00007453417,0.0004272501,0.00019709431,0.0050330884],"category_scores_gemma":[0.00077259325,0.0001740574,0.0001201533,0.0017115852,0.00047675188,0.00009603504,0.00024953604,0.0015231863,0.00020405793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038966802,0.00023502174,0.10027845,0.00040499304,0.000049446535,0.00033190823,0.0005919769,0.000015272282,0.85360736,0.00006528921,0.010126315,0.030397277],"study_design_scores_gemma":[0.0037189098,0.00021493791,0.37581795,0.0004928588,0.000008579143,0.000004436001,0.0009649149,0.00009125465,0.46600947,0.00016157923,0.15234704,0.00016806356],"about_ca_topic_score_codex":0.0030782898,"about_ca_topic_score_gemma":0.0014168156,"teacher_disagreement_score":0.38759792,"about_ca_system_score_codex":0.0010047267,"about_ca_system_score_gemma":0.002011096,"threshold_uncertainty_score":0.99587643},"labels":[],"label_agreement":null},{"id":"W4409821538","doi":"10.1158/1538-7445.am2025-lb019","title":"Abstract LB019: LINC00152-regulated PDE4D mediates drug resistance and metastasis in highly aggressive breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Medicine; Breast cancer; Metastasis; Cancer; Oncology; Breast cancer metastasis; Drug resistance; Internal medicine; Cancer research; Pharmacology; Cancer metastasis; Biology; Microbiology","score_opus":0.017707904440830213,"score_gpt":0.3497996167201265,"score_spread":0.3320917122792963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696142,0.024413742,0.000009552536,0.004653887,0.0002762798,0.0002769195,0.00013603893,0.000013239292,0.0006061073],"genre_scores_gemma":[0.98335516,0.0072473474,0.00003757397,0.00016986905,0.00015163183,0.0001994391,0.000077639896,0.000017190046,0.0087441495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854463,0.00012999236,0.00022936975,0.00047109838,0.0002586493,0.00036628527],"domain_scores_gemma":[0.9991692,0.00005473037,0.00008068771,0.00028007056,0.00031535383,0.0000999596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048650586,0.00014632008,0.00017709867,0.00020536459,0.00015706458,0.000055731034,0.0001682612,0.00013601764,0.00013560246],"category_scores_gemma":[0.00009015164,0.00012800827,0.000040738007,0.0004746318,0.00025197706,0.00001227195,0.00014044179,0.00024514765,0.0000038012106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020140586,0.00014354225,0.023953421,0.00037625426,0.00029431976,0.000033755903,0.00031243422,0.00031568768,0.8483025,0.0003004597,0.08882154,0.035132017],"study_design_scores_gemma":[0.0023411443,0.000032063403,0.34412223,0.00084854575,0.00003256644,0.000004651203,0.0002859032,0.00008772415,0.5621715,0.0005777367,0.08910387,0.0003920468],"about_ca_topic_score_codex":0.00089449534,"about_ca_topic_score_gemma":0.006993359,"teacher_disagreement_score":0.3201688,"about_ca_system_score_codex":0.0001197544,"about_ca_system_score_gemma":0.0003742095,"threshold_uncertainty_score":0.5220025},"labels":[],"label_agreement":null},{"id":"W4409821598","doi":"10.1158/1538-7445.am2025-ct262","title":"Abstract CT262: Efficacy and safety of the combination PKMYT1-inhibitor lunresertib and ATR-inhibitor camonsertib in patients with ovarian and endometrial cancers: Phase I MYTHIC study (NCT04855656)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Concordia University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.030832429000582254,"score_gpt":0.3785195236069916,"score_spread":0.34768709460640934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935081,0.0016466785,0.0000069184084,0.0011532193,0.00026309493,0.0032322484,0.000043615193,0.000012339808,0.00013380995],"genre_scores_gemma":[0.99909145,0.00033664738,0.000014777523,0.00006930555,0.00011094199,0.00016222664,0.0000056771673,0.000023593997,0.00018537794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978213,0.00022655132,0.00037857273,0.0004788999,0.00073121587,0.00036348577],"domain_scores_gemma":[0.99867946,0.00036771345,0.000095760566,0.00035869732,0.00035332967,0.00014501238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011283486,0.00018423272,0.0004296704,0.00048105398,0.00022901238,0.000056987632,0.0001177957,0.000101037265,0.000057509253],"category_scores_gemma":[0.00029129878,0.00012589051,0.000030909498,0.0010983846,0.0002983536,0.00011312013,0.0001404087,0.00056155154,2.760795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0874966,0.0041787224,0.76965,0.0009542288,0.00062832533,0.000035405577,0.0053387675,0.000013298086,0.036297917,0.0006487939,0.00073218805,0.09402578],"study_design_scores_gemma":[0.079136446,0.003573361,0.904271,0.0011339402,0.00007184885,0.0000011266284,0.00077826757,0.000043913846,0.010207376,0.0001260336,0.00050418876,0.00015251385],"about_ca_topic_score_codex":0.004234299,"about_ca_topic_score_gemma":0.002525012,"teacher_disagreement_score":0.13462102,"about_ca_system_score_codex":0.00045681238,"about_ca_system_score_gemma":0.00073939457,"threshold_uncertainty_score":0.6401022},"labels":[],"label_agreement":null},{"id":"W4409821748","doi":"10.1158/1538-7445.am2025-ct204","title":"Abstract CT204: Phase 1a/b study of runimotamab, a HER2 x CD3 T cell-engaging bispecific antibody, administered as a single agent and in combination with trastuzumab in patients with HER2-expressing breast cancer (BC)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Trastuzumab; Bispecific antibody; Medicine; Antibody; Internal medicine; Oncology; Cancer; Monoclonal antibody; Immunology; Breast cancer","score_opus":0.05858182442711424,"score_gpt":0.4142998698667913,"score_spread":0.35571804543967706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512315,0.00068986014,0.0000031241113,0.0009267049,0.000042803586,0.0018485923,0.000057960944,0.0000131265515,0.0012946884],"genre_scores_gemma":[0.9985775,0.0002614819,0.000030867424,0.00003539884,0.000032358366,0.00020288116,0.000035556437,0.000035080768,0.00078890007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675965,0.00028502417,0.00045681564,0.0006021026,0.0012330337,0.00066335313],"domain_scores_gemma":[0.9986406,0.00021750868,0.000103523416,0.00031555863,0.0005261225,0.00019666982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068484264,0.00024587434,0.0005238044,0.0009084847,0.0002021336,0.00008785768,0.00020161203,0.00008053705,0.00020082893],"category_scores_gemma":[0.000031762127,0.00018501411,0.0000321699,0.0013164192,0.00034211518,0.00016575953,0.00014844268,0.0009175469,0.0000023678062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02309243,0.01215672,0.91166157,0.0012384551,0.00013358856,0.0002983087,0.0041114828,0.00005874781,0.022282403,0.000011508239,0.00012078819,0.024833983],"study_design_scores_gemma":[0.02173316,0.0043938127,0.95985675,0.0032046845,0.000028846258,0.0000057021866,0.0046918453,0.00014943119,0.0054228776,0.000014753724,0.0002978071,0.00020032995],"about_ca_topic_score_codex":0.01887972,"about_ca_topic_score_gemma":0.0057121357,"teacher_disagreement_score":0.048195165,"about_ca_system_score_codex":0.00059541845,"about_ca_system_score_gemma":0.00085678475,"threshold_uncertainty_score":0.9876537},"labels":[],"label_agreement":null},{"id":"W4409821756","doi":"10.1158/1538-7445.am2025-ct205","title":"Abstract CT205: Updated clinical results, recommended phase 2 dose (RP2D) determination and translational study results for START-001: A phase 1/2 trial of invikafusp alfa, a first-in-class TCR b chain-targeted bispecific antibody in patients with anti-PD(L)1-resistant, antigen-rich solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Oncology; Internal medicine","score_opus":0.10215883900683077,"score_gpt":0.48073573077471016,"score_spread":0.3785768917678794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853335,0.00038229863,0.000005972684,0.0034962164,0.00018406432,0.007297394,0.0028046765,0.000024766478,0.00047108866],"genre_scores_gemma":[0.9955657,0.00065940956,0.00010761591,0.000056282246,0.00015038392,0.00037396632,0.0025323024,0.000043051557,0.00051127735],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9935652,0.0004918659,0.0022330773,0.0011785893,0.0015207713,0.0010104812],"domain_scores_gemma":[0.99568623,0.001870009,0.00035264503,0.00056796044,0.0012341143,0.00028901052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005445714,0.00038837318,0.0011889155,0.0016244524,0.00030061408,0.00007448294,0.0003541613,0.00024296217,0.000087615896],"category_scores_gemma":[0.0011418298,0.00031741947,0.00013248075,0.002003374,0.0004772975,0.00022518549,0.000120033896,0.0011433807,0.0000028924076],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84750175,0.024986392,0.0822591,0.00057593203,0.00034738448,0.0002383571,0.001106107,0.000019907056,0.004233184,0.000031676715,0.003585779,0.03511444],"study_design_scores_gemma":[0.4398732,0.0128202345,0.5350136,0.0008497242,0.000051747735,0.0000011749053,0.00045000616,0.001855717,0.0017592825,0.000058041373,0.006938449,0.00032880067],"about_ca_topic_score_codex":0.0012444283,"about_ca_topic_score_gemma":0.004070972,"teacher_disagreement_score":0.45275453,"about_ca_system_score_codex":0.00021889925,"about_ca_system_score_gemma":0.0012011086,"threshold_uncertainty_score":0.99992776},"labels":[],"label_agreement":null},{"id":"W4409821785","doi":"10.1158/1538-7445.am2025-ct239","title":"Abstract CT239: IND.241: A Canadian cancer trials group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Society for Arts and Technology; Hamilton Health Sciences; Queen's University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Interior Health; Queen Elizabeth II Health Sciences Centre; Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Cancer; Oncology; Breast cancer; Internal medicine; Clinical trial; Randomized controlled trial","score_opus":0.16135548478936873,"score_gpt":0.4902675803125865,"score_spread":0.32891209552321776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592164,0.0079683,0.000017439947,0.016628014,0.0016951375,0.009877412,0.002503922,0.00010703148,0.0019863546],"genre_scores_gemma":[0.96990067,0.0024284157,0.00031864803,0.0013206501,0.001646883,0.019870283,0.00010510678,0.00015981052,0.004249521],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99215406,0.00049018854,0.0018058826,0.0012726921,0.0018224829,0.0024547034],"domain_scores_gemma":[0.99508595,0.0010764954,0.00032100084,0.0010842432,0.0009958079,0.001436513],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042483406,0.0007644504,0.0020467641,0.0025422713,0.00045162483,0.0001842815,0.0005914856,0.0003225236,0.005032357],"category_scores_gemma":[0.00097562256,0.0006122023,0.0003936133,0.0031498224,0.00037928356,0.0004385013,0.00015476052,0.0011036831,0.000076576835],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.5677115,0.0010674482,0.002247439,0.0013825512,0.002858492,0.00072696415,0.0051167514,0.00091640063,0.064392835,0.0005602077,0.0072813206,0.34573814],"study_design_scores_gemma":[0.35848483,0.008441543,0.12346696,0.016429702,0.0014804793,0.000100224905,0.007052876,0.0001819152,0.049148146,0.0017177602,0.43041417,0.0030813816],"about_ca_topic_score_codex":0.5559891,"about_ca_topic_score_gemma":0.7944316,"teacher_disagreement_score":0.42313287,"about_ca_system_score_codex":0.023042422,"about_ca_system_score_gemma":0.024699792,"threshold_uncertainty_score":0.99963295},"labels":[],"label_agreement":null},{"id":"W4409821972","doi":"10.1158/1538-7445.am2025-ct157","title":"Abstract CT157: Phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody, in patients with colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bispecific antibody; Medicine; Colorectal cancer; Antibody; Oncology; Internal medicine; Cancer; Cancer research; Monoclonal antibody; Immunology","score_opus":0.05752751205684187,"score_gpt":0.4536311384396099,"score_spread":0.396103626382768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931281,0.0010069725,0.0000040746695,0.00048131484,0.00012451767,0.002105952,0.000088793124,0.000021054648,0.0030391794],"genre_scores_gemma":[0.99759877,0.00044590898,0.000023310507,0.000030254694,0.00012281931,0.00028219685,0.00008484232,0.00003078589,0.0013811282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964761,0.00023817286,0.00049916666,0.0005699866,0.0014983237,0.0007182485],"domain_scores_gemma":[0.99818105,0.00034566925,0.00008994487,0.0003364217,0.0008548703,0.00019203733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093999534,0.00021748197,0.000497592,0.00094774424,0.00025326724,0.00004340191,0.0002836944,0.000109068555,0.00067248463],"category_scores_gemma":[0.00008194167,0.00016573025,0.000064967,0.0018400837,0.0002884236,0.00013970009,0.00020398574,0.0012278646,0.000014557621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009801352,0.004810006,0.9205643,0.0006290878,0.0001502782,0.000071053015,0.0013503754,0.00011435978,0.044243038,0.000025280046,0.00096308393,0.017277775],"study_design_scores_gemma":[0.012164944,0.001907519,0.96923167,0.000771061,0.000030678202,4.5698712e-7,0.00094725454,0.00026757628,0.013449451,0.000018710514,0.0010529816,0.00015768419],"about_ca_topic_score_codex":0.0087262085,"about_ca_topic_score_gemma":0.0022982722,"teacher_disagreement_score":0.04866737,"about_ca_system_score_codex":0.00048186327,"about_ca_system_score_gemma":0.0009892298,"threshold_uncertainty_score":0.9978748},"labels":[],"label_agreement":null},{"id":"W4409821988","doi":"10.1158/1538-7445.am2025-ct196","title":"Abstract CT196: Phase 1 dose escalation and expansion study of the PTK7-targeted antibody-drug conjugate DAY301 in patients with locally advanced or metastatic solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Antibody-drug conjugate; Medicine; Conjugate; Antibody; Drug; Solid tumor; Cancer research; Oncology; Cancer; Internal medicine; Monoclonal antibody; Pharmacology; Immunology","score_opus":0.038737851740446264,"score_gpt":0.43292732283879937,"score_spread":0.3941894710983531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605626,0.0007133616,0.0000028325812,0.00029123854,0.00006215988,0.0026753657,0.000028412074,0.000010118702,0.00016024789],"genre_scores_gemma":[0.99913156,0.00019220685,0.000019454852,0.00003789884,0.000009088356,0.00027211747,0.000013343346,0.000013427875,0.00031088776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838954,0.000121096746,0.0003131927,0.00032262597,0.0005709162,0.0002826407],"domain_scores_gemma":[0.9990477,0.0001500884,0.00008061939,0.00025709893,0.00040068713,0.000063789565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032073437,0.00014418294,0.00039466648,0.00019794608,0.00016459165,0.0000165365,0.00008953367,0.000020312185,0.000051225776],"category_scores_gemma":[0.00012946609,0.00007607242,0.000025222345,0.00078630587,0.000190506,0.00009125665,0.0001078649,0.00026038138,6.435943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038939502,0.006121249,0.85267895,0.0006655165,0.00057502586,0.000090107555,0.006249751,0.0003038965,0.010771874,0.000010147898,0.0002190046,0.083374985],"study_design_scores_gemma":[0.021444336,0.0027517758,0.96828866,0.0008649008,0.00007602265,3.7758582e-7,0.0027404171,0.00011074554,0.0035799204,0.000020775502,0.00004414246,0.000077932826],"about_ca_topic_score_codex":0.0011328851,"about_ca_topic_score_gemma":0.0025125153,"teacher_disagreement_score":0.11560972,"about_ca_system_score_codex":0.00023201168,"about_ca_system_score_gemma":0.00044697692,"threshold_uncertainty_score":0.31021434},"labels":[],"label_agreement":null},{"id":"W4409822007","doi":"10.1158/1538-7445.am2025-ct251","title":"Abstract CT251: Phase 3 INTerpath-009 study: Individualized neoantigen therapy V940 (mRNA-4157) plus pembrolizumab for resected stage II-IIIB (N2) NSCLC with incomplete pathological response to neoadjuvant immunochemotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Neoadjuvant therapy; Cancer; Immunotherapy; Biology; Breast cancer","score_opus":0.10595116221389714,"score_gpt":0.46931895725833533,"score_spread":0.36336779504443817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97885454,0.004384932,0.00035274008,0.00580879,0.00027425934,0.008950412,0.00046548102,0.00020650163,0.0007023529],"genre_scores_gemma":[0.984542,0.0013673567,0.0005363306,0.0019123305,0.00023547636,0.0031881856,0.0000856619,0.00013214863,0.00800047],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938325,0.0009311501,0.00094488764,0.0013408958,0.0014713815,0.0014791762],"domain_scores_gemma":[0.9960324,0.0009361176,0.00020437216,0.0013435957,0.0010951222,0.00038837275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047346847,0.00061233196,0.0011677839,0.001260619,0.0009970022,0.0002432792,0.0010074957,0.0003109802,0.00193061],"category_scores_gemma":[0.00043872977,0.0004482985,0.00032307458,0.002222683,0.000606592,0.00016488027,0.0003165387,0.0011740106,0.00001983093],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44452572,0.001535691,0.0008025155,0.00010047978,0.0008784521,0.0002685651,0.0053508403,0.0000068888744,0.44442824,0.000016534412,0.0038356634,0.09825041],"study_design_scores_gemma":[0.25138423,0.053715914,0.17073755,0.0024042802,0.0001526314,0.000065023705,0.0081038615,0.00012119766,0.106610745,0.00015377539,0.40516064,0.0013901631],"about_ca_topic_score_codex":0.0015010539,"about_ca_topic_score_gemma":0.00044519643,"teacher_disagreement_score":0.40132496,"about_ca_system_score_codex":0.0014923232,"about_ca_system_score_gemma":0.0030763336,"threshold_uncertainty_score":0.99979687},"labels":[],"label_agreement":null},{"id":"W4409822021","doi":"10.1158/1538-7445.am2025-ct198","title":"Abstract CT198: A first-in-human study evaluating safety, tolerability and efficacy of TEV-56278, as monotherapy and in combination with pembrolizumab in participants with locally advanced or metastatic solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Tolerability; Medicine; Oncology; Solid tumor; Internal medicine; Response Evaluation Criteria in Solid Tumors; Medical physics; Adverse effect; Cancer; Clinical trial; Immunotherapy; Phases of clinical research","score_opus":0.09054043081958066,"score_gpt":0.47378039338914774,"score_spread":0.38323996256956705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950552,0.00096583884,0.0000066016396,0.0006715655,0.000010749008,0.0031709168,0.000004106019,0.000008958671,0.000106090105],"genre_scores_gemma":[0.9988747,0.00036101858,0.00007972233,0.000042597163,0.000005019714,0.00053127616,0.0000029845542,0.000018851793,0.000083785744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768555,0.00027591514,0.00058697816,0.00046050272,0.0005593118,0.00043176505],"domain_scores_gemma":[0.9988061,0.0005325355,0.00010093875,0.00027776146,0.00020776507,0.00007489812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023341603,0.0001672333,0.0005729294,0.00046427033,0.00009230468,0.000027864122,0.000100642625,0.00004006874,0.000074405725],"category_scores_gemma":[0.00022132679,0.000116718445,0.000018010927,0.0010821722,0.00034629068,0.00011827096,0.000039910752,0.00038917654,2.0222268e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19334102,0.0032238462,0.6769013,0.0010918358,0.00024217632,0.00016119066,0.009355024,0.0012383262,0.022890095,0.000016103493,0.000004266426,0.091534816],"study_design_scores_gemma":[0.050001714,0.0063257418,0.9319836,0.0026151591,0.00002635358,0.000004822327,0.0040151547,0.0008278988,0.0039794357,0.00008645554,0.00000858601,0.00012509443],"about_ca_topic_score_codex":0.006249073,"about_ca_topic_score_gemma":0.038117908,"teacher_disagreement_score":0.25508228,"about_ca_system_score_codex":0.00051855337,"about_ca_system_score_gemma":0.00094358245,"threshold_uncertainty_score":0.97943395},"labels":[],"label_agreement":null},{"id":"W4409822055","doi":"10.1158/1538-7445.am2025-ct148","title":"Abstract CT148: Phase 1 study of the anti-immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830 plus pembrolizumab plus chemotherapy in patients with advanced solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Pembrolizumab; Medicine; Monoclonal antibody; Chemotherapy; Antibody; Pharmacokinetics; Internal medicine; Oncology; Cancer research; Pharmacology; Immunotherapy; Cancer; Immunology","score_opus":0.031174710965164075,"score_gpt":0.4027522681327222,"score_spread":0.37157755716755814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267346,0.0021861747,0.000010605891,0.0007554248,0.00035964622,0.0034556908,0.00009784888,0.000030996325,0.00043018354],"genre_scores_gemma":[0.99795353,0.0006180163,0.000018000794,0.00030173536,0.00005192256,0.0002623567,0.000030918112,0.00005281095,0.0007107265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99641514,0.00018529315,0.00070950517,0.0006231339,0.0013070576,0.00075986783],"domain_scores_gemma":[0.9982247,0.00009731391,0.00016392153,0.0008958391,0.0005109864,0.00010723915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006692195,0.00032709553,0.00076783786,0.00045361774,0.00024022335,0.000035551766,0.00062138983,0.00012459168,0.00030618583],"category_scores_gemma":[0.00003348547,0.00022275292,0.00016490452,0.0018080169,0.00048459476,0.00015251331,0.000078571145,0.0008891382,0.0000029611197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25848562,0.012325089,0.2930505,0.0011840177,0.0019743124,0.00012600765,0.0104138395,0.0008631687,0.34375197,0.00001964877,0.0020448687,0.075760946],"study_design_scores_gemma":[0.1018274,0.0029935993,0.8681705,0.0013566825,0.000056014742,0.0000029193725,0.0019737186,0.00008169252,0.021142108,0.000011581049,0.0021243806,0.0002593771],"about_ca_topic_score_codex":0.002417422,"about_ca_topic_score_gemma":0.0004778782,"teacher_disagreement_score":0.57512003,"about_ca_system_score_codex":0.0011333814,"about_ca_system_score_gemma":0.0021145814,"threshold_uncertainty_score":0.90836006},"labels":[],"label_agreement":null},{"id":"W4409822066","doi":"10.1158/1538-7445.am2025-ct195","title":"Abstract CT195: A phase 1 dose escalation/expansion study of GSK5764227, a B7-homolog 3 protein targeted antibody-drug conjugate, in combination with standard of care in patients with advanced solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Antibody-drug conjugate; Conjugate; Standard of care; Medicine; Antibody; Drug; Cancer research; Solid tumor; Cancer; Oncology; Pharmacology; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.022690009711956734,"score_gpt":0.4296070132920876,"score_spread":0.4069170035801309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990719,0.0004526003,0.000009721615,0.00022168843,0.00003350125,0.00809785,0.0001173052,0.000021709478,0.0003266134],"genre_scores_gemma":[0.9985295,0.000044931377,0.00011056927,0.000009798451,0.00001089646,0.0010228829,0.00012603424,0.0000438962,0.00010150631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955715,0.0004050996,0.0007577796,0.00061553216,0.002019344,0.00063076086],"domain_scores_gemma":[0.99641913,0.00015754286,0.00019397607,0.000588889,0.0024944276,0.00014605885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012446395,0.00023108964,0.0008072586,0.0013295515,0.00008676103,0.000020859014,0.0002758235,0.00010094194,0.00010941829],"category_scores_gemma":[0.00033207957,0.00018291338,0.000036023648,0.002804086,0.00038923824,0.00020435058,0.00012439427,0.00097197696,0.0000014911659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075172916,0.0069112116,0.8424975,0.0034035372,0.00012363635,0.0001759849,0.009480844,0.00087519205,0.04090972,0.000042845382,0.00007932887,0.020327274],"study_design_scores_gemma":[0.06097541,0.020533286,0.8202302,0.00743585,0.000023012282,5.23648e-7,0.008882475,0.000121087935,0.08145951,0.00005497372,0.000058498885,0.00022521432],"about_ca_topic_score_codex":0.0036736627,"about_ca_topic_score_gemma":0.0063285735,"teacher_disagreement_score":0.04054979,"about_ca_system_score_codex":0.001532476,"about_ca_system_score_gemma":0.0025848707,"threshold_uncertainty_score":0.74589914},"labels":[],"label_agreement":null},{"id":"W4409822072","doi":"10.1158/1538-7445.am2025-ct188","title":"Abstract CT188: BEHOLD-1: A Phase 1 Dose Escalation Study of GSK5733584, a B7-H4-Targeted Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors, Including Dose Expansion in Patients With Endometrial and Platinum-Resistant Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Princess Margaret Cancer Centre; University of Toronto; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Antibody-drug conjugate; Behold; Conjugate; Drug; Radioimmunotherapy; Solid tumor; Oncology; Internal medicine; Cancer; Antibody; Monoclonal antibody; Pharmacology; Immunology; Chemistry","score_opus":0.022515895903157956,"score_gpt":0.3659990951510461,"score_spread":0.34348319924788817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668753,0.0006590737,0.00001254596,0.000027964732,0.00010089964,0.0021548716,0.00030684052,0.00000575668,0.00004451516],"genre_scores_gemma":[0.9989391,0.00026879797,0.00007168194,0.000024402128,0.000050000144,0.00031131145,0.0002849509,0.000034909408,0.000014832833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976073,0.00013648432,0.00055755704,0.00067378784,0.00053273846,0.0004921351],"domain_scores_gemma":[0.9986982,0.00012779195,0.00020407561,0.00037035902,0.0004826628,0.000116943185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005139159,0.0002482883,0.00042852716,0.0005554706,0.00013807749,0.000052131443,0.0002042464,0.00010640045,0.000019044171],"category_scores_gemma":[0.00023187086,0.00021502946,0.000026081945,0.0009834507,0.00014357272,0.00002888961,0.00023655772,0.00032461307,2.2458609e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030082194,0.0026770183,0.82603425,0.00015042954,0.00012098461,0.000013871113,0.0007126927,0.002620747,0.12952004,0.0000088964225,0.0000685139,0.0079903575],"study_design_scores_gemma":[0.046397336,0.0031569356,0.9267555,0.0005429721,0.0000247652,7.039975e-8,0.00039379075,0.00006902425,0.02230076,0.00001697103,0.00006726487,0.0002745953],"about_ca_topic_score_codex":0.0039814264,"about_ca_topic_score_gemma":0.008263522,"teacher_disagreement_score":0.10721928,"about_ca_system_score_codex":0.00026154268,"about_ca_system_score_gemma":0.00060065545,"threshold_uncertainty_score":0.87686473},"labels":[],"label_agreement":null},{"id":"W4409822130","doi":"10.1158/1538-7445.am2025-ct074","title":"Abstract CT074: Discovery and preliminary clinical findings of MK-6598, a potent and selective inhibitor of the immune checkpoint IL4I1","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Pharmacology; Immune checkpoint; Biology; Medicine; Immunology; Immunotherapy","score_opus":0.053503192831385375,"score_gpt":0.4208308633784346,"score_spread":0.36732767054704923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804458,0.014858532,0.0000039281085,0.0030603271,0.00016131815,0.00066447566,0.000026352183,0.000005062485,0.00077422656],"genre_scores_gemma":[0.99332345,0.0049275397,0.000018374481,0.00006597293,0.00006707973,0.00004204758,0.0000014963492,0.000010407287,0.001543638],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998567,0.00011803335,0.00046335702,0.00026562644,0.00035621593,0.00022976003],"domain_scores_gemma":[0.99900794,0.0003444109,0.000090637324,0.0002761631,0.0002293338,0.000051519277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012555587,0.00009900488,0.0003273535,0.00013631309,0.000090464,0.000017884466,0.00012355589,0.00011170736,0.000026792472],"category_scores_gemma":[0.00025974022,0.0000645399,0.00013116201,0.00045037363,0.0010002435,0.00007146475,0.00020620125,0.0004940562,3.623726e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021521313,0.00044512,0.12719914,0.0014557188,0.00067966065,0.000011482177,0.0011036195,9.792452e-7,0.7771785,0.000113754024,0.0035066279,0.066784024],"study_design_scores_gemma":[0.001861907,0.00056446396,0.71248245,0.0010727285,0.00003654455,0.000005861772,0.00037366635,0.000007348099,0.28283536,0.00009230163,0.00062042597,0.00004693368],"about_ca_topic_score_codex":0.0011676295,"about_ca_topic_score_gemma":0.00005250913,"teacher_disagreement_score":0.58528334,"about_ca_system_score_codex":0.00013928748,"about_ca_system_score_gemma":0.0006645039,"threshold_uncertainty_score":0.36854386},"labels":[],"label_agreement":null},{"id":"W4409822141","doi":"10.1158/1538-7445.am2025-ct073","title":"Abstract CT073: A first-in-human study of oral TNO155 (batoprotafib) alone and in combination with EGF816 (nazartinib) in adult patients with advanced solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Solid tumor; Medicine; Cancer; Internal medicine; Gerontology; Oncology","score_opus":0.021826099649434647,"score_gpt":0.41343379946459047,"score_spread":0.3916076998151558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604774,0.00011978911,0.0000012658342,0.0004588527,0.000016487826,0.0027723538,0.000010474203,0.000008808736,0.00056421827],"genre_scores_gemma":[0.998605,0.000037027992,0.000052119758,0.00002180126,0.0000039553042,0.0010782856,0.000023808527,0.000015980264,0.00016201641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985195,0.000058385092,0.00031725553,0.00033924426,0.0004509002,0.00031476165],"domain_scores_gemma":[0.9991925,0.00006461044,0.000066552115,0.00021144886,0.00039969332,0.00006518983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024084022,0.00012262109,0.00034198494,0.00055708503,0.00007348391,0.00001608342,0.00007265593,0.00003843394,0.000026875869],"category_scores_gemma":[0.000052710013,0.00009104431,0.000010657899,0.0009849106,0.00011219119,0.00013600483,0.00003775324,0.00030482397,6.226843e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002096606,0.003106992,0.9863106,0.0002839323,0.000060902945,0.00006674182,0.0029468825,0.00033125014,0.00018399063,0.000055789857,0.000025400133,0.004530928],"study_design_scores_gemma":[0.026617689,0.0021583757,0.9663341,0.0015237989,0.000022765256,4.366587e-7,0.0023638569,0.000056102144,0.00075473107,0.00006333591,0.00002298719,0.000081813516],"about_ca_topic_score_codex":0.008081001,"about_ca_topic_score_gemma":0.0630185,"teacher_disagreement_score":0.0549375,"about_ca_system_score_codex":0.00050442194,"about_ca_system_score_gemma":0.00035836012,"threshold_uncertainty_score":0.99852425},"labels":[],"label_agreement":null},{"id":"W4409822152","doi":"10.1158/1538-7445.am2025-ct112","title":"Abstract CT112: Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of FXX489 ([<i>177</i>Lu]Lu-NNS309) in patients with pancreatic, lung, breast and colorectal cancers","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tolerability; Medicine; Dosimetry; Nuclear medicine; Breast cancer; Oncology; Internal medicine; Radiology; Adverse effect; Cancer","score_opus":0.08399891952655011,"score_gpt":0.48553901308736036,"score_spread":0.4015400935608102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927264,0.00026986297,0.000008951641,0.0018101471,0.000021148287,0.0044904053,0.00022742023,0.000009439809,0.00043625105],"genre_scores_gemma":[0.99875325,0.000106843414,0.000035186225,0.00009360618,0.000024104458,0.0008118869,0.000012535405,0.00001572045,0.00014686385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811655,0.00018698069,0.00028706985,0.0005350043,0.00050164544,0.0003727319],"domain_scores_gemma":[0.99864113,0.00036747722,0.000044698027,0.0004143296,0.000294762,0.00023760008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010253103,0.00017445798,0.00039482443,0.00010024111,0.00020333136,0.00005371942,0.00028872854,0.00005504175,0.00007075836],"category_scores_gemma":[0.00012167055,0.000119336175,0.000016447935,0.0006999274,0.00042610016,0.00010649811,0.00043035173,0.0005705898,8.6552876e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033257958,0.013184708,0.8719868,0.0006742621,0.00032170967,0.000011516647,0.0010926941,0.000025510386,0.0349904,0.000008105677,0.0005456748,0.043900665],"study_design_scores_gemma":[0.028017292,0.0014248443,0.94632804,0.00043875215,0.00012881708,0.0000034702668,0.00058200664,0.0007207045,0.022130981,0.0000070546253,0.00008548867,0.00013252415],"about_ca_topic_score_codex":0.0017766252,"about_ca_topic_score_gemma":0.0002966688,"teacher_disagreement_score":0.07434127,"about_ca_system_score_codex":0.000481812,"about_ca_system_score_gemma":0.00047778283,"threshold_uncertainty_score":0.4866388},"labels":[],"label_agreement":null},{"id":"W4409822191","doi":"10.1158/1538-7445.am2025-ct094","title":"Abstract CT094: Durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Outcomes by PD-L1 expression in ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Chemoradiotherapy; Placebo; Cancer; Pathology; Immunotherapy; Biology","score_opus":0.04740485122507896,"score_gpt":0.4421369264632889,"score_spread":0.3947320752382099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92162585,0.061845355,0.000018035724,0.00916447,0.0005136695,0.0037656813,0.0002022269,0.00007879902,0.0027859376],"genre_scores_gemma":[0.95129097,0.020316754,0.00006850521,0.0008452338,0.00018665544,0.0069248574,0.000034374425,0.000102858896,0.020229788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941517,0.0004620376,0.00087111164,0.0011912198,0.0015159837,0.0018079609],"domain_scores_gemma":[0.997241,0.00091354654,0.00013042253,0.0009073471,0.00041938553,0.00038830686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019275573,0.0005268767,0.0012130978,0.0012150668,0.00018884438,0.000130306,0.0006431382,0.00029890792,0.0021361813],"category_scores_gemma":[0.0005004543,0.00043912724,0.00019193966,0.0017456677,0.00043437455,0.00019549314,0.0004529551,0.002281477,0.000032609678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008014832,0.0011319066,0.7944107,0.0061646183,0.00036042006,0.00042367095,0.0035713683,0.00012411702,0.08026955,0.000026005564,0.096356854,0.009145962],"study_design_scores_gemma":[0.03564249,0.00043457787,0.77710783,0.010130073,0.000089031244,0.0000021307123,0.0012610293,0.0014474872,0.09923765,0.000040142244,0.07359403,0.0010135205],"about_ca_topic_score_codex":0.007948315,"about_ca_topic_score_gemma":0.007421459,"teacher_disagreement_score":0.0415286,"about_ca_system_score_codex":0.0053079557,"about_ca_system_score_gemma":0.0023803439,"threshold_uncertainty_score":0.99980605},"labels":[],"label_agreement":null},{"id":"W4409822192","doi":"10.1158/1538-7445.am2025-ct039","title":"Abstract CT039: Results of a first-in-human phase 1 trial of anchored IL-12 drug conjugate (ANK-101)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Conjugate; Medicine; Drug; Pharmacology; Computational biology; Biology; Mathematics","score_opus":0.07401649993922951,"score_gpt":0.4467763592428601,"score_spread":0.37275985930363054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318964,0.0017357452,0.0000014842255,0.0028073068,0.00029564896,0.0014170778,0.00024488522,0.00001639901,0.010291834],"genre_scores_gemma":[0.9946025,0.0013092986,0.000014557206,0.00006189753,0.00017722577,0.00017271773,0.000033718297,0.000018121176,0.003609933],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975618,0.00012803404,0.00081196916,0.00037999146,0.0006683479,0.0004498718],"domain_scores_gemma":[0.99847955,0.00032024935,0.0001577675,0.00059502857,0.0003513642,0.00009602379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002256215,0.00014527702,0.00052671065,0.0005867309,0.000089194415,0.0000155419,0.0002707827,0.000117197844,0.00042117195],"category_scores_gemma":[0.00029015657,0.00012649229,0.0001696347,0.00088403013,0.0005299861,0.000065440916,0.00006692297,0.00047472105,0.0000029189723],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5292449,0.0013841095,0.0012171174,0.0010592716,0.0003361025,0.000054337957,0.0014791648,0.00000647873,0.40590322,0.000093881055,0.037099894,0.022121528],"study_design_scores_gemma":[0.42227757,0.0023963547,0.017569242,0.0030695542,0.00006160513,0.0000016898316,0.00076659536,0.0000415674,0.4586439,0.00025999648,0.094688594,0.00022330652],"about_ca_topic_score_codex":0.0076700905,"about_ca_topic_score_gemma":0.002649607,"teacher_disagreement_score":0.10696732,"about_ca_system_score_codex":0.000363169,"about_ca_system_score_gemma":0.0008319726,"threshold_uncertainty_score":0.9989379},"labels":[],"label_agreement":null},{"id":"W4409822224","doi":"10.1158/1538-7445.am2025-ct128","title":"Abstract CT128: RADIANT: A window of opportunity trial exploring preoperative immunomodulatory radiotherapy and durvalumab prior to radical cystectomy in patients with cisplatin-ineligible muscle-invasive bladder carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Alberta Cancer Foundation; Juravinski Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cystectomy; Durvalumab; Medicine; Cisplatin; Urology; Bladder cancer; Radiation therapy; Carcinoma; Surgery; Chemotherapy; Internal medicine; Cancer; Immunotherapy","score_opus":0.0753871562874924,"score_gpt":0.3679530494545817,"score_spread":0.29256589316708925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928908,0.0016626599,0.0000083025925,0.00041392713,0.00014120845,0.0041259695,0.000071334995,0.000020024603,0.00066579506],"genre_scores_gemma":[0.997686,0.00038259185,0.0001410294,0.0001380003,0.00013036132,0.0012167075,0.00001631534,0.000043582022,0.00024538944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974192,0.00020612654,0.0004640086,0.00058825174,0.00075320475,0.0005692106],"domain_scores_gemma":[0.99834895,0.00029624472,0.000072557246,0.00047633823,0.00042607283,0.00037981302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537735,0.00026501232,0.0006347046,0.00068555574,0.00016495564,0.000039279344,0.00017887581,0.00011930232,0.00024311441],"category_scores_gemma":[0.00023780261,0.00021095487,0.00007228266,0.0008193807,0.00029238657,0.00020384294,0.000081685794,0.0005602611,0.0000028208844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.144923,0.0016741006,0.79134774,0.000901145,0.001015181,0.00019129591,0.008375993,0.000058004814,0.012918754,0.00007791129,0.0005891468,0.037927732],"study_design_scores_gemma":[0.088263474,0.0024935047,0.89710957,0.00084221014,0.000056809713,0.0000017697564,0.00040075387,0.0000073688775,0.010352524,0.000015198544,0.0002794812,0.0001773323],"about_ca_topic_score_codex":0.002606046,"about_ca_topic_score_gemma":0.00031585954,"teacher_disagreement_score":0.10576183,"about_ca_system_score_codex":0.00084053614,"about_ca_system_score_gemma":0.0028738617,"threshold_uncertainty_score":0.860249},"labels":[],"label_agreement":null},{"id":"W4409822249","doi":"10.1158/1538-7445.am2025-ct097","title":"Abstract CT097: Associations between percent residual viable tumor (%RVT) and efficacy with perioperative nivolumab (NIVO) for resectable NSCLC in CheckMate 77T","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nivolumab; Medicine; Perioperative; Oncology; Internal medicine; Surgery; Cancer; Immunotherapy","score_opus":0.08282382705091229,"score_gpt":0.44174107134448615,"score_spread":0.35891724429357386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98155093,0.0012797829,0.0000075073976,0.0031168032,0.000052941527,0.0024903184,0.0002203961,0.000041194635,0.0112401005],"genre_scores_gemma":[0.99048847,0.00020332984,0.00020233462,0.00008037507,0.00015710943,0.0012540574,0.000073059,0.00003674925,0.00750451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974873,0.00013557021,0.00032758605,0.00062186806,0.0006310033,0.00079668034],"domain_scores_gemma":[0.9980651,0.00081540726,0.000053766442,0.00030097514,0.0005544588,0.00021029676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094895746,0.0002053199,0.0005567932,0.00037148097,0.0003858682,0.00011100134,0.00014910246,0.00011188958,0.00025818357],"category_scores_gemma":[0.00050762563,0.00016633532,0.00005777748,0.0010018348,0.0002365707,0.00014779367,0.00012888871,0.00069929933,0.000011844944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016431924,0.001450896,0.9259101,0.001177165,0.0013259624,0.0003260193,0.0047112517,0.00014938992,0.016877905,0.00093926967,0.0081152925,0.02258483],"study_design_scores_gemma":[0.011741602,0.0010906605,0.9648183,0.0009757298,0.000084344814,0.0000030254384,0.0006478525,0.000062260544,0.012820199,0.00011460013,0.007433524,0.00020791704],"about_ca_topic_score_codex":0.0047370447,"about_ca_topic_score_gemma":0.0028274332,"teacher_disagreement_score":0.038908187,"about_ca_system_score_codex":0.002217897,"about_ca_system_score_gemma":0.0017488953,"threshold_uncertainty_score":0.71610266},"labels":[],"label_agreement":null},{"id":"W4409822268","doi":"10.1158/1538-7445.am2025-ct088","title":"Abstract CT088: Clinical validation of a novel blood-based protein multi-analyte test for early detection of pancreatic ductal adenocarcinoma (PDAC) in a large, independent high-risk patient population","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Pancreatic ductal adenocarcinoma; Medicine; Pancreatic cancer; Analyte; Population; Oncology; Internal medicine; Blood test; Cancer; Chemistry","score_opus":0.10176028298431135,"score_gpt":0.44856814294469777,"score_spread":0.34680785996038643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256456,0.00032719932,0.0027736796,0.00019090783,0.000066852575,0.0038728646,0.00015553583,0.000014417759,0.000033968638],"genre_scores_gemma":[0.9962678,0.000063108404,0.0020824575,0.00001274335,0.00007062536,0.0012358362,0.00006346008,0.000022980936,0.00018100171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967414,0.0003350748,0.0011218515,0.0004740525,0.0008289433,0.0004986373],"domain_scores_gemma":[0.9967761,0.0013190369,0.00034100877,0.00042200278,0.0010080836,0.00013376598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034074483,0.00015558132,0.0007551175,0.0008455966,0.0001134127,0.000016487467,0.00015843315,0.0002954204,0.00006247041],"category_scores_gemma":[0.0040990724,0.00013885055,0.00016803575,0.00092588837,0.00020367926,0.00009472063,0.00007270875,0.00075290794,0.0000024749365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021157095,0.002515288,0.8893503,0.0007845668,0.00022952614,0.000009597473,0.00013658647,0.000052346364,0.103202246,0.000039924336,0.000007154428,0.0015567781],"study_design_scores_gemma":[0.010109766,0.0018980204,0.8746612,0.0006683155,0.00028244255,0.0000011666915,0.00015497221,0.004626709,0.10742032,0.00008787089,0.000004642633,0.00008459574],"about_ca_topic_score_codex":0.014185251,"about_ca_topic_score_gemma":0.0019040414,"teacher_disagreement_score":0.014689096,"about_ca_system_score_codex":0.00038332146,"about_ca_system_score_gemma":0.001110565,"threshold_uncertainty_score":0.99237937},"labels":[],"label_agreement":null},{"id":"W4409822319","doi":"10.1158/1538-7445.am2025-ct075","title":"Abstract CT075: Phase 1a/1b dose-escalation study of efbalropendekin alfa (XmAb24306) as single-agent and with atezolizumab in solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Atezolizumab; Medicine; Solid tumor; Oncology; Internal medicine; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.05615121560228441,"score_gpt":0.3970706711734598,"score_spread":0.34091945557117537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409986,0.0024602253,0.000017842454,0.00017845596,0.00017337762,0.0010770115,0.000024222558,0.000020657706,0.0019483641],"genre_scores_gemma":[0.99730295,0.0002356802,0.000013316714,0.000029018709,0.000013185038,0.00016768169,0.000021455953,0.000019685494,0.0021970337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981699,0.00029717802,0.00042284207,0.00045115652,0.0001450317,0.00051388144],"domain_scores_gemma":[0.9991823,0.00012904857,0.00010096901,0.0003684293,0.00018639312,0.00003288948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074748835,0.00017821969,0.0003803494,0.00046882822,0.00020562064,0.000036410132,0.00026875292,0.0001546353,0.0006259397],"category_scores_gemma":[0.00007308361,0.00014642005,0.000030451361,0.0005399619,0.000262346,0.00010188532,0.00018274604,0.0006333866,0.0000424964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030155643,0.002463773,0.0019176707,0.000084101266,0.00019577563,0.000056199093,0.0019182418,0.00004089357,0.94885325,0.00059042143,0.0004491383,0.04041494],"study_design_scores_gemma":[0.0345861,0.010154742,0.14680274,0.0012141073,0.000071113725,0.000032658543,0.012932897,0.000026544838,0.787611,0.0011775855,0.0048376606,0.0005528636],"about_ca_topic_score_codex":0.0037145119,"about_ca_topic_score_gemma":0.0012277302,"teacher_disagreement_score":0.16124229,"about_ca_system_score_codex":0.00021567881,"about_ca_system_score_gemma":0.00034661626,"threshold_uncertainty_score":0.6853601},"labels":[],"label_agreement":null},{"id":"W4409822412","doi":"10.1158/1538-7445.am2025-ct032","title":"Abstract CT032: Phase 1/2 trial of the TBL1 inhibitor, tegavivint, in advanced hepatocellular carcinoma (aHCC)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Oncology; Gastroenterology","score_opus":0.0508172791414621,"score_gpt":0.3877290178043117,"score_spread":0.33691173866284957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916726,0.002509877,0.000010782802,0.00034645613,0.0003287462,0.0010192301,0.000049485432,0.000004637886,0.004058232],"genre_scores_gemma":[0.99764866,0.0002729687,0.000017980497,0.000058275436,0.00022082267,0.000356857,0.000014999099,0.000014987894,0.0013944271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984846,0.00019780561,0.0002810904,0.00035251092,0.00030425482,0.00037974367],"domain_scores_gemma":[0.9991034,0.000046020927,0.000058935453,0.0005537166,0.00017954381,0.0000583467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000841639,0.000119282915,0.00017215802,0.00011530773,0.00009861849,0.000018607227,0.00045069592,0.00015586478,0.00007516029],"category_scores_gemma":[0.00029005724,0.00009393131,0.00010632072,0.00048396006,0.0002150255,0.000004437802,0.00026726542,0.00038159633,0.0000039401275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006052388,0.00021922456,0.0051512974,0.00009877431,0.000016311373,0.000004967508,0.00006566576,0.000009391896,0.97809285,0.00014891203,0.0010931405,0.009047062],"study_design_scores_gemma":[0.016228724,0.00031402762,0.0016850056,0.000115266885,0.0000037043005,4.531593e-7,0.00009449753,0.000020998063,0.9584097,0.00023260244,0.022802388,0.0000926341],"about_ca_topic_score_codex":0.0003884362,"about_ca_topic_score_gemma":0.000223367,"teacher_disagreement_score":0.021709248,"about_ca_system_score_codex":0.000074317955,"about_ca_system_score_gemma":0.0007292235,"threshold_uncertainty_score":0.3830408},"labels":[],"label_agreement":null},{"id":"W4409822415","doi":"10.1158/1538-7445.am2025-ct022","title":"Abstract CT022: Divarasib plus migoprotafib combination treatment in patients with <i>KRAS G12C</i>-positive non-small cell lung cancer (NSCLC)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; KRAS; Cancer; Internal medicine; Lung cancer; Oncology; Colorectal cancer","score_opus":0.02211388574136848,"score_gpt":0.39293627723895913,"score_spread":0.37082239149759066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976071,0.0019289843,0.000034425735,0.0015074358,0.00019409013,0.0046623806,0.00016356308,0.00003250584,0.0154056],"genre_scores_gemma":[0.9872829,0.000514381,0.000080984035,0.00017990425,0.00007224333,0.003720083,0.0002030237,0.000040399136,0.007906132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978544,0.000076801254,0.00028925296,0.00057014107,0.00058862177,0.0006207544],"domain_scores_gemma":[0.9985926,0.00011643532,0.00007556894,0.00036931553,0.0006666691,0.00017939183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018063353,0.00026730966,0.000394107,0.0004606988,0.00024985598,0.000063338906,0.00013940818,0.000113817805,0.00023002067],"category_scores_gemma":[0.000016616566,0.00019730153,0.00007445358,0.0009040054,0.00012509334,0.00013567631,0.000054745375,0.00037687522,0.000017047465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023417994,0.0026117254,0.9641811,0.00056674524,0.00067026337,0.000087401575,0.0032018973,0.00025605733,0.0011276021,0.00014086062,0.002531871,0.022282677],"study_design_scores_gemma":[0.019768989,0.00091274176,0.9650243,0.0014594871,0.0002719447,3.879787e-7,0.00031409925,0.00012343579,0.0106268935,0.00004062891,0.0012497788,0.00020734718],"about_ca_topic_score_codex":0.016160818,"about_ca_topic_score_gemma":0.002901155,"teacher_disagreement_score":0.022075329,"about_ca_system_score_codex":0.0055855988,"about_ca_system_score_gemma":0.002869029,"threshold_uncertainty_score":0.99823177},"labels":[],"label_agreement":null},{"id":"W4409822417","doi":"10.1158/1538-7445.am2025-ct011","title":"Abstract CT011: Penpulimab versus placebo in combination with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Placebo; Chemotherapy; Internal medicine; Oncology; Phases of clinical research; Double blind; First line; Radiation therapy; Pathology; Alternative medicine","score_opus":0.20777013175691456,"score_gpt":0.5059154631255456,"score_spread":0.29814533136863103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631397,0.007583863,0.000046271274,0.0093527865,0.0007872179,0.01766542,0.000117496995,0.000041369036,0.0012658918],"genre_scores_gemma":[0.9786853,0.005787347,0.00016508928,0.000121690646,0.0002390901,0.013610339,0.00011911596,0.00003400926,0.0012379742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971525,0.00018334604,0.0006095916,0.0006473415,0.0006831428,0.00072407525],"domain_scores_gemma":[0.99741113,0.0013961067,0.000120903394,0.00035124682,0.00051667244,0.00020392536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012549227,0.00034397445,0.0012673581,0.00028680562,0.00025773916,0.00006364427,0.00017128387,0.00009034308,0.00025007565],"category_scores_gemma":[0.00035665062,0.00022421208,0.00021262356,0.0007974766,0.0002821073,0.00011394912,0.00004628021,0.00032758724,0.000011841786],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9600634,0.004574227,0.000108043765,0.00059753045,0.00086406793,0.000102383994,0.0008341165,0.000012676503,0.000052090472,0.00012489592,0.0012928973,0.031373657],"study_design_scores_gemma":[0.973925,0.016184349,0.00009221066,0.0006605698,0.00034978628,0.000002983501,0.0004376725,0.000589404,0.0022385023,0.0000565059,0.0052784816,0.00018454572],"about_ca_topic_score_codex":0.003022683,"about_ca_topic_score_gemma":0.007338665,"teacher_disagreement_score":0.031189112,"about_ca_system_score_codex":0.003143406,"about_ca_system_score_gemma":0.0027010078,"threshold_uncertainty_score":0.91431034},"labels":[],"label_agreement":null},{"id":"W4409822445","doi":"10.1158/1538-7445.am2025-ct016","title":"Abstract CT016: First-in-human (FIH) phase 1 trial of the oral first-in-class covalent Werner helicase (WRN) inhibitor RO7589831 in patients with microsatellite instable (MSI) and/or mismatch repair deficient (dMMR) advanced solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Helicase; Werner syndrome; Class (philosophy); Genetics; Medicine; Biology; Philosophy; Gene","score_opus":0.03767165438988408,"score_gpt":0.38253453352308786,"score_spread":0.3448628791332038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298966,0.0012333314,0.0000010185031,0.00074350426,0.00042424677,0.0040244274,0.00008431218,0.000026532838,0.0004729538],"genre_scores_gemma":[0.99729407,0.0003184611,0.000087404376,0.00011168947,0.00005888534,0.0007999378,0.000015671307,0.000049308357,0.001264553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591136,0.00019212769,0.000955244,0.0008345464,0.0011392036,0.0009674961],"domain_scores_gemma":[0.99813485,0.00032083277,0.00017436217,0.0007911095,0.00038416756,0.00019468965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012161385,0.00033279113,0.0007605192,0.00060974254,0.00018129086,0.00003941165,0.00034863726,0.0001835865,0.00025053264],"category_scores_gemma":[0.0004302805,0.00022706644,0.00011708128,0.0017019362,0.00053889083,0.00010648916,0.0003167041,0.0009924524,0.0000041515477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31184444,0.00972033,0.6153163,0.004250262,0.00018437985,0.00039093205,0.0061017666,0.0034893234,0.033865515,0.00004285879,0.0027871411,0.01200675],"study_design_scores_gemma":[0.2898626,0.009189151,0.4585568,0.010842764,0.00008992493,0.000007603033,0.0016808565,0.00054539845,0.20638363,0.00008386492,0.021900527,0.00085686916],"about_ca_topic_score_codex":0.0028202506,"about_ca_topic_score_gemma":0.01905911,"teacher_disagreement_score":0.17251812,"about_ca_system_score_codex":0.001478561,"about_ca_system_score_gemma":0.0011950817,"threshold_uncertainty_score":0.9988405},"labels":[],"label_agreement":null},{"id":"W4409919740","doi":"10.1158/0008-5472.can-24-3686","title":"Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; Canadian Cancer Society","keywords":"Immunotherapy; Immunity; CD8; Immunology; Cytotoxic T cell; Cancer immunotherapy; Prime (order theory); Medicine; Cancer research; Immune system; Biology; In vitro","score_opus":0.046932314164065916,"score_gpt":0.41955804543574904,"score_spread":0.37262573127168314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409919740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234206,0.010648525,0.00007340837,0.0035721834,0.00033768624,0.0014874504,0.000034788245,0.000055214976,0.0014486617],"genre_scores_gemma":[0.9885456,0.0037341523,0.00018494984,0.00075467915,0.00010847238,0.00029546386,0.0000044822955,0.000035792775,0.0063364133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978354,0.00015934472,0.00027754775,0.00052063353,0.0005407165,0.0006663351],"domain_scores_gemma":[0.9985164,0.00016018425,0.00003541153,0.00064909126,0.00041743307,0.00022149712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008925758,0.00019425618,0.00039121092,0.00037070335,0.00034511622,0.00012293836,0.00026955298,0.00009116312,0.00041457312],"category_scores_gemma":[0.000082224666,0.00016102573,0.000089258974,0.00093862746,0.0002443399,0.00005428676,0.0002872283,0.0006171328,0.000060073427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013377069,0.00028299,0.0022120788,0.00022664043,0.000125024,0.000016898803,0.000509491,0.000014676916,0.85854536,0.00008379479,0.003379838,0.13326548],"study_design_scores_gemma":[0.0033157747,0.0010899443,0.06826065,0.0006134876,0.00004422646,0.0000026013831,0.0002774939,0.00010538979,0.87783355,0.000036353536,0.04819921,0.00022133536],"about_ca_topic_score_codex":0.0015490671,"about_ca_topic_score_gemma":0.00002303368,"teacher_disagreement_score":0.13304415,"about_ca_system_score_codex":0.00037367133,"about_ca_system_score_gemma":0.00053976476,"threshold_uncertainty_score":0.6566439},"labels":[],"label_agreement":null},{"id":"W4409926927","doi":"10.1158/0008-5472.can-24-1607","title":"The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute; Instituto de Salud Carlos III; American Cancer Society; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute","keywords":"Lung cancer; Database; Computational biology; Cancer; Transcriptome; Biology; Gene expression; Gene; Bioinformatics; Computer science; Medicine; Genetics; Oncology","score_opus":0.05158327192907364,"score_gpt":0.42658020249271705,"score_spread":0.3749969305636434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409926927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94873255,0.01912807,0.028285159,0.00056756684,0.00027110783,0.0019204199,0.00083823316,0.000021179087,0.00023572604],"genre_scores_gemma":[0.9888961,0.0039200825,0.00012704406,0.000079885336,0.00010234406,0.0015291594,0.000039871415,0.000054230695,0.005251322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964555,0.00050244667,0.00041594452,0.0007590401,0.000907139,0.0009599149],"domain_scores_gemma":[0.9974513,0.000089985275,0.00009179435,0.0015586205,0.00067865243,0.00012966382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015002859,0.00024704068,0.00027288945,0.000095517535,0.0012592161,0.00018644297,0.0016216774,0.00021499109,0.000021242877],"category_scores_gemma":[0.00015292432,0.00016348343,0.00017516305,0.0005824767,0.00046118425,0.000019119867,0.001171761,0.00076496677,0.000001034256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000657785,0.0001630086,0.0005197179,0.00008646477,0.00016951101,0.0000016906373,0.00039020466,0.14447701,0.8405862,0.00010621879,0.012498154,0.00034406534],"study_design_scores_gemma":[0.0013703094,0.000074414085,0.000113348455,0.00011058848,0.000027252172,0.0000010101328,0.00049310736,0.082125306,0.912761,0.00009528581,0.002663903,0.00016448459],"about_ca_topic_score_codex":0.0018410548,"about_ca_topic_score_gemma":0.004466576,"teacher_disagreement_score":0.07217482,"about_ca_system_score_codex":0.0002210312,"about_ca_system_score_gemma":0.0016146081,"threshold_uncertainty_score":0.96849996},"labels":[],"label_agreement":null},{"id":"W4409987123","doi":"10.1158/0008-5472.can-24-3425","title":"Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T-cell Therapy in Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"European Research Council; Hector Stiftung; Bayerisches Staatsministerium für Wirtschaft und Medien, Energie und Technologie; Hector Stiftung II; Deutsche Krebshilfe; Technische Universität München; Elitenetzwerk Bayern; José Carreras Leukämie-Stiftung; Fritz-Bender-Stiftung; Jung-Stiftung für Wissenschaft und Forschung; Bundesministerium für Bildung und Forschung; Ludwig-Maximilians-Universität München; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung; European Commission; Horizon 2020 Framework Programme; Else Kröner-Fresenius-Stiftung; Bayerische Forschungsstiftung; European Hematology Association; Melanoma Research Alliance","keywords":"Intracellular; Cancer research; RNA; Innate immune system; Solid tumor; Cancer; Medicine; Biology; Cell biology; Immunology; Internal medicine; Biochemistry; Gene; Immune system","score_opus":0.032080462397010075,"score_gpt":0.35226550641699284,"score_spread":0.32018504401998277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409987123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92435974,0.06973931,0.00009037427,0.00096582854,0.0009554362,0.0006195099,0.000012779757,0.000041120184,0.0032158773],"genre_scores_gemma":[0.95052886,0.0017812605,0.000017553231,0.00018109911,0.00003904725,0.00008079538,0.0000090760495,0.000024402574,0.0473379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706286,0.0011129178,0.00043134877,0.0004329765,0.000102875536,0.0008570218],"domain_scores_gemma":[0.99886143,0.00036961454,0.000053852516,0.00037462,0.00030836446,0.000032108244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015808775,0.00018160987,0.00038878992,0.00068195036,0.00028082085,0.00007317994,0.00041496038,0.00019055716,0.00014946319],"category_scores_gemma":[0.00029703268,0.00016531703,0.000055939356,0.0007981134,0.00021063082,0.00007167696,0.00018561957,0.0008939137,0.00019985219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001398198,0.000043388307,0.00027951298,0.0000933052,0.00005118646,0.00003236357,0.00095040846,0.00014438818,0.97939944,0.00043977972,0.0150050465,0.0021629636],"study_design_scores_gemma":[0.0009776134,0.00011111063,0.00038848934,0.0006478632,0.000002302795,0.0000021297383,0.0016046151,0.000022266586,0.86764896,0.00004289933,0.12838496,0.00016679373],"about_ca_topic_score_codex":0.0017429575,"about_ca_topic_score_gemma":0.0001587719,"teacher_disagreement_score":0.11337991,"about_ca_system_score_codex":0.0004546011,"about_ca_system_score_gemma":0.00045500847,"threshold_uncertainty_score":0.67414325},"labels":[],"label_agreement":null},{"id":"W4410362349","doi":"10.1158/0008-5472.can-24-3990","title":"SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Jewish General Hospital; McGill Genome Centre; McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research","keywords":"SMARCA4; Biology; Cancer research; Ovarian cancer; Polymerase; Cancer; Molecular biology; Chromatin; Chromatin remodeling; DNA; Genetics","score_opus":0.02520908015786484,"score_gpt":0.3666799976417999,"score_spread":0.3414709174839351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410362349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822884,0.014754623,0.000039434126,0.0019778702,0.00010517689,0.0003480593,0.00012689129,0.000025970641,0.0003335251],"genre_scores_gemma":[0.9935028,0.0029839315,0.000112295005,0.0009508723,0.00024374327,0.00029778262,0.000046397192,0.000028198821,0.0018339951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808955,0.00016362173,0.00027596002,0.0006243673,0.00027420453,0.0005722816],"domain_scores_gemma":[0.99909806,0.000062758794,0.000034266646,0.00038153384,0.00023814522,0.00018521606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006395416,0.00017672792,0.00021524268,0.00025394556,0.00025216312,0.000040506504,0.00019851982,0.00016819313,0.00010726272],"category_scores_gemma":[0.00036889277,0.00017329678,0.000052060055,0.000721339,0.00016941372,0.000007636971,0.00046398604,0.0002900892,0.0000034123389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003709122,0.000074974654,0.012998197,0.00012893298,0.000068283676,0.000018044875,0.0001497939,0.00021467984,0.96824825,0.000035464185,0.008809072,0.008883389],"study_design_scores_gemma":[0.0019395219,0.00021682125,0.009656008,0.00086270156,0.00002158705,0.000005692767,0.00023903567,0.00045774374,0.9632493,0.00017655431,0.022775898,0.0003991353],"about_ca_topic_score_codex":0.018303677,"about_ca_topic_score_gemma":0.0066499715,"teacher_disagreement_score":0.013966827,"about_ca_system_score_codex":0.00019402688,"about_ca_system_score_gemma":0.0008853693,"threshold_uncertainty_score":0.9882335},"labels":[],"label_agreement":null},{"id":"W4410401728","doi":"10.1158/0008-5472.can-23-2654","title":"Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Jewish General Hospital; Montreal Clinical Research Institute; Occupational Cancer Research Centre; University of Toronto; McGill University; Université de Montréal","funders":"Fondation du cancer du sein du Québec; Fonds de Recherche du Québec - Santé; Canada Research Chairs; Canadian Cancer Society; Compute Canada; Canadian Institutes of Health Research; American Cancer Society; Cancer Research Society; National Cancer Institute; Melanoma Research Alliance; Samuel Waxman Cancer Research Foundation; U.S. Department of Defense","keywords":"mTORC1; Dormancy; Breast cancer; Metastasis; Cancer research; Cancer cell; Biology; Cancer; Metastatic breast cancer; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology; Genetics","score_opus":0.07199730393775147,"score_gpt":0.408372764377712,"score_spread":0.3363754604399606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410401728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971659,0.011327423,0.00018455175,0.009613446,0.0007751513,0.001712486,0.00021564995,0.00005399477,0.004458313],"genre_scores_gemma":[0.99061316,0.005647173,0.00008464806,0.001004433,0.000429671,0.0007503754,0.00001431395,0.00003487549,0.0014213215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968438,0.00033724282,0.00042938502,0.0005714,0.0010290754,0.0007891035],"domain_scores_gemma":[0.99845636,0.0003548683,0.000090886206,0.00047294464,0.00047796604,0.00014699822],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022033332,0.00021572925,0.00037918967,0.0005550635,0.0003199839,0.00008629614,0.00034778047,0.00010566624,0.0013683053],"category_scores_gemma":[0.00013271155,0.00015649822,0.000101879006,0.001833222,0.0001761162,0.0001490193,0.00017289376,0.0010594424,0.00005429434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00213544,0.00038281298,0.011664685,0.0010277623,0.00034222496,0.00011497831,0.0014419539,0.0060893106,0.8114684,0.0006398014,0.018285137,0.14640749],"study_design_scores_gemma":[0.0045683337,0.00024319458,0.014120694,0.003507984,0.00027011748,0.000011281159,0.0024156761,0.0007683323,0.94239897,0.00039397806,0.03079681,0.0005046085],"about_ca_topic_score_codex":0.0063514467,"about_ca_topic_score_gemma":0.0011758191,"teacher_disagreement_score":0.14590287,"about_ca_system_score_codex":0.001122894,"about_ca_system_score_gemma":0.0012392061,"threshold_uncertainty_score":0.99954456},"labels":[],"label_agreement":null},{"id":"W4410426602","doi":"10.1158/0008-5472.can-25-2070","title":"Cells Keep Diverse Company in Diseased Tissues","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; Amgen (Canada); Occupational Cancer Research Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Biology; Computational biology; Immune system; Immunology","score_opus":0.053047855249690516,"score_gpt":0.3828032877656147,"score_spread":0.32975543251592415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410426602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396724,0.0024962423,0.0001101065,0.00031874303,0.00023232002,0.00019316783,0.000029688736,0.000007173536,0.0026453477],"genre_scores_gemma":[0.99447,0.00084993895,0.000045667406,0.00015087782,0.00011394171,0.000047142283,0.000025682579,0.000009334066,0.004287439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990888,0.00009691258,0.00010474445,0.00026546165,0.0001502695,0.00029376103],"domain_scores_gemma":[0.9995825,0.000018566003,0.000009509768,0.0002291548,0.00009268549,0.000067547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019399589,0.00007459743,0.00009777062,0.00009907508,0.00007867173,0.000028545943,0.00024003143,0.00008092724,0.00008287479],"category_scores_gemma":[0.000026808952,0.00007353596,0.00004014975,0.00023161723,0.00013530883,0.0000021175408,0.0000972354,0.00016094878,0.000016445032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021692105,0.00009190018,0.01781109,0.000053911146,0.000019308185,0.000008160656,0.00006304049,0.00008332798,0.96880996,0.00007852698,0.0069931224,0.0057707117],"study_design_scores_gemma":[0.0011078285,0.00008599179,0.008665417,0.0000788659,0.00000681464,1.5203685e-7,0.00017133601,0.00012739975,0.8693884,0.00022149761,0.12000026,0.00014601463],"about_ca_topic_score_codex":0.0009423751,"about_ca_topic_score_gemma":0.0009056595,"teacher_disagreement_score":0.113007136,"about_ca_system_score_codex":0.000050859402,"about_ca_system_score_gemma":0.0001934422,"threshold_uncertainty_score":0.2998709},"labels":[],"label_agreement":null},{"id":"W4410595770","doi":"10.1158/1538-7445.am2025-3806","title":"Abstract 3806: Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Genetics; Computational biology; Cancer research; Evolutionary biology","score_opus":0.06854202239917861,"score_gpt":0.36745932133291653,"score_spread":0.2989172989337379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410595770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942004,0.0030811531,0.00015756136,0.00057737064,0.000076402546,0.00089714525,0.000022035654,0.000009447386,0.00097845],"genre_scores_gemma":[0.99608266,0.0014945521,0.00048791114,0.000060629744,0.000074979,0.00017016871,0.000008898788,0.000023747041,0.0015964415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976573,0.00013341334,0.00050339365,0.00042536468,0.00070876785,0.00057174737],"domain_scores_gemma":[0.9989214,0.000233373,0.000059000955,0.0003158762,0.00032445483,0.00014590213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068152917,0.00014448415,0.0003803806,0.00086613843,0.000086247375,0.000031107673,0.00019537983,0.00014812236,0.0002031587],"category_scores_gemma":[0.00012903195,0.00013481887,0.000058453836,0.0007720121,0.00025370924,0.00006041846,0.00009183334,0.0006033936,0.000009629808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026663646,0.000163983,0.20632665,0.0015218578,0.00002452927,0.000055099823,0.00042992612,0.000015554027,0.76705116,0.000004545674,0.00045480492,0.02368523],"study_design_scores_gemma":[0.002413169,0.00013500622,0.928716,0.0010755374,0.00001629506,0.0000066010634,0.00017532478,0.0009678701,0.06600234,0.00020020567,0.00019790523,0.00009375521],"about_ca_topic_score_codex":0.0009934638,"about_ca_topic_score_gemma":0.00034284167,"teacher_disagreement_score":0.72238934,"about_ca_system_score_codex":0.00062766124,"about_ca_system_score_gemma":0.0007554244,"threshold_uncertainty_score":0.54977536},"labels":[],"label_agreement":null},{"id":"W4410595779","doi":"10.1158/1538-7445.am2025-3774","title":"Abstract 3774: Detection of post-surgical minimal residual disease (MRD) in colorectal cancer; preliminary results from the VICTORI study","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Providence Health Care; Pancreas Centre (Canada); Spinal Cord Injury BC","funders":"","keywords":"Medicine; Colorectal cancer; Minimal residual disease; Cancer; Disease; Oncology; Internal medicine; Leukemia","score_opus":0.050282523362666615,"score_gpt":0.40911649501230324,"score_spread":0.3588339716496366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410595779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819861,0.009152462,1.2487011e-7,0.0048155533,0.00032734658,0.0017373766,0.00058111176,0.00002371062,0.0013762304],"genre_scores_gemma":[0.99676627,0.0011053518,0.0000029104767,0.00003745898,0.0003612861,0.0011032127,0.0000297973,0.000016785618,0.00057695206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997502,0.00024564084,0.00046554382,0.0005577463,0.0007892088,0.00043984276],"domain_scores_gemma":[0.99782753,0.0011546176,0.00007505917,0.0003331452,0.0004730987,0.00013652876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069784047,0.00018645378,0.00039978357,0.00021135257,0.00024807613,0.000027353348,0.00021542425,0.000081716404,0.00012164244],"category_scores_gemma":[0.00054187095,0.00012434226,0.00009323632,0.0008302285,0.00030156312,0.000063747306,0.00023859936,0.0005956691,0.0000045931088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34584844,0.0035435695,0.53949016,0.00026262272,0.0011938623,0.0013674211,0.011501673,0.00007168579,0.028901532,0.000024566685,0.00350692,0.06428754],"study_design_scores_gemma":[0.0062206844,0.0023818288,0.97697663,0.0004098625,0.00012695417,9.5012143e-7,0.0038288494,0.000023980543,0.008323323,0.00003385763,0.0015746672,0.00009842671],"about_ca_topic_score_codex":0.03519438,"about_ca_topic_score_gemma":0.024342403,"teacher_disagreement_score":0.43748647,"about_ca_system_score_codex":0.00081548817,"about_ca_system_score_gemma":0.0011848867,"threshold_uncertainty_score":0.99346083},"labels":[],"label_agreement":null},{"id":"W4410628148","doi":"10.1158/0008-5472.can-24-0044","title":"Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Baylor Scott and White Research Institute; Division of Cancer Prevention, National Cancer Institute","keywords":"Ovary; SMARCA4; Cancer research; Biology; Intron; Antigen; Internal medicine; Medicine; Gene; Immunology; Genetics; Epigenetics","score_opus":0.054771016888271254,"score_gpt":0.338922561517699,"score_spread":0.28415154462942777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410628148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975161,0.0018709986,0.0000375153,0.000120116034,0.00007551972,0.00018955392,0.000017816743,9.787691e-7,0.0001713964],"genre_scores_gemma":[0.999236,0.00027405727,0.00004381525,0.000024438054,0.00002976449,0.000012211108,0.000013855865,0.000006264056,0.00035961097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999276,0.000117768795,0.00018965881,0.00016684586,0.00011654616,0.00013321698],"domain_scores_gemma":[0.9994062,0.000012320615,0.000050870865,0.0002023818,0.00030895945,0.000019259878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039033563,0.000051929244,0.00011626628,0.00007545222,0.000027810453,0.0000035584424,0.00012821269,0.00006911865,0.000005812846],"category_scores_gemma":[0.000101441816,0.000043661825,0.000031237283,0.00032689556,0.00009378643,0.000001424532,0.000118807286,0.00009573623,1.5656215e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009303442,0.000029130333,0.0785387,0.00011389354,0.0000073191727,1.8794721e-7,0.00007558693,0.00038315586,0.91982925,0.000014583152,0.00038777807,0.0005274025],"study_design_scores_gemma":[0.0003709957,0.0001483877,0.053261954,0.00009539446,0.0000064207907,2.7385053e-7,0.000047189482,0.0006100368,0.94531214,0.000032163938,0.000076668555,0.00003834346],"about_ca_topic_score_codex":0.0010146816,"about_ca_topic_score_gemma":0.00095781265,"teacher_disagreement_score":0.025482943,"about_ca_system_score_codex":0.000055122644,"about_ca_system_score_gemma":0.00029813815,"threshold_uncertainty_score":0.17804775},"labels":[],"label_agreement":null},{"id":"W4411588552","doi":"10.1158/0008-5472.can-24-3349","title":"The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"KWF Kankerbestrijding; Ministerie van Volksgezondheid, Welzijn en Sport; Oncode Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Wellcome Trust; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Cancer Research UK","keywords":"Biology; Receptor tyrosine kinase; Tyrosine kinase; Fibroblast growth factor receptor; Protein kinase domain; Fibroblast growth factor receptor 2; Exon; Molecular biology; Gene; Kinase; Cell biology; Genetics; Cancer research; Signal transduction; Fibroblast growth factor; Receptor","score_opus":0.031177428130702792,"score_gpt":0.39696462916429465,"score_spread":0.36578720103359186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411588552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736077,0.00059341505,0.00018712532,0.00029592402,0.000074798634,0.00034992694,0.000027274684,0.0000031056345,0.0011076782],"genre_scores_gemma":[0.9981382,0.00037333288,0.000054658587,0.000008317917,0.00005249321,0.00008502511,0.000018877465,0.0000078996545,0.0012611889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986948,0.00025566085,0.0001391207,0.00026839096,0.00032286198,0.00031916087],"domain_scores_gemma":[0.99922895,0.00017657415,0.00003605266,0.0002683267,0.00022869781,0.00006139969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006516495,0.00008045456,0.00008874989,0.00010837874,0.00033270434,0.000043329997,0.00025119487,0.000094589814,0.000016395303],"category_scores_gemma":[0.00038540212,0.000059703823,0.00003016712,0.00023374218,0.0006440594,0.000007784767,0.00041104562,0.00024130628,0.0000016688189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040522008,0.000023480547,0.004678215,0.000086952394,0.000034636476,0.0000021533847,0.000073408635,0.0000039720885,0.98694044,0.0007711001,0.0017069613,0.0052734353],"study_design_scores_gemma":[0.00046202898,0.000101004414,0.0071674464,0.00023923692,0.0000028901436,0.0000017553817,0.0002732437,0.0000117025,0.98311067,0.0004840267,0.008089033,0.000056953453],"about_ca_topic_score_codex":0.000085303196,"about_ca_topic_score_gemma":0.00002238927,"teacher_disagreement_score":0.0063820714,"about_ca_system_score_codex":0.000065916516,"about_ca_system_score_gemma":0.0003851961,"threshold_uncertainty_score":0.25589263},"labels":[],"label_agreement":null},{"id":"W4412003337","doi":"10.1158/0008-5472.can-24-3662","title":"RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Cancer research; Carcinogenesis; Targeted therapy; Cancer; Lung cancer; Adenocarcinoma; Oncogene; MAPK/ERK pathway; In vivo; Biology; Medicine; Signal transduction; Oncology; Cell cycle; Internal medicine; Genetics","score_opus":0.02502257374875849,"score_gpt":0.36626524026780877,"score_spread":0.3412426665190503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412003337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81201535,0.18558627,0.00011260974,0.0013064166,0.00005032848,0.0004541594,0.00013691124,0.000005552312,0.00033236138],"genre_scores_gemma":[0.9916325,0.004285829,0.0004357317,0.0003786148,0.000067238914,0.00024671442,0.000015918016,0.000014973641,0.002922439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988643,0.00008922719,0.00014133062,0.00038932552,0.00021791126,0.00029792174],"domain_scores_gemma":[0.99914074,0.000025248739,0.000025661004,0.0004173202,0.00030618775,0.000084824496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002828251,0.000099227786,0.00013848362,0.00011407792,0.000098477445,0.000019747045,0.00027713564,0.00007062968,0.000060319137],"category_scores_gemma":[0.00010530221,0.00009480006,0.000034761353,0.0004061399,0.0001720364,0.0000034366278,0.00023279534,0.000093344635,0.0000022459772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064932957,0.000029666535,0.03507114,0.00011503072,0.00007476994,0.000003807487,0.00010231876,0.0000014582654,0.8840697,0.0013948759,0.07653409,0.001953833],"study_design_scores_gemma":[0.00039494105,0.00009118943,0.0430125,0.00006775438,0.0000039674437,2.8175361e-7,0.000031276406,0.0000014465431,0.9192677,0.00026370925,0.03677991,0.000085304535],"about_ca_topic_score_codex":0.00030909583,"about_ca_topic_score_gemma":0.00011621889,"teacher_disagreement_score":0.18130045,"about_ca_system_score_codex":0.000041208,"about_ca_system_score_gemma":0.00029283867,"threshold_uncertainty_score":0.38658342},"labels":[],"label_agreement":null},{"id":"W4412695782","doi":"10.1158/0008-5472.can-24-3894","title":"Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; University of Toronto; Hamilton Health Sciences; Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; All of Us Research Program; Stand Up To Cancer; Cancer Prevention and Research Institute of Texas; Stand Up To Cancer Canada; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Medulloblastoma; Radioresistance; Medicine; Radiation therapy; Oncology; Acetazolamide; Internal medicine; Radiosensitizer; Cancer research","score_opus":0.020477693055651332,"score_gpt":0.36564725674092896,"score_spread":0.3451695636852776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412695782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889545,0.0014591545,0.0021733313,0.0032279505,0.00029224696,0.000316454,0.000016655413,0.000024885332,0.0035348125],"genre_scores_gemma":[0.99080783,0.0006011153,0.00012761644,0.002309466,0.00045057273,0.00017748804,0.00006509402,0.000016927535,0.0054438785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988502,0.0001450451,0.00012477614,0.00035412313,0.00021697656,0.0003088413],"domain_scores_gemma":[0.99938476,0.000016819142,0.000015228789,0.0002706091,0.00020688167,0.00010570098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040347342,0.000094802796,0.0000918816,0.00019317257,0.00014805158,0.000040461964,0.00007747928,0.0001154883,0.00013564802],"category_scores_gemma":[0.00007797322,0.000094734234,0.000051638155,0.00042939043,0.00008975604,0.00000439465,0.00007484582,0.00016278237,0.000021344391],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024381942,0.000030074492,0.00013596991,0.000016607924,0.000021630496,0.000003255644,0.000029668867,0.00004056367,0.8915447,0.00038791556,0.10477706,0.002768753],"study_design_scores_gemma":[0.0005429634,0.00028455758,0.00043482005,0.0000648104,0.000003039552,0.0000028304646,0.00007684937,0.000027056964,0.8272823,0.0000856268,0.17109701,0.000098113065],"about_ca_topic_score_codex":0.00015445802,"about_ca_topic_score_gemma":0.00040069004,"teacher_disagreement_score":0.06631994,"about_ca_system_score_codex":0.00013403404,"about_ca_system_score_gemma":0.0001665843,"threshold_uncertainty_score":0.386315},"labels":[],"label_agreement":null},{"id":"W4412789813","doi":"10.1158/0008-5472.can-24-3420","title":"Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bioinformatics Solutions (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Programmed cell death; GPX4; Immune system; Cytotoxic T cell; Pharmacology; Oxidative stress; Chemistry; Immunology; Medicine; Apoptosis; In vitro; Biochemistry","score_opus":0.04397261309189472,"score_gpt":0.3615034472039208,"score_spread":0.3175308341120261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885114,0.0062283413,0.00033162342,0.0025609855,0.00010335034,0.00079135696,0.000059863476,0.00002537371,0.0013876974],"genre_scores_gemma":[0.99473476,0.003907837,0.00015325146,0.0004077677,0.00006243004,0.0002098818,0.000025279343,0.00002411225,0.00047464785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835384,0.00014842911,0.00030006416,0.00034384092,0.00055127963,0.00030252844],"domain_scores_gemma":[0.99907994,0.00009986022,0.000051845338,0.00021409804,0.0004527551,0.000101528414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005446705,0.00012989162,0.0002733911,0.00036177633,0.00014104314,0.00004101825,0.000057369976,0.00011606588,0.00009195307],"category_scores_gemma":[0.000017880471,0.00012654856,0.00005800332,0.00061231514,0.00009004498,0.00008070631,0.000034711386,0.00016111752,0.0000041838325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049074396,0.000119069155,0.00197383,0.0003129786,0.000049416805,0.0000023654695,0.0011190551,0.000024107212,0.9350376,0.000022562484,0.002610306,0.05823795],"study_design_scores_gemma":[0.0022478057,0.00027074647,0.0028898907,0.00048102206,0.000040555766,0.0000011632847,0.00064693403,0.000114362185,0.9901892,0.0000355694,0.0029762248,0.00010650517],"about_ca_topic_score_codex":0.0015015965,"about_ca_topic_score_gemma":0.000095496085,"teacher_disagreement_score":0.058131445,"about_ca_system_score_codex":0.00033008377,"about_ca_system_score_gemma":0.00028548102,"threshold_uncertainty_score":0.5160501},"labels":[],"label_agreement":null},{"id":"W4412817743","doi":"10.1158/1538-7445.fcs2024-p87","title":"Abstract P87: Combined therapy with CRIF1/CDK2 interface inhibitor and Taxol against Triple-Negative Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.04215355106974791,"score_gpt":0.3861767924748133,"score_spread":0.34402324140506535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412817743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737566,0.009864375,0.00007540717,0.008381705,0.00043999346,0.0021472883,0.00019686935,0.00009561547,0.0050421413],"genre_scores_gemma":[0.9891031,0.005437722,0.000060133985,0.00068529235,0.00023427795,0.0008628116,0.00001298944,0.00006745541,0.0035362185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973861,0.00013876853,0.00031375015,0.00069309276,0.00076650083,0.0007017607],"domain_scores_gemma":[0.9980672,0.00018122944,0.00008235514,0.0005229128,0.0008467691,0.000299527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004956197,0.00029460472,0.00047231777,0.00043891364,0.0002458148,0.000094911295,0.00021944684,0.00019631877,0.000574229],"category_scores_gemma":[0.00010750979,0.00023069479,0.00007560836,0.001147282,0.0006193521,0.00013031896,0.00013375314,0.0013261933,0.0000206234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025020337,0.0007248773,0.009248007,0.0009056192,0.0015805073,0.00031554865,0.0024819626,0.00018829598,0.7161936,0.00027107203,0.07870335,0.16436683],"study_design_scores_gemma":[0.037076093,0.001901393,0.12420559,0.007600722,0.00014345923,0.000056452653,0.0021720391,0.00035862764,0.7880643,0.00031759593,0.037233386,0.0008703569],"about_ca_topic_score_codex":0.0030954792,"about_ca_topic_score_gemma":0.0012386789,"teacher_disagreement_score":0.16349646,"about_ca_system_score_codex":0.0009647927,"about_ca_system_score_gemma":0.0020323773,"threshold_uncertainty_score":0.940746},"labels":[],"label_agreement":null},{"id":"W4412817868","doi":"10.1158/1538-7445.fcs2024-lt10","title":"Abstract LT10: Molecular mechanisms of SOCS1-mediated tumor suppression in prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Oncology; Cancer research; Suppressor of cytokine signaling 1; Internal medicine; Prostate; Suppressor","score_opus":0.04343921628824534,"score_gpt":0.42939145519286454,"score_spread":0.3859522389046192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412817868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800153,0.008898222,0.000021502501,0.005267879,0.00020473792,0.0020045484,0.00014594861,0.000038485126,0.0034034243],"genre_scores_gemma":[0.9917051,0.0036154706,0.000061329105,0.00018114287,0.000038982056,0.0013054926,0.000059265985,0.000037034362,0.0029961658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701035,0.00015008498,0.0004124951,0.0005184835,0.0010401561,0.00086844654],"domain_scores_gemma":[0.99838525,0.0002526083,0.00006828286,0.0004443233,0.00063614664,0.00021337545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009313839,0.00019400349,0.00045124054,0.00084429095,0.00010255262,0.000029073522,0.0002687751,0.00011163323,0.0011141364],"category_scores_gemma":[0.00029056222,0.00015111979,0.00009660468,0.0016184094,0.00031610258,0.00009819428,0.00020138294,0.00085611676,0.00002473237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021539181,0.00041750591,0.011351565,0.0012585397,0.00014043972,0.00056385994,0.000298444,0.000044470722,0.9712929,0.00042880853,0.004813741,0.007235802],"study_design_scores_gemma":[0.0044687004,0.00021119011,0.033536963,0.0022934338,0.000024695417,0.0000020660252,0.00037091953,0.000108176595,0.954046,0.0023046378,0.002498232,0.00013499381],"about_ca_topic_score_codex":0.003983872,"about_ca_topic_score_gemma":0.00037358233,"teacher_disagreement_score":0.022185398,"about_ca_system_score_codex":0.0008264977,"about_ca_system_score_gemma":0.0025634044,"threshold_uncertainty_score":0.99979895},"labels":[],"label_agreement":null},{"id":"W4413396136","doi":"10.1158/0008-5472.can-25-3656","title":"Transient Nutrient Sensing Shapes T-cell Exhaustion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Context (archaeology); T-cell receptor; Cell biology; T cell; Cell fate determination; Extracellular; Intracellular; Biology; Cytokine; Methionine; Transcription factor; Immune system; Immunology; Biochemistry; Amino acid","score_opus":0.043184227530255116,"score_gpt":0.35867570483002575,"score_spread":0.3154914772997706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413396136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.909307,0.013167137,0.00467935,0.0033568803,0.007819799,0.00061607297,0.0000050851954,0.00013321135,0.060915455],"genre_scores_gemma":[0.8948405,0.0005639747,0.000008953797,0.00019845893,0.00003592383,0.000028016342,0.000021905484,0.000007367497,0.104294926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896455,0.00022851225,0.00016722422,0.00024664076,0.00005669023,0.0003364116],"domain_scores_gemma":[0.9994612,0.0001027722,0.000023215887,0.0001438963,0.00025509502,0.000013843053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040796376,0.00008187337,0.000110612586,0.0002892278,0.00034246081,0.00002805523,0.00010155303,0.00013359997,0.002190636],"category_scores_gemma":[0.000039272625,0.00007538474,0.000056598354,0.00035454138,0.00012987904,0.000068886126,0.000043334647,0.00054822786,0.00070855045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028135322,0.00006678687,0.000032754466,0.00003497847,0.000032357908,0.0000012926442,0.00023491457,0.000019749841,0.8712598,0.000542353,0.116567366,0.010926315],"study_design_scores_gemma":[0.00053493207,0.000050640287,0.00030732216,0.00006828577,0.000007823421,0.000002491176,0.00047583526,0.000025748399,0.51242375,0.00006266368,0.48599046,0.00005005123],"about_ca_topic_score_codex":0.00037381094,"about_ca_topic_score_gemma":0.000023982597,"teacher_disagreement_score":0.36942312,"about_ca_system_score_codex":0.00023448524,"about_ca_system_score_gemma":0.00014041479,"threshold_uncertainty_score":0.9987215},"labels":[],"label_agreement":null},{"id":"W4413754038","doi":"10.1158/0008-5472.can-25-1486","title":"The Multifaceted Role of Osteopontin in Modulating the Tumor Microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Osteopontin; Tumor microenvironment; Cancer research; Cancer; Chemistry; Medicine; Biology; Tumor cells; Immunology; Internal medicine","score_opus":0.034385008900360226,"score_gpt":0.3894257401482125,"score_spread":0.3550407312478523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413754038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768368,0.015090282,0.0000017320226,0.004336364,0.000033604676,0.0006677201,0.000002165153,0.00000439207,0.003026943],"genre_scores_gemma":[0.9958969,0.00048223714,0.000026372287,0.000094743235,0.000026787586,0.00023158104,4.572221e-7,0.00000541272,0.0032355287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990818,0.00010601379,0.00016606456,0.00012578905,0.00028219057,0.00023815678],"domain_scores_gemma":[0.9994401,0.00022077211,0.000023515375,0.00024401999,0.000052425363,0.00001917348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074357213,0.000050257837,0.000120383665,0.000053863663,0.00020426241,0.0000110780875,0.000117715506,0.00001827109,0.000023353306],"category_scores_gemma":[0.00016322352,0.000026237129,0.000031888616,0.00029739746,0.00029266684,0.000013178605,0.00021831915,0.00030330766,0.000008909018],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060162926,0.000110198795,0.12552506,0.0001515805,0.00009708101,0.000013347079,0.0019263752,0.00005912589,0.7720639,0.00034982915,0.0021673194,0.09693455],"study_design_scores_gemma":[0.0019468797,0.00013507128,0.48852545,0.0007018534,0.000019043624,0.0000026625912,0.01846873,0.0009428527,0.45777732,0.00096098153,0.030441219,0.000077928344],"about_ca_topic_score_codex":0.0022735745,"about_ca_topic_score_gemma":0.0006889955,"teacher_disagreement_score":0.3630004,"about_ca_system_score_codex":0.0001286946,"about_ca_system_score_gemma":0.00007179763,"threshold_uncertainty_score":0.34369797},"labels":[],"label_agreement":null},{"id":"W4413844625","doi":"10.1158/0008-5472.can-25-0006","title":"MYADM Activates RhoA-Mediated Ameboid Migration to Drive Metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"Academia Sinica; Taipei Veterans General Hospital; National Defense Medical Center; National Science and Technology Council","keywords":"Metastasis; RHOA; Cancer cell; Biology; Anoikis; Cell biology; Cell migration; Cancer research; Cancer; Cell; Signal transduction; Genetics","score_opus":0.045559170456767065,"score_gpt":0.4016980141462707,"score_spread":0.35613884368950366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413844625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96021044,0.017778644,0.00031405763,0.010785389,0.0025139393,0.0010728664,0.000120283425,0.00013167056,0.007072711],"genre_scores_gemma":[0.960665,0.0014733983,0.000076157245,0.0006628951,0.00006437078,0.0007948767,0.00009667656,0.000025829462,0.036140826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793553,0.0005025826,0.00025453983,0.0004759022,0.00011666485,0.0007148047],"domain_scores_gemma":[0.9982844,0.00065255904,0.000042370637,0.0005024308,0.0004794738,0.00003878889],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007496038,0.00016672994,0.00027504974,0.00054726383,0.0003562776,0.00004350416,0.0005160397,0.00022557277,0.002552975],"category_scores_gemma":[0.00056253275,0.00015184026,0.00007387513,0.0012253884,0.00034031484,0.000101277095,0.00030464793,0.00076722243,0.0018731359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030467616,0.00004934735,0.0009491431,0.000035296376,0.00024413678,0.0000022674262,0.00053368177,0.000017630337,0.84101087,0.00041457437,0.14072564,0.015712714],"study_design_scores_gemma":[0.00042899544,0.0000652146,0.0013175241,0.00007335012,0.000014114894,7.955566e-7,0.00032881272,0.0000013485516,0.60620004,0.00013879291,0.39133438,0.00009659854],"about_ca_topic_score_codex":0.0022805866,"about_ca_topic_score_gemma":0.00086960476,"teacher_disagreement_score":0.25060874,"about_ca_system_score_codex":0.0005734036,"about_ca_system_score_gemma":0.0005921192,"threshold_uncertainty_score":0.99890405},"labels":[],"label_agreement":null},{"id":"W4414007906","doi":"10.1158/0008-5472.can-25-0235","title":"ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Key Research and Development Program of China; Zhongnan Hospital of Wuhan University; China Postdoctoral Science Foundation; National Health Commission of the People's Republic of China; National Natural Science Foundation of China; Postdoctoral Science Foundation of Hubei Province","keywords":"Chemokine; Evasion (ethics); Immune system; Secretion; Immunology; CCL18; Biology; Endocrinology","score_opus":0.03744045424067707,"score_gpt":0.38318604911984855,"score_spread":0.3457455948791715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414007906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98643625,0.002949059,0.000027271612,0.008755364,0.000226179,0.0011091956,0.000026497199,0.000084836676,0.00038536277],"genre_scores_gemma":[0.99394035,0.0009980396,0.00007452497,0.00078328466,0.0003367605,0.00021116044,0.00015363382,0.00002849516,0.0034737214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980355,0.000117307245,0.00032012037,0.00045480055,0.00060043106,0.00047183418],"domain_scores_gemma":[0.99869645,0.00008105683,0.00005473579,0.0003267987,0.00062142377,0.00021954489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230051,0.00015943972,0.0003540285,0.00046993978,0.0001844343,0.000057986534,0.0001328707,0.00012346612,0.00026294484],"category_scores_gemma":[0.0011689982,0.00013827576,0.000047356025,0.0014219453,0.0000983926,0.00009358037,0.00020759167,0.0005702136,0.000038225193],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674542,0.0001438937,0.0068166945,0.00021893276,0.000058939717,0.000015526984,0.00031713047,0.0000030196852,0.9291812,0.000031551932,0.0013724138,0.06127323],"study_design_scores_gemma":[0.0049238577,0.00025615448,0.7602485,0.0011696136,0.000062688305,0.000008587603,0.00007925673,0.0015381982,0.19120346,0.000108385,0.040227186,0.00017411113],"about_ca_topic_score_codex":0.00036054023,"about_ca_topic_score_gemma":0.00004739509,"teacher_disagreement_score":0.7534318,"about_ca_system_score_codex":0.00033164574,"about_ca_system_score_gemma":0.00027038975,"threshold_uncertainty_score":0.5638722},"labels":[],"label_agreement":null},{"id":"W4414056794","doi":"10.1158/0008-5472.can-24-3920","title":"Condensation of the Golgi Apparatus Activates YAP1 to Promote Gastric Cancer Progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Research Foundation of Korea","keywords":"Golgi apparatus; Condensation; Cancer; YAP1; Cancer cell; Signal transduction","score_opus":0.045075958643241855,"score_gpt":0.42078794361496097,"score_spread":0.3757119849717191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414056794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995428,0.0020320697,0.00009913867,0.0009784269,0.00016456813,0.000530662,0.00002952399,0.000006890159,0.00073068327],"genre_scores_gemma":[0.9947931,0.0001817715,0.00007632616,0.00008697709,0.00013074961,0.00035029685,0.0000092195305,0.000011122152,0.004360434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988585,0.00014489872,0.00013679551,0.00028532985,0.00028584845,0.00028860127],"domain_scores_gemma":[0.9991965,0.00001754064,0.000042372503,0.00033107793,0.00035101754,0.00006145695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040286005,0.00008584466,0.000101648366,0.000087026,0.00014922308,0.000022130986,0.00029419898,0.00010304526,0.00003516658],"category_scores_gemma":[0.000151661,0.000059711405,0.000048812395,0.00058156624,0.00011012977,0.00000251277,0.00018797521,0.0001895426,0.0000044695034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012989138,0.000030606185,0.0031702076,0.000057017325,0.00002983382,3.4327212e-7,0.000097187134,0.00012976381,0.9755115,0.000048856687,0.0017008816,0.019093897],"study_design_scores_gemma":[0.00021748772,0.00011146499,0.0023003016,0.00022659964,0.0000063465413,4.2590386e-7,0.000046759964,0.000022138629,0.96662617,0.00008886341,0.030292597,0.000060876646],"about_ca_topic_score_codex":0.00020484213,"about_ca_topic_score_gemma":0.00010214454,"teacher_disagreement_score":0.028591715,"about_ca_system_score_codex":0.00006646083,"about_ca_system_score_gemma":0.00062131975,"threshold_uncertainty_score":0.24349603},"labels":[],"label_agreement":null},{"id":"W4414280732","doi":"10.1158/0008-5472.can-24-3898","title":"The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; University of Wisconsin Carbone Cancer Center; Wisconsin Alumni Research Foundation; University of Wisconsin-Madison; Margaret Q. Landenberger Research Foundation; Pharmaceutical Research and Manufacturers of America Foundation; American Cancer Society","keywords":"Metabolite; Colorectal cancer; Bile acid; Cancer; Cell growth; Cell; Signal transduction","score_opus":0.03209936088026637,"score_gpt":0.4148523306007523,"score_spread":0.3827529697204859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414280732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93923724,0.04041265,0.00004065232,0.011420534,0.0013708051,0.0015754243,0.00007384184,0.00009229703,0.005776554],"genre_scores_gemma":[0.965241,0.007255304,0.000112978676,0.00025971708,0.000528265,0.0012466135,0.000026852356,0.000036895446,0.025292376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757475,0.00013494935,0.00028606536,0.00044299292,0.0007458767,0.0008153759],"domain_scores_gemma":[0.99877363,0.00009453694,0.000045038883,0.00034675645,0.0005578533,0.00018216799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010249759,0.00017683473,0.00030866376,0.0002161177,0.00073452253,0.00008636154,0.00030616202,0.00015191964,0.00028799957],"category_scores_gemma":[0.00006820218,0.000104396815,0.00013553193,0.0011435197,0.0004565052,0.000066981884,0.00010802426,0.0007734516,0.000032743006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016886144,0.00010365168,0.0025524395,0.0002412108,0.0001380834,0.000035196,0.00030575998,0.000002060925,0.92404604,0.0015417368,0.013106666,0.056238547],"study_design_scores_gemma":[0.0011159873,0.000077158635,0.0041110436,0.00057806604,0.000052188487,0.0000023872224,0.00017479513,0.000012449029,0.73571104,0.00024825768,0.25782084,0.00009581748],"about_ca_topic_score_codex":0.00026335465,"about_ca_topic_score_gemma":0.0010876207,"teacher_disagreement_score":0.24471417,"about_ca_system_score_codex":0.0003366286,"about_ca_system_score_gemma":0.001547676,"threshold_uncertainty_score":0.5649428},"labels":[],"label_agreement":null},{"id":"W4414280768","doi":"10.1158/0008-5472.can-24-3095","title":"Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti–PD-1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Fondation contre le Cancer; Kom op tegen Kanker; Vrije Universiteit Brussel; Stichting Tegen Kanker; Fonds Wetenschappelijk Onderzoek","keywords":"Immunotherapy; Cancer immunotherapy; Construct (python library); Cancer; Immune system; Antibody; Autoimmune disease","score_opus":0.03325473000837953,"score_gpt":0.3706434265754012,"score_spread":0.3373886965670217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414280768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889672,0.0058047925,0.000031390413,0.0012269461,0.00020485526,0.0012353898,0.00001819036,0.00005294607,0.0024582811],"genre_scores_gemma":[0.9972749,0.00062280195,0.00039276638,0.00053193956,0.0001770849,0.0001171588,0.000008452166,0.000047525242,0.0008273868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972278,0.00036079556,0.00048412677,0.00047365887,0.0008235655,0.00063004595],"domain_scores_gemma":[0.9978203,0.00047717494,0.0001643176,0.00094350154,0.0004958453,0.00009887265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018694081,0.00022434187,0.00044780356,0.0002741906,0.00045665438,0.000066961795,0.00042785538,0.00009509112,0.00033192453],"category_scores_gemma":[0.00007831925,0.00014633009,0.000119201344,0.0011424244,0.0012760676,0.00010764876,0.000070456255,0.00064850115,0.0000038813514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065455036,0.0001397979,0.017543403,0.00026811694,0.00038482773,0.000024379819,0.0007117028,0.000023299914,0.9303152,0.00023074831,0.0010577076,0.04275534],"study_design_scores_gemma":[0.007841534,0.0010580561,0.09370789,0.0019144714,0.000058259193,0.00004889788,0.0022267858,0.00008795579,0.8838449,0.000041691394,0.00891322,0.00025633452],"about_ca_topic_score_codex":0.0016756373,"about_ca_topic_score_gemma":0.0001408151,"teacher_disagreement_score":0.076164484,"about_ca_system_score_codex":0.0002973358,"about_ca_system_score_gemma":0.001716958,"threshold_uncertainty_score":0.59671676},"labels":[],"label_agreement":null},{"id":"W4414349247","doi":"10.1158/1538-7445.ovarian25-ia002","title":"Abstract IA002: Full circle: Return of value to ovarian cancer research participants, advocates, and survivors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Value (mathematics); Survivorship curve; Literacy; Multidisciplinary approach; Reading (process); Process (computing); Health literacy; Selection (genetic algorithm); Disease","score_opus":0.1131085710530455,"score_gpt":0.5334351779678682,"score_spread":0.4203266069148227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484985,0.024220774,0.00013218287,0.018176863,0.00066913036,0.0012231207,0.00004498071,0.00003606807,0.0069984053],"genre_scores_gemma":[0.9805471,0.012754486,0.00042932932,0.0005487246,0.00049551134,0.0005490623,0.0000048008756,0.000035711997,0.004635275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99660593,0.0004401986,0.0004034093,0.00061130605,0.0008552892,0.0010838548],"domain_scores_gemma":[0.99677956,0.0012488251,0.000050631355,0.00062586856,0.0009126102,0.00038248755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004263956,0.00015249671,0.00048428445,0.00064664724,0.00034508336,0.000024958339,0.00034790096,0.00025095994,0.0009337718],"category_scores_gemma":[0.0010254431,0.00013587654,0.000053978747,0.0017205222,0.0011016624,0.0000908595,0.00019402408,0.001326334,0.000018176068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012915398,0.00081862416,0.124584384,0.0026330121,0.0009930783,0.00026930164,0.0053155804,0.00030219177,0.3442498,0.0047948924,0.066415876,0.43670785],"study_design_scores_gemma":[0.0059826155,0.0020430628,0.46358752,0.0035931412,0.000111272304,0.000020021158,0.0030060434,0.0002403708,0.15072423,0.006110873,0.3640478,0.00053305144],"about_ca_topic_score_codex":0.004980292,"about_ca_topic_score_gemma":0.0023708076,"teacher_disagreement_score":0.43617478,"about_ca_system_score_codex":0.00065553666,"about_ca_system_score_gemma":0.0020787995,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W4414349338","doi":"10.1158/1538-7445.ovarian25-b045","title":"Abstract B045: Evaluating the effectiveness of opportunistic salpingectomy (OS) for the prevention of epithelial ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Saskatchewan; University of Ottawa; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Ovarian cancer; Salpingectomy; Fallopian tube; Population; Cohort; Epithelial ovarian cancer; Pathological","score_opus":0.18868059161593437,"score_gpt":0.5167021843933567,"score_spread":0.3280215927774223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97116625,0.009699777,0.001018924,0.007128874,0.0007973429,0.007033977,0.0003291453,0.000019077466,0.002806633],"genre_scores_gemma":[0.99415237,0.0010253948,0.000068704256,0.00004280303,0.00019488904,0.003971921,0.000012389676,0.000018194223,0.0005133186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818516,0.00037127352,0.00031977298,0.0002772217,0.0005495697,0.00029702505],"domain_scores_gemma":[0.9948353,0.003768934,0.00012693957,0.00046275923,0.00075590005,0.00005016571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048134904,0.00011424974,0.00032103335,0.00011862783,0.00022816026,0.000019510577,0.00021798981,0.000064054395,0.00035211138],"category_scores_gemma":[0.0006441221,0.000063558386,0.00016517848,0.00046728365,0.00026174015,0.000034177992,0.00006954949,0.0002498134,0.0000014239936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013948422,0.0012187252,0.035000227,0.00999933,0.0038788845,0.0000107204805,0.0007545784,0.0009186742,0.27828568,0.026835112,0.0034124204,0.62573725],"study_design_scores_gemma":[0.008809728,0.001466119,0.7642882,0.0072510764,0.0011163994,0.0000019202223,0.00036928063,0.0010741,0.20546074,0.0055846563,0.004431814,0.00014597355],"about_ca_topic_score_codex":0.0029761887,"about_ca_topic_score_gemma":0.0002851092,"teacher_disagreement_score":0.729288,"about_ca_system_score_codex":0.00041267817,"about_ca_system_score_gemma":0.0021557324,"threshold_uncertainty_score":0.44991267},"labels":[],"label_agreement":null},{"id":"W4414349511","doi":"10.1158/1538-7445.ovarian25-b001","title":"Abstract B001: Next-generation sequencing in ovarian cancer to identify actionable mutations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Homologous recombination; Genetic testing; Mutation; Somatic cell; Gene; Cancer; Germline mutation","score_opus":0.12874724424013748,"score_gpt":0.440328377803814,"score_spread":0.31158113356367656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992153,0.0019427977,0.0005864152,0.00205296,0.0005127634,0.00038873445,0.000070207614,0.000005694701,0.0022874442],"genre_scores_gemma":[0.99457306,0.0015415403,0.00015104347,0.0004975966,0.00052263186,0.00063540123,0.00008986472,0.00001591402,0.0019729615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885637,0.000044552286,0.00019042354,0.00037537364,0.00018623105,0.00034707302],"domain_scores_gemma":[0.9993,0.00004070119,0.000025045676,0.00025969706,0.00028681027,0.00008772335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004169523,0.000090916496,0.0000955395,0.00023860806,0.00018075085,0.00012967852,0.00018695922,0.000105921295,0.00017587516],"category_scores_gemma":[0.0002263709,0.000103643906,0.00003511577,0.00051977846,0.00004634705,0.000010678735,0.000116444724,0.0001977866,0.000018362824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039907572,0.00001662662,0.0015340119,0.000026384087,0.000022388915,0.0000035551727,0.000084614534,0.015130683,0.96395844,0.00034114165,0.01437402,0.0044682333],"study_design_scores_gemma":[0.00062947616,0.000051510557,0.02765865,0.00011734937,0.000009760128,9.0956655e-7,0.00038325627,0.00043802836,0.8930894,0.0005613273,0.07684466,0.00021567264],"about_ca_topic_score_codex":0.010891136,"about_ca_topic_score_gemma":0.01919677,"teacher_disagreement_score":0.070869036,"about_ca_system_score_codex":0.0007564796,"about_ca_system_score_gemma":0.001767022,"threshold_uncertainty_score":0.9987003},"labels":[],"label_agreement":null},{"id":"W4414349512","doi":"10.1158/1538-7445.ovarian25-b007","title":"Abstract B007: Parallel epigenetic and transcriptomic profiling of carcinoma and stroma compartments across major ovarian cancer histotypes","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Epigenetics; Stroma; Laser capture microdissection; Ovarian cancer; Transcriptome; Microdissection; Stromal cell; Ovarian carcinoma; Serous fluid; DNA methylation","score_opus":0.08109641091042127,"score_gpt":0.4209440016624834,"score_spread":0.33984759075206217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593413,0.037235547,0.00002052086,0.0017351848,0.00014691649,0.0008677762,0.000103058315,0.000016336695,0.0005333559],"genre_scores_gemma":[0.9949064,0.0035503346,0.00023720066,0.00010736405,0.000077440476,0.00050414936,0.000009604089,0.000023045852,0.0005844526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982286,0.00006570101,0.00032777185,0.0004530584,0.00040377956,0.000521108],"domain_scores_gemma":[0.99918824,0.00006771112,0.000053845575,0.00026856092,0.00024402507,0.00017761081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004588503,0.00016401146,0.00043288697,0.00015452961,0.00020168362,0.000039993083,0.00012998868,0.00010240398,0.00018865117],"category_scores_gemma":[0.000022367984,0.0001442929,0.000059192338,0.0003075206,0.00042823143,0.00005976724,0.00007439483,0.00035865777,0.0000015251159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017102743,0.00019197143,0.8028306,0.0025727132,0.00034106313,0.000017253682,0.0012795053,0.00001875665,0.16674046,0.00043706747,0.0011264164,0.02273396],"study_design_scores_gemma":[0.0034260887,0.00023972614,0.91695195,0.0006164911,0.00009926502,0.0000026009625,0.0005894426,0.00012445045,0.07583771,0.000114047245,0.0018642802,0.00013393538],"about_ca_topic_score_codex":0.004480973,"about_ca_topic_score_gemma":0.0009380587,"teacher_disagreement_score":0.114121415,"about_ca_system_score_codex":0.00027006664,"about_ca_system_score_gemma":0.0005318232,"threshold_uncertainty_score":0.67739207},"labels":[],"label_agreement":null},{"id":"W4414349817","doi":"10.1158/1538-7445.ovarian25-a018","title":"Abstract A018: Identifying and integrating global ovarian cancer patient priorities to guide artificial intelligence (AI) research in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Ovarian cancer; Context (archaeology); Disease; Cancer; Implementation research; Qualitative research; Alliance; MEDLINE","score_opus":0.12218855035724274,"score_gpt":0.5186538183863431,"score_spread":0.3964652680291003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176396,0.0077454904,0.0024371378,0.061290093,0.0012255055,0.0016532444,0.000053283176,0.00006268182,0.007892973],"genre_scores_gemma":[0.9937175,0.0014510779,0.0011775438,0.0013292155,0.00059865444,0.0007513749,0.0000059974577,0.000036205165,0.0009324167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99520636,0.00038016337,0.00075238623,0.0008790753,0.001420102,0.0013618978],"domain_scores_gemma":[0.99762535,0.00047480015,0.00006190685,0.0004438517,0.00090995093,0.00048412822],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045455066,0.00023961229,0.00046878384,0.0009225023,0.00053962856,0.00039858095,0.0004170988,0.00017474353,0.00046492662],"category_scores_gemma":[0.0020521595,0.00021845012,0.000066459696,0.002589126,0.0005522876,0.00018052904,0.0005478931,0.0027122553,0.000016253245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058390276,0.00012794764,0.069738254,0.0008786768,0.00011625777,0.0003171132,0.003985683,0.00047447067,0.025095202,0.011267373,0.010801126,0.876614],"study_design_scores_gemma":[0.0045109056,0.0012785883,0.51725054,0.05845055,0.00021919087,0.00010459846,0.051697023,0.033775833,0.064985275,0.07200287,0.19326867,0.002455984],"about_ca_topic_score_codex":0.095987946,"about_ca_topic_score_gemma":0.015588798,"teacher_disagreement_score":0.874158,"about_ca_system_score_codex":0.002720105,"about_ca_system_score_gemma":0.0028970335,"threshold_uncertainty_score":0.99958855},"labels":[],"label_agreement":null},{"id":"W4414349897","doi":"10.1158/1538-7445.ovarian25-b046","title":"Abstract B046: Homologous recombination DNA repair dependent survival associations in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis consortium study","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Hazard ratio; Proportional hazards model; Serous fluid; Ovarian cancer; Ovarian carcinoma; Logistic regression; Homologous recombination; Confidence interval","score_opus":0.08076117053666851,"score_gpt":0.4354161229136033,"score_spread":0.3546549523769348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117947,0.00036397387,0.00009868934,0.0034194053,0.00062588346,0.0020414281,0.00017467627,0.00018398628,0.0019125055],"genre_scores_gemma":[0.99591565,0.000065517284,0.00013896564,0.00020015496,0.00022681674,0.0011320377,0.00021736707,0.000042507825,0.0020610099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948384,0.0012531567,0.0008336601,0.0009807344,0.0012942194,0.0007998252],"domain_scores_gemma":[0.99715835,0.0004861397,0.00018956195,0.0010162857,0.0008887658,0.000260902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004047933,0.00026514506,0.0007863452,0.0019845734,0.0003970754,0.000109264976,0.00035732344,0.0002071106,0.0008643784],"category_scores_gemma":[0.00041272852,0.0002814737,0.00015604368,0.0042360574,0.00017100062,0.00022720043,0.000108419066,0.001152893,0.0000305068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006997913,0.0033763242,0.9759011,0.00010562625,0.0014818368,0.0008516475,0.0017110119,0.00042318227,0.011047449,0.0012886222,0.0013752265,0.0017381627],"study_design_scores_gemma":[0.0058883517,0.00050124724,0.98315084,0.00006369804,0.00035599203,0.0000061433957,0.001729404,0.00016835169,0.006754645,0.0008694842,0.00028113805,0.0002307162],"about_ca_topic_score_codex":0.038882915,"about_ca_topic_score_gemma":0.03574488,"teacher_disagreement_score":0.0072497088,"about_ca_system_score_codex":0.0035384458,"about_ca_system_score_gemma":0.0016103925,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W4414349913","doi":"10.1158/1538-7445.ovarian25-b018","title":"Abstract B018: Dual roles of LATS1/2 in ovarian cancer reveal critical context dependence of hippo pathway signaling","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Hippo signaling pathway; Gene knockdown; Ovarian cancer; Transcription factor; Context (archaeology); Kinase; Signal transduction; Phosphorylation; Suppressor","score_opus":0.05425187886102571,"score_gpt":0.3969029614725911,"score_spread":0.34265108261156535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897496,0.008069647,0.00011570736,0.00043885695,0.00013505088,0.0002006701,0.00016192066,0.0000051102506,0.0011234537],"genre_scores_gemma":[0.99867547,0.00038831448,0.00008665857,0.000071751565,0.00014610493,0.00009988491,0.000015813268,0.000017636772,0.0004983917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980352,0.00021342588,0.00043923396,0.00043022737,0.0004067844,0.00047512923],"domain_scores_gemma":[0.9987733,0.00019775884,0.00006496309,0.0003378113,0.0005278262,0.00009837241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012778796,0.00014004264,0.00028851777,0.00019388286,0.000077177465,0.000018220231,0.00032196267,0.00023737868,0.00015468943],"category_scores_gemma":[0.000557587,0.00013727073,0.00008822965,0.00036068112,0.00037091787,0.000007187401,0.00015353905,0.0004134549,0.0000028775914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003083034,0.00009392491,0.0049750055,0.0002823493,0.000045132263,0.00001767322,0.00021491558,0.00022268789,0.98257667,0.0007891711,0.00017170752,0.010302474],"study_design_scores_gemma":[0.0005719691,0.00012476329,0.0031867048,0.0006456355,0.000007870356,0.0000012284996,0.00039228957,0.000023127033,0.9931809,0.00042523394,0.0013133945,0.00012689341],"about_ca_topic_score_codex":0.0022532786,"about_ca_topic_score_gemma":0.0018075161,"teacher_disagreement_score":0.010604234,"about_ca_system_score_codex":0.0000670316,"about_ca_system_score_gemma":0.0012823102,"threshold_uncertainty_score":0.5597738},"labels":[],"label_agreement":null},{"id":"W4414350130","doi":"10.1158/1538-7445.ovarian25-a011","title":"Abstract A011: PAX8-dependent signaling networks as drivers of progression and immune evasion in high grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"PAX8; Tumor progression; Neuroblastoma RAS viral oncogene homolog; Tumor microenvironment; SMAD; Transcription factor; Ovarian cancer; MHC class I; Immune system","score_opus":0.032402602929779,"score_gpt":0.38505489274572363,"score_spread":0.35265228981594465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414350130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985261,0.01358484,0.000072864525,0.00025771986,0.00019853916,0.00042322784,0.00002169085,0.000008842542,0.00017127125],"genre_scores_gemma":[0.99757683,0.0017482936,0.00007241472,0.00004969324,0.00011862439,0.0001958526,0.000032635355,0.000020721556,0.00018493737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983778,0.00015852985,0.0002627587,0.0004471035,0.0003570517,0.00039678198],"domain_scores_gemma":[0.99925447,0.00005413682,0.000073166906,0.00032561523,0.00019198608,0.00010063977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073786336,0.00013556072,0.00018108424,0.00013247639,0.0001205985,0.000030541007,0.00027836263,0.00020297569,0.00008448127],"category_scores_gemma":[0.00011034317,0.00012882547,0.00004828377,0.00030671025,0.00018985785,0.0000063413017,0.0002855711,0.00034975068,0.0000010330236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051737094,0.00010204691,0.018481804,0.00015608578,0.000061651226,0.0000264719,0.0000841111,0.004647688,0.960847,0.000081198275,0.0002748922,0.014719648],"study_design_scores_gemma":[0.0013709104,0.00012360403,0.02340547,0.00077834877,0.000016295264,0.0000010941149,0.00014960105,0.00018592861,0.9731612,0.00035766134,0.00029884544,0.00015099475],"about_ca_topic_score_codex":0.002134874,"about_ca_topic_score_gemma":0.000263364,"teacher_disagreement_score":0.014568654,"about_ca_system_score_codex":0.000117823154,"about_ca_system_score_gemma":0.00048802854,"threshold_uncertainty_score":0.525335},"labels":[],"label_agreement":null},{"id":"W4414350165","doi":"10.1158/1538-7445.ovarian25-a016","title":"Abstract A016: Empowering ovarian cancer patients using CancerStop: A webapp for integrating survivorship data, clinical trials, and more features for improved outcomes","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"3v Geomatics (Canada)","funders":"","keywords":"Survivorship curve; Personalized medicine; Scalability; Clinical trial; Precision medicine; JavaScript; Documentation; Cancer","score_opus":0.3622858765974937,"score_gpt":0.6044427043004006,"score_spread":0.24215682770290692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414350165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97472596,0.010093557,0.0012565737,0.003953981,0.00243882,0.005703331,0.001712615,0.000048076316,0.00006706183],"genre_scores_gemma":[0.99088407,0.0029847187,0.0018787235,0.0006748681,0.0013930748,0.0010674858,0.00035906836,0.000076806486,0.00068121566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967177,0.00034358705,0.0008991477,0.0008170355,0.0004255514,0.00079697435],"domain_scores_gemma":[0.9951297,0.0028434005,0.00018929453,0.0007193547,0.00075015944,0.00036811392],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010051422,0.00024332703,0.0012104625,0.00029417986,0.00047734258,0.0001015052,0.00029547964,0.00029376586,0.00002554598],"category_scores_gemma":[0.00844985,0.0001767592,0.0003880323,0.00034428382,0.00019551838,0.00013906286,0.00021280845,0.0008682557,2.8206108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006938257,0.00021638874,0.60700303,0.0042229947,0.0021287021,0.0000057585908,0.0008153631,0.000022787555,0.0027618255,0.00011382055,0.013130175,0.3626409],"study_design_scores_gemma":[0.01930766,0.00039353722,0.9090001,0.002254088,0.0008258063,0.000002228941,0.0017602108,0.0035400356,0.0012285158,0.00015373081,0.06102409,0.0005100063],"about_ca_topic_score_codex":0.04601905,"about_ca_topic_score_gemma":0.016502745,"teacher_disagreement_score":0.36213088,"about_ca_system_score_codex":0.00064428954,"about_ca_system_score_gemma":0.0027365463,"threshold_uncertainty_score":0.9999024},"labels":[],"label_agreement":null},{"id":"W4414494210","doi":"10.1158/1538-7445.pediatric25-a002-pr011","title":"Abstract A002-PR011: Precision Diagnosis in High-Risk Pediatric Oncology through Integrated Whole Genome, Transcriptome, and Epigenome Profiling","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Germline; Epigenome; Precision medicine; Pediatric cancer; Copy-number variation; Germline mutation; Rhabdomyosarcoma; Childhood cancer; DNA methylation","score_opus":0.06733933130728756,"score_gpt":0.41902864920602256,"score_spread":0.35168931789873503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414494210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500342,0.042023186,0.000026030853,0.0039766897,0.00027014,0.0017501117,0.00022014475,0.000039865106,0.0016596051],"genre_scores_gemma":[0.8922477,0.10388975,0.00038056175,0.00014789375,0.00022606304,0.0024937564,0.00007431837,0.000031429063,0.00050854555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736387,0.00022158476,0.0005154601,0.0007246157,0.0004803484,0.0006941071],"domain_scores_gemma":[0.99826777,0.00076159986,0.000077115015,0.00038828843,0.00032100137,0.000184206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001053521,0.00023524275,0.0005947829,0.00073058123,0.00020466851,0.000058952468,0.00017805166,0.00023727841,0.0004511141],"category_scores_gemma":[0.00023327162,0.00019282023,0.00009149495,0.001712962,0.00017815523,0.00014169139,0.000100688536,0.001054604,0.00003803678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010587958,0.0013355857,0.88074565,0.00067807,0.0002078547,0.00023014317,0.001395942,0.0000936189,0.008106863,0.00026583494,0.003263166,0.10261847],"study_design_scores_gemma":[0.005668825,0.0009451218,0.91178125,0.00045345532,0.00019116083,0.0000027221174,0.00070326775,0.000016601753,0.0075968625,0.0010796037,0.07134241,0.00021872905],"about_ca_topic_score_codex":0.012101623,"about_ca_topic_score_gemma":0.0028175693,"teacher_disagreement_score":0.102399744,"about_ca_system_score_codex":0.0018560598,"about_ca_system_score_gemma":0.0012304743,"threshold_uncertainty_score":0.99447685},"labels":[],"label_agreement":null},{"id":"W4414494212","doi":"10.1158/1538-7445.pediatric25-b009","title":"Abstract B009: Cancer-associated fibroblasts remodel the extracellular matrix in Adamantinomatous Craniopharyngioma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Extracellular matrix; Tumor microenvironment; Carcinogenesis; Immune system; Somatic cell; Population; Wnt signaling pathway; Cell; Pituitary tumors","score_opus":0.04591557389301073,"score_gpt":0.4026074429286863,"score_spread":0.35669186903567557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414494212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483411,0.04154015,0.0000060461484,0.0047140205,0.0001373961,0.0008152503,0.00004545307,0.000041968437,0.0043586553],"genre_scores_gemma":[0.98373103,0.0023497408,0.000016394064,0.00010019628,0.00006107804,0.00027852948,0.000027685839,0.000023729777,0.013411617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979977,0.00010306943,0.00029847535,0.00039002282,0.00053603225,0.00067472836],"domain_scores_gemma":[0.99906254,0.00018821281,0.00004588672,0.0004014679,0.00018489483,0.00011697466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005501077,0.00017322661,0.00031395498,0.00030133122,0.00024279757,0.000042766333,0.00020640327,0.00013229817,0.00039498144],"category_scores_gemma":[0.00010216139,0.000119388686,0.0001045772,0.0009835238,0.00013131964,0.00008468996,0.00009372944,0.0005400271,0.000034570287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004943276,0.0040460257,0.72312194,0.001791237,0.0016809764,0.0049614864,0.0019845907,0.001192392,0.09980285,0.002859807,0.093820386,0.059795048],"study_design_scores_gemma":[0.009254552,0.00020106907,0.9708106,0.0018886903,0.00010864059,0.000016365804,0.00042684886,0.0028510166,0.0042279195,0.002603496,0.00732933,0.0002814695],"about_ca_topic_score_codex":0.012667365,"about_ca_topic_score_gemma":0.0033352545,"teacher_disagreement_score":0.24768868,"about_ca_system_score_codex":0.00045886103,"about_ca_system_score_gemma":0.0008284751,"threshold_uncertainty_score":0.9939074},"labels":[],"label_agreement":null},{"id":"W4414494221","doi":"10.1158/1538-7445.pediatric25-a015","title":"Abstract A015: Targetable gene dependencies in Ewing sarcoma subtypes","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation","funders":"","keywords":"Sarcoma; Fusion gene; Cancer; Overall survival; Gene; Disease; Survival analysis; Transcriptome","score_opus":0.09356385813911976,"score_gpt":0.424077510300553,"score_spread":0.33051365216143325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414494221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95531553,0.030193012,0.0000029272273,0.0036149344,0.000113362774,0.00041863613,0.000008280027,0.000026021253,0.010307321],"genre_scores_gemma":[0.99490595,0.0021541598,0.00016037258,0.00019915772,0.00008909275,0.0003511668,0.000010536451,0.000014614607,0.0021149276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984573,0.000054920605,0.00019698791,0.00031395972,0.00045530335,0.00052150496],"domain_scores_gemma":[0.9991576,0.0002450687,0.000016988553,0.00030703572,0.00017290891,0.00010040877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006198705,0.00010659257,0.000245102,0.000418155,0.00011862871,0.000042081065,0.00013359249,0.000075866505,0.00052984967],"category_scores_gemma":[0.00015385501,0.000087779656,0.000061410545,0.00069872965,0.00008182455,0.0000728894,0.00009286179,0.0003791966,0.000085385254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021417486,0.0005264956,0.9044011,0.00019716095,0.00012282835,0.0005756199,0.00020057918,0.000024710818,0.047416814,0.0007430787,0.006785235,0.03879217],"study_design_scores_gemma":[0.0014772803,0.000051412077,0.7657174,0.00038861565,0.000019738447,0.0000054621946,0.00029867882,0.000023824738,0.21946257,0.00055489055,0.011917775,0.00008233972],"about_ca_topic_score_codex":0.004254399,"about_ca_topic_score_gemma":0.0010848735,"teacher_disagreement_score":0.17204575,"about_ca_system_score_codex":0.00057142886,"about_ca_system_score_gemma":0.0005884229,"threshold_uncertainty_score":0.6431407},"labels":[],"label_agreement":null},{"id":"W4414501274","doi":"10.1158/1538-7445.pediatric25-a032","title":"Abstract A032: Molecular insights into KIAA1549::BRAF fusion proteins: Implications for targeted therapy in pediatric low-grade gliomas","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Exon; Targeted therapy; Fusion protein; Oncogene; Fusion gene; Transmembrane protein; Mutant; Breakpoint","score_opus":0.05177316341912982,"score_gpt":0.4160820977085943,"score_spread":0.3643089342894645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552143,0.029670093,0.000047308396,0.010702343,0.000074964475,0.0038625177,0.000013540321,0.00003877933,0.0003761049],"genre_scores_gemma":[0.98446864,0.006744975,0.0002923053,0.00024394778,0.00012987068,0.007948694,0.00006224207,0.000029736675,0.00007959487],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830717,0.00007198648,0.00030314512,0.0004934385,0.0003559985,0.00046828043],"domain_scores_gemma":[0.99868643,0.00020443727,0.000046107405,0.00049664464,0.00041063555,0.00015571405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031323032,0.00016638153,0.0002669508,0.00100164,0.00019930753,0.0000450258,0.00019585664,0.00014170093,0.00006515775],"category_scores_gemma":[0.0001598635,0.00013183239,0.00011366883,0.0019073766,0.000071421484,0.00006904075,0.000065211534,0.00030802586,0.000016993135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005527385,0.0021881151,0.065529875,0.0006302668,0.00014166073,0.000116423624,0.0005538753,0.000056941066,0.8838212,0.0027761818,0.0041754837,0.039457254],"study_design_scores_gemma":[0.005756244,0.00043292769,0.5490324,0.00028906815,0.00003273951,0.0000014293256,0.00006845722,0.000041613726,0.43005896,0.0059082475,0.008216572,0.00016136837],"about_ca_topic_score_codex":0.0010726423,"about_ca_topic_score_gemma":0.00037580627,"teacher_disagreement_score":0.4835025,"about_ca_system_score_codex":0.0005011213,"about_ca_system_score_gemma":0.00071604975,"threshold_uncertainty_score":0.5375969},"labels":[],"label_agreement":null},{"id":"W4414501314","doi":"10.1158/1538-7445.pediatric25-b048","title":"Abstract B048: The Ewing Sarcoma Institute – a catalyst to improve outcomes for patients with Ewing sarcoma globally","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sarcoma; Disease; Critical mass (sociodynamics); Cancer; Ewing's sarcoma; Overall survival; Localized disease","score_opus":0.05405215986866899,"score_gpt":0.4022581310962363,"score_spread":0.3482059712275673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771186,0.0009856108,0.0000555154,0.015931148,0.0003362054,0.0033058238,0.00014536292,0.000044782297,0.0020769197],"genre_scores_gemma":[0.99486583,0.000046394885,0.00040629163,0.0013416128,0.00012538198,0.0021166422,0.000052230953,0.000031980744,0.0010136121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752414,0.000042781103,0.00030172907,0.000537309,0.00084398163,0.000750042],"domain_scores_gemma":[0.9979483,0.000481531,0.000050465165,0.00069602736,0.00060237746,0.00022129781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056794385,0.00023223221,0.00040069903,0.00025086326,0.00049654255,0.00014316128,0.00039279868,0.00007469973,0.00003368633],"category_scores_gemma":[0.0003843444,0.00013384147,0.00014601232,0.0006717235,0.00016114673,0.00013747254,0.00022491015,0.0003268579,0.000026999624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009807983,0.00088136195,0.84774363,0.00027065858,0.0007292721,0.000059913404,0.00034905437,0.000012689627,0.0011444018,0.00088574487,0.0077468613,0.1391956],"study_design_scores_gemma":[0.004929017,0.00040135905,0.94374686,0.0005989897,0.00013565694,0.0000015477276,0.00022249388,0.000010505229,0.00451929,0.00013006615,0.045143325,0.00016088417],"about_ca_topic_score_codex":0.0026091055,"about_ca_topic_score_gemma":0.001176831,"teacher_disagreement_score":0.13903472,"about_ca_system_score_codex":0.0008729008,"about_ca_system_score_gemma":0.0007116885,"threshold_uncertainty_score":0.5457897},"labels":[],"label_agreement":null},{"id":"W4414501315","doi":"10.1158/1538-7445.pediatric25-b006","title":"Abstract B006: Tissue-specific mutational outcomes underlying the late effects of anthracyclines on tumours, blood, and heart","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Somatic cell; Chromatin; Cancer; Doxorubicin; Pediatric cancer; Cardiotoxicity; Germline mutation; Cancer cell; Epigenome","score_opus":0.08474799071712018,"score_gpt":0.4460807572606497,"score_spread":0.3613327665435295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869887,0.002531781,0.00001531277,0.008755847,0.00012878887,0.00056678173,0.0000063234042,0.000015787462,0.0009906604],"genre_scores_gemma":[0.9973331,0.0009732239,0.000031959957,0.00038420488,0.00007616223,0.000060988456,0.000006662772,0.000011224196,0.001122462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989852,0.000073040595,0.00015493769,0.00017308776,0.00042164468,0.00019213997],"domain_scores_gemma":[0.9985783,0.0009871514,0.000030170404,0.00019453652,0.00015887822,0.000050937593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047634981,0.000084604915,0.00020995837,0.0001497387,0.0001638731,0.000027389242,0.00006780399,0.00006368391,0.000038615457],"category_scores_gemma":[0.0001584276,0.000058708792,0.000051934036,0.0002724076,0.00022791364,0.000041727722,0.000023269884,0.00034644167,0.000004904962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012454219,0.0000866569,0.008035845,0.00036736295,0.00010507549,0.000013988713,0.000319777,0.00002082093,0.97422284,0.0010072262,0.001088382,0.014607501],"study_design_scores_gemma":[0.0009312997,0.00007704153,0.42157358,0.00038430234,0.000017966395,0.0000032640598,0.00011904953,0.000003920222,0.5751343,0.00052231626,0.0011970662,0.000035888803],"about_ca_topic_score_codex":0.00011855391,"about_ca_topic_score_gemma":0.0000179856,"teacher_disagreement_score":0.41353774,"about_ca_system_score_codex":0.00006197073,"about_ca_system_score_gemma":0.00016516577,"threshold_uncertainty_score":0.2394075},"labels":[],"label_agreement":null},{"id":"W4414501344","doi":"10.1158/1538-7445.pediatric25-b002","title":"Abstract B002: Rapid and accurate diagnosis of childhood cancers using long-read nanopore RNA sequencing","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nanopore sequencing; Concordance; Pediatric cancer; DNA sequencing; Turnaround time; Liquid biopsy; Cancer; Nanopore; Whole genome sequencing","score_opus":0.051782287145529245,"score_gpt":0.38826439450061,"score_spread":0.3364821073550808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750911,0.021324186,0.00070758606,0.00031526384,0.00020100598,0.0006697248,0.00009068705,0.000012861665,0.0015875795],"genre_scores_gemma":[0.98545146,0.01341592,0.00014657197,0.00010192815,0.00015510492,0.00023384279,0.000033183973,0.000045060897,0.00041690312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753505,0.00017153613,0.00033298502,0.0006775198,0.00055738655,0.0007255517],"domain_scores_gemma":[0.99853903,0.00006888312,0.000095549774,0.0005735096,0.00054406846,0.00017895609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008600615,0.00021451448,0.0002757482,0.00035129098,0.00025506542,0.00006812975,0.00042753594,0.00027829225,0.00025183745],"category_scores_gemma":[0.00032537844,0.00021993111,0.0001027471,0.00072406273,0.00038708796,0.000013319496,0.00045279218,0.00053937326,0.000002485268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015759627,0.00003539523,0.00047579265,0.00029123417,0.00023046446,0.000021082491,0.000115111994,0.0010989791,0.969022,0.000066496956,0.0011851072,0.027300755],"study_design_scores_gemma":[0.0008304046,0.00016265435,0.0019027543,0.00050924026,0.000026919266,0.0000063238176,0.0002481168,0.00017886928,0.992722,0.000120806406,0.0030810058,0.00021090142],"about_ca_topic_score_codex":0.0031482573,"about_ca_topic_score_gemma":0.0007974071,"teacher_disagreement_score":0.027089853,"about_ca_system_score_codex":0.0005415927,"about_ca_system_score_gemma":0.0027344478,"threshold_uncertainty_score":0.896853},"labels":[],"label_agreement":null},{"id":"W4414501450","doi":"10.1158/1538-7445.pediatric25-b039","title":"Abstract B039: Exploring the early genetic determinants of tumor risk in Li-Fraumeni Syndrome","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germline; Loss of heterozygosity; Germline mutation; Cancer; Somatic cell; Copy-number variation; Genetic testing; Somatic evolution in cancer; Phenotype; Mutation","score_opus":0.0894172256259024,"score_gpt":0.3919187760436579,"score_spread":0.3025015504177555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366075,0.0040682917,0.000011182451,0.0002642801,0.00026553826,0.00080775545,0.000019244244,0.000019716212,0.00088324683],"genre_scores_gemma":[0.9975029,0.0013140687,0.00005053432,0.000038518767,0.000052653315,0.00057640445,9.220781e-7,0.000031385596,0.0004326067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790865,0.00014757371,0.0003935405,0.0003584938,0.00064022216,0.000551542],"domain_scores_gemma":[0.9987238,0.0002189679,0.00007252636,0.00067454734,0.00020304252,0.00010709301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091452536,0.0001320935,0.00032004798,0.0004809483,0.00010672538,0.000024278357,0.00033073738,0.000069251866,0.00012463708],"category_scores_gemma":[0.00036723653,0.00010356387,0.00008988012,0.0011409529,0.00024967603,0.00006184295,0.00017152417,0.0010258792,0.00004121053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016867219,0.0004605629,0.524629,0.0019181321,0.00035656197,0.004025616,0.0034975922,0.0008881795,0.20648105,0.00009058437,0.0015145381,0.25445142],"study_design_scores_gemma":[0.0012583361,0.0002152602,0.92538935,0.0014426648,0.00003461643,0.000033445853,0.00021871479,0.00011771713,0.069924764,0.00019206914,0.0010794626,0.00009361415],"about_ca_topic_score_codex":0.007200713,"about_ca_topic_score_gemma":0.0011604418,"teacher_disagreement_score":0.40076032,"about_ca_system_score_codex":0.00045848743,"about_ca_system_score_gemma":0.00084635045,"threshold_uncertainty_score":0.99941045},"labels":[],"label_agreement":null},{"id":"W4414501637","doi":"10.1158/1538-7445.pediatric25-a019","title":"Abstract A019: Precision radiotherapy for incurable brain tumors: Phase 1b dose &amp; regimen optimization study of iopofosine I 131 in inoperable relapsed or refractory pediatric high-grade glioma, interim data assessment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Regimen; Radiation therapy; Refractory (planetary science); Glioma; Dosing; Lesion; Mallinckrodt; Oligodendroglioma","score_opus":0.14727339645582027,"score_gpt":0.5058630963695415,"score_spread":0.35858969991372125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884651,0.002903642,0.0004534173,0.0024308318,0.00018032236,0.0052755745,0.00015974749,0.000032133274,0.00009924729],"genre_scores_gemma":[0.9903825,0.002167635,0.0040676296,0.00006957498,0.00016876159,0.0018112784,0.00045540748,0.000052333166,0.000824892],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673295,0.0003502957,0.00077503,0.0008268865,0.00079400727,0.00052085525],"domain_scores_gemma":[0.9966299,0.0012172912,0.00019187448,0.0013875278,0.00043655967,0.00013686994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024171346,0.0002479184,0.0006799282,0.0012931387,0.0001645654,0.00008312352,0.0005222751,0.00013449909,0.00042269318],"category_scores_gemma":[0.0007383336,0.00018846426,0.0000558379,0.0019302281,0.00007141682,0.0003403234,0.00024626584,0.00048003436,0.0000025779327],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054401197,0.20217949,0.058140185,0.0045213783,0.002283287,0.0011205098,0.005229663,0.020435294,0.31444868,0.00027782284,0.25014004,0.08682244],"study_design_scores_gemma":[0.5854066,0.05392888,0.1890089,0.009417416,0.0012909218,0.000050074064,0.006503981,0.03730169,0.064343326,0.00041911806,0.050187677,0.002141433],"about_ca_topic_score_codex":0.0040150103,"about_ca_topic_score_gemma":0.00082962465,"teacher_disagreement_score":0.5310054,"about_ca_system_score_codex":0.0012427607,"about_ca_system_score_gemma":0.0013511569,"threshold_uncertainty_score":0.76853496},"labels":[],"label_agreement":null},{"id":"W4414501656","doi":"10.1158/1538-7445.pediatric25-a017-pr013","title":"Abstract A017-PR013: Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: An update from the iMATRIX alectinib phase I/II open-label, multi-center study","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Alectinib; Anaplastic lymphoma kinase; Phases of clinical research; Pleomorphic xanthoastrocytoma; Lymphoma; Hematopathology; Crizotinib","score_opus":0.09833172118076185,"score_gpt":0.5130758411045395,"score_spread":0.4147441199237777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414501656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925005,0.0011017598,0.0000096698295,0.0013994294,0.000112316346,0.004442284,0.00021259075,0.000037595502,0.00018386067],"genre_scores_gemma":[0.99683136,0.00067475147,0.00019110196,0.00039085041,0.00013975738,0.0009170708,0.00009537764,0.00004498638,0.0007147282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764436,0.00019408026,0.00035423975,0.00073508377,0.0004790244,0.00059318607],"domain_scores_gemma":[0.99874026,0.00010464146,0.000076952114,0.00061524706,0.00023949763,0.00022342247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005563478,0.00024540108,0.00038892127,0.00025551298,0.0007646455,0.00023114284,0.00045294172,0.000062419946,0.00017869183],"category_scores_gemma":[0.00011659817,0.00014707945,0.000022473896,0.0008612861,0.00016758185,0.0003090269,0.000419698,0.0007532903,0.000009340898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005982412,0.019817693,0.9362654,0.00007495915,0.00083348696,0.00024156016,0.0046275174,0.00001050633,0.0029031988,0.000010162572,0.0023057826,0.02692733],"study_design_scores_gemma":[0.075616,0.0023361985,0.91440153,0.0024218208,0.00023855195,0.000015477817,0.0026573187,0.00012754125,0.0010225243,0.00001902065,0.00090589456,0.00023813926],"about_ca_topic_score_codex":0.01719411,"about_ca_topic_score_gemma":0.0138028,"teacher_disagreement_score":0.06963359,"about_ca_system_score_codex":0.00041385798,"about_ca_system_score_gemma":0.0011740191,"threshold_uncertainty_score":0.9893505},"labels":[],"label_agreement":null},{"id":"W4414502431","doi":"10.1158/1538-7445.pediatric25-b046","title":"Abstract B046: Filtering artifactual signal for DNA-methylation arrays in pediatric tumors: A benchmarking of preprocessing algorithms","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université du Québec; Bureau de Coopération Interuniversitaire; Université Laval","funders":"","keywords":"Preprocessor; Concordance; Context (archaeology); Benchmarking; Pediatric cancer; Epigenetics; Filter (signal processing); Bisulfite sequencing; Pattern recognition (psychology)","score_opus":0.1334748883009748,"score_gpt":0.4814907804443421,"score_spread":0.34801589214336737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414502431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899604,0.0042598005,0.0027382716,0.0005237854,0.00009429569,0.0016437654,0.000019264808,0.000034679622,0.00072577846],"genre_scores_gemma":[0.9968953,0.0003927842,0.0012835973,0.00005915242,0.0004739742,0.0006557274,0.000009441263,0.000035613935,0.00019438213],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969524,0.00012185196,0.0006115301,0.00051972887,0.0009902105,0.0008042716],"domain_scores_gemma":[0.99750334,0.0011954699,0.00010156167,0.00030081166,0.00070181966,0.00019698802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003558204,0.00013765827,0.00035810706,0.0012557565,0.0001673965,0.000042137013,0.0002189042,0.0001298467,0.00023406622],"category_scores_gemma":[0.0012881831,0.0001347536,0.00007379777,0.0015687305,0.00013807273,0.00018205745,0.00012827475,0.00082469505,0.000007151311],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022655514,0.00024457625,0.022277776,0.016505713,0.0000357547,0.00005890625,0.0009983695,0.0006889354,0.23615433,0.00007069903,0.00030884543,0.72039056],"study_design_scores_gemma":[0.005871579,0.0011668233,0.33894515,0.0052555148,0.0000402651,0.000005379925,0.0006825088,0.013463495,0.62665635,0.0017600643,0.0057409974,0.00041187435],"about_ca_topic_score_codex":0.00033272768,"about_ca_topic_score_gemma":0.00008504282,"teacher_disagreement_score":0.7199787,"about_ca_system_score_codex":0.00067581923,"about_ca_system_score_gemma":0.0030402255,"threshold_uncertainty_score":0.5495092},"labels":[],"label_agreement":null},{"id":"W4414502449","doi":"10.1158/1538-7445.pediatric25-b019","title":"Abstract B019: O-mannosylation represents a therapeutic opportunity in BRAF fusion protein oncogenesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Carcinogenesis; Fusion protein; Fusion gene; Gene silencing; MAPK/ERK pathway; Cancer; Gene","score_opus":0.0879244846316891,"score_gpt":0.446756095879901,"score_spread":0.3588316112482119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414502449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896174,0.003126454,0.00003289424,0.0010514444,0.00005958298,0.00095675467,0.000031435637,0.000010880917,0.0051131216],"genre_scores_gemma":[0.9932439,0.001250105,0.000014744342,0.00008757007,0.00009516204,0.0007445395,0.00009299602,0.00001800877,0.004453006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980914,0.00022290222,0.00020886658,0.00050839246,0.00044714517,0.00052126567],"domain_scores_gemma":[0.99903214,0.000030348092,0.00003540995,0.000510393,0.00023606178,0.00015562358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073267106,0.00012968217,0.00013819787,0.00028886448,0.00016659757,0.00005566572,0.00029819802,0.0001446572,0.0002044752],"category_scores_gemma":[0.00019784193,0.000120844095,0.00006471793,0.00058051734,0.00012164194,0.000010230248,0.00025286208,0.0002844692,0.000020074878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008097576,0.000258369,0.029638067,0.00009335599,0.00008545621,0.00003295902,0.000035349036,0.00003270062,0.8871669,0.000080632504,0.0020358188,0.079730645],"study_design_scores_gemma":[0.0023321046,0.00029747884,0.16486648,0.00026308687,0.000008376388,0.0000016951326,0.000118905315,0.000045282908,0.7854233,0.0012545707,0.045159977,0.00022877261],"about_ca_topic_score_codex":0.00588341,"about_ca_topic_score_gemma":0.00453989,"teacher_disagreement_score":0.13522841,"about_ca_system_score_codex":0.00025414865,"about_ca_system_score_gemma":0.0010745454,"threshold_uncertainty_score":0.8893995},"labels":[],"label_agreement":null},{"id":"W4414502452","doi":"10.1158/1538-7445.pediatric25-b040","title":"Abstract B040: Uncovering senescence-driven pathways in diffuse midline glioma progression and treatment resistance","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Senescence; Malignancy; Radiation therapy; Phenotype; Cancer; Microglia; Paracrine signalling; Tumor progression","score_opus":0.06993601726399137,"score_gpt":0.40778049626668833,"score_spread":0.337844479002697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414502452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867755,0.0080505125,0.0000013202255,0.0026853068,0.000072856325,0.00093882316,0.00002146726,0.000031069736,0.0014231168],"genre_scores_gemma":[0.9946937,0.0038398772,0.00016234597,0.000031632797,0.000069449765,0.00075595337,0.000012946706,0.000017061273,0.00041705807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984125,0.000060367,0.00023099531,0.00045105608,0.0003947042,0.00045037802],"domain_scores_gemma":[0.9991757,0.00017291571,0.00003354099,0.00033180707,0.00012940887,0.00015660707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002258239,0.00016356441,0.00029727086,0.00040458405,0.00013851936,0.000049797778,0.00007669059,0.00008630722,0.000042567845],"category_scores_gemma":[0.000075376534,0.000119254,0.000050117458,0.000686321,0.00012679132,0.000062992825,0.000081303486,0.00020339117,0.000008477913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019252481,0.0037669935,0.49753055,0.0007227532,0.00019024996,0.0036802802,0.00083187333,0.000029082505,0.37159663,0.0006288442,0.0014688891,0.117628604],"study_design_scores_gemma":[0.013271029,0.0005042721,0.710554,0.0048293294,0.000052090898,0.000010998243,0.00032052767,0.0000964165,0.25808865,0.0003188135,0.011741526,0.0002123377],"about_ca_topic_score_codex":0.00063685485,"about_ca_topic_score_gemma":0.0021570022,"teacher_disagreement_score":0.21302347,"about_ca_system_score_codex":0.0009354294,"about_ca_system_score_gemma":0.00034742468,"threshold_uncertainty_score":0.4863037},"labels":[],"label_agreement":null},{"id":"W4414509893","doi":"10.1158/1538-7445.pediatric25-a021","title":"Abstract A021: Standardized Oncogenic Classification Guidance of Critical Diagnostic and Therapeutic markers in pediatric cancers: NTRK fusions","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hamilton Health Sciences","funders":"","keywords":"Fusion gene; Trk receptor; Clinical significance; Cancer; Receptor tyrosine kinase; Hematopathology","score_opus":0.06779333936634896,"score_gpt":0.4845084661941785,"score_spread":0.4167151268278295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414509893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511228,0.03486184,0.00007793895,0.005452789,0.00022126827,0.0010060297,0.0001015102,0.00002076333,0.007135019],"genre_scores_gemma":[0.9898207,0.008895354,0.00013069632,0.00011113518,0.000094912866,0.0005411305,0.000010123768,0.00001424582,0.00038165742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984992,0.00010734022,0.00031247234,0.0003220969,0.00041715556,0.0003417289],"domain_scores_gemma":[0.99770033,0.0014639735,0.000039882685,0.00027000453,0.00040606144,0.00011972554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005390856,0.00010677797,0.00025736788,0.0003946166,0.00012604483,0.000022149388,0.00009251016,0.00008470795,0.00023056725],"category_scores_gemma":[0.00094368274,0.00009170112,0.000049617665,0.00092414895,0.00029467404,0.00005517681,0.000041935393,0.00031193768,0.000003820492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027269316,0.001075427,0.77808034,0.004037315,0.00054602313,0.00013074657,0.0021183968,0.00008437654,0.036079578,0.011594652,0.00807146,0.15545474],"study_design_scores_gemma":[0.0027286818,0.00016126908,0.99143624,0.00053010986,0.00022891052,0.0000017295383,0.0006197695,0.00009886012,0.0012260963,0.001103984,0.0017732519,0.00009110675],"about_ca_topic_score_codex":0.0016875028,"about_ca_topic_score_gemma":0.0006438815,"teacher_disagreement_score":0.21335588,"about_ca_system_score_codex":0.001055134,"about_ca_system_score_gemma":0.0025252867,"threshold_uncertainty_score":0.44797504},"labels":[],"label_agreement":null},{"id":"W4414531380","doi":"10.1158/1538-7445.pediatric25-a014","title":"Abstract A014: Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Hospital for Sick Children","funders":"","keywords":"Immune system; Disease; Gene; Cell; Cell type; Population; Cancer; Senescence; Gene expression; Glioma","score_opus":0.14654637777204124,"score_gpt":0.4317627171466533,"score_spread":0.2852163393746121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414531380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882203,0.0076515577,0.00006120879,0.0030401207,0.000059610895,0.0008327236,0.00007616492,0.0000071025747,0.00005124949],"genre_scores_gemma":[0.99795324,0.0012304693,0.000016213018,0.00006249817,0.0001117481,0.00058980327,0.000014169122,0.0000072520093,0.000014614783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992089,0.000038737464,0.0001510639,0.00020588332,0.00018508686,0.00021029379],"domain_scores_gemma":[0.99929345,0.00031582484,0.000033905646,0.00014190526,0.0001616195,0.000053268413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029882885,0.00006810519,0.0001459691,0.00017781179,0.00015834687,0.000011298911,0.000067557805,0.000040690345,0.000022223061],"category_scores_gemma":[0.000053657634,0.000045605357,0.00006569437,0.000311453,0.000081095466,0.000026927293,0.000021511507,0.00011201898,0.0000014004585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004221002,0.00032127523,0.01870219,0.00078698783,0.00013888098,0.000007956455,0.00014024755,0.000014534602,0.9581042,0.019600626,0.0008149423,0.0009460547],"study_design_scores_gemma":[0.0035999352,0.00036268108,0.700164,0.0001423716,0.00017010726,0.0000059981135,0.00032516575,0.00016552144,0.28136852,0.013224323,0.00037597987,0.00009539788],"about_ca_topic_score_codex":0.000043111453,"about_ca_topic_score_gemma":0.000021463418,"teacher_disagreement_score":0.6814618,"about_ca_system_score_codex":0.00018873568,"about_ca_system_score_gemma":0.00018899201,"threshold_uncertainty_score":0.18597324},"labels":[],"label_agreement":null},{"id":"W4414532372","doi":"10.1158/1538-7445.pediatric25-a016","title":"Abstract A016: ews-nf: A custom workflow for tumor cell annotation and analysis of single-cell RNA-sequencing of paired patient Ewing sarcoma specimens from the Sean Karl cohort","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Sarcoma; Cancer; Metastasis; Fusion gene; Workflow; Cell; CD8; Primary tumor","score_opus":0.07708239893147757,"score_gpt":0.3514342762609594,"score_spread":0.27435187732948185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414532372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146706,0.00532753,0.000050801493,0.00060807925,0.00005822653,0.0011687081,0.00022207259,0.000011139238,0.0010863631],"genre_scores_gemma":[0.9985199,0.0002627588,0.0005994623,0.00009182164,0.000051026927,0.00027112008,0.00009374433,0.000017782106,0.00009235869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981779,0.00011513529,0.00044363807,0.00037767124,0.0005570573,0.00032859825],"domain_scores_gemma":[0.9973831,0.0014649477,0.00015967168,0.00041810013,0.00047989018,0.000094296185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000599758,0.00014350584,0.00048645012,0.00037321704,0.00014234518,0.00003223183,0.00012038182,0.000054679418,0.00010803742],"category_scores_gemma":[0.00015057958,0.00010282608,0.00019468104,0.0010226312,0.00015148996,0.000049470298,0.00007016435,0.00018394388,0.000001360888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066787255,0.0009060131,0.6440685,0.00036287378,0.0017977903,0.000045443016,0.0024630043,0.00035829644,0.3100824,0.00003617467,0.00181476,0.037396893],"study_design_scores_gemma":[0.002038479,0.00030994776,0.53561336,0.0006723618,0.0014804357,3.8246225e-7,0.0020381508,0.0015086613,0.45562032,0.00013573706,0.00047284487,0.000109321285],"about_ca_topic_score_codex":0.0043658246,"about_ca_topic_score_gemma":0.00043457982,"teacher_disagreement_score":0.14553791,"about_ca_system_score_codex":0.0005230167,"about_ca_system_score_gemma":0.00036765603,"threshold_uncertainty_score":0.65998495},"labels":[],"label_agreement":null},{"id":"W4414580626","doi":"10.1158/1538-7445.pancreatic25-a108","title":"Abstract A108: A Tissue-Specific Hydrogel Promotes the Enrichment of Pancreatic Cancer Stem Cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"","keywords":"Nestin; Pancreatic cancer; Stem cell; Cell culture; Cancer stem cell; Extracellular matrix; Side population","score_opus":0.10705790510015584,"score_gpt":0.42621835267995084,"score_spread":0.319160447579795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414580626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93356913,0.035822254,0.000017347686,0.0056160525,0.00025049737,0.0030086949,0.000037895024,0.00003720646,0.021640917],"genre_scores_gemma":[0.9469955,0.008263794,0.000029510178,0.00007229956,0.00021867272,0.0011691065,0.0000035537169,0.00003652023,0.043211058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957156,0.00024073302,0.00052368455,0.00058268127,0.0019711247,0.00096614286],"domain_scores_gemma":[0.99696195,0.00083614374,0.000090773145,0.0010184995,0.00082896574,0.00026364977],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023440777,0.00021736504,0.0005182199,0.0004045516,0.00026965962,0.000063000836,0.00063809566,0.00014194078,0.0031110065],"category_scores_gemma":[0.00008343341,0.00014049883,0.000114845825,0.0016493305,0.0006964107,0.00005904657,0.00031270404,0.0010287841,0.00016300095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056182605,0.00030549767,0.0047763544,0.0021757039,0.00029486173,0.0000815502,0.0007832519,0.000034447057,0.88019127,0.00093163276,0.031084253,0.078779325],"study_design_scores_gemma":[0.0010623418,0.00025564374,0.009084261,0.0014317378,0.00004762114,0.000003355024,0.00066469796,0.00009932158,0.8760365,0.00025676662,0.11092026,0.00013744939],"about_ca_topic_score_codex":0.0030854587,"about_ca_topic_score_gemma":0.00017084047,"teacher_disagreement_score":0.07983601,"about_ca_system_score_codex":0.0008314422,"about_ca_system_score_gemma":0.0016090308,"threshold_uncertainty_score":0.9978003},"labels":[],"label_agreement":null},{"id":"W4414580695","doi":"10.1158/1538-7445.pancreatic25-b102","title":"Abstract B102: A model for the origins of transcriptional heterogeneity in human pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Phenotype; KRAS; Pancreatic cancer; Transcriptome; Reprogramming; Genetic heterogeneity; Cancer; Mutation","score_opus":0.1928442172364106,"score_gpt":0.4912892216209611,"score_spread":0.2984450043845505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414580695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918676,0.0040491614,0.00095290935,0.0027497143,0.000047792713,0.0015044671,0.00006786744,0.000009951667,0.0014313511],"genre_scores_gemma":[0.99573433,0.00051059015,0.0002166657,0.00009028369,0.00009867273,0.0011422569,0.00001466648,0.000014093286,0.0021784478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982001,0.00009460629,0.00035595248,0.00029544358,0.0005417684,0.0005120823],"domain_scores_gemma":[0.99842596,0.0006889919,0.000033250508,0.0003677804,0.00038759303,0.0000964266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001564343,0.00010933884,0.00041723382,0.0003352565,0.00021463753,0.000013580669,0.00027353564,0.00012010673,0.0001871201],"category_scores_gemma":[0.00021054644,0.00007662952,0.0001250728,0.0004715017,0.0005398182,0.000045875415,0.000050061186,0.00054767384,0.0000036207884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019501551,0.0005101987,0.77112496,0.0012203584,0.00044548436,0.000028526118,0.0008123521,0.0003159274,0.19173475,0.029179193,0.0018067657,0.0008713491],"study_design_scores_gemma":[0.0035518154,0.00026399523,0.9587514,0.00037755407,0.00013621185,0.0000066693688,0.00030364434,0.027377157,0.0055053267,0.0030209776,0.0006197139,0.00008556945],"about_ca_topic_score_codex":0.002139936,"about_ca_topic_score_gemma":0.0011509137,"teacher_disagreement_score":0.18762642,"about_ca_system_score_codex":0.0007204072,"about_ca_system_score_gemma":0.001805764,"threshold_uncertainty_score":0.32349575},"labels":[],"label_agreement":null},{"id":"W4414580704","doi":"10.1158/1538-7445.pancreatic25-b049","title":"Abstract B049: Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose <i>de novo</i> lipogenesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Lipogenesis; Cachexia; Wasting; Adipose tissue; Pancreatic cancer; Cancer; Regulator","score_opus":0.028283696615052614,"score_gpt":0.3690996843203203,"score_spread":0.3408159877052677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414580704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.938752,0.057675634,0.00006660921,0.00086957525,0.00052394375,0.00039257167,0.0007011878,0.000014606929,0.0010038539],"genre_scores_gemma":[0.94016886,0.053127326,0.0000462606,0.0004325471,0.00078752334,0.000465737,0.00016561228,0.00003895037,0.004767181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801683,0.0001279362,0.0003190215,0.0005214591,0.00040544517,0.00060933095],"domain_scores_gemma":[0.9987281,0.00006021545,0.000091922375,0.0005132205,0.00042698442,0.00017954699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048184107,0.00019711004,0.00031168386,0.0001459361,0.00013606355,0.000031680556,0.0003957179,0.0002604374,0.00036018214],"category_scores_gemma":[0.00014902797,0.0001930187,0.00013375089,0.0005039995,0.0002689913,0.000009210246,0.00015288337,0.00026794034,0.000011341903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027545498,0.000086727625,0.004327438,0.00020610329,0.00021738734,0.0000010990327,0.00016531316,0.000041955474,0.918043,0.00001782544,0.0633196,0.013298057],"study_design_scores_gemma":[0.0008512871,0.00006270129,0.008573368,0.00012994447,0.00007266222,0.0000012727653,0.000089870206,0.000026858079,0.67661077,0.00003119596,0.31337103,0.00017900148],"about_ca_topic_score_codex":0.0042756638,"about_ca_topic_score_gemma":0.0012349017,"teacher_disagreement_score":0.25005144,"about_ca_system_score_codex":0.00016764802,"about_ca_system_score_gemma":0.0011493858,"threshold_uncertainty_score":0.7871074},"labels":[],"label_agreement":null},{"id":"W4414582304","doi":"10.1158/1538-7445.pancreatic25-a114","title":"Abstract A114: CCK-B Receptor Blockade with Proglumide Enhances Antitumor Activity and Persistence of CD8+CD161+ CAR-T Cells in Pancreatic Ductal Adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"CD8; Immunotherapy; Tumor microenvironment; Immune system; T cell; Receptor; Flow cytometry; Proglumide","score_opus":0.05291562931985745,"score_gpt":0.3681261127798817,"score_spread":0.3152104834600243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993737,0.004141747,0.0000028258485,0.0013265687,0.00007502353,0.0015750059,0.00003215258,0.000023920678,0.0028854108],"genre_scores_gemma":[0.98800206,0.002440592,0.00015800743,0.000021696025,0.00011766182,0.00031022847,0.0000050731846,0.00003430167,0.008910381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682504,0.00023130118,0.00031496174,0.0007026753,0.0011040757,0.0008219672],"domain_scores_gemma":[0.99810547,0.0004540634,0.000077151926,0.00056230277,0.0005633013,0.00023771635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012171746,0.00022826825,0.0006125738,0.0006342467,0.00013515321,0.00005693653,0.000305956,0.0001322968,0.0012687963],"category_scores_gemma":[0.00021760068,0.00018777492,0.000070521404,0.0015519736,0.0010782662,0.00016231461,0.00017561622,0.001065766,0.00001568019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002791538,0.00023402524,0.13879889,0.0013807754,0.00013450225,0.00012380879,0.0006124789,0.0000038785684,0.8525812,0.000013299592,0.00029472407,0.0030308927],"study_design_scores_gemma":[0.0016807625,0.00055308477,0.24397431,0.0011118981,0.000032817556,0.000016124191,0.0011048765,0.00003448884,0.75065637,0.000014353202,0.00068269577,0.00013823512],"about_ca_topic_score_codex":0.0054997127,"about_ca_topic_score_gemma":0.0014804251,"teacher_disagreement_score":0.10517542,"about_ca_system_score_codex":0.00053876906,"about_ca_system_score_gemma":0.0020162358,"threshold_uncertainty_score":0.99964416},"labels":[],"label_agreement":null},{"id":"W4414582336","doi":"10.1158/1538-7445.pancreatic25-a004","title":"Abstract A004: Altered RNA splicing drives pancreatic cancer by mimicking chromosome deletions","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"KRAS; RNA splicing; Carcinogenesis; Exon; Mutation; Gene; Mutant; Pancreatic cancer","score_opus":0.04223332603743023,"score_gpt":0.39720825222744505,"score_spread":0.3549749261900148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742834,0.018967379,0.00057154667,0.0019282888,0.00024375453,0.0003427905,0.00012568566,0.00001843289,0.003518723],"genre_scores_gemma":[0.9806701,0.010653145,0.0000671667,0.00027178228,0.00041126617,0.0008194551,0.00008501505,0.000027330241,0.0069947224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984298,0.00007695977,0.00023093412,0.0005056276,0.0002518723,0.00050482346],"domain_scores_gemma":[0.9990092,0.00003614488,0.000053961016,0.000510963,0.0002860455,0.00010368032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030015805,0.00014890752,0.00016391426,0.00012776165,0.00039076962,0.00008848297,0.00037531907,0.00013108295,0.00031628742],"category_scores_gemma":[0.000059051537,0.00014539291,0.00007810594,0.00038870054,0.00019777512,0.000009281944,0.00012740883,0.0002887532,0.000015723264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003502923,0.000040569103,0.0013996834,0.00006714453,0.000096568525,8.51363e-7,0.000049660524,0.00017711161,0.94108975,0.00015555855,0.04513543,0.011752659],"study_design_scores_gemma":[0.00058057316,0.000052398944,0.009305426,0.00030359408,0.000028897448,0.0000011044145,0.00020898005,0.00009491612,0.8047082,0.00018210111,0.18427858,0.00025526478],"about_ca_topic_score_codex":0.0019457346,"about_ca_topic_score_gemma":0.0004736646,"teacher_disagreement_score":0.13914314,"about_ca_system_score_codex":0.00020082234,"about_ca_system_score_gemma":0.0005539782,"threshold_uncertainty_score":0.5928951},"labels":[],"label_agreement":null},{"id":"W4414582358","doi":"10.1158/1538-7445.pancreatic25-b116","title":"Abstract B116: Integrative proteogeonomic profiling of PDAC reveals updated epithelial subtypes and cross-omic predictors of survival","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Public Health Ontario; University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Stromal cell; Mass cytometry; Phenotype; Tumour heterogeneity; Transcriptome; Gene expression profiling; Cancer; Microarray; Microarray analysis techniques","score_opus":0.026080978360912204,"score_gpt":0.37612615006682115,"score_spread":0.35004517170590893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217427,0.005279127,0.000037464324,0.000076882585,0.0005828712,0.0006248043,0.00031160042,0.0000056426416,0.0009073207],"genre_scores_gemma":[0.99552745,0.002463028,0.00009276789,0.000013475625,0.0004545539,0.00011877666,0.000057897843,0.00001612163,0.0012559292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986646,0.00012263615,0.0003344634,0.00037593197,0.00019887341,0.00030347786],"domain_scores_gemma":[0.9989565,0.00004179048,0.00011050173,0.00030243208,0.0005201573,0.0000685994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008954567,0.00013303885,0.00030315598,0.00014349868,0.000075440665,0.00002202744,0.00024108958,0.00015970145,0.000040134983],"category_scores_gemma":[0.00024921578,0.000114401184,0.00007294046,0.00021920586,0.00045349024,0.000008043452,0.00017014133,0.00024244295,0.0000011099171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074832776,0.000034854358,0.021964772,0.00018744264,0.00012441857,2.5000492e-7,0.000099378216,0.000021633366,0.973287,0.00020342164,0.00095521257,0.0023733221],"study_design_scores_gemma":[0.0007447526,0.00010081951,0.050055027,0.00010175744,0.0000150884325,4.2296207e-7,0.00014837498,0.000006020653,0.9404796,0.00019215862,0.008064901,0.000091112386],"about_ca_topic_score_codex":0.00070596975,"about_ca_topic_score_gemma":0.00022674425,"teacher_disagreement_score":0.032807406,"about_ca_system_score_codex":0.000040442625,"about_ca_system_score_gemma":0.0007582215,"threshold_uncertainty_score":0.46651447},"labels":[],"label_agreement":null},{"id":"W4414582475","doi":"10.1158/1538-7445.pancreatic25-b113","title":"Abstract B113: Imaging mass cytometry guided shallow whole genome sequencing for phenotype informed regional copy number profiling in a pancreatic tumor","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Whole genome sequencing; Genome; Cancer genome sequencing; Copy-number variation; Genomics; Genome instability; Copy number analysis; KRAS; DNA sequencing; Single cell sequencing","score_opus":0.056631782850154626,"score_gpt":0.39834394509309334,"score_spread":0.3417121622429387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899843,0.0028675038,0.0013775729,0.0006904298,0.00017830708,0.0009241902,0.00016820371,0.0000134341235,0.0037960582],"genre_scores_gemma":[0.99411356,0.00072173896,0.0023231471,0.00068044354,0.00035700097,0.0007107052,0.00026413525,0.000038350332,0.0007909208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981782,0.000037439433,0.00036819468,0.0004839853,0.00026069186,0.00067149324],"domain_scores_gemma":[0.998825,0.00019997897,0.000071688766,0.00037697563,0.00041788525,0.00010845564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007576189,0.00017326757,0.00022897407,0.00023130453,0.00016072107,0.00010122623,0.00035267277,0.00009780877,0.00005148655],"category_scores_gemma":[0.0006443249,0.00018398982,0.000090436384,0.00047228314,0.00013407356,0.0000119394745,0.0001634709,0.000271537,0.000014404181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034739767,0.000027543138,0.054488238,0.00036321272,0.000056561494,0.000014482857,0.00007475952,0.0006012666,0.9385677,0.00036883078,0.004348209,0.0007418089],"study_design_scores_gemma":[0.009862677,0.0003047446,0.065612465,0.0014746778,0.000090243506,0.000027182776,0.0027804135,0.0029329208,0.64332825,0.0076514543,0.26430395,0.0016310558],"about_ca_topic_score_codex":0.00058630673,"about_ca_topic_score_gemma":0.0004352665,"teacher_disagreement_score":0.29523948,"about_ca_system_score_codex":0.0007095536,"about_ca_system_score_gemma":0.0025211829,"threshold_uncertainty_score":0.7502887},"labels":[],"label_agreement":null},{"id":"W4414582500","doi":"10.1158/1538-7445.pancreatic25-b115","title":"Abstract B115: Integrated spatial and multi-omic analysis reveals functional niches in the pancreatic cancer microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Toronto General Hospital; University of Toronto; University Health Network; Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Stromal cell; Stroma; Tumor microenvironment; Pancreatic cancer; Immune system; Extracellular matrix; Mass cytometry; Transcriptome; Myeloid","score_opus":0.038187925223146346,"score_gpt":0.3530044010312732,"score_spread":0.3148164758081268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861693,0.011148425,0.00047466464,0.0015189693,0.00008986818,0.00031528922,0.00013929456,0.0000023797795,0.0001418432],"genre_scores_gemma":[0.9867949,0.011240546,0.000050566134,0.0005255331,0.00012628321,0.00037075378,0.00009965049,0.000009794263,0.0007819713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882114,0.000113750204,0.00020221055,0.00038615585,0.00017874564,0.00029801548],"domain_scores_gemma":[0.9994124,0.00012077219,0.000037851096,0.00030388773,0.00007570397,0.0000493556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057064224,0.00012013379,0.00016971625,0.00017799156,0.00012303799,0.000061160266,0.000204537,0.00009657875,0.00013349562],"category_scores_gemma":[0.00011583699,0.000093249866,0.000068118105,0.0004171318,0.0001882746,0.0000027481074,0.00012841487,0.00024881572,0.0000032749415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041287756,0.00017292325,0.36516428,0.00008155379,0.00067170407,0.000008435877,0.00020375835,0.0019203122,0.6019159,0.00006478554,0.012098501,0.01728497],"study_design_scores_gemma":[0.0009781342,0.00006265924,0.9389976,0.00006823384,0.00015268468,8.852226e-7,0.00040298825,0.00044521503,0.030524554,0.000095948824,0.028100654,0.00017039772],"about_ca_topic_score_codex":0.0106838485,"about_ca_topic_score_gemma":0.021144986,"teacher_disagreement_score":0.57383335,"about_ca_system_score_codex":0.00018564897,"about_ca_system_score_gemma":0.0003273293,"threshold_uncertainty_score":0.99671656},"labels":[],"label_agreement":null},{"id":"W4414582553","doi":"10.1158/1538-7445.pancreatic25-a005","title":"Abstract A005: An Iron-regulated Signalling Pathway Controls Adipose Browning and Cancer Cachexia","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"MSRA; Methionine; PRDM16; Adipose tissue; Cancer; White adipose tissue; Kinase; Pancreatic cancer; Phosphatase","score_opus":0.05925867881304503,"score_gpt":0.4011828715083442,"score_spread":0.34192419269529917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489263,0.04442378,0.000038516944,0.0017218796,0.00017487336,0.00064202514,0.000034172623,0.00006178162,0.0039766496],"genre_scores_gemma":[0.9927177,0.0023732337,0.00006571232,0.0005172546,0.00027507692,0.00020705281,0.000023830631,0.000033129738,0.003787003],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979256,0.00012217675,0.00027009405,0.00048547843,0.00051641185,0.00068026554],"domain_scores_gemma":[0.998838,0.00015595865,0.000043340708,0.0003199237,0.00033364614,0.0003091048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088435184,0.00017860507,0.00036325929,0.0003249673,0.00028519734,0.00008776302,0.0001622444,0.00015898418,0.00081805495],"category_scores_gemma":[0.00015154907,0.00015466212,0.000053995733,0.0004835932,0.00027954215,0.00016446732,0.00007363684,0.0006487229,0.0000130250955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012111387,0.00016328918,0.013878896,0.0007799802,0.000101943435,0.000059933347,0.0010086952,0.00038358397,0.79119366,0.0012846814,0.0022964682,0.18763775],"study_design_scores_gemma":[0.02907671,0.0008682802,0.6119527,0.0037500607,0.0006524427,0.000017243075,0.0051728277,0.00315075,0.22111718,0.002265558,0.120501034,0.0014751717],"about_ca_topic_score_codex":0.0048144003,"about_ca_topic_score_gemma":0.0005762131,"teacher_disagreement_score":0.59807384,"about_ca_system_score_codex":0.00016044067,"about_ca_system_score_gemma":0.0009910541,"threshold_uncertainty_score":0.8957128},"labels":[],"label_agreement":null},{"id":"W4414582656","doi":"10.1158/1538-7445.pancreatic25-a032","title":"Abstract A032: Interstitial insulin enrichment drives pancreatic cancer growth by enhancing cancer cell metabolic plasticity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of British Columbia","funders":"","keywords":"Pancreatic cancer; Insulin; Cancer; Cancer cell; Anaerobic glycolysis; Glycolysis; Carbohydrate metabolism; Metabolism","score_opus":0.018031717712258657,"score_gpt":0.34157918028735057,"score_spread":0.3235474625750919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8020998,0.19055668,0.00053120387,0.00046731142,0.0022168704,0.0005975793,0.00043866038,0.000029656727,0.0030622066],"genre_scores_gemma":[0.8583663,0.13243139,0.000060027603,0.00053536496,0.0023359233,0.0012510604,0.00005874701,0.000048460042,0.004912736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689966,0.00017862133,0.00044862495,0.00090807985,0.0005671712,0.0009978554],"domain_scores_gemma":[0.99860364,0.00007899041,0.00011801851,0.0004112532,0.00051508663,0.00027302734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046673403,0.0003580035,0.00047604082,0.00017226618,0.00032528708,0.000109423134,0.0005959769,0.00022615297,0.0007952163],"category_scores_gemma":[0.00016609568,0.0003419241,0.00017135682,0.0004686511,0.00031425484,0.0000235551,0.00037253523,0.0005450067,0.00001666259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003839856,0.00013724323,0.00091738976,0.00024867238,0.00021095207,0.0000020099212,0.00020954348,0.00010075842,0.9235687,0.00010352102,0.06496306,0.009154144],"study_design_scores_gemma":[0.0011033965,0.00006629834,0.0036151,0.00017405947,0.00008826281,6.388007e-7,0.00022324579,0.00001672474,0.7057987,0.00004539996,0.28857306,0.0002951404],"about_ca_topic_score_codex":0.021008134,"about_ca_topic_score_gemma":0.009358477,"teacher_disagreement_score":0.22360998,"about_ca_system_score_codex":0.00035291433,"about_ca_system_score_gemma":0.0015850305,"threshold_uncertainty_score":0.99990326},"labels":[],"label_agreement":null},{"id":"W4414582823","doi":"10.1158/1538-7445.pancreatic25-b128","title":"Abstract B128: Spatial proteomics extend tumour subtype and microenvironment classifications across genotype-phenotype axes of pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Mount Sinai Hospital; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Pancreatic cancer; KRAS; Stromal cell; Tumor microenvironment; Stroma; Phenotype; Tumour heterogeneity; CDKN2A; Cell","score_opus":0.031667409528699404,"score_gpt":0.3576482767940253,"score_spread":0.3259808672653259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414582823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837723,0.013628619,0.00040107657,0.000725322,0.0001563196,0.00052899215,0.00038676104,0.0000045458964,0.00039605802],"genre_scores_gemma":[0.98258245,0.015572263,0.00027802857,0.00009113748,0.00021090466,0.00033608006,0.000050364237,0.000024055124,0.0008546938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986945,0.000046342946,0.00025564054,0.00042270764,0.0001864761,0.0003943322],"domain_scores_gemma":[0.9991731,0.000058522368,0.00008660961,0.00039251792,0.00019418019,0.00009506392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031823118,0.00014019034,0.00018764904,0.00006314533,0.00019185973,0.000046318004,0.00024063735,0.00012805316,0.00008244829],"category_scores_gemma":[0.00013076943,0.00013994979,0.000048729442,0.00015298967,0.00037731574,0.0000041731123,0.0002496382,0.00020251684,0.000005352182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026386935,0.000074832125,0.013472905,0.00015620342,0.00008698632,0.0000013846404,0.00010918141,0.00015154976,0.9744912,0.0002566857,0.0019644797,0.00897076],"study_design_scores_gemma":[0.00068620965,0.00013613689,0.28374472,0.00011502033,0.00003579745,9.060958e-7,0.0001893087,0.000053474083,0.6879392,0.0003277613,0.026577359,0.00019406549],"about_ca_topic_score_codex":0.003861448,"about_ca_topic_score_gemma":0.0039543505,"teacher_disagreement_score":0.28655192,"about_ca_system_score_codex":0.00013358482,"about_ca_system_score_gemma":0.0006095862,"threshold_uncertainty_score":0.583738},"labels":[],"label_agreement":null},{"id":"W4414585400","doi":"10.1158/1538-7445.pancreatic25-b081","title":"Abstract B081: Association between clonal hematopoiesis and survival outcomes in pancreatic ductal adenocarcinoma: Analysis from the PASS-01 trial","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hazard ratio; Proportional hazards model; Myeloid leukemia; FOLFIRINOX; Gemcitabine; Confidence interval; Survival analysis; Pancreatic cancer","score_opus":0.09327700628542408,"score_gpt":0.4445054088653408,"score_spread":0.3512284025799167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98076314,0.0020139518,0.000015156612,0.013919017,0.00012176208,0.0009996605,0.000117804935,0.000019145848,0.0020303736],"genre_scores_gemma":[0.9953978,0.0005901849,0.000051569066,0.00010204198,0.00042102014,0.00036205476,0.000070513874,0.000013725284,0.0029910547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963864,0.0007126661,0.00052511337,0.00047815274,0.0012332153,0.0006644641],"domain_scores_gemma":[0.99146307,0.007560689,0.00009571006,0.0004429502,0.00027477933,0.00016280377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00393186,0.0001712952,0.0011421246,0.00054139143,0.00026823784,0.00008183894,0.00026693536,0.00026194265,0.00065947947],"category_scores_gemma":[0.0024880427,0.0001168944,0.00018276933,0.0016545496,0.00028338624,0.00007704889,0.00018707495,0.0010388785,0.00002364125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029437745,0.00012536638,0.99099094,0.00005736496,0.0034107731,0.000042213233,0.00034107082,8.1766854e-7,0.00021342581,0.00012892888,0.0014892677,0.00025604377],"study_design_scores_gemma":[0.013399126,0.00011749404,0.98322916,0.00008332389,0.0013562827,4.0154754e-7,0.0006829368,0.000051003564,0.000068713845,0.0007376261,0.00018334521,0.00009056102],"about_ca_topic_score_codex":0.015331129,"about_ca_topic_score_gemma":0.003985909,"teacher_disagreement_score":0.014634708,"about_ca_system_score_codex":0.0010410062,"about_ca_system_score_gemma":0.0010732985,"threshold_uncertainty_score":0.99122584},"labels":[],"label_agreement":null},{"id":"W4414585447","doi":"10.1158/1538-7445.pancreatic25-b112","title":"Abstract B112: HMGA2 Predicts Treatment Outcome in Pancreatic Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tissue microarray; Pancreatic cancer; Biomarker; Immunohistochemistry; Cohort; Cancer; Basal (medicine); Adenocarcinoma; HMGA2","score_opus":0.08193411608058984,"score_gpt":0.446879133161592,"score_spread":0.36494501708100213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772481,0.016747195,0.0000487646,0.0005470399,0.0001778112,0.0003807713,0.00003577428,0.000006834372,0.004807717],"genre_scores_gemma":[0.98421717,0.009349872,0.000029843044,0.000054600623,0.0001760964,0.0005146566,0.000034994475,0.000014825023,0.005607957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874616,0.00008663709,0.00022764069,0.0003594587,0.00020446611,0.00037565766],"domain_scores_gemma":[0.9993955,0.000043208554,0.000029784578,0.0003277802,0.00012993807,0.00007378242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040613482,0.000117272386,0.00015340882,0.00015531221,0.00008165332,0.00003138951,0.00016562355,0.00013442099,0.00013271415],"category_scores_gemma":[0.00009840068,0.00010228211,0.000052578078,0.00028308574,0.00007848928,0.0000029452556,0.00007697989,0.00014513105,0.000009165338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012234722,0.00010151056,0.38272846,0.000056867677,0.000074389136,0.000006080717,0.00006857744,0.00046460575,0.58351815,0.00006665164,0.0007162592,0.032076146],"study_design_scores_gemma":[0.0010387618,0.00016774861,0.34172034,0.00008640314,0.000014219937,1.1370087e-7,0.000056428435,0.000053063955,0.612103,0.00030350592,0.04432008,0.00013632646],"about_ca_topic_score_codex":0.0028660982,"about_ca_topic_score_gemma":0.0034261367,"teacher_disagreement_score":0.043603823,"about_ca_system_score_codex":0.00025263982,"about_ca_system_score_gemma":0.00044100673,"threshold_uncertainty_score":0.43327022},"labels":[],"label_agreement":null},{"id":"W4414585568","doi":"10.1158/1538-7445.pancreatic25-b002","title":"Abstract B002: Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM Trial","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Proglumide; Phases of clinical research; Biopsy; Biomarker; Cancer; Immunohistochemistry; Tumor microenvironment","score_opus":0.02864626964895328,"score_gpt":0.3688657551176556,"score_spread":0.34021948546870234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999166,0.0011902851,0.000026770962,0.0029837047,0.00007898676,0.0039564013,0.000007369548,0.00002082509,0.001744012],"genre_scores_gemma":[0.9944978,0.00045442564,0.00006396159,0.00028557001,0.000111997746,0.0011380329,0.0000055649602,0.000027166516,0.0034154917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843675,0.00006494386,0.00020835905,0.0002867056,0.0006249273,0.0003783276],"domain_scores_gemma":[0.99912107,0.00023706829,0.00005559126,0.00042832416,0.00007484129,0.00008310063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620938,0.00014138332,0.00032626468,0.00012593753,0.00011916686,0.000016085956,0.00018138818,0.0000475766,0.00024198514],"category_scores_gemma":[0.000042305677,0.000075176446,0.000079445,0.00036889734,0.00031667302,0.000023058667,0.000012218753,0.00041689415,0.000011382696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15844311,0.0029551608,0.0010209113,0.0035418686,0.0006158915,0.00028001633,0.000753606,0.000003586363,0.8098345,0.0012536988,0.0025832602,0.01871439],"study_design_scores_gemma":[0.048061248,0.0020658525,0.0036898362,0.0022780388,0.00008969056,0.0000015653354,0.00018047211,0.0000052593787,0.9361793,0.00013145439,0.007229565,0.00008773399],"about_ca_topic_score_codex":0.00005823427,"about_ca_topic_score_gemma":0.000019882089,"teacher_disagreement_score":0.12634477,"about_ca_system_score_codex":0.00016816617,"about_ca_system_score_gemma":0.0004518841,"threshold_uncertainty_score":0.30656067},"labels":[],"label_agreement":null},{"id":"W4414585571","doi":"10.1158/1538-7445.pancreatic25-b072","title":"Abstract B072: Plasma whole-genome sequencing to monitor pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic cancer; Liquid biopsy; Cancer; Circulating tumor cell; Pancreatic ductal adenocarcinoma; Circulating tumor DNA; Stage (stratigraphy); Disease; Cohort","score_opus":0.04467019958588224,"score_gpt":0.37820109115912376,"score_spread":0.3335308915732415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869453,0.006270499,0.000103268074,0.0016642895,0.0005045897,0.0005095379,0.00038399704,0.000014764362,0.003603775],"genre_scores_gemma":[0.9883346,0.0029243717,0.00015021635,0.0006494085,0.0009027702,0.0007143003,0.000064204294,0.00003806516,0.0062220944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981826,0.00004886147,0.00024135642,0.0005703675,0.0002955427,0.00066126906],"domain_scores_gemma":[0.99874365,0.00008370648,0.000037230555,0.00053832866,0.00036914353,0.00022793721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040378355,0.00017900065,0.0002036454,0.0001944113,0.00023446232,0.00011175644,0.00045319548,0.00015397239,0.00016751933],"category_scores_gemma":[0.0002485796,0.00018367078,0.00007701512,0.00044599894,0.000113312,0.000004701466,0.0003315937,0.00028678932,0.000071761184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016976078,0.000023498662,0.0014260414,0.000093481205,0.00009214841,0.000009501998,0.000092850685,0.0020941193,0.9670095,0.00009483648,0.019387102,0.009507164],"study_design_scores_gemma":[0.00078574725,0.00018727512,0.016250873,0.00026253454,0.000030977364,0.000001824558,0.00035333782,0.000055932644,0.5006377,0.0002019559,0.48084268,0.00038913445],"about_ca_topic_score_codex":0.002749633,"about_ca_topic_score_gemma":0.001851501,"teacher_disagreement_score":0.46637177,"about_ca_system_score_codex":0.0005628247,"about_ca_system_score_gemma":0.0011709236,"threshold_uncertainty_score":0.74898773},"labels":[],"label_agreement":null},{"id":"W4414585601","doi":"10.1158/1538-7445.pancreatic25-b111","title":"Abstract B111: HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HMGA2; Pancreatic cancer; Basal (medicine); Chromatin; Translation (biology); DNA methylation; Methylation; Lineage (genetic)","score_opus":0.043145746699374404,"score_gpt":0.39935450936784306,"score_spread":0.3562087626684687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846897,0.011291049,0.0015143054,0.0004389383,0.00008085734,0.00051331794,0.000039774866,0.000009528597,0.001422518],"genre_scores_gemma":[0.9922064,0.003934756,0.00020406237,0.000039887316,0.0002657155,0.00033737175,0.00004345261,0.000016636779,0.0029517112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998745,0.00011481896,0.00019827235,0.0004017915,0.00023593227,0.0003041484],"domain_scores_gemma":[0.99926394,0.00005472147,0.000050296603,0.00020762808,0.00033586376,0.00008752644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005173867,0.00012320683,0.00014584837,0.00012320445,0.0001805361,0.00005138254,0.0001271222,0.00015457558,0.0000865996],"category_scores_gemma":[0.0002805086,0.0001138911,0.00003132186,0.00023834706,0.00014074819,0.000005944853,0.00012924228,0.00023655595,0.0000042504857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012027681,0.000026127313,0.004141449,0.000090481386,0.000048768492,0.0000013083904,0.00004292249,0.0002560437,0.98279697,0.00013352669,0.00035271206,0.011989388],"study_design_scores_gemma":[0.00047933377,0.00010375818,0.034861386,0.000104736035,0.000017486082,1.07485356e-7,0.000031194995,0.00027766352,0.9490462,0.00030758555,0.014650511,0.00012002275],"about_ca_topic_score_codex":0.0010399432,"about_ca_topic_score_gemma":0.00067454675,"teacher_disagreement_score":0.03375078,"about_ca_system_score_codex":0.000069061076,"about_ca_system_score_gemma":0.00030809682,"threshold_uncertainty_score":0.46443444},"labels":[],"label_agreement":null},{"id":"W4414585619","doi":"10.1158/1538-7445.pancreatic25-b073","title":"Abstract B073: Predicting pancreatic cancer risk from clinical notes using large language models","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; North Pacific Marine Science Organization; Princess Margaret Cancer Centre","funders":"","keywords":"Cohort; Pancreatic cancer; Weighting; Cancer; Stage (stratigraphy); Disease; Cohort study; Sampling (signal processing)","score_opus":0.5698433855608535,"score_gpt":0.6805833097340788,"score_spread":0.11073992417322531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810153,0.009951794,0.0014610097,0.0013133372,0.0018141972,0.0014509289,0.0009675025,0.00014399884,0.0018818841],"genre_scores_gemma":[0.992017,0.0035627005,0.00026660247,0.0007076911,0.0020257542,0.0006932,0.000022615772,0.00005529763,0.0006491836],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9935263,0.0022296114,0.001251311,0.0007448024,0.0007354001,0.0015125654],"domain_scores_gemma":[0.9886317,0.009117222,0.00028173818,0.0007637988,0.00088876864,0.00031675398],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005538433,0.00020475402,0.0005122585,0.0002536912,0.002233992,0.000038975504,0.00054888765,0.0005245749,0.0026841734],"category_scores_gemma":[0.0037029567,0.00018619969,0.000121585916,0.00078051846,0.00023617833,0.00023058003,0.00046527674,0.004105032,0.00021257772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029277152,0.00007169,0.9637714,0.00044801363,0.000123031,0.000014889967,0.00726308,0.0011155719,0.0012351976,0.00064447656,0.0018788273,0.02314107],"study_design_scores_gemma":[0.0020338001,0.00019229863,0.3915,0.01667774,0.0003663244,2.7398616e-7,0.09173377,0.42947087,0.00465305,0.053467445,0.008858371,0.0010460507],"about_ca_topic_score_codex":0.3836801,"about_ca_topic_score_gemma":0.09497423,"teacher_disagreement_score":0.5722714,"about_ca_system_score_codex":0.0010544803,"about_ca_system_score_gemma":0.0036016365,"threshold_uncertainty_score":0.999065},"labels":[],"label_agreement":null},{"id":"W4414585727","doi":"10.1158/1538-7445.pancreatic25-b086","title":"Abstract B086: External validation of a multimodal machine learning system to predict outcomes in advanced pancreatic cancer in the PASS-01 trial","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Université de Montréal; University of British Columbia; University Health Network","funders":"","keywords":"Percentile; Receiver operating characteristic; Cohort; Pancreatic cancer; Hazard ratio; Generalizability theory; Compass; Clinical trial","score_opus":0.03635725401411739,"score_gpt":0.4335930376683845,"score_spread":0.3972357836542671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414585727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910611,0.001187244,0.00028959097,0.004815224,0.0002933339,0.0015617206,0.000012702837,0.000024498146,0.0007545728],"genre_scores_gemma":[0.9977982,0.00035297763,0.0002313597,0.00016066065,0.00017529476,0.0007787701,0.000007883362,0.000019895288,0.00047495315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997365,0.00045390902,0.0005370482,0.00033713106,0.00085625594,0.00045065215],"domain_scores_gemma":[0.9986089,0.00077757274,0.000090881105,0.00028600753,0.00013361688,0.00010301394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003117548,0.00014200088,0.0004982563,0.0005701944,0.00009052914,0.00003831941,0.00030198862,0.000078097306,0.00010219241],"category_scores_gemma":[0.0017078507,0.00009727347,0.00007999679,0.0008592982,0.000093656316,0.000070442686,0.00008040103,0.0013892284,0.000003989727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013823551,0.00032391428,0.84009796,0.0011588932,0.0001075875,0.00012371883,0.0022116576,0.022695297,0.037440166,0.00018248937,0.00019358621,0.08164118],"study_design_scores_gemma":[0.043143287,0.00055521773,0.8975934,0.0069265077,0.000057361052,0.000006294432,0.0015626776,0.044999957,0.0033415286,0.000059635284,0.0015497315,0.00020442736],"about_ca_topic_score_codex":0.011391603,"about_ca_topic_score_gemma":0.00037837823,"teacher_disagreement_score":0.08143675,"about_ca_system_score_codex":0.00058885175,"about_ca_system_score_gemma":0.00045283602,"threshold_uncertainty_score":0.99519163},"labels":[],"label_agreement":null},{"id":"W4415050492","doi":"10.1158/0008-5472.can-25-3596","title":"Distinct Cellular and Molecular Patterns in Pretreatment Peripheral Blood Are Associated with CAR T-cell Outcomes in Diffuse Large B-cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Helen and Martin Kimmel Center for Molecular Design, Weizmann Institute of Science; National Cancer Institute; European Research Council; Azrieli Foundation; Israel Science Foundation; Lotte and John Hecht Memorial Foundation; Elsie and Marvin Dekelboum Family Foundation; Deutsche Forschungsgemeinschaft","keywords":"Lymphoma; Peripheral blood; Immune system; Diffuse large B-cell lymphoma; Peripheral","score_opus":0.02317539412967375,"score_gpt":0.3376043002972652,"score_spread":0.31442890616759145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415050492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930532,0.0028385813,0.000011267354,0.00081103685,0.000048269914,0.0015889469,0.00010092512,0.000030927924,0.0015168429],"genre_scores_gemma":[0.9764091,0.00049931783,0.000010129181,0.00012419584,0.00002290577,0.0006067173,0.000049478065,0.000060763774,0.022217391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641633,0.00049068703,0.00031840111,0.0007025409,0.0009930638,0.0010790016],"domain_scores_gemma":[0.99864143,0.00026190357,0.000052343206,0.00057593064,0.00022710297,0.00024127495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008493987,0.0002866393,0.00061865366,0.0005970193,0.00010329642,0.000078413635,0.00023418473,0.00018048141,0.00037162795],"category_scores_gemma":[0.00013727591,0.00023020779,0.00008347586,0.0010300017,0.00017352757,0.00005600596,0.00023362231,0.0006547877,0.0000040410887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006086885,0.0064114076,0.9019373,0.00036468098,0.00017414498,0.0022753035,0.000724438,0.0000026879368,0.08685033,0.000011194129,0.000073488874,0.00056633045],"study_design_scores_gemma":[0.0660525,0.0008655386,0.78978246,0.0010437521,0.000093749004,0.0000044007916,0.0012426676,0.00027806617,0.13951877,0.000038051352,0.00074488966,0.00033516425],"about_ca_topic_score_codex":0.0035242487,"about_ca_topic_score_gemma":0.008278812,"teacher_disagreement_score":0.11215485,"about_ca_system_score_codex":0.0015323008,"about_ca_system_score_gemma":0.0006157484,"threshold_uncertainty_score":0.93876016},"labels":[],"label_agreement":null},{"id":"W4415713040","doi":"10.1158/0008-5472.can-25-0881","title":"Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada); Vector Institute; Structural Genomics Consortium; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Institute of Genetics; Helsinki Institute of Life Science, Helsingin Yliopisto; Break Through Cancer; Biocenter Finland; Universität Wien; European Commission; Helsingin Yliopisto; Pfizer; Incyte; American Association for Cancer Research; Amgen; Austrian Science Fund; Syöpäsäätiö; Medizinische Universität Wien; BeiGene; China Scholarship Council; Québec Consortium for Drug Discovery; Norges Forskningsråd; Academy of Finland; Kreftforeningen; Gilead Sciences; Bristol-Myers Squibb; Sigrid Juséliuksen Säätiö; Signe ja Ane Gyllenbergin Säätiö","keywords":"Lymphoma; Leukemia; Profiling (computer programming); Drug; Biomarker discovery; Drug discovery","score_opus":0.032980496225568486,"score_gpt":0.3294122974688488,"score_spread":0.29643180124328034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415713040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9223399,0.074847765,0.00007139759,0.00012528112,0.0003046425,0.00024071622,0.000038965558,0.000017235398,0.002014051],"genre_scores_gemma":[0.97968656,0.005760659,0.000038808525,0.000043412416,0.000018431601,0.00006333858,0.00001112429,0.0000089957875,0.014368645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901253,0.00016416404,0.00016956737,0.00024249099,0.000047122536,0.0003641065],"domain_scores_gemma":[0.9994038,0.00023821926,0.000037034297,0.00017141935,0.00013816816,0.000011410556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030567884,0.000100180456,0.00021515717,0.0001754527,0.00028079216,0.000017302973,0.00016336415,0.0001402283,0.000033845256],"category_scores_gemma":[0.000042940985,0.0000750985,0.00004075125,0.00025862874,0.00064644666,0.00005834414,0.00020908413,0.00021389699,0.000012461304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023394353,0.000051623483,0.006249968,0.0001962488,0.00016345053,0.0000011510579,0.00031045623,0.000007267751,0.9824777,0.0011824366,0.0006841102,0.0084416475],"study_design_scores_gemma":[0.0012685094,0.000065681415,0.0035848208,0.00007005491,0.000020149982,8.9606e-7,0.0010918813,0.000011928726,0.9864634,0.0003608533,0.0069814133,0.00008039801],"about_ca_topic_score_codex":0.0010573042,"about_ca_topic_score_gemma":0.00010295897,"teacher_disagreement_score":0.06908711,"about_ca_system_score_codex":0.00016097382,"about_ca_system_score_gemma":0.00044273463,"threshold_uncertainty_score":0.3062428},"labels":[],"label_agreement":null},{"id":"W4415962648","doi":"10.1158/0008-5472.can-25-3502","title":"Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non–Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Kinome; Exon; EGFR inhibitors; Lung; Epidermal growth factor receptor; Erlotinib; Cell","score_opus":0.030792000093462793,"score_gpt":0.4108915992425694,"score_spread":0.3800995991491066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415962648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751475,0.0027718619,0.0013610137,0.009715824,0.000106602114,0.0030969372,0.00018243365,0.00004776179,0.0075700874],"genre_scores_gemma":[0.97716326,0.00019287845,0.002109267,0.0007374597,0.00020486303,0.0026818432,0.000066146225,0.000044198798,0.016800098],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825245,0.000058579382,0.00024353889,0.0005535841,0.00031814,0.00057369575],"domain_scores_gemma":[0.9984327,0.0004842004,0.0000518454,0.00023049898,0.00058326666,0.00021747507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002385731,0.00019171565,0.00030423937,0.00030147278,0.0005066535,0.00007266975,0.00008834865,0.000095340016,0.00009029868],"category_scores_gemma":[0.000088324305,0.0001505367,0.00006612181,0.00077272643,0.00019200948,0.00008528419,0.00003838528,0.00034203078,0.0000033158738],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023189463,0.001756205,0.30354026,0.008124831,0.0045485543,0.00025556385,0.047340564,0.0008674182,0.21847658,0.0018871371,0.2698608,0.12015264],"study_design_scores_gemma":[0.071745835,0.008534757,0.15168071,0.007179296,0.0036970917,0.0000756968,0.015272689,0.0139317615,0.5732019,0.0013475876,0.15161692,0.0017157715],"about_ca_topic_score_codex":0.0019720362,"about_ca_topic_score_gemma":0.0025083565,"teacher_disagreement_score":0.3547253,"about_ca_system_score_codex":0.0014984917,"about_ca_system_score_gemma":0.0029683325,"threshold_uncertainty_score":0.6138708},"labels":[],"label_agreement":null},{"id":"W4416116967","doi":"10.1158/0008-5472.can-24-3329","title":"Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Department of Medicine, University of Toronto; Terry Fox Research Institute; Deutsches Krebsforschungszentrum; Physicians' Services Incorporated Foundation; Princess Margaret Cancer Foundation; Leukemia and Lymphoma Society of Canada; Ministry of Health, Ontario","keywords":"Blockade; Immune checkpoint; Haematopoiesis; Immunotherapy; Immune system; Cancer immunotherapy","score_opus":0.05917256912853262,"score_gpt":0.44006774784438407,"score_spread":0.38089517871585143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416116967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95316154,0.0007267852,0.00008456202,0.03955045,0.000056332115,0.0017696025,0.0000058133937,0.000013421876,0.0046315026],"genre_scores_gemma":[0.9772269,0.00028964927,0.000055851608,0.00027348317,0.00004978171,0.0007819185,0.0000019298245,0.000018161443,0.021302305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654776,0.0008280339,0.0004068386,0.00038067353,0.001282666,0.0005540067],"domain_scores_gemma":[0.99689734,0.0014268343,0.000040882813,0.0009454659,0.0005957123,0.00009378395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053944434,0.00011967558,0.00031193162,0.00080614205,0.00009992608,0.00003365776,0.0005410292,0.000099457466,0.0016681751],"category_scores_gemma":[0.0021692368,0.000089176,0.00008420783,0.0031382677,0.00027757793,0.000058865284,0.00023024688,0.00084006693,0.00003475263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008465814,0.00017304298,0.00056861213,0.0002382246,0.000034813274,0.000019763216,0.006270637,0.000011978924,0.9765384,0.00007193072,0.001051108,0.006555659],"study_design_scores_gemma":[0.0012738396,0.0003649899,0.018044129,0.0007345506,0.0000059225104,0.0000048749575,0.0024697336,0.000037384194,0.9648899,0.00047819977,0.011628184,0.00006829299],"about_ca_topic_score_codex":0.0015756623,"about_ca_topic_score_gemma":0.00009436801,"teacher_disagreement_score":0.03927697,"about_ca_system_score_codex":0.00062912435,"about_ca_system_score_gemma":0.0011071234,"threshold_uncertainty_score":0.99924445},"labels":[],"label_agreement":null},{"id":"W4416987554","doi":"10.1158/0008-5472.can-25-5296","title":"Drink Responsibly: Cancer Cells Also Like Sugary Drinks","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Colorectal cancer; Fructose; Metastasis; Cancer; Sorbitol dehydrogenase; Cancer cell; Glycolysis; Cell","score_opus":0.030376860972341567,"score_gpt":0.3862536798362266,"score_spread":0.35587681886388506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416987554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8779108,0.07422288,0.00020547285,0.0040449994,0.024061598,0.0010177541,0.00021011659,0.0000636428,0.01826277],"genre_scores_gemma":[0.55481756,0.09581255,0.00027642038,0.004266589,0.03654173,0.0021073103,0.00011789663,0.00015556661,0.30590436],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974511,0.00028149216,0.0002652525,0.0007436272,0.00044154865,0.000816935],"domain_scores_gemma":[0.9984065,0.0000604902,0.000044737746,0.0008199308,0.00046286557,0.00020543145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008180562,0.00021594316,0.0002675975,0.00028133797,0.00027798288,0.00007789473,0.00058668794,0.00029169867,0.0004381768],"category_scores_gemma":[0.00009694143,0.0002114976,0.00014210932,0.0006228264,0.0003299184,0.000007428675,0.0004700392,0.0005171248,0.00004423505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033415193,0.000030901545,0.000658439,0.000050125564,0.00007135089,4.785809e-7,0.000053921845,0.00003990183,0.57058084,0.00020216986,0.41737774,0.010599998],"study_design_scores_gemma":[0.00054425193,0.000051068546,0.001660992,0.000060830724,0.000015244366,8.128163e-7,0.00007133665,0.0000068785002,0.30576643,0.00010369274,0.69156027,0.00015816548],"about_ca_topic_score_codex":0.0020032153,"about_ca_topic_score_gemma":0.0023935898,"teacher_disagreement_score":0.32309318,"about_ca_system_score_codex":0.00015691621,"about_ca_system_score_gemma":0.0019351974,"threshold_uncertainty_score":0.86246216},"labels":[],"label_agreement":null},{"id":"W4417001603","doi":"10.1158/1538-7445.canevol25-b002","title":"Abstract B002: Transmissible cancer in bivalves: Mutation and selection in cancer lineages and host genomes through hundreds of years of evolution","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Marine Bivalve and Aquaculture Studies","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genome; Cancer; Lineage (genetic); Transposable element; Somatic cell; Somatic evolution in cancer; Mutation; Mutation Accumulation","score_opus":0.036433732195608214,"score_gpt":0.3889264406190721,"score_spread":0.3524927084234639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98427325,0.013378879,0.000024622273,0.00042560074,0.000022373968,0.00025411407,0.000017884644,0.000004056536,0.0015992268],"genre_scores_gemma":[0.9812632,0.01781644,0.00007729382,0.000010106716,0.000019673185,0.00009670377,8.856586e-7,0.000004988732,0.0007107179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909747,0.000053533968,0.00019839051,0.00022612738,0.00023213023,0.00019234404],"domain_scores_gemma":[0.9997786,0.00007605361,0.00004201647,0.00004745689,0.00003400094,0.000021870654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000338735,0.00006897272,0.00015922307,0.00013605916,0.000050766597,0.000009381173,0.00006911766,0.000056961795,0.00026233663],"category_scores_gemma":[0.000036323236,0.00006562015,0.000018929912,0.0007903632,0.00029610717,0.00014633028,0.00006825535,0.0001784557,6.6541395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011458058,0.00007391203,0.69239414,0.00042984373,0.000035987094,0.0000014706657,0.004326568,0.0013923997,0.24355249,0.00019724859,0.00031700425,0.05716437],"study_design_scores_gemma":[0.00040597835,0.0000327357,0.9841872,0.00022003369,0.0000075015355,1.8096422e-7,0.00048019664,0.00008898789,0.012235586,0.00044015612,0.0018393182,0.00006212694],"about_ca_topic_score_codex":0.0792181,"about_ca_topic_score_gemma":0.08092121,"teacher_disagreement_score":0.29179308,"about_ca_system_score_codex":0.00030485573,"about_ca_system_score_gemma":0.00008581966,"threshold_uncertainty_score":0.9358496},"labels":[],"label_agreement":null},{"id":"W4417001662","doi":"10.1158/1538-7445.canevol25-b013","title":"Abstract B013: Chromosomal rearrangements at the YAP/TAZ pathway genes are associated with heterogeneity and stem cell-like castration-resistant prostate cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenomics; Prostate cancer; Androgen receptor; Epigenetics; Transcriptome; Chromoplexy; Gene; Chromatin; Cancer","score_opus":0.041490857159148214,"score_gpt":0.3319708320288087,"score_spread":0.2904799748696605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859206,0.012053548,0.0000025036047,0.00034597926,0.00012040056,0.00058559445,0.00048966485,0.000016769374,0.0004649404],"genre_scores_gemma":[0.98967063,0.001375186,0.000005188683,0.000119116536,0.00011107936,0.00046304383,0.000087710694,0.00003063622,0.008137424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979703,0.00022812013,0.00022296996,0.0005849235,0.00045011393,0.00054361793],"domain_scores_gemma":[0.9989153,0.000049395196,0.00011054827,0.0004147207,0.0003885768,0.000121439014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064118276,0.00020920519,0.00018804842,0.00006115097,0.00062716706,0.00011216406,0.00024829872,0.00015515374,0.000070739734],"category_scores_gemma":[0.00001995204,0.00014757567,0.000055189685,0.00026132874,0.0002877011,0.000008052933,0.00018679048,0.00026159178,0.0000066376474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003825609,0.000057576803,0.021881731,0.00011114729,0.0001672386,0.000022745924,0.00013148219,0.00017704628,0.97408795,0.0000024524445,0.00092744036,0.002050633],"study_design_scores_gemma":[0.0009310377,0.0002076827,0.048574276,0.00025399722,0.000026300602,0.0000017349902,0.00031500985,0.00001770553,0.9335121,0.000005409505,0.01593929,0.00021546181],"about_ca_topic_score_codex":0.0006792224,"about_ca_topic_score_gemma":0.015051514,"teacher_disagreement_score":0.04057585,"about_ca_system_score_codex":0.00018317185,"about_ca_system_score_gemma":0.0005988348,"threshold_uncertainty_score":0.8399098},"labels":[],"label_agreement":null},{"id":"W4417002254","doi":"10.1158/1538-7445.canevol25-b004","title":"Abstract B004: Mapping loss of heterozygosity in Li-Fraumeni syndrome to uncover early molecular drivers of tumorigenesis","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Loss of heterozygosity; Carcinogenesis; Allele; Germline; Cancer; Germline mutation; Somatic cell; Tumor suppressor gene","score_opus":0.03780029639250727,"score_gpt":0.3689225692814465,"score_spread":0.33112227288893925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527746,0.0010783735,0.0003059044,0.00073400396,0.00016912386,0.0009205273,0.00004244578,0.000018595698,0.0014535579],"genre_scores_gemma":[0.9989951,0.00018408636,0.0001743998,0.00010455707,0.000017161203,0.000107499036,0.0000052063197,0.000029860781,0.00038209607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974994,0.00010644542,0.000470219,0.0004662303,0.00090940023,0.00054831925],"domain_scores_gemma":[0.99852717,0.00009395258,0.000077415236,0.00063832966,0.00047402302,0.00018912269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007239707,0.00016460578,0.00052196253,0.0010866403,0.000043743523,0.000012876853,0.0003156579,0.00015886889,0.0001648112],"category_scores_gemma":[0.00020157782,0.00017588133,0.00015011751,0.0020995159,0.00021334268,0.00006307711,0.00022788518,0.00057450583,0.000023001923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218444,0.00018544354,0.043016214,0.0010102724,0.00021777472,0.00096979475,0.00072593126,0.0013078009,0.9492382,0.00014958778,0.00048512616,0.0021720177],"study_design_scores_gemma":[0.001990598,0.00036725626,0.38413256,0.0025607042,0.000036511166,0.000013508708,0.00019892634,0.000019353773,0.60919845,0.00017264052,0.0011403267,0.00016912918],"about_ca_topic_score_codex":0.005371731,"about_ca_topic_score_gemma":0.00024758876,"teacher_disagreement_score":0.34111637,"about_ca_system_score_codex":0.0009584215,"about_ca_system_score_gemma":0.0009930178,"threshold_uncertainty_score":0.8120486},"labels":[],"label_agreement":null},{"id":"W4417009357","doi":"10.1158/1538-7445.canevol25-b033","title":"Abstract B033: Single-nuclei profiling of LFS development reveals tumour susceptibility","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Embryonic stem cell; Embryogenesis; Germline; Transcriptome; Embryo; Rhabdomyosarcoma; In utero; PAX3; Myocyte","score_opus":0.10525510615763754,"score_gpt":0.412399369737219,"score_spread":0.30714426357958147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822576,0.002525737,0.0001388176,0.0009932389,0.00021787581,0.0011700059,0.000017627282,0.000060857354,0.012618245],"genre_scores_gemma":[0.996365,0.00011805918,0.0015565908,0.00009533997,0.00009791339,0.00015811583,0.00001908875,0.000033955923,0.001555921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972501,0.00011552359,0.00056819204,0.00054345385,0.00089840154,0.0006243759],"domain_scores_gemma":[0.9980287,0.00015800224,0.00008950305,0.00060380995,0.000931584,0.00018842252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018131555,0.00016579691,0.00040674396,0.00041365903,0.00014357515,0.000024705736,0.000249626,0.00016848583,0.00043907875],"category_scores_gemma":[0.00073523493,0.00015790865,0.000106042804,0.0010041705,0.00027009778,0.000053592747,0.00019999608,0.00082445523,0.000046742407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004095802,0.0002461189,0.0076130256,0.0011867635,0.00011234139,0.000038853086,0.00027811958,0.000024280906,0.9728708,0.00022598323,0.0025554257,0.014438667],"study_design_scores_gemma":[0.0011115662,0.00013398858,0.05288462,0.0015150146,0.000025923126,0.0000036745732,0.00023630196,0.000014437758,0.9390908,0.00022156723,0.0046355976,0.00012652169],"about_ca_topic_score_codex":0.00031555325,"about_ca_topic_score_gemma":0.00018661121,"teacher_disagreement_score":0.045271594,"about_ca_system_score_codex":0.0014673212,"about_ca_system_score_gemma":0.002765384,"threshold_uncertainty_score":0.6439328},"labels":[],"label_agreement":null},{"id":"W4417247353","doi":"10.1158/0008-5472.can-25-0149","title":"Comprehensive Multiomics Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"University of Texas MD Anderson Cancer Center; Guangzhou Municipal Science and Technology Bureau; Guangdong Science and Technology Department","keywords":"Perineural invasion; Cervical cancer; Pathological; Cancer; Transcriptome; Cohort","score_opus":0.06607955185145598,"score_gpt":0.40324175626626957,"score_spread":0.3371622044148136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417247353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243546,0.0046165483,0.000024581475,0.0017888343,0.00011539711,0.00078729464,0.000042903386,0.000011421083,0.00017754833],"genre_scores_gemma":[0.99087304,0.008332229,0.000024664096,0.00029749036,0.000038881637,0.00023317809,0.000031094463,0.000012853805,0.00015657648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986652,0.00018214803,0.00024508464,0.0002930482,0.0003381532,0.00027636456],"domain_scores_gemma":[0.9989314,0.0004648846,0.00004292508,0.00017052426,0.00030074437,0.00008948755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001539643,0.0001223417,0.00033253283,0.00035709862,0.000053394324,0.000024904335,0.00009066838,0.000091610265,0.00016353038],"category_scores_gemma":[0.00012569176,0.000102147074,0.000043685493,0.00090812304,0.00019238354,0.000067176254,0.0001003562,0.00027829158,0.0000015085732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013009509,0.00014322335,0.23504065,0.0009190282,0.00012912885,0.000050178634,0.00024670595,0.000028113427,0.7359865,0.00052183034,0.000021605654,0.025612088],"study_design_scores_gemma":[0.0042865914,0.00028533305,0.95256126,0.0009273576,0.000064733744,0.0000024400827,0.00047944643,0.0001484839,0.040098224,0.0004946001,0.0005489241,0.000102580794],"about_ca_topic_score_codex":0.001708714,"about_ca_topic_score_gemma":0.00014671088,"teacher_disagreement_score":0.71752065,"about_ca_system_score_codex":0.0002966871,"about_ca_system_score_gemma":0.0003388107,"threshold_uncertainty_score":0.4165437},"labels":[],"label_agreement":null},{"id":"W6884643746","doi":"10.1158/1538-7445.am2025-6270","title":"Abstract 6270: Al-derived tumor-infiltrating lymphocytes predicts risk of invasive breast cancer recurrence in ductal carcinoma in situ (DCIS)","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Context (archaeology); Tumor-infiltrating lymphocytes; Breast cancer; Stromal cell; Ductal carcinoma; Cancer; Estrogen receptor; Cohort; Tumor microenvironment","score_opus":0.030773230732908854,"score_gpt":0.32954067151581096,"score_spread":0.2987674407829021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6884643746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939011,0.0041904883,0.000008289411,0.00022476686,0.00019612402,0.00036003694,0.00023065756,0.000005650394,0.0008828889],"genre_scores_gemma":[0.9957819,0.0037300964,0.00003742389,0.00008101614,0.000108261294,0.0001584466,0.000032936714,0.000017642187,0.00005229757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981792,0.00017560861,0.00037583977,0.0005019912,0.00027652088,0.00049086014],"domain_scores_gemma":[0.9991382,0.00010807282,0.0000901764,0.0002973414,0.00028555305,0.00008070393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005437364,0.00016734819,0.00024894014,0.0002178335,0.00008076317,0.00002836369,0.0003632223,0.0001316306,0.00003983532],"category_scores_gemma":[0.00027536266,0.00016739573,0.00006647588,0.000527521,0.00026534783,0.0000127836165,0.000120657576,0.00041149594,0.000001457752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003363385,0.00006791683,0.35003144,0.00012685067,0.000022823855,0.00001647069,0.00020442969,0.0003015611,0.64643717,0.000005326394,0.00030369672,0.0021459963],"study_design_scores_gemma":[0.0010442998,0.000059625756,0.40019727,0.00036732396,0.0000053219237,0.0000037052203,0.00024681323,0.000090525326,0.59775907,0.000037153855,0.00007217975,0.00011668138],"about_ca_topic_score_codex":0.017330782,"about_ca_topic_score_gemma":0.023419011,"teacher_disagreement_score":0.050165843,"about_ca_system_score_codex":0.00023565808,"about_ca_system_score_gemma":0.0016786926,"threshold_uncertainty_score":0.99440104},"labels":[],"label_agreement":null},{"id":"W6903621888","doi":"10.1158/1538-7445.am2025-6782","title":"Abstract 6782: ACADS as a novel target of selinexor activity in diffuse large B cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Mitochondrion; Lymphoma; Glycolysis; Cell; Stable isotope labeling by amino acids in cell culture; Cell culture; Extracellular; Diffuse large B-cell lymphoma","score_opus":0.022009568904946833,"score_gpt":0.36040715718148014,"score_spread":0.3383975882765333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6903621888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361545,0.0005925253,0.00016220823,0.00021957232,0.00013518971,0.00016508262,0.000054325417,0.000004689265,0.005050961],"genre_scores_gemma":[0.9973789,0.0003009583,0.00007549873,0.000108578315,0.000117572854,0.000032337823,0.000019256095,0.000013173873,0.001953714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990752,0.000044089134,0.00012486444,0.0002787477,0.00018145915,0.00029565324],"domain_scores_gemma":[0.99949586,0.000021398768,0.00003196206,0.00027268147,0.00013097015,0.000047134086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034444666,0.00008614036,0.000118984775,0.00012180228,0.00005366908,0.000012926225,0.00018396098,0.00017904882,0.0000747757],"category_scores_gemma":[0.00007898931,0.00008021642,0.000049721137,0.0002796343,0.00006874349,0.0000047831422,0.00013482697,0.00018950817,0.000007609419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043589197,0.00057909556,0.002227415,0.000091248396,0.00001908789,0.0000019886893,0.000040426818,0.000009173131,0.99058473,0.00009839797,0.0023368988,0.0035756228],"study_design_scores_gemma":[0.0031085277,0.00009228533,0.04138294,0.00003107698,0.0000035418989,6.097771e-7,0.00007048069,0.000040675448,0.88608915,0.00013165166,0.06896352,0.000085524895],"about_ca_topic_score_codex":0.00053727673,"about_ca_topic_score_gemma":0.00022950019,"teacher_disagreement_score":0.104495585,"about_ca_system_score_codex":0.00005732854,"about_ca_system_score_gemma":0.00033721994,"threshold_uncertainty_score":0.32711306},"labels":[],"label_agreement":null},{"id":"W6922045719","doi":"10.1158/1538-7445.am2025-6453","title":"Abstract 6453: Dual-omic characterization of the immune landscape of pediatric solid tumors revealed putative epigenetic mechanisms of immune evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université Laval","funders":"","keywords":"Immune system; Epigenetics; DNA methylation; Methylation; Immune checkpoint; Gene; Carcinogenesis; Transcription factor; Gene expression","score_opus":0.03207054382274045,"score_gpt":0.374661879833338,"score_spread":0.34259133601059755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6922045719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673104,0.0009601031,0.00004190421,0.0005352937,0.00010104272,0.0011357836,0.00010485436,0.000008262439,0.00038168425],"genre_scores_gemma":[0.997232,0.0014172103,0.00002265803,0.00000930363,0.000039338487,0.000109329485,0.00003879802,0.000020103766,0.0011112109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977224,0.00023841392,0.00059500465,0.00025219304,0.00083985424,0.00035217425],"domain_scores_gemma":[0.9982152,0.00021523419,0.00026531037,0.00046519947,0.0007614185,0.00007766366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072589173,0.00012652237,0.0004441692,0.00051014766,0.00009593163,0.0000073743286,0.00021968168,0.000072134746,0.00023049186],"category_scores_gemma":[0.0003199488,0.00008781155,0.00014857875,0.0012917517,0.00018264502,0.000055053908,0.00019037348,0.00035073448,0.000008187063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008745506,0.0003069363,0.005394148,0.0008753542,0.00013186611,0.000014885012,0.00015578639,0.000015311161,0.9904796,0.0001259261,0.000032443015,0.0015932124],"study_design_scores_gemma":[0.0011435269,0.0002963148,0.4048768,0.0003164971,0.00004075256,0.0000016358085,0.000052837353,0.00003329011,0.5929039,0.00030033867,0.0000034353898,0.000030653886],"about_ca_topic_score_codex":0.00023571405,"about_ca_topic_score_gemma":0.00000804064,"teacher_disagreement_score":0.39948267,"about_ca_system_score_codex":0.00012083948,"about_ca_system_score_gemma":0.00096591207,"threshold_uncertainty_score":0.35808513},"labels":[],"label_agreement":null},{"id":"W6922632988","doi":"10.1158/1538-7445.am2025-7377","title":"Abstract 7377: Intrauterine device use and ovarian cancer risk among 11 case-control studies and 7 prospective cohort studies","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"COVID-19 Impact on Reproduction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prospective cohort study; Ovarian cancer; Logistic regression; Cohort; Odds ratio; Cohort study; Confidence interval; Epidemiology","score_opus":0.12553798832304713,"score_gpt":0.4924160556210618,"score_spread":0.36687806729801464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6922632988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949142,0.041009936,0.000017064494,0.007146718,0.0003069078,0.0021997865,0.000063702915,0.000065966815,0.00004794606],"genre_scores_gemma":[0.94945806,0.047919586,0.00006205245,0.0002700827,0.0004002234,0.0010494866,0.0000011592679,0.000026110161,0.00081324106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776983,0.00018568631,0.00031043205,0.0007974086,0.00043165652,0.00050498074],"domain_scores_gemma":[0.9968772,0.0009982458,0.00008994734,0.00045837215,0.0013945397,0.00018172292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018025218,0.00022915893,0.0005827383,0.00038129516,0.00045742982,0.00010239157,0.00006591365,0.00008652852,0.000042369094],"category_scores_gemma":[0.004280814,0.00018148293,0.000038458977,0.00065765507,0.0008739973,0.0003224363,0.00020811714,0.0006823203,0.0000017567719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006697563,0.00004794234,0.97452116,0.0012154769,0.0028588574,0.0004984946,0.0021732356,0.0000224922,0.0016001405,0.00008245075,0.002089289,0.014220713],"study_design_scores_gemma":[0.0024009722,0.00013987016,0.98936754,0.0007555294,0.00054353656,0.000069186906,0.002678745,0.00004989309,0.001931055,0.00039619385,0.0015158189,0.00015164065],"about_ca_topic_score_codex":0.02935219,"about_ca_topic_score_gemma":0.019954568,"teacher_disagreement_score":0.014846406,"about_ca_system_score_codex":0.0011907347,"about_ca_system_score_gemma":0.00046966525,"threshold_uncertainty_score":0.9979287},"labels":[],"label_agreement":null},{"id":"W6940746723","doi":"10.1158/1538-7445.am2025-4099","title":"Abstract 4099: Leveraging the cell-free DNA hydroxymethylome as a prognostic biomarker in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mycorrhizal Fungi and Plant Interactions","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Lung cancer; Cancer; Small Cell Lung Carcinoma; KEGG; Mutation; Gene; Carcinoma; Survival analysis; Overall survival","score_opus":0.05112284820479999,"score_gpt":0.3349456822814956,"score_spread":0.2838228340766956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6940746723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95603645,0.008404286,0.000001178604,0.0056030774,0.00037317284,0.00066235574,0.00033578157,0.000031058993,0.028552655],"genre_scores_gemma":[0.98830676,0.0032529656,0.0000059173353,0.0003337955,0.00015119447,0.0005133407,0.000061738385,0.0000021367323,0.007372165],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981965,0.00022279064,0.00023495122,0.0004048537,0.00030727967,0.00063366944],"domain_scores_gemma":[0.9959065,0.0036518325,0.000046721092,0.0001574442,0.0001376513,0.000099881756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082955917,0.00015116333,0.00015720924,0.00008360536,0.00041639913,0.00017787058,0.00078913826,0.000105018305,0.0077157095],"category_scores_gemma":[0.00028966423,0.00005753437,0.00008307171,0.0012254134,0.000033336546,0.000091253045,0.0002470879,0.0006940999,0.00015981591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015016353,0.00017076149,0.14410496,0.0001551451,0.000032250613,0.000046688914,0.00033506224,0.00006651319,0.7657001,0.00020575343,0.06495539,0.024077196],"study_design_scores_gemma":[0.00061267975,0.00016762548,0.5229992,0.0018598756,0.00006551539,0.000009844438,0.002045731,0.0019226319,0.1079472,0.0045312583,0.3570409,0.0007974772],"about_ca_topic_score_codex":0.0439069,"about_ca_topic_score_gemma":0.009708449,"teacher_disagreement_score":0.65775293,"about_ca_system_score_codex":0.00018206124,"about_ca_system_score_gemma":0.00015499082,"threshold_uncertainty_score":0.99319136},"labels":[],"label_agreement":null},{"id":"W6941173876","doi":"10.1158/1538-7445.am2025-6623","title":"Abstract 6623: Ultra-deep multi-omics sequencing to identify drivers of glioblastoma recurrence and evolution","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mycorrhizal Fungi and Plant Interactions","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; DNA methylation; Germline; Methylation; Copy-number variation; Somatic evolution in cancer; KRAS; Whole genome sequencing; Deep sequencing","score_opus":0.05711807802117403,"score_gpt":0.37129564567715245,"score_spread":0.31417756765597843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6941173876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968789,0.00063002267,0.00004563134,0.00051091233,0.00022949312,0.00023618016,0.00038604476,0.00001598136,0.001066833],"genre_scores_gemma":[0.99843556,0.0010372126,0.000051769057,0.00003494856,0.00005868669,0.000029223918,0.000026906277,5.363492e-7,0.00032515512],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990973,0.00006281755,0.00015067997,0.00023511314,0.0002058837,0.00024823556],"domain_scores_gemma":[0.9987083,0.00089030573,0.000031860403,0.00005080091,0.00022668407,0.00009201666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036801345,0.000068575384,0.00010350666,0.00006648566,0.00020402671,0.000049307964,0.00019403802,0.000063030806,0.00057694636],"category_scores_gemma":[0.00033398703,0.000033598684,0.000033734166,0.0006512948,0.000027963168,0.00011243566,0.00005581764,0.00024387882,0.00006268646],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007730667,0.000017680683,0.020357918,0.00003141344,0.000009249245,0.000002285531,0.00015123727,0.00004895183,0.9614247,0.0004698836,0.0018949048,0.015514457],"study_design_scores_gemma":[0.00025880203,0.0005215333,0.5545159,0.0016834721,0.000025545358,0.0000143006155,0.0060247155,0.0009982027,0.40896326,0.0020904257,0.024437878,0.0004659815],"about_ca_topic_score_codex":0.005877678,"about_ca_topic_score_gemma":0.0027762777,"teacher_disagreement_score":0.55246145,"about_ca_system_score_codex":0.00016689904,"about_ca_system_score_gemma":0.00004906568,"threshold_uncertainty_score":0.888533},"labels":[],"label_agreement":null},{"id":"W6959419952","doi":"10.1158/1538-7445.am2025-7382","title":"Abstract 7382: Trends in next generation sequencing (NGS) testing by social determinants of health for metastatic cancer patients, 2016-2022","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Plant pathogens and resistance mechanisms","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Cancer; Colorectal cancer; Cohort; Social determinants of health; Incidence (geometry); Health equity; Lung cancer; Health care","score_opus":0.28039362633687487,"score_gpt":0.41285284264020305,"score_spread":0.1324592163033282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6959419952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620897,0.0018110315,0.0000067080714,0.0005148604,0.00012692287,0.00030813194,0.00094319804,0.000008105218,0.00007207796],"genre_scores_gemma":[0.9985158,0.0002968717,0.00006967281,0.000073809555,0.00009555117,0.00025429268,0.0001321479,0.0000014616955,0.0005604234],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853665,0.00013417278,0.0003348083,0.0002766064,0.00028523285,0.0004325238],"domain_scores_gemma":[0.99940175,0.00019646075,0.00012856322,0.00003221236,0.00019827743,0.000042759653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001009925,0.00009169425,0.00023456279,0.00006611424,0.00038104857,0.00004110378,0.0001728884,0.00005133923,0.00011039521],"category_scores_gemma":[0.00007709283,0.00004262832,0.000046668494,0.000810247,0.00004475431,0.00008837674,0.00003946476,0.00013944981,5.166476e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019469788,0.000037058115,0.0026944978,0.000053105665,0.000004567566,5.7359574e-7,0.000053541844,0.0000073340584,0.6384726,0.000017076267,0.0032919152,0.35534826],"study_design_scores_gemma":[0.0030184074,0.0015374582,0.49791718,0.0020521504,0.000047015626,0.0000010975042,0.0033858183,0.0074585937,0.4627315,0.0014103666,0.01937765,0.0010627421],"about_ca_topic_score_codex":0.0062452285,"about_ca_topic_score_gemma":0.02257918,"teacher_disagreement_score":0.4952227,"about_ca_system_score_codex":0.00034365227,"about_ca_system_score_gemma":0.00018728855,"threshold_uncertainty_score":0.9952562},"labels":[],"label_agreement":null},{"id":"W6959855855","doi":"10.1158/1538-7445.am2025-6192","title":"Abstract 6192: Disparities in cancer-causing substance use in trans and gender diverse communities: Canadian population-based data","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Wheat and Barley Genetics and Pathology","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Confidence interval; Odds ratio; Logistic regression; Odds; Imputation (statistics); Harm reduction; Covariate; Behavioral Risk Factor Surveillance System; Mental health; Generalized estimating equation","score_opus":0.34026647664441345,"score_gpt":0.39763394776186456,"score_spread":0.05736747111745111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6959855855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524456,0.0018895465,7.91309e-7,0.0018994435,0.000075341326,0.00017301917,0.0005372512,0.000005148405,0.00017492141],"genre_scores_gemma":[0.9978937,0.0015041669,0.000010209517,0.00023100612,0.000037906808,0.000033917753,0.0002133724,9.126388e-7,0.00007483856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989919,0.00013353549,0.00013846262,0.00021240916,0.00013063522,0.0003930581],"domain_scores_gemma":[0.99943,0.00030669497,0.000012374824,0.0001135804,0.00005485105,0.00008248953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045823786,0.00007778011,0.0001232112,0.00009360768,0.0002558877,0.00009905982,0.00026327555,0.00008452133,0.00022198856],"category_scores_gemma":[0.000016171027,0.00004138057,0.000011954356,0.00046769695,0.0001211606,0.00011562772,0.000050401497,0.00028945436,4.488549e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031040945,0.000018380195,0.98494864,0.000035476467,0.0000038283433,0.000017153992,0.00034399453,0.0002263901,0.004518251,0.000116687,0.00021566967,0.009524493],"study_design_scores_gemma":[0.0001637377,0.0000117970785,0.9966793,0.000110883615,0.0000022625638,1.88529e-7,0.00076898193,0.0003373289,0.00011794284,0.00034973002,0.0013722305,0.00008559814],"about_ca_topic_score_codex":0.93954384,"about_ca_topic_score_gemma":0.9963331,"teacher_disagreement_score":0.05678924,"about_ca_system_score_codex":0.00014862421,"about_ca_system_score_gemma":0.00013913284,"threshold_uncertainty_score":0.24306192},"labels":[],"label_agreement":null},{"id":"W7108455675","doi":"10.1158/1538-7445.canevol25-pr003","title":"Abstract PR003: NADPH-producing enzymes restrict precancer progression in the pancreas","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Pancreas; Downregulation and upregulation; In vivo; Ex vivo; Lipid peroxidation; Metaplasia; Reactive oxygen species","score_opus":0.06227785656330878,"score_gpt":0.44387535288423563,"score_spread":0.3815974963209269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108455675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95724404,0.029776478,0.0000801823,0.0035730225,0.00033184548,0.0011098273,0.000025773834,0.000016572725,0.007842288],"genre_scores_gemma":[0.9935767,0.00303341,0.00026429555,0.0003204963,0.00041602703,0.0010889773,0.000021975018,0.00002230593,0.0012557884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975246,0.00037563665,0.00025871606,0.0006420863,0.00060384726,0.00059507636],"domain_scores_gemma":[0.99870354,0.00009128145,0.00005834584,0.00083692046,0.00024331103,0.00006658781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024255249,0.00015834445,0.0001705247,0.00020019052,0.00020539918,0.000090090354,0.0007642473,0.00014354457,0.000113014314],"category_scores_gemma":[0.00056648534,0.00011509427,0.000065787965,0.0007829909,0.00014947173,0.000009648101,0.00023627555,0.0004895737,0.00000895627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006061217,0.00013784449,0.0038666332,0.00024446286,0.00008099651,0.000019197565,0.0002874065,0.000093256225,0.7818192,0.0012690814,0.06641767,0.14515811],"study_design_scores_gemma":[0.00060895673,0.00013850872,0.019220047,0.0003309849,0.000011177702,0.0000022683328,0.00029016452,0.0000069012426,0.8060475,0.0007055965,0.17247215,0.0001657437],"about_ca_topic_score_codex":0.00072343746,"about_ca_topic_score_gemma":0.0007655481,"teacher_disagreement_score":0.14499237,"about_ca_system_score_codex":0.00013146666,"about_ca_system_score_gemma":0.0008828715,"threshold_uncertainty_score":0.4693408},"labels":[],"label_agreement":null},{"id":"W7108467264","doi":"10.1158/1538-7445.canevol25-ia007","title":"Abstract IA007: Evolutionary cancer epidemiology","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Cancer; Somatic evolution in cancer; Population; Cancer incidence; Epidemiology of cancer; Evolutionary dynamics; Cancer cell; Biological evolution","score_opus":0.08075432706532724,"score_gpt":0.4528611267341087,"score_spread":0.37210679966878146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108467264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84401804,0.12563698,0.00042275182,0.014212664,0.0020133813,0.00059103355,0.0003310075,0.00002511952,0.012748993],"genre_scores_gemma":[0.9679786,0.020769602,0.0001907564,0.0017495069,0.0011762568,0.0005861899,0.00009081427,0.000024735671,0.007433536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843216,0.00011911384,0.00024798934,0.00048556243,0.00014338281,0.00057179213],"domain_scores_gemma":[0.9988195,0.00024839983,0.000043667696,0.00044357264,0.000326813,0.000118102675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079134834,0.00012498924,0.000184127,0.00012765032,0.00020458091,0.000016564041,0.0003505871,0.00019821651,0.0003580547],"category_scores_gemma":[0.00063838635,0.00012414352,0.00008956852,0.0002300165,0.0002854345,0.0000027339615,0.00029086045,0.00030523227,0.00004152909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029881918,0.00007683579,0.03613281,0.00011576543,0.00014988851,0.0000057537895,0.000021305257,0.0011544543,0.2046407,0.0046075676,0.7333427,0.019453375],"study_design_scores_gemma":[0.0005112493,0.00007594332,0.049303234,0.00008410388,0.000011318301,0.0000010212957,0.000045681758,0.000045850233,0.030681128,0.0033282866,0.91573673,0.00017545422],"about_ca_topic_score_codex":0.0019919148,"about_ca_topic_score_gemma":0.00083306036,"teacher_disagreement_score":0.182394,"about_ca_system_score_codex":0.00021290443,"about_ca_system_score_gemma":0.0011996211,"threshold_uncertainty_score":0.5062426},"labels":[],"label_agreement":null},{"id":"W7117476920","doi":"10.1158/0008-5472.can-24-2648","title":"C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Yonsei University College of Medicine; Oncode Institute; KWF Kankerbestrijding; National Research Foundation of Korea; Ministerie van Volksgezondheid, Welzijn en Sport","keywords":"Fibroblast growth factor; Exon; Truncation (statistics); Fibroblast growth factor receptor 3; Fusion gene; Phenotype; Fusion protein; In vivo; Gene; In vitro","score_opus":0.05066013110091243,"score_gpt":0.42309604005284407,"score_spread":0.3724359089519316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117476920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698406,0.0010867646,0.00009958933,0.00033822493,0.000046001514,0.00024405945,0.000017475906,0.0000040455457,0.0011797571],"genre_scores_gemma":[0.9954832,0.00054749846,0.00007783255,0.00003039583,0.000083312705,0.00007627604,0.000022458153,0.000010100628,0.0036688813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879193,0.00015992914,0.00015712378,0.00030792804,0.0002926463,0.0002904382],"domain_scores_gemma":[0.99922734,0.000048307804,0.000027723245,0.00030086588,0.00032102832,0.00007474146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054770743,0.00008004417,0.000113272676,0.00015109393,0.00009753441,0.000019754914,0.0002017729,0.00011138435,0.00006366896],"category_scores_gemma":[0.00019972146,0.00007301164,0.000036155547,0.00026328614,0.00028803936,0.0000045884412,0.000345844,0.00017605236,0.0000034973127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027190833,0.000031707903,0.010736454,0.00013525746,0.000019938345,0.0000018465608,0.00003347117,0.0000025261397,0.97130024,0.00009567229,0.0022904433,0.015080547],"study_design_scores_gemma":[0.000472242,0.00026303413,0.030282943,0.00007420841,0.000005114667,0.0000031129316,0.000038383554,0.000077092984,0.9525468,0.0001379134,0.016025906,0.00007325243],"about_ca_topic_score_codex":0.00021016668,"about_ca_topic_score_gemma":0.00014894553,"teacher_disagreement_score":0.019546488,"about_ca_system_score_codex":0.000050221115,"about_ca_system_score_gemma":0.0003693543,"threshold_uncertainty_score":0.2977328},"labels":[],"label_agreement":null},{"id":"W746076057","doi":"10.1158/1538-7445.am2015-2379","title":"Abstract 2379: The lung microenvironment influences the metastatic behavior of breast cancer cells in an innovative 3D ex vivo pulmonary metastasis model","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Breast cancer; Metastasis; Medicine; CD44; Tumor microenvironment; Lung cancer; Cancer; Cancer stem cell; Cancer research; Metastatic breast cancer; CA15-3; Pathology; Ex vivo; Population; Lung; Internal medicine; In vivo; Biology; Cell","score_opus":0.07242628806049252,"score_gpt":0.38540932104553544,"score_spread":0.31298303298504293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W746076057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820543,0.015665164,0.000025775587,0.00045783052,0.00022060833,0.00070755475,0.00072364724,0.0000034229656,0.00014173242],"genre_scores_gemma":[0.9934398,0.0047358843,0.0001221928,0.00017649737,0.0003391514,0.00082626205,0.000023605826,0.000031477644,0.00030511792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977973,0.0002851168,0.0003518453,0.00044073298,0.0006180687,0.0005069158],"domain_scores_gemma":[0.9986832,0.00003646302,0.00013196841,0.00060663745,0.00040754557,0.00013418698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013891392,0.00019771367,0.00024770037,0.00010967665,0.00011686669,0.00004312561,0.000674734,0.00007874537,0.000102053426],"category_scores_gemma":[0.000026935119,0.00012384496,0.000066559034,0.00049556023,0.0006281076,0.000026026433,0.0002596208,0.0003827064,0.0000030049418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002668402,0.00018821027,0.0020839395,0.000038205504,0.00008414105,0.000003570786,0.0008698886,0.009350491,0.9740488,0.000012203582,0.002662117,0.010391608],"study_design_scores_gemma":[0.001326337,0.0001687483,0.050085846,0.00009398176,0.00016518068,0.000019128556,0.0035795223,0.0016813044,0.9154961,0.00009874554,0.026803972,0.00048112968],"about_ca_topic_score_codex":0.0034904515,"about_ca_topic_score_gemma":0.0010821574,"teacher_disagreement_score":0.058552682,"about_ca_system_score_codex":0.00013668321,"about_ca_system_score_gemma":0.00084363937,"threshold_uncertainty_score":0.5276542},"labels":[],"label_agreement":null},{"id":"W753296469","doi":"10.1158/1538-7445.sabcs14-p1-15-10","title":"Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Population; Breast-conserving surgery; Cancer; Stage (stratigraphy); Oncology; Retrospective cohort study; Cohort; Internal medicine; Dose fractionation; Mastectomy; Biology","score_opus":0.11290243767588402,"score_gpt":0.42925412799615725,"score_spread":0.3163516903202732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W753296469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813671,0.015306518,0.0000482581,0.001524767,0.00011308184,0.0008372254,0.0006698917,0.00000340327,0.00012972075],"genre_scores_gemma":[0.98690325,0.011344489,0.000016030468,0.000038624585,0.00022471166,0.0009910635,0.000037952937,0.000018722923,0.00042518202],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989564,0.000093012844,0.00017974629,0.0002226784,0.00030659113,0.00024157963],"domain_scores_gemma":[0.99900556,0.00012613447,0.00008666977,0.0003219944,0.0004234805,0.000036176545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035039964,0.00011635101,0.00015588141,0.00005841004,0.00008598383,0.000012881275,0.00021174563,0.000071485425,0.00011410704],"category_scores_gemma":[0.00002583109,0.00006694133,0.000072486786,0.00024685226,0.00023184317,0.000008046649,0.00001919812,0.000060153783,8.8375106e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02163158,0.0041507217,0.2578811,0.00041597703,0.0032436645,0.000011822321,0.009805247,0.01619904,0.34159848,0.00030240434,0.022811426,0.32194853],"study_design_scores_gemma":[0.0055300053,0.0010714157,0.7101446,0.00007896578,0.00005460907,0.00000446878,0.0013451482,0.00020863711,0.19386664,0.00004788685,0.08745476,0.00019286973],"about_ca_topic_score_codex":0.008321412,"about_ca_topic_score_gemma":0.0021847475,"teacher_disagreement_score":0.45226347,"about_ca_system_score_codex":0.0002371831,"about_ca_system_score_gemma":0.00038294066,"threshold_uncertainty_score":0.99828225},"labels":[],"label_agreement":null},{"id":"W755048376","doi":"10.1158/1538-7445.sabcs14-p4-01-01","title":"Abstract P4-01-01: Circulating tumor cell (CTC) enumeration and HER2 assessment as predictors of breast cancer outcomes in the ALTTO (BIG 2-06, Alliance N063D) Trial","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lapatinib; Trastuzumab; Breast cancer; Internal medicine; Oncology; Circulating tumor cell; Metastatic breast cancer; Cancer; Clinical endpoint; Stage (stratigraphy); Clinical trial; Metastasis","score_opus":0.12213865768116128,"score_gpt":0.4484369535614017,"score_spread":0.3262982958802404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W755048376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887031,0.0029328982,0.000028405218,0.0042633284,0.00039297526,0.0018195767,0.00010615391,0.000030021012,0.0017235933],"genre_scores_gemma":[0.9967833,0.00045509456,0.00020895142,0.00030636805,0.00091772137,0.00089641917,0.000018367637,0.000051262607,0.0003625185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963953,0.00029813783,0.0005678512,0.0005179885,0.0015900977,0.0006306591],"domain_scores_gemma":[0.99814266,0.00042144218,0.00022392998,0.00050653727,0.00045039022,0.00025501882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018823276,0.00025493564,0.0005384996,0.00017070904,0.00013323697,0.00006654588,0.00029767375,0.00010266365,0.00020105127],"category_scores_gemma":[0.00019852081,0.00018412762,0.00008155842,0.0005256188,0.00033145884,0.0002475587,0.00009144467,0.0008169822,0.000008620643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0329174,0.0017541432,0.7615175,0.0018684227,0.0005888428,0.00031320518,0.014821401,0.002225946,0.1113717,0.0006486604,0.0020716158,0.06990112],"study_design_scores_gemma":[0.05057091,0.0009141768,0.92505014,0.0010562845,0.00008959646,0.000075058095,0.0063462355,0.00023935197,0.007185257,0.00074817496,0.007273272,0.00045154174],"about_ca_topic_score_codex":0.007115058,"about_ca_topic_score_gemma":0.0016135131,"teacher_disagreement_score":0.16353261,"about_ca_system_score_codex":0.00096409826,"about_ca_system_score_gemma":0.0021351469,"threshold_uncertainty_score":0.99949664},"labels":[],"label_agreement":null},{"id":"W761243188","doi":"10.1158/1538-7445.panca2014-b113","title":"Abstract B113: Prevalence of germline BRCA and mismatch repair (MMR) gene mutations in pancreatic cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"MSH6; MSH2; Germline mutation; Pancreatic cancer; MLH1; Medicine; Cancer; CHEK2; Oncology; Germline; MUTYH; Internal medicine; Genetics; Mutation; Biology; DNA mismatch repair; Gene; Colorectal cancer","score_opus":0.05890352744098586,"score_gpt":0.3860166753627664,"score_spread":0.32711314792178053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W761243188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744031,0.024300642,0.000016816624,0.00031429116,0.000090163245,0.00028889035,0.00021359845,0.0000059842023,0.00036650535],"genre_scores_gemma":[0.98459804,0.013829676,0.000297502,0.000057420384,0.00021723796,0.00021925417,0.000030425866,0.000021122549,0.0007293487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877673,0.00005890324,0.00025233434,0.00034774086,0.0002541259,0.00031018417],"domain_scores_gemma":[0.9990128,0.000071925046,0.00006022277,0.00032607757,0.0003657006,0.00016323663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058974215,0.00010446449,0.00016069936,0.00009594028,0.00004420638,0.000017681263,0.0001668822,0.000100414516,0.00006812235],"category_scores_gemma":[0.00032392456,0.00010535779,0.000040470015,0.00020431889,0.00021207478,0.0000055624114,0.00013973551,0.00015732124,0.0000029853911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039903453,0.00017607358,0.19064794,0.00076541817,0.00009452796,0.000024752466,0.0007653557,0.0022174355,0.7885756,0.000101380865,0.011769914,0.004462576],"study_design_scores_gemma":[0.0033924985,0.00064607884,0.37704518,0.0004887381,0.000071573,0.000016482703,0.00061277195,0.000608589,0.59150535,0.0010044741,0.02402412,0.0005841273],"about_ca_topic_score_codex":0.0035547025,"about_ca_topic_score_gemma":0.0021425597,"teacher_disagreement_score":0.19707023,"about_ca_system_score_codex":0.000106392494,"about_ca_system_score_gemma":0.0008119942,"threshold_uncertainty_score":0.53736705},"labels":[],"label_agreement":null},{"id":"W771618049","doi":"","title":"Prolonged G2 arrest and Chk1 overactivation following DNA damage in the absence of DNA-PK activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"DNA damage; CHEK1; Cell cycle checkpoint; G2-M DNA damage checkpoint; DNA repair; DNA; Molecular biology; Cell cycle; Biology; Cell biology; Chemistry; Cancer research; Cell; Biochemistry","score_opus":0.039058989181237874,"score_gpt":0.3718619805283823,"score_spread":0.3328029913471444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W771618049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980382,0.00023467338,0.000027838829,0.00059710717,0.000043915024,0.0003179877,0.000005410222,0.0000036264837,0.00073127914],"genre_scores_gemma":[0.9993214,0.00011092797,0.000074810756,0.00005351083,0.00013256646,0.000104456696,0.0000058877727,0.000010008585,0.00018642966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989502,0.00020124171,0.000091758644,0.00024309788,0.0002882758,0.00022543814],"domain_scores_gemma":[0.99953467,0.000053877422,0.000036119818,0.00028642287,0.000056455912,0.00003244488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009641731,0.00006838278,0.00008336302,0.000052516858,0.00006969332,0.000022093402,0.00019168029,0.000077982746,0.000012206517],"category_scores_gemma":[0.00019443485,0.00005503094,0.000030928364,0.00016852323,0.000073656774,0.0000140136635,0.000105416984,0.00019586582,0.0000015373736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093949275,0.000045406014,0.002710251,0.000018637074,0.00001139783,0.0000028501697,0.00021803424,0.000018924005,0.99272484,0.00004363564,0.00018785348,0.003924221],"study_design_scores_gemma":[0.00031410548,0.000097085445,0.04029221,0.000027957934,0.000001863557,9.754673e-7,0.000111719324,0.00010560093,0.95631534,0.00006992474,0.0026018012,0.00006141102],"about_ca_topic_score_codex":0.00015508886,"about_ca_topic_score_gemma":0.00057290355,"teacher_disagreement_score":0.037581958,"about_ca_system_score_codex":0.00004050279,"about_ca_system_score_gemma":0.00011758698,"threshold_uncertainty_score":0.22440967},"labels":[],"label_agreement":null},{"id":"W840302514","doi":"","title":"Molecular basis for the accelerated senescence response to Adriamycin in MCF-7 breast and HCT-116 tumor cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Senescence; MCF-7; Cancer research; Population; Cyclin-dependent kinase 1; Cell cycle; Biology; Apoptosis; Cell culture; Cancer; Molecular biology; Cancer cell; Cell biology; Medicine; Genetics","score_opus":0.054126750357805384,"score_gpt":0.37929151710475156,"score_spread":0.32516476674694617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W840302514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845436,0.0016775873,0.00015719813,0.011633945,0.000107287626,0.0016140443,0.00012251655,0.000033960783,0.00010984803],"genre_scores_gemma":[0.9965914,0.00020434517,0.00022857527,0.00073418167,0.00021234082,0.0005352947,0.0000070100655,0.000043652635,0.0014431914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744886,0.00030889295,0.0002956105,0.0005498621,0.00061772024,0.0007790756],"domain_scores_gemma":[0.9978654,0.000889469,0.000034988505,0.00050364854,0.00045540562,0.00025109897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017228919,0.00018559939,0.0003016016,0.00038754422,0.00021221454,0.00008631134,0.00027384565,0.00007973472,0.00012730158],"category_scores_gemma":[0.00038128352,0.00013699639,0.00005668398,0.0012884316,0.0002345174,0.00007363759,0.00011612831,0.00040008267,0.000026513782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006206841,0.00010220733,0.0064157126,0.0001251558,0.000017414146,0.00022994244,0.00032713628,0.00009232159,0.97253895,0.00006349709,0.006639461,0.007241356],"study_design_scores_gemma":[0.0030637519,0.00042684082,0.2829939,0.0006428881,0.00003362233,0.000112490736,0.0009568251,0.0008968772,0.68085617,0.000066766006,0.029591443,0.0003584186],"about_ca_topic_score_codex":0.003869248,"about_ca_topic_score_gemma":0.000789189,"teacher_disagreement_score":0.29168278,"about_ca_system_score_codex":0.00029638063,"about_ca_system_score_gemma":0.00061717693,"threshold_uncertainty_score":0.5849171},"labels":[],"label_agreement":null},{"id":"W844282522","doi":"10.1158/1538-7445.sabcs14-p3-07-13","title":"Abstract P3-07-13: Outcomes of women with small, early-stage breast cancer in Manitoba from 1995-2011","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Cancer registry; Cohort; Internal medicine; Radiation therapy; Hormonal therapy; Stage (stratigraphy); Gynecology; Disease; Cumulative incidence","score_opus":0.07337140935439554,"score_gpt":0.34925205622803746,"score_spread":0.2758806468736419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W844282522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527353,0.0022217561,0.0000045921383,0.000686928,0.000114708775,0.00031194248,0.0009110813,0.000010749143,0.00046472283],"genre_scores_gemma":[0.9976317,0.00079613645,0.0000658892,0.00006429795,0.00023825788,0.0006614698,0.00003224246,0.00004504622,0.00046494754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979334,0.000089180954,0.0002357458,0.00052719633,0.0004786721,0.0007358324],"domain_scores_gemma":[0.9987617,0.000043251257,0.00008751683,0.0005009537,0.0003681193,0.00023842779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040412685,0.00022747548,0.0003563882,0.000115500094,0.00006326874,0.000027511227,0.000375464,0.0001296303,0.00036723496],"category_scores_gemma":[0.000028227536,0.0001776156,0.00004463713,0.00018150147,0.0003077835,0.0000125091665,0.00025906277,0.0002524718,0.000037248392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00219335,0.00018093134,0.9731129,0.000044441455,0.00043676083,0.000029827861,0.0011264421,0.00010396356,0.015265513,0.0000072457265,0.0007897727,0.006708891],"study_design_scores_gemma":[0.002101724,0.00018804776,0.9780792,0.000069586036,0.000012777931,0.0000016752219,0.001715512,0.0000010170115,0.015329822,0.0000424137,0.0022543299,0.00020389211],"about_ca_topic_score_codex":0.15271938,"about_ca_topic_score_gemma":0.07491229,"teacher_disagreement_score":0.0778071,"about_ca_system_score_codex":0.00071231707,"about_ca_system_score_gemma":0.0006827898,"threshold_uncertainty_score":0.94196814},"labels":[],"label_agreement":null},{"id":"W857806473","doi":"10.1158/1538-7445.sabcs14-p1-10-05","title":"Abstract P1-10-05: A cost utility analysis from a Chinese health care perspective of Nab-paclitaxel or docetaxel, both as alternatives to solvent-based paclitaxel in metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Oncology; Neutropenia; Febrile neutropenia; Internal medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Cancer","score_opus":0.1695356685572058,"score_gpt":0.5457196015391899,"score_spread":0.37618393298198405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W857806473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96422553,0.014440536,0.000031380565,0.012246675,0.00018991975,0.0024287102,0.005596819,0.000033977227,0.0008064592],"genre_scores_gemma":[0.99571925,0.0006405755,0.0002198866,0.0007209182,0.00026855542,0.0013657083,0.00020223836,0.000047558093,0.00081531756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555117,0.00060951116,0.00065792206,0.0009613548,0.001281131,0.00093892857],"domain_scores_gemma":[0.9961607,0.0005530383,0.00023526602,0.000620506,0.0014363077,0.0009941998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011848762,0.00038648673,0.0013246188,0.001133047,0.00012661998,0.000043863474,0.0003450751,0.000094483665,0.0060445205],"category_scores_gemma":[0.00035861493,0.00028750062,0.0002966282,0.003087103,0.00038592014,0.00016177326,0.00012455555,0.00065712177,0.000029810302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11158526,0.009821244,0.6311408,0.002209283,0.015336447,0.001555896,0.12454091,0.0035814676,0.009797684,0.000125687,0.05507714,0.035228156],"study_design_scores_gemma":[0.03205933,0.0054979497,0.8876006,0.0011920955,0.0017455939,0.00001537775,0.057415325,0.0013812851,0.0055558505,0.00057778903,0.006063075,0.0008957378],"about_ca_topic_score_codex":0.3691267,"about_ca_topic_score_gemma":0.15847886,"teacher_disagreement_score":0.25645977,"about_ca_system_score_codex":0.005451614,"about_ca_system_score_gemma":0.0077681346,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W862841228","doi":"10.1158/1538-7445.panca2014-b119","title":"Abstract B119: Triptolide abrogates expression of the Met and epidermal growth factor receptors in pancreatic cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Triptolide; Pancreatic cancer; Receptor tyrosine kinase; Cancer research; Cancer; Receptor; Epidermal growth factor; Tyrosine kinase; Biology; In vivo; Epidermal growth factor receptor; Growth factor receptor; Medicine; Internal medicine; Apoptosis","score_opus":0.12122080897499708,"score_gpt":0.4328915102445766,"score_spread":0.3116707012695795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W862841228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841784,0.012957298,2.0058346e-7,0.001498992,0.00019051605,0.00055213465,0.000038936872,0.000014970901,0.00056853326],"genre_scores_gemma":[0.9976792,0.0009698032,0.00009213974,0.000052889216,0.000116043986,0.00022660012,0.0000053055574,0.000021335361,0.00083668996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805856,0.00022003202,0.00026292662,0.00028701147,0.00079164177,0.0003798559],"domain_scores_gemma":[0.9986865,0.00029969524,0.000072175775,0.00032072642,0.00033074187,0.00029019197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004604305,0.00014113329,0.0003274915,0.00022202318,0.00006476725,0.000017580833,0.00018621248,0.00008354705,0.0005002826],"category_scores_gemma":[0.00059759105,0.00008219697,0.000063566724,0.0005437851,0.00025730228,0.00010927087,0.00015298811,0.00046849184,0.000004777731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015878503,0.0002436236,0.8626571,0.0004659333,0.00010448672,0.00004556674,0.0014940125,0.000013864852,0.108944945,0.00004626519,0.014912329,0.009483981],"study_design_scores_gemma":[0.0032960135,0.00018479445,0.59007937,0.0013490412,0.000047699752,0.0000052125806,0.0005516517,0.0000133329,0.40230337,0.0006270319,0.0014117014,0.00013077709],"about_ca_topic_score_codex":0.004038598,"about_ca_topic_score_gemma":0.00028199694,"teacher_disagreement_score":0.29335842,"about_ca_system_score_codex":0.00070238736,"about_ca_system_score_gemma":0.0005709368,"threshold_uncertainty_score":0.61051786},"labels":[],"label_agreement":null},{"id":"W866387138","doi":"10.1158/1538-7445.panca2014-a102","title":"Abstract A102: Combination treatment with hypoxia-activated prodrug TH-302 and radiation reduce pancreatic tumor initiating cells and tumor growth in patient-derived xenografts","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pancreatic cancer; Tumor hypoxia; Medicine; Hypoxia (environmental); Radiation therapy; Prodrug; Metastasis; Immunostaining; Cancer research; Combination therapy; Pancreatic tumor; Primary tumor; Tumor progression; Cancer; Internal medicine; Pharmacology; Chemistry; Immunohistochemistry; Oxygen","score_opus":0.0444329143173956,"score_gpt":0.3374101986801193,"score_spread":0.2929772843627237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W866387138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621356,0.002210717,0.0000019155652,0.00017726528,0.00003258274,0.0010016043,0.000051260777,0.00001054494,0.00030056355],"genre_scores_gemma":[0.997858,0.0011748691,0.0000717378,0.000025567873,0.000072184936,0.00061891787,0.000107337444,0.000029814179,0.0000415595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998343,0.0001819092,0.0001823601,0.0004684936,0.0003718256,0.000452431],"domain_scores_gemma":[0.9991688,0.00004755841,0.00007920835,0.00017909758,0.00026887187,0.00025646048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028624386,0.00017793853,0.0001874588,0.00016459476,0.0001289506,0.00009268396,0.00007770266,0.000050641556,0.000008378224],"category_scores_gemma":[0.000105389845,0.00014338721,0.000018834351,0.00026895167,0.00016694741,0.000031038548,0.00007567482,0.00015744632,0.0000027048548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014346195,0.00040183144,0.016739437,0.00008671149,0.00011282627,0.000094598436,0.0009259793,0.00001387188,0.96506095,0.000007411037,0.00022786367,0.014893887],"study_design_scores_gemma":[0.0044191736,0.0029745712,0.02076023,0.00010345008,0.000012797615,0.00001849395,0.0007089683,0.000038168575,0.97029257,0.00007108949,0.00041980416,0.00018067288],"about_ca_topic_score_codex":0.0043929815,"about_ca_topic_score_gemma":0.00069826806,"teacher_disagreement_score":0.014713214,"about_ca_system_score_codex":0.00034078638,"about_ca_system_score_gemma":0.0005106137,"threshold_uncertainty_score":0.66409034},"labels":[],"label_agreement":null},{"id":"W877173793","doi":"10.1158/1538-7445.sabcs14-p1-03-04","title":"Abstract P1-03-04: The impact of Angelina Jolie (AJ)'s story on genetic referral and testing at an academic cancer centre","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Family history; Medicine; Breast cancer; Genetic counseling; Referral; Family medicine; Genetic testing; Cancer; Christian ministry; BRCA mutation; Ovarian cancer; Gynecology; Internal medicine; Genetics","score_opus":0.20807235797125032,"score_gpt":0.47026610485632026,"score_spread":0.2621937468850699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W877173793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452485,0.013440603,0.0000017344107,0.0005890791,0.00013692312,0.00031623157,0.00014124985,0.0000089135865,0.00084042316],"genre_scores_gemma":[0.99671954,0.0015099383,0.00008969884,0.000081145,0.000727883,0.00011381843,0.000026312084,0.00004255826,0.00068908517],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981705,0.00023515944,0.00020313764,0.00045845128,0.0004454772,0.00048727114],"domain_scores_gemma":[0.9985795,0.000089775815,0.00009820035,0.0005208103,0.0004693527,0.00024236394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008402815,0.0001678671,0.00015270142,0.00008574827,0.00020887454,0.000023698454,0.00039454855,0.00020129888,0.000101700476],"category_scores_gemma":[0.00030927995,0.00012322402,0.000053042426,0.00023826672,0.00044977284,0.00000918621,0.00023186656,0.00056683813,0.000010657966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005714958,0.0000582082,0.059619244,0.000056677985,0.0001287879,0.000006553672,0.0013113343,0.009509666,0.82888234,0.0000070241613,0.061564054,0.03828461],"study_design_scores_gemma":[0.002151183,0.0014922111,0.5958746,0.00023848955,0.00004751239,0.0000282492,0.0014709046,0.00066470227,0.36779094,0.00031935834,0.029304352,0.00061751204],"about_ca_topic_score_codex":0.0020218738,"about_ca_topic_score_gemma":0.00087433454,"teacher_disagreement_score":0.53625536,"about_ca_system_score_codex":0.00083464826,"about_ca_system_score_gemma":0.0015187763,"threshold_uncertainty_score":0.50249296},"labels":[],"label_agreement":null},{"id":"W887460205","doi":"10.1158/1538-7445.sabcs14-p4-04-12","title":"Abstract P4-04-12: Both metabolic syndrome and statin use are more common in women with breast inflammation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Internal medicine; Medicine; Metabolic syndrome; Endocrinology; Breast cancer; Adiponectin; Insulin resistance; Inflammation; Cancer; Insulin; Obesity","score_opus":0.09999976224207527,"score_gpt":0.3979784724186584,"score_spread":0.2979787101765832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W887460205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968739,0.00085339067,0.0000017394909,0.0014327285,0.00003444179,0.0005387579,0.00009733572,0.000024119747,0.00014357883],"genre_scores_gemma":[0.9987157,0.00050564454,0.000033381326,0.00005838717,0.000100135985,0.00022681085,0.000015943655,0.000031959957,0.00031204632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982677,0.00006841834,0.00020541916,0.00027468678,0.0007025274,0.00048125055],"domain_scores_gemma":[0.9989779,0.00007572666,0.00006491766,0.00027752022,0.00020610949,0.00039783947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006688271,0.00013221514,0.00034630272,0.00030437118,0.000056235946,0.00008236172,0.00008446585,0.00007067789,0.00012722092],"category_scores_gemma":[0.00005659105,0.00009963653,0.000014137839,0.000411597,0.00019277816,0.0003027228,0.000057793655,0.0005165052,0.000009368553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037678443,0.00011686426,0.9377168,0.00030708947,0.0001048463,0.00056521996,0.0083077345,0.000116300755,0.0024653696,0.00005058088,0.0014384063,0.045042947],"study_design_scores_gemma":[0.0023094313,0.00020532076,0.98947275,0.00032582282,0.0000097843795,0.0000894437,0.0023634576,0.00004218055,0.00031520813,0.000050703744,0.0046996516,0.00011622904],"about_ca_topic_score_codex":0.018730897,"about_ca_topic_score_gemma":0.0065134843,"teacher_disagreement_score":0.05175597,"about_ca_system_score_codex":0.00055038015,"about_ca_system_score_gemma":0.0004992332,"threshold_uncertainty_score":0.98780346},"labels":[],"label_agreement":null},{"id":"W899581155","doi":"10.1158/1538-7445.panca2014-a106","title":"Abstract A106: BRCA mutation sensitizes pancreatic tumors to treatment with cisplatin","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Cisplatin; PARP inhibitor; Medicine; Chemotherapy; BRCA mutation; Pancreatic cancer; In vivo; Cancer research; Internal medicine; Oncology; Cancer; DNA repair; Ovarian cancer; Poly ADP ribose polymerase; Biology; Genetics; DNA","score_opus":0.15412511588980551,"score_gpt":0.4606634936270426,"score_spread":0.30653837773723713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W899581155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735541,0.00042293564,0.000064767046,0.0039406777,0.000041599218,0.001458858,0.000017698803,0.000054187032,0.020445207],"genre_scores_gemma":[0.9881024,0.0001309315,0.0012652295,0.00017232906,0.00033376622,0.0006725413,0.000032487806,0.000040263094,0.009250068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722004,0.00018400978,0.00025845523,0.0004282335,0.0011672812,0.0007419701],"domain_scores_gemma":[0.9973388,0.00042831808,0.00004181406,0.00042698873,0.00087462255,0.00088946876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011245309,0.0001823135,0.00053058064,0.0003644216,0.00016066531,0.000045721976,0.0001086464,0.00009713997,0.0004596863],"category_scores_gemma":[0.00037196165,0.00012391269,0.000045468027,0.0006586276,0.00026009092,0.00007599653,0.0000485508,0.00030740388,0.00049176347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024346432,0.0019249045,0.6983477,0.00088402623,0.0016256839,0.011036006,0.019898752,0.00041499865,0.06559462,0.0006914727,0.044750955,0.13048448],"study_design_scores_gemma":[0.02997129,0.036934126,0.8211517,0.0026779163,0.0006875524,0.0013203628,0.015656266,0.0020477406,0.05436285,0.0010893397,0.032980006,0.0011208744],"about_ca_topic_score_codex":0.004060294,"about_ca_topic_score_gemma":0.00080572115,"teacher_disagreement_score":0.12936361,"about_ca_system_score_codex":0.0014648284,"about_ca_system_score_gemma":0.0027980146,"threshold_uncertainty_score":0.6320789},"labels":[],"label_agreement":null},{"id":"W899967719","doi":"10.1158/1538-7445.sabcs14-p6-08-40","title":"Abstract P6-08-40: Survival of metastatic hormone receptor (HR) positive/HER2 negative; HER2+; and triple negative (TN) breast cancer based on initial presentation","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Metastatic breast cancer; Trastuzumab; Oncology; Cohort; Cancer; Biomarker; Hazard ratio; Confidence interval","score_opus":0.10831332894221743,"score_gpt":0.43870156604621263,"score_spread":0.33038823710399523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W899967719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98524326,0.0021194366,0.0003447869,0.005983413,0.00042284516,0.002189242,0.0017829847,0.00006996557,0.001844064],"genre_scores_gemma":[0.9966644,0.00039915094,0.00080102606,0.00021581585,0.000555638,0.0006096775,0.000080493875,0.00009104041,0.00058274466],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99590844,0.00056427426,0.00048601703,0.0006543937,0.0016844504,0.00070243335],"domain_scores_gemma":[0.9960924,0.00092309806,0.00024171399,0.00041144234,0.0017971974,0.0005341542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011115462,0.0003399308,0.00068286783,0.0004186509,0.0001664257,0.00005216969,0.00021062445,0.00011465615,0.00092301134],"category_scores_gemma":[0.00049346435,0.0002959651,0.00010003801,0.0009350609,0.00089806865,0.000417592,0.00008560922,0.0007767023,0.000031630818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20899688,0.0034868827,0.016441114,0.0019521393,0.0033165128,0.00037396714,0.030569823,0.004279064,0.32574022,0.00050654734,0.013637101,0.39069974],"study_design_scores_gemma":[0.045142114,0.0049005304,0.6599584,0.0023300252,0.00035760665,0.00005733978,0.011615815,0.0021151328,0.2673101,0.0027383324,0.0022997872,0.0011747527],"about_ca_topic_score_codex":0.010750412,"about_ca_topic_score_gemma":0.00074309873,"teacher_disagreement_score":0.6435173,"about_ca_system_score_codex":0.0010186047,"about_ca_system_score_gemma":0.001678551,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W909604369","doi":"","title":"Fibrin(ogen) stimulates breast, ovarian, and prostate cancer cell line invasiveness on the chick chorioallantoic membrane","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Angiogenesis; Chorioallantoic membrane; Ovarian cancer; Pathology; Cancer cell; Metastasis; Fibrin; Cancer; Vasculogenic mimicry; Cancer research; Prostate cancer; Biology; Cell culture; Chemistry; Medicine; Immunology; Internal medicine","score_opus":0.04253029947951989,"score_gpt":0.35718669705697637,"score_spread":0.31465639757745645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W909604369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845816,0.0048927534,0.000009576389,0.0046851113,0.00011040488,0.0008748029,0.0003226909,0.000014948653,0.0006315528],"genre_scores_gemma":[0.98543394,0.01038731,0.00001837755,0.00018161316,0.0005351797,0.00036414593,0.00007523183,0.00006152531,0.0029426683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734306,0.00025752076,0.00020457014,0.00068588514,0.0006795918,0.000829365],"domain_scores_gemma":[0.99849194,0.00010986387,0.00004800048,0.000642523,0.0004560726,0.0002515791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721161,0.000238952,0.00020396514,0.00008729108,0.00031113563,0.0001375742,0.0005422414,0.00018167109,0.00041386773],"category_scores_gemma":[0.00012252649,0.00016909081,0.00006452497,0.0003309776,0.00039622083,0.000012871986,0.0004520487,0.0005278179,0.00004152684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007449921,0.000097421995,0.0029596775,0.00015278904,0.00008822163,0.000019999898,0.0001857978,0.0017076368,0.99033,0.00010540021,0.0010133926,0.0025947017],"study_design_scores_gemma":[0.0014539404,0.00044335923,0.0046454784,0.00014038703,0.000008870325,0.000017604745,0.00012553555,0.00003748547,0.9808752,0.00016701777,0.011833664,0.00025144717],"about_ca_topic_score_codex":0.0059908624,"about_ca_topic_score_gemma":0.0021927073,"teacher_disagreement_score":0.010820271,"about_ca_system_score_codex":0.00021737762,"about_ca_system_score_gemma":0.000978325,"threshold_uncertainty_score":0.90564317},"labels":[],"label_agreement":null},{"id":"W932773846","doi":"10.1158/1538-7445.sabcs14-p5-10-06","title":"Abstract P5-10-06: Risk of recurrence estimates with IHC4 are tolerant of variations in staining and scoring","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunohistochemistry; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.0732847647193188,"score_gpt":0.37923963459439086,"score_spread":0.30595486987507203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W932773846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573964,0.0034208517,0.00022631584,0.00005442936,0.000024901783,0.00012975495,0.00010388904,0.0000013932492,0.0002988244],"genre_scores_gemma":[0.9977972,0.0014731587,0.00059402577,0.0000042187335,0.000048804188,0.000034139754,0.000013690689,0.000009270656,0.000025477651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992834,0.000030191468,0.0001520205,0.0001880149,0.00016687921,0.00017954488],"domain_scores_gemma":[0.99921393,0.000090587375,0.000091077614,0.00017993068,0.0003500591,0.00007438673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000531163,0.00006282722,0.00012463686,0.000074910444,0.00003226365,0.000014288661,0.00010294777,0.00004633824,0.000008828862],"category_scores_gemma":[0.00049793697,0.000056745877,0.000012779914,0.00015384713,0.0001288888,0.0000042747456,0.00009331794,0.00011864045,5.1341823e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008970304,0.00017226256,0.82597506,0.00033770897,0.00010701923,0.000013290796,0.0014299299,0.014908499,0.1428788,0.00040440628,0.0014107272,0.011465254],"study_design_scores_gemma":[0.0041572135,0.0015741439,0.5219672,0.0013443663,0.000049238835,0.0000068606932,0.0030023013,0.0027512014,0.45838198,0.0014196803,0.004830095,0.00051577366],"about_ca_topic_score_codex":0.0015337064,"about_ca_topic_score_gemma":0.0010604743,"teacher_disagreement_score":0.31550318,"about_ca_system_score_codex":0.00003791304,"about_ca_system_score_gemma":0.0004383991,"threshold_uncertainty_score":0.23185156},"labels":[],"label_agreement":null},{"id":"W951540943","doi":"10.1158/1538-7445.sabcs14-p1-09-29","title":"Abstract P1-09-29: A new model of care for breast cancer survivorship","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Psychosocial; Survivorship curve; Breast cancer; Cancer; Oncology; Disease; Adjuvant therapy; Family medicine; Health care; Adjuvant; Internal medicine; Gynecology; Psychiatry","score_opus":0.33005454113380644,"score_gpt":0.5245493284618102,"score_spread":0.1944947873280038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W951540943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96658266,0.014975425,0.000050488525,0.0077142213,0.00049187447,0.0016912504,0.0012408717,0.000044408003,0.007208779],"genre_scores_gemma":[0.98876095,0.00090968364,0.00014557716,0.00013391572,0.0009667697,0.00059611915,0.000039649054,0.00004313496,0.008404216],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983526,0.000042338135,0.00021304771,0.00031965267,0.0005380592,0.0005343304],"domain_scores_gemma":[0.9980663,0.00013258065,0.000054746353,0.00026001906,0.00097424584,0.0005121026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040042892,0.00014274324,0.0003690035,0.00018076303,0.00006910414,0.000013103764,0.00017180103,0.000119665674,0.0009455376],"category_scores_gemma":[0.000038185357,0.00012024499,0.00011271328,0.00029825312,0.00014716262,0.00007234218,0.000054208424,0.00031246402,0.000015127909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034658507,0.0010000073,0.07892382,0.00466905,0.0011805273,0.00006182288,0.018993407,0.00531272,0.14192393,0.0009137071,0.47884822,0.23351426],"study_design_scores_gemma":[0.11925009,0.009219679,0.12874562,0.004581052,0.002397785,0.00010919894,0.013281914,0.011840711,0.4323461,0.008736286,0.26674873,0.0027428274],"about_ca_topic_score_codex":0.029890835,"about_ca_topic_score_gemma":0.012758173,"teacher_disagreement_score":0.2904222,"about_ca_system_score_codex":0.00084442925,"about_ca_system_score_gemma":0.00419946,"threshold_uncertainty_score":0.99996775},"labels":[],"label_agreement":null},{"id":"W964189940","doi":"","title":"An aglycon ginsenoside induces apoptosis and blocks p-glycoprotein in multidrug resistance cancer cells","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytotoxicity; Apoptosis; Pharmacology; Ginsenoside; Ginseng; P-glycoprotein; Programmed cell death; Protopanaxadiol; Cancer cell; Cancer; Chemistry; Cancer research; Multiple drug resistance; Biology; Medicine; Biochemistry; In vitro; Internal medicine; Pathology","score_opus":0.03607817591176915,"score_gpt":0.3776099489971796,"score_spread":0.34153177308541044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W964189940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954007,0.002382683,0.000040869614,0.0013506779,0.00003826468,0.00051734876,0.000048113183,0.000012354466,0.0002089486],"genre_scores_gemma":[0.9953488,0.0026863168,0.0003245036,0.00016294292,0.0001777469,0.0008418896,0.000020099773,0.000018085508,0.00041958454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985866,0.00012362598,0.00015118741,0.0005470452,0.00017530186,0.00041625736],"domain_scores_gemma":[0.9993519,0.000028751743,0.000034694713,0.00032913647,0.000105753206,0.00014974175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003885395,0.00013317318,0.00014026971,0.000072677634,0.00016386693,0.00004810961,0.00024202863,0.00017575866,0.00002955032],"category_scores_gemma":[0.000047814377,0.00011217152,0.000027335263,0.00025417784,0.00026723457,0.000006686853,0.0000957162,0.00029478665,0.000004156227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008548265,0.000082916755,0.00034258832,0.000025956919,0.000009246103,0.000002620467,0.00008770724,0.0002651437,0.9960352,0.00014190708,0.00028698845,0.0026342373],"study_design_scores_gemma":[0.00062624953,0.00014480097,0.0025189733,0.00006892111,0.0000026937546,5.796432e-7,0.000091893504,0.000008713907,0.9876108,0.00030981592,0.008456338,0.00016021384],"about_ca_topic_score_codex":0.0031535297,"about_ca_topic_score_gemma":0.0031636993,"teacher_disagreement_score":0.0084243985,"about_ca_system_score_codex":0.00008264767,"about_ca_system_score_gemma":0.00017700208,"threshold_uncertainty_score":0.47672147},"labels":[],"label_agreement":null},{"id":"W978701329","doi":"10.1158/1538-7445.sabcs14-p2-05-05","title":"Abstract P2-05-05: A four gene signature predicts anthracycline benefit: Evidence from the BR9601 and MA5 breast cancer trials","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Hamilton Health Sciences; University of Toronto; Sunnybrook Health Science Centre; Occupational Cancer Research Centre","funders":"","keywords":"Anthracycline; Internal medicine; Breast cancer; Oncology; Pathological; Proportional hazards model; Medicine; Univariate analysis; Cancer; Multivariate analysis","score_opus":0.15018549473711842,"score_gpt":0.4181100113806469,"score_spread":0.26792451664352845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W978701329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89075774,0.09584901,0.000047838552,0.009162183,0.0006508535,0.00062230136,0.0028364789,0.0000113290025,0.000062241845],"genre_scores_gemma":[0.9292602,0.065398686,0.0001072886,0.0007080094,0.0037971784,0.00025979758,0.00010712096,0.000046025794,0.00031570086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975284,0.0002146815,0.00039580688,0.00068282895,0.00059933163,0.00057897647],"domain_scores_gemma":[0.99742526,0.00069064,0.00014877463,0.0006692386,0.0006843131,0.00038180448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023057375,0.00023654131,0.00035560207,0.00005403148,0.00022011368,0.00018049416,0.000571675,0.00027722804,0.00019361805],"category_scores_gemma":[0.0016272265,0.00016992827,0.00010275584,0.0002116909,0.00031072047,0.000016215115,0.0004675577,0.0004861304,0.000009693236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017527037,0.00007683142,0.0102856355,0.00004712625,0.00025233973,0.00005040735,0.00033793968,0.0008210194,0.7587167,0.000020433572,0.18292224,0.04471665],"study_design_scores_gemma":[0.0075384765,0.00097572,0.21579207,0.0012360724,0.0002825796,0.00011003646,0.0007851615,0.00047574882,0.5623827,0.0023276,0.20681587,0.00127796],"about_ca_topic_score_codex":0.007475682,"about_ca_topic_score_gemma":0.004318474,"teacher_disagreement_score":0.20550643,"about_ca_system_score_codex":0.00014593118,"about_ca_system_score_gemma":0.0011013856,"threshold_uncertainty_score":0.99913365},"labels":[],"label_agreement":null},{"id":"W981418970","doi":"10.1158/1538-7445.sabcs14-p2-14-02","title":"Abstract P2-14-02: Complications of breast reconstruction in a provincial population of breast cancer survivors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Breast reconstruction; Population; Cohort; Cancer; Surgery; General surgery; Internal medicine","score_opus":0.09571173435450066,"score_gpt":0.39788451743770487,"score_spread":0.3021727830832042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W981418970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964382,0.00019098789,0.0000081225035,0.000984104,0.00038790362,0.0005779665,0.00047487213,0.000019111892,0.0009187414],"genre_scores_gemma":[0.9992684,0.000057924855,0.000082903185,0.0000043065606,0.00030696407,0.00010118738,0.000061698665,0.000017439315,0.00009918738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834734,0.00009989312,0.00046336316,0.0002506,0.0005511797,0.00028760184],"domain_scores_gemma":[0.9983806,0.00005421015,0.0001792379,0.00023037526,0.0009875434,0.00016802126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000719089,0.000106640655,0.0003117104,0.0005130475,0.000055074557,0.000009636978,0.00010240415,0.00014436452,0.00020139929],"category_scores_gemma":[0.000030721923,0.00009514474,0.000058196743,0.0007186383,0.00028377483,0.00017524464,0.000034419056,0.00037834514,0.0000069466623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009228246,0.00014829818,0.61272025,0.0002978126,0.00003896894,0.000002317595,0.00028671368,0.000053604443,0.012873454,0.00017782,0.00016605799,0.3723119],"study_design_scores_gemma":[0.0012363808,0.000046442863,0.9923487,0.00058723707,0.000019025489,0.003231252,0.0004363307,0.00012379914,0.0015818387,0.0002729713,0.000028060369,0.000087977096],"about_ca_topic_score_codex":0.079845734,"about_ca_topic_score_gemma":0.022952307,"teacher_disagreement_score":0.37962845,"about_ca_system_score_codex":0.0004903884,"about_ca_system_score_gemma":0.0009171703,"threshold_uncertainty_score":0.99487627},"labels":[],"label_agreement":null},{"id":"W982817032","doi":"10.1158/1538-7445.sabcs14-s1-02","title":"Abstract S1-02: Prognostic effects of gene mutation in estrogen receptor positive breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Oncology; Exome; Massive parallel sequencing; Exome sequencing; Cancer; Estrogen receptor; Tamoxifen; Internal medicine; DNA sequencing; Biology; Genetics; Medicine; Gene; Mutation","score_opus":0.026000722664474257,"score_gpt":0.3542061104490886,"score_spread":0.3282053877846144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W982817032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919655,0.006333285,0.000033323522,0.0003002349,0.00023614224,0.0005602029,0.00035756847,0.0000042986803,0.00020948144],"genre_scores_gemma":[0.99737453,0.0013877531,0.00012624699,0.000054817476,0.00040897785,0.00036915074,0.00016701475,0.000029564786,0.00008194101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868053,0.000084083265,0.00020473731,0.0003401086,0.00031388618,0.00037667737],"domain_scores_gemma":[0.9988708,0.00010385688,0.000068738766,0.00022927596,0.00055289647,0.00017442851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003319668,0.00012232426,0.00016173779,0.000110671484,0.000037878137,0.000024205867,0.00019732102,0.00012623782,0.000051198575],"category_scores_gemma":[0.0003161319,0.00012360344,0.000046901372,0.00025259223,0.00013799976,0.000006421067,0.00009253755,0.0001785405,0.000019308964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005418938,0.0001579742,0.027012207,0.00014078453,0.000069695045,0.000028138244,0.00031653448,0.00089387293,0.95271397,0.000057416088,0.0056900852,0.012377458],"study_design_scores_gemma":[0.0013228462,0.00035877276,0.060493257,0.00017671194,0.000014136774,0.000007877512,0.00012881035,0.000029555784,0.93578714,0.000101504585,0.0013992542,0.00018011192],"about_ca_topic_score_codex":0.003164129,"about_ca_topic_score_gemma":0.0007131658,"teacher_disagreement_score":0.033481047,"about_ca_system_score_codex":0.00023638812,"about_ca_system_score_gemma":0.0010259291,"threshold_uncertainty_score":0.50404024},"labels":[],"label_agreement":null}]}